Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" A1BG ENSG00000121410 "Alpha-1-B glycoprotein" P04217 19 58345178-58353499 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 180 "liver: 299.6" "Cell line enhanced" "Detected in some" "HEK 293: 5.0;Hep G2: 4.8;REH: 6.4;U-266/70: 4.8" "Cancer enriched" "Detected in single" 85 "liver cancer: 22.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB016673, HPA044252" Supported "Secreted to blood" 200000000000 49000000000 "CAB016673: AB_1611892, HPA044252: " "unprognostic (9.95e-2)" "unprognostic (5.31e-2)" "unprognostic (3.67e-2)" "unprognostic (3.44e-2)" "unprognostic (1.18e-1)" "unprognostic (1.66e-2)" "prognostic favourable (3.97e-4)" "unprognostic (1.09e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-1)" "unprognostic (1.47e-2)" "unprognostic (1.37e-2)" "unprognostic (4.19e-5)" "unprognostic (2.37e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (6.72e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 299.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.1 0.0 1.0 0.7 0.0 0.7 0.1 1.3 0.0 0.3 0.6 1.9 0.0 0.0 0.0 0.2 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.9 5.0 2.6 0.0 4.8 0.0 1.0 0.4 0.2 0.4 0.0 0.0 0.0 0.8 0.0 0.0 1.8 0.9 1.6 0.3 0.4 6.4 3.1 1.3 0.0 0.0 0.0 0.4 0.7 0.2 0.8 1.0 1.1 0.0 1.8 0.3 0.0 0.0 4.8 2.1 1.6 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.4 0.5 0.5 0.6 0.0 0.3 0.0 0.0 0.0 1.6 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AADAT "KAT2, KATII, KYAT2" ENSG00000109576 "Aminoadipate aminotransferase" Q8N5Z0 4 170060222-170091699 "Enzymes, Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 56.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA037502 Enhanced Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA037502: AB_10671759" "unprognostic (1.90e-1)" "unprognostic (1.82e-2)" "prognostic favourable (5.59e-4)" "unprognostic (4.21e-2)" "unprognostic (1.30e-1)" "unprognostic (1.06e-1)" "unprognostic (7.41e-2)" "unprognostic (1.03e-2)" "unprognostic (2.97e-2)" "unprognostic (3.38e-2)" "unprognostic (1.23e-2)" "unprognostic (3.55e-1)" "unprognostic (1.35e-1)" "unprognostic (1.23e-2)" "unprognostic (1.39e-1)" "unprognostic (7.28e-3)" "unprognostic (1.17e-2)" 3.0 3.1 9.2 2.2 9.0 0.9 4.7 0.8 10.8 8.3 4.7 10.3 2.9 1.9 9.7 5.8 2.8 5.7 3.9 2.8 7.2 6.4 6.3 56.5 4.7 1.1 8.2 8.0 4.7 4.6 7.6 8.9 2.2 6.0 13.3 5.0 6.6 1.7 5.4 3.6 1.8 2.0 7.0 7.0 2.0 3.2 7.2 9.2 0.9 7.0 1.2 1.3 5.5 4.9 0.4 0.4 0.0 0.7 0.0 0.7 0.0 2.1 5.4 16.4 0.0 3.2 12.8 5.9 5.6 2.7 3.2 3.3 5.2 0.6 0.0 0.9 6.2 1.9 7.3 2.6 2.3 0.0 6.3 0.0 6.1 8.8 2.6 0.0 2.4 5.2 1.6 2.6 3.4 3.0 0.9 0.1 12.3 5.5 2.6 0.1 12.4 4.9 0.0 5.1 0.0 2.9 9.8 13.2 15.5 4.4 1.1 5.4 0.0 1.0 2.0 8.3 8.9 9.3 8.7 0.0 0.0 0.0 8.3 0.0 9.7 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.3 0.3 0.4 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.7 0.0 9.2 9.0 0.8 10.8 7.2 6.4 8.2 8.0 6.0 9.2 AAK1 "DKFZp686K16132, KIAA1048" ENSG00000115977 "AP2 associated kinase 1" Q2M2I8 2 69457997-69674349 "Enzymes, Predicted intracellular proteins" Endocytosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 109.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017931, HPA020289" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA017931: AB_1844406, HPA020289: AB_1844407" "unprognostic (2.11e-3)" "unprognostic (3.18e-2)" "unprognostic (3.67e-1)" "unprognostic (1.01e-3)" "unprognostic (5.06e-2)" "unprognostic (4.04e-2)" "unprognostic (4.23e-2)" "unprognostic (1.14e-1)" "unprognostic (3.52e-1)" "prognostic unfavourable (3.19e-4)" "unprognostic (1.24e-1)" "unprognostic (7.65e-2)" "unprognostic (4.18e-2)" "unprognostic (1.30e-1)" "unprognostic (5.40e-2)" "unprognostic (6.76e-3)" "unprognostic (1.18e-1)" 5.1 5.9 11.0 5.7 11.9 7.8 6.9 25.2 26.5 4.8 4.2 3.9 6.3 3.8 4.7 7.1 3.8 4.9 4.3 7.9 14.4 12.8 7.2 3.1 7.5 6.8 9.4 11.6 3.3 6.7 109.7 10.3 6.9 10.2 5.0 4.6 4.7 3.6 12.3 6.8 3.7 3.7 5.4 9.3 5.5 5.4 4.1 6.9 4.7 16.0 2.1 5.3 4.9 5.8 1.0 0.8 4.1 3.9 2.8 5.6 1.3 16.5 9.9 9.1 8.8 8.7 9.7 29.3 13.5 10.7 8.2 7.2 10.0 6.6 0.5 3.3 17.5 7.7 7.0 7.0 16.7 12.3 2.9 9.0 6.0 6.8 7.9 6.3 21.4 8.3 6.2 15.4 19.9 17.3 1.9 9.3 14.2 2.8 5.8 3.3 4.4 5.5 3.9 9.9 1.4 6.4 34.7 3.0 4.8 7.8 6.0 7.0 3.5 8.9 17.2 18.3 12.3 13.1 13.2 9.2 2.4 1.0 15.3 10.7 12.5 2.5 1.4 0.6 4.5 0.6 4.2 0.4 4.0 3.0 0.8 1.0 5.6 4.5 4.1 2.8 3.9 0.7 3.1 1.3 11.0 11.9 25.2 26.5 14.4 12.8 9.4 11.6 10.2 6.9 ABCA2 ABC2 ENSG00000107331 "ATP binding cassette subfamily A member 2" Q9BZC7 9 137007227-137028922 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 84.3" "Cell line enhanced" "Detected in many" "T-47d: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "dendritic cells: 2.7;NK-cells: 1.2;T-cells: 2.2" "Low region specificity" "Detected in all" HPA042886 Approved "HPA042886: " "unprognostic (1.01e-2)" "unprognostic (9.21e-3)" "unprognostic (9.59e-2)" "unprognostic (6.15e-2)" "unprognostic (1.02e-1)" "unprognostic (8.08e-2)" "unprognostic (2.20e-2)" "unprognostic (1.13e-2)" "unprognostic (5.61e-3)" "unprognostic (1.76e-1)" "unprognostic (2.93e-2)" "unprognostic (2.74e-2)" "unprognostic (6.78e-3)" "unprognostic (3.14e-3)" "unprognostic (1.37e-1)" "unprognostic (2.80e-1)" "unprognostic (1.36e-1)" 7.8 6.1 20.0 3.9 42.4 5.7 2.6 16.7 54.2 4.0 4.5 84.3 0.9 3.2 2.8 4.7 3.5 6.3 5.7 7.1 32.2 17.6 4.8 3.8 4.1 4.1 57.5 21.9 2.5 8.6 8.1 7.8 3.3 31.1 5.2 2.5 3.8 8.0 5.1 5.7 6.3 4.1 2.7 70.5 8.3 6.1 3.0 47.7 0.2 9.5 0.1 2.2 3.3 1.8 0.4 2.7 0.4 0.3 1.2 2.2 1.1 4.3 4.8 2.4 9.5 6.0 6.4 4.1 4.8 1.9 2.2 0.8 1.4 5.3 0.2 13.8 5.2 7.4 1.5 3.6 0.4 3.2 3.0 0.4 13.7 1.7 2.9 6.8 7.6 2.7 3.3 1.5 0.4 1.2 1.1 0.8 2.7 13.0 0.0 14.7 1.2 4.8 6.7 2.4 6.4 1.5 1.0 9.1 10.5 5.2 10.2 3.7 34.6 8.9 6.2 6.0 3.3 8.5 2.0 0.1 0.1 0.0 10.1 1.3 3.0 0.0 0.3 0.0 2.2 0.2 1.3 0.4 0.2 0.7 0.3 0.2 0.0 0.9 0.4 1.2 0.0 2.7 1.0 1.1 20.0 42.4 16.7 30.7 32.2 17.6 57.5 21.9 31.1 47.7 ABCA4 "ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1" ENSG00000198691 "ATP binding cassette subfamily A member 4" P78363 1 93992835-94121132 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" "Age-related macular degeneration, Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 142.7" "Cell line enhanced" "Detected in some" "BEWO: 5.0;EFO-21: 11.2;HeLa: 3.5;SK-BR-3: 4.2" "Cancer enhanced" "Detected in many" "lung cancer: 3.1" "Region enriched" "Detected in some" 13 "pons and medulla: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA078826 Enhanced "HPA078826: " "unprognostic (1.25e-1)" "unprognostic (3.93e-1)" "unprognostic (3.29e-2)" "unprognostic (7.17e-4)" "unprognostic (1.28e-1)" "unprognostic (3.00e-1)" "unprognostic (1.38e-2)" "prognostic favourable (2.45e-4)" "unprognostic (3.77e-2)" "unprognostic (5.25e-1)" "unprognostic (3.70e-1)" "unprognostic (5.18e-2)" "unprognostic (1.17e-9)" "unprognostic (1.61e-2)" "unprognostic (1.55e-1)" "unprognostic (2.47e-1)" "prognostic unfavourable (2.72e-4)" 0.7 0.0 0.3 0.2 0.4 0.0 1.1 0.2 0.9 0.7 0.2 3.2 0.2 3.7 0.2 12.9 0.2 0.6 0.2 0.2 2.0 0.2 6.7 1.2 0.4 0.3 0.3 0.2 0.3 0.2 0.0 0.2 0.8 25.5 0.3 0.0 142.7 0.2 2.1 0.2 3.5 4.2 0.2 0.2 0.2 0.1 2.1 0.2 0.2 0.7 0.2 0.2 0.3 0.2 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 5.0 0.2 0.3 0.0 0.2 0.1 0.0 0.0 11.2 0.5 1.1 0.0 0.0 0.1 0.0 0.0 0.7 3.5 1.2 0.6 0.0 0.0 0.5 0.0 0.5 0.0 1.0 0.0 0.2 0.0 1.4 0.5 0.0 2.0 0.0 0.2 0.4 0.3 0.5 0.5 0.0 0.0 1.0 4.2 0.2 0.4 0.0 0.2 0.3 2.2 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.9 2.0 0.2 0.3 0.2 25.5 0.2 ABCB11 "ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP" ENSG00000073734 "ATP binding cassette subfamily B member 11" O95342 2 168922938-169031322 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "liver: 47.4" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.0;NB-4: 1.6;PC-3: 1.0;THP-1: 2.5;TIME: 1.8;U-2197: 2.8" "Cancer enriched" "Detected in single" 87 "liver cancer: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA019035 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA019035: AB_1844429" "unprognostic (7.78e-2)" "unprognostic (3.92e-1)" "unprognostic (8.31e-2)" "unprognostic (2.56e-1)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "unprognostic (1.00e-2)" "unprognostic (9.71e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (5.64e-3)" "unprognostic (3.71e-1)" "unprognostic (5.26e-6)" "unprognostic (7.12e-2)" "unprognostic (1.82e-1)" "unprognostic (1.94e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 1.6 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 ABCB4 "GBD1, MDR2, MDR3, PFIC-3, PGY3" ENSG00000005471 "ATP binding cassette subfamily B member 4" P21439 7 87401697-87480435 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 93.2" "Group enriched" "Detected in some" 5 "SH-SY5Y: 11.7;WM-115: 22.3" "Cancer enriched" "Detected in some" 11 "liver cancer: 16.3" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "memory B-cell: 4.9;naive B-cell: 11.4" "Lineage enriched" "Detected in many" 8 "B-cells: 11.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA049395, HPA053288" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" "Nucleoplasm, Plasma membrane, Actin filaments" "Focal adhesion sites" "HPA049395: , HPA053288: " "unprognostic (7.92e-2)" "unprognostic (8.87e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (8.95e-2)" "unprognostic (1.06e-2)" "unprognostic (2.35e-3)" "unprognostic (9.91e-2)" "unprognostic (3.53e-1)" "unprognostic (1.19e-1)" "unprognostic (2.44e-3)" "unprognostic (8.43e-2)" "unprognostic (2.83e-2)" "unprognostic (8.01e-3)" "unprognostic (7.12e-2)" "unprognostic (2.11e-2)" "unprognostic (2.47e-1)" 0.5 4.1 0.2 4.3 0.2 0.2 0.3 0.1 1.1 0.2 0.6 0.4 0.0 0.0 0.1 0.2 0.6 0.1 0.3 4.0 0.3 0.2 0.4 93.2 0.1 4.1 0.3 0.2 0.3 0.1 0.0 0.5 0.0 0.3 0.3 0.4 0.8 0.4 0.1 2.9 0.6 1.2 1.6 0.5 5.2 0.2 0.5 0.4 0.1 0.4 4.2 3.2 0.6 0.5 11.4 1.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 11.7 0.0 0.5 2.2 0.2 0.5 0.0 0.2 1.6 0.1 0.0 0.0 0.0 2.7 0.2 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.1 1.4 11.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.2 0.1 1.1 0.3 0.2 0.3 0.2 0.3 0.4 ABCC11 MRP8 ENSG00000121270 "ATP binding cassette subfamily C member 11" Q96J66 16 48166910-48247568 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "breast: 37.3" "Cell line enriched" "Detected in some" 4 "T-47d: 38.4" "Group enriched" "Detected in some" 6 "breast cancer: 8.7;prostate cancer: 2.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 2.6" "Group enriched" "Detected in many" 5 "B-cells: 2.6;T-cells: 1.2" "Not detected" "Not detected" "HPA031980, HPA031981, HPA031982, CAB032513" Approved "CAB032513: AB_2221208, HPA031980: AB_10602303, HPA031981: , HPA031982: " "unprognostic (1.35e-1)" "unprognostic (3.47e-2)" "unprognostic (3.87e-2)" "unprognostic (2.47e-1)" "unprognostic (1.57e-1)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (1.56e-2)" "unprognostic (8.11e-2)" "unprognostic (2.39e-1)" "unprognostic (2.64e-1)" "unprognostic (7.05e-2)" "unprognostic (1.14e-1)" "unprognostic (2.21e-2)" "unprognostic (1.58e-1)" "unprognostic (1.13e-2)" "unprognostic (5.54e-4)" 0.1 0.0 0.8 0.1 0.8 0.1 37.3 0.2 0.5 0.1 0.1 0.1 0.1 0.2 0.1 9.3 0.1 0.4 0.1 0.1 0.4 0.2 0.1 4.0 0.1 0.1 0.7 0.1 0.4 0.1 0.0 2.0 0.1 0.6 2.7 0.0 8.4 0.1 0.1 0.1 0.9 0.1 0.1 0.4 0.1 0.0 3.4 0.1 0.1 0.2 0.1 0.1 0.1 0.1 2.6 0.3 0.0 0.2 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 9.1 0.0 38.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 2.6 0.2 1.2 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.2 0.5 0.4 0.2 0.7 0.1 0.6 0.1 ABHD1 "FLJ36128, LABH1" ENSG00000143994 "Abhydrolase domain containing 1" Q96SE0 2 27123789-27130812 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 58.4" "Cell line enhanced" "Detected in some" "RPMI-8226: 3.2;T-47d: 6.6;U-266/70: 6.4;U-266/84: 5.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044390 Uncertain "HPA044390: AB_10959380" "unprognostic (1.20e-3)" "unprognostic (6.07e-3)" "unprognostic (7.71e-4)" "unprognostic (1.63e-2)" "unprognostic (6.68e-2)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-3)" "unprognostic (2.75e-1)" "unprognostic (1.76e-1)" "unprognostic (9.09e-4)" "unprognostic (9.76e-2)" "unprognostic (1.70e-2)" "unprognostic (6.88e-2)" "unprognostic (4.06e-2)" "unprognostic (3.09e-2)" "unprognostic (7.97e-2)" 1.3 0.9 0.9 0.2 1.4 0.0 0.7 0.3 0.8 0.3 0.2 1.2 0.5 0.1 0.4 1.4 0.2 0.3 0.3 1.6 0.5 0.4 0.5 4.4 0.2 0.8 0.6 1.0 0.5 0.3 0.6 0.4 0.0 1.0 1.0 0.0 1.1 6.4 0.3 2.2 0.2 0.2 0.5 0.8 0.3 0.3 58.4 0.2 0.0 0.5 1.5 0.1 0.2 0.2 2.3 0.3 1.9 0.8 0.0 2.7 0.7 0.2 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.2 0.5 0.2 0.0 0.2 0.0 0.0 0.0 1.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.0 3.2 0.2 0.0 0.0 0.7 0.1 0.6 0.3 6.6 0.5 0.0 0.0 0.1 0.0 0.4 6.4 5.3 0.1 0.2 0.2 0.2 0.1 0.8 1.9 2.7 0.1 0.9 2.3 1.4 1.3 0.2 0.7 1.4 0.7 1.3 0.0 0.0 0.3 0.0 0.7 0.9 1.4 0.3 0.8 0.5 0.4 0.6 1.0 1.0 0.2 AC002094.3 ENSG00000273171 17 28364288-28368012 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 82 "liver: 75.7" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;NTERA-2: 1.0;RT4: 1.1;U-2197: 1.1;U-266/84: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.54e-2)" 0.0 0.6 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 75.7 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 1.2 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 AC004233.2 ENSG00000270168 16 2988256-3002016 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "skin 1: 8.9" "Cell line enhanced" "Detected in some" "A-431: 2.9;CAPAN-2: 3.5;HaCaT: 7.5;hTCEpi: 5.6;MCF7: 3.9;SCLC-21H: 5.7;T-47d: 3.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (7.38e-2)" "unprognostic (2.28e-1)" "unprognostic (1.04e-1)" "unprognostic (6.21e-2)" "unprognostic (7.98e-3)" "unprognostic (1.50e-1)" "unprognostic (2.72e-1)" "unprognostic (9.48e-2)" "unprognostic (2.06e-2)" "unprognostic (1.42e-1)" "unprognostic (2.30e-1)" "unprognostic (3.61e-1)" "unprognostic (1.97e-3)" "unprognostic (1.28e-1)" "unprognostic (6.73e-2)" "unprognostic (4.21e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.2 0.1 0.6 0.1 0.1 1.1 0.1 0.1 8.9 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.8 0.0 0.0 0.6 0.4 0.1 0.2 0.5 0.2 3.5 0.0 0.2 0.0 7.5 0.0 0.2 0.1 0.7 0.0 0.0 0.1 0.2 0.0 0.1 0.4 0.1 5.6 0.2 0.0 0.0 0.6 0.3 0.0 3.9 0.0 0.4 0.0 0.0 0.0 1.0 0.1 0.0 0.2 5.7 0.2 0.5 2.4 0.1 3.0 0.1 0.0 0.1 0.2 0.2 0.4 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 AC004754.1 ENSG00000269881 16 249547-269943 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "intestine: 15.3" "Cell line enhanced" "Detected in some" "ASC diff: 2.5;ASC TERT1: 2.4;EFO-21: 5.1;HHSteC: 2.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA011651: , HPA071871: " "unprognostic (1.22e-1)" "unprognostic (2.09e-2)" "unprognostic (2.26e-1)" "unprognostic (1.75e-2)" "unprognostic (5.40e-2)" "unprognostic (2.56e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (3.37e-2)" "unprognostic (5.06e-2)" "unprognostic (5.24e-3)" "unprognostic (4.66e-2)" "unprognostic (7.84e-2)" "unprognostic (1.10e-1)" "unprognostic (1.32e-1)" "unprognostic (1.69e-1)" "unprognostic (2.95e-2)" 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.3 0.6 0.6 0.2 15.3 0.3 0.3 0.1 0.2 0.0 0.9 0.4 1.4 0.3 0.1 0.0 0.0 0.7 0.1 1.7 0.0 0.2 0.0 0.2 0.0 0.0 0.3 1.0 0.1 7.4 0.2 0.7 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.8 0.4 1.8 2.5 2.4 0.5 0.0 1.2 0.0 0.1 0.3 0.1 0.0 5.1 1.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 2.5 0.0 0.0 1.0 0.0 0.2 1.0 0.7 0.0 0.3 0.0 2.2 0.0 0.2 1.2 0.0 1.3 0.0 0.0 0.9 0.0 0.3 1.0 0.0 0.0 0.4 1.0 0.6 0.0 0.4 0.0 1.0 0.0 0.1 0.2 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.8 0.0 0.5 1.5 0.4 0.0 0.4 0.0 0.0 0.0 0.0 AC004832.3 ENSG00000249590 22 30409255-30428990 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "epididymis: 32.4" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.9;hTERT-HME1: 10.5;HUVEC TERT2: 11.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.9;T-reg: 2.1" "Lineage enriched" "Detected in single" 6 "T-cells: 2.9" 0.7 1.5 1.6 2.7 1.2 0.2 1.0 0.6 0.9 1.2 1.0 1.0 4.7 5.5 0.7 32.4 0.6 0.8 1.0 0.8 1.0 1.4 2.3 6.4 1.1 0.6 1.9 0.6 1.0 1.2 1.2 0.6 0.9 0.8 2.4 2.1 0.8 1.7 0.6 0.6 0.9 3.9 0.6 1.5 0.6 1.5 1.3 0.6 0.6 1.6 0.6 1.9 0.7 0.7 0.2 0.5 0.2 0.1 0.0 2.9 0.7 3.6 0.0 1.9 1.6 0.4 1.7 0.0 0.0 3.2 5.1 6.4 0.0 2.1 0.6 0.7 1.1 5.2 1.8 16.9 7.3 0.0 0.0 0.0 0.0 0.0 0.7 0.3 2.3 1.1 3.6 5.3 10.5 11.5 0.0 0.3 2.8 0.0 1.0 1.1 0.6 0.0 0.7 3.0 0.0 5.6 0.3 0.4 0.7 3.0 2.4 1.9 1.2 0.2 0.8 2.5 2.9 1.5 3.3 0.1 0.0 0.2 0.6 0.0 2.0 0.2 0.1 0.0 0.0 0.1 1.4 0.2 0.3 0.0 0.0 0.0 0.7 2.9 0.0 0.0 0.0 0.5 2.1 0.7 1.6 1.2 0.6 0.9 1.0 1.4 1.9 0.6 0.8 0.6 AC005726.1 ENSG00000258472 17 28455752-28614197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 16.8" "Cell line enhanced" "Detected in some" "A549: 6.4;Karpas-707: 3.4;PC-3: 3.2;THP-1: 3.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: " "unprognostic (1.26e-2)" "unprognostic (1.82e-1)" "unprognostic (6.04e-3)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (7.25e-2)" "unprognostic (5.96e-2)" "unprognostic (4.58e-2)" "unprognostic (9.22e-3)" "unprognostic (3.17e-3)" "unprognostic (1.49e-4)" "unprognostic (1.25e-1)" "unprognostic (2.65e-1)" "unprognostic (7.50e-2)" "unprognostic (3.79e-4)" 0.5 0.6 6.3 0.4 16.4 1.6 0.5 3.5 16.8 2.8 0.9 0.0 0.0 1.6 1.3 0.6 1.4 2.3 2.4 1.0 5.1 3.6 0.9 1.5 3.6 0.5 1.6 6.6 0.8 3.6 0.2 3.1 0.4 6.9 1.0 0.2 3.6 0.5 0.2 0.6 0.5 0.5 0.8 1.1 0.5 1.0 0.6 2.1 0.0 2.6 0.0 1.3 3.5 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 6.4 0.2 0.8 0.0 0.0 0.2 0.3 0.0 0.2 0.0 2.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 3.4 0.0 0.5 0.0 0.9 0.0 3.2 0.3 0.0 0.0 0.2 1.3 0.0 0.4 0.3 0.9 0.0 0.6 3.4 0.0 0.8 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 6.3 16.4 3.5 16.8 5.1 3.6 1.6 6.6 6.9 2.1 AC006518.7 ENSG00000284826 12 10881011-10884255 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 913 "salivary gland: 2376.3" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1.2;hTCEpi: 1.3;MCF7: 1.2;RT4: 1.8;SiHa: 2.1;WM-115: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2376.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.3 0.0 0.4 1.2 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 AC007325.1 ENSG00000276017 Unmapped 72411-74814 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 14.0" "Cell line enhanced" "Detected in some" "ASC diff: 1.0;ASC TERT1: 2.8;HSkMC: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.5 0.3 0.6 0.8 0.5 0.3 0.0 0.0 0.0 0.0 0.0 1.0 2.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.8 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.1 0.5 0.2 0.3 0.2 0.5 0.0 0.3 0.0 0.0 AC007906.2 ENSG00000277639 16 53035690-53052873 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "fallopian tube: 29.9" "Cell line enhanced" "Detected in many" "ASC diff: 9.1;ASC TERT1: 7.8;BEWO: 12.4;HSkMC: 7.7;RPTEC TERT1: 8.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 31.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.97e-2)" "unprognostic (8.34e-3)" "unprognostic (1.63e-1)" "unprognostic (5.38e-3)" "unprognostic (1.70e-1)" "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (1.06e-1)" "unprognostic (3.34e-1)" "unprognostic (2.25e-2)" "unprognostic (1.54e-2)" "unprognostic (5.02e-2)" "unprognostic (6.07e-2)" "unprognostic (5.68e-2)" "unprognostic (1.32e-1)" "unprognostic (1.02e-2)" "unprognostic (4.46e-3)" 0.0 0.0 0.0 0.0 1.7 0.0 4.3 1.0 0.0 0.4 0.0 2.8 29.9 3.4 0.0 3.8 0.0 3.0 0.0 0.0 3.7 0.0 0.0 3.1 1.4 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 2.6 4.4 2.2 9.1 7.8 12.4 1.2 1.0 0.1 0.0 0.3 1.8 0.2 2.2 1.8 0.7 0.0 1.7 0.5 0.2 0.1 0.0 0.1 0.6 1.8 0.0 2.0 7.7 6.7 2.5 0.8 1.8 0.1 0.1 4.0 0.1 0.1 0.0 4.9 0.6 1.1 0.0 0.0 8.0 1.7 0.2 0.0 0.3 0.0 0.1 0.9 0.1 2.1 2.9 3.0 0.1 0.0 0.0 0.0 0.0 3.6 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 AC008162.2 ENSG00000278646 X 120877496-120878924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 6.3" "Cell line enriched" "Detected in some" 4 "U-266/70: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported "HPA042483: " 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 AC008687.4 ENSG00000268655 19 49017496-49020523 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "pancreas: 13.7" "Cell line enhanced" "Detected in some" "HDLM-2: 2.6;HEK 293: 3.9;SiHa: 2.6;U-2 OS: 3.0;U-251 MG: 2.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.06e-1)" "unprognostic (7.61e-3)" "unprognostic (7.17e-3)" "unprognostic (1.12e-2)" "unprognostic (2.93e-1)" "unprognostic (1.23e-1)" "unprognostic (5.63e-2)" "unprognostic (4.91e-2)" "unprognostic (3.85e-1)" "unprognostic (7.96e-4)" "unprognostic (9.37e-3)" "unprognostic (4.19e-2)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (6.96e-2)" "unprognostic (1.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.6 0.2 0.0 0.6 0.2 0.0 0.7 0.3 0.1 0.0 0.0 0.6 1.3 0.7 0.1 0.3 0.3 0.1 0.0 0.1 2.6 3.9 0.0 0.4 0.1 0.1 0.7 0.6 0.0 0.1 0.1 0.0 0.0 0.7 1.5 0.0 0.2 0.0 0.2 0.2 0.1 1.5 0.4 1.2 0.0 0.1 0.4 0.2 2.6 0.2 0.2 0.3 0.3 0.0 0.6 3.0 0.0 2.7 1.2 2.2 1.2 0.5 1.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 AC010255.3 ENSG00000250803 "Uncharacterized protein LOC100505841 " 5 122129622-122183949 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "testis: 59.7" "Cell line enhanced" "Detected in some" "CACO-2: 2.9;HUVEC TERT2: 1.6;U-2197: 1.7;U-266/84: 1.3;U-87 MG: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (8.24e-2)" "unprognostic (3.81e-3)" "unprognostic (3.43e-2)" "unprognostic (1.42e-1)" "unprognostic (8.28e-2)" "unprognostic (1.76e-1)" "unprognostic (4.18e-1)" "unprognostic (5.54e-2)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 2.3 0.0 0.0 0.1 2.2 0.0 1.7 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.7 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.1 2.9 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 1.7 0.1 0.0 1.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010319.2 ENSG00000269035 19 17436611-17460804 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 32 "retina: 41.6" "Cell line enhanced" "Detected in some" "ASC diff: 1.2;HHSteC: 1.0;THP-1: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA041580 Approved Uncertain "Nuclear membrane" "Nuclear membrane" "HPA041580: AB_10795700" 0.9 0.2 0.4 0.1 0.5 0.1 0.3 0.1 0.5 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.3 0.5 0.4 0.1 0.1 0.3 0.1 0.2 0.0 0.7 0.1 0.1 0.3 0.1 1.2 0.1 0.1 41.6 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.1 0.5 0.5 0.4 0.2 0.0 1.2 0.0 AC010325.1 ENSG00000261341 19 50776141-50793142 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 51.5" "Cell line enhanced" "Detected in many" "AF22: 6.6;HEK 293: 8.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (1.46e-1)" "unprognostic (1.67e-1)" "unprognostic (2.63e-2)" "unprognostic (2.47e-1)" "unprognostic (9.62e-3)" "unprognostic (9.41e-2)" "unprognostic (1.11e-2)" "unprognostic (5.95e-3)" "unprognostic (1.14e-1)" "unprognostic (1.98e-2)" "unprognostic (1.06e-1)" "unprognostic (1.52e-1)" "unprognostic (5.32e-7)" "unprognostic (3.63e-1)" "unprognostic (2.21e-1)" "unprognostic (3.37e-3)" "unprognostic (3.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 51.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.7 0.4 1.6 1.1 2.2 0.8 0.7 0.0 6.6 2.1 0.0 0.0 1.3 2.0 0.0 3.9 3.0 0.0 0.3 0.2 0.5 0.7 1.4 0.4 0.0 0.0 1.3 8.8 0.5 0.0 0.7 0.0 0.6 0.8 0.0 0.0 1.6 4.6 1.8 1.8 4.1 0.6 1.0 0.7 0.2 4.9 0.6 0.5 3.9 1.0 0.4 1.3 0.8 0.6 0.4 0.0 0.0 0.5 0.4 0.0 0.0 2.1 3.0 0.2 0.3 3.0 0.7 1.5 1.1 2.1 0.0 1.6 0.0 2.2 0.2 1.0 0.3 1.3 2.2 2.6 1.6 0.8 0.6 0.4 1.1 0.4 2.7 1.8 0.8 AC010616.1 ENSG00000268041 19 41907705-41928516 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 5.9" "Cell line enhanced" "Detected in some" "Daudi: 9.5;HMC-1: 7.0;U-2 OS: 4.3;U-266/70: 3.8;U-698: 5.8;U-937: 4.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "unprognostic (1.97e-1)" "unprognostic (1.84e-3)" "unprognostic (3.88e-4)" "unprognostic (3.01e-1)" "unprognostic (2.07e-1)" "unprognostic (2.75e-2)" "unprognostic (6.71e-2)" "unprognostic (1.12e-2)" "unprognostic (2.44e-1)" "unprognostic (2.97e-2)" "unprognostic (3.42e-1)" "unprognostic (1.57e-1)" "unprognostic (1.21e-14)" "unprognostic (5.11e-1)" "unprognostic (1.54e-1)" "unprognostic (7.40e-2)" "unprognostic (9.98e-3)" 0.0 0.0 2.4 1.2 0.0 0.2 0.0 0.4 0.2 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 2.2 0.8 0.7 0.0 2.4 0.0 0.1 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.1 0.7 0.3 0.0 0.3 0.2 0.3 0.2 0.0 0.8 9.5 0.3 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.3 0.4 7.0 0.1 0.4 0.4 0.2 0.0 0.3 0.5 0.0 1.0 0.0 0.0 0.0 0.3 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 4.3 0.2 0.0 3.8 0.2 5.8 0.2 4.1 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 AC011005.1 ENSG00000230626 7 129126518-129130793 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 7.8" "Cell line enhanced" "Detected in some" "Hep G2: 1.6;MCF7: 2.2;RT4: 1.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA051993 Uncertain Approved Cytosol Cytosol "HPA051993: " "unprognostic (2.03e-1)" "unprognostic (7.97e-2)" "unprognostic (8.08e-2)" "unprognostic (2.28e-3)" "unprognostic (1.58e-1)" "unprognostic (2.67e-3)" "unprognostic (1.35e-2)" "unprognostic (1.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (3.11e-2)" "unprognostic (3.61e-1)" "unprognostic (2.60e-2)" "unprognostic (3.01e-1)" "unprognostic (1.06e-1)" "unprognostic (4.36e-5)" "unprognostic (3.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.6 0.4 0.9 0.3 0.7 0.6 0.1 0.1 0.6 0.3 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.7 1.6 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.5 0.0 2.2 0.4 0.1 0.2 0.5 0.2 0.0 0.0 0.0 1.9 0.3 0.1 0.0 0.0 0.8 0.0 0.7 0.0 0.2 0.0 0.9 0.3 0.2 0.1 0.3 0.4 0.0 0.0 0.5 0.3 0.9 0.3 0.3 0.5 0.4 0.3 0.6 0.4 0.6 0.4 0.4 0.8 0.7 0.2 0.0 0.5 0.1 AC011195.2 ENSG00000266826 17 58660424-58692018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 99 "testis: 48.2" "Cell line enhanced" "Detected in some" "AN3-CA: 3.1;BEWO: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000634, HPA001004" Uncertain Approved Microtubules Microtubules "HPA000634: AB_1079102, HPA001004: AB_1079104" "unprognostic (3.14e-2)" "unprognostic (1.59e-1)" "unprognostic (2.37e-1)" "unprognostic (8.67e-2)" "unprognostic (1.13e-1)" "unprognostic (2.94e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 48.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.0 3.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.0 0.2 AC011604.2 ENSG00000257046 12 20815674-21090245 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "breast: 22.5" "Cell line enhanced" "Detected in some" "A-431: 3.9;A549: 2.4;CAPAN-2: 4.0;HeLa: 6.5;PC-3: 1.5;U-2 OS: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050892 Uncertain "HPA050892: " "unprognostic (2.74e-1)" "unprognostic (1.39e-3)" "unprognostic (3.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC018709.1 ENSG00000272297 4 186426546-186555328 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "testis: 25.5" "Group enriched" "Detected in some" 5 "A-431: 6.9;T-47d: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC021072.1 ENSG00000283536 12 53241889-53245134 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "retina: 24.8" "Cell line enhanced" "Detected in some" "MCF7: 1.3;NTERA-2: 2.8" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 AC021097.2 ENSG00000285480 7 151207837-151210378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 8.0" "Cell line enhanced" "Detected in some" "U-266/70: 9.0;U-266/84: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA043013 Uncertain "HPA043013: " 1.0 0.2 0.2 0.5 1.2 0.0 0.2 0.0 0.0 1.5 0.0 0.6 0.0 1.1 0.0 0.0 0.0 1.0 1.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 8.0 0.0 0.5 1.2 0.0 0.1 0.0 0.2 0.0 0.5 0.1 0.8 0.4 0.0 0.5 0.0 0.0 0.8 0.0 0.6 2.0 2.3 0.0 0.6 0.3 0.3 0.0 1.9 1.2 1.3 0.6 0.4 0.0 0.0 0.5 0.0 1.0 3.5 0.4 0.4 0.0 1.0 0.5 1.8 2.5 0.4 0.0 3.3 0.8 0.3 3.0 0.0 0.5 0.2 0.2 0.2 1.2 0.8 0.0 1.1 0.0 0.0 0.4 0.0 0.4 0.0 1.4 0.0 2.3 0.9 0.0 0.4 1.2 0.2 9.0 5.9 0.3 0.7 2.8 0.2 0.0 0.3 0.0 0.2 0.4 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.5 0.8 0.0 0.0 0.0 0.3 0.0 AC022167.5 ENSG00000283516 16 8881634-8885351 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 17.1" "Low cell line specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" 0.1 0.1 0.1 0.1 0.1 1.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.3 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.1 1.7 0.4 0.1 0.1 0.1 0.1 17.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 2.4 1.6 3.5 1.4 2.0 1.2 0.6 0.8 0.5 0.0 0.7 0.0 0.4 2.9 0.5 0.0 0.0 0.0 0.3 1.5 0.6 0.6 0.0 0.9 0.0 0.5 0.0 1.9 0.0 1.0 1.8 1.0 0.0 0.8 1.3 0.2 0.3 1.3 0.6 0.0 0.8 2.7 0.4 1.3 1.4 1.7 0.0 0.7 1.0 0.6 1.3 0.4 1.4 0.7 0.3 0.5 1.3 0.1 1.5 0.2 1.3 0.8 2.5 0.0 0.5 1.8 2.5 0.3 0.3 0.5 0.3 3.5 1.4 0.9 1.2 0.8 1.2 1.5 1.1 0.8 0.3 2.4 1.2 1.2 3.3 2.0 0.7 1.6 0.8 0.6 AC023491.2 ENSG00000278633 Unmapped 10598-13001 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "testis: 28.4" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;HEK 293: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.1 0.1 0.7 0.1 0.2 0.3 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.7 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.6 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.7 0.2 0.0 0.0 0.3 0.0 AC025594.2 ENSG00000272899 7 128866308-128872044 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 45.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 9.6;HDLM-2: 6.8;HMC-1: 7.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.0" "Lineage enriched" "Detected in single" 7 "T-cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (8.17e-2)" "unprognostic (3.00e-1)" "unprognostic (1.45e-2)" "prognostic unfavourable (8.21e-4)" "unprognostic (1.23e-1)" "unprognostic (9.98e-2)" "unprognostic (5.10e-2)" "unprognostic (1.18e-3)" "unprognostic (1.39e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-2)" "unprognostic (2.20e-1)" "unprognostic (1.56e-2)" "unprognostic (1.50e-1)" "unprognostic (2.71e-1)" "unprognostic (1.87e-1)" "unprognostic (4.33e-3)" 1.1 0.0 0.4 0.2 0.2 0.0 0.2 0.2 3.6 0.2 0.2 0.2 0.2 2.4 0.2 0.5 0.2 0.0 1.6 0.8 0.2 2.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.6 1.0 5.3 0.3 0.2 0.2 0.0 45.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.1 0.0 0.1 0.0 1.0 0.0 1.4 0.5 0.5 4.8 1.4 0.7 0.2 0.4 0.6 0.6 0.4 0.4 9.6 1.6 0.6 0.2 1.5 0.5 0.2 0.4 6.8 1.0 2.4 0.3 0.1 0.8 0.2 7.7 0.6 0.4 0.3 0.3 0.2 1.2 3.5 0.4 0.6 0.5 2.2 0.2 0.5 1.0 1.7 1.4 0.2 0.4 2.5 1.0 0.4 2.5 0.5 0.7 1.1 0.2 2.6 0.5 4.5 0.4 5.2 6.0 1.2 3.2 2.5 0.8 0.0 0.0 0.0 0.2 0.1 0.7 0.0 0.1 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 AC026786.1 ENSG00000256825 12 133130984-133202369 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "pituitary gland: 21.5" "Cell line enhanced" "Detected in some" "A549: 1.5;BJ: 1.6;CACO-2: 3.6;TIME: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in many" 1.4 1.5 1.5 1.3 3.3 1.3 1.3 3.9 2.7 2.1 1.4 1.9 4.5 1.3 3.7 4.4 1.9 1.6 2.7 1.6 1.5 1.4 1.4 1.9 2.0 1.3 2.1 1.3 3.2 1.5 1.3 21.5 1.3 2.1 1.8 1.3 2.3 1.4 5.3 2.4 1.8 1.3 3.6 2.2 1.5 1.4 5.3 1.9 1.4 2.4 0.8 1.3 1.4 1.4 0.3 1.8 0.0 0.7 0.0 1.3 0.2 0.4 1.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.6 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.3 0.3 0.2 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.7 1.8 0.1 0.2 1.5 3.3 3.9 2.7 1.5 1.4 2.1 1.3 2.1 1.9 AC064853.5 ENSG00000284667 2 227666804-227667061 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "placenta: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC064853.6 ENSG00000284704 2 227614538-227614840 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "placenta: 1.7" "Cell line enriched" "Detected in single" 32 "HeLa: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC079341.3 ENSG00000284849 4 121758930-121765185 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "brain: 16.4" "Cell line enriched" "Detected in some" 5 "MOLT-4: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA077585 Approved "HPA077585: " 0.3 0.3 1.1 0.3 7.1 0.3 0.3 0.0 16.4 0.3 0.3 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 6.8 0.3 0.3 0.3 0.4 0.0 7.6 0.3 0.3 0.3 0.0 1.1 0.4 0.3 0.3 0.5 0.3 0.4 0.3 0.3 0.5 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 AC083902.2 ENSG00000248713 "Homo sapiens uncharacterized LOC285556 (LOC285556), mRNA." 4 99636529-99654648 "Disease related genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 40.9" "Cell line enhanced" "Detected in some" "RH-30: 5.4;SK-BR-3: 3.5;SK-MEL-30: 2.0;WM-115: 1.8" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "unprognostic (3.91e-2)" "unprognostic (3.76e-1)" "unprognostic (4.27e-2)" "unprognostic (1.81e-2)" "unprognostic (1.76e-2)" "unprognostic (4.00e-3)" "unprognostic (2.31e-3)" "unprognostic (1.50e-1)" "unprognostic (4.31e-2)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" "unprognostic (2.20e-1)" "unprognostic (2.42e-3)" "unprognostic (1.89e-2)" "unprognostic (2.10e-2)" "unprognostic (1.20e-3)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.2 0.0 4.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 40.9 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.1 0.7 6.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 3.5 2.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 AC091980.2 ENSG00000275038 5 171305981-171308755 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "brain: 3.4" "Group enriched" "Detected in some" 20 "HeLa: 3.3;RH-30: 1.4;SH-SY5Y: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.98e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092042.3 ENSG00000273291 3 42809446-43055871 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 29 "testis: 57.2" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;U-2197: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.83e-2)" "unprognostic (2.13e-1)" "unprognostic (3.09e-1)" "unprognostic (3.69e-3)" "unprognostic (1.02e-1)" "unprognostic (3.74e-2)" "unprognostic (2.04e-1)" "unprognostic (6.65e-3)" "unprognostic (4.46e-2)" "unprognostic (8.42e-2)" "unprognostic (1.48e-1)" "unprognostic (1.73e-1)" "unprognostic (1.40e-2)" "unprognostic (2.54e-2)" "unprognostic (2.15e-1)" "unprognostic (4.20e-2)" "unprognostic (2.81e-1)" 0.5 0.5 0.4 0.4 1.5 0.4 0.5 1.5 1.7 0.7 0.5 1.1 0.4 0.4 1.0 1.9 0.5 0.4 0.6 1.6 0.6 0.5 0.5 0.4 0.5 0.4 0.4 0.6 0.7 1.4 0.4 1.1 0.6 1.0 1.0 1.3 1.6 0.5 0.4 0.5 0.5 0.5 1.3 0.9 0.5 0.5 57.2 0.0 0.0 1.2 0.0 0.4 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 1.5 1.5 1.7 0.6 0.5 0.4 0.6 1.0 0.0 AC092442.1 ENSG00000284684 4 6064977-6070162 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 16 "blood: 1.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.5;naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Region enriched" "Detected in single" 15 "hypothalamus: 0.7" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 AC093762.1 ENSG00000284635 2 227745845-227746681 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "skin 1: 2.5" "Cell line enhanced" "Detected in single" "hTCEpi: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC097637.1 ENSG00000173366 3 52221081-52231190 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "blood: 31.7" "Group enriched" "Detected in some" 5 "Daudi: 11.4;RPMI-8226: 21.3;U-698: 10.5" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 31.7" "Lineage enriched" "Detected in many" 4 "dendritic cells: 31.7" "unprognostic (4.08e-2)" "unprognostic (9.63e-2)" 0.3 0.0 0.4 2.9 0.7 0.3 0.1 1.1 0.5 0.3 0.4 0.1 0.2 0.0 0.1 0.1 0.6 0.3 0.4 0.4 0.2 0.1 0.1 6.5 0.3 0.8 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.1 1.4 0.3 4.0 0.0 0.3 6.2 0.5 0.0 0.1 5.3 1.0 0.2 7.0 31.7 0.1 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.2 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.6 0.0 0.2 0.7 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 1.8 0.4 10.5 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 1.2 7.0 0.5 0.5 0.1 3.7 0.0 0.2 0.1 0.0 0.0 31.7 1.1 0.6 AC104389.5 ENSG00000284931 11 5248270-5254783 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 26 "placenta: 321.8" "Group enriched" "Detected in some" 1410 "HEL: 421.0;K-562: 155.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA043234 Uncertain "HPA043234: " 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 321.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 421.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 155.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 AC106774.10 ENSG00000284552 5 17486231-17486829 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "blood: 12.2" "Cell line enriched" "Detected in single" 10 "U-937: 8.3" "Cell type enriched" "Detected in single" 122 "neutrophil: 12.2" "Lineage enriched" "Detected in single" 122 "granulocytes: 12.2" 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 AC106774.6 ENSG00000284234 5 17525235-17525831 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 AC107959.5 ENSG00000284956 8 23084403-23115536 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "blood: 69.8" "Cell line enhanced" "Detected in many" "AN3-CA: 13.3;HDLM-2: 16.3" "Cell type enriched" "Detected in some" 9 "neutrophil: 69.8" "Lineage enriched" "Detected in single" 153 "granulocytes: 69.8" 0.3 2.0 0.0 1.5 0.0 3.1 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 2.7 0.0 0.0 3.5 0.0 0.4 0.0 0.7 0.0 0.4 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 9.7 0.5 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.1 69.8 0.4 0.0 0.0 0.1 2.6 3.7 0.7 13.3 0.0 1.7 2.8 0.0 0.5 0.2 2.1 0.4 1.1 2.7 4.0 0.9 0.1 0.4 0.5 1.9 16.3 1.6 0.0 2.0 7.5 1.6 0.5 5.7 1.7 2.1 0.7 0.7 2.5 0.7 0.0 0.6 0.0 0.0 0.7 3.5 0.5 0.1 0.9 0.3 0.8 0.1 0.1 0.1 0.2 1.9 4.8 1.8 0.3 1.3 4.7 6.7 6.7 0.8 6.3 4.7 0.2 5.2 1.2 4.0 0.6 0.4 8.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 69.8 0.0 0.3 0.0 0.0 0.1 AC115220.1 ENSG00000241149 7 63998874-64016130 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 10.9" "Cell line enhanced" "Detected in some" "SH-SY5Y: 4.3;T-47d: 1.4;U-266/70: 1.3" "Cancer enriched" "Detected in single" 19 "testis cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (6.95e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 AC118470.1 ENSG00000239395 1 247711813-247723764 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 44 "testis: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC119396.1 ENSG00000263264 I3L1I5 19 7348943-7383385 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 61.5" "Cell line enhanced" "Detected in some" "Daudi: 28.2;HL-60: 12.1;HMC-1: 7.7;MOLT-4: 11.7;REH: 10.8;THP-1: 11.7;U-698: 18.3;U-937: 9.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA049151 Uncertain "HPA049151: " "unprognostic (7.21e-3)" "unprognostic (2.33e-1)" "unprognostic (1.07e-1)" "unprognostic (2.65e-2)" "unprognostic (1.52e-1)" "unprognostic (1.23e-5)" "unprognostic (7.56e-2)" "unprognostic (4.87e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (2.06e-2)" "unprognostic (1.35e-1)" "unprognostic (2.16e-1)" "unprognostic (4.53e-2)" "unprognostic (1.12e-2)" "unprognostic (9.22e-2)" "unprognostic (3.55e-2)" 0.5 2.8 0.2 26.7 0.2 13.3 0.4 0.2 0.2 0.7 6.1 0.1 0.0 0.4 6.1 0.3 1.7 0.8 1.9 0.3 0.2 0.2 0.7 0.4 2.0 28.7 0.3 0.5 0.3 0.3 0.0 0.3 0.4 0.1 0.4 0.4 0.4 7.8 0.5 0.3 0.2 9.3 4.0 0.2 21.0 2.9 0.4 0.1 61.5 0.7 0.6 25.9 1.9 0.4 12.1 1.8 15.1 3.9 0.8 4.7 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 12.1 7.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 1.7 0.0 0.0 10.8 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 18.3 0.0 9.6 0.0 1.2 2.4 15.1 2.7 3.0 2.0 7.3 3.8 2.7 1.3 12.1 4.7 3.1 9.9 0.8 3.9 1.8 3.4 1.3 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.5 0.1 0.1 AC134669.1 ENSG00000265118 17 31305213-31318831 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "blood: 57.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 5.4;HMC-1: 5.2;Karpas-707: 4.8;MOLT-4: 9.3;RPMI-8226: 7.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 57.6" "Low lineage specificity" "Detected in all" HPA045033 Uncertain "HPA045033: " "unprognostic (5.33e-2)" "unprognostic (3.44e-1)" "unprognostic (2.70e-2)" "unprognostic (2.23e-2)" "unprognostic (5.88e-2)" "unprognostic (2.94e-2)" "unprognostic (2.40e-2)" "unprognostic (4.63e-2)" "unprognostic (3.23e-1)" "unprognostic (5.45e-5)" "unprognostic (1.89e-3)" "unprognostic (1.81e-1)" "unprognostic (4.53e-2)" 2.4 0.3 1.4 6.6 2.1 3.0 0.5 0.5 4.5 0.3 1.1 0.5 0.2 1.2 0.5 1.1 0.8 0.7 2.0 0.4 2.6 1.5 0.6 0.7 4.9 4.0 6.8 1.8 0.6 0.3 0.1 0.4 2.0 2.1 0.7 1.2 0.5 2.2 0.6 0.6 0.4 2.6 1.1 4.4 4.5 2.4 0.8 4.3 2.2 0.7 0.2 5.9 1.7 0.5 9.3 14.7 57.6 24.1 4.7 12.3 20.3 0.1 0.0 0.0 0.0 0.0 5.4 0.1 0.4 1.0 0.6 1.2 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 3.4 1.7 5.2 1.2 0.0 0.0 2.2 0.0 0.0 4.8 1.8 0.0 9.3 0.8 0.0 0.0 2.9 0.6 7.5 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.1 1.8 2.1 0.9 0.2 1.1 1.2 4.6 0.0 3.5 0.3 1.6 1.1 1.7 24.1 2.0 8.6 11.0 7.9 9.3 10.0 8.9 14.7 5.6 10.1 9.1 57.6 4.7 10.9 4.8 12.3 20.3 1.4 2.1 0.5 4.5 2.6 1.5 6.8 1.8 2.1 4.3 AC134980.5 ENSG00000285472 15 22015233-22095857 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 103 "testis: 10.2" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Approved Centrosome Centrosome "HPA057442: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135068.1 ENSG00000182974 15 21637909-21638992 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 4.3" "Cell line enriched" "Detected in single" 26 "U-2 OS: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058889 Uncertain "HPA058889: " 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 AC138647.1 ENSG00000226490 8 141514638-141518737 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "testis: 39.4" "Cell line enriched" "Detected in single" 20 "SCLC-21H: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.0 2.6 0.9 1.3 0.1 0.0 0.0 0.0 AC171558.1 ENSG00000274792 Unmapped 386278-387620 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "testis: 1.6" "Group enriched" "Detected in some" 11 "NTERA-2: 1.0;U-2 OS: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Uncertain Centrosome Centrosome "HPA057442: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC171558.3 ENSG00000275249 Unmapped 372322-373405 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 20 "testis: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058889 Uncertain "HPA058889: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC187653.1 ENSG00000248767 7 290170-294422 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC233724.15 ENSG00000283740 5 17604177-17605377 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.5" "Cell line enriched" "Detected in some" 4 "U-2 OS: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 AC233724.16 ENSG00000283776 5 17632088-17632684 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "urinary bladder: 1.4" "Cell line enriched" "Detected in single" 26 "U-2 OS: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC233724.19 ENSG00000284356 5 17597232-17597828 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 AC245033.1 ENSG00000260836 15 82536788-82573194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 11.3" "Cell line enriched" "Detected in some" 5 "U-2197: 18.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA055060 Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum" "Nucleoli, Cytosol" "HPA055060: " "unprognostic (2.91e-2)" 1.5 0.9 5.3 0.9 7.1 0.9 1.3 6.1 11.3 0.9 1.0 1.4 0.0 0.9 0.9 0.9 1.5 0.9 0.9 1.3 3.9 1.6 0.9 1.0 1.1 0.9 3.2 6.1 0.9 1.0 0.9 2.0 1.0 7.3 1.1 1.1 1.9 0.9 0.9 2.0 0.9 1.4 0.9 2.4 1.1 0.9 1.4 1.7 0.0 1.0 0.0 1.0 1.7 0.8 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.7 0.7 18.5 0.3 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.1 6.1 11.3 3.9 1.6 3.2 6.1 7.3 1.7 ACAA2 DSAEC ENSG00000167315 "Acetyl-CoA acyltransferase 2" P42765 18 49782167-49813960 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 245.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042303 Approved Supported Mitochondria 3200000 Mitochondria "HPA042303: AB_10794046" "unprognostic (7.94e-2)" "unprognostic (3.14e-2)" "unprognostic (2.20e-3)" "prognostic unfavourable (8.53e-4)" "unprognostic (2.92e-2)" "unprognostic (2.28e-2)" "unprognostic (7.63e-2)" "unprognostic (1.70e-1)" "unprognostic (7.97e-2)" "unprognostic (8.03e-3)" "unprognostic (1.72e-1)" "unprognostic (3.84e-1)" "prognostic favourable (1.36e-10)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (8.26e-3)" "unprognostic (3.41e-1)" 22.7 12.9 9.4 6.9 10.7 4.4 13.0 3.6 7.0 4.1 27.2 8.0 7.8 25.9 5.1 5.1 7.1 4.1 9.2 38.9 6.8 7.0 60.3 245.7 7.9 7.5 10.7 6.1 6.4 13.6 6.3 7.1 7.5 6.7 7.9 18.4 9.5 3.3 6.2 22.9 4.2 37.0 11.3 9.7 6.9 6.0 6.5 7.5 8.4 15.7 8.8 5.0 8.1 4.9 13.0 31.8 27.5 33.0 35.5 40.9 28.6 0.7 13.9 23.2 21.2 30.7 16.2 11.8 7.1 11.6 12.0 9.3 29.5 12.0 12.4 15.2 26.1 0.9 38.6 4.5 11.9 37.9 9.1 8.8 18.1 34.9 14.5 0.1 16.6 21.4 1.5 19.4 6.1 19.6 7.6 11.7 33.2 16.0 0.5 19.1 21.0 5.6 30.4 49.6 45.4 40.5 0.6 33.3 26.4 0.5 16.3 1.1 9.2 12.8 9.3 10.2 12.9 15.4 7.7 23.8 27.4 31.6 7.3 17.9 9.3 13.1 25.9 27.5 32.1 33.0 40.9 13.0 19.2 28.6 31.8 9.7 16.4 24.3 2.5 35.5 31.1 14.9 22.6 28.6 9.4 10.7 3.6 7.0 6.8 7.0 10.7 6.1 6.7 7.5 ACBD7 "bA455B2.2, FLJ38219" ENSG00000176244 "Acyl-CoA binding domain containing 7" Q8N6N7 10 15077523-15088776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 35.3" "Cell line enhanced" "Detected in many" "MOLT-4: 21.7;U-266/84: 16.3;U-698: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 5 "olfactory region: 21.6" "Low region specificity" "Detected in all" "HPA043326, HPA062478" Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA043326: , HPA062478: " "unprognostic (2.15e-1)" "unprognostic (8.94e-2)" "unprognostic (7.79e-3)" "unprognostic (6.53e-3)" "unprognostic (7.30e-2)" "unprognostic (6.89e-3)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.32e-1)" "unprognostic (6.34e-2)" "unprognostic (3.59e-3)" "unprognostic (3.06e-1)" "unprognostic (2.18e-4)" "unprognostic (9.72e-2)" "unprognostic (2.95e-1)" "unprognostic (2.14e-1)" "unprognostic (6.90e-2)" 1.1 1.1 25.0 1.5 27.1 3.9 8.3 12.9 35.3 1.1 1.4 9.3 0.0 2.5 1.4 2.7 1.7 4.4 1.7 1.2 25.3 9.8 1.4 1.7 1.4 2.1 15.0 16.2 1.7 1.5 1.5 0.7 1.3 14.0 1.5 1.6 0.0 4.7 1.4 2.0 3.0 1.9 1.3 6.6 1.6 1.8 5.9 11.7 2.9 4.2 0.0 1.7 1.4 0.5 1.7 1.5 3.8 0.6 2.1 1.1 0.2 2.6 0.6 10.5 5.0 0.6 0.5 1.2 0.7 0.6 1.9 3.2 2.9 3.2 2.4 3.6 2.4 0.6 6.2 1.9 2.7 5.4 8.5 2.6 0.8 1.6 0.1 0.5 1.1 0.1 0.2 0.7 0.1 2.6 2.0 2.9 2.1 8.3 21.7 2.3 5.2 1.9 11.7 3.7 5.7 1.2 1.0 8.6 5.2 2.6 5.9 1.1 8.5 0.7 0.7 0.4 5.8 1.0 2.2 8.2 16.3 18.7 1.7 0.5 0.7 3.8 0.6 0.8 1.1 0.6 0.9 1.3 0.6 0.6 0.3 1.7 1.1 1.1 3.7 2.1 0.5 1.5 0.5 0.2 25.0 27.1 12.9 21.8 25.3 9.8 15.0 16.2 14.0 11.7 ACE "ACE1, CD143, DCP1" ENSG00000159640 "Angiotensin I converting enzyme" P12821 17 63477061-63498380 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 205.6" "Group enriched" "Detected in some" 4 "ASC TERT1: 35.9;HUVEC TERT2: 18.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Group enriched" "Detected in many" 23 "B-cells: 3.7;monocytes: 2.0;T-cells: 1.9" "CAB002426, CAB002921, HPA029298, HPA069790" Enhanced Approved Vesicles "Secreted to blood" 121920000 92000000 Vesicles "CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: " "unprognostic (4.72e-2)" "unprognostic (4.16e-1)" "unprognostic (1.93e-3)" "unprognostic (6.06e-2)" "unprognostic (2.78e-1)" "unprognostic (1.35e-2)" "unprognostic (4.37e-1)" "unprognostic (1.54e-1)" "unprognostic (1.56e-1)" "unprognostic (1.25e-2)" "unprognostic (3.13e-2)" "unprognostic (2.38e-1)" "unprognostic (7.66e-2)" "unprognostic (9.07e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (2.76e-2)" 6.8 2.0 0.5 2.4 4.2 0.0 2.9 0.5 1.1 5.3 83.2 0.7 37.7 46.4 4.5 5.1 1.7 1.5 4.4 4.7 0.6 0.7 2.6 1.4 16.3 2.2 0.4 0.7 1.4 3.0 3.6 3.6 3.6 0.8 3.4 1.4 1.7 2.5 20.1 3.6 1.3 205.6 2.4 0.6 1.4 1.9 32.6 1.3 0.5 6.9 3.1 2.2 1.7 1.6 3.7 0.1 0.0 2.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 1.5 35.9 0.4 1.3 2.6 0.0 0.0 0.5 3.1 0.7 1.0 6.1 0.0 1.7 0.0 0.0 0.0 0.7 3.4 0.0 0.0 0.8 0.0 0.0 2.4 0.0 0.0 0.0 18.3 3.0 0.0 0.0 0.6 0.0 0.7 0.2 0.3 0.1 0.2 0.5 0.0 0.0 4.5 3.2 0.0 0.0 0.0 1.6 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.6 0.9 3.7 1.9 1.4 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.4 0.5 4.2 0.5 1.1 0.6 0.7 0.4 0.7 0.8 1.3 ACE2 ENSG00000130234 "Angiotensin I converting enzyme 2" Q9BYF1 X 15561033-15602148 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" "Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 122.0" "Cell line enhanced" "Detected in some" "BEWO: 2.4;HaCaT: 4.1;Hep G2: 2.4;NB-4: 2.2;RPMI-8226: 2.0;RT4: 2.4;SH-SY5Y: 2.8" "Cancer enhanced" "Detected in many" "renal cancer: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA000288, CAB026174" Enhanced "Secreted to blood" 85000 "CAB026174: , HPA000288: AB_1078160" "unprognostic (1.40e-1)" "unprognostic (7.26e-2)" "unprognostic (2.76e-2)" "unprognostic (5.71e-2)" "unprognostic (2.51e-1)" "unprognostic (5.26e-2)" "prognostic favourable (4.21e-4)" "unprognostic (2.34e-2)" "unprognostic (6.74e-3)" "unprognostic (2.54e-3)" "unprognostic (1.00e-1)" "unprognostic (1.74e-1)" "prognostic favourable (2.12e-5)" "unprognostic (1.94e-1)" "unprognostic (9.62e-2)" "unprognostic (2.11e-1)" "unprognostic (7.10e-2)" 4.5 0.4 0.2 0.8 0.2 0.0 2.3 0.2 0.2 0.4 49.1 0.2 2.3 46.0 0.4 2.7 1.2 0.6 16.4 10.5 0.2 0.1 23.2 1.2 0.8 0.6 0.2 0.2 1.3 1.6 0.0 0.2 1.0 0.2 0.5 1.3 0.2 1.1 1.2 0.7 0.2 122.0 0.3 0.2 0.2 0.5 17.9 0.2 0.2 4.5 0.5 0.2 0.4 0.9 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.0 0.4 0.0 0.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 4.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.2 0.0 0.0 2.0 0.4 2.4 0.6 2.8 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 ACOT12 "Cach, STARD15, THEAL" ENSG00000172497 "Acyl-CoA thioesterase 12" Q8WYK0 5 81330005-81394179 "Enzymes, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "liver: 49.6" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;CACO-2: 2.4;Karpas-707: 1.8;SK-MEL-30: 4.1" "Cancer enriched" "Detected in single" 76 "liver cancer: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037723, HPA037724" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA037723: AB_10672606, HPA037724: " "unprognostic (6.06e-2)" "unprognostic (1.39e-1)" "prognostic favourable (5.30e-4)" "unprognostic (7.68e-2)" "unprognostic (8.22e-2)" "unprognostic (5.68e-3)" "unprognostic (2.46e-1)" "unprognostic (6.86e-2)" "unprognostic (1.46e-2)" "unprognostic (3.07e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.2 49.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.7 0.0 0.4 0.1 0.0 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 ACOX2 "BRCACOX, BRCOX, THCCox" ENSG00000168306 "Acyl-CoA oxidase 2" Q99424 3 58505136-58537319 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 70.5" "Cell line enhanced" "Detected in some" "ASC diff: 12.2;ASC TERT1: 20.2;fHDF/TERT166: 6.6;Hep G2: 7.8;HSkMC: 13.1" "Cancer enhanced" "Detected in many" "liver cancer: 25.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA038280, HPA064845" Enhanced Approved Vesicles,Cytosol 190000 Vesicles Cytosol "HPA038280: AB_10672623, HPA064845: AB_2685368" "unprognostic (6.62e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-1)" "unprognostic (2.51e-2)" "unprognostic (8.34e-2)" "unprognostic (1.48e-2)" "unprognostic (8.67e-3)" "unprognostic (6.45e-2)" "unprognostic (1.00e-1)" "unprognostic (1.85e-1)" "unprognostic (1.70e-3)" "unprognostic (1.26e-2)" "unprognostic (1.68e-3)" "unprognostic (4.00e-3)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (5.63e-3)" 4.0 5.3 1.9 3.8 2.5 0.1 3.4 1.6 2.1 4.4 10.2 2.7 9.5 10.0 9.0 6.2 3.8 4.4 4.8 8.8 2.4 1.4 17.1 70.5 2.8 0.7 2.0 1.7 5.1 2.9 3.8 3.0 1.4 4.0 7.2 3.4 11.4 3.0 5.9 4.2 1.7 13.7 10.6 2.5 0.9 2.6 4.0 2.0 1.0 7.7 2.7 1.6 5.4 5.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.2 20.2 3.5 2.3 0.2 0.0 0.3 0.6 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 1.8 0.0 0.0 13.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.5 1.6 2.1 2.4 1.4 2.0 1.7 4.0 2.0 ACPP "ACP-3, ACP3, PAP" ENSG00000014257 "Acid phosphatase, prostate" P15309 3 132317367-132368298 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "prostate: 345.2" "Cell line enhanced" "Detected in some" "BJ hTERT+: 10.2;NB-4: 7.7;RPMI-8226: 32.3;U-698: 9.4;U-87 MG: 9.0" "Cancer enriched" "Detected in many" 275 "prostate cancer: 1227.2" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "eosinophil: 43.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB000071, HPA004335, HPA063916" Enhanced "Secreted to blood" 9200 "CAB000071: , HPA004335: AB_1079684, HPA063916: " "unprognostic (6.67e-2)" "unprognostic (4.70e-2)" "unprognostic (1.76e-1)" "unprognostic (7.77e-2)" "unprognostic (1.74e-1)" "unprognostic (2.58e-2)" "unprognostic (2.46e-1)" "unprognostic (7.41e-2)" "unprognostic (1.81e-1)" "unprognostic (3.78e-3)" "unprognostic (2.14e-1)" "unprognostic (5.95e-2)" "unprognostic (9.38e-2)" "unprognostic (1.35e-1)" "unprognostic (1.18e-1)" "unprognostic (3.91e-2)" "unprognostic (1.71e-1)" 0.4 0.6 0.4 0.7 1.6 1.4 0.8 0.3 0.7 3.9 0.4 0.2 0.0 0.4 0.3 2.5 14.7 0.6 0.2 0.9 0.3 0.3 6.2 0.3 2.0 2.7 0.6 0.8 0.4 0.8 0.5 0.3 5.3 0.7 345.2 0.7 0.8 9.1 0.2 0.3 2.5 0.4 0.4 2.2 1.0 0.5 1.0 0.6 0.2 1.3 6.6 6.8 0.5 1.5 0.2 11.2 43.1 9.7 0.9 0.0 2.9 0.2 0.0 0.0 0.0 0.1 0.6 7.0 0.1 10.2 0.0 0.0 0.2 0.2 5.7 0.4 0.0 2.9 0.0 0.0 0.0 0.0 0.3 1.1 0.2 0.1 0.1 4.1 0.1 0.6 0.8 0.0 0.0 0.0 0.1 1.6 0.1 0.1 0.0 7.7 0.4 1.2 0.0 0.0 32.3 3.1 3.8 0.0 2.5 0.0 1.2 0.3 0.2 3.7 0.0 0.0 0.1 1.5 0.0 0.4 0.2 9.4 9.0 7.3 0.1 0.0 9.7 43.1 0.0 8.6 0.0 0.2 0.0 0.0 11.2 0.0 0.0 0.0 8.5 0.9 7.7 0.8 0.0 2.9 0.4 1.6 0.3 0.7 0.3 0.3 0.6 0.8 0.7 0.6 ACR ENSG00000100312 Acrosin P10323 22 50738196-50745334 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 87 "testis: 106.3" "Cell line enhanced" "Detected in some" "Hep G2: 1.7;HUVEC TERT2: 1.1;NTERA-2: 1.7;TIME: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA048687 Enhanced "Secreted in male reproductive system" "HPA048687: " "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" "unprognostic (6.27e-3)" "unprognostic (3.58e-2)" "unprognostic (8.04e-2)" "unprognostic (3.30e-3)" "unprognostic (5.41e-2)" "unprognostic (1.51e-1)" "unprognostic (2.28e-1)" "unprognostic (1.34e-2)" "unprognostic (2.12e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-2)" "unprognostic (1.71e-1)" "unprognostic (2.27e-1)" "unprognostic (1.25e-1)" 0.9 0.0 0.2 0.2 0.3 0.0 0.6 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.7 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.3 0.6 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 1.2 0.0 106.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.6 0.2 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 1.4 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 ACRBP "CT23, OY-TES-1, SP32" ENSG00000111644 "Acrosin binding protein" Q8NEB7 12 6638075-6647460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 170.4" "Cell line enhanced" "Detected in some" "HEL: 5.4;HMC-1: 7.2;U-266/70: 16.0;U-266/84: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "classical monocyte: 7.7;intermediate monocyte: 9.8;myeloid DC: 11.0;non-classical monocyte: 17.6" "Group enriched" "Detected in many" 8 "dendritic cells: 11.0;monocytes: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039081, HPA039082" Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "HPA039081: AB_10670920, HPA039082: AB_10671036" "unprognostic (7.76e-3)" "unprognostic (2.27e-1)" "unprognostic (3.41e-3)" "unprognostic (2.31e-2)" "unprognostic (3.65e-2)" "unprognostic (2.13e-2)" "unprognostic (2.42e-1)" "unprognostic (3.40e-3)" "unprognostic (2.85e-1)" "unprognostic (5.47e-3)" "unprognostic (1.17e-2)" "unprognostic (1.43e-1)" "unprognostic (9.41e-3)" "unprognostic (1.25e-1)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" "unprognostic (2.80e-4)" 0.8 0.4 0.3 0.9 0.8 2.5 0.5 1.3 0.6 0.4 1.6 0.6 0.5 2.2 0.4 4.2 0.5 0.6 1.7 1.0 0.6 0.3 0.9 0.7 0.8 3.6 0.4 0.3 0.4 1.5 0.0 0.5 0.4 0.8 0.7 0.4 0.8 0.5 0.1 0.3 0.4 3.3 0.6 0.6 2.3 0.6 170.4 0.3 0.5 3.9 0.3 0.8 0.7 0.5 1.2 11.0 1.6 17.6 0.3 0.1 6.5 0.2 0.1 0.8 2.7 0.9 1.3 1.4 0.0 0.0 0.1 0.1 0.0 1.9 0.3 0.9 0.2 0.0 0.5 0.0 0.2 0.6 0.0 5.4 0.6 0.0 2.0 0.1 7.2 0.1 3.6 1.0 0.1 0.6 3.6 0.0 0.1 0.4 0.2 1.9 1.6 0.0 0.3 0.1 0.3 0.6 0.1 1.1 0.1 0.0 0.7 1.2 0.0 2.0 0.8 0.1 0.8 0.6 0.0 16.0 10.5 0.5 0.6 2.0 0.0 0.9 7.7 0.7 0.1 9.8 0.0 0.8 0.0 0.0 11.0 1.2 0.1 0.1 1.6 0.3 17.6 2.8 0.0 6.5 0.3 0.8 1.3 0.6 0.6 0.3 0.4 0.3 0.8 0.3 ACRV1 "D11S4365, SP-10, SPACA2" ENSG00000134940 "Acrosomal vesicle protein 1" P26436 11 125671522-125681123 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "testis: 57.2" "Cell line enhanced" "Detected in many" "AF22: 5.9;HEL: 6.9" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038718, HPA038719" Enhanced "Intracellular and membrane" "HPA038718: AB_2676171, HPA038719: AB_10670787" "unprognostic (3.58e-2)" "unprognostic (8.68e-3)" "unprognostic (1.46e-1)" "unprognostic (6.18e-2)" "unprognostic (4.58e-2)" "unprognostic (7.91e-3)" "unprognostic (6.73e-4)" "unprognostic (1.76e-1)" "unprognostic (2.12e-3)" "unprognostic (8.39e-2)" "unprognostic (7.09e-2)" "unprognostic (2.90e-3)" "unprognostic (1.80e-8)" "unprognostic (5.26e-3)" "unprognostic (2.52e-1)" "unprognostic (1.95e-1)" "unprognostic (3.75e-1)" 0.1 0.0 0.3 0.1 0.8 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.1 1.8 0.1 0.0 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.0 57.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.7 0.0 0.3 1.8 5.9 4.2 0.0 0.0 1.7 1.5 0.0 0.2 0.0 2.3 2.2 4.2 0.8 0.0 0.6 0.0 0.0 0.6 3.0 0.6 6.9 1.1 1.6 0.2 3.7 1.8 0.0 0.0 0.0 0.3 0.1 1.9 3.3 0.8 1.2 4.3 3.8 2.1 1.5 3.1 1.7 0.5 0.0 0.7 0.8 1.0 0.7 0.2 0.2 1.2 1.0 0.9 2.2 1.6 0.3 0.5 1.7 1.9 1.8 0.4 1.9 3.5 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.8 0.1 0.5 0.3 0.3 0.2 0.1 0.1 0.1 ACSBG2 "BGR, DKFZp434K1635, PRTD-NY3" ENSG00000130377 "Acyl-CoA synthetase bubblegum family member 2" Q5FVE4 19 6135247-6193094 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Fatty acid metabolism, Lipid metabolism, Spermatogenesis" "Developmental protein, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 71.3" "Cell line enhanced" "Detected in some" "BEWO: 1.5;HEL: 3.4;Karpas-707: 2.6;MCF7: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043421, HPA051013" Enhanced Uncertain Cytosol Cytosol "HPA043421: AB_10794182, HPA051013: " "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (2.47e-1)" "unprognostic (3.27e-2)" "unprognostic (4.33e-2)" "unprognostic (1.92e-4)" "unprognostic (1.96e-2)" "unprognostic (4.17e-2)" "unprognostic (2.07e-1)" "unprognostic (2.62e-1)" "unprognostic (6.88e-3)" "unprognostic (3.13e-2)" "unprognostic (3.91e-3)" "unprognostic (2.20e-1)" "unprognostic (9.23e-2)" "unprognostic (8.78e-2)" "unprognostic (4.70e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.4 0.0 0.1 0.0 0.6 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.0 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.4 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 ACSL3 "ACS3, FACL3, PRO2194" ENSG00000123983 "Acyl-CoA synthetase long chain family member 3" O95573 2 222860934-222944639 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 206.1" "Cell line enhanced" "Detected in all" "SK-MEL-30: 92.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011315, HPA071021" Approved Approved "Nucleoli,Lipid droplets" Nucleoli "Lipid droplets" "HPA011315: AB_1848344, HPA071021: " "unprognostic (1.87e-1)" "unprognostic (5.64e-2)" "unprognostic (2.36e-1)" "unprognostic (9.35e-3)" "unprognostic (7.53e-2)" "unprognostic (2.07e-2)" "prognostic unfavourable (2.75e-4)" "prognostic unfavourable (8.78e-4)" "unprognostic (3.90e-2)" "unprognostic (2.50e-1)" "unprognostic (2.64e-1)" "unprognostic (4.26e-2)" "unprognostic (1.17e-3)" "unprognostic (1.36e-1)" "unprognostic (2.72e-1)" "unprognostic (2.65e-1)" "unprognostic (1.60e-1)" 14.7 17.0 22.8 9.9 26.0 16.3 51.5 19.4 45.9 15.3 16.5 16.1 11.6 12.7 10.9 18.4 28.3 9.0 11.8 22.7 20.9 22.8 17.9 22.3 15.6 10.5 19.6 21.2 11.7 10.3 206.1 8.8 19.1 24.4 44.4 16.7 14.4 34.2 15.5 19.1 11.4 12.7 12.2 22.2 9.7 28.3 13.7 14.2 13.5 17.3 11.2 8.7 14.6 15.4 15.0 22.5 21.8 16.8 16.6 20.1 16.5 9.9 17.6 27.0 29.3 11.8 29.3 7.5 12.7 33.0 15.2 32.2 15.8 25.7 4.8 7.4 12.1 29.4 5.8 28.3 19.8 8.6 11.1 11.2 14.3 17.7 26.0 7.4 5.5 15.1 40.1 25.2 44.0 16.6 21.2 18.3 21.5 21.2 14.4 8.7 13.7 9.2 7.9 22.9 8.1 21.9 40.9 14.2 10.6 7.5 20.3 92.7 10.2 18.1 11.4 10.2 16.3 8.8 9.3 6.5 3.1 16.5 11.0 6.9 30.9 16.6 14.6 21.8 20.1 16.8 19.3 11.6 12.8 14.6 15.7 15.0 18.7 16.7 21.8 16.6 15.9 22.5 9.5 16.5 22.8 26.0 19.4 45.9 20.9 22.8 19.6 21.2 24.4 14.2 ACSL5 "ACS2, ACS5, FACL5" ENSG00000197142 "Acyl-CoA synthetase long chain family member 5" Q9ULC5 10 112374018-112428380 "Enzymes, Plasma proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 278.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 42.4;RT4: 43.4;U-937: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007162, CAB035986, CAB062546" Enhanced Supported Nucleoplasm,Mitochondria 22000 Mitochondria Nucleoplasm "CAB035986: AB_941506, CAB062546: , HPA007162: AB_2667761" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (3.08e-2)" "prognostic favourable (1.13e-4)" "unprognostic (2.45e-1)" "unprognostic (2.13e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-2)" "unprognostic (1.67e-1)" "unprognostic (4.06e-2)" "unprognostic (4.18e-3)" "unprognostic (7.40e-2)" "unprognostic (5.25e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (5.92e-3)" "unprognostic (1.08e-3)" 10.0 1.4 3.1 12.7 3.5 2.2 6.4 1.2 3.1 9.3 84.6 1.6 3.8 64.5 8.7 41.8 4.2 8.0 11.2 3.1 3.3 3.1 3.2 56.5 10.8 7.1 4.0 1.2 5.0 1.6 0.1 1.2 2.1 3.9 7.0 21.5 8.4 2.4 4.0 2.6 1.3 278.7 2.6 3.8 12.4 7.7 2.3 2.5 6.3 3.1 2.7 7.2 17.4 6.7 10.8 19.4 16.3 17.0 16.2 25.1 11.7 11.4 0.2 0.2 0.0 0.8 0.1 1.0 0.3 2.2 0.0 0.1 10.4 42.4 14.0 2.6 0.5 0.1 0.0 0.0 0.2 11.6 0.0 10.9 0.4 18.1 2.8 16.9 18.5 1.9 0.0 0.2 0.0 0.8 0.0 6.3 0.0 0.0 0.0 7.8 0.0 0.4 3.8 0.0 8.5 1.1 43.4 0.0 0.2 16.9 6.5 0.0 0.0 9.5 12.3 0.1 0.1 0.7 0.7 4.6 0.0 6.8 0.3 21.2 0.0 14.5 9.3 16.3 16.7 17.0 16.6 10.8 13.7 18.4 19.4 8.2 9.5 14.5 2.5 16.2 15.9 6.2 25.1 11.7 3.1 3.5 1.2 3.1 3.3 3.1 4.0 1.2 3.9 2.5 ACSM1 "BUCS1, MACS1" ENSG00000166743 "Acyl-CoA synthetase medium chain family member 1" Q08AH1 16 20623237-20698890 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "breast: 83.4" "Cell line enriched" "Detected in some" 5 "NTERA-2: 18.4" "Group enriched" "Detected in many" 8 "liver cancer: 14.7;prostate cancer: 36.7" "Cell type enhanced" "Detected in some" "eosinophil: 3.5;memory B-cell: 3.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA046291 Uncertain "HPA046291: AB_10960704" "unprognostic (1.08e-2)" "unprognostic (3.07e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (5.49e-4)" "unprognostic (1.66e-1)" "unprognostic (3.50e-2)" "unprognostic (9.46e-2)" "unprognostic (3.10e-1)" "unprognostic (8.44e-3)" "unprognostic (2.10e-1)" "unprognostic (2.64e-1)" "unprognostic (8.24e-2)" "unprognostic (3.79e-2)" "unprognostic (3.01e-1)" "unprognostic (9.58e-2)" "unprognostic (2.33e-3)" 0.0 0.1 0.0 0.0 0.0 1.1 83.4 0.1 0.1 1.7 0.4 0.2 2.3 0.2 0.1 2.4 0.2 0.1 0.0 0.0 1.2 3.8 0.2 0.1 0.0 2.8 1.4 0.5 0.0 0.0 3.4 0.2 1.2 0.2 0.1 2.2 0.4 0.3 0.0 0.2 2.1 4.5 0.2 0.1 1.1 1.5 3.4 0.0 3.5 0.9 1.3 0.6 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.9 0.1 0.0 0.3 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.1 18.4 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.6 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 3.5 0.1 0.2 0.1 3.4 0.6 0.0 0.0 2.9 0.5 0.2 0.0 1.3 0.0 0.0 0.0 0.1 ACSM5 FLJ20581 ENSG00000183549 "Acyl-CoA synthetase medium chain family member 5" Q6NUN0 16 20409534-20441336 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 94.6" "Group enriched" "Detected in some" 5 "ASC diff: 5.6;ASC TERT1: 12.3;HSkMC: 14.6;U-87 MG: 9.0" "Group enriched" "Detected in some" 7 "liver cancer: 20.5;renal cancer: 9.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.8;intermediate monocyte: 1.9;myeloid DC: 3.2;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 8 "dendritic cells: 3.2;monocytes: 2.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA041435 Uncertain Uncertain Vesicles Vesicles "HPA041435: AB_10961121" "unprognostic (1.01e-1)" "unprognostic (1.61e-3)" "unprognostic (3.73e-2)" "unprognostic (1.98e-2)" "unprognostic (1.03e-1)" "unprognostic (1.59e-2)" "unprognostic (1.84e-2)" "unprognostic (4.64e-3)" "unprognostic (1.64e-1)" "unprognostic (2.01e-2)" "unprognostic (2.15e-2)" "unprognostic (2.33e-1)" "unprognostic (5.11e-3)" "unprognostic (2.09e-2)" "unprognostic (3.85e-2)" "unprognostic (2.78e-2)" "unprognostic (1.57e-1)" 11.1 1.1 1.9 0.7 2.1 0.4 3.2 1.3 1.6 1.0 1.0 2.9 0.0 0.5 0.3 2.8 0.5 0.6 1.0 0.9 3.0 1.9 8.9 94.6 0.9 1.6 2.9 2.1 0.4 1.4 0.4 0.1 0.7 2.0 0.4 0.6 0.5 0.5 0.5 4.4 0.6 0.6 0.5 2.9 1.7 0.9 1.0 3.0 0.1 1.7 0.6 0.4 0.5 0.7 0.3 3.2 0.3 2.8 0.0 0.3 0.5 0.0 0.0 0.1 0.1 5.6 12.3 0.0 0.1 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.2 0.0 14.6 0.0 0.8 0.1 0.0 0.1 0.6 1.7 0.0 0.0 0.3 0.2 0.0 0.0 0.1 2.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 9.0 0.1 0.0 0.3 2.8 0.1 0.1 1.9 0.1 0.1 0.3 0.2 3.2 0.3 0.2 0.3 0.1 0.0 1.3 0.1 0.0 0.5 1.9 2.1 1.3 1.6 3.0 1.9 2.9 2.1 2.0 3.0 ACTC1 "ACTC, CMD1R" ENSG00000159251 "Actin, alpha, cardiac muscle 1" P68032 15 34788096-34796139 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Atrial septal defect, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "heart muscle: 243.9" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 36.4;LHCN-M2: 147.6;RH-30: 70.7" "Group enriched" "Detected in many" 6 "head and neck cancer: 20.7;prostate cancer: 5.1;testis cancer: 6.9;urothelial cancer: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB037330, HPA041264, HPA041271" Enhanced 6200000000 "CAB037330: , HPA041264: , HPA041271: " "unprognostic (8.18e-3)" "unprognostic (3.74e-2)" "unprognostic (4.82e-3)" "unprognostic (1.19e-2)" "unprognostic (3.04e-2)" "prognostic unfavourable (3.72e-5)" "unprognostic (3.26e-1)" "unprognostic (2.05e-3)" "unprognostic (2.26e-1)" "unprognostic (7.98e-2)" "unprognostic (1.14e-2)" "unprognostic (2.10e-3)" "unprognostic (5.68e-4)" "unprognostic (8.79e-2)" "unprognostic (1.65e-1)" "unprognostic (1.48e-2)" "prognostic unfavourable (9.32e-4)" 1.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 243.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.6 12.5 8.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 9.5 0.9 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 147.6 0.0 0.0 0.0 0.1 0.0 0.0 70.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 ACTL10 C20orf134 ENSG00000182584 "Actin like 10" Q5JWF8 20 33666498-33668525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 46.3" "Cell line enhanced" "Detected in many" "HaCaT: 6.1;RPMI-8226: 8.0;SiHa: 5.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "unprognostic (5.69e-3)" "unprognostic (3.62e-1)" "unprognostic (3.79e-2)" "unprognostic (1.58e-1)" "unprognostic (5.91e-3)" "unprognostic (4.00e-3)" "unprognostic (1.80e-1)" "unprognostic (1.72e-1)" "unprognostic (5.31e-2)" "unprognostic (2.35e-1)" "unprognostic (2.58e-1)" "unprognostic (2.67e-3)" "unprognostic (5.90e-2)" "unprognostic (1.15e-1)" "unprognostic (1.27e-1)" "unprognostic (1.14e-1)" "unprognostic (8.61e-2)" 0.3 0.3 0.3 0.4 0.4 0.1 0.4 0.2 0.9 0.6 0.9 0.4 1.2 0.9 0.5 1.9 1.0 0.6 1.7 0.4 0.6 0.2 0.8 0.2 0.3 1.1 0.1 0.2 0.9 6.4 0.4 0.5 0.3 0.2 1.3 0.4 0.3 1.6 0.7 0.2 0.8 0.7 0.1 0.1 0.8 1.9 46.3 0.4 0.9 1.0 0.2 0.9 0.7 1.3 3.6 1.3 2.4 1.8 6.0 6.5 0.7 0.1 0.0 0.1 0.1 1.2 0.7 0.3 1.1 0.4 0.3 0.6 2.4 3.4 3.4 1.8 0.8 6.1 0.0 1.1 0.0 3.0 0.0 1.3 0.6 0.0 0.5 0.0 1.8 0.5 0.7 0.3 0.3 0.7 0.1 3.1 0.0 2.7 0.1 1.4 0.3 3.4 0.0 0.2 8.0 0.9 1.2 2.3 1.3 5.7 4.5 1.0 2.1 0.5 2.0 0.3 0.1 0.3 0.0 2.0 2.4 0.4 1.3 0.6 0.1 0.0 1.1 2.4 1.3 1.0 1.3 1.0 2.5 3.4 1.3 3.6 1.7 1.9 0.0 6.0 1.8 1.0 6.5 0.7 0.3 0.4 0.2 0.9 0.6 0.2 0.1 0.2 0.2 0.4 ACTL6B "ACTL6, BAF53B" ENSG00000077080 "Actin like 6B" O94805 7 100643097-100656461 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 43.6" "Group enriched" "Detected in some" 75 "SCLC-21H: 21.0;SH-SY5Y: 21.4" "Group enriched" "Detected in some" 11 "glioma: 3.9;pancreatic cancer: 1.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045126 Uncertain Approved Nucleoli Nucleoli "HPA045126: AB_10961265" "unprognostic (3.31e-2)" "unprognostic (6.89e-2)" "unprognostic (4.59e-3)" "unprognostic (4.15e-2)" "unprognostic (1.27e-3)" "unprognostic (4.81e-3)" "unprognostic (6.00e-2)" "unprognostic (8.26e-3)" "unprognostic (1.29e-1)" "unprognostic (4.72e-3)" "unprognostic (1.28e-1)" "unprognostic (3.01e-4)" "unprognostic (1.64e-1)" "unprognostic (6.84e-2)" "unprognostic (2.01e-2)" 1.1 3.8 9.4 1.1 17.4 1.1 1.0 25.9 43.6 1.0 1.2 0.8 0.0 1.3 1.0 1.0 1.0 1.0 1.0 1.0 9.7 9.9 1.1 1.0 1.1 1.0 5.3 12.2 1.0 2.2 1.0 7.0 1.0 9.4 1.0 1.1 0.3 1.0 1.0 1.0 1.1 1.2 1.1 1.6 1.0 2.0 1.7 1.9 0.0 1.1 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 17.4 25.9 26.8 9.7 9.9 5.3 12.2 9.4 1.9 ACTL7A ENSG00000187003 "Actin like 7A" Q9Y615 9 108862266-108863759 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 145 "testis: 81.7" "Cell line enhanced" "Detected in some" "BEWO: 1.7;NB-4: 1.0;U-2197: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA021624 Enhanced "HPA021624: AB_1844549" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACTL7B Tact1 ENSG00000148156 "Actin like 7B" Q9Y614 9 108854589-108856967 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 437 "testis: 43.6" "Cell line enhanced" "Detected in single" "BEWO: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021803, HPA024664" Enhanced "HPA021803: AB_1844551, HPA024664: AB_1844552" "unprognostic (7.64e-2)" "unprognostic (1.62e-1)" "unprognostic (3.09e-1)" "unprognostic (3.83e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.5 0.0 1.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACTL8 CT57 ENSG00000117148 "Actin like 8" Q9H568 1 17755313-17827063 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 42 "testis: 23.6" "Cell line enriched" "Detected in some" 8 "U-266/84: 70.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027176 Approved Cytosol Cytosol "HPA027176: AB_1844553" "unprognostic (1.79e-3)" "unprognostic (3.18e-2)" "unprognostic (4.62e-2)" "prognostic unfavourable (1.62e-6)" "unprognostic (6.18e-2)" "prognostic unfavourable (7.02e-4)" "unprognostic (1.63e-3)" "unprognostic (2.33e-2)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "unprognostic (3.69e-1)" "unprognostic (4.89e-1)" "unprognostic (1.43e-1)" "unprognostic (5.49e-2)" "unprognostic (4.68e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.7 4.1 0.0 0.7 0.0 0.0 2.8 0.0 0.0 0.0 8.3 0.0 0.0 0.1 0.0 0.0 1.6 0.1 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 70.7 0.0 1.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 ACTL9 MGC33407 ENSG00000181786 "Actin like 9" Q8TC94 19 8697397-8698822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 85 "testis: 59.5" "Cell line enriched" "Detected in single" 6 "HMC-1: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019231, HPA026693" Uncertain "HPA019231: AB_1853883, HPA026693: AB_1853884" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 ACTN3 ENSG00000248746 "Actinin alpha 3 (gene/pseudogene)" Q08043 11 66546395-66563329 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "skeletal muscle: 185.5" "Cell line enriched" "Detected in some" 11 "HDLM-2: 16.7" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA006035 Uncertain Uncertain "Actin filaments" 29000000 "Actin filaments" "HPA006035: AB_1078095" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (6.16e-2)" "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (3.35e-4)" "unprognostic (1.40e-3)" "unprognostic (5.37e-3)" "unprognostic (5.09e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.66e-2)" "unprognostic (6.71e-9)" "unprognostic (2.06e-1)" "unprognostic (6.98e-2)" "unprognostic (5.16e-2)" "unprognostic (2.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 185.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 7.7 1.9 0.1 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.2 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 ACTRT1 "AIP1, ARIP1, Arp-T1, KIAA0705" ENSG00000123165 "Actin related protein T1" Q8TDG2 X 128050962-128052398 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 83 "testis: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003119 Supported "HPA003119: AB_1078219" "unprognostic (3.68e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACTRT2 "Arp-T2, ARPM2, FLJ25424" ENSG00000169717 "Actin related protein T2" Q8TDY3 1 3021483-3022903 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 139 "testis: 60.2" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;NTERA-2: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006480, HPA025079" Enhanced "HPA006480: AB_1845047, HPA025079: AB_1845048" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACTRT3 ARPM1 ENSG00000184378 "Actin related protein T3" Q9BYD9 3 169766921-169769895 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "testis: 57.4" "Cell line enhanced" "Detected in many" "ASC diff: 15.6;HSkMC: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.4" "Group enriched" "Detected in many" 4 "B-cells: 1.2;T-cells: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035817, HPA035818" Approved Approved Nucleoplasm Nucleoplasm "HPA035817: AB_10671938, HPA035818: " "unprognostic (2.35e-1)" "unprognostic (9.39e-2)" "unprognostic (2.10e-2)" "prognostic unfavourable (4.11e-4)" "unprognostic (1.89e-2)" "unprognostic (1.75e-1)" "unprognostic (3.29e-1)" "unprognostic (1.24e-1)" "unprognostic (7.31e-4)" "unprognostic (2.64e-1)" "unprognostic (9.16e-2)" "unprognostic (4.41e-2)" "unprognostic (8.03e-2)" "unprognostic (8.49e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-3)" "unprognostic (2.22e-1)" 1.0 0.7 0.9 0.4 1.1 0.5 1.5 2.4 1.3 1.0 0.5 0.5 1.3 0.7 0.7 1.4 0.6 1.4 0.5 0.7 0.7 0.9 1.8 1.7 0.7 0.6 1.0 0.4 1.1 0.3 0.8 1.0 0.7 1.1 1.0 0.4 0.6 0.5 1.3 0.7 0.3 0.5 1.0 0.6 0.1 0.8 57.4 0.7 0.2 1.0 0.1 0.5 1.5 3.1 1.2 0.5 0.0 0.0 0.0 3.4 0.4 3.5 2.1 0.1 1.1 15.6 5.0 0.0 4.3 2.5 2.7 2.3 0.0 4.5 0.0 6.0 4.8 2.3 1.2 2.0 2.8 2.6 1.5 8.2 1.8 0.4 2.6 0.9 0.7 10.1 0.5 3.3 0.6 4.8 0.0 0.0 4.7 1.8 0.3 0.1 3.8 4.5 0.6 0.0 0.1 2.8 0.9 2.8 2.0 5.1 1.3 0.1 2.2 3.6 2.1 0.0 0.0 2.2 0.0 0.5 0.2 0.2 1.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 3.4 1.2 0.0 1.1 0.5 1.1 0.4 0.4 0.0 0.0 0.0 0.5 0.0 0.4 0.9 1.1 2.4 1.3 0.7 0.9 1.0 0.4 1.1 0.7 ADAD1 Tenr ENSG00000164113 "Adenosine deaminase domain containing 1" Q96M93 4 122378966-122429802 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 331 "testis: 65.5" "Cell line enhanced" "Detected in single" "NB-4: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "pons and medulla: 0.2" "unprognostic (1.37e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 ADAD2 "FLJ00337, TENRL" ENSG00000140955 "Adenosine deaminase domain containing 2" Q8NCV1 16 84191138-84197168 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "testis: 68.1" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "myeloid DC: 1.6" "Lineage enhanced" "Detected in single" "dendritic cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.73e-2)" "unprognostic (1.26e-2)" "unprognostic (1.06e-2)" "unprognostic (2.18e-2)" "unprognostic (6.72e-2)" "unprognostic (1.16e-2)" "unprognostic (1.39e-3)" "unprognostic (2.46e-1)" "unprognostic (1.82e-1)" "unprognostic (5.95e-2)" "unprognostic (3.01e-2)" "unprognostic (6.68e-2)" "unprognostic (1.69e-1)" "unprognostic (7.40e-2)" "unprognostic (3.18e-1)" "unprognostic (3.52e-1)" "unprognostic (2.47e-2)" 0.2 0.0 0.9 0.1 1.1 0.0 0.1 0.1 0.6 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 1.9 0.0 68.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 1.6 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 7.7 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.9 1.1 0.1 0.6 0.3 0.0 0.1 0.1 0.1 0.1 ADAM12 "MCMPMltna, MLTN" ENSG00000148848 "ADAM metallopeptidase domain 12" O43184 10 126012381-126388455 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 50 "placenta: 487.4" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 46.4;hTEC/SVTERT24-B: 29.2;U-2197: 28.8;U-251 MG: 25.7;U-87 MG: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 9.8" "Lineage enriched" "Detected in single" 98 "T-cells: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA030866, HPA030867, HPA030868" Enhanced Supported "Plasma membrane" "Secreted in female reproductive system" "Plasma membrane" "HPA030866: , HPA030867: AB_10602428, HPA030868: " "unprognostic (3.35e-1)" "unprognostic (1.05e-3)" "unprognostic (3.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.34e-2)" "unprognostic (2.16e-1)" "unprognostic (2.91e-6)" "unprognostic (2.17e-2)" "unprognostic (4.85e-2)" "unprognostic (1.30e-2)" "unprognostic (2.53e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.39e-14)" "unprognostic (3.11e-3)" "unprognostic (9.06e-3)" "unprognostic (4.70e-3)" "unprognostic (3.47e-3)" 6.0 0.0 0.6 2.1 2.8 0.0 5.9 0.6 0.6 8.0 0.5 0.5 0.4 0.0 2.6 0.5 0.5 0.1 4.6 0.7 0.6 0.7 1.0 0.4 1.1 1.0 0.8 0.5 8.2 0.6 0.0 1.1 487.4 0.8 0.7 0.1 0.9 1.1 0.4 0.5 0.3 0.4 1.5 0.7 0.5 0.1 0.7 0.6 0.5 0.4 0.5 1.2 4.5 0.8 0.0 0.0 0.0 0.0 0.0 9.8 0.1 4.9 0.7 2.0 0.0 5.9 12.2 0.0 12.9 1.0 4.4 11.1 0.0 0.0 0.0 0.0 46.4 0.0 0.0 0.4 4.8 0.5 0.1 0.0 7.9 0.0 0.9 0.0 10.3 14.9 0.0 29.2 0.9 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.8 0.0 1.5 1.3 0.1 13.3 0.1 8.8 1.5 0.0 0.2 0.0 0.0 0.0 15.9 5.3 28.8 25.7 0.0 0.1 0.0 22.1 0.0 9.8 0.0 0.0 0.0 0.5 0.0 9.8 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.6 2.8 0.6 0.6 0.6 0.7 0.8 0.5 0.8 0.6 ADAM18 "ADAM27, tMDCIII" ENSG00000168619 "ADAM metallopeptidase domain 18" Q9Y3Q7 8 39584489-39730064 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 98 "testis: 42.7" "Cell line enhanced" "Detected in single" "Karpas-707: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low region specificity" "Detected in many" "Intracellular and membrane" "unprognostic (2.10e-4)" "unprognostic (1.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAM2 "CT15, FTNB, PH-30b, PH30" ENSG00000104755 "ADAM metallopeptidase domain 2" Q99965 8 39743735-39838289 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 416 "testis: 50.6" "Cell line enriched" "Detected in single" 21 "U-266/70: 2.0" "Cancer enhanced" "Detected in single" "prostate cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB022390, HPA024621, HPA026581" Enhanced "CAB022390: , HPA024621: AB_1844576, HPA026581: AB_1844577" "unprognostic (4.74e-2)" "unprognostic (1.67e-3)" "unprognostic (3.82e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAM20 ENSG00000134007 "ADAM metallopeptidase domain 20" O43506 14 70522358-70535015 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 18 "testis: 18.7" "Low cell line specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" HPA059377 Enhanced "HPA059377: " "unprognostic (4.13e-3)" "unprognostic (3.45e-2)" "unprognostic (1.14e-1)" "unprognostic (8.34e-2)" "unprognostic (2.06e-1)" "unprognostic (1.57e-2)" "unprognostic (5.61e-2)" "unprognostic (2.89e-2)" "unprognostic (1.58e-3)" "unprognostic (1.77e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.46e-3)" "unprognostic (2.64e-1)" "unprognostic (6.83e-2)" "unprognostic (5.06e-2)" "unprognostic (9.52e-3)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.7 0.4 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.0 18.7 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.6 0.0 1.0 0.0 0.3 0.3 0.4 0.2 0.0 0.0 0.3 0.2 0.1 0.3 0.3 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.5 0.4 0.2 0.0 0.0 0.3 0.6 0.6 0.2 0.5 0.0 0.0 0.1 1.1 0.6 0.4 0.6 0.3 0.9 0.4 0.2 0.0 0.3 0.5 0.6 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.7 0.4 0.0 0.1 0.2 0.0 0.5 0.2 0.4 0.1 0.1 0.0 0.0 0.2 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.7 0.4 0.1 0.1 0.1 0.1 0.1 0.1 ADAM21 ADAM31 ENSG00000139985 "ADAM metallopeptidase domain 21" Q9UKJ8 14 70452157-70459899 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 19.7" "Cell line enhanced" "Detected in some" "U-138 MG: 4.5;U-251 MG: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA059016 Uncertain "HPA059016: " "unprognostic (7.85e-2)" "unprognostic (7.67e-3)" "unprognostic (4.20e-2)" "unprognostic (1.35e-2)" "unprognostic (5.12e-1)" "unprognostic (1.48e-1)" "unprognostic (5.98e-2)" "unprognostic (2.16e-1)" "unprognostic (3.30e-1)" "unprognostic (2.41e-1)" "unprognostic (1.16e-1)" "unprognostic (2.72e-1)" "unprognostic (6.78e-2)" "unprognostic (1.82e-2)" "unprognostic (1.52e-1)" "unprognostic (2.08e-1)" "unprognostic (2.72e-1)" 0.1 0.6 0.1 0.1 0.1 0.0 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 19.7 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 1.6 0.3 0.9 0.2 0.3 0.8 1.6 1.6 0.5 0.9 0.6 0.1 0.4 0.1 1.0 0.0 0.6 0.7 0.1 0.5 1.6 1.0 0.6 0.8 0.6 0.1 0.4 0.3 0.0 0.3 1.0 0.1 0.4 0.9 0.3 0.1 0.8 2.1 0.0 2.0 0.2 0.1 0.2 1.2 1.2 0.0 0.3 0.0 0.7 0.7 0.0 0.7 1.7 0.5 1.7 0.5 4.5 0.2 0.3 4.3 0.3 2.3 0.0 2.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.2 0.2 0.0 0.8 0.8 1.6 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.1 0.3 0.4 0.1 0.3 0.2 0.1 0.1 0.1 ADAM29 "CT73, svph1" ENSG00000168594 "ADAM metallopeptidase domain 29" Q9UKF5 4 174829668-174978180 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 38.2" "Cell line enhanced" "Detected in some" "Karpas-707: 3.2;RH-30: 2.1;U-266/70: 1.7;U-698: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MAIT T-cell: 1.0;naive CD8 T-cell: 1.3;T-reg: 2.2" "Lineage enriched" "Detected in single" 7 "T-cells: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (6.40e-3)" "unprognostic (2.03e-2)" "unprognostic (4.72e-3)" "unprognostic (4.93e-2)" "unprognostic (1.16e-6)" "unprognostic (1.35e-1)" "unprognostic (1.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.3 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 ADAM30 svph4 ENSG00000134249 "ADAM metallopeptidase domain 30" Q9UKF2 1 119893533-119896495 "Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 301 "testis: 30.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA026080 Uncertain "HPA026080: AB_1844581" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAM32 ENSG00000197140 "ADAM metallopeptidase domain 32" Q8TC27 8 39106990-39284911 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 47.0" "Cell line enhanced" "Detected in some" "MCF7: 2.7;U-2 OS: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA044156, HPA062151" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA044156: AB_10796798, HPA062151: " "unprognostic (2.13e-1)" "unprognostic (6.92e-2)" "unprognostic (4.63e-3)" "unprognostic (8.99e-2)" "unprognostic (1.48e-1)" "unprognostic (1.52e-2)" "unprognostic (5.66e-3)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-1)" "unprognostic (3.38e-2)" "unprognostic (1.13e-7)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (8.34e-3)" "unprognostic (7.82e-2)" 0.6 0.6 0.3 0.2 0.4 0.4 0.6 0.3 0.5 0.6 0.3 0.2 0.2 0.0 0.3 0.8 0.2 0.3 0.5 0.4 0.3 0.7 0.2 0.2 0.2 0.2 0.3 0.6 0.5 1.2 0.1 0.2 0.2 0.4 0.3 0.4 0.4 0.2 0.7 0.2 0.8 0.3 0.2 0.2 0.5 0.1 47.0 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.9 0.2 1.5 0.4 2.6 0.9 0.0 0.7 0.3 0.1 0.4 2.0 0.2 0.2 1.3 0.4 1.2 0.4 0.1 2.6 0.0 0.5 2.3 0.2 0.5 0.0 1.5 0.1 0.3 0.0 2.2 0.3 0.3 0.2 0.8 2.7 0.2 0.1 0.0 0.1 0.2 0.5 1.3 2.7 0.4 0.6 0.0 0.0 0.2 0.1 0.0 0.1 0.3 0.9 0.4 0.2 0.3 0.0 1.1 0.0 0.0 2.6 3.7 0.1 1.4 0.0 0.4 0.1 0.9 0.1 0.7 1.5 0.4 0.2 0.7 0.4 0.3 0.9 0.6 0.9 0.1 0.8 0.7 0.8 1.0 2.6 0.4 0.2 0.2 0.0 0.3 0.4 0.3 0.5 0.3 0.7 0.3 0.6 0.4 0.2 ADAM7 "EAPI, GP-83" ENSG00000069206 "ADAM metallopeptidase domain 7" Q9H2U9 8 24440930-24526970 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "epididymis: 309.9" "Group enriched" "Detected in some" 31 "BEWO: 4.3;NB-4: 10.8;RPMI-8226: 2.8;SH-SY5Y: 3.3" "Group enriched" "Detected in some" 16 "prostate cancer: 1.0;renal cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA008879 Enhanced "Intracellular and membrane" "HPA008879: AB_10601789" "unprognostic (1.03e-3)" "unprognostic (3.96e-4)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 21.7 0.0 0.1 309.9 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 1.3 0.1 0.3 0.1 0.0 0.1 0.1 0.1 6.8 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 ADAMTS13 "C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP" ENSG00000160323 "ADAM metallopeptidase with thrombospondin type 1 motif 13" Q76LX8 9 133414358-133459402 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 53.7" "Cell line enhanced" "Detected in many" "SH-SY5Y: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.3" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042014, HPA042844, HPA052077" Approved Approved Vesicles "Secreted to blood" 1301000000 38000000 Vesicles "HPA042014: , HPA042844: , HPA052077: " "unprognostic (1.09e-1)" "unprognostic (1.45e-1)" "unprognostic (8.75e-4)" "unprognostic (1.49e-2)" "unprognostic (1.83e-1)" "unprognostic (3.02e-1)" "unprognostic (4.76e-2)" "unprognostic (2.54e-1)" "unprognostic (2.33e-2)" "unprognostic (1.88e-1)" "unprognostic (4.52e-5)" "unprognostic (1.11e-1)" "unprognostic (9.91e-2)" "unprognostic (4.78e-2)" "unprognostic (3.57e-1)" "unprognostic (1.82e-2)" "unprognostic (2.30e-3)" 1.4 1.0 3.1 1.4 3.7 0.5 1.4 6.6 4.2 1.4 1.4 1.4 1.4 4.1 1.6 4.0 1.4 2.1 1.5 1.7 3.4 2.2 1.8 53.7 4.8 1.4 2.1 1.4 2.3 1.8 2.2 4.2 1.7 1.6 1.6 1.1 1.6 2.5 2.0 2.6 2.9 4.4 1.4 2.0 1.4 5.5 3.8 1.4 1.4 1.7 1.4 1.4 1.7 1.4 0.3 0.0 2.3 0.0 0.0 0.5 0.1 0.0 1.4 3.4 4.7 2.7 2.5 1.2 1.1 0.9 0.5 0.7 0.5 3.7 0.4 1.5 0.8 0.6 0.3 0.6 0.1 2.0 3.1 0.4 1.4 0.7 2.0 0.1 1.1 6.6 1.7 0.5 1.3 0.3 0.1 1.4 0.5 5.6 0.1 1.5 3.6 2.0 0.4 0.4 1.6 1.5 1.4 2.2 6.9 2.4 1.3 1.8 5.9 0.6 0.8 2.5 1.4 1.6 0.0 2.5 0.6 0.5 2.1 0.4 2.8 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 3.7 6.6 4.2 3.4 2.2 2.1 1.4 1.6 1.4 ADAMTS6 ADAM-TS6 ENSG00000049192 "ADAM metallopeptidase with thrombospondin type 1 motif 6" Q9UKP5 5 65148736-65481920 "Cancer-related genes, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 32.4" "Cell line enhanced" "Detected in many" "BJ: 9.8;HBF TERT88: 10.8;hTEC/SVTERT24-B: 10.0;hTERT-HME1: 11.9;TIME: 11.2;U-2197: 12.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 4.8;naive B-cell: 3.6" "Group enriched" "Detected in many" 13 "B-cells: 4.8;T-cells: 1.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043441 Enhanced "Secreted to extracellular matrix" "HPA043441: " "unprognostic (1.53e-1)" "unprognostic (1.40e-1)" "unprognostic (2.70e-3)" "unprognostic (4.33e-2)" "unprognostic (1.03e-2)" "unprognostic (2.39e-2)" "unprognostic (8.24e-2)" "unprognostic (1.65e-2)" "unprognostic (4.77e-2)" "unprognostic (8.04e-2)" "unprognostic (1.56e-1)" "unprognostic (2.13e-1)" "unprognostic (1.13e-6)" "unprognostic (3.23e-5)" "unprognostic (2.09e-1)" "unprognostic (3.02e-4)" "unprognostic (4.18e-3)" 2.2 0.7 0.9 2.0 0.8 0.3 1.8 0.2 1.8 2.9 1.4 0.8 1.6 0.6 5.1 3.0 1.0 2.7 6.3 2.3 0.8 0.9 1.5 0.5 2.3 1.7 0.8 1.4 1.8 0.5 0.4 2.0 32.4 2.9 2.3 0.9 1.4 0.6 0.9 0.4 0.8 2.4 5.4 3.2 3.4 1.8 1.9 0.7 3.3 0.9 1.2 1.9 3.6 1.7 4.8 0.2 0.0 0.0 0.0 1.4 0.1 2.0 0.0 0.5 0.5 0.0 1.6 0.0 9.8 5.8 6.1 7.2 0.0 0.2 0.0 0.0 3.7 0.4 0.1 1.9 10.8 1.5 0.0 0.1 3.6 0.2 0.3 0.0 0.5 0.7 0.0 10.0 11.9 5.4 0.0 0.0 3.7 0.0 0.5 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 11.2 2.4 3.6 12.8 7.8 0.0 0.0 0.0 2.7 0.5 0.0 0.0 0.0 0.0 1.3 0.0 1.0 4.8 0.3 0.5 0.0 3.6 1.3 1.4 0.0 0.0 0.0 0.2 0.0 0.1 0.9 0.8 0.2 1.4 0.8 0.9 0.8 1.4 2.9 0.7 ADAMTSL4 "DKFZP434K1772, TSRC1" ENSG00000143382 "ADAMTS like 4" Q6UY14 1 150549369-150560937 "Disease related genes, Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 157.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 29.5;BEWO: 62.2;HSkMC: 13.9;K-562: 19.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 1.6;intermediate monocyte: 1.8;neutrophil: 2.3;non-classical monocyte: 3.5" "Group enriched" "Detected in many" 5 "granulocytes: 2.3;monocytes: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA006279 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" 47000000 "Plasma membrane, Cytosol" "HPA006279: AB_1078102" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "prognostic unfavourable (1.86e-4)" "unprognostic (8.09e-4)" "prognostic unfavourable (2.43e-4)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (7.52e-2)" "unprognostic (3.56e-2)" "unprognostic (1.68e-2)" "unprognostic (1.28e-2)" "unprognostic (1.51e-1)" "prognostic unfavourable (4.35e-7)" "unprognostic (1.90e-1)" "unprognostic (5.23e-2)" "unprognostic (1.44e-2)" "unprognostic (7.40e-3)" 14.4 2.4 0.8 8.9 1.4 2.2 13.2 0.7 1.1 11.0 8.2 1.5 3.9 2.2 9.7 8.1 19.7 11.1 6.6 10.7 1.0 0.2 3.4 14.9 13.3 2.3 1.4 0.4 14.5 1.8 0.2 1.3 157.1 3.4 9.4 2.4 19.1 5.7 2.3 21.1 5.4 6.0 17.4 2.2 3.9 8.9 3.3 1.1 0.8 3.8 15.5 4.8 19.1 15.9 0.0 0.5 2.3 3.5 0.0 0.1 0.6 6.5 0.1 0.1 1.2 6.0 29.5 62.2 6.3 5.6 3.8 2.2 0.5 2.5 0.0 1.3 4.3 3.3 0.2 0.9 1.5 0.5 0.1 1.8 0.7 2.6 4.8 0.0 0.9 13.9 0.2 0.9 2.1 0.0 19.9 0.1 0.6 0.1 0.0 0.3 1.1 0.2 0.0 0.0 0.0 0.6 0.2 0.0 0.2 2.0 4.9 0.0 1.4 3.4 1.1 0.2 1.8 2.6 0.1 0.5 0.1 1.4 0.2 1.2 0.1 0.0 1.6 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 3.5 0.0 0.0 0.6 0.8 1.4 0.7 1.1 1.0 0.2 1.4 0.4 3.4 1.1 ADGRB1 BAI1 ENSG00000181790 "Adhesion G protein-coupled receptor B1" O14514 8 142449430-142545009 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity, Myogenesis, Neurogenesis, Phagocytosis" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 27.4" "Cell line enhanced" "Detected in some" "AN3-CA: 11.5;MCF7: 4.2;NB-4: 5.6;RPMI-8226: 15.9;U-2 OS: 10.9" "Cancer enhanced" "Detected in many" "glioma: 11.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" "unprognostic (9.57e-4)" "unprognostic (1.28e-1)" "unprognostic (3.87e-3)" "unprognostic (8.50e-3)" "unprognostic (9.98e-2)" "unprognostic (5.87e-2)" "unprognostic (3.39e-1)" "unprognostic (2.14e-2)" "unprognostic (2.76e-1)" "unprognostic (2.55e-1)" "unprognostic (6.48e-2)" "unprognostic (3.43e-1)" "unprognostic (7.30e-11)" "unprognostic (6.27e-2)" "unprognostic (7.42e-2)" "unprognostic (4.52e-3)" "unprognostic (3.29e-2)" 1.0 3.4 13.6 1.4 18.1 0.9 1.1 5.4 27.4 2.0 1.0 3.1 0.1 1.4 1.8 2.3 0.9 1.4 0.9 0.9 11.0 11.9 1.1 0.8 1.2 1.6 8.7 9.2 1.6 1.1 0.9 2.7 2.5 9.1 1.3 0.9 0.9 2.6 1.9 0.7 3.1 1.4 1.0 2.3 3.7 1.5 2.1 3.2 0.0 0.9 0.0 1.0 0.9 0.4 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 5.6 1.8 0.0 0.1 0.0 15.9 0.0 0.0 3.1 3.1 0.0 0.0 0.2 0.1 0.3 0.0 0.1 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 18.1 5.4 19.5 11.0 11.9 8.7 9.2 9.1 3.2 ADGRB2 BAI2 ENSG00000121753 "Adhesion G protein-coupled receptor B2" O60241 1 31727117-31764893 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 52.0" "Cell line enhanced" "Detected in many" "HeLa: 20.5;SH-SY5Y: 15.0;T-47d: 17.3;U-2 OS: 16.9" "Cancer enhanced" "Detected in many" "glioma: 20.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052612, HPA054617" Enhanced Centrosome 49000 Centrosome "HPA052612: , HPA054617: " "prognostic favourable (6.46e-4)" "unprognostic (1.74e-1)" "unprognostic (7.98e-2)" "unprognostic (4.34e-2)" "unprognostic (1.90e-1)" "unprognostic (2.40e-1)" "unprognostic (8.17e-4)" "prognostic unfavourable (4.02e-5)" "unprognostic (2.31e-2)" "unprognostic (1.54e-2)" "unprognostic (1.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-3)" "unprognostic (1.63e-1)" "unprognostic (1.23e-1)" "unprognostic (1.75e-3)" "unprognostic (7.98e-2)" 2.2 5.4 15.9 1.3 26.8 1.1 1.4 7.9 52.0 2.4 1.4 7.3 0.0 5.2 2.4 1.2 1.6 2.2 2.1 2.8 18.9 8.0 1.4 0.9 1.3 1.3 7.4 16.5 1.8 1.4 1.3 2.7 3.8 8.4 2.4 1.1 1.3 1.4 3.1 1.1 1.5 5.0 2.4 2.9 1.8 1.8 3.2 6.3 1.5 3.2 0.0 1.1 2.0 0.5 0.4 0.0 0.0 0.0 0.0 0.9 0.3 0.5 4.4 4.1 11.9 1.2 0.7 2.0 2.8 4.5 2.7 4.9 0.2 1.3 0.0 2.8 1.2 0.4 1.8 0.2 0.4 3.1 1.8 0.0 20.5 0.0 0.1 0.0 1.5 0.7 0.3 3.8 0.0 0.4 0.4 0.1 3.0 0.4 7.8 0.1 5.1 1.3 11.9 0.4 0.4 0.0 5.6 3.1 15.0 6.4 0.4 0.5 17.3 0.0 0.1 2.1 16.9 0.3 0.7 0.0 0.0 0.4 6.6 0.0 5.0 0.0 0.0 0.0 0.9 0.0 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 15.9 26.8 7.9 37.6 18.9 8.0 7.4 16.5 8.4 6.3 ADGRG2 "EDDM6, GPR64, HE6, TM7LN2" ENSG00000173698 "Adhesion G protein-coupled receptor G2" Q8IZP9 X 18989309-19122637 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "epididymis: 202.4" "Cell line enhanced" "Detected in some" "A549: 6.1;BEWO: 7.7;HeLa: 6.4;NTERA-2: 6.7;SH-SY5Y: 7.0;U-2197: 15.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA001478, HPA050029" Enhanced Approved "Plasma membrane,Cytosol" 7900000 "Plasma membrane, Cytosol" "HPA001478: AB_1078923, HPA050029: AB_2680996" "unprognostic (3.33e-2)" "unprognostic (3.20e-1)" "unprognostic (2.40e-1)" "unprognostic (2.55e-2)" "unprognostic (1.58e-1)" "unprognostic (4.43e-3)" "unprognostic (2.63e-4)" "unprognostic (2.66e-1)" "unprognostic (1.27e-3)" "unprognostic (1.12e-1)" "unprognostic (1.78e-2)" "unprognostic (1.07e-1)" "unprognostic (3.54e-7)" "unprognostic (6.37e-2)" "unprognostic (3.19e-1)" "unprognostic (2.83e-1)" "unprognostic (1.35e-1)" 4.4 0.3 0.4 0.9 0.2 0.2 2.8 0.1 0.2 0.8 1.0 0.1 6.6 0.2 0.5 202.4 0.9 6.9 1.4 1.8 0.6 0.6 0.7 0.9 1.7 3.1 0.2 0.2 0.9 0.9 24.8 1.9 0.6 0.3 3.2 0.2 1.6 9.6 0.8 0.6 0.3 1.4 0.6 0.2 1.2 3.5 4.7 0.2 2.7 1.8 0.6 1.9 1.1 1.5 0.1 0.2 0.9 0.6 0.0 0.2 0.0 0.2 6.1 0.0 0.0 0.1 0.9 7.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 6.4 0.2 0.9 0.0 0.0 0.1 0.1 0.0 1.2 0.0 0.0 0.2 0.0 1.0 0.0 2.3 6.7 2.0 0.0 0.1 4.4 0.0 1.2 2.3 7.0 1.5 0.1 0.0 0.1 0.1 0.1 0.2 0.4 15.3 2.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.9 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.7 0.0 0.6 0.1 0.0 0.0 0.4 0.2 0.1 0.2 0.6 0.6 0.2 0.2 0.3 0.2 ADGRG4 "GPR112, PGR17, RP1-299I16" ENSG00000156920 "Adhesion G protein-coupled receptor G4" Q8IZF6 X 136300963-136416888 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 21 "intestine: 23.6" "Cell line enhanced" "Detected in single" "TIME: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035324 Uncertain "HPA035324: AB_10671512" "unprognostic (3.40e-3)" "unprognostic (7.68e-5)" "unprognostic (7.61e-2)" 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.9 0.0 0.0 7.1 0.7 1.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.0 23.6 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADH1A ADH1 ENSG00000187758 "Alcohol dehydrogenase 1A (class I), alpha polypeptide" P07327 4 99276367-99291028 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 322 "liver: 250.3" "Cell line enriched" "Detected in some" 5 "ASC diff: 10.9" "Cancer enriched" "Detected in some" 251 "liver cancer: 165.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009562, HPA047814, HPA060902" Enhanced Approved "Plasma membrane,Cytosol" 12000000 "Plasma membrane, Cytosol" "CAB009562: AB_2257984, HPA047814: , HPA060902: " "unprognostic (5.89e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (2.07e-1)" "unprognostic (4.40e-1)" "prognostic favourable (2.38e-4)" "unprognostic (2.78e-3)" "unprognostic (4.25e-1)" "unprognostic (4.79e-3)" "unprognostic (6.21e-2)" "unprognostic (9.36e-2)" "unprognostic (3.25e-2)" "unprognostic (1.40e-1)" "unprognostic (2.86e-2)" 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 250.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 10.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 ADH4 ADH-2 ENSG00000198099 "Alcohol dehydrogenase 4 (class II), pi polypeptide" P08319 4 99123657-99157792 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 345.2" "Cell line enriched" "Detected in some" 11 "Hep G2: 21.9" "Cancer enriched" "Detected in some" 60 "liver cancer: 230.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020525 Enhanced Uncertain Nucleoplasm,Cytosol 5300000 "Nucleoplasm, Cytosol" "HPA020525: AB_1844609" "unprognostic (2.75e-1)" "unprognostic (1.69e-2)" "unprognostic (1.85e-2)" "unprognostic (5.54e-3)" "unprognostic (2.14e-2)" "unprognostic (1.33e-2)" "prognostic favourable (7.08e-6)" "unprognostic (1.49e-1)" "unprognostic (1.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.88e-1)" "unprognostic (2.34e-2)" "unprognostic (7.16e-3)" "unprognostic (2.20e-1)" "unprognostic (5.89e-3)" 0.3 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.2 3.6 0.0 0.1 11.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.2 345.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.4 0.1 4.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.1 0.1 0.5 1.2 0.7 2.8 0.5 0.4 0.9 0.1 0.3 0.3 0.2 0.3 0.4 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.2 0.5 0.3 0.0 0.3 0.0 0.2 0.4 0.2 0.1 0.5 0.8 21.9 0.1 1.8 0.5 0.3 0.0 0.2 0.2 0.1 0.4 1.0 0.1 0.3 0.3 0.6 0.3 0.2 0.2 1.8 0.5 0.2 0.4 0.2 0.3 2.0 0.3 0.0 0.5 0.0 0.4 0.5 0.2 0.4 0.1 0.6 0.4 0.7 0.1 0.7 0.1 2.8 0.4 0.5 0.9 0.5 0.8 0.4 0.5 0.5 0.1 1.2 0.8 0.8 1.0 0.4 0.5 0.7 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 ADH6 ADH-5 ENSG00000172955 "Alcohol dehydrogenase 6 (class V)" P28332 4 99202638-99219537 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 123.3" "Cell line enriched" "Detected in some" 5 "Hep G2: 30.5" "Cancer enriched" "Detected in many" 18 "liver cancer: 46.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA067946, HPA069081" Enhanced 480000 "HPA067946: AB_2732776, HPA069081: AB_2732127" "unprognostic (1.38e-2)" "unprognostic (1.83e-2)" "unprognostic (5.82e-2)" "unprognostic (1.49e-3)" "unprognostic (8.49e-2)" "unprognostic (1.08e-1)" "unprognostic (5.11e-3)" "unprognostic (2.40e-1)" "unprognostic (3.60e-2)" "unprognostic (1.35e-1)" "unprognostic (9.72e-3)" "unprognostic (1.67e-1)" "unprognostic (3.66e-3)" "unprognostic (1.35e-1)" "unprognostic (2.43e-1)" "unprognostic (8.74e-3)" "unprognostic (3.86e-3)" 0.1 0.1 0.1 1.1 0.1 0.0 0.1 0.1 0.1 0.1 6.0 0.0 0.0 7.2 0.1 0.2 0.2 1.5 5.6 0.1 0.1 0.1 10.6 123.3 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 1.4 0.0 0.1 0.0 0.1 0.6 23.7 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.5 0.0 1.3 0.1 0.2 0.2 0.3 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 30.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 6.4 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.2 0.0 0.0 0.3 0.1 0.2 1.3 0.2 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 ADIG "MGC39724, RP5-1100H13.2, SMAF1" ENSG00000182035 Adipogenin Q0VDE8 20 38581195-38588463 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 31.4" "Cell line enhanced" "Detected in some" "BEWO: 1.4;Hep G2: 1.2;NB-4: 1.3" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA041124 Uncertain "HPA041124: AB_10795534" "unprognostic (2.97e-2)" "unprognostic (7.69e-3)" "unprognostic (2.27e-1)" "unprognostic (4.52e-3)" "unprognostic (1.34e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 7.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.1 0.1 0.0 31.4 0.1 0.1 3.2 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 AFM "ALB2, ALBA" ENSG00000079557 Afamin P43652 4 73481683-73504001 "Plasma proteins, Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "liver: 169.0" "Cell line enriched" "Detected in some" 5 "CACO-2: 5.8" "Cancer enriched" "Detected in single" 167 "liver cancer: 62.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA017006, HPA052437" Enhanced "Secreted to blood" 54865000000 5000000000 "HPA017006: AB_1844635, HPA052437: AB_2732575" "prognostic favourable (1.80e-4)" "unprognostic (5.73e-2)" "unprognostic (4.24e-2)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 169.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 AGBL5 "CCP5, FLJ21839" ENSG00000084693 "ATP/GTP binding protein like 5" Q8NDL9 2 27042364-27070622 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "testis: 91.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030981 Uncertain Supported "Microtubules,Cytokinetic bridge,Cytosol" "Cytokinetic bridge" "Microtubules, Cytosol" "HPA030981: AB_10611673" "unprognostic (1.29e-2)" "unprognostic (8.70e-2)" "unprognostic (2.26e-1)" "unprognostic (3.13e-3)" "unprognostic (1.95e-1)" "unprognostic (1.07e-1)" "prognostic unfavourable (6.87e-5)" "unprognostic (1.86e-1)" "unprognostic (4.34e-1)" "unprognostic (6.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.20e-1)" "unprognostic (3.41e-2)" "unprognostic (5.56e-2)" "unprognostic (2.05e-1)" "unprognostic (1.69e-2)" "unprognostic (4.50e-2)" 3.8 8.1 3.9 3.5 4.8 3.8 4.2 3.1 6.6 5.0 6.8 6.6 11.7 2.8 5.4 9.3 6.3 7.2 6.6 4.1 3.4 3.9 8.2 3.0 3.6 3.2 3.5 3.4 5.9 5.9 11.2 6.2 6.3 5.4 6.8 3.8 7.7 8.2 5.9 2.6 6.8 3.9 8.6 3.4 4.6 5.4 91.6 3.5 8.4 9.9 4.9 4.4 7.8 3.5 5.7 5.4 7.1 2.3 11.2 6.3 4.6 22.8 14.8 24.3 16.2 5.2 10.5 27.2 4.7 10.2 13.6 14.1 12.8 17.5 12.7 14.8 8.1 10.5 19.4 21.2 15.1 10.6 28.8 18.6 18.5 27.6 10.6 8.9 6.3 10.9 16.1 11.9 9.8 14.2 15.9 10.4 13.1 9.0 26.0 13.5 17.2 10.2 26.9 27.5 19.9 13.9 5.8 16.3 23.3 9.2 7.3 15.1 10.9 6.9 6.7 12.7 17.5 6.1 10.0 20.7 10.8 26.0 14.1 10.3 11.3 7.1 2.3 5.7 4.5 1.3 3.4 5.7 5.7 6.3 5.4 3.0 5.1 2.8 1.4 11.2 0.9 3.0 3.6 4.6 3.9 4.8 3.1 6.6 3.4 3.9 3.5 3.4 5.4 3.5 AGER "RAGE, SCARJ1" ENSG00000204305 "Advanced glycosylation end-product specific receptor" Q15109 6 32180968-32184324 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Inflammatory response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lung: 178.6" "Cell line enhanced" "Detected in some" "HEK 293: 5.3;MCF7: 4.5;RPTEC TERT1: 5.5;U-266/70: 6.6" "Cancer enhanced" "Detected in all" "lung cancer: 27.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB011682, HPA064436, HPA069474" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane,Cell Junctions" "Secreted in other tissues" 140000 "Plasma membrane, Cell Junctions" "Nucleoli fibrillar center" "CAB011682: AB_2258049, HPA064436: , HPA069474: " "unprognostic (9.37e-2)" "unprognostic (3.70e-1)" "unprognostic (2.37e-2)" "unprognostic (1.14e-1)" "unprognostic (4.55e-2)" "unprognostic (1.59e-3)" "unprognostic (4.36e-2)" "unprognostic (1.00e-1)" "unprognostic (4.38e-2)" "unprognostic (1.27e-1)" "prognostic favourable (3.41e-4)" "unprognostic (1.24e-1)" "prognostic unfavourable (9.01e-7)" "unprognostic (3.57e-1)" "unprognostic (3.70e-2)" "unprognostic (4.44e-2)" "prognostic favourable (2.74e-6)" 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.9 0.2 0.3 0.3 0.2 0.2 0.2 0.3 0.6 0.4 0.4 0.2 0.2 0.2 0.0 0.5 0.2 178.6 0.2 0.2 0.2 0.5 0.3 0.1 0.7 0.4 0.4 0.5 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.0 0.2 0.2 0.2 0.2 22.6 0.2 0.2 0.2 0.3 0.7 0.7 1.0 0.3 0.1 0.5 0.1 0.2 0.2 0.0 0.6 0.3 2.1 2.9 0.1 0.3 0.1 0.2 0.1 0.5 0.2 2.3 0.5 2.3 0.2 1.2 0.4 0.4 5.3 1.4 0.1 0.0 0.0 0.6 2.4 0.3 0.3 0.1 0.2 0.4 0.0 0.8 0.3 4.5 0.3 1.7 0.0 0.0 0.1 0.3 0.3 5.5 0.1 0.1 0.5 0.1 0.0 2.0 1.3 0.1 0.3 0.0 1.6 1.6 0.2 6.6 3.4 2.4 2.3 0.5 0.6 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.3 0.2 0.0 0.7 0.4 0.3 1.0 0.1 0.2 0.7 0.0 0.1 0.2 0.2 0.9 0.2 0.2 0.0 0.2 0.2 0.4 0.2 AGFG2 "HRBL, RABR" ENSG00000106351 "ArfGAP with FG repeats 2" O95081 7 100539211-100568219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "salivary gland: 154.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019689, HPA073562" Enhanced "HPA019689: AB_1855074, HPA073562: " "unprognostic (7.67e-2)" "unprognostic (1.04e-3)" "unprognostic (7.42e-2)" "unprognostic (2.03e-1)" "unprognostic (1.39e-2)" "unprognostic (1.26e-2)" "unprognostic (2.03e-1)" "unprognostic (6.99e-3)" "unprognostic (9.93e-2)" "unprognostic (1.21e-1)" "prognostic favourable (9.64e-4)" "unprognostic (3.00e-1)" "prognostic favourable (1.03e-6)" "unprognostic (7.83e-2)" "unprognostic (7.47e-2)" "unprognostic (9.90e-3)" "unprognostic (9.31e-2)" 4.8 13.6 9.2 5.5 12.5 3.8 3.7 8.8 9.6 6.6 8.7 6.6 8.5 7.0 7.1 4.5 14.3 7.7 7.9 5.1 9.1 5.1 7.1 21.4 4.7 5.6 7.2 8.6 11.3 9.7 3.4 8.4 2.7 7.7 5.9 6.9 4.0 154.3 9.5 3.8 11.7 6.5 5.7 10.0 11.7 5.5 6.8 7.5 4.0 6.5 3.7 10.9 5.2 4.7 1.4 1.0 4.5 0.4 1.1 4.5 1.1 6.7 11.1 1.4 3.3 10.2 5.3 2.0 3.3 8.9 5.2 5.5 9.7 6.2 4.3 11.0 3.8 5.7 1.6 3.3 2.4 15.1 4.4 1.3 5.1 20.8 4.1 1.4 7.7 8.8 2.6 4.2 4.7 14.2 4.0 6.0 4.2 6.0 5.5 5.0 0.9 4.7 2.7 1.6 3.8 3.0 3.6 2.0 2.5 6.4 9.2 2.9 2.6 1.9 3.5 6.5 4.4 16.2 3.4 3.7 19.0 1.6 4.9 4.1 3.7 3.6 0.1 4.5 3.8 0.4 3.3 0.7 3.8 4.5 0.2 1.4 1.3 1.7 0.9 1.1 0.1 1.0 3.0 1.1 9.2 12.5 8.8 9.6 9.1 5.1 7.2 8.6 7.7 7.5 AGT SERPINA8 ENSG00000135744 Angiotensinogen P01019 1 230702523-230714297 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 309.0" "Group enriched" "Detected in some" 6 "Hep G2: 108.5;THP-1: 41.4" "Group enriched" "Detected in all" 10 "glioma: 275.3;liver cancer: 1163.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB025798 Supported "Secreted to blood" 2420000 110000000000 "CAB025798: " "unprognostic (7.77e-2)" "unprognostic (4.46e-1)" "unprognostic (2.15e-2)" "unprognostic (2.07e-2)" "unprognostic (2.67e-1)" "unprognostic (3.61e-2)" "unprognostic (5.75e-2)" "unprognostic (2.50e-1)" "unprognostic (2.20e-2)" "unprognostic (4.46e-2)" "unprognostic (4.32e-3)" "unprognostic (6.70e-2)" "unprognostic (9.28e-2)" "unprognostic (4.42e-3)" "unprognostic (2.17e-1)" "unprognostic (3.89e-1)" "unprognostic (1.38e-1)" 2.8 3.2 23.6 1.9 25.0 1.4 1.6 17.1 37.0 3.8 2.1 24.2 0.0 1.9 1.7 1.8 2.0 2.3 22.5 30.9 18.0 11.9 9.3 309.0 1.6 1.5 19.5 15.0 1.8 2.3 1.8 2.6 1.5 23.8 2.5 2.2 0.0 1.5 1.9 7.8 1.4 2.2 2.6 29.8 1.4 2.4 2.0 15.9 0.0 1.9 0.5 1.4 3.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 108.5 0.3 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.9 0.0 41.4 0.0 0.0 0.2 0.0 0.1 0.5 7.6 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 25.0 17.1 20.0 18.0 11.9 19.5 15.0 23.8 15.9 AGXT "AGT, AGT1, AGXT1, PH1, SPAT, SPT" ENSG00000172482 "Alanine-glyoxylate aminotransferase" P21549 2 240868479-240880502 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 172 "liver: 247.3" "Cell line enriched" "Detected in some" 5 "Hep G2: 13.1" "Cancer enriched" "Detected in some" 425 "liver cancer: 253.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035370, HPA035371" Enhanced Supported Vesicles 5200000 Vesicles "HPA035370: AB_10673218, HPA035371: AB_2674593" "unprognostic (3.14e-2)" "unprognostic (2.58e-1)" "unprognostic (3.37e-4)" "unprognostic (1.04e-1)" "unprognostic (1.23e-2)" "unprognostic (9.56e-2)" "prognostic favourable (5.92e-5)" "unprognostic (8.28e-2)" "unprognostic (2.77e-1)" "unprognostic (5.39e-2)" "unprognostic (1.55e-1)" "unprognostic (7.57e-3)" "unprognostic (2.54e-1)" "unprognostic (9.22e-2)" "unprognostic (1.37e-1)" "unprognostic (3.26e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 247.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 13.1 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.2 0.0 0.0 0.0 0.1 0.0 0.8 2.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 AHNAK2 C14orf78 ENSG00000185567 "AHNAK nucleoprotein 2" Q8IVF2 14 104937244-104978357 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 131.1" "Cell line enhanced" "Detected in many" "ASC diff: 28.1;ASC TERT1: 32.0;HBEC3-KT: 28.1;hTCEpi: 70.8;hTERT-HME1: 30.2;TIME: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.6" "HPA000878, HPA002940, HPA004145, HPA020111" Enhanced Enhanced "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA000878: , HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: " "unprognostic (3.56e-1)" "unprognostic (6.04e-2)" "unprognostic (6.19e-3)" "unprognostic (1.31e-3)" "unprognostic (9.55e-4)" "unprognostic (1.76e-1)" "unprognostic (1.36e-1)" "prognostic unfavourable (2.79e-5)" "unprognostic (3.43e-1)" "unprognostic (3.06e-3)" "prognostic unfavourable (4.05e-6)" "unprognostic (1.48e-1)" "unprognostic (1.17e-2)" "unprognostic (1.39e-2)" "unprognostic (6.97e-2)" "unprognostic (2.05e-1)" "prognostic unfavourable (2.23e-5)" 6.9 1.8 2.9 2.0 5.6 1.0 8.5 3.0 13.7 17.2 23.0 2.9 5.7 1.7 16.3 2.9 25.8 7.1 3.2 1.5 2.4 3.1 1.1 10.8 2.3 1.0 2.7 11.6 1.8 1.2 1.2 0.7 1.8 23.3 5.7 5.1 10.1 6.0 14.6 1.6 131.1 4.8 19.9 4.8 1.1 7.1 3.2 0.8 0.0 1.2 14.4 3.0 10.0 19.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.6 19.7 0.0 1.3 28.1 32.0 0.0 2.4 5.0 0.8 0.4 0.0 8.8 0.0 3.3 18.5 14.2 0.0 28.1 0.4 0.0 0.1 0.0 13.0 0.1 2.6 0.0 0.9 4.1 70.8 2.8 30.2 12.3 0.0 0.0 14.2 1.6 0.0 0.0 0.0 9.7 0.0 1.3 0.0 19.2 0.0 0.1 0.1 10.4 0.0 0.4 1.3 0.0 31.7 6.8 4.2 7.7 2.1 0.0 0.0 0.0 20.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.9 5.6 3.0 13.7 2.4 3.1 2.7 11.6 23.3 0.8 AHRR "AHH, AHHR, bHLHe77, KIAA1234" ENSG00000063438 "Aryl-hydrocarbon receptor repressor" A9YTQ3 5 304176-438291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 44.3" "Cell line enhanced" "Detected in many" "HeLa: 23.4;HMC-1: 35.1;NB-4: 42.2;WM-115: 24.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA021483 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA021483: AB_1855110" "unprognostic (2.06e-4)" "unprognostic (3.48e-2)" "unprognostic (8.71e-3)" "unprognostic (2.23e-1)" "unprognostic (1.09e-1)" "unprognostic (9.33e-4)" "unprognostic (4.08e-2)" "unprognostic (1.06e-1)" "unprognostic (1.17e-1)" "unprognostic (1.02e-5)" "unprognostic (1.87e-1)" "unprognostic (5.07e-2)" "unprognostic (1.65e-6)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (1.20e-1)" "unprognostic (3.55e-2)" 0.8 0.4 1.0 4.6 0.8 0.2 2.4 0.4 1.4 2.4 1.2 0.7 1.4 0.7 1.6 0.9 1.4 0.5 4.4 0.3 1.2 1.0 0.6 0.4 6.2 0.4 0.3 0.0 2.1 1.0 0.1 1.3 2.1 0.9 0.6 1.2 2.7 0.9 0.3 0.6 5.8 1.7 0.9 0.3 4.7 0.7 44.3 0.3 0.1 0.9 1.8 4.2 2.0 3.6 0.9 2.3 1.0 0.5 0.0 1.0 0.3 0.1 3.9 0.6 0.5 2.1 4.5 4.6 8.3 11.2 4.7 9.3 0.1 3.1 0.3 4.4 15.1 0.2 0.7 0.2 2.1 0.6 1.7 3.9 23.4 0.1 1.6 1.1 35.1 0.9 0.3 3.2 0.4 1.7 0.6 0.3 5.0 0.3 0.3 42.2 0.1 3.9 0.6 0.2 0.4 0.1 0.0 5.5 0.2 11.1 2.1 5.7 0.2 14.4 2.0 8.7 1.1 9.8 0.3 1.3 2.1 0.3 3.7 0.3 24.7 0.0 0.5 1.0 0.3 0.0 0.1 0.2 0.6 0.3 0.0 0.9 0.1 0.1 0.5 0.0 0.1 2.3 1.0 0.3 1.0 0.8 0.4 1.4 1.2 1.0 0.3 0.0 0.9 0.3 AHSG "A2HS, FETUA, HSGA" ENSG00000145192 "Alpha 2-HS glycoprotein" P02765 3 186612923-186621318 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Mineral balance" "Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 269 "liver: 402.0" "Cell line enriched" "Detected in some" 77 "Hep G2: 210.3" "Cancer enriched" "Detected in some" 284 "liver cancer: 1231.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.4" "Lineage enhanced" "Detected in single" "NK-cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001524, HPA001525, CAB026209" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" 225100000000 140000000000 "Golgi apparatus" "CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849" "unprognostic (6.40e-2)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (3.20e-2)" "unprognostic (1.07e-2)" "unprognostic (1.16e-2)" "unprognostic (7.47e-3)" "unprognostic (3.05e-1)" "unprognostic (5.27e-2)" "unprognostic (8.64e-2)" "unprognostic (3.99e-7)" "unprognostic (5.21e-2)" "unprognostic (5.21e-2)" "unprognostic (1.04e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 402.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 210.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 AHSP "EDRF, ERAF" ENSG00000169877 "Alpha hemoglobin stabilizing protein" Q9NZD4 16 31527864-31528803 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "bone marrow: 189.3" "Cell line enhanced" "Detected in some" "hTCEpi: 7.5;K-562: 3.2;MOLT-4: 2.1;NTERA-2: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040940 Enhanced 8400000 "HPA040940: AB_10796231" "unprognostic (3.00e-1)" "unprognostic (2.01e-1)" "unprognostic (8.44e-2)" "unprognostic (3.76e-1)" "unprognostic (1.53e-1)" "unprognostic (3.10e-1)" "unprognostic (2.16e-1)" "unprognostic (3.70e-3)" "unprognostic (2.04e-2)" "unprognostic (9.02e-2)" "unprognostic (3.25e-2)" 0.6 0.1 0.3 0.3 0.4 189.3 0.9 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.3 0.1 0.2 0.1 0.1 4.0 0.2 0.2 1.0 3.5 20.0 0.1 0.7 0.0 0.8 1.1 0.1 1.1 30.2 0.2 0.5 0.1 1.0 0.1 0.1 0.7 0.3 0.1 0.1 0.3 18.9 0.1 2.8 0.1 1.1 2.1 0.0 0.1 1.5 0.8 0.3 0.2 0.8 0.1 0.0 0.2 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 3.2 0.0 0.0 0.0 2.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 9.2 0.3 0.4 0.0 0.1 0.2 0.2 0.7 0.0 0.2 0.1 AIPL1 LCA4 ENSG00000129221 "Aryl hydrocarbon receptor interacting protein like 1" Q9NZN9 17 6393693-6435199 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "retina: 123.7" "Cell line enhanced" "Detected in some" "HaCaT: 5.4;HeLa: 2.2" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA026578 Enhanced Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA026578: " "unprognostic (2.42e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-2)" "unprognostic (1.68e-3)" "unprognostic (3.24e-1)" "unprognostic (1.13e-3)" "unprognostic (3.76e-1)" "unprognostic (5.35e-2)" 0.1 0.1 1.4 0.4 0.3 2.9 0.1 0.5 0.8 0.2 0.1 0.1 0.1 0.0 0.1 0.3 1.1 0.0 0.3 0.1 0.6 0.5 0.1 0.1 0.2 0.1 0.5 0.1 0.2 0.1 0.0 0.8 0.1 0.1 0.1 0.0 123.7 2.3 0.1 0.1 2.4 0.1 0.1 0.1 1.0 0.2 3.3 0.1 0.2 0.4 0.1 0.2 0.1 0.1 1.0 1.1 2.2 0.7 1.1 0.6 0.0 0.2 2.0 0.6 0.2 0.1 0.1 0.5 0.0 0.4 0.1 0.7 0.1 0.2 0.4 0.2 0.0 5.4 0.2 0.2 0.3 0.3 0.4 0.6 2.2 0.6 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.5 0.3 0.1 1.1 1.7 0.2 0.0 0.0 0.1 1.4 0.2 0.3 1.1 0.4 0.0 0.3 0.0 0.0 0.4 0.3 0.6 0.4 0.4 0.2 0.1 0.9 0.6 0.2 0.9 0.7 0.6 0.6 0.3 0.3 0.6 0.3 0.1 0.3 1.0 0.3 0.4 2.2 1.1 0.5 1.1 0.4 0.0 1.4 0.3 0.5 0.5 0.6 0.5 0.5 0.1 0.1 0.1 AK5 ENSG00000154027 "Adenylate kinase 5" Q9Y6K8 1 77282051-77559969 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.5" "Cell line enhanced" "Detected in many" "ASC TERT1: 29.7;BJ: 20.3;fHDF/TERT166: 23.1;LHCN-M2: 58.2;U-2 OS: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 10.9;naive CD4 T-cell: 14.2" "Group enriched" "Detected in many" 15 "dendritic cells: 10.9;T-cells: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019128, HPA057255" Enhanced Supported "Centriolar satellite,Cytosol" Cytosol "Centriolar satellite" "HPA019128: AB_1844682, HPA057255: " "unprognostic (4.07e-2)" "unprognostic (4.23e-1)" "unprognostic (1.13e-1)" "unprognostic (2.85e-2)" "unprognostic (1.03e-1)" "unprognostic (6.04e-2)" "unprognostic (2.20e-1)" "unprognostic (2.01e-2)" "unprognostic (1.84e-1)" "unprognostic (1.51e-1)" "unprognostic (1.91e-2)" "prognostic favourable (3.88e-4)" "unprognostic (3.56e-3)" "unprognostic (6.17e-4)" "unprognostic (1.18e-1)" "unprognostic (5.96e-2)" "unprognostic (6.76e-2)" 1.8 2.1 43.8 1.9 35.7 3.7 14.1 1.3 95.5 2.0 1.8 20.4 0.0 1.8 1.6 1.5 1.8 1.8 1.7 1.5 35.8 11.8 2.0 1.2 1.4 2.5 13.0 41.1 1.5 2.1 2.4 1.4 1.8 11.4 2.7 1.8 0.0 3.1 2.7 1.3 2.4 1.7 1.7 14.2 2.4 2.9 7.3 13.9 0.0 1.7 0.0 2.1 1.5 0.4 0.8 10.9 0.7 0.7 0.1 14.2 1.9 0.0 1.1 0.8 0.0 10.9 29.7 0.4 20.3 4.3 3.3 1.4 0.1 0.5 0.1 0.1 23.1 0.1 0.0 0.0 1.7 0.7 0.2 0.1 0.1 0.0 0.5 0.1 0.0 3.6 0.1 0.6 1.3 9.5 0.2 0.2 58.2 0.2 0.0 0.1 1.1 7.4 0.5 2.1 0.3 9.0 0.3 4.5 1.1 0.0 0.0 1.2 0.1 0.1 2.3 8.0 18.2 0.4 0.6 4.7 4.2 0.0 1.6 1.0 2.9 0.7 0.7 0.0 3.4 0.1 0.5 0.8 3.2 1.6 10.9 0.8 14.2 7.8 0.5 0.1 0.2 1.2 1.4 1.9 43.8 35.7 1.3 47.1 35.8 11.8 13.0 41.1 11.4 13.9 AKAP3 "AKAP110, CT82, FSP95, SOB1" ENSG00000111254 "A-kinase anchoring protein 3" O75969 12 4615508-4649047 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 60.3" "Cell line enhanced" "Detected in many" "ASC diff: 5.5;NTERA-2: 7.9" "Cancer enriched" "Detected in many" 6 "testis cancer: 6.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 8 "B-cells: 1.5;NK-cells: 2.0;T-cells: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039765 Enhanced "HPA039765: AB_10795113" "unprognostic (2.89e-2)" "unprognostic (2.89e-1)" "unprognostic (5.85e-2)" "unprognostic (2.36e-2)" "unprognostic (2.69e-1)" "unprognostic (1.66e-1)" "unprognostic (6.88e-2)" "unprognostic (7.03e-3)" "unprognostic (8.73e-3)" "unprognostic (5.81e-3)" "unprognostic (3.08e-1)" "unprognostic (2.90e-2)" "unprognostic (8.07e-6)" "unprognostic (3.22e-3)" "unprognostic (3.21e-1)" "unprognostic (3.02e-2)" "unprognostic (1.92e-1)" 0.2 0.6 1.1 0.3 1.1 0.0 0.5 0.5 1.7 0.3 0.3 2.1 0.1 0.5 0.3 1.8 0.3 1.4 0.2 2.5 0.8 0.7 1.3 0.6 0.4 0.2 1.0 0.6 0.5 1.1 0.6 1.6 0.4 1.7 0.5 0.3 0.3 0.8 0.4 0.4 0.4 0.4 0.4 1.4 0.3 0.4 60.3 1.0 0.5 0.9 0.2 0.4 0.4 0.6 1.5 0.1 0.0 0.2 2.0 2.8 0.5 0.1 0.7 2.0 0.5 5.5 0.5 1.2 0.6 0.6 0.7 1.9 0.2 3.8 0.4 0.1 1.3 0.0 3.0 0.1 0.9 2.9 3.6 0.4 0.0 0.5 0.3 0.3 0.9 1.1 0.9 1.2 1.4 0.7 1.6 4.2 1.4 0.6 0.6 0.1 7.9 0.2 1.1 0.2 0.5 2.3 0.3 0.7 0.2 0.5 0.4 1.8 0.0 0.0 0.2 0.3 0.6 1.4 0.2 1.8 2.4 0.9 2.0 0.5 1.1 0.0 0.0 0.0 0.6 0.0 0.7 0.8 0.9 1.5 0.0 1.5 2.2 2.8 0.0 2.0 0.2 0.1 0.0 0.5 1.1 1.1 0.5 1.7 0.8 0.7 1.0 0.6 1.7 1.0 AKAP4 "AKAP82, CT99, Fsc1, hAKAP82, HI, p82" ENSG00000147081 "A-kinase anchoring protein 4" Q5JQC9 X 50190768-50201013 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 63 "testis: 86.0" "Group enriched" "Detected in some" 13 "NB-4: 1.4;U-2197: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005949, HPA020046" Enhanced "HPA005949: AB_1078120, HPA020046: AB_1844693" "unprognostic (2.94e-2)" "unprognostic (1.86e-2)" "unprognostic (2.47e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AKAP5 "AKAP75, AKAP79" ENSG00000179841 "A-kinase anchoring protein 5" P24588 14 64465499-64474503 "Plasma proteins, Predicted intracellular proteins, Transporters" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 39.1" "Cell line enhanced" "Detected in many" "CACO-2: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "basophil: 5.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 5.7" "Group enriched" "Detected in many" 5 "amygdala: 34.7;basal ganglia: 98.5;cerebral cortex: 52.2;hippocampal formation: 56.3" "CAB004308, HPA053891" Enhanced Supported Approved Nucleoplasm Nucleoplasm "CAB004308: AB_626655, HPA053891: " "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (3.44e-4)" "unprognostic (2.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.24e-3)" "unprognostic (1.08e-1)" "unprognostic (3.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.02e-3)" "unprognostic (8.23e-2)" "unprognostic (1.42e-1)" "unprognostic (5.44e-2)" "unprognostic (4.49e-4)" "unprognostic (2.11e-1)" "unprognostic (2.42e-1)" "unprognostic (7.45e-2)" 0.7 0.8 17.3 2.2 39.1 1.0 1.1 2.9 21.8 0.7 5.9 0.2 0.0 1.1 2.3 0.6 1.0 0.8 1.6 0.6 9.9 1.4 2.4 1.2 3.0 2.9 1.3 9.2 0.7 0.5 1.5 1.3 1.8 0.9 1.0 6.1 0.0 0.7 1.0 0.6 1.0 2.4 2.2 0.7 2.0 1.1 0.7 1.3 0.1 1.1 0.0 2.5 1.4 0.7 0.7 0.4 5.7 0.3 0.9 1.0 0.2 1.7 1.4 1.7 1.0 0.6 0.1 5.7 1.3 0.6 1.6 2.1 14.0 4.3 1.3 2.7 1.0 0.6 3.7 0.3 1.6 2.6 3.1 4.2 2.6 1.2 0.1 0.5 0.6 0.6 0.1 1.1 0.0 0.6 0.5 1.0 1.0 1.0 3.3 0.3 1.3 0.7 4.2 0.8 0.3 2.6 1.6 4.4 2.0 1.5 0.1 0.3 1.3 0.3 0.8 1.9 5.8 0.2 2.1 2.9 3.2 3.2 1.3 0.5 0.3 5.7 0.3 0.2 1.0 0.1 0.2 0.5 0.3 0.9 0.2 0.7 0.4 0.5 0.7 0.9 0.1 0.4 0.1 0.2 17.3 39.1 2.9 19.9 9.9 1.4 1.3 9.2 0.9 1.3 AKNAD1 "C1orf62, MGC26989" ENSG00000162641 "AKNA domain containing 1" Q5T1N1 1 108815898-108858228 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 57 "testis: 12.1" "Cell line enhanced" "Detected in some" "HAP1: 3.5;HBEC3-KT: 1.2;hTCEpi: 3.9;hTERT-HME1: 2.1;LHCN-M2: 1.2" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030270, HPA030271, HPA030272" Uncertain "HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342" "unprognostic (4.93e-2)" "unprognostic (1.72e-1)" "unprognostic (5.52e-2)" "unprognostic (2.00e-3)" "unprognostic (7.22e-2)" "unprognostic (1.08e-1)" "unprognostic (1.09e-5)" "unprognostic (8.15e-2)" "unprognostic (5.95e-2)" "unprognostic (2.83e-2)" "unprognostic (1.89e-1)" "unprognostic (2.24e-1)" "unprognostic (3.00e-8)" "unprognostic (1.08e-1)" "unprognostic (4.69e-2)" "unprognostic (5.75e-2)" "unprognostic (8.22e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.9 0.6 0.0 0.9 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.5 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 2.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AKR1C4 "3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581" ENSG00000198610 "Aldo-keto reductase family 1 member C4" P17516 10 5195462-5218949 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "liver: 127.0" "Cell line enriched" "Detected in some" 6 "HDLM-2: 11.8" "Cancer enriched" "Detected in some" 86 "liver cancer: 108.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 1.2;gdT-cell: 1.1" "Group enriched" "Detected in many" 6 "granulocytes: 1.2;T-cells: 1.1" "HPA044720, HPA068265" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" 1800000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA044720: , HPA068265: " "unprognostic (2.21e-1)" "unprognostic (3.04e-1)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (5.99e-2)" "unprognostic (9.40e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (1.52e-2)" "unprognostic (1.29e-1)" "unprognostic (3.31e-1)" "unprognostic (7.34e-2)" "unprognostic (1.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 127.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 1.1 0.1 0.0 1.5 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.5 0.3 1.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 AKR1D1 SRD5B1 ENSG00000122787 "Aldo-keto reductase family 1 member D1" P51857 7 138002324-138117986 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease mutation, FDA approved drug targets, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "liver: 103.2" "Cell line enriched" "Detected in single" 20 "Hep G2: 16.5" "Cancer enriched" "Detected in single" 77 "liver cancer: 20.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA057002 Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA057002: " "unprognostic (2.38e-1)" "unprognostic (1.65e-2)" "unprognostic (1.02e-2)" "unprognostic (1.52e-2)" "prognostic favourable (9.91e-5)" "unprognostic (6.11e-2)" "unprognostic (2.31e-1)" "unprognostic (1.30e-1)" "unprognostic (6.87e-2)" "unprognostic (2.94e-1)" "unprognostic (9.68e-3)" "unprognostic (2.90e-1)" "unprognostic (5.80e-2)" "unprognostic (3.11e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 2.7 0.5 0.7 0.7 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.8 0.2 0.2 0.1 0.0 0.3 0.0 0.0 0.2 0.3 0.1 0.4 0.3 16.5 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.3 0.2 0.1 0.2 0.1 0.4 0.0 0.3 0.0 0.1 0.2 0.2 0.1 0.1 0.2 0.4 0.2 0.2 0.1 0.3 0.2 0.3 0.3 0.2 0.2 0.2 0.3 2.7 0.5 0.6 0.4 0.4 0.3 0.6 0.4 0.4 0.3 1.1 0.5 0.7 1.8 0.7 0.5 0.5 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 AKR1E2 "AKR1CL2, AKRDC1, MGC10612" ENSG00000165568 "Aldo-keto reductase family 1 member E2" Q96JD6 10 4786629-4848062 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "testis: 35.0" "Cell line enhanced" "Detected in many" "CACO-2: 8.2;RT4: 9.6;U-2197: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 3.2;myeloid DC: 1.6;naive CD4 T-cell: 1.4;plasmacytoid DC: 1.8" "Group enriched" "Detected in many" 5 "dendritic cells: 1.8;granulocytes: 3.2;T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037821, HPA037822" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA037821: , HPA037822: AB_10671722" "unprognostic (2.33e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (8.27e-2)" "unprognostic (7.33e-2)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (7.42e-3)" "unprognostic (7.47e-2)" "unprognostic (2.77e-2)" "unprognostic (1.32e-1)" "unprognostic (1.53e-1)" "unprognostic (3.06e-2)" "unprognostic (2.74e-1)" "unprognostic (2.04e-2)" "unprognostic (1.62e-4)" "unprognostic (5.62e-2)" 3.3 1.6 1.8 3.2 2.6 2.4 4.2 1.4 2.5 2.6 2.3 0.7 3.4 1.8 5.0 1.7 1.9 1.4 5.0 2.7 1.5 1.5 1.8 1.1 4.4 2.8 1.4 2.1 1.5 2.7 3.7 1.2 2.6 1.9 1.7 1.7 5.0 1.9 2.6 2.3 2.0 1.7 2.9 2.1 1.5 2.1 35.0 0.9 0.8 4.5 2.0 0.6 1.7 2.9 0.1 1.8 3.2 0.4 0.0 1.4 0.3 0.4 5.3 2.0 0.9 0.0 0.0 0.1 2.1 0.1 0.1 0.0 8.2 0.8 0.0 0.0 5.3 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 1.0 5.6 1.0 0.0 6.0 4.6 0.0 0.0 4.9 0.6 0.0 2.2 3.9 0.0 0.0 0.0 1.5 9.6 0.0 4.5 7.7 2.1 4.1 4.1 2.2 3.6 0.0 1.8 18.3 0.0 2.5 0.0 0.0 0.1 0.0 1.5 3.2 0.4 0.3 0.1 0.2 0.0 0.1 0.4 0.2 1.6 0.0 1.4 0.4 0.1 0.0 0.0 1.8 0.0 0.3 1.8 2.6 1.4 2.5 1.5 1.5 1.4 2.1 1.9 0.9 AL031777.3 ENSG00000282988 6 26195595-26199293 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 184.8" "Cell line enhanced" "Detected in some" "K-562: 7.8;SiHa: 7.4;U-2 OS: 5.6;U-266/70: 9.4;U-266/84: 6.1" "Cell type enriched" "Detected in many" 4 "neutrophil: 18.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 18.7" HPA041189 Uncertain "HPA041189: " 1.3 1.3 0.1 10.9 0.2 13.1 4.8 0.3 0.7 3.9 3.4 0.0 2.2 0.7 1.0 2.2 7.1 1.2 1.9 4.2 0.0 1.0 1.1 3.5 12.7 0.0 0.1 2.4 1.2 0.7 0.0 3.4 0.4 2.9 0.9 0.9 1.1 3.2 0.7 0.7 3.2 1.5 2.6 8.5 1.7 4.3 0.1 184.8 0.9 3.9 11.4 4.0 0.0 2.7 1.1 18.7 1.0 0.6 1.1 0.7 0.8 0.5 0.2 0.7 0.2 0.1 0.0 0.7 0.1 1.4 0.4 0.6 0.9 0.8 2.4 0.0 1.2 0.3 0.0 0.0 2.6 0.3 0.7 2.4 1.5 0.0 0.2 0.8 1.1 0.0 0.8 0.5 0.2 7.8 1.6 0.0 1.1 2.8 1.7 0.2 2.3 0.7 0.2 4.3 0.0 0.0 0.9 0.2 7.4 0.0 0.5 4.7 0.0 0.8 0.8 5.6 0.0 0.2 9.4 6.1 0.9 0.5 2.2 0.3 4.3 0.0 1.2 0.3 0.3 0.4 0.9 0.6 0.6 0.4 2.7 0.5 0.8 18.7 0.6 1.0 1.1 1.1 0.7 AL034430.1 ENSG00000285508 20 10413520-10431922 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "blood: 31.4" "Cell line enhanced" "Detected in many" "Hep G2: 39.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" 4.4 1.7 5.0 6.3 0.0 0.6 0.0 2.5 3.2 0.0 0.0 1.2 0.0 0.0 6.2 0.0 2.8 0.0 1.0 0.0 3.7 0.0 0.4 1.3 0.0 1.6 0.0 0.0 0.0 2.3 0.0 0.0 4.3 2.9 0.0 0.0 0.0 8.2 31.4 19.1 16.3 4.3 7.4 5.0 17.6 9.3 5.8 7.6 0.0 1.0 8.1 12.5 3.6 5.2 5.7 6.4 19.3 5.0 8.0 2.8 13.1 0.0 11.5 10.0 1.4 3.0 9.2 7.7 39.5 2.9 17.8 6.0 1.5 0.0 2.9 6.3 7.8 10.7 13.4 6.9 7.2 4.2 20.0 11.0 8.7 8.1 16.8 11.2 4.3 12.0 2.7 4.4 11.5 19.9 25.8 9.5 8.5 9.2 11.9 14.3 10.2 16.1 6.8 10.3 12.4 5.8 10.2 11.4 19.1 13.7 15.7 4.7 16.3 5.5 8.2 5.6 7.4 13.4 6.7 5.3 6.4 11.8 4.3 13.7 31.4 6.5 5.0 AL035460.1 ENSG00000241690 20 2814968-2818066 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 44 "testis: 61.9" "Cell line enriched" "Detected in some" 5 "HDLM-2: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL049629.2 ENSG00000284969 "CD59 glycoprotein " 11 33698261-33722467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "placenta: 65.2" "Cell line enhanced" "Detected in many" "HBEC3-KT: 19.0;HUVEC TERT2: 24.4;TIME: 29.9;U-2197: 25.5" "Group enriched" "Detected in some" 6 "memory CD8 T-cell: 1.6;T-reg: 2.5" "Lineage enriched" "Detected in single" 8 "T-cells: 2.5" HPA026494 Uncertain Uncertain "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA026494: AB_1846321" 3.2 0.4 0.3 2.8 0.5 1.2 2.2 0.4 2.6 0.7 0.5 0.1 0.9 1.5 1.3 2.3 1.5 0.3 2.6 2.4 1.6 2.0 0.6 1.9 2.0 0.9 1.0 0.4 1.3 0.1 0.2 65.2 0.9 0.4 0.4 0.5 3.1 1.3 3.9 0.0 0.1 1.4 0.7 0.4 3.6 1.0 0.5 0.2 1.0 1.4 1.4 0.8 2.9 0.0 0.3 0.0 0.0 0.0 2.5 0.2 0.5 1.5 0.1 1.0 1.6 3.7 0.0 8.2 3.7 1.1 1.0 0.0 4.2 0.0 0.9 5.6 0.9 0.1 19.0 1.8 0.8 0.1 0.1 3.3 0.3 0.4 0.2 0.5 1.3 1.3 0.4 6.7 24.4 0.2 3.2 7.0 0.4 0.7 0.3 0.2 11.2 0.2 0.7 0.5 2.2 0.9 0.0 0.1 0.9 1.5 2.7 0.4 0.0 29.9 3.1 1.2 25.5 3.2 1.7 1.5 0.1 7.2 0.0 7.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 AL096814.1 ENSG00000214732 6 42155426-42163439 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 183 "testis: 78.6" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.4;HL-60: 1.5;hTCEpi: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL109810.2 ENSG00000235710 1 231184098-231187627 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "brain: 1.4" "Cell line enriched" "Detected in single" 5 "A549: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL121845.2 ENSG00000273047 20 63738270-63740398 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "liver: 75.1" "Cell line enhanced" "Detected in some" "Hep G2: 10.8;HHSteC: 2.4;U-266/70: 2.2;U-698: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.6" "Group enriched" "Detected in many" 26 "dendritic cells: 7.6;T-cells: 5.7" "unprognostic (3.96e-2)" "unprognostic (1.60e-1)" 2.0 0.1 0.1 0.0 0.2 0.3 1.2 0.2 0.1 0.3 1.6 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.1 0.1 0.0 8.5 75.1 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 2.3 0.0 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.1 0.1 2.4 0.1 0.2 7.6 0.0 0.2 0.0 5.7 1.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 2.2 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.0 1.3 0.2 4.7 5.7 0.0 0.2 3.2 1.9 0.0 0.0 0.2 7.6 4.4 1.1 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 AL163636.2 ENSG00000259171 14 20684587-20700576 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "liver: 164.0" "Cell line enhanced" "Detected in many" "ASC diff: 13.5;ASC TERT1: 28.9;Hep G2: 18.0;HSkMC: 12.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 12.8;memory B-cell: 4.4;myeloid DC: 6.9" "Group enriched" "Detected in many" 12 "B-cells: 4.4;dendritic cells: 6.9;monocytes: 12.8" "unprognostic (1.88e-1)" "unprognostic (3.10e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-2)" "unprognostic (1.33e-2)" "unprognostic (2.81e-3)" "unprognostic (1.93e-1)" "unprognostic (1.27e-1)" "unprognostic (2.60e-1)" "unprognostic (8.66e-2)" "unprognostic (6.61e-2)" "unprognostic (6.87e-3)" "unprognostic (8.58e-3)" "unprognostic (2.88e-1)" "unprognostic (2.53e-2)" "unprognostic (5.11e-2)" 34.3 2.1 1.3 6.1 1.6 0.0 33.2 1.0 1.2 29.1 18.6 2.5 13.9 9.8 22.0 21.0 16.8 13.3 26.8 9.1 2.2 1.4 21.5 164.0 14.5 5.5 3.0 1.2 35.6 18.7 1.4 3.0 4.7 2.6 35.2 14.2 11.8 40.5 16.1 7.8 9.9 15.5 19.9 4.0 3.3 22.6 15.0 1.8 0.0 9.3 11.8 8.1 28.9 30.3 4.4 6.9 0.2 12.8 0.0 0.6 3.2 1.6 0.5 1.4 0.0 13.5 28.9 0.0 1.8 4.5 0.0 1.1 0.2 1.9 0.0 0.3 6.8 0.6 0.4 0.2 0.0 4.2 0.4 0.3 0.0 18.0 1.0 0.0 0.1 12.8 1.0 0.0 0.6 0.8 0.0 7.5 1.8 0.0 0.1 0.2 0.0 0.4 0.2 1.0 1.3 0.4 0.7 0.0 0.1 3.0 1.1 1.2 1.4 0.0 1.6 2.1 0.6 1.5 0.2 1.5 1.3 0.0 2.3 0.3 2.4 0.0 12.8 0.0 0.0 0.7 0.3 4.4 0.6 0.3 6.9 0.9 0.2 0.1 0.2 0.0 0.0 1.4 0.6 3.2 1.3 1.6 1.0 1.2 2.2 1.4 3.0 1.2 2.6 1.8 AL353572.3 ENSG00000283205 9 87956214-87956883 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "testis: 9.5" "Cell line enriched" "Detected in single" 7 "U-2 OS: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL354761.1 ENSG00000236543 9 135604345-135618952 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 52 "skin 1: 20.8" "Cell line enriched" "Detected in single" 16 "BEWO: 13.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL358075.4 ENSG00000278139 1 46043661-46176488 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 27 "testis: 43.2" "Group enriched" "Detected in some" 5 "HeLa: 4.5;RT4: 14.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA005751 Uncertain "HPA005751: AB_1855350" 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 43.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 1.4 0.0 1.8 0.5 0.0 0.0 0.5 0.0 0.2 0.0 0.0 2.0 0.4 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.0 AL365214.3 ENSG00000281613 6 112236806-112350094 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 11 "testis: 9.9" "Cell line enriched" "Detected in single" 14 "RPTEC TERT1: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059324 Uncertain "HPA059324: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.1 0.3 0.0 0.3 0.2 0.2 0.1 0.0 0.2 0.3 0.5 0.0 0.1 0.0 0.0 0.2 0.4 0.6 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 9.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 AL391650.1 ENSG00000236782 1 26169516-26171821 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "retina: 18.5" "Cell line enhanced" "Detected in some" "Daudi: 3.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "unprognostic (4.80e-2)" "unprognostic (3.89e-2)" "unprognostic (1.78e-1)" "unprognostic (2.24e-3)" "unprognostic (9.79e-2)" "unprognostic (4.84e-2)" "unprognostic (4.87e-3)" "unprognostic (6.44e-4)" "unprognostic (4.45e-1)" "unprognostic (9.33e-2)" "unprognostic (1.93e-2)" "unprognostic (2.29e-1)" "unprognostic (1.17e-1)" "unprognostic (3.23e-1)" "unprognostic (7.73e-2)" "unprognostic (1.57e-2)" "unprognostic (2.26e-1)" 0.1 0.5 0.1 0.1 0.1 0.4 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.2 0.7 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.2 0.3 0.1 0.1 1.1 2.4 0.0 0.1 0.1 0.1 0.2 0.0 18.5 0.3 0.1 3.3 0.3 0.5 0.1 0.1 0.1 0.3 0.6 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.6 0.2 0.0 0.9 0.0 1.4 0.0 1.0 0.4 0.7 0.4 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.2 0.9 3.2 0.3 0.0 0.8 0.0 0.0 0.0 1.0 1.8 0.6 0.4 0.7 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 2.2 1.4 0.0 0.2 0.7 0.4 2.5 0.0 1.2 0.9 0.4 0.0 0.5 2.2 0.6 0.2 0.7 1.8 0.6 0.0 0.0 0.1 1.8 1.3 0.3 1.2 0.4 2.2 0.0 1.2 1.3 0.0 0.3 0.0 1.0 0.6 0.1 0.4 0.3 0.6 0.2 0.6 1.4 1.0 0.0 0.0 0.9 0.0 1.0 0.0 AL451007.3 ENSG00000284188 1 244729898-244730962 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 12.4" "Cell line enhanced" "Detected in some" "CACO-2: 1.5;NTERA-2: 1.2;SCLC-21H: 1.6" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.3 0.6 0.0 0.0 0.0 0.8 0.4 0.0 0.0 1.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 2.3 0.0 0.2 1.6 1.5 0.2 0.2 12.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.3 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.1 AL590132.1 ENSG00000284299 1 210858125-211134146 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "brain: 17.5" "Cell line enhanced" "Detected in some" "RH-30: 2.1;SH-SY5Y: 4.7;SK-MEL-30: 3.0;T-47d: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" 0.8 1.3 5.3 1.3 11.4 0.6 0.6 16.5 17.5 0.6 0.7 2.6 0.0 0.7 0.7 0.6 0.6 0.6 0.6 0.6 3.1 0.7 0.6 0.6 0.7 0.0 6.3 0.6 0.6 0.8 0.2 0.6 1.2 0.7 0.7 0.0 0.8 0.6 1.5 0.6 0.6 0.6 0.0 0.7 0.7 0.7 1.1 0.0 0.6 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.1 0.3 0.0 0.4 0.1 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.2 0.0 0.2 2.1 0.1 0.1 0.0 0.2 4.7 0.0 0.2 3.0 2.0 0.0 0.0 0.7 0.2 1.1 0.6 0.0 0.0 0.0 0.6 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL645922.1 ENSG00000244255 6 31927698-31952048 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 115.5" "Cell line enhanced" "Detected in some" "EFO-21: 1.3;Hep G2: 1.5;Karpas-707: 2.4;U-266/84: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000951, HPA001817, HPA001832" Approved Approved "Endoplasmic reticulum,Vesicles,Cell Junctions" "Endoplasmic reticulum, Vesicles" "Cell Junctions" "HPA000951: , HPA001817: AB_1078779, HPA001832: AB_1078778" "unprognostic (7.68e-2)" "unprognostic (1.86e-2)" 5.3 0.9 0.6 2.9 0.7 0.3 3.9 0.6 0.7 0.7 3.7 0.3 0.0 0.8 0.9 3.0 0.9 1.1 0.8 4.4 0.7 0.6 10.8 115.5 15.8 9.7 0.7 0.0 1.5 0.7 0.3 0.7 5.0 0.6 0.8 0.6 1.1 0.8 0.3 0.8 0.7 4.3 1.5 0.8 9.7 1.3 1.3 0.0 0.3 0.7 0.0 1.3 1.5 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.7 0.6 0.7 0.7 0.6 0.7 0.0 0.6 0.0 AL662820.1 ENSG00000285064 6 33321386-33329286 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "retina: 26.6" "Group enriched" "Detected in some" 6 "U-266/84: 1.5;U-698: 3.2;U-937: 1.6" "Cell type enhanced" "Detected in some" "naive B-cell: 2.5;neutrophil: 2.4" "Group enriched" "Detected in many" 4 "B-cells: 2.5;granulocytes: 2.4;T-cells: 1.6" 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 2.5 0.0 2.4 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.2 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 2.5 0.3 1.6 2.4 0.5 0.0 0.0 0.3 0.0 AL672043.1 ENSG00000250719 "Homo sapiens uncharacterized LOC110117498 (LOC110117498), mRNA." 1 46175486-46176478 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 64 "testis: 42.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL772284.2 ENSG00000277535 X 119073226-119076373 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 55 "testis: 9.7" "Cell line enhanced" "Detected in single" "U-266/84: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported "HPA042483: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 AL845331.2 ENSG00000259916 2 94588522-94604573 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "adipose tissue: 12.1" "Cell line enriched" "Detected in single" 11 "ASC diff: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "unprognostic (8.07e-3)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.15e-1)" "unprognostic (9.15e-3)" "unprognostic (6.22e-2)" "unprognostic (4.66e-2)" 12.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALB ENSG00000163631 Albumin P02768 4 73397114-73421412 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 81 "liver: 3075.8" "Cell line enriched" "Detected in some" 39 "Hep G2: 308.4" "Cancer enriched" "Detected in many" 384 "liver cancer: 14213.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB006262, HPA031024, HPA031025" Enhanced Enhanced "Endoplasmic reticulum,Golgi apparatus" "Secreted to blood" 40000000000000 "Golgi apparatus" "Endoplasmic reticulum" "CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704" "unprognostic (1.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.73e-1)" "unprognostic (2.60e-1)" "unprognostic (4.44e-1)" "unprognostic (2.46e-1)" "unprognostic (9.53e-3)" "unprognostic (2.16e-2)" "unprognostic (2.40e-1)" "unprognostic (6.43e-2)" "unprognostic (3.84e-2)" "unprognostic (5.37e-2)" "unprognostic (1.25e-1)" "prognostic unfavourable (7.87e-4)" "unprognostic (7.23e-2)" "unprognostic (1.05e-3)" "unprognostic (1.02e-2)" 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.0 4.9 3075.8 0.1 0.1 0.1 0.1 0.1 38.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.0 0.0 0.3 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.1 308.4 0.0 7.9 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 6.8 0.0 0.0 0.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.5 0.0 2.5 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.2 0.1 ALDOA ENSG00000149925 "Aldolase, fructose-bisphosphate A" P04075 16 30064164-30070457 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 1296.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA004177, CAB006252" Enhanced Supported Cytosol 1200000000 Cytosol "CAB006252: AB_437007, HPA004177: AB_1078128" "unprognostic (2.63e-2)" "unprognostic (3.22e-2)" "unprognostic (6.80e-2)" "unprognostic (1.33e-1)" "unprognostic (6.74e-3)" "unprognostic (4.28e-3)" "prognostic unfavourable (5.79e-5)" "prognostic unfavourable (7.32e-5)" "unprognostic (1.68e-1)" "unprognostic (1.81e-1)" "unprognostic (2.30e-2)" "unprognostic (1.57e-1)" "unprognostic (1.81e-1)" "unprognostic (1.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.19e-3)" "unprognostic (4.48e-2)" 27.9 30.9 34.7 24.2 42.3 36.0 25.3 31.2 59.7 21.0 32.8 16.3 25.9 29.4 21.9 33.9 73.5 22.1 24.4 109.3 31.6 33.4 28.2 11.1 17.9 34.0 35.0 49.6 23.4 19.4 51.0 25.2 19.9 38.0 23.6 23.5 24.6 37.9 36.9 1296.2 28.4 21.5 30.1 22.7 17.4 24.4 9.2 18.9 18.5 26.6 189.8 29.0 36.8 27.7 61.1 142.9 165.7 166.3 50.5 93.2 217.0 138.7 104.6 31.5 101.2 48.3 55.1 100.7 84.0 87.6 85.7 107.2 73.9 107.0 94.6 137.8 84.8 106.0 63.1 183.2 62.9 41.6 83.0 77.4 83.9 163.2 75.4 112.5 83.1 75.5 64.7 96.2 64.7 63.1 66.6 62.5 90.8 197.9 68.4 93.0 78.3 88.2 102.1 50.6 211.5 106.7 79.0 63.1 44.4 52.4 221.1 78.4 94.0 76.3 75.0 126.6 50.5 69.0 90.8 123.5 84.3 86.6 235.6 109.3 99.9 106.7 164.0 130.3 70.2 156.8 79.1 61.1 76.8 72.5 142.9 55.5 73.8 70.3 165.7 50.5 166.3 53.8 93.2 217.0 34.7 42.3 31.2 59.7 31.6 33.4 35.0 49.6 38.0 18.9 ALLC ALC ENSG00000151360 Allantoicase 2 3658195-3702671 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 35 "testis: 34.9" "Cell line enriched" "Detected in single" 18 "U-266/84: 11.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "unprognostic (5.47e-2)" "unprognostic (3.24e-2)" "unprognostic (2.91e-3)" "unprognostic (4.75e-1)" "unprognostic (2.17e-1)" "unprognostic (1.06e-1)" "unprognostic (9.83e-3)" "unprognostic (5.42e-2)" "unprognostic (1.74e-4)" "unprognostic (1.01e-2)" "unprognostic (2.73e-1)" 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALOXE3 "E-LOX, eLOX3" ENSG00000179148 "Arachidonate lipoxygenase 3" Q9BYJ1 17 8095900-8119047 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Isomerase, Lyase, Oxidoreductase" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 30.2" "Cell line enhanced" "Detected in some" "A-431: 6.5;HBEC3-KT: 10.6;hTCEpi: 7.8;hTERT-HME1: 14.8;T-47d: 4.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.9" "Group enriched" "Detected in many" 8 "basal ganglia: 1.1;cerebellum: 1.4;cerebral cortex: 2.3;pons and medulla: 1.1" "Group enriched" "Detected in some" 5 "gdT-cell: 1.0;naive CD4 T-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA023120, HPA078597" Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA023120: AB_10959300, HPA078597: " "unprognostic (2.40e-1)" "unprognostic (3.01e-2)" "unprognostic (1.87e-3)" "unprognostic (2.09e-4)" "unprognostic (1.07e-2)" "unprognostic (4.06e-2)" "unprognostic (3.56e-4)" "unprognostic (3.60e-1)" "unprognostic (4.65e-2)" "unprognostic (3.82e-2)" "unprognostic (3.72e-1)" "unprognostic (3.66e-5)" "unprognostic (9.81e-2)" "unprognostic (2.55e-1)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" 0.1 0.0 0.1 0.1 1.1 0.0 1.6 1.4 2.3 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.0 0.1 0.1 0.1 0.1 30.2 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 1.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 2.7 0.2 6.5 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.1 0.4 0.1 0.5 0.2 0.2 0.1 0.4 0.9 10.6 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.8 0.1 14.8 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.7 0.0 4.7 0.0 0.1 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 1.4 2.3 0.1 0.1 0.1 0.1 1.1 0.1 ALPI ENSG00000163295 "Alkaline phosphatase, intestinal" P09923 2 232456123-232460032 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 406 "intestine: 133.2" "Cell line enriched" "Detected in some" 12 "CACO-2: 12.4" "Cancer enhanced" "Detected in many" "liver cancer: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038764, HPA038765, HPA051699" Supported Approved "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA038764: , HPA038765: , HPA051699: " "unprognostic (1.01e-1)" "unprognostic (7.71e-2)" "unprognostic (4.14e-2)" "unprognostic (1.47e-1)" "unprognostic (9.57e-4)" "unprognostic (8.07e-2)" "unprognostic (1.71e-1)" "unprognostic (9.99e-2)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 63.0 0.0 0.0 57.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 1.3 0.0 0.1 0.0 0.1 0.1 133.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 ALPP ENSG00000163283 "Alkaline phosphatase, placental" P05187 2 232378534-232382889 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "placenta: 240.2" "Group enriched" "Detected in some" 6 "HaCaT: 86.1;SiHa: 23.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "CAB026327, HPA038764, HPA038765, HPA051699" Enhanced Approved "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "CAB026327: , HPA038764: , HPA038765: , HPA051699: " "unprognostic (4.86e-2)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (2.60e-1)" "unprognostic (2.44e-3)" "unprognostic (1.26e-2)" "prognostic unfavourable (4.33e-4)" "unprognostic (1.44e-1)" "unprognostic (4.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 240.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.5 1.6 0.5 1.1 0.5 0.3 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 9.7 0.0 0.0 0.0 86.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 23.7 8.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.7 0.5 0.2 0.5 0.3 0.3 0.3 0.1 1.0 0.4 0.4 1.6 1.1 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AMBN ENSG00000178522 Ameloblastin Q9NP70 4 70592256-70607288 "Disease related genes, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 10.6" "Cell line enriched" "Detected in some" 8 "HEK 293: 12.1" "Group enriched" "Detected in some" 7 "cervical cancer: 2.6;endometrial cancer: 2.9" "Region enriched" "Detected in some" 5 "basal ganglia: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036099 Approved Nucleoplasm,Vesicles "Secreted in other tissues" Vesicles Nucleoplasm "HPA036099: " "unprognostic (3.22e-1)" 0.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 2.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.1 0.0 1.2 0.2 1.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 10.6 0.0 2.0 0.0 0.4 0.1 0.0 0.4 2.0 AMBP "EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI" ENSG00000106927 "Alpha-1-microglobulin/bikunin precursor" P02760 9 114060127-114078472 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "liver: 592.2" "Cell line enriched" "Detected in some" 154 "Hep G2: 164.4" "Cancer enriched" "Detected in many" 115 "liver cancer: 2620.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001497, CAB069436, HPA075585" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" 71000000000 "Golgi apparatus" Cytosol "CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: " "unprognostic (6.92e-2)" "unprognostic (3.61e-1)" "unprognostic (4.95e-3)" "prognostic favourable (1.20e-4)" "unprognostic (9.79e-2)" "unprognostic (2.90e-1)" "unprognostic (1.04e-3)" "unprognostic (7.59e-2)" "unprognostic (2.83e-2)" "unprognostic (2.04e-1)" "unprognostic (2.14e-1)" "unprognostic (7.84e-2)" "unprognostic (4.36e-2)" "unprognostic (2.89e-3)" "unprognostic (4.66e-2)" "unprognostic (2.97e-3)" "unprognostic (9.45e-3)" 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 7.8 0.1 0.0 0.0 1.7 592.2 0.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.1 164.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.8 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 AMDHD1 MGC35366 ENSG00000139344 "Amidohydrolase domain containing 1" Q96NU7 12 95943293-95968716 "Enzymes, Predicted intracellular proteins" "Histidine metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 99.0" "Cell line enhanced" "Detected in many" "A-431: 19.1;HMC-1: 21.1;Karpas-707: 26.1;SiHa: 17.5;SK-BR-3: 19.6;U-266/70: 21.1;U-266/84: 24.7" "Cancer enriched" "Detected in many" 14 "liver cancer: 23.4" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039720, HPA040149" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" 410000 Cytosol "Nucleoplasm, Plasma membrane" "HPA039720: AB_10672967, HPA040149: " "unprognostic (4.81e-2)" "unprognostic (2.91e-1)" "unprognostic (1.53e-1)" "unprognostic (2.09e-2)" "unprognostic (1.80e-2)" "unprognostic (2.88e-2)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (1.06e-1)" "unprognostic (7.01e-2)" "unprognostic (3.35e-3)" "unprognostic (1.17e-1)" "unprognostic (4.63e-3)" "unprognostic (3.98e-2)" "unprognostic (1.70e-1)" "unprognostic (4.08e-3)" "unprognostic (2.61e-1)" 1.1 5.7 0.5 2.4 0.8 2.0 0.9 0.5 1.3 0.7 0.7 0.6 0.4 1.9 0.9 0.5 0.8 0.5 0.7 1.1 0.6 0.5 4.4 99.0 1.3 1.4 0.5 0.4 0.7 1.1 0.0 1.2 0.6 1.0 0.7 0.0 0.8 1.3 0.7 11.3 2.2 1.9 0.6 0.6 2.9 1.9 6.2 0.5 0.7 0.6 0.7 0.7 0.8 0.9 1.5 1.2 3.7 3.8 5.7 1.6 1.4 19.1 4.2 0.3 2.8 0.1 0.0 4.3 0.6 0.2 0.3 0.6 1.9 2.5 1.7 1.9 0.0 3.6 0.1 0.0 0.1 6.6 0.7 1.8 2.9 3.7 0.0 2.5 21.1 0.0 0.1 0.3 0.0 0.1 1.3 26.1 0.0 2.9 1.6 4.7 2.0 1.0 3.5 0.1 2.1 0.0 1.8 2.2 3.1 17.5 19.6 2.2 2.0 3.6 0.0 2.7 9.5 3.4 2.4 21.1 24.7 2.6 1.9 5.1 3.1 0.3 1.6 3.7 1.2 1.4 1.1 1.5 0.6 1.6 1.2 1.0 1.0 1.1 1.2 5.7 3.8 0.6 0.3 1.4 0.5 0.8 0.5 0.6 0.6 0.5 0.5 0.4 1.0 0.5 AMER2 "FAM123A, FLJ25477" ENSG00000165566 "APC membrane recruitment protein 2" Q8N7J2 13 25161684-25172288 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "brain: 57.0" "Group enriched" "Detected in some" 6 "AF22: 5.9;SCLC-21H: 5.0;U-266/70: 11.3" "Cancer enriched" "Detected in single" 24 "glioma: 4.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039458 Enhanced "HPA039458: AB_10795677" "unprognostic (1.69e-2)" "unprognostic (4.13e-2)" "unprognostic (7.43e-3)" "unprognostic (2.32e-1)" "unprognostic (3.00e-3)" "unprognostic (5.00e-3)" "unprognostic (7.28e-2)" "unprognostic (2.34e-2)" "unprognostic (5.90e-4)" "unprognostic (1.60e-2)" "unprognostic (1.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.13e-1)" "unprognostic (1.34e-1)" 1.2 1.4 15.5 1.2 33.5 1.2 1.2 11.7 57.0 1.2 1.2 24.7 0.0 1.2 1.2 1.2 1.2 2.2 1.2 1.2 19.9 9.7 1.2 1.2 1.2 1.2 41.9 9.2 1.2 1.2 1.1 1.6 1.2 15.8 1.4 1.2 0.0 1.2 1.5 1.4 1.3 1.2 1.2 15.9 1.2 1.2 2.0 47.8 0.0 1.2 0.0 1.2 1.2 0.0 0.4 0.4 1.1 0.4 0.7 0.3 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.4 0.0 0.2 0.0 0.1 1.1 0.3 0.2 0.2 0.3 0.3 0.3 0.2 0.2 0.1 0.4 0.3 0.3 0.9 0.7 0.4 0.4 0.3 0.0 15.5 33.5 11.7 20.9 19.9 9.7 41.9 9.2 15.8 47.8 AMER3 "FAM123C, FLJ38377" ENSG00000178171 "APC membrane recruitment protein 3" Q8N944 2 130755435-130768134 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 30.1" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 15.0" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Region enhanced" "Detected in many" "cerebellum: 30.1" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045593, HPA054230" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA045593: AB_10965021, HPA054230: " "unprognostic (6.68e-2)" "unprognostic (3.73e-1)" "unprognostic (2.17e-2)" "unprognostic (1.83e-1)" "unprognostic (2.71e-1)" "unprognostic (5.33e-3)" "unprognostic (1.51e-1)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (6.46e-3)" 0.5 2.4 4.8 0.7 6.0 0.8 0.5 30.1 13.9 0.5 0.8 0.0 0.0 2.0 0.6 0.5 0.5 0.5 0.5 0.5 2.7 4.3 0.5 0.5 0.5 0.6 1.8 5.6 0.6 3.3 0.4 3.4 0.5 3.0 0.6 0.8 0.7 0.5 0.5 0.5 0.7 1.2 0.5 0.8 0.6 2.5 1.6 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.3 0.3 1.5 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 15.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.1 0.2 1.5 0.2 0.1 0.3 0.1 0.0 4.8 6.0 30.1 10.3 2.7 4.3 1.8 5.6 3.0 0.7 AMH MIS ENSG00000104899 "Anti-Mullerian hormone" P03971 19 2249309-2252073 "Disease related genes, Predicted secreted proteins" "Differentiation, Gonadal differentiation" "Growth factor" "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 35.7" "Cell line enhanced" "Detected in some" "HEK 293: 17.4;NTERA-2: 6.7;REH: 6.9;SH-SY5Y: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA066973 Approved Vesicles,Aggresome "Secreted to blood" 56000 "Vesicles, Aggresome" "HPA066973: " "unprognostic (8.10e-5)" "unprognostic (1.15e-1)" "prognostic unfavourable (9.21e-5)" "unprognostic (8.73e-3)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "unprognostic (8.03e-2)" "unprognostic (8.99e-2)" "unprognostic (2.55e-1)" "unprognostic (3.53e-1)" "unprognostic (5.95e-3)" "unprognostic (1.34e-2)" "unprognostic (8.73e-8)" "unprognostic (4.64e-2)" "unprognostic (4.14e-2)" "unprognostic (2.15e-1)" "unprognostic (2.76e-1)" 0.3 0.2 1.0 0.3 2.8 0.3 0.3 4.8 1.4 0.3 0.5 0.3 0.3 0.2 0.4 0.6 0.3 0.2 0.3 0.3 0.5 1.3 0.3 0.3 0.4 0.5 0.3 0.3 1.1 0.7 0.2 3.5 0.4 0.3 0.3 0.2 0.3 0.3 0.3 2.6 0.4 0.6 0.3 0.3 0.5 0.6 35.7 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.1 0.4 0.0 0.0 4.4 0.7 0.0 0.0 0.0 0.1 0.2 0.5 1.7 0.0 0.0 0.0 0.0 0.0 2.9 17.4 0.1 0.6 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 2.5 0.4 0.0 0.5 0.1 1.3 6.7 1.5 6.9 1.4 0.9 0.0 0.2 0.5 8.0 0.1 0.0 1.5 0.8 0.0 0.7 0.6 1.3 0.9 2.5 4.9 3.6 0.8 0.3 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.8 4.8 1.4 0.5 1.3 0.3 0.3 0.3 0.3 AMMECR1L MGC4268 ENSG00000144233 "AMMECR1 like" Q6DCA0 2 127861630-127885922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "retina: 45.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000590, HPA057234" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA000590: , HPA057234: " "unprognostic (1.34e-1)" "unprognostic (1.29e-3)" "unprognostic (8.95e-2)" "prognostic unfavourable (6.10e-4)" "unprognostic (1.92e-1)" "unprognostic (9.10e-2)" "unprognostic (2.66e-2)" "unprognostic (1.19e-2)" "unprognostic (2.70e-1)" "unprognostic (1.11e-1)" "unprognostic (4.98e-2)" "unprognostic (2.27e-2)" "unprognostic (4.06e-3)" "unprognostic (7.75e-2)" "unprognostic (4.54e-1)" "unprognostic (1.12e-2)" "unprognostic (8.91e-2)" 7.8 6.4 5.2 5.2 5.2 5.0 7.1 5.7 5.2 7.6 5.5 5.2 5.2 4.6 8.7 5.2 6.4 6.9 5.9 5.2 5.2 3.3 5.2 7.7 5.6 5.2 5.2 5.2 7.6 8.8 7.6 5.2 7.3 5.2 6.4 5.7 45.9 5.9 5.2 5.2 7.2 5.8 7.5 5.2 6.8 6.1 7.9 5.2 5.2 6.1 5.2 5.4 5.8 7.3 4.2 5.4 9.0 3.7 3.5 6.1 3.2 12.2 8.2 16.9 13.8 16.1 13.1 16.0 14.5 13.2 16.0 14.5 18.2 9.2 11.9 9.7 14.3 12.2 16.4 12.1 17.6 14.1 12.0 15.1 12.2 10.3 19.2 14.9 15.5 14.4 26.5 19.6 26.5 16.7 13.8 12.0 12.8 8.7 13.9 14.5 13.4 15.2 14.6 13.6 6.8 12.7 10.7 11.2 12.6 12.0 18.8 29.1 8.7 10.4 16.6 19.8 18.6 9.2 10.9 10.1 14.8 12.3 9.5 9.6 13.1 1.6 3.2 9.0 4.7 3.7 6.1 3.6 4.5 4.1 4.8 4.2 4.1 3.8 4.3 3.5 3.7 5.4 4.2 3.2 5.2 5.2 5.7 5.2 5.2 3.3 5.2 5.2 5.2 5.2 AMN amnionless ENSG00000166126 "Amnion associated transmembrane protein" Q9BXJ7 14 102922656-102933596 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 97.6" "Cell line enhanced" "Detected in some" "CACO-2: 11.0;Hep G2: 10.8;U-698: 5.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA000817 Approved "HPA000817: AB_1078146" "unprognostic (2.02e-2)" "unprognostic (1.67e-1)" "unprognostic (3.94e-3)" "unprognostic (7.39e-3)" "unprognostic (9.32e-2)" "unprognostic (1.88e-3)" "unprognostic (8.68e-2)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (2.97e-2)" "unprognostic (7.57e-2)" "unprognostic (2.43e-2)" "prognostic favourable (9.62e-5)" "unprognostic (8.02e-2)" "unprognostic (1.58e-1)" "unprognostic (1.83e-1)" "unprognostic (1.66e-1)" 0.4 0.0 0.1 3.3 0.1 0.0 0.7 0.1 0.1 0.6 44.3 0.1 0.2 19.3 0.2 3.1 2.6 0.6 10.4 0.2 0.1 0.0 17.2 17.8 1.8 0.5 0.1 0.0 0.1 0.2 0.0 0.4 0.2 0.1 0.4 2.1 0.2 0.7 0.0 0.0 0.9 97.6 0.1 0.0 0.6 3.9 0.3 0.1 0.7 0.7 0.1 1.1 0.5 1.0 0.3 1.8 0.0 0.0 0.0 0.7 0.1 0.6 0.1 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 11.0 0.3 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.5 0.2 0.0 0.8 10.8 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.9 1.6 0.2 0.0 0.2 0.1 0.2 0.0 0.0 1.0 0.7 0.1 0.1 0.1 0.0 1.4 0.0 0.0 0.0 0.2 0.0 1.0 0.6 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.3 0.7 0.6 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 AMPD1 "MAD, MADA" ENSG00000116748 "Adenosine monophosphate deaminase 1" P23109 1 114673090-114695618 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 212.4" "Cell line enriched" "Detected in single" 32 "U-266/70: 13.9" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 31 "memory B-cell: 3.0" "Lineage enriched" "Detected in single" 31 "B-cells: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA026478, HPA028080" Enhanced "Intracellular and membrane" "HPA026478: AB_10599969, HPA028080: AB_10600776" "unprognostic (1.98e-3)" "unprognostic (1.43e-3)" "unprognostic (8.75e-3)" "unprognostic (8.03e-2)" "unprognostic (1.95e-2)" "unprognostic (5.61e-3)" "unprognostic (8.21e-2)" "unprognostic (4.29e-3)" "unprognostic (2.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.36e-5)" "unprognostic (1.68e-1)" "unprognostic (3.70e-1)" "unprognostic (3.36e-1)" "unprognostic (4.02e-1)" 2.9 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.2 3.3 0.0 0.0 3.5 0.1 3.3 1.4 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.6 1.2 0.0 2.1 1.5 212.4 0.1 1.4 0.0 0.1 0.5 0.7 0.1 0.0 0.0 0.2 25.3 2.8 0.2 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 AMPH ENSG00000078053 Amphiphysin P49418 7 38383704-38631567 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 57.2" "Cell line enhanced" "Detected in some" "ASC diff: 31.8;ASC TERT1: 18.8;BJ hTERT+ SV40 Large T+: 12.3;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HBF TERT88: 11.3;HSkMC: 11.0;U-138 MG: 12.1;WM-115: 10.8" "Cancer enhanced" "Detected in many" "glioma: 3.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008559, HPA019828, HPA019829" Enhanced Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802" "unprognostic (1.76e-2)" "unprognostic (1.59e-1)" "unprognostic (5.94e-2)" "unprognostic (7.36e-2)" "unprognostic (3.24e-3)" "unprognostic (2.92e-1)" "unprognostic (4.90e-2)" "unprognostic (2.55e-2)" "unprognostic (4.37e-1)" "unprognostic (1.08e-1)" "prognostic favourable (9.96e-4)" "unprognostic (5.06e-2)" "unprognostic (5.81e-5)" "unprognostic (1.23e-2)" "unprognostic (5.63e-2)" "unprognostic (8.03e-2)" "unprognostic (1.68e-3)" 3.8 2.4 17.4 2.5 17.7 1.0 2.8 29.7 57.2 7.7 2.2 1.8 0.0 1.4 5.1 4.7 4.5 5.7 4.2 6.5 13.5 16.0 3.7 1.4 1.6 1.3 10.4 20.4 1.7 2.9 1.2 12.6 1.0 26.5 2.4 2.5 4.8 1.5 4.2 2.9 1.3 1.9 5.0 4.9 1.9 2.0 3.5 1.5 0.0 1.2 0.2 1.1 2.9 1.7 0.2 1.6 0.0 0.8 0.7 2.9 0.2 0.0 0.0 8.0 0.0 31.8 18.8 0.0 1.1 0.0 12.3 14.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 11.3 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 11.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.1 0.0 0.1 4.0 0.0 0.0 0.0 0.9 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.1 8.5 4.2 4.5 0.0 0.1 0.0 8.2 0.1 10.8 0.0 0.8 0.0 2.9 0.2 1.7 0.0 1.0 1.5 0.2 0.2 0.4 2.0 0.0 0.7 0.2 1.6 0.2 0.2 17.4 17.7 29.7 32.9 13.5 16.0 10.4 20.4 26.5 1.5 AMY1A AMY1 ENSG00000237763 "Amylase, alpha 1A (salivary)" P04745 1 103655290-103664554 "Enzymes, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 100 "salivary gland: 654.0" "Cell line enhanced" "Detected in some" "NTERA-2: 1.3;SH-SY5Y: 2.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "CAB004310, HPA045394, HPA045399, HPA046980" Enhanced "Secreted to digestive system" 68000000 "CAB004310: AB_626668, HPA045394: , HPA045399: , HPA046980: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 654.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.3 0.3 0.6 0.0 1.1 0.7 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.1 0.6 0.0 0.1 1.1 0.1 0.3 0.1 0.0 0.7 0.2 0.0 0.5 0.0 0.1 0.7 AMY1B AMY1 ENSG00000174876 "Amylase, alpha 1B (salivary)" P04745 1 103687415-103696680 "Enzymes, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "salivary gland: 302.4" "Cell line enhanced" "Detected in some" "NTERA-2: 1.2;SH-SY5Y: 2.1;U-266/70: 1.8" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "HPA045394, HPA045399, HPA046980" Supported "Secreted to digestive system" 68000000 "HPA045394: , HPA045399: , HPA046980: " "unprognostic (7.34e-2)" "unprognostic (2.59e-1)" "unprognostic (6.05e-2)" "unprognostic (6.08e-2)" "unprognostic (1.96e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 6.5 0.2 0.2 0.2 0.0 0.2 0.2 0.2 4.0 0.2 0.2 0.2 0.0 0.2 0.2 0.7 0.2 0.2 0.2 0.2 23.0 0.0 0.2 0.2 0.2 0.2 0.0 0.2 302.4 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.2 1.1 0.2 0.2 0.2 0.2 0.1 0.3 0.3 0.6 0.0 1.1 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 1.2 0.0 0.7 0.1 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.2 0.6 0.0 0.1 1.1 0.1 0.3 0.1 0.0 0.7 0.2 0.0 0.5 0.0 0.1 0.7 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 AMY2A AMY2 ENSG00000243480 "Amylase, alpha 2A (pancreatic)" P04746 1 103616811-103625780 "Enzymes, FDA approved drug targets, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "pancreas: 1849.4" "Cell line enhanced" "Detected in some" "THP-1: 1.0;U-2 OS: 1.2" "Cancer enriched" "Detected in single" 2010 "pancreatic cancer: 200.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045394, HPA045399, CAB045960, HPA046980" Enhanced "Secreted to digestive system" 77000000 "CAB045960: AB_2226891, HPA045394: , HPA045399: , HPA046980: " "unprognostic (3.27e-1)" "unprognostic (1.78e-3)" "unprognostic (3.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.13e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.9 1849.4 0.0 0.2 0.2 0.2 0.2 0.0 0.2 59.9 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 AMY2B AMY2 ENSG00000240038 "Amylase, alpha 2B (pancreatic)" P19961 1 103553815-103579534 "Enzymes, Plasma proteins, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "pancreas: 939.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 11.3;EFO-21: 11.6" "Cancer enriched" "Detected in many" 15 "pancreatic cancer: 25.1" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "classical monocyte: 8.5" "Low lineage specificity" "Detected in many" "HPA045394, HPA045399, HPA046980" Supported "Secreted to digestive system" 75000000 "HPA045394: , HPA045399: , HPA046980: " "unprognostic (8.69e-4)" "unprognostic (3.71e-3)" "unprognostic (6.41e-2)" "unprognostic (9.75e-2)" "unprognostic (1.32e-1)" "unprognostic (1.51e-4)" "unprognostic (1.21e-2)" "unprognostic (1.63e-2)" "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (1.07e-1)" "unprognostic (2.49e-2)" "unprognostic (7.41e-3)" "unprognostic (1.55e-2)" "unprognostic (5.74e-2)" "unprognostic (4.22e-1)" "unprognostic (3.12e-4)" 1.7 0.5 0.8 0.8 1.5 0.4 1.0 2.6 0.8 0.9 0.9 0.8 0.8 0.5 0.8 1.0 0.8 1.5 0.9 1.1 0.8 0.5 1.5 1.1 1.0 1.1 1.0 0.9 1.2 939.9 0.8 1.1 0.8 0.8 0.9 0.4 0.9 145.7 1.0 1.7 1.3 0.9 0.8 0.8 1.0 0.4 0.8 0.8 0.8 2.4 1.1 0.8 0.8 0.8 1.8 2.6 1.9 8.5 0.1 1.1 1.9 0.0 0.6 1.2 0.0 6.3 11.3 1.2 0.9 0.9 0.7 1.7 0.0 0.2 1.1 11.6 0.3 1.3 0.1 1.4 1.6 1.4 1.7 2.0 4.3 0.8 0.9 2.6 2.8 7.7 7.5 0.8 1.3 0.2 0.0 3.4 0.9 0.0 2.0 0.5 0.1 1.6 0.6 0.0 5.0 6.5 2.1 3.1 0.5 2.6 1.2 0.8 0.1 1.5 0.9 0.4 1.0 0.5 0.7 3.9 0.1 0.3 2.1 1.9 0.2 0.0 8.5 1.7 0.8 3.9 0.6 1.7 0.3 0.4 2.6 1.8 1.1 0.4 1.9 0.1 3.6 0.8 0.3 1.9 0.8 1.5 2.6 0.8 0.8 0.5 1.0 0.9 0.8 0.8 ANG "RAA1, RNASE5" ENSG00000214274 Angiogenin P03950 14 20684177-20698971 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Stress response" "Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 371.4" "Cell line enriched" "Detected in many" 5 "Hep G2: 56.6" "Cancer enriched" "Detected in all" 17 "liver cancer: 279.2" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "classical monocyte: 18.1;myeloid DC: 10.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055896 Approved "Nucleoli,Actin filaments" "Secreted to blood" 307535000 230000000 Nucleoli "Actin filaments" "HPA055896: " "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.77e-2)" "prognostic favourable (6.85e-4)" "unprognostic (5.71e-3)" "unprognostic (6.99e-2)" "prognostic favourable (7.83e-5)" "unprognostic (1.16e-1)" "unprognostic (3.20e-3)" "unprognostic (9.19e-3)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (6.65e-2)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (2.00e-1)" "unprognostic (3.09e-1)" 17.0 0.9 0.7 2.6 0.7 0.7 16.4 0.5 0.7 14.4 9.0 0.7 6.6 3.5 10.7 10.3 8.0 3.8 13.3 3.8 0.8 0.7 10.6 371.4 6.9 2.3 1.0 0.1 17.7 9.0 1.3 1.1 1.9 0.8 17.5 6.5 5.5 20.2 7.7 3.5 4.0 7.4 9.7 1.5 1.5 7.9 7.1 0.4 0.0 4.2 5.5 3.6 14.3 15.0 4.5 10.4 0.3 18.1 0.0 0.9 4.8 1.4 3.7 0.9 0.0 9.3 11.2 0.1 1.6 3.2 0.4 1.5 2.2 1.9 0.1 0.4 4.5 1.4 1.0 1.1 0.5 6.2 1.4 0.3 2.0 56.6 2.0 1.4 0.2 9.0 0.9 0.5 1.9 2.1 0.0 10.4 1.3 0.2 0.3 0.4 0.2 4.1 0.2 1.5 4.2 0.9 1.1 0.0 0.1 1.6 0.6 2.5 1.5 0.2 1.8 0.6 1.1 0.5 0.2 2.2 1.7 0.2 1.1 0.7 1.8 0.0 18.1 0.0 0.3 2.1 0.2 4.5 0.9 0.8 10.4 2.4 0.2 0.2 0.3 0.0 0.1 1.6 0.4 4.8 0.7 0.7 0.5 0.6 0.8 0.7 1.0 0.1 0.8 0.4 ANGPTL3 ANGPT5 ENSG00000132855 "Angiopoietin like 3" Q9Y5C1 1 62597487-62606159 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Lipid metabolism" Heparin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 276.6" "Cell line enhanced" "Detected in some" "Hep G2: 1.1;HL-60: 2.1" "Cancer enriched" "Detected in some" 39 "liver cancer: 94.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038097 Approved "Secreted to blood" 224800000 45000000 "HPA038097: AB_10675628" "unprognostic (2.29e-1)" "unprognostic (8.01e-2)" "unprognostic (2.51e-1)" "unprognostic (4.06e-2)" "unprognostic (2.70e-1)" "unprognostic (1.25e-2)" "unprognostic (4.06e-2)" "unprognostic (1.56e-2)" "unprognostic (8.11e-3)" "unprognostic (6.85e-3)" "unprognostic (2.89e-2)" "unprognostic (1.20e-2)" "unprognostic (1.09e-2)" "unprognostic (3.08e-2)" "unprognostic (1.09e-2)" "unprognostic (5.38e-2)" "unprognostic (7.62e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.7 276.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.2 1.1 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.0 0.7 0.2 0.0 0.6 0.1 0.0 0.1 0.0 0.2 0.7 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANGPTL6 "AGF, ARP5" ENSG00000130812 "Angiopoietin like 6" Q8NI99 19 10092338-10102796 "Plasma proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "liver: 31.8" "Cell line enriched" "Detected in some" 8 "HMC-1: 36.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted to blood" 450310 550000 "unprognostic (1.28e-1)" "unprognostic (2.18e-6)" "unprognostic (1.42e-2)" "unprognostic (1.54e-1)" "unprognostic (2.16e-1)" "unprognostic (1.02e-2)" "unprognostic (8.77e-2)" "unprognostic (5.25e-2)" "unprognostic (1.00e-1)" "unprognostic (2.99e-2)" "unprognostic (1.23e-2)" "unprognostic (1.85e-1)" "unprognostic (2.26e-10)" "unprognostic (8.96e-2)" "unprognostic (4.41e-2)" "unprognostic (1.25e-2)" "unprognostic (1.32e-1)" 0.3 0.3 0.7 2.1 1.6 2.6 0.3 0.7 2.7 0.2 0.5 0.7 0.5 0.7 0.1 0.2 0.7 0.7 0.9 0.7 0.6 0.7 0.9 31.8 0.5 3.3 1.6 0.2 0.4 1.2 0.0 0.4 2.3 1.4 0.2 0.4 0.1 0.5 0.0 0.1 0.3 2.9 0.2 0.9 3.0 1.6 1.3 0.5 0.3 0.3 0.0 3.4 0.6 0.9 2.9 0.6 0.0 1.4 1.3 2.6 0.9 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 4.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.1 0.0 0.3 36.1 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.7 2.7 0.1 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 2.9 0.0 0.0 0.0 0.0 0.0 3.1 0.7 1.7 0.1 0.4 0.4 0.0 1.3 0.0 2.6 1.4 1.8 2.9 1.6 1.8 0.6 2.8 1.0 1.6 0.0 1.3 0.7 0.4 2.0 0.9 0.7 1.6 0.7 2.7 0.6 0.7 1.6 0.2 1.4 0.5 ANGPTL8 "C19orf80, RIFL, TD26" ENSG00000130173 "Angiopoietin like 8" Q6UXH0 19 11237450-11241943 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid metabolism" Hormone "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "liver: 81.0" "Group enriched" "Detected in some" 27 "Hep G2: 26.2;MCF7: 15.2" "Cancer enriched" "Detected in some" 37 "liver cancer: 84.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042131 Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" 835950 320000 "Golgi apparatus" Nucleoplasm "HPA042131: AB_10794413" "unprognostic (2.37e-2)" "unprognostic (1.86e-1)" "unprognostic (1.15e-1)" "unprognostic (1.31e-2)" "unprognostic (1.17e-1)" "unprognostic (1.00e-1)" "unprognostic (3.73e-1)" "unprognostic (2.80e-1)" "unprognostic (3.49e-1)" "unprognostic (1.02e-1)" "unprognostic (9.67e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (1.84e-6)" "unprognostic (1.09e-1)" "unprognostic (3.55e-1)" "unprognostic (4.57e-1)" "unprognostic (1.75e-2)" 8.0 0.1 0.0 0.6 0.0 0.0 5.1 0.0 0.1 0.1 5.7 0.0 0.0 0.2 0.1 0.8 0.1 0.1 1.0 0.6 0.0 0.0 1.5 81.0 0.1 3.0 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 4.8 0.1 0.7 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.7 26.2 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 15.2 0.0 0.5 0.1 0.0 0.1 0.3 0.7 0.0 0.2 0.0 0.2 0.2 0.7 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 ANHX ENSG00000227059 "Anomalous homeobox" E9PGG2 12 133218312-133236095 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 9.9" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 55 "testis cancer: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.28e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD2 ARPP ENSG00000165887 "Ankyrin repeat domain 2" Q9GZV1 10 97572499-97583884 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skeletal muscle: 472.2" "Cell line enhanced" "Detected in some" "A-431: 14.5;BJ hTERT+ SV40 Large T+: 5.4;HaCaT: 11.5;RPTEC TERT1: 12.8" "Cancer enhanced" "Detected in many" "testis cancer: 5.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 18 "granulocytes: 1.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA040842, HPA040884" Enhanced Enhanced Vesicles Vesicles "HPA040842: AB_10963794, HPA040884: AB_10969453" "unprognostic (1.27e-2)" "unprognostic (9.99e-2)" "unprognostic (2.86e-1)" "unprognostic (1.39e-2)" "unprognostic (1.37e-1)" "unprognostic (1.61e-2)" "unprognostic (2.53e-1)" "unprognostic (5.60e-3)" "unprognostic (2.17e-1)" "unprognostic (3.12e-1)" "unprognostic (4.91e-2)" "unprognostic (2.22e-1)" "unprognostic (1.05e-2)" "unprognostic (3.69e-3)" "unprognostic (4.56e-2)" "unprognostic (1.39e-1)" "unprognostic (2.13e-1)" 2.3 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.2 2.7 0.0 0.1 47.2 0.0 0.1 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.3 472.2 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 3.0 1.2 1.1 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 14.5 5.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 5.4 3.5 0.2 4.5 0.0 0.6 0.1 11.5 0.0 3.9 3.6 0.1 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.6 1.7 3.2 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.8 0.7 0.0 0.0 0.0 3.7 0.0 1.8 0.3 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 ANKRD20A2 ENSG00000183148 "Ankyrin repeat domain 20 family member A2" Q5SQ80 9 40223285-40266392 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "testis: 7.6" "Cell line enhanced" "Detected in some" "Karpas-707: 16.3;U-266/70: 2.7;U-266/84: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753" Uncertain "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: " "unprognostic (4.24e-3)" "unprognostic (9.19e-2)" 0.1 0.1 0.4 0.0 1.4 0.2 0.3 1.0 1.2 0.1 0.4 0.0 0.0 0.5 1.2 0.7 0.1 1.9 0.7 0.7 0.3 0.2 1.2 0.0 0.4 0.0 1.4 1.1 0.8 0.0 0.4 1.1 1.1 0.4 0.3 0.2 0.1 0.0 0.1 1.5 0.0 7.6 0.5 0.0 0.0 0.3 0.1 0.9 0.9 0.0 0.0 0.6 0.0 0.2 1.3 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.1 1.5 16.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.1 2.7 4.8 0.0 0.0 0.0 0.8 0.1 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 ANKRD23 "DARP, FLJ32449, MARP3" ENSG00000163126 "Ankyrin repeat domain 23" Q86SG2 2 96824526-96857934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 184.5" "Cell line enriched" "Detected in some" 8 "Karpas-707: 29.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA036201 Approved Supported "Nucleoplasm,Actin filaments" Nucleoplasm "Actin filaments" "HPA036201: AB_10673347" "unprognostic (2.48e-1)" "unprognostic (7.83e-4)" "unprognostic (4.93e-4)" "unprognostic (1.21e-2)" "unprognostic (4.28e-1)" "unprognostic (3.28e-1)" "unprognostic (3.27e-2)" "unprognostic (6.66e-2)" "unprognostic (2.46e-2)" "unprognostic (3.59e-2)" "unprognostic (1.81e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-6)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.54e-1)" "unprognostic (2.70e-4)" 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.1 2.6 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 0.1 0.1 0.7 0.0 0.1 2.2 0.1 184.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 12.2 0.9 0.1 0.1 0.4 0.2 0.5 0.0 0.9 1.2 0.4 0.3 0.5 0.3 0.6 0.0 0.2 0.8 0.2 0.0 0.2 0.1 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.2 0.1 0.8 0.7 0.3 0.4 0.1 0.1 0.5 1.3 0.2 0.2 0.4 0.0 0.1 0.6 29.0 0.2 0.7 0.3 0.6 0.3 0.2 1.0 0.0 3.6 0.1 0.6 1.0 0.1 0.2 0.5 0.0 0.8 0.0 0.2 0.3 0.4 0.5 0.0 1.3 0.4 0.2 0.3 0.8 0.3 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.9 0.0 0.2 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 ANKRD30B NY-BR-1.1 ENSG00000180777 "Ankyrin repeat domain 30B" Q9BXX2 18 14728272-14852738 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 17 "testis: 42.2" "Cell line enriched" "Detected in some" 7 "U-2197: 31.3" "Cancer enhanced" "Detected in single" "breast cancer: 2.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA060455, HPA071849" Uncertain Uncertain Nucleoli Nucleoli "HPA060455: , HPA071849: " "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" "unprognostic (1.65e-1)" "unprognostic (1.86e-1)" "unprognostic (9.74e-2)" "unprognostic (2.84e-1)" "unprognostic (1.55e-9)" "unprognostic (1.38e-2)" "unprognostic (1.53e-1)" "unprognostic (7.98e-2)" 0.3 0.2 1.2 0.1 2.5 0.1 2.3 0.0 1.8 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.9 0.1 0.1 0.1 0.1 0.4 1.2 0.1 0.6 0.1 0.0 0.1 1.0 0.1 0.2 2.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 42.2 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.7 2.5 0.1 31.3 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.5 0.0 1.8 0.9 0.9 0.4 1.2 1.0 0.0 ANKRD30BL "ANKRD30BP3, NCRNA00164" ENSG00000163046 "Ankyrin repeat domain 30B like" A7E2S9 2 132147591-132257969 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 6.4" "Cell line enhanced" "Detected in some" "MOLT-4: 1.2;U-266/70: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.67e-1)" "unprognostic (1.42e-1)" "unprognostic (5.57e-2)" "unprognostic (2.15e-1)" "unprognostic (2.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.42e-1)" 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD34A ANKRD34 ENSG00000272031 "Ankyrin repeat domain 34A" Q69YU3 1 145959442-145964582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 18.1" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.4" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.5;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029642, HPA029643" Uncertain Enhanced Cytosol Cytosol "HPA029642: AB_10599277, HPA029643: AB_10601878" "unprognostic (1.98e-1)" "unprognostic (5.66e-2)" "unprognostic (1.90e-2)" "unprognostic (1.05e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-2)" "unprognostic (4.36e-2)" "unprognostic (1.41e-1)" "unprognostic (2.51e-1)" "unprognostic (3.19e-1)" "unprognostic (2.15e-2)" "unprognostic (6.68e-3)" "unprognostic (9.66e-8)" "unprognostic (6.36e-2)" "unprognostic (9.01e-2)" "unprognostic (1.76e-1)" "unprognostic (9.23e-2)" 0.8 1.3 6.4 2.0 10.5 0.3 0.6 7.8 18.1 0.9 0.7 1.2 0.0 1.6 1.5 1.2 0.9 0.7 1.1 1.7 4.2 0.5 0.2 0.7 1.4 0.4 6.7 1.6 0.5 2.0 1.2 0.5 5.7 1.7 0.4 1.3 0.8 2.2 2.3 0.8 1.6 1.6 0.0 1.4 1.1 0.5 1.0 0.0 0.6 0.0 1.5 0.9 0.0 1.5 0.4 0.6 0.3 0.3 3.5 1.0 1.4 0.7 0.7 2.4 3.5 2.7 0.3 2.7 5.1 0.6 1.7 0.2 0.8 2.7 0.3 3.4 0.6 1.1 0.8 0.4 5.8 1.7 0.2 2.1 0.0 0.5 0.3 2.3 2.4 0.3 2.2 2.5 0.9 1.3 6.3 4.0 2.5 1.1 0.8 0.3 3.0 0.3 0.6 12.4 1.1 0.1 3.4 2.5 0.5 0.1 1.6 3.6 0.4 0.8 6.2 4.2 5.3 1.3 4.4 8.4 0.4 6.1 2.2 0.4 0.0 0.1 0.6 3.5 0.3 2.6 1.5 1.7 1.9 0.4 1.4 2.3 3.4 0.3 0.3 0.0 0.1 1.7 1.0 ANKRD34B DP58 ENSG00000189127 "Ankyrin repeat domain 34B" A5PLL1 5 80556755-80570488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 31.0" "Cell line enriched" "Detected in some" 29 "RPTEC TERT1: 45.8" "Cancer enhanced" "Detected in some" "prostate cancer: 2.3" "Region enriched" "Detected in many" 6 "basal ganglia: 31.0" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043327 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "HPA043327: AB_10794180" "unprognostic (1.05e-1)" "unprognostic (4.16e-6)" "unprognostic (2.07e-4)" "unprognostic (1.05e-1)" "unprognostic (3.03e-1)" "unprognostic (8.25e-4)" "unprognostic (6.44e-2)" "unprognostic (1.80e-1)" "unprognostic (9.41e-2)" "unprognostic (6.52e-3)" "unprognostic (1.93e-1)" "unprognostic (4.28e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.94e-2)" 0.1 0.3 0.9 1.5 31.0 5.7 0.3 0.0 0.9 0.5 0.1 0.4 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.0 4.1 2.8 0.1 0.2 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.2 0.0 0.3 0.2 0.0 0.1 0.1 0.2 0.4 1.0 0.1 1.0 5.1 0.0 0.1 0.0 4.6 0.1 0.0 0.0 0.0 7.2 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 45.8 0.0 0.1 0.2 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.3 0.9 31.0 0.0 0.9 1.0 4.1 1.2 0.2 0.7 5.1 ANKRD60 "bA196N14.3, C20orf86" ENSG00000124227 "Ankyrin repeat domain 60" Q9BZ19 20 58218495-58228653 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 40 "testis: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060561 Uncertain "HPA060561: " 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ANKRD62 DKFZp779B1634 ENSG00000181626 "Ankyrin repeat domain 62" A6NC57 18 12093853-12129749 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 47.1" "Cell line enriched" "Detected in single" 6 "U-2 OS: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059835 Enhanced "HPA059835: " "unprognostic (2.45e-2)" "unprognostic (1.18e-1)" "unprognostic (2.37e-3)" "unprognostic (9.46e-2)" "unprognostic (3.01e-1)" "unprognostic (1.98e-1)" "unprognostic (6.61e-2)" "unprognostic (7.95e-2)" "unprognostic (3.27e-1)" "unprognostic (2.55e-4)" "unprognostic (1.13e-1)" "unprognostic (3.28e-2)" "unprognostic (4.52e-3)" "unprognostic (8.70e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 5.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 ANKRD63 ENSG00000230778 "Ankyrin repeat domain 63" C9JTQ0 15 40281444-40282586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 22.4" "Cell line enhanced" "Detected in some" "EFO-21: 2.1;HEK 293: 5.4;HEL: 2.6;NB-4: 1.9;SCLC-21H: 2.0;THP-1: 3.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 8 "basal ganglia: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 50.7" "Region enhanced" "Detected in many" "basal ganglia: 40.3" "unprognostic (9.36e-2)" "unprognostic (7.45e-2)" "unprognostic (8.32e-2)" "unprognostic (4.42e-1)" 0.2 0.2 1.8 0.4 22.4 0.2 0.2 0.3 4.7 0.2 0.2 0.0 0.0 0.2 0.3 0.2 0.2 0.7 0.3 0.5 0.3 0.4 1.3 0.2 0.2 0.3 0.3 1.1 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.5 0.2 0.0 0.7 0.3 0.7 1.8 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 2.1 0.0 0.0 0.4 0.0 0.0 0.0 5.4 2.6 1.1 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.2 1.9 0.2 0.4 1.4 0.0 0.4 0.0 0.1 2.0 0.2 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 22.4 0.3 2.8 0.3 0.4 0.3 1.1 0.0 1.8 ANKRD7 TSA806 ENSG00000106013 "Ankyrin repeat domain 7" Q92527 7 118214669-118496171 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "testis: 184.1" "Cell line enhanced" "Detected in some" "Daudi: 5.2;SCLC-21H: 9.9;U-266/70: 12.7;WM-115: 4.0" "Cancer enhanced" "Detected in some" "testis cancer: 1.9" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043489, HPA052941" Enhanced Nucleoplasm Nucleoplasm "HPA043489: AB_10959304, HPA052941: " "unprognostic (1.29e-1)" "unprognostic (7.22e-4)" "unprognostic (3.13e-3)" "unprognostic (6.16e-2)" "unprognostic (8.49e-2)" "unprognostic (1.69e-1)" "unprognostic (5.51e-1)" "unprognostic (9.46e-2)" "unprognostic (1.44e-1)" "unprognostic (2.63e-3)" "unprognostic (1.45e-2)" "unprognostic (1.55e-2)" "unprognostic (3.35e-2)" "unprognostic (3.57e-4)" "unprognostic (3.32e-2)" 0.1 0.1 0.5 0.0 0.8 0.0 0.1 0.1 1.0 0.1 0.1 0.0 0.0 0.1 0.1 1.3 0.1 0.1 0.0 0.1 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.9 0.0 1.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 184.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 3.1 0.4 1.0 0.0 0.0 0.8 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.2 1.6 0.0 0.0 0.1 0.3 0.1 1.4 1.0 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.4 0.7 0.0 0.0 0.0 2.2 1.4 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 2.4 0.0 0.0 1.9 0.0 1.2 0.4 0.0 1.1 0.3 0.0 12.7 0.6 0.5 1.8 0.0 4.0 0.0 0.0 1.0 0.4 0.0 0.3 3.1 0.2 0.6 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.4 0.0 0.1 0.5 0.8 0.1 1.0 0.4 0.1 0.1 0.3 1.0 0.0 AOC2 "DAO2, RAO" ENSG00000131480 "Amine oxidase, copper containing 2" O75106 17 42844600-42850707 "Enzymes, Predicted intracellular proteins" "Catecholamine metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "retina: 133.5" "Cell line enhanced" "Detected in many" "ASC diff: 14.3" "Cancer enhanced" "Detected in some" "testis cancer: 3.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "neutrophil: 4.0" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA057779 Uncertain "Intracellular and membrane" "HPA057779: " "unprognostic (3.79e-2)" "unprognostic (2.33e-1)" "unprognostic (5.10e-4)" "unprognostic (1.90e-2)" "unprognostic (1.48e-2)" "unprognostic (2.42e-1)" "unprognostic (4.63e-2)" "unprognostic (2.63e-2)" "unprognostic (1.39e-1)" "unprognostic (3.64e-2)" "unprognostic (2.16e-2)" "unprognostic (8.27e-3)" "unprognostic (4.55e-5)" "unprognostic (3.55e-2)" "unprognostic (2.73e-1)" "unprognostic (1.63e-2)" "prognostic favourable (2.47e-4)" 11.6 1.2 0.9 1.3 3.2 1.8 3.1 3.2 1.6 1.5 1.1 0.9 0.9 0.6 1.5 1.2 1.0 1.5 1.5 1.3 1.2 1.8 0.9 3.6 2.2 1.0 0.9 0.9 1.0 1.2 0.8 2.1 0.9 0.9 1.3 0.5 133.5 1.2 1.2 1.4 1.2 1.0 1.3 1.0 1.7 0.7 6.5 0.9 1.0 1.0 0.9 1.2 1.6 0.9 0.1 0.0 4.0 0.0 0.0 0.6 0.0 0.2 2.8 0.6 3.1 14.3 1.4 7.4 0.9 0.9 2.0 2.8 2.2 0.3 1.1 1.4 0.3 1.2 2.7 0.7 4.1 2.3 7.3 0.4 1.3 2.2 0.9 0.4 2.8 2.2 2.5 1.9 2.9 0.5 0.7 2.6 0.6 0.3 0.6 1.1 1.1 0.9 1.4 2.8 2.2 0.4 4.4 1.0 0.6 0.1 1.0 4.0 0.5 0.2 0.5 1.9 4.0 2.5 1.2 5.7 5.5 1.1 0.5 2.6 1.0 0.0 0.0 0.8 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.2 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.9 3.2 3.2 1.6 1.2 1.8 0.9 0.9 0.9 0.9 AOX1 "AO, AOH1" ENSG00000138356 "Aldehyde oxidase 1" Q06278 2 200585868-200677064 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 228.8" "Cell line enhanced" "Detected in many" "ASC diff: 83.9;ASC TERT1: 43.1;HSkMC: 17.3;hTERT-HME1: 17.3" "Cancer enriched" "Detected in many" 9 "liver cancer: 122.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040199, HPA040215" Enhanced 410000 "HPA040199: AB_10795273, HPA040215: AB_10795360" "unprognostic (4.39e-2)" "unprognostic (1.03e-3)" "unprognostic (1.96e-1)" "unprognostic (3.15e-2)" "unprognostic (1.17e-4)" "unprognostic (1.92e-2)" "unprognostic (2.34e-2)" "unprognostic (3.54e-1)" "unprognostic (1.15e-1)" "unprognostic (4.93e-2)" "unprognostic (5.48e-2)" "unprognostic (2.00e-2)" "prognostic favourable (6.05e-5)" "unprognostic (1.33e-2)" "unprognostic (8.16e-3)" "unprognostic (3.38e-2)" "unprognostic (4.99e-3)" 12.8 55.6 0.1 1.8 0.4 0.2 10.5 0.3 0.2 2.9 3.2 1.3 18.6 0.3 2.0 11.1 3.9 8.1 4.0 3.5 0.3 0.0 20.8 228.8 3.6 7.5 0.2 0.2 12.2 28.5 0.2 0.8 1.9 0.6 4.4 1.0 1.6 2.7 20.1 2.5 3.2 1.7 6.9 0.4 1.7 2.4 10.8 0.2 0.1 4.8 2.7 0.6 7.1 10.6 0.0 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.0 0.0 0.0 83.9 43.1 0.0 1.3 2.5 1.1 2.1 0.0 0.0 0.0 0.1 1.7 0.0 0.0 3.8 4.7 0.0 0.1 0.0 1.0 4.2 5.6 0.1 0.0 17.3 1.0 5.5 17.3 0.0 0.0 0.0 3.8 0.1 0.0 0.0 1.7 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 6.6 2.9 2.3 0.0 0.5 0.0 0.0 0.5 2.3 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.3 0.2 0.3 0.0 0.2 0.2 0.6 0.2 AP000311.1 ENSG00000249209 21 33584687-33931607 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "blood: 10.8" "Cell line enhanced" "Detected in many" "U-2 OS: 10.7" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "gdT-cell: 5.4;MAIT T-cell: 7.8;memory CD4 T-cell: 7.9;memory CD8 T-cell: 8.1;naive CD4 T-cell: 7.4;naive CD8 T-cell: 6.9;T-reg: 10.8" "Lineage enriched" "Detected in many" 9 "T-cells: 10.8" HPA039558 Uncertain "HPA039558: " "unprognostic (4.72e-1)" 0.4 0.4 0.5 1.4 0.6 0.0 0.4 0.8 0.6 0.6 0.5 0.9 0.6 1.8 0.5 0.6 0.3 1.2 0.4 0.4 0.4 0.9 1.0 2.5 0.4 0.7 0.4 0.0 0.3 2.3 0.9 1.1 1.6 0.0 1.2 0.9 0.9 0.0 0.4 0.4 0.9 1.6 0.3 0.0 0.5 0.3 1.1 0.7 1.2 0.4 0.3 10.8 1.2 4.0 0.4 0.1 0.1 0.2 0.0 1.4 0.7 0.0 0.2 0.1 4.4 2.2 0.0 3.5 0.2 1.9 1.0 0.2 0.0 2.7 0.2 1.1 0.2 0.1 0.4 1.8 1.3 0.5 0.0 0.2 0.2 0.0 2.3 5.1 0.0 0.9 2.5 1.0 3.4 2.4 3.5 0.8 1.4 0.0 1.3 3.7 0.4 3.8 2.4 0.3 2.3 2.4 0.0 0.2 10.7 0.3 0.2 2.9 1.7 0.6 2.9 0.8 0.0 1.2 0.4 0.3 5.4 0.3 7.8 1.0 7.9 8.1 0.3 1.1 7.4 6.9 0.6 0.3 0.4 0.7 10.8 1.2 AP003071.5 ENSG00000284713 11 69155478-69159752 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "stomach 1: 19.5" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;NB-4: 2.4;RH-30: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.1 0.9 2.6 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.7 19.5 1.0 0.1 0.1 0.1 0.1 2.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.4 0.1 1.0 0.1 0.5 0.2 0.2 1.7 0.1 0.0 0.2 0.2 0.5 0.0 0.0 0.2 0.2 0.4 0.2 0.0 1.4 0.4 0.3 0.4 0.4 0.2 0.1 0.3 0.0 0.5 0.1 0.0 0.9 0.1 2.4 0.3 1.2 0.5 2.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.3 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APBA2 "D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L" ENSG00000034053 "Amyloid beta precursor protein binding family A member 2" Q99767 15 28884483-29118315 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 33.4" "Cell line enhanced" "Detected in some" "HEL: 7.4;SH-SY5Y: 18.3;U-937: 13.1" "Cancer enhanced" "Detected in many" "glioma: 17.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.8;naive CD8 T-cell: 7.5" "Lineage enriched" "Detected in many" 4 "T-cells: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037065, HPA058796, HPA070376" Uncertain Enhanced "Golgi apparatus" "Golgi apparatus" "CAB037065: AB_477178, HPA058796: , HPA070376: " "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.42e-1)" "unprognostic (5.96e-2)" "unprognostic (1.41e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-1)" "unprognostic (8.19e-2)" "unprognostic (4.71e-2)" "unprognostic (9.25e-2)" "unprognostic (4.21e-5)" "unprognostic (1.98e-2)" "unprognostic (4.74e-2)" "unprognostic (7.63e-3)" "unprognostic (4.28e-1)" 1.8 3.3 17.6 3.0 12.1 3.0 1.7 33.4 28.9 1.2 2.0 3.6 0.0 2.5 2.1 2.5 6.7 1.4 2.1 1.6 24.2 14.9 1.4 1.8 2.1 3.6 15.1 14.9 1.8 2.6 1.2 2.3 1.6 7.5 3.0 2.1 1.6 1.8 1.7 1.6 1.8 2.7 1.4 16.2 7.9 1.8 5.6 2.7 1.9 1.9 0.0 3.4 2.9 0.4 0.0 0.0 0.1 0.0 1.8 7.8 2.5 0.0 1.4 0.6 3.4 0.0 0.0 0.0 0.8 1.2 0.1 0.5 0.0 0.0 0.0 3.2 0.0 0.0 0.5 0.0 0.0 0.0 2.8 7.4 0.0 0.1 2.9 0.0 0.2 0.4 2.3 0.4 0.0 3.9 4.3 0.1 0.0 0.4 0.2 2.1 1.0 3.0 0.0 0.3 0.1 0.0 0.0 4.9 18.3 0.0 0.0 0.1 0.0 0.9 3.9 0.0 4.0 0.0 0.8 0.0 0.1 0.0 0.1 13.1 1.6 0.0 0.0 0.0 1.4 0.0 0.2 0.0 2.1 4.7 0.0 0.0 7.8 7.5 0.1 1.8 0.0 0.0 0.0 2.5 17.6 12.1 33.4 28.9 24.2 14.9 15.1 14.9 7.5 2.7 APC2 APCL ENSG00000115266 "APC2, WNT signaling pathway regulator" O95996 19 1446302-1473244 "Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 59.4" "Cell line enhanced" "Detected in some" "AF22: 6.3;SCLC-21H: 7.6;SH-SY5Y: 25.9" "Cancer enriched" "Detected in some" 27 "glioma: 17.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078002 Supported "Cytokinetic bridge,Midbody,Cytosol" "Cytokinetic bridge, Midbody" Cytosol "HPA078002: " "unprognostic (1.78e-3)" "unprognostic (1.65e-1)" "unprognostic (2.88e-5)" "unprognostic (3.64e-2)" "unprognostic (3.59e-1)" "unprognostic (1.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (1.38e-2)" "unprognostic (1.30e-2)" "unprognostic (3.45e-2)" "unprognostic (9.49e-3)" "unprognostic (7.39e-2)" "unprognostic (3.70e-2)" "unprognostic (4.99e-2)" "unprognostic (1.98e-3)" 1.5 4.7 17.3 1.4 16.4 1.5 1.3 21.7 59.4 1.4 1.6 20.7 0.0 2.1 1.4 1.4 1.4 1.5 1.6 1.4 16.8 13.9 1.3 1.3 1.4 1.4 15.0 14.0 1.3 2.0 1.3 3.0 1.4 17.1 1.4 1.4 0.8 1.7 1.4 1.6 1.4 1.8 1.5 13.9 1.4 1.4 1.8 14.5 0.0 1.5 0.0 1.3 1.6 0.0 1.1 0.2 0.4 0.0 0.0 0.1 0.1 0.2 0.5 6.3 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.9 0.3 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.1 0.2 0.1 0.1 0.4 0.1 0.0 0.7 0.0 0.0 7.6 25.9 0.9 0.0 0.4 0.1 0.0 0.0 0.5 0.5 0.2 0.2 1.9 0.4 0.3 0.7 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 17.3 16.4 21.7 21.3 16.8 13.9 15.0 14.0 17.1 14.5 APCS "MGC88159, PTX2, SAP" ENSG00000132703 "Amyloid P component, serum" P02743 1 159587825-159588865 "Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 81 "liver: 316.6" "Cell line enhanced" "Detected in some" "HL-60: 3.3;RH-30: 4.2;SiHa: 2.1" "Cancer enriched" "Detected in some" 25 "liver cancer: 826.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB007817, HPA053294" Supported "Secreted to blood" 27700000000 76000000000 "CAB007817: AB_598185, HPA053294: " "unprognostic (3.19e-3)" "unprognostic (2.30e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.7 316.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.8 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 3.3 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.7 4.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.7 0.2 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 APLP1 APLP ENSG00000105290 "Amyloid beta precursor like protein 1" P51693 19 35867899-35879791 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Endocytosis" Heparin-binding Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 147.5" "Cell line enhanced" "Detected in many" "AF22: 24.8;AN3-CA: 46.0;EFO-21: 24.4;HMC-1: 23.8;SCLC-21H: 26.8;SH-SY5Y: 27.2" "Cancer enhanced" "Detected in many" "glioma: 63.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028970, HPA028971" Enhanced 3900000 "HPA028970: AB_2672847, HPA028971: AB_10601334" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (9.36e-3)" "prognostic unfavourable (3.87e-4)" "unprognostic (7.32e-3)" "unprognostic (1.26e-2)" "unprognostic (1.04e-3)" "unprognostic (2.24e-2)" "unprognostic (4.98e-2)" "unprognostic (6.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.13e-1)" "unprognostic (2.57e-11)" "unprognostic (1.38e-3)" "unprognostic (7.12e-2)" "unprognostic (5.43e-2)" "prognostic unfavourable (2.65e-5)" 2.6 15.6 37.0 2.9 47.9 1.6 1.6 13.1 147.5 2.4 2.6 91.6 0.0 2.0 2.3 2.1 2.2 2.3 4.3 6.0 53.2 37.4 2.4 1.5 2.4 2.1 54.6 24.6 1.9 32.1 5.6 17.6 1.9 38.4 2.3 2.6 3.3 2.4 2.4 1.5 2.0 2.4 2.9 118.2 1.7 9.6 5.7 36.9 0.0 2.2 0.0 2.2 2.1 0.1 1.5 0.4 2.2 0.7 3.0 0.6 0.2 1.4 10.4 24.8 46.0 2.4 1.0 3.2 2.1 1.1 2.4 0.3 2.4 1.4 0.2 24.4 5.3 0.7 7.7 0.5 1.6 17.3 0.9 0.1 3.1 1.4 0.7 0.0 23.8 1.1 0.6 1.0 0.0 0.8 0.9 0.4 7.0 2.3 0.0 0.0 1.2 6.1 2.4 0.1 0.3 0.4 0.3 26.8 27.2 8.0 1.1 0.3 6.0 1.3 0.6 16.7 9.6 9.4 1.3 1.1 0.4 0.1 11.0 0.3 8.4 2.2 0.7 0.4 0.4 0.5 0.3 0.7 0.4 0.6 0.2 1.5 0.5 0.6 2.1 3.0 0.7 0.4 0.2 0.2 37.0 47.9 13.1 54.6 53.2 37.4 54.6 24.6 38.4 36.9 APOA1 ENSG00000118137 "Apolipoprotein A1" P02647 11 116835751-116837950 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Amyloidosis, Atherosclerosis, Cancer-related genes, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 573.5" "Cell line enriched" "Detected in some" 18 "Hep G2: 247.4" "Cancer enriched" "Detected in many" 48 "liver cancer: 4515.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 4 "dendritic cells: 3.6;T-cells: 2.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB016778, HPA046715" Supported Approved Vesicles,Cytosol "Secreted to blood" 2185000000000 220000000000 Vesicles Cytosol "CAB016778: , HPA046715: " "unprognostic (1.88e-3)" "unprognostic (4.53e-2)" "unprognostic (7.46e-2)" "unprognostic (4.00e-3)" "unprognostic (3.70e-2)" "unprognostic (1.41e-1)" "prognostic favourable (5.05e-4)" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "unprognostic (9.60e-3)" "unprognostic (1.59e-3)" "unprognostic (7.02e-2)" "prognostic unfavourable (1.67e-8)" "unprognostic (3.46e-3)" "unprognostic (1.15e-1)" "unprognostic (6.24e-2)" "unprognostic (9.54e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 24.6 0.2 0.2 55.6 0.2 0.3 0.2 0.1 0.3 1.3 0.2 0.0 0.2 573.5 0.2 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.0 127.9 0.2 0.2 0.4 0.3 11.8 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.5 3.6 0.0 0.7 0.7 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 13.8 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 247.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 1.2 1.5 0.0 0.2 0.4 1.7 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.2 0.0 2.4 0.7 0.3 0.0 0.2 1.8 0.8 0.5 0.8 1.7 0.0 0.7 0.0 3.6 2.1 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 APOA2 ENSG00000158874 "Apolipoprotein A2" P02652 1 161222292-161223631 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction, Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 321 "liver: 932.2" "Cell line enriched" "Detected in some" 9 "Hep G2: 596.2" "Cancer enriched" "Detected in many" 329 "liver cancer: 11230.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.1;neutrophil: 2.9" "Group enriched" "Detected in many" 20 "dendritic cells: 1.0;granulocytes: 2.9;monocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB025885 Supported "Secreted to blood" 229315000000 210000000000 "CAB025885: " "unprognostic (2.05e-1)" "unprognostic (4.70e-2)" "unprognostic (1.12e-1)" "unprognostic (2.99e-1)" "unprognostic (9.82e-2)" "unprognostic (1.92e-1)" "unprognostic (3.16e-1)" "unprognostic (2.79e-1)" "unprognostic (1.57e-2)" "unprognostic (4.40e-3)" "unprognostic (3.16e-2)" "unprognostic (2.22e-1)" "unprognostic (1.60e-1)" "unprognostic (6.09e-2)" 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.2 932.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.0 2.9 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 65.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 596.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 1.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.9 0.0 0.8 0.7 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 APOA4 ENSG00000110244 "Apolipoprotein A4" P06727 11 116820700-116823306 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 593.6" "Cell line enhanced" "Detected in some" "BEWO: 7.9;CACO-2: 8.0;Hep G2: 7.5;NB-4: 7.3;RPMI-8226: 11.7;SH-SY5Y: 10.8" "Cancer enriched" "Detected in some" 29 "liver cancer: 291.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA001352, HPA002549, CAB068250, CAB068251, CAB068252" Enhanced Approved Vesicles "Secreted to blood" 148500000000 140000000000 Vesicles "CAB068250: , CAB068251: , CAB068252: , HPA001352: AB_1078179, HPA002549: AB_1078177" "unprognostic (8.81e-2)" "unprognostic (2.12e-2)" "unprognostic (1.75e-2)" "unprognostic (7.91e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 293.8 0.0 0.0 175.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 93.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 593.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 11.7 0.0 0.0 3.2 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOA5 "APOA-V, RAP3" ENSG00000110243 "Apolipoprotein A5" Q6Q788 11 116789367-116792420 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 209 "liver: 112.2" "Cell line enriched" "Detected in single" 65 "Hep G2: 35.8" "Cancer enriched" "Detected in single" 489 "liver cancer: 112.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" 113600000 15000000 "unprognostic (1.57e-4)" "unprognostic (4.67e-3)" "unprognostic (5.57e-2)" "unprognostic (2.60e-3)" "unprognostic (2.40e-1)" "unprognostic (2.31e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 35.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOBEC1 "APOBEC-1, BEDP, CDAR1, HEPR" ENSG00000111701 "Apolipoprotein B mRNA editing enzyme catalytic subunit 1" P41238 12 7649400-7665903 "Enzymes, Predicted intracellular proteins" "mRNA processing" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 51 "intestine: 56.1" "Cell line enriched" "Detected in single" 20 "CAPAN-2: 7.7" "Group enriched" "Detected in some" 9 "colorectal cancer: 6.2;pancreatic cancer: 6.1;stomach cancer: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "unprognostic (2.35e-1)" "unprognostic (3.80e-4)" "unprognostic (7.96e-3)" "unprognostic (1.79e-1)" "unprognostic (4.38e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 56.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOC1 ENSG00000130208 "Apolipoprotein C1" P02654 19 44914247-44919349 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "liver: 702.7" "Cell line enhanced" "Detected in many" "Hep G2: 98.0;HSkMC: 60.7;K-562: 25.5;SK-MEL-30: 45.2" "Cancer enriched" "Detected in all" 21 "liver cancer: 3253.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "myeloid DC: 8.9" "Lineage enriched" "Detected in single" 13 "dendritic cells: 8.9" "Low region specificity" "Detected in many" HPA051518 Supported "Secreted to blood" 60000000000 26000000000 "HPA051518: " "unprognostic (3.51e-2)" "unprognostic (3.31e-3)" "unprognostic (1.14e-1)" "unprognostic (2.59e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "prognostic favourable (1.15e-7)" "unprognostic (9.51e-3)" "unprognostic (1.30e-1)" "unprognostic (4.18e-2)" "unprognostic (1.11e-1)" "unprognostic (2.52e-1)" "unprognostic (7.13e-3)" "unprognostic (3.48e-3)" "unprognostic (1.65e-1)" "unprognostic (2.01e-3)" "unprognostic (1.65e-1)" 1.5 58.9 6.6 1.6 30.0 2.4 3.6 0.6 4.4 1.5 1.8 4.9 0.3 0.9 0.6 2.5 0.4 0.8 1.8 0.4 4.1 7.8 0.6 702.7 12.6 6.1 20.2 1.0 4.1 1.1 0.4 2.6 2.3 6.6 0.6 1.1 1.3 2.0 0.4 1.2 1.4 1.0 0.5 11.7 9.6 1.3 1.0 5.2 1.0 0.7 0.5 1.9 1.2 0.3 0.2 8.9 0.0 0.6 0.2 0.0 0.6 0.4 4.6 2.1 0.8 6.7 7.0 19.8 0.2 0.3 0.8 1.3 9.7 8.7 1.4 1.7 0.1 0.3 2.7 0.3 0.4 0.0 11.2 6.2 0.6 98.0 6.0 4.6 3.2 60.7 0.5 0.8 0.3 0.2 25.5 0.1 0.3 0.6 0.2 0.3 20.0 0.9 1.0 2.8 0.1 1.2 0.3 0.9 0.5 3.3 0.0 45.2 0.4 17.0 0.7 0.0 0.3 0.0 0.2 0.8 0.8 1.5 0.1 1.3 0.5 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.9 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.6 6.6 30.0 0.6 3.1 4.1 7.8 20.2 1.0 6.6 5.2 APOC2 ENSG00000234906 "Apolipoprotein C2" P02655 19 44945982-44949565 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Disease mutation, Hyperlipidemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 78 "liver: 506.5" "Group enriched" "Detected in some" 4 "Hep G2: 82.9;THP-1: 153.3" "Cancer enriched" "Detected in some" 17 "liver cancer: 49.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 21 "NK-cell: 6.5" "Lineage enriched" "Detected in single" 21 "NK-cells: 6.5" "Not detected" "Not detected" HPA055877 Supported "Secreted to blood" 43000000000 110000000000 "HPA055877: " "unprognostic (4.28e-2)" "unprognostic (7.73e-3)" "unprognostic (1.33e-1)" "unprognostic (3.66e-2)" "unprognostic (8.91e-2)" "unprognostic (1.90e-1)" "unprognostic (2.07e-1)" "unprognostic (5.41e-2)" "unprognostic (2.56e-1)" "unprognostic (1.96e-2)" "unprognostic (2.86e-1)" "unprognostic (1.15e-2)" "unprognostic (5.14e-8)" "unprognostic (1.32e-1)" "unprognostic (1.45e-1)" "unprognostic (1.77e-2)" "unprognostic (9.80e-3)" 0.2 0.4 2.8 0.3 3.7 0.2 0.5 0.4 1.6 0.4 2.1 3.7 0.0 2.8 0.2 0.5 0.3 0.4 0.4 0.2 2.3 2.2 1.2 506.5 2.2 0.8 4.7 0.5 0.2 0.2 0.3 0.2 0.3 2.2 0.2 0.4 0.0 0.3 0.3 0.3 0.4 6.3 0.2 4.7 0.3 0.3 0.2 2.1 0.0 0.2 0.0 0.7 0.3 0.0 0.1 0.3 0.0 0.0 6.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 14.4 0.2 82.9 0.0 1.7 28.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 13.8 0.0 0.0 0.1 0.6 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.8 0.0 153.3 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 2.8 3.7 0.4 1.6 2.3 2.2 4.7 0.5 2.2 2.1 APOC3 ENSG00000110245 "Apolipoprotein C3" P02656 11 116829706-116833072 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 714.1" "Group enriched" "Detected in some" 19 "CACO-2: 27.8;Hep G2: 75.2" "Cancer enriched" "Detected in many" 643 "liver cancer: 4021.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065365, HPA073918" Supported Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Secreted to blood" 88520000000 97000000000 Nucleoplasm "Nucleoli, Cell Junctions" "HPA065365: , HPA073918: " "prognostic favourable (3.77e-4)" "unprognostic (2.33e-1)" "prognostic unfavourable (6.87e-5)" "unprognostic (1.60e-2)" "unprognostic (5.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 38.7 0.1 0.1 31.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.4 714.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 91.3 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 27.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 75.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.6 0.9 0.0 0.0 0.3 1.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 APOC4 ENSG00000267467 "Apolipoprotein C4" P55056 19 44942238-44945496 "Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "liver: 126.0" "Cell line enhanced" "Detected in some" "HEL: 4.2;SK-MEL-30: 6.4" "Cancer enriched" "Detected in single" 15 "liver cancer: 0.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA062671 Approved "Secreted to blood" 1000000000 1500000000 "HPA062671: " "unprognostic (1.82e-3)" 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 126.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 3.1 4.3 1.7 0.8 1.2 0.1 0.8 0.0 0.0 0.8 0.0 0.9 1.6 0.0 0.0 1.1 0.2 0.0 0.2 1.1 0.1 0.0 0.1 0.6 0.4 0.3 0.2 0.4 4.2 0.0 2.6 0.0 0.3 1.2 2.4 0.3 0.0 0.4 0.0 1.2 1.9 0.7 1.0 0.3 0.0 0.0 0.5 0.0 0.5 0.8 0.0 1.4 0.5 0.2 0.7 0.8 6.4 1.3 0.0 3.0 0.6 0.3 0.4 0.0 0.8 0.8 2.0 0.2 1.3 0.0 2.1 0.8 1.9 0.9 1.7 0.4 0.6 0.9 1.2 0.4 1.4 0.6 0.6 4.3 0.8 0.8 3.1 0.5 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.2 0.0 0.0 0.0 APOC4-APOC2 ENSG00000224916 "APOC4-APOC2 readthrough (NMD candidate)" 19 44942238-44949565 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 267 "liver: 178.9" "Cell line enriched" "Detected in some" 5 "THP-1: 11.3" "Cancer enriched" "Detected in some" 17 "liver cancer: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055877 Supported "HPA055877: " "unprognostic (1.45e-1)" "unprognostic (4.00e-2)" "unprognostic (1.86e-1)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (1.42e-1)" "unprognostic (1.49e-2)" "unprognostic (2.07e-2)" "unprognostic (1.52e-1)" "unprognostic (4.73e-2)" "unprognostic (1.25e-1)" "unprognostic (1.85e-1)" "unprognostic (2.01e-4)" "unprognostic (2.28e-1)" "unprognostic (2.88e-1)" "unprognostic (5.95e-2)" "unprognostic (1.68e-2)" 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.2 0.1 178.9 0.1 0.1 0.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 1.5 2.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.7 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.3 0.2 0.6 0.1 0.1 0.1 APOD ENSG00000189058 "Apolipoprotein D" P05090 3 195568702-195584205 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "breast: 840.7" "Group enriched" "Detected in some" 7 "ASC diff: 233.9;ASC TERT1: 126.0" "Cancer enhanced" "Detected in all" "melanoma: 925.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "memory B-cell: 6.7" "Lineage enriched" "Detected in single" 10 "B-cells: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040520 Enhanced Approved "Plasma membrane" "Secreted to blood" 27730000 220000000000 "Plasma membrane" "HPA040520: " "prognostic favourable (5.51e-4)" "unprognostic (7.62e-3)" "unprognostic (7.85e-3)" "unprognostic (3.34e-3)" "unprognostic (2.20e-1)" "unprognostic (1.02e-2)" "unprognostic (3.09e-2)" "unprognostic (2.06e-3)" "unprognostic (1.26e-1)" "unprognostic (3.45e-1)" "unprognostic (3.38e-1)" "unprognostic (3.19e-1)" "unprognostic (6.90e-3)" "prognostic unfavourable (6.02e-4)" "unprognostic (1.38e-1)" "prognostic unfavourable (4.12e-4)" "unprognostic (1.71e-3)" 134.4 15.2 39.7 5.7 39.9 3.4 840.7 14.7 66.1 75.0 16.4 79.7 10.9 12.9 36.6 30.0 46.1 42.9 36.4 124.7 45.5 29.2 8.5 3.5 11.8 6.5 96.9 28.2 19.4 28.3 9.0 14.3 59.6 50.9 39.7 13.1 99.1 152.5 35.1 110.4 66.0 7.2 30.4 81.6 3.6 28.7 32.0 56.5 0.0 87.7 42.2 6.6 62.1 95.7 6.7 0.1 0.4 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 233.9 126.0 0.3 2.0 0.5 0.0 0.0 12.9 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 6.4 1.4 0.0 1.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 2.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 25.3 0.4 0.1 0.0 0.1 0.1 0.0 6.7 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.1 39.7 39.9 14.7 39.5 45.5 29.2 96.9 28.2 50.9 56.5 APOF ENSG00000175336 "Apolipoprotein F" Q13790 12 56360569-56362823 "Plasma proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 53 "liver: 114.0" "Cell line enriched" "Detected in single" 10 "Hep G2: 9.7" "Cancer enriched" "Detected in some" 6 "liver cancer: 34.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Secreted to blood" 18000000000 4000000000 "unprognostic (3.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.48e-2)" "unprognostic (8.99e-3)" "unprognostic (9.84e-2)" "unprognostic (3.29e-2)" "unprognostic (2.08e-3)" "unprognostic (7.84e-2)" "unprognostic (4.22e-1)" "unprognostic (5.69e-2)" "unprognostic (2.68e-3)" "unprognostic (8.55e-2)" "unprognostic (2.42e-2)" "unprognostic (2.77e-1)" "unprognostic (5.57e-2)" "unprognostic (2.87e-1)" "unprognostic (4.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 114.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.9 1.8 0.5 1.1 1.4 0.1 0.2 0.2 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.7 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.3 0.6 0.9 9.7 0.0 0.9 0.3 0.2 0.0 0.1 0.1 0.0 0.5 0.3 0.1 0.3 0.2 0.1 0.5 0.4 0.3 0.4 0.6 0.5 0.4 0.3 0.1 0.4 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.3 0.0 0.8 0.4 0.4 0.2 0.4 0.3 1.8 0.5 0.3 0.5 0.2 0.8 1.6 0.7 0.6 0.1 2.1 1.4 1.1 1.3 1.1 0.4 0.9 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOH "B2G1, BG" ENSG00000091583 "Apolipoprotein H" P02749 17 66212033-66256525 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 550 "liver: 823.7" "Cell line enriched" "Detected in some" 20 "Hep G2: 162.9" "Cancer enriched" "Detected in many" 232 "liver cancer: 2878.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001654, HPA003732, CAB022214" Enhanced Supported "Golgi apparatus" "Secreted to blood" 171400000000 44000000000 "Golgi apparatus" "CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183" "unprognostic (2.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "prognostic favourable (2.39e-7)" "unprognostic (1.26e-1)" "unprognostic (5.99e-2)" "unprognostic (2.88e-3)" "prognostic unfavourable (1.10e-6)" "unprognostic (1.26e-2)" "unprognostic (5.76e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.1 823.7 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.4 0.7 0.9 1.3 1.0 1.3 0.2 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 162.9 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.1 0.3 0.0 0.0 1.3 0.4 1.3 0.5 1.3 0.8 0.8 0.6 0.7 1.4 0.9 0.8 0.9 1.0 0.4 0.5 0.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 APOM "ApoM, G3a, NG20" ENSG00000204444 "Apolipoprotein M" O95445 6 31652416-31658210 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 94.6" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in all" 13 "liver cancer: 185.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enhanced" "Detected in single" "basal ganglia: 0.3" "Low region specificity" "Detected in all" "CAB034086, HPA051006" Approved Approved "Golgi apparatus" "Secreted to blood" 7404315000 18000000000 "Golgi apparatus" "CAB034086: AB_1119033, HPA051006: " "unprognostic (2.76e-3)" "unprognostic (1.69e-2)" "unprognostic (8.66e-2)" "unprognostic (2.61e-2)" "unprognostic (1.12e-1)" "unprognostic (5.28e-2)" "unprognostic (3.78e-1)" "unprognostic (1.97e-2)" "unprognostic (1.80e-1)" "unprognostic (6.04e-3)" "unprognostic (2.27e-2)" "unprognostic (1.48e-1)" "unprognostic (7.28e-2)" "unprognostic (5.71e-2)" "unprognostic (1.96e-1)" "unprognostic (1.30e-1)" "unprognostic (3.20e-2)" 1.3 1.5 1.8 1.5 1.6 6.8 1.9 1.3 2.0 1.3 1.8 2.2 1.9 2.4 2.3 3.0 1.6 1.5 1.4 1.5 1.5 1.3 15.2 94.6 1.0 3.6 1.7 1.9 3.7 3.3 1.4 1.9 0.7 1.6 1.1 0.9 2.1 3.1 1.6 2.2 2.4 2.4 1.5 2.4 1.3 1.4 6.6 1.1 3.6 2.7 1.7 3.1 1.1 1.0 3.3 1.6 5.8 2.1 1.0 2.2 1.0 2.1 1.1 2.5 4.1 2.0 2.5 0.5 1.5 2.7 1.0 2.4 1.5 3.2 3.4 0.8 2.6 3.5 1.4 1.6 2.1 2.1 2.5 2.4 1.8 3.1 3.3 4.2 1.1 3.3 1.6 1.0 3.0 0.9 4.2 2.2 2.7 3.2 3.6 4.1 2.1 0.5 2.2 1.8 3.8 2.8 3.2 2.2 1.0 2.1 0.2 1.8 4.5 3.0 0.4 1.4 0.5 2.8 0.6 3.9 3.4 4.1 1.3 6.5 0.6 5.8 1.9 1.7 1.1 0.9 1.7 3.3 1.3 1.1 1.6 1.9 1.7 1.8 1.7 1.0 2.1 1.4 2.2 1.0 1.8 1.6 1.3 1.8 1.5 1.3 1.7 1.9 1.6 1.1 AQP10 ENSG00000143595 "Aquaporin 10" Q96PS8 1 154321090-154325325 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 59.9" "Cell line enhanced" "Detected in some" "HEL: 15.6;HMC-1: 6.5;K-562: 17.9;SH-SY5Y: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062621, HPA065947" Enhanced Approved "Nuclear bodies,Vesicles,Plasma membrane" "Nuclear bodies, Vesicles, Plasma membrane" "HPA062621: , HPA065947: " "unprognostic (6.84e-2)" "unprognostic (4.97e-2)" "unprognostic (4.19e-2)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (8.45e-4)" "unprognostic (1.63e-1)" "unprognostic (3.07e-1)" "unprognostic (4.08e-2)" "unprognostic (3.99e-1)" "unprognostic (1.22e-1)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-1)" "unprognostic (7.64e-3)" 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 36.0 0.0 0.0 37.2 0.2 0.3 0.1 4.3 0.5 0.7 0.4 0.0 0.0 0.1 2.2 0.4 0.1 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 59.9 0.0 0.0 2.7 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.9 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 6.5 0.0 0.1 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 7.6 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 AQP11 ENSG00000178301 "Aquaporin 11" Q8NBQ7 11 77589391-77610355 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 60.1" "Cell line enhanced" "Detected in many" "CACO-2: 8.7;Hep G2: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 2.0;NK-cells: 2.0;T-cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042879 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA042879: AB_10794919" "unprognostic (4.95e-2)" "unprognostic (7.61e-2)" "unprognostic (2.15e-2)" "unprognostic (9.62e-5)" "unprognostic (2.42e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-1)" "unprognostic (3.48e-2)" "unprognostic (2.65e-1)" "prognostic favourable (9.89e-4)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.73e-2)" "unprognostic (2.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.66e-3)" 1.0 14.5 4.2 0.8 3.5 0.6 1.1 5.0 4.8 0.6 22.4 2.1 0.7 24.7 0.8 1.2 0.5 0.9 2.4 0.7 2.5 4.5 5.2 13.9 0.6 0.9 3.4 3.4 9.3 3.6 0.9 1.8 3.5 3.4 3.9 2.1 3.8 0.8 0.7 1.0 1.0 60.1 0.6 1.5 1.0 2.3 7.4 1.7 0.0 1.6 0.2 0.4 0.8 0.6 2.0 0.1 0.3 0.1 2.0 2.3 0.8 1.1 3.6 1.5 2.4 3.5 0.9 1.6 1.9 0.8 1.8 0.8 8.7 1.7 1.8 0.9 0.8 1.1 0.6 0.1 0.9 5.3 1.5 1.4 1.2 14.4 1.1 3.0 1.7 0.9 0.3 1.0 0.2 0.3 0.9 1.1 2.0 1.8 1.1 2.0 1.6 3.4 1.6 3.9 0.6 1.0 1.4 1.5 1.1 2.4 0.5 0.9 1.8 0.4 1.0 1.4 4.6 2.8 1.2 1.2 0.8 1.4 0.5 0.2 2.0 0.0 0.0 0.3 1.9 0.0 1.3 0.3 0.8 1.5 0.1 2.0 2.3 0.7 0.0 2.0 0.1 0.1 0.1 0.8 4.2 3.5 5.0 4.8 2.5 4.5 3.4 3.4 3.4 1.7 AQP12A AQP12 ENSG00000184945 "Aquaporin 12A" Q8IXF9 2 240691845-240698483 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 182 "pancreas: 65.3" "Cell line enhanced" "Detected in single" "HMC-1: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042216 Supported "HPA042216: " "unprognostic (9.82e-2)" "unprognostic (1.63e-2)" "unprognostic (9.48e-2)" "unprognostic (2.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AQP12B INSSA3 ENSG00000185176 "Aquaporin 12B" A6NM10 2 240676418-240682906 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 386 "pancreas: 82.5" "Cell line enhanced" "Detected in single" "U-138 MG: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042216 Supported "HPA042216: " "unprognostic (1.30e-1)" "unprognostic (2.87e-2)" "unprognostic (1.68e-1)" "unprognostic (3.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AQP6 AQP2L ENSG00000086159 "Aquaporin 6" Q13520 12 49967194-49977139 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "kidney: 40.1" "Cell line enhanced" "Detected in some" "A549: 2.5;SH-SY5Y: 2.6" "Cancer enriched" "Detected in many" 9 "renal cancer: 9.1" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in some" 7 "cerebellum: 23.5" "Low region specificity" "Detected in all" HPA015278 Enhanced "HPA015278: AB_10600982" "unprognostic (1.23e-1)" "unprognostic (1.32e-2)" "unprognostic (9.53e-2)" "unprognostic (2.02e-2)" "unprognostic (6.46e-2)" "unprognostic (4.60e-3)" "unprognostic (3.45e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (1.71e-1)" "unprognostic (2.00e-1)" "unprognostic (1.74e-1)" "unprognostic (6.85e-2)" "unprognostic (9.22e-2)" "unprognostic (9.03e-2)" "unprognostic (1.77e-1)" 0.1 0.2 0.6 0.1 1.1 0.0 0.1 0.3 1.6 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.7 0.5 40.1 0.2 0.1 0.1 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 0.1 1.0 0.3 0.1 0.0 0.1 0.1 0.4 0.1 0.2 0.7 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.8 0.5 1.2 0.2 0.2 0.4 0.2 0.4 2.5 0.1 0.3 0.1 0.0 0.0 0.5 0.3 0.0 0.0 1.4 1.6 0.0 1.1 0.0 0.3 0.4 0.0 0.1 0.2 1.7 0.0 0.1 0.9 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.7 0.0 1.2 0.0 0.7 0.5 1.3 1.2 0.2 0.7 1.2 0.0 0.6 2.6 0.8 0.0 0.8 0.0 0.1 0.0 0.7 1.1 0.0 0.7 0.2 0.2 0.0 0.3 0.3 0.5 1.2 0.2 0.1 0.4 0.1 0.1 0.3 0.1 0.2 0.5 0.8 0.2 0.3 1.1 0.2 0.2 0.2 0.3 0.2 0.6 1.1 0.3 0.3 0.7 0.5 1.2 0.1 0.3 0.1 ARG1 ENSG00000118520 "Arginase 1" P05089 6 131573144-131584332 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 284.1" "Cell line enhanced" "Detected in some" "Hep G2: 1.6;HL-60: 3.9;RH-30: 1.6;SiHa: 1.8;U-698: 2.2" "Cancer enriched" "Detected in some" 45 "liver cancer: 167.7" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "neutrophil: 24.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 24.4" "Region enhanced" "Detected in single" "cerebellum: 2.7" "Low region specificity" "Detected in single" "HPA003595, CAB009434, HPA024006, CAB056159" Enhanced 15000000 "CAB009434: AB_2058955, CAB056159: , HPA003595: AB_1078190, HPA024006: AB_1844987" "unprognostic (2.00e-1)" "unprognostic (2.09e-1)" "unprognostic (2.49e-1)" "unprognostic (1.74e-1)" "unprognostic (9.95e-2)" "unprognostic (7.96e-2)" "unprognostic (7.73e-2)" "unprognostic (1.68e-1)" "unprognostic (1.22e-1)" "unprognostic (1.56e-2)" "unprognostic (7.55e-3)" "unprognostic (8.35e-2)" "unprognostic (1.25e-2)" "unprognostic (2.90e-2)" "unprognostic (2.75e-1)" "unprognostic (1.11e-2)" "unprognostic (1.79e-2)" 1.0 0.0 0.1 0.1 0.1 34.3 0.6 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.3 0.1 3.0 0.2 0.0 0.1 284.1 5.1 0.8 0.2 0.1 0.4 0.2 0.0 0.1 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.3 14.6 0.1 0.1 0.1 3.5 0.0 0.3 0.1 0.5 0.3 1.7 0.3 0.3 0.7 0.1 0.1 24.4 0.4 0.0 4.7 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.1 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.2 1.6 0.0 3.9 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.5 0.1 0.3 0.1 0.0 0.0 1.6 0.4 0.0 0.3 0.2 0.1 1.8 0.4 0.2 0.1 0.5 0.0 0.0 0.2 0.3 0.1 1.0 0.1 2.2 0.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.4 0.1 24.4 0.0 0.4 0.1 4.7 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.1 ARHGAP22 RhoGAP2 ENSG00000128805 "Rho GTPase activating protein 22" Q7Z5H3 10 48446034-48656265 "Predicted intracellular proteins" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 32.3" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 15.4;LHCN-M2: 26.1;TIME: 27.7;U-87 MG: 34.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.2;myeloid DC: 2.9;naive B-cell: 2.6" "Group enriched" "Detected in many" 29 "B-cells: 2.6;dendritic cells: 2.9;monocytes: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020696, HPA040391, HPA064439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB020696: , HPA040391: , HPA064439: " "unprognostic (1.87e-1)" "unprognostic (3.98e-2)" "unprognostic (2.38e-2)" "unprognostic (2.62e-1)" "unprognostic (1.07e-1)" "unprognostic (6.74e-3)" "unprognostic (4.81e-3)" "unprognostic (2.78e-1)" "unprognostic (1.66e-1)" "unprognostic (3.03e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "prognostic unfavourable (2.16e-8)" "unprognostic (7.40e-2)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (3.66e-2)" 2.6 3.1 10.2 6.7 12.5 3.0 2.0 7.3 12.2 1.8 2.7 32.3 1.0 1.7 2.1 1.9 1.6 2.2 4.4 3.3 12.5 9.6 1.2 0.8 2.9 6.0 18.3 6.6 7.7 1.5 2.7 1.8 2.2 24.6 3.2 2.8 1.6 3.4 3.2 3.9 3.4 2.5 3.4 27.3 6.2 2.3 4.6 18.4 2.0 6.0 0.4 5.4 3.1 1.9 2.6 2.9 0.0 3.2 0.0 0.0 0.9 2.5 0.5 0.1 0.0 2.2 8.8 1.7 13.5 6.2 1.2 1.7 2.7 0.3 0.0 0.5 5.2 4.9 0.1 4.5 2.2 0.2 4.6 7.1 0.0 0.0 1.1 0.8 0.8 2.1 4.6 15.4 1.2 8.4 6.7 1.3 26.1 0.1 0.1 0.0 2.9 0.2 0.0 0.0 3.2 2.6 0.2 0.4 2.7 0.6 0.0 0.2 0.1 0.1 27.7 12.7 0.2 1.6 9.4 0.0 0.0 0.0 34.4 0.1 2.0 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 2.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 10.2 12.5 7.3 9.2 12.5 9.6 18.3 6.6 24.6 18.4 ARHGEF33 ENSG00000214694 "Rho guanine nucleotide exchange factor 33" A8MVX0 2 38889841-38975449 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 42.5" "Group enriched" "Detected in some" 4 "BEWO: 8.8;HeLa: 3.9;SiHa: 11.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 5 "cerebellum: 42.5" "Cell type enriched" "Detected in single" 8 "eosinophil: 6.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.7" "Region enriched" "Detected in single" 32 "cerebellum: 314.4" "Region enriched" "Detected in many" 11 "cerebellum: 47.0" "HPA034661, HPA041051" Enhanced Supported Vesicles Vesicles "HPA034661: AB_10669679, HPA041051: " "unprognostic (8.38e-2)" "unprognostic (7.05e-4)" "unprognostic (1.95e-1)" "unprognostic (4.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-1)" "unprognostic (3.66e-1)" "unprognostic (3.37e-1)" "unprognostic (5.82e-2)" "unprognostic (2.05e-3)" "unprognostic (4.99e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.56e-1)" "unprognostic (2.42e-1)" "unprognostic (1.99e-1)" 0.3 4.0 3.7 1.0 8.6 0.0 1.7 42.5 3.4 2.3 0.7 0.6 0.7 0.1 2.8 5.1 0.7 2.2 1.4 0.8 3.3 3.6 1.4 0.2 1.2 0.5 2.0 2.9 6.8 0.2 2.2 3.5 0.8 3.2 1.7 0.6 0.8 0.4 1.2 0.4 1.3 0.6 1.0 1.5 0.5 0.9 10.1 2.4 0.2 1.4 0.2 0.4 1.2 0.6 0.2 0.1 6.7 0.8 0.0 0.2 0.1 0.3 0.0 0.4 0.2 0.2 0.2 8.8 0.8 0.0 0.0 0.0 0.1 0.2 0.4 0.1 0.8 0.0 0.0 0.0 0.0 1.8 0.9 0.2 3.9 0.3 0.7 0.3 0.3 0.8 0.9 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.9 0.4 0.4 0.3 11.0 0.4 0.0 0.0 0.3 0.6 0.2 1.4 0.0 0.1 0.5 0.2 0.0 0.2 0.2 0.1 0.0 0.6 6.7 0.0 0.8 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 3.7 8.6 42.5 3.4 3.3 3.6 2.0 2.9 3.2 2.4 ARID3C ENSG00000205143 "AT-rich interaction domain 3C" A6NKF2 9 34621379-34628107 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 12 "liver: 16.8" "Cell line enhanced" "Detected in some" "HDLM-2: 4.5;Karpas-707: 5.9;T-47d: 6.0" "Group enriched" "Detected in some" 6 "liver cancer: 2.2;ovarian cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (4.66e-2)" "unprognostic (2.38e-1)" "unprognostic (2.05e-3)" "unprognostic (4.42e-3)" "unprognostic (6.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.76e-3)" "unprognostic (1.47e-1)" "unprognostic (1.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.21e-2)" "unprognostic (7.79e-2)" "unprognostic (3.28e-14)" "unprognostic (3.06e-1)" "unprognostic (1.43e-1)" "unprognostic (7.91e-2)" "unprognostic (4.26e-3)" 0.0 0.0 0.2 0.0 0.5 0.0 0.2 1.4 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.6 0.0 16.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.1 0.4 2.2 0.3 0.7 0.0 0.6 0.1 0.2 0.5 0.1 0.3 0.1 0.2 0.7 0.0 0.4 0.0 0.0 4.5 0.6 0.1 0.6 0.0 1.5 0.0 0.2 0.3 1.1 0.0 0.1 0.1 0.0 5.9 0.1 0.0 0.1 1.9 0.0 0.2 0.5 0.1 1.0 0.0 0.0 0.0 0.8 0.2 1.5 0.4 6.0 0.3 0.0 0.1 0.3 1.2 0.0 1.1 0.9 0.0 0.5 1.8 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 ARL13A ARL13 ENSG00000174225 "ADP ribosylation factor like GTPase 13A" Q5H913 X 100969708-100990829 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 16.6" "Cell line enhanced" "Detected in some" "CACO-2: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037377, HPA037378" Uncertain "HPA037377: , HPA037378: AB_10670932" "unprognostic (4.40e-2)" "unprognostic (1.05e-1)" "unprognostic (1.02e-1)" "unprognostic (1.08e-2)" "unprognostic (1.93e-1)" "unprognostic (9.06e-3)" "unprognostic (2.58e-1)" "unprognostic (3.95e-2)" "unprognostic (1.82e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (1.51e-2)" "unprognostic (4.50e-3)" "unprognostic (1.46e-1)" "unprognostic (2.46e-1)" "unprognostic (9.37e-4)" "unprognostic (2.14e-1)" 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.6 0.0 0.5 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 1.2 0.4 0.1 0.1 0.2 0.3 16.6 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.8 0.2 0.0 0.4 0.1 0.5 0.0 1.0 1.9 0.1 0.6 0.0 0.0 0.5 0.3 0.1 0.0 0.0 6.5 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.1 1.1 0.7 0.0 1.6 0.1 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.1 0.7 0.0 0.2 0.0 1.5 0.0 0.1 0.7 0.0 0.4 0.0 0.1 1.2 0.3 0.0 0.3 1.9 0.6 0.3 0.0 0.0 0.3 0.2 0.2 1.2 0.3 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.1 0.0 0.1 0.4 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 ARL5C ARL12 ENSG00000141748 "ADP ribosylation factor like GTPase 5C" A6NH57 17 39156894-39167484 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 21.1" "Cell line enhanced" "Detected in some" "HMC-1: 1.5;MOLT-4: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 28 "plasmacytoid DC: 2.7" "Lineage enriched" "Detected in single" 28 "dendritic cells: 2.7" "Low region specificity" "Detected in many" HPA069849 Uncertain "HPA069849: " "unprognostic (2.57e-1)" "unprognostic (2.34e-1)" "unprognostic (1.60e-7)" "unprognostic (7.60e-2)" "unprognostic (1.11e-2)" 0.2 0.2 0.2 0.2 0.6 0.0 0.6 0.2 0.5 1.3 0.2 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.1 0.6 0.2 0.1 0.4 0.1 1.5 0.2 0.0 0.1 3.0 0.0 0.1 0.7 0.4 0.1 0.2 0.8 0.1 1.1 0.3 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.0 21.1 0.1 0.0 1.3 1.2 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.6 0.2 0.5 0.6 0.2 0.2 0.0 0.4 0.0 ARMC12 "C6orf81, FLJ25390" ENSG00000157343 "Armadillo repeat containing 12" Q5T9G4 6 35737032-35749079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 60.2" "Cell line enhanced" "Detected in some" "ASC diff: 7.2;HSkMC: 9.5;MOLT-4: 6.5;U-698: 7.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.2;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 11 "dendritic cells: 2.9;monocytes: 1.0;T-cells: 3.2" "Not detected" "Not detected" "HPA030895, HPA075457, HPA075777" Enhanced Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA030895: AB_10602114, HPA075457: , HPA075777: " "unprognostic (1.94e-4)" "unprognostic (2.21e-1)" "unprognostic (3.24e-1)" "unprognostic (1.32e-2)" "unprognostic (2.34e-1)" "unprognostic (1.19e-1)" "unprognostic (2.52e-1)" "unprognostic (2.12e-1)" "unprognostic (4.48e-1)" "unprognostic (3.52e-2)" "unprognostic (6.36e-4)" "unprognostic (8.99e-2)" "unprognostic (1.17e-12)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (2.09e-1)" 0.5 0.4 0.9 0.5 1.2 0.7 0.7 0.5 0.9 0.6 0.5 0.5 0.5 0.0 0.5 5.8 0.5 0.6 0.8 0.5 0.7 0.9 0.5 1.4 0.5 1.1 0.7 0.5 1.0 0.5 0.1 4.8 0.5 0.5 1.1 0.3 0.6 0.5 1.0 0.5 0.5 0.5 0.6 0.5 0.8 0.1 60.2 0.5 0.5 0.7 0.5 0.6 0.5 0.5 0.1 2.9 0.0 1.0 0.2 3.2 0.4 0.0 0.5 3.1 3.8 7.2 3.4 0.0 0.1 0.2 0.3 0.4 0.1 0.2 0.7 0.1 0.1 0.1 1.1 0.2 0.2 1.6 0.9 0.4 0.1 0.1 3.7 0.0 0.0 9.5 2.3 0.1 1.3 0.7 0.1 4.4 1.1 0.4 6.5 0.8 0.5 0.2 3.0 0.0 0.0 0.8 0.0 0.9 3.1 0.0 0.0 0.5 2.0 0.3 0.0 0.6 0.3 0.1 0.0 1.0 0.3 7.1 0.3 3.9 0.3 0.0 1.0 0.0 0.1 0.0 1.2 0.0 1.2 0.5 0.7 0.1 0.7 3.2 0.0 0.2 0.1 2.9 0.0 0.4 0.9 1.2 0.5 0.6 0.7 0.9 0.7 0.5 0.5 0.5 ARNT2 "bHLHe1, KIAA0307" ENSG00000172379 "Aryl hydrocarbon receptor nuclear translocator 2" Q9HBZ2 15 80404350-80597937 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 73.2" "Cell line enhanced" "Detected in many" "AF22: 16.0;BJ hTERT+ SV40 Large T+ RasG12V: 16.2;LHCN-M2: 14.5;SK-MEL-30: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001056, CAB005081" Enhanced Supported Nucleoplasm Nucleoplasm "CAB005081: AB_2243005, HPA001056: AB_1845042" "unprognostic (2.04e-3)" "unprognostic (8.32e-2)" "unprognostic (2.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.11e-1)" "unprognostic (5.65e-2)" "unprognostic (2.61e-2)" "unprognostic (1.48e-1)" "unprognostic (2.74e-2)" "unprognostic (3.00e-1)" "prognostic favourable (1.46e-6)" "unprognostic (2.20e-1)" "prognostic favourable (7.51e-4)" "unprognostic (2.53e-1)" "unprognostic (2.31e-1)" "unprognostic (3.39e-1)" "unprognostic (3.62e-2)" 1.4 2.3 30.6 2.3 35.5 1.0 1.8 9.1 73.2 4.2 2.4 14.3 0.0 2.0 5.3 7.2 2.3 4.9 2.7 3.7 32.8 17.4 11.5 1.0 4.4 2.3 19.2 23.4 9.3 3.2 4.2 3.6 1.7 11.9 5.1 2.4 2.0 1.5 4.8 7.0 2.3 2.5 3.7 13.2 3.2 3.9 8.0 12.7 0.0 6.0 0.0 2.9 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.9 16.0 0.0 0.1 2.1 0.0 6.8 9.6 7.9 16.2 0.0 0.0 0.0 1.7 8.0 0.2 5.8 0.3 10.1 0.0 1.6 0.3 0.0 0.5 0.5 0.0 4.1 7.6 0.3 3.5 0.1 0.0 0.0 0.1 14.5 7.5 0.0 0.0 3.2 0.1 0.0 0.2 0.0 3.4 11.3 8.5 11.7 0.8 0.1 17.3 0.3 0.0 0.0 12.6 2.5 0.3 8.0 0.0 0.0 0.0 4.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 35.5 9.1 36.0 32.8 17.4 19.2 23.4 11.9 12.7 ARR3 ARRX ENSG00000120500 "Arrestin 3" P36575 X 70268305-70281840 "Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "retina: 62.9" "Cell line enhanced" "Detected in many" "Karpas-707: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA063129 Enhanced "HPA063129: " "unprognostic (1.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.70e-2)" "unprognostic (5.37e-2)" "unprognostic (2.82e-1)" "unprognostic (1.37e-2)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.33e-1)" "unprognostic (4.02e-3)" "unprognostic (2.77e-7)" "unprognostic (8.64e-2)" "unprognostic (6.53e-2)" "unprognostic (6.06e-2)" "unprognostic (1.43e-1)" 0.3 0.5 0.3 1.0 0.3 0.7 0.3 0.3 0.3 0.3 1.2 0.3 0.3 1.4 0.7 0.3 0.3 0.4 0.7 0.7 0.3 0.2 0.4 0.3 0.3 1.9 0.3 0.3 0.6 0.7 0.0 0.4 0.4 0.3 0.4 0.2 62.9 0.4 0.3 0.5 5.6 3.6 0.3 0.3 0.9 0.8 0.4 0.3 0.3 0.9 0.3 0.3 0.8 0.3 1.3 0.7 0.5 0.4 0.0 1.6 0.3 0.4 0.7 3.2 2.1 0.0 0.0 1.8 1.8 0.0 0.0 0.0 0.6 1.1 1.3 0.4 0.0 0.7 0.0 0.0 0.0 1.4 3.3 0.4 1.1 0.0 0.0 0.7 1.6 0.1 0.0 0.0 0.0 0.0 0.4 5.9 0.0 0.5 1.2 0.6 0.9 0.7 1.1 0.6 0.1 0.0 1.5 0.4 1.0 0.6 0.2 0.1 0.1 0.4 2.5 1.5 2.0 1.4 0.1 1.4 0.8 0.8 1.4 2.0 1.4 0.0 0.4 0.5 0.9 0.2 0.0 1.3 0.4 0.0 0.5 0.4 1.6 0.1 0.1 0.0 0.0 0.7 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 ARRDC5 ENSG00000205784 "Arrestin domain containing 5" A6NEK1 19 4890437-4902867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 29.1" "Cell line enriched" "Detected in single" 16 "REH: 6.7" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (2.85e-2)" "unprognostic (3.83e-5)" "unprognostic (2.53e-1)" "unprognostic (7.22e-5)" "unprognostic (1.70e-1)" "unprognostic (7.16e-5)" "unprognostic (1.65e-2)" "unprognostic (1.18e-2)" "unprognostic (8.00e-2)" "unprognostic (9.03e-2)" "unprognostic (8.76e-2)" "unprognostic (6.45e-2)" "unprognostic (7.18e-8)" "unprognostic (1.76e-1)" "unprognostic (3.07e-1)" "unprognostic (1.95e-1)" "unprognostic (3.79e-2)" 0.2 0.0 0.2 0.7 0.2 2.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.1 0.2 0.2 0.5 2.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 1.0 0.2 0.3 2.3 0.2 29.1 0.2 0.2 0.2 0.2 0.8 0.2 0.2 2.6 3.9 3.3 1.2 1.7 3.5 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 6.7 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 1.2 3.3 3.5 0.9 1.9 2.6 0.7 2.3 1.4 2.5 3.2 3.4 0.2 1.7 0.4 3.9 1.5 0.9 0.2 0.2 0.2 0.6 0.2 0.1 0.2 0.2 0.2 0.2 ASAH2 ENSG00000188611 "N-acylsphingosine amidohydrolase 2" Q9NR71 10 50182778-50248610 "Enzymes, Predicted intracellular proteins" "Apoptosis, Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "intestine: 43.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA061171 Supported Approved "Focal adhesion sites" "Intracellular and membrane" 1200000 "Focal adhesion sites" "HPA061171: " "unprognostic (3.59e-2)" "unprognostic (3.63e-2)" "unprognostic (1.66e-1)" "unprognostic (3.84e-2)" "unprognostic (3.66e-1)" "unprognostic (4.48e-2)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.65e-2)" "unprognostic (4.33e-2)" "unprognostic (2.17e-1)" "unprognostic (1.14e-1)" "unprognostic (8.29e-2)" "unprognostic (1.86e-2)" "unprognostic (5.64e-2)" "unprognostic (3.22e-1)" "unprognostic (1.02e-3)" 0.3 1.1 0.6 0.2 0.9 0.0 0.5 0.5 1.3 1.7 0.5 43.9 0.7 0.3 0.7 0.5 0.2 0.9 0.5 1.4 0.6 1.6 0.4 0.2 1.2 1.4 1.5 0.3 1.0 0.4 0.5 0.3 0.9 0.2 0.8 0.7 33.4 0.7 0.6 0.2 2.5 1.1 0.6 0.1 1.0 0.5 0.9 0.9 0.0 0.0 0.0 2.2 0.1 1.8 1.4 1.6 2.2 2.9 1.1 2.0 2.0 1.3 3.8 3.5 1.0 4.6 0.0 2.2 2.7 1.7 2.1 0.7 4.7 2.3 3.8 1.3 3.8 2.9 1.8 0.4 0.2 0.4 2.6 6.5 7.4 0.8 2.5 1.2 2.5 1.5 1.4 0.1 4.8 4.1 0.0 6.4 1.6 2.1 0.3 2.7 7.3 2.5 1.8 3.3 1.5 1.0 2.0 1.9 4.3 4.7 6.0 1.9 0.2 0.0 5.5 0.0 1.7 0.0 0.0 0.0 0.7 0.0 2.2 0.9 0.4 1.7 0.0 0.1 1.4 2.1 0.0 0.0 0.0 0.9 0.6 0.1 ASB17 ENSG00000154007 "Ankyrin repeat and SOCS box containing 17" Q8WXJ9 1 75918873-75932431 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 33.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (7.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASB5 ENSG00000164122 "Ankyrin repeat and SOCS box containing 5" Q8WWX0 4 176213673-176277571 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 133.4" "Cell line enriched" "Detected in some" 16 "LHCN-M2: 161.1" "Cancer enhanced" "Detected in some" "prostate cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028870 Approved "Plasma membrane" "Plasma membrane" "HPA028870: AB_10611679" "unprognostic (1.76e-1)" "prognostic unfavourable (5.67e-4)" "unprognostic (1.90e-1)" "unprognostic (7.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-2)" "unprognostic (4.28e-2)" "unprognostic (1.65e-1)" "unprognostic (6.80e-3)" 2.3 0.0 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.3 3.5 0.0 0.0 0.1 0.2 6.3 7.9 0.0 0.4 1.3 0.2 0.2 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.6 1.3 0.0 8.0 0.1 133.4 0.0 0.5 23.5 1.0 0.0 2.0 2.2 0.0 0.0 2.3 31.4 2.2 15.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.9 0.0 3.5 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 161.1 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.0 0.0 ASCL3 "bHLHa42, HASH3, Sgn1" ENSG00000176009 "Achaete-scute family bHLH transcription factor 3" Q9NQ33 11 8937579-8938211 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 37 "salivary gland: 13.7" "Cell line enhanced" "Detected in some" "A549: 2.5;CACO-2: 1.1;U-2 OS: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA027032 Uncertain "HPA027032: AB_10602434" "unprognostic (8.91e-2)" "unprognostic (1.32e-1)" "unprognostic (3.53e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 2.5 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.3 0.8 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 2.0 0.4 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASGR1 CLEC4H1 ENSG00000141505 "Asialoglycoprotein receptor 1" P07306 17 7173431-7179564 "Predicted intracellular proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 171.0" "Cell line enriched" "Detected in some" 30 "Hep G2: 102.0" "Cancer enriched" "Detected in many" 90 "liver cancer: 131.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "classical monocyte: 39.1;intermediate monocyte: 17.9;myeloid DC: 13.7" "Group enriched" "Detected in many" 13 "dendritic cells: 13.7;monocytes: 39.1" "Region enriched" "Detected in many" 9 "cerebellum: 49.4" "Not detected" "Not detected" "HPA011954, HPA012852" Enhanced Supported "Vesicles,Cell Junctions" "Intracellular and membrane" Vesicles "Cell Junctions" "HPA011954: AB_1845079, HPA012852: AB_1845080" "unprognostic (3.56e-3)" "unprognostic (3.57e-1)" "unprognostic (8.76e-2)" "unprognostic (4.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-2)" "unprognostic (5.37e-2)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (8.55e-5)" "unprognostic (1.55e-1)" "unprognostic (8.33e-11)" "unprognostic (1.45e-1)" "unprognostic (2.00e-1)" "unprognostic (1.73e-3)" "unprognostic (4.46e-3)" 0.2 0.1 0.8 0.9 0.6 0.6 0.2 2.8 1.8 0.1 0.2 0.2 0.2 0.5 0.2 0.1 0.1 0.1 0.7 0.1 0.8 0.8 0.1 171.0 0.7 0.3 0.4 1.2 0.1 0.3 0.9 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.3 0.7 0.3 0.3 0.3 0.5 0.2 2.9 0.2 0.1 1.4 0.1 0.1 0.3 0.1 0.2 13.7 2.1 39.1 0.1 0.3 10.1 0.0 0.1 2.0 0.9 0.0 0.0 0.1 0.1 0.1 0.2 0.3 3.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.3 102.0 0.0 0.1 0.4 0.2 0.0 0.1 0.0 1.8 0.2 0.1 0.1 0.0 0.1 0.2 0.3 0.1 0.1 0.7 0.0 0.0 0.1 0.1 0.8 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 2.1 39.1 0.1 0.1 17.9 0.3 0.1 0.0 0.0 13.7 0.2 0.1 0.1 1.1 0.1 4.5 0.6 0.1 10.1 0.8 0.6 2.8 1.8 0.8 0.8 0.4 1.2 0.7 0.2 ASGR2 CLEC4H2 ENSG00000161944 "Asialoglycoprotein receptor 2" P07307 17 7101322-7115700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 154.1" "Cell line enriched" "Detected in some" 8 "Hep G2: 105.4" "Cancer enriched" "Detected in many" 66 "liver cancer: 214.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 36.9;myeloid DC: 21.7" "Group enriched" "Detected in many" 52 "dendritic cells: 21.7;monocytes: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014899, HPA015998" Enhanced Supported "Endoplasmic reticulum,Plasma membrane" 4700000 "Endoplasmic reticulum, Plasma membrane" "HPA014899: AB_1845085, HPA015998: AB_1845084" "unprognostic (6.76e-2)" "unprognostic (7.45e-7)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (4.99e-2)" "unprognostic (1.16e-3)" "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (9.74e-2)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (9.35e-4)" "unprognostic (1.54e-3)" "unprognostic (6.95e-2)" "unprognostic (1.86e-1)" "unprognostic (7.31e-2)" 0.2 0.0 0.3 1.4 0.1 1.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.1 3.4 0.2 0.2 0.0 0.2 154.1 0.5 4.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.9 0.1 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 21.7 0.5 36.9 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 36.9 0.2 0.0 3.8 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 9.5 0.3 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 ASIC1 "ACCN2, BNaC2, hBNaC2" ENSG00000110881 "Acid sensing ion channel subunit 1" P78348 12 50057548-50083611 "FDA approved drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 43.7" "Cell line enhanced" "Detected in many" "HEK 293: 16.8;SH-SY5Y: 19.4" "Cancer enhanced" "Detected in many" "glioma: 12.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058870 Supported "Golgi apparatus,Plasma membrane" "Golgi apparatus, Plasma membrane" "HPA058870: " "unprognostic (5.32e-3)" "unprognostic (1.70e-1)" "unprognostic (4.00e-2)" "unprognostic (3.56e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-3)" "unprognostic (2.92e-3)" "unprognostic (3.00e-2)" "unprognostic (1.72e-1)" "unprognostic (9.37e-2)" "unprognostic (2.34e-2)" "unprognostic (2.86e-3)" "unprognostic (6.97e-7)" "unprognostic (7.19e-2)" "unprognostic (3.73e-1)" "unprognostic (2.78e-3)" "unprognostic (8.27e-5)" 2.5 1.7 13.9 1.8 20.3 0.8 2.9 20.1 43.7 5.3 3.1 12.8 0.3 2.3 2.5 1.2 3.4 3.6 4.0 2.2 12.3 14.3 1.6 0.9 1.3 1.3 12.9 8.5 1.4 1.4 5.2 0.5 1.5 10.2 4.5 2.5 1.8 5.6 3.4 1.3 1.5 2.5 3.6 5.4 1.1 4.3 1.4 11.0 0.4 1.1 0.0 1.0 2.6 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 2.1 4.7 6.2 14.0 1.9 2.9 3.5 1.5 4.1 2.7 2.7 3.3 1.7 1.3 3.2 0.9 2.2 6.1 5.2 1.6 1.3 16.8 4.2 6.6 2.0 2.7 6.3 15.8 7.4 2.5 0.4 0.6 0.5 2.8 0.1 2.2 2.6 6.0 12.3 2.6 8.3 6.1 5.9 2.8 1.3 0.2 9.2 19.4 3.5 1.2 2.1 7.7 4.1 0.4 2.7 9.1 1.8 0.8 0.0 0.0 0.0 3.5 5.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 13.9 20.3 20.1 18.3 12.3 14.3 12.9 8.5 10.2 11.0 ASIC5 "ACCN5, HINAC, INAC" ENSG00000256394 "Acid sensing ion channel subunit family member 5" Q9NY37 4 155829729-155866273 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "intestine: 7.3" "Cell line enhanced" "Detected in single" "Karpas-707: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014903, HPA029444" Approved "HPA014903: AB_1844498, HPA029444: AB_10611671" "unprognostic (8.52e-5)" "unprognostic (2.52e-1)" "unprognostic (1.25e-1)" "unprognostic (4.05e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 7.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.3 0.0 0.2 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 ASPM "ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5" ENSG00000066279 "Abnormal spindle microtubule assembly" Q8IZT6 1 197084128-197146694 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Calmodulin-binding "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 62.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "plasmacytoid DC: 1.5;T-reg: 2.4" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;T-cells: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB017816 Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB017816: " "unprognostic (3.24e-1)" "unprognostic (1.56e-1)" "unprognostic (2.81e-2)" "prognostic unfavourable (1.97e-4)" "unprognostic (3.67e-1)" "unprognostic (3.47e-2)" "prognostic unfavourable (1.25e-4)" "prognostic unfavourable (2.41e-4)" "unprognostic (4.67e-3)" "unprognostic (9.29e-2)" "prognostic unfavourable (2.40e-4)" "unprognostic (1.03e-1)" "unprognostic (0.00e+0)" "unprognostic (7.31e-3)" "unprognostic (1.23e-1)" "unprognostic (4.94e-2)" "unprognostic (3.66e-2)" 0.7 0.7 0.2 12.4 0.4 13.8 1.5 0.2 0.4 1.2 2.8 0.2 0.2 2.8 0.3 1.5 8.7 0.2 0.4 0.6 0.2 0.2 0.5 1.3 1.9 7.0 0.3 0.2 0.5 0.3 0.0 0.2 1.8 0.5 0.4 2.8 0.3 1.5 0.2 0.5 4.6 3.1 0.8 0.5 4.3 1.7 6.3 0.2 62.8 0.3 5.0 6.9 1.2 2.3 0.0 1.5 0.0 0.0 0.3 2.4 0.0 19.8 11.1 18.1 11.0 1.0 2.5 6.8 15.9 11.2 15.8 12.5 7.7 15.5 20.3 5.7 12.4 20.1 15.5 6.3 19.7 18.2 11.8 14.2 26.2 7.4 0.2 21.2 10.1 0.2 0.6 12.7 8.9 16.6 17.8 24.1 16.2 7.8 17.0 9.9 8.2 3.0 13.0 24.8 14.9 5.7 5.5 9.5 13.5 22.6 11.7 5.1 13.0 8.8 12.6 9.8 9.5 16.8 28.9 6.9 9.4 11.7 7.7 5.8 19.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 2.4 0.0 0.2 0.4 0.2 0.4 0.2 0.2 0.3 0.2 0.5 0.2 ASPRV1 "FLJ25084, SASPase, Taps" ENSG00000244617 "Aspartic peptidase retroviral like 1" Q53RT3 2 69960089-69962265 "Plasma proteins, Predicted membrane proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 75.3" "Cell line enhanced" "Detected in many" "REH: 8.8" "Group enriched" "Detected in many" 8 "head and neck cancer: 23.1;melanoma: 35.1" "Cell type enriched" "Detected in some" 6 "neutrophil: 11.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034809, HPA034810" Enhanced 83000 "HPA034809: AB_2674343, HPA034810: AB_10601456" "unprognostic (4.75e-4)" "unprognostic (1.90e-3)" "unprognostic (2.34e-2)" "unprognostic (3.34e-2)" "unprognostic (2.65e-1)" "unprognostic (1.17e-2)" "unprognostic (1.93e-3)" "unprognostic (1.51e-1)" "unprognostic (1.36e-1)" "unprognostic (2.51e-1)" "unprognostic (4.19e-3)" "unprognostic (1.27e-1)" "unprognostic (4.01e-2)" "unprognostic (3.00e-1)" "unprognostic (1.74e-1)" "unprognostic (4.84e-2)" "unprognostic (2.43e-2)" 0.2 0.2 0.5 0.1 0.6 0.0 5.5 0.8 0.4 0.3 0.0 0.3 0.3 0.6 0.0 0.4 0.1 0.1 0.6 0.7 0.2 0.0 0.1 0.1 0.7 0.9 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.2 1.0 75.3 0.2 0.2 1.0 0.4 0.1 0.4 0.0 0.1 0.0 0.6 0.1 1.2 11.2 0.1 0.3 0.9 0.5 0.1 0.7 1.8 3.5 2.3 0.8 0.5 0.4 0.7 0.4 0.3 1.2 0.1 1.3 0.3 0.3 0.5 1.6 0.2 0.4 2.4 4.6 2.7 0.4 1.2 0.9 2.3 2.0 1.1 0.7 0.4 0.7 0.4 1.0 3.6 0.4 0.5 1.9 5.2 1.8 0.4 8.8 1.0 0.5 0.1 0.1 2.0 0.5 0.2 1.4 1.4 0.1 1.0 0.2 0.1 1.8 0.1 0.3 3.9 2.3 2.7 0.2 1.6 2.0 0.0 0.1 1.9 0.7 0.1 0.7 0.0 0.3 0.6 0.1 0.1 0.2 0.6 11.2 0.3 0.1 1.2 0.9 0.5 ASZ1 "ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3" ENSG00000154438 "Ankyrin repeat, SAM and basic leucine zipper domain containing 1" Q8WWH4 7 117363222-117428123 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 15.7" "Group enriched" "Detected in some" 24 "Daudi: 3.9;U-266/70: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA020558 Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA020558: AB_1845123" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATCAY BNIP-H ENSG00000167654 "ATCAY, caytaxin" Q86WG3 19 3879864-3928079 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 70.1" "Cell line enhanced" "Detected in some" "NTERA-2: 8.1;SCLC-21H: 15.0;SH-SY5Y: 10.6" "Cancer enriched" "Detected in some" 8 "glioma: 15.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017755 Enhanced "HPA017755: " "unprognostic (7.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.63e-2)" "unprognostic (1.91e-1)" "unprognostic (7.11e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" "unprognostic (3.05e-2)" "unprognostic (4.89e-2)" "unprognostic (9.83e-4)" "unprognostic (7.22e-2)" "unprognostic (8.78e-3)" "unprognostic (1.78e-1)" "unprognostic (1.36e-1)" "unprognostic (1.24e-2)" "unprognostic (2.67e-1)" 1.3 8.2 19.6 1.8 19.8 1.5 1.3 14.1 70.1 1.8 1.5 3.4 0.1 1.7 1.3 1.3 1.4 1.2 1.4 1.3 16.9 25.5 1.3 1.3 1.3 1.4 12.2 21.4 1.3 1.5 1.2 10.1 1.3 16.0 3.1 1.6 1.1 1.3 4.6 2.3 1.6 1.8 1.4 4.3 1.3 1.6 1.4 4.2 0.0 1.4 0.0 1.2 1.4 0.3 1.4 0.8 3.2 0.7 1.7 0.8 0.6 0.5 0.1 3.1 0.3 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.2 0.7 0.5 0.2 0.0 0.5 0.2 0.0 0.0 0.2 0.3 0.9 1.1 0.2 0.0 1.1 1.3 0.0 0.0 0.0 0.1 0.0 0.5 0.6 0.1 0.2 0.2 0.4 8.1 0.1 0.3 0.5 0.3 0.1 0.2 15.0 10.6 0.2 0.2 0.1 0.2 0.3 0.5 0.5 0.7 0.5 0.7 0.4 0.3 0.3 0.4 1.5 0.2 2.2 0.7 0.9 0.6 0.5 0.5 0.6 0.7 0.6 0.3 1.4 0.8 0.8 3.2 1.7 0.4 0.8 0.5 0.6 19.6 19.8 14.1 33.0 16.9 25.5 12.2 21.4 16.0 4.2 ATF5 ENSG00000169136 "Activating transcription factor 5" Q9Y2D1 19 49928702-49933935 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 24 "liver: 470.7" "Cell line enhanced" "Detected in all" "Karpas-707: 78.3;THP-1: 65.2;U-266/84: 99.3;U-698: 46.7" "Cancer enriched" "Detected in all" 7 "liver cancer: 200.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 11.9;intermediate monocyte: 11.7;myeloid DC: 7.5;plasmacytoid DC: 18.7" "Group enriched" "Detected in all" 7 "dendritic cells: 18.7;monocytes: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030187 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030187: AB_10601666" "unprognostic (2.09e-2)" "prognostic favourable (1.14e-4)" "unprognostic (9.38e-3)" "prognostic unfavourable (1.16e-4)" "unprognostic (1.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.52e-1)" "unprognostic (6.70e-2)" "unprognostic (3.11e-2)" "unprognostic (2.36e-1)" "unprognostic (4.83e-2)" "unprognostic (2.96e-3)" "prognostic unfavourable (3.39e-7)" "unprognostic (3.06e-2)" "unprognostic (8.06e-2)" "unprognostic (1.19e-1)" "unprognostic (2.51e-1)" 4.6 6.6 2.1 5.0 2.7 2.9 7.0 1.3 2.2 2.4 2.9 2.4 3.9 4.6 2.3 4.0 3.4 2.6 3.1 4.2 2.1 2.1 3.0 470.7 2.8 5.0 2.2 1.4 2.6 3.8 1.4 1.9 4.4 2.1 2.8 1.6 2.6 3.1 2.5 4.3 2.1 4.2 2.5 2.6 3.3 2.8 5.3 1.9 3.8 20.0 3.3 5.5 5.6 7.1 1.1 18.7 2.2 11.9 1.5 1.3 2.5 9.8 6.9 2.6 1.8 2.8 2.4 2.7 7.2 6.0 7.4 4.6 5.2 5.4 8.8 3.7 4.1 3.6 3.3 2.9 3.5 45.0 3.3 6.0 2.1 3.9 1.9 23.3 17.2 16.6 4.7 5.4 1.3 3.2 5.4 78.3 3.6 9.2 3.3 5.1 1.3 9.3 27.9 2.9 3.6 8.4 13.4 4.3 3.0 16.7 7.2 5.0 5.8 65.2 5.4 14.5 9.2 1.7 7.3 2.1 99.3 46.7 11.3 9.3 5.4 0.3 11.9 0.7 0.7 11.7 1.3 1.1 0.9 0.9 7.5 0.7 0.7 0.9 2.2 1.5 3.0 18.7 0.9 2.5 2.1 2.7 1.3 2.2 2.1 2.1 2.2 1.4 2.1 1.9 ATG9B "APG9L2, FLJ14885, NOS3AS, SONE" ENSG00000181652 "Autophagy related 9B" Q674R7 7 151012209-151024499 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 67.1" "Group enriched" "Detected in some" 6 "BEWO: 16.6;CAPAN-2: 5.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 6.0;naive CD4 T-cell: 11.0;naive CD8 T-cell: 4.1;T-reg: 5.9" "Lineage enriched" "Detected in many" 7 "T-cells: 11.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.59e-1)" "unprognostic (2.18e-2)" "unprognostic (1.31e-1)" "unprognostic (5.03e-2)" "unprognostic (1.53e-3)" "unprognostic (1.05e-3)" "unprognostic (2.79e-3)" "unprognostic (6.66e-2)" "unprognostic (2.38e-3)" "unprognostic (6.76e-2)" "unprognostic (2.02e-1)" "unprognostic (5.06e-2)" "unprognostic (2.08e-6)" "unprognostic (2.82e-2)" "unprognostic (2.70e-2)" "unprognostic (6.34e-2)" "unprognostic (2.63e-1)" 0.0 0.5 0.0 0.2 8.8 0.1 0.1 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.5 1.2 15.4 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 6.1 67.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 8.8 10.5 0.0 0.1 1.6 0.8 0.2 0.1 0.4 11.0 1.9 0.7 0.0 0.9 0.2 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.1 5.4 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.7 1.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 1.9 0.5 0.7 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.2 1.3 0.0 1.2 1.1 6.0 1.6 0.0 1.6 11.0 4.1 0.0 0.4 0.1 0.8 5.9 1.9 ATOH1 "bHLHa14, HATH1, MATH-1, Math1" ENSG00000172238 "Atonal bHLH transcription factor 1" Q92858 4 93828753-93830964 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "intestine: 29.5" "Cell line enhanced" "Detected in some" "HAP1: 3.6;HL-60: 2.3" "Cancer enhanced" "Detected in some" "colorectal cancer: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "prognostic favourable (3.26e-5)" "unprognostic (5.20e-1)" "unprognostic (2.69e-1)" "unprognostic (1.26e-1)" "unprognostic (2.70e-1)" 0.0 0.0 0.1 6.4 0.1 0.0 0.1 0.1 0.1 0.1 22.5 0.0 0.0 8.8 0.1 0.0 0.1 0.1 2.7 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 15.0 0.0 0.1 0.0 0.0 0.1 29.5 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 2.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.5 0.0 0.2 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 ATP1B2 AMOG ENSG00000129244 "ATPase Na+/K+ transporting subunit beta 2" P14415 17 7646627-7657768 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 148.8" "Cell line enhanced" "Detected in some" "AF22: 13.9;HAP1: 4.2;K-562: 6.3" "Cancer enriched" "Detected in many" 17 "glioma: 200.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010698 Enhanced 17000 "HPA010698: AB_1845174" "unprognostic (9.39e-2)" "unprognostic (1.86e-2)" "unprognostic (3.89e-3)" "unprognostic (4.96e-3)" "unprognostic (3.90e-3)" "unprognostic (9.33e-2)" "unprognostic (4.86e-1)" "unprognostic (5.93e-2)" "unprognostic (5.43e-2)" "unprognostic (1.29e-2)" "prognostic favourable (1.05e-4)" "unprognostic (1.10e-1)" "prognostic unfavourable (4.17e-4)" "unprognostic (4.60e-3)" "unprognostic (1.43e-1)" "unprognostic (2.24e-1)" "unprognostic (3.79e-2)" 4.1 6.5 54.7 2.5 61.6 8.1 2.5 62.9 148.8 9.4 3.4 25.1 0.0 2.7 8.0 15.1 3.4 10.9 4.4 5.0 46.1 33.4 6.9 3.4 3.9 2.9 42.4 41.9 23.3 3.3 3.8 10.8 5.0 68.9 4.6 3.8 28.4 3.3 7.6 4.6 2.7 3.0 5.8 58.7 4.8 2.4 4.3 25.7 0.0 4.4 0.0 2.6 3.3 2.0 1.3 0.7 1.5 1.0 1.3 2.0 0.5 0.0 0.0 13.9 0.6 0.4 0.3 0.1 0.2 0.0 0.5 0.4 0.5 0.0 0.4 0.3 0.1 0.4 4.2 0.3 0.2 0.1 1.7 0.3 0.1 0.1 0.2 0.1 1.3 0.8 0.0 0.5 0.0 0.0 6.3 0.8 0.0 0.4 0.3 0.4 2.9 0.3 0.2 0.1 0.2 0.1 0.1 0.2 2.7 0.0 0.1 0.1 0.2 0.3 0.0 0.2 1.1 0.1 0.2 0.6 0.2 0.1 1.3 0.3 0.3 0.9 1.0 0.5 2.0 0.3 1.8 1.3 0.7 1.4 0.3 0.8 1.1 1.0 1.5 1.3 0.2 0.7 0.2 0.5 54.7 61.6 62.9 50.8 46.1 33.4 42.4 41.9 68.9 25.7 ATP4A ATP6A ENSG00000105675 "ATPase H+/K+ transporting alpha subunit" P20648 19 35550043-35563658 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Potassium transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "stomach 1: 120.1" "Cell line enhanced" "Detected in some" "THP-1: 1.1;U-138 MG: 1.5" "Cancer enriched" "Detected in single" 21 "stomach cancer: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA039154 Enhanced 790000 "HPA039154: AB_10672772" "unprognostic (3.54e-2)" "unprognostic (6.98e-3)" "unprognostic (2.77e-2)" "unprognostic (1.43e-1)" "unprognostic (5.84e-3)" "unprognostic (4.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.50e-1)" "unprognostic (9.68e-2)" "unprognostic (1.47e-3)" "unprognostic (3.90e-3)" "unprognostic (3.92e-2)" "unprognostic (4.86e-2)" "unprognostic (1.23e-1)" "unprognostic (2.18e-1)" 0.1 0.2 0.1 0.1 0.6 0.0 0.1 0.1 0.6 0.1 0.1 3.4 0.1 0.0 0.1 0.1 4.9 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 2.1 0.1 0.1 120.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.1 0.0 1.5 0.3 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 ATP4B ATP6B ENSG00000186009 "ATPase H+/K+ transporting beta subunit" P51164 13 113648804-113658186 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Hydrogen ion transport, Ion transport, Potassium transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "stomach 1: 156.3" "Cell line enhanced" "Detected in some" "REH: 3.8;RPMI-8226: 1.6;SCLC-21H: 2.6" "Cancer enriched" "Detected in some" 12 "stomach cancer: 8.9" "Region enriched" "Detected in single" 9 "cerebral cortex: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045400, HPA052649" Enhanced "HPA045400: AB_2679314, HPA052649: AB_2681900" "unprognostic (9.92e-2)" "unprognostic (2.19e-1)" "unprognostic (2.66e-1)" "unprognostic (4.86e-1)" "unprognostic (6.43e-3)" "unprognostic (7.81e-3)" "unprognostic (1.95e-1)" "unprognostic (3.22e-1)" "unprognostic (6.50e-2)" "unprognostic (6.65e-4)" "unprognostic (2.25e-1)" "unprognostic (2.78e-1)" "unprognostic (3.78e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 1.0 0.1 0.1 2.0 0.1 0.0 0.1 0.1 1.5 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 6.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 156.3 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 3.8 0.0 1.6 0.0 0.0 2.6 0.9 0.2 0.7 0.0 0.1 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.1 0.1 0.1 ATP5F1D ATP5D ENSG00000099624 "ATP synthase F1 subunit delta" P30049 19 1241746-1244826 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 337.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002865 Approved 4200000 "HPA002865: AB_1078244" "unprognostic (4.80e-2)" "unprognostic (9.34e-2)" "unprognostic (7.77e-2)" "prognostic favourable (1.23e-4)" "unprognostic (1.64e-2)" "unprognostic (1.95e-1)" "unprognostic (4.63e-2)" "unprognostic (6.75e-2)" "unprognostic (1.38e-1)" "unprognostic (2.91e-1)" "prognostic favourable (4.60e-4)" "unprognostic (6.95e-2)" "prognostic favourable (3.46e-5)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "unprognostic (3.74e-1)" "unprognostic (3.49e-2)" 30.4 25.7 27.4 13.7 30.1 19.5 19.8 22.6 51.7 14.4 36.7 16.7 16.0 42.7 14.3 14.9 23.9 15.3 18.1 59.3 25.9 20.6 33.3 51.8 12.2 33.4 25.6 24.1 15.2 46.5 15.5 18.4 12.4 28.5 17.6 14.1 17.9 48.1 23.1 337.3 24.3 33.2 21.1 14.5 19.2 33.4 10.2 9.8 21.5 23.0 60.6 22.9 17.6 14.5 67.7 78.2 33.9 64.6 52.8 64.3 50.8 24.2 13.3 4.1 15.5 4.8 7.2 15.6 16.7 7.1 9.9 7.3 13.9 6.5 24.7 10.8 5.8 20.9 4.6 17.3 1.3 17.0 45.2 14.9 16.4 18.1 12.1 26.0 22.2 14.2 4.8 4.0 5.5 10.5 21.6 19.8 4.5 36.9 28.2 18.8 18.1 65.7 27.0 11.0 51.3 16.5 16.0 16.6 19.1 11.1 17.7 27.5 13.2 12.4 15.1 9.1 12.4 21.7 13.8 50.6 25.5 9.2 16.7 12.3 13.6 33.9 64.6 27.1 50.7 61.3 61.1 64.8 64.3 55.7 72.1 67.7 59.9 54.9 22.5 52.8 49.0 78.2 62.0 50.8 27.4 30.1 22.6 51.7 25.9 20.6 25.6 24.1 28.5 9.8 ATP6V0D2 "ATP6D2, FLJ38708, VMA6" ENSG00000147614 "ATPase H+ transporting V0 subunit d2" Q8N8Y2 8 85987323-86154228 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 56.8" "Cell line enhanced" "Detected in some" "SK-MEL-30: 6.2;U-87 MG: 9.5" "Cancer enriched" "Detected in many" 9 "renal cancer: 36.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055327, HPA058496" Enhanced Approved Vesicles Vesicles "HPA055327: , HPA058496: " "unprognostic (3.79e-2)" "unprognostic (1.59e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (8.43e-3)" "unprognostic (5.36e-5)" "unprognostic (4.02e-2)" "unprognostic (1.16e-1)" "unprognostic (7.75e-3)" "unprognostic (2.32e-2)" "unprognostic (1.61e-1)" "prognostic favourable (2.20e-6)" "unprognostic (8.58e-2)" "unprognostic (1.77e-2)" "unprognostic (3.67e-1)" "unprognostic (1.97e-2)" 6.6 0.3 0.2 1.3 0.3 0.8 0.3 0.2 0.2 0.2 1.5 0.0 11.9 0.7 0.2 1.0 0.2 0.2 0.1 0.2 0.3 0.3 56.8 0.3 12.2 1.2 0.5 0.0 0.8 0.2 0.3 0.2 0.2 0.0 0.8 2.0 5.7 1.1 1.2 0.2 0.9 1.0 0.0 0.3 0.4 0.3 0.2 0.0 1.0 0.4 0.3 0.6 0.3 0.2 2.2 1.7 4.6 1.0 2.0 1.5 0.3 0.6 1.3 0.7 0.8 0.0 0.6 2.5 0.0 0.0 1.1 0.3 0.3 0.4 0.4 0.3 0.1 2.8 0.8 1.8 0.5 0.4 0.1 0.9 1.8 0.2 0.0 0.8 1.5 0.6 0.1 1.0 0.8 0.5 0.5 0.8 0.5 1.0 0.0 0.8 0.3 0.2 0.2 0.3 0.3 0.0 1.2 3.8 0.3 0.1 0.9 6.2 2.0 0.1 0.3 0.7 0.9 0.8 0.5 0.5 0.2 0.7 9.5 0.7 0.8 2.6 1.0 0.8 1.1 0.5 0.8 1.2 1.0 0.9 0.5 2.2 1.5 1.3 4.6 2.0 1.0 1.7 0.9 0.3 0.2 0.3 0.2 0.2 0.3 0.3 0.5 0.0 0.0 0.0 ATP6V1G2 "ATP6G, ATP6G2, Em:AC004181.3, NG38, Vma10" ENSG00000213760 "ATPase H+ transporting V1 subunit G2" O95670 6 31544462-31548427 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "brain: 91.9" "Cell line enhanced" "Detected in some" "HDLM-2: 6.4;Karpas-707: 7.1" "Cancer enriched" "Detected in many" 11 "glioma: 15.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "CAB004616, HPA068667" Enhanced "CAB004616: AB_667829, HPA068667: " "unprognostic (9.95e-2)" "unprognostic (8.75e-2)" "unprognostic (9.21e-3)" "unprognostic (2.11e-4)" "unprognostic (2.40e-1)" "unprognostic (1.63e-1)" "unprognostic (2.34e-1)" "unprognostic (1.65e-2)" "unprognostic (1.52e-1)" "unprognostic (1.78e-2)" "unprognostic (1.41e-5)" "unprognostic (1.36e-1)" "unprognostic (7.22e-3)" "unprognostic (3.94e-2)" "unprognostic (1.77e-1)" "unprognostic (3.86e-2)" "unprognostic (1.02e-1)" 2.8 3.3 41.8 3.5 25.7 1.8 1.6 91.9 53.3 1.8 2.3 8.1 0.0 1.5 2.5 2.4 2.2 1.8 1.9 2.9 39.4 27.1 2.6 1.6 2.0 4.7 26.6 29.5 3.1 2.1 2.9 1.2 1.7 43.7 2.6 2.0 2.0 2.0 3.3 4.3 2.0 2.7 2.1 16.3 3.4 1.9 2.7 6.4 0.0 2.3 0.0 4.8 1.7 0.2 0.7 0.7 0.0 0.1 0.8 1.5 0.1 0.2 1.7 3.1 1.5 1.3 1.7 0.0 0.6 0.0 0.0 0.2 0.0 0.9 1.7 0.7 0.6 1.4 0.1 0.6 0.1 6.4 0.0 0.5 0.0 0.9 0.2 0.7 0.6 1.3 0.8 0.5 0.3 0.5 0.7 7.1 0.8 0.2 3.3 1.2 0.0 0.5 0.8 0.0 0.7 0.0 0.0 2.8 3.9 0.0 0.0 0.0 2.1 0.3 1.6 2.0 0.3 0.1 0.0 0.7 1.5 2.4 0.7 0.7 1.4 0.0 0.1 0.0 0.1 0.0 1.5 0.1 0.0 0.8 0.7 0.7 1.2 1.5 0.0 0.8 0.0 0.0 1.1 0.1 41.8 25.7 91.9 53.3 39.4 27.1 26.6 29.5 43.7 6.4 ATP8B3 ATPIK ENSG00000130270 "ATPase phospholipid transporting 8B3" O60423 19 1782075-1812276 "Enzymes, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 55.8" "Cell line enhanced" "Detected in many" "HMC-1: 10.5;Karpas-707: 18.4;U-266/70: 15.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "intermediate monocyte: 6.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (6.50e-2)" "unprognostic (1.81e-2)" "unprognostic (1.02e-1)" "unprognostic (6.05e-5)" "unprognostic (6.66e-2)" "unprognostic (7.91e-2)" "unprognostic (1.86e-2)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (2.55e-3)" "unprognostic (1.28e-2)" "unprognostic (6.15e-3)" "prognostic unfavourable (4.80e-9)" "unprognostic (8.05e-2)" "unprognostic (3.20e-1)" "unprognostic (3.19e-2)" "unprognostic (1.19e-1)" 0.6 3.1 0.2 3.1 0.2 7.1 0.6 0.2 0.7 1.5 0.7 0.2 0.2 0.4 1.8 4.3 0.6 0.6 1.0 2.2 0.3 0.2 0.4 1.0 1.9 1.1 0.2 0.5 1.9 0.3 0.3 0.6 0.5 0.4 0.5 0.4 1.1 0.5 1.6 0.2 0.8 0.7 1.0 0.7 4.8 0.4 55.8 0.0 5.5 0.7 1.2 1.5 0.8 1.0 0.1 1.2 1.7 6.9 2.2 2.8 1.2 0.6 5.1 0.6 0.8 0.7 0.5 0.0 2.0 3.0 2.0 1.9 0.0 2.0 2.2 2.3 1.5 0.1 0.4 0.0 0.9 2.1 0.0 0.6 2.4 0.9 0.2 1.3 10.5 0.2 0.1 0.0 2.1 0.5 1.6 18.4 3.3 0.0 1.3 3.9 0.1 2.4 2.2 0.4 0.2 2.7 0.1 0.0 0.7 0.5 0.0 0.3 0.6 6.4 4.8 0.1 4.0 0.7 2.1 15.4 7.5 0.6 3.9 6.4 2.6 0.0 2.2 1.7 1.9 6.9 0.8 0.0 1.4 1.1 1.2 0.1 0.6 1.9 0.6 2.2 1.8 0.5 2.8 1.2 0.2 0.2 0.2 0.7 0.3 0.2 0.2 0.5 0.4 0.0 ATXN3L MJDL ENSG00000123594 "Ataxin 3 like" Q9H3M9 X 13318236-13320399 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 30 "testis: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024123, HPA027539" Uncertain "HPA024123: AB_1845133, HPA027539: AB_10602435" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AUNIP "AIBp, C1orf135, MGC2603" ENSG00000127423 "Aurora kinase A and ninein interacting protein" Q9H7T9 1 25831913-25859458 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 35.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA028730 Uncertain Supported Centrosome Centrosome "HPA028730: AB_10670830" "unprognostic (8.05e-2)" "unprognostic (1.98e-2)" "unprognostic (3.96e-3)" "prognostic unfavourable (3.94e-4)" "unprognostic (9.51e-2)" "unprognostic (8.86e-2)" "unprognostic (9.70e-6)" "unprognostic (5.00e-3)" "unprognostic (9.06e-3)" "unprognostic (4.59e-3)" "unprognostic (1.42e-3)" "unprognostic (1.12e-2)" "unprognostic (1.01e-6)" "unprognostic (3.61e-2)" "unprognostic (4.41e-2)" "unprognostic (4.70e-2)" "unprognostic (3.62e-1)" 0.4 1.6 2.5 3.4 1.4 7.2 0.6 2.1 4.0 0.5 1.1 0.2 0.1 1.3 0.5 0.8 2.1 0.5 0.4 0.8 2.8 0.9 0.6 0.8 0.6 1.6 0.9 1.4 0.5 0.5 0.2 0.7 7.0 2.6 0.6 1.3 0.0 0.6 1.7 0.9 0.8 1.1 0.5 0.5 1.2 0.8 35.3 0.0 5.3 0.5 3.2 2.3 0.9 0.9 1.4 2.0 4.4 3.5 1.5 2.3 1.1 11.5 3.3 5.3 6.7 0.2 0.4 5.2 6.7 3.1 13.4 11.0 2.8 8.9 11.5 5.1 2.3 9.4 14.3 6.5 10.8 6.4 11.5 25.2 5.4 4.3 0.1 12.2 11.1 0.3 3.3 8.2 5.7 3.0 15.5 5.7 3.7 6.3 8.9 10.4 9.4 4.2 7.3 10.4 7.1 4.1 3.8 7.7 3.6 9.3 10.5 7.3 3.8 6.3 1.2 3.9 6.1 8.1 5.9 2.2 4.5 8.6 2.7 20.6 6.3 4.4 2.5 1.7 0.6 3.5 0.4 0.9 1.0 0.8 2.0 1.4 0.9 1.3 2.2 1.5 2.1 1.6 2.3 1.1 2.5 1.4 2.1 4.0 2.8 0.9 0.9 1.4 2.6 0.0 AURKC "ARK3, AurC, STK13" ENSG00000105146 "Aurora kinase C" Q9UQB9 19 57230802-57235548 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 21 "testis: 72.0" "Cell line enriched" "Detected in some" 7 "NTERA-2: 29.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034859 Uncertain "HPA034859: AB_10670298" "unprognostic (7.27e-2)" "unprognostic (1.76e-1)" "unprognostic (6.45e-2)" "unprognostic (8.07e-3)" "unprognostic (3.29e-1)" "unprognostic (5.99e-2)" "unprognostic (1.11e-2)" "unprognostic (7.02e-2)" "unprognostic (1.13e-1)" "unprognostic (2.09e-1)" "unprognostic (1.47e-2)" "unprognostic (2.51e-1)" "unprognostic (1.20e-5)" "unprognostic (4.26e-2)" "unprognostic (1.61e-1)" "unprognostic (1.55e-1)" "unprognostic (6.46e-4)" 0.6 0.5 0.9 0.9 1.2 0.7 1.5 0.7 2.0 0.4 0.6 0.6 0.2 0.0 0.8 1.3 0.5 0.6 2.6 0.9 0.9 1.1 0.8 1.8 1.3 2.2 1.2 0.2 0.4 0.5 0.1 1.3 1.2 1.7 0.5 0.8 1.1 0.5 0.9 2.3 0.6 0.4 1.1 2.1 3.4 0.4 72.0 0.6 0.7 0.8 1.0 1.3 0.5 0.4 2.1 1.0 1.7 1.0 1.0 0.6 0.2 0.2 0.1 0.7 0.3 0.2 0.7 0.3 1.2 0.6 0.9 3.4 0.8 0.1 0.0 0.1 0.5 0.0 0.0 0.7 0.6 0.0 3.7 0.1 0.3 0.0 1.1 0.0 0.2 0.9 0.7 0.7 0.5 0.6 0.1 0.0 1.2 0.0 1.1 0.6 29.3 0.8 0.1 0.2 0.6 0.6 1.2 1.4 0.4 0.0 0.2 0.1 0.1 1.3 0.3 0.2 4.1 0.3 0.7 1.4 1.8 0.6 0.8 0.0 0.0 0.0 0.1 1.7 0.6 1.0 0.0 1.9 0.0 0.0 0.9 2.1 0.0 0.0 0.1 1.0 0.3 1.0 0.0 0.2 0.9 1.2 0.7 1.6 0.9 1.1 1.2 0.2 1.7 0.6 AVP "ADH, ARVP" ENSG00000101200 "Arginine vasopressin" P01185 20 3082556-3084724 "Disease related genes, Predicted secreted proteins" "Hormone, Vasoactive, Vasoconstrictor" "Diabetes insipidus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "brain: 270.1" "Cell line enriched" "Detected in single" 13 "NB-4: 6.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 18 "hypothalamus: 270.1" "Cell type enriched" "Detected in some" 6 "eosinophil: 6.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.1" "Region enriched" "Detected in some" 10 "hypothalamus: 273.6" "Group enriched" "Detected in some" 645 "basal ganglia: 1065.4;hypothalamus: 1058.2" "CAB025318, HPA071892" Enhanced Supported "Secreted to blood" 19255 "CAB025318: , HPA071892: " "unprognostic (1.15e-1)" "unprognostic (2.61e-1)" 0.7 0.9 11.7 0.4 15.0 4.2 0.0 0.0 0.9 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 270.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 1.0 0.1 11.7 15.0 0.0 0.9 3.4 270.1 0.0 0.0 0.8 0.0 AVPR1B AVPR3 ENSG00000198049 "Arginine vasopressin receptor 1B" P47901 1 206109692-206117699 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "pituitary gland: 52.8" "Cell line enhanced" "Detected in single" "PC-3: 3.5" "Cancer enhanced" "Detected in some" "renal cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA075404 Enhanced "HPA075404: " "unprognostic (4.87e-2)" "unprognostic (1.44e-1)" "unprognostic (4.82e-1)" "unprognostic (2.82e-1)" "unprognostic (2.87e-1)" "unprognostic (1.08e-2)" "unprognostic (3.33e-1)" "unprognostic (2.96e-2)" "unprognostic (6.23e-2)" "unprognostic (7.65e-2)" "unprognostic (1.86e-1)" "unprognostic (6.66e-3)" 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.6 0.5 0.1 1.3 0.0 0.0 1.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 52.8 0.1 0.1 0.2 0.8 0.0 0.0 0.4 0.0 0.0 1.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.9 3.5 0.0 0.0 0.2 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 AXDND1 "C1orf125, FLJ32940" ENSG00000162779 "Axonemal dynein light chain domain containing 1" Q5T1B0 1 179365720-179554735 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 18.0" "Cell line enhanced" "Detected in some" "BEWO: 2.8;HBF TERT88: 1.8;SH-SY5Y: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071114 Enhanced "HPA071114: " "unprognostic (1.67e-2)" "unprognostic (8.37e-2)" "unprognostic (2.81e-2)" "unprognostic (1.05e-1)" "unprognostic (3.34e-1)" "unprognostic (1.73e-1)" "unprognostic (3.78e-4)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (6.99e-3)" "unprognostic (2.09e-2)" "unprognostic (1.31e-1)" "unprognostic (5.17e-3)" "unprognostic (1.92e-1)" "unprognostic (5.48e-2)" "unprognostic (5.04e-2)" "unprognostic (2.25e-1)" 0.0 0.5 0.1 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.3 0.2 0.0 0.0 0.0 2.1 0.0 0.3 0.2 0.0 0.1 0.1 0.7 0.0 0.3 0.0 0.0 0.6 0.0 0.1 0.1 0.3 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.1 1.7 1.2 0.3 18.0 0.0 0.0 0.6 0.0 0.3 0.3 0.0 0.2 0.0 2.1 0.4 0.0 0.6 0.0 0.4 0.0 0.0 0.9 0.0 0.0 2.8 0.9 0.3 0.9 0.2 0.0 0.9 0.3 0.1 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 1.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.1 1.2 0.6 0.0 0.0 0.3 1.7 0.0 0.0 0.2 0.7 0.0 0.2 0.7 0.5 0.0 0.1 1.0 1.4 0.0 0.8 0.0 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.8 0.1 0.1 0.0 0.6 0.5 0.0 AZU1 "AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC" ENSG00000172232 "Azurocidin 1" P20160 19 825097-832018 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 238.2" "Cell line enriched" "Detected in some" 7 "THP-1: 150.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "classical monocyte: 3.3;neutrophil: 7.6" "Group enriched" "Detected in many" 6 "granulocytes: 7.6;monocytes: 3.3" "Not detected" "Not detected" "HPA055851, HPA075964" Enhanced Enhanced Vesicles "Secreted to blood" 290000 Vesicles "HPA055851: , HPA075964: " "unprognostic (1.12e-2)" "unprognostic (3.71e-2)" "unprognostic (4.44e-2)" "unprognostic (8.85e-3)" "unprognostic (1.62e-2)" "unprognostic (1.29e-1)" "unprognostic (1.39e-1)" "unprognostic (8.12e-2)" "unprognostic (3.32e-1)" "unprognostic (4.22e-3)" "unprognostic (2.58e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-6)" "unprognostic (1.11e-2)" "unprognostic (1.10e-1)" "unprognostic (2.46e-2)" "unprognostic (3.04e-2)" 0.3 0.2 0.4 0.2 0.5 238.2 0.6 0.0 0.6 0.2 0.2 1.0 0.0 0.2 0.2 0.2 0.2 0.8 0.2 34.6 0.4 0.5 0.2 1.5 15.3 0.2 0.2 0.0 0.5 0.1 0.1 0.9 3.8 0.2 0.2 0.2 0.2 0.6 0.2 1.0 0.4 0.2 0.2 0.1 18.6 0.2 1.2 0.0 20.6 1.3 0.0 0.2 0.1 0.4 0.0 0.8 7.6 3.3 0.0 0.3 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 150.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 3.3 0.2 0.3 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 7.6 0.0 0.5 0.0 0.0 4.1 0.4 0.5 0.0 0.6 0.4 0.5 0.2 0.0 0.2 0.0 B3GAT1 "CD57, GlcAT-P, HNK-1, LEU7, NK-1" ENSG00000109956 "Beta-1,3-glucuronyltransferase 1" Q9P2W7 11 134378504-134411918 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 76.0" "Cell line enhanced" "Detected in some" "AF22: 17.0;HMC-1: 18.8;NTERA-2: 16.3;SH-SY5Y: 6.2" "Group enriched" "Detected in some" 11 "glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.8;naive CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 39 "T-cells: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002500, CAB010893, HPA069468" Enhanced Supported Vesicles "Secreted in brain" Vesicles "CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: " "unprognostic (6.72e-2)" "unprognostic (3.97e-4)" "unprognostic (2.13e-2)" "unprognostic (1.40e-3)" "unprognostic (5.52e-2)" "unprognostic (2.60e-3)" "unprognostic (6.30e-2)" "unprognostic (1.96e-2)" "unprognostic (8.74e-2)" "unprognostic (2.72e-1)" "unprognostic (1.57e-3)" "unprognostic (1.58e-1)" "unprognostic (9.34e-3)" "unprognostic (3.87e-3)" "unprognostic (2.42e-1)" "unprognostic (4.07e-2)" "unprognostic (2.26e-2)" 1.5 5.8 38.9 1.7 23.7 2.1 5.6 9.2 76.0 1.7 1.5 25.8 0.0 1.8 1.6 1.7 1.4 1.6 1.7 1.5 43.4 14.9 2.1 6.0 1.8 3.3 30.3 19.5 1.5 1.7 1.4 0.9 1.4 19.7 4.2 1.5 2.1 2.2 1.8 1.4 1.8 1.6 1.5 45.1 2.1 6.0 1.8 25.2 0.0 7.7 0.0 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.4 0.0 0.0 17.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 2.9 0.0 0.8 1.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 16.3 0.0 0.3 0.0 1.2 0.0 0.1 2.3 6.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.2 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.8 1.9 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.4 38.9 23.7 9.2 33.7 43.4 14.9 30.3 19.5 19.7 25.2 B3GAT2 GlcAT-S ENSG00000112309 "Beta-1,3-glucuronyltransferase 2" Q9NPZ5 6 70856679-70957038 "Enzymes, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 27.2" "Cell line enriched" "Detected in some" 20 "SCLC-21H: 22.2" "Group enriched" "Detected in some" 20 "glioma: 4.7;testis cancer: 1.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012059 Uncertain "HPA012059: AB_2061050" "unprognostic (7.10e-3)" "unprognostic (7.81e-2)" "unprognostic (1.63e-1)" "unprognostic (1.10e-3)" "unprognostic (2.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.96e-2)" "unprognostic (4.88e-2)" "unprognostic (4.22e-2)" "unprognostic (9.16e-4)" "unprognostic (8.09e-2)" "unprognostic (7.43e-3)" "unprognostic (6.88e-7)" "unprognostic (2.72e-2)" "unprognostic (3.35e-2)" "unprognostic (2.53e-2)" "unprognostic (3.45e-3)" 1.8 1.5 9.5 1.9 7.8 1.6 1.1 3.2 27.2 0.8 1.1 26.2 0.0 2.3 1.4 1.1 1.4 1.1 1.4 1.5 19.2 11.5 1.0 1.3 1.2 2.0 9.7 13.6 1.1 2.2 0.8 0.5 1.2 21.0 1.3 0.9 0.4 1.5 0.9 1.5 1.9 2.4 1.1 17.3 2.0 1.5 2.9 16.3 0.0 1.5 0.0 0.9 1.3 0.9 1.2 1.0 2.0 1.2 1.1 2.2 0.2 0.3 0.0 0.6 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.2 1.1 0.1 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.5 0.7 0.1 0.1 0.2 0.2 0.0 0.2 22.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.5 0.0 0.1 0.1 0.1 0.1 1.3 1.2 1.2 1.0 1.0 0.9 1.0 1.5 2.1 0.4 1.2 1.7 1.8 2.0 1.1 1.1 1.0 2.2 0.2 9.5 7.8 3.2 11.2 19.2 11.5 9.7 13.6 21.0 16.3 BAALC ENSG00000164929 "BAALC, MAP3K1 and KLF4 binding" Q8WXS3 8 103140710-103230305 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 121.3" "Cell line enhanced" "Detected in some" "AF22: 24.4;BJ hTERT+: 8.5;SCLC-21H: 13.3;SH-SY5Y: 9.8;U-87 MG: 36.2" "Cancer enriched" "Detected in many" 8 "glioma: 139.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "NK-cell: 6.9" "Lineage enriched" "Detected in single" 25 "NK-cells: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027132, HPA068307" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA027132: AB_10600985, HPA068307: " "unprognostic (1.68e-1)" "unprognostic (9.17e-3)" "unprognostic (1.40e-2)" "unprognostic (4.62e-4)" "unprognostic (1.75e-2)" "unprognostic (2.84e-2)" "unprognostic (1.39e-1)" "unprognostic (7.87e-2)" "unprognostic (2.00e-1)" "unprognostic (4.99e-2)" "unprognostic (4.17e-2)" "unprognostic (2.18e-2)" "unprognostic (7.58e-2)" "unprognostic (2.51e-3)" "unprognostic (2.76e-2)" "unprognostic (1.70e-1)" "unprognostic (9.27e-3)" 7.8 11.1 42.3 3.2 51.9 3.9 3.0 12.5 121.3 2.8 2.9 18.9 0.0 2.3 3.0 2.0 2.2 4.6 2.9 3.2 38.1 34.5 2.8 3.4 4.9 2.6 48.3 25.1 2.7 2.6 1.9 5.2 5.7 41.4 2.0 2.9 0.0 2.1 2.4 3.0 2.7 2.8 3.1 51.2 8.8 2.4 2.6 24.6 0.0 2.8 0.0 2.2 2.8 0.3 0.2 0.1 0.0 0.0 6.9 0.1 0.4 0.2 1.4 24.4 0.2 0.2 7.3 0.0 1.2 8.5 0.0 0.1 0.2 0.0 0.1 0.2 4.6 0.4 0.4 0.0 0.0 0.0 1.4 0.2 0.3 0.0 0.5 0.0 0.5 1.4 1.4 0.3 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.6 0.4 0.1 0.1 0.5 0.0 0.0 13.3 9.8 0.2 0.0 0.0 0.1 0.1 1.4 7.7 0.5 0.2 0.5 0.0 0.1 0.1 36.2 0.1 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.9 0.0 0.1 0.0 0.4 42.3 51.9 12.5 43.6 38.1 34.5 48.3 25.1 41.4 24.6 BAAT BAT ENSG00000136881 "Bile acid-CoA:amino acid N-acyltransferase" Q14032 9 101360417-101383519 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Hydrolase, Serine esterase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 128.4" "Cell line enhanced" "Detected in some" "A549: 6.1;CACO-2: 3.4;Hep G2: 2.4" "Cancer enriched" "Detected in many" 42 "liver cancer: 181.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021251, HPA021330" Enhanced Uncertain Vesicles 470000 Vesicles "HPA021251: AB_1845247, HPA021330: " "unprognostic (2.53e-2)" "unprognostic (1.81e-1)" "unprognostic (9.97e-2)" "unprognostic (9.33e-2)" "unprognostic (7.75e-3)" "unprognostic (4.68e-2)" "prognostic favourable (4.97e-4)" "unprognostic (2.14e-2)" "unprognostic (6.19e-2)" "unprognostic (4.43e-4)" "unprognostic (3.65e-1)" "unprognostic (2.15e-1)" "prognostic unfavourable (4.24e-7)" "unprognostic (1.74e-1)" "unprognostic (2.12e-1)" "unprognostic (2.17e-2)" "unprognostic (1.75e-1)" 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 22.8 0.0 0.1 0.1 0.2 128.4 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.7 0.1 0.1 6.1 0.4 0.3 0.0 0.0 0.0 0.3 0.1 0.1 0.3 3.4 0.1 0.6 0.2 0.0 0.3 0.1 0.2 0.5 0.3 0.1 0.5 0.2 2.4 0.0 0.9 0.3 0.0 1.0 0.1 0.0 0.0 0.7 0.4 0.5 0.1 0.2 0.3 1.0 0.7 0.2 1.1 0.2 0.6 0.2 0.3 0.4 0.4 0.2 0.5 0.0 0.2 0.1 0.6 0.6 0.2 0.4 0.4 0.6 0.5 0.5 0.2 0.6 0.3 0.2 0.0 0.7 0.1 0.1 0.5 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 BABAM2 "BRCC4, BRCC45, BRE" ENSG00000158019 "BRISC and BRCA1 A complex member 2" Q9NXR7 2 27889941-28338901 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "adrenal gland: 172.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017926 Approved Supported Cytosol Cytosol "HPA017926: AB_1845443" "unprognostic (1.28e-1)" "unprognostic (2.30e-1)" "unprognostic (1.53e-3)" "unprognostic (1.61e-3)" "unprognostic (1.89e-1)" "unprognostic (2.68e-3)" "prognostic unfavourable (6.33e-4)" "unprognostic (1.03e-1)" "unprognostic (2.38e-2)" "unprognostic (8.98e-2)" "unprognostic (2.13e-1)" "unprognostic (6.52e-2)" "unprognostic (4.41e-3)" "unprognostic (1.02e-1)" "unprognostic (4.74e-2)" "unprognostic (2.91e-2)" "unprognostic (1.22e-2)" 14.5 172.1 11.7 11.4 19.3 16.9 12.3 9.6 21.3 14.3 11.2 11.3 14.2 8.8 23.2 17.1 12.0 15.5 15.6 25.2 12.5 12.7 25.0 17.1 11.5 18.9 9.9 13.8 16.7 14.5 21.8 23.5 11.6 13.4 11.8 13.1 16.3 10.3 15.6 28.7 11.5 11.1 18.2 9.1 16.7 11.6 26.3 6.7 13.9 11.9 13.6 15.7 14.2 11.8 23.5 39.7 38.6 30.2 24.8 31.7 23.6 14.3 15.8 12.8 13.5 16.5 22.3 12.6 7.3 18.4 13.8 14.3 13.4 14.8 16.3 24.5 17.5 9.6 10.4 19.0 20.3 13.7 13.7 19.4 6.9 14.9 23.9 10.1 15.9 54.2 16.7 19.1 20.0 14.6 9.9 17.9 19.1 12.1 11.7 12.4 9.7 10.4 10.9 20.3 15.6 39.7 7.5 8.4 13.4 8.5 15.1 14.5 10.8 13.4 11.7 13.1 17.6 12.0 9.9 20.4 19.8 21.3 24.4 27.8 13.7 38.6 30.2 12.3 28.5 24.0 31.7 23.5 24.2 26.8 39.7 17.9 23.1 22.0 16.0 24.8 23.3 15.8 27.8 23.6 11.7 19.3 9.6 21.3 12.5 12.7 9.9 13.8 13.4 6.7 BANF2 "BAF-L, BAF2, BAFL, C20orf179, dJ803K15.1" ENSG00000125888 "Barrier to autointegration factor 2" Q9H503 20 17693672-17735871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 58.7" "Group enriched" "Detected in some" 5 "CACO-2: 6.1;SCLC-21H: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042635 Approved "HPA042635: AB_10795707" "unprognostic (2.08e-1)" "unprognostic (9.15e-2)" "unprognostic (6.42e-3)" "unprognostic (1.13e-1)" "unprognostic (1.63e-2)" "unprognostic (3.42e-1)" "unprognostic (3.18e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 11.9 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 58.7 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 BARHL1 ENSG00000125492 "BarH like homeobox 1" Q9BZE3 9 132582185-132590266 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 44 "brain: 40.1" "Cell line enriched" "Detected in single" 105 "SCLC-21H: 19.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "cerebellum: 23.8;pons and medulla: 40.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cerebellum: 3.6;midbrain: 2.9;pons and medulla: 1.1" "Region enhanced" "Detected in many" "cerebellum: 16.3" HPA004809 Enhanced "HPA004809: AB_1078266" "unprognostic (2.29e-1)" "unprognostic (6.42e-2)" "unprognostic (8.07e-2)" "unprognostic (9.31e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 2.2 0.0 0.2 0.9 0.0 0.0 0.0 40.1 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.9 0.0 0.5 2.2 0.0 40.1 0.0 BARHL2 ENSG00000143032 "BarH like homeobox 2" Q9NY43 1 90711539-90717237 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 29.3" "Cell line enhanced" "Detected in some" "HAP1: 2.4;HEK 293: 8.7;HEL: 1.2;HMC-1: 2.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 42 "cerebellum: 29.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "cerebellum: 14.5" "Region enriched" "Detected in single" 21 "cerebellum: 48.3" "unprognostic (1.83e-1)" "unprognostic (1.73e-1)" "unprognostic (6.80e-2)" "unprognostic (3.10e-1)" "unprognostic (1.60e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 8.7 1.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 BARX1 ENSG00000131668 "BARX homeobox 1" Q9HBU1 9 93951622-93955372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "stomach 1: 59.7" "Group enriched" "Detected in some" 7 "AN3-CA: 15.2;HMC-1: 36.4;NTERA-2: 10.8;THP-1: 14.4" "Cancer enhanced" "Detected in many" "stomach cancer: 19.3" "Region enhanced" "Detected in single" "hippocampal formation: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055858 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA055858: " "unprognostic (6.19e-4)" "unprognostic (4.81e-2)" "unprognostic (1.58e-2)" "prognostic unfavourable (8.16e-6)" "unprognostic (4.96e-3)" "prognostic unfavourable (1.02e-4)" "unprognostic (1.46e-2)" "unprognostic (5.20e-3)" "unprognostic (1.23e-2)" "unprognostic (8.75e-2)" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (9.68e-13)" "unprognostic (7.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.60e-1)" "unprognostic (2.16e-2)" 4.3 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.2 2.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.4 1.5 0.0 0.2 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 59.7 5.6 0.0 0.0 0.5 12.3 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 10.8 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.2 0.0 BCAN "BEHAB, CSPG7, MGC13038" ENSG00000132692 Brevican Q96GW7 1 156641390-156659532 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 144.2" "Cell line enhanced" "Detected in many" "HDLM-2: 24.2;K-562: 34.1;U-266/70: 20.5;U-266/84: 39.4" "Group enriched" "Detected in many" 77 "glioma: 348.5;melanoma: 75.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 8.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007865, CAB025862" Enhanced Supported "Secreted in brain" 98000 "CAB025862: , HPA007865: AB_1078299" "unprognostic (7.14e-2)" "unprognostic (3.14e-1)" "unprognostic (1.95e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (9.03e-2)" "unprognostic (4.58e-2)" "unprognostic (2.02e-2)" "unprognostic (4.80e-2)" "unprognostic (6.87e-2)" "unprognostic (1.65e-1)" "unprognostic (1.30e-2)" "unprognostic (9.47e-3)" "unprognostic (2.76e-2)" "unprognostic (8.54e-2)" "unprognostic (5.40e-1)" "unprognostic (1.90e-1)" 1.4 5.8 51.8 1.6 35.9 1.3 1.4 10.4 144.2 2.3 2.4 30.5 1.3 4.6 2.7 9.5 1.6 2.4 3.1 1.5 40.8 22.9 1.4 1.3 1.5 1.5 26.6 21.5 1.4 1.3 1.3 0.7 1.7 15.1 1.4 1.3 4.3 2.0 2.4 1.6 9.0 5.0 2.4 13.0 1.6 2.4 2.0 26.7 0.0 1.4 0.0 1.3 2.3 0.3 0.6 0.0 8.2 0.4 0.0 0.0 0.0 13.7 9.5 0.0 2.6 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.3 6.8 0.0 14.7 0.0 9.7 0.1 0.0 0.0 24.2 0.8 2.4 6.3 7.8 0.0 0.9 2.4 0.0 0.0 0.0 0.0 0.0 34.1 6.7 0.0 4.0 0.0 0.0 0.7 1.4 0.0 15.8 0.0 0.0 1.7 0.0 0.2 0.0 0.0 14.3 0.0 0.9 2.9 0.0 7.8 2.8 3.7 20.5 39.4 0.0 2.9 6.4 1.1 8.2 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.8 35.9 10.4 33.3 40.8 22.9 26.6 21.5 15.1 26.7 BCHE "CHE1, CHE2, E1" ENSG00000114200 Butyrylcholinesterase P06276 3 165772904-165837472 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 145.4" "Cell line enriched" "Detected in some" 9 "Karpas-707: 128.6" "Group enriched" "Detected in many" 6 "glioma: 24.0;liver cancer: 13.7;melanoma: 18.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA001560 Approved "Secreted to blood" 13000000000 "HPA001560: AB_1078271" "unprognostic (4.74e-2)" "unprognostic (2.00e-1)" "unprognostic (9.21e-4)" "unprognostic (8.19e-8)" "unprognostic (2.66e-2)" "prognostic unfavourable (1.06e-4)" "unprognostic (1.44e-1)" "unprognostic (5.04e-2)" "unprognostic (6.15e-2)" "unprognostic (9.59e-2)" "unprognostic (5.15e-2)" "unprognostic (3.65e-2)" "unprognostic (3.18e-3)" "unprognostic (4.46e-5)" "unprognostic (2.17e-2)" "unprognostic (5.92e-2)" "unprognostic (4.26e-4)" 14.0 3.9 6.7 6.2 4.3 0.4 1.9 3.6 9.1 24.4 15.5 4.7 8.3 1.8 20.2 13.4 20.0 18.0 2.2 7.8 6.1 4.4 2.8 145.4 3.7 0.7 5.5 2.7 10.3 1.1 0.4 1.2 0.5 4.7 4.7 5.3 0.7 1.0 10.5 1.1 2.8 6.4 13.9 3.4 3.7 1.9 1.8 6.1 1.0 0.8 0.4 0.5 9.7 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 14.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.2 0.0 0.0 0.0 5.3 0.0 0.0 0.9 0.0 0.9 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 4.1 0.2 0.0 1.3 0.6 0.0 128.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 4.7 10.7 0.1 0.0 0.0 0.1 0.0 0.0 7.4 5.7 0.0 0.0 3.2 0.0 0.0 1.3 0.5 0.0 0.2 1.3 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 4.3 3.6 4.3 6.1 4.4 5.5 2.7 4.7 6.1 BCL2L15 "Bfk, C1orf178, FLJ22588" ENSG00000188761 "BCL2 like 15" Q5TBC7 1 113878168-113887547 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 84.0" "Group enriched" "Detected in some" 4 "CAPAN-2: 22.6;EFO-21: 7.8;RPTEC TERT1: 6.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 10.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.6;neutrophil: 1.9" "Group enriched" "Detected in many" 6 "granulocytes: 1.9;T-cells: 1.6" "Region enriched" "Detected in single" 32 "cerebellum: 36.9" "Low region specificity" "Detected in all" "HPA029732, HPA029733" Enhanced "HPA029732: AB_10599615, HPA029733: AB_10600422" "unprognostic (5.96e-2)" "unprognostic (6.41e-3)" "unprognostic (5.82e-2)" "prognostic favourable (5.63e-4)" "unprognostic (2.16e-1)" "unprognostic (6.23e-3)" "unprognostic (4.97e-4)" "unprognostic (1.74e-1)" "unprognostic (2.95e-1)" "unprognostic (1.46e-2)" "unprognostic (1.27e-2)" "unprognostic (1.49e-1)" "unprognostic (2.42e-7)" "unprognostic (5.20e-2)" "unprognostic (2.24e-2)" "unprognostic (9.04e-3)" "unprognostic (4.27e-2)" 0.4 0.2 0.4 3.8 0.4 5.7 0.4 0.9 0.4 2.6 30.5 0.4 0.7 25.4 0.6 2.4 2.3 0.5 4.9 0.4 0.4 0.2 1.3 0.4 0.7 0.4 0.4 0.4 0.6 9.4 0.0 0.4 0.4 0.4 0.5 18.8 0.4 0.4 0.4 0.4 0.2 84.0 0.4 0.4 0.5 9.4 0.6 0.4 0.4 0.4 0.9 0.6 0.8 0.6 0.0 0.0 1.9 0.3 0.0 1.6 0.4 0.0 2.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.1 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.4 0.0 2.1 0.3 0.2 0.0 0.0 0.0 0.3 0.5 6.7 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.2 0.4 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 1.2 0.5 0.0 0.0 0.2 0.0 1.9 0.0 0.3 0.0 0.0 0.4 0.4 0.4 0.9 0.4 0.4 0.2 0.4 0.4 0.4 0.4 BDH1 "BDH, SDR9C1" ENSG00000161267 "3-hydroxybutyrate dehydrogenase 1" Q02338 3 197509783-197573323 "Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "liver: 156.0" "Cell line enhanced" "Detected in many" "U-937: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030947, HPA058709" Enhanced Enhanced Mitochondria Mitochondria "HPA030947: AB_10669548, HPA058709: " "unprognostic (2.72e-2)" "prognostic favourable (1.09e-4)" "unprognostic (1.13e-1)" "unprognostic (3.93e-1)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic favourable (9.86e-7)" "unprognostic (2.08e-1)" "unprognostic (3.85e-2)" "unprognostic (4.53e-2)" "unprognostic (5.17e-3)" "unprognostic (5.85e-3)" "prognostic favourable (7.12e-8)" "unprognostic (5.62e-2)" "unprognostic (1.74e-1)" "unprognostic (6.22e-2)" "unprognostic (1.02e-1)" 3.5 2.8 6.6 5.2 11.2 4.7 4.6 18.1 13.8 4.0 13.9 4.6 6.3 9.6 2.1 3.6 12.9 5.5 6.1 19.6 6.3 5.8 6.0 156.0 2.0 4.2 5.9 9.1 3.0 2.8 5.8 3.6 1.4 7.7 4.5 11.1 6.2 8.6 4.4 7.3 8.0 13.7 2.4 3.5 2.3 4.7 1.8 3.6 5.4 5.2 11.3 7.4 3.6 3.6 6.1 4.6 2.9 1.6 4.7 9.9 4.0 10.5 1.4 0.6 5.4 0.9 0.0 0.0 1.2 1.0 5.5 3.1 9.5 3.5 0.0 15.7 0.3 4.9 4.8 2.5 2.1 0.1 0.0 5.6 3.6 3.2 4.0 12.4 5.9 1.6 3.0 2.1 4.6 1.3 0.0 4.2 0.1 18.8 9.5 8.4 4.1 1.9 9.1 2.0 14.4 5.8 4.8 10.0 4.3 3.8 0.5 2.0 12.7 10.4 0.1 0.3 1.8 0.0 9.9 4.9 9.2 0.1 0.3 35.3 0.7 2.9 1.6 0.6 5.9 0.2 8.2 6.1 6.5 5.3 4.2 5.5 9.9 5.9 0.0 4.7 0.3 4.6 4.2 4.0 6.6 11.2 18.1 13.8 6.3 5.8 5.9 9.1 7.7 3.6 BEND2 "CXorf20, MGC33653" ENSG00000177324 "BEN domain containing 2" Q8NDZ0 X 18162931-18220883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 23.2" "Cell line enhanced" "Detected in single" "HeLa: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 4.1;neutrophil: 1.8" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.1" "HPA009420, HPA013142" Enhanced "HPA009420: AB_2064489, HPA013142: AB_2668784" "unprognostic (2.23e-2)" "unprognostic (1.17e-1)" 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 4.1 0.4 0.4 0.4 5.1 0.4 0.2 0.4 0.8 0.0 0.1 0.4 0.5 0.0 0.0 0.2 0.5 0.2 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.4 1.5 0.2 0.1 0.5 0.5 0.0 0.0 0.1 0.2 0.0 0.5 0.8 0.3 0.5 0.1 0.5 0.4 0.3 0.2 0.3 0.7 0.0 0.4 0.4 0.0 0.2 0.3 0.4 0.2 0.1 0.8 0.4 0.2 0.4 0.1 0.8 0.2 0.8 0.2 0.7 0.4 4.1 0.4 0.1 0.3 0.1 0.1 0.2 0.2 0.2 0.1 0.4 0.3 0.4 1.8 0.4 0.1 0.3 0.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BEND4 "CCDC4, FLJ35632, FLJ43965" ENSG00000188848 "BEN domain containing 4" Q6ZU67 4 42110938-42152878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 26.7" "Cell line enhanced" "Detected in some" "HAP1: 24.1;HEK 293: 5.8;HEL: 14.7;MOLT-4: 9.0;U-698: 9.6" "Group enriched" "Detected in some" 43 "prostate cancer: 6.3;testis cancer: 5.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "memory B-cell: 1.1;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 12 "B-cells: 3.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036850 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA036850: AB_10600787" "unprognostic (3.62e-4)" "unprognostic (3.82e-1)" "unprognostic (4.82e-2)" "unprognostic (5.96e-3)" "unprognostic (2.97e-3)" "unprognostic (1.10e-1)" "unprognostic (3.81e-2)" "unprognostic (4.00e-1)" "unprognostic (2.97e-1)" "unprognostic (5.58e-2)" "unprognostic (6.71e-3)" "unprognostic (1.68e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (1.49e-1)" "unprognostic (4.58e-3)" "unprognostic (4.24e-1)" 0.4 0.3 3.9 5.0 1.0 1.6 0.3 0.2 2.6 0.2 0.6 0.0 0.0 0.5 0.4 0.2 0.3 0.2 0.4 0.3 2.8 1.9 0.3 0.5 1.0 3.7 2.8 1.1 0.6 0.3 0.1 3.8 0.8 1.8 6.4 0.7 0.2 0.8 0.2 0.2 0.2 2.8 0.4 0.4 4.8 0.5 26.7 0.3 4.8 0.3 0.0 3.0 0.7 2.3 3.3 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 24.1 0.0 0.0 0.0 5.8 14.7 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 4.4 1.3 0.0 0.0 0.0 0.0 0.0 3.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 3.9 1.0 0.2 2.6 2.8 1.9 2.8 1.1 1.8 0.3 BEST1 "BEST, BMD, RP50, VMD2" ENSG00000167995 "Bestrophin 1" O76090 11 61949821-61965515 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport, Vision" "Chloride channel, Ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "retina: 218.0" "Cell line enhanced" "Detected in some" "ASC diff: 9.2;SK-MEL-30: 32.8;U-266/70: 8.8" "Group enriched" "Detected in some" 6 "glioma: 2.0;melanoma: 6.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "neutrophil: 23.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 23.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057464 Enhanced "HPA057464: " "unprognostic (2.41e-3)" "unprognostic (3.67e-2)" "unprognostic (5.91e-3)" "unprognostic (1.21e-1)" "unprognostic (1.25e-1)" "unprognostic (2.73e-1)" "unprognostic (1.53e-2)" "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (1.07e-3)" "unprognostic (2.06e-1)" "unprognostic (4.27e-10)" "unprognostic (1.38e-1)" "unprognostic (4.93e-2)" "unprognostic (3.59e-3)" "unprognostic (2.72e-3)" 5.2 2.9 7.4 9.5 11.8 26.4 2.3 1.6 12.6 2.0 1.4 16.0 0.7 2.1 2.6 9.6 3.0 2.6 6.2 2.5 9.2 5.3 1.4 1.1 4.7 2.5 14.8 6.0 3.7 2.2 0.5 1.4 2.8 9.4 1.6 1.3 218.0 1.2 1.9 0.7 3.0 2.0 2.1 16.9 5.4 1.3 3.9 13.3 0.3 2.3 0.4 0.6 3.9 2.3 0.3 1.6 23.3 2.8 0.1 0.1 0.9 0.5 0.5 0.2 0.4 9.2 1.9 0.9 0.6 1.1 0.2 0.7 0.2 0.3 0.1 1.3 0.6 0.7 0.0 0.0 0.1 0.1 0.1 0.0 3.5 0.5 2.8 0.1 0.3 2.6 1.1 1.2 2.5 0.0 0.4 5.1 1.1 0.3 0.1 0.4 0.0 1.3 0.0 0.1 0.2 0.0 1.2 0.6 0.5 1.0 0.1 32.8 0.5 1.3 0.1 0.5 0.3 0.5 0.2 8.8 0.5 0.5 3.4 0.3 1.0 1.5 2.3 2.1 0.1 2.7 0.1 0.3 0.1 0.1 1.6 0.1 0.1 0.0 23.3 0.1 2.8 0.3 0.1 0.9 7.4 11.8 1.6 5.9 9.2 5.3 14.8 6.0 9.4 13.3 BEST3 "MGC13168, MGC40411, VMD2L3" ENSG00000127325 "Bestrophin 3" Q8N1M1 12 69643360-69699476 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 125.0" "Group enriched" "Detected in some" 16 "REH: 18.3;RPMI-8226: 19.6;U-698: 32.7" "Cancer enriched" "Detected in single" 9 "glioma: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054582 Approved "HPA054582: " "unprognostic (1.53e-1)" "unprognostic (7.00e-2)" "unprognostic (9.83e-2)" "unprognostic (1.67e-2)" "unprognostic (5.15e-3)" "unprognostic (2.26e-3)" "unprognostic (7.30e-7)" "unprognostic (1.81e-1)" "unprognostic (1.74e-2)" "unprognostic (5.36e-2)" "unprognostic (1.19e-1)" "unprognostic (4.08e-2)" "unprognostic (4.82e-2)" "unprognostic (4.47e-2)" "unprognostic (3.03e-1)" 1.6 0.5 1.7 0.1 1.9 2.4 0.6 6.3 9.3 0.2 0.2 0.9 0.0 0.2 0.2 2.4 1.7 0.1 0.2 0.4 1.8 0.7 0.4 0.3 0.1 0.2 1.8 0.6 0.2 1.0 0.1 0.7 0.3 1.2 1.7 0.2 0.1 1.9 0.1 125.0 0.9 0.1 0.1 1.9 0.1 0.1 2.5 1.0 0.5 0.2 21.9 0.7 0.1 0.0 1.2 0.9 1.7 0.5 0.6 1.0 0.7 0.1 0.2 0.7 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.4 0.1 0.2 1.3 0.3 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.5 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.6 0.1 0.2 0.2 0.0 0.8 0.1 0.0 0.0 0.7 0.3 18.3 0.6 19.6 0.9 0.1 0.4 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.5 0.1 0.7 0.1 0.2 32.7 1.4 0.0 0.1 0.3 0.5 0.3 0.5 0.4 0.8 1.2 1.0 0.7 0.3 0.8 1.0 1.0 1.7 0.6 0.4 0.9 0.4 0.7 1.7 1.9 6.3 1.5 1.8 0.7 1.8 0.6 1.2 1.0 BEST4 VMD2L2 ENSG00000142959 "Bestrophin 4" Q8NFU0 1 44783585-44787705 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 34.3" "Cell line enhanced" "Detected in some" "Hep G2: 7.3;U-698: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058564 Uncertain "HPA058564: " "unprognostic (5.76e-2)" "unprognostic (1.22e-1)" "unprognostic (3.15e-2)" "unprognostic (6.20e-2)" "unprognostic (6.51e-3)" "unprognostic (1.09e-1)" "unprognostic (8.39e-2)" "unprognostic (1.45e-3)" "unprognostic (1.04e-1)" "unprognostic (8.97e-2)" "unprognostic (5.72e-2)" "unprognostic (1.29e-1)" "unprognostic (2.69e-5)" "unprognostic (1.43e-1)" "unprognostic (3.72e-1)" "unprognostic (1.28e-1)" "unprognostic (4.13e-3)" 0.5 1.1 0.6 1.4 2.5 0.4 0.5 2.1 0.7 1.2 32.7 0.5 0.5 8.8 0.7 2.6 0.5 7.2 0.5 0.5 1.0 3.2 0.5 0.5 1.1 0.5 0.5 0.5 0.5 0.5 0.4 1.8 0.5 0.5 0.5 15.9 0.5 0.5 0.5 0.5 1.8 34.3 0.5 0.5 0.5 0.2 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 3.0 0.9 0.7 0.1 0.9 2.8 0.4 0.2 0.6 1.1 1.2 0.4 0.4 3.4 0.8 0.4 0.3 0.1 0.4 1.5 0.3 1.5 0.4 1.6 0.2 0.2 0.4 0.7 0.7 0.2 1.8 7.3 0.4 0.0 0.9 0.7 0.9 0.4 0.7 1.0 0.2 0.6 0.2 0.2 0.0 0.5 2.4 0.2 0.4 0.3 0.6 0.5 0.1 2.5 0.9 0.3 0.2 0.3 1.2 0.1 1.7 0.5 0.5 0.5 0.5 1.2 0.3 5.2 1.2 0.3 0.2 0.1 0.1 0.5 1.1 0.1 2.7 3.0 1.9 2.8 0.0 2.0 1.0 1.8 0.7 0.9 0.0 0.9 2.2 0.4 0.6 2.5 2.1 0.7 1.0 3.2 0.5 0.5 0.5 0.5 BFSP2 "CP47, CP49, LIFL-L, phakinin" ENSG00000170819 "Beaded filament structural protein 2" Q13515 3 133399995-133475222 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "blood: 12.7" "Group enriched" "Detected in some" 7 "Daudi: 5.5;U-698: 6.5" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 7 "T-reg: 12.7" "Lineage enriched" "Detected in single" 48 "T-cells: 12.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA038464, HPA062959" Enhanced Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038464: AB_10672746, HPA062959: AB_2684912" "unprognostic (1.58e-3)" "unprognostic (7.47e-4)" "unprognostic (1.04e-2)" "unprognostic (2.32e-1)" "unprognostic (9.59e-2)" "unprognostic (4.04e-5)" "unprognostic (8.13e-2)" "unprognostic (5.57e-2)" "unprognostic (6.71e-2)" "unprognostic (1.91e-3)" "unprognostic (1.74e-2)" "unprognostic (4.70e-2)" "unprognostic (1.68e-5)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "unprognostic (8.23e-2)" "unprognostic (2.21e-2)" 0.0 0.0 0.1 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.1 0.2 0.0 0.0 12.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.8 6.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 1.7 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BHLHA9 "bHLHa9, BHLHF42" ENSG00000205899 "Basic helix-loop-helix family member a9" Q7RTU4 17 1270559-1271460 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "brain: 4.0" "Cell line enhanced" "Detected in some" "CACO-2: 1.1;HDLM-2: 1.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "unprognostic (9.27e-2)" "unprognostic (2.63e-1)" "unprognostic (2.99e-1)" "unprognostic (7.74e-2)" 0.1 0.0 1.4 0.0 0.3 0.0 0.0 0.4 4.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.9 1.6 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.4 3.2 0.9 1.6 0.5 0.0 1.6 0.0 BHLHE22 "Beta3, BHLHB5, bHLHe22, CAGL85, TNRC20" ENSG00000180828 "Basic helix-loop-helix family member e22" Q8NFJ8 8 64580367-64583628 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 30.7" "Cell line enriched" "Detected in some" 23 "THP-1: 40.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 31.9;cerebellum: 34.4;cerebral cortex: 22.4;hippocampal formation: 50.8" "Group enriched" "Detected in many" 8 "amygdala: 37.8;cerebellum: 21.5;cerebral cortex: 22.5;hippocampal formation: 63.6" "HPA064128, HPA064872, HPA067500" Enhanced "HPA064128: AB_2685195, HPA064872: AB_2685377, HPA067500: AB_2685855" "unprognostic (9.17e-2)" "unprognostic (1.11e-2)" "unprognostic (5.44e-2)" "unprognostic (2.28e-5)" "unprognostic (7.22e-3)" "unprognostic (6.47e-4)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (1.30e-1)" "unprognostic (6.58e-2)" "unprognostic (1.52e-1)" "unprognostic (3.71e-2)" "unprognostic (2.86e-7)" "unprognostic (3.20e-2)" "unprognostic (2.29e-1)" "unprognostic (6.72e-3)" "unprognostic (1.86e-1)" 2.9 1.3 30.7 2.9 1.4 0.3 1.7 21.1 15.8 1.7 1.7 1.2 0.3 1.1 0.5 0.4 2.2 0.6 1.1 0.8 27.2 2.1 0.5 1.3 1.4 2.4 1.7 6.5 0.4 1.3 0.5 1.2 0.2 3.4 0.5 1.4 2.5 1.2 5.4 0.5 0.8 1.7 1.1 2.6 2.9 1.1 0.7 0.2 0.0 0.6 0.0 1.3 2.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 40.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 1.4 21.1 10.6 27.2 2.1 1.7 6.5 3.4 0.2 BHMG1 HMGDC ENSG00000237452 "Basic helix-loop-helix and HMG-box containing 1" C9JSJ3 19 45733251-45764534 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 33 "testis: 17.8" "Group enriched" "Detected in some" 5 "Daudi: 3.4;K-562: 8.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049521 Uncertain Approved Nucleoplasm Nucleoplasm "HPA049521: " "unprognostic (4.15e-2)" "unprognostic (2.97e-2)" "unprognostic (2.64e-1)" "unprognostic (1.53e-1)" "unprognostic (8.33e-2)" "unprognostic (6.29e-2)" "unprognostic (1.70e-3)" "unprognostic (3.31e-2)" "unprognostic (3.34e-1)" "unprognostic (1.15e-2)" "unprognostic (1.08e-1)" "unprognostic (6.53e-12)" "unprognostic (2.29e-1)" "unprognostic (1.07e-1)" "unprognostic (6.11e-3)" "unprognostic (1.87e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.0 3.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 8.1 0.3 0.0 1.2 0.0 0.4 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.3 0.9 0.3 0.2 0.4 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BIN1 "AMPH2, AMPHL, SH3P9" ENSG00000136717 "Bridging integrator 1" O00499 2 127048027-127107355 "Disease related genes, Predicted intracellular proteins" "Differentiation, Endocytosis, Host-virus interaction" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "skeletal muscle: 399.9" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 37.0;MAIT T-cell: 32.5;memory B-cell: 32.2;memory CD4 T-cell: 38.4;memory CD8 T-cell: 36.9;naive B-cell: 34.1;naive CD4 T-cell: 36.2;naive CD8 T-cell: 34.4;NK-cell: 31.2;T-reg: 45.0" "Group enriched" "Detected in many" 9 "B-cells: 34.1;NK-cells: 31.2;T-cells: 45.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001945, HPA003894, HPA005437" Enhanced Supported Cytosol 1200000 Cytosol "CAB001945: , HPA003894: AB_1845360, HPA005437: AB_1078284" "unprognostic (2.20e-2)" "unprognostic (1.61e-1)" "unprognostic (2.65e-2)" "unprognostic (9.65e-2)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (3.06e-2)" "unprognostic (2.21e-1)" "unprognostic (3.52e-1)" "unprognostic (1.55e-1)" "unprognostic (1.02e-3)" "unprognostic (1.85e-1)" "unprognostic (1.42e-3)" "unprognostic (1.26e-2)" "unprognostic (2.57e-1)" "unprognostic (2.41e-3)" "unprognostic (3.22e-3)" 9.5 12.1 21.0 6.7 26.8 3.7 4.2 10.3 24.9 6.2 5.4 36.2 3.6 5.3 5.6 7.3 8.8 7.8 6.4 3.1 24.8 15.2 10.3 4.9 4.6 9.3 26.8 15.8 6.8 5.3 7.3 4.9 6.5 17.3 9.2 4.4 7.9 4.9 7.2 399.9 2.7 5.0 11.6 22.1 10.4 6.1 3.1 26.8 0.0 4.7 30.8 7.3 9.0 7.9 34.1 4.0 1.1 0.6 31.2 45.0 22.4 15.3 8.4 10.1 12.0 30.4 24.4 3.5 4.6 10.1 11.1 7.3 32.2 9.5 0.0 14.3 8.7 2.0 4.5 7.6 3.0 1.7 1.2 4.5 13.8 2.1 27.4 0.0 0.9 22.2 1.9 24.0 4.4 15.0 0.9 0.5 13.7 0.3 1.4 12.8 7.6 9.6 3.5 11.2 1.4 39.3 0.0 6.6 18.8 16.8 6.5 5.1 0.4 2.9 17.9 12.8 12.6 16.3 15.5 0.4 0.4 0.0 18.9 0.8 5.8 0.1 0.6 0.1 37.0 0.3 32.5 32.2 38.4 36.9 2.8 34.1 36.2 34.4 1.1 31.2 0.5 4.0 45.0 22.4 21.0 26.8 10.3 24.9 24.8 15.2 26.8 15.8 17.3 26.8 BIRC8 "hILP2, ILP-2, RNF136" ENSG00000163098 "Baculoviral IAP repeat containing 8" Q96P09 19 53289601-53291626 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 246 "testis: 24.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BLM "BS, RECQ2, RECQL3" ENSG00000197299 "Bloom syndrome RecQ like helicase" P54132 15 90717327-90816165 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 36.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005689 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA005689: AB_1845372" "unprognostic (2.77e-1)" "unprognostic (3.82e-3)" "unprognostic (4.03e-2)" "unprognostic (2.98e-2)" "unprognostic (4.75e-2)" "unprognostic (9.89e-2)" "unprognostic (6.12e-5)" "unprognostic (2.82e-2)" "unprognostic (4.55e-3)" "unprognostic (5.24e-3)" "unprognostic (1.80e-3)" "unprognostic (9.12e-2)" "unprognostic (1.55e-15)" "unprognostic (6.53e-3)" "unprognostic (6.55e-2)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" 1.8 0.4 3.1 11.4 1.5 5.5 0.6 4.7 2.6 0.7 1.9 0.9 0.5 1.4 1.2 1.1 2.9 0.4 1.3 1.0 2.3 2.4 0.9 0.5 2.0 7.7 2.8 0.2 0.9 0.4 0.0 1.2 3.6 0.5 0.7 2.5 0.7 7.8 0.0 1.7 0.6 2.8 0.5 1.9 6.7 1.4 4.9 0.5 36.7 0.6 3.1 9.3 1.4 0.7 7.4 1.2 4.3 1.6 4.6 5.0 1.6 5.4 7.8 8.7 5.1 0.0 0.4 5.5 4.1 1.2 4.7 5.1 6.8 3.8 14.1 2.6 1.1 9.1 13.4 3.7 6.1 8.5 9.9 14.7 8.4 2.2 0.0 14.1 7.3 0.0 0.0 4.7 2.4 3.3 12.7 4.4 4.9 3.4 10.6 7.8 9.3 1.7 10.8 16.4 5.4 1.1 9.8 6.5 6.1 3.3 4.4 2.6 3.1 11.6 1.8 3.4 6.3 3.5 8.7 3.2 13.1 14.7 1.9 10.0 5.8 2.5 1.0 4.3 3.1 1.2 4.8 7.4 2.8 3.8 1.2 4.3 2.0 2.2 0.8 4.6 1.6 1.2 5.0 1.6 3.1 1.5 4.7 1.7 2.3 2.4 2.8 0.2 0.5 0.5 BMP10 ENSG00000163217 "Bone morphogenetic protein 10" O95393 2 68865481-68871517 "Predicted secreted proteins" "Cell adhesion" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "heart muscle: 110.1" "Cell line enhanced" "Detected in single" "MOLT-4: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "T-reg: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" 120000 "unprognostic (1.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.1 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BMP8A ENSG00000183682 "Bone morphogenetic protein 8a" Q7Z5Y6 1 39491646-39525935 "Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "thyroid gland: 45.6" "Cell line enhanced" "Detected in some" "U-2197: 15.9;U-266/70: 7.7;U-266/84: 7.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" "unprognostic (9.62e-3)" "unprognostic (2.11e-2)" "unprognostic (7.79e-2)" "unprognostic (1.22e-1)" "unprognostic (1.37e-1)" "unprognostic (2.00e-1)" "unprognostic (2.91e-3)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-1)" "unprognostic (1.54e-1)" "unprognostic (5.33e-3)" "unprognostic (2.95e-9)" "unprognostic (2.62e-2)" "unprognostic (1.49e-1)" "unprognostic (2.28e-3)" "unprognostic (2.55e-2)" 0.7 1.0 1.7 1.2 2.0 0.9 0.5 0.8 3.6 3.3 1.0 8.5 0.0 1.4 3.7 1.2 0.7 2.0 2.6 1.2 1.9 1.3 0.6 0.5 0.7 5.6 4.6 1.1 8.9 3.8 0.5 0.9 1.0 4.8 1.0 0.6 0.4 1.3 1.8 1.4 1.6 2.2 1.9 8.3 1.4 1.0 4.0 2.3 1.7 45.6 0.0 0.6 0.9 0.9 0.7 0.0 0.0 0.6 0.0 0.1 0.4 0.4 0.8 0.4 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.3 0.0 0.1 0.3 0.2 0.6 0.0 0.0 0.0 0.4 1.8 0.0 1.6 0.3 3.8 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.9 0.0 1.6 0.0 2.1 1.1 0.1 0.5 0.3 2.4 0.1 0.1 1.4 0.4 0.1 0.2 1.1 0.7 2.9 0.1 0.0 0.7 15.9 0.0 7.7 7.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 2.0 0.8 3.6 1.9 1.3 4.6 1.1 4.8 2.3 BMX "ETK, PSCTK3" ENSG00000102010 "BMX non-receptor tyrosine kinase" P51813 X 15464246-15556529 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell adhesion, Stress response" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 57.1" "Cell line enriched" "Detected in single" 121 "HUVEC TERT2: 88.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "neutrophil: 10.5" "Lineage enriched" "Detected in single" 105 "granulocytes: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001048, CAB032495" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB032495: AB_2290760, HPA001048: AB_1078289" "unprognostic (7.80e-2)" "unprognostic (4.92e-3)" "unprognostic (1.16e-2)" "unprognostic (4.07e-3)" "unprognostic (2.69e-1)" "unprognostic (2.14e-1)" "unprognostic (1.06e-3)" "unprognostic (2.36e-1)" "unprognostic (1.87e-1)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.06e-1)" "unprognostic (1.26e-2)" "unprognostic (1.84e-2)" "unprognostic (3.64e-2)" "unprognostic (1.26e-1)" "unprognostic (2.81e-2)" 8.2 0.3 0.1 1.0 0.7 3.6 5.4 0.1 0.3 2.2 5.5 0.1 4.6 2.4 2.6 57.1 1.5 2.5 2.6 10.5 0.5 0.0 0.2 0.9 3.7 6.5 0.4 0.0 1.4 0.9 0.2 0.6 2.6 0.7 2.2 1.4 0.5 1.5 0.6 4.2 1.6 5.5 2.2 0.4 2.4 1.5 1.9 0.1 0.2 2.2 1.1 0.8 2.8 2.4 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.3 0.5 0.0 0.4 0.0 0.7 0.1 BOD1L2 "BOD1P, FAM44C, MGC33608" ENSG00000228075 "Biorientation of chromosomes in cell division 1 like 2" Q8IYS8 18 57147062-57150300 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "testis: 197.8" "Cell line enhanced" "Detected in single" "U-2197: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA036293 Uncertain "HPA036293: AB_10673127" "unprognostic (2.35e-3)" "unprognostic (3.72e-1)" "unprognostic (2.47e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 197.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 BOLL BOULE ENSG00000152430 "Boule homolog, RNA binding protein" Q8N9W6 2 197726879-197786762 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 83.6" "Cell line enhanced" "Detected in some" "MCF7: 1.6;U-266/70: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "T-reg: 4.7" "Lineage enriched" "Detected in single" 12 "T-cells: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA018678, HPA048813" Enhanced "HPA018678: AB_1845411, HPA048813: AB_2680529" "unprognostic (3.55e-2)" "unprognostic (1.69e-1)" "unprognostic (6.05e-2)" "unprognostic (3.08e-2)" "unprognostic (7.93e-2)" "unprognostic (3.20e-1)" "unprognostic (3.73e-1)" "unprognostic (1.77e-1)" "unprognostic (2.80e-1)" "unprognostic (3.08e-1)" "unprognostic (9.49e-2)" "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 83.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.1 4.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.5 0.3 0.6 0.6 0.0 0.7 0.4 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.3 0.5 0.0 1.6 0.0 0.2 0.2 0.3 0.3 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.2 3.5 0.6 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPGM ENSG00000172331 "Bisphosphoglycerate mutase" P07738 7 134646808-134679813 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "placenta: 184.7" "Cell line enhanced" "Detected in all" "HDLM-2: 37.1;RT4: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016493, HPA028735" Enhanced Approved Nucleoplasm,Nucleoli 69000000 Nucleoli Nucleoplasm "HPA016493: AB_1845414, HPA028735: AB_10600791" "unprognostic (2.56e-1)" "prognostic favourable (7.95e-4)" "unprognostic (3.19e-1)" "unprognostic (3.94e-1)" "unprognostic (1.78e-1)" "unprognostic (5.22e-2)" "unprognostic (3.81e-3)" "unprognostic (1.96e-1)" "unprognostic (7.74e-2)" "unprognostic (4.67e-3)" "unprognostic (7.42e-2)" "unprognostic (5.69e-2)" "prognostic favourable (1.54e-8)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.78e-2)" 6.1 7.3 13.6 4.5 11.1 37.7 6.9 11.7 11.6 7.1 6.9 9.1 6.1 4.3 5.4 10.2 14.6 4.7 6.9 7.3 12.5 14.2 19.1 8.1 8.0 5.2 13.9 7.8 5.7 5.4 16.5 14.4 184.7 12.4 7.5 5.4 6.7 10.6 10.3 17.7 5.5 6.0 6.6 15.9 8.6 6.8 7.4 8.8 8.5 7.5 22.2 13.3 24.9 9.5 11.6 10.2 28.2 12.8 9.8 14.5 12.8 4.4 5.4 7.2 9.7 8.3 4.9 7.2 13.4 16.2 5.2 7.8 2.1 6.0 5.4 4.0 7.5 3.6 7.6 7.4 9.2 37.1 6.7 3.1 5.0 2.5 5.7 5.9 4.1 4.8 6.7 9.8 5.3 18.9 9.0 6.8 12.3 2.1 9.6 8.2 7.4 5.2 7.3 5.1 3.9 11.8 59.6 6.2 10.4 6.2 7.5 6.7 4.9 3.8 14.3 8.3 2.0 11.1 10.8 11.3 12.9 6.8 14.4 5.7 14.2 28.2 9.8 27.6 14.5 12.8 10.4 11.6 9.5 12.7 10.2 10.5 13.2 13.4 18.0 9.8 12.5 6.7 12.0 12.8 13.6 11.1 11.7 11.6 12.5 14.2 13.9 7.8 12.4 8.8 BPI BPIFD1 ENSG00000101425 "Bactericidal/permeability-increasing protein" P17213 20 38304123-38337505 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 197.4" "Cell line enhanced" "Detected in some" "BJ: 1.3;BJ hTERT+: 2.1;HL-60: 5.1;RPMI-8226: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "classical monocyte: 13.6;neutrophil: 6.4" "Group enriched" "Detected in many" 18 "granulocytes: 6.4;monocytes: 13.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061284 Enhanced "Secreted to blood" 7290000 "HPA061284: " "unprognostic (9.30e-4)" "unprognostic (5.49e-2)" "unprognostic (1.97e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-1)" "unprognostic (1.56e-1)" "unprognostic (4.50e-2)" "unprognostic (1.98e-1)" "unprognostic (3.07e-2)" "unprognostic (1.14e-1)" "unprognostic (2.60e-2)" "unprognostic (1.50e-1)" "unprognostic (8.83e-6)" "unprognostic (2.66e-4)" "unprognostic (9.29e-2)" "unprognostic (2.32e-2)" "unprognostic (9.47e-3)" 0.2 0.1 0.0 0.1 0.1 197.4 0.2 0.1 0.8 1.8 0.1 0.3 0.0 0.1 0.6 0.5 0.1 0.2 0.2 15.3 0.0 0.0 0.6 0.5 6.0 0.1 0.0 0.0 1.7 0.1 0.1 0.5 2.8 0.3 0.2 0.1 0.2 0.3 0.4 0.6 0.3 0.1 0.1 0.1 10.5 0.1 41.7 0.1 5.3 1.3 0.0 0.1 0.1 0.7 0.0 0.5 6.4 13.6 0.0 0.0 6.7 0.0 0.0 0.6 0.0 0.1 0.2 0.0 1.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 13.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.4 0.0 0.5 0.0 0.0 6.7 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.3 0.1 BPIFA2 "bA49G10.1, C20orf70, PSP, SPLUNC2" ENSG00000131050 "BPI fold containing family A member 2" Q96DR5 20 33161768-33181412 "Predicted secreted proteins" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 265 "salivary gland: 1210.9" "Group enriched" "Detected in some" 5 "RT4: 4.8;SK-BR-3: 1.9" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044006 Enhanced "Secreted to digestive system" "HPA044006: AB_10963580" "unprognostic (9.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.95e-1)" "unprognostic (3.56e-2)" "unprognostic (3.03e-2)" "unprognostic (1.49e-2)" "unprognostic (1.02e-1)" "unprognostic (1.04e-1)" "unprognostic (6.14e-4)" 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.4 0.1 1.2 0.1 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1210.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.6 1.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 BPIFA3 "bA49G10.4, C20orf71, SPLUNC3" ENSG00000131059 "BPI fold containing family A member 3" Q9BQP9 20 33217310-33227758 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "testis: 86.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062708 Enhanced "Secreted in male reproductive system" "HPA062708: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 86.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPIFB6 "BPIL3, LPLUNC6" ENSG00000167104 "BPI fold containing family B member 6" Q8NFQ5 20 33031648-33044047 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "salivary gland: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043057 Uncertain "Intracellular and membrane" "HPA043057: AB_10796683" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPY2 "BPY2A, VCY2, VCY2A" ENSG00000183753 "Basic charge, Y-linked, 2" O14599 Y 22973819-23005465 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 5.1" "Cell line enriched" "Detected in single" 25 "RPTEC TERT1: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPY2B VCY2B ENSG00000183795 "Basic charge, Y-linked, 2B" O14599 Y 24607560-24639207 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 5.2" "Cell line enriched" "Detected in single" 25 "RPTEC TERT1: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPY2C VCY2C ENSG00000185894 "Basic charge, Y-linked, 2C" O14599 Y 25030901-25062548 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 5.2" "Cell line enriched" "Detected in single" 25 "RPTEC TERT1: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BRDT "BRD6, CT9" ENSG00000137948 "Bromodomain testis associated" Q58F21 1 91949371-92014426 "Disease related genes, Predicted intracellular proteins" "Differentiation, Meiosis, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 66.4" "Cell line enriched" "Detected in single" 28 "BEWO: 20.9" "Group enriched" "Detected in some" 10 "lung cancer: 1.3;testis cancer: 6.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012237 Approved "CAB012237: AB_304756" "unprognostic (5.00e-2)" "unprognostic (2.86e-1)" "unprognostic (2.22e-3)" "unprognostic (2.24e-1)" "unprognostic (1.49e-1)" "unprognostic (5.25e-2)" "unprognostic (2.53e-3)" "unprognostic (6.26e-2)" "unprognostic (1.97e-1)" "unprognostic (4.22e-13)" "unprognostic (2.70e-1)" "unprognostic (1.77e-1)" "unprognostic (1.75e-1)" "unprognostic (2.00e-3)" 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 66.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 3.9 1.4 1.0 1.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 20.9 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.7 0.2 0.1 0.1 0.1 0.0 0.2 0.4 0.0 0.1 0.1 0.3 0.0 0.2 0.1 0.0 0.1 0.0 0.1 3.9 1.4 0.9 1.0 0.4 0.9 0.5 0.4 0.6 0.2 1.1 0.9 0.6 2.9 1.0 0.4 0.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BRINP1 "DBC1, DBCCR1, FAM5A" ENSG00000078725 "BMP/retinoic acid inducible neural specific 1" O60477 9 119153458-119369467 "Predicted intracellular proteins, Transporters" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 47.0" "Cell line enhanced" "Detected in some" "HSkMC: 9.2;NTERA-2: 17.5;SCLC-21H: 7.8;SH-SY5Y: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038828 Approved Uncertain Microtubules "Intracellular and membrane" Microtubules "HPA038828: AB_10670909" "unprognostic (8.60e-5)" "unprognostic (2.31e-2)" "unprognostic (1.24e-1)" "unprognostic (5.09e-5)" "unprognostic (1.12e-1)" "unprognostic (1.14e-2)" "unprognostic (1.37e-1)" "unprognostic (2.98e-1)" "unprognostic (1.76e-1)" "unprognostic (1.02e-1)" "unprognostic (2.28e-4)" "unprognostic (1.51e-2)" "unprognostic (5.06e-3)" "unprognostic (1.39e-3)" "unprognostic (1.56e-1)" "unprognostic (7.59e-2)" "unprognostic (1.41e-1)" 1.0 5.6 17.7 1.0 16.5 0.9 3.8 19.7 47.0 1.4 1.1 5.1 0.0 1.1 1.2 7.2 1.2 1.0 2.7 2.8 16.0 12.4 3.0 1.7 1.1 0.9 7.4 10.7 1.0 0.9 1.0 1.0 0.9 5.8 2.9 1.0 0.2 1.7 7.6 1.2 0.9 1.7 1.0 9.7 1.3 1.0 1.5 5.1 0.0 1.3 0.0 0.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 17.5 0.0 0.0 1.8 0.0 0.1 0.0 7.8 3.3 0.0 0.0 0.0 0.7 0.0 0.0 1.2 1.9 0.0 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 16.5 19.7 32.2 16.0 12.4 7.4 10.7 5.8 5.1 BRS3 "BB3, BB3R" ENSG00000102239 "Bombesin receptor subtype 3" P32247 X 136487887-136493780 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "epididymis: 27.4" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basal ganglia: 3.6;hypothalamus: 2.8" "Cell type enhanced" "Detected in some" "naive B-cell: 1.2;naive CD8 T-cell: 1.0" "Group enriched" "Detected in many" 11 "B-cells: 1.2;T-cells: 1.0" "Group enriched" "Detected in some" 9 "basal ganglia: 1.6;hypothalamus: 7.1" "Low region specificity" "Detected in all" "unprognostic (1.49e-1)" "unprognostic (1.31e-1)" "unprognostic (2.07e-1)" "unprognostic (1.79e-2)" "unprognostic (3.73e-6)" "unprognostic (1.59e-1)" "unprognostic (1.86e-1)" "unprognostic (5.59e-2)" 0.1 0.1 0.1 0.1 3.6 0.0 0.5 0.4 0.4 0.3 0.1 0.1 0.1 0.0 0.2 27.4 0.1 2.4 0.1 0.1 0.1 2.8 0.1 0.1 0.1 0.1 0.1 0.1 2.9 0.3 0.0 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.2 0.1 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.2 0.1 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 0.4 0.4 0.1 2.8 0.1 0.1 0.3 0.1 BRSK1 KIAA1811 ENSG00000160469 "BR serine/threonine kinase 1" Q8TDC3 19 55282072-55312533 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 65.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 25.9;SH-SY5Y: 23.2;WM-115: 21.1" "Cancer enhanced" "Detected in all" "glioma: 12.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021212, HPA061719" Enhanced Supported Nucleoplasm Nucleoplasm "HPA021212: AB_1845455, HPA061719: " "unprognostic (1.42e-3)" "unprognostic (2.92e-2)" "unprognostic (1.20e-1)" "unprognostic (6.69e-3)" "unprognostic (2.71e-1)" "unprognostic (4.21e-2)" "unprognostic (3.06e-6)" "unprognostic (4.24e-1)" "unprognostic (2.06e-2)" "unprognostic (3.04e-1)" "prognostic favourable (1.02e-4)" "unprognostic (3.00e-1)" "prognostic unfavourable (7.98e-6)" "unprognostic (1.16e-1)" "unprognostic (6.61e-3)" "unprognostic (1.34e-1)" "unprognostic (2.09e-1)" 1.4 9.8 28.6 3.2 23.6 1.0 1.6 26.7 65.0 1.8 2.2 7.9 0.1 3.3 5.4 3.7 3.0 2.3 3.9 6.5 33.4 20.0 1.4 0.8 1.7 2.4 20.4 14.8 2.4 2.6 12.4 11.0 1.5 13.3 3.8 1.9 2.8 2.5 4.6 1.0 1.1 2.6 4.9 9.2 1.5 1.9 4.4 7.2 0.0 3.0 0.0 1.6 3.2 0.7 0.0 0.3 0.0 0.9 0.1 0.8 0.2 0.3 1.2 15.3 8.0 0.0 0.6 0.1 2.4 3.4 3.3 4.8 5.9 2.7 3.1 1.7 2.7 0.1 3.2 0.1 3.1 14.4 12.6 2.0 1.6 0.6 3.3 0.6 5.9 2.1 0.3 3.3 0.0 0.1 2.8 18.8 2.9 0.8 3.6 0.7 11.1 1.0 8.3 3.8 0.5 0.2 0.0 25.9 23.2 0.0 0.4 5.6 1.3 1.7 0.0 6.3 6.7 3.5 4.6 15.6 11.4 7.0 6.5 1.4 21.1 0.0 0.9 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.2 28.6 23.6 26.7 40.2 33.4 20.0 20.4 14.8 13.3 7.2 BSN ZNF231 ENSG00000164061 "Bassoon presynaptic cytomatrix protein" Q9UPA5 3 49554489-49671545 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 36.9" "Cell line enhanced" "Detected in some" "K-562: 3.8;SCLC-21H: 8.9;SH-SY5Y: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034757 Enhanced "HPA034757: AB_10671233" "unprognostic (8.57e-2)" "unprognostic (3.45e-1)" "unprognostic (7.31e-2)" "unprognostic (3.50e-4)" "unprognostic (7.40e-2)" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (5.46e-3)" "unprognostic (1.14e-1)" "unprognostic (1.70e-1)" "unprognostic (6.21e-5)" "unprognostic (2.50e-3)" "unprognostic (5.38e-5)" "unprognostic (9.33e-2)" "unprognostic (3.03e-1)" "unprognostic (2.30e-1)" "unprognostic (7.34e-2)" 1.2 3.9 23.0 1.3 22.4 1.1 1.2 25.4 36.9 1.3 1.2 1.8 0.0 1.3 1.5 7.0 1.2 1.4 1.2 1.3 13.1 5.1 1.4 1.3 1.3 1.2 3.9 19.1 1.6 2.1 1.7 4.4 1.3 7.9 1.3 1.2 0.7 1.3 1.4 1.4 1.3 1.3 1.3 1.6 1.3 1.7 5.1 4.0 0.0 1.4 0.0 1.1 1.1 0.3 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.2 0.4 2.1 1.4 0.1 0.0 0.7 0.0 0.0 0.1 0.1 0.5 0.4 2.4 0.5 0.0 0.3 0.3 0.0 0.1 0.4 1.0 0.3 0.6 1.1 0.0 0.4 0.9 0.1 0.0 0.0 0.4 0.0 3.8 0.4 0.1 0.8 0.4 0.2 1.7 1.0 0.0 0.2 0.4 0.0 0.4 8.9 5.5 0.8 0.1 0.1 0.1 0.4 0.0 0.2 0.2 0.2 0.1 0.3 1.0 0.2 0.2 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.0 23.0 22.4 25.4 36.9 13.1 5.1 3.9 19.1 7.9 4.0 BSPH1 "BSP1, ELSPBP2" ENSG00000188334 "Binder of sperm protein homolog 1" Q075Z2 19 47968046-47992170 "Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "epididymis: 97.1" "Group enriched" "Detected in some" 5 "BEWO: 1.2;HMC-1: 1.3;NB-4: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048335 Enhanced "Secreted in male reproductive system" "HPA048335: " 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 97.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BTBD17 "BTBD17A, LGALS3BPL, TANGO10A" ENSG00000204347 "BTB domain containing 17" A6NE02 17 74356416-74361946 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 18.2" "Group enriched" "Detected in some" 20 "AF22: 3.8;NTERA-2: 5.0;SCLC-21H: 15.0" "Group enriched" "Detected in some" 11 "glioma: 9.5;testis cancer: 1.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025022 Approved "Secreted in brain" "HPA025022: AB_2067352" "unprognostic (2.63e-1)" "unprognostic (2.77e-1)" "unprognostic (4.82e-5)" "unprognostic (3.89e-2)" "unprognostic (2.55e-1)" "unprognostic (9.89e-3)" 0.4 1.5 5.4 0.4 5.1 0.4 0.4 5.6 18.2 0.4 0.4 2.7 0.0 1.2 0.4 0.4 0.4 0.4 0.4 0.4 3.7 5.7 0.4 0.4 0.4 0.4 3.8 1.8 0.4 0.4 0.4 0.2 0.4 6.1 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.5 0.4 3.7 0.6 1.4 0.5 2.2 0.0 0.6 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.3 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 5.4 5.1 5.6 8.2 3.7 5.7 3.8 1.8 6.1 2.2 BTBD8 ENSG00000189195 "BTB domain containing 8" Q5XKL5 1 92080305-92184725 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 42.3" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA024216, HPA035311" Enhanced Supported Nucleoplasm Nucleoplasm "HPA024216: AB_1852385, HPA035311: AB_10671933" "unprognostic (2.94e-1)" "unprognostic (2.97e-2)" "unprognostic (1.99e-1)" "unprognostic (3.06e-2)" "unprognostic (1.83e-1)" "unprognostic (3.17e-2)" "unprognostic (2.72e-2)" "unprognostic (7.56e-2)" "unprognostic (1.36e-2)" "unprognostic (2.97e-1)" "unprognostic (2.82e-2)" "unprognostic (8.42e-2)" "unprognostic (3.73e-3)" "unprognostic (5.04e-2)" "unprognostic (9.49e-2)" "unprognostic (2.39e-2)" "unprognostic (3.15e-1)" 3.4 4.6 11.7 1.2 27.3 0.7 3.3 20.3 42.3 2.3 2.4 4.0 0.6 1.7 3.4 4.7 2.0 3.3 2.3 2.8 7.8 2.1 2.4 1.9 2.5 1.4 4.5 23.3 5.0 2.7 5.1 6.0 2.5 16.4 3.3 2.5 1.2 2.8 2.7 2.3 1.8 2.1 2.0 6.6 1.8 2.4 8.3 9.9 0.2 3.7 0.0 1.1 4.7 2.7 0.5 0.8 0.6 0.7 0.9 2.3 0.4 2.8 2.3 1.7 0.0 5.2 10.5 5.7 1.8 2.5 1.5 1.9 0.5 3.3 1.2 6.7 1.6 0.8 1.3 3.3 2.4 2.9 1.9 2.1 0.6 0.9 1.1 1.1 1.3 6.1 2.8 0.9 1.8 1.6 2.5 0.8 2.8 1.7 0.8 2.2 1.7 1.8 1.8 1.7 0.2 3.3 2.1 0.9 1.5 3.0 1.5 1.5 2.3 1.6 1.1 2.0 1.2 1.1 0.7 2.2 0.9 0.0 1.6 0.2 0.4 0.0 0.6 0.0 2.3 0.1 0.5 0.5 1.0 0.9 0.0 0.5 1.8 1.4 0.6 0.9 0.7 0.8 0.9 0.4 11.7 27.3 20.3 42.3 7.8 2.1 4.5 23.3 16.4 9.9 BTG4 "APRO3, PC3B" ENSG00000137707 "BTG anti-proliferation factor 4" Q9NY30 11 111467526-111512354 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 24.8" "Cell line enhanced" "Detected in some" "CACO-2: 6.2;Karpas-707: 8.4;U-266/70: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "T-reg: 1.8" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA057157 Approved "Endoplasmic reticulum,Golgi apparatus" "Endoplasmic reticulum, Golgi apparatus" "HPA057157: " "unprognostic (1.58e-1)" "unprognostic (2.68e-3)" "unprognostic (3.20e-2)" "unprognostic (2.80e-4)" "unprognostic (1.42e-2)" "unprognostic (3.14e-1)" "unprognostic (9.39e-2)" "unprognostic (1.31e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.2 0.0 0.2 0.4 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.7 1.6 0.1 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.4 5.8 2.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.8 0.2 BTN1A1 "BT, BTN, BTN1" ENSG00000124557 "Butyrophilin subfamily 1 member A1" Q13410 6 26501221-26510422 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "breast: 27.4" "Cell line enriched" "Detected in some" 5 "CACO-2: 9.8" "Cancer enhanced" "Detected in single" "breast cancer: 0.6" "Cell type enhanced" "Detected in some" "memory B-cell: 5.6;naive B-cell: 2.6" "Lineage enriched" "Detected in many" 4 "B-cells: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011126, CAB037340" Supported "Secreted in female reproductive system" "CAB037340: , HPA011126: AB_1845491" "unprognostic (4.07e-2)" "unprognostic (1.40e-1)" "unprognostic (1.90e-2)" "unprognostic (1.67e-1)" "unprognostic (2.32e-1)" "unprognostic (1.77e-2)" "unprognostic (5.50e-2)" "unprognostic (1.04e-1)" "unprognostic (3.24e-3)" "unprognostic (2.85e-1)" "unprognostic (1.88e-1)" "unprognostic (5.35e-10)" "unprognostic (4.62e-2)" "unprognostic (1.38e-1)" "unprognostic (4.14e-2)" "unprognostic (5.31e-4)" 0.0 0.0 0.0 0.2 0.0 0.0 27.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 1.0 1.6 0.0 1.3 0.0 0.6 0.1 0.0 5.6 0.0 0.7 1.2 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.8 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 5.6 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 BTNL3 "BTN9.1, BTNLR" ENSG00000168903 "Butyrophilin like 3" Q6UXE8 5 180988845-181006727 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 82.5" "Cell line enhanced" "Detected in some" "BEWO: 1.0;CACO-2: 2.4;HMC-1: 1.0;RPMI-8226: 2.4;U-266/84: 2.4" "Group enriched" "Detected in some" 7 "colorectal cancer: 5.5;pancreatic cancer: 1.2;stomach cancer: 2.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 178 "neutrophil: 17.8" "Lineage enriched" "Detected in single" 178 "granulocytes: 17.8" "unprognostic (4.07e-2)" "unprognostic (3.64e-2)" "unprognostic (9.21e-2)" "unprognostic (4.00e-1)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" "unprognostic (5.57e-2)" "unprognostic (2.19e-2)" "unprognostic (5.41e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" 0.1 0.0 0.1 2.1 0.1 0.0 0.1 0.1 0.1 0.1 32.5 0.1 0.1 44.2 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 9.4 0.1 0.1 0.1 0.1 0.0 82.5 0.1 0.1 0.5 0.4 0.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.4 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 BX072566.1 ENSG00000277630 Unmapped 108007-139659 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 96 "testis: 9.6" "Cell line enhanced" "Detected in single" "U-2 OS: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BX248415.1 ENSG00000276911 1 196819745-196959210 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 938 "liver: 93.7" "Cell line enhanced" "Detected in single" "RH-30: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038915, HPA040726, HPA049813" Supported "Secreted to blood" "HPA038915: , HPA040726: , HPA049813: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BX276092.9 ENSG00000283599 X 71667542-71671524 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 23 "testis: 10.7" "Cell line enhanced" "Detected in some" "SK-BR-3: 4.6;U-87 MG: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf120 bA318C4.1 ENSG00000183559 "Chromosome 10 open reading frame 120" Q5SQS8 10 122697709-122699822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf53 Em:AC069546.1 ENSG00000178645 "Chromosome 10 open reading frame 53" Q8N6V4 10 49679651-49710261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 71 "testis: 50.8" "Cell line enhanced" "Detected in some" "NB-4: 3.8;U-937: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA037951 Enhanced "HPA037951: AB_10671382" "unprognostic (9.09e-2)" 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 50.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.3 0.0 0.7 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.6 0.0 0.6 0.0 0.2 0.4 0.0 0.2 0.2 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.5 0.0 0.3 0.0 0.2 0.1 0.1 0.5 0.0 0.0 0.8 3.8 0.2 0.0 0.3 0.1 0.0 0.0 0.4 0.2 0.2 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.1 0.6 0.0 0.2 0.0 1.7 0.3 0.1 0.3 0.1 0.4 0.0 0.7 0.1 0.3 0.1 0.1 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.2 0.0 0.1 0.3 0.0 C10orf55 bA417O11.3 ENSG00000222047 "Chromosome 10 open reading frame 55" Q5SWW7 10 73909969-73922777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 14.0" "Cell line enhanced" "Detected in some" "A-431: 5.0;CAPAN-2: 4.8;HaCaT: 4.8;RPTEC TERT1: 7.6;U-251 MG: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA045739 Approved Approved Nucleoplasm Nucleoplasm "HPA045739: AB_10961861" "unprognostic (5.50e-2)" "unprognostic (1.82e-1)" "unprognostic (1.84e-2)" "unprognostic (2.25e-2)" "unprognostic (4.42e-2)" "unprognostic (2.71e-2)" "unprognostic (9.68e-3)" "unprognostic (5.61e-3)" "unprognostic (4.99e-2)" "unprognostic (8.84e-2)" "unprognostic (3.62e-3)" "unprognostic (1.30e-1)" "unprognostic (2.15e-3)" "unprognostic (1.27e-1)" "unprognostic (3.90e-2)" "unprognostic (5.94e-3)" "unprognostic (3.13e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.1 0.5 1.0 0.0 0.0 0.0 0.1 0.0 14.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 1.6 0.4 0.3 0.0 4.8 0.0 0.3 0.2 4.8 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.4 0.6 1.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.7 0.0 2.1 0.0 7.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.4 3.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf62 bA548K23.1 ENSG00000203942 "Chromosome 10 open reading frame 62" Q5T681 10 97589727-97590934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "testis: 81.1" "Cell line enhanced" "Detected in some" "AN3-CA: 2.3;Hep G2: 2.8;T-47d: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA072947 Enhanced "HPA072947: " "unprognostic (3.66e-2)" "unprognostic (3.97e-2)" "unprognostic (2.81e-1)" "unprognostic (5.36e-2)" "unprognostic (3.62e-1)" "unprognostic (1.20e-1)" "unprognostic (3.63e-2)" "unprognostic (2.53e-2)" "unprognostic (2.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.7 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.5 2.8 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C11orf40 NOV1 ENSG00000171987 "Chromosome 11 open reading frame 40" Q8WZ69 11 4571423-4577820 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "epididymis: 2.4" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;RPMI-8226: 1.4;SK-MEL-30: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C11orf42 MGC34805 ENSG00000180878 "Chromosome 11 open reading frame 42" Q8N5U0 11 6205566-6211132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 27.9" "Cell line enhanced" "Detected in some" "HEK 293: 4.1;HeLa: 4.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063404 Enhanced "HPA063404: " "unprognostic (4.79e-2)" "unprognostic (1.83e-1)" "unprognostic (3.18e-1)" "unprognostic (2.56e-1)" "unprognostic (1.39e-3)" "unprognostic (3.49e-3)" "unprognostic (2.05e-1)" "unprognostic (5.39e-2)" "unprognostic (1.26e-1)" "unprognostic (3.50e-2)" "unprognostic (9.30e-2)" "unprognostic (6.47e-3)" "unprognostic (7.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (2.07e-2)" "unprognostic (4.74e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 1.0 1.2 0.1 0.2 0.1 0.1 1.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 2.0 0.9 0.1 0.1 0.1 0.3 27.9 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.4 0.0 0.1 0.0 0.4 2.5 0.4 1.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 2.1 0.8 0.6 0.1 0.0 1.9 0.0 0.0 0.0 0.6 4.1 0.0 4.7 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.8 0.9 0.4 1.4 1.3 0.8 1.2 0.2 0.0 0.4 1.1 0.3 0.2 1.1 0.5 0.4 0.9 0.4 1.0 0.4 1.9 0.3 0.5 1.1 0.4 0.7 1.7 0.4 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 C11orf65 MGC33948 ENSG00000166323 "Chromosome 11 open reading frame 65" Q8NCR3 11 108308519-108467531 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 45.0" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "unprognostic (8.05e-2)" "unprognostic (4.89e-2)" "unprognostic (1.62e-1)" "unprognostic (2.11e-2)" "unprognostic (4.15e-2)" "unprognostic (3.79e-2)" "unprognostic (2.07e-1)" "unprognostic (5.78e-2)" "unprognostic (3.54e-5)" "unprognostic (2.72e-1)" "unprognostic (2.48e-1)" "unprognostic (1.02e-1)" "unprognostic (1.04e-2)" "unprognostic (1.25e-1)" "unprognostic (1.84e-1)" "unprognostic (8.87e-2)" "unprognostic (2.50e-2)" 1.0 1.7 2.6 1.1 3.8 0.6 1.1 3.5 2.6 1.0 0.9 3.6 1.4 0.6 0.9 3.3 1.0 2.0 1.3 1.2 2.0 1.2 2.7 2.9 1.6 1.1 2.0 2.5 1.2 3.1 2.2 6.3 0.9 3.1 1.1 0.9 2.0 1.6 2.4 0.9 1.2 1.0 0.8 2.2 1.2 1.1 45.0 3.5 2.4 2.2 0.2 0.9 1.0 1.1 1.2 1.9 1.8 1.6 0.8 2.7 0.5 1.4 0.5 1.0 1.7 1.9 3.7 2.7 1.1 0.5 0.4 0.3 1.9 4.3 1.4 4.2 1.1 2.1 2.9 2.2 1.3 1.6 1.5 1.9 0.6 0.2 1.3 1.6 0.3 4.0 1.3 0.8 4.8 1.1 3.6 1.6 3.2 2.0 1.8 1.2 0.7 1.5 1.4 1.3 1.9 2.3 1.3 3.8 0.6 1.8 0.8 1.6 7.3 0.3 1.8 1.6 1.9 0.6 0.2 2.5 1.3 5.6 1.4 1.9 1.3 1.8 0.4 0.0 0.5 1.6 2.7 0.6 0.6 0.6 0.2 1.2 1.6 0.8 0.1 0.8 0.5 1.9 1.4 0.5 2.6 3.8 3.5 2.6 2.0 1.2 2.0 2.5 3.1 3.5 C11orf71 FLJ20010 ENSG00000180425 "Chromosome 11 open reading frame 71" Q6IPW1 11 114391443-114400511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "testis: 83.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA063943, HPA074787" Supported Nucleoplasm Nucleoplasm "HPA063943: , HPA074787: " "unprognostic (1.24e-1)" "unprognostic (2.53e-2)" "unprognostic (1.42e-2)" "prognostic favourable (6.94e-4)" "unprognostic (7.35e-2)" "unprognostic (4.53e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-3)" "unprognostic (1.58e-1)" "unprognostic (3.04e-3)" "unprognostic (1.39e-2)" "unprognostic (2.85e-2)" "prognostic favourable (7.01e-9)" "unprognostic (5.68e-2)" "unprognostic (5.43e-2)" "unprognostic (1.87e-1)" "unprognostic (1.17e-2)" 3.9 7.3 5.7 3.4 12.1 2.2 5.7 4.1 8.1 4.2 4.9 10.2 5.6 5.5 3.7 18.0 3.2 5.4 3.9 5.4 6.9 6.1 10.6 15.0 3.9 4.3 10.3 4.7 5.0 6.9 8.7 6.9 2.5 6.7 5.6 4.6 5.7 7.2 5.0 9.9 5.6 5.1 2.1 5.7 5.4 5.2 83.2 12.2 6.4 9.5 4.7 3.2 3.1 3.1 10.5 13.6 14.5 17.7 13.2 11.9 11.3 1.1 3.2 3.4 11.0 5.2 3.0 2.4 0.5 1.4 1.3 1.2 2.7 19.6 5.2 7.0 0.8 5.1 2.2 2.3 1.7 6.0 1.3 3.9 2.3 5.3 5.0 2.3 4.5 4.9 2.6 1.8 5.6 1.7 4.1 4.9 2.6 4.5 4.1 3.5 1.8 2.1 3.1 2.8 13.4 3.0 2.4 9.5 3.7 12.3 1.4 1.9 9.3 1.2 1.7 0.3 5.2 3.9 0.9 4.8 7.9 4.1 0.7 5.4 1.4 11.7 17.7 11.1 10.3 11.1 6.3 7.0 7.0 7.1 10.6 10.5 11.4 11.9 14.5 13.2 12.2 13.6 7.7 11.3 5.7 12.1 4.1 8.1 6.9 6.1 10.3 4.7 6.7 12.2 C11orf86 FLJ22675 ENSG00000173237 "Chromosome 11 open reading frame 86" A6NJI1 11 66975277-66977004 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "intestine: 57.7" "Group enriched" "Detected in some" 5 "HeLa: 6.7;SiHa: 22.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039348 Uncertain "HPA039348: AB_10673421" "unprognostic (1.54e-2)" "unprognostic (7.67e-3)" "unprognostic (3.02e-2)" "unprognostic (1.20e-1)" "unprognostic (3.90e-4)" "prognostic unfavourable (8.97e-4)" "unprognostic (4.17e-1)" "prognostic unfavourable (6.97e-5)" "prognostic unfavourable (1.02e-5)" "unprognostic (7.04e-2)" "unprognostic (1.51e-1)" "unprognostic (1.69e-2)" "unprognostic (3.58e-3)" 0.1 4.0 0.1 1.1 0.1 0.0 0.1 0.1 0.1 0.1 24.4 0.1 0.1 33.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.5 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 2.1 0.1 0.1 3.0 0.1 0.1 0.1 0.1 0.0 57.7 0.2 0.1 0.1 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 22.8 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 C11orf87 "LOC399947, LOH11CR1A, NEURIM1" ENSG00000185742 "Chromosome 11 open reading frame 87" Q6NUJ2 11 109422120-109429114 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 32.3" "Group enriched" "Detected in some" 4 "BJ hTERT+ SV40 Large T+: 3.9;fHDF/TERT166: 15.4;SCLC-21H: 4.0" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA034656 Approved "HPA034656: AB_10600788" "unprognostic (5.42e-2)" "unprognostic (2.09e-1)" "unprognostic (2.28e-1)" "unprognostic (8.55e-2)" "unprognostic (3.87e-2)" "unprognostic (1.85e-1)" "unprognostic (1.63e-1)" "unprognostic (1.55e-2)" "unprognostic (1.62e-1)" "unprognostic (2.44e-2)" "unprognostic (2.45e-1)" "unprognostic (5.28e-5)" "unprognostic (8.38e-2)" "unprognostic (9.65e-2)" "unprognostic (2.72e-6)" 0.7 1.0 5.8 0.7 18.1 0.7 0.8 2.7 32.3 2.3 0.8 1.5 0.0 0.8 2.2 1.2 0.8 1.1 0.7 0.7 8.3 3.8 0.8 0.7 0.7 0.7 2.5 12.0 0.7 0.7 0.7 0.3 0.8 11.1 0.9 0.7 0.0 0.8 0.8 0.7 0.8 0.7 0.8 1.2 2.2 0.8 0.8 0.1 0.0 0.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.5 0.0 0.1 0.2 3.9 1.9 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 18.1 2.7 27.7 8.3 3.8 2.5 12.0 11.1 0.1 C11orf94 ENSG00000234776 "Chromosome 11 open reading frame 94" C9JXX5 11 45906513-45907282 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 28 "testis: 43.4" "Cell line enhanced" "Detected in many" "HEK 293: 3.8;U-266/84: 3.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Secreted in male reproductive system" "unprognostic (1.55e-1)" "unprognostic (2.71e-1)" "unprognostic (2.28e-1)" "unprognostic (2.36e-1)" "unprognostic (7.28e-2)" "unprognostic (5.99e-2)" "unprognostic (6.21e-3)" "unprognostic (1.97e-1)" "unprognostic (1.43e-1)" "unprognostic (7.11e-2)" "unprognostic (3.33e-2)" "unprognostic (4.24e-2)" "unprognostic (9.05e-4)" "unprognostic (1.90e-1)" "unprognostic (1.10e-1)" "unprognostic (3.28e-1)" "unprognostic (1.47e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 43.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.7 0.0 0.0 1.0 0.0 1.4 0.0 2.5 3.8 1.1 2.3 0.0 1.4 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.3 0.6 1.4 0.0 0.0 1.2 1.9 1.4 0.6 1.5 0.8 0.0 0.0 0.5 0.0 0.0 0.6 1.0 1.1 1.1 0.0 1.5 1.0 2.0 0.0 2.4 3.1 0.0 1.6 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C12orf40 FLJ40126 ENSG00000180116 "Chromosome 12 open reading frame 40" Q86WS4 12 39626167-39908300 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "testis: 26.4" "Cell line enriched" "Detected in some" 8 "K-562: 7.5" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA039032 Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA039032: " "unprognostic (1.75e-1)" "unprognostic (2.76e-6)" "unprognostic (3.45e-1)" "unprognostic (1.96e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.5 0.2 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C12orf42 FLJ25323 ENSG00000179088 "Chromosome 12 open reading frame 42" Q96LP6 12 103237591-103496010 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 45.4" "Cell line enhanced" "Detected in some" "MOLT-4: 1.7;NTERA-2: 1.1;SCLC-21H: 1.5;U-266/70: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 7.4;naive B-cell: 8.3" "Low lineage specificity" "Detected in many" "unprognostic (9.21e-2)" "unprognostic (1.63e-2)" "unprognostic (2.96e-2)" "unprognostic (1.05e-2)" "unprognostic (2.66e-1)" "unprognostic (9.83e-2)" "unprognostic (3.39e-2)" "unprognostic (6.01e-3)" "unprognostic (6.09e-2)" "unprognostic (1.61e-1)" "unprognostic (8.96e-4)" "unprognostic (4.89e-2)" "unprognostic (2.20e-3)" "unprognostic (3.89e-2)" "unprognostic (2.55e-1)" "unprognostic (1.67e-2)" "unprognostic (3.30e-1)" 0.0 0.0 0.4 0.6 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 45.4 0.0 0.4 0.0 0.0 1.0 0.1 0.0 8.3 1.5 0.0 0.0 0.0 2.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.6 1.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 7.4 1.9 2.3 0.2 8.3 2.1 2.3 0.0 0.0 0.0 1.5 2.9 1.3 0.4 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.4 0.0 C12orf50 FLJ35821 ENSG00000165805 "Chromosome 12 open reading frame 50" Q8NA57 12 87980035-88034037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "testis: 37.8" "Cell line enriched" "Detected in single" 6 "SK-MEL-30: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "thalamus: 0.8" "Low region specificity" "Detected in many" "unprognostic (2.23e-2)" "unprognostic (6.61e-3)" "unprognostic (4.91e-2)" "unprognostic (1.00e-1)" "unprognostic (1.64e-1)" "unprognostic (4.80e-2)" "unprognostic (1.34e-1)" "unprognostic (6.03e-2)" "unprognostic (8.85e-3)" "unprognostic (3.47e-1)" "unprognostic (2.84e-7)" "unprognostic (6.31e-2)" "unprognostic (2.17e-2)" "unprognostic (3.03e-1)" "unprognostic (7.20e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C12orf54 MGC35033 ENSG00000177627 "Chromosome 12 open reading frame 54" Q6X4T0 12 48482503-48496512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "testis: 34.8" "Group enriched" "Detected in some" 4 "HaCaT: 2.8;HBEC3-KT: 9.2;hTCEpi: 2.6;hTERT-HME1: 5.5" "Group enriched" "Detected in some" 9 "cervical cancer: 2.9;head and neck cancer: 2.1;lung cancer: 1.6;urothelial cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA073090 Approved "Intermediate filaments" "Intermediate filaments" "HPA073090: " "unprognostic (2.59e-3)" "unprognostic (5.49e-2)" "unprognostic (7.94e-3)" "unprognostic (2.60e-2)" "unprognostic (2.48e-2)" "unprognostic (8.99e-2)" "unprognostic (5.96e-2)" "unprognostic (1.62e-1)" "unprognostic (8.01e-2)" "unprognostic (1.36e-4)" "unprognostic (2.37e-1)" "unprognostic (5.06e-3)" "unprognostic (7.53e-2)" "unprognostic (1.34e-1)" "unprognostic (1.97e-1)" "unprognostic (1.92e-1)" 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.6 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.0 34.8 0.1 0.1 0.1 0.1 0.9 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 9.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.2 0.1 0.3 0.1 0.1 0.1 C13orf42 LINC00371 ENSG00000226792 "Chromosome 13 open reading frame 42" 13 51082119-51200252 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "testis: 3.2" "Group enriched" "Detected in some" 123 "HAP1: 10.8;NTERA-2: 13.7" "Cancer enriched" "Detected in single" 46 "testis cancer: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (9.77e-2)" "unprognostic (5.61e-2)" "unprognostic (1.73e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C13orf46 ENSG00000283199 "Chromosome 13 open reading frame 46" 13 113953705-113974079 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 21.7" "Cell line enhanced" "Detected in some" "HBF TERT88: 2.9;hTEC/SVTERT24-B: 3.5;RPMI-8226: 4.1;T-47d: 3.0;U-138 MG: 3.0" "Cell type enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" 0.1 0.0 0.1 0.1 0.1 0.6 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.8 0.4 0.1 0.1 0.1 0.5 2.4 0.1 0.1 0.1 0.1 4.8 0.0 0.1 0.1 1.0 1.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 4.9 21.7 0.1 0.1 0.5 0.1 0.1 0.4 0.1 0.0 0.0 1.3 0.1 0.0 0.6 0.0 0.3 0.2 0.8 0.7 0.5 0.5 0.0 0.3 0.3 0.7 0.4 0.0 1.3 0.0 0.9 1.4 0.0 0.0 0.1 2.9 0.0 0.1 1.7 1.9 0.0 0.2 0.1 0.0 0.5 0.0 3.5 1.0 0.4 0.0 0.2 0.8 0.0 0.4 0.1 0.0 0.6 0.5 0.3 4.1 0.1 0.0 0.1 0.0 0.3 1.3 1.1 3.0 0.3 0.8 3.0 2.1 0.6 1.1 0.0 0.0 0.0 1.1 0.4 1.1 1.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 C15orf41 "FLJ22851, HH114, MGC11326" ENSG00000186073 "Chromosome 15 open reading frame 41" Q9Y2V0 15 36579611-36810248 "Disease related genes, Predicted intracellular proteins" "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 79.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061023 Uncertain Approved Nucleoplasm Nucleoplasm "HPA061023: " "unprognostic (1.82e-1)" "unprognostic (1.14e-1)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (2.93e-3)" "unprognostic (2.27e-2)" "unprognostic (2.37e-2)" "unprognostic (2.02e-2)" "unprognostic (3.40e-2)" "unprognostic (3.29e-2)" "unprognostic (2.59e-3)" "unprognostic (9.14e-2)" "unprognostic (3.74e-6)" "unprognostic (1.22e-2)" "unprognostic (4.54e-2)" "unprognostic (1.62e-4)" "unprognostic (1.58e-1)" 2.3 4.1 3.4 4.1 8.9 0.8 2.4 4.2 4.1 5.5 4.0 2.8 3.5 4.9 8.8 2.7 7.0 3.3 4.7 79.9 2.5 2.4 2.3 2.8 2.9 1.9 3.1 2.3 3.6 1.9 2.7 3.5 1.8 2.8 5.4 2.7 2.7 3.5 5.3 7.9 4.2 3.0 16.0 3.4 2.0 2.8 4.9 3.7 2.8 2.2 7.2 3.9 7.7 6.2 3.6 2.4 0.4 2.1 4.9 7.8 2.0 12.8 7.0 8.8 3.3 9.7 11.8 3.6 6.3 3.1 7.9 6.5 9.6 5.2 2.0 6.4 15.2 23.8 9.1 5.3 9.1 1.0 6.3 6.8 6.4 7.0 8.8 5.9 5.0 8.8 5.9 6.7 3.7 7.5 8.6 2.2 10.8 5.9 1.7 3.3 4.8 3.6 5.4 2.5 1.4 5.1 17.8 5.1 3.2 4.2 4.2 3.3 3.9 9.0 5.3 7.8 4.3 5.2 1.7 5.3 7.2 9.5 9.9 10.3 7.2 0.0 0.8 0.4 4.3 2.1 3.9 3.6 3.4 4.2 2.4 3.5 4.1 3.5 0.1 4.9 0.8 1.8 7.8 2.0 3.4 8.9 4.2 4.1 2.5 2.4 3.1 2.3 2.8 3.7 C16orf78 MGC33367 ENSG00000166152 "Chromosome 16 open reading frame 78" Q8WTQ4 16 49373823-49399431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 96 "testis: 30.6" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C16orf90 LOC646174 ENSG00000215131 "Chromosome 16 open reading frame 90" A8MZG2 16 3493484-3495480 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 111 "testis: 27.8" "Cell line enhanced" "Detected in some" "NB-4: 1.3;NTERA-2: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "unprognostic (1.96e-2)" "unprognostic (1.03e-3)" "unprognostic (3.17e-1)" "unprognostic (2.18e-1)" "unprognostic (1.08e-1)" "unprognostic (9.33e-2)" "unprognostic (1.20e-2)" "unprognostic (1.59e-2)" "unprognostic (6.29e-3)" "unprognostic (1.26e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.7 0.0 1.3 1.8 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.0 0.3 0.0 0.0 0.7 0.5 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C16orf92 FLJ25404 ENSG00000167194 "Chromosome 16 open reading frame 92" Q96LL3 16 30023334-30027736 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 17.0" "Cell line enhanced" "Detected in some" "Karpas-707: 2.3;MCF7: 2.3;NTERA-2: 2.3;RPMI-8226: 3.8;SCLC-21H: 12.8;SH-SY5Y: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.48e-1)" "unprognostic (4.97e-2)" 0.1 1.8 0.4 0.1 0.2 0.4 0.1 1.2 3.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 17.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 2.3 0.5 0.1 2.3 0.0 0.6 0.1 3.8 0.0 0.0 12.8 2.9 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.8 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 1.2 0.4 0.4 0.2 0.2 0.1 0.1 0.1 C16orf95 ENSG00000260456 "Chromosome 16 open reading frame 95" Q9H693 16 87083562-87317420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 47.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA040850, HPA067924" Supported Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA040850: AB_10794882, HPA067924: " "unprognostic (3.51e-1)" "unprognostic (1.95e-1)" "unprognostic (1.77e-2)" "unprognostic (4.30e-2)" "unprognostic (3.92e-2)" "unprognostic (4.60e-2)" "unprognostic (1.13e-1)" "unprognostic (2.45e-1)" "unprognostic (1.97e-2)" "unprognostic (1.09e-1)" "unprognostic (6.71e-2)" "unprognostic (1.79e-1)" "unprognostic (2.02e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.61e-2)" "unprognostic (1.23e-1)" 1.5 1.7 1.7 1.0 2.6 2.2 0.8 1.5 2.0 0.5 1.0 1.5 1.2 1.2 0.7 1.2 0.5 0.8 1.2 1.0 1.7 1.4 1.1 2.6 0.7 0.9 1.9 0.9 0.7 2.1 1.0 0.9 0.5 1.8 0.6 0.6 0.9 1.1 1.2 3.0 0.5 1.2 1.2 1.3 0.7 1.1 47.2 1.1 1.2 0.7 0.6 0.9 0.7 0.4 3.4 6.0 1.1 6.0 1.5 5.7 3.2 3.2 9.0 3.1 3.8 3.6 2.1 5.4 2.9 1.2 3.0 2.3 4.3 5.1 8.0 8.5 0.6 2.6 2.9 2.0 1.4 3.9 5.2 7.5 3.1 5.9 3.2 0.8 1.5 3.7 0.7 3.4 1.1 2.8 6.7 4.1 3.5 8.3 2.7 6.8 2.9 5.4 6.3 1.4 4.5 1.7 1.3 3.9 3.2 7.3 0.4 2.4 4.4 3.6 3.2 5.5 2.3 3.2 2.8 12.4 10.0 15.2 7.3 7.5 3.7 0.0 4.9 1.1 4.9 4.8 3.6 3.4 4.3 4.5 4.5 2.9 3.5 5.7 0.8 1.5 6.0 6.0 5.1 3.2 1.7 2.6 1.5 2.0 1.7 1.4 1.9 0.9 1.8 1.1 C16orf96 ENSG00000205832 "Chromosome 16 open reading frame 96" A6NNT2 16 4556490-4600714 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 36.0" "Cell line enhanced" "Detected in some" "NTERA-2: 2.4;REH: 4.1;SCLC-21H: 2.0;U-266/70: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.94e-3)" "unprognostic (1.55e-1)" "unprognostic (3.57e-4)" "unprognostic (1.12e-1)" "unprognostic (4.47e-2)" "unprognostic (5.21e-3)" "unprognostic (1.32e-2)" "unprognostic (1.19e-1)" "unprognostic (4.26e-1)" "unprognostic (1.36e-2)" "unprognostic (1.06e-5)" "unprognostic (3.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.22e-1)" "unprognostic (9.23e-2)" "unprognostic (4.24e-4)" "unprognostic (2.66e-1)" 0.1 0.1 0.5 0.1 0.6 0.1 0.1 0.2 0.6 0.2 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.5 0.4 0.1 0.4 0.1 0.1 0.6 0.1 0.1 0.7 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.7 0.1 0.1 0.7 0.1 0.0 36.0 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.6 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.3 0.0 0.4 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 2.4 0.1 4.1 0.0 0.5 0.0 0.0 2.0 0.2 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.3 0.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.2 0.4 0.5 0.4 0.6 0.1 0.1 0.1 C17orf47 FLJ40121 ENSG00000181013 "Chromosome 17 open reading frame 47" Q8NEP4 17 58541587-58544368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 36 "testis: 26.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;Karpas-707: 1.5;MCF7: 2.6;SCLC-21H: 1.5;T-47d: 1.6;U-138 MG: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA028424 Uncertain "HPA028424: AB_10601690" "unprognostic (4.97e-2)" "unprognostic (1.26e-2)" "unprognostic (3.41e-1)" "unprognostic (1.69e-1)" "unprognostic (2.65e-1)" "unprognostic (4.71e-2)" "unprognostic (1.93e-1)" "unprognostic (2.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.62e-3)" "unprognostic (4.03e-2)" "unprognostic (2.57e-2)" "unprognostic (2.62e-8)" "unprognostic (9.29e-2)" "unprognostic (1.68e-1)" "unprognostic (2.01e-3)" "unprognostic (3.37e-3)" 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.4 0.3 0.1 0.1 0.1 0.1 0.5 0.0 0.3 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.4 0.3 26.7 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 2.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 2.6 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 1.5 0.3 0.1 0.2 0.0 1.6 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.6 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 C17orf50 ENSG00000270806 "Chromosome 17 open reading frame 50" Q8WW18 17 35760897-35765079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 63.6" "Cell line enriched" "Detected in some" 5 "HaCaT: 10.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.3;dendritic cells: 3.5;T-cells: 3.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA043184, HPA063464" Supported Nucleoplasm Nucleoplasm "HPA043184: , HPA063464: " "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (4.36e-2)" "unprognostic (4.01e-2)" "unprognostic (5.84e-2)" "unprognostic (5.12e-3)" "unprognostic (2.04e-2)" "unprognostic (1.97e-2)" "unprognostic (7.94e-2)" "unprognostic (5.36e-2)" "unprognostic (1.14e-2)" "unprognostic (2.71e-1)" "unprognostic (6.68e-2)" "unprognostic (4.67e-2)" "unprognostic (1.54e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 3.5 0.0 0.6 0.2 3.7 0.6 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.2 0.1 0.0 10.6 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.1 0.1 0.0 0.0 0.3 0.0 0.5 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.6 1.9 2.3 2.0 1.2 0.0 1.9 3.5 3.7 0.0 0.2 0.0 3.5 0.0 0.6 C17orf51 "FLJ12977, FLJ31874, FLJ33618" ENSG00000212719 "Chromosome 17 open reading frame 51" A8MQB3 17 21524790-21574458 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 41.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA052106 Enhanced Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA052106: " "unprognostic (1.99e-1)" "unprognostic (5.29e-2)" "unprognostic (6.35e-3)" "unprognostic (2.78e-3)" "unprognostic (3.72e-1)" "unprognostic (4.09e-2)" "unprognostic (4.36e-3)" "unprognostic (5.80e-2)" "unprognostic (2.55e-1)" "unprognostic (1.53e-1)" "unprognostic (2.51e-3)" "unprognostic (7.42e-3)" "unprognostic (2.29e-2)" "unprognostic (1.23e-1)" "unprognostic (3.17e-1)" "unprognostic (6.42e-5)" "unprognostic (9.05e-3)" 6.1 7.2 8.0 4.2 8.4 0.8 3.0 41.2 20.5 5.3 4.5 5.2 3.1 3.2 8.3 10.1 3.2 6.7 3.6 6.5 8.6 7.3 4.0 3.8 3.0 3.0 5.9 8.1 5.9 6.6 7.8 8.9 2.1 5.5 6.3 3.2 3.8 5.0 7.0 7.3 3.0 2.4 6.6 5.0 3.3 4.1 9.2 5.9 1.2 2.9 2.2 3.0 4.0 4.7 4.2 4.1 1.2 3.9 2.6 6.0 1.8 2.6 6.1 2.3 7.9 7.3 6.9 2.1 7.1 3.5 5.2 5.9 12.1 0.4 3.5 4.0 3.9 0.3 9.8 3.7 8.6 11.0 15.2 0.7 5.6 5.0 13.6 0.9 3.9 6.5 3.4 10.5 11.4 3.7 1.9 0.8 4.4 0.0 7.6 0.3 4.3 5.2 7.4 4.8 0.5 1.9 0.5 5.1 0.9 6.6 0.2 5.2 0.1 0.3 6.6 6.1 6.3 14.5 8.5 2.3 2.8 13.5 7.3 1.3 7.1 0.0 3.9 0.0 4.0 1.8 3.1 2.2 1.9 1.8 1.9 4.2 6.0 5.1 1.2 2.6 1.0 4.1 1.7 1.8 8.0 8.4 41.2 14.5 8.6 7.3 5.9 8.1 5.5 5.9 C17orf64 ENSG00000141371 "Chromosome 17 open reading frame 64" Q86WR6 17 60392429-60431421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 74.5" "Cell line enhanced" "Detected in some" "MCF7: 10.8;THP-1: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.8" "Group enriched" "Detected in many" 4 "dendritic cells: 5.8;granulocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA044415 Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA044415: AB_10797148" "unprognostic (3.00e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.77e-1)" "unprognostic (1.51e-2)" "unprognostic (2.30e-2)" "unprognostic (3.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (6.85e-2)" "unprognostic (1.68e-6)" "unprognostic (3.30e-1)" "unprognostic (2.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.46e-2)" 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 74.5 0.1 0.2 0.0 0.1 0.1 0.0 0.0 1.0 5.8 2.5 0.6 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 1.2 0.0 0.0 0.0 0.6 0.7 1.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.7 0.2 0.5 1.7 0.0 0.1 0.0 0.0 0.0 0.6 0.0 10.8 0.3 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 2.7 0.3 0.0 0.1 0.0 0.0 1.7 1.3 0.2 0.0 1.4 0.0 0.0 0.6 0.0 0.1 0.5 0.0 1.0 0.3 0.0 1.8 0.2 0.0 0.6 2.5 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.1 C17orf78 FLJ39647 ENSG00000278505 "Chromosome 17 open reading frame 78" Q8N4C9 17 37375986-37392708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 401 "intestine: 83.8" "Cell line enhanced" "Detected in some" "BEWO: 1.5;NB-4: 1.6;RPMI-8226: 1.4" "Group enriched" "Detected in some" 8 "colorectal cancer: 0.8;stomach cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (8.73e-3)" "unprognostic (1.91e-1)" "unprognostic (8.98e-2)" "unprognostic (4.90e-3)" "unprognostic (5.31e-2)" "unprognostic (7.83e-2)" "unprognostic (2.59e-2)" "unprognostic (2.02e-1)" "unprognostic (7.62e-2)" "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (1.43e-1)" "unprognostic (5.53e-6)" "unprognostic (1.94e-2)" "unprognostic (7.23e-3)" "unprognostic (4.85e-2)" "unprognostic (3.19e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.2 0.0 1.6 0.2 0.3 0.2 0.1 1.4 0.1 0.0 0.9 0.7 0.2 0.0 0.2 0.3 0.0 0.3 0.1 0.1 0.8 0.2 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C17orf98 LOC388381 ENSG00000275489 "Chromosome 17 open reading frame 98" A8MV24 17 38835088-38841455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 10.7" "Cell line enriched" "Detected in some" 6 "hTCEpi: 7.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051696 Uncertain Approved "Nucleoli,Intermediate filaments" "Intermediate filaments" Nucleoli "HPA051696: " "unprognostic (2.30e-1)" "unprognostic (3.25e-4)" "unprognostic (1.46e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-3)" "unprognostic (1.14e-2)" "unprognostic (8.69e-3)" "unprognostic (2.56e-1)" "unprognostic (7.58e-2)" "unprognostic (9.02e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 1.3 0.5 0.4 0.4 0.2 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.2 0.3 0.0 0.0 7.7 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.0 1.2 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.1 0.0 1.0 0.5 0.0 1.3 0.3 0.5 0.0 0.2 0.2 0.5 0.7 0.0 C17orf99 "GLPG464, UNQ464" ENSG00000187997 "Chromosome 17 open reading frame 99" Q6UX52 17 78146353-78166177 "Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 13.5" "Group enriched" "Detected in some" 11 "HaCaT: 5.5;HMC-1: 11.3;K-562: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 1.2;non-classical monocyte: 1.1" "Low lineage specificity" "Detected in many" HPA029655 Uncertain "Secreted to blood" "HPA029655: AB_10601691" "unprognostic (3.55e-5)" "unprognostic (1.87e-2)" "unprognostic (2.06e-1)" "unprognostic (1.22e-1)" "unprognostic (1.88e-1)" "unprognostic (1.45e-3)" "unprognostic (1.47e-3)" "unprognostic (2.39e-1)" "unprognostic (3.86e-1)" "unprognostic (9.77e-2)" "unprognostic (2.05e-2)" "unprognostic (5.13e-2)" "unprognostic (1.38e-4)" "unprognostic (6.58e-2)" "unprognostic (4.72e-2)" "unprognostic (2.66e-1)" "unprognostic (5.78e-3)" 0.2 0.0 0.1 0.1 0.1 13.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.7 0.9 0.1 0.1 0.1 0.0 0.1 0.1 1.6 1.2 0.1 0.1 0.6 0.1 0.0 0.1 1.9 0.1 0.2 0.0 0.1 0.4 0.1 0.1 2.0 0.6 0.1 0.1 1.3 0.0 0.1 0.1 0.1 0.1 0.1 1.1 1.9 0.9 1.2 0.0 0.0 1.1 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 5.5 0.0 0.6 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 11.3 0.0 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 C18orf63 DKFZP781G0119 ENSG00000206043 "Chromosome 18 open reading frame 63" Q68DL7 18 74315813-74359187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "testis: 17.4" "Cell line enhanced" "Detected in single" "CACO-2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042233 Approved Mitochondria Mitochondria "HPA042233: AB_10960843" "unprognostic (1.40e-1)" "unprognostic (1.43e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C19orf18 MGC41906 ENSG00000177025 "Chromosome 19 open reading frame 18" Q8NEA5 19 57958437-57974534 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 22.6" "Cell line enhanced" "Detected in many" "AN3-CA: 4.5;HEK 293: 6.5;RT4: 4.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA014527 Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA014527: AB_1845612" "unprognostic (5.38e-2)" "unprognostic (6.36e-3)" "unprognostic (3.70e-2)" "prognostic favourable (5.07e-4)" "unprognostic (4.85e-2)" "unprognostic (9.50e-2)" "unprognostic (2.75e-1)" "unprognostic (5.40e-3)" "unprognostic (5.78e-2)" "unprognostic (1.64e-1)" "unprognostic (4.08e-5)" "unprognostic (1.11e-2)" "unprognostic (8.75e-5)" "unprognostic (1.53e-1)" "unprognostic (1.15e-1)" "unprognostic (6.41e-2)" "unprognostic (1.05e-3)" 1.1 1.7 1.4 1.1 1.8 0.4 3.6 1.1 1.1 1.1 1.3 1.1 1.1 0.8 1.4 5.6 1.1 1.8 1.4 4.2 1.9 1.8 1.1 1.1 1.1 1.1 2.1 1.1 1.3 1.1 1.0 3.6 1.1 3.1 2.7 0.8 1.1 1.2 1.6 4.2 1.2 1.1 1.1 2.3 1.1 0.8 22.6 1.1 1.1 1.3 1.1 1.1 1.1 1.1 2.8 1.6 0.7 0.9 0.8 1.2 0.4 0.2 0.0 1.8 4.5 1.1 1.5 1.4 2.2 0.5 0.6 1.4 0.0 0.4 0.4 1.0 0.6 0.1 0.1 0.0 1.5 0.0 6.5 0.4 0.0 1.5 1.6 0.0 1.1 1.8 2.6 0.1 0.4 0.3 0.2 0.0 3.2 0.0 0.9 0.0 0.1 0.4 1.3 0.0 1.2 1.1 4.3 1.9 0.4 0.9 0.0 0.6 1.5 1.4 0.9 0.3 0.4 0.5 0.5 0.9 3.8 0.1 0.0 0.0 0.5 0.0 0.6 0.7 0.1 0.2 0.0 2.8 1.0 0.6 1.6 1.3 0.6 1.2 0.5 0.8 0.9 1.0 0.0 0.4 1.4 1.8 1.1 1.1 1.9 1.8 2.1 1.1 3.1 1.1 C19orf67 ENSG00000188032 "Chromosome 19 open reading frame 67" A6NJJ6 19 14081619-14085875 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 6 "testis: 11.6" "Cell line enhanced" "Detected in some" "AN3-CA: 1.7;BEWO: 1.8;Hep G2: 2.2;hTCEpi: 1.1;U-266/70: 1.1;U-266/84: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.21e-1)" "unprognostic (6.84e-2)" "unprognostic (1.40e-1)" "unprognostic (6.45e-4)" "unprognostic (1.25e-1)" "unprognostic (6.81e-2)" "unprognostic (1.41e-1)" "unprognostic (4.76e-3)" "unprognostic (9.22e-2)" "unprognostic (1.65e-3)" "unprognostic (4.20e-3)" "unprognostic (3.74e-1)" "unprognostic (1.63e-2)" "unprognostic (3.25e-1)" "unprognostic (1.36e-1)" "unprognostic (1.51e-2)" "unprognostic (1.94e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.9 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 1.0 0.1 1.4 11.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.5 1.9 0.3 0.8 0.8 0.3 0.2 0.0 0.2 1.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.9 0.5 2.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.1 1.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.3 0.8 0.4 0.8 1.9 0.8 0.3 0.5 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 C19orf71 LOC100128569 ENSG00000183397 "Chromosome 19 open reading frame 71" A6NCJ1 19 3539154-3544030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 88.8" "Group enriched" "Detected in many" 4 "HeLa: 26.7;SK-MEL-30: 16.3;WM-115: 58.2" "Cancer enriched" "Detected in all" 5 "melanoma: 23.7" "Region enriched" "Detected in all" 4 "cerebellum: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048654 Uncertain Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Endoplasmic reticulum" "HPA048654: " "unprognostic (1.06e-1)" "unprognostic (1.21e-1)" "unprognostic (7.04e-3)" "unprognostic (7.37e-2)" "unprognostic (4.74e-2)" "prognostic favourable (2.35e-4)" "unprognostic (4.21e-1)" "unprognostic (2.00e-1)" "unprognostic (7.23e-2)" "unprognostic (3.13e-2)" "prognostic favourable (2.03e-5)" "unprognostic (6.19e-2)" "prognostic favourable (2.02e-5)" "unprognostic (5.52e-3)" "unprognostic (1.02e-1)" "unprognostic (3.84e-2)" "unprognostic (1.97e-3)" 1.6 2.3 1.6 4.1 2.2 5.1 1.6 9.8 2.2 1.7 1.6 2.0 1.6 4.7 2.5 1.9 1.6 2.6 1.6 1.6 1.6 1.3 3.5 1.6 2.1 4.9 1.8 1.9 2.8 4.2 0.0 4.5 1.6 1.7 2.2 0.0 1.6 7.6 1.6 1.6 7.4 3.9 1.6 1.6 5.2 3.2 88.8 1.8 1.6 6.3 1.6 1.6 1.7 1.6 0.3 0.5 0.0 0.2 0.0 0.7 0.1 5.2 4.3 1.4 1.9 0.0 0.0 2.9 3.3 0.0 0.0 0.0 2.7 1.6 0.9 2.5 0.0 4.7 0.0 0.2 0.0 5.3 2.5 0.7 26.7 0.8 0.0 0.7 3.3 0.0 0.0 0.1 0.0 0.0 3.6 4.8 0.0 3.7 1.1 1.7 1.2 1.3 1.7 2.1 4.9 0.0 2.1 3.4 3.1 5.8 2.9 16.3 3.3 1.7 4.4 2.6 3.5 8.0 3.0 3.8 1.0 1.3 7.9 3.1 58.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.6 0.7 0.0 0.0 0.2 0.5 0.0 0.1 1.6 2.2 9.8 2.2 1.6 1.3 1.8 1.9 1.7 1.8 C19orf81 ENSG00000235034 "Chromosome 19 open reading frame 81" C9J6K1 19 50649445-50659310 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 10.7" "Cell line enhanced" "Detected in some" "HEK 293: 9.2;HMC-1: 3.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA060238 Enhanced Approved Vesicles,Aggresome "Vesicles, Aggresome" "HPA060238: " "unprognostic (2.29e-2)" "unprognostic (2.75e-2)" "unprognostic (2.17e-3)" "unprognostic (1.15e-1)" "unprognostic (3.39e-2)" "unprognostic (2.03e-2)" "unprognostic (1.70e-2)" "unprognostic (4.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.48e-2)" "unprognostic (6.01e-4)" "unprognostic (4.41e-1)" "unprognostic (1.17e-2)" "unprognostic (3.77e-1)" "unprognostic (7.58e-2)" "unprognostic (1.95e-1)" "unprognostic (5.04e-2)" 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.6 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.7 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 1.1 1.4 0.0 0.0 0.7 0.0 0.0 1.2 9.2 0.9 0.0 0.0 0.5 0.0 3.3 0.0 0.0 0.0 0.0 0.4 2.1 1.8 0.0 0.0 0.5 1.5 0.5 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.7 0.0 0.0 1.1 0.5 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.6 0.0 0.1 C19orf84 ENSG00000262874 "Chromosome 19 open reading frame 84" I3L1E1 19 51388289-51390574 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 39.0" "Cell line enriched" "Detected in some" 8 "K-562: 12.1" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 1.5;plasmacytoid DC: 1.7" "Group enriched" "Detected in many" 6 "dendritic cells: 1.7;T-cells: 1.5" "Low region specificity" "Detected in single" HPA068082 Uncertain Approved Vesicles Vesicles "HPA068082: " "unprognostic (5.94e-2)" "unprognostic (7.72e-2)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (2.08e-1)" "unprognostic (1.47e-1)" "unprognostic (2.13e-3)" "unprognostic (9.28e-4)" "unprognostic (1.31e-1)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (3.84e-1)" "unprognostic (2.61e-7)" "unprognostic (8.30e-3)" "unprognostic (1.86e-1)" "unprognostic (2.92e-2)" "unprognostic (3.99e-3)" 0.0 0.0 0.1 0.3 0.2 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.1 0.1 0.2 0.6 0.1 0.0 0.0 0.1 0.3 0.4 0.0 0.4 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.5 0.0 39.0 0.2 1.0 0.0 0.2 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.2 1.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.1 0.2 0.2 0.2 0.6 0.1 0.4 0.0 0.6 0.2 C1orf100 ENSG00000173728 "Chromosome 1 open reading frame 100" Q5SVJ3 1 244352635-244389663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 65.3" "Cell line enriched" "Detected in single" 51 "K-562: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA031179, HPA031180" Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA031179: AB_10599995, HPA031180: AB_10599026" "unprognostic (9.84e-2)" "unprognostic (2.14e-3)" "unprognostic (3.37e-2)" "unprognostic (9.07e-2)" "unprognostic (6.63e-2)" "unprognostic (1.49e-2)" "unprognostic (5.45e-3)" "unprognostic (2.17e-2)" "unprognostic (4.00e-2)" "unprognostic (3.44e-1)" "unprognostic (9.67e-5)" "unprognostic (1.85e-2)" "unprognostic (2.08e-3)" "unprognostic (2.53e-2)" "unprognostic (1.79e-1)" "unprognostic (2.85e-1)" "unprognostic (1.27e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 C1orf146 ENSG00000203910 "Chromosome 1 open reading frame 146" Q5VVC0 1 92217940-92245813 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 12.7" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.6" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "unprognostic (2.89e-2)" "unprognostic (4.26e-3)" "unprognostic (1.81e-1)" "unprognostic (5.37e-3)" "unprognostic (8.77e-2)" "unprognostic (1.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-1)" "unprognostic (1.89e-3)" "unprognostic (1.90e-1)" "unprognostic (7.13e-2)" "unprognostic (4.17e-2)" "unprognostic (2.78e-7)" "unprognostic (3.36e-2)" "unprognostic (6.76e-2)" "unprognostic (3.17e-1)" "unprognostic (5.19e-3)" 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.5 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.3 1.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.1 12.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.5 0.5 2.6 0.1 0.7 0.5 0.0 0.4 0.0 0.9 2.3 0.0 0.5 1.1 0.3 0.0 0.6 0.7 0.0 1.2 2.1 0.3 0.0 0.8 0.3 0.0 0.0 0.5 1.0 0.9 0.7 0.0 0.0 0.7 1.9 0.5 0.3 0.9 0.0 0.3 0.0 0.8 0.0 1.3 1.1 1.7 0.7 0.0 0.6 0.2 0.3 0.0 1.6 0.7 0.1 0.4 1.2 0.0 0.2 1.2 1.0 1.2 0.9 1.0 0.9 1.9 0.4 0.9 0.5 1.0 0.5 0.2 0.1 0.1 0.5 0.0 0.1 0.1 0.2 0.4 0.1 0.5 0.3 0.2 2.6 0.7 0.1 0.5 0.0 0.0 0.1 0.2 0.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 C1orf167 "DKFZp434E1410, RP11-56N19.2" ENSG00000215910 "Chromosome 1 open reading frame 167" Q5SNV9 1 11761787-11789585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 22 "testis: 34.0" "Cell line enriched" "Detected in single" 52 "U-698: 25.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" HPA039114 Enhanced "HPA039114: AB_10673606" "unprognostic (2.93e-3)" "unprognostic (1.34e-2)" "unprognostic (7.48e-3)" "unprognostic (3.96e-1)" "unprognostic (2.38e-4)" "unprognostic (2.71e-1)" "unprognostic (5.55e-3)" "unprognostic (3.92e-2)" "unprognostic (5.10e-2)" "unprognostic (4.90e-3)" "unprognostic (3.96e-2)" "unprognostic (8.38e-5)" "unprognostic (5.46e-4)" "unprognostic (1.52e-1)" "unprognostic (2.71e-1)" "unprognostic (2.38e-2)" 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.1 34.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.2 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.3 0.0 0.9 1.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 C1orf185 FLJ27485 ENSG00000204006 "Chromosome 1 open reading frame 185" Q5T7R7 1 51102234-51148086 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 23.8" "Cell line enhanced" "Detected in some" "LHCN-M2: 1.1;THP-1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1orf61 CROC4 ENSG00000125462 "Chromosome 1 open reading frame 61" Q13536 1 156404250-156430701 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 29 "brain: 184.8" "Cell line enriched" "Detected in some" 9 "BEWO: 16.9" "Cancer enriched" "Detected in some" 116 "glioma: 77.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 6.3;MAIT T-cell: 5.2" "Lineage enriched" "Detected in single" 34 "T-cells: 6.3" "unprognostic (6.20e-2)" "unprognostic (2.46e-3)" "unprognostic (3.32e-1)" "unprognostic (1.28e-1)" "unprognostic (7.12e-2)" "unprognostic (2.37e-1)" "unprognostic (1.35e-2)" "unprognostic (9.00e-2)" "unprognostic (1.75e-1)" "unprognostic (2.64e-1)" "unprognostic (1.37e-2)" "unprognostic (3.64e-2)" "unprognostic (8.16e-7)" "unprognostic (5.87e-3)" "unprognostic (9.89e-2)" "unprognostic (1.44e-2)" "unprognostic (5.88e-2)" 2.0 1.9 71.9 1.9 69.5 2.1 2.0 20.2 184.8 1.9 2.0 19.3 0.0 2.0 2.0 2.0 2.0 2.0 1.9 1.9 48.9 45.2 1.9 2.0 1.9 2.1 65.3 23.6 1.9 1.9 2.0 0.0 1.9 27.4 1.9 2.0 1.4 2.0 1.9 1.9 1.9 2.0 2.0 22.7 2.1 1.9 3.1 14.8 0.0 1.9 0.0 2.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.5 0.0 0.8 0.0 0.3 0.0 0.0 16.9 0.0 0.0 0.0 0.1 0.3 0.3 1.2 0.0 0.0 0.2 0.6 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 1.3 0.8 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 0.3 0.4 0.0 0.0 0.0 6.3 0.0 5.2 0.0 1.5 3.3 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.6 0.5 71.9 69.5 20.2 43.5 48.9 45.2 65.3 23.6 27.4 14.8 C1orf68 "LEP7, XP32" ENSG00000198854 "Chromosome 1 open reading frame 68" Q5T750 1 152719522-152720470 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "skin 1: 123.1" "Cell line enriched" "Detected in some" 5 "HaCaT: 6.3" "Group enriched" "Detected in some" 13 "head and neck cancer: 2.4;melanoma: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 61000 "unprognostic (1.73e-1)" "unprognostic (7.46e-2)" "unprognostic (9.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 123.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1orf94 MGC15882 ENSG00000142698 "Chromosome 1 open reading frame 94" Q6P1W5 1 34166883-34219131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 24.6" "Group enriched" "Detected in some" 7 "NTERA-2: 11.2;U-87 MG: 32.2" "Cancer enriched" "Detected in single" 10 "glioma: 1.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045805 Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA045805: AB_10969626" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (9.77e-2)" "unprognostic (4.09e-2)" "unprognostic (1.65e-2)" "unprognostic (2.31e-1)" 0.0 0.1 0.6 0.0 0.8 0.0 0.0 1.2 1.8 0.0 0.1 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 24.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.6 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.2 1.8 0.5 0.7 0.5 0.0 3.2 0.0 C1QL2 "C1QTNF10, CTRP10" ENSG00000144119 "Complement C1q like 2" Q7Z5L3 2 119156243-119158889 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 15.4" "Group enriched" "Detected in some" 14 "NTERA-2: 2.2;SCLC-21H: 7.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hippocampal formation: 25.0" "Low region specificity" "Detected in many" HPA057934 Uncertain "Secreted in brain" "HPA057934: " "unprognostic (6.95e-2)" "unprognostic (9.74e-2)" "unprognostic (4.48e-3)" "unprognostic (1.08e-1)" "unprognostic (9.91e-4)" "unprognostic (2.60e-5)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" 0.7 0.7 15.3 0.7 6.8 0.7 1.1 0.9 15.1 0.7 0.7 3.1 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.8 15.4 9.0 0.7 0.8 0.7 1.3 4.5 5.4 0.7 0.7 0.7 0.3 0.7 1.3 0.7 0.7 2.4 1.0 0.7 0.7 0.9 0.7 0.7 1.5 0.8 0.7 1.1 3.1 0.0 0.7 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 6.8 0.9 15.1 15.4 9.0 4.5 5.4 1.3 3.1 C1QL3 "C1ql, C1QTNF13, CTRP13, K100" ENSG00000165985 "Complement C1q like 3" Q5VWW1 10 16513743-16522005 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 33.8" "Group enriched" "Detected in some" 7 "HDLM-2: 24.3;SCLC-21H: 15.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 99.4;cerebral cortex: 74.9;hippocampal formation: 78.6" "Secreted in brain" "unprognostic (7.24e-2)" "unprognostic (2.54e-1)" "unprognostic (1.62e-1)" "unprognostic (1.16e-1)" "unprognostic (8.19e-3)" "unprognostic (6.31e-2)" "unprognostic (5.12e-2)" "unprognostic (3.89e-2)" "unprognostic (2.76e-2)" "unprognostic (2.00e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "prognostic favourable (6.29e-5)" "unprognostic (3.27e-2)" "unprognostic (1.66e-1)" "unprognostic (8.59e-2)" "unprognostic (6.12e-2)" 1.2 1.5 24.8 1.0 14.6 0.5 0.5 7.4 33.8 0.5 0.6 0.1 0.0 2.6 0.7 0.4 0.7 0.5 0.6 1.4 22.8 4.3 1.9 0.8 0.9 1.3 1.4 23.4 0.4 0.9 0.4 0.3 0.6 2.3 1.0 0.4 0.2 1.0 0.5 1.7 1.6 1.2 0.4 0.9 1.0 0.9 0.5 0.0 0.0 1.6 0.0 0.5 1.2 0.4 1.0 0.9 0.8 2.0 0.7 2.8 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 1.6 0.8 2.7 0.0 0.0 0.3 0.0 0.0 0.0 24.3 0.2 1.3 0.9 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.1 0.1 0.9 0.1 0.9 0.2 1.3 0.1 0.5 15.0 1.2 1.3 0.2 0.8 0.1 0.2 0.0 0.0 0.1 0.7 0.0 0.5 0.7 0.7 0.1 1.4 0.6 0.0 1.1 0.8 2.1 2.0 1.3 1.0 1.6 1.8 0.5 0.8 1.7 2.8 0.2 0.7 1.4 0.9 1.7 0.6 24.8 14.6 7.4 29.5 22.8 4.3 1.4 23.4 2.3 0.0 C1QTNF3 "2310005P21Rik, Corcs, Cors, Cors-26, CTRP3" ENSG00000082196 "C1q and TNF related 3" Q9BXJ4 5 34019448-34043832 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "salivary gland: 171.5" "Cell line enriched" "Detected in single" 199 "U-266/84: 129.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.3" "Low lineage specificity" "Detected in single" "HPA064996, HPA066011" Uncertain Approved "Golgi apparatus" "Secreted to blood" 44100000 27000000 "Golgi apparatus" "HPA064996: , HPA066011: " "unprognostic (7.71e-2)" "unprognostic (2.81e-3)" "unprognostic (5.83e-2)" "unprognostic (6.58e-2)" "unprognostic (3.14e-2)" "unprognostic (1.98e-1)" "unprognostic (2.21e-1)" "unprognostic (2.09e-3)" "unprognostic (5.18e-2)" "unprognostic (1.68e-2)" "unprognostic (1.35e-2)" "unprognostic (2.70e-2)" "prognostic unfavourable (6.29e-4)" "unprognostic (4.89e-3)" "unprognostic (1.80e-1)" "unprognostic (9.38e-3)" "unprognostic (2.35e-1)" 4.4 0.3 5.7 2.7 6.4 0.2 4.5 9.6 3.4 2.4 7.9 1.8 4.8 2.1 2.5 3.9 22.5 2.0 3.6 0.9 4.2 3.1 4.0 0.5 2.6 0.5 4.3 1.4 1.1 1.0 0.3 0.7 0.8 3.7 30.2 6.6 2.4 171.5 3.2 1.3 1.4 5.5 14.4 5.6 0.5 8.4 7.9 2.6 0.6 1.0 3.6 0.7 13.1 3.2 0.4 0.1 0.4 0.0 0.0 1.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.1 0.0 0.1 0.1 129.4 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.1 0.4 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.4 5.7 6.4 9.6 2.8 4.2 3.1 4.3 1.4 3.7 2.6 C1QTNF4 "CTRP4, ZACRP4" ENSG00000172247 "C1q and TNF related 4" Q9BXJ3 11 47589664-47594659 "Predicted secreted proteins" Cytokine "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 37.8" "Cell line enriched" "Detected in some" 6 "REH: 10.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041032 Approved "Secreted in brain" "HPA041032: AB_10671170" "unprognostic (1.84e-3)" "unprognostic (1.58e-1)" "unprognostic (8.98e-4)" "unprognostic (8.19e-2)" "unprognostic (3.59e-2)" "unprognostic (2.26e-3)" "unprognostic (6.78e-2)" "unprognostic (6.11e-2)" "unprognostic (6.35e-2)" "unprognostic (4.00e-1)" "unprognostic (4.91e-4)" "unprognostic (1.22e-1)" "unprognostic (8.22e-6)" "unprognostic (6.02e-3)" "unprognostic (1.00e-1)" "unprognostic (2.80e-2)" "unprognostic (6.28e-2)" 2.5 1.5 14.2 1.4 34.2 4.1 1.6 16.8 37.8 1.6 1.5 2.0 0.0 1.7 2.1 1.4 1.3 1.5 1.6 1.4 9.7 7.1 1.4 1.4 1.4 1.5 7.9 15.5 3.3 2.2 6.3 4.7 1.4 14.5 1.8 1.4 0.0 1.3 1.7 1.8 1.5 1.6 1.8 5.2 1.6 1.5 2.0 3.7 0.0 1.5 0.0 1.4 1.3 0.3 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.0 0.7 0.0 10.9 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 14.2 34.2 16.8 37.8 9.7 7.1 7.9 15.5 14.5 3.7 C2 ENSG00000166278 "Complement C2" P06681 6 31897785-31945672 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 132.7" "Group enriched" "Detected in some" 5 "Hep G2: 16.9;Karpas-707: 52.8" "Cancer enriched" "Detected in all" 9 "liver cancer: 100.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "classical monocyte: 2.9;intermediate monocyte: 6.4;non-classical monocyte: 6.5" "Lineage enriched" "Detected in single" 8 "monocytes: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" CAB016775 Supported "Secreted to blood" 52000000000 "CAB016775: " "unprognostic (2.05e-1)" "unprognostic (1.22e-1)" "unprognostic (7.68e-2)" "unprognostic (1.49e-3)" "unprognostic (7.40e-2)" "unprognostic (3.34e-2)" "unprognostic (1.36e-2)" "unprognostic (8.88e-3)" "unprognostic (3.02e-1)" "unprognostic (2.59e-3)" "unprognostic (3.27e-2)" "unprognostic (3.15e-3)" "prognostic unfavourable (2.64e-7)" "unprognostic (2.05e-1)" "unprognostic (4.42e-2)" "unprognostic (7.37e-2)" "unprognostic (2.55e-2)" 9.2 3.2 0.9 4.8 1.5 0.8 5.0 1.2 1.3 2.0 5.3 1.8 1.6 2.5 2.0 4.8 1.9 3.3 3.2 5.4 0.8 0.8 13.1 132.7 19.4 13.1 1.2 0.3 2.7 2.1 0.8 2.8 7.6 1.7 1.8 4.3 2.9 2.4 1.5 0.7 1.6 6.6 3.5 1.8 12.1 1.9 2.0 1.0 1.8 1.2 0.8 3.4 2.7 1.5 0.2 0.5 0.8 6.5 0.1 0.3 1.2 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.6 0.3 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 16.9 0.3 0.0 0.2 0.9 0.1 0.2 0.0 0.0 0.1 52.8 0.0 0.0 0.1 0.2 0.1 0.0 0.0 1.3 0.6 0.0 0.0 0.1 0.1 1.0 0.1 0.0 0.1 2.3 0.1 0.1 0.2 0.2 0.0 0.2 6.6 1.0 0.2 0.3 0.0 0.1 2.9 0.0 0.1 6.4 0.1 0.1 0.1 0.1 0.5 0.2 0.3 0.2 0.8 0.1 6.5 0.0 0.1 1.2 0.9 1.5 1.2 1.2 0.8 0.8 1.2 0.3 1.7 1.0 C20orf141 dJ860F19.4 ENSG00000258713 "Chromosome 20 open reading frame 141" Q9NUB4 20 2814987-2815833 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 42 "testis: 63.6" "Group enriched" "Detected in some" 8 "HDLM-2: 20.3;U-2197: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (4.52e-1)" "unprognostic (1.40e-2)" "unprognostic (1.35e-2)" "unprognostic (7.53e-2)" "unprognostic (1.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.0 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C20orf144 "bclt, dJ63M2.6" ENSG00000149609 "Chromosome 20 open reading frame 144" Q9BQM9 20 33662284-33665619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 165 "testis: 53.4" "Cell line enhanced" "Detected in some" "BJ: 1.4;PC-3: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA019029 Enhanced "HPA019029: " "unprognostic (2.16e-2)" "unprognostic (2.04e-2)" "unprognostic (2.32e-2)" "unprognostic (4.37e-2)" "unprognostic (2.09e-1)" "unprognostic (5.00e-2)" "unprognostic (1.54e-3)" "unprognostic (3.21e-2)" "unprognostic (2.13e-1)" "unprognostic (3.64e-2)" "unprognostic (4.60e-2)" "unprognostic (2.32e-1)" "unprognostic (2.02e-2)" "unprognostic (1.53e-1)" "unprognostic (3.36e-2)" "unprognostic (5.66e-2)" "unprognostic (2.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C20orf173 dJ477O4.4 ENSG00000125975 "Chromosome 20 open reading frame 173" Q96LM9 20 35523186-35529652 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 89 "testis: 28.3" "Cell line enhanced" "Detected in single" "PC-3: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C22orf15 "FLJ36561, N27C7-3" ENSG00000169314 "Chromosome 22 open reading frame 15" Q8WYQ4 22 23763021-23765861 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "fallopian tube: 22.3" "Cell line enhanced" "Detected in some" "AF22: 3.3;BJ: 2.5;BJ hTERT+: 5.4;HSkMC: 2.3;MOLT-4: 3.4" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.7" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.9" "Low lineage specificity" "Detected in many" "Secreted in female reproductive system" "unprognostic (2.37e-2)" "unprognostic (3.28e-3)" "unprognostic (1.28e-1)" "prognostic favourable (8.53e-5)" "unprognostic (1.86e-2)" "unprognostic (2.07e-2)" "unprognostic (4.38e-2)" "unprognostic (6.14e-2)" "unprognostic (3.60e-2)" "unprognostic (7.70e-2)" "unprognostic (4.58e-2)" "unprognostic (2.60e-1)" "unprognostic (9.79e-2)" "unprognostic (2.29e-1)" "unprognostic (3.02e-1)" "unprognostic (3.28e-2)" "unprognostic (3.08e-3)" 0.0 0.1 1.0 0.0 1.7 0.4 0.1 0.0 0.0 0.8 0.1 0.0 0.2 0.0 0.0 22.3 0.2 0.0 1.4 1.9 0.0 0.0 2.7 0.2 0.0 0.5 0.0 0.0 1.5 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.6 2.9 0.0 0.0 0.0 1.8 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 2.5 5.4 0.0 0.5 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.4 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.0 0.6 1.0 0.8 0.4 0.5 1.8 0.5 0.0 0.0 0.0 2.9 0.0 0.2 C22orf23 "EVG1, FLJ32787, LOC84645" ENSG00000128346 "Chromosome 22 open reading frame 23" Q9BZE7 22 37943050-37953669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "testis: 189.0" "Cell line enhanced" "Detected in many" "HaCaT: 16.8;U-138 MG: 17.4;U-87 MG: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000650 Approved Nucleoplasm Nucleoplasm "HPA000650: " "unprognostic (6.09e-3)" "unprognostic (3.02e-1)" "unprognostic (1.09e-1)" "unprognostic (2.99e-2)" "unprognostic (1.95e-1)" "unprognostic (1.80e-1)" "unprognostic (7.42e-5)" "unprognostic (1.50e-2)" "unprognostic (2.60e-1)" "unprognostic (2.72e-2)" "unprognostic (1.04e-1)" "unprognostic (5.80e-2)" "unprognostic (8.18e-3)" "unprognostic (4.21e-1)" "unprognostic (1.09e-1)" "unprognostic (1.82e-2)" "unprognostic (8.46e-2)" 0.9 0.9 1.3 2.0 1.8 0.7 0.8 1.7 3.3 1.2 4.1 2.8 0.8 0.8 3.7 2.8 6.1 6.0 2.5 1.8 1.7 1.7 1.2 1.1 2.7 1.0 1.9 2.0 2.2 3.4 0.1 2.2 2.0 5.5 1.8 0.0 2.0 4.1 1.4 1.8 11.3 1.2 1.2 3.2 0.8 3.8 189.0 1.2 0.8 3.4 0.9 0.9 5.2 1.6 0.7 0.3 0.9 0.2 0.1 1.4 0.2 3.5 2.8 6.1 5.6 0.1 0.2 7.5 9.7 0.3 0.3 0.4 3.3 3.1 1.8 2.9 0.2 16.8 0.2 0.1 0.3 3.5 7.2 1.0 2.2 2.3 0.2 2.8 2.4 0.2 0.1 1.1 0.1 0.0 1.2 1.1 0.0 2.1 0.1 1.6 0.9 2.4 3.3 8.7 0.7 0.1 15.4 3.1 2.3 4.5 1.7 5.5 2.0 3.8 14.7 17.4 5.8 13.5 5.2 2.5 1.1 0.9 26.1 1.3 9.8 0.9 0.1 0.0 1.3 0.2 1.4 0.7 0.3 0.1 0.0 0.7 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.2 1.3 1.8 1.7 1.8 1.7 1.7 1.9 2.0 5.5 1.2 C2CD4B "FAM148B, NLF2" ENSG00000205502 "C2 calcium dependent domain containing 4B" A6NLJ0 15 62163535-62165283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "pancreas: 192.0" "Cell line enhanced" "Detected in some" "EFO-21: 1.8;HUVEC TERT2: 6.1;NTERA-2: 2.5;SCLC-21H: 1.8;TIME: 1.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046880 Uncertain "HPA046880: AB_10959458" "unprognostic (6.60e-2)" "prognostic favourable (4.22e-4)" "unprognostic (2.24e-2)" "unprognostic (1.25e-1)" "unprognostic (4.15e-1)" "unprognostic (4.06e-3)" "unprognostic (2.29e-1)" "unprognostic (5.02e-2)" "unprognostic (3.36e-2)" "unprognostic (2.33e-1)" "unprognostic (5.30e-2)" "unprognostic (1.83e-1)" "unprognostic (6.16e-3)" "unprognostic (7.89e-2)" "unprognostic (5.24e-1)" "unprognostic (8.64e-3)" "unprognostic (1.48e-1)" 12.1 1.0 0.2 4.3 0.5 3.0 7.9 0.1 0.7 1.7 2.0 0.3 0.4 2.2 3.7 3.2 3.2 1.2 5.0 2.0 0.3 0.3 0.7 1.7 9.2 0.7 0.5 0.0 1.6 192.0 0.7 2.5 1.4 0.6 2.2 0.6 0.5 0.9 1.0 2.8 1.6 1.8 1.5 0.9 0.4 7.8 1.0 0.2 4.6 0.9 4.1 0.6 3.9 4.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.3 0.3 0.3 0.5 0.0 0.6 0.2 C2CD6 "ALS2CR11, FLJ25351" ENSG00000155754 "C2 calcium dependent domain containing 6" Q53TS8 2 201487425-201619178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 35.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.2;HSkMC: 3.4;hTEC/SVTERT24-B: 3.2;SCLC-21H: 3.8;THP-1: 3.2;U-2197: 12.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "unprognostic (2.64e-1)" "unprognostic (1.14e-1)" "unprognostic (8.77e-3)" "unprognostic (7.13e-6)" "unprognostic (1.33e-1)" "unprognostic (4.38e-2)" "unprognostic (2.16e-1)" "unprognostic (4.81e-2)" "unprognostic (3.15e-2)" "unprognostic (6.53e-2)" "unprognostic (3.43e-1)" "unprognostic (2.10e-1)" "unprognostic (5.13e-10)" "unprognostic (1.95e-1)" "unprognostic (6.35e-2)" "unprognostic (2.00e-1)" "unprognostic (2.18e-1)" 0.7 0.9 0.6 0.2 1.2 0.2 0.4 0.4 1.0 0.3 0.3 1.0 0.0 0.3 0.4 0.3 0.4 0.3 0.6 1.9 1.1 0.5 0.3 0.2 0.4 0.3 2.7 0.2 0.9 0.2 0.2 6.1 0.3 2.9 0.5 0.2 1.5 0.2 0.3 0.3 0.4 0.2 0.8 2.2 0.3 0.2 35.2 0.9 0.0 0.3 0.0 0.2 0.4 0.3 0.8 0.7 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.4 3.2 0.6 0.5 0.5 0.1 0.1 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 3.4 0.0 3.2 0.0 0.2 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.0 0.3 0.3 0.0 3.2 0.0 0.0 0.9 12.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.7 0.8 0.5 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.6 1.2 0.4 1.0 1.1 0.5 2.7 0.2 2.9 0.9 C2orf16 DKFZp434G118 ENSG00000221843 "Chromosome 2 open reading frame 16" Q68DN1 2 27537386-27582721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 22.3" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.2;SiHa: 4.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "HPA052136, HPA056962" Uncertain Uncertain "Nuclear bodies" "Nuclear bodies" "HPA052136: , HPA056962: " "unprognostic (4.32e-2)" "unprognostic (1.08e-2)" "unprognostic (8.36e-2)" "unprognostic (3.40e-3)" "unprognostic (6.36e-2)" "unprognostic (6.17e-2)" "unprognostic (6.15e-2)" "unprognostic (3.07e-1)" "unprognostic (9.35e-2)" "unprognostic (3.79e-3)" "unprognostic (4.59e-1)" "unprognostic (2.19e-2)" "unprognostic (8.82e-2)" "unprognostic (8.00e-2)" "unprognostic (1.44e-1)" "unprognostic (1.46e-2)" "unprognostic (8.53e-3)" 0.2 0.5 0.2 0.2 0.2 0.0 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.2 1.0 0.5 0.1 0.4 0.5 0.2 0.2 0.2 0.9 0.2 0.2 0.2 0.2 0.4 0.4 0.0 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.6 22.3 0.2 0.2 0.7 0.2 0.2 0.4 0.2 0.0 0.3 0.3 1.0 0.0 0.6 0.1 1.5 1.6 2.3 1.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.2 2.1 0.8 2.0 0.0 0.5 0.0 0.0 0.0 1.4 0.4 3.0 1.2 1.5 0.0 1.7 1.3 0.0 0.0 0.2 0.0 0.2 1.2 2.1 0.1 0.3 0.0 0.8 0.4 0.0 1.2 1.3 0.5 0.0 1.5 6.2 1.1 4.4 1.1 0.6 1.0 1.1 2.7 1.4 2.0 0.9 1.0 0.4 0.0 1.9 0.5 0.3 2.0 0.0 1.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.3 0.0 0.8 0.2 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 C2orf71 "FLJ34931, RP54" ENSG00000179270 "Chromosome 2 open reading frame 71" A6NGG8 2 29060976-29074261 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Ciliopathy, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.28e-3)" "unprognostic (1.23e-1)" "unprognostic (1.13e-1)" "unprognostic (3.15e-1)" "unprognostic (1.88e-1)" "unprognostic (5.88e-3)" "unprognostic (6.68e-3)" "unprognostic (1.21e-1)" "unprognostic (6.61e-2)" "unprognostic (3.81e-2)" "unprognostic (2.37e-1)" "unprognostic (2.08e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-4)" 0.2 0.1 0.4 0.1 0.9 0.0 0.2 0.1 0.7 0.4 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.4 0.1 3.6 0.7 0.3 1.3 0.1 1.1 0.1 0.5 0.4 2.0 0.1 0.0 0.3 0.1 0.1 0.5 0.0 28.6 0.4 0.1 0.7 0.7 0.1 0.1 0.5 0.1 0.2 1.1 0.1 0.1 0.5 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.1 0.7 0.7 0.3 0.5 0.4 0.1 0.1 C2orf78 "COG5373, FLJ43987, hCG1989538" ENSG00000187833 "Chromosome 2 open reading frame 78" A6NCI8 2 73784189-73817147 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 141 "testis: 14.0" "Cell line enhanced" "Detected in some" "U-266/70: 2.4;U-266/84: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.25e-2)" "unprognostic (6.56e-3)" "unprognostic (2.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 2.4 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C2orf80 "GONDA1, LOC389073" ENSG00000188674 "Chromosome 2 open reading frame 80" Q0P641 2 208165343-208190073 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 35.3" "Cell line enhanced" "Detected in some" "NTERA-2: 5.8" "Cancer enriched" "Detected in single" 41 "glioma: 11.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 8.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.4" "Low region specificity" "Detected in all" HPA042639 Approved "Golgi apparatus" "Golgi apparatus" "HPA042639: AB_10794915" "unprognostic (6.36e-2)" "unprognostic (2.12e-1)" "unprognostic (2.95e-1)" "unprognostic (3.05e-1)" "unprognostic (1.83e-1)" "unprognostic (2.98e-2)" 0.9 1.0 20.8 1.3 20.8 2.4 0.9 0.4 35.3 0.7 1.1 1.1 0.0 1.0 1.0 0.9 2.2 1.0 1.4 0.9 16.3 14.2 0.9 1.1 1.0 1.1 8.0 13.1 1.0 0.7 0.8 0.4 0.9 9.6 1.1 1.1 0.5 1.4 1.4 1.2 2.0 1.3 0.9 2.1 1.0 1.2 1.7 2.4 0.0 1.1 0.0 0.8 0.9 0.0 1.5 1.7 8.4 1.2 1.0 0.7 0.2 0.4 0.5 2.7 0.9 0.0 0.0 0.2 0.6 0.6 0.0 0.0 0.9 1.1 1.5 0.9 0.3 0.4 0.0 0.0 0.0 0.4 0.3 0.9 1.3 0.4 0.0 1.1 1.8 0.4 0.5 0.3 0.3 0.0 0.5 1.4 0.0 0.8 0.0 1.5 5.8 1.8 0.4 0.3 0.4 0.0 1.2 0.8 1.3 0.3 0.9 0.2 0.5 0.0 0.7 0.5 0.3 0.3 0.5 0.8 0.3 1.1 0.0 0.6 0.9 4.3 1.2 0.9 0.7 0.7 0.5 0.9 0.7 0.7 0.3 1.5 0.6 0.7 8.4 1.0 0.5 1.7 0.3 0.2 20.8 20.8 0.4 23.1 16.3 14.2 8.0 13.1 9.6 2.4 C2orf83 DKFZp547H025 ENSG00000042304 "Chromosome 2 open reading frame 83" Q53S99 2 227610090-227648606 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "placenta: 16.3" "Cell line enriched" "Detected in single" 14 "U-2197: 12.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA030319 Approved "HPA030319: AB_10602112" "unprognostic (1.12e-2)" "unprognostic (1.03e-1)" 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C2orf92 LINC01125 ENSG00000228486 "Chromosome 2 open reading frame 92" 2 97664217-97703064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 12 "testis: 32.1" "Cell line enhanced" "Detected in some" "AF22: 4.4;HDLM-2: 5.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.53e-2)" "unprognostic (8.76e-2)" "unprognostic (1.65e-2)" "unprognostic (2.08e-1)" "unprognostic (4.81e-2)" "unprognostic (3.09e-3)" "unprognostic (9.29e-2)" "unprognostic (1.22e-2)" "unprognostic (1.30e-1)" "unprognostic (2.22e-1)" "unprognostic (1.98e-3)" "unprognostic (2.76e-2)" "unprognostic (7.45e-7)" "unprognostic (5.57e-2)" "unprognostic (1.28e-1)" "unprognostic (3.11e-1)" "unprognostic (5.23e-5)" 0.7 0.0 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 2.4 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 1.4 0.3 1.6 2.6 0.2 0.2 0.2 1.4 0.0 32.1 0.2 0.2 0.7 0.2 0.3 0.2 0.2 0.1 0.0 0.0 0.3 0.0 0.5 0.0 0.4 0.0 4.4 0.8 2.1 1.6 0.6 0.0 0.2 0.2 0.2 0.0 0.3 1.2 0.6 0.4 0.0 0.0 0.0 2.0 5.0 0.0 2.0 0.4 0.0 0.0 1.2 0.2 1.5 0.3 0.0 0.0 0.0 0.0 0.5 1.2 0.3 0.2 2.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 2.5 2.1 1.1 1.6 0.2 1.8 0.7 2.6 0.0 0.6 0.6 0.1 0.2 0.1 0.3 1.9 2.4 1.4 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 C3 "ARMD9, C3a, C3b, CPAMD1" ENSG00000125730 "Complement C3" P01024 19 6677704-6730562 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Fatty acid metabolism, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Lipid metabolism" "Age-related macular degeneration, Disease mutation, FDA approved drug targets, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "liver: 611.7" "Group enriched" "Detected in many" 7 "BJ hTERT+: 47.4;EFO-21: 99.9;Hep G2: 103.2;HSkMC: 73.7;SiHa: 27.6" "Cancer enhanced" "Detected in all" "liver cancer: 1213.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 13.3" "Group enriched" "Detected in many" 4 "granulocytes: 4.2;monocytes: 13.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003563, CAB004209, HPA020432" Enhanced "Secreted to blood" 1003333333333 250000000000 "CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118" "unprognostic (3.26e-3)" "unprognostic (3.91e-1)" "unprognostic (3.92e-1)" "unprognostic (5.98e-3)" "unprognostic (3.31e-1)" "unprognostic (1.04e-1)" "prognostic favourable (8.11e-4)" "unprognostic (1.99e-1)" "unprognostic (9.26e-2)" "unprognostic (5.80e-2)" "unprognostic (8.12e-3)" "unprognostic (5.48e-2)" "prognostic unfavourable (1.09e-5)" "unprognostic (2.63e-2)" "unprognostic (2.49e-2)" "unprognostic (6.03e-3)" "unprognostic (3.88e-1)" 59.7 34.1 9.3 20.0 19.6 1.0 47.3 0.7 10.2 28.3 17.8 13.9 3.7 3.2 9.1 19.9 17.9 38.8 37.9 57.6 7.0 4.1 21.6 611.7 22.6 25.2 12.3 2.2 42.4 22.2 3.1 3.0 2.7 12.8 12.7 9.6 3.9 18.7 7.6 6.8 5.8 15.1 19.1 29.6 1.6 12.6 11.2 10.7 0.1 10.3 3.2 14.1 25.2 38.2 1.2 0.8 4.2 13.3 2.0 0.4 0.8 8.3 3.0 0.0 0.0 1.5 5.0 10.0 0.6 47.4 0.9 1.7 0.5 6.5 0.2 99.9 0.0 6.1 0.0 5.7 0.9 3.0 0.0 0.4 4.4 103.2 2.2 0.8 1.2 73.7 1.7 8.2 3.7 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.6 0.0 4.3 0.8 0.0 0.0 27.6 0.0 0.0 2.3 1.1 0.4 0.7 0.9 0.6 0.4 0.2 0.5 0.5 10.2 0.6 0.0 1.7 1.5 0.9 0.4 2.7 0.3 0.7 0.3 0.2 0.8 1.2 0.4 0.4 4.2 2.0 13.3 0.7 0.2 0.8 9.3 19.6 0.7 10.2 7.0 4.1 12.3 2.2 12.8 10.7 C3orf20 DKFZP434N1817 ENSG00000131379 "Chromosome 3 open reading frame 20" Q8ND61 3 14675099-14773034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 30.9" "Group enriched" "Detected in some" 4 "Daudi: 5.6;HEL: 11.9;U-698: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA039584 Uncertain Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039584: AB_10795152" "unprognostic (1.23e-1)" "unprognostic (2.82e-1)" "unprognostic (5.88e-3)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.76e-3)" "unprognostic (1.81e-1)" "unprognostic (7.82e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (9.08e-2)" "unprognostic (4.74e-2)" "unprognostic (3.24e-1)" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-4)" 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 30.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 5.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 11.9 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.9 0.0 0.5 0.8 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 1.2 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 C3orf22 MGC34728 ENSG00000180697 "Chromosome 3 open reading frame 22" Q8N5N4 3 126526999-126558965 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "testis: 28.3" "Cell line enhanced" "Detected in single" "MCF7: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA059199 Enhanced "HPA059199: " "unprognostic (2.10e-1)" "unprognostic (5.14e-5)" "unprognostic (2.55e-1)" "unprognostic (9.21e-2)" "unprognostic (2.01e-1)" "unprognostic (2.75e-1)" "unprognostic (1.08e-3)" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C3orf30 "FLJ32859, TSCPA" ENSG00000163424 "Chromosome 3 open reading frame 30" Q96M34 3 119146150-119160042 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 156 "testis: 46.4" "Cell line enhanced" "Detected in some" "HaCaT: 1.9;HEL: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062468 Enhanced "HPA062468: " "unprognostic (4.06e-3)" "unprognostic (3.67e-2)" "unprognostic (2.66e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C3orf56 FLJ40141 ENSG00000214324 "Chromosome 3 open reading frame 56" Q8N813 3 127193131-127198185 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "testis: 3.9" "Cell line enhanced" "Detected in single" "U-937: 1.1" "Cancer enriched" "Detected in single" 15 "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.12e-1)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C3orf84 ENSG00000236980 "Chromosome 3 open reading frame 84" H3BNL1 3 49177632-49191858 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 10.8" "Cell line enriched" "Detected in single" 11 "NB-4: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 C3orf85 FLJ22763 ENSG00000241224 "Chromosome 3 open reading frame 85" 3 109118252-109150514 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 5 "intestine: 50.1" "Cell line enhanced" "Detected in some" "BEWO: 1.2;CACO-2: 4.9;RPMI-8226: 1.4;SH-SY5Y: 1.5" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (9.10e-2)" "unprognostic (9.48e-3)" "unprognostic (3.80e-4)" "unprognostic (1.15e-1)" "unprognostic (6.70e-2)" 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 36.2 0.0 0.6 0.0 0.0 0.0 0.4 0.0 6.8 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 50.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C4BPA C4BP ENSG00000123838 "Complement component 4 binding protein alpha" P04003 1 207104262-207144972 "Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "liver: 377.2" "Cell line enriched" "Detected in some" 7 "Hep G2: 28.3" "Cancer enriched" "Detected in many" 7 "liver cancer: 434.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 153 "neutrophil: 21.6" "Lineage enriched" "Detected in single" 153 "granulocytes: 21.6" "HPA000926, HPA001578" Enhanced "Secreted to blood" 30800000000 34000000000 "HPA000926: AB_1078355, HPA001578: AB_1078354" "unprognostic (3.85e-4)" "unprognostic (9.07e-2)" "unprognostic (2.06e-1)" "prognostic favourable (6.37e-5)" "unprognostic (3.58e-2)" "unprognostic (2.41e-1)" "prognostic favourable (2.24e-4)" "unprognostic (3.64e-2)" "unprognostic (1.94e-1)" "unprognostic (5.90e-4)" "unprognostic (4.47e-2)" "unprognostic (2.58e-1)" "unprognostic (5.51e-7)" "unprognostic (9.74e-2)" "unprognostic (2.52e-2)" "unprognostic (6.92e-2)" "unprognostic (2.66e-1)" 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.6 0.2 0.1 0.1 0.0 0.6 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.2 377.2 26.0 0.1 0.1 0.1 0.3 1.8 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 21.6 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 28.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 C4BPB C4BP ENSG00000123843 "Complement component 4 binding protein beta" P20851 1 207088842-207099993 "Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 156.5" "Group enriched" "Detected in some" 18 "CACO-2: 38.3;HeLa: 15.9;Hep G2: 49.8" "Cancer enriched" "Detected in many" 19 "liver cancer: 83.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.5;plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 16 "dendritic cells: 3.6;T-cells: 2.5" "Low region specificity" "Detected in all" HPA051620 Approved "Secreted to blood" 265000000000 1300000000 "HPA051620: " "unprognostic (1.73e-1)" "unprognostic (2.62e-1)" "unprognostic (3.26e-1)" "unprognostic (2.07e-3)" "unprognostic (1.72e-1)" "unprognostic (2.54e-2)" "unprognostic (4.58e-3)" "unprognostic (9.49e-2)" "unprognostic (1.37e-1)" "unprognostic (4.25e-1)" "unprognostic (6.39e-2)" "unprognostic (2.64e-2)" "unprognostic (1.21e-2)" "unprognostic (1.55e-1)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (8.25e-2)" 0.5 0.0 0.1 0.5 0.1 0.0 0.3 0.1 0.1 0.5 2.0 0.1 0.1 0.6 0.1 0.9 0.2 0.1 1.0 0.6 0.1 0.0 0.2 156.5 0.6 0.1 0.1 0.1 9.9 2.2 0.0 0.1 1.3 0.1 0.3 0.3 0.1 0.2 0.1 0.2 0.0 0.9 0.2 0.1 0.1 1.5 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 3.6 0.0 0.0 0.0 2.5 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.3 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 49.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.5 0.8 0.0 0.0 0.0 3.6 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 C4orf17 DKFZP434G072 ENSG00000138813 "Chromosome 4 open reading frame 17" Q53FE4 4 99511004-99542303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 115 "testis: 31.8" "Cell line enhanced" "Detected in single" "HHSteC: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA060374, HPA060564" Uncertain "HPA060374: , HPA060564: " "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C4orf45 FLJ25371 ENSG00000164123 "Chromosome 4 open reading frame 45" Q96LM5 4 158893134-159038760 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 16.1" "Cell line enhanced" "Detected in some" "HMC-1: 1.7;U-2197: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (1.64e-1)" "unprognostic (1.14e-1)" "unprognostic (2.13e-1)" "unprognostic (9.87e-2)" "unprognostic (5.71e-2)" "unprognostic (2.55e-1)" "unprognostic (2.17e-1)" "unprognostic (7.82e-2)" "unprognostic (1.21e-1)" "unprognostic (3.09e-1)" "unprognostic (5.45e-2)" 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.2 0.3 0.2 0.3 0.0 0.3 0.0 0.4 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 C4orf50 FLJ46481 ENSG00000181215 "Chromosome 4 open reading frame 50" Q6ZRC1 4 5897373-6018507 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "brain: 6.0" "Cell line enriched" "Detected in some" 4 "RPMI-8226: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (7.02e-3)" "unprognostic (6.55e-3)" "unprognostic (2.35e-1)" "unprognostic (1.09e-1)" "unprognostic (1.19e-1)" "unprognostic (6.64e-3)" "unprognostic (1.11e-1)" "unprognostic (4.35e-2)" "unprognostic (9.94e-5)" "unprognostic (4.31e-2)" "unprognostic (4.86e-3)" "unprognostic (2.61e-1)" "unprognostic (2.88e-6)" "unprognostic (3.29e-1)" "unprognostic (2.23e-1)" "unprognostic (2.47e-2)" "unprognostic (4.68e-2)" 0.0 0.5 1.0 0.2 6.0 0.2 0.0 0.0 4.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.2 1.7 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.9 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 C4orf51 ENSG00000237136 "Chromosome 4 open reading frame 51" C9J302 4 145680115-145771032 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 12 "testis: 10.8" "Cell line enhanced" "Detected in some" "BJ: 1.0;CAPAN-2: 1.2" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.37e-2)" "unprognostic (1.44e-1)" "unprognostic (1.03e-1)" "unprognostic (1.93e-2)" "unprognostic (4.37e-1)" "unprognostic (1.32e-1)" "unprognostic (2.19e-3)" "unprognostic (8.13e-2)" "unprognostic (2.16e-1)" "unprognostic (3.97e-2)" "unprognostic (1.39e-1)" "unprognostic (1.48e-1)" "unprognostic (1.98e-1)" "unprognostic (6.07e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C5 "C5a, C5b, CPAMD4" ENSG00000106804 "Complement C5" P01031 9 120952335-121050276 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 55 "liver: 259.9" "Cell line enhanced" "Detected in many" "A549: 20.1;Hep G2: 21.1" "Cancer enriched" "Detected in many" 17 "liver cancer: 73.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA029339 Supported "Secreted to blood" 113184500000 46000000000 "HPA029339: AB_10601125" "unprognostic (2.51e-1)" "unprognostic (5.88e-3)" "unprognostic (2.50e-3)" "unprognostic (1.57e-2)" "unprognostic (5.05e-2)" "unprognostic (9.52e-3)" "prognostic favourable (9.43e-4)" "unprognostic (1.83e-1)" "unprognostic (3.19e-2)" "unprognostic (1.55e-1)" "unprognostic (2.35e-2)" "unprognostic (4.41e-2)" "unprognostic (1.46e-5)" "unprognostic (5.91e-2)" "unprognostic (1.20e-1)" "unprognostic (3.67e-2)" "unprognostic (2.75e-1)" 0.5 0.3 0.4 0.3 0.5 0.3 0.4 0.3 0.3 0.4 1.1 0.3 0.3 0.7 0.5 0.7 0.3 0.6 0.4 0.3 0.4 0.3 1.1 259.9 2.3 0.3 0.4 0.3 0.7 4.7 0.8 0.7 0.3 0.4 0.6 0.2 0.3 0.3 0.4 0.3 0.7 3.2 0.3 0.5 0.3 1.2 0.4 0.3 0.3 0.3 0.3 0.3 0.5 0.4 1.8 2.1 1.8 1.6 0.1 1.2 0.5 1.1 20.1 4.6 8.1 6.0 6.9 0.2 2.4 2.5 0.7 1.4 0.6 1.9 2.9 0.1 1.2 7.9 0.2 0.2 1.1 0.6 0.0 1.2 1.0 21.1 1.1 0.7 0.5 3.1 0.4 1.4 2.7 0.7 0.5 2.8 1.5 3.9 0.3 0.1 1.2 7.8 1.7 2.0 0.3 1.2 0.6 1.2 4.8 1.1 0.0 2.0 1.6 2.6 0.9 2.0 0.1 5.4 2.4 1.6 1.2 1.2 1.6 2.7 4.9 0.0 1.6 1.8 0.3 0.4 1.2 1.8 0.6 0.5 2.1 1.0 0.5 0.3 0.1 0.1 0.1 0.1 0.1 0.5 0.4 0.5 0.3 0.3 0.4 0.3 0.4 0.3 0.4 0.3 C5orf47 LOC133491 ENSG00000185056 "Chromosome 5 open reading frame 47" Q569G3 5 173973779-174006140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 241 "testis: 70.1" "Cell line enriched" "Detected in single" 7 "U-266/84: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (7.54e-2)" "unprognostic (4.81e-3)" "unprognostic (3.81e-1)" "unprognostic (1.64e-2)" "unprognostic (1.31e-2)" "unprognostic (3.94e-1)" "unprognostic (8.72e-3)" "unprognostic (2.00e-2)" "unprognostic (2.82e-1)" "unprognostic (4.09e-2)" "unprognostic (3.03e-3)" "unprognostic (2.59e-1)" "unprognostic (2.63e-1)" "unprognostic (2.99e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 C5orf52 ENSG00000187658 "Chromosome 5 open reading frame 52" A6NGY3 5 157671553-157680143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 45.2" "Cell line enhanced" "Detected in single" "PC-3: 1.7" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.20e-2)" "unprognostic (1.01e-1)" "unprognostic (2.73e-2)" "unprognostic (3.50e-1)" "unprognostic (3.64e-1)" "unprognostic (1.32e-1)" 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.4 0.0 1.9 0.0 0.0 0.7 0.0 0.9 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.1 0.0 C5orf58 ENSG00000234511 "Chromosome 5 open reading frame 58" C9J3I9 5 170232447-170252575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 78.5" "Cell line enriched" "Detected in some" 11 "U-266/84: 36.8" "Cancer enhanced" "Detected in single" "testis cancer: 1.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "unprognostic (9.24e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-2)" "unprognostic (5.55e-2)" "unprognostic (2.92e-1)" "unprognostic (1.35e-1)" "unprognostic (5.33e-6)" "unprognostic (1.01e-1)" "unprognostic (5.61e-2)" "unprognostic (8.48e-2)" "unprognostic (1.85e-1)" "unprognostic (2.78e-1)" "unprognostic (3.29e-10)" "unprognostic (4.83e-3)" "unprognostic (5.45e-2)" "unprognostic (3.94e-2)" "unprognostic (8.27e-2)" 0.4 0.2 0.1 0.9 0.1 2.0 0.2 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.1 0.5 0.2 0.0 0.4 0.1 0.1 0.0 0.1 0.1 1.3 0.7 0.1 0.1 0.2 0.1 0.0 0.1 0.3 0.3 0.4 0.0 0.3 0.1 0.1 0.2 0.0 0.3 0.1 0.4 1.0 0.0 78.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.3 1.1 2.0 3.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 2.1 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.4 0.0 0.0 0.0 0.0 0.0 1.3 36.8 0.0 0.0 0.5 0.0 0.0 0.8 1.5 2.3 0.9 1.2 0.0 1.3 2.0 0.1 0.1 1.3 3.1 3.3 2.0 1.1 0.0 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.3 0.1 C6 ENSG00000039537 "Complement C6" P13671 5 41142234-41261438 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" "Complement pathway, Cytolysis, Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 176.1" "Group enriched" "Detected in some" 13 "ASC diff: 5.1;ASC TERT1: 7.1;HSkMC: 18.8" "Group enriched" "Detected in many" 7 "liver cancer: 49.0;pancreatic cancer: 12.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA043823, CAB069427" Enhanced "Secreted to blood" 7600000000 "CAB069427: AB_1614336, HPA043823: AB_10960262" "unprognostic (9.79e-2)" "unprognostic (1.96e-2)" "unprognostic (5.94e-3)" "unprognostic (3.02e-2)" "unprognostic (1.67e-1)" "unprognostic (1.18e-1)" "unprognostic (1.12e-3)" "unprognostic (4.66e-2)" "unprognostic (3.72e-2)" "unprognostic (1.53e-1)" "unprognostic (2.34e-1)" "unprognostic (3.04e-3)" "prognostic favourable (4.31e-4)" "unprognostic (2.69e-4)" "unprognostic (1.61e-1)" "unprognostic (1.40e-2)" "unprognostic (3.51e-2)" 2.3 0.1 0.2 0.1 0.2 0.0 1.0 0.1 0.2 0.3 0.5 0.5 0.1 0.1 0.2 2.7 0.3 8.8 2.4 24.1 0.2 0.0 5.2 176.1 0.9 0.8 0.1 0.1 3.2 10.1 0.0 0.4 0.4 0.6 0.2 0.0 0.2 0.1 0.1 0.2 0.0 0.8 0.1 0.2 0.1 0.4 1.7 0.1 0.1 0.4 0.7 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 7.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 18.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.6 0.1 C6orf10 TSBP ENSG00000204296 "Chromosome 6 open reading frame 10" Q5SRN2 6 32288526-32371912 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 28.6" "Cell line enhanced" "Detected in single" "U-2197: 1.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.00e-1)" "unprognostic (2.24e-1)" "unprognostic (1.05e-1)" "unprognostic (5.63e-2)" "unprognostic (2.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.55e-1)" "unprognostic (4.32e-4)" "unprognostic (2.42e-1)" "unprognostic (8.19e-2)" "unprognostic (6.56e-2)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C6orf163 ENSG00000203872 "Chromosome 6 open reading frame 163" Q5TEZ5 6 87344849-87365463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 20.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 4 "basal ganglia: 1.4" "Low region specificity" "Detected in all" "HPA044797, HPA052927" Uncertain Uncertain Nucleoplasm Nucleoplasm "HPA044797: AB_10962365, HPA052927: " "unprognostic (4.98e-2)" "unprognostic (6.42e-2)" "unprognostic (1.65e-1)" "unprognostic (2.33e-2)" "unprognostic (4.18e-2)" "unprognostic (3.49e-2)" "unprognostic (7.55e-3)" "unprognostic (3.96e-3)" "unprognostic (1.37e-1)" "unprognostic (1.95e-2)" "unprognostic (5.60e-4)" "unprognostic (6.66e-2)" "unprognostic (3.77e-3)" "unprognostic (1.46e-1)" "unprognostic (1.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.42e-2)" 0.7 0.8 0.5 0.5 4.3 3.2 1.3 0.7 1.0 0.8 0.8 1.5 0.5 0.0 1.4 3.0 0.5 2.3 0.5 1.0 0.9 0.4 0.6 0.9 1.7 0.9 0.5 0.5 3.3 1.1 1.7 1.8 0.5 4.6 1.2 1.2 0.5 1.2 0.5 1.5 2.4 1.1 0.5 0.5 1.7 0.8 20.2 1.2 0.5 1.1 0.5 0.8 0.6 0.6 1.4 0.7 3.4 0.9 1.2 1.8 0.4 0.2 0.6 3.0 4.5 0.5 3.3 3.6 0.0 0.0 0.6 1.0 1.3 0.9 1.8 0.5 0.4 0.8 1.2 2.6 0.0 1.6 1.8 2.3 1.0 1.0 0.0 1.1 0.6 1.6 1.5 0.8 0.8 0.5 3.5 1.6 0.4 0.7 0.3 1.5 0.7 0.2 3.9 1.0 0.1 1.9 2.9 2.3 1.2 0.3 0.5 1.2 0.6 1.3 1.0 1.8 1.4 0.9 1.4 0.5 0.8 0.3 0.2 2.1 1.1 0.5 0.7 0.3 1.8 0.4 0.9 1.3 1.8 1.2 0.7 1.4 1.7 1.8 3.4 1.2 0.9 0.4 1.0 0.4 0.5 4.3 0.7 1.0 0.9 0.4 0.5 0.5 4.6 1.2 C6orf201 dJ1013A10.5 ENSG00000185689 "Chromosome 6 open reading frame 201" Q7Z4U5 6 4079206-4130951 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 46 "testis: 27.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.51e-1)" "unprognostic (9.19e-2)" "unprognostic (1.11e-2)" "unprognostic (3.87e-1)" "unprognostic (3.91e-2)" "unprognostic (4.85e-3)" "unprognostic (1.22e-3)" "unprognostic (2.69e-3)" "unprognostic (3.47e-1)" "unprognostic (4.48e-2)" "unprognostic (1.29e-1)" "unprognostic (9.86e-2)" "unprognostic (4.72e-3)" "unprognostic (3.35e-1)" "unprognostic (1.96e-1)" "unprognostic (5.37e-2)" "unprognostic (3.08e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C6orf222 DKFZp779B1540 ENSG00000189325 "Chromosome 6 open reading frame 222" P0C671 6 36315757-36336885 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 46.7" "Group enriched" "Detected in some" 4 "CACO-2: 3.1;Daudi: 3.4;REH: 3.3;RT4: 1.6;U-937: 3.6" "Group enriched" "Detected in some" 19 "colorectal cancer: 8.7;pancreatic cancer: 5.1;stomach cancer: 8.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA038407, HPA058189" Uncertain "HPA038407: AB_10669644, HPA058189: " "unprognostic (1.97e-5)" "unprognostic (5.46e-3)" "unprognostic (3.93e-1)" "unprognostic (1.49e-1)" "unprognostic (7.52e-2)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (4.13e-1)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" "unprognostic (6.75e-2)" "unprognostic (3.04e-2)" "unprognostic (4.55e-2)" "unprognostic (3.16e-2)" "unprognostic (3.98e-1)" "unprognostic (1.66e-4)" 0.1 0.0 0.1 0.7 0.1 0.0 0.1 0.1 0.2 0.1 14.0 0.1 0.1 19.8 0.1 0.1 0.1 0.0 1.2 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.1 4.7 0.0 0.1 0.1 0.1 0.1 4.6 0.1 0.1 0.1 0.1 0.2 46.7 0.1 0.1 0.1 5.8 1.4 0.1 0.3 0.1 0.1 0.1 0.1 0.1 1.3 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.6 0.0 1.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 1.3 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 C7orf31 ENSG00000153790 "Chromosome 7 open reading frame 31" Q8N865 7 25134697-25180356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 60.9" "Cell line enhanced" "Detected in many" "U-266/70: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA020346 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA020346: AB_1845758" "unprognostic (3.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (6.90e-3)" "prognostic unfavourable (1.81e-4)" "unprognostic (1.19e-1)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (2.90e-1)" "unprognostic (1.06e-1)" "unprognostic (3.12e-3)" "unprognostic (8.26e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.15e-2)" 2.4 6.2 1.5 4.8 3.1 1.3 2.3 4.0 1.6 3.3 5.1 2.9 2.0 3.3 3.3 2.9 2.4 2.6 3.7 3.1 1.9 1.5 2.6 1.2 2.8 7.0 2.0 2.2 4.6 1.8 4.3 2.1 1.1 2.3 3.2 3.6 4.1 6.0 2.3 0.9 1.8 3.9 2.4 2.9 3.7 3.4 60.9 2.4 5.9 4.6 0.9 3.3 3.5 5.1 3.0 5.9 2.3 1.3 2.8 2.8 0.9 2.9 2.1 4.7 5.3 1.8 1.0 2.6 1.2 5.1 3.8 5.8 4.0 2.8 7.4 1.9 2.3 1.2 5.2 1.4 4.1 3.5 5.0 3.5 0.2 5.4 4.4 5.6 8.5 3.2 4.0 3.1 0.7 0.7 5.2 4.1 1.0 0.0 5.7 7.2 1.9 1.9 7.2 5.4 1.1 2.6 3.7 1.4 3.9 1.2 5.0 4.8 0.8 9.5 1.0 2.4 6.4 0.0 1.8 18.5 5.9 10.6 0.7 5.4 10.8 1.4 1.3 2.3 1.7 0.6 2.3 3.0 1.1 1.5 1.7 2.1 2.8 2.2 0.1 2.8 0.8 5.9 2.8 0.9 1.5 3.1 4.0 1.6 1.9 1.5 2.0 2.2 2.3 2.4 C7orf61 IMAGE:4839025 ENSG00000185955 "Chromosome 7 open reading frame 61" Q8IZ16 7 100456615-100464271 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 80.4" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 21.7;NB-4: 8.0;TIME: 12.7" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA060395 Enhanced Approved Vesicles Vesicles "HPA060395: " "unprognostic (1.88e-1)" "unprognostic (5.02e-1)" "unprognostic (1.26e-2)" "unprognostic (7.70e-5)" "unprognostic (1.65e-1)" "unprognostic (2.63e-2)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (4.26e-1)" "unprognostic (2.25e-1)" "unprognostic (4.43e-2)" "unprognostic (2.53e-1)" "unprognostic (6.39e-13)" "unprognostic (9.54e-2)" "unprognostic (2.93e-1)" "unprognostic (1.33e-2)" "unprognostic (1.24e-2)" 0.5 0.3 2.8 0.6 3.1 1.2 0.5 1.4 3.4 0.5 0.5 0.5 0.5 0.1 0.8 0.8 0.5 0.7 0.6 0.5 3.0 2.3 0.5 0.5 0.5 0.8 3.2 0.5 1.0 0.5 0.4 0.9 0.6 0.6 0.5 0.2 0.5 0.5 0.7 0.5 0.7 0.5 0.5 3.1 1.0 0.1 80.4 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.1 0.6 1.3 1.2 0.8 2.9 0.2 0.8 0.2 0.7 0.8 0.8 1.9 0.3 0.3 1.3 0.2 0.7 0.9 0.4 0.6 1.4 0.7 0.5 0.3 0.0 0.5 0.8 1.4 1.2 1.6 0.0 1.0 0.4 0.3 0.3 0.3 0.8 1.2 21.7 0.6 1.1 1.2 2.0 0.4 8.0 0.5 0.9 2.1 0.0 0.4 0.3 0.3 0.0 0.0 0.5 0.7 1.3 0.3 2.2 12.7 1.1 1.9 2.4 0.3 0.3 0.2 0.8 0.2 1.9 0.1 0.0 1.2 0.0 0.8 0.7 0.3 0.0 1.1 0.6 0.6 0.1 0.1 1.6 1.3 0.8 0.4 0.0 2.9 0.2 2.8 3.1 1.4 1.5 3.0 2.3 3.2 0.5 0.6 0.5 C8A ENSG00000157131 "Complement C8 alpha chain" P07357 1 56854806-56918221 "Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 305 "liver: 210.3" "Cell line enriched" "Detected in some" 5 "Hep G2: 5.4" "Cancer enriched" "Detected in single" 279 "liver cancer: 85.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "Secreted to blood" 3400000000 "unprognostic (3.73e-3)" "unprognostic (2.44e-1)" "unprognostic (1.28e-1)" "unprognostic (6.40e-2)" "unprognostic (9.82e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 210.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C8B ENSG00000021852 "Complement C8 beta chain" P07358 1 56929210-56966140 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 52 "liver: 240.9" "Cell line enriched" "Detected in some" 5 "Hep G2: 5.7" "Cancer enriched" "Detected in some" 181 "liver cancer: 107.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 47 "basophil: 4.6" "Lineage enriched" "Detected in single" 47 "granulocytes: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA023694 Supported "Secreted to blood" 3600000000 "HPA023694: AB_1847128" "unprognostic (6.65e-2)" "prognostic favourable (9.31e-5)" "unprognostic (2.37e-1)" "unprognostic (2.37e-1)" "unprognostic (1.29e-2)" "unprognostic (6.57e-2)" "unprognostic (5.12e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 240.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 5.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C8G ENSG00000176919 "Complement C8 gamma chain" P07360 9 136945246-136946974 "Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 165.8" "Cell line enriched" "Detected in some" 13 "HMC-1: 59.5" "Cancer enriched" "Detected in all" 58 "liver cancer: 260.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 3.4" "Group enriched" "Detected in many" 18 "dendritic cells: 1.5;T-cells: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA046269 Approved "Secreted to blood" 1500000000 "HPA046269: " "unprognostic (5.00e-2)" "unprognostic (4.05e-3)" "prognostic unfavourable (2.99e-4)" "unprognostic (3.94e-1)" "unprognostic (4.53e-1)" "unprognostic (2.75e-2)" "unprognostic (1.71e-3)" "unprognostic (2.79e-1)" "unprognostic (1.88e-1)" "unprognostic (3.67e-1)" "unprognostic (2.96e-2)" "unprognostic (3.00e-1)" "unprognostic (5.02e-3)" "unprognostic (2.16e-1)" "unprognostic (7.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.05e-2)" 0.2 0.7 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 6.0 0.2 0.2 14.6 0.2 0.2 0.2 0.2 2.7 0.2 0.2 0.1 0.4 165.8 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.8 0.3 12.1 0.2 0.2 0.6 0.6 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 1.5 0.0 0.1 0.0 3.4 0.3 0.1 0.8 0.1 0.2 0.1 0.0 0.6 0.3 0.0 0.0 0.0 1.1 0.6 1.1 0.7 0.0 0.9 0.0 0.1 0.0 1.1 0.1 0.3 1.6 4.5 0.0 0.0 59.5 0.0 0.2 0.2 0.0 0.2 0.1 0.6 0.2 0.8 0.1 0.5 0.0 0.2 0.1 0.2 0.8 0.2 0.5 0.2 0.2 0.2 1.7 0.3 1.5 0.4 0.6 0.3 0.1 0.1 0.2 0.3 0.5 0.0 0.2 0.5 0.2 0.0 0.1 0.0 3.4 0.0 0.4 0.0 0.7 1.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 1.5 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 C8orf46 MGC33510 ENSG00000169085 "Chromosome 8 open reading frame 46" Q8TAG6 8 66460003-66518524 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 51.7" "Cell line enhanced" "Detected in some" "A-431: 3.2;CAPAN-2: 3.2;fHDF/TERT166: 3.2;LHCN-M2: 4.2;SK-MEL-30: 4.6;T-47d: 5.9;WM-115: 5.8" "Cancer enriched" "Detected in many" 6 "glioma: 16.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "amygdala: 164.2;basal ganglia: 80.3;cerebral cortex: 305.1;hippocampal formation: 240.3" "Low region specificity" "Detected in all" HPA075134 Approved "Nuclear speckles" "Nuclear speckles" "HPA075134: " "unprognostic (6.87e-2)" "unprognostic (7.85e-2)" "unprognostic (2.01e-1)" "unprognostic (8.36e-4)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (7.53e-4)" "unprognostic (7.87e-3)" "unprognostic (1.45e-1)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "unprognostic (1.82e-1)" "unprognostic (6.36e-3)" "unprognostic (3.53e-4)" "unprognostic (1.86e-1)" "unprognostic (4.98e-2)" "unprognostic (2.91e-2)" 1.2 1.4 14.9 1.2 16.6 1.2 1.2 1.8 51.7 1.6 1.2 16.3 0.0 1.0 1.6 1.3 1.5 1.2 1.7 2.2 39.1 8.3 1.3 1.2 1.4 1.4 13.8 19.4 1.1 1.8 1.1 0.2 1.1 10.9 2.2 1.3 0.0 1.7 5.3 3.1 1.4 1.4 2.0 17.9 1.2 1.1 1.4 10.0 0.0 1.3 0.0 1.1 1.5 0.2 0.0 0.7 0.0 0.0 0.0 0.7 0.1 3.2 0.2 0.5 2.1 0.0 0.1 0.0 0.3 0.4 0.5 0.1 0.0 3.2 0.0 0.3 3.2 0.1 0.0 0.0 2.3 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.2 4.2 0.5 0.0 0.0 0.2 0.2 0.0 0.5 0.0 1.3 0.1 0.5 0.0 0.0 0.0 4.6 5.9 0.0 0.0 0.4 0.7 0.2 2.8 0.1 1.2 0.0 1.2 0.1 5.8 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.9 16.6 1.8 26.7 39.1 8.3 13.8 19.4 10.9 10.0 C8orf74 ENSG00000171060 "Chromosome 8 open reading frame 74" Q6P047 8 10672637-10700593 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 30.2" "Cell line enhanced" "Detected in single" "A549: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027986 Uncertain Uncertain Nucleoplasm Nucleoplasm "HPA027986: AB_10600762" "unprognostic (4.24e-2)" "unprognostic (5.62e-2)" "unprognostic (4.68e-2)" "unprognostic (5.54e-2)" "unprognostic (2.37e-2)" "unprognostic (1.56e-4)" "unprognostic (6.82e-2)" "unprognostic (2.20e-2)" 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.6 0.6 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 1.4 0.0 0.1 0.0 0.2 0.1 30.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.5 0.1 0.0 0.6 1.3 0.5 0.9 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.8 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.5 0.5 0.3 0.6 0.0 0.1 0.1 0.0 0.0 0.4 0.7 0.8 0.2 0.3 0.0 0.1 0.2 0.3 0.0 0.3 0.1 0.2 0.3 0.4 0.5 0.1 0.5 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C9 ENSG00000113600 "Complement C9" P02748 5 39284262-39424868 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Age-related macular degeneration, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 577 "liver: 419.5" "Cell line enhanced" "Detected in some" "HL-60: 2.5;RH-30: 1.6;SiHa: 1.0;U-698: 6.3" "Cancer enriched" "Detected in single" 244 "liver cancer: 90.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002151, HPA029577" Uncertain "Secreted to blood" 69605000000 97000000000 "CAB002151: AB_563670, HPA029577: AB_10603779" "unprognostic (1.00e-1)" "unprognostic (1.57e-1)" "unprognostic (1.50e-1)" "unprognostic (2.01e-1)" "unprognostic (6.58e-2)" "unprognostic (1.30e-1)" "unprognostic (2.91e-1)" "unprognostic (5.49e-3)" "unprognostic (1.91e-2)" "unprognostic (1.29e-2)" "unprognostic (2.19e-2)" "unprognostic (9.43e-5)" "unprognostic (1.36e-1)" "unprognostic (1.80e-1)" "unprognostic (2.04e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 419.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C9orf131 MGC41945 ENSG00000174038 "Chromosome 9 open reading frame 131" Q5VYM1 9 35041095-35045991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 46.6" "Cell line enhanced" "Detected in some" "HeLa: 3.9;RT4: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA022029 Approved Mitochondria Mitochondria "HPA022029: AB_10960628" "unprognostic (1.10e-2)" "unprognostic (8.99e-2)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (1.91e-1)" "unprognostic (1.23e-3)" "unprognostic (2.47e-1)" "unprognostic (6.57e-2)" "unprognostic (3.66e-1)" "unprognostic (9.45e-2)" "unprognostic (4.63e-2)" "unprognostic (1.75e-2)" "unprognostic (2.37e-2)" "unprognostic (9.34e-2)" "unprognostic (1.82e-1)" "unprognostic (9.90e-4)" "unprognostic (4.19e-3)" 0.2 0.1 0.2 0.2 0.3 1.3 0.3 0.6 0.3 1.0 0.2 0.2 0.2 0.0 2.2 0.8 0.2 0.2 1.4 0.2 0.2 0.2 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.3 0.7 0.2 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.8 0.5 0.2 0.2 0.2 0.2 0.2 46.6 0.2 0.2 0.3 0.2 0.2 0.3 0.2 1.0 0.1 2.7 0.5 0.9 1.4 0.0 3.3 0.1 0.3 0.8 0.7 0.0 1.0 1.0 0.0 0.0 0.0 0.9 1.8 0.7 0.3 0.0 2.1 0.0 0.0 0.4 0.3 0.5 1.2 3.9 0.9 0.0 0.4 1.2 0.0 0.5 0.0 0.0 0.4 3.3 2.4 0.0 0.5 0.7 1.8 0.6 0.0 0.0 0.3 0.0 0.3 13.7 0.3 0.0 1.2 0.0 0.5 0.7 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.9 1.3 0.3 0.5 1.5 2.7 0.5 0.0 0.5 0.0 0.0 0.5 0.4 1.4 0.0 1.0 0.5 0.8 1.3 0.9 0.0 0.1 0.1 0.0 0.2 0.3 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 C9orf153 bA507D14.1 ENSG00000187753 "Chromosome 9 open reading frame 153" Q5TBE3 9 86220265-86259657 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 24.5" "Cell line enhanced" "Detected in many" "hTCEpi: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "unprognostic (2.03e-1)" "unprognostic (1.79e-1)" "unprognostic (1.13e-2)" "unprognostic (2.33e-2)" "unprognostic (1.78e-1)" "unprognostic (5.30e-3)" "unprognostic (7.49e-2)" "unprognostic (2.75e-2)" "unprognostic (3.37e-1)" "unprognostic (6.85e-2)" "unprognostic (9.70e-2)" "unprognostic (1.49e-1)" "unprognostic (2.01e-6)" "unprognostic (9.43e-2)" "unprognostic (1.92e-1)" "unprognostic (9.64e-2)" "unprognostic (2.10e-1)" 0.1 0.2 0.1 0.1 0.1 2.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.1 0.1 0.1 0.0 0.6 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 24.5 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.4 0.5 0.6 0.2 0.8 1.1 0.0 0.6 2.2 0.0 1.2 0.1 1.3 1.6 1.2 0.0 0.0 0.8 0.0 2.5 2.4 0.9 2.3 0.5 1.2 2.0 1.6 0.6 1.0 0.1 2.8 0.4 0.1 0.4 1.1 0.3 4.5 1.5 0.0 1.0 0.0 1.9 1.7 0.1 0.8 0.4 0.7 1.6 0.4 0.8 3.0 0.3 0.0 0.3 0.1 0.0 0.0 0.4 0.0 0.6 0.2 0.9 2.1 0.2 0.8 2.0 0.3 0.7 0.1 0.5 1.0 0.6 0.2 0.1 1.1 0.0 0.4 0.2 0.1 0.0 0.0 0.4 0.8 0.3 0.0 0.8 0.0 0.5 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 C9orf43 MGC17358 ENSG00000157653 "Chromosome 9 open reading frame 43" Q8TAL5 9 113410054-113429684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 39.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA021310 Approved Cytosol Cytosol "HPA021310: AB_1845825" "unprognostic (2.91e-2)" "unprognostic (9.63e-2)" "unprognostic (2.19e-1)" "unprognostic (1.18e-1)" "unprognostic (2.63e-1)" "unprognostic (6.58e-3)" "unprognostic (2.06e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (8.90e-2)" "unprognostic (1.97e-2)" "unprognostic (5.96e-3)" "unprognostic (1.51e-1)" "unprognostic (7.32e-2)" "unprognostic (1.33e-1)" "unprognostic (3.21e-2)" "unprognostic (1.63e-1)" 0.5 1.6 1.5 0.4 2.4 1.8 1.3 2.1 2.3 0.5 0.4 1.6 0.2 0.4 0.4 1.6 0.5 0.9 0.6 0.4 1.4 0.8 1.0 1.7 0.5 0.6 0.8 1.9 1.0 3.5 1.3 3.8 0.5 1.6 0.7 0.5 1.0 0.9 0.7 0.4 0.8 0.5 0.3 1.8 0.6 0.6 39.4 1.0 0.6 1.0 0.0 0.6 0.5 0.5 1.5 1.3 2.3 1.5 1.0 2.1 0.8 1.2 1.2 0.6 1.9 1.5 0.8 0.9 0.6 1.1 1.8 1.3 1.3 1.1 3.3 1.1 0.3 2.5 0.7 1.7 0.7 2.7 0.5 2.9 2.1 0.6 1.3 0.5 0.4 1.9 2.6 2.2 2.6 1.5 1.8 3.1 0.9 2.4 1.4 0.8 0.9 4.0 0.8 0.7 1.9 1.8 0.6 3.1 0.7 3.1 1.4 1.7 4.1 0.3 0.2 2.6 0.6 1.7 2.6 2.0 3.6 5.0 1.4 1.1 0.9 0.0 0.7 0.0 1.5 1.5 0.0 1.5 0.8 2.1 0.8 0.8 1.4 2.1 2.3 1.0 0.3 1.3 0.1 0.8 1.5 2.4 2.1 2.3 1.4 0.8 0.8 1.9 1.6 1.0 C9orf57 ENSG00000204669 "Chromosome 9 open reading frame 57" Q5W0N0 9 72051376-72072721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 114 "testis: 31.4" "Cell line enriched" "Detected in single" 7 "Daudi: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.26e-2)" "unprognostic (1.15e-1)" "unprognostic (5.05e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C9orf84 FLJ32779 ENSG00000165181 "Chromosome 9 open reading frame 84" Q5VXU9 9 111686173-111795008 "Predicted intracellular proteins, Predicted membrane proteins" Meiosis "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 33.0" "Cell line enriched" "Detected in some" 5 "U-2 OS: 21.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 15 "granulocytes: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA032108 Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA032108: AB_10669884" "unprognostic (2.63e-1)" "unprognostic (1.83e-4)" "unprognostic (9.12e-2)" "unprognostic (3.17e-1)" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (9.05e-2)" "unprognostic (5.02e-2)" "unprognostic (6.22e-2)" "unprognostic (1.65e-1)" "unprognostic (8.14e-2)" "unprognostic (2.30e-1)" "unprognostic (8.33e-5)" "unprognostic (6.93e-2)" "unprognostic (2.84e-1)" "unprognostic (3.77e-1)" "unprognostic (7.31e-2)" 0.1 2.9 0.1 0.5 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.7 0.0 0.3 0.6 0.2 0.0 0.1 0.1 0.1 0.0 2.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 1.1 33.0 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.2 0.2 4.1 0.0 0.1 0.2 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 4.7 1.1 0.4 0.0 0.2 0.0 0.0 21.9 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 4.1 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CA3 "CAIII, Car3" ENSG00000164879 "Carbonic anhydrase 3" P07451 8 85373436-85449040 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "skeletal muscle: 347.5" "Group enriched" "Detected in some" 32 "HEL: 23.3;RH-30: 39.2" "Group enriched" "Detected in many" 7 "glioma: 23.1;prostate cancer: 9.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB004967, HPA021775, HPA026700" Enhanced 31000000 "CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991" "prognostic favourable (4.24e-6)" "unprognostic (1.40e-1)" "unprognostic (1.50e-2)" "unprognostic (2.22e-3)" "unprognostic (4.71e-2)" "unprognostic (8.43e-3)" "unprognostic (3.56e-2)" "unprognostic (4.04e-2)" "unprognostic (1.11e-1)" "unprognostic (3.68e-1)" "unprognostic (4.71e-2)" "unprognostic (3.54e-1)" "unprognostic (3.19e-2)" "unprognostic (1.18e-1)" "unprognostic (9.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.19e-1)" 18.0 0.4 0.2 0.1 0.2 0.5 0.6 0.2 0.1 0.5 0.3 0.0 0.1 0.1 0.6 29.0 9.5 1.0 0.2 1.3 0.2 0.1 0.2 0.2 4.1 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 6.6 0.0 0.0 5.5 0.2 347.5 0.3 0.4 1.4 0.1 0.1 0.3 0.5 0.0 0.0 0.3 14.1 3.4 0.7 0.5 0.5 1.8 0.0 0.0 0.0 0.8 0.2 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 23.3 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 CA5A "CA5, CAV, CAVA" ENSG00000174990 "Carbonic anhydrase 5A" P35218 16 87881546-87936529 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 26.4" "Cell line enhanced" "Detected in some" "Hep G2: 6.7" "Cancer enriched" "Detected in single" 26 "liver cancer: 2.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (1.91e-1)" "unprognostic (8.64e-3)" "unprognostic (3.36e-2)" "unprognostic (6.11e-2)" "unprognostic (2.49e-2)" "unprognostic (2.96e-1)" "unprognostic (8.39e-3)" "unprognostic (3.50e-3)" "unprognostic (1.42e-2)" "unprognostic (1.12e-1)" "unprognostic (6.55e-2)" "unprognostic (4.23e-2)" "unprognostic (7.99e-3)" "unprognostic (1.77e-1)" "unprognostic (5.03e-3)" "unprognostic (3.37e-2)" "unprognostic (2.76e-2)" 0.0 0.0 0.3 0.8 0.4 2.7 0.0 0.1 0.7 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.4 0.3 0.0 26.4 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.7 0.1 0.0 0.3 0.8 0.0 0.3 0.1 0.0 0.0 0.0 1.9 1.6 4.7 1.1 1.9 1.1 0.4 0.2 0.3 0.3 0.7 0.1 0.0 0.5 0.4 0.1 0.0 0.1 0.5 0.6 0.6 0.2 0.2 0.5 0.2 0.2 0.1 0.4 0.3 0.4 1.1 6.7 0.0 0.4 1.7 0.7 0.0 0.2 0.4 0.3 0.4 1.6 0.1 0.5 0.2 1.0 0.5 0.6 0.4 0.4 0.2 0.2 0.5 0.4 0.2 0.2 0.3 0.1 0.6 0.3 0.4 0.8 0.2 0.5 0.3 0.7 0.4 0.4 0.5 0.9 0.4 4.1 1.1 1.0 0.8 0.7 0.8 0.9 0.8 0.6 0.3 1.9 1.1 1.1 4.7 1.9 0.7 1.6 0.5 0.4 CA6 ENSG00000131686 "Carbonic anhydrase 6" P23280 1 8945867-8975092 "Enzymes, Predicted secreted proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 50 "salivary gland: 1237.9" "Cell line enhanced" "Detected in many" "Daudi: 5.3;U-2197: 4.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 15.4" "Lineage enriched" "Detected in many" 10 "T-cells: 15.4" "Low region specificity" "Detected in all" "HPA028550, HPA028692" Enhanced "Secreted to digestive system" 34000000 "HPA028550: AB_10600105, HPA028692: AB_10601883" "unprognostic (2.54e-5)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (2.37e-1)" "unprognostic (2.90e-1)" "unprognostic (9.28e-2)" "unprognostic (2.70e-3)" "unprognostic (1.24e-1)" "unprognostic (1.73e-1)" "unprognostic (5.93e-2)" "unprognostic (4.41e-2)" "unprognostic (4.29e-5)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "unprognostic (2.35e-1)" 0.3 0.0 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1237.9 0.0 0.1 24.9 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.6 0.4 1.5 0.3 0.4 15.4 1.6 1.1 0.5 0.9 1.8 0.3 0.3 1.4 0.9 0.1 0.2 0.6 1.0 1.5 5.3 0.6 0.5 1.5 0.4 0.1 0.8 0.6 0.6 0.8 1.9 1.0 0.4 2.0 1.9 0.0 1.0 0.9 0.1 0.6 0.7 3.3 0.1 0.8 1.0 1.5 1.1 0.7 1.4 0.6 0.3 0.2 1.0 1.0 0.9 0.2 0.9 0.3 1.4 0.8 0.3 2.7 1.4 4.6 1.2 1.4 0.5 1.7 0.6 1.8 1.3 1.1 0.3 0.2 0.4 0.2 0.4 0.3 0.8 2.8 0.0 0.6 5.6 15.4 1.5 0.4 0.2 0.4 0.3 1.6 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 CA7 ENSG00000168748 "Carbonic anhydrase 7" P43166 16 66844379-66854153 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 37.2" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;HAP1: 1.8;NTERA-2: 1.5;REH: 3.3;SCLC-21H: 2.7;THP-1: 5.5" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA047237 Uncertain "HPA047237: " "unprognostic (8.77e-4)" "unprognostic (5.23e-4)" "unprognostic (1.57e-1)" "unprognostic (1.96e-2)" "unprognostic (2.19e-1)" "unprognostic (2.16e-2)" "unprognostic (7.90e-2)" "unprognostic (1.59e-1)" "unprognostic (1.84e-2)" "unprognostic (9.62e-2)" "unprognostic (1.69e-2)" "unprognostic (7.12e-3)" "unprognostic (8.47e-2)" "unprognostic (5.20e-1)" "unprognostic (1.90e-2)" "unprognostic (6.46e-2)" 0.2 0.2 3.2 0.4 7.5 0.2 0.2 3.9 7.7 0.2 37.2 0.3 0.0 4.8 0.3 0.9 0.3 0.2 0.2 0.2 6.3 0.5 0.2 0.2 0.2 0.2 0.7 2.9 0.2 0.2 0.2 0.0 0.2 1.8 0.2 32.0 0.0 1.1 0.4 0.2 0.2 22.8 1.0 0.1 0.2 0.2 0.5 1.3 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.9 3.3 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 7.5 3.9 7.7 6.3 0.5 0.7 2.9 1.8 1.3 CABP1 ENSG00000157782 "Calcium binding protein 1" Q9NZU7 12 120640552-120667324 "Predicted intracellular proteins" "Sensory transduction, Vision" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 90.6" "Cell line enhanced" "Detected in some" "AF22: 3.9;NTERA-2: 9.1;RPTEC TERT1: 3.6;RT4: 5.2;SCLC-21H: 4.3;U-87 MG: 11.7" "Cancer enhanced" "Detected in some" "renal cancer: 2.2" "Region enhanced" "Detected in many" "cerebral cortex: 90.6" "Cell type enhanced" "Detected in single" "myeloid DC: 3.1" "Lineage enriched" "Detected in single" 6 "dendritic cells: 3.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 177.9" HPA051438 Uncertain "Intracellular and membrane" "HPA051438: " "unprognostic (2.57e-1)" "unprognostic (4.79e-2)" "unprognostic (1.92e-4)" "unprognostic (1.16e-1)" "unprognostic (4.13e-3)" "unprognostic (6.28e-2)" "unprognostic (4.61e-2)" "unprognostic (2.85e-1)" "unprognostic (8.12e-3)" "unprognostic (7.59e-2)" "unprognostic (1.04e-2)" "unprognostic (6.60e-2)" "unprognostic (7.73e-3)" "unprognostic (1.60e-1)" "unprognostic (1.82e-1)" "unprognostic (3.61e-2)" "unprognostic (2.85e-1)" 9.0 2.0 26.2 1.0 18.1 0.4 1.1 13.1 90.6 1.8 2.0 0.3 0.2 1.1 2.6 3.6 1.7 2.0 1.3 3.7 29.3 5.7 8.9 0.5 0.9 0.6 6.7 18.4 1.2 0.9 3.7 1.0 1.4 3.5 1.9 1.9 1.0 0.8 3.9 2.6 0.8 1.4 2.5 2.5 1.0 1.6 0.9 0.0 0.0 0.6 0.0 0.6 2.1 0.6 0.0 3.1 0.5 0.4 0.0 0.0 0.2 0.2 0.7 3.9 1.2 0.0 0.1 0.0 0.1 0.4 0.2 0.2 0.3 0.0 0.0 0.6 0.0 0.3 3.4 0.0 0.2 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.1 9.1 0.6 2.2 0.0 0.0 3.6 5.2 4.3 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 11.7 0.0 0.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.5 0.0 0.1 0.9 0.0 0.2 26.2 18.1 13.1 90.6 29.3 5.7 6.7 18.4 3.5 0.0 CABP2 DFNB93 ENSG00000167791 "Calcium binding protein 2" Q9NPB3 11 67518912-67524517 "Disease related genes, Predicted intracellular proteins" "Hearing, Sensory transduction, Vision" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 10.7" "Cell line enhanced" "Detected in single" "AF22: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 22 "cerebellum: 5.2" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CABP5 CaBP3 ENSG00000105507 "Calcium binding protein 5" Q9NP86 19 48029953-48044053 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 53.0" "Cell line enhanced" "Detected in single" "HBF TERT88: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 2.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA043698 Enhanced "HPA043698: AB_10797147" 0.0 0.1 0.1 0.0 0.2 2.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.2 0.2 0.2 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 53.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.2 0.0 0.4 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.4 9.9 0.1 0.2 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.0 CABS1 "C4orf35, CLPH, FLJ32897, NYD-SP26" ENSG00000145309 "Calcium binding protein, spermatid associated 1" Q96KC9 4 70334966-70337116 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 46 "testis: 75.3" "Cell line enriched" "Detected in single" 5 "NTERA-2: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044016, HPA055352" Enhanced "HPA044016: AB_10964494, HPA055352: AB_2682790" "unprognostic (1.36e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CABYR "CBP86, CT88, FSP-2" ENSG00000154040 "Calcium binding tyrosine phosphorylation regulated" O75952 18 24138956-24161603 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 91.1" "Cell line enhanced" "Detected in many" "SiHa: 18.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 6.3;memory B-cell: 6.6;naive B-cell: 7.1;neutrophil: 2.9" "Group enriched" "Detected in many" 5 "B-cells: 7.1;granulocytes: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040703, HPA047801" Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA040703: , HPA047801: " "unprognostic (1.18e-3)" "unprognostic (4.18e-1)" "unprognostic (1.73e-1)" "unprognostic (2.65e-1)" "unprognostic (5.26e-2)" "unprognostic (9.07e-3)" "prognostic unfavourable (4.75e-4)" "unprognostic (1.46e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-2)" "unprognostic (7.24e-3)" "unprognostic (1.58e-1)" "unprognostic (3.21e-4)" "unprognostic (2.52e-2)" "unprognostic (5.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 0.8 1.2 3.9 0.7 3.2 0.7 2.3 0.7 4.8 3.0 0.7 3.5 0.0 0.7 1.5 1.2 1.0 1.8 1.0 0.5 3.6 2.1 0.6 0.5 0.6 0.8 3.1 3.0 0.9 0.7 0.4 9.5 0.7 5.4 1.0 0.8 0.6 0.9 1.0 0.6 1.1 0.7 1.7 2.3 0.7 0.8 91.1 2.9 0.0 0.7 0.0 0.7 1.5 0.6 7.1 0.7 6.3 0.5 1.3 1.0 0.4 3.3 9.0 2.5 1.3 2.8 7.0 10.7 6.0 3.9 7.4 8.1 1.7 6.7 0.1 4.9 8.9 3.3 2.5 5.2 7.9 0.4 4.0 0.2 4.9 2.0 4.0 0.2 0.4 8.4 8.4 9.6 2.5 2.2 0.0 0.2 2.0 1.0 0.1 0.3 8.0 5.2 0.5 0.3 0.1 3.2 4.2 5.3 6.5 18.4 3.8 0.3 8.4 0.9 1.2 0.6 1.8 2.5 0.1 0.2 0.2 0.0 3.6 0.6 0.3 6.3 0.5 1.0 0.4 0.3 0.2 6.6 0.5 0.5 0.2 7.1 0.4 1.0 2.9 1.3 0.5 0.7 0.2 0.4 3.9 3.2 0.7 4.8 3.6 2.1 3.1 3.0 5.4 2.9 CACNA1A "APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6" ENSG00000141837 "Calcium voltage-gated channel subunit alpha1 A" O00555 19 13206442-13633025 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 77.9" "Group enriched" "Detected in some" 5 "SCLC-21H: 30.5;U-87 MG: 17.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 4 "cerebellum: 77.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064258, HPA071902" Enhanced Supported Uncertain "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA064258: , HPA071902: " "unprognostic (1.09e-1)" "unprognostic (3.73e-3)" "unprognostic (2.27e-1)" "unprognostic (2.78e-4)" "unprognostic (4.00e-2)" "unprognostic (2.29e-3)" "unprognostic (5.47e-2)" "unprognostic (3.13e-1)" "unprognostic (2.86e-1)" "unprognostic (1.14e-2)" "prognostic favourable (4.32e-4)" "unprognostic (5.31e-3)" "unprognostic (5.03e-6)" "unprognostic (6.29e-2)" "unprognostic (1.59e-1)" "unprognostic (2.61e-2)" "unprognostic (6.25e-2)" 2.2 5.3 7.6 1.0 12.2 0.7 0.9 77.9 19.7 0.8 1.5 1.8 0.0 3.9 1.2 2.8 0.7 2.2 0.8 1.1 5.7 5.1 0.7 0.5 0.7 1.3 3.9 7.3 1.1 3.0 0.7 1.5 0.6 7.2 0.8 1.7 1.2 0.9 0.8 1.3 0.7 2.8 0.9 3.3 1.3 7.7 1.9 2.8 0.0 0.7 0.0 1.0 0.8 0.3 2.8 0.8 1.9 1.1 0.8 0.8 0.4 0.0 0.1 0.0 3.8 0.1 0.3 0.0 1.6 1.5 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 2.0 0.0 1.2 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.1 0.9 0.2 0.4 0.0 0.1 0.0 0.1 30.5 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 17.2 0.0 0.4 1.9 0.4 0.7 0.5 0.5 0.8 2.8 0.5 0.3 0.4 1.7 0.6 0.7 1.6 0.8 1.1 0.8 0.6 0.4 7.6 12.2 77.9 17.4 5.7 5.1 3.9 7.3 7.2 2.8 CACNA1E "BII, CACH6, CACNL1A6, Cav2.3" ENSG00000198216 "Calcium voltage-gated channel subunit alpha1 E" Q15878 1 181317690-181808084 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 30.8" "Cell line enhanced" "Detected in some" "CACO-2: 4.0;NB-4: 2.5;NTERA-2: 2.9;SCLC-21H: 2.3;U-266/70: 7.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042515, CAB079032" Approved Approved "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane" "Actin filaments, Cytosol" "CAB079032: , HPA042515: " "unprognostic (3.96e-3)" "unprognostic (1.89e-1)" "unprognostic (1.05e-2)" "unprognostic (1.54e-5)" "unprognostic (6.56e-2)" "unprognostic (3.16e-2)" "unprognostic (4.30e-3)" "unprognostic (1.18e-1)" "unprognostic (2.40e-1)" "unprognostic (9.48e-3)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (9.85e-7)" "unprognostic (1.74e-2)" "unprognostic (2.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.75e-2)" 0.6 3.0 17.9 2.1 19.7 3.1 0.5 3.9 22.5 0.6 0.8 1.3 0.0 0.6 0.6 4.4 1.1 2.3 0.6 0.6 30.8 5.8 3.8 0.6 0.6 1.4 2.4 10.6 0.5 0.6 0.5 0.2 0.8 4.2 0.5 0.8 0.5 0.5 0.5 0.6 0.5 1.1 1.0 5.2 0.9 0.8 2.8 2.4 0.0 0.6 0.0 1.0 0.6 0.1 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 1.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.9 0.0 0.0 0.0 1.0 1.3 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 7.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 17.9 19.7 3.9 22.5 30.8 5.8 2.4 10.6 4.2 2.4 CACNA1F "AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2" ENSG00000102001 "Calcium voltage-gated channel subunit alpha1 F" O60840 X 49205063-49233371 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Sensory transduction, Transport, Vision" "Calcium channel, Ion channel, Voltage-gated channel" "Cone-rod dystrophy, Congenital stationary night blindness, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "retina: 55.8" "Cell line enhanced" "Detected in some" "A549: 2.5;BEWO: 2.5;MCF7: 2.8;U-266/70: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA068379 Enhanced "HPA068379: " "unprognostic (1.20e-3)" "unprognostic (8.62e-2)" "unprognostic (4.25e-3)" "unprognostic (1.56e-2)" "unprognostic (8.46e-2)" "unprognostic (1.84e-1)" "unprognostic (1.23e-2)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (9.04e-2)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (6.08e-7)" "unprognostic (8.03e-2)" "unprognostic (1.09e-1)" "unprognostic (4.65e-2)" "unprognostic (3.77e-3)" 0.7 0.8 1.8 0.7 1.5 4.0 1.8 5.3 2.0 0.7 1.0 0.7 0.7 1.9 0.7 2.7 0.7 1.0 0.7 0.7 0.8 0.6 0.7 0.7 1.4 2.7 0.7 0.7 0.7 1.4 0.0 0.7 0.7 0.7 0.7 1.5 55.8 1.2 0.9 0.7 2.4 3.7 0.7 0.7 1.8 1.0 0.7 0.7 0.7 1.2 0.7 0.9 0.7 0.7 1.4 4.6 2.0 0.9 0.5 1.0 0.2 0.2 2.5 0.2 0.0 0.6 0.0 2.5 0.4 0.2 0.0 0.0 0.1 0.9 1.4 0.5 0.5 0.1 0.4 0.0 0.0 0.1 0.0 0.7 0.0 0.5 0.5 0.1 0.8 0.6 0.0 0.4 0.0 0.7 1.0 0.3 0.0 2.8 1.3 1.5 1.1 0.0 0.1 0.0 0.5 0.4 1.5 0.6 0.0 0.0 0.1 0.0 0.9 1.5 1.0 0.2 0.3 0.2 0.1 4.6 1.6 0.0 0.8 0.4 0.0 0.9 0.7 0.6 0.6 0.5 0.5 0.7 0.8 0.4 0.8 1.4 0.5 1.0 2.0 0.5 0.9 4.6 0.7 0.2 1.8 1.5 5.3 2.0 0.8 0.6 0.7 0.7 0.7 0.7 CACNA1S "CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5" ENSG00000081248 "Calcium voltage-gated channel subunit alpha1 S" Q13698 1 201039512-201112566 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 83.1" "Group enriched" "Detected in some" 32 "BEWO: 5.4;HSkMC: 6.9" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 20 "olfactory region: 5.3" "CAB009507, HPA048892, HPA056815" Enhanced "CAB009507: AB_2069576, HPA048892: , HPA056815: " "unprognostic (2.14e-2)" "unprognostic (1.38e-1)" "unprognostic (1.12e-2)" "unprognostic (1.09e-1)" "unprognostic (3.52e-3)" "unprognostic (4.53e-2)" "unprognostic (2.84e-1)" "unprognostic (2.23e-1)" "unprognostic (2.53e-2)" "unprognostic (1.51e-1)" "unprognostic (4.72e-3)" "unprognostic (1.12e-1)" "unprognostic (5.28e-2)" "unprognostic (7.36e-2)" "unprognostic (1.57e-1)" 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.6 0.0 83.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.1 0.1 0.1 0.1 0.0 CACNA2D2 KIAA0558 ENSG00000007402 "Calcium voltage-gated channel auxiliary subunit alpha2delta 2" Q9NY47 3 50362799-50504244 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lung: 86.1" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 64.9" "Cancer enhanced" "Detected in many" "testis cancer: 20.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034771, HPA071829" Enhanced Approved Vesicles 1000000 Vesicles "HPA034771: AB_10603555, HPA071829: " "unprognostic (2.06e-1)" "unprognostic (2.37e-1)" "unprognostic (1.72e-2)" "prognostic unfavourable (7.62e-5)" "unprognostic (6.59e-2)" "unprognostic (6.37e-2)" "unprognostic (6.91e-2)" "unprognostic (6.57e-3)" "unprognostic (4.39e-2)" "unprognostic (1.17e-1)" "prognostic favourable (1.21e-4)" "unprognostic (2.71e-2)" "unprognostic (1.57e-4)" "unprognostic (3.03e-1)" "unprognostic (4.14e-2)" "unprognostic (3.55e-1)" "unprognostic (4.22e-2)" 1.0 0.9 1.6 1.3 11.1 1.1 1.4 14.9 6.5 1.1 1.7 0.9 0.6 1.4 1.7 1.2 0.9 1.1 0.9 7.6 1.7 9.1 1.6 0.5 86.1 1.3 3.9 3.2 2.2 4.0 3.8 6.0 1.9 6.1 3.0 2.0 6.1 1.5 1.4 1.7 2.6 1.7 1.4 1.4 1.5 4.1 5.8 2.5 0.2 2.3 0.1 0.7 0.7 0.7 1.8 0.3 0.7 0.1 2.3 3.6 1.1 0.0 0.0 1.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2.6 0.1 0.0 0.0 0.2 0.0 0.0 6.2 64.9 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 2.2 0.0 2.7 1.8 2.6 2.0 0.0 1.3 3.6 2.2 0.0 2.3 0.1 0.3 3.2 1.1 1.6 11.1 14.9 6.5 1.7 9.1 3.9 3.2 6.1 2.5 CACNA2D4 ENSG00000151062 "Calcium voltage-gated channel auxiliary subunit alpha2delta 4" Q7Z3S7 12 1791957-1918836 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 47.0" "Cell line enhanced" "Detected in some" "Hep G2: 5.3;HL-60: 3.1;HMC-1: 16.6;NB-4: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 9 "dendritic cells: 4.5;monocytes: 6.6;T-cells: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA031952 Uncertain "HPA031952: AB_10600798" "unprognostic (5.04e-2)" "unprognostic (2.82e-2)" "unprognostic (5.32e-1)" "unprognostic (7.50e-2)" "unprognostic (1.15e-1)" "unprognostic (8.18e-4)" "unprognostic (1.10e-2)" "unprognostic (1.31e-1)" "unprognostic (2.08e-1)" "unprognostic (3.30e-3)" "unprognostic (1.24e-2)" "unprognostic (1.41e-1)" "unprognostic (1.62e-5)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "unprognostic (2.04e-1)" "unprognostic (2.13e-1)" 1.8 0.7 0.6 2.2 0.9 2.2 0.8 0.1 1.1 1.4 0.8 0.6 0.2 2.3 1.1 0.5 0.8 0.3 1.6 1.6 0.8 0.5 1.5 0.3 1.4 2.2 1.2 0.2 0.4 1.5 0.1 3.9 2.1 1.0 0.7 0.3 47.0 0.7 0.5 0.2 0.2 1.4 1.5 1.3 2.2 0.6 1.7 0.7 1.2 0.5 0.9 1.4 2.3 0.5 0.0 4.5 0.2 6.6 0.6 6.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 5.3 0.3 3.1 16.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.5 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 6.6 0.0 3.5 2.4 6.7 0.0 1.6 2.5 4.5 0.0 0.9 0.5 0.2 0.6 0.7 0.2 0.9 2.3 0.6 0.9 0.1 1.1 0.8 0.5 1.2 0.2 1.0 0.7 CACNB1 CACNLB1 ENSG00000067191 "Calcium voltage-gated channel auxiliary subunit beta 1" Q02641 17 39173456-39197703 "FDA approved drug targets, Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 130.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023343 Approved "HPA023343: AB_1845866" "unprognostic (3.44e-2)" "unprognostic (1.89e-2)" "unprognostic (1.69e-3)" "prognostic unfavourable (3.80e-4)" "unprognostic (3.99e-2)" "unprognostic (1.52e-2)" "unprognostic (1.37e-2)" "unprognostic (2.80e-3)" "unprognostic (4.43e-1)" "unprognostic (1.04e-3)" "unprognostic (5.98e-2)" "unprognostic (3.38e-1)" "unprognostic (1.94e-11)" "unprognostic (7.62e-2)" "unprognostic (2.30e-1)" "unprognostic (1.34e-2)" "unprognostic (7.44e-3)" 2.0 2.4 7.8 2.2 14.9 1.6 2.0 5.4 22.0 3.3 2.3 2.0 6.0 1.7 2.3 3.7 4.2 2.3 2.0 2.8 8.6 6.4 1.3 1.1 3.0 2.1 3.3 11.0 2.6 1.4 1.6 2.0 1.8 7.6 3.6 2.2 0.8 3.4 5.7 130.9 5.8 1.7 2.4 1.9 2.0 1.8 2.3 2.1 1.7 2.0 7.3 1.8 1.8 1.6 0.1 3.1 0.1 1.2 1.8 3.2 0.8 6.0 2.7 3.4 7.8 3.8 4.7 0.1 3.6 4.5 3.4 4.3 2.0 6.1 10.4 3.8 5.4 5.6 3.3 6.0 2.6 4.9 3.7 1.4 6.4 0.8 7.8 0.3 0.9 5.1 1.9 7.1 8.1 2.4 0.9 9.1 3.5 1.6 7.4 2.7 2.4 2.0 5.1 11.3 4.5 1.4 1.9 8.5 5.2 2.1 11.5 3.4 8.1 4.1 3.4 6.1 7.1 4.5 3.6 4.3 1.4 1.7 5.1 0.0 2.5 0.0 1.2 0.0 2.0 0.6 3.2 0.1 1.9 2.6 0.5 0.1 0.6 1.2 0.1 1.8 0.3 3.1 0.5 0.8 7.8 14.9 5.4 22.0 8.6 6.4 3.3 11.0 7.6 2.1 CACNG1 CACNLG ENSG00000108878 "Calcium voltage-gated channel auxiliary subunit gamma 1" Q06432 17 67044590-67056797 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 126.7" "Group enriched" "Detected in some" 5 "HSkMC: 8.1;SH-SY5Y: 2.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "basal ganglia: 3.0" "Not detected" "Not detected" "unprognostic (1.76e-1)" "unprognostic (9.83e-3)" "unprognostic (1.75e-5)" "unprognostic (2.60e-1)" "unprognostic (6.72e-3)" "unprognostic (2.85e-1)" "unprognostic (1.44e-2)" "unprognostic (4.84e-3)" "unprognostic (1.07e-1)" "unprognostic (4.20e-2)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (3.03e-1)" "unprognostic (1.94e-1)" 5.7 0.4 0.3 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 1.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 126.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.7 25.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 8.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 CACNG2 "MGC138502, MGC138504, stargazin" ENSG00000166862 "Calcium voltage-gated channel auxiliary subunit gamma 2" Q9Y698 22 36563921-36703558 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 30.7" "Group enriched" "Detected in some" 8 "SCLC-21H: 7.6;SH-SY5Y: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (7.54e-2)" "unprognostic (3.06e-1)" "unprognostic (8.80e-3)" "unprognostic (2.34e-2)" "unprognostic (3.07e-2)" 0.7 2.7 5.6 0.8 6.4 0.9 0.7 30.7 21.9 0.6 0.7 0.3 0.0 0.8 0.6 0.6 0.7 0.6 0.6 0.6 3.8 4.7 0.7 0.7 0.7 0.7 2.9 7.8 0.6 1.1 0.6 2.7 0.7 6.9 0.7 0.7 0.1 0.6 0.6 1.0 0.8 0.8 0.7 1.7 0.7 0.7 1.0 0.8 0.0 0.7 0.0 0.6 0.7 0.1 0.3 1.0 1.0 0.3 0.3 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.2 7.6 3.4 0.0 0.1 0.0 0.3 0.0 0.3 0.2 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.4 0.4 0.3 0.1 0.3 0.3 0.2 0.0 0.3 0.4 0.4 1.0 0.3 0.2 1.0 0.2 0.1 5.6 6.4 30.7 12.3 3.8 4.7 2.9 7.8 6.9 0.8 CACNG3 ENSG00000006116 "Calcium voltage-gated channel auxiliary subunit gamma 3" O60359 16 24255553-24362801 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "brain: 32.2" "Cell line enhanced" "Detected in some" "HeLa: 1.3;Karpas-707: 1.0;U-266/70: 1.0" "Cancer enriched" "Detected in single" 15 "glioma: 0.7" "Group enriched" "Detected in many" 6 "amygdala: 12.8;basal ganglia: 13.1;cerebral cortex: 20.0;hippocampal formation: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077238 Enhanced "HPA077238: " "unprognostic (5.61e-2)" "unprognostic (3.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.17e-1)" 0.4 1.8 12.8 0.4 13.1 0.5 0.3 0.2 32.2 0.3 0.4 0.1 0.0 0.3 0.3 0.4 0.3 0.4 0.3 0.3 12.7 2.2 0.3 0.4 0.3 0.4 1.8 2.3 0.4 0.3 0.3 0.0 0.4 0.3 0.4 0.4 0.1 0.3 0.4 0.3 0.4 0.3 0.4 0.3 0.4 0.4 0.6 0.0 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.0 0.0 0.2 0.9 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 12.8 13.1 0.2 20.0 12.7 2.2 1.8 2.3 0.3 0.0 CACNG7 ENSG00000105605 "Calcium voltage-gated channel auxiliary subunit gamma 7" P62955 19 53909335-53943941 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "brain: 54.4" "Cell line enhanced" "Detected in some" "AF22: 28.8;HMC-1: 22.4;NTERA-2: 7.6;SH-SY5Y: 17.7;U-2 OS: 6.1" "Cancer enriched" "Detected in some" 16 "glioma: 29.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.11e-2)" "unprognostic (7.18e-2)" "unprognostic (6.24e-2)" "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (1.01e-5)" "unprognostic (1.51e-1)" "unprognostic (7.36e-2)" 1.2 1.8 22.2 1.3 15.6 1.2 1.2 22.7 54.4 1.2 1.3 8.3 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 21.4 13.7 1.2 1.2 1.3 1.2 16.5 10.3 1.2 1.3 1.2 1.8 1.2 9.9 1.2 1.2 0.3 1.2 1.3 1.2 1.2 1.4 1.3 13.5 1.2 1.3 1.5 4.5 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 28.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 22.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.1 0.0 0.0 0.0 1.7 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 15.6 22.7 25.9 21.4 13.7 16.5 10.3 9.9 4.5 CADM2 "IGSF4D, Necl-3, NECL3, SynCAM2" ENSG00000175161 "Cell adhesion molecule 2" Q8N3J6 3 84958981-86074429 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 52.7" "Cell line enhanced" "Detected in some" "AF22: 6.3;AN3-CA: 17.9;U-266/70: 3.1" "Cancer enriched" "Detected in some" 9 "glioma: 7.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 5.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010024 Enhanced 350000 "HPA010024: AB_2068039" "unprognostic (2.23e-2)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (1.90e-4)" "unprognostic (8.64e-2)" "unprognostic (2.27e-1)" "unprognostic (4.76e-3)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (1.90e-1)" "unprognostic (8.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.07e-5)" "unprognostic (9.82e-3)" "unprognostic (1.26e-2)" "unprognostic (4.17e-3)" "unprognostic (1.16e-2)" 5.8 6.3 33.5 2.1 22.7 1.7 3.6 44.8 52.7 2.3 3.0 7.0 0.0 2.0 2.0 2.2 2.7 4.6 2.6 4.2 28.6 11.7 1.9 2.5 2.2 1.8 16.3 31.0 2.3 2.4 3.0 5.5 1.9 24.2 3.4 2.7 8.8 2.3 6.2 4.9 2.0 2.6 2.1 14.0 2.0 3.2 2.2 20.5 0.0 2.1 0.0 1.8 2.0 1.1 1.0 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 6.3 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 22.7 44.8 49.5 28.6 11.7 16.3 31.0 24.2 20.5 CADPS2 CAPS2 ENSG00000081803 "Calcium dependent secretion activator 2" Q86UW7 7 122318425-122886759 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 105.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 21.6;Karpas-707: 28.2;MCF7: 14.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 105.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 325.7" HPA056398 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA056398: " "unprognostic (1.93e-1)" "unprognostic (5.05e-2)" "unprognostic (1.91e-1)" "unprognostic (3.67e-3)" "unprognostic (8.69e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (1.33e-1)" "unprognostic (4.07e-1)" "unprognostic (4.33e-2)" "unprognostic (3.93e-2)" "unprognostic (1.30e-1)" "prognostic favourable (1.01e-7)" "unprognostic (9.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.71e-2)" "unprognostic (3.45e-2)" 5.1 11.2 5.1 1.9 7.1 0.0 9.5 105.4 21.1 16.5 5.3 1.4 13.3 6.1 16.3 16.4 5.7 5.7 8.0 4.6 6.8 8.8 20.3 6.2 9.0 1.3 14.0 9.3 5.2 13.2 15.4 17.7 2.7 7.0 10.4 5.4 4.7 23.0 11.5 2.6 2.4 4.7 11.2 4.1 3.3 9.8 1.9 1.4 0.4 9.4 2.4 1.6 4.4 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.6 2.7 0.1 0.2 6.7 1.5 6.8 0.0 6.2 0.0 0.0 3.1 0.0 0.2 0.9 0.6 0.0 5.5 2.1 0.0 12.1 8.7 0.0 0.1 2.8 1.2 1.1 0.9 21.6 0.0 28.2 0.1 14.8 0.0 0.0 6.3 10.7 0.0 0.0 11.1 0.3 7.0 10.9 0.0 0.3 12.2 0.5 4.7 0.0 6.1 2.4 1.6 0.0 4.3 8.4 0.3 0.0 9.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 7.1 105.4 21.1 6.8 8.8 14.0 9.3 7.0 1.4 CAGE1 "bA69L16.7, CT95, CTAG3" ENSG00000164304 "Cancer antigen 1" Q8TC20 6 7326656-7389743 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 13.2" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029832 Uncertain "HPA029832: AB_10602412" "unprognostic (1.34e-1)" "unprognostic (4.82e-2)" "unprognostic (1.80e-2)" "unprognostic (2.25e-4)" "unprognostic (4.80e-2)" "unprognostic (4.24e-1)" "unprognostic (2.44e-3)" "unprognostic (3.88e-2)" "unprognostic (2.79e-2)" "unprognostic (8.80e-2)" "unprognostic (1.09e-2)" "unprognostic (3.23e-1)" "unprognostic (4.38e-6)" "unprognostic (4.71e-2)" "unprognostic (3.29e-2)" "unprognostic (1.62e-4)" "unprognostic (1.60e-1)" 0.2 0.2 0.3 0.2 1.5 0.4 0.2 0.9 1.1 0.2 0.2 0.6 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 1.2 0.9 0.7 0.0 0.2 1.8 0.1 1.8 0.2 1.4 0.2 0.2 0.5 0.6 0.1 0.2 0.2 0.2 0.2 0.2 0.4 0.2 13.2 0.0 0.8 0.2 0.8 0.2 0.2 0.2 1.1 1.2 1.5 0.4 0.4 0.6 0.0 0.1 0.3 0.3 0.3 0.0 0.2 0.0 0.0 0.1 0.6 0.3 0.8 0.3 0.7 0.4 0.0 0.3 0.6 0.5 0.1 0.8 0.2 0.0 0.2 0.4 0.5 0.1 0.3 0.2 0.0 0.7 0.2 0.4 0.5 1.4 0.2 0.9 0.2 0.4 0.5 0.5 0.1 0.3 0.5 0.2 0.4 0.6 0.3 0.6 1.1 0.3 0.3 0.6 0.5 0.8 0.5 0.4 0.3 0.5 0.9 1.1 0.3 0.4 0.3 1.0 0.4 0.5 0.6 0.3 0.4 0.3 0.4 0.3 0.1 1.1 0.4 0.4 1.5 0.4 0.4 1.2 0.2 0.0 0.3 1.5 0.9 1.1 0.5 0.2 0.7 0.0 1.4 0.0 CALR3 "CRT2, CT93, FLJ25355, MGC26577" ENSG00000269058 "Calreticulin 3" Q96L12 19 16479057-16496192 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" Chaperone "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 43.6" "Cell line enhanced" "Detected in some" "hTCEpi: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB025749, HPA043355, HPA048460" Enhanced "Intracellular and membrane" "CAB025749: , HPA043355: AB_2678442, HPA048460: AB_2680403" "unprognostic (1.19e-1)" "unprognostic (3.84e-1)" "unprognostic (7.17e-2)" "unprognostic (4.34e-1)" "unprognostic (2.32e-1)" "unprognostic (2.95e-1)" "unprognostic (1.30e-2)" "unprognostic (1.44e-1)" "unprognostic (4.28e-2)" "unprognostic (1.18e-2)" "unprognostic (6.69e-7)" "unprognostic (1.60e-1)" "unprognostic (2.78e-1)" "unprognostic (6.28e-3)" "unprognostic (6.34e-3)" 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 43.6 0.3 0.8 0.1 0.0 0.0 0.0 0.0 1.3 0.8 2.2 0.1 0.0 0.6 0.1 0.2 0.0 0.1 0.5 0.0 0.0 0.7 0.2 0.0 1.1 0.0 1.0 0.9 0.6 0.1 0.0 0.2 1.1 0.2 0.0 1.3 1.3 0.9 0.0 0.0 0.5 0.0 1.1 0.0 3.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.4 1.3 0.0 0.0 0.0 0.0 0.9 1.1 1.0 0.1 0.7 0.7 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.1 1.4 1.7 1.1 0.2 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.2 1.2 0.2 0.0 0.2 1.3 0.6 0.1 2.2 0.0 0.0 0.8 0.0 0.1 0.5 0.4 0.8 0.8 0.4 0.0 0.4 0.0 0.3 0.3 CAMKK2 "CAMKK, CAMKKB, KIAA0787, MGC15254" ENSG00000110931 "Calcium/calmodulin dependent protein kinase kinase 2" Q96RR4 12 121237691-121298308 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 125.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 125.5" "Group enriched" "Detected in many" 5 "classical monocyte: 14.2;eosinophil: 26.1;intermediate monocyte: 19.4;myeloid DC: 7.2;neutrophil: 17.2;non-classical monocyte: 16.5" "Group enriched" "Detected in all" 5 "dendritic cells: 7.2;granulocytes: 26.1;monocytes: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017389, HPA063713" Approved Supported Supported Cytosol Cytosol "HPA017389: AB_1845956, HPA063713: " "unprognostic (5.08e-2)" "unprognostic (1.81e-1)" "unprognostic (1.38e-1)" "unprognostic (3.08e-1)" "unprognostic (1.88e-1)" "unprognostic (1.12e-1)" "unprognostic (2.62e-3)" "unprognostic (2.80e-2)" "unprognostic (1.93e-1)" "unprognostic (7.76e-2)" "unprognostic (5.01e-2)" "unprognostic (1.70e-1)" "unprognostic (1.75e-1)" "unprognostic (4.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.67e-1)" "unprognostic (1.38e-1)" 11.7 6.5 19.7 7.8 30.2 13.8 8.8 125.5 45.5 9.0 9.5 7.1 2.6 12.8 8.6 5.3 8.3 11.8 6.3 6.9 11.2 5.1 7.1 8.9 9.6 6.9 6.2 17.3 10.5 5.8 6.4 4.1 7.5 9.1 12.2 9.7 6.2 7.5 13.2 5.1 9.1 13.2 10.3 6.2 14.1 7.6 3.6 5.8 5.2 6.1 4.5 7.2 7.2 7.4 2.2 7.2 26.1 19.4 3.6 2.2 6.3 12.3 9.3 6.9 13.4 20.8 19.4 10.6 10.2 10.9 8.4 7.7 9.7 5.3 19.1 8.6 20.7 10.2 8.5 11.0 6.6 13.1 16.7 9.5 6.2 9.5 14.1 21.6 9.1 12.5 16.4 7.9 18.0 19.6 11.0 10.4 8.1 12.0 23.9 17.8 5.0 10.5 15.6 8.0 16.9 8.1 13.8 26.6 10.6 13.4 7.2 8.5 17.9 26.4 14.3 6.9 5.6 5.8 5.6 39.7 23.6 14.5 12.9 15.1 6.8 0.7 14.2 26.1 2.1 19.4 2.2 2.2 1.7 1.9 7.2 1.2 1.5 1.7 17.2 3.6 16.5 1.6 1.3 6.3 19.7 30.2 125.5 45.5 11.2 5.1 6.2 17.3 9.1 5.8 CAMKV "MGC8407, VACAMKL" ENSG00000164076 "CaM kinase like vesicle associated" Q8NCB2 3 49857988-49870222 "Enzymes, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 36 "brain: 77.2" "Cell line enhanced" "Detected in some" "AF22: 5.2;HAP1: 6.9;NTERA-2: 24.6;RPMI-8226: 4.7;SCLC-21H: 8.4;SH-SY5Y: 5.4" "Group enriched" "Detected in some" 11 "glioma: 4.0;testis cancer: 5.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007656, CAB034931" Enhanced Supported Approved "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "CAB034931: AB_2068550, HPA007656: AB_1078391" "unprognostic (9.47e-4)" "unprognostic (5.65e-3)" "unprognostic (1.42e-1)" "unprognostic (2.70e-7)" "unprognostic (2.76e-1)" "unprognostic (7.95e-4)" "unprognostic (3.09e-2)" "unprognostic (2.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (8.11e-2)" "unprognostic (1.00e-3)" "unprognostic (7.61e-2)" "unprognostic (9.51e-2)" "unprognostic (1.67e-3)" 1.2 2.1 20.7 1.2 77.2 1.2 1.2 0.5 62.8 1.2 1.2 1.7 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 33.4 11.7 1.2 1.2 1.2 1.2 3.3 23.5 1.2 1.2 1.2 1.8 1.2 2.1 1.2 1.2 0.0 1.2 1.2 1.2 1.3 1.2 1.2 1.9 1.2 1.3 2.1 6.0 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 5.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.7 0.1 24.6 0.1 0.7 0.0 4.7 0.0 0.0 8.4 5.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 20.7 77.2 0.5 34.0 33.4 11.7 3.3 23.5 2.1 6.0 CAND2 "KIAA0667, TIP120B, Tp120b" ENSG00000144712 "Cullin associated and neddylation dissociated 2 (putative)" O75155 3 12796472-12871916 "Predicted intracellular proteins" "Transcription, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 76.2" "Cell line enhanced" "Detected in many" "HEK 293: 18.2;REH: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005777 Approved Approved "Nuclear bodies,Cytosol" "Nuclear bodies" Cytosol "HPA005777: " "unprognostic (6.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.52e-3)" "unprognostic (6.09e-2)" "unprognostic (4.22e-1)" "unprognostic (2.35e-1)" "unprognostic (1.12e-2)" "unprognostic (1.67e-2)" "unprognostic (2.00e-2)" "unprognostic (9.03e-2)" "unprognostic (6.36e-3)" "unprognostic (1.03e-1)" "unprognostic (4.78e-5)" "unprognostic (1.31e-2)" "unprognostic (2.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.96e-3)" 2.9 2.8 6.4 1.4 7.6 1.4 1.4 7.2 11.8 2.3 3.2 3.7 0.5 1.5 3.7 2.6 2.6 3.6 2.1 17.8 4.7 4.3 1.7 1.7 1.9 1.4 2.7 5.5 3.3 2.5 6.4 4.9 1.4 3.1 3.0 1.4 4.2 2.2 3.4 76.2 1.6 1.7 5.2 2.2 2.2 2.1 11.4 2.6 0.1 2.4 11.1 1.2 3.0 5.0 1.2 0.2 0.7 0.5 0.0 2.2 0.6 0.7 1.5 5.8 0.2 0.2 0.1 0.3 1.6 0.6 3.1 4.2 0.8 0.3 0.9 1.7 0.8 0.2 6.4 0.1 2.8 1.6 18.2 1.3 2.2 1.2 4.9 0.1 0.1 1.3 0.3 3.0 0.1 0.7 4.7 0.9 0.9 2.9 2.3 0.7 4.0 1.8 11.2 1.1 0.9 0.2 1.3 3.9 5.2 0.1 0.8 1.0 1.7 5.5 0.4 0.9 1.0 0.9 1.2 1.5 8.9 8.6 0.5 1.1 1.9 0.0 0.5 0.0 1.2 0.2 0.6 1.2 0.6 2.2 0.1 0.5 1.3 0.9 0.7 0.0 0.1 0.2 1.6 0.6 6.4 7.6 7.2 11.8 4.7 4.3 2.7 5.5 3.1 2.6 CAP2 ENSG00000112186 "Cyclase associated actin cytoskeleton regulatory protein 2" P40123 6 17393216-17557792 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 165.7" "Cell line enhanced" "Detected in many" "LHCN-M2: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "MAIT T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050530, HPA054147" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA050530: AB_2681159, HPA054147: AB_2682400" "unprognostic (7.27e-2)" "unprognostic (5.71e-3)" "unprognostic (1.63e-2)" "unprognostic (1.55e-1)" "unprognostic (4.86e-1)" "unprognostic (2.23e-2)" "unprognostic (9.94e-2)" "unprognostic (3.58e-2)" "unprognostic (7.72e-2)" "unprognostic (1.65e-1)" "unprognostic (6.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-1)" "unprognostic (8.05e-2)" "unprognostic (1.75e-3)" 5.8 4.1 13.8 3.0 20.1 0.7 3.9 7.5 26.4 5.6 7.7 1.9 2.0 1.9 9.2 5.9 7.0 5.8 3.8 31.2 19.9 8.7 3.3 2.0 2.1 1.1 5.3 17.3 2.1 1.6 3.2 1.7 6.2 8.6 8.4 3.6 2.9 2.5 10.1 165.7 0.9 2.6 13.1 2.0 1.6 3.3 1.1 1.3 0.0 2.3 14.5 1.3 4.6 6.4 0.0 0.0 0.0 0.0 0.0 2.9 0.1 5.4 8.4 16.3 19.6 0.1 0.0 3.5 19.3 14.1 15.9 14.5 2.8 2.4 0.0 18.2 20.7 2.8 7.2 7.2 23.0 0.0 2.7 0.0 5.4 9.2 1.5 0.0 0.0 1.2 3.5 8.0 3.5 0.7 0.0 0.0 33.5 8.7 0.0 0.0 6.2 4.8 1.8 21.7 0.3 8.3 2.2 2.1 4.1 6.5 21.0 11.4 23.2 3.9 0.0 12.9 12.3 0.3 16.9 0.0 0.0 0.0 4.2 0.0 17.5 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 20.1 7.5 26.4 19.9 8.7 5.3 17.3 8.6 1.3 CAPN11 ENSG00000137225 "Calpain 11" Q9UMQ6 6 44158811-44184402 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 63.7" "Group enriched" "Detected in some" 5 "NTERA-2: 4.3;TIME: 10.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB018070, HPA030955" Enhanced "CAB018070: AB_2069481, HPA030955: " "unprognostic (2.20e-2)" "unprognostic (1.87e-1)" "unprognostic (1.64e-2)" "unprognostic (2.75e-1)" "unprognostic (6.22e-2)" "unprognostic (3.34e-2)" "unprognostic (3.99e-2)" "unprognostic (4.57e-2)" "unprognostic (1.29e-1)" "unprognostic (8.96e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-1)" "unprognostic (3.62e-6)" "unprognostic (2.38e-2)" "unprognostic (3.51e-1)" "unprognostic (2.27e-2)" "unprognostic (8.89e-2)" 1.1 0.3 0.1 0.2 0.1 0.2 1.9 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.6 0.3 0.2 0.1 0.1 0.0 63.7 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.4 1.2 1.3 0.1 0.1 0.8 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.4 0.4 0.0 0.0 0.0 0.3 4.3 0.0 0.7 0.2 0.4 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 10.8 0.5 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.3 0.4 0.1 0.2 1.3 0.1 0.0 1.2 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CAPZA3 "CAPPA3, Gsg3" ENSG00000177938 "Capping actin protein of muscle Z-line alpha subunit 3" Q96KX2 12 18738101-18739187 "Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "testis: 67.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA038688 Enhanced "HPA038688: " "unprognostic (5.56e-2)" "unprognostic (1.43e-1)" "unprognostic (4.45e-3)" "unprognostic (5.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.3 67.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CARMIL2 "LRRC16C, RLTPR" ENSG00000159753 "Capping protein regulator and myosin 1 linker 2" Q6F5E8 16 67644919-67657569 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 47.7" "Cell line enhanced" "Detected in some" "Daudi: 22.1;MOLT-4: 21.6;REH: 36.4;RPMI-8226: 19.8;U-698: 36.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041402 Approved "HPA041402: AB_10795591" "unprognostic (1.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.35e-2)" "unprognostic (6.37e-2)" "unprognostic (5.47e-3)" "unprognostic (4.27e-4)" "unprognostic (1.38e-2)" "unprognostic (1.44e-1)" "unprognostic (3.85e-2)" "unprognostic (1.52e-1)" "unprognostic (7.90e-5)" "unprognostic (4.07e-2)" "unprognostic (5.14e-10)" "unprognostic (2.25e-1)" "unprognostic (1.89e-1)" "unprognostic (1.85e-1)" "unprognostic (6.57e-2)" 0.7 0.6 5.8 23.0 6.4 5.5 0.3 5.9 7.4 0.6 2.0 0.4 0.3 1.9 0.6 1.0 1.9 0.3 2.4 0.5 10.0 3.9 0.9 0.3 1.8 24.4 2.3 0.4 0.4 3.0 0.1 2.8 0.5 0.6 0.5 0.8 0.5 6.1 0.7 0.5 0.4 8.0 0.5 0.7 12.9 1.9 0.7 0.4 47.7 0.4 0.5 21.6 2.5 0.3 1.5 1.1 0.0 0.0 1.7 2.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 6.5 0.2 0.0 0.2 0.0 3.3 0.2 22.1 0.4 0.0 0.0 2.1 0.0 0.0 4.9 2.8 1.3 0.1 0.4 0.2 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 21.6 10.9 3.8 0.1 36.4 0.0 19.8 0.0 0.0 5.6 0.6 0.0 0.0 0.1 0.1 0.6 0.0 0.3 0.7 0.0 0.1 6.4 11.1 36.8 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.7 0.9 2.7 0.7 0.1 1.5 0.8 0.5 0.0 1.7 0.0 1.1 2.5 0.4 5.8 6.4 5.9 7.4 10.0 3.9 2.3 0.4 0.6 0.4 CASKIN1 "ANKS5A, KIAA1306" ENSG00000167971 "CASK interacting protein 1" Q8WXD9 16 2177180-2196525 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 30.4" "Cell line enhanced" "Detected in some" "AN3-CA: 4.5;HDLM-2: 16.6;HEK 293: 3.7;SCLC-21H: 7.7;SH-SY5Y: 3.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055990, CAB079050" Enhanced Supported Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB079050: , HPA055990: " "unprognostic (4.91e-2)" "unprognostic (2.48e-1)" "unprognostic (4.84e-2)" "unprognostic (1.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.05e-1)" "unprognostic (2.80e-2)" "unprognostic (8.02e-2)" "unprognostic (6.58e-2)" "unprognostic (4.59e-1)" "unprognostic (2.21e-4)" "unprognostic (2.67e-2)" "unprognostic (2.62e-1)" "unprognostic (9.70e-3)" "unprognostic (1.72e-1)" "unprognostic (7.34e-3)" "unprognostic (3.39e-1)" 1.1 1.8 17.7 1.2 18.1 1.1 1.4 15.0 30.4 1.5 1.2 2.3 0.0 1.2 1.5 1.3 1.2 1.4 1.2 2.5 16.4 12.8 1.3 1.1 1.1 1.1 12.4 11.7 1.2 1.5 1.9 1.4 1.2 11.1 1.8 1.2 1.8 2.5 1.4 1.3 2.2 1.3 1.2 2.8 1.1 1.3 1.8 4.0 0.0 1.6 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 4.5 0.0 0.0 2.2 0.0 0.0 0.1 0.0 1.5 0.1 0.0 0.9 0.0 0.0 1.2 0.3 0.0 16.6 3.7 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 1.3 0.0 0.9 0.7 0.0 0.9 0.0 0.4 0.2 0.0 7.7 3.7 0.1 0.2 0.2 1.0 0.5 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 18.1 15.0 21.7 16.4 12.8 12.4 11.7 11.1 4.0 CASP14 "MGC119078, MGC119079, MICE" ENSG00000105141 "Caspase 14" P31944 19 15049384-15058293 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Hydrolase, Protease, Thiol protease" Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 109.4" "Cell line enriched" "Detected in some" 7 "hTCEpi: 32.4" "Cancer enhanced" "Detected in many" "cervical cancer: 62.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB010059, HPA027062" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol 2200000 "Nucleoplasm, Cytosol" Mitochondria "CAB010059: AB_626800, HPA027062: " "unprognostic (1.17e-2)" "unprognostic (6.44e-3)" "unprognostic (6.22e-2)" "unprognostic (2.77e-1)" "prognostic unfavourable (7.59e-4)" "unprognostic (9.42e-2)" "unprognostic (2.19e-2)" "prognostic unfavourable (5.96e-4)" "unprognostic (2.68e-1)" "unprognostic (4.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.97e-1)" 0.2 0.2 0.2 0.0 0.3 0.0 1.9 0.2 0.3 17.9 0.2 0.0 0.8 0.0 1.1 0.3 1.2 0.1 0.0 0.2 0.3 0.2 0.4 0.3 0.2 0.0 0.2 0.0 0.1 0.3 0.0 0.2 0.5 0.0 7.7 0.0 0.0 0.8 2.7 0.3 109.4 0.2 0.0 0.2 0.1 0.2 1.6 0.0 2.3 0.2 0.9 0.0 0.6 4.0 0.8 0.5 2.3 0.6 0.1 0.6 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.6 0.4 0.4 0.2 0.4 0.3 0.6 0.4 0.1 0.8 0.5 0.4 2.3 0.1 0.2 0.5 0.6 0.0 0.2 0.3 0.2 0.3 0.3 0.2 0.2 0.0 0.0 0.0 CASP4 "ICE(rel)II, ICH-2, TX" ENSG00000196954 "Caspase 4" P49662 11 104942866-104969436 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity, Necrosis" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 82.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA027588, CAB037167" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" Cytosol "Plasma membrane" "CAB037167: AB_258864, HPA027588: AB_10603781" "unprognostic (1.19e-2)" "unprognostic (3.73e-1)" "unprognostic (3.44e-1)" "unprognostic (1.99e-2)" "unprognostic (7.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.26e-2)" "unprognostic (1.56e-2)" "unprognostic (5.31e-2)" "unprognostic (2.71e-1)" "unprognostic (2.38e-3)" "unprognostic (8.39e-3)" "prognostic unfavourable (3.27e-11)" "unprognostic (6.75e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-2)" "unprognostic (4.08e-3)" 10.6 6.3 0.5 9.7 0.5 6.1 9.4 0.0 0.0 4.7 3.5 8.9 3.5 5.9 14.1 5.8 7.3 4.9 0.5 0.5 6.7 16.5 14.0 10.5 1.0 7.5 16.8 0.0 3.0 10.7 5.8 4.0 11.2 1.9 1.6 10.4 8.8 4.3 2.0 19.0 8.2 0.2 4.2 11.3 8.2 8.0 20.5 29.3 82.8 43.2 29.6 35.7 46.8 6.3 2.1 0.0 2.8 13.7 31.2 5.3 11.0 21.5 17.7 24.8 5.3 29.0 3.3 23.7 14.2 10.6 0.0 19.0 16.9 3.7 0.1 8.6 1.6 13.8 33.6 8.6 4.2 28.3 28.5 21.1 29.5 30.7 0.2 0.0 13.5 0.6 5.0 10.2 0.0 6.3 3.8 4.1 2.9 14.8 10.1 0.1 0.0 10.1 7.2 10.0 2.9 12.6 15.9 18.7 6.5 16.4 7.7 0.0 0.0 0.0 9.5 19.7 13.0 14.9 39.1 7.0 31.5 43.2 34.6 20.5 24.2 30.1 29.3 20.0 14.8 22.0 82.8 29.6 33.5 4.9 35.7 46.8 CASR "FHH, GPRC2A, HHC, HHC1, NSHPT" ENSG00000036828 "Calcium sensing receptor" P41180 3 122183683-122291629 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "parathyroid gland: 155.3" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 4.0" "Cancer enriched" "Detected in some" 7 "pancreatic cancer: 5.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA039686, HPA050335" Enhanced "HPA039686: AB_10673536, HPA050335: AB_2681092" "unprognostic (1.97e-2)" "unprognostic (7.40e-2)" "unprognostic (8.20e-4)" "unprognostic (3.15e-1)" "unprognostic (8.55e-4)" "unprognostic (1.58e-1)" "unprognostic (7.32e-2)" "unprognostic (7.67e-2)" "unprognostic (1.62e-1)" "unprognostic (1.48e-1)" "unprognostic (1.91e-5)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (1.24e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 21.0 0.0 0.1 0.2 18.1 0.5 0.0 0.0 0.1 0.0 0.6 12.1 155.3 0.6 0.0 0.2 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.6 0.3 0.2 0.2 0.5 0.3 0.0 0.1 1.6 0.0 0.1 0.7 0.0 1.4 0.5 1.1 0.3 0.8 1.1 0.2 0.6 1.3 0.7 1.1 0.3 0.3 0.7 0.7 0.0 0.0 0.1 0.6 0.8 1.1 0.9 0.4 0.5 0.2 0.2 0.3 0.8 0.1 1.4 1.1 1.1 0.0 0.7 0.8 0.4 0.4 0.4 0.2 0.2 0.6 2.0 0.3 0.7 0.5 0.9 1.4 0.6 0.6 0.5 0.6 4.0 1.5 0.6 0.8 0.9 0.5 0.3 0.9 0.3 1.3 1.0 1.8 1.0 0.3 1.6 1.1 0.5 0.7 0.6 1.0 1.0 0.3 0.1 0.9 0.2 0.9 0.7 0.9 0.9 0.1 1.4 0.7 0.6 1.1 0.8 0.2 0.5 1.1 0.2 0.0 0.0 0.0 0.6 0.1 0.2 0.1 0.0 0.2 0.0 CATSPER2 ENSG00000166762 "Cation channel sperm associated 2" Q96P56 15 43628503-43668118 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 43.7" "Cell line enhanced" "Detected in many" "HeLa: 12.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 9.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "unprognostic (6.88e-3)" "unprognostic (6.79e-2)" "unprognostic (2.08e-2)" "unprognostic (2.65e-2)" "unprognostic (4.05e-1)" "unprognostic (1.05e-2)" "unprognostic (7.11e-3)" "unprognostic (1.48e-2)" "unprognostic (6.35e-2)" "unprognostic (1.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.37e-2)" "unprognostic (3.74e-3)" "unprognostic (1.15e-1)" "unprognostic (6.04e-2)" "unprognostic (8.87e-2)" "unprognostic (8.23e-5)" 1.1 0.9 1.1 1.1 1.4 3.2 1.3 9.0 1.1 1.1 1.7 1.1 1.1 2.7 1.1 5.2 1.9 1.1 1.1 1.1 1.1 1.3 1.1 1.1 1.1 1.3 1.1 1.1 1.4 1.1 4.0 3.0 1.1 1.1 1.3 1.9 1.1 1.1 1.9 1.1 4.8 3.1 1.1 1.6 1.1 1.3 43.7 1.1 1.1 1.7 1.1 1.1 1.2 1.1 3.3 1.8 2.3 1.2 1.8 2.9 0.2 2.4 3.5 1.5 5.5 0.0 0.0 2.5 0.9 2.1 1.5 3.7 0.8 1.3 2.9 1.3 0.6 5.4 1.4 4.8 1.5 2.5 6.7 8.4 12.6 1.2 2.3 1.9 2.8 0.3 3.8 2.1 5.4 1.9 3.3 3.1 0.5 0.6 1.6 3.4 0.5 1.5 2.3 1.7 1.4 3.1 3.9 3.3 1.1 1.4 2.1 0.1 4.1 1.9 0.5 3.9 1.6 0.0 2.3 0.6 0.3 5.8 2.7 6.0 1.4 0.4 1.2 0.5 1.3 0.5 1.6 3.3 1.1 1.8 0.8 1.7 1.5 2.9 2.3 1.8 1.2 1.8 0.5 0.2 1.1 1.4 9.0 1.1 1.1 1.3 1.1 1.1 1.1 1.1 CATSPER3 CACRC ENSG00000152705 "Cation channel sperm associated 3" Q86XQ3 5 134967906-135011707 "Predicted membrane proteins, Transporters" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 31.9" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 7.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "unprognostic (2.59e-2)" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (2.26e-1)" "unprognostic (4.26e-2)" "unprognostic (1.57e-2)" "unprognostic (4.87e-2)" "unprognostic (2.63e-1)" "unprognostic (3.71e-2)" "unprognostic (8.00e-2)" "unprognostic (2.28e-3)" "unprognostic (1.55e-1)" "unprognostic (3.04e-2)" "unprognostic (5.58e-3)" "unprognostic (9.39e-2)" "unprognostic (1.51e-1)" "unprognostic (4.96e-3)" 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.5 0.4 0.5 0.4 0.8 0.4 0.4 0.4 0.4 0.6 1.0 0.4 0.4 0.4 0.4 0.6 0.8 0.2 0.4 0.4 0.4 0.4 0.4 0.4 0.6 0.4 2.7 0.3 0.4 0.4 0.4 0.4 0.3 31.9 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.3 1.4 0.4 0.6 3.2 1.8 0.4 0.4 3.5 1.3 1.6 1.1 0.4 0.8 0.6 0.3 7.1 0.6 2.0 3.0 1.4 1.8 0.3 1.1 2.3 1.2 0.7 1.9 2.6 0.3 2.0 1.2 0.7 0.9 0.8 0.3 1.8 0.6 2.8 0.0 1.5 2.5 0.5 1.6 1.5 2.3 0.4 1.9 1.8 0.6 0.8 3.1 0.5 1.1 1.1 1.2 1.0 1.0 1.4 2.1 1.0 0.1 1.3 0.3 1.6 1.2 1.0 0.4 0.7 2.3 0.5 0.0 0.6 0.0 0.4 0.1 0.0 0.8 0.7 0.7 1.4 3.3 1.8 0.7 0.4 3.2 0.1 0.7 0.0 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 CATSPER4 ENSG00000188782 "Cation channel sperm associated 4" Q7RTX7 1 26190561-26202968 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "testis: 13.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.1;hTCEpi: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045257 Enhanced "HPA045257: AB_10968995" "unprognostic (7.20e-2)" "unprognostic (2.06e-2)" "unprognostic (4.56e-2)" "unprognostic (2.69e-2)" "unprognostic (3.49e-1)" "unprognostic (3.86e-2)" "unprognostic (1.52e-2)" "unprognostic (2.16e-1)" "unprognostic (3.06e-1)" "unprognostic (6.78e-2)" "unprognostic (6.98e-2)" "unprognostic (6.67e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CATSPERD "MGC39581, TMEM146" ENSG00000174898 "Cation channel sperm associated auxiliary subunit delta" Q86XM0 19 5720677-5778734 "Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 32.8" "Cell line enriched" "Detected in single" 60 "HEL: 12.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA024056 Enhanced "HPA024056: AB_1858093" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (3.77e-3)" "unprognostic (9.91e-2)" "unprognostic (3.74e-2)" "unprognostic (6.85e-2)" "unprognostic (2.63e-3)" "unprognostic (2.19e-2)" "unprognostic (5.18e-2)" "unprognostic (2.50e-1)" "unprognostic (5.95e-8)" "unprognostic (2.54e-2)" "unprognostic (9.92e-2)" "unprognostic (2.83e-1)" "unprognostic (3.74e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 32.8 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.5 0.5 0.6 0.0 0.1 0.1 0.1 0.1 CATSPERE "C1orf101, MGC33370" ENSG00000179397 "Catsper channel auxiliary subunit epsilon" Q5SY80 1 244454377-244641177 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 26.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (3.22e-1)" "unprognostic (4.50e-2)" "unprognostic (2.02e-1)" "unprognostic (7.31e-2)" "unprognostic (3.32e-1)" "unprognostic (2.50e-3)" "unprognostic (3.76e-3)" "unprognostic (5.39e-4)" "unprognostic (1.96e-2)" "unprognostic (3.41e-2)" "unprognostic (4.37e-4)" "unprognostic (4.43e-2)" "unprognostic (9.09e-2)" "unprognostic (1.76e-1)" "unprognostic (5.79e-2)" "unprognostic (6.74e-3)" "unprognostic (5.85e-2)" 0.9 1.1 1.3 0.5 3.2 1.1 1.2 1.7 2.7 1.2 0.5 4.6 0.4 0.5 1.6 4.1 0.6 2.1 0.9 0.5 3.1 1.3 1.4 1.5 1.0 1.8 1.2 1.3 1.4 2.4 2.6 2.2 0.9 3.2 1.0 0.5 1.3 0.9 1.1 1.0 0.7 0.7 1.5 2.8 0.9 0.7 26.9 0.7 0.5 1.6 0.0 0.6 1.0 0.8 0.8 0.9 0.8 0.1 0.1 0.8 0.1 0.3 0.0 0.6 0.0 1.3 2.8 0.2 1.5 1.5 0.2 0.2 0.0 0.7 0.5 1.8 1.8 0.7 0.4 0.2 0.5 0.0 1.5 0.0 0.4 0.1 0.9 0.0 1.5 2.3 0.8 0.2 0.0 0.7 0.2 0.6 0.2 0.0 0.2 0.3 0.3 0.2 1.4 0.0 0.0 0.8 0.0 1.6 1.0 0.7 0.0 0.4 0.1 0.8 1.8 0.2 0.0 0.0 1.0 0.9 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.7 0.0 0.2 0.8 0.1 0.3 0.0 0.6 0.8 0.1 0.0 0.1 0.1 0.9 0.2 0.1 1.3 3.2 1.7 2.7 3.1 1.3 1.2 1.3 3.2 0.7 CATSPERG "C19orf15, DKFZp434A1022, FLJ46353" ENSG00000099338 "Cation channel sperm associated auxiliary subunit gamma" Q6ZRH7 19 38335775-38370943 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.7" "Cell line enhanced" "Detected in some" "BEWO: 4.1;HMC-1: 5.2;MCF7: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 5 "granulocytes: 4.8;monocytes: 1.8" "Low region specificity" "Detected in all" HPA052777 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in male reproductive system" Nucleoli "Nucleoplasm, Cytosol" "HPA052777: " "unprognostic (8.50e-5)" "unprognostic (5.12e-2)" "unprognostic (3.57e-3)" "unprognostic (1.51e-1)" "unprognostic (2.63e-1)" "unprognostic (3.18e-1)" "unprognostic (2.60e-1)" "unprognostic (2.87e-3)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.50e-1)" "unprognostic (4.37e-4)" "unprognostic (9.99e-2)" "unprognostic (2.01e-1)" "unprognostic (4.61e-2)" "unprognostic (1.07e-3)" 0.9 0.8 2.9 0.8 7.7 1.1 1.3 4.3 5.8 1.2 1.1 6.5 1.9 1.2 1.2 1.8 0.9 1.4 0.9 0.8 3.9 1.0 1.0 1.0 1.1 1.0 7.4 2.2 1.3 1.0 1.0 1.2 0.8 5.2 1.3 1.0 0.4 2.0 1.1 1.0 2.0 1.1 0.9 3.2 0.9 1.0 35.7 6.5 2.2 1.3 0.0 1.0 0.9 3.3 0.1 0.6 4.8 1.8 0.2 0.5 0.2 0.2 0.4 0.2 1.8 0.8 0.0 4.1 0.2 0.0 0.0 0.0 1.3 0.8 0.3 0.0 0.0 0.6 0.5 0.1 0.0 0.9 0.2 0.1 0.2 0.0 0.1 0.3 5.2 0.0 0.8 0.0 0.5 0.1 0.0 1.3 0.0 4.2 0.0 0.0 0.0 0.8 0.1 0.0 0.8 1.9 0.1 0.4 0.5 0.4 0.9 0.2 0.4 0.0 0.3 0.0 1.0 0.6 0.0 0.7 0.9 0.0 0.2 0.2 0.0 0.3 0.8 1.8 0.4 0.9 0.2 0.0 0.1 0.2 0.6 0.1 0.5 0.2 4.8 0.2 1.8 0.4 0.3 0.2 2.9 7.7 4.3 5.8 3.9 1.0 7.4 2.2 5.2 6.5 CATSPERZ "C11orf20, DKFZP566E164, TEX40" ENSG00000219435 "Catsper channel auxiliary subunit zeta" Q9NTU4 11 64300391-64304770 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 105 "testis: 139.5" "Cell line enhanced" "Detected in some" "BEWO: 5.6;CACO-2: 15.3;PC-3: 9.1;T-47d: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052822 Approved Nucleoplasm Nucleoplasm "HPA052822: " "unprognostic (1.89e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (8.23e-2)" "unprognostic (2.18e-1)" "unprognostic (1.11e-1)" "unprognostic (5.66e-4)" "unprognostic (5.96e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" 0.1 0.0 0.5 0.0 0.4 0.0 0.8 0.1 0.9 0.2 0.1 0.1 0.2 0.0 0.1 0.7 0.1 0.0 0.2 0.0 0.5 0.2 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.3 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 139.5 0.1 0.0 0.4 0.0 0.1 0.1 0.2 0.5 0.4 0.6 0.6 0.0 0.3 0.0 0.0 4.1 0.3 0.0 0.5 1.0 5.6 0.0 0.3 0.0 0.0 15.3 3.2 0.1 0.2 0.1 3.4 3.1 0.5 0.1 0.0 0.0 1.5 0.1 1.0 0.1 0.0 0.0 0.1 0.3 0.9 0.0 0.2 1.6 0.7 0.2 0.7 0.0 0.7 1.1 9.1 1.7 0.0 2.0 4.5 1.4 0.1 0.9 1.7 0.5 0.2 7.5 0.4 0.2 0.2 0.1 2.1 0.0 0.4 0.1 0.5 0.2 0.0 0.1 0.0 0.3 0.0 0.3 0.2 0.1 0.5 0.0 0.2 0.0 0.1 0.1 0.0 0.6 0.0 0.6 0.4 0.0 0.0 0.5 0.4 0.1 0.3 0.5 0.2 0.1 0.2 0.1 0.1 CBLL2 "CT138, FLJ25735, HAKAIL, ZNF645" ENSG00000175809 "Cbl proto-oncogene like 2" Q8N7E2 X 22272943-22274461 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 52 "testis: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 CBLN1 ENSG00000102924 "Cerebellin 1 precursor" P23435 16 49277917-49281831 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 106.6" "Group enriched" "Detected in some" 28 "NTERA-2: 16.3;SCLC-21H: 51.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 8.5" "Region enriched" "Detected in many" 12 "cerebellum: 106.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "cerebellum: 688.3" "Region enriched" "Detected in many" 15 "cerebellum: 300.1" "Secreted in brain" 2900000 "unprognostic (1.39e-2)" "unprognostic (1.88e-2)" "unprognostic (1.53e-1)" "unprognostic (3.16e-1)" "unprognostic (1.62e-1)" "unprognostic (6.07e-2)" "unprognostic (9.65e-3)" "unprognostic (1.18e-2)" "unprognostic (6.31e-2)" "unprognostic (1.89e-2)" "unprognostic (2.02e-1)" "unprognostic (4.04e-2)" "unprognostic (7.68e-2)" "unprognostic (2.45e-1)" "unprognostic (1.06e-2)" "prognostic favourable (7.10e-4)" "unprognostic (1.60e-2)" 9.9 0.8 0.9 0.1 1.0 0.0 1.2 106.6 4.9 2.0 0.4 0.4 0.4 0.6 5.9 1.4 0.8 0.9 9.0 4.2 0.7 9.2 0.2 0.7 0.1 0.9 4.5 1.0 0.5 2.4 0.0 0.9 0.4 4.6 0.3 0.4 1.1 0.7 3.0 0.5 0.3 0.5 1.5 2.3 0.1 0.5 16.0 0.4 0.2 0.6 0.6 2.4 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 1.1 1.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.1 0.0 0.0 0.0 0.0 0.0 51.9 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 106.6 1.4 0.7 9.2 4.5 1.0 4.6 0.4 CBLN2 ENSG00000141668 "Cerebellin 2 precursor" Q8IUK8 18 72536680-72638521 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 33.8" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 34.7" "Cancer enriched" "Detected in single" 7 "breast cancer: 3.1" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in brain" 1300000 "unprognostic (2.03e-2)" "unprognostic (3.52e-1)" "unprognostic (1.13e-3)" "unprognostic (9.09e-5)" "unprognostic (7.10e-2)" "unprognostic (6.27e-3)" "unprognostic (7.39e-2)" "unprognostic (2.17e-1)" "unprognostic (1.37e-4)" "unprognostic (5.01e-4)" "unprognostic (8.15e-2)" "unprognostic (6.07e-4)" "unprognostic (7.19e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (4.93e-2)" 0.6 0.7 5.4 0.8 10.4 0.4 0.6 0.8 33.8 1.0 2.9 0.9 0.0 2.5 0.5 0.4 0.5 0.5 0.4 0.4 4.5 9.5 1.5 0.9 0.4 0.5 7.0 16.4 0.6 0.4 0.4 0.3 0.4 17.8 1.8 2.6 1.9 0.4 8.2 0.4 0.9 3.8 1.5 2.6 0.4 0.6 0.6 0.0 0.0 0.4 0.0 1.3 0.5 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 34.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 10.4 0.8 33.8 4.5 9.5 7.0 16.4 17.8 0.0 CBLN3 ENSG00000139899 "Cerebellin 3 precursor" Q6UW01 14 24426532-24430954 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 105.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.8;HDLM-2: 12.5;HSkMC: 18.6;Karpas-707: 14.0;U-266/70: 9.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 23 "cerebellum: 105.2" "Cell type enhanced" "Detected in some" "memory B-cell: 1.5;naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in some" 25 "cerebellum: 481.8" "Region enriched" "Detected in some" 48 "cerebellum: 583.0" HPA041266 Enhanced Supported Approved Nucleoplasm "Secreted in brain" Nucleoplasm "HPA041266: AB_10674430" "unprognostic (5.02e-2)" "unprognostic (3.26e-1)" "unprognostic (1.43e-3)" "prognostic unfavourable (4.22e-4)" "unprognostic (4.39e-4)" "unprognostic (5.39e-3)" "unprognostic (1.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.16e-2)" "unprognostic (9.76e-2)" "unprognostic (6.20e-2)" "unprognostic (2.71e-2)" "prognostic unfavourable (6.20e-6)" "unprognostic (2.75e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (9.02e-2)" 2.1 7.7 1.2 4.5 1.3 0.0 1.2 105.2 1.7 1.8 1.1 1.9 1.0 0.6 1.3 4.8 1.0 1.2 3.1 1.6 1.0 1.1 1.2 1.4 1.3 7.9 1.3 1.4 3.3 1.0 1.0 1.3 1.7 4.6 1.2 0.7 1.7 1.6 1.6 1.4 1.6 1.3 1.3 2.0 7.4 1.4 1.6 1.1 1.1 1.2 1.5 5.3 1.9 1.3 2.3 0.3 0.1 0.8 0.0 0.3 0.0 1.1 1.0 0.5 1.9 4.9 10.8 0.3 4.1 8.5 1.6 2.1 0.5 2.0 1.8 0.9 2.6 0.3 0.6 2.2 1.1 12.5 0.4 0.0 3.4 0.8 2.7 0.3 0.7 18.6 1.0 2.1 1.7 1.4 0.5 14.0 2.1 0.6 0.0 0.5 0.1 1.1 0.0 0.0 1.3 1.0 0.4 0.7 0.4 0.3 0.1 0.5 0.6 0.4 6.5 6.0 1.2 2.4 0.2 9.8 2.3 1.9 0.3 0.8 1.0 0.0 0.0 0.1 0.0 0.8 0.3 1.5 0.1 0.1 0.0 2.3 0.2 0.0 0.1 0.0 0.1 0.3 0.0 0.0 1.2 1.3 105.2 1.7 1.0 1.1 1.3 1.4 4.6 1.1 CBY3 ENSG00000204659 "Chibby family member 3" A6NI87 5 179678583-179680974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 15.8" "Cell line enhanced" "Detected in some" "AN3-CA: 2.8;BEWO: 1.9;HDLM-2: 5.2;HeLa: 3.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA069037 Uncertain "HPA069037: " "unprognostic (1.33e-1)" "unprognostic (1.57e-1)" "unprognostic (1.23e-2)" "unprognostic (1.15e-2)" "unprognostic (1.76e-1)" "unprognostic (8.68e-3)" "unprognostic (7.69e-3)" "unprognostic (5.71e-2)" "unprognostic (1.56e-2)" "unprognostic (9.14e-2)" "unprognostic (6.10e-4)" "unprognostic (2.69e-2)" "unprognostic (1.67e-2)" "unprognostic (9.76e-3)" "unprognostic (7.85e-2)" "unprognostic (5.04e-3)" "unprognostic (4.98e-2)" 0.4 0.6 1.1 0.5 1.3 0.2 0.4 0.8 1.2 0.4 0.4 0.4 0.4 0.6 0.4 0.4 0.4 0.3 0.4 0.4 1.1 1.3 0.4 0.4 0.4 0.8 1.9 0.4 0.9 1.1 0.0 0.6 0.4 0.4 0.5 0.0 0.4 0.4 0.4 1.1 1.6 0.9 0.4 2.1 1.2 0.9 15.8 0.4 0.4 0.9 0.4 0.4 0.4 0.4 2.9 1.2 0.1 1.0 0.4 2.1 0.6 0.0 0.5 0.0 2.8 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.2 0.3 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.1 0.9 0.1 0.0 0.3 0.0 0.3 0.0 0.1 1.3 0.1 0.6 0.1 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.3 0.7 0.0 0.5 0.0 2.0 1.0 1.1 1.2 2.1 0.7 1.2 2.9 2.1 1.3 0.1 0.4 0.1 0.9 1.4 0.6 1.1 1.3 0.8 0.5 1.1 1.3 1.9 0.4 0.4 0.4 CCDC105 FLJ40365 ENSG00000160994 "Coiled-coil domain containing 105" Q8IYK2 19 15010744-15023269 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 94 "testis: 38.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA058585 Approved "HPA058585: " 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 38.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 CCDC116 FLJ36046 ENSG00000161180 "Coiled-coil domain containing 116" Q8IYX3 22 21632716-21637327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 45.3" "Cell line enhanced" "Detected in some" "HMC-1: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (7.01e-2)" "unprognostic (6.01e-4)" "unprognostic (1.04e-1)" "unprognostic (6.85e-3)" "unprognostic (1.34e-2)" "unprognostic (1.15e-1)" "unprognostic (1.67e-2)" "unprognostic (5.13e-2)" "unprognostic (2.01e-1)" "unprognostic (4.75e-2)" "unprognostic (1.37e-3)" "unprognostic (4.14e-1)" "unprognostic (5.79e-4)" "unprognostic (1.82e-1)" "unprognostic (3.13e-2)" "unprognostic (2.47e-2)" "unprognostic (8.64e-2)" 0.3 0.1 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.6 0.5 0.2 0.2 0.0 0.8 0.7 0.2 0.4 0.3 0.5 0.2 0.0 0.2 0.2 0.3 0.3 0.2 0.2 0.7 0.2 0.3 0.2 0.6 0.2 0.6 0.2 0.2 0.4 0.6 0.4 0.2 0.7 0.2 0.2 0.4 0.3 45.3 0.2 0.2 0.5 0.2 0.4 0.2 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.0 0.6 1.1 0.8 0.1 1.6 1.7 0.0 0.7 0.4 0.1 0.5 1.0 1.1 0.4 0.5 0.3 0.2 0.3 0.4 0.7 0.4 0.5 0.4 0.1 0.2 7.4 0.1 0.2 0.6 0.1 0.1 3.0 0.4 0.3 2.5 2.7 0.2 0.1 0.3 0.9 1.2 0.0 0.0 0.6 0.2 0.7 0.2 0.3 0.0 0.7 0.4 0.0 2.4 2.7 0.8 0.3 3.1 1.7 0.3 1.2 2.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 CCDC155 "FLJ32658, KASH5" ENSG00000161609 "Coiled-coil domain containing 155" Q8N6L0 19 49388218-49417994 "Predicted intracellular proteins, Predicted membrane proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 51.2" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.0;U-266/70: 8.4;U-698: 2.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Region enriched" "Detected in single" 39 "cerebellum: 7.7" "Cell type enhanced" "Detected in single" "naive B-cell: 1.3" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA019937, HPA019940" Enhanced "HPA019937: AB_1848877, HPA019940: AB_1848879" "unprognostic (1.31e-1)" "unprognostic (4.23e-2)" "unprognostic (2.28e-2)" "unprognostic (1.09e-2)" "unprognostic (3.99e-1)" "unprognostic (1.79e-1)" "unprognostic (6.41e-2)" "unprognostic (5.31e-2)" "unprognostic (8.96e-2)" "unprognostic (1.84e-1)" "unprognostic (1.06e-1)" "unprognostic (2.57e-1)" "unprognostic (7.11e-9)" "unprognostic (6.50e-2)" "unprognostic (4.18e-1)" "unprognostic (3.08e-3)" "unprognostic (1.20e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 1.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.2 0.0 1.6 0.1 0.9 0.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 8.4 1.3 2.1 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 7.7 0.1 0.0 0.0 0.1 0.0 0.1 0.0 CCDC158 FLJ25770 ENSG00000163749 "Coiled-coil domain containing 158" Q5M9N0 4 76312997-76421868 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 26.3" "Cell line enhanced" "Detected in some" "HSkMC: 1.2;SiHa: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "unprognostic (3.31e-2)" "unprognostic (1.63e-1)" "unprognostic (7.49e-2)" "unprognostic (3.30e-2)" "unprognostic (3.29e-3)" "unprognostic (1.60e-1)" "unprognostic (2.60e-3)" "unprognostic (6.99e-2)" "unprognostic (1.57e-1)" "unprognostic (9.70e-2)" "unprognostic (1.08e-3)" "unprognostic (2.18e-1)" "unprognostic (9.77e-3)" "unprognostic (6.22e-2)" "unprognostic (3.65e-2)" "unprognostic (9.29e-2)" "unprognostic (2.68e-1)" 0.2 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.1 0.2 0.2 1.2 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 26.3 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 1.5 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC166 ENSG00000255181 "Coiled-coil domain containing 166" P0CW27 8 143706694-143708109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025058 Uncertain "HPA025058: " "unprognostic (2.65e-1)" "unprognostic (3.64e-1)" "unprognostic (6.18e-2)" "unprognostic (4.97e-1)" "unprognostic (1.67e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC168 "C13orf40, FLJ40176" ENSG00000175820 "Coiled-coil domain containing 168" Q8NDH2 13 102729369-102759070 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 23.7" "Cell line enhanced" "Detected in some" "HL-60: 1.5;MOLT-4: 1.3;NB-4: 1.0;THP-1: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048184, HPA058793" Uncertain "HPA048184: , HPA058793: " "unprognostic (2.06e-1)" "unprognostic (7.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.38e-1)" "unprognostic (2.39e-4)" "unprognostic (2.09e-2)" "unprognostic (3.68e-2)" "unprognostic (2.74e-1)" "unprognostic (5.05e-2)" "unprognostic (3.61e-1)" "unprognostic (2.89e-3)" "unprognostic (1.73e-1)" "unprognostic (1.44e-5)" "unprognostic (2.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.85e-1)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.9 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.7 0.1 0.0 0.0 0.3 0.0 0.2 0.3 0.2 0.7 0.1 0.0 0.0 1.5 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.3 1.0 0.0 0.3 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.0 2.0 0.0 0.0 0.1 0.3 0.3 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC169 "C13orf38, LOC728591, RP11-251J8.1" ENSG00000242715 "Coiled-coil domain containing 169" A6NNP5 13 36222008-36297840 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "testis: 46.7" "Cell line enhanced" "Detected in many" "HL-60: 17.2;U-937: 10.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "unprognostic (9.12e-3)" "unprognostic (1.05e-1)" "unprognostic (7.09e-2)" "unprognostic (2.38e-1)" "unprognostic (3.51e-2)" "unprognostic (7.26e-4)" "unprognostic (6.91e-2)" "unprognostic (3.31e-2)" "unprognostic (5.78e-3)" "unprognostic (2.82e-2)" "unprognostic (1.83e-1)" "unprognostic (2.80e-1)" "unprognostic (1.09e-1)" "unprognostic (8.65e-2)" "unprognostic (2.26e-2)" "unprognostic (1.14e-2)" 0.5 0.7 0.7 0.5 2.2 2.2 0.7 0.4 1.8 0.6 0.9 0.5 5.6 0.3 1.3 2.4 0.5 0.5 0.4 0.5 0.7 0.7 0.9 0.4 0.4 0.3 0.7 1.6 0.4 0.5 2.5 0.4 3.9 1.5 1.1 0.4 0.8 0.4 10.2 0.7 0.5 0.5 3.5 1.3 0.4 0.6 46.7 0.2 0.0 0.5 0.0 0.1 2.0 0.5 1.4 0.6 2.2 0.7 0.9 0.9 0.1 0.2 0.5 0.9 0.4 1.6 2.8 5.9 1.0 1.3 0.7 0.7 0.3 0.3 0.7 0.6 0.3 0.5 5.8 0.2 1.6 0.8 0.6 5.0 1.3 0.3 4.0 17.2 0.5 2.0 1.3 0.6 1.1 3.6 4.2 1.7 2.9 0.2 0.5 6.2 0.5 0.4 0.5 1.4 0.3 0.7 2.4 0.8 2.6 0.4 0.7 0.3 0.5 6.9 1.2 1.0 2.5 0.8 1.9 0.8 0.7 0.2 0.9 10.2 0.9 1.2 0.7 0.3 0.8 0.5 0.9 0.7 0.6 0.6 0.6 1.4 0.7 0.7 2.2 0.9 0.6 0.6 0.2 0.1 0.7 2.2 0.4 1.8 0.7 0.7 0.7 1.6 1.5 0.2 CCDC169-SOHLH2 C13orf38-SOHLH2 ENSG00000250709 "CCDC169-SOHLH2 readthrough" 13 36168794-36297842 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 42.2" "Cell line enhanced" "Detected in some" "BEWO: 3.3;HEL: 2.3;HL-60: 6.1;LHCN-M2: 2.3;NB-4: 3.5;U-937: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA029182 Uncertain Vesicles Vesicles "HPA029182: AB_10602409" "unprognostic (5.56e-2)" "unprognostic (3.93e-1)" "unprognostic (3.60e-2)" "unprognostic (4.66e-1)" "unprognostic (2.17e-1)" "unprognostic (1.84e-2)" "unprognostic (6.12e-2)" "unprognostic (3.43e-2)" 0.4 0.5 0.5 0.2 1.8 0.2 0.4 0.4 1.4 0.5 0.8 0.3 4.9 0.2 1.0 2.0 0.3 0.4 0.3 1.1 0.5 0.6 0.7 0.3 0.3 0.2 0.5 1.3 0.4 0.4 0.3 0.3 3.3 1.1 0.6 0.3 0.5 0.4 9.1 0.5 0.3 0.4 3.0 1.0 0.3 0.6 42.2 0.0 0.0 0.4 0.0 0.2 1.6 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 3.3 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.3 6.1 0.0 0.1 0.0 0.8 0.0 0.8 0.1 0.0 2.3 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 1.7 0.0 0.1 0.0 0.1 1.1 0.6 0.0 0.3 0.1 0.6 0.0 0.0 0.0 0.1 5.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.4 1.4 0.5 0.6 0.5 1.3 1.1 0.0 CCDC172 "C10orf96, MGC35062" ENSG00000182645 "Coiled-coil domain containing 172" P0C7W6 10 116324428-116380029 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 23.4" "Cell line enriched" "Detected in single" 164 "NTERA-2: 26.1" "Cancer enriched" "Detected in single" 14 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "pons and medulla: 0.1" "unprognostic (9.85e-2)" 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.5 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 CCDC177 "C14orf162, PLPL" ENSG00000267909 "Coiled-coil domain containing 177" Q9NQR7 14 69569816-69574837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 17.5" "Cell line enhanced" "Detected in some" "AF22: 1.9;NTERA-2: 2.8;SCLC-21H: 5.5;SH-SY5Y: 1.0;SK-BR-3: 1.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (2.21e-1)" "unprognostic (2.33e-2)" "unprognostic (6.94e-3)" "unprognostic (1.34e-2)" "unprognostic (2.64e-3)" "unprognostic (1.77e-3)" "unprognostic (6.34e-4)" "unprognostic (2.58e-2)" "unprognostic (1.19e-1)" "unprognostic (1.99e-2)" "unprognostic (3.16e-1)" "unprognostic (7.84e-5)" "unprognostic (2.15e-4)" "unprognostic (3.81e-1)" "unprognostic (1.45e-1)" 0.4 1.1 3.2 0.4 3.7 0.3 1.0 17.5 8.5 0.3 0.3 0.2 0.0 0.3 0.4 3.1 0.4 0.4 0.3 0.3 2.2 1.6 0.3 0.6 0.3 0.3 0.5 4.4 0.4 0.3 0.3 0.3 0.3 2.3 0.3 0.3 1.8 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.3 0.3 1.5 0.0 0.0 0.3 0.0 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 5.5 1.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.7 17.5 8.5 2.2 1.6 0.5 4.4 2.3 0.0 CCDC179 ENSG00000255359 "Coiled-coil domain containing 179" H3BU77 11 22846931-22860426 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 42 "testis: 41.8" "Cell line enhanced" "Detected in single" "Karpas-707: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 3.6" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CCDC180 "BDAG1, C9orf174, DKFZp434I2420, KIAA1529" ENSG00000197816 "Coiled-coil domain containing 180" Q9P1Z9 9 97307304-97378524 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 54.4" "Cell line enhanced" "Detected in many" "HDLM-2: 6.5;U-266/70: 9.6;U-266/84: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;memory B-cell: 1.5" "Group enriched" "Detected in many" 14 "B-cells: 1.5;T-cells: 1.1" "Low region specificity" "Detected in some" "unprognostic (9.92e-2)" "unprognostic (9.73e-2)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-3)" "unprognostic (2.94e-2)" "unprognostic (3.52e-2)" "unprognostic (2.94e-1)" "unprognostic (1.52e-1)" "unprognostic (5.53e-5)" "unprognostic (2.33e-2)" "unprognostic (7.34e-3)" "unprognostic (1.64e-1)" "unprognostic (2.54e-1)" "unprognostic (1.41e-2)" "unprognostic (7.50e-3)" 0.5 0.8 1.2 0.3 4.1 0.3 1.1 8.4 2.2 1.2 0.9 4.8 0.7 0.0 1.8 5.7 0.5 8.4 0.6 0.7 1.5 1.5 1.0 0.5 3.1 0.7 1.4 0.3 2.7 0.9 1.4 5.4 0.9 8.1 1.1 0.6 0.5 0.7 0.9 0.8 0.3 0.7 1.2 1.6 0.9 0.6 54.4 1.2 0.9 4.2 0.3 0.5 0.7 1.0 1.5 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.9 1.5 0.9 1.1 3.3 0.0 0.6 1.1 1.1 0.9 1.5 0.9 0.0 1.8 0.0 0.0 1.1 0.0 0.3 6.5 0.6 2.2 1.8 0.8 0.3 2.8 3.7 1.9 1.3 0.0 0.5 0.0 1.5 1.2 0.0 0.2 0.6 3.0 1.0 0.2 0.0 0.3 0.4 0.8 1.1 1.5 1.3 0.3 0.0 1.0 1.0 0.8 0.0 1.1 0.5 2.9 1.6 9.6 6.7 0.0 0.2 0.0 2.8 0.0 0.0 0.0 1.1 0.0 0.6 1.5 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.2 1.2 4.1 8.4 2.2 1.5 1.5 1.4 0.3 8.1 1.2 CCDC182 ENSG00000166329 "Coiled-coil domain containing 182" A6NF36 17 57744481-57745312 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 21.5" "Cell line enhanced" "Detected in some" "REH: 3.0;THP-1: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 0.5" HPA023446 Uncertain "HPA023446: AB_1859510" "unprognostic (1.22e-1)" "unprognostic (3.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 CCDC183 "bA216L13.7, KIAA1984, MGC15438" ENSG00000213213 "Coiled-coil domain containing 183" Q5T5S1 9 136796350-136807741 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 26.4" "Cell line enhanced" "Detected in some" "Hep G2: 2.0;HL-60: 1.4;HSkMC: 1.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 4.5" "Lineage enriched" "Detected in single" 5 "dendritic cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA043812 Uncertain "HPA043812: AB_10961860" "unprognostic (2.91e-1)" "unprognostic (8.34e-2)" "unprognostic (1.54e-2)" "unprognostic (1.38e-1)" "unprognostic (5.27e-2)" "unprognostic (2.37e-1)" "unprognostic (6.89e-5)" "unprognostic (3.45e-2)" "unprognostic (2.26e-2)" "unprognostic (6.49e-2)" "unprognostic (8.16e-3)" "unprognostic (4.32e-2)" "unprognostic (6.98e-2)" "unprognostic (1.86e-2)" "unprognostic (1.30e-1)" "unprognostic (6.20e-2)" "unprognostic (5.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.6 0.2 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.3 1.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC185 "C1orf65, FLJ35728" ENSG00000178395 "Coiled-coil domain containing 185" Q8N715 1 223393417-223395470 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 150 "testis: 31.6" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.71e-1)" "unprognostic (1.55e-2)" "unprognostic (2.41e-6)" "unprognostic (9.69e-2)" "unprognostic (1.79e-2)" "unprognostic (1.12e-2)" "unprognostic (1.53e-1)" "unprognostic (4.65e-1)" "unprognostic (2.58e-1)" "unprognostic (1.37e-3)" "unprognostic (3.13e-1)" "unprognostic (2.61e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 2.9 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 CCDC192 LINC01183 ENSG00000230561 "Coiled-coil domain containing 192" P0DO97 5 127703389-127941634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 16.5" "Cell line enhanced" "Detected in some" "AF22: 6.4;EFO-21: 1.7;HDLM-2: 1.6;HSkMC: 2.6;NTERA-2: 1.4;U-266/70: 3.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.3" "Lineage enhanced" "Detected in single" "T-cells: 1.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "unprognostic (2.64e-1)" "unprognostic (4.24e-2)" "unprognostic (9.22e-2)" "unprognostic (1.09e-2)" "unprognostic (2.44e-2)" "unprognostic (3.01e-2)" "unprognostic (4.07e-5)" "unprognostic (2.46e-2)" "unprognostic (9.34e-2)" "unprognostic (8.18e-2)" "unprognostic (1.35e-1)" "unprognostic (2.86e-2)" "unprognostic (1.52e-6)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (1.98e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 6.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 1.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.3 0.2 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CCDC196 "C14orf53, LINC00238, NCRNA00238" ENSG00000196553 "Coiled-coil domain containing 196" A0A1B0GTZ2 14 66411704-66498677 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 38 "testis: 45.9" "Cell line enhanced" "Detected in single" "HDLM-2: 1.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.96e-2)" "unprognostic (6.53e-2)" "unprognostic (6.56e-2)" "unprognostic (2.57e-2)" "unprognostic (2.53e-1)" "unprognostic (4.47e-1)" "unprognostic (7.20e-2)" "unprognostic (9.22e-2)" "unprognostic (3.60e-6)" "unprognostic (5.72e-2)" "unprognostic (7.10e-2)" "unprognostic (6.03e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CCDC197 "C14orf48, LINC00521" ENSG00000175699 "Coiled-coil domain containing 197" 14 93987225-94008863 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 16 "testis: 25.7" "Cell line enhanced" "Detected in some" "HeLa: 1.5;Karpas-707: 3.4;U-266/70: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.01e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.5 0.3 0.4 0.6 0.1 0.3 0.0 0.2 0.6 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.7 0.7 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.4 0.2 1.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.7 0.0 0.3 0.2 0.2 0.2 0.0 0.8 0.6 0.2 0.0 0.1 4.8 0.1 0.1 0.0 0.2 0.2 0.5 0.3 0.0 0.3 0.0 0.1 0.3 0.3 0.1 0.0 0.9 0.4 0.6 0.3 0.4 0.0 0.4 0.1 0.1 CCDC27 FLJ32825 ENSG00000162592 "Coiled-coil domain containing 27" Q2M243 1 3746460-3771645 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 81 "testis: 53.3" "Cell line enriched" "Detected in single" 9 "THP-1: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.36e-1)" "unprognostic (6.67e-3)" "unprognostic (3.23e-4)" "unprognostic (3.13e-2)" "unprognostic (3.42e-1)" "unprognostic (2.07e-1)" "unprognostic (1.79e-2)" "unprognostic (7.18e-2)" "unprognostic (1.20e-1)" "unprognostic (2.17e-2)" "unprognostic (2.54e-3)" "unprognostic (2.66e-2)" "unprognostic (2.46e-2)" "unprognostic (2.28e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 53.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC28B "MGC1203, RP4-622L5.5" ENSG00000160050 "Coiled-coil domain containing 28B" Q9BUN5 1 32200386-32205387 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 66.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 140.1" "Low region specificity" "Detected in all" HPA028589 Uncertain "HPA028589: AB_10602175" "prognostic favourable (2.92e-4)" "unprognostic (6.01e-3)" "unprognostic (1.04e-1)" "unprognostic (2.61e-2)" "unprognostic (2.59e-3)" "unprognostic (5.18e-2)" "unprognostic (7.50e-3)" "unprognostic (7.87e-2)" "unprognostic (5.15e-2)" "unprognostic (1.79e-2)" "prognostic favourable (1.10e-5)" "unprognostic (2.61e-2)" "unprognostic (1.22e-2)" "unprognostic (1.44e-2)" "unprognostic (1.67e-1)" "unprognostic (7.83e-2)" "unprognostic (1.07e-2)" 2.0 6.5 7.0 4.1 7.2 3.4 1.6 12.4 6.5 2.2 3.1 2.0 1.4 2.4 3.1 3.2 3.2 2.7 3.9 8.6 6.3 4.6 2.9 1.1 2.0 6.8 5.0 6.0 3.4 3.5 4.4 10.1 3.0 4.3 2.7 1.7 4.7 4.0 2.6 66.7 2.6 1.9 3.8 3.6 3.4 2.8 11.7 5.2 4.5 3.2 11.7 4.7 3.2 1.9 9.3 14.2 3.1 4.3 15.8 15.6 8.4 4.6 1.6 10.3 9.9 3.0 3.9 0.8 3.3 4.8 5.9 4.0 3.0 5.3 10.3 5.4 4.0 1.3 8.3 3.9 1.1 11.7 11.8 13.3 7.2 1.8 4.3 0.3 4.6 4.7 1.8 6.6 0.1 8.0 8.5 1.3 3.9 0.6 17.3 2.6 10.5 2.5 18.4 5.0 8.3 5.3 0.7 20.1 8.9 4.8 1.0 5.8 3.2 3.9 4.7 3.4 4.4 4.5 2.1 2.8 0.7 0.6 5.6 17.9 3.2 3.1 4.3 0.9 15.6 2.0 7.8 7.8 7.4 13.2 9.8 9.3 12.4 12.3 0.4 15.8 0.5 14.2 9.6 8.4 7.0 7.2 12.4 6.5 6.3 4.6 5.0 6.0 4.3 5.2 CCDC36 "CT74, FLJ25320" ENSG00000173421 "Coiled-coil domain containing 36" Q8IYA8 3 49198428-49258104 "Predicted intracellular proteins" "Differentiation, DNA recombination, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.4" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 3.8;hTEC/SVTERT24-B: 13.0;LHCN-M2: 5.4;U-2197: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 3.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA045690, HPA069534" Approved Approved Nucleoplasm Nucleoplasm "HPA045690: AB_10964634, HPA069534: " "unprognostic (1.54e-1)" "unprognostic (9.53e-3)" "unprognostic (2.16e-1)" "unprognostic (5.05e-2)" "unprognostic (3.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.36e-2)" "unprognostic (1.49e-2)" "unprognostic (9.94e-3)" "unprognostic (2.62e-1)" "unprognostic (1.38e-1)" "unprognostic (1.36e-2)" "unprognostic (5.51e-4)" "unprognostic (3.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.59e-2)" "unprognostic (6.33e-2)" 6.5 1.7 0.8 1.8 0.8 0.4 3.6 0.8 0.7 3.7 2.2 0.7 2.1 0.4 6.3 1.2 1.1 1.3 1.4 1.9 0.9 0.4 0.5 0.4 1.4 0.5 1.1 0.1 5.0 0.4 0.2 0.4 1.4 2.0 0.6 0.4 2.6 2.0 0.8 1.6 0.8 0.6 3.9 0.4 0.7 0.6 35.4 0.3 0.0 1.3 0.3 0.6 1.2 0.9 0.9 0.6 3.6 0.3 0.8 0.5 0.2 0.0 0.1 0.1 0.2 2.8 3.0 0.1 2.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 3.4 0.0 0.2 2.4 0.0 13.0 0.0 1.6 0.0 0.3 5.4 0.0 0.0 0.2 3.4 0.1 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 2.4 7.0 0.1 0.1 0.1 0.1 0.0 0.2 3.6 2.1 0.3 0.6 0.4 0.2 0.3 0.8 0.4 0.3 0.1 0.9 0.4 0.5 3.6 0.8 0.2 0.6 0.3 0.2 0.8 0.8 0.8 0.7 0.9 0.4 1.1 0.1 2.0 0.3 CCDC38 FLJ40089 ENSG00000165972 "Coiled-coil domain containing 38" Q502W7 12 95867048-95942974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 37.0" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.76e-1)" "unprognostic (1.49e-1)" "unprognostic (7.54e-3)" "unprognostic (2.00e-2)" "unprognostic (3.62e-1)" "unprognostic (5.22e-2)" "unprognostic (1.61e-3)" "unprognostic (3.29e-1)" "unprognostic (5.11e-2)" "unprognostic (8.37e-2)" "unprognostic (1.17e-3)" "unprognostic (2.25e-2)" "unprognostic (2.32e-1)" "unprognostic (1.14e-1)" "unprognostic (1.59e-1)" "unprognostic (4.96e-5)" "unprognostic (1.08e-2)" 0.1 0.7 0.1 0.1 0.2 0.6 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.3 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.2 3.3 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.1 0.7 0.0 37.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.7 3.0 0.5 0.7 0.7 0.1 0.6 1.5 0.9 0.9 0.5 0.2 0.8 0.3 0.1 0.4 0.7 0.8 0.5 0.7 0.3 0.2 1.1 0.8 0.2 0.9 1.5 1.3 1.2 1.3 0.6 0.2 1.1 0.3 0.5 0.7 1.1 0.2 0.1 0.2 1.4 0.2 0.4 0.8 1.3 0.7 1.4 0.6 0.4 0.7 0.4 0.7 1.5 3.5 1.6 0.9 1.8 0.6 1.0 0.3 1.0 1.0 1.8 0.3 1.9 2.1 1.2 1.1 0.6 0.9 1.4 0.5 0.9 0.6 0.3 0.4 0.5 0.4 0.3 0.2 1.2 0.6 0.7 3.0 0.7 0.2 0.7 0.6 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.3 0.1 0.2 0.1 CCDC42 "CCDC42A, FLJ32734" ENSG00000161973 "Coiled-coil domain containing 42" Q96M95 17 8729934-8745219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "testis: 119.7" "Cell line enhanced" "Detected in some" "BEWO: 1.2;HDLM-2: 2.0;REH: 3.8;U-266/84: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "unprognostic (1.66e-1)" "unprognostic (2.92e-2)" "unprognostic (2.30e-2)" "unprognostic (3.60e-2)" "unprognostic (9.24e-2)" "unprognostic (1.13e-4)" "unprognostic (8.35e-2)" "unprognostic (9.71e-2)" "unprognostic (3.06e-2)" "unprognostic (4.36e-3)" "unprognostic (6.08e-2)" "unprognostic (1.04e-5)" "unprognostic (5.74e-2)" "unprognostic (7.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.32e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 119.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.7 0.0 1.9 0.5 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.2 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 2.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.0 1.4 2.0 1.9 1.3 0.2 1.2 0.4 0.6 0.0 0.0 0.7 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC54 "FLJ25362, NYD-SP17, SP17" ENSG00000138483 "Coiled-coil domain containing 54" Q8NEL0 3 107377194-107378637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "testis: 53.5" "Cell line enhanced" "Detected in some" "AN3-CA: 2.1;U-138 MG: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "naive B-cell: 1.9" "Lineage enriched" "Detected in single" 9 "B-cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "unprognostic (2.83e-1)" "unprognostic (4.53e-1)" "unprognostic (9.56e-3)" "unprognostic (1.56e-1)" "unprognostic (2.16e-1)" "unprognostic (2.98e-1)" "unprognostic (5.27e-2)" "unprognostic (9.79e-2)" "unprognostic (7.38e-3)" "unprognostic (1.53e-2)" "unprognostic (7.32e-2)" "unprognostic (5.20e-2)" "unprognostic (1.87e-3)" "unprognostic (8.75e-4)" "unprognostic (5.58e-2)" "unprognostic (5.78e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.2 0.5 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.0 0.5 0.0 0.0 0.5 0.2 0.4 0.0 1.6 0.7 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC62 "CT109, ERAP75, FLJ40344, TSP-NY" ENSG00000130783 "Coiled-coil domain containing 62" Q6P9F0 12 122774327-122827528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 44.3" "Cell line enhanced" "Detected in some" "U-2 OS: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039021, HPA058741" Approved Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA039021: AB_10673604, HPA058741: " "unprognostic (3.39e-2)" "unprognostic (4.16e-2)" "unprognostic (1.46e-2)" "unprognostic (7.48e-2)" "unprognostic (1.58e-2)" "unprognostic (9.37e-2)" "unprognostic (1.65e-1)" "unprognostic (7.09e-2)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (2.21e-4)" "unprognostic (5.23e-1)" "unprognostic (6.39e-6)" "unprognostic (2.78e-2)" "unprognostic (6.18e-2)" "unprognostic (7.27e-2)" "unprognostic (3.25e-4)" 0.2 0.2 0.3 0.1 0.3 0.1 0.1 0.3 0.7 0.2 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.7 0.2 0.1 0.3 0.1 0.6 0.1 0.2 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.5 0.3 0.2 0.1 0.1 0.2 0.3 0.0 44.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 1.1 2.4 0.6 0.8 1.9 0.4 0.4 0.5 0.3 0.9 0.1 0.7 0.9 0.2 0.3 0.8 0.3 0.3 0.7 1.6 0.2 0.0 0.3 0.5 0.2 0.4 0.7 0.7 2.6 0.3 0.2 0.0 1.7 2.1 0.3 1.0 1.1 0.4 0.1 0.9 0.8 1.1 0.3 0.2 3.3 0.4 1.9 2.0 0.8 0.3 0.5 0.3 1.5 0.0 0.3 0.9 1.2 0.1 1.6 0.4 0.9 7.6 0.4 0.4 1.0 0.7 0.7 0.0 0.7 0.5 1.5 0.6 0.4 0.5 0.3 0.9 0.3 0.3 0.4 0.2 1.0 0.8 0.7 2.4 0.8 0.3 1.1 1.9 0.4 0.3 0.3 0.3 0.7 0.7 0.2 0.1 0.2 0.2 0.1 CCDC63 "FLJ35843, ODA5" ENSG00000173093 "Coiled-coil domain containing 63" Q8NA47 12 110846769-110907535 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 26.2" "Cell line enriched" "Detected in single" 18 "MCF7: 9.7" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "cerebellum: 10.3" "Not detected" "Not detected" HPA061568 Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA061568: " "unprognostic (1.98e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-1)" "unprognostic (2.65e-1)" "unprognostic (5.59e-2)" "unprognostic (1.09e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC7 "BIOT2, C10orf68, FLJ13031, FLJ32762" ENSG00000216937 "Coiled-coil domain containing 7" Q96M83 10 32446140-32882874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 65.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA075536 Approved "Nucleoli,Mitotic spindle,Cytosol" Nucleoli "Mitotic spindle, Cytosol" "HPA075536: " "unprognostic (3.43e-3)" "unprognostic (4.75e-2)" "unprognostic (1.85e-1)" "unprognostic (1.01e-2)" "unprognostic (2.69e-2)" "unprognostic (3.75e-3)" "unprognostic (2.65e-5)" "unprognostic (6.95e-2)" "unprognostic (7.57e-2)" "unprognostic (1.55e-1)" "unprognostic (2.44e-3)" "unprognostic (2.84e-2)" "unprognostic (2.95e-5)" "unprognostic (7.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" 2.1 2.1 3.2 3.8 3.6 2.8 2.2 4.8 3.6 2.3 2.1 4.2 4.3 2.0 3.4 5.1 2.0 1.7 1.9 2.3 2.6 1.9 1.9 1.7 2.0 2.8 4.2 1.5 2.7 2.3 2.1 8.5 1.8 3.0 2.1 2.3 1.8 2.0 3.2 2.0 2.0 1.8 2.1 5.4 2.0 2.0 65.5 3.2 3.4 2.7 0.3 2.2 2.3 2.3 2.4 1.7 0.1 0.6 2.9 5.9 0.5 2.5 2.8 0.8 3.5 2.4 1.9 1.3 2.3 0.8 0.8 2.5 0.6 3.8 1.9 1.2 1.6 1.3 1.3 1.4 3.1 6.6 0.3 1.0 2.0 0.7 4.3 1.0 1.9 1.7 0.7 1.7 0.6 1.0 1.5 6.5 3.2 0.4 0.8 0.6 0.7 2.8 1.6 3.6 0.3 2.3 0.5 1.9 1.9 0.4 0.4 1.5 1.9 1.5 3.8 2.0 2.3 2.6 1.3 2.1 1.4 1.9 2.5 7.3 1.1 0.0 0.6 0.1 3.4 0.3 3.3 2.4 5.3 2.9 0.3 1.2 5.9 3.9 0.1 2.9 0.3 1.7 3.5 0.5 3.2 3.6 4.8 3.6 2.6 1.9 4.2 1.5 3.0 3.2 CCDC70 "DKFZP434K1172, FLJ25853" ENSG00000123171 "Coiled-coil domain containing 70" Q6NSX1 13 51861981-51866232 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 470 "testis: 46.9" "Cell line enriched" "Detected in single" 6 "TIME: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in male reproductive system" "unprognostic (5.73e-3)" "unprognostic (1.88e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC73 NY-SAR-79 ENSG00000186714 "Coiled-coil domain containing 73" Q6ZRK6 11 32602246-32794658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 13.7" "Cell line enhanced" "Detected in some" "BJ: 2.7;MOLT-4: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.3;naive B-cell: 1.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA038668, HPA038669" Uncertain "HPA038668: AB_10673292, HPA038669: " "unprognostic (9.41e-3)" "unprognostic (2.46e-2)" "unprognostic (2.36e-1)" "unprognostic (8.65e-2)" "unprognostic (5.79e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.73e-4)" "unprognostic (1.74e-1)" "unprognostic (2.02e-2)" "unprognostic (2.10e-2)" "unprognostic (3.27e-2)" "unprognostic (1.62e-5)" "unprognostic (3.87e-1)" "unprognostic (1.02e-1)" "unprognostic (1.68e-1)" "unprognostic (1.20e-3)" 0.2 0.6 0.2 0.2 0.2 0.7 0.2 0.8 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.5 0.4 1.0 0.2 0.4 0.2 0.2 1.7 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 1.1 0.0 13.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.2 0.5 1.3 0.0 0.0 0.2 0.1 0.0 0.5 0.5 0.0 0.0 0.4 2.7 0.0 0.0 0.1 0.1 0.4 0.5 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.3 0.9 0.1 0.0 0.9 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.3 5.7 1.2 0.4 0.5 0.2 0.4 0.2 0.0 0.7 0.3 0.4 0.2 0.3 0.0 0.2 0.2 0.0 0.4 0.3 0.4 1.3 1.6 0.4 0.4 0.2 0.8 0.1 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.2 0.2 0.2 0.8 0.4 0.2 0.5 0.2 0.2 0.2 0.2 CCDC83 "CT148, FLJ42119, MGC34732" ENSG00000150676 "Coiled-coil domain containing 83" Q8IWF9 11 85855101-85920021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 27.7" "Cell line enriched" "Detected in single" 10 "MCF7: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039707, HPA039882" Uncertain "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA039707: AB_10795259, HPA039882: AB_10795410" "unprognostic (1.14e-1)" "unprognostic (4.09e-1)" "unprognostic (1.49e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-6)" "unprognostic (3.52e-1)" "unprognostic (2.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.8 0.8 0.3 0.6 0.0 0.1 0.0 0.5 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.7 0.3 0.3 0.2 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.1 0.3 7.7 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.6 0.3 0.1 0.1 0.1 0.5 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.2 0.1 0.3 0.8 0.6 0.3 0.6 0.4 0.4 0.3 0.3 0.3 0.3 0.4 0.3 0.5 1.8 0.3 0.8 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC86 MGC2574 ENSG00000110104 "Coiled-coil domain containing 86" Q9H6F5 11 60842071-60851081 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 200.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041117, HPA041540" Enhanced Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA041117: AB_10794984, HPA041540: AB_10794299" "unprognostic (2.93e-1)" "unprognostic (6.59e-2)" "unprognostic (2.38e-1)" "unprognostic (1.47e-3)" "unprognostic (3.64e-1)" "prognostic unfavourable (7.36e-5)" "prognostic unfavourable (1.71e-4)" "unprognostic (1.65e-3)" "unprognostic (9.52e-2)" "unprognostic (1.25e-2)" "unprognostic (6.12e-2)" "unprognostic (4.47e-1)" "unprognostic (3.76e-2)" "unprognostic (7.54e-3)" "unprognostic (2.90e-1)" "unprognostic (2.16e-1)" "unprognostic (6.25e-2)" 13.5 12.4 7.3 8.6 11.0 6.1 11.2 3.3 11.2 5.8 6.7 7.9 3.4 7.4 8.4 5.0 9.3 7.4 8.3 9.3 6.7 6.4 8.1 11.4 5.4 8.2 10.0 6.0 11.3 13.6 200.8 12.7 7.3 8.5 11.9 4.7 6.7 6.4 6.2 20.2 10.4 6.2 7.3 6.7 9.3 7.7 47.8 8.7 10.2 7.9 12.6 6.5 8.6 6.5 6.9 20.0 5.0 19.5 4.2 8.5 6.7 20.9 28.6 7.1 20.4 5.7 9.5 9.7 14.1 11.0 26.0 14.0 24.3 14.1 25.7 27.0 7.6 19.7 23.9 17.0 12.0 9.0 26.4 13.1 12.7 33.9 19.1 20.4 22.4 10.9 13.0 24.0 15.2 19.2 41.7 13.2 12.7 24.8 30.6 31.1 28.6 41.1 21.0 10.6 64.6 9.0 8.9 16.0 10.3 9.1 21.0 16.5 21.2 8.2 12.5 25.9 15.9 35.1 30.5 11.2 16.5 27.8 21.2 22.1 31.3 2.6 9.1 5.0 6.5 19.5 6.9 6.9 6.9 6.0 20.0 6.5 8.5 7.4 0.7 4.2 6.3 11.2 6.2 6.7 7.3 11.0 3.3 11.2 6.7 6.4 10.0 6.0 8.5 8.7 CCDC87 FLJ10786 ENSG00000182791 "Coiled-coil domain containing 87" Q9NVE4 11 66590176-66593083 "Predicted intracellular proteins" "Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 31.1" "Cell line enhanced" "Detected in some" "A549: 3.7;SCLC-21H: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.2" "Lineage enhanced" "Detected in single" "dendritic cells: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (3.48e-2)" "unprognostic (1.06e-1)" "unprognostic (4.96e-2)" "unprognostic (6.37e-2)" "unprognostic (2.25e-3)" "unprognostic (2.71e-2)" "unprognostic (8.59e-3)" "unprognostic (1.66e-1)" "unprognostic (1.37e-1)" "unprognostic (5.17e-2)" "unprognostic (2.16e-3)" "unprognostic (2.56e-2)" "unprognostic (3.97e-3)" "unprognostic (8.25e-2)" "unprognostic (2.29e-1)" "unprognostic (3.39e-2)" "unprognostic (2.42e-1)" 0.3 0.6 1.9 0.4 2.2 0.1 0.5 1.1 2.4 0.6 0.5 0.7 2.0 0.3 0.5 3.4 0.4 0.7 0.4 0.5 0.6 0.7 0.9 0.5 0.3 0.2 0.5 1.0 0.4 0.5 3.0 3.5 0.2 0.9 0.5 0.3 2.3 0.7 1.3 0.5 0.4 0.3 0.6 0.4 0.3 0.5 31.1 0.3 0.0 1.7 0.1 0.2 0.5 0.3 0.0 2.2 0.1 0.5 0.0 0.0 0.0 1.1 3.7 0.6 0.9 1.0 0.5 0.5 0.2 1.1 0.8 0.4 2.4 1.0 0.0 1.4 0.5 1.8 0.6 0.2 0.4 0.5 0.2 0.6 0.8 0.4 0.8 0.1 0.6 0.4 0.7 0.1 0.0 0.6 0.4 0.4 0.8 1.4 0.6 0.5 0.9 0.6 1.0 0.9 0.0 1.4 0.2 6.6 0.9 1.6 1.4 0.2 1.6 0.2 0.0 0.1 0.4 0.7 0.3 0.1 0.5 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 2.2 0.0 0.0 1.9 2.2 1.1 2.4 0.6 0.7 0.5 1.0 0.9 0.3 CCDC96 FLJ90575 ENSG00000173013 "Coiled-coil domain containing 96" Q2M329 4 7040849-7042939 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 52.9" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA047546 Enhanced "HPA047546: " "unprognostic (6.20e-3)" "unprognostic (4.03e-2)" "unprognostic (7.95e-2)" "prognostic favourable (4.05e-4)" "unprognostic (1.22e-2)" "unprognostic (3.51e-3)" "unprognostic (1.77e-1)" "unprognostic (9.24e-3)" "unprognostic (1.01e-2)" "unprognostic (3.92e-1)" "prognostic favourable (4.87e-4)" "unprognostic (1.43e-1)" "prognostic favourable (3.80e-5)" "unprognostic (4.37e-2)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (1.10e-2)" 0.8 1.4 1.7 0.5 3.9 1.1 1.2 1.1 2.6 0.8 0.6 2.4 0.6 0.9 0.9 3.3 0.8 10.5 1.0 0.5 2.4 2.7 1.2 0.5 1.7 0.7 1.5 2.4 3.0 1.3 1.1 3.0 0.5 4.0 0.9 0.6 0.8 0.9 1.2 0.6 1.6 0.6 0.7 1.2 0.8 1.0 52.9 1.5 0.0 1.5 0.5 0.6 0.6 1.0 0.6 1.6 0.5 3.8 0.4 1.6 0.6 1.6 4.6 2.5 2.0 3.3 2.3 0.5 4.7 2.8 5.2 3.2 1.6 4.1 1.0 1.3 2.6 2.1 0.9 2.1 1.6 0.1 0.7 1.0 2.1 1.1 1.6 1.3 2.6 2.0 2.2 3.2 0.4 2.1 0.7 0.4 3.3 4.0 2.7 1.7 1.0 2.8 1.1 1.7 0.3 9.2 1.7 6.8 1.5 3.7 1.7 0.8 1.8 2.4 2.3 4.4 1.2 2.7 3.5 0.0 0.1 0.9 3.5 0.1 1.4 0.0 1.6 0.0 0.3 3.8 0.7 0.6 0.4 0.0 1.6 0.0 0.3 1.6 0.5 0.4 2.9 0.0 0.0 0.6 1.7 3.9 1.1 2.6 2.4 2.7 1.5 2.4 4.0 1.5 CCER1 "C12orf12, MGC26598" ENSG00000197651 "Coiled-coil glutamate rich protein 1" Q8TC90 12 90905622-90955176 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 67 "testis: 51.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "amygdala: 1.4;basal ganglia: 1.0;cerebral cortex: 1.6;hippocampal formation: 1.4" "unprognostic (1.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 CCHCR1 "C6orf18, HCR" ENSG00000204536 "Coiled-coil alpha-helical rod protein 1" Q8TD31 6 31142439-31158238 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 50.1" "Cell line enhanced" "Detected in many" "A-431: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054167 Supported Cytosol Cytosol "HPA054167: " "unprognostic (6.68e-2)" "unprognostic (7.98e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.88e-1)" "unprognostic (3.11e-3)" "unprognostic (2.23e-3)" "unprognostic (1.99e-1)" "unprognostic (2.74e-1)" "unprognostic (5.36e-3)" "unprognostic (1.65e-1)" "unprognostic (2.07e-1)" "unprognostic (3.85e-3)" "unprognostic (1.06e-1)" "unprognostic (4.35e-2)" "unprognostic (3.57e-1)" "unprognostic (4.17e-2)" 2.4 2.7 5.6 2.8 6.2 1.2 3.1 5.2 6.4 3.7 4.5 2.9 9.1 9.4 6.3 5.6 3.9 8.0 2.9 2.5 4.0 2.7 4.3 2.9 3.0 5.5 4.1 5.6 5.5 7.6 1.7 2.5 1.5 4.5 5.3 3.2 3.4 3.5 6.8 10.1 7.0 5.9 3.9 2.6 3.4 6.6 50.1 3.8 4.3 6.2 3.1 4.2 3.4 4.0 2.0 3.4 1.4 2.1 2.5 4.3 2.3 22.3 1.7 6.3 1.0 3.9 4.6 5.9 1.9 0.6 0.3 0.7 9.0 0.4 2.9 10.7 5.0 0.9 0.3 9.0 0.9 3.3 14.3 10.6 7.4 6.8 2.2 0.2 7.0 5.9 1.0 4.1 0.9 4.8 4.1 6.2 2.6 1.6 3.9 11.8 0.4 0.1 7.1 8.4 5.4 5.8 2.2 17.7 2.9 7.3 0.0 1.8 2.5 5.6 0.6 9.3 3.0 0.2 5.6 14.5 8.4 12.1 1.9 2.6 0.9 0.3 2.1 1.4 2.9 0.9 2.5 1.3 2.6 4.3 1.5 2.0 4.0 4.0 0.6 2.5 1.2 3.4 4.0 2.3 5.6 6.2 5.2 6.4 4.0 2.7 4.1 5.6 4.5 3.8 CCIN "BTBD20, KBTBD14" ENSG00000185972 Calicin Q13939 9 36169394-36171334 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 72.9" "Cell line enhanced" "Detected in some" "BEWO: 3.5;BJ: 5.4;fHDF/TERT166: 6.4;hTEC/SVTERT24-B: 8.1;TIME: 10.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "myeloid DC: 1.8" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.10e-2)" "unprognostic (9.26e-3)" "unprognostic (6.27e-2)" "unprognostic (8.26e-6)" "unprognostic (1.78e-2)" "unprognostic (5.38e-2)" "unprognostic (1.57e-2)" "unprognostic (7.74e-3)" "unprognostic (5.43e-3)" "unprognostic (4.49e-2)" "unprognostic (1.77e-1)" "unprognostic (1.36e-1)" "unprognostic (5.98e-5)" "unprognostic (3.27e-3)" "unprognostic (7.86e-2)" "unprognostic (1.07e-1)" "unprognostic (2.43e-3)" 0.2 0.2 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.7 0.5 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 1.1 0.1 0.1 0.0 72.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.4 3.5 5.4 0.5 0.1 0.2 0.0 0.0 0.0 1.5 6.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 2.2 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.1 1.8 0.3 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CCL16 "CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4" ENSG00000275152 "C-C motif chemokine ligand 16" O15467 17 35976493-35981496 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 127 "liver: 79.1" "Cell line enriched" "Detected in single" 23 "Hep G2: 14.6" "Cancer enriched" "Detected in single" 154 "liver cancer: 49.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" 749700 20000000 "unprognostic (3.85e-1)" "unprognostic (4.71e-1)" "unprognostic (1.49e-1)" "unprognostic (3.75e-2)" "unprognostic (2.72e-1)" "unprognostic (4.58e-2)" "unprognostic (2.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.54e-1)" "unprognostic (1.91e-2)" "unprognostic (3.57e-1)" "unprognostic (1.40e-3)" "unprognostic (1.66e-2)" "unprognostic (2.32e-1)" "unprognostic (1.09e-1)" "unprognostic (4.08e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 CCL19 "CKb11, ELC, exodus-3, MIP-3b, SCYA19" ENSG00000172724 "C-C motif chemokine ligand 19" Q99731 9 34689567-34691277 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 418.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.9;Daudi: 2.5;HDLM-2: 7.5;HL-60: 1.9;TIME: 3.7" "Cancer enhanced" "Detected in all" "testis cancer: 118.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "intermediate monocyte: 2.3" "Lineage enriched" "Detected in single" 6 "monocytes: 2.3" "Low region specificity" "Detected in many" HPA067758 Enhanced "Secreted to blood" 195000 "HPA067758: " "prognostic favourable (2.88e-5)" "prognostic favourable (9.91e-6)" "unprognostic (8.25e-3)" "unprognostic (1.16e-1)" "unprognostic (1.65e-1)" "unprognostic (1.67e-2)" "unprognostic (1.30e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-2)" "unprognostic (8.36e-3)" "unprognostic (8.31e-2)" "unprognostic (2.43e-1)" "prognostic unfavourable (8.63e-7)" "unprognostic (7.98e-2)" "unprognostic (1.68e-2)" "unprognostic (2.03e-1)" "unprognostic (1.87e-1)" 22.5 0.6 1.2 82.3 1.1 0.0 10.2 0.8 1.3 5.8 4.7 1.5 1.5 1.0 1.5 5.9 16.3 3.4 10.4 16.5 0.8 0.7 11.8 12.8 13.6 418.9 2.1 1.0 3.4 1.7 0.0 2.0 0.6 1.5 7.0 11.0 7.4 23.1 1.0 0.7 8.7 40.2 4.5 2.2 8.2 9.0 2.8 0.6 73.1 14.9 9.9 90.9 13.4 2.3 0.0 0.0 0.3 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.4 0.0 0.0 0.0 7.5 0.0 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.9 0.0 1.6 0.4 0.0 0.0 0.3 0.0 0.4 0.0 0.7 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.2 1.1 0.8 1.3 0.8 0.7 2.1 1.0 1.5 0.6 CCL21 "6Ckine, CKb9, ECL, exodus-2, SCYA21, SLC, TCA4" ENSG00000137077 "C-C motif chemokine ligand 21" O00585 9 34709005-34710124 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 430.9" "Cell line enhanced" "Detected in some" "Daudi: 3.6;HL-60: 2.3;K-562: 3.8;RH-30: 2.4;U-937: 1.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005067, HPA051210" Enhanced "Secreted to blood" 197877 770000 "CAB005067: AB_2071925, HPA051210: " "unprognostic (3.06e-3)" "unprognostic (7.19e-3)" "unprognostic (9.89e-2)" "unprognostic (5.50e-2)" "unprognostic (4.51e-3)" "unprognostic (1.21e-2)" "unprognostic (1.04e-2)" "unprognostic (8.07e-2)" "unprognostic (4.15e-2)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (8.99e-3)" "unprognostic (3.50e-3)" "unprognostic (1.58e-1)" "unprognostic (2.66e-2)" "unprognostic (8.91e-2)" 24.4 6.5 0.3 83.5 0.4 0.0 18.0 0.3 0.4 13.6 25.5 0.4 5.9 3.7 26.8 23.7 80.1 23.0 23.2 18.8 0.3 0.0 19.6 11.0 30.5 430.9 0.3 0.3 13.8 3.3 0.0 0.4 7.4 0.5 9.4 11.9 0.7 96.9 4.1 4.7 7.6 71.2 10.6 0.3 35.9 10.7 5.5 0.3 2.3 91.0 44.8 181.2 15.7 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.3 0.0 0.4 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.7 2.3 0.3 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 1.2 0.8 0.0 0.9 2.4 0.6 0.0 0.0 0.3 0.5 1.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.5 0.0 0.8 0.0 0.8 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.4 0.3 0.0 0.3 0.3 0.5 0.3 CCL22 "A-152E5.1, ABCD-1, DC/B-CK, MDC, MGC34554, SCYA22, STCP-1" ENSG00000102962 "C-C motif chemokine ligand 22" O00626 16 57358772-57366190 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 89.8" "Cell line enriched" "Detected in some" 18 "HDLM-2: 32.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Secreted to blood" 828500 "unprognostic (2.67e-2)" "unprognostic (7.68e-3)" "prognostic favourable (2.98e-4)" "prognostic favourable (2.23e-6)" "unprognostic (8.87e-2)" "prognostic favourable (9.17e-5)" "unprognostic (1.20e-1)" "unprognostic (8.85e-2)" "unprognostic (1.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.85e-2)" "unprognostic (2.55e-1)" "unprognostic (1.15e-2)" "unprognostic (7.71e-2)" "unprognostic (3.43e-2)" "unprognostic (3.12e-2)" "unprognostic (3.88e-2)" 10.5 0.6 0.3 27.7 0.5 0.3 1.9 0.2 0.3 1.6 1.3 0.0 0.4 1.0 0.6 0.5 4.6 0.4 2.6 0.4 0.3 0.3 0.6 0.5 4.6 11.9 0.3 0.0 0.3 0.9 0.0 0.3 0.2 0.1 0.7 5.4 0.1 5.9 0.2 0.3 7.1 7.4 0.7 0.3 5.5 1.1 0.3 0.0 89.8 0.7 5.9 31.8 3.6 1.6 3.1 2.6 3.7 0.8 1.4 0.7 0.5 0.3 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.1 0.1 0.9 0.0 0.0 0.1 32.4 0.1 0.1 0.2 0.3 0.0 0.1 1.0 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.2 0.3 0.0 0.1 0.1 1.2 0.0 1.8 0.2 0.1 0.1 1.4 0.0 0.2 1.6 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 3.6 0.8 0.6 0.6 0.4 0.4 3.1 0.5 0.4 2.6 1.6 0.6 0.7 3.7 1.4 0.4 1.0 0.4 0.5 0.3 0.5 0.2 0.3 0.3 0.3 0.3 0.0 0.1 0.0 CCL27 "ALP, CTACK, CTAK, ESkine, ILC, PESKY, SCYA27, skinkine" ENSG00000213927 "C-C motif chemokine ligand 27" Q9Y4X3 9 34661880-34664048 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "skin 1: 96.5" "Cell line enhanced" "Detected in some" "AN3-CA: 5.5;HAP1: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 2.0" "Group enriched" "Detected in many" 15 "B-cells: 1.0;T-cells: 2.0" "Not detected" "Not detected" HPA073848 Enhanced "Secreted to blood" 436040 "HPA073848: " 0.1 0.0 0.1 0.1 0.1 0.1 5.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 2.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 96.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 8.0 0.1 0.1 0.1 0.1 0.1 1.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.1 5.5 1.8 1.6 0.5 0.0 0.0 0.5 0.0 0.9 0.0 0.3 0.1 0.0 2.1 3.5 0.0 2.4 2.1 0.0 0.0 1.8 0.8 0.7 0.0 0.0 3.0 1.9 0.6 0.0 0.0 0.5 2.3 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 2.8 0.0 0.4 1.6 0.0 0.0 0.2 1.6 0.0 0.0 2.5 2.0 2.0 0.0 0.3 1.0 0.1 0.9 0.4 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CCL28 "CCK1, MEC, SCYA28" ENSG00000151882 "C-C motif chemokine ligand 28" Q9NRJ3 5 43376645-43412391 "Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "salivary gland: 207.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.8;EFO-21: 8.4;SiHa: 18.9;SK-MEL-30: 10.4;T-47d: 25.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA077434 Supported "Secreted to blood" 700000000 "HPA077434: " "unprognostic (1.04e-2)" "unprognostic (2.66e-1)" "unprognostic (8.14e-3)" "unprognostic (1.94e-2)" "unprognostic (8.85e-4)" "unprognostic (4.93e-3)" "unprognostic (1.20e-3)" "unprognostic (3.56e-2)" "unprognostic (4.91e-3)" "unprognostic (4.14e-2)" "prognostic unfavourable (1.43e-4)" "unprognostic (4.43e-1)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (2.52e-1)" "unprognostic (1.78e-1)" "unprognostic (6.53e-2)" 1.2 0.6 0.8 5.3 0.6 0.6 15.7 0.4 0.8 4.0 8.2 0.2 0.2 6.2 1.4 1.0 2.0 1.1 5.2 0.9 0.6 0.7 1.9 1.0 1.5 2.5 0.6 0.6 0.9 29.8 1.2 1.5 3.1 0.7 1.3 7.6 4.1 207.1 1.1 0.4 2.7 4.9 0.3 1.1 3.0 3.9 1.1 0.5 1.1 9.0 8.4 5.4 1.1 1.4 6.7 1.3 3.8 0.4 4.3 7.7 1.9 0.5 0.0 0.1 0.1 0.6 0.1 3.1 0.4 0.3 0.0 0.0 1.3 6.8 0.0 8.4 0.2 1.1 0.0 0.1 0.0 0.1 0.2 0.5 0.8 0.0 0.5 0.1 0.1 0.7 1.7 0.1 0.3 0.0 0.0 0.2 0.8 0.2 1.1 0.0 0.1 1.1 0.0 0.0 0.3 0.1 0.9 0.2 0.1 18.9 0.7 10.4 25.7 5.0 0.1 0.1 0.8 0.1 0.1 0.5 0.0 0.0 0.0 0.1 5.7 3.8 0.4 0.4 4.8 0.3 3.7 5.5 5.3 3.9 0.8 6.7 6.4 4.6 1.2 4.3 0.2 1.3 7.7 1.9 0.8 0.6 0.4 0.8 0.6 0.7 0.6 0.6 0.7 0.5 CCL5 "D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228" ENSG00000271503 "C-C motif chemokine ligand 5" P13501 17 35871491-35880793 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 169.0" "Cell line enriched" "Detected in some" 4 "NB-4: 71.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 157.7;memory CD8 T-cell: 169.0" "Lineage enriched" "Detected in many" 4 "T-cells: 169.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "Secreted to blood" 21766000 8200000 "unprognostic (3.91e-3)" "unprognostic (1.50e-3)" "unprognostic (8.63e-2)" "prognostic favourable (1.34e-5)" "unprognostic (1.36e-3)" "unprognostic (6.37e-3)" "unprognostic (8.70e-2)" "unprognostic (2.64e-2)" "prognostic favourable (2.42e-4)" "unprognostic (3.26e-3)" "unprognostic (1.64e-2)" "unprognostic (2.88e-1)" "prognostic unfavourable (3.61e-7)" "unprognostic (1.70e-2)" "unprognostic (7.55e-2)" "unprognostic (8.56e-3)" "unprognostic (3.73e-2)" 3.6 2.4 0.0 28.8 0.1 17.1 2.6 0.0 0.2 6.0 14.7 1.0 0.6 7.1 5.0 7.2 5.2 1.7 20.5 7.5 0.0 2.7 4.7 29.8 33.5 2.8 0.0 5.9 2.3 0.0 0.1 4.8 1.7 7.8 4.0 8.0 5.5 6.4 2.8 0.0 38.7 2.3 2.2 38.8 6.9 1.9 0.0 12.2 1.6 5.5 27.9 11.5 0.0 1.2 1.1 9.9 0.6 40.8 169.0 106.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 2.4 2.8 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.2 0.0 0.1 11.3 0.1 0.0 0.0 0.7 0.0 0.0 0.0 1.6 0.0 0.0 0.0 71.3 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.1 1.7 0.0 16.7 0.0 0.0 0.0 0.1 0.0 2.1 0.7 0.1 0.0 15.3 0.1 9.9 0.6 0.7 157.7 0.4 103.8 1.2 36.7 169.0 1.1 0.7 8.8 99.3 4.6 40.8 0.5 0.9 0.5 106.5 CCNA2 "CCN1, CCNA" ENSG00000145386 "Cyclin A2" P20248 4 121816444-121823933 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 122.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 6.8" "Group enriched" "Detected in many" 5 "NK-cells: 1.7;T-cells: 6.8" "Low region specificity" "Detected in single" "CAB000114, HPA020626" Enhanced Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB000114: AB_563675, HPA020626: AB_1847376" "unprognostic (4.02e-2)" "unprognostic (1.93e-1)" "unprognostic (7.66e-3)" "prognostic unfavourable (8.78e-4)" "unprognostic (1.25e-1)" "unprognostic (1.67e-2)" "prognostic unfavourable (9.17e-5)" "prognostic unfavourable (4.27e-4)" "unprognostic (3.92e-3)" "unprognostic (2.65e-2)" "prognostic unfavourable (4.43e-6)" "unprognostic (8.38e-3)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (6.07e-2)" "unprognostic (1.59e-1)" 3.2 1.5 1.3 18.6 1.7 21.6 1.8 5.1 1.2 2.5 6.3 1.0 0.8 6.6 2.2 2.1 11.7 1.7 2.4 3.2 1.8 1.8 1.7 1.6 3.4 15.6 1.6 0.8 4.5 0.9 0.5 3.2 12.0 1.3 2.2 7.8 1.0 2.1 0.8 1.1 4.2 7.4 2.4 1.8 8.9 2.9 8.4 0.8 122.3 1.4 18.8 18.4 2.5 5.1 0.3 0.9 0.6 0.3 1.7 6.8 1.9 38.1 9.9 27.3 11.6 1.4 3.8 22.3 26.6 11.7 35.5 26.4 21.6 23.7 35.1 7.2 14.0 12.9 34.3 15.7 29.2 16.8 15.8 28.2 13.2 21.0 0.3 42.4 20.0 0.9 1.2 14.6 8.8 21.2 40.0 35.3 28.1 13.7 54.0 24.6 21.5 11.1 24.8 52.8 17.1 10.0 7.6 11.6 12.3 14.0 17.1 7.4 14.3 18.0 12.4 16.6 25.2 17.5 25.4 22.4 23.7 40.2 9.5 43.2 18.4 0.0 0.3 0.6 0.2 0.1 0.1 0.3 2.0 1.4 0.9 0.1 0.0 0.5 0.3 1.7 0.3 0.1 6.8 1.9 1.3 1.7 5.1 1.2 1.8 1.8 1.6 0.8 1.3 0.8 CCR3 "CC-CKR-3, CD193, CKR3, CMKBR3" ENSG00000183625 "C-C motif chemokine receptor 3" P51677 3 46163604-46266706 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "blood: 175.9" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 24.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 22 "basophil: 175.9;eosinophil: 152.0" "Lineage enriched" "Detected in many" 92 "granulocytes: 175.9" "Not detected" "Not detected" "Not detected" "Not detected" CAB003795 Uncertain "CAB003795: AB_562259" "unprognostic (1.56e-2)" "unprognostic (6.65e-3)" "unprognostic (1.01e-1)" "unprognostic (3.98e-2)" "unprognostic (1.41e-1)" "unprognostic (3.25e-3)" "unprognostic (3.11e-7)" "unprognostic (4.36e-2)" "unprognostic (3.35e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (3.94e-2)" "unprognostic (3.17e-6)" "unprognostic (1.35e-2)" "unprognostic (1.72e-2)" "unprognostic (2.41e-1)" "unprognostic (9.81e-2)" 0.6 0.2 0.3 2.9 1.1 0.4 0.3 0.2 0.8 0.3 1.3 0.2 0.2 2.9 0.8 0.2 0.4 0.5 1.3 0.3 0.2 0.2 0.5 1.2 5.8 0.6 0.3 0.2 0.2 0.3 0.0 0.3 7.0 0.7 1.0 1.4 0.9 2.4 0.2 3.2 3.6 5.1 1.6 0.5 2.7 2.2 0.4 0.2 0.6 1.8 2.8 0.6 4.0 0.3 0.0 0.2 175.9 0.0 0.0 1.9 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 2.2 0.0 0.7 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.1 0.3 0.1 0.0 0.2 0.0 24.9 0.0 2.0 0.1 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.1 2.7 2.1 0.0 0.0 0.5 0.0 175.9 0.0 152.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.2 1.9 0.3 0.3 1.1 0.2 0.8 0.2 0.2 0.3 0.2 0.7 0.2 CCR9 "CDw199, GPR-9-6, GPR28" ENSG00000173585 "C-C motif chemokine receptor 9" P51686 3 45886504-45903177 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 130.2" "Cell line enriched" "Detected in single" 324 "MOLT-4: 48.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 17.5;naive B-cell: 9.2;T-reg: 5.7" "Group enriched" "Detected in many" 42 "B-cells: 17.5;T-cells: 5.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" CAB006839 Uncertain "CAB006839: " "unprognostic (3.08e-3)" "unprognostic (3.37e-1)" "unprognostic (5.56e-2)" "unprognostic (1.78e-1)" "unprognostic (8.65e-3)" "unprognostic (7.88e-3)" "unprognostic (4.54e-1)" "unprognostic (2.94e-2)" "unprognostic (3.00e-1)" "unprognostic (1.77e-1)" "unprognostic (8.06e-2)" "unprognostic (1.16e-1)" "unprognostic (2.59e-2)" "unprognostic (1.88e-1)" "unprognostic (4.34e-1)" "unprognostic (2.27e-1)" "unprognostic (7.20e-3)" 0.1 0.1 0.1 1.8 0.1 0.7 0.1 0.1 0.3 0.1 2.2 0.1 0.1 7.0 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.2 0.8 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.2 0.1 10.7 0.1 0.2 2.2 0.3 0.1 0.1 130.2 0.1 0.1 0.7 0.1 0.1 17.5 0.2 0.0 0.0 0.0 5.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 17.5 2.2 1.8 0.2 9.2 0.3 0.1 0.0 0.0 0.0 0.2 5.7 1.8 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 CCT6B "Cctz2, TSA303" ENSG00000132141 "Chaperonin containing TCP1 subunit 6B" Q92526 17 34927859-34981078 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "testis: 71.5" "Cell line enhanced" "Detected in many" "RPMI-8226: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA042996, HPA045576, HPA049949" Uncertain Approved Cytosol Cytosol "HPA042996: , HPA045576: , HPA049949: " "unprognostic (1.56e-1)" "unprognostic (1.72e-2)" "unprognostic (2.99e-3)" "unprognostic (6.11e-2)" "unprognostic (3.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.12e-3)" "unprognostic (3.61e-2)" "unprognostic (1.75e-1)" "unprognostic (1.44e-3)" "unprognostic (9.56e-3)" "unprognostic (3.61e-2)" "unprognostic (4.82e-7)" "unprognostic (1.24e-1)" "unprognostic (4.30e-1)" "unprognostic (4.23e-4)" "unprognostic (1.49e-1)" 1.3 1.7 1.0 0.7 2.8 1.5 2.7 1.3 1.9 1.1 0.7 2.4 1.9 0.6 0.9 3.2 0.8 1.3 0.6 0.8 1.3 1.0 1.9 2.6 0.5 0.6 1.6 1.7 1.2 1.2 1.3 1.3 0.4 2.0 1.3 0.5 1.3 1.5 1.3 2.2 1.3 0.6 0.8 2.2 0.7 0.9 71.5 0.8 0.7 1.4 1.1 0.8 0.9 0.7 2.5 6.2 2.2 2.7 3.8 2.7 1.3 0.8 1.2 3.2 1.3 4.1 2.6 1.1 1.6 6.5 2.7 3.9 0.8 2.5 5.9 0.6 2.9 1.2 0.2 0.9 0.8 0.7 2.3 0.9 0.2 0.7 5.6 2.8 0.8 3.4 1.7 0.3 3.3 0.7 0.5 6.1 3.0 2.2 0.6 6.1 1.7 0.8 2.8 1.5 14.2 1.7 0.9 3.7 1.8 2.9 1.2 4.8 2.4 2.9 0.7 1.2 0.1 1.5 0.7 5.4 1.2 5.7 1.3 1.8 1.5 0.0 2.7 2.2 1.6 2.7 1.7 2.5 1.8 1.1 6.2 2.3 2.7 2.6 0.1 3.8 2.6 1.4 0.9 1.3 1.0 2.8 1.3 1.9 1.3 1.0 1.6 1.7 2.0 0.8 CCT8L2 CESK1 ENSG00000198445 "Chaperonin containing TCP1 subunit 8 like 2" Q96SF2 22 16590751-16592810 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 187 "testis: 18.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CD109 "CPAMD7, DKFZp762L1111, FLJ38569" ENSG00000156535 "CD109 molecule" Q6YHK3 6 73695785-73828316 "CD markers, Plasma proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "parathyroid gland: 203.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 61.6;BJ hTERT+: 37.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA008992, HPA015723" Enhanced Supported "Plasma membrane" 120000000 "Plasma membrane" "HPA008992: , HPA015723: " "unprognostic (2.28e-1)" "unprognostic (1.03e-1)" "unprognostic (7.76e-2)" "unprognostic (1.52e-2)" "unprognostic (9.17e-3)" "unprognostic (1.36e-1)" "unprognostic (1.03e-3)" "unprognostic (1.23e-3)" "unprognostic (7.49e-2)" "unprognostic (2.47e-1)" "unprognostic (1.15e-3)" "unprognostic (8.81e-2)" "prognostic unfavourable (2.65e-4)" "prognostic unfavourable (7.96e-5)" "unprognostic (9.50e-2)" "unprognostic (2.02e-1)" "prognostic unfavourable (4.68e-4)" 27.4 1.5 1.6 1.9 2.2 1.9 6.5 0.4 1.9 15.0 7.1 3.4 2.0 1.5 22.5 8.5 22.4 3.4 2.4 8.2 1.8 1.4 3.5 1.4 14.5 1.4 1.7 1.4 2.8 1.2 203.4 0.6 5.0 3.0 7.1 2.1 0.6 4.2 2.2 4.1 12.4 2.4 12.6 4.5 1.7 1.5 3.3 2.8 6.3 1.7 16.8 4.7 8.7 8.0 0.3 2.6 1.4 0.4 0.6 0.4 0.3 9.2 8.3 0.5 0.0 12.7 61.6 0.0 8.4 37.8 2.8 6.1 0.0 5.4 0.0 5.2 17.3 26.1 0.9 16.9 3.7 2.5 1.4 3.3 6.8 1.4 2.7 0.0 0.0 16.9 13.4 5.2 21.1 20.0 0.0 0.0 12.6 0.2 0.2 0.0 0.6 5.4 0.7 2.4 11.4 1.2 1.0 0.0 0.0 19.1 0.1 8.3 0.2 1.5 18.5 26.4 3.7 4.7 7.2 0.1 5.2 0.0 10.6 0.0 23.4 0.6 0.4 0.3 0.2 0.2 0.1 0.2 0.3 0.2 2.6 0.3 0.4 0.2 1.4 0.6 0.2 1.4 0.1 0.3 1.6 2.2 0.4 1.9 1.8 1.4 1.7 1.4 3.0 2.8 CD1A CD1 ENSG00000158477 "CD1a molecule" P06126 1 158254137-158258269 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 105.1" "Cell line enriched" "Detected in single" 106 "MOLT-4: 35.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "classical monocyte: 5.9;intermediate monocyte: 3.7;memory B-cell: 6.8;myeloid DC: 10.2;naive B-cell: 5.4" "Group enriched" "Detected in many" 35 "B-cells: 6.8;dendritic cells: 10.2;monocytes: 5.9" "CAB000009, HPA010734" Enhanced "CAB000009: AB_2073290, HPA010734: AB_1078452" "unprognostic (7.21e-5)" "prognostic favourable (6.37e-4)" "unprognostic (1.37e-5)" "unprognostic (2.55e-2)" "unprognostic (2.83e-1)" "unprognostic (1.16e-2)" "unprognostic (9.93e-4)" "unprognostic (1.49e-2)" "unprognostic (3.12e-1)" "unprognostic (3.86e-2)" "unprognostic (6.99e-2)" "unprognostic (5.12e-2)" "unprognostic (5.49e-5)" "unprognostic (5.58e-2)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (8.81e-2)" 0.1 0.0 0.1 0.9 0.1 0.0 1.0 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.2 0.1 8.0 0.0 0.6 0.1 0.1 0.0 0.2 0.1 1.8 1.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.2 0.1 0.9 0.1 0.1 20.9 0.3 0.1 0.1 1.4 0.3 0.2 0.1 105.1 0.1 1.0 2.7 0.4 1.1 6.8 10.2 0.0 5.9 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.9 0.0 0.0 3.7 0.2 6.8 0.0 0.0 10.2 5.4 0.1 0.0 0.0 0.0 0.2 0.2 0.0 1.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CD1B CD1 ENSG00000158485 "CD1b molecule" P29016 1 158327951-158331531 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 188.8" "Cell line enriched" "Detected in single" 1104 "MOLT-4: 110.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "myeloid DC: 16.3" "Lineage enriched" "Detected in many" 6 "dendritic cells: 16.3" HPA021824 Approved "HPA021824: AB_1846262" "unprognostic (7.72e-3)" "unprognostic (1.55e-4)" "unprognostic (1.66e-5)" "unprognostic (1.04e-2)" "unprognostic (1.06e-3)" "unprognostic (1.81e-1)" "unprognostic (2.89e-4)" "unprognostic (2.27e-2)" "unprognostic (2.19e-1)" "unprognostic (1.33e-1)" "unprognostic (9.53e-2)" "unprognostic (3.23e-1)" "unprognostic (3.52e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-1)" "unprognostic (3.53e-2)" 0.8 0.1 0.2 1.9 0.2 0.0 0.6 0.2 0.2 0.8 0.6 0.3 0.2 0.0 0.3 0.2 0.9 0.7 1.3 0.2 0.2 0.0 0.6 0.3 1.7 4.0 0.2 0.2 0.3 0.3 0.0 0.2 0.2 0.2 0.2 5.6 0.2 0.6 0.2 0.2 6.2 0.8 0.3 0.2 1.9 0.9 0.2 0.2 188.8 0.4 0.4 2.4 0.5 0.8 0.0 16.3 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.3 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 CD1E ENSG00000158488 "CD1e molecule" P15812 1 158353696-158357553 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 308.0" "Cell line enriched" "Detected in single" 1338 "MOLT-4: 167.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 13 "myeloid DC: 29.7" "Lineage enriched" "Detected in many" 13 "dendritic cells: 29.7" "Low region specificity" "Detected in all" HPA057769 Uncertain "Intracellular and membrane" "HPA057769: " "unprognostic (7.94e-3)" "unprognostic (1.85e-5)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.33e-1)" "unprognostic (1.54e-3)" "unprognostic (1.24e-1)" "unprognostic (1.74e-1)" "unprognostic (1.60e-1)" "unprognostic (8.55e-2)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (8.50e-2)" "unprognostic (2.45e-1)" 1.0 0.2 0.7 2.8 0.7 0.0 1.1 0.7 0.7 1.5 1.0 0.7 0.7 1.2 0.9 0.7 7.0 1.9 3.9 0.7 0.7 0.2 2.0 0.7 2.4 4.7 0.7 0.7 0.7 0.8 0.0 0.7 0.7 0.7 1.8 4.8 0.8 1.9 0.8 0.8 11.5 2.1 0.8 0.7 3.8 3.1 0.9 0.7 308.0 1.0 1.3 8.1 2.4 2.7 0.0 29.7 0.0 2.2 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 167.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.1 0.1 0.0 0.0 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.7 0.7 0.7 0.7 0.2 0.7 0.7 0.7 0.7 CD24 CD24A ENSG00000272398 "CD24 molecule" 6 106969831-106975627 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "kidney: 383.7" "Cell line enhanced" "Detected in many" "NTERA-2: 65.1;RPTEC TERT1: 307.7;SK-BR-3: 89.5" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 26 "eosinophil: 30.4;memory B-cell: 23.4;naive B-cell: 15.0" "Group enriched" "Detected in many" 202 "B-cells: 23.4;granulocytes: 30.4" "HPA045879, CAB078471" Enhanced Vesicles "Intracellular and membrane" Vesicles "CAB078471: AB_10983158, HPA045879: " "prognostic unfavourable (2.44e-5)" "unprognostic (6.64e-2)" "prognostic favourable (3.29e-4)" "unprognostic (1.87e-1)" "unprognostic (1.41e-2)" "unprognostic (9.98e-2)" "prognostic unfavourable (7.58e-4)" "unprognostic (2.32e-1)" "unprognostic (2.74e-1)" "unprognostic (1.04e-1)" "unprognostic (2.28e-2)" "unprognostic (1.51e-1)" "unprognostic (5.10e-2)" "unprognostic (2.92e-1)" "unprognostic (1.16e-1)" "unprognostic (2.01e-1)" "unprognostic (3.13e-1)" 0.5 0.5 12.8 2.4 9.9 17.9 25.5 0.5 2.9 69.5 30.6 0.7 1.6 1.2 34.5 5.9 38.1 6.0 25.1 4.2 22.7 383.7 0.8 0.7 0.9 4.8 7.2 15.6 40.0 0.0 5.7 48.2 13.0 3.2 21.2 0.7 15.9 16.6 0.4 0.5 0.8 2.2 4.9 0.7 16.4 0.5 6.5 0.4 48.8 1.2 11.3 4.0 8.1 23.4 0.0 30.4 0.1 0.0 0.0 0.6 22.9 14.2 0.2 1.8 0.0 0.0 27.0 0.0 0.1 0.1 0.0 0.2 0.1 2.2 7.1 0.0 47.5 8.1 17.9 0.1 0.0 0.1 0.0 17.6 1.0 0.0 0.3 0.1 0.1 20.7 0.2 1.2 0.1 0.5 0.0 0.4 28.8 0.1 0.1 65.1 5.5 53.8 0.0 0.2 307.7 59.3 40.3 29.7 16.3 89.5 0.0 41.3 0.1 0.0 0.0 0.2 0.2 0.7 0.0 0.1 30.4 0.3 0.1 0.1 0.1 0.0 30.4 0.0 0.0 0.0 23.4 0.0 0.0 0.0 15.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.6 CD3E ENSG00000198851 "CD3e molecule" P07766 11 118304545-118316175 "CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 294.2" "Cell line enriched" "Detected in some" 77 "MOLT-4: 118.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 36 "gdT-cell: 59.5;MAIT T-cell: 50.2;memory CD4 T-cell: 50.7;memory CD8 T-cell: 55.7;naive CD4 T-cell: 61.3;naive CD8 T-cell: 62.0;NK-cell: 21.8;T-reg: 46.8" "Group enriched" "Detected in many" 29 "NK-cells: 21.8;T-cells: 62.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000010, HPA040957, HPA043955, CAB072863, CAB072864" Enhanced "CAB000010: AB_2631163, CAB072863: , CAB072864: , HPA040957: AB_2677222, HPA043955: AB_2678747" "prognostic favourable (1.72e-4)" "prognostic favourable (1.62e-4)" "unprognostic (1.51e-2)" "prognostic favourable (2.30e-6)" "unprognostic (4.31e-2)" "prognostic favourable (1.32e-4)" "unprognostic (3.60e-3)" "unprognostic (3.85e-2)" "prognostic favourable (1.18e-4)" "unprognostic (6.11e-3)" "unprognostic (1.59e-1)" "unprognostic (3.59e-1)" "prognostic unfavourable (1.12e-5)" "unprognostic (5.46e-2)" "unprognostic (9.28e-2)" "unprognostic (3.13e-2)" "unprognostic (1.12e-2)" 3.9 1.0 0.5 16.7 0.7 6.8 1.9 0.5 0.7 2.1 4.7 0.9 0.7 4.4 2.0 1.4 3.3 3.0 4.0 1.4 0.5 0.5 3.3 2.6 7.3 40.9 1.3 0.6 1.5 1.3 0.0 0.9 1.2 0.9 2.6 3.9 1.9 6.4 1.1 0.8 1.3 21.1 1.1 1.9 34.5 4.6 1.2 0.5 294.2 3.4 2.1 37.8 6.3 3.0 0.2 0.9 1.4 0.2 21.8 62.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 118.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 1.5 0.0 0.1 0.0 1.3 0.2 0.2 59.5 0.1 50.2 0.1 50.7 55.7 0.1 0.2 61.3 62.0 1.4 21.8 0.2 0.9 46.8 32.9 0.5 0.7 0.5 0.7 0.5 0.5 1.3 0.6 0.9 0.5 CD3G ENSG00000160654 "CD3g molecule" P09693 11 118344344-118355161 "CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 187.6" "Cell line enriched" "Detected in single" 78 "MOLT-4: 64.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 30 "gdT-cell: 43.5;MAIT T-cell: 25.6;memory CD4 T-cell: 36.1;memory CD8 T-cell: 37.1;naive CD4 T-cell: 37.6;naive CD8 T-cell: 46.7;T-reg: 34.2" "Lineage enriched" "Detected in many" 37 "T-cells: 46.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017520, HPA038494" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB017520: AB_831094, HPA038494: " "prognostic favourable (6.33e-4)" "prognostic favourable (2.61e-4)" "unprognostic (4.58e-3)" "unprognostic (3.12e-5)" "unprognostic (6.30e-2)" "prognostic favourable (3.00e-4)" "unprognostic (1.98e-2)" "unprognostic (1.54e-2)" "unprognostic (8.25e-3)" "unprognostic (1.08e-3)" "unprognostic (1.54e-2)" "unprognostic (2.19e-1)" "prognostic unfavourable (9.33e-5)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (4.13e-2)" "unprognostic (2.10e-3)" 1.1 0.6 0.4 7.1 0.4 0.5 0.8 0.3 0.3 0.7 2.3 0.4 0.4 2.0 0.9 0.6 1.5 1.1 1.9 0.6 0.4 0.4 1.2 0.9 2.4 17.2 0.5 0.2 0.7 0.7 0.0 0.5 0.4 0.3 1.0 1.6 0.9 2.9 0.3 5.9 0.6 8.1 0.2 0.8 11.5 2.4 0.5 0.2 187.6 1.4 1.7 19.2 2.5 1.1 0.1 0.2 1.2 0.2 0.2 46.7 14.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.2 64.9 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.6 0.2 0.2 43.5 0.1 25.6 0.1 36.1 37.1 0.1 0.1 37.6 46.7 1.2 0.2 0.1 0.2 34.2 14.1 0.4 0.4 0.3 0.3 0.4 0.4 0.5 0.2 0.3 0.2 CD5L "API6, Spalpha" ENSG00000073754 "CD5 molecule like" O43866 1 157830914-157898256 "Plasma proteins, Predicted secreted proteins" "Apoptosis, Immunity, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 178.3" "Cell line enhanced" "Detected in some" "HaCaT: 1.1;Karpas-707: 1.9;REH: 2.0;RH-30: 1.2;U-266/70: 3.5" "Cancer enriched" "Detected in some" 5 "liver cancer: 4.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.2" "Lineage enriched" "Detected in single" 13 "monocytes: 1.2" "Not detected" "Not detected" "HPA065686, HPA068384" Enhanced "Secreted to blood" 5525000000 6800000000 "HPA065686: AB_2685532, HPA068384: AB_2685979" "unprognostic (2.96e-1)" "unprognostic (2.90e-1)" "unprognostic (1.08e-1)" "unprognostic (1.94e-1)" "prognostic favourable (8.88e-5)" "unprognostic (1.73e-2)" "unprognostic (4.51e-2)" "unprognostic (1.89e-1)" "unprognostic (1.56e-1)" "unprognostic (5.95e-3)" "unprognostic (2.26e-1)" "unprognostic (1.06e-1)" "unprognostic (3.63e-1)" 0.2 0.0 0.1 0.1 0.1 2.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 21.3 0.2 2.6 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 178.3 0.0 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.0 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.0 0.8 0.0 2.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 CDCA7 "FLJ14736, JPO1" ENSG00000144354 "Cell division cycle associated 7" Q9BWT1 2 173354820-173368997 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 71.4" "Cell line enhanced" "Detected in many" "MOLT-4: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 9.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 8.3;olfactory region: 21.4" "Low region specificity" "Detected in all" HPA005565 Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA005565: AB_2078680" "unprognostic (1.67e-3)" "unprognostic (2.26e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" "unprognostic (2.16e-1)" "unprognostic (1.44e-2)" "prognostic unfavourable (4.20e-4)" "unprognostic (7.54e-2)" "prognostic unfavourable (5.50e-4)" "unprognostic (4.96e-2)" "unprognostic (2.83e-1)" "unprognostic (8.97e-3)" "unprognostic (0.00e+0)" "unprognostic (4.53e-3)" "unprognostic (1.96e-1)" "unprognostic (2.04e-1)" "unprognostic (2.47e-2)" 1.1 0.6 1.2 28.0 1.5 9.7 1.8 0.5 1.4 8.3 12.3 2.8 2.6 14.9 7.9 1.7 12.9 2.3 6.6 0.9 2.0 1.4 0.8 0.4 1.3 17.2 1.3 2.2 1.1 2.9 0.0 0.4 7.3 3.4 3.2 14.8 1.1 3.3 0.6 4.3 8.3 16.4 1.5 2.0 2.9 7.6 8.1 2.0 71.4 0.9 10.5 24.0 2.3 8.0 2.6 4.2 0.3 0.7 3.6 9.4 2.7 9.8 7.6 17.9 19.4 0.8 3.3 18.7 5.9 2.1 14.2 16.0 11.7 12.5 27.6 7.6 3.6 10.3 28.3 10.7 20.7 13.2 15.6 6.2 5.5 14.8 0.9 40.3 5.9 2.7 0.9 7.7 6.4 6.4 14.9 6.3 4.1 7.9 61.8 40.7 21.1 5.3 43.7 13.6 17.5 6.8 8.7 5.2 9.2 9.3 3.1 5.0 0.0 15.9 2.9 9.3 4.0 3.0 10.9 1.7 3.7 38.7 5.8 22.5 7.8 0.0 0.7 0.0 1.4 0.0 0.5 2.6 3.9 7.6 4.2 0.3 0.3 1.4 0.3 3.6 0.0 0.6 9.4 2.7 1.2 1.5 0.5 1.4 2.0 1.4 1.3 2.2 3.4 2.0 CDH10 ENSG00000040731 "Cadherin 10" Q9Y6N8 5 24487100-24644978 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 45.4" "Cell line enhanced" "Detected in some" "AF22: 11.5;AN3-CA: 1.8;HAP1: 7.3;U-138 MG: 2.5" "Group enriched" "Detected in some" 7 "glioma: 5.3;prostate cancer: 1.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010651 Approved "HPA010651: AB_1078370" "unprognostic (4.31e-3)" "unprognostic (2.77e-1)" "unprognostic (1.88e-1)" "unprognostic (3.66e-2)" "unprognostic (4.48e-1)" "unprognostic (6.11e-3)" "unprognostic (6.27e-2)" "unprognostic (1.59e-7)" "unprognostic (1.65e-2)" "unprognostic (1.41e-1)" "unprognostic (8.74e-3)" 0.9 2.1 9.4 0.8 9.6 0.8 1.0 45.4 34.0 0.9 1.1 1.5 0.0 0.9 0.9 0.8 0.9 0.9 1.2 0.9 9.4 5.2 1.0 0.8 1.1 0.8 3.6 13.4 0.8 0.9 0.8 2.1 0.8 6.0 8.6 1.3 0.0 0.8 1.4 0.8 0.8 1.1 0.9 7.0 0.8 1.0 1.4 3.7 0.0 0.8 0.0 0.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 2.5 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 9.6 45.4 21.3 9.4 5.2 3.6 13.4 6.0 3.7 CDH16 ENSG00000166589 "Cadherin 16" O75309 16 66908122-66918984 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 139.7" "Cell line enriched" "Detected in single" 96 "RPTEC TERT1: 69.3" "Cancer enriched" "Detected in many" 15 "renal cancer: 96.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB013526, HPA036260" Enhanced "CAB013526: , HPA036260: " "unprognostic (1.07e-1)" "unprognostic (2.47e-1)" "unprognostic (1.96e-1)" "unprognostic (9.81e-2)" "unprognostic (4.24e-3)" "unprognostic (5.81e-2)" "unprognostic (5.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.23e-2)" "prognostic favourable (1.02e-7)" "unprognostic (2.19e-1)" "unprognostic (1.99e-1)" "unprognostic (7.36e-3)" "unprognostic (2.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.0 0.3 0.0 3.5 0.1 3.4 0.2 0.0 0.0 0.0 139.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.3 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDH17 "cadherin, HPT-1" ENSG00000079112 "Cadherin 17" Q12864 8 94127171-94217303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 184.4" "Group enriched" "Detected in some" 7 "CACO-2: 33.3;U-266/70: 55.3" "Group enriched" "Detected in many" 6 "colorectal cancer: 156.4;stomach cancer: 54.9" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 5 "neutrophil: 12.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023614, HPA023616, CAB025143, HPA026556" Enhanced Enhanced "Nucleoplasm,Cell Junctions" 3400000 "Cell Junctions" Nucleoplasm "CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897" "unprognostic (2.08e-1)" "unprognostic (5.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (3.02e-1)" "unprognostic (3.06e-2)" "unprognostic (5.60e-2)" "unprognostic (3.38e-3)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (5.47e-2)" "unprognostic (3.74e-2)" "unprognostic (2.36e-1)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "unprognostic (7.33e-2)" "unprognostic (1.46e-2)" 0.3 0.2 0.2 17.6 0.3 0.3 0.3 0.2 0.2 0.3 88.9 0.2 0.2 54.5 0.4 0.3 0.4 0.4 7.0 0.6 0.2 0.3 0.3 0.3 0.3 0.5 0.2 0.2 0.3 0.4 0.0 0.3 0.2 0.2 0.4 44.0 0.2 0.3 0.2 0.3 0.2 184.4 1.4 0.2 0.6 0.3 0.3 0.2 0.3 0.2 0.2 0.5 0.4 0.3 1.5 0.8 12.1 1.0 1.4 0.6 0.1 0.1 6.1 0.3 0.4 0.0 0.1 0.5 0.1 0.1 0.0 0.1 33.3 1.5 0.2 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.5 0.1 0.6 0.2 0.1 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.4 0.2 0.5 0.2 0.2 0.4 0.1 1.0 0.1 0.1 0.6 0.4 0.2 0.2 0.2 0.3 0.3 0.2 0.3 0.3 0.5 0.2 55.3 0.1 0.1 0.1 0.2 0.3 2.5 1.0 1.2 0.5 0.8 0.3 0.6 0.5 0.4 0.8 1.5 0.5 0.6 12.1 1.4 0.5 0.7 0.5 0.1 0.2 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 CDH18 "CDH14, EY-CADHERIN" ENSG00000145526 "Cadherin 18" Q13634 5 19472951-20575873 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 105.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.1;BEWO: 3.7;EFO-21: 6.3;U-2 OS: 9.9;U-2197: 8.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 7 "cerebellum: 105.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014416 Uncertain "Intracellular and membrane" "HPA014416: " "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (5.26e-7)" "unprognostic (6.36e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (1.20e-1)" "unprognostic (8.78e-2)" "unprognostic (3.30e-2)" "unprognostic (1.51e-2)" "unprognostic (8.69e-2)" "unprognostic (1.76e-2)" 0.7 9.3 6.9 0.7 7.1 0.7 0.6 105.4 23.2 1.0 0.6 0.0 0.0 0.7 0.6 0.6 0.7 0.7 0.7 0.6 4.6 8.1 0.9 0.6 0.7 0.8 1.8 8.3 0.7 1.2 2.1 11.3 0.6 7.1 0.8 0.7 2.2 0.6 0.8 0.9 0.8 0.7 0.6 2.2 0.7 0.6 3.7 1.3 0.0 0.6 0.0 0.6 0.6 0.3 0.7 0.3 1.2 0.5 0.6 0.4 0.5 1.6 0.0 0.3 0.0 1.0 4.1 3.7 0.2 2.3 0.1 0.7 0.0 0.0 0.0 6.3 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.1 2.5 0.0 0.2 0.7 0.4 0.2 0.0 0.2 0.3 0.2 0.0 0.1 1.2 0.0 0.0 0.8 0.2 0.1 0.1 0.0 0.1 0.0 0.0 1.9 9.9 8.7 0.0 2.4 0.0 0.0 2.8 0.0 0.0 1.1 0.5 0.3 0.4 0.1 0.2 0.3 0.2 0.2 0.2 0.7 0.4 0.4 1.2 0.6 0.4 0.3 0.2 0.5 6.9 7.1 105.4 14.1 4.6 8.1 1.8 8.3 7.1 1.3 CDH22 "C20orf25, dJ998H6.1" ENSG00000149654 "Cadherin 22" Q9UJ99 20 46173733-46308498 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.8" "Cell line enriched" "Detected in single" 18 "SCLC-21H: 8.3" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in all" "cerebellum: 55.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012164, HPA012715" Uncertain Supported "HPA012164: AB_1845902, HPA012715: " "unprognostic (2.41e-4)" "unprognostic (1.72e-2)" "unprognostic (3.10e-1)" "unprognostic (4.32e-3)" "unprognostic (3.39e-2)" "unprognostic (4.73e-1)" "unprognostic (4.32e-1)" "unprognostic (2.54e-2)" "unprognostic (5.54e-2)" "unprognostic (4.50e-4)" "unprognostic (2.62e-1)" "unprognostic (3.09e-1)" "unprognostic (7.26e-3)" "unprognostic (5.93e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (9.83e-2)" 0.7 4.2 10.2 0.5 5.7 0.5 0.8 55.8 15.5 0.7 0.6 1.0 0.0 0.6 0.7 0.7 1.2 4.0 0.5 1.0 3.5 3.7 0.7 0.5 0.6 0.5 1.2 8.7 0.9 4.2 0.5 1.1 0.5 3.0 1.5 0.7 1.8 1.0 1.8 1.2 10.4 0.9 0.5 1.9 0.5 0.9 1.4 1.3 0.0 0.7 0.0 0.5 0.5 0.6 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 10.2 5.7 55.8 14.8 3.5 3.7 1.2 8.7 3.0 1.3 CDH7 ENSG00000081138 "Cadherin 7" Q9ULB5 18 65750252-65890341 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 16.7" "Cell line enhanced" "Detected in some" "AF22: 16.9;HEK 293: 3.2;Karpas-707: 6.2;RH-30: 8.1;U-87 MG: 3.8" "Cancer enhanced" "Detected in single" "prostate cancer: 0.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061419 Approved "HPA061419: " "unprognostic (2.81e-3)" "unprognostic (6.95e-2)" "unprognostic (2.26e-1)" "unprognostic (2.24e-2)" "unprognostic (3.45e-2)" "unprognostic (2.41e-1)" "unprognostic (3.95e-3)" "unprognostic (2.88e-1)" "unprognostic (4.28e-4)" "unprognostic (2.70e-2)" "unprognostic (1.49e-1)" "unprognostic (1.72e-1)" 0.4 0.6 2.6 0.3 4.3 0.6 0.4 15.3 7.5 0.3 0.3 0.0 0.0 0.4 0.3 0.6 0.3 0.3 0.4 0.4 0.5 2.5 0.3 0.6 0.4 0.3 1.5 2.1 1.6 0.3 0.3 1.2 0.3 16.7 3.6 0.5 1.3 0.4 1.9 1.0 0.5 0.3 0.2 1.3 0.4 0.3 1.8 0.1 0.7 0.5 0.0 0.4 0.3 0.2 0.8 0.5 1.9 0.4 0.6 0.4 0.1 0.0 0.2 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.1 0.7 0.3 0.1 8.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.8 1.3 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 3.8 0.0 0.0 1.2 0.4 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.0 0.8 0.4 0.4 1.9 0.6 0.3 0.5 0.2 0.1 2.6 4.3 15.3 5.2 0.5 2.5 1.5 2.1 16.7 0.1 CDH9 ENSG00000113100 "Cadherin 9" Q9ULB4 5 26880600-27121150 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 46.8" "Cell line enhanced" "Detected in some" "K-562: 9.2;NTERA-2: 13.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "amygdala: 46.8;basal ganglia: 24.6;cerebral cortex: 23.7;hippocampal formation: 15.9;olfactory region: 15.6" "Cell type enhanced" "Detected in some" "neutrophil: 8.3" "Group enriched" "Detected in many" 5 "B-cells: 4.1;granulocytes: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007167 Approved "HPA007167: AB_1078489" "unprognostic (1.49e-1)" "unprognostic (2.27e-4)" 0.7 0.5 46.8 1.0 24.6 2.8 0.7 0.5 23.7 0.5 0.8 0.0 0.0 0.6 0.9 1.2 0.7 0.5 0.7 0.5 15.9 3.5 10.5 0.5 0.6 1.6 1.2 15.6 0.6 1.1 1.0 0.5 0.8 1.5 1.0 1.2 0.0 0.5 0.1 0.5 1.9 1.5 0.8 0.6 0.8 0.9 3.7 2.6 0.0 1.9 0.0 1.7 0.5 0.5 4.1 0.9 8.3 1.1 0.1 0.8 1.1 2.4 0.9 0.5 0.8 0.4 0.0 1.6 0.0 0.9 0.3 0.6 0.0 0.9 1.3 0.3 0.3 0.3 0.1 0.5 0.0 0.1 0.2 0.5 0.7 2.5 0.0 0.0 1.5 0.6 0.7 0.0 0.0 0.2 9.2 2.3 0.0 1.5 0.8 0.5 13.6 0.5 0.3 0.3 0.4 0.5 0.5 3.1 0.3 0.0 0.4 0.4 0.5 0.9 1.7 0.1 0.8 0.8 0.3 2.7 1.0 4.3 1.0 1.0 0.8 1.3 0.2 0.4 0.2 0.7 0.6 4.1 0.4 0.2 0.1 2.5 0.3 0.5 8.3 0.1 1.1 0.9 0.8 1.1 46.8 24.6 0.5 23.7 15.9 3.5 1.2 15.6 1.5 2.6 CDHR2 "FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC" ENSG00000074276 "Cadherin related family member 2" Q9BYE9 5 176542511-176595974 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 179.8" "Cell line enriched" "Detected in some" 14 "Hep G2: 21.7" "Group enriched" "Detected in many" 14 "colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "hypothalamus: 2.5" "Low region specificity" "Detected in many" "HPA012569, HPA017053" Enhanced 3600000 "HPA012569: AB_1845298, HPA017053: AB_1845297" "unprognostic (1.34e-2)" "unprognostic (8.90e-4)" "unprognostic (3.82e-2)" "unprognostic (8.51e-2)" "unprognostic (5.10e-4)" "unprognostic (4.24e-3)" "unprognostic (6.66e-2)" "unprognostic (2.06e-3)" "unprognostic (1.54e-1)" "unprognostic (1.99e-1)" "unprognostic (7.66e-3)" "unprognostic (1.75e-1)" "prognostic favourable (9.29e-4)" "unprognostic (6.58e-2)" "unprognostic (3.55e-1)" "unprognostic (2.30e-2)" "unprognostic (1.42e-1)" 0.1 0.0 0.1 2.5 0.3 0.0 0.1 0.1 0.3 0.1 80.0 0.1 0.1 67.2 0.1 0.8 0.1 0.2 7.1 0.1 0.1 0.4 3.0 26.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 2.9 0.5 0.1 0.1 0.1 0.1 179.8 0.1 0.1 0.1 2.8 1.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.3 0.0 0.1 0.1 0.0 0.2 0.3 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.5 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.3 1.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.1 0.3 0.1 0.3 0.1 0.4 0.1 0.1 0.1 0.1 CDHR5 "FLJ20219, MU-PCDH, MUCDHL, MUPCDH" ENSG00000099834 "Cadherin related family member 5" Q9HBB8 11 616565-626078 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 296.7" "Cell line enhanced" "Detected in some" "BEWO: 2.4;CACO-2: 6.6;RPMI-8226: 3.7" "Group enriched" "Detected in many" 17 "colorectal cancer: 33.2;liver cancer: 61.6;pancreatic cancer: 12.7;renal cancer: 35.4;stomach cancer: 26.7" "Region enriched" "Detected in single" 7 "pons and medulla: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA009081, HPA009173, CAB025004" Enhanced "Intracellular and membrane" 170000000 "CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429" "unprognostic (7.65e-2)" "unprognostic (1.42e-1)" "unprognostic (9.85e-2)" "unprognostic (1.21e-1)" "unprognostic (1.05e-1)" "unprognostic (5.56e-3)" "unprognostic (4.89e-2)" "unprognostic (3.85e-2)" "unprognostic (5.75e-2)" "unprognostic (6.36e-2)" "unprognostic (7.95e-2)" "unprognostic (5.07e-2)" "unprognostic (5.01e-2)" "unprognostic (3.90e-1)" "unprognostic (8.85e-2)" "unprognostic (2.29e-1)" "unprognostic (2.14e-2)" 0.1 0.3 0.1 8.1 0.1 0.0 0.1 0.1 0.1 0.1 118.7 0.4 0.0 34.3 0.1 0.8 0.1 0.2 12.1 0.1 0.2 0.1 10.9 43.8 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.2 0.0 1.6 0.1 21.3 5.1 0.1 0.0 0.1 0.1 296.7 0.8 0.1 0.1 1.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 2.4 0.0 0.0 0.0 0.0 6.6 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 1.5 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.1 0.7 0.8 0.0 0.1 0.1 3.7 0.0 0.3 0.0 1.6 0.0 0.2 0.0 0.0 0.2 0.6 0.1 0.1 0.3 1.1 0.0 0.3 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 1.6 0.0 CDK1 "CDC2, CDC28A" ENSG00000170312 "Cyclin dependent kinase 1" P06493 10 60778331-60794852 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis" "Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 88.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 6.1;T-reg: 5.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7" "Low region specificity" "Detected in single" "HPA003387, CAB003799" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB003799: AB_344898, HPA003387: AB_1846356" "unprognostic (6.34e-2)" "prognostic favourable (8.81e-4)" "unprognostic (1.90e-1)" "unprognostic (6.82e-2)" "unprognostic (6.67e-2)" "unprognostic (3.83e-2)" "prognostic unfavourable (1.10e-6)" "prognostic unfavourable (7.88e-4)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "prognostic unfavourable (4.15e-6)" "unprognostic (1.80e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.27e-1)" "unprognostic (2.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.60e-1)" 4.1 2.2 0.8 17.8 2.4 17.8 4.4 0.7 1.6 4.2 6.5 1.1 3.4 6.1 2.9 4.8 19.0 1.5 2.4 2.3 0.9 0.7 3.1 1.7 5.7 15.1 1.7 0.6 2.2 1.0 0.5 4.4 13.3 1.2 1.5 8.3 1.0 3.8 2.9 1.0 4.9 8.3 2.7 2.5 8.3 5.0 13.8 1.2 88.4 1.8 16.7 20.1 3.2 6.9 0.9 1.7 0.0 0.2 6.1 5.7 1.8 48.2 18.4 48.9 19.3 3.2 4.9 20.1 36.5 26.6 44.5 42.9 43.0 42.7 44.2 14.2 10.0 30.0 33.2 21.2 46.4 31.4 24.2 23.2 18.1 24.9 0.5 35.5 24.0 0.9 2.1 28.8 28.1 26.7 35.3 54.5 49.5 12.8 44.6 25.5 21.5 38.7 38.8 45.5 21.7 17.0 16.0 22.9 20.1 24.5 37.3 18.9 40.2 21.8 11.0 19.0 40.6 20.0 49.8 21.4 34.3 39.9 16.4 39.8 23.6 0.0 0.0 0.0 0.5 0.2 0.5 0.9 1.5 2.7 0.5 0.5 0.5 1.5 0.0 6.1 0.2 1.7 5.7 1.8 0.8 2.4 0.7 1.6 0.9 0.7 1.7 0.6 1.2 1.2 CDK5R1 "Nck5a, p35, p35nck5a" ENSG00000176749 "Cyclin dependent kinase 5 regulatory subunit 1" Q15078 17 32486619-32491256 "Predicted intracellular proteins" "Biological rhythms" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 58.8" "Cell line enhanced" "Detected in many" "SCLC-21H: 31.5;SK-MEL-30: 22.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000252 Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA000252: " "unprognostic (1.08e-1)" "unprognostic (9.13e-2)" "unprognostic (1.79e-2)" "unprognostic (3.65e-1)" "unprognostic (1.97e-1)" "unprognostic (8.09e-2)" "unprognostic (2.74e-5)" "unprognostic (1.81e-2)" "unprognostic (3.32e-1)" "unprognostic (2.18e-1)" "unprognostic (5.90e-2)" "unprognostic (5.60e-1)" "unprognostic (6.98e-2)" "unprognostic (1.60e-1)" "unprognostic (7.92e-2)" "unprognostic (8.81e-2)" "unprognostic (1.03e-1)" 1.6 3.3 21.9 6.4 21.1 4.9 1.8 26.0 58.8 1.2 1.6 3.6 0.0 2.0 1.6 1.0 5.5 1.5 1.6 1.6 21.4 17.3 1.5 1.3 1.4 11.5 7.6 24.5 3.2 2.0 1.3 3.0 1.4 7.8 1.4 1.5 0.9 1.2 1.3 1.8 2.2 2.0 1.3 4.1 7.7 2.2 5.2 3.2 1.2 1.1 0.3 12.3 1.7 1.1 0.6 1.8 2.9 0.9 0.7 4.2 1.5 2.0 1.1 5.2 1.6 0.6 1.0 0.6 1.2 0.7 1.5 2.0 3.0 0.5 1.0 1.2 1.0 0.9 2.0 1.2 2.1 0.3 3.9 0.3 0.5 1.1 0.2 0.6 1.1 0.6 3.1 1.6 1.3 1.1 2.0 1.2 3.2 0.8 1.7 0.8 3.3 1.1 1.5 3.1 3.6 0.7 0.9 31.5 8.5 1.2 0.7 22.6 1.3 2.4 1.1 2.1 3.2 0.8 3.2 0.6 0.8 1.0 1.8 2.9 5.1 0.0 0.9 1.2 2.3 0.8 1.8 0.6 3.1 1.3 0.2 0.5 4.2 2.6 2.9 0.7 0.4 1.8 0.4 1.5 21.9 21.1 26.0 37.3 21.4 17.3 7.6 24.5 7.8 3.2 CDKN3 "CDI1, KAP" ENSG00000100526 "Cyclin dependent kinase inhibitor 3" Q16667 14 54396849-54420218 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 80.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 16.1" "Group enriched" "Detected in all" 5 "NK-cells: 5.8;T-cells: 16.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005285, HPA039311, HPA058874" Enhanced Cytosol Cytosol "CAB005285: AB_2078884, HPA039311: , HPA058874: " "unprognostic (3.46e-2)" "unprognostic (9.95e-2)" "unprognostic (5.79e-2)" "unprognostic (6.78e-3)" "unprognostic (2.73e-1)" "unprognostic (6.08e-2)" "unprognostic (1.51e-3)" "prognostic unfavourable (4.52e-4)" "unprognostic (2.50e-3)" "unprognostic (2.85e-3)" "prognostic unfavourable (7.46e-4)" "unprognostic (5.89e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.71e-1)" "unprognostic (7.30e-2)" "unprognostic (7.92e-2)" "unprognostic (4.31e-2)" 2.4 1.0 1.6 6.5 1.7 12.8 1.5 1.5 2.5 1.0 4.5 0.2 0.2 3.8 0.9 1.1 4.4 0.7 0.9 3.0 1.4 1.9 1.0 1.1 1.1 8.8 1.7 1.9 0.9 0.7 0.0 1.0 2.3 2.8 0.9 5.8 0.9 1.7 0.1 3.9 1.8 4.0 2.2 1.0 2.3 1.8 80.3 0.3 18.3 1.1 6.4 9.5 2.1 1.8 2.0 1.6 1.1 1.4 5.8 16.1 2.9 55.8 21.5 16.5 16.4 2.7 3.3 9.5 13.4 19.7 28.5 31.6 16.1 27.9 27.5 9.8 20.8 41.2 25.0 16.2 53.3 32.9 12.1 14.0 15.4 26.7 2.0 17.5 10.0 1.2 1.0 17.8 31.0 18.1 7.0 35.3 34.2 39.8 24.0 14.2 5.8 46.6 14.9 14.5 5.9 15.1 12.3 6.7 8.6 24.4 14.5 10.7 30.0 14.9 6.6 12.7 43.4 19.9 31.6 8.5 9.8 18.9 21.2 25.2 23.1 0.0 1.3 1.1 1.2 1.4 0.6 2.0 5.2 4.3 1.6 0.9 2.7 2.2 0.9 5.8 0.9 1.2 16.1 2.9 1.6 1.7 1.5 2.5 1.4 1.9 1.7 1.9 2.8 0.3 CDR1 "CDR, CDR34, CDR62A" ENSG00000184258 "Cerebellar degeneration related protein 1" P51861 X 140782405-140784871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 56.2" "Cell line enhanced" "Detected in some" "AF22: 3.3;BJ: 6.5;MOLT-4: 4.1;U-87 MG: 23.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA073147 Approved "Nucleoplasm,Golgi apparatus,Centrosome" "Nucleoplasm, Golgi apparatus, Centrosome" "HPA073147: " "unprognostic (7.10e-2)" "unprognostic (2.87e-2)" "unprognostic (2.85e-1)" "unprognostic (3.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.41e-3)" "unprognostic (1.46e-4)" "unprognostic (1.55e-1)" "unprognostic (1.84e-1)" 3.2 1.3 9.1 0.5 26.3 0.0 0.0 56.2 28.7 0.0 0.1 0.2 0.4 0.0 0.6 0.2 1.5 1.5 9.2 2.8 0.1 0.0 0.6 0.1 3.7 0.1 3.9 0.0 7.1 0.4 0.1 0.0 0.6 0.0 0.2 9.4 0.1 0.0 3.6 0.9 0.5 0.1 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 3.3 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.1 0.0 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.4 0.0 1.2 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDRT15L2 ENSG00000214819 "CMT1A duplicated region transcript 15 like 2" A8MXV6 17 20579724-20580911 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 15.3" "Cell line enhanced" "Detected in some" "A549: 1.3;AN3-CA: 1.7;Hep G2: 1.3;HMC-1: 1.4;U-138 MG: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.3 0.1 1.7 0.0 0.0 1.0 0.3 0.0 0.2 0.0 1.0 0.0 0.7 0.2 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.8 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.7 0.0 2.2 0.0 0.0 0.3 0.8 0.2 0.5 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 CDX1 ENSG00000113722 "Caudal type homeobox 1" P47902 5 150166795-150184558 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 83.7" "Cell line enriched" "Detected in some" 5 "BJ hTERT+: 11.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 125.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "thalamus: 0.3" "Group enriched" "Detected in some" 10 "midbrain: 1.0;pons and medulla: 1.2;thalamus: 2.1" HPA055196 Enhanced "HPA055196: " "unprognostic (2.50e-3)" "unprognostic (3.90e-1)" "unprognostic (1.65e-2)" "unprognostic (1.09e-2)" "unprognostic (5.89e-2)" "unprognostic (1.54e-2)" "unprognostic (2.07e-2)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (7.20e-2)" "unprognostic (1.59e-1)" "unprognostic (2.96e-1)" "unprognostic (1.83e-7)" "unprognostic (2.10e-1)" "unprognostic (4.25e-1)" "unprognostic (5.42e-3)" "unprognostic (2.16e-3)" 0.2 0.1 0.1 18.6 0.2 0.0 0.2 0.1 0.2 0.2 63.6 0.2 0.1 19.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 38.5 0.1 0.1 0.1 0.1 0.2 83.7 1.5 0.1 0.1 0.1 0.9 0.1 0.5 0.1 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.3 0.0 11.9 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 CDX2 CDX3 ENSG00000165556 "Caudal type homeobox 2" Q99626 13 27962137-27971139 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "intestine: 21.2" "Group enriched" "Detected in some" 6 "CACO-2: 14.4;CAPAN-2: 4.8;HEK 293: 8.0" "Cancer enriched" "Detected in many" 6 "colorectal cancer: 63.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002221, HPA045669, HPA049580" Enhanced Enhanced Nucleoplasm Nucleoplasm "CAB002221: AB_563649, HPA045669: , HPA049580: " "unprognostic (1.42e-1)" "unprognostic (2.41e-1)" "unprognostic (2.92e-1)" "unprognostic (8.11e-3)" "unprognostic (4.19e-6)" "unprognostic (1.73e-4)" "unprognostic (1.71e-1)" "unprognostic (1.58e-1)" "unprognostic (5.51e-2)" "unprognostic (6.07e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 21.2 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 14.3 0.0 0.0 0.0 0.0 16.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.4 4.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 8.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDY1 CDY1A ENSG00000172288 "Chromodomain Y-linked 1" Q9Y6F8 Y 25622162-25624902 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 47 "testis: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA066682 Supported "HPA066682: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDY1B ENSG00000172352 "Chromodomain Y-linked 1B" Q9Y6F8 Y 24045229-24048019 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 72 "testis: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA066682 Supported "HPA066682: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDY2B CDY ENSG00000129873 "Chromodomain Y-linked 2B" Q9Y6F7 Y 17877410-17880220 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "testis: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA066682 Supported "HPA066682: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CEACAM18 ENSG00000213822 "Carcinoembryonic antigen related cell adhesion molecule 18" A8MTB9 19 51478622-51490952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 62 "intestine: 31.3" "Group enriched" "Detected in some" 13 "CACO-2: 9.4;RT4: 3.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 0.8;stomach cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059487 Uncertain Approved Midbody Midbody "HPA059487: " "unprognostic (1.12e-1)" "unprognostic (1.87e-2)" "unprognostic (1.00e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 16.6 0.0 0.0 14.6 0.1 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 31.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 CEACAM20 UNQ9366 ENSG00000273777 "Carcinoembryonic antigen related cell adhesion molecule 20" 19 44501677-44529788 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "intestine: 64.6" "Cell line enriched" "Detected in single" 7 "U-266/70: 5.5" "Group enriched" "Detected in some" 9 "liver cancer: 1.2;prostate cancer: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (1.04e-2)" "unprognostic (5.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.92e-1)" "unprognostic (1.23e-2)" "unprognostic (3.75e-1)" "unprognostic (9.89e-2)" "unprognostic (1.07e-2)" "unprognostic (7.58e-2)" "unprognostic (2.14e-5)" "unprognostic (7.13e-2)" "unprognostic (2.51e-2)" "unprognostic (1.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 64.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CEL "BSSL, MODY8" ENSG00000170835 "Carboxyl ester lipase" 9 133061978-133071861 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 348 "pancreas: 1584.8" "Cell line enhanced" "Detected in many" "HMC-1: 8.4" "Cancer enriched" "Detected in many" 29 "pancreatic cancer: 469.3" "Region enriched" "Detected in single" 9 "cerebral cortex: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA008023, HPA052701" Enhanced "Secreted to digestive system" "HPA008023: AB_1846509, HPA052701: AB_2681921" "prognostic unfavourable (4.14e-4)" "unprognostic (2.30e-2)" "unprognostic (4.49e-2)" "unprognostic (3.14e-2)" "unprognostic (2.22e-1)" "unprognostic (2.48e-1)" "unprognostic (1.49e-1)" "unprognostic (6.27e-2)" "unprognostic (3.04e-2)" "unprognostic (1.47e-2)" "unprognostic (2.51e-1)" "unprognostic (5.55e-2)" "unprognostic (2.26e-3)" "unprognostic (2.98e-1)" "unprognostic (4.41e-1)" "unprognostic (4.37e-2)" "unprognostic (1.02e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 2.3 0.2 0.2 0.2 0.2 0.1 0.2 2.9 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 3.5 0.2 0.2 0.2 0.8 1584.8 0.0 4.5 0.2 0.2 0.2 0.0 0.2 0.2 4.5 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 1.6 0.2 0.2 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.4 1.1 4.4 2.7 1.5 1.0 4.5 0.9 0.5 0.6 0.8 1.3 0.8 1.3 2.2 0.8 3.0 1.0 8.2 0.3 2.6 1.6 2.2 0.6 2.9 0.6 0.9 8.4 2.2 5.4 0.8 0.5 0.8 1.3 1.1 0.8 1.8 1.3 4.4 7.3 1.4 2.4 1.3 0.9 0.5 3.8 7.6 1.9 1.0 0.9 0.4 1.4 4.0 0.6 2.1 2.8 2.5 0.6 0.6 4.5 1.0 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.2 0.2 2.3 0.2 0.0 0.2 0.2 0.2 0.2 CELA2A ELA2A ENSG00000142615 "Chymotrypsin like elastase family member 2A" P08217 1 15456728-15472091 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1559 "pancreas: 2376.3" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;HEL: 1.2;HL-60: 1.0;HMC-1: 4.9;K-562: 1.1;U-2 OS: 1.6" "Cancer enriched" "Detected in single" 3819 "pancreatic cancer: 463.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Secreted to digestive system" "unprognostic (9.78e-2)" "unprognostic (3.33e-2)" "unprognostic (5.60e-2)" "unprognostic (5.27e-2)" "unprognostic (3.63e-3)" "unprognostic (2.35e-1)" "unprognostic (4.14e-1)" "unprognostic (1.96e-2)" "unprognostic (1.38e-1)" "unprognostic (2.48e-1)" "unprognostic (3.94e-9)" "unprognostic (4.10e-2)" "unprognostic (3.42e-1)" "unprognostic (3.55e-2)" 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.8 2376.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.7 1.2 0.0 0.0 0.0 1.0 4.9 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CELA2B "ELA2B, RP11-265F14.2" ENSG00000215704 "Chymotrypsin like elastase family member 2B" P08218 1 15465909-15491400 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 188 "pancreas: 697.9" "Cell line enriched" "Detected in some" 5 "U-138 MG: 9.1" "Cancer enriched" "Detected in single" 574 "pancreatic cancer: 69.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 3.7;neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.7" "Secreted to digestive system" "unprognostic (4.36e-3)" "unprognostic (5.45e-2)" "unprognostic (6.66e-2)" "unprognostic (5.31e-3)" "unprognostic (4.47e-3)" "unprognostic (1.37e-3)" "unprognostic (4.66e-2)" "unprognostic (6.32e-2)" "unprognostic (2.73e-1)" "unprognostic (2.44e-1)" "unprognostic (2.94e-1)" "unprognostic (3.85e-2)" "unprognostic (1.22e-6)" "unprognostic (2.47e-1)" "unprognostic (6.67e-2)" "unprognostic (1.88e-1)" "unprognostic (7.80e-2)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 697.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.7 0.2 0.0 0.5 0.0 0.1 1.5 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.7 0.9 1.8 0.7 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.4 0.0 0.0 9.1 0.0 0.0 0.0 0.9 0.1 0.3 0.4 0.0 0.0 3.7 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 CELA3A "ELA3, ELA3A" ENSG00000142789 "Chymotrypsin like elastase family member 3A" P09093 1 22001656-22012539 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 2051 "pancreas: 2541.2" "Cell line enriched" "Detected in single" 24 "MOLT-4: 21.1" "Cancer enriched" "Detected in some" 2497 "pancreatic cancer: 1481.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028086, HPA045650" Supported Approved Cytosol "Secreted to digestive system" Cytosol "HPA028086: , HPA045650: " "unprognostic (1.27e-1)" "unprognostic (2.71e-1)" "unprognostic (1.79e-1)" "unprognostic (6.32e-2)" "unprognostic (2.67e-1)" 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.2 2541.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CELA3B "CBPP, ELA3B" ENSG00000219073 "Chymotrypsin like elastase family member 3B" P08861 1 21977021-21998642 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 196 "pancreas: 1614.4" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in single" 1218 "pancreatic cancer: 408.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA028086, HPA045650" Supported Approved Cytosol "Secreted to digestive system" Cytosol "HPA028086: , HPA045650: " "unprognostic (2.89e-1)" "unprognostic (4.01e-3)" "unprognostic (6.53e-3)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" "unprognostic (6.40e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.6 1614.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 5.9 5.3 8.2 3.0 2.3 3.2 0.9 0.6 4.9 1.7 1.3 2.5 1.5 2.2 1.1 1.8 1.7 1.7 5.3 2.7 5.4 2.6 1.4 1.6 1.0 0.5 0.0 2.4 4.1 2.4 4.9 3.9 1.3 1.9 3.2 2.3 2.4 1.4 0.0 2.4 2.5 5.5 0.4 2.5 2.1 1.5 1.3 3.5 3.6 0.9 4.2 0.0 3.6 3.1 1.7 3.4 0.8 0.3 2.5 2.8 3.6 2.9 1.6 2.3 1.0 4.8 4.7 2.4 1.8 4.7 0.6 5.1 2.5 1.8 3.1 3.0 2.0 3.7 2.2 2.8 1.4 5.9 3.2 3.0 8.2 2.3 1.7 5.3 2.9 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CELF4 BRUNOL4 ENSG00000101489 "CUGBP Elav-like family member 4" Q9BZC1 18 37243047-37566037 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 69.1" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 31.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013322, HPA037986" Enhanced Supported Nucleoplasm Nucleoplasm "HPA013322: , HPA037986: AB_10673035" "unprognostic (7.87e-3)" "unprognostic (2.31e-2)" "unprognostic (4.31e-3)" "unprognostic (3.42e-7)" "unprognostic (2.95e-2)" "unprognostic (2.95e-2)" "unprognostic (3.72e-3)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.87e-3)" "unprognostic (1.92e-2)" "unprognostic (1.00e-2)" "unprognostic (3.49e-1)" "unprognostic (1.69e-2)" "unprognostic (2.48e-1)" "unprognostic (8.32e-3)" "unprognostic (6.13e-2)" 1.4 10.7 40.2 1.7 25.2 1.1 1.3 45.3 69.1 1.1 1.6 0.9 0.0 1.6 1.3 1.5 1.4 1.3 2.0 1.7 27.0 26.3 1.4 1.3 1.4 1.6 13.5 26.3 2.0 4.2 1.2 8.1 1.7 13.1 1.5 1.3 0.5 2.5 1.1 8.3 2.0 1.9 1.3 3.7 1.7 1.6 3.9 5.6 0.0 2.3 0.0 1.0 1.2 0.0 0.7 0.5 2.4 0.9 0.9 0.9 0.4 0.1 0.1 0.5 0.4 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.2 0.7 0.0 0.4 0.0 0.1 0.0 0.5 0.3 0.0 1.2 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.0 0.2 0.1 0.4 1.1 0.2 0.1 0.0 1.4 0.0 0.1 31.0 7.6 0.8 0.2 0.0 0.1 0.1 0.0 1.0 0.4 0.2 0.1 2.0 0.3 0.1 0.1 0.1 0.1 2.4 0.5 0.5 0.7 0.6 0.7 0.7 0.4 0.4 0.3 0.7 0.8 0.9 1.3 0.9 0.9 0.5 0.6 0.4 40.2 25.2 45.3 31.1 27.0 26.3 13.5 26.3 13.1 5.6 CELF5 BRUNOL5 ENSG00000161082 "CUGBP Elav-like family member 5" Q8N6W0 19 3224703-3297076 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 35.8" "Cell line enhanced" "Detected in some" "NTERA-2: 6.0;REH: 7.4;SCLC-21H: 7.6;SH-SY5Y: 4.6" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042012, HPA060336" Enhanced "HPA042012: AB_10796896, HPA060336: " "unprognostic (1.09e-1)" "unprognostic (9.24e-2)" "unprognostic (9.25e-3)" "unprognostic (3.48e-2)" "unprognostic (1.69e-1)" "unprognostic (5.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.17e-1)" "unprognostic (1.22e-3)" "unprognostic (1.35e-1)" "unprognostic (4.70e-3)" "unprognostic (1.11e-2)" "unprognostic (1.74e-3)" "unprognostic (1.23e-2)" "unprognostic (2.63e-2)" "unprognostic (1.25e-1)" "unprognostic (8.07e-2)" 0.8 1.1 16.2 0.8 21.2 0.7 1.5 19.6 35.8 0.8 1.0 0.8 0.0 0.8 1.3 1.1 0.8 1.5 0.7 0.8 9.5 12.2 0.8 0.8 0.8 0.7 2.6 15.5 7.1 1.1 2.6 0.5 0.8 3.4 0.9 1.0 0.0 2.0 1.0 1.3 0.8 0.9 0.8 0.9 0.8 1.2 2.5 2.7 0.2 0.8 0.0 0.7 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.4 1.3 1.6 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.1 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 1.0 0.1 0.0 6.0 0.1 7.4 0.0 0.0 0.0 0.0 7.6 4.6 0.3 0.5 0.0 0.8 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.2 21.2 19.6 19.6 9.5 12.2 2.6 15.5 3.4 2.7 CEND1 "BM88, FLJ90066" ENSG00000184524 "Cell cycle exit and neuronal differentiation 1" Q8N111 11 787104-790123 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 85.2" "Cell line enhanced" "Detected in some" "Karpas-707: 16.7;SCLC-21H: 30.0;SH-SY5Y: 11.2;U-266/70: 11.7;U-87 MG: 15.6" "Cancer enriched" "Detected in many" 13 "glioma: 24.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042527 Enhanced Approved Mitochondria Mitochondria "HPA042527: AB_2678038" "unprognostic (4.62e-3)" "unprognostic (1.34e-4)" "unprognostic (9.66e-3)" "unprognostic (1.27e-2)" "prognostic unfavourable (4.38e-5)" "unprognostic (2.20e-3)" "unprognostic (4.11e-2)" "unprognostic (6.72e-2)" "unprognostic (2.60e-2)" "unprognostic (2.26e-1)" "unprognostic (2.00e-3)" "unprognostic (4.24e-3)" "unprognostic (1.94e-3)" "unprognostic (4.43e-2)" "unprognostic (1.71e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-1)" 1.9 8.2 28.5 2.9 34.7 1.8 1.8 46.5 85.2 1.8 2.3 8.3 1.3 2.5 1.9 2.0 2.2 1.8 1.9 2.1 34.2 25.3 2.1 1.8 1.8 2.1 32.0 30.7 1.8 1.9 1.9 5.1 1.8 42.4 3.2 1.9 2.1 1.8 3.6 1.8 1.9 2.7 2.3 10.2 1.8 1.9 1.9 5.9 0.0 1.8 0.0 2.0 2.1 0.1 3.6 0.2 0.0 0.7 0.0 1.9 0.3 0.0 0.4 0.4 0.7 0.1 0.1 0.1 0.7 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.1 0.0 2.9 0.3 0.0 0.4 0.0 0.1 0.0 16.7 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 30.0 11.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 11.7 3.2 0.7 15.6 0.1 0.2 0.0 0.0 0.0 0.9 0.7 0.3 3.6 1.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.3 28.5 34.7 46.5 65.2 34.2 25.3 32.0 30.7 42.4 5.9 CENPA "CenH3, CENP-A" ENSG00000115163 "Centromere protein A" P49450 2 26764289-26801067 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 53.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.6" "Lineage enriched" "Detected in single" 16 "T-cells: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB008371, HPA073086" Enhanced Supported Nucleoplasm Nucleoplasm "CAB008371: AB_591074, HPA073086: " "unprognostic (3.94e-2)" "unprognostic (1.38e-1)" "unprognostic (2.29e-2)" "prognostic unfavourable (2.38e-4)" "unprognostic (1.13e-1)" "unprognostic (2.89e-2)" "prognostic unfavourable (2.88e-8)" "prognostic unfavourable (3.70e-4)" "unprognostic (1.69e-3)" "unprognostic (7.80e-2)" "prognostic unfavourable (1.30e-4)" "unprognostic (4.21e-3)" "unprognostic (0.00e+0)" "unprognostic (5.74e-2)" "unprognostic (1.33e-1)" "unprognostic (7.68e-2)" "unprognostic (2.07e-1)" 1.2 0.9 0.2 12.1 0.2 3.5 3.0 0.2 0.2 1.3 3.5 0.4 0.3 5.3 0.9 1.5 8.5 0.1 1.2 1.5 0.2 0.3 0.8 0.7 1.4 8.2 0.3 0.0 0.5 0.7 0.0 0.3 3.1 0.3 0.5 3.2 0.1 1.7 0.0 0.3 4.5 3.6 0.8 0.3 4.9 1.8 7.8 0.0 53.7 0.4 9.2 10.0 1.3 2.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 30.8 7.1 11.1 6.1 0.8 1.8 9.2 9.6 7.3 13.0 11.1 5.1 10.1 9.3 6.2 3.4 9.1 9.9 5.1 12.8 27.5 9.6 15.7 3.2 8.6 0.2 9.1 17.5 0.1 0.6 5.1 7.1 6.7 12.7 19.2 10.2 10.4 13.1 14.0 9.9 13.1 15.6 19.8 10.2 5.7 1.4 9.5 9.5 9.2 10.2 7.5 6.1 9.7 4.7 8.0 20.3 9.5 15.8 19.2 19.0 37.9 3.9 18.8 15.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.0 0.3 0.0 CEP128 "C14orf145, C14orf61" ENSG00000100629 "Centrosomal protein 128" Q6ZU80 14 80476983-80959517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lymphoid tissue: 61.2" "Cell line enhanced" "Detected in many" "Karpas-707: 25.2;MOLT-4: 21.6;U-266/70: 45.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 8.6;T-cells: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000602, HPA001116, HPA018498" Uncertain Supported "Centriolar satellite,Cytosol" "Centriolar satellite" Cytosol "HPA000602: , HPA001116: AB_1078323, HPA018498: AB_1845560" "unprognostic (6.13e-3)" "unprognostic (5.82e-2)" "unprognostic (1.65e-2)" "unprognostic (3.49e-2)" "unprognostic (4.32e-2)" "unprognostic (5.93e-2)" "unprognostic (2.64e-2)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (1.87e-1)" "unprognostic (3.42e-1)" "unprognostic (1.94e-2)" "unprognostic (2.60e-3)" "unprognostic (1.21e-1)" "unprognostic (3.37e-1)" "unprognostic (2.45e-1)" "unprognostic (1.48e-1)" 3.8 2.0 5.2 6.5 7.6 10.5 7.5 13.6 5.4 3.4 3.6 4.2 2.7 3.2 4.0 2.2 4.4 4.8 2.0 3.1 3.8 2.5 2.4 2.0 3.8 8.1 6.9 3.1 4.4 2.1 4.2 8.6 2.3 4.5 2.9 3.3 2.3 4.5 3.2 3.1 5.1 3.0 4.0 5.5 6.3 3.1 9.0 6.8 61.2 5.7 3.1 9.1 6.0 4.4 2.2 8.6 1.7 0.8 1.1 9.6 0.8 5.9 3.1 2.8 2.3 0.6 1.1 1.5 6.7 2.0 3.9 3.9 2.1 3.4 13.7 1.2 1.9 3.2 3.0 1.9 7.5 7.7 1.9 2.6 3.9 1.1 0.3 2.7 3.5 0.2 0.5 5.6 3.0 2.9 3.3 25.2 3.7 3.7 21.6 1.4 2.1 3.9 3.9 6.9 10.7 0.8 3.1 3.6 1.7 5.4 2.2 1.1 2.5 2.0 2.7 8.6 4.7 2.3 6.5 45.6 1.8 6.1 2.4 3.6 2.9 0.0 0.8 1.7 2.9 0.3 2.3 2.2 3.2 2.2 2.5 0.9 2.8 1.3 0.1 1.1 0.5 8.6 9.6 0.8 5.2 7.6 13.6 5.4 3.8 2.5 6.9 3.1 4.5 6.8 CEP295NL "DDC8, KIAA1731NL" ENSG00000178404 "CEP295 N-terminal like" Q96MC4 17 78870910-78903217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 37.7" "Cell line enhanced" "Detected in some" "BEWO: 4.0;Karpas-707: 3.2;TIME: 3.2;U-2 OS: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 3.5" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.5" "HPA023609, HPA024619, HPA025717" Uncertain Approved Vesicles Vesicles "HPA023609: AB_10610974, HPA024619: AB_10602076, HPA025717: AB_10601900" "unprognostic (1.68e-3)" "unprognostic (4.56e-2)" "unprognostic (2.62e-1)" "unprognostic (5.04e-3)" "unprognostic (1.88e-1)" "unprognostic (1.59e-1)" "unprognostic (1.89e-1)" "unprognostic (9.03e-2)" "unprognostic (8.16e-2)" "unprognostic (9.80e-2)" "unprognostic (2.08e-1)" "unprognostic (3.89e-3)" "unprognostic (3.65e-3)" "unprognostic (1.03e-1)" "unprognostic (2.09e-1)" "unprognostic (1.28e-1)" "unprognostic (6.75e-3)" 0.1 0.0 0.1 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 37.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.2 3.5 0.4 0.1 0.1 0.0 0.7 0.1 0.0 0.9 0.2 0.6 4.0 1.7 0.1 0.6 1.1 0.2 0.6 0.0 1.1 0.6 0.1 0.0 0.2 0.6 0.0 0.0 0.0 1.3 0.3 0.4 0.2 0.1 0.3 0.0 1.2 0.0 0.4 0.0 3.2 0.1 0.0 0.3 0.0 0.3 0.6 0.8 0.5 0.1 0.2 0.0 0.1 0.9 0.5 0.4 0.7 0.1 1.0 3.2 1.4 5.4 1.7 0.7 1.2 1.6 0.0 0.0 0.1 1.7 0.0 0.4 0.7 0.0 0.4 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.0 3.5 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CERS1 "LAG1, LASS1, UOG1" ENSG00000223802 "Ceramide synthase 1" P27544 19 18868545-18896727 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 86.3" "Cell line enhanced" "Detected in many" "AN3-CA: 17.4;EFO-21: 12.7;HEK 293: 17.7;NB-4: 19.0;NTERA-2: 13.0" "Cancer enhanced" "Detected in many" "glioma: 13.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.7" HPA045724 Enhanced Approved "Endoplasmic reticulum" "Intracellular and membrane" "Endoplasmic reticulum" "HPA045724: AB_10969762" "unprognostic (8.25e-2)" "unprognostic (8.91e-2)" "unprognostic (2.12e-2)" "unprognostic (2.14e-1)" "unprognostic (3.59e-2)" "unprognostic (6.47e-2)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "unprognostic (4.02e-1)" "unprognostic (7.04e-3)" "unprognostic (3.52e-3)" "unprognostic (1.92e-1)" "unprognostic (4.59e-2)" "unprognostic (2.99e-2)" "unprognostic (3.15e-2)" "unprognostic (9.15e-2)" "unprognostic (3.49e-1)" 2.4 4.7 28.9 2.3 32.9 1.7 1.7 12.5 86.3 2.2 2.1 40.5 0.0 1.6 2.0 2.1 2.5 2.1 3.9 3.4 29.5 23.2 1.6 1.6 1.9 1.6 31.9 20.5 4.3 2.4 1.7 3.2 1.9 33.8 2.0 1.8 1.8 2.3 2.1 17.8 2.0 1.9 3.0 37.8 1.7 1.8 15.7 22.2 0.0 2.4 0.0 1.6 2.6 0.4 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.1 1.7 10.7 17.4 0.6 0.2 0.3 1.1 0.1 3.0 2.2 8.5 0.6 0.0 12.7 0.8 0.1 7.8 0.3 1.2 0.0 17.7 0.1 0.4 6.4 1.4 1.7 0.2 0.6 0.1 1.0 0.3 0.7 1.1 0.1 2.0 4.4 0.1 19.0 13.0 0.3 0.0 0.3 0.3 2.3 0.0 9.1 9.1 0.4 0.0 7.7 2.9 10.6 0.2 0.0 2.4 1.7 2.5 0.3 0.2 0.0 0.0 0.6 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 28.9 32.9 12.5 35.7 29.5 23.2 31.9 20.5 33.8 22.2 CES1 "CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1" ENSG00000198848 "Carboxylesterase 1" P23141 16 55802851-55833337 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 355.0" "Group enriched" "Detected in some" 5 "Hep G2: 93.9;THP-1: 101.2" "Cancer enriched" "Detected in all" 6 "liver cancer: 711.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 18 "classical monocyte: 32.6;myeloid DC: 32.9" "Group enriched" "Detected in many" 20 "dendritic cells: 32.9;monocytes: 32.6" "Not detected" "Not detected" "HPA012023, HPA046717" Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" 40000000 "Endoplasmic reticulum" "HPA012023: AB_1846554, HPA046717: AB_2679770" "unprognostic (1.04e-2)" "unprognostic (9.85e-2)" "unprognostic (2.94e-1)" "unprognostic (1.28e-1)" "unprognostic (1.55e-3)" "unprognostic (7.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.42e-1)" "unprognostic (3.51e-1)" "unprognostic (5.74e-2)" "unprognostic (4.62e-2)" "unprognostic (3.29e-2)" "unprognostic (1.91e-2)" "unprognostic (5.32e-2)" "unprognostic (1.92e-1)" "unprognostic (2.87e-1)" "prognostic unfavourable (9.92e-4)" 27.1 1.7 0.3 0.5 0.4 2.1 24.7 0.4 0.6 3.1 8.9 0.5 1.5 2.4 7.3 2.1 4.5 6.7 57.7 8.1 0.3 0.0 0.7 355.0 19.8 2.3 0.3 0.6 3.9 1.3 0.0 0.8 1.1 0.6 11.2 1.0 3.8 3.9 4.0 1.6 1.4 3.5 10.2 0.7 4.4 7.0 1.0 0.3 0.4 1.7 2.3 1.5 8.2 16.1 0.2 32.9 0.2 32.6 0.1 1.6 12.1 0.0 0.6 0.0 0.0 14.1 0.0 0.4 0.0 0.0 0.0 0.0 6.5 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 101.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 20.3 0.0 0.0 32.6 0.1 1.3 1.8 0.5 0.2 0.2 1.6 32.9 0.2 0.2 0.4 0.2 0.1 0.4 1.7 0.1 12.1 0.3 0.4 0.4 0.6 0.3 0.0 0.3 0.6 0.6 0.3 CES5A "CAUXIN, CES4C1, CES5, CES7, FLJ31547" ENSG00000159398 "Carboxylesterase 5A" Q6NT32 16 55846154-55956031 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "epididymis: 43.4" "Cell line enriched" "Detected in single" 44 "U-266/70: 13.0" "Cancer enhanced" "Detected in single" "liver cancer: 0.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" "unprognostic (2.07e-1)" "unprognostic (2.55e-1)" "unprognostic (6.34e-2)" "unprognostic (4.82e-2)" "unprognostic (3.78e-1)" "unprognostic (2.33e-1)" "unprognostic (3.12e-2)" "unprognostic (1.72e-7)" "unprognostic (1.55e-2)" "unprognostic (2.27e-1)" 0.1 0.1 0.7 0.1 0.6 0.0 0.1 0.1 0.8 0.1 0.1 0.1 3.6 0.0 0.1 43.4 0.1 0.0 1.4 0.1 0.8 0.5 0.1 6.6 0.1 0.1 1.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.3 0.1 1.2 0.1 0.1 1.8 0.1 0.0 1.7 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.1 0.8 0.8 0.5 1.4 0.1 0.1 0.1 CETN1 "CEN1, CETN" ENSG00000177143 "Centrin 1" Q12798 18 580357-582114 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 181 "testis: 87.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 10 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028956, CAB037244, HPA069157" Enhanced "CAB037244: AB_476871, HPA028956: AB_10601798, HPA069157: " "unprognostic (1.51e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFAP97D1 C17orf105 ENSG00000231256 "CFAP97 domain containing 1" B2RV13 17 43780435-43787612 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 45.9" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053028 Approved "HPA053028: " "unprognostic (7.80e-2)" "unprognostic (5.46e-2)" "unprognostic (3.37e-1)" "unprognostic (1.83e-1)" "unprognostic (9.64e-2)" "unprognostic (1.87e-1)" "unprognostic (1.36e-1)" "unprognostic (1.98e-1)" "unprognostic (2.77e-1)" "unprognostic (4.80e-2)" "unprognostic (3.09e-1)" "unprognostic (4.49e-1)" "unprognostic (1.73e-1)" "unprognostic (6.24e-2)" "unprognostic (2.28e-3)" "unprognostic (1.41e-1)" 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.1 0.1 45.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.9 3.0 1.0 1.3 0.7 0.3 1.0 0.1 0.2 1.0 0.2 0.2 0.5 0.4 0.0 0.0 0.2 0.4 0.6 0.8 0.2 0.1 0.6 0.3 0.4 0.3 0.4 0.7 1.8 1.2 0.6 0.1 0.4 0.9 0.5 0.0 0.7 0.6 0.5 0.5 1.0 0.1 0.1 1.1 2.0 0.6 0.5 0.9 0.7 0.2 0.3 0.6 1.1 1.0 0.6 0.6 0.6 1.5 1.8 0.6 1.0 1.7 0.9 0.4 0.4 0.5 0.2 0.7 1.6 0.6 2.1 1.0 0.9 0.7 0.6 0.5 0.8 0.5 0.3 0.4 1.5 0.7 0.7 3.0 1.3 0.7 0.9 0.4 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 CFB "BF, BFD, H2-Bf" ENSG00000243649 "Complement factor B" P00751 6 31945650-31952084 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "liver: 461.5" "Cell line enhanced" "Detected in some" "ASC diff: 6.0;ASC TERT1: 5.8;CAPAN-2: 6.9;fHDF/TERT166: 11.3;HSkMC: 18.7" "Cancer enhanced" "Detected in all" "liver cancer: 78.3" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "HPA000951, HPA001817, HPA001832, CAB016381" Supported Approved "Endoplasmic reticulum,Vesicles,Cell Junctions" "Secreted to blood" 878700000 180000000000 "Endoplasmic reticulum, Vesicles" "Cell Junctions" "CAB016381: AB_627562, HPA000951: , HPA001817: AB_1078779, HPA001832: AB_1078778" "prognostic favourable (2.76e-5)" "unprognostic (1.02e-1)" "unprognostic (1.44e-1)" "unprognostic (7.94e-2)" "unprognostic (1.82e-2)" "unprognostic (8.56e-2)" "unprognostic (8.08e-3)" "unprognostic (8.81e-2)" "unprognostic (3.51e-1)" "unprognostic (2.26e-2)" "unprognostic (1.32e-2)" "unprognostic (6.57e-2)" "prognostic unfavourable (1.53e-5)" "unprognostic (1.36e-1)" "unprognostic (5.13e-2)" "unprognostic (1.05e-2)" "unprognostic (3.68e-2)" 9.3 1.0 0.3 4.1 0.4 0.3 2.4 0.2 0.4 1.3 9.0 0.4 0.9 3.2 0.5 3.7 2.2 4.0 8.9 3.3 0.2 0.0 16.1 461.5 2.5 2.1 0.7 0.1 2.8 5.8 0.4 1.0 4.0 1.0 4.0 1.6 2.6 3.1 0.3 0.5 0.5 4.7 2.6 0.6 0.8 4.1 1.4 0.3 0.3 1.8 0.5 1.7 1.6 0.4 0.1 1.6 0.0 0.8 0.0 0.2 0.0 0.0 1.8 0.1 0.1 6.0 5.8 0.0 0.0 0.3 1.5 0.6 0.0 6.9 0.1 5.1 11.3 0.0 0.0 1.9 1.4 0.4 0.3 0.4 0.3 0.5 0.0 0.7 0.1 18.7 0.1 0.9 0.6 0.2 0.2 0.7 0.1 0.1 0.1 0.4 0.3 0.1 0.2 0.4 0.2 1.6 0.0 0.0 0.0 0.5 1.2 0.2 0.0 0.2 0.0 0.2 0.5 0.3 0.3 0.5 1.9 0.5 3.1 0.5 0.5 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.3 0.4 0.2 0.3 0.2 0.0 0.7 0.1 1.0 0.3 CFH "ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS" ENSG00000000971 "Complement factor H" P08603 1 196651878-196747504 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity" "Age-related macular degeneration, Cancer-related genes, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 295.2" "Cell line enhanced" "Detected in many" "ASC diff: 25.2;HHSteC: 31.8;HSkMC: 31.0;RH-30: 23.2;RT4: 56.3" "Cancer enriched" "Detected in all" 9 "liver cancer: 151.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 16.5" "Lineage enriched" "Detected in single" 27 "T-cells: 16.5" "CAB016385, CAB016769, HPA038922, HPA049176, HPA053326" Supported Approved Vesicles "Secreted to blood" 395836666667 110000000000 Vesicles "CAB016385: AB_627572, CAB016769: , HPA038922: , HPA049176: , HPA053326: " "unprognostic (2.40e-1)" "unprognostic (9.86e-2)" "unprognostic (1.22e-1)" "unprognostic (8.39e-2)" "unprognostic (5.40e-3)" "unprognostic (1.80e-1)" "unprognostic (3.75e-3)" "unprognostic (7.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.04e-1)" "unprognostic (9.08e-2)" "unprognostic (2.08e-1)" "prognostic unfavourable (1.92e-6)" "unprognostic (6.50e-3)" "unprognostic (4.49e-3)" "unprognostic (1.73e-1)" "unprognostic (1.37e-1)" 28.6 5.5 1.6 3.7 3.8 0.1 8.8 2.6 2.7 10.4 9.1 1.0 3.9 3.7 2.5 8.7 15.2 3.4 17.0 47.3 2.0 1.2 7.0 295.2 11.0 10.3 5.3 1.7 40.9 1.9 1.7 4.3 5.1 5.3 10.3 10.4 6.3 19.0 3.3 10.0 11.5 8.1 12.6 4.2 3.3 5.8 6.4 2.9 0.7 22.0 22.8 5.8 17.2 16.8 0.0 0.1 0.6 0.1 0.0 16.5 1.0 0.0 16.1 0.0 0.0 25.2 14.3 0.0 6.5 15.9 0.9 3.5 0.0 3.0 0.0 2.4 0.0 0.5 0.0 5.9 0.6 0.3 0.0 4.8 19.1 0.0 31.8 0.2 0.0 31.0 0.1 4.7 2.0 19.8 18.1 0.6 22.5 0.0 0.1 0.0 0.1 0.0 0.0 23.2 5.1 0.0 56.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 19.2 0.2 0.2 0.2 0.2 0.0 0.0 3.4 0.0 1.4 0.0 0.1 0.0 1.8 0.0 16.5 0.0 6.0 3.5 0.1 0.0 0.4 1.4 0.6 0.0 0.0 0.0 0.0 1.0 1.6 3.8 2.6 2.7 2.0 1.2 5.3 1.7 5.3 2.9 CFHR1 "CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2" ENSG00000244414 "Complement factor H related 1" Q03591 1 196819757-196832189 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 174 "liver: 218.9" "Cell line enhanced" "Detected in some" "ASC diff: 2.6;HeLa: 3.1;HL-60: 4.7;U-266/70: 6.2" "Cancer enriched" "Detected in single" 798 "liver cancer: 182.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038915, HPA038922, HPA040726" Supported Approved Vesicles "Secreted to blood" 15000000000 Vesicles "HPA038915: , HPA038922: , HPA040726: " "unprognostic (2.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.50e-2)" "unprognostic (1.88e-2)" "prognostic favourable (8.71e-6)" "unprognostic (3.02e-1)" "unprognostic (3.70e-1)" "unprognostic (2.50e-1)" "unprognostic (8.48e-2)" "unprognostic (7.21e-4)" "unprognostic (7.01e-4)" "unprognostic (1.13e-1)" "unprognostic (6.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 218.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.3 0.2 2.6 1.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.2 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 1.6 3.1 0.2 0.2 4.7 0.8 0.1 0.0 0.0 0.0 0.1 0.3 2.3 0.8 0.0 1.4 0.0 0.8 0.0 0.8 2.0 0.0 0.0 0.3 0.0 0.1 0.9 0.0 0.2 0.4 0.0 1.4 0.9 0.4 0.2 0.2 6.2 0.0 1.1 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 CFHR2 "CFHL2, FHR2, HFL3" ENSG00000080910 "Complement factor H related 2" P36980 1 196943772-196959226 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1462 "liver: 146.2" "Cell line enhanced" "Detected in some" "HEL: 2.8;TIME: 1.2" "Cancer enriched" "Detected in single" 175 "liver cancer: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038915, HPA040726, HPA049813" Supported "Secreted to blood" 5700000000 "HPA038915: , HPA040726: , HPA049813: " "unprognostic (1.25e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 146.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFHR3 "CFHL3, DOWN16, FHR-3, FHR3, HLF4" ENSG00000116785 "Complement factor H related 3" Q02985 1 196774795-196795406 "Plasma proteins, Predicted secreted proteins" "Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 171 "liver: 121.9" "Group enriched" "Detected in some" 5 "NTERA-2: 3.3;T-47d: 6.8;U-266/70: 12.4" "Cancer enriched" "Detected in single" 80 "liver cancer: 27.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" 582000000 3800000000 "unprognostic (1.73e-1)" "unprognostic (2.11e-1)" "unprognostic (7.16e-2)" "unprognostic (6.77e-2)" "unprognostic (4.46e-1)" "unprognostic (4.20e-3)" "prognostic favourable (2.86e-5)" "unprognostic (1.78e-1)" "unprognostic (2.05e-2)" "unprognostic (1.98e-1)" "unprognostic (1.19e-2)" "unprognostic (6.11e-3)" "unprognostic (2.06e-10)" "unprognostic (2.67e-4)" "unprognostic (3.00e-1)" "unprognostic (3.29e-2)" "unprognostic (1.32e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 121.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.4 0.0 0.6 0.2 0.1 1.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.4 0.5 0.0 1.3 0.0 0.0 0.0 0.7 0.0 6.8 0.0 0.0 0.1 0.3 0.3 0.0 12.4 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.2 0.3 0.4 0.6 0.1 0.5 0.3 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFHR4 "CFHL4, FHR-4, FHR4" ENSG00000134365 "Complement factor H related 4" Q92496 1 196850241-196918972 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 188 "liver: 61.3" "Cell line enhanced" "Detected in some" "Karpas-707: 2.9;RPMI-8226: 2.0;U-2197: 2.5;U-266/70: 4.9;U-266/84: 2.0" "Cancer enriched" "Detected in single" 145 "liver cancer: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" 180000000 "unprognostic (5.97e-1)" "prognostic favourable (1.57e-6)" "unprognostic (1.89e-1)" "unprognostic (4.79e-2)" "unprognostic (1.26e-1)" "unprognostic (1.68e-2)" "unprognostic (4.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 61.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 2.5 0.0 4.9 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFHR5 "CFHL5, FHR-5, FHR5" ENSG00000134389 "Complement factor H related 5" Q9BXR6 1 196977556-197009674 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 241 "liver: 85.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 396 "liver cancer: 57.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038915, HPA040726" Supported "Secreted to blood" 1700000000 "HPA038915: , HPA040726: " "unprognostic (9.12e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.6 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFTR "ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR" ENSG00000001626 "Cystic fibrosis transmembrane conductance regulator" P13569 7 117465784-117715971 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Isomerase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pancreas: 103.0" "Group enriched" "Detected in some" 22 "CACO-2: 12.5;MOLT-4: 47.0;U-266/70: 25.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.9;pancreatic cancer: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Region enriched" "Detected in many" 5 "olfactory region: 6.3" "CAB001951, HPA021939" Enhanced "CAB001951: , HPA021939: AB_1846578" "unprognostic (6.38e-3)" "unprognostic (9.55e-2)" "unprognostic (1.77e-2)" "unprognostic (1.44e-2)" "unprognostic (8.74e-2)" "unprognostic (8.57e-2)" "prognostic unfavourable (9.44e-4)" "unprognostic (3.20e-3)" "unprognostic (1.13e-1)" "unprognostic (8.89e-2)" "unprognostic (1.55e-2)" "unprognostic (2.14e-2)" "unprognostic (4.78e-3)" "unprognostic (1.24e-1)" "unprognostic (2.58e-1)" "unprognostic (9.08e-2)" "unprognostic (6.64e-2)" 0.4 0.2 0.4 10.5 0.4 0.0 0.3 0.3 0.3 2.5 19.8 0.1 0.8 10.5 0.6 2.1 0.4 0.4 15.8 0.3 0.4 0.3 1.1 1.4 5.7 0.1 0.5 0.1 0.3 103.0 0.0 0.3 0.1 0.1 1.5 12.5 0.1 22.4 0.1 0.3 1.1 24.2 0.3 0.7 0.3 0.6 0.9 0.1 0.1 0.3 0.2 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.3 0.4 0.3 0.5 0.1 0.1 0.1 CGB1 ENSG00000267631 "Chorionic gonadotropin beta subunit 1" A6NKQ9 19 49035610-49036895 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "pancreas: 8.4" "Cell line enriched" "Detected in some" 5 "HMC-1: 20.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038925, HPA038934" Uncertain Approved Cytosol "Secreted to blood" Cytosol "HPA038925: , HPA038934: " 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.9 0.1 0.1 0.0 0.0 0.5 0.3 4.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CGB5 HCG ENSG00000189052 "Chorionic gonadotropin beta subunit 5" P0DN86 19 49043884-49045311 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 105.2" "Group enriched" "Detected in some" 24 "BEWO: 45.8;U-251 MG: 20.8" "Cancer enhanced" "Detected in some" "pancreatic cancer: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted to blood" Cytosol "HPA038925: , HPA038934: " "unprognostic (1.38e-1)" "unprognostic (1.68e-1)" "unprognostic (1.51e-3)" "prognostic unfavourable (1.18e-5)" "unprognostic (1.07e-1)" "prognostic unfavourable (9.47e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 12.7 105.2 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.2 0.0 0.0 0.0 0.0 45.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 20.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHGA ENSG00000100604 "Chromogranin A" P10645 14 92923080-92935293 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "parathyroid gland: 577.6" "Group enriched" "Detected in some" 134 "SCLC-21H: 43.3;SH-SY5Y: 117.9" "Cancer enhanced" "Detected in many" "pancreatic cancer: 114.8" "Region enhanced" "Detected in many" "cerebral cortex: 97.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000023, HPA017369, CAB040544, CAB055506, CAB058688" Enhanced Supported Vesicles "Intracellular and membrane" 78000000 Vesicles "CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: , HPA017369: AB_1846698" "prognostic favourable (7.85e-5)" "unprognostic (4.89e-2)" "unprognostic (5.96e-2)" "unprognostic (1.17e-1)" "unprognostic (1.43e-2)" "unprognostic (5.95e-2)" "prognostic unfavourable (2.40e-4)" "unprognostic (1.74e-1)" "unprognostic (2.23e-1)" "unprognostic (4.56e-2)" "prognostic favourable (4.07e-4)" "unprognostic (1.85e-1)" "unprognostic (8.81e-13)" "unprognostic (1.07e-2)" "unprognostic (1.77e-1)" "unprognostic (9.17e-2)" "prognostic unfavourable (3.99e-4)" 2.0 81.9 6.6 3.1 18.7 1.3 1.3 0.5 97.9 1.9 36.1 4.0 0.0 15.8 1.3 1.3 1.2 1.3 1.3 1.2 11.2 14.0 1.3 1.2 1.4 1.2 8.0 36.1 1.2 15.9 577.6 81.1 1.2 17.1 2.0 7.9 0.4 1.3 1.3 1.2 1.3 38.8 1.3 2.5 1.3 51.9 32.5 0.7 0.0 5.9 0.0 1.2 1.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 43.3 117.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.6 18.7 0.5 97.9 11.2 14.0 8.0 36.1 17.1 0.7 CHI3L1 "GP39, YKL40" ENSG00000133048 "Chitinase 3 like 1" P36222 1 203178931-203186749 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Inflammatory response" Antimicrobial "Asthma, Cancer-related genes, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 336.4" "Cell line enhanced" "Detected in some" "ASC diff: 39.8;ASC TERT1: 88.7;HSkMC: 78.7;THP-1: 125.5;U-138 MG: 37.2;U-87 MG: 37.1" "Cancer enriched" "Detected in all" 8 "glioma: 1313.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 490 "neutrophil: 81.3" "Lineage enriched" "Detected in single" 490 "granulocytes: 81.3" "Low region specificity" "Detected in all" "Region enriched" "Detected in single" 13 "olfactory region: 10.7" HPA077365 Approved "Golgi apparatus" "Secreted to blood" 25100000 230000000 "Golgi apparatus" "HPA077365: " "unprognostic (2.11e-3)" "unprognostic (1.21e-1)" "unprognostic (1.29e-1)" "unprognostic (1.07e-1)" "unprognostic (6.01e-3)" "unprognostic (8.81e-2)" "unprognostic (2.09e-1)" "unprognostic (1.48e-1)" "unprognostic (4.46e-2)" "unprognostic (1.30e-1)" "unprognostic (7.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (1.98e-2)" "unprognostic (3.43e-2)" "unprognostic (1.14e-2)" "unprognostic (9.39e-3)" 19.0 0.8 20.3 53.4 58.0 81.6 23.9 1.2 69.4 4.3 2.1 5.0 0.0 0.9 4.3 25.5 3.5 10.2 1.9 2.6 9.1 17.8 11.9 336.4 10.0 12.4 32.3 3.6 4.5 2.5 0.8 22.9 4.7 66.4 1.5 1.6 9.1 19.3 1.1 10.5 10.0 2.2 3.3 23.5 2.9 1.7 3.4 6.5 0.9 2.0 1.7 14.6 61.5 4.0 0.0 0.0 81.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 39.8 88.7 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 78.7 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 125.5 0.0 37.2 0.1 0.0 0.0 0.2 4.7 0.0 37.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.3 0.0 0.1 0.0 0.0 0.1 20.3 58.0 1.2 28.9 9.1 17.8 32.3 3.6 66.4 6.5 CHIA "AMCase, CHIT2, TSA1902" ENSG00000134216 "Chitinase, acidic" Q9BZP6 1 111290862-111320566 "Enzymes, Predicted intracellular proteins" "Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "stomach 1: 66.6" "Group enriched" "Detected in some" 4 "ASC diff: 5.9;HAP1: 3.1" "Cancer enhanced" "Detected in some" "lung cancer: 1.8;stomach cancer: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA059193 Approved "Intracellular and membrane" "HPA059193: " "unprognostic (8.00e-2)" "unprognostic (7.08e-2)" "unprognostic (2.02e-2)" "unprognostic (4.99e-2)" "unprognostic (7.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.7 0.5 0.8 0.3 0.1 0.1 0.1 0.0 0.5 1.0 13.2 0.2 0.1 0.1 0.1 0.1 0.6 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 66.6 0.5 0.1 0.1 0.5 0.1 0.1 0.1 0.1 1.6 0.7 0.0 0.1 0.6 0.6 0.3 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.7 0.2 0.2 0.0 1.6 0.6 0.0 0.0 0.6 0.0 0.7 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CHMP1B "C18orf2, CHMP1.5, Vps46B" ENSG00000255112 "Charged multivesicular body protein 1B" Q7LBR1 18 11851396-11854449 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "skeletal muscle: 250.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061997, HPA062896" Supported Supported Nucleoplasm,Midbody "Nucleoplasm, Midbody" "HPA061997: , HPA062896: " "unprognostic (6.73e-2)" "unprognostic (5.35e-2)" "unprognostic (1.09e-2)" "unprognostic (6.74e-3)" "unprognostic (1.80e-1)" "unprognostic (1.35e-3)" "unprognostic (1.44e-1)" "unprognostic (8.44e-3)" "unprognostic (1.90e-1)" "unprognostic (9.44e-3)" "unprognostic (2.37e-3)" "unprognostic (9.20e-2)" "prognostic favourable (7.37e-8)" "unprognostic (1.88e-2)" "unprognostic (1.59e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-1)" 16.0 13.6 14.9 12.5 11.6 19.5 13.3 8.8 16.0 10.1 14.1 10.0 13.8 14.0 10.4 14.7 14.5 9.1 14.6 17.0 11.2 12.3 12.2 11.2 11.3 14.0 11.6 11.9 11.3 11.2 9.7 12.4 11.8 12.1 10.3 14.1 9.4 12.6 29.5 250.9 15.2 20.4 11.6 13.8 11.3 12.8 6.8 10.0 14.2 19.9 19.4 9.9 14.3 10.1 6.7 13.1 34.4 16.5 7.4 9.1 10.6 12.8 12.6 16.4 13.8 21.5 15.1 23.8 13.8 23.3 9.4 12.6 16.3 13.0 8.0 20.7 14.9 11.0 7.4 19.2 8.4 7.4 9.2 5.8 19.2 13.4 15.9 22.1 10.0 21.9 41.6 10.5 24.5 13.6 9.8 10.4 14.8 15.9 15.3 17.0 6.8 6.3 7.9 8.4 13.7 25.2 17.7 16.0 16.0 23.4 11.0 21.1 9.0 20.4 19.8 21.2 11.2 16.7 14.7 12.5 14.3 10.2 19.6 10.3 10.0 10.9 16.5 27.7 7.2 15.3 6.6 6.5 6.7 8.5 13.1 6.7 8.4 7.7 34.4 7.4 15.0 11.7 9.1 10.6 14.9 11.6 8.8 16.0 11.2 12.3 11.6 11.9 12.1 10.0 CHN1 "ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2" ENSG00000128656 "Chimerin 1" P15882 2 174799363-175005369 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Neurogenesis "GTPase activation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 145.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 58.9;BJ hTERT+ SV40 Large T+ RasG12V: 29.7" "Cancer enhanced" "Detected in all" "glioma: 18.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 9.0;memory CD8 T-cell: 2.9;T-reg: 10.0" "Lineage enriched" "Detected in single" 35 "T-cells: 10.0" "Low region specificity" "Detected in all" HPA036111 Approved Cytosol Cytosol "HPA036111: AB_10671241" "unprognostic (3.18e-3)" "unprognostic (4.19e-2)" "unprognostic (9.69e-2)" "unprognostic (3.42e-3)" "unprognostic (1.92e-1)" "unprognostic (2.65e-2)" "unprognostic (7.45e-2)" "unprognostic (9.14e-2)" "unprognostic (3.71e-2)" "unprognostic (1.34e-2)" "unprognostic (5.29e-2)" "unprognostic (2.95e-1)" "prognostic unfavourable (5.07e-4)" "unprognostic (7.31e-3)" "unprognostic (4.07e-1)" "unprognostic (2.08e-2)" "unprognostic (9.46e-2)" 3.8 5.2 63.4 3.4 60.8 1.0 2.4 9.1 145.3 4.7 2.5 4.4 0.2 1.7 3.9 15.1 3.2 2.9 4.7 5.2 74.0 21.4 2.1 1.4 7.1 7.4 21.4 51.7 2.8 1.9 31.7 5.2 14.4 23.0 7.2 2.6 3.1 1.4 4.6 1.2 1.9 1.8 5.5 5.1 2.7 2.1 7.5 9.1 0.0 4.0 0.0 7.2 4.5 1.2 0.2 0.2 0.0 0.0 0.1 10.0 1.1 0.0 3.3 14.6 4.2 4.5 20.7 0.1 14.1 58.9 20.3 29.7 0.1 1.9 0.1 0.4 21.2 0.5 18.6 0.4 8.2 0.2 8.1 2.5 4.8 1.4 10.0 1.3 0.3 18.4 0.5 9.8 3.1 7.5 0.1 0.6 14.9 2.7 6.7 0.6 17.3 5.0 2.1 20.6 0.1 0.2 0.1 18.0 19.5 11.2 0.1 1.7 0.6 0.3 2.3 8.6 1.3 2.8 5.1 1.6 7.8 0.2 1.9 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.7 0.2 9.0 2.9 0.0 0.0 1.3 0.3 0.0 0.1 0.0 0.2 10.0 1.1 63.4 60.8 9.1 135.3 74.0 21.4 21.4 51.7 23.0 9.1 CHODL "C21orf68, FLJ12627, MT75, PRED12" ENSG00000154645 Chondrolectin Q9H9P2 21 17901263-18267373 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 59.6" "Cell line enhanced" "Detected in some" "U-266/70: 4.0;U-266/84: 9.8;U-87 MG: 11.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 6.8;hypothalamus: 8.2;pons and medulla: 8.6" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 4.9" "Lineage enriched" "Detected in single" 8 "T-cells: 4.9" "Group enriched" "Detected in many" 4 "basal ganglia: 4.1;hypothalamus: 14.3;pons and medulla: 11.4" "Region enriched" "Detected in all" 6 "olfactory region: 208.8" HPA017282 Enhanced "HPA017282: AB_1846687" "unprognostic (3.91e-1)" "unprognostic (3.18e-2)" "unprognostic (2.37e-2)" "prognostic unfavourable (1.18e-6)" "unprognostic (6.74e-2)" "unprognostic (6.82e-2)" "unprognostic (1.06e-3)" "unprognostic (6.79e-2)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.87e-1)" "unprognostic (4.83e-2)" "unprognostic (1.02e-1)" 2.3 1.9 0.8 2.1 6.8 0.0 1.1 0.5 0.8 0.3 2.3 0.5 4.0 1.5 0.7 1.1 1.4 0.5 0.8 3.4 1.3 8.2 4.7 0.0 0.3 0.3 1.4 0.8 0.5 0.0 0.5 2.1 1.7 8.6 8.2 3.4 1.4 0.6 1.8 1.3 2.1 0.9 0.4 2.2 12.3 0.7 59.6 1.1 0.1 0.9 4.3 1.1 1.1 1.1 0.4 0.6 0.0 0.1 0.4 4.9 0.3 0.0 0.0 0.9 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 2.4 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.6 0.1 2.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.3 0.0 1.0 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 4.0 9.8 0.3 11.3 0.0 0.1 0.0 0.0 0.0 0.7 0.0 4.9 0.4 0.3 0.8 0.1 0.2 0.0 1.1 0.0 0.4 0.1 0.6 1.0 0.3 0.8 6.8 0.5 0.8 1.3 8.2 1.4 0.8 8.6 1.1 CHRM5 ENSG00000184984 "Cholinergic receptor muscarinic 5" P08912 15 33968720-34067457 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 22.8" "Group enriched" "Detected in some" 5 "BEWO: 5.4;HMC-1: 18.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.8" "Region enhanced" "Detected in many" "hypothalamus: 15.4" "Low region specificity" "Detected in many" HPA013172 Uncertain "HPA013172: AB_1854212" "unprognostic (8.19e-2)" "unprognostic (2.13e-1)" "unprognostic (7.67e-2)" "unprognostic (4.32e-1)" "unprognostic (3.05e-3)" "unprognostic (2.77e-1)" "unprognostic (2.49e-2)" "unprognostic (2.79e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-2)" "unprognostic (4.61e-4)" "unprognostic (7.95e-2)" "unprognostic (1.33e-6)" "unprognostic (1.42e-1)" "unprognostic (4.53e-2)" "unprognostic (1.38e-1)" "unprognostic (9.07e-2)" 0.3 0.5 1.2 0.9 15.7 1.3 2.1 0.8 6.9 0.3 0.4 5.1 0.0 1.1 0.5 0.8 0.5 0.3 0.6 0.3 6.8 4.4 0.6 0.9 0.4 1.0 5.8 4.5 0.5 1.0 0.1 0.5 4.8 17.8 0.6 0.3 0.0 0.5 0.1 0.7 1.8 1.8 0.2 22.8 0.7 0.6 5.2 0.0 0.0 2.3 0.0 0.3 0.4 0.3 0.3 0.9 4.8 0.3 0.2 0.3 0.0 0.1 0.2 0.8 0.3 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.5 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.7 0.3 0.2 0.0 0.5 18.8 0.4 0.0 0.2 0.1 0.0 0.6 1.2 0.1 0.2 0.2 2.2 0.2 0.3 0.1 0.3 0.2 0.0 0.4 0.3 0.3 0.3 0.7 0.2 0.2 1.1 0.2 0.2 0.2 0.2 0.1 0.9 0.3 0.4 0.1 0.2 0.3 1.5 0.3 0.2 0.3 0.1 0.3 0.2 0.2 0.2 0.1 0.3 0.1 0.2 4.8 0.2 0.1 0.9 0.2 0.0 1.2 15.7 0.8 6.9 6.8 4.4 5.8 4.5 17.8 0.0 CHRNA1 CHRNA ENSG00000138435 "Cholinergic receptor nicotinic alpha 1 subunit" P02708 2 174747592-174787935 "Disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 96.7" "Group enriched" "Detected in some" 18 "LHCN-M2: 87.3;RH-30: 71.4" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Region enhanced" "Detected in single" "hippocampal formation: 2.0" "Cell type enriched" "Detected in single" 27 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 27 "dendritic cells: 2.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA071554 Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA071554: " "unprognostic (1.49e-1)" "unprognostic (1.97e-1)" "unprognostic (1.22e-3)" "unprognostic (2.28e-2)" "unprognostic (2.96e-1)" "unprognostic (8.55e-3)" "unprognostic (5.34e-2)" "unprognostic (5.29e-3)" "unprognostic (9.59e-2)" "unprognostic (9.64e-2)" "unprognostic (9.66e-2)" "unprognostic (6.37e-2)" "unprognostic (4.18e-4)" "unprognostic (2.04e-1)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-2)" 4.5 0.0 0.5 0.5 0.1 0.0 0.6 0.0 0.4 0.7 1.7 0.0 0.1 0.2 0.0 4.6 1.2 0.0 0.0 0.3 2.0 0.1 0.0 0.2 0.7 0.9 0.1 0.0 0.0 0.0 0.0 12.1 0.2 0.0 2.4 1.0 0.0 1.5 0.0 96.7 0.0 0.0 0.0 0.8 0.1 0.0 0.3 0.0 0.5 0.0 4.5 1.3 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.2 0.0 0.0 87.3 0.0 0.0 0.0 0.0 0.0 0.0 71.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.5 0.1 0.0 0.4 2.0 0.1 0.1 0.0 0.0 0.0 CHRNA10 ENSG00000129749 "Cholinergic receptor nicotinic alpha 10 subunit" Q9GZZ6 11 3665587-3671384 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 33.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 6 "olfactory region: 8.9" "Not detected" "Not detected" "unprognostic (3.04e-1)" "unprognostic (2.23e-1)" "unprognostic (4.04e-2)" "unprognostic (1.11e-4)" "unprognostic (1.50e-1)" "unprognostic (1.71e-2)" "unprognostic (8.22e-2)" "unprognostic (1.50e-1)" "unprognostic (3.79e-2)" "unprognostic (2.74e-1)" "unprognostic (6.90e-5)" "unprognostic (4.35e-2)" "unprognostic (1.06e-5)" "unprognostic (5.60e-2)" "unprognostic (1.70e-2)" "unprognostic (2.32e-1)" "unprognostic (4.39e-3)" 0.2 0.2 0.2 0.4 0.3 0.2 0.1 1.1 0.1 0.2 0.2 0.4 0.2 0.2 0.4 0.3 0.1 0.2 0.2 0.2 0.3 0.6 0.4 0.3 0.1 0.3 0.1 0.0 0.7 0.1 0.7 0.1 0.3 0.1 33.6 0.4 0.2 0.1 0.0 1.0 0.2 0.3 0.5 0.1 0.1 0.0 0.3 0.3 2.2 0.6 0.2 1.0 0.2 1.4 1.5 2.1 2.8 0.9 0.3 1.4 1.7 0.4 1.3 1.3 1.1 2.5 2.5 1.0 0.8 3.1 1.6 0.9 1.1 1.6 5.2 0.7 3.9 0.5 1.2 0.6 2.7 0.9 1.0 0.9 0.3 0.8 2.0 0.6 1.0 0.4 1.5 4.1 2.9 2.0 2.7 0.9 0.4 1.0 2.0 1.9 0.8 0.9 0.9 1.5 0.6 3.2 0.7 1.8 2.3 1.3 2.1 0.7 1.7 1.3 0.9 1.3 1.2 0.0 0.4 0.4 1.0 0.0 0.3 0.0 0.8 0.2 0.1 0.3 0.4 0.5 2.2 0.2 0.6 0.3 0.6 0.2 CHRNB2 ENSG00000160716 "Cholinergic receptor nicotinic beta 2 subunit" P17787 1 154567781-154580026 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 28.4" "Group enriched" "Detected in some" 6 "SCLC-21H: 20.2;SH-SY5Y: 20.0" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.13e-1)" "unprognostic (6.33e-2)" "unprognostic (8.15e-3)" "unprognostic (3.32e-1)" "unprognostic (4.37e-3)" "unprognostic (2.25e-1)" "unprognostic (3.51e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.37e-1)" "unprognostic (1.24e-3)" "unprognostic (1.83e-1)" "unprognostic (4.36e-1)" "unprognostic (2.32e-1)" "unprognostic (1.45e-1)" "unprognostic (5.65e-2)" "unprognostic (1.84e-1)" 0.9 3.2 7.8 1.2 16.4 1.0 1.8 8.1 28.4 0.9 1.1 1.6 0.0 1.4 1.0 0.9 1.1 1.0 0.9 0.9 9.4 8.9 0.9 0.9 0.9 0.9 7.9 9.8 1.0 2.1 0.9 3.3 0.9 15.4 0.9 1.2 3.1 1.0 0.9 0.9 1.3 1.2 1.1 1.4 0.9 1.6 2.0 1.7 0.0 0.9 0.0 0.9 0.9 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 20.2 20.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 7.8 16.4 8.1 22.1 9.4 8.9 7.9 9.8 15.4 1.7 CHRND ACHRD ENSG00000135902 "Cholinergic receptor nicotinic delta subunit" Q07001 2 232525993-232536667 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 49.1" "Cell line enriched" "Detected in single" 72 "RH-30: 42.8" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "olfactory region: 1.4" "HPA056404, HPA065404" Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA056404: , HPA065404: " "unprognostic (1.69e-2)" "unprognostic (7.93e-2)" "unprognostic (3.28e-3)" "unprognostic (7.75e-3)" "unprognostic (6.04e-2)" "unprognostic (1.10e-1)" "unprognostic (7.25e-2)" "unprognostic (1.90e-1)" "unprognostic (4.97e-8)" "unprognostic (7.52e-2)" "unprognostic (2.86e-1)" "unprognostic (2.46e-1)" 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 49.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 42.8 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHST4 "HEC-GLCNAC-6-ST, LSST" ENSG00000140835 "Carbohydrate sulfotransferase 4" Q8NCG5 16 71525233-71538746 "Predicted intracellular proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "gallbladder: 46.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.0;HL-60: 3.3;NB-4: 6.1;NTERA-2: 9.5;SCLC-21H: 4.7" "Cancer enriched" "Detected in many" 6 "pancreatic cancer: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA021955 Enhanced "Intracellular and membrane" "HPA021955: AB_1846723" "unprognostic (2.22e-3)" "unprognostic (1.41e-1)" "unprognostic (8.87e-2)" "unprognostic (3.35e-2)" "unprognostic (4.76e-3)" "unprognostic (6.86e-2)" "prognostic unfavourable (9.24e-4)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (1.15e-2)" "unprognostic (1.00e-1)" "unprognostic (2.27e-6)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (5.46e-2)" "unprognostic (1.73e-1)" 0.6 1.7 0.0 0.7 0.1 0.0 0.1 0.0 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.4 2.9 46.9 0.0 0.3 0.0 0.0 5.9 0.3 0.5 0.0 0.2 0.7 9.6 0.0 0.6 0.0 0.4 0.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.3 0.1 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.4 0.1 0.0 0.1 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.1 9.5 0.0 0.0 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.1 2.2 0.0 0.1 0.1 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.2 0.4 0.0 CHST5 "FLJ22167, I-GLCNAC-6-ST" ENSG00000135702 "Carbohydrate sulfotransferase 5" Q9GZS9 16 75528535-75535247 "Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 32.9" "Cell line enhanced" "Detected in many" "PC-3: 4.6" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.4;stomach cancer: 1.5" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA043804 Enhanced "Intracellular and membrane" "HPA043804: AB_10960563" "unprognostic (6.82e-3)" "unprognostic (2.02e-1)" "unprognostic (1.99e-3)" "unprognostic (1.03e-2)" "unprognostic (2.60e-1)" "unprognostic (1.46e-2)" "unprognostic (6.76e-2)" "unprognostic (1.66e-1)" "unprognostic (2.09e-2)" "unprognostic (9.03e-3)" "unprognostic (4.27e-2)" "unprognostic (2.05e-3)" "unprognostic (3.56e-1)" "unprognostic (2.52e-2)" "unprognostic (1.46e-1)" "unprognostic (1.42e-2)" 0.4 0.0 0.7 0.4 1.7 0.0 0.4 2.4 1.1 0.4 17.5 0.4 0.4 32.9 0.4 0.4 0.4 1.1 0.4 0.4 0.8 0.8 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.5 0.4 0.4 0.4 21.6 0.4 0.4 0.4 2.1 0.0 28.5 0.4 0.4 0.4 1.7 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.3 1.1 3.0 1.3 1.1 1.1 0.4 0.4 1.0 1.4 1.6 0.4 0.9 0.7 0.0 0.3 0.6 0.5 0.6 1.9 1.2 0.6 0.3 1.1 0.1 0.7 0.0 0.4 1.4 0.2 0.5 1.8 0.3 0.7 0.8 1.1 0.1 0.0 0.4 0.2 0.4 1.3 0.0 2.7 0.7 3.7 0.9 4.6 0.5 0.4 2.6 1.6 0.4 2.1 3.6 1.9 1.4 0.2 1.0 0.3 0.3 1.5 1.0 2.6 0.3 0.7 1.8 0.2 1.0 0.3 0.9 3.0 1.0 1.0 0.9 1.0 0.8 1.0 0.8 0.7 0.5 1.3 1.1 1.1 2.6 1.1 1.3 1.1 0.7 0.4 0.7 1.7 2.4 1.1 0.8 0.8 0.4 0.4 0.4 0.4 CIB4 ENSG00000157884 "Calcium and integrin binding family member 4" A0PJX0 2 26581202-26641368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 22.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.0;EFO-21: 1.5;SCLC-21H: 1.5" "Cancer enhanced" "Detected in some" "thyroid cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036130, HPA036131" Uncertain "HPA036130: AB_10670709, HPA036131: " "unprognostic (3.63e-3)" "unprognostic (1.78e-1)" "unprognostic (2.61e-4)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (4.29e-4)" "unprognostic (1.57e-1)" "unprognostic (3.19e-5)" "unprognostic (1.20e-2)" "unprognostic (3.63e-1)" "unprognostic (1.76e-3)" "unprognostic (3.50e-1)" 0.1 1.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.5 1.1 0.3 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 22.5 0.1 0.1 3.7 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 CLC "Gal-10, LGALS10, MGC149659" ENSG00000105205 "Charcot-Leyden crystal galectin" Q05315 19 39731250-39738028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "blood: 489.7" "Cell line enriched" "Detected in some" 13 "HMC-1: 408.3" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 256 "basophil: 489.7;eosinophil: 448.3" "Lineage enriched" "Detected in single" 1987 "granulocytes: 489.7" HPA041751 Enhanced 240000 "HPA041751: AB_10793973" "unprognostic (4.53e-2)" "unprognostic (3.04e-2)" "unprognostic (4.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.72e-1)" "unprognostic (1.34e-2)" "unprognostic (6.60e-2)" "unprognostic (2.21e-1)" "unprognostic (4.28e-2)" "unprognostic (5.74e-2)" "unprognostic (1.24e-1)" 1.0 0.3 1.1 5.0 0.7 80.4 0.3 0.3 1.3 0.7 1.6 1.9 0.3 4.8 0.3 1.3 0.3 0.2 2.9 0.6 0.3 2.3 0.3 1.2 6.3 0.3 0.4 1.2 0.3 0.7 0.0 0.6 1.5 0.7 0.3 1.2 0.3 2.6 0.3 1.5 0.2 8.1 4.4 0.4 13.8 2.8 0.6 0.3 6.4 0.4 0.3 0.3 9.2 0.3 0.1 0.1 489.7 0.2 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 408.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 489.7 0.1 448.3 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 1.8 0.0 0.2 0.1 0.0 1.6 1.1 0.7 0.3 1.3 0.3 2.3 0.4 1.2 0.7 0.3 CLCA1 "CaCC, CLCRG1" ENSG00000016490 "Chloride channel accessory 1" A8K7I4 1 86468368-86500289 "Predicted secreted proteins, Transporters" "Calcium transport, Ion transport, Transport" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 242.9" "Cell line enhanced" "Detected in some" "BEWO: 4.5;K-562: 1.7;NB-4: 5.2;RPMI-8226: 5.6;SH-SY5Y: 4.0;U-2197: 3.3" "Group enriched" "Detected in some" 9 "colorectal cancer: 86.8;pancreatic cancer: 27.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA052787, HPA059301" Enhanced "Secreted to digestive system" 70000 "HPA052787: AB_2681947, HPA059301: AB_2683971" "prognostic favourable (2.98e-4)" "unprognostic (3.42e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-1)" 0.2 0.2 0.2 41.7 0.2 0.0 0.2 0.2 0.2 0.2 100.0 0.1 0.1 80.7 0.2 0.1 0.2 0.3 4.4 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.2 98.0 0.2 0.2 0.1 0.2 0.2 242.9 1.1 0.2 0.2 0.2 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.6 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 CLDN15 ENSG00000106404 "Claudin 15" P56746 7 101232092-101238820 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "intestine: 194.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (8.85e-2)" "unprognostic (1.48e-1)" "unprognostic (4.93e-2)" "unprognostic (3.66e-1)" "unprognostic (1.11e-1)" "unprognostic (6.81e-2)" "unprognostic (1.58e-2)" "unprognostic (1.03e-1)" "unprognostic (6.56e-2)" "unprognostic (1.79e-1)" "prognostic favourable (2.56e-4)" "unprognostic (2.02e-2)" "prognostic unfavourable (5.31e-5)" "unprognostic (9.98e-2)" "unprognostic (2.89e-2)" "unprognostic (9.64e-2)" "prognostic favourable (3.30e-4)" 15.4 0.7 1.0 5.2 1.0 3.9 12.5 1.3 1.1 2.5 172.9 1.1 1.2 76.6 2.4 4.4 1.8 3.2 7.2 2.1 1.7 0.8 3.7 7.0 2.2 2.9 1.7 0.8 4.4 1.3 1.1 1.3 2.0 1.7 2.2 2.4 0.8 1.4 1.2 1.1 2.1 194.8 1.6 2.3 5.7 1.7 2.4 1.4 1.0 1.8 1.3 2.3 2.7 3.0 1.0 1.8 1.7 1.2 0.8 1.9 1.4 2.1 6.7 3.6 5.6 5.7 4.6 2.5 2.1 2.7 2.7 3.9 4.5 2.6 7.3 3.8 1.4 4.1 5.9 1.2 2.7 9.0 12.7 3.3 3.8 5.8 5.0 3.7 7.3 4.4 6.0 3.5 4.6 2.2 15.6 11.8 2.0 7.5 5.9 21.4 2.8 4.7 8.0 3.1 6.0 1.6 2.7 3.5 12.4 1.9 3.7 10.4 3.4 7.5 3.2 8.8 7.7 13.3 2.6 12.5 15.7 7.7 2.5 9.8 5.1 0.2 1.2 0.1 1.9 0.7 0.6 0.4 1.9 0.2 0.8 1.0 1.3 1.4 1.7 0.8 0.9 1.8 0.8 1.4 1.0 1.0 1.3 1.0 1.7 0.8 1.7 0.8 1.7 1.4 CLDN16 "HOMG3, PCLN1" ENSG00000113946 "Claudin 16" Q9Y5I7 3 190322541-190412143 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease mutation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "kidney: 55.9" "Group enriched" "Detected in some" 131 "EFO-21: 99.0;RPTEC TERT1: 34.8" "Group enriched" "Detected in many" 15 "ovarian cancer: 39.8;thyroid cancer: 29.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA056020 Enhanced "HPA056020: " "unprognostic (5.01e-2)" "unprognostic (7.83e-3)" "unprognostic (1.96e-1)" "prognostic unfavourable (1.99e-5)" "unprognostic (6.06e-4)" "unprognostic (1.30e-1)" "unprognostic (2.07e-1)" "unprognostic (2.39e-2)" "unprognostic (3.31e-1)" "unprognostic (4.20e-1)" "unprognostic (2.76e-3)" "unprognostic (3.70e-1)" "unprognostic (1.96e-1)" "unprognostic (5.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.62e-2)" "unprognostic (1.15e-1)" 0.2 0.8 0.4 0.2 0.3 0.0 0.2 0.2 0.5 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.6 0.2 0.2 0.3 0.4 55.9 1.2 0.2 0.7 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.6 0.5 0.2 1.8 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.4 3.4 0.2 0.4 0.3 0.2 0.5 0.4 1.4 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 1.4 0.1 0.2 0.2 0.2 0.1 0.4 0.2 0.1 0.0 0.5 0.3 0.2 1.2 0.3 0.2 0.4 0.1 0.0 0.4 0.3 0.2 0.5 0.3 0.4 0.3 0.2 0.2 0.2 CLDN34 ENSG00000234469 "Claudin 34" H7C241 X 9967358-9968352 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 8 "testis: 5.4" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.2;RT4: 4.3;U-138 MG: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.54e-2)" "unprognostic (6.73e-5)" "unprognostic (1.25e-1)" "unprognostic (2.80e-1)" "unprognostic (5.43e-2)" "unprognostic (1.53e-1)" "unprognostic (1.54e-1)" "unprognostic (6.82e-2)" "unprognostic (2.27e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-3)" "unprognostic (5.39e-1)" "unprognostic (8.13e-2)" "unprognostic (3.23e-1)" "unprognostic (2.89e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.5 0.4 0.1 0.0 0.0 0.1 0.0 0.4 0.4 0.3 0.0 0.0 0.6 0.5 0.0 0.1 0.2 0.5 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.5 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLEC12B ENSG00000256660 "C-type lectin domain family 12 member B" Q2HXU8 12 10010627-10018619 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 30.9" "Cell line enriched" "Detected in single" 14 "U-937: 12.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Region enhanced" "Detected in single" "pons and medulla: 0.8" "Low region specificity" "Detected in many" "unprognostic (2.08e-2)" "unprognostic (4.81e-2)" "unprognostic (3.60e-1)" "unprognostic (1.81e-1)" "unprognostic (3.76e-1)" "unprognostic (3.36e-3)" "unprognostic (4.14e-4)" "unprognostic (7.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.02e-5)" "unprognostic (1.41e-2)" "unprognostic (1.99e-1)" "unprognostic (5.48e-1)" "unprognostic (8.95e-4)" 0.4 0.0 0.2 0.5 0.2 5.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.0 0.2 0.2 1.3 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.1 0.2 0.2 0.2 0.2 5.4 0.2 0.2 0.2 2.7 0.1 30.9 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.5 1.3 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 12.3 0.4 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.0 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.3 0.2 CLEC18A MRCL ENSG00000157322 "C-type lectin domain family 18 member A" A5D8T8 16 69950705-69964452 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 19.6" "Cell line enhanced" "Detected in some" "AF22: 2.7;BEWO: 3.5" "Cancer enriched" "Detected in single" 7 "renal cancer: 1.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" HPA048976 Uncertain "Secreted to blood" "HPA048976: " "unprognostic (1.68e-1)" "unprognostic (3.06e-2)" "unprognostic (1.19e-2)" "unprognostic (1.48e-1)" "unprognostic (3.14e-2)" "unprognostic (4.62e-2)" "unprognostic (1.36e-1)" "unprognostic (4.14e-2)" "unprognostic (1.04e-1)" "unprognostic (4.40e-2)" "unprognostic (6.77e-4)" "unprognostic (6.73e-2)" "unprognostic (4.58e-2)" "unprognostic (2.06e-1)" "unprognostic (9.03e-4)" "unprognostic (1.52e-1)" "unprognostic (2.53e-2)" 0.1 1.3 0.3 0.0 0.8 0.3 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.3 0.5 19.6 0.1 0.1 0.1 0.3 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.7 0.1 0.0 0.1 0.5 0.0 1.0 0.7 0.5 3.4 0.1 0.1 0.4 0.0 0.9 0.3 1.6 0.0 0.5 0.1 0.0 0.3 0.3 2.7 0.2 0.0 0.7 3.5 0.0 0.0 0.6 0.2 0.6 0.1 0.5 0.3 0.0 0.0 0.0 0.4 0.3 0.6 0.9 0.0 0.0 1.5 0.0 0.7 1.8 0.0 1.4 1.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.0 0.2 0.3 0.0 0.0 0.9 1.5 0.1 0.8 0.0 0.1 0.7 1.6 0.0 0.6 1.9 0.2 0.0 0.7 0.8 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.9 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 CLEC18B MRCL2 ENSG00000140839 "C-type lectin domain family 18 member B" Q6UXF7 16 74408270-74421953 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "kidney: 28.1" "Cell line enhanced" "Detected in some" "AF22: 3.0;K-562: 7.4;U-266/70: 2.8" "Group enriched" "Detected in some" 12 "glioma: 2.7;ovarian cancer: 1.2;renal cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA048976 Uncertain "Secreted to blood" "HPA048976: " "unprognostic (5.69e-2)" "unprognostic (1.46e-1)" "unprognostic (5.30e-3)" "unprognostic (9.37e-2)" "prognostic unfavourable (2.07e-4)" "unprognostic (7.15e-2)" "unprognostic (7.51e-2)" "unprognostic (4.49e-3)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" "unprognostic (9.91e-2)" "unprognostic (3.58e-2)" "unprognostic (1.42e-2)" "unprognostic (2.31e-2)" "unprognostic (5.87e-2)" "unprognostic (5.43e-2)" "unprognostic (4.27e-2)" 0.1 1.1 1.1 0.3 1.4 0.1 0.1 2.5 1.2 0.1 0.1 0.4 0.1 0.6 1.2 0.1 0.3 0.0 1.0 1.0 28.1 0.1 0.0 0.1 1.0 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.0 0.2 0.1 2.0 0.1 0.1 6.1 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 1.6 3.0 1.8 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.2 1.1 0.5 1.1 1.0 0.0 0.1 0.3 0.3 0.4 0.3 0.1 0.7 0.0 0.3 1.8 0.4 0.1 0.1 0.0 7.4 0.0 0.3 0.0 0.0 0.0 1.2 0.8 0.4 0.0 1.6 0.0 0.3 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.4 0.2 0.9 2.8 1.6 0.3 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 CLEC2A "INPE5792, KACL, PILAR, UNQ5792" ENSG00000188393 "C-type lectin domain family 2 member A" Q6UVW9 12 9898673-9932381 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 37.0" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 13.2;U-937: 32.9" "Cancer enhanced" "Detected in some" "cervical cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048530, HPA072407" Approved Uncertain "Plasma membrane" "Plasma membrane" "HPA048530: , HPA072407: " "unprognostic (3.10e-1)" "unprognostic (5.29e-2)" "unprognostic (2.23e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.3 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 CLEC4C "BDCA2, CD303, CLECSF11, CLECSF7, DLEC, HECL" ENSG00000198178 "C-type lectin domain family 4 member C" Q8WTT0 12 7729415-7751605 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "blood: 80.0" "Cell line enriched" "Detected in some" 4 "HDLM-2: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 16 "plasmacytoid DC: 80.0" "Lineage enriched" "Detected in many" 16 "dendritic cells: 80.0" HPA029432 Approved "HPA029432: AB_10601259" "unprognostic (3.55e-3)" "unprognostic (3.01e-2)" "unprognostic (1.03e-1)" "unprognostic (3.70e-2)" "unprognostic (7.37e-5)" "unprognostic (2.36e-2)" "unprognostic (2.06e-1)" "unprognostic (2.55e-2)" "unprognostic (6.98e-2)" "unprognostic (1.39e-1)" "unprognostic (1.88e-3)" "unprognostic (2.82e-2)" "unprognostic (3.18e-3)" "unprognostic (2.36e-2)" "unprognostic (1.25e-1)" 0.3 0.2 0.2 1.6 0.2 1.8 2.0 0.2 0.6 0.2 0.2 0.1 0.1 0.0 0.2 0.1 0.3 0.5 1.2 0.3 0.2 0.2 0.5 0.3 1.5 7.0 0.2 0.1 0.4 0.2 0.0 0.2 0.1 0.1 0.2 0.0 0.4 0.3 2.0 0.2 0.3 0.3 0.1 0.2 4.6 0.3 9.9 0.1 6.7 0.3 0.1 7.1 1.9 0.3 0.5 80.0 4.9 0.1 0.5 0.0 0.5 0.2 0.0 0.3 0.3 0.5 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.6 0.3 0.0 0.0 0.3 0.0 0.0 0.2 6.5 0.1 0.3 0.7 0.2 0.0 0.6 1.3 0.4 0.3 0.0 0.0 0.1 0.2 1.0 0.0 0.1 0.1 0.8 1.4 0.2 0.1 0.0 0.1 0.1 0.4 0.2 0.2 0.1 0.1 0.0 0.9 0.1 0.4 0.4 0.2 0.1 0.1 0.6 0.2 1.4 0.1 0.3 0.3 0.9 0.1 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.5 0.0 0.0 2.6 0.5 0.0 80.0 0.0 0.5 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.1 0.1 0.1 CLPB "ANKCLB, FLJ13152, HSP78, SKD3" ENSG00000162129 "ClpB homolog, mitochondrial AAA ATPase chaperonin" Q9H078 11 72285495-72434680 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Cataract, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 87.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 18.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039005, HPA039006, HPA064571" Enhanced "HPA039005: AB_2676305, HPA039006: AB_10672767, HPA064571: " "unprognostic (9.36e-2)" "unprognostic (1.06e-2)" "unprognostic (2.51e-1)" "unprognostic (1.23e-1)" "unprognostic (2.99e-1)" "unprognostic (2.05e-2)" "unprognostic (8.22e-2)" "unprognostic (8.37e-2)" "unprognostic (2.61e-1)" "unprognostic (1.02e-1)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "prognostic favourable (8.36e-8)" "unprognostic (9.29e-2)" "unprognostic (1.25e-1)" "unprognostic (5.83e-2)" "unprognostic (3.28e-2)" 4.4 6.1 5.7 4.8 7.2 7.9 3.4 5.6 10.5 3.1 3.1 6.7 2.5 3.2 3.8 3.1 3.7 2.9 2.9 4.1 4.9 4.1 6.7 8.5 3.7 3.0 5.7 5.9 3.2 5.5 8.6 3.4 6.5 7.9 2.7 3.1 3.1 4.2 3.3 6.5 2.8 2.9 4.5 3.9 3.9 3.7 87.9 6.4 2.7 4.7 1.8 2.9 3.7 3.0 1.6 18.3 4.0 11.7 1.8 2.4 5.2 6.4 18.5 5.8 11.9 7.9 5.8 15.0 7.0 4.3 10.5 7.9 24.7 9.8 16.7 16.1 6.6 13.8 15.5 15.3 12.9 15.1 11.6 14.1 19.2 14.7 6.8 14.1 25.1 7.7 5.1 18.6 18.8 11.8 19.1 11.8 7.5 17.1 12.7 13.4 6.1 18.5 11.6 8.7 7.2 6.1 11.1 14.6 11.1 9.5 21.9 16.3 11.3 12.3 9.2 15.0 9.7 15.1 13.5 5.7 8.1 9.5 8.0 12.0 11.4 4.0 11.7 0.6 2.4 9.3 2.4 1.5 1.4 2.1 18.3 1.6 1.8 1.4 1.0 1.8 5.2 3.3 0.8 5.2 5.7 7.2 5.6 10.5 4.9 4.1 5.7 5.9 7.9 6.4 CLPS ENSG00000137392 Colipase P04118 6 35794982-35797344 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Digestion, Lipid degradation, Lipid metabolism" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1551 "pancreas: 4260.9" "Cell line enhanced" "Detected in some" "EFO-21: 2.6;HDLM-2: 1.3;T-47d: 3.3;U-2 OS: 3.0;U-266/84: 2.4" "Cancer enriched" "Detected in many" 188 "pancreatic cancer: 1726.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA010512 Enhanced "Secreted to digestive system" 1100000 "HPA010512: AB_1846979" "unprognostic (2.00e-1)" "unprognostic (1.11e-1)" "unprognostic (8.12e-3)" "unprognostic (2.47e-1)" "unprognostic (1.33e-1)" "unprognostic (1.61e-1)" 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.6 4260.9 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.4 2.7 0.4 1.3 1.1 0.1 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 3.0 0.0 1.0 0.0 2.4 1.0 0.0 0.9 0.0 0.5 0.4 1.3 0.1 0.2 0.0 0.3 1.1 0.1 0.4 0.5 0.3 0.0 2.7 1.3 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 CLPSL2 "C6orf126, dJ510O8.5, UNQ3045" ENSG00000196748 "Colipase like 2" Q6UWE3 6 35776594-35779552 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "epididymis: 124.8" "Cell line enriched" "Detected in some" 6 "T-47d: 12.3" "Cancer enhanced" "Detected in some" "breast cancer: 2.6" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 25 "plasmacytoid DC: 2.4" "Lineage enriched" "Detected in single" 25 "dendritic cells: 2.4" HPA051655 Approved "Secreted in male reproductive system" "HPA051655: " "unprognostic (2.38e-1)" "unprognostic (3.65e-1)" "unprognostic (6.39e-3)" "unprognostic (9.38e-2)" "unprognostic (4.03e-2)" "unprognostic (2.47e-1)" "unprognostic (4.85e-3)" "unprognostic (8.69e-2)" "unprognostic (3.17e-2)" "unprognostic (3.95e-2)" "unprognostic (1.49e-1)" "unprognostic (1.13e-1)" "unprognostic (2.37e-1)" 0.0 0.0 0.4 0.0 0.2 0.0 0.7 0.0 1.1 0.0 0.0 0.0 2.3 0.0 0.0 124.8 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 9.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.3 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.0 0.4 0.5 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.3 1.3 1.1 0.3 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.6 0.0 12.3 1.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.4 0.4 0.2 0.0 1.1 0.8 0.1 0.2 0.2 0.0 0.0 CLTRN "NX17, TMEM27" ENSG00000147003 "Collectrin, amino acid transport regulator" Q9HBJ8 X 15627318-15665031 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "kidney: 204.4" "Cell line enhanced" "Detected in many" "HaCaT: 10.7;hTERT-HME1: 6.1;RPTEC TERT1: 9.8" "Cancer enriched" "Detected in many" 35 "renal cancer: 106.2" "Region enriched" "Detected in single" 9 "pons and medulla: 5.0" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA048543 Enhanced Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" "HPA048543: " "unprognostic (1.27e-1)" "unprognostic (4.77e-2)" "unprognostic (2.45e-2)" "unprognostic (2.66e-2)" "unprognostic (5.20e-2)" "unprognostic (5.23e-2)" "unprognostic (1.25e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-2)" "prognostic favourable (5.65e-4)" "unprognostic (1.05e-2)" "unprognostic (3.03e-1)" "prognostic favourable (6.78e-9)" "unprognostic (1.77e-1)" "unprognostic (2.60e-2)" "unprognostic (2.58e-1)" "unprognostic (1.33e-2)" 0.1 0.2 0.3 0.1 0.4 0.0 0.3 0.1 0.2 0.2 0.2 0.5 0.1 0.1 0.2 1.6 0.2 0.4 0.6 0.2 0.5 0.4 204.4 11.5 0.6 0.1 0.3 0.1 0.8 1.2 4.0 0.2 0.7 5.0 0.3 0.0 11.3 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 2.4 0.3 0.1 0.2 0.7 0.1 0.1 0.4 0.2 0.9 0.6 0.0 0.5 0.0 3.0 0.4 3.0 2.2 1.5 0.6 0.8 1.2 1.0 0.1 0.0 0.1 0.1 0.2 0.5 0.3 2.1 0.1 10.7 0.9 2.5 0.0 0.4 1.4 0.3 0.0 1.0 1.6 0.0 0.0 0.2 2.4 0.4 6.1 0.0 0.7 0.6 0.3 3.5 0.2 0.4 3.6 3.1 0.3 0.5 1.3 9.8 0.2 1.4 1.3 0.8 0.2 2.0 1.0 0.3 0.1 0.2 0.5 0.4 0.0 0.6 0.3 0.4 0.9 0.1 0.1 0.0 0.5 0.0 0.6 0.2 1.3 0.4 0.8 0.5 0.6 0.9 3.0 0.9 0.0 0.0 0.0 0.0 0.8 0.4 0.3 0.4 0.1 0.2 0.5 0.4 0.3 0.1 5.0 0.1 CLVS2 "bA160A10.4, C6orf212, C6orf213, RLBP1L2" ENSG00000146352 "Clavesin 2" Q5SYC1 6 122995971-123072927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 39.9" "Group enriched" "Detected in some" 8 "HEL: 14.3;SCLC-21H: 11.2" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043764 Uncertain "HPA043764: AB_10960281" "unprognostic (1.35e-1)" "unprognostic (3.28e-2)" "unprognostic (4.68e-2)" "unprognostic (3.60e-1)" "unprognostic (2.38e-1)" "unprognostic (7.04e-2)" "unprognostic (1.43e-2)" "unprognostic (5.72e-3)" "unprognostic (9.60e-2)" "unprognostic (8.71e-2)" 0.7 2.8 5.0 0.9 9.6 0.7 0.8 39.9 22.6 2.1 1.1 0.6 0.0 0.9 3.1 0.7 0.8 0.7 0.8 0.7 5.8 3.9 0.7 0.8 0.7 0.8 3.0 10.2 0.7 0.7 0.7 6.3 0.7 8.5 7.9 1.1 0.1 0.8 1.1 0.7 0.8 0.9 2.8 1.3 0.7 0.8 1.0 1.8 0.0 0.7 0.0 0.7 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 9.6 39.9 22.6 5.8 3.9 3.0 10.2 8.5 1.8 CMTM1 "CKLFH, CKLFH1a, CKLFSF1" ENSG00000089505 "CKLF like MARVEL transmembrane domain containing 1" Q8IZ96 16 66566393-66579137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 80.7" "Cell line enhanced" "Detected in many" "REH: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.7" "HPA013801, HPA017136" Uncertain Approved Nucleoplasm Nucleoplasm "HPA013801: AB_1846990, HPA017136: AB_1846992" "unprognostic (2.37e-2)" "unprognostic (7.48e-2)" "unprognostic (3.10e-1)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (5.32e-2)" "unprognostic (2.97e-3)" "unprognostic (5.12e-3)" "unprognostic (1.25e-1)" "unprognostic (1.76e-1)" "prognostic unfavourable (5.68e-5)" "unprognostic (2.47e-2)" "unprognostic (1.56e-4)" "unprognostic (1.06e-1)" "unprognostic (1.22e-1)" "unprognostic (3.41e-1)" "unprognostic (3.49e-1)" 0.9 0.8 0.8 1.9 1.2 0.0 0.5 2.2 1.3 0.7 0.9 0.5 0.5 1.7 1.3 1.1 0.6 0.8 1.5 0.7 0.8 1.1 0.8 0.5 0.9 1.2 0.8 0.6 1.7 0.5 0.3 1.1 0.9 0.7 0.7 0.2 0.5 0.6 0.5 0.6 0.6 1.2 0.5 0.9 2.8 0.9 80.7 0.7 0.8 0.7 0.5 0.6 0.9 0.6 0.3 1.9 8.7 2.1 1.3 1.9 1.1 4.2 6.7 1.2 5.6 2.4 2.3 1.2 5.6 2.6 4.5 4.6 1.3 2.8 1.9 2.9 1.6 3.3 1.9 0.3 2.4 7.3 1.3 0.7 2.9 1.4 1.1 3.9 4.9 1.9 0.5 4.0 0.5 2.3 3.4 2.7 1.9 1.6 7.3 3.7 1.0 2.4 16.6 14.3 4.6 4.0 1.9 3.2 4.2 7.7 0.6 2.0 2.0 2.8 5.6 7.9 12.6 4.7 2.4 2.7 6.6 7.2 3.8 5.3 9.3 8.7 2.1 7.1 1.9 0.6 1.6 0.2 0.6 0.9 1.9 0.3 0.5 0.6 8.4 1.3 1.2 0.5 0.6 1.1 0.8 1.2 2.2 1.0 0.8 1.1 0.8 0.6 0.7 0.7 CMTM2 "CKLFSF2, FLJ25732, MGC39436" ENSG00000140932 "CKLF like MARVEL transmembrane domain containing 2" Q8TAZ6 16 66579448-66588275 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "testis: 165.2" "Cell line enriched" "Detected in some" 20 "REH: 26.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 3.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.8" "Low region specificity" "Detected in all" "unprognostic (2.81e-1)" "unprognostic (3.75e-2)" "unprognostic (6.94e-2)" "unprognostic (2.20e-1)" "unprognostic (2.18e-1)" "unprognostic (2.23e-1)" "unprognostic (8.71e-2)" "unprognostic (3.31e-1)" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (1.91e-2)" "unprognostic (3.27e-2)" "unprognostic (1.02e-4)" "unprognostic (1.80e-2)" "unprognostic (1.07e-1)" "unprognostic (1.43e-2)" "unprognostic (1.32e-1)" 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 165.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.2 0.0 0.7 2.8 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.2 0.4 0.1 0.0 26.0 0.2 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.6 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.7 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CNBD1 FLJ35802 ENSG00000176571 "Cyclic nucleotide binding domain containing 1" Q8NA66 8 86866442-87615219 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 16.9" "Group enriched" "Detected in some" 11 "Karpas-707: 9.1;U-266/70: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA025037, HPA027469, HPA027786" Uncertain "Secreted in male reproductive system" "HPA025037: AB_10794318, HPA027469: AB_10599492, HPA027786: AB_10600231" "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CNGA2 "CNCA, CNCA1, CNG2, FLJ46312, OCNC1, OCNCa, OCNCALPHA" ENSG00000183862 "Cyclic nucleotide gated channel alpha 2" Q16280 X 151738451-151745304 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Olfaction, Sensory transduction, Transport" "Calmodulin-binding, Ion channel, Ligand-gated ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 26 "testis: 2.5" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "olfactory region: 0.6" "Not detected" "Not detected" HPA015065 Uncertain "HPA015065: AB_1847034" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CNGA3 "ACHM2, CCNC1, CCNCa, CNCG3, CNG3" ENSG00000144191 "Cyclic nucleotide gated channel alpha 3" Q16281 2 98346155-98398601 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pituitary gland: 32.0" "Cell line enriched" "Detected in some" 7 "U-87 MG: 12.5" "Cancer enriched" "Detected in some" 9 "glioma: 7.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 1.9;hypothalamus: 2.2" "Not detected" "Not detected" "HPA049378, CAB079025" Approved Approved "CAB079025: , HPA049378: " "unprognostic (2.34e-2)" "unprognostic (1.83e-2)" "unprognostic (4.96e-2)" "unprognostic (4.81e-2)" "unprognostic (1.13e-1)" "unprognostic (2.18e-1)" "unprognostic (4.17e-4)" "unprognostic (4.65e-2)" "unprognostic (1.86e-3)" "unprognostic (2.88e-1)" "unprognostic (3.85e-3)" "unprognostic (8.98e-2)" "unprognostic (5.90e-2)" "unprognostic (3.71e-2)" 0.1 0.0 0.3 1.4 0.7 0.0 0.7 0.1 2.9 0.1 6.1 2.4 0.1 2.8 0.1 0.1 4.6 0.8 0.4 0.1 1.2 4.0 0.1 0.1 0.2 0.1 0.8 0.4 0.1 1.5 0.0 32.0 0.1 4.9 0.1 3.2 1.2 0.2 0.5 0.1 0.0 4.0 2.2 4.3 0.1 3.0 1.1 0.3 0.1 0.1 0.1 0.1 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 1.5 1.2 4.0 0.8 0.4 4.9 0.3 CNGB1 "CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45" ENSG00000070729 "Cyclic nucleotide gated channel beta 1" Q14028 16 57882340-57971116 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Olfaction, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 79.8" "Cell line enhanced" "Detected in some" "EFO-21: 2.9;RPMI-8226: 3.3;SCLC-21H: 9.4;SiHa: 5.4" "Cancer enriched" "Detected in single" 6 "head and neck cancer: 2.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.6" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA039159, HPA060355" Approved Vesicles,Cytosol Cytosol Vesicles "HPA039159: AB_10795579, HPA060355: " "unprognostic (5.52e-3)" "unprognostic (4.51e-3)" "unprognostic (1.06e-1)" "unprognostic (2.73e-3)" "unprognostic (6.20e-2)" "unprognostic (1.76e-1)" "unprognostic (8.56e-4)" "unprognostic (3.08e-1)" "unprognostic (9.84e-2)" "unprognostic (2.83e-1)" "unprognostic (2.14e-4)" "unprognostic (5.42e-2)" "unprognostic (1.01e-3)" "unprognostic (5.20e-2)" "unprognostic (1.88e-1)" "unprognostic (4.57e-2)" "unprognostic (9.07e-2)" 0.2 7.2 13.1 3.0 3.0 0.7 0.2 0.2 6.3 0.2 1.7 0.0 0.0 0.5 0.2 0.5 0.2 0.4 0.8 0.2 7.1 11.0 0.2 0.2 0.4 0.7 1.3 4.0 0.1 1.5 0.0 0.5 1.2 4.2 0.2 1.2 79.8 0.3 0.4 0.1 0.5 1.8 0.2 0.7 0.2 0.2 1.3 0.0 0.0 0.2 0.0 0.4 0.3 0.2 0.4 0.3 2.6 0.3 0.3 0.4 0.0 0.6 1.2 0.0 0.2 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.6 1.7 0.9 0.0 0.0 0.2 0.0 0.1 0.0 1.7 0.0 0.0 0.4 0.0 0.1 0.6 0.1 0.2 0.2 0.1 0.0 3.3 0.0 1.2 9.4 0.1 5.4 2.7 0.0 0.1 0.1 0.7 0.3 0.4 0.4 0.1 0.2 0.5 0.1 0.1 0.3 0.1 0.6 0.3 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.4 0.4 0.2 2.6 0.3 0.3 0.3 0.0 0.0 13.1 3.0 0.2 6.3 7.1 11.0 1.3 4.0 4.2 0.0 CNGB3 "ACHM1, ACHM3, RMCH" ENSG00000170289 "Cyclic nucleotide gated channel beta 3" Q9NQW8 8 86553977-86743675 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 68.9" "Cell line enriched" "Detected in some" 13 "SCLC-21H: 21.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057244 Enhanced "HPA057244: " "unprognostic (5.35e-1)" "unprognostic (1.68e-3)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" "unprognostic (3.62e-2)" "unprognostic (2.58e-1)" "unprognostic (6.25e-2)" "unprognostic (1.18e-1)" "unprognostic (2.91e-1)" "unprognostic (2.17e-1)" "unprognostic (3.82e-1)" "unprognostic (9.28e-2)" "unprognostic (2.77e-4)" "unprognostic (1.40e-4)" "unprognostic (1.66e-2)" "unprognostic (8.76e-2)" "unprognostic (1.84e-1)" 0.2 0.1 0.4 0.4 0.2 7.9 0.2 0.2 1.0 0.9 0.1 0.1 0.1 0.9 0.7 0.4 0.2 2.8 0.1 0.3 0.2 0.2 0.2 0.1 0.1 0.3 0.6 0.1 1.0 1.5 0.0 0.6 0.1 1.8 0.1 0.0 68.9 0.3 0.1 0.1 2.4 0.4 0.1 0.8 0.1 0.6 5.4 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 1.3 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.0 1.6 21.2 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.5 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.2 0.2 1.0 0.2 0.2 0.6 0.1 1.8 0.1 CNIH2 "CNIH-2, Cnil, MGC50896" ENSG00000174871 "Cornichon family AMPA receptor auxiliary protein 2" Q6PI25 11 66278190-66285301 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 74.5" "Cell line enhanced" "Detected in some" "AF22: 8.9;NTERA-2: 8.3;SCLC-21H: 34.7;SH-SY5Y: 16.0" "Cancer enhanced" "Detected in many" "glioma: 20.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.84e-2)" "unprognostic (3.53e-3)" "unprognostic (3.40e-3)" "unprognostic (1.04e-2)" "prognostic unfavourable (9.18e-4)" "unprognostic (1.81e-1)" "unprognostic (1.74e-2)" "unprognostic (3.29e-1)" "unprognostic (3.25e-1)" "unprognostic (3.80e-2)" "unprognostic (7.66e-3)" "unprognostic (4.16e-2)" "unprognostic (6.95e-8)" "unprognostic (3.53e-1)" "unprognostic (3.19e-2)" "unprognostic (3.17e-2)" "unprognostic (3.55e-2)" 1.5 6.5 33.9 1.5 37.6 3.2 1.4 8.4 49.5 1.2 1.4 6.2 0.0 2.1 1.5 1.3 1.3 2.0 1.5 1.2 74.5 17.3 1.2 1.2 1.4 1.4 9.6 15.5 1.2 4.2 1.6 8.8 2.0 4.6 1.4 1.6 0.0 1.3 1.2 1.2 3.1 1.6 1.6 2.4 1.6 2.8 2.6 4.7 0.5 1.3 0.0 1.3 1.3 0.0 0.8 0.3 0.0 0.0 0.0 0.8 0.0 0.2 0.4 8.9 7.7 0.1 0.1 1.1 0.5 0.6 1.1 0.1 0.2 0.0 0.0 0.1 0.1 0.1 2.0 0.0 0.1 0.8 0.7 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.1 1.1 0.5 7.5 1.2 0.1 8.3 0.6 3.6 0.0 0.0 0.0 0.4 34.7 16.0 0.0 4.3 0.3 7.5 0.1 0.0 1.0 0.4 0.2 0.3 0.2 0.2 0.3 2.3 0.2 5.8 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.1 0.8 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 33.9 37.6 8.4 36.5 74.5 17.3 9.6 15.5 4.6 4.7 CNKSR2 "CNK2, KIAA0902, KSR2" ENSG00000149970 "Connector enhancer of kinase suppressor of Ras 2" Q8WXI2 X 21372801-21654695 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 38.4" "Cell line enhanced" "Detected in some" "A549: 6.7;AF22: 4.7;NTERA-2: 10.8;PC-3: 5.5;RH-30: 10.1;U-251 MG: 6.7" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.9;naive CD4 T-cell: 3.0" "Group enriched" "Detected in many" 5 "B-cells: 2.9;T-cells: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001502 Approved "Golgi apparatus,Plasma membrane" "Golgi apparatus, Plasma membrane" "HPA001502: AB_1078542" "unprognostic (1.33e-2)" "unprognostic (1.00e-3)" "unprognostic (5.35e-2)" "unprognostic (4.90e-4)" "unprognostic (1.26e-1)" "unprognostic (5.40e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-2)" "unprognostic (3.47e-1)" "unprognostic (7.16e-2)" "unprognostic (1.35e-2)" "unprognostic (2.01e-1)" "unprognostic (1.78e-2)" "unprognostic (2.72e-2)" "unprognostic (3.93e-2)" "unprognostic (2.27e-2)" "unprognostic (4.13e-2)" 2.0 5.2 23.5 1.4 29.6 1.3 2.1 31.3 38.4 1.4 1.2 1.7 0.0 1.1 1.4 1.8 1.1 2.3 1.2 1.7 26.4 4.4 1.0 2.0 2.8 2.4 3.1 20.8 1.9 4.9 1.0 1.0 1.1 1.8 2.2 1.1 3.5 1.7 1.2 7.4 1.1 1.2 1.2 1.7 1.8 1.3 1.8 5.0 0.6 1.2 0.0 2.6 1.3 0.7 2.9 0.1 0.6 0.0 0.0 3.0 0.3 0.0 6.7 4.7 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 1.4 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.1 10.8 5.5 0.0 10.1 0.0 0.0 0.0 4.6 1.8 0.0 0.1 0.2 0.0 0.6 0.0 0.1 2.1 0.0 6.7 3.5 0.0 3.5 0.9 0.0 2.6 0.1 0.0 0.6 0.1 0.0 0.4 1.1 0.6 0.0 0.0 2.9 3.0 1.0 0.0 0.0 0.0 0.1 0.8 0.3 23.5 29.6 31.3 24.4 26.4 4.4 3.1 20.8 1.8 5.0 CNP ENSG00000173786 "2',3'-cyclic nucleotide 3' phosphodiesterase" P09543 17 41966741-41977731 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 211.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 49.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002672, HPA023266, HPA023278, HPA023280, HPA023338" Enhanced Supported Enhanced Nucleoplasm,Cytosol 730000 Nucleoplasm Cytosol "CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062" "unprognostic (2.17e-1)" "unprognostic (4.48e-2)" "unprognostic (3.85e-3)" "unprognostic (1.41e-1)" "unprognostic (3.09e-1)" "unprognostic (9.71e-2)" "unprognostic (2.58e-3)" "unprognostic (2.08e-1)" "unprognostic (2.23e-1)" "unprognostic (1.62e-1)" "unprognostic (5.76e-3)" "unprognostic (1.87e-1)" "unprognostic (2.99e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (8.86e-2)" "unprognostic (1.10e-3)" 9.1 8.9 51.4 9.5 72.8 6.7 8.1 13.4 125.3 10.3 7.5 211.7 2.3 7.1 8.0 12.7 15.0 9.3 10.8 7.6 78.4 40.7 14.7 9.6 6.7 10.5 86.7 49.0 11.2 9.2 5.8 4.4 7.8 66.7 11.7 6.4 3.6 15.1 13.2 7.6 11.1 6.4 10.1 160.2 7.1 7.4 4.6 63.5 2.1 7.2 2.2 11.2 9.8 5.7 9.9 49.1 7.3 13.1 7.3 7.5 9.1 13.7 23.5 22.3 27.5 19.1 18.0 9.6 17.2 26.5 44.8 50.6 18.4 12.6 14.6 13.9 22.4 23.7 15.0 11.4 15.6 14.5 19.0 14.2 16.2 31.9 20.6 13.8 12.9 29.7 8.2 24.5 6.0 20.4 10.0 12.0 15.6 8.7 35.4 12.5 5.2 16.8 22.1 32.8 14.2 11.9 14.1 13.1 17.7 21.8 32.9 38.3 14.7 20.7 20.4 17.5 19.2 23.7 20.3 13.5 15.3 11.7 17.3 10.7 68.2 4.9 12.1 7.3 7.5 13.1 5.9 9.9 6.5 6.0 11.1 7.0 5.9 6.9 2.6 7.3 10.3 49.1 7.2 9.1 51.4 72.8 13.4 93.8 78.4 40.7 86.7 49.0 66.7 63.5 CNTD1 "CNTD, FLJ40137" ENSG00000176563 "Cyclin N-terminal domain containing 1" Q8N815 17 42798792-42811587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 31.0" "Cell line enhanced" "Detected in some" "A-431: 6.1;ASC diff: 4.2;SiHa: 3.3;T-47d: 2.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA023324 Uncertain "Nucleoplasm,Plasma membrane,Focal adhesion sites" Nucleoplasm "Plasma membrane, Focal adhesion sites" "HPA023324: AB_1848931" "unprognostic (5.92e-2)" "unprognostic (1.99e-3)" "unprognostic (3.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.25e-1)" "unprognostic (6.29e-3)" "unprognostic (6.61e-2)" "unprognostic (1.09e-2)" "unprognostic (7.82e-2)" "unprognostic (6.18e-2)" "unprognostic (1.36e-2)" "unprognostic (2.07e-1)" "unprognostic (5.89e-7)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.81e-4)" 0.2 0.1 0.7 0.0 1.4 0.0 1.6 0.2 1.7 0.2 0.6 0.4 0.0 0.0 0.1 0.9 0.1 0.5 0.0 0.1 1.5 0.3 1.2 0.1 0.3 0.0 0.5 0.8 0.3 0.8 0.0 0.1 0.0 0.9 1.1 1.5 0.1 0.5 0.0 0.2 0.1 0.2 0.7 0.8 0.1 2.3 31.0 1.6 0.0 0.1 0.0 0.0 0.2 0.1 0.9 0.1 2.7 0.3 0.1 0.3 0.3 6.1 0.7 0.4 1.3 4.2 1.5 0.0 0.0 0.3 0.4 1.4 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.6 1.3 0.0 0.0 0.2 0.5 0.0 0.0 0.2 0.0 0.3 0.7 0.0 0.0 0.0 3.3 0.3 0.8 2.4 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.3 0.1 0.1 0.5 0.4 0.0 0.3 0.0 0.3 0.2 0.3 0.4 0.1 0.0 0.1 0.9 0.0 0.0 2.7 0.1 0.1 0.0 0.0 0.3 0.7 1.4 0.2 1.7 1.5 0.3 0.5 0.8 0.9 1.6 CNTF HCNTF ENSG00000242689 "Ciliary neurotrophic factor" P26441 11 58622673-58625733 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.5" "Cell line enhanced" "Detected in many" "U-2197: 12.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "midbrain: 47.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA019654 Approved Approved Vesicles Vesicles "HPA019654: AB_1859050" "unprognostic (1.88e-1)" "unprognostic (2.64e-3)" "unprognostic (1.01e-2)" "unprognostic (4.37e-2)" "unprognostic (1.52e-1)" "unprognostic (5.91e-2)" "unprognostic (1.63e-1)" "unprognostic (9.24e-2)" "unprognostic (5.87e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-4)" "unprognostic (5.42e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-1)" "unprognostic (1.91e-1)" "unprognostic (9.50e-2)" "unprognostic (9.67e-2)" 2.0 0.7 1.4 0.9 4.8 10.0 0.8 1.2 1.6 0.3 0.9 2.5 1.1 1.4 0.3 1.4 0.9 8.3 0.8 2.5 1.8 1.6 0.9 0.9 0.8 0.6 47.5 0.9 0.3 0.5 1.2 0.5 0.6 9.3 0.6 1.3 3.1 1.3 0.4 3.7 0.9 0.9 0.6 22.8 0.6 0.5 0.7 1.2 0.2 1.0 3.7 0.6 0.6 0.3 0.4 0.0 0.0 0.3 0.0 0.7 0.2 2.1 0.8 3.4 3.5 1.0 0.3 1.7 1.6 2.2 1.6 1.2 2.9 2.9 4.3 1.2 2.2 3.8 3.6 3.9 3.2 3.0 2.1 2.3 4.3 1.6 0.4 3.3 4.2 1.0 1.3 5.3 1.7 1.7 3.4 1.0 2.0 0.9 3.2 3.1 2.1 1.5 2.2 2.4 3.0 1.9 2.5 1.5 4.2 2.2 2.3 5.8 2.9 2.4 1.2 2.5 1.9 12.7 4.0 2.4 4.9 3.7 6.6 1.7 2.9 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 1.4 4.8 1.2 1.4 1.8 1.6 47.5 0.9 9.3 1.2 CNTN2 "AXT, TAG-1, TAX, TAX1" ENSG00000184144 "Contactin 2" Q02246 1 205042937-205078284 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Cell adhesion" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 78.5" "Group enriched" "Detected in some" 7 "NTERA-2: 5.6;SCLC-21H: 14.0" "Cancer enriched" "Detected in some" 9 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001397, HPA012497" Approved "Secreted in brain" 13000 "HPA001397: AB_1847146, HPA012497: AB_1847147" "unprognostic (1.90e-1)" "unprognostic (1.86e-1)" "unprognostic (2.87e-2)" "unprognostic (4.52e-3)" "unprognostic (2.98e-2)" "unprognostic (5.96e-2)" "unprognostic (3.25e-1)" "unprognostic (1.43e-2)" "unprognostic (8.56e-2)" "unprognostic (2.40e-1)" "unprognostic (3.44e-3)" "unprognostic (5.62e-2)" "unprognostic (1.73e-7)" "unprognostic (9.82e-3)" "unprognostic (1.19e-1)" "unprognostic (3.35e-2)" "unprognostic (3.07e-2)" 2.0 2.4 15.6 2.1 52.5 1.6 1.6 11.0 68.8 1.8 2.3 78.5 0.0 1.7 1.6 1.7 1.9 1.7 1.8 1.7 27.4 15.9 1.6 1.6 1.6 1.7 59.8 22.0 1.6 1.6 1.6 2.7 1.6 41.9 1.8 2.3 0.0 2.2 2.4 1.6 2.3 2.2 1.8 55.4 1.7 1.7 9.1 48.3 0.0 1.6 0.0 2.0 1.6 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 15.6 52.5 11.0 28.4 27.4 15.9 59.8 22.0 41.9 48.3 CNTNAP4 "CASPR4, KIAA1763" ENSG00000152910 "Contactin associated protein like 4" Q9C0A0 16 76277278-76559238 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "brain: 36.9" "Group enriched" "Detected in some" 6 "Daudi: 13.7;HSkMC: 5.5;Karpas-707: 4.7;RPMI-8226: 8.7" "Cancer enriched" "Detected in single" 5 "glioma: 1.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031859 Enhanced 73000 "HPA031859: AB_10601360" "unprognostic (7.88e-2)" "unprognostic (7.19e-2)" "unprognostic (6.58e-2)" "unprognostic (2.46e-1)" "unprognostic (1.55e-2)" "unprognostic (1.50e-3)" "unprognostic (9.42e-3)" "unprognostic (1.91e-2)" "unprognostic (5.26e-4)" "unprognostic (1.83e-2)" "unprognostic (2.00e-2)" "unprognostic (4.56e-1)" "unprognostic (1.09e-1)" 0.9 2.4 10.2 0.9 19.1 0.9 0.9 13.2 36.9 1.3 0.9 27.6 0.0 1.2 0.9 0.9 0.9 0.9 0.9 0.9 9.9 2.2 1.0 0.9 0.9 1.0 23.1 15.1 1.0 0.9 0.9 0.8 0.9 25.0 1.3 0.9 0.0 0.9 1.4 0.9 0.9 1.1 1.0 30.9 0.9 0.9 2.2 21.4 0.0 0.9 0.0 1.0 0.9 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.3 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.2 19.1 13.2 14.4 9.9 2.2 23.1 15.1 25.0 21.4 CNTNAP5 "caspr5, FLJ31966" ENSG00000155052 "Contactin associated protein like 5" Q8WYK1 2 124025287-124915287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 22.4" "Cell line enhanced" "Detected in some" "AF22: 3.2;HMC-1: 2.1;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 7.2" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA069095, HPA069356" Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA069095: , HPA069356: " "unprognostic (6.32e-3)" "unprognostic (6.38e-2)" "unprognostic (1.23e-1)" "unprognostic (2.25e-1)" "unprognostic (1.68e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (3.11e-2)" "unprognostic (2.62e-6)" "unprognostic (3.65e-3)" "unprognostic (5.32e-2)" "unprognostic (9.58e-2)" 0.7 2.8 12.9 0.7 7.9 1.0 0.7 3.3 22.4 0.6 0.8 1.5 0.0 1.0 0.7 0.7 0.7 0.6 4.2 0.7 14.0 4.0 1.2 0.7 0.7 0.7 2.2 8.4 0.6 1.1 0.7 0.8 0.7 15.2 0.8 0.8 0.4 0.6 1.0 0.7 0.8 0.9 0.8 1.9 0.7 0.7 0.9 2.8 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.1 0.0 1.3 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.9 7.9 3.3 22.4 14.0 4.0 2.2 8.4 15.2 2.8 COL11A2 "DFNA13, DFNB53, HKE5" ENSG00000204248 "Collagen type XI alpha 2 chain" P13942 6 33162681-33192499 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Deafness, Disease mutation, Dwarfism, Non-syndromic deafness, Stickler syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "pituitary gland: 28.8" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;HMC-1: 2.1;U-266/70: 2.3;U-698: 2.9" "Cancer enriched" "Detected in many" 8 "melanoma: 13.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" 720000 "unprognostic (4.62e-1)" "unprognostic (8.69e-2)" "unprognostic (1.65e-4)" "unprognostic (5.15e-3)" "unprognostic (1.14e-1)" "unprognostic (1.69e-1)" "unprognostic (1.04e-2)" "unprognostic (9.67e-2)" "unprognostic (2.05e-2)" "unprognostic (4.47e-2)" "unprognostic (1.22e-1)" "unprognostic (3.41e-3)" "unprognostic (2.26e-6)" "unprognostic (8.27e-2)" "unprognostic (2.17e-1)" "unprognostic (1.88e-1)" "unprognostic (5.96e-2)" 1.6 0.7 0.8 0.6 1.5 0.2 0.4 6.6 2.8 1.2 0.4 2.5 0.1 1.2 0.6 1.2 0.4 0.3 0.5 1.6 1.1 0.9 0.4 0.8 0.7 0.3 2.7 0.1 0.5 1.7 0.2 28.8 0.5 1.7 0.8 0.2 2.6 2.2 0.6 2.5 1.6 1.5 0.9 2.2 0.8 3.5 4.5 1.8 1.1 2.1 0.9 0.6 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.1 0.2 0.1 2.0 0.3 1.6 0.9 0.2 0.2 0.0 0.0 0.5 0.3 0.2 0.4 0.0 0.0 0.0 0.3 2.1 0.3 0.0 0.1 0.1 0.1 0.5 0.8 0.1 0.3 0.0 0.6 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 1.4 1.2 0.4 0.2 0.8 1.5 0.0 0.1 2.3 1.7 2.9 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.4 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.8 1.5 6.6 1.2 1.1 0.9 2.7 0.1 1.7 1.8 COL20A1 KIAA1510 ENSG00000101203 "Collagen type XX alpha 1 chain" Q9P218 20 63293186-63334851 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 21.6" "Cell line enhanced" "Detected in some" "MCF7: 1.6;SK-MEL-30: 3.3;U-266/70: 2.4" "Cancer enriched" "Detected in single" 19 "glioma: 8.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051962 Uncertain "Secreted to extracellular matrix" "HPA051962: " "unprognostic (6.34e-4)" "unprognostic (2.52e-1)" "unprognostic (1.29e-2)" "unprognostic (1.69e-1)" "unprognostic (2.01e-1)" "unprognostic (5.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.45e-1)" "unprognostic (1.21e-1)" "unprognostic (1.70e-2)" "unprognostic (1.71e-1)" "unprognostic (2.89e-1)" "unprognostic (8.41e-7)" "unprognostic (7.85e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-2)" "unprognostic (1.16e-1)" 0.6 0.9 6.9 0.6 3.9 0.6 0.5 2.2 21.6 1.0 0.6 14.0 0.0 0.5 0.5 1.2 0.5 0.6 0.5 0.6 5.6 3.0 0.6 0.6 0.5 0.5 4.7 4.5 0.7 0.5 0.5 1.1 0.6 3.5 0.6 0.5 0.7 0.8 0.6 0.5 0.5 0.6 0.5 4.3 2.0 0.5 3.0 5.0 0.0 0.5 0.2 0.5 0.5 0.1 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.9 0.0 0.3 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.6 0.7 0.1 2.4 0.5 0.3 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 6.9 3.9 2.2 6.3 5.6 3.0 4.7 4.5 3.5 5.0 COLEC10 CL-L1 ENSG00000184374 "Collectin subfamily member 10" Q9Y6Z7 8 118995452-119106582 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 47.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.2;HHSteC: 3.4;SK-BR-3: 14.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" 5700000 "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" "unprognostic (3.79e-4)" "unprognostic (6.25e-3)" "unprognostic (1.80e-3)" "unprognostic (7.73e-2)" "prognostic favourable (5.79e-4)" "unprognostic (1.05e-1)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (9.25e-2)" "unprognostic (9.02e-5)" "unprognostic (2.47e-1)" "unprognostic (1.82e-1)" "unprognostic (5.85e-5)" "unprognostic (7.12e-2)" 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.1 0.1 0.3 47.4 0.7 0.6 0.1 0.0 0.0 0.0 0.0 0.1 8.5 0.1 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.7 8.2 0.0 0.0 0.1 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 1.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 COQ8A "ADCK3, CABC1, COQ8, SCAR9" ENSG00000163050 "Coenzyme Q8A" Q8NI60 1 226897536-226987545 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Kinase, Transferase" "Disease mutation, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 216.5" "Cell line enhanced" "Detected in many" "HEK 293: 33.0;RPMI-8226: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061662 Supported Mitochondria Mitochondria "HPA061662: " "unprognostic (6.37e-3)" "unprognostic (2.09e-2)" "unprognostic (2.29e-1)" "unprognostic (9.06e-2)" "unprognostic (8.94e-2)" "unprognostic (2.49e-1)" "unprognostic (4.42e-2)" "unprognostic (3.50e-3)" "unprognostic (1.81e-1)" "unprognostic (4.02e-1)" "unprognostic (4.15e-3)" "unprognostic (8.67e-2)" "unprognostic (2.40e-2)" "unprognostic (9.24e-2)" "unprognostic (2.82e-1)" "unprognostic (8.88e-2)" "unprognostic (2.62e-1)" 13.3 25.4 2.8 2.7 4.5 5.3 8.5 14.5 3.9 3.2 7.3 4.1 4.2 6.9 3.6 5.5 7.3 5.0 6.1 41.0 2.7 1.8 3.8 17.7 2.7 4.1 5.0 2.4 7.2 20.3 1.6 1.6 2.0 3.8 6.5 2.0 1.9 7.2 5.0 216.5 4.4 4.4 7.8 2.9 3.5 8.8 3.0 4.7 2.7 4.6 50.2 5.8 10.2 3.5 15.2 9.3 32.3 11.5 9.9 11.8 11.6 3.2 5.8 1.5 4.5 4.7 3.1 23.6 1.5 1.3 2.2 2.9 9.2 5.2 9.5 7.3 1.0 3.7 2.9 3.3 0.5 9.9 33.0 6.6 4.8 15.1 1.0 10.0 4.1 5.9 5.1 1.7 2.3 1.0 11.4 7.8 0.3 4.3 5.8 14.7 6.4 12.0 5.7 7.1 30.2 0.7 2.4 24.3 9.9 3.0 11.8 8.5 6.2 13.6 1.2 2.5 2.3 3.5 5.5 17.6 15.4 5.0 2.3 11.4 2.4 19.7 11.5 32.3 8.7 8.6 8.3 12.1 8.5 7.7 9.3 15.2 11.8 9.0 21.9 9.9 6.5 4.1 10.6 11.6 2.8 4.5 14.5 3.9 2.7 1.8 5.0 2.4 3.8 4.7 CORO6 FLJ14871 ENSG00000167549 "Coronin 6" Q6QEF8 17 29614756-29622907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 130.9" "Cell line enhanced" "Detected in many" "REH: 12.2;RH-30: 13.9;SH-SY5Y: 17.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 19 "basophil: 3.9;eosinophil: 2.4" "Lineage enriched" "Detected in single" 23 "granulocytes: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021556 Supported "Golgi apparatus" "Golgi apparatus" "HPA021556: " "unprognostic (7.12e-3)" "unprognostic (2.68e-2)" "unprognostic (2.60e-4)" "unprognostic (9.25e-4)" "unprognostic (1.45e-2)" "unprognostic (1.15e-1)" "unprognostic (1.11e-2)" "unprognostic (1.62e-1)" "unprognostic (3.00e-4)" "unprognostic (6.70e-2)" "unprognostic (6.61e-2)" "unprognostic (1.22e-1)" "prognostic unfavourable (9.61e-7)" "unprognostic (8.48e-2)" "unprognostic (4.09e-1)" "unprognostic (1.92e-1)" "unprognostic (1.13e-2)" 2.7 1.6 5.7 1.2 17.7 0.9 2.2 4.5 12.4 1.4 4.4 0.7 1.6 1.3 3.3 3.4 6.9 3.5 2.4 28.4 5.2 3.3 0.9 0.8 2.1 1.0 1.8 8.7 1.2 1.0 11.7 1.0 25.7 8.1 4.0 1.7 1.2 3.8 2.7 130.9 2.0 2.4 5.6 1.3 1.1 2.1 1.0 3.6 0.0 21.3 18.3 1.1 4.9 1.9 0.0 0.0 3.9 0.0 0.0 0.1 0.1 7.5 3.3 2.9 0.0 4.6 2.5 4.7 2.5 0.9 1.6 0.7 0.2 0.0 0.1 0.6 4.0 8.0 2.2 0.4 0.8 0.1 3.8 0.0 6.3 0.9 7.5 0.0 0.4 9.1 0.7 0.8 0.0 1.7 0.5 0.1 5.4 0.0 5.0 0.2 1.0 0.1 12.2 13.9 0.3 0.4 0.0 0.0 17.1 0.7 2.3 0.0 0.0 1.1 0.5 1.1 0.0 1.3 1.1 6.4 3.4 0.9 2.4 0.0 0.0 3.9 0.0 2.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 17.7 4.5 12.4 5.2 3.3 1.8 8.7 8.1 3.6 CORT MGC32686 ENSG00000241563 Cortistatin O00230 1 10449719-10451902 "Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 28.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 33 "amygdala: 13.7;basal ganglia: 5.1;cerebral cortex: 16.9;hippocampal formation: 11.6;olfactory region: 6.1" "Low region specificity" "Detected in many" "Secreted in brain" "unprognostic (1.25e-2)" "unprognostic (1.79e-2)" "unprognostic (1.65e-1)" "unprognostic (3.70e-3)" "unprognostic (8.87e-2)" "unprognostic (1.67e-2)" "unprognostic (1.02e-2)" "unprognostic (1.20e-1)" "unprognostic (1.05e-1)" "unprognostic (7.94e-3)" "unprognostic (7.08e-7)" "unprognostic (2.01e-1)" "unprognostic (9.01e-4)" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (3.02e-1)" "unprognostic (2.14e-4)" 1.0 0.7 3.3 0.9 28.8 0.9 0.6 3.2 26.6 0.7 1.0 0.1 0.0 1.3 0.8 1.0 0.5 0.7 1.0 0.6 2.3 2.5 1.2 0.8 0.7 0.7 1.0 6.2 1.0 0.9 1.0 3.2 1.7 0.0 1.1 0.8 0.0 0.7 0.8 0.8 1.1 1.2 0.7 0.7 0.8 0.9 2.1 20.3 0.0 1.1 0.0 0.5 0.8 0.5 0.2 0.4 0.0 0.1 1.2 0.3 0.3 1.2 3.7 1.8 2.3 0.2 0.2 0.8 1.1 0.2 0.4 0.4 3.1 0.5 1.2 0.8 0.0 1.0 1.1 0.0 0.0 2.0 3.1 1.7 2.7 3.0 0.4 2.4 1.1 0.0 0.3 0.5 0.0 0.0 1.0 1.0 0.3 2.5 0.5 2.2 0.3 4.4 0.9 1.6 0.5 0.2 0.9 1.5 0.8 0.9 1.1 0.7 0.7 0.0 1.7 0.3 1.8 2.2 0.6 0.9 2.7 1.0 0.7 1.8 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.4 0.2 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.3 3.3 28.8 3.2 21.5 2.3 2.5 1.0 6.2 0.0 20.3 COX6B2 "COXVIB2, CT59, FLJ32865" ENSG00000160471 "Cytochrome c oxidase subunit 6B2" Q6YFQ2 19 55349306-55354814 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 66.5" "Group enriched" "Detected in some" 6 "CAPAN-2: 22.1;SCLC-21H: 9.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA035014 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA035014: AB_10601261" "unprognostic (7.43e-3)" "unprognostic (8.72e-2)" "unprognostic (1.42e-1)" "unprognostic (5.75e-2)" "unprognostic (2.59e-2)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (6.82e-2)" "prognostic unfavourable (9.70e-5)" "unprognostic (8.11e-2)" "unprognostic (1.81e-6)" "unprognostic (9.91e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-2)" "unprognostic (2.02e-1)" 0.3 0.0 0.4 0.6 0.6 0.7 0.5 0.3 0.6 0.2 3.3 0.2 0.2 0.0 0.2 0.8 0.5 0.4 0.2 0.2 0.2 0.5 0.5 0.2 0.2 0.6 0.4 0.2 0.4 0.2 0.0 0.4 0.2 0.6 0.2 3.5 0.7 0.6 0.2 0.2 1.8 0.2 0.2 0.7 0.2 0.0 66.5 0.3 0.2 0.2 0.2 1.2 0.2 0.4 1.3 1.4 5.7 1.0 1.6 0.9 0.8 2.7 0.4 0.1 0.1 0.0 0.0 0.2 0.4 0.1 0.3 0.5 0.1 22.1 0.1 0.2 0.2 1.7 0.7 0.2 0.2 0.8 0.6 0.0 1.7 0.1 0.3 0.1 1.7 0.2 2.4 0.4 0.5 0.0 0.4 0.2 0.0 0.4 0.1 0.2 0.6 0.5 0.1 0.0 0.2 0.0 0.4 9.5 0.3 0.3 0.1 0.0 0.4 0.0 0.3 0.3 0.5 0.1 0.2 1.5 1.2 0.1 0.1 0.3 0.2 1.9 1.0 1.0 0.8 0.5 0.5 0.7 0.7 0.6 0.3 1.3 0.7 0.9 5.7 1.6 0.7 1.4 0.6 0.8 0.4 0.6 0.3 0.6 0.2 0.5 0.4 0.2 0.6 0.3 COX7B2 ENSG00000170516 "Cytochrome c oxidase subunit 7B2" Q8TF08 4 46734827-46909235 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "testis: 43.9" "Cell line enriched" "Detected in some" 15 "Karpas-707: 27.8" "Cancer enhanced" "Detected in many" "liver cancer: 7.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (2.82e-1)" "unprognostic (2.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 3.4 0.2 0.6 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.4 0.1 0.1 0.0 0.4 0.1 0.0 3.4 0.6 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COX8C COX8-3 ENSG00000187581 "Cytochrome c oxidase subunit 8C" Q7Z4L0 14 93347191-93348356 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 72 "testis: 72.8" "Cell line enriched" "Detected in some" 9 "U-937: 17.6" "Group enriched" "Detected in some" 8 "ovarian cancer: 2.9;testis cancer: 6.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA003127 Approved "HPA003127: AB_1078560" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (3.76e-3)" "unprognostic (2.11e-1)" "unprognostic (2.77e-2)" "unprognostic (7.71e-2)" "unprognostic (3.83e-1)" "unprognostic (1.99e-2)" "unprognostic (8.28e-2)" "unprognostic (6.33e-2)" "unprognostic (2.64e-2)" "unprognostic (9.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 72.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CP ENSG00000047457 Ceruloplasmin P00450 3 149162410-149222055 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Copper transport, Ion transport, Transport" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "liver: 311.1" "Cell line enriched" "Detected in some" 9 "EFO-21: 80.4" "Cancer enhanced" "Detected in many" "liver cancer: 98.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001834, CAB008591" Supported "Secreted to blood" 160000000000 830000000000 "CAB008591: AB_1613734, HPA001834: AB_1078502" "unprognostic (3.58e-1)" "unprognostic (4.24e-1)" "unprognostic (9.61e-2)" "unprognostic (1.80e-2)" "unprognostic (4.14e-2)" "unprognostic (1.02e-2)" "unprognostic (1.06e-1)" "unprognostic (2.97e-2)" "unprognostic (2.07e-1)" "unprognostic (8.75e-2)" "unprognostic (6.03e-2)" "unprognostic (1.70e-1)" "prognostic unfavourable (1.14e-7)" "unprognostic (2.68e-2)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (2.70e-1)" 1.8 0.7 2.6 0.6 5.7 0.4 3.5 2.6 3.5 10.5 2.0 2.5 0.0 1.7 2.3 0.3 1.1 1.5 0.5 6.6 3.6 1.7 1.6 311.1 2.1 2.4 4.2 0.9 0.4 1.2 1.4 5.3 1.9 9.4 2.1 2.7 15.5 6.9 0.4 1.2 2.0 2.6 0.7 4.8 3.5 0.7 0.5 4.4 0.0 2.8 0.4 3.0 3.2 2.9 1.3 0.8 0.6 1.0 0.3 1.3 0.4 0.0 4.7 4.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 1.7 4.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 1.0 0.5 0.8 0.6 0.8 0.9 0.4 0.5 0.6 1.3 0.4 1.3 0.4 0.3 0.4 0.8 0.4 0.4 2.6 5.7 2.6 3.5 3.6 1.7 4.2 0.9 9.4 4.4 CPA1 CPA ENSG00000091704 "Carboxypeptidase A1" P15085 7 130380339-130388114 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 3231 "pancreas: 3541.6" "Cell line enriched" "Detected in some" 5 "AN3-CA: 15.8" "Cancer enriched" "Detected in some" 639 "pancreatic cancer: 1377.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA021836, CAB025197, HPA052215" Enhanced "Secreted to digestive system" 17000000 "CAB025197: , HPA021836: AB_1846005, HPA052215: " "unprognostic (8.41e-2)" "unprognostic (9.24e-4)" "unprognostic (5.22e-2)" "unprognostic (1.76e-1)" "unprognostic (3.97e-1)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" "unprognostic (1.15e-2)" "unprognostic (1.35e-1)" "unprognostic (1.34e-6)" "unprognostic (4.99e-1)" "unprognostic (1.67e-1)" "unprognostic (2.16e-1)" "unprognostic (4.37e-2)" 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.0 3541.6 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.5 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.3 0.0 1.9 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 CPA2 ENSG00000158516 "Carboxypeptidase A2" P48052 7 130266827-130289798 "Enzymes, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 529 "pancreas: 1357.9" "Cell line enhanced" "Detected in some" "AN3-CA: 4.4;CACO-2: 7.3;RH-30: 6.1;SCLC-21H: 3.3" "Cancer enriched" "Detected in many" 60 "pancreatic cancer: 411.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA020342, HPA021317" Enhanced Approved "Golgi apparatus" "Secreted to digestive system" 1500000 "Golgi apparatus" "HPA020342: AB_1846007, HPA021317: AB_1846008" "unprognostic (1.12e-1)" "unprognostic (3.97e-1)" "unprognostic (4.21e-2)" "unprognostic (1.82e-2)" "unprognostic (1.38e-1)" "unprognostic (6.76e-2)" "unprognostic (4.65e-2)" "unprognostic (1.08e-1)" "unprognostic (1.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.66e-1)" "unprognostic (3.84e-5)" "unprognostic (7.52e-2)" "unprognostic (1.42e-1)" "unprognostic (7.12e-2)" "unprognostic (8.48e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.4 1357.9 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.0 0.1 0.2 0.1 2.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 4.4 0.0 0.1 0.0 0.0 0.0 0.7 0.0 7.3 0.0 0.0 1.0 0.0 0.0 1.4 0.0 0.1 1.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.4 0.0 6.1 0.1 0.1 0.6 3.3 0.0 0.2 0.0 2.0 0.0 0.2 0.0 0.0 1.1 0.8 0.6 0.0 0.7 0.2 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CPB1 ENSG00000153002 "Carboxypeptidase B1" P15086 3 148791102-148860187 "Enzymes, Plasma proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 590 "pancreas: 3628.4" "Cell line enhanced" "Detected in some" "ASC diff: 2.7;EFO-21: 2.9;HDLM-2: 3.0;U-2 OS: 5.1;U-251 MG: 1.5;U-266/84: 2.4" "Group enriched" "Detected in some" 312 "breast cancer: 293.8;pancreatic cancer: 641.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "CAB026158, HPA038069, HPA046340" Enhanced "Secreted to digestive system" 6600000 "CAB026158: , HPA038069: , HPA046340: " "unprognostic (6.90e-2)" "unprognostic (3.79e-2)" "unprognostic (3.34e-2)" "unprognostic (2.64e-2)" "unprognostic (5.58e-2)" "unprognostic (3.27e-2)" "unprognostic (6.26e-4)" "unprognostic (1.90e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" "unprognostic (7.59e-2)" "unprognostic (4.51e-2)" "unprognostic (5.50e-8)" "unprognostic (3.08e-1)" "unprognostic (1.60e-1)" "unprognostic (4.93e-2)" 0.2 1.7 0.1 0.1 0.2 0.0 0.7 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.2 3628.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.7 0.2 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 1.8 1.1 6.1 1.0 3.1 3.5 0.9 0.0 0.0 0.0 0.0 2.7 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 2.9 0.0 0.0 0.0 0.0 0.1 3.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 5.1 0.0 1.5 0.0 2.4 0.6 0.0 0.0 0.0 6.1 0.7 1.1 3.0 0.9 2.2 0.9 1.3 2.6 0.3 1.8 0.9 3.5 4.5 3.1 1.0 1.1 0.6 0.9 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2 CPB2 "CPU, PCPB, TAFI" ENSG00000080618 "Carboxypeptidase B2" Q96IY4 13 46053195-46105033 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 82 "liver: 246.8" "Cell line enriched" "Detected in single" 76 "Hep G2: 61.1" "Cancer enriched" "Detected in some" 112 "liver cancer: 268.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA004146 Approved "Secreted to blood" 14000000000 "HPA004146: AB_1078397" "unprognostic (3.44e-2)" "unprognostic (1.25e-1)" "unprognostic (2.94e-2)" "unprognostic (1.89e-2)" "unprognostic (7.69e-2)" "unprognostic (1.17e-2)" "prognostic favourable (2.06e-4)" "unprognostic (1.89e-1)" "unprognostic (2.74e-1)" "unprognostic (2.48e-1)" "unprognostic (3.17e-2)" "unprognostic (4.83e-2)" "unprognostic (3.20e-3)" "unprognostic (1.34e-1)" "unprognostic (7.10e-2)" "unprognostic (3.34e-2)" "unprognostic (9.61e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 246.8 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.5 0.5 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 61.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.4 0.2 0.5 0.4 0.5 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CPHXL ENSG00000283755 "Cytoplasmic polyadenylated homeobox like" 16 75714224-75726442 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 18 "testis: 3.5" "Cell line enhanced" "Detected in single" "Daudi: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CPLX1 CPX-I ENSG00000168993 "Complexin 1" O14810 4 784957-826198 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 98.8" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071191, HPA074390" Supported Uncertain Vesicles Vesicles "HPA071191: , HPA074390: " "unprognostic (9.21e-3)" "prognostic unfavourable (4.20e-4)" "unprognostic (3.45e-2)" "unprognostic (4.68e-2)" "unprognostic (1.16e-2)" "unprognostic (1.02e-1)" "unprognostic (3.14e-2)" "unprognostic (2.26e-2)" "unprognostic (9.52e-3)" "unprognostic (2.01e-2)" "prognostic favourable (5.05e-4)" "unprognostic (1.10e-3)" "unprognostic (3.32e-1)" "unprognostic (2.05e-2)" "unprognostic (1.12e-1)" "unprognostic (1.34e-1)" "unprognostic (7.77e-2)" 7.8 6.5 13.1 2.9 40.7 1.5 2.4 26.3 98.8 2.2 2.5 3.9 0.0 2.8 4.2 1.5 1.6 2.3 1.9 3.0 16.9 7.6 2.4 2.4 2.8 2.4 16.3 18.3 2.4 3.0 3.4 1.7 1.8 52.8 4.4 1.7 3.8 4.4 2.5 4.5 3.0 2.8 2.0 5.4 5.6 3.2 4.9 4.2 0.0 1.8 0.0 1.6 1.7 1.7 0.2 2.3 0.1 0.0 0.0 0.8 0.0 2.7 0.2 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 8.0 0.8 2.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.2 0.0 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.9 0.1 0.0 1.1 1.1 0.0 1.3 1.3 0.0 0.0 0.7 0.0 0.2 42.0 5.8 0.2 2.7 0.0 4.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 2.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 13.1 40.7 26.3 98.8 16.9 7.6 16.3 18.3 52.8 4.2 CPLX4 CPX-IV ENSG00000166569 "Complexin 4" Q7Z7G2 18 59275156-59318649 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "retina: 61.9" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "cerebellum: 6.3" "Cell type enhanced" "Detected in single" "neutrophil: 1.7" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA047627 Enhanced "HPA047627: " "unprognostic (1.85e-1)" "unprognostic (4.46e-1)" "unprognostic (4.20e-2)" "unprognostic (4.05e-2)" "unprognostic (9.90e-3)" 0.1 0.3 0.2 0.0 0.1 2.8 0.1 6.3 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.8 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.2 0.3 0.2 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.4 0.1 0.0 61.9 0.3 0.0 0.3 1.9 0.1 0.0 0.2 0.3 0.1 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.6 0.7 1.7 0.3 0.8 0.7 0.1 0.1 0.8 0.4 0.8 0.7 0.2 0.8 0.8 0.0 0.1 0.0 0.3 0.6 0.5 0.1 0.2 1.1 0.2 0.0 1.2 0.3 0.0 0.2 1.5 0.8 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.1 0.7 0.6 0.4 0.3 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.4 0.2 0.0 0.9 0.0 0.1 0.3 0.6 0.6 0.2 0.9 0.0 0.8 0.4 0.4 0.1 0.2 0.6 0.4 0.3 0.1 0.3 0.0 0.3 0.1 0.4 0.3 0.0 0.6 0.2 0.7 1.7 0.8 0.1 0.7 0.2 0.1 0.2 0.1 6.3 0.1 0.1 0.1 0.3 0.0 0.4 0.0 CPN1 ENSG00000120054 "Carboxypeptidase N subunit 1" P15169 10 100042193-100081877 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 127 "liver: 76.8" "Cell line enriched" "Detected in some" 17 "SK-MEL-30: 55.2" "Group enriched" "Detected in some" 12 "liver cancer: 26.6;melanoma: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "Secreted to blood" 22000000000 "unprognostic (2.97e-2)" "unprognostic (2.23e-2)" "unprognostic (3.93e-2)" "unprognostic (1.64e-1)" "unprognostic (6.75e-2)" "unprognostic (2.93e-2)" "unprognostic (5.26e-2)" "unprognostic (2.63e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CPN2 ACBP ENSG00000178772 "Carboxypeptidase N subunit 2" P22792 3 194339765-194351328 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "liver: 225.5" "Cell line enriched" "Detected in some" 25 "Hep G2: 36.3" "Cancer enriched" "Detected in some" 32 "liver cancer: 72.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004732 Uncertain "Secreted to blood" 42000000000 "HPA004732: AB_1078561" "unprognostic (4.27e-2)" "unprognostic (3.04e-1)" "unprognostic (1.42e-1)" "unprognostic (4.12e-2)" "prognostic favourable (2.05e-4)" "unprognostic (1.27e-1)" "unprognostic (8.65e-2)" "unprognostic (8.56e-2)" "unprognostic (1.64e-1)" "prognostic unfavourable (4.59e-4)" "unprognostic (2.91e-2)" "unprognostic (2.40e-1)" "unprognostic (6.90e-5)" "unprognostic (8.42e-2)" 0.2 1.1 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 8.5 225.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 2.5 0.3 0.2 0.6 0.0 0.1 0.0 0.1 0.2 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.5 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.3 36.3 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.3 0.0 0.1 0.2 0.2 0.1 0.2 0.1 0.2 0.1 0.8 1.1 0.1 1.4 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.3 0.5 0.5 0.2 0.4 0.2 0.5 0.4 0.0 0.6 0.3 0.6 2.5 0.2 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 CPNE9 KIAA4217 ENSG00000144550 "Copine family member 9" Q8IYJ1 3 9703807-9729908 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 46.9" "Cell line enhanced" "Detected in some" "Daudi: 5.8;U-937: 5.2" "Cancer enhanced" "Detected in single" "testis cancer: 1.6" "Group enriched" "Detected in all" 4 "cerebellum: 26.6;cerebral cortex: 17.0;pons and medulla: 46.9" "Group enriched" "Detected in some" 7 "classical monocyte: 1.2;intermediate monocyte: 3.5;non-classical monocyte: 2.4;plasmacytoid DC: 1.4" "Group enriched" "Detected in many" 25 "dendritic cells: 1.4;monocytes: 3.5" "Low region specificity" "Detected in many" "unprognostic (2.96e-1)" "unprognostic (4.75e-2)" "unprognostic (1.34e-1)" "unprognostic (5.04e-3)" "unprognostic (1.10e-1)" "unprognostic (1.96e-1)" "unprognostic (2.13e-3)" "unprognostic (1.03e-2)" "unprognostic (3.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.20e-4)" "unprognostic (2.67e-2)" "unprognostic (5.44e-4)" "unprognostic (1.47e-2)" "unprognostic (8.59e-2)" "unprognostic (3.45e-1)" "unprognostic (7.48e-2)" 0.7 1.4 1.7 0.8 3.1 2.8 0.6 26.6 18.2 0.7 0.8 2.3 0.0 1.1 0.7 0.5 0.6 0.6 0.8 0.4 1.9 7.2 0.8 0.6 1.1 1.0 7.0 5.1 0.6 0.5 0.4 3.4 0.7 46.9 0.5 0.8 0.3 0.8 1.0 0.4 4.2 1.1 0.8 2.3 0.9 0.7 3.0 1.4 0.0 0.4 0.0 0.7 0.8 0.1 0.0 1.4 0.0 3.5 0.0 0.0 0.4 0.1 0.9 0.2 0.0 0.8 0.2 0.9 0.3 0.3 0.1 0.0 0.1 0.3 5.8 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.6 0.1 0.0 0.6 0.7 0.9 0.0 0.7 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.6 0.1 0.1 0.0 0.5 0.0 0.7 1.6 1.3 0.1 0.0 0.5 1.9 2.4 0.0 0.0 0.2 0.7 0.1 0.3 1.7 1.1 0.8 5.2 0.4 0.0 1.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.4 1.4 0.0 0.4 1.7 3.1 26.6 17.0 1.9 7.2 7.0 5.1 46.9 1.4 CPO ENSG00000144410 "Carboxypeptidase O" Q8IVL8 2 206939554-206969474 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 71.1" "Cell line enhanced" "Detected in some" "ASC diff: 2.9;BEWO: 1.7;hTCEpi: 2.2;NB-4: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "basophil: 10.3" "Lineage enriched" "Detected in single" 42 "granulocytes: 10.3" "Low region specificity" "Detected in many" "Intracellular and membrane" "unprognostic (9.39e-2)" "unprognostic (2.64e-1)" "unprognostic (2.95e-2)" "unprognostic (5.21e-2)" "unprognostic (2.28e-1)" "unprognostic (1.27e-2)" "unprognostic (1.16e-1)" "unprognostic (9.06e-2)" "unprognostic (4.03e-1)" "unprognostic (1.33e-1)" "unprognostic (3.75e-3)" "unprognostic (1.22e-1)" "unprognostic (3.60e-2)" "unprognostic (2.52e-1)" "unprognostic (6.56e-2)" "unprognostic (4.03e-2)" "unprognostic (4.89e-2)" 0.2 0.4 0.2 0.1 0.9 0.0 0.3 0.1 0.4 0.2 0.6 0.1 1.1 0.1 0.1 9.4 0.1 0.1 0.1 0.1 0.2 0.5 0.5 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.6 0.5 0.1 0.1 0.3 0.1 0.1 0.3 0.3 0.2 0.1 71.1 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 10.3 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.0 2.9 1.0 1.7 0.4 0.0 0.0 0.1 0.3 0.2 0.1 0.7 0.0 0.0 0.3 0.2 0.1 0.2 0.5 0.0 0.0 0.2 0.0 0.7 0.2 0.9 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 4.0 0.2 0.6 0.1 0.0 0.2 1.5 0.1 0.3 0.0 0.0 0.3 0.0 0.2 0.6 0.0 0.0 1.0 0.7 0.4 0.1 0.9 0.0 0.0 0.3 0.5 10.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.1 0.4 0.2 0.5 0.2 0.1 0.1 0.1 CPS1 ENSG00000021826 "Carbamoyl-phosphate synthase 1" P31327 2 210477682-210679107 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Urea cycle" "Allosteric enzyme, Ligase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "liver: 298.3" "Cell line enhanced" "Detected in many" "HeLa: 88.4;SK-BR-3: 26.7" "Cancer enriched" "Detected in many" 8 "liver cancer: 136.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB003781, HPA021400" Enhanced Supported Nucleoli 2100000 Nucleoli "CAB003781: , HPA021400: AB_1847197" "unprognostic (1.67e-2)" "unprognostic (3.72e-2)" "unprognostic (4.02e-2)" "unprognostic (7.21e-7)" "unprognostic (3.81e-2)" "unprognostic (2.52e-1)" "prognostic favourable (6.93e-5)" "unprognostic (1.23e-2)" "unprognostic (2.65e-1)" "unprognostic (1.35e-2)" "unprognostic (5.38e-2)" "unprognostic (1.94e-3)" "unprognostic (2.38e-4)" "unprognostic (5.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.14e-2)" "unprognostic (3.74e-2)" 0.4 0.1 0.5 0.3 1.6 0.0 0.8 0.3 0.7 0.4 0.2 0.7 0.3 31.5 0.3 0.7 0.5 0.2 0.4 0.3 0.5 0.4 0.6 298.3 0.2 0.3 1.5 0.8 0.7 0.2 0.0 0.4 1.1 1.4 0.3 0.0 0.6 0.2 0.2 0.3 0.3 17.2 0.4 2.3 0.3 0.2 1.3 0.5 0.0 0.4 0.4 0.1 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.3 2.3 6.2 4.2 4.1 7.2 6.6 2.2 2.7 2.6 4.1 0.6 0.0 1.0 0.1 2.4 1.1 0.2 3.7 6.6 0.0 1.9 3.9 88.4 5.5 1.3 2.0 0.0 3.7 2.8 5.2 5.3 0.2 3.9 0.3 4.3 1.1 0.1 0.2 2.4 0.6 0.2 5.7 0.5 5.6 0.0 0.1 0.4 15.5 26.7 3.0 0.0 0.6 2.9 6.8 2.1 2.0 4.8 0.0 0.3 0.0 4.5 4.3 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.3 0.7 0.5 0.4 1.5 0.8 1.4 0.5 CPXCR1 CT77 ENSG00000147183 "CPX chromosome region, candidate 1" Q8N123 X 88747225-88754785 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 54 "testis: 12.1" "Cell line enhanced" "Detected in some" "HDLM-2: 1.4;Karpas-707: 3.4;U-266/70: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CR2 "C3DR, CD21" ENSG00000117322 "Complement C3d receptor 2" P20023 1 207454230-207489895 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 97.2" "Cell line enhanced" "Detected in some" "Daudi: 21.1;MOLT-4: 11.5;RPMI-8226: 4.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "memory B-cell: 13.3;naive B-cell: 16.2" "Lineage enriched" "Detected in many" 9 "B-cells: 16.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "CAB002659, HPA052942, HPA060715" Enhanced 150000000 "CAB002659: , HPA052942: AB_2681994, HPA060715: AB_2684349" "prognostic favourable (6.90e-4)" "unprognostic (1.22e-1)" "unprognostic (9.95e-2)" "unprognostic (3.64e-2)" "unprognostic (2.65e-1)" "unprognostic (1.27e-3)" "unprognostic (1.18e-1)" "unprognostic (6.62e-3)" "unprognostic (1.91e-2)" "unprognostic (1.79e-1)" "unprognostic (1.20e-1)" "unprognostic (7.95e-2)" "unprognostic (2.14e-1)" "unprognostic (1.12e-1)" "unprognostic (2.19e-1)" "unprognostic (2.09e-2)" "unprognostic (3.35e-2)" 0.5 0.3 0.4 97.2 0.3 0.0 0.4 0.3 0.3 0.3 1.2 0.0 0.0 0.0 0.3 0.0 2.8 0.3 0.3 0.3 0.4 0.4 1.4 0.4 2.0 72.8 0.4 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.5 0.9 0.0 6.0 0.0 0.4 0.3 11.5 0.0 0.4 63.4 1.4 0.5 0.0 6.5 0.7 0.3 56.3 0.6 0.3 16.2 0.0 0.2 0.0 0.0 1.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 11.5 0.0 1.9 0.2 0.0 0.2 4.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 13.3 0.7 0.5 0.0 16.2 1.8 1.6 0.2 0.0 0.0 0.0 0.0 1.1 0.4 0.3 0.3 0.3 0.4 0.4 0.4 0.0 0.0 0.0 CREG2 ENSG00000175874 "Cellular repressor of E1A stimulated genes 2" Q8IUH2 2 101345551-101387595 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 56.0" "Cell line enhanced" "Detected in some" "CACO-2: 4.1;CAPAN-2: 2.4;HaCaT: 10.7;HeLa: 4.1;PC-3: 4.3;RT4: 2.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "T-reg: 2.6" "Lineage enriched" "Detected in single" 5 "T-cells: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038224 Enhanced "Secreted in brain" "HPA038224: AB_10673167" "unprognostic (5.09e-2)" "unprognostic (3.78e-3)" "unprognostic (4.10e-3)" "unprognostic (8.15e-3)" "unprognostic (5.63e-3)" "unprognostic (9.68e-3)" "unprognostic (4.52e-8)" "unprognostic (3.86e-4)" "unprognostic (1.39e-1)" "unprognostic (6.49e-2)" "unprognostic (1.90e-2)" "unprognostic (7.69e-2)" "unprognostic (5.41e-3)" "unprognostic (4.44e-2)" "unprognostic (2.91e-1)" "unprognostic (8.26e-3)" "unprognostic (7.77e-2)" 0.8 0.9 12.6 0.8 13.8 0.9 0.8 0.2 56.0 0.9 0.8 1.0 0.0 0.9 0.8 0.8 0.8 1.1 0.9 0.9 17.2 4.4 0.9 0.8 0.8 0.8 3.3 16.6 0.9 0.8 0.8 0.2 0.9 7.2 0.8 0.9 0.0 0.8 0.8 0.8 0.8 0.9 0.8 1.2 0.8 0.8 0.9 0.5 0.0 0.8 0.0 0.8 0.8 0.6 0.2 0.3 0.5 0.0 0.0 2.6 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 2.4 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.6 0.2 0.0 0.4 0.1 0.0 0.0 0.1 0.1 4.3 0.0 0.0 0.0 0.0 2.9 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.3 2.6 0.0 12.6 13.8 0.2 29.7 17.2 4.4 3.3 16.6 7.2 0.5 CRH "CRF, CRH1" ENSG00000147571 "Corticotropin releasing hormone" P06850 8 66176382-66178725 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 209.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;SCLC-21H: 2.5" "Cancer enriched" "Detected in some" 28 "urothelial cancer: 34.5" "Region enhanced" "Detected in many" "hypothalamus: 28.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062111 Uncertain "Secreted to blood" 10000 "HPA062111: " "unprognostic (1.62e-1)" "unprognostic (9.68e-2)" "unprognostic (1.00e-1)" "unprognostic (9.55e-2)" "unprognostic (7.22e-3)" 2.7 0.2 4.1 0.2 2.1 0.3 0.2 0.0 6.7 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 2.7 28.4 0.2 0.2 0.3 0.2 0.4 1.1 0.2 1.3 0.2 0.1 209.9 13.8 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.2 0.5 0.1 0.2 0.4 0.9 0.0 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 2.1 0.0 6.7 2.7 28.4 0.4 1.1 13.8 0.0 CRIP2 "CRP2, ESP1" ENSG00000182809 "Cysteine rich protein 2" P52943 14 105472962-105480170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "heart muscle: 180.3" "Cell line enhanced" "Detected in many" "A549: 37.7;EFO-21: 38.6;HUVEC TERT2: 36.1;MCF7: 55.4;SK-BR-3: 43.4;T-47d: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 24.0;T-reg: 29.2" "Group enriched" "Detected in many" 19 "B-cells: 17.9;T-cells: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042664 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" 490000 Nucleoli "Nucleoplasm, Plasma membrane" "HPA042664: AB_10797017" "unprognostic (2.68e-1)" "unprognostic (6.53e-3)" "unprognostic (2.11e-3)" "unprognostic (2.19e-1)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.63e-2)" "unprognostic (2.56e-1)" "unprognostic (3.20e-3)" "unprognostic (9.68e-2)" "unprognostic (6.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.25e-2)" "unprognostic (2.35e-2)" "unprognostic (2.39e-2)" "unprognostic (8.26e-3)" 22.8 11.5 27.5 9.1 24.6 1.6 16.9 3.6 30.3 20.2 10.1 9.4 33.7 7.9 15.3 30.6 25.6 29.5 24.5 180.3 22.6 18.7 20.0 6.9 28.5 9.3 13.5 16.9 12.5 12.6 4.3 20.4 29.1 10.4 14.6 3.8 8.8 18.4 28.0 10.7 28.4 9.1 24.9 10.3 13.0 11.3 10.9 7.8 1.0 17.8 23.8 13.3 23.8 17.5 17.9 0.9 0.2 0.5 1.2 29.2 3.4 0.4 37.7 5.5 15.0 0.9 3.9 1.6 1.7 0.4 0.5 0.1 1.1 7.0 0.0 38.6 12.3 21.6 0.7 9.2 0.0 0.2 0.2 0.0 23.7 14.3 4.0 0.0 3.2 1.9 0.8 0.9 5.1 36.1 0.0 0.3 5.4 55.4 0.1 0.1 1.5 22.7 0.0 0.7 1.6 25.4 0.1 8.4 20.9 2.4 43.4 0.3 37.2 0.0 14.0 12.5 5.9 0.3 7.0 0.1 0.1 0.1 3.6 0.0 25.2 0.0 0.5 0.0 2.4 0.2 2.3 14.4 24.0 5.3 0.9 17.9 5.9 1.6 0.2 1.2 0.1 0.1 29.2 3.4 27.5 24.6 3.6 30.3 22.6 18.7 13.5 16.9 10.4 7.8 CRISP1 "AEGL1, ARP, CRISP-1, HSCRISP1D, HSCRISP1G, HUMARP" ENSG00000124812 "Cysteine rich secretory protein 1" P54107 6 49834257-49877096 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "epididymis: 203.0" "Cell line enhanced" "Detected in some" "BEWO: 2.8;NB-4: 7.1;RPMI-8226: 2.0;SH-SY5Y: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028445, HPA030534" Enhanced "Secreted in male reproductive system" "HPA028445: AB_10670428, HPA030534: " 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.0 48.8 0.0 0.2 203.0 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.4 8.8 0.2 0.2 0.6 0.0 0.2 0.2 0.2 7.4 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 CRISP2 "CRISP-2, CT36, GAPDL5, TPX1" ENSG00000124490 "Cysteine rich secretory protein 2" P16562 6 49692358-49713590 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 135.5" "Cell line enhanced" "Detected in some" "HEL: 2.9;U-2 OS: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031248 Enhanced "Secreted in male reproductive system" "HPA031248: AB_10602211" "unprognostic (1.10e-1)" "unprognostic (1.51e-1)" "unprognostic (1.72e-2)" "unprognostic (7.38e-2)" "unprognostic (2.35e-2)" "unprognostic (9.23e-3)" "unprognostic (4.05e-2)" 0.0 0.0 0.0 0.0 0.3 3.5 0.0 0.0 0.1 0.3 0.0 0.1 3.2 0.0 0.0 7.0 0.7 4.4 1.7 0.0 0.2 0.1 0.2 0.0 0.4 0.0 0.0 0.1 0.1 0.7 0.0 0.3 0.0 0.1 0.1 0.0 0.1 3.4 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 135.5 0.0 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.0 CROCC "ROLT, rootletin" ENSG00000058453 "Ciliary rootlet coiled-coil, rootletin" Q5TZA2 1 16740273-16972979 "Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 135.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021191, HPA021762" Enhanced Supported "Plasma membrane,Centrosome" "Plasma membrane, Centrosome" "HPA021191: AB_1856395, HPA021762: AB_1856396" "unprognostic (9.07e-3)" "unprognostic (9.03e-2)" "unprognostic (6.04e-2)" "prognostic favourable (8.34e-5)" "unprognostic (3.27e-1)" "unprognostic (1.25e-3)" "unprognostic (1.42e-3)" "prognostic favourable (7.92e-4)" "unprognostic (2.05e-1)" "unprognostic (7.75e-2)" "unprognostic (3.36e-3)" "unprognostic (5.75e-2)" "prognostic unfavourable (7.97e-4)" "unprognostic (1.58e-1)" "unprognostic (9.83e-2)" "unprognostic (6.05e-2)" "unprognostic (1.76e-3)" 5.0 3.8 3.2 3.2 7.0 2.1 2.5 12.9 3.0 3.9 2.8 5.4 2.2 2.4 5.1 2.4 3.2 9.9 2.3 2.1 4.6 3.5 2.4 1.8 3.9 3.2 2.1 2.5 5.0 4.2 3.0 3.6 2.2 11.3 3.3 0.6 30.6 135.2 2.9 8.2 14.4 3.1 1.8 2.3 6.4 3.5 1.9 4.3 2.1 2.5 2.3 1.8 2.9 3.8 1.1 0.6 1.7 0.8 1.3 2.8 0.6 4.1 1.7 3.2 3.2 2.3 2.1 1.3 3.0 1.0 1.0 1.1 0.2 1.9 10.9 2.8 1.2 4.9 0.8 2.2 0.1 0.9 5.8 5.0 5.3 0.8 3.9 0.3 5.1 1.8 5.2 0.9 0.9 1.6 0.7 2.8 0.3 3.5 3.3 1.2 11.6 2.7 3.1 4.2 3.7 0.7 1.1 9.8 10.6 3.2 2.1 9.7 4.2 1.4 4.3 2.8 3.7 7.0 2.3 5.0 3.6 2.2 2.7 0.7 3.3 0.0 0.4 1.7 1.6 0.8 2.8 0.7 1.3 1.3 0.2 1.1 1.1 0.9 0.1 1.3 0.3 0.6 1.3 0.6 3.2 7.0 12.9 3.0 4.6 3.5 2.1 2.5 11.3 4.3 CRP PTX1 ENSG00000132693 "C-reactive protein" P02741 1 159712289-159714589 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "liver: 1139.7" "Cell line enhanced" "Detected in some" "EFO-21: 8.0;HDLM-2: 7.6;U-2 OS: 5.4;U-266/84: 12.8" "Cancer enriched" "Detected in some" 13 "liver cancer: 1010.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005036, HPA027367, HPA027396" Supported Approved "Nucleoplasm,Vesicles,Intermediate filaments" "Secreted to blood" 1832500000 5400000000 "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217" "unprognostic (3.74e-1)" "unprognostic (5.31e-2)" "unprognostic (2.97e-2)" "unprognostic (1.27e-1)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" "unprognostic (3.13e-1)" "prognostic unfavourable (4.17e-10)" "unprognostic (3.39e-2)" "unprognostic (3.48e-1)" "unprognostic (5.60e-2)" "unprognostic (6.61e-2)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 17.2 0.1 0.1 0.0 0.1 1139.7 0.1 0.1 0.1 0.1 0.1 7.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.3 0.0 0.0 0.0 7.6 0.0 0.3 0.0 0.0 0.0 0.3 0.1 1.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.1 0.9 0.0 12.8 2.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CRTAM CD355 ENSG00000109943 "Cytotoxic and regulatory T cell molecule" O95727 11 122838500-122872639 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 140.8" "Cell line enriched" "Detected in single" 34 "SCLC-21H: 17.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 24 "cerebellum: 140.8" "Cell type enhanced" "Detected in many" "NK-cell: 25.7" "Group enriched" "Detected in many" 5 "NK-cells: 25.7;T-cells: 16.7" "Region enriched" "Detected in single" 44 "cerebellum: 115.2" "Low region specificity" "Detected in all" 3200000 "unprognostic (3.51e-3)" "unprognostic (6.73e-4)" "unprognostic (1.33e-2)" "unprognostic (3.73e-3)" "unprognostic (2.40e-2)" "unprognostic (5.25e-4)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (5.27e-2)" "unprognostic (1.71e-1)" "unprognostic (5.49e-3)" "unprognostic (2.32e-1)" "unprognostic (1.83e-4)" "unprognostic (6.01e-2)" "unprognostic (4.26e-2)" "unprognostic (3.87e-2)" "unprognostic (6.59e-2)" 0.4 0.3 0.3 2.7 0.4 1.9 0.4 140.8 0.4 0.3 0.4 0.2 0.1 0.4 0.8 0.4 0.3 0.3 1.8 0.3 0.3 0.3 0.3 1.0 2.2 10.6 0.4 0.1 0.3 0.3 0.0 0.3 0.2 5.8 0.3 0.5 0.3 0.7 0.1 0.3 0.3 1.3 0.2 1.2 4.4 0.7 0.3 0.1 3.3 0.3 0.2 4.3 1.1 0.3 0.1 1.7 0.6 4.4 25.7 16.7 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 2.2 0.2 6.7 2.7 6.5 0.0 0.7 13.5 1.7 0.1 2.2 16.7 0.6 25.7 4.4 0.1 0.0 2.8 0.3 0.4 140.8 0.4 0.3 0.3 0.4 0.1 5.8 0.1 CRX "CORD2, CRD, LCA7, OTX3" ENSG00000105392 "Cone-rod homeobox" O43186 19 47819779-47843330 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding" "Cone-rod dystrophy, Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 42 "retina: 125.2" "Cell line enhanced" "Detected in some" "NTERA-2: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036762, HPA036763" Enhanced "HPA036762: AB_10673663, HPA036763: AB_10670922" "unprognostic (1.09e-2)" "unprognostic (1.25e-2)" "unprognostic (1.58e-1)" "unprognostic (2.56e-2)" "unprognostic (3.22e-2)" "unprognostic (2.69e-1)" "unprognostic (2.77e-2)" "unprognostic (3.71e-1)" "unprognostic (3.82e-2)" "unprognostic (1.33e-2)" "unprognostic (1.95e-10)" "unprognostic (9.27e-2)" "unprognostic (1.82e-2)" "unprognostic (8.94e-2)" "unprognostic (1.78e-3)" 0.1 0.1 0.1 0.3 0.1 1.0 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.2 0.2 0.4 0.1 0.5 0.3 0.3 0.2 0.1 1.8 0.1 0.2 0.2 0.0 0.4 0.7 0.0 0.1 0.0 0.9 0.1 0.0 125.2 0.4 0.0 2.9 0.9 0.3 0.0 0.1 0.1 0.2 1.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 1.3 1.0 2.9 0.6 0.9 0.6 0.3 0.2 0.6 0.3 0.2 0.1 0.0 0.7 0.5 0.0 0.1 0.0 0.3 0.5 0.4 0.3 0.0 0.5 0.2 0.0 0.1 0.2 0.3 0.6 0.7 0.6 0.0 0.7 0.4 0.0 0.0 0.1 0.1 0.0 0.2 0.9 0.0 0.4 0.2 0.8 3.1 0.0 0.4 0.3 0.0 0.0 0.7 0.4 0.3 0.6 0.7 0.0 0.3 0.5 0.0 1.1 0.3 0.3 0.9 0.6 0.2 0.4 0.1 0.3 0.3 2.1 0.6 0.5 0.4 0.3 0.5 0.6 0.4 0.4 0.2 1.3 0.6 0.5 2.9 0.9 0.4 1.0 0.3 0.3 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.0 0.9 0.0 CRYAA "CRYA1, HSPB4" ENSG00000160202 "Crystallin alpha A" P02489 21 43169008-43172805 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Chaperone, Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 45.5" "Cell line enriched" "Detected in single" 140 "Hep G2: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037737, HPA038430" Supported Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA037737: , HPA038430: " "unprognostic (3.68e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 CRYAA2 ENSG00000276076 "Crystallin alpha A2" 21 6560714-6564489 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "kidney: 34.4" "Cell line enriched" "Detected in single" 200 "Hep G2: 28.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037737, HPA038430" Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA037737: , HPA038430: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.3 0.0 0.0 CRYBB2 "CCA2, CRYB2, CRYB2A" ENSG00000244752 "Crystallin beta B2" P43320 22 25219522-25231869 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 26.9" "Cell line enhanced" "Detected in some" "HeLa: 5.1;THP-1: 1.7;U-138 MG: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA043749 Supported Approved Nucleoplasm Nucleoplasm "HPA043749: " "unprognostic (1.28e-1)" "unprognostic (2.71e-2)" "unprognostic (4.09e-2)" "unprognostic (1.95e-1)" "unprognostic (5.06e-2)" "unprognostic (7.04e-2)" "unprognostic (8.57e-3)" "unprognostic (9.51e-3)" "unprognostic (8.55e-2)" "unprognostic (2.46e-2)" "unprognostic (4.13e-2)" "unprognostic (2.01e-1)" "unprognostic (1.73e-5)" "unprognostic (1.44e-2)" "unprognostic (1.60e-1)" "unprognostic (3.28e-1)" "unprognostic (9.89e-3)" 0.8 0.7 2.0 0.5 3.7 0.1 1.7 0.5 1.8 1.0 1.3 0.5 0.5 0.8 0.5 1.8 1.1 0.4 0.5 0.6 2.9 1.5 0.5 0.5 1.4 0.5 0.8 0.5 0.5 0.5 0.0 2.6 0.5 0.9 0.9 1.5 26.9 1.2 0.5 0.6 0.4 1.0 1.0 0.5 0.5 0.2 4.0 0.5 0.5 1.7 0.5 0.5 0.5 0.5 1.4 1.3 0.5 1.1 1.7 1.4 0.7 0.2 0.5 0.1 0.7 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.6 0.0 0.8 0.0 0.0 0.2 0.0 1.1 0.6 5.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.3 1.2 0.3 0.6 0.0 0.2 0.1 0.6 0.0 0.2 0.0 0.8 1.7 0.0 2.9 0.7 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.5 0.8 0.4 1.4 0.6 0.6 1.4 1.2 0.7 1.1 1.0 1.1 1.2 0.1 1.7 1.1 1.3 0.4 0.7 2.0 3.7 0.5 1.8 2.9 1.5 0.8 0.5 0.9 0.5 CRYGC CRYG3 ENSG00000163254 "Crystallin gamma C" P07315 2 208128137-208129830 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 5.4" "Cell line enhanced" "Detected in some" "AF22: 1.0;CACO-2: 1.0;EFO-21: 2.0;U-2 OS: 1.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.8;ovarian cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043386 Supported "HPA043386: " "unprognostic (1.89e-1)" "unprognostic (2.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 CRYGD CRYG4 ENSG00000118231 "Crystallin gamma D" P07320 2 208121607-208124501 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "ovary: 17.7" "Cell line enriched" "Detected in single" 19 "HEL: 15.0" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041269, HPA043386" Supported Approved "Plasma membrane,Intermediate filaments,Cytokinetic bridge" "Plasma membrane, Intermediate filaments" "Cytokinetic bridge" "HPA041269: , HPA043386: " "unprognostic (4.49e-2)" "unprognostic (2.64e-1)" "unprognostic (3.62e-1)" 0.2 0.2 4.2 0.2 2.0 2.3 0.2 0.0 2.5 0.2 0.2 0.3 0.0 0.4 0.2 0.2 0.3 0.3 0.2 0.6 2.1 4.3 0.2 0.2 0.2 0.2 4.0 1.6 17.7 0.2 0.2 0.4 0.5 1.9 2.0 0.2 2.1 0.2 0.2 0.2 0.2 0.4 0.2 0.4 0.2 0.5 1.4 0.5 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.2 2.0 0.0 2.5 2.1 4.3 4.0 1.6 1.9 0.5 CSH1 "CSA, CSMT, FLJ75407, hCS-A, PL" ENSG00000136488 "Chorionic somatomammotropin hormone 1" P0DML2 17 63894909-63896661 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "placenta: 450.4" "Cell line enriched" "Detected in some" 8 "BEWO: 15.9" "Cancer enriched" "Detected in single" 8 "testis cancer: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026374, HPA043715" Enhanced "Secreted to blood" "CAB026374: , HPA043715: " "unprognostic (6.99e-2)" 2.6 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.0 15.7 450.4 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 1.9 0.1 1.0 0.9 0.8 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 CSH2 "CS-2, CSB, hCS-B" ENSG00000213218 "Chorionic somatomammotropin hormone 2" P0DML3 17 63872012-63873766 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "placenta: 246.2" "Cell line enriched" "Detected in single" 20 "BEWO: 13.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043715 Supported "Secreted to blood" "HPA043715: " "unprognostic (1.68e-1)" "unprognostic (1.85e-1)" "unprognostic (1.86e-1)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 246.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSMD3 ENSG00000164796 "CUB and Sushi multiple domains 3" Q7Z407 8 112222928-113437099 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 26.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 2.3;hTCEpi: 2.3;hTERT-HME1: 1.6;LHCN-M2: 3.3;RH-30: 2.1;SCLC-21H: 1.4;U-2 OS: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029007 Uncertain "HPA029007: AB_10601802" "unprognostic (2.26e-1)" "unprognostic (2.16e-2)" "unprognostic (2.83e-2)" "unprognostic (5.97e-2)" "unprognostic (3.44e-2)" "unprognostic (1.26e-2)" "unprognostic (3.54e-4)" "unprognostic (2.48e-1)" "unprognostic (2.54e-1)" "unprognostic (2.89e-2)" "unprognostic (2.33e-2)" "unprognostic (5.03e-10)" "unprognostic (1.95e-1)" "unprognostic (4.14e-3)" "unprognostic (1.91e-2)" "unprognostic (1.74e-3)" 1.0 1.0 26.6 1.0 21.9 1.0 1.0 6.0 18.3 1.6 1.1 2.2 0.0 1.1 1.1 1.1 1.0 2.3 1.0 1.0 14.2 6.7 1.1 1.0 1.1 1.0 3.0 15.8 1.0 1.0 1.0 5.7 1.0 10.9 2.1 1.2 0.0 1.0 2.1 1.0 1.0 1.2 1.1 3.6 2.4 1.3 5.0 7.0 0.0 1.0 0.0 1.0 1.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 2.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.3 0.0 1.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 21.9 6.0 18.3 14.2 6.7 3.0 15.8 10.9 7.0 CSN1S1 "CASA, CSN1" ENSG00000126545 "Casein alpha s1" P47710 4 69931081-69946574 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Milk protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "breast: 184.8" "Cell line enhanced" "Detected in some" "ASC diff: 2.4;HL-60: 1.4;U-266/70: 1.4" "Cancer enriched" "Detected in some" 10 "breast cancer: 17.1" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "NK-cell: 1.6;plasmacytoid DC: 3.2" "Group enriched" "Detected in many" 11 "dendritic cells: 3.2;NK-cells: 1.6" "HPA035659, HPA057031" Enhanced "Secreted in female reproductive system" "HPA035659: AB_10696356, HPA057031: AB_2683315" "unprognostic (1.52e-2)" "unprognostic (1.01e-1)" 44.7 0.0 0.0 0.0 0.1 0.0 184.8 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 1.2 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.2 0.1 1.6 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 1.6 0.0 3.2 0.0 0.2 0.0 0.1 0.0 0.9 0.1 1.2 0.6 0.0 0.1 0.0 CSN2 CASB ENSG00000135222 "Casein beta" P05814 4 69955256-69961007 "Predicted secreted proteins" "Milk protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "breast: 82.6" "Cell line enriched" "Detected in single" 5 "U-266/70: 1.4" "Cancer enriched" "Detected in single" 156 "breast cancer: 75.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041036 Supported "Secreted in female reproductive system" "HPA041036: AB_10793865" 0.0 0.0 0.0 0.0 0.0 0.0 82.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSNKA2IP ENSG00000283434 "Casein kinase 2 subunit alpha' interacting protein" 3 88338413-88467562 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 24 "testis: 22.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSPG5 NGC ENSG00000114646 "Chondroitin sulfate proteoglycan 5" O95196 3 47562239-47580792 "Predicted membrane proteins" "Differentiation, Growth regulation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 81.1" "Cell line enhanced" "Detected in many" "AF22: 26.2;HEK 293: 7.2" "Cancer enriched" "Detected in many" 19 "glioma: 48.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049529, HPA067818, HPA071779" Enhanced Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA049529: , HPA067818: , HPA071779: " "unprognostic (2.68e-1)" "unprognostic (2.11e-1)" "unprognostic (8.87e-2)" "unprognostic (3.12e-2)" "unprognostic (2.88e-1)" "unprognostic (7.66e-2)" "unprognostic (5.05e-4)" "unprognostic (1.40e-1)" "unprognostic (3.82e-1)" "prognostic favourable (2.14e-4)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (3.41e-4)" "unprognostic (8.08e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" 1.8 1.8 30.6 1.3 25.8 1.1 1.6 7.2 81.1 1.3 1.4 6.7 0.0 1.1 1.3 1.2 1.3 1.4 1.2 1.3 20.2 17.1 1.2 1.2 1.7 1.3 12.9 12.6 1.1 1.4 1.1 0.2 1.8 5.6 1.5 1.3 8.0 1.1 1.1 1.5 1.6 1.3 1.4 6.2 1.1 1.2 2.2 4.1 0.0 1.3 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 26.2 4.6 0.5 0.0 0.7 0.5 0.1 1.0 0.3 0.2 1.6 0.1 2.0 0.0 0.4 2.2 0.2 0.2 0.0 7.2 0.4 1.1 0.0 0.0 0.3 1.2 0.0 0.9 0.1 0.0 0.0 5.1 0.2 0.1 1.2 0.2 0.3 2.5 2.7 0.4 0.2 0.5 1.1 0.9 2.8 1.3 1.6 3.3 0.1 1.2 2.4 0.2 0.0 5.4 0.0 1.5 0.6 0.6 0.0 0.4 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 25.8 7.2 22.4 20.2 17.1 12.9 12.6 5.6 4.1 CST1 ENSG00000170373 "Cystatin SN" P01037 20 23747553-23751268 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 46 "salivary gland: 704.2" "Cell line enriched" "Detected in some" 5 "RT4: 153.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026769, HPA043706, HPA044763" Enhanced "Secreted to digestive system" 6600000 "CAB026769: , HPA043706: , HPA044763: " "prognostic favourable (4.00e-4)" "unprognostic (2.47e-1)" "unprognostic (3.11e-1)" "unprognostic (3.62e-2)" "unprognostic (1.99e-1)" "unprognostic (5.27e-2)" "unprognostic (1.99e-1)" "unprognostic (1.56e-1)" "unprognostic (1.83e-1)" "unprognostic (1.44e-1)" "unprognostic (2.34e-2)" "unprognostic (1.39e-1)" "unprognostic (8.26e-2)" "unprognostic (9.58e-2)" "unprognostic (2.58e-1)" "unprognostic (9.00e-2)" "unprognostic (9.91e-3)" 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 4.8 0.1 0.1 0.3 7.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.0 0.1 0.1 0.1 15.2 0.0 0.1 704.2 0.1 0.1 4.0 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.3 1.6 0.1 0.0 0.2 0.0 0.7 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 153.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 CST11 "CST8L, CTES2, dJ322G13.6" ENSG00000125831 "Cystatin 11" Q9H112 20 23450403-23452857 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "epididymis: 76.3" "Cell line enhanced" "Detected in single" "RT4: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053399 Enhanced "Secreted in male reproductive system" "HPA053399: " "unprognostic (9.42e-2)" "unprognostic (2.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 76.3 0.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.0 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CST2 ENSG00000170369 "Cystatin SA" P09228 20 23823769-23826731 "Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 230 "salivary gland: 1538.3" "Cell line enriched" "Detected in some" 12 "RT4: 38.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB024963, HPA043706, HPA044763" Enhanced "Secreted to digestive system" 110000 "CAB024963: , HPA043706: , HPA044763: " "unprognostic (1.57e-2)" "unprognostic (3.23e-2)" "unprognostic (1.04e-1)" "unprognostic (3.10e-1)" "unprognostic (1.64e-2)" "unprognostic (5.17e-3)" "unprognostic (1.28e-2)" "unprognostic (2.75e-3)" "unprognostic (2.73e-1)" "unprognostic (4.82e-3)" "unprognostic (6.43e-3)" "unprognostic (2.51e-1)" "unprognostic (4.58e-11)" "unprognostic (1.29e-3)" "unprognostic (3.22e-1)" "unprognostic (4.30e-1)" "unprognostic (1.71e-1)" 1.6 6.6 0.1 0.1 0.1 0.0 0.1 0.3 0.1 3.8 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 1.3 0.1 0.1 0.1 0.1 0.7 0.0 5.9 0.7 0.1 2.6 0.0 0.1 1538.3 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.8 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 38.1 0.0 0.0 0.0 0.0 3.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CST4 ENSG00000101441 "Cystatin S" P01036 20 23685640-23689040 "Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 94 "salivary gland: 705.3" "Group enriched" "Detected in some" 4 "CACO-2: 6.6;RT4: 16.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043706, HPA044763" Supported "Secreted to digestive system" 2700000 "HPA043706: , HPA044763: " "unprognostic (2.80e-1)" "unprognostic (7.88e-2)" "unprognostic (2.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.59e-1)" "prognostic unfavourable (4.98e-5)" "unprognostic (1.00e-2)" "unprognostic (9.52e-2)" "unprognostic (2.11e-2)" "unprognostic (2.31e-1)" "unprognostic (7.95e-2)" "prognostic favourable (2.88e-4)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 2.5 0.1 0.1 0.0 1.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.0 0.1 0.1 0.1 7.5 0.0 0.1 705.3 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 4.7 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 6.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 16.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CST5 ENSG00000170367 "Cystatin D" P28325 20 23875935-23879750 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 268 "salivary gland: 1065.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;RPTEC TERT1: 3.7;RT4: 1.9;U-2 OS: 1.6" "Cancer enriched" "Detected in many" 5 "breast cancer: 17.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB024944, HPA061449" Enhanced "Secreted to digestive system" "CAB024944: , HPA061449: " "unprognostic (2.43e-1)" "unprognostic (8.83e-2)" "unprognostic (3.20e-1)" "unprognostic (3.19e-1)" "unprognostic (1.51e-2)" "unprognostic (4.73e-1)" "unprognostic (4.31e-2)" "unprognostic (1.76e-2)" "unprognostic (2.32e-1)" "unprognostic (1.35e-1)" "unprognostic (4.83e-3)" "unprognostic (5.14e-2)" "unprognostic (2.31e-1)" 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.8 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1065.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.8 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.9 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.7 1.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.3 0.8 0.0 0.6 0.9 0.3 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CST6 ENSG00000175315 "Cystatin E/M" Q15828 11 66011841-66013505 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 124.5" "Group enriched" "Detected in some" 6 "A-431: 26.2;CAPAN-2: 73.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 171.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB019316, HPA044963" Enhanced Approved "Plasma membrane,Cytosol" "Secreted in other tissues" 110000000 "Plasma membrane" Cytosol "CAB019316: , HPA044963: " "unprognostic (3.01e-2)" "unprognostic (5.10e-2)" "unprognostic (1.14e-1)" "unprognostic (3.59e-2)" "unprognostic (5.00e-2)" "unprognostic (2.60e-1)" "unprognostic (1.65e-1)" "unprognostic (8.38e-2)" "unprognostic (5.02e-1)" "unprognostic (8.89e-3)" "unprognostic (1.29e-3)" "unprognostic (1.46e-1)" "unprognostic (1.74e-3)" "unprognostic (5.89e-3)" "unprognostic (1.83e-1)" "unprognostic (1.64e-2)" "unprognostic (2.59e-2)" 0.6 0.2 0.1 1.5 0.1 0.2 8.7 0.4 0.2 5.5 0.2 0.0 1.4 0.1 0.3 0.8 11.3 4.3 0.7 2.4 0.1 0.2 1.0 0.1 27.2 1.2 0.1 0.0 1.3 0.2 0.5 0.4 26.5 0.2 0.9 0.1 1.1 1.3 26.5 0.7 124.5 0.2 0.2 0.2 0.2 0.2 1.0 0.0 2.8 14.6 13.6 4.4 0.5 3.7 0.4 0.9 0.0 1.6 0.0 0.2 0.7 26.2 0.0 0.0 0.1 0.0 0.0 7.8 0.2 0.0 0.0 0.0 0.1 73.1 0.0 0.4 0.9 0.9 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 7.3 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.7 0.1 0.1 0.4 0.1 0.1 0.2 0.1 0.0 0.2 0.0 CST8 "CRES, CTES5" ENSG00000125815 "Cystatin 8" O60676 20 23491101-23496018 "Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 31.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CST9 "CLM, CTES7A" ENSG00000173335 "Cystatin 9" Q5W186 20 23602410-23605876 "Predicted secreted proteins" "Antimicrobial, Protease inhibitor, Thiol protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 11 "breast: 6.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 37 "breast cancer: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA029190 Uncertain "Secreted - unknown location" "HPA029190: AB_10602804" "unprognostic (2.06e-2)" "unprognostic (2.21e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CST9L "bA218C14.1, CTES7B" ENSG00000101435 "Cystatin 9 like" Q9H4G1 20 23564732-23568749 "Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 49.8" "Cell line enriched" "Detected in single" 20 "HEL: 5.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" "unprognostic (2.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSTL1 "CTES1, dJ322G13.4" ENSG00000125823 "Cystatin like 1" Q9H114 20 23439685-23444930 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 20 "testis: 7.5" "Cell line enriched" "Detected in single" 5 "MCF7: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Secreted in male reproductive system" "unprognostic (1.14e-1)" "unprognostic (1.54e-1)" "unprognostic (3.25e-3)" "unprognostic (2.04e-1)" "unprognostic (6.58e-2)" "unprognostic (2.68e-1)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (3.63e-1)" "unprognostic (2.97e-1)" "unprognostic (6.87e-2)" "unprognostic (2.35e-1)" "unprognostic (5.36e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.2 7.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A1 "CT45-1, CT45.1" ENSG00000268940 "Cancer/testis antigen family 45 member A1" Q5HYN5 X 135713453-135723539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 12.5" "Group enriched" "Detected in some" 7 "HMC-1: 68.4;Karpas-707: 31.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " "unprognostic (6.58e-3)" "unprognostic (2.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.4 0.0 0.0 0.0 0.0 0.0 0.5 31.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 6.4 0.0 0.0 0.5 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A10 ENSG00000269586 "Cancer/testis antigen family 45 member A10" P0DMU9 X 135881063-135889086 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 14.1" "Cell line enhanced" "Detected in some" "AN3-CA: 32.5;K-562: 9.7;Karpas-707: 36.1;U-266/84: 30.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " "unprognostic (3.55e-1)" "unprognostic (7.08e-3)" "unprognostic (2.08e-1)" 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 9.7 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 7.1 30.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A2 "CT45-2, CT45.2" ENSG00000271449 "Cancer/testis antigen family 45 member A2" Q5DJT8 X 135811668-135820012 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 42 "testis: 4.2" "Cell line enriched" "Detected in some" 4 "HMC-1: 32.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.0 0.0 0.0 0.0 0.0 0.0 3.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A3 "CT45-3, CT45-4, CT45.3, CT45.4, CT45A4" ENSG00000269096 "Cancer/testis antigen family 45 member A3" Q8NHU0 X 135759846-135768191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 15.6" "Cell line enhanced" "Detected in some" "HMC-1: 29.2;T-47d: 17.1;U-266/84: 88.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.0 0.6 0.0 0.0 0.1 88.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A5 "CT45-5, CT45.5" ENSG00000228836 "Cancer/testis antigen family 45 member A5" P0DMU8 X 135777130-135785298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 10.5" "Cell line enhanced" "Detected in some" "HMC-1: 17.9;Karpas-707: 12.5;U-266/84: 64.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 1.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.4 0.0 0.0 0.9 64.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A6 "CT45-6, CT45.6" ENSG00000278289 "Cancer/testis antigen family 45 member A6" P0DMU7 X 135794706-135802656 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.9" "Cell line enriched" "Detected in some" 9 "U-266/84: 46.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A7 ENSG00000273696 "Cancer/testis antigen family 45 member A7" P0DMV0 X 135829247-135837268 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "testis: 4.1" "Cell line enhanced" "Detected in some" "HMC-1: 4.0;Karpas-707: 3.4;PC-3: 1.0;THP-1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A8 ENSG00000278085 "Cancer/testis antigen family 45 member A8" P0DMV1 X 135846499-135854538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 16 "testis: 3.9" "Group enriched" "Detected in some" 5 "AN3-CA: 13.8;HMC-1: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A9 ENSG00000270946 "Cancer/testis antigen family 45 member A9" P0DMV2 X 135863776-135871812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 17 "testis: 4.0" "Cell line enriched" "Detected in some" 9 "HMC-1: 54.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A1 CT47.1 ENSG00000236371 "Cancer/testis antigen family 47, member A1" Q5JQC4 X 120982476-120985788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "testis: 4.2" "Cell line enriched" "Detected in single" 8 "U-266/70: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported "HPA042483: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A10 CT47.10 ENSG00000224089 "Cancer/testis antigen family 47, member A10" Q5JQC4 X 120938701-120942023 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported "HPA042483: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A11 CT47.11 ENSG00000226929 "Cancer/testis antigen family 47, member A11" Q5JQC4 X 120933840-120937158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "testis: 6.7" "Group enriched" "Detected in some" 7 "EFO-21: 1.6;U-87 MG: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported "HPA042483: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A12 CT47.12 ENSG00000226685 "Cancer/testis antigen family 47, member A12" Q5JQC4 X 120930250-120932301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 5.4" "Cell line enhanced" "Detected in some" "U-2197: 1.1;U-266/70: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported "HPA042483: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.2 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 3.1 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A2 CT47.2 ENSG00000242362 "Cancer/testis antigen family 47, member A2" Q5JQC4 X 120977606-120980928 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported "HPA042483: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A3 CT47.3 ENSG00000236126 "Cancer/testis antigen family 47, member A3" Q5JQC4 X 120972746-120976068 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported "HPA042483: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A4 CT47.4 ENSG00000230594 "Cancer/testis antigen family 47, member A4" Q5JQC4 X 120967886-120971208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported "HPA042483: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A5 CT47.5 ENSG00000237957 "Cancer/testis antigen family 47, member A5" Q5JQC4 X 120963026-120966348 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported "HPA042483: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A6 CT47.6 ENSG00000226023 "Cancer/testis antigen family 47, member A6" Q5JQC4 X 120958165-120961487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 3.1" "Group enriched" "Detected in some" 12 "U-266/70: 4.1;U-266/84: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported "HPA042483: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A7 CT47.7 ENSG00000228517 "Cancer/testis antigen family 47, member A7" Q5JQC4 X 120953288-120956600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 1.2" "Cell line enhanced" "Detected in single" "U-138 MG: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported "HPA042483: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A8 CT47.8 ENSG00000230347 "Cancer/testis antigen family 47, member A8" Q5JQC4 X 120948422-120951744 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported "HPA042483: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A9 CT47.9 ENSG00000226600 "Cancer/testis antigen family 47, member A9" Q5JQC4 X 120943561-120946883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported "HPA042483: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47B1 CT47.13 ENSG00000236446 "Cancer/testis antigen family 47, member B1" P0C2W7 X 120872603-120875929 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 61 "testis: 10.7" "Cell line enhanced" "Detected in single" "U-266/84: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported "HPA042483: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT55 "CXorf48, FLJ20527" ENSG00000169551 "Cancer/testis antigen 55" Q8WUE5 X 135156536-135171398 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 9.2" "Cell line enriched" "Detected in single" 14 "K-562: 12.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059575 Approved Vesicles "Secreted in male reproductive system" Vesicles "HPA059575: " "unprognostic (6.20e-2)" "unprognostic (1.39e-1)" "unprognostic (8.36e-2)" "unprognostic (5.86e-3)" "unprognostic (3.47e-1)" "unprognostic (2.67e-1)" "unprognostic (4.44e-2)" "unprognostic (1.49e-1)" 0.1 0.2 0.5 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 9.2 0.2 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 12.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.2 0.6 0.8 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CT62 ENSG00000225362 "Cancer/testis antigen 62" P0C5K7 15 71110244-71115494 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 50 "testis: 31.2" "Cell line enhanced" "Detected in some" "HaCaT: 3.4;T-47d: 7.4;U-2197: 5.9" "Group enriched" "Detected in some" 8 "breast cancer: 2.3;prostate cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045306 Uncertain "HPA045306: AB_10960632" "unprognostic (1.55e-1)" "unprognostic (3.53e-3)" "unprognostic (9.17e-2)" "unprognostic (3.55e-1)" "unprognostic (5.49e-2)" "unprognostic (2.16e-2)" "unprognostic (9.27e-3)" "unprognostic (1.02e-1)" "unprognostic (1.46e-1)" "unprognostic (1.45e-1)" "unprognostic (2.95e-5)" "unprognostic (2.89e-2)" "unprognostic (2.03e-1)" "unprognostic (1.01e-2)" "unprognostic (1.52e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 31.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 1.4 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 3.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 1.5 0.0 7.4 0.0 0.9 0.0 0.0 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 CT83 "CXorf61, FLJ20611, FLJ22913, KK-LC-1" ENSG00000204019 "Cancer/testis antigen 83" Q5H943 X 116461682-116463003 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 46.8" "Cell line enhanced" "Detected in some" "HeLa: 29.2;RPMI-8226: 9.0;U-266/70: 41.3;U-266/84: 20.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.59e-2)" "unprognostic (1.69e-2)" "unprognostic (8.70e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 41.3 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CTAG1B "CT6.1, CTAG, CTAG1, ESO1, LAGE2A, LAGE2B, NY-ESO-1" ENSG00000184033 "Cancer/testis antigen 1B" P78358 X 154617609-154619282 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 56 "testis: 12.0" "Cell line enriched" "Detected in some" 4 "U-266/70: 128.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB015453 Enhanced "CAB015453: AB_784921" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.5 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAGE1 "CT21.1, CT21.2, CTAGE, cTAGE-1, cTAGE-2" ENSG00000212710 "Cutaneous T cell lymphoma-associated antigen 1" "Q96RT6, Q9HC47" 18 22413601-22417915 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 49 "testis: 12.9" "Cell line enhanced" "Detected in some" "HBF TERT88: 2.2;U-2 OS: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922, CAB016204" Uncertain "CAB016204: AB_673617, HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.41e-1)" "unprognostic (5.65e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.52e-1)" "unprognostic (1.70e-2)" "unprognostic (3.15e-1)" "unprognostic (1.63e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAGE15 CTAGE15P ENSG00000271079 "CTAGE family member 15" A4D2H0 7 143571801-143574387 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922" Uncertain "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (2.82e-1)" "unprognostic (8.64e-2)" "unprognostic (3.23e-1)" "unprognostic (3.32e-1)" "unprognostic (2.44e-1)" "unprognostic (2.23e-1)" "unprognostic (4.52e-2)" "unprognostic (9.94e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-2)" "unprognostic (3.72e-1)" "unprognostic (2.47e-1)" "unprognostic (2.33e-1)" "unprognostic (2.91e-2)" "unprognostic (2.39e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.6 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAGE6 "CTAGE6P, MGC41943" ENSG00000271321 "CTAGE family member 6" Q86UF2 7 143755089-143757696 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 40 "testis: 15.0" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;HeLa: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922" Uncertain "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.51e-2)" "unprognostic (8.90e-12)" "unprognostic (1.73e-2)" "unprognostic (2.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.7 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAGE9 ENSG00000236761 "CTAGE family member 9" A4FU28 6 131708684-131711017 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 29 "testis: 11.6" "Cell line enhanced" "Detected in single" "A-431: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922" Uncertain "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (3.92e-2)" "unprognostic (6.84e-2)" "unprognostic (3.48e-2)" "unprognostic (1.92e-1)" "unprognostic (9.89e-3)" "unprognostic (2.36e-1)" "unprognostic (5.55e-2)" "unprognostic (2.34e-1)" "unprognostic (2.52e-2)" "unprognostic (5.74e-4)" "unprognostic (3.15e-2)" "unprognostic (9.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 11.6 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.2 0.2 1.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.2 CTCFL "BORIS, CT27, dJ579F20.2" ENSG00000124092 "CCCTC-binding factor like" Q8NI51 20 57495966-57525652 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 35.4" "Group enriched" "Detected in some" 33 "HMC-1: 32.5;K-562: 44.5" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA001472 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA001472: AB_1078583" "unprognostic (2.50e-1)" "unprognostic (4.01e-2)" "unprognostic (7.70e-2)" "unprognostic (1.85e-5)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-2)" "unprognostic (5.26e-3)" "unprognostic (3.60e-1)" "unprognostic (2.20e-1)" "unprognostic (9.00e-2)" "unprognostic (4.16e-2)" "unprognostic (4.75e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.84e-2)" 0.2 0.1 0.1 0.1 0.4 1.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.3 0.1 0.1 0.1 0.4 0.0 0.5 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.3 0.1 35.4 0.1 0.1 0.4 0.1 0.1 0.1 0.1 2.1 1.0 4.3 0.8 0.8 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 32.5 0.0 0.0 0.0 0.0 0.0 44.5 0.3 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 1.1 0.1 0.1 0.1 1.8 0.7 1.2 0.6 0.7 0.5 1.3 0.4 0.5 0.3 2.1 0.7 0.8 4.3 0.8 0.8 1.0 0.5 0.2 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 CTH ENSG00000116761 "Cystathionine gamma-lyase" P32929 1 70411218-70439851 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" "Calmodulin-binding, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "liver: 104.5" "Cell line enhanced" "Detected in many" "HHSteC: 19.7;Karpas-707: 30.6;SK-MEL-30: 40.0" "Group enriched" "Detected in all" 5 "liver cancer: 30.0;testis cancer: 8.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.5;T-cells: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021591, HPA023300" Enhanced 25000 "HPA021591: AB_1847321, HPA023300: AB_1847322" "unprognostic (3.41e-2)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "unprognostic (2.76e-1)" "unprognostic (7.66e-2)" "unprognostic (2.45e-3)" "prognostic favourable (8.69e-4)" "unprognostic (1.71e-1)" "unprognostic (1.95e-1)" "unprognostic (1.00e-1)" "unprognostic (1.43e-3)" "unprognostic (5.05e-3)" "unprognostic (3.25e-2)" "unprognostic (1.03e-1)" "unprognostic (8.97e-2)" "unprognostic (3.05e-3)" "unprognostic (1.26e-1)" 2.2 8.3 2.3 1.0 3.2 2.2 2.0 3.7 3.6 1.9 3.3 2.2 1.8 3.3 1.7 1.4 2.7 2.3 1.5 1.6 2.1 2.7 8.2 104.5 2.2 1.0 2.4 2.2 18.3 11.6 1.5 1.7 1.0 3.2 2.9 4.1 11.2 4.8 2.8 2.1 1.0 3.2 1.2 2.4 0.8 3.7 5.4 1.3 0.0 11.4 1.2 1.5 2.7 1.2 4.5 1.3 1.1 0.6 0.6 6.4 1.1 5.0 0.7 3.4 4.8 4.2 2.4 7.6 2.0 1.8 1.7 7.6 1.4 3.1 2.7 1.6 1.4 2.4 13.3 1.4 3.5 8.4 2.9 3.2 2.5 4.3 19.7 3.7 0.8 3.7 11.9 3.6 4.2 1.5 6.4 30.6 1.1 1.4 1.3 0.8 3.5 2.7 1.3 1.8 7.7 3.5 0.0 1.9 1.6 3.2 3.8 40.0 1.3 2.0 0.5 0.5 3.9 2.7 1.9 11.8 6.9 1.4 4.7 7.5 1.3 1.1 0.6 0.2 2.5 0.4 4.6 4.5 2.3 3.5 1.0 2.9 6.4 3.1 0.9 0.6 0.5 1.3 0.7 1.1 2.3 3.2 3.7 3.6 2.1 2.7 2.4 2.2 3.2 1.3 CTNND2 "GT24, NPRAP" ENSG00000169862 "Catenin delta 2" Q9UQB3 5 10971840-11904043 "Disease related genes, Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 74.3" "Cell line enhanced" "Detected in some" "AF22: 17.7;MCF7: 8.0;SK-BR-3: 5.3;U-266/84: 15.1" "Cancer enriched" "Detected in many" 16 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015077, CAB037339" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" "Nucleoplasm, Golgi apparatus, Cell Junctions" "CAB037339: , HPA015077: " "unprognostic (7.32e-2)" "unprognostic (1.51e-3)" "unprognostic (2.23e-1)" "unprognostic (5.16e-2)" "unprognostic (5.66e-2)" "unprognostic (2.06e-2)" "unprognostic (1.81e-1)" "unprognostic (2.74e-2)" "unprognostic (9.13e-2)" "unprognostic (9.86e-2)" "unprognostic (8.95e-3)" "unprognostic (2.66e-1)" "unprognostic (9.55e-4)" "unprognostic (5.87e-2)" "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (4.76e-2)" 1.7 2.4 30.9 1.8 26.3 1.4 2.8 21.6 74.3 1.7 1.8 16.6 0.0 1.7 1.6 1.9 1.6 1.7 4.8 6.0 26.0 17.7 1.5 1.7 2.4 1.6 22.8 20.2 2.1 12.5 1.5 5.7 1.9 11.0 2.6 1.9 2.6 1.7 1.7 1.6 1.5 2.0 1.6 13.3 5.7 1.9 4.2 14.7 0.0 1.7 0.0 1.5 1.6 0.1 0.0 0.0 0.8 0.4 0.0 0.3 0.6 0.0 0.1 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.0 0.0 0.0 2.7 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 15.1 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.6 30.9 26.3 21.6 29.1 26.0 17.7 22.8 20.2 11.0 14.7 CTRB1 CTRB ENSG00000168925 "Chymotrypsinogen B1" P17538 16 75219000-75226338 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 2272 "pancreas: 1908.8" "Cell line enhanced" "Detected in some" "EFO-21: 6.3;HDLM-2: 4.9;U-2 OS: 2.4;U-251 MG: 1.6" "Cancer enriched" "Detected in some" 1905 "pancreatic cancer: 962.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" "unprognostic (1.76e-1)" "unprognostic (2.62e-1)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (5.22e-2)" "unprognostic (4.43e-3)" "unprognostic (2.96e-1)" "unprognostic (1.17e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.8 1908.8 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.4 0.2 1.6 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CTRB2 ENSG00000168928 "Chymotrypsinogen B2" Q6GPI1 16 75204096-75207185 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5240 "pancreas: 3761.5" "Cell line enhanced" "Detected in some" "EFO-21: 5.0;HDLM-2: 1.9;U-2 OS: 9.0;U-251 MG: 1.9;U-266/84: 2.6;U-698: 2.4" "Cancer enriched" "Detected in single" 1696 "pancreatic cancer: 540.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" "unprognostic (9.41e-4)" "unprognostic (2.20e-1)" "unprognostic (1.28e-2)" "unprognostic (2.10e-1)" "unprognostic (2.92e-2)" "unprognostic (2.77e-1)" "unprognostic (5.95e-2)" "unprognostic (9.56e-2)" "unprognostic (3.54e-3)" "unprognostic (7.06e-2)" "unprognostic (2.17e-1)" "unprognostic (7.57e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.6 3761.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.0 0.0 1.9 0.1 2.6 2.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 CTRC "CLCR, ELA4" ENSG00000162438 "Chymotrypsin C" Q99895 1 15438439-15449242 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 417 "pancreas: 1443.7" "Cell line enhanced" "Detected in some" "A-431: 3.6" "Cancer enriched" "Detected in some" 168 "pancreatic cancer: 236.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA046920 Enhanced "Secreted to digestive system" "HPA046920: " "unprognostic (2.62e-2)" "unprognostic (2.58e-1)" "unprognostic (1.34e-1)" "unprognostic (2.81e-1)" "unprognostic (8.60e-2)" "unprognostic (1.06e-1)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (2.94e-2)" "unprognostic (7.60e-2)" "unprognostic (3.34e-1)" "unprognostic (2.00e-1)" "unprognostic (9.55e-11)" "unprognostic (4.98e-2)" "unprognostic (1.84e-1)" "unprognostic (1.50e-1)" "unprognostic (5.99e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.6 1443.7 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.4 3.4 0.7 1.5 0.6 0.1 3.6 0.6 0.5 0.7 0.2 0.0 0.2 0.3 0.4 0.0 0.0 0.0 1.7 0.5 1.1 0.0 0.5 0.0 0.1 0.2 1.1 0.5 0.4 0.3 0.1 0.9 0.2 1.7 0.2 0.0 0.0 0.0 0.0 0.1 1.7 0.2 0.5 1.0 1.6 0.4 0.0 0.5 0.1 0.3 0.0 0.1 0.4 1.0 0.4 0.2 0.2 0.3 0.1 0.9 0.4 1.4 0.9 0.2 0.8 1.6 0.3 0.8 0.8 0.3 3.4 0.4 0.4 0.4 0.2 0.2 0.3 0.3 0.6 0.1 1.1 0.3 0.4 1.7 1.5 0.7 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CTRL ENSG00000141086 "Chymotrypsin like" P40313 16 67927640-67932414 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 281 "pancreas: 639.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA034504, HPA034505" Enhanced "Secreted to digestive system" "HPA034504: AB_2674196, HPA034505: AB_10602212" "unprognostic (3.03e-5)" "unprognostic (3.53e-3)" "unprognostic (3.46e-2)" "unprognostic (1.37e-1)" "unprognostic (9.66e-2)" "unprognostic (2.00e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (1.18e-1)" "unprognostic (6.83e-3)" "unprognostic (6.41e-2)" "unprognostic (1.88e-1)" "unprognostic (3.20e-4)" "unprognostic (6.69e-2)" "unprognostic (2.79e-1)" "unprognostic (2.63e-1)" "unprognostic (1.29e-3)" 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 639.8 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 1.1 1.1 0.7 0.0 2.2 0.5 0.5 3.7 1.1 0.3 0.2 0.1 1.8 0.3 0.7 1.1 1.3 2.3 1.4 0.7 0.4 0.7 1.0 5.6 0.7 3.1 1.4 6.3 0.7 1.1 1.4 0.3 0.9 2.5 1.2 0.2 3.9 1.0 0.0 1.5 1.0 0.6 1.0 0.7 2.7 6.2 2.2 2.8 0.5 4.5 0.0 0.9 2.6 1.4 1.3 0.7 0.6 1.2 4.3 1.6 0.1 2.0 0.5 1.6 6.5 2.7 3.6 0.2 0.8 0.8 0.6 0.7 0.3 1.5 0.7 0.2 0.3 1.1 0.5 0.9 0.6 0.5 2.2 1.1 0.0 0.7 1.1 0.0 0.5 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CTSG CG ENSG00000100448 "Cathepsin G" P08311 14 24573522-24576260 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "bone marrow: 450.3" "Cell line enriched" "Detected in some" 7 "THP-1: 437.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "classical monocyte: 6.5;memory CD8 T-cell: 3.5;myeloid DC: 5.1;naive CD8 T-cell: 1.8;neutrophil: 7.1;NK-cell: 5.2;plasmacytoid DC: 5.7" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "CAB000110, HPA047737" Enhanced "Intracellular and membrane" 67000 "CAB000110: , HPA047737: " "unprognostic (1.67e-1)" "unprognostic (2.57e-2)" "unprognostic (6.92e-2)" "unprognostic (1.08e-1)" "prognostic favourable (1.57e-4)" "unprognostic (4.05e-2)" "unprognostic (4.13e-2)" "unprognostic (3.06e-1)" "unprognostic (2.42e-1)" "unprognostic (2.60e-2)" "unprognostic (2.05e-2)" "unprognostic (1.63e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (8.91e-4)" 15.1 0.5 0.0 6.0 0.0 450.3 6.0 0.0 0.6 10.0 5.1 0.0 2.8 1.1 6.2 19.7 6.4 0.8 16.7 23.4 0.0 0.0 2.1 2.0 9.2 3.7 0.0 0.0 1.5 3.4 0.8 0.5 3.0 0.0 8.2 3.2 2.6 6.3 6.9 1.1 19.5 8.9 14.9 0.0 10.7 3.2 2.8 0.0 15.6 0.5 12.0 5.1 2.9 3.3 0.0 5.7 7.1 6.5 5.2 3.5 12.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 437.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 64.9 0.0 0.0 6.5 0.0 1.1 1.0 0.0 0.0 1.0 3.5 5.1 0.0 0.0 1.8 7.1 5.2 0.0 5.7 0.0 12.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 CTSV "CTSL2, CTSU" ENSG00000136943 "Cathepsin V" O60911 9 97029679-97039643 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 154.7" "Cell line enriched" "Detected in many" 8 "BEWO: 113.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "NK-cell: 4.2;plasmacytoid DC: 15.7" "Group enriched" "Detected in many" 42 "dendritic cells: 15.7;NK-cells: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017112 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" 260000 "Nucleoli fibrillar center, Cytosol" "Nucleoplasm, Plasma membrane" "CAB017112: " "unprognostic (2.40e-1)" "unprognostic (2.74e-2)" "unprognostic (1.50e-1)" "prognostic favourable (8.41e-4)" "unprognostic (7.29e-2)" "unprognostic (5.59e-2)" "prognostic unfavourable (2.83e-5)" "unprognostic (7.04e-3)" "unprognostic (6.06e-2)" "unprognostic (1.39e-2)" "prognostic unfavourable (2.87e-4)" "unprognostic (1.86e-2)" "unprognostic (1.78e-1)" "unprognostic (2.41e-2)" "unprognostic (1.33e-1)" "unprognostic (3.04e-3)" "prognostic unfavourable (2.39e-4)" 0.7 0.0 0.4 0.6 0.7 0.0 3.5 0.4 1.0 23.0 1.4 2.0 0.4 0.5 1.5 1.5 9.8 0.6 0.5 0.2 0.8 0.6 9.7 0.4 0.6 0.2 1.5 0.7 0.4 1.1 1.1 0.9 8.7 1.6 0.5 1.6 4.3 5.0 0.6 0.5 25.0 0.6 0.2 3.0 0.2 1.1 32.4 1.0 154.7 0.7 6.3 2.7 0.2 9.9 0.2 15.7 0.2 0.0 4.2 0.0 0.1 7.3 2.2 2.5 6.5 0.1 0.0 113.4 0.0 0.0 1.6 1.3 14.9 7.3 0.1 0.6 0.1 14.0 12.1 8.9 2.3 0.0 1.6 0.3 0.7 2.3 0.0 0.0 1.0 0.0 3.0 0.4 0.3 0.5 0.2 0.0 2.9 2.7 0.2 0.1 15.0 2.1 0.0 5.4 0.1 2.2 0.9 0.6 1.1 7.4 2.6 2.6 4.6 0.8 0.0 0.4 7.4 0.1 0.8 1.5 4.0 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.2 4.2 0.0 15.7 0.0 0.1 0.4 0.7 0.4 1.0 0.8 0.6 1.5 0.7 1.6 1.0 CTXN1 FLJ25968 ENSG00000178531 "Cortexin 1" P60606 19 7924485-7926166 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 91.1" "Cell line enhanced" "Detected in many" "AN3-CA: 33.2;HEK 293: 23.1;NTERA-2: 25.2;REH: 19.1;SCLC-21H: 19.6;SH-SY5Y: 32.9" "Cancer enhanced" "Detected in all" "ovarian cancer: 138.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016669 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" Nucleoplasm "Plasma membrane, Cell Junctions" "HPA016669: AB_1847330" "unprognostic (1.49e-2)" "unprognostic (3.52e-2)" "unprognostic (1.79e-2)" "unprognostic (2.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (5.42e-2)" "unprognostic (2.17e-1)" "unprognostic (2.58e-1)" "unprognostic (2.28e-2)" "unprognostic (1.69e-3)" "unprognostic (3.31e-2)" "unprognostic (1.56e-3)" "unprognostic (4.84e-2)" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "unprognostic (9.41e-2)" 2.1 4.8 47.7 2.5 91.1 1.6 2.1 0.0 74.2 5.2 6.1 5.0 3.6 2.6 17.5 5.1 2.4 16.4 1.8 1.6 49.4 16.8 3.1 1.5 3.0 1.6 15.7 20.1 2.7 2.1 2.3 6.5 2.0 4.0 5.5 2.1 0.0 2.1 16.5 1.6 2.8 2.1 7.1 1.5 2.0 2.2 6.1 8.3 0.0 1.8 0.0 1.6 2.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 2.7 7.1 33.2 0.0 0.1 1.6 2.9 0.8 1.4 0.8 0.8 1.7 0.0 5.6 0.7 12.1 1.6 0.3 0.0 1.0 23.1 0.2 1.9 0.5 0.3 0.5 0.6 0.0 0.9 0.5 0.3 1.8 7.0 0.1 0.1 13.4 6.1 4.5 25.2 11.7 19.1 0.0 2.1 5.1 0.5 19.6 32.9 1.7 0.9 3.0 7.3 0.2 2.8 0.7 11.7 1.3 1.6 0.2 0.3 1.5 2.8 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.7 91.1 0.0 63.8 49.4 16.8 15.7 20.1 4.0 8.3 CUZD1 "ERG-1, UO-44" ENSG00000138161 "CUB and zona pellucida like domains 1" Q86UP6 10 122832149-122850793 "Predicted membrane proteins" "Cell adhesion, Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 200 "pancreas: 650.6" "Cell line enhanced" "Detected in many" "hTERT-HME1: 7.1;LHCN-M2: 7.9" "Cancer enriched" "Detected in some" 54 "pancreatic cancer: 32.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 6 "B-cells: 1.1;T-cells: 3.2" "Low region specificity" "Detected in single" "HPA068479, HPA068660, HPA074117" Enhanced Approved Nucleoli,Vesicles Nucleoli Vesicles "HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: " "unprognostic (4.68e-2)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "unprognostic (1.52e-5)" "unprognostic (8.08e-2)" "unprognostic (5.20e-3)" "unprognostic (1.16e-4)" "unprognostic (4.19e-2)" "unprognostic (3.03e-2)" "unprognostic (5.15e-2)" "unprognostic (8.46e-2)" "unprognostic (6.64e-3)" "unprognostic (2.75e-3)" "unprognostic (4.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.56e-1)" "unprognostic (4.83e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 650.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.3 0.2 0.0 3.2 0.2 1.6 1.6 1.7 0.0 0.4 0.8 1.0 2.5 0.7 0.3 1.7 1.8 3.6 0.9 0.7 1.0 1.7 0.0 1.5 2.6 2.2 2.2 3.5 4.6 0.8 0.3 0.0 3.7 1.1 0.3 1.5 7.1 1.7 1.3 1.5 7.9 0.4 1.9 2.7 1.7 1.3 0.0 4.0 0.6 1.3 1.3 1.8 0.7 0.8 0.4 1.1 1.3 1.9 3.5 0.0 2.4 0.9 0.0 1.9 1.4 3.1 1.2 5.8 0.0 0.0 0.1 0.3 0.8 0.1 1.3 0.6 0.9 1.1 0.1 1.1 1.4 0.7 0.0 0.0 0.2 0.2 3.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CXCL13 "ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13" ENSG00000156234 "C-X-C motif chemokine ligand 13" O43927 4 77511753-77611834 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 82.5" "Cell line enhanced" "Detected in some" "HL-60: 1.4;RH-30: 1.2;U-266/70: 5.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Lineage enhanced" "Detected in single" "T-cells: 1.0" HPA052613 Uncertain "Secreted to blood" 126167 "HPA052613: " "unprognostic (5.25e-3)" "unprognostic (1.19e-2)" "prognostic favourable (9.12e-4)" "prognostic favourable (5.52e-4)" "unprognostic (1.53e-2)" "unprognostic (1.17e-3)" "unprognostic (1.49e-1)" "unprognostic (6.41e-3)" "unprognostic (9.82e-3)" "prognostic favourable (5.41e-4)" "unprognostic (1.13e-1)" "unprognostic (2.07e-1)" "prognostic unfavourable (1.16e-10)" "unprognostic (2.04e-2)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (6.68e-3)" 0.2 0.1 0.0 15.3 0.2 0.0 1.5 0.3 0.0 0.1 1.1 0.0 0.8 0.0 0.6 0.2 0.2 0.0 0.0 0.0 0.3 4.3 0.2 65.1 0.0 0.2 0.0 0.0 0.8 0.0 3.8 1.8 0.8 0.0 0.0 0.1 15.5 0.0 0.0 82.5 3.7 0.3 0.5 57.5 6.2 0.2 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.4 0.1 0.3 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 5.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 CXCR1 "CD181, CDw128a, CKR-1, CMKAR1, IL8RA" ENSG00000163464 "C-X-C motif chemokine receptor 1" P25024 2 218162845-218166995 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 144.6" "Cell line enriched" "Detected in single" 26 "HMC-1: 11.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 16 "neutrophil: 144.6" "Lineage enriched" "Detected in many" 59 "granulocytes: 144.6" "Not detected" "Not detected" HPA031991 Uncertain "HPA031991: " "unprognostic (2.80e-1)" "unprognostic (2.91e-2)" "unprognostic (3.53e-2)" "unprognostic (5.74e-2)" "unprognostic (1.19e-1)" "unprognostic (1.68e-1)" "unprognostic (2.14e-2)" "unprognostic (3.36e-2)" "unprognostic (2.32e-1)" "unprognostic (1.57e-1)" "unprognostic (8.27e-2)" "unprognostic (2.15e-2)" "unprognostic (2.88e-1)" "unprognostic (5.47e-2)" "unprognostic (2.97e-1)" "unprognostic (1.30e-1)" "unprognostic (8.85e-2)" 11.5 0.4 0.8 21.1 0.7 7.3 0.6 0.9 2.6 0.6 0.6 0.2 0.0 0.0 0.5 0.1 1.3 2.8 3.6 3.8 0.9 0.6 0.7 2.9 20.3 33.4 5.9 0.0 1.7 1.2 0.0 0.8 2.1 2.3 0.9 0.1 1.4 0.6 0.0 1.0 0.5 0.6 1.4 3.4 33.7 1.0 1.4 0.7 0.1 0.9 0.6 0.4 4.5 4.1 0.0 0.0 144.6 0.2 0.1 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.2 0.2 2.4 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.9 144.6 0.1 0.2 0.0 0.0 0.7 0.8 0.7 0.9 2.6 0.9 0.6 5.9 0.0 2.3 0.7 CXCR2 "CD182, CMKAR2, IL8RB" ENSG00000180871 "C-X-C motif chemokine receptor 2" P25025 2 218125289-218137253 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 216.1" "Group enriched" "Detected in some" 11 "BEWO: 12.1;HL-60: 6.7;HMC-1: 14.1;THP-1: 12.8;U-937: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 59 "neutrophil: 216.1" "Lineage enriched" "Detected in many" 109 "granulocytes: 216.1" "Low region specificity" "Detected in single" "CAB016268, HPA031999, HPA032017" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle" "Plasma membrane" "Nucleoplasm, Microtubules, Mitotic spindle" "CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112" "unprognostic (4.89e-2)" "unprognostic (2.01e-1)" "unprognostic (5.63e-2)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (3.13e-1)" "unprognostic (1.33e-1)" "unprognostic (2.13e-1)" "unprognostic (5.96e-2)" "unprognostic (1.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-1)" "unprognostic (7.54e-2)" "unprognostic (1.04e-1)" "unprognostic (7.23e-2)" "unprognostic (8.18e-2)" "unprognostic (5.48e-2)" 9.3 0.9 1.3 25.6 1.5 4.0 0.6 1.2 1.3 5.2 0.6 0.5 2.5 0.0 0.8 1.1 18.1 3.3 5.2 4.3 1.5 0.6 0.7 4.6 16.7 40.5 6.6 0.0 1.2 1.7 0.0 0.7 4.5 1.7 1.9 0.3 1.8 3.3 2.6 0.6 3.0 0.7 1.4 4.1 30.6 1.0 1.1 0.7 0.6 0.6 4.8 10.1 5.4 6.4 0.0 1.6 216.1 1.9 0.4 1.9 1.0 0.0 0.0 0.1 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 14.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 1.0 0.2 0.0 0.3 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 12.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 3.6 1.9 3.2 1.9 0.5 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.7 216.1 0.4 0.2 1.6 0.0 1.0 1.3 1.5 1.2 1.3 1.5 0.6 6.6 0.0 1.7 0.7 CXorf49 ENSG00000215115 "Chromosome X open reading frame 49" A8MYA2 X 71714371-71718151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 58 "testis: 5.8" "Cell line enriched" "Detected in some" 6 "A-431: 13.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CXorf49B ENSG00000215113 "Chromosome X open reading frame 49B" A8MYA2 X 71763424-71767204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 58 "testis: 5.8" "Cell line enriched" "Detected in some" 6 "A-431: 13.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CXorf51B ENSG00000235699 "Chromosome X open reading frame 51B" X 146809784-146810409 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 37 "testis: 36.8" "Group enriched" "Detected in some" 36 "RPMI-8226: 2.5;U-138 MG: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CXorf58 FLJ25444 ENSG00000165182 "Chromosome X open reading frame 58" Q96LI9 X 23907801-23939507 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 8.4" "Cell line enhanced" "Detected in some" "PC-3: 2.4;U-266/70: 2.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "monocytes: 1.0;T-cells: 1.8" "HPA031542, HPA031543, HPA031544" Uncertain "HPA031542: , HPA031543: AB_10603789, HPA031544: " "unprognostic (9.74e-2)" "unprognostic (9.17e-3)" "unprognostic (2.52e-1)" "unprognostic (3.64e-2)" "unprognostic (1.90e-2)" "unprognostic (1.24e-1)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (1.68e-2)" "unprognostic (1.43e-1)" "unprognostic (4.14e-3)" "unprognostic (8.19e-2)" "unprognostic (3.82e-2)" "unprognostic (1.10e-1)" "unprognostic (3.21e-2)" "unprognostic (7.39e-2)" "unprognostic (5.06e-3)" 0.1 0.4 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.2 0.2 0.3 0.6 0.2 0.1 0.0 0.2 0.0 0.4 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.3 0.0 0.0 8.4 0.6 0.0 0.2 0.0 0.1 0.2 0.1 1.0 0.0 1.8 0.1 0.8 0.3 0.0 0.0 0.2 0.0 0.4 0.1 0.4 0.1 0.1 0.0 1.0 1.2 0.3 0.0 0.7 0.1 0.9 0.0 0.5 0.7 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.8 0.7 0.6 0.0 0.4 0.2 0.1 0.2 0.1 1.0 0.0 2.4 0.5 0.0 0.1 1.3 0.0 1.2 0.2 0.6 0.1 0.5 1.4 0.1 0.4 0.1 0.0 0.2 0.4 2.3 1.1 0.3 0.2 0.1 0.4 0.0 0.0 0.1 0.3 1.0 1.4 0.1 1.3 1.0 0.0 0.1 1.0 0.7 0.0 0.0 0.2 0.2 1.8 0.1 CXorf65 ENSG00000204165 "Chromosome X open reading frame 65" A6NEN9 X 71103889-71106788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 47.7" "Cell line enhanced" "Detected in some" "HEK 293: 1.2;HEL: 2.7;K-562: 2.6;MOLT-4: 2.4;NB-4: 4.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 23 "naive B-cell: 2.2" "Lineage enriched" "Detected in single" 23 "B-cells: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA047396 Uncertain "HPA047396: " "unprognostic (7.81e-3)" "unprognostic (8.43e-4)" "unprognostic (1.08e-2)" "unprognostic (1.87e-2)" "unprognostic (6.14e-2)" "unprognostic (3.06e-3)" "unprognostic (6.20e-2)" "unprognostic (2.62e-2)" "unprognostic (6.72e-2)" "unprognostic (1.84e-4)" "unprognostic (9.53e-2)" "unprognostic (1.36e-1)" "unprognostic (1.44e-8)" "unprognostic (1.12e-1)" "unprognostic (3.49e-2)" "unprognostic (7.30e-2)" "unprognostic (1.25e-3)" 0.1 0.0 0.1 0.6 0.1 1.6 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 1.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.9 0.1 0.1 2.0 0.0 47.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.6 0.7 0.0 0.0 2.4 4.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CXorf66 "RP11-35F15.2, SGPX" ENSG00000203933 "Chromosome X open reading frame 66" Q5JRM2 X 139955725-139965520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.87e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYLC1 ENSG00000183035 "Cylicin 1" P35663 X 83861126-83886699 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "testis: 24.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA070355 Enhanced "HPA070355: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYLC2 ENSG00000155833 "Cylicin 2" Q14093 9 102995311-103018488 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 61 "testis: 34.0" "Cell line enhanced" "Detected in single" "HL-60: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.7 0.3 0.3 0.0 0.0 1.1 0.3 0.0 0.0 0.6 0.0 0.0 0.1 0.5 0.0 0.0 0.6 0.4 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.5 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 CYP11B1 "CPN1, CYP11B, FHI, P450C11" ENSG00000160882 "Cytochrome P450 family 11 subfamily B member 1" P15538 8 142872356-142879846 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroidogenesis" "Monooxygenase, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 781 "adrenal gland: 224.9" "Group enriched" "Detected in some" 8 "SCLC-21H: 3.0;SH-SY5Y: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049171, HPA056348, HPA057752" Supported "HPA049171: , HPA056348: , HPA057752: " 0.0 224.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP11B2 "ALDOS, CPN2, CYP11B, CYP11BL, P-450C18, P450aldo" ENSG00000179142 "Cytochrome P450 family 11 subfamily B member 2" P19099 8 142910559-142917843 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 259 "adrenal gland: 51.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049171, HPA056348, HPA057752" Supported "HPA049171: , HPA056348: , HPA057752: " 0.0 51.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP17A1 "CPT7, CYP17, P450C17, S17AH" ENSG00000148795 "Cytochrome P450 family 17 subfamily A member 1" P05093 10 102830531-102837533 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Steroidogenesis "Lyase, Monooxygenase, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "adrenal gland: 425.4" "Group enriched" "Detected in some" 4 "HMC-1: 7.8;SCLC-21H: 3.1" "Cancer enriched" "Detected in many" 5 "liver cancer: 22.7" "Region enriched" "Detected in single" 103 "basal ganglia: 19.7" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA048533 Enhanced "Intracellular and membrane" "HPA048533: " "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (3.01e-2)" "unprognostic (9.08e-2)" "unprognostic (1.91e-1)" "unprognostic (6.29e-2)" "unprognostic (2.92e-3)" "unprognostic (2.39e-4)" "unprognostic (8.26e-2)" "unprognostic (2.35e-1)" "unprognostic (5.92e-3)" "unprognostic (1.13e-1)" "prognostic favourable (5.43e-7)" "unprognostic (1.07e-1)" "unprognostic (5.56e-2)" "unprognostic (1.66e-2)" "unprognostic (2.94e-4)" 0.0 425.4 0.0 0.1 19.7 0.0 0.0 0.1 0.1 0.1 0.0 78.5 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.0 6.4 1.7 0.1 0.0 0.0 0.0 3.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 82.3 0.0 0.1 2.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 7.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 19.7 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 CYP19A1 "ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM" ENSG00000137869 "Cytochrome P450 family 19 subfamily A member 1" P11511 15 51208057-51338610 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 49 "placenta: 440.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 44.8;HDLM-2: 7.8;HSkMC: 15.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 8 "basal ganglia: 5.9" "Cell type enriched" "Detected in single" 17 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000355, HPA051194" Enhanced Approved Mitochondria Mitochondria "CAB000355: , HPA051194: " "unprognostic (9.41e-2)" "unprognostic (7.44e-2)" "unprognostic (9.52e-5)" "unprognostic (6.81e-2)" "unprognostic (2.72e-1)" "unprognostic (4.25e-4)" "unprognostic (5.18e-5)" "unprognostic (1.54e-3)" "unprognostic (2.38e-2)" "unprognostic (2.52e-1)" "unprognostic (1.97e-1)" "unprognostic (5.37e-2)" "unprognostic (1.54e-5)" "unprognostic (2.52e-3)" "unprognostic (2.11e-1)" "unprognostic (1.40e-2)" "unprognostic (1.11e-1)" 9.0 4.6 0.2 0.2 5.9 0.1 2.1 0.2 0.3 0.9 0.3 0.3 0.2 0.4 0.2 0.3 0.3 0.2 0.3 1.3 0.2 0.7 0.3 0.2 0.6 0.2 0.2 0.2 4.4 0.6 0.1 0.2 440.1 0.2 0.5 0.1 0.2 0.9 1.4 0.8 2.3 0.2 0.7 0.5 0.5 0.1 3.0 0.2 0.3 3.0 0.2 0.2 1.2 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 44.8 2.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 7.8 0.0 0.3 0.1 3.7 0.2 0.0 0.0 15.0 0.0 0.1 1.8 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.4 0.6 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 5.9 0.2 0.3 0.2 0.7 0.2 0.2 0.2 0.2 CYP1A2 "CP12, P3-450" ENSG00000140505 "Cytochrome P450 family 1 subfamily A member 2" P05177 15 74748844-74756202 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 143.0" "Cell line enhanced" "Detected in many" "SK-BR-3: 6.0" "Group enriched" "Detected in some" 22 "liver cancer: 25.3;urothelial cancer: 6.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" CAB016531 Enhanced "CAB016531: AB_629359" "unprognostic (1.54e-4)" "unprognostic (1.29e-1)" "unprognostic (1.98e-1)" "unprognostic (1.74e-1)" "unprognostic (1.59e-2)" "unprognostic (1.76e-1)" "unprognostic (1.17e-2)" "unprognostic (5.48e-2)" "unprognostic (2.33e-2)" "unprognostic (7.41e-2)" "unprognostic (2.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.7 1.1 4.5 1.2 1.1 0.7 0.3 1.1 1.0 2.7 2.2 0.2 0.0 1.6 0.7 0.0 0.0 0.2 0.6 1.3 2.2 0.5 0.0 1.2 0.1 0.2 0.1 0.6 1.2 2.8 1.6 0.8 0.1 1.9 1.1 0.4 0.3 0.1 0.0 0.2 1.9 4.1 0.0 0.8 2.5 1.3 1.7 0.6 2.6 2.4 0.9 0.0 2.3 2.2 1.1 2.1 6.0 0.4 1.6 1.0 0.4 1.1 1.4 1.1 1.2 1.0 0.7 1.6 1.1 2.4 1.2 3.2 1.2 1.2 0.6 0.6 0.5 0.8 0.7 0.5 0.4 1.7 0.7 0.7 4.5 1.1 0.8 1.1 0.4 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CYP21A2 "CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B" ENSG00000231852 "Cytochrome P450 family 21 subfamily A member 2" P08686 6 32038265-32041670 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Steroidogenesis "Monooxygenase, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "adrenal gland: 170.9" "Cell line enhanced" "Detected in some" "HDLM-2: 11.5;Hep G2: 1.8;Karpas-707: 3.1" "Cancer enhanced" "Detected in some" "liver cancer: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA048979, HPA053371" Enhanced "Intracellular and membrane" "HPA048979: AB_2680584, HPA053371: AB_2682131" "unprognostic (1.03e-2)" "unprognostic (1.65e-1)" "unprognostic (1.02e-4)" "unprognostic (2.58e-1)" "unprognostic (2.97e-1)" "unprognostic (2.93e-2)" "unprognostic (2.76e-2)" "unprognostic (8.75e-2)" "unprognostic (1.39e-1)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (6.67e-7)" "unprognostic (7.39e-2)" "unprognostic (5.24e-2)" "unprognostic (1.09e-1)" "unprognostic (1.82e-1)" 0.1 170.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 6.7 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.3 7.4 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 3.6 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.5 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CYP27B1 "CYP1, P450c1, PDDR, VDD1" ENSG00000111012 "Cytochrome P450 family 27 subfamily B member 1" O15528 12 57762334-57768986 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "kidney: 45.7" "Cell line enriched" "Detected in many" 6 "RH-30: 33.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (8.59e-2)" "unprognostic (1.42e-1)" "unprognostic (8.89e-2)" "unprognostic (2.77e-2)" "unprognostic (4.16e-2)" "unprognostic (1.03e-2)" "unprognostic (1.28e-2)" "unprognostic (1.44e-1)" "unprognostic (2.10e-2)" "unprognostic (4.72e-2)" "unprognostic (2.51e-1)" "unprognostic (1.17e-2)" "unprognostic (1.75e-3)" "unprognostic (4.10e-2)" "unprognostic (3.19e-2)" "prognostic unfavourable (6.79e-4)" "unprognostic (5.67e-3)" 0.5 1.1 0.3 1.4 0.3 1.5 0.6 0.3 0.4 0.4 0.3 0.3 0.9 0.3 0.8 1.0 0.6 0.2 0.8 0.3 0.3 0.1 45.7 0.8 0.8 1.4 0.3 0.3 0.3 3.6 0.7 0.6 0.5 0.3 0.5 0.8 1.1 0.7 0.3 0.3 0.8 0.4 0.3 0.3 0.3 0.7 0.5 0.3 1.0 4.4 0.3 0.8 0.6 0.3 0.0 0.0 0.0 0.0 0.0 2.4 0.1 1.1 0.2 0.5 1.6 0.0 0.3 1.9 0.0 1.7 0.2 0.9 1.9 0.5 2.4 0.2 0.3 1.6 0.8 2.8 1.1 0.5 0.8 1.5 0.3 0.0 0.1 2.6 2.5 0.0 1.1 1.1 0.1 0.0 1.6 5.3 0.0 0.5 0.4 1.1 1.6 1.6 1.2 33.2 1.2 0.0 0.9 0.7 0.7 1.3 0.0 0.2 1.3 1.8 0.0 1.4 2.4 1.3 0.8 2.4 2.2 1.3 0.8 3.2 0.8 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.7 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.4 0.3 0.1 0.3 0.3 0.3 0.3 CYP2A13 "CPAD, CYP2A" ENSG00000197838 "Cytochrome P450 family 2 subfamily A member 13" Q16696 19 41088472-41096195 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 30.7" "Cell line enhanced" "Detected in some" "HaCaT: 2.1;NTERA-2: 1.5" "Cancer enriched" "Detected in single" 5 "liver cancer: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046713, HPA047262" Supported "Intracellular and membrane" "HPA046713: , HPA047262: " "unprognostic (9.79e-2)" "unprognostic (1.00e-1)" "unprognostic (4.51e-3)" "unprognostic (4.92e-2)" "unprognostic (1.99e-1)" "unprognostic (1.49e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 30.7 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 CYP2A6 "CPA6, CYP2A, CYP2A3" ENSG00000255974 "Cytochrome P450 family 2 subfamily A member 6" P11509 19 40843538-40850447 "Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 165 "liver: 199.5" "Cell line enhanced" "Detected in some" "Daudi: 1.2;HL-60: 2.8;K-562: 1.4;RH-30: 4.3;SiHa: 2.2;U-937: 1.0" "Cancer enriched" "Detected in some" 12 "liver cancer: 281.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046713, HPA047262" Supported "Intracellular and membrane" "HPA046713: , HPA047262: " "unprognostic (5.40e-2)" "unprognostic (2.36e-2)" "unprognostic (1.21e-1)" "unprognostic (4.10e-1)" "unprognostic (5.05e-2)" "unprognostic (2.64e-2)" "prognostic favourable (5.38e-5)" "unprognostic (4.98e-3)" "unprognostic (4.86e-2)" "unprognostic (6.23e-2)" "unprognostic (5.20e-2)" "unprognostic (1.95e-1)" "unprognostic (2.25e-2)" "unprognostic (8.83e-3)" "unprognostic (2.46e-1)" "unprognostic (3.07e-2)" "unprognostic (2.55e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 199.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 CYP2A7 CYP2A ENSG00000198077 "Cytochrome P450 family 2 subfamily A member 7" P20853 19 40875439-40882752 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 134 "liver: 53.7" "Cell line enhanced" "Detected in single" "HL-60: 1.9" "Group enriched" "Detected in some" 238 "breast cancer: 9.2;liver cancer: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB033510, HPA046713, HPA047262" Enhanced "Intracellular and membrane" "CAB033510: AB_782366, HPA046713: , HPA047262: " "unprognostic (2.18e-1)" "unprognostic (3.60e-2)" "unprognostic (2.65e-3)" "unprognostic (8.89e-2)" "unprognostic (1.39e-2)" "unprognostic (3.95e-1)" "unprognostic (9.21e-2)" "unprognostic (8.71e-2)" "unprognostic (3.99e-2)" "unprognostic (1.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CYP2B6 "CPB6, CYP2B, CYPIIB6" ENSG00000197408 "Cytochrome P450 family 2 subfamily B member 6" P20813 19 40991250-41018398 "Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "liver: 137.3" "Cell line enhanced" "Detected in some" "HaCaT: 7.4" "Cancer enhanced" "Detected in many" "liver cancer: 28.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB033866, HPA048124, HPA062973" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB033866: AB_2292644, HPA048124: , HPA062973: " "unprognostic (1.86e-1)" "unprognostic (1.23e-2)" "unprognostic (1.13e-2)" "unprognostic (6.13e-2)" "unprognostic (4.59e-2)" "unprognostic (4.63e-2)" "unprognostic (4.41e-2)" "unprognostic (1.73e-1)" "unprognostic (5.78e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (9.43e-2)" "unprognostic (5.44e-1)" 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.0 3.0 137.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 1.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.9 1.8 3.1 0.8 0.7 0.9 0.1 0.4 0.4 0.5 0.4 0.1 0.0 0.4 0.2 0.4 0.0 0.2 1.6 0.0 0.4 0.3 0.3 7.4 0.4 0.1 0.1 0.3 0.6 0.4 0.8 0.5 0.4 0.4 0.4 0.0 0.5 0.3 0.1 0.6 0.4 0.1 0.2 0.1 0.8 1.9 0.7 0.5 0.2 0.5 0.5 1.8 0.1 0.9 0.2 0.3 0.1 0.5 0.8 1.1 0.9 0.6 0.3 0.8 0.6 0.3 0.8 0.9 0.2 1.2 0.3 3.1 0.8 0.4 0.4 0.5 0.4 0.6 0.6 0.4 0.1 1.9 0.5 0.8 2.7 0.7 0.3 1.8 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CYP2C8 CPC8 ENSG00000138115 "Cytochrome P450 family 2 subfamily C member 8" P10632 10 95036772-95069497 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 131 "liver: 247.5" "Cell line enhanced" "Detected in some" "Daudi: 1.7;HL-60: 2.7;SiHa: 2.9;U-266/70: 2.9;U-266/84: 2.2" "Cancer enriched" "Detected in some" 82 "liver cancer: 102.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "gdT-cell: 1.8" "Lineage enriched" "Detected in single" 9 "T-cells: 1.8" "HPA013547, HPA013970, HPA015066" Enhanced "Intracellular and membrane" "HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433" "unprognostic (3.33e-2)" "unprognostic (1.38e-1)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (4.41e-2)" "unprognostic (1.09e-2)" "unprognostic (1.80e-3)" "unprognostic (4.29e-2)" "unprognostic (1.03e-1)" "unprognostic (3.38e-1)" "prognostic favourable (9.82e-4)" "unprognostic (2.85e-1)" "unprognostic (1.44e-3)" "unprognostic (2.63e-1)" "unprognostic (7.88e-2)" "unprognostic (1.39e-1)" "unprognostic (4.05e-4)" 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.1 0.1 0.2 0.3 247.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 1.1 0.2 0.0 0.2 0.0 0.7 1.0 0.0 1.0 0.5 2.7 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.3 0.7 0.1 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 2.9 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.9 2.2 1.1 0.0 0.9 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 CYP2C9 "CYP2C10, P450IIC9" ENSG00000138109 "Cytochrome P450 family 2 subfamily C member 9" P11712 10 94938658-94989391 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 233.0" "Cell line enhanced" "Detected in some" "HL-60: 3.4;NB-4: 1.7;RPMI-8226: 2.5;SiHa: 1.6" "Cancer enriched" "Detected in some" 41 "liver cancer: 118.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015066, CAB016123" Enhanced "Intracellular and membrane" "CAB016123: AB_629363, HPA015066: AB_1847433" "unprognostic (3.37e-1)" "unprognostic (5.68e-2)" "unprognostic (9.67e-2)" "unprognostic (4.16e-2)" "unprognostic (1.83e-2)" "prognostic favourable (2.83e-6)" "unprognostic (2.37e-1)" "unprognostic (2.05e-2)" "unprognostic (4.93e-2)" "unprognostic (1.26e-4)" "unprognostic (7.55e-2)" "unprognostic (1.12e-1)" "unprognostic (2.45e-2)" "unprognostic (1.24e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 45.8 0.0 0.0 13.6 0.0 0.6 1.1 0.0 1.0 0.0 0.0 0.0 0.5 233.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 43.8 0.0 0.0 0.1 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.3 2.5 0.4 0.0 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 CYP2D6 "CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D" ENSG00000100197 "Cytochrome P450 family 2 subfamily D member 6" P10635 22 42126499-42130906 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 78.0" "Cell line enhanced" "Detected in some" "Hep G2: 4.3;HMC-1: 6.0;REH: 3.5;T-47d: 2.3;U-266/70: 4.2" "Cancer enriched" "Detected in many" 35 "liver cancer: 90.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045223 Enhanced Approved "Golgi apparatus" "Golgi apparatus" "HPA045223: AB_10962927" "unprognostic (4.40e-3)" "unprognostic (7.68e-3)" "unprognostic (5.45e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (1.29e-4)" "unprognostic (3.83e-2)" "unprognostic (7.27e-3)" "unprognostic (1.13e-1)" "unprognostic (1.71e-1)" "unprognostic (4.03e-4)" "unprognostic (2.11e-2)" "unprognostic (5.61e-5)" "unprognostic (3.01e-1)" "unprognostic (2.23e-1)" "unprognostic (4.08e-1)" "unprognostic (4.82e-5)" 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.2 0.1 0.1 3.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 78.0 0.1 0.1 0.1 0.1 0.5 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 11.2 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.3 0.2 0.0 0.6 0.2 3.5 0.0 1.1 0.0 0.0 0.1 0.3 1.2 0.1 0.0 2.3 0.0 0.0 0.0 1.6 0.0 0.3 4.2 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 CYP2E1 CYP2E ENSG00000130649 "Cytochrome P450 family 2 subfamily E member 1" P05181 10 133520406-133561220 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 87 "liver: 802.4" "Cell line enhanced" "Detected in many" "HaCaT: 9.6;HL-60: 7.4;HMC-1: 7.9;NB-4: 20.2" "Cancer enriched" "Detected in some" 278 "liver cancer: 265.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.9;myeloid DC: 9.1" "Group enriched" "Detected in many" 17 "dendritic cells: 9.1;T-cells: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA009128, HPA029564" Enhanced "Intracellular and membrane" "HPA009128: AB_1078613, HPA029564: AB_10602213" "unprognostic (6.32e-2)" "unprognostic (1.51e-2)" "unprognostic (3.83e-5)" "unprognostic (1.27e-1)" "unprognostic (3.37e-2)" "unprognostic (1.26e-1)" "unprognostic (2.92e-3)" "unprognostic (6.36e-3)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" "unprognostic (3.21e-2)" "unprognostic (1.70e-4)" "unprognostic (1.72e-1)" "unprognostic (8.36e-2)" "unprognostic (3.78e-1)" "unprognostic (9.59e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.6 0.3 0.1 0.1 0.2 0.7 0.0 0.1 0.3 0.8 0.2 1.3 0.1 0.1 0.1 0.3 802.4 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.1 0.3 0.1 0.0 0.2 0.1 1.1 0.1 0.6 0.1 0.1 0.1 0.4 0.1 0.3 0.1 0.1 0.2 0.2 1.5 0.1 0.1 0.0 9.1 0.0 0.3 0.2 3.9 0.3 0.1 0.0 0.3 0.9 3.2 1.8 0.6 1.4 3.9 0.0 0.3 0.0 2.3 1.2 0.2 0.4 9.6 0.0 0.2 0.3 0.2 1.3 1.5 0.1 1.1 0.5 7.4 7.9 0.9 0.2 0.0 0.6 0.0 0.4 0.3 0.9 0.6 0.5 20.2 5.5 0.3 0.3 5.4 0.0 1.7 0.0 0.0 0.0 3.7 0.0 0.6 0.2 0.8 0.0 1.2 0.4 2.0 0.9 2.0 0.8 2.7 1.3 6.3 0.1 0.0 0.0 0.0 0.1 0.0 3.9 0.0 1.7 1.0 9.1 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.3 0.1 0.2 0.6 0.3 0.1 0.1 0.1 0.1 0.3 0.1 CYP2U1 SPG49 ENSG00000155016 "Cytochrome P450 family 2 subfamily U member 1" Q7Z449 4 107931369-107953457 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 122.7" "Cell line enhanced" "Detected in many" "ASC diff: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041622, HPA046754, HPA064827" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA041622: , HPA046754: , HPA064827: " "unprognostic (3.54e-1)" "unprognostic (2.45e-1)" "unprognostic (3.08e-1)" "unprognostic (2.84e-1)" "unprognostic (5.16e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (1.20e-3)" "unprognostic (3.19e-1)" "unprognostic (8.97e-3)" "unprognostic (5.41e-3)" "unprognostic (3.02e-1)" "prognostic favourable (2.75e-5)" "prognostic unfavourable (6.97e-4)" "unprognostic (1.19e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.6 7.9 7.7 4.4 9.1 0.4 7.3 11.3 9.2 7.8 7.3 7.0 4.1 4.0 9.5 4.6 6.3 9.8 6.6 8.8 7.1 7.9 6.4 6.8 6.6 6.7 8.3 5.2 12.0 2.6 10.3 8.1 2.7 7.8 12.4 4.7 8.6 4.5 11.0 4.3 3.1 6.0 12.3 7.0 8.5 4.6 3.9 7.4 122.7 4.7 3.5 5.4 7.3 5.3 2.6 2.7 0.7 5.9 1.6 1.7 0.4 2.5 1.2 3.4 6.3 18.8 9.0 0.5 10.8 16.3 6.6 10.5 0.0 1.7 6.9 0.8 6.4 0.1 5.3 4.0 10.4 1.9 1.6 1.4 2.4 0.3 7.5 2.0 0.0 10.1 3.4 3.1 2.1 2.5 0.1 3.3 5.5 1.8 7.4 0.0 3.5 3.0 4.2 4.1 0.0 2.1 4.3 6.7 5.0 2.7 4.7 11.5 2.3 1.0 6.8 4.3 0.5 6.1 4.3 14.0 13.2 2.2 3.5 0.0 4.8 0.0 0.3 0.7 1.2 1.1 0.9 2.0 0.9 1.0 2.2 2.6 1.7 1.3 0.0 1.6 5.9 2.7 0.0 0.4 7.7 9.1 11.3 6.9 7.1 7.9 8.3 5.2 7.8 7.4 CYP3A43 ENSG00000021461 "Cytochrome P450 family 3 subfamily A member 43" Q9HB55 7 99828013-99866102 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 32.5" "Low cell line specificity" "Detected in some" "Cancer enriched" "Detected in single" 18 "liver cancer: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "HPA066463, HPA072245" Enhanced Uncertain Cytosol Cytosol "HPA066463: , HPA072245: " "unprognostic (1.20e-3)" "unprognostic (4.74e-2)" "unprognostic (3.64e-3)" "unprognostic (7.24e-2)" "unprognostic (2.52e-1)" "prognostic favourable (3.41e-4)" "unprognostic (1.68e-2)" "unprognostic (1.44e-1)" "unprognostic (2.38e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-2)" "unprognostic (1.23e-2)" "unprognostic (6.46e-2)" "unprognostic (5.90e-2)" "unprognostic (3.10e-1)" "unprognostic (6.37e-4)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.9 0.1 0.0 0.1 0.1 0.1 0.0 0.2 32.5 0.1 0.1 0.1 0.1 0.1 8.0 0.0 2.2 0.1 0.1 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.5 1.6 0.6 0.3 0.6 0.2 0.1 0.0 0.9 0.3 1.1 0.2 0.2 0.0 0.1 0.2 0.2 1.2 0.7 1.5 0.2 0.3 1.3 0.2 0.0 0.7 0.2 0.5 0.9 1.4 1.3 0.3 0.9 1.3 0.0 0.7 0.0 0.0 0.5 1.0 1.0 0.0 0.0 0.0 0.6 0.4 0.0 0.9 0.0 0.2 0.7 1.6 0.5 0.4 0.6 1.7 0.0 0.5 0.0 1.6 0.5 0.2 1.1 0.7 1.1 1.2 0.1 0.8 0.4 0.2 1.5 0.6 0.4 0.6 0.2 0.3 0.3 0.3 0.2 0.1 0.6 0.5 0.5 1.6 0.3 0.2 0.5 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CYP3A7 "CP37, P450-HFLA" ENSG00000160870 "Cytochrome P450 family 3 subfamily A member 7" P24462 7 99684957-99735196 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 82.6" "Group enriched" "Detected in some" 5 "BEWO: 1.8;BJ hTERT+: 3.2;Hep G2: 6.2;HHSteC: 3.6;RT4: 1.9" "Cancer enriched" "Detected in some" 43 "liver cancer: 38.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA072245 Uncertain Cytosol Cytosol "HPA072245: " "unprognostic (8.10e-3)" "unprognostic (1.45e-1)" "unprognostic (3.12e-1)" "unprognostic (5.47e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (4.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.34e-2)" "unprognostic (8.28e-2)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-11)" "unprognostic (2.02e-2)" "unprognostic (5.87e-2)" "unprognostic (2.97e-1)" "unprognostic (1.34e-3)" 0.1 0.4 0.1 0.1 0.0 0.0 2.6 0.1 0.1 0.0 0.7 0.0 0.0 0.1 0.3 0.1 0.2 0.0 3.9 0.0 0.1 0.0 2.8 82.6 0.6 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.8 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.2 3.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 CYP3A7-CYP3A51P ENSG00000282301 "CYP3A7-CYP3A51P readthrough" P24462 7 99685226-99735093 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 73.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.2;U-87 MG: 2.6" "Cell type enhanced" "Detected in single" "eosinophil: 1.1" "Low lineage specificity" "Detected in single" HPA072245 Uncertain Cytosol Cytosol "HPA072245: " 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.1 73.9 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 1.1 0.0 0.0 0.5 0.0 0.3 0.5 1.6 0.5 0.2 4.2 0.0 0.6 0.2 0.0 0.0 0.0 1.3 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.4 0.9 1.3 1.9 0.0 0.0 0.4 0.3 0.4 0.4 0.0 0.3 0.0 0.4 1.0 0.1 0.2 1.1 0.5 0.2 0.2 0.1 0.4 1.4 0.0 0.0 0.3 0.2 0.0 0.5 0.6 0.0 0.1 0.4 0.3 0.5 0.5 0.6 0.9 0.7 0.1 2.6 0.7 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 CYP46A1 CYP46 ENSG00000036530 "Cytochrome P450 family 46 subfamily A member 1" Q9Y6A2 14 99684304-99727301 "Enzymes, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 49.2" "Group enriched" "Detected in some" 4 "AF22: 4.3;U-937: 11.8" "Cancer enriched" "Detected in single" 5 "glioma: 1.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 23 "plasmacytoid DC: 7.0" "Lineage enriched" "Detected in single" 23 "dendritic cells: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" "unprognostic (2.16e-1)" "unprognostic (4.30e-1)" "unprognostic (2.50e-5)" "unprognostic (9.48e-5)" "unprognostic (1.15e-1)" "unprognostic (5.92e-2)" "unprognostic (3.45e-2)" "unprognostic (1.06e-1)" "unprognostic (5.37e-2)" "unprognostic (4.01e-2)" "unprognostic (1.32e-5)" "unprognostic (5.21e-2)" "unprognostic (2.44e-4)" "unprognostic (5.97e-4)" "unprognostic (1.59e-1)" "unprognostic (1.15e-2)" "unprognostic (3.88e-3)" 3.0 3.3 13.8 1.3 47.3 1.0 1.2 2.6 49.2 1.4 1.1 3.7 0.0 1.2 1.9 2.0 1.1 1.6 1.4 6.2 15.7 9.9 2.0 1.5 1.3 1.6 7.1 10.0 2.1 2.3 2.7 5.3 1.0 3.8 1.8 1.1 0.6 2.5 1.7 2.0 1.1 1.0 1.9 3.1 1.0 1.0 2.1 6.1 0.4 1.8 0.0 1.1 1.1 0.1 0.0 7.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.3 1.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.2 0.6 0.2 0.0 0.1 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.1 1.8 0.0 0.1 0.0 1.0 0.0 0.3 0.0 0.0 0.2 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.0 0.0 0.0 13.8 47.3 2.6 21.5 15.7 9.9 7.1 10.0 3.8 6.1 CYP4A22 ENSG00000162365 "Cytochrome P450 family 4 subfamily A member 22" Q5TCH4 1 47137435-47149741 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 71.0" "Cell line enriched" "Detected in some" 4 "RH-30: 5.2" "Cancer enriched" "Detected in some" 13 "liver cancer: 20.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.34e-2)" "unprognostic (1.24e-1)" "unprognostic (3.19e-2)" "unprognostic (2.88e-3)" "unprognostic (2.76e-3)" "unprognostic (1.50e-3)" "unprognostic (2.21e-1)" "unprognostic (2.75e-1)" "unprognostic (1.93e-2)" "unprognostic (5.29e-3)" "unprognostic (1.02e-1)" "unprognostic (1.71e-1)" "unprognostic (8.59e-4)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 1.2 0.1 0.0 0.1 0.1 0.1 0.0 14.4 71.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.4 0.2 0.1 0.6 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.5 0.5 0.5 0.2 0.1 0.2 0.3 0.0 0.1 0.2 0.3 0.1 0.5 0.0 0.0 0.6 0.6 0.2 0.0 0.1 0.2 0.1 0.2 0.5 0.1 0.1 0.4 0.4 0.4 0.0 0.0 5.2 0.0 0.0 0.4 0.5 0.2 0.4 0.1 0.0 0.4 0.7 0.7 0.2 0.1 0.2 0.0 0.0 0.5 0.7 0.2 1.2 0.0 0.0 0.2 0.4 0.5 0.0 0.4 0.5 0.5 0.6 0.1 0.6 0.5 0.6 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CYP4F11 ENSG00000171903 "Cytochrome P450 family 4 subfamily F member 11" Q9HBI6 19 15912367-15934867 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 88.6" "Cell line enhanced" "Detected in some" "A-431: 7.5;CAPAN-2: 29.9;EFO-21: 11.2;Hep G2: 14.4;RPMI-8226: 7.8;RT4: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.2" "Low lineage specificity" "Detected in single" "HPA017265, CAB033648, HPA058960" Enhanced "Intracellular and membrane" "CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: " "prognostic favourable (4.05e-4)" "unprognostic (4.12e-2)" "unprognostic (1.79e-1)" "unprognostic (5.99e-2)" "unprognostic (5.92e-3)" "unprognostic (1.06e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-1)" "unprognostic (2.33e-1)" "unprognostic (1.19e-1)" "prognostic unfavourable (9.28e-4)" "unprognostic (4.44e-2)" "unprognostic (9.50e-3)" "unprognostic (2.14e-2)" "unprognostic (2.24e-1)" "unprognostic (2.78e-2)" "unprognostic (4.64e-2)" 0.4 2.2 3.6 0.5 4.4 0.5 1.7 1.8 5.4 1.1 2.5 4.4 0.0 7.5 0.5 11.8 7.9 2.2 12.9 0.4 3.9 1.4 4.9 88.6 2.4 0.4 2.1 3.8 0.3 3.5 0.2 0.6 0.2 8.3 2.4 1.9 0.6 2.6 3.4 0.5 0.8 15.7 0.2 9.7 0.9 2.7 1.0 3.0 0.0 2.2 2.8 1.8 4.8 2.0 0.1 0.1 0.8 1.2 0.0 0.2 0.1 7.5 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.1 11.2 0.0 0.9 0.0 3.9 0.0 0.0 0.0 0.0 2.3 14.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 6.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 7.8 2.0 8.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.1 0.1 0.3 0.1 0.2 0.9 0.0 0.8 0.5 0.0 0.1 1.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.7 0.1 0.0 0.1 3.6 4.4 1.8 5.4 3.9 1.4 2.1 3.8 8.3 3.0 CYP4F3 "CYP4F, LTB4H" ENSG00000186529 "Cytochrome P450 family 4 subfamily F member 3" Q08477 19 15640897-15662825 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 159.2" "Cell line enhanced" "Detected in some" "A549: 5.3;CAPAN-2: 24.2;HaCaT: 11.1;Hep G2: 13.2" "Cancer enhanced" "Detected in many" "liver cancer: 30.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 68 "neutrophil: 33.1" "Lineage enriched" "Detected in single" 166 "granulocytes: 33.1" HPA058960 Approved "HPA058960: " "unprognostic (1.73e-2)" "unprognostic (9.70e-3)" "unprognostic (1.21e-1)" "unprognostic (1.16e-3)" "unprognostic (5.40e-1)" "unprognostic (1.57e-1)" "unprognostic (7.15e-3)" "unprognostic (5.19e-2)" "unprognostic (2.12e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-2)" "unprognostic (2.32e-1)" "unprognostic (1.59e-3)" "unprognostic (2.36e-1)" "unprognostic (1.12e-1)" "unprognostic (1.07e-2)" "unprognostic (2.07e-1)" 0.4 0.1 0.3 0.3 1.5 24.8 0.1 0.1 2.2 2.1 3.4 6.5 0.0 3.1 0.1 0.4 8.6 0.3 19.8 0.2 0.8 0.2 23.7 159.2 0.7 0.0 0.4 1.9 0.1 0.2 0.0 0.2 0.0 1.6 0.3 0.5 0.0 1.3 0.1 0.1 1.2 13.4 0.1 1.0 2.6 1.7 0.2 1.8 0.0 0.1 1.1 0.8 1.8 2.7 0.0 0.0 33.1 0.1 0.0 0.0 0.0 0.2 5.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 24.2 0.1 0.1 0.0 11.1 0.0 0.1 0.0 0.4 0.0 0.1 2.3 13.2 0.0 0.2 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.1 2.2 0.8 0.2 0.4 1.9 1.6 1.8 CYP4Z1 CYP4A20 ENSG00000186160 "Cytochrome P450 family 4 subfamily Z member 1" Q86W10 1 47067488-47118319 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "breast: 23.1" "Group enriched" "Detected in some" 39 "HDLM-2: 13.4;SK-BR-3: 5.8" "Cancer enriched" "Detected in some" 50 "breast cancer: 42.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (4.11e-2)" "unprognostic (2.57e-2)" "unprognostic (2.46e-1)" "unprognostic (5.12e-2)" "unprognostic (1.37e-1)" "unprognostic (4.33e-4)" "unprognostic (1.10e-1)" "unprognostic (3.53e-3)" "unprognostic (7.76e-3)" "unprognostic (1.21e-1)" "unprognostic (3.53e-1)" "unprognostic (6.82e-3)" "unprognostic (5.09e-3)" "unprognostic (3.88e-2)" "unprognostic (6.46e-2)" "unprognostic (3.49e-3)" 2.5 0.2 0.4 0.4 0.9 0.0 23.1 0.4 2.0 1.0 0.4 0.4 0.4 0.0 0.4 0.8 0.8 0.7 0.4 0.4 0.4 1.8 0.4 1.5 2.1 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.7 1.3 0.0 0.4 1.5 0.8 0.5 2.2 0.4 0.4 0.4 0.4 0.2 1.0 0.4 0.6 0.4 0.4 0.5 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.4 2.0 0.4 1.8 0.4 0.4 0.7 0.4 CYP7A1 CYP7 ENSG00000167910 "Cytochrome P450 family 7 subfamily A member 1" P22680 8 58490178-58500236 "Enzymes, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 70 "liver: 50.4" "Cell line enhanced" "Detected in single" "BJ hTERT+: 1.4" "Cancer enriched" "Detected in single" 96 "liver cancer: 28.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (5.20e-2)" "unprognostic (1.93e-2)" "unprognostic (1.77e-2)" "prognostic favourable (3.19e-4)" "unprognostic (7.60e-2)" "unprognostic (5.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-1)" "unprognostic (8.43e-3)" "unprognostic (3.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.51e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.5 0.0 0.0 1.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.1 0.9 0.0 0.2 0.5 0.4 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP8B1 CYP12 ENSG00000180432 "Cytochrome P450 family 8 subfamily B member 1" Q9UNU6 3 42856005-42876165 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 132.7" "Group enriched" "Detected in some" 5 "BEWO: 6.7;HEL: 1.7;Hep G2: 2.5;SK-BR-3: 3.0" "Cancer enriched" "Detected in some" 46 "liver cancer: 69.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.58e-2)" "unprognostic (5.41e-2)" "unprognostic (6.38e-2)" "unprognostic (1.15e-2)" "unprognostic (8.95e-2)" "unprognostic (1.42e-3)" "unprognostic (4.47e-3)" "unprognostic (1.49e-1)" "unprognostic (9.85e-2)" "unprognostic (4.04e-3)" "unprognostic (5.86e-3)" "unprognostic (2.74e-1)" "unprognostic (3.37e-1)" "unprognostic (1.03e-1)" "unprognostic (3.63e-1)" "unprognostic (3.19e-1)" "unprognostic (1.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 6.7 132.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.4 0.2 0.1 0.2 0.1 0.3 0.6 0.2 0.2 0.0 0.0 6.7 0.1 0.0 0.0 0.0 0.5 0.3 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.2 1.7 0.2 2.5 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.2 0.0 0.3 0.4 0.5 0.6 0.3 0.3 0.4 0.0 0.0 0.6 3.0 0.3 0.3 0.1 0.3 0.3 0.6 0.3 0.2 0.4 0.1 0.3 0.3 0.4 0.1 1.4 0.2 0.3 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.2 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYS1 ENSG00000205795 "Cystin 1" Q717R9 2 10056780-10080944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 75.1" "Cell line enriched" "Detected in some" 18 "RPTEC TERT1: 49.6" "Cancer enhanced" "Detected in many" "renal cancer: 46.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (8.48e-2)" "unprognostic (8.00e-2)" "unprognostic (9.17e-2)" "unprognostic (1.63e-1)" "unprognostic (1.00e-2)" "unprognostic (2.80e-1)" "unprognostic (1.56e-1)" "unprognostic (5.71e-2)" "unprognostic (1.94e-2)" "unprognostic (9.53e-2)" "unprognostic (7.05e-2)" "unprognostic (7.03e-2)" "prognostic favourable (1.27e-5)" "unprognostic (2.19e-3)" "unprognostic (1.47e-1)" "unprognostic (8.93e-2)" "unprognostic (1.20e-2)" 1.4 0.8 3.2 3.2 1.6 0.0 0.9 2.8 2.6 8.1 4.5 2.1 2.7 1.2 5.5 6.6 3.3 3.4 14.9 2.8 2.0 1.9 75.1 0.4 3.1 0.5 1.4 3.1 6.9 17.1 0.2 3.2 0.0 2.4 2.6 0.9 5.9 1.4 3.9 0.5 0.7 1.7 3.1 1.5 1.3 1.9 1.4 0.9 0.1 7.8 2.4 1.0 2.9 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.2 0.0 0.2 0.7 0.1 0.0 0.1 0.0 0.0 0.2 1.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.6 0.0 0.0 0.2 0.2 0.1 0.0 0.9 0.1 0.0 2.7 1.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.6 2.8 2.6 2.0 1.9 1.4 3.1 2.4 0.9 CYSRT1 "C9orf169, MGC59937" ENSG00000197191 "Cysteine rich tail 1" 9 137224635-137226311 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "esophagus: 33.4" "Cell line enhanced" "Detected in many" "A-431: 9.8;CAPAN-2: 12.4;HaCaT: 13.8;HeLa: 12.2;MCF7: 19.1" "Cancer enhanced" "Detected in all" "head and neck cancer: 23.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 3.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021883, HPA021886" Approved Approved "Nuclear speckles,Vesicles,Midbody" "Nuclear speckles" "Vesicles, Midbody" "HPA021883: AB_1853190, HPA021886: AB_1853192" "unprognostic (1.35e-1)" "unprognostic (2.53e-2)" "unprognostic (8.31e-3)" "unprognostic (6.87e-3)" "unprognostic (2.14e-1)" "unprognostic (2.66e-2)" "unprognostic (8.11e-2)" "unprognostic (5.86e-2)" "unprognostic (3.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (6.24e-3)" "unprognostic (7.92e-3)" "unprognostic (1.99e-1)" "unprognostic (1.03e-1)" "unprognostic (2.29e-1)" 0.7 0.4 1.0 0.7 0.9 0.2 0.8 0.7 1.7 1.4 0.7 0.7 0.7 0.3 0.7 0.7 33.4 1.0 0.7 0.7 1.4 1.3 1.4 0.7 0.7 0.7 0.8 0.7 0.7 0.7 0.3 3.5 0.7 0.7 1.1 0.0 0.7 2.2 0.7 0.7 8.1 0.7 0.7 0.7 0.7 0.8 2.2 0.7 0.7 1.3 0.7 5.3 0.7 2.1 0.9 0.6 0.9 3.0 0.9 0.3 0.1 9.8 1.2 1.0 2.1 0.0 0.0 2.7 0.3 0.3 0.3 0.1 0.7 12.4 0.7 0.7 0.2 13.8 0.3 3.1 0.0 1.3 1.0 0.2 12.2 6.5 0.7 0.1 0.6 0.3 1.5 0.4 0.1 0.1 0.4 2.1 0.8 19.1 0.4 0.7 0.5 1.5 1.5 1.3 1.7 0.4 0.7 0.3 1.0 2.0 1.8 0.5 3.9 0.2 0.5 0.8 0.5 1.8 0.3 1.2 0.9 0.7 0.7 0.5 0.8 0.9 0.2 0.2 0.3 1.7 0.1 0.9 0.3 0.2 0.6 0.8 0.2 0.3 0.7 0.9 3.0 0.4 0.2 0.1 1.0 0.9 0.7 1.7 1.4 1.3 0.8 0.7 0.7 0.7 DAZL "DAZH, DAZL1, DAZLA, MGC26406, SPGYLA" ENSG00000092345 "Deleted in azoospermia like" Q92904 3 16586792-16670306 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 68.6" "Cell line enriched" "Detected in some" 8 "HAP1: 20.1" "Cancer enriched" "Detected in single" 51 "testis cancer: 13.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 21 "naive B-cell: 2.7" "Lineage enriched" "Detected in single" 27 "B-cells: 2.7" "Region enhanced" "Detected in many" "basal ganglia: 8.7" "Not detected" "Not detected" "HPA019593, HPA019777, HPA047113" Enhanced "HPA019593: AB_1847494, HPA019777: AB_1847495, HPA047113: " "unprognostic (5.61e-2)" "unprognostic (5.27e-3)" "unprognostic (2.80e-1)" "unprognostic (5.85e-2)" "unprognostic (2.32e-3)" "unprognostic (2.60e-2)" "unprognostic (6.34e-2)" "unprognostic (4.91e-2)" "unprognostic (9.69e-2)" "unprognostic (7.79e-2)" "unprognostic (2.04e-1)" "unprognostic (3.47e-1)" 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 68.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 DCAF4L1 WDR21B ENSG00000182308 "DDB1 and CUL4 associated factor 4 like 1" Q3SXM0 4 41981696-41986467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 37.5" "Cell line enhanced" "Detected in some" "REH: 3.6" "Cancer enriched" "Detected in single" 49 "testis cancer: 8.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" CAB073535 Enhanced "CAB073535: " "unprognostic (6.24e-2)" "unprognostic (7.52e-3)" "unprognostic (8.11e-3)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (9.63e-3)" "unprognostic (4.64e-4)" "unprognostic (1.62e-1)" "unprognostic (1.42e-2)" "unprognostic (3.11e-2)" "unprognostic (2.83e-2)" "unprognostic (4.03e-1)" "unprognostic (3.76e-3)" "unprognostic (4.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.49e-2)" "unprognostic (1.36e-4)" 0.1 0.1 0.1 0.2 0.2 0.1 1.1 0.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.9 0.3 0.1 0.1 0.1 0.5 0.0 37.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.3 1.4 0.3 0.0 0.4 0.0 0.1 0.2 0.3 2.3 0.1 0.1 1.4 0.4 0.1 0.2 0.2 0.3 0.8 0.6 0.3 0.1 0.8 1.9 0.2 0.6 0.2 0.8 2.1 2.0 0.3 0.2 2.3 1.2 0.1 2.2 0.6 0.2 0.0 1.0 0.0 0.2 0.1 0.8 2.9 0.3 0.6 3.6 0.4 0.6 0.2 0.4 0.6 0.7 0.2 0.1 0.3 0.2 0.2 0.4 0.3 2.0 0.6 2.1 0.9 2.8 0.3 0.3 2.0 1.0 0.9 0.3 0.1 0.3 0.2 0.0 0.3 0.4 0.2 0.1 0.6 0.0 0.4 1.4 0.0 0.3 0.3 0.0 0.0 0.1 0.2 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 DCAF4L2 WDR21C ENSG00000176566 "DDB1 and CUL4 associated factor 4 like 2" Q8NA75 8 87870743-87874068 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 26.6" "Cell line enriched" "Detected in single" 26 "U-266/84: 12.4" "Cancer enriched" "Detected in some" 6 "testis cancer: 20.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA067584 Uncertain "HPA067584: " "unprognostic (4.25e-1)" "unprognostic (4.81e-2)" "unprognostic (1.90e-1)" "unprognostic (1.37e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 12.4 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCAF8L1 WDR42B ENSG00000226372 "DDB1 and CUL4 associated factor 8 like 1" A6NGE4 X 27977993-27981449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 8.4" "Cell line enriched" "Detected in single" 23 "Karpas-707: 20.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043787 Enhanced "HPA043787: AB_10961430" "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCAF8L2 WDR42C ENSG00000189186 "DDB1 and CUL4 associated factor 8 like 2" P0C7V8 X 27590382-27748821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 50 "testis: 35.0" "Cell line enriched" "Detected in some" 6 "U-2 OS: 14.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.88e-1)" "unprognostic (1.13e-1)" "unprognostic (5.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.5 2.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCDC2C ENSG00000214866 "Doublecortin domain containing 2C" A8MYV0 2 3703592-3847411 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045848 Uncertain "HPA045848: AB_10961120" "unprognostic (2.63e-2)" "unprognostic (1.81e-1)" "unprognostic (3.81e-3)" "unprognostic (6.98e-2)" 0.2 0.2 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.6 0.1 0.1 0.5 0.0 0.5 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 9.0 0.1 0.1 0.6 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 DCLK1 "DCAMKL1, DCDC3A, DCLK, KIAA0369" ENSG00000133083 "Doublecortin like kinase 1" O15075 13 35768652-36131306 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 76.5" "Cell line enhanced" "Detected in some" "ASC diff: 17.3;ASC TERT1: 16.4;fHDF/TERT166: 13.3;HAP1: 10.3;HSkMC: 15.1;NTERA-2: 21.4" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012405, HPA015040, HPA015655" Enhanced Approved Nucleoplasm,Cytosol 11000 Nucleoplasm Cytosol "CAB012405: , HPA015040: , HPA015655: " "unprognostic (2.29e-1)" "unprognostic (2.56e-1)" "unprognostic (7.45e-2)" "unprognostic (1.30e-2)" "unprognostic (1.99e-1)" "unprognostic (2.35e-2)" "unprognostic (1.48e-1)" "unprognostic (3.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-1)" "unprognostic (7.72e-2)" "unprognostic (2.85e-1)" "prognostic unfavourable (4.42e-4)" "unprognostic (1.93e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-4)" 13.9 3.3 14.3 4.2 25.0 1.1 8.6 8.6 76.5 12.2 3.5 8.6 0.5 2.0 6.4 5.8 5.8 3.3 7.1 5.8 21.9 21.9 1.9 1.2 3.0 4.3 11.9 22.5 6.4 2.1 1.5 7.4 1.1 13.9 4.7 4.4 0.5 2.5 4.7 1.9 4.7 2.7 17.0 10.4 4.6 2.5 2.2 8.5 0.0 2.1 1.4 2.9 5.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.0 17.3 16.4 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 13.3 0.0 10.3 0.2 0.0 0.0 0.6 0.0 0.4 0.0 0.6 0.0 0.0 15.1 7.5 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 21.4 0.2 0.0 1.2 0.0 0.6 0.0 4.3 2.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.5 4.4 0.7 0.1 0.0 0.0 1.4 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 25.0 8.6 45.8 21.9 21.9 11.9 22.5 13.9 8.5 DCLK2 "DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428" ENSG00000170390 "Doublecortin like kinase 2" Q8N568 4 150078274-150257457 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 60.5" "Cell line enhanced" "Detected in many" "AF22: 18.2;BJ hTERT+: 19.0;fHDF/TERT166: 8.3" "Cancer enriched" "Detected in many" 17 "glioma: 53.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.5;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015770 Enhanced "HPA015770: AB_1847509" "unprognostic (7.37e-2)" "unprognostic (1.56e-3)" "unprognostic (9.30e-2)" "unprognostic (1.49e-2)" "unprognostic (4.06e-1)" "unprognostic (6.24e-3)" "unprognostic (1.90e-1)" "unprognostic (7.38e-3)" "unprognostic (2.18e-1)" "prognostic favourable (3.25e-4)" "prognostic favourable (2.48e-4)" "unprognostic (6.87e-2)" "unprognostic (3.93e-3)" "unprognostic (3.74e-3)" "unprognostic (4.53e-2)" "unprognostic (1.48e-1)" "unprognostic (1.45e-2)" 2.9 3.9 23.3 2.1 23.5 1.6 2.0 9.3 60.5 3.1 2.8 16.5 0.8 2.8 4.3 3.5 3.0 2.8 4.0 14.4 23.5 17.5 2.9 1.8 2.7 1.6 14.9 14.5 4.3 3.5 1.4 4.7 2.9 20.2 3.9 3.5 2.1 2.0 3.6 2.3 2.1 2.7 6.4 23.4 2.1 2.2 4.2 15.9 0.0 4.1 0.0 1.5 3.3 2.0 2.5 1.5 0.0 0.5 0.0 0.0 0.0 0.8 3.2 18.2 2.8 0.0 0.9 0.3 8.2 19.0 2.7 0.6 0.1 0.0 0.0 0.3 8.3 0.0 2.6 0.0 3.4 3.7 1.6 0.0 4.7 0.0 3.9 0.5 0.5 0.5 0.0 1.6 0.2 0.9 0.0 0.0 1.9 0.1 0.3 0.0 0.3 1.0 0.0 2.1 0.7 0.0 0.8 7.0 6.6 3.4 2.5 0.8 0.0 0.0 1.6 2.5 1.0 1.6 0.9 0.8 0.0 0.0 2.4 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 23.3 23.5 9.3 19.3 23.5 17.5 14.9 14.5 20.2 15.9 DCUN1D1 "DCUN1L1, RP42, SCCRO, SCRO, Tes3" ENSG00000043093 "Defective in cullin neddylation 1 domain containing 1" Q96GG9 3 182938074-182985953 "Predicted intracellular proteins" "Ubl conjugation pathway" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 95.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035911 Uncertain Approved Nucleoplasm,Cytosol 70000 Nucleoplasm Cytosol "HPA035911: AB_10673489" "unprognostic (2.13e-1)" "unprognostic (2.36e-1)" "unprognostic (4.83e-3)" "unprognostic (1.94e-3)" "unprognostic (1.44e-3)" "unprognostic (6.06e-2)" "unprognostic (5.93e-2)" "unprognostic (1.72e-2)" "unprognostic (9.34e-2)" "unprognostic (9.25e-3)" "unprognostic (4.98e-3)" "unprognostic (7.26e-2)" "unprognostic (1.01e-3)" "unprognostic (1.52e-1)" "unprognostic (2.12e-1)" "unprognostic (5.01e-2)" "unprognostic (3.52e-1)" 5.0 5.2 7.9 5.0 7.1 6.9 4.8 9.3 8.3 4.5 4.9 4.1 2.7 4.9 5.4 4.9 6.7 4.3 4.6 5.5 7.4 5.0 7.2 11.2 4.3 5.0 9.3 6.8 4.7 3.6 4.6 14.6 4.5 8.0 6.1 4.8 2.8 4.9 5.4 14.7 5.2 6.5 8.1 9.2 5.2 4.2 95.0 7.6 7.2 6.7 5.2 6.0 8.4 4.9 7.4 10.7 17.3 9.8 11.2 8.0 5.7 23.0 10.2 13.7 5.9 14.6 14.3 11.6 14.8 16.7 16.7 16.4 15.1 17.2 27.0 32.6 13.8 13.0 11.5 11.9 22.2 22.1 6.2 26.0 8.0 6.3 9.2 15.3 19.7 10.2 14.5 9.3 8.8 11.4 8.7 14.2 12.2 12.4 15.0 8.2 11.2 9.4 11.8 14.5 17.9 12.0 16.3 10.0 9.9 25.9 18.7 13.9 38.2 12.4 11.1 10.4 10.0 14.1 17.4 11.7 21.8 27.5 13.0 14.5 14.9 9.4 9.1 17.3 7.8 9.8 7.5 7.4 6.4 7.7 10.7 4.7 7.5 7.9 15.0 11.2 6.3 8.2 8.0 5.7 7.9 7.1 9.3 8.3 7.4 5.0 9.3 6.8 8.0 7.6 DCXR "DCR, KIDCR, SDR20C1" ENSG00000169738 "Dicarbonyl and L-xylulose reductase" Q7Z4W1 17 82035136-82037732 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Xylose metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 293.8" "Cell line enhanced" "Detected in all" "Hep G2: 64.9;MCF7: 79.8" "Cancer enhanced" "Detected in all" "liver cancer: 305.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023371, HPA023863" Enhanced Uncertain Nucleoli,Microtubules 2700000 "Nucleoli, Microtubules" "HPA023371: AB_1847530, HPA023863: AB_1847531" "unprognostic (3.33e-2)" "unprognostic (1.67e-3)" "unprognostic (3.75e-1)" "unprognostic (1.16e-2)" "unprognostic (1.19e-1)" "unprognostic (8.43e-2)" "unprognostic (4.54e-3)" "unprognostic (1.86e-2)" "unprognostic (3.05e-1)" "unprognostic (2.56e-2)" "prognostic favourable (4.70e-4)" "unprognostic (1.72e-1)" "prognostic favourable (2.13e-4)" "unprognostic (1.81e-1)" "unprognostic (1.36e-1)" "unprognostic (2.64e-1)" "unprognostic (1.10e-2)" 12.7 6.1 12.8 4.3 12.1 5.7 12.2 9.0 15.1 9.9 9.5 8.4 18.1 7.8 4.4 62.7 11.7 6.1 4.8 11.8 9.8 9.7 50.8 293.8 10.5 5.3 14.4 7.3 8.1 13.0 6.7 7.2 9.0 13.4 22.3 5.4 7.8 19.3 14.0 22.5 8.6 6.8 3.6 8.4 4.4 14.9 8.7 9.7 8.3 15.6 12.6 9.1 7.5 6.4 32.8 52.7 25.3 33.1 35.2 43.7 35.8 8.9 12.3 5.7 10.3 23.0 5.8 15.2 4.6 6.0 12.7 8.7 21.8 3.9 18.5 9.0 6.4 10.6 10.4 9.2 4.4 3.9 26.7 17.7 9.2 64.9 24.7 13.6 21.8 8.4 11.5 4.0 14.6 7.1 20.2 13.5 6.7 79.8 11.4 32.7 6.6 13.1 10.5 7.7 24.2 9.4 12.7 15.9 9.4 6.4 55.0 8.0 41.2 13.5 3.6 6.7 8.4 9.0 8.6 13.9 10.2 8.7 5.7 15.0 4.9 13.9 33.1 25.3 24.7 30.6 23.6 28.6 30.8 23.6 52.7 32.8 43.7 31.9 16.5 35.2 28.0 42.5 33.1 35.8 12.8 12.1 9.0 15.1 9.8 9.7 14.4 7.3 13.4 9.7 DDI1 FLJ36017 ENSG00000170967 "DNA damage inducible 1 homolog 1" Q8WTU0 11 104036580-104039188 "Predicted intracellular proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 49 "testis: 53.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "unprognostic (2.98e-1)" "unprognostic (2.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DDIT4L "REDD2, Rtp801L" ENSG00000145358 "DNA damage inducible transcript 4 like" Q96D03 4 100185870-100190782 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 106.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 13.8;BJ: 20.2;fHDF/TERT166: 10.9;HSkMC: 10.5;RPTEC TERT1: 14.4" "Cancer enhanced" "Detected in many" "testis cancer: 19.3" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 7 "T-cells: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050903 Uncertain "Nucleoplasm,Plasma membrane,Actin filaments" "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA050903: " "unprognostic (2.21e-1)" "unprognostic (1.92e-1)" "unprognostic (1.34e-1)" "prognostic favourable (5.77e-4)" "unprognostic (1.66e-3)" "unprognostic (5.92e-2)" "unprognostic (2.72e-2)" "unprognostic (3.12e-1)" "unprognostic (3.21e-1)" "unprognostic (7.18e-2)" "unprognostic (2.59e-1)" "unprognostic (1.41e-1)" "unprognostic (4.47e-2)" "unprognostic (4.82e-3)" "unprognostic (2.09e-2)" "unprognostic (7.53e-5)" "unprognostic (4.99e-3)" 1.4 0.5 1.5 0.3 6.3 0.3 0.6 2.0 1.6 7.9 0.6 1.7 0.0 0.2 0.9 3.0 2.6 0.9 0.3 3.5 2.1 0.7 6.2 0.2 0.4 0.3 1.5 1.6 2.8 0.2 0.3 1.2 1.3 2.7 3.8 0.5 5.2 6.3 2.6 106.4 0.4 0.3 0.8 2.4 0.5 0.2 1.1 1.7 0.0 0.6 18.6 1.2 0.5 0.9 0.2 0.0 0.0 0.2 0.0 2.0 0.2 0.0 1.5 5.9 0.0 2.7 13.8 0.8 20.2 1.7 0.3 0.1 0.1 0.6 0.0 0.5 10.9 0.0 4.2 0.3 0.4 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 10.5 0.1 0.2 1.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 6.7 0.0 0.4 0.0 0.0 14.4 0.0 0.0 0.0 0.4 0.8 2.7 0.0 0.1 0.1 0.0 0.0 0.0 1.5 2.7 0.0 0.0 5.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.1 2.0 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 1.0 0.2 1.5 6.3 2.0 1.6 2.1 0.7 1.5 1.6 2.7 1.7 DDX20 "DP103, GEMIN3" ENSG00000064703 "DEAD-box helicase 20" Q9UHI6 1 111755245-111768016 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 81.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005516, CAB015427" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Intracellular and membrane" "Nucleoplasm, Nuclear bodies" Cytosol "CAB015427: AB_629518, HPA005516: AB_1849612" "unprognostic (3.71e-2)" "unprognostic (5.25e-2)" "prognostic favourable (9.85e-5)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (7.09e-2)" "prognostic unfavourable (6.35e-6)" "unprognostic (1.17e-1)" "unprognostic (5.87e-2)" "unprognostic (7.46e-3)" "unprognostic (4.21e-1)" "unprognostic (5.22e-2)" "unprognostic (1.05e-3)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (4.23e-1)" "unprognostic (1.30e-2)" 3.1 2.8 2.9 2.7 4.3 5.9 9.8 5.8 5.1 2.7 2.6 1.8 2.6 2.0 4.0 2.9 2.6 3.7 1.7 2.0 4.3 1.6 2.7 2.4 4.1 3.8 2.4 1.9 3.9 2.9 4.0 3.9 2.7 3.4 2.9 2.6 1.2 2.6 2.7 5.1 2.5 3.5 2.9 5.6 4.5 2.8 81.7 3.3 5.1 3.2 1.7 4.1 2.9 5.0 11.9 7.4 12.7 7.4 10.5 14.1 7.8 11.4 4.7 12.2 11.0 8.8 7.0 11.4 11.2 8.7 16.1 15.7 7.0 4.0 26.8 8.8 7.6 9.2 14.4 11.3 18.0 12.2 13.0 13.0 9.2 7.2 8.8 12.8 9.6 7.0 9.9 13.7 13.9 11.1 12.4 9.8 12.2 10.8 15.7 13.0 15.3 9.6 15.4 20.1 6.7 10.5 9.0 12.7 11.5 10.8 13.5 18.0 8.4 13.6 9.8 9.8 14.5 17.5 13.0 4.9 6.9 20.5 10.2 13.2 22.1 12.7 7.0 6.9 10.0 7.3 13.3 11.9 11.7 11.8 7.4 10.1 14.1 12.3 5.0 10.5 7.4 5.2 11.7 7.8 2.9 4.3 5.8 5.1 4.3 1.6 2.4 1.9 3.4 3.3 DDX4 VASA ENSG00000152670 "DEAD-box helicase 4" Q9NQI0 5 55738017-55817157 "Enzymes, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 171 "testis: 60.4" "Cell line enhanced" "Detected in some" "BEWO: 5.9;HEK 293: 1.6;NB-4: 1.0;PC-3: 3.3" "Cancer enriched" "Detected in single" 37 "testis cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB026170, HPA037763, HPA037764" Enhanced "CAB026170: , HPA037763: , HPA037764: " "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (1.54e-1)" "unprognostic (2.58e-1)" "unprognostic (3.80e-2)" "unprognostic (3.03e-1)" "unprognostic (5.35e-2)" "unprognostic (3.91e-1)" "unprognostic (3.77e-2)" "unprognostic (3.28e-1)" "unprognostic (5.73e-2)" "unprognostic (5.43e-7)" "unprognostic (4.84e-2)" "unprognostic (1.12e-1)" "unprognostic (5.60e-2)" "unprognostic (1.55e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 60.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 3.3 0.0 0.1 0.0 0.7 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 DDX43 "CT13, DKFZp434H2114, HAGE" ENSG00000080007 "DEAD-box helicase 43" Q9NXZ2 6 73394748-73417569 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 35.2" "Cell line enhanced" "Detected in some" "BEWO: 8.8;CAPAN-2: 14.8;HHSteC: 4.1;U-2 OS: 9.5" "Cancer enriched" "Detected in many" 15 "testis cancer: 13.0" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA031381 Enhanced "HPA031381: AB_10601885" "unprognostic (4.03e-3)" "unprognostic (8.20e-2)" "unprognostic (2.06e-1)" "unprognostic (1.01e-1)" "unprognostic (2.19e-1)" "unprognostic (3.59e-4)" "unprognostic (1.64e-2)" "unprognostic (3.11e-2)" "unprognostic (1.20e-1)" "unprognostic (2.15e-1)" "unprognostic (3.12e-1)" "unprognostic (3.08e-1)" "unprognostic (1.19e-3)" "unprognostic (1.02e-1)" "unprognostic (2.68e-1)" "unprognostic (1.58e-1)" "unprognostic (8.78e-2)" 1.3 0.7 0.6 1.0 0.7 0.7 1.9 0.4 0.8 0.8 2.6 1.2 2.1 1.4 1.0 0.4 1.1 0.7 6.1 1.2 0.7 0.6 0.8 1.0 1.6 0.9 1.0 0.0 2.9 1.9 0.1 0.7 5.7 3.3 1.8 0.7 1.5 4.3 2.2 0.4 1.4 1.7 3.0 1.9 1.2 2.4 35.2 0.7 0.4 1.8 1.3 1.9 1.7 0.7 2.3 0.8 2.9 0.9 1.6 3.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.5 0.0 0.0 0.0 0.1 14.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 2.9 3.3 0.9 2.6 2.3 2.5 2.8 0.8 2.3 1.3 0.4 0.6 1.6 0.8 0.2 1.4 0.7 0.6 0.7 0.4 0.8 0.7 0.6 1.0 0.0 3.3 0.7 DDX53 "CAGE, CT26" ENSG00000184735 "DEAD-box helicase 53" Q86TM3 X 22999961-23003589 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 11.5" "Cell line enhanced" "Detected in some" "K-562: 6.2;RPMI-8226: 3.2;U-2197: 2.1;U-266/84: 14.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003186 Supported Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA003186: AB_1078637" "unprognostic (5.76e-1)" "unprognostic (1.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.4 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DECR2 "PDCR, SDR17C1" ENSG00000242612 "2,4-dienoyl-CoA reductase 2" Q9NUI1 16 401826-412487 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 68.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047631 Approved Peroxisomes Peroxisomes "HPA047631: " "unprognostic (2.74e-2)" "unprognostic (3.84e-1)" "unprognostic (1.83e-1)" "unprognostic (4.44e-3)" "unprognostic (1.77e-1)" "unprognostic (7.45e-2)" "unprognostic (2.38e-2)" "unprognostic (1.17e-1)" "unprognostic (1.91e-1)" "unprognostic (3.02e-2)" "unprognostic (3.11e-2)" "unprognostic (3.38e-1)" "unprognostic (1.12e-1)" "unprognostic (3.40e-1)" "unprognostic (2.21e-1)" "unprognostic (1.94e-1)" "unprognostic (4.22e-3)" 5.7 10.8 3.2 4.3 4.0 3.5 4.0 3.8 5.0 2.9 10.2 2.7 5.0 14.2 4.0 7.3 4.1 2.5 7.8 4.4 2.8 2.3 16.9 68.2 4.3 3.9 2.0 3.0 2.6 9.7 1.8 2.6 2.3 2.0 4.1 2.4 3.0 6.2 5.6 15.9 2.9 14.4 5.1 1.9 1.9 5.9 4.1 1.8 1.2 1.7 4.3 2.9 2.7 2.2 3.3 9.5 0.4 6.1 2.7 5.1 3.9 1.1 10.9 1.4 6.5 1.2 3.0 4.1 3.3 2.5 2.8 3.0 6.9 7.5 3.7 7.2 4.1 2.5 1.1 2.8 0.4 8.3 3.5 0.9 5.3 16.4 8.6 3.3 5.3 4.2 2.1 1.9 2.4 3.6 2.3 3.4 2.4 11.4 1.9 4.6 4.1 5.7 4.5 0.5 6.8 2.8 2.9 2.9 4.4 6.3 7.1 3.7 10.2 4.2 7.4 2.4 2.7 3.4 2.5 4.9 3.9 1.6 3.4 5.0 8.0 0.0 6.1 0.4 3.6 5.6 2.5 2.8 2.2 2.4 6.5 3.3 5.1 3.0 0.3 2.7 4.5 9.5 1.7 3.9 3.2 4.0 3.8 5.0 2.8 2.3 2.0 3.0 2.0 1.8 DEFA1 "DEF1, DEFA2, HNP-1, MRS" ENSG00000206047 "Defensin alpha 1" P59665 8 6977649-6980080 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 825.5" "Cell line enriched" "Detected in single" 17 "NB-4: 6.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.3" "Low lineage specificity" "Detected in single" "CAB032548, HPA052517" Enhanced "Intracellular and membrane" "CAB032548: AB_2277258, HPA052517: " 1.3 0.1 0.2 0.1 0.6 825.5 0.6 0.0 0.4 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 2.3 0.2 0.2 0.2 6.0 41.9 0.3 0.3 0.1 0.1 0.1 1.0 0.6 0.1 0.1 0.6 0.1 0.5 1.8 0.1 0.1 0.0 115.5 0.1 0.1 0.6 0.1 0.1 0.0 0.1 0.3 0.5 0.7 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.1 0.0 0.2 0.0 0.3 0.7 0.0 0.3 0.0 DEFA1B ENSG00000240247 "Defensin alpha 1B" P59665 8 6996766-6999195 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "bone marrow: 734.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 1.8" "Low lineage specificity" "Detected in many" HPA052517 Supported "Intracellular and membrane" "HPA052517: " 0.4 0.0 0.0 0.0 0.0 734.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.0 16.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 49.1 0.0 0.0 0.2 0.0 0.0 0.0 1.8 1.2 0.8 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 1.8 0.5 1.1 1.2 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 DEFA4 "DEF4, HP-4" ENSG00000164821 "Defensin alpha 4" P12838 8 6935822-6938338 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 245.5" "Cell line enriched" "Detected in some" 8 "THP-1: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 9.8" "Lineage enriched" "Detected in single" 12 "granulocytes: 9.8" HPA051266 Enhanced "Secreted to blood" "HPA051266: " 0.3 0.0 0.1 0.1 0.2 245.5 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 35.0 0.1 0.1 0.1 1.5 8.9 0.5 0.1 0.0 0.4 0.0 0.0 0.4 3.5 0.4 0.0 0.0 0.1 0.3 0.0 0.2 0.2 0.0 0.2 0.0 26.5 0.0 0.0 0.0 8.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.3 0.0 0.7 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 16.8 0.1 0.2 0.0 0.3 0.1 0.1 0.1 0.0 0.4 0.0 DEFA5 "DEF5, HD-5" ENSG00000164816 "Defensin alpha 5" Q01523 8 7055304-7056734 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 231 "intestine: 574.2" "Group enriched" "Detected in some" 8 "BEWO: 19.5;NB-4: 16.0;RPMI-8226: 16.8;SH-SY5Y: 13.7;U-2197: 5.9" "Cancer enhanced" "Detected in many" "cervical cancer: 181.1;colorectal cancer: 147.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015309, HPA015775, CAB069919" Enhanced Approved Vesicles,Midbody "Secreted to digestive system" Vesicles Midbody "CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594" "prognostic favourable (9.44e-5)" "unprognostic (3.91e-2)" 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 408.9 0.0 0.0 249.9 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.1 574.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 1.7 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 DEFA6 "DEF6, HD-6" ENSG00000164822 "Defensin alpha 6" Q01524 8 6924693-6926076 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 189 "intestine: 316.3" "Group enriched" "Detected in some" 12 "BEWO: 12.5;NB-4: 13.1;RPMI-8226: 15.4;SH-SY5Y: 10.6;U-2197: 4.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 75.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.6" "Lineage enriched" "Detected in single" 17 "B-cells: 1.6" HPA019462 Enhanced "Secreted to digestive system" "HPA019462: AB_1847595" "unprognostic (7.48e-3)" "unprognostic (1.63e-1)" "unprognostic (1.34e-1)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 262.3 0.0 0.0 181.7 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 316.3 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.9 10.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 DEFB104A "DEFB-4, DEFB104, DEFB4" ENSG00000176782 "Defensin beta 104A" Q8WTQ1 8 7836471-7841242 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "epididymis: 110.0" "Cell line enriched" "Detected in single" 15 "SH-SY5Y: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045292 Supported "Secreted in male reproductive system" "HPA045292: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 110.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DEFB104B ENSG00000177023 "Defensin beta 104B" Q8WTQ1 8 7470308-7475082 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 46 "epididymis: 108.2" "Cell line enriched" "Detected in single" 15 "SH-SY5Y: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045292 Supported "Secreted in male reproductive system" "HPA045292: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 108.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB105A "DEFB-5, DEFB105" ENSG00000186562 "Defensin beta 105A" Q8NG35 8 7821966-7823889 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 438 "epididymis: 227.6" "Cell line enhanced" "Detected in some" "BEWO: 3.3;NB-4: 12.5;SH-SY5Y: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 227.6 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB105B ENSG00000186599 "Defensin beta 105B" Q8NG35 8 7487669-7489593 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 396 "epididymis: 150.1" "Cell line enriched" "Detected in single" 12 "NB-4: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.1 150.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 DEFB106A "DEFB-6, DEFB106" ENSG00000186579 "Defensin beta 106A" Q8N104 8 7825172-7829053 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "epididymis: 22.0" "Group enriched" "Detected in some" 32 "BEWO: 2.9;RPMI-8226: 1.9;SH-SY5Y: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045592 Supported "Secreted in male reproductive system" "HPA045592: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 22.0 0.1 1.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 DEFB106B ENSG00000187082 "Defensin beta 106B" Q8N104 8 7482504-7486400 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 362 "epididymis: 164.2" "Cell line enriched" "Detected in single" 55 "NB-4: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045592 Supported "Secreted in male reproductive system" "HPA045592: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 164.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB107A "DEFB-7, DEFB107" ENSG00000186572 "Defensin beta 107A" Q8IZN7 8 7811720-7815716 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 100 "epididymis: 77.2" "Cell line enhanced" "Detected in single" "NB-4: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045626 Approved "Secreted in male reproductive system" "HPA045626: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.1 0.0 0.3 77.2 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB107B HsT21816 ENSG00000198129 "Defensin beta 107B" Q8IZN7 8 7495846-7509311 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 95 "epididymis: 78.7" "Cell line enhanced" "Detected in single" "NB-4: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045626 Approved "Secreted in male reproductive system" "HPA045626: " 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.0 0.3 78.7 0.1 0.8 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 DEFB110 "DEFB-10, DEFB-11, DEFB111" ENSG00000203970 "Defensin beta 110" Q30KQ9 6 50009138-50021981 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 158 "epididymis: 149.7" "Cell line enriched" "Detected in single" 6 "NB-4: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.5 0.1 0.1 0.0 0.9 0.0 0.1 149.7 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.0 DEFB112 DEFB-12 ENSG00000180872 "Defensin beta 112" Q30KQ8 6 50043575-50048651 "Predicted intracellular proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 54 "epididymis: 58.5" "Cell line enriched" "Detected in single" 29 "NB-4: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 58.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB113 DEFB-13 ENSG00000214642 "Defensin beta 113" Q30KQ7 6 49968677-49969625 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 139 "epididymis: 34.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB114 DEFB-14 ENSG00000177684 "Defensin beta 114" Q30KQ6 6 49960249-49964105 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 67 "epididymis: 39.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 39.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 DEFB115 DEFB-15 ENSG00000215547 "Defensin beta 115" Q30KQ5 20 31257664-31259632 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 22 "epididymis: 5.4" "Cell line enriched" "Detected in single" 60 "U-2 OS: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053160 Uncertain "Secreted in male reproductive system" "HPA053160: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB118 "C20orf63, DEFB-18, dJ1018D12.3, ESC42" ENSG00000131068 "Defensin beta 118" Q96PH6 20 31368618-31373923 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 147 "epididymis: 167.4" "Group enriched" "Detected in some" 5 "BEWO: 2.8;NB-4: 4.4;RPMI-8226: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042634 Enhanced "Secreted in male reproductive system" "HPA042634: AB_10797505" "unprognostic (3.24e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 167.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 DEFB121 DEFB-21 ENSG00000204548 "Defensin beta 121" Q5J5C9 20 31404845-31412838 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 133 "epididymis: 201.9" "Cell line enriched" "Detected in single" 79 "NB-4: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 201.9 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 DEFB125 DEFB-25 ENSG00000178591 "Defensin beta 125" Q8N687 20 87250-97094 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "epididymis: 74.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 13.6 0.0 0.0 74.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 DEFB126 "bA530N10.1, C20orf8, DEFB-26" ENSG00000125788 "Defensin beta 126" Q9BYW3 20 142369-145751 "Disease related genes, Predicted secreted proteins" Fertilization "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "epididymis: 255.5" "Cell line enhanced" "Detected in some" "NB-4: 2.9;RPMI-8226: 1.6;SH-SY5Y: 1.5;SK-BR-3: 1.8;SK-MEL-30: 1.1" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" "unprognostic (1.16e-1)" "unprognostic (1.21e-1)" "unprognostic (3.16e-2)" "unprognostic (2.41e-2)" "unprognostic (2.32e-1)" "unprognostic (1.47e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.0 18.2 0.0 0.1 255.5 0.3 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.5 0.0 1.8 1.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 DEFB127 "bA530N10.2, C20orf73, DEF-27" ENSG00000088782 "Defensin beta 127" Q9H1M4 20 157470-159163 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 56 "epididymis: 170.3" "Group enriched" "Detected in some" 27 "BEWO: 3.0;NB-4: 2.9;SH-SY5Y: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.0 3.0 0.0 0.1 170.3 0.1 0.1 0.0 0.1 0.1 0.1 1.2 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 DEFB128 DEFB-28 ENSG00000185982 "Defensin beta 128" Q7Z7B8 20 187853-189681 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 239 "epididymis: 186.7" "Group enriched" "Detected in some" 26 "BEWO: 2.8;NB-4: 3.1;RPMI-8226: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in male reproductive system" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 186.7 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 DEFB129 "bA530N10.3, C20orf87, DEFB-29" ENSG00000125903 "Defensin beta 129" Q9H1M3 20 227258-229886 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "epididymis: 223.2" "Cell line enhanced" "Detected in some" "BEWO: 2.3;NB-4: 7.0;RPMI-8226: 1.6;SH-SY5Y: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA014581 Supported "Secreted in male reproductive system" "HPA014581: " 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 14.0 0.0 0.2 223.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.3 0.1 0.6 0.1 0.0 0.1 0.1 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 3.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 DEFB130A "DEFB-30, DEFB130, DEFB30" ENSG00000232948 "Defensin beta 130A" P0DP74 8 12310962-12318316 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "epididymis: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB130B ENSG00000233050 "Defensin beta 130B" P0DP73 8 12064389-12071747 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "epididymis: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB131B ENSG00000225805 "Defensin beta 131B" A0A096LNP1 11 71878453-71884561 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "epididymis: 36.6" "Cell line enhanced" "Detected in many" "RH-30: 17.4" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.0" "Low lineage specificity" "Detected in many" "Secreted in male reproductive system" "unprognostic (5.87e-2)" "unprognostic (1.44e-1)" "unprognostic (4.78e-2)" "unprognostic (7.44e-2)" "unprognostic (3.57e-2)" "unprognostic (3.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.91e-1)" "unprognostic (3.09e-3)" "unprognostic (7.45e-2)" "unprognostic (1.41e-1)" "unprognostic (1.43e-1)" "unprognostic (5.21e-2)" "unprognostic (3.39e-1)" "unprognostic (1.05e-2)" "unprognostic (3.62e-1)" 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 36.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.1 1.5 0.0 0.9 0.3 3.0 0.8 0.7 1.4 1.2 0.0 0.6 0.0 3.6 1.4 0.0 0.0 0.4 3.7 0.0 0.0 0.0 4.4 4.1 3.5 1.3 0.0 3.8 0.0 0.0 0.0 2.8 2.9 3.7 2.1 2.5 0.0 4.6 1.7 0.0 0.0 0.0 0.0 0.0 8.4 6.0 0.0 3.3 2.0 1.2 1.1 5.7 3.9 17.4 1.1 0.0 1.1 4.0 1.6 3.4 2.0 3.4 3.5 0.4 2.1 1.3 3.6 2.5 0.3 3.0 1.0 4.7 2.1 4.1 0.8 0.8 0.7 0.0 1.2 0.0 0.0 0.0 0.7 0.0 0.4 0.3 0.4 0.6 0.0 1.4 0.5 3.0 0.9 0.0 DEFB133 ENSG00000214643 "Defensin beta 133" Q30KQ1 6 49946021-49950265 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 30 "epididymis: 18.2" "Cell line enriched" "Detected in single" 42 "K-562: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB134 ENSG00000205882 "Defensin beta 134" Q4QY38 8 11993174-11996312 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "epididymis: 24.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.5;NTERA-2: 1.2;U-87 MG: 1.1;WM-115: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" "unprognostic (3.80e-2)" "unprognostic (2.20e-1)" 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.0 0.2 0.0 0.0 0.0 1.6 0.3 0.0 24.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 DEFB135 ENSG00000205883 "Defensin beta 135" Q30KP9 8 11982321-11984590 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "epididymis: 30.8" "Group enriched" "Detected in some" 4 "HEK 293: 1.8;MCF7: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.0 0.6 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.5 0.3 0.3 0.1 0.0 0.0 0.0 DGAT1 "ARGP1, DGAT" ENSG00000185000 "Diacylglycerol O-acyltransferase 1" O75907 8 144314584-144326910 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "intestine: 161.0" "Cell line enhanced" "Detected in many" "Hep G2: 15.8;PC-3: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB032853 Enhanced Approved "Nucleoli,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoli "CAB032853: AB_2090798" "unprognostic (9.24e-3)" "unprognostic (1.61e-1)" "unprognostic (1.75e-2)" "unprognostic (2.23e-1)" "unprognostic (3.49e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (5.10e-2)" "unprognostic (2.78e-2)" "unprognostic (6.88e-2)" "unprognostic (3.52e-1)" "unprognostic (2.65e-3)" "unprognostic (3.83e-2)" "unprognostic (1.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.67e-3)" 11.8 18.5 3.6 5.7 4.7 6.4 6.8 6.6 5.6 3.3 60.2 4.0 6.4 44.7 3.9 3.6 5.5 3.1 7.9 6.3 3.7 2.7 6.7 14.4 3.8 3.1 4.1 2.7 3.3 3.9 5.0 4.0 4.3 3.6 3.4 6.3 4.1 5.9 4.3 10.0 4.8 161.0 3.6 2.6 5.3 5.7 10.7 4.2 5.1 3.8 6.2 5.0 4.7 3.4 0.7 2.2 2.8 2.0 0.3 1.7 0.8 3.8 4.1 1.9 3.6 3.2 1.3 2.3 2.7 2.7 2.6 1.8 9.7 2.6 1.5 10.6 1.7 3.3 1.6 3.7 0.5 2.8 4.0 2.8 3.3 15.8 2.3 0.7 2.9 1.8 2.9 1.6 1.9 2.0 2.2 3.5 1.7 3.2 4.8 3.1 0.9 17.6 6.2 0.8 2.5 2.4 2.1 2.0 3.4 3.6 4.4 1.8 2.5 2.7 1.6 1.4 4.9 2.8 2.2 2.0 0.4 0.6 1.4 4.9 2.3 0.0 2.0 2.8 1.2 1.3 1.7 0.7 0.9 1.1 2.2 0.5 0.7 0.3 2.3 0.3 1.7 1.1 0.7 0.8 3.6 4.7 6.6 5.6 3.7 2.7 4.1 2.7 3.6 4.2 DGKB "DAGK2, DGK, DGK-BETA, KIAA0718" ENSG00000136267 "Diacylglycerol kinase beta" Q9Y6T7 7 14145049-14974777 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 37.7" "Cell line enhanced" "Detected in some" "AF22: 2.7;fHDF/TERT166: 5.5;hTEC/SVTERT24-B: 2.1;SCLC-21H: 2.8;SH-SY5Y: 2.1;U-266/70: 7.4" "Cancer enriched" "Detected in single" 11 "glioma: 1.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020321 Supported "HPA020321: " "unprognostic (9.89e-2)" "unprognostic (9.72e-5)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (4.32e-2)" "unprognostic (3.37e-1)" "unprognostic (7.34e-2)" "unprognostic (5.91e-2)" "unprognostic (6.19e-2)" "unprognostic (8.87e-2)" "unprognostic (2.72e-2)" "unprognostic (1.18e-1)" "unprognostic (5.98e-2)" "unprognostic (2.37e-3)" "unprognostic (6.13e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-4)" 1.1 5.2 11.5 1.1 37.7 0.8 0.8 1.3 34.0 4.9 1.6 1.4 0.0 0.9 6.1 0.9 1.6 2.7 1.3 1.4 10.5 4.3 2.6 1.1 0.8 0.8 2.2 11.3 0.8 0.9 0.8 1.8 0.7 4.8 1.1 1.7 0.0 0.9 0.9 1.2 0.9 1.2 3.1 3.5 0.8 0.8 0.9 7.9 0.0 0.9 0.0 0.8 1.5 0.6 0.7 0.6 1.3 0.3 0.6 0.5 0.1 0.1 0.0 2.7 0.1 0.0 0.2 0.1 0.0 1.2 0.0 0.3 0.2 0.0 0.1 0.0 5.5 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.4 0.0 0.0 2.8 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 7.4 0.0 0.0 0.1 0.1 0.1 0.7 0.3 0.3 0.5 0.2 0.4 0.3 0.5 0.2 0.1 0.7 0.5 0.4 1.3 0.6 0.2 0.6 0.2 0.1 11.5 37.7 1.3 19.1 10.5 4.3 2.2 11.3 4.8 7.9 DHH "HHG-3, MGC35145" ENSG00000139549 "Desert hedgehog" O43323 12 49089421-49094819 "Disease related genes, Predicted secreted proteins" "Developmental protein, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 35.7" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;EFO-21: 7.1;HUVEC TERT2: 2.8;K-562: 11.9;TIME: 6.4" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 4 "midbrain: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "midbrain: 2.1" "Secreted in male reproductive system" "unprognostic (7.56e-2)" "unprognostic (2.05e-3)" "unprognostic (1.14e-1)" "unprognostic (2.93e-3)" "unprognostic (2.36e-4)" "unprognostic (1.29e-1)" "unprognostic (7.22e-3)" "unprognostic (8.21e-2)" "unprognostic (5.92e-2)" "unprognostic (1.22e-1)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (8.00e-2)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" 0.9 0.4 0.2 1.2 0.6 0.1 1.4 0.3 0.6 0.6 0.5 0.2 0.3 0.3 1.0 0.9 0.5 0.6 1.7 0.9 0.2 0.2 0.6 0.2 0.9 0.2 5.2 0.0 0.4 0.2 0.2 0.8 1.5 1.2 0.7 0.2 1.3 0.7 0.8 0.6 0.3 0.5 1.0 1.2 0.3 0.3 35.7 0.0 0.0 0.4 1.3 0.2 0.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.8 11.9 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.6 0.2 0.2 5.2 0.0 1.2 0.0 DHODH ENSG00000102967 "Dihydroorotate dehydrogenase (quinone)" Q02127 16 72008588-72027664 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Pyrimidine biosynthesis" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 72.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010123, HPA011942" Approved Enhanced Nucleoplasm,Mitochondria,Cytosol Mitochondria "Nucleoplasm, Cytosol" "HPA010123: AB_1847648, HPA011942: AB_1847649" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.41e-3)" "unprognostic (2.10e-1)" "unprognostic (4.27e-2)" "unprognostic (1.31e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-1)" "unprognostic (2.14e-1)" "unprognostic (6.40e-2)" "unprognostic (9.26e-3)" "unprognostic (1.98e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" 5.9 4.2 4.7 8.8 5.1 2.9 5.0 2.7 5.0 5.9 4.4 6.1 1.4 3.4 6.6 2.3 5.1 5.2 2.3 11.5 4.3 3.0 6.6 72.4 3.4 5.5 4.8 2.7 6.2 9.9 7.1 4.0 2.6 5.2 3.9 4.8 5.9 6.0 4.4 11.7 4.0 3.0 7.5 4.0 3.5 3.4 4.3 5.4 4.0 3.6 7.1 5.1 3.5 3.3 11.2 13.4 3.9 8.1 9.3 12.9 6.8 7.3 15.4 4.5 7.4 2.4 3.2 8.5 6.3 2.5 9.6 7.4 12.1 6.8 16.6 8.6 3.4 7.8 8.8 6.8 11.3 3.7 8.3 9.1 7.5 11.8 6.8 12.6 6.7 3.1 7.0 11.6 12.2 6.9 13.9 3.0 5.8 19.6 11.9 12.1 10.1 6.0 15.1 5.9 17.5 5.8 4.9 5.3 6.3 8.5 9.1 4.1 8.1 6.4 3.0 8.8 5.5 8.3 9.2 5.8 10.8 28.1 4.6 13.8 8.0 3.9 8.1 0.9 9.3 7.7 12.7 11.2 8.9 9.0 13.3 10.6 12.4 12.9 2.1 9.3 5.6 13.4 7.1 6.8 4.7 5.1 2.7 5.0 4.3 3.0 4.8 2.7 5.2 5.4 DHRS11 "MGC4172, SDR24C1" ENSG00000278535 "Dehydrogenase/reductase 11" Q6UWP2 17 36591798-36600806 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "intestine: 88.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041226, HPA048236, HPA053623" Enhanced Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" 11000 Cytosol "Golgi apparatus" "HPA041226: , HPA048236: , HPA053623: " "unprognostic (2.00e-3)" "unprognostic (1.22e-2)" "unprognostic (1.06e-2)" "unprognostic (3.74e-1)" "unprognostic (1.61e-3)" "unprognostic (2.03e-2)" "unprognostic (1.78e-1)" "unprognostic (1.80e-2)" "unprognostic (3.67e-1)" "unprognostic (5.94e-2)" "unprognostic (1.33e-2)" "unprognostic (4.11e-2)" "prognostic favourable (3.24e-4)" "unprognostic (1.45e-1)" "unprognostic (1.70e-1)" "unprognostic (2.16e-2)" "unprognostic (9.35e-2)" 1.3 0.6 1.2 4.1 2.4 0.4 0.7 0.5 5.7 0.4 38.7 0.4 0.4 42.7 0.4 0.1 1.2 1.1 1.4 2.0 0.5 2.5 1.7 0.1 0.0 0.0 2.4 0.1 2.8 1.5 0.2 0.0 1.6 0.5 12.4 2.8 2.1 0.8 2.0 0.8 88.0 0.9 0.1 0.0 1.1 2.2 0.3 0.0 1.3 1.3 1.0 0.4 0.0 0.9 0.2 0.9 0.7 0.1 2.7 0.1 6.5 5.9 2.8 7.4 0.6 1.7 5.5 2.0 1.4 6.4 5.8 9.6 5.3 0.7 1.4 2.0 6.9 6.0 4.1 6.5 3.4 11.4 1.7 5.7 18.6 3.1 1.9 0.6 0.9 3.9 4.4 3.3 4.9 15.6 5.8 3.5 5.8 6.4 3.5 2.2 2.3 8.0 7.0 11.0 6.5 5.6 6.0 2.6 7.0 7.3 16.4 10.0 1.8 1.8 0.9 9.1 4.8 5.0 9.5 8.0 2.3 3.3 4.7 2.8 0.4 0.5 0.9 1.0 0.7 0.1 0.4 1.0 0.6 0.1 0.9 1.3 0.9 0.5 0.1 0.1 0.2 2.7 0.1 DIRAS2 "Di-Ras2, DKFZp761C07121" ENSG00000165023 "DIRAS family GTPase 2" Q96HU8 9 90609832-90643105 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 65.3" "Cell line enhanced" "Detected in some" "AF22: 12.3;EFO-21: 3.6;SCLC-21H: 2.3" "Cancer enhanced" "Detected in many" "glioma: 5.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.70e-1)" "unprognostic (6.02e-2)" "unprognostic (1.20e-3)" "unprognostic (4.39e-2)" "unprognostic (1.35e-1)" "unprognostic (6.57e-2)" "unprognostic (4.27e-5)" "unprognostic (3.94e-2)" "unprognostic (4.37e-2)" "unprognostic (9.75e-3)" "unprognostic (9.85e-3)" "unprognostic (1.86e-1)" "unprognostic (5.70e-2)" "unprognostic (2.14e-1)" "unprognostic (5.39e-1)" "unprognostic (2.64e-3)" "unprognostic (2.05e-1)" 0.9 2.8 6.1 0.9 24.5 1.1 1.4 64.5 65.3 8.5 1.1 2.1 0.0 2.4 1.1 1.1 0.9 1.2 4.6 0.8 13.6 5.4 1.4 1.0 0.9 1.0 4.3 23.0 0.8 1.8 3.3 0.6 1.3 3.9 0.9 0.9 2.2 2.1 1.1 0.8 1.5 2.7 0.9 6.2 1.0 1.7 1.0 0.9 0.0 2.9 0.0 0.8 0.8 0.3 1.9 1.0 1.9 1.6 1.6 0.9 0.4 0.1 1.4 12.3 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 0.0 0.5 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.9 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.9 0.0 0.3 0.2 0.4 0.0 0.2 2.3 0.3 0.0 0.1 0.0 0.1 0.1 1.0 0.1 0.6 0.3 0.0 0.2 0.1 0.2 0.2 0.2 0.2 1.8 1.6 1.6 0.7 0.3 0.4 0.8 0.8 0.6 0.2 1.9 0.9 0.9 1.9 1.6 0.6 1.0 0.2 0.4 6.1 24.5 64.5 41.4 13.6 5.4 4.3 23.0 3.9 0.9 DISP2 "C15orf36, DISPB, HsT16908, KIAA1742, LINC00594" ENSG00000140323 "Dispatched RND transporter family member 2" A7MBM2 15 40358235-40378639 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 37.2" "Group enriched" "Detected in some" 5 "HaCaT: 8.0;SCLC-21H: 16.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059903 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA059903: " "unprognostic (3.43e-4)" "unprognostic (7.65e-3)" "unprognostic (4.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.90e-1)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (3.08e-2)" "unprognostic (1.98e-1)" "unprognostic (2.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" "unprognostic (4.47e-8)" "unprognostic (1.96e-1)" "unprognostic (3.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" 0.8 2.5 9.0 1.5 7.6 1.3 0.6 37.2 14.5 0.7 4.0 1.0 0.0 3.4 0.9 0.9 0.7 1.1 1.1 0.8 9.0 7.0 0.5 0.7 0.9 1.5 2.9 14.0 1.3 1.4 0.6 2.8 1.0 11.4 0.8 3.9 0.3 1.2 1.8 0.8 1.3 3.0 1.4 2.0 1.1 3.9 2.4 1.8 0.0 3.4 0.0 0.6 1.2 0.4 0.9 1.1 2.9 0.4 1.1 0.6 0.2 1.5 0.6 0.4 2.5 0.1 0.1 0.9 0.2 0.1 1.0 1.5 2.3 0.7 0.2 1.7 0.9 8.0 0.3 1.3 0.6 0.2 0.5 0.4 0.5 0.1 0.0 0.5 1.5 1.8 0.0 0.3 0.2 0.5 0.6 1.0 1.3 0.3 0.2 0.4 0.4 1.1 0.2 0.4 0.5 0.3 2.1 16.6 2.4 0.3 0.2 0.2 0.4 0.2 0.5 1.1 0.9 0.2 0.2 0.3 0.2 0.3 0.4 0.7 2.3 2.1 0.4 0.5 0.6 0.3 0.4 0.5 0.4 0.4 0.2 0.9 0.5 0.6 2.9 1.1 0.4 1.1 0.4 0.2 9.0 7.6 37.2 14.5 9.0 7.0 2.9 14.0 11.4 1.8 DKK1 "DKK-1, SK" ENSG00000107984 "Dickkopf WNT signaling pathway inhibitor 1" O94907 10 52314296-52318042 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "placenta: 153.6" "Cell line enhanced" "Detected in many" "BJ: 111.1;BJ hTERT+: 61.0;CACO-2: 97.0;fHDF/TERT166: 153.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 9 "pons and medulla: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in female reproductive system" "unprognostic (5.65e-2)" "unprognostic (4.21e-2)" "unprognostic (7.09e-2)" "unprognostic (7.99e-2)" "unprognostic (1.31e-1)" "prognostic unfavourable (4.35e-8)" "unprognostic (7.93e-2)" "prognostic unfavourable (7.80e-6)" "unprognostic (1.54e-1)" "unprognostic (6.87e-2)" "prognostic unfavourable (1.27e-4)" "unprognostic (1.81e-1)" "unprognostic (1.68e-1)" "unprognostic (7.47e-3)" "unprognostic (4.05e-1)" "unprognostic (1.19e-1)" "unprognostic (2.06e-2)" 15.6 0.1 0.5 0.3 0.4 0.0 4.0 0.4 0.6 26.2 0.3 0.6 1.8 0.1 2.1 0.5 5.3 0.1 2.8 0.6 0.8 1.7 0.5 0.2 0.6 0.3 0.7 0.3 0.9 0.1 0.1 0.2 153.6 15.2 4.2 0.1 0.7 1.6 1.3 0.6 11.7 0.2 1.2 0.2 0.4 0.8 1.6 0.4 0.1 0.2 0.1 0.5 10.6 7.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 29.7 20.8 0.0 3.1 15.2 3.1 0.0 111.1 61.0 38.2 20.3 97.0 6.2 0.0 0.1 153.6 23.8 0.0 12.7 36.3 0.0 0.0 0.0 0.4 2.4 3.2 0.0 0.0 3.0 1.5 8.2 49.0 3.5 0.0 0.0 25.1 12.8 0.0 0.0 0.0 53.4 0.0 3.4 0.0 14.6 2.4 0.0 34.1 9.9 0.1 1.6 0.1 0.0 7.6 0.0 0.0 33.5 20.2 0.0 0.0 0.0 0.4 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.6 0.8 1.7 0.7 0.3 15.2 0.4 DKKL1 "CT34, SGY-1" ENSG00000104901 "Dickkopf like acrosomal protein 1" Q9UK85 19 49361783-49375116 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 91.5" "Cell line enhanced" "Detected in some" "AF22: 7.1;AN3-CA: 13.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "memory B-cell: 4.1" "Lineage enriched" "Detected in single" 42 "B-cells: 4.1" "Group enriched" "Detected in many" 17 "amygdala: 27.1;basal ganglia: 15.6;cerebral cortex: 50.1;hippocampal formation: 25.1;olfactory region: 20.8" "Low region specificity" "Detected in all" "CAB025410, HPA047194" Enhanced Approved Vesicles "Secreted in male reproductive system" Vesicles "CAB025410: , HPA047194: " "unprognostic (1.64e-1)" "unprognostic (5.30e-1)" "unprognostic (5.39e-4)" "unprognostic (1.85e-4)" "unprognostic (3.79e-2)" "unprognostic (4.30e-2)" "unprognostic (5.52e-4)" "unprognostic (1.00e-1)" "unprognostic (6.76e-2)" "unprognostic (4.08e-1)" "unprognostic (1.90e-1)" "unprognostic (5.65e-2)" "unprognostic (2.56e-3)" "unprognostic (1.36e-1)" "unprognostic (1.13e-1)" "unprognostic (1.18e-1)" "unprognostic (5.57e-2)" 0.2 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.4 0.5 0.3 0.4 0.2 0.3 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.2 0.1 0.3 0.0 0.3 0.3 0.1 0.0 0.0 0.3 0.4 0.0 0.1 0.0 91.5 0.0 0.0 0.0 0.2 0.1 0.3 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 7.1 13.5 0.1 0.5 0.6 1.3 0.0 0.2 0.4 0.0 0.6 0.0 1.0 0.3 0.1 0.2 0.0 0.0 0.0 2.5 0.0 3.4 0.3 0.0 0.0 1.2 1.0 0.4 0.2 0.5 1.2 1.4 0.6 0.1 0.6 0.0 0.1 2.8 1.5 0.1 0.1 0.1 0.0 0.0 0.0 2.9 1.2 0.0 0.7 1.4 2.7 1.7 1.5 0.9 1.0 0.0 0.6 0.8 0.3 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 DLEU7 FLJ44882 ENSG00000186047 "Deleted in lymphocytic leukemia, 7" Q6UYE1 13 50711008-50843939 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 13.2" "Group enriched" "Detected in some" 8 "NTERA-2: 15.1;U-698: 6.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "intermediate monocyte: 1.5;naive B-cell: 1.3;neutrophil: 1.2;T-reg: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA053750 Uncertain "HPA053750: " "unprognostic (3.97e-2)" "unprognostic (2.53e-1)" "unprognostic (7.03e-2)" "unprognostic (9.31e-2)" "unprognostic (3.08e-1)" "unprognostic (1.08e-1)" "unprognostic (4.47e-3)" "unprognostic (1.09e-1)" "unprognostic (1.24e-1)" "unprognostic (8.75e-3)" "unprognostic (1.23e-1)" "unprognostic (1.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.59e-1)" "unprognostic (4.52e-2)" "unprognostic (1.03e-1)" "unprognostic (1.51e-1)" 0.7 1.0 4.8 0.8 7.8 0.5 0.5 5.8 13.2 0.6 0.7 0.5 0.0 0.6 0.8 3.0 0.5 0.5 0.4 0.5 4.6 5.7 1.4 0.5 0.5 0.4 3.7 4.2 0.6 0.7 0.4 0.1 0.5 4.1 0.7 0.8 0.0 0.4 0.5 0.5 1.0 0.8 0.5 1.2 0.8 0.5 0.9 0.8 1.3 1.9 0.0 0.5 0.4 0.1 1.3 0.0 1.2 1.5 0.0 1.4 0.7 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 15.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.3 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 1.3 0.1 0.0 1.2 0.0 0.0 0.0 1.4 0.7 4.8 7.8 5.8 9.9 4.6 5.7 3.7 4.2 4.1 0.8 DLG4 "PSD-95, PSD95, SAP-90, SAP90" ENSG00000132535 "Discs large MAGUK scaffold protein 4" P78352 17 7189890-7219702 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 83.2" "Cell line enhanced" "Detected in many" "HMC-1: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.6;plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001999, CAB002000, HPA010122" Enhanced "Intracellular and membrane" "CAB001999: , CAB002000: , HPA010122: AB_1855169" "unprognostic (7.08e-2)" "unprognostic (1.06e-2)" "unprognostic (3.50e-3)" "unprognostic (2.48e-2)" "unprognostic (3.23e-2)" "unprognostic (1.80e-1)" "unprognostic (7.18e-3)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (2.72e-2)" "prognostic favourable (8.82e-6)" "unprognostic (3.45e-2)" "prognostic unfavourable (1.70e-4)" "unprognostic (3.12e-2)" "unprognostic (2.83e-2)" "unprognostic (3.68e-2)" "unprognostic (4.77e-3)" 5.5 16.0 58.3 7.5 73.3 4.1 4.5 47.4 83.2 9.7 4.1 5.4 4.3 4.7 13.8 5.0 5.0 9.2 10.7 8.9 58.7 24.2 3.3 3.1 6.0 4.2 14.4 53.9 12.8 4.6 11.5 15.1 8.7 14.8 7.3 3.8 3.1 6.3 12.5 3.6 4.0 4.4 10.7 11.3 7.8 5.7 10.1 17.0 1.7 5.8 0.0 3.5 7.0 4.2 0.0 1.6 0.0 0.9 0.0 1.6 0.6 0.2 7.7 19.3 6.5 7.4 10.9 0.5 10.2 8.8 7.6 7.3 0.3 3.2 1.4 4.5 8.7 0.7 1.1 4.0 3.7 10.1 1.9 5.7 13.8 0.9 6.2 0.1 32.3 12.1 0.5 6.4 6.6 8.9 2.3 5.2 11.4 0.2 4.4 3.5 2.8 0.5 8.0 0.8 0.7 5.5 0.2 7.9 6.3 0.2 0.4 1.2 4.6 3.6 11.0 18.3 8.9 3.7 5.3 0.8 0.5 0.7 13.8 3.7 5.6 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.3 0.1 0.0 0.0 0.1 1.6 0.0 0.6 58.3 73.3 47.4 71.2 58.7 24.2 14.4 53.9 14.8 17.0 DLGAP1 "DAP-1, GKAP, SAPAP1" ENSG00000170579 "DLG associated protein 1" O14490 18 3496032-4455335 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.9" "Cell line enhanced" "Detected in some" "Daudi: 14.3;HAP1: 5.1;U-2197: 4.5;U-87 MG: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.0" "Lineage enhanced" "Detected in single" "granulocytes: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.50e-3)" "unprognostic (7.82e-2)" "unprognostic (2.40e-1)" "unprognostic (1.98e-1)" "unprognostic (1.07e-2)" "unprognostic (3.63e-3)" "unprognostic (2.73e-2)" "unprognostic (1.97e-2)" "unprognostic (2.93e-3)" "unprognostic (5.49e-3)" "unprognostic (5.87e-4)" "unprognostic (2.18e-1)" "unprognostic (2.78e-3)" "unprognostic (3.10e-2)" "unprognostic (4.93e-3)" "unprognostic (8.93e-2)" "unprognostic (9.68e-2)" 1.0 5.1 18.3 1.0 22.6 0.8 2.4 25.9 55.9 1.4 1.0 1.3 4.1 0.9 1.6 9.0 1.0 7.1 4.8 1.2 17.2 4.7 1.4 0.9 1.4 1.0 4.2 20.8 2.7 1.0 0.8 2.0 1.4 6.1 3.8 1.0 0.0 2.4 11.4 0.9 1.0 0.9 1.1 2.2 1.3 0.9 4.3 1.6 0.0 1.3 0.0 0.9 0.9 0.7 0.5 0.0 2.0 0.0 0.0 0.1 0.2 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 14.3 0.0 0.3 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.4 0.0 1.2 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.7 0.0 1.9 1.2 1.7 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.4 0.0 0.2 3.3 0.0 1.3 0.9 0.0 2.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 18.3 22.6 25.9 40.3 17.2 4.7 4.2 20.8 6.1 1.6 DLGAP3 "DAP3, SAPAP3" ENSG00000116544 "DLG associated protein 3" O95886 1 34865436-34929585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 28.7" "Cell line enhanced" "Detected in some" "Daudi: 9.3;NTERA-2: 5.1;SCLC-21H: 15.2" "Group enriched" "Detected in some" 5 "endometrial cancer: 1.0;glioma: 1.5;ovarian cancer: 1.9;testis cancer: 5.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 128.4;basal ganglia: 124.0;cerebral cortex: 122.6;hippocampal formation: 84.0;thalamus: 55.9" "Low region specificity" "Detected in all" HPA026445 Enhanced "HPA026445: AB_1847733" "unprognostic (8.63e-2)" "unprognostic (8.58e-2)" "unprognostic (1.48e-1)" "unprognostic (5.77e-7)" "unprognostic (4.01e-2)" "unprognostic (5.51e-2)" "unprognostic (2.95e-2)" "unprognostic (8.78e-2)" "unprognostic (2.66e-1)" "unprognostic (1.69e-1)" "unprognostic (1.27e-4)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (6.12e-2)" "unprognostic (1.47e-1)" "unprognostic (2.26e-1)" "unprognostic (2.21e-1)" 1.3 1.5 17.4 1.8 20.0 2.8 1.1 14.6 28.7 0.9 1.2 3.3 0.0 1.4 1.0 1.0 0.9 1.0 1.1 1.0 17.7 5.5 1.3 1.0 1.1 1.4 5.4 9.6 1.0 2.2 1.0 1.9 1.0 2.3 1.0 1.0 0.7 1.1 1.5 1.0 1.1 1.3 1.0 1.1 2.5 1.3 6.7 5.0 0.0 1.0 0.0 1.2 1.0 0.0 0.3 3.2 0.4 2.3 0.1 0.8 0.9 0.0 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 9.3 0.2 0.0 0.0 1.5 0.0 0.0 0.2 0.2 0.7 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 1.5 0.0 0.0 5.1 0.0 0.5 0.0 0.2 0.0 0.5 15.2 3.0 0.1 0.1 0.0 0.3 0.1 0.1 0.1 1.6 0.0 0.0 0.2 0.3 1.9 0.1 0.1 0.1 0.4 2.3 0.0 0.2 1.4 0.8 0.3 0.5 0.5 3.2 0.3 0.2 0.8 0.0 0.1 0.1 0.9 0.7 0.9 17.4 20.0 14.6 22.4 17.7 5.5 5.4 9.6 2.3 5.0 DLGAP5 "DLG1, DLG7, HURP, KIAA0008" ENSG00000126787 "DLG associated protein 5" Q15398 14 55148112-55191678 "Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 65.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 8.3" "Lineage enriched" "Detected in many" 6 "T-cells: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA005546 Enhanced Supported "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA005546: AB_1078677" "unprognostic (2.24e-1)" "unprognostic (1.77e-1)" "unprognostic (1.19e-3)" "prognostic unfavourable (4.59e-4)" "unprognostic (1.42e-1)" "unprognostic (1.66e-2)" "prognostic unfavourable (1.52e-6)" "prognostic unfavourable (7.85e-4)" "unprognostic (6.15e-3)" "unprognostic (3.55e-1)" "prognostic unfavourable (9.94e-6)" "unprognostic (4.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.06e-2)" "unprognostic (3.64e-1)" "unprognostic (1.29e-1)" "unprognostic (1.93e-2)" 1.4 0.9 0.3 11.4 0.4 16.2 0.5 0.3 0.5 1.3 3.3 0.2 0.2 2.9 0.9 1.0 8.7 0.3 1.3 0.7 0.2 0.3 1.1 0.8 2.1 10.6 0.3 0.2 0.7 0.4 0.0 0.3 3.3 0.3 0.5 4.1 0.3 1.5 0.2 0.5 1.9 4.1 1.3 0.3 6.6 2.2 13.0 0.2 65.1 0.4 6.4 11.4 1.7 2.4 1.1 0.4 0.4 0.0 1.3 8.3 1.2 37.0 14.7 38.8 17.4 0.9 3.9 12.0 21.5 14.2 31.9 30.4 12.0 20.5 21.6 11.9 12.5 23.1 24.8 17.3 41.9 25.9 12.2 22.1 13.8 10.3 0.1 21.6 13.6 0.7 0.6 14.9 7.2 35.1 17.9 21.6 29.6 17.8 27.3 11.1 20.0 15.4 21.3 37.5 9.9 10.4 12.1 19.8 11.1 22.9 8.6 8.5 19.3 8.1 13.6 14.3 37.4 13.8 24.7 5.3 11.5 28.6 10.0 15.4 22.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.1 2.3 0.4 0.1 0.5 0.2 0.4 1.3 0.0 0.0 8.3 1.2 0.3 0.4 0.3 0.5 0.2 0.3 0.3 0.2 0.3 0.2 DLL3 SCDO1 ENSG00000090932 "Delta like canonical Notch ligand 3" Q9NYJ7 19 39498895-39508481 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 38.5" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 41.1" "Group enriched" "Detected in many" 11 "glioma: 29.2;melanoma: 15.5;testis cancer: 8.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.4;naive CD8 T-cell: 3.3" "Group enriched" "Detected in many" 13 "B-cells: 5.4;T-cells: 3.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA056533 Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA056533: " "unprognostic (2.52e-1)" "unprognostic (3.81e-1)" "unprognostic (3.13e-2)" "prognostic unfavourable (2.94e-4)" "unprognostic (9.85e-2)" "unprognostic (1.41e-2)" "unprognostic (1.65e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.82e-4)" "unprognostic (4.94e-2)" "unprognostic (5.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.97e-1)" 0.6 0.6 8.9 0.7 10.1 0.6 0.6 1.4 38.5 0.5 0.6 10.3 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.6 6.5 6.8 0.5 0.6 0.6 0.7 4.5 1.9 0.6 0.5 0.6 3.2 0.5 4.3 0.6 0.5 0.0 0.6 0.5 0.5 0.6 0.6 0.5 3.6 0.6 0.6 1.2 2.3 0.0 0.7 0.0 0.6 0.6 0.0 5.4 0.3 0.0 0.0 0.0 3.3 0.4 0.0 1.9 0.4 1.0 0.0 0.0 0.3 0.5 0.0 0.3 0.1 0.3 0.4 0.0 1.9 0.0 0.0 1.2 0.5 0.1 0.5 3.0 0.1 0.0 0.1 0.1 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.4 3.1 0.3 0.1 0.1 0.1 0.1 7.3 7.4 1.4 0.0 41.1 0.0 0.1 0.0 0.0 1.3 0.1 0.5 0.7 0.0 0.4 0.0 0.2 1.2 0.0 0.0 0.0 0.9 0.0 0.4 5.4 0.2 1.3 0.3 1.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.4 8.9 10.1 1.4 4.8 6.5 6.8 4.5 1.9 4.3 2.3 DMKN ZD52F10 ENSG00000161249 Dermokine Q6E0U4 19 35497220-35513658 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skin 1: 365.3" "Cell line enhanced" "Detected in many" "A-431: 31.5;CACO-2: 39.0;CAPAN-2: 33.5;HBEC3-KT: 51.1;RPTEC TERT1: 50.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 9.5" "Cell type enhanced" "Detected in many" "NK-cell: 11.1" "Group enriched" "Detected in many" 5 "NK-cells: 11.1;T-cells: 7.0" HPA029406 Enhanced Approved Nucleoplasm,Cytosol "Secreted in other tissues" 29000000 "Nucleoplasm, Cytosol" "HPA029406: AB_10603661" "unprognostic (5.70e-2)" "unprognostic (2.36e-2)" "unprognostic (3.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-2)" "unprognostic (3.82e-2)" "unprognostic (3.23e-1)" "unprognostic (1.03e-1)" "unprognostic (8.82e-2)" "unprognostic (2.54e-1)" "unprognostic (9.93e-2)" "prognostic favourable (5.37e-6)" "unprognostic (3.50e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" 1.4 1.1 0.6 0.5 4.7 0.6 23.9 0.7 2.0 54.8 1.2 1.1 2.5 1.0 5.6 9.2 25.3 8.7 0.6 1.4 0.7 1.1 11.3 0.8 8.8 0.5 0.9 0.6 11.7 29.5 4.7 13.3 1.7 9.5 5.0 1.0 9.5 8.2 9.1 2.4 365.3 1.2 0.9 0.9 0.6 1.8 0.8 2.3 3.1 25.9 62.9 16.9 3.5 27.5 1.7 0.2 0.0 0.0 11.1 7.0 1.2 31.5 5.1 0.0 0.0 1.2 1.9 8.9 0.1 4.2 0.2 0.3 39.0 33.5 0.0 12.8 0.3 17.7 9.6 51.1 0.4 0.1 9.3 0.0 0.0 8.7 1.5 0.0 0.1 17.5 13.8 0.9 29.7 0.0 0.1 0.0 0.1 27.6 0.0 0.0 28.3 2.1 0.0 0.0 1.2 50.5 20.9 0.1 0.0 7.7 0.0 3.1 12.8 0.0 0.0 4.9 15.0 0.1 0.1 0.2 0.0 0.2 4.2 0.0 0.3 0.0 0.0 0.0 7.0 0.0 6.1 1.7 0.6 3.4 0.0 0.2 0.1 2.4 0.0 11.1 0.0 0.2 0.0 1.2 0.6 4.7 0.7 2.0 0.7 1.1 0.9 0.6 9.5 2.3 DMRT1 "CT154, DMT1" ENSG00000137090 "Doublesex and mab-3 related transcription factor 1" Q9Y5R6 9 841690-969090 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 81 "testis: 44.1" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 8.5" "Cancer enriched" "Detected in some" 9 "testis cancer: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027850 Enhanced "HPA027850: AB_10600868" "unprognostic (3.23e-1)" "unprognostic (1.91e-1)" "unprognostic (9.75e-4)" "unprognostic (1.34e-1)" "unprognostic (2.50e-1)" "unprognostic (3.08e-1)" "unprognostic (1.45e-1)" "unprognostic (1.78e-2)" "unprognostic (1.03e-1)" "unprognostic (5.60e-2)" "unprognostic (3.06e-2)" "unprognostic (1.02e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.3 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DMRTB1 ENSG00000143006 "DMRT like family B with proline rich C-terminal 1" Q96MA1 1 53459399-53467488 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 104 "testis: 78.1" "Cell line enhanced" "Detected in single" "NB-4: 1.2" "Cancer enhanced" "Detected in single" "testis cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036490, HPA058553" Enhanced "HPA036490: AB_10671844, HPA058553: " "unprognostic (2.20e-3)" "unprognostic (1.36e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 DMRTC2 ENSG00000142025 "DMRT like family C2" Q8IXT2 19 41844743-41852333 "Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 53.5" "Cell line enhanced" "Detected in some" "HMC-1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 1.3" "Group enriched" "Detected in many" 4 "granulocytes: 1.3;monocytes: 1.1" "Not detected" "Not detected" HPA045016 Uncertain "HPA045016: AB_10960404" "unprognostic (6.80e-3)" "unprognostic (4.38e-2)" "unprognostic (5.36e-2)" "unprognostic (2.69e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.3 1.1 0.2 0.2 0.0 0.2 0.0 0.5 1.0 0.0 0.0 0.3 0.4 0.0 0.5 0.0 0.7 1.1 0.1 0.1 0.2 0.6 0.0 0.0 0.0 1.1 0.6 0.0 0.8 0.2 0.0 0.6 1.6 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 1.1 0.0 1.1 0.7 1.3 0.9 0.1 0.3 0.3 0.4 0.2 0.2 0.9 0.1 1.0 1.2 0.1 0.3 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.2 0.2 1.3 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DNA2 "DNA2L, KIAA0083" ENSG00000138346 "DNA replication helicase/nuclease 2" P51530 10 68414064-68472121 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease" "Disease mutation, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "lymphoid tissue: 49.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 5.5" "Lineage enriched" "Detected in single" 6 "NK-cells: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA037487, HPA057526" Approved Supported Mitochondria Mitochondria "HPA037487: AB_10672493, HPA057526: " "unprognostic (1.79e-1)" "unprognostic (1.35e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-3)" "unprognostic (1.53e-1)" "unprognostic (1.86e-2)" "unprognostic (4.50e-5)" "unprognostic (3.36e-2)" "unprognostic (4.70e-2)" "unprognostic (3.72e-2)" "unprognostic (1.30e-2)" "unprognostic (3.29e-4)" "unprognostic (1.09e-10)" "unprognostic (3.43e-2)" "unprognostic (1.98e-1)" "unprognostic (9.36e-2)" "unprognostic (1.23e-2)" 1.6 1.2 2.0 13.7 2.4 7.0 3.0 6.2 3.8 1.6 4.5 1.1 0.8 3.5 3.0 1.8 3.2 1.0 2.4 2.0 2.5 2.2 3.4 6.2 3.3 8.4 2.9 5.0 1.9 2.4 1.1 2.3 4.0 1.7 3.0 5.0 0.9 2.3 0.8 2.3 2.9 5.2 1.9 3.0 5.2 2.6 7.0 1.4 49.1 1.5 5.1 10.8 2.3 2.0 0.4 0.1 0.9 0.1 5.5 0.6 0.1 13.7 7.1 16.3 11.5 1.8 1.3 11.5 6.8 5.7 9.8 12.1 17.0 9.0 14.1 2.6 2.1 8.5 9.3 3.6 11.8 8.7 7.0 8.6 4.4 6.5 0.5 14.7 9.3 1.0 1.4 7.0 2.0 4.4 12.5 12.8 5.6 4.8 22.7 10.7 11.5 13.4 17.8 11.3 4.5 4.2 6.4 7.4 8.9 9.4 11.9 2.2 9.2 6.3 1.8 3.8 11.7 4.8 12.9 6.5 7.3 21.1 3.2 14.1 4.9 0.0 0.0 0.9 0.2 0.0 0.2 0.4 0.2 0.6 0.1 0.4 0.3 0.3 0.1 5.5 0.1 0.0 0.4 0.1 2.0 2.4 6.2 3.8 2.5 2.2 2.9 5.0 1.7 1.4 DNAH17 "DNAHL1, DNEL2, FLJ40457" ENSG00000187775 "Dynein axonemal heavy chain 17" Q9UFH2 17 78423697-78577394 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 39.4" "Group enriched" "Detected in some" 5 "HeLa: 9.8;MOLT-4: 4.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024354, HPA076261" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" Cytosol "HPA024354: AB_1847911, HPA076261: " "unprognostic (4.98e-4)" "unprognostic (2.26e-1)" "unprognostic (2.30e-3)" "unprognostic (8.70e-3)" "unprognostic (6.66e-2)" "unprognostic (9.23e-2)" "unprognostic (3.72e-3)" "unprognostic (8.41e-2)" "unprognostic (2.66e-1)" "unprognostic (1.11e-1)" "unprognostic (1.20e-3)" "unprognostic (8.35e-3)" "unprognostic (1.58e-10)" "unprognostic (5.25e-2)" "unprognostic (1.54e-1)" "unprognostic (5.12e-1)" "unprognostic (6.04e-3)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.1 0.0 39.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 9.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 DNAH8 hdhc9 ENSG00000124721 "Dynein axonemal heavy chain 8" Q96JB1 6 38715341-39030529 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 36.0" "Cell line enriched" "Detected in some" 8 "HMC-1: 32.3" "Cancer enriched" "Detected in single" 7 "prostate cancer: 2.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "basophil: 5.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA028447 Uncertain "HPA028447: AB_10599600" "unprognostic (2.83e-1)" "unprognostic (4.46e-4)" "unprognostic (1.27e-1)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-3)" "unprognostic (1.02e-1)" "unprognostic (1.22e-2)" "unprognostic (1.41e-1)" "unprognostic (3.47e-3)" "unprognostic (1.19e-1)" "unprognostic (1.39e-1)" "unprognostic (2.17e-9)" "unprognostic (1.46e-3)" "unprognostic (1.56e-1)" "unprognostic (1.62e-1)" "unprognostic (1.48e-3)" 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 4.9 0.0 3.5 0.0 0.0 0.0 0.1 0.0 2.6 0.2 0.0 0.1 5.0 0.0 36.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.7 0.0 5.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 4.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 DNAJB7 HSC3 ENSG00000172404 "DnaJ heat shock protein family (Hsp40) member B7" Q7Z6W7 22 40859549-40862126 "Predicted intracellular proteins" Chaperone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "testis: 24.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA000534 Approved "HPA000534: AB_1078693" "unprognostic (3.89e-2)" "unprognostic (1.12e-2)" "unprognostic (9.61e-2)" "unprognostic (1.27e-1)" "unprognostic (5.45e-2)" "unprognostic (2.66e-2)" "unprognostic (1.16e-2)" "unprognostic (5.56e-3)" "unprognostic (1.62e-1)" "unprognostic (7.42e-2)" "unprognostic (1.22e-3)" "unprognostic (2.81e-2)" "unprognostic (4.46e-4)" "unprognostic (3.32e-3)" "unprognostic (3.06e-2)" "unprognostic (7.05e-2)" "unprognostic (2.45e-2)" 0.1 0.1 0.1 0.2 0.2 0.9 0.1 1.1 0.3 0.2 0.1 0.1 0.1 0.9 0.2 1.3 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.4 0.1 0.0 0.3 0.1 0.3 0.2 0.1 0.1 0.2 0.1 0.6 0.3 0.9 0.1 0.1 0.2 0.3 24.9 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.9 0.5 2.4 0.6 0.5 1.6 0.1 0.4 0.1 1.0 1.5 0.0 0.0 1.7 1.0 0.0 0.0 0.0 0.3 0.3 1.6 0.2 0.1 0.6 0.0 0.0 0.0 0.1 0.7 0.6 2.2 0.6 0.0 1.5 0.5 0.0 0.0 0.2 0.0 0.0 1.1 1.7 0.1 0.6 1.9 1.9 1.3 0.3 1.1 1.1 0.7 0.0 0.6 1.6 0.4 0.5 0.7 0.3 0.3 1.0 0.0 1.0 1.6 1.3 0.5 1.7 0.9 1.0 0.1 0.5 1.3 1.9 0.5 0.3 0.7 0.4 0.7 0.3 0.6 0.6 0.3 0.9 1.6 0.9 2.4 0.5 0.6 0.5 0.2 0.1 0.1 0.2 1.1 0.2 0.1 0.1 0.1 0.1 0.3 0.1 DNAJB8 "CT156, MGC33884" ENSG00000179407 "DnaJ heat shock protein family (Hsp40) member B8" Q8NHS0 3 128462439-128467248 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 286 "testis: 28.6" "Cell line enriched" "Detected in single" 5 "SH-SY5Y: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DNAJC25 bA16L21.2.1 ENSG00000059769 "DnaJ heat shock protein family (Hsp40) member C25" Q9H1X3 9 111631352-111654351 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 41.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019122 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA019122: AB_1853155" "unprognostic (3.07e-1)" "unprognostic (7.42e-2)" "unprognostic (8.94e-3)" "prognostic favourable (3.73e-4)" "unprognostic (2.08e-2)" "unprognostic (5.66e-2)" "unprognostic (1.60e-2)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (9.65e-2)" "unprognostic (9.04e-2)" "unprognostic (5.09e-2)" "unprognostic (2.52e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-1)" "unprognostic (8.30e-2)" "unprognostic (5.19e-2)" 5.1 10.2 3.3 3.9 4.6 1.9 5.8 4.5 4.2 3.4 5.1 2.5 5.7 4.6 4.1 7.7 3.4 3.8 3.6 6.7 4.3 3.8 7.8 41.9 3.5 4.1 2.7 2.3 5.7 7.0 7.4 9.0 4.4 3.3 5.9 3.0 3.6 9.7 4.0 3.6 2.4 6.9 5.0 2.9 2.9 3.7 4.2 1.9 1.4 4.3 2.4 2.2 6.4 4.5 0.6 1.1 1.2 1.9 0.4 0.8 0.3 2.6 2.0 1.4 2.3 14.5 6.5 5.3 10.1 4.8 4.0 3.9 3.8 1.6 2.2 4.0 6.9 8.4 1.5 2.9 3.8 1.9 2.0 2.2 0.0 7.8 4.7 4.2 3.3 5.6 8.2 3.0 5.8 3.3 4.6 2.0 5.0 2.8 1.3 0.2 2.5 4.7 2.2 7.4 2.1 8.2 2.9 2.3 1.2 5.6 7.9 3.5 4.1 1.1 6.3 4.9 2.2 12.8 5.7 3.6 5.5 1.3 8.2 2.1 4.2 0.0 0.1 1.2 0.6 1.9 0.2 0.3 0.5 0.0 0.5 0.6 0.5 0.2 0.8 0.4 1.0 1.1 0.8 0.3 3.3 4.6 4.5 4.2 4.3 3.8 2.7 2.3 3.3 1.9 DNAJC5B "CSP-beta, MGC26226" ENSG00000147570 "DnaJ heat shock protein family (Hsp40) member C5 beta" Q9UF47 8 66021560-66100526 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 52.6" "Group enriched" "Detected in some" 5 "HDLM-2: 14.7;RPTEC TERT1: 17.0;THP-1: 10.4;U-266/70: 9.4;U-937: 8.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 9.6" "Lineage enriched" "Detected in many" 5 "B-cells: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (1.01e-1)" "unprognostic (7.29e-3)" "unprognostic (7.13e-2)" "unprognostic (2.05e-2)" "unprognostic (1.76e-2)" "unprognostic (4.92e-2)" "unprognostic (7.85e-2)" "unprognostic (7.78e-2)" "unprognostic (2.53e-3)" "unprognostic (4.06e-2)" "unprognostic (9.38e-2)" "unprognostic (8.38e-2)" "unprognostic (1.65e-2)" "unprognostic (2.80e-1)" "unprognostic (4.42e-2)" "unprognostic (1.88e-1)" "unprognostic (8.84e-2)" 0.2 0.1 0.2 1.3 0.2 0.0 0.2 0.2 0.2 0.2 0.3 0.2 0.6 0.4 0.2 0.7 0.3 0.1 0.2 0.2 0.2 0.1 0.2 0.7 3.2 3.6 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.3 0.2 0.5 0.2 0.2 0.2 1.2 0.1 0.9 0.2 0.3 0.8 0.1 52.6 0.2 0.2 0.2 1.6 1.8 0.6 0.2 9.6 1.8 0.0 0.9 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 10.4 0.0 0.4 0.0 0.0 0.0 9.4 0.0 0.3 0.1 8.9 0.0 0.0 0.9 0.0 0.0 0.7 0.0 9.6 0.0 0.0 1.8 2.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.3 0.2 DNAJC6 "KIAA0473, PARK19" ENSG00000116675 "DnaJ heat shock protein family (Hsp40) member C6" O75061 1 65248219-65415869 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Chaperone, Hydrolase, Protein phosphatase" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 91.4" "Cell line enhanced" "Detected in many" "HDLM-2: 20.9;HEL: 55.8;K-562: 21.7" "Cancer enhanced" "Detected in many" "glioma: 5.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031182, HPA054917" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA031182: AB_10611957, HPA054917: " "unprognostic (6.99e-2)" "unprognostic (2.00e-3)" "unprognostic (3.19e-1)" "unprognostic (7.94e-7)" "unprognostic (1.59e-1)" "unprognostic (7.61e-3)" "unprognostic (1.87e-4)" "unprognostic (2.98e-1)" "unprognostic (1.89e-1)" "unprognostic (4.14e-1)" "unprognostic (4.22e-3)" "unprognostic (1.53e-1)" "prognostic favourable (2.81e-4)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-1)" "unprognostic (8.67e-3)" 2.1 12.1 18.6 2.2 28.5 5.0 2.0 24.2 91.4 2.2 2.8 26.9 0.0 2.3 1.9 1.8 1.7 2.4 2.3 9.0 25.0 26.7 8.5 1.6 2.7 1.6 28.8 23.8 1.9 3.4 2.1 7.5 8.0 40.5 2.5 3.0 2.2 1.7 2.1 1.6 2.1 2.3 2.2 28.7 3.2 2.9 3.2 21.1 0.0 3.0 0.0 1.7 1.8 0.6 0.5 0.5 0.0 0.0 0.6 1.5 0.3 3.5 0.9 0.0 1.6 0.7 0.2 8.3 7.0 11.4 11.5 11.3 0.9 0.1 3.3 0.6 2.9 0.8 5.0 1.1 9.1 20.9 2.4 55.8 1.9 0.2 0.0 1.8 1.4 1.0 0.8 1.1 4.9 0.2 21.7 0.4 2.3 0.6 0.7 0.0 2.3 0.7 0.0 1.7 0.1 8.7 0.0 13.9 9.6 4.1 5.5 1.9 2.6 0.1 2.1 1.7 1.2 0.2 2.0 2.1 1.3 1.0 4.7 1.4 2.8 0.0 0.0 0.0 1.5 0.0 0.1 0.5 0.5 0.9 0.0 0.0 0.4 0.6 0.0 0.6 0.0 0.5 0.0 0.3 18.6 28.5 24.2 37.4 25.0 26.7 28.8 23.8 40.5 21.1 DNASE2B DLAD ENSG00000137976 "Deoxyribonuclease 2 beta" Q8WZ79 1 84398532-84415018 "Enzymes, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "salivary gland: 98.7" "Cell line enhanced" "Detected in some" "AN3-CA: 1.5;HL-60: 1.0;HUVEC TERT2: 2.1;SK-MEL-30: 2.5;U-266/70: 1.2" "Cancer enhanced" "Detected in some" "prostate cancer: 9.3" "Region enhanced" "Detected in single" "basal ganglia: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" "unprognostic (2.24e-1)" "unprognostic (3.57e-2)" "unprognostic (2.77e-1)" "unprognostic (1.22e-1)" "unprognostic (4.70e-2)" "unprognostic (3.70e-1)" "unprognostic (2.86e-1)" "unprognostic (1.62e-2)" "unprognostic (9.87e-2)" "unprognostic (7.90e-2)" "unprognostic (2.72e-1)" "unprognostic (1.15e-1)" "unprognostic (3.82e-5)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" "unprognostic (6.79e-2)" "unprognostic (3.08e-3)" 16.2 0.1 0.2 0.1 2.2 0.1 0.3 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.6 0.1 0.2 13.0 1.2 0.3 0.0 0.3 0.4 0.0 0.4 0.1 0.2 2.9 0.3 0.0 98.7 0.1 1.8 0.0 0.1 0.1 1.7 0.5 0.6 0.3 0.0 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.5 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.3 0.3 0.6 0.3 0.0 0.2 0.0 DNHD1 "C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184" ENSG00000179532 "Dynein heavy chain domain 1" Q96M86 11 6497260-6593758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 58.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039698, HPA040267, HPA057639" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" "Nucleoplasm, Cytokinetic bridge" "HPA039698: AB_10795111, HPA040267: , HPA057639: " "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (5.87e-2)" "unprognostic (2.18e-2)" "unprognostic (9.96e-2)" "unprognostic (2.00e-3)" "unprognostic (1.43e-1)" "unprognostic (3.11e-1)" "unprognostic (5.38e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-2)" "unprognostic (9.25e-3)" "unprognostic (5.45e-9)" "unprognostic (2.33e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-4)" "unprognostic (8.15e-2)" 1.9 2.1 3.6 1.9 5.9 6.8 2.1 6.8 3.4 2.6 2.9 1.6 2.2 2.2 2.8 3.5 1.3 2.0 3.1 1.8 2.3 1.9 1.5 3.1 3.1 3.4 1.5 1.6 3.3 1.6 1.3 2.0 1.3 2.0 2.3 2.0 2.0 2.3 3.2 1.9 3.4 3.6 6.4 2.2 3.5 1.8 58.7 1.3 1.3 2.5 1.3 2.8 2.2 11.0 1.8 1.5 3.0 0.4 0.1 2.2 0.5 4.3 4.6 4.2 4.0 3.5 5.0 4.2 2.0 1.9 2.3 1.5 3.5 3.8 3.7 0.9 1.6 7.3 2.1 1.7 2.6 2.3 3.8 3.0 5.9 2.7 2.2 4.2 1.9 3.4 2.9 4.2 6.2 1.0 3.7 4.4 1.6 0.9 1.4 4.7 4.2 3.4 2.2 1.8 2.7 2.3 2.5 2.3 4.4 1.3 4.1 3.1 2.2 4.5 1.8 2.3 2.4 5.0 2.9 10.6 8.3 5.6 2.2 4.8 2.7 0.0 0.4 3.0 1.3 0.0 1.4 0.3 1.3 0.5 0.6 1.8 1.9 2.2 1.3 0.1 0.3 1.5 1.3 0.5 3.6 5.9 6.8 3.4 2.3 1.9 1.5 1.6 2.0 1.3 DNM1 DNM ENSG00000106976 "Dynamin 1" Q05193 9 128191655-128255248 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, Motor protein" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 133.5" "Cell line enhanced" "Detected in many" "A549: 48.8;U-87 MG: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005920, HPA049910, HPA061801" Enhanced Supported Nucleoplasm 440000 Nucleoplasm "CAB005920: , HPA049910: , HPA061801: " "unprognostic (3.25e-2)" "unprognostic (5.49e-2)" "unprognostic (1.34e-3)" "unprognostic (3.95e-2)" "unprognostic (4.57e-2)" "unprognostic (1.16e-1)" "unprognostic (3.60e-3)" "unprognostic (1.20e-1)" "unprognostic (5.53e-2)" "unprognostic (6.53e-2)" "unprognostic (6.62e-3)" "unprognostic (6.30e-1)" "unprognostic (9.58e-2)" "unprognostic (1.10e-1)" "unprognostic (2.02e-1)" "unprognostic (3.07e-3)" "unprognostic (1.10e-3)" 5.9 6.1 31.5 3.3 36.9 2.3 4.6 57.7 133.5 11.7 3.0 2.5 0.0 2.4 4.6 2.7 3.3 6.3 9.0 2.7 33.4 24.0 2.9 1.8 2.5 2.5 18.3 33.0 1.6 4.7 3.2 5.5 2.7 33.0 2.9 2.9 4.3 2.6 3.1 2.3 4.6 3.3 4.4 5.1 1.6 2.6 4.0 1.8 0.0 1.9 0.4 2.3 3.6 3.7 0.3 0.4 0.5 0.3 0.0 0.3 0.7 3.2 48.8 4.4 1.0 1.4 14.9 0.2 3.0 7.3 6.2 2.6 0.6 1.0 0.0 4.2 6.3 5.8 0.7 0.3 3.4 0.0 4.7 3.1 7.0 0.2 1.0 0.4 2.2 3.9 0.1 4.8 0.0 0.0 1.1 0.2 0.0 1.3 0.2 1.0 4.7 8.9 5.8 0.1 1.5 0.9 0.0 6.3 10.6 10.4 0.3 0.4 0.1 4.2 0.2 0.2 14.1 14.2 6.2 0.4 0.1 0.3 18.6 0.1 1.0 0.0 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.4 0.2 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.7 31.5 36.9 57.7 71.8 33.4 24.0 18.3 33.0 33.0 1.8 DNTT TDT ENSG00000107447 "DNA nucleotidylexotransferase" P04053 10 96304396-96338564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Terminal addition" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 171.0" "Group enriched" "Detected in some" 420 "MOLT-4: 48.7;REH: 168.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "naive B-cell: 1.2;naive CD4 T-cell: 4.5" "Group enriched" "Detected in many" 15 "B-cells: 1.2;T-cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA036532, HPA044194" Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036532: , HPA044194: AB_10960525" "unprognostic (4.24e-1)" "unprognostic (1.00e-1)" "unprognostic (2.60e-2)" "unprognostic (1.86e-2)" 0.0 0.0 0.1 0.1 0.3 24.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 2.7 0.0 171.0 0.6 0.0 2.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 168.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 DOK2 "Dok-2, p56dok-2" ENSG00000147443 "Docking protein 2" O60496 8 21908873-21913860 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 138.5" "Cell line enhanced" "Detected in some" "HDLM-2: 9.9;HEL: 21.2;HMC-1: 45.5;THP-1: 16.4;U-937: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "eosinophil: 138.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB004379, HPA066571" Enhanced 1200000 "CAB004379: AB_627449, HPA066571: " "unprognostic (5.39e-2)" "unprognostic (8.84e-3)" "unprognostic (8.72e-3)" "unprognostic (1.74e-3)" "unprognostic (2.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.34e-1)" "unprognostic (7.22e-2)" "prognostic favourable (4.31e-4)" "unprognostic (2.22e-1)" "unprognostic (4.19e-2)" "unprognostic (1.90e-1)" "prognostic unfavourable (2.20e-4)" "unprognostic (1.88e-1)" "unprognostic (1.24e-2)" "unprognostic (3.19e-1)" "unprognostic (2.80e-1)" 13.6 3.3 0.6 14.2 0.6 8.4 3.5 0.5 0.6 2.4 4.4 0.4 2.1 3.5 2.0 5.9 3.8 2.8 4.8 3.8 0.6 0.7 2.7 4.6 14.0 12.3 1.5 0.2 2.4 2.3 0.0 1.5 5.3 1.4 3.9 1.6 2.6 2.9 0.6 1.4 1.8 5.9 3.4 2.2 28.6 3.2 1.9 0.7 17.9 1.8 2.7 13.5 4.4 9.8 1.4 38.9 138.5 55.9 27.1 52.8 60.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 21.2 0.0 0.0 0.0 0.1 45.5 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.0 0.3 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.5 15.9 0.0 44.9 45.1 138.5 39.0 55.9 18.0 1.4 27.4 29.5 38.9 0.6 15.4 19.1 3.4 27.1 49.3 0.7 52.8 60.8 0.6 0.6 0.5 0.6 0.6 0.7 1.5 0.2 1.4 0.7 DPEP3 ENSG00000141096 "Dipeptidase 3" Q9H4B8 16 67975663-67980829 "Enzymes, Predicted intracellular proteins" Meiosis "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 56.7" "Cell line enriched" "Detected in single" 11 "U-266/70: 4.8" "Group enriched" "Detected in many" 10 "melanoma: 3.7;ovarian cancer: 16.9;testis cancer: 5.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "neutrophil: 9.2;NK-cell: 2.3" "Group enriched" "Detected in many" 7 "granulocytes: 9.2;NK-cells: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA031870, HPA058607" Enhanced "Intracellular and membrane" 16000000 "HPA031870: AB_2674079, HPA058607: AB_2683775" "unprognostic (9.93e-2)" "unprognostic (2.81e-3)" "unprognostic (1.86e-1)" "unprognostic (9.52e-2)" "unprognostic (3.61e-2)" "unprognostic (1.37e-2)" "unprognostic (1.55e-1)" "unprognostic (6.52e-2)" "unprognostic (1.09e-1)" "unprognostic (2.05e-2)" "unprognostic (3.49e-3)" "unprognostic (9.97e-2)" "unprognostic (1.56e-1)" "unprognostic (3.15e-3)" "unprognostic (1.13e-1)" "unprognostic (3.98e-2)" "unprognostic (1.51e-1)" 0.2 0.0 0.1 0.4 0.4 1.0 0.6 0.1 0.3 0.0 0.1 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.0 0.2 0.3 0.1 0.1 0.0 0.5 0.0 0.4 1.4 0.2 56.7 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.8 0.1 9.2 0.5 2.3 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.2 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.5 0.3 0.4 0.0 0.0 0.1 0.8 0.8 0.3 9.2 2.3 0.1 0.0 0.0 0.3 0.1 0.4 0.1 0.3 0.3 0.1 0.1 0.0 0.9 0.1 DPF1 "BAF45b, NEUD4, neuro-d4" ENSG00000011332 "Double PHD fingers 1" Q92782 19 38211006-38229714 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 31.6" "Cell line enhanced" "Detected in many" "HAP1: 15.4;SCLC-21H: 18.2" "Cancer enhanced" "Detected in some" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049148 Enhanced Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Cytosol" Mitochondria "HPA049148: " "unprognostic (7.72e-2)" "unprognostic (2.33e-1)" "unprognostic (5.38e-2)" "unprognostic (4.11e-3)" "unprognostic (8.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-4)" "unprognostic (1.40e-2)" "unprognostic (2.72e-1)" "unprognostic (5.49e-2)" "unprognostic (4.30e-3)" "unprognostic (2.87e-2)" "unprognostic (1.11e-16)" "unprognostic (2.56e-1)" "unprognostic (3.75e-1)" "unprognostic (6.96e-2)" "unprognostic (8.20e-4)" 1.1 1.5 11.8 1.5 15.7 1.0 0.9 6.4 31.6 0.8 1.0 0.9 0.0 0.9 1.0 0.8 0.8 1.0 1.0 1.0 12.4 7.7 0.8 0.8 1.0 1.1 4.5 11.3 0.9 0.9 0.9 1.3 1.1 2.0 0.9 0.9 0.0 1.2 0.8 1.1 1.2 1.0 1.3 2.1 1.1 0.8 2.5 1.2 0.0 0.8 0.0 1.1 0.9 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 3.4 2.9 12.5 9.1 0.9 0.6 1.2 3.7 2.1 6.3 5.4 2.1 0.3 5.7 2.5 2.8 2.2 15.4 2.1 2.8 5.4 3.0 1.9 1.4 0.8 0.3 1.4 1.6 0.7 0.0 3.8 1.2 1.1 4.2 0.3 6.0 4.8 3.0 0.3 2.2 3.5 5.7 6.3 1.2 0.6 1.0 18.2 6.3 4.2 0.4 0.8 1.9 0.3 1.4 9.2 2.9 2.2 3.3 2.3 7.5 7.6 4.8 2.0 3.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 11.8 15.7 6.4 19.6 12.4 7.7 4.5 11.3 2.0 1.2 DPYSL5 "CRAM, CRMP-5, CRMP5, Ulip6" ENSG00000157851 "Dihydropyrimidinase like 5" Q9BPU6 2 26847747-26950351 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.1" "Group enriched" "Detected in some" 4 "AF22: 41.0;HAP1: 34.1;SCLC-21H: 48.9;SH-SY5Y: 28.9" "Group enriched" "Detected in some" 15 "glioma: 17.7;testis cancer: 8.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034544, HPA072387" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034544: AB_10671228, HPA072387: " "unprognostic (1.07e-4)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (3.64e-6)" "unprognostic (3.94e-1)" "unprognostic (6.21e-2)" "unprognostic (6.12e-2)" "unprognostic (2.66e-1)" "unprognostic (1.54e-1)" "unprognostic (3.54e-2)" "unprognostic (1.35e-1)" "unprognostic (1.77e-2)" "unprognostic (5.67e-3)" "unprognostic (3.62e-2)" "unprognostic (1.08e-1)" "unprognostic (2.43e-1)" 1.2 4.7 6.1 1.6 18.4 1.1 1.1 7.8 36.6 1.4 1.6 43.5 0.0 1.7 1.2 1.1 1.3 1.2 1.1 1.1 10.3 11.3 1.2 1.1 1.1 1.1 24.3 8.8 1.1 1.1 1.1 2.8 1.2 21.9 1.3 1.5 1.6 1.1 1.1 1.2 1.2 1.7 1.6 47.1 1.1 1.1 10.3 19.7 0.0 1.1 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 41.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.3 0.0 0.0 34.1 0.0 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 48.9 28.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 18.4 7.8 11.8 10.3 11.3 24.3 8.8 21.9 19.7 DQX1 FLJ23757 ENSG00000144045 "DEAQ-box RNA dependent ATPase 1" Q8TE96 2 74518131-74526336 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 41.0" "Group enriched" "Detected in some" 4 "HBEC3-KT: 6.4;Hep G2: 18.0;hTCEpi: 6.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039158 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039158: AB_10960125" "unprognostic (2.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (9.95e-2)" "unprognostic (2.20e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-1)" "unprognostic (4.54e-2)" "unprognostic (1.68e-1)" "unprognostic (7.67e-2)" "unprognostic (2.21e-2)" "unprognostic (0.00e+0)" "unprognostic (1.13e-2)" "unprognostic (1.36e-1)" "unprognostic (1.29e-1)" "unprognostic (6.16e-3)" 0.1 0.0 0.1 2.1 0.2 0.0 0.1 0.1 0.1 0.8 13.3 0.2 0.1 14.7 0.1 0.1 3.7 0.2 3.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.0 0.1 0.2 5.1 0.1 0.6 0.1 0.1 1.5 41.0 0.3 0.1 0.2 2.9 0.1 0.1 0.2 0.1 0.7 1.5 1.1 1.4 0.7 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.5 0.1 0.3 0.0 0.0 0.7 0.1 6.4 0.1 0.0 0.3 0.4 0.1 18.0 0.0 0.2 0.3 0.0 6.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.1 0.1 0.1 0.0 1.2 0.0 0.1 0.0 2.5 0.0 0.6 0.0 0.0 0.8 0.2 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 DRD1 ENSG00000184845 "Dopamine receptor D1" P21728 5 175440039-175444208 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 34.5" "Cell line enriched" "Detected in some" 5 "RT4: 23.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "basal ganglia: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "basal ganglia: 147.4" "Region enriched" "Detected in many" 13 "basal ganglia: 95.6" HPA013393 Supported "HPA013393: AB_1847833" "unprognostic (2.74e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-3)" "unprognostic (1.28e-1)" "unprognostic (1.15e-6)" "unprognostic (6.69e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (8.60e-4)" "unprognostic (5.86e-2)" "unprognostic (5.43e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" 0.7 1.5 1.9 0.2 34.5 0.0 0.1 0.1 12.0 0.7 0.7 0.4 0.0 0.5 0.4 0.7 0.7 0.6 1.1 0.3 1.0 0.6 0.7 2.6 1.8 0.1 0.5 1.6 0.3 0.0 0.0 0.1 2.5 0.3 2.7 0.9 2.1 0.1 1.2 0.1 0.1 0.3 0.4 0.1 0.4 0.4 0.1 6.8 0.1 0.1 0.0 0.4 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 34.5 0.1 5.3 1.0 0.6 0.5 1.6 0.3 6.8 DRD4 ENSG00000069696 "Dopamine receptor D4" P21917 11 637293-640706 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "retina: 86.1" "Cell line enhanced" "Detected in some" "HaCaT: 2.6;Hep G2: 2.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 14 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 14 "dendritic cells: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (8.83e-2)" "unprognostic (2.99e-2)" "unprognostic (4.98e-4)" "unprognostic (3.81e-2)" "unprognostic (7.52e-2)" "unprognostic (7.89e-3)" "unprognostic (3.14e-2)" "unprognostic (2.96e-1)" "unprognostic (8.45e-2)" "unprognostic (5.07e-2)" "unprognostic (3.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.05e-4)" "unprognostic (1.26e-2)" "unprognostic (8.21e-2)" "unprognostic (2.36e-2)" "unprognostic (1.85e-1)" 0.9 0.6 1.8 0.5 1.9 1.2 0.7 3.5 1.6 1.2 1.4 4.3 0.5 1.5 1.5 0.5 0.5 1.5 0.6 0.7 2.3 2.0 1.0 0.7 1.1 1.4 1.0 1.1 3.4 1.4 0.5 4.2 1.1 7.3 1.6 0.5 86.1 1.6 0.5 10.2 3.5 2.8 0.8 1.2 1.0 0.6 1.8 0.7 0.7 1.3 0.5 1.0 0.5 1.2 0.0 3.2 0.2 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 2.6 0.0 0.1 0.0 0.3 1.3 0.2 0.3 2.6 0.0 0.6 0.3 0.0 0.3 0.0 0.3 0.0 1.0 0.0 0.0 0.8 0.6 0.1 0.6 0.0 0.2 0.3 0.0 0.0 0.3 0.0 1.0 0.5 0.3 0.1 0.3 0.9 0.0 0.6 0.6 0.1 0.9 1.0 0.9 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 1.8 1.9 3.5 1.6 2.3 2.0 1.0 1.1 7.3 0.7 DRICH1 C22orf43 ENSG00000189269 "Aspartate rich 1" Q6PGQ1 22 23608452-23632321 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 68.5" "Cell line enriched" "Detected in many" 5 "CACO-2: 15.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" HPA020446 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA020446: AB_1853151" "unprognostic (7.48e-3)" "unprognostic (3.91e-2)" "unprognostic (2.02e-2)" "unprognostic (6.22e-4)" "unprognostic (6.46e-2)" "unprognostic (8.35e-4)" "unprognostic (2.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.06e-2)" "unprognostic (2.65e-2)" "unprognostic (5.73e-4)" "unprognostic (3.05e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-2)" "unprognostic (8.68e-3)" "unprognostic (7.70e-4)" "unprognostic (1.08e-3)" 0.5 0.5 0.5 0.5 0.5 1.3 0.8 1.0 0.5 0.5 0.5 0.5 0.5 0.1 1.3 9.7 0.5 0.6 0.5 0.5 0.5 0.3 1.2 0.5 0.5 0.7 0.5 0.5 1.3 0.9 8.3 0.8 0.5 0.5 0.7 0.2 0.5 0.5 0.6 0.5 1.3 0.6 0.5 0.5 0.8 0.4 68.5 0.5 0.5 1.0 0.5 0.5 0.5 0.5 0.0 0.0 0.4 0.6 0.0 1.0 0.0 0.7 0.8 2.1 0.6 2.6 0.6 1.9 0.0 0.0 0.1 0.1 15.3 0.6 1.0 0.1 0.6 1.5 3.0 0.1 0.4 0.2 1.4 0.5 1.2 0.6 0.9 0.3 2.3 1.2 1.3 0.4 0.0 0.4 1.2 0.3 0.2 0.7 0.2 0.7 0.2 0.8 1.6 0.1 0.0 0.4 1.6 0.9 0.7 0.0 1.3 1.1 0.2 0.1 0.4 0.0 2.7 2.4 0.2 1.0 1.4 0.1 2.5 0.6 0.2 0.0 0.3 0.0 1.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.5 0.5 1.0 0.5 0.5 0.3 0.5 0.5 0.5 0.5 DRP2 ENSG00000102385 "Dystrophin related protein 2" Q13474 X 101219769-101264497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.3" "Cell line enhanced" "Detected in some" "RH-30: 11.0;TIME: 18.5;U-87 MG: 4.5" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002949 Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles, Plasma membrane" "HPA002949: AB_1078706" "unprognostic (8.47e-4)" "unprognostic (3.56e-3)" "unprognostic (1.01e-2)" "unprognostic (5.58e-4)" "unprognostic (1.74e-2)" "unprognostic (2.47e-2)" "unprognostic (7.93e-3)" "unprognostic (2.94e-3)" "unprognostic (1.27e-2)" "unprognostic (5.46e-3)" "unprognostic (1.42e-1)" "unprognostic (4.61e-2)" "unprognostic (4.44e-16)" "unprognostic (3.71e-4)" "unprognostic (4.22e-1)" "unprognostic (9.03e-2)" "unprognostic (1.25e-1)" 1.1 1.5 9.3 1.2 17.2 1.1 0.8 0.4 20.3 1.7 2.8 1.2 0.0 1.1 2.5 2.7 1.3 1.0 1.3 0.9 5.8 4.2 0.7 0.6 0.8 0.8 4.6 10.1 4.4 0.6 0.6 2.4 0.7 2.6 4.1 1.8 0.5 0.7 3.1 0.7 0.8 1.2 2.2 3.1 0.7 0.7 1.6 2.2 0.9 0.6 0.0 0.8 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 2.3 0.1 0.1 0.2 0.1 0.4 0.1 0.3 1.0 0.0 0.4 0.3 0.3 0.1 0.0 0.3 0.0 0.7 0.1 0.2 0.2 0.5 0.0 0.2 0.1 0.4 1.5 0.0 0.7 0.0 1.4 0.0 0.9 1.6 0.0 1.3 0.5 0.1 0.1 0.3 11.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.1 18.5 0.2 0.7 0.2 0.4 0.0 0.1 0.0 4.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 9.3 17.2 0.4 20.3 5.8 4.2 4.6 10.1 2.6 2.2 DSC1 CDHF1 ENSG00000134765 "Desmocollin 1" Q08554 18 31129236-31162856 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 78.4" "Cell line enhanced" "Detected in some" "BEWO: 1.3;CACO-2: 1.0;HaCaT: 1.0;HEL: 1.5;hTCEpi: 1.0;MCF7: 1.0" "Group enriched" "Detected in some" 17 "head and neck cancer: 7.3;melanoma: 4.1" "Region enriched" "Detected in single" 13 "cerebral cortex: 7.0" "Group enriched" "Detected in some" 8 "naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.2" "Lineage enriched" "Detected in single" 8 "T-cells: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075379 Enhanced 18000000 "HPA075379: " "unprognostic (1.41e-1)" "unprognostic (1.38e-1)" "unprognostic (2.12e-1)" "unprognostic (1.10e-1)" "unprognostic (6.95e-2)" "unprognostic (2.48e-2)" "unprognostic (3.71e-2)" "unprognostic (8.19e-3)" "unprognostic (1.56e-1)" "unprognostic (1.89e-1)" "unprognostic (1.27e-1)" "unprognostic (1.78e-1)" "unprognostic (5.65e-6)" "unprognostic (5.08e-2)" "unprognostic (2.91e-1)" "unprognostic (6.99e-2)" "unprognostic (4.74e-5)" 0.2 0.1 0.1 0.3 0.5 0.0 3.5 0.1 7.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 2.8 0.1 0.0 9.1 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.4 0.1 1.3 0.0 0.1 0.0 1.3 1.2 0.0 0.2 78.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 1.1 0.1 16.6 1.5 0.1 0.2 0.0 0.0 0.7 0.0 0.0 5.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.0 0.3 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.3 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 5.7 5.2 0.7 0.0 0.0 0.0 0.0 0.9 0.1 0.5 0.1 7.0 0.1 0.1 0.1 0.1 0.0 0.0 DUPD1 DUSP27 ENSG00000188716 "Dual specificity phosphatase and pro isomerase domain containing 1" Q68J44 10 75037836-75058514 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 71 "skeletal muscle: 38.9" "Cell line enhanced" "Detected in single" "NB-4: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042964 Uncertain "HPA042964: AB_10795764" "unprognostic (1.05e-2)" "unprognostic (1.77e-1)" "unprognostic (2.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 38.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 DUSP15 "bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY" ENSG00000149599 "Dual specificity phosphatase 15" Q9H1R2 20 31847637-31870747 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 75.1" "Cell line enhanced" "Detected in some" "CACO-2: 5.3;REH: 17.4;SH-SY5Y: 5.0;SK-MEL-30: 4.3;U-2 OS: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive B-cell: 1.6" "Lineage enriched" "Detected in single" 14 "B-cells: 1.6" "Low region specificity" "Detected in all" HPA076649 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA076649: " "unprognostic (3.84e-2)" "unprognostic (2.30e-1)" "unprognostic (2.28e-1)" "unprognostic (9.01e-3)" "unprognostic (3.88e-2)" "unprognostic (2.36e-1)" "unprognostic (1.47e-2)" "unprognostic (2.24e-2)" "unprognostic (1.43e-1)" "unprognostic (1.76e-1)" "unprognostic (1.48e-5)" "unprognostic (7.31e-2)" "prognostic favourable (5.40e-7)" "unprognostic (2.79e-2)" "unprognostic (1.93e-1)" "unprognostic (3.11e-3)" "unprognostic (2.55e-1)" 1.1 2.1 2.8 0.6 4.0 0.5 1.3 1.2 3.7 1.6 0.8 4.2 6.9 0.9 1.4 10.4 0.6 0.7 1.1 2.7 2.8 3.1 15.4 0.6 0.8 1.0 4.9 2.3 2.1 1.8 10.6 2.7 1.1 5.9 1.9 0.5 5.3 2.1 9.3 2.4 0.7 1.0 2.3 5.2 1.0 1.1 75.1 1.4 0.0 3.5 0.1 0.6 0.7 0.8 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 1.6 0.0 0.3 0.0 0.0 0.0 0.9 0.0 5.3 0.1 1.0 2.2 0.3 0.0 0.4 0.0 0.0 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.7 0.7 0.0 17.4 2.0 0.1 0.0 0.0 2.4 5.0 2.8 0.0 4.3 1.3 1.0 0.0 0.0 4.2 0.0 0.0 1.8 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4.0 1.2 3.7 2.8 3.1 4.9 2.3 5.9 1.4 DUSP21 ENSG00000189037 "Dual specificity phosphatase 21" Q9H596 X 44844004-44844888 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 36 "testis: 15.9" "Group enriched" "Detected in some" 5 "CACO-2: 1.7;K-562: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DUSP26 "DUSP24, MGC1136" ENSG00000133878 "Dual specificity phosphatase 26" Q9BV47 8 33591332-33600106 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 147.1" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 45.1" "Cancer enhanced" "Detected in some" "glioma: 6.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 16 "B-cells: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018221 Approved Supported Nucleoplasm Nucleoplasm "HPA018221: AB_2669813" "unprognostic (2.77e-4)" "unprognostic (2.70e-2)" "unprognostic (2.70e-3)" "unprognostic (5.47e-3)" "unprognostic (2.01e-1)" "unprognostic (1.24e-1)" "unprognostic (1.62e-1)" "unprognostic (2.53e-2)" "unprognostic (2.81e-1)" "unprognostic (1.39e-1)" "unprognostic (4.10e-3)" "unprognostic (1.78e-2)" "unprognostic (2.28e-1)" "unprognostic (1.52e-2)" "unprognostic (1.14e-1)" "unprognostic (8.15e-2)" "unprognostic (5.80e-2)" 1.3 9.3 11.5 1.4 13.1 1.1 1.2 18.2 14.8 1.1 1.7 4.2 0.0 2.4 1.5 3.4 3.0 2.3 1.5 20.1 9.1 15.9 1.6 1.0 1.7 1.1 10.6 8.8 15.1 2.2 1.0 14.0 1.0 7.6 2.6 1.5 4.4 1.5 1.3 147.1 1.0 1.9 2.0 10.0 1.2 2.6 1.6 3.8 0.0 1.1 27.0 1.3 1.4 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 45.1 10.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 13.1 18.2 14.8 9.1 15.9 10.6 8.8 7.6 3.8 DWORF ENSG00000240045 "DWARF open reading frame" 3 155290229-155293775 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 173.0" "Low cell line specificity" "Detected in some" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "basophil: 2.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.9" "Region enriched" "Detected in some" 8 "basal ganglia: 19.5" "unprognostic (6.77e-4)" "unprognostic (1.60e-2)" "unprognostic (6.62e-2)" "unprognostic (1.58e-1)" "unprognostic (7.82e-3)" "unprognostic (1.33e-2)" 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.2 2.9 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.0 173.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.7 23.7 0.9 0.0 0.0 0.5 0.4 2.9 0.2 0.4 0.2 0.0 0.2 0.0 0.5 0.0 0.0 2.3 0.7 0.3 0.0 0.0 0.6 0.0 1.3 0.0 0.4 0.0 0.5 0.3 0.5 0.0 0.3 0.6 0.4 0.5 0.5 0.0 1.8 0.4 2.0 0.0 0.0 0.4 0.8 0.6 1.3 1.2 0.4 0.2 1.7 1.1 0.6 0.3 0.2 0.3 0.0 0.0 1.0 0.9 0.0 0.7 0.1 0.9 1.1 1.9 1.7 1.2 0.8 0.2 0.2 0.3 0.8 0.7 0.3 0.0 2.9 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.5 0.2 0.2 0.8 0.4 0.1 0.4 0.1 0.0 DYDC1 "bA36D19.5, DPY30D1" ENSG00000170788 "DPY30 domain containing 1" Q8WWB3 10 80336105-80356755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 50.4" "Cell line enhanced" "Detected in some" "NTERA-2: 2.5;RH-30: 1.2;SCLC-21H: 1.4;SH-SY5Y: 1.7;U-266/70: 1.7" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.8" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037790, HPA037791" Uncertain "HPA037790: AB_10805351, HPA037791: AB_10796215" "unprognostic (8.95e-2)" "unprognostic (8.28e-3)" "unprognostic (7.11e-2)" "unprognostic (3.12e-1)" "unprognostic (1.87e-1)" "unprognostic (1.90e-1)" "unprognostic (9.96e-2)" "unprognostic (7.95e-2)" 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 1.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.1 4.8 0.7 1.4 0.3 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 2.5 0.0 0.6 1.2 0.0 0.4 0.0 1.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 1.7 0.2 0.0 0.0 0.3 0.4 4.8 0.7 0.5 0.3 0.1 0.0 0.7 0.2 0.2 0.1 1.0 0.2 0.2 1.4 1.4 0.2 1.1 0.1 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 DYRK4 ENSG00000010219 "Dual specificity tyrosine phosphorylation regulated kinase 4" Q9NR20 12 4562204-4615302 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "testis: 85.9" "Cell line enhanced" "Detected in many" "HHSteC: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028065, HPA056073" Enhanced Enhanced Vesicles Vesicles "HPA028065: AB_10601212, HPA056073: AB_2683028" "unprognostic (2.50e-1)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (3.56e-3)" "unprognostic (2.62e-1)" "unprognostic (4.07e-3)" "unprognostic (2.03e-2)" "unprognostic (4.69e-2)" "unprognostic (1.29e-1)" "unprognostic (7.13e-2)" "unprognostic (1.22e-2)" "unprognostic (2.46e-1)" "prognostic unfavourable (6.52e-6)" "unprognostic (1.86e-1)" "unprognostic (9.71e-2)" "unprognostic (1.04e-1)" "unprognostic (3.98e-2)" 1.6 2.1 2.3 2.1 1.8 1.6 2.8 1.9 2.3 2.6 2.1 2.2 2.3 1.7 2.5 9.1 1.6 2.0 1.7 1.7 1.8 1.8 1.9 2.0 2.2 2.5 1.9 2.5 2.2 2.3 2.9 2.7 2.9 2.3 2.3 2.7 2.4 2.3 3.4 1.6 1.9 2.4 2.1 2.7 4.3 1.7 85.9 2.1 1.6 4.3 1.6 2.0 2.4 1.6 7.6 2.7 1.3 5.2 1.1 1.6 1.6 1.9 3.0 3.9 4.2 5.9 7.2 4.6 2.3 4.7 5.3 5.8 0.6 3.1 5.8 0.3 6.6 4.0 2.9 4.3 4.2 4.4 6.6 4.0 0.8 3.3 16.6 3.5 3.2 4.9 9.3 3.7 12.3 7.5 1.6 6.6 4.8 4.0 3.2 8.6 5.2 1.8 0.7 2.8 2.5 6.5 1.9 0.0 1.5 0.4 2.3 3.3 1.8 3.1 0.5 6.3 4.9 0.6 2.9 1.9 2.3 3.4 3.3 5.4 3.2 0.6 2.8 1.3 1.0 2.2 1.1 7.6 1.5 1.6 2.7 5.8 1.6 1.6 0.1 1.1 5.2 1.4 1.1 1.6 2.3 1.8 1.9 2.3 1.8 1.8 1.9 2.5 2.3 2.1 E2F7 ENSG00000165891 "E2F transcription factor 7" Q96AV8 12 77021247-77065580 "Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 42.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 5.0" "Lineage enriched" "Detected in many" 4 "dendritic cells: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "midbrain: 7.6;pons and medulla: 7.4;thalamus: 12.1" HPA064866 Supported "Nuclear speckles" "Nuclear speckles" "HPA064866: " "unprognostic (1.21e-1)" "unprognostic (8.92e-2)" "unprognostic (7.39e-2)" "unprognostic (7.27e-2)" "unprognostic (1.54e-1)" "unprognostic (3.80e-2)" "unprognostic (6.14e-5)" "unprognostic (1.05e-3)" "unprognostic (1.72e-1)" "unprognostic (3.57e-2)" "unprognostic (5.67e-5)" "unprognostic (1.42e-1)" "unprognostic (0.00e+0)" "unprognostic (3.05e-2)" "unprognostic (1.57e-1)" "unprognostic (1.00e-1)" "unprognostic (2.51e-1)" 1.3 0.4 0.6 4.7 0.7 8.4 0.4 0.5 0.8 1.1 1.7 1.2 0.5 1.3 1.2 1.4 5.0 1.2 1.3 0.8 0.7 0.6 0.5 0.5 1.4 2.7 0.5 0.0 0.7 0.7 0.5 1.8 2.1 0.6 0.7 3.0 0.4 0.9 1.0 0.3 2.1 2.3 0.9 0.6 2.4 1.2 6.1 0.2 42.0 0.4 2.3 6.3 1.4 1.7 0.6 5.0 1.2 0.0 0.2 1.0 0.0 9.5 4.5 12.8 5.0 0.4 1.3 15.5 13.4 14.6 7.1 8.6 6.2 3.2 5.3 2.7 2.6 7.4 7.6 14.5 13.7 2.1 5.1 4.7 13.2 3.5 3.0 4.0 4.4 0.4 3.8 18.6 11.5 6.9 4.8 4.4 14.5 4.8 15.0 0.0 9.0 10.8 10.9 11.1 3.0 1.7 8.1 8.1 5.3 11.1 3.9 3.2 6.2 4.2 19.1 26.9 13.6 11.4 17.6 4.7 2.6 3.4 9.7 1.8 16.7 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.2 0.0 5.0 1.0 0.0 0.6 0.7 0.5 0.8 0.7 0.6 0.5 0.0 0.6 0.2 EBI3 "IL27B, IL35B" ENSG00000105246 "Epstein-Barr virus induced 3" Q14213 19 4229498-4237531 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "placenta: 411.9" "Cell line enriched" "Detected in some" 13 "HDLM-2: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 15.5;naive B-cell: 8.5" "Group enriched" "Detected in many" 15 "B-cells: 15.5;monocytes: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046635 Enhanced "Secreted to blood" 1200000 "HPA046635: " "unprognostic (7.26e-2)" "unprognostic (1.49e-2)" "unprognostic (9.44e-2)" "unprognostic (1.31e-1)" "unprognostic (2.59e-1)" "unprognostic (2.24e-2)" "unprognostic (1.02e-1)" "unprognostic (2.10e-2)" "unprognostic (7.78e-2)" "unprognostic (4.87e-2)" "unprognostic (4.25e-3)" "unprognostic (8.27e-2)" "prognostic unfavourable (1.04e-8)" "unprognostic (1.97e-1)" "unprognostic (2.78e-2)" "unprognostic (9.29e-2)" "unprognostic (4.67e-2)" 2.1 2.5 1.9 5.7 1.5 0.4 1.4 0.3 1.0 0.8 1.3 1.1 0.3 1.7 0.6 0.8 0.5 1.7 2.3 0.7 1.7 1.4 2.1 1.9 1.8 18.5 2.5 0.7 0.6 1.0 0.1 1.1 411.9 1.1 1.0 0.7 0.7 1.1 0.6 0.4 0.2 5.1 0.8 3.8 24.6 1.5 0.9 1.3 4.9 0.5 0.3 2.9 2.0 0.5 15.5 0.6 0.1 4.5 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 2.3 0.2 1.3 0.1 0.0 0.4 0.3 1.3 5.3 0.0 0.0 0.0 0.0 0.0 67.2 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.1 0.0 0.6 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 3.7 0.0 15.5 0.0 0.0 0.6 8.5 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.4 1.9 1.5 0.3 1.0 1.7 1.4 2.5 0.7 1.1 1.3 EBLN1 ENSG00000223601 "Endogenous Bornavirus like nucleoprotein 1" P0CF75 10 22208814-22210021 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 7.4" "Cell line enhanced" "Detected in some" "CACO-2: 1.3;SK-MEL-30: 1.4;U-2 OS: 2.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "myeloid DC: 1.3" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.3" "unprognostic (1.39e-2)" "unprognostic (1.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 2.4 0.5 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EDDM3B "FAM12B, HE3-BETA" ENSG00000181552 "Epididymal protein 3B" P56851 14 20768427-20770948 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "epididymis: 261.1" "Cell line enhanced" "Detected in some" "BEWO: 3.7;NB-4: 7.1;RPMI-8226: 1.6;SH-SY5Y: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA001323 Enhanced "Secreted in male reproductive system" "HPA001323: AB_1848377" "unprognostic (2.40e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.1 0.1 0.2 0.1 0.0 12.9 0.0 0.2 261.1 0.1 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.8 0.9 0.2 0.4 0.1 0.0 0.2 0.1 0.1 3.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 EEF1A2 "EEF1AL, HS1, STN, STNL" ENSG00000101210 "Eukaryotic translation elongation factor 1 alpha 2" Q05639 20 63488012-63499322 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Autism spectrum disorder, Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 298.6" "Cell line enhanced" "Detected in many" "HAP1: 55.3;HBF TERT88: 27.8;MCF7: 45.7;SCLC-21H: 29.1;T-47d: 23.7;U-2 OS: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "T-reg: 1.8" "Lineage enriched" "Detected in single" 9 "T-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034019, HPA051759, HPA053862, HPA056990" Approved Supported Cytosol 55000000 Cytosol "CAB034019: AB_1562672, HPA051759: , HPA053862: , HPA056990: " "unprognostic (1.40e-2)" "unprognostic (6.82e-2)" "unprognostic (4.56e-2)" "prognostic unfavourable (2.90e-5)" "unprognostic (5.17e-2)" "prognostic unfavourable (9.11e-4)" "unprognostic (4.85e-1)" "unprognostic (1.68e-1)" "unprognostic (3.02e-2)" "unprognostic (1.74e-2)" "unprognostic (2.20e-2)" "unprognostic (2.30e-1)" "unprognostic (1.86e-1)" "unprognostic (8.29e-3)" "unprognostic (1.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.07e-1)" 2.2 8.0 21.3 2.3 23.5 1.9 2.2 41.1 51.3 1.9 2.3 2.3 0.1 2.2 2.0 2.3 4.1 2.1 2.6 51.9 23.0 21.0 2.0 2.0 2.0 2.1 13.9 31.0 2.0 3.5 6.1 16.6 2.0 23.1 3.7 2.1 1.8 3.4 2.2 298.6 2.2 2.3 2.1 4.8 2.0 3.6 2.3 3.6 0.0 2.0 23.9 2.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.3 0.1 10.6 0.2 2.5 0.0 0.1 1.3 2.1 0.3 10.5 3.5 1.4 7.0 0.0 18.6 0.1 5.0 55.3 0.1 27.8 0.1 2.5 0.0 4.0 0.4 0.6 0.0 2.5 0.2 0.3 0.0 0.2 0.0 0.6 0.0 0.1 45.7 0.1 0.1 1.9 17.8 1.3 0.0 1.7 0.4 0.5 29.1 17.7 16.8 1.9 0.1 23.7 0.6 0.0 0.0 32.4 0.1 0.3 0.0 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 21.3 23.5 41.1 51.3 23.0 21.0 13.9 31.0 23.1 3.6 EFCAB3 FLJ25818 ENSG00000172421 "EF-hand calcium binding domain 3" Q8N7B9 17 62343941-62416479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "testis: 11.3" "Cell line enhanced" "Detected in some" "SH-SY5Y: 2.0;T-47d: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046862 Uncertain "HPA046862: AB_2679844" "unprognostic (2.99e-6)" 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 1.2 1.9 0.3 0.5 1.3 0.3 0.0 0.1 0.3 0.0 0.3 0.7 0.1 0.0 0.5 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.8 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.2 0.9 0.6 1.4 1.4 0.0 1.5 0.0 1.1 0.4 0.6 0.7 2.0 0.0 1.9 0.3 2.1 0.0 0.5 0.2 0.4 0.5 0.1 0.0 0.5 0.2 0.5 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EFCAB8 ENSG00000215529 "EF-hand calcium binding domain 8" A8MWE9 20 32858923-32961609 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 5 "testis: 5.3" "Cell line enhanced" "Detected in some" "AN3-CA: 2.1;BJ hTERT+: 2.6;HMC-1: 2.6;Karpas-707: 1.5;U-937: 1.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "CAB034246, HPA042751" Uncertain "CAB034246: AB_1565078, HPA042751: " "unprognostic (2.48e-1)" "unprognostic (2.44e-1)" "unprognostic (7.35e-2)" "unprognostic (5.04e-2)" "unprognostic (1.96e-1)" "unprognostic (2.16e-4)" "unprognostic (2.35e-2)" "unprognostic (1.50e-1)" "unprognostic (3.26e-1)" "unprognostic (9.35e-2)" "unprognostic (2.10e-4)" "unprognostic (4.48e-2)" "unprognostic (4.44e-10)" "unprognostic (1.66e-1)" "unprognostic (6.57e-2)" "unprognostic (2.31e-1)" "unprognostic (3.74e-3)" 0.1 0.0 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.3 0.4 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.5 1.1 0.0 0.0 0.3 0.1 5.3 0.8 0.7 0.4 0.1 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 2.1 0.0 0.0 0.2 0.0 2.6 0.1 0.0 0.6 0.0 0.1 0.4 0.1 0.4 0.0 0.0 0.1 0.7 0.2 0.4 0.0 0.0 0.0 0.1 2.6 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.1 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.3 0.7 0.1 0.0 0.7 0.2 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.4 1.0 0.0 0.0 0.0 0.0 0.0 EFCAB9 ENSG00000214360 "EF-hand calcium binding domain 9" A8MZ26 5 172194172-172203452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 14.2" "Cell line enhanced" "Detected in some" "MCF7: 1.6;NB-4: 2.3;PC-3: 1.7;WM-115: 5.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 2.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (2.32e-1)" "unprognostic (6.64e-2)" "unprognostic (1.82e-1)" "unprognostic (3.42e-1)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.3 0.6 0.6 0.0 0.8 0.3 0.0 0.0 0.0 0.5 0.2 0.5 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.6 0.0 2.3 0.7 1.7 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.7 0.2 0.0 0.4 0.3 0.0 0.1 0.0 0.5 0.1 0.0 1.1 5.4 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 EGFL6 MAEG ENSG00000198759 "EGF like domain multiple 6" Q8IUX8 X 13569605-13633575 "Predicted secreted proteins" "Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "placenta: 137.5" "Group enriched" "Detected in some" 5 "BJ hTERT+: 9.4;NTERA-2: 3.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001838 Enhanced "Secreted to extracellular matrix" "HPA001838: " "unprognostic (1.66e-1)" "unprognostic (1.32e-2)" "unprognostic (9.15e-3)" "unprognostic (3.76e-3)" "unprognostic (1.77e-2)" "prognostic favourable (9.73e-4)" "unprognostic (4.13e-3)" "unprognostic (1.37e-1)" "unprognostic (5.19e-3)" "prognostic favourable (4.95e-4)" "unprognostic (2.39e-3)" "unprognostic (1.81e-1)" "unprognostic (1.14e-9)" "unprognostic (7.10e-2)" "unprognostic (3.21e-2)" "unprognostic (1.70e-1)" "unprognostic (1.82e-3)" 16.1 0.1 0.3 0.2 0.2 0.1 2.3 0.0 0.2 0.4 4.1 0.0 0.1 0.2 0.5 0.4 3.3 0.6 1.5 0.6 0.1 0.7 0.2 0.1 18.6 0.2 0.1 0.1 0.2 0.3 0.1 1.7 137.5 0.9 0.6 0.2 27.1 0.2 0.1 0.1 0.4 0.2 2.0 0.6 0.2 0.4 0.2 0.0 0.0 0.2 0.2 0.4 4.1 1.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.1 0.7 0.1 0.1 0.9 0.0 EGR4 "NGFI-C, PAT133" ENSG00000135625 "Early growth response 4" Q05215 2 73290929-73293705 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 20.0" "Cell line enriched" "Detected in some" 6 "HMC-1: 5.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA028983 Enhanced "HPA028983: AB_10603665" "unprognostic (7.75e-2)" "unprognostic (1.17e-1)" "unprognostic (1.39e-4)" "unprognostic (2.43e-3)" "unprognostic (2.68e-2)" "unprognostic (8.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.03e-2)" "unprognostic (5.20e-2)" "unprognostic (4.00e-1)" "unprognostic (2.29e-4)" "unprognostic (2.41e-1)" "unprognostic (1.75e-2)" "unprognostic (3.20e-2)" "unprognostic (1.77e-1)" "unprognostic (1.21e-2)" "unprognostic (4.07e-3)" 1.1 0.8 4.9 1.0 15.9 0.9 0.6 17.2 20.0 0.6 0.6 1.2 0.0 0.5 0.6 0.5 0.6 0.6 0.6 0.6 8.8 1.9 0.6 0.6 0.6 0.6 0.3 4.4 0.6 0.5 0.6 2.3 0.6 0.0 0.7 0.6 0.0 0.5 0.5 0.6 0.6 0.6 0.6 0.3 0.6 0.7 4.9 2.6 0.0 0.5 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 15.9 17.2 20.0 8.8 1.9 0.3 4.4 0.0 2.6 EID3 "FLJ25832, NSE4B, NSMCE4B" ENSG00000255150 "EP300 interacting inhibitor of differentiation 3" Q8N140 12 104303739-104305205 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 69.1" "Cell line enhanced" "Detected in many" "A549: 10.0;BJ: 9.3;BJ hTERT+: 7.6;BJ hTERT+ SV40 Large T+ RasG12V: 7.7;HeLa: 8.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;NK-cells: 6.6;T-cells: 9.5" "Low region specificity" "Detected in single" HPA059367 Uncertain Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA059367: " "unprognostic (1.25e-1)" "unprognostic (5.41e-3)" "unprognostic (5.82e-2)" "unprognostic (8.21e-2)" "prognostic unfavourable (1.14e-4)" "unprognostic (8.02e-2)" "unprognostic (5.88e-5)" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-2)" "unprognostic (5.38e-3)" "unprognostic (1.18e-1)" "prognostic unfavourable (5.96e-5)" "unprognostic (8.70e-2)" "unprognostic (3.54e-1)" "unprognostic (2.04e-3)" "unprognostic (2.87e-2)" 1.7 1.7 2.0 2.9 2.7 3.0 1.7 4.0 2.6 1.6 1.8 1.5 0.2 0.6 2.1 1.9 1.3 1.8 1.8 1.2 1.9 1.9 1.2 0.9 1.8 3.7 1.2 2.3 3.4 1.7 0.9 5.3 1.1 2.2 2.7 0.6 1.7 1.3 4.1 1.5 1.6 1.6 1.6 1.2 1.9 1.4 69.1 1.6 2.3 1.0 0.4 2.5 1.5 1.3 2.9 0.5 0.7 1.5 6.6 9.5 2.6 0.3 10.0 0.3 1.0 2.2 2.3 1.9 9.3 7.6 4.5 7.7 0.2 0.5 0.1 0.1 2.1 0.2 0.3 0.8 6.6 0.6 0.1 1.8 8.4 1.5 3.3 0.1 0.5 3.1 0.0 2.8 0.6 0.7 0.1 0.6 2.8 0.1 3.3 1.4 0.5 2.0 0.2 0.0 0.1 2.5 0.3 0.1 0.0 6.2 0.4 0.2 0.0 0.0 1.4 0.1 0.3 2.2 0.4 0.4 0.2 0.1 0.2 0.0 0.9 0.0 0.3 0.5 5.2 1.5 5.5 2.7 6.6 6.2 0.3 2.9 9.5 5.7 0.7 6.6 0.9 0.5 7.6 2.6 2.0 2.7 4.0 2.6 1.9 1.9 1.2 2.3 2.2 1.6 ELANE "ELA2, HLE, HNE, NE" ENSG00000197561 "Elastase, neutrophil expressed" P08246 19 851014-856247 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "bone marrow: 244.3" "Cell line enriched" "Detected in some" 65 "THP-1: 193.2" "Group enriched" "Detected in some" 7 "pancreatic cancer: 3.5;stomach cancer: 3.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "classical monocyte: 3.2;neutrophil: 6.9" "Group enriched" "Detected in many" 9 "granulocytes: 6.9;monocytes: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB015409, HPA066836" Enhanced "Secreted to blood" 59000 "CAB015409: AB_831596, HPA066836: " "unprognostic (3.46e-2)" "unprognostic (1.10e-1)" "unprognostic (1.42e-3)" "unprognostic (2.09e-2)" "unprognostic (1.80e-3)" "unprognostic (3.43e-2)" "unprognostic (3.92e-1)" "unprognostic (6.38e-3)" "unprognostic (5.80e-1)" "unprognostic (2.54e-2)" "unprognostic (4.06e-2)" "unprognostic (3.48e-2)" "unprognostic (1.19e-10)" "unprognostic (6.27e-3)" "unprognostic (4.00e-2)" "unprognostic (2.76e-2)" "unprognostic (4.75e-3)" 1.5 0.3 0.1 0.3 0.1 244.3 1.6 0.2 0.6 0.3 0.6 0.7 0.0 0.3 0.3 0.7 0.5 0.6 0.8 31.2 0.0 0.0 0.3 1.5 17.8 1.6 0.0 0.0 0.3 1.8 0.3 0.4 4.7 0.5 1.4 0.3 1.0 0.7 0.3 1.1 2.1 0.5 0.5 0.0 22.5 0.5 0.3 0.0 23.0 2.3 0.9 0.3 1.0 0.2 0.0 0.0 6.9 3.2 0.0 0.5 11.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 193.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 3.2 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 11.2 0.1 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.0 ELAVL3 "DKFZp547J036, HUC, HUCL, MGC20653, PLE21" ENSG00000196361 "ELAV like RNA binding protein 3" Q14576 19 11451326-11481046 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 53.8" "Group enriched" "Detected in some" 8 "SCLC-21H: 39.6;SH-SY5Y: 22.8" "Cancer enriched" "Detected in some" 10 "glioma: 11.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.9;naive B-cell: 1.9" "Lineage enhanced" "Detected in single" "B-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013066 Enhanced "CAB013066: AB_221448" "unprognostic (1.47e-2)" "unprognostic (2.29e-2)" "unprognostic (1.70e-1)" "unprognostic (7.78e-3)" "unprognostic (8.76e-2)" "unprognostic (2.95e-3)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-2)" "unprognostic (2.44e-1)" "unprognostic (5.93e-3)" "unprognostic (1.86e-2)" "unprognostic (2.15e-3)" "unprognostic (2.26e-2)" "unprognostic (1.09e-1)" "unprognostic (2.63e-1)" "unprognostic (9.60e-3)" 1.0 2.4 14.0 1.5 13.2 1.0 1.0 45.2 53.8 1.0 1.3 12.2 0.0 1.2 1.1 1.6 1.2 1.0 1.0 1.1 17.3 13.0 1.1 1.1 1.1 1.0 14.3 18.3 1.0 1.0 1.0 1.3 1.0 9.5 1.6 1.2 0.1 1.0 1.2 4.0 1.0 1.2 1.2 21.9 1.1 1.2 1.5 5.1 0.0 1.0 0.0 1.0 1.0 0.0 1.9 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 39.6 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 1.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 14.0 13.2 45.2 35.2 17.3 13.0 14.3 18.3 9.5 5.1 ELFN2 "dJ63G5.3, KIAA1904, LRRC62, PPP1R29" ENSG00000166897 "Extracellular leucine rich repeat and fibronectin type III domain containing 2" Q5R3F8 22 37367960-37427470 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 30.0" "Cell line enhanced" "Detected in some" "A-431: 8.7;CAPAN-2: 8.4;PC-3: 7.9;RPMI-8226: 8.4;RPTEC TERT1: 16.4;U-2 OS: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000781 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA000781: AB_1079280" "unprognostic (2.74e-1)" "unprognostic (6.81e-2)" "unprognostic (2.80e-2)" "unprognostic (1.31e-5)" "unprognostic (3.28e-1)" "unprognostic (2.51e-2)" "unprognostic (7.76e-2)" "unprognostic (4.25e-2)" "unprognostic (6.05e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (4.51e-1)" "prognostic unfavourable (7.21e-4)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" 1.0 2.1 26.8 0.9 10.9 0.9 0.9 0.7 30.0 0.9 0.9 1.9 0.0 0.9 0.9 0.9 0.9 1.0 1.9 0.8 16.2 8.7 1.2 0.8 2.0 1.0 6.7 15.0 0.8 1.1 0.8 0.1 0.8 5.8 2.2 0.9 0.9 0.9 0.9 0.9 1.5 0.9 0.8 3.8 0.9 1.1 4.2 3.9 0.1 0.8 0.0 0.9 0.9 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.7 3.7 0.0 0.0 0.0 0.7 0.0 3.9 2.1 0.9 0.0 1.4 8.4 0.2 5.2 2.8 6.1 0.4 0.8 0.1 0.2 0.0 0.0 3.9 0.0 0.2 0.0 0.1 0.7 0.1 0.3 1.2 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.2 7.9 0.1 0.0 8.4 16.4 0.0 0.7 0.0 3.6 4.6 0.0 0.0 0.1 0.4 0.0 18.6 0.1 2.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 10.9 0.7 16.8 16.2 8.7 6.7 15.0 5.8 3.9 ELOA2 "HsT832, TCEB3B, TCEB3L" ENSG00000206181 "Elongin A2" Q8IYF1 18 47032572-47035621 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 30 "testis: 8.0" "Cell line enhanced" "Detected in some" "U-2 OS: 1.8;WM-115: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041009, HPA043501, HPA048971, HPA049178, HPA050086" Approved "HPA041009: AB_10959881, HPA043501: AB_10960403, HPA048971: , HPA049178: , HPA050086: " "unprognostic (2.38e-1)" "unprognostic (4.47e-1)" "unprognostic (2.54e-4)" "unprognostic (2.39e-1)" "unprognostic (8.75e-2)" "unprognostic (5.34e-2)" "unprognostic (3.64e-1)" "unprognostic (5.25e-2)" "unprognostic (1.81e-1)" "unprognostic (1.38e-2)" "unprognostic (3.97e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ELSPBP1 "E12, EDDM12, HE12" ENSG00000169393 "Epididymal sperm binding protein 1" Q96BH3 19 47994651-48025153 "Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "epididymis: 279.8" "Group enriched" "Detected in some" 5 "HMC-1: 14.2;NB-4: 7.7" "Cancer enhanced" "Detected in single" "melanoma: 0.9" "Region enriched" "Detected in single" 11 "hypothalamus: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044256, HPA050341" Enhanced "Secreted in male reproductive system" "HPA044256: AB_2678879, HPA050341: " "unprognostic (1.51e-1)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.1 279.8 0.0 0.0 0.0 0.0 0.1 1.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 1.8 0.1 0.0 0.0 0.0 EMILIN3 "C20orf130, dJ620E11.4, EMILIN5" ENSG00000183798 "Elastin microfibril interfacer 3" Q9NT22 20 41359966-41366827 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 49.9" "Group enriched" "Detected in some" 7 "AF22: 6.8;HAP1: 11.8;NTERA-2: 7.5;SCLC-21H: 14.1" "Cancer enhanced" "Detected in many" "glioma: 10.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 29 "cerebellum: 3.7" "Low region specificity" "Detected in single" "HPA059912, HPA078559" Enhanced "Secreted to extracellular matrix" 650000 "HPA059912: , HPA078559: " "unprognostic (1.66e-4)" "unprognostic (1.85e-2)" "unprognostic (2.50e-2)" "unprognostic (2.14e-1)" "unprognostic (2.65e-1)" "unprognostic (2.15e-2)" "unprognostic (1.71e-1)" "unprognostic (7.66e-2)" "unprognostic (2.18e-3)" "unprognostic (2.57e-1)" "unprognostic (6.54e-2)" "unprognostic (7.66e-2)" "unprognostic (3.13e-7)" "unprognostic (2.64e-2)" "unprognostic (1.05e-1)" "unprognostic (1.97e-1)" "unprognostic (9.62e-2)" 0.9 1.9 2.9 1.6 2.0 0.5 3.5 0.7 8.2 7.1 4.1 1.9 8.5 1.1 2.7 49.9 1.1 3.2 0.9 6.0 3.0 2.9 0.8 0.6 0.7 0.6 3.8 0.7 9.2 0.6 0.5 1.6 0.6 2.7 8.1 0.8 5.8 1.5 10.0 1.3 3.4 1.4 1.6 2.2 0.6 1.9 4.3 2.3 0.3 0.7 2.9 0.8 2.4 5.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 6.8 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 11.8 0.0 0.2 0.0 1.3 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.1 0.0 0.0 14.1 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.9 2.0 0.7 8.2 3.0 2.9 3.8 0.7 2.7 2.3 EN2 ENSG00000164778 "Engrailed homeobox 2" P19622 7 155458129-155464831 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 26.5" "Cell line enhanced" "Detected in some" "AF22: 26.9;AN3-CA: 9.9;HAP1: 5.8;HEK 293: 16.3;SK-MEL-30: 7.9" "Cancer enhanced" "Detected in many" "melanoma: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 8 "cerebellum: 31.1" "Region enriched" "Detected in some" 6 "cerebellum: 71.6" "HPA045646, HPA069809" Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA045646: , HPA069809: " "unprognostic (2.44e-3)" "unprognostic (1.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.99e-3)" "prognostic unfavourable (1.74e-6)" "unprognostic (2.54e-1)" "unprognostic (8.02e-2)" "unprognostic (7.00e-2)" "unprognostic (1.15e-1)" "unprognostic (9.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.94e-1)" "unprognostic (1.03e-13)" "unprognostic (4.91e-3)" "unprognostic (2.72e-1)" "unprognostic (2.24e-1)" "unprognostic (5.64e-3)" 0.3 0.2 0.1 0.0 0.1 0.0 0.1 26.5 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.3 1.3 1.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.4 26.9 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.0 0.0 5.8 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.2 3.4 0.0 0.0 0.0 1.3 0.0 2.1 0.0 0.1 0.2 0.0 0.0 1.9 0.0 7.9 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ENC1 "ENC-1, KLHL37, NRPB, PIG10, TP53I10" ENSG00000171617 "Ectodermal-neural cortex 1" O14682 5 74627406-74641424 "Cancer-related genes, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 106.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 7 "amygdala: 39.7;basal ganglia: 42.7;cerebral cortex: 86.4;hippocampal formation: 44.1;olfactory region: 43.9" "Group enriched" "Detected in many" 6 "classical monocyte: 5.4;eosinophil: 3.4;gdT-cell: 2.3;intermediate monocyte: 4.8;memory CD8 T-cell: 3.0;myeloid DC: 2.4;naive CD8 T-cell: 2.5;neutrophil: 1.4;NK-cell: 2.8;non-classical monocyte: 1.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078061 Uncertain "Plasma membrane" "Plasma membrane" "HPA078061: " "prognostic unfavourable (3.88e-4)" "unprognostic (4.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.00e-3)" "unprognostic (1.05e-1)" "unprognostic (2.22e-3)" "unprognostic (1.36e-1)" "unprognostic (9.74e-2)" "unprognostic (1.24e-1)" "unprognostic (2.59e-1)" "unprognostic (4.98e-2)" "unprognostic (8.08e-2)" "prognostic unfavourable (2.95e-5)" "unprognostic (9.69e-2)" "unprognostic (3.08e-1)" "unprognostic (2.88e-1)" "unprognostic (5.65e-2)" 2.2 1.1 39.7 4.7 42.7 5.4 1.8 1.3 106.8 4.2 5.2 2.4 2.1 6.4 2.9 1.6 2.5 1.3 7.5 3.2 44.1 7.7 2.2 6.4 4.8 2.2 4.6 43.9 6.0 12.3 1.0 2.4 4.2 4.9 4.3 8.1 0.8 5.4 7.4 1.7 1.7 8.1 3.0 2.3 4.0 9.8 4.5 1.5 0.5 1.3 0.3 2.0 6.5 1.3 0.4 2.4 3.4 5.4 2.8 3.0 1.4 11.9 14.8 14.8 7.0 6.4 1.6 31.9 8.0 9.1 9.2 6.8 23.9 20.2 0.0 10.0 6.8 9.7 0.2 15.5 20.1 0.2 1.1 13.2 2.8 10.4 0.6 1.3 0.1 2.5 1.0 24.4 2.4 7.5 2.9 7.7 24.0 2.9 1.2 1.7 15.4 13.3 1.5 9.7 1.2 5.0 9.1 19.9 8.1 1.4 6.6 0.7 3.1 1.6 17.8 15.6 26.1 9.2 25.8 0.1 0.0 0.2 18.0 1.1 23.7 0.0 5.4 3.4 2.3 4.8 0.0 0.1 0.5 3.0 2.4 0.4 0.2 2.5 1.4 2.8 1.3 0.0 0.0 1.4 39.7 42.7 1.3 86.4 44.1 7.7 4.6 43.9 4.9 1.5 ENDOG ENSG00000167136 "Endonuclease G" Q14249 9 128818474-128822677 "Plasma proteins, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 91.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021335, HPA021830" Approved "Intracellular and membrane" "HPA021335: AB_1848151, HPA021830: AB_1848152" "unprognostic (1.35e-1)" "unprognostic (3.41e-1)" "unprognostic (4.86e-2)" "prognostic favourable (5.12e-4)" "unprognostic (2.51e-1)" "unprognostic (3.95e-1)" "unprognostic (6.56e-2)" "unprognostic (2.64e-2)" "unprognostic (4.90e-1)" "unprognostic (6.97e-2)" "unprognostic (8.35e-3)" "unprognostic (1.03e-1)" "prognostic favourable (1.06e-7)" "unprognostic (1.69e-2)" "unprognostic (1.81e-1)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" 5.8 6.4 8.6 3.2 9.1 3.9 8.1 8.1 15.0 4.4 8.4 5.3 8.8 10.3 3.1 2.6 5.7 7.7 4.3 19.9 8.0 8.3 9.9 18.5 3.8 5.7 7.2 7.2 3.5 8.4 8.0 4.8 3.9 6.0 6.9 5.5 4.8 5.9 7.0 91.2 5.2 7.6 3.4 4.1 3.4 7.6 6.1 6.5 5.2 8.1 18.1 3.7 4.3 7.1 3.9 6.9 1.5 3.8 2.3 3.1 1.3 6.6 7.2 1.9 9.9 5.0 4.3 8.5 6.4 3.4 6.1 4.2 4.4 5.3 2.1 5.8 4.2 18.8 6.0 5.6 1.1 4.2 10.7 3.7 7.0 7.7 2.3 11.5 14.3 4.5 6.9 3.6 2.5 4.6 11.6 3.4 3.8 9.6 8.9 23.7 4.7 27.2 10.7 2.1 22.3 9.0 2.4 16.6 16.5 14.3 13.2 3.2 12.6 5.7 4.7 4.3 2.5 6.1 4.7 10.9 1.5 4.1 8.6 8.3 4.4 0.0 2.3 1.5 2.8 3.8 2.5 3.2 2.8 1.3 3.6 3.9 2.7 3.1 0.0 2.3 1.7 6.9 1.1 1.3 8.6 9.1 8.1 15.0 8.0 8.3 7.2 7.2 6.0 6.5 ENHO "C9orf165, UNQ470" ENSG00000168913 "Energy homeostasis associated" Q6UWT2 9 34521040-34523041 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 79.6" "Cell line enhanced" "Detected in some" "AN3-CA: 13.2;NTERA-2: 18.2;SCLC-21H: 9.3;SH-SY5Y: 8.8" "Cancer enhanced" "Detected in many" "glioma: 44.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "myeloid DC: 19.4" "Lineage enriched" "Detected in many" 7 "dendritic cells: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042575 Approved "Secreted to blood" 4236667 "HPA042575: AB_10794914" "unprognostic (2.63e-2)" "unprognostic (9.53e-3)" "unprognostic (2.46e-1)" "prognostic unfavourable (3.71e-4)" "unprognostic (1.30e-1)" "unprognostic (7.51e-2)" "unprognostic (9.93e-2)" "unprognostic (1.34e-2)" "unprognostic (5.86e-2)" "unprognostic (2.19e-2)" "unprognostic (2.78e-4)" "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.47e-2)" "unprognostic (1.87e-1)" "unprognostic (5.50e-2)" "unprognostic (8.76e-2)" 1.5 1.9 58.0 1.9 59.3 1.7 3.7 15.5 79.6 2.9 3.9 13.9 0.0 3.0 1.4 1.4 1.5 3.6 1.8 1.8 36.3 37.5 1.5 12.0 2.0 1.4 52.0 27.1 1.5 2.6 1.2 1.0 1.3 13.7 5.2 3.2 0.1 1.8 1.7 1.6 3.8 3.6 1.3 17.1 1.6 5.3 6.4 13.4 0.0 1.4 0.0 1.4 1.5 0.0 0.0 19.4 0.0 2.5 2.7 0.0 0.4 0.1 0.9 5.2 13.2 0.1 0.0 0.3 0.0 0.0 2.1 2.1 0.5 0.2 2.2 3.6 0.0 0.2 6.0 0.4 0.4 0.3 5.8 0.0 0.1 1.2 0.1 0.0 2.9 0.0 0.1 0.0 0.2 0.0 0.0 1.9 0.4 0.3 0.0 0.0 18.2 3.7 0.1 0.0 0.3 0.5 0.0 9.3 8.8 0.7 4.1 0.4 0.3 1.7 0.0 0.4 2.0 0.1 0.1 1.1 1.2 0.1 0.4 0.0 3.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 2.7 0.7 1.0 0.0 0.4 58.0 59.3 15.5 37.0 36.3 37.5 52.0 27.1 13.7 13.4 ENO2 ENSG00000111674 "Enolase 2" P09104 12 6913745-6923698 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 119.2" "Cell line enhanced" "Detected in many" "U-87 MG: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 8.2;MAIT T-cell: 9.7;memory B-cell: 5.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 9.6;naive B-cell: 3.3;naive CD4 T-cell: 7.1;naive CD8 T-cell: 7.4;neutrophil: 6.2;T-reg: 5.5" "Group enriched" "Detected in many" 7 "B-cells: 5.6;granulocytes: 6.2;T-cells: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000063, HPA068284, HPA068721, CAB073539, CAB079023" Enhanced Supported Supported "Plasma membrane,Cytosol" 89000000 "Plasma membrane, Cytosol" "CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: " "unprognostic (8.96e-2)" "unprognostic (8.28e-2)" "prognostic unfavourable (6.96e-4)" "unprognostic (1.28e-1)" "unprognostic (7.95e-3)" "unprognostic (1.39e-2)" "prognostic unfavourable (5.15e-4)" "unprognostic (1.48e-1)" "unprognostic (9.43e-2)" "unprognostic (1.58e-1)" "unprognostic (1.98e-1)" "unprognostic (2.02e-2)" "prognostic unfavourable (7.89e-11)" "unprognostic (7.61e-2)" "unprognostic (3.06e-1)" "unprognostic (8.10e-3)" "unprognostic (1.24e-1)" 4.2 20.7 31.2 8.3 48.0 4.0 4.9 115.2 119.2 7.6 7.9 10.9 2.6 4.9 11.7 6.3 5.9 9.4 8.0 10.3 30.2 39.2 3.5 2.0 10.1 10.5 29.6 47.4 3.7 4.1 19.1 15.5 4.8 47.7 8.0 7.4 28.6 3.1 15.3 2.1 5.8 6.0 15.2 15.7 5.8 6.4 3.2 13.3 1.7 14.2 0.3 10.3 7.1 5.0 5.6 1.0 6.2 0.2 0.4 10.8 4.5 14.0 8.9 3.2 0.1 4.8 5.2 0.2 10.9 7.0 16.2 25.0 1.7 1.1 19.8 1.8 4.7 2.1 33.7 3.0 24.6 39.6 3.1 27.3 9.1 11.8 3.5 1.6 32.9 2.6 0.1 11.9 2.4 3.4 1.8 0.2 10.8 1.9 12.8 1.7 17.1 5.0 14.2 2.7 4.3 7.9 1.9 25.9 18.2 2.8 0.2 18.6 0.9 0.8 4.3 14.2 15.0 19.1 14.1 14.5 14.5 2.9 81.3 0.0 2.9 1.3 0.0 0.1 8.2 0.0 9.7 5.6 10.8 9.6 0.0 3.3 7.1 7.4 6.2 0.4 0.2 1.0 5.5 4.5 31.2 48.0 115.2 91.3 30.2 39.2 29.6 47.4 47.7 13.3 ENPP5 ENSG00000112796 "Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)" Q9UJA9 6 46159187-46170971 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "epididymis: 116.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.8;HSkMC: 7.9;T-47d: 9.3;U-266/70: 5.8;U-266/84: 8.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 13.4" "Lineage enriched" "Detected in many" 6 "T-cells: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016902 Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" 300000 Cytosol Nucleoplasm "HPA016902: AB_1848172" "unprognostic (1.12e-1)" "unprognostic (5.19e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-1)" "unprognostic (7.61e-2)" "unprognostic (1.63e-1)" "unprognostic (5.01e-2)" "prognostic favourable (4.57e-4)" "unprognostic (1.96e-1)" "unprognostic (9.89e-2)" "prognostic favourable (4.04e-4)" "unprognostic (7.00e-2)" "prognostic favourable (4.44e-13)" "unprognostic (4.40e-2)" "unprognostic (2.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.60e-1)" 1.5 4.8 6.5 1.3 10.3 0.8 7.1 9.2 16.1 6.9 2.0 3.3 28.7 1.5 1.6 116.5 1.6 7.9 3.9 3.9 6.6 9.4 12.1 1.0 4.7 1.2 14.2 10.5 5.4 6.2 21.8 23.3 1.5 14.4 14.6 2.3 11.8 6.9 27.5 6.9 1.3 1.6 5.1 5.5 3.2 3.5 16.2 3.5 1.0 24.3 0.9 1.4 5.7 1.7 0.4 0.0 1.0 0.1 2.2 13.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.6 0.1 0.3 11.8 1.9 3.9 0.3 0.0 0.6 1.6 0.1 0.0 2.6 0.8 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.0 0.5 2.5 0.0 0.0 0.3 0.2 4.9 0.6 5.1 0.2 0.0 4.9 0.0 9.3 0.0 0.0 0.0 1.4 0.0 0.1 5.8 8.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 13.4 0.1 7.2 0.4 2.7 8.6 0.0 0.4 0.8 8.2 1.0 2.2 0.0 0.0 0.0 2.6 6.5 10.3 9.2 16.1 6.6 9.4 14.2 10.5 14.4 3.5 ENPP7 "alk-SMase, NPP7" ENSG00000182156 "Ectonucleotide pyrophosphatase/phosphodiesterase 7" Q6UWV6 17 79730919-79742222 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 71.1" "Group enriched" "Detected in some" 5 "Hep G2: 2.8;Karpas-707: 5.1;U-266/70: 6.9" "Cancer enriched" "Detected in some" 6 "liver cancer: 6.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024603 Approved "Intracellular and membrane" 440000 "HPA024603: AB_1848174" "unprognostic (4.00e-2)" "unprognostic (1.16e-2)" "unprognostic (6.49e-2)" "unprognostic (4.83e-2)" "unprognostic (1.55e-1)" "unprognostic (2.65e-2)" "unprognostic (1.24e-1)" "unprognostic (1.01e-1)" "unprognostic (8.45e-4)" "unprognostic (4.83e-2)" "unprognostic (1.18e-2)" "unprognostic (1.52e-2)" "unprognostic (5.21e-2)" "unprognostic (1.25e-1)" "unprognostic (1.80e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.9 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.7 1.3 0.1 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ENTHD1 FLJ25421 ENSG00000176177 "ENTH domain containing 1" Q8IYW4 22 39743044-39893864 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 15.8" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 6.8" "Cancer enriched" "Detected in single" 30 "melanoma: 7.0" "Region enriched" "Detected in single" 20 "basal ganglia: 2.0" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "Not detected" "Not detected" HPA019800 Uncertain "HPA019800: AB_1848842" "unprognostic (5.28e-3)" "unprognostic (1.27e-1)" "unprognostic (8.04e-2)" "unprognostic (9.84e-3)" "unprognostic (2.97e-4)" "unprognostic (6.02e-2)" "unprognostic (1.16e-1)" "unprognostic (2.17e-1)" "unprognostic (7.32e-2)" "unprognostic (1.47e-4)" "unprognostic (3.60e-2)" "unprognostic (7.75e-10)" "unprognostic (3.68e-2)" "unprognostic (8.56e-2)" "unprognostic (4.99e-2)" "unprognostic (1.06e-1)" 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 15.8 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.9 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ENTPD8 "NTPDase-8, UNQ2492" ENSG00000188833 "Ectonucleoside triphosphate diphosphohydrolase 8" Q5MY95 9 137434364-137441816 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 48.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.0;RPMI-8226: 8.7;T-47d: 4.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA021509 Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA021509: AB_1848185" "unprognostic (3.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.30e-1)" "unprognostic (1.40e-1)" "unprognostic (6.46e-3)" "unprognostic (8.70e-2)" "unprognostic (3.87e-2)" "unprognostic (8.48e-2)" "unprognostic (1.69e-1)" "unprognostic (2.34e-2)" "unprognostic (1.08e-5)" "prognostic favourable (7.17e-4)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-1)" 0.4 0.0 0.4 2.6 0.4 0.0 0.4 0.4 0.4 0.4 19.2 0.4 0.4 18.5 0.4 0.4 0.4 0.3 2.2 0.4 0.5 0.0 2.1 9.8 0.8 0.4 0.4 0.4 0.4 1.8 0.0 4.2 0.5 0.4 0.4 7.5 0.8 4.1 0.4 0.4 0.0 48.1 0.4 0.4 0.4 6.1 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.0 9.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 1.5 0.2 0.0 0.6 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 1.6 0.0 0.2 0.1 0.4 0.0 0.0 8.7 1.4 0.0 0.3 0.9 0.2 0.0 0.1 4.7 0.2 0.1 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.5 0.0 0.4 0.4 0.4 0.4 EPHA7 Hek11 ENSG00000135333 "EPH receptor A7" Q15375 6 93240020-93419547 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "parathyroid gland: 110.4" "Group enriched" "Detected in some" 4 "AF22: 8.7;HEK 293: 25.0;RH-30: 23.8;THP-1: 20.3" "Cancer enhanced" "Detected in many" "renal cancer: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010496 Approved "Intracellular and membrane" 340000 "CAB010496: AB_2099673" "unprognostic (3.34e-1)" "unprognostic (7.82e-2)" "unprognostic (1.41e-1)" "unprognostic (9.32e-2)" "unprognostic (1.19e-1)" "unprognostic (3.56e-2)" "unprognostic (1.62e-2)" "unprognostic (4.07e-1)" "unprognostic (4.16e-2)" "unprognostic (3.19e-2)" "unprognostic (5.69e-2)" "unprognostic (1.69e-1)" "unprognostic (1.74e-2)" "unprognostic (1.35e-1)" "unprognostic (1.56e-2)" "unprognostic (4.82e-2)" 1.3 1.3 6.0 1.7 24.6 1.2 2.2 21.6 8.6 2.4 24.6 0.0 0.1 2.5 2.0 7.5 14.7 1.7 3.1 4.2 13.8 2.9 6.9 1.3 1.5 1.3 2.4 5.8 3.0 1.3 110.4 5.6 1.6 6.7 17.9 3.6 0.4 8.2 1.9 1.3 1.4 6.5 20.2 4.8 4.7 14.9 2.1 4.4 0.0 1.3 0.0 1.3 9.7 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 25.0 0.0 2.4 0.0 0.0 0.0 0.0 0.3 0.0 3.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.5 0.6 4.4 23.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.0 24.6 21.6 8.6 13.8 2.9 2.4 5.8 6.7 4.4 EPHB1 "EPHT2, Hek6" ENSG00000154928 "EPH receptor B1" P54762 3 134597801-135260467 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 74.7" "Group enriched" "Detected in some" 4 "HDLM-2: 33.9;HMC-1: 20.1;RPTEC TERT1: 9.2" "Cancer enriched" "Detected in many" 6 "glioma: 7.0" "Region enhanced" "Detected in all" "cerebellum: 74.7" "Group enriched" "Detected in some" 33 "neutrophil: 15.9;plasmacytoid DC: 15.4" "Group enriched" "Detected in many" 33 "dendritic cells: 15.4;granulocytes: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067740 Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" "Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA067740: " "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.52e-1)" "unprognostic (1.41e-6)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (8.15e-2)" "unprognostic (9.88e-2)" "unprognostic (1.55e-1)" "unprognostic (1.11e-1)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-2)" "unprognostic (1.78e-1)" "unprognostic (1.37e-3)" "unprognostic (4.88e-4)" 2.0 1.5 9.0 1.8 16.6 1.5 5.5 74.7 23.6 3.6 3.4 3.4 3.1 2.8 4.1 2.0 3.8 2.8 3.3 1.1 9.4 5.3 2.3 2.9 1.0 3.3 2.8 7.0 1.7 1.1 0.6 3.8 0.9 7.1 3.3 1.4 1.9 3.9 5.1 7.4 6.0 1.7 1.7 6.0 3.4 1.3 16.7 6.0 0.0 11.6 2.9 3.3 4.5 2.6 0.0 15.4 15.9 0.0 0.0 0.4 0.1 0.0 0.0 4.7 0.0 0.1 0.0 0.1 3.5 0.0 0.2 0.0 0.0 0.0 0.6 1.0 1.8 0.0 3.1 0.0 0.6 33.9 0.4 2.5 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.5 0.1 0.1 0.1 1.3 0.0 0.0 0.5 0.1 9.2 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.6 2.0 0.3 4.2 0.1 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 15.4 0.0 0.1 9.0 16.6 74.7 19.0 9.4 5.3 2.8 7.0 7.1 6.0 EPYC "DSPG3, Pg-Lb, SLRR3B" ENSG00000083782 Epiphycan Q99645 12 90963679-91005026 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "placenta: 67.1" "Group enriched" "Detected in some" 5 "HaCaT: 1.4;U-266/70: 3.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 3.8;basal ganglia: 3.8;cerebral cortex: 6.2;hippocampal formation: 4.4" "HPA038212, HPA045455" Approved "Secreted to extracellular matrix" "HPA038212: AB_10672739, HPA045455: " "unprognostic (2.25e-1)" "unprognostic (2.08e-1)" "unprognostic (2.79e-1)" "unprognostic (4.28e-2)" "unprognostic (1.81e-2)" "unprognostic (4.07e-2)" "unprognostic (9.20e-2)" "unprognostic (3.23e-1)" "prognostic unfavourable (1.85e-4)" "unprognostic (2.77e-2)" "unprognostic (6.44e-9)" "unprognostic (2.83e-2)" "unprognostic (3.08e-1)" "unprognostic (8.68e-2)" "unprognostic (1.20e-1)" 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.8 0.4 0.1 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 2.5 0.0 0.0 0.0 67.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.0 3.9 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EQTN "AFAF, C9orf11, equatorin, SPACA8" ENSG00000120160 Equatorin Q9NQ60 9 27284659-27297139 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 39.9" "Cell line enhanced" "Detected in some" "AF22: 1.0;BEWO: 2.2;HaCaT: 1.2;HAP1: 1.3;HSkMC: 1.8;K-562: 1.3;RT4: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015089, HPA015504" Enhanced "Intracellular and membrane" "HPA015089: AB_1845795, HPA015504: AB_2067598" "unprognostic (7.83e-2)" "unprognostic (1.55e-1)" "unprognostic (5.64e-2)" "unprognostic (8.12e-3)" "unprognostic (1.34e-3)" "unprognostic (4.41e-2)" "unprognostic (3.21e-1)" "unprognostic (1.06e-1)" "unprognostic (4.32e-1)" "unprognostic (1.89e-1)" "unprognostic (5.67e-2)" "unprognostic (1.14e-1)" "unprognostic (4.59e-2)" "unprognostic (8.46e-2)" "unprognostic (3.90e-2)" "unprognostic (1.42e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.1 0.1 39.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.2 1.3 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 1.1 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.2 0.2 ERC2 "CAST, CAST1, ELKSL, KIAA0378, SPBC110, Spc110" ENSG00000187672 "ELKS/RAB6-interacting/CAST family member 2" O15083 3 55508308-56468363 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 30.5" "Cell line enhanced" "Detected in some" "HAP1: 3.7;HUVEC TERT2: 3.6;Karpas-707: 12.0;SH-SY5Y: 3.0;U-266/70: 8.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073739 Enhanced "HPA073739: " "unprognostic (2.13e-2)" "unprognostic (1.39e-1)" "unprognostic (9.10e-2)" "unprognostic (1.93e-2)" "unprognostic (2.62e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (4.50e-2)" "unprognostic (2.95e-2)" "unprognostic (1.22e-1)" "unprognostic (3.06e-2)" "unprognostic (2.69e-1)" "unprognostic (1.75e-2)" "unprognostic (1.46e-2)" "unprognostic (1.24e-2)" "unprognostic (4.49e-2)" "unprognostic (9.09e-2)" 0.9 1.6 13.4 1.0 9.5 0.9 1.1 11.5 30.5 1.0 1.0 0.7 1.3 1.0 1.2 0.9 1.0 1.0 1.1 2.2 9.4 5.3 1.4 0.9 1.1 0.9 3.8 12.6 2.9 1.3 0.9 7.4 1.3 8.8 1.5 1.0 1.1 1.0 3.1 0.9 0.9 1.1 1.1 2.3 0.9 1.2 1.5 1.5 0.0 1.3 0.0 0.9 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.6 0.0 12.0 0.0 1.5 0.0 0.0 2.6 0.3 0.0 0.2 0.0 2.7 0.0 1.4 3.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.0 0.3 8.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.4 9.5 11.5 16.8 9.4 5.3 3.8 12.6 8.8 1.5 ERICH2 ENSG00000204334 "Glutamate rich 2" A1L162 2 170783786-170798971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 61.2" "Cell line enriched" "Detected in many" 4 "hTCEpi: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Low region specificity" "Detected in all" HPA061010 Approved "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" Vesicles "HPA061010: " "unprognostic (1.02e-1)" "unprognostic (1.19e-2)" "unprognostic (2.26e-1)" "prognostic favourable (9.49e-4)" "unprognostic (7.57e-3)" "unprognostic (6.61e-2)" "unprognostic (9.62e-3)" "unprognostic (6.96e-2)" "unprognostic (1.05e-1)" "unprognostic (2.27e-2)" "unprognostic (1.12e-2)" "unprognostic (2.83e-1)" "prognostic unfavourable (8.98e-7)" "unprognostic (1.03e-1)" "unprognostic (5.28e-3)" "unprognostic (7.35e-2)" "unprognostic (2.76e-1)" 0.6 0.3 1.4 0.6 1.1 0.0 1.3 0.6 0.8 2.1 0.6 0.6 0.6 0.0 1.5 1.0 0.6 3.3 0.6 0.9 1.0 1.5 0.9 1.6 4.2 0.6 1.1 0.6 0.6 0.7 0.8 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 0.1 0.6 0.6 0.6 0.6 1.0 61.2 0.6 0.6 6.7 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 5.3 0.0 0.0 4.5 0.0 0.0 0.2 0.0 0.0 0.9 1.8 4.5 1.0 0.0 0.1 0.0 0.1 1.1 0.4 0.0 0.7 1.2 2.3 0.0 0.1 4.7 0.2 0.2 0.7 36.1 0.0 8.4 0.0 5.0 0.0 0.0 1.8 0.0 0.4 5.5 0.9 0.0 0.9 0.0 2.6 0.1 0.6 1.2 3.2 0.0 1.3 0.7 0.7 0.0 1.2 1.0 0.0 0.5 0.0 0.0 0.0 4.5 2.1 3.5 0.0 0.0 0.0 2.7 0.0 0.9 0.0 0.5 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.1 0.6 0.8 1.0 1.5 1.1 0.6 0.6 0.6 ERICH4 "C19orf69, LOC100170765" ENSG00000204978 "Glutamate rich 4" A6NGS2 19 41443158-41444765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 78.1" "Group enriched" "Detected in some" 12 "CACO-2: 4.7;Hep G2: 10.8;THP-1: 3.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA042632, HPA048484" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042632: , HPA048484: " "unprognostic (1.41e-1)" "unprognostic (3.05e-1)" "unprognostic (9.52e-2)" "unprognostic (1.24e-1)" "unprognostic (2.76e-1)" "unprognostic (4.03e-5)" "unprognostic (8.53e-2)" "unprognostic (7.54e-2)" "unprognostic (1.97e-1)" "unprognostic (3.09e-2)" "unprognostic (1.04e-1)" "unprognostic (2.79e-1)" "unprognostic (2.35e-1)" "unprognostic (1.16e-1)" 0.6 0.0 0.2 0.2 0.3 0.0 0.6 0.2 0.3 0.4 21.0 0.2 0.2 27.1 0.4 0.4 0.2 0.4 0.5 1.3 0.2 0.0 10.0 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.9 0.0 78.1 0.2 0.3 0.2 0.1 0.8 0.2 0.2 0.3 0.2 0.2 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.0 0.3 0.2 0.2 0.2 ERICH6 "C3orf44, ERICH6A, FAM194A, MGC39662" ENSG00000163645 "Glutamate rich 6" Q7L0X2 3 150659885-150703971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 35.4" "Cell line enhanced" "Detected in some" "A549: 3.6;SH-SY5Y: 3.9;U-266/70: 4.0;U-266/84: 6.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048373 Enhanced "HPA048373: " "unprognostic (7.38e-2)" "unprognostic (3.89e-3)" "unprognostic (7.02e-3)" "unprognostic (2.52e-2)" "unprognostic (7.38e-3)" "unprognostic (1.86e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (4.44e-1)" "unprognostic (1.96e-1)" "unprognostic (8.44e-2)" "unprognostic (1.71e-2)" "unprognostic (1.80e-2)" "unprognostic (7.27e-2)" "unprognostic (2.21e-1)" "unprognostic (1.49e-2)" "unprognostic (3.16e-2)" 0.4 0.4 0.4 0.2 1.8 0.3 0.3 0.4 1.5 0.3 0.3 0.4 0.1 0.6 0.5 1.9 0.3 0.4 0.8 0.4 0.7 0.4 0.8 0.3 0.3 0.6 0.3 0.6 0.5 0.5 0.0 3.9 0.4 0.5 0.5 0.1 0.3 0.3 0.5 0.2 0.3 0.4 0.4 0.3 0.4 0.4 35.4 0.6 0.0 1.3 0.0 0.2 0.4 0.3 2.6 3.5 0.1 0.1 5.9 8.0 2.0 0.1 3.6 0.2 1.5 0.0 0.0 0.0 0.3 0.0 0.3 0.5 1.6 1.5 0.0 2.2 0.0 0.2 0.0 0.0 0.2 1.6 1.2 1.0 0.6 0.1 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.0 0.0 2.5 0.0 0.6 0.9 0.0 0.9 0.0 1.0 0.9 0.0 0.1 0.8 1.8 3.9 0.0 0.3 0.0 0.9 1.2 0.1 0.6 1.4 1.5 0.2 4.0 6.2 0.7 0.7 0.1 0.0 0.0 0.1 0.1 4.1 0.0 8.0 2.6 2.6 3.1 0.1 2.3 3.5 3.6 0.1 5.9 0.1 3.5 2.5 2.0 0.4 1.8 0.4 1.5 0.7 0.4 0.3 0.6 0.5 0.6 ERICH6B "FAM194B, FLJ32682" ENSG00000165837 "Glutamate rich 6B" Q5W0A0 13 45534522-45615739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 55 "testis: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043559 Uncertain "HPA043559: " "unprognostic (6.77e-3)" "unprognostic (3.52e-3)" "unprognostic (3.80e-2)" "unprognostic (2.06e-2)" "unprognostic (2.05e-1)" "unprognostic (7.08e-2)" "unprognostic (1.25e-1)" "unprognostic (7.98e-3)" "unprognostic (7.27e-3)" "unprognostic (9.81e-2)" "unprognostic (3.05e-3)" "unprognostic (3.37e-3)" "unprognostic (5.70e-8)" "unprognostic (4.42e-2)" "unprognostic (1.88e-1)" "unprognostic (9.74e-2)" "unprognostic (7.89e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ERMN "ERMIN, JN, KIAA1189" ENSG00000136541 Ermin Q8TAM6 2 157318625-157327713 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 106.7" "Cell line enriched" "Detected in some" 6 "HAP1: 20.8" "Group enriched" "Detected in some" 12 "endometrial cancer: 2.2;glioma: 9.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038295, HPA038296" Enhanced Approved "Cell Junctions,Cytosol" "Cell Junctions, Cytosol" "HPA038295: AB_10805353, HPA038296: AB_10796217" "unprognostic (7.89e-2)" "unprognostic (9.06e-3)" "unprognostic (2.71e-2)" "prognostic favourable (6.93e-6)" "unprognostic (1.06e-1)" "unprognostic (2.02e-2)" "unprognostic (9.14e-2)" "unprognostic (1.79e-1)" "unprognostic (4.57e-2)" "unprognostic (4.40e-2)" "unprognostic (1.07e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-3)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (9.97e-3)" "unprognostic (5.76e-2)" 1.6 1.4 29.1 2.9 50.5 9.7 1.6 2.7 106.7 1.4 1.8 52.4 0.0 1.8 1.6 1.5 1.7 1.4 1.9 1.6 40.9 21.4 1.5 1.5 2.0 3.1 75.1 18.4 1.5 1.6 1.4 0.1 1.4 54.5 1.5 1.9 4.3 2.4 1.5 1.7 1.9 1.9 1.6 100.9 2.5 2.2 1.7 69.5 0.0 1.6 0.0 2.7 1.7 0.1 1.7 1.3 3.9 1.6 2.4 2.1 0.7 0.1 0.3 0.3 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.2 1.2 0.0 1.9 0.3 20.8 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.0 0.2 2.8 0.4 0.2 0.7 2.3 0.3 0.5 0.0 0.4 0.5 0.0 1.0 0.4 0.6 0.0 0.1 0.0 0.7 1.2 0.0 0.2 0.1 0.2 0.6 3.4 1.9 0.5 1.8 0.9 1.0 2.6 1.6 1.1 2.1 1.2 1.0 0.7 0.8 0.6 0.6 1.7 1.5 1.6 3.9 2.4 1.0 1.3 0.9 0.7 29.1 50.5 2.7 27.9 40.9 21.4 75.1 18.4 54.5 69.5 ERO1B "ERO1-L(beta), Ero1beta, ERO1LB" ENSG00000086619 "Endoplasmic reticulum oxidoreductase 1 beta" Q86YB8 1 236215555-236281985 "Predicted intracellular proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "pancreas: 160.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028085 Enhanced "Intracellular and membrane" "HPA028085: AB_10601214" "unprognostic (1.16e-1)" "unprognostic (1.33e-3)" "unprognostic (1.00e-1)" "unprognostic (1.41e-1)" "unprognostic (1.07e-1)" "unprognostic (9.80e-2)" "unprognostic (2.49e-2)" "prognostic favourable (7.53e-5)" "unprognostic (1.73e-2)" "unprognostic (2.85e-2)" "unprognostic (4.65e-2)" "unprognostic (5.90e-2)" "unprognostic (8.26e-3)" "unprognostic (7.87e-2)" "unprognostic (3.37e-1)" "unprognostic (2.22e-3)" "unprognostic (8.09e-3)" 2.7 2.5 3.2 4.3 4.8 2.6 6.9 7.4 4.0 2.4 3.3 2.0 5.7 4.4 2.5 10.1 1.4 2.1 4.1 2.9 3.3 2.7 3.7 11.6 2.5 3.5 4.0 1.7 3.4 160.4 5.4 8.5 2.2 3.9 2.7 1.4 1.4 9.0 3.2 1.9 1.7 2.7 2.2 3.0 4.1 17.7 10.9 4.1 4.1 12.5 0.8 2.7 2.4 2.3 2.9 7.2 12.9 1.9 1.3 2.8 0.9 1.9 2.2 3.8 3.2 3.0 2.0 4.6 2.9 2.8 2.1 1.8 0.6 2.0 5.2 8.1 4.6 0.9 1.8 2.6 3.0 5.2 11.3 1.5 0.3 2.0 8.2 2.1 0.9 3.5 5.6 3.7 7.0 2.5 0.8 13.2 2.8 1.0 0.9 0.9 1.5 0.7 10.8 2.7 1.3 4.2 4.5 7.9 4.6 9.4 3.2 7.7 7.7 9.4 2.3 3.1 2.7 3.2 3.8 9.2 0.5 3.0 4.4 3.1 4.8 12.9 1.9 3.2 2.8 1.9 2.5 1.9 1.5 1.9 1.9 2.9 2.3 2.2 3.9 1.3 0.8 7.2 1.4 0.9 3.2 4.8 7.4 4.0 3.3 2.7 4.0 1.7 3.9 4.1 ERP27 "C12orf46, ERp27, FLJ32115, PDIA8" ENSG00000139055 "Endoplasmic reticulum protein 27" Q96DN0 12 14914035-14939082 "Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pancreas: 182.8" "Cell line enriched" "Detected in some" 5 "RT4: 44.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039636, HPA052851" Enhanced "Intracellular and membrane" "HPA039636: AB_10795403, HPA052851: AB_2681972" "unprognostic (9.02e-3)" "unprognostic (2.53e-1)" "unprognostic (1.41e-1)" "unprognostic (4.69e-2)" "unprognostic (8.70e-2)" "unprognostic (3.92e-3)" "unprognostic (2.70e-1)" "unprognostic (1.48e-2)" "unprognostic (2.37e-3)" "unprognostic (5.33e-2)" "unprognostic (2.34e-2)" "unprognostic (1.88e-1)" "unprognostic (7.89e-2)" "unprognostic (4.55e-2)" "unprognostic (8.98e-2)" "unprognostic (1.76e-3)" "unprognostic (3.45e-2)" 0.1 0.1 0.0 0.6 0.4 0.4 0.8 0.0 0.2 0.7 0.1 0.1 1.0 0.0 0.1 7.2 1.1 9.1 0.0 0.6 0.0 0.0 11.6 0.1 5.7 0.4 0.0 0.0 1.8 182.8 0.1 1.3 7.7 0.3 4.2 0.1 1.0 5.1 0.5 0.0 0.4 0.5 0.0 0.5 0.9 0.5 0.4 0.0 0.1 36.0 1.9 1.0 3.6 0.1 2.1 2.9 4.7 5.2 1.4 8.1 3.1 1.5 0.0 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.3 8.9 0.6 0.9 0.0 1.7 0.0 0.1 0.0 0.0 0.0 1.8 0.0 6.9 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 3.1 1.3 2.2 0.0 0.0 0.6 0.0 0.1 0.3 44.2 0.0 0.0 0.0 7.3 0.0 0.3 1.6 1.1 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 3.4 4.2 4.7 6.3 4.8 8.1 2.1 5.6 4.2 2.9 2.0 7.2 7.6 2.0 1.4 5.2 0.3 6.8 3.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 ERVFRD-1 "envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2" ENSG00000244476 "Endogenous retrovirus group FRD member 1, envelope" P60508 6 11102489-11111732 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "placenta: 66.9" "Cell line enriched" "Detected in single" 31 "BEWO: 14.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 2.1" "Low lineage specificity" "Detected in single" "unprognostic (1.99e-1)" "unprognostic (3.29e-4)" "unprognostic (4.75e-2)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (2.19e-3)" "unprognostic (3.35e-1)" "unprognostic (6.44e-2)" "unprognostic (1.24e-1)" "unprognostic (1.99e-1)" "unprognostic (1.30e-2)" "unprognostic (2.78e-3)" "unprognostic (5.80e-4)" "unprognostic (3.40e-2)" "unprognostic (1.82e-1)" "unprognostic (1.95e-2)" "unprognostic (1.37e-2)" 1.4 2.0 0.1 0.1 0.1 0.1 0.8 0.2 0.2 0.5 0.8 0.1 0.1 0.3 1.3 0.8 0.7 0.2 0.5 0.5 0.1 0.0 1.5 0.7 1.5 1.0 0.1 0.1 0.1 0.1 15.8 0.1 66.9 0.1 1.2 0.2 0.7 0.9 0.5 0.1 0.9 1.9 0.8 0.1 0.1 1.0 0.3 0.1 0.6 0.2 0.9 0.3 1.5 2.2 0.5 0.0 0.3 0.1 2.1 0.7 0.1 0.0 0.1 0.1 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.7 0.4 0.3 2.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 ERVV-1 "ENVV1, FLJ32214, HERV-V1" ENSG00000269526 "Endogenous retrovirus group V member 1, envelope" B6SEH8 19 53013921-53016122 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "placenta: 19.7" "Cell line enriched" "Detected in some" 8 "BEWO: 13.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.04e-3)" "unprognostic (7.32e-3)" "unprognostic (2.97e-1)" "unprognostic (2.70e-2)" "unprognostic (1.67e-2)" "unprognostic (9.92e-2)" "unprognostic (6.75e-2)" "unprognostic (4.34e-5)" "unprognostic (3.48e-2)" "unprognostic (5.80e-2)" "unprognostic (3.18e-1)" "unprognostic (1.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ERVV-2 ENVV2 ENSG00000268964 "Endogenous retrovirus group V member 2, envelope" B6SEH9 19 53044738-53051076 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 105 "placenta: 85.9" "Cell line enhanced" "Detected in some" "BEWO: 20.2;T-47d: 5.7;U-266/84: 3.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.14e-3)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (4.33e-9)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" "unprognostic (2.60e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 85.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.8 0.0 0.0 0.0 ERVW-1 "envW, ERVWE1, HERV-7q, HERV-W, HERV-W-ENV, HERVW" ENSG00000242950 "Endogenous retrovirus group W member 1, envelope" Q9UQF0 7 92468380-92477986 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 83.4" "Cell line enriched" "Detected in single" 52 "BEWO: 43.5" "Cancer enriched" "Detected in single" 143 "testis cancer: 31.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 2.2" "Low lineage specificity" "Detected in single" "unprognostic (2.85e-1)" "unprognostic (1.29e-1)" "unprognostic (2.23e-1)" "unprognostic (1.34e-2)" "unprognostic (1.79e-1)" "unprognostic (1.48e-4)" "unprognostic (4.80e-1)" "unprognostic (1.01e-1)" "unprognostic (3.11e-2)" "unprognostic (1.60e-1)" "unprognostic (1.62e-1)" "unprognostic (2.21e-1)" "unprognostic (1.76e-2)" "unprognostic (1.13e-1)" "unprognostic (2.33e-1)" "unprognostic (3.96e-2)" "unprognostic (8.02e-2)" 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 2.0 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 83.4 0.2 0.2 0.1 0.2 0.4 0.2 0.4 0.4 0.2 0.2 0.3 0.3 0.5 10.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.0 2.2 0.8 0.1 0.2 0.0 0.1 0.2 0.3 0.2 0.0 0.3 43.5 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.3 0.2 0.1 0.0 0.1 0.2 0.2 0.5 0.1 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.3 0.7 0.0 0.2 0.2 0.3 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.3 0.0 0.6 0.0 0.1 0.2 0.1 0.0 0.8 0.2 0.1 0.7 0.3 0.1 0.1 0.2 0.0 0.0 0.4 2.2 0.2 0.8 0.1 0.5 0.1 0.0 0.0 0.3 0.0 0.1 0.4 0.1 0.6 0.0 0.1 0.0 0.2 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.2 ESX1 "ESX1L, ESXR1" ENSG00000123576 "ESX homeobox 1" Q8N693 X 104250038-104254933 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 99 "testis: 25.4" "Cell line enriched" "Detected in some" 11 "TIME: 23.2" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051992 Enhanced Supported "Nuclear speckles" "Nuclear speckles" "HPA051992: " "unprognostic (1.87e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 ETDA ENSG00000238210 "Embryonic testis differentiation homolog A" X 135252061-135253583 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 11.4" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;Daudi: 1.4;HEL: 1.1;MCF7: 1.1;PC-3: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.34e-1)" 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ETDB LINC00633 ENSG00000224107 "Embryonic testis differentiation homolog B" X 135118955-135120526 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 29 "testis: 13.5" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;SH-SY5Y: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EXD1 "EXDL1, MGC33637" ENSG00000178997 "Exonuclease 3'-5' domain containing 1" Q8NHP7 15 41182725-41230743 "Predicted intracellular proteins" "Meiosis, RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 30.2" "Cell line enhanced" "Detected in some" "HeLa: 2.0;HHSteC: 2.1;MCF7: 2.1;U-266/70: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.12e-1)" "unprognostic (6.33e-3)" "unprognostic (2.51e-2)" "unprognostic (2.29e-1)" "unprognostic (1.45e-1)" "unprognostic (1.21e-2)" "unprognostic (6.50e-2)" "unprognostic (4.57e-2)" "unprognostic (4.54e-2)" "unprognostic (2.15e-1)" "unprognostic (9.55e-2)" "unprognostic (1.92e-1)" "unprognostic (2.11e-6)" "unprognostic (2.15e-1)" "unprognostic (2.29e-1)" "unprognostic (2.72e-1)" "unprognostic (2.71e-2)" 0.4 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 30.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 1.3 0.0 1.0 1.7 0.3 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 2.0 0.0 2.1 0.0 0.1 1.5 0.9 0.0 0.1 0.0 0.2 1.0 0.0 2.1 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.2 0.1 0.2 0.4 0.4 0.0 0.0 0.6 0.0 0.0 2.2 0.2 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 1.0 0.0 0.3 0.3 0.1 0.2 0.0 1.0 0.5 EYA4 "CMD1J, DFNA10" ENSG00000112319 "EYA transcriptional coactivator and phosphatase 4" O95677 6 133240598-133532120 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 65.6" "Cell line enhanced" "Detected in many" "A549: 12.6;HeLa: 35.3;RH-30: 12.0;U-87 MG: 12.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA004805, HPA038771, HPA038772" Enhanced Approved Nucleoplasm Nucleoplasm "HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119" "unprognostic (1.60e-1)" "unprognostic (3.34e-1)" "unprognostic (1.27e-1)" "unprognostic (2.04e-9)" "unprognostic (1.64e-1)" "unprognostic (3.08e-2)" "unprognostic (3.44e-2)" "unprognostic (7.21e-2)" "unprognostic (9.07e-2)" "unprognostic (2.04e-2)" "unprognostic (2.80e-1)" "unprognostic (2.29e-1)" "unprognostic (8.27e-4)" "unprognostic (1.82e-3)" "unprognostic (6.67e-2)" "unprognostic (9.55e-2)" "unprognostic (2.51e-2)" 1.6 3.0 1.2 0.2 1.3 0.1 2.4 0.4 1.2 9.7 0.6 2.5 11.1 0.4 2.6 1.9 0.7 8.3 0.7 6.2 1.5 1.2 6.1 0.4 2.0 0.2 2.1 0.8 1.6 0.4 0.2 7.2 0.2 3.5 6.6 0.4 2.7 0.8 13.9 65.6 0.4 0.5 1.9 3.5 0.6 0.7 7.4 1.4 1.8 2.5 5.5 0.7 2.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 1.2 0.0 0.0 0.0 0.0 0.0 10.1 0.2 1.5 0.0 0.0 0.0 10.0 0.0 0.0 7.6 3.2 0.0 0.0 9.9 1.3 35.3 0.0 0.3 0.0 3.4 2.6 0.0 7.3 2.2 0.0 0.0 5.4 4.0 0.0 0.0 0.0 0.0 0.7 0.1 12.0 0.0 0.0 1.9 1.8 2.0 0.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 9.0 3.6 1.6 0.0 12.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.4 1.2 1.5 1.2 2.1 0.8 3.5 1.4 EYS "bA166P24.2, bA307F22.3, bA74E24.1, C6orf178, C6orf179, C6orf180, dJ1018A4.2, dJ303F19.1, EGFL10, EGFL11, RP25, SPAM" ENSG00000188107 "Eyes shut homolog (Drosophila)" Q5T1H1 6 63719980-65707225 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "retina: 40.7" "Cell line enhanced" "Detected in some" "Karpas-707: 5.4;SCLC-21H: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "basophil: 3.7;neutrophil: 3.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.7" "Secreted in other tissues" "unprognostic (2.92e-2)" "unprognostic (1.90e-2)" "unprognostic (1.64e-1)" "unprognostic (1.47e-2)" "unprognostic (2.16e-3)" "unprognostic (1.96e-1)" "unprognostic (1.82e-1)" "unprognostic (6.38e-2)" "unprognostic (3.67e-1)" "unprognostic (1.97e-1)" "unprognostic (2.04e-1)" "unprognostic (2.18e-1)" "unprognostic (2.61e-4)" "unprognostic (1.89e-1)" "unprognostic (8.41e-2)" "unprognostic (6.38e-3)" "unprognostic (1.11e-1)" 2.8 0.4 0.4 0.6 0.2 1.1 1.1 1.2 0.8 0.2 0.7 0.2 0.2 0.4 0.3 0.2 0.2 0.3 0.4 0.4 0.4 0.2 0.2 1.7 0.3 0.6 0.2 0.5 0.4 0.6 0.0 2.2 0.3 0.5 0.6 2.6 40.7 0.5 0.2 0.6 1.3 0.6 0.2 0.3 0.3 0.3 2.9 0.2 0.6 0.5 0.2 0.2 0.4 0.3 0.3 0.3 3.7 0.8 0.3 0.4 0.9 0.4 0.3 0.7 0.5 0.0 0.6 0.2 0.4 0.3 0.0 0.0 0.3 0.3 0.8 0.5 0.1 0.2 0.8 0.4 0.0 0.5 0.7 0.5 1.2 1.1 0.1 0.8 0.3 0.3 0.9 0.3 0.1 0.0 0.6 5.4 0.5 0.0 0.3 0.3 0.2 0.6 0.3 0.1 0.4 1.2 0.2 3.8 0.3 0.2 0.1 0.2 0.0 0.8 0.3 0.5 0.6 0.3 0.5 1.5 0.8 0.4 0.6 1.0 0.2 3.7 0.8 0.2 0.3 0.2 0.2 0.2 0.1 0.1 0.3 0.3 0.3 0.4 3.2 0.3 0.3 0.2 0.1 0.9 0.4 0.2 1.2 0.7 0.4 0.2 0.2 0.5 0.5 0.2 F10 ENSG00000126218 "Coagulation factor X" P00742 13 113122814-113149529 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 116.7" "Cell line enhanced" "Detected in some" "BJ: 8.3;CACO-2: 7.1;fHDF/TERT166: 7.4;Hep G2: 32.8;HHSteC: 6.8;SH-SY5Y: 16.2" "Cancer enriched" "Detected in many" 11 "liver cancer: 95.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" 16000000000 "unprognostic (4.18e-2)" "unprognostic (1.07e-1)" "unprognostic (7.62e-2)" "unprognostic (9.88e-2)" "unprognostic (9.44e-2)" "unprognostic (1.15e-2)" "unprognostic (4.90e-2)" "unprognostic (1.02e-2)" "unprognostic (2.54e-1)" "unprognostic (1.24e-1)" "prognostic favourable (1.82e-5)" "unprognostic (6.39e-2)" "prognostic unfavourable (5.14e-5)" "unprognostic (6.60e-2)" "unprognostic (1.21e-1)" "unprognostic (3.87e-2)" "unprognostic (2.23e-3)" 8.1 3.7 0.3 2.9 0.7 0.0 5.4 0.4 0.8 20.3 5.9 0.6 7.6 4.5 12.6 21.4 4.5 9.9 10.0 18.4 0.5 0.5 2.3 116.7 4.9 1.6 0.5 0.7 18.2 3.0 0.0 1.7 3.6 1.0 18.1 0.7 6.9 2.0 6.1 2.6 7.8 7.6 11.7 0.6 1.3 3.2 9.5 0.6 0.6 3.1 5.6 1.8 7.8 10.3 0.0 0.0 0.0 0.0 0.9 1.0 0.3 0.0 0.0 1.4 0.2 4.8 4.9 0.0 8.3 6.6 0.5 0.2 7.1 0.0 0.0 0.3 7.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 32.8 6.8 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.6 16.2 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.9 0.0 0.0 0.0 0.3 0.3 0.7 0.4 0.8 0.5 0.5 0.5 0.7 1.0 0.6 F11 FXI ENSG00000088926 "Coagulation factor XI" P03951 4 186265945-186288806 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 88.9" "Cell line enriched" "Detected in some" 11 "Hep G2: 13.7" "Cancer enriched" "Detected in some" 13 "liver cancer: 16.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039808 Approved Vesicles "Secreted to blood" 4400000000 Vesicles "HPA039808: " "unprognostic (1.28e-1)" "unprognostic (3.15e-1)" "prognostic favourable (3.29e-5)" "unprognostic (1.88e-1)" "unprognostic (2.08e-1)" "unprognostic (2.11e-1)" "unprognostic (1.85e-3)" "unprognostic (2.91e-2)" "unprognostic (7.65e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 2.7 0.1 0.1 5.5 0.2 0.3 0.1 0.1 4.8 0.1 0.1 0.1 10.2 88.9 2.8 0.1 0.1 0.1 0.1 19.0 0.0 0.2 0.1 0.3 0.1 0.0 0.4 0.1 0.1 0.1 0.1 6.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 F12 ENSG00000131187 "Coagulation factor XII" P00748 5 177402140-177409576 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "liver: 180.1" "Cell line enhanced" "Detected in some" "HDLM-2: 8.6;MCF7: 10.9;PC-3: 8.1;SH-SY5Y: 5.5;U-937: 5.6" "Cancer enriched" "Detected in many" 21 "liver cancer: 171.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 2.5;eosinophil: 6.9" "Group enriched" "Detected in many" 5 "granulocytes: 6.9;monocytes: 2.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA003825 Approved "Secreted to blood" 1040000 6600000000 "HPA003825: AB_1078790" "unprognostic (9.75e-2)" "unprognostic (1.71e-1)" "unprognostic (2.93e-1)" "unprognostic (4.47e-2)" "unprognostic (1.01e-1)" "unprognostic (2.32e-1)" "prognostic favourable (4.63e-5)" "unprognostic (6.97e-2)" "unprognostic (1.26e-2)" "unprognostic (3.96e-2)" "unprognostic (4.41e-1)" "unprognostic (6.54e-2)" "prognostic unfavourable (7.09e-4)" "unprognostic (4.11e-2)" "unprognostic (3.69e-1)" "unprognostic (3.40e-6)" "unprognostic (6.48e-2)" 0.1 0.0 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.2 180.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 1.0 6.9 2.5 0.7 0.3 1.0 0.8 2.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.3 1.3 0.0 0.4 0.0 1.4 0.7 0.4 0.0 8.6 1.8 1.3 0.3 0.9 0.2 0.7 3.0 0.2 1.3 0.1 0.4 0.2 0.4 3.2 0.0 10.9 0.1 2.6 0.0 8.1 0.6 0.2 1.8 1.1 0.0 2.5 5.5 0.3 1.0 0.7 0.4 0.0 0.0 0.2 1.1 0.0 0.3 0.5 0.0 0.1 0.1 5.6 0.6 0.0 2.5 6.9 0.3 0.1 0.2 0.5 0.3 0.2 0.1 0.2 0.0 0.1 0.9 0.7 0.9 1.0 0.0 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 F13B FXIIIB ENSG00000143278 "Coagulation factor XIII B chain" P05160 1 197039191-197067267 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 95 "liver: 76.3" "Cell line enhanced" "Detected in some" "A549: 1.8;Hep G2: 2.2" "Cancer enriched" "Detected in single" 816 "liver cancer: 46.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003827, HPA052139" Supported "Secreted to blood" 3400000000 "HPA003827: AB_1078794, HPA052139: " "unprognostic (1.46e-1)" "prognostic favourable (6.78e-5)" "unprognostic (1.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 76.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 F2 ENSG00000180210 "Coagulation factor II, thrombin" P00734 11 46719180-46739506 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 593 "liver: 324.8" "Cell line enriched" "Detected in some" 21 "Hep G2: 76.5" "Cancer enriched" "Detected in some" 110 "liver cancer: 508.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB016780, CAB018650, HPA051476, HPA054698" Enhanced "Secreted to blood" 107500000000 43000000000 "CAB016780: , CAB018650: AB_2246689, HPA051476: , HPA054698: " "unprognostic (1.98e-1)" "unprognostic (2.52e-1)" "unprognostic (2.64e-2)" "unprognostic (1.85e-1)" "unprognostic (2.29e-1)" "unprognostic (2.81e-1)" "unprognostic (2.23e-2)" "unprognostic (3.94e-2)" "unprognostic (5.79e-2)" "unprognostic (8.29e-2)" "unprognostic (4.46e-2)" "prognostic unfavourable (6.75e-12)" "unprognostic (5.65e-3)" "unprognostic (5.80e-2)" "unprognostic (1.54e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 324.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 76.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.5 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 F7 ENSG00000057593 "Coagulation factor VII" P08709 13 113105788-113120681 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "liver: 68.0" "Group enriched" "Detected in some" 9 "CACO-2: 16.2;Hep G2: 10.1" "Cancer enriched" "Detected in some" 17 "liver cancer: 41.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "gdT-cell: 1.7;MAIT T-cell: 1.2;memory CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA004826 Approved Mitochondria "Secreted to blood" 3600000 1500000000 Mitochondria "HPA004826: AB_10602805" "unprognostic (2.06e-1)" "unprognostic (2.55e-1)" "unprognostic (1.03e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.50e-3)" "unprognostic (3.81e-1)" "unprognostic (4.36e-3)" "unprognostic (1.16e-1)" "unprognostic (4.19e-3)" "unprognostic (1.15e-1)" "unprognostic (1.35e-3)" "unprognostic (3.36e-3)" "unprognostic (1.09e-1)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.4 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 68.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 1.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.1 F9 FIX ENSG00000101981 "Coagulation factor IX" P00740 X 139530758-139563458 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets, Hemophilia, Thrombophilia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 2334 "liver: 233.6" "Cell line enhanced" "Detected in some" "HL-60: 1.7;RH-30: 1.9;SiHa: 1.5;U-698: 1.1" "Cancer enriched" "Detected in single" 1354 "liver cancer: 67.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Secreted to blood" 11000000000 "prognostic favourable (6.69e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 233.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.7 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FABP2 I-FABP ENSG00000145384 "Fatty acid binding protein 2" P12104 4 119317250-119322390 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "intestine: 358.6" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Hep G2: 2.4;NB-4: 3.8;RPMI-8226: 3.2;SH-SY5Y: 2.6" "Group enriched" "Detected in some" 9 "colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 2.1;neutrophil: 7.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034607, CAB047325, CAB047326" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" 46000 "Actin filaments, Cytosol" "Plasma membrane" "CAB047325: , CAB047326: , HPA034607: AB_10601317" "unprognostic (3.94e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (4.58e-1)" "unprognostic (1.51e-2)" "unprognostic (2.61e-2)" "unprognostic (1.69e-4)" "unprognostic (1.93e-1)" "unprognostic (1.02e-1)" 0.1 0.2 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.1 47.0 0.0 0.0 50.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 5.9 0.1 0.1 0.0 0.1 0.1 358.6 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.5 7.6 0.7 0.9 0.5 0.0 0.2 0.3 0.2 0.4 0.0 0.0 2.8 0.4 0.0 0.0 0.0 0.4 0.3 0.4 0.1 0.0 0.3 0.0 0.2 0.1 0.1 0.3 0.1 0.4 2.4 0.0 0.5 0.4 0.2 0.0 0.2 0.1 0.0 0.2 0.5 0.0 0.1 0.4 3.8 0.2 0.5 0.3 0.2 3.2 0.0 0.5 1.0 2.6 0.1 0.4 0.0 0.3 0.1 0.9 0.4 0.4 1.4 0.1 0.7 0.2 0.6 0.3 0.2 0.1 2.1 0.7 0.7 0.4 0.3 0.4 0.2 0.4 0.3 0.2 0.5 0.5 0.5 7.6 0.9 0.2 0.5 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 FABP6 "I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP" ENSG00000170231 "Fatty acid binding protein 6" P51161 5 160187367-160238735 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "intestine: 299.2" "Cell line enhanced" "Detected in some" "Daudi: 20.2;EFO-21: 19.4;HDLM-2: 8.5;NB-4: 7.9;RPMI-8226: 9.3;RT4: 8.9;U-2197: 8.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA012601, CAB024713" Enhanced "Intracellular and membrane" 650000 "CAB024713: , HPA012601: AB_1848435" "unprognostic (3.03e-2)" "unprognostic (7.55e-2)" "unprognostic (1.27e-1)" "unprognostic (5.00e-3)" "unprognostic (1.48e-2)" "unprognostic (3.53e-1)" "unprognostic (5.35e-7)" "unprognostic (3.05e-1)" "unprognostic (1.97e-1)" "unprognostic (2.41e-2)" "unprognostic (2.16e-1)" "unprognostic (2.56e-1)" "prognostic unfavourable (4.35e-9)" "unprognostic (2.10e-2)" "unprognostic (1.21e-2)" "unprognostic (2.48e-1)" "unprognostic (1.85e-3)" 0.1 0.9 0.2 0.1 0.4 0.0 0.1 0.1 0.1 0.5 0.1 0.3 0.1 0.2 0.3 0.1 0.1 4.3 0.1 0.1 0.4 0.5 0.1 0.1 1.3 0.1 0.4 0.1 0.5 0.1 0.0 0.2 0.1 1.0 0.1 0.0 0.1 0.4 0.1 0.1 0.0 299.2 0.1 0.2 0.1 0.0 0.1 0.2 1.2 0.1 0.5 0.2 0.2 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 6.3 0.0 0.0 0.0 0.0 3.4 0.6 20.2 19.4 0.0 0.0 0.0 0.0 0.0 8.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.8 0.2 0.0 0.0 0.0 7.9 0.0 1.8 0.0 0.6 9.3 0.0 8.9 1.7 0.4 0.0 5.1 0.1 0.0 0.1 0.0 0.0 0.0 8.4 1.0 1.1 4.4 2.2 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.1 0.4 0.5 0.4 0.1 1.0 0.2 FABP9 "PERF, PERF15, T-FABP" ENSG00000205186 "Fatty acid binding protein 9" Q0Z7S8 8 81458341-81461579 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 28.1" "Cell line enriched" "Detected in single" 26 "PC-3: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA073619 Enhanced "HPA073619: " "unprognostic (2.99e-1)" 2.3 0.0 0.1 0.1 0.1 0.0 5.3 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.2 0.1 0.2 28.1 0.1 0.1 0.1 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 FAIM2 "KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2" ENSG00000135472 "Fas apoptotic inhibitory molecule 2" Q9BWQ8 12 49866896-49904217 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 138.5" "Cell line enhanced" "Detected in some" "HHSteC: 9.2;SH-SY5Y: 4.9;U-87 MG: 28.6" "Cancer enriched" "Detected in many" 8 "glioma: 21.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 1.7;T-reg: 6.2" "Lineage enriched" "Detected in single" 9 "T-cells: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018790, HPA048800" Enhanced Approved "Intermediate filaments" "Intermediate filaments" "HPA018790: AB_1852822, HPA048800: AB_2680526" "unprognostic (1.74e-1)" "unprognostic (5.98e-4)" "unprognostic (2.22e-1)" "unprognostic (9.75e-3)" "unprognostic (3.36e-2)" "unprognostic (2.61e-4)" "unprognostic (2.62e-1)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (1.75e-2)" "unprognostic (5.66e-2)" "unprognostic (1.30e-2)" "unprognostic (3.28e-6)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (2.47e-1)" "unprognostic (6.78e-4)" 3.9 27.2 35.6 4.1 57.5 1.4 2.5 42.4 138.5 3.2 4.7 29.1 0.2 2.7 4.2 6.4 3.9 5.8 7.5 7.4 38.8 51.0 2.0 1.5 2.5 3.5 35.9 33.7 2.6 2.8 14.7 7.8 1.5 65.6 8.8 3.5 3.9 3.0 7.1 2.0 1.8 4.0 8.7 36.9 2.5 2.6 12.1 20.5 0.0 1.7 0.0 3.1 4.7 2.0 0.0 0.0 0.0 0.4 0.6 6.2 0.2 0.0 0.3 0.4 0.5 2.0 1.3 0.1 0.5 2.6 0.5 0.3 0.3 0.0 0.0 0.1 3.6 0.2 1.2 0.0 0.3 0.0 0.0 2.0 0.0 0.0 9.2 0.1 0.0 0.8 0.2 2.0 0.0 0.0 1.1 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 4.9 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 28.6 0.0 0.2 0.0 0.1 0.0 1.7 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 6.2 0.2 35.6 57.5 42.4 99.5 38.8 51.0 35.9 33.7 65.6 20.5 FAM111B CANP ENSG00000189057 "Family with sequence similarity 111 member B" Q6SJ93 11 59107185-59127410 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 43.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "memory B-cell: 5.7;naive B-cell: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038637 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038637: AB_10672522" "unprognostic (2.31e-1)" "unprognostic (2.68e-2)" "unprognostic (1.80e-3)" "unprognostic (6.94e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "prognostic unfavourable (1.76e-4)" "unprognostic (1.49e-3)" "unprognostic (1.40e-2)" "unprognostic (4.85e-2)" "prognostic unfavourable (1.17e-5)" "unprognostic (1.01e-2)" "unprognostic (1.24e-5)" "unprognostic (2.94e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-3)" "unprognostic (1.24e-1)" 1.3 1.3 0.4 8.9 0.8 3.5 1.9 0.3 1.1 1.8 4.7 0.4 0.3 2.5 0.8 2.0 9.3 0.7 1.8 1.0 0.4 0.4 1.8 2.6 2.1 9.9 0.5 0.3 1.0 0.8 1.4 0.9 2.8 0.8 1.2 5.0 0.3 2.6 0.3 0.5 3.5 4.1 1.3 0.6 5.4 2.8 1.0 0.6 43.9 0.7 9.2 11.1 1.5 2.6 5.7 0.3 3.1 0.2 0.1 1.4 0.3 24.0 6.2 9.3 0.1 1.0 1.8 0.1 18.3 9.2 10.9 16.2 13.1 9.6 30.0 12.4 5.3 18.7 13.5 12.3 19.5 15.6 3.3 3.2 11.8 5.7 0.0 0.1 3.9 0.4 0.4 10.5 0.8 5.8 0.9 28.3 12.8 9.1 18.9 0.2 0.1 7.3 20.0 13.8 11.7 5.8 20.8 1.8 5.9 15.1 17.5 3.0 19.4 1.7 3.2 8.5 18.5 25.5 16.6 21.8 15.7 0.2 12.3 0.1 12.1 0.5 0.2 0.2 0.3 0.1 0.2 5.7 0.4 0.7 0.3 5.7 0.2 0.2 3.1 0.1 0.2 0.3 1.4 0.3 0.4 0.8 0.3 1.1 0.4 0.4 0.5 0.3 0.8 0.6 FAM131B KIAA0773 ENSG00000159784 "Family with sequence similarity 131 member B" Q86XD5 7 143353400-143362770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 47.1" "Cell line enhanced" "Detected in some" "CACO-2: 10.1;NTERA-2: 16.5;PC-3: 15.9;SCLC-21H: 16.2" "Cancer enriched" "Detected in many" 11 "glioma: 14.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021371, HPA029992" Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA021371: AB_1852341, HPA029992: " "unprognostic (1.70e-1)" "unprognostic (7.26e-2)" "unprognostic (1.29e-1)" "unprognostic (5.61e-2)" "unprognostic (5.97e-2)" "unprognostic (2.54e-2)" "unprognostic (9.99e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.00e-1)" "unprognostic (7.99e-5)" "unprognostic (1.31e-2)" "unprognostic (1.66e-1)" "unprognostic (1.02e-2)" "unprognostic (3.53e-2)" 1.5 2.1 10.0 2.0 12.4 0.9 1.2 37.2 47.1 2.7 2.0 15.1 0.0 1.7 4.4 1.0 1.7 1.6 1.4 1.1 9.1 6.8 1.1 0.9 1.5 1.3 14.6 12.3 1.0 0.9 6.4 0.4 0.9 13.8 1.0 2.2 0.0 0.9 1.0 7.7 0.8 2.1 5.6 18.6 1.1 1.4 1.2 11.3 0.0 0.9 0.0 1.1 1.2 0.5 0.0 0.2 0.0 0.5 0.1 2.1 0.2 0.0 0.1 4.9 0.0 4.0 5.1 0.0 0.2 1.2 0.8 0.2 10.1 0.0 0.0 0.0 0.3 0.2 2.0 0.4 0.7 2.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 5.6 0.0 0.0 0.0 0.9 0.0 0.0 0.7 0.0 0.0 0.3 16.5 15.9 0.0 0.0 0.0 0.0 0.0 16.2 0.5 0.2 1.1 0.0 0.0 0.0 0.7 0.3 1.6 0.1 0.0 0.0 0.0 0.0 0.1 3.2 0.1 0.0 0.3 0.0 2.1 0.5 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.2 0.0 0.0 0.2 10.0 12.4 37.2 25.0 9.1 6.8 14.6 12.3 13.8 11.3 FAM163B C9orf166 ENSG00000196990 "Family with sequence similarity 163 member B" P0C2L3 9 133578415-133586197 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 41.7" "Cell line enriched" "Detected in some" 21 "SH-SY5Y: 39.0" "Cancer enriched" "Detected in some" 6 "glioma: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067336 Supported Approved "Nuclear bodies,Plasma membrane,Cytosol" "Nuclear bodies, Plasma membrane, Cytosol" "HPA067336: " "unprognostic (2.94e-2)" "unprognostic (6.87e-3)" "unprognostic (2.65e-2)" "unprognostic (2.70e-1)" "unprognostic (1.23e-2)" "unprognostic (9.05e-2)" "unprognostic (1.02e-2)" "unprognostic (3.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (5.75e-4)" "unprognostic (1.07e-1)" "unprognostic (9.54e-2)" "unprognostic (1.65e-1)" "unprognostic (4.73e-4)" 0.1 8.2 10.0 0.0 2.7 0.0 0.0 3.2 41.7 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.4 1.2 6.1 3.9 0.1 2.7 0.0 1.3 3.3 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.4 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.5 0.1 0.0 0.0 0.0 1.8 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM166A ENSG00000188163 "Family with sequence similarity 166 member A" Q6J272 9 137243584-137247770 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 53 "testis: 54.2" "Cell line enhanced" "Detected in some" "T-47d: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA023307 Enhanced "HPA023307: AB_1848930" "unprognostic (2.22e-1)" "unprognostic (8.39e-2)" "unprognostic (1.01e-3)" "unprognostic (1.37e-2)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "unprognostic (9.83e-2)" "unprognostic (2.18e-3)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (2.67e-4)" "unprognostic (7.81e-2)" "unprognostic (1.77e-3)" "unprognostic (1.83e-1)" "unprognostic (2.02e-2)" "unprognostic (2.09e-1)" "unprognostic (4.18e-3)" 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.3 0.1 1.0 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.7 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 54.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 1.4 0.5 1.2 0.8 0.0 0.7 0.0 0.5 0.0 0.0 0.5 2.0 0.6 0.1 0.0 1.0 0.0 0.0 0.0 1.1 0.7 0.5 1.2 1.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.9 0.0 0.3 0.3 0.3 0.3 0.1 0.6 0.1 0.8 0.8 0.8 0.3 1.0 0.8 3.2 0.9 0.7 0.8 1.0 0.3 0.1 0.8 1.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 FAM167B "C1orf90, MGC10820" ENSG00000183615 "Family with sequence similarity 167 member B" Q9BTA0 1 32247233-32248856 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "vagina: 91.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.9;EFO-21: 8.7;SK-MEL-30: 21.0;U-2197: 21.5" "Cancer enhanced" "Detected in all" "melanoma: 46.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 4.5" "Lineage enriched" "Detected in many" 4 "T-cells: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA029398, HPA062074" Uncertain Approved "Actin filaments" "Actin filaments" "HPA029398: AB_10602807, HPA062074: " "unprognostic (2.16e-1)" "unprognostic (2.06e-1)" "prognostic unfavourable (1.11e-4)" "unprognostic (6.03e-2)" "unprognostic (1.74e-2)" "unprognostic (3.36e-3)" "unprognostic (7.44e-3)" "unprognostic (3.64e-1)" "unprognostic (3.00e-3)" "unprognostic (1.02e-2)" "unprognostic (1.30e-2)" "unprognostic (8.89e-2)" "unprognostic (4.80e-2)" "unprognostic (2.69e-2)" "unprognostic (1.60e-1)" "unprognostic (8.04e-2)" "unprognostic (5.08e-2)" 17.2 10.5 1.4 5.0 1.7 0.1 20.1 1.7 1.9 6.1 3.1 1.1 7.4 3.6 7.8 2.2 4.5 3.4 5.5 11.3 1.8 1.7 20.3 18.4 22.4 6.2 3.2 0.6 3.8 6.6 5.2 8.5 5.8 3.3 9.2 2.7 5.2 2.6 8.2 3.3 1.1 4.1 7.5 2.6 1.4 4.0 1.8 2.7 1.2 11.8 1.5 1.9 7.2 91.1 1.0 0.0 0.8 0.0 0.3 4.5 0.7 0.6 1.2 0.4 0.0 0.9 0.8 0.0 3.0 6.9 1.3 1.9 0.0 0.6 0.1 8.7 5.1 1.0 0.2 0.0 0.4 0.1 0.0 0.0 2.7 0.4 0.3 0.0 0.1 0.8 0.5 1.0 0.3 2.5 0.0 0.0 0.1 0.4 0.1 0.0 0.2 2.9 0.6 0.0 0.8 0.8 0.3 1.3 0.3 1.9 0.1 21.0 0.3 0.0 2.2 0.6 0.7 21.5 0.0 0.1 0.2 0.4 0.2 0.1 0.2 0.0 0.0 0.8 2.6 0.0 0.7 0.5 0.8 0.8 0.0 1.0 0.5 1.6 0.0 0.3 0.0 0.0 4.5 0.7 1.4 1.7 1.7 1.9 1.8 1.7 3.2 0.6 3.3 2.7 FAM170A ZNFD ENSG00000164334 "Family with sequence similarity 170 member A" A1A519 5 119629559-119635822 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 37.0" "Cell line enhanced" "Detected in single" "THP-1: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037900, HPA037902" Enhanced "HPA037900: AB_2675728, HPA037902: AB_2675730" "unprognostic (2.26e-1)" "unprognostic (1.13e-1)" "unprognostic (9.70e-3)" "unprognostic (1.89e-1)" "unprognostic (1.06e-1)" "unprognostic (1.02e-4)" "unprognostic (2.12e-1)" "unprognostic (2.25e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.9 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 FAM181B "LOC220382, MGC33846" ENSG00000182103 "Family with sequence similarity 181 member B" A6NEQ2 11 82729941-82733864 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 29.6" "Cell line enhanced" "Detected in some" "RT4: 6.6;SH-SY5Y: 3.5;U-2 OS: 3.4" "Cancer enriched" "Detected in many" 19 "glioma: 29.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066861 Approved Approved "Nuclear membrane,Mitochondria" Mitochondria "Nuclear membrane" "HPA066861: " "unprognostic (2.84e-4)" "unprognostic (3.47e-2)" "unprognostic (1.80e-1)" "prognostic favourable (8.07e-4)" "unprognostic (6.71e-3)" "unprognostic (3.18e-2)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (1.90e-1)" "unprognostic (5.50e-2)" "unprognostic (6.27e-4)" "unprognostic (2.52e-3)" "unprognostic (6.81e-2)" "unprognostic (1.53e-2)" "unprognostic (2.56e-1)" "unprognostic (7.20e-3)" "unprognostic (7.20e-2)" 1.9 2.9 18.3 1.8 13.3 1.5 1.6 16.9 29.6 2.0 1.7 18.6 0.0 1.9 2.2 1.8 1.5 2.6 1.4 2.0 19.6 11.3 2.0 1.3 1.3 1.4 17.1 13.0 2.7 1.5 1.5 1.1 1.4 17.2 1.9 1.5 0.7 3.2 2.7 1.7 1.7 2.3 1.6 16.9 1.3 1.8 1.7 16.7 0.0 2.1 0.0 1.7 2.2 0.5 0.2 0.0 0.6 0.3 0.3 0.4 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.3 0.1 0.4 0.0 0.1 0.1 0.5 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.1 0.1 0.1 1.2 0.1 0.0 0.0 0.0 0.2 6.6 1.0 3.5 0.0 0.0 0.1 0.1 0.4 0.0 0.1 3.4 0.1 0.1 0.3 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.4 0.0 0.6 0.3 0.3 0.0 0.1 0.0 18.3 13.3 16.9 11.4 19.6 11.3 17.1 13.0 17.2 16.7 FAM186A LOC121006 ENSG00000185958 "Family with sequence similarity 186 member A" A6NE01 12 50326230-50396622 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 19.3" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA047128 Uncertain "HPA047128: AB_10967726" "unprognostic (1.01e-1)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" "unprognostic (2.31e-1)" "unprognostic (1.88e-1)" "unprognostic (3.69e-2)" "unprognostic (3.48e-3)" "unprognostic (1.43e-2)" "unprognostic (1.30e-2)" "unprognostic (6.96e-2)" "unprognostic (4.65e-5)" "unprognostic (1.93e-1)" "unprognostic (2.42e-5)" "unprognostic (1.65e-1)" "unprognostic (1.32e-1)" "unprognostic (7.51e-2)" "unprognostic (3.22e-3)" 0.2 0.2 0.4 0.3 0.8 0.9 0.2 0.9 0.8 0.2 0.2 0.2 0.2 0.1 0.2 1.2 0.2 0.1 0.2 0.3 0.4 0.4 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 1.0 0.2 0.2 0.2 0.2 0.2 0.4 0.2 2.0 0.8 0.3 0.2 0.2 0.3 0.0 19.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.9 3.1 1.5 1.8 1.4 0.3 0.6 0.2 0.2 2.1 0.0 0.0 1.0 0.3 0.0 0.1 0.0 0.2 1.0 0.8 0.7 0.6 0.3 0.1 0.2 0.0 1.2 0.8 0.4 0.9 1.0 0.4 0.5 0.9 0.9 0.3 0.0 0.2 0.0 0.9 1.6 1.0 1.7 0.2 0.8 0.9 0.2 0.7 0.5 0.2 0.1 1.3 0.4 0.2 0.4 0.4 0.2 1.1 0.3 0.0 0.6 0.9 0.5 0.5 1.2 0.4 0.8 0.9 0.1 0.2 2.4 1.5 1.2 1.4 0.7 0.8 0.5 0.8 0.5 0.2 0.8 0.9 1.2 3.1 1.8 0.6 0.9 0.4 0.3 0.4 0.8 0.9 0.8 0.4 0.4 0.2 0.2 0.2 0.2 FAM186B "C12orf25, DKFZP434J0113" ENSG00000135436 "Family with sequence similarity 186 member B" Q8IYM0 12 49582885-49605639 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 58.0" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Group enriched" "Detected in many" 7 "B-cells: 2.3;T-cells: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039736, HPA040028" Uncertain "HPA039736: AB_10795295, HPA040028: AB_10795684" "unprognostic (2.96e-1)" "unprognostic (1.25e-1)" "unprognostic (2.86e-1)" "unprognostic (1.94e-1)" "unprognostic (3.00e-1)" "unprognostic (5.55e-2)" "unprognostic (1.53e-1)" "unprognostic (3.37e-3)" "unprognostic (1.44e-1)" "unprognostic (4.11e-2)" "unprognostic (4.47e-2)" "unprognostic (2.80e-1)" "unprognostic (4.42e-5)" "unprognostic (1.56e-1)" "unprognostic (6.18e-2)" "unprognostic (2.10e-5)" "unprognostic (7.23e-2)" 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.3 0.4 0.2 0.2 0.2 0.2 0.5 1.0 0.9 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.1 58.0 0.2 0.2 0.6 0.2 0.2 0.2 0.2 2.3 0.2 0.0 0.2 0.2 1.4 0.0 0.8 3.7 0.4 1.3 0.4 0.2 1.9 0.0 0.5 0.2 0.4 4.7 1.5 2.7 0.9 0.3 1.3 0.7 0.7 0.4 0.9 1.1 1.6 2.1 0.7 0.4 3.0 0.8 0.2 1.0 0.7 2.1 0.3 2.5 2.1 0.7 2.6 0.3 0.3 0.6 1.4 1.0 0.3 1.2 1.4 1.2 3.2 0.8 1.5 0.7 2.3 1.6 1.3 1.5 0.3 1.5 1.3 0.8 1.5 1.1 4.8 0.6 1.3 0.7 0.0 0.2 0.0 0.1 0.1 1.4 0.1 0.4 0.1 0.2 2.3 1.0 0.4 0.0 0.2 0.1 0.2 1.3 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 FAM187B "FLJ25660, TMEM162" ENSG00000177558 "Family with sequence similarity 187 member B" Q17R55 19 35224800-35228729 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 108 "testis: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (3.34e-1)" "unprognostic (4.96e-1)" "unprognostic (2.40e-1)" "unprognostic (2.84e-1)" "unprognostic (2.72e-1)" "unprognostic (2.12e-1)" "unprognostic (1.25e-3)" "unprognostic (2.71e-1)" "unprognostic (2.49e-1)" "unprognostic (1.47e-1)" "unprognostic (1.76e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 56.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 FAM205A C9orf144B ENSG00000205108 "Family with sequence similarity 205 member A" Q6ZU69 9 34723055-34729467 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 243 "testis: 24.3" "Cell line enhanced" "Detected in single" "THP-1: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA071267 Enhanced "HPA071267: " "unprognostic (2.25e-1)" "unprognostic (3.66e-3)" "unprognostic (6.29e-3)" "unprognostic (1.90e-1)" "unprognostic (2.73e-3)" "unprognostic (7.82e-2)" "unprognostic (9.61e-2)" "unprognostic (6.41e-2)" "unprognostic (4.78e-1)" "unprognostic (7.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM205C FAM205CP ENSG00000187791 "Family with sequence similarity 205 member C" A6NFA0 9 34889064-34895778 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 23.2" "Cell line enriched" "Detected in single" 120 "THP-1: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.29e-1)" "unprognostic (1.90e-1)" "unprognostic (3.64e-2)" "unprognostic (8.64e-2)" "unprognostic (2.63e-1)" "unprognostic (1.84e-1)" "unprognostic (7.73e-2)" "unprognostic (1.85e-4)" "unprognostic (1.48e-3)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 FAM209A "C20orf106, dJ1153D9.3" ENSG00000124103 "Family with sequence similarity 209 member A" Q5JX71 20 56517187-56526142 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 40.3" "Cell line enhanced" "Detected in some" "HMC-1: 5.4;Karpas-707: 3.0;U-266/84: 3.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.9;neutrophil: 2.3" "Low lineage specificity" "Detected in many" "unprognostic (1.03e-1)" "unprognostic (1.01e-2)" "unprognostic (2.19e-2)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (8.58e-3)" "unprognostic (1.06e-2)" "unprognostic (2.12e-1)" "unprognostic (2.10e-1)" "unprognostic (9.83e-2)" "unprognostic (5.56e-3)" "unprognostic (7.68e-2)" "unprognostic (1.86e-9)" "unprognostic (2.98e-2)" "unprognostic (2.07e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-2)" 0.2 0.0 0.0 0.3 0.0 8.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.4 0.0 0.0 0.9 0.1 40.3 0.0 0.5 0.0 0.1 0.6 0.3 2.3 0.2 0.0 1.9 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.3 0.0 0.3 0.3 0.3 0.2 1.8 0.3 0.5 0.2 0.5 0.2 0.2 0.3 0.2 0.6 0.4 0.0 0.2 1.4 5.4 0.3 1.6 0.0 0.2 0.0 0.0 3.0 0.0 1.3 0.2 1.9 0.2 0.2 1.0 0.9 1.2 0.0 0.7 0.5 0.0 0.0 2.0 0.5 0.4 0.9 0.0 0.5 0.3 0.8 0.3 1.4 3.9 2.0 0.0 0.2 0.1 0.0 0.2 0.6 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.1 2.3 0.0 0.2 0.3 0.0 0.0 FAM209B "C20orf107, dJ1153D9.4" ENSG00000213714 "Family with sequence similarity 209 member B" Q5JX69 20 56533246-56536520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 40.8" "Cell line enhanced" "Detected in many" "U-266/70: 4.9" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in many" "eosinophil: 3.4" "Low lineage specificity" "Detected in many" HPA042144 Enhanced "HPA042144: AB_10794414" "unprognostic (2.93e-1)" "unprognostic (6.90e-2)" "unprognostic (9.49e-3)" "unprognostic (4.96e-3)" "unprognostic (1.72e-1)" "unprognostic (3.77e-1)" "unprognostic (1.72e-1)" "unprognostic (7.77e-2)" "unprognostic (3.63e-2)" "unprognostic (1.43e-1)" "unprognostic (4.59e-4)" "unprognostic (3.47e-1)" "unprognostic (2.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.55e-1)" "unprognostic (7.13e-2)" "unprognostic (1.48e-4)" 0.2 0.0 0.0 0.2 0.1 4.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.3 0.3 0.2 0.0 0.0 0.9 0.1 40.8 0.0 0.3 0.0 0.0 1.0 0.8 3.4 1.1 0.0 2.1 0.4 0.0 2.7 0.7 0.0 0.0 0.3 0.4 1.0 1.8 2.3 0.9 1.7 0.1 0.3 1.8 1.1 1.4 1.2 0.7 2.1 0.4 1.1 1.1 0.0 1.1 0.0 2.2 4.1 1.3 2.0 0.2 1.4 0.0 0.2 1.9 0.0 2.6 0.8 2.0 0.5 1.4 0.7 0.8 0.2 1.4 0.9 1.7 0.4 0.9 3.3 0.6 1.4 0.6 0.0 0.3 0.6 1.7 0.1 4.9 4.4 0.9 0.3 0.9 0.3 0.0 1.1 3.4 2.1 0.4 0.3 0.0 0.1 1.3 0.8 1.0 0.7 0.0 1.8 0.0 0.7 0.0 0.0 0.4 FAM217A "C6orf146, MGC43581" ENSG00000145975 "Family with sequence similarity 217 member A" Q8IXS0 6 4049434-4087344 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "testis: 16.9" "Cell line enhanced" "Detected in single" "HeLa: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" HPA035455 Uncertain "HPA035455: AB_10669905" "unprognostic (5.93e-2)" "unprognostic (3.70e-2)" "unprognostic (1.24e-1)" "unprognostic (8.18e-2)" "unprognostic (1.54e-1)" "unprognostic (2.53e-2)" "unprognostic (2.99e-2)" "unprognostic (1.08e-2)" "unprognostic (2.09e-2)" "unprognostic (1.13e-1)" "unprognostic (1.85e-1)" "unprognostic (4.54e-1)" "unprognostic (6.55e-2)" "unprognostic (2.86e-1)" "unprognostic (1.85e-1)" "unprognostic (1.53e-2)" "unprognostic (5.51e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.4 1.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.5 0.3 0.1 0.3 0.4 0.5 1.3 0.0 0.4 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM228A "C2orf84, FLJ30851" ENSG00000186453 "Family with sequence similarity 228 member A" Q86W67 2 24175069-24200849 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 15 "testis: 54.1" "Group enriched" "Detected in some" 5 "HHSteC: 5.5;TIME: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.1" "Low lineage specificity" "Detected in many" "unprognostic (2.57e-1)" "unprognostic (7.14e-2)" "unprognostic (2.92e-2)" "unprognostic (1.98e-3)" "unprognostic (7.13e-4)" "unprognostic (2.19e-3)" "unprognostic (1.55e-1)" "unprognostic (3.05e-1)" "unprognostic (9.57e-2)" "unprognostic (2.14e-1)" "unprognostic (4.44e-5)" "unprognostic (1.73e-2)" "unprognostic (1.04e-4)" "unprognostic (1.96e-1)" "unprognostic (1.34e-1)" "unprognostic (2.30e-1)" "unprognostic (1.33e-2)" 1.4 0.9 1.1 0.6 0.9 0.0 1.0 0.6 1.4 0.7 1.4 0.5 3.0 0.2 0.7 0.9 0.9 0.3 1.1 1.2 0.8 0.9 0.3 0.3 1.5 0.7 0.8 0.2 0.6 0.2 0.0 0.2 1.1 0.6 1.0 0.3 0.8 0.6 3.2 0.3 0.3 0.4 3.6 0.7 0.3 0.4 54.1 0.2 0.6 0.7 0.2 0.5 1.1 0.2 0.0 3.1 0.7 1.1 0.0 1.6 0.5 0.2 0.0 0.8 0.0 0.4 0.2 0.0 0.6 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 5.5 0.1 0.2 0.4 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.5 1.1 0.0 0.0 0.4 0.0 0.2 8.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 1.2 0.0 0.0 0.6 0.0 0.6 1.1 1.6 0.0 0.3 0.6 0.0 0.0 0.6 0.8 0.7 0.0 0.3 3.1 0.0 0.5 1.1 0.9 0.6 1.1 0.8 0.9 0.8 0.2 0.6 0.2 FAM229A ENSG00000225828 "Family with sequence similarity 229 member A" H3BQW9 1 32361270-32364278 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 17 "testis: 71.8" "Cell line enhanced" "Detected in some" "HEK 293: 12.6;U-266/70: 5.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.8" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (5.73e-3)" "unprognostic (1.16e-1)" "unprognostic (4.82e-1)" "unprognostic (4.59e-3)" "unprognostic (1.99e-3)" "unprognostic (2.02e-2)" "unprognostic (1.29e-1)" "unprognostic (2.06e-1)" "unprognostic (2.73e-3)" "unprognostic (4.60e-2)" "prognostic unfavourable (1.73e-5)" "unprognostic (2.46e-2)" "unprognostic (1.12e-1)" "unprognostic (8.03e-2)" "prognostic favourable (2.33e-4)" 1.7 1.0 1.3 0.6 1.3 4.1 0.5 1.4 2.1 1.0 1.4 1.0 0.5 1.1 1.0 1.6 0.5 1.2 0.7 0.5 0.9 0.8 1.5 1.8 0.9 0.5 0.8 1.5 2.3 0.5 0.2 0.6 0.6 1.0 1.3 0.3 1.0 0.5 0.6 2.2 3.5 1.5 0.5 1.1 3.2 0.9 71.8 1.1 0.6 1.3 0.8 0.6 0.6 0.6 0.6 0.0 0.9 0.1 0.0 1.8 0.4 0.6 0.3 0.2 0.4 0.0 0.0 3.3 0.4 0.0 0.0 0.0 0.4 0.0 0.3 1.1 0.0 0.6 0.0 0.0 0.0 0.8 12.6 0.7 0.7 0.2 0.0 0.4 1.1 0.3 0.0 0.0 0.2 0.0 0.8 0.9 0.0 1.2 0.4 3.3 1.5 0.1 3.1 0.4 1.9 0.1 0.0 0.8 3.0 0.0 0.3 1.4 0.4 0.7 1.0 0.6 3.9 0.7 1.5 5.6 1.7 0.0 0.9 0.4 0.0 0.0 0.1 0.8 0.4 0.0 1.5 0.0 0.0 0.1 0.0 0.6 1.8 0.6 0.9 0.0 0.0 0.0 0.0 0.4 1.3 1.3 1.4 2.1 0.9 0.8 0.8 1.5 1.0 1.1 FAM229B "C6orf225, DKFZp586F0922, LOC619208" ENSG00000203778 "Family with sequence similarity 229 member B" Q4G0N7 6 112087599-112102790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 118.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036068 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Nucleoplasm "Nucleoli, Golgi apparatus" "HPA036068: AB_10673495" "unprognostic (1.65e-1)" "unprognostic (9.41e-2)" "unprognostic (4.29e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (2.71e-2)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-3)" "unprognostic (4.74e-2)" "prognostic favourable (8.76e-4)" "unprognostic (3.74e-3)" "unprognostic (1.36e-1)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" 4.7 7.4 18.4 2.1 16.8 2.0 7.7 5.8 14.8 8.2 4.2 17.3 4.3 2.2 9.6 17.0 3.8 23.7 8.8 16.8 15.7 16.2 11.6 11.0 5.2 2.0 20.7 11.2 10.7 4.3 10.0 15.4 5.2 15.3 7.3 3.1 8.6 3.9 11.0 5.9 1.9 2.3 8.6 21.7 2.3 4.3 118.9 13.6 1.6 9.7 2.6 2.0 4.6 2.6 4.0 3.4 2.7 0.3 5.4 8.1 2.8 1.6 4.2 17.5 8.5 15.4 15.4 0.8 6.4 24.6 9.3 19.6 0.7 4.1 1.3 19.1 11.8 1.0 3.6 9.3 14.8 0.4 12.0 1.5 2.0 6.6 9.6 3.4 0.8 9.3 6.3 15.3 2.6 9.0 2.0 3.4 11.3 0.4 6.2 5.4 4.5 10.1 9.7 4.4 1.4 13.6 0.2 16.3 6.8 5.1 0.6 9.9 8.3 3.1 5.1 7.7 3.3 29.5 8.5 2.6 0.1 11.8 12.3 2.8 10.2 0.1 0.1 2.7 4.2 0.0 5.3 2.5 3.7 3.3 0.5 4.0 8.1 7.2 0.4 5.4 0.3 3.4 0.4 2.8 18.4 16.8 5.8 14.0 15.7 16.2 20.7 11.2 15.3 13.6 FAM230A DGCR15 ENSG00000277870 "Family with sequence similarity 230 member A" 22 18422244-18500594 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "testis: 16.4" "Cell line enhanced" "Detected in some" "A549: 16.0;Karpas-707: 7.5;RH-30: 6.7;U-266/84: 13.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "classical monocyte: 1.1;myeloid DC: 1.3" "Group enriched" "Detected in many" 12 "dendritic cells: 1.3;monocytes: 1.1" 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 16.4 0.2 0.0 0.2 0.1 1.3 0.0 1.1 0.0 0.0 0.1 1.8 16.0 1.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 6.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 7.5 0.0 4.1 0.3 0.6 3.1 1.2 1.1 6.7 4.5 0.0 0.8 5.6 0.0 0.3 4.4 0.9 0.0 2.0 0.0 1.4 0.2 0.0 0.2 0.6 13.2 0.0 0.0 3.3 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 FAM236A "DMRTC1-AS1, LINC00684" ENSG00000275520 "Family with sequence similarity 235 member A" A0A1B0GUQ0 X 72938163-72938958 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "testis: 29.1" "Cell line enhanced" "Detected in some" "AF22: 2.4;AN3-CA: 1.4;CAPAN-2: 3.5;U-266/70: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 29.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 FAM236B ENSG00000268994 "Family with sequence similarity 236 member B" A0A1B0GV22 X 72781865-72782660 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 52 "testis: 36.2" "Group enriched" "Detected in some" 24 "Daudi: 2.4;HDLM-2: 2.9;MOLT-4: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM24A AC073585.4 ENSG00000203795 "Family with sequence similarity 24 member A" A6NFZ4 10 122910701-122913111 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 95 "testis: 20.9" "Cell line enhanced" "Detected in some" "HMC-1: 1.9;LHCN-M2: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052490 Supported "Secreted in male reproductive system" "HPA052490: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.7 0.7 1.2 0.0 0.0 0.5 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM25G bA301J7.4 ENSG00000189090 "Family with sequence similarity 25 member G" B3EWG6 10 47487219-47491693 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 42.4" "Cell line enriched" "Detected in single" 29 "SK-BR-3: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044808 Uncertain "HPA044808: " "unprognostic (1.97e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 3.8 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 42.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM46D "CT1.26, CT112, MGC26999" ENSG00000174016 "Family with sequence similarity 46 member D" Q8NEK8 X 80335504-80445311 "Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 53 "testis: 8.9" "Group enriched" "Detected in some" 12 "AN3-CA: 4.5;K-562: 2.4;U-2 OS: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059362 Uncertain "HPA059362: " "unprognostic (3.49e-1)" "unprognostic (1.14e-2)" "unprognostic (4.36e-1)" "unprognostic (1.59e-1)" "unprognostic (4.64e-1)" "unprognostic (4.28e-2)" "unprognostic (8.21e-3)" "unprognostic (2.95e-3)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM47A MGC27003 ENSG00000185448 "Family with sequence similarity 47 member A" Q5JRC9 X 34129756-34132314 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 127 "testis: 12.7" "Group enriched" "Detected in some" 7 "REH: 1.4;U-266/84: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA000610 Uncertain "HPA000610: AB_1078805" "unprognostic (1.68e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM47B FLJ35782 ENSG00000189132 "Family with sequence similarity 47 member B" Q8NA70 X 34942796-34944915 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 44 "testis: 18.8" "Cell line enhanced" "Detected in single" "U-138 MG: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046829, HPA050996" Uncertain "HPA046829: , HPA050996: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM47C ENSG00000198173 "Family with sequence similarity 47 member C" Q5HY64 X 37008397-37011666 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 22 "testis: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (8.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM71A FLJ32796 ENSG00000162771 "Family with sequence similarity 71 member A" Q8IYT1 1 212624474-212626778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 149 "testis: 57.1" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;SK-BR-3: 1.5;U-266/70: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA028462 Enhanced "HPA028462: AB_10601904" 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 57.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM71B MGC26988 ENSG00000170613 "Family with sequence similarity 71 member B" Q8TC56 5 157161846-157166264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 71 "testis: 31.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039478, HPA040771" Enhanced "HPA039478: AB_10795106, HPA040771: AB_10805829" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM71C MGC39520 ENSG00000180219 "Family with sequence similarity 71 member C" Q8NEG0 12 99647753-99650046 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 60 "testis: 31.7" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "cerebellum: 18.6" "unprognostic (6.82e-2)" "unprognostic (3.58e-2)" "unprognostic (3.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM71D C14orf54 ENSG00000172717 "Family with sequence similarity 71 member D" Q8N9W8 14 67189393-67228550 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 42.6" "Cell line enhanced" "Detected in some" "HEK 293: 2.5;U-2 OS: 4.0;U-937: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.58e-2)" "unprognostic (8.05e-4)" "unprognostic (2.34e-2)" "unprognostic (2.86e-1)" "unprognostic (5.80e-2)" "unprognostic (1.05e-1)" "unprognostic (2.44e-3)" "unprognostic (6.62e-2)" "unprognostic (5.01e-1)" "unprognostic (6.72e-2)" "unprognostic (4.52e-2)" "unprognostic (2.06e-1)" "unprognostic (2.96e-5)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" "unprognostic (8.85e-2)" "unprognostic (5.01e-5)" 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 42.6 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.4 1.8 2.0 0.7 0.9 0.9 0.1 0.9 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.7 0.3 0.0 0.6 0.0 0.0 0.6 0.4 2.5 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.8 0.0 0.0 1.0 0.7 0.0 0.0 0.6 0.7 0.7 0.0 0.0 1.6 1.0 0.0 0.7 0.3 0.0 0.8 0.0 0.5 0.0 0.0 1.0 4.0 0.3 0.5 0.9 1.1 0.2 0.6 3.0 0.0 0.1 0.7 0.0 0.9 0.3 0.0 0.4 0.2 0.2 0.2 0.4 0.7 0.6 2.0 0.9 0.3 1.8 0.5 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 FAM71E2 "C19orf16, DKFZp434G1729" ENSG00000180043 "Family with sequence similarity 71 member E2" Q8N5Q1 19 55354908-55363260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 103 "testis: 41.0" "Cell line enriched" "Detected in single" 18 "SCLC-21H: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.97e-2)" "unprognostic (2.27e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 FAM71F1 "FAM137A, NYD-SP18" ENSG00000135248 "Family with sequence similarity 71 member F1" Q96KD3 7 128709061-128731743 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 146 "testis: 64.8" "Cell line enriched" "Detected in some" 12 "NTERA-2: 19.0" "Cancer enriched" "Detected in single" 23 "testis cancer: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA020636 Uncertain Cytosol Cytosol "HPA020636: AB_1854739" "unprognostic (3.09e-2)" "unprognostic (3.39e-3)" "unprognostic (6.03e-2)" "unprognostic (5.25e-1)" "unprognostic (2.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-2)" "unprognostic (2.17e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-5)" "unprognostic (1.48e-1)" "unprognostic (2.18e-6)" "unprognostic (6.97e-2)" "unprognostic (2.09e-1)" "unprognostic (2.19e-3)" "unprognostic (1.99e-1)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 64.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 19.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.2 1.5 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 FAM71F2 FAM137B ENSG00000205085 "Family with sequence similarity 71 member F2" Q6NXP2 7 128672288-128687872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "testis: 28.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA020513, HPA024248" Enhanced Approved Nucleoplasm Nucleoplasm "HPA020513: AB_1853077, HPA024248: " "unprognostic (1.01e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (9.83e-2)" "unprognostic (8.29e-3)" "unprognostic (6.22e-2)" "unprognostic (2.67e-2)" "unprognostic (6.13e-2)" "unprognostic (7.60e-2)" "unprognostic (3.65e-4)" "unprognostic (3.17e-2)" "unprognostic (3.85e-4)" "unprognostic (3.00e-2)" "unprognostic (2.79e-2)" "unprognostic (2.40e-4)" "unprognostic (2.47e-2)" 1.4 1.1 0.7 0.7 1.2 1.3 0.7 1.8 1.1 0.7 0.7 0.7 0.7 0.4 0.7 1.6 0.7 0.5 0.8 0.9 0.7 0.7 0.9 0.7 0.7 0.7 0.7 0.7 0.9 0.7 0.2 2.5 0.7 0.7 0.9 0.5 0.7 1.6 0.7 1.6 1.3 0.7 1.0 0.7 1.2 1.0 28.1 0.7 0.7 0.9 0.7 0.7 0.7 0.7 1.4 1.3 4.2 0.8 1.2 0.9 0.2 0.8 1.3 1.5 2.9 2.6 2.0 0.7 1.7 0.4 0.4 1.0 0.3 1.4 0.9 0.8 2.8 1.9 0.2 0.7 0.7 0.8 1.3 0.5 2.6 0.2 0.7 0.7 1.8 1.6 0.7 2.9 0.5 0.4 0.4 1.4 1.2 1.3 0.4 1.4 0.9 1.9 1.0 0.3 0.4 1.0 3.5 1.2 0.7 0.7 0.8 2.2 1.0 0.4 4.2 1.8 0.7 3.8 1.5 2.9 2.4 0.9 1.0 1.2 1.2 3.9 0.8 0.6 0.5 0.4 0.5 0.8 0.6 0.5 0.3 1.4 0.6 0.6 4.2 1.2 0.5 1.3 0.9 0.2 0.7 1.2 1.8 1.1 0.7 0.7 0.7 0.7 0.7 0.7 FAM9A TEX39A ENSG00000183304 "Family with sequence similarity 9 member A" Q8IZU1 X 8790795-8801383 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 9.2" "Cell line enriched" "Detected in single" 19 "U-266/84: 13.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.3" HPA056076 Uncertain "HPA056076: " "unprognostic (3.43e-2)" 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.8 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.3 9.2 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 FANCD2OS "C3orf24, MGC40179" ENSG00000163705 "FANCD2 opposite strand" Q96PS1 3 10081317-10108231 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 53.0" "Cell line enhanced" "Detected in some" "CACO-2: 4.7;Daudi: 1.5;HEL: 2.4;MCF7: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "neutrophil: 8.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "unprognostic (5.99e-2)" "unprognostic (4.33e-3)" "unprognostic (8.04e-2)" "unprognostic (1.11e-3)" "unprognostic (3.51e-1)" "unprognostic (2.63e-2)" "unprognostic (4.78e-2)" "unprognostic (3.49e-1)" "unprognostic (2.53e-3)" "unprognostic (3.91e-2)" "unprognostic (9.45e-2)" "unprognostic (2.11e-7)" "unprognostic (2.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 8.4 1.6 0.4 0.4 0.1 0.3 0.4 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.7 0.6 1.5 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 1.3 0.0 0.1 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.8 0.2 0.1 0.0 1.1 0.6 0.3 0.8 0.6 0.4 0.5 0.3 0.3 0.4 0.2 0.4 0.2 0.1 0.8 0.3 0.3 8.4 0.4 1.6 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FATE1 "CT43, FATE" ENSG00000147378 "Fetal and adult testis expressed 1" Q969F0 X 151716035-151723194 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 155 "testis: 100.9" "Cell line enhanced" "Detected in some" "BEWO: 2.1;U-2197: 1.6;U-266/70: 1.4;U-87 MG: 1.3" "Group enriched" "Detected in some" 9 "renal cancer: 1.2;testis cancer: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA034604 Enhanced "HPA034604: AB_10602318" "unprognostic (1.82e-2)" "unprognostic (7.13e-2)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.40e-5)" "unprognostic (2.10e-1)" "unprognostic (3.70e-3)" "unprognostic (2.58e-1)" "unprognostic (1.16e-1)" "unprognostic (5.07e-3)" "unprognostic (1.55e-1)" "unprognostic (3.50e-2)" "prognostic unfavourable (2.88e-4)" "unprognostic (4.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.68e-1)" "unprognostic (5.34e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 100.9 0.0 0.6 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 1.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 FBN2 "CCA, DA9" ENSG00000138829 "Fibrillin 2" P35556 5 128257909-128659185 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "placenta: 175.9" "Cell line enhanced" "Detected in many" "HHSteC: 37.3;HSkMC: 26.6;hTERT-HME1: 58.9;HUVEC TERT2: 33.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5;non-classical monocyte: 5.0" "Lineage enriched" "Detected in many" 5 "monocytes: 5.0" "Region enhanced" "Detected in single" "olfactory region: 2.6" "Low region specificity" "Detected in some" "HPA012853, CAB026401" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" 4600000 Cytosol Nucleoplasm "CAB026401: , HPA012853: AB_1848588" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (7.29e-3)" "unprognostic (1.79e-3)" "unprognostic (6.74e-2)" "unprognostic (2.33e-1)" "unprognostic (4.92e-3)" "unprognostic (9.41e-2)" "unprognostic (1.06e-2)" "unprognostic (4.66e-1)" "unprognostic (1.12e-1)" "unprognostic (8.69e-2)" "unprognostic (8.60e-5)" "unprognostic (1.04e-2)" "unprognostic (3.19e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (7.41e-5)" 0.3 7.9 0.3 1.0 0.3 1.6 0.1 0.2 0.3 1.5 0.7 0.4 1.0 0.2 2.9 0.6 1.1 0.6 0.2 6.7 0.2 0.5 0.2 0.2 0.2 1.3 0.2 0.4 0.9 0.1 0.0 1.3 175.9 0.4 1.0 0.8 6.2 0.4 0.9 0.2 0.3 0.5 0.8 0.4 0.6 0.5 4.6 0.2 0.3 0.9 0.4 0.7 0.4 1.2 0.0 1.1 0.6 5.0 0.0 0.0 0.4 0.0 4.4 16.1 0.0 2.6 4.6 3.3 17.6 0.0 15.6 11.7 0.0 0.0 0.0 0.0 23.5 2.6 10.4 2.6 14.7 0.0 4.2 0.0 7.4 0.0 37.3 2.3 0.0 26.6 1.4 6.6 58.9 33.1 0.0 0.0 9.6 0.0 0.0 0.8 6.9 5.3 5.1 5.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 4.9 0.0 6.3 12.0 17.9 0.0 0.0 0.0 0.0 1.8 0.0 6.6 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.0 5.0 0.0 0.0 0.4 0.3 0.3 0.2 0.3 0.2 0.5 0.2 0.4 0.4 0.2 FBXL16 "C16orf22, Fbl16, MGC33974" ENSG00000127585 "F-box and leucine rich repeat protein 16" Q8N461 16 692498-705829 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 102.2" "Cell line enhanced" "Detected in many" "AN3-CA: 12.8;MCF7: 10.4;SCLC-21H: 21.5;SH-SY5Y: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.3" "Lineage enriched" "Detected in single" 9 "T-cells: 3.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 279.3;basal ganglia: 710.3;cerebral cortex: 403.7;hippocampal formation: 376.0" "HPA039504, HPA056354" Enhanced "HPA039504: AB_10794197, HPA056354: AB_2683105" "unprognostic (5.51e-2)" "unprognostic (3.39e-3)" "unprognostic (1.34e-1)" "prognostic unfavourable (6.24e-5)" "unprognostic (2.58e-2)" "unprognostic (4.79e-3)" "unprognostic (1.83e-1)" "unprognostic (1.19e-2)" "unprognostic (2.19e-1)" "unprognostic (1.75e-1)" "prognostic favourable (7.34e-5)" "unprognostic (1.62e-3)" "prognostic favourable (1.87e-4)" "unprognostic (1.90e-2)" "unprognostic (4.71e-2)" "unprognostic (2.33e-1)" "unprognostic (4.36e-2)" 1.7 5.7 53.5 2.0 75.8 1.6 1.8 17.7 102.2 1.6 1.8 2.5 0.1 2.2 1.6 1.6 1.7 1.8 1.6 1.6 44.9 10.2 2.1 1.6 1.7 1.8 10.2 25.8 1.6 3.6 2.6 3.8 1.6 5.1 1.9 1.6 0.0 5.5 2.4 1.6 2.2 1.9 1.5 2.5 2.0 2.8 5.0 11.9 0.0 2.0 0.0 1.7 1.6 0.0 0.3 0.0 0.0 0.0 0.0 3.3 0.3 0.4 0.6 0.2 12.8 0.1 0.1 0.4 0.4 0.1 2.3 0.1 1.2 0.1 0.2 3.5 0.0 2.3 1.0 1.3 0.1 6.4 0.3 0.0 3.0 0.5 0.0 1.3 0.2 0.0 2.0 0.0 1.2 0.0 0.6 3.2 0.0 10.4 0.3 0.0 0.6 4.1 0.0 0.0 7.2 0.1 0.0 21.5 16.0 2.2 0.4 0.2 1.1 0.0 0.0 0.1 4.4 0.0 1.6 0.6 3.7 1.6 1.8 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.3 1.5 0.2 0.0 0.0 3.3 0.7 0.0 0.0 0.0 0.0 1.2 0.3 53.5 75.8 17.7 56.5 44.9 10.2 10.2 25.8 5.1 11.9 FBXO24 FBX24 ENSG00000106336 "F-box protein 24" O75426 7 100583982-100601117 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 43.3" "Cell line enhanced" "Detected in many" "U-2 OS: 5.9" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA050951 Enhanced "HPA050951: " "unprognostic (3.73e-1)" "unprognostic (2.83e-1)" "unprognostic (3.76e-4)" "unprognostic (3.52e-2)" "unprognostic (3.19e-2)" "unprognostic (2.63e-2)" "unprognostic (1.34e-1)" "unprognostic (3.86e-4)" "unprognostic (2.31e-2)" "unprognostic (1.15e-2)" "unprognostic (9.34e-3)" "unprognostic (1.44e-1)" "unprognostic (9.20e-2)" "unprognostic (7.71e-2)" "unprognostic (1.27e-1)" "unprognostic (1.05e-2)" "unprognostic (1.48e-2)" 0.2 0.2 0.2 0.3 0.6 0.2 0.2 0.2 0.5 0.4 0.2 0.3 0.2 0.0 0.6 0.4 0.3 0.4 0.5 0.3 0.2 0.1 0.3 0.2 0.6 0.6 0.5 0.2 1.0 0.2 0.0 0.7 0.3 0.3 0.4 0.0 0.3 1.6 0.2 0.2 0.8 0.3 0.2 1.1 0.4 0.2 43.3 0.3 0.3 0.2 0.2 0.2 0.2 0.4 1.7 2.1 1.7 0.7 0.1 1.8 1.2 1.1 1.0 1.4 1.9 3.9 0.2 0.8 0.9 0.6 0.5 0.4 1.9 3.3 1.7 0.6 0.1 0.9 0.2 0.4 0.0 0.6 2.3 0.2 0.6 0.1 0.8 0.0 2.9 1.9 1.9 0.0 0.0 0.6 0.5 2.5 0.0 2.9 0.5 3.7 2.1 0.9 0.1 0.1 0.5 0.1 1.2 0.2 2.3 1.7 2.3 1.2 1.9 0.8 0.0 1.5 5.9 4.6 0.3 1.3 0.6 0.6 0.6 2.0 2.4 0.0 0.5 0.0 0.2 0.7 0.6 1.7 0.5 0.3 1.1 0.6 0.7 1.0 1.7 0.1 0.0 2.1 1.8 1.2 0.2 0.6 0.2 0.5 0.2 0.1 0.5 0.2 0.3 0.3 FBXO32 "ATROGIN1, Fbx32, MAFbx" ENSG00000156804 "F-box protein 32" Q969P5 8 123497889-123541206 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 200.5" "Group enriched" "Detected in some" 5 "HDLM-2: 59.7;U-251 MG: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 2.9;gdT-cell: 3.7;MAIT T-cell: 3.6;memory CD4 T-cell: 5.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 6.0;naive CD8 T-cell: 7.6;NK-cell: 4.4;T-reg: 4.5" "Group enriched" "Detected in many" 7 "granulocytes: 2.9;NK-cells: 4.4;T-cells: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA058955, HPA065209" Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA058955: , HPA065209: " "unprognostic (2.55e-1)" "unprognostic (3.62e-1)" "unprognostic (1.80e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.11e-2)" "unprognostic (1.23e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "prognostic unfavourable (6.73e-4)" "unprognostic (8.58e-3)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (7.97e-3)" 3.5 1.5 2.4 4.9 5.1 0.8 13.2 1.0 3.8 5.6 31.1 8.9 14.4 2.6 25.3 5.8 8.1 15.8 16.6 26.1 2.9 2.1 1.5 1.0 1.7 4.1 10.2 2.5 9.5 2.0 0.9 5.6 4.9 7.3 19.7 8.0 4.2 8.0 23.1 200.5 3.7 6.5 36.9 8.8 1.7 10.8 3.5 7.6 0.2 9.0 15.1 3.1 24.8 16.1 0.6 0.2 2.9 0.3 4.4 7.6 1.4 1.8 0.3 0.0 0.0 3.8 0.9 0.6 0.3 4.0 0.2 0.4 0.0 1.0 0.0 1.1 2.9 0.1 0.0 0.3 0.3 59.7 1.4 0.0 2.1 0.0 5.2 0.0 0.2 7.7 2.6 0.9 1.1 0.2 0.1 0.5 0.2 0.4 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.6 0.6 0.1 0.4 0.4 6.8 6.9 6.6 0.1 0.2 1.1 0.3 0.4 17.9 6.2 0.8 0.1 4.5 0.0 0.8 2.9 0.3 0.0 3.7 0.2 3.6 0.6 5.1 5.4 0.2 0.6 6.0 7.6 0.2 4.4 0.2 0.1 4.5 1.4 2.4 5.1 1.0 3.8 2.9 2.1 10.2 2.5 7.3 7.6 FBXO39 "CT144, Fbx39, MGC35179" ENSG00000177294 "F-box protein 39" Q8N4B4 17 6776223-6797101 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "testis: 39.2" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 3.4;Karpas-707: 4.6;REH: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 16 "gdT-cell: 1.6" "Lineage enriched" "Detected in single" 16 "T-cells: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.16e-1)" "unprognostic (6.73e-2)" "unprognostic (1.69e-2)" "unprognostic (1.78e-2)" "unprognostic (2.15e-2)" "unprognostic (7.19e-2)" "unprognostic (7.93e-2)" "unprognostic (2.89e-1)" "unprognostic (3.30e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-3)" "unprognostic (2.36e-1)" "unprognostic (3.73e-9)" "unprognostic (5.11e-2)" "unprognostic (2.67e-1)" "unprognostic (5.93e-2)" "unprognostic (3.79e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.1 0.1 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 39.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.0 0.0 0.0 0.3 1.1 0.0 0.0 1.3 0.8 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 1.3 0.0 0.0 0.0 0.0 1.4 0.0 0.7 0.3 0.0 0.2 0.0 1.3 0.0 4.6 0.0 0.0 0.0 0.4 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 FBXW10 "C17orf1, C17orf1A, Fbw10, HREP, SM2SH2" ENSG00000171931 "F-box and WD repeat domain containing 10" Q5XX13 17 18744024-18779349 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 15.9" "Cell line enhanced" "Detected in some" "A549: 5.7;ASC diff: 2.1;CAPAN-2: 3.0;HaCaT: 4.3;HeLa: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA047457 Approved Nucleoplasm Nucleoplasm "HPA047457: " "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "unprognostic (9.59e-2)" "unprognostic (7.47e-2)" "unprognostic (4.54e-1)" "unprognostic (5.08e-2)" "unprognostic (6.67e-2)" "unprognostic (3.89e-1)" "unprognostic (2.30e-1)" "unprognostic (6.30e-2)" "unprognostic (5.65e-2)" "unprognostic (3.49e-2)" "unprognostic (2.20e-7)" "unprognostic (3.16e-1)" "unprognostic (2.32e-1)" "unprognostic (1.30e-2)" "unprognostic (1.05e-1)" 0.1 0.7 0.1 0.1 0.7 0.0 0.1 1.9 0.6 0.6 0.1 0.1 0.1 0.4 0.1 2.1 0.2 0.8 0.4 0.1 0.6 0.3 0.2 1.1 0.3 0.1 0.1 0.8 0.1 0.1 0.1 0.4 0.1 1.6 0.1 0.0 0.4 0.3 0.2 0.8 0.1 0.4 0.1 0.1 0.1 0.3 15.9 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 5.7 0.0 0.1 2.1 1.3 0.1 0.0 0.2 0.0 0.3 0.0 3.0 0.1 0.1 0.4 4.3 0.0 0.0 0.2 0.1 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.4 1.5 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.9 0.6 0.6 0.3 0.1 0.8 1.6 0.1 FBXW12 "Fbw12, FBXO35" ENSG00000164049 "F-box and WD repeat domain containing 12" Q6X9E4 3 48372219-48401259 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "pancreas: 12.4" "Cell line enhanced" "Detected in some" "BEWO: 1.1;HEK 293: 1.7;SH-SY5Y: 1.0;THP-1: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037491, HPA037492" Uncertain "HPA037491: , HPA037492: " "unprognostic (5.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.81e-1)" "unprognostic (1.69e-1)" "unprognostic (1.25e-1)" "unprognostic (1.63e-2)" "unprognostic (8.56e-2)" "unprognostic (2.17e-1)" "unprognostic (9.48e-2)" "unprognostic (2.95e-1)" "unprognostic (1.21e-3)" "unprognostic (6.96e-3)" "unprognostic (2.36e-1)" "unprognostic (6.29e-3)" "unprognostic (1.43e-1)" "unprognostic (1.29e-1)" "unprognostic (8.81e-3)" 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.1 12.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.9 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.2 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.8 1.0 0.0 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.3 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FCER1A FCE1A ENSG00000179639 "Fc fragment of IgE receptor Ia" P12319 1 159289714-159308224 "FDA approved drug targets, Predicted membrane proteins" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "blood: 494.6" "Cell line enriched" "Detected in some" 94 "HEL: 97.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "basophil: 494.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 494.6" "Low region specificity" "Detected in all" "CAB022102, HPA036051, CAB055526" Approved "CAB022102: , CAB055526: , HPA036051: " "unprognostic (1.78e-2)" "unprognostic (2.26e-2)" "unprognostic (7.32e-2)" "unprognostic (7.51e-2)" "unprognostic (1.32e-2)" "unprognostic (1.44e-3)" "unprognostic (7.19e-2)" "unprognostic (1.97e-3)" "unprognostic (2.44e-1)" "unprognostic (7.20e-2)" "unprognostic (8.54e-2)" "unprognostic (2.74e-1)" "prognostic favourable (1.20e-4)" "unprognostic (1.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.70e-1)" "unprognostic (3.39e-2)" 5.8 1.4 1.6 3.6 0.8 6.0 9.2 0.9 1.3 8.0 3.4 1.1 3.4 3.2 10.6 5.6 12.1 2.0 25.4 4.1 4.3 1.3 3.6 2.4 27.8 0.6 1.0 5.3 1.5 2.6 0.5 1.9 0.5 2.7 9.4 5.4 6.5 5.9 4.7 1.2 17.9 4.1 6.0 2.8 3.5 2.3 1.5 6.8 2.4 2.5 19.7 16.2 3.8 4.9 0.0 75.4 494.6 0.3 0.4 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.8 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 494.6 0.3 0.9 0.0 0.1 0.1 0.0 0.1 0.0 75.4 0.0 0.0 0.1 0.4 0.4 0.2 10.4 0.0 3.0 1.6 0.8 0.9 1.3 4.3 1.3 1.0 5.3 2.7 6.8 FCGR3B "CD16, CD16b, FCG3, FCGR3" ENSG00000162747 "Fc fragment of IgG receptor IIIb" O75015 1 161623196-161631963 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "blood: 334.5" "Cell line enhanced" "Detected in single" "K-562: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 95 "neutrophil: 334.5" "Lineage enriched" "Detected in many" 95 "granulocytes: 334.5" "Secreted to blood" "unprognostic (1.60e-1)" "unprognostic (1.36e-1)" "unprognostic (1.59e-3)" "unprognostic (4.16e-2)" "unprognostic (1.15e-1)" "unprognostic (6.52e-2)" "unprognostic (3.97e-2)" "unprognostic (6.96e-3)" "unprognostic (2.53e-2)" "unprognostic (1.02e-1)" "unprognostic (1.07e-1)" "unprognostic (8.67e-2)" "unprognostic (5.16e-2)" "unprognostic (1.35e-1)" "unprognostic (8.37e-3)" "unprognostic (2.28e-1)" "unprognostic (9.24e-2)" 9.9 0.8 1.8 30.8 1.5 13.8 1.5 0.9 1.8 0.9 0.8 0.5 0.2 0.0 0.4 0.5 1.7 2.8 6.8 4.6 1.2 0.9 0.9 2.9 15.2 16.9 5.0 0.5 1.2 1.2 0.0 0.6 4.5 1.9 1.5 0.0 1.3 0.9 0.9 0.8 1.4 0.8 2.0 4.0 44.3 1.3 1.5 0.9 0.6 0.8 0.2 0.9 11.1 4.7 0.0 0.1 334.5 3.5 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.5 0.5 1.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 334.5 0.1 3.5 0.0 0.0 0.5 1.8 1.5 0.9 1.8 1.2 0.9 5.0 0.5 1.9 0.9 FCN2 "EBP-37, FCNL, ficolin-2, P35" ENSG00000160339 "Ficolin 2" Q15485 9 134880812-134887520 "Plasma proteins, Predicted secreted proteins" "Complement activation lectin pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 77.4" "Cell line enhanced" "Detected in some" "RH-30: 1.3;SCLC-21H: 1.1;T-47d: 1.3;U-698: 1.2" "Group enriched" "Detected in some" 8 "breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 6.0;intermediate monocyte: 5.6" "Low lineage specificity" "Detected in many" "Secreted to blood" 8100000000 1800000000 "unprognostic (1.91e-1)" "unprognostic (1.07e-1)" "unprognostic (6.96e-4)" "unprognostic (3.73e-2)" "unprognostic (2.09e-2)" "unprognostic (3.81e-1)" "unprognostic (2.82e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" "unprognostic (1.05e-1)" "unprognostic (3.07e-1)" 2.0 11.4 0.2 0.2 0.2 0.0 4.0 0.2 0.3 0.2 0.3 0.3 0.5 0.0 0.3 0.6 0.2 0.0 0.2 0.5 0.2 0.0 2.2 77.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.5 0.2 0.3 1.5 0.0 0.2 1.4 0.2 0.2 0.0 0.2 0.2 0.2 1.4 0.0 0.3 0.2 0.2 0.9 0.2 0.2 0.3 0.2 0.0 3.3 1.3 6.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.9 0.0 0.0 6.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.3 0.0 2.5 0.0 0.0 7.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.3 0.2 FEM1A ENSG00000141965 "Fem-1 homolog A" Q9BSK4 19 4791681-4801273 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 103.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016565, HPA063622" Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus" Cytosol "HPA016565: AB_1848489, HPA063622: " "unprognostic (4.62e-2)" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (6.75e-2)" "unprognostic (3.60e-1)" "unprognostic (2.42e-3)" "unprognostic (2.04e-1)" "unprognostic (6.74e-2)" "unprognostic (1.25e-2)" "unprognostic (9.21e-2)" "unprognostic (2.28e-3)" "unprognostic (6.25e-2)" "unprognostic (6.18e-5)" "unprognostic (3.72e-3)" "unprognostic (1.25e-1)" "unprognostic (1.91e-1)" "unprognostic (4.70e-2)" 3.0 2.4 3.3 2.2 4.4 3.3 4.0 4.1 5.0 2.0 2.7 3.0 0.9 2.2 2.7 4.0 4.2 2.1 1.9 8.6 3.3 2.6 2.2 4.4 2.3 3.8 3.2 2.5 2.1 4.2 4.4 2.3 4.5 3.1 2.8 2.0 2.7 3.1 2.1 103.9 6.9 2.3 2.3 2.2 2.7 2.2 2.2 3.2 4.2 2.1 18.6 3.0 2.5 2.3 7.2 6.8 9.1 8.2 6.8 6.9 4.2 7.2 5.0 4.7 10.2 5.3 3.1 6.8 4.3 3.6 7.0 4.9 7.8 3.4 8.2 4.5 5.4 7.5 8.2 7.2 4.6 9.7 9.4 8.0 4.0 5.8 7.9 13.2 10.3 4.5 11.1 5.4 7.8 5.0 11.7 15.8 4.8 7.3 11.0 4.9 14.5 12.2 10.3 6.1 8.7 6.3 9.3 15.3 10.9 5.7 10.8 8.1 8.3 11.5 7.0 6.5 4.6 10.0 11.4 18.4 15.2 7.1 6.6 9.6 9.0 9.1 7.3 7.1 6.9 8.2 6.0 5.3 5.5 6.3 6.8 7.2 5.0 5.7 6.6 6.8 7.3 6.6 3.9 4.2 3.3 4.4 4.1 5.0 3.3 2.6 3.2 2.5 3.1 3.2 FER1L5 DKFZp434I0121 ENSG00000249715 "Fer-1 like family member 5" A0AVI2 2 96642737-96704887 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 17.9" "Cell line enhanced" "Detected in some" "A-431: 1.3;AF22: 1.9;BJ hTERT+ SV40 Large T+ RasG12V: 1.4;HSkMC: 1.4;NTERA-2: 1.1;U-87 MG: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.11e-2)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" "unprognostic (3.34e-3)" "unprognostic (5.81e-3)" "unprognostic (2.06e-1)" "unprognostic (1.12e-4)" "unprognostic (4.49e-4)" "unprognostic (1.39e-2)" "unprognostic (6.10e-2)" "unprognostic (1.27e-1)" "unprognostic (1.40e-1)" "unprognostic (2.95e-2)" "unprognostic (2.68e-2)" "unprognostic (2.30e-1)" "unprognostic (2.37e-2)" "unprognostic (1.16e-3)" 0.2 0.2 2.8 0.2 3.7 0.2 1.2 2.0 3.2 0.4 0.2 1.5 1.9 0.2 0.4 1.5 0.3 0.8 0.5 0.3 1.6 0.6 0.2 0.5 0.2 0.0 3.8 0.7 1.3 0.3 3.2 0.5 0.4 1.0 0.2 2.0 0.4 3.0 0.2 0.2 0.2 0.3 0.2 0.3 0.3 17.9 0.6 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 1.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.9 0.5 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 FER1L6 C8ORFK23 ENSG00000214814 "Fer-1 like family member 6" Q2WGJ9 8 123851987-124120061 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "stomach 1: 29.3" "Cell line enhanced" "Detected in some" "AF22: 2.7;ASC TERT1: 4.9;BJ hTERT+: 3.2;PC-3: 4.4;U-87 MG: 4.3" "Group enriched" "Detected in some" 6 "pancreatic cancer: 4.2;stomach cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054117 Enhanced "HPA054117: " "unprognostic (1.90e-1)" "unprognostic (3.08e-3)" "unprognostic (2.06e-3)" "unprognostic (3.91e-2)" "unprognostic (2.09e-1)" "unprognostic (9.49e-3)" "unprognostic (1.36e-1)" "unprognostic (3.83e-1)" "unprognostic (2.66e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (3.32e-2)" "unprognostic (3.23e-6)" "unprognostic (7.09e-2)" "unprognostic (8.43e-2)" "unprognostic (2.79e-3)" "unprognostic (6.39e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 3.1 1.7 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.4 0.0 3.8 0.0 0.0 0.0 29.3 3.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.7 0.0 0.2 4.9 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.9 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.3 4.4 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.1 0.0 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FETUB ENSG00000090512 "Fetuin B" Q9UGM5 3 186635969-186653141 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 76.1" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.5;Hep G2: 4.4;NTERA-2: 1.6" "Cancer enriched" "Detected in some" 12 "liver cancer: 44.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035132 Supported "Secreted to blood" 47505000000 4500000000 "HPA035132: AB_10601650" "unprognostic (9.01e-2)" "unprognostic (1.95e-1)" "unprognostic (4.62e-1)" "unprognostic (8.74e-2)" "unprognostic (6.28e-3)" "unprognostic (1.24e-2)" "unprognostic (7.55e-2)" "unprognostic (9.78e-2)" "unprognostic (1.73e-2)" "unprognostic (9.18e-2)" "unprognostic (1.79e-1)" "unprognostic (8.39e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 76.1 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 2.6 11.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.5 0.0 0.9 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.2 0.6 0.4 0.2 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 FEZ1 UNC-76 ENSG00000149557 "Fasciculation and elongation protein zeta 1" Q99689 11 125445745-125496317 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 123.4" "Cell line enhanced" "Detected in many" "AF22: 39.9;HBEC3-KT: 38.6;NTERA-2: 36.5;SCLC-21H: 39.0" "Cancer enriched" "Detected in all" 10 "glioma: 68.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 30.8;MAIT T-cell: 18.0;memory CD8 T-cell: 8.9;naive CD8 T-cell: 7.7" "Lineage enriched" "Detected in many" 14 "T-cells: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038490, HPA076844" Approved Supported Microtubules,Cytosol Microtubules Cytosol "HPA038490: AB_10672647, HPA076844: " "unprognostic (5.68e-2)" "prognostic unfavourable (9.06e-5)" "unprognostic (7.40e-2)" "unprognostic (3.73e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-2)" "unprognostic (2.72e-1)" "unprognostic (2.06e-1)" "unprognostic (8.30e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-1)" "unprognostic (5.63e-2)" "prognostic unfavourable (2.16e-6)" "unprognostic (2.14e-2)" "unprognostic (2.68e-1)" "unprognostic (3.99e-2)" "unprognostic (1.02e-1)" 6.6 5.6 48.3 4.4 50.1 1.3 4.3 28.2 121.4 6.4 5.1 58.8 0.2 2.9 6.9 4.0 5.9 4.1 9.4 12.4 54.2 38.2 2.7 7.4 10.0 3.5 68.2 29.8 6.0 1.4 5.0 2.3 6.0 43.4 6.6 5.3 1.4 2.4 12.9 1.7 3.5 3.5 13.0 123.4 3.9 2.5 7.2 51.4 0.0 2.2 0.0 2.9 16.8 2.1 0.0 0.4 2.1 0.5 1.0 30.8 5.0 0.0 0.0 39.9 0.0 26.3 24.0 0.0 6.2 8.0 1.5 0.3 0.0 0.0 0.0 7.3 11.7 0.1 18.1 38.6 0.8 3.2 0.2 18.3 0.0 0.0 22.2 0.0 0.1 19.6 8.9 7.2 19.1 17.6 2.4 0.2 1.9 0.9 0.1 0.0 36.5 0.4 0.0 0.0 0.0 0.0 14.0 39.0 4.1 0.1 0.0 0.6 2.9 17.9 15.8 0.1 1.0 0.0 5.2 0.4 0.1 0.0 4.3 0.0 16.8 2.1 0.5 0.0 30.8 0.1 18.0 0.0 1.1 8.9 0.4 0.0 0.4 7.7 0.6 1.0 0.0 0.0 0.0 5.0 48.3 50.1 28.2 97.4 54.2 38.2 68.2 29.8 43.4 51.4 FEZF2 "FEZL, FKSG36, FLJ10142, TOF, Zfp312, ZNF312" ENSG00000153266 "FEZ family zinc finger 2" Q8TBJ5 3 62369681-62374324 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 22.0" "Group enriched" "Detected in some" 5 "AF22: 5.0;NTERA-2: 3.4;U-266/84: 2.3" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Group enriched" "Detected in many" 7 "amygdala: 12.2;basal ganglia: 6.4;cerebral cortex: 11.3;hippocampal formation: 22.0;olfactory region: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 15.6;cerebral cortex: 15.0;hippocampal formation: 26.2" "unprognostic (2.37e-1)" "unprognostic (1.74e-2)" "unprognostic (1.70e-1)" 0.7 0.5 12.2 0.4 6.4 0.4 0.5 0.0 18.0 0.4 1.4 1.8 0.0 0.4 0.5 0.4 0.4 0.5 0.5 0.5 22.0 1.8 0.7 0.5 0.5 0.4 1.1 10.0 0.5 0.4 0.4 0.7 0.5 0.0 0.6 0.4 1.1 0.5 0.5 0.8 0.6 0.5 0.4 0.0 0.8 0.9 0.5 0.3 3.3 0.5 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.6 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 6.4 0.0 11.3 22.0 1.8 1.1 10.0 0.0 0.3 FGA ENSG00000171560 "Fibrinogen alpha chain" P02671 4 154583126-154590766 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity" "Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 740 "liver: 2009.3" "Cell line enriched" "Detected in some" 15 "Hep G2: 94.6" "Cancer enriched" "Detected in many" 43 "liver cancer: 2431.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016776, HPA051370, HPA064755" Supported Approved "Endoplasmic reticulum" "Secreted to blood" 406800000 170000000000 "Endoplasmic reticulum" "CAB016776: , HPA051370: , HPA064755: " "unprognostic (5.95e-2)" "unprognostic (6.25e-2)" "unprognostic (2.02e-1)" "unprognostic (5.68e-2)" "prognostic favourable (7.33e-4)" "unprognostic (1.29e-3)" "unprognostic (1.84e-1)" "prognostic unfavourable (4.23e-6)" "unprognostic (4.20e-1)" "unprognostic (1.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 2.7 2009.3 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 94.6 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 FGB ENSG00000171564 "Fibrinogen beta chain" P02675 4 154562956-154571086 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 189 "liver: 1908.6" "Cell line enriched" "Detected in some" 12 "Hep G2: 75.9" "Cancer enriched" "Detected in many" 42 "liver cancer: 2262.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA001900, HPA001901, CAB008624" Enhanced Enhanced "Endoplasmic reticulum" "Secreted to blood" 120000000000 "Endoplasmic reticulum" "CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864" "unprognostic (1.16e-1)" "unprognostic (3.89e-2)" "unprognostic (4.65e-2)" "unprognostic (3.44e-1)" "unprognostic (2.20e-3)" "unprognostic (1.42e-2)" "unprognostic (1.79e-1)" "prognostic unfavourable (5.72e-5)" "unprognostic (2.48e-2)" "unprognostic (7.91e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.1 1908.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 75.9 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FGF17 FGF-13 ENSG00000158815 "Fibroblast growth factor 17" O60258 8 22042398-22048809 "Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 31.3" "Cell line enhanced" "Detected in some" "HaCaT: 3.2;Hep G2: 2.3;MOLT-4: 2.2;RPMI-8226: 4.4" "Cancer enhanced" "Detected in some" "testis cancer: 3.9" "Region enriched" "Detected in many" 4 "cerebellum: 31.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 2.2" "Low region specificity" "Detected in some" HPA052600 Uncertain "Secreted in brain" "HPA052600: " "unprognostic (3.45e-2)" "unprognostic (1.64e-2)" "unprognostic (3.03e-2)" "unprognostic (1.34e-1)" "unprognostic (1.33e-2)" "unprognostic (3.51e-2)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (7.92e-5)" "unprognostic (6.85e-2)" "unprognostic (2.58e-4)" "unprognostic (6.55e-3)" "unprognostic (7.18e-2)" "unprognostic (2.41e-1)" "unprognostic (1.95e-3)" 0.4 4.9 2.5 0.4 3.2 0.2 0.4 31.3 7.7 0.5 0.4 0.4 0.4 0.2 2.2 0.6 0.4 0.7 0.6 0.4 2.2 4.7 0.4 0.4 0.5 0.4 1.3 2.9 0.5 2.6 3.6 2.1 0.4 3.3 1.2 0.2 0.4 2.4 0.5 0.4 0.9 0.4 1.0 0.9 3.0 0.8 0.6 0.4 1.6 2.3 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.2 0.6 0.6 1.0 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 0.0 0.9 0.7 0.0 2.3 0.1 0.0 1.5 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.7 2.2 0.8 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.0 1.5 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.2 31.3 7.7 2.2 4.7 1.3 2.9 3.3 0.4 FGF18 "FGF-18, ZFGF5" ENSG00000156427 "Fibroblast growth factor 18" O76093 5 171419656-171457623 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "heart muscle: 23.0" "Cell line enriched" "Detected in some" 57 "EFO-21: 65.1" "Group enriched" "Detected in many" 6 "endometrial cancer: 19.0;ovarian cancer: 21.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA018795 Uncertain "Secreted in other tissues" "HPA018795: AB_1848523" "unprognostic (3.01e-1)" "unprognostic (2.38e-2)" "unprognostic (1.23e-1)" "unprognostic (3.66e-3)" "unprognostic (6.62e-3)" "unprognostic (1.50e-1)" "unprognostic (3.20e-2)" "unprognostic (1.72e-2)" "unprognostic (2.98e-3)" "unprognostic (3.65e-2)" "unprognostic (3.18e-2)" "unprognostic (2.29e-1)" "unprognostic (1.37e-8)" "unprognostic (7.33e-2)" "unprognostic (2.58e-1)" "unprognostic (3.19e-1)" "unprognostic (2.76e-2)" 4.4 0.6 0.6 2.8 0.6 0.1 2.0 0.4 1.2 1.3 0.8 0.5 0.0 1.1 1.6 1.5 0.9 2.0 1.4 23.0 0.5 0.4 1.3 0.4 2.9 0.5 0.4 0.0 1.6 0.9 0.1 1.8 0.9 1.6 2.2 0.3 0.3 1.0 0.7 5.4 1.8 2.2 1.2 0.9 1.1 0.7 1.0 0.3 0.2 2.2 2.5 0.8 2.2 0.5 0.9 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 65.1 0.0 0.1 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.6 0.4 1.2 0.5 0.4 0.4 0.0 1.6 0.3 FGF19 ENSG00000162344 "Fibroblast growth factor 19" O95750 11 69698232-69704642 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "gallbladder: 62.4" "Cell line enriched" "Detected in some" 16 "CAPAN-2: 46.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 0.8" "Region enriched" "Detected in single" 18 "basal ganglia: 0.9" HPA036082 Approved "Secreted to blood" 132900 "HPA036082: AB_10669665" "unprognostic (7.46e-3)" "unprognostic (2.43e-3)" "unprognostic (5.52e-3)" "unprognostic (1.22e-1)" "unprognostic (4.68e-3)" "unprognostic (6.45e-2)" "unprognostic (5.72e-3)" "unprognostic (2.26e-1)" "unprognostic (6.39e-3)" "unprognostic (1.66e-2)" "unprognostic (8.82e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.4 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FGF21 ENSG00000105550 "Fibroblast growth factor 21" Q9NSA1 19 48755559-48758333 "Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 113 "liver: 37.8" "Group enriched" "Detected in some" 9 "HHSteC: 3.0;U-2 OS: 10.3" "Cancer enriched" "Detected in single" 315 "liver cancer: 33.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061286 Supported "Secreted to blood" 253850 "HPA061286: " "unprognostic (1.64e-2)" "unprognostic (3.62e-1)" "unprognostic (3.21e-2)" "unprognostic (3.42e-1)" "unprognostic (1.54e-1)" "unprognostic (1.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 3.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 10.3 0.0 0.0 0.1 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FGF3 "HBGF-3, INT2" ENSG00000186895 "Fibroblast growth factor 3" P11487 11 69809969-69819024 "Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "brain: 16.6" "Cell line enriched" "Detected in single" 48 "CAPAN-2: 4.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 38 "cerebellum: 16.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 2.7" "Not detected" "Not detected" HPA012692 Enhanced "Secreted in brain" "HPA012692: AB_1848526" "unprognostic (6.42e-3)" "unprognostic (7.82e-2)" "unprognostic (1.89e-1)" "unprognostic (3.61e-1)" "unprognostic (7.75e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 FGF5 ENSG00000138675 "Fibroblast growth factor 5" P12034 4 80266599-80336680 "Disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Mitogen" "Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 38.2" "Cell line enhanced" "Detected in some" "BJ: 19.7;BJ hTERT+: 37.4;fHDF/TERT166: 26.9;HBF TERT88: 28.1;LHCN-M2: 25.2;U-138 MG: 34.9;U-251 MG: 16.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "cerebellum: 38.2" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB010313, HPA042442" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Secreted in brain" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB010313: AB_2102677, HPA042442: " "unprognostic (6.44e-2)" "unprognostic (6.24e-3)" "unprognostic (8.49e-4)" "unprognostic (1.10e-1)" "unprognostic (2.91e-1)" "unprognostic (2.80e-3)" "unprognostic (6.87e-4)" "unprognostic (2.53e-1)" "unprognostic (1.69e-1)" "unprognostic (3.57e-3)" "unprognostic (1.17e-2)" "unprognostic (3.33e-16)" "unprognostic (3.02e-3)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" 0.1 0.1 0.1 1.7 0.1 0.5 0.1 38.2 1.3 0.1 3.1 0.0 0.0 0.4 0.4 0.1 1.3 0.1 9.2 0.3 1.6 0.2 2.3 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.0 1.3 0.1 4.1 0.2 0.1 0.0 0.1 0.0 0.5 0.4 2.8 2.4 0.3 0.1 0.8 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.7 1.7 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 1.9 7.1 0.0 19.7 37.4 5.2 3.8 0.0 0.0 0.0 0.0 26.9 0.0 0.0 6.9 28.1 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 2.0 0.0 15.3 7.3 1.7 0.0 0.1 25.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 6.4 34.9 1.4 1.7 16.7 0.0 0.0 0.0 2.0 0.0 0.7 1.7 0.3 0.3 0.4 0.2 0.5 0.2 0.3 0.4 0.2 0.7 0.5 0.5 0.9 0.2 0.2 0.7 0.2 0.0 0.1 0.1 38.2 1.3 1.6 0.2 0.2 0.2 4.1 0.1 FGF8 AIGF ENSG00000107831 "Fibroblast growth factor 8" P55075 10 101770130-101780369 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 30.5" "Cell line enriched" "Detected in some" 20 "RH-30: 30.6" "Group enriched" "Detected in some" 8 "endometrial cancer: 2.1;testis cancer: 3.3;urothelial cancer: 0.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted in other tissues" "unprognostic (1.56e-1)" "unprognostic (3.90e-3)" "unprognostic (1.12e-2)" "unprognostic (4.88e-1)" "unprognostic (2.47e-2)" "unprognostic (9.09e-2)" "unprognostic (8.75e-3)" "unprognostic (8.12e-2)" "unprognostic (1.75e-1)" "unprognostic (2.95e-2)" "unprognostic (1.17e-2)" "unprognostic (2.35e-9)" "unprognostic (6.17e-3)" "unprognostic (9.01e-2)" "unprognostic (1.97e-1)" 0.3 0.0 0.6 0.1 0.6 0.0 0.2 0.1 2.2 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.6 0.0 0.1 0.1 1.9 1.9 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 30.5 0.0 0.1 0.1 0.2 0.3 0.0 3.1 0.1 1.1 0.1 0.1 0.1 0.1 0.1 2.1 1.6 4.8 3.0 2.6 2.5 1.3 0.4 0.1 0.2 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.5 0.0 0.4 0.2 0.0 0.0 0.7 0.7 0.2 0.1 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.0 0.3 0.4 1.5 0.1 0.0 0.4 30.6 0.6 0.0 0.2 0.6 0.6 0.0 0.4 0.3 0.5 0.0 0.4 0.5 0.9 0.6 0.1 0.1 0.5 0.9 0.6 0.5 0.6 4.8 1.5 1.8 1.2 1.9 2.5 1.6 1.9 1.5 1.4 2.1 2.4 2.3 4.2 2.6 3.0 1.6 1.7 1.3 0.6 0.6 0.1 2.2 1.9 1.9 0.3 0.1 0.1 0.1 FGFBP3 "C10orf13, MGC39320" ENSG00000174721 "Fibroblast growth factor binding protein 3" Q8TAT2 10 91906589-91909483 "Predicted secreted proteins" "Growth factor binding, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 20.6" "Cell line enriched" "Detected in some" 9 "AF22: 83.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA053943 Uncertain "Secreted in brain" "HPA053943: " "unprognostic (8.66e-2)" "unprognostic (6.00e-2)" "unprognostic (4.47e-2)" "unprognostic (2.88e-1)" "unprognostic (9.98e-3)" "unprognostic (7.76e-2)" "unprognostic (1.43e-1)" "unprognostic (1.96e-2)" "unprognostic (1.06e-1)" "unprognostic (1.12e-1)" "unprognostic (3.39e-3)" "unprognostic (2.61e-1)" "unprognostic (3.90e-1)" "unprognostic (6.95e-2)" "unprognostic (2.85e-1)" "unprognostic (2.63e-1)" "unprognostic (6.76e-3)" 1.4 2.1 6.4 1.4 4.6 1.0 2.0 3.4 20.6 1.3 1.6 4.1 0.3 1.1 1.8 2.8 1.0 1.1 0.6 2.1 6.9 5.9 1.4 0.8 1.1 2.2 4.0 5.6 2.5 1.9 2.0 2.3 0.9 6.7 2.3 1.9 0.5 1.9 1.4 3.3 1.8 1.1 1.0 3.9 1.7 2.2 1.1 4.4 0.9 2.7 0.3 1.2 1.0 0.8 3.7 0.6 2.0 0.5 0.9 1.9 0.2 0.0 0.6 83.8 1.2 0.3 0.1 0.3 0.0 0.0 0.1 0.2 0.2 0.3 0.1 0.1 0.1 0.3 0.5 0.0 0.2 0.3 0.9 1.6 0.6 0.9 0.2 8.9 0.2 0.2 0.1 0.4 0.4 0.0 0.8 0.3 0.0 0.7 1.0 3.6 6.2 0.3 2.6 0.5 0.1 0.1 0.2 0.8 1.1 0.2 0.0 1.4 0.3 0.1 0.1 0.1 0.6 0.1 0.2 0.2 0.5 0.3 0.0 1.0 0.1 2.0 0.5 0.0 1.7 0.1 0.6 2.1 1.1 0.9 0.6 3.7 1.9 1.4 0.0 0.9 0.0 0.3 0.1 0.2 6.4 4.6 3.4 6.4 6.9 5.9 4.0 5.6 6.7 4.4 FGFR3 "ACH, CD333, CEK2, JTK4" ENSG00000068078 "Fibroblast growth factor receptor 3" P22607 4 1793293-1808872 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" Apoptosis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skin 1: 131.7" "Cell line enhanced" "Detected in many" "CACO-2: 19.1;HaCaT: 14.9;Hep G2: 32.1;NTERA-2: 15.6;RT4: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004231, HPA067204" Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" 670000 "Endoplasmic reticulum" "CAB004231: AB_627596, HPA067204: " "unprognostic (1.34e-1)" "unprognostic (5.29e-3)" "unprognostic (1.49e-1)" "prognostic unfavourable (3.77e-4)" "unprognostic (5.90e-2)" "unprognostic (1.24e-3)" "unprognostic (7.22e-2)" "unprognostic (2.54e-1)" "unprognostic (1.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.38e-1)" "unprognostic (2.88e-2)" "unprognostic (1.30e-1)" "unprognostic (9.11e-3)" "unprognostic (1.98e-1)" "unprognostic (4.74e-2)" "unprognostic (1.97e-1)" 1.5 1.5 24.7 1.7 30.3 1.6 4.2 10.2 22.0 4.1 4.9 15.8 3.4 9.9 1.8 2.7 26.9 2.0 5.0 2.0 21.6 11.7 9.6 7.4 4.5 1.3 17.6 21.5 1.1 23.0 1.2 3.0 5.6 15.1 3.7 3.8 1.7 3.8 9.0 1.7 131.7 7.4 1.3 9.0 2.1 4.9 8.1 10.6 0.1 1.3 8.5 7.3 8.5 10.1 0.1 0.6 0.1 0.1 0.2 0.3 0.0 0.0 1.5 9.0 2.6 0.0 0.1 9.2 1.0 0.1 0.4 0.2 19.1 0.4 0.0 7.6 0.3 14.9 2.6 0.1 0.1 0.1 9.6 5.9 1.5 32.1 0.0 0.0 0.1 0.0 5.0 0.1 0.0 0.0 6.4 0.0 0.0 9.5 0.3 0.2 15.6 0.0 0.5 0.5 0.1 1.3 19.1 2.6 0.7 0.8 1.6 0.0 8.9 1.1 0.4 0.0 0.9 0.2 0.6 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.6 0.1 0.0 24.7 30.3 10.2 22.0 21.6 11.7 17.6 21.5 15.1 10.6 FGG ENSG00000171557 "Fibrinogen gamma chain" P02679 4 154604134-154612967 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 495 "liver: 2225.7" "Cell line enriched" "Detected in some" 55 "Hep G2: 125.7" "Cancer enriched" "Detected in many" 19 "liver cancer: 1503.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027529, CAB033120, HPA074638" Supported Approved "Endoplasmic reticulum" "Secreted to blood" 267000000000 68000000000 "Endoplasmic reticulum" "CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: " "unprognostic (1.26e-2)" "unprognostic (4.77e-3)" "unprognostic (6.33e-3)" "unprognostic (3.69e-3)" "unprognostic (2.18e-3)" "unprognostic (9.63e-2)" "unprognostic (7.57e-3)" "prognostic unfavourable (1.00e-6)" "unprognostic (1.75e-3)" "unprognostic (3.21e-1)" "unprognostic (1.14e-1)" 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 2.7 2225.7 4.4 0.0 0.0 0.0 0.2 0.7 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 125.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 FGL1 HFREP-1 ENSG00000104760 "Fibrinogen like 1" Q08830 8 17864380-17910365 "Plasma proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 450.7" "Group enriched" "Detected in some" 15 "A549: 21.7;Hep G2: 51.0" "Cancer enriched" "Detected in some" 40 "liver cancer: 399.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "Secreted to blood" 1800000 "unprognostic (3.62e-2)" "unprognostic (1.14e-2)" "unprognostic (1.75e-5)" "unprognostic (3.00e-1)" "unprognostic (3.54e-2)" "unprognostic (7.89e-2)" "unprognostic (2.15e-1)" "unprognostic (2.62e-1)" "unprognostic (2.71e-1)" "unprognostic (1.09e-2)" "unprognostic (2.86e-7)" "prognostic unfavourable (5.38e-4)" "unprognostic (3.62e-1)" "unprognostic (2.58e-2)" "unprognostic (1.35e-1)" 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 450.7 0.2 0.1 0.1 0.1 0.1 71.3 0.0 0.1 0.6 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 21.7 0.0 2.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 51.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 FHDC1 KIAA1727 ENSG00000137460 "FH2 domain containing 1" Q9C0D6 4 152936352-152979696 "Predicted intracellular proteins" "Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "placenta: 86.7" "Cell line enhanced" "Detected in some" "BEWO: 24.1;RT4: 8.0;SK-BR-3: 11.2;WM-115: 8.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008527 Uncertain "HPA008527: AB_2104099" "unprognostic (5.42e-2)" "unprognostic (8.12e-2)" "unprognostic (2.42e-2)" "unprognostic (1.99e-3)" "unprognostic (1.16e-1)" "unprognostic (2.25e-1)" "unprognostic (2.95e-4)" "unprognostic (1.37e-1)" "unprognostic (2.15e-1)" "unprognostic (1.80e-1)" "unprognostic (1.25e-2)" "unprognostic (2.40e-1)" "prognostic favourable (1.33e-5)" "unprognostic (4.04e-2)" "unprognostic (1.90e-1)" "unprognostic (9.36e-2)" "unprognostic (1.30e-1)" 0.7 0.2 0.5 2.0 4.3 11.3 1.9 2.8 4.4 2.4 4.0 0.5 1.4 3.0 1.8 1.6 8.0 1.1 4.9 0.6 0.9 0.8 1.5 0.4 7.7 0.8 0.9 0.8 1.0 1.8 7.4 3.4 86.7 1.5 6.8 4.3 6.9 4.4 1.4 0.4 11.0 6.7 1.0 0.9 4.4 4.2 1.5 0.7 0.8 15.0 4.6 8.7 1.3 3.8 0.5 0.4 2.8 0.3 1.0 0.3 0.0 4.2 0.4 0.7 0.6 0.4 0.2 24.1 0.3 0.9 0.9 0.1 0.3 2.6 0.2 0.1 0.4 0.9 0.2 1.7 0.3 0.5 0.3 0.4 2.5 0.3 0.1 0.1 0.7 0.1 2.2 0.0 0.5 0.0 1.1 0.5 0.3 2.6 0.1 0.1 4.9 0.3 0.0 0.2 0.1 4.4 8.0 4.3 0.2 1.5 11.2 1.6 1.7 0.3 0.1 0.3 0.8 2.0 1.0 0.6 0.4 0.1 0.2 0.1 8.2 0.6 0.3 0.5 0.2 0.2 0.1 0.3 0.2 0.2 0.1 0.5 0.2 0.3 2.8 1.0 0.2 0.4 0.1 0.0 0.5 4.3 2.8 1.6 0.9 0.8 0.9 0.8 1.5 0.7 FHL5 "ACT, dJ393D12.2, FLJ33049" ENSG00000112214 "Four and a half LIM domains 5" Q5TD97 6 96562548-96616636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 95.7" "Cell line enriched" "Detected in some" 10 "ASC diff: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (6.56e-2)" "unprognostic (9.97e-2)" "unprognostic (2.40e-1)" "unprognostic (1.22e-1)" "prognostic favourable (4.81e-4)" "unprognostic (4.93e-2)" "unprognostic (1.91e-2)" "unprognostic (1.12e-1)" "unprognostic (3.46e-2)" "unprognostic (6.56e-2)" "unprognostic (1.84e-1)" "unprognostic (9.30e-2)" "unprognostic (1.71e-3)" "unprognostic (1.11e-3)" "unprognostic (1.18e-1)" "unprognostic (2.22e-1)" "unprognostic (3.48e-3)" 14.6 4.0 1.7 1.7 2.0 0.0 5.5 1.7 1.9 12.6 1.7 1.7 1.7 0.4 6.1 7.4 3.6 6.3 4.9 1.8 1.7 0.7 2.4 1.7 5.4 1.7 1.7 1.7 4.6 1.7 1.0 1.7 1.7 1.9 1.7 1.6 1.7 1.7 4.4 3.0 1.7 1.7 3.5 1.7 1.7 1.4 95.7 1.7 1.7 3.4 1.7 1.7 2.4 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.0 1.7 1.9 1.7 0.7 1.7 1.7 1.9 1.7 FITM2 "C20orf142, dJ881L22.2, FIT2" ENSG00000197296 "Fat storage inducing transmembrane protein 2" Q8N6M3 20 44302838-44311169 "Predicted membrane proteins" "Deafness, Disease mutation, Dystonia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "heart muscle: 56.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.92e-2)" "unprognostic (7.61e-2)" "unprognostic (2.27e-2)" "unprognostic (2.10e-3)" "unprognostic (1.02e-1)" "unprognostic (3.57e-3)" "unprognostic (1.63e-2)" "unprognostic (3.90e-2)" "unprognostic (8.43e-2)" "unprognostic (5.19e-2)" "unprognostic (6.56e-3)" "unprognostic (1.19e-1)" "prognostic favourable (8.98e-12)" "unprognostic (2.07e-1)" "unprognostic (2.54e-1)" "unprognostic (3.38e-3)" "unprognostic (2.49e-3)" 8.8 9.9 5.0 2.6 5.7 1.2 9.5 7.1 8.2 4.0 4.5 4.3 3.8 3.8 3.7 7.7 3.1 3.5 3.3 56.7 4.9 5.1 7.7 8.0 3.6 2.0 4.7 5.5 4.3 7.8 13.0 4.5 1.9 6.6 5.8 5.3 4.7 5.3 4.2 6.9 4.5 3.7 4.6 4.7 2.5 3.8 3.6 5.1 0.2 5.5 4.4 2.4 3.9 3.8 2.0 2.7 1.7 3.0 3.8 6.2 2.5 4.4 6.9 2.9 4.2 20.9 8.6 3.0 7.3 5.3 5.8 3.2 8.5 3.2 3.1 4.3 8.2 10.1 3.7 4.9 6.3 0.9 1.7 0.9 4.3 14.2 4.4 1.9 2.6 6.5 11.2 4.0 3.1 4.1 1.7 9.1 5.8 13.9 0.7 2.1 0.7 8.9 1.2 5.5 3.0 3.3 4.2 1.8 2.1 15.5 8.7 6.5 10.7 1.5 5.0 18.6 8.3 10.7 4.3 3.4 8.7 0.8 8.2 3.1 9.2 1.4 3.0 1.7 3.4 2.7 3.5 1.8 3.6 2.8 2.7 2.0 6.2 4.8 1.4 3.8 2.1 1.7 3.2 2.5 5.0 5.7 7.1 8.2 4.9 5.1 4.7 5.5 6.6 5.1 FKBP4 "FKBP52, FKBP59" ENSG00000004478 "FK506 binding protein 4" Q02790 12 2794953-2805423 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Chaperone, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "vagina: 209.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006148, CAB017441, HPA062857" Approved Enhanced Nucleoplasm,Cytosol 110000 Cytosol Nucleoplasm "CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: " "unprognostic (1.46e-2)" "unprognostic (1.73e-2)" "unprognostic (1.31e-2)" "prognostic unfavourable (7.65e-4)" "unprognostic (1.97e-1)" "unprognostic (1.07e-1)" "prognostic unfavourable (6.12e-5)" "prognostic unfavourable (1.44e-4)" "unprognostic (3.43e-1)" "unprognostic (3.25e-2)" "unprognostic (1.72e-1)" "unprognostic (3.14e-1)" "unprognostic (3.89e-2)" "unprognostic (1.59e-2)" "unprognostic (1.76e-1)" "unprognostic (1.59e-1)" "unprognostic (2.22e-1)" 16.2 21.6 26.0 13.7 30.7 13.3 40.7 50.4 31.9 19.9 22.6 22.8 36.2 13.1 20.1 30.7 34.2 25.7 16.4 20.4 25.0 32.5 31.6 31.3 15.8 11.7 44.7 23.4 23.9 30.3 30.1 19.5 32.0 39.4 30.2 25.3 11.5 30.1 31.6 33.5 25.3 16.1 26.4 25.2 11.5 25.3 36.0 42.1 15.6 47.1 16.5 18.5 17.4 209.6 13.8 6.0 10.9 13.7 8.4 14.0 9.9 15.5 34.6 10.0 16.8 12.5 7.4 48.1 15.3 5.5 25.3 17.2 34.4 19.0 20.8 4.4 9.8 21.3 62.3 20.7 30.5 38.0 39.9 22.9 25.5 12.2 9.6 17.9 6.2 6.7 19.0 29.9 30.0 14.7 21.0 29.7 10.1 44.7 31.3 16.2 85.5 25.0 18.8 17.6 12.4 21.3 19.9 14.5 20.8 17.7 48.4 7.7 65.3 12.1 7.8 12.5 39.3 14.0 38.5 7.4 11.3 30.7 11.1 26.7 12.7 10.9 10.8 5.9 12.5 9.8 14.0 13.3 11.1 11.8 6.0 13.8 11.8 13.7 1.5 8.4 13.7 5.3 10.1 9.9 26.0 30.7 50.4 31.9 25.0 32.5 44.7 23.4 39.4 42.1 FKBP6 "FKBP36, PPIase" ENSG00000077800 "FK506 binding protein 6" O75344 7 73328164-73358637 "Disease related genes, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 33.0" "Cell line enhanced" "Detected in some" "HMC-1: 1.3;Karpas-707: 1.4;SiHa: 2.1;U-266/84: 1.3" "Cancer enriched" "Detected in single" 9 "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA061109 Enhanced "HPA061109: AB_2684430" "unprognostic (5.07e-2)" "unprognostic (3.34e-2)" "unprognostic (1.56e-1)" "unprognostic (1.91e-1)" "unprognostic (1.05e-1)" "unprognostic (3.98e-2)" "unprognostic (8.72e-3)" "unprognostic (4.34e-2)" "unprognostic (1.51e-1)" "unprognostic (3.60e-1)" "unprognostic (4.29e-2)" "unprognostic (1.48e-1)" "unprognostic (6.20e-2)" "unprognostic (9.15e-2)" "unprognostic (2.47e-1)" "unprognostic (6.86e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.6 0.8 0.3 0.0 0.0 0.0 0.6 0.0 0.3 0.3 0.3 2.1 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.8 0.2 0.7 1.3 0.0 0.4 0.3 0.3 0.5 0.3 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FLG2 IFPS ENSG00000143520 "Filaggrin family member 2" Q5D862 1 152348735-152360006 "Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 107.4" "Cell line enhanced" "Detected in single" "HaCaT: 1.7" "Cancer enriched" "Detected in some" 8 "melanoma: 7.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" HPA028699 Approved 19000000 "HPA028699: AB_10601905" "unprognostic (2.58e-1)" "unprognostic (2.33e-1)" "unprognostic (3.08e-1)" "unprognostic (6.85e-2)" "unprognostic (6.59e-3)" "unprognostic (1.34e-1)" "unprognostic (2.25e-1)" "unprognostic (1.09e-1)" "unprognostic (2.08e-2)" "unprognostic (1.12e-1)" "unprognostic (1.96e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 7.7 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.6 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.3 107.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 2.9 0.1 19.6 0.4 0.1 0.2 0.3 0.3 1.2 0.2 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.7 0.2 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.3 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 1.2 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.2 0.3 0.9 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 FLNC "ABP-280, ABPL, FLN2" ENSG00000128591 "Filamin C" Q14315 7 128830377-128859274 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Actin-binding "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 546.8" "Cell line enhanced" "Detected in many" "BJ: 78.6;fHDF/TERT166: 35.8;hTEC/SVTERT24-B: 38.9;U-2 OS: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006135 Enhanced Supported "Plasma membrane,Cytosol" 54000000 "Plasma membrane, Cytosol" "HPA006135: AB_1848602" "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" "unprognostic (4.47e-2)" "unprognostic (1.40e-2)" "prognostic unfavourable (2.80e-4)" "unprognostic (1.64e-3)" "unprognostic (4.42e-3)" "prognostic unfavourable (2.17e-5)" "unprognostic (1.03e-3)" "unprognostic (2.35e-2)" "unprognostic (1.35e-3)" "unprognostic (6.37e-2)" "prognostic unfavourable (5.69e-4)" "unprognostic (5.68e-3)" "unprognostic (1.15e-1)" "unprognostic (1.52e-3)" "prognostic unfavourable (3.73e-5)" 2.6 0.8 0.5 7.1 0.7 0.2 0.7 0.3 1.0 5.2 24.4 1.4 18.4 1.9 14.0 10.1 16.0 4.8 13.3 70.0 0.8 0.5 0.4 0.3 1.4 0.3 1.4 0.5 3.1 0.6 1.0 0.3 0.6 1.9 11.9 2.1 1.7 3.1 20.2 546.8 1.0 5.2 69.0 4.7 0.3 10.0 1.3 0.6 0.0 4.7 40.0 2.2 39.6 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 7.1 8.6 0.8 78.6 14.9 22.4 10.8 24.4 0.2 0.0 13.3 35.8 0.0 4.8 0.1 13.3 0.0 2.6 0.0 4.0 0.0 9.0 0.0 0.0 16.3 0.0 38.9 0.0 13.9 9.4 0.0 15.2 0.0 0.0 0.3 13.1 4.5 0.0 26.0 0.2 0.0 0.0 0.4 1.4 0.1 0.0 0.0 0.1 0.3 28.8 7.8 33.6 2.0 0.0 0.0 0.0 0.0 26.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.6 0.8 0.5 1.4 0.5 1.9 0.6 FLT1 "FLT, VEGFR1" ENSG00000102755 "Fms related tyrosine kinase 1" P17948 13 28300344-28495145 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "placenta: 155.3" "Cell line enhanced" "Detected in some" "BJ: 17.0;BJ hTERT+: 13.5;HMC-1: 84.6;HUVEC TERT2: 15.3;WM-115: 30.3" "Cancer enhanced" "Detected in all" "renal cancer: 28.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1" "Group enriched" "Detected in many" 5 "B-cells: 3.7;granulocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011740, HPA014290, CAB068189, CAB068190" Enhanced Supported "Plasma membrane,Actin filaments" "Secreted to blood" 875697 54000 "Plasma membrane, Actin filaments" "CAB068189: , CAB068190: , HPA011740: AB_1858737, HPA014290: AB_1858738" "unprognostic (3.33e-2)" "unprognostic (3.52e-3)" "unprognostic (1.13e-3)" "unprognostic (5.02e-2)" "unprognostic (3.65e-1)" "unprognostic (5.03e-2)" "unprognostic (8.25e-2)" "unprognostic (2.27e-3)" "unprognostic (9.91e-2)" "unprognostic (6.61e-2)" "unprognostic (2.33e-1)" "unprognostic (1.57e-1)" "prognostic unfavourable (2.19e-4)" "unprognostic (4.20e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (6.32e-2)" 18.9 4.0 9.9 4.0 14.3 1.2 13.5 8.0 15.9 7.1 4.6 3.5 1.7 3.5 7.2 2.2 3.4 4.0 6.9 18.3 11.4 7.3 10.3 7.6 12.3 2.5 10.3 3.2 5.1 5.4 13.4 3.7 155.3 13.8 5.1 3.1 9.1 3.0 5.0 12.5 2.6 3.4 7.3 9.6 7.2 4.6 6.8 10.2 0.0 19.1 3.8 2.8 7.6 9.2 3.7 0.5 2.1 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.0 17.0 13.5 6.2 3.6 0.0 0.0 0.0 0.0 2.2 0.0 1.6 0.0 11.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 84.6 0.1 0.0 0.0 0.2 15.3 0.4 0.0 0.0 0.0 1.0 0.8 9.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.1 0.0 30.3 0.2 0.1 0.1 0.1 0.1 0.0 1.1 0.1 0.1 0.0 3.7 0.4 0.4 2.1 0.2 0.1 0.5 0.2 0.2 9.9 14.3 8.0 15.9 11.4 7.3 10.3 3.2 13.8 10.2 FMO1 ENSG00000010932 "Flavin containing monooxygenase 1" Q01740 1 171248471-171285978 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 70.4" "Cell line enriched" "Detected in some" 7 "HSkMC: 21.5" "Cancer enriched" "Detected in many" 8 "renal cancer: 18.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 36 "naive B-cell: 3.5" "Lineage enriched" "Detected in single" 36 "B-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA023680 Uncertain "HPA023680: AB_1848966" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" "unprognostic (5.87e-2)" "unprognostic (1.34e-1)" "unprognostic (5.32e-3)" "unprognostic (1.89e-2)" "unprognostic (1.04e-1)" "unprognostic (4.04e-1)" "unprognostic (9.16e-2)" "unprognostic (9.03e-2)" "unprognostic (1.36e-2)" "unprognostic (2.23e-1)" "prognostic favourable (2.81e-4)" "unprognostic (6.49e-4)" "unprognostic (1.40e-1)" "unprognostic (3.58e-1)" "unprognostic (1.37e-1)" 3.4 3.6 0.1 0.1 0.3 0.0 5.6 0.1 0.4 5.6 0.8 0.3 0.8 0.0 2.5 3.0 5.0 3.3 1.8 0.9 0.1 0.0 70.4 1.0 0.8 0.1 0.1 0.1 5.9 2.4 0.1 1.1 0.8 0.2 1.1 0.0 4.0 4.2 1.5 0.1 4.0 14.4 1.5 0.1 0.1 0.5 1.6 0.1 1.8 1.7 5.3 10.3 1.4 1.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.2 0.1 FMO3 ENSG00000007933 "Flavin containing monooxygenase 3" P31513 1 171090877-171117819 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 170.2" "Group enriched" "Detected in some" 4 "ASC diff: 24.8;ASC TERT1: 18.8" "Cancer enriched" "Detected in many" 13 "liver cancer: 94.9" "Region enriched" "Detected in single" 5 "pons and medulla: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA013750 Enhanced "HPA013750: AB_1848968" "unprognostic (1.87e-2)" "unprognostic (6.30e-2)" "unprognostic (1.00e-1)" "unprognostic (6.81e-3)" "unprognostic (2.64e-1)" "unprognostic (1.31e-3)" "prognostic favourable (3.46e-4)" "prognostic favourable (5.60e-5)" "unprognostic (2.95e-1)" "unprognostic (9.34e-2)" "unprognostic (3.02e-1)" "unprognostic (7.21e-2)" "prognostic unfavourable (1.13e-4)" "unprognostic (1.84e-1)" "unprognostic (2.59e-1)" "unprognostic (3.45e-1)" "unprognostic (7.27e-2)" 9.5 2.0 0.0 0.8 0.2 0.0 1.3 0.1 0.1 0.2 0.8 0.1 0.1 0.3 0.6 1.2 1.7 2.3 0.3 0.8 0.0 0.1 6.4 170.2 3.7 1.5 0.2 0.0 0.9 0.7 0.3 2.7 0.0 1.4 0.2 0.1 3.6 0.9 0.1 1.9 0.8 0.4 0.2 0.1 0.1 0.6 0.5 0.1 0.0 0.8 1.2 2.6 0.2 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 18.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.2 0.0 1.4 0.1 FMR1NB "CT37, FLJ25736, NY-SAR-35" ENSG00000176988 "FMR1 neighbor" Q8N0W7 X 147981329-148026667 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 87 "testis: 38.0" "Group enriched" "Detected in some" 23 "U-266/70: 34.3;U-266/84: 26.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011284, CAB026403" Enhanced "CAB026403: , HPA011284: AB_1078898" "unprognostic (2.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.83e-1)" "unprognostic (4.38e-2)" "unprognostic (4.11e-3)" "unprognostic (2.85e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FNDC11 "C20orf195, MGC5356" ENSG00000125531 "Fibronectin type III domain containing 11" Q9BVV2 20 63547891-63556708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 52.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.4;EFO-21: 4.9;HaCaT: 2.7;SH-SY5Y: 5.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 3.2;naive B-cell: 6.6" "Lineage enriched" "Detected in many" 6 "B-cells: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA041341 Approved Nucleoplasm,Vesicles,Aggresome "Nucleoplasm, Vesicles" Aggresome "HPA041341: AB_10794991" "unprognostic (2.01e-1)" "unprognostic (6.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (9.99e-3)" "unprognostic (7.94e-2)" "unprognostic (8.30e-4)" "unprognostic (3.68e-1)" "unprognostic (8.33e-2)" "unprognostic (3.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (3.75e-1)" "unprognostic (6.81e-2)" 0.1 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 2.2 0.2 1.1 0.2 0.1 0.1 0.3 0.2 0.1 0.5 0.4 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.3 52.5 0.2 0.1 0.1 0.1 0.3 0.2 0.2 6.6 0.0 1.0 0.0 0.0 0.8 0.2 0.3 0.0 1.8 0.0 0.1 0.1 0.0 0.3 0.6 0.0 0.0 0.1 9.4 0.5 4.9 0.1 2.7 0.2 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.0 1.2 0.0 0.2 0.7 0.0 0.9 0.7 0.0 0.0 1.0 0.0 0.1 0.2 0.8 0.0 0.0 0.1 1.7 0.0 0.4 5.9 0.0 0.0 0.3 0.1 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.6 0.3 0.0 0.0 1.0 0.1 0.0 0.0 3.2 0.2 0.6 0.0 6.6 0.4 0.2 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.4 0.2 FNDC8 DKFZp434H2215 ENSG00000073598 "Fibronectin type III domain containing 8" Q8TC99 17 35121579-35130732 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 41 "testis: 85.2" "Cell line enhanced" "Detected in some" "HEK 293: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0" "Group enriched" "Detected in many" 15 "B-cells: 1.3;T-cells: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA026521 Supported "HPA026521: AB_2106163" "unprognostic (1.45e-1)" "unprognostic (6.58e-2)" "unprognostic (2.32e-1)" "unprognostic (1.17e-1)" "unprognostic (1.25e-2)" "unprognostic (2.10e-1)" "unprognostic (5.88e-2)" "unprognostic (1.91e-1)" "unprognostic (2.02e-1)" "unprognostic (1.70e-1)" "unprognostic (8.43e-2)" "unprognostic (3.48e-3)" "unprognostic (9.02e-2)" "unprognostic (6.41e-3)" "unprognostic (1.09e-2)" "unprognostic (1.47e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 2.0 0.2 0.7 2.2 0.8 0.6 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 2.5 0.4 0.0 0.3 0.2 0.0 0.0 0.6 4.3 0.1 0.7 0.2 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.1 0.4 1.8 1.1 0.6 0.4 2.6 1.2 2.5 0.0 0.7 0.5 0.7 0.9 0.6 0.4 0.5 0.7 0.0 0.0 0.2 0.7 0.9 1.7 2.1 2.4 0.2 0.7 0.6 0.0 0.1 0.0 0.2 0.1 1.3 0.6 0.6 0.0 0.0 1.3 2.0 0.7 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 FNTB FPTB ENSG00000257365 "Farnesyltransferase, CAAX box, beta" P49356 14 64986720-65062652 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 75.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062743 Uncertain Approved Centrosome Centrosome "HPA062743: " "unprognostic (2.79e-1)" "unprognostic (1.50e-2)" "unprognostic (1.54e-1)" "unprognostic (8.57e-3)" "unprognostic (1.88e-1)" "unprognostic (6.88e-2)" "prognostic unfavourable (6.03e-4)" "unprognostic (6.21e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-2)" "unprognostic (1.70e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-3)" "unprognostic (2.36e-2)" "unprognostic (3.60e-1)" "unprognostic (5.56e-2)" "unprognostic (1.11e-3)" 7.4 9.0 6.3 4.9 21.9 2.3 7.8 11.4 13.7 8.0 6.3 24.3 6.2 5.6 6.4 6.6 13.5 9.0 5.1 12.0 8.1 7.9 8.0 5.6 7.0 5.1 34.0 7.2 7.4 5.9 13.6 7.9 8.2 25.4 8.9 7.9 4.4 8.0 9.6 14.3 10.3 5.1 11.6 75.0 4.6 5.7 9.0 22.2 4.7 5.6 5.8 7.3 7.4 7.8 2.4 6.4 12.3 10.3 2.8 8.8 5.3 18.3 13.4 10.4 5.9 6.7 5.9 7.6 10.6 7.8 12.0 12.4 7.1 7.6 3.1 6.1 11.2 12.2 25.0 8.3 9.9 4.4 7.0 12.4 3.6 10.3 4.4 4.2 17.2 5.0 7.2 5.2 2.8 10.0 6.7 4.5 7.0 12.1 6.4 7.0 4.5 13.6 6.3 9.7 3.9 8.3 6.8 6.6 6.6 6.6 13.0 14.4 12.0 7.4 7.9 8.7 18.0 3.9 6.8 2.3 2.6 3.2 10.1 5.5 20.1 12.3 10.3 9.2 3.6 8.6 8.8 2.4 5.5 4.3 6.4 1.9 4.5 3.3 2.7 2.8 4.3 4.9 5.1 5.3 6.3 21.9 11.4 13.7 8.1 7.9 34.0 7.2 25.4 22.2 FOCAD "FLJ20375, KIAA1797" ENSG00000188352 Focadhesin Q5VW36 9 20658309-20995955 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 62.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "pons and medulla: 62.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055015 Uncertain Uncertain Mitochondria Mitochondria "HPA055015: " "unprognostic (3.05e-2)" "unprognostic (1.02e-1)" "prognostic favourable (3.25e-4)" "unprognostic (3.69e-3)" "unprognostic (4.14e-2)" "unprognostic (5.35e-2)" "prognostic unfavourable (4.41e-5)" "unprognostic (9.64e-2)" "unprognostic (7.38e-2)" "unprognostic (1.23e-1)" "unprognostic (5.26e-2)" "unprognostic (9.15e-2)" "prognostic favourable (3.09e-8)" "unprognostic (1.90e-1)" "unprognostic (2.33e-1)" "unprognostic (3.99e-2)" "unprognostic (1.41e-2)" 3.6 9.0 4.5 3.6 7.2 1.9 3.9 8.7 9.0 4.9 4.8 15.0 3.6 1.8 3.9 6.3 3.6 7.4 3.6 5.3 7.1 7.3 3.8 3.6 3.7 3.6 4.4 3.6 3.6 5.5 10.4 11.8 4.1 62.1 5.6 5.6 6.8 5.8 3.7 5.1 4.2 3.6 4.7 3.6 3.6 4.2 3.6 3.6 3.6 11.8 3.6 3.6 3.6 3.6 3.4 6.9 8.9 5.7 4.5 7.1 3.1 16.1 11.2 12.2 9.1 11.4 13.1 6.4 9.6 15.4 6.8 7.9 7.4 5.6 6.6 5.1 13.7 5.6 10.5 19.0 12.0 29.4 7.8 5.2 13.8 9.1 5.9 8.6 6.7 12.1 13.1 6.8 11.2 26.1 0.1 9.8 11.4 6.2 6.4 16.2 9.6 11.3 0.0 5.5 4.4 10.6 7.0 8.1 4.1 6.3 10.9 2.6 6.8 5.0 15.9 0.0 4.5 7.5 8.7 2.4 13.5 7.5 0.0 12.1 4.0 8.9 2.8 8.0 5.3 5.7 7.1 2.7 4.7 5.1 6.9 3.4 4.2 5.0 2.2 4.5 3.1 2.8 4.3 3.1 4.5 7.2 8.7 9.0 7.1 7.3 4.4 3.6 62.1 3.6 FOXB1 "FKH5, HFKH-5" ENSG00000171956 "Forkhead box B1" Q99853 15 60004222-60061730 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 16.7" "Group enriched" "Detected in some" 4 "AF22: 7.0;HDLM-2: 15.2;HEK 293: 11.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Region enhanced" "Detected in many" "pons and medulla: 16.7" "Cell type enriched" "Detected in single" 4 "T-reg: 3.8" "Lineage enriched" "Detected in single" 38 "T-cells: 3.8" "Region enhanced" "Detected in some" "hypothalamus: 7.7" "Low region specificity" "Detected in many" HPA073369 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA073369: " "unprognostic (1.69e-1)" "unprognostic (3.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.40e-3)" "unprognostic (1.33e-3)" "unprognostic (1.17e-2)" "unprognostic (1.47e-2)" "unprognostic (5.32e-4)" "unprognostic (1.06e-1)" "unprognostic (9.21e-2)" "unprognostic (3.21e-1)" "unprognostic (8.12e-9)" "unprognostic (8.74e-2)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" 0.0 0.0 0.3 0.5 4.1 0.2 0.2 0.6 0.0 0.1 0.1 0.6 0.0 0.0 0.6 0.0 0.2 0.9 0.1 0.2 0.1 6.2 0.0 0.1 0.1 1.8 6.5 0.0 0.0 0.4 0.0 0.0 1.9 16.7 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 8.4 0.1 1.8 2.6 3.7 0.0 0.1 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 2.6 0.0 7.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.2 11.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.3 4.1 0.6 0.0 0.1 6.2 6.5 0.0 16.7 3.7 FOXE1 "FKHL15, FOXE2, HFKH4, TITF2, TTF-2" ENSG00000178919 "Forkhead box E1" O00358 9 97853254-97856715 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "thyroid gland: 115.1" "Cell line enhanced" "Detected in some" "A-431: 10.7;BJ hTERT+: 6.7;HaCaT: 6.2;HeLa: 15.9;RPTEC TERT1: 15.8;SiHa: 11.6" "Cancer enhanced" "Detected in some" "thyroid cancer: 84.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "basal ganglia: 0.4" "unprognostic (8.78e-3)" "unprognostic (9.18e-3)" "unprognostic (3.79e-5)" "unprognostic (2.19e-4)" "unprognostic (8.29e-3)" "unprognostic (1.04e-1)" "unprognostic (7.65e-2)" "unprognostic (1.39e-1)" "unprognostic (3.11e-1)" "unprognostic (3.86e-1)" "unprognostic (6.05e-5)" "unprognostic (8.41e-2)" "unprognostic (1.86e-1)" "unprognostic (6.59e-2)" "unprognostic (1.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 115.1 4.7 20.4 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.2 0.0 10.7 3.6 0.0 0.0 0.0 0.0 0.0 1.0 6.7 0.8 1.1 0.0 0.9 0.0 0.4 0.0 6.2 0.7 0.1 3.3 0.0 0.5 0.0 15.9 0.0 0.0 0.0 1.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 15.8 1.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXG1 "BF1, FKH2, FKHL1, FKHL2, FKHL3, FKHL4, FOXG1A, FOXG1B, FOXG1C, HBF-3, HFK1, HFK2, HFK3, QIN" ENSG00000176165 "Forkhead box G1" P55316 14 28760330-28770277 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 32.4" "Cell line enhanced" "Detected in some" "HEK 293: 8.3;SCLC-21H: 21.6;U-138 MG: 13.3;U-251 MG: 13.3" "Cancer enriched" "Detected in some" 10 "glioma: 15.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "amygdala: 34.1;basal ganglia: 45.4;cerebral cortex: 40.1;hippocampal formation: 49.3;olfactory region: 31.7" "Group enriched" "Detected in many" 5 "amygdala: 84.2;basal ganglia: 118.5;cerebral cortex: 107.8;hippocampal formation: 165.6;olfactory region: 132.9" "unprognostic (2.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.92e-1)" "unprognostic (3.49e-1)" "unprognostic (1.17e-3)" "unprognostic (2.14e-2)" "unprognostic (1.27e-11)" "unprognostic (4.10e-2)" "unprognostic (1.08e-1)" "unprognostic (1.60e-2)" 0.8 0.8 15.0 0.8 22.4 0.8 0.8 0.0 32.4 0.8 0.8 8.3 0.0 0.8 0.8 0.8 1.2 0.8 0.8 0.8 16.7 2.2 0.8 0.8 0.8 1.5 1.0 14.2 1.3 0.8 0.9 2.1 0.8 0.0 0.8 0.8 0.0 0.8 0.8 0.8 0.8 0.8 0.8 0.0 0.8 0.8 5.4 7.8 0.0 0.8 0.0 0.9 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 3.4 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.9 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 1.3 13.3 0.0 0.0 0.0 4.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 15.0 22.4 0.0 18.8 16.7 2.2 1.0 14.2 0.0 7.8 FOXN4 ENSG00000139445 "Forkhead box N4" Q96NZ1 12 109277979-109309220 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.1" "Cell line enhanced" "Detected in some" "HEK 293: 2.4;SCLC-21H: 6.3;SH-SY5Y: 6.5;U-266/70: 8.9" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Region enriched" "Detected in single" 11 "basal ganglia: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050018 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "HPA050018: " "unprognostic (1.09e-3)" "unprognostic (9.63e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (2.52e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (7.93e-3)" "unprognostic (2.30e-1)" "unprognostic (1.02e-3)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (6.00e-2)" 0.2 0.0 0.1 0.1 2.7 0.0 0.1 0.2 0.1 1.4 0.3 0.1 0.1 0.0 0.6 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.2 0.9 2.3 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.4 0.1 0.4 0.1 0.1 0.0 13.1 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 6.3 6.5 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.0 8.9 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 FOXR1 "DLNB13, FOXN5" ENSG00000176302 "Forkhead box R1" Q6PIV2 11 118971707-118981291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 8.9" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;HaCaT: 1.3;RT4: 1.1;U-937: 1.1" "Cancer enriched" "Detected in single" 34 "testis cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.84e-2)" "unprognostic (4.80e-2)" "unprognostic (1.16e-1)" "unprognostic (1.52e-1)" "unprognostic (1.47e-1)" 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FOXR2 "FOXN6, MGC21658" ENSG00000189299 "Forkhead box R2" Q6PJQ5 X 55623400-55625325 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 6.0" "Group enriched" "Detected in some" 114 "NTERA-2: 11.4;SH-SY5Y: 10.1;U-266/70: 6.7;U-266/84: 17.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA034487, HPA057358" Uncertain Supported Nucleoplasm Nucleoplasm "HPA034487: AB_10795354, HPA057358: AB_2683418" "unprognostic (3.81e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRZB "FRE, FRITZ, FRP-3, FRZB-1, FRZB-PEN, FRZB1, FZRB, hFIZ, SFRP3, SRFP3" ENSG00000162998 "Frizzled related protein" Q92765 2 182833275-182867162 "Disease related genes, Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "retina: 265.8" "Cell line enhanced" "Detected in some" "AF22: 17.3;ASC diff: 8.4;NTERA-2: 7.0;SH-SY5Y: 6.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "pons and medulla: 21.7" "Group enriched" "Detected in some" 9 "memory B-cell: 3.0;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 12 "B-cells: 3.0" "Region enhanced" "Detected in many" "olfactory region: 69.9" "Low region specificity" "Detected in all" "Secreted in other tissues" 27000 "unprognostic (5.39e-2)" "unprognostic (1.48e-2)" "unprognostic (1.18e-1)" "unprognostic (1.79e-2)" "unprognostic (1.93e-1)" "unprognostic (2.09e-3)" "unprognostic (1.64e-2)" "unprognostic (2.38e-2)" "unprognostic (4.67e-2)" "unprognostic (8.58e-2)" "unprognostic (5.41e-2)" "unprognostic (2.34e-1)" "prognostic unfavourable (8.97e-6)" "unprognostic (3.53e-2)" "unprognostic (1.05e-2)" "unprognostic (6.04e-2)" "unprognostic (3.21e-1)" 4.4 1.4 2.8 4.8 5.4 0.0 5.1 2.9 3.5 7.1 5.1 3.3 2.6 4.5 5.5 3.5 3.6 2.8 12.9 8.4 2.8 2.8 5.5 2.2 3.7 4.8 3.6 3.4 4.4 2.4 0.6 11.3 44.3 21.7 4.0 6.6 265.8 5.1 5.4 8.4 4.3 4.7 10.5 2.9 28.2 12.0 4.2 2.3 3.1 5.0 3.1 3.4 3.5 6.2 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 17.3 0.2 8.4 0.2 0.1 0.0 0.8 3.0 2.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.7 0.6 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 7.0 0.0 0.6 0.7 0.0 0.0 0.0 1.1 6.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 5.4 2.9 3.5 2.8 2.8 3.6 3.4 21.7 2.3 FSCB "C14orf155, DKFZP434F1017" ENSG00000189139 "Fibrous sheath CABYR binding protein" Q5H9T9 14 44504342-44507279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 27.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003546 Supported "HPA003546: AB_1845561" "unprognostic (8.13e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FSCN3 ENSG00000106328 "Fascin actin-bundling protein 3" Q9NQT6 7 127591409-127602144 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "testis: 62.1" "Cell line enhanced" "Detected in some" "hTCEpi: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA075174 Enhanced "HPA075174: " "unprognostic (7.77e-2)" "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (9.59e-2)" "unprognostic (1.39e-1)" "unprognostic (3.87e-1)" "unprognostic (5.69e-2)" "unprognostic (1.50e-1)" "unprognostic (2.91e-3)" "unprognostic (2.00e-1)" "unprognostic (1.68e-4)" "unprognostic (1.34e-1)" "unprognostic (1.14e-5)" "unprognostic (1.27e-1)" "unprognostic (9.21e-3)" "unprognostic (2.01e-1)" "unprognostic (7.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 62.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.3 0.0 0.0 0.3 0.0 0.0 1.0 0.3 0.8 0.0 0.0 1.4 0.1 0.4 0.3 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 2.4 0.6 0.0 0.0 0.3 0.6 0.0 0.7 0.7 0.7 1.3 0.0 0.5 0.7 0.2 0.0 0.5 0.2 0.3 0.0 1.4 0.0 0.0 0.6 0.0 0.0 0.1 0.5 0.0 0.8 0.3 0.7 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FSHB ENSG00000131808 "Follicle stimulating hormone beta subunit" P01225 11 30231016-30235261 "Cancer-related genes, Disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 90 "pituitary gland: 70.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB023410, HPA069703" Enhanced "Secreted to blood" 47000 "CAB023410: AB_324983, HPA069703: " "unprognostic (1.04e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 70.7 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.5 0.0 0.0 0.3 0.3 0.0 FSIP2 FLJ34780 ENSG00000188738 "Fibrous sheath interacting protein 2" Q5CZC0 2 185738895-185833290 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 27.6" "Cell line enhanced" "Detected in some" "AF22: 2.7;HeLa: 2.2;Karpas-707: 2.8;RT4: 4.7;U-266/70: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA036139 Approved Microtubules,Mitochondria Microtubules Mitochondria "HPA036139: AB_10602134" "unprognostic (5.28e-2)" "unprognostic (1.20e-2)" "unprognostic (4.17e-1)" "unprognostic (5.81e-2)" "unprognostic (1.67e-1)" "unprognostic (2.95e-1)" "unprognostic (6.31e-2)" "unprognostic (2.76e-3)" "unprognostic (1.55e-1)" "unprognostic (5.24e-2)" "unprognostic (4.37e-3)" "unprognostic (2.79e-3)" "unprognostic (4.89e-3)" "unprognostic (1.28e-1)" "unprognostic (7.52e-2)" "unprognostic (5.17e-2)" "unprognostic (4.64e-5)" 0.4 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.3 0.3 2.7 0.1 0.1 0.0 0.6 0.5 0.1 0.2 0.1 0.1 0.1 0.0 0.6 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.4 0.6 0.5 0.5 0.3 1.4 0.3 0.2 0.1 0.1 0.3 0.6 0.6 0.1 0.5 3.6 27.6 0.1 0.1 0.4 0.1 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 2.8 0.1 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.5 0.1 FSTL3 "FLRG, FSRP" ENSG00000070404 "Follistatin like 3" O95633 19 676365-683399 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Osteogenesis, Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "placenta: 201.0" "Cell line enhanced" "Detected in many" "BEWO: 35.5;hTCEpi: 39.2;SiHa: 72.5;U-2197: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB024899, HPA045378" Approved Approved Nucleoplasm "Secreted in other tissues" 6800000 Nucleoplasm "CAB024899: , HPA045378: " "unprognostic (9.86e-3)" "unprognostic (1.32e-3)" "prognostic unfavourable (3.01e-4)" "prognostic unfavourable (3.03e-4)" "unprognostic (2.19e-3)" "unprognostic (1.51e-3)" "unprognostic (8.64e-3)" "prognostic unfavourable (4.61e-7)" "unprognostic (9.50e-2)" "prognostic unfavourable (1.65e-4)" "unprognostic (3.50e-2)" "unprognostic (5.91e-2)" "unprognostic (1.03e-3)" "unprognostic (7.22e-3)" "unprognostic (3.07e-1)" "unprognostic (3.75e-1)" "unprognostic (5.89e-3)" 19.9 29.1 4.0 10.7 6.2 5.6 24.7 1.3 4.2 13.1 14.9 3.8 8.1 3.8 12.8 15.6 12.7 14.1 13.1 27.0 5.0 2.0 13.7 5.1 26.9 8.7 7.3 4.5 16.8 11.7 1.4 5.3 201.0 6.0 14.3 3.1 12.0 4.5 11.0 4.1 6.2 6.5 20.6 10.4 3.9 9.1 34.5 4.9 0.7 7.2 5.5 1.4 16.7 18.3 0.9 2.2 0.1 4.4 0.6 2.6 2.0 1.9 15.6 1.1 0.8 4.9 12.6 35.5 26.5 3.9 6.6 2.4 5.7 3.0 0.8 10.7 17.8 13.7 0.8 22.6 2.2 1.6 1.8 0.7 21.8 4.6 21.2 1.3 2.6 15.7 39.2 7.3 30.7 1.1 1.6 1.1 10.0 6.8 0.5 0.8 1.3 5.4 1.4 0.7 1.7 9.2 0.3 0.7 1.2 72.5 1.4 0.8 1.3 0.7 15.9 6.7 23.1 37.4 9.7 1.8 0.8 0.4 1.0 4.2 3.0 0.0 4.4 0.0 1.0 4.4 0.2 0.3 1.4 1.1 2.2 0.9 2.6 1.6 0.1 0.6 3.2 0.9 0.2 2.0 4.0 6.2 1.3 4.2 5.0 2.0 7.3 4.5 6.0 4.9 FSTL5 "DKFZp566D234, KIAA1263" ENSG00000168843 "Follistatin like 5" Q8N475 4 161383897-162164035 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 106.9" "Cell line enriched" "Detected in some" 5 "Karpas-707: 39.8" "Cancer enriched" "Detected in single" 6 "melanoma: 1.7" "Region enriched" "Detected in all" 6 "cerebellum: 106.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" "unprognostic (4.90e-2)" "unprognostic (4.46e-1)" "unprognostic (1.52e-2)" "unprognostic (2.03e-1)" "unprognostic (3.66e-2)" "unprognostic (2.99e-2)" "unprognostic (3.00e-1)" "unprognostic (2.05e-2)" "unprognostic (1.10e-1)" "unprognostic (3.39e-2)" "unprognostic (1.61e-1)" "unprognostic (1.08e-10)" "unprognostic (8.45e-4)" "unprognostic (1.53e-1)" "unprognostic (1.52e-1)" "unprognostic (6.60e-3)" 0.5 12.1 3.5 0.6 6.9 0.5 0.5 106.9 19.9 0.5 0.6 0.6 0.0 0.5 0.5 1.7 0.5 0.6 0.5 0.5 3.2 5.9 0.6 0.5 0.5 0.5 3.0 3.0 0.5 1.0 0.5 1.1 0.7 18.2 0.5 0.8 7.1 0.5 0.6 0.5 0.8 0.6 0.6 3.1 0.5 0.5 1.5 2.9 0.0 0.6 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 5.7 0.0 39.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 5.7 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 8.6 0.0 3.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 6.9 106.9 6.9 3.2 5.9 3.0 3.0 18.2 2.9 FTCD ENSG00000160282 "Formimidoyltransferase cyclodeaminase" O95954 21 46136262-46155567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" "Lyase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 126.8" "Cell line enriched" "Detected in some" 29 "Hep G2: 44.4" "Cancer enriched" "Detected in some" 8 "liver cancer: 87.3" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 2.5" "Lineage enriched" "Detected in single" 25 "T-cells: 2.5" "HPA020073, HPA030928, HPA030929, HPA036114" Enhanced Approved "Plasma membrane,Cytosol" 580000 Cytosol "Plasma membrane" "HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947" "unprognostic (1.71e-1)" "unprognostic (2.27e-1)" "unprognostic (4.62e-5)" "unprognostic (2.90e-2)" "unprognostic (1.13e-1)" "unprognostic (2.96e-1)" "prognostic favourable (1.70e-4)" "unprognostic (1.85e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-1)" "prognostic favourable (6.78e-5)" "unprognostic (1.80e-1)" "prognostic favourable (5.78e-4)" "unprognostic (3.80e-2)" "unprognostic (3.60e-1)" "unprognostic (9.37e-2)" "unprognostic (2.10e-1)" 0.2 0.0 0.6 0.2 1.6 0.0 0.2 0.2 0.7 0.2 0.3 0.2 0.2 0.3 0.2 2.0 0.2 0.0 0.2 0.2 0.5 0.4 25.9 126.8 0.2 0.2 0.4 0.2 0.2 1.0 0.0 0.2 0.2 0.2 0.3 0.0 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.2 0.1 1.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 44.4 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 2.5 0.1 0.6 1.6 0.2 0.7 0.5 0.4 0.4 0.2 0.2 0.2 FTHL17 CT38 ENSG00000132446 "Ferritin heavy chain like 17" Q9BXU8 X 31071241-31072053 "Predicted intracellular proteins" "Iron storage" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 12.7" "Group enriched" "Detected in some" 14 "hTERT-HME1: 1.4;T-47d: 1.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FTMT MtF ENSG00000181867 "Ferritin mitochondrial" Q8N4E7 5 121851955-121852833 "Enzymes, Predicted intracellular proteins" "Iron storage" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 59 "testis: 68.0" "Cell line enriched" "Detected in single" 4 "HDLM-2: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (4.39e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 FUT4 "CD15, ELFT, FCT3A, FUC-TIV" ENSG00000196371 "Fucosyltransferase 4" P22083 11 94543840-94549898 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "bone marrow: 71.3" "Cell line enhanced" "Detected in many" "HL-60: 20.4;NB-4: 13.2;THP-1: 25.8;U-937: 18.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB000014, CAB016129" Enhanced Supported Vesicles Vesicles "CAB000014: , CAB016129: AB_626918" "unprognostic (6.36e-2)" "unprognostic (7.53e-2)" "unprognostic (4.70e-3)" "unprognostic (2.46e-3)" "unprognostic (1.46e-2)" "unprognostic (2.29e-2)" "unprognostic (1.66e-2)" "prognostic unfavourable (3.64e-4)" "unprognostic (7.26e-2)" "unprognostic (4.14e-1)" "unprognostic (4.81e-3)" "unprognostic (1.27e-1)" "unprognostic (9.08e-3)" "unprognostic (8.17e-2)" "unprognostic (1.37e-1)" "unprognostic (4.04e-1)" "unprognostic (3.10e-3)" 5.5 2.4 5.5 6.1 6.2 71.3 6.3 3.0 6.0 4.4 8.3 6.7 4.7 10.9 5.9 2.5 3.0 4.6 7.5 3.7 6.2 2.2 4.1 3.0 6.0 5.4 8.1 2.5 4.9 11.4 1.4 2.9 3.4 4.8 3.4 8.3 3.8 6.3 2.9 1.7 1.9 10.1 5.8 5.7 6.5 9.7 2.9 4.5 10.4 2.9 1.9 3.1 4.4 3.0 0.7 1.9 2.5 3.9 0.8 1.9 0.8 1.6 0.8 1.0 0.0 3.1 2.8 5.1 1.4 0.7 1.3 1.5 6.9 2.2 0.0 3.5 2.4 0.8 1.6 0.1 1.2 10.5 1.6 5.2 1.1 0.1 1.6 20.4 4.6 2.4 0.0 1.7 0.0 2.0 5.2 0.0 1.5 0.7 4.2 13.2 1.9 1.9 3.8 0.0 0.0 1.4 1.1 1.4 0.5 0.8 2.1 0.8 1.2 25.8 1.9 1.0 2.9 0.0 0.5 0.6 0.3 0.0 0.9 18.3 0.6 2.0 3.1 2.5 1.1 1.5 0.7 0.6 1.0 1.3 1.8 0.7 1.1 0.7 1.7 0.8 3.9 1.9 1.9 0.8 5.5 6.2 3.0 6.0 6.2 2.2 8.1 2.5 4.8 4.5 FUZ "FLJ22688, Fy" ENSG00000010361 "Fuzzy planar cell polarity protein" Q9BT04 19 49806869-49817376 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 116.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041779, HPA042196" Approved Approved Cytosol Cytosol "HPA041779: AB_10793974, HPA042196: AB_10797383" "unprognostic (2.40e-3)" "unprognostic (1.31e-1)" "unprognostic (7.73e-2)" "unprognostic (2.13e-1)" "unprognostic (1.49e-2)" "unprognostic (1.18e-2)" "unprognostic (4.36e-3)" "unprognostic (9.67e-2)" "unprognostic (1.47e-1)" "unprognostic (1.97e-2)" "unprognostic (1.06e-2)" "unprognostic (1.80e-1)" "prognostic favourable (1.50e-5)" "unprognostic (1.26e-2)" "unprognostic (2.03e-1)" "unprognostic (1.54e-1)" "unprognostic (1.70e-1)" 5.6 7.8 7.4 2.1 8.4 4.7 4.1 5.4 9.0 6.5 3.8 11.3 3.5 3.7 6.1 6.6 3.4 17.8 4.7 4.5 7.7 5.8 9.0 3.0 4.4 4.1 7.8 5.6 9.8 7.0 5.6 5.2 3.6 6.8 4.5 1.7 4.8 6.2 7.1 15.1 2.0 3.2 3.8 7.9 3.6 4.6 116.2 8.1 5.4 6.8 3.4 3.2 3.5 3.0 5.7 12.3 14.9 4.0 3.0 4.6 2.4 0.0 6.5 6.1 7.9 5.4 6.2 1.6 3.0 3.3 5.2 7.1 0.5 10.7 1.8 6.4 2.9 2.8 1.5 5.7 2.3 6.1 12.4 7.4 4.4 0.0 6.5 4.5 4.3 6.5 3.8 10.1 2.4 4.4 1.8 5.3 2.5 0.4 8.8 9.5 10.2 3.4 15.2 4.4 4.2 5.8 1.4 17.2 19.9 0.6 6.6 10.6 3.7 2.8 2.3 4.4 3.9 1.1 1.1 15.3 15.2 4.9 4.9 0.1 5.3 5.4 4.0 14.9 4.6 1.9 3.6 4.6 2.8 3.7 3.2 5.7 3.5 4.0 8.9 3.0 1.3 12.3 3.2 2.4 7.4 8.4 5.4 9.0 7.7 5.8 7.8 5.6 6.8 8.1 FXR1 ENSG00000114416 "FMR1 autosomal homolog 1" P51114 3 180868141-180982753 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Myogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 215.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018246, HPA055475" Approved Enhanced Cytosol Cytosol "HPA018246: AB_1849204, HPA055475: " "unprognostic (1.38e-1)" "unprognostic (1.59e-2)" "unprognostic (5.23e-2)" "prognostic unfavourable (5.96e-4)" "unprognostic (1.04e-2)" "unprognostic (1.90e-3)" "prognostic unfavourable (2.70e-4)" "unprognostic (7.77e-3)" "unprognostic (9.20e-2)" "unprognostic (2.75e-2)" "prognostic unfavourable (7.30e-4)" "unprognostic (3.28e-2)" "prognostic unfavourable (2.19e-5)" "unprognostic (7.85e-2)" "unprognostic (2.06e-1)" "unprognostic (2.02e-1)" "unprognostic (2.84e-2)" 12.4 13.8 13.0 7.6 16.1 13.7 11.7 14.8 15.0 11.5 14.3 10.5 11.4 7.5 14.7 10.1 13.4 11.7 8.9 36.1 13.7 14.3 10.1 11.3 8.5 9.4 19.4 9.6 16.9 11.4 11.4 17.3 12.7 18.1 13.1 7.4 6.5 10.2 11.8 215.4 7.7 7.9 12.3 23.4 9.1 10.5 39.1 19.4 17.2 16.2 22.7 10.0 15.6 28.8 13.8 14.9 11.4 14.0 11.0 21.8 9.4 37.8 17.6 38.1 29.6 29.3 33.5 17.2 30.1 30.8 33.9 33.6 25.9 19.1 19.3 49.9 20.7 18.3 30.7 18.5 47.5 25.5 20.7 19.7 23.3 29.5 31.3 12.2 16.3 35.3 21.2 17.1 41.0 34.1 15.7 23.5 42.6 13.7 23.2 20.5 43.0 19.4 16.1 48.7 20.6 26.1 11.9 16.1 20.6 26.1 30.4 38.9 42.2 23.5 27.2 25.6 28.6 16.0 59.2 22.0 27.5 23.0 26.7 17.6 32.5 8.9 12.9 10.0 12.9 14.0 13.6 13.8 13.8 11.7 14.9 9.5 17.6 14.4 11.4 11.0 10.2 10.5 21.8 9.4 13.0 16.1 14.8 15.0 13.7 14.3 19.4 9.6 18.1 19.4 FXYD4 CHIF ENSG00000150201 "FXYD domain containing ion transport regulator 4" P59646 10 43371642-43376335 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 27 "kidney: 119.5" "Cell line enhanced" "Detected in some" "EFO-21: 1.3;HSkMC: 1.0;hTCEpi: 1.3;RT4: 1.1;SK-BR-3: 1.0;U-266/84: 1.3" "Group enriched" "Detected in many" 5 "renal cancer: 10.7;urothelial cancer: 20.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058421 Enhanced "HPA058421: AB_2683714" "unprognostic (2.92e-3)" "unprognostic (5.25e-1)" "unprognostic (9.46e-2)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.32e-1)" "unprognostic (2.00e-1)" "unprognostic (5.17e-2)" "unprognostic (2.19e-1)" "unprognostic (6.12e-2)" "unprognostic (7.88e-2)" "unprognostic (1.26e-1)" "unprognostic (3.20e-1)" "unprognostic (2.09e-2)" 0.1 0.0 0.4 0.0 2.2 0.0 0.0 0.1 1.0 0.0 0.1 2.0 0.1 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.6 0.3 119.5 0.0 1.3 0.0 1.6 0.4 0.0 0.0 0.0 0.1 0.0 1.0 0.6 0.0 0.0 4.4 1.5 0.6 0.0 0.0 0.0 0.5 0.0 2.4 0.2 1.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.2 0.1 1.0 0.6 0.3 1.6 0.4 1.0 1.4 G6PC "G6PT, GSD1a" ENSG00000131482 "Glucose-6-phosphatase catalytic subunit" P35575 17 42900797-42913369 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Gluconeogenesis Hydrolase "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "liver: 305.4" "Cell line enhanced" "Detected in some" "RH-30: 2.2" "Cancer enriched" "Detected in some" 72 "liver cancer: 151.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052324 Enhanced "HPA052324: " "unprognostic (4.23e-2)" "unprognostic (1.49e-2)" "prognostic favourable (5.42e-5)" "unprognostic (8.37e-2)" "prognostic favourable (3.79e-5)" "unprognostic (4.79e-2)" "unprognostic (6.46e-2)" "unprognostic (2.56e-3)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 5.0 0.0 0.0 5.8 0.1 0.0 0.1 0.1 1.9 0.1 0.1 0.1 23.7 305.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 33.7 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 2.2 0.5 1.1 0.2 0.5 0.4 0.0 0.4 0.2 0.2 0.5 0.6 0.0 0.7 0.2 0.2 0.0 0.1 0.2 0.3 0.7 0.2 0.2 0.4 0.0 0.0 0.2 0.3 0.1 0.1 0.5 0.8 0.0 1.3 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.7 0.0 0.1 0.5 1.1 0.3 0.3 0.6 2.2 0.2 0.1 0.7 0.4 0.6 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.7 0.2 0.9 0.3 1.4 0.2 1.1 0.2 0.1 0.3 0.1 0.2 1.0 0.2 0.2 0.0 2.2 0.4 0.4 1.1 0.5 0.1 0.5 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 GAB4 ENSG00000215568 "GRB2 associated binding protein family member 4" Q2WGN9 22 16961936-17008222 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 17 "testis: 19.6" "Cell line enhanced" "Detected in single" "HAP1: 1.1" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA044621 Uncertain "HPA044621: AB_10967265" 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.1 0.8 0.0 0.1 0.0 0.4 0.6 0.1 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 1.1 0.0 0.5 0.0 GABBR2 "GABABR2, GPR51, GPRC3B, HG20" ENSG00000136928 "Gamma-aminobutyric acid type B receptor subunit 2" O75899 9 98288082-98709197 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 52.7" "Cell line enhanced" "Detected in some" "BJ: 10.9;fHDF/TERT166: 5.4;HUVEC TERT2: 22.5;U-138 MG: 8.8" "Group enriched" "Detected in many" 10 "glioma: 7.2;thyroid cancer: 11.6;urothelial cancer: 3.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013820, HPA031684, CAB079065" Enhanced Approved "CAB079065: , HPA013820: AB_1849364, HPA031684: " "unprognostic (2.00e-1)" "unprognostic (7.56e-2)" "unprognostic (3.75e-1)" "unprognostic (3.09e-5)" "unprognostic (2.52e-1)" "unprognostic (1.16e-1)" "unprognostic (2.81e-2)" "unprognostic (1.42e-1)" "unprognostic (2.66e-1)" "unprognostic (4.43e-2)" "unprognostic (1.43e-2)" "unprognostic (2.06e-1)" "unprognostic (1.76e-2)" "unprognostic (3.52e-2)" "unprognostic (1.91e-1)" "unprognostic (2.68e-2)" "unprognostic (3.45e-2)" 0.9 4.4 13.6 1.0 14.6 0.8 0.9 19.7 52.7 0.8 0.9 2.1 0.0 0.8 1.1 1.1 0.9 0.8 0.9 0.9 14.6 11.1 0.9 0.9 1.0 0.9 7.6 17.6 0.8 0.8 0.9 0.3 0.9 10.3 0.9 0.8 0.6 0.9 0.9 3.2 0.9 0.8 1.0 2.2 0.9 1.0 1.3 0.2 0.0 2.3 0.0 1.1 1.5 0.1 0.7 0.7 1.7 1.1 1.7 1.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 1.0 10.9 2.2 2.3 4.2 0.0 0.1 0.0 0.7 5.4 0.0 0.1 0.2 0.8 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.8 0.2 22.5 0.2 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.6 3.1 0.0 0.0 2.8 0.0 0.0 0.1 1.0 8.8 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 1.7 0.4 0.8 0.6 0.7 1.0 0.7 0.7 0.7 0.4 0.6 0.8 0.9 1.2 1.7 1.1 0.7 1.0 0.4 13.6 14.6 19.7 35.0 14.6 11.1 7.6 17.6 10.3 0.2 GABRA1 EJM5 ENSG00000022355 "Gamma-aminobutyric acid type A receptor alpha1 subunit" P14867 5 161847063-161899981 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 58.6" "Cell line enhanced" "Detected in some" "HEL: 3.6;SCLC-21H: 1.1;U-2 OS: 1.5;U-87 MG: 2.3;WM-115: 1.2" "Cancer enriched" "Detected in single" 5 "glioma: 1.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022502, HPA055746" Enhanced Supported "CAB022502: , HPA055746: " "unprognostic (2.58e-2)" "unprognostic (4.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.31e-1)" "unprognostic (2.43e-1)" 1.0 2.6 8.5 1.0 21.9 1.0 1.0 35.2 58.6 1.0 1.0 1.8 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 10.5 8.8 1.0 1.0 1.0 1.0 6.7 22.0 1.0 1.0 1.0 0.1 1.0 7.4 1.2 1.0 0.2 1.0 1.1 1.0 1.0 1.0 1.0 1.3 1.1 1.5 1.1 0.0 0.0 1.0 0.0 1.3 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.6 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 2.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 21.9 35.2 49.8 10.5 8.8 6.7 22.0 7.4 0.0 GABRA2 ENSG00000151834 "Gamma-aminobutyric acid type A receptor alpha2 subunit" P47869 4 46248427-46475230 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 52.6" "Cell line enhanced" "Detected in some" "U-2 OS: 9.4;U-87 MG: 4.4;WM-115: 5.0" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079061 Supported "Intracellular and membrane" "CAB079061: " "unprognostic (2.03e-2)" "unprognostic (2.77e-1)" "unprognostic (2.45e-4)" "unprognostic (6.87e-3)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.09e-1)" "unprognostic (6.90e-3)" "unprognostic (8.83e-2)" "unprognostic (2.22e-5)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.67e-1)" "unprognostic (3.04e-2)" 2.2 1.3 38.5 1.4 34.4 1.2 1.9 10.4 52.6 1.7 4.5 4.9 0.0 2.0 1.4 11.7 1.7 1.0 1.6 1.0 38.9 7.7 8.8 1.4 1.0 1.4 3.7 31.0 1.9 1.0 0.9 0.6 1.5 10.5 1.0 3.5 0.0 1.2 1.9 1.0 1.3 7.7 1.3 6.9 2.3 1.6 1.5 7.1 0.0 1.1 0.0 1.4 1.2 0.8 0.2 0.3 1.0 0.1 0.1 0.1 0.0 0.5 0.5 0.1 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 2.1 0.6 0.2 0.5 0.0 0.8 0.0 0.0 0.1 0.5 0.5 0.1 0.7 0.2 0.8 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.8 0.2 0.0 0.4 0.0 0.3 0.9 0.1 0.0 0.6 0.4 0.1 0.6 0.2 0.0 0.1 0.3 0.0 0.3 0.4 0.1 0.5 9.4 0.5 0.1 0.7 1.2 0.2 4.4 0.4 5.0 1.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.1 0.1 0.3 0.0 0.0 38.5 34.4 10.4 31.4 38.9 7.7 3.7 31.0 10.5 7.1 GABRA3 ENSG00000011677 "Gamma-aminobutyric acid type A receptor alpha3 subunit" P34903 X 152166234-152451358 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 30.1" "Cell line enhanced" "Detected in some" "HMC-1: 7.8;Karpas-707: 13.2;PC-3: 7.6;U-2 OS: 6.5;U-266/70: 7.1;U-266/84: 11.7;U-87 MG: 7.7" "Cancer enriched" "Detected in many" 7 "testis cancer: 16.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA000839 Approved Supported "HPA000839: AB_1078929" "unprognostic (9.63e-3)" "unprognostic (2.04e-1)" "unprognostic (2.02e-1)" "unprognostic (1.18e-2)" "unprognostic (7.07e-2)" "unprognostic (5.42e-2)" "unprognostic (2.34e-6)" "unprognostic (1.24e-1)" "unprognostic (2.70e-1)" "unprognostic (2.39e-2)" "unprognostic (2.63e-2)" "unprognostic (1.73e-1)" "unprognostic (7.29e-6)" "unprognostic (7.42e-3)" "unprognostic (6.20e-2)" "unprognostic (8.13e-2)" 0.7 0.7 7.7 0.6 15.2 0.7 0.7 1.3 30.1 2.2 0.8 3.3 0.0 0.8 1.2 0.8 1.3 0.7 0.7 0.7 10.9 15.9 0.7 0.7 0.7 0.7 4.7 10.5 0.6 0.7 0.6 0.9 5.2 6.2 0.8 0.8 0.4 0.7 1.8 0.8 1.1 0.9 0.8 2.1 0.7 0.7 1.8 1.1 0.0 0.7 0.0 0.9 1.8 0.4 0.0 0.1 1.5 0.3 0.3 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 1.3 13.2 0.0 0.0 0.0 0.0 2.4 7.6 0.0 0.0 0.0 0.0 0.0 0.2 4.8 0.0 4.9 0.4 0.1 1.2 0.0 5.0 6.5 0.3 1.4 7.1 11.7 0.0 7.7 0.0 4.9 1.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.1 0.2 0.0 7.7 15.2 1.3 28.4 10.9 15.9 4.7 10.5 6.2 1.1 GABRA4 ENSG00000109158 "Gamma-aminobutyric acid type A receptor alpha4 subunit" P48169 4 46918900-46994407 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 16.1" "Cell line enriched" "Detected in single" 173 "REH: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.78e-2)" "unprognostic (6.57e-3)" "unprognostic (2.46e-1)" "unprognostic (2.23e-1)" "unprognostic (3.17e-1)" "unprognostic (1.11e-1)" "unprognostic (6.91e-2)" 0.0 0.1 2.7 0.1 8.9 0.0 0.0 0.3 16.1 0.1 0.1 0.6 0.0 0.0 0.2 0.0 0.1 4.0 1.9 1.4 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 GABRA5 ENSG00000186297 "Gamma-aminobutyric acid type A receptor alpha5 subunit" P31644 15 26866363-26949207 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 52.6" "Group enriched" "Detected in some" 12 "A549: 25.8;HAP1: 8.9;NTERA-2: 10.7;U-2 OS: 9.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA077031, CAB079022" Supported Supported "Plasma membrane" "Plasma membrane" "CAB079022: , HPA077031: " "unprognostic (6.33e-2)" "unprognostic (8.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (9.50e-3)" "unprognostic (2.57e-1)" "unprognostic (7.63e-2)" "unprognostic (8.50e-2)" "unprognostic (1.44e-2)" 0.8 0.8 12.0 0.8 48.2 0.8 0.8 0.1 52.6 0.8 0.8 0.8 0.0 0.8 0.8 0.7 2.5 0.8 1.5 0.9 20.9 6.0 0.9 0.8 0.8 0.8 2.3 15.2 0.7 0.7 0.7 0.1 0.8 1.0 1.0 0.7 0.0 0.7 0.9 0.7 0.8 0.7 1.4 0.3 0.8 1.1 1.4 2.0 1.3 0.9 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 8.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 48.2 0.1 26.0 20.9 6.0 2.3 15.2 1.0 2.0 GABRA6 ENSG00000145863 "Gamma-aminobutyric acid type A receptor alpha6 subunit" Q16445 5 161547063-161702593 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "brain: 96.4" "Group enriched" "Detected in some" 9 "AF22: 1.0;PC-3: 1.4;TIME: 1.0;U-266/70: 2.4" "Not detected" "Not detected" "Region enriched" "Detected in some" 36 "cerebellum: 96.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 40 "cerebellum: 1204.9" "Region enriched" "Detected in single" 44 "cerebellum: 189.6" CAB022462 Approved "CAB022462: " "unprognostic (3.79e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 0.1 0.0 0.0 0.0 0.0 2.6 0.0 GABRB2 ENSG00000145864 "Gamma-aminobutyric acid type A receptor beta2 subunit" P47870 5 161288429-161549044 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 48.7" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 22.8" "Cancer enriched" "Detected in some" 20 "thyroid cancer: 10.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001964, HPA067632" Enhanced "CAB001964: , HPA067632: " "unprognostic (5.46e-2)" "unprognostic (1.03e-1)" "unprognostic (3.29e-1)" "unprognostic (2.26e-6)" "unprognostic (2.33e-2)" "unprognostic (6.65e-2)" "unprognostic (3.58e-2)" "unprognostic (1.82e-1)" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (5.19e-3)" "unprognostic (2.24e-4)" "unprognostic (1.22e-1)" "unprognostic (1.33e-2)" "unprognostic (1.58e-1)" "unprognostic (7.18e-3)" "unprognostic (1.04e-2)" 1.2 3.6 7.7 0.8 19.2 0.7 0.9 48.7 45.4 1.3 1.5 0.9 0.0 2.0 0.9 5.8 0.8 1.2 0.8 0.9 8.1 4.6 2.8 0.7 1.8 0.8 3.7 16.3 0.9 0.9 0.8 0.5 1.0 4.3 0.9 2.2 0.1 1.3 1.5 0.8 0.8 1.4 0.9 1.1 3.4 1.2 1.5 1.8 0.0 1.3 0.0 0.8 0.8 0.3 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.2 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.7 19.2 48.7 34.1 8.1 4.6 3.7 16.3 4.3 1.8 GABRD ENSG00000187730 "Gamma-aminobutyric acid type A receptor delta subunit" O14764 1 2019298-2030758 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 87.0" "Cell line enhanced" "Detected in some" "EFO-21: 2.8;HMC-1: 2.5;MCF7: 8.2;NB-4: 5.2;SH-SY5Y: 3.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 87.0" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044371 Enhanced Uncertain "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA044371: " "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-8)" "unprognostic (6.34e-3)" "unprognostic (2.66e-3)" "unprognostic (1.04e-2)" "unprognostic (3.44e-3)" "unprognostic (2.14e-1)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.99e-1)" "prognostic unfavourable (4.12e-8)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "unprognostic (5.16e-2)" 1.2 3.4 8.8 0.9 16.8 1.0 1.0 87.0 40.0 1.0 1.2 1.7 0.0 0.9 1.3 1.2 1.3 1.0 1.5 1.7 6.0 1.7 1.1 0.9 1.4 1.3 3.3 11.1 0.9 0.9 1.4 0.7 1.2 17.1 1.0 1.0 0.0 1.1 0.9 1.3 1.4 1.0 1.4 1.4 1.0 1.0 3.3 1.5 0.0 1.6 0.0 1.0 1.2 0.1 0.0 1.2 0.2 0.1 0.0 0.0 0.8 0.0 0.7 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 5.2 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.1 0.0 0.0 1.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.8 8.8 16.8 87.0 40.0 6.0 1.7 3.3 11.1 17.1 1.5 GABRG1 ENSG00000163285 "Gamma-aminobutyric acid type A receptor gamma1 subunit" Q8N1C3 4 46035769-46124081 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 35.7" "Cell line enhanced" "Detected in some" "Karpas-707: 1.3;THP-1: 2.6;U-2 OS: 1.8;U-266/70: 5.3" "Cancer enriched" "Detected in single" 8 "glioma: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035622 Approved "HPA035622: AB_10603669" "unprognostic (2.50e-1)" "unprognostic (2.20e-1)" "unprognostic (6.06e-2)" "unprognostic (1.46e-2)" "unprognostic (7.39e-4)" "unprognostic (1.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.99e-1)" 1.5 1.5 20.3 1.2 25.9 1.2 1.3 26.4 35.7 1.3 1.3 12.2 0.0 1.4 1.4 1.3 1.3 1.7 1.3 1.2 26.0 14.6 1.4 1.4 1.2 1.3 10.2 14.0 3.9 1.2 1.3 1.6 1.2 17.9 1.2 1.3 0.0 1.2 1.3 1.2 1.2 1.4 1.4 17.8 1.4 1.3 1.8 17.8 0.0 1.5 0.0 1.2 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.6 0.0 0.3 1.8 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 25.9 26.4 18.5 26.0 14.6 10.2 14.0 17.9 17.8 GABRG2 ENSG00000113327 "Gamma-aminobutyric acid type A receptor gamma2 subunit" P18507 5 162000057-162162977 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 47.1" "Cell line enhanced" "Detected in many" "CACO-2: 10.7;Karpas-707: 8.5;RPMI-8226: 10.3;U-266/70: 17.9;U-266/84: 14.1" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.3" "Group enriched" "Detected in many" 5 "B-cells: 2.9;granulocytes: 7.3;T-cells: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079060 Supported "CAB079060: " "unprognostic (2.88e-2)" "unprognostic (1.56e-2)" "unprognostic (6.31e-3)" "unprognostic (3.07e-3)" "unprognostic (1.52e-1)" 1.1 5.7 9.7 1.2 28.8 3.3 0.9 21.7 47.1 0.7 1.5 1.1 0.0 2.2 1.2 1.3 1.3 1.3 3.8 1.6 10.6 19.6 1.0 1.2 1.9 1.2 7.5 19.1 1.5 1.0 0.8 5.3 2.9 17.6 1.0 1.3 0.6 1.3 0.8 1.2 3.3 1.9 1.6 2.6 1.2 3.3 1.7 1.8 0.0 1.8 0.0 1.3 1.5 0.3 2.9 0.7 7.3 0.3 0.9 3.2 0.2 3.6 1.7 2.0 0.3 0.0 0.0 2.1 0.6 0.0 0.0 0.0 10.7 4.7 0.7 5.3 0.0 1.6 1.2 0.0 0.0 0.8 1.1 0.0 2.1 1.3 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 1.8 8.5 0.0 2.5 0.4 0.1 6.1 2.9 0.4 0.1 10.3 0.0 3.4 0.9 0.8 0.3 0.6 3.4 5.7 5.7 0.2 0.3 4.5 0.3 0.5 17.9 14.1 0.5 0.2 0.4 0.4 7.3 0.3 0.6 0.4 0.3 2.7 2.9 0.7 0.6 0.0 2.5 3.2 0.7 1.6 0.9 0.2 0.7 0.6 0.2 9.7 28.8 21.7 38.1 10.6 19.6 7.5 19.1 17.6 1.8 GABRR2 ENSG00000111886 "Gamma-aminobutyric acid type A receptor rho2 subunit" P28476 6 89257208-89315299 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "retina: 18.8" "Cell line enhanced" "Detected in some" "U-266/70: 4.3;U-266/84: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Lineage enhanced" "Detected in single" "dendritic cells: 1.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "unprognostic (2.05e-2)" "unprognostic (1.47e-4)" "unprognostic (1.56e-1)" "unprognostic (1.88e-4)" "unprognostic (4.19e-1)" "unprognostic (1.07e-1)" "unprognostic (2.24e-2)" "unprognostic (9.13e-2)" "unprognostic (2.87e-1)" "unprognostic (1.10e-2)" "unprognostic (2.65e-1)" "unprognostic (1.41e-1)" "unprognostic (1.54e-6)" "unprognostic (3.69e-2)" "unprognostic (7.81e-2)" "unprognostic (5.79e-2)" "unprognostic (7.15e-3)" 0.2 0.6 0.2 0.5 0.4 0.3 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.0 0.7 0.5 0.2 0.1 0.4 0.2 0.3 0.2 0.3 0.4 0.1 0.9 0.3 0.1 0.1 0.8 0.0 0.2 0.1 0.1 0.3 0.0 18.8 0.6 0.2 1.5 0.5 0.1 0.1 0.2 0.4 0.1 0.6 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.3 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.6 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.2 0.0 0.0 0.2 0.9 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.4 0.0 0.0 0.0 4.3 1.5 0.0 0.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.2 0.4 0.3 0.3 0.3 0.2 0.3 0.1 0.1 0.1 GABRR3 ENSG00000183185 "Gamma-aminobutyric acid type A receptor rho3 subunit (gene/pseudogene)" A8MPY1 3 97986673-98035304 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 7 "retina: 18.2" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;U-266/70: 2.0;U-698: 4.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 25 "plasmacytoid DC: 2.4" "Lineage enriched" "Detected in single" 25 "dendritic cells: 2.4" "Not detected" "Not detected" "unprognostic (3.22e-2)" "unprognostic (2.06e-3)" "unprognostic (5.65e-2)" "unprognostic (2.82e-1)" "unprognostic (1.43e-4)" "unprognostic (2.84e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 18.2 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 GAD1 GAD ENSG00000128683 "Glutamate decarboxylase 1" Q99259 2 170813213-170861151 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Decarboxylase, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 53.9" "Cell line enhanced" "Detected in many" "HaCaT: 10.5;HEL: 34.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "olfactory region: 888.9" "CAB004415, HPA031949, HPA058412, CAB078176" Enhanced Supported Approved Vesicles Vesicles "CAB004415: AB_627650, CAB078176: , HPA031949: , HPA058412: " "unprognostic (1.28e-1)" "prognostic favourable (7.31e-4)" "unprognostic (1.87e-2)" "prognostic favourable (8.61e-4)" "unprognostic (1.12e-1)" "unprognostic (3.05e-1)" "unprognostic (4.97e-7)" "unprognostic (1.51e-1)" "unprognostic (7.72e-2)" "unprognostic (4.27e-4)" "unprognostic (6.75e-2)" "unprognostic (9.18e-3)" "unprognostic (6.90e-5)" "unprognostic (2.93e-2)" "unprognostic (6.57e-2)" "unprognostic (1.56e-2)" "unprognostic (3.08e-3)" 1.2 2.0 14.5 0.9 28.1 3.7 1.0 10.6 53.9 1.8 1.0 3.1 0.0 1.0 2.6 5.5 1.2 1.1 1.0 1.0 10.8 24.4 6.0 1.0 1.1 1.1 8.6 17.5 1.1 1.1 9.5 2.8 1.4 6.0 1.8 1.0 1.3 1.0 1.3 0.9 1.0 1.1 1.0 2.6 1.0 1.0 4.0 3.4 0.0 1.1 0.0 1.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.3 0.0 3.7 0.0 0.0 0.0 0.2 0.0 1.4 0.9 2.5 3.5 0.0 0.5 0.2 10.5 1.2 0.3 0.8 1.4 7.2 34.2 3.0 0.1 0.0 0.1 0.6 0.0 3.1 0.0 1.2 0.0 8.8 0.1 0.4 0.8 0.0 0.0 4.2 3.7 0.5 2.5 0.2 4.6 4.9 3.6 1.1 6.5 0.0 1.8 0.1 0.0 0.0 6.4 0.9 1.3 3.7 0.0 0.0 0.0 6.2 1.7 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 28.1 10.6 36.7 10.8 24.4 8.6 17.5 6.0 3.4 GAD2 GAD65 ENSG00000136750 "Glutamate decarboxylase 2" Q05329 10 26216307-26304558 "Enzymes, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 66.2" "Group enriched" "Detected in some" 12 "MOLT-4: 5.0;SCLC-21H: 11.4" "Group enriched" "Detected in some" 21 "glioma: 0.7;pancreatic cancer: 3.0;testis cancer: 1.2" "Region enhanced" "Detected in all" "basal ganglia: 66.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044637, CAB078177" Enhanced "CAB078177: , HPA044637: AB_10794053" "unprognostic (8.67e-2)" "unprognostic (1.11e-1)" "unprognostic (4.93e-2)" "unprognostic (2.52e-5)" "unprognostic (5.44e-2)" "unprognostic (8.08e-2)" 1.0 0.9 6.3 0.9 66.2 1.0 0.9 5.6 28.7 0.9 0.9 1.4 0.0 1.2 0.9 1.1 0.9 0.9 0.9 0.9 5.2 13.2 1.0 0.9 0.9 0.9 5.4 10.0 0.9 12.9 0.9 0.4 0.9 6.8 1.2 1.0 0.0 0.9 0.9 0.9 1.3 1.1 0.9 1.3 0.9 1.2 1.7 8.1 0.0 0.9 0.0 0.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.3 66.2 5.6 18.2 5.2 13.2 5.4 10.0 6.8 8.1 GADL1 ENSG00000144644 "Glutamate decarboxylase like 1" Q6ZQY3 3 30726200-30894765 "Enzymes, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 21.6" "Cell line enhanced" "Detected in many" "HAP1: 9.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039160, HPA040229" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039160: AB_10796222, HPA040229: AB_10796118" "unprognostic (4.96e-2)" "unprognostic (1.30e-2)" "unprognostic (9.83e-2)" "unprognostic (1.39e-2)" "unprognostic (5.60e-2)" "unprognostic (7.32e-2)" "unprognostic (5.05e-3)" "unprognostic (8.37e-2)" "unprognostic (1.23e-2)" "unprognostic (2.02e-3)" "unprognostic (1.63e-1)" "unprognostic (1.98e-5)" "unprognostic (8.81e-2)" "unprognostic (4.54e-2)" "unprognostic (4.39e-1)" "unprognostic (1.06e-1)" 0.5 0.3 0.2 0.2 0.3 1.0 0.4 0.5 0.7 0.4 0.2 0.0 0.0 0.1 0.2 1.6 1.4 0.2 2.0 2.3 0.2 0.3 0.7 0.2 1.6 0.3 0.3 0.8 0.5 0.3 0.1 0.6 0.5 2.1 0.5 0.1 0.3 0.3 0.0 21.6 0.8 0.2 2.5 0.7 0.5 0.2 1.1 0.0 0.0 1.2 3.3 0.7 0.5 0.3 1.7 0.5 1.9 0.8 0.5 1.3 0.3 1.3 0.3 0.8 1.1 0.9 0.5 1.5 0.6 0.3 0.3 0.2 1.3 1.2 1.1 0.5 0.2 0.9 9.7 0.3 0.4 1.7 0.5 1.6 1.5 0.5 0.4 0.9 3.3 0.4 0.5 0.7 0.3 0.6 1.2 4.0 0.9 1.1 0.6 1.3 1.8 0.5 1.9 2.1 1.0 1.0 1.5 1.1 0.9 1.1 0.7 2.9 1.1 0.8 5.0 1.5 1.4 1.9 0.7 1.6 0.8 0.7 0.6 0.9 1.9 1.9 0.7 0.8 1.0 0.6 0.8 1.2 0.9 0.6 0.4 1.7 1.1 1.0 1.7 0.5 0.8 0.5 1.3 0.3 0.2 0.3 0.5 0.7 0.2 0.3 0.3 0.8 2.1 0.0 GAGE1 CT4.1 ENSG00000205777 "G antigen 1" Q13068 X 49589496-49608536 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "testis: 36.8" "Cell line enriched" "Detected in some" 4 "AN3-CA: 243.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.6 1.0 0.7 0.8 0.1 0.7 0.0 0.0 0.0 0.0 243.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 56.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 22.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 0.1 0.3 0.3 0.7 0.0 0.2 0.3 0.3 0.0 0.0 0.6 0.1 0.3 0.7 0.1 0.8 1.0 0.1 0.0 GAGE12C ENSG00000237671 "G antigen 12C" A1L429 X 49532211-49539538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 23.7" "Group enriched" "Detected in some" 11 "U-2 OS: 7.6;U-266/84: 27.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 7.6 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12D ENSG00000227488 "G antigen 12D" A1L429 X 49541767-49549094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 23.7" "Group enriched" "Detected in some" 11 "U-2 OS: 7.6;U-266/84: 27.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 7.6 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12E ENSG00000216649 "G antigen 12E" A1L429 X 49551333-49558649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 9.6" "Cell line enhanced" "Detected in some" "AN3-CA: 7.3;HeLa: 4.0;Karpas-707: 1.9;T-47d: 1.7;U-266/84: 4.3;WM-115: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.5 0.8 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.7 0.0 0.0 0.5 0.3 0.0 0.0 0.7 4.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 GAGE12H ENSG00000224902 "G antigen 12H" A6NDE8 X 49579983-49587301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 223 "testis: 22.3" "Group enriched" "Detected in some" 52 "A-431: 19.2;U-266/84: 56.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 56.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12J GAGE11 ENSG00000224659 "G antigen 12J" A6NER3 X 49322057-49329384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 20.2" "Group enriched" "Detected in some" 5 "AN3-CA: 47.2;K-562: 47.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 20.2 0.0 0.0 0.0 0.0 0.8 0.6 0.4 0.7 0.8 1.6 0.0 0.0 0.0 0.0 47.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.8 9.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.2 0.4 0.8 0.7 0.9 0.0 0.7 1.6 0.4 0.4 0.8 0.5 0.6 1.4 0.0 GAGE13 GAGE12A ENSG00000274274 "G antigen 13" X 49331616-49338952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 26.8" "Cell line enriched" "Detected in some" 6 "AN3-CA: 126.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 126.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 4.6 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 GAGE2A "CT4.2, GAGE2" ENSG00000189064 "G antigen 2A" Q6NT46 X 49589529-49596827 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "testis: 46.7" "Group enriched" "Detected in some" 5 "Karpas-707: 19.2;T-47d: 66.1;WM-115: 72.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " "unprognostic (1.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 1.0 0.7 0.4 0.7 0.5 0.6 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 19.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 66.1 0.0 0.0 10.7 2.3 0.0 0.0 0.2 2.8 0.0 0.6 0.0 72.7 0.4 0.6 0.1 0.1 0.7 0.0 1.0 0.5 0.6 0.0 0.4 0.5 0.2 0.0 0.5 0.6 0.7 0.6 1.3 GAL "GAL-GMAP, GALN, GLNN, GMAP" ENSG00000069482 "Galanin and GMAP prepropeptide" P22466 11 68683779-68691175 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Hormone, Neuropeptide" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "pituitary gland: 149.9" "Cell line enhanced" "Detected in some" "CACO-2: 46.9;HEK 293: 21.9;K-562: 24.3;NB-4: 86.7;SH-SY5Y: 35.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 8 "hypothalamus: 18.8" "Cell type enriched" "Detected in single" 15 "intermediate monocyte: 1.5" "Lineage enriched" "Detected in single" 15 "monocytes: 1.5" "Region enhanced" "Detected in many" "hypothalamus: 111.6" "Low region specificity" "Detected in all" "HPA049864, CAB079779" Enhanced Supported Supported "Golgi apparatus,Vesicles" "Secreted to blood" 60030 "Golgi apparatus" Vesicles "CAB079779: , HPA049864: " "unprognostic (8.56e-2)" "unprognostic (1.45e-2)" "unprognostic (7.50e-2)" "prognostic unfavourable (1.22e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (8.07e-3)" "prognostic unfavourable (8.17e-4)" "unprognostic (5.98e-2)" "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (7.42e-2)" "unprognostic (1.20e-1)" "unprognostic (8.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.38e-2)" "unprognostic (3.24e-2)" 2.8 0.2 0.1 14.8 0.5 0.4 4.5 0.6 2.0 0.2 6.0 0.1 0.4 1.7 0.2 0.7 0.7 0.2 0.3 0.6 1.3 18.8 0.3 0.2 0.2 0.1 0.2 0.6 0.2 2.9 0.0 149.9 0.9 2.2 0.7 4.1 0.6 0.5 1.8 0.3 4.5 2.2 9.7 0.3 0.2 1.5 0.5 0.4 0.7 0.2 0.4 0.3 1.5 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 4.4 6.6 0.0 0.1 0.0 46.9 1.7 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 21.9 1.1 14.1 0.0 0.2 0.6 0.0 0.3 0.7 0.0 0.0 1.1 24.3 0.0 0.0 13.3 0.0 86.7 11.2 4.2 0.0 0.0 8.9 0.1 0.0 9.1 35.0 4.6 0.2 0.0 0.2 10.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.7 1.3 18.8 0.2 0.6 2.2 0.4 GALNT14 "FLJ12691, GalNac-T10, GalNac-T14" ENSG00000158089 "Polypeptide N-acetylgalactosaminyltransferase 14" Q96FL9 2 30910467-31155202 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 42.7" "Cell line enhanced" "Detected in many" "A549: 12.9;RPMI-8226: 14.9;RPTEC TERT1: 22.0;RT4: 16.3" "Cancer enriched" "Detected in many" 7 "renal cancer: 45.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "neutrophil: 10.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 10.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030138 Approved "Nucleoplasm,Golgi apparatus" 9400 "Golgi apparatus" Nucleoplasm "HPA030138: " "unprognostic (5.69e-2)" "unprognostic (1.35e-1)" "unprognostic (2.05e-2)" "unprognostic (2.82e-3)" "unprognostic (3.85e-2)" "unprognostic (2.10e-2)" "unprognostic (3.32e-1)" "unprognostic (7.58e-2)" "unprognostic (1.96e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-3)" "unprognostic (5.18e-3)" "unprognostic (2.67e-2)" "unprognostic (2.56e-1)" "unprognostic (9.51e-3)" 1.2 1.5 1.5 0.9 3.7 4.3 1.1 1.8 9.6 1.4 0.6 1.8 0.3 0.6 0.6 1.0 10.2 1.1 3.7 0.4 1.6 1.5 42.7 1.2 0.6 2.6 1.2 2.3 0.9 2.7 7.6 5.7 0.2 0.9 1.7 0.2 2.1 1.7 0.2 0.4 1.9 3.1 0.7 0.8 1.8 0.6 1.6 0.3 0.1 1.1 1.0 4.2 2.0 1.4 1.4 0.0 10.6 0.0 0.0 0.0 0.1 10.9 12.9 0.0 0.0 0.0 0.0 0.0 3.6 1.9 2.4 0.3 0.0 0.0 10.2 3.7 0.2 0.0 0.4 0.5 0.4 0.3 1.3 5.7 0.0 0.0 0.0 8.2 0.0 0.0 2.3 0.0 8.5 0.0 0.0 9.1 0.0 5.0 0.0 0.0 6.1 0.0 7.1 0.0 14.9 22.0 16.3 12.1 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.2 0.9 2.8 0.0 0.0 5.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.1 1.5 3.7 1.8 9.6 1.6 1.5 1.2 2.3 0.9 0.3 GALNT9 GALNAC-T9 ENSG00000182870 "Polypeptide N-acetylgalactosaminyltransferase 9" Q9HCQ5 12 132196372-132329349 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 52.4" "Cell line enriched" "Detected in some" 5 "U-87 MG: 26.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 2.6;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 9 "B-cells: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075016 Approved Vesicles Vesicles "HPA075016: " "unprognostic (1.13e-1)" "unprognostic (3.47e-2)" "unprognostic (1.47e-1)" "unprognostic (6.44e-2)" "unprognostic (1.03e-1)" "unprognostic (6.53e-2)" "unprognostic (2.65e-1)" "unprognostic (1.32e-2)" "unprognostic (2.03e-1)" "unprognostic (1.64e-3)" "unprognostic (2.85e-1)" "unprognostic (6.62e-2)" "unprognostic (5.17e-2)" "unprognostic (1.89e-1)" "unprognostic (1.71e-1)" "unprognostic (3.89e-2)" "unprognostic (5.69e-2)" 2.6 2.2 9.3 1.0 6.7 0.6 0.5 52.4 27.9 1.1 0.8 0.8 0.0 1.1 1.8 7.7 0.5 1.9 0.7 0.6 12.9 6.8 3.2 0.5 0.9 1.3 4.3 10.8 1.3 0.4 1.9 2.7 0.5 6.9 1.0 0.6 0.3 1.2 1.7 0.5 0.9 1.0 0.6 1.7 1.2 0.7 0.9 1.1 0.0 6.1 0.0 0.4 0.7 0.1 2.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 26.3 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 2.6 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.3 6.7 52.4 20.2 12.9 6.8 4.3 10.8 6.9 1.1 GALNTL5 "GalNAc-T5L, GALNT15" ENSG00000106648 "Polypeptide N-acetylgalactosaminyltransferase like 5" Q7Z4T8 7 151956379-152019934 "Disease related genes, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 45.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011140 Enhanced "HPA011140: AB_1078944" "unprognostic (2.33e-2)" "unprognostic (2.09e-1)" "unprognostic (1.55e-1)" 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 1.9 1.1 0.0 0.0 0.0 0.0 0.0 GAN "GAN1, KLHL16" ENSG00000261609 Gigaxonin Q9H2C0 16 81314952-81390884 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skin 1: 46.9" "Cell line enhanced" "Detected in many" "BEWO: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011825, HPA049473" Approved Supported Microtubules Microtubules "CAB011825: AB_732515, HPA049473: " "unprognostic (1.78e-1)" "unprognostic (1.55e-1)" "unprognostic (8.23e-2)" "unprognostic (2.51e-2)" "unprognostic (8.37e-2)" "unprognostic (1.43e-1)" "unprognostic (2.42e-4)" "unprognostic (1.90e-1)" "unprognostic (3.86e-1)" "unprognostic (1.20e-1)" "unprognostic (1.22e-3)" "unprognostic (5.91e-3)" "unprognostic (3.12e-3)" "unprognostic (5.93e-2)" "unprognostic (9.98e-2)" "unprognostic (1.46e-2)" "unprognostic (5.86e-2)" 3.1 2.8 7.5 2.9 7.6 2.8 6.2 8.0 7.8 3.9 4.0 10.9 3.2 3.0 3.3 3.7 8.4 2.6 2.8 2.9 10.8 5.0 2.5 2.5 3.0 2.8 5.5 7.5 3.0 3.5 4.1 2.9 3.1 7.5 3.9 3.9 2.7 4.1 3.0 4.0 46.9 3.0 4.3 8.1 3.0 4.2 3.2 7.7 2.0 3.1 6.2 4.0 3.3 6.6 2.2 3.3 2.4 1.6 3.2 3.7 0.6 2.1 3.1 2.0 2.6 2.6 1.3 13.2 1.8 1.2 1.4 0.7 6.3 2.4 3.3 2.1 2.1 3.9 4.1 1.7 3.0 0.9 1.8 2.9 2.5 4.9 2.5 2.7 3.2 1.5 4.8 1.9 4.6 2.4 3.7 1.5 1.5 11.1 2.4 3.5 5.1 1.1 4.6 2.0 1.3 2.1 6.9 2.3 1.3 6.3 5.3 1.7 3.8 2.4 3.3 3.0 3.9 1.2 2.4 2.8 3.6 8.1 1.6 2.9 2.4 2.4 1.6 0.8 3.1 1.4 2.8 1.7 3.1 2.5 0.9 2.2 2.9 3.7 1.3 3.2 1.3 3.3 2.2 0.6 7.5 7.6 8.0 7.8 10.8 5.0 5.5 7.5 7.5 7.7 GAP43 "B-50, PP46" ENSG00000172020 "Growth associated protein 43" P17677 3 115623324-115721490 "Plasma proteins, Predicted intracellular proteins, Transporters" "Differentiation, Growth regulation, Neurogenesis" "Calmodulin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 132.7" "Cell line enhanced" "Detected in some" "AF22: 16.4;NTERA-2: 34.8;SCLC-21H: 22.4;SH-SY5Y: 16.8;U-87 MG: 7.8" "Cancer enriched" "Detected in many" 43 "glioma: 245.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "naive CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004417, HPA013392, HPA015600, CAB078783" Enhanced Supported Enhanced "Plasma membrane" "Plasma membrane" "CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466" "unprognostic (1.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.15e-2)" "unprognostic (5.72e-5)" "unprognostic (7.44e-3)" "unprognostic (2.19e-2)" "unprognostic (3.97e-3)" "unprognostic (3.15e-3)" "unprognostic (6.08e-4)" "unprognostic (3.33e-1)" "unprognostic (2.17e-2)" "unprognostic (1.62e-1)" "unprognostic (5.35e-8)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (1.29e-3)" 1.8 5.0 48.8 5.2 38.3 1.4 1.9 31.2 132.7 1.6 4.1 4.3 0.0 2.7 1.5 1.5 1.9 1.5 3.8 3.6 29.0 56.6 1.4 1.4 1.5 1.5 30.6 42.2 1.4 1.8 1.4 1.5 2.2 25.7 1.7 4.0 0.8 2.2 1.5 1.4 1.4 4.3 3.6 6.1 1.4 1.5 1.6 5.7 0.0 1.5 0.0 1.6 1.7 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 22.4 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 48.8 38.3 31.2 75.7 29.0 56.6 30.6 42.2 25.7 5.7 GAPDH GAPD ENSG00000111640 "Glyceraldehyde-3-phosphate dehydrogenase" P04406 12 6533927-6538374 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Glycolysis, Translation regulation" "Oxidoreductase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 1236.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB005197, CAB016392, HPA040067, HPA061280" Supported Supported "Nuclear membrane,Vesicles,Plasma membrane,Cytosol" 2200000000 "Plasma membrane, Cytosol" "Nuclear membrane, Vesicles" "CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463" "unprognostic (3.03e-1)" "unprognostic (2.62e-3)" "unprognostic (3.58e-2)" "unprognostic (4.20e-1)" "unprognostic (9.73e-3)" "unprognostic (1.77e-3)" "prognostic unfavourable (1.79e-6)" "unprognostic (2.89e-3)" "unprognostic (2.86e-1)" "unprognostic (2.06e-2)" "unprognostic (9.50e-3)" "unprognostic (4.52e-1)" "prognostic unfavourable (6.25e-10)" "unprognostic (2.33e-1)" "unprognostic (4.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.26e-2)" 50.0 59.4 104.1 57.6 101.0 195.5 38.4 58.0 151.3 49.4 73.3 80.7 24.0 75.8 37.3 46.8 146.9 50.2 58.0 215.1 95.0 95.5 88.4 221.0 41.3 90.1 111.8 58.0 62.0 27.0 66.1 46.1 98.2 115.9 48.3 76.7 74.5 60.8 63.2 1236.8 54.4 74.4 68.0 95.6 50.7 41.1 36.4 35.9 101.9 38.3 238.7 105.3 89.5 50.5 57.9 171.0 110.0 201.6 60.5 108.8 271.9 196.0 345.9 99.8 155.5 97.4 160.6 217.5 149.0 212.2 218.1 227.7 244.1 134.6 229.2 29.5 175.6 111.7 92.7 345.6 151.4 201.0 100.7 126.8 217.1 207.3 131.3 204.9 102.1 134.3 112.9 214.3 242.1 240.0 68.1 48.3 247.7 391.1 233.5 107.9 368.8 115.3 189.9 177.7 109.1 248.1 239.9 70.7 113.5 131.5 343.1 197.9 53.6 144.8 149.7 170.2 205.7 87.8 257.4 109.8 79.8 295.4 360.8 129.9 266.3 110.0 201.6 37.0 74.1 103.2 65.3 57.9 77.9 74.4 171.0 32.2 44.1 51.2 106.5 60.5 92.3 25.2 108.8 271.9 104.1 101.0 58.0 151.3 95.0 95.5 111.8 58.0 115.9 35.9 GAPDHS "GAPD2, GAPDH-2, GAPDS" ENSG00000105679 "Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic" O14556 19 35533412-35545316 "Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "testis: 154.6" "Cell line enhanced" "Detected in many" "A549: 16.2" "Cancer enriched" "Detected in single" 97 "melanoma: 13.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042666 Enhanced Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA042666: " "unprognostic (3.74e-1)" "unprognostic (1.59e-1)" "unprognostic (7.41e-2)" "unprognostic (1.56e-1)" "unprognostic (2.06e-1)" "unprognostic (1.04e-1)" "unprognostic (8.81e-2)" "unprognostic (2.96e-1)" "unprognostic (1.03e-1)" "unprognostic (6.45e-3)" "unprognostic (2.37e-1)" 0.3 0.5 0.3 0.8 0.3 0.2 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.6 0.5 1.6 0.6 0.2 0.8 0.8 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 0.7 1.3 0.0 0.3 0.3 0.3 0.3 0.0 4.2 1.3 0.3 0.3 4.4 0.6 0.3 0.3 1.2 0.4 154.6 0.3 0.3 3.6 0.3 0.3 0.6 0.3 2.1 1.0 1.2 0.8 1.4 2.0 0.8 4.4 16.2 4.5 6.8 0.0 0.0 3.8 1.3 0.0 0.0 0.0 9.8 7.4 7.4 2.1 0.0 5.4 0.0 0.0 0.0 7.2 7.9 4.9 10.3 5.0 0.1 4.4 5.9 0.0 0.0 0.0 0.0 0.0 11.8 4.4 0.0 13.8 1.7 2.1 6.1 2.2 5.2 3.2 5.7 0.0 4.4 8.1 3.7 1.6 4.1 4.8 3.4 1.9 1.5 5.2 5.8 1.3 1.8 12.1 3.2 4.3 2.8 8.0 1.9 0.0 0.8 1.2 1.1 0.6 2.0 1.1 0.4 1.9 1.0 2.1 1.1 1.2 0.0 1.4 0.3 0.8 0.3 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 GAPT "C5orf29, FLJ33641" ENSG00000175857 "GRB2 binding adaptor protein, transmembrane" Q8N292 5 58491435-58497090 "Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 117.8" "Cell line enhanced" "Detected in some" "HEL: 26.8;HL-60: 15.5;NB-4: 16.1;THP-1: 12.7;U-937: 44.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "eosinophil: 117.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 117.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011070 Uncertain "HPA011070: AB_1848887" "unprognostic (9.79e-2)" "unprognostic (5.67e-3)" "unprognostic (2.39e-2)" "unprognostic (3.26e-2)" "unprognostic (3.36e-2)" "unprognostic (8.09e-4)" "unprognostic (4.32e-1)" "unprognostic (1.23e-3)" "unprognostic (4.14e-2)" "unprognostic (9.47e-3)" "unprognostic (7.28e-2)" "unprognostic (2.93e-1)" "unprognostic (3.52e-3)" "unprognostic (3.74e-2)" "unprognostic (2.42e-2)" "unprognostic (2.33e-2)" "unprognostic (1.40e-2)" 1.4 0.8 1.4 15.5 2.7 8.5 1.0 0.6 1.2 1.8 1.4 1.6 0.4 1.8 1.3 2.2 3.3 1.2 3.1 1.1 1.5 1.7 1.6 1.0 7.2 19.4 4.5 0.9 0.7 1.2 0.0 1.5 0.8 4.4 2.6 2.0 1.4 2.3 0.4 0.5 0.9 8.2 2.4 5.9 25.8 1.7 0.8 3.2 5.2 1.1 0.5 23.5 5.1 1.2 12.0 25.4 117.8 8.2 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 15.5 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 16.1 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.6 0.0 12.3 8.2 117.8 0.0 5.7 0.0 12.0 0.0 0.0 9.4 11.9 0.0 0.0 10.1 0.1 6.6 25.4 0.0 3.4 1.4 2.7 0.6 1.2 1.5 1.7 4.5 0.9 4.4 3.2 GAST GAS ENSG00000184502 Gastrin P01350 17 41712326-41715969 "Cancer-related genes, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 61 "stomach 1: 529.2" "Group enriched" "Detected in some" 6 "BEWO: 5.0;HaCaT: 9.5;hTCEpi: 5.9" "Group enriched" "Detected in many" 6 "pancreatic cancer: 38.8;stomach cancer: 23.5" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" CAB000038 Enhanced "Secreted to digestive system" 43000 "CAB000038: " "unprognostic (1.27e-1)" "unprognostic (4.27e-3)" "unprognostic (1.12e-1)" "unprognostic (1.07e-2)" "unprognostic (2.75e-2)" "unprognostic (5.68e-2)" "unprognostic (2.11e-1)" "unprognostic (2.85e-1)" "unprognostic (3.17e-1)" "unprognostic (9.07e-2)" 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.2 0.1 1.7 6.9 0.0 2.4 7.3 0.0 0.0 0.0 2.6 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 529.2 0.1 0.0 8.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.3 0.0 0.0 0.0 0.6 0.0 0.2 0.7 0.0 9.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.2 0.1 0.3 0.1 0.0 0.0 0.0 GBP7 "FLJ38822, GBP4L" ENSG00000213512 "Guanylate binding protein 7" Q8N8V2 1 89131751-89176040 "Predicted intracellular proteins" Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "liver: 48.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 58 "liver cancer: 10.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA051245 Uncertain "HPA051245: " "unprognostic (4.22e-5)" "unprognostic (7.32e-2)" "unprognostic (6.30e-2)" "unprognostic (1.29e-1)" "unprognostic (1.63e-1)" "unprognostic (3.66e-3)" "unprognostic (4.93e-3)" "unprognostic (2.15e-2)" "unprognostic (2.80e-1)" "unprognostic (8.79e-2)" "unprognostic (1.57e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" "unprognostic (8.15e-2)" "unprognostic (1.57e-1)" "unprognostic (6.35e-2)" 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.3 1.3 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.5 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.5 0.0 0.2 0.0 0.2 0.9 0.2 0.1 0.3 0.2 0.1 0.1 0.3 0.2 0.2 1.3 1.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GBX2 ENSG00000168505 "Gastrulation brain homeobox 2" P52951 2 236165236-236168369 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 11.9" "Cell line enhanced" "Detected in some" "AF22: 31.8;BEWO: 5.5;PC-3: 9.3;TIME: 5.0" "Group enriched" "Detected in some" 6 "glioma: 1.7;testis cancer: 6.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 0.7;thalamus: 1.4" "Region enhanced" "Detected in many" "thalamus: 6.3" HPA067809 Approved Nucleoplasm Nucleoplasm "HPA067809: " "unprognostic (5.30e-2)" "unprognostic (1.15e-1)" "unprognostic (7.09e-2)" "unprognostic (1.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.72e-2)" "unprognostic (2.91e-1)" "unprognostic (8.13e-2)" "unprognostic (6.99e-2)" "unprognostic (3.55e-4)" "unprognostic (8.69e-7)" "unprognostic (2.08e-1)" "unprognostic (1.01e-2)" "unprognostic (5.47e-2)" "unprognostic (9.39e-4)" 0.1 0.1 0.3 0.4 5.8 0.1 0.1 11.9 3.6 0.1 0.2 4.2 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.4 0.6 3.8 0.2 0.3 0.1 0.1 1.2 0.3 0.1 0.1 0.1 0.2 1.4 6.3 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.2 0.3 4.6 0.1 0.1 1.3 2.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 31.8 1.2 0.0 0.0 5.5 0.4 0.0 0.8 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.2 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.1 0.0 0.4 0.7 0.0 0.2 0.8 9.3 0.0 3.4 0.0 0.3 0.0 0.4 0.2 1.0 0.0 0.3 0.0 0.0 5.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.8 11.9 0.0 0.6 3.8 1.2 0.3 6.3 2.8 GC "DBP, hDBP, VDBP" ENSG00000145321 "GC, vitamin D binding protein" P02774 4 71741693-71804041 "Plasma proteins, Predicted secreted proteins" Transport Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "liver: 552.1" "Cell line enhanced" "Detected in some" "HL-60: 4.1;RH-30: 6.4;SiHa: 3.1;U-698: 2.3" "Cancer enriched" "Detected in many" 18 "liver cancer: 1016.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001526, CAB008596, HPA019855" Supported "Secreted to blood" 142606666667 69000000000 "CAB008596: AB_1622398, HPA001526: AB_1078959, HPA019855: AB_1849545" "prognostic favourable (8.08e-4)" "unprognostic (1.06e-3)" "prognostic unfavourable (5.81e-5)" "unprognostic (1.55e-1)" "unprognostic (2.15e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.9 0.0 0.0 2.6 0.1 0.2 0.1 0.1 43.7 0.1 0.1 0.1 2.0 552.1 0.1 0.0 0.1 0.0 0.1 6.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 1.0 0.0 0.1 0.4 2.6 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 1.0 0.0 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.0 1.7 0.0 1.7 0.0 0.0 0.8 0.0 2.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 GCG "GLP-1, GLP1, GLP2, GRPP" ENSG00000115263 Glucagon P01275 2 162142873-162152404 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "pancreas: 202.8" "Group enriched" "Detected in some" 5 "EFO-21: 37.1;U-2 OS: 52.8" "Cancer enriched" "Detected in some" 209 "pancreatic cancer: 428.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 10 "pons and medulla: 3.7" "Region enhanced" "Detected in single" "midbrain: 2.0" "CAB000040, HPA036760, HPA036761" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to blood" 77950 "Endoplasmic reticulum" Vesicles "CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297" "unprognostic (3.13e-3)" "unprognostic (9.99e-2)" "unprognostic (1.16e-2)" "unprognostic (1.26e-2)" 1.0 0.1 0.2 0.6 0.2 1.1 0.2 0.2 1.8 0.2 6.6 0.2 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.1 3.4 0.2 0.2 0.2 0.2 0.2 0.2 202.8 0.0 0.2 0.2 0.5 0.2 12.6 0.2 0.2 0.2 0.2 2.5 11.0 0.2 0.2 0.2 2.4 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.8 0.0 2.9 0.0 1.4 8.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.1 0.2 0.2 0.5 0.2 GCGR GGR ENSG00000215644 "Glucagon receptor" P47871 17 81804132-81814013 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 68.8" "Cell line enhanced" "Detected in some" "HeLa: 3.8;MCF7: 6.0;SK-BR-3: 5.2;U-87 MG: 6.0" "Cancer enhanced" "Detected in many" "liver cancer: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 0.9" "Low region specificity" "Detected in all" HPA071228 Approved "Golgi apparatus" "Golgi apparatus" "HPA071228: " "unprognostic (3.28e-4)" "unprognostic (9.30e-2)" "unprognostic (2.20e-1)" "unprognostic (1.53e-4)" "unprognostic (1.11e-1)" "unprognostic (2.30e-3)" "unprognostic (4.38e-2)" "unprognostic (1.79e-3)" "unprognostic (2.18e-1)" "unprognostic (2.77e-1)" "unprognostic (3.09e-1)" "unprognostic (2.61e-1)" "unprognostic (6.42e-2)" "unprognostic (5.99e-3)" "unprognostic (1.71e-1)" "unprognostic (1.17e-3)" "unprognostic (8.36e-3)" 0.2 3.9 0.1 0.6 0.3 0.0 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.0 11.4 68.8 0.1 0.1 0.1 0.1 0.1 0.5 3.9 0.1 0.1 0.5 0.2 0.0 1.4 0.3 0.1 0.1 0.9 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.2 0.6 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.8 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.0 5.2 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.5 0.1 GCK "HK4, MODY2" ENSG00000106633 Glucokinase P35557 7 44144271-44198170 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pituitary gland: 46.8" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 12.0" "Cancer enhanced" "Detected in some" "liver cancer: 4.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 4.4;naive CD4 T-cell: 4.8" "Group enriched" "Detected in many" 17 "B-cells: 4.4;T-cells: 4.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA007034, HPA007093" Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA007034: AB_1079050, HPA007093: AB_1079051" "unprognostic (3.09e-1)" "unprognostic (2.99e-2)" "unprognostic (3.32e-2)" "unprognostic (6.64e-7)" "unprognostic (8.00e-2)" "unprognostic (2.75e-1)" "unprognostic (1.07e-2)" "unprognostic (2.68e-1)" "unprognostic (1.24e-1)" "unprognostic (5.48e-2)" "unprognostic (8.11e-3)" "unprognostic (3.08e-1)" "unprognostic (3.79e-3)" "unprognostic (2.01e-2)" "unprognostic (3.24e-1)" "unprognostic (4.36e-2)" "unprognostic (1.53e-1)" 1.1 0.5 3.2 0.7 2.8 0.0 0.7 9.5 3.7 1.4 1.4 1.3 0.7 0.3 1.5 1.5 0.7 2.3 0.9 7.1 2.1 7.5 0.7 8.7 0.7 0.7 2.9 1.2 2.2 2.9 0.0 46.8 3.3 1.6 0.8 0.5 0.8 0.7 1.6 0.7 1.2 0.7 0.7 1.7 0.7 0.9 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.9 4.4 0.2 0.0 0.0 0.0 4.8 0.7 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.2 0.6 0.3 0.0 0.0 0.0 0.1 0.8 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.6 0.9 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 2.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.6 4.4 1.6 0.4 0.2 0.7 4.8 0.9 0.0 0.0 0.0 0.0 0.0 0.7 3.2 2.8 9.5 2.4 2.1 7.5 2.9 1.2 1.6 0.7 GCKR ENSG00000084734 "Glucokinase regulator" 2 27496842-27523684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 60.9" "Cell line enhanced" "Detected in some" "HEL: 12.4;Hep G2: 19.0;HUVEC TERT2: 6.1;TIME: 3.7" "Cancer enriched" "Detected in some" 8 "liver cancer: 14.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB034098, HPA064305" Enhanced Approved "Intermediate filaments" "Intermediate filaments" "CAB034098: AB_2247323, HPA064305: " "unprognostic (3.31e-1)" "unprognostic (2.11e-3)" "unprognostic (2.27e-1)" "unprognostic (6.97e-2)" "unprognostic (1.68e-2)" "unprognostic (5.70e-2)" "unprognostic (2.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.52e-1)" "unprognostic (4.12e-1)" "unprognostic (2.25e-3)" "unprognostic (1.65e-1)" "unprognostic (1.02e-7)" "unprognostic (6.51e-2)" "unprognostic (1.18e-1)" "unprognostic (9.27e-3)" "unprognostic (1.50e-2)" 0.2 2.0 0.1 0.1 0.3 0.2 0.1 0.2 0.2 0.1 0.4 0.1 0.1 0.2 0.1 0.3 0.4 0.0 3.9 0.5 0.1 0.0 0.2 60.9 0.1 0.1 0.1 0.1 2.0 0.9 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.2 1.3 0.1 0.1 0.5 3.1 0.9 0.2 0.1 0.1 0.1 0.2 0.1 0.1 2.4 0.8 2.6 1.2 1.7 0.9 0.7 0.2 0.4 0.4 0.2 0.3 0.2 0.1 0.0 0.1 0.3 0.0 0.4 0.1 0.2 0.5 0.6 0.2 0.2 0.0 0.0 0.1 0.0 12.4 0.5 19.0 0.8 0.1 0.4 0.3 0.9 0.5 0.1 6.1 0.0 0.2 0.2 0.1 0.1 0.7 0.1 0.0 0.3 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.5 0.1 3.7 0.1 0.3 0.6 0.2 0.3 0.1 0.2 1.1 0.1 0.2 2.6 1.2 0.3 0.6 1.0 0.6 0.8 0.4 0.4 0.1 2.4 0.9 0.8 2.1 1.7 0.3 0.8 0.1 0.7 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.2 GCM1 "GCMA, hGCMa" ENSG00000137270 "Glial cells missing homolog 1" Q9NP62 6 53126964-53148829 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "placenta: 102.4" "Cell line enriched" "Detected in some" 22 "BEWO: 29.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.5" "Group enriched" "Detected in many" 8 "B-cells: 1.8;granulocytes: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011343, HPA073469" Enhanced Approved Vesicles Vesicles "HPA011343: , HPA073469: " "unprognostic (2.81e-2)" "unprognostic (4.09e-2)" "unprognostic (1.89e-2)" "unprognostic (1.53e-1)" "unprognostic (3.17e-1)" "unprognostic (7.68e-2)" "unprognostic (8.47e-3)" "unprognostic (2.83e-2)" "unprognostic (2.81e-1)" "unprognostic (4.04e-2)" "unprognostic (1.42e-1)" "unprognostic (5.98e-2)" "unprognostic (1.29e-4)" "unprognostic (1.86e-1)" "unprognostic (7.42e-2)" "unprognostic (2.96e-2)" 0.3 0.3 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.0 1.5 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.2 102.4 0.1 0.2 0.0 0.1 0.1 0.1 3.1 0.0 0.4 0.1 0.1 2.2 0.0 2.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.8 0.2 4.5 0.3 0.4 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 29.6 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.1 0.6 0.3 2.2 0.2 0.1 0.2 0.7 0.1 0.1 0.2 1.8 0.2 0.2 4.5 0.4 0.3 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 GCM2 "GCMB, hGCMb" ENSG00000124827 "Glial cells missing homolog 2" O75603 6 10873223-10881941 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "parathyroid gland: 110.5" "Cell line enhanced" "Detected in some" "HL-60: 1.2;HMC-1: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (1.55e-1)" "unprognostic (4.94e-1)" "unprognostic (2.18e-2)" "unprognostic (7.17e-2)" "unprognostic (2.63e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GCNA "ACRC, NAAR1" ENSG00000147174 "Germ cell nuclear acidic peptidase" Q96QF7 X 71578411-71613583 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 29.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA023476 Enhanced Approved Vesicles Vesicles "HPA023476: AB_1844530" "unprognostic (6.01e-2)" "unprognostic (2.30e-1)" "unprognostic (1.43e-2)" "unprognostic (4.37e-3)" "unprognostic (1.39e-1)" "unprognostic (2.35e-4)" "unprognostic (5.84e-2)" "unprognostic (1.31e-1)" "unprognostic (3.16e-1)" "unprognostic (1.68e-1)" "unprognostic (1.03e-2)" "unprognostic (2.06e-1)" "unprognostic (5.07e-10)" "unprognostic (2.30e-1)" "unprognostic (5.06e-2)" "unprognostic (4.74e-1)" "unprognostic (1.15e-5)" 1.4 6.9 1.2 1.7 1.7 1.6 1.2 3.7 1.7 1.2 1.2 1.2 1.2 1.0 1.2 1.4 1.2 0.9 1.2 1.2 1.3 2.5 1.2 1.8 1.4 2.6 1.2 1.2 1.5 1.7 0.4 1.2 1.2 1.7 1.2 1.0 1.2 1.2 1.2 3.1 1.7 1.5 1.2 1.2 3.9 0.9 29.4 1.2 1.2 1.6 1.2 1.4 1.2 1.2 1.4 0.6 1.1 0.6 1.4 3.3 0.5 0.6 1.1 2.2 2.0 4.5 4.1 1.3 3.6 1.9 1.2 2.1 2.0 1.3 5.5 2.7 1.9 2.6 4.3 0.2 1.8 0.9 2.9 1.1 4.9 0.5 1.2 1.0 5.1 1.6 6.9 1.0 0.9 0.8 1.5 3.4 2.5 0.7 0.4 3.9 2.2 2.5 1.0 0.1 4.0 2.8 1.5 1.3 0.2 1.2 0.6 3.0 0.4 3.4 1.4 1.3 2.6 1.8 1.0 1.0 2.5 2.2 2.5 2.1 2.2 0.6 0.6 0.1 0.7 0.3 1.3 1.4 1.7 3.3 0.3 0.5 1.0 1.1 1.1 1.4 0.1 0.6 3.0 0.5 1.2 1.7 3.7 1.7 1.3 2.5 1.2 1.2 1.7 1.2 GCSAML-AS1 ENSG00000284824 "GCSAML antisense RNA 1" Q8N628 1 247524679-247532613 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 4.5" "Cell line enhanced" "Detected in some" "HMC-1: 2.0;SK-MEL-30: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA058578 Uncertain "Plasma membrane" "Plasma membrane" "HPA058578: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 0.0 GDAP1L1 ENSG00000124194 "Ganglioside induced differentiation associated protein 1 like 1" Q96MZ0 20 44247099-44280917 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.4" "Group enriched" "Detected in some" 5 "NTERA-2: 9.6;SCLC-21H: 23.6;SH-SY5Y: 11.6" "Cancer enriched" "Detected in single" 14 "glioma: 6.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054182, HPA063265" Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA054182: , HPA063265: " "unprognostic (6.58e-3)" "unprognostic (2.58e-1)" "unprognostic (2.30e-1)" "unprognostic (2.23e-4)" "unprognostic (3.69e-1)" "unprognostic (5.15e-1)" "unprognostic (6.45e-2)" "unprognostic (7.69e-2)" "unprognostic (1.53e-1)" "unprognostic (5.07e-1)" "unprognostic (4.74e-3)" "unprognostic (2.41e-1)" "unprognostic (3.81e-5)" "unprognostic (8.57e-2)" "unprognostic (1.87e-1)" "unprognostic (3.21e-2)" "unprognostic (1.13e-1)" 1.1 3.9 18.9 1.3 14.9 1.2 1.1 17.8 47.4 1.2 1.2 1.4 0.0 1.0 1.5 1.1 1.1 1.2 1.1 1.3 13.1 14.3 1.1 1.0 1.0 1.0 9.1 12.2 3.0 1.8 2.4 7.1 1.0 10.6 1.1 1.1 0.9 1.0 1.1 1.1 1.5 1.3 1.2 2.6 1.0 1.9 2.8 1.6 0.0 1.1 0.0 1.0 1.1 0.0 0.1 0.0 0.7 0.1 0.5 0.8 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 23.6 11.6 0.0 0.1 1.0 0.0 3.0 0.0 0.9 0.5 0.2 0.0 0.0 0.1 0.6 0.8 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.7 0.5 0.1 0.0 0.0 0.0 18.9 14.9 17.8 25.7 13.1 14.3 9.1 12.2 10.6 1.6 GDF15 "MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB" ENSG00000130513 "Growth differentiation factor 15" Q99988 19 18374731-18389176 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 463.0" "Cell line enhanced" "Detected in many" "BEWO: 70.7;Hep G2: 36.4;HHSteC: 98.3;TIME: 35.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 10 "pons and medulla: 6.5" "Cell type enhanced" "Detected in some" "neutrophil: 6.3" "Group enriched" "Detected in many" 5 "granulocytes: 6.3;monocytes: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011191, CAB062554, HPA070957" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" 1258667 890000 "Golgi apparatus" "CAB062554: , HPA011191: AB_1078962, HPA070957: " "unprognostic (1.04e-1)" "unprognostic (1.89e-2)" "unprognostic (3.45e-2)" "unprognostic (3.36e-2)" "unprognostic (2.04e-2)" "unprognostic (2.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.30e-2)" "unprognostic (2.80e-1)" "unprognostic (2.89e-1)" "unprognostic (5.09e-2)" "unprognostic (1.46e-1)" "unprognostic (6.55e-3)" "unprognostic (3.81e-2)" "unprognostic (8.45e-2)" "unprognostic (1.25e-1)" "unprognostic (3.04e-3)" 13.4 2.2 0.4 1.0 0.6 0.0 13.1 0.4 0.5 3.9 13.0 1.0 1.9 1.8 5.9 1.9 2.4 1.1 13.1 1.2 0.5 0.0 64.7 24.1 12.6 0.8 0.4 0.5 2.9 21.9 0.3 2.4 463.0 6.5 25.5 11.0 1.6 2.4 5.1 13.6 1.1 1.8 4.8 1.2 1.4 12.0 2.5 0.4 0.4 5.2 0.5 0.8 47.0 2.7 0.2 0.8 6.3 2.3 0.0 0.0 0.3 0.3 15.8 1.5 0.5 3.8 3.2 70.7 5.5 3.0 0.2 3.2 0.7 4.9 0.0 10.0 0.4 0.1 0.0 2.0 0.8 0.0 0.3 0.2 1.5 36.4 98.3 0.0 6.1 8.4 23.8 15.4 10.0 16.7 24.3 0.1 3.8 3.8 0.0 0.1 0.9 8.9 0.0 0.6 0.0 11.7 15.6 0.1 0.1 0.0 0.9 19.8 0.4 0.0 35.3 0.0 1.3 0.3 0.2 0.2 0.6 0.0 8.9 0.0 4.6 0.0 1.8 2.1 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 6.3 0.0 2.3 0.0 0.0 0.3 0.4 0.6 0.4 0.5 0.5 0.0 0.4 0.5 6.5 0.4 GDF2 "BMP-9, BMP9" ENSG00000263761 "Growth differentiation factor 2" Q9UK05 10 47322490-47326270 "Disease related genes, Plasma proteins, Predicted secreted proteins" Angiogenesis "Cytokine, Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 273 "liver: 27.3" "Cell line enhanced" "Detected in single" "K-562: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB023357 Uncertain "Secreted to blood" 2207333 300000 "CAB023357: AB_2111086" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GDI1 "FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4" ENSG00000203879 "GDP dissociation inhibitor 1" P31150 X 154436913-154443467 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 122.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012979, HPA049290, HPA057668" Enhanced Approved Vesicles 70000000 Vesicles "CAB012979: AB_2533970, HPA049290: , HPA057668: " "prognostic unfavourable (6.84e-4)" "unprognostic (1.13e-2)" "prognostic unfavourable (3.83e-5)" "unprognostic (3.53e-1)" "unprognostic (1.22e-1)" "unprognostic (1.92e-3)" "unprognostic (1.31e-3)" "unprognostic (1.36e-1)" "unprognostic (1.46e-2)" "unprognostic (1.30e-1)" "unprognostic (2.98e-3)" "unprognostic (3.86e-2)" "unprognostic (3.88e-3)" "unprognostic (1.70e-1)" "unprognostic (8.12e-2)" "unprognostic (1.92e-2)" "unprognostic (1.72e-1)" 19.8 27.1 51.7 16.2 65.3 10.5 12.0 61.3 122.3 16.7 13.6 46.2 6.5 11.5 20.1 15.7 14.4 23.0 15.2 25.7 53.7 54.3 13.7 10.3 16.9 15.1 45.1 49.6 27.7 16.2 18.8 26.9 19.0 65.3 19.6 13.9 13.8 13.6 24.0 14.3 17.2 13.1 25.6 46.4 17.1 13.5 12.9 31.3 6.8 12.7 6.2 15.7 13.9 11.8 7.6 8.3 20.6 13.4 5.6 13.0 4.9 20.3 18.9 42.7 35.2 17.5 20.7 13.4 29.5 19.8 31.1 32.5 11.0 10.8 16.3 30.9 29.9 16.1 37.4 18.0 21.6 29.4 18.4 5.1 27.7 7.3 25.8 4.9 18.6 21.2 22.3 36.0 22.1 20.0 6.2 25.9 36.9 20.6 15.6 12.4 11.3 34.5 15.6 11.1 9.3 21.7 9.6 59.1 45.7 14.2 18.5 22.4 11.0 8.9 22.6 28.7 24.9 29.7 43.1 36.7 38.9 25.9 31.2 11.1 35.2 14.9 5.7 17.2 8.9 8.6 13.0 7.3 9.6 8.6 4.7 7.6 7.6 7.5 20.6 5.6 13.4 8.3 10.8 4.9 51.7 65.3 61.3 96.6 53.7 54.3 45.1 49.6 65.3 31.3 GDPD4 GDE6 ENSG00000178795 "Glycerophosphodiester phosphodiesterase domain containing 4" Q6W3E5 11 77216558-77301687 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 7.6" "Cell line enhanced" "Detected in some" "BEWO: 1.6;HEL: 3.4;U-937: 1.1" "Cancer enriched" "Detected in single" 10 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 24 "olfactory region: 2.8" "unprognostic (6.73e-6)" "unprognostic (3.30e-1)" "unprognostic (2.01e-2)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (3.55e-4)" "unprognostic (4.13e-2)" "unprognostic (5.41e-2)" "unprognostic (1.53e-1)" "unprognostic (2.63e-2)" "unprognostic (3.10e-2)" "unprognostic (4.75e-2)" "unprognostic (1.05e-4)" "unprognostic (1.68e-2)" "unprognostic (1.19e-1)" "unprognostic (1.29e-2)" "unprognostic (1.64e-2)" 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GFAP FLJ45472 ENSG00000131095 "Glial fibrillary acidic protein" P14136 17 44903161-44916937 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 61 "brain: 595.5" "Cell line enhanced" "Detected in many" "U-87 MG: 9.5" "Cancer enriched" "Detected in some" 368 "glioma: 2468.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.8" "Group enriched" "Detected in many" 5 "granulocytes: 9.8;NK-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000039, HPA056030, HPA063513" Enhanced Supported Supported "Intermediate filaments" 220000000 "Intermediate filaments" "CAB000039: AB_10013382, HPA056030: , HPA063513: " "unprognostic (1.79e-2)" "unprognostic (2.74e-1)" "unprognostic (9.83e-2)" "unprognostic (2.12e-5)" "unprognostic (4.08e-1)" "unprognostic (5.09e-1)" "unprognostic (1.26e-1)" "unprognostic (6.53e-2)" "unprognostic (6.57e-3)" "unprognostic (7.35e-2)" "unprognostic (5.86e-2)" "unprognostic (1.24e-1)" "unprognostic (7.63e-2)" "unprognostic (2.75e-5)" "unprognostic (1.49e-1)" "unprognostic (1.66e-1)" "unprognostic (1.64e-1)" 3.0 2.9 122.2 3.2 105.4 5.8 3.0 33.9 595.5 2.7 3.0 171.0 0.0 2.8 2.9 3.0 3.6 3.2 3.1 4.0 143.0 175.1 3.0 2.8 3.0 3.1 227.0 67.3 3.0 3.0 3.4 1.3 2.8 212.7 3.0 2.9 0.0 3.1 2.9 3.2 3.3 2.8 2.9 482.0 3.0 3.0 2.9 119.0 0.0 3.0 0.0 2.9 3.4 0.0 1.1 0.8 9.8 1.2 2.9 0.8 0.3 1.7 1.1 2.0 3.8 0.0 0.8 0.5 1.7 2.0 2.4 2.0 2.1 2.4 3.5 3.1 0.9 4.3 2.2 0.7 3.0 4.3 1.9 2.8 2.9 1.4 0.1 0.8 4.2 0.2 1.3 1.7 0.0 0.0 1.3 8.3 0.6 2.2 2.9 4.1 2.7 5.2 1.2 1.2 2.8 1.1 1.5 2.7 2.9 0.5 3.4 0.3 2.2 2.2 1.2 2.1 1.6 1.9 2.5 1.2 2.3 2.7 9.5 3.4 3.3 1.9 1.2 0.5 0.5 1.1 0.4 0.4 0.5 0.7 0.3 1.1 0.6 0.8 9.8 2.9 0.7 0.8 0.4 0.3 122.2 105.4 33.9 69.4 143.0 175.1 227.0 67.3 212.7 119.0 GGCX VKCFD1 ENSG00000115486 "Gamma-glutamyl carboxylase" P38435 2 85544723-85561547 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" Lyase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 74.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018284 Approved "HPA018284: AB_1849641" "unprognostic (4.88e-3)" "unprognostic (1.13e-2)" "unprognostic (1.22e-2)" "prognostic unfavourable (1.82e-6)" "unprognostic (5.67e-2)" "unprognostic (1.85e-3)" "unprognostic (2.96e-2)" "unprognostic (3.77e-2)" "unprognostic (5.64e-2)" "unprognostic (2.18e-2)" "unprognostic (6.45e-3)" "unprognostic (5.23e-2)" "unprognostic (8.17e-3)" "unprognostic (7.85e-2)" "unprognostic (2.59e-1)" "unprognostic (7.63e-3)" "unprognostic (9.38e-2)" 7.1 7.8 4.8 4.2 6.3 1.6 10.8 6.3 6.6 6.4 4.9 5.4 8.3 4.0 6.3 8.1 6.5 5.9 7.0 6.8 5.4 3.6 9.0 74.8 8.1 5.4 5.4 5.0 7.0 11.4 15.1 5.6 13.8 5.9 6.3 5.5 5.8 7.4 7.9 6.8 4.9 5.5 7.2 5.1 4.5 6.0 3.6 5.7 3.4 8.5 5.3 5.4 7.3 6.0 0.9 4.9 6.0 7.2 2.2 3.2 3.2 6.8 11.1 7.9 8.8 40.0 11.4 17.6 12.2 14.4 9.0 12.8 19.0 8.4 2.4 12.5 20.0 11.1 5.6 15.4 10.0 4.3 7.7 4.4 7.4 18.0 14.9 2.7 4.2 14.1 9.1 18.2 12.5 12.7 5.3 3.6 26.1 8.9 1.4 2.1 3.7 9.6 2.6 18.6 6.1 12.5 13.1 3.0 5.0 10.9 21.6 11.3 10.5 2.7 11.6 11.6 10.2 11.2 8.3 2.8 7.8 2.0 11.1 2.8 16.2 6.0 7.2 3.6 3.2 7.2 3.0 0.7 1.3 1.2 4.9 0.9 3.2 3.0 3.2 2.2 4.4 4.0 1.9 3.2 4.8 6.3 6.3 6.6 5.4 3.6 5.4 5.0 5.9 5.7 GGN "FLJ35713, MGC33369" ENSG00000179168 Gametogenetin Q86UU5 19 38384265-38388082 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 84.1" "Cell line enhanced" "Detected in many" "BEWO: 6.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "eosinophil: 3.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (8.33e-2)" "unprognostic (3.51e-3)" "unprognostic (1.38e-2)" "unprognostic (6.22e-3)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (1.40e-1)" "unprognostic (1.88e-2)" "unprognostic (1.64e-1)" "unprognostic (8.10e-2)" "unprognostic (1.06e-2)" "unprognostic (5.89e-4)" "unprognostic (4.86e-4)" "unprognostic (1.30e-2)" "unprognostic (1.97e-1)" "unprognostic (2.00e-1)" "unprognostic (2.40e-1)" 0.3 0.0 0.6 0.2 0.5 0.3 0.1 0.3 0.9 0.2 2.2 0.1 0.1 3.2 0.3 1.0 0.3 0.1 0.5 0.1 0.7 0.4 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.4 0.2 0.6 0.3 0.3 0.3 0.0 0.6 0.6 0.3 0.2 0.5 4.6 0.1 0.1 0.1 0.1 84.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.4 3.2 0.6 0.0 0.2 0.1 0.4 1.0 0.3 0.6 0.0 0.6 6.3 3.5 0.7 0.4 0.8 1.5 0.7 0.7 2.5 1.0 0.9 0.0 0.1 0.0 2.2 4.3 0.6 1.0 0.6 0.7 1.7 0.2 0.3 0.0 1.1 0.0 1.7 1.8 1.1 0.1 0.5 0.2 0.1 0.5 1.5 0.4 0.6 0.0 1.6 0.8 0.5 3.8 0.5 0.4 0.1 0.8 0.0 2.1 0.5 3.3 2.2 1.6 0.6 1.3 0.0 2.2 0.7 1.8 0.0 0.2 3.2 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.1 0.6 0.5 0.3 0.8 0.7 0.4 0.3 0.1 0.3 0.1 GGTLC2 GGTL4 ENSG00000100121 "Gamma-glutamyltransferase light chain 2" Q14390 22 22644475-22647903 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 11.1" "Cell line enhanced" "Detected in some" "BEWO: 1.5;RPMI-8226: 4.5;THP-1: 2.8;U-2 OS: 2.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA045635, HPA047534" Uncertain "HPA045635: , HPA047534: " "unprognostic (2.58e-2)" "unprognostic (2.35e-2)" "unprognostic (7.17e-2)" "unprognostic (2.96e-1)" "unprognostic (4.31e-1)" "unprognostic (1.57e-2)" "unprognostic (1.06e-3)" "unprognostic (1.48e-2)" "unprognostic (1.55e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 11.1 0.2 0.0 0.0 0.0 0.3 0.9 1.4 1.3 0.8 0.7 0.6 0.0 0.5 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.5 1.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 2.8 0.0 0.0 2.3 0.0 0.0 0.7 0.5 0.1 0.0 0.2 0.0 0.5 1.3 0.0 0.0 0.5 0.2 0.3 0.7 0.4 0.9 0.0 0.0 0.3 1.4 0.8 0.7 0.0 0.7 0.6 GH1 "GH, GH-N, GHN, hGH-N" ENSG00000259384 "Growth hormone 1" P01241 17 63917200-63918838 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pituitary gland: 994.5" "Cell line enriched" "Detected in some" 5 "U-698: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.1;T-reg: 2.2" "Group enriched" "Detected in many" 4 "B-cells: 2.1;T-cells: 2.2" HPA043715 Supported "Secreted to blood" 1735000 180000 "HPA043715: " "unprognostic (1.91e-2)" "unprognostic (3.51e-2)" "unprognostic (1.72e-2)" "unprognostic (2.98e-1)" "unprognostic (9.45e-4)" "unprognostic (2.48e-1)" "unprognostic (2.09e-4)" "unprognostic (2.03e-2)" "unprognostic (6.57e-2)" "unprognostic (2.33e-1)" 0.3 0.0 0.0 0.5 0.0 1.1 0.2 0.1 0.1 0.4 0.4 0.0 0.0 3.3 1.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.6 0.0 0.0 0.0 0.0 0.3 994.5 217.7 0.1 0.2 0.5 0.0 0.1 0.2 0.8 0.9 0.4 0.1 0.0 1.6 0.3 0.5 0.0 0.0 0.0 0.0 0.6 0.1 0.0 2.1 0.0 0.0 0.5 0.0 2.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 1.5 7.4 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.5 0.0 2.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 GHRH GHRF ENSG00000118702 "Growth hormone releasing hormone" P01286 20 37251082-37261835 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 37.3" "Group enriched" "Detected in some" 7 "NTERA-2: 3.5;U-266/84: 12.4" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 8.5" "Region enriched" "Detected in some" 15 "hypothalamus: 37.3" "Cell type enhanced" "Detected in single" "eosinophil: 2.7" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in some" 9 "hypothalamus: 38.7" "Low region specificity" "Detected in many" "Secreted in other tissues" "unprognostic (4.78e-2)" "unprognostic (2.57e-2)" "unprognostic (1.58e-1)" "unprognostic (3.10e-1)" 0.1 2.7 0.3 0.1 2.4 0.0 0.6 0.1 1.0 0.1 4.0 0.1 0.1 8.1 0.1 0.1 0.7 0.0 0.1 6.5 0.1 37.3 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 7.7 0.1 0.1 0.1 1.9 0.1 0.1 7.5 0.4 0.1 0.1 0.1 0.1 0.0 0.7 2.7 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.4 0.1 1.0 0.1 37.3 0.1 0.8 0.1 0.1 GHRHR ENSG00000106128 "Growth hormone releasing hormone receptor" Q02643 7 30938669-30993254 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "pituitary gland: 108.9" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Cancer enhanced" "Detected in single" "liver cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" "unprognostic (8.32e-2)" "unprognostic (1.45e-1)" "unprognostic (9.30e-2)" "unprognostic (1.39e-1)" "unprognostic (7.23e-2)" "unprognostic (4.15e-1)" "unprognostic (2.28e-2)" "unprognostic (1.54e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (1.43e-2)" "unprognostic (1.47e-1)" "unprognostic (5.87e-3)" 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 108.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GIF "IF, IFMH, INF, TCN3" ENSG00000134812 "Gastric intrinsic factor" P27352 11 59829268-59845501 "Disease related genes, Predicted secreted proteins" "Cobalt transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "stomach 1: 185.6" "Cell line enriched" "Detected in single" 4 "THP-1: 3.8" "Cancer enriched" "Detected in some" 11 "stomach cancer: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039908, HPA040774" Enhanced "Secreted to digestive system" "HPA039908: AB_10796335, HPA040774: AB_10795626" "unprognostic (2.78e-4)" "unprognostic (1.04e-1)" "unprognostic (2.45e-1)" "unprognostic (3.59e-1)" "unprognostic (1.66e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 7.1 0.0 0.0 0.0 0.0 3.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 185.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 GIMD1 ENSG00000250298 "GIMAP family P-loop NTPase domain containing 1" P0DJR0 4 106357485-106368825 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "intestine: 24.0" "Cell line enhanced" "Detected in some" "CACO-2: 1.8;HBF TERT88: 1.0;HEL: 1.0;NB-4: 1.2;U-138 MG: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 23.5 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GIP ENSG00000159224 "Gastric inhibitory polypeptide" P09681 17 48958554-48968596 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 64 "intestine: 87.5" "Group enriched" "Detected in some" 4 "A549: 8.6;BEWO: 7.8;Hep G2: 12.3" "Cancer enriched" "Detected in some" 63 "testis cancer: 74.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016729, HPA021612" Enhanced "Secreted to blood" 33915 "CAB016729: , HPA021612: AB_1849506" "unprognostic (2.95e-1)" "unprognostic (2.70e-3)" "unprognostic (4.42e-2)" "unprognostic (1.82e-1)" 0.2 0.3 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 87.5 0.0 0.0 75.4 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 61.7 0.0 0.1 0.1 0.2 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.4 0.7 7.8 0.3 0.0 0.1 0.0 2.2 0.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 1.5 12.3 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 2.1 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 GJA10 CX62 ENSG00000135355 "Gap junction protein alpha 10" Q969M2 6 89894469-89921760 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "testis: 2.3" "Group enriched" "Detected in some" 9 "HAP1: 2.8;NTERA-2: 1.6" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA021145 Uncertain "HPA021145: " "unprognostic (1.09e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJA5 CX40 ENSG00000265107 "Gap junction protein alpha 5" P36382 1 147756199-147773362 "Disease related genes, Predicted membrane proteins" "Atrial fibrillation, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "placenta: 60.6" "Cell line enriched" "Detected in some" 10 "SK-BR-3: 54.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB013080, HPA071370" Enhanced "CAB013080: AB_2533263, HPA071370: " "unprognostic (1.25e-1)" "unprognostic (6.34e-2)" "unprognostic (1.22e-2)" "unprognostic (2.94e-2)" "unprognostic (3.88e-2)" "unprognostic (8.95e-2)" "unprognostic (1.23e-3)" "unprognostic (5.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.16e-1)" "unprognostic (4.27e-2)" "unprognostic (7.57e-2)" "unprognostic (1.97e-2)" "unprognostic (2.44e-1)" "unprognostic (4.41e-2)" "unprognostic (3.43e-2)" "unprognostic (8.93e-2)" 8.8 0.2 0.6 1.5 1.1 0.0 2.1 0.7 0.7 2.1 2.2 0.8 2.8 0.6 1.2 1.6 1.2 2.6 1.7 15.1 0.9 7.0 0.2 9.3 0.3 0.9 0.0 2.2 0.7 0.8 0.0 60.6 1.2 1.6 0.9 2.0 0.2 3.1 1.7 0.0 1.4 2.5 0.9 1.9 0.0 1.3 0.3 0.0 2.1 0.4 0.5 2.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.1 0.0 0.0 0.0 2.3 1.7 0.9 0.9 0.2 0.0 0.1 0.0 0.5 0.3 0.1 0.0 3.7 1.4 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.1 54.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 GJA8 "CAE, CAE1, CX50, CZP1" ENSG00000121634 "Gap junction protein alpha 8" P48165 1 147907956-147909257 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 76 "testis: 18.0" "Cell line enriched" "Detected in single" 13 "RPTEC TERT1: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014715, HPA062940" Enhanced "HPA014715: AB_2732411, HPA062940: AB_2732693" "unprognostic (3.73e-2)" "unprognostic (2.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJA9 "CX58, CX59, GJA10" ENSG00000131233 "Gap junction protein alpha 9" P57773 1 38874451-38881587 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 15.8" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067850 Uncertain "HPA067850: " "unprognostic (2.00e-1)" "unprognostic (8.78e-2)" "unprognostic (4.55e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-2)" "unprognostic (1.20e-2)" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" "unprognostic (2.75e-2)" "unprognostic (1.90e-2)" "unprognostic (2.63e-1)" "unprognostic (4.11e-3)" "unprognostic (2.32e-2)" 1.1 0.1 0.7 0.4 0.9 0.2 0.4 0.9 1.0 0.4 0.7 0.7 0.4 0.9 0.4 0.4 1.4 0.6 0.8 2.3 1.2 0.6 0.4 0.4 0.4 0.4 1.2 0.4 0.4 0.4 0.0 0.9 0.4 0.7 0.5 1.3 1.8 0.8 0.4 0.6 1.9 0.5 0.4 1.8 0.4 1.2 15.8 0.4 0.4 1.1 0.4 0.4 1.2 0.7 1.5 1.0 1.8 1.2 0.4 1.5 0.4 0.6 0.9 0.8 0.6 0.0 0.0 0.7 0.7 0.0 0.1 0.0 0.2 2.0 0.4 0.1 0.0 0.2 0.0 0.4 0.3 0.8 0.8 0.4 0.7 1.3 0.0 1.0 0.7 0.0 0.4 0.4 0.0 0.0 0.4 1.5 0.1 0.2 0.5 0.1 0.3 0.4 0.7 0.2 0.2 0.0 1.5 0.8 0.8 0.0 0.6 1.7 0.3 0.4 2.2 1.9 0.5 0.4 0.1 0.4 0.7 0.5 1.9 0.6 0.8 0.0 1.1 0.0 0.6 1.2 0.4 0.9 0.5 0.3 1.0 1.5 1.1 0.6 1.8 0.4 0.3 0.3 1.5 0.4 0.7 0.9 0.9 1.0 1.2 0.6 1.2 0.4 0.7 0.4 GJC2 "CX46.6, CX47, GJA12, SPG44" ENSG00000198835 "Gap junction protein gamma 2" Q5T442 1 228149852-228159826 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 34.3" "Cell line enhanced" "Detected in some" "EFO-21: 9.7;SCLC-21H: 5.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069619 Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA069619: " "unprognostic (2.67e-1)" "unprognostic (1.81e-2)" "unprognostic (6.42e-2)" "unprognostic (8.19e-3)" "unprognostic (4.24e-1)" "unprognostic (1.57e-1)" "unprognostic (6.94e-2)" "unprognostic (2.56e-1)" "unprognostic (4.99e-2)" "unprognostic (7.09e-2)" "unprognostic (7.88e-3)" "unprognostic (9.67e-2)" "unprognostic (6.09e-3)" "unprognostic (2.53e-2)" "unprognostic (7.36e-2)" "unprognostic (1.54e-1)" "unprognostic (2.02e-1)" 2.4 1.9 4.6 1.2 10.0 0.5 2.0 2.2 14.8 2.8 2.6 34.3 0.0 0.6 4.5 2.0 1.7 4.8 1.4 1.6 9.3 5.3 0.6 0.5 3.1 1.2 27.2 5.6 3.4 0.9 2.9 0.6 1.2 18.3 2.1 0.8 0.0 1.5 4.0 1.5 2.4 1.2 3.8 32.6 1.9 1.2 1.0 15.7 0.0 0.9 0.0 0.7 1.3 1.8 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.2 0.5 1.3 0.7 1.8 1.4 0.4 0.6 0.7 0.9 1.2 0.2 9.7 2.6 0.9 0.3 0.3 0.3 0.3 1.5 0.3 2.4 2.1 2.5 0.0 0.0 0.4 0.2 0.8 0.5 0.2 1.0 0.3 0.4 0.5 1.8 0.6 0.6 1.9 0.4 0.3 0.1 0.8 0.0 5.1 3.0 0.4 0.1 0.3 0.1 0.3 4.5 1.3 3.7 4.4 1.5 0.3 0.6 0.2 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 4.6 10.0 2.2 10.4 9.3 5.3 27.2 5.6 18.3 15.7 GK2 "GKP2, GKTA" ENSG00000196475 "Glycerol kinase 2" Q14410 4 79406352-79408293 "Enzymes, Plasma proteins, Predicted membrane proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 90 "testis: 61.0" "Cell line enriched" "Detected in single" 52 "SCLC-21H: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 2.0" HPA060687 Uncertain "HPA060687: " "unprognostic (1.31e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GK3P "GKP3, GKTB" ENSG00000229894 "Glycerol kinase 3 pseudogene" Q14409 4 165277812-165279679 "Enzymes, Predicted membrane proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 17.0" "Cell line enhanced" "Detected in single" "TIME: 1.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 2.9" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.9" HPA060687 Uncertain "HPA060687: " "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (3.01e-2)" "unprognostic (1.17e-2)" "unprognostic (2.11e-2)" "unprognostic (3.94e-1)" "unprognostic (1.61e-1)" "unprognostic (2.04e-1)" "unprognostic (6.19e-2)" "unprognostic (6.99e-2)" "unprognostic (4.63e-2)" "unprognostic (2.02e-1)" "unprognostic (4.56e-1)" "unprognostic (3.34e-4)" 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.1 2.9 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.4 0.0 0.2 1.0 0.0 0.1 0.0 0.1 0.0 0.4 0.8 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.9 0.0 0.1 0.0 0.1 0.0 GKN1 "AMP18, BRICD1, CA11" ENSG00000169605 "Gastrokine 1" Q9NS71 2 68974573-68980974 "Plasma proteins, Predicted secreted proteins" Mitogen "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 41 "stomach 1: 918.9" "Cell line enhanced" "Detected in some" "HaCaT: 5.1;HMC-1: 13.9;MOLT-4: 9.7;NTERA-2: 13.2;REH: 5.6;U-2 OS: 8.6;U-266/70: 8.6" "Cancer enriched" "Detected in some" 116 "stomach cancer: 255.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA047684 Enhanced "Secreted to digestive system" 26000000 "HPA047684: " "unprognostic (5.40e-2)" "prognostic unfavourable (1.54e-4)" "unprognostic (4.54e-1)" "prognostic favourable (4.53e-4)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 22.4 0.0 2.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 918.9 0.0 0.0 1.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 5.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.7 0.0 13.2 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 8.6 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 GKN2 "blottin, BRICD1B, GDDR, PRO813, TFIZ1, VLTI465" ENSG00000183607 "Gastrokine 2" Q86XP6 2 68945232-68952970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "stomach 1: 311.1" "Cell line enhanced" "Detected in some" "A549: 3.6;HMC-1: 3.6;MOLT-4: 2.8;NTERA-2: 4.2;PC-3: 7.7;U-2 OS: 3.0;U-266/70: 3.4" "Cancer enriched" "Detected in some" 8 "stomach cancer: 43.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 19 "granulocytes: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA057765 Enhanced "Secreted to digestive system" "HPA057765: " "unprognostic (1.81e-1)" "unprognostic (1.44e-4)" "unprognostic (2.22e-1)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.1 2.1 0.1 0.0 0.1 0.1 0.2 0.0 1.4 0.1 0.1 0.0 0.1 0.1 38.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 311.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 4.2 7.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 3.0 0.3 0.0 3.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 GLIPR1L1 MGC26856 ENSG00000173401 "GLIPR1 like 1" Q6UWM5 12 75334639-75370560 "Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 45.6" "Cell line enriched" "Detected in single" 100 "NTERA-2: 49.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042095 Enhanced "Secreted in male reproductive system" "HPA042095: AB_10796898" "unprognostic (2.45e-3)" "unprognostic (1.56e-1)" "unprognostic (4.40e-2)" "unprognostic (1.72e-1)" "unprognostic (7.47e-2)" "unprognostic (3.04e-1)" "unprognostic (2.70e-1)" "unprognostic (4.79e-2)" "unprognostic (3.01e-1)" "unprognostic (2.89e-1)" "unprognostic (7.90e-3)" "unprognostic (1.08e-1)" "unprognostic (9.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.65e-1)" "unprognostic (2.00e-1)" "unprognostic (2.11e-2)" 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.4 0.8 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.5 0.1 0.5 0.9 0.1 0.1 0.3 0.1 0.2 0.2 0.1 0.1 0.5 0.1 0.0 0.3 0.1 0.3 0.1 0.0 0.1 0.4 0.1 0.2 0.8 0.1 0.1 0.1 0.2 0.2 45.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 2.4 1.5 0.4 1.7 0.5 1.5 0.4 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 49.2 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.4 1.5 0.4 0.8 1.3 1.1 0.3 0.2 2.4 0.5 0.9 0.0 0.5 1.7 1.5 0.6 0.4 0.1 0.1 0.4 0.8 0.1 0.1 0.1 0.1 0.3 0.1 GLIPR1L2 MGC39497 ENSG00000180481 "GLIPR1 like 2" Q4G1C9 12 75391070-75432688 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 44.0" "Cell line enhanced" "Detected in some" "Hep G2: 5.7;SK-BR-3: 8.4;U-2 OS: 11.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039795, HPA039866" Enhanced Approved "Golgi apparatus,Vesicles,Cytosol" Vesicles "Golgi apparatus, Cytosol" "HPA039795: AB_10805595, HPA039866: AB_10795235" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (3.32e-1)" "unprognostic (2.27e-1)" "unprognostic (7.74e-2)" "unprognostic (1.33e-1)" "unprognostic (8.78e-3)" "unprognostic (2.29e-2)" "unprognostic (1.48e-1)" "unprognostic (2.82e-1)" "unprognostic (7.68e-3)" "unprognostic (1.20e-1)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (5.91e-2)" "unprognostic (2.57e-2)" 1.3 3.1 5.5 1.2 10.4 0.8 3.0 2.9 5.8 2.2 1.2 4.2 2.9 1.0 2.7 4.2 1.4 3.5 1.5 2.5 5.5 4.6 2.5 1.9 2.7 1.1 6.6 3.9 7.7 3.0 7.3 5.2 1.3 6.2 2.3 0.8 2.0 1.4 3.6 2.4 2.2 1.2 1.5 8.1 1.9 1.0 44.0 5.0 1.4 2.8 0.5 0.8 1.7 1.4 1.4 2.6 2.0 0.7 1.0 3.4 0.6 0.3 0.5 0.3 0.5 4.3 2.5 0.7 0.6 0.5 0.2 0.3 0.1 0.4 0.3 1.5 0.4 0.2 0.1 0.1 0.4 0.8 0.3 0.1 0.6 5.7 3.2 0.5 0.1 0.8 1.3 0.6 2.3 0.2 0.3 0.7 1.1 0.1 0.6 0.4 0.3 0.2 0.1 0.1 0.3 0.1 0.4 1.1 0.6 0.7 8.4 2.4 2.5 0.2 1.2 1.0 11.1 1.2 0.4 1.0 1.0 0.3 0.4 0.3 0.8 1.8 0.3 0.5 1.1 0.2 0.7 1.1 1.2 2.0 0.4 1.4 2.2 3.3 2.0 1.0 0.7 2.6 3.4 0.6 5.5 10.4 2.9 5.8 5.5 4.6 6.6 3.9 6.2 5.0 GLRA1 STHE ENSG00000145888 "Glycine receptor alpha 1" P23415 5 151822513-151924842 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 31.7" "Cell line enhanced" "Detected in single" "HeLa: 1.3" "Not detected" "Not detected" "Region enriched" "Detected in many" 10 "pons and medulla: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "hypothalamus: 11.0;midbrain: 18.1;pons and medulla: 27.6" "Region enhanced" "Detected in many" "pons and medulla: 54.9" "HPA016502, CAB079042" Uncertain Supported "CAB079042: , HPA016502: AB_1849819" "unprognostic (3.17e-1)" "unprognostic (2.47e-1)" "unprognostic (3.85e-7)" "unprognostic (8.24e-2)" "unprognostic (9.45e-3)" 0.3 3.2 1.2 0.1 0.7 0.2 0.1 3.2 0.9 0.1 0.2 0.0 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.3 0.1 2.7 0.2 0.1 0.1 0.1 2.7 0.0 0.1 2.2 0.1 0.1 0.2 31.7 0.1 0.1 1.6 0.1 0.1 0.6 0.1 0.1 0.1 12.6 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 3.2 0.9 0.1 2.7 2.7 0.0 31.7 0.0 GLS2 "GA, GLS, hLGA, LGA" ENSG00000135423 "Glutaminase 2" Q9UI32 12 56470944-56488414 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 92.2" "Cell line enhanced" "Detected in some" "Daudi: 25.1;SCLC-21H: 7.1" "Cancer enhanced" "Detected in single" "liver cancer: 1.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 29 "B-cells: 1.8;T-cells: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038608 Uncertain "HPA038608: AB_10673176" "unprognostic (5.59e-2)" "unprognostic (1.51e-2)" "unprognostic (8.73e-2)" "unprognostic (7.15e-2)" "unprognostic (1.23e-2)" "unprognostic (9.56e-2)" "unprognostic (3.27e-3)" "unprognostic (1.98e-6)" "unprognostic (1.55e-1)" "unprognostic (5.33e-2)" "unprognostic (1.29e-2)" "unprognostic (1.52e-1)" "unprognostic (5.65e-5)" "unprognostic (1.42e-2)" "unprognostic (2.59e-1)" "unprognostic (9.02e-2)" "unprognostic (4.44e-2)" 0.9 1.7 5.7 1.0 8.6 0.9 1.4 12.8 15.0 1.0 1.2 0.2 0.0 1.0 1.2 2.0 1.4 2.8 0.9 1.0 4.2 4.1 1.6 92.2 1.4 1.2 1.9 9.7 1.2 15.8 3.0 6.2 0.8 8.6 1.4 1.7 2.5 1.4 2.0 0.9 2.0 1.0 1.1 3.2 1.1 1.4 1.1 1.4 0.0 1.4 0.0 1.4 1.1 0.8 1.8 0.0 0.0 0.0 0.0 3.8 1.4 4.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 3.4 0.9 25.1 0.4 0.0 0.6 0.0 3.7 0.0 0.0 3.7 0.0 0.3 4.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.8 0.4 0.0 0.1 4.5 2.6 1.7 7.1 0.4 0.8 0.2 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.3 1.8 3.3 1.0 0.0 0.6 3.8 3.5 0.0 0.0 0.0 0.0 0.6 1.4 5.7 8.6 12.8 15.0 4.2 4.1 1.9 9.7 8.6 1.4 GLT6D1 GLTDC1 ENSG00000204007 "Glycosyltransferase 6 domain containing 1" Q7Z4J2 9 135623656-135639540 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 28 "testis: 10.3" "Cell line enhanced" "Detected in single" "CACO-2: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA023424 Uncertain "Intracellular and membrane" "HPA023424: AB_1849729" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLYATL1 "FLJ34646, MGC15397" ENSG00000166840 "Glycine-N-acyltransferase like 1" Q969I3 11 58905398-59043527 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 113.8" "Cell line enhanced" "Detected in some" "CACO-2: 3.9;Daudi: 9.6;RPTEC TERT1: 3.2;U-2197: 2.5" "Group enriched" "Detected in some" 8 "liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 4 "T-cells: 1.3" HPA039501 Supported Uncertain "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA039501: " "unprognostic (9.46e-3)" "unprognostic (5.33e-2)" "unprognostic (3.90e-5)" "unprognostic (3.93e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-1)" "prognostic favourable (3.69e-4)" "unprognostic (3.62e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (2.08e-1)" "unprognostic (2.92e-1)" "prognostic favourable (3.03e-5)" "unprognostic (1.50e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-2)" "unprognostic (4.55e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.1 27.7 113.8 0.1 0.0 0.2 0.0 0.2 0.2 0.9 0.1 0.0 0.5 2.1 0.0 0.5 1.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.3 0.0 0.1 1.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.4 1.3 0.0 0.5 0.2 1.1 0.8 3.9 0.0 9.6 0.0 0.7 0.0 0.0 0.0 1.6 0.0 0.4 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.4 3.2 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.2 0.1 2.5 1.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.5 0.1 GLYCTK "HBEBP2, HBEBP4" ENSG00000168237 "Glycerate kinase" Q8IVS8 3 52287089-52293476 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 108.4" "Cell line enhanced" "Detected in many" "CACO-2: 18.9;Hep G2: 25.1" "Cancer enriched" "Detected in all" 6 "liver cancer: 52.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006913 Approved Approved "Golgi apparatus,Cytosol,Rods & Rings" Cytosol "Golgi apparatus, Rods & Rings" "HPA006913: AB_1078993" "unprognostic (1.51e-2)" "unprognostic (2.55e-1)" "unprognostic (1.25e-1)" "unprognostic (3.46e-2)" "unprognostic (1.18e-1)" "prognostic favourable (1.64e-4)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (7.73e-3)" "unprognostic (1.82e-1)" "unprognostic (3.36e-3)" "unprognostic (2.15e-1)" "unprognostic (3.30e-2)" "unprognostic (3.42e-1)" "unprognostic (3.77e-1)" "unprognostic (3.82e-2)" "unprognostic (9.00e-3)" 6.4 4.9 1.9 8.4 5.0 5.2 4.8 2.7 6.2 2.3 7.9 7.1 4.2 23.8 4.3 4.8 2.8 2.5 7.2 2.7 1.9 2.2 10.7 108.4 3.1 6.5 2.5 4.9 2.3 3.6 1.9 2.5 3.1 3.9 2.8 3.5 4.7 3.2 3.0 7.0 1.9 17.8 1.9 1.8 5.5 6.0 2.7 1.8 3.3 3.1 2.4 5.9 2.7 2.2 8.3 9.1 10.9 9.5 5.7 11.8 6.3 2.2 5.5 3.0 1.1 16.0 2.2 1.8 2.5 2.6 4.7 3.5 18.9 1.9 5.9 1.5 2.2 1.5 1.7 6.2 0.9 1.6 1.9 8.3 6.7 25.1 1.5 2.7 5.0 2.1 3.1 6.9 2.7 9.0 2.2 4.3 3.6 1.7 4.6 2.2 1.6 4.6 1.5 2.7 8.9 4.8 3.1 2.2 2.2 2.4 1.3 2.5 3.1 1.3 3.8 3.7 4.4 2.4 4.8 4.5 3.1 3.8 2.5 4.5 2.8 3.0 9.5 10.9 11.8 5.1 6.1 8.3 9.0 10.3 9.1 5.7 6.8 10.1 7.8 5.7 6.1 5.6 11.7 6.3 1.9 5.0 2.7 6.2 1.9 2.2 2.5 4.9 3.9 1.8 GML LY6DL ENSG00000104499 "Glycosylphosphatidylinositol anchored molecule like" Q99445 8 142834247-142916506 "Predicted intracellular proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "adrenal gland: 68.3" "Group enriched" "Detected in some" 19 "HMC-1: 1.3;SK-MEL-30: 1.7;U-937: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.2" "Lineage enhanced" "Detected in single" "T-cells: 2.2" "Intracellular and membrane" 0.0 68.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.4 0.0 2.2 0.0 0.8 1.4 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.1 GNAO1 G-ALPHA-o ENSG00000087258 "G protein subunit alpha o1" P09471 16 56191347-56357457 "Disease related genes, Predicted intracellular proteins" Transducer "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 102.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 16.6;BJ hTERT+ SV40 Large T+: 11.1;SCLC-21H: 33.9" "Cancer enriched" "Detected in many" 5 "glioma: 11.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.7" "Lineage enriched" "Detected in single" 14 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008387, HPA040878" Enhanced "CAB008387: AB_591430, HPA040878: " "unprognostic (1.50e-1)" "unprognostic (1.36e-3)" "unprognostic (8.12e-2)" "unprognostic (1.63e-1)" "unprognostic (2.21e-1)" "unprognostic (3.63e-2)" "unprognostic (6.87e-2)" "unprognostic (1.68e-4)" "unprognostic (3.08e-1)" "unprognostic (1.74e-1)" "prognostic favourable (5.93e-4)" "unprognostic (1.71e-1)" "unprognostic (6.86e-3)" "unprognostic (6.28e-2)" "unprognostic (1.21e-1)" "unprognostic (6.00e-1)" "unprognostic (9.70e-5)" 4.6 9.4 42.6 4.7 50.8 1.8 2.3 40.6 102.5 3.4 9.9 24.4 9.1 4.7 5.2 4.6 4.5 4.3 4.2 12.8 37.9 34.8 2.3 7.7 2.6 2.7 28.1 38.5 2.6 5.4 1.9 10.2 2.2 25.2 6.9 6.7 3.1 2.7 18.2 3.5 2.7 5.3 11.2 20.5 2.9 6.2 10.2 32.5 0.0 2.5 0.0 2.7 5.9 0.9 0.0 0.1 0.0 0.0 0.0 1.7 1.0 4.0 0.0 0.3 0.0 0.0 0.0 0.5 4.2 16.6 11.1 5.3 0.2 0.0 0.0 0.1 0.0 0.3 2.6 0.0 7.4 0.1 0.5 0.0 1.1 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 6.2 0.0 0.0 3.9 0.0 0.0 0.0 33.9 6.7 6.8 0.1 0.4 0.1 0.0 0.0 0.1 3.9 0.0 1.9 0.4 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.7 0.5 0.1 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 1.0 42.6 50.8 40.6 45.7 37.9 34.8 28.1 38.5 25.2 32.5 GNAT1 CSNBAD3 ENSG00000114349 "G protein subunit alpha transducin 1" P11488 3 50191612-50196516 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" Transducer "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "retina: 171.9" "Cell line enhanced" "Detected in some" "Hep G2: 1.4;MCF7: 2.3;RT4: 2.5;SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045393 Enhanced "HPA045393: " "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "unprognostic (8.56e-3)" "unprognostic (3.32e-2)" "unprognostic (2.13e-1)" "unprognostic (7.72e-2)" "unprognostic (2.82e-3)" "unprognostic (6.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.87e-1)" "unprognostic (3.02e-1)" "unprognostic (9.48e-3)" 0.3 0.5 0.3 0.0 0.3 0.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.2 0.0 0.3 0.3 0.1 0.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 171.9 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.3 0.3 0.3 0.2 0.0 0.0 0.0 GNAT2 ACHM4 ENSG00000134183 "G protein subunit alpha transducin 2" P19087 1 109603267-109619929 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "retina: 27.6" "Cell line enhanced" "Detected in some" "HAP1: 5.4;U-698: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "eosinophil: 3.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" 0.1 0.4 0.1 0.1 0.3 0.0 0.4 0.2 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.4 0.6 0.2 0.2 0.2 0.1 2.5 0.5 0.3 0.1 0.1 0.1 0.4 0.4 0.8 1.2 0.3 0.2 0.5 27.6 0.4 0.3 0.1 0.1 0.6 0.2 0.1 0.4 0.1 6.4 0.1 0.1 0.2 0.1 0.4 0.3 0.1 0.2 0.3 3.0 0.4 0.0 0.3 0.0 0.8 0.2 0.3 0.9 0.4 0.3 0.0 0.5 0.3 0.5 0.1 2.2 0.8 2.4 2.1 0.1 0.2 5.4 0.1 0.9 0.0 0.1 0.1 0.5 0.9 0.0 2.2 0.3 1.1 0.7 1.3 1.0 1.4 1.3 1.5 0.8 1.7 0.7 0.2 1.0 0.5 0.7 0.0 1.1 0.6 0.6 1.7 0.0 1.8 0.5 2.9 0.4 0.0 0.0 0.4 0.6 1.0 0.5 2.6 1.6 3.8 0.7 0.4 0.5 0.0 0.0 3.0 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.1 0.3 0.2 0.3 0.2 0.2 0.1 0.1 0.3 0.1 GNAT3 "GDCA, gustducin" ENSG00000214415 "G protein subunit alpha transducin 3" A8MTJ3 7 80458671-80512020 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 14.5" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 8.6" "Group enriched" "Detected in some" 6 "breast cancer: 0.8;urothelial cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 17 "olfactory region: 1.8" "unprognostic (2.01e-1)" 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 6.8 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.1 1.1 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 GNG3 ENSG00000162188 "G protein subunit gamma 3" P63215 11 62707658-62709201 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 136.6" "Group enriched" "Detected in some" 7 "Karpas-707: 38.2;SCLC-21H: 75.6" "Cancer enriched" "Detected in some" 14 "glioma: 12.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 30 "memory B-cell: 13.4;naive B-cell: 11.8" "Lineage enriched" "Detected in single" 32 "B-cells: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.43e-2)" "unprognostic (2.57e-2)" "unprognostic (1.78e-1)" "unprognostic (4.68e-4)" "unprognostic (2.73e-2)" "unprognostic (7.60e-2)" "unprognostic (1.77e-2)" "unprognostic (1.69e-1)" "unprognostic (6.03e-3)" "unprognostic (3.04e-1)" "unprognostic (2.33e-3)" "unprognostic (1.50e-1)" "unprognostic (5.37e-5)" "unprognostic (3.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.00e-1)" "unprognostic (1.00e-1)" 1.7 11.8 51.6 2.9 47.6 2.3 1.7 41.0 136.6 1.7 3.5 6.0 0.0 2.5 1.8 2.3 1.8 1.8 1.9 1.8 45.3 39.6 1.9 1.9 1.7 1.9 39.8 36.0 1.9 2.0 2.2 6.7 1.8 43.7 1.8 3.5 1.5 2.0 2.2 2.0 1.9 3.2 2.5 7.4 1.8 2.0 5.7 4.8 0.0 2.0 0.0 1.8 1.6 0.0 13.4 0.0 0.4 0.2 0.2 0.1 0.3 0.1 0.2 1.8 0.1 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.6 0.3 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.2 0.1 0.5 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 38.2 0.0 0.3 0.0 1.0 8.4 0.0 0.4 0.3 0.2 0.1 0.6 75.6 0.6 0.2 0.2 0.0 0.4 0.1 0.1 0.4 0.7 0.2 0.1 0.2 0.5 0.2 0.4 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 13.4 0.1 0.1 0.0 11.8 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 51.6 47.6 41.0 83.2 45.3 39.6 39.8 36.0 43.7 4.8 GNG7 FLJ00058 ENSG00000176533 "G protein subunit gamma 7" O60262 19 2511219-2702709 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 115.9" "Cell line enhanced" "Detected in some" "Daudi: 10.3;REH: 30.3;SK-MEL-30: 14.0;U-266/70: 29.2;U-266/84: 13.4" "Cancer enhanced" "Detected in all" "glioma: 21.9" "Region enriched" "Detected in all" 5 "basal ganglia: 115.9" "Group enriched" "Detected in many" 4 "memory B-cell: 23.9;naive B-cell: 20.5;plasmacytoid DC: 19.9" "Group enriched" "Detected in many" 4 "B-cells: 23.9;dendritic cells: 19.9" "Region enriched" "Detected in many" 6 "basal ganglia: 1142.7" "Region enriched" "Detected in all" 6 "basal ganglia: 484.6" HPA057790 Supported Supported "HPA057790: " "unprognostic (3.97e-3)" "unprognostic (1.16e-4)" "unprognostic (4.92e-2)" "unprognostic (2.72e-1)" "unprognostic (2.79e-1)" "unprognostic (8.42e-4)" "prognostic favourable (3.05e-4)" "prognostic favourable (1.35e-5)" "unprognostic (1.27e-2)" "unprognostic (4.95e-2)" "prognostic favourable (3.71e-4)" "unprognostic (1.27e-1)" "prognostic favourable (0.00e+0)" "unprognostic (6.96e-2)" "unprognostic (1.46e-1)" "unprognostic (6.36e-2)" "unprognostic (4.96e-2)" 3.1 4.8 19.8 4.5 115.9 5.4 4.1 9.7 28.2 2.6 3.8 23.4 0.8 4.7 4.8 4.9 11.1 6.5 3.3 22.5 20.3 11.4 6.0 2.2 3.0 8.0 20.0 10.0 10.0 7.2 5.4 4.6 1.4 20.9 7.1 3.0 12.2 22.8 5.7 2.9 1.7 4.9 3.4 28.5 11.0 5.8 5.5 22.0 0.1 3.7 0.4 8.2 3.4 1.4 23.9 19.9 5.0 0.6 0.0 0.5 1.3 0.1 0.0 1.5 3.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 10.3 0.5 0.1 0.1 1.6 0.0 0.0 0.0 1.4 0.2 0.0 1.2 0.7 0.0 6.1 0.2 0.2 0.0 0.1 0.0 0.1 6.7 0.0 1.0 0.2 0.6 1.2 0.6 30.3 0.0 2.7 0.1 0.0 0.0 4.4 0.0 0.0 14.0 0.2 2.6 0.0 0.0 1.5 0.1 0.1 29.2 13.4 2.2 0.1 3.2 7.7 1.1 0.6 3.2 0.1 0.2 0.4 23.9 0.2 0.1 2.5 20.5 0.5 0.3 5.0 0.0 0.0 19.9 0.0 1.3 19.8 115.9 9.7 20.0 20.3 11.4 20.0 10.0 20.9 22.0 GNGT1 GNG1 ENSG00000127928 "G protein subunit gamma transducin 1" P63211 7 93591573-93911265 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "retina: 107.2" "Cell line enhanced" "Detected in some" "EFO-21: 12.5;HeLa: 4.2;SK-BR-3: 4.0;T-47d: 6.8;U-266/70: 3.9;U-266/84: 5.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA042721 Enhanced "HPA042721: AB_10806370" "unprognostic (1.30e-1)" "unprognostic (2.55e-4)" "unprognostic (3.32e-4)" "unprognostic (5.01e-2)" "unprognostic (2.54e-2)" "unprognostic (1.84e-1)" "unprognostic (3.73e-2)" "unprognostic (4.55e-1)" "unprognostic (2.23e-4)" "unprognostic (1.40e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.5 0.3 0.1 1.9 0.0 0.0 0.0 0.4 0.0 2.6 0.1 0.1 0.1 7.9 0.3 0.0 0.0 107.2 1.0 0.0 0.0 0.4 0.0 0.1 0.3 0.1 0.4 0.7 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.5 0.5 1.6 0.2 0.1 1.2 0.6 1.4 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.1 12.5 0.0 0.1 0.2 0.0 0.0 0.1 0.4 0.0 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.1 1.9 0.1 0.0 2.0 0.1 0.0 0.0 0.6 0.3 1.5 3.6 1.3 0.2 4.0 0.1 6.8 0.2 0.2 0.0 3.7 0.2 0.0 3.9 5.2 0.0 0.2 0.0 0.0 1.6 0.0 0.1 0.7 0.1 0.9 0.5 1.0 0.9 0.3 0.4 0.8 0.8 1.3 0.1 0.2 0.5 1.2 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.3 0.0 GNLY "D2S69E, LAG-2, LAG2, NKG5, TLA519" ENSG00000115523 Granulysin P22749 2 85685175-85698854 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "blood: 444.6" "Cell line enhanced" "Detected in some" "BEWO: 1.4;NB-4: 3.5;THP-1: 1.2;U-2197: 2.0;U-87 MG: 2.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 226.1;NK-cell: 444.6" "Group enriched" "Detected in many" 55 "NK-cells: 444.6;T-cells: 226.1" "CAB025186, HPA058021" Enhanced "Secreted to blood" 2923333 "CAB025186: , HPA058021: " "unprognostic (5.80e-2)" "unprognostic (5.64e-3)" "unprognostic (6.68e-2)" "prognostic favourable (3.48e-5)" "unprognostic (4.34e-2)" "unprognostic (9.22e-2)" "unprognostic (2.60e-1)" "unprognostic (2.79e-2)" "prognostic favourable (6.60e-5)" "unprognostic (2.61e-2)" "unprognostic (1.88e-1)" "unprognostic (1.82e-1)" "prognostic unfavourable (1.50e-4)" "unprognostic (8.46e-2)" "unprognostic (3.37e-1)" "unprognostic (1.86e-1)" "prognostic favourable (8.07e-4)" 7.1 1.0 2.1 3.5 2.3 72.0 3.3 1.2 2.0 1.7 2.4 5.8 0.0 1.2 31.5 2.2 4.4 2.0 2.1 4.0 2.3 3.2 1.8 5.7 20.8 10.7 3.8 0.8 1.0 0.6 0.1 1.4 45.2 3.6 3.2 2.1 4.9 2.6 1.9 5.7 0.8 12.4 1.4 4.2 34.3 1.5 0.7 1.8 2.0 2.4 3.9 5.9 2.3 1.6 0.8 1.5 6.1 0.8 444.6 226.1 175.3 0.0 0.0 0.0 0.0 0.7 0.0 1.4 0.0 0.6 0.3 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.3 0.8 0.0 0.0 0.0 3.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.0 0.0 0.4 0.1 0.0 2.5 0.6 0.0 4.0 0.7 0.4 226.1 0.6 61.2 0.8 26.0 96.4 0.6 0.5 7.4 89.8 6.1 444.6 0.8 1.5 1.0 175.3 2.1 2.3 1.2 2.0 2.3 3.2 3.8 0.8 3.6 1.8 GNRHR "GRHR, LHRHR" ENSG00000109163 "Gonadotropin releasing hormone receptor" P30968 4 67739328-67754360 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "pituitary gland: 56.6" "Cell line enhanced" "Detected in some" "K-562: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA013424 Enhanced "HPA013424: " "unprognostic (2.77e-1)" "unprognostic (1.58e-1)" "unprognostic (4.05e-1)" "unprognostic (1.78e-1)" "unprognostic (4.65e-1)" "unprognostic (8.75e-3)" "unprognostic (3.09e-2)" "unprognostic (1.34e-1)" "unprognostic (1.90e-1)" "unprognostic (1.01e-1)" "unprognostic (6.84e-2)" "unprognostic (1.63e-1)" "unprognostic (9.03e-2)" "unprognostic (3.23e-2)" "unprognostic (9.67e-2)" "unprognostic (1.22e-3)" "unprognostic (3.99e-2)" 0.1 3.9 0.1 0.4 0.2 0.2 0.1 0.3 1.7 0.3 0.1 0.1 0.1 0.7 0.1 0.1 1.6 0.0 0.2 0.2 0.2 0.2 0.1 0.1 0.1 1.1 0.1 0.1 0.2 0.3 0.0 56.6 0.1 0.5 0.2 0.0 0.1 0.3 0.1 0.2 0.9 0.1 0.1 0.1 0.2 0.3 0.3 0.1 0.2 1.0 0.1 0.4 0.1 0.5 1.3 0.2 0.0 0.0 0.4 0.3 0.0 0.2 1.5 1.5 1.6 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.5 1.7 1.2 0.2 0.0 0.5 0.0 0.0 0.0 0.3 0.5 0.2 0.3 0.7 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.7 0.6 0.4 0.9 0.0 0.6 1.2 0.6 0.0 0.0 0.8 2.0 0.0 0.3 0.0 0.3 0.2 1.0 0.1 0.2 0.6 0.2 1.1 0.3 0.6 1.4 0.8 0.9 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.1 0.0 0.0 1.3 0.1 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.2 0.3 0.3 0.2 0.2 0.1 0.1 0.5 0.1 GOLGA6C ENSG00000167195 "Golgin A6 family member C" A6NDK9 15 75258599-75270199 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 12.5" "Cell line enhanced" "Detected in single" "HEL: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044978, HPA050087" Supported "HPA044978: , HPA050087: " "unprognostic (6.53e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.0 0.2 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.4 0.0 0.1 0.3 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.8 0.0 0.1 0.2 0.0 0.9 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6D ENSG00000140478 "Golgin A6 family member D" P0CG33 15 75282835-75295807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 14.2" "Group enriched" "Detected in some" 4 "HMC-1: 2.8;Karpas-707: 1.2;NTERA-2: 1.6;U-266/70: 3.1;U-266/84: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044978, HPA050087" Supported "HPA044978: , HPA050087: " "unprognostic (7.95e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 2.8 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 3.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6L1 ENSG00000273976 "Golgin A6 family-like 1" 15 23128268-23136822 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047733 Uncertain "HPA047733: " 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.3 0.1 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.2 0.0 0.0 0.4 0.1 0.1 0.0 GOLGA6L2 "CT105, FLJ36144" ENSG00000174450 "Golgin A6 family-like 2" Q8N9W4 15 23439498-23447234 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 125 "testis: 29.9" "Cell line enriched" "Detected in some" 6 "U-266/70: 18.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.45e-1)" "unprognostic (4.86e-2)" "unprognostic (4.12e-1)" "unprognostic (1.92e-2)" "unprognostic (1.24e-1)" "unprognostic (5.52e-2)" "unprognostic (8.71e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6L22 ENSG00000277865 "Golgin A6 family-like 22" 15 22458903-22469230 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 7.7" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;HeLa: 1.0;Karpas-707: 1.0;U-266/70: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.4" HPA047733 Uncertain "HPA047733: " "unprognostic (2.71e-2)" "unprognostic (1.08e-1)" 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 7.7 0.0 0.0 0.0 0.2 0.3 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.5 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 GOLGA6L6 FLJ36131 ENSG00000277322 "Golgin A6 family-like 6" A8MZA4 15 20531856-20541800 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 21 "testis: 7.2" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;SCLC-21H: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047733 Uncertain "HPA047733: " "unprognostic (1.10e-1)" "unprognostic (1.67e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 GOLGA6L7 GOLGA6L7P ENSG00000261649 "Golgin A6 family like 7" 15 28841833-28848675 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 17 "testis: 17.3" "Cell line enhanced" "Detected in some" "HMC-1: 3.0;THP-1: 2.6;U-266/70: 4.1;U-266/84: 4.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (3.65e-5)" "unprognostic (3.84e-1)" "unprognostic (6.81e-2)" "unprognostic (1.66e-2)" "unprognostic (5.10e-2)" "unprognostic (5.62e-11)" "unprognostic (2.53e-1)" "unprognostic (3.14e-1)" "unprognostic (2.59e-1)" 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.4 0.0 1.0 0.2 0.2 0.6 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 1.5 0.6 0.8 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.1 0.0 4.1 4.1 0.0 0.0 0.1 0.0 0.6 0.2 0.1 0.3 0.2 0.1 0.3 0.6 0.0 0.0 0.4 0.1 0.1 1.0 0.2 0.1 0.0 0.1 0.0 GOLGA8F DKFZp434P162 ENSG00000153684 "Golgin A8 family member F" Q08AF8 15 28378621-28392018 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 136 "testis: 13.6" "Cell line enriched" "Detected in single" 35 "NB-4: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (4.96e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA8G DKFZp434K052 ENSG00000183629 "Golgin A8 family member G" 15 28519611-28533014 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 126 "testis: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (7.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA8J ENSG00000179938 "Golgin A8 family member J" A6NMD2 15 30083053-30093499 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 19 "testis: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA8K ENSG00000249931 "Golgin A8 family member K" D6RF30 15 32392782-32403292 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 5 "testis: 9.2" "Cell line enhanced" "Detected in some" "AF22: 2.2;HEK 293: 1.6;HEL: 2.0;HMC-1: 2.3;THP-1: 4.3;U-937: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.47e-1)" "unprognostic (3.27e-1)" "unprognostic (4.01e-2)" "unprognostic (1.09e-2)" "unprognostic (6.62e-2)" "unprognostic (7.35e-2)" "unprognostic (2.86e-1)" "unprognostic (5.75e-2)" "unprognostic (1.37e-1)" "unprognostic (1.21e-1)" "unprognostic (1.97e-1)" "unprognostic (7.00e-3)" "unprognostic (4.81e-2)" "unprognostic (1.18e-2)" "unprognostic (9.81e-2)" 0.7 0.2 0.0 0.2 0.1 1.3 0.3 0.0 0.2 0.6 0.3 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.5 1.7 0.5 0.5 0.0 0.2 0.1 0.2 0.2 0.1 0.2 0.4 0.3 0.2 0.3 0.2 9.2 1.8 0.4 0.9 0.3 0.1 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.6 2.0 0.0 0.0 0.0 0.7 2.3 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.6 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 GOLGA8Q ENSG00000178115 "Golgin A8 family member Q" 15 30552078-30562501 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "thyroid gland: 18.7" "Group enriched" "Detected in some" 7 "THP-1: 9.2;U-937: 12.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "NK-cell: 2.0" "Lineage enriched" "Detected in single" 8 "NK-cells: 2.0" "unprognostic (2.65e-2)" "unprognostic (6.48e-2)" "unprognostic (2.24e-1)" "unprognostic (5.52e-4)" "unprognostic (9.86e-3)" "unprognostic (1.26e-1)" "unprognostic (7.17e-2)" "unprognostic (3.26e-1)" "unprognostic (2.31e-1)" 1.3 0.4 0.0 0.2 0.1 2.9 0.9 0.0 0.1 1.4 0.7 0.1 1.7 3.0 0.3 1.3 0.2 1.1 0.1 0.0 0.5 0.5 1.1 0.1 0.2 2.7 2.1 2.7 2.3 0.1 0.8 0.5 0.8 0.4 0.4 0.6 0.6 1.0 0.5 0.3 0.7 4.1 18.7 0.2 1.2 0.9 0.0 0.0 0.0 0.0 2.0 0.2 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.5 0.6 0.0 1.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 1.1 0.0 0.0 0.4 9.2 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 12.5 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 GOLGA8S ENSG00000261739 "Golgin A8 family member S" 15 23354748-23367231 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 10 "testis: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.64e-2)" "unprognostic (7.02e-2)" "unprognostic (1.35e-1)" "unprognostic (2.11e-2)" "unprognostic (1.20e-1)" "unprognostic (1.00e-1)" "unprognostic (3.68e-1)" "unprognostic (2.80e-2)" "unprognostic (1.75e-2)" "unprognostic (9.39e-3)" "unprognostic (8.10e-2)" "unprognostic (3.01e-1)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA8T ENSG00000261247 "Golgin A8 family member T" 15 30135149-30145567 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.01e-1)" "unprognostic (1.38e-1)" "unprognostic (2.05e-1)" "unprognostic (2.41e-1)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (5.20e-2)" "unprognostic (5.37e-2)" "unprognostic (2.10e-2)" 0.2 0.2 0.0 0.2 0.1 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.7 0.8 0.2 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 8.4 1.4 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GORASP2 "GOLPH6, GRASP55, GRS2" ENSG00000115806 "Golgi reassembly stacking protein 2" Q9H8Y8 2 170928464-170967129 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 120.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035274, HPA035275, CAB075758" Enhanced Enhanced "Golgi apparatus" "Golgi apparatus" "CAB075758: , HPA035274: AB_2674546, HPA035275: AB_10602600" "unprognostic (2.04e-2)" "unprognostic (4.37e-3)" "unprognostic (4.61e-1)" "unprognostic (1.64e-1)" "unprognostic (9.94e-2)" "prognostic unfavourable (7.32e-4)" "unprognostic (3.13e-2)" "unprognostic (3.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.58e-1)" "unprognostic (4.56e-3)" "unprognostic (2.45e-1)" "prognostic unfavourable (1.38e-8)" "unprognostic (1.26e-1)" "unprognostic (2.13e-1)" "unprognostic (6.56e-2)" "unprognostic (3.13e-1)" 6.6 9.4 6.6 6.6 6.9 4.0 7.3 6.6 6.6 12.1 6.9 6.6 9.6 7.2 9.1 15.5 9.0 6.5 6.6 10.1 6.6 7.1 6.6 10.3 6.6 6.6 6.6 6.6 6.7 13.6 6.6 13.1 10.4 6.6 7.4 7.1 6.6 12.8 9.8 7.1 7.5 6.6 7.2 7.0 6.6 7.5 120.2 6.6 6.6 8.7 6.6 6.6 7.5 6.9 12.3 16.9 11.7 10.7 16.0 23.7 14.2 11.7 9.7 13.8 11.2 27.1 20.5 16.9 19.5 21.6 17.2 21.9 25.5 15.9 17.6 11.1 27.0 14.8 15.6 18.1 20.5 10.3 21.4 19.9 9.0 39.9 27.4 16.6 12.9 15.5 20.4 17.2 29.0 18.9 17.3 13.4 15.7 19.4 15.3 26.6 14.6 12.1 12.9 12.7 21.8 25.1 16.9 12.5 11.3 11.0 19.5 19.5 12.4 15.8 17.1 16.6 11.1 15.9 10.6 14.7 9.4 21.1 17.2 11.9 18.8 11.7 10.0 6.4 15.2 10.6 23.7 12.3 17.2 18.1 12.6 10.2 17.4 14.5 2.4 16.0 10.7 16.9 14.5 14.2 6.6 6.9 6.6 6.6 6.6 7.1 6.6 6.6 6.6 6.6 GOT1L1 MGC33309 ENSG00000169154 "Glutamic-oxaloacetic transaminase 1 like 1" Q8NHS2 8 37934281-37940129 "Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "testis: 16.4" "Cell line enriched" "Detected in single" 5 "MOLT-4: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA028778 Uncertain "HPA028778: AB_10602138" "unprognostic (6.93e-3)" "unprognostic (5.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GP1BA "CD42b, GP1B, GPIbalpha" ENSG00000185245 "Glycoprotein Ib platelet alpha subunit" P07359 17 4932297-4935030 "CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease mutation, von Willebrand disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 37.8" "Cell line enriched" "Detected in some" 24 "HEL: 39.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 7 "basophil: 7.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002496, HPA013316" Supported 2000000000 "CAB002496: AB_563748, HPA013316: AB_1855459" "unprognostic (4.87e-4)" "unprognostic (8.21e-2)" "unprognostic (2.81e-2)" "unprognostic (6.11e-3)" "unprognostic (1.50e-2)" "unprognostic (1.59e-3)" "unprognostic (7.30e-3)" "unprognostic (5.58e-2)" "unprognostic (2.19e-1)" "unprognostic (1.64e-1)" "unprognostic (6.54e-4)" "unprognostic (1.27e-1)" "unprognostic (4.85e-3)" "unprognostic (4.58e-3)" "unprognostic (2.56e-1)" "unprognostic (3.53e-4)" "unprognostic (8.35e-2)" 0.7 0.1 0.4 15.8 1.2 5.3 0.7 1.9 0.7 0.7 1.0 0.2 0.2 1.5 0.6 0.7 5.7 0.8 0.3 4.2 0.5 0.4 1.0 1.6 3.5 37.8 0.4 0.2 0.7 0.4 0.0 0.4 1.1 0.4 0.7 0.6 0.3 7.7 0.2 3.0 4.6 3.7 0.2 0.4 13.0 0.9 0.6 0.2 2.0 0.8 0.8 17.6 0.9 1.1 0.0 0.3 7.5 0.2 0.0 0.2 3.6 0.0 1.3 0.3 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 1.1 0.1 1.2 0.4 0.0 1.3 0.0 0.0 0.0 0.4 1.0 39.3 0.5 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.4 0.3 0.2 0.1 0.2 0.6 0.3 0.2 0.0 0.7 0.0 0.2 0.5 0.0 0.2 1.6 0.7 0.1 0.2 0.2 0.8 0.1 0.7 0.2 0.9 0.6 0.6 0.4 7.5 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.1 1.0 0.0 0.1 0.3 0.0 3.6 0.4 1.2 1.9 0.4 0.5 0.4 0.4 0.2 0.4 0.2 GP2 ZAP75 ENSG00000169347 "Glycoprotein 2" P55259 16 20309572-20327808 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 354 "pancreas: 1812.8" "Low cell line specificity" "Detected in some" "Cancer enriched" "Detected in many" 14 "pancreatic cancer: 320.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015739, HPA016668" Enhanced "Intracellular and membrane" 27000 "HPA015739: AB_1849905, HPA016668: AB_1849907" "unprognostic (2.14e-2)" "unprognostic (1.97e-2)" "unprognostic (5.68e-2)" "unprognostic (4.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.84e-1)" "unprognostic (6.35e-2)" "unprognostic (8.17e-3)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.8 0.1 0.1 0.1 0.0 5.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.4 1812.8 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.4 1.4 2.3 0.9 0.6 0.8 0.3 0.5 0.3 0.6 1.0 0.0 0.2 1.3 0.3 0.0 0.5 0.2 1.3 0.7 1.3 1.4 0.4 0.6 0.1 0.4 0.7 0.3 0.2 0.4 1.3 0.2 0.0 0.4 0.9 0.0 0.3 0.1 0.0 0.0 0.7 0.8 0.5 0.0 0.4 0.6 0.1 1.2 0.7 0.7 1.8 0.1 0.2 0.7 0.5 0.6 1.4 0.2 0.5 0.5 0.0 1.1 2.2 0.8 1.0 0.7 0.8 0.3 0.3 0.6 0.3 2.0 0.9 0.7 0.8 0.3 0.5 0.6 0.7 0.7 0.1 1.4 0.7 0.7 2.3 0.6 0.2 1.4 0.5 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 GPA33 A33 ENSG00000143167 "Glycoprotein A33" Q99795 1 167052836-167166479 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 101.1" "Cell line enhanced" "Detected in some" "HL-60: 1.9;MOLT-4: 2.3;NB-4: 1.1;NTERA-2: 4.0;RPMI-8226: 2.9;THP-1: 1.1" "Cancer enriched" "Detected in many" 6 "colorectal cancer: 84.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 17.8;T-reg: 13.0" "Lineage enriched" "Detected in many" 7 "T-cells: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018858, CAB025943" Enhanced "CAB025943: , HPA018858: AB_1849909" "unprognostic (2.41e-2)" "unprognostic (1.71e-3)" "unprognostic (1.08e-2)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (8.39e-4)" "unprognostic (1.55e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-2)" "unprognostic (9.63e-2)" "unprognostic (2.10e-2)" "unprognostic (9.44e-2)" "unprognostic (6.75e-2)" "unprognostic (5.22e-3)" "unprognostic (3.13e-1)" "unprognostic (9.68e-3)" "unprognostic (2.96e-3)" 0.2 0.2 0.2 12.1 0.2 0.0 0.2 0.2 0.2 0.2 46.9 0.2 0.1 31.6 0.2 0.1 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 1.2 1.6 0.2 0.1 0.2 0.2 0.0 0.2 0.3 0.2 0.2 43.5 0.2 0.3 0.1 0.2 0.2 101.1 1.4 0.2 0.6 0.2 0.2 0.1 0.6 0.2 0.1 0.6 0.2 0.2 1.7 1.7 0.1 2.5 0.1 17.8 4.6 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.1 4.0 0.1 0.0 0.0 2.9 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 2.5 1.1 0.1 7.6 3.9 1.7 1.7 17.8 2.4 0.1 0.1 1.6 0.0 13.0 4.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.1 GPC3 "DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1" ENSG00000147257 "Glypican 3" P51654 X 133535745-133985895 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 262.7" "Group enriched" "Detected in some" 8 "HAP1: 53.1;Hep G2: 209.8" "Cancer enhanced" "Detected in all" "liver cancer: 269.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 5.0;naive CD8 T-cell: 3.5;NK-cell: 1.7" "Group enriched" "Detected in many" 12 "NK-cells: 1.7;T-cells: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006316 Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA006316: AB_1078994" "unprognostic (2.06e-1)" "unprognostic (2.36e-1)" "unprognostic (9.51e-2)" "unprognostic (4.17e-2)" "unprognostic (1.78e-1)" "unprognostic (1.46e-1)" "unprognostic (6.10e-2)" "unprognostic (1.17e-2)" "unprognostic (2.07e-2)" "unprognostic (3.92e-3)" "unprognostic (6.06e-2)" "unprognostic (1.71e-1)" "unprognostic (3.81e-3)" "prognostic unfavourable (4.83e-4)" "unprognostic (1.43e-1)" "unprognostic (2.21e-1)" "unprognostic (1.60e-1)" 30.1 5.9 0.4 3.6 0.7 0.0 50.2 0.6 0.4 3.3 4.5 0.5 2.2 0.5 2.5 11.7 2.0 3.4 9.2 8.0 0.4 1.1 21.2 1.1 37.0 1.9 1.6 0.4 6.0 4.6 0.3 16.9 262.7 1.6 3.6 1.0 6.3 3.8 2.3 4.1 5.5 1.8 3.3 2.1 0.9 4.0 2.1 0.3 2.3 7.2 11.2 3.0 7.6 8.0 0.0 0.2 0.0 0.0 1.7 5.0 0.6 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 53.1 0.0 0.0 0.0 2.4 0.0 0.1 209.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 14.5 0.6 1.7 4.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.2 0.0 5.0 3.5 0.0 1.7 0.0 0.0 0.0 0.6 0.4 0.7 0.6 0.4 0.4 1.1 1.6 0.4 1.6 0.3 GPHA2 "A2, GPA2, MGC126572, ZSIG51" ENSG00000149735 "Glycoprotein hormone alpha 2" Q96T91 11 64934471-64935888 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pancreas: 98.0" "Cell line enriched" "Detected in some" 10 "Hep G2: 21.2" "Cancer enriched" "Detected in some" 7 "testis cancer: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA067068 Approved Vesicles "Secreted to blood" Vesicles "HPA067068: " "unprognostic (1.13e-1)" "unprognostic (8.31e-3)" "unprognostic (1.51e-2)" "unprognostic (9.22e-4)" "unprognostic (7.88e-3)" "unprognostic (2.62e-1)" "unprognostic (1.45e-1)" "unprognostic (3.20e-2)" "unprognostic (1.82e-1)" "unprognostic (1.75e-1)" "unprognostic (5.03e-2)" "unprognostic (9.86e-3)" "unprognostic (1.70e-1)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.2 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 6.7 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.7 98.0 0.0 15.1 0.1 0.2 0.7 0.0 0.7 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 4.2 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 21.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.3 0.2 0.1 0.0 0.1 0.1 0.2 0.1 GPHB5 "GPB5, ZLUT1" ENSG00000179600 "Glycoprotein hormone beta 5" Q86YW7 14 63312835-63318879 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "testis: 1.7" "Cell line enhanced" "Detected in single" "AF22: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPLD1 ENSG00000112293 "Glycosylphosphatidylinositol specific phospholipase D1" P80108 6 24424565-24495205 "Enzymes, Plasma proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 61.6" "Cell line enhanced" "Detected in many" "Daudi: 10.2;U-698: 10.4" "Cancer enriched" "Detected in some" 11 "liver cancer: 6.8" "Region enriched" "Detected in many" 4 "cerebellum: 8.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008625, HPA012500" Uncertain "Secreted to blood" 102626666667 3700000000 "CAB008625: AB_1621070, HPA012500: AB_1849931" "unprognostic (6.80e-3)" "unprognostic (2.27e-1)" "unprognostic (1.59e-1)" "unprognostic (4.81e-5)" "unprognostic (3.65e-1)" "unprognostic (1.02e-1)" "prognostic favourable (1.12e-4)" "unprognostic (6.37e-4)" "unprognostic (7.93e-2)" "unprognostic (2.86e-2)" "unprognostic (6.07e-4)" "unprognostic (2.68e-1)" "unprognostic (5.28e-4)" "unprognostic (2.20e-1)" "unprognostic (9.98e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" 2.2 0.4 0.8 0.6 1.2 0.3 0.6 8.5 1.8 0.6 0.6 0.6 0.6 0.1 0.8 0.6 0.6 0.4 0.6 0.6 0.6 1.9 0.6 61.6 0.6 0.6 0.7 0.6 0.7 0.6 1.5 1.3 0.6 0.6 1.0 0.1 0.6 0.6 3.3 0.7 4.8 0.6 0.8 0.6 0.6 0.3 0.8 0.6 6.6 1.6 0.6 0.7 1.0 1.0 1.1 1.6 0.4 0.2 0.1 1.8 0.0 0.7 1.3 1.2 1.8 0.0 0.1 3.0 0.1 0.3 0.4 0.3 5.2 0.1 10.2 1.2 0.2 0.0 1.7 0.3 0.2 1.3 3.4 1.4 1.3 4.3 0.0 1.8 0.2 0.1 0.2 0.1 0.0 0.0 0.6 0.5 0.3 0.7 1.0 0.6 3.9 0.5 2.0 0.3 0.1 0.4 5.1 3.3 3.4 1.1 0.1 0.5 0.5 0.5 0.1 1.2 1.3 0.1 1.4 3.0 4.7 10.4 0.1 0.5 0.5 0.4 0.2 0.1 0.4 0.1 1.4 0.6 0.3 0.2 0.0 1.1 0.3 1.8 0.4 0.1 0.1 1.6 0.2 0.0 0.8 1.2 8.5 1.8 0.6 1.9 0.7 0.6 0.6 0.6 GPM6A GPM6 ENSG00000150625 "Glycoprotein M6A" P51674 4 175632934-176002664 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 249.7" "Group enriched" "Detected in some" 10 "AF22: 26.2;Daudi: 21.8;HAP1: 9.0;U-251 MG: 25.9" "Cancer enriched" "Detected in many" 107 "glioma: 110.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 22.2;naive B-cell: 9.1" "Lineage enriched" "Detected in many" 12 "B-cells: 22.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017338 Supported "HPA017338: AB_1849933" "unprognostic (1.36e-4)" "unprognostic (3.35e-3)" "unprognostic (2.96e-2)" "unprognostic (1.34e-2)" "unprognostic (9.45e-2)" "unprognostic (1.34e-1)" "unprognostic (3.82e-5)" "unprognostic (2.24e-1)" "unprognostic (9.13e-3)" "unprognostic (1.06e-1)" "unprognostic (3.69e-2)" "unprognostic (7.73e-2)" "unprognostic (2.24e-2)" "unprognostic (3.53e-2)" "unprognostic (1.45e-1)" "unprognostic (1.36e-3)" "unprognostic (2.60e-3)" 2.4 3.1 81.8 2.0 51.1 1.8 2.5 83.3 249.7 4.1 4.1 15.9 0.0 2.2 4.3 2.7 2.3 4.4 3.1 2.3 54.4 31.2 4.3 6.2 8.8 2.4 23.5 39.4 6.5 2.2 2.0 1.0 1.7 13.1 3.7 3.8 6.3 1.9 4.2 1.8 1.9 2.3 5.5 9.6 6.9 2.0 2.1 17.0 0.0 5.9 0.0 2.0 2.4 0.5 22.2 1.7 0.3 0.1 0.0 0.0 0.4 0.1 0.4 26.2 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.5 0.3 21.8 0.1 0.1 0.4 9.0 0.7 0.0 0.1 2.1 0.2 1.7 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.5 0.8 0.3 0.6 0.3 0.1 0.1 0.1 0.0 1.1 0.2 0.2 0.1 0.4 0.1 0.3 0.0 0.1 0.5 0.3 0.3 25.9 0.8 0.0 1.3 0.9 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.1 9.1 0.0 0.0 0.1 0.0 0.1 1.7 0.0 0.4 81.8 51.1 83.3 79.7 54.4 31.2 23.5 39.4 13.1 17.0 GPM6B "M6B, MGC17150, MGC54284" ENSG00000046653 "Glycoprotein M6B" Q13491 X 13771031-13938638 "Predicted membrane proteins" "Differentiation, Neurogenesis, Osteogenesis, Protein transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 219.5" "Cell line enhanced" "Detected in some" "AF22: 41.9;AN3-CA: 41.6;ASC TERT1: 21.3;HSkMC: 31.4;SK-MEL-30: 41.3" "Group enriched" "Detected in many" 14 "glioma: 192.5;melanoma: 41.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 222 "plasmacytoid DC: 33.4" "Lineage enriched" "Detected in single" 240 "dendritic cells: 33.4" "Low region specificity" "Detected in all" HPA002913 Approved "HPA002913: AB_2263553" "unprognostic (1.56e-2)" "unprognostic (3.42e-1)" "unprognostic (1.83e-1)" "unprognostic (3.70e-2)" "unprognostic (8.55e-2)" "unprognostic (2.75e-3)" "unprognostic (2.12e-2)" "unprognostic (1.92e-2)" "unprognostic (4.27e-2)" "prognostic favourable (2.67e-4)" "unprognostic (1.79e-2)" "unprognostic (4.78e-2)" "unprognostic (2.38e-3)" "unprognostic (8.34e-2)" "unprognostic (2.12e-1)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" 4.6 5.5 68.4 3.9 55.1 2.0 12.4 24.1 219.5 10.2 5.7 68.7 1.1 3.6 4.3 6.7 6.4 4.2 3.9 5.9 62.6 33.1 4.5 2.0 6.7 2.6 68.9 47.3 3.1 2.9 1.9 2.6 2.1 44.1 9.9 4.9 3.2 7.4 16.9 2.1 7.1 4.3 3.8 109.4 7.2 3.3 3.0 64.8 0.0 3.5 0.0 2.3 3.3 2.7 0.1 33.4 0.1 0.0 0.1 0.1 0.2 0.1 0.1 41.9 41.6 11.9 21.3 0.1 0.2 1.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 2.1 0.2 0.0 0.1 6.8 0.1 2.8 0.1 0.4 0.1 0.2 31.4 0.2 0.0 0.5 0.0 0.1 1.9 0.4 0.1 0.8 0.1 13.1 0.7 0.5 3.8 6.3 0.0 0.1 2.1 1.2 0.2 1.2 41.3 0.2 0.9 0.0 0.2 0.3 0.1 0.5 0.1 0.0 0.0 0.3 0.0 3.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 33.4 0.0 0.2 68.4 55.1 24.1 43.1 62.6 33.1 68.9 47.3 44.1 64.8 GPR101 ENSG00000165370 "G protein-coupled receptor 101" Q96P66 X 137030148-137031674 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "brain: 11.1" "Cell line enriched" "Detected in single" 4 "HEK 293: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hypothalamus: 44.7" "Low region specificity" "Detected in many" HPA001084 Uncertain "HPA001084: AB_1078920" 0.0 0.0 0.0 0.0 11.1 0.1 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR143 OA1 ENSG00000101850 "G protein-coupled receptor 143" P51810 X 9725346-9786297 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Albinism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "retina: 51.5" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 57.3" "Cancer enriched" "Detected in all" 9 "melanoma: 84.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "basophil: 5.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 5.0" "Not detected" "Not detected" HPA003648 Enhanced "HPA003648: " "unprognostic (4.60e-2)" "prognostic favourable (8.73e-4)" "unprognostic (7.43e-3)" "unprognostic (5.41e-2)" "unprognostic (4.62e-3)" "unprognostic (2.00e-2)" "unprognostic (3.05e-1)" "unprognostic (2.64e-3)" "unprognostic (3.78e-1)" "unprognostic (5.89e-2)" "unprognostic (8.18e-2)" "unprognostic (8.40e-2)" "prognostic favourable (2.45e-5)" "unprognostic (2.75e-1)" "unprognostic (2.07e-1)" "unprognostic (8.76e-2)" "unprognostic (1.59e-2)" 0.8 1.3 4.2 0.0 7.6 0.0 2.1 1.5 4.5 2.0 1.6 3.0 3.6 0.6 3.9 7.0 2.8 3.7 1.1 0.4 3.4 3.7 6.6 2.0 1.2 0.4 5.7 3.1 4.5 2.1 3.0 2.0 7.9 6.3 3.4 1.8 51.5 4.1 6.3 0.2 11.5 0.5 1.2 4.3 0.2 0.9 1.0 2.2 1.0 4.2 1.0 1.8 1.8 1.1 0.5 0.1 5.0 0.3 0.1 0.3 0.0 0.6 0.1 1.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.2 0.9 0.0 1.3 0.0 0.6 0.0 0.0 2.5 0.0 0.0 0.0 4.3 0.0 0.0 4.1 0.0 0.0 0.0 0.0 8.3 1.1 0.3 0.0 0.1 0.0 57.3 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.3 0.2 0.3 0.1 0.1 0.4 0.1 0.1 0.1 0.5 0.1 0.2 0.8 0.1 0.1 0.0 0.0 0.0 4.2 7.6 1.5 4.5 3.4 3.7 5.7 3.1 6.3 2.2 GPR174 FKSG79 ENSG00000147138 "G protein-coupled receptor 174" Q9BXC1 X 79144663-79175315 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 73.8" "Cell line enriched" "Detected in some" 7 "MOLT-4: 41.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA041025 Enhanced Uncertain Vesicles Vesicles "HPA041025: AB_10794260" "unprognostic (6.38e-3)" "unprognostic (9.87e-3)" "unprognostic (4.36e-2)" "unprognostic (1.18e-2)" "unprognostic (1.84e-1)" "unprognostic (8.48e-4)" "unprognostic (7.12e-2)" "unprognostic (1.05e-2)" "unprognostic (1.75e-1)" "unprognostic (2.02e-1)" "unprognostic (2.46e-1)" "unprognostic (1.05e-1)" "unprognostic (6.53e-5)" "unprognostic (2.27e-1)" "unprognostic (2.64e-2)" "unprognostic (1.21e-1)" "unprognostic (1.78e-2)" 2.2 0.5 0.4 20.3 0.4 2.6 1.3 0.3 0.4 2.4 5.1 0.0 0.5 2.1 1.6 0.9 2.6 0.9 1.9 1.0 0.4 0.4 1.9 1.7 8.2 16.6 0.5 0.0 1.0 0.7 0.0 1.1 0.3 0.2 1.7 2.0 1.6 3.8 0.1 0.5 0.7 9.1 0.2 1.0 21.0 2.2 0.5 0.0 73.8 2.5 1.6 28.1 5.1 1.8 4.0 1.8 6.0 9.1 6.5 8.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 41.8 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.1 0.0 0.0 0.0 6.0 0.0 4.7 5.7 3.4 1.7 4.0 7.5 8.6 0.1 3.9 6.1 6.8 0.4 6.5 9.1 1.8 7.6 2.7 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.0 0.2 0.0 GPR26 ENSG00000154478 "G protein-coupled receptor 26" Q8NDV2 10 123666355-123694607 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "brain: 8.6" "Cell line enriched" "Detected in single" 16 "SCLC-21H: 5.3" "Cancer enriched" "Detected in single" 13 "breast cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062736 Enhanced "HPA062736: " "unprognostic (4.15e-2)" "unprognostic (5.75e-2)" "unprognostic (3.42e-1)" "unprognostic (2.12e-1)" "unprognostic (9.09e-2)" "unprognostic (9.98e-2)" "unprognostic (2.12e-2)" "unprognostic (1.16e-2)" "unprognostic (1.12e-1)" 0.0 0.0 1.0 0.1 0.2 0.1 0.0 0.0 8.6 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 2.6 2.4 0.0 0.3 0.0 0.1 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 GPR32 RVDR1 ENSG00000142511 "G protein-coupled receptor 32" O75388 19 50770464-50771732 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 52 "parathyroid gland: 63.4" "Cell line enriched" "Detected in single" 289 "BEWO: 28.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "unprognostic (4.77e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 63.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 GPR35 ENSG00000178623 "G protein-coupled receptor 35" Q9HC97 2 240605431-240631259 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 109.6" "Cell line enhanced" "Detected in some" "CACO-2: 11.1;CAPAN-2: 27.9;HDLM-2: 9.3;Hep G2: 17.7;HMC-1: 17.6;NB-4: 8.6;U-937: 9.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 20.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "classical monocyte: 16.4;eosinophil: 16.8;intermediate monocyte: 22.7;myeloid DC: 14.5;non-classical monocyte: 6.1" "Group enriched" "Detected in many" 14 "dendritic cells: 14.5;granulocytes: 16.8;monocytes: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "unprognostic (1.05e-1)" "unprognostic (2.89e-2)" "unprognostic (4.35e-2)" "unprognostic (1.53e-1)" "unprognostic (5.99e-2)" "unprognostic (3.94e-3)" "unprognostic (2.71e-2)" "prognostic unfavourable (5.86e-4)" "unprognostic (2.01e-1)" "unprognostic (2.07e-1)" "unprognostic (7.98e-2)" "unprognostic (1.36e-2)" "prognostic unfavourable (2.59e-5)" "unprognostic (7.03e-3)" "unprognostic (1.30e-1)" "unprognostic (1.23e-2)" "unprognostic (1.10e-3)" 0.8 0.2 1.5 7.0 1.8 2.4 1.4 2.4 2.2 1.6 50.4 1.0 0.5 27.2 1.7 1.8 1.1 3.4 24.1 0.8 1.5 1.5 2.2 0.7 3.1 6.6 1.6 0.8 2.5 0.5 0.3 3.2 0.7 1.8 1.8 11.2 0.6 0.8 0.7 3.9 1.2 109.6 1.3 1.4 8.9 10.8 2.0 1.6 1.9 1.2 0.9 2.4 1.0 1.0 0.0 14.5 16.8 22.7 0.3 1.3 5.5 0.0 0.2 0.1 0.6 0.5 0.0 0.2 0.0 0.2 0.0 0.1 11.1 27.9 0.1 0.1 0.1 0.2 0.0 0.0 0.0 9.3 0.3 4.6 0.2 17.7 0.2 0.2 17.6 0.1 0.1 0.3 0.1 0.0 0.2 1.6 0.0 0.3 0.2 8.6 0.4 0.1 1.0 0.0 0.2 0.1 0.1 1.1 0.4 0.0 0.1 0.2 0.1 3.1 0.4 0.1 0.1 0.7 0.1 1.9 0.8 0.1 0.0 9.7 0.2 0.0 16.4 16.8 0.7 22.7 1.3 0.0 0.4 0.4 14.5 0.0 0.2 0.5 0.2 0.3 6.1 0.3 0.1 5.5 1.5 1.8 2.4 2.2 1.5 1.5 1.6 0.8 1.8 1.6 GPR37 "EDNRBL, hET(B)R-LP, PAELR" ENSG00000170775 "G protein-coupled receptor 37" O15354 7 124745997-124765627 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 62.4" "Cell line enhanced" "Detected in many" "AF22: 9.4;fHDF/TERT166: 21.9;hTCEpi: 9.7;SK-BR-3: 8.5;TIME: 15.3" "Cancer enhanced" "Detected in many" "glioma: 19.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042903, HPA068009" Approved Approved "Nuclear membrane,Cytosol" 48000 "Nuclear membrane, Cytosol" "HPA042903: , HPA068009: " "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-2)" "unprognostic (7.29e-2)" "unprognostic (1.06e-1)" "unprognostic (2.45e-1)" "prognostic unfavourable (6.00e-5)" "unprognostic (6.19e-2)" "prognostic favourable (7.26e-4)" "unprognostic (6.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.16e-2)" "unprognostic (6.12e-3)" "unprognostic (2.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.71e-4)" 1.6 1.0 14.5 1.1 19.6 0.9 1.7 2.3 52.6 1.5 1.4 62.4 0.0 1.0 2.1 1.4 7.8 2.1 1.4 0.9 23.9 11.3 1.2 8.8 1.3 1.1 33.5 12.3 1.0 3.0 0.8 0.3 10.0 23.3 1.8 1.5 3.5 1.6 1.8 1.1 4.1 1.3 3.0 49.4 4.3 1.2 15.5 26.5 0.0 0.9 0.0 0.9 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 9.4 0.0 0.0 0.0 2.7 0.5 2.5 2.4 0.6 0.4 0.8 0.0 0.0 21.9 0.2 2.7 0.0 0.5 0.4 1.2 0.1 5.9 0.0 2.8 0.0 0.4 0.0 9.7 0.0 0.1 4.5 0.0 4.3 0.0 0.5 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.1 2.2 3.3 0.0 8.5 3.2 2.2 0.0 15.3 2.0 0.7 0.0 0.0 1.3 0.0 0.0 1.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 19.6 2.3 19.6 23.9 11.3 33.5 12.3 23.3 26.5 GPR37L1 ETBR-LP-2 ENSG00000170075 "G protein-coupled receptor 37 like 1" O60883 1 202122858-202133592 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 44.0" "Group enriched" "Detected in some" 4 "HaCaT: 2.8;MCF7: 3.2;T-47d: 8.7" "Cancer enriched" "Detected in some" 57 "glioma: 36.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064454 Enhanced "HPA064454: " "unprognostic (2.12e-2)" "unprognostic (1.83e-1)" "unprognostic (2.96e-1)" "unprognostic (1.61e-3)" "unprognostic (4.52e-1)" "unprognostic (8.20e-2)" "unprognostic (2.26e-4)" "unprognostic (5.83e-2)" "unprognostic (3.46e-3)" "unprognostic (2.07e-1)" "unprognostic (1.83e-1)" "unprognostic (3.28e-2)" "unprognostic (4.86e-3)" "unprognostic (1.14e-1)" "unprognostic (4.58e-2)" "unprognostic (1.18e-3)" "unprognostic (3.49e-1)" 1.6 2.0 20.5 1.6 25.2 1.9 1.6 13.2 44.0 2.0 2.4 33.4 0.0 1.9 1.8 1.8 1.7 1.8 1.7 1.6 22.3 12.6 1.5 1.6 1.6 1.5 17.7 22.1 1.7 1.5 1.5 0.4 1.6 23.8 1.7 1.9 0.9 1.9 2.3 1.7 1.8 2.1 1.7 11.1 1.6 1.6 1.9 15.7 0.0 1.8 0.0 1.5 1.6 0.2 0.9 0.9 1.8 0.9 0.6 1.4 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.6 0.0 0.1 0.0 2.8 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.1 1.2 0.0 8.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.0 0.8 0.7 0.5 0.9 0.7 0.6 0.3 0.2 0.6 0.9 0.7 0.5 1.8 0.6 0.4 0.9 1.4 0.2 20.5 25.2 13.2 39.3 22.3 12.6 17.7 22.1 23.8 15.7 GPR45 "PSP24, PSP24A" ENSG00000135973 "G protein-coupled receptor 45" Q9Y5Y3 2 105241743-105243049 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 5.7" "Group enriched" "Detected in some" 11 "BEWO: 3.1;U-2 OS: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055940 Uncertain "HPA055940: " "unprognostic (3.80e-3)" "unprognostic (5.92e-2)" "unprognostic (2.19e-3)" "unprognostic (4.71e-1)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (6.87e-2)" "unprognostic (2.21e-1)" "unprognostic (1.13e-1)" "unprognostic (3.96e-1)" "unprognostic (1.61e-3)" "unprognostic (1.11e-2)" "unprognostic (3.13e-4)" "unprognostic (2.25e-1)" "unprognostic (2.76e-1)" "unprognostic (1.39e-1)" "unprognostic (3.99e-2)" 0.1 0.1 1.4 0.1 2.3 0.0 0.1 0.0 5.7 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 1.4 3.1 0.1 0.0 0.0 0.3 1.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.1 0.2 0.4 0.4 0.0 0.4 0.2 0.2 1.2 0.3 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 9.6 0.0 0.1 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR50 "H9, Mel1c" ENSG00000102195 "G protein-coupled receptor 50" Q13585 X 151176653-151181465 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "pituitary gland: 64.9" "Cell line enriched" "Detected in some" 8 "HEK 293: 10.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "hypothalamus: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "hypothalamus: 16.8" "Region enriched" "Detected in single" 9 "hypothalamus: 6.4" "HPA049862, HPA054678" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA049862: , HPA054678: " "unprognostic (8.84e-3)" "unprognostic (5.59e-2)" "unprognostic (1.15e-1)" 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 1.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 64.9 3.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.0 GPR52 ENSG00000203737 "G protein-coupled receptor 52" Q9Y2T5 1 174448111-174449198 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "brain: 28.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.0;Daudi: 1.4;Karpas-707: 2.5" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "basal ganglia: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.93e-1)" "unprognostic (1.15e-1)" "unprognostic (8.60e-2)" "unprognostic (2.61e-2)" "unprognostic (3.65e-1)" "unprognostic (2.27e-1)" "unprognostic (4.49e-1)" 0.3 0.3 0.8 0.2 28.0 2.2 0.1 0.2 7.4 0.1 0.2 0.1 0.0 0.1 0.4 0.4 0.2 0.2 0.2 0.3 0.2 0.7 0.2 0.2 0.2 0.4 0.2 0.1 0.2 0.1 0.1 0.9 0.4 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.6 0.2 0.6 0.0 0.2 0.3 0.4 5.0 0.0 0.1 0.0 0.8 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.2 0.0 0.0 0.2 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.5 0.0 0.0 0.4 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.4 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.1 0.7 0.0 0.0 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 28.0 0.2 3.2 0.2 0.7 0.2 0.1 0.0 5.0 GPR6 ENSG00000146360 "G protein-coupled receptor 6" P46095 6 109978256-109980718 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "brain: 42.5" "Cell line enriched" "Detected in single" 22 "SCLC-21H: 4.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "basal ganglia: 42.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 11 "basal ganglia: 81.5" "unprognostic (1.14e-2)" "unprognostic (1.59e-2)" "unprognostic (7.10e-3)" 0.4 0.5 3.5 0.4 42.5 0.5 0.4 0.0 6.5 0.4 0.4 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.3 1.8 0.4 0.4 0.4 0.4 0.1 0.8 0.4 0.4 0.4 2.2 0.4 0.0 0.4 0.4 0.0 0.5 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.8 0.5 4.6 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 42.5 0.0 4.0 1.3 1.8 0.1 0.8 0.0 4.6 GPR62 ENSG00000180929 "G protein-coupled receptor 62" Q9BZJ7 3 51955314-51957504 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 24.2" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 6.4" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (9.56e-3)" "unprognostic (3.32e-3)" "unprognostic (2.21e-1)" "unprognostic (6.38e-2)" "unprognostic (7.98e-2)" "unprognostic (1.66e-2)" "unprognostic (9.02e-2)" "unprognostic (6.49e-2)" "unprognostic (2.03e-2)" "unprognostic (6.17e-2)" "unprognostic (3.05e-2)" "unprognostic (1.26e-1)" "unprognostic (1.82e-5)" "unprognostic (3.64e-2)" "unprognostic (2.45e-1)" "unprognostic (1.16e-2)" "unprognostic (1.77e-2)" 1.0 1.3 5.6 0.6 12.5 0.6 0.8 1.4 16.2 0.8 0.7 24.2 0.0 0.7 1.1 1.4 0.8 1.1 1.0 1.3 9.7 5.3 1.2 1.0 0.7 0.7 17.8 5.4 2.1 0.8 1.3 0.4 0.7 10.6 0.9 0.7 0.0 1.1 1.0 1.3 0.8 0.7 0.8 18.6 0.8 1.0 0.8 14.5 0.0 0.9 0.0 0.7 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.2 0.2 0.2 0.0 0.0 0.1 6.4 1.2 1.0 0.0 1.1 0.0 0.0 0.0 0.1 1.0 0.2 0.1 0.6 0.2 0.0 0.4 0.9 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 12.5 1.4 8.5 9.7 5.3 17.8 5.4 10.6 14.5 GPR78 ENSG00000155269 "G protein-coupled receptor 78" Q96P69 4 8558725-8619761 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "placenta: 53.3" "Cell line enriched" "Detected in single" 202 "BEWO: 21.2" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA013209 Uncertain "HPA013209: AB_10601657" "unprognostic (6.41e-2)" "unprognostic (1.77e-2)" "unprognostic (1.17e-2)" "unprognostic (2.51e-1)" "unprognostic (1.81e-2)" "unprognostic (3.70e-2)" "unprognostic (3.82e-4)" "unprognostic (6.46e-3)" "unprognostic (1.20e-1)" "unprognostic (3.80e-2)" "unprognostic (2.29e-1)" "unprognostic (4.88e-15)" "unprognostic (5.55e-3)" "unprognostic (3.93e-2)" "unprognostic (9.90e-3)" "unprognostic (8.15e-2)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 GPR88 ENSG00000181656 "G protein-coupled receptor 88" Q9GZN0 1 100538137-100542018 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Mental retardation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 62.7" "Group enriched" "Detected in some" 8 "HSkMC: 4.8;SCLC-21H: 5.9" "Cancer enriched" "Detected in some" 9 "liver cancer: 12.0" "Group enriched" "Detected in many" 7 "basal ganglia: 62.7;thalamus: 32.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 11 "basal ganglia: 643.5" "Region enriched" "Detected in some" 35 "basal ganglia: 223.4" HPA007488 Approved "HPA007488: " "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (8.30e-2)" "unprognostic (8.37e-3)" "unprognostic (5.41e-1)" "unprognostic (5.63e-2)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "unprognostic (1.03e-2)" "unprognostic (7.76e-2)" "unprognostic (8.23e-3)" "unprognostic (2.45e-1)" "unprognostic (3.93e-4)" "unprognostic (1.85e-2)" "unprognostic (5.56e-2)" "unprognostic (4.41e-1)" "unprognostic (1.35e-2)" 0.7 0.6 1.2 0.5 62.7 0.2 10.9 0.0 6.8 0.1 0.3 0.8 0.0 0.6 0.2 0.2 0.2 0.1 0.2 0.4 0.9 0.8 0.3 13.1 0.2 0.3 0.7 1.1 3.8 0.1 4.6 0.5 0.2 7.0 0.6 0.5 0.3 0.7 0.1 0.3 0.1 0.5 0.3 0.5 13.7 0.4 0.2 32.8 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 62.7 0.0 6.8 0.9 0.8 0.7 1.1 7.0 32.8 GPRIN1 "GRIN1, KIAA1893" ENSG00000169258 "G protein regulated inducer of neurite outgrowth 1" Q7Z2K8 5 176595802-176610133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 28.2" "Cell line enhanced" "Detected in many" "HDLM-2: 27.3;SCLC-21H: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036478, HPA070892" Enhanced Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA036478: , HPA070892: " "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.41e-2)" "unprognostic (5.66e-2)" "unprognostic (6.54e-3)" "unprognostic (3.06e-1)" "unprognostic (4.76e-6)" "prognostic unfavourable (6.83e-6)" "unprognostic (1.11e-1)" "unprognostic (1.45e-1)" "unprognostic (2.59e-3)" "unprognostic (1.56e-3)" "prognostic unfavourable (2.79e-7)" "unprognostic (4.24e-3)" "unprognostic (5.60e-2)" "unprognostic (2.21e-1)" "unprognostic (3.32e-3)" 1.3 3.2 16.9 1.8 6.4 0.9 0.9 16.9 28.2 1.1 1.6 0.2 0.0 6.4 1.3 0.6 1.1 0.7 1.1 0.7 11.1 11.1 0.7 0.7 1.1 1.7 3.6 11.4 0.5 1.5 0.7 5.8 1.0 4.4 0.7 1.3 0.7 0.7 0.6 0.7 1.5 4.0 1.7 1.9 0.9 1.9 2.2 0.7 0.0 0.8 0.0 2.3 0.9 0.1 0.9 0.0 0.0 0.0 0.5 0.3 0.0 3.6 3.9 4.9 7.1 1.1 2.4 4.2 4.9 2.5 3.8 4.9 4.7 2.4 8.3 10.0 2.6 3.2 3.1 3.4 3.3 27.3 2.1 0.1 2.1 1.6 0.4 0.2 2.1 1.1 2.6 4.1 0.6 2.7 4.3 12.1 3.1 9.5 0.8 0.0 5.0 7.7 15.4 5.5 4.9 4.3 3.8 30.3 17.4 5.6 1.6 8.5 3.7 3.1 3.3 7.1 8.2 2.7 7.1 0.2 1.0 2.3 6.1 0.4 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.9 6.4 16.9 14.3 11.1 11.1 3.6 11.4 4.4 0.7 GPX5 ENSG00000224586 "Glutathione peroxidase 5" O75715 6 28525925-28534952 "Enzymes, Predicted secreted proteins" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "epididymis: 27.7" "Group enriched" "Detected in some" 7 "BEWO: 1.0;NB-4: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in male reproductive system" "unprognostic (3.34e-2)" "unprognostic (3.74e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPX6 GPXP3 ENSG00000198704 "Glutathione peroxidase 6" P59796 6 28503296-28528215 "Enzymes, Predicted secreted proteins" "Oxidoreductase, Peroxidase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "epididymis: 9.3" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;HEL: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 16 "basal ganglia: 21.3" "Low region specificity" "Detected in single" "Secreted in male reproductive system" "unprognostic (2.99e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 GRAP2 "GADS, GRBLG, GrbX, Grf40, Mona" ENSG00000100351 "GRB2-related adaptor protein 2" O75791 22 39901082-39973721 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 138.0" "Cell line enhanced" "Detected in some" "HDLM-2: 9.4;HEL: 18.1;K-562: 17.3;MOLT-4: 47.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "gdT-cell: 19.5;MAIT T-cell: 14.4;memory CD4 T-cell: 14.4;memory CD8 T-cell: 21.1;naive CD4 T-cell: 12.2;naive CD8 T-cell: 22.5;T-reg: 12.0" "Lineage enriched" "Detected in many" 9 "T-cells: 22.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005788, CAB022073" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" 260000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB022073: , HPA005788: AB_1079021" "unprognostic (1.96e-4)" "unprognostic (1.82e-4)" "unprognostic (4.19e-2)" "unprognostic (8.91e-4)" "unprognostic (2.92e-2)" "unprognostic (5.56e-5)" "unprognostic (1.27e-2)" "unprognostic (8.41e-3)" "unprognostic (4.69e-2)" "unprognostic (9.29e-2)" "unprognostic (5.17e-3)" "unprognostic (2.83e-2)" "unprognostic (1.75e-3)" "unprognostic (2.10e-1)" "unprognostic (2.20e-2)" "unprognostic (1.34e-1)" "unprognostic (8.06e-2)" 1.6 0.4 0.3 7.7 0.7 7.6 1.5 0.3 0.4 1.1 2.3 0.6 0.4 2.9 2.3 1.6 1.6 1.2 3.5 2.8 0.6 0.4 1.2 1.8 6.4 12.6 0.9 0.4 1.0 0.8 0.0 0.6 1.1 0.6 2.4 1.9 1.2 2.4 1.2 0.5 1.4 6.2 2.0 2.2 13.2 2.9 2.4 0.3 138.0 1.3 1.5 11.3 3.0 1.9 2.1 0.4 2.5 0.2 1.7 22.5 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 18.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 47.7 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.8 0.2 0.0 19.5 0.1 14.4 1.0 14.4 21.1 0.4 2.1 12.2 22.5 2.5 1.7 0.1 0.3 12.0 25.9 0.3 0.7 0.3 0.4 0.6 0.4 0.9 0.4 0.6 0.3 GRHPR "GLXR, PH2" ENSG00000137106 "Glyoxylate and hydroxypyruvate reductase" Q9UBQ7 9 37422666-37436990 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 172.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022971 Uncertain Approved Nucleoplasm,Cytosol 1400000 Cytosol Nucleoplasm "HPA022971: AB_1849975" "prognostic favourable (7.00e-5)" "unprognostic (6.84e-2)" "unprognostic (2.62e-1)" "unprognostic (2.64e-3)" "unprognostic (5.78e-3)" "unprognostic (3.04e-1)" "unprognostic (1.02e-3)" "unprognostic (1.22e-1)" "unprognostic (2.24e-1)" "unprognostic (4.49e-2)" "unprognostic (5.88e-2)" "unprognostic (2.36e-1)" "prognostic favourable (5.39e-9)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" 12.8 33.7 16.3 13.8 17.4 9.9 12.3 9.5 22.3 12.1 17.6 27.5 11.6 17.2 14.3 18.1 17.6 12.9 18.1 29.2 15.8 14.7 41.9 172.0 9.7 13.8 20.0 16.5 17.0 15.5 9.5 8.8 13.2 15.5 14.2 10.2 13.5 21.6 14.0 40.0 14.8 14.6 14.2 19.4 10.0 13.3 13.0 18.7 9.5 15.1 25.2 13.6 13.4 11.7 30.6 33.2 17.8 30.3 28.9 25.9 22.4 31.3 45.2 25.6 23.4 23.6 26.2 26.0 25.1 33.3 34.2 37.2 17.1 13.6 30.1 14.8 29.4 14.2 14.7 32.7 20.5 40.2 18.4 17.6 42.1 30.3 37.3 16.7 18.3 31.3 28.7 19.8 25.5 29.6 32.2 12.4 30.0 24.0 16.3 17.2 15.6 19.7 16.1 18.8 16.7 45.6 17.8 10.7 19.2 21.6 41.2 23.4 23.2 21.6 32.2 18.8 30.2 13.0 21.6 9.8 7.6 20.1 26.7 9.6 27.5 17.8 30.2 15.0 19.4 30.3 16.2 28.6 20.7 22.0 33.2 30.6 20.4 17.3 7.0 28.9 24.7 29.8 25.9 22.4 16.3 17.4 9.5 22.3 15.8 14.7 20.0 16.5 15.5 18.7 GRIA1 "GluA1, GLUR1, GLURA" ENSG00000155511 "Glutamate ionotropic receptor AMPA type subunit 1" P42261 5 153489615-153813869 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 52.6" "Cell line enhanced" "Detected in some" "AF22: 13.4;ASC diff: 4.1;BJ: 6.4;LHCN-M2: 9.4;U-266/70: 6.8" "Cancer enriched" "Detected in some" 15 "glioma: 9.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001965, HPA035202" Enhanced "CAB001965: , HPA035202: " "unprognostic (2.51e-1)" "unprognostic (4.76e-3)" "unprognostic (1.97e-1)" "unprognostic (4.20e-2)" "unprognostic (6.95e-2)" "unprognostic (2.43e-1)" "unprognostic (2.61e-1)" "unprognostic (1.18e-2)" "unprognostic (2.04e-1)" "unprognostic (2.35e-2)" "unprognostic (5.14e-4)" "unprognostic (7.97e-2)" "unprognostic (2.96e-2)" "unprognostic (1.01e-1)" "unprognostic (1.70e-1)" "unprognostic (2.80e-1)" "unprognostic (7.61e-2)" 1.8 1.6 44.9 1.2 23.1 1.0 1.5 23.6 52.6 1.4 1.2 3.7 0.0 1.3 1.2 2.0 1.2 1.2 1.1 2.0 50.4 13.4 1.1 1.1 9.5 1.0 4.8 20.0 1.3 1.4 1.2 0.5 1.1 4.6 1.1 1.2 0.7 1.1 1.7 1.1 1.1 1.3 2.3 2.3 1.1 1.2 2.1 5.2 0.0 1.1 0.0 1.1 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 4.1 2.8 0.0 6.4 3.3 0.4 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 9.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.9 23.1 23.6 24.3 50.4 13.4 4.8 20.0 4.6 5.2 GRIA2 "GluA2, GLUR2, GLURB" ENSG00000120251 "Glutamate ionotropic receptor AMPA type subunit 2" P42262 4 157204182-157366075 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.9" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 19.4" "Group enriched" "Detected in some" 10 "breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008441 Enhanced "HPA008441: AB_1078983" "unprognostic (1.36e-1)" "unprognostic (9.60e-3)" "unprognostic (4.15e-2)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (3.87e-1)" "unprognostic (1.53e-1)" "unprognostic (3.92e-3)" "unprognostic (7.40e-2)" "unprognostic (2.91e-5)" "unprognostic (2.42e-1)" "unprognostic (1.31e-1)" "unprognostic (1.82e-1)" "unprognostic (6.55e-2)" 1.2 6.5 36.9 1.3 39.1 1.1 2.0 22.1 95.9 8.2 1.3 5.6 0.0 1.2 13.5 9.8 1.2 9.6 1.2 1.2 30.1 15.7 1.5 1.1 1.4 1.2 10.0 30.6 1.7 2.2 1.2 10.5 1.2 7.1 1.8 1.2 0.1 2.1 3.0 1.2 1.1 1.2 6.1 6.9 1.3 1.5 2.1 8.8 0.0 1.2 0.0 1.2 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.4 2.7 0.0 0.0 0.0 0.9 0.0 0.0 1.1 0.1 0.0 0.0 0.6 0.0 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 39.1 22.1 41.2 30.1 15.7 10.0 30.6 7.1 8.8 GRIA4 "GluA4, GLUR4, GLURD" ENSG00000152578 "Glutamate ionotropic receptor AMPA type subunit 4" P48058 11 105609994-105982092 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 55.4" "Cell line enhanced" "Detected in some" "AF22: 15.5;NTERA-2: 5.1;RPMI-8226: 3.0;SCLC-21H: 5.6" "Group enriched" "Detected in some" 18 "glioma: 5.9;renal cancer: 1.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "unprognostic (4.09e-4)" "unprognostic (4.45e-3)" "unprognostic (1.92e-3)" "unprognostic (4.14e-4)" "unprognostic (1.40e-2)" "unprognostic (3.73e-4)" "unprognostic (1.62e-1)" "unprognostic (3.89e-1)" "unprognostic (2.04e-1)" "unprognostic (1.53e-1)" "unprognostic (1.70e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (3.35e-2)" "unprognostic (1.28e-1)" 1.1 7.4 11.4 1.5 13.1 0.9 4.5 55.4 52.9 2.6 1.8 8.1 0.0 0.9 1.5 2.9 1.0 2.2 1.2 0.9 9.3 16.0 1.4 0.9 1.0 1.6 12.1 17.4 1.3 1.6 0.9 2.2 1.3 24.8 1.2 2.0 2.8 4.1 1.5 1.0 1.5 4.5 1.0 11.5 0.9 6.6 1.1 6.9 0.0 1.0 0.0 1.3 1.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.1 0.2 0.0 0.0 3.0 0.0 0.0 5.6 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.1 55.4 23.3 9.3 16.0 12.1 17.4 24.8 6.9 GRID2IP ENSG00000215045 "Grid2 interacting protein" A4D2P6 7 6497462-6551436 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 23.6" "Cell line enriched" "Detected in some" 4 "REH: 8.7" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 23.6" "Cell type enhanced" "Detected in single" "NK-cell: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebellum: 25.2;thalamus: 7.9" "Group enriched" "Detected in many" 5 "cerebellum: 14.3;midbrain: 10.0;pons and medulla: 9.7;thalamus: 14.7" HPA045381 Approved "Plasma membrane" "Plasma membrane" "HPA045381: AB_10962495" "unprognostic (1.77e-1)" "unprognostic (2.64e-1)" "unprognostic (3.39e-4)" "unprognostic (1.19e-3)" "unprognostic (5.52e-2)" "unprognostic (2.50e-2)" "unprognostic (2.82e-1)" "unprognostic (2.37e-2)" "unprognostic (1.92e-3)" "unprognostic (2.06e-3)" "unprognostic (1.64e-1)" "unprognostic (3.40e-2)" "unprognostic (3.38e-2)" "unprognostic (5.54e-2)" "unprognostic (8.08e-2)" "unprognostic (1.87e-1)" "unprognostic (3.17e-1)" 0.2 1.7 0.8 0.6 3.6 1.1 1.1 23.6 6.6 0.6 1.4 6.5 0.0 1.8 0.4 0.1 1.2 1.1 0.6 0.3 1.6 1.6 0.7 0.3 1.2 0.5 0.7 1.2 0.9 1.8 3.9 3.0 0.2 5.5 2.3 0.7 0.3 2.1 1.6 0.2 3.4 1.6 0.0 1.5 1.4 2.2 1.2 6.8 2.5 1.6 0.0 0.6 0.9 0.8 0.7 0.2 0.0 0.2 1.1 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.7 0.0 0.2 0.0 8.7 0.3 0.2 0.1 0.3 0.1 1.1 0.0 0.8 0.0 2.0 0.2 0.1 0.0 0.9 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.6 0.4 0.0 0.0 1.1 0.2 0.2 0.0 0.1 0.8 3.6 23.6 6.6 1.6 1.6 0.7 1.2 5.5 6.8 GRIN1 "GluN1, NMDAR1" ENSG00000176884 "Glutamate ionotropic receptor NMDA type subunit 1" Q05586 9 137138390-137168762 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 38 "brain: 97.5" "Cell line enhanced" "Detected in some" "REH: 3.0;RPMI-8226: 4.3;SCLC-21H: 9.8;SH-SY5Y: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067773 Enhanced "HPA067773: " "unprognostic (3.58e-2)" "unprognostic (4.51e-1)" "unprognostic (2.68e-2)" "unprognostic (5.48e-4)" "unprognostic (5.20e-2)" "unprognostic (1.25e-1)" "unprognostic (2.34e-2)" "unprognostic (2.81e-2)" "unprognostic (6.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (1.21e-3)" "unprognostic (4.47e-2)" "unprognostic (1.44e-1)" "unprognostic (3.56e-3)" "unprognostic (4.72e-2)" 1.7 2.0 23.6 2.0 47.5 1.7 1.8 28.1 97.5 1.8 2.0 3.2 0.0 2.2 1.7 1.8 1.7 1.7 1.7 1.7 29.1 26.4 1.8 1.7 1.8 1.8 15.4 37.9 1.7 1.8 1.8 0.0 1.7 22.0 2.2 1.8 0.7 2.5 1.8 1.7 1.8 2.2 1.8 4.7 1.8 1.8 1.9 6.3 0.0 1.7 0.0 1.8 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.4 1.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 1.5 0.1 0.0 0.2 0.2 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.9 0.0 0.0 0.1 0.0 3.0 0.0 4.3 0.0 0.0 9.8 6.8 0.1 0.5 0.0 2.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 23.6 47.5 28.1 87.9 29.1 26.4 15.4 37.9 22.0 6.3 GRIN2A "GluN2A, NMDAR2A" ENSG00000183454 "Glutamate ionotropic receptor NMDA type subunit 2A" Q12879 16 9753404-10182754 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 25.2" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 7.7;RPMI-8226: 2.9;U-138 MG: 8.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB022725 Enhanced "CAB022725: " "unprognostic (6.43e-2)" "unprognostic (2.47e-1)" "unprognostic (5.97e-2)" "unprognostic (3.21e-2)" "unprognostic (3.13e-2)" "unprognostic (1.59e-2)" "unprognostic (1.62e-1)" "unprognostic (2.10e-1)" "unprognostic (2.08e-1)" "unprognostic (5.39e-2)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "unprognostic (3.75e-3)" "unprognostic (4.79e-3)" "unprognostic (2.05e-1)" "unprognostic (3.92e-3)" "unprognostic (3.33e-2)" 0.9 1.0 5.4 0.5 5.9 0.4 0.6 8.5 25.2 0.6 0.7 1.5 0.0 0.9 0.8 4.5 2.1 4.1 0.5 4.0 8.0 1.9 0.9 0.4 1.0 0.5 1.7 10.3 0.5 0.6 0.4 0.3 0.4 1.4 0.5 0.7 1.4 0.7 1.0 0.5 1.2 0.7 0.9 1.2 0.4 1.1 5.2 0.8 0.0 0.8 0.0 0.7 0.6 0.5 0.6 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 1.8 0.5 1.4 0.0 0.1 0.0 0.0 7.7 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.8 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 5.4 5.9 8.5 17.9 8.0 1.9 1.7 10.3 1.4 0.8 GRIN2B "GluN2B, NMDAR2B" ENSG00000273079 "Glutamate ionotropic receptor NMDA type subunit 2B" Q13224 12 13437942-13981957 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "brain: 36.5" "Cell line enhanced" "Detected in some" "A549: 1.4;AF22: 3.3;CACO-2: 3.8;Daudi: 1.5;NTERA-2: 4.8;RPTEC TERT1: 4.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 19.5;basal ganglia: 26.0;cerebral cortex: 36.5;hippocampal formation: 19.6;olfactory region: 15.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA069762 Approved "HPA069762: " "unprognostic (2.01e-2)" "unprognostic (4.07e-2)" "unprognostic (7.89e-2)" "unprognostic (3.77e-3)" "unprognostic (3.39e-3)" "unprognostic (9.36e-2)" "unprognostic (5.92e-2)" "unprognostic (1.77e-2)" "unprognostic (6.85e-2)" "unprognostic (2.24e-1)" "unprognostic (4.68e-2)" "unprognostic (4.12e-2)" "unprognostic (4.48e-5)" "unprognostic (2.43e-1)" "unprognostic (8.76e-2)" "unprognostic (1.63e-1)" "unprognostic (2.37e-1)" 1.9 0.9 19.5 0.8 26.0 0.8 0.9 0.9 36.5 0.8 1.9 1.9 0.0 0.8 0.8 0.8 0.9 0.8 0.8 0.8 19.6 3.5 1.0 1.6 0.8 1.4 1.8 15.0 0.9 0.8 0.8 0.4 0.9 2.6 0.8 1.2 0.0 0.8 0.8 0.8 0.8 1.8 0.8 0.8 0.9 1.0 1.5 3.6 0.0 0.8 0.0 1.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 26.0 0.9 36.5 19.6 3.5 1.8 15.0 2.6 3.6 GRIN3A GluN3A ENSG00000198785 "Glutamate ionotropic receptor NMDA type subunit 3A" Q8TCU5 9 101569353-101738580 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 17.3" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 6.3" "Cancer enriched" "Detected in single" 7 "prostate cancer: 3.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "intermediate monocyte: 3.3;non-classical monocyte: 2.5" "Lineage enriched" "Detected in single" 7 "monocytes: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.29e-1)" "unprognostic (7.10e-3)" "unprognostic (3.01e-5)" "unprognostic (3.39e-2)" "unprognostic (6.32e-2)" "unprognostic (7.06e-4)" "unprognostic (1.74e-1)" "unprognostic (2.59e-1)" "unprognostic (7.56e-2)" "unprognostic (7.34e-3)" "unprognostic (1.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (1.42e-1)" "unprognostic (4.87e-1)" "unprognostic (9.41e-2)" 0.6 0.6 7.4 0.8 4.2 0.5 0.7 0.4 17.3 4.1 1.0 2.6 0.0 0.6 1.0 1.0 0.5 0.6 0.5 1.2 6.8 6.4 0.6 0.6 0.7 1.1 3.8 12.4 2.4 0.5 0.4 0.4 0.4 4.6 1.8 0.8 2.7 0.6 2.6 0.7 1.0 0.7 0.7 3.0 1.8 0.6 1.0 2.3 0.0 0.5 0.0 0.8 0.5 0.6 0.0 0.4 0.1 3.3 0.0 0.4 0.2 0.0 0.2 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.2 0.0 0.2 0.5 0.0 0.0 0.6 0.1 0.0 0.1 0.2 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.3 0.7 0.5 0.3 0.4 0.1 0.0 0.3 6.3 0.6 0.2 0.2 0.2 0.2 0.3 0.3 0.4 0.1 0.7 0.2 0.6 1.0 0.3 0.7 0.3 1.2 0.0 0.6 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 2.5 0.0 0.4 0.2 7.4 4.2 0.4 13.4 6.8 6.4 3.8 12.4 4.6 2.3 GRK1 "GPRK1, RHOK, RK" ENSG00000185974 "G protein-coupled receptor kinase 1" Q15835 13 113667155-113737735 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" "Kinase, Serine/threonine-protein kinase, Transferase" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "retina: 51.5" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035200, HPA059376" Enhanced "HPA035200: AB_2674515, HPA059376: AB_2683996" "unprognostic (7.93e-2)" "unprognostic (2.50e-1)" "unprognostic (1.87e-1)" "unprognostic (1.24e-5)" "unprognostic (1.76e-3)" "unprognostic (1.53e-1)" "unprognostic (3.59e-2)" "unprognostic (2.21e-2)" "unprognostic (1.84e-3)" "unprognostic (2.00e-2)" "unprognostic (4.02e-2)" "unprognostic (6.91e-2)" "unprognostic (6.18e-2)" "unprognostic (6.11e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 51.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 GRM1 "GPRC1A, mGlu1, MGLUR1, PPP1R85" ENSG00000152822 "Glutamate metabotropic receptor 1" Q13255 6 146027646-146437598 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 39.9" "Cell line enhanced" "Detected in some" "AF22: 1.6;HeLa: 1.4;Karpas-707: 1.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 39.9" "Cell type enriched" "Detected in single" 4 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015701 Approved Supported Approved Vesicles Vesicles "HPA015701: AB_1853917" "unprognostic (1.04e-2)" "unprognostic (7.33e-2)" "unprognostic (3.73e-3)" "unprognostic (9.77e-3)" "unprognostic (6.75e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-2)" "unprognostic (4.31e-2)" "unprognostic (2.93e-2)" "unprognostic (9.48e-3)" "unprognostic (7.92e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (3.50e-2)" "unprognostic (8.33e-3)" "unprognostic (9.76e-2)" 0.5 0.5 6.6 0.4 6.0 0.4 0.5 39.9 13.0 0.5 0.5 0.9 0.0 0.4 0.5 0.7 0.5 0.7 0.5 7.7 6.0 2.7 2.7 0.5 0.6 0.5 2.6 4.1 0.5 0.5 0.4 0.2 0.5 3.6 0.5 0.4 2.6 0.5 0.8 0.4 0.5 0.5 0.5 1.0 0.6 0.5 1.3 0.9 0.0 0.8 0.0 0.4 0.5 0.1 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.1 1.6 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.4 1.4 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 1.5 0.1 0.0 0.0 0.4 0.2 0.8 0.0 0.0 0.0 0.1 0.0 1.1 0.6 0.1 0.1 0.5 0.0 0.5 0.1 0.1 0.1 0.7 0.2 0.2 0.1 0.1 0.5 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 6.6 6.0 39.9 10.5 6.0 2.7 2.6 4.1 3.6 0.9 GRM2 "GPRC1B, mGlu2, MGLUR2" ENSG00000164082 "Glutamate metabotropic receptor 2" Q14416 3 51707070-51718613 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 13.2" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 11.7" "Cancer enhanced" "Detected in single" "testis cancer: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027868, HPA065166" Approved Supported "HPA027868: , HPA065166: " "unprognostic (1.01e-1)" "unprognostic (8.61e-4)" "unprognostic (7.66e-2)" "unprognostic (7.29e-3)" "unprognostic (1.98e-1)" "unprognostic (3.68e-2)" "unprognostic (7.10e-2)" "unprognostic (1.27e-1)" "unprognostic (1.39e-2)" "unprognostic (2.05e-1)" "unprognostic (4.45e-1)" "unprognostic (1.74e-1)" "unprognostic (1.37e-2)" "unprognostic (1.35e-1)" "unprognostic (1.82e-1)" "unprognostic (2.93e-2)" "unprognostic (1.19e-2)" 0.8 0.6 4.6 0.8 6.3 1.6 0.7 3.8 13.2 0.6 0.6 0.4 0.0 0.6 0.8 0.4 0.5 0.5 0.4 0.9 3.0 3.1 0.5 0.5 0.6 0.7 1.2 7.0 0.5 0.4 0.4 0.4 0.6 8.3 0.7 0.5 0.6 0.8 0.6 1.8 1.3 0.5 0.6 0.5 1.1 0.5 1.3 0.2 0.0 0.5 0.0 0.5 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 6.3 3.8 13.2 3.0 3.1 1.2 7.0 8.3 0.2 GRM3 "GPRC1C, mGlu3, MGLUR3" ENSG00000198822 "Glutamate metabotropic receptor 3" Q14832 7 86643914-86864884 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 24 "brain: 53.3" "Cell line enriched" "Detected in some" 6 "AF22: 28.0" "Cancer enriched" "Detected in single" 7 "glioma: 2.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" "unprognostic (2.05e-1)" "unprognostic (3.78e-2)" "unprognostic (1.90e-1)" "unprognostic (2.70e-3)" "unprognostic (3.16e-1)" "unprognostic (1.07e-3)" "unprognostic (6.99e-3)" "unprognostic (2.98e-1)" "unprognostic (2.71e-1)" "unprognostic (9.13e-3)" "unprognostic (1.88e-3)" "unprognostic (2.04e-1)" "unprognostic (3.91e-3)" "unprognostic (4.00e-2)" "unprognostic (9.34e-2)" "unprognostic (1.72e-3)" "unprognostic (1.12e-2)" 1.2 2.2 10.6 1.2 22.5 1.2 1.2 4.6 53.3 1.3 1.3 23.9 0.0 1.3 1.3 1.2 1.2 1.2 1.3 1.3 12.6 5.6 1.4 1.2 1.3 1.2 18.9 13.0 1.2 1.2 1.2 0.2 1.2 11.5 1.7 1.2 0.0 1.3 1.3 2.1 1.2 1.2 1.2 12.0 1.8 1.3 2.2 22.1 0.0 1.2 0.0 1.2 1.4 0.1 0.5 0.1 0.5 0.0 0.1 0.3 0.1 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 10.6 22.5 4.6 20.2 12.6 5.6 18.9 13.0 11.5 22.1 GRM4 "GPRC1D, mGlu4, MGLUR4" ENSG00000124493 "Glutamate metabotropic receptor 4" Q14833 6 34018645-34155622 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "brain: 101.6" "Group enriched" "Detected in some" 8 "BEWO: 6.4;SCLC-21H: 25.4" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Region enriched" "Detected in many" 21 "cerebellum: 101.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in all" "cerebellum: 83.5" "Region enriched" "Detected in many" 4 "cerebellum: 252.6" CAB022096 Enhanced "CAB022096: " "unprognostic (1.29e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (7.00e-2)" "unprognostic (4.03e-2)" "unprognostic (8.36e-2)" "unprognostic (9.05e-3)" "unprognostic (3.56e-1)" "unprognostic (9.45e-2)" "unprognostic (2.08e-2)" "unprognostic (6.21e-3)" "unprognostic (2.44e-1)" "unprognostic (2.15e-11)" "unprognostic (5.32e-2)" "unprognostic (9.16e-2)" "unprognostic (6.57e-2)" "unprognostic (3.07e-1)" 0.2 0.1 0.4 0.3 4.9 0.2 0.2 101.6 7.2 0.6 0.1 0.3 0.1 0.5 0.5 0.1 0.1 0.3 0.1 0.1 0.5 0.9 0.2 0.3 0.3 0.2 0.3 0.4 0.2 3.5 0.1 0.0 0.3 4.3 0.3 0.2 0.1 0.1 0.2 0.3 0.6 0.8 0.7 1.1 0.1 0.2 1.6 0.5 0.0 0.3 0.0 0.7 0.4 0.0 0.2 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 25.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.9 101.6 1.0 0.5 0.9 0.3 0.4 4.3 0.5 GRM5 "GPRC1E, mGlu5, MGLUR5, PPP1R86" ENSG00000168959 "Glutamate metabotropic receptor 5" P41594 11 88504576-89065945 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 27.7" "Cell line enhanced" "Detected in some" "Hep G2: 2.2;U-266/70: 1.5;U-937: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" "unprognostic (1.94e-1)" "unprognostic (9.62e-2)" "unprognostic (9.57e-2)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (2.62e-1)" "unprognostic (1.26e-1)" "unprognostic (7.16e-2)" "unprognostic (8.15e-4)" "unprognostic (3.43e-2)" 0.5 0.5 11.4 0.5 11.0 0.6 0.5 2.6 27.7 0.6 0.5 1.0 0.0 0.5 0.5 0.5 0.5 0.7 0.7 0.5 6.0 3.2 0.7 0.5 0.7 0.5 2.1 10.0 0.5 0.5 0.5 0.8 0.6 1.5 0.5 0.5 0.0 0.5 0.5 0.6 1.1 0.5 0.5 1.2 0.6 0.5 3.1 1.5 0.0 0.5 0.0 0.5 0.5 0.2 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.7 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.2 0.0 0.0 1.5 0.0 0.2 0.1 1.1 0.8 1.6 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 11.4 11.0 2.6 13.2 6.0 3.2 2.1 10.0 1.5 1.5 GRM6 "CSNB1B, GPRC1F, mGlu6, MGLUR6" ENSG00000113262 "Glutamate metabotropic receptor 6" O15303 5 178978327-178996206 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Receptor, Transducer" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 22.0" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA014511 Enhanced "HPA014511: " "unprognostic (1.85e-1)" "unprognostic (1.54e-1)" "unprognostic (8.41e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-1)" "unprognostic (2.25e-3)" "unprognostic (7.72e-2)" "unprognostic (2.32e-2)" "unprognostic (2.12e-3)" "unprognostic (6.27e-2)" "unprognostic (3.34e-4)" "unprognostic (2.58e-1)" "unprognostic (3.36e-4)" "unprognostic (1.23e-1)" "unprognostic (6.45e-2)" "unprognostic (7.59e-3)" "unprognostic (1.97e-1)" 0.3 0.5 0.6 0.4 0.6 1.6 0.3 1.9 1.6 0.4 0.4 0.3 0.3 0.3 0.6 0.5 0.3 0.5 0.7 0.4 0.5 1.2 0.4 0.4 0.4 0.5 0.8 0.3 0.7 0.9 0.1 2.9 0.3 1.2 1.1 0.1 22.0 0.6 0.3 1.3 1.8 0.3 0.3 0.3 0.5 0.3 2.2 0.3 0.3 0.9 0.3 0.3 0.3 0.3 0.9 1.1 2.4 0.4 0.6 0.6 0.1 0.5 0.3 0.7 1.3 0.3 0.1 0.7 0.2 0.0 0.1 0.0 0.5 0.9 0.8 0.6 0.0 0.7 0.0 0.1 0.0 0.2 0.7 0.5 0.7 1.0 0.2 0.8 0.9 0.1 0.3 0.1 0.5 0.0 0.9 1.7 0.0 1.0 0.2 0.7 0.6 0.6 0.6 0.3 0.8 0.1 0.6 0.9 1.2 0.5 0.7 0.5 0.9 1.1 0.9 0.5 0.5 0.4 0.5 0.7 0.6 0.4 0.4 0.7 0.3 1.9 0.4 0.5 0.6 0.3 0.4 0.4 0.4 0.3 0.2 0.9 0.4 0.4 2.4 0.6 0.2 1.1 0.2 0.1 0.6 0.6 1.9 0.5 0.5 1.2 0.8 0.3 1.2 0.3 GRXCR1 "DFNB25, PPP1R88" ENSG00000215203 "Glutaredoxin and cysteine rich domain containing 1" A8MXD5 4 42893267-43030658 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "seminal vesicle: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040824 Uncertain "HPA040824: AB_10794863" 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSC2 GSCL ENSG00000063515 "Goosecoid homeobox 2" O15499 22 19148576-19150283 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "testis: 6.3" "Cell line enriched" "Detected in single" 8 "THP-1: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043011 Uncertain "HPA043011: AB_10959883" "unprognostic (3.29e-1)" "unprognostic (1.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 GSG1 MGC3146 ENSG00000111305 "Germ cell associated 1" Q2KHT4 12 13083560-13103683 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "testis: 156.4" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 9.3;LHCN-M2: 10.7;RPTEC TERT1: 13.4;U-2 OS: 6.8" "Cancer enhanced" "Detected in single" "testis cancer: 1.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" "unprognostic (1.50e-1)" "unprognostic (2.21e-2)" "unprognostic (6.33e-2)" "unprognostic (2.36e-2)" "unprognostic (1.34e-1)" "unprognostic (8.01e-2)" "unprognostic (1.04e-1)" "unprognostic (4.52e-1)" "unprognostic (6.85e-2)" "unprognostic (8.23e-2)" "unprognostic (5.91e-2)" "unprognostic (3.20e-3)" "unprognostic (1.48e-1)" "unprognostic (3.65e-2)" "unprognostic (1.79e-1)" "unprognostic (6.32e-3)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.2 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 156.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 2.6 0.7 0.5 1.2 0.1 0.1 0.5 0.3 0.1 2.3 1.3 0.5 0.2 0.4 0.4 0.5 0.2 0.1 0.2 0.2 9.3 0.1 0.1 0.0 0.9 0.2 0.0 0.2 0.6 0.3 0.0 0.2 0.1 0.9 0.0 1.8 0.1 0.0 0.1 1.8 10.7 0.3 0.1 1.1 2.3 0.2 0.1 3.9 0.2 13.4 0.2 0.6 0.3 0.2 0.0 0.1 0.1 1.5 0.1 0.6 6.8 0.3 0.3 0.6 0.3 0.1 2.9 0.3 0.2 1.3 0.5 0.9 1.2 0.4 0.6 0.8 0.6 1.0 0.4 1.3 0.8 0.9 2.6 0.5 0.7 0.7 0.5 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.2 0.0 GSTT2B GSTT2P ENSG00000133433 "Glutathione S-transferase theta 2B (gene/pseudogene)" P0CG30 22 23957414-23961186 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "breast: 83.4" "Cell line enhanced" "Detected in many" "AN3-CA: 22.4;HHSteC: 33.0;SK-MEL-30: 22.8;T-47d: 25.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA000750 Uncertain Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA000750: AB_1849804" "prognostic favourable (5.06e-4)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (7.13e-2)" "unprognostic (8.41e-3)" "unprognostic (2.58e-1)" "unprognostic (7.99e-2)" "unprognostic (1.15e-1)" "unprognostic (1.92e-1)" "unprognostic (1.76e-2)" "unprognostic (4.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.48e-2)" "unprognostic (2.19e-3)" 1.6 11.7 2.7 0.7 1.9 0.0 83.4 0.0 4.2 2.6 1.5 0.1 1.7 2.9 2.6 1.4 1.1 2.4 1.7 2.9 1.3 6.1 2.0 0.1 2.5 3.1 3.2 0.9 3.6 0.8 6.1 0.2 1.2 2.5 1.3 11.4 0.7 2.7 1.4 0.9 2.6 0.5 2.5 0.1 0.7 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 6.4 0.3 0.0 22.4 0.4 0.5 0.9 3.1 1.8 4.6 4.8 9.6 0.0 0.0 5.1 7.8 9.4 0.0 9.9 2.1 0.0 0.8 0.3 12.6 1.5 33.0 0.0 3.6 13.6 1.6 13.1 2.7 3.6 0.0 0.0 2.7 0.1 0.0 0.0 0.1 4.7 0.0 16.7 0.0 10.1 0.0 0.4 9.4 3.1 0.0 22.8 25.2 0.3 12.2 3.8 2.5 0.5 2.4 0.0 0.0 0.0 2.4 0.0 9.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 GSTT4 "GSTTP1, HS322B1A" ENSG00000276950 "Glutathione S-transferase theta 4" 22 23998401-24005453 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 63 "testis: 20.0" "Group enriched" "Detected in some" 18 "Karpas-707: 1.6;PC-3: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.66e-2)" "unprognostic (1.77e-2)" "unprognostic (6.83e-4)" "unprognostic (4.36e-1)" "unprognostic (5.47e-1)" "unprognostic (2.23e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSTZ1 "GSTZ1-1, MAAI, MAI" ENSG00000100577 "Glutathione S-transferase zeta 1" O43708 14 77320884-77331597 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Isomerase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 90.4" "Cell line enhanced" "Detected in all" "MCF7: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004701 Approved Approved Nucleoplasm,Cytosol 62000 Cytosol Nucleoplasm "HPA004701: AB_1078990" "prognostic favourable (4.93e-4)" "unprognostic (1.08e-1)" "unprognostic (2.56e-1)" "unprognostic (2.16e-3)" "unprognostic (4.55e-1)" "unprognostic (3.03e-2)" "unprognostic (8.03e-3)" "unprognostic (1.98e-1)" "unprognostic (2.18e-1)" "prognostic favourable (3.73e-4)" "unprognostic (7.90e-2)" "unprognostic (1.73e-1)" "prognostic favourable (1.12e-7)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" "unprognostic (4.12e-1)" "unprognostic (4.92e-2)" 4.6 12.9 5.6 5.9 6.8 2.8 8.5 2.1 9.0 5.0 8.1 10.8 7.5 8.1 4.1 9.5 9.0 5.5 8.0 5.5 5.4 5.0 8.9 90.4 4.4 10.7 6.9 6.9 2.8 7.1 9.3 5.1 11.0 5.8 8.0 8.0 9.5 22.5 4.7 14.8 7.4 7.2 3.8 7.9 5.0 5.9 18.2 5.2 8.6 8.3 14.3 8.9 4.9 4.5 8.2 15.3 7.2 16.0 3.4 5.6 5.0 6.4 12.4 9.8 6.9 6.2 8.6 16.6 4.1 4.1 7.6 10.8 4.2 16.4 14.4 5.8 4.8 8.3 6.7 7.8 7.3 7.6 6.6 7.0 4.7 8.8 9.8 2.6 5.8 8.1 8.5 4.4 7.5 6.5 5.8 13.3 5.1 60.2 4.0 5.5 2.9 9.9 6.9 10.3 11.2 11.6 8.0 10.8 9.8 9.0 18.0 12.7 29.4 3.8 4.4 5.9 20.2 6.7 3.0 10.0 10.7 12.7 15.5 3.9 7.5 6.6 11.1 7.2 1.9 16.0 1.9 6.4 3.4 2.8 15.3 8.2 2.9 2.4 1.1 3.4 13.5 10.4 5.6 5.0 5.6 6.8 2.1 9.0 5.4 5.0 6.9 6.9 5.8 5.2 GSX1 "Gsh-1, GSH1" ENSG00000169840 "GS homeobox 1" Q9H4S2 13 27792643-27794768 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "brain: 7.1" "Cell line enhanced" "Detected in some" "AF22: 1.0;THP-1: 1.5" "Cancer enriched" "Detected in single" 29 "glioma: 3.9" "Region enhanced" "Detected in many" "hypothalamus: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "unprognostic (1.62e-1)" 0.1 0.1 1.6 0.1 3.2 0.1 0.1 0.9 4.0 0.1 0.1 2.5 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.7 7.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.9 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.2 0.9 1.5 0.7 7.1 0.2 0.0 0.1 0.0 GTF2A1L ALF ENSG00000242441 "General transcription factor IIA subunit 1 like" Q9UNN4 2 48617798-48733148 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 47.7" "Cell line enhanced" "Detected in some" "ASC diff: 5.4;HHSteC: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.59e-1)" "unprognostic (7.00e-2)" "unprognostic (2.63e-1)" "unprognostic (4.77e-1)" "unprognostic (5.02e-2)" 0.7 0.2 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.9 4.3 0.3 0.3 0.4 2.3 0.9 0.6 0.8 0.7 0.3 0.3 0.0 0.4 0.3 0.3 0.3 0.3 0.3 0.9 0.3 0.1 0.3 0.3 0.3 0.9 0.1 0.3 0.3 0.3 0.4 0.1 0.6 0.5 0.3 0.4 1.4 47.7 0.3 0.3 0.3 0.3 0.3 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 5.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 3.0 0.0 0.0 0.9 0.4 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.0 0.7 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.2 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 GTSF1L "C20orf65, dJ1028D15.4, FAM112A" ENSG00000124196 "Gametocyte specific factor 1 like" Q9H1H1 20 43726164-43726998 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 104.1" "Cell line enhanced" "Detected in some" "Daudi: 1.3;EFO-21: 1.2;REH: 3.9;U-698: 4.3" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 7.5" "Lineage enriched" "Detected in many" 5 "T-cells: 7.5" "Low region specificity" "Detected in some" HPA054694 Enhanced Uncertain Nucleoli Nucleoli "HPA054694: " "unprognostic (2.61e-2)" "unprognostic (4.24e-6)" "unprognostic (9.96e-3)" "unprognostic (1.30e-4)" "unprognostic (3.50e-2)" "unprognostic (6.70e-2)" "unprognostic (2.15e-2)" "unprognostic (3.06e-2)" "unprognostic (2.45e-7)" "unprognostic (1.19e-1)" "unprognostic (9.54e-2)" "unprognostic (6.07e-3)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 104.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.9 4.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 1.0 0.0 1.4 0.6 0.8 0.0 0.0 0.0 0.0 7.5 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 GUCA1B "GCAP2, RP48" ENSG00000112599 "Guanylate cyclase activator 1B" Q9UMX6 6 42184401-42194916 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "retina: 88.4" "Cell line enhanced" "Detected in many" "hTCEpi: 8.4;U-698: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA055479 Enhanced "HPA055479: " "unprognostic (1.61e-1)" "unprognostic (3.28e-1)" "unprognostic (1.14e-6)" "unprognostic (5.39e-2)" "unprognostic (1.73e-2)" "unprognostic (2.87e-3)" "unprognostic (6.06e-3)" "unprognostic (1.12e-1)" "unprognostic (1.34e-1)" "unprognostic (5.57e-1)" "unprognostic (1.66e-1)" "unprognostic (1.72e-2)" "unprognostic (3.28e-7)" "unprognostic (4.50e-2)" "unprognostic (2.20e-1)" "unprognostic (1.76e-2)" "unprognostic (2.59e-3)" 1.8 0.9 1.9 1.4 2.5 2.7 2.9 6.6 2.5 1.8 1.4 1.4 1.4 0.7 2.8 2.8 1.4 2.6 1.4 1.4 1.8 1.6 1.4 1.9 1.4 1.4 2.0 1.4 3.5 1.4 0.7 1.4 1.4 1.4 1.4 1.1 88.4 1.4 1.7 6.0 7.0 1.4 2.8 1.9 2.3 0.6 2.7 1.4 1.4 1.4 1.4 2.2 1.4 1.4 0.7 0.7 0.5 0.1 0.0 1.2 0.0 0.2 1.6 3.5 1.0 2.3 2.4 0.8 1.4 1.8 2.3 1.7 3.6 0.9 3.7 1.7 0.3 1.1 3.5 0.7 2.2 2.9 1.2 0.8 0.0 0.5 0.7 2.8 1.1 0.9 8.4 1.7 2.8 0.2 2.1 2.7 0.3 2.0 1.4 2.0 0.1 0.6 0.3 1.5 0.0 1.0 1.2 1.2 2.4 0.0 0.4 0.2 0.3 2.4 0.0 0.5 3.5 0.8 1.2 5.4 2.3 8.3 0.5 1.1 0.5 0.0 0.1 0.0 0.1 0.0 0.7 0.6 0.2 0.0 0.0 0.7 0.0 1.2 0.5 0.0 0.0 0.7 0.1 0.0 1.9 2.5 6.6 1.7 1.8 1.6 2.0 1.4 1.4 1.4 GUCA2A "GUCA2, STARA" ENSG00000197273 "Guanylate cyclase activator 2A" Q02747 1 42162691-42164718 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "intestine: 265.7" "Cell line enhanced" "Detected in some" "BEWO: 14.5;CACO-2: 11.3;NB-4: 3.7;U-2197: 3.2" "Group enriched" "Detected in many" 7 "colorectal cancer: 31.6;urothelial cancer: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "amygdala: 0.2" HPA018215 Enhanced "Secreted to blood" 26000000 "HPA018215: AB_1850443" "unprognostic (7.98e-3)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (9.07e-2)" "unprognostic (1.14e-1)" "unprognostic (8.06e-2)" "unprognostic (2.89e-1)" "unprognostic (3.10e-1)" "unprognostic (9.15e-2)" 0.2 0.1 0.2 8.0 0.2 0.0 0.2 0.2 0.2 0.2 87.3 0.2 0.2 6.6 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.7 0.0 0.2 3.5 0.2 0.2 91.9 0.2 0.2 0.2 0.2 0.1 265.7 2.1 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 11.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 GUCA2B ENSG00000044012 "Guanylate cyclase activator 2B" Q16661 1 42153421-42155824 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "intestine: 92.4" "Group enriched" "Detected in some" 6 "A549: 3.3;CACO-2: 8.9" "Cancer enhanced" "Detected in many" "liver cancer: 5.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "intermediate monocyte: 1.9" "Lineage enriched" "Detected in single" 19 "monocytes: 1.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "cerebral cortex: 0.8;hippocampal formation: 0.5" "Secreted to blood" 740000 "unprognostic (2.59e-2)" "unprognostic (1.44e-2)" "unprognostic (1.34e-1)" "unprognostic (6.22e-2)" "unprognostic (1.86e-1)" 0.1 0.0 0.1 1.2 0.1 0.0 0.1 0.1 0.1 0.1 55.2 0.1 0.1 13.5 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.0 0.1 2.1 0.1 0.1 0.1 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 8.7 0.1 0.1 0.1 0.1 0.0 92.4 0.1 0.1 0.2 5.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 8.9 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 GUCY2C "GUC2C, STAR" ENSG00000070019 "Guanylate cyclase 2C" P25092 12 14612632-14696585 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters" "cGMP biosynthesis" "Lyase, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "intestine: 85.1" "Cell line enhanced" "Detected in some" "AN3-CA: 3.7;BEWO: 2.2;CACO-2: 3.1;CAPAN-2: 4.5;SiHa: 4.2" "Group enriched" "Detected in many" 5 "colorectal cancer: 23.9;stomach cancer: 9.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 4.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA037655, HPA073759" Uncertain Uncertain Vesicles Vesicles "HPA037655: AB_10672388, HPA073759: " "unprognostic (1.08e-1)" "unprognostic (2.12e-1)" "unprognostic (3.58e-2)" "unprognostic (2.11e-2)" "unprognostic (1.60e-2)" "unprognostic (5.67e-3)" "prognostic unfavourable (1.37e-5)" "unprognostic (9.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.95e-1)" "unprognostic (1.58e-1)" "unprognostic (5.40e-2)" "unprognostic (2.35e-4)" "unprognostic (8.02e-2)" "unprognostic (1.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.98e-1)" 0.2 0.1 0.2 3.4 0.2 0.0 0.2 0.2 0.2 0.2 38.8 0.2 0.2 28.0 0.3 0.2 0.4 0.2 0.3 0.4 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.2 17.5 0.2 0.5 0.2 0.2 1.0 85.1 0.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 4.3 0.7 2.7 1.7 0.0 0.0 0.6 1.1 0.1 0.0 3.7 0.0 0.0 2.2 0.1 0.0 0.0 0.0 3.1 4.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.4 0.4 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.5 4.2 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.9 0.1 1.3 0.8 1.3 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.5 0.0 4.3 0.0 0.0 0.7 2.3 0.0 0.0 2.7 0.0 0.0 0.7 0.0 0.6 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 GUCY2F "CYGF, GC-F, GUC2DL, RetGC-2, ROS-GC2" ENSG00000101890 "Guanylate cyclase 2F, retinal" P51841 X 109372906-109482072 "Enzymes, Plasma proteins, Predicted membrane proteins" "cGMP biosynthesis, Sensory transduction, Vision" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "retina: 23.1" "Group enriched" "Detected in some" 5 "THP-1: 4.4;U-266/70: 1.6;U-937: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.91e-1)" "unprognostic (4.45e-2)" "unprognostic (2.96e-1)" "unprognostic (2.23e-1)" 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.1 0.0 1.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 GYPA "CD235a, GPA, MN, MNS" ENSG00000170180 "Glycophorin A (MNS blood group)" P02724 4 144109303-144140786 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Host-virus interaction" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 56.9" "Cell line enriched" "Detected in some" 4 "HEL: 55.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "CAB002658, HPA014811" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "CAB002658: , HPA014811: AB_1849827" "unprognostic (1.60e-1)" "unprognostic (2.47e-2)" 0.1 0.0 0.2 0.1 0.4 56.9 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 1.7 1.3 3.2 0.1 0.3 0.1 0.1 0.1 0.0 0.3 4.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.5 0.3 0.4 0.2 0.2 0.6 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.2 0.9 0.1 0.2 0.2 1.5 0.2 0.6 0.2 0.2 0.2 0.3 0.0 0.8 0.2 0.4 0.1 0.5 0.2 0.3 0.3 0.1 0.1 0.1 GYPB "CD235b, GPB, MNS, SS" ENSG00000250361 "Glycophorin B (MNS blood group)" P06028 4 143996104-144019345 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 37.1" "Cell line enriched" "Detected in some" 4 "HEL: 59.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" 0.2 0.0 0.2 0.1 0.1 37.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.8 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.2 3.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.2 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 GYS2 ENSG00000111713 "Glycogen synthase 2" P54840 12 21536189-21604847 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Allosteric enzyme, Glycosyltransferase, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "liver: 75.1" "Cell line enhanced" "Detected in some" "CACO-2: 5.1;HEL: 1.8" "Cancer enriched" "Detected in single" 29 "liver cancer: 12.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 8 "T-cells: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039482 Approved "HPA039482: AB_10795107" "unprognostic (7.22e-3)" "unprognostic (2.85e-2)" "unprognostic (8.88e-2)" "unprognostic (1.78e-2)" "unprognostic (5.68e-2)" "unprognostic (3.16e-1)" "prognostic favourable (7.62e-5)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (1.68e-1)" "unprognostic (4.68e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-1)" "unprognostic (4.22e-2)" "unprognostic (6.53e-2)" "unprognostic (1.85e-1)" "unprognostic (2.66e-4)" 8.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.1 75.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 2.4 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 5.1 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.4 0.2 0.6 1.8 0.2 0.0 0.3 0.5 0.4 0.5 0.2 0.0 0.4 0.0 0.0 0.1 0.6 0.0 0.3 0.3 0.2 0.0 0.5 0.2 0.0 1.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.4 0.0 0.1 0.2 0.1 0.2 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GZMB "CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT" ENSG00000100453 "Granzyme B" P10144 14 24630954-24634267 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Cytolysis" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "blood: 298.5" "Cell line enriched" "Detected in some" 5 "HMC-1: 20.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 298.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 298.5" "CAB000376, HPA003418" Enhanced "Secreted to blood" "CAB000376: AB_323716, HPA003418: AB_1079020" "prognostic favourable (7.27e-4)" "unprognostic (2.82e-3)" "unprognostic (8.54e-2)" "prognostic favourable (1.58e-5)" "unprognostic (2.07e-3)" "unprognostic (1.48e-3)" "unprognostic (4.43e-2)" "unprognostic (8.25e-2)" "unprognostic (3.70e-2)" "unprognostic (3.05e-3)" "unprognostic (4.26e-2)" "unprognostic (1.58e-1)" "prognostic unfavourable (1.10e-7)" "unprognostic (1.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-1)" "unprognostic (2.71e-3)" 6.4 0.7 0.8 8.0 1.1 26.4 3.2 0.7 0.7 1.6 3.0 0.5 1.3 0.8 3.9 1.5 4.0 1.0 3.1 4.8 0.7 2.4 2.1 5.7 21.7 16.7 1.1 0.0 1.4 0.7 0.0 1.0 7.5 0.8 2.6 0.9 4.0 2.7 2.3 3.5 0.6 2.9 1.8 1.5 33.0 3.5 0.9 0.4 6.1 4.4 5.3 16.8 6.0 1.5 0.2 298.5 2.0 0.2 19.9 60.5 53.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.7 2.9 0.3 0.1 0.2 60.5 0.1 0.7 0.2 4.6 28.4 0.2 0.1 1.4 28.7 2.0 19.9 0.2 298.5 0.1 53.6 0.8 1.1 0.7 0.7 0.7 2.4 1.1 0.0 0.8 0.4 GZMH "CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2" ENSG00000100450 "Granzyme H" P20718 14 24606480-24609699 "Enzymes, Predicted secreted proteins" Cytolysis "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "blood: 134.9" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;RPMI-8226: 2.0;THP-1: 1.4;U-266/70: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "gdT-cell: 134.9;memory CD4 T-cell: 41.8;memory CD8 T-cell: 109.7;naive CD8 T-cell: 102.7" "Lineage enriched" "Detected in many" 8 "T-cells: 134.9" "Low region specificity" "Detected in all" HPA029200 Enhanced "Secreted to blood" "HPA029200: AB_10602908" "unprognostic (3.72e-3)" "unprognostic (1.47e-3)" "unprognostic (5.35e-2)" "prognostic favourable (2.00e-6)" "unprognostic (8.80e-2)" "unprognostic (1.65e-3)" "unprognostic (2.08e-3)" "unprognostic (1.13e-1)" "unprognostic (1.62e-2)" "unprognostic (4.41e-2)" "unprognostic (1.14e-1)" "unprognostic (2.68e-1)" "prognostic unfavourable (1.74e-6)" "unprognostic (1.23e-1)" "unprognostic (1.80e-1)" "unprognostic (3.35e-2)" "unprognostic (2.77e-3)" 3.6 3.1 1.1 5.0 1.2 16.5 3.6 0.5 1.0 1.9 3.1 0.4 0.2 0.9 1.0 2.7 2.6 1.8 8.1 4.8 1.0 1.1 1.7 3.6 16.4 11.5 2.6 1.3 3.0 1.1 0.0 3.7 1.6 1.2 4.5 1.1 5.1 5.4 4.2 4.5 0.8 2.2 2.0 3.1 22.6 2.5 2.5 0.7 0.2 2.5 3.4 6.4 5.1 1.9 0.4 3.2 1.8 0.3 17.6 134.9 82.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.4 0.9 1.8 0.2 0.1 134.9 0.2 2.4 0.4 41.8 109.7 0.2 0.2 13.9 102.7 1.5 17.6 0.3 3.2 0.3 82.9 1.1 1.2 0.5 1.0 1.0 1.1 2.6 1.3 1.2 0.7 H1FNT "H1T2, HANP1" ENSG00000187166 "H1 histone family member N, testis specific" Q75WM6 12 48328980-48330279 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 57 "testis: 71.7" "Group enriched" "Detected in some" 7 "U-266/70: 4.9;U-266/84: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Not detected" "Not detected" HPA046204 Approved "HPA046204: " "unprognostic (2.94e-1)" "unprognostic (2.50e-1)" "unprognostic (1.95e-1)" "unprognostic (1.50e-3)" "unprognostic (1.30e-1)" "unprognostic (2.88e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-5)" "unprognostic (1.91e-1)" "unprognostic (7.68e-4)" "unprognostic (3.41e-1)" "unprognostic (2.87e-2)" "unprognostic (5.79e-3)" "unprognostic (9.84e-2)" 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 71.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 1.2 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H1FOO ENSG00000178804 "H1 histone family member O oocyte specific" Q8IZA3 3 129543214-129551467 "Predicted intracellular proteins" Meiosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 80 "testis: 10.8" "Cell line enhanced" "Detected in some" "Hep G2: 1.0;SCLC-21H: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA037992 Enhanced "HPA037992: AB_10671517" "unprognostic (5.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H2AFB1 ENSG00000274183 "H2A histone family member B1" P0C5Y9 X 154884972-154885558 "Predicted intracellular proteins" "mRNA processing" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 6.4" "Cell line enriched" "Detected in single" 19 "HDLM-2: 16.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.6 0.1 0.3 0.0 6.4 0.0 0.0 0.0 0.9 0.0 1.5 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.4 0.1 0.8 0.5 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.6 0.0 0.0 0.0 0.1 0.1 0.7 0.7 0.0 0.0 0.0 0.9 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.0 H2AFB3 H2AFB ENSG00000277745 "H2A histone family member B3" P0C5Z0 X 155459415-155460005 "Predicted intracellular proteins" "mRNA processing" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "testis: 14.6" "Cell line enriched" "Detected in some" 5 "HDLM-2: 13.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 14.6 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.0 0.7 0.0 0.5 2.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.5 0.0 0.0 0.0 0.0 0.0 13.6 0.2 0.0 2.3 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.2 0.0 0.6 0.8 1.2 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 H2AFX H2AX ENSG00000188486 "H2A histone family member X" P16104 11 119093854-119095467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 135.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012264, HPA041189, HPA051647" Supported Supported "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "CAB012264: AB_297215, HPA041189: , HPA051647: " "unprognostic (1.44e-1)" "unprognostic (1.96e-1)" "unprognostic (6.46e-2)" "unprognostic (6.41e-2)" "unprognostic (3.07e-1)" "unprognostic (3.25e-1)" "prognostic unfavourable (1.51e-4)" "unprognostic (2.32e-3)" "unprognostic (1.93e-1)" "unprognostic (3.07e-3)" "unprognostic (6.78e-2)" "unprognostic (9.31e-2)" "prognostic unfavourable (5.47e-9)" "unprognostic (1.21e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.99e-2)" 5.9 10.1 10.7 17.9 9.4 24.0 4.2 9.4 13.9 5.0 12.0 15.2 2.5 15.4 5.7 2.8 9.8 5.5 4.0 4.7 10.6 10.1 6.4 5.0 7.1 17.0 13.3 5.3 8.0 9.2 3.8 8.1 12.8 9.3 6.4 5.4 6.3 5.8 6.3 7.2 10.8 13.7 4.2 13.6 11.1 12.6 28.3 9.5 135.1 5.9 11.3 23.2 4.8 6.6 2.0 3.4 7.4 2.4 3.8 3.4 1.8 26.1 15.8 25.0 14.9 2.3 1.7 26.4 29.8 9.1 16.8 14.8 25.0 11.3 18.0 18.0 6.8 27.2 11.8 8.5 4.5 26.5 33.1 36.4 4.3 25.7 2.4 17.9 22.7 1.4 1.8 7.1 4.4 8.4 29.4 29.6 8.0 66.7 40.9 53.6 18.2 33.5 40.0 29.5 8.4 7.6 11.4 26.7 31.7 23.6 13.8 4.1 20.6 13.6 10.3 16.3 43.1 13.2 22.1 8.1 7.9 18.2 3.7 29.2 31.8 7.0 2.4 7.4 3.4 1.1 1.8 2.0 3.4 3.4 3.4 1.8 2.3 2.0 1.2 3.8 1.5 1.5 2.8 1.8 10.7 9.4 9.4 13.9 10.6 10.1 13.3 5.3 9.3 9.5 H2BFM ENSG00000101812 "H2B histone family member M" P0C1H6 X 104039949-104042454 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 19.0" "Cell line enhanced" "Detected in many" "AF22: 5.5;Karpas-707: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "unprognostic (1.87e-1)" "unprognostic (1.87e-1)" "unprognostic (1.54e-1)" 0.4 0.3 0.6 0.4 0.7 0.7 0.9 0.5 0.5 0.4 0.4 0.4 0.4 0.0 2.4 1.5 0.4 1.4 0.9 0.4 0.6 0.5 0.4 0.4 0.4 1.2 0.4 0.4 4.0 0.4 0.4 0.4 0.4 0.4 0.8 0.2 0.4 0.4 1.0 0.4 1.0 0.4 2.0 0.4 0.6 0.3 19.0 0.4 0.4 0.4 0.4 1.1 0.5 0.4 0.3 1.1 2.6 0.0 0.4 0.4 0.1 0.0 0.6 5.5 3.8 1.0 2.0 0.5 0.7 0.5 1.2 1.6 1.2 0.2 1.2 0.4 0.4 0.0 0.5 0.0 2.4 1.4 2.7 0.7 0.0 0.0 1.3 0.4 0.8 0.3 0.5 1.7 0.4 1.1 0.0 7.1 2.4 0.9 3.4 0.0 2.6 0.5 1.8 2.3 0.7 1.8 1.3 1.1 4.7 0.0 0.0 0.0 0.0 0.8 1.7 4.1 0.7 0.8 1.3 0.4 0.0 2.4 0.7 0.4 0.8 2.6 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.3 0.4 0.2 0.0 0.4 0.0 1.1 0.0 0.1 0.6 0.7 0.5 0.5 0.6 0.5 0.4 0.4 0.4 0.4 H2BFS ENSG00000234289 "H2B histone family member S" P57053 21 43565189-43565648 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 65.0" "Cell line enhanced" "Detected in many" "K-562: 23.2;U-2 OS: 22.9;U-266/84: 23.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.29e-1)" "unprognostic (4.33e-3)" "unprognostic (2.06e-2)" 1.1 0.9 0.2 7.4 0.3 1.8 2.6 0.3 0.8 1.8 1.7 0.4 1.1 2.3 2.4 4.3 4.9 4.2 4.2 4.9 0.5 0.5 4.0 3.3 12.2 0.1 0.5 2.2 4.2 0.0 0.0 4.5 0.4 5.3 1.8 0.8 3.0 2.1 1.0 0.4 3.0 1.8 0.7 5.7 2.0 7.9 0.0 65.0 2.6 7.1 6.1 2.1 1.3 7.7 6.2 16.0 4.9 1.6 3.6 3.2 2.0 3.2 0.6 0.9 2.2 0.8 2.3 2.5 1.3 3.2 1.9 4.5 1.0 0.5 8.6 0.8 2.4 0.2 0.7 0.9 2.1 3.5 0.5 4.9 0.2 0.3 0.9 4.4 2.4 0.4 0.6 0.0 0.3 23.2 2.7 0.8 6.0 1.0 2.2 0.3 2.6 0.8 0.5 8.5 0.6 0.7 3.4 2.4 10.2 3.1 2.0 10.9 1.4 0.9 1.7 22.9 1.1 0.6 7.4 23.3 4.9 1.1 11.6 1.0 10.0 2.1 15.0 1.2 2.2 1.0 5.7 1.2 1.3 2.8 7.7 1.6 1.1 16.0 1.6 4.9 6.2 3.6 3.2 H2BFS ENSG00000274559 "H2B histone family member S" 21 5972924-5973383 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 16.0" "Cell line enhanced" "Detected in many" "K-562: 23.2;U-2 OS: 22.9;U-266/84: 23.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (3.37e-2)" "unprognostic (2.63e-1)" 0.4 0.3 0.5 1.0 0.0 0.0 1.0 0.9 1.4 1.3 2.9 3.3 2.8 2.8 0.0 0.0 2.2 0.3 2.3 0.2 1.2 0.0 0.8 3.7 0.9 1.9 0.0 0.0 0.0 1.8 0.7 0.6 1.1 0.9 1.6 1.0 1.2 7.7 6.2 16.0 4.9 1.6 3.6 3.2 2.0 3.2 0.6 0.9 2.2 0.8 2.3 2.5 1.3 3.2 1.9 4.5 1.0 0.5 8.6 0.8 2.4 0.2 0.7 0.9 2.1 3.5 0.5 4.9 0.2 0.3 0.9 4.4 2.4 0.4 0.6 0.0 0.3 23.2 2.7 0.8 6.0 1.0 2.2 0.3 2.6 0.8 0.5 8.5 0.6 0.7 3.4 2.4 10.2 3.1 2.0 10.9 1.4 0.9 1.7 22.9 1.1 0.6 7.4 23.3 4.9 1.1 11.6 1.0 10.0 2.1 15.0 1.2 2.2 1.0 5.7 1.2 1.3 2.8 7.7 1.6 1.1 16.0 1.6 4.9 6.2 3.6 3.2 HABP2 "FSAP, HABP, HGFAL, PHBP" ENSG00000148702 "Hyaluronan binding protein 2" Q14520 10 113550837-113589602 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 135.4" "Cell line enriched" "Detected in some" 6 "RPTEC TERT1: 33.3" "Cancer enriched" "Detected in many" 5 "liver cancer: 92.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA019518 Uncertain "Secreted to blood" 20206666667 3200000000 "HPA019518: AB_1850467" "unprognostic (3.89e-2)" "unprognostic (6.15e-2)" "unprognostic (1.33e-1)" "unprognostic (1.24e-1)" "unprognostic (1.45e-1)" "unprognostic (6.92e-2)" "unprognostic (1.01e-1)" "unprognostic (5.86e-3)" "unprognostic (1.67e-1)" "unprognostic (9.78e-2)" "unprognostic (5.10e-2)" "unprognostic (4.77e-2)" "unprognostic (9.18e-3)" "unprognostic (2.62e-3)" "unprognostic (2.11e-1)" "unprognostic (3.22e-1)" "unprognostic (9.05e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.6 0.6 0.3 0.0 0.4 26.4 0.4 0.0 0.0 20.9 135.4 0.2 0.0 0.0 0.0 0.8 11.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 33.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 HAMP "HEPC, HFE2B, LEAP-1, LEAP1" ENSG00000105697 "Hepcidin antimicrobial peptide" P81172 19 35280716-35285143 "Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Fungicide, Hormone" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 716.5" "Cell line enriched" "Detected in single" 229 "Hep G2: 68.3" "Group enriched" "Detected in many" 12 "glioma: 6.5;liver cancer: 16.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "myeloid DC: 2.5;plasmacytoid DC: 7.6" "Lineage enriched" "Detected in single" 13 "dendritic cells: 7.6" "Not detected" "Not detected" "Secreted to blood" 1900000 3900000 "unprognostic (5.53e-2)" "unprognostic (5.02e-4)" "unprognostic (2.10e-3)" "unprognostic (4.69e-3)" "unprognostic (5.35e-2)" "unprognostic (2.24e-1)" "unprognostic (3.92e-2)" "unprognostic (9.36e-2)" "unprognostic (2.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.61e-1)" "unprognostic (1.86e-1)" "unprognostic (3.68e-7)" "unprognostic (4.11e-2)" "unprognostic (3.93e-2)" "unprognostic (4.08e-2)" "unprognostic (7.77e-2)" 0.4 0.5 1.8 0.6 10.8 1.2 0.7 0.2 4.4 0.6 0.3 0.2 0.0 0.5 0.4 0.4 0.4 0.9 0.4 45.1 10.0 1.8 0.3 716.5 0.4 1.0 4.2 0.0 1.1 8.7 0.4 0.5 0.7 6.7 0.6 0.3 0.0 0.4 0.6 0.5 0.4 0.3 0.4 13.9 0.3 0.4 0.5 4.0 0.0 0.3 0.0 1.0 0.4 0.0 0.5 7.6 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 68.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 2.5 0.5 0.0 0.0 0.0 0.5 0.0 7.6 0.0 0.0 1.8 10.8 0.2 4.4 10.0 1.8 4.2 0.0 6.7 4.0 HAO1 "GOX, GOX1" ENSG00000101323 "Hydroxyacid oxidase 1" Q9UJM8 20 7882981-7940474 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 594 "liver: 121.8" "Cell line enhanced" "Detected in some" "HL-60: 1.6;RH-30: 2.2;U-251 MG: 2.4" "Cancer enriched" "Detected in some" 184 "liver cancer: 93.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049552 Enhanced 200000 "HPA049552: " "unprognostic (4.88e-2)" "unprognostic (2.87e-3)" "unprognostic (1.08e-2)" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 121.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.8 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HAPLN1 CRTL1 ENSG00000145681 "Hyaluronan and proteoglycan link protein 1" P10915 5 83637805-83721613 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 41.8" "Group enriched" "Detected in some" 37 "PC-3: 44.7;TIME: 28.2;U-2 OS: 46.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019105, HPA019482, HPA025238" Enhanced Approved Supported Vesicles "Secreted to extracellular matrix" Vesicles "HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: " "unprognostic (5.74e-4)" "unprognostic (2.94e-2)" "unprognostic (6.58e-3)" "unprognostic (2.30e-2)" "unprognostic (1.30e-1)" "unprognostic (2.76e-3)" "unprognostic (6.01e-4)" "unprognostic (2.52e-2)" "unprognostic (1.70e-1)" "unprognostic (9.04e-3)" "unprognostic (1.31e-1)" "unprognostic (2.28e-2)" "prognostic unfavourable (4.81e-9)" "unprognostic (6.87e-2)" "unprognostic (2.04e-1)" "unprognostic (8.62e-2)" "unprognostic (3.91e-2)" 0.1 0.0 5.4 1.5 3.9 0.0 0.1 0.6 4.7 0.1 4.7 0.1 0.1 3.8 0.5 0.1 1.2 0.0 0.5 1.8 3.4 1.3 0.4 0.1 0.9 0.1 1.7 0.7 0.2 0.2 0.0 0.1 41.8 1.5 4.9 5.8 1.5 0.9 0.1 0.1 0.5 9.3 0.3 0.6 0.1 2.4 0.1 0.1 0.1 0.3 0.5 0.3 0.9 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.2 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.4 3.9 0.6 4.4 3.4 1.3 1.7 0.7 1.5 0.1 HAPLN2 BRAL1 ENSG00000132702 "Hyaluronan and proteoglycan link protein 2" Q9GZV7 1 156619294-156625725 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 39 "brain: 108.1" "Cell line enhanced" "Detected in some" "SH-SY5Y: 1.1;U-266/70: 4.5;U-87 MG: 1.3" "Cancer enriched" "Detected in some" 10 "glioma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045765 Enhanced "Secreted in brain" "HPA045765: AB_10964781" "unprognostic (3.19e-3)" "unprognostic (1.06e-1)" "unprognostic (1.02e-2)" "unprognostic (3.41e-1)" "unprognostic (1.88e-1)" "unprognostic (2.44e-1)" "unprognostic (1.92e-1)" "unprognostic (2.04e-3)" "unprognostic (1.31e-1)" "unprognostic (8.25e-2)" "unprognostic (5.54e-3)" "unprognostic (2.72e-2)" "unprognostic (2.70e-2)" "unprognostic (1.08e-1)" "unprognostic (2.25e-1)" "unprognostic (1.05e-1)" "unprognostic (4.17e-3)" 1.5 1.5 11.0 1.3 21.1 1.3 1.3 4.4 45.3 1.3 1.3 43.6 0.0 2.7 1.6 1.3 1.3 1.4 1.3 1.3 21.2 13.9 1.4 1.3 1.4 1.3 49.3 9.3 1.3 1.3 1.6 0.0 1.3 43.1 1.9 1.3 0.0 1.4 1.5 1.9 1.6 1.7 1.3 108.1 1.3 1.3 1.7 31.5 0.0 1.3 0.0 1.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.6 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 4.5 0.1 0.2 1.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 21.1 4.4 15.1 21.2 13.9 49.3 9.3 43.1 31.5 HAVCR1 "CD365, HAVCR, HAVCR-1, KIM1, TIM-1, TIM1, TIMD1" ENSG00000113249 "Hepatitis A virus cellular receptor 1" Q96D42 5 157029413-157059119 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 37.6" "Group enriched" "Detected in some" 6 "A549: 35.8;CACO-2: 43.0;RPTEC TERT1: 17.1" "Cancer enriched" "Detected in many" 12 "renal cancer: 26.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA007173, CAB075697" Uncertain Approved Vesicles Vesicles "CAB075697: , HPA007173: AB_1080282" "unprognostic (1.24e-1)" "unprognostic (1.66e-1)" "unprognostic (5.76e-2)" "unprognostic (2.00e-1)" "unprognostic (6.99e-2)" "unprognostic (2.46e-3)" "unprognostic (4.75e-3)" "unprognostic (3.20e-2)" "unprognostic (3.21e-1)" "unprognostic (8.70e-4)" "unprognostic (3.81e-3)" "unprognostic (7.10e-3)" "prognostic unfavourable (7.81e-4)" "unprognostic (1.38e-1)" "unprognostic (1.57e-1)" "prognostic favourable (1.32e-4)" 0.4 0.1 0.2 1.0 0.2 0.9 0.2 0.2 0.2 0.2 6.7 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.5 0.2 0.3 0.2 37.6 0.5 0.6 0.6 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 5.3 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.5 0.5 0.2 1.1 0.2 0.2 0.2 0.2 0.2 0.3 0.2 1.3 1.2 2.0 1.8 2.1 3.4 2.3 0.0 35.8 0.1 0.0 0.1 0.0 5.6 0.0 0.0 0.0 0.0 43.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.0 1.8 0.5 0.7 1.1 1.0 0.8 1.8 0.9 1.2 1.3 3.4 2.5 1.3 2.1 0.8 0.8 2.8 2.3 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.2 0.2 HBA1 HBA-T3 ENSG00000206172 "Hemoglobin subunit alpha 1" P69905 16 176680-177522 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 1020.7" "Group enriched" "Detected in some" 37 "HEL: 243.0;K-562: 171.3" "Cancer enhanced" "Detected in many" "glioma: 6.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 11.7;plasmacytoid DC: 7.4" "Group enriched" "Detected in many" 4 "dendritic cells: 7.4;granulocytes: 11.7" "CAB032534, HPA043780" Enhanced 17000000000 "CAB032534: AB_2294993, HPA043780: " "unprognostic (1.16e-1)" "unprognostic (1.45e-2)" "unprognostic (8.87e-2)" "unprognostic (9.78e-3)" "unprognostic (3.02e-1)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (1.35e-1)" "unprognostic (6.21e-3)" "unprognostic (1.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.02e-2)" "unprognostic (3.59e-2)" "unprognostic (3.79e-1)" "unprognostic (6.61e-2)" "unprognostic (2.67e-2)" "unprognostic (9.56e-2)" 12.6 8.8 7.1 5.0 6.6 1020.7 5.0 7.9 10.0 2.2 3.2 3.0 2.2 1.3 2.2 4.1 2.8 4.8 4.0 16.9 5.2 5.1 20.6 15.7 30.3 8.1 10.1 5.8 4.9 2.2 0.9 7.5 104.1 3.3 4.8 1.4 4.5 6.7 3.3 9.4 1.9 2.2 5.1 7.9 101.4 1.6 6.7 2.2 2.2 9.3 2.2 2.2 3.4 9.4 0.6 7.4 11.7 0.5 0.9 2.1 186.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 243.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 171.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.0 0.0 0.5 0.3 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 3.3 1.9 0.0 0.0 0.6 0.2 0.7 0.7 0.4 0.7 2.1 11.7 0.9 0.0 7.4 0.0 186.1 7.1 6.6 7.9 10.0 5.2 5.1 10.1 5.8 3.3 2.2 HBB "beta-globin, CD113t-C" ENSG00000244734 "Hemoglobin subunit beta" P68871 11 5225464-5229395 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Hypotensive agent, Vasoactive" "Congenital dyserythropoietic anemia, Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "bone marrow: 3646.7" "Cell line enhanced" "Detected in some" "HEL: 5.4;SCLC-21H: 4.7;SH-SY5Y: 5.9;U-266/70: 21.8;U-266/84: 3.6" "Cancer enhanced" "Detected in all" "glioma: 244.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "neutrophil: 19.3;plasmacytoid DC: 9.9" "Group enriched" "Detected in many" 12 "dendritic cells: 9.9;granulocytes: 19.3" "CAB009526, HPA043234" Enhanced 15000000000 "CAB009526: AB_2143058, HPA043234: " "unprognostic (2.41e-1)" "unprognostic (8.55e-2)" "unprognostic (2.40e-1)" "unprognostic (4.40e-2)" "unprognostic (1.14e-1)" "unprognostic (3.22e-1)" "unprognostic (4.88e-2)" "unprognostic (7.46e-2)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (8.11e-3)" "unprognostic (2.40e-2)" "unprognostic (5.81e-2)" "unprognostic (1.42e-1)" "unprognostic (8.87e-3)" "unprognostic (6.41e-2)" 32.7 20.0 20.9 10.1 21.0 3646.7 43.4 6.5 10.7 9.2 11.3 7.2 3.4 3.2 7.3 11.1 36.6 28.4 30.4 38.9 17.9 17.4 45.0 37.6 305.8 7.0 31.6 10.8 82.6 28.4 2.9 18.6 236.8 23.7 23.1 7.5 32.0 17.4 12.8 29.5 3.8 3.9 12.0 26.5 216.8 4.0 9.3 3.8 5.6 46.4 20.2 7.6 124.5 256.7 0.6 9.9 19.3 0.6 1.2 1.1 523.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.1 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.3 0.3 0.0 0.0 4.7 5.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 21.8 3.6 0.0 0.0 0.0 0.0 2.2 0.6 1.9 0.9 0.0 0.1 0.6 0.2 0.0 0.9 0.4 0.4 1.1 19.3 1.2 0.1 9.9 0.0 523.2 20.9 21.0 6.5 10.7 17.9 17.4 31.6 10.8 23.7 3.8 HBD ENSG00000223609 "Hemoglobin subunit delta" P02042 11 5232678-5243657 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 233.7" "Group enriched" "Detected in some" 5 "HEL: 30.6;U-266/70: 41.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "CAB037087, HPA043234" Supported 11000000000 "CAB037087: AB_260051, HPA043234: " "unprognostic (1.32e-2)" "unprognostic (4.87e-2)" "unprognostic (4.14e-2)" "unprognostic (2.26e-3)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "unprognostic (1.04e-1)" "unprognostic (8.67e-2)" "unprognostic (2.83e-2)" "unprognostic (3.17e-1)" "unprognostic (6.24e-2)" "unprognostic (3.17e-1)" 1.6 0.2 0.4 0.3 0.6 233.7 0.8 0.1 0.5 0.2 0.2 1.5 0.0 0.2 0.4 0.2 0.9 0.5 0.2 4.3 1.3 0.4 1.4 3.9 22.5 0.2 1.0 0.0 1.1 0.2 0.2 1.3 12.0 0.8 0.5 0.2 1.0 0.9 0.2 1.0 0.2 0.2 0.2 0.4 29.6 0.2 0.2 0.0 1.2 4.4 0.0 0.4 1.7 11.9 0.0 0.5 0.8 0.0 0.0 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 30.6 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.6 7.3 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 31.6 0.4 0.6 0.1 0.5 1.3 0.4 1.0 0.0 0.8 0.0 HBG1 HBG-T2 ENSG00000213934 "Hemoglobin subunit gamma 1" P69891 11 5248079-5249859 "Predicted intracellular proteins" "Oxygen transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "placenta: 74.0" "Cell line enriched" "Detected in some" 27 "K-562: 190.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043234 Approved "HPA043234: " "unprognostic (3.17e-2)" 1.5 0.1 0.5 0.1 0.6 0.4 0.1 0.5 0.4 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 1.1 0.5 0.4 1.2 0.9 2.6 0.1 0.7 0.2 0.1 0.1 0.4 74.0 0.1 0.1 0.2 0.2 0.9 0.1 0.1 0.1 1.1 7.0 0.5 0.2 0.8 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 190.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.5 HBG2 HBG-T1 ENSG00000196565 "Hemoglobin subunit gamma 2" P69892 11 5253190-5505605 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Oxygen transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 41 "placenta: 553.0" "Group enriched" "Detected in some" 175 "HEL: 313.8;K-562: 326.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016143, HPA043234" Approved "CAB016143: AB_2295004, HPA043234: " "unprognostic (4.48e-3)" "unprognostic (2.42e-1)" "unprognostic (6.24e-2)" "unprognostic (1.41e-1)" "unprognostic (8.94e-2)" "unprognostic (4.22e-1)" "unprognostic (5.29e-1)" "unprognostic (3.95e-2)" "unprognostic (2.99e-1)" "unprognostic (3.52e-2)" "unprognostic (4.27e-1)" "unprognostic (3.75e-2)" "unprognostic (7.70e-5)" "unprognostic (1.64e-1)" "unprognostic (2.65e-1)" "unprognostic (1.02e-1)" "unprognostic (1.20e-1)" 2.6 0.3 1.4 0.7 1.2 3.7 0.7 0.9 0.8 0.7 0.7 0.7 0.7 0.4 0.7 0.7 0.7 0.3 0.7 2.3 1.0 1.0 2.3 2.2 5.5 0.7 1.7 0.7 0.7 0.8 0.3 1.0 553.0 0.7 0.7 0.3 0.8 0.7 0.7 1.3 0.3 0.7 0.7 2.3 13.3 0.5 1.1 0.7 0.7 1.7 0.7 0.7 0.7 0.8 0.0 0.1 0.4 0.7 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 313.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 326.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 9.5 1.4 1.2 0.9 0.8 1.0 1.0 1.7 0.7 0.7 0.7 HCRT "OX, PPOX" ENSG00000161610 "Hypocretin neuropeptide precursor" O43612 17 42184060-42185452 "Disease related genes, Predicted secreted proteins" Neuropeptide "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "brain: 84.3" "Cell line enhanced" "Detected in some" "HDLM-2: 1.9;Karpas-707: 1.0;RPMI-8226: 3.6" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.7;granulocytes: 2.3;T-cells: 2.2" "Region enriched" "Detected in some" 5 "hypothalamus: 110.5" "Region enriched" "Detected in single" 56 "hypothalamus: 152.0" "HPA064801, CAB079778" Enhanced Supported "Secreted to blood" "CAB079778: , HPA064801: " "unprognostic (3.34e-2)" "unprognostic (7.76e-5)" "unprognostic (3.21e-2)" "unprognostic (3.01e-2)" "unprognostic (2.20e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" 0.9 0.0 0.0 1.1 0.2 0.9 0.0 0.0 0.7 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 84.3 0.4 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 2.7 0.4 2.3 0.5 0.4 2.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.8 0.8 0.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.2 0.7 0.8 0.2 0.0 0.1 0.0 2.3 0.5 0.0 1.2 0.4 2.2 1.5 0.9 1.6 0.4 2.7 1.4 1.3 0.1 0.4 0.2 0.3 0.5 0.1 HCRTR2 OX2R ENSG00000137252 "Hypocretin receptor 2" O43614 6 55106460-55282620 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 17.4" "Cell line enriched" "Detected in single" 6 "AF22: 4.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "pons and medulla: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054516 Enhanced "HPA054516: " "unprognostic (4.86e-1)" "unprognostic (2.69e-2)" "unprognostic (1.86e-2)" "unprognostic (2.32e-1)" "unprognostic (7.45e-2)" "unprognostic (7.39e-2)" 0.1 0.2 1.7 0.0 1.3 0.0 0.1 0.6 2.2 0.1 0.1 0.3 0.0 0.0 0.1 0.5 0.0 0.1 0.1 1.1 0.9 4.2 3.7 0.1 0.4 0.1 2.6 1.7 1.7 0.0 0.0 0.3 2.2 17.4 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.2 0.1 0.5 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 1.3 0.6 2.2 0.9 4.2 2.6 1.7 17.4 0.0 HDGFL1 "dJ309H15.1, Hdgfrp1, HRP-1, PWWP1" ENSG00000112273 "HDGF like 1" Q5TGJ6 6 22569493-22571666 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 296 "testis: 97.1" "Cell line enriched" "Detected in single" 8 "K-562: 4.9" "Cancer enriched" "Detected in some" 41 "testis cancer: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045679, HPA063707" Enhanced "HPA045679: AB_2679415, HPA063707: AB_2685099" "unprognostic (1.55e-1)" "unprognostic (6.18e-2)" "unprognostic (4.03e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HEATR9 "C17orf66, FLJ32830" ENSG00000270379 "HEAT repeat containing 9" A2RTY3 17 35854946-35868891 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "testis: 30.7" "Cell line enhanced" "Detected in some" "A549: 3.1;U-937: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023129 Uncertain "HPA023129: AB_1845599" "unprognostic (1.02e-1)" "unprognostic (2.63e-3)" "unprognostic (5.04e-3)" "unprognostic (1.35e-1)" "unprognostic (2.05e-2)" "unprognostic (7.44e-4)" "unprognostic (1.30e-3)" "unprognostic (2.43e-2)" "unprognostic (2.63e-1)" "unprognostic (3.28e-1)" "unprognostic (1.09e-2)" "unprognostic (1.05e-2)" "unprognostic (1.61e-10)" "unprognostic (6.78e-2)" "unprognostic (1.93e-1)" "unprognostic (4.52e-2)" "unprognostic (5.61e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 30.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.9 0.5 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.4 0.9 0.1 0.0 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.5 HEPHL1 DKFZp686F22190 ENSG00000181333 "Hephaestin like 1" Q6MZM0 11 94021361-94113751 "Predicted membrane proteins" "Copper transport, Ion transport, Transport" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "tongue: 68.0" "Cell line enhanced" "Detected in some" "BEWO: 1.4;HaCaT: 4.1;HBEC3-KT: 7.3" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 20.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in single" 21 "olfactory region: 1.4" "Not detected" "Not detected" HPA031517 Uncertain 51000000 "HPA031517: AB_10603769" "unprognostic (9.16e-2)" "prognostic unfavourable (4.94e-4)" "unprognostic (2.40e-1)" "unprognostic (3.26e-6)" "unprognostic (3.17e-1)" "unprognostic (3.45e-1)" "unprognostic (1.72e-2)" "unprognostic (6.71e-2)" "unprognostic (5.34e-1)" "unprognostic (1.09e-1)" "unprognostic (7.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.20e-2)" "unprognostic (1.00e-1)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (1.25e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 6.5 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 68.0 16.2 0.0 4.8 1.1 0.3 0.1 0.0 0.9 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 1.4 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.3 0.0 4.1 0.0 7.3 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.3 1.1 0.0 0.1 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HEPN1 ENSG00000221932 "Hepatocellular carcinoma, down-regulated 1" Q6WQI6 11 124919244-124920677 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 43.3" "Cell line enriched" "Detected in single" 335 "Hep G2: 33.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043768, HPA063054" Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA043768: , HPA063054: " 8.4 0.5 22.0 0.4 20.4 0.3 0.3 4.2 43.3 0.3 0.4 0.3 0.4 0.3 0.4 0.3 0.3 0.5 17.9 11.0 0.4 4.5 0.3 0.5 19.3 0.4 0.3 0.3 0.0 0.3 0.3 0.3 0.5 0.3 0.5 0.3 0.5 0.3 19.4 0.3 0.4 0.4 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HES3 bHLHb43 ENSG00000173673 "Hes family bHLH transcription factor 3" Q5TGS1 1 6244192-6245578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 6.8" "Cell line enriched" "Detected in some" 7 "NTERA-2: 15.7" "Cancer enriched" "Detected in single" 28 "testis cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 30 "cerebellum: 39.0" "Low region specificity" "Detected in many" "HPA047927, HPA072697" Uncertain Approved Nucleoplasm Nucleoplasm "HPA047927: , HPA072697: " "unprognostic (7.42e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 HGD "AKU, HGO" ENSG00000113924 "Homogentisate 1,2-dioxygenase" Q93099 3 120628173-120682571 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 176.7" "Cell line enhanced" "Detected in some" "CACO-2: 13.1;EFO-21: 23.3;Hep G2: 44.9;RPTEC TERT1: 58.4" "Cancer enhanced" "Detected in many" "liver cancer: 119.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047374, HPA052359" Enhanced Approved "Golgi apparatus" 210000 "Golgi apparatus" "HPA047374: AB_2680019, HPA052359: AB_2681798" "unprognostic (1.36e-1)" "unprognostic (9.89e-2)" "unprognostic (3.93e-2)" "prognostic favourable (1.78e-4)" "unprognostic (1.56e-1)" "unprognostic (2.05e-1)" "unprognostic (5.65e-3)" "unprognostic (7.20e-2)" "unprognostic (6.05e-2)" "unprognostic (2.41e-3)" "unprognostic (2.68e-2)" "unprognostic (1.16e-1)" "unprognostic (4.29e-3)" "unprognostic (8.57e-2)" "unprognostic (1.78e-1)" "unprognostic (3.71e-3)" "unprognostic (1.43e-1)" 0.2 0.2 0.2 0.6 0.6 0.0 1.8 0.2 0.5 3.7 7.2 0.3 1.4 4.7 0.6 4.0 0.2 0.4 11.5 0.3 0.2 0.1 33.3 176.7 0.7 0.3 0.2 0.2 0.3 6.9 0.0 0.4 0.3 0.3 6.7 2.7 5.9 3.3 1.0 0.4 0.3 15.0 0.3 0.4 0.3 3.9 0.3 0.2 0.2 8.1 0.3 0.3 0.2 0.2 0.0 0.3 2.8 0.4 0.0 0.0 5.1 0.0 2.9 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13.1 3.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 44.9 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 58.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.4 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 5.1 0.2 0.6 0.2 0.5 0.2 0.1 0.2 0.2 0.3 0.2 HGFAC "HGFA, HGFAP" ENSG00000109758 "HGF activator" Q04756 4 3441887-3449495 "Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 141 "liver: 128.0" "Cell line enriched" "Detected in some" 8 "Hep G2: 10.7" "Cancer enriched" "Detected in some" 22 "liver cancer: 26.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA058279, HPA059076" Enhanced "Secreted to blood" 7586667 11000000000 "HPA058279: AB_2683665, HPA059076: AB_2683898" "unprognostic (2.70e-2)" "unprognostic (8.20e-2)" "unprognostic (1.57e-1)" "unprognostic (1.86e-1)" "unprognostic (1.36e-1)" "unprognostic (1.39e-2)" "unprognostic (2.85e-3)" "unprognostic (5.37e-3)" "unprognostic (5.90e-2)" "unprognostic (1.81e-1)" "unprognostic (8.54e-3)" "unprognostic (5.52e-2)" "prognostic unfavourable (9.31e-4)" "unprognostic (2.87e-1)" "unprognostic (2.24e-1)" "unprognostic (9.49e-2)" "unprognostic (3.74e-4)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 128.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.2 1.2 0.7 0.4 0.1 0.0 0.0 0.6 1.1 0.0 0.0 0.3 0.1 0.0 0.0 0.5 0.7 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 HHLA2 "B7-H5, B7H7, B7y" ENSG00000114455 "HERV-H LTR-associating 2" Q9UM44 3 108296490-108378285 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "intestine: 125.2" "Cell line enhanced" "Detected in some" "HDLM-2: 7.9;Karpas-707: 5.8" "Group enriched" "Detected in many" 12 "colorectal cancer: 9.2;lung cancer: 5.0;pancreatic cancer: 5.1;renal cancer: 16.6;stomach cancer: 6.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 5.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055478 Enhanced "HPA055478: " "unprognostic (1.12e-2)" "unprognostic (2.29e-1)" "unprognostic (1.03e-1)" "unprognostic (3.11e-1)" "unprognostic (2.30e-1)" "unprognostic (1.59e-2)" "unprognostic (8.14e-5)" "unprognostic (1.76e-1)" "unprognostic (2.28e-1)" "unprognostic (1.08e-1)" "unprognostic (6.42e-3)" "unprognostic (1.24e-1)" "unprognostic (1.62e-3)" "unprognostic (1.47e-1)" "unprognostic (2.31e-1)" "unprognostic (2.67e-1)" "unprognostic (1.66e-2)" 0.2 0.2 0.3 4.3 0.3 0.0 0.2 0.2 0.3 0.3 39.6 0.2 0.2 25.5 0.2 0.5 0.2 0.9 8.5 0.2 0.3 0.3 7.8 0.4 2.2 0.2 0.3 0.2 0.6 1.2 0.0 0.3 0.2 0.2 0.2 25.2 0.2 0.2 0.2 0.2 0.1 125.2 0.3 0.5 0.3 2.5 1.9 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.3 5.1 1.2 1.5 0.3 0.5 0.7 0.4 0.6 0.4 0.5 0.0 0.0 1.5 0.0 0.0 0.0 0.5 3.5 0.4 0.3 0.4 0.1 0.4 1.2 0.0 0.0 7.9 0.2 0.2 2.7 0.5 0.0 1.7 1.0 0.0 0.0 0.0 0.0 0.1 0.7 5.8 0.0 0.5 0.8 3.0 1.2 0.6 0.7 0.3 1.6 0.1 0.3 1.4 1.4 1.4 0.1 0.3 0.3 0.4 0.3 0.3 1.5 0.5 0.4 3.1 1.4 0.8 0.1 0.9 0.2 1.2 0.3 1.1 0.1 0.4 0.1 0.3 0.2 0.5 5.1 0.3 0.2 0.1 0.5 0.3 1.5 0.1 0.0 0.7 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.2 0.2 HIGD2B HIGD2BP ENSG00000175202 "HIG1 hypoxia inducible domain family member 2B" Q4VC39 15 72675783-72686149 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 11.6" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;ASC TERT1: 1.1;Karpas-707: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019016, HPA042715" Uncertain Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA019016: AB_1850711, HPA042715: " "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.24e-3)" "unprognostic (5.09e-2)" "unprognostic (3.34e-1)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "unprognostic (1.39e-1)" "unprognostic (6.98e-2)" "unprognostic (3.90e-1)" "unprognostic (8.80e-2)" "unprognostic (6.11e-4)" "unprognostic (6.95e-2)" "unprognostic (2.97e-1)" "unprognostic (1.11e-2)" "unprognostic (3.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.0 0.6 0.2 0.0 0.7 0.0 1.3 0.7 1.1 0.0 0.0 0.4 0.0 0.6 0.6 0.8 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 1.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.8 0.7 0.0 0.0 0.0 0.3 0.3 0.2 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 HIPK4 FLJ32818 ENSG00000160396 "Homeodomain interacting protein kinase 4" Q8NE63 19 40379271-40390187 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 34.7" "Cell line enhanced" "Detected in some" "A549: 3.0;AN3-CA: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA027733 Uncertain "HPA027733: AB_1850734" "unprognostic (2.07e-2)" "unprognostic (6.25e-2)" "unprognostic (2.58e-2)" "unprognostic (5.53e-3)" "unprognostic (4.00e-2)" "unprognostic (1.36e-1)" "unprognostic (3.69e-2)" "unprognostic (2.52e-3)" "unprognostic (1.08e-1)" "unprognostic (7.48e-3)" "unprognostic (8.85e-2)" "unprognostic (9.09e-2)" "unprognostic (3.06e-2)" "unprognostic (8.71e-3)" "unprognostic (3.64e-2)" "unprognostic (2.03e-2)" "unprognostic (4.63e-2)" 0.3 0.1 2.3 0.3 7.4 0.2 0.3 1.2 5.7 0.3 0.3 0.3 0.3 0.2 0.4 0.3 0.5 0.2 0.3 0.8 2.9 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.1 0.3 0.4 0.3 1.4 0.2 0.3 0.3 0.3 0.3 0.1 34.7 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.7 0.0 0.4 1.1 0.3 0.1 0.1 3.0 0.2 2.3 0.1 0.3 0.0 0.7 1.1 0.8 0.4 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.5 1.2 0.3 0.3 0.1 0.3 0.0 0.2 0.7 0.1 0.1 0.1 0.4 0.1 0.3 0.3 0.0 0.4 0.0 0.3 0.4 0.1 0.0 0.4 0.1 0.6 1.3 1.2 1.1 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 2.3 7.4 1.2 3.5 2.9 0.3 0.3 0.3 0.3 0.3 HIST1H1B "H1.5, H1b, H1F5, H1s-3" ENSG00000184357 "Histone cluster 1 H1 family member b" P16401 6 27866849-27867529 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 342.6" "Cell line enhanced" "Detected in many" "MOLT-4: 13.7;NB-4: 7.5;U-698: 5.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 4.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 13.0;dendritic cells: 12.7;T-cells: 3.4" "CAB012241, HPA055907" Approved Supported Nucleoplasm 510000 Nucleoplasm "CAB012241: , HPA055907: " "unprognostic (2.34e-1)" "unprognostic (3.75e-4)" "unprognostic (2.12e-2)" "unprognostic (3.63e-2)" "unprognostic (1.05e-1)" "unprognostic (2.37e-2)" "unprognostic (1.91e-2)" "unprognostic (4.93e-2)" "unprognostic (1.20e-1)" "unprognostic (8.47e-2)" "unprognostic (6.23e-3)" "unprognostic (5.85e-2)" "unprognostic (5.68e-4)" "unprognostic (2.10e-1)" "unprognostic (9.79e-2)" "unprognostic (1.35e-1)" 1.1 0.4 0.4 22.9 0.5 18.2 2.1 0.5 0.4 1.7 7.3 0.0 0.0 0.3 0.5 1.0 10.2 0.3 1.9 0.6 0.5 0.5 0.4 0.6 3.9 10.7 0.5 0.0 0.4 0.4 0.3 0.4 6.4 0.0 0.4 0.5 0.0 0.8 0.3 0.4 1.4 7.0 0.3 1.7 14.4 1.3 1.7 0.0 342.6 0.6 10.5 26.0 2.0 0.7 13.0 12.7 0.7 1.1 1.8 3.4 2.1 2.2 0.0 0.8 0.0 0.0 0.0 1.7 0.7 0.6 1.0 0.6 0.7 1.5 2.6 0.4 0.8 0.8 0.0 0.0 0.1 0.8 0.9 3.5 0.1 0.0 0.0 0.0 0.8 0.0 0.0 1.2 0.0 0.9 2.6 1.9 0.1 0.4 13.7 7.5 2.1 0.0 4.2 0.0 0.0 0.4 0.0 1.9 1.1 2.3 0.3 0.0 1.0 2.4 0.8 1.4 0.1 1.3 1.0 2.8 0.0 5.8 1.9 0.9 1.3 0.0 0.9 0.0 3.3 0.9 1.7 4.8 3.1 3.4 5.1 13.0 1.7 1.8 0.7 1.8 1.1 12.7 3.4 2.1 0.4 0.5 0.5 0.4 0.5 0.5 0.5 0.0 0.0 0.0 HIST1H1D "H1.3, H1d, H1F3, H1s-2" ENSG00000124575 "Histone cluster 1 H1 family member d" P16402 6 26234268-26234933 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 182.1" "Cell line enhanced" "Detected in some" "BEWO: 8.4;MOLT-4: 13.3;NB-4: 6.1;REH: 5.5;SiHa: 5.4;U-266/70: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA055907 Supported "HPA055907: " "unprognostic (8.78e-2)" "unprognostic (1.01e-4)" "unprognostic (8.69e-2)" "unprognostic (5.67e-2)" "unprognostic (2.50e-1)" "unprognostic (1.28e-1)" "unprognostic (1.11e-2)" "unprognostic (2.13e-1)" "unprognostic (3.06e-2)" "unprognostic (1.99e-1)" "unprognostic (1.14e-2)" "unprognostic (8.96e-2)" "unprognostic (3.61e-8)" "unprognostic (8.78e-2)" "unprognostic (1.60e-1)" "unprognostic (1.23e-3)" "unprognostic (1.33e-2)" 3.2 1.1 0.4 14.7 0.9 37.5 5.0 2.8 0.9 4.1 5.2 0.1 2.0 1.0 3.9 4.8 10.7 1.3 3.7 2.5 0.8 0.8 1.5 1.1 9.9 21.2 0.6 0.0 3.4 0.9 0.9 0.6 2.3 0.1 3.7 2.4 1.4 1.8 1.0 0.9 6.1 4.9 1.2 4.4 14.2 1.6 4.6 0.0 182.1 1.7 4.5 17.6 8.3 9.2 26.3 17.9 8.6 3.8 12.5 21.2 8.0 1.0 0.7 0.2 0.0 0.4 0.0 8.4 0.4 0.3 1.1 0.8 0.2 0.9 0.0 0.2 0.1 1.0 0.3 0.0 0.5 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.7 0.0 0.2 0.2 0.3 0.4 2.3 2.3 0.1 0.0 13.3 6.1 0.7 2.5 5.5 0.1 3.1 0.0 0.0 2.8 0.4 5.4 2.3 0.0 1.1 1.3 0.0 0.4 0.0 0.2 0.9 6.9 3.4 0.4 1.0 1.8 0.7 8.6 3.8 3.2 17.7 2.4 12.6 16.5 16.3 12.0 9.5 26.3 21.2 16.4 1.4 12.5 3.4 17.9 12.1 8.0 0.4 0.9 2.8 0.8 0.8 0.8 0.6 0.0 0.1 0.0 HIST1H1T "H1FT, H1t" ENSG00000187475 "Histone cluster 1 H1 family member t" P22492 6 26107419-26108136 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 59 "testis: 257.2" "Cell line enhanced" "Detected in some" "EFO-21: 1.8;SiHa: 3.9;U-266/84: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 44 "neutrophil: 4.3" "Lineage enriched" "Detected in single" 44 "granulocytes: 4.3" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "olfactory region: 5.1" "HPA065718, HPA068266" Enhanced "HPA065718: AB_2685543, HPA068266: AB_2685967" "unprognostic (1.06e-2)" "unprognostic (1.80e-2)" "unprognostic (9.52e-2)" "unprognostic (9.94e-2)" "unprognostic (5.12e-1)" "unprognostic (1.57e-1)" "unprognostic (7.48e-3)" "unprognostic (6.51e-2)" "unprognostic (6.86e-3)" "unprognostic (1.14e-1)" "unprognostic (2.46e-1)" "unprognostic (6.28e-3)" 0.0 0.0 0.2 0.8 0.3 0.4 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.0 0.0 0.3 0.1 0.1 0.6 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.2 0.2 0.0 257.2 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.3 0.0 1.8 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 3.9 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 1.7 0.2 0.3 0.0 0.2 0.3 0.1 0.2 0.0 0.0 0.0 HIST1H2AA "bA317E16.2, H2AFR" ENSG00000164508 "Histone cluster 1 H2A family member a" Q96QV6 6 25726132-25726527 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 518 "testis: 453.1" "Cell line enriched" "Detected in single" 29 "HEK 293: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041189 Supported "HPA041189: " "unprognostic (4.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 453.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 HIST1H2AB "H2A/m, H2AFM" ENSG00000278463 "Histone cluster 1 H2A family member b" P04908 6 26033176-26033568 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "lymphoid tissue: 133.2" "Cell line enhanced" "Detected in many" "Hep G2: 9.1" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA041189 Supported "HPA041189: " "unprognostic (9.53e-3)" "unprognostic (3.93e-2)" "unprognostic (5.40e-2)" "unprognostic (5.96e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (7.13e-2)" "unprognostic (2.58e-1)" "unprognostic (2.49e-1)" "unprognostic (1.04e-3)" "unprognostic (3.28e-1)" "unprognostic (7.78e-2)" "unprognostic (1.47e-1)" "unprognostic (1.47e-3)" 0.7 0.3 0.2 7.6 0.0 9.6 2.6 0.2 0.6 0.5 1.7 0.0 0.0 0.3 0.5 0.3 5.0 0.3 0.7 2.6 0.0 0.6 0.3 1.7 5.9 0.0 0.0 0.3 0.3 0.3 0.0 2.6 0.0 0.5 0.3 0.2 0.3 0.3 0.3 0.3 2.2 0.3 0.1 8.2 0.7 8.3 0.0 133.2 0.3 1.5 12.2 0.3 0.0 4.2 1.8 3.4 1.5 1.4 2.4 0.3 0.2 1.0 0.4 3.6 0.0 0.0 0.0 0.0 0.0 0.9 1.7 0.0 0.3 1.8 0.9 0.0 0.6 0.5 0.0 0.6 0.9 2.2 1.0 0.5 9.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 1.4 1.0 0.0 1.4 2.0 1.9 3.6 3.4 1.1 0.7 1.5 0.0 3.0 0.4 0.1 2.1 0.0 0.1 0.6 1.0 0.0 0.3 3.9 0.3 0.2 1.4 2.4 0.0 0.6 3.7 0.3 0.0 0.1 3.4 0.8 1.5 0.0 4.2 1.5 2.4 1.8 3.1 0.6 0.8 0.7 1.4 0.1 0.2 0.6 0.3 HIST1H2AD "H2A.3, H2A/g, H2AFG" ENSG00000196866 "Histone cluster 1 H2A family member d" P20671 6 26198851-26199243 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 14 "lymphoid tissue: 225.6" "Cell line enhanced" "Detected in many" "U-266/70: 20.7;U-266/84: 6.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 16.0" "Low lineage specificity" "Detected in all" HPA041189 Supported "HPA041189: " "unprognostic (5.03e-2)" "unprognostic (1.11e-2)" "unprognostic (7.27e-2)" "unprognostic (3.56e-1)" "unprognostic (9.17e-2)" "unprognostic (1.45e-1)" "unprognostic (9.09e-3)" "unprognostic (6.72e-2)" "unprognostic (1.92e-1)" "unprognostic (4.34e-1)" "unprognostic (1.81e-1)" "unprognostic (2.88e-2)" "unprognostic (1.10e-9)" "unprognostic (2.00e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (2.14e-2)" 2.6 1.8 0.9 13.8 1.1 14.7 6.3 0.8 1.3 8.0 4.6 0.0 3.2 1.5 2.0 3.1 9.2 1.3 2.8 5.5 1.2 1.3 2.3 3.6 4.8 15.9 1.1 0.5 3.4 1.9 1.1 1.5 4.6 1.0 6.8 2.2 1.5 2.5 4.3 1.2 3.2 4.3 2.3 3.6 10.8 1.8 5.7 0.6 225.6 1.4 5.1 14.3 5.3 8.6 7.0 5.7 16.0 1.8 1.1 3.8 0.8 0.8 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.3 1.9 0.0 2.4 0.3 0.0 1.6 0.3 0.4 0.0 0.3 0.2 0.1 1.3 0.2 1.5 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 3.4 1.6 0.0 0.1 2.9 1.3 1.6 0.3 1.5 0.5 1.5 0.3 0.1 1.5 0.3 0.7 1.4 0.1 0.5 0.5 0.0 1.5 4.0 0.0 1.1 20.7 6.7 2.5 0.8 1.8 0.7 2.2 0.2 3.2 1.1 1.8 1.1 2.0 1.5 3.8 1.0 7.0 1.4 1.1 16.0 1.1 1.3 5.7 2.0 0.8 0.9 1.1 0.8 1.3 1.2 1.3 1.1 0.5 1.0 0.6 HIST1H2AE "H2A.1, H2A/a, H2AFA" ENSG00000277075 "Histone cluster 1 H2A family member e" P04908 6 26216975-26217483 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 139.6" "Cell line enhanced" "Detected in many" "U-266/70: 26.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB012242, HPA041189" Supported Supported Nucleoplasm Nucleoplasm "CAB012242: AB_470265, HPA041189: " "unprognostic (4.26e-2)" "unprognostic (1.55e-2)" "unprognostic (4.66e-2)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (1.50e-1)" "unprognostic (2.48e-2)" "unprognostic (7.22e-2)" "unprognostic (1.24e-2)" "unprognostic (6.99e-2)" "unprognostic (1.21e-3)" "unprognostic (1.30e-2)" "unprognostic (7.64e-2)" "unprognostic (1.15e-1)" "unprognostic (2.41e-1)" "unprognostic (2.20e-1)" "unprognostic (9.36e-2)" 0.3 1.8 0.9 19.1 0.9 13.5 33.8 4.9 6.2 3.7 3.8 0.2 3.2 2.8 2.2 13.6 7.2 3.0 2.4 2.2 0.5 0.8 1.5 1.9 11.4 0.0 3.0 2.0 1.1 0.4 0.0 2.9 0.5 10.6 1.6 1.4 2.7 2.5 0.1 2.4 3.4 2.0 3.5 5.9 2.0 5.1 0.0 139.6 2.0 7.4 11.4 2.3 0.0 6.1 15.4 11.4 2.1 4.0 4.2 10.1 2.8 0.0 2.1 0.0 3.5 0.7 0.5 0.9 1.4 3.1 2.1 1.4 2.3 0.1 7.7 0.3 2.3 1.0 1.4 1.2 3.0 2.5 1.8 4.1 1.7 0.6 0.2 2.9 6.1 0.7 1.3 0.1 1.5 7.6 2.1 0.2 5.1 6.2 5.4 2.5 2.6 5.0 1.7 9.8 1.3 1.6 8.5 3.6 7.6 2.6 1.7 10.5 2.8 0.0 0.1 0.6 1.3 1.2 26.4 0.0 0.0 1.1 3.7 1.8 11.4 2.0 6.3 2.7 2.1 3.8 4.3 3.0 4.2 5.0 6.1 1.6 2.1 9.4 4.0 1.2 15.4 3.6 10.1 HIST1H2AG "H2A.1b, H2A/p, H2AFP, pH2A/f" ENSG00000196787 "Histone cluster 1 H2A family member g" P0C0S8 6 27133042-27135291 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 305.4" "Cell line enhanced" "Detected in many" "K-562: 9.7;SiHa: 11.2;U-266/84: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 9.7" "Group enriched" "Detected in many" 4 "B-cells: 4.4;granulocytes: 9.7;T-cells: 3.8" HPA041189 Supported "HPA041189: " "unprognostic (4.86e-2)" "unprognostic (6.89e-2)" "unprognostic (1.66e-1)" "unprognostic (3.94e-1)" "unprognostic (8.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.95e-1)" "unprognostic (5.78e-2)" "unprognostic (2.41e-1)" "unprognostic (2.37e-1)" "unprognostic (2.14e-3)" "unprognostic (1.53e-2)" "unprognostic (7.36e-2)" "unprognostic (5.98e-2)" "unprognostic (6.48e-2)" "unprognostic (8.22e-3)" "unprognostic (9.54e-2)" 2.4 1.6 1.1 25.1 1.2 6.3 8.7 0.7 1.0 3.3 9.7 0.0 1.0 3.8 2.0 3.7 15.7 1.0 3.2 2.7 1.3 1.6 1.1 2.6 6.0 13.5 2.3 0.0 1.4 0.9 0.3 1.0 8.7 0.3 2.5 2.3 0.3 2.1 1.5 1.1 1.4 7.1 0.9 2.3 20.2 1.8 16.1 0.0 305.4 1.5 12.3 28.9 2.4 2.0 4.4 1.3 9.7 0.8 1.1 3.8 7.7 1.3 1.8 1.5 1.4 4.8 1.0 1.0 0.5 0.7 1.6 0.2 0.7 1.4 0.4 2.0 0.5 2.7 1.8 0.8 1.1 2.4 1.0 0.7 3.5 0.0 1.0 0.7 1.4 1.8 0.3 0.5 0.5 0.5 9.7 4.6 0.1 1.7 1.8 1.1 0.9 1.2 1.2 1.5 4.9 0.3 0.3 6.0 1.4 11.2 1.8 0.6 0.0 0.4 0.5 1.8 3.9 1.4 0.7 8.2 30.5 3.1 0.3 1.1 1.1 9.7 0.4 0.7 0.6 0.3 1.3 3.0 2.3 1.6 0.6 4.4 2.2 1.8 3.5 1.1 0.8 1.3 3.8 7.7 1.1 1.2 0.7 0.9 1.3 1.6 2.3 0.0 0.3 0.0 HIST1H2AH "dJ86C11.1, H2A/S, H2AFALii" ENSG00000274997 "Histone cluster 1 H2A family member h" Q96KK5 6 27147129-27147515 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "lymphoid tissue: 301.1" "Cell line enhanced" "Detected in many" "HEK 293: 8.9;MOLT-4: 9.2;NB-4: 10.0" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in many" "naive B-cell: 16.2" "Low lineage specificity" "Detected in many" "CAB004030, HPA041189" Supported "CAB004030: AB_2118804, HPA041189: " "unprognostic (4.07e-1)" "unprognostic (2.73e-3)" "unprognostic (4.04e-2)" "unprognostic (4.01e-1)" "unprognostic (2.02e-1)" "unprognostic (5.35e-3)" "unprognostic (3.90e-2)" "unprognostic (3.20e-1)" "unprognostic (2.36e-1)" "unprognostic (2.38e-3)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (9.74e-3)" "unprognostic (1.87e-1)" "unprognostic (1.26e-4)" 0.8 0.7 0.0 26.0 0.0 20.2 1.5 0.0 0.4 3.1 6.6 0.0 0.6 1.0 1.8 2.6 6.4 1.0 2.7 1.3 0.0 0.5 0.4 4.1 5.4 0.0 0.0 2.4 0.5 0.4 0.0 9.0 0.0 0.6 0.9 0.1 1.7 0.6 0.4 0.6 6.5 0.9 0.0 13.9 0.7 23.5 0.0 301.1 0.6 9.0 27.3 1.9 0.0 16.2 2.2 0.0 2.4 5.1 4.7 2.3 2.5 3.4 1.1 4.8 0.0 0.0 0.7 0.3 0.6 0.6 0.0 2.6 1.0 3.7 0.9 0.0 0.3 1.0 0.0 0.0 2.1 8.9 4.6 3.0 0.0 0.0 3.2 1.7 0.0 0.0 1.1 0.0 0.8 4.7 2.4 0.9 0.4 9.2 10.0 3.1 1.2 3.4 3.0 4.9 0.0 0.3 2.4 0.6 1.4 0.5 0.2 0.9 1.5 0.0 0.8 2.7 0.2 2.7 2.9 2.9 6.0 1.3 4.5 0.8 0.0 0.9 0.0 2.6 2.4 1.2 3.8 4.7 4.2 2.2 16.2 2.4 1.6 0.0 5.1 1.5 1.5 0.8 2.3 HIST1H2AI "H2A/c, H2AFC" ENSG00000196747 "Histone cluster 1 H2A family member i" P0C0S8 6 27808199-27808701 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "lymphoid tissue: 349.3" "Cell line enhanced" "Detected in many" "K-562: 17.3;U-266/84: 47.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA041189 Supported "HPA041189: " "unprognostic (1.23e-1)" "unprognostic (6.21e-3)" "unprognostic (6.82e-2)" "unprognostic (5.57e-3)" "unprognostic (1.38e-1)" "unprognostic (4.48e-2)" "unprognostic (9.11e-3)" "unprognostic (1.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.27e-1)" "unprognostic (9.54e-5)" "unprognostic (5.50e-2)" "unprognostic (1.50e-5)" "unprognostic (1.43e-1)" "unprognostic (1.85e-1)" "unprognostic (1.89e-1)" "unprognostic (6.24e-2)" 1.7 1.2 0.7 36.2 0.9 10.7 2.8 0.6 0.7 1.5 6.3 0.0 0.5 2.3 1.1 1.4 14.2 1.4 2.8 4.8 1.1 1.1 1.0 1.3 3.5 25.8 0.6 0.0 1.2 0.4 1.4 0.6 5.4 0.0 1.3 5.8 0.0 1.3 0.3 0.5 1.1 7.1 0.5 4.3 21.9 2.2 4.3 0.0 349.3 1.0 15.2 26.8 2.3 2.0 3.0 2.6 4.8 0.8 2.5 4.0 2.0 0.9 3.6 0.8 0.6 0.4 0.2 0.3 0.7 0.1 1.1 0.9 1.1 0.6 1.0 2.2 0.3 0.7 0.0 0.6 0.5 3.5 4.7 1.5 5.8 3.0 0.4 0.4 0.8 1.6 0.2 0.4 0.1 0.2 17.3 4.1 0.0 4.5 2.5 2.7 0.9 1.3 1.2 0.0 6.7 1.3 0.6 5.1 1.0 10.1 1.5 0.3 6.1 0.4 0.2 0.5 1.9 0.4 0.4 3.8 47.5 2.0 0.4 4.0 0.3 0.0 0.5 3.6 0.9 0.8 0.7 2.1 3.2 0.9 2.3 3.0 0.7 0.4 4.8 2.5 0.8 2.6 4.0 2.0 0.7 0.9 0.6 0.7 1.1 1.1 0.6 0.0 0.0 0.0 HIST1H2AJ "H2A/E, H2AFE" ENSG00000276368 "Histone cluster 1 H2A family member j" Q99878 6 27814354-27814740 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "lymphoid tissue: 357.7" "Cell line enhanced" "Detected in many" "Hep G2: 9.8;Karpas-707: 11.9;MCF7: 16.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" HPA041189 Supported "HPA041189: " "unprognostic (8.95e-3)" "unprognostic (4.08e-3)" "unprognostic (3.28e-2)" "unprognostic (5.72e-3)" "unprognostic (2.29e-2)" "unprognostic (2.69e-2)" "unprognostic (6.06e-2)" "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" "unprognostic (9.39e-3)" "unprognostic (3.43e-1)" "unprognostic (9.35e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-2)" 0.6 0.1 0.0 7.2 0.0 16.5 0.2 0.0 0.2 1.0 5.2 0.0 0.0 0.3 0.3 0.6 6.6 0.3 0.8 0.2 0.0 0.3 0.4 2.2 3.1 0.0 0.0 0.1 0.1 0.1 0.0 3.6 0.0 0.2 0.4 0.0 0.1 0.1 0.1 0.4 3.9 0.1 0.0 10.5 0.8 5.2 0.0 357.7 0.1 7.9 23.1 1.5 0.0 4.2 2.7 2.5 0.5 0.4 5.9 5.0 3.9 0.0 1.2 0.0 0.0 0.0 0.9 1.2 1.1 1.0 2.5 2.1 0.1 3.9 0.4 0.7 1.1 0.0 1.1 0.6 1.8 0.6 5.5 0.5 9.8 0.3 0.0 2.1 0.0 0.3 0.5 0.3 1.4 0.0 11.9 0.3 16.5 6.6 6.0 1.9 3.5 5.8 0.0 2.3 0.2 2.4 0.5 0.8 1.1 1.1 0.5 0.4 4.0 0.0 0.0 2.3 0.4 0.2 6.1 3.9 3.7 1.3 4.4 2.8 0.0 0.1 0.0 0.7 0.5 0.9 0.7 3.4 3.1 2.7 4.2 1.1 0.4 2.5 0.4 0.2 0.3 5.9 5.0 HIST1H2AK "H2A/d, H2AFD" ENSG00000275221 "Histone cluster 1 H2A family member k" P0C0S8 6 27837947-27838339 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 115.7" "Cell line enhanced" "Detected in some" "A549: 4.2;AN3-CA: 4.8;HeLa: 4.9;SCLC-21H: 4.7;U-266/84: 7.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA041189 Supported "HPA041189: " 1.5 4.1 0.0 11.1 0.5 3.2 3.5 0.9 1.3 2.8 2.3 0.2 0.5 1.0 1.7 1.6 4.4 2.7 4.1 2.5 0.0 0.2 0.4 4.4 8.4 0.8 0.0 3.3 0.0 0.0 0.1 1.7 0.3 2.3 0.4 0.9 1.7 1.1 0.7 0.0 1.5 0.3 1.6 7.0 1.3 3.9 0.5 115.7 1.6 2.8 12.3 2.1 0.0 6.0 1.2 0.0 0.6 1.1 3.8 5.1 0.0 4.2 0.0 4.8 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.4 0.0 0.2 0.2 0.8 2.1 1.0 0.0 0.5 1.3 1.2 1.7 4.9 0.6 0.7 0.3 0.0 0.0 0.0 0.6 0.0 0.0 1.9 0.0 0.0 0.7 1.5 0.0 0.0 0.0 0.6 0.4 0.0 0.9 0.3 4.7 0.8 0.0 0.0 0.0 0.5 0.0 0.2 0.5 0.5 0.0 0.3 1.8 7.0 1.0 0.0 0.3 0.5 0.0 0.1 0.0 2.3 0.0 1.8 5.8 2.6 2.4 0.0 6.0 3.8 2.8 0.0 1.1 0.6 1.2 2.7 5.1 HIST1H2AL "dJ193B12.9, H2A/i, H2AFI" ENSG00000276903 "Histone cluster 1 H2A family member l" P0C0S8 6 27865355-27865747 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 288.3" "Cell line enhanced" "Detected in many" "HEK 293: 7.1;MOLT-4: 8.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA041189 Supported "HPA041189: " "unprognostic (2.45e-2)" "unprognostic (2.94e-2)" "unprognostic (5.88e-2)" "unprognostic (2.46e-3)" "unprognostic (3.17e-1)" "unprognostic (1.82e-1)" "unprognostic (3.86e-2)" "unprognostic (2.08e-2)" "unprognostic (4.18e-1)" "unprognostic (2.38e-1)" "unprognostic (4.01e-2)" "unprognostic (4.29e-1)" "unprognostic (2.41e-2)" "unprognostic (2.12e-1)" "unprognostic (6.21e-2)" 1.1 0.5 0.0 24.8 0.0 16.4 1.3 0.0 0.5 1.1 4.5 0.0 0.0 1.1 0.8 1.7 7.6 0.3 1.8 1.5 0.0 0.4 0.4 3.4 10.2 0.0 0.0 0.3 0.3 1.5 0.0 5.2 0.0 0.3 0.3 0.0 0.7 0.3 0.3 0.5 4.4 0.3 0.0 12.9 0.7 13.1 0.0 288.3 0.3 9.6 26.4 0.5 0.0 9.6 4.7 8.8 3.6 0.1 2.0 1.1 4.1 1.7 0.8 0.0 0.0 0.0 1.1 1.7 0.7 1.4 1.6 0.0 1.4 3.1 1.1 0.0 1.2 0.0 0.0 0.4 3.1 7.1 1.2 0.0 1.1 0.0 0.8 1.5 0.0 0.0 0.4 0.0 0.0 5.4 3.2 0.4 3.7 8.7 6.3 2.9 1.3 4.5 0.0 0.4 0.6 2.6 2.0 2.0 1.2 0.0 0.8 0.4 1.2 0.0 0.2 0.0 1.4 2.9 5.5 0.0 6.3 1.4 4.0 1.3 2.4 2.0 1.3 0.1 1.7 0.0 3.3 1.7 2.0 4.7 9.6 0.7 1.0 8.8 0.1 3.6 3.4 1.7 1.1 HIST1H2AM "H2A.1, H2A/n, H2AFN" ENSG00000278677 "Histone cluster 1 H2A family member m" P0C0S8 6 27892757-27893149 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "lymphoid tissue: 315.3" "Cell line enhanced" "Detected in many" "U-266/84: 24.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA041189 Supported "HPA041189: " "unprognostic (6.05e-2)" "unprognostic (4.03e-1)" "unprognostic (2.04e-1)" "unprognostic (2.79e-1)" "unprognostic (1.26e-1)" "unprognostic (1.11e-2)" "unprognostic (6.48e-2)" "unprognostic (2.70e-1)" "unprognostic (6.36e-2)" "unprognostic (4.64e-3)" "unprognostic (2.65e-3)" "unprognostic (4.24e-1)" "unprognostic (8.85e-6)" "unprognostic (2.44e-1)" "unprognostic (3.18e-1)" "unprognostic (8.80e-2)" "unprognostic (1.30e-1)" 1.2 1.5 0.0 30.7 0.0 9.3 2.3 0.2 0.2 2.1 6.1 0.1 2.3 1.4 1.3 2.6 10.7 0.3 3.9 2.2 0.0 0.6 1.7 4.7 12.7 0.0 0.0 0.4 1.2 0.0 0.0 10.4 0.3 0.9 1.8 0.0 1.3 2.2 0.7 1.0 6.5 0.0 1.1 15.3 1.7 4.8 0.0 315.3 1.3 11.4 28.9 2.5 0.0 10.3 14.7 28.7 6.2 4.8 8.5 7.0 3.1 2.7 2.1 5.0 0.3 0.3 4.4 0.9 0.7 2.6 3.4 1.0 1.3 5.3 3.6 0.7 2.2 1.6 1.7 1.6 3.4 1.3 2.7 3.4 3.5 0.0 1.6 2.2 1.3 0.0 1.8 0.0 2.5 11.4 7.3 0.4 5.2 10.7 7.7 3.7 1.2 6.6 3.5 9.4 1.3 0.7 8.0 1.4 5.5 0.6 0.6 4.8 1.6 0.0 1.1 0.1 1.2 1.6 7.9 24.7 12.3 1.5 9.3 0.9 28.7 3.4 12.5 6.8 3.8 4.1 8.9 5.9 5.7 11.4 10.3 2.5 2.8 11.5 4.8 6.2 14.7 8.5 7.0 HIST1H2BA "bA317E16.3, H2BFU, STBP, TSH2B" ENSG00000146047 "Histone cluster 1 H2B family member a" Q96A08 6 25726777-25727292 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 695 "testis: 617.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB011603, HPA042205, HPA043013" Enhanced "CAB011603: AB_2118143, HPA042205: , HPA043013: " "unprognostic (3.94e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 617.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 HIST1H2BB "H2B/f, H2BFF" ENSG00000276410 "Histone cluster 1 H2B family member b" P33778 6 26043277-26043657 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 104.9" "Cell line enhanced" "Detected in some" "K-562: 3.6;Karpas-707: 3.5;MOLT-4: 4.4;NB-4: 4.8;THP-1: 5.4;U-266/84: 5.9" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (2.92e-2)" "unprognostic (9.15e-2)" "unprognostic (3.29e-1)" "unprognostic (2.18e-1)" "unprognostic (2.36e-1)" "unprognostic (1.26e-1)" "unprognostic (6.10e-2)" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (2.58e-1)" 0.4 0.3 1.0 6.4 0.3 6.6 0.6 0.5 1.0 0.5 1.0 0.0 0.0 1.1 0.4 0.5 4.1 0.6 0.3 1.0 0.2 0.8 0.3 1.7 3.0 0.1 0.4 0.3 0.5 0.3 0.0 0.9 1.0 0.3 0.3 0.2 0.3 0.3 1.3 1.0 0.8 0.3 0.8 5.8 0.5 15.8 0.1 104.9 0.3 4.8 7.4 0.3 0.0 2.1 10.5 4.2 1.1 0.2 3.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 1.1 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 1.3 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.6 0.0 1.4 3.6 3.5 0.0 0.0 4.4 4.8 2.1 2.0 2.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.3 5.4 0.0 0.3 0.3 0.3 0.9 0.8 5.9 0.0 0.7 1.7 1.3 4.2 1.1 0.8 1.5 0.1 3.9 2.1 3.9 1.6 3.3 1.6 2.0 0.8 3.6 0.2 0.4 10.5 2.9 0.6 HIST1H2BD "H2B/b, H2BFB" ENSG00000158373 "Histone cluster 1 H2B family member d" P58876 6 26158146-26171349 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lymphoid tissue: 174.9" "Cell line enhanced" "Detected in many" "U-266/70: 36.8;U-266/84: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "HPA042205, HPA043013, HPA048671, CAB062336" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB062336: AB_10622324, HPA042205: , HPA043013: , HPA048671: " "unprognostic (2.39e-2)" "unprognostic (1.58e-2)" "prognostic unfavourable (3.84e-4)" "unprognostic (1.32e-1)" "unprognostic (1.98e-1)" "unprognostic (2.83e-2)" "unprognostic (1.54e-1)" "unprognostic (8.10e-2)" "unprognostic (2.28e-1)" "unprognostic (3.54e-2)" "unprognostic (3.68e-3)" "unprognostic (2.17e-1)" "unprognostic (4.74e-3)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (3.91e-2)" "unprognostic (1.34e-2)" 7.9 6.6 6.0 33.2 9.0 36.4 17.3 14.0 8.9 33.6 17.0 2.9 13.2 8.2 9.5 21.4 18.2 17.4 11.1 17.4 7.5 4.2 19.9 25.3 13.8 32.3 7.7 7.1 33.1 21.7 2.2 11.5 10.1 7.4 43.4 12.9 8.3 13.0 14.7 12.0 14.7 9.5 13.0 18.7 11.0 18.8 7.1 5.6 174.9 9.5 23.9 18.9 13.2 32.7 15.6 12.9 19.3 4.5 6.8 9.6 2.0 5.3 12.1 3.7 2.1 29.0 2.6 1.1 4.7 2.7 6.1 3.8 4.0 4.4 2.4 29.8 5.6 8.5 2.0 2.0 2.9 10.9 5.2 1.6 9.7 4.2 3.1 2.1 4.6 19.0 3.2 1.7 2.4 1.5 16.7 13.4 1.1 19.1 4.8 5.4 3.9 5.6 1.9 2.3 15.8 5.8 3.8 11.9 5.0 29.6 7.8 4.6 19.6 0.7 0.9 7.7 19.9 3.1 1.0 36.8 38.8 6.1 0.9 9.9 1.5 19.3 1.5 10.5 5.8 3.4 7.4 8.4 8.9 9.6 3.7 15.6 8.4 5.7 16.6 6.8 4.5 12.9 5.8 2.0 6.0 9.0 14.0 8.9 7.5 4.2 7.7 7.1 7.4 5.6 HIST1H2BE "H2B.h, H2B/h, H2BFH" ENSG00000274290 "Histone cluster 1 H2B family member e" P62807 6 26172059-26184655 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "lymphoid tissue: 165.1" "Cell line enhanced" "Detected in many" "NB-4: 8.0;REH: 7.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.27e-1)" "unprognostic (7.06e-3)" "unprognostic (8.28e-2)" "unprognostic (1.31e-1)" "unprognostic (7.98e-2)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (1.69e-2)" "unprognostic (3.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.55e-6)" "unprognostic (3.03e-2)" "unprognostic (4.86e-2)" "unprognostic (2.30e-1)" "unprognostic (3.11e-2)" 0.7 1.1 0.4 12.2 0.8 5.9 1.8 0.6 1.7 2.5 2.9 0.1 1.8 1.1 1.5 2.9 5.5 1.6 1.6 1.9 0.5 1.7 0.3 1.5 6.7 0.0 1.2 2.1 1.2 0.7 0.0 2.4 0.2 5.2 1.5 0.7 4.0 2.2 2.1 1.9 2.0 1.8 1.6 4.5 2.5 5.4 0.0 165.1 1.2 6.4 7.1 1.8 0.0 3.6 3.1 5.5 1.7 1.6 2.9 0.8 0.5 3.6 2.9 0.9 2.9 0.4 0.4 3.0 1.0 0.5 0.3 0.8 2.1 0.6 1.4 0.5 4.2 0.5 1.1 0.6 1.5 0.9 0.5 1.4 0.1 0.2 0.3 2.4 0.6 0.2 0.6 0.2 0.3 2.3 1.8 0.1 1.6 4.5 8.0 2.4 0.9 7.8 0.2 2.5 1.4 1.8 2.7 3.6 3.9 1.4 0.9 2.7 1.6 0.8 1.5 2.6 1.0 1.9 2.3 4.4 0.6 0.6 1.4 0.5 5.2 1.7 2.4 2.0 1.3 1.6 2.1 2.0 2.5 0.7 3.6 1.8 1.7 5.5 1.6 1.5 3.1 2.9 0.8 HIST1H2BF "H2B/g, H2BFG" ENSG00000277224 "Histone cluster 1 H2B family member f" P62807 6 26199520-26200715 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "lymphoid tissue: 252.2" "Group enriched" "Detected in some" 4 "U-266/70: 21.3;U-266/84: 15.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.15e-2)" "unprognostic (2.17e-1)" "unprognostic (1.12e-1)" "unprognostic (1.38e-2)" "unprognostic (4.58e-2)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" "unprognostic (6.80e-3)" "unprognostic (3.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.95e-1)" "unprognostic (7.27e-3)" "unprognostic (4.29e-11)" "unprognostic (4.88e-3)" "unprognostic (4.45e-1)" "unprognostic (1.15e-2)" "unprognostic (1.30e-1)" 0.4 1.2 0.0 17.3 0.1 3.8 5.7 0.3 0.7 2.7 3.3 0.4 1.0 0.5 1.6 1.3 9.9 1.3 1.2 0.6 0.0 0.5 0.4 2.5 7.0 0.0 0.2 0.8 0.6 0.4 0.0 3.2 0.2 5.4 1.1 0.5 1.4 1.3 0.2 0.4 3.0 0.3 0.9 8.3 1.3 2.2 0.1 252.2 0.4 3.3 14.6 2.4 0.0 3.0 0.7 6.2 0.7 0.4 1.5 1.2 0.4 0.2 0.2 0.4 0.2 0.0 0.2 0.1 0.1 0.6 0.1 0.5 0.0 0.5 0.9 0.0 0.8 0.4 0.1 0.3 0.6 0.2 0.3 1.4 0.1 0.1 0.1 0.7 0.2 0.0 0.1 0.1 0.1 1.6 3.8 0.0 0.1 3.2 1.3 0.5 0.5 1.2 0.6 2.4 0.1 0.1 2.1 0.3 4.1 0.8 0.0 3.7 0.2 0.1 0.3 1.9 0.0 0.5 21.3 15.0 1.2 0.1 0.9 0.4 0.0 0.2 1.4 0.7 0.3 1.5 0.7 0.7 0.8 0.4 3.0 0.6 1.2 6.2 0.4 0.7 0.7 0.6 1.2 HIST1H2BH "H2B/j, H2BFJ" ENSG00000275713 "Histone cluster 1 H2B family member h" Q93079 6 26251651-26253710 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "lymphoid tissue: 220.5" "Cell line enhanced" "Detected in many" "U-266/70: 17.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 4.7" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (5.83e-2)" "unprognostic (6.27e-3)" "unprognostic (4.50e-2)" "unprognostic (9.18e-2)" "unprognostic (5.52e-2)" "prognostic unfavourable (7.52e-4)" "unprognostic (5.06e-3)" "unprognostic (3.08e-3)" "unprognostic (1.58e-2)" "unprognostic (2.75e-2)" "unprognostic (1.86e-1)" "unprognostic (3.22e-1)" "unprognostic (2.96e-8)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (2.40e-2)" "unprognostic (1.95e-3)" 0.9 0.6 0.0 25.6 0.0 3.1 2.1 0.0 0.0 0.9 5.5 0.0 0.9 7.8 1.0 2.4 8.4 1.5 4.0 1.8 0.0 0.7 0.0 2.2 11.3 0.0 0.0 0.4 0.1 0.0 0.0 4.9 0.0 1.2 2.2 0.0 1.8 0.1 0.0 0.6 8.1 0.1 0.0 9.6 1.6 3.3 0.0 220.5 0.4 9.5 23.3 1.4 0.0 1.0 0.9 4.7 0.4 1.0 0.7 9.3 1.8 0.1 7.3 0.0 0.0 0.1 1.2 0.9 0.4 1.3 0.6 2.4 1.1 0.0 1.8 0.1 3.6 0.0 0.6 1.8 0.9 0.1 1.3 5.5 0.4 0.0 0.0 4.2 0.3 0.3 0.5 0.5 0.3 2.6 6.5 0.1 2.0 3.8 2.7 1.7 1.9 4.0 0.0 0.9 0.0 2.8 3.4 3.0 4.3 1.4 0.6 2.1 3.3 0.0 0.6 0.0 0.8 3.2 17.7 4.4 0.0 0.5 1.5 3.9 3.5 0.4 0.7 0.5 0.0 0.2 1.0 0.3 0.7 0.9 0.6 0.1 0.2 4.7 1.0 0.2 0.4 0.7 9.3 HIST1H2BI "H2B/k, H2BFK" ENSG00000278588 "Histone cluster 1 H2B family member i" P62807 6 26272976-26273356 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 150.8" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 5.3;MOLT-4: 14.8;THP-1: 6.2" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.59e-1)" "unprognostic (7.10e-2)" "unprognostic (8.53e-2)" "unprognostic (1.52e-1)" "unprognostic (2.80e-1)" "unprognostic (2.03e-2)" "unprognostic (1.02e-1)" "unprognostic (7.22e-3)" "unprognostic (4.82e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" 0.5 0.1 0.0 19.0 0.0 8.9 1.2 0.4 0.1 1.3 3.1 0.0 0.5 0.1 0.7 2.1 6.6 0.4 2.0 1.3 0.0 0.3 0.1 2.0 6.3 0.0 0.0 0.7 0.1 0.1 0.0 2.8 0.0 0.1 0.3 0.0 1.3 0.3 0.1 1.2 1.9 0.1 0.1 11.1 0.4 1.9 0.0 150.8 0.4 8.2 14.5 2.2 0.0 4.7 0.7 0.9 1.3 0.4 4.6 0.2 1.8 0.8 1.2 0.0 0.0 0.0 0.2 0.7 0.7 2.0 5.3 0.8 0.0 0.9 0.4 0.4 0.9 1.8 0.5 0.8 2.6 0.0 0.4 0.8 0.6 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.8 0.0 3.8 0.0 0.7 14.8 2.5 2.8 0.0 4.0 0.0 4.9 0.0 0.4 0.3 0.9 1.1 1.0 0.0 0.0 6.2 0.9 0.8 0.0 0.6 3.0 3.1 0.4 0.0 1.1 0.5 2.2 0.2 0.5 0.0 3.4 1.3 2.2 2.2 3.2 4.6 0.7 4.7 1.4 0.8 0.9 0.4 0.1 0.3 1.5 0.2 HIST1H2BJ "H2B/r, H2BFR" ENSG00000124635 "Histone cluster 1 H2B family member j" P06899 6 27125897-27132750 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 124.3" "Cell line enhanced" "Detected in many" "K-562: 41.2;Karpas-707: 24.3;SiHa: 37.1;U-2 OS: 41.1;U-266/70: 35.0;U-266/84: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 13.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.6" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (4.02e-2)" "prognostic favourable (1.51e-4)" "unprognostic (8.58e-2)" "unprognostic (2.34e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-2)" "unprognostic (3.03e-1)" "unprognostic (2.98e-1)" "unprognostic (1.88e-1)" "unprognostic (1.49e-2)" "unprognostic (1.90e-3)" "unprognostic (2.23e-1)" "unprognostic (3.57e-4)" "unprognostic (8.67e-2)" "unprognostic (5.80e-2)" "unprognostic (1.57e-2)" "unprognostic (6.16e-2)" 4.1 2.2 1.5 30.0 2.4 10.7 11.3 0.9 1.9 12.8 6.2 1.6 3.9 2.1 3.1 5.9 12.8 5.1 2.8 6.0 2.5 1.7 1.9 3.9 7.3 12.0 3.2 0.9 1.3 5.1 0.6 1.2 5.1 2.9 8.0 3.0 0.5 4.0 4.8 5.9 2.9 2.8 2.8 5.9 12.0 5.1 30.5 2.2 124.3 2.7 10.1 22.3 5.2 9.4 2.2 1.0 13.6 0.6 0.7 2.4 14.7 3.7 4.7 1.4 1.3 7.1 0.5 1.8 2.1 1.2 8.3 3.6 4.0 2.2 0.6 6.7 2.2 2.7 2.0 1.8 4.6 4.4 3.5 1.1 5.3 0.2 0.6 0.4 3.0 3.4 0.2 1.7 0.8 0.4 41.2 24.3 2.2 2.0 1.7 2.4 1.7 4.4 0.9 1.2 3.7 1.0 1.4 9.2 1.0 37.1 2.5 1.0 0.1 1.5 1.0 2.1 41.1 1.6 0.9 35.0 43.1 9.9 0.5 11.6 1.0 1.8 0.6 0.7 0.5 0.5 0.8 1.6 0.7 0.3 0.4 2.2 0.4 0.5 13.6 0.7 0.2 1.0 2.4 14.7 1.5 2.4 0.9 1.9 2.5 1.7 3.2 0.9 2.9 2.2 HIST1H2BK "H2BFAiii, H2BFT" ENSG00000197903 "Histone cluster 1 H2B family member k" O60814 6 27146418-27146798 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 243.8" "Cell line enhanced" "Detected in many" "K-562: 115.0;U-2 OS: 104.9;U-266/84: 137.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.78e-2)" "unprognostic (4.70e-3)" "unprognostic (9.00e-3)" "unprognostic (1.30e-1)" "unprognostic (3.81e-1)" "unprognostic (4.50e-2)" "unprognostic (6.50e-2)" "unprognostic (4.27e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-3)" "unprognostic (3.46e-3)" "unprognostic (9.49e-2)" "prognostic unfavourable (5.77e-5)" "unprognostic (3.93e-2)" "unprognostic (1.49e-1)" "unprognostic (7.59e-2)" "unprognostic (2.37e-2)" 9.4 6.0 3.0 39.8 4.1 7.8 8.6 2.4 3.6 14.9 11.0 2.5 10.5 8.4 8.0 14.6 19.1 13.5 10.5 9.8 4.3 3.7 4.0 19.3 12.7 25.9 3.6 2.3 8.5 17.4 0.6 5.9 18.7 2.0 16.0 5.3 3.5 11.3 10.7 3.7 6.3 10.3 6.9 7.6 28.0 13.7 30.6 1.9 243.8 8.9 32.3 26.4 11.5 16.7 26.5 22.1 60.7 16.2 5.0 11.5 12.5 6.1 15.9 2.5 4.4 11.5 4.3 8.8 10.1 7.3 14.7 9.5 14.4 8.1 2.0 34.4 5.8 8.1 3.1 3.1 2.2 9.1 15.4 3.4 10.0 0.4 5.0 2.7 20.9 20.6 2.7 2.5 2.8 3.0 115.0 23.3 6.6 16.8 4.9 4.9 2.3 6.9 3.2 1.7 25.9 5.5 2.7 12.9 7.4 60.5 20.8 5.5 53.7 3.1 3.3 6.6 104.9 6.1 1.7 32.0 137.9 18.3 3.8 27.4 3.7 33.8 9.4 60.7 4.1 8.3 3.9 20.3 4.2 4.1 9.6 26.5 5.0 3.9 60.1 5.0 16.2 22.1 11.5 12.5 3.0 4.1 2.4 3.6 4.3 3.7 3.6 2.3 2.0 1.9 HIST1H2BL "dJ97D16.4, H2B/c, H2BFC" ENSG00000185130 "Histone cluster 1 H2B family member l" Q99880 6 27807444-27807931 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "lymphoid tissue: 217.6" "Cell line enhanced" "Detected in many" "MOLT-4: 12.9;U-266/84: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 7.7" "Low lineage specificity" "Detected in many" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (2.43e-1)" "unprognostic (2.06e-2)" "unprognostic (5.32e-3)" "unprognostic (2.46e-2)" "unprognostic (2.22e-1)" "unprognostic (1.02e-3)" "unprognostic (2.32e-3)" "unprognostic (2.66e-1)" "unprognostic (9.22e-2)" "unprognostic (1.87e-2)" "unprognostic (1.71e-2)" "unprognostic (1.64e-1)" "unprognostic (8.02e-3)" "unprognostic (3.25e-2)" "unprognostic (1.81e-1)" "unprognostic (1.82e-1)" "unprognostic (2.86e-2)" 1.2 1.0 0.2 13.9 1.0 13.7 1.6 1.4 0.6 1.8 5.1 0.0 0.3 0.6 0.8 0.6 7.4 0.9 0.9 1.3 0.9 0.7 0.3 0.6 1.5 3.5 0.5 0.0 1.3 1.2 1.2 0.2 1.9 0.0 1.2 1.1 0.0 0.7 0.2 0.2 0.9 3.9 0.7 2.8 4.8 0.8 1.5 0.0 217.6 1.2 5.9 15.6 1.1 1.2 1.9 1.2 7.7 0.6 0.4 2.0 0.9 2.4 2.2 0.7 2.3 0.0 0.0 0.1 1.4 0.4 1.2 3.2 1.0 1.7 0.9 0.5 0.3 1.5 0.0 0.2 0.4 1.1 3.2 1.7 3.1 3.8 0.0 2.8 2.3 1.0 0.0 0.0 0.0 0.7 2.2 5.7 0.0 6.0 12.9 4.8 2.1 3.3 3.0 0.0 1.4 0.0 2.2 3.0 1.1 3.9 1.6 0.2 1.4 0.9 0.5 0.1 1.6 1.3 1.0 3.3 12.7 4.2 0.4 5.0 0.5 0.6 0.5 4.0 1.1 0.2 1.3 1.9 0.6 1.1 1.2 1.3 0.4 0.6 7.7 0.4 0.6 0.7 2.0 0.9 0.2 1.0 1.4 0.5 0.9 0.7 0.5 0.0 0.0 0.0 HIST1H2BM "dJ160A22.3, H2B/e, H2BFE" ENSG00000273703 "Histone cluster 1 H2B family member m" Q99879 6 27815044-27815424 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "lymphoid tissue: 232.2" "Cell line enhanced" "Detected in many" "Karpas-707: 17.3;NB-4: 11.1;REH: 7.2;U-266/70: 13.4;U-698: 6.8" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.6;NK-cells: 1.5;T-cells: 1.7" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (3.83e-1)" "unprognostic (8.85e-4)" "unprognostic (3.74e-1)" "unprognostic (2.00e-1)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (3.37e-1)" "unprognostic (9.46e-3)" "unprognostic (3.02e-1)" "unprognostic (1.04e-1)" "unprognostic (5.70e-1)" "unprognostic (2.65e-1)" 0.1 0.1 0.0 19.9 0.0 11.6 0.1 0.0 0.2 1.6 3.4 0.0 0.0 0.1 0.7 0.9 8.4 0.1 1.4 0.3 0.0 0.1 0.3 1.8 7.3 0.0 0.0 0.3 0.1 0.1 0.0 1.5 0.0 0.5 1.1 0.0 0.3 0.1 0.1 0.8 3.8 0.1 0.5 13.9 0.5 3.5 0.0 232.2 0.1 9.4 27.6 0.1 0.0 2.6 0.4 0.3 0.3 1.5 1.7 0.0 1.5 0.0 0.3 0.0 0.0 0.0 1.2 0.4 0.2 0.5 2.1 0.4 0.3 2.2 0.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.8 0.2 0.8 0.0 0.0 2.0 0.0 0.0 0.8 0.0 0.0 0.2 17.3 0.0 0.5 4.5 11.1 3.3 0.8 7.2 0.0 0.4 0.0 0.0 0.1 1.9 0.7 1.1 0.0 1.0 3.3 0.0 0.0 2.0 1.2 0.1 13.4 0.5 6.8 1.1 1.2 0.9 0.0 0.1 0.1 1.5 0.3 1.7 1.9 1.7 1.5 0.4 2.6 0.1 1.2 0.3 1.5 0.0 0.2 0.6 0.0 HIST1H2BN "H2B/d, H2BFD" ENSG00000233822 "Histone cluster 1 H2B family member n" Q99877 6 27837760-27865798 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 13 "lymphoid tissue: 193.3" "Cell line enhanced" "Detected in many" "K-562: 8.7;SCLC-21H: 9.6;U-266/84: 9.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 14.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.33e-1)" "unprognostic (3.25e-2)" "unprognostic (3.22e-2)" "unprognostic (6.66e-2)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (3.04e-1)" "unprognostic (4.41e-2)" "unprognostic (2.95e-3)" "unprognostic (2.05e-3)" "unprognostic (1.14e-4)" "unprognostic (9.62e-2)" "unprognostic (3.91e-1)" "unprognostic (9.62e-2)" "unprognostic (2.22e-2)" 2.4 7.2 2.3 14.0 3.3 9.3 3.1 4.9 6.2 3.4 4.5 1.0 4.4 1.8 3.4 3.7 7.6 3.2 3.7 6.4 3.7 2.4 2.3 5.3 5.4 8.0 4.1 4.2 5.0 8.3 4.2 3.8 4.5 1.4 4.0 2.5 1.7 3.3 4.7 4.6 2.3 4.3 2.5 9.4 7.0 2.4 6.8 0.5 193.3 6.1 6.2 10.9 3.6 2.2 6.0 6.2 14.6 2.6 1.0 2.8 1.4 1.4 0.2 1.5 1.5 1.2 1.9 0.9 0.7 1.1 0.7 0.8 0.5 0.8 0.7 3.0 0.7 2.1 1.3 0.4 0.3 1.5 4.4 0.7 3.6 1.3 1.4 0.9 3.6 1.2 0.3 0.1 1.3 0.2 8.7 6.8 0.8 1.8 2.9 4.4 1.3 1.0 2.0 0.9 5.1 0.4 0.9 9.6 1.9 3.5 1.3 2.9 2.4 0.8 1.5 2.1 2.1 1.1 0.6 6.0 9.0 3.5 0.7 1.7 0.7 2.3 2.6 1.7 2.6 2.4 1.8 5.8 2.0 1.9 5.0 6.0 1.3 1.2 14.6 1.0 1.8 6.2 2.8 1.4 2.3 3.3 4.9 6.2 3.7 2.4 4.1 4.2 1.4 0.5 HIST1H2BO "H2B.2, H2B/n, H2BFN" ENSG00000274641 "Histone cluster 1 H2B family member o" P23527 6 27893463-27893843 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 164.5" "Cell line enhanced" "Detected in many" "U-266/84: 28.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (7.22e-2)" "unprognostic (1.77e-3)" "unprognostic (9.47e-2)" "unprognostic (4.43e-2)" "unprognostic (6.67e-2)" "unprognostic (7.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.48e-2)" "unprognostic (1.55e-2)" "unprognostic (7.91e-2)" "unprognostic (7.81e-3)" "unprognostic (2.88e-3)" "unprognostic (4.04e-7)" "unprognostic (4.39e-2)" "unprognostic (3.41e-1)" "unprognostic (4.39e-2)" "prognostic favourable (4.89e-4)" 1.9 0.4 0.0 14.9 0.0 8.1 1.5 0.0 0.0 0.9 3.9 0.0 0.0 0.9 0.6 1.6 9.9 0.0 0.7 1.5 0.0 0.3 0.5 2.6 7.4 0.0 0.0 0.0 0.0 0.7 0.0 4.4 0.1 0.3 1.5 0.0 1.2 0.0 0.3 1.5 2.1 0.1 0.5 8.1 0.7 1.4 0.0 164.5 0.0 7.1 15.4 1.1 0.0 2.6 2.2 6.5 0.8 1.3 1.7 5.5 2.2 2.9 1.4 4.3 0.7 0.0 2.6 0.8 0.1 5.3 5.3 1.1 1.3 2.5 1.9 0.2 2.2 2.4 0.5 0.7 1.7 1.9 1.6 4.4 1.7 0.0 0.2 1.0 0.3 0.0 0.4 0.5 1.4 6.4 7.2 0.2 0.5 10.9 9.3 1.6 2.1 6.4 1.5 4.8 0.9 0.3 6.1 1.3 4.6 1.2 0.7 2.0 0.2 0.0 1.5 0.3 1.7 2.0 8.0 28.8 7.4 0.9 9.3 0.7 1.3 0.3 3.8 0.8 0.6 1.1 1.4 0.8 1.7 2.2 2.6 0.5 0.5 6.5 1.3 0.8 1.7 1.4 5.5 HIST1H3B "H3/l, H3FL" ENSG00000274267 "Histone cluster 1 H3 family member b" P68431 6 26031650-26032060 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "lymphoid tissue: 343.5" "Cell line enhanced" "Detected in many" "U-266/84: 11.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 1.4" "Low lineage specificity" "Detected in many" HPA042570 Approved "HPA042570: " "unprognostic (2.82e-1)" "unprognostic (2.64e-2)" "unprognostic (1.09e-1)" "unprognostic (5.59e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-2)" "unprognostic (2.31e-2)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (2.03e-2)" "unprognostic (1.08e-2)" "unprognostic (5.34e-2)" "unprognostic (2.31e-7)" "unprognostic (8.52e-2)" "unprognostic (2.78e-1)" "unprognostic (1.90e-3)" 1.7 0.7 0.0 36.1 0.0 18.1 3.6 0.0 0.3 0.8 6.9 0.0 0.0 0.3 0.8 2.5 11.8 0.5 1.9 2.4 0.0 0.6 0.3 3.4 10.4 0.0 0.0 0.3 0.3 0.3 0.0 7.8 0.0 0.3 0.8 0.0 1.0 0.3 0.3 0.3 6.3 0.8 0.0 14.7 0.5 26.9 0.0 343.5 0.8 18.2 27.7 0.3 0.0 0.8 0.1 1.2 0.0 0.0 1.4 3.1 1.8 4.6 1.3 4.0 0.0 0.4 0.0 0.2 0.8 0.7 0.7 1.1 1.0 3.0 2.0 0.3 0.7 1.6 1.2 1.7 2.0 4.4 3.2 5.9 1.3 0.0 2.4 2.1 2.9 0.0 0.6 0.0 1.0 6.5 5.9 1.1 0.9 7.3 7.4 3.1 3.2 4.3 2.9 8.4 0.5 0.0 2.0 1.7 5.1 1.6 0.5 2.8 1.5 1.4 1.3 4.1 0.7 1.7 9.5 11.9 3.9 3.4 4.5 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.8 0.1 0.5 0.0 0.2 1.2 0.0 0.0 0.0 1.4 3.1 HIST1H3C "H3.1, H3/c, H3FC" ENSG00000278272 "Histone cluster 1 H3 family member c" P68431 6 26045411-26045821 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 306.0" "Cell line enhanced" "Detected in many" "U-937: 10.9" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA042570 Approved "HPA042570: " "unprognostic (1.29e-1)" "unprognostic (1.91e-1)" "unprognostic (1.81e-1)" "unprognostic (6.18e-2)" "unprognostic (1.79e-1)" "unprognostic (2.21e-1)" "unprognostic (5.78e-3)" "unprognostic (7.63e-2)" "unprognostic (1.42e-1)" "unprognostic (4.39e-3)" "unprognostic (3.08e-3)" "unprognostic (1.65e-1)" "unprognostic (1.13e-2)" "unprognostic (2.08e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" "unprognostic (5.27e-2)" 1.7 0.2 0.0 23.3 0.0 12.8 1.8 0.0 0.7 1.0 5.1 0.0 0.0 1.2 0.5 1.5 10.1 0.4 1.6 1.8 0.0 2.8 0.6 3.0 10.9 0.0 0.0 0.2 0.4 0.2 0.0 6.6 0.0 0.6 1.1 0.0 1.0 0.2 0.2 0.7 5.4 0.2 0.0 18.8 1.0 29.9 0.0 306.0 0.2 9.9 25.2 2.3 0.0 2.2 1.0 0.3 0.2 3.3 3.7 1.9 2.6 0.6 1.3 0.0 0.6 0.0 0.0 2.0 0.9 5.0 5.1 0.0 0.4 0.0 0.1 0.5 1.2 0.0 0.5 3.5 3.6 0.4 4.1 0.5 3.6 0.4 2.6 1.7 0.0 0.4 1.4 0.0 1.6 0.0 0.0 0.0 0.0 4.0 5.1 2.3 5.0 4.6 0.0 0.0 0.6 5.5 0.1 1.6 5.0 3.2 0.5 1.3 1.5 0.0 0.0 0.0 2.1 3.4 2.3 0.1 0.0 1.5 10.9 3.5 0.0 0.2 0.0 1.5 0.1 0.0 1.5 0.6 1.1 1.0 2.2 0.6 2.2 0.3 3.3 0.0 0.9 3.7 1.9 HIST1H3D "H3/b, H3FB" ENSG00000197409 "Histone cluster 1 H3 family member d" P68431 6 26196840-26197250 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 185.6" "Cell line enhanced" "Detected in many" "Karpas-707: 7.9;U-266/70: 11.2;U-266/84: 6.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA042570 Approved "HPA042570: " "unprognostic (8.64e-2)" "unprognostic (1.27e-2)" "unprognostic (9.06e-3)" "unprognostic (2.00e-1)" "unprognostic (6.59e-2)" "unprognostic (1.43e-2)" "unprognostic (8.62e-2)" "unprognostic (1.56e-1)" "unprognostic (2.95e-1)" "unprognostic (2.69e-2)" "unprognostic (2.80e-1)" "unprognostic (1.32e-1)" "prognostic unfavourable (1.78e-6)" "unprognostic (2.44e-1)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (4.94e-2)" 1.2 2.7 0.6 18.3 0.6 24.3 1.5 2.0 1.3 4.4 4.1 0.0 3.0 2.9 1.0 3.0 8.0 1.2 2.3 1.3 1.2 0.9 2.3 3.1 2.5 8.0 0.8 0.7 4.3 1.0 1.0 1.6 2.6 0.3 6.4 1.2 0.7 3.3 4.3 1.0 1.6 3.8 1.4 2.4 9.2 2.2 12.4 0.0 185.6 1.4 5.9 19.9 3.2 6.8 8.9 3.4 15.3 1.8 1.6 6.6 0.5 0.9 0.2 0.0 2.1 0.0 0.5 0.9 0.0 0.5 0.3 2.5 3.5 0.2 2.1 2.1 0.3 0.6 0.2 0.5 0.0 2.9 0.8 0.0 1.7 0.0 0.1 0.7 1.1 0.4 0.4 0.0 0.0 0.3 0.3 7.9 0.0 1.6 2.2 4.0 0.3 1.1 2.5 0.0 1.2 0.0 0.3 0.1 0.0 0.0 2.0 1.0 0.4 2.9 0.0 0.0 3.9 0.0 1.6 11.2 6.1 0.7 2.0 1.7 0.9 8.9 1.4 3.3 2.5 0.8 6.6 5.5 1.6 2.0 3.0 8.9 1.5 2.6 15.3 1.6 1.8 3.4 1.9 0.5 0.6 0.6 2.0 0.6 1.2 0.9 0.8 0.7 0.3 0.0 HIST1H3F "H3/i, H3FI" ENSG00000277775 "Histone cluster 1 H3 family member f" P68431 6 26250195-26250605 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 198.6" "Cell line enhanced" "Detected in many" "NB-4: 8.3;U-266/84: 9.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 4.5" "Low lineage specificity" "Detected in many" "HPA042570, CAB070190" Approved "CAB070190: AB_10001790, HPA042570: " "unprognostic (1.91e-1)" "unprognostic (2.02e-2)" "unprognostic (2.00e-1)" "unprognostic (2.04e-1)" "unprognostic (6.10e-3)" "unprognostic (1.91e-6)" "unprognostic (9.73e-2)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (2.14e-1)" "unprognostic (1.00e-1)" "unprognostic (3.33e-1)" "unprognostic (5.22e-2)" "unprognostic (2.60e-4)" 1.1 0.9 0.0 26.8 0.0 8.0 3.9 0.0 0.2 0.5 4.5 0.0 0.2 1.5 0.7 2.4 8.6 0.4 2.2 4.2 0.0 0.3 0.2 2.5 17.0 0.0 0.0 0.2 0.2 0.2 0.0 3.8 0.0 0.4 0.4 0.0 0.8 0.2 0.7 0.7 4.6 0.5 0.0 10.8 1.1 2.8 0.0 198.6 0.4 11.5 25.3 0.9 0.0 4.5 1.3 0.0 0.6 0.0 0.9 0.4 1.4 0.0 2.2 0.0 0.0 0.0 1.6 1.3 0.0 2.5 0.7 0.0 0.0 0.2 1.1 0.0 0.9 0.0 1.1 0.0 1.4 0.5 1.6 4.5 0.0 0.0 0.0 2.6 0.0 0.0 0.8 0.0 1.3 2.4 1.8 0.0 1.8 3.4 8.3 0.0 2.4 3.8 0.0 1.2 0.0 0.3 4.3 1.0 1.6 0.8 0.0 3.2 2.8 0.0 0.4 0.0 0.2 1.9 2.2 9.4 0.0 2.5 3.0 1.0 0.0 0.5 0.0 0.5 0.0 0.1 4.5 0.1 0.0 1.3 1.3 0.3 0.0 0.0 0.0 0.6 0.0 0.9 0.4 HIST1H3G "H3/h, H3FH" ENSG00000273983 "Histone cluster 1 H3 family member g" P68431 6 26269405-26271815 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 27 "lymphoid tissue: 247.1" "Cell line enhanced" "Detected in some" "CACO-2: 3.9;SiHa: 10.1;U-266/70: 9.6" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA042570 Approved "HPA042570: " "unprognostic (1.88e-1)" "prognostic favourable (8.75e-4)" "unprognostic (3.14e-1)" "unprognostic (2.58e-1)" "unprognostic (6.94e-2)" "unprognostic (8.74e-2)" "unprognostic (1.39e-1)" "unprognostic (7.72e-2)" "unprognostic (2.47e-1)" "unprognostic (2.02e-2)" "unprognostic (3.26e-1)" "unprognostic (2.53e-2)" "unprognostic (1.21e-3)" "unprognostic (3.60e-2)" "unprognostic (1.64e-1)" "unprognostic (3.90e-2)" "unprognostic (7.23e-2)" 0.7 0.4 0.0 14.6 0.0 1.9 1.7 0.0 0.0 0.5 5.2 0.0 0.0 2.1 0.1 2.2 9.1 1.5 0.8 1.1 0.0 0.2 0.0 1.0 7.3 0.0 0.0 0.1 0.0 0.3 0.0 4.8 0.0 0.1 1.6 0.0 0.4 0.4 0.0 0.3 4.7 0.4 0.0 13.6 1.0 5.0 0.0 247.1 1.0 8.0 15.9 0.7 0.0 1.6 0.4 0.6 0.4 0.2 1.5 0.7 1.1 0.2 1.1 0.0 0.1 0.2 0.5 0.4 0.2 1.2 0.4 3.9 0.0 0.0 0.6 0.1 3.3 1.3 0.6 0.8 0.9 0.0 0.1 2.5 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.3 0.3 0.0 2.3 0.0 2.4 1.1 0.4 2.0 0.0 0.8 0.0 1.4 0.7 0.7 0.3 0.6 10.1 3.1 0.0 0.1 0.5 0.3 0.5 0.0 0.0 0.2 9.6 0.3 0.0 0.5 0.0 1.2 0.0 0.0 0.3 0.3 0.1 0.4 1.1 1.5 1.0 0.4 1.6 0.0 0.5 0.6 0.2 0.4 0.0 1.5 0.7 HIST1H3I "H3.f, H3/f, H3FF" ENSG00000275379 "Histone cluster 1 H3 family member i" P68431 6 27871905-27872315 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 236.8" "Cell line enhanced" "Detected in some" "HEL: 4.5;MOLT-4: 8.2;NB-4: 5.5;REH: 8.6" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.0" "Cell type enhanced" "Detected in many" "NK-cell: 12.4" "Low lineage specificity" "Detected in all" HPA042570 Approved "HPA042570: " "unprognostic (1.60e-1)" "unprognostic (5.58e-2)" "unprognostic (8.16e-2)" "unprognostic (1.06e-1)" "unprognostic (6.48e-2)" "unprognostic (2.39e-1)" "unprognostic (1.18e-1)" "unprognostic (1.13e-2)" "unprognostic (1.25e-1)" "unprognostic (1.29e-2)" 1.0 0.8 0.0 16.7 0.0 7.9 2.4 0.0 0.4 0.9 2.9 0.0 1.6 0.4 0.4 1.4 7.1 0.5 2.9 1.8 0.0 0.4 0.4 1.9 9.2 0.0 0.0 0.4 5.0 0.4 0.0 2.4 0.0 0.5 0.4 0.0 1.0 0.7 0.4 0.4 3.6 0.4 0.0 10.2 0.8 1.8 0.0 236.8 0.6 11.6 14.5 0.4 0.0 4.1 4.7 1.0 1.2 12.4 2.4 2.2 1.2 1.8 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.2 2.9 0.4 0.0 0.9 0.0 0.0 0.5 1.3 1.7 4.5 0.0 0.0 1.0 2.7 0.6 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 8.2 5.5 1.2 0.0 8.6 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.2 0.0 1.2 0.5 2.4 0.6 2.0 0.8 2.0 1.5 3.3 4.1 1.7 2.2 1.0 12.4 0.5 4.7 1.9 2.2 HIST1H3J "H3/j, H3FJ" ENSG00000197153 "Histone cluster 1 H3 family member j" P68431 6 27890382-27893106 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 31 "lymphoid tissue: 290.9" "Cell line enhanced" "Detected in many" "U-266/84: 15.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA042570 Approved "HPA042570: " "unprognostic (1.15e-1)" "unprognostic (4.48e-2)" "unprognostic (1.99e-1)" "unprognostic (1.47e-2)" "unprognostic (3.18e-1)" "unprognostic (1.71e-4)" "unprognostic (2.91e-2)" "unprognostic (4.09e-3)" "unprognostic (6.37e-3)" "unprognostic (6.67e-2)" "unprognostic (4.68e-3)" "unprognostic (1.34e-1)" "unprognostic (2.63e-8)" "unprognostic (2.11e-1)" "unprognostic (2.51e-1)" "unprognostic (4.82e-3)" "unprognostic (8.04e-2)" 0.9 0.4 0.2 25.1 0.3 5.7 1.1 0.5 0.4 1.2 5.5 0.0 0.0 0.3 0.4 0.5 9.4 0.4 1.2 0.9 0.4 0.4 0.3 1.2 1.5 8.8 0.4 0.0 0.3 0.4 0.3 0.3 4.7 0.0 0.6 0.3 0.0 0.4 0.6 0.3 1.6 3.7 0.3 1.1 15.1 0.6 2.4 0.0 290.9 0.9 7.8 14.6 1.1 1.1 2.1 2.5 0.0 0.7 0.6 2.5 0.7 1.0 0.7 1.6 0.3 0.5 0.5 0.9 0.0 0.0 1.5 0.2 0.0 0.4 4.7 0.9 0.4 0.2 1.3 0.4 0.0 0.2 0.9 1.1 1.9 0.0 0.4 0.2 0.3 0.0 0.0 0.7 0.0 0.7 2.6 1.1 0.0 1.1 3.6 4.3 2.5 0.4 1.6 0.5 0.5 0.0 0.0 2.8 1.6 1.8 1.2 0.0 0.4 0.8 0.0 0.4 0.0 0.2 0.4 3.5 15.1 1.1 0.8 0.6 2.4 0.0 0.0 0.0 1.4 0.3 0.0 0.0 2.3 2.5 2.5 2.1 0.5 1.0 0.0 0.6 0.7 0.0 2.2 0.7 0.2 0.3 0.5 0.4 0.4 0.4 0.4 0.0 0.0 0.0 HIST1H4A H4FA ENSG00000278637 "Histone cluster 1 H4 family member a" P62805 6 26021679-26021990 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 87.7" "Cell line enhanced" "Detected in many" "MOLT-4: 13.6;NB-4: 9.9;REH: 12.4" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in many" 4 "neutrophil: 14.0" "Lineage enriched" "Detected in many" 10 "granulocytes: 14.0" "CAB021887, HPA042201" Supported 30000000 "CAB021887: AB_2279758, HPA042201: " "unprognostic (5.71e-2)" "unprognostic (3.41e-1)" "unprognostic (3.49e-2)" "unprognostic (2.36e-2)" "unprognostic (1.75e-1)" "unprognostic (1.75e-2)" "unprognostic (1.23e-1)" "unprognostic (1.23e-3)" "unprognostic (9.76e-2)" "unprognostic (5.99e-2)" "unprognostic (6.42e-2)" 0.5 0.5 0.0 5.2 0.0 7.1 2.1 16.7 3.2 0.6 1.5 0.0 0.0 5.2 1.5 1.8 3.7 0.3 1.2 3.2 0.0 0.5 0.1 2.0 3.5 0.0 1.8 1.4 0.8 0.1 0.0 0.8 0.2 0.4 1.0 1.6 0.8 1.0 0.8 0.9 1.1 3.6 0.1 2.5 0.7 2.6 0.0 87.7 2.5 3.6 9.6 2.0 0.0 0.8 0.9 14.0 1.0 1.2 1.4 0.2 3.7 1.7 3.5 0.0 0.8 0.0 0.0 0.3 1.3 1.6 2.3 0.0 5.6 2.6 0.9 0.0 4.9 2.6 0.0 0.5 0.4 1.8 2.5 1.5 0.0 0.0 0.6 6.0 0.0 0.0 0.5 0.0 1.6 1.3 4.1 0.0 1.5 13.6 9.9 2.3 0.0 12.4 2.2 2.2 0.0 0.4 4.2 1.8 1.6 6.1 0.1 3.2 2.7 0.0 3.0 7.7 3.0 3.0 1.5 2.4 0.0 1.4 4.1 5.8 0.0 1.0 3.4 1.3 0.8 0.2 0.4 1.1 0.3 0.9 0.8 0.4 0.3 14.0 1.2 0.2 0.4 1.4 0.2 HIST1H4D "H4/b, H4FB" ENSG00000277157 "Histone cluster 1 H4 family member d" P62805 6 26188765-26189076 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "lymphoid tissue: 71.3" "Cell line enhanced" "Detected in many" "HEK 293: 9.7;RT4: 15.6" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 6.8" "Low lineage specificity" "Detected in many" HPA042201 Supported 30000000 "HPA042201: " "unprognostic (1.33e-1)" "unprognostic (1.81e-2)" "unprognostic (1.09e-2)" "unprognostic (1.98e-2)" "unprognostic (2.06e-2)" "unprognostic (7.63e-2)" "unprognostic (3.80e-2)" "unprognostic (1.36e-1)" "unprognostic (2.92e-1)" "unprognostic (5.37e-2)" "unprognostic (3.53e-2)" "unprognostic (1.30e-1)" "unprognostic (7.77e-4)" "unprognostic (1.56e-1)" "unprognostic (5.44e-2)" "unprognostic (1.17e-1)" "unprognostic (6.11e-3)" 1.4 4.7 1.9 10.1 5.2 6.5 5.6 1.2 4.5 3.9 3.1 0.0 4.5 0.9 3.3 3.5 8.3 6.5 2.0 4.6 1.4 1.6 1.8 1.6 3.5 0.0 4.4 6.5 5.8 0.9 1.3 4.2 1.6 6.0 2.1 1.4 1.4 2.7 0.9 0.9 2.3 2.2 1.6 4.1 2.2 9.8 0.8 71.3 5.3 4.8 9.5 5.5 0.0 6.8 0.6 1.3 0.9 0.2 2.3 0.7 1.3 2.1 1.5 0.0 2.7 0.0 0.8 1.3 0.4 3.6 1.8 3.4 0.8 6.7 0.4 0.0 0.9 4.4 0.7 1.1 0.5 9.7 0.9 6.6 2.4 0.0 0.7 0.2 0.0 0.0 0.5 1.4 3.1 1.7 1.2 0.0 3.4 2.4 3.9 2.3 0.7 0.7 0.0 0.8 0.9 15.6 0.7 0.4 1.4 0.6 0.9 1.2 0.5 0.0 0.5 4.3 0.5 1.7 1.5 1.8 0.0 1.0 1.6 1.0 0.1 0.9 0.0 0.9 0.1 0.6 1.4 2.3 0.5 0.6 6.8 0.3 0.6 1.3 0.2 0.5 0.1 0.1 0.7 HIST1H4E "H4/j, H4FJ" ENSG00000276966 "Histone cluster 1 H4 family member e" P62805 6 26204552-26206038 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 71.9" "Cell line enhanced" "Detected in many" "MOLT-4: 7.4;U-266/70: 14.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA042201 Supported 30000000 "HPA042201: " "unprognostic (8.62e-2)" "unprognostic (4.86e-2)" "unprognostic (5.71e-3)" "unprognostic (1.23e-1)" "unprognostic (1.63e-1)" "unprognostic (1.57e-1)" "unprognostic (5.08e-3)" "unprognostic (7.99e-2)" "unprognostic (1.21e-1)" "unprognostic (6.57e-2)" "unprognostic (2.34e-3)" "unprognostic (4.34e-2)" "prognostic unfavourable (2.00e-6)" "unprognostic (1.28e-2)" "unprognostic (1.88e-1)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" 2.2 4.8 2.4 5.4 6.8 13.0 4.6 15.1 17.3 7.3 4.7 5.2 5.1 7.4 4.9 6.6 5.2 6.5 5.0 5.1 2.0 3.0 1.9 2.6 5.1 1.3 5.7 11.2 1.6 2.5 2.6 4.7 2.4 10.5 5.0 6.7 7.5 4.6 1.8 2.2 4.6 6.5 2.0 4.9 4.8 7.7 1.8 71.9 6.5 2.7 7.7 7.8 0.0 10.4 5.1 4.8 8.0 3.7 5.9 2.1 1.3 0.9 1.7 3.9 0.6 0.0 0.9 1.5 0.4 0.7 0.5 0.5 1.4 0.5 2.0 0.4 2.4 0.8 0.1 1.0 1.1 1.0 0.4 1.6 0.8 0.0 0.6 1.6 0.4 0.1 0.6 0.4 0.5 2.8 3.3 0.2 0.5 7.4 3.5 1.6 1.3 3.3 1.8 3.3 0.6 0.5 4.8 1.2 1.1 1.6 0.5 1.5 0.7 0.7 2.0 2.7 0.6 1.2 14.6 5.6 2.1 0.4 1.4 1.4 3.2 3.7 2.9 3.8 3.1 5.3 3.9 5.5 3.6 5.1 10.4 5.9 4.5 4.8 3.7 8.0 4.7 3.3 2.1 HIST1H4F "H4, H4/c, H4FC" ENSG00000274618 "Histone cluster 1 H4 family member f" P62805 6 26240426-26240737 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 118.4" "Cell line enhanced" "Detected in some" "MCF7: 2.8;MOLT-4: 11.0;REH: 5.0" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA042201 Supported 30000000 "HPA042201: " "unprognostic (1.47e-1)" "unprognostic (1.17e-2)" "unprognostic (2.05e-1)" 1.2 0.5 0.0 8.8 0.0 7.1 0.5 0.0 1.7 0.9 1.3 0.0 1.8 0.5 1.2 2.2 5.9 0.5 1.4 1.8 0.0 1.2 0.5 2.1 4.5 0.0 0.0 0.6 0.5 0.5 0.0 4.1 0.0 0.6 1.0 0.1 0.5 0.5 0.5 0.5 1.3 0.5 0.0 9.3 0.8 18.9 0.0 118.4 3.1 3.7 19.1 2.4 0.0 7.9 7.9 14.8 3.6 2.2 5.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 1.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.8 11.0 1.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.6 4.3 3.9 2.8 3.2 6.2 4.9 5.1 4.6 7.9 4.3 2.7 14.8 2.2 2.4 7.9 1.3 2.0 HIST1H4G "H4/l, H4FL" ENSG00000275663 "Histone cluster 1 H4 family member g" Q99525 6 26246681-26246977 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "intestine: 2.1" "Group enriched" "Detected in some" 20 "AF22: 1.0;CAPAN-2: 1.2;PC-3: 3.3;SCLC-21H: 1.7;THP-1: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042201 Supported "HPA042201: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 HIST1H4I "H4/m, H4FM" ENSG00000276180 "Histone cluster 1 H4 family member i" P62805 6 27138588-27139881 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 14.5" "Cell line enhanced" "Detected in many" "K-562: 29.3;SiHa: 17.6;U-2 OS: 30.2;U-266/84: 30.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA042201 Approved 30000000 "HPA042201: " "unprognostic (2.49e-2)" "prognostic favourable (9.70e-4)" "unprognostic (1.97e-2)" "unprognostic (2.51e-2)" "unprognostic (2.26e-1)" "unprognostic (2.25e-1)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" "unprognostic (2.85e-1)" "unprognostic (1.29e-3)" "unprognostic (1.86e-3)" "unprognostic (1.95e-1)" "prognostic unfavourable (1.32e-5)" "unprognostic (6.28e-2)" "unprognostic (1.49e-1)" "unprognostic (1.80e-1)" "unprognostic (2.02e-2)" 0.1 2.5 2.4 1.7 0.0 0.1 0.0 0.8 2.7 1.1 0.0 1.7 0.0 1.3 0.5 0.0 1.9 0.8 2.6 0.8 2.7 0.0 1.5 2.0 0.0 1.6 0.0 0.0 0.2 2.9 0.0 2.3 3.2 1.8 2.6 0.0 1.9 6.0 5.5 14.5 4.6 2.4 3.4 3.1 1.6 3.4 1.9 1.2 1.3 0.1 2.1 3.3 0.1 0.1 0.1 3.2 2.4 0.5 9.4 0.0 2.6 0.3 0.1 0.0 2.2 5.0 1.1 5.5 0.1 0.2 0.9 6.1 0.4 0.1 0.0 0.1 0.1 29.3 9.0 0.0 5.0 1.4 2.2 0.7 2.1 1.3 1.1 8.2 0.1 0.9 6.3 2.3 17.6 8.1 1.9 15.5 0.7 1.1 2.3 30.2 2.8 0.3 9.1 30.4 5.7 1.3 6.6 2.3 9.2 2.6 14.1 1.5 2.0 1.3 4.6 1.3 1.4 2.5 6.0 1.6 1.7 14.5 2.4 4.6 5.5 3.4 3.1 HIST1H4L "H4.k, H4/k, H4FK" ENSG00000275126 "Histone cluster 1 H4 family member l" P62805 6 27873199-27873510 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "lymphoid tissue: 133.0" "Cell line enhanced" "Detected in some" "MOLT-4: 10.0;NB-4: 5.4;REH: 2.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.2" "Cell type enhanced" "Detected in many" "naive B-cell: 7.7" "Low lineage specificity" "Detected in many" HPA042201 Approved 30000000 "HPA042201: " "unprognostic (1.15e-1)" "unprognostic (6.05e-4)" 0.4 0.3 0.0 23.6 0.0 4.6 2.8 0.0 0.3 0.4 3.0 0.0 0.5 0.3 0.3 0.3 3.4 0.3 1.2 0.5 0.0 0.3 0.3 1.2 4.2 0.0 0.0 0.3 8.4 0.3 0.0 2.5 0.0 0.3 1.0 0.0 0.5 0.3 0.3 0.3 2.2 0.3 0.0 11.5 0.8 4.0 0.0 133.0 0.3 7.6 16.4 0.3 0.0 7.7 3.8 0.0 1.8 1.7 1.9 0.6 1.1 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 10.0 5.4 0.0 0.0 2.6 0.7 0.0 0.0 0.0 0.0 1.2 1.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 1.0 0.0 1.3 0.8 0.3 1.8 1.1 1.9 2.6 7.7 0.5 1.4 0.0 1.7 1.8 3.8 1.3 0.6 HIST2H2AB ENSG00000184270 "Histone cluster 2 H2A family member b" Q8IUE6 1 149887524-149887916 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 126.3" "Cell line enhanced" "Detected in many" "MOLT-4: 7.8;U-266/70: 4.8;U-266/84: 5.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB011483, HPA041189" Supported Approved Nucleoplasm Nucleoplasm "CAB011483: AB_732909, HPA041189: " "unprognostic (6.31e-2)" "unprognostic (6.63e-2)" "unprognostic (2.22e-2)" "unprognostic (2.31e-1)" "unprognostic (3.09e-1)" "unprognostic (3.34e-1)" "unprognostic (2.42e-3)" "unprognostic (1.99e-1)" "unprognostic (1.53e-1)" "unprognostic (2.03e-1)" "unprognostic (1.84e-1)" "unprognostic (1.69e-1)" "unprognostic (9.97e-3)" "unprognostic (5.33e-2)" "unprognostic (2.00e-2)" "unprognostic (4.36e-2)" 2.4 1.6 1.2 6.4 1.6 21.1 2.9 2.6 2.4 6.8 2.6 0.6 0.6 1.2 1.9 1.6 5.1 1.5 2.2 1.5 1.4 1.3 1.6 1.8 4.2 3.0 1.2 1.9 7.4 3.0 2.2 1.4 2.3 0.0 4.2 2.0 3.9 1.9 1.9 2.5 4.7 2.9 4.0 2.7 4.8 1.9 2.1 0.1 126.3 1.7 2.1 9.0 7.1 2.4 10.2 4.3 11.6 2.0 4.3 4.5 0.8 1.3 0.0 0.7 0.7 0.0 0.0 1.1 0.9 0.0 0.0 1.4 0.0 0.9 0.8 0.5 0.0 1.0 1.0 0.0 0.0 0.3 1.5 0.0 0.8 0.7 0.0 0.0 1.5 0.0 0.0 0.6 0.0 0.0 1.0 1.1 0.7 0.0 7.8 3.3 0.9 1.7 1.6 0.5 1.3 0.0 0.5 2.3 1.0 2.2 0.0 0.1 0.2 3.4 0.0 0.9 3.3 0.0 0.7 4.8 5.2 1.4 2.0 0.3 0.6 1.3 1.6 0.8 2.7 2.0 2.7 3.8 4.5 4.0 2.3 10.2 2.7 2.7 11.6 4.3 1.9 4.3 2.6 0.8 1.2 1.6 2.6 2.4 1.4 1.3 1.2 1.9 0.0 0.1 HIST2H2BF ENSG00000203814 "Histone cluster 2 H2B family member f" Q5QNW6 1 149782689-149812373 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 117.6" "Cell line enhanced" "Detected in many" "U-266/70: 31.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "neutrophil: 21.7" "Lineage enriched" "Detected in many" 11 "granulocytes: 21.7" "Not detected" "Not detected" "CAB007814, HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB007814: AB_598159, HPA042205: , HPA043013: , HPA048671: " "unprognostic (9.02e-3)" "unprognostic (7.78e-2)" "unprognostic (5.30e-4)" "unprognostic (3.00e-1)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.08e-2)" "unprognostic (8.33e-2)" "unprognostic (3.46e-2)" "unprognostic (5.36e-2)" "unprognostic (3.87e-5)" "unprognostic (3.72e-2)" "unprognostic (3.54e-7)" "unprognostic (1.84e-1)" "unprognostic (2.59e-2)" "unprognostic (9.42e-3)" "unprognostic (7.62e-2)" 5.6 17.7 3.9 14.9 3.5 3.7 7.1 8.5 5.6 17.4 3.8 3.7 3.2 1.5 5.6 6.2 7.1 7.9 3.6 12.1 3.4 2.4 5.0 4.2 14.6 27.5 3.2 3.8 24.2 6.2 2.6 4.4 5.1 3.2 16.7 2.5 3.5 3.7 5.5 1.2 10.9 3.4 6.0 7.7 12.7 7.9 5.9 3.1 117.6 4.4 6.3 16.7 6.1 21.5 2.0 0.8 21.7 1.1 0.6 0.8 0.2 0.4 0.6 0.5 0.6 4.5 3.0 0.3 7.7 4.0 5.9 5.2 0.3 2.2 0.4 0.6 4.4 1.3 0.1 0.5 4.6 1.2 0.9 0.4 1.5 0.0 6.6 0.2 1.7 5.4 0.0 7.6 1.9 3.3 1.2 2.3 0.8 0.9 3.1 3.7 0.4 1.0 0.3 1.1 0.7 2.8 0.4 2.6 7.2 4.1 3.5 0.3 1.3 9.6 1.4 1.5 0.0 11.2 2.0 31.4 1.0 1.3 5.2 0.3 3.3 0.0 1.0 0.2 0.6 0.8 0.7 0.6 0.8 0.3 0.8 2.0 0.4 0.3 21.7 0.6 1.1 0.8 0.2 0.2 3.9 3.5 8.5 5.6 3.4 2.4 3.2 3.8 3.2 3.1 HIST2H3A "H3/n, H3/o" ENSG00000203852 "Histone cluster 2 H3 family member a" Q71DI3 1 149852619-149854274 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "lymphoid tissue: 126.9" "Cell line enhanced" "Detected in many" "HEK 293: 5.5;SiHa: 8.3;U-266/70: 7.3;U-266/84: 7.2" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 5.0" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" HPA042570 Approved "HPA042570: " "unprognostic (1.15e-1)" "unprognostic (1.30e-1)" "unprognostic (3.99e-2)" 1.3 0.9 1.3 22.4 2.0 4.6 2.1 5.0 3.6 0.5 4.4 0.0 0.0 1.2 0.5 1.5 6.6 0.9 1.3 1.9 1.3 0.6 0.4 1.0 1.6 5.9 0.7 0.0 0.3 2.4 0.2 0.7 4.5 0.0 2.4 0.3 0.0 1.3 0.3 0.6 0.9 2.9 0.2 1.1 6.1 1.5 2.1 0.0 126.9 0.4 8.5 12.6 0.7 0.7 0.4 0.6 1.6 0.2 0.2 0.1 0.2 0.5 3.2 0.6 0.4 0.1 0.0 1.1 0.5 0.1 0.7 0.1 0.5 0.6 0.3 0.5 0.0 2.6 0.0 0.1 0.2 0.8 5.5 0.5 2.5 0.1 0.0 0.4 1.5 0.0 0.0 0.1 0.2 0.1 2.5 3.1 0.1 2.2 1.5 2.0 1.7 1.3 1.3 0.3 1.5 0.0 0.3 4.9 1.1 8.3 2.3 0.4 1.4 1.8 0.0 0.6 4.7 0.3 0.4 7.3 7.2 1.7 0.5 0.6 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.1 0.1 1.6 0.2 0.2 0.6 0.0 0.2 1.3 2.0 5.0 1.1 1.3 0.6 0.7 0.0 0.0 0.0 HIST2H4A "H4/n, H4F2, H4FN, HIST2H4" ENSG00000270882 "Histone cluster 2 H4 family member a" P62805 1 149832659-149839767 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 56.4" "Cell line enhanced" "Detected in many" "SiHa: 27.0;U-2 OS: 24.1;U-266/70: 22.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042201 Approved 30000000 "HPA042201: " "unprognostic (1.90e-1)" "unprognostic (6.29e-2)" "unprognostic (1.50e-2)" "unprognostic (6.68e-2)" "unprognostic (3.65e-2)" "unprognostic (1.99e-2)" "unprognostic (6.99e-2)" "unprognostic (8.36e-2)" "unprognostic (4.66e-2)" "unprognostic (3.44e-1)" "unprognostic (4.91e-2)" "unprognostic (8.70e-2)" "unprognostic (6.78e-4)" "unprognostic (6.15e-2)" "unprognostic (3.63e-3)" "unprognostic (1.62e-2)" "unprognostic (5.99e-2)" 1.5 2.3 0.8 10.5 1.9 4.6 1.7 3.8 2.0 3.7 2.9 0.8 0.6 1.9 2.0 1.5 4.1 5.9 4.3 3.5 1.0 1.9 0.2 1.8 4.7 0.8 1.2 3.0 5.5 0.0 1.4 2.5 1.9 6.4 0.0 0.9 2.9 3.4 0.4 0.0 3.2 1.8 0.7 4.9 1.7 3.5 0.5 56.4 4.8 5.1 7.0 5.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 18.2 1.0 3.2 3.8 1.2 1.4 1.4 1.2 4.9 2.3 3.6 4.8 1.1 5.3 0.5 8.6 0.0 3.2 0.1 6.8 10.2 1.2 13.7 1.3 3.5 1.2 1.1 5.6 4.2 1.6 2.5 0.8 5.5 12.3 0.2 16.4 4.4 2.9 4.3 6.9 3.8 2.5 10.1 0.5 1.2 17.6 5.1 27.0 2.6 4.1 11.3 2.3 0.0 2.3 24.1 3.1 2.5 22.5 19.0 6.5 2.3 3.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HIST3H2BB ENSG00000196890 "Histone cluster 3 H2B family member b" Q8N257 1 228458107-228460470 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 56.0" "Cell line enriched" "Detected in some" 4 "U-266/70: 18.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 12.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (5.53e-3)" "unprognostic (2.41e-1)" "unprognostic (3.39e-3)" "unprognostic (5.25e-2)" "unprognostic (8.20e-3)" "unprognostic (8.78e-3)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.21e-1)" "unprognostic (2.96e-2)" "unprognostic (1.05e-1)" "unprognostic (2.34e-2)" "unprognostic (9.74e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-1)" "unprognostic (2.59e-1)" 2.0 4.7 1.2 12.1 3.1 2.8 1.3 12.8 3.2 8.9 1.3 1.1 0.6 2.1 1.4 2.0 4.1 6.2 1.7 2.2 1.5 2.2 1.3 0.9 2.1 5.4 1.2 1.5 1.6 1.7 1.7 2.0 1.5 4.1 2.2 1.5 3.4 2.0 2.0 1.8 4.8 1.7 1.2 6.2 4.5 2.4 2.1 0.7 56.0 1.7 5.9 11.8 2.0 7.9 1.5 1.1 3.4 1.5 1.1 0.9 0.5 0.2 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.5 1.0 0.1 0.1 0.0 2.5 0.1 0.1 0.1 0.6 0.6 0.0 0.8 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.3 0.4 0.1 0.4 0.2 0.0 0.0 0.8 0.0 0.2 1.4 0.5 0.9 0.4 0.3 3.7 0.1 0.1 0.0 0.0 0.5 0.1 18.1 4.3 0.0 0.2 0.1 0.1 1.7 1.0 0.5 0.5 0.5 0.7 1.3 0.8 0.9 0.2 1.5 0.9 0.7 3.4 1.1 1.5 1.1 0.7 0.5 1.2 3.1 12.8 3.1 1.5 2.2 1.2 1.5 4.1 0.7 HIST3H3 "H3.4, H3/g, H3FT, H3t" ENSG00000168148 "Histone cluster 3 H3" Q16695 1 228424845-228425325 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 194 "testis: 107.8" "Cell line enhanced" "Detected in some" "BEWO: 1.5;MCF7: 1.3;THP-1: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB001386, CAB003812, HPA042570" Approved Supported Nucleoplasm Nucleoplasm "CAB001386: , CAB003812: AB_365490, HPA042570: " "unprognostic (4.45e-1)" "unprognostic (4.66e-2)" "unprognostic (1.36e-1)" "unprognostic (3.78e-3)" "unprognostic (1.75e-2)" "unprognostic (4.04e-2)" "unprognostic (1.39e-2)" "unprognostic (2.26e-2)" 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.1 107.8 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 1.8 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.2 0.0 0.8 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 HKDC1 "FLJ22761, FLJ37767" ENSG00000156510 "Hexokinase domain containing 1" Q2TB90 10 69220303-69267559 "Enzymes, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 77.4" "Cell line enhanced" "Detected in some" "A549: 14.7;CACO-2: 20.9;CAPAN-2: 41.4;EFO-21: 12.8;Hep G2: 12.1;RPTEC TERT1: 30.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 8.3;T-reg: 6.6" "Lineage enriched" "Detected in single" 29 "T-cells: 8.3" "Region enhanced" "Detected in some" "cerebral cortex: 12.2" "Low region specificity" "Detected in all" "HPA011956, HPA064198, HPA064230" Approved Enhanced Mitochondria Mitochondria "HPA011956: AB_1850758, HPA064198: , HPA064230: " "unprognostic (1.29e-2)" "unprognostic (2.26e-2)" "unprognostic (1.86e-1)" "unprognostic (8.47e-2)" "unprognostic (1.55e-1)" "unprognostic (3.05e-1)" "unprognostic (6.31e-3)" "unprognostic (5.03e-2)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (1.23e-3)" "unprognostic (3.11e-1)" "unprognostic (1.04e-3)" "unprognostic (1.35e-1)" "unprognostic (2.24e-1)" "unprognostic (2.10e-3)" "unprognostic (2.19e-1)" 0.2 0.0 0.9 1.2 1.6 0.0 0.2 0.8 1.4 0.5 29.8 0.5 0.2 29.9 0.5 1.0 0.3 2.5 11.2 0.2 0.5 0.6 15.6 4.6 1.3 0.3 0.3 0.2 1.0 4.7 0.0 0.5 0.2 0.4 0.2 2.3 12.0 0.2 0.2 0.2 0.0 77.4 0.2 0.2 0.2 0.4 0.6 0.2 0.2 5.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 8.3 1.6 0.4 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.9 41.4 0.0 12.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.1 1.0 0.0 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.7 0.0 4.4 1.4 0.0 0.0 8.3 3.2 0.0 0.2 0.0 0.0 6.6 1.6 0.9 1.6 0.8 0.4 0.5 0.6 0.3 0.2 0.4 0.2 HLA-G ENSG00000204632 "Major histocompatibility complex, class I, G" P17693 6 29826967-29831125 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" Immunity "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 66.0" "Cell line enriched" "Detected in single" 5 "CAPAN-2: 2.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" CAB016158 Enhanced "Secreted to blood" 32800000 "CAB016158: AB_627938" "unprognostic (1.13e-2)" "unprognostic (9.95e-2)" "unprognostic (1.30e-1)" "unprognostic (3.40e-2)" "unprognostic (8.35e-2)" "unprognostic (1.35e-1)" "unprognostic (1.18e-3)" "unprognostic (2.51e-1)" "prognostic favourable (3.91e-5)" "unprognostic (6.34e-2)" "unprognostic (8.31e-2)" "unprognostic (1.78e-1)" "unprognostic (1.03e-2)" "unprognostic (6.56e-3)" "unprognostic (1.40e-1)" "unprognostic (1.52e-2)" "unprognostic (3.19e-3)" 0.2 0.1 0.0 0.5 0.1 0.2 0.3 0.1 0.1 0.2 0.5 0.1 0.0 1.2 0.2 0.6 0.1 0.1 0.2 0.3 0.2 0.0 0.5 0.2 2.8 0.7 0.1 0.1 0.3 1.9 0.1 15.2 66.0 0.1 0.2 0.2 0.3 0.4 0.6 0.2 0.2 0.8 0.1 0.2 1.2 0.9 2.2 0.2 1.3 0.4 0.2 0.2 0.2 0.3 0.3 0.3 2.2 0.9 0.2 1.2 5.7 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.2 0.0 2.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.6 0.9 1.2 0.7 0.5 1.2 0.3 0.1 0.5 0.3 0.3 0.6 1.2 2.2 0.2 0.6 0.1 0.5 5.7 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.2 HMGB4 FLJ40388 ENSG00000176256 "High mobility group box 4" Q8WW32 1 33860475-33864791 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 346 "testis: 34.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA035699 Enhanced "HPA035699: AB_10960531" "unprognostic (1.33e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HMGCS2 ENSG00000134240 "3-hydroxy-3-methylglutaryl-CoA synthase 2" P54868 1 119747996-119768905 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 257.0" "Cell line enriched" "Detected in some" 16 "RT4: 66.2" "Cancer enhanced" "Detected in many" "liver cancer: 441.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA027423, HPA027442, CAB032906" Enhanced Supported Mitochondria 820000 Mitochondria "CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277" "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" "unprognostic (7.62e-2)" "unprognostic (1.49e-2)" "prognostic favourable (2.43e-7)" "unprognostic (9.68e-2)" "unprognostic (3.21e-2)" "prognostic favourable (2.17e-4)" "unprognostic (1.20e-1)" "unprognostic (6.42e-2)" "prognostic favourable (3.43e-5)" "unprognostic (9.57e-2)" "unprognostic (2.31e-1)" "unprognostic (5.00e-2)" "unprognostic (1.54e-3)" 0.3 0.1 0.3 8.7 0.3 0.0 20.6 0.3 0.3 0.3 30.8 0.4 0.3 13.8 0.3 0.3 0.7 0.1 4.4 42.0 0.4 0.0 7.4 257.0 0.8 0.3 0.3 0.3 0.3 1.4 0.0 0.3 0.8 0.7 3.8 19.8 18.9 5.1 0.3 1.4 1.8 12.2 1.9 0.3 0.3 8.1 6.1 0.3 0.4 0.3 0.6 2.1 7.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 66.2 0.0 0.2 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.4 0.0 0.3 0.3 0.7 0.3 HMGXB3 "HMGX3, KIAA0194, SMF" ENSG00000113716 "HMG-box containing 3" Q12766 5 150000046-150053142 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "parathyroid gland: 151.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005967 Approved Nucleoli Nucleoli "HPA005967: AB_1080044" "unprognostic (3.66e-2)" "unprognostic (3.74e-1)" "unprognostic (1.47e-1)" "unprognostic (1.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.82e-2)" "prognostic unfavourable (3.37e-5)" "unprognostic (9.72e-2)" "unprognostic (3.36e-1)" "unprognostic (3.89e-3)" "unprognostic (3.74e-2)" "unprognostic (2.11e-1)" "unprognostic (3.24e-3)" "unprognostic (1.30e-1)" "unprognostic (2.11e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-2)" 12.0 14.2 8.2 14.5 14.4 15.3 16.1 14.5 17.4 11.3 10.3 15.0 15.4 8.3 13.9 20.0 9.3 13.5 12.1 9.4 8.6 8.3 11.6 11.7 14.7 10.3 10.1 11.0 15.0 13.8 151.8 15.3 11.8 12.9 17.6 10.8 16.8 12.4 18.4 12.5 13.1 9.9 12.8 8.9 14.4 12.0 17.7 7.3 15.3 14.7 10.1 12.0 11.2 10.1 5.8 6.2 5.1 5.9 2.2 8.1 3.7 12.2 14.4 10.2 16.1 14.7 12.5 17.8 11.9 22.0 17.9 22.6 20.2 15.0 11.7 14.0 16.2 9.1 19.4 20.4 15.5 10.9 13.9 10.3 15.2 9.8 20.4 19.6 23.4 16.3 15.3 26.2 20.7 12.7 13.4 12.3 18.8 9.7 12.2 10.2 7.7 21.7 10.6 14.2 11.3 10.7 15.4 13.2 13.3 10.4 25.5 26.4 11.9 12.8 10.9 26.8 11.4 12.9 21.9 14.6 13.7 16.7 31.3 15.1 13.8 5.1 4.7 4.0 7.0 5.9 5.5 5.8 5.7 4.9 6.2 5.0 4.4 4.6 0.5 2.2 3.9 4.6 8.1 3.7 8.2 14.4 14.5 17.4 8.6 8.3 10.1 11.0 12.9 7.3 HMSD "ACC-6, ACC6, C18orf53" ENSG00000221887 "Histocompatibility minor serpin domain containing" "A8MTL9, P0C7T4" 18 63949301-63981774 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 26.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 7.7;HDLM-2: 18.1;Karpas-707: 7.1" "Cancer enhanced" "Detected in single" "cervical cancer: 1.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 18 "plasmacytoid DC: 5.0" "Lineage enriched" "Detected in single" 18 "dendritic cells: 5.0" "Secreted to blood" "unprognostic (5.83e-3)" "unprognostic (1.40e-1)" "unprognostic (1.40e-2)" "unprognostic (5.42e-3)" "unprognostic (6.20e-2)" "unprognostic (1.16e-2)" "unprognostic (4.91e-2)" "unprognostic (3.80e-1)" "unprognostic (1.41e-2)" "unprognostic (5.19e-3)" "unprognostic (8.67e-2)" "unprognostic (1.44e-1)" "unprognostic (7.14e-6)" "unprognostic (1.22e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-3)" "unprognostic (3.55e-1)" 1.7 1.9 3.9 3.4 8.4 0.5 1.5 0.6 4.8 0.4 0.8 11.3 0.0 0.7 0.3 0.2 1.3 0.8 0.4 1.0 5.8 4.2 0.3 1.9 3.0 5.9 15.1 1.0 1.2 0.9 0.2 0.3 0.3 12.1 0.3 2.1 0.0 0.6 0.5 0.5 2.9 1.0 0.4 26.1 2.1 1.5 2.1 11.2 1.4 0.8 0.2 4.9 0.5 1.3 0.2 5.0 0.0 0.0 0.0 0.0 0.2 3.2 0.0 0.0 0.0 3.3 7.7 0.0 0.6 2.1 0.3 4.1 0.0 0.8 0.0 0.0 0.9 3.3 1.3 0.2 2.6 18.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 4.2 0.0 2.8 0.1 0.0 0.0 7.1 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.0 0.2 1.3 0.0 0.0 3.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.2 3.9 8.4 0.6 3.7 5.8 4.2 15.1 1.0 12.1 11.2 HNF4G NR2A2 ENSG00000164749 "Hepatocyte nuclear factor 4 gamma" Q14541 8 75407914-75566843 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 139.6" "Cell line enhanced" "Detected in some" "A549: 4.6;CAPAN-2: 17.3;Karpas-707: 4.9;PC-3: 5.3;THP-1: 5.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "gdT-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005438, HPA010610" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA005438: AB_1850822, HPA010610: " "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.77e-2)" "unprognostic (9.44e-2)" "unprognostic (5.60e-2)" "unprognostic (4.65e-2)" "unprognostic (5.26e-2)" "unprognostic (1.27e-2)" "unprognostic (3.92e-1)" "unprognostic (8.09e-2)" "unprognostic (3.68e-2)" "unprognostic (1.83e-2)" "unprognostic (6.93e-3)" "unprognostic (1.67e-2)" "unprognostic (2.11e-1)" "unprognostic (4.22e-2)" "unprognostic (2.47e-2)" 0.2 0.2 0.5 5.0 0.5 0.0 0.3 0.3 0.3 0.6 56.2 0.1 0.3 35.9 0.4 1.1 0.4 0.3 12.6 0.2 0.3 0.3 6.1 12.1 0.4 0.0 0.4 0.2 0.2 10.9 0.0 0.2 0.0 0.3 0.6 6.9 0.2 0.4 0.6 0.2 0.2 139.6 0.2 0.3 0.2 2.6 0.9 0.1 0.1 0.2 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.1 4.6 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.3 17.3 0.0 2.5 0.0 0.0 2.2 0.0 0.0 0.0 1.9 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 4.9 0.0 0.0 0.0 0.3 0.3 5.3 0.0 0.0 0.3 3.0 0.1 0.3 1.7 0.4 0.1 0.0 0.3 5.8 0.0 0.4 0.2 0.1 0.0 1.2 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.3 0.3 0.3 0.4 0.2 0.3 0.1 HORMAD1 "CT46, DKFZP434A1315" ENSG00000143452 "HORMA domain containing 1" Q86X24 1 150698060-150720888 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 78.1" "Cell line enhanced" "Detected in some" "A549: 5.6;HeLa: 4.4;hTCEpi: 19.3;SiHa: 5.9;THP-1: 11.1;U-2 OS: 3.7" "Cancer enhanced" "Detected in many" "testis cancer: 6.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 1.2;neutrophil: 4.4" "Group enriched" "Detected in many" 4 "granulocytes: 4.4;monocytes: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028346, HPA037850" Enhanced Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA028346: , HPA037850: AB_10696358" "unprognostic (7.21e-2)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (9.06e-2)" "unprognostic (3.91e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-2)" "unprognostic (5.17e-3)" "unprognostic (3.79e-9)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 1.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 3.2 0.1 0.1 0.1 0.4 0.0 78.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.6 4.4 1.2 0.0 0.2 0.1 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.1 4.4 0.0 0.0 0.0 0.1 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.1 0.0 11.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.2 0.3 0.2 0.4 0.0 0.2 0.1 0.0 0.6 0.1 0.0 0.0 4.4 0.0 0.5 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 HORMAD2 "CT46.2, MGC26710" ENSG00000176635 "HORMA domain containing 2" Q8N7B1 22 30080174-30177075 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 21.3" "Cell line enhanced" "Detected in some" "THP-1: 1.1;U-2197: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 7 "hippocampal formation: 0.9" HPA003074 Enhanced "HPA003074: AB_1850916" "unprognostic (1.43e-1)" "unprognostic (6.77e-3)" "unprognostic (2.33e-1)" "unprognostic (1.36e-2)" "unprognostic (8.19e-3)" "unprognostic (1.96e-1)" "unprognostic (2.50e-2)" "unprognostic (2.12e-1)" 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.3 HP ENSG00000257017 Haptoglobin P00738 16 72054592-72061055 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Immunity" "Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "liver: 1156.9" "Group enriched" "Detected in some" 5 "Hep G2: 64.7;HSkMC: 37.1" "Cancer enriched" "Detected in many" 81 "liver cancer: 1297.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 20.0;eosinophil: 30.9" "Group enriched" "Detected in many" 7 "granulocytes: 30.9;monocytes: 20.0" "CAB003787, HPA047750" Enhanced Approved Vesicles "Secreted to blood" 181000000 140000000000 Vesicles "CAB003787: , HPA047750: " "unprognostic (6.38e-3)" "unprognostic (7.73e-3)" "unprognostic (1.23e-1)" "unprognostic (2.41e-2)" "unprognostic (2.34e-3)" "unprognostic (2.07e-1)" "unprognostic (7.79e-3)" "unprognostic (1.37e-1)" "unprognostic (2.31e-1)" "unprognostic (1.84e-1)" "unprognostic (6.30e-2)" "unprognostic (8.18e-2)" "prognostic unfavourable (6.94e-13)" "unprognostic (4.34e-4)" "unprognostic (1.80e-1)" "unprognostic (6.61e-2)" "unprognostic (2.49e-2)" 9.8 0.0 0.3 0.4 0.3 4.4 0.3 0.3 0.3 1.5 0.4 0.3 0.3 0.0 0.3 0.5 0.3 1.1 0.3 3.0 0.3 0.0 0.4 1156.9 1.4 0.4 0.3 0.3 0.3 0.5 0.0 0.5 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 1.4 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.5 0.0 3.5 30.9 20.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 64.7 0.1 9.2 1.7 37.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.5 0.1 0.7 0.0 0.3 6.9 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 2.1 1.4 0.0 0.2 0.0 0.0 1.2 0.0 4.4 0.0 3.6 0.0 2.6 20.0 30.9 0.0 0.8 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 5.8 0.0 0.9 0.0 0.0 5.0 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 HPCA ENSG00000121905 Hippocalcin P84074 1 32885994-32898441 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 46 "brain: 118.9" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 10.0" "Cancer enriched" "Detected in many" 9 "glioma: 8.0" "Group enriched" "Detected in many" 5 "basal ganglia: 118.9;cerebral cortex: 40.4;hippocampal formation: 42.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basal ganglia: 1321.6;hippocampal formation: 1344.5" "CAB012340, HPA043245" Enhanced "CAB012340: AB_2120209, HPA043245: " "unprognostic (4.60e-2)" "unprognostic (5.96e-3)" "unprognostic (2.16e-3)" "unprognostic (1.19e-3)" "unprognostic (6.72e-3)" "unprognostic (5.18e-2)" "unprognostic (9.08e-3)" "unprognostic (6.71e-3)" "unprognostic (1.18e-1)" "unprognostic (1.33e-1)" "unprognostic (2.32e-3)" "unprognostic (1.98e-2)" "unprognostic (2.36e-2)" "unprognostic (1.12e-2)" "unprognostic (6.42e-2)" "unprognostic (3.09e-2)" "unprognostic (2.85e-3)" 1.2 1.5 13.5 1.2 118.9 1.1 1.2 4.8 82.2 1.4 1.5 2.2 0.0 1.2 1.4 1.2 1.1 1.4 1.3 1.2 42.5 2.8 1.3 1.1 1.1 1.2 3.7 14.5 1.5 1.2 1.1 0.0 1.2 0.0 1.3 1.5 0.6 1.3 1.3 1.1 1.2 1.4 1.3 0.8 1.2 1.2 2.5 12.2 0.0 1.3 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.6 1.4 0.3 0.4 0.0 0.1 0.1 0.3 0.8 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.6 0.0 0.0 10.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 1.0 0.8 0.0 0.5 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 13.5 118.9 4.8 40.4 42.5 2.8 3.7 14.5 0.0 12.2 HPCAL4 "DKFZp761G122, HLP4" ENSG00000116983 "Hippocalcin like 4" Q9UM19 1 39678648-39691689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 80.4" "Cell line enhanced" "Detected in some" "Karpas-707: 3.9;SH-SY5Y: 13.1;SK-MEL-30: 4.1;U-2 OS: 2.8;U-266/70: 3.4;U-266/84: 4.2" "Group enriched" "Detected in some" 11 "glioma: 5.4;thyroid cancer: 4.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 5.6;naive CD4 T-cell: 5.0" "Lineage enriched" "Detected in single" 33 "T-cells: 5.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 336.7;basal ganglia: 201.9;cerebral cortex: 348.1;hippocampal formation: 324.0;olfactory region: 266.4" HPA053808 Approved Cytosol Cytosol "HPA053808: " "unprognostic (2.62e-1)" "unprognostic (2.37e-1)" "unprognostic (2.13e-2)" "unprognostic (8.56e-4)" "unprognostic (4.73e-3)" "unprognostic (1.99e-1)" "unprognostic (7.57e-2)" "unprognostic (4.89e-3)" "unprognostic (1.27e-1)" "unprognostic (3.18e-2)" "unprognostic (4.67e-2)" "unprognostic (2.19e-1)" "unprognostic (2.62e-3)" "unprognostic (3.78e-3)" "unprognostic (2.77e-2)" "unprognostic (3.97e-2)" "unprognostic (2.63e-1)" 1.2 10.2 35.8 1.8 46.0 1.5 1.2 31.1 80.4 1.2 1.2 3.7 0.0 1.3 1.2 1.5 5.5 1.2 1.3 1.4 28.3 17.0 3.5 1.2 1.7 1.9 7.5 32.7 3.7 4.7 1.2 0.4 1.2 6.8 1.4 1.3 0.0 1.2 1.3 2.1 1.2 1.3 1.2 4.4 1.4 1.3 4.1 3.0 0.0 1.2 0.0 1.8 1.3 0.0 0.0 0.1 0.0 0.0 0.0 5.6 1.8 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.0 0.3 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.6 0.0 1.2 13.1 0.4 0.0 4.1 0.0 0.1 0.0 0.0 2.8 0.0 0.0 3.4 4.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.4 0.0 5.6 1.0 0.1 0.0 5.0 1.8 0.0 0.0 0.0 0.0 3.8 1.8 35.8 46.0 31.1 40.4 28.3 17.0 7.5 32.7 6.8 3.0 HPD "4-HPPD, 4HPPD, GLOD3, PPD" ENSG00000158104 "4-hydroxyphenylpyruvate dioxygenase" P32754 12 121839527-121863596 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Dioxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 267.5" "Cell line enriched" "Detected in some" 30 "Hep G2: 104.7" "Cancer enriched" "Detected in many" 100 "liver cancer: 540.9" "Region enriched" "Detected in single" 29 "pons and medulla: 13.7" "Group enriched" "Detected in many" 4 "eosinophil: 9.8;neutrophil: 4.8;plasmacytoid DC: 5.0" "Group enriched" "Detected in many" 5 "dendritic cells: 5.0;granulocytes: 9.8" "Region enriched" "Detected in single" 8 "amygdala: 0.4" "Low region specificity" "Detected in many" "HPA038321, HPA038322" Enhanced Uncertain "Nuclear speckles" 23000000 "Nuclear speckles" "HPA038321: AB_2675957, HPA038322: AB_10670778" "unprognostic (3.01e-2)" "unprognostic (2.30e-1)" "unprognostic (4.81e-3)" "unprognostic (1.42e-3)" "unprognostic (1.10e-2)" "unprognostic (9.08e-2)" "unprognostic (1.13e-2)" "unprognostic (8.84e-2)" "unprognostic (5.58e-2)" "unprognostic (6.14e-3)" "unprognostic (9.72e-3)" "unprognostic (8.61e-3)" "unprognostic (7.16e-2)" "unprognostic (1.97e-1)" "unprognostic (4.12e-1)" "unprognostic (3.06e-2)" "unprognostic (2.34e-1)" 0.1 0.5 0.0 0.1 0.1 0.0 0.4 0.1 0.3 0.2 0.1 2.1 0.3 0.0 0.3 0.4 0.1 0.7 0.2 0.3 0.4 0.0 51.3 267.5 0.2 0.4 0.1 0.0 0.7 0.7 0.0 0.1 0.0 13.7 0.5 0.0 3.8 0.0 0.8 0.2 0.0 0.1 0.4 0.2 0.2 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.6 0.2 0.1 5.0 9.8 1.4 0.0 0.3 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 104.7 2.5 0.3 3.5 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.1 2.1 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.8 9.8 0.0 1.0 0.1 0.1 0.1 0.1 1.3 0.1 0.3 0.2 4.8 0.0 1.4 5.0 0.0 0.3 0.0 0.1 0.1 0.3 0.4 0.0 0.1 0.0 13.7 0.1 HPDL "4-HPPD-L, GLOXD1, MGC15668" ENSG00000186603 "4-hydroxyphenylpyruvate dioxygenase like" Q96IR7 1 45326905-45328533 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 38.4" "Cell line enhanced" "Detected in some" "BEWO: 46.3;HL-60: 13.1;NB-4: 16.3;SK-BR-3: 29.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 18 "hippocampal formation: 0.7;hypothalamus: 0.9;midbrain: 2.0;pons and medulla: 0.9;thalamus: 0.8" "HPA031997, HPA057346" Supported Mitochondria Mitochondria "HPA031997: AB_10602909, HPA057346: " "prognostic favourable (1.81e-4)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "prognostic unfavourable (1.60e-5)" "unprognostic (1.02e-2)" "unprognostic (6.71e-2)" "unprognostic (3.93e-3)" "unprognostic (1.25e-1)" "unprognostic (1.63e-1)" "prognostic favourable (1.03e-4)" "unprognostic (1.08e-3)" "unprognostic (2.52e-2)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" "unprognostic (1.00e-1)" "unprognostic (3.03e-2)" "unprognostic (1.43e-1)" 0.9 0.7 2.7 3.1 4.2 3.6 1.0 7.6 3.4 2.0 8.4 2.4 0.0 5.4 1.0 1.3 3.6 1.0 1.8 3.0 2.7 2.4 0.7 0.2 0.8 2.6 2.5 1.8 1.0 0.3 0.2 0.4 5.1 3.1 1.7 7.1 38.4 1.3 0.6 3.3 1.1 4.7 0.9 2.2 2.8 7.8 1.4 0.6 6.4 1.0 4.2 2.3 0.8 1.6 3.1 0.7 0.0 0.3 2.1 1.5 0.8 0.0 0.4 0.1 0.0 0.0 0.1 46.3 0.6 0.0 0.8 0.1 11.5 3.0 2.3 0.1 0.5 2.8 0.0 0.1 0.2 0.0 0.1 0.2 5.0 0.0 0.3 13.1 0.3 0.5 0.1 0.4 0.0 0.9 0.0 2.1 0.1 5.7 8.4 16.3 0.2 0.0 2.5 0.0 7.6 0.1 0.1 9.1 0.6 5.8 29.3 4.5 0.0 2.4 0.4 0.0 0.1 0.4 0.0 0.3 0.1 8.2 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.1 1.5 3.1 0.7 1.2 0.7 0.3 0.9 0.8 0.0 2.1 0.0 0.0 0.4 0.8 2.7 4.2 7.6 3.4 2.7 2.4 2.5 1.8 3.1 0.6 HPR ENSG00000261701 "Haptoglobin-related protein" P00739 16 72063224-72077246 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "liver: 151.4" "Cell line enriched" "Detected in some" 14 "Hep G2: 32.8" "Cancer enriched" "Detected in some" 53 "liver cancer: 185.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA047750 Supported Approved Vesicles "Secreted to blood" 49000000000 77000000000 Vesicles "HPA047750: " "unprognostic (2.43e-1)" "unprognostic (4.69e-2)" "unprognostic (5.97e-3)" "unprognostic (2.42e-1)" "unprognostic (2.32e-3)" "unprognostic (2.36e-1)" "unprognostic (1.66e-1)" "unprognostic (8.21e-2)" "unprognostic (2.30e-1)" "unprognostic (3.44e-6)" "unprognostic (2.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.29e-1)" 0.2 0.0 1.3 0.0 1.6 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 15.2 0.7 0.8 0.1 151.4 0.0 0.1 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 2.9 1.1 1.0 0.4 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 1.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 1.1 1.3 1.0 0.1 0.5 0.4 0.4 0.3 1.1 2.0 1.1 0.3 0.4 0.3 2.9 2.3 0.3 HPX ENSG00000110169 Hemopexin P02790 11 6431049-6442617 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Host-virus interaction, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 949 "liver: 528.6" "Cell line enriched" "Detected in some" 7 "Hep G2: 20.8" "Cancer enriched" "Detected in many" 79 "liver cancer: 571.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" CAB016725 Supported "Secreted to blood" 425000000000 230000000000 "CAB016725: " "unprognostic (3.39e-2)" "unprognostic (9.26e-2)" "unprognostic (3.88e-1)" "unprognostic (6.19e-4)" "unprognostic (2.05e-2)" "unprognostic (2.41e-1)" "prognostic favourable (2.26e-4)" "unprognostic (6.33e-2)" "unprognostic (5.67e-3)" "unprognostic (3.88e-1)" "unprognostic (5.08e-3)" "unprognostic (2.78e-2)" "unprognostic (5.82e-12)" "unprognostic (2.01e-1)" "unprognostic (4.48e-1)" "unprognostic (1.84e-2)" "unprognostic (2.14e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 528.6 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.6 0.0 0.0 0.1 0.1 0.3 1.4 0.0 0.8 0.1 0.0 0.2 0.0 0.1 0.1 0.2 0.2 0.6 0.1 20.8 0.0 2.9 0.0 0.8 0.6 0.1 0.0 0.1 0.4 0.1 0.1 0.4 0.0 0.0 0.3 0.0 0.1 1.3 0.2 0.0 0.1 0.2 0.0 1.0 3.0 0.2 1.1 0.0 0.4 0.3 0.2 1.0 0.1 0.3 0.2 0.9 0.2 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 HRG "HPRG, HRGP" ENSG00000113905 "Histidine rich glycoprotein" P04196 3 186660216-186678240 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis" Heparin-binding "Disease mutation, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 205 "liver: 425.4" "Cell line enhanced" "Detected in some" "HEL: 1.7;HL-60: 5.7;RH-30: 6.8;SiHa: 2.4" "Cancer enriched" "Detected in some" 262 "liver cancer: 406.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA050269, HPA054598" Supported "Secreted to blood" 120050000000 30000000000 "HPA050269: , HPA054598: " "unprognostic (2.67e-1)" "unprognostic (1.74e-2)" "unprognostic (7.58e-5)" "prognostic favourable (9.64e-5)" "unprognostic (1.44e-1)" "unprognostic (2.98e-3)" "unprognostic (2.22e-1)" "unprognostic (1.55e-2)" "unprognostic (1.14e-1)" "unprognostic (5.50e-2)" "unprognostic (1.05e-1)" "unprognostic (1.46e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 425.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.2 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 5.7 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.8 0.0 1.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.7 0.0 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HRH3 GPCR97 ENSG00000101180 "Histamine receptor H3" Q9Y5N1 20 62214970-62220267 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "brain: 50.1" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 18.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "unprognostic (1.56e-1)" "unprognostic (3.22e-1)" "unprognostic (4.15e-2)" "unprognostic (1.79e-1)" "unprognostic (2.77e-2)" "unprognostic (1.62e-2)" "unprognostic (7.30e-2)" "unprognostic (3.17e-4)" "unprognostic (2.40e-1)" "unprognostic (3.66e-3)" "unprognostic (3.30e-1)" "unprognostic (3.59e-2)" 1.0 2.3 5.7 0.8 50.1 0.9 0.9 16.7 20.6 0.8 0.9 2.8 0.0 1.0 0.8 0.8 0.9 0.8 0.8 0.8 5.1 16.5 0.9 0.9 0.9 0.9 2.7 8.7 0.8 0.8 0.8 0.7 0.8 2.6 1.4 0.9 0.0 1.1 0.8 0.8 1.6 0.9 0.9 1.0 0.8 0.9 1.6 10.5 0.0 0.8 0.0 0.9 2.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.9 0.0 0.0 0.0 1.2 0.0 0.1 18.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.7 50.1 16.7 15.1 5.1 16.5 2.7 8.7 2.6 10.5 HRH4 "AXOR35, GPCR105, GPRv53, H4R, HH4R" ENSG00000134489 "Histamine receptor H4" Q9H3N8 18 24460629-24479957 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "blood: 48.5" "Cell line enhanced" "Detected in some" "HEL: 2.9;HL-60: 4.9;HMC-1: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 96 "basophil: 48.5;eosinophil: 16.7" "Lineage enriched" "Detected in single" 142 "granulocytes: 48.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA035009 Uncertain "HPA035009: AB_10671507" "unprognostic (1.88e-1)" "unprognostic (2.62e-1)" "unprognostic (4.68e-2)" "unprognostic (9.83e-6)" "unprognostic (1.31e-2)" "unprognostic (3.61e-2)" "unprognostic (1.22e-1)" "unprognostic (8.96e-2)" "unprognostic (2.20e-1)" "unprognostic (3.30e-1)" "unprognostic (7.25e-2)" "unprognostic (2.91e-1)" "unprognostic (6.65e-7)" "unprognostic (1.89e-2)" "unprognostic (2.41e-1)" "unprognostic (2.03e-4)" "unprognostic (7.70e-2)" 1.7 0.6 0.4 1.5 0.4 2.8 0.6 0.3 0.3 0.4 0.6 0.3 0.3 2.1 1.4 1.9 1.3 0.3 0.8 0.5 0.4 0.4 0.4 1.7 1.9 0.7 0.4 0.3 0.8 0.4 0.0 2.5 0.3 0.8 1.0 0.4 1.0 1.1 0.3 0.8 2.3 1.9 2.8 2.6 1.4 0.9 1.4 0.3 0.3 0.5 0.3 5.1 1.9 0.6 0.0 0.0 48.5 0.0 0.0 0.3 0.1 0.4 0.3 0.2 0.9 0.1 0.0 0.5 0.2 0.0 0.0 0.1 0.8 0.6 0.1 0.5 0.2 0.8 0.2 0.3 0.2 0.2 0.2 2.9 0.9 0.6 0.2 4.9 2.9 0.2 1.0 0.1 0.0 0.3 0.2 0.5 0.1 0.4 0.4 0.8 0.3 0.3 0.3 0.3 0.3 0.5 0.6 0.4 0.2 0.2 0.1 0.2 0.3 1.1 0.3 1.2 0.2 0.8 0.1 0.5 0.2 0.2 0.9 0.8 0.5 48.5 0.0 16.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.4 0.3 0.3 0.4 0.4 0.4 0.3 0.8 0.3 HS3ST4 3OST4 ENSG00000182601 "Heparan sulfate-glucosamine 3-sulfotransferase 4" Q9Y661 16 25692026-26137688 "Enzymes, Predicted membrane proteins" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 23.9" "Group enriched" "Detected in some" 4 "NTERA-2: 5.4;SCLC-21H: 2.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (1.09e-2)" "unprognostic (1.87e-1)" "unprognostic (2.95e-1)" "unprognostic (2.24e-1)" "unprognostic (1.43e-3)" "unprognostic (1.27e-1)" "unprognostic (3.84e-1)" "unprognostic (8.81e-3)" "unprognostic (6.71e-2)" "unprognostic (2.39e-1)" "unprognostic (1.92e-1)" "unprognostic (2.51e-2)" "unprognostic (3.67e-2)" 0.7 0.8 6.9 0.6 9.3 0.6 5.1 6.8 23.9 1.1 0.6 2.6 0.0 0.6 0.7 1.3 0.9 0.7 0.6 0.6 11.5 10.0 0.7 0.6 0.6 0.6 5.9 10.8 0.7 0.6 0.6 0.1 0.6 14.3 2.0 0.6 0.3 0.8 0.6 0.6 0.7 0.6 0.6 2.2 3.7 1.1 1.3 1.5 0.0 0.6 0.0 0.8 1.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.9 9.3 6.8 13.4 11.5 10.0 5.9 10.8 14.3 1.5 HSD11B1 "HSD11, HSD11B, SDR26C1" ENSG00000117594 "Hydroxysteroid 11-beta dehydrogenase 1" P28845 1 209686178-209734950 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 183.4" "Cell line enriched" "Detected in some" 5 "ASC diff: 148.3" "Cancer enriched" "Detected in all" 28 "liver cancer: 197.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 9.2" "Lineage enriched" "Detected in single" 20 "T-cells: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047729 Enhanced 77000 "HPA047729: " "unprognostic (1.08e-3)" "unprognostic (2.13e-1)" "unprognostic (2.32e-1)" "unprognostic (1.40e-1)" "unprognostic (1.57e-1)" "unprognostic (3.68e-1)" "unprognostic (2.02e-2)" "unprognostic (1.12e-1)" "unprognostic (1.30e-1)" "unprognostic (3.63e-2)" "unprognostic (8.35e-3)" "unprognostic (8.69e-2)" "prognostic unfavourable (1.97e-10)" "unprognostic (3.41e-2)" "unprognostic (3.91e-2)" "unprognostic (6.45e-2)" "unprognostic (1.59e-2)" 4.6 1.6 1.1 3.0 3.1 0.3 2.4 9.9 3.9 0.6 1.0 1.6 2.7 0.5 0.8 8.7 1.5 0.9 1.9 3.0 1.8 0.9 2.6 183.4 7.2 1.3 8.2 2.0 12.6 0.9 0.3 1.5 26.5 3.3 7.1 0.9 1.5 0.6 3.0 1.5 6.3 0.9 2.7 1.3 3.5 1.4 2.3 2.5 0.0 1.0 0.6 0.6 3.9 1.4 0.2 0.0 0.2 0.1 0.4 9.2 0.8 0.0 0.0 0.0 0.0 148.3 15.4 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.2 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.6 0.2 9.2 2.0 0.0 0.0 0.2 0.0 0.2 0.4 0.0 0.0 2.4 0.8 1.1 3.1 9.9 3.9 1.8 0.9 8.2 2.0 3.3 2.5 HSD17B1 "EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1" ENSG00000108786 "Hydroxysteroid 17-beta dehydrogenase 1" P14061 17 42549214-42555213 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "placenta: 217.6" "Cell line enriched" "Detected in many" 8 "BEWO: 87.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA021032, HPA065296" Enhanced Supported Cytosol Cytosol "HPA021032: AB_1844345, HPA065296: AB_2685457" "unprognostic (1.13e-1)" "unprognostic (1.40e-2)" "unprognostic (1.68e-2)" "unprognostic (9.25e-2)" "unprognostic (1.73e-1)" "unprognostic (3.88e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (9.35e-2)" "unprognostic (6.04e-2)" "unprognostic (2.88e-5)" "unprognostic (2.17e-1)" "unprognostic (1.30e-1)" "unprognostic (2.60e-2)" "unprognostic (5.09e-1)" "unprognostic (4.98e-1)" "unprognostic (1.32e-2)" 2.8 1.5 2.0 1.7 2.1 1.1 1.8 2.7 3.1 1.3 1.3 1.3 1.3 1.9 1.5 1.3 4.3 1.4 1.3 1.4 2.4 1.4 1.4 1.3 1.3 1.6 2.4 1.3 5.8 2.6 0.2 1.4 217.6 1.3 1.5 0.2 1.3 2.9 1.3 3.5 4.1 1.9 1.3 1.9 2.1 2.0 2.3 1.3 1.3 1.8 1.3 1.3 1.3 1.8 6.0 5.5 7.5 8.6 6.1 5.4 5.5 1.6 1.7 0.9 4.5 0.6 0.1 87.6 1.2 0.0 0.0 0.0 1.0 0.9 0.0 1.1 0.0 2.6 0.1 0.7 0.0 2.4 2.8 1.2 1.1 1.5 0.2 1.0 1.4 0.2 2.5 0.1 0.5 0.0 1.6 0.3 0.0 1.5 1.3 1.1 0.4 0.8 1.3 1.1 0.7 0.1 1.3 1.2 1.8 0.7 8.9 1.4 10.7 0.8 1.4 1.4 1.7 0.9 0.8 2.5 1.4 0.6 0.5 0.9 1.0 3.6 7.6 7.5 4.9 8.6 5.3 5.6 5.4 5.1 5.5 6.0 5.1 4.4 7.2 6.1 5.3 4.3 3.7 5.5 2.0 2.1 2.7 1.5 2.4 1.4 2.4 1.3 1.3 1.3 HSD17B13 "SCDR9, SDR16C3" ENSG00000170509 "Hydroxysteroid 17-beta dehydrogenase 13" Q7Z5P4 4 87303789-87322906 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 158.8" "Cell line enhanced" "Detected in some" "NB-4: 4.8" "Cancer enriched" "Detected in some" 26 "liver cancer: 52.9" "Region enriched" "Detected in single" 6 "cerebellum: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA029125 Uncertain Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" Vesicles "Golgi apparatus" "HPA029125: AB_10601580" "unprognostic (2.49e-1)" "unprognostic (7.46e-2)" "unprognostic (7.02e-2)" "unprognostic (1.86e-4)" "unprognostic (4.74e-2)" "unprognostic (8.44e-2)" "prognostic favourable (2.94e-4)" "prognostic favourable (7.80e-4)" "unprognostic (4.97e-1)" "unprognostic (2.22e-2)" "unprognostic (1.00e-1)" "unprognostic (2.46e-1)" "unprognostic (7.18e-4)" "unprognostic (3.62e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (1.52e-3)" 8.0 0.1 0.1 0.2 0.1 0.3 1.8 1.0 0.1 1.3 0.3 0.1 0.1 0.1 1.2 0.2 0.1 0.1 0.1 0.9 0.1 0.0 0.1 158.8 0.8 0.1 0.1 0.1 0.1 2.4 0.0 0.1 0.3 0.1 2.4 0.1 0.1 0.2 0.1 0.1 1.4 0.1 1.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.4 0.1 0.3 2.7 1.8 0.6 3.7 0.7 0.8 0.8 0.1 0.2 0.3 0.8 0.9 1.1 0.8 0.6 0.1 0.3 0.0 0.1 0.0 1.8 0.6 0.6 0.3 0.4 0.2 0.2 0.2 0.5 0.3 0.9 1.1 1.7 0.8 2.6 1.0 0.4 0.0 0.0 0.1 0.3 0.8 0.9 0.3 0.3 0.4 4.8 0.4 0.5 0.8 1.0 0.3 0.3 0.5 0.5 2.0 0.6 0.4 0.2 0.2 1.6 1.0 0.5 2.7 0.7 0.4 0.5 0.3 0.5 0.2 2.0 1.0 3.7 0.7 1.5 0.4 0.2 0.4 1.8 0.4 0.4 0.1 1.1 0.8 0.7 2.8 0.8 0.3 0.6 0.4 0.1 0.1 0.1 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 HSD17B3 SDR12C2 ENSG00000130948 "Hydroxysteroid 17-beta dehydrogenase 3" P37058 9 96235306-96302152 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 41.9" "Group enriched" "Detected in some" 5 "HBEC3-KT: 4.9;HEL: 4.3;U-2 OS: 8.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056833 Enhanced Supported Vesicles Vesicles "HPA056833: " "unprognostic (2.78e-1)" "unprognostic (6.61e-3)" "unprognostic (1.03e-1)" "unprognostic (5.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (3.08e-2)" "unprognostic (6.15e-2)" "unprognostic (1.74e-1)" "unprognostic (5.13e-2)" "unprognostic (3.26e-4)" "unprognostic (3.45e-1)" "unprognostic (5.48e-8)" "unprognostic (8.47e-3)" "unprognostic (1.15e-1)" "unprognostic (7.24e-2)" "unprognostic (3.11e-2)" 0.5 0.4 1.0 0.5 1.0 0.4 0.5 0.5 0.9 0.8 0.5 0.5 0.5 0.4 0.5 0.5 0.5 1.3 0.5 0.5 1.7 0.5 1.0 6.3 0.5 0.5 1.6 0.5 0.5 1.3 0.4 0.5 0.5 0.5 0.8 0.4 0.5 0.5 0.5 0.5 0.5 1.1 0.5 1.9 0.5 0.4 41.9 0.5 0.5 4.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.0 1.0 0.5 0.9 1.7 0.5 1.6 0.5 0.5 0.5 HSD17B6 "HSE, RODH, SDR9C6" ENSG00000025423 "Hydroxysteroid 17-beta dehydrogenase 6" O14756 12 56752161-56787790 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 241.2" "Cell line enhanced" "Detected in many" "Karpas-707: 11.7;U-266/84: 14.6" "Cancer enriched" "Detected in many" 5 "liver cancer: 170.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059141 Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA059141: " "unprognostic (7.70e-2)" "unprognostic (8.76e-2)" "unprognostic (5.08e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (3.79e-2)" "prognostic favourable (6.32e-4)" "unprognostic (1.06e-2)" "unprognostic (3.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (2.50e-10)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (1.08e-1)" "unprognostic (1.05e-1)" 1.1 0.5 3.6 1.4 5.2 0.2 0.3 1.2 2.4 9.4 3.3 0.5 2.6 0.6 4.1 0.7 1.6 0.9 2.6 0.4 1.6 1.4 0.5 241.2 8.7 0.3 2.0 2.6 1.1 0.3 0.2 0.0 0.9 0.6 7.9 1.3 1.4 0.2 10.2 0.2 0.2 0.7 11.3 1.0 6.2 0.8 3.2 0.8 0.0 13.3 0.0 0.3 9.9 2.3 2.0 2.0 0.1 1.3 0.1 3.4 0.8 0.3 0.7 1.6 0.3 1.7 1.2 2.0 3.6 3.1 1.7 1.7 0.4 0.4 10.2 1.5 0.4 0.3 5.3 0.9 1.0 6.5 2.0 3.2 1.0 0.5 1.1 1.6 5.3 0.9 0.3 1.0 0.5 0.0 0.9 11.7 0.8 2.1 4.6 1.0 6.6 0.6 6.3 0.7 2.5 0.2 1.2 9.7 2.0 1.7 3.1 0.8 0.5 1.3 0.3 0.8 0.8 3.6 0.9 10.3 14.6 6.7 1.2 5.8 0.6 0.0 0.2 0.1 3.0 0.6 3.4 2.0 2.5 2.4 0.6 1.1 3.3 2.2 0.0 0.1 1.3 2.0 2.8 0.8 3.6 5.2 1.2 2.4 1.6 1.4 2.0 2.6 0.6 0.8 HSD3B1 "HSD3B, HSDB3, SDR11E1" ENSG00000203857 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1" P14060 1 119507198-119515054 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Isomerase, Multifunctional enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "placenta: 231.4" "Cell line enriched" "Detected in some" 9 "CACO-2: 37.0" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043261, HPA043264, HPA044028" Supported Approved "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: , HPA043264: , HPA044028: " "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-1)" "prognostic favourable (4.59e-5)" 0.1 0.6 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 231.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.5 11.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 4.1 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 HSD3B2 SDR11E2 ENSG00000203859 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2" P26439 1 119414931-119423035 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis "Isomerase, Multifunctional enzyme, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "adrenal gland: 223.2" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;TIME: 1.2;WM-115: 3.2" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Region enriched" "Detected in single" 198 "basal ganglia: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043261, HPA043264, HPA044028" Supported Uncertain "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: , HPA043264: , HPA044028: " "unprognostic (3.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.80e-1)" "unprognostic (2.72e-2)" "unprognostic (8.87e-2)" "unprognostic (3.91e-2)" "unprognostic (3.43e-2)" "unprognostic (1.94e-1)" "unprognostic (6.51e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" 0.0 223.2 0.0 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.5 43.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 1.5 1.4 0.0 0.0 5.1 0.0 0.0 1.2 0.2 0.1 0.1 0.7 0.0 0.0 0.0 0.8 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSF2BP ENSG00000160207 "Heat shock transcription factor 2 binding protein" O75031 21 43529192-43659493 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 28.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 14.9;hTCEpi: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.5;NK-cells: 1.5;T-cells: 2.8" "Low region specificity" "Detected in some" "HPA031724, HPA075775" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA031724: AB_10601022, HPA075775: " "unprognostic (1.91e-2)" "unprognostic (1.19e-1)" "unprognostic (7.27e-3)" "unprognostic (1.54e-4)" "unprognostic (2.62e-1)" "unprognostic (1.78e-2)" "unprognostic (9.36e-4)" "unprognostic (3.38e-2)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (1.79e-1)" "unprognostic (3.11e-1)" "unprognostic (1.44e-2)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (8.77e-4)" "unprognostic (6.00e-2)" 0.7 0.8 1.3 0.6 3.1 0.5 1.1 1.4 4.1 0.9 0.6 3.5 1.8 0.6 1.1 1.1 0.8 1.2 0.7 0.7 1.3 1.5 0.8 0.6 0.6 0.7 2.3 3.0 1.4 0.6 1.2 2.3 1.6 2.7 0.8 0.6 2.6 1.2 1.4 0.5 0.8 0.7 0.7 2.0 0.5 0.7 28.5 1.6 1.0 1.0 0.0 0.6 0.8 0.8 1.5 0.2 0.0 0.1 1.5 2.8 0.8 5.2 1.1 1.4 0.6 0.3 1.4 1.3 1.8 1.1 1.9 1.7 7.1 5.2 4.0 2.9 1.1 2.1 0.7 14.9 0.6 1.0 1.3 0.7 2.2 0.4 1.8 1.7 0.5 0.9 9.8 0.8 4.6 0.5 1.5 1.3 4.6 0.9 2.3 1.6 4.6 2.2 3.4 1.4 0.5 2.3 1.0 1.5 1.1 3.9 1.9 2.1 2.1 1.9 3.0 1.0 3.6 0.2 2.7 1.4 1.0 3.2 1.0 3.5 2.6 0.0 0.1 0.0 0.2 0.0 1.6 1.2 0.5 1.4 0.2 1.5 2.7 2.8 0.0 1.5 0.1 0.2 0.0 0.8 1.3 3.1 1.4 3.6 1.3 1.5 2.3 3.0 2.7 1.6 HSF5 FLJ40311 ENSG00000176160 "Heat shock transcription factor 5" Q4G112 17 58420167-58488384 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 65.6" "Cell line enhanced" "Detected in single" "CACO-2: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 3.7;T-cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA063613 Enhanced "HPA063613: " "unprognostic (2.13e-1)" "unprognostic (1.21e-4)" "unprognostic (1.71e-1)" "unprognostic (3.58e-2)" "unprognostic (2.36e-1)" "unprognostic (1.09e-3)" "unprognostic (4.17e-2)" "unprognostic (7.48e-3)" "unprognostic (7.40e-2)" "unprognostic (8.85e-3)" "unprognostic (2.13e-3)" "unprognostic (2.58e-2)" "unprognostic (6.65e-4)" "unprognostic (1.21e-1)" "unprognostic (7.39e-2)" "unprognostic (8.75e-2)" "unprognostic (3.64e-2)" 0.1 0.0 0.0 2.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.8 0.0 65.6 0.0 3.3 0.0 0.1 2.4 0.0 0.0 3.7 0.1 0.0 0.0 0.5 3.2 0.8 0.0 0.0 0.1 0.4 0.0 0.6 0.2 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.1 3.1 1.7 1.5 0.1 3.7 3.2 2.2 0.0 0.5 0.0 0.1 2.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSFX2 ENSG00000268738 "Heat shock transcription factor family, X-linked 2" Q9UBD0 X 149592515-149594716 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 9.3" "Cell line enhanced" "Detected in some" "HaCaT: 2.6;hTCEpi: 3.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.7;naive CD4 T-cell: 1.8" "Low lineage specificity" "Detected in many" HPA063040 Supported "HPA063040: " "unprognostic (7.64e-2)" "unprognostic (6.92e-3)" "unprognostic (2.00e-1)" 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.1 0.2 0.0 0.5 0.1 0.1 0.3 0.6 1.3 0.1 0.5 0.0 0.1 0.0 0.0 9.3 0.0 0.0 0.1 0.2 0.5 1.7 0.2 0.2 1.8 0.3 0.6 0.0 1.8 0.3 0.0 1.1 0.2 1.0 0.8 1.2 0.1 1.6 0.0 0.4 0.0 0.0 2.6 0.0 0.9 0.8 0.0 0.9 0.8 0.0 0.2 0.2 0.2 0.8 1.6 3.3 1.2 0.0 0.0 0.0 0.0 0.0 1.0 0.2 2.4 0.9 1.3 0.1 0.0 0.4 1.4 0.8 0.0 0.4 0.0 0.5 1.1 0.3 0.9 1.4 2.3 0.0 0.1 0.0 0.2 0.0 0.3 0.6 0.5 0.5 1.7 0.2 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.2 1.8 0.1 1.1 0.2 0.2 0.5 0.0 0.3 HSFX3 ENSG00000283697 "Heat shock transcription factor family, X-linked member 3" A0A1B0GWH4 X 149548210-149549932 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 13.9" "Cell line enhanced" "Detected in some" "Daudi: 1.5;HEK 293: 1.3;HeLa: 1.5;NB-4: 2.3;PC-3: 1.5;SK-BR-3: 1.0;U-87 MG: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.4 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.2 0.0 0.0 0.2 1.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 2.3 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.5 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.4 0.1 0.3 0.0 0.4 0.2 0.2 0.2 0.1 HSFY1 "HSF2L, HSFY" ENSG00000172468 "Heat shock transcription factor, Y-linked 1" Q96LI6 Y 18546671-18588963 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 17.8" "Cell line enhanced" "Detected in some" "Karpas-707: 1.4;THP-1: 1.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.8 0.2 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.7 0.6 1.8 0.5 0.5 0.5 0.2 0.2 0.0 0.1 0.7 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.5 0.4 0.4 0.0 0.6 0.7 0.0 0.0 0.0 0.5 0.9 0.0 0.3 0.8 0.8 0.3 0.4 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.1 0.7 0.0 0.2 0.0 0.5 0.3 0.2 0.8 0.5 0.0 0.2 0.5 0.6 1.6 0.6 0.4 0.0 0.0 0.9 0.4 0.3 0.2 0.2 0.1 0.5 1.8 0.5 0.3 0.3 0.2 0.2 0.3 0.3 0.4 0.2 0.7 0.2 0.4 1.0 0.5 0.1 0.6 0.5 0.2 HSFY2 FLJ25453 ENSG00000169953 "Heat shock transcription factor, Y-linked 2" Q96LI6 Y 18731440-18828662 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 25 "testis: 18.2" "Cell line enhanced" "Detected in single" "TIME: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSPH1 "HSP105A, HSP105B, KIAA0201, NY-CO-25" ENSG00000120694 "Heat shock protein family H (Hsp110) member 1" Q92598 13 31134974-31162388 "Cancer-related genes, Predicted intracellular proteins" "Stress response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "vagina: 286.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002060, HPA028675, HPA031569" Uncertain Enhanced Nucleoplasm,Cytosol 820000 Cytosol Nucleoplasm "CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938" "unprognostic (1.10e-2)" "unprognostic (4.94e-2)" "unprognostic (5.44e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (4.90e-4)" "prognostic unfavourable (1.41e-5)" "unprognostic (5.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (1.53e-1)" "unprognostic (3.13e-1)" "unprognostic (7.45e-3)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (2.04e-1)" "unprognostic (7.89e-2)" 13.7 19.8 36.6 12.2 57.1 9.8 33.7 11.7 44.0 14.7 10.6 9.8 13.0 6.1 13.3 21.7 13.9 31.0 18.1 14.2 34.8 40.3 16.6 14.8 15.9 17.4 36.5 16.3 13.4 10.1 15.1 24.1 19.8 32.7 14.5 14.5 3.6 7.0 17.3 10.5 11.0 6.4 15.7 34.8 9.0 12.2 35.0 34.6 12.1 22.5 7.8 23.8 17.0 286.1 9.0 6.8 2.1 14.6 13.7 12.8 5.5 14.5 27.8 23.0 2.2 22.1 12.6 15.3 25.2 22.4 39.2 18.3 32.7 22.6 37.7 15.8 17.5 28.2 88.5 22.4 50.6 29.5 11.1 32.7 15.4 28.8 7.3 22.6 26.1 7.9 51.8 26.1 15.0 22.6 27.3 6.0 27.4 19.8 32.4 25.9 32.7 20.8 25.6 18.8 12.5 29.5 17.7 23.8 19.8 22.9 22.6 11.6 7.5 22.0 13.7 13.5 17.2 19.4 27.8 4.7 15.4 32.3 11.2 27.5 22.5 1.0 3.9 2.1 6.6 9.6 8.1 9.0 8.4 10.0 6.8 7.8 12.8 11.9 0.4 13.7 14.6 5.3 5.3 5.5 36.6 57.1 11.7 44.0 34.8 40.3 36.5 16.3 32.7 34.6 HTN1 HIS1 ENSG00000126550 "Histatin 1" P15515 4 70050402-70058845 "Predicted secreted proteins" Biomineralization "Antibiotic, Antimicrobial, Fungicide" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1306 "salivary gland: 1826.6" "Cell line enhanced" "Detected in some" "hTCEpi: 1.0;SK-MEL-30: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA077315 Approved "Secreted to digestive system" "HPA077315: " "unprognostic (2.22e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1826.6 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 1.3 1.1 0.1 0.1 0.2 0.4 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.6 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 HTN3 HIS2 ENSG00000205649 "Histatin 3" P15516 4 70028413-70036538 "Predicted secreted proteins, Transporters" Biomineralization "Antibiotic, Antimicrobial, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 535 "salivary gland: 3346.6" "Cell line enhanced" "Detected in many" "HDLM-2: 4.4;HL-60: 4.8" "Cancer enhanced" "Detected in single" "melanoma: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" CAB073541 Enhanced "Secreted to digestive system" "CAB073541: " 0.1 0.4 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.2 1.4 0.0 6.2 0.0 0.0 0.2 0.0 0.0 3346.6 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 3.3 0.3 0.1 0.1 1.2 0.6 2.2 1.2 0.5 1.0 0.4 1.1 1.3 0.5 0.5 0.0 0.3 0.4 0.2 0.0 0.6 0.6 0.1 1.6 1.7 0.8 0.2 0.8 0.0 0.3 0.1 4.4 0.7 0.3 0.9 0.6 0.0 4.8 3.5 0.3 0.8 0.1 0.0 0.6 0.6 3.0 0.5 0.6 1.2 2.3 1.2 1.4 2.9 0.8 0.6 0.3 0.6 2.0 1.1 1.1 0.8 0.9 2.1 1.2 0.0 1.2 1.8 1.1 0.9 1.9 2.3 0.7 1.1 1.5 2.5 2.2 0.7 0.5 0.5 1.1 0.3 1.0 0.8 0.4 0.4 1.2 1.0 0.6 2.0 0.5 1.2 0.6 0.5 0.4 0.1 0.2 0.2 0.1 0.1 0.4 0.1 0.0 0.0 0.0 HTR2A "5-HT2A, HTR2" ENSG00000102468 "5-hydroxytryptamine receptor 2A" P28223 13 46831550-46897076 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "Behavior, Host-virus interaction" "G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 30.4" "Cell line enhanced" "Detected in some" "ASC diff: 3.7;ASC TERT1: 9.1;BEWO: 2.8;HEL: 2.8;U-138 MG: 4.6;U-2 OS: 2.9;U-87 MG: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "neutrophil: 1.2;plasmacytoid DC: 1.2" "Group enriched" "Detected in many" 8 "dendritic cells: 1.2;granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014011 Enhanced "HPA014011: AB_1856709" "unprognostic (8.01e-2)" "unprognostic (2.71e-2)" "unprognostic (9.49e-2)" "unprognostic (7.40e-2)" "unprognostic (2.78e-1)" "unprognostic (1.99e-1)" "unprognostic (2.70e-2)" "unprognostic (4.31e-2)" "unprognostic (5.27e-2)" "unprognostic (3.97e-2)" "unprognostic (2.61e-1)" "unprognostic (2.90e-1)" "unprognostic (9.94e-5)" "unprognostic (4.78e-3)" "unprognostic (2.54e-1)" "unprognostic (2.91e-2)" "unprognostic (8.28e-2)" 1.9 1.0 9.5 1.7 13.5 0.6 1.3 0.6 30.4 1.6 1.2 1.2 0.0 1.1 1.6 0.6 1.4 1.1 2.9 1.5 3.8 5.1 0.7 0.6 1.0 0.6 3.3 13.3 1.0 0.6 0.6 0.5 0.6 1.8 0.9 1.6 2.0 0.6 1.5 0.9 0.7 1.1 4.4 1.2 0.6 1.0 1.5 0.7 0.0 0.7 0.0 0.8 1.9 1.5 0.1 1.2 1.2 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 3.7 9.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.0 0.1 4.6 2.9 0.0 0.2 0.1 0.0 0.0 2.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 1.2 0.0 1.5 9.5 13.5 0.6 26.4 3.8 5.1 3.3 13.3 1.8 0.7 HTR2C "5-HT2C, 5HTR2C, HTR1C" ENSG00000147246 "5-hydroxytryptamine receptor 2C" P28335 X 114584078-114910061 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "brain: 45.3" "Group enriched" "Detected in some" 4 "EFO-21: 4.9;RPMI-8226: 2.4;U-266/70: 8.7;U-266/84: 7.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Region enhanced" "Detected in many" "basal ganglia: 45.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (2.14e-1)" "unprognostic (6.09e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (2.89e-2)" "unprognostic (3.42e-2)" "unprognostic (9.22e-4)" "unprognostic (1.37e-1)" "unprognostic (6.84e-2)" 0.5 0.5 2.4 0.4 45.3 0.5 0.5 0.0 9.4 2.3 0.4 8.5 0.0 0.4 0.5 0.6 0.4 0.4 0.5 0.4 2.4 9.8 0.5 0.5 0.5 0.4 2.0 1.2 0.4 0.4 0.4 0.3 1.0 29.7 0.9 0.4 0.8 0.4 1.1 0.4 0.4 0.4 0.4 1.7 0.4 0.4 0.6 2.4 0.0 0.4 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 1.3 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.9 0.0 0.0 8.7 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.4 45.3 0.0 4.6 2.4 9.8 2.0 1.2 29.7 2.4 HTR3C ENSG00000178084 "5-hydroxytryptamine receptor 3C" Q8WXA8 3 184053047-184060671 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lung: 6.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.1;HEL: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (4.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.39e-1)" "unprognostic (1.61e-1)" "unprognostic (2.88e-2)" "unprognostic (1.68e-2)" "unprognostic (8.72e-2)" "unprognostic (1.75e-1)" "unprognostic (3.88e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.2 0.0 0.6 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR3E ENSG00000186038 "5-hydroxytryptamine receptor 3E" A5X5Y0 3 184097064-184106995 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 7.0" "Cell line enriched" "Detected in single" 6 "RH-30: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049764 Enhanced "HPA049764: " "unprognostic (4.12e-2)" "unprognostic (5.86e-2)" "unprognostic (2.15e-1)" "unprognostic (4.57e-4)" "unprognostic (3.61e-3)" "unprognostic (1.15e-1)" "unprognostic (3.16e-1)" "unprognostic (4.47e-1)" "unprognostic (3.32e-1)" "unprognostic (2.67e-1)" "unprognostic (4.16e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 HTR5A 5-HT5A ENSG00000157219 "5-hydroxytryptamine receptor 5A" P47898 7 155070324-155085749 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 15.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB017467 Approved "CAB017467: AB_2122566" "unprognostic (1.62e-2)" "unprognostic (1.15e-1)" 0.4 0.4 2.6 0.4 3.9 0.4 0.4 15.4 15.0 0.4 0.4 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 2.6 5.9 0.4 0.4 0.4 0.4 2.3 2.5 0.4 0.4 0.4 0.1 0.4 2.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.8 0.4 0.4 1.4 0.3 3.3 0.4 0.0 0.4 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 3.9 15.4 9.8 2.6 5.9 2.3 2.5 2.4 0.3 HTR6 "5-HT6, 5-HT6R" ENSG00000158748 "5-hydroxytryptamine receptor 6" P50406 1 19665287-19679562 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 24.6" "Cell line enhanced" "Detected in some" "MCF7: 1.2;NTERA-2: 2.4;SH-SY5Y: 6.5" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Group enriched" "Detected in many" 5 "basal ganglia: 24.6;cerebral cortex: 6.6" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.4;naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 9.5" HPA068165 Uncertain "HPA068165: " "unprognostic (2.34e-2)" "unprognostic (1.84e-1)" "unprognostic (7.19e-3)" "unprognostic (3.84e-5)" "unprognostic (1.38e-4)" "unprognostic (2.69e-2)" "unprognostic (1.36e-1)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (5.33e-3)" "unprognostic (8.63e-2)" "unprognostic (5.47e-4)" "unprognostic (1.28e-1)" "unprognostic (2.49e-1)" "unprognostic (6.13e-3)" "unprognostic (2.02e-1)" 0.4 0.5 1.2 1.4 24.6 0.4 0.4 0.2 6.6 0.6 0.4 0.0 0.0 0.6 0.6 0.5 0.5 0.6 0.5 0.4 1.4 1.0 0.3 0.3 0.3 1.4 0.5 2.2 0.3 0.3 0.3 0.4 0.3 0.4 0.4 0.3 0.0 0.5 0.3 0.3 0.8 0.5 0.5 0.2 0.4 0.5 0.8 3.2 0.0 0.3 0.0 2.7 0.6 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.4 0.0 1.0 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.2 24.6 0.2 6.6 1.4 1.0 0.5 2.2 0.4 3.2 HTRA4 FLJ90724 ENSG00000169495 "HtrA serine peptidase 4" P83105 8 38974164-38988662 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "placenta: 55.2" "Cell line enriched" "Detected in single" 134 "BEWO: 71.1" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enhanced" "Detected in some" "hippocampal formation: 2.3" "Low region specificity" "Detected in all" HPA045402 Enhanced "Secreted in female reproductive system" "HPA045402: " "unprognostic (1.20e-1)" "unprognostic (5.83e-4)" "unprognostic (8.02e-2)" "unprognostic (2.13e-2)" "unprognostic (8.20e-2)" "unprognostic (2.42e-2)" "unprognostic (1.80e-1)" "unprognostic (7.40e-3)" "unprognostic (1.40e-1)" "unprognostic (5.14e-4)" "unprognostic (1.01e-1)" "unprognostic (8.68e-2)" "unprognostic (1.42e-1)" "unprognostic (4.58e-1)" "unprognostic (5.19e-3)" "unprognostic (2.39e-3)" "unprognostic (1.19e-3)" 2.6 1.1 0.2 0.3 0.2 3.4 0.9 0.2 0.4 1.2 0.5 0.2 1.9 0.0 2.3 0.5 0.5 0.1 0.2 0.2 0.2 0.0 0.2 0.2 4.3 1.0 0.2 0.2 0.4 0.3 0.4 0.5 55.2 0.4 0.5 0.3 1.8 0.8 0.5 0.6 0.4 0.6 0.3 1.8 2.5 0.1 0.4 0.2 0.2 0.6 0.2 0.8 0.5 0.9 3.1 2.2 2.5 1.0 1.0 1.7 0.0 0.1 0.1 0.1 0.1 0.3 0.2 71.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.3 0.1 0.1 0.5 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.1 0.2 0.0 0.2 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.3 0.1 1.5 0.8 2.3 1.4 0.7 1.7 1.5 1.3 1.2 0.6 3.1 1.3 1.4 2.5 1.0 1.0 2.2 1.4 0.0 0.2 0.2 0.2 0.4 0.2 0.0 0.2 0.2 0.4 0.2 HYPM "CXorf27, HIP17" ENSG00000187516 "Huntingtin interacting protein M" O75409 X 37990817-37991317 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 110 "testis: 28.3" "Cell line enriched" "Detected in single" 4 "NTERA-2: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003356 Enhanced "HPA003356: AB_1078593" "unprognostic (2.99e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 IAPP "AMYLIN, DAP, IAP" ENSG00000121351 "Islet amyloid polypeptide" P10997 12 21354959-21379978 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "pancreas: 63.1" "Cell line enhanced" "Detected in some" "EFO-21: 3.1;U-2 OS: 4.8;U-698: 1.6" "Cancer enriched" "Detected in single" 76 "pancreatic cancer: 21.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000352, HPA053194" Enhanced "Secreted to blood" 11900 "CAB000352: AB_2121635, HPA053194: " "unprognostic (5.52e-3)" "unprognostic (1.00e-1)" "unprognostic (4.16e-1)" "unprognostic (1.74e-1)" "unprognostic (1.91e-1)" 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 1.1 0.1 0.1 0.1 0.1 0.1 63.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 1.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 1.3 1.8 0.6 0.7 0.7 0.1 0.1 0.0 0.9 0.3 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 3.1 0.0 0.3 0.0 0.2 0.1 0.5 0.4 0.2 1.1 0.0 0.1 0.6 0.0 0.0 0.2 0.3 0.1 0.1 0.5 0.9 0.1 0.3 0.0 0.2 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.3 4.8 0.1 0.7 0.5 1.1 1.6 0.2 0.2 0.1 1.8 0.6 0.1 0.4 0.2 0.1 0.4 0.5 0.2 0.3 0.7 0.4 0.7 1.5 0.7 0.2 1.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 ICAM5 "TLCN, TLN" ENSG00000105376 "Intercellular adhesion molecule 5" Q9UMF0 19 10289981-10296778 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 32.6" "Cell line enhanced" "Detected in some" "HEL: 13.2;K-562: 10.5;RPMI-8226: 12.0;U-266/70: 14.5;U-87 MG: 8.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 4.8" "Group enriched" "Detected in many" 15 "amygdala: 22.5;basal ganglia: 24.3;cerebral cortex: 32.6;hippocampal formation: 23.0;olfactory region: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 9 "amygdala: 111.1;basal ganglia: 75.7;cerebral cortex: 76.7;hippocampal formation: 105.7;olfactory region: 63.4" "Group enriched" "Detected in many" 14 "amygdala: 58.8;basal ganglia: 55.2;cerebral cortex: 67.5;hippocampal formation: 103.7;olfactory region: 57.5" "HPA008943, HPA009083, CAB025178" Enhanced 2400000 "CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094" "unprognostic (7.76e-2)" "unprognostic (1.91e-1)" "unprognostic (1.66e-2)" "unprognostic (4.24e-2)" "unprognostic (8.23e-3)" "unprognostic (2.58e-1)" "unprognostic (8.12e-2)" "unprognostic (9.99e-3)" "unprognostic (2.58e-1)" "unprognostic (2.44e-2)" "unprognostic (3.90e-3)" "unprognostic (9.89e-3)" "unprognostic (5.29e-5)" "unprognostic (6.47e-2)" "unprognostic (4.86e-2)" "unprognostic (5.44e-3)" "unprognostic (6.28e-3)" 0.8 0.9 22.5 0.8 24.3 2.0 0.9 0.0 32.6 0.8 0.8 1.0 0.0 0.8 0.8 0.8 0.8 0.9 0.8 1.0 23.0 1.4 1.1 0.8 3.6 1.2 0.9 15.9 1.4 0.8 0.8 0.1 1.1 0.0 0.9 0.8 0.0 0.8 0.9 0.8 0.8 1.0 0.8 0.1 1.0 1.0 1.9 1.6 0.0 0.8 0.0 0.9 0.8 0.3 0.0 0.0 0.4 0.0 0.0 0.4 0.0 2.8 0.0 0.0 6.1 0.0 0.0 0.1 4.3 0.7 0.1 0.4 0.0 0.1 4.6 1.9 0.0 5.3 0.2 0.0 0.0 0.1 0.9 13.2 4.2 0.4 0.1 0.0 2.6 0.0 0.5 0.1 0.0 0.0 10.5 0.1 0.0 0.6 0.0 1.8 0.0 4.3 0.1 0.0 12.0 0.2 0.0 0.8 0.1 1.9 0.1 0.3 2.2 0.0 0.0 1.3 0.0 0.6 0.0 14.5 2.3 2.6 8.6 0.0 1.3 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 24.3 0.0 32.6 23.0 1.4 0.9 15.9 0.0 1.6 ID4 bHLHb27 ENSG00000172201 "Inhibitor of DNA binding 4, HLH protein" P47928 6 19837386-19840684 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "thyroid gland: 154.6" "Cell line enhanced" "Detected in some" "AF22: 16.9;AN3-CA: 22.2;EFO-21: 50.7;HEK 293: 28.4;SCLC-21H: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060800 Supported Nucleoplasm Nucleoplasm "HPA060800: " "unprognostic (3.25e-3)" "unprognostic (7.37e-3)" "unprognostic (1.80e-1)" "unprognostic (6.34e-3)" "unprognostic (4.17e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-1)" "unprognostic (2.87e-1)" "unprognostic (1.65e-2)" "prognostic favourable (2.49e-4)" "unprognostic (7.26e-2)" "unprognostic (1.66e-3)" "unprognostic (2.41e-2)" "unprognostic (3.13e-2)" "unprognostic (1.03e-3)" "unprognostic (2.57e-3)" 33.1 2.1 29.3 5.3 29.6 1.1 16.9 13.2 31.1 21.1 5.1 29.0 7.2 4.9 22.9 7.0 12.1 34.1 6.8 25.2 32.3 20.6 11.7 2.4 14.6 3.5 14.5 19.0 22.9 11.8 2.0 13.1 13.2 24.9 18.7 4.6 5.7 16.0 26.6 1.8 31.3 4.0 14.2 12.5 11.4 11.9 10.8 20.0 0.0 154.6 4.4 3.5 10.5 11.5 1.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 16.9 22.2 0.5 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.0 50.7 5.7 8.6 0.0 0.0 0.2 0.0 28.4 0.0 0.0 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.4 0.0 0.0 0.0 0.0 3.0 6.0 45.8 0.6 0.0 0.7 2.9 1.4 0.0 0.0 0.1 2.6 0.0 0.7 0.0 0.0 0.5 0.7 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 29.3 29.6 13.2 19.2 32.3 20.6 14.5 19.0 24.9 20.0 IDI2 IPPI2 ENSG00000148377 "Isopentenyl-diphosphate delta isomerase 2" Q9BXS1 10 1018907-1025859 "Enzymes, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 125 "skeletal muscle: 141.6" "Cell line enhanced" "Detected in some" "HEL: 1.3;NB-4: 2.6;NTERA-2: 1.5;SK-MEL-30: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "unprognostic (6.69e-3)" "unprognostic (4.05e-2)" "unprognostic (1.64e-1)" 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 141.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.7 0.5 0.1 0.0 0.7 0.0 0.8 0.1 0.0 1.0 0.0 0.0 0.4 0.4 0.8 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.7 0.0 0.5 0.0 0.3 0.9 1.3 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 2.6 1.5 0.0 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 3.4 1.0 0.1 0.0 0.1 0.1 0.4 0.0 0.2 0.4 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFITM5 "BRIL, fragilis4, Hrmp1" ENSG00000206013 "Interferon induced transmembrane protein 5" A6NNB3 11 298200-299526 "Disease related genes, Predicted membrane proteins" "Mineral balance" "Developmental protein" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 11.7" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;HMC-1: 1.3;Karpas-707: 4.9;NB-4: 1.0;PC-3: 1.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (9.84e-2)" "unprognostic (2.15e-1)" "unprognostic (1.38e-1)" "unprognostic (5.80e-2)" "unprognostic (7.46e-2)" "unprognostic (4.20e-2)" "unprognostic (4.42e-2)" "unprognostic (8.31e-2)" "unprognostic (7.99e-3)" "unprognostic (1.94e-3)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (4.90e-2)" 0.1 0.0 0.1 0.3 0.1 2.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.3 2.2 0.3 0.1 0.1 0.1 11.7 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.0 0.4 0.1 0.1 0.5 0.0 0.2 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.2 1.0 0.0 1.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 IFT122 "SPG, WDR10, WDR10p, WDR140" ENSG00000163913 "Intraflagellar transport 122" Q9HBG6 3 129440036-129520507 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 84.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041815 Uncertain Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA041815: AB_10804118" "unprognostic (7.16e-2)" "unprognostic (3.71e-3)" "unprognostic (3.67e-1)" "unprognostic (7.61e-3)" "unprognostic (5.29e-2)" "unprognostic (5.33e-3)" "unprognostic (4.68e-2)" "unprognostic (1.82e-1)" "unprognostic (7.90e-2)" "unprognostic (3.30e-1)" "unprognostic (1.67e-2)" "unprognostic (3.50e-2)" "unprognostic (1.09e-2)" "unprognostic (7.67e-2)" "unprognostic (5.33e-1)" "unprognostic (9.91e-2)" "unprognostic (4.20e-3)" 7.4 5.7 11.1 4.9 14.0 6.4 9.1 13.3 13.1 10.2 5.6 7.6 6.4 3.5 10.2 9.6 5.4 18.5 5.0 10.0 7.8 6.4 8.8 6.7 6.7 4.5 4.4 9.2 19.0 9.6 13.1 18.9 7.7 7.2 5.7 5.2 10.5 6.3 6.7 3.7 9.9 4.1 7.6 4.2 3.7 6.7 84.7 5.7 7.6 9.6 2.0 4.2 5.3 6.9 4.7 6.0 8.3 5.7 2.8 5.5 3.8 10.8 16.5 14.3 9.4 20.8 14.8 7.6 5.8 8.8 10.2 9.9 7.9 7.2 7.0 6.9 7.5 7.0 5.5 5.1 9.3 3.8 5.9 5.3 13.5 6.7 5.7 14.7 5.0 17.3 3.9 7.8 6.1 13.7 5.4 15.1 8.2 12.0 12.0 7.6 9.5 4.7 10.7 5.5 5.0 10.9 2.0 18.2 7.4 16.7 5.6 5.0 15.3 11.8 6.0 7.2 6.2 9.3 6.9 10.3 7.2 6.1 6.5 7.5 5.5 8.3 5.7 6.6 1.9 3.9 3.3 3.8 3.3 4.5 6.0 4.7 3.7 4.5 2.7 2.8 1.7 1.4 5.5 3.8 11.1 14.0 13.3 13.1 7.8 6.4 4.4 9.2 7.2 5.7 IGF2 "C11orf43, FLJ44734, IGF-II" ENSG00000167244 "Insulin like growth factor 2" P01344 11 2129112-2149603 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism, Osteogenesis" "Growth factor, Hormone, Mitogen" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 330.5" "Cell line enhanced" "Detected in some" "CACO-2: 112.8;Hep G2: 77.4;LHCN-M2: 44.5;RH-30: 55.3;SH-SY5Y: 67.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA007556, HPA007993" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" 609000000 1700000000 Vesicles "Nucleoplasm, Cytosol" "HPA007556: , HPA007993: AB_1851474" "unprognostic (1.54e-1)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" "unprognostic (7.08e-2)" "unprognostic (2.30e-3)" "unprognostic (2.59e-1)" "prognostic favourable (7.12e-4)" "unprognostic (7.92e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (3.69e-2)" "unprognostic (1.85e-1)" "unprognostic (1.79e-3)" "unprognostic (2.00e-2)" "unprognostic (8.98e-2)" "unprognostic (8.93e-3)" "unprognostic (5.78e-2)" 16.6 8.0 1.3 4.5 2.0 0.5 23.3 2.3 1.9 23.4 5.0 3.4 4.7 1.0 9.9 32.0 5.2 17.2 4.5 20.5 1.5 1.6 8.1 39.7 1.9 1.1 3.5 1.6 20.4 5.5 0.7 5.0 330.5 7.6 10.4 1.0 33.2 2.6 6.7 21.9 1.7 2.3 7.5 17.0 2.0 3.2 12.4 0.2 1.8 2.6 14.5 1.8 15.2 14.1 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 14.9 0.1 0.4 0.0 112.8 0.0 0.0 1.1 0.0 0.0 0.1 0.9 1.0 0.0 0.0 0.0 0.0 77.4 19.8 0.0 0.0 24.1 0.0 0.1 0.0 0.1 0.0 0.0 44.5 0.2 0.0 0.1 0.1 0.2 0.0 55.3 0.1 0.0 0.1 4.4 67.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 1.3 2.0 2.3 1.4 1.5 1.6 3.5 1.6 7.6 0.2 IGF2 ENSG00000284779 "Insulin like growth factor 2" 11 2129112-2158658 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "liver: 24.1" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;RH-30: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGF2BP3 "CT98, IMP-3, IMP3" ENSG00000136231 "Insulin like growth factor 2 mRNA binding protein 3" O00425 7 23310209-23470467 "Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "placenta: 74.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 52.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA002037, HPA076951" Enhanced Supported Cytosol Cytosol "HPA002037: AB_1851483, HPA076951: " "unprognostic (5.72e-2)" "unprognostic (3.12e-1)" "unprognostic (7.25e-2)" "unprognostic (3.56e-3)" "unprognostic (1.45e-1)" "unprognostic (3.00e-2)" "unprognostic (2.64e-3)" "unprognostic (3.18e-2)" "unprognostic (2.60e-3)" "unprognostic (3.67e-1)" "unprognostic (1.02e-5)" "unprognostic (8.76e-2)" "unprognostic (0.00e+0)" "unprognostic (1.43e-1)" "unprognostic (7.95e-2)" "unprognostic (2.87e-4)" "unprognostic (7.51e-3)" 0.4 0.2 0.3 0.9 0.2 0.3 0.2 0.2 0.3 0.4 0.3 0.4 0.1 0.0 0.2 1.3 4.8 0.7 0.1 0.5 0.3 0.2 0.2 0.3 1.2 3.4 0.2 0.0 0.2 1.5 0.0 0.2 74.0 0.7 0.2 0.0 0.3 0.7 0.1 0.2 0.2 0.3 0.0 1.2 1.0 0.2 6.5 0.0 11.4 0.6 0.2 6.0 0.2 0.6 1.2 0.4 1.5 1.5 0.0 0.2 3.0 14.5 4.3 32.7 9.7 5.2 13.8 20.0 2.4 11.0 6.1 7.6 13.8 11.6 11.0 13.2 6.5 9.6 14.1 10.8 10.8 1.7 5.6 5.8 11.7 11.5 16.1 10.5 4.1 14.1 7.6 4.7 2.0 52.3 26.4 0.0 14.8 0.0 6.4 7.1 26.1 13.4 9.9 10.9 14.1 12.1 1.3 8.6 18.8 1.4 0.1 12.2 0.0 2.0 21.0 5.9 0.3 12.8 6.3 0.0 4.6 17.3 23.5 11.8 22.6 0.0 1.5 0.0 0.1 0.8 0.0 1.2 0.0 0.0 0.4 0.9 0.2 0.0 1.5 0.0 0.0 0.0 0.0 3.0 0.3 0.2 0.2 0.3 0.3 0.2 0.2 0.0 0.7 0.0 IGFALS ALS ENSG00000099769 "Insulin like growth factor binding protein acid labile subunit" P35858 16 1790413-1794971 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "liver: 107.6" "Cell line enhanced" "Detected in some" "Hep G2: 5.2;T-47d: 2.1;U-266/70: 5.1" "Cancer enhanced" "Detected in many" "liver cancer: 11.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040692, HPA040948" Supported "Secreted to blood" 14650000000 44000000000 "HPA040692: AB_10794067, HPA040948: AB_10794999" "unprognostic (2.74e-3)" "unprognostic (1.95e-1)" "unprognostic (9.13e-2)" "prognostic unfavourable (6.06e-4)" "unprognostic (2.54e-1)" "unprognostic (1.37e-2)" "prognostic favourable (5.97e-4)" "unprognostic (5.54e-4)" "unprognostic (3.00e-1)" "unprognostic (1.17e-1)" "unprognostic (9.06e-2)" "unprognostic (1.05e-2)" "unprognostic (1.10e-1)" "unprognostic (1.49e-1)" "unprognostic (1.23e-1)" "unprognostic (4.39e-1)" "unprognostic (5.51e-2)" 0.1 0.0 0.1 0.1 0.2 0.2 0.1 0.8 0.2 0.1 0.4 0.1 0.1 0.2 0.2 0.1 0.1 0.2 7.4 0.1 0.1 0.2 0.2 107.6 0.4 0.1 0.1 0.1 0.1 0.8 0.0 0.2 0.1 0.4 0.1 0.0 1.4 0.6 0.1 0.2 0.2 0.1 0.1 0.3 0.1 5.0 0.5 0.1 1.7 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 5.2 0.0 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.9 1.0 0.0 1.2 0.2 0.5 0.2 0.0 1.3 0.5 1.5 0.0 0.0 0.4 0.3 0.3 0.0 0.7 2.1 0.2 0.2 0.4 1.4 0.2 0.2 5.1 1.8 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.2 0.1 0.2 0.1 0.1 0.4 0.1 IGFL3 UNQ483 ENSG00000188624 "IGF like family member 3" Q6UXB1 19 46120071-46124674 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 22.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.1;CACO-2: 2.1;hTEC/SVTERT24-B: 2.8;U-2 OS: 3.0;U-87 MG: 5.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 5.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" HPA062776 Uncertain "Secreted in other tissues" "HPA062776: " "unprognostic (8.61e-2)" "unprognostic (6.26e-2)" "unprognostic (2.69e-1)" "unprognostic (4.78e-2)" "unprognostic (7.45e-3)" "unprognostic (2.03e-1)" "unprognostic (7.90e-2)" "unprognostic (1.90e-1)" "unprognostic (1.86e-4)" "unprognostic (2.86e-2)" "unprognostic (1.90e-1)" "unprognostic (3.69e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 2.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 22.4 0.1 0.1 0.1 0.1 0.0 2.9 0.1 1.9 0.1 2.7 0.1 0.1 0.1 1.5 0.2 0.0 0.2 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.1 0.6 0.5 2.1 0.3 0.0 0.4 0.0 0.1 0.0 0.0 1.4 0.3 0.0 0.0 0.6 0.3 0.0 0.0 0.1 1.1 0.5 2.8 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.1 0.6 0.0 0.2 5.4 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.6 0.6 0.1 0.2 0.2 1.5 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 IGFN1 "DKFZp434B1231, EEF1A2BP1" ENSG00000163395 "Immunoglobulin-like and fibronectin type III domain containing 1" Q86VF2 1 201190825-201228952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skeletal muscle: 118.8" "Cell line enriched" "Detected in some" 9 "HeLa: 36.8" "Group enriched" "Detected in some" 11 "renal cancer: 1.8;thyroid cancer: 8.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA050415 Enhanced Approved "Midbody ring" "Midbody ring" "HPA050415: " "unprognostic (2.09e-1)" "unprognostic (1.63e-3)" "unprognostic (1.82e-2)" "unprognostic (3.25e-1)" "unprognostic (1.02e-2)" "unprognostic (2.00e-2)" "unprognostic (9.80e-3)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (1.51e-1)" "unprognostic (2.07e-1)" "unprognostic (3.80e-2)" "prognostic unfavourable (1.27e-8)" "unprognostic (3.55e-4)" "unprognostic (6.06e-2)" "unprognostic (1.10e-1)" "unprognostic (5.42e-2)" 0.5 0.0 0.6 0.1 0.4 0.0 0.1 0.4 1.4 0.3 0.2 0.3 0.1 0.0 4.3 6.4 0.1 0.3 0.1 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.3 0.2 0.3 4.6 0.0 0.7 0.1 1.7 0.2 0.0 1.6 0.1 0.1 118.8 0.0 0.1 0.3 0.1 0.1 0.0 1.1 0.2 0.1 11.3 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 2.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.4 0.3 0.3 0.2 0.3 0.2 1.7 0.2 IGSF1 "IGCD1, IGDC1, INHBP, KIAA0364, MGC75490, PGSF2" ENSG00000147255 "Immunoglobulin superfamily member 1" Q8N6C5 X 131273506-131578899 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "pituitary gland: 138.7" "Group enriched" "Detected in some" 5 "Hep G2: 23.0;SH-SY5Y: 20.7" "Cancer enriched" "Detected in many" 8 "thyroid cancer: 65.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA012732, HPA035582" Enhanced Approved Cytosol "Intracellular and membrane" 430000 Cytosol "HPA012732: AB_2732404, HPA035582: AB_2674687" "unprognostic (1.40e-3)" "unprognostic (1.79e-1)" "unprognostic (4.11e-1)" "prognostic unfavourable (4.25e-8)" "unprognostic (1.01e-1)" "unprognostic (2.40e-2)" "unprognostic (1.90e-3)" "unprognostic (2.52e-3)" "unprognostic (8.03e-3)" "unprognostic (9.36e-2)" "unprognostic (5.65e-2)" "unprognostic (1.13e-1)" "unprognostic (1.38e-1)" "unprognostic (5.96e-2)" "unprognostic (1.66e-1)" "unprognostic (2.35e-1)" "unprognostic (5.13e-2)" 0.8 11.9 1.4 0.4 5.3 0.0 2.7 0.6 6.2 2.7 0.5 3.3 1.2 0.2 1.1 1.5 1.3 1.6 0.8 5.6 3.3 15.4 0.5 1.5 0.2 0.0 3.8 1.9 1.0 1.7 0.0 138.7 0.6 4.7 3.9 0.2 2.2 2.0 6.4 0.3 0.6 0.4 3.2 2.7 0.2 0.5 11.8 1.9 0.2 5.3 0.8 0.5 0.6 0.5 0.6 0.4 1.5 0.3 0.3 0.3 0.2 0.3 0.4 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.1 0.0 0.0 1.2 0.0 0.0 4.0 0.3 0.0 1.7 23.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 1.9 20.7 0.0 0.2 0.0 0.4 0.0 0.0 0.3 0.6 0.0 2.3 0.7 0.3 0.0 0.0 0.0 0.0 1.5 0.3 0.2 0.2 0.1 0.2 0.3 0.3 0.3 0.1 0.6 0.3 0.2 1.2 0.3 0.1 0.4 0.3 0.2 1.4 5.3 0.6 2.3 3.3 15.4 3.8 1.9 4.7 1.9 IGSF22 "FLJ37794, IGFN2" ENSG00000179057 "Immunoglobulin superfamily member 22" Q8N9C0 11 18704305-18726230 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "salivary gland: 22.7" "Cell line enhanced" "Detected in single" "RH-30: 2.9" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in some" "basal ganglia: 3.9" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" CAB026459 Uncertain "CAB026459: " "unprognostic (4.05e-2)" "unprognostic (3.65e-2)" "unprognostic (2.34e-2)" "unprognostic (1.84e-1)" "unprognostic (1.23e-1)" "unprognostic (8.93e-2)" "unprognostic (1.02e-1)" "unprognostic (8.38e-2)" "unprognostic (8.70e-2)" "unprognostic (4.24e-2)" "unprognostic (1.99e-4)" "unprognostic (9.35e-2)" "unprognostic (3.72e-4)" "unprognostic (2.87e-1)" "unprognostic (2.18e-1)" "unprognostic (3.43e-1)" "unprognostic (7.94e-3)" 0.3 0.1 0.7 0.2 3.9 0.0 0.2 0.2 2.3 0.2 0.2 0.2 0.2 0.6 0.3 0.2 0.2 0.1 0.7 0.3 0.4 1.5 0.2 0.2 0.2 0.3 0.3 0.2 1.2 0.5 0.0 0.5 0.2 0.2 0.2 0.0 0.2 22.7 0.2 0.5 4.6 0.4 0.2 0.2 0.2 0.0 2.2 0.2 0.2 0.2 1.3 0.3 0.5 0.2 0.2 0.0 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.1 0.2 0.7 3.9 0.2 1.1 0.4 1.5 0.3 0.2 0.2 0.2 IL13 "ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600" ENSG00000169194 "Interleukin 13" P35225 5 132656263-132661110 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 20.7" "Cell line enriched" "Detected in single" 177 "HDLM-2: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042421 Approved "Plasma membrane,Cytosol" "Secreted to blood" 33773 "Plasma membrane, Cytosol" "HPA042421: AB_10795504" "unprognostic (2.17e-1)" "unprognostic (2.29e-2)" "unprognostic (7.48e-2)" "unprognostic (2.18e-2)" "unprognostic (1.92e-1)" "unprognostic (5.21e-3)" "unprognostic (1.79e-1)" "unprognostic (2.69e-1)" "unprognostic (5.20e-1)" "unprognostic (7.10e-2)" "unprognostic (3.61e-3)" "unprognostic (3.34e-1)" "unprognostic (5.97e-4)" "unprognostic (4.70e-2)" "unprognostic (2.05e-1)" "unprognostic (7.39e-2)" "unprognostic (1.38e-1)" 0.3 0.0 0.1 0.8 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.1 3.0 0.0 0.0 0.1 0.0 0.0 1.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.2 0.2 0.6 0.0 0.0 0.0 0.0 20.7 0.0 2.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 IL1RAPL1 "IL1R8, IL1RAPL, MRX10, MRX21, MRX34, OPHN4, TIGIRR-2" ENSG00000169306 "Interleukin 1 receptor accessory protein like 1" Q9NZN1 X 28587399-29956723 "Disease related genes, Plasma proteins, Predicted membrane proteins" Receptor "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 26.7" "Cell line enhanced" "Detected in some" "LHCN-M2: 1.5;SK-MEL-30: 2.0;U-2 OS: 1.9;WM-115: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (2.51e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (3.75e-3)" "unprognostic (1.17e-1)" "unprognostic (3.98e-1)" "unprognostic (2.25e-2)" "unprognostic (4.45e-2)" "unprognostic (1.29e-1)" "unprognostic (5.85e-2)" "unprognostic (3.95e-2)" "unprognostic (8.02e-2)" "unprognostic (1.08e-2)" "unprognostic (5.74e-4)" "unprognostic (2.29e-1)" "unprognostic (5.22e-2)" "unprognostic (3.58e-3)" 1.5 1.0 12.9 1.0 21.8 0.9 1.5 6.9 17.2 1.2 1.5 15.0 0.0 1.1 1.2 1.5 1.7 1.0 1.5 2.7 10.9 3.3 1.1 1.8 1.1 1.1 21.7 10.1 2.3 1.2 1.0 1.5 1.6 12.3 2.1 1.5 0.0 1.2 2.1 2.2 0.9 1.7 1.2 9.9 0.9 1.4 1.6 26.7 0.0 1.7 0.0 1.0 2.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.6 0.4 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.3 0.0 1.1 0.1 0.0 1.5 0.0 0.0 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 7.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 21.8 6.9 17.2 10.9 3.3 21.7 10.1 12.3 26.7 IL20 "IL-20, IL10D, ZCYTO10" ENSG00000162891 "Interleukin 20" Q9NYY1 1 206865354-206869223 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "seminal vesicle: 19.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.8;hTCEpi: 1.0;SiHa: 5.8;SK-MEL-30: 2.6" "Cancer enhanced" "Detected in some" "breast cancer: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB025802 Uncertain "Secreted to blood" 108507 "CAB025802: " "unprognostic (3.08e-2)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (1.16e-2)" "unprognostic (6.45e-2)" "unprognostic (3.36e-2)" "unprognostic (1.01e-1)" "unprognostic (3.46e-1)" "unprognostic (1.60e-1)" "unprognostic (3.38e-2)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" 4.6 2.2 0.2 0.2 0.2 0.0 1.3 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.8 0.2 0.4 0.7 1.3 0.2 0.2 0.0 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.3 0.0 0.2 0.6 19.5 0.2 3.8 0.2 3.2 0.2 0.2 0.0 1.0 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.8 0.0 2.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 IL21 "IL-21, Za11" ENSG00000138684 "Interleukin 21" Q9HBE4 4 122612628-122621069 "Disease related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 16.1" "Group enriched" "Detected in some" 4 "HeLa: 4.2;Karpas-707: 1.1;SiHa: 3.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "memory CD4 T-cell: 2.2;T-reg: 1.0" "Lineage enriched" "Detected in single" 22 "T-cells: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted to blood" 55657 "unprognostic (2.42e-1)" "unprognostic (2.12e-1)" "unprognostic (6.80e-2)" 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 3.5 0.1 7.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 IL22RA1 "CRF2-9, IL22R" ENSG00000142677 "Interleukin 22 receptor subunit alpha 1" Q8N6P7 1 24119771-24143121 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "pancreas: 123.4" "Cell line enhanced" "Detected in some" "CACO-2: 13.1;CAPAN-2: 5.7;HaCaT: 6.0;Hep G2: 9.3;U-266/70: 5.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.68e-3)" "unprognostic (2.53e-1)" "unprognostic (1.09e-1)" "unprognostic (2.00e-3)" "unprognostic (1.48e-1)" "unprognostic (3.28e-1)" "unprognostic (1.74e-1)" "unprognostic (1.59e-3)" "unprognostic (1.12e-1)" "unprognostic (7.63e-2)" "unprognostic (1.72e-3)" "unprognostic (2.28e-1)" "unprognostic (4.78e-3)" "unprognostic (1.05e-2)" "unprognostic (2.57e-1)" "unprognostic (2.63e-1)" "unprognostic (1.64e-2)" 0.2 0.1 0.2 1.1 0.3 0.0 0.8 0.6 0.3 1.2 10.9 0.2 0.5 7.8 0.4 0.6 5.2 0.4 3.2 0.2 0.2 0.0 2.8 2.0 0.4 0.1 0.2 0.1 0.4 123.4 0.0 1.0 0.4 0.4 0.4 3.9 0.2 0.9 0.3 0.2 12.9 22.3 0.1 0.2 0.2 1.2 0.3 0.3 0.1 0.7 4.6 3.6 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.7 0.1 3.3 2.4 0.0 0.0 0.0 0.0 0.3 0.0 1.2 1.6 1.9 13.1 5.7 0.0 1.1 0.3 6.0 0.8 3.5 0.6 4.3 0.0 0.0 1.7 9.3 0.0 0.0 0.0 0.0 2.1 0.5 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.2 1.2 0.0 0.1 0.2 0.0 0.7 0.1 0.1 1.7 0.0 1.9 0.8 0.0 0.0 0.0 2.0 0.1 0.1 5.1 1.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.6 0.3 0.2 0.0 0.2 0.1 0.4 0.3 IL31 IL-31 ENSG00000204671 "Interleukin 31" Q6EBC2 12 122172030-122174199 "Predicted secreted proteins" Immunity Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 1.9" "Group enriched" "Detected in some" 11 "HDLM-2: 1.3;Karpas-707: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB025657 Uncertain "Secreted to blood" 37797 "CAB025657: " "unprognostic (1.70e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL37 "FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7" ENSG00000125571 "Interleukin 37" Q9NZH6 2 112912971-112918882 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 55.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.8;PC-3: 10.4;RT4: 5.5" "Cancer enriched" "Detected in some" 6 "lung cancer: 6.5" "Cell type enriched" "Detected in single" 28 "NK-cell: 2.8" "Lineage enriched" "Detected in single" 28 "NK-cells: 2.8" "HPA054371, HPA057950" Uncertain Supported Nucleoplasm,Vesicles "Secreted to blood" 76703 "Nucleoplasm, Vesicles" "HPA054371: , HPA057950: " "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" "unprognostic (3.71e-5)" "unprognostic (1.11e-1)" "unprognostic (2.58e-2)" "unprognostic (1.09e-2)" "unprognostic (1.28e-2)" "unprognostic (9.54e-2)" "unprognostic (8.26e-3)" "unprognostic (3.95e-2)" "unprognostic (1.66e-1)" "unprognostic (8.92e-2)" "unprognostic (1.35e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 55.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.9 0.0 0.8 0.1 0.0 0.0 0.2 0.4 4.8 0.3 0.5 0.4 0.5 0.0 0.5 0.3 0.1 0.2 0.8 1.5 0.3 0.0 1.8 0.2 0.8 0.0 0.0 0.3 0.0 0.0 0.5 1.2 0.0 0.0 0.1 1.1 0.0 0.0 1.4 0.5 10.4 0.1 0.0 0.0 0.0 5.5 0.4 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 IL4 "BCGF-1, BCGF1, BSF1, IL-4, MGC79402" ENSG00000113520 "Interleukin 4" P05112 5 132673986-132682676 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "B-cell activation" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "blood: 73.8" "Cell line enriched" "Detected in some" 5 "MOLT-4: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 679 "basophil: 73.8" "Lineage enriched" "Detected in single" 679 "granulocytes: 73.8" "Low region specificity" "Detected in many" HPA072995 Approved "Secreted to blood" 7157 "HPA072995: " "unprognostic (3.40e-2)" "unprognostic (9.19e-2)" "unprognostic (1.41e-1)" "unprognostic (2.49e-1)" "unprognostic (2.02e-1)" "unprognostic (1.96e-1)" "unprognostic (1.69e-1)" "unprognostic (7.33e-2)" "unprognostic (2.26e-2)" "unprognostic (1.96e-1)" "unprognostic (1.47e-10)" "unprognostic (9.21e-3)" "unprognostic (2.88e-1)" "unprognostic (4.93e-2)" "unprognostic (1.24e-2)" 0.4 1.2 0.3 1.1 0.3 0.9 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.0 1.1 0.3 0.7 0.8 0.8 0.3 0.3 0.1 0.5 0.3 4.6 1.1 0.3 0.3 0.3 0.3 3.7 1.4 0.3 0.3 0.4 0.0 0.3 0.4 0.3 0.3 1.6 1.0 0.3 0.3 0.7 0.2 1.0 0.3 1.3 0.8 0.3 0.3 0.3 0.3 0.0 0.0 73.8 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 73.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.4 0.3 0.3 0.1 0.3 0.3 0.3 0.3 IMPG1 "GP147, IPM150, SPACR" ENSG00000112706 "Interphotoreceptor matrix proteoglycan 1" Q17R60 6 75921115-76072678 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "retina: 110.5" "Cell line enhanced" "Detected in some" "A-431: 2.0;AF22: 2.9;HaCaT: 4.0;TIME: 2.4" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "basal ganglia: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027142, HPA030332, HPA030333" Enhanced "Secreted in other tissues" "HPA027142: AB_2672132, HPA030332: AB_2673432, HPA030333: AB_2673433" "unprognostic (6.65e-2)" "unprognostic (4.13e-2)" "unprognostic (1.20e-1)" "unprognostic (8.69e-2)" "unprognostic (1.22e-1)" "unprognostic (5.49e-3)" "unprognostic (5.97e-2)" "unprognostic (3.56e-3)" "unprognostic (1.89e-2)" "unprognostic (2.20e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-3)" "unprognostic (2.84e-1)" "unprognostic (1.73e-2)" "unprognostic (2.09e-1)" "unprognostic (6.01e-2)" "unprognostic (1.96e-2)" 0.6 0.0 0.4 0.4 10.3 0.0 0.4 1.0 2.8 0.4 0.4 0.4 0.4 2.8 0.4 0.4 0.4 0.1 1.1 0.5 0.5 0.4 0.8 0.4 0.5 0.4 0.5 0.4 0.4 5.4 0.0 0.4 0.6 0.4 0.7 0.0 110.5 0.6 0.4 0.6 4.0 2.3 0.4 0.4 0.5 0.7 0.9 0.4 0.4 0.8 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.1 2.9 0.0 0.0 0.6 1.5 0.8 0.0 0.0 0.0 1.7 0.6 0.0 0.3 0.0 4.0 0.0 0.0 0.0 0.1 1.5 0.7 0.1 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.6 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.7 0.7 1.2 0.0 1.8 0.3 0.0 0.3 2.4 0.4 0.0 0.0 0.2 0.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.3 1.0 1.9 0.5 0.4 0.5 0.4 0.4 0.4 IMPG2 "IPM200, RP56" ENSG00000081148 "Interphotoreceptor matrix proteoglycan 2" Q9BZV3 3 101222546-101320560 "Disease related genes, Predicted membrane proteins" "Heparin-binding, Receptor" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "retina: 72.1" "Low cell line specificity" "Detected in some" "Cancer enriched" "Detected in single" 12 "ovarian cancer: 2.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008779, HPA015907" Enhanced "HPA008779: , HPA015907: " "unprognostic (2.00e-1)" "unprognostic (4.91e-2)" "unprognostic (1.40e-1)" "unprognostic (9.58e-3)" "unprognostic (1.28e-1)" "unprognostic (4.80e-5)" "unprognostic (6.66e-4)" "unprognostic (1.85e-1)" "unprognostic (1.09e-1)" "unprognostic (6.59e-2)" "unprognostic (7.51e-3)" "unprognostic (1.28e-1)" "unprognostic (4.50e-9)" "unprognostic (7.12e-2)" "unprognostic (2.70e-1)" "unprognostic (2.81e-2)" "unprognostic (6.08e-2)" 0.2 0.3 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.1 0.1 0.3 0.3 0.1 16.5 0.2 0.3 0.3 0.6 0.3 0.1 0.1 0.4 0.5 0.1 0.4 0.2 0.1 0.4 0.1 0.4 0.2 0.2 72.1 0.2 0.1 0.2 0.2 0.4 0.3 0.2 0.6 0.5 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.6 0.1 1.0 0.1 1.1 0.3 0.0 0.1 0.0 1.1 1.3 0.4 1.0 0.1 0.1 0.2 0.3 0.5 0.0 0.1 0.1 1.0 0.1 0.0 0.3 0.1 1.1 0.3 0.3 0.5 0.4 0.1 0.1 0.3 1.9 1.3 0.7 0.2 0.0 1.7 0.0 1.2 0.9 0.1 0.2 0.2 0.0 0.3 0.2 0.0 0.1 0.7 0.3 1.6 0.2 0.0 0.0 0.1 0.2 0.4 1.4 1.2 0.6 0.4 0.7 0.6 1.0 0.2 0.0 0.0 1.2 0.6 0.1 0.3 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.3 1.0 1.1 0.1 0.1 0.1 0.0 0.2 0.4 0.2 0.2 0.3 0.6 0.5 0.1 0.4 0.1 INA "NEF5, NF-66" ENSG00000148798 "Internexin neuronal intermediate filament protein alpha" Q16352 10 103277163-103290351 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 65.4" "Cell line enhanced" "Detected in some" "NTERA-2: 20.6;SCLC-21H: 40.5;SH-SY5Y: 23.0;SiHa: 27.4" "Cancer enhanced" "Detected in many" "testis cancer: 18.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002059, HPA007572, HPA008057" Enhanced Supported Approved "Intermediate filaments" "Intermediate filaments" "CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833" "unprognostic (1.77e-1)" "unprognostic (2.50e-2)" "unprognostic (9.54e-2)" "unprognostic (5.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.45e-3)" "unprognostic (1.31e-1)" "unprognostic (2.29e-2)" "unprognostic (2.08e-2)" "unprognostic (1.98e-1)" "unprognostic (8.09e-3)" "unprognostic (3.07e-2)" "unprognostic (1.78e-3)" "unprognostic (1.66e-1)" "unprognostic (1.90e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" 1.5 15.7 16.6 2.6 21.3 1.3 1.3 26.9 65.2 1.3 2.7 2.3 0.0 2.0 1.3 1.4 1.9 1.3 1.5 1.3 13.2 34.0 1.3 1.4 1.5 1.4 27.2 17.7 1.3 3.6 1.3 12.8 1.5 65.4 1.5 2.8 5.5 1.3 1.4 1.3 2.2 2.5 2.2 7.9 1.3 2.6 4.1 3.3 0.0 1.5 0.0 1.5 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 4.6 0.0 0.0 0.0 7.5 5.1 1.2 1.2 0.1 0.0 0.0 0.0 2.1 0.3 0.7 4.2 0.0 0.3 9.2 1.9 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.0 20.6 0.0 0.0 0.0 0.0 3.2 0.0 40.5 23.0 27.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 1.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 21.3 26.9 42.0 13.2 34.0 27.2 17.7 65.4 3.3 INCA1 ENSG00000196388 "Inhibitor of CDK, cyclin A1 interacting protein 1" Q0VD86 17 4988130-4997610 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 41.6" "Cell line enhanced" "Detected in many" "Daudi: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044359, HPA052401" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA044359: AB_10794289, HPA052401: " "unprognostic (1.78e-2)" "unprognostic (9.38e-2)" "unprognostic (4.08e-2)" "unprognostic (9.81e-2)" "unprognostic (1.22e-2)" "unprognostic (1.02e-2)" "unprognostic (9.54e-3)" "unprognostic (7.88e-2)" "unprognostic (2.68e-1)" "unprognostic (2.66e-2)" "prognostic favourable (3.61e-5)" "unprognostic (3.14e-2)" "unprognostic (1.68e-1)" "unprognostic (9.54e-2)" "unprognostic (2.04e-1)" "unprognostic (1.17e-1)" "unprognostic (1.05e-1)" 1.7 2.2 5.5 3.5 6.3 0.5 2.5 10.1 7.2 2.3 2.2 3.1 1.0 7.0 3.3 1.6 3.1 2.0 4.5 3.9 4.9 2.1 2.3 2.6 2.7 5.0 5.1 3.0 5.5 2.2 0.9 4.4 1.6 5.9 2.7 0.3 1.7 3.6 1.5 6.1 5.0 4.9 1.2 4.1 4.3 3.1 41.6 3.6 0.5 5.2 1.3 0.4 2.8 9.4 1.5 1.3 0.7 4.4 0.3 2.4 0.6 3.9 4.5 3.2 3.0 2.2 0.9 3.8 4.3 0.4 1.1 1.2 3.2 4.7 18.8 2.9 1.1 11.2 0.5 0.2 0.7 7.8 4.8 4.0 5.4 2.1 1.5 0.6 10.0 1.2 0.0 0.6 0.3 0.4 5.1 8.9 0.8 2.0 5.7 1.3 1.4 1.2 7.0 1.6 1.7 0.8 1.2 9.6 2.9 2.1 2.7 2.5 5.6 0.9 8.6 4.0 1.5 3.9 3.2 1.5 0.7 0.9 4.0 10.0 2.0 0.5 2.4 0.0 0.8 4.4 2.0 1.5 1.2 1.7 0.9 1.0 2.4 1.9 0.7 0.3 3.4 1.3 0.7 0.6 5.5 6.3 10.1 7.2 4.9 2.1 5.1 3.0 5.9 3.6 INHBA ENSG00000122641 "Inhibin beta A subunit" P08476 7 41667168-41705834 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Growth factor, Hormone" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "placenta: 148.2" "Cell line enhanced" "Detected in many" "HBEC3-KT: 19.5;hTEC/SVTERT24-B: 59.6;hTERT-HME1: 24.7;TIME: 30.7;U-138 MG: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.8;non-classical monocyte: 1.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to blood" 290000 "unprognostic (4.11e-3)" "prognostic unfavourable (1.46e-5)" "unprognostic (4.22e-2)" "unprognostic (1.08e-1)" "unprognostic (5.18e-2)" "prognostic unfavourable (4.34e-4)" "unprognostic (2.05e-2)" "prognostic unfavourable (7.72e-4)" "unprognostic (1.44e-1)" "unprognostic (1.31e-1)" "unprognostic (1.23e-2)" "unprognostic (2.04e-1)" "prognostic unfavourable (7.91e-8)" "unprognostic (6.22e-3)" "unprognostic (1.11e-2)" "unprognostic (3.25e-2)" "unprognostic (3.18e-3)" 1.7 1.0 1.2 3.6 3.7 6.6 1.3 0.7 3.5 1.7 1.5 0.8 1.3 0.3 13.6 4.2 3.8 1.6 17.3 9.3 1.9 1.6 2.0 7.9 26.4 0.6 1.2 0.7 5.2 1.2 0.0 0.8 148.2 4.8 2.4 0.2 1.4 4.3 3.8 1.2 2.9 0.8 3.8 8.7 0.4 1.5 3.9 1.3 0.4 1.5 2.6 0.7 4.8 1.8 0.2 0.7 1.8 1.3 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.8 1.9 0.0 4.7 0.5 2.6 0.8 0.0 0.1 0.0 0.3 1.7 3.9 0.0 19.5 2.5 1.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 1.8 1.1 59.6 24.7 2.1 0.1 0.0 5.9 0.0 0.0 0.1 0.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.8 0.1 0.0 0.0 0.0 30.7 46.4 13.4 4.9 4.8 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 1.8 0.0 1.3 0.0 0.0 0.3 1.2 3.7 0.7 1.3 1.9 1.6 1.2 0.7 4.8 1.3 INHBC ENSG00000175189 "Inhibin beta C subunit" P55103 12 57434760-57450828 "Plasma proteins, Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 256 "liver: 121.3" "Cell line enhanced" "Detected in some" "Hep G2: 9.6;Karpas-707: 9.8;RH-30: 4.9;U-266/70: 5.0" "Cancer enriched" "Detected in single" 85 "liver cancer: 22.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" 11000000 "unprognostic (5.26e-2)" "unprognostic (4.58e-1)" "unprognostic (3.43e-3)" "unprognostic (4.08e-3)" "unprognostic (3.76e-1)" "unprognostic (1.98e-2)" "unprognostic (1.03e-2)" "unprognostic (1.10e-1)" "unprognostic (1.34e-1)" "unprognostic (1.23e-1)" "unprognostic (6.10e-2)" "unprognostic (2.48e-2)" "unprognostic (1.68e-4)" "unprognostic (2.90e-2)" "unprognostic (1.52e-1)" "unprognostic (3.55e-3)" "unprognostic (5.05e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.2 0.1 0.0 0.2 0.2 0.1 0.1 1.5 0.1 0.5 0.0 9.6 0.0 0.4 0.1 0.3 0.0 0.0 0.6 0.0 0.1 9.8 0.0 0.2 0.1 0.0 0.0 0.1 0.3 4.9 0.7 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.0 0.5 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 INHBE "activin, MGC4638" ENSG00000139269 "Inhibin beta E subunit" P58166 12 57452323-57459280 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 40 "liver: 127.6" "Cell line enhanced" "Detected in some" "HHSteC: 14.8;Karpas-707: 22.3;U-266/70: 75.2" "Cancer enriched" "Detected in some" 27 "liver cancer: 34.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory region: 0.5" "HPA016843, CAB034017" Enhanced Supported Vesicles "Secreted to blood" 1400000 Vesicles "CAB034017: AB_2233745, HPA016843: AB_1851796" "unprognostic (7.34e-2)" "unprognostic (6.73e-2)" "unprognostic (3.45e-1)" "unprognostic (4.69e-5)" "unprognostic (2.61e-1)" "unprognostic (2.50e-1)" "unprognostic (3.13e-1)" "unprognostic (1.24e-1)" "unprognostic (8.79e-3)" "unprognostic (1.44e-1)" "unprognostic (3.22e-1)" "unprognostic (2.70e-1)" "prognostic unfavourable (5.66e-8)" "unprognostic (4.09e-3)" "unprognostic (1.56e-1)" "unprognostic (3.57e-2)" "unprognostic (7.52e-3)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 127.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 1.0 0.9 3.1 0.6 0.6 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.8 2.1 0.0 2.6 0.1 0.0 1.0 0.5 0.2 0.1 0.5 0.0 0.3 4.9 0.0 0.0 0.0 3.2 14.8 0.6 0.6 1.4 1.5 0.3 3.3 0.0 1.3 22.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 2.3 0.0 0.0 5.5 0.2 0.0 0.0 2.1 0.1 2.4 0.0 0.0 1.2 0.0 0.1 75.2 2.3 1.0 0.4 0.1 0.1 1.9 0.5 0.5 0.3 0.4 0.4 0.9 0.1 0.2 0.1 1.0 0.2 0.5 3.1 0.6 0.6 0.9 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 INS "IDDM1, IDDM2" ENSG00000254647 Insulin P01308 11 2159779-2161341 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism" Hormone "Cancer-related genes, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 193 "pancreas: 514.0" "Group enriched" "Detected in some" 9 "EFO-21: 52.5;U-2 OS: 68.8;U-698: 21.7" "Cancer enriched" "Detected in single" 7166 "pancreatic cancer: 1751.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "midbrain: 1.7" "CAB000048, HPA004932, CAB012098, CAB053843" Enhanced "Secreted to blood" 437220 "CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816" "unprognostic (7.61e-2)" 0.4 0.1 0.1 0.1 0.1 1.1 0.1 0.1 0.7 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 1.4 0.1 0.1 0.1 0.1 0.1 0.1 514.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 2.6 0.1 0.1 0.1 0.1 1.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.8 0.0 5.2 0.0 2.4 21.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 INS-IGF2 ENSG00000129965 "INS-IGF2 readthrough" F8WCM5 11 2132538-2161209 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 148 "pancreas: 467.6" "Group enriched" "Detected in some" 5 "SCLC-21H: 2.1;SH-SY5Y: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB019430 Enhanced "Secreted to digestive system" "CAB019430: AB_10691857" "unprognostic (1.33e-1)" "unprognostic (2.34e-1)" 0.1 0.4 0.1 0.0 0.2 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.3 0.1 0.0 0.3 0.0 0.4 467.6 0.0 0.1 3.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.1 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.3 0.1 0.3 0.0 0.0 0.0 INSL3 "MGC119818, MGC119819, RLF, RLNL" ENSG00000248099 "Insulin like 3" P51460 19 17816512-17821574 "Disease related genes, Predicted secreted proteins" Hormone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 234.1" "Cell line enhanced" "Detected in some" "Karpas-707: 8.8;PC-3: 4.0;SCLC-21H: 8.0;SH-SY5Y: 7.2" "Cancer enriched" "Detected in many" 21 "testis cancer: 39.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA028615 Enhanced "Secreted to blood" 566000 "HPA028615: AB_10600717" "unprognostic (3.25e-1)" "unprognostic (2.25e-4)" "unprognostic (3.50e-5)" "unprognostic (7.04e-2)" "unprognostic (1.74e-4)" "unprognostic (4.60e-2)" "unprognostic (2.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.44e-1)" "unprognostic (1.73e-1)" "unprognostic (4.46e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-10)" "unprognostic (6.80e-3)" "unprognostic (1.41e-1)" "unprognostic (8.85e-2)" "unprognostic (1.09e-5)" 0.1 0.4 0.1 1.1 0.2 0.3 0.1 0.2 0.6 0.1 0.1 0.1 0.1 0.3 0.1 1.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.1 0.1 9.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 1.1 0.1 234.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 2.4 0.3 5.7 1.2 1.3 2.9 1.1 0.3 1.0 0.2 0.7 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.1 1.7 0.2 2.2 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.7 0.0 0.3 0.0 0.1 1.9 1.3 0.9 0.0 0.0 0.0 0.1 8.8 0.0 1.5 0.3 1.5 0.0 4.0 1.3 0.0 0.2 0.2 0.5 8.0 7.2 0.1 2.4 0.0 0.6 0.0 0.0 0.0 0.0 2.1 0.0 0.7 3.1 0.2 0.1 2.0 0.0 0.8 0.5 0.0 1.8 1.2 1.8 0.3 2.4 2.3 0.3 2.4 2.1 2.9 5.7 1.3 0.3 0.3 2.0 1.1 0.1 0.2 0.2 0.6 0.1 0.0 0.1 0.1 0.1 0.1 INSL4 EPIL ENSG00000120211 "Insulin like 4" Q14641 9 5231419-5235304 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "placenta: 88.0" "Cell line enriched" "Detected in some" 11 "A549: 23.1" "Cancer enhanced" "Detected in some" "lung cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" "unprognostic (9.77e-2)" "unprognostic (2.02e-1)" "unprognostic (4.66e-1)" "unprognostic (7.74e-2)" 0.1 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 1.8 0.1 0.0 0.0 0.2 0.0 0.1 0.8 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 88.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.1 0.0 0.0 23.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 INSL5 ENSG00000172410 "Insulin like 5" Q9Y5Q6 1 66797741-66801256 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "intestine: 52.9" "Cell line enhanced" "Detected in some" "HEK 293: 1.4;hTCEpi: 1.1" "Group enriched" "Detected in some" 5 "colorectal cancer: 1.2;prostate cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030100, CAB033849" Enhanced "Secreted to blood" 38500000 "CAB033849: AB_2264904, HPA030100: AB_10601915" "unprognostic (2.48e-1)" "unprognostic (4.41e-2)" "unprognostic (2.91e-1)" "unprognostic (1.18e-1)" "unprognostic (2.76e-2)" "unprognostic (1.30e-1)" "unprognostic (2.62e-2)" "unprognostic (7.53e-2)" 0.0 0.0 0.8 0.0 1.3 0.0 0.0 0.1 1.0 0.0 30.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.1 1.8 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.2 52.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 INSL6 RIF1 ENSG00000120210 "Insulin like 6" Q9Y581 9 5131979-5185668 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 22.3" "Cell line enhanced" "Detected in some" "HEL: 1.1;HL-60: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA021364 Enhanced "Secreted to blood" "HPA021364: AB_1851807" "unprognostic (3.85e-4)" "unprognostic (7.41e-4)" "unprognostic (1.28e-1)" "unprognostic (1.94e-1)" "unprognostic (2.22e-1)" "unprognostic (6.92e-2)" "unprognostic (2.31e-2)" "unprognostic (3.82e-2)" "unprognostic (2.30e-1)" "unprognostic (2.52e-3)" 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 22.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 IQCA1L "IQCA1P1, TCAG_9762" ENSG00000278685 "IQ motif containing with AAA domain 1 like" 7 151190873-151205496 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 7.0" "Cell line enriched" "Detected in single" 5 "U-266/70: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.13e-1)" "unprognostic (2.26e-2)" "unprognostic (2.65e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.0 3.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IQCF1 MGC39725 ENSG00000173389 "IQ motif containing F1" Q8N6M8 3 51894876-51903335 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 228 "testis: 47.4" "Cell line enhanced" "Detected in some" "hTCEpi: 1.4;PC-3: 3.0;U-2 OS: 1.0" "Cancer enriched" "Detected in single" 30 "testis cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "unprognostic (2.76e-1)" "unprognostic (1.96e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IQCF2 ENSG00000184345 "IQ motif containing F2" Q8IXL9 3 51861629-51863424 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "testis: 22.3" "Cell line enhanced" "Detected in some" "HL-60: 1.5;U-2197: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 IQCF3 ENSG00000229972 "IQ motif containing F3" P0C7M6 3 51817604-51830856 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 48 "testis: 71.2" "Cell line enhanced" "Detected in some" "HMC-1: 1.1;U-2 OS: 2.1;U-698: 1.0;U-937: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 1.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.4" "unprognostic (2.83e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.1 0.2 0.7 0.0 1.0 0.0 4.5 0.1 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 IQCF5 ENSG00000214681 "IQ motif containing F5" A8MTL0 3 51873721-51875584 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 92 "testis: 41.2" "Cell line enhanced" "Detected in some" "HHSteC: 2.0;U-2 OS: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "unprognostic (3.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IQCF6 ENSG00000214686 "IQ motif containing F6" A8MYZ5 3 51778561-51779241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "testis: 19.2" "Group enriched" "Detected in some" 5 "Karpas-707: 2.7;U-937: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (4.98e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IQCJ ENSG00000214216 "IQ motif containing J" Q1A5X6 3 158962928-159266307 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 19.5" "Cell line enriched" "Detected in single" 21 "Daudi: 10.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052835 Uncertain "HPA052835: " "unprognostic (1.99e-2)" 0.5 0.5 19.5 0.5 10.0 0.5 1.6 0.4 14.5 0.5 0.5 0.1 0.0 0.5 0.5 0.5 0.8 0.5 0.7 1.0 9.4 0.6 0.6 0.5 0.5 0.9 0.9 7.4 0.6 0.5 0.5 3.6 0.5 6.8 0.5 0.5 0.0 0.5 0.9 0.5 0.5 0.5 0.5 0.5 0.5 0.5 4.8 1.5 0.0 0.5 0.0 0.6 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 10.0 0.4 14.5 9.4 0.6 0.9 7.4 6.8 1.5 IQCM ENSG00000234828 "IQ motif containing M" A0A1B0GVH7 4 149351903-149896233 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 20 "testis: 16.9" "Cell line enriched" "Detected in single" 5 "fHDF/TERT166: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.22e-1)" "unprognostic (1.17e-3)" "unprognostic (2.18e-1)" "unprognostic (2.85e-2)" "unprognostic (1.91e-1)" "unprognostic (8.47e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IQCN KIAA1683 ENSG00000130518 "IQ motif containing N" Q9H0B3 19 18257097-18274509 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "testis: 59.9" "Cell line enhanced" "Detected in many" "A549: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "neutrophil: 5.3" "Low lineage specificity" "Detected in all" HPA042409 Enhanced "HPA042409: AB_10794421" "unprognostic (1.36e-3)" "unprognostic (5.42e-3)" "unprognostic (2.21e-1)" "unprognostic (1.70e-1)" "unprognostic (1.05e-1)" "unprognostic (2.15e-4)" "unprognostic (9.79e-2)" "unprognostic (9.53e-3)" "unprognostic (5.44e-2)" "unprognostic (1.12e-1)" "unprognostic (1.64e-4)" "unprognostic (4.17e-2)" "unprognostic (2.58e-1)" "unprognostic (1.88e-1)" "unprognostic (7.68e-2)" "unprognostic (1.30e-1)" "unprognostic (4.92e-3)" 0.8 0.2 0.7 0.7 0.7 2.3 1.2 1.5 0.7 1.7 0.7 0.7 0.7 0.0 2.7 1.6 0.7 2.4 0.7 0.7 0.7 0.6 1.0 2.7 1.5 0.7 0.7 0.7 2.7 0.8 0.4 1.6 0.7 0.7 0.8 0.4 0.7 0.7 0.7 1.3 2.2 1.0 1.0 0.7 1.4 0.8 59.9 0.7 0.7 2.0 0.7 0.7 0.7 0.9 2.4 2.0 5.3 1.0 1.3 1.2 0.4 0.0 5.9 0.9 3.6 1.6 2.8 1.0 0.8 0.7 0.0 0.4 1.9 2.0 1.5 0.6 1.8 0.1 0.0 0.6 0.0 1.6 0.4 2.2 2.2 1.2 0.2 0.4 0.7 1.5 0.5 0.5 1.1 0.7 0.3 1.7 0.0 2.3 0.7 1.0 0.7 0.0 0.5 0.0 0.6 0.9 1.4 2.7 0.6 0.5 0.9 1.3 2.0 0.7 0.0 0.2 0.7 2.1 0.0 0.8 0.5 0.5 1.2 0.1 0.0 1.4 1.0 0.8 1.1 0.4 0.5 1.0 1.0 0.4 0.3 2.4 1.2 0.9 5.3 1.3 0.4 2.0 0.7 0.4 0.7 0.7 1.5 0.7 0.7 0.6 0.7 0.7 0.7 0.7 IRAK1BP1 "AIP70, SIMPL" ENSG00000146243 "Interleukin 1 receptor associated kinase 1 binding protein 1" Q5VVH5 6 78867472-78946440 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 79.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035742, HPA035743" Uncertain Approved Vesicles Vesicles "HPA035742: AB_10670119, HPA035743: " "unprognostic (2.62e-1)" "unprognostic (1.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-1)" "unprognostic (5.82e-2)" "unprognostic (2.12e-1)" "unprognostic (2.38e-3)" "unprognostic (3.93e-2)" "unprognostic (6.55e-2)" "unprognostic (2.34e-2)" "unprognostic (1.32e-2)" "unprognostic (9.88e-2)" "unprognostic (2.81e-2)" "unprognostic (4.64e-2)" "unprognostic (1.82e-1)" "unprognostic (3.39e-2)" "unprognostic (2.58e-1)" 2.8 4.0 6.9 3.4 12.4 79.6 3.9 8.8 8.1 6.4 4.1 3.4 6.2 3.5 7.2 7.7 3.2 7.3 5.3 3.6 5.6 4.1 7.0 2.6 4.4 6.0 3.0 6.5 7.0 8.1 4.2 17.9 2.8 4.3 5.2 2.7 5.1 4.2 6.5 2.3 5.7 4.7 4.1 3.6 4.7 5.5 15.4 5.7 8.8 7.6 1.9 2.3 4.5 4.0 1.4 1.6 3.9 1.4 1.3 2.0 0.4 1.6 3.2 5.2 4.6 2.2 4.8 4.5 1.1 2.7 1.1 1.9 3.8 3.0 3.1 1.4 2.5 3.0 9.3 4.4 1.9 4.7 3.8 4.0 4.7 2.0 2.8 9.7 3.7 4.2 4.4 2.0 2.5 3.5 5.1 7.7 1.7 0.8 2.9 6.4 2.4 2.7 1.1 2.9 2.2 4.8 6.5 6.9 8.2 1.5 1.7 1.2 3.8 6.5 3.1 2.7 2.6 1.5 4.0 7.8 4.6 4.8 0.8 0.7 3.1 3.9 0.3 0.4 1.5 0.2 1.1 1.4 1.4 0.8 0.6 0.9 1.9 2.0 2.5 1.3 1.4 1.6 1.6 0.4 6.9 12.4 8.8 8.1 5.6 4.1 3.0 6.5 4.3 5.7 IRGC "CINEMA, Iigp5, IRGC1" ENSG00000124449 "Immunity related GTPase cinema" Q6NXR0 19 43716010-43720021 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 41 "testis: 49.4" "Cell line enhanced" "Detected in single" "Karpas-707: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA046769, HPA060064" Enhanced "HPA046769: , HPA060064: " "unprognostic (3.38e-2)" "unprognostic (3.83e-2)" "unprognostic (8.52e-2)" "unprognostic (1.26e-1)" "unprognostic (2.55e-1)" "unprognostic (2.81e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IRS4 "IRS-4, PY160" ENSG00000133124 "Insulin receptor substrate 4" O14654 X 108732482-108736409 "Cancer-related genes, Predicted intracellular proteins" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pituitary gland: 56.0" "Cell line enhanced" "Detected in some" "HEK 293: 13.6;NTERA-2: 1.7;RT4: 4.0;WM-115: 3.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 7 "hypothalamus: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 12.8;hypothalamus: 52.4" "Group enriched" "Detected in some" 6 "basal ganglia: 21.5;hypothalamus: 55.3" HPA017372 Uncertain "HPA017372: " "unprognostic (3.74e-3)" "unprognostic (3.27e-2)" "unprognostic (1.32e-2)" "unprognostic (2.52e-1)" "unprognostic (1.89e-1)" "unprognostic (2.12e-1)" "unprognostic (1.65e-1)" "unprognostic (1.05e-2)" "unprognostic (1.77e-1)" "unprognostic (9.28e-4)" "unprognostic (8.71e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.6 1.9 0.0 0.1 0.3 0.1 2.6 0.3 0.3 0.5 0.0 0.0 0.3 4.6 0.0 0.0 0.1 0.0 0.5 0.1 9.5 0.0 0.0 56.0 0.1 0.6 0.2 0.0 2.7 0.0 0.5 0.0 0.6 0.0 1.0 0.2 0.1 0.5 0.1 0.5 5.1 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.3 0.3 4.6 0.5 0.1 0.6 0.5 ISG20L2 FLJ12671 ENSG00000143319 "Interferon stimulated exonuclease gene 20 like 2" Q9H9L3 1 156721891-156728799 "Predicted intracellular proteins" "Ribosome biogenesis" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 98.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028005, HPA054285" Approved Approved Nucleoplasm Nucleoplasm "HPA028005: AB_2126319, HPA054285: " "unprognostic (1.67e-2)" "unprognostic (7.87e-2)" "unprognostic (2.80e-1)" "prognostic unfavourable (4.63e-4)" "unprognostic (3.52e-1)" "unprognostic (1.65e-2)" "prognostic unfavourable (6.15e-5)" "unprognostic (1.02e-1)" "unprognostic (9.55e-2)" "unprognostic (6.05e-2)" "unprognostic (2.40e-1)" "unprognostic (8.17e-2)" "prognostic unfavourable (4.80e-5)" "unprognostic (5.11e-2)" "unprognostic (2.68e-1)" "unprognostic (3.82e-3)" "unprognostic (2.32e-1)" 8.0 7.9 8.5 9.5 10.5 12.1 9.7 15.4 11.2 8.6 8.9 10.2 8.9 7.7 10.6 8.5 13.8 9.3 7.9 8.2 7.9 6.1 8.6 10.1 7.9 11.1 8.5 7.6 11.1 9.3 8.4 10.6 10.5 8.3 8.8 11.3 7.5 8.8 9.0 7.2 10.6 10.5 11.6 7.9 10.6 9.2 98.1 9.4 14.1 8.4 7.6 14.3 9.8 9.2 9.5 8.0 20.4 10.6 11.9 9.9 5.5 13.6 10.3 9.5 10.2 9.9 7.7 14.7 9.7 9.2 13.4 9.3 14.0 10.9 25.8 12.3 7.9 18.9 22.1 16.3 10.3 13.3 13.8 13.9 7.9 7.9 9.9 33.3 15.1 7.7 16.1 12.5 13.7 12.1 22.2 12.0 8.6 18.6 15.0 8.6 30.2 17.7 18.6 10.8 17.0 9.2 10.7 18.7 23.6 11.7 32.1 9.4 20.7 21.4 7.2 7.6 11.1 8.8 18.8 16.0 24.7 33.4 6.8 16.9 9.9 20.4 8.3 15.5 8.5 10.1 9.9 7.7 7.0 8.7 8.0 9.5 6.8 8.3 16.0 11.9 10.6 5.1 6.2 5.5 8.5 10.5 15.4 11.2 7.9 6.1 8.5 7.6 8.3 9.4 ISM2 "FLJ32147, TAIL1, THSD3" ENSG00000100593 "Isthmin 2" Q6H9L7 14 77474394-77498850 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "placenta: 193.8" "Cell line enriched" "Detected in some" 15 "BEWO: 89.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "basal ganglia: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039314, HPA039742" Supported Supported Nucleoplasm "Secreted in female reproductive system" Nucleoplasm "HPA039314: AB_10673239, HPA039742: AB_10673427" "unprognostic (5.69e-2)" "unprognostic (9.17e-3)" "unprognostic (2.58e-2)" "unprognostic (1.41e-3)" "unprognostic (3.73e-2)" "unprognostic (2.34e-1)" "unprognostic (2.16e-2)" "unprognostic (3.09e-3)" "unprognostic (2.11e-1)" "unprognostic (4.13e-1)" "unprognostic (8.10e-2)" "unprognostic (1.42e-2)" "unprognostic (9.36e-2)" "unprognostic (1.83e-1)" "unprognostic (5.67e-2)" "unprognostic (3.95e-1)" 0.7 0.0 0.2 0.2 4.2 0.0 0.1 0.1 0.3 1.1 0.2 0.1 0.3 0.1 2.7 0.9 0.2 0.5 0.1 0.1 0.1 0.8 0.6 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.5 193.8 0.2 3.2 0.0 0.2 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.2 0.1 0.2 0.1 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.1 0.3 0.1 0.8 0.1 0.1 0.2 0.2 ISX RAXLX ENSG00000175329 "Intestine specific homeobox" Q2M1V0 22 35066136-35087387 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "intestine: 22.2" "Group enriched" "Detected in some" 15 "CACO-2: 3.4;Hep G2: 9.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA060328 Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA060328: " "unprognostic (5.02e-2)" "unprognostic (2.68e-1)" "unprognostic (2.23e-1)" "unprognostic (3.33e-1)" "unprognostic (3.86e-1)" "unprognostic (2.55e-1)" 0.1 0.0 0.1 2.0 0.1 0.0 0.1 0.1 0.1 0.1 16.3 0.1 0.1 22.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 15.8 0.1 0.1 0.1 0.1 0.0 19.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 ITGAD "ADB2, CD11d" ENSG00000156886 "Integrin subunit alpha D" Q13349 16 31393312-31426505 "CD markers, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "lymphoid tissue: 25.4" "Cell line enhanced" "Detected in single" "NB-4: 1.7" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;NK-cell: 2.6" "Group enriched" "Detected in many" 19 "NK-cells: 2.6;T-cells: 1.1" "Low region specificity" "Detected in many" HPA026786 Uncertain "HPA026786: AB_10603773" "unprognostic (2.79e-2)" "unprognostic (2.39e-4)" "unprognostic (2.88e-2)" "unprognostic (3.24e-2)" "unprognostic (6.17e-2)" "unprognostic (1.79e-2)" "unprognostic (7.44e-4)" "unprognostic (6.99e-3)" "unprognostic (6.89e-3)" "unprognostic (5.02e-4)" "unprognostic (5.50e-2)" "unprognostic (1.67e-1)" "unprognostic (1.74e-1)" "unprognostic (3.80e-2)" "unprognostic (3.17e-1)" "unprognostic (8.10e-2)" "unprognostic (5.51e-2)" 0.3 0.1 0.1 1.0 0.1 2.5 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 1.2 0.0 0.4 0.2 0.2 0.2 0.1 0.1 0.1 1.2 0.7 4.0 0.1 0.0 1.6 0.1 0.0 0.1 1.2 0.0 0.1 0.0 0.2 1.5 0.0 1.3 0.1 0.3 0.0 0.2 25.4 0.1 0.2 0.0 0.4 0.1 0.0 1.4 0.2 0.1 0.0 0.0 0.0 0.0 2.6 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.7 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.6 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 ITIH1 "H1P, IATIH, ITIH" ENSG00000055957 "Inter-alpha-trypsin inhibitor heavy chain 1" P19827 3 52777592-52792068 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 95 "liver: 321.2" "Cell line enhanced" "Detected in some" "ASC diff: 10.7;Hep G2: 3.2;HL-60: 2.5" "Cancer enriched" "Detected in some" 598 "liver cancer: 329.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 3.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041639, HPA042049" Approved Approved Vesicles "Secreted to blood" 4490000 31000000000 Vesicles "HPA041639: AB_10796349, HPA042049: AB_10797379" "unprognostic (1.87e-4)" "unprognostic (1.31e-3)" "unprognostic (2.38e-1)" "unprognostic (8.55e-2)" "unprognostic (1.03e-1)" "unprognostic (2.64e-3)" "prognostic favourable (1.89e-5)" "unprognostic (2.27e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (2.91e-2)" "unprognostic (8.45e-2)" "unprognostic (4.53e-4)" "unprognostic (4.02e-3)" "unprognostic (5.70e-3)" "unprognostic (2.08e-1)" "unprognostic (2.24e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 321.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.3 0.8 0.0 0.9 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.0 2.5 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.7 0.0 0.0 3.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ITIH2 H2P ENSG00000151655 "Inter-alpha-trypsin inhibitor heavy chain 2" P19823 10 7703269-7749520 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 202 "liver: 249.0" "Cell line enriched" "Detected in single" 1079 "Hep G2: 151.9" "Cancer enriched" "Detected in many" 279 "liver cancer: 626.9" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059150 Supported Approved "Golgi apparatus" "Secreted to blood" 22000000000 "Golgi apparatus" "HPA059150: " "unprognostic (4.82e-2)" "unprognostic (6.10e-2)" "unprognostic (2.48e-2)" "unprognostic (1.21e-2)" "unprognostic (2.01e-2)" "unprognostic (2.55e-3)" "prognostic favourable (1.48e-4)" "unprognostic (1.37e-1)" "unprognostic (1.79e-1)" "unprognostic (1.47e-2)" "unprognostic (2.28e-1)" "unprognostic (2.02e-1)" "unprognostic (2.10e-8)" "unprognostic (9.91e-3)" "unprognostic (1.70e-1)" "unprognostic (2.35e-1)" "unprognostic (4.46e-4)" 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.2 249.0 0.1 0.0 0.5 0.5 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.4 0.3 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 151.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.6 0.1 0.4 0.4 0.6 0.4 0.1 0.5 0.3 0.6 0.2 0.8 0.2 1.2 0.1 0.0 0.1 0.6 0.1 0.4 0.4 0.3 0.5 0.5 1.1 0.1 ITIH3 H3P ENSG00000162267 "Inter-alpha-trypsin inhibitor heavy chain 3" Q06033 3 52794768-52809009 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 233 "liver: 326.9" "Cell line enriched" "Detected in single" 24 "Hep G2: 19.2" "Cancer enriched" "Detected in some" 247 "liver cancer: 273.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA017373 Approved "Secreted to blood" 4500000000 "HPA017373: AB_1851954" "unprognostic (2.07e-2)" "unprognostic (5.79e-2)" "unprognostic (1.89e-1)" "unprognostic (3.30e-4)" "unprognostic (4.28e-2)" "unprognostic (3.26e-2)" "unprognostic (5.97e-2)" "unprognostic (6.07e-2)" "unprognostic (1.49e-1)" "unprognostic (7.05e-2)" "unprognostic (1.04e-1)" "unprognostic (3.19e-1)" "prognostic unfavourable (4.49e-8)" "unprognostic (2.09e-4)" "unprognostic (1.70e-1)" "unprognostic (2.55e-2)" "unprognostic (9.31e-2)" 0.9 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.8 0.3 0.1 0.3 0.0 0.5 0.5 0.3 0.3 0.5 0.2 0.1 0.0 0.2 326.9 0.4 0.3 0.2 0.1 0.6 0.0 0.0 0.1 0.3 0.2 0.2 0.1 0.2 0.2 0.4 0.3 0.1 0.1 0.1 0.1 1.4 0.1 0.4 0.1 0.1 0.3 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 ITIH4 "H4P, IHRP, ITIHL1" ENSG00000055955 "Inter-alpha-trypsin inhibitor heavy chain family member 4" Q14624 3 52812975-52831479 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 461.4" "Cell line enhanced" "Detected in some" "HDLM-2: 5.4;U-266/70: 6.6" "Cancer enriched" "Detected in single" 27 "liver cancer: 7.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 2.6" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001835, HPA003948, CAB072872" Enhanced Approved Vesicles "Secreted to blood" 3056667 53000000000 Vesicles "CAB072872: , HPA001835: AB_1079432, HPA003948: AB_1079433" "unprognostic (6.08e-2)" "unprognostic (4.45e-2)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "unprognostic (2.64e-1)" "unprognostic (1.96e-1)" "unprognostic (5.86e-2)" "unprognostic (1.98e-2)" "unprognostic (5.64e-2)" "unprognostic (1.02e-1)" "unprognostic (2.47e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-14)" "unprognostic (1.71e-3)" "unprognostic (2.96e-2)" "unprognostic (1.52e-1)" "unprognostic (4.21e-5)" 0.5 1.8 0.1 0.1 0.1 1.0 0.1 0.1 0.2 0.4 0.2 0.1 0.1 0.1 0.1 1.3 0.2 0.1 0.1 0.6 0.1 0.0 0.2 461.4 0.2 0.1 0.1 0.2 0.2 22.8 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.2 4.1 0.1 0.1 0.2 0.1 0.5 0.1 0.3 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.3 0.3 0.6 0.6 2.6 0.8 0.0 0.0 0.4 1.0 2.1 1.1 0.0 0.4 0.1 0.0 0.0 0.2 0.3 0.2 1.3 0.0 0.5 1.1 0.0 0.0 0.5 5.4 0.2 2.2 0.0 2.9 0.9 2.5 0.2 0.3 0.4 0.0 0.1 0.0 0.6 1.8 0.0 0.2 0.5 0.7 1.0 0.0 1.8 1.0 0.0 0.8 0.7 0.1 1.0 0.7 0.0 0.4 1.1 0.7 0.2 0.0 0.9 1.0 0.0 6.6 3.1 0.5 0.1 0.7 1.2 0.0 0.6 0.0 0.1 0.1 0.1 0.3 0.7 0.0 0.0 0.2 0.0 0.8 0.6 2.6 0.1 0.3 0.4 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.2 0.1 ITLN2 HL-2 ENSG00000158764 "Intelectin 2" Q8WWU7 1 160945025-160954799 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "intestine: 88.4" "Cell line enhanced" "Detected in some" "HEL: 15.3;HHSteC: 2.6;HMC-1: 4.6;SK-MEL-30: 4.9" "Cancer enhanced" "Detected in many" "testis cancer: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006683, HPA067326" Enhanced "Secreted to digestive system" "HPA006683: AB_2129681, HPA067326: " "unprognostic (1.42e-1)" "unprognostic (9.62e-3)" "unprognostic (4.61e-2)" "unprognostic (7.45e-2)" "unprognostic (2.25e-1)" "unprognostic (6.84e-4)" "unprognostic (2.47e-2)" "unprognostic (5.74e-2)" "unprognostic (1.31e-2)" "unprognostic (1.36e-1)" "unprognostic (5.01e-1)" "unprognostic (1.84e-1)" "unprognostic (1.49e-1)" "unprognostic (2.31e-1)" "unprognostic (4.91e-2)" 3.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 27.4 0.1 0.1 53.3 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 2.5 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 88.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 2.6 0.0 4.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 IVNS1ABP "HSPC068, KIAA0850, KLHL39, ND1, NS-1, NS1-BP" ENSG00000116679 "Influenza virus NS1A binding protein" Q9Y6Y0 1 185296388-185317329 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 171.2" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 73.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003405 Approved Supported Cytosol Cytosol "HPA003405: AB_1079141" "unprognostic (4.11e-3)" "unprognostic (9.69e-2)" "unprognostic (4.29e-2)" "unprognostic (1.77e-1)" "unprognostic (2.03e-2)" "unprognostic (4.42e-2)" "unprognostic (4.31e-3)" "unprognostic (4.18e-1)" "unprognostic (7.04e-2)" "unprognostic (5.13e-2)" "unprognostic (4.28e-1)" "unprognostic (5.42e-3)" "unprognostic (1.85e-3)" "unprognostic (3.73e-2)" "unprognostic (1.28e-1)" "unprognostic (4.07e-2)" "unprognostic (4.13e-2)" 23.7 8.7 9.9 19.8 35.8 171.2 29.0 9.9 13.8 12.5 17.0 19.2 28.5 16.2 10.2 12.9 17.1 9.0 15.9 19.3 10.9 8.6 38.7 10.2 26.5 29.9 23.0 7.8 12.7 17.1 11.6 11.9 15.8 16.8 12.6 21.5 9.2 36.2 38.8 13.5 19.5 14.3 7.9 19.3 12.8 18.3 9.0 20.8 13.1 17.3 16.0 16.3 11.5 22.5 4.6 9.1 24.5 8.1 7.4 7.9 8.1 6.8 7.6 22.3 8.9 8.0 2.6 21.0 13.6 4.2 8.6 7.8 8.1 11.0 11.0 11.3 6.6 9.6 8.1 8.9 9.2 8.1 7.8 10.4 11.4 6.5 3.1 7.2 4.1 1.9 10.1 6.5 21.1 11.0 6.9 6.2 15.4 5.2 11.9 5.1 14.0 1.7 7.1 5.9 5.9 73.0 9.2 15.6 13.3 12.0 10.0 8.1 4.5 3.5 7.5 12.0 7.3 3.0 9.6 8.9 7.1 6.5 8.9 7.4 5.3 5.1 8.1 7.7 7.9 5.9 7.0 4.6 6.0 5.7 9.1 3.3 6.7 6.3 24.5 7.4 7.2 2.5 6.1 8.1 9.9 35.8 9.9 13.8 10.9 8.6 23.0 7.8 16.8 20.8 IYD "C6orf71, DEHAL1, dJ422F24.1" ENSG00000009765 "Iodotyrosine deiodinase" Q6PHW0 6 150368892-150405969 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "thyroid gland: 212.3" "Group enriched" "Detected in some" 6 "CACO-2: 3.3;SK-BR-3: 8.2" "Cancer enriched" "Detected in many" 20 "thyroid cancer: 80.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "hippocampal formation: 8.1;thalamus: 2.6" "Low region specificity" "Detected in all" HPA059627 Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA059627: " "unprognostic (3.73e-4)" "unprognostic (2.93e-2)" "unprognostic (5.97e-2)" "unprognostic (1.95e-2)" "unprognostic (1.55e-1)" "unprognostic (2.98e-2)" "prognostic favourable (6.22e-4)" "unprognostic (1.11e-1)" "unprognostic (3.80e-2)" "unprognostic (1.17e-1)" "unprognostic (7.41e-2)" "unprognostic (1.02e-1)" "unprognostic (3.07e-9)" "unprognostic (9.79e-3)" "unprognostic (2.04e-1)" "unprognostic (2.03e-2)" "unprognostic (2.18e-2)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 8.2 0.1 0.1 3.6 0.1 0.3 0.1 0.1 6.7 0.1 0.1 0.1 5.4 6.8 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.5 0.1 1.2 0.0 0.3 0.0 0.1 0.2 13.5 0.0 0.1 0.1 0.3 0.1 0.0 0.0 212.3 0.0 0.1 0.1 0.1 1.4 1.0 5.9 1.3 2.3 0.7 2.3 0.2 0.0 0.2 0.3 0.1 0.9 0.5 0.0 0.0 0.1 0.0 3.3 0.6 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.3 0.5 0.8 0.3 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.5 0.0 0.4 0.3 0.2 0.3 0.2 0.2 0.0 0.8 0.4 0.2 0.0 8.2 0.0 0.8 0.1 0.2 0.2 0.2 0.3 0.0 0.3 0.1 0.1 0.5 0.3 0.2 3.3 1.3 0.7 0.7 1.1 0.5 0.6 0.6 0.5 0.1 1.4 0.6 0.7 5.9 2.3 0.5 1.0 0.5 2.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.0 IZUMO1 "IZUMO, MGC34799, OBF" ENSG00000182264 "Izumo sperm-egg fusion 1" Q8IYV9 19 48740852-48746909 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 17.2" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;CAPAN-2: 2.6;HaCaT: 1.8;hTCEpi: 4.3;K-562: 2.0;RT4: 2.7;U-266/84: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA038104 Enhanced "HPA038104: AB_10670655" "unprognostic (2.03e-1)" "unprognostic (1.86e-3)" "unprognostic (3.73e-2)" "unprognostic (1.37e-2)" "unprognostic (1.17e-2)" "unprognostic (7.92e-2)" "unprognostic (3.49e-2)" "unprognostic (2.53e-4)" "unprognostic (3.61e-2)" "unprognostic (1.69e-2)" "unprognostic (1.45e-1)" "unprognostic (4.83e-2)" "unprognostic (1.32e-2)" "unprognostic (3.68e-1)" "unprognostic (2.92e-1)" "unprognostic (4.31e-3)" "unprognostic (6.92e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.6 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 17.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 2.6 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 IZUMO2 "C19orf41, MGC33947, SCRL" ENSG00000161652 "IZUMO family member 2" Q6UXV1 19 50152548-50163195 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "testis: 33.0" "Cell line enhanced" "Detected in some" "EFO-21: 1.6;RH-30: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042143 Uncertain "HPA042143: AB_10794078" "unprognostic (1.21e-2)" "unprognostic (3.18e-2)" "unprognostic (4.31e-2)" "unprognostic (1.81e-1)" "unprognostic (1.94e-1)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (8.75e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.0 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.1 0.8 0.1 0.0 0.1 0.0 0.1 0.0 IZUMO3 "bA20A20.1, C9orf134" ENSG00000205442 "IZUMO family member 3" Q5VZ72 9 24542952-24545946 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 169 "testis: 16.9" "Cell line enriched" "Detected in single" 62 "SCLC-21H: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IZUMO4 C19orf36 ENSG00000099840 "IZUMO family member 4" Q1ZYL8 19 2096429-2099593 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 108.2" "Cell line enhanced" "Detected in many" "Karpas-707: 10.8;RPMI-8226: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048496 Enhanced "Secreted in male reproductive system" "HPA048496: " "unprognostic (2.75e-3)" "unprognostic (1.10e-2)" "unprognostic (3.65e-2)" "prognostic favourable (7.08e-4)" "unprognostic (1.40e-1)" "unprognostic (2.18e-5)" "unprognostic (2.67e-2)" "unprognostic (1.02e-3)" "unprognostic (1.30e-1)" "unprognostic (2.48e-1)" "prognostic favourable (1.69e-4)" "unprognostic (2.12e-1)" "unprognostic (6.58e-5)" "unprognostic (6.38e-2)" "unprognostic (2.17e-1)" "unprognostic (5.68e-1)" "unprognostic (7.51e-3)" 1.6 1.1 4.4 0.9 5.6 0.6 0.9 1.3 4.4 1.0 0.8 2.9 1.2 0.6 0.9 1.6 1.0 1.4 1.3 1.6 4.4 2.1 1.1 2.0 0.9 1.1 10.5 3.3 3.0 8.3 0.8 2.7 0.6 4.2 1.9 0.8 0.6 1.4 1.6 0.9 1.4 0.7 0.7 3.6 0.8 1.0 108.2 6.6 0.4 1.3 0.8 1.4 0.9 0.6 5.3 2.8 3.4 3.1 1.0 5.1 2.6 0.7 0.7 0.4 3.3 1.5 1.6 0.4 0.5 0.8 0.6 0.1 0.3 0.7 0.6 0.8 0.8 0.7 0.1 3.7 0.2 1.5 0.2 0.0 1.3 1.0 4.2 0.0 0.6 0.6 1.4 1.0 1.1 0.0 0.0 10.8 1.4 0.2 1.0 0.3 0.3 0.9 0.8 0.0 13.1 1.7 0.4 0.6 0.9 0.5 1.2 0.5 0.6 1.2 0.5 0.5 0.2 0.1 0.3 1.2 1.4 1.0 1.8 1.1 0.3 0.0 1.6 1.4 1.6 2.2 3.5 5.3 5.1 3.7 2.2 1.8 4.1 1.7 3.4 1.0 3.1 2.8 4.7 2.6 4.4 5.6 1.3 4.4 4.4 2.1 10.5 3.3 4.2 6.6 JAK3 "JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK" ENSG00000105639 "Janus kinase 3" P52333 19 17824780-17848071 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 68.3" "Cell line enhanced" "Detected in some" "HDLM-2: 20.1;HEL: 9.0;HMC-1: 9.2;Karpas-707: 23.5;U-266/70: 9.1;U-266/84: 13.5;U-937: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA070314 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA070314: " "unprognostic (5.59e-3)" "prognostic favourable (6.42e-5)" "unprognostic (5.71e-2)" "unprognostic (2.34e-1)" "unprognostic (6.13e-3)" "unprognostic (1.11e-3)" "unprognostic (4.21e-2)" "unprognostic (2.60e-1)" "unprognostic (2.38e-2)" "unprognostic (2.36e-1)" "unprognostic (3.58e-2)" "unprognostic (1.94e-1)" "prognostic unfavourable (2.89e-14)" "unprognostic (2.28e-1)" "unprognostic (2.21e-2)" "unprognostic (4.43e-2)" "unprognostic (7.61e-2)" 6.8 1.7 4.0 24.5 8.5 12.0 2.7 2.4 3.1 1.9 2.3 1.0 0.0 2.2 1.7 2.0 2.5 3.5 3.6 4.3 2.7 2.8 3.8 2.0 8.4 68.3 7.5 0.0 11.0 2.0 0.4 2.3 4.1 5.3 3.0 2.4 1.6 6.1 1.5 0.7 1.3 9.5 2.5 8.4 36.1 3.2 1.8 5.8 20.9 3.4 1.7 28.8 5.3 2.4 7.4 4.5 16.9 9.6 8.4 15.0 6.8 0.1 0.3 0.3 1.0 0.4 1.4 0.2 0.5 0.0 0.0 0.1 0.0 0.9 0.4 1.9 0.4 0.1 0.0 0.2 0.0 20.1 0.0 9.0 0.0 0.8 0.7 0.0 9.2 5.0 0.2 0.0 0.0 0.2 0.0 23.5 0.0 0.4 3.6 0.0 0.1 0.7 4.6 0.0 0.4 0.5 0.0 0.0 0.3 0.1 0.2 0.0 2.0 1.3 0.4 0.0 0.4 0.0 0.0 9.1 13.5 2.5 0.1 13.7 0.2 1.2 4.9 0.2 12.6 9.6 14.5 6.5 15.0 13.1 4.5 7.4 14.9 13.0 16.9 8.4 8.8 3.7 11.8 6.8 4.0 8.5 2.4 3.1 2.7 2.8 7.5 0.0 5.3 5.8 JAML "AMICA, AMICA1, Gm638" ENSG00000160593 "Junction adhesion molecule like" Q86YT9 11 118193740-118225094 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 202.6" "Cell line enriched" "Detected in some" 5 "HMC-1: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 202.6" "Group enriched" "Detected in many" 4 "dendritic cells: 60.5;granulocytes: 202.6;monocytes: 59.0" "Region enriched" "Detected in single" 9 "cerebellum: 7.0" "Region enriched" "Detected in many" 12 "cerebellum: 113.6" HPA047919 Approved 1400000 "HPA047919: " "unprognostic (3.91e-3)" "unprognostic (1.55e-3)" "unprognostic (3.00e-2)" "unprognostic (1.28e-3)" "unprognostic (2.87e-3)" "prognostic favourable (3.11e-4)" "unprognostic (2.80e-1)" "prognostic favourable (3.92e-4)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (8.69e-2)" "unprognostic (5.08e-1)" "unprognostic (6.43e-3)" "unprognostic (8.96e-2)" "unprognostic (3.12e-2)" "unprognostic (4.10e-2)" "unprognostic (1.58e-2)" 6.7 2.1 0.9 23.1 1.1 6.6 2.1 5.3 0.8 4.1 8.4 0.7 1.3 6.1 3.8 9.6 4.0 3.1 8.9 3.1 0.9 0.9 3.4 4.3 34.4 43.2 3.7 0.5 2.1 1.8 0.0 2.7 4.2 2.3 3.4 8.3 6.7 6.7 1.1 1.0 2.2 14.0 4.7 1.8 43.4 3.9 1.9 0.6 14.3 2.6 5.9 25.0 9.8 3.0 0.3 60.5 202.6 59.0 1.4 25.2 40.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.7 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.2 0.0 5.8 59.0 202.6 3.9 36.6 25.2 0.3 7.0 7.4 60.5 0.1 8.3 6.7 126.6 1.4 17.1 46.6 11.1 40.1 0.9 1.1 5.3 0.8 0.9 0.9 3.7 0.5 2.3 0.6 JHY "C11orf63, FLJ23554, Jhy" ENSG00000109944 "Junctional cadherin complex regulator" Q6NUN7 11 122882528-122959798 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 51.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039612, HPA040344, HPA077658, HPA077748" Enhanced Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA039612: AB_10674424, HPA040344: , HPA077658: , HPA077748: " "unprognostic (5.27e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" "prognostic favourable (7.94e-5)" "unprognostic (9.97e-5)" "unprognostic (1.64e-1)" "unprognostic (2.02e-3)" "unprognostic (1.94e-3)" "unprognostic (1.77e-1)" "unprognostic (1.49e-1)" "unprognostic (4.13e-2)" "unprognostic (2.97e-1)" "prognostic favourable (8.77e-4)" "unprognostic (6.46e-3)" "unprognostic (2.54e-1)" "prognostic unfavourable (2.58e-4)" "unprognostic (7.79e-2)" 3.6 0.9 1.9 1.6 2.1 0.2 2.3 1.6 2.2 2.1 2.4 1.2 1.0 0.7 1.5 2.5 1.0 5.1 1.5 1.6 1.5 2.6 5.3 1.0 2.8 1.0 1.7 1.4 2.1 1.5 6.3 4.2 2.3 1.7 2.3 0.8 1.9 1.0 1.5 2.4 1.0 1.2 1.0 2.2 1.3 1.0 51.0 1.3 1.4 3.4 1.5 1.2 1.7 1.2 2.4 4.9 0.3 0.6 4.3 4.1 1.1 2.8 3.9 2.3 0.1 0.6 0.4 0.7 6.0 7.0 2.5 1.1 0.2 10.5 0.0 1.5 9.2 2.4 2.7 1.4 1.2 9.3 2.8 0.1 1.9 0.1 0.9 1.6 4.9 2.9 7.7 0.4 0.6 3.8 0.0 0.0 1.9 1.7 0.0 0.6 0.3 3.6 0.9 0.0 1.2 7.2 3.2 6.0 4.3 7.2 3.9 2.6 4.8 0.6 1.2 8.3 1.0 0.2 4.8 0.1 0.0 0.0 2.2 2.1 5.5 0.3 0.6 0.1 2.9 0.1 4.1 2.4 3.0 3.9 4.9 1.4 2.1 2.1 0.3 4.3 0.0 1.1 0.6 1.1 1.9 2.1 1.6 2.2 1.5 2.6 1.7 1.4 1.7 1.3 JPH1 JP-1 ENSG00000104369 "Junctophilin 1" Q9HDC5 8 74234700-74321328 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 97.2" "Cell line enhanced" "Detected in many" "MOLT-4: 10.2;RT4: 9.0;SK-BR-3: 24.3;T-47d: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008996, HPA009413, CAB013461" Enhanced Enhanced Nucleoplasm Nucleoplasm "CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163" "unprognostic (2.91e-3)" "unprognostic (3.01e-1)" "unprognostic (8.85e-2)" "unprognostic (8.73e-6)" "unprognostic (2.07e-1)" "unprognostic (1.86e-1)" "unprognostic (3.63e-2)" "prognostic favourable (5.77e-5)" "unprognostic (8.97e-2)" "unprognostic (1.30e-1)" "unprognostic (2.38e-1)" "unprognostic (5.99e-2)" "unprognostic (9.80e-2)" "unprognostic (6.87e-2)" "unprognostic (3.03e-1)" "unprognostic (4.88e-2)" "unprognostic (1.08e-2)" 1.7 0.6 1.8 0.7 5.7 0.5 0.8 13.7 3.1 0.8 1.9 0.8 0.4 0.8 1.5 1.7 1.8 0.6 0.6 3.3 2.1 0.7 0.8 0.5 2.2 0.5 1.0 4.2 0.5 3.5 1.1 0.4 1.1 2.4 1.8 2.8 0.0 1.3 0.8 97.2 0.7 0.9 1.4 2.4 0.5 0.9 0.9 2.3 2.4 1.2 21.5 1.4 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.4 0.1 3.1 0.0 1.0 0.0 4.6 3.9 3.1 1.0 0.0 5.9 0.0 3.7 0.0 0.5 2.0 0.2 0.6 2.6 0.0 2.9 0.0 0.5 0.0 0.3 2.8 10.2 0.0 6.8 2.0 5.2 3.9 0.0 0.1 9.0 5.2 0.7 0.0 24.3 1.2 17.3 0.1 0.0 1.2 1.7 0.4 1.0 0.0 0.0 0.0 2.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 5.7 13.7 3.1 2.1 0.7 1.0 4.2 2.4 2.3 JPH3 "CAGL237, HDL2, JP-3, JP3, TNRC22" ENSG00000154118 "Junctophilin 3" Q8WXH2 16 87601835-87698156 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 44.2" "Cell line enhanced" "Detected in some" "MCF7: 6.4;NTERA-2: 5.7;SH-SY5Y: 7.3;SiHa: 4.7;U-2 OS: 23.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076304 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA076304: " "unprognostic (8.97e-3)" "unprognostic (3.17e-2)" "unprognostic (1.57e-3)" "unprognostic (4.82e-3)" "unprognostic (3.43e-1)" "unprognostic (9.12e-2)" "unprognostic (1.68e-2)" "unprognostic (8.10e-2)" "unprognostic (5.53e-2)" "unprognostic (1.48e-1)" "unprognostic (5.61e-3)" "unprognostic (2.80e-2)" "unprognostic (1.28e-4)" "unprognostic (3.01e-2)" "unprognostic (2.09e-1)" "unprognostic (1.87e-2)" "unprognostic (1.36e-2)" 1.3 3.6 27.2 1.6 24.1 1.1 1.2 18.9 44.2 1.5 1.4 1.2 0.0 1.4 1.3 1.2 2.4 1.4 1.2 1.2 30.9 14.6 1.2 1.2 1.2 1.2 8.3 12.2 1.1 1.5 1.2 4.4 1.2 6.4 1.3 1.3 0.8 1.2 1.7 1.1 1.2 1.7 1.3 3.3 1.2 1.5 1.8 3.5 0.0 1.2 0.0 1.2 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.4 0.0 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.5 7.3 4.7 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 27.2 24.1 18.9 30.3 30.9 14.6 8.3 12.2 6.4 3.5 KANSL1L "C2orf67, FLJ23861, FLJ32349, KIAA1267L, MSL1v2" ENSG00000144445 "KAT8 regulatory NSL complex subunit 1 like" A0AUZ9 2 210021423-210171383 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "parathyroid gland: 178.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043102, HPA046790" Uncertain Approved Cytosol Cytosol "HPA043102: , HPA046790: " "unprognostic (3.85e-2)" "unprognostic (2.37e-1)" "unprognostic (1.04e-1)" "unprognostic (7.55e-3)" "unprognostic (1.45e-2)" "unprognostic (2.55e-3)" "unprognostic (5.52e-2)" "unprognostic (1.46e-1)" "unprognostic (5.99e-3)" "unprognostic (4.65e-2)" "unprognostic (5.89e-3)" "unprognostic (5.75e-2)" "unprognostic (5.95e-3)" "unprognostic (7.44e-2)" "unprognostic (4.60e-2)" "unprognostic (3.21e-2)" "unprognostic (1.30e-3)" 8.4 5.6 8.3 6.0 12.9 3.8 8.8 12.7 10.9 10.4 6.9 7.5 11.1 4.4 11.3 9.9 5.9 8.9 8.9 7.9 8.8 5.7 12.3 5.8 9.8 4.3 12.1 5.5 16.2 10.0 178.9 14.4 5.3 9.5 14.3 4.7 6.2 7.6 9.9 8.8 7.7 4.9 9.8 13.0 4.5 7.2 12.4 13.6 21.6 14.2 4.4 3.8 11.1 33.0 2.1 2.1 2.7 2.2 3.1 1.7 0.5 2.4 1.3 12.9 5.4 10.4 7.8 3.8 3.7 4.7 2.4 6.6 2.5 9.6 6.8 4.9 2.3 3.5 2.9 1.2 3.8 2.9 2.4 5.6 5.0 4.4 6.5 6.5 4.0 4.9 5.7 2.3 1.7 5.2 4.1 6.3 3.5 2.4 7.2 16.7 7.7 1.8 5.2 3.7 5.3 14.1 3.7 8.1 7.7 3.3 2.3 2.6 2.3 13.8 4.5 5.1 4.1 1.8 2.8 4.5 1.9 6.7 6.3 3.2 6.2 1.1 1.4 2.7 1.2 2.2 1.1 0.9 1.0 1.4 2.1 2.1 1.7 1.7 2.4 3.1 0.9 1.4 0.8 0.5 8.3 12.9 12.7 10.9 8.8 5.7 12.1 5.5 9.5 13.6 KCNA1 "AEMK, HUK1, Kv1.1, MBK1, RBK1" ENSG00000111262 "Potassium voltage-gated channel subfamily A member 1" Q09470 12 4909893-4918256 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 24.1" "Group enriched" "Detected in some" 11 "LHCN-M2: 2.3;NTERA-2: 2.0;SCLC-21H: 3.8;U-2 OS: 3.7" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "basal ganglia: 13.7;cerebellum: 23.8;cerebral cortex: 21.1;pons and medulla: 24.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074471 Approved "HPA074471: " "unprognostic (6.39e-3)" "unprognostic (2.64e-1)" "unprognostic (1.09e-1)" "unprognostic (8.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.79e-2)" "unprognostic (4.69e-3)" "unprognostic (2.48e-1)" "unprognostic (8.77e-5)" "unprognostic (6.30e-2)" "unprognostic (1.08e-4)" 0.8 0.7 1.5 0.7 13.7 0.7 1.3 23.8 21.1 1.6 0.9 0.9 0.0 0.9 1.0 0.7 0.7 0.7 0.9 0.7 4.6 1.1 0.7 0.7 0.8 0.7 2.2 3.5 0.7 0.7 4.0 0.6 0.7 24.1 0.7 0.9 0.0 1.9 0.8 0.7 0.8 0.8 1.1 1.1 0.7 1.0 0.7 1.4 0.2 2.0 0.0 0.7 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 13.7 23.8 21.1 4.6 1.1 2.2 3.5 24.1 1.4 KCNA2 "HK4, Kv1.2" ENSG00000177301 "Potassium voltage-gated channel subfamily A member 2" P16389 1 110519837-110631474 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 28.0" "Cell line enhanced" "Detected in some" "Karpas-707: 10.6;SCLC-21H: 2.7;U-2 OS: 2.4;U-266/70: 3.5;U-266/84: 5.3;WM-115: 2.9" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.1" "Lineage enriched" "Detected in single" 8 "T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB001976 Enhanced "CAB001976: " "unprognostic (1.84e-2)" "unprognostic (9.70e-3)" "unprognostic (1.97e-1)" "unprognostic (2.98e-1)" "unprognostic (7.17e-3)" "unprognostic (6.68e-3)" "unprognostic (5.05e-3)" "unprognostic (2.02e-1)" "unprognostic (1.29e-1)" "unprognostic (4.50e-3)" "unprognostic (3.08e-3)" "unprognostic (2.93e-4)" "unprognostic (2.15e-1)" "unprognostic (3.55e-1)" "unprognostic (6.41e-2)" "unprognostic (2.83e-1)" 3.2 1.4 7.1 2.2 13.1 0.8 1.2 17.2 28.0 1.2 1.6 3.1 0.0 1.4 1.0 1.3 1.7 1.1 1.6 1.6 7.2 6.1 0.9 0.9 1.0 1.9 7.2 14.5 1.1 1.9 0.8 1.4 0.7 21.1 1.8 2.0 1.4 1.8 2.4 2.1 1.6 1.6 1.6 2.8 1.3 1.3 2.5 3.8 0.3 5.3 0.0 3.5 1.4 0.5 0.5 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 1.4 0.0 0.0 2.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 2.4 0.0 0.0 3.5 5.3 0.2 0.1 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.3 0.5 1.8 1.3 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 4.1 0.1 7.1 13.1 17.2 26.3 7.2 6.1 7.2 14.5 21.1 3.8 KCNA3 "HLK3, HPCN3, Kv1.3, MK3" ENSG00000177272 "Potassium voltage-gated channel subfamily A member 3" P22001 1 110672465-110675033 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 59.4" "Cell line enhanced" "Detected in some" "HDLM-2: 12.4;Karpas-707: 25.6;U-266/70: 18.5;U-266/84: 16.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 3.3;T-cells: 11.5" "Low region specificity" "Detected in all" HPA016625 Approved "HPA016625: " "unprognostic (2.17e-2)" "unprognostic (5.07e-3)" "unprognostic (3.92e-3)" "unprognostic (1.20e-2)" "unprognostic (2.35e-1)" "unprognostic (1.76e-5)" "unprognostic (1.70e-4)" "unprognostic (8.48e-2)" "unprognostic (1.49e-2)" "unprognostic (5.92e-4)" "unprognostic (1.81e-2)" "unprognostic (3.96e-2)" "unprognostic (1.39e-1)" "unprognostic (3.13e-2)" "unprognostic (2.99e-2)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" 1.9 1.3 4.0 7.8 5.7 5.6 1.3 5.0 5.6 1.7 3.1 0.5 0.0 3.2 1.1 0.4 1.1 1.3 2.3 1.4 3.5 4.3 1.5 1.3 7.8 14.5 1.5 3.1 1.3 0.9 0.4 1.8 0.9 3.1 1.1 2.6 0.5 3.7 0.3 0.5 0.8 5.9 0.7 1.9 7.7 5.3 1.4 1.5 59.4 2.1 0.3 10.9 5.8 1.3 3.3 1.0 0.0 0.7 0.9 11.5 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 5.3 0.0 0.5 0.0 0.0 0.0 5.1 0.0 0.0 3.6 0.3 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.4 0.0 0.0 18.5 16.6 6.4 0.0 1.5 0.0 0.0 0.7 0.0 7.2 0.0 8.2 2.3 10.8 11.5 1.0 3.3 8.5 6.4 0.0 0.9 0.1 0.5 9.5 2.9 4.0 5.7 5.0 5.6 3.5 4.3 1.5 3.1 3.1 1.5 KCNA7 "HAK6, Kv1.7" ENSG00000104848 "Potassium voltage-gated channel subfamily A member 7" Q96RP8 19 49067418-49072941 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 40.6" "Cell line enhanced" "Detected in some" "HMC-1: 3.9;U-251 MG: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (2.00e-1)" "unprognostic (2.10e-2)" "unprognostic (1.19e-1)" "unprognostic (2.72e-1)" "unprognostic (1.68e-1)" "unprognostic (4.31e-2)" "unprognostic (3.17e-2)" "unprognostic (6.97e-2)" "unprognostic (2.94e-2)" "unprognostic (1.26e-1)" "unprognostic (2.21e-8)" "unprognostic (1.70e-1)" "unprognostic (2.62e-1)" "unprognostic (5.80e-2)" "unprognostic (5.29e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 40.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.6 0.3 0.0 0.0 1.1 0.9 3.3 0.8 0.9 0.8 0.2 0.7 0.3 0.4 2.0 0.0 0.2 0.7 0.4 0.0 0.1 0.0 0.5 0.9 0.4 0.2 0.2 1.3 0.1 0.2 0.0 0.4 0.6 0.2 1.4 0.4 0.1 0.6 3.9 0.1 0.3 0.1 0.1 0.0 0.5 1.1 0.1 0.5 0.3 0.6 0.5 0.3 0.4 0.1 0.4 0.2 0.5 0.4 0.4 1.5 0.2 0.1 0.5 1.1 0.7 1.4 0.5 0.9 3.9 0.7 0.3 0.3 0.6 0.4 0.5 3.3 0.8 0.7 0.8 0.4 0.5 0.5 0.7 0.7 0.2 1.1 0.7 0.8 2.6 0.9 0.7 0.9 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNC1 Kv3.1 ENSG00000129159 "Potassium voltage-gated channel subfamily C member 1" P48547 11 17734774-17856804 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.5" "Cell line enhanced" "Detected in some" "RH-30: 7.4;SCLC-21H: 7.0;SH-SY5Y: 4.3" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Region enhanced" "Detected in all" "cerebellum: 67.5" "Cell type enhanced" "Detected in some" "basophil: 5.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047634, HPA048249" Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA047634: , HPA048249: " "unprognostic (1.79e-2)" "unprognostic (2.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.09e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-1)" "unprognostic (7.04e-5)" "unprognostic (5.89e-2)" "unprognostic (7.32e-4)" "unprognostic (1.29e-1)" "unprognostic (5.44e-2)" "unprognostic (1.05e-2)" "unprognostic (7.83e-2)" 0.7 2.3 8.2 1.0 10.0 2.9 0.9 67.5 33.3 3.0 1.0 1.0 0.0 1.4 1.5 0.6 1.1 0.9 1.3 0.6 5.6 4.9 0.9 1.1 1.0 1.2 3.3 12.6 1.1 0.9 0.6 1.4 0.7 19.5 1.2 0.8 0.7 1.2 0.7 1.7 1.8 1.2 0.8 1.9 1.0 1.3 2.9 2.0 0.0 1.5 0.0 0.8 2.4 0.5 1.7 0.8 5.8 0.8 0.7 1.1 0.3 0.4 0.1 3.0 1.2 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.2 0.0 1.1 1.8 0.0 0.3 0.3 2.1 0.6 2.9 0.2 0.3 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.5 1.4 0.0 0.5 0.5 1.1 1.5 0.0 0.7 7.4 0.9 0.0 0.4 7.0 4.3 0.4 0.4 0.0 0.6 0.5 0.1 0.2 2.3 0.3 0.3 0.5 0.6 1.0 0.5 0.3 0.9 5.8 0.7 1.1 1.1 0.7 0.7 0.7 0.9 0.5 0.2 1.7 0.7 0.8 3.8 0.7 0.8 0.8 0.4 0.3 8.2 10.0 67.5 33.3 5.6 4.9 3.3 12.6 19.5 2.0 KCNC2 Kv3.2 ENSG00000166006 "Potassium voltage-gated channel subfamily C member 2" Q96PR1 12 75040077-75209868 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 39.3" "Cell line enhanced" "Detected in single" "Karpas-707: 1.0" "Group enriched" "Detected in some" 8 "breast cancer: 1.5;prostate cancer: 4.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019664, CAB022571" Uncertain Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "CAB022571: , HPA019664: AB_1855578" "unprognostic (2.01e-1)" "unprognostic (1.14e-1)" "unprognostic (2.68e-1)" "unprognostic (5.58e-3)" "unprognostic (4.46e-2)" "unprognostic (3.39e-2)" 0.7 0.7 8.7 0.7 12.9 0.7 3.3 0.4 39.3 0.7 0.8 1.9 0.0 0.7 0.9 0.9 0.7 0.7 0.7 0.7 7.4 10.4 0.7 0.9 0.7 0.7 4.7 13.5 0.7 0.7 0.7 6.0 0.7 19.1 4.4 0.8 1.3 1.1 0.7 0.7 0.7 0.8 0.7 1.0 0.7 0.7 1.0 0.6 0.0 0.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.7 12.9 0.4 27.3 7.4 10.4 4.7 13.5 19.1 0.6 KCND2 "KIAA1044, Kv4.2, RK5" ENSG00000184408 "Potassium voltage-gated channel subfamily D member 2" Q9NZV8 7 120273668-120750331 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 41.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.4;HSkMC: 4.0;NTERA-2: 3.1;RT4: 3.2;SCLC-21H: 16.2" "Cancer enhanced" "Detected in many" "glioma: 6.2" "Region enhanced" "Detected in all" "cerebellum: 41.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029068 Enhanced "HPA029068: AB_10601436" "unprognostic (4.22e-1)" "unprognostic (2.79e-4)" "unprognostic (3.79e-2)" "unprognostic (3.40e-1)" "unprognostic (1.23e-1)" "unprognostic (3.91e-2)" "unprognostic (4.98e-3)" "unprognostic (9.07e-3)" "unprognostic (1.03e-1)" "unprognostic (1.14e-1)" "unprognostic (9.77e-3)" "unprognostic (1.51e-1)" "unprognostic (4.51e-4)" "unprognostic (4.07e-5)" "unprognostic (2.71e-2)" "unprognostic (2.92e-2)" "unprognostic (1.83e-3)" 2.9 1.0 3.9 1.0 6.7 0.3 1.9 41.1 20.6 2.4 0.7 1.5 0.0 0.7 5.6 0.5 0.5 1.7 7.0 0.5 3.7 5.4 0.3 0.4 0.6 0.5 4.2 3.6 5.9 0.6 2.5 6.6 0.8 12.1 0.5 0.6 0.0 0.7 1.7 0.5 0.3 0.5 3.7 3.7 0.3 0.5 2.9 4.5 0.0 0.8 1.1 0.3 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 6.4 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.6 0.0 0.0 4.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.0 3.2 16.2 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 6.7 41.1 5.3 3.7 5.4 4.2 3.6 12.1 4.5 KCNE2 "LQT6, MiRP1" ENSG00000159197 "Potassium voltage-gated channel subfamily E regulatory subunit 2" Q9Y6J6 21 34364024-34371389 "Disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Atrial fibrillation, Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "stomach 1: 66.8" "Cell line enhanced" "Detected in many" "Karpas-707: 4.2;SCLC-21H: 5.0;U-266/70: 4.1" "Cancer enriched" "Detected in some" 6 "stomach cancer: 2.9" "Region enhanced" "Detected in single" "pons and medulla: 3.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 30.5" "Not detected" "Not detected" "HPA029706, HPA051553" Enhanced "HPA029706: AB_2673159, HPA051553: AB_2681532" "unprognostic (5.29e-4)" "unprognostic (3.13e-1)" "unprognostic (6.69e-2)" "unprognostic (2.65e-5)" "unprognostic (7.45e-2)" "unprognostic (7.33e-3)" "unprognostic (5.77e-3)" "unprognostic (6.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.33e-2)" "unprognostic (9.30e-2)" "unprognostic (3.41e-2)" "unprognostic (2.19e-3)" "unprognostic (1.48e-1)" "unprognostic (3.97e-2)" "unprognostic (2.02e-1)" "unprognostic (8.81e-2)" 0.1 0.0 0.2 1.2 0.2 0.0 0.1 0.1 0.9 0.1 0.2 1.3 0.1 2.4 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.2 0.1 0.1 11.8 0.0 0.1 0.1 3.4 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 1.2 0.1 0.1 66.8 0.8 0.1 0.1 0.3 0.1 0.1 0.1 0.1 1.4 1.6 2.2 1.6 0.0 2.0 0.7 0.8 0.3 2.0 3.7 0.2 0.2 2.7 0.9 0.5 0.0 0.1 0.8 1.0 0.8 1.3 0.0 0.0 0.2 0.0 1.0 1.0 1.2 0.9 0.2 0.0 0.0 0.7 0.5 0.2 0.1 0.0 0.0 0.0 0.2 4.2 0.3 1.6 0.2 0.7 2.8 1.6 0.7 0.6 1.0 0.4 0.2 5.0 0.4 1.4 0.6 1.3 1.3 1.0 0.0 1.2 0.6 0.5 0.3 4.1 2.3 0.7 0.4 2.1 1.1 0.0 1.6 2.2 0.6 0.1 0.6 0.8 1.1 0.5 1.6 1.4 2.0 0.3 0.0 0.0 0.0 0.8 1.4 0.7 0.2 0.2 0.1 0.9 0.1 0.3 0.2 0.1 3.4 0.1 KCNF1 "IK8, KCNF, kH1, Kv5.1" ENSG00000162975 "Potassium voltage-gated channel modifier subfamily F member 1" Q9H3M0 2 10911937-10914225 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 36.9" "Cell line enhanced" "Detected in some" "A549: 16.5;MCF7: 5.8;T-47d: 7.2" "Cancer enriched" "Detected in many" 7 "glioma: 27.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "amygdala: 70.7;basal ganglia: 55.9;cerebral cortex: 78.2;hippocampal formation: 69.5;olfactory region: 141.1" "Low region specificity" "Detected in all" "HPA014738, HPA062278" Enhanced Approved "Golgi apparatus" "Golgi apparatus" "HPA014738: AB_1852114, HPA062278: " "unprognostic (2.54e-1)" "unprognostic (6.06e-3)" "unprognostic (1.37e-1)" "unprognostic (3.07e-2)" "unprognostic (4.39e-2)" "unprognostic (7.41e-4)" "unprognostic (1.54e-3)" "unprognostic (4.83e-5)" "unprognostic (1.57e-1)" "unprognostic (6.95e-2)" "unprognostic (1.60e-2)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (3.10e-4)" "unprognostic (2.37e-1)" "unprognostic (4.28e-2)" "unprognostic (4.08e-2)" 0.9 0.9 11.5 1.0 25.5 0.8 1.2 0.8 36.9 0.9 1.2 2.4 0.0 1.2 1.9 0.8 1.6 1.1 1.0 1.1 13.1 4.7 1.1 0.9 1.0 1.0 3.1 10.5 0.9 2.2 0.8 0.2 0.9 3.6 1.0 1.2 0.0 0.8 1.4 0.8 0.8 1.1 1.0 1.0 1.5 1.1 1.0 3.1 0.5 0.8 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 16.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.8 0.0 0.0 2.5 1.7 0.0 0.1 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 7.2 0.8 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 11.5 25.5 0.8 28.5 13.1 4.7 3.1 10.5 3.6 3.1 KCNG2 "KCNF2, Kv6.2" ENSG00000178342 "Potassium voltage-gated channel modifier subfamily G member 2" Q9UJ96 18 79863668-79900184 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 5.3" "Cell line enhanced" "Detected in some" "NB-4: 3.5;U-2 OS: 1.1;U-937: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 4 "hippocampal formation: 31.7" HPA048628 Enhanced "HPA048628: " "unprognostic (1.07e-2)" "unprognostic (1.34e-2)" "unprognostic (8.39e-2)" "unprognostic (4.41e-1)" "unprognostic (1.99e-1)" "unprognostic (9.69e-2)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (2.40e-1)" "unprognostic (3.78e-1)" "unprognostic (3.61e-3)" "unprognostic (1.09e-1)" "unprognostic (3.18e-5)" "unprognostic (1.05e-1)" "unprognostic (7.72e-2)" "unprognostic (4.08e-2)" "unprognostic (3.63e-2)" 0.2 0.1 1.5 0.8 2.2 0.6 0.0 0.1 2.4 0.0 0.3 1.1 0.3 0.0 0.1 0.0 0.0 0.0 5.3 1.0 0.9 0.1 0.2 0.4 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.2 0.3 0.3 1.2 0.0 0.0 0.5 0.0 0.6 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.0 0.7 0.3 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.7 0.1 0.1 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 KCNH1 "eag, eag1, h-eag, Kv10.1" ENSG00000143473 "Potassium voltage-gated channel subfamily H member 1" O95259 1 210676823-211134180 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 20.2" "Cell line enhanced" "Detected in some" "LHCN-M2: 4.2;RH-30: 7.1;RPTEC TERT1: 4.1;SH-SY5Y: 9.0;SK-MEL-30: 8.5;T-47d: 6.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014551, HPA019445" Enhanced Supported Vesicles Vesicles "HPA014551: , HPA019445: AB_1852118" "unprognostic (9.12e-2)" "unprognostic (4.82e-3)" "unprognostic (2.63e-1)" "unprognostic (6.70e-2)" "unprognostic (3.56e-1)" "unprognostic (3.63e-2)" "unprognostic (1.73e-1)" "unprognostic (9.36e-2)" "unprognostic (1.41e-1)" "unprognostic (1.98e-1)" "unprognostic (1.46e-2)" "unprognostic (2.77e-2)" "unprognostic (1.42e-3)" "unprognostic (1.17e-1)" "unprognostic (8.89e-2)" "unprognostic (1.36e-1)" "unprognostic (9.70e-2)" 0.9 2.3 6.3 1.3 13.3 0.7 0.6 19.1 20.2 1.0 1.3 3.3 0.2 1.2 1.5 1.0 0.9 1.2 1.0 0.7 3.8 1.7 1.0 0.7 0.7 0.7 1.1 7.5 0.8 0.9 0.9 0.8 1.1 1.7 1.3 1.3 0.0 0.8 0.9 0.7 0.9 1.0 1.0 2.1 0.6 1.5 2.4 1.5 0.0 0.8 0.0 0.7 0.9 0.7 0.1 0.7 0.7 0.1 0.1 0.3 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.1 0.6 0.1 1.4 1.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.1 0.0 0.0 7.1 0.0 4.1 0.0 0.3 9.0 1.6 0.1 8.5 6.3 0.0 0.0 1.1 0.1 1.3 0.8 0.0 0.0 0.0 0.2 0.0 0.5 0.7 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.7 0.1 0.0 6.3 13.3 19.1 20.2 3.8 1.7 1.1 7.5 1.7 1.5 KCNJ1 "Kir1.1, ROMK1" ENSG00000151704 "Potassium voltage-gated channel subfamily J member 1" P48048 11 128836315-128867373 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Bartter syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 51 "kidney: 123.2" "Cell line enriched" "Detected in some" 40 "RPTEC TERT1: 50.6" "Cancer enriched" "Detected in some" 7 "renal cancer: 3.4" "Region enriched" "Detected in single" 4 "basal ganglia: 2.3" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA026962 Enhanced "HPA026962: AB_10601934" "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (1.14e-1)" "unprognostic (3.19e-1)" "unprognostic (7.55e-2)" "unprognostic (1.29e-1)" "unprognostic (3.01e-2)" "unprognostic (2.69e-1)" "unprognostic (1.46e-1)" "unprognostic (2.44e-2)" "unprognostic (6.47e-2)" "unprognostic (2.78e-1)" "unprognostic (6.05e-2)" "unprognostic (4.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.28e-1)" "unprognostic (7.81e-3)" 0.1 0.0 0.5 0.2 2.3 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 123.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.3 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.9 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 2.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KCNJ11 "BIR, Kir6.2" ENSG00000187486 "Potassium voltage-gated channel subfamily J member 11" Q14654 11 17385859-17389331 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 63.1" "Cell line enhanced" "Detected in many" "Daudi: 7.1;HEK 293: 13.4;MCF7: 10.7;SCLC-21H: 9.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA048891 Approved "HPA048891: " "unprognostic (1.95e-2)" "unprognostic (6.18e-3)" "unprognostic (7.79e-2)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.25e-1)" "unprognostic (4.81e-5)" "unprognostic (1.83e-3)" "unprognostic (5.45e-2)" "unprognostic (8.09e-3)" "unprognostic (3.72e-3)" "unprognostic (9.23e-3)" "prognostic favourable (1.56e-4)" "unprognostic (4.05e-2)" "unprognostic (2.10e-2)" "unprognostic (1.67e-1)" "unprognostic (4.75e-2)" 2.5 1.1 2.9 1.0 7.8 0.8 2.7 13.6 7.8 1.0 1.1 0.7 4.9 1.4 1.1 2.1 1.7 1.1 1.1 6.2 3.5 2.4 1.3 0.9 1.3 1.2 2.7 5.2 0.8 8.7 2.7 3.3 0.7 3.5 2.5 1.0 0.1 1.2 7.6 63.1 1.0 1.1 0.8 1.7 1.0 4.6 0.8 1.9 0.0 4.1 4.5 1.0 0.9 1.1 0.8 0.4 1.4 0.3 0.8 0.4 0.4 1.5 2.3 0.3 4.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 2.5 0.2 7.1 0.2 0.0 0.3 4.8 0.1 0.3 1.6 13.4 3.6 0.9 0.8 0.1 0.4 0.3 0.1 0.3 0.0 0.1 0.0 3.7 3.8 0.0 10.7 0.7 0.1 1.0 0.3 1.4 1.7 2.0 0.4 0.9 9.1 0.8 0.0 3.5 0.0 4.6 0.2 0.0 0.0 1.2 0.0 0.1 0.2 6.0 0.9 0.0 1.0 0.0 1.4 0.3 0.2 0.4 0.3 0.3 0.7 0.4 0.4 0.1 0.8 0.4 0.4 1.3 0.8 0.1 0.4 0.3 0.4 2.9 7.8 13.6 7.8 3.5 2.4 2.7 5.2 3.5 1.9 KCNJ9 "GIRK3, Kir3.3" ENSG00000162728 "Potassium voltage-gated channel subfamily J member 9" Q92806 1 160081570-160090563 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 27 "brain: 52.0" "Group enriched" "Detected in some" 5 "SCLC-21H: 2.3;SH-SY5Y: 2.7;U-266/70: 2.8" "Cancer enriched" "Detected in single" 35 "glioma: 2.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070478 Enhanced "HPA070478: " "unprognostic (2.35e-1)" "unprognostic (6.53e-2)" "unprognostic (2.17e-2)" "unprognostic (4.73e-1)" "unprognostic (1.05e-1)" "unprognostic (7.29e-3)" "unprognostic (1.66e-1)" "unprognostic (3.33e-2)" "unprognostic (2.64e-1)" "unprognostic (3.29e-1)" "unprognostic (3.44e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-2)" "unprognostic (2.66e-1)" "unprognostic (1.34e-1)" "unprognostic (2.44e-1)" "unprognostic (5.24e-2)" 1.4 1.9 15.6 1.4 15.3 1.4 1.4 32.1 52.0 1.4 1.4 11.9 0.0 1.4 1.4 1.4 1.4 1.4 1.4 1.4 18.4 11.1 1.5 1.4 1.4 1.4 18.3 20.6 1.4 1.4 1.4 0.7 1.4 7.4 1.4 1.4 0.0 1.4 1.4 1.4 1.4 1.5 1.4 11.4 1.4 1.5 1.7 11.6 0.0 1.4 0.0 1.4 1.4 0.0 0.8 0.0 0.0 0.3 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 2.3 2.7 0.0 0.1 0.3 0.0 0.1 0.3 0.0 0.0 0.5 0.0 2.8 0.2 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.5 0.3 1.1 0.4 0.2 1.1 0.0 0.8 0.6 0.1 0.0 0.5 0.0 0.0 0.0 0.0 15.6 15.3 32.1 27.2 18.4 11.1 18.3 20.6 7.4 11.6 KCNK12 "K2p12.1, THIK-2, THIK2" ENSG00000184261 "Potassium two pore domain channel subfamily K member 12" Q9HB15 2 47516581-47570939 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 22.7" "Group enriched" "Detected in some" 6 "REH: 21.6;SCLC-21H: 8.5" "Cancer enriched" "Detected in single" 12 "testis cancer: 2.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (6.10e-2)" "unprognostic (1.24e-1)" "unprognostic (6.02e-3)" "unprognostic (3.29e-2)" "unprognostic (2.50e-1)" "unprognostic (3.77e-2)" "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (2.54e-2)" "unprognostic (2.14e-1)" "unprognostic (6.55e-3)" "unprognostic (2.12e-1)" "unprognostic (1.12e-6)" "unprognostic (1.36e-1)" "unprognostic (1.34e-1)" "unprognostic (3.06e-2)" "unprognostic (2.25e-1)" 1.1 1.7 9.8 5.1 4.6 1.0 0.9 22.7 16.1 0.8 1.1 2.4 0.0 1.0 1.0 1.0 1.0 0.9 0.9 0.9 5.6 3.4 1.0 0.8 1.0 1.6 7.2 4.0 1.2 0.8 0.9 5.5 1.7 8.1 1.0 0.9 0.6 0.9 0.8 1.2 1.0 0.9 0.9 10.1 1.1 1.2 1.5 2.1 0.0 1.0 0.0 1.5 1.0 0.3 0.7 0.1 0.2 0.0 0.4 1.8 0.2 0.0 0.1 0.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.2 0.5 21.6 0.0 1.6 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.7 1.0 1.8 0.1 0.2 1.1 1.0 0.2 0.4 0.0 0.0 1.1 0.2 9.8 4.6 22.7 16.1 5.6 3.4 7.2 4.0 8.1 2.1 KCNK2 "K2p2.1, TREK-1" ENSG00000082482 "Potassium two pore domain channel subfamily K member 2" O95069 1 215005775-215237093 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "adrenal gland: 49.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 31.2;fHDF/TERT166: 27.5;T-47d: 41.8;U-2197: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.43e-2)" "unprognostic (1.02e-1)" "unprognostic (6.91e-2)" "unprognostic (3.81e-4)" "unprognostic (2.58e-1)" "unprognostic (3.58e-2)" "unprognostic (3.48e-3)" "unprognostic (1.26e-1)" "unprognostic (1.49e-2)" "unprognostic (1.82e-1)" "unprognostic (1.03e-1)" "unprognostic (1.38e-1)" "unprognostic (2.98e-6)" "unprognostic (1.63e-2)" "unprognostic (4.37e-2)" "unprognostic (7.69e-3)" "unprognostic (7.46e-3)" 2.9 49.1 4.8 1.1 7.4 0.5 6.1 1.1 6.2 2.3 1.1 2.5 0.0 0.6 0.8 2.6 1.2 1.0 1.6 0.5 5.1 4.3 1.2 0.5 0.7 0.5 2.3 7.3 3.5 2.0 0.5 0.5 0.5 3.3 1.2 1.6 0.0 0.8 3.7 1.2 3.4 2.3 1.5 4.5 0.4 3.7 1.5 3.3 0.0 8.9 2.7 0.4 2.6 3.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 7.8 31.2 0.0 11.0 7.3 3.5 8.2 0.0 0.4 0.0 0.0 27.5 0.0 4.8 0.0 6.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 8.1 0.0 8.4 0.8 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.8 0.2 0.1 41.8 0.0 0.0 6.1 0.2 14.9 0.6 0.6 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.8 7.4 1.1 6.2 5.1 4.3 2.3 7.3 3.3 3.3 KCNK4 "K2p4.1, TRAAK" ENSG00000182450 "Potassium two pore domain channel subfamily K member 4" Q9NYG8 11 64291302-64300031 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 12.3" "Cell line enhanced" "Detected in some" "BEWO: 2.1;MCF7: 1.5;SH-SY5Y: 2.9;U-2197: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.85e-1)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (2.84e-1)" 0.7 0.5 12.2 0.5 11.6 0.5 0.5 1.0 12.3 1.6 0.6 0.3 0.0 0.6 1.2 0.5 0.5 0.6 0.6 0.6 10.2 3.1 0.7 0.5 0.6 0.6 1.5 4.0 0.5 0.5 0.5 0.0 2.0 2.7 0.9 0.5 1.1 0.5 0.8 0.5 0.5 0.7 0.5 0.3 0.6 0.6 0.9 0.1 0.0 0.6 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.2 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.2 0.0 1.5 0.0 0.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 1.2 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 11.6 1.0 12.3 10.2 3.1 1.5 4.0 2.7 0.1 KCNN1 "hSK1, KCa2.1" ENSG00000105642 "Potassium calcium-activated channel subfamily N member 1" Q92952 19 17951293-18000080 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 12 "brain: 32.5" "Cell line enriched" "Detected in some" 12 "REH: 57.4" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065938 Approved "Actin filaments,Cytosol" "Actin filaments, Cytosol" "HPA065938: " "unprognostic (7.55e-2)" "unprognostic (4.03e-2)" "unprognostic (1.82e-1)" "unprognostic (7.80e-2)" "unprognostic (1.90e-1)" "unprognostic (8.94e-5)" "unprognostic (3.92e-3)" "unprognostic (1.01e-1)" "unprognostic (8.42e-2)" "unprognostic (3.59e-1)" "unprognostic (2.71e-3)" "unprognostic (3.38e-1)" "unprognostic (5.21e-3)" "unprognostic (2.70e-2)" "unprognostic (1.14e-1)" "unprognostic (7.24e-3)" "unprognostic (3.24e-1)" 0.8 0.9 25.8 1.5 11.3 0.9 0.8 3.3 27.0 1.6 1.0 0.5 0.1 1.0 1.7 1.0 1.0 0.9 1.0 1.3 32.5 3.3 0.9 0.8 0.8 1.0 5.0 8.7 2.6 0.9 0.7 0.2 0.8 4.1 1.2 0.8 0.0 1.5 1.3 1.0 0.9 1.2 0.9 1.2 0.9 0.9 2.8 1.6 0.0 0.9 0.0 1.0 0.9 0.0 0.2 0.2 2.3 0.1 0.1 0.2 0.0 0.0 0.2 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.1 0.1 0.9 1.8 0.1 0.0 0.0 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.0 57.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.5 0.1 0.0 0.2 0.0 0.0 25.8 11.3 3.3 22.4 32.5 3.3 5.0 8.7 4.1 1.6 KCNQ2 "BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2" ENSG00000075043 "Potassium voltage-gated channel subfamily Q member 2" O43526 20 63400210-63472677 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.8" "Cell line enhanced" "Detected in some" "AF22: 8.3;AN3-CA: 13.7;NTERA-2: 7.6;SCLC-21H: 26.9;SH-SY5Y: 47.2" "Cancer enriched" "Detected in some" 9 "glioma: 8.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.2;T-reg: 1.5" "Lineage enriched" "Detected in single" 22 "T-cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016642, HPA057112" Enhanced Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA016642: AB_1855555, HPA057112: " "unprognostic (2.35e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-4)" "unprognostic (8.21e-6)" "unprognostic (6.18e-2)" "unprognostic (7.58e-2)" "unprognostic (6.06e-2)" "unprognostic (3.16e-1)" "unprognostic (1.73e-1)" "unprognostic (1.92e-1)" "unprognostic (9.96e-2)" "unprognostic (9.39e-2)" "unprognostic (1.43e-5)" "unprognostic (4.36e-2)" "unprognostic (1.02e-1)" "unprognostic (1.81e-1)" "unprognostic (2.70e-2)" 1.2 10.0 18.7 1.3 21.4 1.2 1.2 24.1 50.8 1.2 1.3 2.4 0.0 1.3 1.2 1.3 1.2 1.7 1.7 1.2 15.4 10.0 1.2 1.2 1.2 1.2 8.4 14.1 1.2 1.9 1.2 9.2 1.2 8.9 2.8 1.2 0.0 1.2 1.2 1.2 1.2 1.3 1.2 2.6 1.2 1.3 6.9 4.2 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 8.3 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 26.9 47.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 1.5 0.0 18.7 21.4 24.1 31.2 15.4 10.0 8.4 14.1 8.9 4.2 KCNQ3 "EBN2, Kv7.3" ENSG00000184156 "Potassium voltage-gated channel subfamily Q member 3" O43525 8 132120858-132481019 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 29.5" "Cell line enhanced" "Detected in some" "HBEC3-KT: 3.8;hTERT-HME1: 10.2;RPMI-8226: 4.1;U-2 OS: 6.7;U-87 MG: 5.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (2.90e-1)" "unprognostic (1.26e-3)" "unprognostic (1.45e-2)" "unprognostic (3.65e-5)" "unprognostic (2.32e-1)" "unprognostic (4.60e-2)" "unprognostic (5.57e-6)" "unprognostic (5.82e-2)" "unprognostic (7.32e-2)" "unprognostic (6.09e-2)" "unprognostic (7.09e-2)" "unprognostic (3.22e-1)" "unprognostic (2.71e-4)" "unprognostic (1.14e-3)" "unprognostic (3.52e-1)" "unprognostic (7.92e-2)" "unprognostic (2.50e-2)" 1.8 3.3 10.6 1.5 13.1 0.7 1.4 0.9 29.5 1.4 1.0 1.7 0.0 1.0 1.0 0.9 0.8 1.2 1.3 1.8 8.0 7.3 1.8 0.7 2.0 0.9 7.4 11.5 0.8 1.2 1.2 1.4 1.0 6.5 1.4 1.0 0.0 1.0 1.8 0.7 1.3 1.7 1.6 2.1 1.3 0.9 1.0 4.7 0.0 1.2 0.0 1.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.5 1.6 0.0 0.5 1.6 0.0 0.0 0.0 1.6 0.0 1.8 2.3 0.0 0.0 3.8 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 2.7 10.2 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.7 0.3 0.0 0.0 4.1 2.4 0.0 1.9 1.7 0.7 0.0 0.0 0.0 1.5 0.0 0.0 6.7 0.2 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 13.1 0.9 13.3 8.0 7.3 7.4 11.5 6.5 4.7 KCNS2 Kv9.2 ENSG00000156486 "Potassium voltage-gated channel modifier subfamily S member 2" Q9ULS6 8 98427022-98432848 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.9" "Group enriched" "Detected in some" 6 "HSkMC: 3.9;SCLC-21H: 11.6" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051417 Uncertain "HPA051417: " "unprognostic (7.83e-2)" "unprognostic (9.39e-3)" "unprognostic (5.25e-2)" "unprognostic (2.87e-1)" "unprognostic (1.38e-2)" "unprognostic (2.59e-2)" "unprognostic (1.21e-1)" "unprognostic (1.12e-2)" "unprognostic (4.27e-2)" "unprognostic (4.58e-2)" "unprognostic (1.47e-1)" "unprognostic (5.30e-5)" "unprognostic (2.43e-2)" "unprognostic (1.42e-2)" "unprognostic (2.31e-1)" "unprognostic (1.30e-1)" "unprognostic (1.27e-3)" 1.6 1.4 2.9 0.6 6.6 0.3 0.7 0.7 20.9 2.0 1.0 0.1 0.5 0.4 1.3 1.7 0.9 1.0 1.5 0.4 1.9 2.8 0.7 0.3 0.7 0.4 0.8 6.4 1.9 0.8 0.8 1.2 4.4 3.4 0.9 0.9 0.1 0.3 3.3 0.2 0.3 0.7 0.6 0.9 0.3 1.5 1.0 0.4 0.0 0.5 0.0 0.3 2.5 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 1.3 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 6.6 0.7 20.9 1.9 2.8 0.8 6.4 3.4 0.4 KCNU1 "KCa5.1, Kcnma3, KCNMC1, Slo3" ENSG00000215262 "Potassium calcium-activated channel subfamily U member 1" A8MYU2 8 36784324-36936128 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 15.8" "Cell line enriched" "Detected in some" 5 "HDLM-2: 12.8" "Cancer enhanced" "Detected in single" "liver cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA063317 Uncertain "Plasma membrane" "Plasma membrane" "HPA063317: " "unprognostic (2.42e-3)" "unprognostic (4.26e-2)" "unprognostic (2.07e-1)" "unprognostic (4.76e-3)" "unprognostic (7.57e-2)" "unprognostic (1.12e-1)" "unprognostic (1.11e-1)" "unprognostic (2.71e-1)" "unprognostic (1.98e-1)" "unprognostic (7.73e-2)" "unprognostic (1.24e-2)" 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.1 12.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNV1 Kv8.1 ENSG00000164794 "Potassium voltage-gated channel modifier subfamily V member 1" Q6PIU1 8 109963645-109975847 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 22.4" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in single" "renal cancer: 0.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (1.41e-1)" "unprognostic (1.81e-2)" "unprognostic (5.01e-4)" "unprognostic (2.30e-1)" "unprognostic (3.76e-2)" "unprognostic (1.13e-2)" "unprognostic (3.89e-2)" "unprognostic (2.27e-1)" "unprognostic (4.17e-2)" 0.5 0.5 10.6 0.6 10.2 1.1 0.6 0.2 22.4 0.4 1.1 0.0 0.0 0.5 0.6 1.2 0.5 0.4 0.5 0.5 3.9 1.6 0.6 0.5 0.5 0.7 0.9 8.2 0.8 1.0 0.4 0.7 0.6 0.9 0.7 0.9 0.0 0.6 0.5 0.5 1.1 0.8 0.4 0.4 0.6 0.5 0.7 0.0 0.0 0.9 0.0 0.5 0.4 0.2 0.8 0.6 2.5 0.9 0.6 0.5 0.1 2.0 2.6 1.9 0.8 0.3 0.3 0.7 0.6 0.0 0.4 0.4 0.5 0.8 0.7 0.6 0.1 2.1 0.7 0.3 0.5 1.0 0.3 1.2 2.0 0.5 0.1 1.1 1.5 0.3 0.4 0.6 0.5 0.4 1.0 2.6 0.3 0.6 0.8 1.2 0.9 1.2 0.2 1.0 0.3 3.4 1.0 1.5 0.7 0.4 0.4 0.6 1.0 0.5 1.3 2.3 1.9 1.5 0.6 0.9 0.5 0.4 1.0 0.9 0.9 2.5 0.8 0.3 0.5 0.9 0.4 0.6 0.5 0.5 0.5 0.8 0.5 0.5 1.1 0.6 0.8 0.6 0.3 0.1 10.6 10.2 0.2 19.5 3.9 1.6 0.9 8.2 0.9 0.0 KCNV2 Kv8.2 ENSG00000168263 "Potassium voltage-gated channel modifier subfamily V member 2" Q8TDN2 9 2717502-2730037 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 82.3" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HDLM-2: 2.8;HeLa: 2.3" "Cancer enriched" "Detected in single" 78 "testis cancer: 6.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA031131 Enhanced "HPA031131: AB_10609996" "unprognostic (5.06e-2)" "unprognostic (1.47e-3)" "unprognostic (3.45e-3)" "unprognostic (6.41e-2)" "unprognostic (1.31e-1)" "unprognostic (2.28e-2)" "unprognostic (1.12e-3)" "unprognostic (5.38e-2)" "unprognostic (1.39e-2)" "unprognostic (1.69e-1)" "unprognostic (5.21e-2)" "unprognostic (2.35e-1)" "unprognostic (7.96e-8)" "unprognostic (3.01e-1)" "unprognostic (4.90e-2)" "unprognostic (9.90e-2)" "unprognostic (1.06e-2)" 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 82.3 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.1 0.0 0.6 0.0 0.2 0.7 0.2 0.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.9 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 2.8 1.3 0.8 2.3 0.3 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.5 0.6 0.1 0.2 0.0 0.3 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.1 0.6 0.0 0.0 0.7 0.3 0.5 0.3 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 KCTD16 KIAA1317 ENSG00000183775 "Potassium channel tetramerization domain containing 16" Q68DU8 5 144170832-144485686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 25.1" "Cell line enhanced" "Detected in some" "SCLC-21H: 6.9;TIME: 13.1;U-87 MG: 3.0" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Group enriched" "Detected in many" 5 "amygdala: 11.4;basal ganglia: 14.5;cerebral cortex: 25.1;hippocampal formation: 14.5;olfactory region: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044590, HPA050154" Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA044590: AB_2679008, HPA050154: AB_2681034" "unprognostic (7.22e-2)" "unprognostic (3.63e-1)" "unprognostic (2.54e-2)" "unprognostic (6.81e-5)" "unprognostic (9.88e-2)" "unprognostic (1.21e-1)" "unprognostic (7.74e-3)" "unprognostic (3.23e-2)" "unprognostic (1.94e-2)" "unprognostic (9.57e-2)" "unprognostic (9.38e-3)" "unprognostic (6.20e-3)" "unprognostic (2.52e-8)" "unprognostic (1.55e-3)" "unprognostic (2.34e-1)" "unprognostic (5.80e-3)" "unprognostic (1.22e-2)" 1.0 2.0 11.4 0.7 14.5 0.6 0.9 0.7 25.1 1.5 0.8 0.4 0.0 1.0 0.9 1.5 0.8 1.2 1.4 0.9 14.5 3.2 2.9 0.8 2.4 0.7 1.7 12.0 1.0 5.2 0.8 1.7 0.9 1.3 0.8 0.7 0.0 0.7 1.1 0.6 0.7 1.2 0.9 1.6 0.7 0.8 4.4 2.4 0.0 2.2 0.0 0.7 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.1 0.6 0.0 1.9 1.6 0.6 0.8 0.4 0.0 0.0 0.6 0.5 0.0 0.0 0.3 0.8 0.2 0.1 0.0 0.5 0.1 0.2 0.0 0.0 0.4 0.1 1.1 0.1 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 6.9 0.3 0.1 0.0 0.1 0.0 0.0 13.1 1.0 0.7 0.2 0.0 0.2 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 14.5 0.7 25.1 14.5 3.2 1.7 12.0 1.3 2.4 KCTD19 FLJ40162 ENSG00000168676 "Potassium channel tetramerization domain containing 19" Q17RG1 16 67289428-67326763 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 57.3" "Cell line enhanced" "Detected in some" "HBF TERT88: 3.9;U-2197: 3.6;U-266/70: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 1.6;neutrophil: 6.6;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 5 "dendritic cells: 5.3;granulocytes: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA049310, HPA053321" Uncertain "HPA049310: , HPA053321: " "unprognostic (2.44e-1)" "unprognostic (2.14e-2)" "unprognostic (4.39e-2)" "unprognostic (2.48e-2)" "unprognostic (1.38e-1)" "unprognostic (1.60e-2)" "unprognostic (9.01e-2)" "unprognostic (9.32e-2)" "unprognostic (1.75e-1)" "unprognostic (5.91e-2)" "unprognostic (1.88e-4)" "unprognostic (4.44e-1)" "unprognostic (2.76e-3)" "unprognostic (1.19e-2)" "unprognostic (2.91e-2)" "unprognostic (9.71e-2)" "unprognostic (8.44e-2)" 0.2 0.1 0.2 0.7 0.8 3.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.3 0.7 0.4 0.3 0.6 0.1 0.1 0.4 0.3 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.0 0.3 0.2 0.3 0.1 0.1 0.4 0.1 0.1 0.4 1.4 0.1 0.1 0.1 0.3 0.3 57.3 0.3 1.4 0.2 0.1 0.1 0.4 0.1 1.1 5.3 6.6 0.9 1.0 0.6 0.6 0.0 0.6 0.3 0.0 0.0 0.0 0.6 0.7 0.8 1.2 0.6 1.0 0.6 0.9 0.6 0.0 0.3 1.2 0.0 3.9 0.7 2.7 1.0 0.0 0.0 0.6 0.4 0.4 0.8 1.0 1.1 0.6 0.2 1.1 0.3 0.0 0.0 1.1 1.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.7 1.5 0.2 0.7 0.2 0.2 0.6 1.1 0.0 0.8 3.6 0.1 10.9 1.9 0.6 1.2 0.1 1.0 1.6 0.9 0.8 0.6 0.5 0.4 0.6 0.4 0.5 0.3 1.1 0.5 0.5 6.6 1.0 0.5 5.3 0.4 0.6 0.2 0.8 0.1 0.2 0.1 0.4 0.1 0.4 0.3 0.3 KCTD4 bA321C24.3 ENSG00000180332 "Potassium channel tetramerization domain containing 4" Q8WVF5 13 45192853-45194717 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 45.5" "Cell line enhanced" "Detected in some" "hTERT-HME1: 4.7;RPTEC TERT1: 9.5;U-138 MG: 11.5;U-87 MG: 22.8" "Group enriched" "Detected in some" 5 "glioma: 1.2;renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040734 Uncertain Approved "Centriolar satellite" "Centriolar satellite" "HPA040734: AB_10963227" "unprognostic (1.36e-1)" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.19e-2)" "unprognostic (1.70e-1)" "unprognostic (4.68e-2)" "unprognostic (1.74e-1)" "unprognostic (1.66e-3)" "unprognostic (1.63e-1)" "unprognostic (1.73e-1)" "unprognostic (2.15e-1)" "unprognostic (2.98e-2)" 0.5 0.6 33.1 0.6 45.5 0.7 1.5 0.2 22.0 0.7 1.1 1.5 0.0 0.9 0.5 0.6 0.5 0.5 1.8 0.9 9.8 4.0 0.9 0.5 0.5 0.5 3.6 4.8 0.5 0.9 0.5 1.1 0.9 3.9 0.5 0.9 1.8 1.5 0.8 0.5 6.4 1.0 1.8 2.7 0.5 0.5 0.5 7.0 0.0 0.5 0.0 0.5 0.5 0.0 0.0 0.0 0.5 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 2.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.5 0.0 0.0 2.4 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.7 0.6 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 33.1 45.5 0.2 9.3 9.8 4.0 3.6 4.8 3.9 7.0 KDM4D "FLJ10251, JMJD2D" ENSG00000186280 "Lysine demethylase 4D" Q6B0I6 11 94973681-94999518 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 37.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 5.1" "Low lineage specificity" "Detected in many" "HPA055854, HPA064037" Approved Approved Nucleoplasm Nucleoplasm "HPA055854: , HPA064037: " "unprognostic (1.98e-1)" "unprognostic (5.71e-2)" "unprognostic (1.83e-1)" "unprognostic (9.65e-3)" "unprognostic (3.19e-1)" "unprognostic (5.12e-2)" "unprognostic (2.84e-2)" "unprognostic (3.16e-1)" "unprognostic (3.11e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (5.62e-2)" "unprognostic (4.49e-2)" "unprognostic (8.14e-2)" "unprognostic (1.84e-1)" "unprognostic (2.45e-1)" "unprognostic (2.88e-1)" 0.6 0.8 1.2 0.4 2.0 0.1 0.8 1.4 2.1 0.6 0.3 1.2 1.7 0.2 0.6 0.9 0.4 1.0 0.5 1.0 0.7 0.7 0.6 0.4 0.4 0.7 0.6 1.3 1.3 0.4 1.4 2.1 0.5 1.1 0.6 0.4 1.2 0.7 0.7 1.0 0.7 0.5 0.6 0.9 0.7 0.4 37.5 1.0 0.3 0.8 0.6 0.6 0.6 0.4 1.3 1.2 0.0 5.1 0.1 1.4 0.2 0.9 1.4 5.8 4.2 1.2 1.5 2.7 1.9 2.1 5.4 4.8 1.5 1.8 2.1 6.3 1.6 1.7 3.7 4.1 4.1 2.3 3.8 1.9 0.7 2.2 1.1 0.9 0.6 2.8 2.2 5.3 4.8 2.0 2.1 1.0 2.0 1.8 3.2 2.1 2.5 7.0 4.4 2.5 1.6 1.3 0.6 3.4 4.1 2.3 2.0 1.6 2.2 0.6 1.5 3.7 2.1 5.7 2.9 1.4 4.2 0.3 1.3 1.1 4.0 0.0 0.3 0.0 0.3 0.2 0.2 1.3 0.6 1.0 0.0 0.2 0.8 0.1 0.0 0.1 5.1 1.2 1.4 0.2 1.2 2.0 1.4 2.1 0.7 0.7 0.6 1.3 1.1 1.0 KIAA0319 NMIG ENSG00000137261 KIAA0319 Q5VV43 6 24544104-24646155 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 23.5" "Cell line enhanced" "Detected in some" "A-431: 3.6;A549: 4.1;HDLM-2: 4.8;SCLC-21H: 7.8;U-266/84: 6.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 1.4;neutrophil: 5.0" "Group enriched" "Detected in many" 32 "B-cells: 1.4;granulocytes: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015607, HPA076313" Enhanced Supported Approved Vesicles "Secreted in brain" Vesicles "HPA015607: AB_1852299, HPA076313: " "unprognostic (1.64e-1)" "unprognostic (2.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (1.77e-1)" "unprognostic (1.72e-2)" "unprognostic (4.65e-2)" "unprognostic (9.70e-2)" "unprognostic (2.21e-5)" "unprognostic (7.88e-4)" "unprognostic (9.53e-4)" "unprognostic (1.44e-6)" "unprognostic (1.20e-1)" "unprognostic (6.97e-2)" "unprognostic (3.13e-1)" "unprognostic (3.41e-2)" 0.9 1.9 9.9 1.3 10.2 0.9 1.1 10.7 23.5 0.9 1.6 4.0 0.0 0.9 0.9 0.9 0.8 4.8 1.4 0.8 9.7 7.7 0.9 0.8 2.2 0.9 5.8 12.1 0.8 3.0 0.8 3.8 1.1 10.2 1.7 1.7 0.0 0.8 0.9 0.8 2.4 1.1 1.1 1.4 1.1 3.2 3.5 2.3 0.0 0.8 0.0 1.1 0.9 0.1 1.4 0.0 5.0 0.0 0.0 0.0 0.0 3.6 4.1 0.2 2.6 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.2 1.5 1.1 2.0 0.0 1.7 0.7 0.0 0.0 4.8 1.8 0.0 3.5 0.2 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.0 0.5 0.3 0.2 0.0 0.8 0.1 0.2 7.8 0.5 0.1 2.2 0.0 0.8 0.0 0.0 0.0 0.6 0.4 0.7 0.6 6.3 0.3 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 9.9 10.2 10.7 14.9 9.7 7.7 5.8 12.1 10.2 2.3 KIAA1024L ENSG00000186367 "KIAA1024 like" P59773 5 129748079-129766732 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 26.0" "Cell line enhanced" "Detected in some" "SH-SY5Y: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA013760 Uncertain "HPA013760: AB_1852363" "unprognostic (1.77e-1)" "unprognostic (5.13e-1)" 0.0 0.0 0.1 0.0 0.9 0.1 0.1 0.0 2.8 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.1 2.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.0 26.0 0.0 0.0 0.0 0.3 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.6 2.8 4.1 1.1 0.8 0.8 0.1 0.6 0.1 0.1 1.9 0.2 0.1 0.5 0.3 0.2 0.3 0.4 0.1 3.1 1.0 1.3 0.2 1.6 0.0 0.3 0.2 1.6 1.2 0.4 0.7 0.8 0.0 0.2 1.4 0.6 0.4 0.1 0.4 0.2 0.4 2.1 0.5 0.4 1.5 1.7 1.2 1.6 0.3 0.5 0.6 0.5 0.8 0.8 4.7 0.2 3.1 0.5 1.2 0.3 0.2 1.6 1.2 0.9 0.3 0.2 0.8 0.5 1.2 0.1 2.4 4.1 1.1 0.6 0.8 0.6 0.8 0.6 0.6 0.5 0.3 1.6 0.6 0.8 2.6 0.8 1.0 2.8 0.3 0.1 0.1 0.9 0.0 2.8 0.1 2.0 0.3 0.0 1.9 0.0 KIF11 "Eg5, HKSP, KNSL1, TRIP5" ENSG00000138160 "Kinesin family member 11" P52732 10 92593286-92655395 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 74.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA006916, HPA010093, HPA010568, CAB017617" Enhanced Supported "Mitotic spindle,Cytosol" Cytosol "Mitotic spindle" "CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: , HPA010568: AB_1848034" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (1.59e-2)" "unprognostic (3.35e-2)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "prognostic unfavourable (8.19e-7)" "prognostic unfavourable (3.27e-4)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.30e-4)" "unprognostic (6.59e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.35e-3)" "unprognostic (7.23e-2)" "unprognostic (9.08e-2)" "unprognostic (2.01e-1)" 2.3 1.6 1.0 20.2 2.6 14.3 1.6 0.7 1.5 2.4 4.6 0.7 0.5 3.7 1.4 1.9 11.5 0.8 2.6 2.0 1.1 1.2 1.1 1.1 2.8 12.1 1.0 1.0 1.1 1.1 0.5 0.7 3.1 1.4 1.0 5.4 0.5 2.7 0.2 0.6 4.2 4.4 1.6 1.8 5.2 2.7 10.5 1.1 74.2 1.2 7.5 13.4 2.2 3.8 2.4 0.9 2.5 1.2 3.5 3.9 1.0 30.6 13.7 31.0 28.8 2.2 3.4 7.7 22.1 19.3 24.6 24.4 12.0 20.4 33.9 11.4 10.3 22.2 22.1 11.3 28.9 20.2 12.7 21.2 13.1 12.5 0.4 34.1 19.8 1.1 1.0 19.0 17.7 15.2 15.0 39.7 18.5 12.3 29.0 19.2 12.3 9.5 31.3 30.7 12.0 6.4 9.0 9.5 13.6 17.3 7.8 9.0 21.2 10.9 8.6 11.2 16.2 11.4 29.0 11.1 17.0 34.9 9.1 24.7 15.2 2.5 0.5 0.5 0.4 1.2 1.1 2.4 1.4 1.9 0.9 1.0 0.5 0.7 1.4 3.5 0.4 0.4 3.9 1.0 1.0 2.6 0.7 1.5 1.1 1.2 1.0 1.0 1.4 1.1 KIF1A "ATSV, C2orf20, SPG30, UNC104" ENSG00000130294 "Kinesin family member 1A" Q12756 2 240713764-240820308 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 144.1" "Cell line enhanced" "Detected in some" "AN3-CA: 18.8;HAP1: 33.3;K-562: 29.1;SCLC-21H: 89.7;SH-SY5Y: 14.4" "Cancer enhanced" "Detected in many" "glioma: 20.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Low region specificity" "Detected in all" HPA005442 Approved "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA005442: AB_1079210" "unprognostic (1.19e-1)" "unprognostic (2.17e-3)" "unprognostic (7.31e-2)" "prognostic unfavourable (4.97e-4)" "unprognostic (1.65e-1)" "unprognostic (4.74e-3)" "unprognostic (2.32e-2)" "unprognostic (1.82e-1)" "unprognostic (2.11e-1)" "unprognostic (3.09e-2)" "unprognostic (2.06e-2)" "unprognostic (2.60e-1)" "unprognostic (2.54e-1)" "unprognostic (3.83e-2)" "unprognostic (1.96e-1)" "unprognostic (1.74e-3)" "unprognostic (3.90e-2)" 2.1 15.2 47.0 2.9 37.0 2.0 2.0 28.4 144.1 1.9 2.7 35.8 0.0 2.9 2.3 3.1 2.0 2.3 2.1 8.2 40.9 28.4 2.1 2.3 2.1 2.0 35.1 46.8 3.5 31.3 2.0 15.7 2.0 38.7 6.4 2.6 8.6 2.0 2.2 1.9 2.8 2.9 2.3 35.0 2.2 5.0 10.0 30.9 0.0 2.9 0.0 1.9 2.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.5 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 1.0 0.0 0.0 33.3 0.0 0.0 2.6 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 29.1 0.1 0.0 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 89.7 14.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 47.0 37.0 28.4 62.2 40.9 28.4 35.1 46.8 38.7 30.9 KIF2B ENSG00000141200 "Kinesin family member 2B" Q8N4N8 17 53822901-53825213 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 261 "testis: 103.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023081, HPA023103, HPA024795" Uncertain Supported "Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle" "Microtubules, Cytokinetic bridge, Mitotic spindle" Nucleoli "HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KIF3C ENSG00000084731 "Kinesin family member 3C" O14782 2 25926596-25982749 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 72.9" "Cell line enhanced" "Detected in many" "SH-SY5Y: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035755 Approved "Nuclear membrane,Nuclear bodies,Intermediate filaments" "Nuclear bodies, Intermediate filaments" "Nuclear membrane" "HPA035755: AB_10602242" "unprognostic (3.95e-1)" "unprognostic (1.40e-2)" "unprognostic (7.85e-2)" "prognostic unfavourable (1.32e-5)" "unprognostic (2.75e-1)" "unprognostic (4.69e-2)" "unprognostic (3.96e-4)" "unprognostic (1.53e-2)" "prognostic favourable (1.22e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-2)" "unprognostic (1.55e-1)" "prognostic unfavourable (7.57e-4)" "unprognostic (3.90e-2)" "unprognostic (3.54e-1)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" 3.0 7.3 22.8 2.9 21.2 2.2 2.6 22.7 72.9 3.6 2.4 3.8 0.0 2.1 3.9 2.6 3.0 3.3 4.1 3.0 21.6 18.9 2.0 1.6 2.6 2.0 17.5 20.3 7.3 2.3 4.5 4.8 2.8 22.8 3.3 2.6 1.9 1.9 4.6 2.4 2.3 2.7 4.8 6.2 2.2 2.0 3.0 5.2 0.5 2.5 0.0 2.0 3.5 1.5 0.1 0.3 2.4 0.2 0.7 2.0 1.3 13.0 19.8 10.6 8.1 6.2 7.2 8.5 6.8 3.4 4.1 4.7 3.5 2.0 0.0 5.7 6.2 1.4 8.0 4.1 2.8 2.2 3.8 4.7 1.5 7.1 3.7 1.2 4.1 5.2 1.2 12.9 2.6 13.6 1.7 1.7 4.3 0.9 3.3 1.6 10.8 5.8 5.3 5.2 0.8 9.4 3.2 12.9 29.1 2.7 1.2 14.3 0.4 1.6 10.7 7.2 7.4 3.2 6.6 0.4 2.3 1.5 16.3 6.4 6.1 0.0 0.2 0.0 0.4 0.0 1.1 0.0 1.6 1.5 0.3 0.1 0.5 0.6 2.4 0.7 0.0 0.2 2.0 1.3 22.8 21.2 22.7 40.0 21.6 18.9 17.5 20.3 22.8 5.2 KIF4B ENSG00000226650 "Kinesin family member 4B" Q2VIQ3 5 155013755-155018132 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 9.0" "Cell line enhanced" "Detected in some" "Karpas-707: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034745, HPA034746, HPA061583" Uncertain Uncertain Nucleoplasm,Midbody "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: " "unprognostic (9.87e-3)" "unprognostic (1.17e-1)" "unprognostic (3.91e-3)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.71e-1)" "unprognostic (4.76e-2)" "unprognostic (1.94e-1)" "unprognostic (1.06e-1)" "unprognostic (4.37e-2)" "unprognostic (6.48e-9)" "unprognostic (7.24e-2)" "unprognostic (5.10e-2)" "unprognostic (1.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.4 0.1 0.0 0.1 0.6 0.0 0.1 0.2 0.0 0.9 0.0 0.5 0.0 0.5 0.1 0.0 0.1 0.7 0.0 0.4 1.0 0.4 0.0 0.4 0.7 0.0 0.3 0.2 0.0 1.1 0.2 2.4 0.4 0.0 0.8 0.5 0.5 0.5 0.7 1.1 1.0 0.0 0.7 0.5 0.5 1.3 0.2 0.3 0.5 0.5 0.2 0.7 1.2 0.7 1.2 0.4 0.6 0.5 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 KIF5A "D12S1889, MY050, NKHC, SPG10" ENSG00000155980 "Kinesin family member 5A" Q12840 12 57549998-57586632 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Amyotrophic lateral sclerosis, Disease mutation, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 138.6" "Cell line enhanced" "Detected in some" "HDLM-2: 20.0;K-562: 8.4;NTERA-2: 10.3;SCLC-21H: 21.3;U-87 MG: 7.9" "Cancer enriched" "Detected in some" 5 "glioma: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.4;naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004469, HPA073448" Enhanced Approved "Nucleoplasm,Mitotic spindle,Cytosol" "Nucleoplasm, Cytosol" "Mitotic spindle" "HPA004469: AB_1079212, HPA073448: " "unprognostic (7.94e-2)" "unprognostic (4.95e-3)" "unprognostic (3.87e-1)" "unprognostic (3.34e-3)" "unprognostic (7.12e-2)" "unprognostic (4.22e-2)" "unprognostic (3.22e-5)" "unprognostic (2.82e-1)" "unprognostic (2.01e-1)" "unprognostic (1.52e-2)" "prognostic favourable (5.23e-4)" "unprognostic (7.61e-2)" "unprognostic (2.26e-4)" "unprognostic (4.75e-2)" "unprognostic (1.46e-1)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" 1.8 7.6 85.4 3.0 47.6 1.9 1.9 15.2 138.6 2.1 2.8 4.0 0.0 2.4 3.4 2.1 1.9 2.0 1.9 1.7 52.4 18.3 2.0 1.7 1.8 1.8 12.9 43.6 1.8 2.3 6.0 2.5 1.7 21.6 1.9 2.8 0.6 2.0 2.0 1.7 1.7 3.0 2.8 9.0 1.8 2.1 4.4 12.9 0.0 2.8 0.0 1.8 1.8 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.7 3.2 0.0 0.0 0.1 0.2 0.7 1.3 1.7 0.0 0.0 1.6 0.0 0.6 0.1 2.0 0.0 1.0 20.0 1.4 0.1 0.1 1.6 0.6 0.0 0.1 0.2 0.1 1.0 0.0 0.2 8.4 4.4 0.0 0.0 0.3 0.0 10.3 0.0 0.0 0.0 0.0 0.2 0.0 21.3 4.8 0.0 0.2 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.9 2.8 3.4 0.3 7.9 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.4 0.8 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.3 0.0 85.4 47.6 15.2 112.0 52.4 18.3 12.9 43.6 21.6 12.9 KIF5C ENSG00000168280 "Kinesin family member 5C" O60282 2 148875250-149026759 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Transport "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 95.8" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 65.3" "Cancer enhanced" "Detected in many" "prostate cancer: 19.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 5.9" "Lineage enriched" "Detected in single" 7 "T-cells: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035210, HPA062272" Enhanced Approved Vesicles Vesicles "HPA035210: AB_10671931, HPA062272: " "unprognostic (1.95e-1)" "unprognostic (2.39e-1)" "unprognostic (2.54e-1)" "unprognostic (4.70e-4)" "unprognostic (1.89e-1)" "unprognostic (3.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.90e-2)" "unprognostic (2.86e-1)" "unprognostic (1.41e-2)" "unprognostic (6.61e-3)" "unprognostic (1.56e-1)" "unprognostic (6.55e-6)" "unprognostic (8.34e-3)" "unprognostic (3.69e-1)" "unprognostic (3.63e-2)" "unprognostic (4.46e-2)" 1.8 10.5 32.0 2.3 31.8 1.3 1.6 33.8 95.8 2.2 2.5 21.7 0.0 1.6 1.8 11.0 1.4 1.6 1.7 1.6 25.4 13.7 1.6 1.2 1.5 1.8 15.8 25.5 3.3 2.5 1.5 12.6 1.3 27.1 21.9 3.2 0.4 1.4 7.5 1.3 1.4 2.3 2.0 20.1 1.6 2.4 13.5 18.3 0.0 3.6 0.0 1.7 2.4 1.0 0.8 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 12.6 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.6 0.0 0.1 0.0 7.3 0.0 1.4 3.7 1.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 12.7 3.9 0.0 0.1 0.0 0.0 2.7 65.3 15.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 1.1 0.0 1.8 1.2 0.2 0.0 4.6 0.2 0.4 0.0 0.0 0.0 0.3 0.0 5.9 0.5 1.1 1.4 0.0 0.8 0.2 0.3 0.0 0.0 0.0 0.0 0.7 0.0 32.0 31.8 33.8 40.3 25.4 13.7 15.8 25.5 27.1 18.3 KIFC1 "HSET, KNSL2" ENSG00000237649 "Kinesin family member C1" Q9BW19 6 33391536-33409924 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 60.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA055997, HPA062674" Enhanced Approved Centrosome Centrosome "HPA055997: , HPA062674: " "unprognostic (7.33e-2)" "unprognostic (1.28e-2)" "unprognostic (2.17e-1)" "unprognostic (2.65e-2)" "unprognostic (1.41e-1)" "unprognostic (2.30e-2)" "prognostic unfavourable (7.07e-8)" "unprognostic (6.34e-3)" "unprognostic (9.36e-3)" "unprognostic (8.58e-2)" "prognostic unfavourable (4.21e-4)" "unprognostic (1.83e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (5.17e-2)" "unprognostic (6.66e-2)" "unprognostic (1.48e-1)" "unprognostic (4.52e-1)" 0.9 0.8 0.0 18.0 0.3 9.6 1.5 0.0 0.5 1.7 5.7 0.1 0.3 3.0 0.9 1.6 10.1 0.5 2.2 0.8 0.0 0.0 0.7 0.7 2.2 6.3 0.1 0.2 1.5 0.3 0.2 0.2 3.6 0.4 0.6 2.5 0.6 1.7 0.1 0.4 3.3 4.2 0.7 0.4 4.7 2.5 9.7 0.2 60.9 0.4 7.4 14.6 0.6 2.8 0.8 0.3 0.0 0.1 0.2 1.4 0.7 10.6 1.8 10.2 10.7 0.2 0.4 6.2 7.7 1.9 6.1 5.2 3.7 4.7 7.0 3.0 1.6 5.8 2.6 3.6 6.7 4.1 5.8 5.7 8.6 5.4 0.0 4.6 6.3 0.0 0.9 5.1 1.5 0.5 1.7 17.4 4.6 2.7 2.7 9.3 4.7 2.2 7.0 5.7 2.4 0.9 2.4 9.3 4.1 2.8 5.9 1.4 6.2 4.8 1.4 3.2 10.0 5.4 11.4 5.7 10.9 6.8 0.0 6.9 5.7 0.0 0.1 0.0 0.4 0.0 0.6 0.8 0.3 1.4 0.3 0.8 0.3 0.3 0.0 0.2 0.0 0.1 0.6 0.7 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.2 0.4 0.2 KIRREL2 "DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1" ENSG00000126259 "Kirre like nephrin family adhesion molecule 2" Q6UWL6 19 35855861-35867109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "pancreas: 38.5" "Cell line enhanced" "Detected in some" "HDLM-2: 15.5;HMC-1: 25.0;U-937: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 5 "T-cells: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA071587, HPA074326" Enhanced Supported "Centriolar satellite" "Intracellular and membrane" "Centriolar satellite" "HPA071587: , HPA074326: " "unprognostic (1.28e-2)" "unprognostic (1.80e-1)" "unprognostic (3.29e-2)" "unprognostic (3.16e-3)" "unprognostic (2.05e-3)" "unprognostic (2.29e-1)" "unprognostic (2.00e-1)" "unprognostic (1.72e-3)" "unprognostic (3.30e-2)" "unprognostic (5.56e-2)" "unprognostic (4.85e-2)" "unprognostic (2.62e-2)" "unprognostic (2.43e-6)" "unprognostic (1.72e-1)" "unprognostic (4.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.62e-2)" 0.2 0.0 0.4 0.3 0.8 0.0 0.0 0.2 1.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.5 0.2 0.4 0.0 38.5 0.0 0.9 0.1 0.5 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.2 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.5 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.8 0.5 0.0 0.1 0.0 0.1 2.2 0.0 0.0 15.5 0.0 0.0 0.0 0.2 0.0 0.0 25.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.4 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.0 3.1 1.0 0.0 0.0 0.0 0.0 3.9 0.0 0.6 1.0 0.2 0.0 0.0 0.0 0.3 0.0 5.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.2 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.8 0.2 1.2 0.7 0.0 0.2 0.4 0.5 0.2 KISS1 ENSG00000170498 "KiSS-1 metastasis suppressor" Q15726 1 204190341-204196486 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "placenta: 267.2" "Group enriched" "Detected in some" 22 "BJ: 54.6;U-2 OS: 22.2" "Cancer enhanced" "Detected in many" "urothelial cancer: 9.2" "Group enriched" "Detected in some" 8 "basal ganglia: 11.3;hypothalamus: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017775, HPA035542" Enhanced Approved Vesicles "Secreted in female reproductive system" Vesicles "CAB017775: , HPA035542: " "unprognostic (9.64e-2)" "unprognostic (1.78e-2)" "unprognostic (1.86e-2)" "unprognostic (1.18e-2)" "unprognostic (3.89e-1)" "unprognostic (6.87e-2)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (1.63e-1)" "unprognostic (8.98e-12)" "unprognostic (2.25e-1)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "prognostic favourable (6.29e-6)" 0.2 0.0 0.2 0.2 11.3 0.0 0.2 1.0 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 4.2 1.1 2.7 0.5 0.2 0.2 0.2 0.2 0.4 0.1 2.5 267.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.5 0.2 0.2 0.7 1.4 3.6 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 54.6 0.7 0.9 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 22.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.3 1.0 0.2 0.2 4.2 0.2 0.2 0.2 0.2 KLC1 "hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A" ENSG00000126214 "Kinesin light chain 1" Q07866 14 103561896-103714249 "Predicted intracellular proteins" "Host-virus interaction" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 117.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB009798, HPA044617, HPA052450" Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009798: AB_2280879, HPA044617: , HPA052450: " "unprognostic (6.93e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (7.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-3)" "unprognostic (2.67e-2)" "unprognostic (9.21e-2)" "unprognostic (5.62e-2)" "prognostic favourable (6.75e-4)" "unprognostic (6.84e-3)" "prognostic unfavourable (7.17e-4)" "unprognostic (6.58e-2)" "unprognostic (8.69e-2)" "unprognostic (4.05e-1)" "unprognostic (1.49e-1)" 19.5 20.4 61.3 15.7 45.6 17.6 16.6 103.0 117.9 15.2 14.8 22.4 11.5 10.5 21.1 18.7 19.7 16.0 15.7 27.1 61.0 65.1 8.6 8.9 20.0 15.9 66.2 47.9 19.8 14.8 25.2 17.0 17.9 50.7 16.3 14.1 14.1 16.9 19.7 28.2 22.4 12.8 23.1 56.0 18.3 13.8 14.3 23.2 7.9 13.8 13.0 18.1 15.7 14.9 7.3 10.4 12.4 8.6 4.1 10.9 3.1 16.3 22.0 42.5 23.1 28.7 31.4 19.5 38.5 31.6 36.2 24.8 18.8 17.9 21.7 20.1 41.5 27.3 25.9 20.3 34.4 26.1 13.0 12.1 26.0 19.0 32.7 23.7 24.1 22.8 33.1 27.3 33.3 31.1 18.0 24.9 31.5 27.5 15.9 20.9 13.6 40.6 15.3 17.8 10.7 22.5 36.3 50.1 28.0 31.3 15.9 25.4 14.0 11.7 45.2 26.9 13.3 36.8 21.3 20.0 13.9 24.1 30.8 13.7 28.8 7.6 5.8 12.4 10.3 6.0 9.5 6.4 9.3 10.9 6.8 7.3 7.9 7.2 7.0 4.1 8.6 10.4 8.4 3.1 61.3 45.6 103.0 90.3 61.0 65.1 66.2 47.9 50.7 23.2 KLF17 "FLJ40160, Zfp393, ZNF393" ENSG00000171872 "Kruppel like factor 17" Q5JT82 1 44118850-44135140 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 31.5" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 3.7;BJ hTERT+ SV40 Large T+ RasG12V: 3.2;HBF TERT88: 3.9;U-138 MG: 6.5" "Cancer enriched" "Detected in single" 25 "testis cancer: 4.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA024629 Enhanced "HPA024629: AB_1848933" "unprognostic (1.73e-2)" "unprognostic (1.18e-4)" "unprognostic (4.02e-4)" "unprognostic (2.38e-1)" "unprognostic (4.64e-2)" "unprognostic (5.17e-2)" "unprognostic (1.58e-2)" "unprognostic (1.88e-1)" "unprognostic (9.70e-3)" "unprognostic (5.30e-3)" "unprognostic (8.35e-2)" "unprognostic (5.54e-2)" "unprognostic (6.60e-2)" "unprognostic (8.04e-3)" 0.1 0.8 0.2 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.0 1.6 0.1 1.2 0.3 0.4 0.1 0.1 0.0 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 2.5 0.2 0.1 0.1 31.5 0.1 0.1 0.1 0.1 0.1 1.8 0.1 0.3 0.3 2.5 0.4 0.8 0.9 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.8 2.0 3.7 3.2 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.1 3.9 0.0 0.0 1.1 0.9 0.0 0.0 0.0 1.1 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.1 0.0 6.5 0.8 0.2 1.8 0.0 0.0 0.1 0.6 0.2 0.1 1.2 0.4 0.9 0.3 0.3 0.2 0.3 0.4 0.4 0.0 0.3 0.9 0.6 2.5 0.8 0.3 0.3 0.8 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KLF18 ENSG00000283039 "Kruppel like factor 18" 1 44137821-44141631 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "testis: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLHDC7A FLJ38753 ENSG00000179023 "Kelch domain containing 7A" Q5VTJ3 1 18480982-18486126 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 36.4" "Cell line enhanced" "Detected in some" "A549: 5.2;CAPAN-2: 10.2;EFO-21: 5.2;NTERA-2: 5.7;RPTEC TERT1: 11.6;RT4: 9.2;T-47d: 10.2" "Cancer enhanced" "Detected in many" "renal cancer: 10.9" "Region enriched" "Detected in single" 4 "pons and medulla: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA056616 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA056616: " "unprognostic (4.63e-1)" "unprognostic (3.74e-2)" "unprognostic (2.18e-1)" "unprognostic (5.25e-2)" "unprognostic (1.68e-3)" "unprognostic (2.02e-1)" "unprognostic (1.31e-2)" "unprognostic (1.80e-3)" "unprognostic (2.94e-2)" "unprognostic (1.91e-1)" "unprognostic (9.01e-2)" "unprognostic (2.79e-1)" "prognostic favourable (7.81e-9)" "unprognostic (4.64e-3)" "unprognostic (1.37e-1)" "unprognostic (3.44e-1)" "prognostic favourable (1.88e-4)" 0.6 0.0 0.0 0.3 0.2 0.0 5.0 0.5 0.5 2.5 0.6 0.7 2.6 0.3 0.0 2.6 1.8 0.8 7.4 0.3 0.0 0.0 36.4 6.9 1.4 0.0 0.1 0.6 0.2 5.7 0.0 0.3 0.3 2.9 0.5 0.7 2.8 2.2 1.2 0.0 0.1 0.4 1.0 0.1 0.0 4.8 0.2 0.0 0.0 1.6 0.3 0.8 5.5 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 5.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.0 10.2 0.0 5.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.2 0.0 0.0 11.6 9.2 2.8 0.0 0.0 0.8 0.0 10.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.5 0.5 0.0 0.0 0.1 0.6 2.9 0.0 KLHDC8A FLJ10748 ENSG00000162873 "Kelch domain containing 8A" Q8IYD2 1 205336065-205357090 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 12 "ovary: 93.4" "Cell line enhanced" "Detected in some" "AF22: 5.5;HAP1: 11.3;NTERA-2: 2.7;SCLC-21H: 11.5" "Cancer enhanced" "Detected in many" "glioma: 45.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (4.18e-2)" "unprognostic (4.80e-2)" "unprognostic (3.43e-2)" "unprognostic (3.21e-1)" "unprognostic (2.63e-2)" "unprognostic (2.97e-1)" "unprognostic (4.92e-1)" "unprognostic (8.37e-3)" "unprognostic (7.39e-3)" "unprognostic (4.03e-2)" "unprognostic (1.84e-7)" "unprognostic (4.53e-3)" "unprognostic (5.83e-2)" "prognostic favourable (8.01e-4)" "unprognostic (1.20e-2)" 0.3 8.0 2.2 0.4 6.0 2.3 0.5 7.8 2.4 0.7 0.5 2.3 0.1 0.6 1.2 1.7 1.4 5.7 0.5 0.4 3.6 5.0 0.3 0.3 0.4 0.3 2.2 1.8 93.4 1.1 0.3 6.5 0.3 8.0 0.4 0.5 3.0 2.2 0.3 0.3 0.5 0.5 1.2 1.3 0.4 1.4 1.8 0.8 0.0 1.5 1.7 1.4 0.3 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 11.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.5 0.0 0.0 11.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 6.0 7.8 2.4 3.6 5.0 2.2 1.8 8.0 0.8 KLHL1 "FLJ30047, KIAA1490, MRP2" ENSG00000150361 "Kelch like family member 1" Q9NR64 13 69700594-70108493 "Predicted intracellular proteins" Actin-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "brain: 17.6" "Cell line enriched" "Detected in single" 14 "HeLa: 7.2" "Cancer enriched" "Detected in single" 7 "breast cancer: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021196 Uncertain "HPA021196: AB_1852567" "unprognostic (5.81e-2)" "unprognostic (7.40e-3)" "unprognostic (2.43e-1)" "unprognostic (1.41e-1)" 0.3 1.4 2.0 0.5 5.0 0.3 0.3 3.5 6.9 0.3 0.5 0.0 0.0 0.4 0.3 0.3 0.4 0.3 0.3 0.3 1.8 7.6 0.8 0.3 0.3 0.3 17.6 2.3 0.3 0.7 0.5 1.9 0.3 16.2 2.1 0.4 1.0 0.3 0.4 0.3 0.3 0.6 0.4 5.3 0.3 0.7 1.5 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.0 3.5 4.2 1.8 7.6 17.6 2.3 16.2 0.0 KLHL10 FLJ32662 ENSG00000161594 "Kelch like family member 10" Q6JEL2 17 41835685-41848384 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 33.4" "Cell line enhanced" "Detected in some" "ASC diff: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA067538 Enhanced "HPA067538: " "unprognostic (3.46e-4)" "unprognostic (1.95e-1)" "unprognostic (3.23e-1)" "unprognostic (1.52e-1)" "unprognostic (5.18e-3)" "unprognostic (1.22e-2)" "unprognostic (3.20e-1)" "unprognostic (5.08e-3)" "unprognostic (1.90e-1)" "unprognostic (3.82e-2)" "unprognostic (4.07e-2)" "unprognostic (8.58e-2)" "unprognostic (1.35e-3)" "unprognostic (1.90e-2)" "unprognostic (2.65e-2)" "unprognostic (1.96e-1)" "unprognostic (5.17e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.2 1.0 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.4 0.1 0.1 0.2 33.4 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.0 0.7 0.0 1.2 0.3 0.7 0.0 0.7 0.0 3.5 0.5 1.1 0.8 0.7 0.8 0.4 0.3 0.1 0.8 0.4 0.3 0.0 0.9 0.7 2.4 0.5 0.3 0.1 0.4 0.3 0.8 0.2 0.0 1.5 0.5 1.2 0.1 0.1 0.3 0.0 0.9 0.8 0.0 0.5 0.0 0.9 0.1 0.6 1.1 0.1 0.8 0.1 0.1 0.1 0.8 0.1 0.9 0.9 1.5 0.0 0.3 1.1 0.3 0.1 1.0 0.6 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.2 0.2 0.2 0.3 0.1 0.1 0.6 0.2 0.0 0.0 0.3 0.0 0.8 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KLHL3 KIAA1129 ENSG00000146021 "Kelch like family member 3" Q9UH77 5 137617500-137736090 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 64.2" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 6.3;RT4: 6.6;TIME: 14.6;U-266/70: 8.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 64.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051291 Approved "HPA051291: " "unprognostic (4.31e-2)" "unprognostic (5.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (6.17e-2)" "unprognostic (1.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.41e-1)" "unprognostic (6.39e-3)" "unprognostic (3.28e-1)" "unprognostic (9.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.71e-1)" "unprognostic (5.20e-3)" "unprognostic (1.50e-4)" 4.1 5.8 9.1 3.2 11.9 1.2 2.7 64.2 12.0 5.3 2.1 0.8 1.7 2.6 5.0 2.7 2.2 5.1 5.8 14.7 6.2 4.2 10.2 1.8 2.8 5.2 4.7 9.3 9.0 2.2 1.3 5.9 3.3 5.0 2.3 2.4 10.4 1.6 2.2 2.2 3.1 1.9 3.6 4.2 3.5 5.1 5.5 1.7 3.7 12.1 1.3 4.0 3.0 3.4 0.1 1.2 1.6 0.0 2.2 3.2 0.6 0.4 0.3 1.5 0.0 0.9 1.2 1.0 0.3 0.4 0.2 0.2 0.5 5.8 1.4 3.1 0.0 0.2 0.3 2.6 0.2 1.4 0.7 0.6 1.0 0.0 0.3 0.0 1.1 1.1 0.2 0.7 0.0 6.3 0.3 1.2 0.2 0.0 3.1 0.9 2.7 0.9 2.5 0.0 0.0 1.0 6.6 1.8 1.0 0.4 0.0 0.5 0.0 0.5 14.6 0.4 0.4 0.0 0.4 8.8 4.9 0.0 5.6 0.1 0.7 0.0 0.0 1.6 0.7 0.0 0.8 0.0 3.0 1.1 0.1 0.1 3.2 1.8 0.0 2.2 0.0 1.2 1.3 0.6 9.1 11.9 64.2 12.0 6.2 4.2 4.7 9.3 5.0 1.7 KLHL30 FLJ43374 ENSG00000168427 "Kelch like family member 30" Q0D2K2 2 238138722-238152947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "skeletal muscle: 62.8" "Cell line enhanced" "Detected in some" "BEWO: 6.0;CAPAN-2: 3.1;EFO-21: 3.0;RH-30: 8.6;THP-1: 4.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 35 "olfactory region: 11.6" "Low region specificity" "Detected in all" HPA062095 Approved "Centriolar satellite" "Centriolar satellite" "HPA062095: " "unprognostic (3.42e-2)" "unprognostic (1.04e-1)" "unprognostic (2.07e-4)" "unprognostic (6.02e-5)" "unprognostic (1.29e-1)" "unprognostic (1.22e-2)" "unprognostic (1.31e-1)" "unprognostic (4.54e-3)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (5.57e-3)" "unprognostic (2.24e-1)" "unprognostic (1.93e-1)" "unprognostic (8.17e-4)" "unprognostic (2.75e-2)" "unprognostic (2.30e-1)" "unprognostic (2.06e-1)" 4.4 0.1 0.1 0.3 0.1 0.1 2.4 0.1 0.1 1.2 0.5 0.1 0.1 0.2 1.2 2.3 1.3 0.4 0.4 6.1 0.1 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.7 0.3 1.4 0.1 0.8 1.7 0.6 62.8 0.2 0.3 1.5 0.1 0.1 0.3 0.4 0.0 0.0 0.9 8.7 0.2 1.6 1.4 0.7 1.4 1.1 2.5 0.5 0.3 0.3 0.1 0.1 0.0 0.1 0.0 0.0 6.0 0.0 0.1 0.1 0.0 0.2 3.1 0.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.6 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.0 0.2 2.1 0.2 0.0 2.6 8.6 1.4 0.6 0.0 0.1 0.2 0.1 0.8 0.2 0.0 4.2 0.0 0.1 0.5 0.2 0.0 0.3 0.3 0.1 0.2 0.5 0.1 0.5 2.5 0.3 0.2 0.5 0.2 0.7 0.1 0.1 1.4 0.6 0.2 0.3 1.1 0.5 0.3 0.4 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 KLHL33 ENSG00000185271 "Kelch like family member 33" A6NCF5 14 20425852-20436158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 39.2" "Cell line enriched" "Detected in some" 9 "REH: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "plasmacytoid DC: 9.3" "Lineage enriched" "Detected in single" 24 "dendritic cells: 9.3" "Low region specificity" "Detected in many" "HPA049985, HPA056560" Enhanced "HPA049985: , HPA056560: " "unprognostic (6.92e-2)" "unprognostic (6.39e-2)" "unprognostic (2.07e-1)" "unprognostic (4.81e-1)" "unprognostic (2.43e-1)" "unprognostic (2.26e-1)" "unprognostic (2.38e-3)" "unprognostic (1.60e-1)" "unprognostic (9.77e-2)" "unprognostic (1.25e-1)" "unprognostic (7.39e-2)" "unprognostic (4.15e-2)" "unprognostic (4.60e-2)" "unprognostic (7.43e-3)" "unprognostic (4.88e-3)" "unprognostic (3.32e-5)" "unprognostic (2.32e-1)" 1.2 0.1 0.1 0.1 0.1 0.0 0.3 0.6 0.6 0.6 0.4 0.3 0.1 0.0 0.8 0.7 0.4 0.4 0.3 0.5 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.6 0.1 0.7 0.1 0.1 0.4 0.5 0.0 0.1 0.8 0.5 39.2 0.0 0.3 0.2 0.1 0.2 0.1 0.2 0.1 0.1 0.2 8.5 0.6 0.3 0.8 0.3 9.3 0.3 0.1 0.1 0.3 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.3 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.4 0.3 0.3 0.1 0.2 0.4 0.7 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.2 0.2 0.4 0.0 9.3 0.1 0.2 0.0 0.2 0.2 0.3 0.0 0.1 0.1 0.2 0.4 0.2 1.0 0.5 0.1 0.1 0.3 0.3 0.2 0.1 0.6 0.2 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.3 0.2 0.1 0.0 9.3 0.0 0.2 0.1 0.1 0.6 0.6 0.1 0.1 0.1 0.1 0.4 0.1 KLHL34 "FLJ34960, RP11-450P7.3" ENSG00000185915 "Kelch like family member 34" Q8N239 X 21654690-21658330 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "skeletal muscle: 31.1" "Cell line enhanced" "Detected in some" "NTERA-2: 1.1;PC-3: 1.1;SCLC-21H: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0" "Lineage enriched" "Detected in single" 4 "T-cells: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA060287 Uncertain "HPA060287: " "unprognostic (2.00e-2)" "unprognostic (8.73e-2)" "unprognostic (1.79e-1)" "unprognostic (3.02e-1)" "unprognostic (3.14e-2)" "unprognostic (8.68e-2)" "unprognostic (9.17e-2)" "unprognostic (3.24e-1)" "unprognostic (3.40e-2)" "unprognostic (3.74e-1)" "unprognostic (6.89e-2)" "unprognostic (3.00e-1)" "unprognostic (8.46e-2)" "unprognostic (1.42e-1)" "unprognostic (2.64e-1)" "unprognostic (2.46e-1)" "unprognostic (3.29e-1)" 0.3 0.1 0.7 0.1 0.9 0.0 0.0 1.7 0.8 0.0 0.3 0.1 0.0 1.1 0.0 0.0 0.3 0.0 0.0 1.8 0.5 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 3.1 0.6 0.0 31.1 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 2.8 0.4 0.1 0.0 0.7 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.5 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.1 0.0 1.1 1.1 0.1 0.8 0.2 0.0 0.2 1.0 0.5 0.0 0.1 0.0 0.1 0.1 0.8 0.2 0.1 0.1 0.5 0.1 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.3 3.0 0.9 0.0 0.0 0.0 0.0 0.6 0.5 0.7 0.9 1.7 0.8 0.5 0.3 0.2 0.0 0.2 0.0 KLHL38 C8ORFK36 ENSG00000175946 "Kelch like family member 38" Q2WGJ6 8 123645527-123652950 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 72.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;HHSteC: 1.9;SK-BR-3: 5.4;SK-MEL-30: 1.7;U-2197: 9.5" "Cancer enhanced" "Detected in some" "melanoma: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA024770, HPA027115" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA024770: AB_10599286, HPA027115: AB_10599950" "unprognostic (8.62e-3)" "unprognostic (3.86e-3)" "unprognostic (1.02e-2)" "unprognostic (8.94e-2)" "unprognostic (4.68e-1)" "unprognostic (2.09e-2)" "unprognostic (8.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.54e-1)" "unprognostic (4.02e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-2)" "unprognostic (5.73e-6)" "unprognostic (8.46e-3)" "unprognostic (3.82e-2)" "unprognostic (6.52e-2)" "unprognostic (2.84e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.5 0.7 0.6 0.1 0.1 16.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.2 0.1 72.0 0.0 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 1.7 1.0 0.0 0.0 0.0 0.2 9.5 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KLHL40 "KBTBD5, NEM8, SRYP" ENSG00000157119 "Kelch like family member 40" Q2TBA0 3 42685519-42692544 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein" "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 132.0" "Group enriched" "Detected in some" 19 "HSkMC: 3.1;RH-30: 3.7" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024463, HPA052201" Enhanced "HPA024463: AB_1852095, HPA052201: " "unprognostic (1.13e-1)" "unprognostic (3.28e-2)" "unprognostic (1.19e-1)" "unprognostic (2.09e-1)" "unprognostic (7.85e-2)" "unprognostic (2.50e-1)" "unprognostic (4.04e-1)" 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.1 0.0 132.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.7 19.6 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLK13 KLK-L4 ENSG00000167759 "Kallikrein related peptidase 13" Q9UKR3 19 51056206-51065114 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "esophagus: 100.5" "Cell line enriched" "Detected in some" 11 "HaCaT: 20.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 42.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062136 Enhanced "Secreted in other tissues" "HPA062136: " "unprognostic (1.99e-3)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (3.43e-1)" "unprognostic (2.99e-2)" "unprognostic (1.69e-1)" "unprognostic (6.76e-2)" "unprognostic (2.18e-2)" "unprognostic (8.30e-2)" "unprognostic (7.07e-6)" "unprognostic (7.33e-2)" "unprognostic (2.53e-1)" "unprognostic (6.38e-2)" "unprognostic (7.06e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.2 15.7 0.4 0.2 0.1 0.2 0.3 0.1 100.5 0.2 0.9 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.4 1.7 0.0 0.5 0.1 0.2 0.1 0.0 0.3 12.4 0.1 1.2 2.1 0.4 0.1 0.1 0.1 0.2 6.1 0.1 0.1 0.1 17.9 12.8 0.1 19.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 20.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 KLK2 ENSG00000167751 "Kallikrein related peptidase 2" P20151 19 50861568-50880567 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "prostate: 163.5" "Cell line enhanced" "Detected in many" "NB-4: 9.9" "Cancer enriched" "Detected in some" 1666 "prostate cancer: 989.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA000764 Supported "Secreted in male reproductive system" "HPA000764: AB_1079700" "unprognostic (3.05e-2)" "unprognostic (2.40e-1)" "unprognostic (1.69e-1)" "unprognostic (8.53e-2)" "unprognostic (1.15e-1)" "unprognostic (8.97e-2)" "unprognostic (3.22e-1)" "unprognostic (6.44e-2)" "unprognostic (8.06e-2)" "unprognostic (3.61e-1)" "unprognostic (2.11e-3)" "unprognostic (7.56e-2)" "unprognostic (8.10e-2)" "unprognostic (1.68e-1)" "unprognostic (2.04e-1)" 0.0 0.1 0.0 0.1 0.0 1.1 0.2 0.0 0.6 0.0 0.0 0.0 0.6 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 163.5 0.0 0.1 2.3 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.2 0.0 2.2 1.9 5.7 2.2 1.6 1.3 0.5 1.7 1.1 0.6 1.6 0.0 0.8 4.9 0.5 0.3 0.2 0.2 0.6 0.7 1.8 0.2 0.0 2.0 0.2 0.0 0.3 1.7 1.1 0.0 1.3 0.4 0.0 0.3 3.1 0.4 0.3 0.3 0.4 0.0 1.4 1.9 0.3 1.8 1.2 9.9 1.1 0.0 0.9 0.0 2.8 0.0 1.6 0.9 1.5 0.3 1.3 1.3 1.2 0.4 0.8 1.3 1.9 4.8 1.6 1.8 3.2 0.8 1.9 1.7 1.4 0.9 2.2 1.6 1.2 1.0 1.0 1.0 0.8 1.0 0.5 2.2 0.8 1.3 5.7 1.6 0.8 1.9 0.4 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 KLK3 "APS, PSA" ENSG00000142515 "Kallikrein related peptidase 3" P07288 19 50854915-50860764 "Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 115 "prostate: 447.4" "Group enriched" "Detected in some" 135 "BEWO: 21.9;NB-4: 18.5;RPMI-8226: 12.2;SH-SY5Y: 7.3;U-2197: 7.5" "Cancer enriched" "Detected in some" 3905 "prostate cancer: 4241.6" "Region enriched" "Detected in single" 8 "cerebral cortex: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000070, HPA000764" Enhanced "Secreted in male reproductive system" "CAB000070: , HPA000764: AB_1079700" "unprognostic (5.06e-3)" "unprognostic (5.60e-2)" "unprognostic (9.93e-2)" "unprognostic (3.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.26e-2)" "unprognostic (1.88e-2)" "unprognostic (1.54e-1)" "unprognostic (5.13e-3)" "unprognostic (1.94e-1)" "unprognostic (4.64e-1)" "unprognostic (3.15e-1)" 0.1 0.3 0.0 0.1 0.0 0.0 0.7 0.0 1.0 0.1 0.1 0.0 0.2 0.1 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 447.4 0.0 0.1 3.8 1.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 KLK4 "EMSP, EMSP1, KLK-L1, PRSS17, PSTS" ENSG00000167749 "Kallikrein related peptidase 4" Q9Y5K2 19 50906352-50910738 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Hydrolase, Protease, Serine protease" "Amelogenesis imperfecta, Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "prostate: 79.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.2;HaCaT: 10.1;SK-BR-3: 6.5" "Cancer enriched" "Detected in many" 55 "prostate cancer: 463.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA051839 Enhanced "Secreted in male reproductive system" "HPA051839: " "unprognostic (3.58e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-3)" "unprognostic (1.66e-3)" "unprognostic (3.11e-2)" "unprognostic (4.35e-1)" "unprognostic (3.18e-1)" "unprognostic (6.66e-2)" "unprognostic (9.69e-2)" "unprognostic (8.23e-3)" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (4.20e-3)" "unprognostic (3.27e-3)" "unprognostic (2.21e-2)" "unprognostic (1.64e-2)" "unprognostic (1.34e-1)" 0.2 0.8 0.1 0.3 0.1 0.1 0.7 0.2 0.5 2.0 1.2 0.0 3.8 1.8 1.5 7.7 0.4 0.2 0.1 0.1 0.3 0.2 0.2 0.1 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.5 79.3 0.8 0.2 3.2 2.1 0.7 2.4 1.2 0.6 0.1 0.1 0.3 0.6 0.1 0.0 8.7 0.0 0.0 0.2 0.2 0.1 0.4 0.6 0.1 0.0 0.3 0.0 5.0 2.1 0.2 0.3 0.0 0.0 4.5 0.1 0.0 0.0 0.0 4.6 8.2 0.5 0.4 0.1 10.1 0.0 5.4 0.0 1.3 1.4 1.6 3.7 1.7 0.0 1.7 2.3 0.0 2.6 0.0 0.0 0.0 0.9 4.2 0.0 1.2 0.1 2.5 0.1 0.4 0.3 0.5 1.1 0.0 3.3 0.0 0.6 0.3 6.5 0.0 5.2 0.4 1.1 0.3 0.3 1.3 0.3 2.6 1.0 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.5 0.3 0.2 0.2 0.0 0.5 0.1 KLK9 KLK-L3 ENSG00000213022 "Kallikrein related peptidase 9" Q9UKQ9 19 51003111-51009634 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "tongue: 37.6" "Group enriched" "Detected in some" 27 "HaCaT: 1.2;HBEC3-KT: 4.1" "Cancer enriched" "Detected in single" 6 "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB025049 Enhanced "Secreted to digestive system" "CAB025049: " "unprognostic (3.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 37.6 3.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLKB1 KLK3 ENSG00000164344 "Kallikrein B1" P03952 4 186208979-186258471 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response" "Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 76 "liver: 102.9" "Cell line enhanced" "Detected in some" "NTERA-2: 7.1;SCLC-21H: 4.9;SK-MEL-30: 2.1;U-937: 2.4" "Cancer enriched" "Detected in some" 17 "liver cancer: 27.6" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 7 "gdT-cell: 1.3" "Lineage enriched" "Detected in single" 8 "T-cells: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" 28860000000 4900000000 "unprognostic (4.80e-2)" "unprognostic (4.53e-3)" "unprognostic (4.36e-2)" "unprognostic (4.17e-2)" "unprognostic (5.93e-2)" "unprognostic (1.90e-2)" "unprognostic (1.15e-2)" "unprognostic (2.83e-1)" "unprognostic (8.14e-2)" "unprognostic (1.35e-1)" "unprognostic (1.38e-2)" "unprognostic (1.15e-1)" "unprognostic (1.45e-2)" "unprognostic (6.01e-2)" "unprognostic (7.30e-2)" "unprognostic (1.20e-1)" "unprognostic (1.59e-2)" 0.3 0.3 0.8 0.3 1.2 0.0 0.3 0.7 0.5 0.3 0.4 0.3 0.3 0.7 0.4 0.4 0.3 0.2 0.7 0.5 0.6 0.5 1.3 102.9 0.3 0.3 0.5 0.5 0.3 1.3 0.5 1.0 0.4 0.4 0.3 0.3 0.5 0.3 0.3 0.5 0.1 0.6 0.3 0.3 0.5 0.0 0.3 0.3 0.4 0.3 0.3 0.4 0.3 0.3 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 7.1 0.0 0.1 0.0 0.2 1.3 0.0 4.9 0.4 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 1.2 0.7 0.5 0.6 0.5 0.5 0.5 0.4 0.3 KLRB1 "CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A" ENSG00000111796 "Killer cell lectin like receptor B1" Q12918 12 9594551-9607886 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "blood: 178.9" "Cell line enhanced" "Detected in some" "HEL: 3.0;Karpas-707: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "MAIT T-cell: 178.9" "Group enriched" "Detected in many" 133 "NK-cells: 53.0;T-cells: 178.9" "Low region specificity" "Detected in all" HPA039113 Approved Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039113: AB_10674979" "prognostic favourable (3.51e-5)" "unprognostic (1.23e-3)" "unprognostic (7.03e-3)" "prognostic favourable (1.42e-5)" "unprognostic (1.69e-1)" "prognostic favourable (6.99e-5)" "unprognostic (1.54e-3)" "unprognostic (7.15e-3)" "unprognostic (4.12e-1)" "unprognostic (8.23e-3)" "unprognostic (3.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "prognostic favourable (5.61e-4)" "unprognostic (1.17e-2)" 3.8 0.8 0.8 22.8 0.8 18.6 2.1 0.5 0.6 2.9 9.1 0.0 1.3 5.0 1.8 3.7 2.6 1.8 7.3 1.3 0.7 0.8 3.8 4.9 11.8 23.7 1.1 0.2 2.0 1.0 0.0 0.9 2.1 0.8 1.8 3.9 0.9 4.8 1.4 0.9 0.8 20.4 0.6 1.8 25.2 4.4 1.3 0.2 6.2 1.9 2.9 17.7 5.5 2.0 0.1 0.3 0.8 0.2 53.0 178.9 18.5 0.0 0.0 1.5 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.1 0.0 0.2 1.9 0.0 0.0 0.2 0.0 3.0 0.0 0.4 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.8 0.8 0.6 0.5 0.0 1.1 0.2 0.9 0.0 0.5 0.4 0.6 0.6 0.7 0.1 0.3 0.2 0.0 1.6 0.0 0.4 0.7 0.6 0.4 1.5 0.0 1.8 0.9 0.5 0.1 0.0 43.1 0.1 178.9 0.1 25.6 28.1 0.1 0.1 1.5 8.7 0.8 53.0 0.2 0.3 5.7 18.5 0.8 0.8 0.5 0.6 0.7 0.8 1.1 0.2 0.8 0.2 KLRG1 "2F1, CLEC15A, MAFA, MAFA-L" ENSG00000139187 "Killer cell lectin like receptor G1" Q96E93 12 8950044-9010760 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 83.1" "Group enriched" "Detected in many" 5 "HEL: 23.0;HUVEC TERT2: 8.1;NTERA-2: 15.8;U-937: 14.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 71.3;MAIT T-cell: 83.1" "Lineage enriched" "Detected in many" 28 "T-cells: 83.1" "Low region specificity" "Detected in some" "HPA051403, HPA076494" Approved Enhanced Vesicles Vesicles "HPA051403: , HPA076494: " "unprognostic (1.54e-2)" "unprognostic (8.42e-4)" "unprognostic (1.06e-1)" "unprognostic (1.28e-1)" "unprognostic (2.94e-1)" "unprognostic (1.53e-4)" "unprognostic (3.05e-1)" "unprognostic (2.27e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-2)" "unprognostic (3.45e-3)" "unprognostic (6.88e-2)" "unprognostic (1.71e-2)" "unprognostic (2.05e-2)" "unprognostic (4.17e-2)" "unprognostic (4.96e-2)" "unprognostic (7.86e-2)" 15.4 3.9 4.4 7.3 5.8 5.6 5.7 12.3 5.0 3.2 3.5 7.1 0.8 1.7 5.6 4.2 2.2 2.6 7.7 5.1 4.4 5.8 3.2 6.4 5.5 17.3 8.3 3.4 2.7 1.9 1.5 5.6 1.5 5.5 4.8 4.7 5.6 3.5 1.8 3.1 2.2 5.0 3.9 5.5 19.0 3.6 2.2 6.8 6.8 2.9 2.3 11.1 8.3 2.6 0.5 1.3 2.4 0.6 2.9 83.1 14.0 0.1 2.2 1.2 1.7 2.0 0.4 1.1 0.3 0.3 0.2 0.7 0.7 0.7 3.1 0.1 0.3 0.2 2.8 0.3 0.3 2.2 1.4 23.0 0.3 1.2 0.5 0.7 1.2 1.4 0.3 0.3 0.0 8.1 1.0 0.3 0.1 0.5 0.5 1.6 15.8 1.5 0.9 0.7 0.0 0.3 0.3 0.3 3.1 0.7 0.4 0.9 0.2 1.0 0.5 0.5 0.7 0.4 1.0 1.0 2.7 1.7 1.4 14.5 0.2 2.4 0.3 0.2 71.3 0.4 83.1 0.5 15.8 43.4 1.3 0.5 4.3 29.9 0.9 2.9 0.6 0.5 1.2 14.0 4.4 5.8 12.3 5.0 4.4 5.8 8.3 3.4 5.5 6.8 KNG1 "BDK, BK, KNG" ENSG00000113889 "Kininogen 1" P01042 3 186717276-186744410 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis, Inflammatory response" "Protease inhibitor, Thiol protease inhibitor, Vasoactive, Vasodilator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 323.8" "Cell line enhanced" "Detected in some" "CACO-2: 5.1;Hep G2: 4.4;HL-60: 2.4;RH-30: 3.9;SiHa: 2.6" "Cancer enriched" "Detected in some" 126 "liver cancer: 608.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA001616, HPA001645, CAB009809" Enhanced "Secreted to blood" 90000000000 64000000000 "CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215" "unprognostic (3.88e-1)" "unprognostic (1.63e-1)" "unprognostic (2.82e-1)" "unprognostic (3.27e-1)" "unprognostic (8.30e-3)" "unprognostic (2.04e-1)" "prognostic favourable (1.28e-6)" "unprognostic (1.29e-2)" "unprognostic (1.10e-1)" "unprognostic (1.97e-2)" "unprognostic (9.96e-2)" "unprognostic (1.65e-1)" "unprognostic (3.45e-3)" "unprognostic (5.20e-2)" "unprognostic (2.46e-1)" "unprognostic (4.52e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 41.9 323.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.4 2.3 0.2 0.7 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 1.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.1 4.4 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.1 0.7 0.0 0.1 3.9 0.0 0.2 0.0 0.5 0.1 2.6 0.4 0.0 0.1 0.0 0.8 0.0 0.2 0.0 0.0 0.9 0.0 1.9 0.0 2.0 0.0 2.3 0.2 0.3 0.3 0.1 0.0 0.2 0.1 0.1 0.0 0.5 0.1 0.2 1.6 0.7 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 KPNA3 "hSRP1, IPOA4, SRP1gamma, SRP4" ENSG00000102753 "Karyopherin subunit alpha 3" O00505 13 49699307-49792921 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 71.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046852 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA046852: " "unprognostic (4.20e-2)" "prognostic unfavourable (2.80e-4)" "unprognostic (3.69e-2)" "unprognostic (1.23e-1)" "prognostic favourable (2.03e-4)" "unprognostic (6.27e-3)" "unprognostic (6.79e-2)" "unprognostic (9.40e-3)" "unprognostic (1.56e-2)" "unprognostic (4.57e-3)" "unprognostic (3.93e-3)" "unprognostic (4.66e-2)" "prognostic unfavourable (3.81e-4)" "unprognostic (9.78e-2)" "unprognostic (7.83e-2)" "unprognostic (5.68e-3)" "unprognostic (4.60e-3)" 12.4 8.0 15.2 9.1 11.8 14.1 12.4 10.9 14.4 8.5 11.4 7.5 8.1 7.0 9.5 6.8 14.5 7.3 8.4 17.2 12.3 11.4 8.0 13.6 9.6 9.4 11.1 11.4 8.1 6.3 9.1 8.1 8.3 13.0 9.4 9.7 5.9 8.3 11.4 71.8 9.0 8.5 14.3 13.2 8.1 8.3 15.1 11.8 11.4 10.9 14.6 10.8 15.0 16.3 6.0 5.0 7.6 6.8 8.1 12.1 4.1 13.8 9.6 18.5 15.4 18.9 20.9 9.3 25.3 20.9 22.2 16.2 29.1 13.0 29.9 5.2 29.3 16.4 22.0 20.3 37.1 17.9 15.4 21.9 9.5 33.9 18.5 32.7 14.2 15.3 14.7 18.6 24.6 27.4 12.1 8.1 30.6 6.3 17.5 17.8 21.3 6.8 23.0 18.2 9.1 13.6 11.5 7.8 12.4 9.2 11.6 10.0 6.8 13.2 24.8 16.5 13.4 15.0 16.8 6.6 9.2 26.4 10.0 15.1 16.3 7.6 4.6 4.3 8.6 5.5 12.1 6.0 8.8 8.4 5.0 4.0 8.8 7.9 2.8 8.1 6.8 2.9 10.1 4.1 15.2 11.8 10.9 14.4 12.3 11.4 11.1 11.4 13.0 11.8 KPRP C1orf45 ENSG00000203786 "Keratinocyte proline rich protein" Q5T749 1 152759561-152762052 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 72.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.0;hTEC/SVTERT24-B: 5.7;LHCN-M2: 1.9;U-2197: 3.4;U-87 MG: 2.4" "Group enriched" "Detected in some" 22 "head and neck cancer: 6.9;melanoma: 13.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031988, HPA031990" Enhanced 2700000 "HPA031988: AB_10671582, HPA031990: " "unprognostic (1.03e-1)" "unprognostic (2.67e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 3.2 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 72.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 5.7 0.9 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT1 "EHK1, KRT1A" ENSG00000167768 "Keratin 1" P04264 12 52674736-52680407 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Ichthyosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 606.8" "Group enriched" "Detected in some" 37 "HaCaT: 43.9;hTCEpi: 18.5" "Group enriched" "Detected in many" 5 "head and neck cancer: 313.8;melanoma: 478.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "memory CD4 T-cell: 5.8;memory CD8 T-cell: 2.1;naive CD4 T-cell: 1.8" "Lineage enriched" "Detected in single" 59 "T-cells: 5.8" "CAB002153, HPA017917, HPA062908" Enhanced 65000000000 "CAB002153: AB_563790, HPA017917: AB_1852192, HPA062908: " "unprognostic (8.05e-2)" "unprognostic (8.49e-3)" "unprognostic (5.06e-3)" "unprognostic (6.44e-2)" "unprognostic (1.25e-2)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (3.24e-1)" "unprognostic (1.30e-1)" "unprognostic (2.16e-1)" "unprognostic (9.24e-2)" "unprognostic (6.63e-2)" "unprognostic (3.23e-4)" "unprognostic (1.58e-1)" "unprognostic (3.40e-2)" "unprognostic (1.36e-1)" "unprognostic (1.09e-2)" 0.3 0.0 0.1 0.1 0.1 0.4 24.2 0.1 0.3 63.4 0.1 0.1 0.1 0.0 38.6 0.1 2.5 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.0 0.1 16.2 0.1 2.0 606.8 0.1 0.1 0.2 0.1 0.0 0.1 0.1 24.1 0.1 114.6 0.4 0.1 46.2 0.0 0.0 0.0 0.0 0.0 5.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 2.1 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 KRT10 "CK10, K10, KPP" ENSG00000186395 "Keratin 10" P13645 17 40818117-40822595 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 20 "skin 1: 1236.8" "Cell line enhanced" "Detected in many" "hTCEpi: 129.0" "Cancer enhanced" "Detected in all" "melanoma: 562.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000132, HPA012014" Enhanced "Intracellular and membrane" 34000000000 "CAB000132: , HPA012014: AB_1852195" "unprognostic (3.07e-1)" "unprognostic (5.19e-2)" "unprognostic (1.71e-1)" "unprognostic (1.37e-2)" "unprognostic (2.00e-2)" "unprognostic (2.60e-1)" "unprognostic (3.02e-2)" "unprognostic (1.29e-2)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (1.00e-2)" "unprognostic (2.14e-1)" "prognostic unfavourable (9.32e-5)" "unprognostic (1.64e-1)" "unprognostic (1.85e-1)" "unprognostic (1.66e-2)" "unprognostic (8.10e-2)" 4.1 4.4 5.3 3.7 6.0 3.9 41.4 7.2 6.4 37.3 3.7 1.4 8.2 4.0 14.9 5.4 7.4 3.0 3.7 9.3 6.4 2.9 5.9 7.6 3.0 5.3 5.2 3.2 3.3 9.2 2.6 8.1 5.7 4.9 5.6 2.9 2.4 17.4 8.3 12.2 1236.8 4.9 3.0 4.0 3.7 4.3 9.6 6.1 11.6 5.5 21.7 5.8 3.3 62.7 17.5 15.4 21.7 5.7 13.2 13.4 3.4 17.5 22.4 6.6 7.0 8.1 7.3 6.1 15.8 9.8 6.6 6.0 8.5 6.6 4.9 23.9 7.0 35.4 2.7 6.0 8.4 11.6 17.6 4.6 29.2 15.5 9.4 9.7 13.6 5.6 129.0 4.3 9.4 4.5 24.8 9.3 7.6 13.2 12.7 9.5 8.4 14.3 9.5 9.5 10.4 6.7 19.1 5.7 6.7 11.3 27.1 20.6 21.1 13.3 5.1 11.1 16.3 13.6 19.6 0.2 11.8 13.8 15.0 6.4 13.7 21.7 4.7 19.1 9.8 4.2 11.1 17.5 10.8 13.4 7.7 10.1 12.1 11.8 1.6 13.2 5.7 15.4 10.3 3.4 5.3 6.0 7.2 6.4 6.4 2.9 5.2 3.2 4.9 6.1 KRT16 NEPPK ENSG00000186832 "Keratin 16" P08779 17 41609778-41615899 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "tongue: 503.5" "Cell line enriched" "Detected in some" 9 "hTCEpi: 134.9" "Group enriched" "Detected in many" 7 "cervical cancer: 713.1;head and neck cancer: 2720.5;melanoma: 712.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000136, HPA000539" Approved Approved "Intermediate filaments" 2200000000 "Intermediate filaments" "CAB000136: , HPA000539: " "unprognostic (3.95e-3)" "unprognostic (6.90e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (1.41e-2)" "unprognostic (1.00e-2)" "unprognostic (7.14e-3)" "unprognostic (1.03e-3)" "unprognostic (2.05e-1)" "unprognostic (3.07e-2)" "prognostic unfavourable (1.09e-5)" "unprognostic (8.23e-2)" "unprognostic (6.53e-8)" "unprognostic (3.81e-1)" "unprognostic (1.83e-1)" "unprognostic (7.40e-2)" "unprognostic (3.61e-2)" 1.6 0.2 0.2 0.2 0.2 0.0 2.1 0.2 0.2 32.4 0.2 0.2 0.2 0.0 1.1 0.2 112.4 0.1 0.6 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.6 0.2 0.7 0.0 0.3 15.5 9.9 0.4 41.4 0.2 0.2 0.2 0.2 0.1 0.6 0.2 3.0 0.2 503.5 26.4 0.6 50.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 3.9 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 134.9 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 15.3 0.1 0.9 0.0 0.0 9.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 KRT2 "KRT2A, KRTE" ENSG00000172867 "Keratin 2" P35908 12 52644558-52652164 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 289.9" "Group enriched" "Detected in some" 6 "HEL: 6.5;HMC-1: 2.8" "Group enriched" "Detected in some" 35 "head and neck cancer: 4.7;melanoma: 23.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "naive CD4 T-cell: 4.4;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 45 "T-cells: 4.4" "Group enriched" "Detected in some" 6 "amygdala: 1.8;hippocampal formation: 2.9" "Low region specificity" "Detected in single" "HPA006299, CAB037321" Enhanced Approved "Golgi apparatus,Intermediate filaments,Cytosol" 14000000000 "Intermediate filaments, Cytosol" "Golgi apparatus" "CAB037321: , HPA006299: AB_1079180" "unprognostic (1.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.56e-1)" "unprognostic (8.47e-3)" "unprognostic (1.69e-2)" "unprognostic (1.84e-1)" "unprognostic (3.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.76e-2)" "unprognostic (3.56e-7)" "unprognostic (6.43e-2)" "unprognostic (5.98e-3)" "unprognostic (6.69e-2)" "unprognostic (3.46e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 9.5 0.1 0.1 18.3 0.1 0.1 0.1 0.0 2.0 0.1 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 4.4 289.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 6.8 0.1 19.2 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 4.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 4.4 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KRT20 "CK20, K20, MGC35423" ENSG00000171431 "Keratin 20" P35900 17 40875941-40885227 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 232.0" "Cell line enhanced" "Detected in some" "A549: 2.3;BEWO: 2.6;NB-4: 2.3;RPMI-8226: 2.8;RT4: 7.2;SH-SY5Y: 2.2" "Group enriched" "Detected in many" 6 "colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 0.7" "Low region specificity" "Detected in all" "CAB000032, HPA024309, HPA024684, HPA027236" Enhanced Supported Cytosol 34000000 Cytosol "CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224" "unprognostic (3.49e-1)" "unprognostic (3.13e-1)" "unprognostic (1.71e-1)" "unprognostic (6.38e-3)" "unprognostic (5.12e-2)" "unprognostic (2.66e-3)" "prognostic unfavourable (7.05e-4)" "unprognostic (2.63e-2)" "unprognostic (4.87e-3)" "unprognostic (2.37e-2)" "prognostic unfavourable (1.32e-4)" "unprognostic (5.71e-2)" "unprognostic (6.30e-2)" "unprognostic (7.27e-2)" 0.2 0.1 0.2 38.0 0.2 0.0 0.2 0.2 0.2 0.2 75.5 0.2 0.2 40.4 0.2 0.2 0.3 0.3 3.9 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.3 45.0 0.2 0.3 0.2 0.2 0.2 232.0 2.7 0.2 0.2 13.6 0.2 0.2 0.2 0.2 0.3 0.2 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.1 0.0 0.0 2.8 0.0 7.2 0.4 2.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.3 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 KRT25 KRT25A ENSG00000204897 "Keratin 25" Q7Z3Z0 17 40748021-40755332 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 44.5" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 5.5" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "cerebellum: 9.7" "Group enriched" "Detected in some" 5 "cerebral cortex: 8.3;hippocampal formation: 6.1" "HPA053977, HPA058943" Enhanced Approved Vesicles Vesicles "HPA053977: AB_2682329, HPA058943: AB_2683859" "unprognostic (8.19e-2)" "unprognostic (5.89e-8)" "unprognostic (1.79e-1)" 1.6 0.0 0.0 0.0 0.9 0.0 8.6 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 44.5 0.1 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.0 0.0 0.0 0.0 0.0 1.9 0.0 KRT27 KRT25C ENSG00000171446 "Keratin 27" Q7Z3Y8 17 40776808-40782534 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 37.4" "Group enriched" "Detected in some" 6 "EFO-21: 5.5;SK-BR-3: 1.4" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.9" "Region enriched" "Detected in single" 9 "basal ganglia: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 4 "hippocampal formation: 104.2" HPA055114 Enhanced "HPA055114: " "unprognostic (1.13e-1)" "unprognostic (1.87e-1)" "unprognostic (2.18e-1)" "unprognostic (5.75e-4)" "unprognostic (5.11e-2)" "unprognostic (3.08e-2)" "unprognostic (8.41e-2)" "unprognostic (4.16e-1)" "unprognostic (1.53e-1)" "unprognostic (4.90e-1)" "unprognostic (1.56e-1)" "unprognostic (5.64e-3)" 1.1 0.0 0.1 0.1 1.2 0.0 4.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 37.4 0.2 0.1 0.1 0.1 0.0 1.0 0.1 2.8 0.5 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KRT33A "Ha-3I, Krt1-3, KRTHA3A" ENSG00000006059 "Keratin 33A" O76009 17 41346092-41350812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 30.4" "Cell line enriched" "Detected in some" 5 "RT4: 5.4" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055194 Supported 160000000 "HPA055194: " "unprognostic (1.93e-1)" "unprognostic (1.30e-2)" "unprognostic (4.58e-2)" "unprognostic (4.34e-1)" "unprognostic (2.16e-1)" 0.5 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 5.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 30.4 0.1 0.1 0.1 0.1 0.0 3.3 0.1 2.8 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KRT33B "Ha-3II, KRTHA3B" ENSG00000131738 "Keratin 33B" Q14525 17 41363494-41369800 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 40.6" "Cell line enhanced" "Detected in some" "BJ: 8.8;BJ hTERT+ SV40 Large T+: 1.9;BJ hTERT+ SV40 Large T+ RasG12V: 2.1;hTEC/SVTERT24-B: 3.4;U-2197: 2.3" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055194 Supported 460000000 "HPA055194: " "unprognostic (3.34e-2)" "unprognostic (5.19e-2)" "unprognostic (3.04e-1)" "unprognostic (1.55e-2)" "unprognostic (6.28e-2)" 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.0 0.5 0.0 0.0 0.0 1.0 0.0 2.7 0.0 7.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 8.8 0.7 1.9 2.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 KRT35 "Ha-5, KRTHA5" ENSG00000197079 "Keratin 35" Q92764 17 41476689-41481140 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 33.1" "Cell line enhanced" "Detected in single" "HDLM-2: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 270000000 1.8 0.0 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 2.1 0.1 0.1 33.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KRT36 KRTHA6 ENSG00000126337 "Keratin 36" O76013 17 41486136-41492546 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "tongue: 109.3" "Cell line enriched" "Detected in single" 15 "Karpas-707: 8.3" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 2.3;intermediate monocyte: 1.0" "Lineage enhanced" "Detected in single" "monocytes: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" 150000000 "unprognostic (4.39e-2)" "unprognostic (2.24e-3)" "unprognostic (9.85e-2)" "unprognostic (4.66e-1)" "unprognostic (1.70e-2)" "unprognostic (3.19e-2)" "unprognostic (1.34e-1)" "unprognostic (5.36e-2)" "unprognostic (2.25e-1)" "unprognostic (1.81e-1)" "unprognostic (7.19e-2)" "unprognostic (8.24e-2)" "unprognostic (8.50e-2)" "unprognostic (3.74e-1)" "unprognostic (6.66e-2)" "unprognostic (1.49e-1)" "unprognostic (7.11e-2)" 0.3 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.3 0.1 1.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.6 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.5 0.1 0.1 5.6 0.3 0.1 0.1 1.6 0.0 0.6 0.1 1.9 0.1 109.3 5.1 0.1 1.4 0.0 0.8 0.0 2.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KRT37 KRTHA7 ENSG00000108417 "Keratin 37" O76014 17 41420753-41424523 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 11.7" "Cell line enhanced" "Detected in single" "Hep G2: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.15e-1)" "unprognostic (4.54e-1)" "unprognostic (8.63e-2)" "unprognostic (5.15e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT38 KRTHA8 ENSG00000171360 "Keratin 38" O76015 17 41436446-41440921 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 18.3" "Cell line enhanced" "Detected in some" "BJ: 2.2;fHDF/TERT166: 1.3" "Group enriched" "Detected in some" 8 "head and neck cancer: 1.1;urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" 170000000 "unprognostic (1.37e-1)" "unprognostic (4.05e-1)" 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 2.2 0.6 0.1 0.4 0.8 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 KRT39 KA35 ENSG00000196859 "Keratin 39" Q6A163 17 40958417-40966892 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "skin 1: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" 270000 "unprognostic (1.38e-1)" "unprognostic (5.06e-2)" "unprognostic (4.92e-1)" "unprognostic (3.85e-1)" "unprognostic (9.03e-3)" "unprognostic (9.89e-3)" "unprognostic (5.00e-2)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (2.20e-1)" "unprognostic (9.42e-10)" "unprognostic (3.95e-1)" "unprognostic (3.04e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT76 "HUMCYT2A, KRT2B, KRT2P" ENSG00000185069 "Keratin 76" Q01546 12 52768155-52777345 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "tongue: 81.4" "Cell line enhanced" "Detected in single" "HaCaT: 2.4" "Cancer enriched" "Detected in single" 12 "head and neck cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA019696 Approved 430000000 "HPA019696: AB_1852243" "unprognostic (2.00e-1)" "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.4 7.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT77 KRT1B ENSG00000189182 "Keratin 77" Q7Z794 12 52689626-52703463 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "skin 1: 77.7" "Cell line enriched" "Detected in single" 90 "HaCaT: 8.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 9.3;basal ganglia: 6.7;cerebral cortex: 4.7;hippocampal formation: 8.3;hypothalamus: 6.3" "Not detected" "Not detected" HPA045934 Enhanced Approved "Nuclear membrane,Plasma membrane" 2100000000 "Nuclear membrane, Plasma membrane" "HPA045934: AB_10960065" "unprognostic (3.52e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-1)" "unprognostic (3.79e-1)" "unprognostic (2.61e-1)" "unprognostic (2.11e-1)" "unprognostic (2.06e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 6.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 77.7 0.1 0.1 0.1 0.1 0.0 0.1 0.1 4.6 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KRT82 "Hb-2, KRTHB2" ENSG00000161850 "Keratin 82" Q9NSB4 12 52393931-52406355 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 14.9" "Cell line enriched" "Detected in single" 5 "U-87 MG: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058715, HPA067230" Enhanced 20000000 "HPA058715: AB_2683798, HPA067230: AB_2685807" "unprognostic (3.04e-1)" "unprognostic (3.59e-3)" 0.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 14.9 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 4.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT83 "Hb-3, KRTHB3" ENSG00000170523 "Keratin 83" P78385 12 52314301-52321398 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 36.3" "Cell line enriched" "Detected in some" 4 "RPMI-8226: 16.6" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.1" "Group enriched" "Detected in many" 5 "amygdala: 1.2;cerebral cortex: 1.2;pons and medulla: 3.3;thalamus: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA049778 Supported 170000000 "HPA049778: " "unprognostic (7.03e-2)" "unprognostic (2.17e-1)" "unprognostic (2.99e-1)" "unprognostic (3.30e-5)" "unprognostic (3.08e-1)" "unprognostic (1.41e-1)" "unprognostic (1.76e-2)" "unprognostic (2.43e-1)" "unprognostic (1.12e-3)" "unprognostic (7.49e-3)" "unprognostic (2.16e-2)" "unprognostic (1.78e-1)" "unprognostic (2.63e-1)" 0.8 0.0 1.2 0.0 0.0 0.0 1.5 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.6 0.1 0.0 36.3 0.0 0.0 2.1 0.0 0.0 0.8 2.7 0.7 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 3.2 0.0 0.0 0.0 0.2 0.0 0.0 16.6 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.2 0.0 0.0 0.4 0.0 3.3 2.7 KRT84 "Hb-4, KRTHB4" ENSG00000161849 "Keratin 84" Q9NSB2 12 52377812-52385652 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "tongue: 86.0" "Cell line enhanced" "Detected in some" "A-431: 1.2;HaCaT: 1.6;U-251 MG: 1.0" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "gdT-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA039714 Supported 79000000 "HPA039714: " "unprognostic (1.08e-1)" "unprognostic (1.65e-2)" "unprognostic (1.65e-1)" "unprognostic (3.47e-1)" "unprognostic (1.59e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.4 0.0 86.0 3.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 KRTAP1-1 "HB2A, KAP1.1, KAP1.1A, KAP1.1B" ENSG00000188581 "Keratin associated protein 1-1" Q07627 17 41040559-41041461 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "skin 1: 38.7" "Cell line enhanced" "Detected in some" "BJ: 2.3;fHDF/TERT166: 1.9;LHCN-M2: 2.3;U-2197: 1.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 14 "basal ganglia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.90e-1)" 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 38.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP1-3 KAP1.3 ENSG00000221880 "Keratin associated protein 1-3" Q8IUG1 17 41033884-41034855 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 88 "skin 1: 40.7" "Cell line enriched" "Detected in single" 9 "SCLC-21H: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 40.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP1-4 KAP1.4 ENSG00000204887 "Keratin associated protein 1-4" P0C5Y4 17 41029697-41030104 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "skin 1: 4.8" "Group enriched" "Detected in some" 15 "HDLM-2: 1.7;HeLa: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP1-5 KAP1.5 ENSG00000221852 "Keratin associated protein 1-5" Q9BYS1 17 41026026-41027202 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 37.4" "Group enriched" "Detected in some" 5 "BJ: 18.5;BJ hTERT+: 8.0;fHDF/TERT166: 23.9;LHCN-M2: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.76e-1)" "unprognostic (2.96e-2)" "unprognostic (2.24e-2)" "unprognostic (2.55e-1)" "unprognostic (1.90e-1)" "unprognostic (9.98e-2)" "unprognostic (1.80e-2)" "unprognostic (5.60e-2)" 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 18.5 8.0 1.7 0.7 0.0 0.0 0.0 0.0 23.9 0.0 0.0 0.0 1.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-1 "KAP10.1, KAP18.1, KRTAP18-1" ENSG00000215455 "Keratin associated protein 10-1" P60331 21 44538981-44540195 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "skin 1: 13.1" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 13.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-10 "KAP10.10, KAP18.10, KRTAP18-10" ENSG00000221859 "Keratin associated protein 10-10" P60014 21 44637356-44638455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "skin 1: 18.0" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 KRTAP10-11 "KAP10.11, KAP18.11, KRTAP18-11, KRTAP18.11" ENSG00000243489 "Keratin associated protein 10-11" P60412 21 44646414-44647650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "skin 1: 12.2" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-12 "KAP10.12, KRTAP18-12, KRTAP18.12" ENSG00000189169 "Keratin associated protein 10-12" P60413 21 44697172-44698044 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 18 "skin 1: 13.2" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.8;SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-2 "KAP10.2, KAP18.2, KRTAP18-2" ENSG00000205445 "Keratin associated protein 10-2" P60368 21 44550357-44551505 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "skin 1: 16.0" "Cell line enriched" "Detected in single" 6 "U-266/84: 3.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enhanced" "Detected in single" "granulocytes: 1.5" "unprognostic (1.26e-1)" 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.3 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 KRTAP10-3 "KAP10.3, KAP18.3, KRTAP18-3" ENSG00000212935 "Keratin associated protein 10-3" P60369 21 44557790-44558760 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "skin 1: 19.5" "Cell line enriched" "Detected in single" 4 "SCLC-21H: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-4 "KAP10.4, KRTAP18-4, KRTAP18.4" ENSG00000215454 "Keratin associated protein 10-4" P60372 21 44573724-44638284 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 10.6" "Group enriched" "Detected in some" 15 "RPMI-8226: 1.4;SCLC-21H: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-5 "KAP10.5, KAP18.5, KRTAP18-5" ENSG00000241123 "Keratin associated protein 10-5" P60370 21 44579455-44580604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "skin 1: 16.6" "Cell line enriched" "Detected in single" 4 "SCLC-21H: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-6 "KAP10.6, KAP18.6, KRTAP18-6, KRTAP18.6" ENSG00000188155 "Keratin associated protein 10-6" P60371 21 44591268-44592505 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "skin 1: 7.5" "Cell line enriched" "Detected in single" 26 "SCLC-21H: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 KRTAP10-8 "KAP10.8, KRTAP18-8, KRTAP18.8" ENSG00000187766 "Keratin associated protein 10-8" P60410 21 44612079-44612954 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 79 "skin 1: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-9 "KAP10.9, KAP18.9, KRTAP18-9" ENSG00000221837 "Keratin associated protein 10-9" P60411 21 44627123-44628293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 41 "skin 1: 13.4" "Cell line enriched" "Detected in single" 13 "SCLC-21H: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP12-1 "KAP12.1, KRTAP12.1" ENSG00000187175 "Keratin associated protein 12-1" P59990 21 44681576-44682163 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 20.4" "Cell line enriched" "Detected in single" 35 "SCLC-21H: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (4.04e-1)" 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP12-2 "KAP12.2, KRTAP12.2" ENSG00000221864 "Keratin associated protein 12-2" P59991 21 44666189-44666927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "skin 1: 19.8" "Cell line enhanced" "Detected in single" "T-47d: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP16-1 KAP16.1 ENSG00000212657 "Keratin associated protein 16-1" A8MUX0 17 41307700-41309253 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 16.9" "Group enriched" "Detected in some" 6 "HDLM-2: 1.1;SCLC-21H: 1.6;U-87 MG: 1.7;U-937: 2.0" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "cerebral cortex: 1.4" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA070954 Enhanced "HPA070954: " "unprognostic (3.65e-5)" "unprognostic (4.61e-2)" 0.6 0.0 0.0 2.5 0.0 3.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 16.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.9 0.0 1.9 0.3 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.8 0.0 0.9 0.3 0.2 1.9 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP17-1 KAP17.1 ENSG00000186860 "Keratin associated protein 17-1" Q9BYP8 17 41314917-41315695 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 9 "skin 1: 20.6" "Group enriched" "Detected in some" 48 "HDLM-2: 12.6;SCLC-21H: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.6 0.1 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-1 KAP19.1 ENSG00000184351 "Keratin associated protein 19-1" Q8IUB9 21 30479699-30480344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "skin 1: 17.6" "Cell line enriched" "Detected in some" 12 "HEK 293: 21.7" "Cancer enriched" "Detected in some" 19 "melanoma: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.36e-2)" "unprognostic (8.67e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-4 KAP19.4 ENSG00000186967 "Keratin associated protein 19-4" Q3LI73 21 30496824-30497133 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 15 "skin 1: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-5 KAP19.5 ENSG00000186977 "Keratin associated protein 19-5" Q3LI72 21 30501657-30502117 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "skin 1: 23.5" "Cell line enriched" "Detected in some" 6 "HEK 293: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 2100000 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-7 KAP19.7 ENSG00000244362 "Keratin associated protein 19-7" Q3SYF9 21 30560875-30561314 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "skin 1: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP2-1 KAP2.1A ENSG00000212725 "Keratin associated protein 2-1" Q9BYU5 17 41046541-41047316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 62 "skin 1: 34.7" "Cell line enhanced" "Detected in some" "CACO-2: 3.1;SCLC-21H: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059203 Supported "HPA059203: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 34.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP2-2 KAP2.2 ENSG00000214518 "Keratin associated protein 2-2" Q9BYT5 17 41054498-41055230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 305 "skin 1: 30.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059203 Supported "HPA059203: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP2-3 KAP2.3 ENSG00000212724 "Keratin associated protein 2-3" P0C7H8 17 41059240-41060114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 19.5" "Cell line enhanced" "Detected in some" "BJ: 20.8;fHDF/TERT166: 12.4;HBF TERT88: 18.6;LHCN-M2: 23.4;U-2 OS: 9.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059203 Supported "HPA059203: " "unprognostic (2.22e-1)" "unprognostic (2.58e-2)" "unprognostic (3.79e-3)" "unprognostic (3.25e-3)" "unprognostic (2.78e-2)" "unprognostic (6.91e-2)" "unprognostic (1.38e-1)" "unprognostic (6.41e-4)" "unprognostic (7.83e-6)" "unprognostic (1.71e-1)" "unprognostic (9.36e-2)" 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 19.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.7 5.2 4.4 0.2 0.1 0.0 0.0 12.4 0.0 0.0 0.3 18.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 3.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 9.0 0.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP2-4 KAP2.4 ENSG00000213417 "Keratin associated protein 2-4" Q9BYR9 17 41065116-41065879 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 55 "skin 1: 27.4" "Cell line enhanced" "Detected in single" "PC-3: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059203 Supported "HPA059203: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP20-2 KAP20.2 ENSG00000184032 "Keratin associated protein 20-2" Q3LI61 21 30635236-30635619 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 12 "skin 1: 5.1" "Group enriched" "Detected in some" 22 "ASC diff: 3.2;U-2 OS: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP20-4 KAP20.4 ENSG00000206105 "Keratin associated protein 20-4" Q3LI62 21 30620627-30620850 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 41 "testis: 6.8" "Cell line enriched" "Detected in some" 9 "U-2 OS: 10.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.31e-1)" "unprognostic (2.73e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP23-1 KAP23.1 ENSG00000186980 "Keratin associated protein 23-1" A1A580 21 30348399-30348609 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "skin 1: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP24-1 KAP24.1 ENSG00000188694 "Keratin associated protein 24-1" Q3LI83 21 30281309-30282958 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "skin 1: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA017604 Enhanced "HPA017604: " 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP3-1 KAP3.1 ENSG00000212901 "Keratin associated protein 3-1" Q9BYR8 17 41008521-41019324 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 64.5" "Cell line enhanced" "Detected in some" "BJ: 4.1;CACO-2: 10.8;HaCaT: 2.9;Hep G2: 5.4;T-47d: 3.2" "Cancer enhanced" "Detected in some" "stomach cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (4.24e-1)" "unprognostic (3.00e-2)" "unprognostic (7.37e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 1.7 0.0 0.0 64.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 11.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.4 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-1 "KAP4.1, KAP4.10, KRTAP4-10" ENSG00000198443 "Keratin associated protein 4-1" Q9BYQ7 17 41184102-41185342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 14.8" "Cell line enhanced" "Detected in some" "A-431: 2.2;A549: 3.4;CAPAN-2: 2.5;HDLM-2: 9.6;SCLC-21H: 2.4;SK-BR-3: 2.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.21e-1)" "unprognostic (3.57e-1)" "unprognostic (1.64e-2)" "unprognostic (2.78e-2)" "unprognostic (1.04e-1)" "unprognostic (2.49e-2)" "unprognostic (2.42e-2)" "unprognostic (1.06e-1)" 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 2.4 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 0.1 1.3 0.1 0.1 0.2 0.1 14.8 1.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.0 2.4 0.0 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KRTAP4-11 "KAP4.11, KAP4.14, KRTAP4-14" ENSG00000212721 "Keratin associated protein 4-11" Q9BYQ6 17 41117181-41118360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skin 1: 13.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-12 KAP4.12 ENSG00000213416 "Keratin associated protein 4-12" Q9BQ66 17 41123091-41124167 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 21.4" "Cell line enriched" "Detected in single" 5 "BJ: 3.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "pons and medulla: 1.5" "Cell type enhanced" "Detected in single" "naive B-cell: 2.9" "Lineage enhanced" "Detected in single" "B-cells: 2.9" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 2.9 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 KRTAP4-16 "KAP4A, KRTAP4-16P, KRTAP4P1" ENSG00000241241 "Keratin associated protein 4-16" 17 41101502-41102209 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "pancreas: 1.4" "Cell line enriched" "Detected in single" 5 "PC-3: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-2 KAP4.2 ENSG00000244537 "Keratin associated protein 4-2" Q9BYR5 17 41177446-41178208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "skin 1: 20.1" "Cell line enriched" "Detected in single" 12 "HDLM-2: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 1200000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-3 KAP4.3 ENSG00000196156 "Keratin associated protein 4-3" Q9BYR4 17 41167231-41168194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 17.3" "Cell line enriched" "Detected in single" 51 "HDLM-2: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "memory CD4 T-cell: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" 390000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-4 "KAP4.13, KAP4.4, KRTAP4-13" ENSG00000171396 "Keratin associated protein 4-4" Q9BYR3 17 41159651-41160731 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 18.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 1300000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-5 KAP4.5 ENSG00000198271 "Keratin associated protein 4-5" Q9BYR2 17 41148924-41149802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "skin 1: 14.7" "Cell line enhanced" "Detected in single" "HaCaT: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-6 "KAP4.15, KAP4.6, KRTAP4-15" ENSG00000198090 "Keratin associated protein 4-6" Q9BYQ5 17 41139433-41140487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "skin 1: 24.2" "Group enriched" "Detected in some" 13 "CACO-2: 1.1;HaCaT: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.5" "Lineage enriched" "Detected in single" 13 "B-cells: 1.5" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-7 KAP4.7 ENSG00000240871 "Keratin associated protein 4-7" Q9BYR0 17 41084150-41085141 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 52 "skin 1: 30.9" "Group enriched" "Detected in some" 4 "fHDF/TERT166: 3.0;SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-8 KAP4.8 ENSG00000204880 "Keratin associated protein 4-8" Q9BYQ9 17 41096981-41098141 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "skin 1: 20.7" "Cell line enhanced" "Detected in some" "BJ: 2.1;BJ hTERT+ SV40 Large T+: 1.2;HBF TERT88: 4.0" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "pons and medulla: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 KRTAP4-9 KAP4.9 ENSG00000212722 "Keratin associated protein 4-9" Q9BYQ8 17 41105332-41106488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "skin 1: 28.2" "Cell line enhanced" "Detected in some" "BJ: 1.9;BJ hTERT+ SV40 Large T+: 1.4;U-138 MG: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-11 "KRTAP5-6, KRTAP5.11" ENSG00000204571 "Keratin associated protein 5-11" Q6L8G4 11 71579714-71603353 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skin 1: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.08e-1)" 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.6 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-3 "KRTAP5-9, KRTAP5.3" ENSG00000196224 "Keratin associated protein 5-3" Q6L8H2 11 1607565-1608463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 11.4" "Cell line enriched" "Detected in single" 5 "RT4: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 11.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-5 "KRTAP5-11, KRTAP5.5" ENSG00000185940 "Keratin associated protein 5-5" Q701N2 11 1629775-1630707 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "skin 1: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.45e-2)" "unprognostic (1.00e-2)" "unprognostic (7.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.7 0.0 1.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 9.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP6-1 "C21orf103, KAP6.1" ENSG00000184724 "Keratin associated protein 6-1" Q3LI64 21 30613431-30613930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP8-1 KAP8.1 ENSG00000183640 "Keratin associated protein 8-1" Q8IUC2 21 30812697-30813252 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 33.2" "Cell line enriched" "Detected in single" 17 "U-937: 1.6" "Cancer enriched" "Detected in single" 21 "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-2 KAP9.2 ENSG00000239886 "Keratin associated protein 9-2" Q9BYQ4 17 41226648-41227652 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "skin 1: 23.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-3 KAP9.3 ENSG00000204873 "Keratin associated protein 9-3" Q9BYQ3 17 41232463-41233454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "skin 1: 29.4" "Cell line enriched" "Detected in single" 14 "SCLC-21H: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 150000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-4 KAP9.4 ENSG00000241595 "Keratin associated protein 9-4" Q9BYQ2 17 41249687-41250653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "skin 1: 26.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-6 "KAP9.6, KRTAP9L2" ENSG00000212659 "Keratin associated protein 9-6" A8MVA2 17 41265339-41266641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "skin 1: 6.9" "Cell line enhanced" "Detected in single" "Karpas-707: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 6.9 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.7 0.3 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.4 0.1 0.3 0.3 0.4 0.5 0.7 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.3 0.1 0.1 0.0 0.0 0.5 0.2 0.7 0.3 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.4 0.0 0.5 0.7 0.0 0.1 0.2 0.0 0.0 KRTAP9-7 "KAP9.7, KRTAP9L1" ENSG00000180386 "Keratin associated protein 9-7" A8MTY7 17 41275659-41276697 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 47 "skin 1: 11.8" "Cell line enriched" "Detected in single" 7 "HDLM-2: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-8 KAP9.8 ENSG00000187272 "Keratin associated protein 9-8" Q9BYQ0 17 41238045-41239004 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "skin 1: 26.2" "Cell line enriched" "Detected in single" 59 "HDLM-2: 5.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 18 "pons and medulla: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 KRTAP9-9 "KAP9.5, KAP9.9, KRTAP9-5" ENSG00000198083 "Keratin associated protein 9-9" Q9BYP9 17 41255384-41256364 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 208 "skin 1: 20.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LACRT LACRITIN ENSG00000135413 Lacritin Q9GZZ8 12 54630811-54634895 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 72 "salivary gland: 67.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 304 "breast cancer: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" 460000 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LACTBL1 ENSG00000215906 "Lactamase beta like 1" A8MY62 1 22953043-22965338 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 2.2" "Cell line enriched" "Detected in single" 10 "Hep G2: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LALBA LYZL7 ENSG00000167531 "Lactalbumin alpha" P00709 12 48567684-48570066 "Cancer-related genes, Predicted secreted proteins" "Lactose biosynthesis" "Milk protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 194 "breast: 217.7" "Cell line enhanced" "Detected in some" "HDLM-2: 1.5;MCF7: 1.3" "Cancer enriched" "Detected in single" 599 "breast cancer: 29.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB026343, HPA029855, HPA029856" Enhanced "Secreted in female reproductive system" "CAB026343: , HPA029855: AB_2673222, HPA029856: AB_10671362" "unprognostic (7.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 217.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LAMP3 "CD208, DC-LAMP, DCLAMP, LAMP, TSC403" ENSG00000078081 "Lysosomal associated membrane protein 3" Q9UQV4 3 183122213-183163839 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lung: 123.9" "Group enriched" "Detected in some" 6 "EFO-21: 57.2;HDLM-2: 14.5;HHSteC: 21.2;hTCEpi: 19.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 7.6" "Group enriched" "Detected in many" 8 "granulocytes: 7.6;T-cells: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB025133, HPA051467" Enhanced Enhanced Vesicles 47000 Vesicles "CAB025133: , HPA051467: " "unprognostic (1.43e-3)" "unprognostic (2.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.99e-3)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (7.67e-2)" "unprognostic (8.64e-2)" "unprognostic (4.95e-2)" "prognostic favourable (9.90e-4)" "unprognostic (1.80e-3)" "unprognostic (5.80e-2)" "prognostic unfavourable (1.89e-7)" "unprognostic (3.12e-1)" "unprognostic (4.13e-2)" "unprognostic (8.35e-2)" "unprognostic (1.29e-1)" 0.5 0.7 0.4 14.1 0.4 0.0 0.5 0.3 0.4 1.0 0.6 0.1 0.6 0.4 0.4 1.0 2.5 0.5 0.8 0.4 0.4 0.4 0.8 0.6 123.9 11.2 0.4 0.1 0.4 8.3 0.0 0.6 1.0 0.6 1.0 1.7 0.2 6.8 1.9 0.4 1.9 1.4 0.8 0.5 2.0 0.8 8.4 0.0 21.3 8.3 3.1 11.3 3.3 0.9 0.4 0.0 7.6 0.1 0.8 6.6 1.1 3.4 0.1 0.0 0.5 0.0 0.0 2.8 0.0 0.9 0.6 0.1 0.8 1.8 0.0 57.2 0.2 0.5 1.2 2.1 0.1 14.5 1.7 0.0 0.1 0.1 21.2 0.0 0.5 0.3 19.4 0.0 2.5 2.6 0.1 3.4 0.1 0.0 0.8 0.1 0.1 0.8 0.0 0.0 0.2 0.0 1.1 0.2 0.1 0.2 0.1 1.5 1.1 0.1 2.7 0.0 1.0 0.1 0.0 1.2 4.3 0.1 0.0 0.0 0.0 0.4 0.1 7.6 0.4 0.0 3.2 0.1 2.7 1.7 0.0 0.4 3.5 2.0 1.9 0.8 0.1 0.0 6.6 1.1 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.1 0.6 0.0 LBHD1 "C11orf48, MGC2477" ENSG00000162194 "LBH domain containing 1" Q9BQE6 11 62662817-62672255 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "heart muscle: 67.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA012127, HPA023592" Uncertain "HPA012127: AB_1845527, HPA023592: AB_1845528" "unprognostic (4.34e-4)" "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" "unprognostic (7.90e-3)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.18e-8)" "unprognostic (2.75e-1)" "unprognostic (1.03e-1)" "unprognostic (1.52e-2)" "unprognostic (2.81e-1)" "unprognostic (6.79e-2)" "unprognostic (2.78e-8)" "unprognostic (3.69e-2)" "unprognostic (1.62e-1)" "unprognostic (5.79e-2)" "unprognostic (4.72e-3)" 4.7 14.7 1.7 6.2 3.9 6.9 4.2 3.4 3.6 3.8 4.0 3.9 7.6 4.0 2.3 5.4 4.0 4.1 5.3 67.7 3.4 2.1 4.1 8.3 4.4 8.3 1.8 3.3 3.3 4.1 7.5 4.4 2.3 3.7 4.6 4.1 4.5 4.2 10.0 4.8 2.6 6.0 2.5 3.1 10.4 4.6 6.7 2.3 6.2 4.6 3.0 6.5 4.8 2.6 4.9 7.1 5.7 6.2 8.0 7.0 4.3 2.0 3.5 2.2 1.7 3.4 6.4 4.9 2.8 4.1 4.6 3.7 2.8 23.7 7.1 6.1 3.4 9.2 2.3 6.4 3.6 9.5 7.3 5.9 9.7 2.0 5.0 5.5 7.8 8.7 0.7 8.1 2.6 2.5 6.1 6.5 2.9 3.5 3.4 8.3 2.7 3.1 8.4 5.4 13.0 6.0 4.0 2.4 3.6 3.1 4.3 8.8 7.8 8.3 1.9 2.9 1.8 2.9 2.9 10.7 9.2 6.7 2.6 5.7 2.9 2.2 6.2 5.7 6.6 4.5 5.7 4.6 3.7 7.0 5.4 4.9 5.1 4.1 1.8 8.0 3.4 7.1 2.2 4.3 1.7 3.9 3.4 3.6 3.4 2.1 1.8 3.3 3.7 2.3 LBP BPIFD2 ENSG00000129988 "Lipopolysaccharide binding protein" P18428 20 38346356-38377023 "Plasma proteins, Predicted secreted proteins, Transporters" "Immunity, Innate immunity, Lipid transport, Transport" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "liver: 429.7" "Group enriched" "Detected in some" 10 "ASC diff: 12.1;HSkMC: 14.3" "Cancer enriched" "Detected in many" 20 "liver cancer: 356.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001508, CAB025905" Approved "Secreted to blood" 25011600000 910000000 "CAB025905: , HPA001508: AB_1079241" "unprognostic (4.20e-2)" "prognostic unfavourable (5.56e-4)" "unprognostic (4.54e-2)" "unprognostic (2.47e-1)" "unprognostic (3.80e-2)" "unprognostic (2.53e-2)" "unprognostic (5.50e-2)" "unprognostic (2.48e-3)" "unprognostic (6.15e-2)" "unprognostic (2.12e-1)" "unprognostic (7.93e-2)" "unprognostic (2.62e-1)" "prognostic unfavourable (3.62e-12)" "prognostic unfavourable (5.76e-4)" "unprognostic (1.69e-1)" "unprognostic (1.22e-1)" "unprognostic (1.67e-1)" 12.8 0.0 0.1 4.7 0.1 0.0 0.7 0.1 0.1 0.6 0.4 0.1 0.1 0.0 0.4 0.2 0.1 0.0 0.1 0.4 0.1 0.0 3.1 429.7 0.1 0.5 0.1 0.1 0.2 0.2 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 4.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 1.4 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.1 0.0 12.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 14.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 LCA5L "C21orf13, MGC33295" ENSG00000157578 "LCA5L, lebercilin like" O95447 21 39405844-39445805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 57.2" "Cell line enhanced" "Detected in many" "MCF7: 6.7;T-47d: 7.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019790, HPA032010" Enhanced Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA019790: AB_1845690, HPA032010: " "unprognostic (1.02e-1)" "unprognostic (3.81e-1)" "unprognostic (2.43e-1)" "unprognostic (2.54e-3)" "unprognostic (4.69e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-2)" "unprognostic (6.34e-2)" "unprognostic (1.27e-2)" "unprognostic (1.85e-2)" "unprognostic (5.50e-2)" "unprognostic (2.37e-1)" "unprognostic (7.53e-3)" "unprognostic (1.40e-1)" "unprognostic (1.04e-2)" "unprognostic (9.68e-3)" "unprognostic (1.95e-1)" 0.4 1.3 1.4 0.3 3.7 0.3 1.2 1.1 1.6 1.2 0.6 2.3 2.7 0.4 0.9 4.6 0.4 4.4 1.0 0.5 1.9 1.2 1.6 1.3 1.0 0.3 0.7 1.2 0.8 1.1 1.7 9.1 0.3 3.1 0.7 0.4 2.2 0.8 1.8 1.7 0.7 0.4 0.5 0.7 0.4 0.6 57.2 1.1 0.3 2.9 0.4 0.3 0.5 0.5 0.3 0.7 0.2 0.5 0.0 1.1 0.0 1.7 1.8 1.0 3.1 1.5 1.3 0.2 0.4 0.8 0.9 0.1 1.0 1.9 1.2 1.5 1.6 0.4 0.1 1.0 0.6 0.6 1.5 0.9 1.8 0.2 1.3 2.0 0.0 1.2 4.2 3.0 3.3 0.6 3.1 1.2 1.1 6.7 0.6 0.7 6.0 1.8 0.4 0.3 1.2 3.2 0.6 2.1 0.9 3.8 1.6 2.4 7.2 0.3 0.1 0.5 0.4 1.8 0.5 3.6 1.9 0.4 2.7 0.7 1.2 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.5 0.6 0.2 0.3 0.0 1.1 0.2 0.0 0.5 0.7 0.0 0.0 1.4 3.7 1.1 1.6 1.9 1.2 0.7 1.2 3.1 1.1 LCE1A LEP1 ENSG00000186844 "Late cornified envelope 1A" Q5T7P2 1 152827473-152827894 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skin 1: 97.7" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 6 "melanoma: 14.4" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.82e-2)" "unprognostic (1.70e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 97.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE1B "LEP2, SPRL2A" ENSG00000196734 "Late cornified envelope 1B" Q5T7P3 1 152811971-152813109 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 59.7" "Group enriched" "Detected in some" 8 "HBEC3-KT: 1.7;hTCEpi: 6.5" "Cancer enriched" "Detected in some" 10 "melanoma: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.79e-1)" "unprognostic (1.24e-2)" "unprognostic (6.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 59.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE1C LEP3 ENSG00000197084 "Late cornified envelope 1C" Q5T751 1 152804835-152806628 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "skin 1: 100.1" "Group enriched" "Detected in some" 5 "BJ hTERT+: 2.5;HBEC3-KT: 5.1;hTEC/SVTERT24-B: 2.7;hTERT-HME1: 6.9" "Cancer enriched" "Detected in some" 6 "melanoma: 17.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.35e-2)" "unprognostic (5.95e-2)" "unprognostic (3.46e-2)" "unprognostic (3.35e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 8.6 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.0 0.1 0.1 0.1 0.7 100.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 3.1 0.1 8.8 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.9 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.7 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 LCE1D LEP4 ENSG00000172155 "Late cornified envelope 1D" Q5T752 1 152796751-152798181 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 46.0" "Group enriched" "Detected in some" 16 "HaCaT: 1.6;Karpas-707: 1.5" "Cancer enriched" "Detected in single" 8 "melanoma: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (7.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 46.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE1E LEP5 ENSG00000186226 "Late cornified envelope 1E" Q5T753 1 152786214-152788426 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 39.5" "Cell line enriched" "Detected in some" 4 "HaCaT: 14.5" "Cancer enhanced" "Detected in single" "melanoma: 0.7" "Region enriched" "Detected in single" 15 "cerebellum: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (9.92e-2)" "unprognostic (9.50e-2)" "unprognostic (2.30e-2)" "unprognostic (2.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.3 39.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 2.6 0.0 0.0 14.5 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE1F LEP6 ENSG00000240386 "Late cornified envelope 1F" Q5T754 1 152776372-152776728 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "skin 1: 69.5" "Group enriched" "Detected in some" 4 "BJ hTERT+: 11.4;hTERT-HME1: 5.3" "Group enriched" "Detected in some" 13 "head and neck cancer: 5.5;melanoma: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.21e-1)" "unprognostic (8.43e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 3.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 69.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 LCE2B "LEP10, SPRL1B, XP5" ENSG00000159455 "Late cornified envelope 2B" O14633 1 152686123-152687401 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skin 1: 101.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.1;BJ hTERT+ SV40 Large T+: 2.0" "Cancer enriched" "Detected in some" 5 "melanoma: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.04e-2)" "unprognostic (1.36e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 101.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE2C LEP11 ENSG00000187180 "Late cornified envelope 2C" Q5TA81 1 152675295-152676574 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skin 1: 75.3" "Cell line enhanced" "Detected in some" "BJ: 1.0;CACO-2: 1.9" "Group enriched" "Detected in some" 30 "head and neck cancer: 2.0;melanoma: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.47e-2)" "unprognostic (7.00e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 75.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE2D "LEP12, SPRL1A" ENSG00000187223 "Late cornified envelope 2D" Q5TA82 1 152663396-152664659 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 52.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.4;U-2197: 1.0" "Group enriched" "Detected in some" 42 "head and neck cancer: 1.2;melanoma: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.94e-2)" "unprognostic (5.63e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 3.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.8 52.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 6.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 LCE3A LEP13 ENSG00000185962 "Late cornified envelope 3A" Q5TA76 1 152622834-152623103 "Predicted intracellular proteins" Keratinization Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 50.6" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.0;LHCN-M2: 3.5;U-138 MG: 4.0;U-87 MG: 1.4" "Group enriched" "Detected in some" 9 "head and neck cancer: 26.6;melanoma: 9.8" "Cell type enriched" "Detected in single" 33 "plasmacytoid DC: 3.3" "Lineage enriched" "Detected in single" 33 "dendritic cells: 3.3" "unprognostic (7.47e-2)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 50.6 0.0 10.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 LCE3B LEP14 ENSG00000187238 "Late cornified envelope 3B" Q5TA77 1 152613811-152614098 "Predicted intracellular proteins" Keratinization Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 23 "lymphoid tissue: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE4A "LEP8, SPRL4A" ENSG00000187170 "Late cornified envelope 4A" Q5TA78 1 152708160-152709491 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 10.1" "Group enriched" "Detected in some" 11 "BJ: 1.2;BJ hTERT+: 1.0;THP-1: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.61e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE5A "LEP18, SPRL5A" ENSG00000186207 "Late cornified envelope 5A" Q5TCM9 1 152510844-152512177 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 42.7" "Cell line enhanced" "Detected in some" "A549: 1.6;hTERT-HME1: 1.1" "Cancer enhanced" "Detected in single" "melanoma: 0.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "NK-cell: 1.4" "Lineage enriched" "Detected in single" 14 "NK-cells: 1.4" "unprognostic (2.51e-1)" "unprognostic (7.27e-3)" "unprognostic (9.27e-2)" "unprognostic (1.89e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 7.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 42.7 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 4.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 LCE6A C1orf44 ENSG00000235942 "Late cornified envelope 6A" A0A183 1 152842868-152843983 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "skin 1: 77.1" "Cell line enriched" "Detected in single" 15 "RPMI-8226: 1.5" "Cancer enriched" "Detected in some" 5 "melanoma: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046376 Enhanced "HPA046376: AB_10965998" "unprognostic (4.25e-2)" "unprognostic (8.73e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 6.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.2 0.0 0.1 0.1 0.1 0.2 77.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.8 0.1 6.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 LCN1 "MGC71975, PMFA, TLC, TP, VEGP" ENSG00000160349 "Lipocalin 1" P31025 9 135521438-135526532 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Sensory transduction, Taste, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "tongue: 204.2" "Cell line enhanced" "Detected in some" "EFO-21: 2.3;U-87 MG: 2.0" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.1" "Region enhanced" "Detected in single" "hippocampal formation: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" 20000000 "unprognostic (5.50e-3)" "unprognostic (1.10e-1)" "unprognostic (7.12e-2)" "unprognostic (3.99e-1)" "unprognostic (1.08e-2)" "unprognostic (1.11e-4)" "unprognostic (1.22e-1)" "unprognostic (7.84e-2)" "unprognostic (9.47e-2)" "unprognostic (3.94e-8)" "unprognostic (2.07e-3)" "unprognostic (3.03e-2)" "unprognostic (5.83e-2)" 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.1 0.0 16.8 3.3 0.0 0.7 2.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.3 0.0 2.2 0.4 0.0 0.1 0.0 0.0 0.4 15.8 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 204.2 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 2.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.6 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.3 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 2.0 0.0 0.1 0.0 0.0 0.0 LCN12 MGC48935 ENSG00000184925 "Lipocalin 12" Q6JVE5 9 136949551-136955497 "Predicted intracellular proteins, Predicted secreted proteins" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "epididymis: 131.5" "Cell line enhanced" "Detected in some" "A549: 2.8;BEWO: 1.3;Daudi: 1.0;EFO-21: 1.7;HEL: 1.5;SH-SY5Y: 1.0" "Cancer enhanced" "Detected in many" "thyroid cancer: 44.8" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 21 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 21 "dendritic cells: 2.0" "Not detected" "Not detected" "Secreted in male reproductive system" "unprognostic (7.27e-3)" "unprognostic (5.72e-3)" "unprognostic (2.45e-2)" "unprognostic (7.14e-2)" "unprognostic (4.53e-4)" "unprognostic (9.33e-3)" "unprognostic (1.97e-3)" "unprognostic (1.41e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-1)" "unprognostic (7.33e-3)" "unprognostic (2.18e-1)" "unprognostic (5.73e-2)" "unprognostic (5.21e-3)" "unprognostic (3.06e-1)" "unprognostic (5.00e-2)" "unprognostic (7.91e-4)" 0.3 0.4 0.9 0.3 1.8 0.3 0.3 0.2 0.9 0.9 0.3 0.4 24.4 0.4 0.5 131.5 0.3 2.4 0.3 0.3 0.8 0.8 2.3 1.2 0.3 0.3 1.0 0.7 0.6 0.7 0.3 1.9 0.3 1.2 0.3 0.3 1.6 0.3 10.9 0.3 0.3 0.4 0.3 0.9 0.6 0.4 1.1 0.9 0.0 8.6 0.0 0.3 0.3 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.9 1.8 0.2 0.9 0.8 0.8 1.0 0.7 1.2 0.9 LCN6 ENSG00000267206 "Lipocalin 6" P62502 9 136744011-136748528 "Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "epididymis: 261.0" "Group enriched" "Detected in some" 6 "NB-4: 4.6;REH: 14.6" "Cancer enriched" "Detected in some" 10 "thyroid cancer: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" "unprognostic (4.05e-2)" "unprognostic (1.01e-3)" "unprognostic (1.12e-1)" "unprognostic (5.88e-2)" "unprognostic (3.23e-1)" "unprognostic (1.26e-1)" "unprognostic (3.83e-4)" "unprognostic (3.41e-2)" "unprognostic (7.47e-2)" "unprognostic (1.08e-2)" "unprognostic (2.89e-3)" "unprognostic (1.78e-1)" "unprognostic (5.55e-2)" "unprognostic (2.96e-2)" "unprognostic (7.19e-2)" "unprognostic (1.20e-2)" "unprognostic (1.45e-1)" 4.5 0.5 0.4 1.3 0.6 1.1 4.4 0.4 0.6 5.1 1.6 0.4 13.9 0.5 10.1 261.0 1.5 6.5 1.8 8.3 0.4 0.0 0.8 0.5 1.1 0.6 0.6 0.5 2.6 1.0 0.6 0.3 0.5 0.6 3.4 0.6 0.6 2.0 1.2 1.5 0.5 3.1 1.4 0.7 1.0 3.1 3.2 0.4 0.3 2.2 0.4 0.5 2.9 3.8 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 14.6 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.4 0.6 0.4 0.0 0.6 0.5 0.6 0.4 LCN8 LCN5 ENSG00000204001 "Lipocalin 8" Q6JVE9 9 136754386-136758543 "Predicted intracellular proteins, Predicted secreted proteins" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "epididymis: 72.1" "Cell line enriched" "Detected in some" 6 "REH: 7.0" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Region enriched" "Detected in single" 7 "cerebellum: 5.3" "Group enriched" "Detected in some" 57 "memory B-cell: 5.3;naive B-cell: 9.3" "Lineage enriched" "Detected in single" 72 "B-cells: 9.3" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 0.6" "Secreted in male reproductive system" "unprognostic (1.64e-2)" "unprognostic (1.00e-1)" "unprognostic (6.71e-2)" "unprognostic (2.11e-2)" "unprognostic (2.92e-1)" "unprognostic (2.89e-1)" "unprognostic (2.00e-1)" 0.0 0.0 0.2 0.1 0.0 0.0 0.0 5.3 0.7 0.1 0.0 0.0 2.5 0.0 0.2 72.1 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.5 0.0 0.0 0.9 0.0 0.6 0.0 0.0 1.9 0.0 0.2 0.0 0.0 9.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 7.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 5.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 LCT ENSG00000115850 Lactase P09848 2 135787840-135837180 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 133 "intestine: 255.5" "Group enriched" "Detected in some" 5 "MOLT-4: 6.8;RPMI-8226: 13.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 19 "dendritic cells: 1.9" "Region enriched" "Detected in single" 16 "hippocampal formation: 17.3" "unprognostic (2.21e-2)" "unprognostic (1.65e-4)" "unprognostic (2.54e-1)" "unprognostic (2.06e-1)" "unprognostic (3.39e-2)" "unprognostic (8.03e-4)" "unprognostic (3.55e-3)" "unprognostic (6.71e-3)" "unprognostic (1.89e-1)" "unprognostic (3.57e-1)" "unprognostic (1.69e-1)" "unprognostic (9.32e-2)" "unprognostic (1.64e-4)" "unprognostic (4.90e-2)" "unprognostic (8.92e-2)" "unprognostic (8.97e-2)" "unprognostic (1.02e-1)" 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.1 0.1 209.8 0.0 0.0 67.7 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 255.5 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.8 1.1 0.0 0.0 1.6 0.0 13.6 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.1 0.2 0.1 0.3 0.2 0.1 0.0 0.0 0.0 LDHAL6A "LDH6A, MGC23940" ENSG00000166800 "Lactate dehydrogenase A like 6A" Q6ZMR3 11 18455824-18479600 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 18.9" "Cell line enriched" "Detected in some" 6 "HL-60: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "unprognostic (1.41e-1)" "unprognostic (4.84e-2)" "unprognostic (8.95e-2)" "unprognostic (5.35e-2)" "unprognostic (1.03e-1)" "unprognostic (3.31e-2)" "unprognostic (7.34e-2)" "unprognostic (1.75e-1)" "unprognostic (1.23e-1)" "unprognostic (1.60e-1)" "unprognostic (2.35e-2)" "unprognostic (3.58e-1)" "unprognostic (2.22e-2)" "unprognostic (2.51e-1)" "unprognostic (1.81e-1)" "unprognostic (8.31e-3)" "unprognostic (1.48e-1)" 0.2 0.7 0.6 0.4 0.6 1.4 0.2 2.4 1.9 0.1 0.2 0.4 0.0 0.9 0.2 0.4 0.4 0.2 0.3 1.1 0.4 0.5 0.4 0.2 0.2 0.6 0.3 0.7 0.7 0.4 0.0 0.4 0.2 2.2 0.2 0.1 1.9 0.3 0.3 0.2 1.5 0.8 0.0 0.3 0.4 0.4 18.9 0.0 0.1 0.8 0.0 0.1 0.2 0.2 1.3 0.7 3.5 0.5 1.6 1.9 0.2 0.2 0.4 1.0 0.7 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.5 0.5 0.8 0.2 0.0 0.6 0.1 0.3 0.4 0.7 0.9 0.6 0.8 0.5 0.0 15.3 0.7 0.1 0.2 0.0 0.2 0.0 0.4 1.2 0.1 0.2 0.4 1.1 0.3 0.7 0.7 0.4 1.5 0.1 1.1 0.6 0.5 0.5 0.3 0.2 0.4 2.2 0.8 0.5 0.2 1.0 0.3 2.7 0.5 0.2 0.3 0.6 0.3 2.1 0.4 0.4 1.9 0.3 0.3 0.9 0.5 0.5 0.7 1.3 1.1 1.0 3.5 1.6 0.5 0.5 1.3 0.2 0.6 0.6 2.4 1.9 0.4 0.5 0.3 0.7 2.2 0.0 LDHAL6B "LDH6B, LDHAL6, LDHL" ENSG00000171989 "Lactate dehydrogenase A like 6B" Q9BYZ2 15 59206823-59208515 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "testis: 56.6" "Cell line enhanced" "Detected in some" "A549: 1.1;CAPAN-2: 1.5;HaCaT: 1.6;HeLa: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "olfactory region: 1.7" HPA053962 Enhanced "HPA053962: " "unprognostic (1.59e-1)" "unprognostic (9.41e-2)" "unprognostic (2.37e-1)" "unprognostic (4.46e-2)" "unprognostic (6.59e-2)" "unprognostic (2.23e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-1)" "unprognostic (2.29e-1)" "unprognostic (1.66e-1)" "unprognostic (5.13e-3)" "unprognostic (1.64e-1)" "unprognostic (3.12e-7)" "unprognostic (3.47e-2)" "unprognostic (1.49e-2)" "unprognostic (8.53e-2)" "unprognostic (7.80e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 56.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.8 0.0 0.4 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 1.5 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.4 0.4 0.7 0.3 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 LDHC CT32 ENSG00000166796 "Lactate dehydrogenase C" P07864 11 18412307-18452058 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "testis: 143.9" "Cell line enhanced" "Detected in some" "U-2197: 8.5;U-266/70: 7.6;U-266/84: 6.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA045442 Enhanced "HPA045442: AB_10966720" "unprognostic (2.32e-2)" "unprognostic (3.42e-3)" "unprognostic (1.87e-1)" "unprognostic (2.83e-2)" "unprognostic (2.19e-1)" "unprognostic (8.56e-4)" "unprognostic (1.35e-1)" "unprognostic (5.74e-2)" "unprognostic (6.65e-2)" "unprognostic (1.73e-1)" "unprognostic (2.04e-1)" "unprognostic (1.18e-2)" "unprognostic (1.08e-1)" "unprognostic (9.30e-2)" "unprognostic (3.00e-1)" "unprognostic (4.25e-1)" "unprognostic (1.93e-1)" 0.1 0.1 0.7 0.0 0.9 0.1 0.1 0.6 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.5 0.2 0.1 0.1 0.4 0.0 0.1 0.3 0.0 0.1 0.4 0.0 0.3 0.0 0.4 0.1 0.0 0.2 0.1 0.0 0.2 0.1 0.3 0.0 0.3 0.0 0.0 143.9 0.3 0.0 0.2 0.1 0.2 0.0 0.0 2.4 2.7 3.6 1.1 0.2 3.8 1.2 0.0 0.0 0.3 1.9 1.4 1.6 1.9 0.1 0.1 0.1 0.1 0.2 0.3 0.2 0.1 0.4 0.2 0.0 0.0 0.1 0.2 2.7 0.2 1.0 0.0 0.0 0.2 0.3 0.0 0.4 0.1 0.1 1.0 0.1 0.6 0.0 0.4 0.2 0.5 0.0 0.5 0.1 0.0 0.1 0.0 0.0 1.9 0.0 2.2 3.4 0.5 0.2 0.1 0.8 0.3 2.7 8.5 0.1 7.6 6.7 0.3 0.1 0.0 0.1 1.3 0.7 1.0 0.6 1.0 2.3 0.8 1.8 2.2 0.0 2.4 3.8 2.6 3.6 0.2 1.1 2.7 1.7 1.2 0.7 0.9 0.6 0.4 0.2 0.1 0.3 0.0 0.4 0.3 LEAP2 LEAP-2 ENSG00000164406 "Liver enriched antimicrobial peptide 2" Q969E1 5 132872322-132875046 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "liver: 52.4" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in many" 17 "liver cancer: 40.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" 1300000 "unprognostic (2.14e-2)" "unprognostic (8.78e-2)" "unprognostic (4.75e-1)" "unprognostic (2.16e-1)" "unprognostic (2.82e-1)" "unprognostic (1.06e-2)" "unprognostic (2.78e-3)" "unprognostic (6.53e-2)" "unprognostic (3.86e-2)" "unprognostic (1.62e-1)" "unprognostic (7.08e-3)" "unprognostic (2.91e-2)" "unprognostic (1.02e-1)" "unprognostic (2.39e-1)" "unprognostic (3.97e-1)" "unprognostic (1.11e-1)" "prognostic favourable (2.68e-4)" 0.1 0.1 0.0 0.2 0.1 0.0 0.2 1.5 0.0 0.2 0.3 1.5 0.1 0.1 0.3 0.2 0.4 0.2 0.1 0.0 1.4 52.4 0.2 0.3 0.1 0.2 0.5 0.5 0.2 0.0 0.7 0.5 0.3 0.1 0.9 0.4 2.6 0.0 0.1 0.7 0.5 0.1 0.6 0.5 1.8 0.4 1.6 0.9 4.2 1.3 0.9 2.0 0.3 0.4 2.3 2.3 4.8 2.6 1.3 1.7 1.0 0.2 0.7 1.6 2.3 2.8 2.0 0.4 0.2 4.1 3.8 1.1 0.5 3.5 1.6 1.6 5.7 1.6 0.7 0.9 1.2 1.1 1.9 0.6 1.3 0.7 1.4 4.8 0.7 1.2 1.6 3.8 1.4 1.1 1.4 1.5 1.5 1.0 2.0 1.6 1.1 1.0 1.0 0.8 1.5 1.2 0.4 2.7 1.5 1.2 0.6 5.7 4.3 1.6 0.7 2.7 1.1 4.2 1.3 0.2 1.3 0.9 1.4 1.5 0.9 0.6 0.9 1.6 1.1 1.2 3.2 0.9 0.5 0.8 2.0 0.3 LECT2 "chm-II, chm2" ENSG00000145826 "Leukocyte cell derived chemotaxin 2" O14960 5 135922279-135955034 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 100.7" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in single" 216 "liver cancer: 35.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043883 Enhanced "Secreted to blood" 26543333 820000 "HPA043883: " "prognostic favourable (4.16e-5)" "unprognostic (2.57e-2)" "unprognostic (3.52e-1)" 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 100.7 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.0 3.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.3 0.5 2.5 1.2 0.1 0.8 0.3 1.0 1.2 1.5 2.5 0.6 2.2 2.3 0.5 0.2 0.0 0.0 0.9 1.4 2.4 1.9 1.0 1.5 0.2 0.7 0.2 0.9 3.2 2.4 3.3 4.1 1.0 3.0 0.5 0.8 0.7 1.1 1.1 1.1 0.9 2.0 2.0 1.5 1.2 1.3 1.7 1.9 1.6 1.4 0.7 1.6 2.7 1.0 1.9 0.0 0.6 0.1 0.3 1.6 2.5 0.9 1.5 1.3 0.4 3.6 1.7 1.0 1.1 2.8 2.4 2.4 1.2 0.4 0.7 0.8 0.5 1.3 0.8 0.8 0.2 1.0 0.7 0.5 2.5 0.1 0.6 0.5 0.7 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 LEF1 "TCF10, TCF1ALPHA, TCF7L3" ENSG00000138795 "Lymphoid enhancer binding factor 1" Q9UJU2 4 108047545-108168956 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 231.5" "Group enriched" "Detected in some" 5 "MOLT-4: 103.2;REH: 79.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 42.2" "Lineage enriched" "Detected in many" 5 "T-cells: 42.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002087, CAB019405" Enhanced Approved Nucleoplasm Nucleoplasm "CAB019405: AB_823558, HPA002087: AB_1079245" "unprognostic (1.03e-3)" "unprognostic (7.36e-3)" "unprognostic (2.97e-2)" "prognostic favourable (1.37e-5)" "unprognostic (9.08e-2)" "unprognostic (5.24e-2)" "unprognostic (3.81e-2)" "unprognostic (1.10e-2)" "unprognostic (1.77e-1)" "unprognostic (5.21e-2)" "unprognostic (9.99e-2)" "unprognostic (1.37e-1)" "prognostic unfavourable (2.47e-6)" "unprognostic (1.12e-1)" "unprognostic (5.22e-2)" "unprognostic (7.88e-2)" "unprognostic (8.91e-2)" 0.9 13.5 3.5 9.3 5.4 7.6 2.0 1.6 3.4 3.6 1.0 2.9 0.8 0.4 6.0 3.5 3.4 5.0 2.8 0.5 4.7 5.2 2.7 0.3 2.4 25.3 4.9 1.9 1.8 0.8 0.0 1.1 7.8 3.1 2.8 1.0 1.6 3.1 0.7 0.5 2.4 3.9 2.9 4.4 7.0 0.9 8.2 2.3 231.5 2.7 1.3 20.6 4.8 3.2 0.3 0.1 0.5 0.0 8.9 42.2 9.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.8 4.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 3.2 1.2 0.0 0.0 0.0 4.0 0.6 0.0 0.1 0.0 0.1 0.0 2.3 0.0 0.5 0.1 103.2 0.0 0.3 0.2 79.7 1.5 0.0 0.4 0.2 0.5 0.9 0.0 0.0 15.2 0.4 0.0 0.0 2.2 1.8 0.0 2.6 6.7 2.8 18.3 1.3 0.0 8.8 0.0 0.0 0.0 2.6 0.0 0.5 0.1 19.7 8.8 0.0 0.3 42.2 29.2 0.5 8.9 0.0 0.1 25.7 9.5 3.5 5.4 1.6 3.4 4.7 5.2 4.9 1.9 3.1 2.3 LELP1 ENSG00000203784 "Late cornified envelope like proline rich 1" Q5T871 1 153203443-153205120 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 65 "testis: 147.4" "Cell line enhanced" "Detected in single" "BEWO: 1.6" "Cancer enriched" "Detected in single" 10 "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA070231 Enhanced "HPA070231: " "unprognostic (1.77e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 147.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 LGALS13 "PLAC8, PP13" ENSG00000105198 "Galectin 13" Q9UHV8 19 39602501-39607476 "Predicted intracellular proteins" Apoptosis Hemagglutinin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "placenta: 58.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Group enriched" "Detected in some" 7 "cerebellum: 1.5;hypothalamus: 1.2;midbrain: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 58.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.5 0.2 0.0 1.2 2.0 0.0 0.2 0.0 LGALS14 "CLC2, PPL13" ENSG00000006659 "Galectin 14" Q8TCE9 19 39704306-39709444 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "placenta: 110.8" "Group enriched" "Detected in some" 5 "EFO-21: 5.3;U-266/70: 12.6" "Cancer enriched" "Detected in single" 16 "liver cancer: 5.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" HPA065180 Supported Nucleoplasm Nucleoplasm "HPA065180: " "unprognostic (1.95e-1)" 0.0 0.2 0.1 0.1 0.1 0.2 1.1 0.1 0.3 1.5 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.2 0.0 0.2 110.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.6 0.2 0.0 0.3 0.3 0.1 1.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.6 0.0 0.0 3.2 0.6 0.3 0.0 0.4 0.7 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.2 0.5 0.0 5.3 0.1 0.8 0.1 0.0 0.2 1.9 0.2 0.1 1.0 0.4 0.0 0.2 1.2 0.0 0.3 0.3 0.4 0.0 0.1 1.3 0.0 0.5 0.2 0.3 0.2 0.4 0.0 0.0 0.1 0.0 0.2 0.4 0.3 0.1 0.4 0.2 0.1 0.2 0.0 0.5 0.7 1.0 0.3 12.6 0.7 0.1 0.4 0.3 0.3 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.1 3.2 0.2 0.6 0.0 0.0 0.3 0.0 0.6 0.1 0.1 0.1 0.3 0.1 0.3 0.4 0.0 0.0 0.0 LGALS16 ENSG00000249861 "Galectin 16" A8MUM7 19 39655894-39660647 "Predicted intracellular proteins" Apoptosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "placenta: 14.2" "Cell line enriched" "Detected in single" 95 "BEWO: 9.5" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Region enhanced" "Detected in some" "cerebellum: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 2.6 0.5 0.1 1.3 1.2 0.0 0.0 0.0 LGALS7B GAL7 ENSG00000178934 "Galectin 7B" P47929 19 38789211-38791749 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skin 1: 260.5" "Cell line enriched" "Detected in single" 18 "HaCaT: 9.5" "Group enriched" "Detected in many" 7 "cervical cancer: 142.7;head and neck cancer: 185.0;melanoma: 42.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.3" "Low lineage specificity" "Detected in single" "HPA001549, CAB025100" Supported "Intracellular and membrane" 3700000 "CAB025100: , HPA001549: AB_1078938" "unprognostic (4.20e-2)" "unprognostic (2.15e-1)" "unprognostic (4.10e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (1.81e-1)" "unprognostic (3.54e-2)" "unprognostic (2.78e-2)" "unprognostic (1.01e-1)" "unprognostic (5.92e-2)" "unprognostic (3.66e-3)" "unprognostic (6.17e-2)" "unprognostic (2.93e-2)" "unprognostic (1.60e-1)" "unprognostic (1.21e-1)" "unprognostic (3.20e-2)" "unprognostic (1.29e-3)" 0.3 0.1 0.3 0.3 0.3 0.2 10.3 0.3 0.3 20.7 0.3 0.3 0.3 0.1 1.6 0.6 61.8 0.2 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.1 0.3 6.7 0.3 11.6 260.5 0.3 0.3 0.3 0.5 0.1 0.3 0.3 0.8 0.3 21.4 2.1 0.3 33.4 0.1 0.7 0.0 0.2 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.7 0.1 0.0 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 LGI1 "EPITEMPIN, EPT, ETL1, IB1099" ENSG00000108231 "Leucine rich glioma inactivated 1" O95970 10 93757809-93806272 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 45.1" "Group enriched" "Detected in some" 5 "AF22: 13.2;NTERA-2: 8.9" "Group enriched" "Detected in some" 7 "glioma: 1.8;testis cancer: 0.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" "unprognostic (1.26e-1)" "unprognostic (4.68e-2)" "unprognostic (2.45e-2)" "unprognostic (1.01e-1)" "unprognostic (8.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "unprognostic (1.24e-3)" "unprognostic (1.85e-1)" "unprognostic (4.07e-3)" "unprognostic (8.71e-2)" "unprognostic (2.21e-1)" "unprognostic (5.93e-2)" "unprognostic (4.65e-1)" 1.4 4.5 15.3 1.4 30.6 1.1 1.5 18.1 45.1 1.4 4.4 7.3 0.0 1.3 1.3 1.2 7.2 1.2 2.6 1.5 16.3 10.1 1.2 5.4 1.2 1.2 9.6 17.3 1.3 1.5 1.1 6.5 1.1 35.6 2.2 5.2 10.9 1.1 1.9 9.2 1.2 2.3 2.1 7.3 1.1 2.4 1.5 10.4 0.0 1.2 0.0 1.3 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 30.6 18.1 20.7 16.3 10.1 9.6 17.3 35.6 10.4 LGI2 "FLJ10675, KIAA1916" ENSG00000153012 "Leucine rich repeat LGI family member 2" Q8N0V4 4 24998847-25030879 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "parathyroid gland: 113.9" "Cell line enhanced" "Detected in some" "AF22: 22.2;HAP1: 4.0;RPMI-8226: 10.2;SCLC-21H: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.3" "Lineage enriched" "Detected in single" 10 "monocytes: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017140 Approved Approved Centrosome "Secreted to blood" Centrosome "HPA017140: AB_1852833" "unprognostic (1.62e-1)" "unprognostic (1.40e-1)" "unprognostic (4.31e-2)" "unprognostic (1.20e-5)" "unprognostic (3.99e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-2)" "unprognostic (8.54e-2)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (3.47e-2)" "unprognostic (1.62e-1)" "unprognostic (9.38e-5)" "unprognostic (5.78e-2)" "unprognostic (1.61e-1)" "unprognostic (2.06e-4)" "unprognostic (5.03e-3)" 2.5 1.6 2.8 6.7 3.3 0.8 2.3 7.9 7.8 3.7 4.0 0.0 1.0 1.1 8.9 4.9 4.1 11.4 4.2 3.7 2.4 3.9 3.0 0.9 1.4 2.0 7.2 0.4 9.1 2.6 113.9 0.5 2.6 18.7 1.0 1.6 6.0 0.9 1.4 0.9 0.9 2.6 7.1 2.9 1.2 2.4 2.0 0.9 0.6 1.8 0.6 4.6 1.8 1.1 0.0 0.1 0.0 1.3 0.0 0.0 0.2 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.6 0.0 0.0 4.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.6 0.7 0.0 0.9 10.2 0.4 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.6 0.0 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 3.3 7.9 7.8 2.4 3.9 7.2 0.4 18.7 0.9 LHB "CGB4, hLHB, LSH-B" ENSG00000104826 "Luteinizing hormone beta polypeptide" P01229 19 49015980-49017081 "Cancer-related genes, Disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "pituitary gland: 301.4" "Cell line enhanced" "Detected in many" "A549: 6.5;U-266/84: 7.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.8;T-reg: 1.3" "Lineage enriched" "Detected in single" 12 "T-cells: 1.8" "CAB022241, CAB022707, HPA038925" Enhanced Approved Cytosol "Secreted to blood" Cytosol "CAB022241: , CAB022707: , HPA038925: " "unprognostic (8.12e-2)" "unprognostic (3.59e-1)" "unprognostic (2.34e-3)" "unprognostic (1.41e-2)" "unprognostic (8.89e-2)" "unprognostic (6.25e-2)" "unprognostic (3.90e-3)" "unprognostic (5.69e-2)" "unprognostic (7.04e-2)" "unprognostic (6.06e-2)" "prognostic unfavourable (6.78e-4)" "unprognostic (2.47e-2)" "unprognostic (1.68e-3)" "unprognostic (1.38e-1)" "unprognostic (4.46e-1)" "unprognostic (9.52e-2)" "unprognostic (4.86e-2)" 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.4 0.1 23.1 0.0 301.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.5 0.1 0.1 0.1 0.5 1.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 1.8 0.1 1.3 6.5 0.2 1.3 0.0 0.0 1.8 0.5 0.0 1.0 0.5 5.3 1.9 1.7 0.1 0.0 0.5 0.0 0.4 0.0 1.7 5.1 0.3 1.7 2.5 0.3 0.4 1.7 0.0 0.0 0.3 0.0 0.3 4.7 2.8 0.3 0.3 0.1 0.6 0.7 0.5 2.8 1.1 1.3 0.0 1.3 3.0 1.2 1.9 0.4 2.2 2.0 0.0 0.0 2.6 2.7 0.3 3.3 2.4 7.0 1.8 1.3 3.0 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 LHFPL3 LHFPL4 ENSG00000187416 "LHFPL tetraspan subfamily member 3" Q86UP9 7 104328656-104907232 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "brain: 36.5" "Cell line enhanced" "Detected in some" "K-562: 2.2;SCLC-21H: 4.0;SH-SY5Y: 5.3;SK-BR-3: 4.5;SK-MEL-30: 2.3" "Cancer enriched" "Detected in some" 12 "glioma: 27.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069691 Approved Vesicles Vesicles "HPA069691: " "unprognostic (1.20e-2)" "unprognostic (6.91e-2)" "unprognostic (4.59e-3)" "unprognostic (5.03e-2)" "unprognostic (2.27e-2)" "unprognostic (2.22e-1)" "unprognostic (1.07e-1)" "unprognostic (6.96e-2)" "unprognostic (5.81e-2)" "unprognostic (5.99e-3)" "unprognostic (8.50e-3)" "unprognostic (3.07e-1)" "unprognostic (1.33e-1)" 0.5 0.6 6.4 0.6 7.7 0.5 0.5 2.3 36.5 4.3 0.8 6.1 0.0 2.0 0.7 0.5 0.5 0.9 0.5 0.5 4.9 5.6 1.4 0.5 2.2 0.5 4.8 4.2 0.7 1.5 0.5 0.1 0.5 5.6 0.7 0.6 3.8 0.5 0.5 0.5 0.7 1.4 0.5 6.0 0.9 0.8 0.7 6.7 0.0 0.5 0.0 0.6 0.5 0.2 0.5 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 4.0 5.3 0.0 4.5 2.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 7.7 2.3 7.1 4.9 5.6 4.8 4.2 5.6 6.7 LHX3 ENSG00000107187 "LIM homeobox 3" Q9UBR4 9 136196250-136205128 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "pituitary gland: 33.4" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.6;U-266/70: 5.1;U-698: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (4.17e-2)" "unprognostic (4.72e-1)" "unprognostic (1.33e-1)" "unprognostic (2.57e-1)" "unprognostic (3.31e-2)" "unprognostic (6.18e-2)" 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 5.1 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 LHX4 Gsh4 ENSG00000121454 "LIM homeobox 4" Q969G2 1 180230286-180278982 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 21.0" "Cell line enhanced" "Detected in many" "BEWO: 14.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055705 Approved "Nuclear speckles" "Nuclear speckles" "HPA055705: " "unprognostic (2.83e-2)" "unprognostic (3.23e-2)" "unprognostic (1.94e-1)" "unprognostic (2.86e-2)" "unprognostic (9.38e-2)" "unprognostic (5.76e-5)" "unprognostic (9.39e-4)" "unprognostic (1.47e-1)" "unprognostic (2.39e-3)" "unprognostic (2.95e-1)" "unprognostic (3.77e-3)" "unprognostic (2.72e-3)" "unprognostic (4.07e-8)" "unprognostic (3.63e-1)" "unprognostic (1.43e-1)" "unprognostic (6.44e-3)" "unprognostic (7.83e-3)" 0.8 1.4 0.8 2.3 0.8 1.5 0.9 4.3 1.4 0.9 1.2 0.8 0.8 2.5 1.3 0.8 1.2 1.3 1.2 0.8 0.8 0.4 4.6 0.8 1.0 2.2 0.8 0.8 2.2 2.5 0.0 2.4 2.8 2.1 1.2 1.1 21.0 1.4 0.8 1.3 3.4 2.4 0.8 1.4 2.2 1.4 3.6 0.8 0.8 1.9 0.8 0.8 1.3 1.5 0.6 0.1 0.6 0.7 0.2 0.7 0.0 1.4 6.0 1.5 3.2 0.0 0.0 14.3 1.6 0.4 0.4 0.1 1.1 2.6 1.5 0.4 0.0 2.5 2.8 0.0 0.7 0.8 2.3 1.0 5.7 0.6 0.0 1.6 1.8 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.0 3.0 0.9 3.0 1.3 0.3 1.0 3.8 0.6 0.0 1.2 1.5 1.3 1.7 1.3 0.5 3.4 0.3 1.9 1.4 2.6 1.5 1.0 1.1 0.4 1.3 0.5 1.2 1.5 0.0 0.7 0.0 0.6 0.2 0.4 0.6 0.3 0.4 0.0 0.5 0.6 0.3 0.6 0.2 0.5 0.1 0.7 0.0 0.8 0.8 4.3 0.8 0.8 0.4 0.8 0.8 2.1 0.8 LIM2 "MP17, MP19" ENSG00000105370 "Lens intrinsic membrane protein 2" P55344 19 51379909-51387960 "Disease related genes, Predicted membrane proteins" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "blood: 12.9" "Cell line enhanced" "Detected in some" "HEK 293: 1.2;Hep G2: 1.0" "Cancer enriched" "Detected in single" 40 "testis cancer: 18.3" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "gdT-cell: 12.9" "Lineage enriched" "Detected in many" 8 "T-cells: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.25e-2)" "unprognostic (1.09e-3)" "unprognostic (1.21e-1)" 0.1 0.1 0.1 0.1 0.1 2.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.3 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.2 1.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.4 0.0 1.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 1.5 12.9 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.2 1.6 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 1.5 0.0 0.0 0.0 1.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 LIN28A "CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1" ENSG00000131914 "Lin-28 homolog A" Q9H9Z2 1 26410778-26429722 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 9.8" "Cell line enriched" "Detected in some" 10 "NTERA-2: 137.5" "Cancer enriched" "Detected in single" 261 "testis cancer: 101.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "CAB020785, HPA063074, HPA068814" Enhanced Supported "Nucleoli,Cytosol,Rods & Rings" Cytosol "Nucleoli, Rods & Rings" "CAB020785: , HPA063074: , HPA068814: " "unprognostic (9.64e-3)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.85e-1)" "unprognostic (2.21e-1)" "unprognostic (2.49e-2)" "unprognostic (1.83e-1)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.5 0.5 0.1 0.1 0.1 0.2 0.3 9.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.3 0.6 2.3 0.5 1.0 0.8 0.1 0.0 0.0 13.5 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.5 0.7 0.7 0.3 0.4 1.0 0.5 0.6 0.2 1.3 0.8 0.7 2.2 1.0 0.3 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 LIN28B "CSDD2, FLJ16517" ENSG00000187772 "Lin-28 homolog B" Q6ZN17 6 104936616-105083332 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "placenta: 51.9" "Cell line enhanced" "Detected in some" "AF22: 13.9;BEWO: 71.7;K-562: 23.2;NTERA-2: 12.6" "Cancer enriched" "Detected in single" 25 "testis cancer: 12.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA036630, HPA061745" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA036630: AB_10669911, HPA061745: AB_2684601" "unprognostic (2.00e-4)" "unprognostic (6.75e-2)" "unprognostic (2.02e-1)" "unprognostic (2.57e-2)" "unprognostic (1.59e-2)" "unprognostic (4.10e-2)" 0.1 0.1 1.2 0.0 0.8 0.3 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.0 0.1 0.1 0.1 0.5 0.8 0.0 0.0 0.0 1.0 51.9 1.2 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 5.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.7 2.1 0.4 0.2 0.5 0.3 0.0 0.9 13.9 2.8 0.0 0.0 71.7 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 6.7 9.9 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 0.3 0.0 0.0 1.4 1.6 12.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 1.1 0.0 2.9 0.3 0.0 1.5 0.0 0.0 4.2 5.9 0.0 0.0 0.0 0.0 1.6 0.4 0.2 0.5 0.4 0.3 0.5 0.3 0.1 0.2 0.7 0.1 0.2 2.1 0.2 0.4 0.7 0.2 0.3 1.2 0.8 0.1 1.3 0.9 1.3 0.5 0.8 1.2 0.4 LINC00483 "C17orf73, FLJ20694" ENSG00000167117 "Long intergenic non-protein coding RNA 483" 17 50761029-50767557 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "intestine: 73.0" "Group enriched" "Detected in some" 5 "CACO-2: 12.6;HDLM-2: 9.4" "Group enriched" "Detected in some" 12 "colorectal cancer: 3.3;pancreatic cancer: 0.8;stomach cancer: 2.0" "Cell type enhanced" "Detected in some" "neutrophil: 6.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.5" "Region enhanced" "Detected in single" "basal ganglia: 0.4" "Low region specificity" "Detected in all" "unprognostic (2.98e-1)" "unprognostic (1.96e-2)" "unprognostic (2.02e-3)" "unprognostic (2.76e-1)" "unprognostic (4.52e-1)" "unprognostic (1.95e-1)" "unprognostic (2.09e-2)" "unprognostic (8.37e-2)" "unprognostic (1.57e-2)" "unprognostic (6.81e-2)" "unprognostic (1.67e-1)" "unprognostic (1.05e-3)" 0.1 0.0 0.1 4.6 0.1 0.7 0.1 0.1 0.1 0.1 28.3 0.1 0.1 27.1 0.1 0.1 0.1 0.0 2.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 9.7 0.1 0.1 0.1 0.1 0.2 73.0 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.8 6.5 1.5 0.9 0.9 0.4 0.6 1.0 0.6 1.4 0.0 0.6 1.2 0.5 0.0 0.0 0.0 12.6 0.8 0.3 0.3 0.3 0.8 0.0 0.2 0.1 9.4 0.8 0.7 2.1 1.6 0.0 0.7 1.9 0.6 0.1 0.2 0.0 0.0 0.2 0.9 0.0 0.5 0.4 1.3 0.2 0.5 0.9 0.6 0.5 0.1 2.1 0.4 1.0 0.5 1.0 0.1 1.2 0.0 1.0 1.2 0.7 0.8 0.4 0.5 0.4 1.0 0.4 0.4 0.5 4.6 1.5 0.8 0.7 0.8 0.4 0.7 0.7 0.7 0.2 1.1 0.9 0.6 6.5 0.9 0.8 0.8 0.5 0.4 LINC00672 ENSG00000263874 "Long intergenic non-protein coding RNA 672" 17 38925168-38929384 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 16.8" "Cell line enhanced" "Detected in many" "NTERA-2: 11.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "unprognostic (3.28e-1)" "unprognostic (9.28e-2)" "unprognostic (6.62e-2)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (2.06e-1)" "unprognostic (4.15e-2)" "unprognostic (8.81e-2)" "unprognostic (7.08e-2)" "unprognostic (2.02e-2)" "unprognostic (4.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.68e-6)" "unprognostic (7.29e-2)" "unprognostic (6.58e-2)" "unprognostic (3.44e-2)" "unprognostic (2.59e-4)" 0.7 2.5 4.6 1.0 9.6 3.5 0.9 5.1 16.8 0.4 1.1 4.0 0.0 1.0 2.5 3.1 0.7 1.5 1.8 1.1 5.0 0.3 0.2 1.4 1.4 2.8 7.5 2.7 0.3 0.4 0.4 1.0 7.1 1.5 1.7 2.1 0.6 3.1 0.6 2.3 1.8 2.3 3.5 1.9 1.6 0.3 3.7 0.0 0.2 0.0 0.9 0.8 0.0 1.3 1.0 4.0 1.2 1.4 2.8 0.5 0.7 1.0 2.1 1.4 1.2 1.5 0.3 0.9 0.7 0.2 0.6 0.4 3.8 0.7 0.7 1.3 2.0 0.0 0.5 0.7 0.4 0.6 1.1 1.1 0.1 0.7 1.4 2.6 1.5 0.8 0.7 0.3 0.3 0.2 0.8 0.5 0.7 0.7 1.5 11.5 0.0 3.2 0.2 1.0 1.2 0.9 0.2 4.4 1.2 1.2 0.7 1.4 1.3 2.2 0.6 0.9 0.8 0.4 1.1 1.6 0.8 1.1 1.5 0.4 1.6 1.2 1.9 1.1 0.5 0.5 0.7 0.8 0.8 0.5 1.3 0.9 2.8 4.0 1.4 0.7 1.0 0.7 0.5 LINC02203 ENSG00000280709 "Long intergenic non-protein coding RNA 2203" 15 21552795-21653276 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 11.7" "Cell line enriched" "Detected in single" 21 "U-2 OS: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Approved Centrosome Centrosome "HPA057442: " 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 LINGO1 "FLJ14594, LERN1, LRRN6A" ENSG00000169783 "Leucine rich repeat and Ig domain containing 1" Q96FE5 15 77613027-77820900 "Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 67.2" "Cell line enhanced" "Detected in some" "AF22: 13.2;AN3-CA: 11.0;HAP1: 16.6;HEK 293: 11.7;MCF7: 7.1;NTERA-2: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074653 Enhanced Approved "Plasma membrane" 8400 "Plasma membrane" "HPA074653: " "unprognostic (1.06e-1)" "unprognostic (7.07e-2)" "unprognostic (2.16e-2)" "unprognostic (1.48e-2)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.84e-2)" "unprognostic (3.77e-2)" "unprognostic (3.40e-1)" "unprognostic (1.10e-1)" "unprognostic (7.36e-2)" "unprognostic (2.74e-2)" "prognostic unfavourable (3.23e-7)" "unprognostic (2.07e-1)" "unprognostic (7.06e-2)" "unprognostic (2.85e-1)" "unprognostic (2.59e-2)" 3.0 1.6 27.4 1.7 21.8 0.8 1.3 9.1 67.2 3.8 2.0 5.9 0.0 2.0 3.3 2.7 1.4 3.1 2.5 9.7 29.8 12.2 2.2 1.1 1.1 1.3 10.3 21.8 1.7 2.7 1.1 0.5 6.1 6.8 1.7 1.5 1.8 3.4 2.5 1.0 3.0 1.5 4.5 6.8 3.3 2.0 3.7 3.9 0.0 1.7 0.0 1.1 3.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 13.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 16.6 0.0 0.0 0.0 11.7 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.7 0.1 0.0 7.1 0.0 0.0 31.3 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.7 0.0 1.3 2.8 0.2 0.2 1.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 21.8 9.1 47.5 29.8 12.2 10.3 21.8 6.8 3.9 LIPC "HL, HTGL" ENSG00000166035 "Lipase C, hepatic type" P11150 15 58410569-58569843 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 91.7" "Cell line enhanced" "Detected in some" "CACO-2: 6.8;EFO-21: 5.2;Hep G2: 19.5;HMC-1: 5.7;MOLT-4: 4.4;U-2197: 15.4" "Group enriched" "Detected in some" 14 "liver cancer: 20.4;renal cancer: 10.4" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 8 "granulocytes: 3.7;NK-cells: 3.0;T-cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" 3200000 "unprognostic (1.76e-2)" "unprognostic (9.15e-3)" "unprognostic (7.89e-2)" "unprognostic (7.15e-4)" "unprognostic (1.40e-1)" "unprognostic (1.33e-2)" "unprognostic (9.93e-3)" "unprognostic (6.25e-2)" "unprognostic (3.79e-2)" "unprognostic (1.10e-2)" "unprognostic (3.06e-1)" "unprognostic (2.31e-1)" "unprognostic (2.82e-2)" "unprognostic (1.41e-1)" "unprognostic (2.87e-2)" "unprognostic (1.80e-2)" "unprognostic (2.27e-2)" 0.2 0.1 0.4 1.1 0.7 0.0 0.7 0.1 0.4 0.3 0.2 0.6 0.0 0.7 0.1 0.4 0.2 0.4 0.3 0.3 0.4 0.2 3.0 91.7 0.3 0.2 1.2 0.2 0.3 1.0 0.0 1.0 0.1 1.5 0.3 0.3 0.5 0.1 1.5 0.1 0.3 0.3 0.1 1.2 0.4 0.2 0.1 0.5 2.7 0.5 0.0 0.1 1.1 0.2 0.1 0.2 3.7 0.4 3.0 4.5 2.5 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.7 0.0 0.0 6.8 0.0 0.0 5.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 2.4 0.0 19.5 0.4 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 4.4 0.6 0.0 0.0 0.9 0.3 0.0 2.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 15.4 0.0 0.0 0.0 0.1 0.1 0.4 0.0 3.7 0.3 0.0 3.0 0.2 4.5 0.0 0.8 2.2 0.2 0.1 1.0 3.2 0.4 3.0 0.4 0.1 2.1 2.5 0.4 0.7 0.1 0.4 0.4 0.2 1.2 0.2 1.5 0.5 LIPF "HGL, HLAL" ENSG00000182333 "Lipase F, gastric type" P07098 10 88664441-88678814 "Enzymes, FDA approved drug targets, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "stomach 1: 762.9" "Cell line enhanced" "Detected in some" "HMC-1: 6.2;MOLT-4: 4.9;NTERA-2: 5.2;REH: 3.0;THP-1: 9.8;U-2 OS: 3.5;U-266/70: 4.8" "Cancer enriched" "Detected in some" 75 "stomach cancer: 278.5" "Region enhanced" "Detected in single" "cerebral cortex: 1.9" "Cell type enriched" "Detected in single" 16 "eosinophil: 1.5" "Lineage enriched" "Detected in single" 16 "granulocytes: 1.5" "Region enriched" "Detected in single" 51 "olfactory region: 9.9" HPA045930 Enhanced "Secreted to digestive system" "HPA045930: AB_10959518" "unprognostic (1.53e-1)" "unprognostic (1.83e-1)" 0.1 0.0 0.1 0.1 0.5 0.0 0.1 0.1 1.9 0.1 0.2 28.2 0.1 8.2 0.1 0.1 31.6 0.1 0.6 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 9.9 0.1 0.1 0.0 0.1 0.1 0.1 0.1 762.9 0.1 0.1 0.2 0.1 1.1 0.1 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 5.2 0.0 3.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 3.5 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 1.9 0.1 0.0 0.1 0.1 0.1 0.1 LIPI "CT17, LPDL, mPA-PLA1beta, PLA1C, PRED5" ENSG00000188992 "Lipase I" Q6XZB0 21 14108813-14210891 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "epididymis: 113.2" "Cell line enhanced" "Detected in some" "NB-4: 3.1;REH: 2.0;SH-SY5Y: 1.9" "Cancer enriched" "Detected in single" 6 "thyroid cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in male reproductive system" "unprognostic (2.60e-2)" "unprognostic (3.49e-1)" "unprognostic (1.12e-3)" "unprognostic (1.14e-1)" "unprognostic (1.08e-2)" "unprognostic (1.19e-1)" "unprognostic (2.05e-2)" "unprognostic (1.68e-1)" "unprognostic (4.53e-2)" "unprognostic (2.90e-1)" "unprognostic (3.64e-13)" "unprognostic (2.82e-1)" "unprognostic (4.14e-2)" "unprognostic (2.90e-1)" "unprognostic (7.87e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 1.0 0.0 0.6 0.0 1.2 113.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 1.4 0.0 0.0 4.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.9 0.0 0.0 1.5 0.9 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.4 0.8 0.2 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 3.1 1.5 0.4 2.0 0.5 1.0 0.0 0.0 0.3 1.9 0.7 0.1 0.1 0.1 0.1 0.0 0.5 0.3 0.8 0.2 0.3 0.0 0.3 0.3 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LIPJ "bA425M17.2, LIPL1" ENSG00000204022 "Lipase family member J" Q5W064 10 88586753-88606976 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 11.5" "Cell line enhanced" "Detected in some" "Karpas-707: 2.6;NB-4: 1.0;SK-MEL-30: 2.3;U-2197: 1.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" HPA048594 Uncertain "HPA048594: " "unprognostic (4.79e-3)" "unprognostic (6.77e-2)" "unprognostic (4.80e-2)" "unprognostic (2.36e-1)" "unprognostic (2.70e-2)" "unprognostic (9.33e-2)" "unprognostic (2.90e-3)" "unprognostic (7.50e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (4.73e-2)" "unprognostic (1.73e-2)" "unprognostic (6.21e-4)" "unprognostic (9.87e-2)" "unprognostic (9.57e-2)" "unprognostic (1.85e-1)" "unprognostic (1.88e-1)" 0.2 0.0 0.3 0.0 0.3 0.0 0.2 1.0 0.3 0.1 0.0 0.4 0.2 1.6 0.0 1.1 0.1 0.1 0.4 0.5 0.2 0.7 0.0 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.3 0.2 0.6 0.0 0.4 0.1 0.1 0.3 0.1 0.1 0.3 11.5 0.9 0.4 0.5 0.1 0.7 0.0 1.0 0.1 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.3 0.0 0.8 0.0 0.1 0.7 1.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 LIPK "bA186O14.2, LIPL2" ENSG00000204021 "Lipase family member K" Q5VXJ0 10 88724544-88752786 "Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "skin 1: 27.1" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 7.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" "unprognostic (7.65e-2)" "unprognostic (8.64e-2)" "unprognostic (3.57e-2)" "unprognostic (3.19e-7)" "unprognostic (1.25e-1)" "unprognostic (1.60e-2)" "unprognostic (2.13e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LIPM "bA304I5.1, LIPL3" ENSG00000173239 "Lipase family member M" Q5VYY2 10 88802730-88820546 "Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "skin 1: 30.1" "Cell line enhanced" "Detected in some" "A-431: 2.2;CAPAN-2: 7.2;HaCaT: 2.0;HL-60: 4.0;NB-4: 3.4;RT4: 3.0;T-47d: 3.5;U-937: 3.3" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.0" "Lineage enhanced" "Detected in single" "monocytes: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" "unprognostic (7.72e-2)" "unprognostic (8.49e-4)" "unprognostic (1.42e-2)" "unprognostic (2.23e-4)" "unprognostic (6.70e-3)" "unprognostic (3.01e-3)" "unprognostic (5.75e-2)" "unprognostic (6.63e-2)" "unprognostic (5.61e-2)" "unprognostic (1.45e-2)" "prognostic unfavourable (6.47e-4)" "unprognostic (1.59e-2)" "unprognostic (5.93e-2)" "unprognostic (7.05e-3)" "unprognostic (4.17e-2)" "unprognostic (9.02e-2)" "unprognostic (9.70e-6)" 0.0 0.0 0.0 0.8 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.1 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.2 1.0 0.0 0.1 0.1 2.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.3 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.7 0.0 3.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.8 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 LIX1 "C5orf11, Lft" ENSG00000145721 "Limb and CNS expressed 1" Q8N485 5 97091867-97142872 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 35.9" "Cell line enriched" "Detected in some" 12 "RPTEC TERT1: 26.8" "Cancer enhanced" "Detected in many" "glioma: 13.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "naive B-cell: 5.9" "Lineage enriched" "Detected in single" 9 "B-cells: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058426 Uncertain Approved "Vesicles,Cytokinetic bridge,Cytosol" Cytosol "Vesicles, Cytokinetic bridge" "HPA058426: " "unprognostic (3.18e-1)" "unprognostic (4.53e-2)" "unprognostic (9.46e-2)" "prognostic unfavourable (2.48e-4)" "unprognostic (8.96e-2)" "unprognostic (6.60e-2)" "unprognostic (1.34e-1)" "unprognostic (4.70e-1)" "unprognostic (7.63e-2)" "unprognostic (1.58e-2)" "unprognostic (3.52e-1)" "unprognostic (2.01e-1)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (1.26e-1)" "unprognostic (9.61e-2)" 1.0 1.2 14.9 1.3 16.9 1.4 1.1 6.1 35.9 1.0 1.3 19.2 1.0 1.2 1.2 1.2 1.0 1.2 1.1 1.1 24.6 10.7 4.9 1.0 1.1 1.6 11.7 13.2 1.0 1.0 1.0 1.2 1.4 12.4 3.0 1.4 3.3 1.1 8.3 1.1 1.1 1.2 1.2 10.1 1.2 1.2 1.1 13.0 0.0 6.5 0.0 1.0 1.0 0.2 5.9 0.1 0.6 0.1 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.2 1.2 0.1 0.0 0.0 5.9 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 14.9 16.9 6.1 11.9 24.6 10.7 11.7 13.2 12.4 13.0 LLCFC1 "C7orf34, CTM-1" ENSG00000165131 "LLLL and CFNLAS motif containing 1" Q96L11 7 142939343-142940868 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 21 "testis: 31.9" "Group enriched" "Detected in some" 5 "K-562: 3.1;RT4: 3.3;SiHa: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enhanced" "Detected in single" "granulocytes: 1.3" "Intracellular and membrane" "unprognostic (5.05e-2)" "unprognostic (9.94e-2)" "unprognostic (5.49e-3)" "unprognostic (2.76e-2)" "unprognostic (1.13e-1)" "unprognostic (1.14e-1)" "unprognostic (3.29e-1)" "unprognostic (2.23e-2)" "unprognostic (1.85e-3)" "unprognostic (3.54e-1)" "unprognostic (2.02e-1)" 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.5 0.0 31.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.2 0.0 0.0 0.0 3.3 0.0 0.1 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 LLGL1 "DLG4, HUGL, HUGL-1, Lgl1, LLGL, Mgl1" ENSG00000131899 "LLGL1, scribble cell polarity complex component" Q15334 17 18225587-18244875 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 53.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022924, HPA023569" Enhanced "HPA022924: AB_1852926, HPA023569: AB_1852928" "unprognostic (1.15e-1)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" "unprognostic (1.88e-2)" "unprognostic (2.94e-1)" "unprognostic (1.90e-2)" "prognostic unfavourable (2.72e-4)" "unprognostic (7.71e-2)" "unprognostic (3.06e-1)" "unprognostic (7.18e-2)" "unprognostic (3.27e-3)" "unprognostic (8.99e-3)" "unprognostic (1.40e-1)" "unprognostic (6.02e-2)" "unprognostic (2.35e-1)" "unprognostic (1.31e-2)" "unprognostic (2.40e-2)" 5.6 10.0 15.0 5.1 21.2 3.5 3.7 7.3 24.1 6.0 3.7 53.5 3.1 3.6 8.1 4.6 10.3 8.0 6.1 6.0 18.4 11.9 3.4 1.4 4.5 5.7 30.4 12.5 10.6 5.1 3.8 4.4 8.2 17.3 5.2 2.4 3.0 6.6 6.5 8.5 8.8 4.2 5.6 32.5 6.1 4.3 6.8 24.2 3.9 3.9 2.9 4.5 6.9 4.8 0.6 0.2 1.0 0.5 1.2 1.6 0.2 11.4 7.5 18.9 18.3 7.3 6.7 7.8 5.1 8.2 10.1 9.1 16.8 2.2 6.9 8.9 4.4 10.6 5.6 6.7 3.0 11.5 15.0 3.2 5.5 5.9 3.5 1.2 7.3 8.3 3.7 5.1 2.4 6.4 2.3 1.5 3.9 8.1 8.2 1.9 8.0 4.2 10.5 13.5 3.8 3.0 4.3 5.0 10.7 6.2 2.9 4.8 3.5 2.0 8.9 8.0 10.3 10.6 7.9 2.4 1.6 2.2 15.9 3.0 7.0 1.0 0.3 0.0 0.4 0.5 0.3 0.5 0.4 0.3 0.1 0.6 0.3 0.1 1.0 1.2 0.1 0.2 1.6 0.2 15.0 21.2 7.3 17.2 18.4 11.9 30.4 12.5 17.3 24.2 LMTK3 "KIAA1883, LMR3, PPP1R101, TYKLM3" ENSG00000142235 "Lemur tyrosine kinase 3" Q96Q04 19 48485271-48513189 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.1" "Cell line enhanced" "Detected in many" "HMC-1: 8.4;SK-BR-3: 10.0;U-266/70: 9.3;U-266/84: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040203, HPA077070" Enhanced Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA040203: AB_10671690, HPA077070: " "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (5.37e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-1)" "unprognostic (1.71e-2)" "unprognostic (5.67e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-1)" "unprognostic (2.51e-3)" "unprognostic (5.71e-2)" "unprognostic (1.47e-1)" "prognostic favourable (3.18e-8)" "unprognostic (1.38e-1)" "unprognostic (3.22e-2)" "unprognostic (3.24e-1)" "unprognostic (6.11e-2)" 1.3 4.4 19.8 2.3 28.6 2.0 2.0 20.0 38.1 2.0 1.5 6.0 0.2 6.2 1.4 1.5 2.3 1.6 1.9 1.7 17.2 11.1 2.5 1.3 3.2 2.2 6.5 23.8 1.3 2.1 8.5 6.1 2.1 12.5 3.5 1.2 1.6 5.2 3.1 1.2 2.4 4.0 1.2 6.6 1.8 2.9 1.5 10.3 0.0 2.3 0.0 2.2 1.6 1.2 0.0 0.0 0.0 0.2 0.0 0.4 0.1 4.5 3.0 0.3 0.0 0.0 0.0 4.4 0.0 0.2 0.0 0.1 2.2 3.6 1.6 1.2 0.0 2.1 0.3 1.6 0.0 0.0 1.2 0.2 0.3 0.7 0.0 0.0 8.4 0.2 0.9 0.0 0.0 0.1 1.4 2.8 0.0 3.0 0.6 0.8 1.1 0.9 3.8 0.0 1.3 1.1 0.7 0.7 2.8 0.1 10.0 0.0 3.8 0.2 0.1 0.0 0.8 0.1 0.0 9.3 7.5 0.4 0.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 19.8 28.6 20.0 38.1 17.2 11.1 6.5 23.8 12.5 10.3 LNPEP "CAP, IRAP, P-LAP, PLAP" ENSG00000113441 "Leucyl and cystinyl aminopeptidase" Q9UIQ6 5 96935394-97037515 "Enzymes, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 104.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043642 Approved "Intracellular and membrane" 390000 "HPA043642: AB_10964137" "unprognostic (1.52e-1)" "unprognostic (5.39e-2)" "unprognostic (7.78e-2)" "unprognostic (1.53e-2)" "unprognostic (6.38e-2)" "unprognostic (6.59e-3)" "unprognostic (6.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.11e-1)" "unprognostic (3.54e-3)" "unprognostic (6.24e-2)" "unprognostic (2.08e-1)" "unprognostic (3.28e-1)" "unprognostic (4.13e-3)" "unprognostic (1.46e-1)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" 9.8 4.7 5.6 12.0 7.3 13.2 7.7 23.3 12.9 6.3 7.6 6.9 7.8 4.2 8.2 4.4 10.2 6.6 4.3 10.1 5.2 5.6 7.6 4.3 6.9 15.9 7.7 8.8 8.2 5.9 13.8 9.7 104.4 9.1 7.9 6.8 3.9 7.8 7.7 13.2 14.0 9.0 6.6 7.5 10.0 8.5 3.3 7.7 23.6 7.2 2.9 15.8 8.9 7.7 4.1 3.5 5.0 12.8 11.2 7.9 4.3 5.3 6.2 2.8 3.0 17.1 8.2 3.3 5.5 7.3 6.5 9.9 5.2 8.7 26.5 10.4 7.4 7.1 3.6 10.4 6.8 9.4 2.0 6.6 4.5 3.6 4.4 7.6 9.2 6.3 6.5 9.4 6.9 6.8 2.8 17.6 7.4 4.8 9.0 5.3 0.6 3.3 6.6 10.6 4.0 23.2 11.1 5.5 1.4 6.7 5.9 3.3 18.1 10.1 13.5 9.5 5.3 7.5 8.3 3.8 8.8 24.2 8.4 7.3 4.3 5.0 3.3 4.4 7.9 5.5 6.8 3.1 5.9 6.1 3.5 4.1 5.9 6.4 4.1 11.2 12.8 3.3 5.1 4.3 5.6 7.3 23.3 12.9 5.2 5.6 7.7 8.8 9.1 7.7 LOR ENSG00000203782 Loricrin P23490 1 153259700-153262122 "Disease related genes, Predicted intracellular proteins" Keratinization "Ichthyosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 181.8" "Cell line enriched" "Detected in single" 88 "HDLM-2: 27.5" "Cancer enriched" "Detected in some" 11 "melanoma: 45.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA076123, HPA077266" Enhanced "HPA076123: AB_2732302, HPA077266: AB_2732338" "unprognostic (1.97e-2)" "unprognostic (1.93e-2)" "unprognostic (4.16e-2)" "prognostic favourable (8.53e-4)" "unprognostic (1.65e-1)" "unprognostic (2.69e-1)" "unprognostic (1.61e-1)" "unprognostic (3.41e-1)" "unprognostic (1.47e-1)" "unprognostic (3.03e-1)" "unprognostic (1.02e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 6.4 0.1 0.1 0.7 0.1 0.1 0.1 0.0 0.9 0.1 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.3 181.8 0.1 0.1 0.1 0.1 0.0 0.1 0.1 15.7 0.1 31.2 2.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 LPA "LP, Lp(a)" ENSG00000198670 Lipoprotein(a) P08519 6 160531483-160664259 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid transport, Transport" "Hydrolase, Protease, Serine protease" Atherosclerosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 71 "liver: 43.4" "Cell line enriched" "Detected in single" 6 "RT4: 4.6" "Cancer enriched" "Detected in single" 38 "liver cancer: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016072, HPA060604" Supported "Secreted to blood" 78800000000 2900000000 "CAB016072: AB_2135240, HPA060604: " "unprognostic (2.16e-1)" "unprognostic (5.10e-1)" "unprognostic (7.75e-3)" "unprognostic (6.70e-2)" "unprognostic (1.60e-1)" "unprognostic (4.17e-3)" "unprognostic (1.59e-1)" "unprognostic (6.38e-3)" "unprognostic (3.63e-2)" "unprognostic (3.18e-1)" "unprognostic (7.45e-3)" "unprognostic (2.56e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (3.72e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.2 0.2 43.4 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 4.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 LPO SPO ENSG00000167419 Lactoperoxidase P22079 17 58218548-58268518 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrogen peroxide" "Antimicrobial, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 262 "salivary gland: 345.7" "Cell line enriched" "Detected in some" 9 "THP-1: 14.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028688 Enhanced Supported "Secreted to digestive system" "HPA028688: AB_10601909" "unprognostic (2.74e-1)" "unprognostic (5.12e-2)" "unprognostic (4.14e-3)" "unprognostic (1.56e-3)" "unprognostic (2.41e-2)" "unprognostic (9.71e-2)" "unprognostic (2.06e-2)" "unprognostic (1.53e-1)" "unprognostic (2.40e-2)" "unprognostic (6.27e-3)" "unprognostic (6.32e-2)" "unprognostic (2.56e-1)" "unprognostic (0.00e+0)" "unprognostic (3.41e-2)" "unprognostic (3.15e-1)" "unprognostic (2.72e-2)" "unprognostic (1.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 345.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.2 0.0 0.0 1.2 0.8 1.3 0.7 0.8 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 1.0 1.5 0.0 0.9 0.7 0.4 0.6 0.3 0.5 0.9 0.7 0.6 0.2 1.2 0.6 0.9 1.3 0.8 0.3 0.8 0.4 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 LRAT LCA14 ENSG00000121207 "Lecithin retinol acyltransferase" O95237 4 154626945-154753118 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction, Vision" "Acyltransferase, Transferase" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 82.4" "Cell line enriched" "Detected in some" 8 "NTERA-2: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 4.5" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA070726 Uncertain "Endoplasmic reticulum,Golgi apparatus" "Golgi apparatus" "Endoplasmic reticulum" "HPA070726: " "unprognostic (3.64e-3)" "unprognostic (1.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (4.75e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (9.15e-2)" "unprognostic (2.48e-1)" "unprognostic (2.24e-1)" "unprognostic (2.65e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-4)" "unprognostic (4.49e-6)" "unprognostic (6.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.98e-1)" 0.9 0.8 2.2 0.8 3.2 1.8 1.4 0.7 1.1 0.9 4.2 3.0 0.8 3.7 0.5 1.2 0.5 0.9 2.3 0.6 3.1 4.2 0.6 3.3 1.0 0.5 2.9 2.4 1.0 2.9 0.3 1.0 0.3 8.9 1.6 0.4 82.4 0.5 1.6 2.3 1.4 11.1 0.3 7.0 0.7 0.9 2.9 3.1 0.0 4.9 0.2 0.6 0.5 0.7 0.9 3.7 2.0 4.5 0.6 0.3 3.9 0.6 0.5 0.4 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.1 0.8 0.6 0.1 0.1 0.2 0.5 0.3 0.3 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.3 16.1 0.0 0.1 0.0 0.1 1.9 0.5 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.4 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.2 0.5 1.0 4.5 0.4 0.3 1.6 0.3 0.5 0.3 0.3 3.7 0.9 0.3 0.3 2.0 0.6 0.5 0.5 0.2 3.9 2.2 3.2 0.7 1.1 3.1 4.2 2.9 2.4 8.9 3.1 LRCOL1 ENSG00000204583 "Leucine rich colipase like 1" A6NCL2 12 132603150-132610543 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "epididymis: 54.8" "Cell line enhanced" "Detected in some" "BEWO: 1.7;BJ hTERT+ SV40 Large T+: 1.2;RPMI-8226: 1.0" "Cancer enhanced" "Detected in some" "liver cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" "unprognostic (5.09e-3)" "unprognostic (7.83e-3)" "unprognostic (3.26e-1)" "unprognostic (6.94e-2)" "unprognostic (3.15e-2)" "unprognostic (2.38e-2)" "prognostic favourable (7.04e-4)" "unprognostic (4.54e-2)" "unprognostic (6.08e-2)" "unprognostic (5.29e-2)" "unprognostic (4.66e-3)" "unprognostic (1.52e-1)" "unprognostic (6.50e-6)" "unprognostic (1.46e-3)" "unprognostic (9.63e-2)" "unprognostic (3.31e-1)" "unprognostic (4.00e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 4.4 0.1 0.0 54.8 0.0 0.2 0.4 0.0 0.2 0.1 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.7 0.5 1.2 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 LRFN2 "FIGLER2, KIAA1246, SALM1" ENSG00000156564 "Leucine rich repeat and fibronectin type III domain containing 2" Q9ULH4 6 40391586-40587465 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 21.7" "Group enriched" "Detected in some" 5 "REH: 3.4;SH-SY5Y: 10.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 1.8;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;T-cells: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA076660 Enhanced Supported Vesicles Vesicles "HPA076660: " "unprognostic (1.93e-2)" "unprognostic (2.04e-1)" "unprognostic (3.61e-2)" "unprognostic (4.58e-4)" "unprognostic (3.10e-1)" "unprognostic (1.21e-1)" "unprognostic (2.69e-1)" "unprognostic (5.75e-3)" "unprognostic (4.94e-2)" "unprognostic (1.80e-1)" "unprognostic (9.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (1.64e-1)" "unprognostic (2.98e-1)" "unprognostic (1.16e-1)" "unprognostic (2.66e-4)" 0.5 1.4 5.9 0.5 7.6 1.3 0.6 4.5 21.7 0.5 0.8 0.0 0.0 0.5 0.6 0.4 1.8 0.6 0.6 0.4 5.0 5.2 0.5 0.4 0.4 0.5 2.3 7.4 2.1 0.7 0.4 0.6 0.5 0.9 0.5 0.7 2.7 0.4 0.4 0.4 0.5 0.5 0.5 0.8 3.1 0.7 2.5 0.5 0.0 0.7 0.0 0.6 0.5 0.2 0.0 1.3 0.0 0.0 0.3 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 3.4 0.0 0.0 0.0 0.3 1.4 10.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.4 0.0 0.3 0.0 1.3 0.0 0.2 5.9 7.6 4.5 21.7 5.0 5.2 2.3 7.4 0.9 0.5 LRG1 LRG ENSG00000171236 "Leucine rich alpha-2-glycoprotein 1" P02750 19 4536409-4540474 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "liver: 636.5" "Cell line enhanced" "Detected in some" "Hep G2: 8.0;HMC-1: 8.2;SK-BR-3: 8.7;THP-1: 14.5;U-937: 26.8" "Cancer enriched" "Detected in many" 9 "liver cancer: 160.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 19 "neutrophil: 58.9" "Lineage enriched" "Detected in many" 42 "granulocytes: 58.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA001888, HPA001889" Enhanced Approved Vesicles "Secreted to blood" 21000000000 74000000000 Vesicles "HPA001888: AB_1079276, HPA001889: AB_1079275" "unprognostic (5.54e-3)" "unprognostic (1.78e-1)" "unprognostic (1.78e-1)" "unprognostic (1.42e-1)" "unprognostic (2.64e-2)" "unprognostic (1.05e-1)" "unprognostic (1.88e-1)" "unprognostic (1.13e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-2)" "unprognostic (1.46e-3)" "unprognostic (9.83e-2)" "prognostic unfavourable (3.66e-6)" "unprognostic (4.06e-2)" "unprognostic (1.45e-1)" "prognostic favourable (3.49e-4)" "unprognostic (2.60e-2)" 1.7 0.9 0.2 3.3 0.4 5.4 0.9 0.2 0.3 1.7 1.3 0.2 2.2 1.1 0.3 1.1 4.5 1.9 3.0 0.9 0.4 0.2 3.5 636.5 2.2 5.7 0.7 0.1 1.5 8.1 0.0 0.7 0.4 0.4 1.1 0.8 0.3 4.1 3.0 0.5 0.8 0.6 0.2 0.3 4.3 2.3 0.5 0.3 0.3 0.9 1.7 3.4 1.4 1.3 0.1 0.3 58.9 1.4 0.0 0.2 0.4 5.8 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.6 4.3 2.1 7.5 0.0 0.8 0.0 0.9 0.0 7.6 0.2 0.1 0.1 8.0 0.0 0.2 8.2 2.3 0.0 0.0 0.0 0.0 5.3 0.1 0.0 0.3 0.0 5.8 0.1 0.0 0.0 0.1 6.1 0.5 1.1 0.0 0.0 0.0 8.7 0.1 2.5 14.5 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 26.8 0.0 0.5 1.4 3.0 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 58.9 0.0 0.2 0.0 0.2 0.4 0.2 0.4 0.2 0.3 0.4 0.2 0.7 0.1 0.4 0.3 LRRC10 "HRLRRP, LRRC10A" ENSG00000198812 "Leucine rich repeat containing 10" Q5BKY1 12 69608564-69611162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "heart muscle: 42.5" "Cell line enhanced" "Detected in some" "HDLM-2: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (3.76e-4)" "unprognostic (4.59e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.1 1.0 0.5 0.4 0.8 0.1 0.1 0.5 0.6 0.6 0.0 0.0 0.5 0.1 0.0 0.9 0.4 0.3 0.3 1.0 0.3 0.1 0.7 0.0 0.1 0.0 2.4 0.7 0.5 0.7 0.6 0.1 0.0 0.8 0.2 0.6 0.6 0.0 0.4 0.6 0.1 0.1 0.0 0.8 0.4 0.2 0.4 0.9 0.1 0.1 0.8 1.2 0.8 0.9 0.0 0.1 0.0 0.3 0.1 0.3 0.2 0.8 0.4 0.4 0.6 0.3 0.8 1.0 1.3 0.1 0.4 0.5 0.4 0.6 0.2 0.5 0.7 0.5 0.6 0.1 1.3 0.8 0.7 1.0 0.4 0.3 1.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC15 LIB ENSG00000172061 "Leucine rich repeat containing 15" Q8TF66 3 194355247-194369743 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 48.1" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 47.8;U-138 MG: 9.3;U-87 MG: 25.8" "Cancer enhanced" "Detected in many" "breast cancer: 25.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035503 Uncertain Approved "Vesicles,Plasma membrane" 1800000 Vesicles "Plasma membrane" "HPA035503: AB_10961253" "unprognostic (3.20e-2)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (6.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (3.53e-2)" "unprognostic (3.97e-2)" "unprognostic (1.88e-3)" "unprognostic (1.22e-8)" "unprognostic (5.81e-2)" "unprognostic (1.11e-1)" "unprognostic (5.62e-3)" "unprognostic (7.54e-3)" 3.3 0.5 0.5 3.1 0.6 0.0 5.3 0.5 0.5 4.6 2.1 0.2 0.0 0.4 3.5 0.3 1.0 1.3 2.0 1.8 0.5 0.5 0.5 0.5 2.5 0.8 0.5 0.0 3.1 0.8 0.0 0.5 48.1 0.3 0.6 4.2 0.7 1.6 0.0 1.0 9.1 0.8 0.7 0.5 1.3 1.9 0.9 0.0 1.1 1.8 7.7 7.7 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 0.1 0.0 0.0 0.4 47.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.3 1.5 1.2 0.0 0.0 0.0 0.0 25.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 LRRC20 "FLJ10751, FLJ10844" ENSG00000172731 "Leucine rich repeat containing 20" Q8TCA0 10 70298970-70382650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "skeletal muscle: 111.8" "Cell line enhanced" "Detected in many" "U-2 OS: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039630 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039630: AB_10795467" "unprognostic (3.14e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.60e-1)" "unprognostic (7.17e-2)" "unprognostic (1.94e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-2)" "unprognostic (3.18e-1)" "unprognostic (2.16e-1)" "unprognostic (9.43e-2)" "unprognostic (1.30e-1)" "prognostic favourable (1.41e-4)" "unprognostic (1.50e-3)" "unprognostic (1.60e-1)" "unprognostic (1.32e-1)" "unprognostic (1.30e-1)" 1.3 2.5 5.6 1.4 7.2 1.6 1.4 5.2 11.2 3.3 3.2 2.5 0.0 1.4 2.7 3.1 7.1 2.4 2.1 15.8 5.0 3.9 1.2 8.3 2.2 1.7 3.7 6.3 2.2 1.3 2.1 3.6 1.1 4.9 2.6 2.0 1.8 1.8 2.4 111.8 1.6 1.4 3.5 2.0 1.4 1.6 3.5 1.9 1.6 2.6 14.3 3.1 2.2 4.8 0.9 2.6 0.0 1.0 1.1 4.1 1.1 14.6 11.3 7.3 15.6 4.1 3.3 0.0 1.9 6.6 5.0 4.7 9.6 15.3 2.9 7.8 1.4 5.3 7.1 10.6 3.5 8.2 2.3 1.7 2.5 22.0 4.5 4.2 1.4 1.3 3.2 6.9 2.3 9.7 2.1 4.7 4.6 2.3 16.0 3.5 2.4 25.7 13.4 4.2 8.3 6.5 1.5 18.5 8.0 1.2 1.3 5.1 1.9 4.3 5.9 4.0 34.6 5.3 4.5 7.6 13.4 4.8 6.5 17.4 0.8 0.0 0.9 0.0 1.7 1.0 1.4 0.9 1.3 1.9 2.6 0.0 4.1 1.5 0.0 1.1 0.7 0.4 0.2 1.1 5.6 7.2 5.2 11.2 5.0 3.9 3.7 6.3 4.9 1.9 LRRC23 "B7, LRPB7" ENSG00000010626 "Leucine rich repeat containing 23" Q53EV4 12 6873569-6914243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "fallopian tube: 94.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037766, HPA057533" Enhanced Supported Nucleoli Nucleoli "HPA037766: AB_10672609, HPA057533: " "prognostic favourable (6.02e-4)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (4.37e-3)" "unprognostic (1.23e-1)" "unprognostic (5.90e-2)" "unprognostic (7.94e-3)" "unprognostic (1.42e-1)" "unprognostic (3.54e-2)" "unprognostic (4.64e-1)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (2.29e-1)" "unprognostic (6.57e-2)" "unprognostic (1.60e-1)" "unprognostic (2.68e-1)" "unprognostic (6.25e-2)" 3.6 4.2 11.4 2.4 12.8 3.4 4.8 10.5 10.9 5.8 3.1 10.8 6.9 2.2 6.0 13.1 2.9 94.2 4.2 4.7 12.2 12.9 6.9 3.7 9.4 2.9 7.3 9.6 5.9 2.5 9.3 9.0 3.4 9.9 4.8 3.3 9.4 4.0 5.0 5.5 3.5 2.1 4.8 7.0 3.5 4.5 21.1 8.4 2.2 7.1 2.4 3.7 3.1 3.1 7.8 5.9 9.0 4.4 5.3 4.7 2.2 5.5 10.8 1.8 4.0 8.2 6.2 6.4 2.2 7.7 3.8 7.1 2.2 11.4 4.9 2.5 5.9 1.4 3.3 4.7 8.0 3.8 1.6 3.5 4.2 4.4 6.6 1.9 3.3 4.3 8.8 7.1 6.5 5.0 2.0 2.8 4.3 6.2 4.2 1.3 1.2 3.2 4.0 9.0 5.6 7.6 1.6 3.0 7.0 3.6 4.8 6.8 2.4 4.4 2.2 3.7 9.9 4.2 2.5 2.6 1.8 4.0 9.1 2.5 5.3 1.3 4.4 9.0 3.7 4.2 4.7 7.8 3.6 3.1 4.0 4.8 4.1 4.0 0.7 5.3 3.8 5.9 0.2 2.2 11.4 12.8 10.5 10.9 12.2 12.9 7.3 9.6 9.9 8.4 LRRC26 bA350O14.10 ENSG00000184709 "Leucine rich repeat containing 26" Q2I0M4 9 137168758-137170051 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "salivary gland: 173.1" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 51.5" "Cancer enriched" "Detected in many" 5 "prostate cancer: 47.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 408 "plasmacytoid DC: 40.8" "Lineage enriched" "Detected in single" 408 "dendritic cells: 40.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA056312 Approved Supported "Nucleoli fibrillar center,Plasma membrane" "Plasma membrane" "Nucleoli fibrillar center" "HPA056312: " "unprognostic (1.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.04e-2)" "prognostic favourable (4.82e-6)" "unprognostic (3.39e-1)" "unprognostic (1.67e-2)" "unprognostic (1.82e-1)" "unprognostic (2.13e-2)" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "prognostic favourable (3.48e-4)" "unprognostic (3.27e-1)" "unprognostic (2.29e-1)" 0.1 0.0 0.0 1.3 0.0 0.0 2.1 0.7 0.1 0.3 6.8 0.0 11.2 1.2 0.3 0.1 0.7 0.3 0.4 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 15.4 0.4 0.0 173.1 20.0 0.0 1.3 4.0 0.0 0.0 0.1 1.0 0.0 0.0 0.7 0.0 10.3 4.6 0.0 0.1 0.0 40.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 8.5 0.0 51.5 0.0 0.0 0.4 0.1 0.2 2.5 0.0 1.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 LRRC27 KIAA1674 ENSG00000148814 "Leucine rich repeat containing 27" Q9C0I9 10 132332154-132379918 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "testis: 52.9" "Cell line enhanced" "Detected in many" "AN3-CA: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037595, HPA067395" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA037595: , HPA067395: " "unprognostic (1.97e-1)" "unprognostic (5.76e-4)" "unprognostic (1.48e-3)" "unprognostic (1.94e-3)" "unprognostic (6.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.41e-1)" "unprognostic (1.04e-2)" "unprognostic (8.26e-2)" "unprognostic (1.75e-2)" "unprognostic (5.94e-3)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (5.74e-2)" "unprognostic (1.72e-1)" "unprognostic (4.49e-2)" "unprognostic (9.27e-4)" 2.1 2.8 8.1 1.5 8.4 1.0 4.1 2.2 8.9 3.6 2.1 6.1 7.5 2.0 3.8 5.6 1.6 10.5 3.5 2.2 6.6 5.4 4.4 2.4 3.1 1.9 4.3 7.3 5.4 3.1 7.5 5.8 2.1 6.5 4.1 2.1 4.8 3.1 4.0 1.2 2.1 2.6 3.4 3.5 3.3 3.0 52.9 4.5 0.7 5.1 1.0 1.2 2.5 1.8 4.7 7.8 4.4 6.8 3.1 2.8 2.7 2.7 5.0 11.2 15.7 9.8 10.1 1.1 2.7 8.8 4.5 4.1 0.8 5.7 1.5 1.6 6.3 1.9 2.5 1.3 2.9 3.2 2.2 0.3 3.5 2.6 7.0 1.2 1.8 4.4 8.7 4.6 6.1 3.2 0.9 1.1 3.5 4.6 2.3 3.4 3.1 1.7 2.1 1.8 0.8 8.1 0.7 2.0 5.7 1.3 0.9 3.5 2.5 2.8 4.2 1.8 2.3 4.1 1.6 0.8 0.3 0.8 8.3 2.3 1.1 4.4 6.8 1.1 1.7 5.7 1.3 3.4 1.1 1.0 7.3 4.7 2.8 1.6 0.5 3.1 3.6 7.8 0.7 2.7 8.1 8.4 2.2 8.9 6.6 5.4 4.3 7.3 6.5 4.5 LRRC30 ENSG00000206422 "Leucine rich repeat containing 30" A6NM36 18 7231125-7232047 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 30 "skeletal muscle: 18.7" "Cell line enriched" "Detected in single" 12 "SH-SY5Y: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041039 Uncertain "HPA041039: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC37A2 FLJ45049 ENSG00000238083 "Leucine rich repeat containing 37 member A2" A6NM11 17 46511511-46555650 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.5" "Cell line enhanced" "Detected in some" "Daudi: 4.0;THP-1: 4.2" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "eosinophil: 2.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.9" "HPA042121, HPA043056, HPA045090, HPA049080" Supported Approved Vesicles Vesicles "HPA042121: , HPA043056: , HPA045090: , HPA049080: " "unprognostic (1.59e-2)" "unprognostic (3.75e-2)" "unprognostic (8.96e-2)" "unprognostic (6.35e-2)" "unprognostic (2.53e-1)" "unprognostic (2.97e-3)" "unprognostic (4.61e-3)" "unprognostic (1.63e-1)" "unprognostic (6.47e-2)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (8.00e-2)" "unprognostic (3.02e-7)" "unprognostic (8.40e-2)" "unprognostic (2.82e-1)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" 0.5 0.0 0.3 0.4 0.7 0.9 0.8 0.9 0.4 0.1 0.4 0.0 0.2 0.1 0.5 0.3 0.0 0.1 0.4 0.4 0.5 0.4 0.7 0.5 0.1 0.3 0.1 0.1 1.2 0.1 0.4 0.9 0.4 0.7 0.6 0.9 0.4 0.5 0.2 0.0 0.5 13.5 0.4 0.5 0.6 0.3 0.2 0.3 2.9 0.1 0.1 0.4 0.0 0.4 0.6 0.3 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.8 0.0 4.0 0.1 0.3 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.9 0.5 0.7 0.0 0.0 0.0 0.8 0.0 0.3 1.9 0.0 0.8 2.0 0.0 0.3 0.1 0.2 0.1 1.8 0.8 0.4 0.0 1.4 0.2 0.4 0.3 0.0 0.3 1.4 4.2 0.8 2.5 1.9 0.0 0.8 1.3 1.0 0.5 0.2 0.9 1.5 0.0 0.0 2.9 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 LRRC4C "KIAA1580, NGL-1" ENSG00000148948 "Leucine rich repeat containing 4C" Q9HCJ2 11 40114203-41459773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 31.5" "Group enriched" "Detected in some" 6 "AF22: 16.9;U-2 OS: 18.6" "Cancer enhanced" "Detected in some" "glioma: 3.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "naive B-cell: 1.7" "Lineage enriched" "Detected in single" 18 "B-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054800, HPA075816" Approved Approved Cytosol Cytosol "HPA054800: , HPA075816: " "unprognostic (4.86e-3)" "unprognostic (3.43e-2)" "unprognostic (7.62e-3)" "unprognostic (4.87e-3)" "unprognostic (6.48e-2)" "unprognostic (1.42e-1)" "unprognostic (2.84e-1)" "unprognostic (4.64e-2)" "unprognostic (1.93e-1)" "unprognostic (2.22e-1)" "unprognostic (2.44e-1)" "unprognostic (1.49e-1)" "unprognostic (4.90e-13)" "unprognostic (5.05e-4)" "unprognostic (5.21e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-3)" 1.6 5.7 20.2 1.6 23.7 0.5 2.6 3.6 31.5 5.3 1.9 3.3 0.0 1.1 2.3 1.0 1.2 1.3 1.8 2.6 16.7 8.7 0.9 2.1 1.6 1.4 7.5 10.3 1.6 1.0 4.3 3.2 0.5 8.7 1.5 1.6 1.3 1.4 3.0 0.7 0.7 1.3 2.4 6.0 1.3 0.9 0.9 7.9 0.0 4.0 0.0 1.6 1.1 1.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 18.6 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 23.7 3.6 16.4 16.7 8.7 7.5 10.3 8.7 7.9 LRRC52 FLJ25811 ENSG00000162763 "Leucine rich repeat containing 52" Q8N7C0 1 165544007-165563961 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "testis: 31.9" "Cell line enriched" "Detected in single" 10 "U-937: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (9.09e-2)" "unprognostic (1.76e-2)" "unprognostic (6.48e-2)" "unprognostic (3.79e-2)" "unprognostic (8.45e-2)" "unprognostic (6.70e-4)" "unprognostic (6.05e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 31.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC66 ENSG00000188993 "Leucine rich repeat containing 66" Q68CR7 4 51993702-52017620 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 50.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.5;CAPAN-2: 5.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014549, HPA027839" Uncertain "HPA014549: AB_1853062, HPA027839: AB_10602705" "unprognostic (1.10e-1)" "unprognostic (4.87e-2)" "unprognostic (8.62e-2)" "unprognostic (2.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.87e-1)" "unprognostic (2.57e-2)" "unprognostic (4.83e-3)" "unprognostic (2.93e-1)" "unprognostic (4.09e-3)" "unprognostic (1.61e-2)" "unprognostic (1.89e-1)" "unprognostic (6.31e-3)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (3.05e-1)" "unprognostic (4.06e-1)" 0.5 0.1 0.8 2.6 1.0 0.0 0.5 1.4 0.9 0.5 11.3 0.5 0.5 19.6 0.5 0.5 0.5 0.5 1.6 0.6 0.8 0.8 0.9 0.5 0.5 0.5 0.8 0.5 0.5 0.5 0.5 3.1 0.5 0.5 0.5 5.2 0.5 0.5 0.5 6.7 0.0 50.2 0.5 0.6 0.5 4.6 0.7 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.2 0.4 0.7 1.9 4.5 0.2 0.7 1.1 0.4 0.8 0.2 5.7 0.0 0.1 1.1 0.0 0.3 0.3 0.3 1.8 0.7 0.0 0.2 0.0 0.2 0.1 0.1 1.7 1.0 0.9 0.3 0.4 0.0 0.0 2.2 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.2 0.2 0.0 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.4 1.2 0.1 0.7 0.5 0.7 0.0 0.1 0.1 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 1.4 0.9 0.8 0.8 0.8 0.5 0.5 0.5 LRRC7 "densin-180, KIAA1365" ENSG00000033122 "Leucine rich repeat containing 7" Q96NW7 1 69568398-70151945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 29.1" "Group enriched" "Detected in some" 6 "HaCaT: 10.3;HEL: 30.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3" "Group enriched" "Detected in many" 14 "granulocytes: 1.4;T-cells: 1.7" "Low region specificity" "Detected in many" HPA005625 Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA005625: AB_1853340" "unprognostic (2.81e-2)" "unprognostic (1.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.98e-3)" "unprognostic (2.47e-1)" "unprognostic (1.73e-1)" "unprognostic (1.04e-1)" "unprognostic (3.50e-2)" "unprognostic (4.84e-3)" "unprognostic (2.92e-2)" "unprognostic (1.06e-3)" "unprognostic (1.46e-1)" "unprognostic (5.64e-6)" "unprognostic (1.31e-2)" "unprognostic (1.74e-2)" "unprognostic (5.13e-3)" "unprognostic (2.08e-3)" 1.0 1.3 20.2 1.0 29.1 1.0 0.8 0.5 21.9 1.2 1.9 5.0 0.0 1.0 1.2 1.0 1.3 0.8 3.2 2.8 15.4 5.8 2.8 1.2 0.8 0.9 4.4 17.6 1.0 2.7 0.7 0.4 1.2 2.4 1.5 2.4 0.2 0.9 1.1 2.8 1.1 1.3 1.2 2.5 0.8 0.8 5.8 7.6 0.0 6.7 0.0 0.8 0.9 0.5 0.0 0.1 1.4 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 3.3 0.0 10.3 0.2 0.0 0.0 0.0 0.5 30.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.7 1.3 0.0 0.0 0.0 0.0 0.0 0.1 20.2 29.1 0.5 19.2 15.4 5.8 4.4 17.6 2.4 7.6 LRRC72 ENSG00000205858 "Leucine rich repeat containing 72" A6NJI9 7 16526880-16581568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 15.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "pons and medulla: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA020554 Uncertain "HPA020554: AB_1859508" "unprognostic (1.58e-2)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 LRRC74A "C14orf166B, LRRC74" ENSG00000100565 "Leucine rich repeat containing 74A" Q0VAA2 14 76826372-76870302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 19.8" "Group enriched" "Detected in some" 8 "NTERA-2: 1.0;RH-30: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035094 Uncertain "HPA035094: AB_10600793" "unprognostic (7.71e-3)" "unprognostic (1.77e-1)" "unprognostic (2.77e-1)" "unprognostic (6.38e-2)" "unprognostic (3.44e-1)" "unprognostic (5.29e-3)" "unprognostic (3.22e-1)" "unprognostic (1.11e-2)" "unprognostic (1.16e-1)" "unprognostic (3.30e-1)" "unprognostic (5.49e-3)" "unprognostic (1.11e-2)" "unprognostic (5.21e-4)" "unprognostic (1.72e-1)" "unprognostic (9.96e-2)" "unprognostic (6.36e-2)" "unprognostic (1.09e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LRRC75A "C17orf76, FAM211A, FLJ35696" ENSG00000181350 "Leucine rich repeat containing 75A" Q8NAA5 17 16441577-16492153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 42.3" "Cell line enhanced" "Detected in some" "HEL: 11.8;HUVEC TERT2: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028528, HPA065840" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA028528: AB_10600755, HPA065840: " "unprognostic (1.09e-1)" "unprognostic (5.60e-2)" "unprognostic (5.79e-2)" "unprognostic (3.85e-5)" "unprognostic (3.93e-2)" "unprognostic (3.23e-2)" "unprognostic (3.44e-1)" "unprognostic (7.66e-3)" "unprognostic (7.74e-2)" "unprognostic (2.84e-1)" "prognostic favourable (7.46e-5)" "unprognostic (8.36e-2)" "unprognostic (4.28e-3)" "unprognostic (8.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-3)" "unprognostic (2.06e-1)" 1.0 8.9 5.2 2.8 3.7 1.7 0.6 0.7 6.3 2.2 26.3 1.5 1.4 15.0 1.9 0.5 0.4 0.9 0.5 0.4 4.1 2.4 0.8 0.2 1.6 1.9 1.6 3.2 1.8 1.6 3.7 4.1 1.5 2.1 1.1 10.4 1.9 0.3 1.7 0.4 0.4 42.3 3.0 0.8 6.4 1.3 8.5 0.4 0.5 1.2 0.0 1.9 1.3 0.7 0.8 0.0 0.3 0.6 0.3 0.6 0.2 1.1 1.0 1.2 0.8 0.3 0.5 0.1 0.3 0.8 2.7 2.2 1.1 0.3 0.0 0.8 0.1 0.4 0.3 0.2 0.1 0.4 0.9 11.8 0.6 0.0 0.4 0.2 0.9 0.0 0.0 0.6 0.0 3.8 0.5 0.2 0.0 1.9 1.9 0.8 0.2 0.1 0.6 0.7 0.1 0.5 0.2 2.3 0.6 0.0 0.2 2.8 0.2 0.1 0.0 0.3 1.4 0.9 1.5 1.5 0.3 0.2 0.1 0.7 1.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.6 0.3 0.3 0.6 0.0 0.0 0.2 5.2 3.7 0.7 6.3 4.1 2.4 1.6 3.2 2.1 0.4 LRRD1 IMAGE:4798971 ENSG00000240720 "Leucine rich repeats and death domain containing 1" A4D1F6 7 92112159-92179531 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 19.1" "Cell line enhanced" "Detected in some" "HL-60: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.8" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (3.72e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (1.12e-1)" "unprognostic (5.39e-2)" "unprognostic (1.14e-1)" "unprognostic (3.29e-1)" "unprognostic (1.27e-2)" "unprognostic (1.56e-2)" "unprognostic (1.81e-3)" "unprognostic (1.77e-1)" "unprognostic (7.67e-2)" "unprognostic (2.02e-1)" "unprognostic (3.13e-3)" 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 19.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.7 3.8 0.6 0.7 0.8 0.1 0.9 0.2 0.9 0.9 0.4 1.7 0.6 0.8 0.0 0.5 0.4 0.3 1.3 0.9 0.2 0.0 0.7 0.1 0.0 0.7 0.9 0.8 0.6 1.0 0.3 0.4 3.3 1.1 0.2 0.4 0.7 0.3 0.5 1.2 2.3 0.9 1.9 0.8 2.5 0.4 0.7 0.5 0.9 0.5 0.1 0.7 0.7 0.6 0.1 0.3 0.1 0.5 0.4 1.3 1.0 1.2 1.0 0.7 1.2 0.3 1.3 0.4 0.9 0.4 3.8 0.6 0.4 0.5 0.3 0.4 0.5 0.5 0.4 0.1 1.0 0.4 0.5 1.9 0.7 0.4 0.7 0.8 0.1 0.1 0.1 0.5 0.1 0.1 0.3 0.1 0.1 0.1 0.1 LRRIQ3 "LRRC44, MGC22773" ENSG00000162620 "Leucine rich repeats and IQ motif containing 3" A6PVS8 1 74026015-74198187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 34.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030799 Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA030799: AB_10601337" "unprognostic (5.94e-3)" "unprognostic (6.00e-2)" "unprognostic (6.49e-3)" "unprognostic (1.63e-1)" "unprognostic (6.62e-2)" "unprognostic (2.78e-1)" "unprognostic (2.27e-2)" "unprognostic (2.27e-1)" "unprognostic (8.17e-2)" "unprognostic (2.44e-1)" "unprognostic (1.12e-3)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-1)" "unprognostic (1.88e-2)" "unprognostic (4.65e-2)" 1.8 1.3 0.9 0.9 2.7 0.2 0.9 0.3 1.5 0.8 0.4 1.1 0.1 0.3 0.4 1.2 0.6 2.8 0.6 0.6 1.0 1.1 3.5 1.7 1.6 0.9 2.5 1.4 2.5 0.6 2.1 7.2 0.3 2.4 0.6 0.3 0.6 0.8 0.6 0.4 0.3 0.4 0.2 1.3 1.6 0.5 34.1 1.0 1.4 1.9 0.0 0.8 0.5 0.4 3.9 1.1 1.9 1.1 1.1 4.0 0.9 0.4 1.9 0.3 0.8 2.1 0.8 1.3 1.2 0.9 1.7 1.8 0.2 2.8 2.8 2.5 0.2 0.3 4.3 4.0 2.1 6.8 0.1 2.5 0.6 1.3 0.3 4.4 1.4 1.4 2.2 2.9 1.1 0.8 2.1 3.9 2.7 0.0 1.7 0.7 2.2 1.3 2.1 1.6 2.8 2.5 0.3 2.1 1.4 0.3 0.3 6.0 1.7 2.5 0.3 0.3 1.4 1.0 2.3 4.0 1.4 2.2 3.0 0.5 2.2 0.0 0.2 1.9 2.3 1.1 2.9 3.9 2.6 2.9 0.3 2.0 2.5 3.5 0.0 1.1 0.3 1.1 4.0 0.9 0.9 2.7 0.3 1.5 1.0 1.1 2.5 1.4 2.4 1.0 LRRIQ4 LRRC64 ENSG00000188306 "Leucine rich repeats and IQ motif containing 4" A6NIV6 3 169821922-169837775 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 7.1" "Cell line enhanced" "Detected in some" "HDLM-2: 2.0;HEL: 2.6;RT4: 4.8;SCLC-21H: 1.9;T-47d: 4.4" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 13 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA036706 Uncertain "HPA036706: " "unprognostic (5.09e-2)" "unprognostic (8.85e-2)" "unprognostic (2.55e-1)" "unprognostic (1.30e-4)" "unprognostic (5.26e-3)" "unprognostic (2.32e-2)" "unprognostic (2.04e-1)" "unprognostic (2.31e-1)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (9.72e-2)" "unprognostic (1.42e-1)" "unprognostic (2.12e-1)" "unprognostic (7.47e-2)" "unprognostic (1.55e-1)" "unprognostic (6.74e-2)" "unprognostic (4.56e-3)" 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.1 1.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.6 7.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.3 0.0 0.3 0.2 0.0 0.4 0.0 0.0 1.7 0.3 0.2 0.0 0.7 0.0 0.4 2.0 0.1 2.6 0.0 0.0 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.5 0.4 0.7 1.0 0.0 0.0 0.1 4.8 1.9 0.6 0.1 0.4 0.0 4.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRTM2 KIAA0416 ENSG00000146006 "Leucine rich repeat transmembrane neuronal 2" O43300 5 138868923-138875368 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 33.1" "Group enriched" "Detected in some" 7 "HDLM-2: 17.8;SCLC-21H: 5.8" "Cancer enriched" "Detected in single" 11 "glioma: 4.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.77e-2)" "unprognostic (2.39e-1)" "unprognostic (1.48e-1)" "unprognostic (2.85e-1)" "unprognostic (3.58e-1)" "unprognostic (8.72e-2)" "unprognostic (4.31e-2)" "unprognostic (4.48e-1)" "unprognostic (4.47e-2)" "unprognostic (8.54e-2)" "unprognostic (1.13e-2)" "unprognostic (3.13e-2)" "unprognostic (2.86e-2)" "unprognostic (8.11e-2)" "unprognostic (1.08e-1)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" 2.3 4.1 11.0 1.1 15.7 1.1 1.5 15.6 33.1 1.3 1.4 5.1 0.0 1.3 1.1 1.0 1.0 1.1 1.4 1.1 9.7 9.1 1.2 1.3 1.1 1.2 5.4 17.7 1.2 1.4 0.9 0.7 4.5 8.4 1.0 1.4 1.0 1.0 0.9 1.1 1.2 1.5 1.4 5.8 1.9 1.0 0.9 9.9 0.0 1.1 0.0 1.0 1.2 0.3 0.5 0.0 1.0 0.8 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.1 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 17.8 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 1.5 0.0 0.8 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 11.0 15.7 15.6 20.8 9.7 9.1 5.4 17.7 8.4 9.9 LRTM2 ENSG00000166159 "Leucine rich repeats and transmembrane domains 2" Q8N967 12 1820267-1836752 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "brain: 18.7" "Group enriched" "Detected in some" 8 "HEL: 9.0;SCLC-21H: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA055094, HPA062745" Uncertain Approved Cytosol Cytosol "HPA055094: , HPA062745: " "unprognostic (1.84e-3)" "unprognostic (4.83e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (5.49e-2)" "unprognostic (1.60e-1)" "unprognostic (1.34e-3)" "unprognostic (2.25e-1)" "unprognostic (1.24e-1)" "unprognostic (6.20e-4)" "unprognostic (2.21e-1)" "unprognostic (8.02e-2)" 0.7 0.7 5.1 0.7 12.3 0.7 0.7 0.8 18.7 0.7 0.7 1.7 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 3.3 5.0 0.7 0.7 0.7 0.7 1.7 10.5 0.7 0.7 0.7 0.1 0.7 4.7 0.7 0.7 0.1 0.7 0.8 0.7 0.7 0.7 0.7 1.7 0.7 0.8 0.9 4.3 0.0 0.7 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 12.3 0.8 18.7 3.3 5.0 1.7 10.5 4.7 4.3 LRWD1 "CENP-33, DKFZp434K1815, ORCA" ENSG00000161036 "Leucine rich repeats and WD repeat domain containing 1" Q9UFC0 7 102464929-102473168 "Predicted intracellular proteins" "DNA replication" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "testis: 129.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021320 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA021320: AB_1853372" "unprognostic (1.50e-1)" "unprognostic (1.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.66e-3)" "unprognostic (1.60e-2)" "unprognostic (2.08e-3)" "unprognostic (1.72e-3)" "unprognostic (4.97e-2)" "unprognostic (3.34e-1)" "unprognostic (3.04e-2)" "prognostic favourable (8.71e-5)" "unprognostic (1.00e-1)" "prognostic unfavourable (1.25e-4)" "unprognostic (1.46e-2)" "unprognostic (4.14e-2)" "unprognostic (7.82e-2)" "unprognostic (9.20e-2)" 2.7 4.6 3.6 3.8 5.0 7.6 1.9 7.9 5.8 2.5 2.5 3.4 3.4 2.9 2.8 2.8 2.1 7.1 2.5 2.6 4.3 4.0 4.0 5.1 2.6 4.4 3.4 3.7 3.1 3.4 3.4 4.9 2.0 4.2 2.2 1.6 1.7 3.3 4.0 3.6 2.2 4.3 2.7 2.4 6.6 3.3 129.9 3.8 3.9 2.7 1.6 4.2 2.3 1.8 12.6 9.8 9.2 4.0 9.9 10.4 5.8 7.3 10.2 5.5 15.5 4.2 3.2 8.6 7.8 5.1 13.3 9.2 9.7 4.3 18.1 11.2 5.9 7.8 8.1 7.0 4.0 6.3 15.7 3.7 4.6 6.0 5.6 6.9 7.3 3.0 4.3 15.4 3.3 7.0 17.5 5.6 7.2 22.1 21.0 16.7 11.7 14.7 11.1 5.1 19.5 4.0 4.6 7.3 20.7 8.6 8.2 7.6 4.7 5.8 4.1 7.4 15.8 22.8 12.4 20.6 35.5 17.3 8.2 6.5 12.8 9.1 2.5 9.2 10.4 4.0 9.9 11.1 9.1 9.1 2.8 12.6 5.8 7.4 5.9 9.9 3.5 9.8 9.0 5.8 3.6 5.0 7.9 5.8 4.3 4.0 3.4 3.7 4.2 3.8 LTA "LT, TNFB, TNFSF1" ENSG00000226979 "Lymphotoxin alpha" P01374 6 31572054-31574324 "Cancer-related genes, Disease related genes, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 25.3" "Cell line enhanced" "Detected in some" "MOLT-4: 3.9;U-266/84: 1.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA007729 Uncertain "Secreted to blood" 13100 "HPA007729: AB_1852906" "unprognostic (3.76e-2)" "unprognostic (1.48e-2)" "unprognostic (1.36e-3)" "unprognostic (8.99e-5)" "unprognostic (3.22e-1)" "unprognostic (5.13e-3)" "unprognostic (2.07e-1)" "unprognostic (4.71e-2)" "unprognostic (3.10e-2)" "unprognostic (3.39e-4)" "unprognostic (2.68e-2)" "unprognostic (6.77e-2)" "unprognostic (8.72e-12)" "unprognostic (2.59e-1)" "unprognostic (5.49e-2)" "unprognostic (4.30e-2)" "unprognostic (3.03e-1)" 0.4 0.1 0.2 25.3 0.6 1.1 0.1 1.3 0.2 0.2 0.5 0.1 0.0 0.1 0.1 0.1 0.9 0.2 0.1 0.1 0.2 0.1 0.3 0.4 2.0 7.2 0.1 0.0 0.3 0.1 0.1 0.1 0.3 0.0 0.6 0.4 0.2 2.4 0.5 0.3 0.2 2.8 0.2 0.3 10.0 0.4 6.0 0.0 11.2 0.2 0.5 17.5 0.7 0.1 0.2 0.0 0.5 0.6 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.6 0.5 0.1 0.6 0.0 0.1 0.0 0.2 0.6 1.3 0.2 0.2 0.1 0.1 0.0 0.0 0.0 LUM "LDC, SLRR2D" ENSG00000139329 Lumican P51884 12 91102629-91111831 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "placenta: 344.8" "Cell line enriched" "Detected in some" 5 "BJ hTERT+: 182.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 103 "basophil: 10.2" "Lineage enriched" "Detected in single" 103 "granulocytes: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001522, CAB025783" Supported "Secreted to extracellular matrix" 59000000000 "CAB025783: , HPA001522: AB_1079285" "unprognostic (5.54e-2)" "unprognostic (2.27e-1)" "unprognostic (3.32e-1)" "unprognostic (2.75e-1)" "unprognostic (1.65e-1)" "unprognostic (8.38e-2)" "unprognostic (1.09e-1)" "unprognostic (2.87e-1)" "unprognostic (4.08e-2)" "unprognostic (1.19e-1)" "unprognostic (1.65e-2)" "unprognostic (2.20e-2)" "prognostic unfavourable (1.75e-6)" "unprognostic (5.25e-3)" "unprognostic (2.27e-2)" "unprognostic (2.38e-2)" "unprognostic (2.06e-2)" 44.8 25.3 0.8 15.1 0.7 0.0 19.7 0.7 0.7 56.7 26.9 0.7 28.1 5.1 64.8 77.8 28.1 12.2 76.6 48.8 0.8 0.7 26.9 6.4 77.1 32.0 0.9 0.6 73.0 9.1 0.7 2.7 344.8 2.8 77.4 13.3 1.4 5.6 9.9 9.1 8.3 24.0 48.7 4.0 1.3 8.2 30.9 0.3 1.7 18.1 32.3 11.5 65.3 20.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 22.5 11.1 0.0 36.9 182.3 1.5 2.3 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 17.6 0.0 0.0 15.2 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.9 0.0 0.0 0.0 1.5 0.4 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.7 0.7 0.8 0.7 0.9 0.6 2.8 0.3 LUZP4 "CT-8, CT28, HOM-TES-85" ENSG00000102021 "Leucine zipper protein 4" Q9P127 X 115289727-115307556 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 142 "testis: 21.2" "Cell line enhanced" "Detected in some" "SK-MEL-30: 2.3;U-266/70: 1.1" "Cancer enriched" "Detected in some" 9 "testis cancer: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046436, HPA051999" Enhanced "HPA046436: AB_10964168, HPA051999: AB_2681688" "unprognostic (1.84e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.4 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 LVRN "APQ, AQPEP, FLJ90650, TAQPEP" ENSG00000172901 Laeverin Q6Q4G3 5 115962454-116027619 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 75.1" "Cell line enhanced" "Detected in some" "ASC diff: 2.3;ASC TERT1: 3.8;CAPAN-2: 1.8;SiHa: 1.5;U-266/70: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053254 Enhanced "Intracellular and membrane" "HPA053254: " "unprognostic (1.47e-1)" "unprognostic (3.38e-3)" "unprognostic (5.81e-2)" "unprognostic (2.97e-3)" "unprognostic (5.38e-2)" "unprognostic (1.32e-1)" "unprognostic (2.59e-3)" "unprognostic (1.88e-2)" "unprognostic (2.23e-1)" "unprognostic (2.23e-2)" "unprognostic (3.83e-3)" "unprognostic (1.22e-1)" "unprognostic (1.67e-7)" "unprognostic (1.05e-2)" "unprognostic (5.94e-2)" "unprognostic (6.53e-2)" "unprognostic (3.31e-2)" 10.6 0.1 0.0 0.5 0.0 0.1 3.9 0.0 0.0 0.3 1.4 0.0 0.4 0.1 0.0 0.0 1.8 0.2 0.4 1.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.1 75.1 0.0 0.7 0.4 0.0 0.6 1.2 1.3 1.0 1.7 0.5 0.0 0.0 0.4 0.3 0.0 0.0 0.3 1.7 0.1 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.1 2.3 3.8 0.8 0.2 0.3 0.1 0.3 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.5 1.1 0.1 0.0 0.9 0.0 0.0 0.2 0.3 1.3 0.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.6 1.5 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LY6H NMLY6 ENSG00000176956 "Lymphocyte antigen 6 family member H" O94772 8 143157914-143160711 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 58.2" "Cell line enhanced" "Detected in some" "MOLT-4: 6.7;NTERA-2: 1.3;SCLC-21H: 3.8" "Cancer enhanced" "Detected in many" "glioma: 9.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077218 Enhanced "Intracellular and membrane" "HPA077218: " "unprognostic (8.76e-2)" "unprognostic (2.76e-1)" "unprognostic (1.41e-2)" "unprognostic (9.45e-4)" "unprognostic (3.34e-3)" "unprognostic (1.82e-1)" "unprognostic (1.71e-4)" "unprognostic (2.26e-2)" "unprognostic (1.56e-1)" "unprognostic (5.07e-3)" "unprognostic (3.76e-3)" "unprognostic (5.97e-2)" "unprognostic (2.20e-5)" "unprognostic (6.43e-3)" "unprognostic (1.54e-1)" "unprognostic (8.98e-2)" "unprognostic (9.89e-3)" 1.4 1.4 46.7 1.6 26.3 1.3 1.3 0.0 42.8 1.3 2.8 3.2 0.0 5.6 1.5 1.4 1.5 2.6 1.4 1.2 58.2 53.4 1.3 1.2 1.4 1.4 10.9 32.5 1.2 1.3 1.2 8.4 1.3 7.1 1.3 1.3 0.0 1.3 1.4 1.4 1.2 2.2 1.8 4.0 1.2 4.3 2.3 1.9 0.0 1.3 0.0 1.2 1.4 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.7 0.0 1.3 0.0 0.0 0.0 0.7 0.0 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 46.7 26.3 0.0 36.9 58.2 53.4 10.9 32.5 7.1 1.9 LY6L ENSG00000261667 "Lymphocyte antigen 6 family member L" H3BQJ8 8 143080457-143083001 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 7 "epididymis: 48.8" "Cell line enriched" "Detected in single" 8 "BEWO: 1.1" "Cancer enriched" "Detected in single" 6 "prostate cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.25e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 48.8 0.0 0.0 0.0 0.0 0.0 0.2 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 LYG1 SALW1939 ENSG00000144214 "Lysozyme g1" Q8N1E2 2 99284238-99304742 "Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "kidney: 22.5" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in many" 15 "renal cancer: 31.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted - unknown location" "unprognostic (1.53e-2)" "unprognostic (3.13e-2)" "unprognostic (1.53e-2)" "unprognostic (3.73e-1)" "unprognostic (9.74e-2)" "unprognostic (3.76e-4)" "unprognostic (6.94e-4)" "unprognostic (2.58e-2)" "unprognostic (4.72e-2)" "unprognostic (9.74e-3)" "unprognostic (5.01e-2)" "unprognostic (1.06e-2)" "prognostic favourable (8.44e-4)" "unprognostic (1.31e-1)" "unprognostic (2.58e-1)" "unprognostic (1.07e-1)" "unprognostic (2.31e-3)" 1.0 0.4 1.0 1.1 1.0 0.7 2.1 2.3 1.0 1.1 1.0 1.0 1.0 1.2 1.4 1.9 1.0 0.7 1.0 1.0 1.0 0.4 22.5 3.1 1.0 1.5 1.0 1.0 1.1 1.0 0.0 1.0 1.0 1.0 1.6 1.1 1.0 1.0 1.0 2.0 1.5 1.2 1.0 1.0 2.6 0.6 2.9 1.0 1.0 1.2 1.0 1.2 1.0 1.0 1.0 0.4 1.2 0.9 0.0 2.4 0.5 0.5 3.9 3.0 4.9 6.9 4.1 3.4 1.5 1.7 1.6 2.7 0.8 3.5 0.8 2.7 0.7 1.7 4.0 0.6 1.9 2.7 2.4 2.2 2.9 1.3 1.4 0.8 5.4 3.2 4.3 2.6 1.0 0.8 1.2 2.6 1.8 0.8 2.0 6.7 0.7 3.8 4.9 1.7 1.3 6.9 1.5 1.7 1.0 0.6 1.2 1.1 0.5 0.7 2.2 2.0 2.5 3.6 1.7 3.0 1.8 0.6 0.6 4.0 1.0 0.0 0.9 1.2 1.5 0.1 1.4 0.2 0.2 0.6 0.4 1.0 1.2 0.7 0.0 0.0 0.0 0.0 2.4 0.5 1.0 1.0 2.3 1.0 1.0 0.4 1.0 1.0 1.0 1.0 LYPD4 MGC42718 ENSG00000273111 "LY6/PLAUR domain containing 4" Q6UWN0 19 41837074-41844697 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "testis: 120.3" "Cell line enhanced" "Detected in single" "BEWO: 2.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Intracellular and membrane" "unprognostic (4.07e-2)" "unprognostic (2.92e-1)" "unprognostic (3.21e-1)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 1.8 1.2 1.7 0.9 0.5 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 0.0 0.7 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.3 1.8 0.3 0.5 0.6 0.4 0.9 0.6 0.5 0.5 0.5 0.5 0.6 0.8 1.5 1.7 1.2 0.7 0.5 0.5 LYZL1 "LYC2, MGC33408" ENSG00000120563 "Lysozyme like 1" Q6UWQ5 10 29289061-29318328 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 371 "testis: 39.5" "Group enriched" "Detected in some" 11 "A549: 1.5;HEK 293: 1.1;Hep G2: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" "unprognostic (1.88e-1)" "unprognostic (8.40e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LYZL2 ENSG00000151033 "Lysozyme like 2" Q7Z4W2 10 30611779-30629762 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 84 "testis: 34.2" "Cell line enriched" "Detected in some" 6 "SK-BR-3: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" "unprognostic (2.83e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LYZL4 "LYC4, MGC26768" ENSG00000157093 "Lysozyme like 4" Q96KX0 3 42397078-42410600 "Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "testis: 29.0" "Cell line enhanced" "Detected in some" "HEL: 1.0;SK-BR-3: 1.2;WM-115: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA038806 Approved "Secreted in male reproductive system" "HPA038806: AB_10674841" "unprognostic (4.03e-1)" "unprognostic (5.68e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 LYZL6 "LYC1, PRO1485, TKAL754" ENSG00000275722 "Lysozyme like 6" O75951 17 35934518-35943699 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 33.2" "Cell line enriched" "Detected in single" 5 "NB-4: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA025734, HPA053073" Enhanced "Secreted in male reproductive system" "HPA025734: AB_1853444, HPA053073: " 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MACROD1 LRP16 ENSG00000133315 "MACRO domain containing 1" Q9BQ69 11 63998558-64166106 "Disease related genes, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 142.5" "Cell line enhanced" "Detected in many" "MCF7: 26.5;RPMI-8226: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041031, HPA071075" Uncertain Supported Nucleoplasm Nucleoplasm "HPA041031: AB_10794435, HPA071075: " "unprognostic (1.19e-2)" "unprognostic (2.15e-1)" "unprognostic (1.38e-1)" "unprognostic (3.14e-2)" "unprognostic (3.88e-2)" "unprognostic (6.03e-2)" "unprognostic (1.95e-2)" "unprognostic (2.82e-1)" "unprognostic (2.44e-2)" "unprognostic (1.34e-1)" "prognostic unfavourable (2.90e-4)" "unprognostic (1.15e-1)" "prognostic favourable (4.68e-6)" "unprognostic (2.45e-2)" "unprognostic (9.92e-2)" "unprognostic (2.36e-1)" "unprognostic (2.86e-2)" 4.9 3.0 2.9 2.8 3.3 2.5 3.9 6.2 4.6 3.6 6.9 2.8 7.0 4.3 3.4 6.5 7.8 3.2 3.9 29.0 2.2 3.4 10.6 10.4 3.0 1.8 3.0 3.1 5.2 16.6 2.5 2.7 2.1 3.1 6.1 1.9 4.6 16.4 8.1 142.5 5.5 3.9 6.2 2.4 2.7 5.6 1.9 2.7 0.8 12.7 25.0 3.3 4.6 4.5 0.6 0.7 0.0 1.2 0.0 2.0 0.4 3.9 2.1 0.6 3.7 0.6 0.4 3.6 2.3 1.1 1.9 1.7 2.0 10.8 15.1 8.3 0.2 10.2 0.5 0.0 0.1 1.1 7.1 5.4 8.6 10.7 2.2 4.5 0.6 0.9 1.2 0.2 0.5 0.6 4.9 3.0 0.3 26.5 6.2 15.6 1.8 8.0 5.6 4.3 50.0 0.6 0.2 5.2 10.8 2.1 15.6 14.2 11.2 0.1 1.0 1.7 2.5 2.5 0.2 6.1 0.9 2.4 1.1 4.6 1.5 0.0 0.2 0.0 2.0 1.2 1.9 0.6 1.8 1.1 0.4 0.4 0.9 0.8 0.0 0.0 0.0 0.7 0.0 0.4 2.9 3.3 6.2 4.6 2.2 3.4 3.0 3.1 3.1 2.7 MAEL "CT128, FLJ14904, SPATA35" ENSG00000143194 "Maelstrom spermatogenic transposon silencer" Q96JY0 1 166975582-167022214 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 90.7" "Cell line enriched" "Detected in some" 8 "NTERA-2: 8.6" "Cancer enhanced" "Detected in many" "testis cancer: 3.9" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 19 "dendritic cells: 1.9" "Region enriched" "Detected in single" 5 "thalamus: 1.2" "Low region specificity" "Detected in many" HPA078602 Approved "HPA078602: " "unprognostic (1.36e-1)" "unprognostic (7.01e-2)" "unprognostic (5.81e-2)" "unprognostic (3.15e-1)" "unprognostic (9.78e-2)" "unprognostic (3.08e-1)" "unprognostic (2.68e-3)" "unprognostic (4.99e-2)" "unprognostic (1.42e-1)" "unprognostic (9.00e-3)" "unprognostic (3.04e-1)" "unprognostic (8.88e-2)" "unprognostic (5.49e-2)" "unprognostic (1.26e-1)" "unprognostic (3.32e-1)" "unprognostic (8.67e-2)" "unprognostic (1.85e-1)" 0.1 0.0 0.8 0.1 0.2 0.0 0.1 0.6 1.3 0.1 0.3 0.1 0.1 0.0 0.1 0.7 0.2 0.0 0.2 2.1 0.7 0.5 0.6 0.3 0.1 0.1 0.4 0.1 0.1 0.6 0.0 0.2 3.5 0.2 0.2 0.0 0.2 0.1 0.4 0.2 0.0 0.1 0.1 0.1 0.1 0.0 90.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 8.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.3 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.8 0.2 0.6 1.3 0.7 0.5 0.4 0.1 0.2 0.1 MAFA "hMafA, RIPE3b1" ENSG00000182759 "MAF bZIP transcription factor A" Q8NHW3 8 143419182-143430406 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 25.6" "Cell line enhanced" "Detected in some" "HaCaT: 2.7;MCF7: 4.4;RH-30: 2.7;SCLC-21H: 6.4;T-47d: 6.1;U-2 OS: 4.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "amygdala: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "unprognostic (5.92e-3)" "unprognostic (9.89e-3)" "unprognostic (2.81e-3)" "unprognostic (1.42e-8)" "unprognostic (1.75e-2)" "unprognostic (8.67e-2)" "unprognostic (6.08e-2)" "unprognostic (5.67e-2)" "unprognostic (4.41e-1)" "unprognostic (3.71e-1)" "unprognostic (1.37e-1)" "unprognostic (1.21e-1)" "unprognostic (1.68e-5)" "unprognostic (2.11e-2)" "unprognostic (1.00e-1)" "unprognostic (3.36e-1)" "unprognostic (3.38e-2)" 0.2 0.1 2.5 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.2 0.0 0.0 0.1 0.1 0.3 0.6 0.1 0.1 2.1 0.4 0.2 0.3 0.1 0.7 0.1 0.1 0.2 0.1 2.2 0.2 0.5 1.8 0.9 0.3 0.1 0.7 0.4 0.1 25.6 0.1 0.1 0.1 0.7 0.1 0.1 3.4 0.0 0.4 2.5 5.5 0.4 0.1 0.1 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.7 0.9 0.0 0.0 0.1 1.8 0.9 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.4 0.1 0.0 4.4 0.1 0.6 0.6 0.4 0.6 2.7 0.4 0.0 0.0 6.4 0.2 1.5 0.0 0.0 6.1 0.1 0.0 0.1 4.2 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 2.5 0.2 0.0 0.6 0.4 0.2 0.1 0.2 0.9 0.0 MAG "GMA, S-MAG, SIGLEC-4A, SIGLEC4A" ENSG00000105695 "Myelin associated glycoprotein" P20916 19 35292125-35313804 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 113.6" "Cell line enriched" "Detected in some" 22 "WM-115: 28.1" "Cancer enriched" "Detected in some" 7 "glioma: 20.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 6.4" "Lineage enriched" "Detected in single" 15 "dendritic cells: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009345, HPA012499" Enhanced "CAB009345: AB_670104, HPA012499: AB_1854238" "unprognostic (2.70e-3)" "unprognostic (2.70e-2)" "unprognostic (8.06e-3)" "unprognostic (1.23e-1)" "unprognostic (6.93e-2)" "unprognostic (3.74e-1)" "unprognostic (1.50e-1)" "unprognostic (2.39e-1)" "unprognostic (1.06e-1)" "unprognostic (2.00e-1)" "unprognostic (5.62e-2)" "unprognostic (5.18e-4)" "unprognostic (6.29e-2)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.66e-1)" 1.5 2.3 19.5 1.4 29.9 1.4 1.5 3.6 90.8 1.5 1.4 97.0 0.0 1.4 1.6 1.4 1.5 5.1 1.4 1.4 36.7 19.1 1.5 1.6 1.7 1.5 48.9 18.0 21.8 1.4 1.4 0.1 1.7 38.0 1.5 1.4 0.0 1.4 1.7 1.4 1.4 1.5 1.4 113.6 1.6 1.4 1.7 38.1 0.0 1.8 0.0 1.5 1.4 0.1 0.4 6.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 28.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 6.4 0.0 0.1 19.5 29.9 3.6 38.5 36.7 19.1 48.9 18.0 38.0 38.1 MAGEA1 "CT1.1, MAGE1, MGC9326" ENSG00000198681 "MAGE family member A1" P43355 X 153179285-153183880 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 13.5" "Cell line enhanced" "Detected in some" "HEL: 17.4;HMC-1: 30.3;RPMI-8226: 15.0;U-2 OS: 29.0;U-266/70: 43.3;U-266/84: 69.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB002620 Enhanced Supported Cytosol Cytosol "CAB002620: " "unprognostic (8.65e-2)" "unprognostic (1.33e-1)" "unprognostic (6.40e-3)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (1.18e-1)" "unprognostic (2.35e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 3.2 0.0 0.0 0.0 30.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.1 0.0 0.0 29.0 0.1 0.1 43.3 69.0 0.0 2.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 MAGEA10 "CT1.10, MAGE10, MGC10599" ENSG00000124260 "MAGE family member A10" P43363 X 152133310-152138578 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 48.7" "Group enriched" "Detected in some" 7 "PC-3: 9.3;SH-SY5Y: 5.9;U-266/84: 6.3;WM-115: 14.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA003333, HPA070780" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA003333: AB_10962837, HPA070780: " "unprognostic (1.92e-1)" "unprognostic (1.06e-1)" "unprognostic (2.02e-1)" "unprognostic (6.95e-2)" "unprognostic (9.91e-2)" "unprognostic (5.97e-3)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 48.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 6.6 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.9 0.8 2.6 0.8 1.2 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.4 0.0 0.0 0.1 0.0 9.3 0.0 0.1 0.0 0.0 0.0 0.2 5.9 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.2 0.0 0.0 1.2 6.3 0.0 0.5 0.0 14.9 2.6 0.8 0.7 0.4 0.7 0.4 0.7 0.5 0.4 0.3 0.9 0.6 0.7 2.6 1.2 0.5 0.8 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 MAGEA2 "CT1.2, MAGE2, MAGEA2A" ENSG00000268606 "MAGE family member A2" P43356 X 152749863-152753884 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "testis: 9.2" "Cell line enhanced" "Detected in some" "HMC-1: 16.4;K-562: 22.0;SH-SY5Y: 17.7;SK-BR-3: 17.3;U-266/70: 43.3;U-266/84: 29.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.67e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 22.0 9.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 7.0 17.7 0.0 17.3 4.7 0.0 1.9 0.1 0.2 1.3 0.4 0.1 43.3 29.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA2B "MAGE2, MAGEA2, MAGEA2b, MGC16973" ENSG00000183305 "MAGE family member A2B" P43356 X 152714586-152718607 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 5.9" "Cell line enhanced" "Detected in some" "BEWO: 18.4;HMC-1: 19.3;K-562: 16.2;SH-SY5Y: 26.0;U-266/70: 13.6;U-266/84: 20.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.20e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 16.2 5.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 6.0 26.0 0.0 7.8 0.9 0.0 0.6 0.0 0.0 0.7 0.1 0.2 13.6 20.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA3 "CT1.3, HIP8, HYPD, MAGE3, MGC14613" ENSG00000221867 "MAGE family member A3" P43357 X 152698752-152702347 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "testis: 12.8" "Cell line enhanced" "Detected in some" "HMC-1: 23.4;K-562: 35.6;PC-3: 33.2;SH-SY5Y: 33.0;SK-BR-3: 37.6;U-266/70: 52.7;U-266/84: 58.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.29e-1)" "unprognostic (9.34e-2)" "prognostic unfavourable (3.58e-4)" "unprognostic (4.20e-2)" "unprognostic (2.48e-1)" "unprognostic (2.53e-3)" "unprognostic (3.95e-2)" "unprognostic (2.92e-1)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.2 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 35.6 3.6 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.0 0.6 0.0 0.0 7.1 33.0 0.0 37.6 1.8 0.3 2.2 0.2 2.3 4.4 2.1 3.1 52.7 58.6 0.0 0.2 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA6 "CT1.6, MAGE-3b, MAGE3B, MAGE6" ENSG00000197172 "MAGE family member A6" P43360 X 152766136-152769747 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 11.7" "Cell line enhanced" "Detected in some" "HMC-1: 39.1;K-562: 31.8;PC-3: 36.1;SK-BR-3: 34.2;U-2 OS: 25.1;U-266/70: 43.7;U-266/84: 27.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.09e-1)" "unprognostic (5.94e-2)" "unprognostic (3.77e-2)" "prognostic unfavourable (1.93e-4)" "unprognostic (3.50e-2)" "unprognostic (1.74e-1)" "unprognostic (5.33e-2)" "unprognostic (8.33e-2)" "unprognostic (6.00e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.1 0.2 0.0 0.0 39.1 0.0 0.0 0.0 0.0 0.0 31.8 18.5 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 2.0 0.0 0.0 1.9 14.3 0.0 34.2 4.7 0.5 2.4 0.1 16.0 25.1 0.9 4.7 43.7 27.2 0.0 0.3 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA8 "CT1.8, MAGE8, MGC2182" ENSG00000156009 "MAGE family member A8" P43361 X 149881141-149885835 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "placenta: 24.6" "Group enriched" "Detected in some" 24 "U-2 OS: 19.1;U-266/70: 35.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003998 Enhanced "HPA003998: AB_10965020" "unprognostic (6.81e-2)" "unprognostic (7.56e-2)" "unprognostic (1.02e-1)" "unprognostic (3.07e-3)" "unprognostic (1.62e-1)" "unprognostic (1.07e-2)" "unprognostic (2.27e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-1)" "unprognostic (1.50e-2)" "unprognostic (5.89e-2)" "unprognostic (2.49e-2)" "unprognostic (5.07e-3)" "unprognostic (1.69e-2)" "unprognostic (2.95e-1)" "unprognostic (2.80e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 24.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 35.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA9 "CT1.9, MAGE9, MGC8421" ENSG00000123584 "MAGE family member A9" P43362 X 149781930-149787737 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 9.3" "Group enriched" "Detected in some" 7 "U-266/70: 28.9;U-266/84: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA045401: , HPA051687: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.9 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA9B ENSG00000267978 "MAGE family member A9B" P43362 X 149581653-149587453 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 35 "testis: 14.2" "Group enriched" "Detected in some" 14 "RT4: 48.6;U-266/70: 21.1;U-266/84: 26.0" "Cancer enhanced" "Detected in some" "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA045401: , HPA051687: " "unprognostic (6.12e-3)" "unprognostic (3.26e-1)" 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 48.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 21.1 26.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB1 "CT3.1, DAM10, MAGE-Xp, MAGEL1, MGC9322" ENSG00000214107 "MAGE family member B1" P43366 X 30243730-30252038 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "testis: 23.9" "Group enriched" "Detected in some" 68 "K-562: 13.4;U-266/70: 30.6;U-266/84: 21.3" "Cancer enriched" "Detected in some" 9 "testis cancer: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001193, HPA002820" Enhanced "HPA001193: AB_1079296, HPA002820: AB_1079295" "unprognostic (1.26e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 30.6 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB16 ENSG00000189023 "MAGE family member B16" A2A368 X 35798342-35803735 "Predicted intracellular proteins" "Tumor antigen" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 44 "testis: 9.0" "Cell line enriched" "Detected in some" 5 "U-266/70: 36.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055743, HPA076456" Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA055743: , HPA076456: " "unprognostic (2.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB18 MGC33889 ENSG00000176774 "MAGE family member B18" Q96M61 X 26138343-26140735 "Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 4.2" "Cell line enriched" "Detected in single" 29 "Karpas-707: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046141 Enhanced "HPA046141: AB_2679554" "unprognostic (1.66e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 MAGEB2 "CT3.2, DAM6, MAGE-XP-2, MGC26438" ENSG00000099399 "MAGE family member B2" O15479 X 30215560-30220089 "Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 35.8" "Cell line enhanced" "Detected in some" "HL-60: 25.5;K-562: 18.3;Karpas-707: 22.3;U-2 OS: 26.5;U-266/70: 43.8;U-266/84: 45.7" "Cancer enriched" "Detected in many" 7 "testis cancer: 33.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.4" "Low lineage specificity" "Detected in single" "HPA065224, HPA074544, HPA075519" Enhanced Approved Cytosol Cytosol "HPA065224: , HPA074544: AB_2732258, HPA075519: AB_2732294" "unprognostic (4.52e-1)" "unprognostic (2.55e-2)" "unprognostic (6.39e-2)" "unprognostic (5.02e-1)" "unprognostic (6.57e-2)" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.0 0.0 18.3 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 26.5 0.0 0.0 43.8 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB5 "CT3.3, MAGE-B5" ENSG00000188408 "MAGE family member B5" Q9BZ81 X 26216169-26218270 "Cancer-related genes, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 10 "testis: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052627 Uncertain "HPA052627: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB6 "CT3.4, FLJ40242, MAGE-B6, MAGEB6A" ENSG00000176746 "MAGE family member B6" Q8N7X4 X 26192440-26195646 "Cancer-related genes, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 87 "testis: 8.6" "Cell line enriched" "Detected in single" 10 "K-562: 9.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041853, HPA076711" Enhanced "HPA041853: AB_10796785, HPA076711: " "unprognostic (2.05e-1)" "unprognostic (1.31e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB6B MAGEB6P1 ENSG00000232030 "MAGE family member B6B" X 26160601-26161824 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 34 "testis: 3.3" "Cell line enhanced" "Detected in some" "K-562: 2.3;U-2197: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEC1 "CT7, CT7.1, MAGE-C1, MGC39366" ENSG00000155495 "MAGE family member C1" O60732 X 141903894-141909388 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 23.5" "Cell line enhanced" "Detected in some" "K-562: 22.3;Karpas-707: 22.4;U-2 OS: 15.1;U-2197: 28.5;U-266/70: 20.4;U-266/84: 18.0" "Cancer enhanced" "Detected in many" "melanoma: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004622, CAB015452" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB015452: AB_784404, HPA004622: AB_1853495" "unprognostic (5.63e-2)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (4.52e-2)" "unprognostic (9.96e-2)" "unprognostic (3.47e-1)" "unprognostic (8.56e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 15.1 28.5 0.0 20.4 18.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEC2 "CT10, HCA587, MAGE-C2, MAGEE1" ENSG00000046774 "MAGE family member C2" Q9UBF1 X 142202345-142205290 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 319 "testis: 31.8" "Group enriched" "Detected in some" 8 "K-562: 34.9;U-266/84: 39.4" "Cancer enhanced" "Detected in many" "melanoma: 19.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062230 Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA062230: " "unprognostic (1.25e-1)" "unprognostic (5.68e-2)" "unprognostic (3.99e-1)" "unprognostic (2.82e-1)" "unprognostic (1.04e-1)" "unprognostic (4.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 1.5 0.0 0.0 0.1 2.4 0.4 4.8 0.0 0.0 39.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEH1 APR1 ENSG00000187601 "MAGE family member H1" Q9H213 X 55452105-55453566 "Predicted membrane proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "epididymis: 207.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011324 Uncertain Approved Nucleoli Nucleoli "HPA011324: AB_1853499" "unprognostic (2.50e-1)" "unprognostic (3.01e-1)" "unprognostic (4.07e-2)" "prognostic unfavourable (1.37e-4)" "unprognostic (3.95e-2)" "unprognostic (8.50e-2)" "unprognostic (1.13e-2)" "unprognostic (9.93e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "prognostic favourable (2.60e-4)" "unprognostic (6.37e-2)" "unprognostic (1.81e-2)" "unprognostic (1.29e-3)" "unprognostic (1.90e-1)" "unprognostic (3.95e-2)" "unprognostic (2.52e-1)" 8.3 13.2 21.5 7.6 21.6 3.0 8.1 19.9 29.7 13.5 7.5 14.4 13.8 5.2 13.3 207.1 5.2 19.2 8.3 10.2 22.8 32.1 11.4 8.7 10.2 9.0 19.8 20.6 16.1 11.9 9.0 22.5 9.2 17.9 20.8 5.9 11.4 8.9 19.6 5.7 5.6 6.3 11.8 17.2 8.1 9.3 18.2 15.3 10.8 12.4 5.2 7.5 8.5 10.0 9.4 14.0 9.5 8.5 8.3 26.0 9.4 0.0 2.5 14.8 0.0 23.9 14.5 0.2 16.0 14.8 4.4 11.9 0.0 3.3 0.0 22.0 16.0 2.2 5.6 6.0 7.0 18.4 0.9 4.9 0.0 2.0 7.9 0.2 6.4 12.0 0.5 2.5 1.8 6.7 2.7 19.8 4.8 9.5 13.1 4.2 4.2 3.0 8.3 1.8 10.4 8.0 0.0 0.1 11.2 0.0 4.3 6.6 2.1 3.7 7.8 6.1 7.1 3.7 0.8 11.8 14.8 2.0 11.4 6.9 7.7 5.0 4.4 9.5 11.3 6.8 10.1 9.4 18.7 12.9 6.7 8.8 26.0 16.1 0.6 8.3 8.5 14.0 24.7 9.4 21.5 21.6 19.9 28.4 22.8 32.1 19.8 20.6 17.9 15.3 MAJIN C11orf85 ENSG00000168070 "Membrane anchored junction protein" Q3KP22 11 64937517-64972085 "Predicted intracellular proteins" Meiosis DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 43.7" "Group enriched" "Detected in some" 9 "CAPAN-2: 12.2;SiHa: 5.1" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "cerebellum: 4.9" "Cell type enhanced" "Detected in some" "memory B-cell: 4.1;naive B-cell: 1.7" "Lineage enriched" "Detected in single" 5 "B-cells: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.37e-1)" "unprognostic (6.43e-3)" "unprognostic (3.69e-2)" "unprognostic (7.05e-2)" "unprognostic (9.64e-3)" "unprognostic (2.92e-2)" "unprognostic (4.46e-2)" "unprognostic (1.06e-1)" "unprognostic (9.11e-2)" "unprognostic (4.11e-2)" "unprognostic (1.61e-2)" "unprognostic (2.58e-1)" "unprognostic (1.48e-2)" "unprognostic (2.43e-1)" "unprognostic (2.79e-1)" "unprognostic (4.18e-3)" "unprognostic (1.76e-2)" 0.2 0.2 0.2 1.2 0.7 0.0 0.2 4.9 0.4 0.3 0.2 0.1 0.7 0.0 0.2 2.2 0.2 1.1 2.9 0.4 0.1 0.1 1.4 1.0 0.2 1.5 0.2 0.0 0.1 1.7 0.0 1.5 0.0 0.7 0.3 0.1 0.5 0.3 0.6 0.1 1.2 0.6 0.0 0.2 1.6 0.2 43.7 0.0 0.0 0.8 0.1 1.2 0.3 0.5 4.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.7 0.0 0.0 1.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 4.9 0.4 0.1 0.1 0.2 0.0 0.7 0.0 MAL ENSG00000172005 "Mal, T cell differentiation protein" P21145 2 95025677-95053996 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "esophagus: 447.4" "Cell line enhanced" "Detected in some" "HDLM-2: 44.8;MOLT-4: 62.7;RPTEC TERT1: 227.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 42.0;naive CD4 T-cell: 57.9;naive CD8 T-cell: 26.4;T-reg: 40.1" "Lineage enriched" "Detected in many" 44 "T-cells: 57.9" "Low region specificity" "Detected in all" HPA065691 Approved "Golgi apparatus,Centrosome" "Golgi apparatus" Centrosome "HPA065691: " "unprognostic (1.57e-3)" "unprognostic (2.64e-2)" "unprognostic (1.08e-2)" "prognostic unfavourable (5.18e-6)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (5.13e-2)" "unprognostic (2.35e-2)" "unprognostic (1.06e-1)" "unprognostic (3.59e-1)" "unprognostic (4.61e-2)" "unprognostic (3.89e-2)" "prognostic favourable (3.96e-9)" "unprognostic (1.91e-1)" "unprognostic (2.84e-2)" "unprognostic (5.35e-2)" "unprognostic (1.57e-1)" 2.3 2.0 14.3 3.5 21.8 3.7 2.0 1.8 20.6 35.8 3.7 43.2 0.4 2.0 1.8 3.4 447.4 3.4 2.2 3.3 18.2 8.3 53.1 1.7 4.3 5.9 27.4 13.2 2.0 1.9 1.6 0.2 2.2 11.8 2.5 2.9 2.8 42.5 3.9 2.0 3.7 2.4 2.1 27.6 3.2 9.3 1.7 27.2 35.0 5.8 56.1 90.1 2.6 64.8 0.6 0.2 0.4 0.1 1.3 57.9 13.7 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 44.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.7 0.0 0.0 0.0 0.0 0.0 22.2 227.3 5.7 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.4 0.6 42.0 7.5 0.0 0.5 57.9 26.4 0.4 1.3 0.0 0.2 40.1 13.7 14.3 21.8 1.8 20.6 18.2 8.3 27.4 13.2 11.8 27.2 MALRD1 "bA265G8.2, C10orf112, Diet1" ENSG00000204740 "MAM and LDL receptor class A domain containing 1" Q5VYJ5 10 19048771-19790401 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "intestine: 60.5" "Cell line enriched" "Detected in some" 10 "Karpas-707: 31.2" "Cancer enhanced" "Detected in some" "stomach cancer: 1.1" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035732, HPA038106, HPA046848" Uncertain Enhanced "Golgi apparatus" "Golgi apparatus" "HPA035732: , HPA038106: , HPA046848: " "unprognostic (9.03e-3)" "unprognostic (1.38e-1)" "unprognostic (2.40e-2)" "unprognostic (4.05e-3)" "unprognostic (2.49e-1)" "unprognostic (3.77e-1)" "unprognostic (2.74e-2)" "unprognostic (5.57e-2)" "unprognostic (5.01e-1)" "unprognostic (1.00e-1)" "unprognostic (3.55e-1)" "unprognostic (7.69e-2)" "unprognostic (3.16e-2)" "unprognostic (9.80e-2)" "unprognostic (8.90e-2)" "unprognostic (3.13e-2)" "unprognostic (3.78e-4)" 0.5 0.8 2.0 0.3 2.0 0.4 0.6 0.3 0.9 0.8 19.4 0.6 0.1 25.2 1.3 2.3 0.3 0.3 0.4 1.3 1.6 0.8 1.3 0.3 0.9 0.2 0.8 0.0 1.1 0.3 0.1 4.7 0.4 0.8 0.9 0.2 1.4 0.5 0.4 0.5 0.4 60.5 1.3 0.7 0.3 0.5 1.7 0.7 2.6 0.6 0.3 0.1 0.5 0.5 0.0 3.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 31.2 0.0 3.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.0 3.6 0.0 0.0 2.0 2.0 0.3 0.9 1.6 0.8 0.8 0.0 0.8 0.7 MAN1A2 MAN1B ENSG00000198162 "Mannosidase alpha class 1A member 2" O60476 1 117367449-117528872 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 122.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034559, HPA057364" Enhanced Enhanced "Golgi apparatus" 1100000 "Golgi apparatus" "HPA034559: AB_10671229, HPA057364: " "unprognostic (2.24e-1)" "unprognostic (1.20e-1)" "unprognostic (2.92e-3)" "unprognostic (2.15e-1)" "unprognostic (3.11e-2)" "unprognostic (9.70e-2)" "unprognostic (1.95e-2)" "unprognostic (8.01e-2)" "unprognostic (8.19e-3)" "prognostic favourable (4.08e-4)" "unprognostic (1.41e-1)" "unprognostic (4.38e-2)" "unprognostic (6.84e-2)" "unprognostic (1.45e-1)" "unprognostic (7.39e-2)" "unprognostic (1.17e-1)" "unprognostic (5.08e-2)" 11.1 9.7 13.9 9.1 15.8 3.8 9.7 11.9 15.2 14.4 10.7 8.5 9.4 8.1 15.8 10.7 11.5 12.2 9.2 11.0 11.2 9.2 11.8 16.4 8.1 9.9 12.0 13.9 11.2 27.4 21.7 9.6 122.4 11.3 11.2 9.5 8.3 11.1 10.5 10.5 7.5 9.0 13.7 10.4 10.4 10.3 10.1 14.4 16.1 19.4 6.9 9.8 13.6 9.8 3.7 4.4 4.0 2.7 6.0 9.8 2.4 14.1 6.2 10.6 9.1 14.0 16.9 34.1 11.8 18.5 5.3 5.0 4.7 8.2 10.6 21.9 15.1 8.5 4.9 10.0 12.1 13.3 7.4 6.3 8.7 5.2 8.5 9.9 14.5 11.3 10.8 8.1 7.1 15.8 10.1 16.4 11.1 27.6 6.0 3.1 5.4 6.5 5.4 23.1 7.2 7.3 19.4 5.8 8.5 11.7 12.6 9.3 6.2 6.3 15.0 12.1 9.9 8.5 12.0 11.2 7.6 7.2 15.9 7.9 28.5 1.3 2.7 4.0 5.2 2.1 6.2 3.3 4.3 4.3 2.3 3.7 3.6 5.2 2.1 6.0 1.7 4.4 9.8 2.4 13.9 15.8 11.9 15.2 11.2 9.2 12.0 13.9 11.3 14.4 MAP1A MAP1L ENSG00000166963 "Microtubule associated protein 1A" P78559 15 43510958-43531620 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 103.6" "Cell line enhanced" "Detected in many" "ASC diff: 21.4;BJ hTERT+: 21.1;fHDF/TERT166: 31.5;hTEC/SVTERT24-B: 20.0;U-87 MG: 42.4" "Cancer enhanced" "Detected in many" "glioma: 18.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 74 "plasmacytoid DC: 12.3" "Lineage enriched" "Detected in single" 74 "dendritic cells: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039063, HPA039064, HPA066488" Enhanced Approved Cytosol Cytosol "HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: " "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (3.29e-2)" "unprognostic (1.86e-3)" "unprognostic (4.45e-2)" "unprognostic (3.58e-2)" "unprognostic (5.66e-2)" "unprognostic (1.12e-1)" "unprognostic (2.65e-2)" "unprognostic (1.13e-3)" "unprognostic (8.36e-3)" "unprognostic (3.45e-3)" "prognostic unfavourable (6.59e-5)" "unprognostic (5.83e-2)" "unprognostic (2.53e-1)" "prognostic unfavourable (1.09e-5)" "prognostic unfavourable (1.66e-5)" 5.2 7.9 43.6 5.4 42.8 2.5 4.3 24.5 103.6 10.5 5.4 18.3 1.0 3.0 5.6 4.3 4.8 9.1 5.9 14.8 40.9 30.2 2.8 1.9 3.4 2.7 34.7 31.3 7.1 2.7 4.1 4.4 4.4 56.2 6.7 5.3 3.1 2.5 9.6 4.5 3.1 3.2 14.5 21.4 2.6 2.7 5.4 12.6 6.5 3.7 0.1 2.7 6.3 2.8 0.0 12.3 0.0 0.0 0.0 0.1 0.2 0.1 0.8 3.8 2.2 21.4 14.7 0.0 12.2 21.1 3.6 3.5 1.4 0.0 0.0 5.3 31.5 0.1 5.1 0.0 2.1 1.8 0.5 4.7 1.2 0.1 2.0 0.1 2.0 11.0 0.0 20.0 0.1 2.7 7.8 0.1 14.6 0.1 8.6 0.2 2.8 0.3 2.3 11.1 0.0 0.0 0.0 12.0 3.6 0.4 0.0 0.1 0.7 0.2 0.5 11.7 3.9 3.9 0.1 0.0 0.5 1.7 42.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.1 0.2 43.6 42.8 24.5 63.1 40.9 30.2 34.7 31.3 56.2 12.6 MAP1B "MAP5, PPP1R102" ENSG00000131711 "Microtubule associated protein 1B" P46821 5 72107234-72209570 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 102.5" "Cell line enhanced" "Detected in many" "TIME: 64.1" "Cancer enriched" "Detected in all" 5 "glioma: 48.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009792, HPA022275" Enhanced Supported Enhanced Cytosol 140000 Cytosol "CAB009792: AB_2137420, HPA022275: AB_1853944" "unprognostic (9.96e-2)" "unprognostic (3.97e-2)" "unprognostic (1.57e-2)" "unprognostic (3.70e-1)" "unprognostic (4.67e-3)" "unprognostic (2.98e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-1)" "unprognostic (1.42e-1)" "unprognostic (7.00e-2)" "unprognostic (4.78e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-2)" "unprognostic (1.13e-2)" "unprognostic (1.90e-1)" "unprognostic (1.75e-2)" "prognostic unfavourable (8.22e-5)" 20.3 18.1 27.5 10.2 39.6 1.6 9.3 52.3 101.9 15.3 6.1 21.6 3.5 3.2 9.2 9.8 12.8 7.7 10.7 17.1 37.6 40.7 4.4 3.3 3.7 3.2 42.4 42.5 7.8 4.5 3.0 7.0 9.5 102.5 19.0 6.2 9.4 7.6 24.0 3.6 10.2 3.9 22.9 45.7 2.4 7.2 11.0 11.3 0.0 5.7 0.1 2.6 13.4 5.9 0.2 0.4 0.6 0.0 0.0 0.3 2.1 0.3 12.1 30.5 11.0 19.0 33.3 0.0 6.5 5.0 6.6 7.9 0.1 0.4 0.0 15.7 24.1 0.1 16.6 0.6 10.0 0.0 2.4 1.3 4.3 3.9 10.1 0.0 1.0 33.4 2.1 26.6 9.9 20.6 1.9 0.0 11.2 0.1 0.0 0.0 8.2 3.9 0.1 3.6 0.0 0.5 0.0 19.7 13.6 6.4 0.0 3.3 0.0 1.2 64.1 21.0 9.9 15.3 29.4 1.4 0.0 0.0 22.7 0.0 16.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.1 0.2 0.6 0.0 0.0 0.4 0.2 2.1 27.5 39.6 52.3 59.1 37.6 40.7 42.4 42.5 102.5 11.3 MAP1LC3B2 ATG8G ENSG00000258102 "Microtubule associated protein 1 light chain 3 beta 2" A6NCE7 12 116548105-116576448 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "blood: 33.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 11.1" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA042824: , HPA052474: , HPA052484: , HPA053767: " "unprognostic (1.50e-1)" "unprognostic (6.94e-2)" "unprognostic (9.14e-2)" "unprognostic (3.89e-3)" "unprognostic (1.62e-1)" "unprognostic (1.22e-1)" "unprognostic (2.43e-3)" "unprognostic (3.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (1.11e-3)" "unprognostic (6.66e-3)" "unprognostic (1.65e-1)" "unprognostic (1.53e-2)" "unprognostic (3.42e-1)" 0.4 3.5 0.4 0.4 0.4 2.0 0.4 0.4 1.8 0.4 0.7 0.4 0.4 2.2 1.0 0.4 0.5 0.0 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.0 0.4 0.4 2.6 0.4 0.2 0.4 0.8 0.4 3.9 1.1 0.8 0.6 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.5 0.7 0.4 7.0 8.0 33.1 10.1 7.2 11.4 8.5 2.6 0.0 0.7 2.9 0.4 1.4 1.6 3.0 0.6 0.2 0.4 3.7 2.6 0.1 3.7 0.7 1.6 1.1 0.8 1.2 0.7 0.0 0.0 0.6 3.1 2.3 1.9 1.8 0.4 1.0 2.3 1.9 0.5 1.6 4.7 0.7 0.9 1.4 2.9 1.6 0.7 2.0 0.4 0.6 0.4 1.4 0.9 4.3 1.2 1.1 11.1 1.5 0.2 0.9 4.0 1.1 3.5 2.6 3.8 2.9 4.6 4.7 1.2 2.4 22.7 9.3 25.1 6.6 8.9 6.2 7.0 7.4 6.3 7.7 6.1 5.1 5.6 33.1 7.2 10.1 8.0 11.4 8.5 MAP2 "MAP2A, MAP2B, MAP2C" ENSG00000078018 "Microtubule associated protein 2" P11137 2 209424058-209734118 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 122.3" "Cell line enhanced" "Detected in some" "AF22: 74.6;NTERA-2: 26.7;SCLC-21H: 37.5;SH-SY5Y: 21.0" "Cancer enhanced" "Detected in many" "glioma: 30.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 2.6;naive B-cell: 3.4" "Lineage enriched" "Detected in single" 15 "B-cells: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001984, HPA008273, HPA012828" Enhanced Supported "CAB001984: , HPA008273: AB_1853945, HPA012828: AB_1853946" "unprognostic (2.47e-2)" "unprognostic (2.81e-1)" "unprognostic (2.58e-2)" "prognostic unfavourable (1.98e-6)" "unprognostic (2.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.13e-2)" "unprognostic (6.06e-2)" "unprognostic (1.31e-1)" "unprognostic (9.84e-2)" "unprognostic (1.09e-2)" "unprognostic (1.60e-1)" "unprognostic (1.23e-1)" "unprognostic (2.69e-3)" "unprognostic (2.54e-1)" "unprognostic (7.28e-2)" "unprognostic (4.10e-5)" 4.6 9.2 62.1 2.1 63.1 1.5 4.9 24.7 122.3 4.4 2.5 3.8 0.0 2.0 2.9 4.0 5.6 2.8 6.3 6.2 73.6 53.8 3.9 3.7 9.3 2.4 31.0 48.8 6.4 8.2 12.5 14.7 1.9 35.4 6.5 2.5 7.6 4.9 4.7 2.2 12.1 2.0 3.2 19.9 2.4 2.6 5.4 11.4 0.0 12.2 0.4 2.9 2.8 1.5 3.4 0.1 0.0 0.0 0.0 0.2 0.3 0.6 0.1 74.6 0.0 1.0 0.5 0.0 0.4 0.5 0.1 0.5 0.0 4.0 0.0 0.4 0.9 1.0 5.7 0.4 0.2 0.0 0.3 0.2 2.3 0.0 9.4 0.0 0.0 0.8 2.4 0.0 1.4 1.9 0.0 0.7 0.0 0.2 0.0 0.0 26.7 0.1 0.0 0.1 0.0 0.9 0.0 37.5 21.0 1.5 0.2 0.9 2.0 0.0 0.0 0.0 0.4 0.0 1.0 0.5 0.0 0.0 3.9 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 62.1 63.1 24.7 79.6 73.6 53.8 31.0 48.8 35.4 11.4 MAPK12 "ERK6, p38gamma, PRKM12, SAPK-3, SAPK3" ENSG00000188130 "Mitogen-activated protein kinase 12" P53778 22 50245450-50261825 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "skeletal muscle: 104.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 31 "NK-cell: 3.0" "Lineage enriched" "Detected in single" 31 "NK-cells: 3.0" "Region enhanced" "Detected in many" "cerebellum: 35.4" "Low region specificity" "Detected in all" "CAB025483, HPA054562" Enhanced Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "CAB025483: , HPA054562: " "unprognostic (3.68e-2)" "unprognostic (1.72e-1)" "unprognostic (4.53e-3)" "unprognostic (1.54e-1)" "unprognostic (3.22e-2)" "unprognostic (6.35e-3)" "unprognostic (3.90e-3)" "unprognostic (3.16e-2)" "unprognostic (6.02e-2)" "unprognostic (5.70e-2)" "unprognostic (3.48e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (5.00e-6)" "unprognostic (2.57e-1)" "unprognostic (8.88e-2)" "unprognostic (1.11e-2)" "unprognostic (4.28e-3)" 3.0 1.6 4.5 2.1 4.5 1.0 1.8 9.0 7.0 2.1 1.4 2.1 1.6 2.0 5.4 5.1 3.3 2.9 2.4 5.1 3.9 3.6 2.5 1.0 2.1 2.0 3.5 5.7 3.0 1.4 1.2 7.0 2.3 2.6 2.9 1.1 2.2 1.4 3.7 104.2 0.9 1.5 4.2 2.6 1.6 1.5 1.6 2.4 0.0 1.3 10.8 1.1 2.4 1.9 0.0 0.0 0.0 0.0 3.0 0.0 0.0 10.3 6.4 2.4 7.4 5.6 6.2 3.5 7.9 6.9 13.3 8.5 9.2 3.2 19.4 10.8 8.7 6.9 11.0 1.6 2.5 5.6 15.4 12.7 19.3 11.4 17.9 11.9 25.2 13.4 2.9 3.0 0.0 15.0 11.2 18.1 6.1 5.7 0.0 15.9 7.5 10.4 18.1 6.7 19.7 7.9 1.4 8.5 2.9 6.1 0.2 9.8 3.3 13.8 7.8 13.7 12.4 2.9 4.9 4.2 3.2 10.4 3.5 11.2 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 4.5 4.5 9.0 7.0 3.9 3.6 3.5 5.7 2.6 2.4 MAPK8IP2 "IB2, JIP2, PRKM8IPL" ENSG00000008735 "Mitogen-activated protein kinase 8 interacting protein 2" Q13387 22 50600685-50613981 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 48.9" "Cell line enhanced" "Detected in many" "HEK 293: 8.7;SCLC-21H: 17.5;SH-SY5Y: 15.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034780 Uncertain "HPA034780: AB_10670283" "unprognostic (7.82e-2)" "unprognostic (7.62e-2)" "unprognostic (3.48e-2)" "unprognostic (1.31e-2)" "unprognostic (5.80e-2)" "unprognostic (6.72e-2)" "unprognostic (1.18e-1)" "unprognostic (2.90e-1)" "unprognostic (5.23e-2)" "unprognostic (9.19e-2)" "unprognostic (8.57e-3)" "unprognostic (8.78e-3)" "unprognostic (6.33e-3)" "unprognostic (6.77e-2)" "unprognostic (1.72e-1)" "unprognostic (5.29e-2)" "unprognostic (4.75e-2)" 1.9 8.4 12.2 0.9 14.5 0.6 1.9 13.4 48.9 3.0 2.0 2.1 0.0 1.3 1.6 0.8 2.3 1.7 0.7 2.0 12.0 1.3 2.0 1.8 1.8 0.7 1.4 19.0 4.7 3.1 2.4 4.1 1.2 20.1 1.9 0.9 0.9 4.3 1.1 1.7 1.6 2.0 1.0 3.1 2.1 2.4 3.5 3.8 0.0 2.2 0.0 0.7 3.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 4.4 4.0 0.5 0.0 4.6 0.0 0.1 1.4 0.7 2.6 0.8 0.6 1.2 0.1 0.0 5.6 0.0 0.0 0.2 8.7 0.0 0.2 1.6 0.5 0.0 0.9 0.2 5.6 0.0 0.2 0.0 1.3 2.1 0.0 0.2 0.0 0.0 2.9 2.4 0.8 0.5 0.0 0.0 0.0 17.5 15.8 4.7 5.1 0.2 1.1 0.0 0.0 0.1 0.2 0.4 0.0 1.1 2.8 0.3 0.3 0.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 14.5 13.4 29.7 12.0 1.3 1.4 19.0 20.1 3.8 MARCH10 "FLJ35757, MARCH-X, RNF190" ENSG00000173838 "Membrane associated ring-CH-type finger 10" Q8NA82 17 62701314-62808344 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 80.2" "Cell line enhanced" "Detected in some" "BEWO: 3.8;EFO-21: 7.2;HSkMC: 3.2;SCLC-21H: 12.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 3.4" "Lineage enriched" "Detected in single" 5 "T-cells: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA023322 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA023322: AB_1856351" "unprognostic (2.79e-2)" "unprognostic (2.32e-1)" "unprognostic (9.60e-3)" "unprognostic (6.95e-2)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-2)" "unprognostic (1.67e-1)" "unprognostic (1.39e-1)" "unprognostic (7.99e-4)" "unprognostic (3.16e-1)" "unprognostic (2.85e-3)" "unprognostic (1.38e-1)" "unprognostic (4.83e-2)" "unprognostic (9.37e-3)" "unprognostic (2.66e-1)" 0.2 0.1 0.7 0.2 1.6 0.0 0.1 0.1 0.3 0.5 0.1 1.9 0.6 0.0 0.3 4.8 0.1 7.9 0.1 0.1 1.0 1.0 0.6 0.1 1.4 0.1 0.2 0.5 1.0 0.1 0.3 4.5 0.1 1.8 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 80.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.0 0.6 3.4 0.3 0.1 0.0 0.2 0.0 0.0 0.2 3.8 1.6 0.2 1.2 0.3 0.0 0.1 0.0 7.2 0.5 0.0 0.0 0.4 1.3 0.0 0.0 1.2 0.7 0.0 1.5 0.0 0.0 3.2 0.0 0.3 0.0 0.0 0.0 0.0 0.8 1.4 0.1 0.1 0.3 0.2 0.0 0.0 0.2 1.1 0.0 12.4 0.0 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.7 0.1 1.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 3.4 0.0 1.5 0.0 0.7 0.3 0.7 0.1 0.6 1.8 0.0 0.6 0.0 0.0 0.7 0.3 0.7 1.6 0.1 0.3 1.0 1.0 0.2 0.5 1.8 0.3 MARCH11 "MARCH-XI, RNF226" ENSG00000183654 "Membrane associated ring-CH-type finger 11" A6NNE9 5 16067139-16180762 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 42.1" "Cell line enriched" "Detected in some" 14 "SH-SY5Y: 43.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (9.91e-3)" "unprognostic (1.08e-1)" "unprognostic (2.98e-1)" "unprognostic (1.50e-1)" "unprognostic (1.54e-1)" "unprognostic (1.52e-1)" "unprognostic (3.55e-2)" 0.4 1.1 1.8 0.3 3.4 0.3 0.4 3.7 3.7 0.3 0.4 0.0 0.0 0.3 0.4 0.3 0.3 0.3 0.3 2.2 2.0 3.2 0.5 0.5 0.4 0.3 1.5 2.0 0.5 1.0 0.3 6.8 0.4 2.1 0.6 0.4 0.6 1.4 0.3 0.3 0.3 0.4 0.3 0.5 0.3 0.4 42.1 0.0 0.0 0.3 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.4 3.7 3.7 2.0 3.2 1.5 2.0 2.1 0.0 MASP2 MASP1P1 ENSG00000009724 "Mannan binding lectin serine peptidase 2" O00187 1 11026523-11047233 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 98 "liver: 185.1" "Cell line enriched" "Detected in many" 7 "Hep G2: 20.1" "Cancer enriched" "Detected in some" 71 "liver cancer: 41.9" "Region enriched" "Detected in single" 4 "cerebellum: 1.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA029313, HPA029314" Uncertain Supported "Golgi apparatus" "Secreted to blood" 339700000 880000000 "Golgi apparatus" "HPA029313: AB_10669654, HPA029314: AB_10670029" "unprognostic (7.00e-2)" "unprognostic (8.37e-2)" "unprognostic (2.75e-2)" "unprognostic (2.89e-1)" "unprognostic (1.86e-1)" "unprognostic (3.26e-3)" "prognostic favourable (1.60e-4)" "unprognostic (2.92e-3)" "unprognostic (3.13e-2)" "unprognostic (4.04e-2)" "unprognostic (6.90e-3)" "unprognostic (8.30e-4)" "unprognostic (7.14e-2)" "unprognostic (3.91e-1)" "unprognostic (2.62e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-4)" 0.3 0.2 0.3 0.4 0.3 1.8 0.3 1.7 0.5 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.3 0.3 0.3 0.1 0.3 185.1 0.3 0.6 0.3 0.3 0.5 0.4 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.7 0.3 1.4 1.4 0.5 0.3 0.3 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.4 1.2 1.2 0.2 0.8 1.3 0.0 0.5 0.3 2.9 1.6 0.0 0.1 0.4 0.8 0.0 0.0 0.0 1.3 1.1 2.3 0.6 0.0 0.7 0.0 0.0 0.0 0.6 2.3 1.4 2.5 20.1 0.0 2.1 1.6 0.0 0.0 0.1 0.0 0.0 0.8 0.5 0.0 0.6 0.6 1.1 0.4 0.6 1.8 1.0 0.5 0.0 1.4 1.8 0.7 0.9 0.5 0.5 0.6 1.3 1.1 0.9 0.6 1.0 0.6 0.7 1.1 1.7 0.6 1.9 0.4 1.2 0.2 1.1 0.7 0.1 1.0 0.7 0.9 0.8 0.5 1.4 1.3 1.3 0.2 0.8 0.2 1.2 0.1 0.0 0.3 0.3 1.7 0.3 0.3 0.1 0.3 0.3 0.3 0.3 MAST1 "KIAA0973, SAST" ENSG00000105613 "Microtubule associated serine/threonine kinase 1" Q9Y2H9 19 12833951-12874951 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 51.0" "Cell line enhanced" "Detected in many" "AN3-CA: 14.8;SCLC-21H: 26.2;SH-SY5Y: 13.0;U-266/70: 10.7" "Cancer enhanced" "Detected in many" "glioma: 3.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 3.6;T-reg: 2.0" "Lineage enriched" "Detected in single" 8 "T-cells: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028181, HPA073106" Enhanced Approved Vesicles Vesicles "HPA028181: AB_10603872, HPA073106: " "unprognostic (6.32e-2)" "unprognostic (3.66e-2)" "unprognostic (3.93e-2)" "unprognostic (2.83e-5)" "unprognostic (1.72e-1)" "unprognostic (4.19e-2)" "unprognostic (2.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.04e-1)" "unprognostic (3.64e-1)" "unprognostic (8.89e-3)" "unprognostic (3.43e-2)" "unprognostic (3.84e-3)" "unprognostic (1.19e-1)" "unprognostic (7.04e-2)" "unprognostic (2.49e-2)" "unprognostic (1.96e-1)" 1.2 5.2 20.4 1.7 13.6 1.6 1.5 51.0 40.1 1.1 1.5 1.4 0.0 1.7 1.3 1.2 1.3 1.2 1.6 1.3 16.1 16.3 1.2 1.3 1.2 1.3 8.8 19.5 1.5 1.6 1.2 10.4 1.2 19.9 1.2 1.3 1.6 1.3 1.2 1.2 4.1 1.6 1.3 4.2 1.2 1.5 3.9 2.7 0.0 1.2 0.0 1.3 1.2 0.2 0.4 0.0 0.0 0.2 0.0 3.6 0.1 2.2 1.0 0.9 14.8 0.0 0.0 1.2 0.1 0.1 0.2 0.6 0.5 0.9 3.6 1.6 0.0 0.0 4.3 0.0 0.0 2.5 2.9 0.3 3.6 1.6 0.0 0.7 0.7 0.3 0.0 0.5 0.5 0.0 3.1 1.9 0.0 0.5 1.5 0.4 4.4 4.5 9.8 2.9 5.1 0.2 0.1 26.2 13.0 0.5 0.9 2.6 2.4 1.3 0.0 1.8 2.8 2.0 0.4 10.7 8.5 2.1 3.3 2.0 0.1 0.0 0.2 0.0 0.0 0.2 3.6 0.1 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 2.0 0.1 20.4 13.6 51.0 34.3 16.1 16.3 8.8 19.5 19.9 2.7 MAT1A "MAT, MATA1, SAMS, SAMS1" ENSG00000151224 "Methionine adenosyltransferase 1A" Q00266 10 80271820-80289684 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "liver: 178.8" "Cell line enriched" "Detected in some" 15 "Hep G2: 44.8" "Cancer enriched" "Detected in many" 54 "liver cancer: 209.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA048627 Supported 530000 "HPA048627: " "unprognostic (6.92e-2)" "unprognostic (2.63e-1)" "unprognostic (2.88e-2)" "unprognostic (9.43e-2)" "unprognostic (3.79e-2)" "unprognostic (2.49e-2)" "unprognostic (2.03e-3)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.58e-2)" "unprognostic (1.76e-1)" "unprognostic (8.66e-2)" "unprognostic (1.11e-16)" "unprognostic (8.59e-3)" "unprognostic (9.90e-2)" "unprognostic (3.58e-1)" "unprognostic (5.98e-2)" 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 12.5 0.1 0.2 0.2 0.1 0.0 0.0 0.3 178.8 0.1 0.1 0.1 0.0 0.7 9.9 0.0 0.6 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.0 0.7 0.0 0.0 0.4 0.2 0.0 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.0 44.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 MBD3L1 MBD3L ENSG00000170948 "Methyl-CpG binding domain protein 3 like 1" Q8WWY6 19 8832398-8843340 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 20.8" "Cell line enhanced" "Detected in some" "NB-4: 1.3;U-266/84: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043121, HPA046753" Supported "HPA043121: , HPA046753: AB_2679786" "unprognostic (1.10e-3)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.4 1.3 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L2B ENSG00000196589 "Methyl-CpG binding domain protein 3 like 2B" A0A1B0GVZ6 19 7018969-7021450 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 18 "testis: 2.0" "Cell line enriched" "Detected in single" 4 "U-2 OS: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051259 Uncertain "HPA051259: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L3 ENSG00000182315 "Methyl-CpG binding domain protein 3 like 3" A6NE82 19 7056209-7058640 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "testis: 3.7" "Cell line enhanced" "Detected in single" "HUVEC TERT2: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051259 Uncertain "HPA051259: " 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L4 ENSG00000205718 "Methyl-CpG binding domain protein 3 like 4" A6NDZ8 19 7037748-7040179 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 1.4" "Cell line enhanced" "Detected in single" "U-2 OS: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051259 Uncertain "HPA051259: " 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBL2 "COLEC1, MBL" ENSG00000165471 "Mannose binding lectin 2" P11226 10 52765380-52771700 "Plasma proteins, Predicted secreted proteins" "Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 825 "liver: 82.5" "Cell line enriched" "Detected in single" 10 "Hep G2: 6.9" "Cancer enriched" "Detected in single" 275 "liver cancer: 22.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "pons and medulla: 0.5" "Region enriched" "Detected in single" 35 "basal ganglia: 1.1" "HPA002027, CAB016782" Enhanced "Secreted to blood" 1219000000 1700000000 "CAB016782: , HPA002027: AB_1079324" "unprognostic (1.72e-2)" "unprognostic (3.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBP ENSG00000197971 "Myelin basic protein" P02686 18 76978827-77133683 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autoimmune encephalomyelitis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 43 "brain: 1297.7" "Cell line enhanced" "Detected in many" "HL-60: 28.4;SK-MEL-30: 59.1" "Group enriched" "Detected in all" 9 "glioma: 47.5;melanoma: 20.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002300, HPA049222, HPA064368" Enhanced Supported Approved "Plasma membrane" "Plasma membrane" "CAB002300: AB_563893, HPA049222: , HPA064368: " "unprognostic (9.36e-2)" "unprognostic (7.60e-2)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" "unprognostic (6.93e-2)" "unprognostic (2.81e-1)" "unprognostic (1.14e-1)" "unprognostic (3.31e-1)" "unprognostic (9.87e-2)" "unprognostic (2.90e-2)" "unprognostic (5.25e-2)" "unprognostic (1.95e-1)" "prognostic favourable (4.48e-12)" "unprognostic (2.90e-1)" "unprognostic (5.99e-2)" "unprognostic (1.33e-1)" "unprognostic (6.03e-2)" 4.0 3.4 271.6 6.1 244.9 10.1 4.5 28.7 418.9 5.6 5.5 487.7 0.0 5.9 4.4 3.6 6.4 9.0 5.7 6.8 355.0 247.6 6.2 5.9 6.2 7.1 645.5 43.4 3.7 6.8 16.4 0.7 2.7 242.9 4.5 5.6 0.4 5.0 4.9 29.9 7.9 6.2 3.8 1297.7 7.6 5.1 2.9 224.3 0.0 6.8 0.0 7.7 6.0 0.6 3.4 6.8 23.7 4.7 15.4 17.1 5.6 7.4 6.5 0.0 0.2 11.0 16.4 2.6 0.1 0.2 0.2 0.1 0.9 11.5 4.6 1.3 0.5 14.7 1.1 6.5 0.2 17.8 1.6 2.9 1.1 1.5 6.9 28.4 19.8 2.3 5.5 5.9 9.1 1.9 0.0 1.0 0.0 0.9 1.1 14.6 0.6 5.2 0.4 0.1 10.2 10.4 10.1 0.5 0.1 0.9 0.0 59.1 0.2 17.4 0.0 0.0 0.1 0.0 0.8 0.0 0.1 4.9 1.7 18.0 0.7 11.0 4.7 17.8 13.2 4.6 8.0 3.4 9.4 17.1 5.3 3.3 5.7 10.5 23.7 15.4 4.4 6.8 7.9 5.6 271.6 244.9 28.7 127.7 355.0 247.6 645.5 43.4 242.9 224.3 MC3R MC3 ENSG00000124089 "Melanocortin 3 receptor" P41968 20 56248732-56249815 "G-protein coupled receptors, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 6.4" "Cell line enriched" "Detected in single" 24 "hTERT-HME1: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "basal ganglia: 4.8;hypothalamus: 3.3;thalamus: 2.6" HPA074739 Uncertain "HPA074739: " 0.0 0.4 0.1 0.0 0.3 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCCD1 ENSG00000204511 "Mitochondrial coiled-coil domain 1" P59942 6 31528717-31530232 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 188 "kidney: 63.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "liver cancer: 2.4;renal cancer: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (2.71e-1)" "unprognostic (3.22e-2)" "prognostic favourable (1.73e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCMDC2 "C8orf45, FLJ25692" ENSG00000178460 "Minichromosome maintenance domain containing 2" Q4G0Z9 8 66870749-66922048 "Predicted intracellular proteins" "DNA damage, DNA repair, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 32.8" "Cell line enhanced" "Detected in many" "SK-MEL-30: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA026522 Approved "Actin filaments" "Actin filaments" "HPA026522: AB_10603453" "unprognostic (6.97e-2)" "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.85e-2)" "unprognostic (6.16e-3)" "unprognostic (5.54e-2)" "unprognostic (2.38e-2)" "unprognostic (3.03e-1)" "unprognostic (1.42e-1)" "unprognostic (9.46e-2)" "unprognostic (9.89e-2)" "unprognostic (4.04e-1)" "unprognostic (6.79e-3)" "unprognostic (7.87e-2)" "unprognostic (3.06e-2)" "unprognostic (8.49e-2)" "unprognostic (2.31e-5)" 1.2 2.0 1.1 1.2 2.2 3.9 1.2 0.9 2.1 1.1 1.0 3.7 0.7 1.4 1.2 1.9 1.7 1.0 1.0 3.0 1.3 1.2 1.6 1.1 2.0 2.7 1.2 0.3 3.6 1.8 1.6 7.0 0.7 3.0 1.0 0.5 2.0 1.3 0.7 6.1 2.3 1.3 0.3 2.1 1.1 1.1 32.8 1.6 0.4 1.4 1.3 0.3 1.4 1.2 3.1 3.4 1.9 1.4 3.6 4.7 1.6 2.8 6.2 3.1 3.7 0.4 1.5 1.7 2.7 0.4 0.2 0.2 5.1 3.9 4.4 1.1 0.2 2.5 0.0 0.1 0.9 2.2 7.6 5.5 9.0 6.2 0.7 2.5 3.0 1.0 0.9 0.1 0.0 0.2 3.4 4.2 1.3 5.7 6.1 7.7 3.9 5.7 2.1 1.2 1.9 0.6 4.4 2.2 3.9 0.9 1.1 12.4 3.9 6.5 1.3 2.1 3.0 3.5 3.3 3.5 1.9 4.1 2.4 5.2 2.2 1.9 1.4 0.6 2.6 1.0 3.3 2.9 4.2 3.3 3.0 3.1 4.7 3.8 0.6 3.6 0.9 3.4 3.0 1.6 1.1 2.2 0.9 1.8 1.3 1.2 1.2 0.3 3.0 1.6 MDGA1 "GPIM, MAMDC3" ENSG00000112139 "MAM domain containing glycosylphosphatidylinositol anchor 1" Q8NFP4 6 37630679-37699306 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 94.7" "Cell line enhanced" "Detected in many" "ASC diff: 13.8;HaCaT: 8.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 17 "cerebellum: 94.7" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 3.1" "Group enriched" "Detected in many" 22 "B-cells: 1.1;T-cells: 3.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031235, HPA050382" Approved Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" 490000 "Plasma membrane" "Golgi apparatus" "HPA031235: AB_10603017, HPA050382: " "unprognostic (4.67e-2)" "unprognostic (6.97e-3)" "unprognostic (3.24e-1)" "unprognostic (5.69e-4)" "unprognostic (2.75e-2)" "unprognostic (2.41e-1)" "unprognostic (1.45e-2)" "unprognostic (2.00e-1)" "unprognostic (2.02e-2)" "unprognostic (1.45e-1)" "unprognostic (2.16e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-5)" "unprognostic (9.19e-3)" "unprognostic (5.28e-3)" "unprognostic (3.80e-3)" "unprognostic (4.60e-2)" 1.5 3.7 3.4 3.1 2.4 0.0 1.0 94.7 5.1 3.0 1.3 1.5 1.0 0.0 3.0 1.5 1.8 2.1 3.4 1.2 5.0 2.0 0.8 0.5 3.5 3.4 1.7 2.4 8.4 2.6 6.6 2.6 0.5 5.4 1.5 1.1 3.4 0.7 1.2 0.9 6.7 1.5 2.6 4.1 3.9 1.2 1.4 1.3 0.6 1.1 1.7 2.7 1.1 3.1 1.1 0.0 0.0 0.0 0.0 3.1 0.4 0.1 3.8 6.9 2.6 13.8 5.6 3.0 2.7 2.7 3.5 3.9 0.7 0.0 0.9 0.6 1.7 8.9 0.5 0.0 1.1 6.9 4.0 0.0 0.5 0.0 0.6 0.0 0.9 1.0 0.1 1.4 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.5 0.0 0.4 7.4 2.4 0.0 0.8 4.2 6.3 0.0 1.5 0.4 3.3 3.2 0.6 0.5 3.7 1.2 1.3 5.0 0.0 0.1 0.0 5.9 1.1 2.4 0.0 0.0 0.0 1.4 0.0 0.4 1.1 1.2 0.8 0.0 1.0 3.1 0.8 0.0 0.0 0.0 0.0 1.8 0.4 3.4 2.4 94.7 2.7 5.0 2.0 1.7 2.4 5.4 1.3 MEF2B RSRFR2 ENSG00000213999 "Myocyte enhancer factor 2B" Q02080 19 19145568-19170289 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "lymphoid tissue: 81.2" "Group enriched" "Detected in some" 12 "Daudi: 49.8;U-266/70: 50.0;U-698: 65.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004734 Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (7.31e-3)" "unprognostic (4.06e-2)" "unprognostic (9.44e-5)" "unprognostic (5.07e-2)" "unprognostic (2.01e-1)" "unprognostic (7.19e-3)" "unprognostic (1.64e-1)" "unprognostic (1.78e-1)" "unprognostic (2.76e-1)" "unprognostic (1.98e-2)" "unprognostic (8.66e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-11)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (3.68e-1)" "unprognostic (8.98e-3)" 2.0 1.0 0.8 81.2 1.2 1.4 1.9 0.6 1.4 2.7 3.0 0.9 0.6 1.5 2.2 1.1 1.5 2.3 2.2 1.9 1.0 0.6 1.8 2.9 2.0 32.3 1.1 0.9 3.7 0.8 0.8 2.1 0.8 1.0 3.7 1.0 1.8 3.5 1.1 1.4 2.3 3.1 1.1 1.2 6.7 1.7 1.7 0.8 1.6 3.0 3.5 58.7 1.9 2.9 0.1 0.2 1.1 0.9 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 49.8 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.5 0.0 0.2 0.3 0.3 0.0 0.9 0.4 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.5 0.1 0.0 0.4 0.5 0.1 50.0 4.6 65.8 0.1 0.3 0.0 0.0 0.9 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.6 1.4 1.0 0.6 1.1 0.9 1.0 0.8 MEIKIN ENSG00000239642 "Meiotic kinetochore factor" A0A087WXM9 5 131806993-131945698 "Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 16.3" "Cell line enriched" "Detected in single" 6 "U-2 OS: 5.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.7;non-classical monocyte: 3.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (3.21e-1)" "unprognostic (2.30e-1)" "unprognostic (2.64e-2)" "unprognostic (5.27e-2)" "unprognostic (4.31e-1)" "unprognostic (4.64e-6)" "unprognostic (2.38e-1)" "unprognostic (3.81e-1)" 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.3 0.0 0.0 0.2 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 1.5 0.0 3.2 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 2.7 0.4 0.5 0.1 0.1 1.5 0.5 1.0 0.0 0.0 0.0 3.2 0.0 0.0 0.2 MEIOB "C16orf73, MGC35212" ENSG00000162039 "Meiosis specific with OB domains" Q8N635 16 1833987-1884294 "Disease related genes, Predicted intracellular proteins" Meiosis "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 44 "testis: 41.2" "Group enriched" "Detected in some" 7 "HMC-1: 12.2;K-562: 39.4;THP-1: 33.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (7.18e-2)" "unprognostic (1.91e-1)" "unprognostic (3.04e-2)" "unprognostic (9.73e-2)" "unprognostic (1.67e-1)" "unprognostic (7.68e-3)" "unprognostic (2.00e-2)" "unprognostic (2.68e-2)" "unprognostic (7.30e-3)" "unprognostic (1.34e-1)" "unprognostic (3.80e-1)" "unprognostic (2.18e-3)" 0.1 0.1 0.8 0.0 0.9 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.6 0.3 0.9 0.3 0.0 0.0 0.1 0.8 0.3 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.1 0.0 0.3 0.0 0.1 41.2 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 39.4 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 4.1 0.4 0.0 0.4 33.7 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.1 0.3 0.2 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.9 0.0 0.7 0.6 0.3 0.1 0.8 0.2 0.1 MEIOC "C17orf104, FLJ35848" ENSG00000180336 "Meiosis specific with coiled-coil domain" A2RUB1 17 44656404-44690308 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 59.6" "Cell line enhanced" "Detected in some" "HAP1: 13.4;HMC-1: 20.6;NTERA-2: 7.1;SiHa: 7.5;THP-1: 10.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA027266 Enhanced Uncertain "Cell Junctions" "Cell Junctions" "HPA027266: AB_1848900" "unprognostic (5.82e-2)" "unprognostic (6.86e-2)" "unprognostic (2.50e-2)" "unprognostic (1.96e-2)" "unprognostic (9.12e-2)" "unprognostic (2.31e-1)" "unprognostic (2.13e-1)" "unprognostic (3.63e-2)" "unprognostic (8.89e-2)" "unprognostic (7.58e-2)" "unprognostic (6.83e-4)" "unprognostic (1.85e-1)" "unprognostic (6.24e-3)" "unprognostic (1.72e-1)" "unprognostic (1.75e-1)" "unprognostic (9.91e-3)" "unprognostic (8.89e-3)" 0.2 0.2 0.4 0.2 0.8 0.6 0.2 2.5 0.9 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.0 0.2 0.3 0.7 0.6 1.4 0.3 0.2 0.3 0.4 0.2 0.2 0.2 0.0 0.4 0.2 0.3 0.2 0.0 0.2 0.2 0.2 1.5 0.7 0.2 0.2 0.3 0.2 0.1 59.6 0.2 0.2 0.3 0.2 0.3 0.2 0.2 1.8 1.9 2.2 0.8 0.8 1.0 0.1 0.2 6.2 0.9 1.0 0.2 0.0 0.5 0.8 0.0 0.5 1.7 0.4 0.2 0.7 1.5 0.3 0.2 13.4 0.0 0.2 0.6 5.4 0.5 0.8 0.3 0.0 0.5 20.6 0.0 0.0 0.8 0.0 0.0 0.4 0.6 0.1 1.2 0.4 1.2 7.1 0.6 0.3 0.7 0.4 0.0 0.2 1.5 2.0 7.5 0.2 0.1 0.9 10.2 0.2 0.4 0.2 1.5 0.7 0.5 0.8 0.3 0.5 0.7 1.2 1.9 0.8 0.7 0.9 0.5 0.5 0.9 0.8 0.5 0.2 1.8 1.0 0.9 2.2 0.8 0.6 1.9 0.5 0.1 0.4 0.8 2.5 0.9 0.7 0.6 0.4 0.2 0.3 0.2 MELTF "CD228, FLJ38863, MAP97, MFI2, MGC4856, MTf, MTF1" ENSG00000163975 Melanotransferrin P08582 3 196988621-197029816 "CD markers, Plasma proteins, Predicted intracellular proteins" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 65.7" "Cell line enhanced" "Detected in many" "A-431: 46.1;SK-MEL-30: 57.0" "Cancer enhanced" "Detected in all" "melanoma: 32.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 3.3" "Group enriched" "Detected in many" 5 "dendritic cells: 1.9;monocytes: 2.1;T-cells: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA004880 Approved "Intracellular and membrane" 230000000 "HPA004880: AB_1853844" "unprognostic (8.68e-3)" "unprognostic (3.68e-2)" "unprognostic (1.75e-2)" "unprognostic (7.68e-3)" "unprognostic (1.06e-2)" "unprognostic (1.08e-2)" "unprognostic (5.53e-2)" "unprognostic (1.64e-3)" "unprognostic (1.20e-2)" "unprognostic (1.23e-1)" "unprognostic (3.68e-3)" "unprognostic (8.14e-2)" "prognostic unfavourable (6.99e-11)" "unprognostic (2.29e-1)" "unprognostic (2.11e-1)" "unprognostic (5.75e-2)" "unprognostic (2.09e-2)" 6.0 1.6 1.9 3.5 2.0 1.8 7.5 2.7 2.8 4.4 5.1 3.3 3.5 2.1 4.9 4.8 2.4 6.4 2.5 3.3 1.8 1.1 5.1 1.4 1.6 1.7 1.0 1.0 1.3 4.3 15.9 1.8 4.4 2.9 3.7 1.9 2.9 65.7 4.7 1.4 10.5 8.7 3.1 1.1 1.0 1.1 2.6 0.9 3.6 2.0 1.3 2.4 2.0 5.4 0.2 1.9 0.2 2.1 0.5 3.3 0.6 46.1 10.1 0.1 0.3 1.4 1.9 1.2 0.8 0.4 1.5 1.9 2.8 6.9 1.3 10.0 1.6 14.4 0.5 0.0 0.7 2.1 3.2 1.6 2.2 1.2 9.4 0.2 9.2 10.1 1.2 1.3 0.1 0.2 1.2 9.1 0.9 2.8 2.6 0.0 1.0 6.6 3.8 1.6 0.5 0.2 0.4 0.9 3.4 9.5 0.8 57.0 2.8 1.4 0.3 0.3 8.1 1.6 5.7 1.5 12.8 1.2 1.1 2.7 0.0 0.1 0.3 0.0 1.2 1.0 3.3 0.2 1.0 1.0 1.9 0.2 0.3 0.1 0.2 0.5 2.1 0.0 0.1 0.6 1.9 2.0 2.7 2.8 1.8 1.1 1.0 1.0 2.9 0.9 MEP1A PPHA ENSG00000112818 "Meprin A subunit alpha" Q16819 6 46793390-46839782 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 52 "intestine: 243.0" "Cell line enhanced" "Detected in some" "BEWO: 3.0;CACO-2: 6.9;Hep G2: 1.8;NB-4: 3.0;RPMI-8226: 3.4;SH-SY5Y: 2.1;U-2197: 2.0" "Cancer enriched" "Detected in many" 5 "colorectal cancer: 38.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.6" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025163, HPA029416" Enhanced 990000 "CAB025163: , HPA029416: AB_10600823" "unprognostic (1.83e-1)" "unprognostic (2.81e-4)" "unprognostic (2.03e-1)" "unprognostic (8.53e-2)" "unprognostic (8.73e-2)" "unprognostic (1.13e-1)" "unprognostic (2.43e-2)" "unprognostic (5.27e-4)" "unprognostic (2.05e-1)" "unprognostic (2.35e-2)" "unprognostic (1.42e-1)" "unprognostic (2.11e-1)" "unprognostic (1.11e-3)" "unprognostic (1.45e-1)" "unprognostic (1.91e-2)" "unprognostic (4.70e-3)" "unprognostic (1.68e-1)" 0.1 0.1 0.1 4.7 0.1 0.0 0.1 0.1 0.1 0.1 100.5 0.1 0.1 51.7 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 19.8 0.1 0.2 0.1 0.1 0.1 243.0 0.2 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.4 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 MEP1B ENSG00000141434 "Meprin A subunit beta" Q16820 18 32185069-32220404 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 167 "intestine: 241.5" "Cell line enhanced" "Detected in some" "SCLC-21H: 10.3" "Group enriched" "Detected in some" 5 "pancreatic cancer: 3.0;stomach cancer: 0.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029119 Enhanced "Secreted to digestive system" 120000 "HPA029119: " "unprognostic (1.33e-1)" "unprognostic (6.72e-2)" "unprognostic (2.79e-2)" "unprognostic (1.00e-1)" "unprognostic (3.50e-4)" "unprognostic (1.27e-1)" "unprognostic (1.74e-2)" "unprognostic (4.30e-1)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.55e-1)" "unprognostic (8.31e-4)" "unprognostic (4.74e-2)" "unprognostic (3.39e-1)" "unprognostic (2.71e-1)" "unprognostic (3.39e-2)" "unprognostic (3.75e-2)" 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.3 0.1 0.1 78.8 0.0 0.0 54.5 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 241.5 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.1 0.4 0.3 0.3 0.0 1.4 0.5 0.2 0.0 0.0 0.5 0.6 0.0 2.0 1.0 0.3 0.2 0.1 0.5 1.4 1.7 0.5 0.0 0.2 0.0 0.0 0.0 0.7 0.9 1.1 0.7 0.6 0.4 1.3 0.3 0.0 0.7 0.0 0.1 0.4 1.1 0.2 0.0 1.9 1.3 4.0 1.3 0.0 1.8 1.7 2.9 0.0 0.7 10.3 2.3 0.8 0.2 0.3 0.4 3.0 0.9 1.3 0.8 3.4 0.0 0.5 2.2 0.5 2.6 0.0 0.5 0.0 0.3 0.3 1.0 0.1 1.3 1.1 0.7 1.4 0.4 0.1 1.2 0.3 0.2 0.0 0.1 0.2 0.5 0.5 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 MEPE ENSG00000152595 "Matrix extracellular phosphoglycoprotein" Q9NQ76 4 87821411-87846817 "Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "brain: 34.2" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "amygdala: 34.2;cerebral cortex: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "amygdala: 1.3" "HPA038003, HPA038004" Uncertain "Secreted to extracellular matrix" 24000000 "HPA038003: , HPA038004: AB_10670537" "unprognostic (2.88e-1)" "unprognostic (8.15e-2)" "unprognostic (3.62e-1)" "unprognostic (1.91e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.14e-2)" "unprognostic (1.98e-1)" "unprognostic (2.41e-1)" "unprognostic (5.64e-4)" 0.2 0.2 34.2 0.2 5.2 0.3 0.5 0.0 10.0 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.2 2.4 1.7 0.3 0.2 0.3 0.2 0.5 5.4 0.2 0.2 0.2 0.1 0.3 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.3 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.2 5.2 0.0 10.0 2.4 1.7 0.5 5.4 0.0 0.0 MGAM MGA ENSG00000257335 Maltase-glucoamylase O43451 7 141907813-142106747 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 155.5" "Cell line enhanced" "Detected in some" "A549: 3.6;BJ hTERT+: 3.2;HL-60: 5.3;U-937: 8.5;WM-115: 2.0" "Cancer enriched" "Detected in some" 7 "renal cancer: 4.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "neutrophil: 14.1" "Lineage enriched" "Detected in single" 104 "granulocytes: 14.1" "Region enriched" "Detected in single" 12 "olfactory region: 3.1" HPA002270 Enhanced 68000 "HPA002270: AB_1079366" "unprognostic (1.02e-2)" "unprognostic (1.45e-1)" "unprognostic (1.13e-1)" "unprognostic (6.95e-3)" "unprognostic (2.80e-1)" "unprognostic (7.81e-2)" "unprognostic (7.32e-3)" "unprognostic (3.83e-2)" "unprognostic (4.97e-1)" "unprognostic (2.17e-2)" "unprognostic (6.86e-2)" "unprognostic (1.99e-1)" "prognostic favourable (6.16e-5)" "unprognostic (1.82e-1)" "unprognostic (2.82e-1)" "unprognostic (1.34e-3)" "unprognostic (3.03e-1)" 0.9 0.2 0.3 0.8 0.2 6.9 0.3 0.2 0.2 0.2 59.4 0.1 7.6 25.2 0.2 36.0 0.2 1.0 0.1 0.3 0.2 0.2 8.7 0.4 2.1 0.1 0.3 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.6 0.0 0.1 0.2 3.2 0.2 0.1 155.5 0.1 0.3 8.3 0.7 4.3 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.0 14.1 0.1 0.0 0.0 0.0 0.0 3.6 0.2 0.1 0.0 0.0 0.4 0.1 3.2 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.3 1.0 0.4 0.1 0.3 0.0 0.1 0.0 8.5 2.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.1 0.1 MGAT4D GnT1IP ENSG00000205301 "MGAT4 family member D" A6NG13 4 140442262-140498377 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 56 "testis: 33.8" "Cell line enriched" "Detected in single" 9 "HEL: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036523 Enhanced "HPA036523: AB_10670110" "unprognostic (2.70e-1)" "unprognostic (3.16e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 MGAT5B "FLJ25132, GnT-IX, GnT-VB" ENSG00000167889 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B" Q3V5L5 17 76868456-76950393 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 28.1" "Cell line enhanced" "Detected in many" "A549: 21.6;SCLC-21H: 11.1;U-138 MG: 13.1;U-2 OS: 14.2" "Group enriched" "Detected in many" 5 "glioma: 2.6;melanoma: 7.1;testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011082 Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" "Nucleoplasm, Mitotic spindle" "Cytokinetic bridge" "HPA011082: " "unprognostic (6.37e-2)" "unprognostic (9.16e-3)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (5.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.28e-3)" "unprognostic (1.52e-3)" "unprognostic (5.30e-2)" "unprognostic (3.89e-2)" "unprognostic (1.68e-1)" "unprognostic (5.67e-2)" "unprognostic (1.46e-7)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.04e-1)" "unprognostic (3.01e-1)" 1.1 1.2 9.3 1.1 13.4 1.0 0.9 4.4 28.1 1.0 0.9 1.1 0.0 0.8 1.1 0.7 0.9 1.0 0.9 0.8 5.5 2.8 0.9 0.7 1.0 0.9 2.3 8.1 1.2 0.8 1.0 0.6 1.1 2.6 0.8 0.8 1.1 0.8 0.8 0.7 0.9 0.9 0.8 0.7 1.4 1.0 2.3 1.7 0.0 0.8 0.0 0.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 21.6 4.4 2.2 0.0 0.0 2.3 0.3 0.9 7.9 4.7 0.0 0.5 0.0 1.7 1.0 0.1 1.0 0.2 2.1 0.0 0.3 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.2 1.4 0.1 0.0 0.0 1.0 0.0 0.0 1.2 2.2 3.0 3.8 4.5 6.2 0.0 11.1 4.2 3.8 1.7 3.4 0.1 0.1 4.0 13.1 14.2 0.2 4.1 0.0 0.0 0.5 0.4 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 13.4 4.4 27.4 5.5 2.8 2.3 8.1 2.6 1.7 MIB2 "FLJ39787, skeletrophin, ZZANK1, ZZZ5" ENSG00000197530 "Mindbomb E3 ubiquitin protein ligase 2" Q96AX9 1 1615415-1630610 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" "Actin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 72.5" "Cell line enhanced" "Detected in many" "HaCaT: 13.1;SCLC-21H: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068322 Enhanced "HPA068322: " "unprognostic (3.93e-2)" "unprognostic (6.02e-2)" "unprognostic (2.34e-2)" "unprognostic (6.60e-2)" "unprognostic (2.08e-1)" "unprognostic (1.70e-2)" "unprognostic (7.36e-3)" "unprognostic (2.61e-1)" "unprognostic (1.54e-1)" "unprognostic (6.57e-2)" "unprognostic (1.15e-3)" "unprognostic (3.17e-2)" "unprognostic (2.22e-3)" "unprognostic (1.29e-1)" "unprognostic (3.58e-2)" "unprognostic (2.49e-1)" "unprognostic (1.01e-2)" 6.4 3.9 8.7 6.4 10.0 4.5 4.7 8.8 11.5 4.8 6.9 7.1 4.7 5.3 5.1 5.4 11.4 4.1 3.7 6.1 9.1 7.9 5.5 6.2 5.1 3.7 5.3 7.1 5.8 7.0 3.7 9.4 4.0 5.7 4.7 3.7 6.6 5.4 6.5 72.5 9.6 4.6 5.4 3.4 9.0 8.5 5.2 5.8 7.4 5.9 9.7 4.1 4.5 4.1 2.9 9.2 1.9 0.1 7.3 4.7 1.0 6.5 0.9 0.4 1.5 1.7 0.6 9.1 3.1 1.4 1.0 2.3 1.3 1.6 0.7 4.4 0.9 13.1 0.5 2.0 0.0 3.4 5.6 0.5 1.9 1.2 2.4 0.8 2.2 1.4 1.4 0.6 0.2 0.5 2.6 1.2 0.2 1.0 3.6 8.3 1.1 10.4 6.1 1.9 8.9 0.1 0.8 14.0 5.1 5.2 0.7 5.0 1.0 3.2 0.6 0.9 2.1 5.1 0.9 6.8 2.0 1.8 2.3 2.6 1.1 0.0 0.1 1.9 4.3 0.1 4.3 2.6 3.3 4.7 0.0 2.9 3.9 2.9 0.5 7.3 0.0 9.2 2.3 1.0 8.7 10.0 8.8 11.5 9.1 7.9 5.3 7.1 5.7 5.8 MICAL2 KIAA0750 ENSG00000133816 "Microtubule associated monooxygenase, calponin and LIM domain containing 2" "O94851, Q6ZW33" 11 12094008-12359144 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Actin-binding, Developmental protein, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 138.4" "Cell line enhanced" "Detected in many" "U-138 MG: 39.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebellum: 138.4;cerebral cortex: 39.8" "Cell type enhanced" "Detected in many" "neutrophil: 12.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030437, HPA039895, HPA040438" Approved Uncertain "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus, Cytosol" "Nucleoplasm, Plasma membrane" "HPA030437: AB_10601873, HPA039895: , HPA040438: AB_10672896" "unprognostic (2.68e-2)" "unprognostic (1.77e-2)" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "prognostic unfavourable (6.88e-4)" "unprognostic (2.20e-2)" "unprognostic (3.60e-2)" "unprognostic (9.32e-2)" "unprognostic (2.86e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-2)" "unprognostic (6.47e-2)" "prognostic unfavourable (3.63e-5)" "unprognostic (4.61e-2)" "unprognostic (1.97e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 4.1 3.3 15.4 7.3 15.1 6.8 2.9 138.4 39.8 6.6 14.7 2.7 2.9 7.2 14.7 7.7 11.5 5.4 11.1 24.8 22.0 6.9 2.9 3.9 12.8 2.3 5.6 17.9 3.9 4.4 0.7 2.4 5.0 5.5 3.3 15.1 2.8 2.9 8.4 14.6 9.3 10.8 22.7 7.6 2.6 5.9 24.6 0.6 0.0 4.5 1.9 2.2 7.8 3.2 0.2 5.5 12.2 6.7 3.7 3.5 2.1 11.6 6.2 0.2 1.4 1.6 2.9 7.4 18.6 21.1 7.3 11.4 13.0 8.4 0.3 4.0 13.0 8.2 2.2 30.0 18.2 13.5 1.5 11.0 1.2 0.9 14.1 2.0 1.4 5.2 5.3 32.2 31.5 16.6 19.3 0.5 11.7 0.7 0.1 1.0 0.4 5.8 0.1 7.4 7.8 1.5 14.7 6.1 0.5 6.1 17.1 1.2 1.7 0.6 29.7 39.8 15.0 6.5 16.2 0.4 0.9 0.4 24.2 2.9 0.8 0.1 6.7 0.5 2.8 1.7 3.5 0.2 1.7 1.7 5.5 0.2 0.2 0.9 12.2 3.7 0.5 1.0 2.1 2.1 15.4 15.1 138.4 39.8 22.0 6.9 5.6 17.9 5.5 0.6 MIOX ALDRL6 ENSG00000100253 "Myo-inositol oxygenase" Q9UGB7 22 50486784-50490648 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "kidney: 136.7" "Cell line enhanced" "Detected in some" "HDLM-2: 21.3;Hep G2: 4.8;Karpas-707: 11.4;U-266/70: 6.8" "Cancer enriched" "Detected in many" 16 "renal cancer: 56.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039451, HPA039562" Enhanced "HPA039451: AB_2676513, HPA039562: AB_2676574" "unprognostic (2.11e-1)" "unprognostic (4.32e-2)" "unprognostic (2.22e-2)" "unprognostic (1.30e-2)" "unprognostic (9.83e-2)" "unprognostic (5.25e-2)" "unprognostic (1.61e-2)" "unprognostic (3.84e-3)" "unprognostic (2.84e-1)" "unprognostic (4.72e-2)" "unprognostic (1.85e-2)" "unprognostic (9.83e-2)" "prognostic favourable (2.60e-6)" "unprognostic (1.77e-1)" "unprognostic (1.50e-1)" "unprognostic (1.36e-2)" "unprognostic (2.23e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.0 136.7 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.4 2.7 0.1 0.1 0.1 0.1 1.3 0.6 3.1 0.7 0.4 1.4 0.4 0.0 0.0 0.1 0.3 0.2 0.1 1.8 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.6 0.3 0.1 0.1 0.0 0.0 21.3 0.0 0.1 0.3 4.8 2.8 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.1 11.4 0.0 1.1 0.0 0.1 0.2 0.4 0.1 0.1 0.1 2.2 0.1 0.1 0.3 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.5 0.1 0.0 6.8 0.6 0.3 0.1 0.0 0.2 3.1 0.4 0.6 0.5 0.3 0.2 1.3 0.5 1.4 0.1 0.9 0.5 0.6 1.8 0.4 0.7 0.6 0.4 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 MLANA MART1 ENSG00000120215 Melan-A Q16655 9 5890802-5910606 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 191.5" "Cell line enriched" "Detected in single" 384 "SK-MEL-30: 120.4" "Cancer enriched" "Detected in single" 556 "melanoma: 277.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB000057, HPA048662" Enhanced "CAB000057: AB_442107, HPA048662: " "unprognostic (2.52e-2)" "unprognostic (6.87e-2)" "unprognostic (5.20e-2)" "unprognostic (5.61e-2)" "unprognostic (2.58e-2)" "unprognostic (1.46e-1)" "unprognostic (4.53e-1)" "unprognostic (3.32e-1)" "unprognostic (2.82e-2)" "unprognostic (1.71e-3)" "unprognostic (3.60e-3)" "unprognostic (1.20e-1)" "unprognostic (1.45e-2)" "unprognostic (1.60e-1)" "unprognostic (8.01e-2)" "unprognostic (5.78e-2)" "unprognostic (9.43e-2)" 0.1 0.1 0.1 0.2 0.1 0.6 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 191.5 1.2 0.1 0.2 31.5 0.1 0.1 0.8 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.3 2.1 1.6 3.5 1.2 1.8 1.5 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.5 1.2 0.8 1.4 0.8 1.1 1.4 1.3 1.2 0.4 2.1 1.4 1.5 2.9 1.8 1.1 1.6 0.6 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 MLN ENSG00000096395 Motilin P12872 6 33794673-33804011 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 175 "intestine: 76.0" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;BEWO: 1.8;CACO-2: 7.4;RPMI-8226: 1.7;TIME: 3.4" "Cancer enriched" "Detected in some" 6 "testis cancer: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA069392 Enhanced "Secreted to blood" 450000 "HPA069392: " "unprognostic (7.70e-2)" "unprognostic (6.70e-2)" "unprognostic (4.44e-2)" "unprognostic (3.14e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 58.4 0.0 0.0 76.0 0.1 0.0 0.3 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 30.6 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 3.4 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 MMP10 STMY2 ENSG00000166670 "Matrix metallopeptidase 10" P09238 11 102770503-102780628 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "endometrium 1: 89.4" "Cell line enhanced" "Detected in some" "BJ: 12.3;HUVEC TERT2: 15.8;SCLC-21H: 5.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 102.2" "Region enriched" "Detected in single" 9 "pons and medulla: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB002159 Uncertain Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" Cytosol "Plasma membrane" "CAB002159: AB_564103" "unprognostic (8.76e-2)" "unprognostic (3.38e-1)" "unprognostic (1.98e-3)" "unprognostic (2.72e-3)" "unprognostic (7.17e-3)" "unprognostic (1.52e-2)" "unprognostic (5.67e-8)" "unprognostic (2.08e-3)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (1.67e-2)" "unprognostic (2.67e-1)" "unprognostic (6.99e-5)" "unprognostic (2.66e-2)" "unprognostic (7.98e-2)" "unprognostic (5.46e-2)" "prognostic favourable (7.12e-4)" 0.1 0.1 0.0 2.6 0.2 0.1 0.1 0.0 0.3 1.7 0.5 0.0 0.0 0.4 89.4 0.1 0.2 0.1 0.5 0.1 0.0 0.1 0.1 3.6 11.0 0.1 0.0 0.0 0.5 0.3 0.1 0.9 19.8 2.8 3.2 0.2 0.0 2.9 0.1 0.1 0.1 0.7 0.1 0.0 0.2 3.3 0.5 0.0 1.2 0.1 0.0 1.9 0.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.2 12.3 0.7 0.1 0.1 0.3 0.0 0.0 3.6 1.9 2.8 0.0 1.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.6 15.8 0.7 0.0 0.0 0.0 0.0 0.3 2.9 1.7 0.0 0.0 0.0 0.0 0.7 5.0 0.0 2.5 0.0 0.0 0.0 0.0 2.0 3.8 1.2 0.4 0.5 0.0 0.0 0.0 0.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 2.8 0.0 MMP21 ENSG00000154485 "Matrix metallopeptidase 21" Q8N119 10 125766453-125775821 "Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets, Heterotaxy" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "epididymis: 37.6" "Cell line enhanced" "Detected in some" "BEWO: 1.0;NB-4: 1.2;U-266/70: 2.1;U-266/84: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Secreted to extracellular matrix" "unprognostic (1.32e-2)" "unprognostic (1.28e-1)" "unprognostic (8.51e-2)" "unprognostic (2.19e-2)" "unprognostic (4.02e-2)" "unprognostic (2.21e-2)" "unprognostic (4.22e-3)" "unprognostic (1.01e-1)" "unprognostic (2.12e-1)" "unprognostic (1.48e-1)" "unprognostic (2.89e-2)" "unprognostic (3.62e-2)" "unprognostic (9.70e-8)" "unprognostic (1.30e-2)" "unprognostic (7.69e-2)" "unprognostic (7.00e-2)" "unprognostic (2.18e-1)" 0.2 0.1 0.1 0.1 0.4 0.1 0.3 0.7 0.0 0.1 0.2 0.1 0.1 37.6 0.1 0.4 0.2 0.9 0.0 0.4 0.1 1.0 0.1 0.1 0.0 2.8 0.8 0.0 0.3 0.0 0.6 0.1 0.5 0.1 0.0 0.1 0.5 0.1 0.0 0.7 0.2 0.1 0.6 0.1 0.2 0.0 1.1 0.0 0.0 0.1 0.5 0.6 0.0 0.1 0.0 0.0 0.8 0.3 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.7 0.5 0.0 0.0 0.2 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 2.1 1.7 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 1.1 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 MMP24 MT5-MMP ENSG00000125966 "Matrix metallopeptidase 24" Q9Y5R2 20 35226654-35277000 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.5" "Cell line enhanced" "Detected in some" "A549: 19.6;CACO-2: 29.9;EFO-21: 8.8;RPTEC TERT1: 13.5;U-2 OS: 10.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 38.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 91.3" "HPA049280, HPA078816" Approved Approved "Nucleoli,Plasma membrane" "Secreted to extracellular matrix" "Nucleoli, Plasma membrane" "HPA049280: , HPA078816: " "unprognostic (1.52e-3)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "unprognostic (4.51e-4)" "unprognostic (2.47e-2)" "unprognostic (7.61e-3)" "unprognostic (1.22e-1)" "unprognostic (4.59e-2)" "unprognostic (2.32e-2)" "unprognostic (8.82e-2)" "unprognostic (9.20e-3)" "unprognostic (7.12e-2)" "prognostic favourable (8.17e-11)" "unprognostic (3.32e-2)" "unprognostic (5.63e-2)" "unprognostic (1.69e-2)" "unprognostic (9.90e-4)" 1.6 1.3 4.0 0.4 7.8 0.6 0.4 38.5 8.9 0.7 0.3 1.3 0.2 2.8 1.6 0.9 0.2 2.8 0.6 1.0 2.7 3.2 8.6 0.9 6.1 0.3 1.8 1.5 0.9 8.0 0.0 3.8 0.6 1.7 2.2 0.1 0.5 0.4 6.0 0.2 1.5 1.7 2.5 0.9 0.6 0.7 0.4 1.4 0.2 0.8 0.2 0.2 0.5 0.2 0.8 0.4 2.2 0.8 0.6 1.2 0.3 0.3 19.6 0.0 0.1 0.1 0.0 0.6 1.1 1.2 2.1 1.1 29.9 5.3 0.0 8.8 1.3 0.3 4.6 0.0 0.9 0.1 0.2 1.0 0.5 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.1 7.5 1.3 0.0 0.1 0.0 13.5 0.1 7.8 5.4 1.4 0.5 0.2 0.3 0.1 0.3 4.2 10.1 1.0 0.4 0.1 0.1 0.0 0.9 0.1 0.6 1.0 0.6 0.1 1.0 0.7 1.2 0.6 0.7 0.8 0.4 0.8 0.6 0.6 2.2 0.6 0.8 0.2 0.0 0.3 4.0 7.8 38.5 5.3 2.7 3.2 1.8 1.5 1.7 1.4 MMP26 "endometase, MGC126590, MGC126592" ENSG00000167346 "Matrix metallopeptidase 26" Q9NRE1 11 4704927-4992429 "Enzymes, FDA approved drug targets, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "endometrium 1: 19.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "endometrial cancer: 8.8;prostate cancer: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" "unprognostic (4.21e-3)" "unprognostic (2.63e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MMP8 CLG1 ENSG00000118113 "Matrix metallopeptidase 8" P22894 11 102711795-102727050 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "bone marrow: 119.3" "Cell line enriched" "Detected in some" 8 "WM-115: 39.2" "Cancer enriched" "Detected in single" 17 "melanoma: 5.7" "Region enhanced" "Detected in single" "cerebral cortex: 1.7" "Group enriched" "Detected in some" 32 "neutrophil: 1.4;non-classical monocyte: 4.9" "Group enriched" "Detected in many" 32 "granulocytes: 1.4;monocytes: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021221, HPA022935" Enhanced "Secreted to extracellular matrix" 83000 "HPA021221: AB_1854043, HPA022935: AB_1854044" "unprognostic (3.03e-1)" "unprognostic (8.49e-5)" "unprognostic (1.08e-2)" "unprognostic (3.95e-3)" "unprognostic (1.80e-1)" "unprognostic (1.01e-2)" "unprognostic (7.68e-3)" "unprognostic (1.27e-1)" "unprognostic (4.92e-2)" "unprognostic (6.64e-3)" "unprognostic (2.45e-6)" "unprognostic (2.33e-4)" "unprognostic (1.33e-1)" "unprognostic (4.97e-1)" "unprognostic (2.30e-2)" 1.9 0.1 0.2 0.2 0.4 119.3 0.3 0.1 1.7 0.1 0.2 0.0 0.0 0.1 0.6 0.1 0.1 0.1 0.1 9.0 0.2 0.3 0.4 0.8 12.6 2.6 0.3 0.0 0.9 0.9 0.1 0.6 1.4 0.2 0.1 0.1 0.1 0.3 0.1 0.6 0.3 0.1 0.2 0.3 18.7 0.2 0.1 0.1 5.2 1.9 0.0 0.1 0.2 7.6 0.0 0.0 1.4 4.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 4.9 0.0 0.0 1.7 0.2 0.4 0.1 1.7 0.2 0.3 0.3 0.0 0.2 0.1 MNX1 "HB9, HLXB9, HOXHB9, SCRA1" ENSG00000130675 "Motor neuron and pancreas homeobox 1" P50219 7 156994051-157010651 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 43.3" "Cell line enhanced" "Detected in many" "AN3-CA: 11.5;EFO-21: 11.1;HEK 293: 8.8;RPMI-8226: 24.2;SCLC-21H: 13.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA071717 Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA071717: " "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.87e-2)" "unprognostic (3.72e-3)" "unprognostic (8.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.07e-1)" "unprognostic (4.07e-2)" "unprognostic (5.06e-2)" "unprognostic (8.62e-4)" "unprognostic (1.00e-2)" "unprognostic (3.35e-2)" "unprognostic (2.23e-5)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (5.58e-2)" "unprognostic (1.08e-1)" 0.1 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.1 6.0 0.2 0.1 9.0 0.1 0.1 0.3 0.0 7.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 43.3 0.0 3.2 0.1 0.2 0.8 3.7 0.1 1.9 0.1 0.1 0.1 7.3 0.1 0.2 0.1 2.7 1.0 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 3.8 0.0 11.5 0.0 0.0 8.6 0.0 0.0 0.1 0.0 5.0 1.6 0.9 11.1 0.0 0.2 2.0 1.5 0.9 1.4 8.8 0.0 0.7 2.3 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 3.6 1.9 0.0 6.4 0.6 0.1 0.0 0.7 0.0 1.7 24.2 4.3 0.4 13.0 0.0 1.6 1.4 0.2 3.6 2.9 0.0 0.0 0.0 0.0 0.0 3.6 1.8 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 MOBP ENSG00000168314 "Myelin-associated oligodendrocyte basic protein" Q13875 3 39467198-39529479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 32 "brain: 194.3" "Cell line enriched" "Detected in single" 52 "HAP1: 20.2" "Cancer enriched" "Detected in single" 63 "glioma: 4.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA035152 Supported Supported "Cytoplasmic bodies" "Cytoplasmic bodies" "HPA035152: AB_10603020" "unprognostic (1.76e-2)" "unprognostic (2.34e-1)" "unprognostic (3.53e-2)" "unprognostic (7.35e-2)" "unprognostic (5.67e-2)" "unprognostic (3.60e-2)" "unprognostic (7.47e-2)" "unprognostic (2.82e-1)" "unprognostic (7.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.01e-1)" "unprognostic (2.07e-1)" "unprognostic (2.04e-5)" "unprognostic (2.28e-1)" "unprognostic (8.98e-2)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" 1.7 1.8 35.0 1.7 58.5 1.7 1.7 3.8 101.8 1.7 2.3 102.1 0.0 1.6 1.8 1.7 1.7 2.7 1.7 1.7 51.4 33.4 1.7 1.6 2.3 1.6 84.8 14.7 2.1 1.6 6.0 0.0 1.6 68.2 1.6 1.8 0.0 1.6 1.7 1.8 1.7 1.7 1.8 194.3 1.6 1.7 5.0 64.2 0.0 1.7 0.0 1.6 1.7 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 35.0 58.5 3.8 29.1 51.4 33.4 84.8 14.7 68.2 64.2 MOG "BTN6, BTNL11" ENSG00000204655 "Myelin oligodendrocyte glycoprotein" Q16653 6 29656981-29672372 "Disease related genes, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 47 "brain: 106.4" "Group enriched" "Detected in some" 7 "BEWO: 3.4;HEK 293: 2.1" "Cancer enriched" "Detected in single" 45 "glioma: 15.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021873 Enhanced "HPA021873: AB_1854055" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (7.87e-2)" "unprognostic (3.00e-4)" "unprognostic (4.89e-2)" "unprognostic (4.90e-2)" 1.9 1.7 22.1 1.7 35.1 1.7 1.7 3.1 30.0 1.7 1.9 79.5 0.0 1.7 1.7 1.7 1.7 1.7 1.7 1.7 40.2 19.6 2.0 1.7 1.8 1.7 49.2 17.1 2.0 1.7 1.7 0.0 1.8 39.8 1.8 2.1 0.0 1.7 2.2 1.7 1.7 2.0 1.7 106.4 1.7 1.7 2.0 46.4 0.0 1.7 0.0 1.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 22.1 35.1 3.1 30.0 40.2 19.6 49.2 17.1 39.8 46.4 MOGAT1 "DGAT2L, DGAT2L1, MGAT1" ENSG00000124003 "Monoacylglycerol O-acyltransferase 1" Q96PD6 2 222671786-222709930 "Enzymes, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "gallbladder: 40.9" "Cell line enhanced" "Detected in single" "Hep G2: 1.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 0.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 3.4" "Lineage enriched" "Detected in single" 7 "dendritic cells: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA049944 Uncertain "HPA049944: " "unprognostic (6.32e-2)" "unprognostic (2.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.41e-1)" "unprognostic (4.28e-3)" "unprognostic (4.39e-2)" "unprognostic (4.32e-2)" "unprognostic (9.44e-2)" "unprognostic (1.91e-1)" "unprognostic (8.59e-2)" "unprognostic (3.07e-3)" "unprognostic (4.99e-2)" "unprognostic (3.89e-1)" "unprognostic (9.03e-3)" 2.3 0.1 0.6 0.1 0.5 0.1 1.3 0.2 0.9 0.3 0.6 0.5 0.2 0.0 1.0 1.1 0.5 0.1 40.9 0.8 0.5 0.2 5.7 7.6 1.1 0.3 0.2 0.9 0.1 1.5 2.3 0.4 0.0 0.9 0.2 0.1 0.0 1.4 2.6 0.5 1.6 0.2 0.1 0.3 0.1 1.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 3.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 1.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.6 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.5 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.6 0.5 0.2 0.9 0.5 0.2 0.2 0.9 0.9 0.0 MORC1 "CT33, MORC, ZCW6" ENSG00000114487 "MORC family CW-type zinc finger 1" Q86VD1 3 108958239-109118142 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 21.0" "Group enriched" "Detected in some" 10 "Karpas-707: 4.2;RPMI-8226: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.0" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036413 Enhanced "HPA036413: AB_10669989" "unprognostic (1.66e-1)" "unprognostic (4.30e-2)" "unprognostic (2.17e-2)" "unprognostic (2.63e-1)" "unprognostic (7.45e-6)" "unprognostic (4.80e-2)" "unprognostic (2.49e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 MORC4 "FLJ11565, ZCW4, ZCWCC2" ENSG00000133131 "MORC family CW-type zinc finger 4" Q8TE76 X 106813871-107000244 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "placenta: 94.5" "Cell line enhanced" "Detected in all" "A549: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA000395, HPA015547, HPA050250" Enhanced Enhanced Nucleoplasm Nucleoplasm "HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: " "prognostic unfavourable (3.56e-5)" "unprognostic (3.30e-3)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (1.40e-1)" "unprognostic (6.29e-3)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.30e-2)" "unprognostic (5.56e-2)" "unprognostic (8.59e-2)" "unprognostic (1.60e-1)" "unprognostic (1.60e-2)" "unprognostic (6.57e-2)" "unprognostic (4.89e-2)" "unprognostic (8.69e-2)" 8.7 20.0 3.2 6.0 4.8 5.1 6.2 4.9 3.6 8.0 5.3 4.6 12.7 4.6 8.8 8.5 6.8 7.3 6.7 5.3 4.3 2.8 4.9 9.7 6.0 2.2 4.9 2.2 12.3 9.1 6.0 4.9 94.5 5.8 7.7 4.9 4.2 8.7 8.8 9.4 8.6 4.9 7.4 5.4 2.6 5.6 12.5 5.0 2.3 7.6 7.5 5.2 6.3 15.1 6.0 4.6 10.5 3.8 2.8 4.0 0.7 11.5 46.3 4.6 10.6 14.1 16.3 24.2 11.3 12.0 5.7 7.3 24.5 5.3 1.8 5.9 11.6 9.1 15.4 9.9 6.9 2.7 8.9 2.8 15.7 10.3 10.4 2.0 5.9 8.6 9.6 7.8 11.4 5.1 1.6 17.6 12.7 10.2 4.2 2.8 4.1 17.6 2.0 9.3 2.0 18.5 9.2 4.0 5.1 13.7 13.4 8.9 8.0 2.0 5.3 9.2 9.3 18.2 6.2 5.0 6.5 4.6 9.8 1.8 6.6 10.5 3.8 3.1 3.7 3.0 3.2 3.3 3.6 2.8 1.6 6.0 4.0 3.4 8.2 2.8 3.6 4.6 2.6 0.7 3.2 4.8 4.9 3.6 4.3 2.8 4.9 2.2 5.8 5.0 MOS ENSG00000172680 "MOS proto-oncogene, serine/threonine kinase" P00540 8 56112942-56113982 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (3.28e-1)" 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MOV10L1 "CHAMP, DJ402G11.8, DKFZp434B0717" ENSG00000073146 "Mov10 RISC complex RNA helicase like 1" Q9BXT6 22 50089879-50161690 "Enzymes, Predicted intracellular proteins" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 27.7" "Cell line enhanced" "Detected in some" "HHSteC: 3.2;HUVEC TERT2: 15.7;TIME: 7.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA019034 Approved "HPA019034: AB_1854070" "unprognostic (1.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.88e-2)" "unprognostic (7.91e-2)" "unprognostic (4.29e-2)" "unprognostic (4.05e-2)" "unprognostic (1.21e-1)" "unprognostic (2.69e-1)" "unprognostic (9.43e-2)" "unprognostic (7.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.03e-1)" "unprognostic (8.02e-3)" "unprognostic (1.47e-1)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (1.37e-1)" 0.4 0.1 0.7 0.2 1.5 0.3 0.2 1.3 1.3 0.9 0.8 0.6 0.2 0.1 3.0 2.0 0.4 1.0 1.2 0.3 0.9 0.6 0.3 1.0 0.3 0.2 0.5 1.5 1.8 0.2 0.1 0.4 0.6 2.1 1.0 0.2 0.6 0.2 0.2 0.2 0.3 0.4 1.9 0.7 0.2 0.1 27.7 0.2 0.2 0.5 0.2 0.3 0.4 2.0 0.0 0.0 0.0 0.6 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.5 1.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 3.2 0.0 1.5 0.2 0.0 0.0 0.0 15.7 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 7.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.5 1.3 1.3 0.9 0.6 0.5 1.5 2.1 0.2 MPC1L SLC54A3 ENSG00000238205 "Mitochondrial pyruvate carrier 1 like" P0DKB6 X 40623566-40624136 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 26.1" "Cell line enhanced" "Detected in some" "BJ: 1.1;BJ hTERT+: 1.0;PC-3: 1.8;U-2197: 1.4" "Cancer enriched" "Detected in single" 9 "testis cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "unprognostic (8.47e-4)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.3 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MPO ENSG00000005381 Myeloperoxidase P05164 17 58269856-58280935 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "bone marrow: 315.2" "Group enriched" "Detected in some" 93 "HL-60: 212.9;NB-4: 279.1" "Cancer enhanced" "Detected in single" "stomach cancer: 1.1" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "classical monocyte: 7.6;intermediate monocyte: 3.8;myeloid DC: 3.2;neutrophil: 2.0" "Group enriched" "Detected in many" 30 "dendritic cells: 3.2;granulocytes: 2.0;monocytes: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000059, HPA021147, HPA061464" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" 15000000 Vesicles Nucleoplasm "CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531" "unprognostic (1.91e-1)" "unprognostic (9.08e-2)" "unprognostic (4.62e-2)" "unprognostic (2.90e-2)" "unprognostic (2.13e-3)" "unprognostic (2.78e-1)" "unprognostic (3.23e-1)" "unprognostic (2.91e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (6.92e-2)" "unprognostic (8.34e-3)" "unprognostic (4.91e-2)" "unprognostic (3.07e-3)" "unprognostic (2.83e-1)" "unprognostic (1.14e-2)" "unprognostic (8.05e-2)" 0.2 0.1 0.5 0.1 0.8 315.2 0.1 0.4 1.0 0.1 0.1 1.4 0.0 0.1 0.2 0.2 0.1 0.1 0.1 21.5 0.6 0.8 0.1 1.4 6.9 0.8 0.6 0.0 0.6 0.1 0.1 1.0 2.9 0.4 0.2 0.1 0.2 6.3 0.1 0.7 0.5 0.1 0.1 0.4 17.8 0.1 0.4 0.2 19.7 0.6 0.0 0.5 0.1 0.0 0.0 3.2 2.0 7.6 0.0 0.1 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 212.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 279.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.6 0.0 0.0 3.8 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 2.0 0.0 0.8 0.0 0.1 7.2 0.5 0.8 0.4 1.0 0.6 0.8 0.6 0.0 0.4 0.2 MPP4 DLG6 ENSG00000082126 "Membrane palmitoylated protein 4" Q96JB8 2 201644870-201698694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "retina: 78.2" "Cell line enhanced" "Detected in some" "HBF TERT88: 11.0;hTEC/SVTERT24-B: 10.2;LHCN-M2: 41.4;TIME: 8.2;U-87 MG: 10.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "cerebellum: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057393 Supported "Actin filaments,Cytosol" Cytosol "Actin filaments" "HPA057393: " "unprognostic (1.42e-2)" "unprognostic (1.82e-2)" "unprognostic (2.55e-1)" "unprognostic (2.50e-2)" "unprognostic (2.22e-2)" "unprognostic (6.66e-2)" "unprognostic (1.09e-2)" "unprognostic (9.42e-2)" "unprognostic (1.19e-1)" "unprognostic (1.39e-1)" "unprognostic (1.19e-1)" "unprognostic (9.20e-2)" "unprognostic (3.33e-16)" "unprognostic (1.82e-2)" "unprognostic (8.23e-2)" "unprognostic (1.29e-1)" "unprognostic (3.34e-2)" 0.4 1.7 0.3 0.5 0.6 0.0 0.3 4.9 1.1 1.2 0.2 0.2 0.2 0.0 0.8 0.4 0.3 0.1 0.4 0.2 0.5 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.2 0.0 0.7 0.7 0.3 0.3 0.3 78.2 0.2 0.5 0.6 4.1 0.2 0.3 0.2 3.8 0.1 2.2 0.2 0.2 0.6 0.6 0.2 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 5.3 1.3 3.3 3.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 11.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.0 10.2 0.0 6.0 0.0 0.0 41.4 0.0 0.0 0.0 0.3 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 4.2 1.2 0.9 3.7 0.0 0.0 0.0 10.8 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 4.9 0.6 0.5 0.4 0.2 0.2 0.3 0.2 MRGBP "C20orf20, Eaf7, FLJ10914, MRG15BP" ENSG00000101189 "MRG domain binding protein" Q9NV56 20 62796453-62801738 "Plasma proteins, Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 55.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017012 Enhanced Supported Nucleoplasm Nucleoplasm "HPA017012: AB_1845679" "unprognostic (1.90e-1)" "unprognostic (1.60e-1)" "unprognostic (2.07e-1)" "prognostic unfavourable (2.33e-4)" "unprognostic (8.56e-2)" "unprognostic (1.80e-3)" "prognostic unfavourable (3.80e-6)" "unprognostic (2.02e-2)" "unprognostic (3.06e-1)" "unprognostic (1.45e-1)" "unprognostic (1.17e-1)" "unprognostic (8.79e-2)" "prognostic unfavourable (2.48e-6)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "unprognostic (2.25e-1)" "unprognostic (6.01e-3)" 5.7 6.7 6.3 6.1 6.6 6.6 5.8 7.8 9.1 5.4 7.7 6.8 4.4 9.2 5.7 4.6 6.2 5.2 5.4 8.9 5.6 5.3 6.5 9.4 5.6 8.0 6.5 5.5 10.5 10.6 5.9 6.6 8.4 5.1 5.7 4.9 6.5 8.4 7.3 8.5 6.3 9.7 8.4 4.0 8.5 6.7 55.3 6.0 8.3 6.2 6.2 6.1 6.6 7.5 1.7 2.0 2.8 3.7 0.6 3.8 1.2 14.1 9.0 7.4 11.3 4.1 6.2 7.2 8.2 10.7 32.1 14.0 32.0 11.4 13.0 16.5 6.3 12.1 8.4 13.9 18.2 4.0 7.2 9.5 9.7 18.4 6.4 11.0 17.9 5.3 10.3 8.7 9.3 7.6 12.9 7.2 8.0 21.5 20.9 21.0 6.2 16.3 18.8 14.1 9.7 4.8 5.9 10.5 8.5 11.7 10.5 14.8 13.0 16.2 7.8 20.1 20.9 13.5 17.4 9.7 5.9 15.5 19.8 11.1 11.2 0.0 2.2 2.8 2.0 3.7 2.7 1.5 2.5 2.7 1.5 1.7 1.9 3.8 2.4 0.6 1.5 2.0 2.7 1.2 6.3 6.6 7.8 9.1 5.6 5.3 6.5 5.5 5.1 6.0 MRGPRE "GPR167, mrgE" ENSG00000184350 "MAS related GPR family member E" Q86SM8 11 3227698-3232386 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 34.9" "Group enriched" "Detected in some" 6 "NB-4: 2.6;RPMI-8226: 4.9;SCLC-21H: 8.0" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.9" "Region enriched" "Detected in many" 14 "pons and medulla: 34.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA046556 Uncertain "HPA046556: AB_10961404" "unprognostic (1.18e-1)" "unprognostic (7.52e-4)" "unprognostic (1.04e-1)" "unprognostic (9.09e-2)" "unprognostic (6.65e-2)" "unprognostic (1.77e-2)" "unprognostic (1.27e-1)" "unprognostic (1.83e-1)" "unprognostic (2.22e-2)" "unprognostic (1.19e-1)" 0.1 0.8 0.1 0.1 0.3 2.1 0.8 1.5 2.0 3.5 0.8 0.0 0.0 0.0 2.0 0.7 0.6 1.7 0.5 1.1 0.6 2.3 0.1 0.0 0.3 0.0 2.5 0.0 0.1 0.3 0.0 0.5 1.8 34.9 1.1 0.0 3.9 1.6 1.3 0.1 0.3 0.3 0.5 1.5 1.9 0.1 0.2 0.1 0.0 0.9 0.2 0.0 0.6 1.6 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.9 0.0 0.0 8.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.1 0.3 1.5 2.0 0.6 2.3 2.5 0.0 34.9 0.1 MRGPRG "GPR169, mrgG" ENSG00000182170 "MAS related GPR family member G" Q86SM5 11 3217944-3218813 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "testis: 4.4" "Group enriched" "Detected in some" 4 "NB-4: 1.1;REH: 2.5;SCLC-21H: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058909 Uncertain "HPA058909: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MROH2B "DKFZp781F0822, FLJ40243, HEATR7B2" ENSG00000171495 "Maestro heat like repeat family member 2B" Q7Z745 5 40998017-41071342 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 107 "testis: 46.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "liver cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059457 Enhanced "HPA059457: " "unprognostic (1.81e-1)" "unprognostic (3.54e-2)" "unprognostic (1.08e-1)" "unprognostic (3.41e-2)" "unprognostic (2.35e-1)" "unprognostic (8.91e-5)" "unprognostic (2.51e-3)" "unprognostic (2.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MROH7 "C1orf175, FLJ46354, HEATR8" ENSG00000184313 "Maestro heat like repeat family member 7" Q68CQ1 1 54641754-54710266 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 54.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.6;SH-SY5Y: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 29 "eosinophil: 2.9" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.9" HPA071840 Enhanced "HPA071840: " "unprognostic (1.52e-3)" "unprognostic (1.51e-3)" "unprognostic (1.65e-2)" "unprognostic (2.77e-4)" "unprognostic (1.81e-1)" "unprognostic (9.88e-4)" "unprognostic (1.09e-1)" "unprognostic (2.84e-1)" "unprognostic (1.84e-1)" "unprognostic (2.11e-1)" "unprognostic (4.16e-2)" "unprognostic (1.79e-2)" "unprognostic (7.93e-2)" "unprognostic (7.40e-3)" "unprognostic (2.38e-1)" "unprognostic (5.83e-2)" "unprognostic (4.15e-2)" 0.3 0.0 0.5 0.3 0.4 0.5 0.3 0.3 0.4 0.3 1.0 0.3 0.8 0.1 0.3 0.9 0.5 0.4 0.3 0.7 0.3 0.4 0.7 0.3 0.3 0.3 0.3 0.3 1.3 0.3 0.7 1.8 0.3 0.3 0.8 0.3 0.3 1.4 0.6 0.6 0.9 0.4 0.3 0.3 0.3 0.5 54.2 0.3 0.3 2.3 0.3 0.3 0.8 0.3 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.3 0.4 0.3 0.4 0.3 0.3 0.3 0.3 MS4A10 "CD20L7, MS4A9" ENSG00000172689 "Membrane spanning 4-domains A10" Q96PG2 11 60785348-60801305 "Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "intestine: 115.7" "Cell line enhanced" "Detected in some" "BEWO: 2.3;NB-4: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA014778 Uncertain "HPA014778: " "unprognostic (7.67e-3)" "unprognostic (1.28e-1)" "unprognostic (8.73e-3)" "unprognostic (1.27e-1)" "unprognostic (5.21e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 28.3 0.0 0.0 33.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 115.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 3.5 0.5 0.9 0.5 0.1 0.3 0.9 0.4 0.2 0.2 0.0 2.3 0.2 0.1 0.1 0.0 0.8 0.2 0.4 0.3 0.1 0.7 0.2 0.3 0.2 0.0 0.3 2.1 0.7 0.3 0.1 0.5 1.8 0.0 0.0 0.5 0.3 0.0 0.5 1.4 0.7 0.3 0.5 2.4 0.0 0.3 0.2 0.0 1.7 0.1 0.4 1.0 0.9 0.4 0.6 0.0 0.4 0.2 1.4 0.7 0.2 1.4 0.3 0.2 0.2 0.4 0.4 0.7 0.2 3.5 0.4 0.7 0.5 0.3 0.4 0.5 0.3 0.3 0.2 0.8 0.5 0.5 1.4 0.9 0.5 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A13 ENSG00000204979 "Membrane spanning 4-domains A13" Q5J8X5 11 60515413-60542721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 85 "testis: 8.4" "Group enriched" "Detected in some" 5 "U-2 OS: 2.0;U-266/70: 6.2;U-266/84: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045017, HPA063626" Uncertain "HPA045017: AB_10962976, HPA063626: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.7 0.0 6.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A2 "APY, FCER1B, IGER, MS4A1" ENSG00000149534 "Membrane spanning 4-domains A2" Q01362 11 60088261-60098466 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 72.0" "Cell line enhanced" "Detected in some" "HEL: 6.9;NB-4: 2.6;THP-1: 4.1;U-937: 1.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 720 "basophil: 72.0" "Lineage enriched" "Detected in single" 720 "granulocytes: 72.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059967 Enhanced "HPA059967: " "unprognostic (7.28e-2)" "unprognostic (9.21e-2)" "unprognostic (2.50e-4)" "unprognostic (4.97e-2)" "unprognostic (4.47e-1)" "unprognostic (2.40e-6)" "unprognostic (1.88e-2)" "unprognostic (6.21e-3)" "unprognostic (3.96e-1)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (6.63e-3)" "unprognostic (6.49e-3)" "unprognostic (9.95e-2)" "unprognostic (4.03e-2)" "unprognostic (1.57e-1)" "unprognostic (1.74e-1)" 4.9 0.5 0.4 5.1 0.4 0.2 2.1 0.4 0.4 11.9 4.6 0.1 4.5 4.7 14.3 11.2 5.9 1.1 14.6 2.1 0.4 0.4 1.5 0.9 12.9 0.5 0.4 0.1 1.1 1.2 0.2 0.6 0.6 0.1 17.5 5.6 4.5 3.2 5.4 1.5 4.3 7.4 15.9 0.4 0.6 4.5 2.7 0.2 1.2 0.6 6.7 3.4 5.1 4.1 0.0 0.0 72.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.2 0.0 0.3 0.0 0.0 0.1 0.3 0.2 0.4 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.3 0.0 6.9 0.4 0.2 0.3 0.8 0.4 0.1 0.1 0.0 0.1 0.1 0.9 0.3 0.0 0.1 0.0 2.6 0.1 0.1 0.1 0.0 0.2 0.0 1.0 0.2 0.1 0.1 0.2 0.0 0.3 4.1 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.2 1.8 0.2 72.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.1 0.1 0.2 MS4A5 CD20L2 ENSG00000166930 "Membrane spanning 4-domains A5" Q9H3V2 11 60429589-60455214 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 54 "testis: 46.6" "Cell line enhanced" "Detected in some" "U-138 MG: 2.1;U-2 OS: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043732 Uncertain "HPA043732: AB_10959759" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A6E ENSG00000166926 "Membrane spanning 4-domains A6E" Q96DS6 11 60334831-60396596 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 28.2" "Cell line enriched" "Detected in single" 4 "K-562: 3.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "intermediate monocyte: 1.2" "Lineage enriched" "Detected in single" 6 "monocytes: 1.2" "unprognostic (2.58e-1)" "unprognostic (3.35e-1)" "unprognostic (3.47e-1)" "unprognostic (6.81e-3)" "unprognostic (4.55e-4)" "unprognostic (1.08e-1)" "unprognostic (1.71e-1)" "unprognostic (1.76e-1)" 2.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 28.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 MSANTD3-TMEFF1 C9orf30-TMEFF1 ENSG00000251349 "MSANTD3-TMEFF1 readthrough" 9 100442271-100577636 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 21.4" "Cell line enhanced" "Detected in many" "AF22: 42.0;NTERA-2: 21.2;SCLC-21H: 22.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (8.53e-3)" "unprognostic (1.95e-3)" "unprognostic (5.92e-2)" "unprognostic (5.32e-2)" "unprognostic (8.87e-2)" "unprognostic (3.00e-1)" "unprognostic (3.39e-4)" "unprognostic (6.34e-2)" "unprognostic (2.19e-1)" "unprognostic (8.88e-3)" "unprognostic (1.46e-1)" "unprognostic (9.55e-3)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.02e-3)" 0.6 0.6 7.7 1.1 4.9 0.0 0.5 7.1 21.4 2.3 0.8 0.0 3.5 1.0 0.6 0.6 1.1 0.7 5.5 3.9 0.4 0.0 0.5 0.0 2.9 1.2 0.0 0.1 0.0 1.1 1.1 0.6 0.0 2.0 0.3 0.0 0.3 2.8 3.5 0.0 0.2 3.3 3.7 0.2 0.9 0.1 0.2 1.0 1.0 0.0 0.0 1.0 0.7 1.1 1.9 42.0 3.4 5.2 2.9 7.0 4.5 3.2 3.4 3.6 0.2 1.3 0.8 2.2 4.1 0.7 13.2 1.3 7.8 3.2 2.5 0.3 1.4 0.6 2.6 0.8 0.7 1.3 1.1 3.3 3.9 8.5 0.8 0.5 6.8 0.8 5.1 0.7 21.2 1.8 6.3 17.8 0.1 3.3 0.4 22.6 10.6 1.4 0.9 2.2 0.5 2.6 3.0 3.6 3.7 4.2 4.1 2.0 4.4 3.9 5.5 0.5 3.4 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.4 0.3 1.0 0.2 0.3 0.5 1.0 0.0 0.0 0.0 0.0 0.7 MSH4 ENSG00000057468 "MutS homolog 4" O15457 1 75796882-75913238 "Predicted intracellular proteins" Meiosis DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 33.0" "Cell line enhanced" "Detected in some" "AN3-CA: 5.8;HDLM-2: 2.8;hTCEpi: 1.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebellum: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (6.64e-2)" "unprognostic (2.11e-1)" "unprognostic (3.46e-2)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (1.99e-2)" "unprognostic (6.88e-3)" "unprognostic (1.74e-2)" "unprognostic (4.37e-2)" "unprognostic (3.00e-1)" "unprognostic (3.58e-3)" "unprognostic (9.72e-2)" "unprognostic (6.88e-8)" "unprognostic (5.33e-2)" "unprognostic (4.90e-2)" "unprognostic (5.08e-2)" "unprognostic (4.63e-2)" 0.3 0.2 0.3 0.3 0.6 0.1 0.5 2.6 0.4 0.3 0.8 0.3 0.3 0.1 0.6 4.8 0.3 0.6 0.3 0.6 0.3 0.0 0.3 0.3 0.4 0.3 0.3 0.3 1.0 0.3 0.0 0.3 0.6 0.3 0.3 0.3 0.3 0.3 0.3 1.6 0.5 0.4 0.7 0.7 1.2 0.2 33.0 0.3 0.3 0.3 0.3 0.3 0.5 0.5 0.7 0.4 0.0 0.1 0.0 0.5 0.0 0.8 0.1 0.0 5.8 1.1 0.4 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.1 0.2 0.0 0.3 0.1 2.8 0.6 0.2 0.2 0.0 0.0 0.1 0.4 1.1 1.8 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.1 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.9 0.4 0.1 0.1 0.1 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.1 0.2 0.7 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.6 2.6 0.4 0.3 0.0 0.3 0.3 0.3 0.3 MSMB "IGBF, MSP, MSPB, PN44, PRPS, PSP, PSP-94, PSP57, PSP94" ENSG00000263639 "Microseminoprotein beta" P08118 10 46033307-46046269 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "prostate: 437.8" "Cell line enhanced" "Detected in some" "BEWO: 20.0;NB-4: 16.1;RPMI-8226: 8.4;SH-SY5Y: 4.6;SK-BR-3: 4.7;U-2197: 9.5" "Cancer enriched" "Detected in many" 42 "prostate cancer: 3435.3" "Cell type enriched" "Detected in single" 5 "eosinophil: 1.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.9" "CAB026357, HPA051257" Enhanced "Secreted in male reproductive system" 3700000 "CAB026357: , HPA051257: " "unprognostic (6.47e-2)" "unprognostic (7.21e-3)" "unprognostic (1.37e-2)" "unprognostic (8.18e-3)" "unprognostic (4.28e-3)" "unprognostic (9.24e-3)" "unprognostic (1.66e-1)" "unprognostic (8.66e-2)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" "unprognostic (2.01e-1)" "unprognostic (7.04e-2)" "unprognostic (1.39e-1)" "prognostic favourable (7.19e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 1.0 0.8 0.0 0.1 0.1 0.0 1.8 0.1 0.0 7.2 0.0 0.0 0.0 0.0 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 437.8 0.0 0.0 14.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 26.8 0.6 0.0 0.0 0.0 0.1 0.7 0.7 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.2 16.1 0.2 0.0 0.0 0.0 8.4 0.0 1.2 0.9 4.6 0.0 4.7 0.0 0.3 0.0 0.0 0.0 0.0 9.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MST1 "D3F15S2, DNF15S2, HGFL, MSP, NF15S2" ENSG00000173531 "Macrophage stimulating 1" 3 49683947-49689501 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "liver: 117.0" "Cell line enhanced" "Detected in many" "Hep G2: 41.5;NB-4: 8.4;U-266/70: 11.3" "Cancer enriched" "Detected in many" 7 "liver cancer: 42.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;memory B-cell: 1.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024036 Approved "Secreted to blood" "HPA024036: AB_1854147" "unprognostic (5.13e-3)" "unprognostic (1.45e-1)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" "unprognostic (1.83e-1)" "unprognostic (2.00e-2)" "unprognostic (1.16e-2)" "unprognostic (9.42e-3)" "unprognostic (8.24e-2)" "unprognostic (2.97e-1)" "prognostic favourable (7.14e-4)" "unprognostic (3.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.11e-1)" "unprognostic (2.48e-1)" "unprognostic (8.03e-2)" "unprognostic (1.68e-3)" 3.7 3.5 4.0 0.3 4.8 1.4 1.0 4.9 5.4 0.9 1.4 2.5 1.9 14.4 1.2 3.3 0.8 1.7 1.9 0.5 6.5 1.1 8.8 117.0 1.6 0.7 2.0 2.9 1.7 1.9 3.8 4.8 1.5 4.8 1.5 0.5 1.6 3.4 3.7 2.8 4.0 8.2 1.3 4.2 1.7 0.8 9.9 2.3 0.9 5.0 0.3 1.1 0.8 0.7 1.2 0.9 0.0 0.2 0.0 1.1 0.2 0.1 0.2 0.6 1.0 1.9 4.0 1.9 0.5 0.7 0.3 0.4 1.9 0.6 0.1 1.3 0.6 0.4 0.3 0.8 0.3 0.6 0.3 0.3 0.9 41.5 3.0 0.0 0.8 5.4 1.3 0.3 1.1 0.7 0.3 5.0 0.9 0.3 0.2 8.4 0.1 0.5 0.2 0.2 1.1 2.2 0.3 0.1 1.4 0.0 0.9 0.2 0.7 2.8 0.4 1.0 0.3 0.0 0.1 11.3 1.4 0.2 1.1 1.5 0.7 0.0 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.2 4.0 4.8 4.9 5.4 6.5 1.1 2.0 2.9 4.8 2.3 MT1B "MT1, MT1Q" ENSG00000169688 "Metallothionein 1B" P07438 16 56651899-56653204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 21.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.6;EFO-21: 2.1" "Cancer enriched" "Detected in single" 209 "liver cancer: 57.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "unprognostic (2.66e-1)" 0.5 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.3 0.9 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MT3 GIF ENSG00000087250 "Metallothionein 3" P25713 16 56589074-56591088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 243.8" "Group enriched" "Detected in some" 5 "RPMI-8226: 5.2;SCLC-21H: 9.0;U-87 MG: 15.2" "Cancer enriched" "Detected in many" 58 "glioma: 392.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "naive CD8 T-cell: 8.0" "Lineage enriched" "Detected in single" 81 "T-cells: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004011, CAB017779" Enhanced "CAB017779: , HPA004011: AB_1854158" "unprognostic (6.63e-3)" "unprognostic (1.40e-1)" "unprognostic (1.25e-1)" "unprognostic (4.34e-2)" "unprognostic (8.11e-2)" "unprognostic (1.02e-1)" "unprognostic (3.49e-3)" "unprognostic (2.45e-2)" "unprognostic (7.99e-2)" "unprognostic (1.66e-1)" "unprognostic (8.30e-2)" "unprognostic (1.70e-1)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.55e-1)" "unprognostic (2.03e-1)" "unprognostic (9.26e-2)" 2.7 19.8 168.7 2.6 140.5 2.3 2.4 42.2 243.8 2.5 3.6 20.2 0.0 2.4 2.4 2.3 3.2 2.5 2.4 3.8 107.2 80.5 3.1 2.3 2.5 2.5 129.1 53.2 2.6 2.3 2.3 1.1 2.7 37.0 2.6 3.1 0.0 17.4 2.5 2.8 2.5 2.8 2.4 53.7 2.4 2.4 5.9 48.6 0.0 2.4 0.0 5.9 2.4 0.2 0.0 0.0 0.0 0.0 0.0 8.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 5.2 0.0 0.0 9.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 1.7 8.0 0.0 0.0 0.0 0.0 0.0 0.9 168.7 140.5 42.2 102.1 107.2 80.5 129.1 53.2 37.0 48.6 MT4 MTIV ENSG00000102891 "Metallothionein 4" P47944 16 56565049-56568957 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "skin 1: 42.3" "Group enriched" "Detected in some" 19 "HaCaT: 2.4;K-562: 1.2" "Group enriched" "Detected in many" 6 "cervical cancer: 6.7;endometrial cancer: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "thalamus: 0.4" "Low region specificity" "Detected in many" "unprognostic (8.81e-2)" 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 1.5 0.1 0.1 0.1 0.0 0.1 0.1 1.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.7 42.3 0.1 0.1 0.1 0.1 0.0 2.0 0.1 0.6 0.1 8.5 0.1 0.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 MTCL1 "CCDC165, KIAA0802, SOGA2" ENSG00000168502 "Microtubule crosslinking factor 1" Q9Y4B5 18 8705661-8832778 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 61.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 61.5" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 63.6" HPA046245 Uncertain "HPA046245: AB_10962580" "unprognostic (2.64e-1)" "prognostic unfavourable (6.45e-4)" "unprognostic (2.35e-1)" "unprognostic (2.27e-2)" "unprognostic (1.70e-1)" "unprognostic (1.01e-1)" "unprognostic (4.41e-4)" "unprognostic (1.30e-2)" "unprognostic (7.19e-2)" "unprognostic (9.95e-2)" "unprognostic (2.51e-1)" "unprognostic (1.79e-2)" "prognostic unfavourable (5.19e-4)" "unprognostic (2.82e-1)" "unprognostic (3.67e-1)" "unprognostic (7.17e-3)" "unprognostic (1.08e-2)" 1.4 1.2 1.8 3.2 3.4 0.4 1.4 61.5 10.0 5.5 8.5 2.4 4.1 2.3 3.4 2.0 3.8 1.3 12.5 3.8 1.7 2.4 1.4 1.3 1.4 0.9 2.4 3.8 1.3 3.4 4.8 2.7 3.0 5.2 1.7 2.3 8.4 1.5 4.4 2.4 1.6 2.7 7.0 3.3 1.1 4.9 8.2 1.2 1.4 1.1 1.1 0.6 9.9 4.8 0.6 1.1 0.0 0.0 0.0 0.0 0.0 8.8 19.0 9.5 5.5 4.3 8.0 0.3 12.4 9.2 10.3 7.4 5.5 3.1 5.5 7.1 8.6 1.3 3.0 5.0 4.7 1.1 2.4 2.7 5.0 4.9 6.1 0.1 4.0 4.7 3.8 5.8 4.0 8.0 0.6 9.7 4.7 2.6 0.3 1.3 4.3 8.3 7.4 6.9 2.0 14.7 16.0 21.8 4.9 5.7 1.6 1.5 0.5 0.3 15.2 18.9 9.9 15.1 12.7 1.9 1.4 2.7 4.7 0.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.8 3.4 61.5 10.0 1.7 2.4 2.4 3.8 5.2 1.2 MTHFD1 "MTHFC, MTHFD" ENSG00000100714 "Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1" P11586 14 64388031-64463457 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis" "Hydrolase, Ligase, Multifunctional enzyme, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 121.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000704, HPA001290, HPA015006, HPA050052" Approved Enhanced Cytosol 250000 Cytosol "HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: " "unprognostic (3.58e-2)" "unprognostic (5.50e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (1.37e-1)" "unprognostic (7.01e-2)" "unprognostic (8.85e-3)" "unprognostic (7.62e-3)" "unprognostic (1.28e-1)" "unprognostic (2.29e-2)" "prognostic unfavourable (6.96e-4)" "unprognostic (1.84e-1)" "prognostic favourable (5.93e-5)" "unprognostic (2.45e-2)" "unprognostic (1.75e-1)" "unprognostic (7.30e-2)" "unprognostic (2.29e-2)" 18.9 9.0 8.1 8.4 18.1 9.7 12.2 5.7 15.9 7.1 9.3 9.0 4.0 7.5 8.5 6.9 12.0 6.7 6.4 10.6 8.4 6.5 20.5 121.6 6.8 9.2 8.0 10.4 10.1 13.4 13.1 5.6 5.6 10.0 5.5 11.4 9.3 11.6 5.6 26.5 7.6 7.3 8.8 6.9 8.3 7.9 2.3 7.4 15.6 8.6 14.0 12.5 8.7 7.3 21.1 12.8 0.5 13.2 12.8 14.9 8.4 72.1 41.1 15.6 34.0 16.8 13.7 25.3 28.3 19.5 36.8 36.5 39.9 33.3 30.4 13.4 16.8 35.5 48.2 28.2 43.1 30.1 31.7 37.6 41.2 30.2 12.4 28.8 20.5 10.7 9.1 32.8 17.8 22.9 28.0 25.0 27.8 59.9 46.4 16.9 28.6 43.6 37.1 54.3 27.5 27.6 42.3 33.8 13.1 47.4 25.8 14.2 40.1 14.6 14.1 27.8 48.1 25.5 33.9 16.7 20.5 53.5 25.4 33.4 31.4 0.2 8.2 0.1 8.1 13.2 10.9 21.1 9.0 9.9 12.8 11.6 7.6 10.1 0.5 12.8 10.3 3.2 14.9 8.4 8.1 18.1 5.7 15.9 8.4 6.5 8.0 10.4 10.0 7.4 MTRNR2L1 ENSG00000256618 "MT-RNR2-like 1" P0CJ68 17 22523111-22524663 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 4 "blood: 249.5" "Cell line enhanced" "Detected in all" "HeLa: 184.9;Hep G2: 127.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 249.5" "Lineage enriched" "Detected in all" 7 "granulocytes: 249.5" "Secreted to blood" "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.08e-1)" "unprognostic (4.41e-3)" "unprognostic (2.99e-2)" "unprognostic (9.82e-3)" "prognostic favourable (8.99e-4)" "unprognostic (2.14e-1)" "unprognostic (2.59e-2)" "unprognostic (1.48e-2)" "unprognostic (2.42e-2)" "unprognostic (1.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.35e-2)" "unprognostic (1.64e-1)" "unprognostic (1.49e-2)" "unprognostic (5.21e-3)" 9.4 16.2 7.9 3.7 10.0 2.3 3.0 4.0 8.4 2.5 8.9 3.3 4.8 4.5 2.6 6.8 4.8 2.6 3.3 34.3 8.1 6.1 17.8 12.8 4.2 5.6 8.9 3.0 4.1 15.0 1.5 3.4 2.5 4.6 3.5 7.7 3.3 5.9 5.0 55.5 5.3 5.2 7.5 5.9 3.3 5.6 4.4 4.0 1.8 2.7 6.8 1.8 3.3 2.6 29.4 21.6 249.5 34.3 15.0 18.3 28.7 20.2 47.2 18.2 61.2 28.9 11.9 23.1 19.1 4.5 4.4 5.1 28.9 32.8 27.5 20.9 9.8 53.9 1.3 6.9 5.5 16.1 33.8 25.2 184.9 127.1 9.4 5.9 30.3 26.7 14.8 4.9 12.0 4.7 20.4 16.9 13.2 16.4 9.1 40.4 5.2 10.6 15.0 11.5 14.3 25.1 28.9 9.7 17.2 9.2 17.5 28.1 16.4 42.1 9.1 24.3 20.6 29.0 11.8 15.7 5.0 13.0 13.9 37.2 5.3 74.4 34.3 62.1 10.9 16.7 13.5 28.7 13.9 11.8 12.1 29.4 18.3 15.9 249.5 15.0 16.1 21.6 12.1 28.7 7.9 10.0 4.0 6.8 8.1 6.1 8.9 3.0 4.6 4.0 MTRNR2L12 ENSG00000269028 "MT-RNR2-like 12" P0DMP1 3 96617188-96618236 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "blood: 603.3" "Cell line enhanced" "Detected in all" "HeLa: 487.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 603.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 603.3" "Secreted to blood" "unprognostic (3.79e-2)" "unprognostic (1.05e-1)" "unprognostic (1.88e-2)" "unprognostic (1.37e-1)" "unprognostic (1.09e-1)" "unprognostic (9.76e-3)" "unprognostic (1.69e-3)" "unprognostic (1.81e-2)" "unprognostic (7.77e-2)" "unprognostic (3.55e-2)" "unprognostic (2.08e-2)" "unprognostic (4.90e-2)" "unprognostic (9.59e-3)" "unprognostic (1.81e-2)" "unprognostic (2.61e-1)" "unprognostic (2.08e-1)" "unprognostic (1.85e-2)" 18.0 29.1 32.5 5.2 31.0 4.5 7.5 8.8 19.2 5.1 20.2 6.4 5.7 8.1 5.1 75.3 10.9 3.8 40.2 114.2 26.3 19.8 32.9 29.8 5.4 7.8 26.2 7.5 4.9 9.7 4.3 6.6 5.0 10.4 6.9 16.5 6.8 10.8 9.3 101.3 10.6 9.3 6.9 15.3 5.3 13.3 9.7 8.7 72.1 5.1 11.0 5.3 6.0 8.5 69.1 53.1 603.3 81.8 37.9 45.5 57.6 97.6 120.2 90.1 323.3 140.0 75.5 82.8 127.4 26.1 24.5 31.8 66.0 157.9 215.4 103.8 48.0 270.1 6.3 53.8 33.6 63.0 116.3 228.1 487.9 278.0 53.3 45.2 126.3 136.6 64.5 25.8 70.9 27.3 161.6 74.3 83.3 51.1 39.0 142.9 26.2 36.3 62.5 86.6 66.4 147.3 72.7 41.1 80.1 82.9 84.4 109.3 86.7 132.1 120.8 101.7 84.5 113.6 36.0 39.5 24.7 107.0 63.0 285.2 27.4 183.7 81.8 153.2 28.1 44.0 37.0 65.7 35.7 29.9 31.2 69.1 45.5 40.8 603.3 37.9 42.3 53.1 31.4 57.6 32.5 31.0 8.8 19.0 26.3 19.8 26.2 7.5 10.4 8.7 MTURN "C7orf41, Ells1, FLJ25903" ENSG00000180354 "Maturin, neural progenitor differentiation regulator homolog" Q8N3F0 7 30134810-30162762 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 189.2" "Cell line enhanced" "Detected in many" "ASC diff: 22.6;HEL: 39.3;SCLC-21H: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 9.9" "Group enriched" "Detected in many" 4 "granulocytes: 9.9;NK-cells: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029507 Enhanced Approved Cytosol Cytosol "HPA029507: AB_10601149" "unprognostic (1.99e-1)" "unprognostic (1.38e-2)" "unprognostic (3.70e-1)" "unprognostic (7.14e-2)" "unprognostic (1.84e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-3)" "unprognostic (9.80e-2)" "unprognostic (1.94e-1)" "unprognostic (1.11e-3)" "unprognostic (8.11e-3)" "prognostic favourable (7.64e-13)" "unprognostic (9.50e-2)" "unprognostic (7.64e-2)" "unprognostic (4.64e-1)" "unprognostic (3.26e-1)" 35.9 5.7 113.5 4.8 86.7 9.3 14.2 21.7 100.8 12.9 5.2 97.0 3.3 3.0 7.9 45.6 9.6 8.2 5.3 11.2 122.8 79.5 24.7 2.3 10.1 2.8 162.4 26.2 16.5 6.2 9.7 2.7 4.0 54.2 9.2 5.3 2.9 14.9 12.0 14.3 7.8 3.4 8.5 189.2 4.1 10.0 4.5 49.4 0.0 6.7 2.4 3.0 6.0 6.5 0.7 1.4 9.9 0.4 3.0 0.8 2.4 5.0 0.9 3.0 3.1 22.6 15.4 2.7 2.5 2.9 0.8 1.2 0.4 2.0 0.3 2.0 5.4 0.9 6.7 9.6 2.7 2.1 5.4 39.3 6.2 2.7 1.7 1.9 13.0 7.6 4.5 2.5 4.6 1.3 2.4 2.1 5.7 1.9 2.2 0.9 2.0 3.1 0.2 6.9 8.4 10.1 2.0 29.0 7.7 1.5 7.9 7.9 5.6 3.0 6.3 3.3 3.6 6.9 3.4 3.5 5.0 0.4 4.4 4.2 1.6 9.9 0.4 4.8 0.5 0.2 0.1 0.7 0.3 0.2 0.6 0.5 0.2 0.5 3.1 3.0 0.0 1.4 0.8 2.4 113.5 86.7 21.7 51.7 122.8 79.5 162.4 26.2 54.2 49.4 MUC12 MUC11 ENSG00000205277 "Mucin 12, cell surface associated" Q9UKN1 7 100969623-101018949 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 35.6" "Cell line enhanced" "Detected in single" "NTERA-2: 1.7" "Cancer enriched" "Detected in some" 7 "colorectal cancer: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA023835 Enhanced "HPA023835: AB_1854199" "unprognostic (1.38e-1)" "unprognostic (2.09e-1)" "unprognostic (2.80e-2)" "unprognostic (1.60e-1)" "unprognostic (3.84e-4)" "unprognostic (4.40e-2)" "unprognostic (1.30e-3)" "unprognostic (1.84e-2)" "unprognostic (1.40e-1)" "unprognostic (6.52e-2)" "unprognostic (3.72e-1)" "unprognostic (1.92e-1)" "unprognostic (3.33e-7)" "unprognostic (8.42e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-1)" "unprognostic (7.54e-2)" 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 35.6 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 MUC13 DRCC1 ENSG00000173702 "Mucin 13, cell surface associated" Q9H3R2 3 124905442-124953819 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "intestine: 334.4" "Cell line enhanced" "Detected in some" "A549: 8.0;CACO-2: 6.9;CAPAN-2: 14.9;Karpas-707: 8.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 198.4;stomach cancer: 152.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045163 Enhanced "Secreted to digestive system" "HPA045163: AB_10960396" "unprognostic (8.42e-2)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (1.55e-3)" "unprognostic (2.93e-1)" "unprognostic (2.11e-2)" "unprognostic (1.26e-1)" "unprognostic (3.48e-2)" "unprognostic (2.94e-1)" "unprognostic (5.10e-2)" "unprognostic (2.02e-1)" "unprognostic (9.64e-2)" "prognostic unfavourable (9.73e-5)" "unprognostic (2.05e-3)" "unprognostic (1.10e-1)" "unprognostic (2.29e-1)" "unprognostic (1.42e-1)" 0.5 0.6 0.5 16.4 0.5 0.0 0.5 0.5 0.5 0.5 83.1 0.0 0.0 79.9 0.5 0.3 0.5 0.5 16.7 0.5 0.5 0.5 3.3 8.7 0.5 0.0 0.5 0.0 0.5 1.8 0.0 0.5 0.1 0.1 0.5 40.6 0.1 0.5 0.0 0.5 0.5 334.4 1.0 0.5 0.5 4.1 0.5 0.0 0.1 0.5 0.0 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 1.2 1.0 0.0 0.0 0.1 6.9 14.9 0.0 0.9 0.2 1.1 0.0 0.0 0.0 0.1 0.2 0.0 1.7 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.1 0.0 0.0 1.1 0.0 1.2 0.1 0.1 2.7 0.0 0.0 0.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.4 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.0 0.1 0.0 MUC17 ENSG00000169876 "Mucin 17, cell surface associated" Q685J3 7 101020072-101058745 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 299 "intestine: 125.2" "Cell line enhanced" "Detected in single" "BEWO: 1.3" "Group enriched" "Detected in some" 29 "colorectal cancer: 6.1;pancreatic cancer: 4.9;stomach cancer: 22.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031634 Enhanced "Intracellular and membrane" "HPA031634: AB_10603021" "unprognostic (2.37e-2)" "unprognostic (2.41e-1)" "unprognostic (8.17e-3)" "unprognostic (5.57e-3)" "unprognostic (6.07e-2)" "unprognostic (8.79e-8)" "unprognostic (1.28e-1)" "unprognostic (2.47e-2)" 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 64.7 0.0 0.0 15.8 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 2.5 0.0 0.1 0.0 0.1 0.1 125.2 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 MUC19 FLJ35746 ENSG00000205592 "Mucin 19, oligomeric" 12 40393395-40570832 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "salivary gland: 22.6" "Cell line enriched" "Detected in some" 4 "U-937: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" "unprognostic (7.80e-3)" "unprognostic (2.84e-1)" "unprognostic (1.69e-1)" "unprognostic (2.53e-1)" "unprognostic (4.25e-3)" "unprognostic (8.16e-2)" "unprognostic (1.27e-1)" "unprognostic (5.45e-2)" "unprognostic (8.63e-2)" "unprognostic (6.99e-2)" "unprognostic (8.64e-3)" "unprognostic (2.57e-2)" "unprognostic (1.60e-1)" "unprognostic (2.12e-1)" "unprognostic (7.35e-3)" 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC2 ENSG00000198788 "Mucin 2, oligomeric mucus/gel-forming" 11 1074875-1110511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "intestine: 28.1" "Cell line enhanced" "Detected in some" "NB-4: 1.0;RPMI-8226: 1.0;RT4: 2.6" "Group enriched" "Detected in many" 13 "colorectal cancer: 93.2;pancreatic cancer: 27.7;stomach cancer: 21.9" "Not detected" "Not detected" "Not detected" "Not detected" CAB016275 Enhanced "Intracellular and membrane" "CAB016275: AB_627970" "unprognostic (6.37e-2)" "unprognostic (8.32e-2)" "unprognostic (5.76e-3)" "unprognostic (5.09e-2)" "unprognostic (6.18e-3)" "unprognostic (3.39e-2)" "unprognostic (1.71e-2)" "unprognostic (5.76e-3)" "unprognostic (7.87e-2)" "unprognostic (2.04e-1)" "unprognostic (7.37e-3)" "unprognostic (4.20e-2)" "unprognostic (3.64e-5)" "unprognostic (1.38e-1)" "unprognostic (1.22e-1)" "unprognostic (3.10e-2)" 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC22 PBMUCL1 ENSG00000261272 "Mucin 22" E2RYF6 6 31010474-31035402 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "esophagus: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.38e-1)" "unprognostic (1.57e-1)" "unprognostic (1.46e-1)" "unprognostic (1.91e-1)" "unprognostic (4.03e-1)" "unprognostic (1.46e-2)" "unprognostic (9.88e-2)" "unprognostic (1.14e-1)" "unprognostic (3.65e-1)" "unprognostic (1.35e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC7 "FLJ27047, MG2" ENSG00000171195 "Mucin 7, secreted" Q8TAX7 4 70430492-70482997 "Disease related genes, Predicted secreted proteins" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "salivary gland: 1562.5" "Cell line enriched" "Detected in single" 6 "BJ hTERT+: 4.2" "Group enriched" "Detected in some" 12 "head and neck cancer: 8.1;melanoma: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA006411 Enhanced "Secreted to digestive system" "HPA006411: AB_1854204" "unprognostic (5.49e-2)" "unprognostic (3.20e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1562.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 265.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUSK ENSG00000030304 "Muscle associated receptor tyrosine kinase" O15146 9 110668771-110801620 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein, Kinase, Muscle protein, Receptor, Transferase, Tyrosine-protein kinase" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "skeletal muscle: 50.0" "Group enriched" "Detected in some" 15 "LHCN-M2: 19.3;RH-30: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 4.5" "Not detected" "Not detected" "unprognostic (6.12e-2)" "unprognostic (9.01e-2)" "unprognostic (5.39e-2)" "unprognostic (3.66e-1)" "unprognostic (3.14e-1)" "unprognostic (1.20e-2)" "unprognostic (1.50e-2)" "unprognostic (2.46e-1)" "unprognostic (3.13e-1)" "unprognostic (7.58e-2)" "unprognostic (6.03e-5)" "unprognostic (4.58e-2)" "unprognostic (1.62e-1)" "unprognostic (9.67e-2)" "unprognostic (5.11e-2)" 7.5 0.3 0.6 5.8 0.7 0.0 0.2 0.1 0.2 0.3 6.8 0.0 0.0 2.3 0.2 4.0 3.8 0.1 2.1 3.2 0.9 0.7 0.2 0.5 4.2 0.9 0.2 0.1 0.3 0.3 0.0 0.2 0.6 0.3 1.9 5.3 0.0 0.4 0.0 50.0 0.3 5.0 3.0 0.3 0.2 2.6 5.9 0.0 0.0 0.3 1.4 3.9 3.6 2.9 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.4 0.2 0.0 19.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.1 0.2 0.9 0.7 0.2 0.1 0.3 0.0 MUSTN1 Mustang ENSG00000272573 "Musculoskeletal, embryonic nuclear protein 1" Q8IVN3 3 52833114-52835219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "skeletal muscle: 252.5" "Cell line enhanced" "Detected in some" "Hep G2: 9.4;HSkMC: 5.9;RH-30: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Lineage enhanced" "Detected in single" "granulocytes: 2.1" "unprognostic (2.79e-2)" "unprognostic (3.73e-2)" "unprognostic (4.11e-1)" "unprognostic (2.60e-2)" "unprognostic (2.34e-2)" "unprognostic (6.21e-3)" "unprognostic (2.78e-1)" "unprognostic (1.13e-2)" "unprognostic (1.66e-2)" "unprognostic (1.04e-1)" "unprognostic (1.65e-3)" "unprognostic (6.00e-2)" "unprognostic (1.79e-1)" "unprognostic (8.11e-2)" "unprognostic (1.88e-2)" 12.1 1.8 2.5 1.8 5.2 1.3 6.1 1.5 5.7 16.0 4.6 2.6 2.4 1.7 11.1 18.9 7.9 6.4 10.6 15.5 2.6 2.2 1.8 0.8 3.2 1.4 4.3 3.9 5.1 1.6 0.8 1.1 1.3 5.2 11.6 3.4 3.8 5.9 8.9 252.5 2.7 2.6 6.1 2.2 0.9 2.3 6.4 0.2 0.0 5.4 26.9 3.6 8.1 7.9 0.0 0.0 2.1 0.6 0.0 0.3 0.2 0.1 0.2 2.9 0.0 0.8 2.0 3.4 0.2 0.9 0.4 0.3 0.4 0.4 0.0 0.0 1.4 1.2 0.7 0.5 0.4 0.1 0.9 0.0 1.5 9.4 1.4 1.9 0.6 5.9 1.0 0.9 0.0 1.2 0.2 0.0 0.1 0.6 0.7 2.7 0.4 2.1 1.0 8.3 0.0 0.6 0.0 0.3 0.3 0.6 0.7 1.4 0.0 0.7 0.0 0.3 0.7 1.2 0.6 0.0 0.0 0.0 0.3 2.4 0.3 0.0 0.4 0.0 0.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.6 0.0 0.0 0.2 2.5 5.2 1.5 5.7 2.6 2.2 4.3 3.9 5.2 0.2 MYADML2 LOC255275 ENSG00000185105 "Myeloid associated differentiation marker like 2" A6NDP7 17 81939645-81947233 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 20 "skeletal muscle: 44.5" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 8.2" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041856, HPA048476" Uncertain "HPA041856: , HPA048476: " "unprognostic (1.83e-1)" "unprognostic (1.71e-2)" "unprognostic (7.07e-2)" "unprognostic (2.90e-4)" "unprognostic (2.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.32e-1)" "unprognostic (6.09e-2)" "unprognostic (1.44e-2)" "unprognostic (3.37e-2)" "unprognostic (4.16e-7)" "unprognostic (1.86e-1)" "unprognostic (1.91e-1)" "unprognostic (8.68e-2)" 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.4 2.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 1.5 0.6 1.5 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 44.5 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.3 1.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.6 0.0 0.1 0.6 0.5 0.0 0.4 0.1 0.0 0.2 8.2 0.6 0.2 0.2 0.6 0.2 0.0 0.0 0.3 0.7 0.2 0.0 1.5 1.1 0.3 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYB c-myb ENSG00000118513 "MYB proto-oncogene, transcription factor" P10242 6 135181315-135219173 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 104.9" "Cell line enhanced" "Detected in many" "HL-60: 38.9;MOLT-4: 70.8;NB-4: 36.9;REH: 43.7;THP-1: 61.8;U-937: 33.7" "Cancer enhanced" "Detected in many" "breast cancer: 17.7" "Region enhanced" "Detected in some" "basal ganglia: 4.7" "Group enriched" "Detected in some" 4 "basophil: 5.6;eosinophil: 10.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "CAB017704, HPA071605" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB017704: , HPA071605: " "unprognostic (1.69e-1)" "unprognostic (5.82e-2)" "unprognostic (1.82e-3)" "unprognostic (1.37e-2)" "unprognostic (4.06e-1)" "unprognostic (8.35e-3)" "unprognostic (1.13e-3)" "unprognostic (2.48e-2)" "unprognostic (6.44e-2)" "unprognostic (1.00e-1)" "unprognostic (3.71e-2)" "prognostic favourable (9.65e-4)" "unprognostic (2.41e-11)" "prognostic favourable (9.87e-4)" "unprognostic (8.35e-2)" "unprognostic (3.04e-2)" "unprognostic (9.40e-2)" 0.5 0.7 1.3 9.1 4.7 18.9 13.2 0.3 0.6 1.4 15.4 0.5 0.3 6.5 0.9 1.0 3.7 5.0 1.7 0.6 0.7 0.7 0.4 0.5 1.8 3.3 0.3 0.5 1.0 0.3 0.4 0.3 0.6 0.5 1.6 16.7 0.5 0.8 1.5 1.0 3.5 5.9 0.7 0.4 1.4 0.9 2.0 0.6 104.9 0.4 2.0 4.7 0.7 1.5 0.1 1.7 10.0 0.8 0.0 0.5 0.1 0.3 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 1.8 0.0 0.0 0.1 1.0 0.0 0.1 3.1 0.4 24.8 0.1 0.0 0.0 38.9 19.6 0.0 0.0 0.1 0.0 0.0 20.1 3.7 0.2 2.0 70.8 36.9 0.2 0.3 43.7 1.0 6.0 0.0 0.2 1.9 1.2 0.0 1.9 0.0 1.4 61.8 0.0 0.0 0.3 1.4 0.4 4.7 1.2 12.0 0.0 33.7 0.4 5.6 0.8 10.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 1.7 0.5 0.1 1.3 4.7 0.3 0.6 0.7 0.7 0.3 0.5 0.5 0.6 MYBPC1 ENSG00000196091 "Myosin binding protein C, slow type" Q00872 12 101568353-101686018 "Disease related genes, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 739.9" "Cell line enhanced" "Detected in some" "AF22: 2.5;HSkMC: 3.3;SCLC-21H: 1.0" "Cancer enhanced" "Detected in many" "prostate cancer: 33.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "intermediate monocyte: 1.4" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Group enriched" "Detected in some" 9 "cerebellum: 41.6;olfactory region: 12.2" "Low region specificity" "Detected in all" "HPA021004, HPA027614" Enhanced "HPA021004: AB_1854232, HPA027614: AB_10602711" "prognostic favourable (4.76e-5)" "unprognostic (7.72e-2)" "unprognostic (1.09e-1)" "unprognostic (1.81e-2)" "unprognostic (3.33e-2)" "unprognostic (4.63e-2)" "unprognostic (8.67e-2)" "unprognostic (2.93e-1)" "unprognostic (9.98e-3)" "unprognostic (2.56e-1)" "unprognostic (2.55e-1)" "unprognostic (1.19e-2)" "unprognostic (4.10e-2)" "unprognostic (7.96e-2)" "unprognostic (6.13e-2)" "unprognostic (5.55e-3)" 10.4 0.1 0.2 0.1 0.2 0.1 3.3 0.1 0.6 0.2 0.3 0.0 0.0 0.1 0.1 20.1 6.2 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.1 0.0 4.5 0.1 0.0 8.1 0.1 739.9 0.2 0.5 0.1 0.2 0.1 0.2 0.3 0.0 0.0 2.7 164.9 9.7 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.7 1.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.6 0.2 0.2 0.2 0.0 0.0 0.0 MYBPC3 "CMH4, FHC, MYBP-C" ENSG00000134571 "Myosin binding protein C, cardiac" Q14896 11 47331397-47352702 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 108 "heart muscle: 199.6" "Cell line enriched" "Detected in single" 17 "U-937: 11.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Lineage enhanced" "Detected in single" "granulocytes: 1.8" "Region enriched" "Detected in single" 33 "cerebellum: 38.5" "Low region specificity" "Detected in many" "HPA040147, HPA043898" Enhanced 44000 "HPA040147: AB_2676861, HPA043898: AB_2678720" "unprognostic (1.06e-1)" "unprognostic (1.47e-6)" "unprognostic (2.17e-1)" "unprognostic (6.16e-2)" "unprognostic (3.00e-3)" "unprognostic (1.40e-4)" "unprognostic (7.47e-2)" "unprognostic (2.72e-2)" "unprognostic (2.53e-1)" "unprognostic (1.62e-1)" "unprognostic (9.53e-2)" "unprognostic (4.22e-2)" "unprognostic (1.11e-3)" "unprognostic (2.11e-1)" "unprognostic (1.96e-1)" "unprognostic (4.15e-1)" "unprognostic (3.21e-2)" 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 199.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.7 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 MYBPH ENSG00000133055 "Myosin binding protein H" Q13203 1 203167811-203175813 "Predicted intracellular proteins" "Cell adhesion" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 53.8" "Group enriched" "Detected in some" 5 "CACO-2: 17.2;HSkMC: 33.7;THP-1: 8.4" "Group enriched" "Detected in many" 7 "glioma: 4.9;head and neck cancer: 20.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 6.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA061383 Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Mitochondria" Nucleoli "HPA061383: " "unprognostic (2.26e-4)" "unprognostic (2.04e-1)" "unprognostic (3.50e-1)" "unprognostic (1.06e-1)" "unprognostic (3.82e-2)" "unprognostic (1.32e-3)" "unprognostic (3.42e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-1)" "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (1.75e-1)" "unprognostic (7.62e-4)" "unprognostic (1.51e-1)" "unprognostic (3.34e-2)" "unprognostic (1.14e-1)" "unprognostic (1.74e-1)" 0.8 0.1 1.1 0.8 0.8 0.3 0.4 0.4 0.6 0.1 0.1 0.0 0.0 0.1 0.4 4.4 3.9 0.2 0.1 0.2 0.4 0.3 1.1 1.5 0.2 0.3 1.3 0.0 0.1 0.2 0.1 0.6 0.3 1.0 4.2 0.1 0.0 8.8 0.1 53.8 0.2 0.1 0.1 0.4 0.4 0.1 0.2 2.1 0.9 3.9 12.7 2.0 0.3 0.8 0.0 6.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.3 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.5 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 6.1 0.0 0.1 1.1 0.8 0.4 0.6 0.4 0.3 1.3 0.0 1.0 2.1 MYBPHL ENSG00000221986 "Myosin binding protein H like" A2RUH7 1 109292365-109307041 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 46 "heart muscle: 64.6" "Cell line enhanced" "Detected in some" "BEWO: 2.3;Daudi: 1.5;Hep G2: 6.5;K-562: 1.7;RH-30: 3.8;THP-1: 1.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (6.07e-3)" "unprognostic (1.43e-1)" "unprognostic (2.78e-1)" "unprognostic (1.17e-2)" "unprognostic (1.47e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-2)" "unprognostic (1.24e-2)" "unprognostic (5.53e-2)" "unprognostic (5.89e-1)" "unprognostic (5.22e-3)" "unprognostic (4.10e-1)" "unprognostic (7.05e-9)" "unprognostic (6.01e-2)" "unprognostic (1.53e-1)" "unprognostic (5.81e-2)" "unprognostic (2.64e-1)" 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.3 1.3 0.0 64.6 0.4 0.1 0.0 0.0 0.7 0.0 1.4 0.1 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.4 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.1 0.4 0.1 0.2 0.0 0.8 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.1 0.6 0.4 0.1 1.4 0.1 0.4 0.9 MYCBPAP "AMAP-1, DKFZp434N1415" ENSG00000136449 "MYCBP associated protein" Q8TBZ2 17 50508384-50531501 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 81.2" "Cell line enhanced" "Detected in many" "HDLM-2: 7.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023257, HPA024405" Enhanced Approved Vesicles Vesicles "HPA023257: , HPA024405: " "unprognostic (2.05e-2)" "unprognostic (1.79e-2)" "unprognostic (9.13e-3)" "unprognostic (3.98e-5)" "unprognostic (8.62e-4)" "unprognostic (3.65e-2)" "unprognostic (1.52e-3)" "unprognostic (1.61e-1)" "unprognostic (2.38e-3)" "unprognostic (1.11e-1)" "unprognostic (7.32e-4)" "unprognostic (2.52e-1)" "unprognostic (1.39e-4)" "unprognostic (7.15e-2)" "unprognostic (1.97e-1)" "unprognostic (7.37e-2)" "unprognostic (2.02e-2)" 0.5 0.6 1.1 0.4 1.6 0.9 0.4 1.3 1.4 0.9 0.4 1.6 0.8 0.1 1.3 2.2 0.6 3.5 1.0 0.4 1.2 0.8 0.4 0.2 1.1 0.6 0.4 0.9 1.9 0.2 0.4 0.7 0.2 3.5 0.8 0.2 0.6 0.7 1.2 0.6 0.8 0.3 0.7 0.9 0.5 0.3 81.2 0.4 0.3 0.6 0.0 0.4 0.4 0.5 0.3 0.2 2.8 0.4 1.0 1.0 0.3 0.3 1.5 0.8 0.6 2.0 1.3 1.5 0.7 0.4 0.5 0.7 1.4 3.4 0.5 0.2 0.4 0.9 0.4 2.4 0.4 7.8 0.7 2.7 2.6 0.8 1.8 0.1 0.7 2.8 0.6 1.3 4.2 1.5 0.9 0.8 1.6 0.9 0.3 0.7 0.2 1.2 0.4 0.7 0.4 0.1 0.9 1.5 3.5 0.9 0.5 0.6 0.8 1.6 4.3 0.9 1.3 0.3 0.3 4.8 1.6 0.4 1.1 0.5 2.4 1.2 0.4 0.7 0.3 0.3 0.4 0.1 0.4 0.3 0.1 0.3 0.9 0.4 2.8 1.0 0.1 0.2 1.0 0.3 1.1 1.6 1.3 1.4 1.2 0.8 0.4 0.9 3.5 0.4 MYF6 "bHLHc4, MRF4" ENSG00000111046 "Myogenic factor 6" P23409 12 80707498-80709474 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skeletal muscle: 175.1" "Cell line enriched" "Detected in some" 17 "LHCN-M2: 22.6" "Group enriched" "Detected in some" 11 "head and neck cancer: 3.0;prostate cancer: 0.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "unprognostic (2.20e-2)" "prognostic unfavourable (2.05e-4)" "unprognostic (9.88e-2)" "unprognostic (6.64e-1)" 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 175.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 17.1 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYH1 "MGC133384, MYHa, MyHC-2X/D, MYHSA1" ENSG00000109061 "Myosin heavy chain 1" P12882 17 10492307-10518543 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "skeletal muscle: 428.9" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;U-2 OS: 2.2" "Cancer enriched" "Detected in single" 45 "head and neck cancer: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001349, CAB010759" Enhanced 49000000 "CAB010759: AB_477248, HPA001349: AB_1079437" "unprognostic (2.87e-2)" "unprognostic (3.27e-3)" "unprognostic (1.91e-1)" "unprognostic (8.95e-3)" "unprognostic (4.49e-2)" "unprognostic (7.31e-2)" "unprognostic (5.63e-3)" "unprognostic (9.85e-4)" "unprognostic (1.92e-1)" "unprognostic (4.58e-2)" 5.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 428.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYH4 "MYH2B, MyHC-2B, MyHC-IIb" ENSG00000264424 "Myosin heavy chain 4" Q9Y623 17 10443290-10469559 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 29 "skeletal muscle: 15.1" "Cell line enhanced" "Detected in some" "CACO-2: 2.5;U-2 OS: 1.4" "Cancer enriched" "Detected in single" 115 "liver cancer: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "amygdala: 0.9" HPA001349 Supported 34000000 "HPA001349: AB_1079437" "unprognostic (3.27e-2)" "unprognostic (2.94e-2)" "unprognostic (4.94e-2)" "unprognostic (1.69e-2)" "unprognostic (4.72e-1)" "unprognostic (1.37e-1)" "unprognostic (3.32e-2)" "unprognostic (1.21e-3)" "unprognostic (3.52e-4)" "unprognostic (9.97e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 MYH6 ENSG00000197616 "Myosin heavy chain 6" P13533 14 23381990-23408277 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Atrial septal defect, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "heart muscle: 313.7" "Cell line enriched" "Detected in single" 23 "NTERA-2: 10.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001239, HPA001349, CAB075723, CAB075724, CAB075725" Enhanced 20000000 "CAB075723: , CAB075724: , CAB075725: , HPA001239: AB_1079438, HPA001349: AB_1079437" "unprognostic (2.09e-2)" "unprognostic (8.53e-4)" "unprognostic (1.80e-2)" "unprognostic (2.99e-1)" "unprognostic (1.66e-1)" "unprognostic (2.09e-1)" "unprognostic (1.66e-1)" "unprognostic (5.73e-2)" "unprognostic (1.44e-2)" "unprognostic (5.34e-3)" "unprognostic (6.90e-2)" "unprognostic (1.42e-1)" "unprognostic (1.85e-1)" "unprognostic (1.22e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.2 0.2 0.0 0.1 313.7 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 8.6 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.7 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 MYL4 "ALC1, AMLC, GT1, PRO1957" ENSG00000198336 "Myosin light chain 4" P12829 17 47200446-47223679 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Atrial fibrillation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "heart muscle: 712.3" "Cell line enriched" "Detected in some" 4 "HEL: 107.4" "Group enriched" "Detected in some" 7 "testis cancer: 2.4;thyroid cancer: 11.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 11 "dendritic cells: 5.2" "Group enriched" "Detected in many" 6 "amygdala: 25.9;cerebral cortex: 83.3;hippocampal formation: 27.8" "Low region specificity" "Detected in all" "HPA046859, HPA051884, HPA063034" Enhanced Approved "Plasma membrane" 140000 "Plasma membrane" "HPA046859: , HPA051884: , HPA063034: " "unprognostic (2.43e-2)" "unprognostic (9.57e-2)" "unprognostic (2.25e-1)" "unprognostic (5.51e-2)" "unprognostic (2.33e-1)" "unprognostic (4.12e-3)" "unprognostic (5.06e-3)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (6.52e-2)" "unprognostic (2.10e-2)" "unprognostic (7.37e-2)" "unprognostic (1.00e-6)" "unprognostic (1.92e-4)" "unprognostic (2.54e-1)" "unprognostic (6.51e-3)" "unprognostic (1.50e-1)" 0.1 0.0 0.0 0.1 0.0 10.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 712.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.7 0.0 0.0 0.7 0.1 0.0 0.0 0.8 3.3 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.2 0.7 0.0 0.1 0.6 4.6 0.1 0.1 0.2 0.2 5.2 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 107.4 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.2 25.4 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 MYL7 "MYL2A, MYLC2A" ENSG00000106631 "Myosin light chain 7" Q01449 7 44138864-44141332 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 822 "heart muscle: 639.9" "Group enriched" "Detected in some" 21 "BEWO: 15.0;CACO-2: 50.9" "Cancer enriched" "Detected in some" 7 "testis cancer: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013331, CAB033884, HPA039262" Enhanced "CAB033884: AB_2266773, HPA013331: AB_1854245, HPA039262: " "unprognostic (1.00e-2)" "unprognostic (7.99e-2)" "unprognostic (4.36e-3)" "unprognostic (2.31e-1)" "unprognostic (2.51e-1)" "unprognostic (1.28e-1)" "unprognostic (7.85e-2)" "unprognostic (1.67e-1)" "unprognostic (7.28e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 639.9 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.1 0.0 50.9 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 MYLK2 "KMLC, MLCK2, skMLCK" ENSG00000101306 "Myosin light chain kinase 2" Q9H1R3 20 31819308-31834689 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skeletal muscle: 176.1" "Cell line enhanced" "Detected in some" "Karpas-707: 5.2;RH-30: 13.2;RPMI-8226: 10.7" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA059704, HPA059890" Enhanced Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA059704: , HPA059890: " "unprognostic (1.74e-2)" "unprognostic (1.87e-1)" "unprognostic (8.84e-2)" "unprognostic (5.27e-2)" "prognostic favourable (4.00e-4)" "unprognostic (5.58e-2)" "unprognostic (1.38e-7)" "unprognostic (2.29e-1)" "unprognostic (2.60e-3)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (4.73e-2)" "unprognostic (7.25e-11)" "unprognostic (2.01e-1)" "unprognostic (3.15e-1)" "unprognostic (2.60e-2)" "unprognostic (2.70e-2)" 1.4 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.4 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.3 176.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 1.1 18.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.8 0.0 0.0 0.5 0.1 0.0 0.4 0.1 0.3 0.3 0.6 0.4 0.0 0.1 0.1 0.0 0.2 0.2 0.2 0.7 0.3 0.0 0.0 0.6 0.1 0.0 0.0 0.4 0.0 1.0 0.2 5.2 0.1 0.8 0.7 0.4 0.6 0.4 0.7 13.2 10.7 0.1 0.1 0.7 0.6 3.4 0.1 0.0 0.1 0.1 2.6 0.2 1.0 0.6 2.9 0.1 0.9 0.2 0.2 3.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 MYO15A "DFNB3, MYO15" ENSG00000091536 "Myosin XVA" Q9UKN7 17 18108706-18179806 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Hearing "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pituitary gland: 46.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.6;EFO-21: 2.8;HSkMC: 2.2;RPMI-8226: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 3.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "hippocampal formation: 2.7" HPA078501 Enhanced "HPA078501: " "unprognostic (2.48e-3)" "unprognostic (5.31e-2)" "unprognostic (2.87e-3)" "unprognostic (7.35e-3)" "unprognostic (4.92e-3)" "unprognostic (2.33e-1)" "unprognostic (8.32e-4)" "unprognostic (4.51e-2)" "unprognostic (1.51e-1)" "unprognostic (1.24e-1)" "unprognostic (4.66e-3)" "unprognostic (8.38e-2)" "unprognostic (4.18e-3)" "unprognostic (5.69e-3)" "unprognostic (9.89e-2)" "unprognostic (1.47e-1)" "unprognostic (2.21e-2)" 0.5 0.0 0.5 0.6 0.7 0.0 0.5 2.3 1.6 0.5 0.5 0.5 0.5 0.2 1.7 3.4 0.5 1.0 0.5 0.5 0.5 1.2 0.5 0.8 1.5 0.5 0.5 0.5 3.0 0.5 2.2 46.1 0.5 0.7 0.5 0.4 0.5 0.5 1.6 0.5 0.1 0.9 0.5 0.5 0.5 0.6 7.4 0.5 0.5 0.9 0.5 0.5 0.5 0.5 0.7 0.4 3.8 0.9 0.6 0.3 0.1 0.1 0.0 1.5 0.0 0.9 2.6 0.4 0.1 0.9 0.0 0.0 0.5 0.3 0.2 2.8 0.9 0.4 0.0 0.8 0.0 1.3 0.6 0.0 0.3 0.0 0.4 0.0 0.0 2.2 0.0 0.4 0.6 0.0 0.1 0.4 0.0 0.5 0.1 0.5 0.1 0.0 0.2 0.4 3.4 0.0 0.0 0.1 0.2 0.0 0.0 0.2 1.4 0.4 0.2 0.0 0.1 0.0 0.0 1.0 1.4 0.1 0.0 0.1 0.4 3.8 0.5 0.5 0.2 0.9 0.3 0.7 0.1 0.1 0.2 0.4 0.2 0.3 1.4 0.6 0.2 0.4 0.1 0.1 0.5 0.7 2.3 1.5 0.5 1.2 0.5 0.5 0.7 0.5 MYO15B MYO15BP ENSG00000266714 "Myosin XVB" 17 75588058-75626501 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 10 "intestine: 155.3" "Cell line enhanced" "Detected in many" "A549: 25.6;HEL: 10.7;HMC-1: 14.7;THP-1: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "HPA022857, HPA023105" Approved Cytosol Cytosol "HPA022857: AB_1848813, HPA023105: AB_1859526" "prognostic favourable (9.34e-4)" "unprognostic (7.55e-2)" "unprognostic (6.99e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "unprognostic (5.59e-4)" "unprognostic (7.29e-3)" "unprognostic (1.48e-1)" "unprognostic (4.97e-2)" "unprognostic (2.28e-1)" "unprognostic (8.54e-3)" "unprognostic (1.04e-2)" "unprognostic (1.49e-1)" "unprognostic (6.39e-2)" "unprognostic (1.68e-1)" "unprognostic (3.35e-1)" "prognostic favourable (6.90e-5)" 7.5 2.8 4.2 7.3 5.3 13.8 8.9 1.6 4.3 8.0 58.9 8.1 5.4 48.9 13.6 4.5 2.8 10.8 13.5 5.8 4.5 1.7 13.0 2.0 10.7 5.0 6.5 5.5 14.9 3.6 1.8 3.7 4.0 5.1 7.1 5.9 6.5 5.2 4.5 3.1 3.9 155.3 5.9 4.0 13.2 4.8 3.1 5.9 5.5 14.0 2.3 4.0 4.9 7.2 2.8 2.0 6.2 1.5 1.9 1.4 1.1 0.3 25.6 0.3 0.9 0.2 0.4 0.3 0.1 0.0 0.0 0.0 3.3 7.3 0.3 1.0 0.0 0.4 0.0 0.0 0.0 0.3 1.9 10.7 4.9 6.3 0.7 0.0 14.7 0.7 0.4 0.0 0.0 0.1 0.6 2.8 0.0 3.5 0.2 4.2 0.5 6.4 6.6 0.2 1.1 0.1 0.5 1.0 2.0 0.2 0.4 0.8 2.2 21.1 0.5 0.1 1.1 0.1 0.1 1.4 0.8 0.1 0.6 5.2 0.4 2.4 1.5 1.2 1.4 1.4 0.9 1.5 0.7 0.5 0.8 2.8 0.5 1.0 6.2 1.9 1.5 2.0 0.2 1.1 4.2 5.3 1.6 4.3 4.5 1.7 6.5 5.5 5.1 5.9 MYO18A "KIAA0216, MysPDZ" ENSG00000196535 "Myosin XVIIIA" Q92614 17 29071124-29180412 "Plasma proteins, Predicted intracellular proteins" "Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "skeletal muscle: 179.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019646 Supported 80000 "HPA019646: AB_1854249" "unprognostic (2.54e-2)" "unprognostic (1.08e-1)" "unprognostic (5.36e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-1)" "unprognostic (3.48e-1)" "unprognostic (1.72e-1)" "unprognostic (3.31e-2)" "unprognostic (8.70e-2)" "prognostic unfavourable (3.28e-4)" "unprognostic (1.94e-1)" "unprognostic (1.74e-1)" "prognostic favourable (3.18e-4)" "unprognostic (6.94e-2)" "unprognostic (2.12e-2)" "unprognostic (6.95e-3)" "unprognostic (1.95e-1)" 8.3 3.6 11.9 5.8 15.5 7.7 8.6 23.1 18.7 6.1 6.7 15.9 3.6 9.0 6.5 5.4 11.8 4.4 7.2 24.6 15.2 9.4 4.0 9.2 5.2 4.8 13.6 9.9 5.1 9.3 7.4 3.4 4.0 11.4 6.0 4.8 4.4 7.4 5.1 179.7 11.7 9.0 6.3 15.7 4.8 9.0 4.3 12.9 8.0 5.7 14.5 9.1 4.8 5.9 2.2 2.3 2.9 1.8 2.1 3.0 0.7 15.0 21.3 8.2 4.2 2.2 3.8 13.2 7.2 7.2 6.3 4.4 5.3 10.7 1.5 8.1 5.1 17.3 3.2 12.0 2.5 17.5 6.0 1.3 6.3 5.8 3.3 1.8 1.9 4.4 7.1 3.8 1.7 2.3 18.6 2.8 3.1 5.2 5.4 1.5 1.7 4.7 19.0 9.2 4.7 4.9 11.2 4.3 4.4 7.1 24.1 5.3 5.6 2.2 2.6 4.1 5.1 2.8 4.9 5.3 8.9 3.0 5.2 1.3 11.0 2.5 1.6 2.4 2.3 1.8 3.0 0.9 1.7 1.8 1.8 2.2 2.4 1.4 2.9 2.1 1.7 2.3 1.3 0.7 11.9 15.5 23.1 18.7 15.2 9.4 13.6 9.9 11.4 12.9 MYO18B BK125H2.1 ENSG00000133454 "Myosin XVIIIB" 22 25742144-26031041 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 141.2" "Cell line enhanced" "Detected in some" "HDLM-2: 7.6;REH: 10.9;RH-30: 23.3;U-2 OS: 10.3;U-266/70: 7.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA000953 Uncertain Supported Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA000953: AB_1079440" "unprognostic (3.28e-2)" "unprognostic (1.79e-1)" "unprognostic (1.86e-2)" "unprognostic (1.23e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-2)" "unprognostic (5.93e-4)" "unprognostic (2.46e-1)" "unprognostic (1.22e-1)" "unprognostic (7.14e-2)" "unprognostic (4.36e-3)" "unprognostic (2.96e-3)" "unprognostic (3.93e-7)" "unprognostic (1.14e-1)" "unprognostic (3.12e-1)" "unprognostic (5.06e-2)" "unprognostic (1.65e-1)" 3.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.4 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 1.0 0.0 141.2 0.1 0.0 1.5 0.0 0.0 0.3 2.4 0.0 0.3 1.1 16.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 3.9 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 1.9 0.7 2.9 0.0 0.3 1.1 0.0 0.0 10.9 23.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 7.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYO1A "DFNA48, MYHL" ENSG00000166866 "Myosin IA" Q9UBC5 12 57028517-57051198 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "intestine: 148.0" "Cell line enhanced" "Detected in some" "BEWO: 3.0;CACO-2: 11.9;Hep G2: 7.9;NB-4: 2.3" "Group enriched" "Detected in many" 13 "colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8" "Region enhanced" "Detected in single" "pons and medulla: 1.3" "Group enriched" "Detected in some" 5 "classical monocyte: 1.2;intermediate monocyte: 1.1;myeloid DC: 2.9" "Group enriched" "Detected in many" 6 "dendritic cells: 2.9;monocytes: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA053490 Enhanced Approved Nucleoplasm Nucleoplasm "HPA053490: " "unprognostic (2.77e-2)" "unprognostic (2.00e-3)" "unprognostic (1.04e-1)" "unprognostic (1.20e-1)" "unprognostic (7.31e-2)" "unprognostic (7.11e-2)" "unprognostic (4.57e-2)" "unprognostic (1.57e-1)" "unprognostic (6.04e-2)" "unprognostic (4.26e-2)" "unprognostic (8.96e-2)" "unprognostic (2.14e-1)" "unprognostic (2.38e-2)" "unprognostic (6.89e-2)" "unprognostic (5.01e-1)" "unprognostic (5.81e-2)" "unprognostic (8.72e-2)" 0.1 0.1 0.1 5.2 0.2 0.0 0.1 0.1 0.2 0.1 57.2 0.3 0.1 70.0 0.1 0.1 0.1 0.1 5.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.2 1.3 0.1 14.1 0.1 0.2 0.1 0.1 0.1 148.0 0.4 4.7 0.1 3.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 2.9 0.0 1.2 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.0 11.9 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 7.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 2.3 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.8 0.7 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.5 0.1 1.3 0.1 MYO1H FLJ37587 ENSG00000174527 "Myosin IH" Q8N1T3 12 109347903-109455523 "Predicted intracellular proteins" "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 4.7" "Cell line enhanced" "Detected in some" "SK-BR-3: 1.3;U-266/70: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA039516 Uncertain "HPA039516: AB_10794198" "unprognostic (1.92e-1)" "unprognostic (8.00e-3)" "unprognostic (1.05e-1)" "unprognostic (1.97e-1)" "unprognostic (2.47e-1)" "unprognostic (4.07e-7)" "unprognostic (7.13e-2)" "unprognostic (6.26e-4)" "unprognostic (1.51e-1)" "unprognostic (2.09e-1)" "unprognostic (7.90e-2)" "unprognostic (2.88e-1)" "unprognostic (1.12e-3)" "unprognostic (2.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.44e-1)" "unprognostic (1.52e-1)" 0.6 0.0 0.0 0.2 0.2 0.1 0.4 0.0 0.0 0.4 0.1 0.2 0.2 0.2 0.7 0.1 0.2 0.7 0.0 0.5 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 4.7 0.9 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.4 0.2 0.8 0.1 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 2.6 0.1 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYO5B KIAA1119 ENSG00000167306 "Myosin VB" Q9ULV0 18 49822813-50195093 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 92.2" "Cell line enhanced" "Detected in many" "A-431: 20.6;HaCaT: 32.6;RH-30: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA040593, HPA040902, HPA069773" Enhanced Approved "Plasma membrane" "Plasma membrane" "HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: " "unprognostic (2.51e-1)" "unprognostic (2.15e-2)" "unprognostic (2.12e-2)" "unprognostic (6.17e-3)" "unprognostic (2.14e-1)" "unprognostic (8.84e-3)" "unprognostic (1.32e-1)" "unprognostic (2.59e-1)" "unprognostic (4.13e-2)" "unprognostic (3.46e-1)" "prognostic unfavourable (2.26e-5)" "unprognostic (4.48e-2)" "prognostic favourable (1.45e-11)" "unprognostic (2.17e-3)" "unprognostic (1.50e-1)" "unprognostic (6.56e-2)" "unprognostic (3.28e-1)" 2.0 1.2 1.1 12.7 1.3 0.0 5.2 0.4 2.5 7.5 56.9 1.0 13.7 23.5 1.8 10.4 20.3 4.6 20.6 2.0 1.8 1.2 19.1 13.9 9.4 0.6 0.7 1.5 1.7 16.4 9.3 10.5 13.5 2.1 6.0 17.5 8.4 21.6 8.7 0.6 14.5 92.2 0.8 0.7 0.9 13.1 5.5 0.3 2.4 16.3 14.9 17.4 4.0 11.8 1.0 0.1 0.0 0.0 2.4 0.6 0.0 20.6 5.6 0.1 0.1 0.0 0.0 11.3 0.1 0.8 0.4 0.0 14.6 8.8 0.0 5.2 0.0 32.6 7.4 8.8 0.4 0.0 2.2 0.0 2.5 10.3 0.0 0.0 0.0 0.0 7.8 0.2 5.4 0.7 0.1 8.1 0.8 8.0 0.0 0.0 1.5 2.3 0.0 50.5 3.5 18.6 4.2 11.2 0.2 7.9 9.3 0.0 5.5 0.0 0.4 0.0 11.4 0.1 2.1 5.5 3.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 1.0 0.4 0.1 0.0 0.0 0.2 0.4 0.0 2.4 0.0 0.1 0.1 0.0 1.1 1.3 0.4 2.5 1.8 1.2 0.7 1.5 2.1 0.3 MYO7B ENSG00000169994 "Myosin VIIB" Q6PIF6 2 127535802-127637729 "Predicted intracellular proteins" Differentiation "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 124.3" "Cell line enriched" "Detected in some" 18 "MOLT-4: 77.4" "Group enriched" "Detected in many" 8 "colorectal cancer: 17.2;pancreatic cancer: 5.4;renal cancer: 3.7;stomach cancer: 9.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "classical monocyte: 7.2;naive B-cell: 9.1" "Group enriched" "Detected in many" 24 "B-cells: 9.1;dendritic cells: 3.3;monocytes: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA039131 Enhanced "HPA039131: AB_10672771" "unprognostic (4.10e-3)" "unprognostic (3.81e-2)" "unprognostic (3.80e-2)" "unprognostic (2.23e-4)" "unprognostic (1.14e-2)" "unprognostic (2.23e-1)" "unprognostic (2.07e-1)" "unprognostic (8.51e-2)" "unprognostic (3.76e-1)" "unprognostic (3.86e-2)" "unprognostic (2.32e-1)" "unprognostic (1.03e-1)" "prognostic favourable (1.25e-4)" "unprognostic (2.80e-2)" "unprognostic (8.76e-2)" "unprognostic (1.57e-1)" "unprognostic (2.88e-1)" 0.2 0.2 0.2 8.4 0.3 2.0 0.2 0.2 0.3 0.2 67.2 0.0 0.7 41.3 0.2 7.2 0.3 0.3 21.0 0.2 0.3 0.3 8.9 0.4 0.5 2.0 0.5 0.0 0.2 0.3 0.0 0.2 0.3 0.0 0.2 9.2 0.0 0.2 0.0 0.3 0.2 124.3 0.2 0.4 7.3 0.2 0.9 0.0 3.0 0.2 0.0 0.5 0.2 0.2 9.1 3.3 0.2 7.2 0.0 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 4.1 1.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 77.4 0.2 0.0 0.5 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 2.4 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.1 0.0 2.7 0.0 1.2 0.0 0.0 3.3 9.1 0.0 0.2 0.2 0.0 1.7 0.8 0.0 2.7 0.2 0.3 0.2 0.3 0.3 0.3 0.5 0.0 0.0 0.0 MYOD1 "bHLHc1, MYF3, MYOD, PUM" ENSG00000129152 "Myogenic differentiation 1" P15172 11 17719568-17722131 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 31.8" "Cell line enriched" "Detected in some" 15 "RH-30: 101.2" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "hippocampal formation: 0.5" "HPA055436, HPA078647" Enhanced Nucleoplasm Nucleoplasm "HPA055436: , HPA078647: " "unprognostic (1.07e-3)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.5 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 4.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 101.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 MYOG "bHLHc3, MYF4" ENSG00000122180 Myogenin P15173 1 203083132-203086036 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 60.0" "Group enriched" "Detected in some" 200 "HSkMC: 17.6;RH-30: 33.6" "Group enriched" "Detected in some" 6 "head and neck cancer: 3.9;testis cancer: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA028336 Supported Nucleoplasm Nucleoplasm "HPA028336: " "unprognostic (1.71e-1)" "unprognostic (1.64e-1)" "unprognostic (1.05e-3)" "unprognostic (2.22e-1)" "unprognostic (2.79e-9)" "unprognostic (3.96e-1)" "unprognostic (2.56e-1)" 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.3 0.0 0.0 2.4 0.0 60.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.7 13.3 1.7 0.0 0.0 0.8 0.8 2.3 1.3 1.8 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 33.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.4 0.8 0.4 0.7 1.0 0.8 0.5 0.6 0.3 0.6 0.9 1.0 1.4 1.8 1.3 0.8 0.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYRFL "bcm1377, C12orf15, C12orf28, FLJ25056" ENSG00000166268 "Myelin regulatory factor-like" Q96LU7 12 69825304-69959097 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "intestine: 56.1" "Cell line enhanced" "Detected in some" "NTERA-2: 6.8;SK-BR-3: 3.4;T-47d: 15.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "cerebellum: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049340 Approved Approved Nucleoli "Intracellular and membrane" Nucleoli "HPA049340: AB_2680719" "unprognostic (2.95e-2)" "unprognostic (6.25e-2)" "unprognostic (2.49e-2)" "unprognostic (1.42e-1)" "unprognostic (5.18e-2)" "unprognostic (2.34e-1)" "unprognostic (5.45e-2)" "unprognostic (6.50e-2)" "unprognostic (3.37e-1)" "unprognostic (2.65e-1)" "unprognostic (3.08e-1)" "unprognostic (8.99e-2)" "unprognostic (1.91e-2)" "unprognostic (3.89e-2)" "unprognostic (2.07e-2)" "unprognostic (1.17e-1)" "unprognostic (9.96e-2)" 0.3 0.3 0.5 0.0 0.6 0.0 0.5 3.6 0.6 0.1 20.7 0.0 0.4 21.4 0.1 0.9 0.1 0.1 0.7 0.2 0.4 0.2 2.0 0.3 0.2 0.2 0.5 0.2 0.0 0.8 0.0 1.0 0.3 0.7 0.6 0.1 0.3 1.3 0.4 0.0 1.6 56.1 0.1 1.0 0.1 0.1 2.4 0.5 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.8 0.0 0.1 0.0 1.1 1.0 0.0 0.3 0.1 0.0 3.4 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.4 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 3.6 0.6 0.4 0.2 0.5 0.2 0.7 0.5 MYT1 "MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A" ENSG00000196132 "Myelin transcription factor 1" Q01538 20 64102394-64242253 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 69.5" "Cell line enhanced" "Detected in some" "HAP1: 4.7;REH: 13.0;SCLC-21H: 16.2;SH-SY5Y: 4.2" "Cancer enhanced" "Detected in some" "glioma: 3.2" "Region enriched" "Detected in all" 13 "cerebellum: 69.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006303 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA006303: AB_1079446" "unprognostic (1.09e-1)" "unprognostic (4.65e-2)" "unprognostic (3.68e-2)" "unprognostic (2.05e-7)" "unprognostic (1.28e-1)" "unprognostic (8.34e-2)" "unprognostic (1.20e-1)" "unprognostic (7.10e-2)" "unprognostic (9.33e-3)" "unprognostic (2.28e-2)" "unprognostic (8.45e-4)" "unprognostic (9.73e-2)" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (9.68e-2)" "unprognostic (2.91e-3)" "unprognostic (1.23e-1)" 0.4 7.4 4.3 0.5 5.0 2.4 0.4 69.5 11.0 0.3 0.7 2.7 0.0 0.9 0.4 0.5 0.3 0.6 0.5 0.8 4.2 5.3 0.6 0.4 0.4 0.4 3.7 2.2 0.4 4.7 0.4 3.7 0.4 5.1 0.6 0.6 3.7 0.3 0.4 0.3 0.4 0.6 0.4 2.0 0.5 1.0 2.1 4.8 0.0 1.4 0.0 0.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.6 0.0 0.0 4.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 1.4 0.0 0.7 0.2 13.0 0.0 0.0 0.0 0.0 16.2 4.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 4.3 5.0 69.5 3.1 4.2 5.3 3.7 2.2 5.1 4.8 MYT1L "KIAA1106, NZF1, ZC2H2C2, ZC2HC4B" ENSG00000186487 "Myelin transcription factor 1 like" Q9UL68 2 1789113-2331348 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Autism spectrum disorder, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.2" "Group enriched" "Detected in some" 9 "SCLC-21H: 11.0;SH-SY5Y: 8.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.3;naive CD8 T-cell: 1.6" "Group enriched" "Detected in many" 8 "granulocytes: 2.3;T-cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060245 Approved Vesicles Vesicles "HPA060245: " "unprognostic (9.90e-3)" "unprognostic (3.74e-1)" "unprognostic (1.30e-1)" "unprognostic (9.61e-3)" "unprognostic (7.17e-2)" "unprognostic (3.73e-2)" "unprognostic (2.44e-1)" "unprognostic (2.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.93e-2)" "unprognostic (2.46e-1)" "unprognostic (7.96e-2)" "unprognostic (1.21e-2)" "unprognostic (1.04e-2)" 1.2 3.4 11.0 1.4 20.0 1.1 1.1 19.5 50.2 1.1 1.2 0.5 0.0 1.1 1.2 1.1 1.3 1.1 1.1 1.1 15.6 10.3 1.1 1.1 1.1 1.2 5.1 14.5 1.1 1.5 1.0 10.7 1.1 6.8 1.3 1.3 0.4 1.1 1.1 1.1 1.1 1.2 1.1 1.5 1.0 1.1 4.6 2.0 0.0 1.1 0.0 1.1 1.1 0.0 0.0 0.2 2.3 0.0 0.0 1.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.6 0.1 0.0 0.0 11.0 8.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.2 0.0 0.6 11.0 20.0 19.5 26.7 15.6 10.3 5.1 14.5 6.8 2.0 NACA2 "MGC71999, NACAL" ENSG00000253506 "Nascent polypeptide associated complex alpha subunit 2" Q9H009 17 61590426-61591202 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 76.7" "Cell line enhanced" "Detected in some" "NB-4: 7.6;SK-MEL-30: 4.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA073152, HPA073648" Approved Cytosol Cytosol "HPA073152: , HPA073648: " "unprognostic (2.37e-1)" "unprognostic (1.50e-2)" "unprognostic (9.59e-2)" "unprognostic (5.33e-3)" "unprognostic (3.37e-1)" "unprognostic (1.45e-1)" "unprognostic (8.14e-3)" "unprognostic (4.91e-2)" "unprognostic (3.51e-2)" "unprognostic (1.18e-2)" "unprognostic (7.80e-2)" "unprognostic (2.08e-1)" "unprognostic (1.80e-2)" "unprognostic (6.88e-2)" "unprognostic (7.53e-3)" "unprognostic (5.45e-3)" "unprognostic (3.09e-3)" 2.5 2.5 2.4 2.7 2.8 2.2 5.6 2.2 2.8 6.6 2.4 1.0 0.8 2.2 2.1 2.6 5.0 2.2 1.9 3.7 2.2 2.0 4.7 5.5 3.3 6.5 2.2 2.1 9.5 14.3 2.3 2.1 3.6 1.3 3.3 2.1 1.3 2.2 2.0 7.2 2.8 4.1 5.4 2.9 4.2 2.2 76.7 2.8 4.8 4.1 3.2 2.7 6.3 2.4 2.1 1.9 0.7 3.2 1.7 2.0 2.9 0.8 0.0 0.7 0.8 0.3 0.6 2.3 0.2 0.8 0.3 0.5 0.6 0.4 0.0 1.3 0.0 0.2 0.2 0.2 0.6 0.6 0.2 0.2 0.8 0.8 0.2 0.3 0.8 0.0 0.9 0.0 0.0 0.4 0.2 2.6 0.2 0.2 1.1 7.6 1.9 0.2 0.9 0.5 2.5 0.3 0.1 0.9 1.8 0.5 1.2 4.3 1.9 2.8 0.0 0.4 1.0 1.5 0.8 0.8 0.7 0.8 1.0 0.5 0.7 0.4 1.4 0.7 1.2 3.2 1.4 2.1 1.6 1.6 1.9 1.8 2.0 1.8 0.4 1.7 3.0 1.8 1.9 2.9 2.4 2.8 2.2 2.8 2.2 2.0 2.2 2.1 1.3 2.8 NADK2 "C5orf33, FLJ30596, MNADK, NADKD1" ENSG00000152620 "NAD kinase 2, mitochondrial" Q4G0N4 5 36192592-36242279 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 128.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038366, HPA038367, HPA061492" Enhanced 28000 "HPA038366: AB_2675977, HPA038367: AB_10672743, HPA061492: " "unprognostic (1.15e-2)" "unprognostic (2.63e-2)" "unprognostic (3.01e-2)" "unprognostic (3.10e-3)" "unprognostic (1.64e-1)" "unprognostic (1.97e-2)" "unprognostic (4.06e-3)" "unprognostic (8.84e-2)" "unprognostic (3.32e-2)" "unprognostic (1.93e-3)" "unprognostic (1.09e-1)" "unprognostic (1.76e-1)" "unprognostic (9.73e-2)" "unprognostic (1.93e-1)" "unprognostic (1.58e-1)" "unprognostic (2.54e-2)" "unprognostic (1.75e-2)" 5.7 10.2 13.7 4.1 12.5 4.4 6.8 6.7 13.4 6.6 6.0 13.3 5.9 7.0 5.9 4.1 4.9 6.0 5.5 8.3 14.3 8.5 10.0 128.6 4.0 4.2 11.6 12.0 8.8 12.2 4.8 3.1 7.2 11.6 9.5 6.2 3.9 5.6 7.7 11.1 3.3 5.5 24.8 20.3 3.8 7.6 7.3 11.4 2.5 7.6 3.5 5.1 15.2 5.9 5.1 3.3 9.1 4.2 9.5 3.2 1.7 8.9 5.9 9.0 10.3 13.8 11.8 12.3 8.4 5.6 7.8 5.7 16.5 11.3 32.2 6.3 9.6 6.3 8.4 6.1 10.8 8.9 7.4 8.6 17.4 9.6 10.1 18.7 3.5 12.9 9.5 8.5 12.9 8.1 22.7 11.6 7.7 3.6 17.4 7.2 5.0 8.5 16.9 22.3 6.9 9.9 7.7 4.0 9.2 43.4 13.8 4.5 9.8 16.4 6.1 15.1 8.2 11.3 10.0 10.5 12.7 9.5 6.4 24.3 5.9 9.1 2.0 1.9 2.1 2.0 2.7 2.2 3.2 2.5 3.3 5.1 2.7 2.2 0.1 9.5 4.2 1.5 2.9 1.7 13.7 12.5 6.7 11.4 14.3 8.5 11.6 12.0 11.6 11.4 NANOS2 "NOS2, ZC2HC12B" ENSG00000188425 "Nanos C2HC-type zinc finger 2" P60321 19 45913214-45914870 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 26 "testis: 8.5" "Cell line enriched" "Detected in single" 6 "BEWO: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA014190 Approved "HPA014190: " "unprognostic (2.65e-1)" "unprognostic (1.01e-1)" "unprognostic (3.69e-1)" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.2 0.1 0.3 0.1 0.0 0.0 0.0 NAP1L2 "BPX, MGC26243" ENSG00000186462 "Nucleosome assembly protein 1 like 2" Q9ULW6 X 73212299-73214848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 49.8" "Cell line enhanced" "Detected in some" "EFO-21: 12.0;Karpas-707: 10.0;NTERA-2: 12.8;U-2 OS: 7.5;U-2197: 10.4;U-266/84: 20.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054050, HPA057065" Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA054050: , HPA057065: " "unprognostic (1.12e-1)" "unprognostic (6.64e-5)" "unprognostic (4.22e-2)" "unprognostic (9.64e-4)" "unprognostic (1.78e-1)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (8.51e-3)" "unprognostic (1.76e-2)" "unprognostic (2.66e-1)" "prognostic favourable (5.41e-4)" "unprognostic (1.53e-2)" "unprognostic (1.54e-2)" "unprognostic (6.95e-4)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.45e-2)" 2.3 5.8 15.7 2.2 20.0 0.9 3.2 37.5 49.8 4.5 2.8 2.0 0.2 1.3 4.9 8.0 2.8 4.2 2.5 7.2 21.0 22.8 8.0 1.3 2.5 2.9 15.7 28.7 8.6 2.6 10.5 10.2 0.5 20.5 10.4 3.1 2.6 3.1 5.9 1.1 4.9 1.7 4.6 8.3 3.9 2.0 2.2 4.9 0.0 8.0 0.0 1.8 2.6 2.5 0.9 0.0 0.0 0.0 1.2 3.6 1.4 0.0 3.3 0.1 6.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 12.0 0.0 0.7 2.4 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.6 0.3 0.9 0.1 1.7 0.2 0.2 10.0 0.0 1.2 3.9 0.0 12.8 5.9 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.8 0.0 1.2 0.0 0.1 0.0 7.5 10.4 0.8 4.7 20.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.4 0.9 3.4 2.3 0.0 0.1 1.6 3.6 0.0 1.2 0.0 0.0 2.6 1.4 15.7 20.0 37.5 42.1 21.0 22.8 15.7 28.7 20.5 4.9 NAPB "SNAP-BETA, SNAPB" ENSG00000125814 "NSF attachment protein beta" Q9H115 20 23374519-23421519 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 110.9" "Cell line enhanced" "Detected in all" "SCLC-21H: 24.0;U-937: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037225, CAB037227, HPA046149, HPA050196" Supported Uncertain Cytosol Cytosol "CAB037225: AB_477555, CAB037227: AB_477554, HPA046149: , HPA050196: " "unprognostic (3.89e-1)" "unprognostic (2.71e-1)" "unprognostic (5.95e-2)" "unprognostic (1.05e-1)" "unprognostic (2.54e-2)" "unprognostic (3.92e-2)" "unprognostic (1.32e-3)" "unprognostic (1.25e-1)" "unprognostic (4.71e-2)" "unprognostic (6.37e-2)" "unprognostic (4.46e-3)" "unprognostic (7.52e-3)" "prognostic unfavourable (1.14e-4)" "unprognostic (1.42e-1)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (4.60e-2)" 3.2 15.5 32.7 3.8 32.7 6.0 4.4 46.0 110.9 4.0 4.0 4.4 2.6 3.8 4.7 6.3 3.7 4.6 3.8 3.7 30.5 32.0 4.4 3.8 3.9 4.0 26.1 40.1 6.4 3.4 6.1 4.6 5.9 50.2 4.0 5.0 6.1 4.0 4.6 3.4 5.0 5.5 4.5 9.7 4.5 4.3 5.3 4.0 0.7 5.1 0.1 3.4 3.6 2.3 2.4 1.9 6.0 2.1 1.5 5.1 2.1 4.2 2.7 4.5 4.7 5.1 4.7 6.4 5.5 3.0 4.4 3.9 3.2 3.8 6.2 6.5 3.2 5.4 5.8 3.7 5.4 2.0 4.3 6.8 3.6 7.6 6.0 5.0 4.0 4.7 4.9 3.1 4.0 3.3 5.7 8.2 7.0 2.8 5.1 4.6 1.9 5.0 3.4 3.6 4.6 5.8 4.6 24.0 7.6 3.1 3.1 5.1 3.2 3.1 3.8 4.3 3.2 4.7 3.9 6.0 4.7 2.8 2.2 23.9 4.2 6.0 1.2 0.0 5.1 1.3 1.5 1.7 2.0 2.4 1.9 2.4 2.0 3.3 1.5 1.5 2.1 1.5 2.5 2.1 32.7 32.7 46.0 57.7 30.5 32.0 26.1 40.1 50.2 4.0 NAT8 "ATase2, GLA, Hcml1, TSC501" ENSG00000144035 "N-acetyltransferase 8 (putative)" Q9UHE5 2 73640832-73642393 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 140.4" "Cell line enriched" "Detected in some" 15 "Hep G2: 16.5" "Cancer enriched" "Detected in some" 5 "renal cancer: 242.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA067855, HPA074519" Enhanced Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA067855: , HPA074519: " "unprognostic (4.51e-2)" "unprognostic (6.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (4.95e-3)" "unprognostic (2.46e-1)" "unprognostic (1.90e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-1)" "unprognostic (2.13e-2)" "unprognostic (8.60e-2)" "unprognostic (1.37e-3)" "unprognostic (2.07e-2)" "unprognostic (4.11e-3)" "unprognostic (2.13e-2)" "unprognostic (8.36e-5)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 140.4 15.8 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 1.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 16.5 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 NBPF12 "COAS1, KIAA1245" ENSG00000268043 "NBPF member 12" 1 146938744-146996202 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "pancreas: 29.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (5.48e-2)" "unprognostic (3.97e-1)" "unprognostic (1.74e-1)" "unprognostic (8.96e-3)" "unprognostic (4.57e-2)" "unprognostic (5.00e-3)" "unprognostic (2.03e-2)" "unprognostic (5.76e-3)" "unprognostic (4.57e-2)" "unprognostic (2.90e-1)" "prognostic favourable (9.01e-7)" "unprognostic (2.23e-1)" "unprognostic (1.69e-3)" "unprognostic (2.96e-2)" "unprognostic (2.86e-1)" "unprognostic (2.08e-1)" "prognostic favourable (2.47e-5)" 2.7 1.7 2.2 4.0 3.9 5.1 3.2 4.4 4.7 2.6 1.9 5.8 2.2 2.4 6.0 3.6 1.5 2.4 3.1 0.9 2.3 1.7 6.1 2.8 3.4 4.2 4.2 4.3 29.8 4.2 5.0 1.8 3.8 2.5 1.8 4.2 3.5 4.0 0.9 2.5 1.9 3.0 3.2 3.1 5.3 7.0 1.1 3.3 2.9 0.9 2.9 1.2 3.9 3.8 2.6 6.1 2.3 0.9 3.5 0.8 6.9 5.6 11.8 10.1 5.5 5.2 7.6 7.2 5.4 5.1 5.2 5.1 6.6 15.5 4.5 6.2 5.2 8.4 4.1 5.0 5.8 5.9 6.8 12.1 4.3 4.6 5.1 10.1 5.4 7.5 5.1 11.8 4.6 10.8 2.7 4.1 10.6 10.9 6.4 6.8 7.3 10.6 4.3 3.7 3.9 15.4 5.9 12.4 9.5 8.4 4.7 7.1 15.4 5.5 4.6 7.5 10.3 10.0 9.5 7.0 6.5 4.9 3.6 5.1 6.1 2.3 1.8 3.5 1.1 2.0 3.4 2.3 1.9 1.0 3.8 2.6 2.0 0.7 0.9 1.4 2.6 2.2 0.8 NCAN CSPG3 ENSG00000130287 Neurocan O14594 19 19211973-19252233 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 48 "brain: 88.4" "Cell line enhanced" "Detected in some" "AF22: 2.9;SCLC-21H: 6.3;SH-SY5Y: 4.4" "Cancer enriched" "Detected in some" 57 "glioma: 71.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036814 Enhanced "Secreted in brain" 340000 "HPA036814: AB_10673666" "unprognostic (1.02e-2)" "unprognostic (2.84e-3)" "unprognostic (1.92e-1)" "unprognostic (1.56e-2)" "unprognostic (2.35e-2)" "unprognostic (1.65e-2)" "unprognostic (1.70e-2)" "unprognostic (1.03e-3)" "unprognostic (1.76e-1)" "unprognostic (2.12e-1)" "unprognostic (4.58e-3)" "unprognostic (4.38e-2)" "unprognostic (9.09e-6)" "unprognostic (1.10e-2)" "unprognostic (2.79e-2)" "unprognostic (2.91e-1)" "unprognostic (2.58e-2)" 1.1 1.2 21.2 1.1 23.2 1.1 1.1 5.4 88.4 1.1 1.1 12.9 0.0 1.1 1.1 1.1 1.1 1.1 1.1 1.1 16.8 8.3 1.1 1.2 1.1 1.1 7.8 15.2 1.1 1.1 1.1 0.1 1.1 12.3 1.1 1.1 0.0 1.2 1.1 1.1 1.1 1.1 1.1 4.0 1.1 1.1 1.8 5.6 0.0 1.1 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 6.3 4.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 23.2 5.4 22.8 16.8 8.3 7.8 15.2 12.3 5.6 NCAPD2 "CAP-D2, CNAP1, hCAP-D2, KIAA0159" ENSG00000010292 "Non-SMC condensin I complex subunit D2" Q15021 12 6493356-6531955 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 84.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012423, HPA036947, HPA037363" Approved Supported Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-2)" "unprognostic (1.03e-2)" "unprognostic (7.84e-2)" "prognostic unfavourable (1.79e-8)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (5.00e-2)" "unprognostic (5.41e-3)" "unprognostic (4.53e-1)" "prognostic unfavourable (1.13e-7)" "unprognostic (4.80e-3)" "unprognostic (1.18e-1)" "unprognostic (4.53e-1)" "unprognostic (8.75e-2)" 6.8 8.8 6.5 24.6 12.7 16.7 7.7 7.7 9.0 8.0 11.3 16.2 7.0 10.6 11.5 8.8 17.7 8.1 6.5 6.2 7.5 5.4 7.0 5.1 7.7 20.4 16.5 6.2 7.7 7.2 9.6 6.3 13.9 8.7 8.2 12.4 8.1 10.5 8.3 7.0 14.8 13.0 8.2 12.7 16.4 9.9 17.2 11.4 84.1 11.4 12.4 24.3 10.9 9.5 5.0 4.8 7.2 2.8 7.8 7.4 3.2 21.9 20.4 21.9 15.8 5.7 6.0 25.6 15.1 12.2 24.6 19.9 18.3 23.3 23.1 4.5 9.9 19.4 36.0 17.7 47.0 41.8 20.2 21.1 23.3 10.4 2.4 26.2 15.3 3.8 6.6 19.2 19.6 16.2 13.4 9.4 21.7 10.9 29.6 17.2 34.2 15.9 25.3 49.8 12.2 8.2 12.3 9.0 9.5 22.6 10.7 8.1 4.7 16.5 10.1 16.2 26.6 10.9 29.4 7.4 9.9 32.9 9.5 15.2 20.0 7.2 2.0 3.6 6.3 2.8 5.6 5.0 6.2 7.3 3.0 3.8 7.4 7.2 1.9 7.8 1.9 4.8 7.2 3.2 6.5 12.7 7.7 9.0 7.5 5.4 16.5 6.2 8.7 11.4 NCAPG "CAP-G, FLJ12450, hCAP-G, YCG1" ENSG00000109805 "Non-SMC condensin I complex subunit G" Q9BPX3 4 17810902-17844862 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 65.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.9" "Lineage enriched" "Detected in single" 5 "T-cells: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039613 Uncertain "HPA039613: AB_10805481" "unprognostic (5.23e-2)" "unprognostic (3.37e-1)" "unprognostic (1.59e-3)" "prognostic unfavourable (8.28e-4)" "unprognostic (4.22e-2)" "unprognostic (1.12e-1)" "prognostic unfavourable (3.13e-6)" "unprognostic (1.18e-3)" "unprognostic (1.63e-2)" "unprognostic (6.70e-2)" "prognostic unfavourable (7.65e-5)" "unprognostic (3.44e-2)" "unprognostic (0.00e+0)" "unprognostic (1.94e-2)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (2.07e-1)" 1.4 1.1 0.3 18.0 0.4 12.5 2.5 0.7 0.5 1.4 2.9 0.3 0.2 3.7 0.8 1.2 7.1 0.3 0.7 1.6 0.4 0.7 0.9 1.1 1.8 8.3 2.0 0.3 0.6 0.5 0.0 0.4 3.7 0.5 0.7 2.4 0.3 1.6 0.9 0.6 3.4 3.3 0.7 1.0 6.4 1.9 11.8 0.3 65.4 0.5 6.7 8.6 1.6 2.0 0.5 0.5 0.0 0.4 0.3 2.9 1.7 16.2 10.5 24.0 15.7 1.5 3.0 8.8 21.1 8.3 20.8 21.4 13.3 10.0 24.3 4.3 5.9 7.4 20.3 8.1 28.7 11.0 10.0 19.3 14.3 10.7 0.1 13.6 7.6 0.5 0.5 15.4 7.1 10.4 18.9 27.8 20.6 4.8 15.5 13.2 12.3 10.3 15.4 21.7 10.2 6.3 5.1 18.9 11.2 19.0 4.1 6.0 9.5 7.7 8.5 20.0 9.1 11.3 28.7 8.7 8.1 20.7 8.3 14.2 13.2 0.0 0.0 0.0 0.5 0.2 0.0 0.5 1.0 0.6 0.5 0.2 0.1 0.7 0.0 0.3 0.4 0.0 2.9 1.7 0.3 0.4 0.7 0.5 0.4 0.7 2.0 0.3 0.5 0.3 NCDN "NCDN-1, NCDN-2" ENSG00000020129 Neurochondrin Q9UBB6 1 35557473-35567274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 144.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023676 Enhanced Supported Supported Cytosol Cytosol "HPA023676: AB_1854325" "unprognostic (1.15e-1)" "unprognostic (7.11e-2)" "unprognostic (1.08e-1)" "unprognostic (6.05e-2)" "unprognostic (6.12e-3)" "unprognostic (2.39e-1)" "prognostic unfavourable (1.91e-5)" "unprognostic (4.66e-2)" "unprognostic (1.41e-1)" "unprognostic (4.36e-2)" "prognostic favourable (3.73e-4)" "unprognostic (5.91e-3)" "unprognostic (5.34e-3)" "unprognostic (5.88e-3)" "unprognostic (2.87e-1)" "unprognostic (3.24e-2)" "unprognostic (2.23e-2)" 5.2 11.3 33.4 6.0 144.3 3.4 3.6 28.7 104.9 9.9 3.5 8.7 1.2 3.9 6.2 4.8 4.5 8.1 6.5 12.0 45.4 25.0 4.0 2.5 4.5 5.9 15.8 32.3 9.2 6.1 6.2 5.5 4.7 26.4 7.1 2.9 3.6 6.7 8.0 5.3 5.6 3.2 6.5 10.7 5.0 4.7 5.8 15.6 0.8 6.5 0.6 4.6 6.0 2.4 5.9 2.7 0.8 4.5 3.0 6.5 5.5 8.7 10.6 8.9 14.0 12.9 16.0 6.1 11.6 12.1 12.2 9.8 10.6 13.0 10.0 11.3 10.7 13.5 8.7 14.1 4.5 9.7 18.0 12.4 15.6 5.4 17.9 11.2 14.3 15.3 11.8 21.6 8.7 6.5 13.4 16.0 9.9 15.7 10.2 7.2 39.9 18.7 8.4 4.9 12.9 8.2 9.8 11.1 16.0 13.2 12.2 16.3 11.7 7.4 8.8 15.6 11.2 11.4 15.8 22.6 15.9 7.4 19.4 18.0 14.2 0.0 4.5 0.8 3.1 2.6 3.8 5.9 4.8 4.8 2.7 2.7 6.5 5.3 0.7 3.0 4.2 1.6 2.7 5.5 33.4 144.3 28.7 61.4 45.4 25.0 15.8 32.3 26.4 15.6 NDST4 ENSG00000138653 "N-deacetylase and N-sulfotransferase 4" Q9H3R1 4 114827763-115113876 "Enzymes, Predicted intracellular proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 34.6" "Cell line enriched" "Detected in some" 4 "RH-30: 17.6" "Not detected" "Not detected" "Region enriched" "Detected in many" 17 "pons and medulla: 34.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA011129 Uncertain "HPA011129: AB_1079460" "unprognostic (5.58e-2)" "unprognostic (5.90e-2)" "unprognostic (4.82e-1)" "unprognostic (1.71e-2)" "unprognostic (1.08e-1)" "unprognostic (1.11e-1)" "unprognostic (1.94e-1)" "unprognostic (6.55e-2)" 0.1 0.0 1.3 0.0 1.7 0.0 0.1 0.2 3.4 1.4 0.3 0.3 0.3 0.1 1.5 0.0 0.1 0.1 0.3 0.1 0.7 1.9 0.1 0.0 0.1 0.0 1.3 1.4 5.7 0.1 0.0 0.6 0.0 34.6 1.5 0.1 0.0 0.5 0.6 0.1 0.2 0.1 1.6 1.0 2.5 1.1 0.7 0.0 0.0 0.1 0.1 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 0.2 1.7 0.7 1.9 1.3 1.4 34.6 0.0 NDUFS7 "CI-20, FLJ45860, FLJ46880, PSST" ENSG00000115286 "NADH:ubiquinone oxidoreductase core subunit S7" O75251 19 1383527-1395589 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 198.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (7.36e-2)" "prognostic favourable (2.03e-4)" "unprognostic (5.30e-2)" "unprognostic (3.81e-2)" "unprognostic (1.12e-1)" "unprognostic (5.28e-2)" "unprognostic (2.41e-2)" "unprognostic (5.85e-2)" "unprognostic (4.88e-2)" "unprognostic (2.29e-1)" "unprognostic (1.99e-3)" "unprognostic (8.12e-2)" "prognostic favourable (4.90e-7)" "unprognostic (2.95e-1)" "unprognostic (2.82e-1)" "unprognostic (1.57e-1)" "unprognostic (2.34e-2)" 22.4 17.6 15.3 10.1 17.6 9.9 7.0 16.6 22.7 6.1 18.7 20.6 7.6 34.5 7.1 9.6 13.3 6.7 10.0 35.9 16.1 15.1 20.7 20.7 7.1 9.1 19.6 11.9 7.2 28.7 5.0 12.0 6.8 17.6 11.9 4.0 12.0 23.6 10.2 198.0 8.3 25.2 7.5 20.1 11.5 18.2 14.2 14.6 9.7 8.0 39.2 10.0 6.7 7.9 29.1 41.8 19.8 39.1 17.2 29.2 20.8 18.2 18.5 0.6 4.3 0.6 1.7 9.5 11.0 1.1 2.3 2.5 30.3 4.5 27.0 11.3 0.6 9.6 0.8 2.2 0.1 30.1 21.3 8.5 19.8 18.8 2.8 14.7 9.5 1.4 3.8 0.4 0.0 3.2 16.8 10.6 0.6 19.1 14.6 6.1 6.6 22.9 14.2 7.1 27.5 1.1 14.1 10.4 10.6 9.7 9.2 17.9 7.3 9.2 13.8 4.4 6.1 9.6 14.2 42.7 37.2 18.3 11.1 19.9 6.2 19.8 33.6 16.1 21.3 39.1 18.1 29.1 20.1 20.0 41.8 27.1 19.7 19.1 9.1 17.2 31.7 31.6 29.2 20.8 15.3 17.6 16.6 22.7 16.1 15.1 19.6 11.9 17.6 14.6 NEB "NEB177D, NEM2" ENSG00000183091 Nebulin P20929 2 151485336-151734487 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 505.8" "Cell line enhanced" "Detected in some" "Karpas-707: 6.7;RH-30: 26.6;U-266/70: 10.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "cerebellum: 7.4;olfactory region: 4.9" "Region enriched" "Detected in some" 7 "cerebellum: 25.3" HPA016601 Enhanced "HPA016601: AB_1854361" "unprognostic (2.40e-2)" "unprognostic (6.71e-2)" "unprognostic (2.13e-2)" "unprognostic (2.52e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-3)" "unprognostic (2.54e-2)" "unprognostic (1.45e-1)" "unprognostic (4.41e-2)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (1.07e-1)" "unprognostic (4.45e-13)" "unprognostic (6.80e-2)" "unprognostic (2.22e-2)" "unprognostic (4.07e-3)" "unprognostic (4.06e-2)" 9.6 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 5.2 4.0 0.0 0.8 1.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.0 0.0 3.8 0.0 505.8 0.3 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 3.0 65.9 2.6 0.1 0.0 1.3 0.5 1.7 0.6 0.8 0.9 0.3 0.3 0.3 0.6 0.5 0.1 0.1 1.7 0.3 0.0 0.0 0.0 4.6 0.5 1.2 0.9 0.1 0.9 0.1 0.0 0.0 0.6 0.7 0.4 0.6 1.5 0.0 0.8 1.1 4.0 0.2 0.0 0.0 0.6 0.9 6.7 0.4 0.5 0.4 0.7 1.1 0.8 1.1 26.6 0.1 0.0 0.9 1.5 0.2 0.2 0.3 0.1 0.7 0.8 0.6 0.7 0.9 0.1 0.9 10.0 1.4 0.3 0.1 0.6 1.1 1.2 0.6 1.7 0.9 0.0 0.9 1.2 0.8 0.5 0.0 1.3 0.3 0.4 1.1 0.8 0.0 0.5 0.4 0.3 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 NEBL "LASP2, LNEBL" ENSG00000078114 Nebulette O76041 10 20779973-21174187 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "heart muscle: 123.6" "Cell line enhanced" "Detected in many" "HSkMC: 13.6;SCLC-21H: 27.5;SH-SY5Y: 16.6;SK-BR-3: 26.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA013994, HPA013995" Approved "HPA013994: AB_1854359, HPA013995: AB_1854360" "unprognostic (3.79e-2)" "unprognostic (1.92e-3)" "unprognostic (3.44e-2)" "unprognostic (3.57e-3)" "unprognostic (1.50e-1)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (6.25e-2)" "unprognostic (1.05e-1)" "unprognostic (6.20e-3)" "unprognostic (2.36e-2)" "unprognostic (8.42e-2)" "prognostic favourable (2.77e-8)" "unprognostic (3.51e-1)" "unprognostic (8.11e-2)" "unprognostic (4.46e-2)" "prognostic unfavourable (5.56e-4)" 1.3 6.9 16.4 1.0 17.2 0.7 13.2 21.1 16.1 2.6 2.9 9.8 0.1 1.0 1.3 1.0 10.8 1.1 1.7 123.6 16.5 12.7 12.0 1.7 14.1 0.9 12.7 13.3 1.5 6.0 6.6 16.0 5.1 12.6 7.3 4.0 2.2 18.8 8.1 0.8 16.2 1.3 1.4 10.6 0.8 4.0 2.8 12.5 0.5 30.8 3.9 3.8 2.1 4.4 0.0 0.0 1.4 0.8 0.0 0.5 0.2 0.6 5.1 7.8 0.3 0.0 0.1 10.9 0.0 0.0 0.0 0.0 0.6 0.7 1.5 8.0 0.0 4.7 0.5 0.0 0.0 0.0 3.3 0.0 2.5 0.0 12.3 0.0 0.0 13.6 12.7 0.0 1.3 0.3 0.3 2.1 0.0 12.0 0.1 0.0 5.7 3.1 0.0 0.1 0.0 1.9 1.1 27.5 16.6 1.4 26.0 0.0 8.8 0.0 10.8 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.8 0.0 0.5 0.2 16.4 17.2 21.1 14.1 16.5 12.7 12.7 13.3 12.6 12.5 NECAB1 EFCBP1 ENSG00000123119 "N-terminal EF-hand calcium binding protein 1" Q8N987 8 90791550-90959408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 56.4" "Cell line enhanced" "Detected in many" "HEL: 6.1;MOLT-4: 6.4;U-266/70: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210" Enhanced Supported Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB068208: , CAB068209: , CAB068210: , HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815" "unprognostic (8.09e-3)" "unprognostic (3.78e-1)" "unprognostic (8.17e-3)" "unprognostic (5.96e-5)" "unprognostic (2.51e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-3)" "unprognostic (8.38e-2)" "unprognostic (1.78e-3)" "unprognostic (2.60e-1)" "unprognostic (2.25e-2)" "unprognostic (2.57e-2)" "unprognostic (2.19e-3)" "unprognostic (4.45e-3)" "unprognostic (1.68e-2)" "unprognostic (2.42e-3)" "unprognostic (5.39e-3)" 2.7 4.9 19.7 2.0 27.3 3.2 1.5 0.5 56.4 1.4 3.7 12.1 0.3 1.7 4.1 4.4 3.6 1.6 3.1 10.9 19.5 9.8 3.4 1.1 6.8 1.4 16.0 30.7 3.8 1.3 1.9 1.9 2.8 10.8 2.6 1.1 4.1 2.5 2.0 1.3 1.9 1.8 1.3 18.7 2.4 2.1 5.2 17.4 0.0 2.9 0.0 1.0 4.2 1.2 0.5 1.8 0.3 0.0 0.7 0.9 0.2 0.2 0.1 2.3 0.4 0.0 0.1 0.1 2.5 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.0 1.0 0.0 0.1 0.0 4.7 6.1 2.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 4.1 4.4 0.0 4.9 6.4 3.1 0.9 0.1 0.0 4.0 0.0 0.0 0.0 4.1 4.4 0.1 0.0 2.1 0.0 0.2 1.5 3.9 3.8 0.0 1.6 6.1 3.7 3.2 3.8 0.0 1.8 0.0 0.0 0.1 0.6 0.0 0.4 0.2 0.4 0.6 0.1 0.5 0.6 0.9 0.3 0.7 0.0 1.8 0.9 0.2 19.7 27.3 0.5 37.1 19.5 9.8 16.0 30.7 10.8 17.4 NEFL "CMT1F, CMT2E, NF68, NFL, PPP1R110" ENSG00000277586 "Neurofilament light" P07196 8 24950955-24957110 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.1" "Group enriched" "Detected in some" 5 "HEK 293: 112.2;PC-3: 30.1" "Cancer enhanced" "Detected in many" "renal cancer: 24.0" "Cell type enriched" "Detected in some" 5 "memory CD4 T-cell: 13.7" "Lineage enriched" "Detected in single" 138 "T-cells: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014850, HPA015021" Enhanced Supported Approved "Nuclear speckles,Intermediate filaments" "Nuclear speckles" "Intermediate filaments" "HPA014850: AB_1854397, HPA015021: " "unprognostic (7.63e-2)" "unprognostic (1.36e-2)" "unprognostic (9.53e-2)" "unprognostic (6.81e-2)" "unprognostic (2.82e-2)" "unprognostic (6.69e-2)" "unprognostic (3.69e-2)" "unprognostic (3.78e-3)" "unprognostic (3.06e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic unfavourable (4.91e-4)" "unprognostic (5.76e-3)" "unprognostic (7.88e-2)" "unprognostic (3.97e-3)" "unprognostic (3.17e-3)" 0.7 12.0 10.3 1.4 20.1 0.6 0.6 2.3 92.1 1.8 1.8 3.0 0.0 1.0 0.7 0.8 3.8 0.7 0.6 0.6 14.1 3.5 0.6 0.6 0.7 0.0 23.8 0.7 0.7 0.6 0.0 0.6 95.1 1.6 1.5 5.0 0.6 9.5 0.6 0.7 1.7 1.2 18.0 0.7 1.1 1.6 2.1 0.0 1.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 13.7 2.1 0.0 0.1 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 112.2 0.0 0.0 0.0 4.9 0.0 0.1 1.8 0.4 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.8 30.1 0.0 0.0 0.0 6.9 1.0 6.2 6.4 2.6 0.0 0.4 0.0 0.0 0.0 0.6 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.7 1.5 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.2 2.1 NEFM "NEF3, NF-M, NFM" ENSG00000104722 "Neurofilament medium" P07197 8 24913012-24919098 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 144.7" "Cell line enriched" "Detected in some" 23 "HEK 293: 286.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "MAIT T-cell: 1.0;memory CD4 T-cell: 1.0;naive CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010900, CAB012976, HPA022845, HPA023138" Enhanced Enhanced "Intermediate filaments" "Intermediate filaments" "CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398" "unprognostic (1.41e-2)" "unprognostic (1.83e-1)" "unprognostic (2.59e-2)" "unprognostic (9.38e-2)" "unprognostic (5.17e-2)" "unprognostic (6.32e-3)" "unprognostic (6.10e-3)" "unprognostic (2.57e-1)" "unprognostic (8.55e-3)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-2)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (4.76e-2)" "unprognostic (2.61e-2)" 1.5 18.9 20.3 2.0 24.2 1.3 1.3 10.9 87.6 9.7 2.0 5.6 0.0 1.3 3.8 1.3 4.7 1.3 1.4 1.3 36.1 25.0 2.2 1.2 1.3 1.3 52.2 22.4 2.0 2.5 1.2 3.3 1.4 144.7 2.5 1.9 3.4 1.3 26.9 1.9 1.3 1.5 3.3 26.7 1.3 1.5 12.4 4.9 0.0 1.3 0.0 1.6 1.3 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 286.0 0.0 0.0 0.0 6.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.3 24.2 10.9 71.9 36.1 25.0 52.2 22.4 144.7 4.9 NEIL3 "FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3" ENSG00000109674 "Nei like DNA glycosylase 3" Q8TAT5 4 177309836-177362943 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 70.8" "Cell line enhanced" "Detected in many" "HDLM-2: 26.5;HL-60: 28.8;Karpas-707: 37.9;MOLT-4: 29.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065761 Enhanced Nucleoplasm Nucleoplasm "HPA065761: " "unprognostic (6.03e-2)" "unprognostic (5.79e-2)" "unprognostic (1.42e-1)" "prognostic unfavourable (5.45e-4)" "unprognostic (4.91e-2)" "unprognostic (2.05e-1)" "unprognostic (3.64e-7)" "prognostic unfavourable (1.16e-4)" "unprognostic (6.09e-3)" "unprognostic (7.67e-2)" "unprognostic (6.51e-4)" "unprognostic (2.82e-3)" "unprognostic (0.00e+0)" "unprognostic (3.25e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (1.04e-2)" 0.5 0.4 0.2 7.4 0.2 9.3 0.7 0.1 0.2 0.8 1.5 0.1 0.1 1.5 0.5 0.1 5.6 0.2 0.3 0.5 0.2 0.2 0.4 0.4 0.9 5.1 0.2 0.1 0.3 0.2 0.0 0.2 1.6 0.2 0.2 2.1 0.2 0.8 0.1 0.2 3.4 1.7 0.5 0.7 1.5 0.8 3.5 0.3 70.8 0.2 1.1 5.0 0.7 1.3 0.2 0.3 0.8 0.0 1.6 1.6 0.2 7.0 5.9 6.3 3.1 0.7 1.3 3.1 8.8 3.2 9.8 5.8 2.1 6.2 7.8 1.3 2.3 3.3 6.6 3.5 14.2 26.5 4.3 5.4 4.6 5.6 0.2 28.8 3.7 0.1 0.2 10.1 2.2 3.7 5.5 37.9 6.3 3.1 29.2 11.1 2.9 4.3 5.9 4.3 2.5 2.5 0.9 4.9 3.4 4.4 5.1 2.4 4.1 7.5 1.7 5.9 4.6 3.0 8.8 2.6 1.7 12.4 3.9 10.3 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.0 0.2 0.0 1.1 0.8 1.6 0.0 0.3 1.6 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.3 NETO1 "BCTL1, BTCL1" ENSG00000166342 "Neuropilin and tolloid like 1" Q8TDF5 18 72742314-72868146 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 47.9" "Cell line enhanced" "Detected in some" "MOLT-4: 14.8;REH: 14.5;RPMI-8226: 23.2;RT4: 15.4;SCLC-21H: 20.5;U-2 OS: 7.5" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 27 "memory B-cell: 1.6;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 38 "B-cells: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA064630 Approved "Golgi apparatus" "Intracellular and membrane" "Golgi apparatus" "HPA064630: " "unprognostic (4.02e-2)" "unprognostic (4.08e-3)" "unprognostic (2.75e-1)" "unprognostic (1.55e-2)" "unprognostic (6.04e-2)" "unprognostic (1.35e-5)" "unprognostic (4.05e-1)" "unprognostic (4.73e-2)" "unprognostic (3.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.63e-2)" "unprognostic (1.20e-1)" "unprognostic (1.73e-2)" "unprognostic (3.70e-2)" "unprognostic (3.35e-2)" "unprognostic (1.59e-1)" "unprognostic (9.13e-3)" 2.0 0.8 9.1 1.3 18.3 1.0 1.7 0.4 47.9 0.9 0.9 0.7 0.0 0.8 0.9 0.9 1.0 0.8 0.9 1.4 15.9 3.9 1.0 0.8 0.9 3.8 3.0 15.1 0.8 0.8 1.0 0.3 0.8 5.0 0.9 1.1 3.9 1.1 0.8 0.8 1.2 0.8 0.8 1.1 4.0 0.9 2.0 2.8 0.8 2.3 0.0 2.7 1.2 0.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.8 0.0 6.7 0.0 14.5 0.0 23.2 3.6 15.4 20.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 18.3 0.4 22.8 15.9 3.9 3.0 15.1 5.0 2.8 NEU2 SIAL2 ENSG00000115488 "Neuraminidase 2" Q9Y3R4 2 233032672-233035057 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "skin 1: 6.1" "Group enriched" "Detected in some" 4 "A-431: 1.1;BEWO: 1.6;PC-3: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebral cortex: 2.2;hippocampal formation: 1.1" CAB022336 Uncertain 9000 "CAB022336: " "unprognostic (1.30e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEUROD1 "BETA2, BHF-1, bHLHa3, MODY6, NeuroD" ENSG00000162992 "Neuronal differentiation 1" Q13562 2 181673088-181680876 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 101.9" "Cell line enriched" "Detected in some" 72 "SCLC-21H: 79.2" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.3" "Region enriched" "Detected in many" 16 "cerebellum: 101.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in many" 14 "cerebellum: 242.4" "Region enriched" "Detected in some" 20 "cerebellum: 447.6" "HPA003278, CAB022450" Approved "CAB022450: , HPA003278: AB_1845331" "unprognostic (1.29e-1)" "prognostic favourable (1.34e-4)" "unprognostic (6.92e-3)" "unprognostic (1.27e-1)" 0.2 0.2 6.3 0.2 0.8 0.1 0.2 101.9 5.6 0.2 3.1 0.0 0.0 8.9 0.2 0.1 0.2 0.2 0.0 0.2 4.7 0.4 0.2 0.2 0.2 0.0 0.4 1.2 0.2 13.3 0.0 0.8 0.0 3.9 0.2 1.9 14.4 0.2 0.0 0.2 0.2 5.8 0.0 1.4 0.2 7.6 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.2 1.1 1.0 3.5 1.8 1.4 1.5 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.2 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.6 1.0 0.8 1.1 1.5 1.1 1.1 0.8 0.8 1.0 1.3 1.4 1.8 1.4 1.8 1.0 1.0 0.7 6.3 0.8 101.9 2.5 4.7 0.4 0.4 1.2 3.9 0.0 NEUROD2 "bHLHa1, NDRF" ENSG00000171532 "Neuronal differentiation 2" Q15784 17 39603536-39609777 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "brain: 51.4" "Cell line enriched" "Detected in single" 239 "SCLC-21H: 23.9" "Cancer enhanced" "Detected in some" "cervical cancer: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 13 "amygdala: 28.0;cerebellum: 127.9;cerebral cortex: 45.1;hippocampal formation: 107.5" "unprognostic (5.70e-2)" "unprognostic (3.85e-2)" "unprognostic (2.87e-1)" "unprognostic (3.51e-3)" "unprognostic (2.44e-2)" "unprognostic (3.04e-1)" "unprognostic (4.69e-1)" "unprognostic (1.72e-1)" "unprognostic (2.16e-1)" "unprognostic (3.96e-1)" "unprognostic (6.15e-2)" "unprognostic (4.09e-2)" "unprognostic (3.21e-6)" "unprognostic (4.20e-1)" "unprognostic (2.66e-1)" "unprognostic (2.52e-2)" "unprognostic (2.57e-3)" 0.7 0.7 10.9 0.7 8.3 0.7 0.7 51.4 22.1 0.7 0.7 0.2 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 18.8 0.6 0.7 0.7 0.7 0.7 1.1 18.3 0.7 0.7 0.7 0.2 0.7 12.3 0.7 0.7 0.0 0.7 0.7 0.7 0.8 0.7 0.7 1.1 0.7 0.9 0.7 0.0 0.0 0.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 8.3 51.4 18.8 18.8 0.6 1.1 18.3 12.3 0.0 NEUROD4 "ATH-3, Atoh3, bHLHa4, MATH-3" ENSG00000123307 "Neuronal differentiation 4" Q9HD90 12 55019945-55030014 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pituitary gland: 54.8" "Group enriched" "Detected in some" 6 "AF22: 3.6;SCLC-21H: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA015545 Enhanced "HPA015545: " "unprognostic (1.78e-2)" 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 54.8 0.0 0.7 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.7 0.0 NEUROD6 "Atoh2, bHLHa2, Math-2, Nex1, NEX1M" ENSG00000164600 "Neuronal differentiation 6" Q96NK8 7 31337461-31340894 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "brain: 30.6" "Cell line enriched" "Detected in single" 116 "SCLC-21H: 11.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 8.3;basal ganglia: 10.7;cerebral cortex: 25.5;hippocampal formation: 30.6;olfactory region: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebral cortex: 99.2;hippocampal formation: 246.6" "Group enriched" "Detected in some" 10 "cerebral cortex: 26.0;hippocampal formation: 108.7" HPA074530 Enhanced "HPA074530: " "unprognostic (3.68e-2)" 0.5 0.5 8.3 0.5 10.7 0.5 0.5 3.9 25.5 0.5 0.5 0.7 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.5 30.6 0.5 0.5 0.5 0.5 0.5 1.3 17.4 0.5 0.5 0.5 0.1 0.5 0.4 0.5 0.5 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.4 0.5 0.5 0.5 0.0 0.0 0.5 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 10.7 3.9 25.5 30.6 0.5 1.3 17.4 0.4 0.0 NFATC3 "NFAT4, NFATX" ENSG00000072736 "Nuclear factor of activated T cells 3" Q12968 16 68084751-68229259 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 129.5" "Cell line enhanced" "Detected in all" "HMC-1: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050665 Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA050665: " "unprognostic (1.19e-1)" "unprognostic (1.56e-2)" "unprognostic (7.74e-2)" "unprognostic (7.25e-3)" "unprognostic (6.41e-2)" "unprognostic (1.28e-2)" "unprognostic (7.28e-3)" "unprognostic (2.97e-1)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (8.93e-2)" "unprognostic (9.07e-3)" "unprognostic (1.60e-1)" "unprognostic (1.58e-1)" "unprognostic (4.04e-2)" "unprognostic (1.30e-1)" 9.6 6.8 4.3 16.0 6.6 12.0 7.8 7.5 5.8 9.8 11.0 9.7 7.6 7.1 12.2 6.5 7.7 8.3 7.6 7.0 4.7 4.0 8.2 12.1 11.3 14.2 8.7 3.5 10.0 7.0 18.7 6.8 6.6 5.1 10.5 6.1 11.1 7.9 7.6 27.1 14.0 12.0 9.0 6.7 12.3 6.2 25.9 5.8 129.5 11.0 8.1 16.0 10.2 14.1 6.7 3.1 12.0 7.1 13.4 15.6 9.0 4.9 5.8 9.4 10.3 8.4 5.4 8.6 3.2 4.0 9.1 7.9 8.4 4.4 16.5 4.9 5.3 7.4 11.7 5.5 8.9 3.4 7.6 16.2 6.1 18.9 5.6 14.5 42.7 4.1 7.1 9.2 5.0 7.6 20.9 4.7 6.7 9.9 22.3 19.7 6.1 3.1 12.7 9.0 17.0 3.9 5.7 7.1 7.6 24.0 6.1 3.1 8.4 11.0 4.8 4.7 5.1 5.4 4.8 6.5 11.2 30.0 3.6 13.5 6.5 12.0 2.4 5.3 15.6 3.7 14.8 5.2 8.9 15.2 2.9 6.7 9.1 14.0 3.3 13.4 7.1 3.1 6.0 9.0 4.3 6.6 7.5 5.8 4.7 4.0 8.7 3.5 5.1 5.8 NFE2L3 Nrf3 ENSG00000050344 "Nuclear factor, erythroid 2 like 3" Q9Y4A8 7 26152240-26187125 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 54.9" "Cell line enhanced" "Detected in many" "BEWO: 43.4;NTERA-2: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055889 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "HPA055889: " "unprognostic (4.99e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-3)" "unprognostic (5.37e-2)" "unprognostic (8.41e-2)" "unprognostic (4.00e-3)" "unprognostic (7.29e-3)" "unprognostic (1.87e-1)" "unprognostic (2.12e-1)" "unprognostic (9.88e-2)" "prognostic unfavourable (6.62e-5)" "unprognostic (2.32e-1)" "prognostic unfavourable (7.58e-12)" "prognostic favourable (2.14e-4)" "unprognostic (2.40e-1)" "unprognostic (8.25e-2)" "unprognostic (4.13e-3)" 3.5 2.5 0.8 7.8 1.2 1.6 4.1 6.2 1.6 1.8 6.7 4.0 2.4 6.2 1.9 1.7 3.1 2.4 7.1 3.6 1.3 1.1 4.2 2.3 5.8 6.9 2.5 0.8 1.7 7.5 0.0 2.1 54.9 2.1 3.7 4.0 2.1 7.7 0.4 3.4 8.2 7.1 0.8 3.7 10.4 5.6 2.5 1.5 11.2 1.6 1.5 8.9 3.1 2.1 1.4 2.8 0.8 1.1 1.1 2.6 0.4 12.5 1.1 0.5 1.3 0.0 0.0 43.4 2.5 4.9 4.9 9.0 8.3 22.0 0.9 16.6 0.2 2.6 1.9 4.2 11.2 8.6 2.7 1.7 1.8 6.1 3.4 1.5 16.8 0.4 0.5 2.0 0.7 11.3 2.6 22.3 0.9 1.7 1.0 2.7 36.4 4.4 1.5 0.1 6.2 6.6 12.4 3.9 4.7 0.0 1.0 0.3 0.6 0.9 23.5 0.4 0.7 0.2 10.1 13.6 21.6 1.0 0.0 5.4 16.8 0.0 1.1 0.0 0.5 1.1 1.6 1.0 2.1 1.0 2.8 1.4 1.2 0.7 0.8 1.1 0.3 0.9 2.6 0.4 0.8 1.2 6.2 1.6 1.3 1.1 2.5 0.8 2.1 1.5 NHSL1 "bA43P8.1, C6orf63, KIAA1357" ENSG00000135540 "NHS like 1" Q5SYE7 6 138422043-138692571 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 93.0" "Cell line enhanced" "Detected in many" "Hep G2: 22.1;TIME: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8;non-classical monocyte: 3.8" "Group enriched" "Detected in many" 14 "dendritic cells: 1.2;granulocytes: 1.0;monocytes: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029966, HPA029967" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA029966: AB_10601972, HPA029967: " "unprognostic (1.85e-1)" "unprognostic (9.71e-2)" "unprognostic (6.19e-2)" "unprognostic (1.81e-1)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (3.27e-1)" "unprognostic (8.34e-2)" "unprognostic (5.21e-2)" "unprognostic (9.99e-2)" "unprognostic (1.10e-1)" "unprognostic (8.00e-2)" "unprognostic (4.19e-2)" "unprognostic (3.73e-2)" "unprognostic (1.52e-1)" "unprognostic (6.55e-2)" "unprognostic (4.06e-2)" 7.4 1.1 6.0 5.4 5.7 0.2 2.4 3.7 8.6 2.2 46.3 4.3 3.4 13.4 3.0 11.2 10.0 0.9 7.2 18.4 4.8 3.4 17.4 19.5 15.0 2.0 4.2 1.3 1.2 4.6 2.8 1.7 3.5 6.3 1.7 10.0 7.9 3.4 0.4 2.3 10.5 93.0 3.0 2.8 2.0 6.8 1.6 1.6 0.2 1.2 3.6 1.7 2.4 3.9 0.1 1.2 1.0 3.8 0.1 0.1 0.7 2.6 2.3 16.4 6.9 4.8 5.9 6.1 2.3 1.1 0.8 0.8 3.0 1.5 0.0 3.0 2.0 6.0 9.9 6.1 0.4 0.2 6.6 1.6 1.1 22.1 7.1 5.8 1.1 8.5 3.5 0.4 7.1 11.5 0.0 0.9 3.6 5.1 0.6 0.4 6.5 4.3 6.7 1.7 0.5 5.6 6.7 6.2 0.0 2.5 5.1 16.5 1.6 1.8 31.5 2.3 2.3 2.3 6.5 0.6 1.2 0.0 0.2 2.4 12.6 1.0 3.4 0.5 0.1 3.8 0.1 0.1 0.0 0.1 1.2 0.0 0.1 0.1 0.1 0.1 3.8 0.7 0.0 0.7 6.0 5.7 3.7 3.5 4.8 3.4 4.2 1.3 6.3 1.6 NKAIN2 "FAM77B, TCBA1" ENSG00000188580 "Sodium/potassium transporting ATPase interacting 2" Q5VXU1 6 123804141-124825657 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 43.2" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Daudi: 3.8;HEK 293: 6.4;HEL: 8.0;Karpas-707: 13.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 44 "basophil: 4.3" "Lineage enriched" "Detected in single" 44 "granulocytes: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045860 Approved Cytosol Cytosol "HPA045860: AB_10983192" "unprognostic (3.09e-2)" "unprognostic (1.06e-2)" "unprognostic (2.33e-2)" "unprognostic (4.53e-3)" "unprognostic (5.67e-2)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.19e-1)" "unprognostic (5.41e-3)" "unprognostic (2.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.95e-3)" "unprognostic (3.63e-3)" "unprognostic (1.77e-1)" "unprognostic (1.66e-1)" "unprognostic (1.63e-1)" 2.2 1.6 12.9 1.1 12.1 1.9 1.3 17.3 43.2 1.4 1.7 24.9 0.0 1.1 1.2 1.6 1.4 1.4 1.3 2.6 17.5 8.8 1.3 1.2 1.3 1.3 18.1 10.9 1.2 1.0 1.0 1.1 1.2 18.0 1.4 1.3 0.5 1.1 1.3 4.8 1.1 1.5 1.5 42.9 1.1 1.0 1.6 16.1 0.0 1.2 0.5 1.3 1.5 0.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 6.4 8.0 0.0 0.0 0.5 0.0 0.0 1.6 0.2 0.0 0.5 0.0 0.0 13.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 12.1 17.3 15.3 17.5 8.8 18.1 10.9 18.0 16.1 NKAIN4 "bA261N11.2, C20orf58, FAM77A" ENSG00000101198 "Sodium/potassium transporting ATPase interacting 4" Q8IVV8 20 63240784-63272694 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 51.7" "Cell line enhanced" "Detected in some" "AF22: 4.9;BEWO: 16.6;MOLT-4: 26.9;REH: 4.8;SK-MEL-30: 6.0" "Cancer enriched" "Detected in many" 6 "glioma: 45.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "amygdala: 3.2;cerebral cortex: 3.9;hippocampal formation: 2.5" HPA029876 Approved "HPA029876: AB_10602038" "unprognostic (1.26e-1)" "unprognostic (4.27e-1)" "unprognostic (6.07e-5)" "prognostic unfavourable (3.14e-4)" "unprognostic (6.65e-2)" "unprognostic (2.59e-1)" "unprognostic (7.07e-3)" "unprognostic (1.94e-1)" "unprognostic (3.62e-2)" "unprognostic (2.69e-2)" "unprognostic (1.83e-2)" "unprognostic (1.27e-1)" "unprognostic (2.12e-2)" "unprognostic (1.44e-4)" "unprognostic (5.66e-2)" "unprognostic (6.74e-2)" "unprognostic (4.01e-1)" 1.1 1.9 21.7 1.2 23.0 1.0 1.0 5.7 51.7 1.3 1.1 9.9 0.0 1.2 1.4 1.3 0.9 1.3 1.0 0.9 15.5 15.5 10.9 0.9 0.9 0.9 18.5 11.8 0.9 1.0 0.9 0.4 3.9 6.2 1.0 1.0 1.0 0.9 1.1 0.9 1.4 1.1 1.0 9.1 1.0 1.1 2.7 7.1 0.0 1.2 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.9 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.7 0.5 0.0 2.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 26.9 0.0 3.3 0.0 4.8 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.1 6.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 23.0 5.7 13.2 15.5 15.5 18.5 11.8 6.2 7.1 NKPD1 FLJ33600 ENSG00000179846 "NTPase KAP family P-loop domain containing 1" Q17RQ9 19 45149750-45158737 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 17.5" "Cell line enhanced" "Detected in some" "hTCEpi: 4.0;SiHa: 3.5;U-266/70: 7.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA043339 Uncertain "HPA043339: AB_10962493" "unprognostic (3.98e-2)" "unprognostic (5.94e-2)" "unprognostic (2.14e-1)" "unprognostic (8.30e-4)" "unprognostic (2.23e-1)" "unprognostic (4.60e-2)" "unprognostic (2.41e-3)" "unprognostic (2.01e-2)" "unprognostic (2.60e-1)" "unprognostic (2.35e-2)" "unprognostic (7.73e-4)" "unprognostic (1.30e-1)" "unprognostic (2.77e-5)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (8.90e-2)" "unprognostic (2.13e-1)" 0.0 0.1 0.0 0.0 0.1 0.2 0.8 0.5 0.2 0.9 0.0 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.8 0.1 17.5 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 2.4 0.2 0.2 0.5 0.1 0.2 1.8 0.0 0.2 0.2 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.4 0.3 0.7 0.0 0.3 0.0 0.0 0.0 0.5 0.6 1.4 0.1 0.1 0.1 0.0 0.0 0.2 4.0 0.0 0.1 0.1 0.4 0.6 0.0 1.1 0.7 0.5 0.3 0.4 0.1 0.0 0.3 0.0 0.1 0.6 0.3 3.5 1.7 0.1 1.3 0.3 0.0 0.0 0.0 0.0 0.0 7.2 1.6 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.5 0.6 0.0 0.2 1.8 0.1 0.4 0.2 0.0 0.2 0.0 0.0 NKX2-5 "CSX, CSX1, NKX2.5, NKX2E, NKX4-1" ENSG00000183072 "NK2 homeobox 5" P52952 5 173232109-173235357 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Atrial septal defect, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 95.6" "Cell line enhanced" "Detected in some" "HEK 293: 20.5;NTERA-2: 7.4;SK-MEL-30: 9.1;U-2 OS: 16.9;U-251 MG: 12.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA065034 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA065034: " "unprognostic (3.81e-1)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (9.57e-3)" "unprognostic (3.22e-3)" "unprognostic (6.63e-2)" "unprognostic (1.57e-1)" "unprognostic (2.72e-1)" "unprognostic (2.31e-1)" "unprognostic (5.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.77e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 95.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.1 0.0 0.0 0.2 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.0 1.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 20.5 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 5.7 0.0 0.0 0.0 0.1 0.3 4.2 0.0 9.1 0.0 0.0 0.0 3.9 16.9 5.2 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX3-1 "BAPX2, NKX3.1, NKX3A" ENSG00000167034 "NK3 homeobox 1" Q99801 8 23678693-23682927 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "prostate: 95.3" "Cell line enhanced" "Detected in many" "SiHa: 17.5;U-138 MG: 17.8;U-251 MG: 15.2" "Cancer enriched" "Detected in many" 65 "prostate cancer: 392.7" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 7 "eosinophil: 23.5;neutrophil: 23.4" "Lineage enriched" "Detected in many" 19 "granulocytes: 23.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA025693, HPA078571" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA025693: AB_1854522, HPA078571: " "unprognostic (1.47e-2)" "unprognostic (4.03e-2)" "unprognostic (2.67e-1)" "unprognostic (5.87e-2)" "unprognostic (2.56e-6)" "unprognostic (6.90e-3)" "unprognostic (1.13e-1)" "unprognostic (4.11e-3)" "unprognostic (9.42e-2)" "unprognostic (1.41e-1)" "unprognostic (3.00e-2)" "unprognostic (1.87e-1)" "unprognostic (4.37e-2)" "unprognostic (4.60e-2)" "unprognostic (3.88e-2)" "unprognostic (3.09e-2)" "unprognostic (1.69e-1)" 0.6 1.3 0.3 0.6 0.9 0.6 1.5 0.1 0.8 1.1 0.6 0.2 0.5 0.5 0.7 0.5 1.2 0.7 0.8 2.4 0.8 0.3 0.4 1.6 0.8 0.7 0.6 0.2 1.6 0.6 0.5 0.4 0.3 1.2 95.3 0.2 0.5 17.9 0.7 2.0 0.2 0.4 0.7 0.6 0.3 0.5 12.3 0.7 0.0 0.6 3.2 20.5 0.7 2.5 1.0 0.0 23.5 0.0 0.2 1.2 0.1 3.2 2.4 0.0 5.9 2.2 0.5 4.9 4.4 2.8 9.5 11.2 1.4 3.7 0.0 0.6 3.3 0.8 2.3 5.1 7.5 0.0 1.2 2.2 1.8 3.5 4.2 0.0 0.8 0.8 1.3 9.6 0.5 0.5 0.1 0.0 3.7 1.0 7.6 0.6 1.4 1.7 0.0 3.8 0.3 0.5 3.8 1.1 0.3 17.5 3.3 0.3 2.3 0.3 0.6 17.8 6.3 1.3 15.2 0.0 0.0 0.0 8.7 1.7 2.1 3.4 0.0 23.5 0.5 0.0 0.1 1.0 0.2 0.5 0.0 0.9 0.7 1.2 23.4 0.2 0.0 0.0 0.0 0.1 0.3 0.9 0.1 0.8 0.8 0.3 0.6 0.2 1.2 0.7 NLRC3 "CLR16.2, FLJ00348, NOD3" ENSG00000167984 "NLR family CARD domain containing 3" Q7RTR2 16 3539033-3577400 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 27.0" "Cell line enhanced" "Detected in some" "HEL: 6.2;HL-60: 12.9;HMC-1: 6.5;NB-4: 13.8;U-698: 19.9;U-937: 9.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA048062 Supported "Vesicles,Centriolar satellite,Cytosol" Cytosol "Vesicles, Centriolar satellite" "HPA048062: " "unprognostic (4.93e-3)" "unprognostic (3.84e-4)" "unprognostic (7.61e-4)" "unprognostic (4.94e-7)" "unprognostic (9.56e-2)" "unprognostic (3.76e-5)" "unprognostic (1.86e-3)" "unprognostic (6.70e-3)" "unprognostic (2.66e-2)" "unprognostic (7.02e-2)" "unprognostic (3.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.40e-2)" "unprognostic (5.13e-2)" "unprognostic (7.15e-3)" "unprognostic (4.54e-2)" "unprognostic (2.08e-2)" 0.2 0.4 0.0 20.1 0.1 2.8 0.0 0.0 0.2 0.4 1.3 0.0 0.2 1.2 1.0 0.1 1.0 0.0 1.8 0.8 0.0 0.6 0.5 6.0 11.2 0.2 0.0 0.1 1.5 0.0 0.0 0.6 0.2 0.9 0.7 0.9 2.7 0.2 0.5 0.0 2.4 0.1 0.0 10.5 1.4 0.0 0.0 27.0 0.4 1.1 18.1 1.6 1.0 1.0 0.0 2.6 0.0 4.7 4.1 3.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 5.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 6.2 0.1 0.0 0.0 12.9 6.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 5.4 13.8 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 3.3 0.4 0.2 0.0 0.2 0.1 0.3 0.0 19.9 0.1 9.7 0.0 2.6 0.0 0.0 3.7 0.0 4.1 1.0 2.7 3.8 0.0 0.8 2.1 2.0 0.0 4.7 0.0 0.0 3.1 3.3 NLRP13 "CLR19.7, NALP13, NOD14, PAN13" ENSG00000173572 "NLR family pyrin domain containing 13" Q86W25 19 55891699-55932336 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "breast: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060459 Uncertain "HPA060459: " "unprognostic (2.16e-1)" "unprognostic (4.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 NLRP5 "CLR19.8, MATER, NALP5, PAN11, PYPAF8" ENSG00000171487 "NLR family pyrin domain containing 5" P59047 19 55999726-56061813 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "parathyroid gland: 19.3" "Group enriched" "Detected in some" 14 "Karpas-707: 3.0;U-2 OS: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056271 Uncertain "Intracellular and membrane" "HPA056271: " "unprognostic (9.67e-2)" "unprognostic (2.22e-2)" "unprognostic (5.03e-1)" "unprognostic (7.78e-2)" "unprognostic (1.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 19.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLRP6 "CLR11.4, NALP6, PAN3, PYPAF5" ENSG00000174885 "NLR family pyrin domain containing 6" P59044 11 278365-285359 "Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 63.8" "Group enriched" "Detected in some" 4 "REH: 4.3;U-266/70: 8.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 14.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA043681, HPA048500" Supported "HPA043681: , HPA048500: " "unprognostic (6.37e-3)" "unprognostic (4.69e-2)" "unprognostic (4.26e-2)" "unprognostic (3.42e-2)" "unprognostic (6.40e-2)" "unprognostic (1.18e-2)" "prognostic favourable (4.23e-5)" "unprognostic (8.82e-2)" "unprognostic (2.40e-1)" "unprognostic (1.66e-1)" "unprognostic (5.16e-3)" "unprognostic (2.19e-1)" "unprognostic (3.11e-3)" "unprognostic (4.96e-2)" "unprognostic (2.14e-2)" "unprognostic (6.90e-3)" "unprognostic (3.69e-2)" 0.4 0.0 0.1 1.3 0.1 0.2 0.1 0.1 0.1 0.1 29.1 0.1 0.1 25.9 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.9 1.6 0.6 0.6 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 63.8 0.1 0.1 2.7 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.1 14.6 4.0 0.9 2.4 0.6 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 0.4 0.5 1.0 0.3 0.0 4.3 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.3 0.0 8.6 0.5 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.3 1.4 0.3 1.7 1.2 0.1 0.1 2.0 2.4 14.6 0.9 4.0 0.0 0.0 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 NOBOX "OG2, Og2x" ENSG00000106410 "NOBOX oogenesis homeobox" O60393 7 144397240-144410227 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 2.7" "Cell line enhanced" "Detected in single" "AN3-CA: 1.0" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (7.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NOTUM ENSG00000185269 "Notum, palmitoleoyl-protein carboxylesterase" Q6P988 17 81952507-81961840 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "placenta: 127.4" "Cell line enriched" "Detected in some" 26 "Hep G2: 94.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in female reproductive system" 59000 "unprognostic (1.49e-1)" "unprognostic (1.55e-1)" "unprognostic (1.23e-2)" "unprognostic (4.80e-3)" "unprognostic (1.97e-1)" "unprognostic (9.02e-3)" "unprognostic (3.01e-2)" "unprognostic (1.01e-2)" "unprognostic (6.49e-2)" "unprognostic (8.72e-2)" "unprognostic (1.40e-1)" "unprognostic (2.01e-2)" "unprognostic (4.48e-6)" "unprognostic (1.76e-1)" "unprognostic (9.88e-2)" "unprognostic (1.22e-3)" "unprognostic (1.00e-1)" 0.2 0.1 1.1 0.2 1.2 0.1 0.2 0.3 1.0 0.2 0.2 0.2 0.5 0.6 1.0 1.3 0.3 0.2 0.3 0.3 0.5 0.9 0.8 10.4 1.8 0.2 0.7 0.4 0.2 0.2 0.0 0.2 127.4 0.6 0.4 0.0 0.2 0.3 0.2 4.9 2.4 0.2 0.2 0.3 0.3 0.9 3.0 0.5 0.2 0.2 0.3 0.2 1.3 1.3 0.7 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.4 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.5 0.6 94.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.3 0.9 0.4 1.3 0.0 1.1 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 1.2 0.3 1.0 0.5 0.9 0.7 0.4 0.6 0.5 NOV "CCN3, IGFBP9" ENSG00000136999 "Nephroblastoma overexpressed" P48745 8 119416306-119424353 "Plasma proteins, Predicted secreted proteins, Transporters" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "adrenal gland: 236.7" "Group enriched" "Detected in many" 5 "BJ hTERT+: 43.0;U-2197: 44.5" "Cancer enhanced" "Detected in all" "melanoma: 62.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 113 "eosinophil: 28.1;neutrophil: 14.0" "Lineage enriched" "Detected in single" 151 "granulocytes: 28.1" "Group enriched" "Detected in many" 7 "amygdala: 134.6;basal ganglia: 51.6;cerebral cortex: 101.0;hippocampal formation: 166.1" "Low region specificity" "Detected in many" "HPA018449, HPA019684, CAB034423" Enhanced Enhanced Vesicles "Secreted to blood" 269030000 2900000 Vesicles "CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190" "unprognostic (5.04e-2)" "unprognostic (1.01e-1)" "unprognostic (7.36e-3)" "unprognostic (1.30e-3)" "unprognostic (9.35e-3)" "unprognostic (4.92e-1)" "unprognostic (8.10e-2)" "unprognostic (6.04e-2)" "unprognostic (1.79e-2)" "unprognostic (9.17e-2)" "unprognostic (1.67e-1)" "unprognostic (3.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.74e-3)" "unprognostic (1.51e-1)" "unprognostic (1.98e-1)" "unprognostic (2.72e-2)" 6.3 236.7 2.2 1.4 7.9 1.0 5.6 3.1 12.3 5.0 2.0 3.6 3.6 1.5 5.8 2.9 1.9 3.0 2.0 5.7 3.5 1.9 4.9 0.9 2.9 1.1 2.1 15.1 1.8 2.7 2.1 13.4 0.8 7.4 5.6 2.2 1.2 1.2 5.0 1.6 3.6 1.5 2.5 2.5 1.0 1.6 2.6 0.0 0.0 6.9 4.8 1.1 3.3 2.5 0.0 0.1 28.1 0.1 0.0 0.0 0.0 0.0 1.0 0.6 0.0 3.9 1.0 0.0 5.7 43.0 5.2 3.0 0.0 0.1 0.0 4.5 7.2 3.6 0.2 0.0 1.7 0.0 0.1 0.0 3.3 0.0 0.1 0.0 0.0 0.2 0.0 2.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 8.6 0.0 0.0 0.0 5.5 0.0 1.3 0.0 2.1 0.0 8.0 0.0 0.0 0.0 3.7 5.7 44.5 1.1 0.0 0.0 0.0 5.9 1.8 4.3 0.0 0.1 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 2.2 7.9 3.1 12.3 3.5 1.9 2.1 15.1 7.4 0.0 NOX4 "KOX, KOX-1" ENSG00000086991 "NADPH oxidase 4" Q9NPH5 11 89324356-89498187 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 65.2" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 15.4;TIME: 34.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015475 Approved Nucleoplasm Nucleoplasm "HPA015475: AB_1854574" "unprognostic (2.91e-2)" "unprognostic (1.08e-1)" "unprognostic (1.74e-3)" "unprognostic (6.58e-3)" "unprognostic (1.92e-1)" "unprognostic (2.33e-1)" "unprognostic (8.83e-3)" "unprognostic (8.95e-3)" "unprognostic (3.80e-1)" "unprognostic (6.88e-2)" "unprognostic (1.56e-2)" "unprognostic (1.73e-1)" "prognostic favourable (6.14e-4)" "unprognostic (1.99e-4)" "unprognostic (9.71e-2)" "unprognostic (5.69e-2)" "unprognostic (3.03e-3)" 7.5 0.6 0.2 0.6 0.6 0.3 6.5 0.3 0.5 1.2 0.9 1.1 0.4 0.3 7.3 2.5 1.5 0.8 1.3 6.9 0.6 0.2 65.2 0.3 1.2 0.3 0.3 0.2 0.7 1.1 3.8 0.8 1.7 1.0 2.6 0.4 0.8 2.6 0.9 5.1 1.1 0.5 3.5 1.2 0.4 0.4 1.0 0.0 0.0 1.7 1.7 0.4 2.1 1.1 0.4 0.3 1.7 0.3 0.8 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 15.4 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.1 0.0 0.0 0.2 0.3 0.0 34.4 0.1 2.7 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.4 0.3 0.3 1.7 0.8 0.2 0.3 0.2 0.0 0.2 0.6 0.3 0.5 0.6 0.2 0.3 0.2 1.0 0.0 NOXRED1 "C14orf148, FLJ32809" ENSG00000165555 "NADP dependent oxidoreductase domain containing 1" Q6NXP6 14 77394021-77423517 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 2.9" "Lineage enhanced" "Detected in single" "granulocytes: 2.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055658 Approved "HPA055658: " "unprognostic (1.92e-2)" "unprognostic (4.83e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-1)" "unprognostic (2.49e-2)" "unprognostic (9.87e-2)" "unprognostic (1.92e-2)" "unprognostic (1.36e-1)" "unprognostic (2.39e-2)" "unprognostic (2.61e-1)" "unprognostic (1.08e-3)" "unprognostic (1.24e-2)" "unprognostic (1.29e-2)" "unprognostic (2.60e-1)" "unprognostic (5.70e-2)" "unprognostic (1.70e-3)" "unprognostic (1.07e-3)" 0.4 0.8 0.5 0.4 0.9 0.1 0.7 0.4 0.4 0.4 0.7 0.4 0.4 0.7 0.6 0.8 0.4 1.2 0.9 0.4 0.5 0.7 0.6 0.5 0.4 0.8 0.4 0.4 0.4 0.7 0.8 1.4 0.4 0.4 0.4 0.6 0.4 0.4 0.5 0.4 1.8 0.4 0.6 0.4 0.6 0.2 13.9 0.4 0.4 1.5 0.4 0.4 0.4 0.4 0.2 0.0 2.9 0.0 0.0 0.8 0.0 1.2 2.6 1.0 1.4 0.5 2.5 1.8 1.2 1.8 1.3 0.8 1.4 1.2 2.5 0.6 2.1 0.7 0.5 0.5 1.5 1.2 0.9 1.4 0.1 2.4 0.9 0.5 2.3 1.4 3.4 1.1 1.8 0.7 0.6 1.8 0.6 2.7 0.6 0.8 0.0 2.2 0.7 0.6 0.1 1.2 0.6 2.5 1.8 1.6 0.6 0.4 2.4 1.5 3.1 0.9 0.8 1.6 0.4 2.5 2.3 1.4 1.3 0.3 1.0 0.0 0.0 2.9 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.8 0.0 0.5 0.9 0.4 0.4 0.5 0.7 0.4 0.4 0.4 0.4 NPAP1 C15orf2 ENSG00000185823 "Nuclear pore associated protein 1" Q9NZP6 15 24675868-24683393 "Predicted intracellular proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 17.7" "Cell line enhanced" "Detected in some" "U-266/70: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA018828, HPA019562" Uncertain "HPA018828: , HPA019562: " "unprognostic (4.40e-2)" "unprognostic (1.85e-2)" "unprognostic (6.98e-3)" "unprognostic (7.45e-2)" "unprognostic (9.90e-2)" "unprognostic (1.08e-2)" "unprognostic (5.11e-3)" 0.2 0.2 0.2 0.2 1.2 1.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.8 0.6 0.2 0.2 0.2 0.2 0.2 1.4 0.9 0.0 1.1 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.8 0.2 0.2 0.4 0.3 0.2 17.7 0.2 0.2 1.2 0.2 0.2 0.6 0.2 0.4 0.3 1.6 0.1 0.9 1.2 0.0 0.4 0.2 0.5 0.7 0.1 0.0 0.8 0.4 0.0 0.1 0.0 0.5 0.5 0.5 0.2 0.1 0.4 0.2 0.4 0.1 0.2 0.5 0.4 0.9 0.4 0.0 0.5 0.2 0.2 0.4 0.3 0.2 0.0 0.6 0.5 0.0 0.5 0.2 0.6 0.9 0.6 0.1 0.1 0.1 0.1 1.4 0.5 0.2 0.3 0.7 0.1 0.8 0.1 0.9 0.5 1.6 0.2 0.2 3.4 0.2 0.7 0.5 0.3 0.2 1.6 0.1 0.2 1.1 0.1 0.5 0.2 0.2 1.0 0.1 0.4 0.2 1.2 0.9 0.9 0.1 0.3 0.2 0.0 0.2 1.2 0.2 0.2 0.2 0.8 0.2 0.2 0.2 0.2 NPBWR2 GPR8 ENSG00000125522 "Neuropeptides B and W receptor 2" P48146 20 64105820-64107171 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "cerebral cortex: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "unprognostic (1.44e-1)" 0.2 2.4 0.3 0.3 1.8 0.3 0.2 0.4 14.8 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.2 2.3 0.2 0.2 0.2 1.6 0.2 0.1 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.8 0.4 14.8 0.2 0.5 0.2 2.3 0.1 0.0 NPC2 "EDDM1, HE1, NP-C2" ENSG00000119655 "NPC intracellular cholesterol transporter 2" P61916 14 74476192-74494177 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Disease mutation, Niemann-Pick disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "epididymis: 982.9" "Cell line enhanced" "Detected in many" "ASC diff: 146.9" "Cancer enhanced" "Detected in all" "thyroid cancer: 769.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 139.0;granulocytes: 44.2;monocytes: 112.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000835 Enhanced "Secreted to blood" 63000000 "HPA000835: AB_1079499" "unprognostic (1.27e-3)" "unprognostic (1.69e-2)" "prognostic unfavourable (4.83e-5)" "unprognostic (1.17e-1)" "unprognostic (1.82e-2)" "unprognostic (3.72e-2)" "prognostic unfavourable (3.13e-4)" "unprognostic (6.67e-3)" "unprognostic (3.26e-2)" "unprognostic (1.04e-1)" "unprognostic (9.15e-2)" "unprognostic (1.32e-1)" "unprognostic (3.11e-3)" "prognostic unfavourable (2.66e-4)" "unprognostic (1.97e-1)" "prognostic favourable (6.55e-4)" "unprognostic (1.42e-1)" 34.8 23.7 9.0 14.7 12.2 13.9 27.2 2.4 7.6 21.1 16.0 12.5 92.3 11.9 16.8 982.9 17.1 14.9 17.5 34.1 9.1 9.9 29.2 13.6 65.0 48.8 15.1 6.7 25.3 14.6 4.5 21.3 22.1 25.5 17.8 14.4 39.8 21.8 54.0 9.4 16.6 19.1 12.1 26.5 30.0 13.6 26.6 10.6 7.6 49.8 15.9 15.4 16.4 18.1 18.7 139.0 44.2 112.5 6.3 12.2 67.2 30.2 19.1 12.7 16.1 146.9 43.2 40.1 21.8 73.6 19.3 43.1 32.6 38.2 7.3 16.1 17.0 60.0 16.4 40.5 17.0 11.8 12.8 3.0 9.9 25.0 32.8 4.8 56.5 43.8 34.4 17.4 33.6 24.9 3.0 57.1 18.6 12.7 7.4 7.4 6.6 30.7 3.6 22.8 25.0 43.9 66.2 0.5 8.9 31.3 11.6 27.3 19.8 20.7 27.0 27.3 37.4 39.6 19.2 26.6 45.4 2.6 29.1 15.2 15.3 34.1 83.8 17.9 6.6 112.5 6.2 18.7 9.2 6.6 39.1 17.0 9.0 7.5 44.2 6.3 76.2 139.0 12.2 67.2 9.0 12.2 2.4 7.6 9.1 9.9 15.1 6.7 25.5 10.6 NPFF FMRFAL ENSG00000139574 "Neuropeptide FF-amide peptide precursor" O15130 12 53506690-53507638 "Predicted secreted proteins" Neuropeptide "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 28 "epididymis: 154.7" "Cell line enriched" "Detected in some" 7 "HHSteC: 17.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebellum: 2.0;hypothalamus: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "pons and medulla: 11.9" "Region enriched" "Detected in all" 8 "cerebellum: 143.2" "Secreted in male reproductive system" 0.3 0.1 0.1 0.1 0.3 0.0 0.1 2.0 0.1 0.5 0.2 0.1 1.1 0.2 0.1 154.7 0.1 0.2 0.1 0.1 0.1 1.4 0.1 0.1 0.5 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 5.5 0.2 0.1 1.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.7 0.2 0.8 0.2 0.0 0.0 0.2 0.1 0.2 0.0 0.3 0.1 1.9 0.4 0.8 0.2 0.0 0.3 0.2 0.5 1.9 0.1 0.0 0.2 0.0 0.2 2.4 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 2.0 0.1 0.1 1.4 0.1 0.1 0.3 0.1 NPFFR1 "GPR147, NPFF1R1, OT7T022" ENSG00000148734 "Neuropeptide FF receptor 1" Q9GZQ6 10 70247329-70283676 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 34.9" "Cell line enhanced" "Detected in some" "U-2 OS: 4.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Group enriched" "Detected in all" 5 "basal ganglia: 10.2;cerebellum: 34.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basal ganglia: 16.1;hypothalamus: 7.3" "Low region specificity" "Detected in many" HPA037521 Uncertain "HPA037521: " "unprognostic (1.73e-3)" "unprognostic (7.29e-4)" "unprognostic (2.12e-1)" "unprognostic (3.50e-2)" "unprognostic (2.07e-1)" "unprognostic (8.66e-3)" "unprognostic (1.37e-1)" "unprognostic (1.48e-1)" "unprognostic (4.14e-2)" "unprognostic (3.51e-1)" "unprognostic (9.62e-2)" "unprognostic (6.78e-2)" "unprognostic (5.84e-5)" "unprognostic (1.37e-1)" "unprognostic (3.93e-2)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" 0.6 0.5 1.9 1.8 10.2 1.3 0.9 34.9 2.6 0.9 0.6 2.6 0.0 0.8 1.0 1.2 0.4 1.6 0.6 0.4 2.7 4.1 0.5 0.5 1.3 2.5 2.2 4.1 0.8 0.3 0.9 0.4 0.4 4.7 0.6 0.8 5.4 0.4 1.1 1.0 1.0 0.8 0.4 4.0 1.0 1.4 4.7 2.0 0.0 0.6 0.0 1.4 0.6 0.7 1.0 1.2 2.4 2.2 1.3 0.6 2.6 1.1 0.7 0.9 0.7 0.8 1.2 0.7 0.3 0.4 0.3 0.3 1.3 2.3 0.8 0.7 1.0 1.0 2.2 1.2 0.7 0.7 0.8 1.0 1.0 1.0 0.8 0.8 1.3 0.7 1.0 0.5 0.8 0.9 0.9 0.9 0.5 0.9 0.7 0.9 0.7 0.3 0.9 0.8 0.5 0.8 0.8 0.8 0.8 0.8 1.1 0.4 0.5 0.6 1.0 0.9 4.7 0.8 1.0 0.7 0.8 0.5 0.6 0.9 0.7 2.4 2.2 0.4 0.5 0.7 0.5 0.5 0.5 0.4 1.2 1.0 0.6 0.6 1.9 1.3 0.4 0.9 0.4 2.6 1.9 10.2 34.9 2.6 2.7 4.1 2.2 4.1 4.7 2.0 NPHS2 "PDCN, SRN1" ENSG00000116218 "NPHS2, podocin" Q9NP85 1 179550539-179575952 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 143 "kidney: 66.5" "Cell line enriched" "Detected in single" 24 "NTERA-2: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB037267, HPA049486" Enhanced "CAB037267: AB_261982, HPA049486: " "unprognostic (6.77e-2)" "unprognostic (9.71e-2)" "unprognostic (1.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPB6 ENSG00000198156 "Nuclear pore complex interacting protein family member B6" E9PJ23 16 28342555-28363508 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 26.8" "Cell line enhanced" "Detected in many" "A549: 5.9;BEWO: 5.5;hTCEpi: 5.8;NB-4: 5.8;RPMI-8226: 5.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 3.1;naive B-cell: 1.8" "Lineage enriched" "Detected in single" 5 "B-cells: 3.1" "HPA011188, HPA053611" Approved Approved Nucleoplasm Nucleoplasm "HPA011188: , HPA053611: " "unprognostic (1.99e-1)" "unprognostic (1.81e-2)" "unprognostic (7.76e-3)" "unprognostic (1.06e-1)" "unprognostic (6.86e-2)" "unprognostic (2.43e-1)" "unprognostic (3.21e-1)" "unprognostic (1.02e-1)" "unprognostic (1.54e-1)" "unprognostic (1.31e-1)" "unprognostic (2.31e-1)" "unprognostic (1.97e-1)" "unprognostic (6.79e-4)" "unprognostic (3.20e-1)" "unprognostic (8.36e-2)" "unprognostic (4.78e-1)" "unprognostic (1.04e-3)" 0.2 0.0 0.9 0.3 1.4 0.5 0.6 1.8 0.9 0.4 0.5 0.3 0.7 1.0 0.1 0.9 0.1 0.1 1.1 0.7 0.1 0.1 0.2 0.4 0.7 1.2 0.2 0.4 0.9 0.2 0.7 0.6 0.2 0.5 0.6 1.8 0.3 0.4 0.9 0.6 0.6 26.8 0.6 0.2 0.2 0.3 3.1 0.1 0.1 0.0 0.1 0.6 0.5 0.2 5.9 2.8 0.6 1.4 0.3 5.5 0.3 0.5 0.1 0.5 0.2 2.4 1.9 0.5 0.2 0.7 0.3 0.5 0.3 1.3 0.5 1.4 1.1 0.0 0.0 1.7 0.4 0.9 5.8 0.4 1.3 0.1 0.2 4.7 0.0 1.4 0.5 5.8 1.6 0.2 3.1 2.5 5.9 0.1 0.1 0.7 1.2 0.2 0.3 0.6 1.2 0.4 0.5 0.7 2.3 0.5 0.4 2.2 2.2 0.7 0.2 0.9 0.2 0.0 0.0 0.0 0.3 0.0 0.0 3.1 0.6 0.5 0.0 1.8 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.5 NPIPB7 "LOC440350, NPIPL1" ENSG00000233232 "Nuclear pore complex interacting protein family member B7" O75200 16 28456372-28471175 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 14.9" "Cell line enhanced" "Detected in some" "BEWO: 6.1;hTCEpi: 2.4;U-266/70: 1.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "HPA011188, HPA053611" Approved Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA011188: , HPA053611: " "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" "unprognostic (8.35e-2)" "unprognostic (1.94e-1)" "unprognostic (1.94e-1)" "unprognostic (7.43e-2)" "unprognostic (3.07e-3)" "unprognostic (3.35e-2)" "unprognostic (3.44e-1)" "unprognostic (2.78e-2)" "unprognostic (3.62e-2)" "unprognostic (3.04e-2)" "unprognostic (4.40e-1)" "unprognostic (2.22e-1)" "unprognostic (7.73e-2)" "unprognostic (2.03e-2)" 0.0 0.0 0.5 0.2 0.9 0.1 0.1 2.3 0.5 0.1 0.3 0.3 0.3 0.3 0.0 0.2 0.1 0.1 0.5 0.8 0.0 0.0 0.2 0.4 0.3 0.5 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.8 0.2 0.1 0.2 0.1 0.1 14.9 0.4 0.1 0.1 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 6.1 0.0 0.2 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.4 0.4 0.2 0.0 0.0 0.1 0.0 0.9 0.1 1.0 0.6 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.4 0.1 0.0 1.6 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 NPIPB8 ENSG00000255524 "Nuclear pore complex interacting protein family member B8" E9PQR5 16 28637654-28658682 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 14.4" "Cell line enriched" "Detected in single" 29 "hTCEpi: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011188, HPA053611" Uncertain Approved Nucleoplasm Nucleoplasm "HPA011188: , HPA053611: " "unprognostic (8.28e-2)" "unprognostic (1.88e-1)" "unprognostic (1.10e-1)" "unprognostic (5.78e-2)" "unprognostic (1.05e-2)" "unprognostic (2.64e-1)" "unprognostic (1.19e-1)" 0.4 0.7 0.0 0.6 0.3 0.5 0.5 1.6 0.4 0.3 0.9 2.2 0.6 0.7 0.5 0.3 0.1 0.1 0.1 0.0 0.3 1.1 0.6 0.3 0.1 1.1 1.1 0.1 1.3 0.2 1.1 0.4 1.3 0.4 0.9 0.7 2.2 0.2 0.1 0.6 0.7 14.4 1.0 0.4 0.5 0.6 0.6 0.3 0.1 0.1 0.5 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.6 0.2 21.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.1 0.3 0.4 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.0 NPIPB9 ENSG00000196993 "Nuclear pore complex interacting protein family member B9" F8W1W9 16 28751787-28772807 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "testis: 13.6" "Cell line enhanced" "Detected in many" "hTCEpi: 7.9;U-266/70: 6.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "HPA011188, HPA053611" Approved Approved Nucleoplasm Nucleoplasm "HPA011188: , HPA053611: " "unprognostic (7.38e-2)" "unprognostic (6.63e-4)" "unprognostic (6.63e-2)" "unprognostic (5.05e-2)" "unprognostic (5.53e-2)" "unprognostic (4.44e-2)" "unprognostic (1.53e-1)" "unprognostic (9.36e-2)" "unprognostic (7.52e-2)" "unprognostic (2.84e-1)" "unprognostic (2.86e-1)" "unprognostic (2.31e-1)" "unprognostic (4.71e-2)" 0.6 0.3 1.7 0.9 1.8 1.6 0.4 2.7 1.4 0.4 1.0 0.0 1.1 2.4 0.4 1.5 0.6 0.2 2.2 1.3 0.4 0.4 0.4 1.5 1.7 1.4 0.2 0.5 1.4 0.4 1.2 0.8 0.9 0.9 1.1 2.8 0.8 0.8 2.2 1.1 0.5 13.6 1.7 1.0 0.3 0.7 3.1 0.1 0.5 0.2 1.8 0.7 0.3 0.4 3.9 1.1 0.6 0.5 1.3 3.2 0.0 0.1 0.0 0.0 0.4 2.1 1.5 1.1 0.0 0.4 0.7 0.2 0.1 0.4 1.9 0.7 0.0 0.8 0.1 2.5 2.7 0.1 7.9 0.6 1.5 0.0 0.4 2.4 0.2 2.9 0.8 3.3 1.6 0.9 3.3 0.0 1.5 0.0 0.3 0.1 0.0 0.2 0.4 0.2 2.2 1.1 0.0 0.0 2.8 1.9 0.6 6.6 2.8 2.0 0.1 0.9 0.5 0.0 0.2 0.0 0.7 0.0 0.2 3.1 0.4 0.1 0.1 1.2 0.3 0.1 0.5 1.8 0.2 0.0 0.3 0.3 NPPA "ANP, PND" ENSG00000175206 "Natriuretic peptide A" P01160 1 11845709-11848345 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hormone, Vasoactive" "Atrial fibrillation, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 418 "heart muscle: 1267.7" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.2;SH-SY5Y: 11.7" "Cancer enriched" "Detected in some" 9 "glioma: 7.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in some" 8 "olfactory region: 28.1" "Region enriched" "Detected in some" 5 "olfactory region: 21.2" HPA058269 Enhanced "Secreted to blood" 190000 "HPA058269: " "unprognostic (1.27e-3)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (1.30e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "unprognostic (2.02e-1)" "unprognostic (2.01e-1)" "unprognostic (1.48e-1)" "unprognostic (3.25e-2)" "unprognostic (9.72e-3)" "unprognostic (2.21e-1)" "unprognostic (5.93e-4)" "unprognostic (2.31e-1)" "unprognostic (1.59e-1)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 1267.7 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 1.7 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.3 0.0 0.3 0.8 0.0 0.5 3.0 1.1 1.6 2.6 2.1 0.0 0.0 1.6 0.9 0.0 0.0 0.0 6.5 2.6 4.2 0.3 0.0 4.0 0.0 0.0 0.0 1.0 2.6 2.7 1.5 6.4 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 5.8 5.0 0.0 0.9 0.5 7.5 1.9 0.7 0.6 0.8 0.8 0.0 1.8 12.2 11.7 0.7 0.0 2.2 1.6 0.2 0.4 2.1 4.2 3.4 0.3 1.3 3.1 4.8 0.2 3.4 1.1 0.0 0.4 0.0 0.1 0.8 0.4 1.3 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.5 0.0 0.0 3.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 NPPB ENSG00000120937 "Natriuretic peptide B" P16860 1 11857464-11858931 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Hormone, Vasoactive" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 296 "heart muscle: 348.6" "Group enriched" "Detected in some" 8 "BEWO: 33.4;CACO-2: 86.9" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to blood" 9675 "unprognostic (3.87e-1)" "unprognostic (1.29e-2)" "unprognostic (2.49e-1)" "unprognostic (4.23e-1)" "unprognostic (3.28e-2)" 0.1 0.0 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 348.6 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.9 0.5 0.4 0.7 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.5 0.2 86.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.3 0.8 0.4 1.0 1.0 0.6 1.0 0.5 0.5 1.1 1.1 0.0 0.7 0.3 0.9 0.7 0.9 0.1 0.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 NPTX1 ENSG00000171246 "Neuronal pentraxin 1" Q15818 17 80467148-80477843 "Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 68.9" "Cell line enhanced" "Detected in some" "HAP1: 12.1;HeLa: 9.5;SiHa: 15.4;U-138 MG: 33.0;WM-115: 45.3" "Cancer enhanced" "Detected in many" "glioma: 4.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "NK-cell: 1.5" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 74.8;cerebellum: 228.3;cerebral cortex: 119.6;hippocampal formation: 173.6" HPA077062 Enhanced "Secreted in brain" 1000000 "HPA077062: " "unprognostic (2.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.81e-2)" "unprognostic (6.95e-2)" "unprognostic (4.16e-3)" "unprognostic (2.43e-2)" "unprognostic (1.48e-2)" "unprognostic (3.63e-1)" "unprognostic (1.31e-2)" "unprognostic (2.07e-1)" "unprognostic (1.81e-2)" "unprognostic (9.63e-3)" "unprognostic (1.05e-6)" "unprognostic (1.41e-4)" "unprognostic (1.35e-1)" "unprognostic (8.86e-6)" "unprognostic (2.71e-3)" 1.0 3.4 28.8 1.4 14.7 0.8 1.1 68.9 62.5 0.8 9.1 0.2 0.0 1.3 1.3 2.5 1.4 1.4 1.7 0.7 15.5 3.0 0.8 0.7 1.0 1.4 1.0 18.2 0.7 0.7 0.7 0.8 1.6 4.6 1.3 2.5 0.6 0.7 2.9 1.0 3.2 1.5 1.4 1.9 2.3 1.5 1.3 0.0 0.9 0.7 0.0 0.7 0.9 0.2 0.0 0.0 0.0 0.0 1.5 0.3 0.1 0.0 0.7 0.2 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 12.1 0.0 0.0 0.0 7.5 0.0 9.5 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.5 0.0 0.0 3.1 0.0 0.0 8.2 0.0 15.4 0.0 0.0 0.0 0.2 0.1 33.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 45.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 28.8 14.7 68.9 29.9 15.5 3.0 1.0 18.2 4.6 0.0 NPTXR ENSG00000221890 "Neuronal pentraxin receptor" O95502 22 38818452-38843982 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 73.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 14.8;SiHa: 11.0;U-87 MG: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA001079 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" 280000 "Plasma membrane, Cytosol" Nucleoplasm "HPA001079: AB_1078414" "unprognostic (6.29e-2)" "prognostic favourable (3.93e-4)" "unprognostic (6.82e-3)" "prognostic unfavourable (2.85e-4)" "unprognostic (9.55e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (1.52e-3)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.49e-2)" "unprognostic (9.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.77e-2)" 2.3 3.8 39.1 1.8 17.5 0.8 1.9 16.2 73.6 5.8 2.6 4.3 0.5 1.5 5.6 3.3 2.7 6.1 2.0 10.5 57.4 15.2 1.3 0.8 1.7 1.6 5.6 20.7 6.2 3.6 5.9 2.0 0.9 4.5 6.2 1.7 1.0 3.2 5.6 0.9 1.2 1.4 5.7 3.3 2.1 2.0 1.6 4.0 0.0 2.5 0.0 1.6 2.5 1.9 0.3 0.2 0.6 0.2 0.6 2.3 0.4 0.4 2.9 0.1 0.8 5.9 0.6 0.0 1.9 0.4 3.8 1.3 2.9 0.6 0.0 3.4 0.5 0.4 0.8 0.1 1.2 0.2 1.0 0.0 0.1 4.4 0.6 0.0 0.1 1.9 0.1 3.4 0.0 0.1 3.5 0.1 0.1 4.4 0.0 0.2 3.5 1.0 0.7 0.0 6.9 0.9 7.9 14.8 0.9 11.0 0.0 0.3 4.7 1.1 0.2 6.8 4.2 0.0 0.3 1.0 0.0 0.0 42.5 8.6 3.5 0.5 0.2 0.1 1.8 0.0 1.3 0.1 1.0 2.3 0.0 0.3 1.5 1.2 0.6 0.6 0.1 0.2 0.0 0.4 39.1 17.5 16.2 49.0 57.4 15.2 5.6 20.7 4.5 4.0 NR1H4 "FXR, HRR-1, HRR1, RIP14" ENSG00000012504 "Nuclear receptor subfamily 1 group H member 4" Q96RI1 12 100473708-100564413 "Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Disease mutation, FDA approved drug targets, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 109.4" "Group enriched" "Detected in some" 32 "Hep G2: 17.9;HHSteC: 10.8;RPTEC TERT1: 29.0" "Group enriched" "Detected in some" 11 "liver cancer: 18.7;renal cancer: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047699 Approved Nucleoplasm Nucleoplasm "HPA047699: AB_10965320" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (6.68e-2)" "unprognostic (2.49e-1)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (2.01e-1)" "unprognostic (1.88e-2)" "unprognostic (1.16e-1)" "unprognostic (2.43e-1)" "unprognostic (3.77e-3)" 0.1 11.3 0.1 1.4 0.4 0.0 0.2 0.1 0.2 0.2 5.8 0.4 0.1 11.3 0.1 0.4 0.1 0.1 7.0 0.1 0.1 0.0 25.0 109.4 0.6 2.4 0.1 0.1 7.7 2.7 0.0 2.9 0.2 0.3 0.5 0.4 0.6 0.1 0.1 0.1 0.0 19.5 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.3 0.3 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 NR1I3 "CAR, CAR1, MB67" ENSG00000143257 "Nuclear receptor subfamily 1 group I member 3" Q14994 1 161229666-161238302 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "liver: 63.1" "Cell line enhanced" "Detected in many" "CACO-2: 9.2" "Cancer enriched" "Detected in single" 67 "liver cancer: 17.6" "Region enriched" "Detected in single" 6 "basal ganglia: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051365 Approved Nucleoplasm Nucleoplasm "HPA051365: AB_2616454" "unprognostic (2.59e-3)" "unprognostic (1.06e-2)" "unprognostic (9.33e-2)" "unprognostic (6.92e-4)" "unprognostic (2.55e-1)" "unprognostic (1.88e-2)" "unprognostic (1.91e-2)" "unprognostic (5.51e-2)" "unprognostic (8.69e-2)" "unprognostic (1.85e-1)" "unprognostic (6.23e-2)" "unprognostic (5.63e-3)" "unprognostic (2.71e-1)" "unprognostic (5.79e-2)" "unprognostic (6.44e-2)" "unprognostic (5.48e-3)" "unprognostic (2.62e-2)" 0.1 0.0 0.2 0.1 1.9 0.1 0.1 0.1 0.2 0.1 0.7 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 3.5 63.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.3 2.3 0.1 0.1 0.1 0.0 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.7 0.3 0.0 0.6 0.3 0.3 0.9 1.1 0.6 0.0 0.0 0.9 0.3 0.0 0.0 0.0 9.2 0.3 1.0 0.6 0.0 0.6 0.0 0.0 0.0 1.0 0.9 0.0 0.1 2.2 0.0 1.7 1.6 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.8 0.3 0.6 1.7 1.2 0.9 0.8 0.5 0.0 1.8 2.2 1.4 0.3 2.9 0.4 2.0 1.1 2.2 0.6 0.7 1.4 0.2 1.4 2.1 1.2 0.5 2.8 0.5 0.7 0.2 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.3 0.2 1.9 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.3 NR2E1 "TLL, TLX, XTLL" ENSG00000112333 "Nuclear receptor subfamily 2 group E member 1" Q9Y466 6 108166058-108188809 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 19.0" "Cell line enhanced" "Detected in some" "BEWO: 6.3;HEK 293: 2.2;RH-30: 1.6;U-251 MG: 8.1" "Cancer enriched" "Detected in single" 14 "glioma: 6.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 11 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036954, HPA055642" Uncertain Approved "Nuclear bodies" "Nuclear bodies" "HPA036954: AB_10670958, HPA055642: " "unprognostic (3.43e-1)" "unprognostic (1.41e-1)" "unprognostic (1.77e-1)" "unprognostic (9.60e-2)" "unprognostic (6.27e-2)" "unprognostic (6.00e-1)" "unprognostic (1.78e-2)" "unprognostic (7.31e-2)" "unprognostic (8.64e-2)" "unprognostic (9.59e-8)" "unprognostic (2.87e-1)" "unprognostic (2.49e-1)" "unprognostic (3.07e-1)" 0.6 1.1 14.5 0.6 16.0 0.8 0.8 0.0 19.0 0.6 0.6 2.8 0.0 0.7 0.6 0.6 0.6 0.6 0.6 0.7 10.8 4.3 0.9 0.6 0.6 0.7 3.5 7.5 0.7 0.7 0.8 0.1 0.7 0.0 0.6 0.6 3.3 1.0 0.6 0.7 0.9 0.6 0.6 0.0 0.7 0.7 0.8 4.1 0.0 0.7 0.0 0.6 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 8.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 14.5 16.0 0.0 10.0 10.8 4.3 3.5 7.5 0.0 4.1 NR2E3 "PNR, rd7, RP37" ENSG00000278570 "Nuclear receptor subfamily 2 group E member 3" Q9Y5X4 15 71792638-71818259 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "DNA-binding, Receptor, Repressor" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "retina: 50.2" "Cell line enhanced" "Detected in some" "AN3-CA: 3.1;MCF7: 3.2;T-47d: 3.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (9.90e-2)" "unprognostic (2.50e-1)" "unprognostic (8.25e-3)" "unprognostic (2.63e-3)" "unprognostic (2.04e-1)" "unprognostic (1.01e-1)" "unprognostic (9.85e-3)" "unprognostic (3.60e-2)" "unprognostic (2.59e-1)" "unprognostic (2.89e-1)" "unprognostic (3.51e-1)" "unprognostic (3.65e-1)" "unprognostic (4.75e-2)" "unprognostic (2.11e-2)" "unprognostic (2.75e-1)" "unprognostic (2.55e-1)" "unprognostic (1.82e-1)" 0.1 0.4 0.1 0.1 0.1 0.2 1.5 0.1 0.1 1.9 0.2 0.1 0.1 0.0 0.2 1.3 0.1 0.7 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 1.8 0.2 50.2 0.9 0.1 0.1 0.7 0.5 0.1 0.1 0.1 0.9 1.3 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.7 0.0 0.3 1.9 0.0 3.1 0.1 0.9 0.0 0.7 0.4 0.1 0.1 0.3 0.3 1.3 1.2 0.0 2.2 1.0 0.7 0.2 0.0 0.9 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.5 0.3 0.0 0.0 0.1 3.2 0.0 0.8 0.2 1.4 0.1 1.0 0.0 1.6 0.2 0.3 0.2 0.3 0.4 0.5 3.0 0.3 1.7 0.4 0.2 1.1 0.2 0.4 0.5 0.2 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.7 0.0 NRG4 HRG4 ENSG00000169752 "Neuregulin 4" Q8WWG1 15 75935969-76059795 "Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 36.6" "Cell line enhanced" "Detected in some" "HeLa: 8.5;HL-60: 3.1;THP-1: 2.9;U-698: 2.8;U-937: 5.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in all" 4 "cerebellum: 282.0" HPA010957 Uncertain "Secreted to digestive system" "HPA010957: AB_1079504" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (3.94e-2)" "unprognostic (1.67e-2)" "unprognostic (5.66e-2)" "unprognostic (4.10e-2)" "unprognostic (1.12e-2)" "unprognostic (1.17e-2)" "unprognostic (2.81e-2)" "unprognostic (2.82e-5)" "unprognostic (1.91e-2)" "unprognostic (1.56e-2)" "unprognostic (6.90e-5)" "unprognostic (8.28e-2)" "unprognostic (7.45e-2)" "unprognostic (1.08e-2)" "unprognostic (2.06e-1)" 0.4 0.5 3.5 0.2 1.3 0.8 0.3 6.9 2.7 0.3 0.4 0.5 0.0 0.2 0.3 2.1 0.8 2.2 0.2 0.4 1.4 1.0 0.5 1.1 0.7 0.2 0.5 1.8 0.3 36.6 0.2 2.5 0.8 2.1 1.2 0.3 0.0 1.5 0.3 4.8 0.6 0.3 0.2 0.5 0.4 3.0 6.3 0.3 0.0 0.4 0.5 0.2 0.5 0.3 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 1.8 0.8 0.0 1.3 0.4 0.1 0.0 0.1 1.5 0.1 8.5 0.4 0.0 3.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 2.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 5.2 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.3 6.9 2.7 1.4 1.0 0.5 1.8 2.1 0.3 NRGN RC3 ENSG00000154146 Neurogranin Q92686 11 124739846-124747210 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 223.3" "Cell line enhanced" "Detected in many" "HEL: 48.3;PC-3: 39.1" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 7 "amygdala: 79.5;basal ganglia: 172.6;cerebral cortex: 220.7;hippocampal formation: 63.6;olfactory region: 71.9" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 2.5;granulocytes: 3.8;monocytes: 5.0" "Group enriched" "Detected in many" 9 "amygdala: 797.3;basal ganglia: 614.3;cerebral cortex: 1197.5;hippocampal formation: 705.6" "Group enriched" "Detected in all" 5 "basal ganglia: 2514.3;cerebral cortex: 5912.4;hippocampal formation: 3143.5" "CAB006908, HPA038171" Enhanced 10000000 "CAB006908: , HPA038171: " "unprognostic (1.37e-1)" "unprognostic (8.24e-3)" "unprognostic (3.95e-2)" "unprognostic (1.45e-2)" "unprognostic (3.49e-2)" "unprognostic (5.33e-3)" "unprognostic (1.02e-2)" "unprognostic (9.16e-2)" "unprognostic (2.87e-2)" "unprognostic (3.72e-3)" "unprognostic (4.14e-3)" "unprognostic (5.20e-2)" "prognostic unfavourable (1.52e-5)" "unprognostic (8.29e-2)" "unprognostic (2.12e-1)" "unprognostic (4.06e-2)" "unprognostic (4.03e-2)" 4.3 2.8 79.5 4.0 172.6 11.8 1.7 0.3 223.3 2.8 2.7 3.2 0.0 2.1 3.5 2.5 2.5 4.6 3.3 3.8 63.6 13.3 3.7 1.8 14.9 2.6 9.5 71.9 2.8 1.9 1.5 0.5 3.5 4.6 2.0 2.0 0.0 1.9 2.4 2.5 1.9 2.6 3.2 1.8 8.5 2.6 2.3 17.5 0.0 2.5 0.0 2.0 2.9 0.7 0.6 2.5 3.8 5.0 0.2 0.3 9.4 4.1 3.5 14.9 16.6 0.2 0.0 0.5 2.0 1.2 1.9 1.2 2.4 6.5 11.8 7.2 0.4 1.3 2.9 5.0 0.8 1.9 7.9 48.3 1.6 1.4 0.0 1.2 15.3 0.1 0.0 1.5 0.3 9.5 2.6 4.8 1.5 15.9 0.0 0.6 5.1 39.1 6.7 7.0 1.1 1.0 2.9 2.6 5.3 2.7 9.0 0.5 8.3 12.9 9.8 7.1 5.2 2.9 5.2 1.1 0.1 0.1 5.0 12.5 8.7 1.6 5.0 1.1 0.2 2.8 0.3 0.4 0.3 0.1 2.5 0.6 0.3 0.2 3.8 0.2 1.7 0.7 0.1 9.4 79.5 172.6 0.3 220.7 63.6 13.3 9.5 71.9 4.6 17.5 NRIP2 DKFZP761G1913 ENSG00000053702 "Nuclear receptor interacting protein 2" Q9BQI9 12 2825348-2835544 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 48.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039197, HPA039860" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039197: AB_10673416, HPA039860: AB_10794203" "unprognostic (3.28e-3)" "unprognostic (3.83e-1)" "prognostic unfavourable (8.05e-4)" "unprognostic (2.10e-2)" "unprognostic (8.11e-2)" "unprognostic (4.26e-3)" "unprognostic (5.66e-2)" "unprognostic (4.42e-3)" "unprognostic (2.89e-1)" "unprognostic (4.39e-2)" "prognostic favourable (8.69e-5)" "unprognostic (7.15e-2)" "unprognostic (2.82e-2)" "unprognostic (7.55e-2)" "unprognostic (5.23e-2)" "unprognostic (1.00e-1)" "unprognostic (8.97e-2)" 5.4 5.1 5.8 3.9 20.1 4.3 3.9 48.5 20.9 6.0 4.2 13.5 1.1 2.9 9.8 9.9 3.0 5.9 7.4 6.2 9.7 7.3 9.2 1.6 2.0 4.6 27.6 5.6 11.7 2.5 0.5 2.6 3.3 11.9 3.2 3.8 4.6 4.3 6.6 5.4 3.2 4.1 6.4 7.2 8.0 3.3 2.6 27.7 0.7 5.9 3.0 3.0 3.8 6.3 2.1 0.8 5.9 1.1 1.1 2.3 0.3 0.8 1.7 2.9 1.7 0.0 0.0 3.7 2.1 0.0 0.0 0.0 4.4 2.2 2.3 0.6 0.0 1.7 0.0 0.0 0.0 1.6 2.6 3.7 4.6 0.5 0.0 4.5 2.8 0.1 0.0 0.0 0.0 0.0 2.1 5.4 0.0 1.8 2.8 2.4 3.0 0.8 1.7 3.1 1.4 0.0 3.0 2.3 3.4 1.6 2.4 0.5 1.7 0.8 2.3 1.2 1.5 1.8 3.1 0.9 0.2 3.5 3.0 2.2 1.5 5.9 1.1 0.4 1.7 0.7 0.9 2.1 1.3 1.5 0.7 2.0 2.3 1.0 0.5 1.1 0.4 0.8 0.5 0.3 5.8 20.1 48.5 20.9 9.7 7.3 27.6 5.6 11.9 27.7 NRL "D14S46E, NRL-MAF, RP27" ENSG00000129535 "Neural retina leucine zipper" P54845 14 24080107-24115014 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "retina: 124.5" "Cell line enhanced" "Detected in many" "U-266/70: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026066, HPA064599" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB026066: , HPA064599: " "unprognostic (2.71e-2)" "unprognostic (8.17e-4)" "unprognostic (4.60e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (1.99e-2)" "unprognostic (5.29e-2)" "unprognostic (1.88e-5)" "unprognostic (3.59e-2)" "unprognostic (7.84e-3)" "unprognostic (1.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.38e-5)" "unprognostic (2.56e-2)" "unprognostic (1.10e-1)" "unprognostic (1.73e-1)" "unprognostic (1.35e-3)" 1.5 2.7 4.4 2.3 4.1 1.0 1.8 2.1 2.8 1.9 1.3 1.7 1.7 3.2 1.4 7.9 1.3 1.4 1.2 2.7 3.8 3.1 3.5 3.9 1.7 1.9 3.9 1.4 1.8 3.4 5.4 2.8 1.8 2.1 1.8 1.0 124.5 1.6 2.4 4.1 0.9 1.9 1.0 4.4 2.6 1.3 4.3 1.2 3.3 4.3 1.8 1.6 1.5 2.2 3.8 1.4 4.1 1.3 2.0 2.7 1.2 0.8 1.7 0.5 1.8 0.5 0.5 1.6 0.4 0.4 2.2 1.0 1.1 0.8 2.5 0.8 1.0 1.0 1.0 1.2 0.3 1.8 1.5 0.7 0.5 3.7 1.2 1.9 3.3 0.7 1.0 0.6 1.2 1.1 1.6 3.0 0.8 2.6 2.2 1.8 0.6 1.8 2.2 2.1 0.7 1.2 1.7 2.0 2.0 1.3 1.5 1.6 1.1 2.6 0.4 1.4 0.8 0.6 1.2 7.6 3.2 2.7 0.2 1.6 1.5 0.0 1.1 4.1 1.1 1.2 0.7 3.8 1.1 1.6 1.3 2.4 2.7 2.3 0.2 2.0 1.3 1.4 1.0 1.2 4.4 4.1 2.1 2.8 3.8 3.1 3.9 1.4 2.1 1.2 NRSN1 "p24, VMP" ENSG00000152954 "Neurensin 1" Q8IZ57 6 24126122-24154900 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 67.2" "Cell line enhanced" "Detected in some" "SCLC-21H: 14.3;SH-SY5Y: 11.4" "Cancer enriched" "Detected in single" 17 "glioma: 3.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019681, HPA061006" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA019681: , HPA061006: " "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (8.00e-3)" "unprognostic (8.01e-3)" "unprognostic (1.70e-1)" "unprognostic (4.53e-3)" "unprognostic (7.29e-2)" "unprognostic (1.36e-3)" "unprognostic (2.40e-3)" "unprognostic (1.45e-1)" "unprognostic (1.57e-1)" 1.3 6.9 21.5 1.7 27.7 1.7 1.3 5.3 67.2 1.3 1.7 2.1 0.0 1.7 1.5 1.4 1.4 1.3 1.5 1.4 15.3 25.0 1.5 1.4 1.4 1.5 12.4 25.4 1.3 2.6 1.4 12.9 1.3 27.4 1.4 1.7 0.3 1.5 1.3 3.3 1.5 1.6 1.6 6.7 1.5 1.9 1.6 5.0 0.0 1.4 0.0 1.3 1.3 0.1 0.5 0.2 1.8 0.2 0.1 0.3 0.0 0.7 0.0 0.3 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.6 0.1 1.6 0.0 0.3 0.1 0.0 0.1 1.6 0.6 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 1.9 1.2 0.1 0.2 0.3 0.9 0.7 2.5 0.5 0.2 0.5 0.0 0.0 14.3 11.4 0.0 0.1 0.9 1.7 3.4 0.2 0.4 0.6 0.1 0.4 0.8 2.2 0.9 0.7 0.0 1.3 1.8 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.3 1.0 0.1 0.2 0.2 0.0 0.0 21.5 27.7 5.3 34.1 15.3 25.0 12.4 25.4 27.4 5.0 NRXN1 "Hs.22998, KIAA0578" ENSG00000179915 "Neurexin 1" "P58400, Q9ULB1" 2 49918505-51225575 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Angiogenesis, Cell adhesion" "Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 81.9" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 28.3" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "neutrophil: 4.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071400 Supported "Plasma membrane" "Intracellular and membrane" 620000 "Plasma membrane" "HPA071400: " "unprognostic (7.01e-2)" "unprognostic (9.96e-2)" "unprognostic (7.68e-2)" "unprognostic (1.74e-4)" "unprognostic (2.46e-1)" "unprognostic (8.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.85e-1)" "unprognostic (8.19e-2)" "unprognostic (6.37e-4)" "unprognostic (2.85e-2)" "unprognostic (6.68e-7)" "unprognostic (3.40e-2)" "unprognostic (1.75e-1)" "unprognostic (5.57e-2)" "unprognostic (1.99e-3)" 2.1 3.2 22.4 2.1 20.3 1.4 1.7 56.5 81.9 2.8 5.1 3.0 0.5 2.1 2.1 3.7 3.0 1.4 2.2 3.8 16.9 13.8 1.5 1.6 1.5 1.4 8.3 25.9 2.1 2.3 1.3 4.8 1.1 12.6 2.5 3.8 2.0 3.5 9.3 1.3 2.0 3.1 2.1 6.5 1.3 2.3 6.5 4.7 0.0 1.4 0.0 1.4 2.0 1.6 0.0 0.0 4.4 0.1 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.2 0.0 0.0 28.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 2.4 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.3 0.0 0.0 0.0 0.0 22.4 20.3 56.5 33.2 16.9 13.8 8.3 25.9 12.6 4.7 NRXN2 ENSG00000110076 "Neurexin 2" "P58401, Q9P2S2" 11 64606174-64723188 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 101.5" "Cell line enhanced" "Detected in some" "REH: 27.8;SCLC-21H: 13.9;U-2 OS: 16.2;U-87 MG: 11.4" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 2.0;non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 6 "monocytes: 2.0" "Low region specificity" "Detected in all" "unprognostic (3.87e-2)" "unprognostic (1.54e-4)" "unprognostic (2.60e-2)" "unprognostic (1.96e-1)" "unprognostic (8.07e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (5.08e-2)" "unprognostic (3.23e-1)" "unprognostic (5.93e-3)" "unprognostic (3.40e-1)" "unprognostic (9.97e-3)" "unprognostic (2.39e-2)" "unprognostic (6.99e-2)" "unprognostic (4.27e-4)" "unprognostic (5.46e-3)" 3.4 7.5 33.3 4.1 26.3 2.5 2.3 68.8 101.5 7.3 4.6 6.5 1.0 3.1 11.7 3.3 2.5 6.4 4.4 2.9 28.8 23.5 3.8 2.4 2.5 3.0 15.2 32.8 6.3 2.5 2.2 1.3 2.8 14.0 4.5 2.7 3.5 3.2 5.6 2.5 2.2 3.0 4.7 12.4 3.5 2.4 11.6 8.7 0.0 2.9 0.0 2.5 2.4 2.5 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.2 0.0 0.2 0.2 1.5 0.0 1.9 0.0 0.0 0.2 0.2 3.8 0.0 0.0 0.0 0.0 0.3 0.7 0.0 2.7 0.0 0.0 0.0 5.4 1.8 0.0 0.4 0.2 4.6 0.0 27.8 0.8 1.1 0.0 0.0 13.9 6.4 0.0 0.0 0.0 0.0 0.0 0.2 0.7 16.2 0.3 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 33.3 26.3 68.8 41.2 28.8 23.5 15.2 32.8 14.0 8.7 NSG2 "CALY3, HMP19, Nsg2" ENSG00000170091 "Neuronal vesicle trafficking associated 2" Q9Y328 5 174045604-174243501 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 120.8" "Group enriched" "Detected in some" 58 "SCLC-21H: 21.3;SH-SY5Y: 34.3" "Cancer enriched" "Detected in some" 8 "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046531, HPA056191" Enhanced Enhanced "Golgi apparatus" "Golgi apparatus" "HPA046531: , HPA056191: " "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (3.27e-1)" "unprognostic (3.36e-5)" "unprognostic (1.93e-1)" "unprognostic (2.77e-1)" "unprognostic (3.81e-2)" "unprognostic (3.07e-1)" "unprognostic (3.29e-1)" "unprognostic (1.76e-1)" "unprognostic (3.86e-3)" "unprognostic (8.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.02e-2)" "unprognostic (5.20e-2)" "unprognostic (9.31e-4)" "unprognostic (1.55e-1)" 1.7 23.1 31.6 3.0 92.4 1.4 1.4 19.7 120.8 1.4 3.6 5.0 0.0 2.8 1.4 1.7 1.5 1.4 1.6 1.6 27.3 40.2 1.6 1.4 1.6 1.4 20.2 27.6 1.4 2.0 1.4 0.9 1.4 22.5 1.4 4.1 0.8 1.4 1.5 1.4 1.4 3.8 2.5 4.6 1.4 3.3 5.0 11.7 0.0 1.8 0.0 1.4 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 92.4 19.7 49.8 27.3 40.2 20.2 27.6 22.5 11.7 NSMF NELF ENSG00000165802 "NMDA receptor synaptonuclear signaling and neuronal migration factor" Q6X4W1 9 137447573-137459334 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 96.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 12.1;non-classical monocyte: 10.5" "Group enriched" "Detected in many" 5 "dendritic cells: 6.0;granulocytes: 3.1;monocytes: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044316 Enhanced Supported Nucleoplasm Nucleoplasm "HPA044316: AB_10964877" "unprognostic (1.48e-1)" "unprognostic (4.03e-2)" "unprognostic (5.40e-2)" "unprognostic (3.92e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.35e-1)" "unprognostic (7.96e-2)" "unprognostic (3.26e-2)" "unprognostic (2.38e-3)" "unprognostic (2.34e-3)" "prognostic favourable (1.85e-6)" "unprognostic (1.97e-2)" "unprognostic (4.14e-2)" "unprognostic (4.61e-2)" "unprognostic (3.97e-2)" 8.8 8.8 61.7 6.9 34.4 6.1 5.3 6.4 67.3 6.0 8.1 18.2 2.1 16.9 8.6 6.6 6.6 7.2 5.7 5.0 96.4 21.8 15.3 6.2 5.2 6.9 20.4 30.2 5.0 14.7 10.8 13.7 4.2 12.1 9.0 6.3 5.4 11.5 8.7 4.0 9.7 13.7 8.2 9.6 6.8 9.6 7.8 15.0 2.4 5.1 1.3 5.8 6.4 3.8 0.2 6.0 3.1 12.1 0.0 1.5 1.4 7.7 6.3 11.2 16.7 26.4 12.5 9.7 7.5 10.0 7.2 5.6 16.8 4.7 9.7 10.2 11.0 23.7 16.5 10.1 4.3 12.7 17.8 7.5 14.9 22.3 14.3 5.1 17.3 14.2 19.3 8.4 19.7 7.6 17.3 1.6 9.6 18.0 0.2 22.3 14.3 17.0 4.7 17.8 21.6 5.0 3.9 47.2 38.5 18.0 10.0 11.3 7.1 10.7 19.1 12.8 10.5 31.0 12.7 3.4 5.3 14.8 7.3 6.9 11.7 1.5 2.0 3.1 1.5 12.1 0.2 0.2 0.5 0.9 6.0 0.1 0.6 0.7 0.3 0.0 10.5 0.2 0.7 1.4 61.7 34.4 6.4 62.9 96.4 21.8 20.4 30.2 12.1 15.0 NT5C1B "AIRP, CN-IB" ENSG00000185013 "5'-nucleotidase, cytosolic IB" Q96P26 2 18562872-18589572 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 52.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA056683 Uncertain "HPA056683: " "unprognostic (4.18e-2)" "unprognostic (1.20e-2)" "unprognostic (7.67e-2)" "unprognostic (1.31e-1)" "unprognostic (1.02e-1)" "unprognostic (4.97e-2)" "unprognostic (4.96e-2)" "unprognostic (4.84e-1)" "unprognostic (8.49e-2)" "unprognostic (4.42e-2)" "unprognostic (2.91e-2)" "unprognostic (2.35e-1)" "unprognostic (1.61e-1)" "unprognostic (6.96e-2)" "unprognostic (2.50e-1)" "unprognostic (1.15e-1)" "unprognostic (3.77e-1)" 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.3 0.7 0.0 0.4 0.3 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.5 52.6 0.1 0.1 0.5 0.1 0.1 0.5 0.1 1.2 3.7 0.0 0.1 0.7 2.6 0.4 3.2 0.7 0.3 0.0 0.0 0.0 0.5 2.5 0.0 0.0 0.0 0.0 3.5 1.6 0.5 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.9 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.0 1.1 0.2 0.0 2.9 0.1 0.2 0.7 1.7 0.3 0.7 0.8 0.1 3.0 2.5 1.2 2.6 0.4 1.5 0.8 0.7 1.7 1.5 1.0 2.9 0.5 1.0 0.7 2.0 2.5 0.0 1.2 0.0 0.1 0.0 1.3 0.0 2.3 0.1 1.3 1.3 0.3 1.2 2.6 2.2 0.0 0.7 0.1 3.7 0.5 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 NT5C1B-RDH14 ENSG00000250741 "NT5C1B-RDH14 readthrough" 2 18555545-18589564 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 74 "testis: 49.4" "Cell line enhanced" "Detected in single" "TIME: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056683 Uncertain "HPA056683: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NTS ENSG00000133636 Neurotensin P30990 12 85874295-85882992 "Predicted secreted proteins" Vasoactive "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 115.3" "Cell line enriched" "Detected in some" 5 "HEL: 32.5" "Cancer enhanced" "Detected in many" "lung cancer: 155.1" "Group enriched" "Detected in many" 4 "hippocampal formation: 10.3;hypothalamus: 22.1;midbrain: 6.3;pons and medulla: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 81.8" HPA026664 Enhanced "Secreted to digestive system" 120000 "HPA026664: " "unprognostic (3.63e-1)" "prognostic favourable (9.94e-5)" "unprognostic (8.18e-2)" "prognostic unfavourable (5.10e-4)" "unprognostic (1.99e-2)" "unprognostic (3.04e-1)" "unprognostic (7.62e-2)" "unprognostic (2.43e-1)" "unprognostic (1.53e-3)" "unprognostic (8.83e-2)" "unprognostic (1.74e-2)" "unprognostic (3.76e-2)" "unprognostic (1.30e-6)" "unprognostic (2.94e-2)" "unprognostic (2.25e-1)" "unprognostic (2.17e-1)" "unprognostic (7.48e-2)" 2.9 0.6 3.9 1.4 3.2 0.1 2.5 0.3 0.4 0.5 5.2 2.5 0.0 2.8 0.2 1.6 2.5 0.5 0.8 0.8 10.3 22.1 0.9 0.7 2.0 15.1 6.3 0.1 0.7 0.4 0.1 15.0 0.3 25.0 0.4 0.7 0.0 1.6 0.5 0.1 0.1 115.3 0.5 2.7 0.2 18.8 0.3 0.4 0.1 0.9 0.8 1.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.7 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.2 2.7 0.0 1.1 0.0 0.0 0.0 3.6 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 3.2 0.3 0.4 10.3 22.1 6.3 0.1 25.0 0.4 NTSR2 NTR2 ENSG00000169006 "Neurotensin receptor 2" O95665 2 11658178-11670164 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 33.4" "Cell line enhanced" "Detected in some" "HEK 293: 1.0;NTERA-2: 1.8" "Cancer enriched" "Detected in single" 15 "glioma: 6.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (5.40e-2)" "unprognostic (2.30e-2)" "unprognostic (2.36e-2)" "unprognostic (5.32e-2)" "unprognostic (2.23e-1)" "unprognostic (1.80e-1)" "unprognostic (2.75e-1)" "unprognostic (4.98e-1)" "unprognostic (1.64e-1)" 1.3 1.8 22.3 1.1 30.7 1.1 1.1 2.1 33.4 1.1 1.1 11.9 0.0 1.1 1.1 1.2 1.1 1.1 1.1 1.1 13.4 15.6 1.1 1.1 1.1 1.1 26.8 13.8 2.8 1.7 1.1 0.0 1.1 10.6 1.1 1.1 0.0 1.1 1.1 1.2 1.1 1.1 1.1 4.3 1.1 1.1 1.5 8.7 0.0 1.1 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 30.7 2.1 14.5 13.4 15.6 26.8 13.8 10.6 8.7 NUP210L ENSG00000143552 "Nucleoporin 210 like" Q5VU65 1 153992685-154155116 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 42.7" "Cell line enriched" "Detected in single" 43 "MCF7: 18.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA047195, HPA064245, HPA066707" Enhanced Approved "Nuclear bodies" "Nuclear bodies" "HPA047195: , HPA064245: , HPA066707: " "unprognostic (2.11e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.80e-2)" "unprognostic (1.63e-2)" "unprognostic (1.72e-3)" "unprognostic (6.90e-2)" "unprognostic (1.79e-3)" "unprognostic (3.45e-2)" "unprognostic (5.57e-2)" "unprognostic (4.51e-4)" "unprognostic (1.15e-1)" "unprognostic (9.35e-10)" "unprognostic (4.20e-2)" "unprognostic (3.78e-2)" "unprognostic (7.45e-2)" "unprognostic (4.09e-2)" 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.9 0.1 0.1 1.5 0.0 0.0 1.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.2 0.0 0.4 0.4 0.6 0.1 0.0 0.8 0.9 0.4 0.1 0.1 0.1 3.4 0.2 0.1 0.1 42.7 0.0 0.3 0.3 0.0 0.1 1.2 0.1 0.6 0.6 1.8 0.2 0.9 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.3 0.1 0.2 0.6 0.4 0.5 0.0 0.5 0.8 0.3 1.8 0.9 0.0 0.6 0.7 0.0 0.1 0.3 0.1 0.9 0.1 0.2 0.1 0.0 0.6 0.0 NUPR2 NUPR1L ENSG00000185290 "Nuclear protein 2, transcriptional regulator" A6NF83 7 56114681-56116400 "Predicted intracellular proteins" "Cell cycle, Growth arrest, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 93.5" "Cell line enhanced" "Detected in many" "RPMI-8226: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 9.3" "Lineage enriched" "Detected in many" 4 "T-cells: 9.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "unprognostic (5.81e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" "unprognostic (9.52e-2)" "unprognostic (3.25e-2)" "unprognostic (2.46e-1)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (1.50e-2)" "prognostic favourable (9.53e-5)" "unprognostic (1.66e-1)" "unprognostic (8.44e-2)" "unprognostic (2.74e-1)" "unprognostic (5.44e-2)" 1.1 2.1 2.0 0.4 2.7 0.3 1.6 2.0 1.5 1.0 0.3 0.1 7.8 0.5 0.2 6.5 0.3 0.9 1.1 0.6 0.8 1.5 4.1 1.3 0.8 0.2 0.8 0.7 0.7 3.2 1.1 3.7 0.3 1.2 1.8 0.3 0.2 5.2 11.8 0.7 0.4 0.2 0.2 0.4 0.2 1.9 93.5 0.1 0.0 4.8 0.0 0.4 0.3 0.3 0.9 1.4 2.1 0.7 0.6 9.3 1.6 1.1 3.8 1.8 5.0 4.7 2.0 0.6 0.2 1.7 0.9 0.6 0.5 2.7 0.4 5.9 0.2 0.4 2.3 0.6 1.1 0.9 7.5 2.8 1.7 3.3 2.5 0.9 0.5 3.6 2.6 1.3 5.6 1.7 3.5 3.2 1.8 4.0 1.5 3.7 1.6 4.1 1.4 2.0 14.2 2.8 0.7 4.9 4.6 2.3 0.6 6.6 1.5 0.9 1.3 0.8 2.1 1.2 0.9 4.7 5.5 5.5 3.0 3.6 1.3 2.1 0.6 1.0 0.6 0.1 0.9 0.8 3.2 1.0 0.7 0.9 9.3 2.6 0.1 0.6 0.7 1.4 0.8 1.6 2.0 2.7 2.0 1.5 0.8 1.5 0.8 0.7 1.2 0.1 NUTM1 "C15orf55, DKFZp434O192, FAM22H, NUT" ENSG00000184507 "NUT midline carcinoma family member 1" Q86Y26 15 34343315-34357737 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 127 "testis: 48.9" "Cell line enhanced" "Detected in some" "BEWO: 1.0;NTERA-2: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040421 Enhanced "HPA040421: AB_10793965" "unprognostic (4.14e-2)" "unprognostic (3.61e-1)" "unprognostic (2.11e-1)" "unprognostic (7.38e-2)" "unprognostic (1.99e-1)" "unprognostic (8.37e-2)" "unprognostic (8.66e-2)" "unprognostic (2.76e-1)" "unprognostic (1.34e-1)" "unprognostic (5.55e-2)" "unprognostic (1.34e-2)" "unprognostic (5.97e-3)" "unprognostic (1.61e-1)" "unprognostic (2.77e-1)" "unprognostic (4.27e-2)" "unprognostic (4.79e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 48.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.4 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.5 0.3 0.0 0.0 0.4 0.5 0.1 0.2 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 2.2 0.3 0.2 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.6 0.2 0.0 0.7 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NUTM2F "DKFZp434I1117, FAM22F" ENSG00000130950 "NUT family member 2F" A1L443 9 94318196-94328644 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 9 "testis: 5.5" "Cell line enriched" "Detected in single" 9 "NTERA-2: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA064635 Approved "Nuclear bodies" "Nuclear bodies" "HPA064635: " "unprognostic (1.40e-1)" "unprognostic (4.93e-3)" "unprognostic (4.16e-2)" "unprognostic (1.47e-1)" "unprognostic (9.26e-3)" "unprognostic (1.03e-1)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (6.72e-3)" "unprognostic (8.48e-2)" "unprognostic (1.11e-2)" "unprognostic (5.14e-1)" "unprognostic (1.83e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 NXF2B bA353J17.1 ENSG00000269437 "Nuclear RNA export factor 2B" Q9GZY0 X 102360396-102439932 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "epididymis: 18.9" "Cell line enriched" "Detected in single" 52 "U-266/84: 27.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA002079 Uncertain "HPA002079: AB_1079515" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NXNL1 "RDCVF, TXNL6" ENSG00000171773 "Nucleoredoxin like 1" Q96CM4 19 17455425-17460954 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 48.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (2.62e-1)" "unprognostic (5.49e-1)" "unprognostic (1.81e-1)" "unprognostic (3.63e-1)" "unprognostic (1.13e-1)" 5.6 4.3 1.2 0.3 1.8 0.5 2.2 0.4 1.0 0.3 0.3 0.5 0.3 0.3 0.3 0.3 0.6 0.3 0.3 0.9 1.2 0.6 0.3 0.3 0.4 0.4 1.6 0.3 0.8 0.3 0.0 0.3 0.3 1.8 0.5 0.1 48.8 1.2 0.3 1.9 1.9 0.3 0.3 0.8 0.3 0.2 0.7 0.3 0.3 0.9 0.3 0.3 0.3 0.3 1.8 1.8 1.8 1.0 0.7 1.3 0.2 0.9 2.2 1.2 1.7 2.4 1.6 0.9 0.7 0.2 2.1 0.4 1.0 0.4 0.2 0.9 1.8 1.0 1.0 1.1 0.2 0.8 1.5 1.1 0.5 1.7 1.8 0.8 1.6 0.4 0.5 0.9 1.1 0.0 0.8 2.2 0.0 2.5 0.3 1.1 0.7 1.4 1.1 2.3 0.5 0.6 0.3 1.7 0.6 0.3 0.0 1.7 0.6 0.4 0.1 0.3 0.9 1.4 0.3 1.4 1.4 2.0 0.1 1.2 0.0 0.2 1.0 1.2 0.8 0.9 0.2 0.7 0.7 0.4 0.2 1.8 1.1 0.7 1.8 0.7 0.6 1.8 1.3 0.2 1.2 1.8 0.4 1.0 1.2 0.6 1.6 0.3 1.8 0.3 NYX "CLRP, CSNB1, CSNB1A, CSNB4" ENSG00000188937 Nyctalopin Q9GZU5 X 41447434-41475710 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 13.9" "Group enriched" "Detected in some" 7 "HDLM-2: 7.2;NTERA-2: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" "unprognostic (3.27e-2)" "unprognostic (6.72e-2)" "unprognostic (4.21e-2)" "unprognostic (4.10e-4)" "unprognostic (1.83e-1)" "unprognostic (3.96e-2)" "unprognostic (1.80e-1)" 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 13.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.7 0.0 0.0 0.1 0.0 0.3 0.0 OAZ3 ENSG00000143450 "Ornithine decarboxylase antizyme 3" Q9UMX2 1 151762899-151771334 "Predicted intracellular proteins" "Polyamine biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 102.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030136 Supported Nucleoplasm Nucleoplasm "HPA030136: " "unprognostic (2.12e-1)" "unprognostic (3.86e-1)" "unprognostic (1.53e-1)" "unprognostic (5.44e-3)" "unprognostic (1.71e-1)" "unprognostic (1.01e-2)" "unprognostic (1.48e-3)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (1.01e-4)" "unprognostic (1.57e-2)" "unprognostic (2.89e-1)" "unprognostic (8.05e-6)" "unprognostic (3.94e-2)" "unprognostic (1.32e-1)" "unprognostic (2.50e-2)" "unprognostic (8.36e-2)" 0.4 0.3 0.5 0.7 0.5 0.0 0.6 0.6 0.6 0.3 0.4 0.4 0.7 0.1 0.3 2.0 0.4 0.2 0.3 0.6 0.5 0.5 0.5 0.8 0.6 0.8 0.5 0.5 0.3 0.6 1.4 0.6 0.3 0.4 4.0 0.5 0.3 3.1 0.7 1.0 0.3 0.3 0.5 0.6 0.6 0.2 102.2 0.2 0.3 0.8 0.7 0.4 0.4 0.6 1.4 3.2 2.2 5.0 2.6 2.4 1.6 1.2 2.3 1.3 3.2 1.1 3.3 2.9 2.2 0.5 2.2 1.0 1.3 3.0 1.0 1.9 0.7 1.1 1.2 2.2 0.6 7.2 6.7 1.1 4.3 1.8 1.3 0.6 1.2 5.0 1.3 2.6 3.5 3.4 1.4 3.6 2.3 9.5 0.9 1.6 3.2 2.5 0.4 1.0 1.6 0.4 2.9 1.5 3.5 1.0 5.1 4.5 10.2 2.6 3.0 1.3 0.7 2.6 1.3 5.0 9.3 2.5 1.6 1.6 3.4 2.2 3.0 0.6 1.4 1.5 1.3 1.4 1.3 2.4 3.2 1.2 1.5 2.2 2.1 2.6 5.0 1.3 2.2 1.6 0.5 0.5 0.6 0.4 0.5 0.5 0.5 0.5 0.4 0.2 ODAM "APin, FLJ20513" ENSG00000109205 "Odontogenic, ameloblast associated" A1E959 4 70196496-70204576 "Cancer-related genes, Predicted intracellular proteins" Biomineralization "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "salivary gland: 157.7" "Cell line enriched" "Detected in some" 17 "Hep G2: 25.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA036279, HPA036543, HPA070297" Supported Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA036279: , HPA036543: AB_10669797, HPA070297: " "unprognostic (2.34e-2)" "unprognostic (2.43e-1)" "unprognostic (1.26e-1)" "unprognostic (1.75e-1)" "unprognostic (3.34e-3)" "unprognostic (1.06e-1)" "unprognostic (1.88e-2)" "unprognostic (3.47e-1)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (2.72e-1)" "unprognostic (1.86e-2)" "unprognostic (2.50e-2)" 0.0 0.2 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.8 0.0 2.5 0.2 0.1 1.9 0.1 0.1 0.1 0.0 0.0 0.2 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.2 0.0 0.4 0.1 0.0 157.7 2.6 0.0 0.0 0.3 1.9 0.1 0.0 2.5 0.0 0.0 0.0 5.1 10.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 ODF1 "CT133, HSPB10, ODF27, ODFPG, RT7" ENSG00000155087 "Outer dense fiber of sperm tails 1" Q14990 8 102551572-102561017 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 62 "testis: 80.3" "Cell line enhanced" "Detected in some" "HDLM-2: 1.6;SH-SY5Y: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA064295 Approved "HPA064295: " "unprognostic (3.79e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ODF2 "CT134, ODF84" ENSG00000136811 "Outer dense fiber of sperm tails 2" Q5BJF6 9 128455186-128501292 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 101.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001874, HPA048841" Enhanced Supported Centrosome Centrosome "HPA001874: AB_1079522, HPA048841: " "unprognostic (4.54e-3)" "unprognostic (9.91e-2)" "unprognostic (4.02e-2)" "unprognostic (1.57e-3)" "unprognostic (6.11e-2)" "unprognostic (2.25e-2)" "prognostic unfavourable (1.58e-4)" "unprognostic (1.88e-1)" "unprognostic (1.79e-2)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" "prognostic unfavourable (1.72e-4)" "unprognostic (1.93e-2)" "unprognostic (9.23e-3)" "unprognostic (1.47e-1)" "unprognostic (1.62e-1)" "unprognostic (7.65e-2)" 6.2 4.8 5.6 9.9 6.7 10.2 7.0 14.3 7.7 7.1 5.7 6.7 5.4 4.0 9.7 6.4 5.2 8.8 5.7 5.7 6.3 5.1 4.7 6.7 5.8 8.9 6.2 4.1 6.4 5.1 7.6 18.2 6.0 7.5 6.6 6.0 5.4 5.3 8.3 3.7 7.2 5.3 8.0 5.2 7.3 5.7 101.1 7.1 18.4 5.5 3.7 9.6 6.4 6.4 8.3 8.8 16.0 16.3 11.0 14.6 9.1 14.5 17.7 29.6 33.6 11.8 14.2 23.8 24.6 11.5 20.5 10.8 17.4 10.8 26.2 9.3 19.9 38.4 21.5 14.6 20.9 17.3 10.0 23.3 26.8 14.5 6.8 25.1 29.4 11.6 9.3 21.7 15.4 17.8 27.4 14.8 19.3 44.7 26.6 30.7 11.5 12.8 24.4 28.5 20.3 10.6 11.3 17.8 15.2 23.0 22.1 8.0 20.6 18.3 16.9 25.6 15.8 29.4 23.8 27.7 39.8 18.9 11.7 22.9 22.2 16.0 8.9 9.8 12.4 13.4 14.6 8.3 10.9 12.9 8.8 8.2 7.9 10.0 3.1 11.0 16.3 8.4 8.0 9.1 5.6 6.7 14.3 7.7 6.3 5.1 6.2 4.1 7.5 7.1 ODF3 "CT135, hSHIPPO, SHIPPO1" ENSG00000177947 "Outer dense fiber of sperm tails 3" Q96PU9 11 196738-200261 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 12.5" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038919, HPA039241" Enhanced "HPA038919: AB_2676270, HPA039241: AB_10673417" "unprognostic (4.17e-1)" "unprognostic (2.41e-1)" "unprognostic (1.24e-2)" "unprognostic (1.99e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 1.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.6 ODF3L1 MGC48986 ENSG00000182950 "Outer dense fiber of sperm tails 3 like 1" Q8IXM7 15 75723977-75727688 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "testis: 53.2" "Cell line enhanced" "Detected in some" "A549: 3.0;CAPAN-2: 2.7;HaCaT: 2.7;HeLa: 3.5;U-87 MG: 3.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 25 "myeloid DC: 2.4" "Lineage enriched" "Detected in single" 25 "dendritic cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (6.24e-2)" "unprognostic (1.97e-2)" "unprognostic (4.58e-2)" "unprognostic (8.42e-2)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (2.77e-1)" "unprognostic (1.56e-1)" "unprognostic (1.99e-1)" "unprognostic (2.74e-1)" "unprognostic (7.55e-4)" "unprognostic (9.65e-2)" "unprognostic (9.96e-3)" "unprognostic (6.40e-2)" "unprognostic (4.14e-2)" "unprognostic (8.94e-3)" "unprognostic (1.45e-2)" 1.5 0.1 0.5 0.8 0.7 0.1 1.3 0.3 0.5 0.6 1.2 0.3 0.5 0.4 1.3 1.5 1.8 1.1 3.1 1.2 0.6 0.6 0.3 1.2 1.8 0.1 0.3 0.4 0.8 0.3 0.0 1.2 1.3 0.8 0.8 0.3 0.8 0.5 0.5 0.1 1.7 1.5 3.0 0.2 0.4 2.0 53.2 0.2 0.5 1.6 1.2 0.6 0.6 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.8 0.0 0.2 0.6 0.2 0.4 1.5 0.1 0.2 0.6 2.7 0.0 0.1 0.4 2.7 0.1 1.7 0.0 2.1 1.2 0.0 3.5 0.5 0.8 0.0 0.0 1.9 0.1 0.6 1.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.1 1.5 0.0 0.7 0.1 0.0 0.1 0.6 0.2 0.0 3.8 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.5 0.6 0.6 0.3 0.4 0.8 0.2 ODF4 "CT136, OPPO1" ENSG00000184650 "Outer dense fiber of sperm tails 4" Q2M2E3 17 8339864-8346048 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 15.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA072129 Enhanced "HPA072129: " "unprognostic (5.16e-2)" "unprognostic (5.13e-1)" "unprognostic (3.54e-4)" "unprognostic (3.64e-1)" "unprognostic (5.40e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OIT3 "FLJ39116, LZP" ENSG00000138315 "Oncoprotein induced transcript 3" Q8WWZ8 10 72893581-72933033 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 49.1" "Group enriched" "Detected in some" 6 "CACO-2: 5.6;Hep G2: 5.9" "Cancer enhanced" "Detected in many" "liver cancer: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" 150000000 "unprognostic (2.42e-2)" "unprognostic (6.76e-2)" "unprognostic (7.98e-4)" "unprognostic (9.26e-2)" "unprognostic (9.47e-4)" "unprognostic (3.05e-1)" "unprognostic (4.33e-2)" "unprognostic (1.99e-2)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" "unprognostic (8.50e-3)" "unprognostic (1.41e-1)" "unprognostic (4.11e-2)" "unprognostic (1.35e-1)" "unprognostic (2.44e-1)" "unprognostic (3.68e-3)" "unprognostic (1.19e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 2.2 0.1 0.1 0.3 0.0 0.1 2.0 0.1 0.0 0.6 49.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.5 0.1 0.1 6.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.3 0.0 0.1 0.0 0.0 0.0 5.6 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.4 0.3 5.9 0.2 0.2 0.1 0.4 0.2 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.3 0.1 OLFM1 "AMY, NOE1, NOELIN, OlfA" ENSG00000130558 "Olfactomedin 1" Q99784 9 135075422-135121179 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 159.5" "Cell line enhanced" "Detected in some" "HeLa: 25.2;MCF7: 21.2;NTERA-2: 28.3;SCLC-21H: 40.8;SiHa: 33.8;T-47d: 52.4;U-2197: 22.8" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 38 "classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 51 "dendritic cells: 5.1;monocytes: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057444 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in brain" 130000000 Nucleoli "Nucleoplasm, Cytosol" "HPA057444: " "unprognostic (6.77e-2)" "prognostic favourable (7.14e-4)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "prognostic unfavourable (6.58e-4)" "unprognostic (3.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.69e-3)" "unprognostic (2.67e-1)" "unprognostic (6.04e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (9.46e-3)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (6.20e-2)" "unprognostic (7.53e-4)" 7.7 10.0 80.5 5.0 41.5 0.9 4.7 30.9 159.5 7.4 5.4 4.6 0.7 2.5 6.9 26.4 5.0 4.4 3.8 3.9 77.2 19.1 3.4 2.4 4.7 5.2 18.8 36.5 6.2 5.1 3.6 9.9 1.1 13.5 4.8 5.7 0.9 2.6 7.5 6.1 4.5 3.5 6.9 6.1 5.8 3.9 2.8 2.8 0.3 2.7 0.8 7.1 4.1 6.2 0.0 5.1 0.0 5.0 0.0 0.0 0.6 0.0 1.5 3.1 0.0 0.4 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.2 1.3 0.6 0.6 0.0 0.0 3.6 0.2 0.0 25.2 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 21.2 0.1 0.0 28.3 0.0 0.0 0.0 11.9 0.0 0.0 40.8 5.4 33.8 0.1 2.1 52.4 0.0 0.0 2.0 4.5 22.8 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 3.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 80.5 41.5 30.9 119.7 77.2 19.1 18.8 36.5 13.5 2.8 OLFM3 NOE3 ENSG00000118733 "Olfactomedin 3" Q96PB7 1 101802574-101997030 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 30.0" "Group enriched" "Detected in some" 11 "AF22: 9.3;HAP1: 6.4;HEL: 5.7;SCLC-21H: 3.7;SH-SY5Y: 3.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050297 Uncertain Vesicles "Secreted in brain" Vesicles "HPA050297: " "unprognostic (4.19e-1)" "unprognostic (4.19e-4)" "unprognostic (1.26e-1)" "unprognostic (4.61e-2)" "unprognostic (2.93e-1)" "unprognostic (1.47e-2)" "unprognostic (3.58e-4)" "unprognostic (2.48e-1)" "unprognostic (5.68e-2)" 0.7 3.2 5.0 1.4 13.7 0.7 0.8 24.2 30.0 0.9 1.8 0.4 0.0 1.0 0.9 1.2 0.7 0.8 0.8 0.7 4.8 7.4 1.5 0.8 0.7 0.7 6.0 11.9 0.8 0.7 0.7 2.4 0.8 16.6 0.7 1.7 0.3 0.8 0.7 0.7 0.7 2.1 1.3 1.5 0.9 1.0 0.9 0.7 0.0 1.2 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.3 0.0 0.0 3.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 13.7 24.2 26.7 4.8 7.4 6.0 11.9 16.6 0.7 OLIG1 "BHLHB6, bHLHe21" ENSG00000184221 "Oligodendrocyte transcription factor 1" Q8TAK6 21 33070144-33072420 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 95.6" "Group enriched" "Detected in some" 6 "NB-4: 23.8;RPMI-8226: 12.4;THP-1: 15.6;U-937: 17.8" "Cancer enriched" "Detected in some" 18 "glioma: 116.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 6.3;eosinophil: 22.0" "Lineage enriched" "Detected in many" 14 "granulocytes: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (4.13e-2)" "unprognostic (6.46e-2)" "unprognostic (4.06e-1)" "unprognostic (3.58e-1)" "unprognostic (9.01e-3)" "unprognostic (2.40e-1)" "unprognostic (7.93e-2)" "unprognostic (1.50e-1)" "unprognostic (3.82e-3)" "unprognostic (5.19e-2)" "unprognostic (8.17e-2)" "unprognostic (2.51e-1)" "unprognostic (4.05e-2)" "unprognostic (5.96e-3)" "unprognostic (3.20e-2)" "unprognostic (1.17e-1)" 1.8 1.8 44.6 1.9 51.6 2.5 1.9 7.3 95.6 1.8 1.8 58.3 0.0 1.9 1.8 1.8 1.8 1.8 1.8 1.8 42.7 30.4 3.1 1.8 1.9 1.8 40.7 22.7 1.8 1.9 1.8 0.1 1.8 35.5 1.8 1.8 0.0 1.9 1.8 3.0 1.8 2.0 1.8 41.4 2.3 2.0 2.2 35.7 0.0 1.8 0.0 1.8 1.9 0.0 0.0 0.2 22.0 1.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 1.6 0.4 0.0 0.0 0.0 0.0 1.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 23.8 0.1 0.0 0.0 0.1 12.4 0.0 0.0 0.8 0.0 0.0 0.0 2.9 0.1 15.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 17.8 1.0 6.3 1.6 22.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 1.4 0.1 0.0 0.3 44.6 51.6 7.3 35.2 42.7 30.4 40.7 22.7 35.5 35.7 OLIG2 "BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17" ENSG00000205927 "Oligodendrocyte transcription factor 2" Q13516 21 33025845-33029196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 66.2" "Cell line enhanced" "Detected in some" "HMC-1: 29.3;NB-4: 21.2;THP-1: 18.4;WM-115: 6.0" "Cancer enriched" "Detected in some" 52 "glioma: 46.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 15.4" "Lineage enriched" "Detected in single" 154 "granulocytes: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003254, CAB019381" Enhanced Uncertain "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "CAB019381: , HPA003254: AB_1854795" "unprognostic (5.14e-1)" "unprognostic (4.56e-1)" "unprognostic (1.44e-2)" "unprognostic (8.27e-2)" "unprognostic (3.24e-2)" "unprognostic (4.34e-2)" "unprognostic (4.81e-2)" "unprognostic (5.41e-2)" "unprognostic (1.39e-1)" "unprognostic (5.78e-5)" "unprognostic (2.76e-1)" 1.3 1.3 24.1 1.4 19.1 1.4 1.3 4.2 66.2 1.3 1.3 41.4 0.0 1.7 1.3 1.3 1.3 1.3 1.3 1.3 23.6 15.6 1.3 1.3 1.3 1.3 20.9 15.5 1.3 1.3 1.3 0.0 1.3 17.1 1.3 1.3 0.0 1.3 1.3 1.3 1.3 1.5 1.3 16.8 1.3 1.4 1.3 16.6 0.0 1.3 0.0 1.3 1.4 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.6 4.2 0.0 0.0 0.0 0.8 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.2 1.9 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 6.0 1.8 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 19.1 4.2 27.6 23.6 15.6 20.9 15.5 17.1 16.6 OMG OMGP ENSG00000126861 "Oligodendrocyte myelin glycoprotein" P23515 17 31272013-31297539 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 40 "brain: 89.6" "Cell line enhanced" "Detected in some" "HAP1: 3.5;U-87 MG: 1.4" "Group enriched" "Detected in some" 7 "endometrial cancer: 3.5;glioma: 9.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008206, HPA012693" Enhanced "Intracellular and membrane" "HPA008206: AB_1854240, HPA012693: AB_1854239" "unprognostic (8.05e-4)" "unprognostic (2.11e-2)" "unprognostic (1.27e-1)" "unprognostic (3.03e-3)" "unprognostic (1.85e-1)" "unprognostic (4.16e-2)" "unprognostic (1.63e-1)" "unprognostic (3.81e-2)" "unprognostic (9.54e-2)" "unprognostic (8.60e-2)" "unprognostic (7.03e-2)" "unprognostic (1.52e-1)" "unprognostic (3.96e-13)" "unprognostic (7.80e-3)" "unprognostic (6.00e-2)" "unprognostic (3.24e-1)" "unprognostic (2.42e-2)" 1.6 1.8 25.2 1.6 25.4 2.2 1.6 10.2 89.6 1.6 1.7 20.3 0.0 1.7 1.6 1.6 1.6 1.6 1.6 1.6 26.8 20.6 1.6 1.6 1.6 1.6 30.8 23.2 1.6 1.6 1.6 0.1 1.6 36.8 1.6 1.7 1.4 1.6 1.6 1.7 1.6 1.7 1.6 23.0 1.7 1.6 1.6 39.6 0.0 1.6 0.0 1.6 1.6 0.0 0.0 0.1 1.6 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.2 0.2 3.5 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.6 1.4 0.0 0.7 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 25.2 25.4 10.2 34.1 26.8 20.6 30.8 23.2 36.8 39.6 OOSP2 "FLJ36198, PLAC1L, TMEM122" ENSG00000149507 "Oocyte secreted protein 2" Q86WS3 11 60040275-60048044 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 48.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 32 "basophil: 3.2" "Lineage enriched" "Detected in single" 32 "granulocytes: 3.2" "Not detected" "Not detected" HPA050914 Enhanced "Secreted in male reproductive system" "HPA050914: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPALIN "HTMP10, TMEM10, TMP10" ENSG00000197430 "Oligodendrocytic myelin paranodal and inner loop protein" Q96PE5 10 96343216-96359365 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 43 "brain: 69.7" "Group enriched" "Detected in some" 11 "MOLT-4: 2.2;REH: 4.5" "Cancer enriched" "Detected in single" 36 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014372 Supported "HPA014372: AB_2158172" "unprognostic (1.18e-1)" 1.5 1.5 35.0 1.5 42.1 1.6 1.5 2.8 69.7 1.5 1.5 52.5 0.0 1.5 1.5 1.5 1.5 1.5 1.5 1.5 40.1 15.1 1.5 1.5 1.5 1.5 19.9 17.8 1.5 1.5 1.5 0.0 1.5 13.8 1.5 1.5 0.0 1.5 1.5 1.5 1.5 1.5 1.5 17.8 1.5 1.5 1.5 29.5 0.0 1.5 0.0 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 42.1 2.8 33.4 40.1 15.1 19.9 17.8 13.8 29.5 OPCML "IGLON1, OBCAM, OPCM" ENSG00000183715 "Opioid binding protein/cell adhesion molecule like" Q14982 11 132414977-133532519 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 49.9" "Cell line enriched" "Detected in some" 5 "BJ: 14.0" "Group enriched" "Detected in some" 10 "glioma: 3.7;renal cancer: 0.7;thyroid cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" 6300000 "unprognostic (1.59e-1)" "unprognostic (2.26e-2)" "unprognostic (3.70e-2)" "unprognostic (3.31e-4)" "unprognostic (8.23e-2)" "unprognostic (3.53e-2)" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (8.46e-3)" "unprognostic (2.59e-2)" "unprognostic (2.80e-1)" "unprognostic (4.73e-2)" "unprognostic (1.11e-2)" "unprognostic (1.13e-2)" "unprognostic (1.76e-1)" "unprognostic (9.71e-2)" "unprognostic (2.19e-1)" 1.2 1.5 10.5 1.1 22.3 0.9 1.0 31.4 49.9 1.6 1.1 3.9 0.0 1.1 1.7 1.1 1.5 1.6 1.3 1.4 14.7 8.9 2.9 1.0 1.0 1.0 4.2 21.2 1.3 1.0 7.0 1.1 0.9 4.0 1.1 1.2 4.8 1.2 1.8 1.0 1.1 1.1 1.7 2.6 1.8 1.2 1.5 6.6 0.0 1.2 0.0 1.0 1.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 14.0 0.1 2.1 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 2.0 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.5 22.3 31.4 35.6 14.7 8.9 4.2 21.2 4.0 6.6 OPN1LW "CBBM, CBP, COD5, RCP" ENSG00000102076 "Opsin 1, long wave sensitive" P04000 X 154144224-154159032 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "retina: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (6.05e-2)" 0.3 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.1 0.0 1.2 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPN1MW2 ENSG00000166160 "Opsin 1, medium wave sensitive 2" P0DN77 X 154219756-154233286 "Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 4 "skin 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPN5 "dJ402H5.1, neuropsin, TMEM13" ENSG00000124818 "Opsin 5" Q6U736 6 47781982-47832780 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 7.3" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;SK-BR-3: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA026084 Supported "HPA026084: " "unprognostic (1.95e-1)" "unprognostic (6.18e-2)" "unprognostic (4.84e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPRM1 MOR1 ENSG00000112038 "Opioid receptor mu 1" P35372 6 154010496-154246867 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 37.9" "Cell line enriched" "Detected in single" 24 "SH-SY5Y: 12.8" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 37.9" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA014509, HPA067435" Enhanced Supported "HPA014509: AB_1854801, HPA067435: " "unprognostic (7.34e-2)" "unprognostic (6.91e-2)" 0.5 3.4 7.0 0.6 17.5 1.8 0.9 37.9 7.6 0.5 0.6 0.8 0.0 0.6 0.7 1.4 3.7 0.5 1.0 0.5 2.6 2.3 0.5 0.5 0.5 0.9 0.6 9.3 0.8 0.7 0.4 0.6 0.5 5.2 0.7 0.4 0.0 0.6 0.2 0.9 1.8 0.5 0.3 1.9 0.6 1.0 8.0 0.5 0.0 1.0 0.0 0.3 0.5 0.5 0.5 0.2 2.1 0.1 0.1 0.7 0.0 0.1 0.0 0.2 0.4 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.2 0.4 0.4 0.1 0.0 0.3 0.3 0.2 0.1 0.2 0.1 0.1 0.4 0.1 0.0 0.3 0.5 0.1 0.5 0.0 0.1 0.1 0.1 0.3 0.3 0.2 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.1 0.3 12.8 0.0 0.0 0.3 0.3 0.1 0.3 0.4 0.1 0.3 0.1 0.4 0.2 0.1 0.3 0.1 0.0 0.2 0.1 0.6 0.6 0.0 0.7 0.2 0.3 0.5 0.1 0.5 0.4 0.1 2.1 0.1 0.0 0.2 0.3 0.0 7.0 17.5 37.9 7.6 2.6 2.3 0.6 9.3 5.2 0.5 OPTC ENSG00000188770 Opticin Q9UBM4 1 203494143-203508864 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 92 "retina: 245.8" "Cell line enhanced" "Detected in some" "BJ: 1.0;HeLa: 1.5;NTERA-2: 2.5;RT4: 1.6;SCLC-21H: 1.2;U-2 OS: 1.0" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA034951, HPA034952" Enhanced "Secreted in other tissues" "HPA034951: AB_10669852, HPA034952: AB_2674379" "unprognostic (3.29e-1)" "unprognostic (1.56e-1)" "unprognostic (7.69e-2)" "unprognostic (3.19e-2)" "unprognostic (1.70e-3)" "unprognostic (8.24e-2)" "unprognostic (3.65e-2)" 0.3 0.0 0.2 0.1 0.2 0.0 0.2 0.4 1.0 0.4 1.3 0.1 0.1 0.4 1.3 2.2 0.8 0.8 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 1.1 0.3 0.0 0.1 0.4 0.1 0.7 0.3 245.8 0.1 0.6 0.1 1.1 0.2 1.1 0.1 0.1 0.1 2.6 0.1 0.1 0.2 0.1 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.2 1.0 0.3 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.7 0.0 0.1 0.0 0.0 1.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.1 0.1 0.2 0.2 0.1 0.1 0.1 OPTN "FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP" ENSG00000123240 Optineurin Q96CV9 10 13099449-13138308 "Disease related genes, Predicted intracellular proteins" "Autophagy, Host-virus interaction, Immunity, Innate immunity" "Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 170.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003279, HPA003360, CAB019303" Approved Enhanced Cytosol Cytosol "CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528" "unprognostic (2.84e-2)" "unprognostic (3.37e-1)" "unprognostic (3.79e-3)" "unprognostic (6.46e-3)" "unprognostic (5.58e-2)" "unprognostic (3.74e-2)" "unprognostic (5.15e-3)" "unprognostic (3.14e-2)" "unprognostic (2.68e-2)" "unprognostic (2.16e-1)" "unprognostic (1.40e-2)" "unprognostic (6.14e-1)" "prognostic unfavourable (5.81e-5)" "unprognostic (7.62e-2)" "unprognostic (5.67e-2)" "unprognostic (7.93e-2)" "unprognostic (2.09e-2)" 19.3 21.4 16.1 8.4 15.4 9.6 17.9 17.1 20.4 9.5 11.8 9.4 5.8 14.3 9.4 6.9 14.5 7.3 10.1 32.5 11.9 13.6 16.6 16.7 12.0 9.5 16.2 18.0 22.1 8.2 8.9 9.9 13.0 21.0 9.9 13.4 5.8 10.2 10.2 170.7 17.6 16.0 10.3 16.9 12.4 12.7 16.0 12.5 4.9 6.4 24.5 8.4 11.0 19.8 6.0 1.8 11.9 1.1 16.0 34.5 9.2 18.5 5.3 3.0 4.1 41.1 42.4 3.5 22.4 25.6 17.0 28.2 9.3 24.9 0.1 8.9 30.5 17.4 3.9 21.5 13.0 43.2 2.1 3.8 7.4 5.0 42.1 0.1 14.0 22.7 17.0 16.2 17.0 14.4 4.7 28.8 22.8 3.9 1.8 0.5 1.2 2.4 0.3 5.9 1.9 20.7 13.3 0.8 3.2 19.4 5.9 14.5 12.7 2.6 39.2 14.0 6.9 18.9 6.2 14.9 5.1 0.1 21.0 3.2 2.6 11.9 0.8 0.1 19.7 0.5 15.0 6.0 24.9 22.6 0.1 3.4 10.1 12.3 0.7 16.0 1.1 1.8 34.5 9.2 16.1 15.4 17.1 20.4 11.9 13.6 16.2 18.0 21.0 12.5 OR10D3 "HTPCRX09, OR10D3P" ENSG00000197309 "Olfactory receptor family 10 subfamily D member 3 (putative)" Q8NH80 11 124183345-124188780 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "testis: 3.7" "Cell line enhanced" "Detected in single" "PC-3: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G7 ENSG00000182634 "Olfactory receptor family 10 subfamily G member 7" Q8NGN6 11 124036013-124041325 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 4 "pancreas: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10J1 "HGMP07J, HSHGMP07J" ENSG00000196184 "Olfactory receptor family 10 subfamily J member 1" P30954 1 159437845-159443078 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 10.9" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.8 0.4 2.4 0.5 0.5 0.5 0.2 0.2 0.5 0.3 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.6 0.7 0.3 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.1 0.3 0.8 0.0 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.2 1.1 0.0 0.5 0.2 0.2 0.2 0.0 0.2 0.2 1.0 0.1 1.1 0.1 0.0 0.1 0.3 0.0 0.4 0.3 0.0 0.6 0.6 0.2 0.4 0.3 0.2 0.3 0.4 0.2 0.3 2.4 0.5 0.4 0.3 0.2 0.2 0.3 0.3 0.3 0.1 0.8 0.3 0.5 2.1 0.5 0.5 0.4 0.1 0.2 OR10J5 ENSG00000184155 "Olfactory receptor family 10 subfamily J member 5" Q8NHC4 1 159535078-159536007 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "liver: 1.8" "Cell line enhanced" "Detected in single" "HSkMC: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10Z1 ENSG00000198967 "Olfactory receptor family 10 subfamily Z member 1" Q8NGY1 1 158605268-158612514 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 17 "bone marrow: 12.1" "Cell line enriched" "Detected in some" 5 "K-562: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058072 Uncertain "HPA058072: " 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.1 0.7 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.9 0.1 0.2 0.0 0.1 1.0 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.1 0.2 4.6 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.8 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 OR11G2 ENSG00000196832 "Olfactory receptor family 11 subfamily G member 2" Q8NGC1 14 20190894-20201075 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 5 "blood: 5.9" "Cell line enriched" "Detected in single" 14 "HEL: 7.1" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "neutrophil: 5.9" "Lineage enriched" "Detected in single" 12 "granulocytes: 5.9" 0.4 0.2 0.1 0.4 0.1 1.0 0.1 0.1 0.2 0.3 0.1 0.4 0.3 0.6 0.1 0.2 0.5 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.4 0.0 0.1 0.2 0.2 0.0 0.5 0.0 0.5 0.8 0.2 0.0 0.1 0.7 0.2 1.2 0.4 0.0 0.2 0.1 0.3 0.2 5.9 0.3 0.4 0.2 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.2 7.1 0.3 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.8 0.3 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.2 0.2 5.9 0.4 0.2 0.2 0.0 0.0 OR13C3 ENSG00000204246 "Olfactory receptor family 13 subfamily C member 3" Q8NGS6 9 104535749-104536856 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 9 "testis: 2.1" "Cell line enhanced" "Detected in single" "HL-60: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053978 Uncertain "HPA053978: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13D1 ENSG00000179055 "Olfactory receptor family 13 subfamily D member 1" Q8NGV5 9 104694379-104695485 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.3" "Cell line enhanced" "Detected in single" "HL-60: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055921 Uncertain "HPA055921: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 OR14A2 "OR5AX1, OR5AX1P" ENSG00000241128 "Olfactory receptor family 14 subfamily A member 2" Q96R54 1 247722957-247724043 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 12 "testis: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052685 Uncertain "HPA052685: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 OR14I1 "OR5BU1, OR5BU1P" ENSG00000189181 "Olfactory receptor family 14 subfamily I member 1" A6ND48 1 248681369-248682304 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 7.4" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.68e-1)" "unprognostic (1.63e-1)" 0.0 0.0 1.2 0.0 1.9 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A4 OR2A10 ENSG00000180658 "Olfactory receptor family 2 subfamily A member 4" O95047 6 131699644-131701401 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "blood: 10.6" "Cell line enhanced" "Detected in some" "HEL: 1.2;HMC-1: 1.1;MCF7: 1.7" "Cancer enriched" "Detected in single" 17 "renal cancer: 0.8" "Group enriched" "Detected in some" 48 "basophil: 10.6;NK-cell: 3.8" "Group enriched" "Detected in many" 48 "granulocytes: 10.6;NK-cells: 3.8" HPA058272 Uncertain "HPA058272: " "unprognostic (1.22e-5)" "unprognostic (3.60e-2)" 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.2 1.4 2.1 0.0 0.0 0.4 0.4 0.8 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 1.0 0.0 1.0 0.3 0.5 0.0 0.6 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.9 0.2 0.0 0.0 10.6 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.5 0.5 0.0 0.6 0.1 0.5 0.0 0.0 0.0 0.9 0.0 0.3 1.2 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.9 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 OR2H1 "OR2H6, OR2H8, OR6-2" ENSG00000204688 "Olfactory receptor family 2 subfamily H member 1" Q9GZK4 6 29457181-29464328 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 124 "testis: 12.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T10 ENSG00000184022 "Olfactory receptor family 2 subfamily T member 10" Q8NGZ9 1 248590487-248597700 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "kidney: 11.2" "Group enriched" "Detected in some" 7 "BJ hTERT+: 3.0;Karpas-707: 2.3" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Lineage enriched" "Detected in single" 15 "B-cells: 1.4" HPA052019 Uncertain "HPA052019: " "unprognostic (8.58e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T2 OR2T2P ENSG00000196240 "Olfactory receptor family 2 subfamily T member 2" Q6IF00 1 248445512-248455725 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "kidney: 14.1" "Cell line enriched" "Detected in single" 22 "Karpas-707: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Lineage enriched" "Detected in single" 20 "B-cells: 1.9" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 1.5 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OR2W1 hs6M1-15 ENSG00000204704 "Olfactory receptor family 2 subfamily W member 1" Q9Y3N9 6 29044213-29045240 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4A16 OR4A16Q ENSG00000181961 "Olfactory receptor family 4 subfamily A member 16" Q8NH70 11 55343151-55344231 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "testis: 1.1" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K1 ENSG00000155249 "Olfactory receptor family 4 subfamily K member 1" Q8NGD4 14 19930917-19936757 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "testis: 2.2" "Cell line enriched" "Detected in single" 5 "HEL: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA028877 Uncertain "HPA028877: AB_10600923" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 OR4M1 ENSG00000176299 "Olfactory receptor family 4 subfamily M member 1" Q8NGD0 14 19773504-19783696 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 32 "testis: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058889 Uncertain "HPA058889: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4N2 ENSG00000176294 "Olfactory receptor family 4 subfamily N member 2" Q8NGD1 14 19719015-19830253 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 9.0" "Group enriched" "Detected in some" 6 "hTERT-HME1: 2.7;U-2 OS: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.80e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 OR4N4 ENSG00000183706 "Olfactory receptor family 4 subfamily N member 4" Q8N0Y3 15 22094522-22095472 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 22 "testis: 13.5" "Cell line enhanced" "Detected in some" "Karpas-707: 1.7;THP-1: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Uncertain Centrosome Centrosome "HPA057442: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51A7 ENSG00000176895 "Olfactory receptor family 51 subfamily A member 7" Q8NH64 11 4903783-4909462 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA061356 Uncertain "HPA061356: " "unprognostic (4.57e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52D1 ENSG00000181609 "Olfactory receptor family 52 subfamily D member 1" Q9H346 11 5488685-5489749 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "testis: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046965 Uncertain "HPA046965: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E2 ENSG00000176787 "Olfactory receptor family 52 subfamily E member 2" Q8NGJ4 11 5058650-5059627 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 10 "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045748 Uncertain "HPA045748: AB_10959665" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E5 ENSG00000277932 "Olfactory receptor family 52 subfamily E member 5" Q8NH55 11 5893208-5902730 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AK2 ENSG00000181273 "Olfactory receptor family 5 subfamily AK member 2" Q8NH90 11 56988872-56989867 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 42 "lymphoid tissue: 11.0" "Cell line enhanced" "Detected in single" "AF22: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5V1 hs6M1-21 ENSG00000243729 "Olfactory receptor family 5 subfamily V member 1" Q9UGF6 6 29353749-29431967 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046707 Uncertain "HPA046707: " 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B2 OR6B2P ENSG00000182083 "Olfactory receptor family 6 subfamily B member 2" Q6IFH4 2 240028965-240030456 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.9" "Cell line enhanced" "Detected in single" "MCF7: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047529 Uncertain "HPA047529: " 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6F1 OST731 ENSG00000169214 "Olfactory receptor family 6 subfamily F member 1" Q8NGZ6 1 247711436-247716646 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "testis: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.75e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6K6 ENSG00000180433 "Olfactory receptor family 6 subfamily K member 6" Q8NGW6 1 158754720-158755891 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "blood: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 57 "basophil: 5.7" "Lineage enriched" "Detected in single" 57 "granulocytes: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6P1 ENSG00000186440 "Olfactory receptor family 6 subfamily P member 1" Q8NGX9 1 158560606-158570580 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 10 "testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047466 Uncertain "HPA047466: AB_10963091" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7E24 "HSHT2, OR19-8, OR7E24P, OR7E24Q" ENSG00000237521 "Olfactory receptor family 7 subfamily E member 24" Q6IFN5 19 9247344-9252625 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 5.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 14 "testis cancer: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.09e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B12 ENSG00000170953 "Olfactory receptor family 8 subfamily B member 12" Q8NGG6 11 124539635-124545333 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.8" "Cell line enhanced" "Detected in single" "MCF7: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B2 ENSG00000284680 "Olfactory receptor family 8 subfamily B member 2" Q96RD0 11 124382394-124384462 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 52 "testis: 5.2" "Cell line enhanced" "Detected in single" "MCF7: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B3 ENSG00000284609 "Olfactory receptor family 8 subfamily B member 3" Q8NGG8 11 124395534-124399024 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 28 "testis: 2.7" "Cell line enhanced" "Detected in single" "BJ hTERT+ SV40 Large T+ RasG12V: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8D2 ENSG00000279116 "Olfactory receptor family 8 subfamily D member 2 (gene/pseudogene)" Q9GZM6 11 124319238-124320288 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 1.1" "Cell line enhanced" "Detected in single" "K-562: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8G1 "HSTPCR25, OR8G1P, TPCR25" ENSG00000197849 "Olfactory receptor family 8 subfamily G member 1 (gene/pseudogene)" Q15617 11 124241095-124254364 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 23 "testis: 18.2" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.1 0.3 18.2 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.5 0.3 0.7 0.4 0.1 0.3 0.0 0.3 0.1 0.7 0.2 0.0 0.6 1.2 0.4 0.4 0.7 0.1 0.0 0.7 0.7 0.2 0.0 0.6 0.3 0.4 0.2 0.2 0.3 0.5 0.6 0.5 0.1 1.2 0.5 0.1 0.2 0.4 0.3 0.1 1.0 0.6 0.1 1.1 0.5 0.5 0.6 0.4 0.2 0.3 0.1 0.0 0.3 0.9 0.4 0.1 0.3 0.0 0.4 0.5 0.8 0.3 0.2 0.7 0.2 0.4 0.6 0.3 0.2 0.3 0.4 0.3 0.4 0.2 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.7 0.1 0.2 0.3 0.0 0.0 OR9A2 ENSG00000179468 "Olfactory receptor family 9 subfamily A member 2" Q8NGT5 7 143026158-143027195 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9Q1 ENSG00000186509 "Olfactory receptor family 9 subfamily Q member 1" Q8NGQ5 11 58023881-58181616 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "skeletal muscle: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.65e-3)" "unprognostic (2.27e-1)" 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.1 0.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.5 0.4 0.3 0.7 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.5 0.2 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.8 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 ORM1 ENSG00000229314 "Orosomucoid 1" P02763 9 114323056-114326475 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Acute phase, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 834.6" "Cell line enriched" "Detected in some" 11 "Hep G2: 157.9" "Cancer enriched" "Detected in many" 16 "liver cancer: 2506.9" "Cell type enriched" "Detected in some" 45 "neutrophil: 53.4" "Lineage enriched" "Detected in many" 45 "granulocytes: 53.4" "CAB006265, HPA046438, HPA047725, HPA057726" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" 945333333333 120000000000 Vesicles "Golgi apparatus" "CAB006265: AB_425575, HPA046438: , HPA047725: , HPA057726: " "unprognostic (3.85e-1)" "unprognostic (2.12e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" "unprognostic (3.22e-2)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (1.16e-1)" "unprognostic (4.85e-2)" "unprognostic (1.74e-1)" "prognostic unfavourable (2.35e-4)" "unprognostic (2.10e-1)" "unprognostic (4.38e-2)" "unprognostic (9.32e-3)" "unprognostic (4.51e-2)" 0.1 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 834.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 157.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 13.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 0.0 0.2 0.0 0.0 0.3 ORM2 "AGP-B, AGP-B', AGP2" ENSG00000228278 "Orosomucoid 2" P19652 9 114329869-114333252 "Plasma proteins, Predicted secreted proteins" "Acute phase, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 404.1" "Cell line enriched" "Detected in single" 237 "Hep G2: 133.4" "Cancer enriched" "Detected in many" 34 "liver cancer: 873.1" "Cell type enriched" "Detected in single" 35 "neutrophil: 13.2" "Lineage enriched" "Detected in single" 35 "granulocytes: 13.2" "HPA046438, HPA047725, HPA057726" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" 422277500 61000000000 Vesicles "Golgi apparatus" "HPA046438: , HPA047725: , HPA057726: " "unprognostic (6.77e-2)" "unprognostic (8.00e-2)" "unprognostic (1.19e-1)" "unprognostic (4.44e-3)" "unprognostic (1.18e-1)" "unprognostic (5.61e-2)" "unprognostic (5.66e-2)" "unprognostic (9.70e-2)" "unprognostic (3.05e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-2)" "unprognostic (5.76e-2)" "prognostic unfavourable (1.23e-9)" "unprognostic (3.23e-1)" "unprognostic (6.80e-2)" "unprognostic (7.62e-2)" "unprognostic (9.15e-4)" 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 404.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 133.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.0 0.0 0.1 OTOL1 "C1QTNF15, C1QTNF16" ENSG00000182447 "Otolin 1" A6NHN0 3 161496808-161503942 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 8 "brain: 3.7" "Cell line enhanced" "Detected in single" "Karpas-707: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.1" HPA041030 Uncertain "Secreted in other tissues" "HPA041030: AB_10795000" 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTP ENSG00000171540 "Orthopedia homeobox" Q5XKR4 5 77628712-77639688 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 16.2" "Cell line enhanced" "Detected in some" "HDLM-2: 3.2;SCLC-21H: 1.5;THP-1: 1.5" "Cancer enriched" "Detected in single" 6 "glioma: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "hypothalamus: 23.4" "Region enhanced" "Detected in some" "hypothalamus: 24.0" HPA059342 Enhanced Supported "HPA059342: " "unprognostic (1.00e-1)" "unprognostic (2.40e-2)" "unprognostic (6.25e-2)" "unprognostic (8.06e-3)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (7.77e-2)" "unprognostic (2.39e-2)" "unprognostic (9.66e-2)" "unprognostic (4.64e-2)" "unprognostic (7.76e-14)" "unprognostic (3.38e-2)" "unprognostic (1.84e-1)" "unprognostic (9.49e-3)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.2 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OVCH2 OVTN ENSG00000183378 "Ovochymase 2 (gene/pseudogene)" 11 7689438-7706421 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "epididymis: 60.7" "Cell line enriched" "Detected in some" 7 "REH: 21.9" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 0.2" "Secreted in male reproductive system" "unprognostic (1.59e-2)" "unprognostic (3.74e-1)" "unprognostic (8.03e-2)" "unprognostic (9.77e-2)" "unprognostic (1.85e-1)" "unprognostic (1.70e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (2.84e-2)" "unprognostic (3.06e-1)" "unprognostic (9.27e-2)" "unprognostic (7.65e-2)" "unprognostic (1.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 60.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.6 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.4 0.6 0.6 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 21.9 0.0 0.1 0.2 2.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 OVGP1 "CHIT5, MUC9" ENSG00000085465 "Oviductal glycoprotein 1" Q12889 1 111414314-111427777 "Plasma proteins, Predicted intracellular proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "fallopian tube: 240.9" "Cell line enhanced" "Detected in many" "HEK 293: 7.8;SK-BR-3: 8.0" "Group enriched" "Detected in many" 13 "endometrial cancer: 58.7;ovarian cancer: 27.9" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Region enhanced" "Detected in some" "cerebellum: 6.6" "Low region specificity" "Detected in many" HPA062205 Enhanced "Intracellular and membrane" "HPA062205: " "unprognostic (1.52e-1)" "unprognostic (2.06e-2)" "unprognostic (3.35e-2)" "prognostic favourable (1.36e-4)" "unprognostic (8.39e-2)" "unprognostic (3.58e-2)" "unprognostic (2.33e-2)" "unprognostic (3.34e-2)" "unprognostic (5.44e-2)" "unprognostic (3.82e-2)" "unprognostic (7.68e-3)" "unprognostic (2.58e-1)" "unprognostic (5.35e-3)" "unprognostic (2.39e-1)" "unprognostic (1.38e-1)" "unprognostic (3.86e-3)" "prognostic favourable (3.93e-5)" 0.4 0.1 0.4 0.4 0.9 0.2 0.4 1.9 1.0 0.7 0.4 0.4 0.4 0.2 9.7 7.1 0.4 240.9 0.4 0.4 0.5 0.5 0.5 1.0 0.4 0.4 0.4 0.4 32.5 0.4 1.5 0.4 0.4 0.4 0.7 0.3 0.4 0.4 0.4 0.4 1.1 0.6 0.4 0.4 0.5 0.2 1.3 0.4 0.6 0.4 0.4 0.4 0.5 0.4 0.8 0.9 0.0 0.5 0.0 1.6 0.2 0.7 0.6 1.5 0.8 3.0 3.4 2.7 0.4 2.2 0.5 1.2 0.9 0.0 1.3 2.9 0.9 0.8 0.4 0.5 0.9 3.2 7.8 0.4 1.0 3.7 1.1 1.3 3.6 3.1 4.8 0.1 1.7 0.6 0.5 2.4 0.2 0.8 1.0 1.9 0.4 2.8 1.0 0.3 1.1 2.3 5.8 1.0 0.9 0.3 8.0 1.1 0.6 1.3 1.3 0.3 0.4 4.0 1.1 3.0 0.8 0.7 0.3 2.5 0.3 0.0 0.5 0.0 0.7 0.0 0.0 0.3 0.5 0.0 0.9 0.8 1.6 1.2 0.0 0.0 0.5 0.0 0.1 0.2 0.4 0.9 1.9 1.0 0.5 0.5 0.4 0.4 0.4 0.4 OXCT2 "FKSG25, FLJ00030, SCOT-T" ENSG00000198754 "3-oxoacid CoA-transferase 2" Q9BYC2 1 39769523-39771348 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 31.8" "Cell line enhanced" "Detected in many" "Karpas-707: 9.8;THP-1: 10.5;U-266/70: 8.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "memory B-cell: 3.3;naive B-cell: 1.9;NK-cell: 1.4" "Group enriched" "Detected in many" 9 "B-cells: 3.3;NK-cells: 1.4" HPA075423 Enhanced "HPA075423: " "unprognostic (2.42e-3)" "unprognostic (2.11e-1)" "unprognostic (6.50e-2)" "unprognostic (7.16e-2)" "unprognostic (9.68e-2)" "unprognostic (1.13e-1)" "unprognostic (1.32e-1)" "unprognostic (1.93e-3)" "unprognostic (2.74e-1)" "unprognostic (3.16e-1)" "unprognostic (2.57e-3)" "unprognostic (4.18e-2)" "unprognostic (5.39e-5)" "unprognostic (3.24e-1)" "unprognostic (4.59e-1)" "unprognostic (1.70e-1)" "unprognostic (1.85e-1)" 0.0 0.6 0.2 0.2 0.2 0.1 0.0 0.8 0.5 0.3 0.3 0.4 0.5 0.7 0.4 0.2 0.5 3.9 0.4 0.1 0.0 0.1 0.0 0.3 0.3 1.5 0.4 0.2 0.3 0.0 0.8 0.2 0.0 1.2 0.0 1.4 0.5 0.4 0.4 0.3 0.2 31.8 1.6 0.0 0.1 0.0 3.3 0.0 0.0 0.2 1.4 0.0 0.1 0.5 0.3 0.0 1.2 0.4 1.4 0.0 1.4 0.0 1.4 0.7 4.9 0.6 0.0 1.0 2.0 0.5 1.5 0.1 0.7 0.0 3.2 0.9 3.2 0.2 2.4 0.0 0.5 0.7 0.4 0.2 0.1 1.0 0.3 9.8 0.2 1.4 0.0 1.5 0.1 1.3 1.3 1.5 1.5 0.3 1.0 1.6 0.8 4.3 0.3 1.4 0.5 10.5 1.1 0.0 0.3 4.7 0.0 8.1 4.3 0.6 0.1 0.6 2.3 0.0 0.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 OXT "OT, OT-NPI, OXT-NPI" ENSG00000101405 "Oxytocin/neurophysin I prepropeptide" P01178 20 3071620-3072517 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 232.0" "Group enriched" "Detected in some" 4 "CACO-2: 5.1;HL-60: 1.3;HMC-1: 3.7;PC-3: 2.6" "Cancer enriched" "Detected in some" 5 "testis cancer: 12.1" "Region enriched" "Detected in some" 59 "hypothalamus: 232.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in some" 5 "hypothalamus: 210.0" "Group enriched" "Detected in some" 878 "basal ganglia: 840.1;hypothalamus: 2453.1" HPA071892 Supported Supported "Secreted to blood" 1501000 "HPA071892: " "unprognostic (7.45e-3)" "unprognostic (1.99e-2)" "unprognostic (2.66e-2)" "unprognostic (2.28e-1)" "unprognostic (2.62e-1)" "unprognostic (3.82e-2)" "unprognostic (8.22e-2)" "unprognostic (8.36e-2)" "unprognostic (6.02e-2)" "unprognostic (3.05e-2)" "unprognostic (6.65e-2)" "unprognostic (6.18e-1)" "unprognostic (3.81e-1)" "unprognostic (3.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.81e-1)" "unprognostic (1.10e-1)" 5.0 0.2 0.0 0.1 3.9 0.2 0.2 0.0 0.3 0.1 0.0 0.4 0.0 2.6 0.0 3.8 0.0 0.0 0.0 0.0 0.1 232.0 1.6 24.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 1.8 0.6 0.2 0.2 0.0 0.0 0.4 0.2 0.2 0.2 2.4 0.0 0.0 0.2 0.2 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.7 1.5 6.3 0.4 0.4 3.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 6.3 0.8 0.4 1.0 3.7 1.7 1.1 0.9 3.6 3.2 3.6 1.1 0.4 0.0 1.5 2.4 0.9 0.0 3.9 0.0 0.3 0.1 232.0 0.0 0.0 0.2 0.0 OXTR ENSG00000180914 "Oxytocin receptor" P30559 3 8750408-8769628 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "breast: 42.5" "Cell line enhanced" "Detected in some" "BJ: 79.3;BJ hTERT+: 24.3;BJ hTERT+ SV40 Large T+: 23.0;fHDF/TERT166: 79.4;HBF TERT88: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.18e-1)" "unprognostic (7.94e-2)" "unprognostic (4.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.02e-2)" "unprognostic (2.02e-1)" "unprognostic (1.46e-2)" "unprognostic (2.56e-3)" "unprognostic (2.12e-1)" "unprognostic (3.42e-1)" "unprognostic (2.76e-1)" "unprognostic (3.80e-2)" "unprognostic (4.24e-4)" "unprognostic (8.25e-2)" "unprognostic (4.60e-2)" "unprognostic (2.71e-1)" "unprognostic (1.84e-1)" 0.5 0.4 1.8 0.3 6.5 0.6 42.5 0.9 2.2 0.5 0.3 0.1 0.0 0.3 2.8 0.5 1.1 2.7 1.0 0.6 1.8 4.0 0.6 0.4 1.0 0.4 8.6 0.8 2.8 0.3 0.3 0.3 1.3 3.7 0.9 0.3 1.6 0.4 0.9 0.3 0.4 0.4 0.6 2.5 0.5 0.3 0.5 1.2 0.1 0.4 0.0 0.4 0.4 0.0 0.0 0.2 1.6 0.1 0.1 0.3 1.0 0.2 0.8 0.4 0.1 0.1 0.2 0.1 79.3 24.3 23.0 12.3 0.1 2.1 0.0 0.1 79.4 0.1 0.3 0.1 18.0 0.7 0.4 0.2 0.3 0.1 0.4 0.1 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.1 12.8 0.0 0.1 0.6 0.5 3.5 0.1 0.3 4.7 0.8 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 1.1 0.2 0.2 0.2 0.1 0.2 0.0 0.1 0.2 0.2 0.5 0.0 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.3 1.6 0.1 0.0 0.1 0.1 1.0 1.8 6.5 0.9 2.2 1.8 4.0 8.6 0.8 3.7 1.2 P2RY4 "NRU, P2P, P2Y4, UNR" ENSG00000186912 "Pyrimidinergic receptor P2Y4" P51582 X 70258170-70259764 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 14.2" "Cell line enhanced" "Detected in some" "Hep G2: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB022644 Uncertain "CAB022644: " "unprognostic (4.59e-2)" "unprognostic (4.23e-1)" "unprognostic (7.10e-2)" "unprognostic (1.69e-1)" "unprognostic (9.53e-4)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (6.77e-2)" "unprognostic (2.43e-1)" "unprognostic (2.09e-1)" "unprognostic (8.89e-3)" "unprognostic (2.90e-2)" "unprognostic (3.72e-2)" "unprognostic (3.61e-2)" "unprognostic (1.50e-2)" "unprognostic (3.89e-1)" 0.3 0.1 0.2 0.2 0.2 0.1 0.4 0.2 0.2 2.1 2.9 0.2 0.2 0.7 0.2 0.6 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 1.6 0.2 0.6 0.2 0.2 2.1 14.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.4 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.8 0.3 0.5 0.0 0.2 0.4 0.1 0.3 0.1 0.6 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.5 1.8 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 1.0 0.3 0.8 0.2 0.6 0.1 0.3 0.7 0.3 0.0 0.0 0.4 0.1 0.7 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.8 1.1 0.1 1.2 0.3 0.6 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 PABPC3 "PABP3, PABPL3, tPABP" ENSG00000151846 "Poly(A) binding protein cytoplasmic 3" Q9H361 13 25095868-25099254 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 50.9" "Cell line enriched" "Detected in single" 14 "U-266/84: 11.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA045423, HPA067156" Approved Approved Cytosol Cytosol "HPA045423: , HPA067156: " "unprognostic (2.17e-2)" "unprognostic (6.50e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.78e-1)" "unprognostic (2.98e-1)" "unprognostic (8.76e-3)" "unprognostic (2.27e-1)" "unprognostic (1.43e-1)" "prognostic unfavourable (8.00e-4)" "unprognostic (5.26e-4)" "unprognostic (1.04e-1)" "unprognostic (1.17e-2)" "unprognostic (5.18e-2)" "unprognostic (5.32e-2)" "unprognostic (1.39e-1)" "unprognostic (7.61e-3)" 0.5 0.2 0.2 0.5 0.8 0.2 1.0 0.1 1.1 0.7 0.5 0.1 0.0 0.2 0.2 0.3 0.7 0.2 0.2 0.2 0.3 0.1 0.2 0.2 1.2 2.0 0.2 0.4 0.4 0.3 0.1 0.4 0.2 0.3 0.4 0.2 0.0 0.6 0.9 0.2 0.4 0.5 0.2 0.1 0.4 0.2 50.9 0.0 0.8 0.3 0.0 0.2 0.3 0.4 1.6 1.9 0.5 2.2 1.8 2.5 1.9 0.4 0.0 0.0 0.2 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.5 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.4 0.1 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.7 0.7 0.2 0.0 0.2 0.0 0.1 0.0 0.5 0.7 0.2 0.0 0.2 0.4 0.2 0.0 0.0 0.1 0.1 0.4 0.2 0.3 11.4 0.2 0.1 0.3 0.1 0.4 1.4 0.5 0.7 2.1 1.6 1.6 1.7 1.3 1.9 1.3 2.5 2.2 0.5 1.8 2.2 1.1 1.5 1.9 0.2 0.8 0.1 1.1 0.3 0.1 0.2 0.4 0.3 0.0 PACSIN1 SDPI ENSG00000124507 "Protein kinase C and casein kinase substrate in neurons 1" Q9BY11 6 34466061-34535231 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 81.7" "Cell line enhanced" "Detected in some" "MCF7: 9.7;RPMI-8226: 11.3;T-47d: 18.0;U-266/84: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 15.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009929, HPA028852, HPA055491" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: " "unprognostic (3.33e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (2.97e-1)" "unprognostic (1.72e-2)" "unprognostic (2.47e-3)" "unprognostic (2.14e-2)" "unprognostic (2.65e-1)" "unprognostic (1.74e-1)" "unprognostic (6.63e-2)" "unprognostic (3.95e-4)" "unprognostic (9.12e-2)" "unprognostic (3.02e-2)" "unprognostic (4.18e-2)" "unprognostic (9.90e-2)" "unprognostic (5.50e-2)" "unprognostic (9.33e-2)" 1.5 2.1 42.5 2.4 33.8 2.0 1.4 29.3 81.7 1.5 1.7 2.1 0.0 1.8 1.9 1.5 1.4 2.0 1.7 4.7 32.8 21.9 1.6 1.4 1.5 4.4 14.6 32.9 1.7 6.1 1.4 1.2 1.4 31.6 1.8 1.6 5.5 1.6 1.7 1.5 1.4 1.8 1.5 3.7 2.5 2.4 1.9 4.1 0.0 1.4 0.0 3.4 2.0 0.0 0.0 15.0 0.0 0.0 3.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 3.7 0.7 0.0 0.1 1.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 9.7 0.5 0.0 2.4 0.0 0.1 0.0 11.3 0.0 0.3 3.6 0.2 0.0 1.8 0.0 18.0 1.9 0.0 0.0 0.3 0.0 0.0 3.0 13.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.0 15.0 0.0 0.1 42.5 33.8 29.3 56.3 32.8 21.9 14.6 32.9 31.6 4.1 PADI6 ENSG00000276747 "Peptidyl arginine deiminase 6" Q6TGC4 1 17372196-17401699 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "blood: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 3.5" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low region specificity" "Detected in single" "unprognostic (1.19e-1)" "unprognostic (4.36e-2)" "unprognostic (3.02e-2)" "unprognostic (6.56e-2)" "unprognostic (1.23e-1)" 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 3.5 0.0 0.8 0.0 1.9 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.9 0.1 0.0 0.0 0.2 1.1 3.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 PAGE1 "CT16.3, GAGE-9, GAGEB1, PAGE-1" ENSG00000068985 "PAGE family member 1" O75459 X 49687450-49695993 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 126 "testis: 18.2" "Group enriched" "Detected in some" 7 "A-431: 47.9;Karpas-707: 37.0;U-266/84: 57.0" "Cancer enhanced" "Detected in many" "liver cancer: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003473 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" "Nucleoli fibrillar center" "Nucleoplasm, Mitochondria" "HPA003473: AB_1079558" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 37.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.7 57.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAGE2 "CT16.4, GAGEC2, MGC62094, PAGE-2" ENSG00000234068 "PAGE family member 2" Q7Z2X7 X 55089008-55092842 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 23.6" "Group enriched" "Detected in some" 5 "U-266/70: 118.4;U-266/84: 152.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "naive CD4 T-cell: 1.9" "Lineage enriched" "Detected in single" 5 "T-cells: 1.9" HPA052619 Supported "HPA052619: " "unprognostic (3.49e-2)" "unprognostic (7.73e-2)" 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 29.0 0.1 0.2 118.4 152.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAGE2B CT16.5 ENSG00000238269 "PAGE family member 2B" Q5JRK9 X 55075063-55078909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 33.2" "Group enriched" "Detected in some" 8 "U-266/70: 137.1;U-266/84: 209.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052619 Supported "HPA052619: " "unprognostic (1.32e-1)" "unprognostic (2.85e-2)" "prognostic unfavourable (3.02e-4)" "unprognostic (1.40e-1)" "unprognostic (1.16e-2)" "unprognostic (3.98e-2)" "unprognostic (3.52e-1)" "unprognostic (3.22e-1)" "unprognostic (3.81e-2)" "unprognostic (2.05e-8)" "unprognostic (1.41e-1)" "unprognostic (8.84e-2)" 0.1 0.0 0.1 0.1 0.1 2.8 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.3 0.0 33.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.2 137.1 209.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 PAGE3 "CT16.6, GAGED1, PAGE-3" ENSG00000204279 "PAGE family member 3" Q5JUK9 X 55258412-55264846 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 111 "testis: 11.1" "Cell line enhanced" "Detected in some" "NTERA-2: 1.0;PC-3: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062248 Uncertain "HPA062248: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAGE5 "CT16.1, CT16.2, PAGE-5" ENSG00000158639 "PAGE family member 5" Q96GU1 X 55220355-55224108 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 32.0" "Group enriched" "Detected in some" 164 "Karpas-707: 65.5;U-266/84: 138.3" "Group enriched" "Detected in many" 6 "liver cancer: 5.4;melanoma: 11.8;testis cancer: 6.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.5" "Lineage enriched" "Detected in single" 14 "T-cells: 4.5" "HPA052619, HPA055869" Supported Approved Mitochondria Mitochondria "HPA052619: , HPA055869: " "unprognostic (4.03e-1)" "unprognostic (4.51e-2)" "unprognostic (7.86e-4)" "unprognostic (1.39e-2)" "unprognostic (7.21e-2)" "unprognostic (1.06e-4)" "unprognostic (2.29e-1)" "unprognostic (1.94e-1)" "unprognostic (3.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 32.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.0 4.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 138.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 4.5 0.3 3.8 1.6 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.3 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAK5 "KIAA1264, PAK7" ENSG00000101349 "P21 (RAC1) activated kinase 5" Q9P286 20 9537389-9839041 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 30.3" "Group enriched" "Detected in some" 9 "SCLC-21H: 10.0;SH-SY5Y: 3.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020444 Approved Approved Nucleoplasm Nucleoplasm "HPA020444: AB_1854947" "unprognostic (5.14e-5)" "unprognostic (3.35e-1)" "unprognostic (1.05e-1)" "unprognostic (8.63e-2)" "unprognostic (3.21e-1)" "unprognostic (3.04e-1)" "unprognostic (2.25e-4)" "unprognostic (3.76e-1)" "unprognostic (2.56e-2)" "unprognostic (3.83e-1)" "unprognostic (3.35e-2)" "unprognostic (6.04e-2)" "unprognostic (4.58e-1)" 0.5 5.2 5.7 0.6 11.7 0.5 1.6 30.3 19.6 0.8 0.6 0.8 0.0 0.7 1.0 2.2 1.0 0.7 3.4 0.6 4.0 3.3 1.0 2.3 0.7 0.6 1.6 8.8 0.6 3.5 0.5 2.0 0.6 5.3 1.6 0.6 0.6 1.2 1.6 0.6 1.6 0.6 0.6 1.2 0.6 1.2 1.0 1.7 0.0 0.6 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 10.0 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 5.7 11.7 30.3 13.6 4.0 3.3 1.6 8.8 5.3 1.7 PAPOLB PAPT ENSG00000218823 "Poly(A) polymerase beta" Q9NRJ5 7 4857733-4861994 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 33.0" "Cell line enhanced" "Detected in single" "THP-1: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (7.58e-2)" "unprognostic (1.25e-1)" "unprognostic (1.68e-2)" "unprognostic (1.78e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.5 0.1 PAPPA "ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1" ENSG00000182752 "Pappalysin 1" Q13219 9 116153804-116402322 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 86 "placenta: 484.6" "Cell line enhanced" "Detected in some" "ASC diff: 19.0;ASC TERT1: 14.5;HSkMC: 52.2;U-138 MG: 13.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "midbrain: 10.4;olfactory region: 4.1;pons and medulla: 8.3;thalamus: 4.8" "HPA001667, CAB016724" Enhanced "Secreted in female reproductive system" 41000 "CAB016724: , HPA001667: AB_1854960" "unprognostic (3.25e-1)" "unprognostic (6.18e-6)" "unprognostic (2.47e-1)" "unprognostic (6.49e-2)" "unprognostic (2.01e-2)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (5.42e-3)" "unprognostic (5.44e-2)" "unprognostic (3.87e-2)" "unprognostic (6.87e-3)" "unprognostic (8.25e-2)" "unprognostic (8.00e-3)" "unprognostic (2.37e-3)" "unprognostic (2.48e-1)" "unprognostic (4.01e-1)" "unprognostic (1.02e-3)" 4.8 2.3 0.5 1.0 0.5 0.0 0.8 0.4 0.6 3.6 2.4 0.6 1.0 0.1 3.5 1.0 3.6 2.0 1.1 3.7 0.4 0.0 4.3 0.5 2.4 0.7 0.4 0.4 1.4 0.7 5.6 0.7 484.6 0.7 1.4 0.9 0.9 0.5 1.2 0.5 1.1 0.9 2.4 0.6 0.6 1.0 0.8 0.5 0.4 1.3 1.0 1.0 2.3 3.4 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 5.4 8.3 0.0 19.0 14.5 0.0 4.4 7.8 1.2 2.1 0.0 0.0 0.0 0.0 3.1 0.6 0.0 0.0 5.9 0.0 0.0 0.9 4.5 0.0 9.2 0.0 0.0 52.2 0.0 6.1 0.7 0.0 0.2 0.0 1.4 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 10.5 13.6 0.7 0.3 0.5 0.0 0.0 0.0 9.7 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.4 0.6 0.4 0.0 0.4 0.4 0.7 0.5 PAPPA2 "PAPP-A2, PAPPE, PLAC3" ENSG00000116183 "Pappalysin 2" Q9BXP8 1 176463171-176845605 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "placenta: 406.4" "Cell line enriched" "Detected in some" 5 "U-87 MG: 20.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018412, HPA018430" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted in female reproductive system" "Endoplasmic reticulum, Vesicles" "HPA018412: AB_1854962, HPA018430: AB_1854961" "unprognostic (2.90e-1)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-2)" "unprognostic (9.04e-2)" "unprognostic (1.60e-3)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (1.00e-2)" "unprognostic (3.54e-2)" "unprognostic (1.29e-2)" "unprognostic (4.39e-2)" "unprognostic (2.85e-2)" "unprognostic (1.52e-4)" "unprognostic (1.85e-1)" "unprognostic (8.18e-4)" "unprognostic (4.35e-2)" 0.6 0.0 0.6 0.2 0.2 0.0 3.0 0.8 0.3 5.0 0.6 0.2 0.2 0.0 0.3 0.2 0.2 0.2 1.1 0.2 0.2 0.1 11.6 0.7 0.2 0.2 0.2 0.2 0.2 1.5 0.0 1.2 406.4 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.3 0.5 0.2 1.0 0.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.2 4.5 2.2 3.7 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.8 0.5 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.3 1.7 1.4 0.1 0.6 0.3 0.4 0.0 20.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.8 0.3 0.2 0.1 0.2 0.2 0.3 0.2 PAQR6 "FLJ22672, PRdelta" ENSG00000160781 "Progestin and adipoQ receptor family member 6" Q6TCH4 1 156243321-156248117 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 138.1" "Cell line enhanced" "Detected in many" "U-266/70: 20.7" "Cancer enriched" "Detected in all" 6 "glioma: 34.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "NK-cell: 10.5" "Lineage enriched" "Detected in many" 6 "NK-cells: 10.5" HPA073505 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA073505: " "unprognostic (1.64e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (1.60e-5)" "unprognostic (7.42e-2)" "unprognostic (5.52e-2)" "unprognostic (4.50e-3)" "unprognostic (4.75e-1)" "unprognostic (2.25e-1)" "unprognostic (2.57e-1)" "unprognostic (3.13e-1)" "unprognostic (4.25e-3)" "prognostic unfavourable (1.99e-4)" "prognostic unfavourable (1.58e-8)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" "unprognostic (8.82e-2)" "prognostic favourable (1.86e-4)" 2.1 3.6 42.5 2.2 38.0 7.6 2.2 8.7 71.6 2.0 2.7 102.9 0.0 2.8 2.3 2.9 2.5 2.2 2.9 2.0 48.1 37.6 2.0 2.1 2.1 2.1 82.7 16.1 1.6 1.6 2.4 1.2 2.2 72.5 3.5 2.3 0.0 3.2 3.0 2.1 11.5 3.0 2.0 138.1 2.3 3.1 2.5 46.0 0.0 2.0 0.0 2.0 2.5 0.3 0.8 1.6 0.0 0.0 10.5 1.2 0.1 1.7 2.0 3.3 3.4 0.6 0.5 8.1 0.2 0.5 0.0 0.2 0.9 6.3 3.2 1.5 0.5 5.7 0.0 0.7 0.4 1.9 2.7 2.0 1.7 0.9 0.3 0.6 5.3 1.6 2.6 2.4 2.4 0.2 1.5 9.4 0.5 6.7 0.2 1.0 3.7 0.9 1.4 0.7 1.5 2.3 10.6 2.8 5.7 0.7 0.7 3.8 10.7 1.1 0.5 1.0 5.3 1.7 0.5 20.7 4.5 2.0 0.2 7.4 0.9 0.0 0.0 0.0 0.4 0.0 1.2 0.8 0.6 0.2 0.0 0.1 0.0 0.0 0.0 10.5 0.0 1.6 0.1 0.1 42.5 38.0 8.7 34.4 48.1 37.6 82.7 16.1 72.5 46.0 PASD1 CT63 ENSG00000166049 "PAS domain containing repressor 1" Q8IV76 X 151563622-151676739 "Predicted intracellular proteins" "Biological rhythms" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 301 "testis: 30.0" "Group enriched" "Detected in some" 7 "BEWO: 19.5;HMC-1: 31.1;U-266/84: 14.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011122, HPA011152" Enhanced Enhanced "Nuclear speckles" "Nuclear speckles" "HPA011122: AB_1854990, HPA011152: AB_1854991" "unprognostic (3.34e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PATE3 "HEL-127, PATE-DJ" ENSG00000236027 "Prostate and testis expressed 3" B3GLJ2 11 125788111-125791600 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "epididymis: 86.5" "Cell line enhanced" "Detected in some" "NB-4: 2.7;RPMI-8226: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in male reproductive system" 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.3 0.2 0.1 0.1 0.0 8.7 0.0 0.1 86.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 3.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 PCDH19 "EFMR, EIEE9, KIAA1313" ENSG00000165194 "Protocadherin 19" Q8TAB3 X 100291644-100410273 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 27.1" "Cell line enriched" "Detected in some" 6 "AF22: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027533 Approved Approved Cytosol Cytosol "HPA027533: AB_10602043" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" "unprognostic (2.92e-1)" "unprognostic (5.04e-2)" "unprognostic (2.13e-1)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (4.77e-2)" "unprognostic (3.64e-2)" "unprognostic (1.36e-2)" "unprognostic (2.53e-1)" "unprognostic (2.79e-1)" "unprognostic (9.77e-3)" "unprognostic (2.82e-3)" "unprognostic (1.53e-1)" "unprognostic (1.80e-4)" "unprognostic (1.37e-1)" 4.9 1.1 19.8 1.3 10.5 0.7 3.7 1.0 22.5 5.5 4.0 1.9 0.0 1.2 3.8 1.3 2.9 2.2 2.0 1.6 27.1 12.8 1.4 0.9 1.0 1.3 3.7 14.2 3.6 1.1 1.2 2.1 1.0 7.3 1.4 5.5 6.4 2.1 1.6 2.4 3.3 1.8 3.1 3.7 0.8 2.0 2.3 1.0 0.0 1.1 0.7 0.9 2.3 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 19.6 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 3.4 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 10.5 1.0 22.5 27.1 12.8 3.7 14.2 7.3 1.0 PCDH8 "ARCADLIN, PAPC" ENSG00000136099 "Protocadherin 8" O95206 13 52842889-52848641 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 20.6" "Cell line enriched" "Detected in some" 4 "AF22: 22.5" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010509 Uncertain Uncertain "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA010509: AB_10601384" "unprognostic (3.50e-3)" "unprognostic (6.48e-2)" "unprognostic (1.40e-1)" "unprognostic (9.11e-4)" "unprognostic (2.12e-2)" "unprognostic (1.97e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-1)" "unprognostic (3.59e-1)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (1.32e-1)" 0.8 0.9 11.5 1.1 18.6 0.8 0.8 0.4 20.6 0.9 1.0 1.1 0.0 0.9 1.0 0.8 0.8 0.8 0.8 0.8 18.2 4.8 0.8 0.8 0.9 0.8 3.6 8.4 0.8 0.8 0.8 1.4 0.8 0.8 1.7 0.9 0.8 0.8 0.8 1.4 0.8 1.1 0.9 0.9 0.8 1.2 2.3 2.5 0.0 1.4 0.0 0.8 0.9 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 1.6 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 18.6 0.4 20.6 18.2 4.8 3.6 8.4 0.8 2.5 PCDHA5 "CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5" ENSG00000204965 "Protocadherin alpha 5" Q9Y5H7 5 140821604-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 13.6" "Cell line enhanced" "Detected in some" "A549: 2.6;EFO-21: 7.3;T-47d: 7.5;WM-115: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" HPA044557 Approved Approved "Nuclear speckles,Plasma membrane,Mitochondria" "Plasma membrane" "Nuclear speckles, Mitochondria" "HPA044557: AB_10970597" "unprognostic (4.95e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-1)" "unprognostic (8.81e-4)" "unprognostic (5.10e-2)" "unprognostic (6.25e-3)" "unprognostic (6.74e-2)" "unprognostic (9.79e-2)" "unprognostic (2.46e-2)" "unprognostic (4.49e-2)" "unprognostic (1.44e-2)" "unprognostic (1.10e-4)" "unprognostic (9.30e-4)" "unprognostic (1.07e-1)" "unprognostic (1.39e-1)" "unprognostic (8.17e-5)" "unprognostic (2.11e-1)" 0.9 1.2 3.4 0.5 3.6 0.6 0.6 13.6 10.2 0.6 0.6 0.4 0.0 0.5 1.2 0.5 0.4 0.5 1.1 0.3 1.6 2.0 1.1 0.4 0.7 0.4 1.3 5.1 0.6 1.2 0.4 2.5 0.4 2.3 0.6 0.5 0.0 0.4 0.4 0.4 0.5 0.5 0.7 1.1 0.4 0.7 0.9 0.1 0.0 0.5 0.0 0.3 0.5 0.2 0.6 0.6 1.6 0.5 0.3 0.3 0.2 0.0 2.6 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 7.5 0.1 0.1 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.5 0.5 0.5 0.3 0.3 0.2 0.4 0.3 0.2 0.1 0.6 0.3 0.3 1.6 0.3 0.4 0.6 0.2 0.2 3.4 3.6 13.6 7.2 1.6 2.0 1.3 5.1 2.3 0.1 PCDHAC1 ENSG00000248383 "Protocadherin alpha subfamily C, 1" Q9H158 5 140926369-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "parathyroid gland: 33.3" "Cell line enhanced" "Detected in some" "A549: 8.5;EFO-21: 3.6;hTCEpi: 11.0;PC-3: 6.2;SCLC-21H: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052775 Approved Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Nucleoli" Vesicles "HPA052775: " "unprognostic (2.52e-1)" "unprognostic (1.06e-1)" "unprognostic (3.32e-3)" "unprognostic (9.52e-3)" "unprognostic (1.36e-1)" "unprognostic (9.63e-2)" "unprognostic (4.27e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.24e-2)" "unprognostic (2.09e-1)" "unprognostic (3.64e-3)" "unprognostic (1.04e-3)" "unprognostic (3.25e-3)" "unprognostic (1.35e-1)" "unprognostic (2.96e-1)" "unprognostic (3.29e-2)" 0.3 0.4 0.9 0.3 1.0 0.0 0.0 2.0 2.8 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.9 0.0 1.0 1.6 0.2 0.1 0.8 1.0 1.1 0.0 1.5 33.3 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.8 0.4 0.0 0.0 0.2 0.1 0.5 0.2 0.2 0.1 0.0 0.0 8.5 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.6 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 11.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.2 0.0 0.0 0.0 0.5 0.4 4.9 2.3 0.0 0.6 0.0 0.5 0.0 0.0 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.2 0.1 0.0 0.0 PCDHGA10 PCDH-GAMMA-A10 ENSG00000253846 "Protocadherin gamma subfamily A, 10" Q9Y5H3 5 141412987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 33.7" "Cell line enhanced" "Detected in many" "AF22: 12.0;HSkMC: 13.5;T-47d: 16.0;U-2197: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077276" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA077276: " "unprognostic (2.92e-1)" "unprognostic (2.17e-4)" "unprognostic (1.63e-1)" "unprognostic (3.33e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-2)" "unprognostic (9.99e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.64e-3)" "unprognostic (2.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.06e-1)" "unprognostic (8.83e-3)" 5.2 4.2 7.9 1.6 11.4 1.2 2.7 2.4 33.7 3.6 2.9 9.8 1.2 2.4 3.0 2.4 4.3 3.6 3.7 2.3 9.1 4.4 2.0 6.5 3.5 1.7 5.1 7.2 3.6 1.9 1.4 2.4 7.4 5.3 3.6 2.6 4.9 4.1 4.6 2.0 4.7 2.9 3.1 6.7 2.5 4.7 2.0 6.5 0.0 4.9 1.5 3.3 2.5 3.5 0.9 1.1 1.5 0.7 0.8 1.0 0.2 0.0 0.0 12.0 6.1 5.3 2.3 5.7 2.0 0.1 2.9 4.7 0.2 0.7 0.6 7.9 2.9 0.3 2.8 1.9 2.3 0.7 0.0 0.0 0.3 0.0 2.1 1.2 0.2 13.5 0.3 2.0 0.8 1.1 0.0 0.1 7.3 0.0 0.1 0.3 1.1 0.1 0.1 1.0 0.0 2.0 0.0 1.6 0.6 0.3 0.0 0.3 16.0 1.5 2.6 5.5 0.3 9.4 0.1 0.2 0.9 0.1 2.8 0.0 0.3 1.5 0.3 0.3 1.0 0.4 1.0 0.6 0.4 0.6 0.1 0.9 0.4 0.9 0.9 0.8 0.7 1.1 0.3 0.2 7.9 11.4 2.4 8.5 9.1 4.4 5.1 7.2 5.3 6.5 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 "Protocadherin gamma subfamily C, 4" Q9Y5F7 5 141484997-141512979 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 23.6" "Cell line enhanced" "Detected in some" "REH: 9.7;SCLC-21H: 8.2;SH-SY5Y: 15.9" "Cancer enriched" "Detected in single" 10 "glioma: 4.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (6.05e-2)" "unprognostic (1.26e-3)" "unprognostic (4.78e-2)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (7.84e-2)" "unprognostic (9.48e-2)" "unprognostic (3.27e-1)" "unprognostic (4.55e-1)" "unprognostic (1.17e-1)" "unprognostic (8.72e-3)" "unprognostic (4.73e-3)" "unprognostic (2.20e-4)" "unprognostic (8.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.47e-1)" "unprognostic (2.75e-2)" 0.7 2.9 5.7 0.7 9.5 0.5 0.8 23.6 21.9 1.0 1.1 2.3 0.0 0.6 0.9 1.2 0.8 1.0 1.0 1.3 4.1 10.1 0.6 0.6 1.0 0.9 3.3 4.5 0.8 1.2 0.8 1.3 0.8 8.6 0.8 0.8 1.9 1.0 0.7 1.2 1.5 0.7 0.9 2.3 0.8 0.7 1.5 0.8 0.0 0.7 0.0 1.0 0.6 0.2 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.2 0.2 0.8 0.4 0.2 0.1 0.1 0.2 0.0 0.0 0.3 0.9 0.9 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.7 0.0 1.5 0.0 9.7 0.6 0.0 0.0 0.1 8.2 15.9 0.1 0.0 0.2 0.1 0.3 0.1 0.9 0.1 0.2 0.7 0.2 0.0 0.2 0.6 0.1 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.5 23.6 15.6 4.1 10.1 3.3 4.5 8.6 0.8 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 "Protocadherin gamma subfamily C, 5" Q9Y5F6 5 141489121-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 43.7" "Cell line enhanced" "Detected in some" "U-138 MG: 16.3;U-251 MG: 7.0;U-87 MG: 10.0" "Group enriched" "Detected in some" 13 "glioma: 3.1;head and neck cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4" "HPA008755, HPA010580, HPA076140" Supported Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA076140: " "unprognostic (2.86e-3)" "unprognostic (7.63e-4)" "unprognostic (2.00e-1)" "unprognostic (3.52e-3)" "unprognostic (5.42e-2)" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-2)" "unprognostic (3.90e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-9)" "unprognostic (6.87e-3)" "unprognostic (3.89e-2)" "unprognostic (3.13e-1)" "unprognostic (3.77e-3)" 1.0 1.1 7.4 1.1 34.5 0.9 1.1 3.0 43.7 1.1 1.0 2.8 0.0 0.9 1.4 1.3 1.0 1.2 1.2 2.8 11.8 2.8 0.9 0.9 1.1 0.9 2.2 10.0 1.1 1.0 1.0 1.1 1.0 2.3 1.3 1.0 0.0 0.9 1.6 1.6 1.5 0.9 2.0 0.8 1.0 1.0 1.3 1.1 0.0 1.0 0.0 1.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.7 0.2 0.8 0.6 0.5 0.6 0.0 0.0 0.5 1.6 2.4 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.9 0.8 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.2 0.1 16.3 0.2 0.2 7.0 0.0 0.0 0.0 10.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 34.5 3.0 39.2 11.8 2.8 2.2 10.0 2.3 1.1 PCK1 PEPCK-C ENSG00000124253 "Phosphoenolpyruvate carboxykinase 1" P35558 20 57561080-57568112 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Gluconeogenesis "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 419.5" "Cell line enriched" "Detected in some" 10 "ASC diff: 21.5" "Cancer enriched" "Detected in many" 5 "liver cancer: 99.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA006277, HPA006507, CAB017027" Approved 380000 "CAB017027: , HPA006277: AB_1079579, HPA006507: AB_1079578" "unprognostic (3.50e-2)" "unprognostic (5.60e-2)" "unprognostic (4.60e-2)" "unprognostic (8.62e-3)" "unprognostic (1.99e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-2)" "unprognostic (4.43e-2)" "unprognostic (1.84e-1)" "unprognostic (2.37e-1)" "unprognostic (1.64e-1)" "prognostic favourable (1.47e-5)" "unprognostic (1.03e-1)" "unprognostic (6.40e-2)" "unprognostic (1.05e-3)" "unprognostic (2.21e-1)" 10.0 0.1 0.4 2.2 0.4 0.0 11.1 0.2 0.6 0.1 52.0 0.2 0.1 19.2 0.1 0.7 0.2 0.1 5.6 0.4 0.3 0.2 72.0 419.5 0.2 0.3 0.2 0.2 0.4 0.2 0.0 5.0 0.1 0.5 0.2 14.0 0.2 0.2 0.1 0.3 0.1 58.5 0.4 0.1 0.1 0.1 0.2 0.2 0.1 0.4 0.4 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.6 0.3 0.2 0.2 0.2 0.5 0.2 PCNT "KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4" ENSG00000160299 Pericentrin O95613 21 46324122-46445769 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 82.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 10.7" "Group enriched" "Detected in many" 6 "dendritic cells: 5.3;granulocytes: 4.9;T-cells: 10.7" "Low region specificity" "Detected in all" "HPA016820, HPA019887, HPA032101" Enhanced Enhanced Centrosome Centrosome "HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: " "unprognostic (9.07e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (1.30e-2)" "unprognostic (5.35e-2)" "unprognostic (3.40e-3)" "unprognostic (1.27e-2)" "unprognostic (2.59e-1)" "unprognostic (9.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.59e-3)" "unprognostic (3.86e-2)" "unprognostic (1.95e-2)" "unprognostic (5.83e-2)" "unprognostic (2.90e-1)" "unprognostic (3.36e-1)" "unprognostic (5.86e-2)" 4.7 4.7 16.6 6.9 20.4 12.6 3.6 8.3 16.5 3.2 4.0 4.4 3.8 3.7 3.7 4.1 5.1 3.4 5.0 8.2 12.0 4.2 3.2 4.4 4.3 6.4 7.0 9.7 4.9 3.3 5.9 8.0 3.4 5.6 4.0 4.1 2.0 4.1 4.1 82.3 10.4 4.0 4.2 4.3 5.5 4.6 14.5 9.7 9.1 4.4 2.2 4.8 4.7 5.1 0.4 5.3 4.9 1.2 0.5 10.7 2.3 9.2 7.3 11.3 6.9 5.7 5.8 7.1 7.2 5.0 7.2 6.4 8.8 6.0 9.3 4.6 8.2 6.7 9.1 6.2 5.0 27.0 12.8 24.6 13.6 6.8 1.9 12.4 10.2 3.1 4.7 9.6 4.8 5.5 12.4 14.0 9.8 15.4 12.2 12.8 11.2 5.0 15.2 4.6 8.1 5.6 10.0 13.9 6.2 15.5 9.7 4.7 9.2 9.7 7.5 12.9 6.5 7.3 11.4 12.1 10.1 10.0 8.0 12.2 6.9 4.9 0.8 1.3 2.0 0.6 5.9 0.4 0.9 5.9 2.3 0.2 0.7 10.7 0.5 0.5 1.2 5.3 0.9 2.3 16.6 20.4 8.3 16.5 12.0 4.2 7.0 9.7 5.6 9.7 PCSK4 "DKFZp434B217, MGC34749, PC4, SPC5" ENSG00000115257 "Proprotein convertase subtilisin/kexin type 4" Q6UW60 19 1481428-1490752 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "testis: 50.7" "Cell line enhanced" "Detected in some" "AN3-CA: 9.9;HMC-1: 5.3;U-266/70: 10.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.2;plasmacytoid DC: 1.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.7;T-cells: 1.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA005572 Uncertain "HPA005572: AB_1855087" "unprognostic (1.00e-2)" "unprognostic (9.12e-2)" "unprognostic (2.36e-3)" "prognostic favourable (9.45e-5)" "unprognostic (5.23e-2)" "unprognostic (6.14e-2)" "unprognostic (1.78e-1)" "unprognostic (6.34e-3)" "unprognostic (2.94e-1)" "unprognostic (8.29e-3)" "unprognostic (1.93e-2)" "unprognostic (7.44e-2)" "unprognostic (6.56e-2)" "unprognostic (3.82e-2)" "unprognostic (1.71e-2)" "unprognostic (3.57e-2)" "unprognostic (7.03e-2)" 0.5 1.2 2.5 0.6 3.4 0.9 0.7 0.6 1.8 1.2 0.9 1.8 2.5 2.5 0.8 2.2 0.7 4.2 1.0 0.4 2.5 2.1 1.7 2.0 0.8 0.6 1.0 2.0 0.8 3.8 1.4 4.2 0.5 2.3 1.2 0.4 2.4 1.3 2.4 0.5 0.8 1.1 0.6 1.2 0.7 1.2 50.7 1.8 1.2 2.0 0.0 0.4 0.7 0.6 0.0 1.7 0.0 0.3 0.0 1.2 0.1 0.8 0.5 1.7 9.9 0.2 0.3 2.6 0.7 0.2 0.1 0.3 0.9 1.4 0.0 1.0 0.0 1.1 0.0 0.0 0.0 0.6 0.2 0.4 1.4 1.3 0.7 0.0 5.3 0.8 0.0 0.0 0.1 0.2 1.6 2.5 0.0 0.0 0.2 0.4 0.1 0.5 1.7 0.1 0.2 0.6 0.0 0.0 2.0 0.2 0.4 0.1 3.6 0.5 0.0 0.8 0.1 0.2 0.0 10.9 1.9 0.3 0.5 0.9 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.2 0.0 0.0 1.2 0.1 0.0 0.0 0.0 1.7 0.0 0.1 2.5 3.4 0.6 1.8 2.5 2.1 1.0 2.0 2.3 1.8 PDC MEKA ENSG00000116703 Phosducin P20941 1 186443566-186461122 "Predicted intracellular proteins" "Sensory transduction, Vision" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "retina: 56.6" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.9;BJ: 1.8;BJ hTERT+: 3.5;hTERT-HME1: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062235 Enhanced "HPA062235: " "unprognostic (2.06e-2)" "unprognostic (3.31e-1)" "unprognostic (1.89e-1)" "unprognostic (5.90e-4)" "unprognostic (2.18e-1)" "unprognostic (7.53e-2)" "unprognostic (2.43e-2)" "unprognostic (1.26e-1)" "unprognostic (2.35e-1)" "unprognostic (2.39e-2)" "unprognostic (8.28e-3)" "unprognostic (4.07e-7)" "unprognostic (3.48e-2)" "unprognostic (2.11e-2)" "unprognostic (1.61e-1)" "unprognostic (1.67e-2)" 0.5 0.0 0.3 0.2 0.5 0.2 0.2 2.0 1.5 0.3 0.2 0.2 0.2 0.0 0.3 0.2 0.4 0.1 0.4 0.4 0.5 0.3 0.2 0.2 0.2 0.6 0.4 0.2 0.5 0.5 0.0 0.2 0.2 0.2 0.7 0.0 56.6 0.6 1.2 2.3 0.7 0.2 0.2 0.4 0.2 0.2 1.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.4 0.5 0.2 0.0 1.9 0.0 1.8 3.5 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.2 0.0 0.3 0.6 0.1 0.0 0.0 0.7 0.3 0.0 0.7 0.1 0.0 0.0 0.2 1.9 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.1 0.7 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.4 0.0 1.1 0.2 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.5 2.0 0.5 0.5 0.3 0.4 0.2 0.2 0.2 PDCL2 GCPHLP ENSG00000163440 "Phosducin like 2" Q8N4E4 4 55556525-55592212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 43.0" "Cell line enhanced" "Detected in some" "AF22: 1.1;Daudi: 3.5;HaCaT: 6.0;PC-3: 1.6" "Group enriched" "Detected in some" 5 "endometrial cancer: 0.8;ovarian cancer: 2.0;testis cancer: 3.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.0" "Lineage enriched" "Detected in single" 11 "monocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA048260 Enhanced "HPA048260: AB_2680333" "unprognostic (5.93e-3)" "unprognostic (1.19e-7)" "unprognostic (1.04e-1)" "unprognostic (3.01e-3)" "unprognostic (1.16e-1)" "unprognostic (1.54e-1)" "unprognostic (4.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 43.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.5 0.2 0.0 6.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDE1B PDES1B ENSG00000123360 "Phosphodiesterase 1B" Q01064 12 54549350-54579239 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 52.6" "Cell line enhanced" "Detected in some" "HDLM-2: 11.3;HL-60: 6.3;HMC-1: 12.1;NB-4: 8.0;THP-1: 7.7;U-937: 6.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 52.6" "Cell type enriched" "Detected in single" 4 "naive CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 4 "T-cells: 1.6" "Region enriched" "Detected in all" 6 "basal ganglia: 895.2" "Region enriched" "Detected in all" 7 "basal ganglia: 253.8" HPA018492 Enhanced "HPA018492: AB_1855119" "unprognostic (2.90e-1)" "unprognostic (1.51e-1)" "unprognostic (7.67e-4)" "unprognostic (5.63e-3)" "unprognostic (7.02e-2)" "unprognostic (7.51e-2)" "unprognostic (1.97e-1)" "unprognostic (9.39e-2)" "unprognostic (1.14e-1)" "unprognostic (5.11e-2)" "unprognostic (3.84e-3)" "unprognostic (2.70e-2)" "prognostic unfavourable (4.77e-6)" "unprognostic (6.64e-4)" "unprognostic (2.14e-1)" "unprognostic (3.09e-1)" "unprognostic (2.83e-2)" 12.3 1.4 9.9 4.6 52.6 5.6 2.7 3.1 19.4 2.6 3.7 1.4 0.0 1.2 3.9 2.5 1.7 2.4 2.9 1.9 3.7 3.8 1.3 1.6 2.9 1.6 3.0 9.3 12.5 0.6 11.0 0.5 0.5 5.8 1.0 1.7 0.5 1.3 2.1 0.7 1.0 2.6 4.9 1.2 4.8 2.5 1.1 7.7 0.0 2.7 0.0 1.1 2.8 1.1 0.2 0.3 0.1 0.3 0.1 1.6 0.4 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.1 0.0 0.0 1.8 0.0 0.0 11.3 0.3 4.6 0.0 0.0 0.0 6.3 12.1 0.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.7 8.0 3.3 0.0 2.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.7 0.0 0.0 0.2 0.0 0.0 0.0 0.1 2.4 0.0 6.4 1.2 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.2 1.6 0.0 0.1 0.1 0.0 0.0 0.0 0.4 9.9 52.6 3.1 19.4 3.7 3.8 3.0 9.3 5.8 7.7 PDE6A "PDEA, RP43" ENSG00000132915 "Phosphodiesterase 6A" P16499 5 149857955-149944793 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Disease mutation, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 153.4" "Cell line enriched" "Detected in some" 4 "CACO-2: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016970, HPA074677" Enhanced "HPA016970: AB_1855125, HPA074677: AB_2732264" "unprognostic (6.85e-2)" "unprognostic (8.84e-2)" "unprognostic (1.70e-2)" "unprognostic (4.11e-2)" "unprognostic (1.12e-2)" "unprognostic (5.72e-2)" "unprognostic (4.39e-3)" "unprognostic (8.83e-2)" "unprognostic (6.54e-2)" "unprognostic (5.91e-3)" "unprognostic (1.77e-2)" "unprognostic (9.21e-2)" "unprognostic (7.57e-5)" "unprognostic (9.93e-2)" "unprognostic (3.08e-1)" "unprognostic (1.31e-1)" "unprognostic (2.26e-2)" 0.2 2.3 0.2 0.2 0.2 0.9 0.2 0.3 0.2 0.2 1.8 0.2 0.3 0.2 0.2 20.1 2.4 0.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 4.6 0.2 0.2 0.2 1.0 153.4 1.4 0.2 0.2 1.6 0.2 0.2 0.2 0.2 0.1 3.1 0.2 0.2 0.4 0.3 0.5 0.2 0.2 1.5 0.8 3.3 0.8 1.2 0.8 0.1 0.4 0.7 0.6 0.5 0.3 0.3 0.6 0.3 0.1 0.4 0.1 7.4 0.8 0.9 1.3 0.2 0.7 0.2 0.4 0.5 0.6 0.3 1.0 1.1 0.6 0.2 0.7 0.6 0.3 1.1 0.9 0.6 0.2 0.3 1.4 1.4 0.3 0.4 0.9 0.5 0.5 0.3 0.8 0.7 0.5 0.9 0.8 1.1 0.0 0.7 0.2 1.0 0.5 1.4 0.8 1.6 0.8 0.5 0.6 0.3 0.5 0.8 0.8 0.6 3.3 0.8 0.5 0.6 0.4 0.5 0.7 0.6 0.5 0.2 1.5 0.7 0.8 2.8 1.2 0.5 0.8 0.4 0.1 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 PDE6C "ACHM5, COD4, PDEA2" ENSG00000095464 "Phosphodiesterase 6C" P51160 10 93612588-93666010 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "retina: 12.8" "Cell line enhanced" "Detected in some" "Hep G2: 2.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "cerebellum: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.39e-3)" "unprognostic (7.41e-3)" "unprognostic (2.61e-2)" "unprognostic (2.24e-1)" "unprognostic (3.17e-2)" "unprognostic (5.23e-3)" "unprognostic (2.46e-3)" "unprognostic (2.81e-3)" "unprognostic (9.68e-2)" "unprognostic (2.64e-1)" "unprognostic (1.51e-2)" "unprognostic (2.96e-3)" "unprognostic (2.19e-7)" "unprognostic (1.19e-1)" "unprognostic (6.61e-2)" "unprognostic (1.81e-1)" "unprognostic (1.80e-3)" 0.4 0.6 0.3 0.4 0.4 1.3 0.4 3.0 0.7 0.8 0.3 0.3 0.3 0.4 0.5 0.3 0.3 0.5 0.3 0.3 0.3 0.2 0.3 0.5 0.5 1.0 0.3 0.3 1.0 0.3 0.0 0.8 0.3 0.3 0.7 0.0 12.8 0.8 0.3 3.1 3.1 0.7 0.3 0.3 0.9 0.6 0.7 0.3 0.3 0.6 0.3 0.3 0.4 0.7 0.2 0.1 0.2 0.2 0.3 0.6 0.0 0.2 0.7 0.4 1.4 0.0 0.1 1.0 0.8 0.0 0.0 0.0 0.7 1.0 0.6 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.5 1.4 2.4 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.2 1.0 1.5 0.8 0.4 0.6 0.0 0.1 0.0 0.2 1.2 0.1 0.2 0.0 0.1 0.5 0.3 0.2 0.0 0.4 0.0 0.2 0.7 0.6 0.6 0.5 0.4 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.6 0.5 0.2 0.3 0.2 0.1 0.0 0.0 0.3 0.4 3.0 0.3 0.3 0.2 0.3 0.3 0.3 0.3 PDE6G "PDEG, RP57" ENSG00000185527 "Phosphodiesterase 6G" P18545 17 81650459-81663112 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 260.3" "Cell line enhanced" "Detected in some" "Hep G2: 6.4;NB-4: 6.8;NTERA-2: 11.8;REH: 13.7" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basophil: 29.7;NK-cell: 57.8" "Group enriched" "Detected in all" 5 "granulocytes: 29.7;NK-cells: 57.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA045118 Supported Uncertain Vesicles Vesicles "HPA045118: " "unprognostic (6.16e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.51e-3)" "unprognostic (1.68e-1)" "unprognostic (1.46e-2)" "unprognostic (6.33e-2)" "unprognostic (3.80e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (4.85e-2)" "unprognostic (5.01e-2)" "unprognostic (1.94e-2)" "unprognostic (5.71e-2)" "unprognostic (5.44e-2)" "unprognostic (2.73e-1)" "unprognostic (1.14e-1)" 0.9 1.3 0.4 2.9 0.5 4.7 0.7 0.5 0.6 0.4 0.8 0.5 0.4 0.0 0.4 0.5 0.6 0.3 1.6 0.5 0.5 0.7 3.8 2.6 2.0 13.8 0.6 0.5 0.5 0.4 0.0 0.5 8.6 0.5 0.5 0.5 260.3 0.5 0.4 0.6 0.8 2.8 0.4 0.8 17.9 0.7 2.2 0.5 2.5 0.6 0.4 4.6 2.1 0.4 1.3 8.6 29.7 7.7 57.8 2.4 3.7 0.2 0.3 0.5 0.0 0.3 0.0 0.0 0.3 1.2 1.2 1.3 0.1 0.8 0.6 0.2 0.7 0.1 0.2 0.2 2.9 0.2 0.0 0.9 0.1 6.4 1.0 0.1 0.2 0.0 0.2 1.2 0.0 3.3 0.1 0.3 1.3 0.8 0.1 6.8 11.8 0.4 13.7 0.1 2.1 0.0 0.0 0.1 0.3 0.0 0.3 0.5 0.1 0.8 1.3 0.4 0.1 0.2 0.3 0.1 0.6 1.0 1.6 2.7 0.2 29.7 5.1 8.6 1.2 7.7 0.4 0.8 0.3 0.6 8.6 1.3 0.7 2.4 0.7 57.8 4.2 0.8 0.0 3.7 0.4 0.5 0.5 0.6 0.5 0.7 0.6 0.5 0.5 0.5 PDE6H ENSG00000139053 "Phosphodiesterase 6H" Q13956 12 14973022-14981865 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "retina: 67.4" "Group enriched" "Detected in some" 4 "AN3-CA: 4.2;MOLT-4: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045118 Supported Uncertain Vesicles Vesicles "HPA045118: " "unprognostic (1.47e-3)" "unprognostic (1.07e-2)" 0.1 1.3 1.2 0.2 1.5 9.4 0.1 0.1 4.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 1.0 2.1 0.1 0.1 0.2 0.2 2.2 0.1 0.1 0.1 0.0 0.1 2.5 0.7 0.1 0.1 67.4 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.8 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.6 0.7 0.0 0.0 1.4 0.2 0.0 0.8 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 1.2 1.5 0.1 4.2 1.0 2.1 2.2 0.1 0.7 0.1 PDE8B ENSG00000113231 "Phosphodiesterase 8B" O95263 5 77210449-77429807 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "Cushing syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "thyroid gland: 67.7" "Group enriched" "Detected in some" 4 "BJ hTERT+: 12.1;HeLa: 27.8;SK-BR-3: 7.4" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 35.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA036911, HPA036912" Supported Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA036911: , HPA036912: AB_10670377" "unprognostic (1.30e-1)" "unprognostic (7.95e-2)" "unprognostic (3.35e-2)" "unprognostic (7.61e-4)" "unprognostic (1.59e-2)" "unprognostic (1.41e-1)" "unprognostic (2.66e-2)" "unprognostic (4.48e-2)" "unprognostic (1.71e-1)" "unprognostic (3.26e-2)" "unprognostic (3.98e-2)" "unprognostic (2.44e-1)" "unprognostic (9.04e-3)" "unprognostic (3.40e-2)" "unprognostic (3.76e-2)" "unprognostic (1.98e-1)" "unprognostic (3.19e-2)" 6.8 2.5 9.9 0.7 14.2 0.4 3.8 1.1 16.3 6.3 1.2 2.3 0.3 1.2 11.3 3.2 1.1 10.1 2.1 7.9 8.2 9.2 3.1 1.2 2.2 0.7 5.4 8.3 1.9 4.2 0.3 3.8 13.1 8.6 10.5 0.8 2.0 5.3 7.1 0.4 0.7 1.3 10.3 2.3 0.4 1.5 1.5 5.7 0.3 67.7 0.3 0.7 0.8 1.4 0.2 0.8 1.4 2.3 0.4 0.4 0.1 0.3 3.3 1.3 0.3 1.2 0.0 0.5 1.1 12.1 0.2 0.1 1.3 0.2 0.5 0.2 0.1 0.9 0.1 0.0 0.2 0.2 1.0 0.7 27.8 0.3 0.0 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.6 0.7 0.8 0.1 0.8 1.4 0.7 0.0 0.3 3.7 1.0 1.6 7.4 0.8 1.6 1.1 0.6 0.4 0.2 0.2 0.6 0.9 0.5 0.6 1.6 0.7 0.4 0.0 0.3 1.4 0.3 2.2 0.1 0.2 0.2 0.3 0.8 0.2 0.4 0.0 0.3 0.4 2.3 0.5 0.1 0.1 9.9 14.2 1.1 16.3 8.2 9.2 5.4 8.3 8.6 5.7 PDHA2 PDHAL ENSG00000163114 "Pyruvate dehydrogenase E1 alpha 2 subunit" P29803 4 95840019-95841474 "Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 146 "testis: 60.5" "Cell line enhanced" "Detected in single" "BEWO: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047487, HPA047864, HPA063053" Approved Supported Mitochondria Mitochondria "HPA047487: , HPA047864: , HPA063053: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDIA2 "PDA2, PDI, PDIP, PDIR" ENSG00000185615 "Protein disulfide isomerase family A member 2" Q13087 16 283152-287215 "Enzymes, Predicted intracellular proteins" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "pancreas: 286.5" "Cell line enhanced" "Detected in some" "HAP1: 5.1;HEK 293: 11.3;Hep G2: 8.4;Karpas-707: 3.9;MCF7: 6.0;SH-SY5Y: 4.9" "Cancer enriched" "Detected in many" 5 "pancreatic cancer: 28.6" "Region enhanced" "Detected in many" "cerebellum: 15.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA051692, HPA053492" Enhanced "Intracellular and membrane" "HPA051692: AB_2681575, HPA053492: AB_2682169" "unprognostic (3.46e-2)" "unprognostic (7.98e-3)" "unprognostic (3.01e-2)" "unprognostic (1.30e-1)" "unprognostic (2.21e-1)" "unprognostic (2.17e-2)" "unprognostic (6.27e-3)" "unprognostic (1.11e-2)" "unprognostic (3.98e-1)" "unprognostic (1.76e-1)" "unprognostic (4.42e-2)" "unprognostic (2.90e-2)" "unprognostic (1.58e-14)" "unprognostic (3.06e-2)" "unprognostic (1.66e-1)" "unprognostic (8.75e-2)" "unprognostic (2.87e-2)" 0.3 0.3 2.1 0.2 1.5 0.3 0.2 15.3 3.0 0.2 0.7 4.3 0.2 2.9 0.2 0.3 0.2 0.2 0.8 0.4 2.8 3.0 0.2 0.2 0.2 0.2 4.0 0.5 0.4 286.5 0.2 0.2 0.5 2.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 1.0 0.2 5.4 0.2 10.2 0.3 2.8 0.1 0.2 0.2 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.1 0.1 5.1 0.2 0.6 0.1 11.3 0.0 0.3 8.4 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.4 3.9 0.2 6.0 0.2 0.6 0.4 0.0 0.1 0.0 1.1 0.0 0.0 2.2 4.9 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 1.5 15.3 3.0 2.8 3.0 4.0 0.5 2.2 2.8 PDLIM3 ALP ENSG00000154553 "PDZ and LIM domain 3" Q53GG5 4 185500660-185535612 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 447.7" "Cell line enhanced" "Detected in some" "LHCN-M2: 50.0;RH-30: 12.3;U-266/70: 40.2;U-266/84: 11.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004749 Enhanced Supported Cytosol 270000 Cytosol "HPA004749: AB_1855150" "unprognostic (2.75e-1)" "unprognostic (3.85e-2)" "unprognostic (3.20e-2)" "unprognostic (2.49e-1)" "unprognostic (1.08e-2)" "unprognostic (1.11e-2)" "prognostic unfavourable (7.22e-4)" "unprognostic (3.15e-2)" "unprognostic (3.64e-1)" "unprognostic (1.62e-1)" "unprognostic (9.46e-2)" "unprognostic (3.77e-1)" "prognostic unfavourable (4.97e-7)" "unprognostic (1.64e-3)" "unprognostic (7.77e-2)" "prognostic unfavourable (2.13e-6)" "unprognostic (2.78e-3)" 7.8 1.2 1.6 5.2 1.9 0.1 3.7 2.2 1.0 6.6 16.5 1.4 7.9 2.3 22.2 17.0 27.2 9.3 9.9 29.5 1.5 1.6 0.8 0.8 5.6 1.4 1.6 1.0 11.1 2.1 0.1 1.9 2.2 1.6 15.2 3.6 4.8 5.3 18.7 447.7 1.0 6.1 49.5 1.4 3.4 10.2 3.9 0.7 0.1 6.2 87.3 9.1 28.4 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.4 1.9 5.5 0.0 0.0 3.9 0.0 1.2 0.0 4.1 0.0 0.0 50.0 0.0 0.0 0.0 0.9 0.3 0.0 12.3 0.1 0.0 0.0 7.4 5.6 0.0 0.0 2.9 0.2 0.0 2.7 0.0 3.0 0.0 2.5 40.2 11.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.9 2.2 1.0 1.5 1.6 1.6 1.0 1.6 0.7 PDYN "ADCA, PENKB, SCA23" ENSG00000101327 Prodynorphin P01213 20 1978757-1994285 "Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters" "Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 55.9" "Cell line enhanced" "Detected in some" "AF22: 1.5;NTERA-2: 2.8;THP-1: 2.6" "Group enriched" "Detected in some" 29 "glioma: 2.6;ovarian cancer: 1.6" "Region enriched" "Detected in many" 4 "basal ganglia: 55.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 150.7;hypothalamus: 70.9" "Region enhanced" "Detected in many" "basal ganglia: 131.1" "HPA053342, CAB079777" Enhanced Supported "Secreted in brain" "CAB079777: , HPA053342: " "unprognostic (7.00e-2)" "unprognostic (1.07e-1)" "unprognostic (1.40e-1)" "unprognostic (3.73e-2)" 0.4 0.4 13.2 0.4 55.9 0.4 0.4 0.0 40.3 0.4 0.4 1.2 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 5.0 3.9 0.4 0.4 0.4 0.4 0.7 3.7 0.4 0.4 0.4 0.0 0.4 0.2 0.4 0.4 0.0 0.4 0.4 0.4 0.6 0.4 0.4 2.2 0.4 0.4 3.2 1.1 0.0 0.5 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 55.9 0.0 3.8 5.0 3.9 0.7 3.7 0.2 1.1 PDZD4 "FLJ34125, KIAA1444, LNX5, LU1, PDZK4, PDZRN4L" ENSG00000067840 "PDZ domain containing 4" Q76G19 X 153802166-153830565 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 71.6" "Cell line enhanced" "Detected in some" "AF22: 15.8;NTERA-2: 8.0;RH-30: 11.3;SCLC-21H: 19.2;SH-SY5Y: 18.7;U-2 OS: 9.4" "Cancer enhanced" "Detected in many" "glioma: 20.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.5" "Group enriched" "Detected in many" 25 "NK-cells: 1.5;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003878 Enhanced "HPA003878: AB_2162807" "unprognostic (9.18e-3)" "unprognostic (1.25e-1)" "unprognostic (1.11e-4)" "unprognostic (1.07e-1)" "unprognostic (6.79e-2)" "unprognostic (1.85e-2)" "unprognostic (1.92e-3)" "unprognostic (2.17e-1)" "unprognostic (2.32e-3)" "unprognostic (5.90e-2)" "prognostic favourable (2.96e-5)" "unprognostic (2.27e-1)" "unprognostic (2.54e-4)" "unprognostic (2.27e-2)" "unprognostic (1.48e-1)" "unprognostic (2.83e-2)" "unprognostic (2.87e-2)" 3.3 5.8 42.8 2.6 36.7 2.5 2.0 40.1 71.6 2.3 3.5 5.1 0.4 2.5 4.4 2.2 3.3 7.9 2.8 3.3 40.8 14.8 1.6 1.7 3.0 2.6 9.9 24.9 1.7 2.6 1.5 7.4 1.2 9.0 4.5 2.3 1.8 4.3 10.5 3.6 4.8 3.3 5.0 7.0 7.0 2.3 3.4 6.4 0.0 1.6 0.0 1.6 2.4 1.4 0.0 0.0 0.0 0.0 1.5 3.5 0.6 0.0 1.0 15.8 4.1 0.0 0.1 0.0 0.4 0.0 0.5 0.5 0.4 0.0 0.0 0.2 0.0 0.1 2.8 0.0 0.1 0.0 0.5 0.0 1.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.1 0.1 0.5 8.0 0.2 0.0 11.3 0.0 0.0 0.0 19.2 18.7 0.8 0.0 5.6 1.8 0.1 0.0 0.0 9.4 0.2 1.1 0.0 0.0 0.0 0.1 0.0 5.0 0.0 0.0 0.0 3.5 0.0 0.8 0.0 1.5 2.0 0.0 0.0 0.1 0.9 0.0 1.5 0.0 0.0 0.0 0.6 42.8 36.7 40.1 49.2 40.8 14.8 9.9 24.9 9.0 6.4 PDZD9 "C16orf65, MGC50721" ENSG00000155714 "PDZ domain containing 9" Q8IXQ8 16 21983865-22001110 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "testis: 34.1" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;U-87 MG: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "T-reg: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (4.66e-2)" "unprognostic (6.23e-4)" "unprognostic (2.66e-1)" "unprognostic (2.52e-1)" "unprognostic (1.09e-2)" "unprognostic (2.52e-3)" "unprognostic (8.29e-3)" "unprognostic (2.05e-3)" "unprognostic (3.93e-2)" "unprognostic (1.11e-2)" "unprognostic (3.85e-3)" "unprognostic (1.42e-2)" "unprognostic (1.97e-2)" "unprognostic (3.20e-1)" "unprognostic (1.39e-1)" "unprognostic (1.63e-1)" "unprognostic (4.69e-2)" 0.2 0.2 0.5 0.1 1.2 0.1 0.1 2.6 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.5 0.6 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 34.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.8 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.1 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.9 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.4 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 1.0 0.1 0.5 1.2 2.6 1.0 0.5 0.6 0.4 0.1 0.1 0.1 PDZK1IP1 "DD96, MAP17, SPAP" ENSG00000162366 "PDZK1 interacting protein 1" Q13113 1 47183593-47191044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "kidney: 281.3" "Group enriched" "Detected in some" 6 "EFO-21: 30.8;RPTEC TERT1: 102.0" "Cancer enhanced" "Detected in all" "renal cancer: 340.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA014907 Enhanced Approved "Nuclear speckles,Cytosol" Cytosol "Nuclear speckles" "HPA014907: AB_1855166" "unprognostic (2.97e-1)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "prognostic unfavourable (6.92e-4)" "unprognostic (8.14e-3)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.65e-1)" "unprognostic (2.31e-1)" "prognostic unfavourable (3.45e-4)" "unprognostic (2.64e-2)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (2.07e-1)" "unprognostic (1.75e-3)" "unprognostic (1.89e-1)" 2.7 1.2 0.6 2.4 0.6 3.9 4.1 0.6 0.6 9.2 9.1 0.6 0.6 2.2 1.3 4.8 30.4 2.9 23.9 0.7 0.5 0.0 281.3 1.6 7.2 0.5 0.6 0.5 2.3 16.8 0.0 0.6 3.2 0.6 2.1 3.4 0.8 33.9 12.4 0.7 19.9 9.5 0.5 0.5 0.7 9.0 1.4 0.6 1.1 1.0 18.3 18.5 4.1 8.3 0.1 0.5 2.1 1.1 0.2 0.3 42.4 10.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.4 0.0 30.8 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 102.0 0.0 0.0 0.0 0.1 0.9 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.1 0.2 0.0 0.5 0.3 42.4 0.6 0.6 0.6 0.6 0.5 0.0 0.6 0.5 0.6 0.6 PFKM "PFK-1, PFKX, PPP1R122" ENSG00000152556 "Phosphofructokinase, muscle" P08237 12 48105139-48146404 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 284.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002117 Approved Approved "Endoplasmic reticulum" 1100000 "Endoplasmic reticulum" "HPA002117: AB_1855245" "unprognostic (4.60e-2)" "unprognostic (2.56e-3)" "unprognostic (2.56e-3)" "prognostic unfavourable (5.85e-6)" "unprognostic (4.97e-1)" "prognostic unfavourable (7.91e-5)" "unprognostic (5.93e-3)" "unprognostic (1.63e-1)" "unprognostic (2.80e-1)" "unprognostic (1.86e-1)" "unprognostic (2.29e-3)" "unprognostic (6.73e-2)" "prognostic favourable (2.28e-7)" "unprognostic (1.07e-1)" "unprognostic (1.53e-1)" "unprognostic (5.72e-2)" "unprognostic (1.30e-2)" 4.4 11.6 10.0 3.0 16.2 2.3 3.9 13.0 23.6 5.8 5.3 6.1 5.4 3.0 6.4 5.8 9.1 5.4 4.8 55.5 8.2 10.1 10.9 2.7 3.6 2.4 9.4 10.8 10.8 3.0 14.2 11.4 3.3 17.9 7.1 4.2 10.8 5.2 9.4 284.3 2.6 2.8 8.3 4.6 2.7 4.1 10.3 3.8 0.0 5.5 54.9 4.6 5.3 3.7 10.7 6.7 8.7 3.2 2.2 5.4 3.5 8.7 8.5 27.0 24.6 27.6 20.1 5.5 23.7 21.8 20.5 14.6 21.0 11.0 52.2 19.7 11.5 9.8 23.4 23.9 19.3 1.2 12.2 14.9 19.4 0.7 14.8 0.7 8.6 28.4 14.1 18.0 29.7 23.3 17.8 26.4 18.9 6.6 18.3 1.2 19.3 26.5 30.9 15.8 40.1 14.0 9.7 32.0 23.5 14.0 22.3 23.7 22.5 3.2 20.9 9.5 13.2 13.9 19.7 14.4 38.4 28.6 18.4 1.5 8.0 0.4 3.2 8.7 2.5 2.8 1.0 10.7 4.3 2.4 6.7 7.0 5.4 3.0 0.8 2.2 2.3 1.0 3.8 3.5 10.0 16.2 13.0 23.6 8.2 10.1 9.4 10.8 17.9 3.8 PFN3 ENSG00000196570 "Profilin 3" P60673 5 177400107-177400636 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 24.8" "Cell line enhanced" "Detected in some" "HaCaT: 1.7;HDLM-2: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 0.3" "unprognostic (1.03e-2)" "unprognostic (1.13e-1)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 PFN4 ENSG00000176732 "Profilin family member 4" Q8NHR9 2 24115371-24123477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 82.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.3" "Group enriched" "Detected in many" 5 "B-cells: 1.5;T-cells: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "unprognostic (4.20e-3)" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "unprognostic (1.24e-1)" "unprognostic (3.52e-2)" "unprognostic (1.37e-1)" "unprognostic (4.56e-4)" "unprognostic (1.25e-1)" "unprognostic (3.82e-2)" "unprognostic (2.21e-2)" "unprognostic (2.74e-2)" "unprognostic (8.97e-3)" "unprognostic (1.77e-5)" "unprognostic (2.55e-2)" "unprognostic (1.52e-1)" "unprognostic (1.16e-1)" "unprognostic (9.10e-2)" 0.3 0.4 0.4 0.2 0.6 0.0 0.7 0.4 0.9 0.4 0.3 0.6 1.6 0.0 0.4 1.3 0.5 0.9 0.3 0.5 0.5 0.4 0.5 0.2 0.3 0.1 0.3 0.8 0.9 1.0 0.5 0.7 0.2 0.4 0.4 0.2 0.6 0.7 0.5 0.4 0.2 0.2 0.4 0.3 0.2 0.2 82.3 0.4 0.1 1.1 0.1 0.4 0.2 0.4 1.5 0.4 0.0 0.4 0.4 3.3 0.1 3.9 1.9 0.7 3.6 4.4 5.1 1.5 1.5 0.6 1.5 1.1 1.2 4.4 1.8 0.8 0.0 0.7 0.0 0.7 0.8 2.0 0.0 0.8 0.6 0.2 3.0 0.8 0.2 5.0 2.9 0.7 1.8 1.2 0.5 2.5 2.8 3.1 0.9 0.9 0.7 3.0 0.8 1.8 0.0 2.3 0.7 1.5 2.8 1.6 0.5 1.4 4.8 0.6 1.1 1.9 1.5 0.4 1.2 3.4 2.7 1.7 3.2 0.0 2.8 0.0 0.4 0.0 0.4 0.2 0.6 0.4 0.0 0.4 0.4 1.5 0.0 3.3 0.0 0.4 0.0 0.3 0.0 0.1 0.4 0.6 0.4 0.9 0.5 0.4 0.3 0.8 0.4 0.4 PGA3 ENSG00000229859 "Pepsinogen 3, group I (pepsinogen A)" P0DJD8 11 61203307-61213098 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "stomach 1: 1048.8" "Group enriched" "Detected in some" 5 "HMC-1: 13.4;THP-1: 4.4" "Cancer enriched" "Detected in single" 498 "stomach cancer: 24.8" "Region enriched" "Detected in single" 15 "cerebral cortex: 4.8" "Cell type enhanced" "Detected in many" "intermediate monocyte: 6.7" "Lineage enriched" "Detected in many" 4 "monocytes: 6.7" "CAB026358, HPA046875" Enhanced "Secreted to digestive system" "CAB026358: , HPA046875: " "unprognostic (6.39e-2)" "unprognostic (1.11e-1)" 0.3 0.1 0.0 0.2 0.3 0.0 0.3 0.0 4.8 0.2 0.4 19.9 0.0 0.1 0.1 0.5 36.8 0.2 0.0 0.4 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.4 17.7 0.0 0.0 0.2 0.0 0.2 0.0 0.1 2.0 0.1 0.1 0.0 0.0 0.7 0.0 1.4 1048.8 0.1 0.0 0.0 0.1 3.8 0.0 0.1 0.0 0.3 0.3 1.1 6.7 0.5 1.5 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.1 0.0 1.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 13.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.3 0.4 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.5 4.3 0.2 1.5 6.7 0.9 0.2 0.5 1.4 0.3 0.3 0.2 1.4 1.1 0.5 1.7 0.2 0.1 3.0 0.0 0.3 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 PGA4 ENSG00000229183 "Pepsinogen 4, group I (pepsinogen A)" P0DJD7 11 61222216-61231927 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 120 "stomach 1: 924.0" "Group enriched" "Detected in some" 8 "BJ hTERT+: 17.2;THP-1: 8.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "classical monocyte: 7.6;intermediate monocyte: 5.9;non-classical monocyte: 2.1" "Lineage enriched" "Detected in single" 23 "monocytes: 7.6" HPA046875 Supported "Secreted to digestive system" "HPA046875: " "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 924.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 7.6 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.0 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 2.1 0.0 0.0 1.4 PGA5 ENSG00000256713 "Pepsinogen 5, group I (pepsinogen A)" P0DJD9 11 61241042-61251448 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "stomach 1: 296.9" "Cell line enriched" "Detected in some" 14 "BJ hTERT+: 25.1" "Cancer enriched" "Detected in some" 12 "stomach cancer: 15.0" "Group enriched" "Detected in some" 50 "classical monocyte: 3.4;intermediate monocyte: 7.7;non-classical monocyte: 3.7" "Lineage enriched" "Detected in single" 77 "monocytes: 7.7" HPA046875 Supported "Secreted to digestive system" "HPA046875: " "unprognostic (1.36e-3)" "unprognostic (2.98e-2)" "unprognostic (5.83e-3)" "unprognostic (2.11e-1)" "unprognostic (4.22e-1)" "unprognostic (4.36e-2)" "unprognostic (2.16e-2)" "unprognostic (1.05e-1)" "unprognostic (7.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 296.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.6 PGF "D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760" ENSG00000119630 "Placental growth factor" P49763 14 74941834-74955784 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 177.3" "Group enriched" "Detected in some" 6 "BEWO: 91.3;HUVEC TERT2: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041624 Approved Nucleoplasm,Mitochondria,Cytosol "Secreted to blood" 12380 Nucleoplasm "Mitochondria, Cytosol" "HPA041624: AB_10794522" "unprognostic (1.67e-2)" "unprognostic (4.62e-2)" "unprognostic (9.25e-3)" "unprognostic (1.34e-3)" "unprognostic (8.67e-3)" "unprognostic (2.41e-1)" "prognostic unfavourable (1.40e-4)" "unprognostic (7.26e-2)" "unprognostic (1.48e-1)" "unprognostic (4.45e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-3)" "prognostic unfavourable (1.33e-6)" "unprognostic (2.52e-3)" "unprognostic (1.20e-1)" "unprognostic (3.49e-2)" "unprognostic (1.14e-1)" 4.3 2.7 1.9 4.4 2.4 0.0 4.3 1.6 3.5 13.1 2.3 2.3 4.0 1.3 2.9 6.3 3.9 9.2 3.4 5.1 2.4 4.1 3.1 2.6 3.6 4.9 2.9 2.0 3.8 1.9 5.4 2.0 177.3 4.6 7.5 1.1 3.5 3.8 6.7 3.3 6.0 4.3 4.6 1.7 1.2 1.7 3.3 2.0 1.4 24.2 4.4 2.9 5.1 5.9 0.7 0.7 1.1 1.0 0.0 2.4 0.2 0.3 0.3 0.3 0.2 0.4 0.0 91.3 0.8 0.8 0.4 0.5 2.1 0.1 0.0 2.0 0.6 0.1 0.4 4.1 0.3 0.0 0.5 0.0 0.0 2.2 0.3 0.0 2.4 1.0 1.0 1.6 0.4 43.0 0.0 0.0 12.1 0.1 0.0 0.1 0.4 0.7 0.0 11.3 0.0 0.1 0.2 6.9 3.7 0.0 0.1 1.6 0.0 0.1 8.7 0.0 2.3 0.0 3.6 0.0 0.0 0.1 1.4 0.1 0.1 0.0 0.2 1.1 2.4 1.0 0.0 0.7 0.3 0.7 0.3 0.3 0.6 1.0 0.0 0.0 0.8 0.7 0.5 0.2 1.9 2.4 1.6 2.2 2.4 4.1 2.9 2.0 4.6 2.0 PGGHG "ATHL1, FLJ22635" ENSG00000142102 "Protein-glucosylgalactosylhydroxylysine glucosidase" Q32M88 11 289135-296107 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "pancreas: 148.7" "Cell line enhanced" "Detected in many" "U-266/70: 22.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA039383, HPA058829" Uncertain Enhanced Cytosol Cytosol "HPA039383: AB_10796225, HPA058829: " "unprognostic (1.40e-3)" "unprognostic (2.18e-1)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (1.36e-2)" "unprognostic (5.83e-2)" "unprognostic (7.95e-3)" "unprognostic (2.77e-2)" "unprognostic (2.16e-2)" "unprognostic (2.14e-2)" "unprognostic (2.71e-2)" "unprognostic (3.45e-1)" "unprognostic (1.92e-3)" "unprognostic (2.85e-3)" "unprognostic (1.09e-2)" "unprognostic (1.22e-1)" "prognostic favourable (5.12e-4)" 5.6 1.8 6.0 16.7 9.3 6.3 10.5 2.9 7.7 12.7 5.6 3.3 10.4 21.1 6.9 14.9 5.6 8.4 8.3 4.4 6.3 1.7 14.8 17.0 15.7 24.6 7.6 2.5 3.5 148.7 2.6 3.6 3.4 8.0 8.5 3.0 7.1 8.9 21.8 5.6 2.4 23.2 5.2 10.1 24.2 4.7 2.3 7.5 6.3 18.0 6.4 15.4 7.3 8.7 2.3 2.5 4.9 4.2 6.9 8.5 2.7 3.4 3.7 7.0 7.7 2.8 2.5 5.3 2.7 2.2 1.6 1.4 3.2 9.8 0.0 3.5 3.3 2.1 0.6 1.2 0.2 8.3 2.6 1.6 2.4 4.2 3.6 0.2 15.1 9.4 1.0 0.6 0.4 5.3 6.5 10.5 0.8 4.9 14.3 7.6 5.4 0.6 13.5 1.4 4.8 3.7 1.2 0.0 1.6 1.0 5.1 4.7 3.7 1.9 4.9 3.3 4.7 1.0 0.3 22.8 0.6 3.6 0.5 2.7 3.8 1.5 0.9 1.2 8.5 4.2 7.2 2.1 1.3 4.7 0.6 2.3 3.1 6.1 4.9 6.9 3.2 2.5 0.2 2.7 6.0 9.3 2.9 7.7 6.3 1.7 7.6 2.5 8.0 7.5 PGK2 "PGK-2, PGKPS" ENSG00000170950 "Phosphoglycerate kinase 2" P07205 6 49785651-49787307 "Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 55 "testis: 70.2" "Cell line enhanced" "Detected in some" "RT4: 1.0;U-2197: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045385, HPA073644, HPA073656" Supported "HPA045385: , HPA073644: , HPA073656: " "unprognostic (8.87e-3)" "unprognostic (5.02e-1)" "unprognostic (1.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 70.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.5 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PGLYRP2 "PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like" ENSG00000161031 "Peptidoglycan recognition protein 2" Q96PD5 19 15468645-15498956 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "liver: 95.8" "Group enriched" "Detected in some" 6 "MCF7: 10.6;T-47d: 10.7" "Cancer enriched" "Detected in some" 16 "liver cancer: 42.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "granulocytes: 3.6;monocytes: 7.1;T-cells: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB033468, HPA046311, HPA075237" Supported Approved "Cell Junctions" "Secreted to blood" 160000000000 "Cell Junctions" "CAB033468: AB_1127187, HPA046311: , HPA075237: " "unprognostic (7.39e-3)" "unprognostic (1.52e-2)" "unprognostic (5.22e-2)" "unprognostic (8.79e-2)" "unprognostic (3.97e-1)" "unprognostic (4.88e-4)" "unprognostic (5.93e-3)" "unprognostic (6.48e-2)" "unprognostic (1.99e-1)" "unprognostic (1.18e-2)" "unprognostic (3.15e-2)" "unprognostic (2.40e-1)" "unprognostic (6.66e-16)" "unprognostic (6.35e-3)" "unprognostic (2.80e-1)" "unprognostic (2.45e-2)" "unprognostic (2.81e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 3.6 7.1 0.6 3.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.6 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 3.6 0.7 0.3 2.6 2.4 2.5 0.3 1.6 1.3 0.2 0.0 3.6 3.7 2.5 0.6 7.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PGM1 ENSG00000079739 "Phosphoglucomutase 1" P36871 1 63593276-63660245 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Isomerase "Congenital disorder of glycosylation, Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 233.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004666, HPA024190, HPA024637, HPA046329" Enhanced Approved Cytosol 20000000 Cytosol "CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: " "unprognostic (2.50e-1)" "unprognostic (2.26e-3)" "unprognostic (1.74e-2)" "unprognostic (5.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.63e-1)" "unprognostic (1.28e-2)" "unprognostic (1.86e-3)" "unprognostic (2.42e-3)" "unprognostic (2.20e-1)" "prognostic unfavourable (8.74e-5)" "unprognostic (7.07e-2)" "unprognostic (1.55e-2)" "unprognostic (6.58e-3)" "unprognostic (1.37e-1)" "unprognostic (2.46e-1)" "unprognostic (9.74e-3)" 17.8 14.1 7.0 4.4 8.3 3.5 9.8 4.4 8.3 6.7 12.9 5.2 4.6 10.6 4.6 7.7 8.8 3.3 8.9 36.9 6.4 5.4 10.0 56.4 7.6 2.7 6.2 6.3 9.7 21.6 12.9 6.2 11.5 8.5 8.7 9.1 5.4 7.9 9.4 233.5 5.3 12.4 8.4 5.6 3.0 5.7 3.0 5.5 3.0 6.0 42.8 6.3 9.4 4.7 12.2 25.9 25.6 17.9 21.1 23.3 16.6 30.2 12.7 4.8 15.7 31.7 23.4 38.9 12.5 17.0 13.6 22.3 10.5 14.1 9.6 26.2 19.2 7.2 6.6 26.3 16.1 11.7 8.8 20.2 21.5 10.8 26.2 17.7 1.2 29.5 17.0 15.9 25.2 8.1 0.0 12.8 21.8 1.8 5.1 9.7 21.8 20.4 7.2 22.3 3.1 19.8 9.5 2.9 18.7 27.3 28.6 41.6 8.9 6.7 0.8 20.2 10.3 17.9 10.6 8.1 11.9 15.6 33.0 15.6 8.6 20.5 17.9 25.6 23.3 12.0 18.6 12.2 13.7 17.5 25.9 6.9 12.5 14.5 21.2 21.1 10.2 7.5 10.6 16.6 7.0 8.3 4.4 8.3 6.4 5.4 6.2 6.3 8.5 5.5 PGM2L1 "BM32A, FLJ32029" ENSG00000165434 "Phosphoglucomutase 2 like 1" Q6PCE3 11 74330318-74398473 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 48.6" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 13.1;LHCN-M2: 15.7;RH-30: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056995, HPA060948" Enhanced Approved Mitochondria 64000 Mitochondria "HPA056995: , HPA060948: " "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" "unprognostic (7.28e-3)" "unprognostic (8.91e-2)" "unprognostic (6.16e-2)" "unprognostic (1.55e-1)" "unprognostic (7.16e-6)" "unprognostic (1.43e-1)" "unprognostic (1.95e-1)" "unprognostic (5.97e-3)" "unprognostic (1.70e-2)" "unprognostic (2.98e-1)" "unprognostic (9.33e-3)" "unprognostic (3.71e-1)" "unprognostic (1.97e-1)" "unprognostic (3.04e-1)" "unprognostic (1.03e-2)" 3.0 4.0 30.6 4.9 19.8 4.0 3.2 6.3 48.6 6.1 4.5 1.3 1.0 2.3 6.1 1.9 2.1 4.7 4.8 1.6 30.1 15.1 2.5 2.1 2.7 4.0 9.7 20.4 1.7 4.4 1.4 4.5 2.1 11.7 3.8 5.1 2.9 3.2 2.5 7.1 1.7 2.6 5.6 2.6 2.5 3.4 2.3 0.3 10.0 4.1 1.3 4.0 5.2 2.6 2.4 1.7 2.5 0.6 3.0 7.5 1.1 2.0 2.9 11.5 2.1 3.5 1.5 0.3 2.7 2.1 2.4 2.6 1.0 5.4 0.2 6.8 1.8 1.0 2.3 0.5 2.3 0.8 1.2 1.6 1.6 0.9 0.4 1.9 2.6 0.8 0.5 5.4 1.0 13.1 2.1 1.4 15.7 0.3 7.4 1.6 2.3 2.6 2.3 15.0 0.1 6.2 0.4 0.5 2.3 4.4 1.0 2.0 0.2 0.3 10.9 5.3 5.0 2.1 2.8 1.9 2.8 0.2 0.5 2.6 1.2 2.5 0.6 1.1 2.1 0.6 2.8 2.4 3.5 2.3 0.5 1.8 3.3 1.9 0.7 3.0 0.3 1.7 7.5 1.1 30.6 19.8 6.3 24.4 30.1 15.1 9.7 20.4 11.7 0.3 PGPEP1L ENSG00000183571 "Pyroglutamyl-peptidase I-like" A6NFU8 15 98968230-99007795 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 34.7" "Cell line enhanced" "Detected in some" "HeLa: 1.9;U-2 OS: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "basophil: 2.0;neutrophil: 1.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.0" "Not detected" "Not detected" HPA041781 Uncertain "HPA041781: AB_10795642" "unprognostic (2.48e-1)" "unprognostic (2.82e-2)" "unprognostic (8.26e-2)" "unprognostic (2.43e-3)" "unprognostic (7.18e-2)" "unprognostic (3.99e-2)" "unprognostic (1.69e-1)" "unprognostic (5.44e-2)" "unprognostic (9.78e-2)" "unprognostic (1.58e-1)" "unprognostic (4.53e-3)" "unprognostic (1.86e-1)" "unprognostic (2.62e-1)" "unprognostic (2.00e-2)" "unprognostic (1.65e-1)" 0.7 0.1 0.5 0.2 1.4 0.1 0.6 0.2 0.5 0.4 0.4 0.4 0.0 0.2 0.2 0.4 0.8 0.2 0.5 3.6 0.6 0.4 0.4 0.0 0.2 0.3 0.4 0.2 0.2 0.5 0.0 0.1 0.3 0.4 0.6 0.0 1.6 0.9 0.5 34.7 0.1 0.2 0.3 0.3 0.1 0.2 5.0 0.2 0.1 0.1 8.6 0.5 0.2 0.3 0.0 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.7 0.0 0.2 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 1.9 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.9 1.4 0.1 0.0 0.2 0.4 1.3 0.4 0.4 0.1 1.2 0.0 0.9 0.3 0.4 0.5 1.4 0.2 0.8 0.0 0.7 0.0 4.4 0.2 0.1 0.8 0.2 0.7 0.0 0.5 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 1.4 0.2 0.5 0.6 0.4 0.4 0.2 0.4 0.2 PHACTR3 "C20orf101, PPP1R123" ENSG00000087495 "Phosphatase and actin regulator 3" Q96KR7 20 59577509-59847711 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 56.1" "Cell line enriched" "Detected in some" 4 "THP-1: 51.8" "Group enriched" "Detected in some" 5 "glioma: 3.8;lung cancer: 1.6;pancreatic cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 2.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051834, HPA054847" Enhanced Nucleoplasm Nucleoplasm "HPA051834: , HPA054847: " "unprognostic (7.14e-2)" "unprognostic (1.22e-1)" "unprognostic (3.72e-2)" "unprognostic (1.43e-7)" "unprognostic (1.99e-1)" "unprognostic (2.87e-2)" "unprognostic (5.83e-3)" "unprognostic (8.92e-2)" "unprognostic (5.02e-2)" "unprognostic (2.30e-2)" "unprognostic (7.71e-2)" "unprognostic (7.22e-2)" "unprognostic (1.74e-2)" "unprognostic (1.66e-1)" "unprognostic (5.43e-2)" "unprognostic (2.53e-3)" "unprognostic (1.32e-1)" 1.6 2.7 31.3 1.8 29.2 2.0 1.4 15.9 56.1 1.5 1.9 20.0 0.0 2.1 1.3 2.0 2.8 1.4 3.3 3.0 27.3 14.6 2.0 2.1 5.3 1.4 28.3 19.4 6.9 1.5 1.4 0.5 1.9 21.3 1.4 1.8 0.0 1.3 1.3 1.4 2.6 2.1 1.5 25.4 8.0 1.8 1.8 29.8 0.0 1.4 0.0 1.4 1.6 0.0 0.0 2.5 0.1 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.8 0.0 0.0 0.0 10.1 0.0 0.7 2.7 0.0 0.0 0.0 0.0 51.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 31.3 29.2 15.9 34.1 27.3 14.6 28.3 19.4 21.3 29.8 PHF7 "HSPC226, NYD-SP6" ENSG00000010318 "PHD finger protein 7" Q9BWX1 3 52410657-52423641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 260.7" "Cell line enhanced" "Detected in many" "Karpas-707: 14.0;U-266/70: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036283, HPA070305" Enhanced Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA036283: AB_10795026, HPA070305: " "prognostic favourable (7.38e-5)" "unprognostic (4.57e-2)" "unprognostic (6.97e-3)" "prognostic favourable (9.44e-5)" "unprognostic (3.63e-1)" "unprognostic (2.61e-3)" "unprognostic (7.44e-2)" "unprognostic (5.78e-2)" "unprognostic (2.98e-1)" "unprognostic (6.38e-3)" "unprognostic (1.55e-3)" "unprognostic (1.12e-1)" "prognostic favourable (1.05e-6)" "unprognostic (2.07e-2)" "unprognostic (1.82e-1)" "unprognostic (2.34e-2)" "unprognostic (6.79e-2)" 0.9 0.6 0.3 0.6 1.5 0.8 0.9 1.0 1.4 0.5 1.0 1.2 0.4 0.7 0.5 2.0 0.6 0.6 0.4 1.9 0.6 0.4 0.6 0.9 0.6 0.5 1.1 0.7 0.4 0.9 0.6 0.5 0.5 0.7 0.7 1.0 1.2 1.0 0.7 1.5 1.0 1.0 0.5 0.9 0.7 0.6 260.7 0.4 1.7 0.5 0.6 0.6 0.9 0.5 6.7 2.6 3.9 2.5 2.2 4.9 1.7 2.0 0.6 1.5 6.4 1.1 1.6 2.7 2.0 2.1 1.6 2.0 1.0 0.8 3.3 0.2 1.5 1.1 1.1 3.1 2.8 4.1 1.5 3.8 0.4 2.3 1.1 4.1 7.2 0.9 3.5 1.5 3.3 2.3 2.3 14.0 1.2 0.9 4.9 1.6 0.7 4.3 2.2 1.4 4.0 1.7 0.9 1.1 1.2 1.8 0.1 1.6 0.9 2.1 1.7 2.7 1.9 2.9 4.1 16.6 7.9 2.0 1.1 9.6 1.6 0.7 2.2 3.9 2.1 2.5 2.5 6.7 2.5 3.7 1.1 3.8 1.7 3.5 0.5 2.2 1.4 2.6 4.9 1.7 0.3 1.5 1.0 1.4 0.6 0.4 1.1 0.7 0.7 0.4 PHLDA1 "DT1P1B11, PHRIP, TDAG51" ENSG00000139289 "Pleckstrin homology like domain family A member 1" Q8WV24 12 76025447-76033932 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 142.4" "Cell line enhanced" "Detected in many" "hTERT-HME1: 43.3;RPTEC TERT1: 54.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.4;MAIT T-cell: 3.9;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.5;non-classical monocyte: 2.5;T-reg: 4.1" "Group enriched" "Detected in many" 7 "monocytes: 2.5;T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016160, HPA019000, HPA063520" Enhanced Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: " "unprognostic (9.09e-2)" "unprognostic (2.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.51e-3)" "unprognostic (2.33e-1)" "unprognostic (2.60e-3)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (2.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.21e-3)" "unprognostic (5.03e-2)" "unprognostic (1.21e-1)" "unprognostic (3.34e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-1)" "unprognostic (4.55e-3)" 13.2 15.9 9.4 8.4 12.1 9.0 13.5 6.4 15.7 11.5 4.5 11.1 4.8 3.4 7.1 3.1 33.3 5.1 20.0 9.6 8.2 7.9 13.8 33.2 14.2 3.0 8.4 5.6 10.8 8.8 2.6 6.0 7.1 10.0 4.8 5.5 24.9 142.4 6.5 3.3 6.3 7.0 7.6 9.7 14.6 10.8 2.3 10.1 2.5 18.0 13.2 19.9 17.0 17.8 0.3 0.1 0.4 2.5 0.3 4.1 0.6 13.5 16.3 12.8 7.0 6.0 12.4 0.9 11.5 31.1 5.2 7.3 9.0 16.6 0.0 3.5 4.8 7.0 0.3 19.3 11.3 2.0 0.2 0.3 0.8 15.2 8.7 0.3 3.5 3.8 14.2 21.8 43.3 12.5 1.1 0.4 26.8 1.7 0.0 1.7 4.6 25.2 0.0 3.3 0.4 54.9 30.8 0.9 2.4 2.0 0.1 37.4 8.2 0.1 11.6 17.9 1.7 20.8 11.3 0.2 0.0 0.0 30.2 0.2 22.3 0.3 0.1 0.2 2.4 0.2 3.9 0.3 2.5 2.5 0.0 0.2 0.5 0.6 0.4 0.3 2.5 0.1 4.1 0.6 9.4 12.1 6.4 7.7 8.2 7.9 8.4 5.6 10.0 10.1 PHLDA2 "BWR1C, HLDA2, IPL, TSSC3" ENSG00000181649 "Pleckstrin homology like domain family A member 2" Q53GA4 11 2928273-2929455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 163.9" "Cell line enhanced" "Detected in many" "HDLM-2: 82.0;PC-3: 66.6;SK-MEL-30: 52.3;WM-115: 71.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 8.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003994 Uncertain Nucleoli Nucleoli "HPA003994: AB_1855311" "unprognostic (1.90e-1)" "unprognostic (3.13e-2)" "unprognostic (9.93e-3)" "unprognostic (6.16e-2)" "unprognostic (4.28e-2)" "unprognostic (8.01e-3)" "prognostic unfavourable (4.22e-5)" "unprognostic (1.24e-3)" "unprognostic (3.84e-2)" "unprognostic (8.35e-2)" "unprognostic (1.67e-2)" "unprognostic (6.56e-2)" "prognostic unfavourable (2.63e-6)" "unprognostic (2.83e-1)" "unprognostic (6.13e-2)" "unprognostic (2.16e-2)" "unprognostic (1.59e-1)" 3.8 1.1 0.5 3.6 0.7 1.4 7.7 0.3 1.4 5.6 7.9 0.5 1.7 5.9 2.3 5.5 20.3 2.4 15.6 1.5 0.5 1.9 4.8 3.7 3.9 0.8 1.3 0.5 1.8 4.6 1.2 1.2 163.9 1.9 8.0 1.4 0.8 5.3 2.0 0.8 9.6 7.4 1.9 1.0 1.8 11.1 1.0 0.5 0.2 3.5 24.7 15.1 6.1 8.7 1.5 8.2 0.0 4.9 0.0 3.9 1.5 9.2 8.2 0.3 0.1 0.1 1.7 9.0 20.5 5.2 2.9 2.2 3.3 18.3 0.0 10.0 2.2 11.4 0.0 8.2 0.3 82.0 2.7 0.0 4.4 2.1 6.7 0.0 4.9 2.8 3.7 2.5 2.0 2.4 1.7 0.1 1.2 29.2 0.0 1.4 3.3 66.6 0.0 0.0 5.6 5.9 2.9 0.9 0.0 6.6 4.5 52.3 1.3 0.8 13.6 6.6 3.6 9.2 6.9 0.0 0.1 0.0 5.4 1.4 71.9 0.0 4.9 0.0 0.7 3.0 0.8 1.5 3.9 0.9 8.2 0.0 1.0 0.2 0.0 0.0 0.6 0.0 1.4 1.5 0.5 0.7 0.3 1.4 0.5 1.9 1.3 0.5 1.9 0.5 PIANP "C12orf53, DKFZp547D2210, PANP" ENSG00000139200 "PILR alpha associated neural protein" Q8IYJ0 12 6693792-6700800 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.0;HAP1: 8.0;NTERA-2: 16.9;SH-SY5Y: 15.9;U-2 OS: 8.9" "Cancer enhanced" "Detected in many" "glioma: 14.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 7 "T-cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010631 Enhanced Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA010631: AB_10603680" "unprognostic (1.82e-1)" "unprognostic (9.21e-3)" "unprognostic (1.62e-2)" "unprognostic (7.65e-2)" "unprognostic (1.34e-1)" "unprognostic (3.03e-2)" "unprognostic (6.58e-2)" "unprognostic (1.07e-1)" "unprognostic (1.70e-1)" "unprognostic (6.41e-3)" "unprognostic (1.92e-2)" "unprognostic (3.89e-1)" "unprognostic (3.30e-3)" "unprognostic (3.26e-3)" "unprognostic (1.16e-1)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" 1.5 8.3 28.0 2.2 55.7 1.2 1.5 27.4 52.8 7.2 2.7 2.6 0.5 1.9 11.6 4.1 1.8 2.2 3.3 1.5 19.5 26.2 1.5 1.1 1.5 2.4 11.0 20.9 1.8 1.7 1.2 4.0 1.5 9.0 3.4 2.0 1.7 2.2 8.7 1.3 1.7 2.2 8.1 4.6 1.6 2.1 4.4 8.3 0.0 1.4 0.0 1.7 1.8 2.5 0.3 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.4 6.0 1.2 0.2 0.3 0.2 1.6 8.0 4.2 3.8 0.1 0.2 0.1 0.0 2.8 0.2 8.0 0.2 2.0 0.2 1.0 0.3 0.2 0.0 0.2 0.3 0.3 1.0 0.0 1.7 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 16.9 0.0 1.1 0.0 0.1 0.1 0.1 2.2 15.9 0.0 0.1 0.0 0.0 0.0 0.0 4.3 8.9 4.5 1.1 0.2 0.0 0.3 5.9 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.7 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.0 55.7 27.4 27.8 19.5 26.2 11.0 20.9 9.0 8.3 PILRA FDF03 ENSG00000085514 "Paired immunoglobin like type 2 receptor alpha" Q9UKJ1 7 100367530-100400099 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "blood: 138.4" "Cell line enhanced" "Detected in some" "ASC diff: 20.5;HMC-1: 18.4;NB-4: 13.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 138.4" "Group enriched" "Detected in many" 5 "granulocytes: 138.4;monocytes: 87.3" HPA056132 Approved "Secreted to blood" "HPA056132: " "unprognostic (5.53e-2)" "prognostic favourable (2.99e-4)" "unprognostic (7.61e-2)" "unprognostic (2.88e-1)" "unprognostic (2.20e-1)" "unprognostic (5.88e-2)" "unprognostic (1.44e-1)" "unprognostic (2.85e-1)" "unprognostic (3.01e-3)" "unprognostic (9.95e-2)" "unprognostic (8.57e-2)" "unprognostic (4.56e-2)" "prognostic unfavourable (1.61e-4)" "unprognostic (3.47e-2)" "unprognostic (3.17e-2)" "unprognostic (1.99e-1)" "unprognostic (4.80e-2)" 18.6 5.4 7.2 32.3 7.2 19.4 8.2 15.6 6.2 6.1 4.5 10.6 2.3 3.8 4.8 10.0 2.6 7.5 8.4 6.5 7.7 4.4 8.5 8.0 31.9 30.1 11.0 2.6 5.7 5.1 4.3 9.2 13.2 11.9 6.6 4.9 7.1 3.1 4.1 2.5 2.6 3.9 8.6 18.4 29.5 3.1 6.4 10.7 3.3 5.3 1.1 3.3 9.8 5.4 0.1 24.0 138.4 87.3 0.5 0.2 22.9 0.2 0.2 0.4 0.5 20.5 1.4 0.1 0.1 1.0 0.1 0.3 0.0 0.3 0.4 1.2 0.2 0.6 0.1 0.1 0.0 0.9 0.7 0.4 0.8 0.1 0.2 0.8 18.4 1.4 0.3 0.1 0.4 0.2 0.2 1.2 0.1 0.6 1.4 13.8 0.4 0.2 0.4 0.0 0.3 0.8 0.4 0.5 0.2 0.0 5.1 0.4 0.1 4.2 0.4 0.9 0.9 0.5 0.2 1.8 1.3 0.4 0.2 1.6 0.3 21.3 48.4 1.4 0.2 70.2 0.1 0.1 0.0 0.0 24.0 0.0 0.0 0.1 138.4 0.5 87.3 0.4 0.1 22.9 7.2 7.2 15.6 6.2 7.7 4.4 11.0 2.6 11.9 10.7 PIMREG "CATS, FAM64A, FLJ10156, FLJ10491, RCS1" ENSG00000129195 "PICALM interacting mitotic regulator" Q9BSJ6 17 6444415-6451469 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 27.3" "Cell line enhanced" "Detected in many" "AF22: 49.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA043783, HPA049934" Uncertain Enhanced Nucleoplasm Nucleoplasm "HPA043783: , HPA049934: " "unprognostic (5.32e-3)" "unprognostic (1.14e-2)" "unprognostic (2.33e-1)" "unprognostic (4.37e-3)" "unprognostic (1.46e-1)" "unprognostic (1.24e-2)" "unprognostic (6.55e-3)" "unprognostic (1.23e-3)" "unprognostic (1.80e-1)" "unprognostic (5.88e-2)" "unprognostic (1.47e-3)" "unprognostic (1.50e-2)" "unprognostic (0.00e+0)" "unprognostic (8.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 1.9 4.5 1.2 1.6 1.1 3.1 2.2 1.0 0.8 1.3 4.7 0.6 0.4 4.3 1.6 1.7 6.0 0.3 2.5 1.6 0.5 0.5 0.8 0.9 2.1 1.7 0.6 0.4 1.6 0.4 0.0 1.0 0.9 1.2 0.8 6.2 0.4 1.3 0.4 0.4 3.7 4.5 2.7 1.0 9.5 1.8 1.0 0.4 27.3 0.4 3.9 3.6 2.3 2.0 0.4 0.0 0.8 0.4 3.3 1.5 1.2 12.4 16.8 49.8 22.3 0.4 1.4 3.9 14.6 9.0 24.0 16.2 9.9 5.4 0.0 5.8 11.8 9.1 25.1 6.5 12.9 19.2 10.0 0.0 10.0 12.0 0.0 0.5 15.2 0.7 0.4 9.9 3.9 7.5 2.9 7.1 15.0 8.9 2.7 0.1 21.8 11.0 22.3 20.0 8.7 3.9 1.9 11.3 15.9 12.6 13.2 12.3 6.1 1.2 3.5 18.8 15.3 11.0 23.8 2.5 9.0 0.0 7.3 6.0 28.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.3 0.0 0.4 0.2 0.7 0.8 3.3 0.4 0.0 1.3 1.2 1.2 1.1 1.0 0.7 0.5 0.5 0.6 0.4 1.2 0.4 PITPNM2 "NIR3, RDGB2, RDGBA2" ENSG00000090975 "Phosphatidylinositol transfer protein membrane associated 2" Q9BZ72 12 122983480-123150015 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 11 "lymphoid tissue: 169.5" "Cell line enhanced" "Detected in many" "HEL: 16.5;MOLT-4: 30.5;WM-115: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.7" "Group enriched" "Detected in many" 4 "NK-cells: 4.7;T-cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003414, HPA003978" Approved Supported Vesicles Vesicles "HPA003414: AB_1855410, HPA003978: AB_1855411" "unprognostic (2.43e-1)" "unprognostic (9.29e-2)" "unprognostic (2.00e-1)" "unprognostic (5.39e-2)" "unprognostic (2.14e-1)" "unprognostic (6.76e-2)" "unprognostic (2.26e-2)" "unprognostic (1.08e-1)" "unprognostic (2.55e-1)" "unprognostic (6.44e-2)" "unprognostic (1.03e-1)" "unprognostic (9.28e-2)" "unprognostic (1.50e-3)" "unprognostic (7.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.19e-2)" "unprognostic (9.99e-2)" 3.4 5.9 3.3 3.2 7.9 3.5 3.1 9.3 8.0 3.9 3.5 2.4 3.2 3.5 3.6 5.2 3.7 2.5 2.2 4.6 2.8 2.2 3.7 4.3 5.1 6.1 2.4 2.6 14.0 2.5 5.3 4.2 3.0 2.3 2.7 1.6 3.7 2.7 3.1 3.3 3.0 3.6 4.5 2.5 3.3 2.7 14.8 2.2 169.5 2.3 2.2 4.3 4.7 2.7 0.8 0.0 0.1 0.1 4.7 2.3 1.6 2.5 5.0 1.6 2.3 1.2 2.2 9.8 0.4 0.6 1.3 0.7 2.2 2.1 0.0 2.2 0.8 7.3 1.3 1.2 0.5 0.1 1.6 16.5 2.9 5.9 0.8 0.6 3.5 1.1 2.2 1.7 1.4 2.6 3.7 0.2 1.6 1.6 30.5 3.4 1.9 2.2 8.8 0.1 6.3 2.4 2.7 1.5 0.5 3.6 3.0 2.4 0.6 1.8 7.6 1.9 2.2 3.1 2.8 0.5 0.5 11.7 4.8 1.2 14.7 0.0 0.0 0.1 2.3 0.0 0.2 0.4 0.6 1.7 0.0 0.8 1.5 1.4 0.0 4.7 0.1 0.0 1.1 1.6 3.3 7.9 9.3 8.0 2.8 2.2 2.4 2.6 2.3 2.2 PIWIL1 "CT80.1, HIWI, PIWI" ENSG00000125207 "Piwi like RNA-mediated gene silencing 1" Q96J94 12 130337887-130372637 "Disease related genes, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, Endonuclease, Hydrolase, Nuclease, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 77 "testis: 85.5" "Group enriched" "Detected in some" 4 "CAPAN-2: 7.3;PC-3: 2.7" "Cancer enhanced" "Detected in some" "testis cancer: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB012217, HPA018798" Enhanced "CAB012217: AB_470241, HPA018798: " "unprognostic (1.00e-2)" "unprognostic (1.46e-2)" "unprognostic (8.28e-2)" "unprognostic (2.22e-1)" "unprognostic (1.48e-1)" "unprognostic (3.01e-2)" "unprognostic (2.14e-1)" "unprognostic (8.81e-2)" "unprognostic (3.95e-1)" "unprognostic (1.86e-1)" "unprognostic (9.36e-2)" "unprognostic (9.85e-6)" "unprognostic (3.83e-2)" "unprognostic (2.70e-1)" "unprognostic (2.43e-2)" "unprognostic (3.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.1 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 85.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 PIWIL2 "CT80, FLJ10351, HILI, Mili" ENSG00000197181 "Piwi like RNA-mediated gene silencing 2" Q8TC59 8 22275297-22357563 "Predicted intracellular proteins" "Biological rhythms, Differentiation, Meiosis, Oogenesis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 37.3" "Cell line enriched" "Detected in some" 25 "NTERA-2: 29.0" "Cancer enriched" "Detected in some" 6 "testis cancer: 6.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.91e-2)" "unprognostic (1.77e-2)" "unprognostic (6.51e-2)" "unprognostic (2.18e-1)" "unprognostic (8.29e-2)" "unprognostic (3.58e-3)" "unprognostic (2.60e-1)" "unprognostic (2.37e-1)" "unprognostic (7.59e-2)" "unprognostic (6.68e-2)" "unprognostic (1.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.16e-7)" "unprognostic (1.27e-1)" "unprognostic (7.83e-2)" "unprognostic (1.05e-3)" "unprognostic (2.61e-2)" 0.9 0.2 0.3 0.6 1.3 0.1 5.7 1.5 1.0 1.1 0.7 0.5 0.2 5.7 0.8 0.5 0.3 0.9 0.2 0.9 0.5 1.0 0.2 1.0 0.2 1.0 0.6 0.7 1.9 2.2 0.0 1.4 0.5 0.9 1.6 0.9 1.2 0.8 0.5 2.2 0.5 1.7 0.6 0.8 0.2 1.4 37.3 0.2 0.4 1.3 1.6 0.8 1.0 0.7 0.3 0.0 0.4 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.3 1.3 1.5 1.0 0.5 1.0 0.6 0.7 0.9 0.2 PIWIL3 HIWI3 ENSG00000184571 "Piwi like RNA-mediated gene silencing 3" Q7Z3Z3 22 24719034-24774720 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 4.7" "Cell line enhanced" "Detected in some" "BEWO: 2.7;HeLa: 1.5;RPMI-8226: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA061955 Uncertain "HPA061955: " "unprognostic (9.05e-2)" "unprognostic (2.20e-1)" "unprognostic (3.12e-4)" "unprognostic (2.73e-1)" "unprognostic (7.33e-2)" "unprognostic (1.72e-1)" 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PJVK DFNB59 ENSG00000204311 Pejvakin Q0ZLH3 2 178451346-178461409 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 6.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 6.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042621 Supported Mitochondria Mitochondria "HPA042621: AB_10797503" "unprognostic (4.01e-2)" "unprognostic (4.28e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-1)" "unprognostic (7.21e-3)" "unprognostic (9.36e-2)" "unprognostic (1.22e-1)" "unprognostic (1.14e-1)" "unprognostic (8.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.90e-3)" "unprognostic (9.13e-2)" "prognostic unfavourable (8.92e-4)" "unprognostic (1.22e-1)" "unprognostic (1.47e-1)" "unprognostic (2.41e-2)" "unprognostic (8.06e-3)" 2.2 1.4 2.5 1.0 3.5 0.7 4.4 1.3 3.7 2.1 1.5 1.2 3.5 0.7 3.5 7.2 2.2 2.6 2.6 1.0 2.7 2.2 2.1 2.2 1.0 1.3 2.8 4.4 7.0 1.0 1.4 3.9 1.0 2.0 2.3 0.9 2.4 2.1 2.7 2.7 3.5 1.3 1.7 2.7 1.0 0.9 35.2 1.3 1.0 2.3 1.7 1.2 1.6 1.2 1.5 6.5 0.6 0.3 0.4 1.3 0.1 0.4 3.1 4.0 3.2 5.4 5.9 2.1 2.5 2.5 2.3 3.5 1.2 5.2 3.6 2.6 1.5 1.5 2.9 1.6 1.5 1.1 1.1 1.1 4.3 0.7 5.2 0.9 0.3 5.5 3.9 2.6 5.6 2.6 0.6 2.2 2.6 0.5 3.4 2.2 4.8 1.3 4.4 3.0 2.1 3.6 1.6 2.8 2.4 1.2 0.6 1.0 1.2 1.0 1.7 2.6 1.0 0.8 0.3 7.3 4.5 1.1 1.2 2.0 1.0 0.0 0.3 0.0 0.3 0.2 0.4 0.8 0.4 0.2 0.1 1.5 1.3 0.7 0.6 0.4 0.0 6.5 0.0 0.1 2.5 3.5 1.3 3.7 2.7 2.2 2.8 4.4 2.0 1.3 PKDREJ ENSG00000130943 "Polycystin family receptor for egg jelly" Q9NTG1 22 46255663-46263355 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 13.8" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA034587 Enhanced "HPA034587: AB_10670570" "unprognostic (9.48e-3)" "unprognostic (1.09e-1)" "unprognostic (3.51e-2)" "unprognostic (1.25e-1)" "unprognostic (6.11e-2)" "unprognostic (5.06e-4)" "unprognostic (1.13e-1)" "unprognostic (2.99e-1)" "unprognostic (8.48e-2)" "unprognostic (2.59e-1)" "unprognostic (6.17e-3)" "unprognostic (3.41e-1)" "unprognostic (3.36e-2)" "unprognostic (1.18e-1)" "unprognostic (1.49e-1)" "unprognostic (1.34e-1)" "unprognostic (1.37e-1)" 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.2 0.2 0.5 0.3 0.2 0.3 0.3 0.4 2.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.4 0.0 0.3 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.3 1.5 0.5 0.2 0.2 0.2 0.2 13.8 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.8 0.1 0.5 1.6 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.2 0.1 0.8 0.1 0.0 0.2 0.0 0.0 0.0 2.1 0.9 0.2 0.0 0.4 0.1 0.4 0.8 0.1 0.0 0.0 0.0 0.0 1.5 0.4 0.0 1.2 0.4 0.6 0.3 0.0 0.3 1.4 0.0 0.0 0.3 0.9 1.8 0.6 0.3 1.0 0.0 0.4 0.2 0.2 1.9 0.1 0.3 0.8 0.1 0.1 0.1 1.8 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.7 0.2 PKHD1L1 ENSG00000205038 "PKHD1 like 1" Q86WI1 8 109362477-109530330 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "thyroid gland: 91.7" "Cell line enhanced" "Detected in some" "HHSteC: 4.1;HUVEC TERT2: 2.3;TIME: 4.6;U-266/70: 4.3" "Group enriched" "Detected in some" 18 "endometrial cancer: 5.2;ovarian cancer: 1.9;thyroid cancer: 3.8" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Group enriched" "Detected in some" 9 "memory B-cell: 1.8;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 10 "B-cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA044458 Uncertain 5100000 "HPA044458: " "unprognostic (9.07e-3)" "unprognostic (3.35e-2)" "unprognostic (1.37e-2)" "prognostic favourable (7.61e-4)" "unprognostic (5.57e-2)" "unprognostic (1.30e-2)" "unprognostic (2.91e-2)" "unprognostic (3.45e-2)" "unprognostic (3.31e-2)" "unprognostic (1.98e-1)" "unprognostic (9.65e-3)" "unprognostic (1.92e-1)" "unprognostic (7.76e-6)" "unprognostic (4.56e-2)" "unprognostic (1.52e-1)" "unprognostic (1.90e-3)" "unprognostic (2.73e-2)" 12.4 1.5 0.1 4.2 0.1 0.4 2.6 0.0 0.2 13.8 5.7 0.1 2.1 1.1 3.5 8.9 2.5 11.5 3.5 5.2 0.1 0.1 0.8 0.8 16.9 22.5 0.4 0.0 3.5 0.7 0.2 0.4 0.2 1.1 1.4 1.6 4.2 1.7 1.5 2.0 0.9 2.0 3.2 0.2 0.3 0.8 1.6 0.0 0.0 91.7 2.9 1.1 2.1 3.2 1.8 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 4.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 1.1 0.0 PKIA PRKACN1 ENSG00000171033 "CAMP-dependent protein kinase inhibitor alpha" P61925 8 78516139-78605267 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 258.0" "Cell line enhanced" "Detected in many" "HDLM-2: 22.3;HUVEC TERT2: 37.5;RT4: 35.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 16.5" "Lineage enriched" "Detected in many" 9 "T-cells: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042791 Uncertain "HPA042791: AB_10795761" "unprognostic (3.83e-3)" "unprognostic (1.89e-1)" "unprognostic (1.55e-2)" "unprognostic (5.59e-6)" "unprognostic (8.75e-2)" "unprognostic (1.56e-1)" "unprognostic (5.10e-3)" "unprognostic (1.65e-3)" "unprognostic (3.25e-2)" "unprognostic (2.58e-1)" "unprognostic (4.12e-1)" "unprognostic (1.00e-1)" "unprognostic (2.93e-1)" "prognostic unfavourable (5.41e-4)" "unprognostic (3.14e-1)" "unprognostic (1.38e-1)" "unprognostic (7.52e-3)" 1.6 3.5 17.8 2.4 28.9 1.7 2.1 17.2 18.2 1.6 1.7 4.6 0.0 1.4 1.8 3.1 6.4 2.5 3.1 46.4 13.7 14.9 2.3 1.1 3.2 2.8 8.9 15.8 2.6 1.4 21.2 3.7 1.5 6.7 6.1 1.8 0.7 2.2 2.5 258.0 3.3 1.5 1.7 6.0 2.0 1.5 1.3 6.7 6.2 9.7 46.1 3.7 3.5 1.2 1.9 0.1 0.3 0.1 1.3 16.5 2.1 0.2 0.1 12.5 0.0 6.9 1.8 0.0 11.5 2.2 1.2 2.6 0.0 1.9 5.2 0.0 1.7 0.1 4.0 3.6 8.2 22.3 8.9 6.4 1.4 0.0 0.4 0.0 3.8 2.8 0.5 0.0 3.5 37.5 0.0 5.7 18.6 1.9 9.7 0.0 2.9 12.8 0.0 10.7 0.0 6.8 35.7 6.1 11.9 1.5 9.6 0.0 0.0 0.0 14.7 2.9 2.4 0.6 6.8 2.3 2.3 1.7 13.6 0.0 3.5 0.0 0.0 0.0 0.4 0.0 0.3 1.9 7.7 1.5 0.0 1.8 6.8 3.9 0.3 1.3 0.1 0.1 16.5 2.1 17.8 28.9 17.2 15.5 13.7 14.9 8.9 15.8 6.7 6.7 PKM "OIP3, PK3, PKM2, THBP1" ENSG00000067225 "Pyruvate kinase M1/2" P14618 15 72199029-72231822 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 541.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019421, HPA029501" Uncertain Enhanced Cytosol 540000000 Cytosol "CAB019421: AB_2252325, HPA029501: AB_10602118" "unprognostic (8.73e-3)" "unprognostic (4.63e-3)" "unprognostic (1.68e-2)" "unprognostic (3.09e-1)" "unprognostic (6.51e-2)" "prognostic unfavourable (1.30e-4)" "prognostic unfavourable (2.74e-6)" "prognostic unfavourable (2.85e-4)" "unprognostic (9.51e-2)" "unprognostic (1.17e-2)" "prognostic unfavourable (5.17e-5)" "unprognostic (3.16e-1)" "unprognostic (3.22e-1)" "unprognostic (7.85e-2)" "unprognostic (3.17e-2)" "unprognostic (1.44e-1)" "unprognostic (1.25e-2)" 23.2 76.8 53.8 49.8 70.4 57.5 41.6 56.6 85.9 65.7 31.2 32.1 31.5 26.4 24.7 41.8 76.4 37.9 32.9 94.8 50.1 57.1 60.9 6.1 33.3 39.4 62.5 63.6 26.2 15.6 33.3 28.3 27.1 80.5 34.8 31.9 54.4 47.1 47.5 541.2 51.8 25.1 44.7 34.9 30.7 26.7 29.0 29.4 23.5 23.8 114.4 60.6 53.1 40.9 25.1 79.6 14.9 90.6 11.6 37.4 114.9 81.5 209.8 42.3 50.0 50.9 57.2 35.0 88.5 206.7 142.1 143.9 59.0 100.5 62.1 89.6 165.6 118.9 133.7 180.0 111.4 109.0 63.2 38.0 105.5 48.8 35.5 49.3 82.0 51.9 83.9 109.5 45.0 83.6 9.5 49.8 224.1 50.7 18.4 21.2 52.3 80.1 54.7 135.4 118.3 188.7 105.0 44.0 48.0 115.4 71.2 90.5 49.9 35.9 65.1 161.9 88.6 158.2 160.5 64.0 90.4 54.7 199.3 81.6 158.6 12.6 90.6 14.9 23.5 52.6 22.8 25.1 31.3 23.2 79.6 16.1 27.3 20.2 11.8 11.6 40.2 16.2 37.4 114.9 53.8 70.4 56.6 85.9 50.1 57.1 62.5 63.6 80.5 29.4 PKP2 ENSG00000057294 "Plakophilin 2" Q99959 12 32790745-32896840 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 134.7" "Cell line enhanced" "Detected in many" "CACO-2: 60.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 10.4" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 4 "hippocampal formation: 22.1" "Low region specificity" "Detected in all" "HPA014314, CAB037336, HPA056908" Enhanced Enhanced "Nucleoplasm,Cell Junctions" "Cell Junctions" Nucleoplasm "CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272" "unprognostic (1.89e-1)" "unprognostic (1.70e-2)" "prognostic favourable (8.55e-4)" "unprognostic (2.55e-1)" "unprognostic (1.13e-1)" "unprognostic (3.88e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (6.79e-4)" "unprognostic (2.90e-1)" "unprognostic (1.83e-2)" "unprognostic (5.94e-3)" "unprognostic (2.22e-1)" "unprognostic (4.94e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-1)" "unprognostic (2.41e-2)" "unprognostic (3.76e-2)" 3.1 0.7 1.4 7.9 5.2 1.1 3.3 2.2 1.8 6.1 14.2 1.4 6.9 6.5 1.2 2.0 3.3 21.6 4.4 134.7 3.9 0.9 3.6 13.6 1.1 3.4 0.7 2.0 9.5 5.4 9.6 14.7 24.1 3.8 3.5 13.3 12.6 24.6 5.0 3.4 1.9 13.3 1.3 1.3 2.4 4.8 3.4 0.4 2.7 0.6 2.3 4.3 2.0 2.1 0.6 3.9 10.4 2.1 1.5 1.0 0.6 16.9 3.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 60.7 15.3 0.0 10.4 0.0 15.1 2.1 13.4 0.0 0.0 4.8 0.1 0.7 15.9 9.5 0.9 0.2 0.0 12.7 0.0 14.7 0.5 3.0 4.8 1.4 4.4 0.0 0.1 9.3 2.9 0.0 7.4 5.0 4.5 8.0 1.9 1.6 0.7 3.5 0.0 7.7 0.2 0.1 0.0 6.8 0.0 4.1 4.0 0.0 0.1 0.0 0.0 0.8 5.1 1.4 10.4 0.4 1.6 1.0 0.2 0.6 0.4 3.9 0.6 0.9 0.5 1.2 1.5 2.1 0.8 0.6 0.6 1.4 5.2 2.2 1.8 3.9 0.9 0.7 2.0 3.8 0.4 PLA2G1B "PLA2, PLA2A, PPLA2" ENSG00000170890 "Phospholipase A2 group IB" P04054 12 120322111-120327789 "Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 933 "pancreas: 2360.6" "Cell line enhanced" "Detected in some" "EFO-21: 2.2;Hep G2: 6.3;U-2 OS: 4.6" "Cancer enriched" "Detected in many" 185 "pancreatic cancer: 763.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.5" "Group enriched" "Detected in many" 19 "NK-cells: 1.3;T-cells: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047822, HPA060803" Enhanced "Secreted to digestive system" 3900000 "HPA047822: , HPA060803: " "unprognostic (1.28e-4)" "unprognostic (6.02e-2)" "unprognostic (1.84e-2)" "unprognostic (2.86e-2)" "unprognostic (2.74e-2)" "unprognostic (2.41e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-1)" "unprognostic (2.63e-2)" "unprognostic (3.61e-2)" "unprognostic (1.27e-1)" "unprognostic (1.03e-1)" "unprognostic (2.80e-4)" "unprognostic (2.15e-1)" "unprognostic (1.97e-1)" "unprognostic (3.60e-1)" "unprognostic (8.61e-4)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.1 1.1 2360.6 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.3 2.5 0.9 0.2 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.0 0.0 0.0 2.2 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.5 0.0 0.3 1.3 0.3 1.6 0.0 0.0 0.2 0.0 0.6 0.0 1.0 0.2 4.6 0.6 0.6 0.0 1.1 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 1.7 0.0 0.0 0.3 0.0 0.0 2.5 0.9 0.0 1.3 0.0 0.0 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 PLA2G2D sPLA2S ENSG00000117215 "Phospholipase A2 group IID" Q9UNK4 1 20111939-20119566 "Enzymes, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 39.9" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 13.4" "Cancer enriched" "Detected in many" 6 "testis cancer: 25.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 6.6;naive B-cell: 5.6;plasmacytoid DC: 3.4" "Group enriched" "Detected in many" 5 "B-cells: 6.6;dendritic cells: 3.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Secreted - unknown location" "prognostic favourable (4.35e-4)" "prognostic favourable (8.15e-5)" "unprognostic (3.88e-3)" "prognostic favourable (9.74e-4)" "unprognostic (1.78e-1)" "unprognostic (2.56e-3)" "unprognostic (1.98e-1)" "unprognostic (1.60e-2)" "unprognostic (1.82e-5)" "unprognostic (7.51e-4)" "unprognostic (2.50e-2)" "unprognostic (1.22e-1)" "unprognostic (4.64e-3)" "unprognostic (1.05e-1)" "unprognostic (2.85e-1)" "unprognostic (8.08e-2)" "unprognostic (2.60e-1)" 0.4 0.3 0.3 38.8 0.3 0.0 0.4 0.3 0.3 0.3 0.9 0.0 0.0 0.3 0.3 0.2 0.4 0.5 0.4 0.3 0.3 0.3 0.4 0.4 1.0 39.9 0.3 0.0 0.3 0.3 0.0 0.3 0.2 0.0 0.4 1.2 0.1 5.0 0.3 0.3 0.3 7.7 0.0 0.3 18.1 0.6 0.3 0.0 6.6 0.7 0.5 33.0 2.5 0.3 6.6 3.4 1.0 0.2 0.3 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 13.4 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.3 0.1 2.1 0.1 0.2 0.1 0.1 0.0 1.0 0.2 0.2 0.1 0.1 0.1 6.6 0.1 0.1 0.1 5.6 0.1 0.1 0.4 0.3 0.1 3.4 0.0 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 PLA2G4E FLJ45651 ENSG00000188089 "Phospholipase A2 group IVE" Q3MJ16 15 41981582-42051190 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 19.9" "Group enriched" "Detected in some" 7 "CACO-2: 3.4;HaCaT: 2.1" "Cancer enhanced" "Detected in some" "head and neck cancer: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041105 Enhanced "HPA041105: " "unprognostic (2.98e-1)" "unprognostic (5.52e-1)" "unprognostic (2.60e-1)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.54e-1)" "unprognostic (1.99e-1)" "unprognostic (2.77e-1)" "unprognostic (4.22e-2)" "unprognostic (2.43e-1)" "unprognostic (1.22e-1)" "unprognostic (1.83e-7)" "unprognostic (1.81e-1)" "unprognostic (2.68e-1)" "unprognostic (7.48e-2)" "unprognostic (4.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLAC1 "CT92, OOSP2L" ENSG00000170965 "Placenta specific 1" Q9HBJ0 X 134565838-134764322 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "placenta: 90.4" "Cell line enhanced" "Detected in some" "HEK 293: 18.3;hTCEpi: 14.4;hTERT-HME1: 5.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA063425 Enhanced "Secreted in female reproductive system" "HPA063425: " "unprognostic (2.93e-1)" "unprognostic (2.50e-3)" "unprognostic (2.89e-4)" "unprognostic (1.35e-7)" "unprognostic (3.83e-3)" "unprognostic (2.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.26e-1)" "unprognostic (2.01e-1)" "unprognostic (4.28e-2)" "unprognostic (1.48e-2)" "unprognostic (2.87e-2)" "unprognostic (3.33e-16)" "unprognostic (7.64e-3)" "unprognostic (4.03e-2)" "unprognostic (1.61e-1)" "unprognostic (1.91e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.1 90.4 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.5 0.0 0.0 0.1 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.8 0.0 1.1 0.0 0.2 1.0 0.3 0.3 0.9 0.0 0.2 0.1 1.7 0.3 0.4 18.3 0.0 0.1 0.2 2.2 0.0 0.0 0.8 14.4 0.1 5.8 2.1 0.1 1.6 0.1 0.9 0.0 0.2 0.0 2.4 0.0 0.3 3.2 0.0 0.0 2.8 0.0 0.0 3.4 0.6 0.1 0.0 0.0 0.4 0.7 0.2 0.0 0.4 0.0 0.3 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLAC8L1 ENSG00000173261 "PLAC8 like 1" A1L4L8 5 146084386-146104369 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 20.4" "Cell line enhanced" "Detected in many" "AN3-CA: 9.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA074266 Approved Nucleoplasm Nucleoplasm "HPA074266: " "unprognostic (6.38e-3)" "unprognostic (1.90e-2)" "unprognostic (1.32e-1)" "unprognostic (4.24e-1)" "unprognostic (1.62e-2)" "unprognostic (7.48e-2)" "unprognostic (4.13e-2)" "unprognostic (3.79e-1)" "unprognostic (6.45e-2)" "unprognostic (5.05e-2)" "unprognostic (1.80e-3)" "unprognostic (1.23e-1)" "unprognostic (1.21e-6)" "unprognostic (9.72e-2)" "unprognostic (1.79e-1)" "unprognostic (1.89e-1)" "unprognostic (4.18e-2)" 0.4 0.1 0.9 0.4 1.0 0.1 1.0 1.6 0.8 0.4 0.4 0.4 0.4 0.0 0.5 0.5 0.4 0.6 0.4 0.4 1.0 1.0 0.4 0.5 0.4 0.4 1.1 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.9 3.1 0.6 0.5 1.9 0.4 0.1 20.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.2 1.3 0.0 0.0 0.0 0.5 0.0 0.9 2.7 2.6 9.6 0.7 1.1 0.6 1.0 0.4 4.2 2.7 0.4 1.2 1.5 2.1 1.1 0.7 3.9 0.0 3.4 3.2 5.5 2.2 0.9 1.0 0.5 0.9 1.8 0.0 6.2 3.1 2.5 1.4 0.2 2.0 1.1 0.0 0.9 2.9 0.4 3.8 0.9 0.4 0.0 0.3 0.0 2.3 1.2 1.1 0.4 2.3 0.2 0.8 1.1 0.0 3.6 1.1 1.9 1.2 3.1 1.2 0.7 1.6 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.9 1.0 1.6 0.8 1.0 1.0 1.1 0.4 0.4 0.4 PLB1 "FLJ30866, PLB" ENSG00000163803 "Phospholipase B1" Q6P1J6 2 28457145-28643788 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "intestine: 66.7" "Cell line enhanced" "Detected in some" "AF22: 4.7;BEWO: 7.2;CACO-2: 4.7;RT4: 5.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 14 "classical monocyte: 3.1;eosinophil: 3.3;intermediate monocyte: 4.9;myeloid DC: 6.4;neutrophil: 9.9;non-classical monocyte: 5.2" "Group enriched" "Detected in many" 40 "dendritic cells: 6.4;granulocytes: 9.9;monocytes: 5.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "unprognostic (2.18e-2)" "unprognostic (2.49e-1)" "unprognostic (6.58e-2)" "unprognostic (1.42e-1)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (4.91e-3)" "unprognostic (4.74e-2)" "unprognostic (4.48e-2)" "unprognostic (2.03e-2)" "unprognostic (1.53e-1)" "unprognostic (2.17e-1)" "unprognostic (2.61e-9)" "unprognostic (2.48e-2)" "unprognostic (2.19e-2)" "unprognostic (4.99e-2)" "unprognostic (8.03e-2)" 0.9 3.3 0.7 1.0 2.1 2.9 1.0 0.6 0.7 0.9 0.8 0.6 0.6 0.2 0.8 1.7 1.3 0.7 0.9 1.4 0.6 0.9 0.8 0.6 0.7 0.6 0.8 0.6 0.6 0.6 0.0 0.7 1.3 0.7 1.0 1.1 0.7 0.6 0.9 0.9 5.2 66.7 1.7 0.8 2.8 0.5 1.2 0.6 0.6 1.2 0.9 0.6 0.9 0.6 0.0 6.4 9.9 5.2 0.0 0.1 1.1 0.8 0.1 4.7 0.1 1.0 0.7 7.2 0.2 1.9 0.5 0.4 4.7 0.5 0.5 0.5 0.7 1.0 0.0 3.8 0.4 0.3 0.1 0.4 0.7 0.8 1.6 0.8 0.3 0.8 2.2 0.7 1.2 1.2 0.0 0.1 1.3 0.0 0.0 0.6 0.2 1.0 0.0 0.8 0.0 2.1 5.3 2.1 0.4 0.2 0.3 0.4 0.0 2.5 0.5 0.5 1.4 0.2 0.2 1.0 0.2 0.0 1.7 3.6 0.1 0.0 3.1 3.3 0.0 4.9 0.0 0.0 0.1 0.0 6.4 0.0 0.0 0.0 9.9 0.0 5.2 0.3 0.1 1.1 0.7 2.1 0.6 0.7 0.6 0.9 0.8 0.6 0.7 0.6 PLCB3 ENSG00000149782 "Phospholipase C beta 3" Q01970 11 64251523-64269150 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "intestine: 77.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009257, HPA039279, HPA043907" Enhanced Enhanced Nucleoplasm 94000 Nucleoplasm "CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726" "unprognostic (1.30e-1)" "unprognostic (1.21e-2)" "unprognostic (2.86e-1)" "unprognostic (2.35e-1)" "unprognostic (9.35e-2)" "unprognostic (6.23e-3)" "prognostic unfavourable (1.39e-4)" "unprognostic (2.44e-2)" "unprognostic (6.61e-2)" "unprognostic (1.26e-1)" "unprognostic (8.07e-3)" "unprognostic (1.00e-2)" "prognostic unfavourable (4.31e-5)" "unprognostic (5.04e-3)" "unprognostic (1.52e-1)" "unprognostic (1.20e-1)" "unprognostic (3.88e-2)" 5.8 9.7 6.1 7.0 5.4 3.7 10.9 6.3 5.8 8.6 40.6 3.1 8.8 59.3 9.1 5.9 16.8 7.7 11.8 4.8 5.4 2.6 5.5 3.2 9.1 4.8 3.5 2.2 11.0 4.0 7.6 2.9 11.1 4.8 6.4 7.0 5.0 6.5 6.3 3.8 10.7 77.5 7.0 4.5 7.2 8.0 4.6 5.4 4.2 5.0 8.2 9.3 6.3 8.8 0.3 4.4 0.9 1.4 0.3 0.8 0.4 17.6 9.9 9.8 14.6 10.3 8.0 9.8 14.1 10.7 12.1 7.4 8.7 13.5 1.2 8.5 17.7 30.5 11.0 13.2 4.2 8.5 6.1 13.8 20.5 6.5 7.1 3.3 9.1 6.7 8.8 13.1 9.8 17.6 6.8 1.5 15.3 21.3 4.2 7.0 15.9 10.9 9.2 22.1 5.2 7.4 18.7 2.6 10.8 20.9 26.3 10.0 13.8 6.4 30.5 11.2 13.4 25.6 9.1 1.9 0.9 1.4 18.5 7.9 10.3 0.0 1.4 0.2 0.7 1.4 0.8 0.1 0.8 0.7 1.3 0.3 0.4 0.4 0.9 0.3 1.4 4.4 0.2 0.4 6.1 5.4 6.3 5.8 5.4 2.6 3.5 2.2 4.8 5.4 PLCZ1 "NYD-SP27, PLCzeta" ENSG00000139151 "Phospholipase C zeta 1" Q86YW0 12 18683169-18738057 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fertilization, Lipid degradation, Lipid metabolism" "Developmental protein, Hydrolase, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 29.5" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 3.7;hTERT-HME1: 1.4;NTERA-2: 2.1;U-2 OS: 1.2;U-251 MG: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "unprognostic (1.95e-1)" "unprognostic (2.79e-1)" "unprognostic (1.10e-1)" "unprognostic (1.87e-2)" "unprognostic (1.39e-2)" "unprognostic (1.25e-2)" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 1.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.1 0.7 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLD4 C14orf175 ENSG00000166428 "Phospholipase D family member 4" Q96BZ4 14 104924816-104937790 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "blood: 229.9" "Group enriched" "Detected in some" 5 "HMC-1: 34.0;RPMI-8226: 24.4;THP-1: 61.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 229.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 229.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA051512 Uncertain 2000000 "HPA051512: " "unprognostic (4.50e-3)" "unprognostic (1.78e-4)" "unprognostic (7.12e-2)" "unprognostic (5.30e-3)" "unprognostic (5.54e-2)" "unprognostic (2.91e-3)" "unprognostic (2.56e-1)" "unprognostic (4.76e-3)" "unprognostic (1.45e-3)" "unprognostic (1.19e-3)" "unprognostic (3.45e-3)" "unprognostic (3.89e-1)" "unprognostic (6.90e-3)" "unprognostic (8.94e-2)" "unprognostic (2.83e-1)" "unprognostic (1.28e-2)" "unprognostic (2.41e-1)" 0.7 1.6 8.9 6.7 8.8 15.0 1.9 5.7 10.0 1.5 1.3 23.1 0.1 5.6 1.5 0.5 1.1 2.8 3.5 0.8 8.7 8.4 1.2 0.9 2.6 14.4 14.5 3.4 0.9 1.6 1.0 2.8 1.2 9.0 2.1 0.8 1.5 4.6 2.3 0.5 0.9 5.5 0.9 19.0 11.6 3.5 0.8 9.2 2.7 1.0 0.0 11.2 3.9 0.9 14.7 229.9 43.4 17.7 1.7 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.0 8.6 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 2.8 43.4 0.0 11.9 0.1 14.7 0.0 0.0 35.1 12.3 0.1 0.0 0.6 1.7 17.7 229.9 0.0 4.4 8.9 8.8 5.7 9.6 8.7 8.4 14.5 3.4 9.0 9.2 PLEKHB1 "KPL1, PHR1, PHRET1" ENSG00000021300 "Pleckstrin homology domain containing B1" Q9UF11 11 73646178-73662819 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 220.2" "Cell line enhanced" "Detected in many" "EFO-21: 10.4;Hep G2: 38.0;U-266/84: 14.5" "Cancer enhanced" "Detected in all" "glioma: 59.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 33.1" "Lineage enriched" "Detected in many" 5 "T-cells: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.20e-1)" "unprognostic (5.07e-1)" "unprognostic (2.91e-1)" "unprognostic (9.72e-2)" "unprognostic (2.16e-1)" "unprognostic (1.48e-1)" "unprognostic (2.46e-2)" "unprognostic (1.41e-3)" "unprognostic (3.01e-1)" "unprognostic (3.94e-2)" "prognostic favourable (6.02e-4)" "unprognostic (3.59e-1)" "prognostic favourable (1.99e-6)" "unprognostic (2.64e-1)" "unprognostic (7.23e-2)" "unprognostic (4.47e-1)" "unprognostic (7.44e-2)" 2.0 4.3 87.5 4.3 85.7 1.6 5.8 18.4 144.2 4.2 5.9 120.2 0.4 6.3 2.5 8.3 3.3 12.5 5.8 7.0 89.2 72.8 6.5 1.7 8.0 4.8 143.1 48.7 1.9 11.4 45.4 12.9 1.5 70.1 5.1 5.3 27.8 25.9 5.4 4.8 1.3 7.0 2.5 220.2 2.9 10.1 5.6 69.5 0.0 14.5 0.0 4.4 2.3 0.7 6.9 0.3 0.4 0.1 1.5 33.1 9.9 0.3 1.0 2.4 1.9 1.0 0.3 0.1 0.1 0.0 0.1 0.1 4.2 8.1 0.0 10.4 0.2 0.2 1.3 0.2 0.2 5.4 6.4 0.0 0.4 38.0 0.6 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 5.4 0.1 3.1 2.6 0.1 1.6 0.5 1.9 0.0 1.2 0.4 0.7 6.1 1.4 0.0 0.1 0.6 2.8 0.5 0.0 0.0 1.2 0.1 0.7 9.1 14.5 5.4 1.4 0.0 0.3 0.0 0.1 0.4 6.5 0.0 15.9 6.9 16.1 11.8 0.2 2.9 33.1 18.4 0.3 1.5 0.0 0.3 9.3 9.9 87.5 85.7 18.4 47.9 89.2 72.8 143.1 48.7 70.1 69.5 PLG ENSG00000122194 Plasminogen P00747 6 160702238-160753315 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 269.9" "Cell line enhanced" "Detected in some" "HL-60: 3.5;RH-30: 3.9;U-698: 2.0;U-937: 1.6" "Cancer enriched" "Detected in some" 84 "liver cancer: 180.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000668, CAB016678, HPA021602, HPA048823" Supported "Secreted to blood" 140000000000 41000000000 "CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: " "unprognostic (1.70e-1)" "unprognostic (2.16e-3)" "unprognostic (2.44e-1)" "unprognostic (8.54e-3)" "unprognostic (1.41e-1)" "unprognostic (1.76e-3)" "unprognostic (6.28e-2)" "unprognostic (7.25e-2)" "prognostic favourable (4.22e-4)" "unprognostic (3.97e-3)" "unprognostic (5.21e-2)" "unprognostic (2.33e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 269.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 3.5 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.2 0.8 0.0 0.4 3.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 1.0 0.0 2.0 0.0 1.6 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLGLB1 "PLGL, PRP-B" ENSG00000183281 "Plasminogen-like B1" Q02325 2 87002559-87021852 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in many" 5 "liver: 66.8" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in single" 7 "liver cancer: 0.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Secreted to blood" "unprognostic (7.25e-2)" "unprognostic (7.25e-2)" "unprognostic (2.35e-1)" "unprognostic (1.15e-1)" "unprognostic (1.75e-2)" "unprognostic (1.39e-5)" "unprognostic (7.04e-3)" "unprognostic (1.15e-1)" "unprognostic (8.53e-4)" "unprognostic (1.60e-1)" "unprognostic (4.56e-4)" "unprognostic (9.90e-3)" "unprognostic (2.96e-5)" "unprognostic (1.02e-1)" "unprognostic (1.16e-1)" "unprognostic (4.32e-2)" "unprognostic (3.98e-5)" 0.3 1.3 2.0 0.7 3.4 1.7 0.7 14.3 2.1 0.4 0.5 0.7 1.3 2.1 0.3 0.8 1.0 0.6 1.9 2.1 1.0 66.8 0.6 1.5 1.4 1.5 0.4 0.7 1.6 0.3 1.0 0.3 1.1 0.5 1.9 3.4 0.8 0.2 1.1 1.3 0.7 0.8 1.1 0.5 0.7 0.5 2.7 1.6 5.1 0.8 0.9 2.7 0.4 3.0 4.3 4.8 2.6 4.6 5.4 5.1 3.4 2.5 2.1 2.8 3.3 7.7 7.7 3.5 1.2 2.6 1.3 0.6 2.1 9.2 3.6 6.6 6.4 3.5 3.1 4.1 1.6 5.6 4.6 5.6 5.7 0.9 3.2 6.6 2.6 4.4 13.4 11.4 6.9 2.7 2.2 2.1 4.5 4.7 3.1 3.8 4.2 2.9 2.6 3.0 1.3 7.1 5.5 3.9 2.5 2.2 2.1 7.0 5.4 3.4 2.1 5.5 2.6 5.1 0.4 0.9 1.9 0.2 1.2 2.7 2.0 1.4 0.2 2.2 2.7 1.6 1.9 0.9 0.8 1.6 2.6 0.4 PLGLB2 PLGP1 ENSG00000125551 "Plasminogen-like B2" Q02325 2 87748087-87758793 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 28 "liver: 105.2" "Cell line enhanced" "Detected in many" "AF22: 4.5;RPTEC TERT1: 4.5;U-266/84: 5.1" "Cancer enriched" "Detected in single" 25 "liver cancer: 1.2" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.7;T-reg: 3.7" "Lineage enriched" "Detected in single" 16 "T-cells: 3.7" "Secreted to blood" "unprognostic (1.10e-2)" "unprognostic (8.78e-2)" "unprognostic (3.42e-2)" "unprognostic (7.03e-4)" "unprognostic (1.68e-2)" "unprognostic (3.77e-1)" "unprognostic (1.82e-2)" "unprognostic (5.74e-2)" "unprognostic (2.94e-1)" "unprognostic (5.04e-4)" "unprognostic (6.39e-2)" "unprognostic (4.06e-2)" "unprognostic (3.22e-2)" "unprognostic (7.11e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 105.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 3.7 0.2 0.0 1.4 4.5 1.4 0.0 1.4 0.0 3.8 2.3 0.6 2.6 0.0 1.4 2.8 2.7 0.6 1.0 0.5 0.0 0.8 0.0 1.2 1.0 3.3 0.0 0.3 0.6 0.5 0.0 0.0 0.3 0.4 0.5 0.3 0.0 0.9 0.0 2.6 0.0 0.0 0.0 2.5 0.0 0.0 4.5 0.3 0.0 3.3 0.9 1.1 0.1 0.2 1.8 0.0 0.0 2.0 0.9 1.4 2.9 5.1 0.4 1.6 0.0 1.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 2.7 0.8 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 3.7 0.2 PLK5 "PLK5P, SgK384ps" ENSG00000185988 "Polo like kinase 5" Q496M5 19 1524074-1536046 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 50.1" "Cell line enhanced" "Detected in some" "Daudi: 5.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in all" 6 "cerebellum: 50.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA035024 Enhanced "HPA035024: " "unprognostic (4.32e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (7.69e-2)" "unprognostic (1.11e-2)" "unprognostic (1.33e-1)" "unprognostic (2.69e-1)" "unprognostic (8.38e-2)" "unprognostic (4.06e-2)" "unprognostic (1.74e-1)" "unprognostic (3.36e-2)" "unprognostic (9.94e-3)" "unprognostic (2.18e-3)" "unprognostic (3.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.54e-2)" "unprognostic (4.01e-4)" 0.4 0.7 8.3 0.4 4.8 1.7 0.8 50.1 7.9 5.9 0.4 1.6 0.3 0.5 6.4 6.2 1.6 2.7 0.4 0.3 3.2 1.7 0.3 0.3 0.3 0.4 1.1 1.9 0.8 0.6 0.5 0.5 0.3 2.9 0.9 0.4 8.4 0.6 3.2 0.5 1.0 0.7 2.8 0.8 0.4 0.2 7.4 1.8 0.0 0.4 0.0 0.3 0.2 2.9 1.2 1.2 4.4 0.9 1.0 1.1 0.1 0.2 0.9 0.8 1.2 0.4 0.9 1.0 0.2 0.5 0.5 0.4 0.5 1.0 5.0 0.3 0.5 1.2 0.8 0.5 0.2 0.5 0.6 1.0 1.3 0.8 0.1 0.2 1.1 1.0 0.3 0.8 0.2 0.3 0.8 1.7 0.8 1.0 0.4 1.0 1.4 0.9 1.0 0.3 0.4 0.6 0.1 0.5 0.7 0.7 0.4 0.3 1.5 0.7 0.0 0.9 1.0 1.2 0.2 1.5 0.4 0.6 0.4 0.7 0.5 1.6 0.9 2.2 0.8 0.5 0.5 0.7 0.8 0.5 0.2 1.2 1.1 0.6 4.4 1.0 0.6 1.2 1.0 0.1 8.3 4.8 50.1 7.9 3.2 1.7 1.1 1.9 2.9 1.8 PLN "CMD1P, PLB" ENSG00000198523 Phospholamban P26678 6 118548298-118560730 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 337.5" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1.4;Karpas-707: 1.6;NB-4: 1.9;U-2197: 1.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "eosinophil: 1.3;naive CD4 T-cell: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005597, HPA026900" Enhanced "CAB005597: AB_2252716, HPA026900: AB_1855314" "unprognostic (2.49e-1)" "unprognostic (5.67e-2)" "unprognostic (1.96e-3)" "unprognostic (4.81e-2)" "unprognostic (1.20e-1)" "unprognostic (5.54e-2)" "unprognostic (2.35e-3)" "unprognostic (4.66e-2)" "unprognostic (3.97e-1)" "unprognostic (8.98e-2)" "unprognostic (8.98e-2)" "unprognostic (3.28e-1)" "prognostic unfavourable (4.11e-4)" "unprognostic (2.98e-3)" "unprognostic (1.80e-1)" "unprognostic (2.11e-1)" "prognostic unfavourable (5.59e-4)" 9.0 1.8 0.4 2.7 0.5 0.0 5.4 0.4 0.6 22.3 22.2 0.0 9.8 2.0 21.1 22.3 27.3 11.6 29.8 337.5 0.4 0.5 6.4 0.4 5.3 0.8 0.7 1.4 18.6 0.5 0.1 0.4 0.1 1.4 14.4 3.9 0.0 1.6 6.0 68.4 1.5 14.0 30.8 1.2 0.6 6.5 12.3 0.0 0.0 2.8 23.7 0.8 32.2 6.6 0.3 0.0 1.3 0.4 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 1.4 0.2 0.0 0.0 0.3 0.6 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.3 0.5 0.2 0.0 0.2 1.6 0.1 0.0 0.0 1.9 0.1 0.0 0.0 0.1 1.0 0.0 0.7 0.2 0.8 0.4 0.1 0.0 0.4 0.0 0.5 0.3 0.2 1.3 0.3 0.2 0.3 0.5 0.0 1.1 0.1 0.0 0.4 1.3 0.1 0.0 0.3 0.1 0.4 0.0 0.0 0.3 1.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.4 0.6 0.4 0.5 0.7 1.4 1.4 0.0 PLP1 "GPM6C, PLP, SPG2" ENSG00000123560 "Proteolipid protein 1" P60201 X 103773718-103792619 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "brain: 463.6" "Group enriched" "Detected in some" 5 "SK-MEL-30: 66.3;WM-115: 39.6" "Group enriched" "Detected in many" 22 "glioma: 160.5;melanoma: 75.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "plasmacytoid DC: 2.3" "Lineage enriched" "Detected in single" 9 "dendritic cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004128 Enhanced "HPA004128: AB_1079635" "unprognostic (5.72e-2)" "unprognostic (1.77e-2)" "unprognostic (2.27e-2)" "unprognostic (4.09e-3)" "unprognostic (1.32e-1)" "unprognostic (3.95e-2)" "unprognostic (2.57e-2)" "unprognostic (1.02e-1)" "unprognostic (5.92e-2)" "unprognostic (2.28e-2)" "unprognostic (1.21e-1)" "unprognostic (1.62e-5)" "unprognostic (4.91e-2)" "unprognostic (1.86e-1)" "unprognostic (3.46e-2)" "unprognostic (1.16e-2)" 3.6 5.6 90.6 2.8 109.9 1.9 3.1 8.9 463.6 3.9 5.7 208.1 0.0 3.3 3.6 3.5 4.2 2.5 4.0 5.0 143.8 73.8 2.1 2.1 2.1 2.0 174.8 42.2 3.0 2.2 17.9 0.3 1.9 124.4 3.6 5.4 0.0 3.4 9.3 2.2 7.3 5.1 7.0 453.8 2.0 2.8 9.2 145.2 0.0 2.0 0.0 2.0 2.7 0.8 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 39.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 90.6 109.9 8.9 68.1 143.8 73.8 174.8 42.2 124.4 145.2 PLPPR4 "KIAA0455, LPPR4, PHP1, PRG-1" ENSG00000117600 "Phospholipid phosphatase related 4" Q7Z2D5 1 99263953-99309590 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 55.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 19.8;BJ hTERT+ SV40 Large T+ RasG12V: 7.7;fHDF/TERT166: 6.7;SH-SY5Y: 14.9;U-138 MG: 7.5;U-87 MG: 12.6" "Cancer enhanced" "Detected in many" "glioma: 7.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "non-classical monocyte: 2.1" "Lineage enriched" "Detected in single" 22 "monocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (4.32e-2)" "unprognostic (4.92e-2)" "unprognostic (2.74e-1)" "unprognostic (1.67e-2)" "unprognostic (1.67e-2)" "unprognostic (2.95e-2)" "unprognostic (1.00e-2)" "unprognostic (1.17e-2)" "unprognostic (9.09e-2)" "unprognostic (9.70e-3)" "unprognostic (3.36e-2)" "unprognostic (2.21e-1)" "unprognostic (7.25e-12)" "unprognostic (1.67e-5)" "unprognostic (3.47e-1)" "unprognostic (1.34e-2)" "unprognostic (1.16e-3)" 3.0 1.7 25.1 1.2 25.8 0.8 1.8 2.0 55.3 4.6 1.5 2.6 0.0 1.2 1.7 1.7 3.2 1.3 6.0 1.4 39.2 10.8 1.4 0.8 3.5 1.5 5.2 16.7 0.8 1.5 1.7 9.0 1.9 6.1 1.1 1.9 0.6 1.4 1.3 1.2 4.6 1.5 2.1 2.2 1.3 1.1 5.2 2.7 0.0 1.5 0.4 1.7 7.0 1.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.3 0.0 0.0 3.8 19.8 4.4 7.7 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 14.9 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.1 0.0 0.0 0.0 12.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 25.1 25.8 2.0 33.8 39.2 10.8 5.2 16.7 6.1 2.7 PLS1 "I-plastin, Plastin-1" ENSG00000120756 "Plastin 1" Q14651 3 142596387-142713664 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "intestine: 193.0" "Cell line enhanced" "Detected in many" "A-431: 27.4;BEWO: 36.0;RPTEC TERT1: 45.9;RT4: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 4.9;NK-cells: 5.9;T-cells: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055744 Enhanced 50000000 "HPA055744: " "unprognostic (1.29e-1)" "unprognostic (2.61e-1)" "unprognostic (3.15e-3)" "unprognostic (2.22e-2)" "unprognostic (1.20e-1)" "unprognostic (1.41e-2)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.33e-1)" "unprognostic (7.78e-2)" "prognostic unfavourable (4.84e-4)" "unprognostic (3.14e-2)" "prognostic favourable (8.76e-6)" "unprognostic (1.99e-2)" "unprognostic (8.64e-2)" "unprognostic (7.22e-2)" "unprognostic (3.82e-2)" 0.5 2.3 1.0 8.2 1.0 1.0 1.7 1.5 2.0 2.0 42.3 0.6 0.2 40.0 0.5 1.1 5.7 1.3 6.3 0.9 1.2 1.1 12.5 10.6 4.4 0.3 0.9 1.0 0.6 5.0 3.8 13.6 0.8 4.5 1.8 30.0 2.9 5.3 0.9 0.5 1.2 193.0 0.6 1.2 0.5 9.6 2.6 0.5 2.5 3.7 1.3 1.6 5.1 2.3 0.7 0.9 4.9 0.4 5.9 5.0 1.8 27.4 21.6 1.5 3.3 0.2 0.0 36.0 0.5 0.7 3.0 6.5 9.8 21.7 4.7 11.5 0.1 5.9 5.9 9.0 6.4 1.7 8.5 8.3 3.4 3.5 0.2 3.9 0.5 0.1 1.5 5.7 3.7 1.4 3.5 0.5 0.3 6.4 6.4 2.1 6.0 8.2 2.6 6.5 3.8 45.9 25.4 7.7 3.1 3.1 2.2 2.5 17.7 0.7 0.3 0.3 3.7 1.1 6.6 4.1 3.8 5.5 1.0 3.9 1.1 3.4 0.4 4.9 2.9 0.3 3.8 0.7 3.5 3.8 0.7 0.6 4.3 5.0 3.3 5.9 0.4 0.9 2.1 1.8 1.0 1.0 1.5 2.0 1.2 1.1 0.9 1.0 4.5 0.5 PM20D1 "Cps1, FLJ32569" ENSG00000162877 "Peptidase M20 domain containing 1" Q6GTS8 1 205828022-205850132 "Enzymes, Predicted secreted proteins" "Hydrolase, Lyase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "pancreas: 103.5" "Cell line enriched" "Detected in single" 9 "Karpas-707: 6.4" "Cancer enriched" "Detected in some" 32 "urothelial cancer: 30.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.5" "Lineage enriched" "Detected in single" 5 "T-cells: 4.5" "Low region specificity" "Detected in all" "Secreted to digestive system" 3000000 "unprognostic (1.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.30e-1)" "unprognostic (4.07e-2)" "unprognostic (4.83e-1)" "unprognostic (4.08e-3)" "unprognostic (1.17e-3)" "unprognostic (3.11e-1)" "unprognostic (1.20e-1)" "unprognostic (5.50e-2)" "unprognostic (5.81e-2)" "unprognostic (4.57e-2)" "unprognostic (7.79e-3)" "unprognostic (9.77e-2)" "unprognostic (1.45e-1)" "unprognostic (2.48e-1)" "unprognostic (1.68e-2)" 0.5 0.0 0.0 0.5 0.2 0.0 0.6 0.1 0.4 0.0 0.2 0.6 0.4 0.0 0.2 0.3 0.0 0.1 0.0 0.3 0.3 0.0 3.2 0.1 0.2 0.5 0.2 0.0 0.3 103.5 0.0 0.0 0.1 0.4 0.8 0.0 0.3 0.2 0.4 0.0 14.3 0.1 0.1 0.1 0.4 1.2 0.2 0.1 0.1 0.1 0.1 0.4 1.5 0.3 0.3 0.0 0.8 0.2 0.0 4.5 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.7 0.0 1.3 0.3 0.9 2.4 0.0 0.2 0.3 0.9 0.0 0.0 0.2 0.0 4.5 1.0 0.0 0.2 0.1 0.4 0.3 0.0 0.2 0.0 0.4 0.1 PMCH MCH ENSG00000183395 "Pro-melanin concentrating hormone" P20382 12 102196459-102197845 "Predicted secreted proteins" "Differentiation, Spermatogenesis" "Developmental protein, Hormone, Neuropeptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 124.8" "Cell line enriched" "Detected in some" 8 "HDLM-2: 30.6" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.8" "Region enriched" "Detected in some" 27 "hypothalamus: 124.8" "Cell type enriched" "Detected in some" 8 "T-reg: 11.3" "Lineage enriched" "Detected in single" 81 "T-cells: 11.3" "Group enriched" "Detected in some" 131 "hypothalamus: 737.6;thalamus: 373.6" "Region enriched" "Detected in single" 30 "hypothalamus: 98.6" "HPA046055, HPA061884" Enhanced Supported "Secreted to blood" 274240 "HPA046055: AB_2679517, HPA061884: AB_2684632" "unprognostic (3.23e-3)" "unprognostic (8.04e-2)" "unprognostic (3.96e-4)" "unprognostic (2.09e-2)" "unprognostic (1.75e-1)" "unprognostic (7.73e-2)" "unprognostic (4.31e-3)" "unprognostic (1.43e-2)" "unprognostic (3.18e-3)" "unprognostic (4.51e-2)" "unprognostic (1.21e-1)" "unprognostic (2.16e-6)" "unprognostic (1.17e-2)" "unprognostic (1.93e-1)" "unprognostic (5.10e-2)" "unprognostic (3.53e-2)" 0.1 0.0 0.3 2.1 2.0 2.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 1.1 1.0 0.0 0.2 0.6 0.8 124.8 0.1 0.1 0.2 6.4 0.4 0.1 0.1 0.1 0.0 1.4 0.2 4.5 0.2 0.0 0.1 0.2 0.1 0.1 0.9 0.1 0.1 0.9 1.1 2.0 0.2 0.7 1.0 0.1 0.1 1.7 0.2 0.1 0.0 0.0 0.0 0.0 0.1 11.3 0.0 0.3 0.1 0.3 0.3 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.0 30.6 0.1 0.5 0.6 0.3 0.0 1.0 0.4 0.0 0.0 0.0 0.0 3.7 0.7 0.1 0.0 0.0 0.6 1.0 0.5 1.2 0.3 0.6 1.2 0.0 0.2 0.3 0.4 0.4 0.6 0.1 0.2 0.1 0.4 0.4 0.4 0.1 0.5 0.1 0.5 0.4 0.4 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.3 0.0 0.3 2.0 0.1 0.1 0.8 124.8 0.4 0.1 4.5 0.7 PMEL "D12S53E, gp100, Pmel17, SI, SIL, SILV" ENSG00000185664 "Premelanosome protein" P40967 12 55954105-55973317 "Predicted intracellular proteins, Predicted membrane proteins" "Melanin biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 230.1" "Cell line enriched" "Detected in some" 66 "SK-MEL-30: 431.8" "Cancer enriched" "Detected in many" 500 "melanoma: 2481.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA031649 Enhanced Supported "Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" 14000000 "Endoplasmic reticulum" "Golgi apparatus" "HPA031649: " "unprognostic (4.63e-1)" "unprognostic (8.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.60e-1)" "unprognostic (5.90e-2)" "unprognostic (6.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.46e-3)" "unprognostic (6.44e-2)" "unprognostic (1.21e-1)" "unprognostic (5.12e-2)" "unprognostic (3.98e-1)" "prognostic favourable (3.70e-4)" "unprognostic (2.86e-2)" "unprognostic (1.54e-1)" "unprognostic (7.60e-2)" "unprognostic (1.04e-1)" 0.9 0.1 0.4 0.4 0.5 0.4 3.4 0.4 0.5 38.2 1.0 0.4 0.5 0.4 11.8 0.4 0.4 0.2 0.6 0.5 0.4 0.0 0.6 1.8 0.7 1.9 0.4 0.4 1.6 0.6 0.9 0.4 0.9 0.4 0.5 0.2 230.1 1.1 0.4 0.6 46.8 0.6 1.3 0.8 0.4 0.2 1.5 0.4 0.4 0.4 0.6 0.6 0.5 0.8 1.3 2.3 2.1 1.4 0.2 1.9 0.6 0.7 0.0 0.2 0.0 4.4 0.0 6.5 0.0 0.0 0.1 0.1 0.6 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 431.8 0.2 0.4 0.0 0.0 0.3 0.0 0.4 0.1 0.5 0.1 0.0 0.1 0.0 0.0 1.4 0.7 0.3 0.0 1.9 1.3 0.5 0.4 0.0 0.9 1.1 0.1 2.1 0.2 0.4 2.3 0.4 0.6 0.4 0.5 0.4 0.5 0.4 0.0 0.4 0.4 0.4 0.4 PMIS2 IFITMD9 ENSG00000283758 "PMIS2, transmembrane protein" 19 35586161-35587296 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 43 "testis: 4.2" "Group enriched" "Detected in some" 14 "NTERA-2: 1.2;U-138 MG: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PMP2 "FABP8, M-FABP, MP2" ENSG00000147588 "Peripheral myelin protein 2" P02689 8 81440326-81447523 "Predicted intracellular proteins" Transport "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 30 "brain: 124.8" "Cell line enhanced" "Detected in some" "HaCaT: 1.0;Karpas-707: 1.3;U-87 MG: 1.6;WM-115: 5.3" "Cancer enriched" "Detected in some" 59 "glioma: 239.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 26 "midbrain: 78.0;pons and medulla: 111.5" "unprognostic (5.87e-2)" "unprognostic (5.81e-2)" "unprognostic (1.12e-2)" "unprognostic (1.95e-1)" "unprognostic (8.03e-3)" "unprognostic (1.10e-2)" "unprognostic (8.45e-2)" "unprognostic (4.43e-2)" "unprognostic (7.21e-2)" "unprognostic (4.41e-1)" "unprognostic (3.27e-3)" 2.7 2.5 39.2 2.4 36.9 1.5 1.6 13.4 124.8 2.5 2.2 14.5 0.0 1.8 1.6 2.8 2.0 1.7 2.2 2.4 30.4 31.2 1.6 1.6 1.5 1.5 48.3 18.3 1.7 1.8 1.5 0.0 1.5 66.6 2.0 2.0 0.0 2.2 4.2 1.7 1.7 1.9 1.7 106.3 1.5 1.6 1.6 45.8 0.0 1.5 0.0 1.5 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.2 36.9 13.4 27.8 30.4 31.2 48.3 18.3 66.6 45.8 PNLDC1 "dJ195P10.2, FLJ40240" ENSG00000146453 "PARN like, ribonuclease domain containing 1" Q8NA58 6 159800249-159820704 "Enzymes, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 26.7" "Cell line enhanced" "Detected in some" "AN3-CA: 1.8;HAP1: 2.3;hTCEpi: 3.8;RPMI-8226: 2.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basal ganglia: 5.7;cerebral cortex: 3.9" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.8;plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA052026 Uncertain "HPA052026: " "unprognostic (1.58e-1)" "unprognostic (3.88e-2)" "unprognostic (1.01e-2)" "unprognostic (2.39e-3)" "unprognostic (8.47e-3)" "unprognostic (3.55e-2)" "unprognostic (2.04e-1)" "unprognostic (4.24e-1)" "unprognostic (1.01e-1)" "unprognostic (5.37e-2)" "unprognostic (4.19e-1)" "unprognostic (9.98e-2)" "unprognostic (2.69e-9)" "unprognostic (1.14e-2)" "unprognostic (2.25e-1)" "unprognostic (1.69e-1)" "unprognostic (2.24e-1)" 0.6 0.5 0.6 0.5 5.7 0.4 1.4 0.2 3.9 0.3 0.3 0.3 0.0 0.2 0.3 1.3 0.2 3.6 0.3 0.2 0.7 0.2 0.8 0.8 0.5 0.4 0.4 0.7 0.8 2.3 0.3 0.3 0.3 0.3 0.4 0.3 0.0 1.2 0.4 0.5 1.4 0.3 0.3 0.4 0.5 0.3 26.7 0.3 0.5 0.4 0.3 0.7 0.2 0.0 0.1 1.7 0.0 1.8 0.4 1.0 0.4 0.0 0.4 0.2 1.8 1.0 0.0 1.1 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.2 0.3 0.1 2.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.0 3.8 0.0 0.1 0.0 0.1 0.8 0.2 0.1 0.8 0.1 0.9 0.8 0.1 0.0 2.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.2 0.3 0.0 0.3 0.7 0.1 0.0 0.6 0.1 0.0 0.2 0.0 0.1 1.8 0.0 0.0 0.2 0.0 0.7 0.1 1.0 0.1 0.0 0.4 0.0 1.7 0.5 0.4 0.6 5.7 0.2 3.9 0.7 0.2 0.4 0.7 0.3 0.3 PNLIP PL ENSG00000175535 "Pancreatic lipase" P16233 10 116545931-116567855 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1895 "pancreas: 3207.8" "Cell line enhanced" "Detected in some" "EFO-21: 3.0;HDLM-2: 2.7;U-2 OS: 4.5;U-251 MG: 1.0;U-266/84: 1.5" "Cancer enriched" "Detected in some" 4854 "pancreatic cancer: 2731.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Region enhanced" "Detected in single" "cerebral cortex: 0.4" "HPA062430, HPA062494" Enhanced "Secreted to digestive system" 13000000 "HPA062430: AB_2684761, HPA062494: AB_2684782" "unprognostic (2.05e-2)" "unprognostic (4.46e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.6 3207.8 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 1.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 PNLIPRP1 PLRP1 ENSG00000187021 "Pancreatic lipase related protein 1" P54315 10 116590385-116609175 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 2629 "pancreas: 516.5" "Group enriched" "Detected in some" 7 "EFO-21: 1.1;U-2 OS: 1.7;U-266/84: 4.3" "Cancer enriched" "Detected in single" 475 "pancreatic cancer: 32.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" 210000 "unprognostic (1.21e-1)" "unprognostic (4.08e-3)" "unprognostic (1.40e-1)" "unprognostic (1.80e-1)" "unprognostic (2.76e-2)" "unprognostic (1.41e-1)" "unprognostic (1.46e-1)" "unprognostic (1.49e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 516.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 PNMA2 "MA2, RGAG2" ENSG00000240694 "PNMA family member 2" Q9UL42 8 26504686-26514092 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 82.6" "Cell line enhanced" "Detected in many" "AF22: 27.8;HAP1: 17.2;HUVEC TERT2: 16.4;NTERA-2: 15.3;SH-SY5Y: 20.0;U-87 MG: 16.1" "Cancer enhanced" "Detected in many" "glioma: 28.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 3.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001936 Enhanced "HPA001936: AB_1079647" "unprognostic (1.25e-2)" "unprognostic (1.27e-2)" "unprognostic (6.39e-2)" "unprognostic (1.43e-6)" "unprognostic (1.18e-1)" "unprognostic (1.37e-1)" "unprognostic (8.76e-2)" "prognostic favourable (1.81e-4)" "unprognostic (4.66e-2)" "unprognostic (1.34e-2)" "unprognostic (1.46e-2)" "unprognostic (1.52e-1)" "unprognostic (9.98e-2)" "prognostic unfavourable (6.23e-4)" "unprognostic (5.12e-2)" "unprognostic (4.58e-5)" "unprognostic (9.00e-3)" 2.6 9.5 24.4 1.9 33.2 1.3 2.5 5.9 82.6 4.1 1.9 4.3 0.0 1.7 1.8 1.9 1.5 3.0 4.0 2.9 21.6 36.7 3.0 1.7 6.1 1.4 14.5 26.8 1.4 4.0 2.1 5.1 1.5 16.6 1.7 1.8 1.7 1.2 1.8 1.4 1.6 1.9 2.5 7.0 1.4 3.4 2.3 4.6 0.0 3.1 0.0 1.3 2.6 0.4 0.9 0.4 3.0 0.3 0.4 0.5 0.1 0.0 5.1 27.8 0.3 5.5 1.1 0.0 1.4 7.5 3.4 1.1 0.2 3.7 0.0 1.0 0.5 0.1 17.2 0.0 2.6 0.0 3.1 0.0 3.8 0.0 0.4 0.0 0.2 1.9 0.0 14.8 0.1 16.4 0.0 0.0 2.1 0.1 8.1 0.0 15.3 0.0 0.0 5.6 0.0 8.3 1.8 13.6 20.0 0.0 0.0 0.8 0.1 0.5 8.1 0.3 5.7 7.1 1.1 2.6 1.9 0.0 16.1 0.0 0.4 3.0 0.3 0.2 0.4 0.1 0.2 0.3 0.2 0.2 0.1 0.9 0.3 0.5 0.9 0.4 0.2 0.4 0.2 0.1 24.4 33.2 5.9 42.3 21.6 36.7 14.5 26.8 16.6 4.6 PNMA8C ENSG00000277531 "PNMA family member 8C" A0A1B0GUJ8 19 46424697-46428951 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 23.5" "Group enriched" "Detected in some" 6 "AF22: 2.6;HMC-1: 5.5;SH-SY5Y: 8.3" "Cancer enriched" "Detected in some" 11 "glioma: 7.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "unprognostic (3.25e-2)" "unprognostic (2.38e-1)" "unprognostic (3.89e-2)" "unprognostic (4.91e-3)" "unprognostic (2.58e-1)" "unprognostic (4.61e-3)" "unprognostic (1.16e-2)" "unprognostic (1.69e-1)" "unprognostic (4.49e-2)" "unprognostic (2.39e-2)" "unprognostic (2.92e-2)" 0.4 2.1 5.3 0.5 8.1 0.6 0.6 2.1 23.5 0.4 0.5 3.3 0.0 0.4 0.4 3.7 0.4 2.3 0.7 0.6 4.8 0.4 0.3 0.6 0.3 1.9 11.5 0.6 0.4 0.7 4.6 0.3 7.0 0.9 0.4 0.0 0.4 1.0 1.3 0.5 0.5 0.5 1.8 0.4 0.4 1.2 1.6 0.0 0.4 0.0 0.3 0.4 0.0 1.1 1.4 2.7 0.5 1.7 0.6 0.1 0.0 0.0 2.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 2.7 0.4 0.4 0.4 0.3 0.3 0.4 0.4 0.3 0.2 1.1 0.5 0.6 2.3 1.7 0.5 1.4 0.2 0.1 POM121L12 DKFZp564N2472 ENSG00000221900 "POM121 transmembrane nucleoporin like 12" Q8N7R1 7 53035642-53036924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 175 "testis: 36.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027836 Enhanced "HPA027836: AB_10669592" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POM121L2 POM121-L ENSG00000158553 "POM121 transmembrane nucleoporin like 2" Q96KW2 6 27285903-27312170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 88 "testis: 35.6" "Cell line enhanced" "Detected in some" "HEL: 3.3;HMC-1: 1.9;K-562: 1.5;LHCN-M2: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046150 Uncertain "HPA046150: AB_10960993" "unprognostic (2.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.22e-1)" "unprognostic (1.43e-2)" "unprognostic (5.88e-3)" "unprognostic (3.48e-2)" "unprognostic (1.93e-1)" "unprognostic (3.51e-2)" "unprognostic (2.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 2.5 0.5 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POMC "ACTH, CLIP, LPH, MSH, NPP, POC" ENSG00000115138 Proopiomelanocortin P01189 2 25160853-25168903 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Endorphin, Hormone" "Cancer-related genes, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "pituitary gland: 811.1" "Cell line enhanced" "Detected in some" "CACO-2: 2.6;HMC-1: 4.1;THP-1: 5.4" "Cancer enriched" "Detected in many" 6 "testis cancer: 18.5" "Region enriched" "Detected in single" 5 "hypothalamus: 1.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "hypothalamus: 77.9" "CAB002762, HPA046135, HPA063644" Enhanced "Secreted to blood" "CAB002762: , HPA046135: AB_2679552, HPA063644: AB_2685071" "unprognostic (8.02e-2)" "unprognostic (1.47e-2)" "unprognostic (4.78e-2)" "unprognostic (1.96e-3)" "unprognostic (3.15e-1)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "unprognostic (4.30e-2)" "unprognostic (8.74e-3)" "unprognostic (1.38e-1)" "prognostic favourable (5.70e-4)" "unprognostic (8.02e-2)" "unprognostic (4.29e-2)" "unprognostic (2.94e-3)" "unprognostic (1.42e-1)" "unprognostic (1.37e-3)" "unprognostic (3.84e-2)" 1.0 3.2 0.3 0.8 0.3 0.5 0.3 0.3 0.7 0.3 0.3 0.3 0.3 0.1 0.3 0.5 0.3 0.0 0.3 0.3 0.3 1.8 0.5 0.3 0.3 0.6 0.3 0.3 0.3 22.2 0.0 811.1 0.9 0.3 0.3 0.0 0.3 0.4 0.3 3.6 0.9 0.3 0.3 0.3 1.3 0.4 2.9 0.3 0.3 0.3 0.4 0.3 0.3 0.3 13.7 22.2 6.6 10.1 12.6 10.5 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 4.1 1.1 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 9.9 6.6 9.8 10.1 7.7 12.8 7.5 9.3 12.5 13.7 9.9 10.5 3.1 12.6 5.9 22.2 7.9 7.6 0.3 0.3 0.3 0.3 0.3 1.8 0.3 0.3 0.3 0.3 PON1 "ESA, PON" ENSG00000005421 "Paraoxonase 1" P27169 7 95297676-95324707 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "liver: 144.1" "Cell line enhanced" "Detected in some" "A549: 1.4;RH-30: 1.0" "Cancer enriched" "Detected in some" 78 "liver cancer: 97.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA001610 Approved "Secreted to blood" 96000000000 24000000000 "HPA001610: AB_1079656" "unprognostic (2.02e-2)" "unprognostic (2.41e-2)" "unprognostic (3.04e-1)" "unprognostic (3.54e-2)" "unprognostic (2.70e-1)" "prognostic favourable (7.24e-7)" "unprognostic (2.24e-1)" "unprognostic (1.95e-1)" "unprognostic (9.02e-3)" "unprognostic (1.76e-3)" "unprognostic (3.97e-2)" "unprognostic (6.74e-9)" "unprognostic (1.09e-3)" "unprognostic (2.29e-2)" "unprognostic (2.07e-1)" "unprognostic (5.54e-3)" 0.0 1.7 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 144.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.0 1.0 0.1 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.6 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.4 0.2 0.0 1.0 0.0 0.0 0.3 0.6 0.1 0.0 0.3 0.0 0.4 0.0 0.5 0.0 0.1 0.0 0.2 0.9 0.3 0.0 0.0 0.2 0.2 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.0 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 PON3 ENSG00000105852 "Paraoxonase 3" Q15166 7 95359944-95396368 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 148.0" "Cell line enhanced" "Detected in some" "A549: 19.8;CACO-2: 6.4;CAPAN-2: 4.8;Hep G2: 21.9;T-47d: 12.3" "Group enriched" "Detected in many" 9 "liver cancer: 30.8;lung cancer: 7.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 12 "NK-cells: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA014848, CAB025250" Enhanced "Secreted to blood" 1756666667 350000000 "CAB025250: , HPA014848: AB_1855540" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (6.28e-3)" "unprognostic (5.52e-3)" "unprognostic (1.36e-1)" "unprognostic (4.87e-1)" "unprognostic (1.44e-3)" "unprognostic (6.32e-2)" "unprognostic (1.11e-1)" "unprognostic (6.44e-3)" "unprognostic (9.14e-2)" "unprognostic (7.18e-3)" "unprognostic (8.30e-9)" "unprognostic (1.66e-1)" "unprognostic (1.04e-2)" "unprognostic (8.29e-2)" "unprognostic (5.12e-2)" 0.4 0.7 0.3 0.1 0.6 0.0 6.9 0.2 0.5 0.9 1.0 0.3 2.3 1.5 0.2 1.2 0.2 0.4 0.7 0.4 0.7 0.3 0.7 148.0 4.0 0.0 0.4 0.2 2.4 7.1 0.0 15.5 0.2 0.5 0.2 0.4 0.8 21.4 5.5 0.1 1.8 1.7 0.1 0.3 0.2 0.5 3.6 0.4 0.4 1.5 0.0 1.1 0.5 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.1 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 4.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 12.3 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.5 0.7 0.3 0.4 0.2 0.5 0.4 POPDC2 POP2 ENSG00000121577 "Popeye domain containing 2" Q9HBU9 3 119636457-119665324 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 90.5" "Cell line enriched" "Detected in single" 27 "SH-SY5Y: 25.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA024255 Enhanced "HPA024255: AB_1855545" "unprognostic (1.13e-1)" "unprognostic (1.17e-3)" "unprognostic (8.91e-3)" "unprognostic (9.48e-2)" "unprognostic (5.56e-2)" "unprognostic (7.64e-2)" "unprognostic (2.73e-2)" "unprognostic (2.43e-1)" "unprognostic (3.18e-2)" "unprognostic (1.72e-2)" "unprognostic (5.86e-3)" "unprognostic (1.80e-1)" "unprognostic (1.24e-2)" "unprognostic (6.26e-3)" "unprognostic (1.66e-2)" "unprognostic (2.12e-1)" "unprognostic (2.06e-2)" 1.3 0.3 0.2 1.0 0.2 0.0 0.6 0.3 0.2 1.8 16.0 0.2 7.6 0.6 2.0 1.3 3.3 1.8 6.1 90.5 0.2 0.0 0.5 0.3 0.3 1.4 0.2 0.3 0.8 0.7 0.1 0.2 0.3 0.3 5.0 1.5 0.3 0.6 13.4 12.1 0.4 2.2 12.6 0.2 0.5 2.4 0.5 0.2 0.3 0.5 3.8 0.8 10.2 1.1 0.9 0.7 2.1 3.0 0.3 2.2 0.4 0.0 0.1 0.4 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.9 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.2 25.5 0.0 0.0 0.4 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.7 0.0 0.1 0.1 0.2 0.5 2.1 0.1 1.3 0.9 0.1 1.1 0.3 1.1 1.0 0.1 0.9 2.2 0.7 0.1 0.3 3.0 0.7 1.6 0.4 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.3 0.3 0.2 POTEB "A26B1, CT104.5, POTE-15, POTE15" ENSG00000233917 "POTE ankyrin domain family member B" 15 21846329-21877703 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 77 "testis: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POTEB2 ENSG00000230031 "POTE ankyrin domain family member B2" H3BUK9 15 20835372-20866314 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 72 "testis: 7.1" "Cell line enriched" "Detected in single" 5 "RPMI-8226: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POTEB3 ENSG00000278522 "POTE ankyrin domain family member B3" "A0JP26, Q6S5H4" 15 21408243-21440451 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 53 "testis: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POTEC "A26B2, CT104.6, DKFZp686J0529, POTE-18, POTE18" ENSG00000183206 "POTE ankyrin domain family member C" B2RU33 18 14507339-14543585 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 16 "testis: 5.9" "Cell line enriched" "Detected in single" 14 "U-266/70: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.63e-1)" "unprognostic (9.88e-2)" "unprognostic (8.05e-2)" "unprognostic (1.64e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POTED "A26B3, ANKRD21, CT104.1, POTE, POTE-21, POTE21" ENSG00000166351 "POTE ankyrin domain family member D" Q86YR6 21 13609858-13641585 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 63 "testis: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POTEF "A26C1B, POTE2alpha, POTEACTIN" ENSG00000196604 "POTE ankyrin domain family member F" A5A3E0 2 130074030-130129222 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 5.7" "Cell line enhanced" "Detected in some" "AN3-CA: 4.3;BEWO: 3.5;CACO-2: 4.0;MCF7: 2.9;U-2 OS: 9.6;U-266/70: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041264, HPA041271, HPA043260" Uncertain "HPA041264: , HPA041271: , HPA043260: " "unprognostic (1.36e-1)" "unprognostic (1.23e-1)" "unprognostic (1.04e-1)" "unprognostic (2.98e-1)" "unprognostic (1.01e-1)" "unprognostic (1.18e-2)" "unprognostic (8.13e-3)" "unprognostic (1.44e-2)" "unprognostic (2.90e-2)" "unprognostic (1.16e-1)" "unprognostic (3.38e-1)" "unprognostic (2.23e-1)" "unprognostic (3.50e-1)" "unprognostic (1.02e-1)" "unprognostic (4.48e-1)" "unprognostic (1.05e-2)" "unprognostic (9.35e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.1 0.7 0.7 0.7 0.2 0.5 1.1 0.2 0.2 0.0 4.3 0.0 0.0 3.5 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.3 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 9.6 0.1 0.2 4.6 1.3 0.0 0.0 0.0 0.0 0.5 0.6 0.7 0.4 0.7 0.1 0.1 0.2 0.3 0.7 0.1 0.1 0.3 0.6 0.2 0.7 0.1 0.5 1.1 POU1F1 "GHF-1, PIT1, POU1F1a" ENSG00000064835 "POU class 1 homeobox 1" P28069 3 87259404-87276587 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 49 "pituitary gland: 138.8" "Cell line enhanced" "Detected in some" "A549: 1.8;SiHa: 1.1;U-87 MG: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA041646, HPA050624" Enhanced "HPA041646: AB_10794672, HPA050624: AB_2681192" "unprognostic (1.88e-1)" "unprognostic (2.06e-1)" "unprognostic (4.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.60e-1)" "unprognostic (2.93e-1)" "unprognostic (1.87e-2)" "unprognostic (7.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.50e-1)" "unprognostic (4.69e-3)" "unprognostic (1.55e-1)" "unprognostic (1.52e-2)" "unprognostic (1.87e-2)" "unprognostic (1.22e-1)" "unprognostic (1.05e-4)" 0.3 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 138.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.8 0.3 0.1 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.4 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.7 0.2 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POU3F2 "BRN2, OCT7, OTF7, POUF3" ENSG00000184486 "POU class 3 homeobox 2" P20265 6 98834592-98839470 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "brain: 28.0" "Cell line enhanced" "Detected in some" "AF22: 51.0;SK-MEL-30: 7.0;U-251 MG: 15.6;WM-115: 13.5" "Cancer enriched" "Detected in some" 11 "glioma: 16.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047081, HPA056261" Approved Supported Nucleoplasm Nucleoplasm "HPA047081: , HPA056261: " "unprognostic (5.94e-4)" "unprognostic (7.80e-2)" "unprognostic (3.07e-3)" "unprognostic (1.83e-1)" "unprognostic (3.57e-1)" "unprognostic (1.38e-1)" "unprognostic (1.17e-3)" "unprognostic (1.84e-1)" "unprognostic (1.16e-1)" "unprognostic (1.60e-1)" "unprognostic (1.63e-3)" "unprognostic (4.77e-1)" "unprognostic (9.38e-11)" "unprognostic (4.77e-2)" "unprognostic (2.84e-2)" "unprognostic (8.47e-3)" "unprognostic (4.04e-1)" 0.9 1.0 9.0 0.9 10.8 0.9 0.9 3.4 28.0 0.9 0.9 10.3 0.0 0.9 0.9 0.9 0.9 0.9 0.9 0.9 9.8 7.1 0.9 0.9 0.9 0.9 10.7 6.8 0.9 0.9 0.9 0.0 0.9 9.7 0.9 0.9 0.0 0.9 0.9 0.9 1.0 0.9 0.9 8.4 0.9 0.9 1.2 9.0 0.0 0.9 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 51.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.0 0.2 2.2 1.6 0.4 0.0 0.0 0.0 2.8 1.4 0.0 0.0 7.0 0.4 0.0 0.0 0.3 0.0 0.1 15.6 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.0 10.8 3.4 12.5 9.8 7.1 10.7 6.8 9.7 9.0 POU3F4 "BRN4, DFN3, DFNX2, OTF9" ENSG00000196767 "POU class 3 homeobox 4" P49335 X 83508261-83512127 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "brain: 39.0" "Cell line enriched" "Detected in single" 145 "AF22: 14.7" "Cancer enriched" "Detected in single" 21 "glioma: 5.6" "Region enriched" "Detected in all" 6 "basal ganglia: 39.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062295 Supported Nucleoplasm Nucleoplasm "HPA062295: " "unprognostic (5.73e-2)" "unprognostic (2.00e-1)" 0.5 0.5 3.3 0.5 39.0 0.6 0.5 5.0 15.2 0.5 0.7 2.4 0.0 0.5 0.5 0.5 0.5 0.5 1.3 0.5 2.8 1.6 2.5 0.5 0.5 0.5 2.4 3.7 1.1 0.5 0.5 0.1 0.5 2.4 0.5 0.6 0.0 0.5 0.5 0.5 0.5 0.5 0.6 1.7 0.5 0.5 0.5 6.6 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 39.0 5.0 4.2 2.8 1.6 2.4 3.7 2.4 6.6 POU4F1 "BRN3A, RDC-1" ENSG00000152192 "POU class 4 homeobox 1" Q01851 13 78598362-78603560 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 25.3" "Cell line enhanced" "Detected in some" "HEK 293: 10.9;HEL: 11.5;REH: 8.1;RH-30: 13.9;SCLC-21H: 13.3;U-266/70: 12.5" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 23 "pons and medulla: 25.3" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.1" "Group enriched" "Detected in some" 14 "midbrain: 3.0;pons and medulla: 2.2;thalamus: 2.4" "Group enriched" "Detected in some" 25 "midbrain: 3.1;pons and medulla: 7.4;thalamus: 2.5" HPA068024 Enhanced Approved "HPA068024: " "unprognostic (6.70e-2)" "unprognostic (2.38e-1)" "unprognostic (1.27e-4)" "unprognostic (1.03e-1)" "unprognostic (1.25e-2)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (6.30e-2)" "unprognostic (6.00e-2)" "unprognostic (1.70e-2)" "unprognostic (9.17e-2)" "unprognostic (8.98e-2)" "unprognostic (9.95e-2)" "unprognostic (1.53e-1)" "unprognostic (4.75e-3)" 0.1 0.0 1.1 2.3 1.0 1.2 1.0 0.2 0.4 0.1 0.1 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.2 1.0 1.0 0.0 0.5 0.1 2.3 0.7 0.0 0.0 0.1 0.1 0.0 0.9 25.3 0.0 0.3 6.3 0.2 0.0 1.8 0.4 0.3 0.0 2.5 0.3 0.3 4.4 0.4 2.7 0.0 0.2 3.5 0.3 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 10.9 11.5 0.0 1.4 0.0 5.7 3.4 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.5 0.0 0.8 1.0 0.0 0.0 8.1 13.9 0.0 0.0 0.0 13.3 0.1 0.0 0.0 0.5 0.0 1.1 0.1 0.0 0.0 0.2 0.0 12.5 3.7 0.0 0.0 6.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.1 1.0 0.2 0.4 1.0 1.0 0.7 0.0 25.3 0.4 POU5F2 "FLJ25680, SPRM-1" ENSG00000248483 "POU domain class 5, transcription factor 2" Q8N7G0 5 93733220-93741637 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 26.8" "Cell line enriched" "Detected in some" 7 "U-2 OS: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA077615 Enhanced Approved Nucleoplasm Nucleoplasm "HPA077615: " "unprognostic (1.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.53e-1)" "unprognostic (1.17e-1)" "unprognostic (3.03e-1)" "unprognostic (9.17e-3)" "unprognostic (3.72e-2)" "unprognostic (5.87e-3)" "unprognostic (4.58e-1)" "unprognostic (1.49e-1)" "unprognostic (3.53e-2)" "unprognostic (3.84e-1)" "unprognostic (6.16e-9)" "unprognostic (1.87e-1)" "unprognostic (2.01e-1)" "unprognostic (2.21e-1)" "unprognostic (1.44e-3)" 0.2 0.2 0.2 0.2 0.2 1.2 0.8 0.2 0.9 0.2 0.2 0.2 0.2 0.6 0.2 0.6 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.1 0.2 0.2 0.2 0.2 1.4 0.6 0.2 0.2 0.3 0.5 26.8 0.2 0.2 0.5 0.2 0.2 0.2 0.2 2.0 0.5 2.7 0.6 1.1 1.3 0.3 0.4 0.6 1.1 0.5 0.2 0.4 0.5 0.2 0.0 0.3 0.1 0.3 0.4 0.9 0.4 0.2 0.6 0.8 0.3 0.5 0.5 0.7 0.8 0.7 0.6 0.2 0.8 0.8 0.5 0.7 0.5 0.4 0.1 0.6 1.1 0.3 0.4 0.7 1.0 0.7 0.2 0.5 1.1 0.9 0.2 0.3 1.0 0.9 0.6 0.7 0.2 0.5 0.7 0.6 0.5 8.3 0.7 0.7 0.8 0.5 0.8 0.4 0.9 0.4 1.4 0.6 0.3 1.0 0.4 1.0 0.8 0.7 0.6 0.1 2.0 0.7 1.1 2.7 1.1 0.4 0.5 1.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 PP2D1 "C3orf48, FLJ25449" ENSG00000183977 "Protein phosphatase 2C like domain containing 1" A8MPX8 3 19979961-20012330 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 28.8" "Cell line enhanced" "Detected in some" "U-266/84: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036870, HPA066083" Enhanced Uncertain "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA036870: AB_10671246, HPA066083: " "unprognostic (1.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (2.04e-1)" "unprognostic (3.76e-1)" "unprognostic (6.27e-4)" "unprognostic (3.29e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (3.40e-1)" "unprognostic (4.35e-2)" "unprognostic (6.00e-2)" "unprognostic (3.50e-1)" "unprognostic (8.77e-2)" "unprognostic (1.87e-1)" "unprognostic (4.93e-3)" "unprognostic (1.04e-1)" 0.2 0.1 0.1 0.2 0.1 3.0 0.1 0.7 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.3 0.3 0.2 0.1 0.1 0.3 0.2 28.8 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.7 0.5 1.2 0.6 0.0 0.9 0.0 0.3 0.5 0.7 0.9 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.5 0.8 1.5 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.6 0.6 0.9 0.2 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.2 1.0 0.8 1.0 0.3 0.8 0.9 1.6 0.0 0.3 0.4 1.9 0.1 2.2 1.3 0.7 0.8 0.2 0.0 0.3 0.3 0.5 0.6 4.0 1.6 1.8 0.8 0.3 0.0 0.5 0.9 0.8 0.6 0.3 0.2 0.5 0.4 0.1 0.7 0.9 0.8 1.2 0.0 0.4 0.5 0.0 0.0 0.1 0.1 0.7 0.3 0.1 0.1 0.1 0.1 0.1 0.1 PPDPFL C8orf22 ENSG00000168333 "Pancreatic progenitor cell differentiation and proliferation factor like" Q8WWR9 8 49054311-49076090 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 311.2" "Cell line enriched" "Detected in single" 10 "HEL: 5.6" "Group enriched" "Detected in some" 9 "glioma: 0.7;renal cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060329 Uncertain "HPA060329: " "unprognostic (6.33e-2)" "unprognostic (2.72e-1)" "prognostic unfavourable (2.06e-10)" 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.7 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.5 0.1 311.2 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 57.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 PPEF2 PPP7CB ENSG00000156194 "Protein phosphatase with EF-hand domain 2" O14830 4 75859864-75902571 "Enzymes, Predicted intracellular proteins" "Sensory transduction, Vision" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "retina: 75.7" "Cell line enhanced" "Detected in single" "hTCEpi: 1.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "cerebellum: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.19e-2)" "unprognostic (2.92e-1)" "unprognostic (2.50e-1)" "unprognostic (4.73e-2)" "unprognostic (1.53e-1)" "unprognostic (9.02e-2)" "unprognostic (3.32e-4)" "unprognostic (2.74e-2)" "unprognostic (4.54e-8)" "unprognostic (2.89e-1)" "unprognostic (5.98e-2)" "unprognostic (5.16e-1)" "unprognostic (3.66e-3)" 0.1 0.0 0.0 0.2 0.4 0.2 0.3 3.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 75.7 0.0 0.0 0.3 0.4 0.1 0.1 0.1 0.3 0.1 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 3.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 PPFIA2 ENSG00000139220 "PTPRF interacting protein alpha 2" O75334 12 81257975-81759553 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 48.8" "Group enriched" "Detected in some" 8 "HAP1: 24.7;SCLC-21H: 8.5" "Cancer enhanced" "Detected in some" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 27 "basophil: 2.6" "Lineage enriched" "Detected in single" 27 "granulocytes: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (4.31e-2)" "unprognostic (2.72e-1)" "unprognostic (1.82e-2)" "unprognostic (6.78e-5)" "unprognostic (4.69e-3)" "unprognostic (2.13e-1)" "unprognostic (6.67e-2)" "unprognostic (7.10e-2)" "unprognostic (8.92e-2)" "unprognostic (3.97e-2)" "unprognostic (3.76e-1)" "unprognostic (9.84e-2)" "unprognostic (3.27e-3)" "unprognostic (2.45e-2)" "unprognostic (4.88e-2)" "unprognostic (4.49e-3)" "unprognostic (1.06e-3)" 2.6 8.3 23.0 1.4 17.7 0.9 1.8 7.2 48.8 6.0 2.3 10.5 0.0 1.4 3.2 1.8 1.8 2.4 3.2 1.2 19.2 10.6 2.0 1.3 1.9 1.1 10.1 20.9 2.2 1.7 1.0 4.5 1.0 8.6 2.7 2.7 2.5 1.2 5.5 1.0 1.9 1.7 3.7 7.7 1.2 2.0 8.2 9.7 0.0 1.3 0.0 1.1 2.4 2.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.1 0.0 1.2 0.0 8.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.6 0.0 1.7 0.0 0.0 0.0 0.8 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 17.7 7.2 38.3 19.2 10.6 10.1 20.9 8.6 9.7 PPP1R14D "CPI17-like, FLJ20251, GBPI-1, MGC119014, MGC119016" ENSG00000166143 "Protein phosphatase 1 regulatory inhibitor subunit 14D" Q9NXH3 15 40815445-40828709 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 71.3" "Cell line enhanced" "Detected in some" "Hep G2: 3.5;RPMI-8226: 6.6;RT4: 4.2;SK-BR-3: 2.8;T-47d: 2.6;U-266/84: 4.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 45.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA041846 Uncertain "HPA041846: AB_10794307" "unprognostic (1.29e-2)" "unprognostic (1.49e-1)" "unprognostic (1.35e-1)" "unprognostic (1.82e-1)" "unprognostic (5.91e-3)" "unprognostic (1.17e-2)" "unprognostic (4.68e-2)" "unprognostic (1.89e-1)" "unprognostic (7.74e-2)" "unprognostic (2.86e-1)" "unprognostic (5.26e-3)" "unprognostic (3.16e-2)" "prognostic unfavourable (3.07e-4)" "unprognostic (3.55e-1)" "unprognostic (1.43e-2)" "unprognostic (3.74e-3)" "unprognostic (3.11e-2)" 0.2 0.1 0.2 13.6 0.2 0.0 0.3 0.3 0.2 0.2 33.6 0.2 0.2 33.9 0.2 0.3 0.3 0.4 10.0 0.2 0.2 0.2 2.3 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.0 0.2 0.2 0.2 0.5 28.9 0.2 0.5 0.2 0.2 0.3 71.3 0.8 0.2 0.2 0.4 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 1.2 1.1 0.4 1.9 0.3 1.0 0.2 0.1 0.8 0.1 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.6 2.1 0.2 0.3 0.0 0.3 0.0 0.2 0.0 0.3 0.2 0.2 0.5 3.5 0.0 0.5 0.2 0.0 0.4 0.0 0.0 0.0 0.2 1.2 0.0 0.5 0.1 0.4 0.1 0.0 0.0 0.4 6.6 0.0 4.2 1.2 0.8 0.0 2.8 0.0 2.6 0.0 0.0 0.2 0.0 0.1 0.0 0.2 4.4 0.8 0.1 0.1 0.0 0.4 1.2 0.1 0.6 0.9 0.3 0.1 1.0 0.3 0.1 1.2 0.6 0.8 0.4 0.3 1.9 1.1 0.4 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 PPP1R27 "DYSFIP1, toonin" ENSG00000182676 "Protein phosphatase 1 regulatory subunit 27" Q86WC6 17 81833492-81835050 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "skeletal muscle: 211.0" "Group enriched" "Detected in some" 23 "HL-60: 62.4;THP-1: 121.0" "Cancer enriched" "Detected in single" 10 "head and neck cancer: 3.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048632 Uncertain "HPA048632: " "unprognostic (3.35e-2)" "unprognostic (1.12e-4)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (1.29e-1)" "unprognostic (1.85e-2)" "unprognostic (1.37e-1)" "unprognostic (2.21e-2)" "unprognostic (7.07e-2)" "unprognostic (1.32e-1)" "unprognostic (5.38e-2)" "unprognostic (8.70e-2)" "unprognostic (4.98e-6)" "unprognostic (7.97e-2)" "unprognostic (1.21e-1)" "unprognostic (2.19e-3)" "unprognostic (1.30e-1)" 1.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.7 0.0 0.0 1.7 0.0 211.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 9.6 1.2 0.0 0.0 0.8 0.4 3.2 0.4 0.7 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 121.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.4 0.3 0.3 0.2 0.3 0.4 0.2 0.2 0.3 0.8 0.3 0.4 3.2 0.7 0.3 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPP1R2B "MGC87149, PPP1R2P3" ENSG00000231989 "PPP1R2 family member B" 5 156850538-156852528 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "testis: 36.0" "Cell line enriched" "Detected in single" 13 "U-266/84: 5.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "HPA043729, HPA059420" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043729: , HPA059420: " "unprognostic (1.96e-1)" "unprognostic (2.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (9.36e-2)" "unprognostic (1.46e-2)" "unprognostic (1.89e-1)" "unprognostic (4.47e-2)" "unprognostic (1.39e-2)" "unprognostic (3.26e-2)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (8.51e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-2)" "unprognostic (1.07e-2)" "unprognostic (5.19e-2)" 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.2 0.3 0.3 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 36.0 0.0 0.4 0.4 0.0 0.2 0.1 0.0 0.5 0.4 0.9 0.5 0.5 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.2 0.0 0.1 0.0 0.0 0.5 0.1 0.9 0.2 0.5 0.5 0.5 0.6 0.5 0.4 0.2 1.1 0.5 0.6 0.5 0.2 0.1 0.7 0.2 PPP1R2C "I-4, PPP1R2P9" ENSG00000102055 "PPP1R2C family member C" O14990 X 42777368-42778247 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 37.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 38 "testis cancer: 1.8" "Group enriched" "Detected in some" 7 "memory B-cell: 1.2;T-reg: 2.4" "Group enriched" "Detected in many" 18 "B-cells: 1.2;T-cells: 2.4" "unprognostic (1.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 PPP1R32 "C11orf66, FLJ32771, IIIG9" ENSG00000162148 "Protein phosphatase 1 regulatory subunit 32" Q7Z5V6 11 61481120-61490931 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 141.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039068 Enhanced "HPA039068: AB_10672840" "unprognostic (1.70e-1)" "unprognostic (3.18e-3)" "unprognostic (4.48e-4)" "prognostic favourable (4.13e-4)" "unprognostic (2.23e-1)" "unprognostic (1.07e-2)" "unprognostic (1.50e-3)" "unprognostic (4.52e-2)" "unprognostic (2.81e-1)" "unprognostic (1.60e-1)" "unprognostic (1.04e-2)" "unprognostic (3.03e-2)" "unprognostic (9.44e-9)" "unprognostic (2.64e-1)" "unprognostic (2.71e-1)" "unprognostic (2.32e-1)" "unprognostic (1.75e-2)" 2.1 1.5 4.7 1.5 11.5 2.2 1.9 2.4 3.2 2.8 1.7 13.6 1.1 1.6 3.1 13.8 1.2 22.3 1.6 1.3 5.9 5.6 1.8 3.2 7.0 3.2 1.7 2.2 5.5 1.4 1.1 5.5 1.8 21.2 1.6 1.1 1.1 1.9 2.3 1.8 5.8 1.5 2.3 1.6 2.9 1.4 141.3 3.1 1.1 1.3 1.1 1.9 1.3 1.7 1.4 1.4 5.6 3.5 2.0 3.8 2.7 0.7 1.6 9.8 4.1 4.5 6.7 1.2 2.0 1.6 1.3 1.1 0.5 8.5 1.8 2.8 0.9 1.0 1.4 0.7 2.5 3.0 2.0 2.4 0.5 0.3 4.3 1.6 1.9 6.9 2.5 0.5 7.3 1.0 0.8 5.8 0.5 2.1 2.3 3.4 0.7 0.9 4.6 0.2 0.6 1.2 0.4 1.1 2.4 0.3 4.3 0.7 5.0 5.2 3.6 0.5 2.1 1.5 0.4 9.4 2.4 1.2 1.1 6.8 0.8 3.8 3.0 2.0 3.0 3.5 2.8 1.3 2.0 0.7 1.4 1.4 1.3 3.8 5.6 2.0 1.1 1.1 2.3 2.7 4.7 11.5 2.4 3.2 5.9 5.6 1.7 2.2 21.2 3.1 PPP1R36 C14orf50 ENSG00000165807 "Protein phosphatase 1 regulatory subunit 36" Q96LQ0 14 64549902-64589380 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 37.3" "Cell line enriched" "Detected in some" 5 "CAPAN-2: 17.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077492 Enhanced "HPA077492: " "unprognostic (3.43e-4)" "unprognostic (5.75e-2)" "unprognostic (4.48e-2)" "unprognostic (6.04e-4)" "unprognostic (1.12e-2)" "unprognostic (9.37e-2)" "unprognostic (1.52e-3)" "unprognostic (9.21e-2)" "unprognostic (2.32e-1)" "unprognostic (9.09e-2)" "unprognostic (2.42e-1)" "unprognostic (1.17e-1)" "unprognostic (4.80e-3)" "unprognostic (9.77e-3)" "unprognostic (3.53e-1)" "unprognostic (7.12e-2)" "unprognostic (5.46e-2)" 1.5 0.3 0.7 1.3 1.6 0.0 1.0 0.2 1.1 1.1 6.0 1.4 0.5 5.1 0.6 2.4 0.4 8.9 2.7 0.7 1.1 1.1 2.5 0.5 1.4 0.0 1.5 0.0 2.2 8.3 0.6 2.9 1.1 2.9 0.5 4.0 0.8 6.5 0.6 0.7 0.8 6.7 0.0 2.8 0.5 5.3 37.3 0.7 0.0 0.3 1.2 0.5 1.2 0.8 0.0 0.6 0.4 0.4 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.1 0.3 0.0 0.3 0.7 0.0 17.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.2 0.3 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 1.0 0.0 1.6 1.1 0.6 0.0 0.1 1.4 0.4 0.5 0.2 0.5 1.8 0.0 0.7 1.6 0.2 1.1 1.1 1.1 1.5 0.0 2.9 0.7 PPP1R3C "PPP1R5, PTG" ENSG00000119938 "Protein phosphatase 1 regulatory subunit 3C" Q9UQK1 10 91628442-91633054 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 259.9" "Cell line enhanced" "Detected in many" "HeLa: 17.3;HHSteC: 21.9;LHCN-M2: 41.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027041 Uncertain "HPA027041: AB_1855649" "unprognostic (2.11e-1)" "unprognostic (1.86e-3)" "unprognostic (1.01e-1)" "unprognostic (2.44e-1)" "unprognostic (7.15e-3)" "unprognostic (1.57e-2)" "unprognostic (3.33e-2)" "unprognostic (6.38e-2)" "unprognostic (1.85e-2)" "unprognostic (1.75e-3)" "unprognostic (5.63e-3)" "unprognostic (1.59e-2)" "unprognostic (5.48e-3)" "unprognostic (8.44e-3)" "unprognostic (4.86e-2)" "unprognostic (2.49e-1)" "unprognostic (4.61e-3)" 4.0 5.4 10.4 2.8 18.9 1.5 3.5 1.1 15.8 24.9 4.1 8.0 8.3 2.7 7.1 6.5 26.5 4.5 6.0 53.3 13.1 5.7 5.4 39.5 5.4 1.8 6.1 8.1 6.6 5.6 2.8 1.7 6.3 12.2 11.0 2.8 4.5 10.0 13.4 259.9 4.4 2.2 14.8 9.1 2.2 5.2 2.2 6.1 0.0 2.4 28.2 7.7 11.4 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.7 10.9 5.0 2.4 0.0 12.1 9.4 4.9 5.3 0.0 0.9 0.0 0.5 11.2 0.6 0.2 1.3 9.2 0.0 0.0 0.1 17.3 1.9 21.9 0.0 0.0 8.1 2.1 3.1 0.2 1.2 5.6 0.0 41.9 0.4 0.0 0.0 0.7 0.0 0.0 2.6 0.0 0.4 10.5 0.3 0.7 0.0 0.0 0.0 0.0 1.8 8.2 2.2 2.2 2.9 1.7 0.0 0.2 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 18.9 1.1 15.8 13.1 5.7 6.1 8.1 12.2 6.1 PPP2R2B "B55beta, PR52B, PR55-BETA, SCA12" ENSG00000156475 "Protein phosphatase 2 regulatory subunit Bbeta" Q00005 5 146581146-147084784 "Disease related genes, Predicted intracellular proteins" Apoptosis "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 73.2" "Cell line enriched" "Detected in some" 4 "HDLM-2: 46.4" "Cancer enriched" "Detected in some" 8 "glioma: 7.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 15.1;MAIT T-cell: 13.8;memory CD4 T-cell: 7.1;memory CD8 T-cell: 16.1;naive CD8 T-cell: 12.0;NK-cell: 9.5;T-reg: 8.0" "Group enriched" "Detected in many" 33 "NK-cells: 9.5;T-cells: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038118, HPA042122, HPA042770" Approved Approved Cytosol Cytosol "HPA038118: AB_10697238, HPA042122: , HPA042770: " "unprognostic (4.54e-5)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.80e-4)" "unprognostic (2.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.76e-1)" "unprognostic (1.84e-2)" "unprognostic (2.68e-1)" "unprognostic (3.20e-2)" "unprognostic (9.73e-4)" "unprognostic (4.51e-2)" "unprognostic (1.49e-8)" "unprognostic (2.02e-1)" "unprognostic (3.67e-1)" "unprognostic (5.48e-5)" "unprognostic (1.14e-4)" 2.0 9.7 30.8 2.5 35.2 2.9 1.8 10.2 73.2 1.6 2.7 26.0 0.0 3.0 1.7 1.8 2.9 14.5 2.9 2.9 26.4 20.9 4.7 2.4 2.5 4.3 25.5 22.4 1.6 2.9 16.0 6.4 2.6 27.5 2.7 2.8 4.6 2.0 2.9 1.5 4.9 2.3 3.5 18.6 2.9 2.2 15.7 29.3 0.0 4.2 0.0 2.4 6.8 1.1 0.0 0.0 0.3 0.0 9.5 16.1 4.1 0.4 0.4 2.4 1.0 0.1 0.1 0.2 0.5 0.2 1.1 1.5 1.3 4.7 0.2 0.1 0.0 10.0 0.8 1.0 1.1 46.4 0.2 0.6 2.7 0.5 0.1 0.0 0.2 0.1 0.6 0.0 0.2 0.1 0.6 0.5 0.7 0.3 0.0 0.0 6.1 1.0 0.7 0.1 0.1 4.1 10.7 1.9 0.2 0.3 0.0 0.2 0.4 0.1 0.3 0.2 0.7 2.5 0.4 0.3 0.2 0.0 1.7 4.2 1.3 0.2 0.0 0.0 15.1 0.0 13.8 0.0 7.1 16.1 0.0 0.0 1.3 12.0 0.3 9.5 0.0 0.0 8.0 4.1 30.8 35.2 10.2 34.1 26.4 20.9 25.5 22.4 27.5 29.3 PPP3R2 PPP3RL ENSG00000188386 "Protein phosphatase 3 regulatory subunit B, beta" Q96LZ3 9 101591615-101595021 "FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 90 "testis: 81.9" "Cell line enhanced" "Detected in single" "Karpas-707: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA047157 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA047157: " "unprognostic (8.81e-2)" "unprognostic (2.65e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 PPP4R3C "FLFL3P, FLJ32867, PPP4R3CP, SMEK3P, smk1" ENSG00000224960 "Protein phosphatase 4 regulatory subunit 3C" Q6ZMV5 X 27460211-27463341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "testis: 6.6" "Cell line enriched" "Detected in single" 148 "U-2197: 21.3" "Cancer enhanced" "Detected in some" "liver cancer: 0.6;testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (8.74e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPY PNP ENSG00000108849 "Pancreatic polypeptide" P01298 17 43940804-43942468 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "pancreas: 275.8" "Group enriched" "Detected in some" 4 "BEWO: 7.0;EFO-21: 6.5;U-2 OS: 7.2" "Cancer enriched" "Detected in some" 132 "pancreatic cancer: 630.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "myeloid DC: 4.1" "Lineage enriched" "Detected in single" 42 "dendritic cells: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016735, HPA032122" Enhanced "Secreted to blood" 62720 "CAB016735: , HPA032122: " "unprognostic (5.12e-3)" "unprognostic (1.10e-1)" "unprognostic (3.27e-2)" "unprognostic (1.65e-2)" "unprognostic (7.56e-3)" "unprognostic (8.13e-2)" "unprognostic (1.33e-1)" "unprognostic (7.78e-3)" "unprognostic (1.42e-1)" 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 275.8 7.5 0.1 0.1 0.1 0.1 2.5 0.1 0.1 0.1 0.1 2.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 6.5 0.0 0.0 0.0 0.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 1.0 0.0 7.2 0.8 0.9 0.0 0.5 1.4 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 PRAME "CT130, MAPE" ENSG00000185686 "Preferentially expressed antigen in melanoma" P78395 22 22547701-22559361 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 54.3" "Cell line enriched" "Detected in some" 5 "K-562: 139.9" "Group enriched" "Detected in many" 5 "endometrial cancer: 73.4;melanoma: 139.6;ovarian cancer: 29.4;testis cancer: 51.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045153, HPA068562" Enhanced Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA045153: AB_10797259, HPA068562: " "unprognostic (9.36e-3)" "unprognostic (9.74e-2)" "unprognostic (1.02e-1)" "unprognostic (3.87e-2)" "unprognostic (5.20e-2)" "prognostic unfavourable (3.41e-4)" "unprognostic (3.43e-2)" "unprognostic (4.00e-2)" "unprognostic (1.33e-1)" "unprognostic (6.52e-3)" "unprognostic (9.68e-3)" "unprognostic (2.06e-1)" "prognostic unfavourable (7.48e-9)" "unprognostic (1.95e-1)" "unprognostic (2.21e-1)" "unprognostic (8.87e-2)" "unprognostic (1.26e-1)" 0.1 1.7 0.1 0.3 0.3 0.0 0.1 0.3 0.1 0.2 0.3 0.1 0.5 0.0 2.8 10.9 0.1 0.2 0.1 0.3 0.2 0.0 0.7 0.1 0.1 0.1 0.1 0.1 2.2 0.1 0.0 0.1 0.4 0.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.2 0.0 54.3 0.1 0.3 0.1 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 9.1 0.0 19.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 13.9 0.0 0.0 0.6 0.0 0.0 8.4 2.0 4.9 3.6 0.1 0.0 0.4 26.7 0.0 0.0 0.0 0.0 0.0 139.9 2.2 0.0 1.2 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.1 28.7 0.0 0.0 0.0 4.2 3.4 0.7 0.0 25.2 0.0 0.0 0.4 1.9 0.1 0.0 0.1 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.1 0.2 0.0 0.1 0.1 0.4 0.1 PRAMEF10 ENSG00000187545 "PRAME family member 10" O60809 1 12892896-12898270 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 67 "liver: 7.5" "Cell line enriched" "Detected in single" 26 "SCLC-21H: 2.6" "Cancer enriched" "Detected in single" 29 "liver cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.20e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF11 ENSG00000239810 "PRAME family member 11" 1 12824605-12831410 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 18 "testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF15 ENSG00000204501 "PRAME family member 15" Q5VWM5 1 13315581-13322598 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "liver: 2.2" "Cell line enriched" "Detected in single" 5 "SCLC-21H: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF18 ENSG00000279804 "PRAME family member 18" Q5VWM3 1 13222705-13226106 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 4 "bone marrow: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057423 Uncertain "HPA057423: " 0.0 0.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.5 0.8 0.0 0.2 0.0 0.1 0.1 0.5 0.0 0.2 0.2 0.4 0.2 0.0 0.1 0.1 0.0 0.6 0.1 0.3 0.1 0.1 0.2 0.0 0.5 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 PRB1 "PM, PMF, PMS, PRB1L, PRB1M" ENSG00000251655 "Proline rich protein BstNI subfamily 1" 12 11351823-11395566 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 80 "salivary gland: 605.6" "Cell line enriched" "Detected in single" 5 "U-2 OS: 1.7" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 605.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 PRB2 "cP7, PRPPRB1, Ps" ENSG00000121335 "Proline rich protein BstNI subfamily 2" P02812 12 11391540-11501041 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 94 "salivary gland: 544.2" "Cell line enriched" "Detected in single" 5 "U-2 OS: 2.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 5.8" "Cell type enriched" "Detected in single" 23 "myeloid DC: 2.2" "Lineage enriched" "Detected in single" 23 "dendritic cells: 2.2" "Secreted to digestive system" "unprognostic (1.36e-1)" "unprognostic (1.01e-2)" "unprognostic (2.61e-1)" "unprognostic (2.07e-2)" "unprognostic (9.21e-2)" "unprognostic (5.51e-3)" "unprognostic (1.97e-4)" "unprognostic (1.51e-1)" 0.1 0.0 1.3 0.1 5.8 0.0 0.1 0.1 2.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 2.3 0.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 544.2 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 5.8 0.1 2.9 2.3 0.7 0.1 0.1 0.1 0.1 PRB3 PRG ENSG00000197870 "Proline rich protein BstNI subfamily 3" Q04118 12 11265924-11269805 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 208 "salivary gland: 2125.3" "Cell line enriched" "Detected in some" 5 "NTERA-2: 6.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Lineage enhanced" "Detected in single" "T-cells: 1.4" "Secreted to digestive system" "unprognostic (4.12e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-3)" "unprognostic (1.51e-1)" "unprognostic (7.46e-3)" "unprognostic (4.12e-2)" "unprognostic (9.65e-2)" "unprognostic (1.94e-2)" "unprognostic (8.27e-2)" "unprognostic (9.98e-2)" "unprognostic (2.35e-1)" "unprognostic (2.11e-2)" "unprognostic (1.04e-1)" "unprognostic (2.86e-1)" "unprognostic (1.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 2125.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.9 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.3 0.5 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRB4 ENSG00000230657 "Proline rich protein BstNI subfamily 4" 12 11307083-11310435 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 273 "salivary gland: 3472.8" "Cell line enriched" "Detected in single" 31 "CACO-2: 7.6" "Group enriched" "Detected in some" 10 "lung cancer: 2.0;melanoma: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" "unprognostic (1.05e-1)" "unprognostic (8.25e-2)" 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 12.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3472.8 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.1 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PRCD RP36 ENSG00000214140 "Photoreceptor disc component" Q00LT1 17 76527586-76553578 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "retina: 61.1" "Cell line enhanced" "Detected in some" "ASC diff: 3.4;ASC TERT1: 3.2;BEWO: 3.6;Hep G2: 4.9;HHSteC: 3.2;HSkMC: 4.1;SH-SY5Y: 3.2" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 12 "cerebellum: 14.8" "Group enriched" "Detected in some" 6 "memory B-cell: 1.0;naive B-cell: 1.8;NK-cell: 1.6" "Group enriched" "Detected in many" 7 "B-cells: 1.8;NK-cells: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Intracellular and membrane" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-3)" "unprognostic (3.74e-1)" "unprognostic (1.31e-4)" "unprognostic (6.56e-2)" "unprognostic (4.07e-3)" "unprognostic (1.76e-1)" "unprognostic (2.07e-1)" "unprognostic (4.04e-2)" "unprognostic (2.45e-1)" "unprognostic (1.19e-6)" "unprognostic (1.03e-1)" "unprognostic (1.10e-1)" "unprognostic (8.94e-3)" "unprognostic (1.39e-2)" 1.6 2.2 0.7 0.7 0.7 0.0 1.5 14.8 1.1 1.2 0.7 0.7 0.7 0.7 1.5 3.5 0.7 1.1 1.5 2.0 0.7 0.5 0.7 0.7 1.1 1.4 0.7 0.7 1.3 0.8 4.1 0.7 1.4 1.2 1.1 0.0 61.1 2.3 1.2 1.2 1.5 0.7 0.7 1.0 2.3 0.4 0.7 0.7 0.7 1.0 1.0 0.7 1.7 1.9 1.8 0.0 0.2 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 3.4 3.2 3.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 4.9 3.2 0.0 0.0 4.1 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 1.8 0.0 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.7 0.7 14.8 1.1 0.7 0.5 0.7 0.7 1.2 0.7 PRDM7 ZNF910 ENSG00000126856 "PR/SET domain 7" Q9NQW5 16 90056566-90092072 "Enzymes, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 4.8" "Group enriched" "Detected in some" 20 "REH: 8.9;SK-MEL-30: 6.5" "Cancer enriched" "Detected in single" 30 "melanoma: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA059944 Approved Uncertain "Nuclear speckles" "Nuclear speckles" "HPA059944: " "unprognostic (3.98e-1)" "unprognostic (8.89e-2)" "unprognostic (8.02e-3)" "unprognostic (8.26e-2)" "unprognostic (9.01e-2)" "unprognostic (5.61e-3)" "unprognostic (1.05e-2)" "unprognostic (1.46e-1)" "unprognostic (5.73e-1)" "unprognostic (5.52e-4)" "unprognostic (1.36e-1)" "unprognostic (1.61e-1)" "unprognostic (4.03e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PRG2 "BMPG, MBP, proMBP" ENSG00000186652 "Proteoglycan 2, pro eosinophil major basic protein" P13727 11 57386794-57390657 "Plasma proteins, Predicted intracellular proteins" Immunity "Antibiotic, Antimicrobial, Heparin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "placenta: 322.3" "Group enriched" "Detected in some" 63 "HL-60: 140.2;HMC-1: 222.9;NB-4: 443.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 28 "basophil: 9.1" "Lineage enriched" "Detected in single" 92 "granulocytes: 9.1" "Not detected" "Not detected" HPA038515 Supported "Intracellular and membrane" 130000000 "HPA038515: AB_10675800" "unprognostic (7.32e-2)" "unprognostic (1.68e-1)" "unprognostic (3.39e-2)" "unprognostic (3.49e-1)" "unprognostic (8.62e-4)" "unprognostic (4.77e-3)" "unprognostic (3.20e-2)" "unprognostic (4.17e-2)" "unprognostic (2.26e-2)" "unprognostic (5.19e-3)" "unprognostic (2.17e-1)" "unprognostic (1.40e-11)" "unprognostic (4.26e-2)" "unprognostic (4.52e-3)" "unprognostic (6.47e-2)" "unprognostic (2.32e-1)" 1.5 0.0 0.1 0.1 0.1 16.9 0.9 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.6 0.0 0.2 0.3 0.1 0.0 0.1 2.8 2.2 0.1 0.1 0.1 0.1 0.3 0.0 0.4 322.3 0.1 0.1 0.0 0.1 0.5 0.1 0.3 1.8 0.1 0.1 0.1 6.8 0.1 0.1 0.1 1.6 0.4 0.1 0.2 0.1 0.2 0.0 0.0 9.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 140.2 222.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 443.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 PRH1 Pa ENSG00000231887 "Proline rich protein HaeIII subfamily 1" 12 10824960-11171608 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 916 "salivary gland: 2360.8" "Cell line enhanced" "Detected in some" "BJ: 2.1;BJ hTERT+ SV40 Large T+: 2.5;CAPAN-2: 5.5;HBF TERT88: 1.6;HSkMC: 2.0;U-87 MG: 1.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "unprognostic (1.39e-1)" "unprognostic (1.38e-1)" "unprognostic (3.83e-3)" "unprognostic (3.61e-1)" "unprognostic (1.66e-1)" "unprognostic (3.70e-1)" "unprognostic (6.81e-2)" "unprognostic (6.85e-2)" "unprognostic (7.35e-3)" "unprognostic (2.14e-1)" "unprognostic (5.00e-3)" "unprognostic (1.16e-1)" "unprognostic (1.61e-2)" "unprognostic (1.50e-1)" "unprognostic (1.13e-1)" "unprognostic (1.73e-2)" "unprognostic (2.68e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2360.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.2 0.0 0.0 0.2 1.7 1.2 0.3 1.1 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 1.0 2.5 0.0 0.6 5.5 0.7 0.0 0.0 0.3 0.0 0.6 1.6 0.2 0.0 0.0 0.0 1.4 1.2 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.9 0.7 0.0 0.0 0.1 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 1.2 0.5 0.0 0.3 0.2 0.7 0.1 0.0 0.2 0.4 0.8 0.0 1.1 0.2 1.7 1.6 0.0 PRH2 Pr ENSG00000134551 "Proline rich protein HaeIII subfamily 2" P02810 12 10929236-10932341 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 128 "salivary gland: 2507.3" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;hTERT-HME1: 1.2;PC-3: 1.1" "Cancer enriched" "Detected in some" 11 "head and neck cancer: 11.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" "unprognostic (1.01e-1)" "unprognostic (3.85e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (3.65e-2)" "unprognostic (3.59e-1)" "unprognostic (1.25e-1)" "unprognostic (5.52e-2)" "unprognostic (3.83e-2)" "unprognostic (9.49e-2)" "unprognostic (1.01e-2)" "unprognostic (7.37e-2)" "unprognostic (1.63e-5)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (4.26e-1)" "unprognostic (3.43e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.1 0.1 0.1 0.0 0.2 3.8 0.0 0.1 0.0 0.1 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2507.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 4.6 2.9 0.0 0.0 0.4 0.3 0.1 0.2 0.5 0.9 0.2 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.7 0.4 0.1 0.0 0.3 0.3 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.5 0.2 0.0 0.0 0.3 0.3 0.8 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.1 0.1 0.7 0.2 0.9 0.4 0.3 0.7 0.1 0.2 0.3 0.5 0.1 0.5 0.1 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 PRKACG PKACg ENSG00000165059 "Protein kinase cAMP-activated catalytic subunit gamma" P22612 9 69012529-69014113 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 27.4" "Cell line enhanced" "Detected in single" "CACO-2: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004530, HPA071185" Supported Approved Cytosol Cytosol "CAB004530: AB_628137, HPA071185: " "unprognostic (2.74e-1)" "unprognostic (3.61e-2)" "unprognostic (7.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRKAG3 ENSG00000115592 "Protein kinase AMP-activated non-catalytic subunit gamma 3" Q9UGI9 2 218822383-218832086 "Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 40.4" "Group enriched" "Detected in some" 6 "CAPAN-2: 2.3;HSkMC: 4.6;LHCN-M2: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (3.51e-1)" "unprognostic (4.41e-3)" "unprognostic (2.05e-1)" "unprognostic (1.53e-1)" "unprognostic (2.47e-2)" "unprognostic (1.80e-1)" "unprognostic (1.86e-3)" "unprognostic (7.74e-2)" "unprognostic (3.44e-2)" "unprognostic (5.85e-2)" "unprognostic (3.27e-1)" "unprognostic (9.04e-2)" "unprognostic (9.95e-2)" "unprognostic (1.49e-1)" "unprognostic (2.97e-1)" "unprognostic (7.69e-2)" 2.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.8 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 40.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 8.2 0.7 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRKAR1B ENSG00000188191 "Protein kinase cAMP-dependent type I regulatory subunit beta" P31321 7 549197-727650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 83.6" "Cell line enhanced" "Detected in many" "NTERA-2: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026719 Approved "HPA026719: AB_1855419" "unprognostic (4.90e-2)" "unprognostic (4.92e-2)" "unprognostic (2.69e-1)" "unprognostic (4.34e-2)" "unprognostic (1.74e-3)" "unprognostic (1.02e-3)" "unprognostic (3.28e-2)" "unprognostic (4.24e-2)" "unprognostic (1.73e-1)" "unprognostic (1.41e-2)" "unprognostic (2.01e-3)" "unprognostic (1.95e-1)" "unprognostic (3.38e-3)" "unprognostic (5.18e-2)" "unprognostic (2.64e-1)" "unprognostic (9.23e-2)" "unprognostic (2.00e-1)" 5.0 6.8 33.6 4.3 30.4 4.5 4.0 24.0 83.6 4.8 5.7 3.4 1.6 7.2 7.2 2.7 4.2 6.2 4.6 7.7 35.5 42.8 5.4 3.8 5.5 5.2 22.5 29.2 12.9 4.1 5.6 7.0 3.5 29.7 6.0 4.2 2.5 3.9 5.5 3.8 3.0 7.6 5.3 9.1 8.2 3.8 4.8 3.7 2.5 2.9 1.4 3.3 3.5 2.6 7.0 5.5 1.5 2.6 3.5 12.8 10.3 24.8 17.2 2.6 6.3 1.7 1.5 7.3 5.0 2.3 3.2 1.8 30.7 5.5 18.9 3.5 2.2 18.4 8.6 9.5 1.3 3.9 6.2 1.2 11.1 20.2 3.2 11.9 3.0 4.2 3.0 2.1 6.1 3.4 18.0 3.8 2.8 23.9 14.4 7.8 40.3 6.8 9.3 0.5 8.4 8.0 6.5 33.7 25.5 12.7 12.6 9.9 6.5 4.5 4.1 1.4 3.2 1.9 10.1 2.4 6.8 12.3 2.6 9.3 18.8 1.5 2.0 0.0 4.6 2.6 6.9 6.2 7.9 7.1 2.4 7.0 12.8 11.7 0.8 3.5 0.9 5.5 5.2 10.3 33.6 30.4 24.0 68.6 35.5 42.8 22.5 29.2 29.7 3.7 PRKCG "MGC57564, PKCC, PKCG, SCA14" ENSG00000126583 "Protein kinase C gamma" P05129 19 53879190-53907652 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 49.9" "Cell line enhanced" "Detected in some" "A549: 5.8;HAP1: 2.7;SH-SY5Y: 4.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB013051, HPA047870, HPA054560" Enhanced "CAB013051: AB_2533015, HPA047870: , HPA054560: " "unprognostic (7.14e-2)" "unprognostic (5.42e-2)" "unprognostic (1.85e-1)" "unprognostic (3.86e-2)" "unprognostic (1.41e-1)" "unprognostic (5.38e-2)" "unprognostic (5.96e-2)" "unprognostic (4.46e-2)" "unprognostic (2.09e-1)" "unprognostic (2.64e-2)" "unprognostic (7.48e-3)" "unprognostic (2.68e-1)" "unprognostic (2.22e-7)" "unprognostic (2.41e-2)" "unprognostic (2.61e-1)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" 1.0 0.9 28.0 1.1 49.9 2.2 0.9 12.1 39.2 0.9 1.3 1.6 0.0 1.5 1.0 0.9 1.0 1.4 1.0 0.9 49.7 4.4 0.9 0.9 1.0 0.9 2.9 20.8 0.9 3.5 2.1 0.2 0.9 0.7 0.9 1.2 0.0 0.9 1.0 1.0 0.9 1.3 1.1 1.4 0.9 1.8 4.4 2.1 1.3 0.9 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 5.8 1.3 0.0 0.0 0.2 0.1 0.7 0.4 0.1 0.0 1.5 1.5 0.3 1.7 0.0 0.5 2.7 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.1 0.0 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.6 0.5 0.1 1.0 0.5 1.0 0.6 0.1 1.1 0.0 0.0 4.0 1.6 0.2 0.0 1.9 0.0 1.0 0.0 2.0 0.0 0.0 1.7 0.4 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 49.9 12.1 28.5 49.7 4.4 2.9 20.8 0.7 2.1 PRL ENSG00000172179 Prolactin P01236 6 22287244-22297501 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Lactation Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 81 "pituitary gland: 1739.5" "Cell line enhanced" "Detected in some" "Daudi: 17.6;SCLC-21H: 6.6;U-937: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.2;non-classical monocyte: 1.0" "Group enriched" "Detected in many" 12 "monocytes: 1.0;T-cells: 1.2" "Not detected" "Not detected" "CAB023353, HPA042416, HPA062017" Enhanced "Secreted to blood" 75460000 3300000 "CAB023353: AB_617369, HPA042416: AB_2677987, HPA062017: AB_2684660" "unprognostic (1.66e-1)" "unprognostic (4.08e-3)" "unprognostic (5.89e-3)" "unprognostic (4.83e-3)" "unprognostic (2.87e-1)" "unprognostic (1.11e-4)" "unprognostic (4.54e-1)" "unprognostic (1.57e-1)" "unprognostic (3.79e-2)" "unprognostic (4.29e-5)" "unprognostic (2.20e-1)" 0.2 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1739.5 21.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 1.2 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.3 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 PRM1 CT94.1 ENSG00000175646 "Protamine 1" P04553 16 11280836-11281350 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 125 "testis: 747.3" "Cell line enhanced" "Detected in some" "BEWO: 2.0;Hep G2: 1.0;NB-4: 5.9;U-2197: 4.4;U-698: 2.0" "Cancer enriched" "Detected in single" 161 "testis cancer: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055150 Enhanced "HPA055150: " "unprognostic (2.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 747.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 PRM2 CT94.2 ENSG00000122304 "Protamine 2" P04554 16 11275639-11276480 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 99 "testis: 699.5" "Group enriched" "Detected in some" 8 "BEWO: 3.5;NB-4: 3.7;U-2197: 5.6" "Cancer enriched" "Detected in single" 187 "testis cancer: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB032738, HPA056386" Enhanced "CAB032738: AB_2171312, HPA056386: " "unprognostic (3.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 699.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 PRM3 ENSG00000178257 "Protamine 3" Q9NNZ6 16 11273218-11273641 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 39.0" "Cell line enriched" "Detected in some" 6 "TIME: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 28 "naive CD8 T-cell: 2.8" "Lineage enriched" "Detected in single" 28 "T-cells: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.5 0.0 0.0 0.0 0.0 1.5 0.4 0.6 0.0 0.0 0.3 0.0 8.9 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRMT8 "HRMT1L3, HRMT1L4" ENSG00000111218 "Protein arginine methyltransferase 8" Q9NR22 12 3381349-3593973 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 24.8" "Cell line enriched" "Detected in some" 10 "hTERT-HME1: 32.9" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039747, HPA069769" Enhanced "HPA039747: AB_10697554, HPA069769: " "unprognostic (3.09e-1)" "unprognostic (9.47e-2)" "unprognostic (5.59e-1)" "unprognostic (3.34e-3)" "unprognostic (4.80e-3)" "unprognostic (9.41e-2)" "unprognostic (3.41e-5)" "unprognostic (5.99e-1)" "unprognostic (1.93e-1)" "unprognostic (1.50e-2)" "unprognostic (7.06e-2)" "unprognostic (2.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.64e-1)" "unprognostic (6.02e-2)" "unprognostic (5.49e-2)" 0.6 0.6 4.6 0.6 18.3 0.6 0.7 8.7 24.8 0.8 0.7 0.2 0.1 0.7 0.7 0.6 0.6 3.1 0.6 2.3 4.0 2.1 1.2 0.6 2.2 0.6 3.5 10.0 0.7 1.8 0.6 0.0 0.6 1.4 0.6 0.7 0.0 0.6 0.7 0.6 0.6 0.6 0.6 0.4 0.6 0.7 3.0 1.8 1.0 0.6 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 18.3 8.7 14.6 4.0 2.1 3.5 10.0 1.4 1.8 PRND "dJ1068H6.4, DOPPEL, DPL, PrPLP" ENSG00000171864 "Prion like protein doppel" Q9UKY0 20 4721910-4728460 "Predicted membrane proteins, Transporters" Fertilization Prion "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 80.2" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 2.2;NTERA-2: 3.1;U-698: 1.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.6" "Region enriched" "Detected in single" 28 "pons and medulla: 6.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA043373 Enhanced "HPA043373: " "unprognostic (1.69e-1)" "unprognostic (3.66e-2)" "unprognostic (2.24e-2)" "unprognostic (8.46e-2)" "unprognostic (3.40e-2)" "unprognostic (3.47e-3)" "unprognostic (3.01e-1)" "unprognostic (6.41e-2)" "unprognostic (2.00e-2)" "unprognostic (1.56e-1)" "unprognostic (3.10e-1)" "unprognostic (5.85e-2)" "unprognostic (2.02e-3)" "unprognostic (6.11e-2)" "unprognostic (2.86e-1)" "unprognostic (2.45e-2)" "unprognostic (1.63e-3)" 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 1.1 0.7 0.2 0.0 2.5 0.1 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 6.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.1 80.2 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.9 0.5 2.2 0.5 0.6 0.4 0.1 0.2 0.4 0.1 0.3 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.2 0.3 0.0 0.0 0.6 0.0 2.2 0.0 1.1 0.2 0.2 0.1 0.3 3.1 0.0 0.2 0.0 0.0 0.3 0.4 0.3 0.4 0.0 0.1 0.1 0.3 0.1 0.4 0.3 0.6 0.4 0.1 0.3 0.1 1.3 0.2 0.2 0.0 2.2 0.5 0.5 0.3 0.3 0.2 0.6 0.4 0.2 0.2 0.9 0.3 0.3 1.4 0.6 0.5 0.5 0.3 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 6.0 0.0 PROB1 C5orf65 ENSG00000228672 "Proline rich basic protein 1" E7EW31 5 139390592-139395713 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 37.7" "Cell line enriched" "Detected in some" 6 "HDLM-2: 47.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.1;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060103 Enhanced Approved Nucleoplasm Nucleoplasm "HPA060103: " "unprognostic (4.14e-2)" "prognostic favourable (9.26e-4)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (3.53e-2)" "unprognostic (9.27e-3)" "unprognostic (4.72e-2)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "unprognostic (3.21e-2)" "unprognostic (4.84e-4)" "unprognostic (7.10e-2)" "unprognostic (1.75e-2)" "unprognostic (9.05e-2)" "unprognostic (3.62e-2)" "unprognostic (5.89e-2)" "unprognostic (8.24e-2)" 0.6 1.6 0.7 0.3 0.8 0.0 0.3 0.0 0.3 0.3 0.3 0.6 0.5 0.1 0.3 0.7 0.1 6.6 0.7 0.6 0.7 0.0 0.0 0.4 0.5 0.0 0.0 1.8 0.8 0.2 1.3 0.0 0.7 0.6 37.7 0.0 0.8 0.1 0.2 0.3 0.6 0.0 0.1 0.1 0.3 0.1 0.5 1.1 0.0 0.1 0.0 1.1 0.0 0.6 0.4 0.1 0.1 0.0 0.2 0.2 0.5 0.1 0.5 0.5 1.9 1.2 2.9 0.5 1.5 0.3 0.2 0.0 0.1 47.0 0.6 0.7 1.1 0.2 1.3 0.0 1.6 0.4 0.4 1.1 0.3 0.0 0.2 3.0 1.6 0.5 2.4 1.2 0.6 1.2 7.5 0.2 5.6 0.1 0.0 0.6 0.3 2.8 2.9 0.1 1.1 1.6 0.2 0.0 0.1 0.1 0.2 0.4 0.8 4.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.1 1.1 1.1 0.0 PROC ENSG00000115718 "Protein C, inactivator of coagulation factors Va and VIIIa" P04070 2 127418427-127429246 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 137.5" "Cell line enriched" "Detected in some" 16 "Hep G2: 57.5" "Cancer enriched" "Detected in many" 22 "liver cancer: 118.3" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 9 "plasmacytoid DC: 29.2" "Lineage enriched" "Detected in many" 9 "dendritic cells: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005550, CAB016721, CAB016792" Supported "Secreted to blood" 6400000000 "CAB016721: , CAB016792: , HPA005550: AB_1079687" "unprognostic (2.46e-2)" "unprognostic (1.08e-1)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (6.64e-2)" "unprognostic (3.13e-2)" "unprognostic (4.90e-3)" "unprognostic (2.63e-1)" "unprognostic (1.67e-1)" "unprognostic (3.29e-1)" "unprognostic (3.74e-3)" "unprognostic (2.56e-2)" "unprognostic (8.12e-3)" "unprognostic (2.01e-2)" "unprognostic (1.71e-1)" "unprognostic (4.60e-3)" "unprognostic (8.06e-2)" 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.2 4.2 137.5 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.4 29.2 3.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.5 0.0 0.3 0.0 3.6 0.0 0.1 0.0 0.0 0.0 0.0 2.7 57.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.0 29.2 0.0 0.1 0.4 0.1 0.1 0.2 0.4 0.2 0.1 0.1 0.4 0.0 PROCA1 MGC39650 ENSG00000167525 "Protein interacting with cyclin A1" Q8NCQ7 17 28703197-28711854 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 58.8" "Cell line enhanced" "Detected in many" "NB-4: 12.1;REH: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023648 Approved "HPA023648: AB_1855726" "unprognostic (5.78e-2)" "unprognostic (1.17e-2)" "unprognostic (3.11e-3)" "unprognostic (3.07e-2)" "unprognostic (2.97e-2)" "unprognostic (7.26e-3)" "unprognostic (6.90e-2)" "unprognostic (7.11e-3)" "unprognostic (2.86e-3)" "unprognostic (1.10e-1)" "unprognostic (3.01e-3)" "unprognostic (6.88e-2)" "unprognostic (1.21e-2)" "unprognostic (1.39e-1)" "unprognostic (2.03e-1)" "unprognostic (1.88e-1)" "unprognostic (5.00e-2)" 1.2 1.1 1.7 1.8 2.6 1.6 1.1 7.8 2.8 2.1 2.0 2.6 2.9 1.8 1.8 1.2 0.9 2.2 1.0 1.0 1.9 2.0 1.8 0.5 1.3 2.6 1.7 2.3 3.1 0.7 0.9 1.2 0.9 3.5 1.2 1.0 4.0 0.8 1.4 2.2 1.3 2.1 1.2 2.4 3.5 1.1 58.8 1.6 1.0 0.7 0.0 1.5 0.9 1.6 3.1 5.0 6.2 3.0 1.1 2.2 1.1 1.1 1.4 4.5 8.5 3.3 2.4 3.1 1.4 0.6 1.1 0.9 1.3 4.2 0.2 0.8 0.8 3.6 3.5 0.2 0.6 2.1 1.9 3.3 3.3 0.9 0.5 6.3 0.3 1.6 0.4 1.8 0.7 0.8 4.1 2.7 0.9 0.9 4.0 12.1 7.0 0.9 12.4 4.6 0.1 1.3 1.0 2.1 1.9 1.4 0.6 0.5 6.9 5.3 0.5 0.8 1.4 0.9 0.9 1.5 1.9 1.9 1.3 6.9 1.0 6.2 2.2 6.2 1.1 3.0 0.4 3.1 2.2 0.7 1.4 1.1 1.0 1.8 1.3 1.1 2.5 5.0 1.2 1.1 1.7 2.6 7.8 2.8 1.9 2.0 1.7 2.3 3.5 1.6 PROP1 ENSG00000175325 "PROP paired-like homeobox 1" O75360 5 177992235-177996242 "Disease related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "pituitary gland: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049839 Enhanced "HPA049839: " "unprognostic (2.90e-1)" "unprognostic (4.90e-1)" "unprognostic (2.13e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRORY CYorf17 ENSG00000183146 "Proline rich, Y-linked" Q9H606 Y 21382954-21386360 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "intestine: 5.4" "Cell line enriched" "Detected in some" 8 "U-266/84: 8.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "unprognostic (1.59e-1)" 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.4 0.0 2.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.4 5.4 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.3 1.2 0.4 0.3 0.9 0.2 0.2 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.5 0.1 0.5 0.6 0.0 0.2 0.4 0.9 0.0 0.9 8.4 0.2 0.2 0.7 0.1 0.6 0.2 0.5 0.7 0.4 0.5 0.4 0.4 0.7 0.2 0.9 0.7 0.9 1.2 0.3 0.4 0.3 0.0 0.2 PROX1 ENSG00000117707 "Prospero homeobox 1" Q92786 1 213983181-214041502 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 72.4" "Cell line enhanced" "Detected in some" "Hep G2: 15.7;RH-30: 8.3;SH-SY5Y: 40.2" "Cancer enhanced" "Detected in many" "liver cancer: 15.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA000842, HPA001030" Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA000842: , HPA001030: " "unprognostic (3.07e-1)" "unprognostic (5.98e-2)" "unprognostic (1.06e-3)" "unprognostic (3.42e-1)" "unprognostic (7.71e-2)" "unprognostic (1.39e-1)" "unprognostic (1.45e-2)" "unprognostic (6.59e-2)" "unprognostic (1.85e-2)" "unprognostic (2.31e-1)" "unprognostic (3.29e-3)" "unprognostic (6.64e-2)" "unprognostic (4.56e-6)" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (6.71e-4)" "unprognostic (1.05e-1)" 2.3 9.6 3.7 2.1 8.1 1.0 2.9 14.0 5.8 1.8 3.0 13.1 0.3 2.7 1.9 2.0 1.5 3.0 2.6 13.1 6.2 4.1 5.4 72.4 2.0 13.5 8.4 4.3 7.3 13.9 1.0 11.4 1.3 5.5 1.4 3.2 2.4 1.1 1.3 4.1 1.5 3.1 1.7 9.6 14.9 2.8 5.9 9.2 0.0 7.5 0.6 1.5 1.6 2.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.5 0.3 0.0 15.7 0.0 0.0 0.1 0.1 0.0 0.0 0.1 1.8 2.7 0.0 0.2 0.0 0.2 0.0 0.8 0.7 0.0 8.3 1.2 0.1 0.2 1.2 40.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.5 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 8.1 14.0 5.8 6.2 4.1 8.4 4.3 5.5 9.2 PROZ PZ ENSG00000126231 "Protein Z, vitamin K dependent plasma glycoprotein" P22891 13 113158654-113172383 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 45.0" "Cell line enhanced" "Detected in some" "HaCaT: 4.8;Hep G2: 7.6" "Cancer enriched" "Detected in single" 27 "liver cancer: 12.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.7;T-reg: 1.5" "Group enriched" "Detected in many" 12 "monocytes: 2.7;T-cells: 1.5" "Not detected" "Not detected" HPA052006 Supported "Secreted to blood" 1716566667 510000000 "HPA052006: AB_2681691" "unprognostic (5.03e-2)" "unprognostic (4.05e-2)" "unprognostic (1.11e-1)" "unprognostic (2.36e-1)" "unprognostic (6.48e-2)" "unprognostic (1.39e-1)" "prognostic favourable (3.46e-4)" "unprognostic (4.10e-1)" "unprognostic (2.21e-1)" "unprognostic (2.50e-1)" "unprognostic (5.20e-2)" "unprognostic (2.87e-1)" "unprognostic (9.83e-2)" "unprognostic (5.63e-2)" "unprognostic (1.41e-1)" "unprognostic (9.99e-2)" "unprognostic (2.51e-4)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 9.3 45.0 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.0 2.7 0.0 1.5 0.2 0.9 1.4 0.7 1.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 3.0 1.8 0.8 0.0 0.0 4.8 0.0 0.0 0.0 0.8 2.4 1.0 2.8 7.6 0.1 0.8 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 1.0 0.6 0.8 1.8 0.4 1.3 0.2 0.3 0.0 1.1 2.9 0.2 0.0 0.3 1.3 0.0 1.0 0.7 0.8 0.1 0.8 0.3 1.6 0.9 0.8 1.6 0.9 0.7 0.0 0.0 0.0 0.3 2.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.1 1.5 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 PRPH2 "CACD2, rd2, RDS, RP7, TSPAN22" ENSG00000112619 "Peripherin 2" P23942 6 42696600-42722574 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Sensory transduction, Vision" "Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "retina: 117.8" "Cell line enhanced" "Detected in some" "ASC diff: 4.2;ASC TERT1: 4.8;fHDF/TERT166: 6.9;HHSteC: 10.8;HSkMC: 8.4;LHCN-M2: 4.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA029458 Enhanced "HPA029458: AB_10602193" "unprognostic (2.37e-1)" "unprognostic (4.88e-2)" "unprognostic (6.67e-2)" "unprognostic (8.43e-2)" "unprognostic (1.15e-1)" "unprognostic (2.87e-3)" "unprognostic (4.73e-1)" "unprognostic (1.85e-1)" "unprognostic (6.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (3.18e-2)" "unprognostic (7.07e-4)" "unprognostic (1.13e-3)" "unprognostic (1.59e-1)" "unprognostic (8.42e-2)" "unprognostic (8.96e-3)" 1.0 0.8 1.5 1.0 1.0 0.0 1.0 1.0 4.8 1.7 2.0 1.0 1.0 0.3 2.3 2.3 1.0 0.9 1.2 1.4 1.1 3.0 1.0 1.0 1.2 1.0 1.1 1.0 3.4 2.0 6.9 2.7 1.0 1.0 1.4 0.8 117.8 1.0 1.3 14.4 0.0 1.1 2.3 1.0 1.0 1.0 3.5 1.0 1.0 5.2 1.0 1.0 1.0 1.0 0.6 0.3 3.4 0.6 0.2 0.8 0.0 0.0 0.0 0.0 0.0 4.2 4.8 1.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 10.8 0.0 0.0 8.4 0.0 0.0 0.0 1.2 0.0 0.0 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.3 0.0 0.4 0.2 0.8 0.2 0.3 0.0 0.3 0.6 0.4 0.2 2.5 0.2 0.6 0.0 0.3 0.0 1.5 1.0 1.0 3.0 1.1 3.0 1.1 1.0 1.0 1.0 PRPS1L1 "PRPS3, PRPSL" ENSG00000229937 "Phosphoribosyl pyrophosphate synthetase 1-like 1" P21108 7 18026774-18027863 "Enzymes, Predicted intracellular proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 38.4" "Cell line enhanced" "Detected in some" "BEWO: 1.2;K-562: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "unprognostic (2.39e-2)" "unprognostic (3.18e-2)" "unprognostic (1.11e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.7 0.3 0.6 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.4 0.3 0.6 0.8 0.9 0.5 0.1 0.4 1.1 0.7 0.1 0.6 0.1 0.4 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR18 MGC35308 ENSG00000176381 "Proline rich 18" Q8N4B5 6 166305300-166308448 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 35.7" "Group enriched" "Detected in some" 7 "SCLC-21H: 9.1;SH-SY5Y: 5.3" "Cancer enhanced" "Detected in some" "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077250 Enhanced "HPA077250: " "unprognostic (2.91e-1)" "unprognostic (7.18e-2)" "unprognostic (1.76e-1)" "unprognostic (2.39e-2)" "unprognostic (1.44e-1)" "unprognostic (9.65e-2)" "unprognostic (5.60e-3)" "unprognostic (1.25e-1)" "unprognostic (1.10e-1)" "unprognostic (3.16e-2)" "unprognostic (2.44e-3)" "unprognostic (4.79e-3)" "unprognostic (2.43e-1)" "unprognostic (3.35e-3)" "unprognostic (9.49e-2)" "unprognostic (9.58e-2)" "unprognostic (1.07e-1)" 1.3 0.9 12.4 0.9 17.3 0.9 0.9 1.7 34.8 1.1 0.9 35.7 0.0 1.4 0.9 0.9 0.9 4.4 0.9 0.9 18.6 9.0 1.0 6.4 1.1 0.9 23.1 7.0 1.0 1.1 3.3 0.4 0.9 11.0 1.3 0.9 0.0 1.0 1.1 0.9 0.9 1.0 0.9 21.7 0.9 1.2 0.9 18.9 0.0 1.1 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 9.1 5.3 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 17.3 1.7 14.9 18.6 9.0 23.1 7.0 11.0 18.9 PRR19 MGC70924 ENSG00000188368 "Proline rich 19" A6NJB7 19 42302098-42310821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 25.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA070350 Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Mitochondria" Nucleoli "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA070350: " "unprognostic (2.05e-1)" "unprognostic (8.03e-3)" "unprognostic (4.02e-2)" "unprognostic (7.55e-3)" "unprognostic (7.33e-2)" "unprognostic (1.08e-2)" "unprognostic (2.44e-5)" "unprognostic (3.57e-1)" "unprognostic (1.92e-2)" "unprognostic (8.10e-3)" "unprognostic (3.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.87e-3)" "unprognostic (4.21e-1)" "unprognostic (7.26e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-2)" 0.5 1.0 2.2 1.3 5.8 3.5 0.8 2.6 2.9 1.0 0.5 0.7 0.6 0.7 0.8 0.8 1.0 0.9 1.1 0.3 1.8 1.6 0.7 0.9 0.6 0.9 0.9 0.8 0.9 0.5 1.0 0.8 1.2 1.7 0.9 0.5 0.6 1.0 0.8 0.6 1.3 0.8 0.7 1.6 0.7 0.6 25.8 1.0 1.3 0.8 0.3 0.9 0.8 0.5 3.1 2.3 2.8 2.2 2.6 2.9 1.3 3.9 6.0 3.3 4.4 0.2 0.3 3.5 2.3 1.8 5.3 5.1 2.5 3.7 0.7 6.9 1.9 1.3 1.5 1.7 1.2 2.6 1.5 4.1 3.5 1.4 1.2 1.1 2.5 1.8 2.3 3.5 0.7 0.9 2.2 2.0 2.4 9.2 3.9 2.0 3.5 0.0 1.5 0.6 0.4 1.8 3.4 7.5 3.0 3.2 2.3 0.9 3.0 1.4 1.2 3.5 5.2 0.9 3.1 0.4 1.4 1.2 3.8 2.9 3.6 2.8 2.2 0.6 2.4 1.8 0.8 3.1 1.7 2.3 2.3 2.2 2.3 1.3 2.4 2.6 0.7 1.5 2.9 1.3 2.2 5.8 2.6 2.9 1.8 1.6 0.9 0.8 1.7 1.0 PRR20A "FLJ40296, PRR20" ENSG00000204919 "Proline rich 20A" P86496 13 57140918-57143939 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain "HPA059485: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR20B ENSG00000204918 "Proline rich 20B" P86481 13 57147488-57150509 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 15 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain "HPA059485: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR20C ENSG00000229665 "Proline rich 20C" P86479 13 57140918-57157082 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain "HPA059485: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR20D ENSG00000227151 "Proline rich 20D" P86480 13 57160632-57163653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain "HPA059485: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR20E ENSG00000234278 "Proline rich 20E" P86478 13 57167197-57170218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain "HPA059485: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR22 MGC24975 ENSG00000212123 "Proline rich 22" Q8IZ63 19 5782960-5784765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "testis: 82.5" "Cell line enhanced" "Detected in many" "HMC-1: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044157 Enhanced Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA044157: AB_10960694" "unprognostic (8.09e-2)" "unprognostic (1.53e-3)" "unprognostic (5.19e-3)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (1.80e-1)" "unprognostic (3.20e-2)" "unprognostic (2.89e-2)" "unprognostic (1.20e-1)" "unprognostic (3.77e-2)" "unprognostic (3.42e-3)" "unprognostic (9.37e-3)" "unprognostic (4.18e-2)" "unprognostic (9.93e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-1)" "unprognostic (2.79e-3)" 1.1 1.0 1.1 1.7 1.5 2.0 1.1 1.1 1.7 1.1 1.3 1.2 1.1 3.1 1.1 1.1 1.6 2.5 1.1 1.1 1.1 0.7 2.4 4.4 1.1 1.5 1.1 1.1 1.1 2.7 1.0 1.2 1.1 1.1 2.7 0.3 1.1 3.2 1.1 1.1 5.4 3.3 1.1 1.1 2.7 2.4 82.5 1.1 1.1 2.3 1.1 1.1 1.1 1.1 0.2 0.0 0.0 0.2 0.0 0.9 0.1 1.8 3.1 1.3 6.6 0.0 0.2 6.5 1.3 0.5 1.0 1.6 3.1 1.8 2.9 3.7 0.2 2.3 1.0 1.3 0.2 4.5 10.2 1.3 1.3 1.1 0.5 3.1 15.9 0.8 1.1 1.4 0.4 0.2 7.1 0.0 0.8 6.8 3.5 3.8 8.1 3.2 3.4 1.2 4.5 0.2 2.1 1.7 3.2 0.3 2.4 3.6 2.7 2.5 1.0 2.4 6.7 8.6 1.6 9.3 7.2 5.5 0.2 6.2 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.9 0.4 0.0 0.0 0.2 0.0 0.0 0.1 1.1 1.5 1.1 1.1 1.1 0.7 1.1 1.1 1.1 1.1 PRR23A ENSG00000206260 "Proline rich 23A" A6NEV1 3 139005468-139006268 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 8 "testis: 6.1" "Cell line enhanced" "Detected in single" "MCF7: 2.8" "Cancer enriched" "Detected in single" 17 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain "HPA047473: " "unprognostic (1.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR23B FLJ46116 ENSG00000184814 "Proline rich 23B" Q6ZRT6 3 139019031-139020926 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "testis: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain "HPA047473: " "unprognostic (7.57e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR23D1 ENSG00000255251 "Proline rich 23 domain containing 1" E9PI22 8 7539628-7542450 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "epididymis: 35.2" "Cell line enhanced" "Detected in some" "AN3-CA: 1.2;BJ hTERT+ SV40 Large T+: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 PRR23D2 ENSG00000255378 "Proline rich 23 domain containing 2" P0DMB1 8 7778591-7781413 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "epididymis: 35.2" "Cell line enhanced" "Detected in some" "AN3-CA: 1.2;BJ hTERT+ SV40 Large T+: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 PRR27 C4orf40 ENSG00000187533 "Proline rich 27" Q6MZM9 4 70133616-70176799 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 268 "salivary gland: 669.3" "Cell line enhanced" "Detected in single" "HeLa: 1.2" "Cancer enriched" "Detected in single" 10 "breast cancer: 0.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.4" "HPA036150, HPA036151" Enhanced "Secreted to digestive system" "HPA036150: AB_10673001, HPA036151: AB_2674971" "unprognostic (9.52e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 669.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.5 0.2 2.4 0.3 0.5 0.2 0.0 0.3 0.2 0.1 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.0 0.3 0.0 0.0 0.0 0.7 0.2 0.2 1.2 0.1 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.2 0.5 0.0 0.7 0.1 0.4 0.5 0.1 0.2 0.1 0.5 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.4 0.0 0.3 0.2 0.2 0.2 0.2 0.4 0.1 0.3 0.1 0.0 0.4 1.5 0.3 0.2 0.2 0.2 0.0 0.3 0.1 0.2 0.0 0.5 0.2 0.2 2.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR30 "C2orf53, MGC44505" ENSG00000186143 "Proline rich 30" Q53SZ7 2 27136848-27139410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 67 "testis: 66.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR35 C16orf11 ENSG00000161992 "Proline rich 35" P0CG20 16 560422-565528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "brain: 51.1" "Cell line enhanced" "Detected in some" "HEK 293: 2.3;HMC-1: 1.0;K-562: 2.1;NTERA-2: 1.0;RT4: 1.3;U-2 OS: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in some" 27 "cerebellum: 51.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 4.8" "Region enhanced" "Detected in single" "cerebellum: 0.9" HPA069297 Uncertain "HPA069297: " "unprognostic (6.96e-2)" "unprognostic (3.08e-2)" "unprognostic (5.25e-1)" "unprognostic (8.11e-2)" "unprognostic (2.56e-1)" "unprognostic (3.38e-2)" "unprognostic (1.17e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 51.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 1.8 0.0 0.0 1.1 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.0 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.1 0.2 0.0 0.0 0.0 0.0 1.8 0.0 PRR4 "LPRP, PROL4" ENSG00000111215 "Proline rich 4 (lacrimal)" Q16378 12 10845849-10849475 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "salivary gland: 1184.0" "Cell line enhanced" "Detected in some" "HAP1: 1.5;HBEC3-KT: 1.3;Hep G2: 1.6;NB-4: 2.7;U-2 OS: 2.8;WM-115: 2.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042133 Supported "Secreted to digestive system" 25000000 "HPA042133: AB_10793979" "unprognostic (1.34e-1)" "unprognostic (2.13e-1)" "unprognostic (1.35e-2)" "unprognostic (1.74e-2)" "unprognostic (1.99e-1)" "unprognostic (5.03e-2)" "unprognostic (3.01e-3)" "unprognostic (3.91e-2)" "unprognostic (1.70e-1)" "unprognostic (1.23e-1)" "unprognostic (3.19e-2)" "unprognostic (1.09e-2)" "unprognostic (3.57e-6)" "unprognostic (2.81e-2)" "unprognostic (9.15e-2)" "unprognostic (1.21e-1)" "unprognostic (2.15e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1184.0 1.1 0.0 4.2 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 20.0 38.4 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.4 1.5 1.3 0.0 0.1 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 2.7 0.6 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRRT1 "C6orf31, IFITMD7, NG5" ENSG00000204314 "Proline rich transmembrane protein 1" Q99946 6 32148359-32153083 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 41.1" "Group enriched" "Detected in some" 4 "HEK 293: 1.5;SK-MEL-30: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055149, HPA059099" Enhanced "HPA055149: , HPA059099: " "unprognostic (1.40e-2)" "unprognostic (1.35e-1)" "unprognostic (2.10e-3)" "unprognostic (3.87e-3)" "unprognostic (2.89e-1)" "unprognostic (4.74e-2)" "unprognostic (5.51e-3)" "unprognostic (5.93e-2)" "unprognostic (1.49e-1)" "unprognostic (1.58e-2)" "unprognostic (8.08e-5)" "unprognostic (2.99e-1)" "unprognostic (2.22e-2)" "unprognostic (8.59e-2)" "unprognostic (9.40e-2)" "unprognostic (1.94e-1)" "unprognostic (1.78e-2)" 2.6 4.8 23.9 2.4 25.3 2.2 2.2 35.8 41.1 2.5 2.5 4.9 0.0 2.6 2.6 2.1 2.1 2.4 2.3 2.3 24.4 10.5 2.4 2.2 2.2 2.2 4.9 27.1 6.1 2.4 2.3 3.2 2.5 11.7 2.8 2.3 1.8 2.3 2.7 2.4 2.4 2.4 2.3 3.0 2.4 2.9 2.6 7.7 0.0 2.2 0.0 2.1 2.2 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.8 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.1 0.5 0.7 0.1 0.0 5.5 0.2 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 23.9 25.3 35.8 41.1 24.4 10.5 4.9 27.1 11.7 7.7 PRRT4 ENSG00000224940 "Proline rich transmembrane protein 4" C9JH25 7 128350325-128361685 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 49.0" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 70.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA046373, HPA052681" Uncertain Approved "Nucleoplasm,Peroxisomes,Plasma membrane" "Intracellular and membrane" Nucleoplasm "Peroxisomes, Plasma membrane" "HPA046373: , HPA052681: " "unprognostic (1.72e-1)" "unprognostic (4.55e-2)" "unprognostic (5.36e-3)" "unprognostic (1.20e-4)" "unprognostic (2.60e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (5.62e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-4)" "unprognostic (9.11e-2)" "unprognostic (3.73e-4)" "unprognostic (5.28e-3)" "unprognostic (9.09e-2)" "unprognostic (1.22e-2)" "unprognostic (1.27e-2)" 12.1 1.9 2.0 5.9 11.3 49.0 6.8 6.5 3.1 1.6 2.7 0.6 0.0 0.6 0.7 0.5 1.9 1.0 1.1 2.4 1.7 6.2 0.5 0.7 0.8 0.6 1.6 2.4 1.0 0.6 0.8 0.0 0.6 2.9 0.8 0.7 3.4 1.9 1.3 4.2 1.5 0.8 1.0 2.8 1.3 1.6 0.7 1.5 0.7 0.7 1.7 1.0 2.0 3.2 0.0 0.4 0.4 0.4 0.0 1.5 0.4 0.0 0.0 0.1 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 13.8 0.3 0.0 3.8 0.2 0.3 0.0 0.0 0.1 70.3 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.0 0.0 1.5 0.7 0.4 0.0 0.0 0.4 0.0 0.4 2.0 11.3 6.5 3.1 1.7 6.2 1.6 2.4 2.9 1.5 PRSS1 TRY1 ENSG00000204983 "Serine protease 1" P07477 7 142749468-142753076 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1708 "pancreas: 3057.4" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;HDLM-2: 1.7;RPMI-8226: 6.9;U-2 OS: 4.1;U-251 MG: 1.5;U-266/84: 2.5" "Cancer enriched" "Detected in many" 224 "pancreatic cancer: 1920.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.7" "Low lineage specificity" "Detected in many" "CAB025487, CAB025538, HPA062452, HPA063471" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" 26000000000 Vesicles "Endoplasmic reticulum" "CAB025487: , CAB025538: , HPA062452: , HPA063471: " "unprognostic (6.55e-5)" "unprognostic (5.28e-1)" "unprognostic (7.58e-2)" "prognostic unfavourable (6.41e-6)" "unprognostic (8.26e-2)" "prognostic favourable (7.05e-4)" "unprognostic (1.35e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-1)" "prognostic favourable (4.91e-4)" "unprognostic (3.12e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.6 3057.4 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.4 0.2 0.1 0.0 0.4 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.0 1.7 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 1.5 0.0 2.5 0.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 PRSS16 TSSP ENSG00000112812 "Serine protease 16" Q9NQE7 6 27247701-27256624 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 14 "lymphoid tissue: 242.8" "Cell line enhanced" "Detected in some" "hTCEpi: 19.5;RPMI-8226: 10.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 5.4" "Group enriched" "Detected in many" 39 "B-cells: 5.4;T-cells: 2.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "Secreted in other tissues" "unprognostic (1.50e-1)" "unprognostic (6.95e-2)" "unprognostic (1.91e-2)" "unprognostic (1.51e-1)" "unprognostic (2.21e-2)" "unprognostic (1.74e-2)" "unprognostic (9.21e-3)" "unprognostic (1.57e-1)" "unprognostic (7.89e-2)" "prognostic favourable (6.46e-5)" "unprognostic (1.57e-1)" "unprognostic (3.49e-2)" "unprognostic (5.42e-2)" "unprognostic (1.95e-1)" "unprognostic (5.49e-2)" "unprognostic (2.10e-1)" "unprognostic (1.62e-2)" 0.9 0.5 0.9 0.9 0.9 0.0 3.6 0.9 0.9 2.0 3.3 0.9 0.9 2.3 0.9 9.3 3.6 3.3 2.1 0.9 0.9 0.0 1.4 0.9 2.4 0.9 0.9 0.9 1.2 17.1 6.4 1.8 2.1 0.9 1.8 4.1 0.9 4.3 2.5 0.9 2.9 2.8 0.9 0.9 0.9 3.9 0.9 0.9 242.8 8.7 0.9 0.9 2.0 1.1 5.4 0.0 0.0 0.0 0.0 2.3 0.4 2.9 0.2 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.1 3.4 4.5 0.0 0.7 0.0 1.5 2.5 3.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 1.9 0.5 0.0 19.5 0.0 4.0 0.0 2.2 1.8 0.0 1.1 0.4 0.0 0.6 0.5 0.0 0.0 10.5 2.3 3.4 0.0 0.0 1.3 3.0 0.0 1.9 0.8 0.0 0.0 0.7 0.0 0.0 0.7 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 2.0 5.4 2.3 1.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.9 0.9 0.9 0.9 0.9 0.0 0.9 0.9 0.9 0.9 PRSS2 TRY2 ENSG00000275896 "Serine protease 2" P07478 7 142760398-142774564 "Enzymes, Plasma proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 708 "pancreas: 6267.9" "Cell line enriched" "Detected in some" 5 "RPMI-8226: 37.2" "Cancer enriched" "Detected in many" 72 "pancreatic cancer: 3463.4" "Group enriched" "Detected in some" 6 "basophil: 5.6;T-reg: 5.1" "Group enriched" "Detected in many" 6 "granulocytes: 5.6;T-cells: 5.1" "HPA062452, HPA063471" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" 27000000000 Vesicles "Endoplasmic reticulum" "HPA062452: , HPA063471: " "prognostic favourable (2.32e-4)" "unprognostic (3.80e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-3)" "unprognostic (1.99e-2)" "unprognostic (3.06e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-3)" "unprognostic (1.48e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-2)" "unprognostic (3.50e-1)" "unprognostic (5.36e-3)" "unprognostic (1.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6267.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 5.6 0.0 0.7 5.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.4 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 37.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.5 2.1 0.0 1.6 0.2 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.1 0.3 PRSS3 "PRSS4, TRY3, TRY4" ENSG00000010438 "Serine protease 3" P35030 9 33750466-33799231 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "pancreas: 984.9" "Cell line enriched" "Detected in some" 8 "PC-3: 121.9" "Group enriched" "Detected in many" 7 "colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 82 "basophil: 39.0" "Lineage enriched" "Detected in single" 82 "granulocytes: 39.0" "HPA062452, HPA063471" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" 490000000 Vesicles "Endoplasmic reticulum" "HPA062452: , HPA063471: " "unprognostic (6.90e-2)" "unprognostic (2.26e-1)" "unprognostic (1.69e-2)" "prognostic unfavourable (4.30e-4)" "unprognostic (3.18e-1)" "unprognostic (1.64e-1)" "unprognostic (3.29e-2)" "unprognostic (5.89e-3)" "unprognostic (1.38e-1)" "unprognostic (2.06e-3)" "unprognostic (1.10e-2)" "unprognostic (8.94e-2)" "unprognostic (7.75e-4)" "unprognostic (5.46e-3)" "unprognostic (2.13e-1)" "unprognostic (8.79e-2)" "unprognostic (4.96e-1)" 0.3 0.3 1.6 1.7 1.5 0.2 0.2 2.8 4.2 0.9 8.2 0.0 0.0 2.8 0.2 0.2 2.9 0.2 4.8 0.4 1.2 0.7 0.3 0.4 0.2 0.2 0.3 1.6 0.7 984.9 0.2 0.1 0.2 2.3 0.2 2.3 0.0 0.6 0.2 0.2 2.0 23.9 0.3 0.2 0.2 0.8 0.3 0.0 0.0 0.2 6.6 3.5 0.2 1.3 0.0 0.1 39.0 0.4 0.1 0.3 0.1 1.7 2.0 0.1 0.0 0.0 0.9 0.0 4.8 1.1 0.5 0.2 4.7 0.4 0.0 0.0 2.1 2.1 0.0 4.4 1.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.5 15.9 9.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 121.9 0.0 0.0 0.0 0.0 0.2 0.0 12.3 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 39.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 1.6 1.5 2.8 4.2 1.2 0.7 0.3 1.6 2.3 0.0 PRSS33 EOS ENSG00000103355 "Serine protease 33" Q8NF86 16 2783953-2787948 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "blood: 132.7" "Group enriched" "Detected in some" 9 "HMC-1: 5.1;SK-MEL-30: 10.4;U-2 OS: 3.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 8.0" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 78 "eosinophil: 132.7" "Lineage enriched" "Detected in single" 422 "granulocytes: 132.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" "unprognostic (4.78e-1)" "unprognostic (1.22e-1)" "unprognostic (8.99e-2)" "unprognostic (3.38e-2)" "unprognostic (3.10e-1)" "unprognostic (2.86e-2)" "unprognostic (1.16e-1)" "unprognostic (4.13e-2)" "unprognostic (1.16e-1)" "unprognostic (1.42e-2)" "unprognostic (2.28e-1)" "unprognostic (1.91e-1)" "unprognostic (2.70e-2)" 0.0 0.0 0.3 1.1 0.3 0.1 0.1 0.2 0.4 0.2 0.2 0.2 0.0 0.8 0.1 0.0 0.1 10.2 3.6 0.0 0.1 0.1 0.3 0.0 0.2 1.1 0.1 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.2 22.5 1.9 0.0 0.0 0.0 1.8 0.8 0.0 0.7 1.1 0.9 0.2 0.2 0.2 1.0 0.2 1.0 0.0 0.0 0.0 132.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 10.4 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 132.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.4 0.1 0.1 0.1 0.0 0.0 0.2 PRSS37 ENSG00000165076 "Serine protease 37" A4D1T9 7 141836286-141841487 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 127 "testis: 39.1" "Cell line enhanced" "Detected in some" "HL-60: 2.3;U-937: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA020541 Enhanced "Secreted in male reproductive system" "HPA020541: AB_1853004" "unprognostic (4.70e-2)" "unprognostic (5.56e-2)" "unprognostic (2.69e-1)" "unprognostic (2.41e-1)" "unprognostic (3.21e-2)" "unprognostic (1.30e-1)" "unprognostic (2.74e-2)" "unprognostic (1.23e-2)" "unprognostic (8.30e-7)" "unprognostic (1.42e-1)" "unprognostic (2.06e-1)" "unprognostic (2.72e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 39.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS40B ENSG00000184761 "Serine protease 40B" 2 130539095-130549883 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "testis: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 PRSS50 "CT20, TSP50" ENSG00000283706 "Serine protease 50" Q9UI38 3 46712115-46717907 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 33.4" "Cell line enhanced" "Detected in some" "EFO-21: 2.0;HMC-1: 5.3;NTERA-2: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA040768 Supported "Intracellular and membrane" "HPA040768: " 0.1 0.8 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 2.9 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.3 0.9 1.7 1.1 0.1 0.1 0.2 0.0 0.1 1.6 1.8 0.1 0.0 0.1 0.1 0.1 0.1 0.0 33.4 0.1 0.4 1.6 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.3 0.8 0.4 0.0 0.0 0.0 0.4 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PRSS54 "CT67, FLJ25339, KLKBL4" ENSG00000103023 "Serine protease 54" Q6PEW0 16 58279997-58295047 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 95 "testis: 35.1" "Cell line enhanced" "Detected in single" "BEWO: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA041549 Enhanced "Secreted in male reproductive system" "HPA041549: AB_10795640" "unprognostic (1.13e-1)" "unprognostic (3.24e-2)" "unprognostic (3.09e-2)" "unprognostic (3.08e-1)" "unprognostic (4.88e-2)" "unprognostic (1.23e-1)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 PRSS55 "CT153, T-SP1, UNQ9391" ENSG00000184647 "Serine protease 55" Q6UWB4 8 10525546-10554166 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 67 "testis: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Intracellular and membrane" "unprognostic (3.64e-1)" "unprognostic (8.44e-3)" "unprognostic (6.10e-2)" "unprognostic (7.40e-2)" "unprognostic (6.23e-5)" "unprognostic (6.62e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PRSS57 "PRSSL1, UNQ782" ENSG00000185198 "Serine protease 57" Q6UWY2 19 685546-695498 "Enzymes, Predicted secreted proteins" "Heparin-binding, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 61.8" "Group enriched" "Detected in some" 13 "NB-4: 85.1;THP-1: 42.6" "Cancer enriched" "Detected in single" 10 "pancreatic cancer: 2.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 8.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Secreted to blood" "unprognostic (2.89e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (3.99e-4)" "unprognostic (3.07e-1)" "unprognostic (1.33e-2)" "unprognostic (3.50e-2)" "unprognostic (4.04e-2)" "unprognostic (7.70e-2)" "unprognostic (3.80e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (8.16e-2)" "unprognostic (2.56e-2)" 0.3 0.2 0.0 0.0 0.0 61.8 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.6 0.0 3.9 0.0 0.1 0.2 0.8 4.0 0.1 0.1 0.0 0.9 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.1 0.0 0.2 0.0 9.3 0.3 0.0 0.9 0.0 0.2 0.0 2.2 8.7 1.6 3.1 4.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 85.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 8.7 1.6 0.0 0.6 0.3 0.0 0.0 0.0 4.5 2.2 0.0 0.0 0.8 1.0 3.1 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 PRSS58 TRYX3 ENSG00000258223 "Serine protease 58" Q8IYP2 7 142252143-142258058 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 85 "testis: 27.2" "Cell line enriched" "Detected in single" 22 "RH-30: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted in male reproductive system" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 27.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRTN3 "ACPA, AGP7, C-ANCA, MBT, P29, PR-3" ENSG00000196415 "Proteinase 3" P24158 19 840960-848175 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 167.3" "Cell line enriched" "Detected in some" 5 "THP-1: 148.0" "Cancer enhanced" "Detected in single" "stomach cancer: 1.0" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA005938, CAB017558" Enhanced "Secreted to blood" 120000 "CAB017558: AB_2172317, HPA005938: AB_1855764" "unprognostic (2.81e-2)" "unprognostic (2.10e-1)" "unprognostic (3.83e-3)" "unprognostic (4.20e-1)" "unprognostic (3.31e-2)" "unprognostic (3.34e-1)" "unprognostic (9.98e-3)" "unprognostic (3.67e-2)" "unprognostic (8.62e-6)" "unprognostic (5.31e-2)" "unprognostic (2.00e-1)" "unprognostic (5.14e-2)" 0.3 0.2 0.9 0.2 1.0 167.3 0.2 0.0 2.3 0.2 0.2 0.7 0.0 0.2 0.2 0.2 0.2 0.2 0.2 31.0 0.3 0.6 0.2 1.7 8.1 3.5 0.1 0.1 0.4 0.2 0.2 0.8 4.2 0.8 0.2 0.2 0.3 0.3 0.2 0.5 0.3 0.2 0.2 0.0 25.5 0.2 0.2 0.1 35.0 0.9 0.0 0.2 0.2 0.0 0.0 0.0 1.9 0.1 0.0 0.2 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 6.8 0.9 1.0 0.0 2.3 0.3 0.6 0.1 0.1 0.8 0.1 PSD2 "DKFZp761B0514, EFA6C" ENSG00000146005 "Pleckstrin and Sec7 domain containing 2" Q9BQI7 5 139795821-139844466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "brain: 52.4" "Cell line enhanced" "Detected in some" "HEL: 3.5;SCLC-21H: 2.1;SH-SY5Y: 3.6;U-2 OS: 1.7" "Cancer enriched" "Detected in single" 43 "glioma: 19.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.76e-2)" "unprognostic (1.90e-1)" "unprognostic (1.34e-3)" "unprognostic (2.48e-3)" "unprognostic (1.34e-2)" "unprognostic (5.01e-2)" "unprognostic (1.22e-2)" "unprognostic (6.55e-2)" "unprognostic (2.42e-1)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (4.02e-1)" "unprognostic (4.16e-3)" "unprognostic (3.40e-2)" "unprognostic (2.28e-1)" "unprognostic (3.07e-1)" "unprognostic (2.12e-3)" 1.3 1.7 21.1 1.3 28.9 1.3 1.7 12.6 52.4 1.9 1.3 15.2 0.0 1.4 1.4 3.6 1.3 1.6 1.3 1.4 16.1 15.2 1.3 1.3 1.3 1.3 18.9 14.4 1.3 1.6 1.3 0.2 1.3 24.7 1.4 1.3 0.0 3.5 1.7 1.4 1.3 1.3 1.4 12.8 1.4 1.3 2.2 17.0 0.0 1.3 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.2 0.9 0.1 0.2 0.0 0.0 0.2 0.3 0.9 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.1 0.4 0.1 0.0 0.4 0.0 0.1 0.0 0.1 2.1 3.6 0.0 0.7 0.1 0.0 0.2 0.0 0.2 1.7 0.0 0.0 1.0 0.0 1.5 1.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 28.9 12.6 17.5 16.1 15.2 18.9 14.4 24.7 17.0 PSD4 "EFA6B, TIC" ENSG00000125637 "Pleckstrin and Sec7 domain containing 4" Q8NDX1 2 113157325-113209396 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "lymphoid tissue: 98.7" "Cell line enhanced" "Detected in many" "Daudi: 20.5;HMC-1: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA034722, HPA034723" Approved "HPA034722: AB_10669730, HPA034723: " "unprognostic (1.87e-3)" "unprognostic (1.32e-2)" "unprognostic (2.46e-2)" "unprognostic (1.88e-1)" "unprognostic (2.21e-2)" "unprognostic (1.13e-3)" "prognostic favourable (9.91e-5)" "unprognostic (6.56e-2)" "unprognostic (4.66e-2)" "unprognostic (6.19e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (1.34e-2)" "prognostic favourable (4.00e-4)" "unprognostic (8.12e-2)" "unprognostic (2.41e-1)" "unprognostic (3.60e-3)" 5.2 11.7 2.6 53.9 3.7 6.2 5.5 0.8 2.1 2.3 5.6 2.9 2.3 5.9 2.6 4.7 8.5 1.9 8.1 3.6 2.6 1.6 3.9 16.2 14.1 25.9 3.1 1.9 2.2 9.5 11.1 3.0 2.9 2.8 6.9 4.4 3.0 11.6 2.5 1.6 6.7 13.6 2.1 2.4 29.3 8.4 1.5 3.4 98.7 8.4 2.5 40.4 4.7 3.1 4.8 7.0 14.2 3.7 7.1 6.4 5.2 7.7 0.5 0.5 0.0 0.0 0.0 14.6 1.0 3.2 0.5 0.4 0.7 9.8 20.5 1.5 0.5 6.9 0.0 2.4 0.1 14.1 0.0 13.3 0.3 4.6 0.3 16.8 25.7 0.0 2.4 0.3 0.4 0.0 9.9 8.7 0.0 5.9 16.6 16.6 0.3 1.3 0.2 0.0 11.1 0.2 3.4 0.6 0.0 0.6 10.3 0.0 3.4 15.2 0.0 0.1 0.2 0.1 2.4 9.2 5.4 8.1 0.4 11.7 0.0 1.7 3.3 3.6 6.3 2.6 6.2 4.8 3.4 6.4 3.9 4.6 3.8 4.3 14.2 7.1 3.7 7.0 3.3 5.2 2.6 3.7 0.8 2.1 2.6 1.6 3.1 1.9 2.8 3.4 PSG1 "CD66f, PBG1, PSBG1, PSGGA" ENSG00000231924 "Pregnancy specific beta-1-glycoprotein 1" P11464 19 42866464-42879822 "CD markers, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 362 "placenta: 497.6" "Cell line enriched" "Detected in some" 20 "U-2197: 95.7" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" HPA046327 Supported "Secreted in female reproductive system" "HPA046327: " "unprognostic (2.02e-1)" "unprognostic (3.54e-1)" "unprognostic (2.44e-7)" "unprognostic (2.28e-2)" 1.3 0.0 0.1 0.0 0.1 0.0 0.6 0.5 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 497.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 1.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 1.3 0.3 0.5 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 95.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 1.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.0 0.0 0.0 PSG11 "MGC22484, PSG13, PSG14" ENSG00000243130 "Pregnancy specific beta-1-glycoprotein 11" Q9UQ72 19 43007656-43026512 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 220 "placenta: 151.1" "Cell line enriched" "Detected in single" 25 "U-2197: 19.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042240, HPA046327" Enhanced "Secreted in female reproductive system" "HPA042240: AB_10797384, HPA046327: " "unprognostic (2.58e-1)" 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 151.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 PSG2 "CEA, PSBG2, PSG1, PSGGB" ENSG00000242221 "Pregnancy specific beta-1-glycoprotein 2" P11465 19 43064211-43083045 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 102 "placenta: 75.3" "Cell line enhanced" "Detected in some" "BJ: 6.4;fHDF/TERT166: 13.7;HBF TERT88: 21.4;U-2197: 27.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in female reproductive system" "unprognostic (1.02e-2)" 0.4 0.0 0.2 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 75.3 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.7 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 1.1 0.6 2.8 0.0 0.0 0.0 0.0 13.7 0.3 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 PSG3 ENSG00000221826 "Pregnancy specific beta-1-glycoprotein 3" Q16557 19 42721638-42740569 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 146 "placenta: 495.8" "Cell line enriched" "Detected in single" 6 "U-2197: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046327 Supported "Secreted in female reproductive system" "HPA046327: " 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 495.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.7 0.5 0.2 0.0 0.0 0.0 0.5 0.7 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSG4 ENSG00000243137 "Pregnancy specific beta-1-glycoprotein 4" Q00888 19 43192702-43207299 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 348.5" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 105.1;U-2197: 28.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046327 Supported "Secreted in female reproductive system" "HPA046327: " "unprognostic (4.29e-2)" "unprognostic (5.18e-2)" "unprognostic (9.49e-2)" "unprognostic (2.52e-2)" "unprognostic (3.63e-2)" "unprognostic (1.94e-1)" "unprognostic (2.07e-2)" "unprognostic (1.70e-1)" "unprognostic (7.75e-2)" "unprognostic (8.82e-3)" "unprognostic (1.03e-3)" "unprognostic (1.68e-2)" "unprognostic (2.85e-1)" "unprognostic (2.57e-1)" 0.6 0.4 0.2 0.5 0.2 0.0 1.4 0.2 0.2 0.2 8.2 0.2 0.2 0.0 0.2 0.2 1.2 0.0 0.2 0.2 0.2 0.0 2.0 0.2 0.2 0.2 0.2 0.2 0.2 2.0 49.1 0.6 348.5 0.2 0.6 5.8 0.2 4.4 0.2 0.2 6.3 0.2 0.2 0.2 0.2 1.1 0.2 0.2 0.2 0.2 0.3 0.3 0.2 1.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.5 0.0 0.3 105.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 10.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.8 0.4 1.0 28.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 PSG5 "FL-NCA-3, PSG" ENSG00000204941 "Pregnancy specific beta-1-glycoprotein 5" Q15238 19 43166256-43186536 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 73 "placenta: 171.3" "Group enriched" "Detected in some" 8 "BJ: 51.2;fHDF/TERT166: 176.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA046327 Supported "Secreted in female reproductive system" "HPA046327: " "unprognostic (1.59e-1)" "unprognostic (3.38e-2)" "unprognostic (4.69e-2)" "unprognostic (1.62e-2)" "unprognostic (2.18e-1)" "unprognostic (2.04e-1)" "unprognostic (1.75e-2)" "unprognostic (1.12e-2)" "unprognostic (2.62e-2)" "unprognostic (1.03e-1)" "unprognostic (7.92e-2)" 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.1 171.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.0 0.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 2.0 0.5 0.6 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 51.2 14.7 0.8 7.1 0.0 0.0 0.0 0.0 176.3 1.9 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.4 0.7 0.4 0.5 0.6 0.5 0.5 0.2 1.0 0.7 0.5 2.0 0.6 0.4 0.5 0.4 0.0 0.0 0.1 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 PSG6 ENSG00000170848 "Pregnancy specific beta-1-glycoprotein 6" Q00889 19 42902079-42919563 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 124 "placenta: 330.8" "Cell line enriched" "Detected in some" 17 "U-2197: 56.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 27 "neutrophil: 2.6" "Lineage enriched" "Detected in single" 27 "granulocytes: 2.6" HPA046327 Supported "Secreted in female reproductive system" "HPA046327: " "unprognostic (4.23e-1)" 0.1 0.1 0.2 0.0 0.1 0.8 0.1 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 330.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.2 0.4 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 56.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 PSG7 ENSG00000221878 "Pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene)" 19 42924132-42937178 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 23.1" "Cell line enhanced" "Detected in some" "BJ: 4.0;fHDF/TERT166: 2.8;HBF TERT88: 5.8;U-2197: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046327 Supported "Secreted in female reproductive system" "HPA046327: " 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.9 0.2 1.3 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSG8 ENSG00000124467 "Pregnancy specific beta-1-glycoprotein 8" Q9UQ74 19 42752686-42855691 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 88 "placenta: 142.2" "Cell line enhanced" "Detected in some" "A-431: 1.8;CAPAN-2: 1.1;HBF TERT88: 1.3;U-2197: 2.6" "Cancer enriched" "Detected in single" 17 "thyroid cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046327 Supported "Secreted in female reproductive system" "HPA046327: " "unprognostic (1.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.2 142.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.4 0.0 0.0 1.1 0.0 0.1 0.2 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSG9 "PSG11, PSGII" ENSG00000183668 "Pregnancy specific beta-1-glycoprotein 9" Q00887 19 43211791-43269530 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 205 "placenta: 299.0" "Cell line enhanced" "Detected in some" "BJ: 6.1;BJ hTERT+ SV40 Large T+: 5.4;HBF TERT88: 11.2;T-47d: 5.1;U-2197: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.4" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.4" HPA046327 Supported "Secreted in female reproductive system" "HPA046327: " "unprognostic (9.32e-2)" "unprognostic (3.28e-1)" "unprognostic (2.15e-1)" 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.2 299.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.4 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 6.1 3.4 5.4 2.8 0.1 0.1 0.0 0.2 1.7 0.3 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.7 5.1 0.0 0.3 0.2 2.6 11.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.0 PSMA8 "MGC26605, PSMA7L" ENSG00000154611 "Proteasome subunit alpha 8" Q8TAA3 18 26133852-26193355 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 36.5" "Group enriched" "Detected in some" 95 "Daudi: 23.4;U-266/70: 14.5;U-266/84: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "unprognostic (5.39e-3)" "unprognostic (7.45e-5)" "unprognostic (2.94e-1)" "unprognostic (3.04e-2)" "unprognostic (1.59e-1)" "unprognostic (2.72e-1)" "unprognostic (1.99e-1)" "unprognostic (8.30e-2)" "unprognostic (7.54e-4)" "unprognostic (4.80e-2)" "unprognostic (1.15e-1)" "unprognostic (2.56e-1)" 0.1 0.1 0.1 1.2 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.7 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 1.1 0.0 36.5 0.2 0.7 0.1 0.0 2.2 0.1 0.0 4.0 1.9 0.2 0.1 1.2 5.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 15.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.1 2.2 4.0 2.1 3.9 0.3 3.1 2.4 5.8 0.2 1.2 0.1 1.9 4.3 1.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.7 0.2 PSMB11 beta5t ENSG00000222028 "Proteasome subunit beta 11" A5LHX3 14 23042167-23044276 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 32.7" "Cell line enriched" "Detected in single" 4 "PC-3: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "naive CD4 T-cell: 2.1" "Lineage enriched" "Detected in single" 21 "T-cells: 2.1" "Region enriched" "Detected in single" 7 "olfactory region: 2.3" "Not detected" "Not detected" "HPA028967, HPA056970" Enhanced "HPA028967: AB_2732444, HPA056970: AB_2683293" "unprognostic (7.96e-2)" "unprognostic (2.77e-1)" 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.4 0.0 32.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 PSORS1C1 "C6orf16, SEEK1" ENSG00000204540 "Psoriasis susceptibility 1 candidate 1" Q9UIG5 6 31114750-31140092 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "testis: 52.2" "Cell line enhanced" "Detected in some" "EFO-21: 2.1;hTCEpi: 5.5;U-2 OS: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA045049 Uncertain Nucleoplasm Nucleoplasm "HPA045049: " "unprognostic (1.15e-1)" "unprognostic (4.25e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.72e-1)" "unprognostic (9.23e-2)" "unprognostic (4.77e-3)" "unprognostic (8.48e-2)" "unprognostic (3.05e-3)" "unprognostic (1.66e-2)" "unprognostic (4.17e-2)" "unprognostic (9.56e-2)" "unprognostic (5.72e-3)" "unprognostic (4.80e-2)" "unprognostic (1.59e-1)" "unprognostic (6.33e-2)" "unprognostic (1.30e-1)" 0.9 0.7 1.1 0.7 2.8 0.7 0.8 0.5 1.5 3.4 6.9 2.2 2.6 0.7 7.7 6.4 2.1 1.1 7.5 0.7 0.7 0.6 1.0 0.7 3.7 0.7 4.4 0.0 1.9 1.5 0.7 0.4 1.7 3.0 1.7 1.1 0.2 0.9 1.8 0.7 2.0 6.0 6.5 3.4 0.7 1.1 52.2 0.9 0.0 1.8 1.1 0.7 3.6 3.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 5.5 0.6 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.8 0.5 1.5 0.7 0.6 4.4 0.0 3.0 0.9 PTAFR ENSG00000169403 "Platelet activating factor receptor" P25105 1 28147166-28193936 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 98.3" "Group enriched" "Detected in some" 4 "HBEC3-KT: 14.3;HMC-1: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 28.2;eosinophil: 98.3;neutrophil: 85.7" "Group enriched" "Detected in many" 5 "granulocytes: 98.3;monocytes: 28.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027543 Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Vesicles" "Plasma membrane" "HPA027543: AB_10610287" "unprognostic (2.22e-2)" "unprognostic (2.59e-2)" "unprognostic (6.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.75e-1)" "unprognostic (3.74e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.23e-1)" "unprognostic (2.39e-1)" "unprognostic (1.60e-1)" "unprognostic (2.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.59e-2)" "unprognostic (5.48e-2)" "unprognostic (1.38e-2)" 5.6 2.3 2.4 16.2 1.9 20.3 2.4 0.6 2.0 6.9 3.4 1.6 3.5 1.8 2.8 1.4 16.8 2.8 7.5 3.5 2.1 2.3 6.4 1.8 9.2 6.1 4.1 1.0 1.5 2.7 0.9 0.7 3.5 1.8 2.6 3.4 0.6 3.4 2.6 1.1 2.8 5.0 3.8 5.1 15.4 2.3 2.2 1.1 2.3 1.4 22.2 21.7 5.9 3.6 1.5 13.2 98.3 28.2 0.0 0.1 10.1 7.5 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 2.1 0.5 0.0 0.0 5.2 0.2 14.3 0.3 0.1 0.2 2.8 0.0 0.3 0.0 0.7 52.4 0.0 2.3 0.1 0.1 0.0 0.2 0.2 0.0 0.5 0.0 7.1 0.2 0.1 0.1 0.0 0.0 3.5 0.8 0.1 0.0 0.0 7.1 0.0 0.1 2.0 0.0 0.1 0.3 0.0 0.0 0.5 0.4 2.1 0.0 0.9 0.2 5.9 28.2 98.3 0.0 8.9 0.1 1.5 0.0 0.0 13.2 0.7 0.0 0.0 85.7 0.0 3.5 0.1 0.1 10.1 2.4 1.9 0.6 2.0 2.1 2.3 4.1 1.0 1.8 1.1 PTF1A "bHLHa29, PTF1-p48" ENSG00000168267 "Pancreas specific transcription factor, 1a" Q7RTS3 10 23192327-23194252 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 154 "pancreas: 129.8" "Cell line enriched" "Detected in single" 11 "U-2 OS: 7.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB022612 Approved Nucleoplasm Nucleoplasm "CAB022612: " "unprognostic (2.02e-1)" "unprognostic (1.85e-1)" "unprognostic (4.49e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 129.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 PTH PTH1 ENSG00000152266 "Parathyroid hormone" P01270 11 13492055-13496181 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" Hormone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "parathyroid gland: 963.9" "Cell line enhanced" "Detected in single" "U-2197: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000072, CAB023409, CAB026363, HPA048540" Enhanced "Secreted to blood" 27980 "CAB000072: , CAB023409: AB_619175, CAB026363: , HPA048540: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 963.9 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 129.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PTH1R "PTHR, PTHR1" ENSG00000160801 "Parathyroid hormone 1 receptor" Q03431 3 46877746-46903799 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 90.4" "Cell line enriched" "Detected in some" 7 "RPTEC TERT1: 50.5" "Cancer enhanced" "Detected in many" "renal cancer: 18.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007978 Approved "HPA007978: AB_1854967" "unprognostic (1.26e-1)" "unprognostic (7.09e-2)" "unprognostic (2.24e-5)" "unprognostic (7.46e-2)" "unprognostic (3.46e-1)" "unprognostic (5.02e-2)" "unprognostic (3.84e-3)" "unprognostic (5.47e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (7.51e-2)" "unprognostic (8.44e-2)" "prognostic favourable (6.79e-6)" "unprognostic (4.22e-3)" "unprognostic (1.50e-1)" "unprognostic (1.35e-4)" "unprognostic (6.62e-3)" 8.5 17.9 4.2 1.4 5.9 0.8 5.0 3.7 5.0 6.2 2.3 5.2 1.1 1.5 4.5 2.5 2.3 3.8 2.8 4.3 5.5 3.9 90.4 13.4 4.1 6.9 6.0 5.0 5.4 1.6 1.0 0.9 10.1 4.7 3.2 1.2 3.4 1.5 3.0 4.0 2.6 1.8 4.6 4.1 9.6 1.5 2.2 5.7 0.0 1.2 0.6 1.0 2.8 5.5 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 7.0 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 2.3 0.0 50.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.2 5.9 3.7 5.0 5.5 3.9 6.0 5.0 4.7 5.7 PTPN5 "PTPSTEP, STEP, STEP61" ENSG00000110786 "Protein tyrosine phosphatase, non-receptor type 5" P54829 11 18727928-18792721 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "brain: 70.0" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HMC-1: 3.6;NTERA-2: 5.7" "Group enriched" "Detected in some" 6 "glioma: 1.6;testis cancer: 2.0" "Region enhanced" "Detected in many" "basal ganglia: 70.0" "Cell type enriched" "Detected in single" 9 "basophil: 1.5" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031014, HPA072091" Supported Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA031014: AB_10669550, HPA072091: " "unprognostic (1.23e-1)" "unprognostic (2.91e-2)" "unprognostic (8.93e-3)" "unprognostic (1.09e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-2)" "unprognostic (5.83e-3)" "unprognostic (3.59e-1)" "unprognostic (4.91e-2)" "unprognostic (2.59e-1)" "unprognostic (2.00e-1)" "unprognostic (3.58e-1)" "unprognostic (8.44e-4)" "unprognostic (4.21e-3)" "unprognostic (3.90e-2)" "unprognostic (9.39e-2)" "unprognostic (8.49e-2)" 2.5 1.6 16.3 1.1 70.0 1.1 1.2 0.9 47.5 1.5 1.1 0.4 0.0 1.1 1.2 1.0 1.3 1.7 1.4 4.3 9.1 8.6 1.1 0.9 2.7 1.1 3.5 16.0 2.5 1.2 1.5 0.5 0.9 6.1 1.6 1.4 0.0 1.3 1.7 1.8 1.0 1.4 1.4 2.1 1.3 1.3 3.4 9.3 0.0 1.2 0.0 1.0 1.5 0.3 0.1 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.0 3.6 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 5.7 0.3 0.0 0.1 0.1 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.3 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 70.0 0.9 25.1 9.1 8.6 3.5 16.0 6.1 9.3 PTPRR "EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ" ENSG00000153233 "Protein tyrosine phosphatase, receptor type R" Q15256 12 70638073-70920843 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 56.1" "Group enriched" "Detected in some" 5 "HDLM-2: 14.0;RT4: 26.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 56.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in all" 5 "cerebellum: 100.5" "Low region specificity" "Detected in all" "CAB011461, HPA011851, HPA071067" Uncertain Supported "Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cell Junctions, Cytosol" "CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: " "unprognostic (4.98e-2)" "unprognostic (1.91e-2)" "unprognostic (1.55e-1)" "unprognostic (2.04e-1)" "unprognostic (3.63e-3)" "unprognostic (3.48e-5)" "unprognostic (5.44e-3)" "unprognostic (1.77e-3)" "unprognostic (1.13e-1)" "unprognostic (9.01e-2)" "unprognostic (1.37e-3)" "unprognostic (8.06e-2)" "unprognostic (1.10e-2)" "unprognostic (1.92e-2)" "unprognostic (4.78e-2)" "unprognostic (2.72e-1)" "prognostic favourable (1.40e-5)" 0.4 3.8 18.8 1.6 11.3 0.3 0.4 56.1 20.9 0.5 11.2 0.1 0.0 5.1 8.4 0.3 0.4 0.5 1.9 0.4 8.6 4.9 0.4 0.4 0.4 0.4 1.3 13.2 0.4 0.6 0.3 0.9 0.7 3.3 0.5 7.8 0.8 0.4 2.1 0.4 0.4 11.3 4.9 3.1 0.4 4.4 0.4 1.4 0.0 0.4 0.0 0.3 4.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.3 0.0 0.5 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 26.7 0.1 4.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.8 11.3 56.1 20.9 8.6 4.9 1.3 13.2 3.3 1.4 PTPRZ1 "phosphacan, PTP18, PTPRZ, PTPZ, RPTPB" ENSG00000106278 "Protein tyrosine phosphatase, receptor type Z1" P23471 7 121873089-122062036 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 118.1" "Group enriched" "Detected in some" 9 "AF22: 92.1;NTERA-2: 25.6;WM-115: 40.3" "Cancer enriched" "Detected in many" 14 "glioma: 175.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015103 Enhanced Approved Vesicles,Cytosol "Secreted in brain" 950000 Cytosol Vesicles "HPA015103: AB_1855946" "unprognostic (8.49e-4)" "unprognostic (3.96e-3)" "unprognostic (4.11e-2)" "unprognostic (1.37e-1)" "unprognostic (9.18e-2)" "unprognostic (2.41e-2)" "unprognostic (8.30e-3)" "unprognostic (3.78e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (9.17e-4)" "unprognostic (1.83e-1)" "unprognostic (8.72e-6)" "unprognostic (2.00e-1)" "unprognostic (2.16e-1)" "unprognostic (8.77e-2)" "prognostic unfavourable (9.36e-4)" 2.0 2.5 33.1 2.3 44.1 1.5 4.0 15.4 118.1 2.4 2.2 19.3 0.0 1.9 1.6 2.0 7.0 1.7 1.9 2.0 39.6 15.9 1.6 1.6 2.1 1.5 18.6 17.8 2.0 3.3 1.5 1.6 1.6 67.6 2.1 2.3 0.8 2.4 2.0 1.5 19.3 1.9 2.4 76.6 2.1 9.8 1.7 23.6 0.0 1.5 1.8 3.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 1.1 0.0 0.1 0.0 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 44.1 15.4 39.6 39.6 15.9 18.6 17.8 67.6 23.6 PXDNL "FLJ25471, PMR1" ENSG00000147485 "Peroxidasin like" A1KZ92 8 51319578-51809445 "Enzymes, Predicted intracellular proteins" "Hydrogen peroxide" "Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 59.1" "Group enriched" "Detected in some" 7 "AF22: 10.8;Daudi: 8.1;SH-SY5Y: 8.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 4 "B-cells: 1.5" HPA007919 Approved Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "HPA007919: AB_1855966" "prognostic unfavourable (3.27e-5)" "unprognostic (4.59e-4)" "unprognostic (5.57e-3)" "unprognostic (2.83e-3)" "unprognostic (2.71e-1)" "unprognostic (5.14e-2)" "unprognostic (1.18e-1)" "unprognostic (7.18e-3)" "unprognostic (1.85e-1)" "unprognostic (1.15e-1)" "unprognostic (7.07e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-4)" "unprognostic (2.28e-2)" "unprognostic (3.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.97e-4)" 1.1 0.1 0.3 0.1 0.2 0.0 0.2 0.1 0.9 0.1 0.1 0.0 0.2 0.0 0.3 7.9 0.4 0.1 0.7 59.1 0.2 0.3 1.0 0.1 0.2 0.3 0.3 0.3 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.0 1.8 1.1 0.3 0.9 0.2 0.2 0.1 0.2 0.3 0.1 5.2 0.0 0.1 0.2 2.5 0.3 0.2 0.1 1.5 0.3 0.3 0.0 0.0 0.1 0.0 0.6 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.5 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.3 0.2 0.1 0.9 0.2 0.3 0.3 0.3 0.3 0.0 PYY PYY1 ENSG00000131096 "Peptide YY" P10082 17 43952738-44004469 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 40.0" "Cell line enhanced" "Detected in many" "HMC-1: 7.8" "Group enriched" "Detected in many" 8 "endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 22 "pons and medulla: 1.4" "Low region specificity" "Detected in many" "HPA010973, CAB016734" Enhanced "Secreted to blood" 90700 "CAB016734: AB_876471, HPA010973: AB_1855194" "unprognostic (8.17e-3)" "unprognostic (5.41e-2)" "unprognostic (9.93e-2)" "unprognostic (1.81e-3)" "unprognostic (2.48e-4)" "unprognostic (5.26e-2)" "unprognostic (4.14e-2)" "unprognostic (1.80e-2)" "unprognostic (1.75e-2)" "unprognostic (1.54e-2)" "unprognostic (2.91e-1)" "unprognostic (1.29e-1)" "unprognostic (5.69e-3)" "unprognostic (3.77e-2)" "unprognostic (1.79e-1)" "unprognostic (1.41e-1)" "unprognostic (1.20e-1)" 0.1 0.8 0.1 2.0 0.2 0.0 0.2 0.1 0.1 0.1 40.0 0.1 0.1 1.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.5 0.1 20.6 0.1 0.1 0.3 0.1 0.0 24.8 0.1 0.1 0.1 0.1 1.0 0.1 4.2 0.2 0.1 0.1 0.1 0.1 0.9 0.1 0.0 0.1 0.0 0.4 0.0 0.2 0.5 0.7 1.2 1.0 1.7 0.2 1.2 0.3 1.4 0.8 1.2 0.9 0.7 1.6 1.4 0.7 1.1 0.4 0.9 3.1 0.6 1.8 0.5 0.2 1.2 0.5 7.8 2.2 0.4 1.3 0.6 0.3 0.4 1.3 1.2 1.6 0.5 1.0 1.5 0.7 0.3 0.3 0.2 2.1 0.1 1.3 0.3 0.7 0.0 2.0 1.2 0.1 1.3 1.5 1.4 0.3 1.1 0.1 1.2 0.2 1.8 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.1 PZP CPAMD6 ENSG00000126838 "PZP, alpha-2-macroglobulin like" P20742 12 9148840-9208370 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 56.9" "Group enriched" "Detected in some" 8 "HeLa: 9.7;SiHa: 5.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.0" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "gdT-cell: 3.5;MAIT T-cell: 3.5" "Lineage enriched" "Detected in single" 12 "T-cells: 3.5" "HPA041403, HPA041471" Supported "Secreted to blood" 13000000000 "HPA041403: AB_10804003, HPA041471: AB_10795636" "unprognostic (8.48e-3)" "unprognostic (1.12e-2)" "unprognostic (2.28e-1)" "unprognostic (8.54e-4)" "unprognostic (4.79e-1)" "unprognostic (3.50e-2)" "unprognostic (2.04e-4)" "unprognostic (4.57e-2)" "unprognostic (2.18e-1)" "unprognostic (2.55e-2)" "unprognostic (9.71e-2)" "unprognostic (4.95e-2)" "unprognostic (1.08e-5)" "unprognostic (5.49e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (9.81e-3)" 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.8 0.1 0.0 0.7 0.0 0.0 0.9 0.6 0.0 56.9 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 3.5 0.0 0.7 0.9 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.4 0.0 0.0 0.9 0.6 0.0 0.0 1.4 0.6 QRICH2 DKFZP434P0316 ENSG00000129646 "Glutamine rich 2" Q9H0J4 17 76274049-76307998 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 27.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA052219 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nucleoplasm, Nuclear membrane, Vesicles" "HPA052219: " "unprognostic (3.11e-2)" "unprognostic (2.44e-3)" "unprognostic (9.11e-3)" "unprognostic (4.42e-3)" "unprognostic (1.35e-1)" "unprognostic (1.32e-2)" "unprognostic (2.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.83e-1)" "unprognostic (2.61e-1)" "unprognostic (8.82e-4)" "unprognostic (3.64e-1)" "unprognostic (1.39e-1)" "unprognostic (6.97e-2)" "unprognostic (7.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.71e-3)" 0.9 0.8 1.2 0.9 2.2 1.9 0.9 5.7 2.0 0.9 0.9 0.9 0.9 0.3 0.9 1.0 1.0 1.2 0.9 0.9 1.4 2.0 0.9 1.1 1.1 0.9 1.4 0.9 0.9 1.3 0.6 0.9 1.4 0.9 0.9 0.8 0.9 5.6 0.9 1.4 1.7 0.9 0.9 1.2 0.9 0.3 27.4 0.9 0.9 3.0 0.9 0.9 0.9 0.9 0.9 0.0 0.0 0.1 0.3 0.4 0.3 1.1 2.5 4.7 5.3 2.6 2.3 2.2 2.2 0.5 1.7 0.5 1.3 0.5 6.5 0.9 1.3 0.5 6.2 1.1 2.0 1.8 3.8 0.5 1.7 5.7 1.3 0.8 2.9 2.1 1.0 1.9 0.1 2.0 3.4 1.2 0.5 3.7 3.4 0.7 1.9 5.1 7.5 3.9 0.2 0.8 2.3 4.3 4.3 1.1 0.6 2.6 1.9 2.7 2.1 1.4 5.0 6.7 2.6 1.7 1.6 0.6 1.5 3.8 1.6 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 1.2 2.2 5.7 2.0 1.4 2.0 1.4 0.9 0.9 0.9 RAB3A ENSG00000105649 "RAB3A, member RAS oncogene family" P20336 19 18196784-18204074 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 114.7" "Cell line enhanced" "Detected in many" "PC-3: 13.5;SCLC-21H: 24.7;SH-SY5Y: 11.8;U-2197: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003160, CAB009949, CAB078998" Enhanced Supported Approved Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731" "unprognostic (1.82e-1)" "unprognostic (2.22e-1)" "unprognostic (6.80e-3)" "prognostic unfavourable (3.17e-4)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (1.36e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.64e-1)" "unprognostic (4.46e-3)" "unprognostic (1.13e-1)" "prognostic favourable (6.14e-7)" "unprognostic (1.23e-1)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (6.14e-2)" 2.3 13.0 32.3 2.6 50.5 2.0 2.0 39.1 114.7 2.8 3.1 6.3 0.0 3.6 2.7 2.6 2.4 3.2 2.8 17.0 40.8 32.7 4.1 2.2 2.5 2.4 31.5 35.6 8.0 2.3 5.0 7.5 2.4 38.2 3.8 2.8 5.8 4.2 4.4 7.5 2.5 3.0 2.9 7.0 2.5 2.5 2.2 4.8 0.0 2.9 0.1 2.1 2.9 0.7 4.6 6.0 5.1 3.0 0.7 4.2 2.6 0.9 1.0 2.3 3.2 3.8 1.0 1.4 2.0 1.2 1.4 1.9 0.9 0.5 3.3 2.2 1.6 2.7 10.7 1.3 0.7 0.7 3.4 1.3 3.9 3.7 0.9 2.2 4.1 3.1 1.3 0.8 0.4 0.4 0.7 1.1 1.3 3.2 5.0 0.6 1.9 13.5 3.5 0.2 2.8 1.5 0.5 24.7 11.8 1.0 4.3 2.3 0.9 0.4 0.4 1.2 0.9 17.1 1.1 2.1 4.5 0.8 3.2 1.7 1.1 0.0 3.0 3.8 3.0 2.2 4.0 4.6 3.2 3.0 6.0 2.2 4.1 4.2 5.1 0.7 2.7 5.5 1.8 2.6 32.3 50.5 39.1 95.0 40.8 32.7 31.5 35.6 38.2 4.8 RAB43 "ISY1, RAB11B, RAB41" ENSG00000172780 "RAB43, member RAS oncogene family" Q86YS6 3 129087569-129122801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 73.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.3" "Group enriched" "Detected in all" 5 "granulocytes: 13.3;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046840, HPA060085" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA046840: , HPA060085: " "unprognostic (3.01e-1)" "unprognostic (1.14e-2)" "unprognostic (3.08e-1)" "unprognostic (1.01e-1)" "unprognostic (5.08e-2)" "unprognostic (1.91e-1)" "unprognostic (9.36e-2)" "unprognostic (3.17e-2)" "unprognostic (4.16e-1)" "unprognostic (8.68e-2)" "unprognostic (3.14e-1)" "unprognostic (3.08e-1)" "unprognostic (2.46e-2)" "unprognostic (9.32e-2)" "unprognostic (5.82e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" 5.4 6.2 3.9 8.0 3.3 14.6 5.3 6.0 3.6 6.4 7.0 3.2 7.2 5.8 5.4 6.8 4.1 5.3 12.0 3.8 2.8 2.0 9.1 73.9 11.4 12.1 2.7 1.6 7.8 7.4 2.5 8.0 4.7 3.7 7.3 1.7 7.7 7.4 4.7 1.9 3.0 5.9 4.9 2.7 9.9 5.7 5.2 2.1 17.3 17.1 2.6 13.6 6.6 6.0 1.3 1.1 13.3 1.6 1.5 3.5 1.3 15.4 4.3 1.0 4.1 1.9 0.9 6.1 5.4 3.5 3.0 2.6 6.6 6.7 0.4 12.4 3.9 6.5 0.4 6.1 0.7 7.8 4.1 1.0 0.7 8.6 19.1 3.5 9.2 5.2 3.8 1.5 0.4 6.1 1.7 7.8 4.3 6.6 3.4 6.8 4.9 7.0 7.4 2.3 4.4 9.9 13.2 0.3 1.9 2.3 5.0 9.9 2.1 3.7 8.8 6.8 4.8 5.5 2.0 12.2 6.4 2.4 6.2 0.7 7.3 0.5 1.5 2.6 1.9 1.6 0.9 0.6 1.8 1.5 0.7 1.3 3.5 3.0 13.3 1.5 0.7 1.1 2.7 1.3 3.9 3.3 6.0 3.6 2.8 2.0 2.7 1.6 3.7 2.1 RAB6D "RAB6CL, WTH3DI" ENSG00000233087 "RAB6D, member RAS oncogene family" 2 131361111-131364142 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "parathyroid gland: 13.4" "Group enriched" "Detected in some" 4 "MOLT-4: 6.4;REH: 2.5;U-2 OS: 2.5" "Cancer enhanced" "Detected in some" "prostate cancer: 1.3" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" HPA059131 Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA059131: " "unprognostic (4.19e-2)" "unprognostic (8.54e-2)" "unprognostic (1.16e-1)" "unprognostic (3.03e-2)" "unprognostic (4.08e-1)" "unprognostic (4.79e-2)" "unprognostic (4.41e-2)" "unprognostic (1.01e-1)" "unprognostic (1.87e-2)" "unprognostic (2.42e-1)" "unprognostic (3.21e-1)" "unprognostic (2.55e-2)" "unprognostic (2.61e-2)" "unprognostic (2.50e-1)" "unprognostic (1.82e-1)" "unprognostic (2.12e-1)" 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 1.9 1.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.3 1.4 0.4 0.5 0.5 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6.4 0.1 0.9 0.0 2.5 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 2.5 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.1 1.4 0.3 0.5 0.4 0.4 0.4 0.1 0.5 0.3 0.3 0.2 0.5 0.4 0.2 0.5 0.4 0.1 0.5 0.5 RAD21L1 "dJ545L17.2, RAD21L" ENSG00000244588 "RAD21 cohesin complex component like 1" Q9H4I0 20 1226056-1296421 "Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 17.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.7;BJ hTERT+ SV40 Large T+: 2.5;TIME: 4.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 3.1;cerebral cortex: 1.2;olfactory region: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA053282 Approved "HPA053282: " "unprognostic (2.90e-1)" "unprognostic (3.35e-1)" "unprognostic (1.62e-4)" "unprognostic (2.04e-1)" "unprognostic (8.87e-4)" "unprognostic (1.15e-1)" "unprognostic (1.25e-1)" "unprognostic (1.84e-1)" 0.0 0.0 0.3 0.0 3.1 0.0 0.0 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.1 0.0 0.7 0.0 0.0 17.4 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.6 4.7 2.5 0.9 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.1 1.2 0.8 0.2 0.1 0.1 0.0 0.7 0.0 0.7 0.1 0.0 0.6 0.0 0.7 0.8 0.0 1.4 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.9 0.1 0.1 0.7 0.0 0.0 0.1 0.0 0.0 4.7 0.8 0.1 1.1 0.0 0.8 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.3 3.1 0.1 1.2 0.3 0.1 0.1 1.0 0.2 0.2 RAD23A "HHR23A, MGC111083" ENSG00000179262 "RAD23 homolog A, nucleotide excision repair protein" P54725 19 12945855-12953642 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 225.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026418, HPA053901, HPA057003, HPA065599" Approved Enhanced Nucleoplasm,Cytosol 3100000 Nucleoplasm Cytosol "HPA026418: , HPA053901: , HPA057003: , HPA065599: " "unprognostic (2.09e-1)" "unprognostic (1.58e-3)" "unprognostic (1.23e-3)" "unprognostic (7.90e-3)" "unprognostic (1.45e-1)" "unprognostic (1.48e-1)" "unprognostic (3.78e-3)" "unprognostic (3.57e-3)" "unprognostic (3.13e-1)" "unprognostic (3.12e-3)" "unprognostic (1.09e-1)" "unprognostic (4.08e-2)" "unprognostic (2.09e-3)" "unprognostic (2.32e-3)" "unprognostic (9.99e-2)" "unprognostic (8.56e-2)" "unprognostic (6.59e-3)" 19.6 15.2 19.1 13.4 17.7 19.9 16.0 15.1 25.3 12.9 18.0 14.6 10.7 13.6 15.3 14.3 19.9 17.7 13.6 34.3 16.6 16.0 13.2 24.5 14.2 14.1 15.4 15.6 17.1 21.1 14.0 12.3 17.3 15.5 15.1 10.7 12.6 18.6 15.8 225.3 19.8 11.9 16.5 15.4 15.7 14.9 19.1 12.5 14.6 17.2 37.7 13.8 20.7 17.0 29.5 30.0 22.7 35.6 26.5 32.1 22.5 31.4 11.6 13.5 13.9 22.5 25.8 22.6 15.4 31.0 36.6 33.3 13.0 22.7 26.8 35.5 23.1 24.4 18.4 32.0 13.9 37.8 23.4 10.8 15.0 12.5 43.8 23.3 31.7 26.3 48.0 26.4 50.6 25.1 27.7 24.7 32.9 30.7 29.0 28.9 18.5 28.8 15.3 14.0 43.5 28.5 12.6 25.0 19.7 17.0 31.1 34.0 24.2 40.5 19.7 52.7 14.0 62.5 47.0 35.8 29.9 19.5 43.4 44.1 43.2 10.4 27.9 22.7 29.7 35.6 32.1 29.2 25.3 25.1 23.4 29.5 24.6 27.8 3.9 26.5 34.9 30.0 27.0 22.5 19.1 17.7 15.1 25.3 16.6 16.0 15.4 15.6 15.5 12.5 RAD51AP2 FLJ17540 ENSG00000214842 "RAD51 associated protein 2" Q09MP3 2 17510584-17518439 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 19.1" "Group enriched" "Detected in some" 4 "AN3-CA: 2.5;CAPAN-2: 3.7;HaCaT: 2.9" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "unprognostic (3.87e-2)" "unprognostic (3.31e-2)" "unprognostic (9.98e-2)" "unprognostic (3.12e-2)" "unprognostic (4.61e-1)" "unprognostic (3.51e-1)" "unprognostic (9.80e-2)" "unprognostic (4.84e-3)" "unprognostic (2.64e-1)" "unprognostic (1.92e-1)" "unprognostic (1.71e-1)" "unprognostic (6.26e-3)" "unprognostic (3.82e-2)" "unprognostic (1.62e-3)" "unprognostic (1.15e-1)" 0.0 0.1 0.1 0.0 0.0 0.0 0.2 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.2 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.5 0.1 0.2 0.0 0.0 0.2 0.0 RAD9B FLJ40346 ENSG00000151164 "RAD9 checkpoint clamp component B" Q6WBX8 12 110501655-110532086 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 31.8" "Cell line enhanced" "Detected in some" "SiHa: 6.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 6.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040643 Approved "HPA040643: AB_10805716" "unprognostic (2.32e-1)" "unprognostic (2.55e-5)" "unprognostic (4.76e-2)" "unprognostic (1.30e-3)" "unprognostic (2.93e-1)" "unprognostic (6.27e-3)" "unprognostic (5.44e-2)" "unprognostic (2.00e-1)" "unprognostic (1.56e-2)" "unprognostic (1.22e-1)" "unprognostic (5.92e-2)" "unprognostic (2.26e-1)" "unprognostic (2.68e-3)" "unprognostic (7.33e-2)" "unprognostic (1.99e-1)" "unprognostic (2.15e-2)" "unprognostic (1.80e-2)" 0.3 0.1 0.5 0.1 0.7 0.2 0.4 0.6 0.5 0.3 0.2 0.5 0.1 0.0 0.6 0.9 0.5 0.4 0.1 0.9 0.4 0.3 0.1 0.4 0.3 1.7 0.5 0.1 0.8 0.1 0.3 0.4 0.1 0.6 0.3 0.1 0.4 0.1 0.6 1.0 0.1 0.2 0.5 0.8 0.3 0.1 31.8 0.4 0.6 0.2 0.4 0.5 0.3 0.2 0.9 2.0 6.7 2.0 0.5 0.6 0.8 3.8 0.2 0.0 0.6 0.2 0.1 0.1 1.2 0.2 1.8 1.5 3.5 0.1 2.2 0.8 0.4 0.2 0.5 0.1 0.5 0.3 0.5 2.7 0.1 0.0 0.5 4.1 0.7 0.3 0.5 1.5 1.4 0.1 0.7 2.0 2.2 0.5 0.8 0.8 0.1 1.3 0.3 0.9 0.6 0.1 0.3 0.7 0.1 6.0 0.9 0.6 1.4 2.4 0.6 0.8 0.0 0.6 0.4 0.8 0.6 1.5 0.2 1.7 2.5 6.7 1.2 0.5 0.6 0.8 0.3 0.9 0.5 0.3 2.0 0.8 0.6 0.2 1.1 0.5 2.0 1.1 0.3 0.8 0.5 0.7 0.6 0.5 0.4 0.3 0.5 0.1 0.6 0.4 RAG1 "MGC43321, RNF74" ENSG00000166349 "Recombination activating 1" P15918 11 36510709-36593156 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA recombination, Ubl conjugation pathway" "Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase" "Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 62 "lymphoid tissue: 462.4" "Group enriched" "Detected in some" 110 "MOLT-4: 65.8;REH: 62.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043939 Supported Nucleoplasm Nucleoplasm "HPA043939: " "unprognostic (7.35e-2)" "unprognostic (1.57e-3)" "unprognostic (8.75e-2)" "unprognostic (3.44e-1)" "unprognostic (2.14e-1)" "unprognostic (1.46e-2)" "unprognostic (2.30e-1)" "unprognostic (1.70e-2)" "unprognostic (1.43e-1)" "unprognostic (1.54e-2)" "unprognostic (5.98e-3)" "unprognostic (1.28e-1)" "unprognostic (1.16e-9)" "unprognostic (2.16e-2)" "unprognostic (1.04e-1)" "unprognostic (2.53e-4)" "unprognostic (1.53e-1)" 0.7 2.3 0.5 0.5 0.5 7.4 0.7 0.5 0.5 0.5 0.6 0.5 0.5 1.2 0.5 1.3 0.5 0.6 0.5 0.6 0.5 0.2 2.4 1.2 0.8 0.5 0.5 0.5 0.6 1.1 1.9 0.5 0.8 0.5 0.5 0.4 0.5 1.5 0.5 0.5 0.2 1.5 0.5 0.5 4.4 0.8 0.9 0.5 462.4 4.5 0.5 0.8 0.7 0.5 0.2 0.3 0.0 0.0 0.2 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 65.8 0.0 0.5 0.0 62.9 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.8 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.5 0.5 0.5 0.5 0.2 0.5 0.5 0.5 0.5 RAG2 ENSG00000175097 "Recombination activating 2" P55895 11 36575574-36598279 "Disease related genes, Predicted intracellular proteins" "DNA recombination" "Chromatin regulator" "Disease mutation, SCID" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 165.8" "Group enriched" "Detected in some" 90 "MOLT-4: 15.4;REH: 61.7" "Cancer enriched" "Detected in single" 21 "thyroid cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA065704 Approved Nucleoplasm Nucleoplasm "HPA065704: " "unprognostic (4.30e-2)" "unprognostic (9.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (4.58e-2)" "unprognostic (2.17e-1)" "unprognostic (8.11e-2)" "unprognostic (1.68e-3)" 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.1 0.2 0.0 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 165.8 24.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 61.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 RASA1 "CM-AVM, GAP, p120, p120GAP, p120RASGAP, RASA" ENSG00000145715 "RAS p21 protein activator 1" P20936 5 87267888-87391931 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 13 "placenta: 260.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007789, HPA036393, HPA064556" Enhanced 7900 "CAB007789: AB_598183, HPA036393: , HPA064556: " "unprognostic (1.57e-1)" "unprognostic (7.63e-2)" "unprognostic (1.88e-3)" "unprognostic (2.14e-1)" "unprognostic (1.23e-1)" "unprognostic (1.38e-2)" "unprognostic (6.88e-2)" "unprognostic (8.38e-3)" "unprognostic (2.23e-1)" "unprognostic (1.07e-2)" "unprognostic (4.12e-3)" "unprognostic (1.03e-1)" "unprognostic (3.98e-2)" "unprognostic (1.59e-2)" "unprognostic (5.39e-2)" "unprognostic (1.65e-1)" "unprognostic (1.30e-3)" 12.4 8.8 12.3 8.9 12.8 6.4 11.4 17.3 16.3 11.3 8.1 8.6 9.3 6.9 12.4 11.4 10.2 9.5 9.3 7.2 12.0 10.9 8.7 6.5 8.4 9.2 10.1 13.8 15.9 8.2 20.3 12.2 260.6 9.3 8.0 9.8 9.6 10.6 9.6 6.9 9.7 10.0 9.0 9.4 13.7 7.4 14.4 10.0 10.7 14.4 5.7 9.6 11.3 9.8 2.0 1.3 3.1 2.6 8.1 3.5 1.1 11.5 6.5 11.3 7.3 9.6 14.2 8.8 18.5 12.0 11.4 18.9 4.3 30.6 7.5 4.5 20.2 5.4 5.2 15.0 34.7 7.3 4.2 5.6 5.6 4.7 9.7 4.1 6.7 8.0 9.6 32.1 18.2 15.9 3.1 16.2 39.3 7.0 5.0 6.1 5.9 12.1 6.2 25.7 11.1 9.9 10.0 6.9 7.5 6.8 8.8 9.7 7.9 6.4 23.5 14.6 6.4 7.5 23.0 5.7 5.9 7.6 21.3 8.5 10.4 3.1 1.3 1.4 2.0 2.6 3.5 1.4 2.4 1.9 1.1 2.0 2.1 1.9 1.7 8.1 2.4 1.3 3.0 1.1 12.3 12.8 17.3 16.3 12.0 10.9 10.1 13.8 9.3 10.0 RASA4 "CAPRI, GAPL, KIAA0538" ENSG00000105808 "RAS p21 protein activator 4" O43374 7 102573807-102616757 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 58.0" "Cell line enhanced" "Detected in many" "U-138 MG: 27.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA043010 Uncertain Uncertain Vesicles Vesicles "HPA043010: " "unprognostic (6.44e-2)" "unprognostic (3.64e-2)" "unprognostic (8.93e-3)" "unprognostic (1.69e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (3.44e-1)" "unprognostic (7.45e-2)" "unprognostic (2.92e-1)" "unprognostic (2.29e-1)" "unprognostic (4.62e-3)" "unprognostic (4.19e-2)" "unprognostic (4.81e-2)" "unprognostic (8.87e-3)" "unprognostic (2.47e-2)" "unprognostic (3.34e-1)" "unprognostic (1.18e-2)" 5.5 2.3 4.2 2.5 2.6 1.6 4.4 2.7 4.7 4.9 4.0 3.6 6.3 1.8 1.9 3.6 1.9 1.5 3.6 3.0 3.3 0.2 2.7 3.6 1.9 4.1 2.1 6.8 3.7 4.0 3.3 1.6 2.0 5.6 58.0 5.4 4.3 3.2 1.2 4.1 2.2 0.6 2.2 2.4 3.9 4.7 3.6 11.3 2.2 9.4 1.5 3.7 3.1 0.7 1.2 9.1 1.8 1.6 4.7 0.3 9.3 4.7 3.1 3.3 3.7 2.7 7.1 6.9 14.1 9.1 0.4 0.1 2.3 1.3 2.4 2.0 3.6 0.9 1.8 1.3 2.7 4.3 1.1 0.8 0.4 1.6 3.1 10.5 0.7 3.6 7.1 4.9 0.7 4.7 9.7 2.0 10.2 0.3 3.4 8.9 18.6 1.7 2.1 1.2 1.8 3.6 2.3 27.3 13.3 3.1 2.3 16.6 10.2 6.1 3.4 3.0 3.3 0.4 8.4 0.3 1.9 9.4 3.7 2.8 3.2 2.2 11.3 3.6 3.4 2.4 2.2 1.5 1.2 9.8 3.5 3.1 RASA4B ENSG00000170667 "RAS p21 protein activator 4B" C9J798 7 102482445-102517781 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 47.4" "Cell line enhanced" "Detected in many" "SH-SY5Y: 11.8;U-138 MG: 16.5;U-2 OS: 14.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "classical monocyte: 3.7;intermediate monocyte: 3.7;myeloid DC: 6.2;plasmacytoid DC: 3.9" "Group enriched" "Detected in many" 20 "dendritic cells: 6.2;monocytes: 3.7" HPA043010 Uncertain Uncertain "Vesicles,Cell Junctions" "Cell Junctions" Vesicles "HPA043010: " "unprognostic (1.05e-2)" "unprognostic (1.34e-2)" "unprognostic (1.03e-2)" "unprognostic (1.96e-1)" "unprognostic (1.42e-2)" "unprognostic (1.40e-1)" "unprognostic (4.15e-2)" "unprognostic (1.55e-1)" "unprognostic (2.10e-1)" "unprognostic (6.79e-2)" "unprognostic (3.08e-3)" "unprognostic (2.31e-1)" "unprognostic (5.44e-4)" "unprognostic (1.18e-2)" "unprognostic (3.77e-2)" "unprognostic (4.37e-3)" "unprognostic (1.10e-1)" 2.9 1.1 2.3 1.4 1.2 0.0 2.1 0.5 4.4 3.2 2.4 2.5 4.1 0.0 0.6 1.5 1.3 0.5 1.8 2.0 0.9 0.1 0.8 1.3 1.1 2.2 0.9 0.0 1.1 1.7 1.5 0.0 0.7 3.7 47.4 1.8 3.0 0.5 0.5 1.9 0.8 0.2 0.3 0.2 1.4 2.3 0.1 6.2 0.0 3.7 0.0 0.2 1.8 0.2 0.9 3.2 0.2 0.5 1.9 0.1 5.7 3.0 1.2 2.9 0.2 0.4 2.2 6.4 6.5 7.6 0.0 0.0 0.0 0.2 0.7 0.3 1.7 0.5 0.0 0.0 0.2 2.1 0.3 0.0 0.0 0.8 0.6 8.1 0.7 2.1 0.0 1.1 0.0 0.9 2.3 1.1 3.6 0.0 0.8 2.2 11.8 0.9 0.2 0.2 0.2 1.5 1.0 16.5 14.1 1.3 0.5 2.7 1.8 0.2 1.9 0.4 2.6 0.0 3.7 0.0 0.2 3.7 0.1 0.1 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.0 0.6 3.9 0.0 1.8 RASL10A RRP22 ENSG00000100276 "RAS like family 10 member A" Q92737 22 29312933-29319679 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 35.2" "Cell line enhanced" "Detected in some" "HEK 293: 3.6;NB-4: 5.6;U-2 OS: 2.5;U-266/70: 6.2" "Cancer enhanced" "Detected in some" "testis cancer: 3.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 34.5;basal ganglia: 16.7;cerebral cortex: 33.9;hippocampal formation: 29.1" "Region enhanced" "Detected in many" "cerebral cortex: 43.6" HPA056169 Approved "HPA056169: " "unprognostic (1.94e-1)" "unprognostic (2.51e-4)" "unprognostic (3.78e-2)" "unprognostic (1.75e-1)" "unprognostic (2.94e-2)" "unprognostic (2.74e-1)" "unprognostic (1.16e-1)" "unprognostic (7.99e-2)" "unprognostic (9.42e-2)" "unprognostic (1.61e-2)" "unprognostic (5.00e-4)" "unprognostic (2.44e-1)" "unprognostic (7.00e-4)" "unprognostic (3.12e-1)" "unprognostic (1.19e-1)" "unprognostic (6.61e-2)" "unprognostic (3.61e-3)" 1.2 1.5 19.7 1.3 11.8 1.0 3.9 1.4 35.2 1.0 1.1 1.1 0.0 1.4 1.0 1.1 0.9 1.0 1.0 1.2 12.7 7.9 1.1 1.4 1.1 1.0 5.9 11.3 0.9 0.8 0.8 2.3 1.2 2.8 1.2 1.0 0.0 1.0 1.0 1.5 1.1 1.3 1.0 2.0 1.1 1.2 1.3 1.8 0.0 0.9 0.1 1.1 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.5 0.4 0.0 0.0 0.2 3.6 0.3 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.5 1.2 0.0 0.9 0.0 5.6 1.4 0.0 0.0 0.5 0.0 0.3 0.4 0.7 0.1 0.0 0.4 0.1 1.1 0.5 0.2 0.0 2.5 0.0 0.4 6.2 2.2 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 19.7 11.8 1.4 22.4 12.7 7.9 5.9 11.3 2.8 1.8 RAX2 "ARMD6, CORD11, MGC15631, RAXL1" ENSG00000173976 "Retina and anterior neural fold homeobox 2" Q96IS3 19 3769089-3772221 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" DNA-binding "Age-related macular degeneration, Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 51.7" "Cell line enhanced" "Detected in some" "Karpas-707: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA052533 Uncertain "HPA052533: " "unprognostic (5.53e-2)" "unprognostic (1.39e-2)" "unprognostic (4.48e-1)" 0.2 0.0 0.1 0.2 0.3 1.4 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.2 1.0 0.1 0.1 2.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 3.7 5.9 0.1 0.2 0.1 0.1 51.7 0.1 0.1 0.2 0.9 0.1 0.3 0.1 0.3 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.5 1.8 0.7 1.0 0.8 0.2 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.2 0.1 0.0 0.1 0.7 0.2 0.1 0.0 0.2 0.1 0.0 0.5 0.1 0.0 0.8 0.0 1.0 0.2 0.0 0.2 0.4 0.0 0.0 0.1 0.2 0.0 0.5 1.8 0.4 0.9 0.3 0.9 0.1 0.2 0.1 0.2 0.1 0.1 0.6 0.6 0.6 0.4 0.5 0.0 0.5 0.0 1.1 0.2 0.8 0.2 0.0 0.7 0.2 0.4 0.1 1.2 0.3 1.1 0.7 0.3 0.3 0.4 0.6 0.2 0.4 0.3 0.2 0.9 0.6 0.8 1.8 1.0 0.3 0.5 0.4 0.2 0.1 0.3 0.2 0.4 0.2 0.1 0.1 0.1 0.2 0.1 RBAK-RBAKDN ENSG00000272968 "RBAK-RBAKDN readthrough" 7 4983718-5073221 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 10 "testis: 71.1" "Cell line enhanced" "Detected in many" "MCF7: 5.5;U-266/70: 6.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "unprognostic (3.78e-2)" "unprognostic (3.57e-1)" "unprognostic (5.60e-2)" "unprognostic (1.55e-1)" "unprognostic (2.37e-1)" "unprognostic (1.50e-2)" "unprognostic (3.23e-1)" "unprognostic (5.44e-3)" "unprognostic (6.88e-2)" "unprognostic (1.24e-1)" "unprognostic (1.24e-1)" "unprognostic (2.62e-7)" "unprognostic (2.86e-1)" "unprognostic (4.96e-2)" "unprognostic (9.57e-2)" "unprognostic (3.10e-2)" 3.1 2.0 2.3 4.8 3.4 2.0 2.7 6.4 3.1 2.5 2.2 1.1 3.6 1.9 2.6 2.7 4.6 1.8 1.8 1.6 2.6 2.2 2.3 2.2 2.6 5.4 2.5 3.4 2.7 1.9 1.7 3.4 1.7 2.3 2.3 1.7 1.3 3.2 4.5 1.9 2.7 2.2 2.4 2.3 3.0 2.4 71.1 3.2 6.8 2.9 4.8 2.6 3.2 2.8 0.4 0.3 0.2 0.9 0.8 2.1 0.2 1.4 0.4 0.6 2.6 0.5 1.3 0.5 1.1 0.7 0.7 0.4 2.0 0.6 1.1 3.7 0.9 1.1 0.0 0.6 1.5 0.1 1.9 0.9 1.1 1.3 1.5 3.7 3.7 0.0 1.0 0.8 2.1 0.5 2.3 0.0 0.1 5.5 0.4 0.7 1.3 3.5 0.4 0.4 2.2 0.2 0.2 1.4 2.2 0.0 1.6 1.4 1.3 3.1 0.0 0.9 1.7 1.1 0.9 6.0 1.9 1.2 1.1 1.0 1.0 0.0 0.1 0.2 0.8 0.9 0.2 0.3 2.1 0.2 0.0 0.4 2.0 1.6 0.0 0.8 0.0 0.3 0.0 0.2 2.3 3.4 6.4 3.1 2.6 2.2 2.5 3.4 2.3 3.2 RBM44 FLJ40411 ENSG00000177483 "RNA binding motif protein 44" Q6ZP01 2 237798389-237842808 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 40.1" "Cell line enhanced" "Detected in some" "NB-4: 3.5;RPTEC TERT1: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 33 "basophil: 3.3" "Lineage enriched" "Detected in single" 33 "granulocytes: 3.3" "Not detected" "Not detected" HPA003298 Enhanced "HPA003298: AB_2284846" "unprognostic (1.29e-1)" "unprognostic (2.66e-1)" "unprognostic (5.92e-2)" "unprognostic (1.56e-1)" "unprognostic (8.47e-3)" "unprognostic (3.15e-2)" "unprognostic (2.41e-1)" "unprognostic (2.60e-1)" "unprognostic (1.83e-2)" "unprognostic (8.12e-2)" "unprognostic (4.10e-2)" "unprognostic (4.57e-2)" "unprognostic (5.01e-5)" "unprognostic (1.90e-1)" "unprognostic (4.27e-2)" "unprognostic (6.85e-3)" "unprognostic (7.89e-3)" 0.5 0.0 0.1 0.1 0.1 0.8 0.4 0.1 0.3 0.4 0.2 0.1 0.1 0.0 0.3 0.1 0.2 0.2 0.2 0.2 0.1 0.0 0.3 0.1 0.5 0.8 0.3 0.1 0.2 0.4 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.6 0.1 0.2 0.2 0.2 0.3 0.1 0.4 0.2 40.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.1 0.4 0.9 0.3 1.0 0.7 0.5 0.7 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.3 1.3 0.4 0.2 0.9 0.7 0.1 1.5 1.3 0.8 0.6 1.4 1.3 0.1 1.0 0.2 1.2 0.4 0.1 1.2 0.0 0.2 0.9 3.5 0.7 1.1 0.3 0.2 0.9 3.5 1.1 0.6 0.9 0.0 0.4 0.3 0.5 2.1 0.0 0.0 0.3 0.0 0.8 0.7 0.2 0.2 0.7 1.5 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.3 0.1 0.3 0.1 RBM46 "CT68, MGC27016" ENSG00000151962 "RNA binding motif protein 46" Q8TBY0 4 154781213-154828813 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "testis: 34.5" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 1.0;NTERA-2: 3.8" "Cancer enriched" "Detected in single" 15 "testis cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (4.79e-1)" "unprognostic (1.14e-2)" "unprognostic (3.23e-1)" "unprognostic (1.59e-2)" "unprognostic (3.33e-3)" "unprognostic (1.13e-1)" "unprognostic (8.11e-2)" "unprognostic (2.24e-2)" "unprognostic (2.99e-7)" "unprognostic (4.86e-2)" "unprognostic (7.31e-2)" "unprognostic (4.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 34.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 RBM8A "BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP" ENSG00000265241 "RNA binding motif protein 8A" Q9Y5S9 1 145917714-145927678 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "blood: 120.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018403 Supported Supported "Nuclear speckles" 120000 "Nuclear speckles" "HPA018403: AB_1858908" "unprognostic (3.81e-1)" "unprognostic (3.99e-3)" "unprognostic (1.59e-1)" "unprognostic (6.83e-2)" "unprognostic (1.12e-1)" "unprognostic (3.16e-1)" "unprognostic (4.62e-3)" "unprognostic (1.91e-1)" "unprognostic (1.38e-1)" "unprognostic (8.79e-3)" "unprognostic (7.27e-3)" "prognostic unfavourable (1.55e-4)" "unprognostic (3.30e-3)" "unprognostic (2.18e-1)" "unprognostic (3.77e-2)" "unprognostic (2.02e-1)" "unprognostic (1.64e-3)" 6.2 6.5 9.1 9.5 9.8 18.7 6.1 6.3 9.8 8.3 6.2 9.6 9.8 6.2 7.4 5.0 15.1 5.7 5.0 6.4 7.3 6.4 6.5 5.5 11.2 7.0 7.1 7.6 5.1 6.9 5.5 7.9 13.5 5.7 5.0 5.7 6.2 6.3 24.6 7.2 6.0 6.8 13.2 6.5 5.8 8.5 9.5 6.8 6.3 4.8 11.7 7.1 3.5 101.9 120.1 118.0 85.5 85.3 89.3 115.9 51.2 42.0 38.4 30.5 13.8 13.6 47.2 31.4 21.3 45.2 33.3 55.4 39.0 47.1 49.7 21.6 35.3 40.8 34.3 37.2 41.7 38.9 36.3 31.8 40.9 19.6 60.5 31.9 14.9 25.9 40.4 43.4 33.5 54.5 44.7 34.7 141.6 60.8 48.0 65.9 73.3 54.0 33.5 46.8 28.9 49.5 39.4 48.3 46.8 24.1 42.6 45.1 73.7 34.5 36.5 46.6 35.8 85.8 50.5 79.6 69.1 32.7 36.5 31.4 89.7 77.6 118.0 86.5 85.5 82.1 101.9 82.5 87.8 76.5 90.1 77.7 86.3 89.3 85.3 79.9 120.1 89.3 115.9 RBMXL2 "HNRNPG-T, HNRPGT" ENSG00000170748 "RNA binding motif protein, X-linked like 2" O75526 11 7089027-7090900 "Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 199 "testis: 70.7" "Group enriched" "Detected in some" 4 "HEK 293: 1.6;HUVEC TERT2: 2.1" "Cancer enriched" "Detected in single" 133 "testis cancer: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038912, HPA051842" Enhanced "HPA038912: AB_10670913, HPA051842: " "unprognostic (3.73e-1)" "unprognostic (2.24e-1)" "unprognostic (5.47e-2)" "unprognostic (1.51e-2)" "unprognostic (3.24e-1)" "unprognostic (8.28e-2)" "unprognostic (3.77e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMXL3 "CXorf55, FLJ40249" ENSG00000175718 "RNA binding motif protein, X-linked like 3" Q8N7X1 X 115189427-115192868 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "testis: 6.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 25 "testis cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA051842 Supported "HPA051842: " "unprognostic (1.05e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1A1 "RBM1, RBM2, YRRM1, YRRM2" ENSG00000234414 "RNA binding motif protein, Y-linked, family 1, member A1" P0DJD3 Y 21511372-21549326 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 132 "testis: 14.9" "Cell line enriched" "Detected in some" 10 "U-266/84: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001534, HPA053147" Supported "HPA001534: AB_2178972, HPA053147: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1B ENSG00000242875 "RNA binding motif protein, Y-linked, family 1, member B" A6NDE4 Y 21511338-21549094 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 47 "testis: 6.5" "Cell line enriched" "Detected in single" 5 "HEL: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001534, HPA053147" Supported "HPA001534: AB_2178972, HPA053147: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1D ENSG00000244395 "RNA binding motif protein, Y-linked, family 1, member D" P0C7P1 Y 21880076-21894526 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001534, HPA053147" Supported "HPA001534: AB_2178972, HPA053147: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1E ENSG00000242389 "RNA binding motif protein, Y-linked, family 1, member E" A6NEQ0 Y 21903618-21918067 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 71 "testis: 7.1" "Cell line enriched" "Detected in single" 10 "U-266/84: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001534, HPA053147" Supported "HPA001534: AB_2178972, HPA053147: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1F MGC33094 ENSG00000169800 "RNA binding motif protein, Y-linked, family 1, member F" Q15415 Y 22168542-22182982 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 65 "testis: 8.0" "Group enriched" "Detected in some" 226 "U-266/70: 21.9;U-266/84: 23.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001534, HPA053147" Supported "HPA001534: AB_2178972, HPA053147: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1J ENSG00000226941 "RNA binding motif protein, Y-linked, family 1, member J" Q15415 Y 22403461-22417881 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 5.9" "Group enriched" "Detected in some" 165 "U-266/70: 22.1;U-266/84: 10.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001534, HPA053147" Supported "HPA001534: AB_2178972, HPA053147: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.1 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBP2 "CRABP-II, CRBP2, CRBPII, RBPC2" ENSG00000114113 "Retinol binding protein 2" P50120 3 139452884-139480747 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 198 "intestine: 333.2" "Cell line enriched" "Detected in some" 7 "CACO-2: 40.9" "Cancer enhanced" "Detected in many" "stomach cancer: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 4.6" "Not detected" "Not detected" HPA035866 Enhanced Approved "Golgi apparatus" 96000 "Golgi apparatus" "HPA035866: AB_10672232" "unprognostic (1.74e-1)" "unprognostic (2.66e-2)" "unprognostic (3.34e-2)" "unprognostic (6.72e-6)" "unprognostic (2.33e-1)" "unprognostic (4.10e-2)" "unprognostic (1.56e-2)" "unprognostic (2.24e-1)" "unprognostic (8.51e-3)" "unprognostic (3.92e-2)" "unprognostic (7.35e-2)" "unprognostic (1.24e-3)" "unprognostic (5.57e-3)" "unprognostic (1.10e-1)" "unprognostic (9.23e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 130.1 0.0 0.0 221.8 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.1 1.6 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 333.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 40.9 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 2.1 5.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 RBP3 "D10S64, D10S65, D10S66, RP66" ENSG00000265203 "Retinol binding protein 3" P10745 10 47348371-47357875 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" Transport "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "retina: 135.2" "Group enriched" "Detected in some" 8 "HaCaT: 2.6;HDLM-2: 2.4;SH-SY5Y: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041301, HPA044239" Enhanced "Secreted in other tissues" "HPA041301: , HPA044239: " "unprognostic (3.48e-2)" "unprognostic (4.78e-3)" "unprognostic (1.36e-2)" "unprognostic (4.02e-2)" "unprognostic (1.40e-1)" "unprognostic (1.58e-2)" "unprognostic (5.09e-2)" "unprognostic (5.14e-3)" "unprognostic (7.44e-2)" "unprognostic (1.23e-1)" "unprognostic (4.68e-3)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 135.2 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 2.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBP4 ENSG00000138207 "Retinol binding protein 4" P02753 10 93591687-93601744 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Transport, Vision" "Cancer-related genes, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "liver: 897.1" "Cell line enriched" "Detected in some" 4 "Hep G2: 151.8" "Cancer enriched" "Detected in all" 27 "liver cancer: 3135.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 14 "classical monocyte: 1.2;myeloid DC: 1.5" "Group enriched" "Detected in many" 14 "dendritic cells: 1.5;monocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001641, CAB004555" Supported "Secreted to blood" 46066666667 420000000000 "CAB004555: AB_670938, HPA001641: AB_1079795" "unprognostic (9.42e-3)" "unprognostic (3.40e-2)" "unprognostic (1.90e-1)" "prognostic unfavourable (1.50e-4)" "unprognostic (2.60e-2)" "unprognostic (6.69e-4)" "prognostic favourable (1.74e-8)" "unprognostic (2.39e-1)" "unprognostic (5.76e-2)" "unprognostic (3.26e-2)" "unprognostic (3.26e-1)" "unprognostic (3.44e-1)" "unprognostic (7.14e-3)" "unprognostic (9.88e-3)" "unprognostic (2.31e-1)" "unprognostic (1.03e-1)" "unprognostic (8.60e-2)" 39.0 2.0 1.4 2.4 3.1 0.3 27.0 0.0 2.1 0.3 1.8 0.0 0.1 0.5 0.4 0.4 0.3 0.4 2.1 1.2 1.4 2.2 7.9 897.1 1.5 1.0 0.2 1.1 0.5 4.7 0.3 28.3 1.8 0.4 0.9 0.6 5.6 1.8 0.5 0.4 0.4 0.6 0.3 0.1 0.3 0.7 0.4 0.0 0.0 0.3 0.5 0.2 0.6 1.6 0.0 1.5 0.0 1.2 0.0 0.0 0.4 0.0 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 36.6 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 151.8 0.0 1.2 0.0 2.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.2 17.1 0.0 1.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 3.1 0.0 2.1 1.4 2.2 0.2 1.1 0.4 0.0 RBPJL "RBP-L, RBPSUHL, SUH, SUHL" ENSG00000124232 "Recombination signal binding protein for immunoglobulin kappa J region like" Q9UBG7 20 45306851-45317824 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 279 "pancreas: 188.1" "Cell line enhanced" "Detected in some" "Daudi: 3.1;NB-4: 4.7;SK-MEL-30: 1.2;U-937: 2.6" "Group enriched" "Detected in some" 22 "liver cancer: 1.2;ovarian cancer: 1.2;pancreatic cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "thalamus: 0.5" CAB006846 Enhanced "CAB006846: " "unprognostic (1.19e-1)" "unprognostic (2.28e-2)" "unprognostic (1.34e-2)" "unprognostic (6.09e-1)" "unprognostic (3.07e-2)" "unprognostic (2.08e-1)" "unprognostic (9.60e-2)" "unprognostic (1.43e-1)" "unprognostic (1.92e-1)" "unprognostic (1.65e-1)" "unprognostic (3.92e-3)" "unprognostic (2.48e-7)" "unprognostic (5.08e-1)" "unprognostic (5.40e-2)" "unprognostic (2.26e-2)" "unprognostic (3.49e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 188.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.2 0.0 0.8 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.1 0.0 2.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RCVRN RCV1 ENSG00000109047 Recoverin P35243 17 9896320-9905621 "Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "retina: 208.6" "Cell line enriched" "Detected in some" 6 "WM-115: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015783, CAB022363" Enhanced "CAB022363: , HPA015783: " "unprognostic (1.65e-1)" "unprognostic (1.86e-1)" "unprognostic (1.39e-2)" "unprognostic (1.55e-2)" "unprognostic (1.32e-1)" "unprognostic (7.95e-3)" "unprognostic (4.82e-2)" "unprognostic (1.18e-1)" "unprognostic (1.06e-1)" "unprognostic (5.34e-2)" "unprognostic (1.24e-1)" "unprognostic (1.94e-4)" "unprognostic (1.62e-2)" "unprognostic (2.28e-1)" "unprognostic (1.41e-2)" "unprognostic (9.23e-2)" 1.4 0.0 1.1 0.8 1.4 0.9 0.2 1.5 2.7 0.5 0.3 0.2 0.1 0.7 0.5 0.2 0.1 0.3 0.5 0.8 1.0 0.7 0.1 0.1 0.4 0.2 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.7 0.1 0.1 208.6 0.1 0.3 0.1 0.7 0.4 0.6 0.2 0.8 0.6 0.3 0.1 0.2 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.4 1.5 2.7 1.0 0.7 0.3 0.1 0.7 0.1 RD3L "TDRD9-AS1, TDRD9AS1" ENSG00000227729 "Retinal degeneration 3-like" P0DJH9 14 103940426-103942308 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 16 "heart muscle: 32.6" "Cell line enhanced" "Detected in single" "HEK 293: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory region: 12.7" "Low region specificity" "Detected in all" HPA067971 Enhanced "HPA067971: " 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.1 0.2 0.0 1.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.2 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 RDH16 "RODH-4, SDR9C8" ENSG00000139547 "Retinol dehydrogenase 16 (all-trans)" O75452 12 56951431-56959374 "Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 59 "liver: 114.6" "Group enriched" "Detected in some" 6 "HaCaT: 3.4;hTCEpi: 7.6" "Cancer enriched" "Detected in many" 20 "liver cancer: 44.0" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA038518 Enhanced "HPA038518: AB_10672713" "unprognostic (5.42e-3)" "unprognostic (4.20e-2)" "unprognostic (2.99e-2)" "unprognostic (1.14e-1)" "unprognostic (1.88e-1)" "unprognostic (2.92e-2)" "prognostic favourable (2.16e-5)" "unprognostic (8.83e-3)" "unprognostic (1.04e-1)" "unprognostic (2.84e-1)" "unprognostic (6.85e-2)" "unprognostic (6.10e-1)" "unprognostic (7.99e-12)" "unprognostic (2.24e-1)" "unprognostic (1.29e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 114.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.8 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.6 0.1 0.0 7.6 0.0 0.8 0.0 0.1 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.3 0.2 0.2 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.2 RDH8 "PRRDH, SDR28C2" ENSG00000080511 "Retinol dehydrogenase 8 (all-trans)" 19 10013249-10022279 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "retina: 29.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.8;SK-MEL-30: 3.4" "Group enriched" "Detected in some" 8 "melanoma: 2.2;stomach cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (4.12e-1)" "unprognostic (2.22e-2)" "unprognostic (1.08e-1)" "unprognostic (9.98e-3)" "unprognostic (4.58e-3)" "unprognostic (2.66e-1)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "unprognostic (3.86e-1)" "unprognostic (2.63e-1)" 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 2.8 0.8 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 REC114 "C15orf60, CT147, FLJ27520, FLJ36860, FLJ44083, LOC283677" ENSG00000183324 "REC114 meiotic recombination protein" Q7Z4M0 15 73443158-73560014 "Predicted intracellular proteins" "DNA recombination, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 35.7" "Group enriched" "Detected in some" 4 "NTERA-2: 1.8;U-266/84: 4.4" "Cancer enriched" "Detected in single" 11 "testis cancer: 1.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 5 "T-cells: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.64e-1)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (2.01e-1)" "unprognostic (4.58e-2)" "unprognostic (2.97e-1)" "unprognostic (8.06e-2)" "unprognostic (2.63e-2)" "unprognostic (2.48e-2)" "unprognostic (1.53e-7)" "unprognostic (1.33e-1)" "unprognostic (7.62e-2)" "unprognostic (1.98e-2)" "unprognostic (1.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.2 1.7 0.2 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 4.4 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.8 0.2 0.1 0.0 1.1 1.7 0.3 0.1 0.1 0.3 0.2 0.2 0.3 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 REG1A "PSP, PSPS, PSPS1, PTP, REG" ENSG00000115386 "Regenerating family member 1 alpha" P05451 2 79120362-79123419 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "pancreas: 1772.6" "Cell line enhanced" "Detected in some" "BEWO: 7.8;EFO-21: 11.7;HDLM-2: 9.3;NB-4: 6.7;RPMI-8226: 18.9;SH-SY5Y: 8.1;U-2 OS: 18.9;U-251 MG: 6.3;U-266/84: 6.3" "Group enriched" "Detected in many" 10 "colorectal cancer: 313.8;pancreatic cancer: 1268.4;stomach cancer: 521.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025138, HPA045549, HPA045579" Enhanced "Secreted to digestive system" 61000000 "CAB025138: , HPA045549: , HPA045579: " "unprognostic (1.89e-1)" "unprognostic (2.91e-2)" "unprognostic (3.39e-1)" "unprognostic (1.45e-1)" "unprognostic (2.10e-1)" "unprognostic (1.63e-1)" "unprognostic (5.52e-2)" "unprognostic (3.54e-3)" "unprognostic (5.53e-2)" "unprognostic (5.54e-2)" 0.3 0.1 0.3 2.8 0.4 0.0 0.3 0.3 0.3 0.3 37.9 0.3 0.3 129.0 0.3 0.3 0.3 0.1 1.3 0.3 0.3 0.0 14.6 0.3 0.3 0.3 0.3 0.3 0.3 1772.6 0.0 0.3 0.3 0.3 0.3 4.5 0.3 0.3 0.4 0.3 0.1 74.7 2.5 0.3 0.3 15.9 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.3 0.0 0.0 0.0 18.9 0.0 0.0 0.9 8.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.9 1.3 6.3 0.0 6.3 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 REG1B "PSPS2, REGH, REGI-BETA, REGL" ENSG00000172023 "Regenerating family member 1 beta" P48304 2 79085030-79088019 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "pancreas: 969.2" "Cell line enhanced" "Detected in some" "EFO-21: 7.3;HDLM-2: 4.5;RPMI-8226: 3.2;U-2 OS: 17.1;U-251 MG: 4.2;U-266/84: 3.8" "Cancer enhanced" "Detected in some" "pancreatic cancer: 201.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045549, HPA045579" Supported "Secreted to digestive system" 37000000 "HPA045549: , HPA045579: " "unprognostic (4.08e-1)" "unprognostic (1.09e-1)" "unprognostic (3.51e-3)" "unprognostic (9.20e-2)" 0.5 0.1 0.3 3.7 0.4 0.7 0.3 0.3 0.3 0.3 14.3 0.3 0.3 88.2 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.1 0.5 0.3 0.3 0.3 0.3 0.3 0.3 969.2 0.0 0.3 0.3 0.3 0.3 13.2 0.3 0.3 0.3 0.3 1.6 56.3 13.0 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.1 4.2 0.0 3.8 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 REG3G "LPPM429, PAP1B, UNQ429" ENSG00000143954 "Regenerating family member 3 gamma" Q6UW15 2 79025686-79028505 "Predicted secreted proteins" "Acute phase, Inflammatory response" Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pancreas: 262.6" "Cell line enhanced" "Detected in some" "NB-4: 2.0;SK-MEL-30: 3.1;U-2 OS: 1.6;U-266/84: 1.3" "Cancer enriched" "Detected in many" 13 "pancreatic cancer: 71.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047894, HPA048334, HPA060705" Uncertain Approved Cytosol "Secreted to digestive system" Cytosol "HPA047894: , HPA048334: , HPA060705: " "unprognostic (3.29e-1)" "unprognostic (2.20e-1)" "unprognostic (1.29e-1)" "unprognostic (8.82e-2)" "unprognostic (7.20e-3)" "unprognostic (5.64e-2)" 0.1 3.9 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.8 0.6 0.1 61.1 0.1 0.0 0.1 0.1 0.1 0.0 7.1 0.1 0.1 0.1 0.1 0.1 0.1 262.6 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 2.8 0.3 0.1 0.1 0.0 19.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 1.3 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 RELT "FLJ14993, TNFRSF19L" ENSG00000054967 "RELT, TNF receptor" Q969Z4 11 73376264-73397474 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Receptor "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 92.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062824, HPA071518" Supported Nucleoplasm Nucleoplasm "HPA062824: , HPA071518: " "unprognostic (3.49e-1)" "unprognostic (2.43e-1)" "unprognostic (2.25e-1)" "unprognostic (1.67e-2)" "unprognostic (1.80e-3)" "unprognostic (9.92e-3)" "unprognostic (1.67e-3)" "unprognostic (1.17e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-1)" "unprognostic (8.42e-2)" "unprognostic (4.13e-2)" "prognostic unfavourable (4.07e-11)" "unprognostic (1.64e-1)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (1.69e-1)" 3.5 2.2 3.5 11.7 8.8 92.2 2.8 3.5 5.7 1.4 2.1 7.4 0.0 2.7 1.9 2.5 3.2 1.6 4.1 5.3 4.0 5.2 2.0 2.0 8.4 18.2 8.3 3.9 1.5 1.6 1.8 3.1 4.1 13.9 1.7 2.0 2.3 4.6 1.3 22.1 2.5 5.6 2.8 14.3 18.1 2.5 3.0 4.6 4.8 1.8 3.9 9.0 3.3 2.1 4.7 6.8 12.1 19.2 0.3 1.1 3.1 5.6 5.7 4.4 4.4 0.5 0.6 5.1 6.3 3.9 7.3 4.4 5.4 2.5 10.4 20.8 4.1 8.4 2.8 3.1 2.6 6.3 5.4 9.9 7.1 2.0 1.2 9.8 17.4 0.7 1.3 7.7 2.0 2.6 7.4 13.9 2.0 5.4 7.0 10.1 4.0 7.1 13.9 7.8 9.1 1.4 2.4 5.9 5.6 5.4 4.9 6.6 2.7 8.4 3.6 9.2 6.5 15.2 11.2 4.9 3.8 11.5 5.6 9.6 9.7 0.4 7.0 12.1 0.5 14.3 1.1 4.7 0.6 1.0 6.8 3.7 0.8 0.4 11.6 0.3 19.2 6.8 0.2 3.1 3.5 8.8 3.5 5.7 4.0 5.2 8.3 3.9 13.9 4.6 REN ENSG00000143839 Renin P00797 1 204154819-204190324 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Aspartyl protease, Hydrolase, Protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 63.6" "Cell line enhanced" "Detected in some" "A-431: 2.3;BJ: 4.8;HMC-1: 6.3;RT4: 1.8;SK-BR-3: 4.5" "Cancer enriched" "Detected in many" 8 "renal cancer: 39.4" "Region enriched" "Detected in single" 12 "basal ganglia: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005131, CAB025903" Approved "Secreted to blood" 692000 "CAB025903: , HPA005131: AB_1079174" "unprognostic (4.45e-2)" "unprognostic (3.35e-1)" "unprognostic (1.62e-1)" "unprognostic (8.58e-2)" "unprognostic (2.89e-1)" "unprognostic (1.23e-2)" "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "unprognostic (7.20e-3)" "unprognostic (1.37e-1)" "unprognostic (1.57e-1)" "prognostic unfavourable (6.45e-5)" "unprognostic (1.22e-1)" "unprognostic (1.70e-1)" "unprognostic (4.98e-2)" "unprognostic (6.49e-2)" 0.4 0.3 0.0 0.0 1.2 0.0 0.5 0.0 0.0 3.1 0.2 0.0 0.8 0.1 4.4 13.5 0.1 0.3 0.0 0.6 0.0 0.0 63.6 0.4 0.3 0.0 0.0 0.0 11.6 0.0 0.0 0.4 14.4 0.0 0.3 0.1 0.4 0.3 0.5 0.0 0.0 0.1 1.0 0.0 0.0 0.0 2.0 0.0 0.0 1.1 0.0 0.2 4.4 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 4.8 0.9 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 6.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.8 0.2 0.1 0.0 4.5 0.2 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RESP18 ENSG00000182698 "Regulated endocrine specific protein 18" Q5W5W9 2 219327409-219333177 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "brain: 28.7" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.1" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "basal ganglia: 28.7" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.57e-2)" "unprognostic (2.12e-1)" 0.4 0.4 2.6 0.4 28.7 0.4 0.5 0.1 7.5 0.4 0.4 0.3 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.1 4.0 0.4 0.4 0.4 0.4 3.6 1.0 0.4 0.4 0.4 0.0 0.4 2.3 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.6 2.4 2.5 0.0 0.5 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 28.7 0.1 1.8 3.1 4.0 3.6 1.0 2.3 2.5 RETNLB "FIZZ2, HXCP2, RELMb" ENSG00000163515 "Resistin like beta" Q9BQ08 3 108743424-108757384 "Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "intestine: 71.9" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.6" "Cancer enriched" "Detected in some" 10 "colorectal cancer: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049152 Approved "Secreted to blood" 123000 "HPA049152: " "prognostic favourable (6.86e-5)" "unprognostic (1.19e-3)" "unprognostic (3.37e-2)" "unprognostic (4.69e-2)" "unprognostic (2.67e-2)" "unprognostic (5.78e-2)" "unprognostic (4.26e-1)" 0.1 0.0 0.1 7.0 0.1 0.0 0.1 0.1 0.1 0.1 20.6 0.1 0.1 4.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 71.9 0.1 0.1 0.1 0.1 0.0 24.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 RFLNA "Cfm2, FAM101A, FLJ44614, RefilinA" ENSG00000178882 "Refilin A" Q6ZTI6 12 123973241-124316024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "stomach 1: 118.3" "Group enriched" "Detected in some" 4 "hTEC/SVTERT24-B: 10.0;HUVEC TERT2: 14.2;LHCN-M2: 24.8;RH-30: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA058911, HPA078021" Enhanced Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA058911: , HPA078021: " "unprognostic (1.71e-1)" "unprognostic (6.85e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (3.15e-2)" "unprognostic (8.78e-4)" "unprognostic (2.01e-1)" "prognostic unfavourable (3.16e-5)" "unprognostic (8.87e-2)" "unprognostic (1.59e-1)" "unprognostic (1.71e-3)" "unprognostic (1.15e-3)" "unprognostic (1.77e-8)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "unprognostic (6.27e-2)" "unprognostic (1.37e-2)" 5.5 3.0 6.4 5.2 8.6 2.6 8.2 10.8 6.6 11.7 20.9 9.7 7.0 19.5 4.8 4.8 3.0 5.5 3.7 5.1 6.3 6.3 5.4 5.3 3.2 2.8 9.8 5.2 5.2 7.6 2.7 9.4 3.4 9.0 6.3 15.4 6.3 8.7 5.4 8.5 4.2 20.7 3.4 8.3 2.8 118.3 2.7 8.3 1.9 9.6 2.3 2.8 3.3 4.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 2.5 0.0 0.0 0.3 0.3 1.2 0.9 0.0 0.1 3.5 0.0 1.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.5 0.0 10.0 0.0 14.2 0.0 0.0 24.8 0.0 0.0 0.0 2.1 0.0 0.0 8.1 0.1 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.4 8.6 10.8 6.6 6.3 6.3 9.8 5.2 9.0 8.3 RFPL1 RNF78 ENSG00000128250 "Ret finger protein like 1" O75677 22 29438583-29442455 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 20.4" "Cell line enhanced" "Detected in some" "HDLM-2: 10.9;HMC-1: 4.2;Karpas-707: 4.5;SH-SY5Y: 5.7;SiHa: 2.7;THP-1: 5.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA048320: , HPA072380: " "unprognostic (4.54e-1)" "unprognostic (6.63e-8)" "unprognostic (3.14e-3)" "unprognostic (1.89e-1)" 0.0 3.3 0.2 0.1 0.7 0.0 0.0 0.4 20.4 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 1.9 0.0 0.1 0.4 2.8 0.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 4.5 0.0 0.0 0.0 0.4 1.6 0.9 0.0 1.8 0.0 1.2 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.9 0.7 0.0 1.0 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 5.7 2.7 0.0 0.0 0.0 5.2 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.2 1.2 0.8 0.0 0.6 1.0 0.9 1.6 0.1 1.1 0.0 0.0 1.8 0.0 1.2 0.5 RFPL3 RNF120 ENSG00000128276 "Ret finger protein like 3" O75679 22 32354885-32361161 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 23.4" "Cell line enhanced" "Detected in some" "BEWO: 3.7;NB-4: 4.7;U-266/70: 5.5;U-266/84: 5.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA048320: , HPA072380: " "unprognostic (1.63e-1)" "unprognostic (9.90e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (1.97e-1)" "unprognostic (3.25e-2)" "unprognostic (4.31e-2)" "unprognostic (1.90e-1)" "unprognostic (6.32e-2)" 0.0 0.0 0.3 0.0 0.3 1.0 0.0 0.7 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.4 0.2 0.6 0.5 0.0 0.2 0.0 0.3 0.0 0.4 0.0 0.3 1.1 0.2 0.0 0.1 0.5 0.0 23.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 1.1 0.2 0.1 0.8 2.4 0.7 0.0 0.0 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 2.3 1.1 0.1 0.1 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.8 1.3 4.7 0.2 0.1 2.4 0.5 0.6 0.0 0.4 1.7 0.5 0.1 0.4 1.3 0.0 0.4 0.0 0.0 0.9 0.3 0.0 5.5 5.4 0.1 0.1 1.6 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 RFPL4B RNF211 ENSG00000251258 "Ret finger protein like 4B" Q6ZWI9 6 112347330-112351296 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 8.0" "Cell line enhanced" "Detected in some" "K-562: 3.1;RPTEC TERT1: 4.0;U-266/70: 1.7;U-266/84: 12.4" "Group enriched" "Detected in some" 7 "liver cancer: 0.6;testis cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA059324, HPA066464" Uncertain "HPA059324: , HPA066464: " "unprognostic (4.26e-1)" "unprognostic (1.45e-1)" "unprognostic (6.66e-2)" "unprognostic (3.78e-1)" "unprognostic (2.80e-3)" "unprognostic (3.73e-2)" 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.7 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 RGPD3 RGP3 ENSG00000153165 "RANBP2-like and GRIP domain containing 3" A6NKT7 2 106391290-106468376 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 11.6" "Group enriched" "Detected in some" 4 "HEL: 3.2;MOLT-4: 10.1;RPMI-8226: 3.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA049497: , HPA051675: , HPA067564: " "unprognostic (2.91e-1)" "unprognostic (1.62e-1)" "unprognostic (5.51e-2)" "unprognostic (6.61e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (6.86e-2)" "unprognostic (3.10e-1)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (3.44e-1)" "unprognostic (4.74e-3)" "unprognostic (5.05e-2)" "unprognostic (3.70e-1)" "unprognostic (3.42e-1)" "unprognostic (1.34e-1)" 0.2 0.1 0.3 0.0 0.5 0.4 0.4 0.3 0.9 0.2 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.4 0.4 1.4 0.7 0.1 0.1 0.6 0.2 0.2 0.7 0.7 0.2 0.2 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.4 0.7 0.1 11.6 0.1 0.2 0.2 0.0 0.1 0.2 0.2 0.2 0.0 1.2 0.2 0.4 0.5 0.4 0.4 0.3 0.5 0.1 0.4 0.5 0.4 0.3 0.5 0.0 0.0 0.1 0.3 0.3 1.2 0.1 0.7 0.3 0.1 3.2 0.3 0.5 0.3 0.1 0.1 0.1 0.3 1.1 0.4 0.3 0.6 0.0 0.5 0.2 10.1 0.1 0.4 0.1 0.0 0.1 3.2 0.1 0.5 0.5 0.1 0.4 0.0 0.2 0.1 0.3 0.2 0.3 0.2 0.6 0.5 0.6 0.6 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.3 0.1 0.6 0.5 0.0 0.1 0.7 0.2 0.0 0.0 0.2 0.2 1.2 0.2 RGPD4 "DKFZp686P0288, RGP4" ENSG00000196862 "RANBP2-like and GRIP domain containing 4" Q7Z3J3 2 107826937-107890841 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 8.6" "Cell line enriched" "Detected in single" 12 "U-266/70: 4.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 5 "T-cells: 1.5" "HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA049497: , HPA051675: , HPA067564: " "unprognostic (4.96e-2)" "unprognostic (3.04e-1)" "unprognostic (4.38e-1)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "unprognostic (3.05e-3)" "unprognostic (7.79e-2)" "unprognostic (1.52e-1)" "unprognostic (4.47e-1)" "unprognostic (6.05e-2)" "unprognostic (2.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.3 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.2 0.0 1.5 0.1 RGR RP44 ENSG00000148604 "Retinal G protein coupled receptor" P47804 10 84245053-84259960 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "retina: 228.3" "Cell line enhanced" "Detected in many" "TIME: 4.0" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "midbrain: 30.1;olfactory region: 95.6;thalamus: 30.2" "unprognostic (9.28e-2)" "unprognostic (1.05e-1)" "unprognostic (1.37e-1)" "unprognostic (9.53e-2)" "unprognostic (4.57e-2)" "unprognostic (1.57e-1)" "unprognostic (1.59e-1)" "unprognostic (1.97e-1)" 0.4 0.4 6.6 0.5 6.1 1.3 0.6 0.4 18.1 0.5 0.4 0.6 0.0 0.3 0.5 1.1 0.6 0.3 0.3 0.3 3.0 2.2 0.4 0.4 0.4 0.6 3.2 1.3 0.5 0.3 0.2 0.4 0.4 1.1 0.5 0.6 228.3 0.6 0.4 0.6 1.1 0.5 0.2 0.2 0.5 0.4 1.2 0.7 0.0 0.4 0.0 0.3 0.3 0.0 0.9 0.9 2.2 0.8 1.0 0.7 0.1 0.6 0.7 0.8 1.6 0.6 0.5 0.4 0.4 0.4 1.0 0.4 1.5 0.2 0.8 0.7 1.2 1.2 0.3 0.7 0.2 0.5 0.2 0.3 3.0 1.0 0.2 1.4 1.7 0.3 0.7 0.5 1.2 0.3 0.6 1.4 0.0 1.2 0.5 0.9 1.5 0.2 0.5 0.6 1.5 0.0 1.5 0.3 0.4 1.0 0.7 1.4 0.2 0.1 4.0 1.6 2.1 0.8 0.3 1.2 0.3 1.2 0.3 1.3 1.0 1.0 0.8 0.8 0.6 0.8 0.4 0.8 0.7 0.5 0.3 0.9 0.6 0.6 2.2 1.0 0.4 0.9 0.2 0.1 6.6 6.1 0.4 7.3 3.0 2.2 3.2 1.3 1.1 0.7 RGS20 "RGSZ1, ZGAP1" ENSG00000147509 "Regulator of G protein signaling 20" O76081 8 53851808-53959303 "Plasma proteins, Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 20.0" "Cell line enhanced" "Detected in many" "AF22: 12.5;SK-MEL-30: 19.0;U-87 MG: 18.9" "Cancer enhanced" "Detected in many" "melanoma: 12.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070193 Enhanced "HPA070193: " "unprognostic (2.14e-2)" "unprognostic (2.87e-2)" "unprognostic (1.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.48e-1)" "unprognostic (4.97e-2)" "unprognostic (1.91e-5)" "unprognostic (5.03e-5)" "unprognostic (2.15e-1)" "unprognostic (1.57e-2)" "unprognostic (8.86e-3)" "unprognostic (5.28e-2)" "unprognostic (2.75e-8)" "unprognostic (3.71e-3)" "unprognostic (9.78e-3)" "unprognostic (8.32e-2)" "unprognostic (1.69e-2)" 0.7 0.6 12.4 0.7 20.0 0.6 1.0 3.8 17.6 0.9 0.6 1.3 0.0 0.6 0.8 0.6 1.8 0.6 0.6 0.6 6.2 2.2 0.6 0.6 0.7 0.6 1.9 5.6 0.8 0.6 0.6 0.0 3.8 1.4 0.6 0.6 4.7 0.7 0.6 0.6 3.1 0.6 0.6 1.5 0.6 0.6 0.9 2.9 0.0 4.1 1.4 1.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 6.4 12.5 0.2 0.4 1.5 0.0 5.0 2.9 4.4 2.6 0.0 5.6 0.0 0.2 1.4 6.7 0.2 8.1 2.9 0.0 0.9 1.5 1.0 1.1 2.0 0.0 0.6 0.3 5.3 3.5 10.5 1.7 0.4 0.0 7.2 0.0 0.0 0.3 0.2 2.5 0.0 0.4 0.0 8.5 0.6 7.8 0.7 0.4 0.0 19.0 0.0 0.0 5.4 1.1 0.0 9.3 3.7 1.5 0.0 0.0 18.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 20.0 3.8 8.2 6.2 2.2 1.9 5.6 1.4 2.9 RGS4 SCZD9 ENSG00000117152 "Regulator of G protein signaling 4" P49798 1 163068775-163076802 "Disease related genes, Predicted intracellular proteins" "Signal transduction inhibitor" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 88.0" "Cell line enhanced" "Detected in many" "LHCN-M2: 37.4;SH-SY5Y: 74.4;TIME: 151.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030802 Approved "Intermediate filaments" "Intermediate filaments" "HPA030802: AB_10602295" "unprognostic (1.03e-1)" "unprognostic (1.84e-1)" "unprognostic (3.02e-2)" "unprognostic (6.84e-2)" "prognostic unfavourable (2.62e-4)" "unprognostic (8.26e-2)" "unprognostic (1.27e-1)" "unprognostic (5.34e-3)" "unprognostic (1.82e-1)" "unprognostic (6.45e-2)" "unprognostic (2.12e-2)" "unprognostic (8.47e-2)" "prognostic unfavourable (3.97e-4)" "prognostic unfavourable (1.92e-4)" "unprognostic (1.00e-1)" "unprognostic (8.33e-2)" "unprognostic (2.30e-2)" 2.9 20.9 9.1 2.1 45.3 0.5 1.4 1.1 88.0 4.0 1.7 1.0 0.0 2.9 4.8 1.4 6.3 4.9 11.2 4.7 13.9 10.1 1.5 2.6 2.1 2.3 12.1 36.2 1.1 2.7 1.2 6.2 1.3 16.0 3.3 1.8 1.0 0.9 3.9 0.7 0.6 1.6 3.0 1.9 1.5 3.7 2.1 2.1 0.0 1.5 0.2 0.7 2.8 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 3.7 19.2 0.0 12.9 14.1 1.9 5.0 0.0 0.0 0.0 5.7 8.3 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.1 0.0 20.4 2.5 19.7 0.0 0.0 37.4 0.0 0.0 0.0 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 74.4 0.0 0.0 0.0 0.0 0.0 151.8 15.4 0.7 3.0 21.5 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 9.1 45.3 1.1 78.8 13.9 10.1 12.1 36.2 16.0 2.1 RGSL1 RGSL2 ENSG00000121446 "Regulator of G protein signaling like 1" A5PLK6 1 182409192-182560599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 22.6" "Group enriched" "Detected in some" 12 "CAPAN-2: 1.1;T-47d: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "unprognostic (1.33e-1)" "unprognostic (5.20e-2)" "unprognostic (2.07e-1)" "unprognostic (6.47e-2)" "unprognostic (4.45e-1)" "unprognostic (1.64e-1)" "unprognostic (2.69e-5)" "unprognostic (2.93e-1)" "unprognostic (9.18e-2)" "unprognostic (1.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RHAG "CD241, RH50A, SLC42A1" ENSG00000112077 "Rh associated glycoprotein" Q02094 6 49605158-49636884 "CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "bone marrow: 54.1" "Group enriched" "Detected in some" 190 "HEL: 85.7;K-562: 84.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046051, HPA055331" Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA046051: , HPA055331: " "unprognostic (8.16e-2)" "unprognostic (6.86e-2)" "unprognostic (1.25e-3)" "unprognostic (1.65e-1)" 1.2 0.2 0.0 1.1 0.5 54.1 3.2 0.0 0.1 2.3 1.0 0.5 1.7 0.2 0.4 0.1 2.6 0.5 0.8 5.3 0.0 0.0 0.1 0.7 3.3 0.1 0.0 0.0 0.1 0.2 0.1 0.1 5.8 0.1 1.3 0.2 0.0 0.2 0.5 0.4 0.1 0.9 0.1 0.0 4.5 0.6 0.2 0.0 1.7 1.8 0.0 0.1 0.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 84.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 RHCE "CD240CE, RH" ENSG00000188672 "Rh blood group CcEe antigens" P18577 1 25362249-25430192 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 40.5" "Cell line enriched" "Detected in some" 5 "HEL: 43.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.4" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (1.37e-1)" "unprognostic (3.53e-1)" "unprognostic (2.38e-1)" "unprognostic (6.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.91e-2)" "unprognostic (7.01e-2)" "unprognostic (3.12e-2)" "unprognostic (3.81e-2)" "unprognostic (1.35e-1)" "unprognostic (6.08e-2)" "unprognostic (4.61e-2)" "unprognostic (5.77e-5)" "unprognostic (1.38e-1)" "unprognostic (3.94e-2)" "unprognostic (7.15e-3)" "unprognostic (1.63e-1)" 0.6 0.8 2.0 0.6 5.1 40.5 0.9 3.3 4.7 0.8 0.7 3.5 1.0 0.7 0.7 5.2 1.4 1.6 0.8 2.1 2.6 1.5 0.8 2.2 0.7 1.0 2.1 2.5 0.9 9.6 0.5 4.0 1.6 5.9 1.6 0.8 2.2 8.4 0.8 1.9 1.1 0.6 0.5 2.9 2.1 0.8 2.6 1.4 1.2 1.1 1.2 0.8 0.5 0.6 0.1 0.2 2.4 0.2 0.1 0.3 0.9 0.1 0.0 0.1 0.2 0.4 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.7 0.3 0.5 0.5 0.1 0.0 0.1 0.1 0.2 0.0 43.6 0.0 0.0 0.5 0.0 0.3 0.9 0.7 0.3 0.2 0.0 8.5 0.2 0.2 0.4 0.0 0.3 0.8 0.2 0.0 0.1 1.2 0.0 0.0 0.3 0.4 0.1 0.1 0.5 0.2 0.0 0.0 0.1 0.0 0.4 0.0 2.6 0.6 0.5 1.4 0.4 0.2 2.4 0.2 0.6 0.3 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.2 0.0 1.0 0.1 0.0 0.1 0.3 0.9 2.0 5.1 3.3 4.7 2.6 1.5 2.1 2.5 5.9 1.4 RHEX "C1orf186, FLJ16052" ENSG00000263961 "Regulator of hemoglobinization and erythroid cell expansion" Q6ZWK4 1 206052723-206102459 "Predicted membrane proteins" "Differentiation, Erythrocyte maturation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "blood: 117.7" "Cell line enriched" "Detected in some" 5 "HMC-1: 185.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 42.8;ovarian cancer: 41.1" "Cell type enriched" "Detected in some" 51 "basophil: 117.7" "Lineage enriched" "Detected in many" 51 "granulocytes: 117.7" "Low region specificity" "Detected in all" HPA037859 Supported "Plasma membrane" "Plasma membrane" "HPA037859: AB_10697084" "unprognostic (9.26e-3)" "unprognostic (1.91e-2)" "unprognostic (9.66e-2)" "unprognostic (1.65e-2)" "unprognostic (2.06e-2)" "unprognostic (5.27e-3)" "unprognostic (9.55e-2)" "unprognostic (3.04e-3)" "unprognostic (2.36e-1)" "unprognostic (1.31e-2)" "unprognostic (1.35e-1)" "unprognostic (7.20e-3)" "unprognostic (1.89e-2)" "unprognostic (3.02e-2)" "unprognostic (1.35e-1)" "unprognostic (3.77e-2)" "unprognostic (2.80e-3)" 4.3 0.0 0.0 3.9 0.0 0.0 1.8 0.0 0.0 13.1 3.1 0.0 12.1 0.9 6.2 8.2 3.4 1.6 16.2 0.4 0.0 6.8 1.8 5.2 4.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 9.4 3.3 2.9 0.0 16.9 1.5 0.2 4.0 7.0 0.0 0.4 2.4 1.1 0.0 0.6 0.0 1.7 2.5 4.3 10.0 0.3 2.2 117.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.1 0.0 8.4 185.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 37.2 0.0 0.0 0.0 0.0 0.2 2.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 117.7 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 RHO "CSNBAD1, OPN2, RP4" ENSG00000163914 Rhodopsin P08100 3 129528640-129535169 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Congenital stationary night blindness, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 151 "retina: 415.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cerebellum: 1.6;cerebral cortex: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013440, CAB022486, CAB034887, CAB034888" Enhanced "CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: " "unprognostic (4.32e-2)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "unprognostic (1.83e-1)" "unprognostic (2.87e-1)" "unprognostic (1.94e-1)" "unprognostic (9.19e-11)" "unprognostic (4.24e-2)" "unprognostic (1.84e-1)" "unprognostic (2.91e-1)" 0.2 0.0 0.0 0.0 0.3 0.0 0.1 1.6 2.7 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.5 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.1 415.0 0.3 0.2 0.0 1.8 0.0 0.3 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 2.7 0.2 0.2 0.0 0.0 0.0 0.0 RHOXF2 "CT107, PEPP-2, PEPP2, THG1" ENSG00000131721 "Rhox homeobox family member 2" Q9BQY4 X 120158561-120165630 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 23.0" "Cell line enhanced" "Detected in some" "K-562: 60.7;NB-4: 45.0;THP-1: 16.9;U-266/84: 27.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA003314, CAB020794" Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB020794: , HPA003314: AB_1855193" "unprognostic (1.60e-1)" "unprognostic (5.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 1.0 0.5 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 60.7 0.0 0.0 0.0 0.0 45.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.2 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.0 1.0 0.3 0.4 0.4 0.4 0.4 0.2 0.3 0.2 0.2 0.3 0.3 0.4 0.7 1.1 0.5 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RIMBP3 "KIAA1666, RIMBP3.1, RIMBP3A" ENSG00000275793 "RIMS binding protein 3" Q9UFD9 22 18605815-18611919 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 22.0" "Cell line enhanced" "Detected in many" "MOLT-4: 5.9;THP-1: 6.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.55e-2)" "unprognostic (3.95e-3)" "unprognostic (1.62e-1)" "unprognostic (3.95e-2)" "unprognostic (2.29e-2)" "unprognostic (9.81e-3)" "unprognostic (1.83e-3)" "unprognostic (1.84e-1)" "unprognostic (2.71e-1)" "unprognostic (4.72e-3)" "unprognostic (6.06e-3)" "unprognostic (9.58e-2)" "unprognostic (8.49e-3)" "unprognostic (7.23e-2)" "unprognostic (1.03e-1)" "unprognostic (2.69e-3)" "unprognostic (7.95e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 22.0 0.1 0.2 0.0 0.7 1.1 0.9 1.0 1.7 2.5 1.1 0.8 2.8 1.1 0.9 1.6 0.8 0.1 1.0 3.1 1.4 1.5 0.1 0.0 0.7 1.2 0.3 0.7 0.6 0.0 0.3 2.8 0.9 1.2 0.7 1.1 0.1 3.9 0.1 0.3 0.1 0.6 0.0 0.0 0.5 0.7 1.2 1.3 5.9 3.1 1.2 0.3 2.4 3.5 0.4 0.4 0.2 1.6 0.3 2.5 0.0 0.5 0.3 6.4 0.2 2.1 1.4 1.1 0.5 0.2 0.8 0.6 1.1 1.3 2.3 0.0 1.0 0.9 1.0 0.6 2.5 0.7 1.4 1.4 1.1 0.6 1.8 0.9 0.3 1.7 0.4 0.1 1.2 1.1 RIMBP3B ENSG00000274600 "RIMS binding protein 3B" A6NNM3 22 21383374-21389478 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 11.6" "Cell line enhanced" "Detected in some" "NB-4: 2.8;RH-30: 3.4;THP-1: 4.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (3.78e-1)" "unprognostic (3.54e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-1)" "unprognostic (3.28e-1)" "unprognostic (5.35e-2)" "unprognostic (4.37e-1)" "unprognostic (3.61e-4)" "unprognostic (1.69e-2)" "unprognostic (7.11e-2)" 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.2 0.0 0.3 0.4 0.4 0.9 1.0 1.5 0.4 0.1 1.7 0.2 0.4 1.1 0.7 0.3 0.5 1.2 0.5 0.9 0.2 0.3 0.3 1.0 0.2 0.0 0.7 0.0 0.1 1.7 1.1 0.6 0.3 0.2 0.0 0.5 0.0 0.1 0.0 0.1 0.2 0.0 0.6 0.3 0.6 0.2 2.0 2.8 0.4 0.4 1.9 3.4 0.0 0.1 0.0 0.5 0.0 1.5 0.0 0.5 0.1 4.8 0.0 0.4 0.4 0.4 0.2 0.1 0.1 0.0 0.9 0.4 1.5 0.0 0.5 0.4 1.1 0.2 1.4 0.1 0.7 1.5 0.4 0.3 1.1 0.7 0.1 1.0 0.9 0.1 1.2 0.4 RIMBP3C ENSG00000183246 "RIMS binding protein 3C" A6NJZ7 22 21545357-21551461 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 16.6" "Cell line enhanced" "Detected in some" "NB-4: 3.2;THP-1: 3.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.74e-1)" "unprognostic (4.05e-2)" "unprognostic (3.49e-2)" "unprognostic (2.18e-1)" "unprognostic (8.30e-2)" "unprognostic (4.53e-2)" "unprognostic (6.65e-2)" "unprognostic (1.15e-3)" "unprognostic (6.23e-2)" "unprognostic (2.17e-6)" "unprognostic (3.04e-1)" "unprognostic (3.29e-1)" "unprognostic (3.76e-6)" "unprognostic (1.66e-2)" 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 16.6 0.0 0.3 0.1 0.0 0.5 1.3 0.9 0.8 1.4 1.7 1.0 0.2 0.0 0.5 0.1 0.1 0.0 0.2 0.1 0.8 0.7 0.3 0.1 0.3 0.0 1.5 0.6 0.5 0.7 0.2 0.1 0.7 0.5 0.5 0.0 0.3 0.2 1.5 0.6 0.0 0.2 0.5 0.1 0.3 0.1 0.0 0.1 0.7 1.7 3.2 0.3 0.2 1.4 0.9 0.1 0.1 0.1 0.7 0.2 0.5 0.4 0.2 0.0 3.5 0.0 1.3 0.6 0.7 0.2 0.5 0.4 0.2 1.3 1.1 1.7 0.9 0.8 0.8 0.5 0.5 1.4 0.5 0.9 0.7 1.3 0.4 1.7 0.6 0.8 1.4 0.7 0.1 0.9 1.0 RIMS1 "CORD7, KIAA0340, RAB3IP2, RIM, RIM1" ENSG00000079841 "Regulating synaptic membrane exocytosis 1" Q86UR5 6 71886703-72403143 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 83.1" "Cell line enhanced" "Detected in some" "Daudi: 4.8;EFO-21: 8.7;LHCN-M2: 9.6;RPTEC TERT1: 14.8;SH-SY5Y: 10.4;TIME: 5.1;U-138 MG: 5.0" "Cancer enhanced" "Detected in single" "prostate cancer: 0.7" "Region enriched" "Detected in all" 6 "cerebellum: 83.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076565 Enhanced "HPA076565: " "unprognostic (1.34e-3)" "unprognostic (3.47e-1)" "unprognostic (1.48e-1)" "unprognostic (1.63e-3)" "unprognostic (6.62e-2)" "unprognostic (1.16e-1)" "unprognostic (1.73e-2)" "unprognostic (8.57e-2)" "unprognostic (2.85e-1)" "unprognostic (7.76e-4)" "unprognostic (2.42e-2)" "unprognostic (2.29e-1)" "unprognostic (7.91e-2)" "unprognostic (2.76e-1)" "unprognostic (5.74e-2)" "unprognostic (1.07e-2)" 0.5 2.3 10.5 1.5 9.8 0.4 1.2 83.1 27.7 0.9 0.6 0.5 0.0 1.5 0.8 0.5 3.7 0.5 6.2 0.6 9.3 3.6 0.5 0.4 0.7 0.5 2.8 11.7 0.5 0.8 5.0 4.6 0.4 7.2 4.9 0.6 0.2 1.9 0.9 0.6 0.4 0.8 1.4 1.5 0.4 1.4 5.9 2.7 0.0 0.5 0.0 0.4 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.2 1.3 0.0 0.1 0.0 0.0 4.8 8.7 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.3 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.4 14.8 0.0 0.4 10.4 0.0 0.0 0.0 0.6 0.0 5.1 5.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 9.8 83.1 12.9 9.3 3.6 2.8 11.7 7.2 2.7 RIMS3 "NIM3, RIM3" ENSG00000117016 "Regulating synaptic membrane exocytosis 3" Q9UJD0 1 40620679-40665657 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.7" "Cell line enhanced" "Detected in many" "Daudi: 37.0;SH-SY5Y: 17.5;U-87 MG: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 1.8;plasmacytoid DC: 4.6" "Group enriched" "Detected in many" 9 "dendritic cells: 4.6;T-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055285 Approved Nucleoli,Mitochondria Mitochondria Nucleoli "HPA055285: " "unprognostic (3.51e-3)" "unprognostic (7.18e-3)" "unprognostic (4.44e-3)" "unprognostic (1.44e-4)" "unprognostic (3.70e-1)" "unprognostic (2.88e-2)" "unprognostic (1.44e-5)" "unprognostic (2.41e-1)" "unprognostic (1.53e-1)" "unprognostic (2.87e-1)" "unprognostic (2.54e-1)" "unprognostic (7.93e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.25e-2)" "unprognostic (3.11e-2)" "unprognostic (2.19e-2)" 1.3 7.2 13.6 2.2 19.2 3.7 3.1 21.5 47.7 1.4 3.4 3.4 0.0 1.1 3.0 2.2 2.9 2.1 1.3 1.5 7.8 17.4 1.4 0.7 3.1 2.0 7.4 22.3 2.5 1.1 4.0 0.5 3.8 4.9 3.2 3.8 2.0 2.0 4.1 0.6 2.7 1.7 4.8 3.4 1.7 2.5 3.1 4.4 0.7 2.8 0.0 2.8 1.7 1.0 0.1 4.6 0.1 0.3 0.1 1.8 0.1 1.9 0.7 2.8 3.0 0.1 0.0 0.4 0.0 0.0 0.5 0.6 0.3 0.6 37.0 0.0 0.0 0.3 1.9 0.3 0.3 6.4 0.9 2.1 0.2 1.0 0.1 0.3 1.7 0.0 1.5 0.1 0.1 0.1 1.8 1.4 0.0 3.3 5.4 0.2 1.8 0.2 2.5 2.6 6.8 0.5 0.5 9.9 17.5 0.4 1.8 1.2 0.4 10.3 0.0 0.3 3.0 0.0 0.5 0.3 2.7 8.1 16.1 0.6 0.3 0.1 0.0 0.0 0.1 0.0 1.8 0.0 0.5 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.3 4.6 0.4 0.1 13.6 19.2 21.5 47.7 7.8 17.4 7.4 22.3 4.9 4.4 RIT2 "RIBA, RIN" ENSG00000152214 "Ras like without CAAX 2" Q99578 18 42743227-43115691 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 55.9" "Cell line enhanced" "Detected in some" "CACO-2: 1.1;NTERA-2: 1.4;SH-SY5Y: 1.9" "Cancer enriched" "Detected in single" 49 "glioma: 4.7" "Region enhanced" "Detected in many" "cerebellum: 55.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA072174 Enhanced "HPA072174: " "unprognostic (1.37e-2)" "unprognostic (4.15e-1)" "unprognostic (2.14e-1)" 0.7 5.2 3.7 0.9 15.0 0.6 0.8 55.9 24.1 1.0 0.7 0.1 0.0 0.8 0.6 0.6 0.6 0.7 0.7 0.6 5.1 11.7 0.6 0.7 0.6 0.7 3.6 5.9 0.8 0.6 0.6 0.4 0.8 6.1 0.7 0.9 0.0 0.6 0.8 0.6 0.6 0.7 0.8 2.1 0.6 0.6 1.1 0.8 0.0 0.7 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.6 0.0 0.0 0.0 0.4 1.9 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 15.0 55.9 11.0 5.1 11.7 3.6 5.9 6.1 0.8 RLBP1 CRALBP ENSG00000140522 "Retinaldehyde binding protein 1" P12271 15 89209869-89221751 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Transport, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "retina: 164.1" "Cell line enriched" "Detected in single" 48 "SK-MEL-30: 21.4" "Group enriched" "Detected in some" 30 "glioma: 3.7;melanoma: 7.4" "Group enriched" "Detected in many" 4 "amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7" "Group enriched" "Detected in some" 7 "basophil: 3.3;neutrophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042051, HPA044083" Enhanced Approved Supported Nucleoplasm,Centrosome,Cytosol Cytosol "Nucleoplasm, Centrosome" "HPA042051: , HPA044083: " "unprognostic (3.19e-2)" "unprognostic (2.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (8.68e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (5.21e-2)" "unprognostic (3.17e-1)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.78e-1)" "unprognostic (1.13e-1)" "unprognostic (8.42e-2)" 0.2 0.7 6.9 0.6 10.6 0.6 0.2 0.6 11.5 0.2 0.8 0.3 0.1 0.9 0.2 1.0 0.3 0.2 0.3 0.2 3.7 1.3 0.2 0.2 0.3 0.3 1.6 0.6 0.2 0.2 0.2 1.7 0.3 0.4 0.2 0.8 164.1 0.2 0.2 0.5 0.3 0.6 0.5 0.5 0.3 0.2 1.1 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.0 3.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 6.9 10.6 0.6 7.0 3.7 1.3 1.6 0.6 0.4 0.1 RLN1 H1 ENSG00000107018 "Relaxin 1" P04808 9 5334969-5339873 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "prostate: 25.4" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;HEL: 4.7;SK-BR-3: 1.0" "Cancer enriched" "Detected in some" 106 "prostate cancer: 67.0" "Region enhanced" "Detected in single" "hippocampal formation: 2.1" "Cell type enhanced" "Detected in single" "gdT-cell: 1.6" "Lineage enriched" "Detected in single" 13 "T-cells: 1.6" "Secreted to blood" "unprognostic (7.12e-6)" "unprognostic (2.32e-1)" "unprognostic (7.29e-2)" "unprognostic (1.98e-1)" "unprognostic (2.22e-2)" "unprognostic (1.04e-1)" "unprognostic (4.32e-2)" "unprognostic (3.44e-1)" "unprognostic (5.14e-2)" "unprognostic (4.08e-4)" "unprognostic (8.15e-2)" "unprognostic (2.89e-4)" "unprognostic (8.82e-3)" "unprognostic (3.23e-2)" "unprognostic (3.23e-2)" "unprognostic (1.53e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.1 0.9 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 2.1 0.0 0.0 0.0 0.0 0.0 RLN2 "bA12D24.1.1, bA12D24.1.2, H2, RLXH2" ENSG00000107014 "Relaxin 2" P04090 9 5299868-5304969 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 44.0" "Cell line enhanced" "Detected in some" "Daudi: 5.1;HEL: 19.7;T-47d: 5.7;U-266/84: 9.0" "Cancer enhanced" "Detected in some" "prostate cancer: 6.7" "Region enriched" "Detected in single" 64 "basal ganglia: 44.0" "Group enriched" "Detected in many" 39 "gdT-cell: 2.1;MAIT T-cell: 6.5;memory B-cell: 2.8;memory CD4 T-cell: 4.3;memory CD8 T-cell: 3.5;naive B-cell: 2.1;naive CD4 T-cell: 6.2;naive CD8 T-cell: 4.6;NK-cell: 4.9;T-reg: 2.0" "Group enriched" "Detected in many" 47 "B-cells: 2.8;NK-cells: 4.9;T-cells: 6.5" "Secreted to blood" 24440 "unprognostic (1.63e-3)" "unprognostic (1.26e-1)" "unprognostic (2.09e-3)" "unprognostic (2.84e-1)" "unprognostic (2.03e-2)" "unprognostic (9.99e-2)" "unprognostic (1.48e-1)" "unprognostic (2.77e-2)" "unprognostic (2.91e-3)" "unprognostic (2.50e-3)" "unprognostic (9.18e-2)" "unprognostic (1.74e-6)" "unprognostic (2.36e-1)" "unprognostic (4.71e-2)" "unprognostic (1.88e-2)" "unprognostic (8.41e-4)" 0.6 0.0 0.6 1.6 44.0 0.0 3.2 0.6 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.6 7.5 0.6 0.6 0.6 0.6 2.0 0.6 0.7 3.5 0.6 0.6 0.6 0.9 5.2 5.8 0.7 0.6 6.2 0.3 0.6 0.6 0.7 0.6 0.4 0.8 0.6 0.6 1.4 0.4 4.2 0.6 0.6 0.9 0.6 3.0 0.6 0.6 2.8 0.0 0.0 0.0 4.9 6.5 1.4 2.8 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.9 0.3 1.5 5.1 0.4 0.0 0.9 0.0 2.6 0.7 4.0 1.9 19.7 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.1 0.2 0.5 0.0 0.2 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.5 2.6 2.9 0.0 0.6 0.1 5.7 0.1 0.2 0.0 0.5 0.0 0.1 1.3 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 6.5 2.8 4.3 3.5 0.0 2.1 6.2 4.6 0.0 4.9 0.0 0.0 2.0 1.4 0.6 44.0 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 RNASE1 "RAC1, RNS1" ENSG00000129538 "Ribonuclease A family member 1, pancreatic" P07998 14 20801228-20803278 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "pancreas: 809.6" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 73.2;RT4: 28.7;TIME: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 8.0;myeloid DC: 16.1" "Group enriched" "Detected in many" 9 "dendritic cells: 16.1;monocytes: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001140 Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" 1500000000 Vesicles Nucleoplasm "HPA001140: AB_1079816" "unprognostic (2.32e-2)" "unprognostic (3.16e-2)" "unprognostic (9.51e-3)" "unprognostic (7.77e-2)" "unprognostic (6.93e-2)" "unprognostic (1.28e-1)" "unprognostic (3.42e-3)" "unprognostic (6.59e-3)" "unprognostic (4.69e-2)" "unprognostic (7.92e-2)" "unprognostic (6.32e-2)" "unprognostic (3.56e-2)" "unprognostic (5.14e-3)" "unprognostic (1.11e-2)" "unprognostic (1.47e-1)" "unprognostic (2.43e-2)" "unprognostic (1.67e-1)" 79.2 48.4 28.7 12.0 38.5 1.6 59.7 4.0 32.2 21.3 33.7 57.8 63.6 16.8 13.6 49.1 19.3 24.3 37.5 70.3 41.2 21.6 33.8 8.6 94.3 23.5 39.0 16.0 19.2 809.6 6.7 4.1 79.0 25.1 23.0 39.8 106.4 15.9 35.6 31.7 10.8 20.6 26.6 52.3 34.5 87.9 86.5 27.1 7.8 11.2 14.3 7.2 29.0 10.9 0.0 16.1 1.3 8.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 73.2 7.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.0 28.7 0.3 0.3 0.0 0.2 0.0 0.0 0.0 38.0 0.0 0.6 0.4 0.0 0.1 0.0 0.0 1.0 0.0 1.0 1.3 8.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 2.0 28.7 38.5 4.0 32.2 41.2 21.6 39.0 16.0 25.1 27.1 RNASE12 RAI1 ENSG00000258436 "Ribonuclease A family member 12 (inactive)" Q5GAN4 14 20590193-20590823 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 43 "epididymis: 143.2" "Group enriched" "Detected in some" 5 "NB-4: 3.6;SH-SY5Y: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044175, HPA059465" Enhanced "Secreted in male reproductive system" "HPA044175: AB_10960390, HPA059465: AB_2732638" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 143.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNASE13 RAL1 ENSG00000206150 "Ribonuclease A family member 13 (inactive)" Q5GAN3 14 21032820-21034785 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "epididymis: 95.8" "Cell line enhanced" "Detected in single" "NB-4: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in male reproductive system" "unprognostic (2.54e-1)" "unprognostic (2.52e-1)" "unprognostic (2.86e-1)" "unprognostic (8.40e-2)" "unprognostic (1.93e-1)" "unprognostic (7.15e-2)" "unprognostic (1.63e-3)" "unprognostic (5.20e-4)" "unprognostic (1.47e-2)" 0.5 0.2 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.4 95.8 0.2 0.2 0.2 0.2 0.2 0.0 0.2 2.8 0.5 0.2 0.2 0.2 0.2 0.9 0.0 0.2 0.2 0.2 0.2 0.0 0.2 1.3 0.2 0.5 0.5 0.2 0.2 0.2 1.9 0.0 1.8 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 RNASE4 RAB1 ENSG00000258818 "Ribonuclease A family member 4" P34096 14 20684100-20701215 "Plasma proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "liver: 366.2" "Group enriched" "Detected in many" 4 "ASC diff: 30.8;ASC TERT1: 34.9;Hep G2: 43.4;HSkMC: 20.8" "Cancer enhanced" "Detected in many" "liver cancer: 6.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 17.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to blood" 27000000 "unprognostic (1.07e-1)" "unprognostic (3.46e-1)" "unprognostic (5.21e-2)" "unprognostic (3.18e-4)" "unprognostic (1.20e-1)" "unprognostic (7.05e-2)" "prognostic favourable (9.62e-5)" "unprognostic (1.43e-1)" "unprognostic (2.22e-2)" "unprognostic (6.88e-2)" "unprognostic (3.71e-2)" "unprognostic (1.29e-1)" "unprognostic (3.46e-1)" "unprognostic (2.54e-2)" "unprognostic (1.57e-1)" "unprognostic (9.16e-2)" "unprognostic (4.27e-2)" 29.6 1.7 1.5 5.7 1.8 0.2 28.7 1.0 1.2 25.2 16.3 2.5 12.3 4.9 19.2 18.4 14.7 15.7 23.4 10.3 2.3 1.0 18.9 366.2 12.8 5.2 3.0 1.4 30.8 16.3 3.8 3.0 4.4 2.7 30.4 15.0 10.5 35.0 14.2 7.1 10.6 13.6 17.4 3.8 3.2 19.2 13.2 1.9 0.3 8.4 10.5 7.3 25.1 26.3 4.0 9.7 0.5 17.0 0.4 2.5 5.0 0.8 4.1 0.8 0.0 30.8 34.9 0.2 3.3 7.6 0.5 1.4 1.0 1.1 0.0 0.8 7.7 0.8 0.4 0.8 0.6 5.3 0.4 0.0 0.9 43.4 3.4 0.4 0.1 20.8 1.9 0.5 3.5 4.0 0.0 3.7 2.2 0.5 0.2 0.0 0.1 3.3 0.1 0.6 1.1 0.7 0.7 0.0 0.1 1.2 0.6 0.8 0.9 0.1 4.1 0.9 0.5 1.2 0.1 0.7 0.9 0.1 1.4 0.3 0.8 0.1 17.0 0.0 0.6 0.9 0.8 4.0 1.1 0.4 9.7 2.2 0.2 0.4 0.5 0.4 0.1 2.3 2.5 5.0 1.5 1.8 1.0 1.2 2.3 1.0 3.0 1.4 2.7 1.9 RNASE8 RAE2 ENSG00000173431 "Ribonuclease A family member 8" Q8TDE3 14 21057822-21058455 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 146 "salivary gland: 38.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNASE9 "h461, RAK1" ENSG00000188655 "Ribonuclease A family member 9 (inactive)" P60153 14 20556093-20560931 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "epididymis: 56.1" "Cell line enhanced" "Detected in some" "HEL: 1.6;NB-4: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 56.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 RNF112 "BFP, ZNF179" ENSG00000128482 "Ring finger protein 112" Q9ULX5 17 19411125-19417276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.1;fHDF/TERT166: 4.7;SCLC-21H: 4.7;SH-SY5Y: 8.2;U-87 MG: 26.9" "Cancer enriched" "Detected in some" 8 "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015970 Supported Approved "Nuclear speckles" "Nuclear speckles" "HPA015970: AB_1859103" "unprognostic (1.16e-1)" "unprognostic (3.74e-1)" "unprognostic (8.43e-5)" "unprognostic (3.65e-2)" "unprognostic (2.96e-2)" "unprognostic (6.02e-2)" "unprognostic (1.27e-1)" "unprognostic (2.88e-1)" "unprognostic (4.26e-1)" "unprognostic (5.02e-2)" "unprognostic (3.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.31e-9)" "unprognostic (1.32e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-1)" "unprognostic (4.24e-1)" 2.5 8.1 11.3 2.3 15.9 0.6 1.8 47.5 29.1 1.2 3.6 1.4 0.0 2.9 2.0 6.9 1.1 1.5 4.4 2.3 12.4 8.2 1.2 0.7 1.7 1.4 3.9 14.1 1.3 0.8 0.5 1.9 1.1 3.1 10.2 4.4 1.6 1.3 3.5 2.1 1.9 3.6 3.5 2.9 1.7 2.1 2.0 3.7 0.0 0.9 0.0 0.8 2.8 1.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 4.1 0.1 0.2 0.9 0.0 0.0 0.2 0.0 0.0 0.0 4.7 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.3 0.0 0.0 1.7 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.1 0.1 0.1 0.0 0.0 4.7 8.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 26.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 15.9 47.5 15.9 12.4 8.2 3.9 14.1 3.1 3.7 RNF113B "RNF161, ZNF183L1" ENSG00000139797 "Ring finger protein 113B" Q8IZP6 13 98175785-98177265 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 54.3" "Cell line enriched" "Detected in single" 8 "U-266/84: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.5" "unprognostic (3.69e-1)" "unprognostic (2.22e-1)" "unprognostic (1.78e-1)" "unprognostic (4.10e-2)" "unprognostic (1.38e-3)" "unprognostic (1.75e-1)" "unprognostic (7.48e-2)" "unprognostic (1.92e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.1 0.1 0.0 0.0 0.1 1.3 0.0 1.3 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.2 2.5 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF133 ENSG00000188050 "Ring finger protein 133" Q8WVZ7 7 122697712-122699156 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "testis: 28.3" "Cell line enhanced" "Detected in some" "Karpas-707: 4.0;MCF7: 1.5;NTERA-2: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.82e-1)" "unprognostic (2.52e-2)" "unprognostic (1.77e-1)" "unprognostic (3.04e-2)" "unprognostic (2.45e-3)" "unprognostic (1.67e-1)" "unprognostic (8.87e-3)" "unprognostic (3.56e-2)" "unprognostic (3.72e-1)" "unprognostic (3.29e-3)" "unprognostic (1.26e-1)" "unprognostic (1.02e-2)" "unprognostic (7.76e-2)" "unprognostic (1.10e-1)" "unprognostic (2.39e-1)" "unprognostic (2.37e-2)" "unprognostic (7.61e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.6 0.2 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 4.0 0.0 1.5 0.0 0.0 1.2 1.1 0.0 0.0 0.8 0.0 0.4 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.1 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF148 MGC35222 ENSG00000235631 "Ring finger protein 148" Q8N7C7 7 122701664-122702967 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 31.0" "Cell line enhanced" "Detected in some" "Karpas-707: 7.3;MCF7: 2.8;RPMI-8226: 1.8;SK-BR-3: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (3.19e-1)" "unprognostic (1.21e-2)" "unprognostic (2.85e-1)" "unprognostic (3.23e-2)" "unprognostic (1.04e-2)" "unprognostic (9.81e-2)" "unprognostic (8.48e-2)" "unprognostic (2.14e-2)" "unprognostic (2.18e-1)" "unprognostic (2.37e-1)" "unprognostic (3.33e-2)" "unprognostic (2.24e-2)" "unprognostic (1.24e-1)" "unprognostic (6.63e-2)" "unprognostic (1.09e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 31.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.3 0.0 7.3 0.0 2.8 0.0 0.0 1.0 0.8 0.0 0.0 1.8 0.0 0.6 0.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 1.3 0.1 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 RNF151 ENSG00000179580 "Ring finger protein 151" Q2KHN1 16 1966823-1968975 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "testis: 64.1" "Cell line enhanced" "Detected in some" "RPMI-8226: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "T-reg: 2.1" "Lineage enriched" "Detected in single" 8 "T-cells: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (2.54e-2)" "unprognostic (1.18e-1)" "unprognostic (5.65e-2)" "unprognostic (4.01e-3)" "unprognostic (1.15e-1)" "unprognostic (1.22e-1)" "unprognostic (1.41e-1)" "unprognostic (3.20e-1)" "unprognostic (4.39e-3)" "unprognostic (4.63e-1)" "unprognostic (1.98e-4)" "unprognostic (1.46e-1)" "unprognostic (4.19e-2)" "unprognostic (1.10e-1)" "unprognostic (2.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 64.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.2 0.6 1.2 0.6 0.0 0.0 0.9 0.3 0.0 0.0 0.3 0.6 0.0 1.5 0.2 0.5 1.9 0.0 0.0 0.0 0.2 2.0 0.4 1.6 1.6 0.0 0.6 0.5 0.0 0.8 0.0 0.0 0.0 0.4 0.3 0.0 1.2 0.0 1.6 0.8 0.9 0.0 0.0 2.5 0.0 0.0 0.8 0.1 0.0 0.6 0.3 1.4 0.0 0.0 1.1 1.1 0.7 0.8 0.2 0.9 1.4 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF17 "FLJ11045, Mmip-2, SPATA23, TDRD4" ENSG00000132972 "Ring finger protein 17" Q9BXT8 13 24764152-24879921 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 44.3" "Group enriched" "Detected in some" 4 "BEWO: 2.5;HHSteC: 1.8" "Cancer enriched" "Detected in single" 41 "testis cancer: 4.9" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 4 "T-cells: 1.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in many" 4 "olfactory region: 3.8" "HPA039699, HPA040111" Approved "HPA039699: AB_10795254, HPA040111: AB_10795414" "unprognostic (2.57e-1)" "unprognostic (1.87e-2)" "unprognostic (1.37e-1)" "unprognostic (4.44e-1)" "unprognostic (4.26e-1)" "unprognostic (3.21e-2)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (8.61e-2)" "unprognostic (5.04e-1)" "unprognostic (3.12e-1)" "unprognostic (8.32e-2)" "unprognostic (1.22e-1)" 0.1 0.5 0.2 0.1 0.1 0.0 0.1 0.2 1.0 0.2 0.1 0.0 0.0 0.0 0.2 1.2 0.1 0.2 0.0 0.2 0.3 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.2 0.1 0.0 0.2 2.2 0.2 1.0 0.0 0.0 0.9 0.1 3.7 0.1 0.1 0.0 1.5 0.1 0.2 44.3 0.6 0.0 0.1 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 1.0 0.3 0.1 1.1 0.0 0.2 0.6 RNF217 "C6orf172, dJ84N20.1, IBRDC1, MGC26996" ENSG00000146373 "Ring finger protein 217" Q8TC41 6 124962545-125092633 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 63.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.9;myeloid DC: 1.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029598 Uncertain "HPA029598: AB_10602297" "unprognostic (2.96e-2)" "unprognostic (2.34e-3)" "unprognostic (8.07e-2)" "unprognostic (8.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.06e-2)" "unprognostic (1.06e-1)" "unprognostic (7.22e-3)" "unprognostic (4.94e-2)" "unprognostic (6.69e-2)" "unprognostic (2.47e-1)" "unprognostic (2.61e-1)" "prognostic unfavourable (4.60e-5)" "unprognostic (8.29e-4)" "unprognostic (2.16e-1)" "unprognostic (7.52e-2)" "prognostic unfavourable (1.92e-4)" 9.6 3.5 3.3 4.2 4.7 10.5 14.6 3.8 3.5 8.0 7.7 5.7 6.4 2.3 5.9 5.6 6.2 7.5 12.1 6.5 3.8 1.7 2.5 6.3 7.3 3.7 4.3 2.9 11.5 3.8 63.3 4.0 12.0 3.4 6.4 2.3 6.0 6.0 6.9 10.1 10.9 3.1 13.0 2.3 2.6 4.5 7.4 5.7 0.1 7.4 3.6 1.6 8.7 13.6 0.0 1.2 0.6 1.9 0.3 0.2 0.3 4.1 4.2 1.5 0.5 5.4 2.1 8.5 5.7 7.7 3.9 5.1 0.0 3.9 0.0 7.9 5.4 6.0 0.9 5.1 5.5 0.0 4.8 2.3 6.3 1.3 5.2 0.0 0.2 5.9 4.7 2.9 8.6 4.4 11.6 0.0 6.8 0.0 0.0 0.0 1.3 1.1 0.1 5.9 0.0 4.0 1.9 0.7 0.0 2.5 0.6 2.1 4.1 0.6 6.9 3.2 10.3 0.0 12.1 0.0 0.0 0.0 2.4 0.0 3.8 0.6 1.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.3 0.3 0.0 0.0 0.3 3.3 4.7 3.8 3.5 3.8 1.7 4.3 2.9 3.4 5.7 RNF32 "FKSG33, HSD15, LMBR2" ENSG00000105982 "Ring finger protein 32" Q9H0A6 7 156640281-156677130 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 55.2" "Cell line enhanced" "Detected in many" "CACO-2: 11.2;HDLM-2: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073560 Enhanced "HPA073560: " "unprognostic (9.23e-2)" "unprognostic (3.01e-2)" "prognostic unfavourable (2.21e-4)" "unprognostic (7.85e-2)" "unprognostic (3.98e-2)" "unprognostic (2.21e-2)" "unprognostic (5.73e-3)" "unprognostic (1.71e-2)" "unprognostic (8.72e-3)" "unprognostic (6.08e-4)" "unprognostic (4.64e-2)" "unprognostic (2.06e-1)" "unprognostic (8.15e-3)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" "unprognostic (3.81e-3)" "unprognostic (1.44e-1)" 1.1 1.0 2.2 0.8 2.6 0.9 0.8 1.0 2.2 0.6 1.2 4.7 0.8 1.0 0.6 7.7 0.6 2.2 1.6 0.4 2.0 1.9 1.5 0.8 1.0 1.2 1.8 2.2 1.8 2.6 0.8 2.6 0.9 2.0 1.5 1.0 0.7 1.4 0.6 0.6 1.4 0.9 0.1 2.8 0.8 1.9 55.2 1.9 1.1 1.7 0.0 0.9 0.6 0.6 3.7 3.5 10.5 0.6 0.6 2.8 0.9 4.2 2.2 0.4 1.1 1.0 0.6 0.6 0.7 0.1 1.1 0.9 11.2 4.9 6.8 5.4 0.7 0.1 0.0 0.2 2.2 12.4 2.9 0.6 0.8 0.4 1.0 1.9 4.0 1.6 0.8 0.6 2.3 0.5 9.8 1.9 3.4 7.3 2.7 4.8 2.4 5.4 2.7 0.1 3.1 1.6 1.4 7.1 5.5 4.1 0.4 2.1 1.2 1.4 1.8 0.0 0.1 0.8 0.5 10.0 4.3 3.9 0.8 4.5 1.7 10.5 0.5 1.8 0.6 0.3 2.2 3.7 2.3 0.6 1.4 2.6 0.6 0.7 0.1 0.6 0.6 3.5 2.8 0.9 2.2 2.6 1.0 2.2 2.0 1.9 1.8 2.2 2.0 1.9 ROM1 "ROM, TSPAN23" ENSG00000149489 "Retinal outer segment membrane protein 1" Q03395 11 62611722-62615120 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 108.1" "Cell line enhanced" "Detected in many" "HSkMC: 17.8;U-266/84: 18.7" "Cancer enriched" "Detected in all" 6 "glioma: 14.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA028910 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA028910: " "unprognostic (1.54e-2)" "unprognostic (1.37e-2)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-1)" "unprognostic (4.05e-1)" "prognostic favourable (2.20e-4)" "unprognostic (2.20e-1)" "unprognostic (9.87e-2)" "unprognostic (7.65e-3)" "unprognostic (3.50e-2)" "prognostic unfavourable (2.85e-6)" "unprognostic (2.61e-1)" "unprognostic (4.65e-1)" "unprognostic (1.02e-1)" "unprognostic (7.24e-2)" 9.4 4.6 16.3 2.3 15.0 0.9 3.6 5.7 18.8 4.9 3.1 5.1 3.3 2.0 3.8 5.7 4.7 7.4 5.2 2.7 14.7 9.2 2.4 3.2 3.0 2.3 18.1 4.7 13.2 3.2 4.8 2.1 1.6 8.7 3.8 3.0 108.1 2.5 5.9 2.2 3.7 1.7 6.3 21.6 2.5 2.4 3.7 7.7 0.7 3.0 2.2 2.6 3.1 9.2 1.1 0.8 0.8 1.2 5.6 3.2 1.4 2.1 1.2 2.2 4.6 3.2 15.6 0.4 1.4 2.5 3.1 2.0 0.6 3.6 2.0 10.0 8.1 2.7 1.0 2.8 0.8 3.6 1.8 1.8 5.3 2.5 9.2 0.7 0.6 17.8 4.1 3.1 6.4 4.7 2.6 4.6 6.2 5.3 1.1 1.5 0.5 3.2 1.1 1.8 12.7 3.4 1.2 2.3 3.3 3.5 4.0 1.6 5.6 0.9 5.4 5.1 1.9 5.9 1.6 2.0 18.7 1.6 9.5 2.1 1.0 0.0 1.2 0.8 0.9 0.3 2.4 0.7 3.2 0.8 0.6 1.1 1.5 1.8 0.4 5.6 1.1 0.8 0.9 1.4 16.3 15.0 5.7 8.4 14.7 9.2 18.1 4.7 8.7 7.7 ROPN1 "CT91, ODF6, ROPN1A, ropporin" ENSG00000065371 "Rhophilin associated tail protein 1" Q9HAT0 3 123968521-123992178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 50.7" "Cell line enriched" "Detected in some" 8 "SK-MEL-30: 24.3" "Group enriched" "Detected in some" 33 "breast cancer: 0.8;melanoma: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA052530 Supported "HPA052530: " "unprognostic (1.75e-5)" "unprognostic (2.24e-1)" "unprognostic (4.77e-2)" "unprognostic (7.66e-2)" "unprognostic (1.72e-1)" "unprognostic (1.95e-2)" "unprognostic (3.13e-1)" "unprognostic (2.08e-2)" "unprognostic (8.35e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 50.7 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 24.3 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 2.9 0.5 0.0 0.0 0.9 0.0 0.3 0.0 0.7 0.0 0.0 0.2 0.2 0.4 0.0 0.1 0.0 0.1 0.3 0.2 ROPN1B ENSG00000114547 "Rhophilin associated tail protein 1B" Q9BZX4 3 125969144-125983454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 64.4" "Group enriched" "Detected in some" 6 "SK-MEL-30: 32.5;WM-115: 11.8" "Cancer enhanced" "Detected in some" "melanoma: 4.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.0;plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in many" HPA052530 Supported "HPA052530: " "unprognostic (7.73e-3)" "unprognostic (1.35e-2)" "unprognostic (2.22e-3)" "unprognostic (2.76e-2)" "unprognostic (7.19e-2)" "unprognostic (3.39e-2)" "unprognostic (1.21e-2)" "unprognostic (2.12e-1)" "unprognostic (8.15e-2)" "unprognostic (1.96e-2)" "unprognostic (1.09e-2)" "unprognostic (8.18e-2)" "unprognostic (5.91e-2)" "unprognostic (5.01e-2)" "unprognostic (1.74e-2)" "unprognostic (6.89e-3)" "unprognostic (3.78e-2)" 0.2 0.0 0.4 0.2 0.8 0.0 12.1 0.2 0.5 0.2 0.2 0.2 0.2 0.0 0.5 7.7 0.2 0.0 0.2 0.6 0.2 0.3 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.8 0.4 0.3 0.2 0.0 0.2 4.7 0.2 0.2 1.8 0.2 0.2 0.2 0.2 0.0 64.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 1.2 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 1.9 0.0 0.2 0.1 0.1 0.1 1.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.5 0.2 0.1 0.0 32.5 0.4 0.4 0.0 0.0 0.3 0.1 0.1 3.5 0.6 0.2 0.0 0.0 11.8 0.0 0.0 0.0 0.2 0.0 0.2 0.7 1.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.2 0.3 0.1 0.4 0.8 0.2 0.5 0.2 0.3 0.2 0.2 0.3 0.2 RP1L1 DCDC4B ENSG00000183638 "RP1 like 1" 8 10606349-10712187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "retina: 34.0" "Cell line enhanced" "Detected in some" "A-431: 1.4;TIME: 1.9;U-2 OS: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024686, HPA024744" Enhanced "HPA024686: AB_2671650, HPA024744: AB_2671668" "unprognostic (3.27e-1)" "unprognostic (9.97e-2)" "unprognostic (1.24e-1)" "unprognostic (6.41e-2)" "unprognostic (2.04e-1)" "unprognostic (1.36e-1)" "unprognostic (2.37e-1)" "unprognostic (1.98e-5)" "unprognostic (3.57e-1)" "unprognostic (5.22e-2)" "unprognostic (2.08e-4)" "unprognostic (8.52e-2)" "unprognostic (5.77e-2)" "unprognostic (6.29e-2)" "unprognostic (1.70e-1)" "unprognostic (2.02e-2)" "unprognostic (2.82e-1)" 0.5 0.5 0.1 0.1 0.1 1.6 0.5 0.1 0.1 0.7 0.1 0.1 0.1 0.0 0.4 0.1 0.6 0.2 0.3 0.4 0.1 0.0 0.3 0.1 0.7 0.1 0.1 0.1 0.2 0.2 0.0 1.7 0.7 0.1 0.2 0.1 34.0 0.5 0.1 0.3 2.0 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.1 0.5 0.0 0.9 0.8 0.7 0.2 0.0 0.1 0.2 0.6 0.8 0.4 0.4 0.0 0.0 0.0 0.1 0.6 0.4 0.0 0.3 0.0 0.0 0.0 1.9 0.0 1.4 0.1 0.3 0.7 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 RPE65 "BCO3, LCA2, rd12, RP20" ENSG00000116745 "RPE65, retinoid isomerohydrolase" Q16518 1 68428822-68449959 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" "Hydrolase, Isomerase" "Disease mutation, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "retina: 268.3" "Cell line enhanced" "Detected in some" "A-431: 6.0;PC-3: 10.4;U-2 OS: 2.5" "Group enriched" "Detected in some" 10 "glioma: 5.8;head and neck cancer: 1.5" "Group enriched" "Detected in many" 5 "hypothalamus: 6.0;midbrain: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (1.59e-1)" "unprognostic (1.88e-1)" "unprognostic (3.15e-1)" "prognostic favourable (9.75e-4)" "unprognostic (4.55e-2)" "unprognostic (5.91e-2)" "unprognostic (6.59e-4)" "unprognostic (2.98e-2)" "unprognostic (1.57e-1)" "unprognostic (8.24e-2)" "unprognostic (3.21e-4)" "unprognostic (2.11e-1)" "unprognostic (2.05e-1)" "unprognostic (3.48e-2)" "unprognostic (8.40e-3)" 0.0 0.0 0.9 0.1 0.7 0.0 1.0 0.1 3.8 0.2 0.1 1.3 1.4 0.4 1.4 0.7 0.8 0.6 0.2 0.0 1.5 6.0 0.0 0.0 0.0 0.1 8.8 0.1 0.1 0.0 0.0 0.0 0.0 1.2 4.2 0.2 268.3 0.2 10.5 0.0 0.0 0.1 0.5 1.4 0.2 0.6 0.2 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.1 0.6 1.5 6.0 8.8 0.1 1.2 0.6 RPL10L ENSG00000165496 "Ribosomal protein L10 like" Q96L21 14 46651010-46651821 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "testis: 45.5" "Cell line enriched" "Detected in single" 45 "U-2 OS: 29.6" "Cancer enriched" "Detected in single" 15 "testis cancer: 6.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA011311 Uncertain Approved "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA011311: AB_1856431" "unprognostic (7.36e-2)" "unprognostic (1.32e-1)" "unprognostic (1.92e-2)" "unprognostic (4.18e-2)" "unprognostic (6.67e-2)" "unprognostic (2.92e-1)" "unprognostic (8.70e-4)" "unprognostic (4.69e-2)" "unprognostic (5.27e-3)" "unprognostic (1.30e-1)" "unprognostic (2.36e-1)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.83e-1)" "unprognostic (4.40e-2)" "unprognostic (1.44e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.3 0.6 0.4 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.4 0.3 0.5 1.0 0.6 0.8 0.2 0.7 0.9 0.9 0.0 0.4 0.2 0.4 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPRD1B "C20orf77, CREPT, dJ1057B20.2, DKFZp434P0735, FLJ44520, K-H, Kub5-Hera, NET60" ENSG00000101413 "Regulation of nuclear pre-mRNA domain containing 1B" Q9NQG5 20 38033546-38127780 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 113.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066290, HPA072645" Approved Supported Nucleoplasm Nucleoplasm "HPA066290: , HPA072645: " "unprognostic (3.14e-2)" "unprognostic (3.30e-1)" "unprognostic (5.38e-2)" "unprognostic (1.18e-3)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (2.68e-2)" "unprognostic (4.84e-2)" "unprognostic (1.03e-1)" "unprognostic (3.20e-2)" "unprognostic (1.14e-1)" "unprognostic (5.25e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "unprognostic (5.77e-2)" "unprognostic (1.36e-2)" "unprognostic (3.47e-1)" 8.8 9.4 7.5 14.5 8.3 20.9 9.6 9.8 10.0 9.0 10.2 12.5 11.4 7.3 12.9 10.7 10.7 11.5 10.4 16.4 7.6 6.5 10.2 113.9 8.9 13.4 7.9 7.6 10.5 16.2 13.7 8.6 9.4 8.3 10.7 8.6 11.0 9.1 15.5 24.3 9.6 10.2 9.6 7.5 10.7 9.1 10.2 7.2 11.4 10.4 8.4 19.3 12.7 9.0 5.5 8.3 7.3 10.7 5.6 8.9 6.3 15.5 7.0 13.4 6.8 8.7 12.1 13.8 11.2 9.0 12.6 11.3 35.9 14.7 13.0 16.4 7.4 18.7 11.9 18.2 15.1 6.1 6.8 21.9 9.2 17.9 10.5 16.6 7.5 9.4 18.1 13.0 15.2 7.9 19.1 10.5 9.5 11.0 24.6 11.9 7.7 14.9 15.8 27.3 13.1 6.8 13.0 14.7 10.1 19.4 29.1 13.6 15.5 15.1 9.1 25.5 15.0 9.5 12.3 13.1 12.3 23.9 15.1 9.7 8.3 0.7 8.3 7.3 7.0 9.4 8.9 5.5 6.8 6.3 8.3 5.1 8.7 7.8 6.7 5.6 10.7 4.4 4.0 6.3 7.5 8.3 9.8 10.0 7.6 6.5 7.9 7.6 8.3 7.2 RPRML MGC43894 ENSG00000179673 "Reprimo like" Q8N4K4 17 46978156-46979248 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 27.0" "Cell line enhanced" "Detected in some" "AF22: 2.6;Daudi: 15.8;HEK 293: 4.9;NTERA-2: 2.5;SCLC-21H: 2.5" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Group enriched" "Detected in many" 13 "amygdala: 44.0;basal ganglia: 29.6;cerebral cortex: 41.6;hippocampal formation: 38.9;olfactory region: 24.9" "Region enhanced" "Detected in many" "basal ganglia: 311.4" HPA062668 Uncertain "HPA062668: " "unprognostic (7.79e-4)" "unprognostic (1.66e-2)" "unprognostic (8.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.31e-1)" "unprognostic (8.93e-4)" "unprognostic (2.78e-2)" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" 0.8 0.6 6.6 0.6 27.0 0.6 0.8 3.6 16.5 0.6 0.8 0.0 0.0 0.8 0.6 2.5 0.6 0.7 0.6 0.6 4.9 1.3 0.7 0.6 0.6 0.6 0.8 10.1 0.6 0.6 0.6 0.1 0.6 0.0 0.8 0.6 0.4 0.7 0.6 3.9 1.0 0.8 0.6 0.0 0.7 1.3 0.7 2.7 0.0 0.6 0.0 0.6 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.5 0.6 0.9 0.3 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 27.0 3.6 11.6 4.9 1.3 0.8 10.1 0.0 2.7 RRAD "RAD, REM3" ENSG00000166592 "RRAD, Ras related glycolysis inhibitor and calcium channel regulator" P55042 16 66921679-66925644 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 246.0" "Group enriched" "Detected in some" 8 "HDLM-2: 60.8;U-87 MG: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041755 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA041755: " "unprognostic (1.40e-2)" "unprognostic (2.78e-2)" "unprognostic (9.77e-2)" "unprognostic (3.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.11e-1)" "unprognostic (3.74e-2)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (2.12e-2)" "unprognostic (1.08e-1)" "unprognostic (2.06e-3)" "unprognostic (3.46e-2)" "unprognostic (3.33e-2)" "unprognostic (2.04e-2)" "unprognostic (4.80e-3)" 7.3 2.1 0.4 2.4 2.7 1.3 5.0 1.2 1.7 4.7 2.0 3.2 1.8 1.2 3.3 8.5 20.4 6.3 4.1 61.2 0.7 0.6 5.6 0.8 6.3 1.3 1.5 0.8 4.7 0.7 1.0 2.0 10.7 4.6 4.2 0.4 3.9 4.3 1.4 246.0 2.2 1.2 5.7 1.7 0.8 1.7 2.3 1.2 0.3 3.9 14.7 4.3 4.5 5.7 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 2.8 0.0 0.0 0.0 0.3 0.1 1.6 0.1 0.2 1.4 0.6 1.9 0.0 1.6 0.1 0.1 0.0 0.1 0.2 60.8 0.1 0.0 0.0 0.7 2.7 0.0 0.2 0.8 0.3 4.9 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.2 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 2.0 0.0 0.1 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 2.7 1.2 1.0 0.7 0.6 1.5 0.8 4.6 1.2 RRH peropsin ENSG00000180245 "Retinal pigment epithelium-derived rhodopsin homolog" O14718 4 109827994-109844604 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "retina: 66.3" "Cell line enhanced" "Detected in some" "hTCEpi: 4.0;U-266/84: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.3" "Lineage enriched" "Detected in single" 7 "T-cells: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.59e-1)" "unprognostic (2.47e-2)" "unprognostic (4.94e-2)" "unprognostic (1.96e-2)" "unprognostic (1.48e-1)" "unprognostic (5.25e-2)" "unprognostic (7.56e-2)" "unprognostic (8.47e-2)" "unprognostic (2.33e-1)" "unprognostic (1.86e-2)" "unprognostic (2.03e-2)" "unprognostic (1.62e-3)" "unprognostic (4.65e-1)" "unprognostic (4.38e-3)" "unprognostic (1.22e-1)" "unprognostic (2.27e-1)" "unprognostic (3.18e-2)" 0.4 1.4 1.3 0.5 1.2 0.3 2.1 3.7 1.8 0.8 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.4 0.4 1.2 1.2 1.9 1.0 0.4 0.5 1.2 0.6 0.6 0.5 0.7 0.5 0.4 0.4 0.9 0.8 66.3 0.5 0.7 0.7 2.3 0.4 0.4 0.8 0.5 0.4 0.7 0.4 0.4 0.9 0.4 0.4 0.4 0.4 0.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.2 0.8 0.7 0.0 0.1 0.0 0.2 0.7 0.1 0.1 0.2 0.3 0.8 0.7 0.3 0.0 2.2 0.1 0.2 1.0 0.9 0.1 0.0 0.3 0.1 1.5 0.0 0.0 4.0 0.0 0.3 0.2 1.0 0.3 0.7 0.1 1.2 1.5 0.5 0.2 1.0 0.2 0.6 2.0 0.2 1.1 0.3 0.0 0.4 0.1 0.8 0.5 0.3 0.0 0.2 0.4 0.1 0.6 4.6 0.0 0.2 0.5 1.1 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.3 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.1 1.3 1.2 3.7 1.4 1.2 1.2 1.2 0.6 0.4 0.4 RRM2 ENSG00000171848 "Ribonucleotide reductase regulatory subunit M2" P31350 2 10120698-10131419 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA replication" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 120.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Lineage enriched" "Detected in many" 6 "T-cells: 10.4" HPA056994 Enhanced Supported Cytosol Cytosol "HPA056994: " "unprognostic (2.10e-2)" "unprognostic (1.62e-1)" "unprognostic (6.40e-3)" "unprognostic (4.42e-3)" "unprognostic (5.70e-2)" "unprognostic (1.69e-1)" "prognostic unfavourable (1.39e-5)" "unprognostic (1.04e-3)" "unprognostic (6.67e-3)" "unprognostic (4.53e-2)" "prognostic unfavourable (1.62e-4)" "unprognostic (5.11e-3)" "prognostic unfavourable (0.00e+0)" "unprognostic (3.05e-2)" "unprognostic (2.24e-1)" "unprognostic (1.38e-1)" "unprognostic (2.09e-2)" 4.7 2.2 0.4 32.6 0.4 29.0 4.2 0.4 0.9 3.5 9.3 0.4 0.4 5.2 2.1 1.7 21.6 0.7 5.0 3.3 0.4 0.5 2.0 3.9 5.7 16.4 0.6 0.1 0.9 2.9 0.0 0.7 5.4 0.3 1.0 10.6 0.1 2.9 0.0 0.5 2.8 11.3 3.2 0.8 19.8 5.4 8.0 0.0 120.9 0.8 22.3 33.1 3.8 5.2 1.4 0.3 0.6 0.2 1.8 10.4 2.6 29.1 17.7 25.0 17.1 2.2 4.1 24.8 47.7 23.6 34.1 37.1 29.5 14.0 26.8 6.6 14.9 14.3 40.5 24.6 41.8 60.0 15.6 51.6 17.0 26.0 0.1 38.2 24.8 1.4 0.5 41.7 3.5 27.5 21.6 79.5 42.4 22.0 42.2 20.5 20.2 20.7 31.8 54.6 18.4 16.7 22.2 24.8 20.4 39.2 27.9 4.8 15.0 6.9 9.6 26.1 38.0 19.5 66.8 51.6 40.5 54.7 18.5 32.4 37.5 0.3 0.1 0.1 3.7 0.0 0.0 1.4 2.6 2.9 0.2 0.4 0.2 1.2 0.6 1.8 0.2 0.3 10.4 2.6 0.4 0.4 0.4 0.9 0.4 0.5 0.6 0.1 0.3 0.0 RS1 "RS, XLRS1" ENSG00000102104 "Retinoschisin 1" O15537 X 18639910-18672109 "Disease related genes, Predicted secreted proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "retina: 54.9" "Cell line enhanced" "Detected in single" "HeLa: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059546 Enhanced "Secreted in other tissues" "HPA059546: " "unprognostic (8.31e-2)" "unprognostic (1.79e-1)" "unprognostic (4.99e-2)" "unprognostic (2.39e-2)" "unprognostic (1.86e-1)" "unprognostic (4.80e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-2)" "unprognostic (1.00e-1)" "unprognostic (1.74e-1)" "unprognostic (4.77e-3)" "unprognostic (4.14e-1)" "unprognostic (7.03e-2)" "unprognostic (1.06e-1)" "unprognostic (3.06e-2)" "unprognostic (5.12e-2)" "unprognostic (2.04e-4)" 0.1 0.0 1.0 0.1 2.3 0.0 0.1 0.6 3.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 1.0 0.4 0.4 0.1 5.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 54.9 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.5 0.1 0.2 0.1 0.1 0.5 0.1 0.5 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.2 0.1 0.1 0.1 0.0 1.0 2.3 0.6 2.4 1.0 0.4 0.1 0.1 0.1 0.1 RSPH6A "RSHL1, RSP4, RSP6, RSPH4B" ENSG00000104941 "Radial spoke head 6 homolog A" Q9H0K4 19 45795710-45815319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 48.1" "Cell line enriched" "Detected in single" 11 "RPMI-8226: 7.8" "Cancer enriched" "Detected in single" 5 "thyroid cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA045382 Enhanced "HPA045382: AB_10959735" "unprognostic (1.99e-1)" "unprognostic (3.23e-1)" "unprognostic (6.55e-2)" "unprognostic (1.57e-1)" "unprognostic (2.72e-3)" "unprognostic (4.16e-4)" "unprognostic (2.33e-1)" "unprognostic (5.89e-2)" "unprognostic (1.72e-2)" "unprognostic (7.84e-5)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (1.05e-1)" "unprognostic (5.99e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 7.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTKN2 "bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1" ENSG00000182010 "Rhotekin 2" Q8IZC4 10 62183035-62268707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lung: 67.6" "Cell line enhanced" "Detected in many" "A-431: 24.9;HaCaT: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 7 "T-reg: 15.4" "Lineage enriched" "Detected in single" 47 "T-cells: 15.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037946, HPA038446" Enhanced Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA037946: AB_10795398, HPA038446: AB_10796218" "unprognostic (2.33e-1)" "unprognostic (2.59e-1)" "unprognostic (2.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.26e-1)" "unprognostic (8.92e-3)" "unprognostic (6.66e-5)" "unprognostic (7.81e-3)" "unprognostic (2.33e-2)" "unprognostic (3.24e-1)" "unprognostic (3.72e-2)" "unprognostic (9.48e-4)" "unprognostic (3.70e-11)" "unprognostic (3.95e-2)" "unprognostic (9.34e-3)" "unprognostic (4.68e-3)" "unprognostic (1.55e-1)" 0.3 0.1 0.7 1.8 0.8 0.5 0.7 0.1 1.6 1.5 1.1 0.0 0.1 0.7 0.6 0.1 7.1 0.2 0.4 0.2 0.5 0.2 0.5 0.2 67.6 2.3 0.2 0.5 0.3 0.2 0.2 0.8 0.7 0.1 0.7 1.2 0.1 1.6 0.1 0.1 0.7 1.1 0.3 0.2 0.8 0.7 5.3 0.1 6.9 0.8 1.3 4.1 0.7 3.0 0.3 0.2 0.3 0.1 0.2 15.4 0.2 24.9 1.4 13.4 6.2 0.0 0.1 3.3 3.6 4.2 4.1 6.5 10.4 5.0 0.0 1.6 1.4 20.0 7.5 0.6 4.3 3.5 5.1 4.1 3.0 4.3 0.0 5.5 3.2 0.2 0.3 5.1 0.5 0.6 0.2 0.2 5.5 3.1 10.8 7.2 5.6 5.1 9.3 14.3 0.0 2.6 10.9 7.3 8.4 2.4 8.4 3.4 7.6 3.1 0.0 1.9 12.2 0.1 9.1 0.1 0.0 9.5 2.4 0.0 2.9 0.1 0.1 0.1 1.3 0.0 0.1 0.1 2.1 0.4 0.0 0.3 0.8 0.3 0.3 0.2 0.1 0.2 15.4 0.2 0.7 0.8 0.1 1.6 0.5 0.2 0.2 0.5 0.1 0.1 RTL9 "KIAA1318, Mar9, Mart9, RGAG1, SIRH10" ENSG00000243978 "Retrotransposon Gag like 9" Q8NET4 X 110358816-110456334 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 38.5" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 5.4;U-2197: 4.2;U-87 MG: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001242 Enhanced "HPA001242: AB_1079804" "unprognostic (6.03e-2)" "unprognostic (5.59e-2)" "unprognostic (6.74e-2)" "unprognostic (1.85e-4)" "unprognostic (8.17e-2)" "unprognostic (3.04e-1)" "unprognostic (9.65e-3)" "unprognostic (1.13e-1)" "unprognostic (2.26e-2)" "unprognostic (1.45e-2)" "unprognostic (8.05e-3)" "unprognostic (1.03e-1)" "unprognostic (7.61e-3)" "unprognostic (6.98e-4)" "unprognostic (2.02e-1)" "unprognostic (3.37e-1)" "unprognostic (1.10e-2)" 0.1 0.2 0.4 0.1 2.0 0.0 0.1 0.7 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.4 0.5 0.1 2.1 0.1 0.4 0.1 0.1 1.1 0.1 1.1 0.1 0.0 0.2 1.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 38.5 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.4 0.3 0.1 1.5 0.8 0.6 1.9 0.2 0.0 0.0 0.8 2.1 0.0 0.4 1.6 0.4 0.3 0.1 0.1 0.0 0.0 1.6 0.0 0.2 0.8 0.1 5.4 0.8 0.0 0.7 0.0 0.5 0.0 0.1 0.0 0.6 2.1 0.0 1.9 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.7 4.2 1.3 0.0 0.1 0.0 3.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 0.7 0.1 0.1 2.1 1.1 0.1 0.1 0.1 RTN1 NSP ENSG00000139970 "Reticulon 1" Q16799 14 59595976-59870966 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 144.6" "Group enriched" "Detected in some" 4 "HEL: 22.7;SCLC-21H: 28.1;SH-SY5Y: 45.0" "Cancer enhanced" "Detected in many" "glioma: 19.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9" "Group enriched" "Detected in many" 15 "dendritic cells: 7.9;monocytes: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002745, HPA040945, HPA044249" Enhanced Supported "Nuclear bodies,Endoplasmic reticulum" 140000 "Endoplasmic reticulum" "Nuclear bodies" "CAB002745: , HPA040945: , HPA044249: " "unprognostic (9.40e-3)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (4.24e-2)" "unprognostic (3.04e-3)" "unprognostic (8.67e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (2.79e-1)" "prognostic favourable (3.69e-4)" "unprognostic (5.79e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.75e-1)" "unprognostic (6.71e-2)" "unprognostic (1.62e-2)" 6.3 8.3 27.4 6.1 46.3 1.6 3.0 98.5 144.6 2.6 2.9 11.0 0.0 2.7 2.1 1.6 2.3 8.6 4.4 1.9 32.3 50.7 2.3 1.9 4.8 2.7 21.3 45.9 1.7 3.6 19.2 10.3 2.7 35.1 5.0 3.0 1.2 2.3 2.6 1.6 2.3 3.4 2.7 12.1 10.6 3.6 2.6 10.5 0.0 2.7 0.0 2.3 2.5 0.9 0.0 7.9 0.4 4.6 0.0 0.0 1.0 0.0 0.0 0.3 0.3 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.8 22.7 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.2 0.1 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 28.1 45.0 5.5 0.0 0.0 0.0 0.0 0.0 3.8 1.1 0.0 2.0 0.0 0.0 0.0 7.5 1.6 0.2 0.0 4.5 0.0 0.0 4.6 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 1.0 27.4 46.3 98.5 94.7 32.3 50.7 21.3 45.9 35.1 10.5 RTP3 "LTM1, TMEM7, Z3CXXC3" ENSG00000163825 "Receptor transporter protein 3" Q9BQQ7 3 46497491-46500949 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 91 "liver: 43.3" "Cell line enriched" "Detected in some" 9 "SiHa: 14.8" "Group enriched" "Detected in some" 17 "liver cancer: 22.9;testis cancer: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA075932 Uncertain Mitochondria Mitochondria "HPA075932: " "unprognostic (2.09e-1)" "unprognostic (1.64e-1)" "prognostic favourable (3.11e-6)" "unprognostic (1.08e-1)" "unprognostic (1.58e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTP5 "C2orf85, CXXC11, FLJ33590, Z3CXXC5" ENSG00000188011 "Receptor transporter protein 5 (putative)" Q14D33 2 241869600-241873823 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "brain: 44.8" "Group enriched" "Detected in some" 29 "MOLT-4: 3.6;SCLC-21H: 7.2" "Cancer enriched" "Detected in single" 10 "glioma: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA050902 Enhanced "HPA050902: " "unprognostic (3.26e-2)" "unprognostic (5.38e-4)" "unprognostic (2.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.01e-1)" "unprognostic (9.40e-4)" "unprognostic (8.68e-3)" "unprognostic (2.04e-1)" "unprognostic (6.34e-4)" "unprognostic (3.30e-1)" "unprognostic (9.01e-3)" "unprognostic (3.91e-1)" "unprognostic (9.08e-8)" "unprognostic (1.81e-1)" "unprognostic (1.77e-1)" "unprognostic (2.68e-2)" "unprognostic (3.72e-2)" 0.8 0.8 27.9 1.1 44.8 1.9 0.7 0.2 13.5 0.7 0.7 2.1 0.0 0.9 0.7 0.7 0.7 0.7 0.8 0.8 32.9 24.9 0.7 0.7 0.8 2.4 3.1 4.8 0.7 0.9 0.7 0.0 0.7 7.3 0.7 0.7 0.0 0.9 0.7 0.7 0.7 0.7 0.7 2.1 1.1 0.8 0.7 1.5 0.0 0.7 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 44.8 0.2 12.7 32.9 24.9 3.1 4.8 7.3 1.5 RUNDC3A "RAP2IP, RPIP8" ENSG00000108309 "RUN domain containing 3A" Q59EK9 17 44308413-44318671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 92.6" "Group enriched" "Detected in some" 6 "SCLC-21H: 34.1;SH-SY5Y: 21.8" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 4 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023548, HPA070733" Enhanced Supported Approved Vesicles Vesicles "HPA023548: AB_1856069, HPA070733: AB_2732162" "unprognostic (3.66e-2)" "unprognostic (3.77e-2)" "unprognostic (3.50e-3)" "unprognostic (1.58e-3)" "unprognostic (3.04e-1)" "unprognostic (2.02e-1)" "unprognostic (3.87e-3)" "unprognostic (2.29e-1)" "unprognostic (4.63e-2)" "unprognostic (3.43e-2)" "unprognostic (1.42e-3)" "unprognostic (1.34e-1)" "unprognostic (8.87e-3)" "unprognostic (1.07e-2)" "unprognostic (5.17e-2)" "unprognostic (9.39e-2)" "unprognostic (1.84e-1)" 1.4 12.9 40.5 1.6 28.5 2.8 1.5 33.0 92.6 1.3 1.8 4.8 0.0 2.2 1.6 1.5 1.5 1.5 1.6 1.8 40.9 20.6 1.7 1.3 1.5 1.4 22.0 23.2 1.7 4.3 2.4 16.1 2.5 15.6 1.5 1.8 1.6 1.4 1.6 1.3 4.1 2.2 1.8 8.0 1.5 3.3 5.2 4.4 0.0 2.4 0.0 1.4 1.5 0.0 0.3 0.1 0.0 0.2 0.1 1.3 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.2 0.2 0.0 0.0 0.5 0.1 0.0 34.1 21.8 0.2 0.0 0.2 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.3 1.3 0.3 0.1 0.1 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 40.5 28.5 33.0 49.2 40.9 20.6 22.0 23.2 15.6 4.4 RUNX1T1 "AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2" ENSG00000079102 "RUNX1 translocation partner 1" Q06455 8 91954967-92103286 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 57.8" "Cell line enhanced" "Detected in many" "Daudi: 12.9;fHDF/TERT166: 11.0;HEL: 23.7;HSkMC: 9.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 4 "cerebellum: 57.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049852, HPA070951" Approved Supported Nucleoplasm Nucleoplasm "HPA049852: , HPA070951: " "unprognostic (2.37e-1)" "unprognostic (1.90e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.62e-1)" "unprognostic (3.37e-4)" "unprognostic (2.29e-4)" "unprognostic (5.56e-3)" "unprognostic (1.24e-2)" "unprognostic (1.62e-2)" "unprognostic (2.11e-2)" "unprognostic (2.37e-1)" "unprognostic (5.70e-4)" "unprognostic (8.98e-3)" "unprognostic (6.78e-2)" "unprognostic (1.51e-1)" "unprognostic (7.80e-3)" 9.6 4.6 7.7 4.5 11.5 0.4 6.9 57.8 13.0 14.0 7.8 1.1 2.0 2.0 11.8 5.9 4.1 7.7 7.8 12.3 5.8 4.0 2.5 1.3 6.0 2.0 3.6 9.6 7.7 1.8 1.7 8.6 8.7 4.2 4.2 4.0 5.3 4.7 4.1 5.5 3.6 3.6 10.3 3.0 2.9 4.2 5.6 3.7 0.0 5.2 3.3 1.8 5.7 5.9 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.3 3.5 5.1 0.0 5.1 7.8 3.4 5.3 0.0 0.0 12.9 0.0 11.0 0.0 2.7 0.3 2.3 0.0 2.1 23.7 0.0 0.0 1.4 0.0 0.0 9.5 0.0 5.7 0.2 7.3 0.1 0.0 0.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 7.7 4.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.6 0.0 2.6 0.0 4.1 0.5 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 7.7 11.5 57.8 13.0 5.8 4.0 3.6 9.6 4.2 3.7 RYR1 "CCO, MHS, MHS1, PPP1R137, RYR" ENSG00000196218 "Ryanodine receptor 1" P21817 19 38433699-38587564 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 231.0" "Cell line enhanced" "Detected in some" "HaCaT: 13.7;RH-30: 11.3;SiHa: 22.3;U-2 OS: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 3.2;myeloid DC: 5.3;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 7 "dendritic cells: 5.3;monocytes: 6.3" "Low region specificity" "Detected in some" HPA056416 Enhanced Approved "Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus, Vesicles" Cytosol "HPA056416: " "unprognostic (2.22e-3)" "unprognostic (1.91e-3)" "unprognostic (9.59e-2)" "unprognostic (5.34e-4)" "unprognostic (2.50e-1)" "unprognostic (6.00e-2)" "unprognostic (2.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (3.20e-3)" "unprognostic (3.52e-1)" "unprognostic (2.35e-1)" "unprognostic (1.07e-5)" "unprognostic (1.13e-2)" "unprognostic (8.10e-2)" "unprognostic (6.62e-3)" "unprognostic (1.34e-1)" 5.3 0.7 3.0 0.6 1.9 0.4 0.6 2.7 1.7 0.6 0.4 2.7 0.0 0.4 0.4 6.7 3.0 0.6 0.5 0.4 1.8 4.0 0.5 0.4 0.7 0.6 1.5 1.3 0.4 0.4 0.3 0.3 0.6 1.9 0.9 0.4 0.4 2.2 0.6 231.0 2.4 0.5 0.4 1.1 0.6 0.5 1.6 1.9 0.0 1.6 55.1 3.2 0.6 0.5 0.7 5.3 0.1 6.3 0.0 0.6 0.6 0.0 5.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.0 0.3 0.3 4.7 0.0 13.7 0.2 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.4 1.3 5.6 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 11.3 1.0 0.6 0.0 0.0 1.1 22.3 0.0 0.0 0.5 4.2 0.0 0.0 9.4 0.2 0.0 0.3 0.9 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.4 3.2 0.5 0.4 0.3 0.6 5.3 0.7 0.0 0.0 0.1 0.0 6.3 0.0 0.6 0.6 3.0 1.9 2.7 1.7 1.8 4.0 1.5 1.3 1.9 1.9 RYR2 "ARVC2, ARVD2, VTSIP" ENSG00000198626 "Ryanodine receptor 2" Q92736 1 237042205-237833988 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 106.6" "Cell line enhanced" "Detected in some" "HDLM-2: 7.7;HEK 293: 10.4;K-562: 3.2;NB-4: 2.7;NTERA-2: 3.9;U-937: 4.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020028 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA020028: AB_1856528" "unprognostic (5.23e-3)" "unprognostic (2.15e-2)" "unprognostic (5.02e-4)" "unprognostic (6.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (1.45e-3)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (0.00e+0)" "unprognostic (2.36e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" 1.1 0.9 6.2 0.9 18.7 0.5 1.1 14.8 10.5 1.3 1.2 0.0 1.2 0.7 1.1 0.7 1.8 1.0 1.8 106.6 5.7 1.1 0.9 0.9 1.4 0.6 1.0 7.3 2.2 4.2 0.5 2.0 1.1 1.6 2.0 0.8 0.2 0.9 1.4 0.9 1.0 1.0 4.6 1.0 1.0 1.2 1.1 3.0 0.0 2.7 0.0 0.6 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.3 0.0 0.3 0.5 0.0 0.0 7.7 10.4 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 2.7 3.9 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 18.7 14.8 10.5 5.7 1.1 1.0 7.3 1.6 3.0 S100A7A "S100A15, S100A7f, S100A7L1" ENSG00000184330 "S100 calcium binding protein A7A" Q86SG5 1 153416524-153423225 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "tongue: 178.1" "Cell line enriched" "Detected in single" 8 "SK-BR-3: 3.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA006997 Supported Uncertain Cytosol Cytosol "HPA006997: AB_1079860" "unprognostic (2.18e-1)" "unprognostic (1.26e-1)" "unprognostic (3.73e-2)" "unprognostic (4.65e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" "unprognostic (1.17e-1)" "unprognostic (4.40e-3)" 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 11.5 0.0 0.0 0.0 0.0 1.9 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 178.1 12.5 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 S100A7L2 s100a7b ENSG00000197364 "S100 calcium binding protein A7 like 2" Q5SY68 1 153437058-153439949 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057828 Uncertain "HPA057828: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 S100B S100beta ENSG00000160307 "S100 calcium binding protein B" P04271 21 46598962-46605208 "Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 342.0" "Group enriched" "Detected in some" 7 "SK-MEL-30: 81.0;WM-115: 159.2" "Group enriched" "Detected in all" 58 "glioma: 463.5;melanoma: 495.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 78.0" "Lineage enriched" "Detected in many" 7 "T-cells: 78.0" "Low region specificity" "Detected in all" "CAB000073, HPA015768, CAB078196" Enhanced Supported Supported Nucleoplasm,Vesicles,Cytosol 120000 "Nucleoplasm, Cytosol" Vesicles "CAB000073: AB_10013383, CAB078196: , HPA015768: AB_1856538" "unprognostic (5.67e-3)" "unprognostic (6.39e-3)" "unprognostic (2.08e-3)" "unprognostic (2.08e-2)" "unprognostic (4.54e-3)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (8.57e-3)" "unprognostic (6.70e-2)" "unprognostic (4.41e-7)" "unprognostic (3.55e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" 67.7 14.0 60.9 5.6 51.0 2.0 13.2 39.4 151.2 5.2 9.1 101.0 3.0 4.7 1.5 7.6 8.6 2.1 8.3 6.6 74.6 65.4 1.5 1.6 2.9 9.8 152.0 36.5 2.4 3.0 1.1 3.1 1.4 90.3 3.0 8.3 7.4 10.1 15.3 1.3 5.7 7.5 4.3 342.0 5.7 4.3 1.5 46.4 0.0 1.3 1.8 10.8 8.2 1.6 0.1 3.4 0.7 1.9 11.0 78.0 10.6 0.1 0.0 17.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 81.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.2 1.0 159.2 0.0 0.1 0.0 78.0 1.8 22.4 0.0 0.2 14.5 3.4 0.1 0.6 33.3 0.7 11.0 1.9 0.8 0.0 10.6 60.9 51.0 39.4 37.6 74.6 65.4 152.0 36.5 90.3 46.4 S100G "CABP1, CABP9K, CALB3" ENSG00000169906 "S100 calcium binding protein G" P29377 X 16650158-16654670 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "intestine: 74.2" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;PC-3: 2.2;RPMI-8226: 6.8;SH-SY5Y: 1.2" "Group enriched" "Detected in some" 5 "breast cancer: 4.7;renal cancer: 0.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 5 "T-cells: 1.5" "Region enriched" "Detected in single" 5 "pons and medulla: 1.2" "Low region specificity" "Detected in all" "CAB017688, HPA055873" Enhanced "CAB017688: AB_1119899, HPA055873: " "unprognostic (2.68e-2)" "unprognostic (2.78e-1)" "unprognostic (9.88e-3)" 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.2 18.0 0.0 0.0 74.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.2 0.0 0.0 6.8 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.4 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAA2 ENSG00000134339 "Serum amyloid A2" P0DJI9 11 18239223-18248643 "Disease related genes, Predicted secreted proteins" "Acute phase" Amyloidosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 752.1" "Cell line enhanced" "Detected in some" "A-431: 15.3;EFO-21: 11.8;HaCaT: 14.4;HBEC3-KT: 31.3;HSkMC: 10.2" "Cancer enriched" "Detected in many" 22 "liver cancer: 150.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Secreted to blood" 11000000000 "unprognostic (1.73e-3)" "unprognostic (4.42e-2)" "unprognostic (2.63e-1)" "unprognostic (5.03e-2)" "unprognostic (1.40e-3)" "unprognostic (7.12e-2)" "unprognostic (7.45e-2)" "unprognostic (2.15e-2)" "unprognostic (1.57e-1)" "unprognostic (2.86e-2)" "unprognostic (2.78e-2)" "unprognostic (6.13e-2)" "prognostic unfavourable (1.30e-8)" "unprognostic (1.53e-1)" "unprognostic (9.72e-2)" "unprognostic (7.62e-3)" "unprognostic (1.28e-1)" 68.6 1.7 0.7 16.3 0.7 0.0 9.8 0.7 0.7 33.1 0.7 0.7 0.7 0.0 0.7 0.7 0.7 0.3 1.2 0.7 0.7 0.0 0.7 752.1 0.8 0.7 0.7 0.7 0.7 0.7 0.0 0.7 0.7 0.7 0.8 0.0 0.7 46.0 0.7 5.2 0.3 0.7 0.7 0.7 0.7 0.2 0.7 0.7 1.1 0.7 0.7 0.7 1.1 0.7 2.0 1.0 3.1 1.2 0.6 0.9 0.4 15.3 0.0 0.1 0.1 0.6 0.0 2.1 0.0 0.5 0.0 0.2 0.0 6.9 0.1 11.8 0.1 14.4 0.0 31.3 0.0 0.6 0.0 0.5 0.2 0.0 4.5 0.4 0.1 10.2 4.3 0.0 5.1 0.1 0.0 0.7 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 7.0 0.7 0.1 0.0 1.1 4.8 0.0 0.2 0.3 0.1 0.1 0.6 0.3 0.6 0.2 0.4 1.0 0.0 0.6 0.2 3.0 1.2 1.0 0.6 0.6 0.9 0.8 0.6 0.4 0.3 2.0 0.4 0.6 3.1 0.6 1.0 1.0 0.9 0.4 0.7 0.7 0.7 0.7 0.7 0.0 0.7 0.7 0.7 0.7 SAA4 "C-SAA, CSAA" ENSG00000148965 "Serum amyloid A4, constitutive" P35542 11 18231349-18236893 "Plasma proteins, Predicted secreted proteins" "Acute phase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 132 "liver: 263.3" "Cell line enriched" "Detected in some" 18 "Hep G2: 22.1" "Cancer enriched" "Detected in many" 141 "liver cancer: 118.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 20 "memory B-cell: 1.9" "Lineage enriched" "Detected in single" 20 "B-cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB026061, HPA060139" Supported "Secreted to blood" 65000000000 72000000000 "CAB026061: , HPA060139: " "unprognostic (4.70e-4)" "unprognostic (1.17e-1)" "unprognostic (1.17e-1)" "unprognostic (4.83e-1)" "unprognostic (4.15e-2)" "unprognostic (6.05e-2)" "unprognostic (3.63e-3)" "unprognostic (5.94e-2)" "unprognostic (2.40e-2)" "unprognostic (1.41e-1)" "unprognostic (7.35e-2)" "unprognostic (2.54e-8)" "unprognostic (2.49e-1)" "unprognostic (6.46e-2)" 0.7 0.0 0.1 0.1 0.1 0.0 0.6 0.1 0.1 1.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 263.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 22.1 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SAG "ARRESTIN, RP47" ENSG00000130561 "S-antigen visual arrestin" P10523 2 233307816-233347055 "Disease related genes, Predicted intracellular proteins" "Congenital stationary night blindness, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "retina: 215.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 39 "basal ganglia: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA004946 Enhanced "HPA004946: " "unprognostic (4.76e-2)" "unprognostic (1.94e-2)" "unprognostic (4.52e-3)" "unprognostic (3.95e-1)" "unprognostic (8.54e-2)" "unprognostic (2.89e-2)" "unprognostic (3.86e-2)" "unprognostic (2.26e-2)" "unprognostic (1.78e-1)" "unprognostic (4.54e-1)" "unprognostic (4.57e-2)" "unprognostic (3.02e-1)" "unprognostic (1.12e-9)" "unprognostic (2.56e-1)" "unprognostic (1.61e-1)" "unprognostic (2.85e-1)" "unprognostic (1.03e-5)" 0.0 0.0 0.2 0.0 8.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 215.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SAGE1 "CT14, SAGE" ENSG00000181433 "Sarcoma antigen 1" Q9NXZ1 X 135889205-135913061 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 10.9" "Cell line enhanced" "Detected in some" "AN3-CA: 14.7;K-562: 10.6;Karpas-707: 18.4;U-2 OS: 5.2;U-266/70: 6.4;U-266/84: 16.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003033, HPA003208" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA003033: AB_1079865, HPA003208: AB_1079863" "unprognostic (1.11e-1)" "unprognostic (5.26e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (2.37e-1)" "unprognostic (7.12e-4)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 6.4 16.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAMD14 FLJ36890 ENSG00000167100 "Sterile alpha motif domain containing 14" Q8IZD0 17 50110040-50129882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 45.8" "Cell line enhanced" "Detected in some" "HDLM-2: 10.6;HEL: 6.7;HMC-1: 22.7;SH-SY5Y: 10.7" "Cancer enhanced" "Detected in some" "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051916 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA051916: " "unprognostic (2.33e-2)" "unprognostic (6.05e-2)" "unprognostic (2.85e-1)" "unprognostic (2.10e-1)" "unprognostic (3.24e-1)" "unprognostic (2.31e-1)" "unprognostic (8.84e-3)" "unprognostic (6.77e-2)" "unprognostic (1.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-2)" "unprognostic (4.00e-2)" "unprognostic (9.01e-2)" "unprognostic (7.48e-4)" 2.8 3.8 18.3 3.9 19.5 2.0 1.0 45.8 18.5 2.4 2.2 3.1 1.1 2.0 3.2 4.3 1.6 1.3 2.2 1.5 15.4 10.3 2.9 1.7 5.4 2.2 7.9 16.1 1.7 1.5 2.9 2.1 3.9 10.9 3.9 1.8 4.3 1.3 4.0 6.1 1.6 2.6 2.8 6.8 3.0 3.2 4.6 6.9 0.0 1.3 0.0 3.2 2.2 0.9 0.0 0.0 2.3 0.0 0.3 0.0 0.4 0.0 0.1 3.9 0.0 1.0 0.2 0.0 2.5 0.9 0.0 0.0 0.5 0.0 0.1 3.6 1.0 0.1 0.2 0.0 0.1 10.6 0.1 6.7 0.2 0.0 0.6 0.0 22.7 0.3 0.0 0.0 0.0 0.6 0.2 0.3 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 3.6 10.7 0.0 0.0 0.0 0.2 0.1 0.1 0.4 1.4 0.2 0.0 0.2 0.0 0.0 1.9 0.0 0.8 2.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 18.3 19.5 45.8 18.5 15.4 10.3 7.9 16.1 10.9 6.9 SAMD7 DKFZp686E1583 ENSG00000187033 "Sterile alpha motif domain containing 7" Q7Z3H4 3 169911572-169939175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "retina: 34.7" "Group enriched" "Detected in some" 7 "Daudi: 2.3;U-698: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.27e-3)" "unprognostic (5.46e-2)" 0.0 0.3 0.1 0.0 0.2 0.6 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 34.7 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.5 0.1 1.2 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.5 0.0 0.8 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 4.1 0.0 0.1 0.0 0.4 0.1 0.4 0.2 0.0 0.2 0.4 0.1 0.2 0.0 0.5 0.2 0.1 0.8 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 SATB1 ENSG00000182568 "SATB homeobox 1" Q01826 3 18345387-18445588 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "lymphoid tissue: 331.6" "Cell line enhanced" "Detected in many" "HDLM-2: 92.0;MOLT-4: 21.5;REH: 25.7;T-47d: 20.6;THP-1: 39.3;U-937: 20.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 37.9" "Group enriched" "Detected in many" 6 "NK-cells: 18.6;T-cells: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051769, CAB056144" Enhanced Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "CAB056144: AB_10584780, HPA051769: " "unprognostic (2.16e-1)" "unprognostic (3.99e-1)" "unprognostic (7.13e-2)" "unprognostic (3.58e-1)" "unprognostic (9.15e-2)" "unprognostic (4.22e-3)" "unprognostic (2.16e-1)" "unprognostic (1.62e-3)" "unprognostic (2.90e-2)" "unprognostic (6.14e-2)" "prognostic favourable (8.97e-4)" "unprognostic (1.66e-1)" "prognostic favourable (1.96e-7)" "unprognostic (1.92e-2)" "unprognostic (2.18e-1)" "unprognostic (2.79e-2)" "unprognostic (1.47e-3)" 6.7 5.3 11.8 11.7 11.0 16.4 5.9 10.1 22.7 5.6 15.1 3.6 16.1 6.8 5.9 11.1 5.3 8.0 7.7 10.9 10.8 8.1 5.4 7.2 7.6 25.9 10.0 15.6 6.2 14.8 22.4 12.9 1.8 6.6 10.1 8.2 5.9 17.9 26.2 35.7 9.2 11.3 12.1 8.1 11.5 10.4 2.9 4.5 331.6 11.3 4.6 11.8 18.7 11.0 4.7 1.2 4.7 0.6 18.6 37.9 7.9 0.4 0.0 2.6 0.0 3.7 3.6 0.3 0.7 2.5 0.6 2.1 0.1 4.7 0.9 0.0 0.8 0.0 9.6 1.1 1.2 92.0 5.8 0.0 0.2 0.0 0.5 5.3 0.8 1.6 0.8 0.0 0.1 0.6 0.1 5.1 0.4 0.0 21.5 6.8 3.9 0.3 25.7 1.3 0.9 1.0 3.2 1.2 7.3 0.0 0.8 0.0 20.6 39.3 0.3 2.7 1.7 1.2 0.7 0.2 0.0 2.0 2.2 20.7 1.2 4.7 0.5 1.3 14.3 0.6 25.8 0.5 9.7 7.4 1.0 4.7 37.9 22.6 1.2 18.6 0.3 1.2 1.7 7.9 11.8 11.0 10.1 22.7 10.8 8.1 10.0 15.6 6.6 4.5 SAXO1 "C9orf138, FAM154A, MGC35182" ENSG00000155875 "Stabilizer of axonemal microtubules 1" Q8IYX7 9 18927658-19049354 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 47.2" "Cell line enhanced" "Detected in some" "HEL: 1.8;T-47d: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA023899 Enhanced "HPA023899: AB_1845813" "unprognostic (4.23e-4)" "unprognostic (1.59e-1)" "unprognostic (3.38e-1)" "unprognostic (3.17e-2)" "unprognostic (5.28e-3)" "unprognostic (8.64e-2)" "unprognostic (3.89e-1)" "unprognostic (2.90e-3)" "unprognostic (1.38e-2)" "unprognostic (4.97e-3)" "unprognostic (1.51e-1)" "unprognostic (3.61e-1)" "unprognostic (1.24e-1)" "unprognostic (8.02e-2)" "unprognostic (2.79e-1)" "unprognostic (4.36e-2)" "unprognostic (5.40e-2)" 0.2 0.2 0.2 0.5 0.5 0.1 0.2 0.2 0.8 0.2 0.2 1.5 0.0 0.2 0.3 3.1 0.2 0.4 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.6 0.2 0.0 0.2 0.3 0.2 1.7 0.1 0.8 0.5 0.1 1.3 0.6 1.0 0.2 0.3 0.2 0.1 0.6 0.2 0.2 47.2 0.3 0.5 0.2 0.0 0.5 0.2 0.2 0.2 0.4 0.1 0.1 0.2 2.1 0.1 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.7 1.8 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.0 0.6 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.1 0.6 0.0 1.1 0.2 0.5 0.8 0.2 0.2 1.1 2.1 0.0 0.2 0.0 0.4 0.3 0.1 0.2 0.5 0.2 0.8 0.3 0.2 0.2 0.0 0.8 0.3 SBK3 SgK110 ENSG00000231274 "SH3 domain binding kinase family member 3" P0C264 19 55540656-55545543 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "heart muscle: 24.2" "Cell line enhanced" "Detected in some" "A549: 9.2;CACO-2: 3.2;CAPAN-2: 5.4;NTERA-2: 2.5;RH-30: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA078322 Approved Mitochondria Mitochondria "HPA078322: " "unprognostic (2.15e-1)" "unprognostic (1.99e-3)" "unprognostic (2.71e-1)" "unprognostic (1.39e-3)" "unprognostic (7.52e-2)" "unprognostic (2.83e-1)" "unprognostic (5.47e-5)" "unprognostic (4.64e-3)" "unprognostic (7.24e-2)" "unprognostic (1.65e-1)" "unprognostic (3.38e-1)" "unprognostic (3.08e-3)" "unprognostic (1.21e-2)" "unprognostic (4.92e-2)" "unprognostic (2.41e-1)" "unprognostic (1.79e-1)" 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.1 24.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.8 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.3 3.2 5.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.0 0.0 0.0 2.5 0.6 0.2 4.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 1.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCG3 "FLJ90833, SgIII" ENSG00000104112 "Secretogranin III" Q8WXD2 15 51681353-51721031 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 118.3" "Group enriched" "Detected in some" 7 "NTERA-2: 20.0;SCLC-21H: 47.9;SH-SY5Y: 22.6" "Group enriched" "Detected in many" 7 "glioma: 41.0;pancreatic cancer: 15.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006880, CAB033274, HPA053715" Enhanced Supported Supported Vesicles "Secreted in brain" 4800000 Vesicles "CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: " "unprognostic (1.38e-2)" "unprognostic (2.42e-1)" "unprognostic (1.40e-1)" "unprognostic (5.24e-5)" "unprognostic (1.59e-2)" "unprognostic (3.63e-2)" "unprognostic (1.74e-1)" "unprognostic (9.93e-2)" "unprognostic (1.40e-1)" "unprognostic (2.46e-1)" "unprognostic (1.71e-2)" "unprognostic (8.17e-2)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (2.78e-1)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" 1.7 12.9 29.6 2.1 25.4 1.7 1.7 33.4 118.3 1.5 2.4 6.5 0.0 2.9 1.5 1.6 1.6 1.6 1.6 1.5 22.6 23.5 1.5 1.5 1.8 1.7 13.6 37.7 1.5 11.5 1.4 23.7 1.5 27.1 1.6 2.8 1.3 1.5 1.4 1.5 1.8 2.6 1.7 13.2 1.5 8.7 2.9 7.3 0.0 2.1 0.0 1.5 1.6 0.1 0.9 1.2 1.9 0.5 0.3 0.8 0.2 0.0 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 20.0 0.0 0.1 0.0 0.1 0.0 0.2 47.9 22.6 0.1 0.1 0.0 0.0 1.4 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.3 0.1 4.3 0.4 0.4 0.6 0.8 0.2 0.5 0.9 0.6 0.4 0.4 0.7 0.5 0.6 1.9 0.3 0.5 1.2 0.2 0.2 29.6 25.4 33.4 40.6 22.6 23.5 13.6 37.7 27.1 7.3 SCGB1A1 "CC10, CC16, CCSP, UGB" ENSG00000149021 "Secretoglobin family 1A member 1" P11684 11 62405103-62423195 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Phospholipase A2 inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "lung: 508.4" "Cell line enriched" "Detected in some" 69 "HaCaT: 207.4" "Cancer enriched" "Detected in many" 8 "lung cancer: 215.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025686, HPA031828" Enhanced "Secreted in other tissues" 17000000 "CAB025686: , HPA031828: " "unprognostic (2.40e-3)" "unprognostic (1.55e-2)" "unprognostic (5.46e-2)" "unprognostic (2.70e-2)" "unprognostic (4.69e-3)" "unprognostic (2.12e-2)" "unprognostic (1.23e-2)" "unprognostic (2.31e-2)" "unprognostic (2.63e-2)" "unprognostic (1.63e-1)" "unprognostic (2.40e-2)" 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 28.7 0.0 0.1 0.0 0.1 0.0 0.0 508.4 0.0 0.1 0.0 9.4 0.2 0.0 7.4 0.0 0.1 7.6 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.3 4.8 0.1 0.1 0.0 0.8 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 207.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 SCGB2A2 "MGB1, MGC71974, UGB2" ENSG00000110484 "Secretoglobin family 2A member 2" Q13296 11 62270155-62273156 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "breast: 300.8" "Cell line enriched" "Detected in single" 118 "SK-BR-3: 19.8" "Cancer enriched" "Detected in many" 23 "breast cancer: 823.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB026270 Enhanced "Secreted in female reproductive system" "CAB026270: AB_912980" "unprognostic (2.38e-1)" "unprognostic (7.28e-2)" "prognostic favourable (9.57e-8)" "unprognostic (4.17e-1)" "unprognostic (3.75e-1)" 2.9 0.0 0.2 0.2 0.2 0.0 300.8 0.2 0.2 34.4 0.2 0.2 0.2 0.0 0.6 0.2 7.2 0.0 0.2 0.5 0.2 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 13.9 0.2 0.2 75.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.4 0.2 0.6 5.9 0.2 0.9 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 SCGB3A2 "LU103, PNSP1, UGRP1" ENSG00000164265 "Secretoglobin family 3A member 2" Q96PL1 5 147870682-147882191 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lung: 248.0" "Cell line enhanced" "Detected in some" "A-431: 22.4;EFO-21: 14.0;NTERA-2: 16.0;PC-3: 79.2" "Cancer enriched" "Detected in some" 10 "lung cancer: 211.2" "Region enriched" "Detected in single" 7 "pons and medulla: 1.0" "Cell type enriched" "Detected in single" 40 "basophil: 30.1" "Lineage enriched" "Detected in single" 40 "granulocytes: 30.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted in other tissues" "unprognostic (3.85e-1)" "unprognostic (1.77e-1)" "unprognostic (2.99e-2)" "unprognostic (3.51e-2)" "unprognostic (1.84e-2)" "unprognostic (3.17e-2)" "unprognostic (1.05e-2)" "unprognostic (1.90e-8)" "unprognostic (9.31e-3)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (9.11e-2)" 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 248.0 0.1 0.1 0.1 0.1 0.3 0.0 0.6 0.1 1.0 0.1 0.0 0.1 1.7 0.4 0.1 0.4 0.1 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.7 0.2 0.2 0.1 0.1 0.2 0.3 30.1 0.5 0.7 0.2 0.0 22.4 0.3 0.3 0.5 0.3 0.1 0.6 0.3 0.0 0.0 0.0 0.1 0.3 0.1 14.0 0.0 0.2 0.6 0.3 0.1 0.0 0.4 0.8 2.4 0.0 0.0 0.1 0.8 0.4 0.2 0.1 0.0 0.0 0.6 0.3 0.0 0.4 0.2 0.2 16.0 79.2 0.0 0.2 0.0 0.3 0.1 1.1 0.3 3.1 0.3 0.0 0.3 0.1 0.4 0.3 9.4 0.4 0.3 0.4 0.3 0.1 0.1 0.3 1.0 30.1 0.5 0.1 0.2 0.3 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.1 0.1 0.7 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.1 SCN1A "FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI" ENSG00000144285 "Sodium voltage-gated channel alpha subunit 1" P35498 2 165984641-166149214 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 33.9" "Group enriched" "Detected in some" 4 "ASC TERT1: 11.3;Hep G2: 6.0" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078664 Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA078664: " "unprognostic (9.25e-2)" "unprognostic (3.97e-2)" "unprognostic (6.88e-2)" "unprognostic (7.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "unprognostic (4.70e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-1)" "unprognostic (9.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.03e-9)" "unprognostic (6.92e-2)" "unprognostic (3.69e-2)" "unprognostic (5.06e-3)" "unprognostic (6.93e-1)" 1.1 1.3 5.2 1.1 13.6 1.0 1.1 10.3 26.6 1.1 1.1 2.3 0.0 1.0 1.1 1.1 1.0 6.8 1.0 1.1 6.9 8.3 1.1 1.1 5.6 1.0 5.7 9.7 1.0 1.0 1.1 2.9 1.2 33.9 1.1 1.1 0.3 1.0 1.0 1.2 1.1 1.1 1.1 3.6 1.1 1.1 1.4 4.2 0.0 1.1 0.0 1.0 1.1 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 11.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.2 13.6 10.3 26.6 6.9 8.3 5.7 9.7 33.9 4.2 SCN2A "HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2" ENSG00000136531 "Sodium voltage-gated channel alpha subunit 2" Q99250 2 165194993-165392310 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 68.0" "Cell line enhanced" "Detected in some" "HSkMC: 3.3;SH-SY5Y: 3.1;U-138 MG: 5.7;U-266/84: 11.8;U-87 MG: 3.5" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022567 Enhanced "CAB022567: " "unprognostic (1.16e-1)" "unprognostic (3.56e-4)" "unprognostic (5.28e-2)" "unprognostic (6.12e-3)" "unprognostic (2.97e-1)" "unprognostic (8.62e-3)" "unprognostic (1.18e-1)" "unprognostic (7.25e-3)" "unprognostic (1.40e-1)" "unprognostic (2.78e-1)" "unprognostic (1.32e-2)" "unprognostic (5.21e-2)" "unprognostic (3.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.05e-1)" "unprognostic (4.88e-2)" "unprognostic (2.14e-1)" 1.3 3.0 19.1 1.3 36.4 1.1 2.2 68.0 50.3 1.5 1.3 1.1 0.0 1.5 1.9 2.6 1.2 1.3 2.3 1.3 30.3 8.2 4.0 1.4 1.5 1.2 3.8 23.5 1.5 1.3 1.1 8.2 1.3 9.9 1.3 1.3 0.0 1.5 1.8 1.1 1.2 1.5 2.0 3.7 1.3 1.5 1.5 4.1 0.0 1.1 0.0 1.2 1.3 0.5 1.4 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.7 0.0 0.0 2.7 0.0 2.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.1 1.0 0.7 0.0 0.4 0.0 0.4 0.0 0.2 3.3 0.1 0.3 0.0 0.0 0.0 0.3 1.5 0.0 0.2 0.0 2.0 0.2 0.0 0.0 0.0 0.1 0.1 2.8 3.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.4 0.3 0.0 0.5 11.8 0.0 3.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 19.1 36.4 68.0 43.7 30.3 8.2 3.8 23.5 9.9 4.1 SCN3B HSA243396 ENSG00000166257 "Sodium voltage-gated channel beta subunit 3" Q9NY72 11 123629187-123655244 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 70.3" "Group enriched" "Detected in some" 4 "CACO-2: 2.9;hTCEpi: 9.4;RH-30: 4.2;SCLC-21H: 9.4;SH-SY5Y: 7.0" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041707 Approved "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "HPA041707: " "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (8.13e-4)" "unprognostic (3.93e-3)" "unprognostic (7.05e-2)" "unprognostic (3.29e-3)" "unprognostic (5.64e-2)" "unprognostic (3.34e-4)" "unprognostic (1.72e-1)" "unprognostic (1.13e-2)" "unprognostic (9.16e-4)" "unprognostic (4.01e-1)" "unprognostic (1.89e-4)" "unprognostic (2.01e-2)" "unprognostic (9.01e-2)" "unprognostic (8.23e-2)" "unprognostic (1.43e-2)" 2.2 8.5 17.7 1.5 23.5 1.3 2.0 2.8 70.3 1.6 1.5 1.2 0.0 1.6 1.5 1.5 1.5 1.8 1.4 1.9 26.2 13.2 1.6 1.0 1.4 1.2 5.2 18.8 1.7 1.9 3.9 12.6 1.1 3.8 1.8 1.6 3.7 1.2 1.4 5.8 1.7 1.5 2.1 1.5 1.3 1.4 2.2 1.2 0.0 3.7 0.0 1.2 1.1 0.4 1.2 1.3 2.7 0.6 1.1 0.8 0.1 0.0 0.2 0.3 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.0 2.9 0.1 0.3 1.4 0.4 0.2 1.0 0.1 0.1 0.1 0.6 0.0 0.5 0.3 0.1 0.0 0.5 0.4 9.4 0.1 0.1 0.3 0.4 0.5 0.0 0.1 0.1 0.2 0.8 0.1 0.2 4.2 0.0 0.0 0.2 9.4 7.0 0.6 0.1 0.0 0.0 0.0 0.2 0.1 0.4 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.6 0.6 0.5 0.6 0.4 0.4 0.7 0.7 0.7 0.3 1.2 0.5 0.8 2.7 1.1 0.5 1.3 0.4 0.1 17.7 23.5 2.8 39.5 26.2 13.2 5.2 18.8 3.8 1.2 SCN4A "HYKPP, HYPP, Nav1.4, SkM1" ENSG00000007314 "Sodium voltage-gated channel alpha subunit 4" P35499 17 63938554-63972918 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 53.7" "Group enriched" "Detected in some" 11 "REH: 9.8;RH-30: 30.9" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.2" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Lineage enhanced" "Detected in single" "B-cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053992 Approved "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA053992: " "unprognostic (2.47e-1)" "unprognostic (1.74e-1)" "unprognostic (1.57e-2)" "unprognostic (1.78e-3)" "unprognostic (2.80e-2)" "unprognostic (1.63e-2)" "unprognostic (3.87e-4)" "unprognostic (3.84e-3)" "unprognostic (1.61e-1)" "unprognostic (1.36e-1)" "unprognostic (1.59e-3)" "unprognostic (3.15e-2)" "unprognostic (2.70e-2)" "unprognostic (4.38e-3)" "unprognostic (3.46e-1)" "unprognostic (4.15e-1)" "unprognostic (6.45e-2)" 5.9 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.5 0.0 53.7 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 9.8 30.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 SCN5A "CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1" ENSG00000183873 "Sodium voltage-gated channel alpha subunit 5" Q14524 3 38548057-38649673 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "heart muscle: 67.3" "Group enriched" "Detected in some" 4 "LHCN-M2: 21.5;RH-30: 17.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0" "Low region specificity" "Detected in many" HPA063346 Supported "Nucleoplasm,Nucleoli,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA063346: " "unprognostic (9.29e-4)" "unprognostic (4.05e-2)" "unprognostic (9.95e-2)" "unprognostic (1.74e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (8.48e-2)" "unprognostic (7.12e-3)" "unprognostic (5.28e-2)" "unprognostic (1.16e-4)" "unprognostic (4.85e-3)" "unprognostic (1.09e-1)" "unprognostic (5.35e-2)" "unprognostic (4.95e-3)" 0.3 0.2 1.3 0.2 0.3 0.4 0.6 0.1 2.3 2.0 0.4 0.0 0.4 0.3 0.9 0.8 0.2 0.4 0.3 67.3 0.5 0.7 0.1 0.1 0.2 0.1 0.1 0.3 0.6 0.2 0.1 0.8 0.3 0.0 1.3 0.2 1.2 0.3 1.6 5.5 0.2 0.3 0.4 0.1 0.2 0.2 0.5 0.0 0.0 0.3 0.1 0.1 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.8 0.3 0.0 0.1 0.3 2.7 0.0 0.0 0.0 0.8 2.7 0.0 0.3 0.0 1.1 0.7 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.5 0.0 3.5 0.0 0.0 21.5 1.0 0.0 0.0 2.0 0.0 0.0 17.9 0.0 0.0 2.4 0.3 2.3 0.0 0.0 0.0 0.0 0.0 4.3 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.1 2.3 0.5 0.7 0.1 0.3 0.0 0.0 SCP2D1 "C20orf79, dJ1068E13.2, HSD22" ENSG00000132631 "SCP2 sterol binding domain containing 1" Q9UJQ7 20 18813726-18814392 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 82 "testis: 30.5" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCRT1 "DKFZp547F072, ZNF898" ENSG00000261678 "Scratch family transcriptional repressor 1" Q9BWW7 8 144330565-144336281 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 20.3" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 10.3" "Cancer enhanced" "Detected in single" "glioma: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045265 Uncertain Supported "Nuclear bodies" "Nuclear bodies" "HPA045265: AB_10959521" "unprognostic (7.70e-2)" "unprognostic (7.97e-2)" "unprognostic (6.96e-3)" "unprognostic (6.88e-4)" "unprognostic (2.43e-2)" "unprognostic (1.52e-1)" "unprognostic (4.05e-2)" "unprognostic (1.97e-1)" "unprognostic (8.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.83e-4)" "unprognostic (5.02e-2)" "unprognostic (7.05e-2)" "unprognostic (2.78e-1)" "unprognostic (2.35e-1)" "unprognostic (2.66e-3)" "unprognostic (1.04e-1)" 0.3 2.3 2.1 0.3 6.6 0.3 0.3 5.7 20.3 0.3 0.3 0.0 0.0 0.4 0.3 0.3 0.3 0.3 0.3 0.3 2.2 0.3 0.3 0.3 0.3 0.0 3.8 0.4 0.7 0.3 0.0 0.3 4.2 0.3 0.3 0.0 0.3 0.3 0.5 0.3 0.3 0.3 0.4 0.3 0.3 1.2 2.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SDS SDH ENSG00000135094 "Serine dehydratase" P20132 12 113392445-113426301 "Enzymes, Plasma proteins, Predicted intracellular proteins" Gluconeogenesis Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 276.9" "Cell line enhanced" "Detected in some" "HMC-1: 5.4;SK-BR-3: 3.3" "Cancer enriched" "Detected in all" 31 "liver cancer: 165.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "myeloid DC: 12.8" "Lineage enriched" "Detected in single" 15 "dendritic cells: 12.8" "Low region specificity" "Detected in single" HPA039230 Uncertain Approved Mitochondria,Cytosol Cytosol Mitochondria "HPA039230: AB_10674281" "unprognostic (1.31e-1)" "prognostic favourable (5.24e-4)" "unprognostic (6.37e-3)" "unprognostic (6.94e-2)" "unprognostic (9.19e-3)" "unprognostic (2.65e-2)" "unprognostic (2.35e-2)" "unprognostic (8.85e-2)" "unprognostic (1.79e-1)" "unprognostic (2.55e-1)" "unprognostic (4.89e-2)" "unprognostic (3.20e-1)" "unprognostic (4.08e-3)" "unprognostic (2.12e-1)" "unprognostic (2.07e-2)" "unprognostic (4.35e-1)" "unprognostic (2.99e-2)" 0.9 0.9 2.2 1.4 5.9 0.5 0.4 0.6 2.1 0.5 0.9 0.8 0.0 0.7 0.4 0.2 0.2 0.2 1.4 0.2 1.7 2.5 0.2 276.9 0.6 0.6 4.2 0.7 0.3 0.4 0.1 0.0 1.0 2.8 0.3 0.8 1.3 0.3 0.2 0.2 0.2 0.7 0.3 1.3 0.5 0.9 0.3 0.8 0.1 0.3 0.0 0.3 0.8 0.0 0.0 12.8 0.6 0.8 0.2 0.0 0.3 0.0 0.4 0.2 1.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.2 0.4 2.3 0.0 0.4 0.0 0.0 0.0 0.5 0.5 1.3 0.6 0.6 0.1 0.8 5.4 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 1.4 0.1 0.4 0.8 0.9 0.0 0.8 0.1 0.2 0.5 0.1 0.1 1.6 3.3 0.7 1.2 1.7 0.6 0.0 0.9 1.1 0.3 0.7 0.4 0.2 1.1 0.8 0.3 0.1 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.6 0.2 0.1 1.3 0.0 0.3 2.2 5.9 0.6 1.6 1.7 2.5 4.2 0.7 2.8 0.8 SEL1L2 "C20orf50, DKFZp434C1826" ENSG00000101251 "SEL1L2 ERAD E3 ligase adaptor subunit" Q5TEA6 20 13849247-13996443 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA059121 Approved "HPA059121: " "unprognostic (6.70e-2)" "unprognostic (1.64e-2)" "unprognostic (2.72e-3)" "unprognostic (2.19e-1)" "unprognostic (8.51e-2)" "unprognostic (5.33e-2)" "unprognostic (2.13e-2)" "unprognostic (2.54e-1)" "unprognostic (1.36e-1)" "unprognostic (2.77e-2)" "unprognostic (2.43e-2)" "unprognostic (3.62e-2)" "unprognostic (3.12e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SELENOV SELV ENSG00000186838 "Selenoprotein V" P59797 19 39515113-39520686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 21.7" "Cell line enhanced" "Detected in some" "HEK 293: 1.1;NTERA-2: 1.6;REH: 2.3;SCLC-21H: 1.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059274 Uncertain "HPA059274: " "unprognostic (1.38e-3)" "unprognostic (2.70e-2)" "unprognostic (2.01e-1)" "unprognostic (1.54e-1)" "unprognostic (8.31e-2)" "unprognostic (1.16e-1)" "unprognostic (1.58e-1)" "prognostic unfavourable (7.43e-4)" 0.0 0.0 0.2 0.0 0.8 0.3 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 3.2 0.2 0.0 0.8 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 21.7 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.2 0.0 0.1 0.0 0.3 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.1 1.1 0.2 0.9 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.4 1.6 0.0 2.3 0.0 0.1 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.8 0.0 0.5 0.1 0.2 0.4 0.0 0.5 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.8 0.0 0.7 0.3 0.1 0.1 0.0 0.8 0.0 SEMA3B "LUCA-1, SemA, sema5, SEMAA, semaV" ENSG00000012171 "Semaphorin 3B" Q13214 3 50267558-50277546 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 147.6" "Cell line enhanced" "Detected in many" "HeLa: 22.5;Hep G2: 34.0;SK-BR-3: 17.7;WM-115: 55.3" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "eosinophil: 3.3" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030651 Approved "Secreted in other tissues" 29000 "HPA030651: AB_10602224" "prognostic favourable (1.27e-4)" "unprognostic (6.48e-2)" "unprognostic (5.40e-2)" "unprognostic (1.07e-1)" "unprognostic (1.68e-1)" "unprognostic (4.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.83e-2)" "unprognostic (2.21e-2)" "unprognostic (2.28e-1)" "unprognostic (1.85e-2)" "unprognostic (4.27e-1)" "unprognostic (7.99e-2)" "unprognostic (7.78e-2)" "unprognostic (3.89e-1)" "unprognostic (8.87e-3)" "unprognostic (1.69e-2)" 3.3 18.8 2.5 2.0 7.4 0.0 1.0 0.3 9.2 9.2 6.0 18.6 2.3 13.3 4.4 3.5 2.5 3.4 5.6 3.4 3.6 7.7 0.0 8.1 0.0 12.9 4.9 2.6 5.6 3.5 0.0 147.6 8.2 2.8 2.8 8.5 1.2 6.8 1.5 0.5 19.7 3.9 5.9 0.3 11.9 0.5 9.5 0.0 1.6 0.6 0.0 1.9 0.6 0.0 0.4 3.3 0.0 0.0 0.0 0.0 3.9 2.6 0.2 2.5 0.2 0.3 0.6 5.2 7.1 1.5 2.5 1.9 9.9 0.0 4.8 5.0 0.6 0.1 8.3 0.6 0.0 0.2 0.0 22.5 34.0 5.6 0.0 0.2 1.7 0.1 1.7 1.3 0.0 0.0 0.6 0.2 7.0 0.0 0.2 0.3 1.4 0.1 0.4 0.1 2.4 0.4 0.3 1.2 1.3 17.7 2.6 1.2 0.0 0.1 0.4 5.2 1.4 1.6 1.4 0.0 0.0 2.6 0.0 55.3 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SEPT12 FLJ25410 ENSG00000140623 "Septin 12" Q8IYM1 16 4777669-4788521 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Spermatogenesis" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 69 "testis: 99.8" "Group enriched" "Detected in some" 8 "BEWO: 2.5;SCLC-21H: 1.3;SK-BR-3: 2.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Region enriched" "Detected in single" 8 "cerebellum: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041128 Uncertain Microtubules Microtubules "HPA041128: AB_10796568" "unprognostic (2.11e-2)" "unprognostic (1.11e-1)" "unprognostic (1.56e-2)" "unprognostic (2.29e-2)" "unprognostic (2.71e-1)" "unprognostic (5.45e-2)" "unprognostic (7.40e-2)" "unprognostic (1.39e-1)" "unprognostic (3.80e-2)" "unprognostic (1.61e-1)" "unprognostic (1.49e-8)" "unprognostic (7.41e-2)" "unprognostic (9.87e-2)" "unprognostic (8.36e-3)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 99.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 SEPT3 SEP3 ENSG00000100167 "Septin 3" Q9UH03 22 41969475-41998221 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 101.6" "Cell line enhanced" "Detected in many" "AF22: 13.5;SCLC-21H: 36.5" "Cancer enhanced" "Detected in many" "glioma: 24.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 1.2;granulocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003548, CAB017633" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Actin filaments" "Nucleoplasm, Plasma membrane" "Actin filaments" "CAB017633: AB_2301476, HPA003548: AB_1079908" "unprognostic (2.10e-1)" "unprognostic (4.67e-2)" "unprognostic (1.16e-2)" "prognostic unfavourable (1.78e-4)" "unprognostic (4.56e-2)" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (2.37e-1)" "unprognostic (2.67e-3)" "unprognostic (3.09e-2)" "unprognostic (1.30e-2)" "unprognostic (6.30e-2)" "unprognostic (2.51e-2)" "unprognostic (9.15e-2)" "unprognostic (6.68e-2)" "unprognostic (5.50e-2)" "unprognostic (1.04e-1)" 1.3 4.4 31.3 1.4 26.9 1.3 2.0 35.9 101.6 1.4 1.5 5.6 0.0 1.4 1.4 2.2 1.3 1.2 1.5 1.2 28.9 17.2 1.4 1.2 1.7 1.5 13.2 24.3 1.2 2.0 10.7 1.0 4.9 13.4 2.1 1.5 1.0 1.3 1.2 1.2 2.2 1.4 1.4 7.3 1.3 1.5 2.4 5.3 0.0 1.7 0.0 1.5 1.4 0.1 0.3 1.2 2.1 0.0 0.1 0.2 0.0 0.7 0.8 13.5 10.1 0.1 0.0 6.7 0.1 0.1 0.9 0.4 0.2 1.5 10.9 0.4 0.1 0.0 7.0 0.0 0.3 4.5 2.3 0.0 0.2 0.0 0.1 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 1.7 0.0 1.1 1.8 0.1 9.2 0.3 8.7 0.0 0.6 0.0 1.3 36.5 7.6 5.4 0.0 8.9 1.3 3.3 0.0 0.0 4.8 0.4 0.5 7.2 6.2 0.1 0.1 4.4 1.4 2.1 0.0 0.1 0.1 0.0 0.2 0.3 0.2 0.0 1.2 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.2 0.0 31.3 26.9 35.9 42.1 28.9 17.2 13.2 24.3 13.4 5.3 SEPT8 "KIAA0202, SEP2" ENSG00000164402 "Septin 8" Q92599 5 132750817-132807241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "brain: 150.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005665, HPA036534" Approved Approved "Actin filaments,Cytosol" Cytosol "Actin filaments" "HPA005665: AB_1079910, HPA036534: " "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (9.24e-2)" "unprognostic (7.10e-3)" "unprognostic (2.70e-1)" "unprognostic (2.15e-2)" "unprognostic (2.86e-2)" "unprognostic (1.41e-2)" "unprognostic (1.58e-2)" "unprognostic (2.97e-2)" "unprognostic (2.38e-2)" "unprognostic (3.12e-1)" "prognostic unfavourable (6.98e-5)" "unprognostic (2.86e-2)" "unprognostic (4.30e-1)" "unprognostic (8.04e-3)" "unprognostic (2.70e-1)" 9.5 8.4 43.1 7.0 49.4 2.9 7.1 27.8 74.9 9.3 10.2 66.8 5.2 10.7 6.7 8.2 13.4 7.0 10.7 13.1 56.3 37.0 9.2 4.3 8.4 5.6 76.1 29.3 10.9 9.4 15.9 5.0 18.5 45.8 8.1 11.5 7.9 13.6 9.3 4.1 20.4 10.5 9.0 150.3 5.9 11.0 2.9 64.1 1.5 9.5 5.2 7.5 18.3 6.2 0.8 2.4 1.1 2.0 0.3 5.2 1.7 17.1 8.3 12.0 24.4 16.7 16.4 39.4 18.6 17.8 17.7 21.7 14.5 12.4 0.1 16.6 17.9 13.3 22.4 30.4 19.5 21.9 16.1 16.8 10.5 12.5 12.2 5.9 24.5 11.8 9.8 8.1 11.6 24.5 25.7 3.3 9.4 16.3 19.1 5.5 6.3 5.4 17.6 14.0 1.4 10.3 44.2 16.1 10.0 15.7 3.6 10.4 32.1 7.8 25.4 19.7 12.9 4.8 13.2 4.6 4.3 0.6 12.6 8.8 14.8 1.1 2.0 0.0 4.1 1.1 4.2 0.8 3.4 5.2 2.4 0.3 0.9 2.2 0.0 0.3 0.5 0.0 3.6 1.7 43.1 49.4 27.8 44.6 56.3 37.0 76.1 29.3 45.8 64.1 SERHL2 ENSG00000183569 "Serine hydrolase like 2" Q9H4I8 22 42553617-42574382 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "breast: 155.6" "Cell line enriched" "Detected in some" 11 "SK-BR-3: 77.6" "Group enriched" "Detected in all" 5 "breast cancer: 8.0;prostate cancer: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 4.1;naive B-cell: 8.9;plasmacytoid DC: 4.5" "Group enriched" "Detected in many" 11 "B-cells: 8.9;dendritic cells: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.14e-1)" "unprognostic (1.56e-2)" "unprognostic (8.61e-2)" "unprognostic (2.52e-2)" "unprognostic (3.27e-1)" "unprognostic (7.24e-2)" "unprognostic (1.25e-3)" "unprognostic (1.47e-2)" "unprognostic (1.55e-3)" "unprognostic (1.23e-1)" "unprognostic (1.55e-2)" "unprognostic (2.92e-1)" "unprognostic (7.04e-2)" "unprognostic (4.08e-2)" "unprognostic (2.06e-1)" "unprognostic (1.52e-1)" "unprognostic (1.42e-1)" 1.4 1.8 2.4 1.1 11.9 1.3 155.6 1.1 10.9 2.2 1.4 5.0 10.5 0.9 1.8 14.0 1.6 2.5 1.3 2.3 4.5 3.4 1.5 3.1 1.3 1.8 13.9 2.2 9.5 0.9 2.6 0.7 1.0 8.7 7.3 1.2 0.9 3.9 6.1 1.2 10.9 1.4 1.5 4.3 1.3 1.8 1.9 14.1 0.0 1.7 0.6 1.2 2.3 4.4 8.9 4.5 0.5 0.1 0.2 0.4 0.3 0.0 0.0 0.4 0.7 1.0 2.4 0.1 0.5 0.5 0.6 0.7 0.0 0.1 0.3 0.3 1.5 0.3 0.4 0.2 0.3 0.1 0.1 0.2 0.0 0.7 0.5 0.2 0.5 2.5 0.4 0.3 0.0 0.1 2.9 0.0 0.5 1.0 7.1 0.3 0.0 0.0 3.4 0.0 0.1 0.2 0.1 0.1 0.1 0.1 77.6 0.0 0.2 0.4 0.5 0.2 0.0 0.2 0.0 0.2 0.0 3.2 0.3 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.2 4.1 0.1 0.4 0.1 8.9 0.0 0.1 0.0 0.2 0.1 4.5 0.0 0.3 2.4 11.9 1.1 10.9 4.5 3.4 13.9 2.2 8.7 14.1 SERINC4 FLJ40363 ENSG00000184716 "Serine incorporator 4" A6NH21 15 43794162-43800221 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "retina: 24.5" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;RT4: 1.4;SCLC-21H: 3.1;U-138 MG: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.5 0.0 0.6 0.2 0.1 0.6 0.4 0.0 0.4 0.3 0.0 0.7 0.7 0.0 0.2 0.2 0.0 0.1 0.3 0.3 0.4 0.0 0.4 0.2 0.8 0.0 0.3 0.0 0.0 0.1 0.2 1.8 0.3 0.3 24.5 0.1 0.1 0.2 0.0 0.3 0.0 0.8 0.0 0.1 5.8 0.0 0.0 0.2 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.1 0.0 0.0 1.4 3.1 0.0 0.0 0.8 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.6 0.3 0.3 0.3 0.8 0.0 1.8 0.0 SERPINA1 "A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1" ENSG00000197249 "Serpin family A member 1" P01009 14 94376747-94390693 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "liver: 3314.2" "Cell line enriched" "Detected in some" 8 "Hep G2: 318.5" "Cancer enriched" "Detected in all" 10 "liver cancer: 3850.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "classical monocyte: 110.2;intermediate monocyte: 165.9;neutrophil: 139.3;non-classical monocyte: 203.0" "Group enriched" "Detected in many" 5 "granulocytes: 139.3;monocytes: 203.0" "Region enriched" "Detected in many" 6 "cerebellum: 334.2" "HPA000927, HPA001292, CAB013211, CAB016648, CAB073396" Enhanced Enhanced Vesicles "Secreted to blood" 1663100000000 210000000000 Vesicles "CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762" "prognostic favourable (1.61e-5)" "unprognostic (3.37e-1)" "prognostic favourable (5.86e-4)" "unprognostic (1.38e-2)" "unprognostic (1.98e-2)" "unprognostic (5.50e-3)" "unprognostic (3.81e-2)" "unprognostic (6.78e-2)" "unprognostic (2.54e-2)" "unprognostic (7.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.54e-1)" "unprognostic (1.23e-2)" "unprognostic (1.89e-1)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (1.96e-1)" 0.9 0.4 0.7 4.9 1.4 3.0 2.4 0.2 0.7 2.6 7.5 0.5 3.1 6.3 0.8 8.6 0.4 0.7 14.2 1.0 0.4 0.5 74.1 3314.2 13.6 5.3 1.0 0.2 0.6 7.4 0.0 0.4 0.8 0.8 0.6 4.1 0.6 0.9 3.6 0.2 0.3 36.2 1.4 1.3 8.9 7.0 0.8 0.8 0.5 0.8 0.2 0.9 0.5 0.6 0.3 33.5 139.3 203.0 0.2 0.3 100.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 12.6 40.1 0.1 1.1 0.0 0.1 0.0 0.8 0.0 4.9 0.0 0.2 0.1 318.5 0.0 1.1 0.1 0.2 0.4 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.1 0.5 0.1 1.1 0.1 21.5 0.2 0.0 0.0 0.4 0.1 0.1 18.9 0.1 0.1 0.1 5.0 0.1 0.6 0.2 0.1 0.4 0.3 2.8 0.0 0.4 110.2 29.1 0.2 165.9 0.3 0.3 0.1 0.2 33.5 0.1 0.2 0.1 139.3 0.2 203.0 0.7 0.2 100.0 0.7 1.4 0.2 0.7 0.4 0.5 1.0 0.2 0.8 0.8 SERPINA10 "PZI, ZPI" ENSG00000140093 "Serpin family A member 10" Q9UK55 14 94280455-94293271 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 223 "liver: 169.5" "Cell line enriched" "Detected in many" 8 "Hep G2: 20.7" "Cancer enriched" "Detected in some" 51 "liver cancer: 40.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048739 Approved Nucleoplasm,Cytosol "Secreted to blood" 3955000000 5900000000 Nucleoplasm Cytosol "HPA048739: " "unprognostic (7.14e-2)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.45e-1)" "prognostic favourable (9.00e-4)" "unprognostic (6.11e-2)" "unprognostic (2.81e-4)" "unprognostic (2.31e-4)" "unprognostic (2.77e-2)" "unprognostic (2.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.11e-1)" "unprognostic (7.93e-3)" 0.1 0.0 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 169.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.7 0.1 0.1 0.2 0.0 0.6 0.3 2.0 0.7 0.8 0.7 0.5 0.5 0.6 0.9 0.9 2.5 0.6 2.2 0.3 0.4 0.3 2.4 0.5 1.4 0.9 1.4 2.1 0.7 20.7 0.5 1.7 1.2 0.7 0.5 0.3 0.8 1.1 0.5 1.4 1.1 0.3 1.4 1.1 0.9 0.6 0.9 1.1 0.9 0.5 0.7 1.0 0.9 0.5 0.5 0.2 1.5 0.9 0.5 0.8 0.4 0.7 0.6 1.2 0.5 1.0 1.0 1.9 0.5 0.7 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SERPINA11 ENSG00000186910 "Serpin family A member 11" Q86U17 14 94442464-94452790 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 140 "liver: 189.6" "Cell line enriched" "Detected in some" 8 "Hep G2: 19.1" "Cancer enriched" "Detected in some" 9 "liver cancer: 94.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" 460000000 "unprognostic (2.50e-2)" "unprognostic (3.26e-1)" "unprognostic (9.00e-2)" "prognostic favourable (6.30e-4)" "unprognostic (7.44e-2)" "unprognostic (2.02e-2)" "unprognostic (1.70e-1)" "unprognostic (3.44e-1)" "unprognostic (5.14e-2)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 189.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERPINA12 "OL-64, Vaspin" ENSG00000165953 "Serpin family A member 12" Q8IW75 14 94487274-94517844 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skin 1: 81.9" "Cell line enriched" "Detected in some" 6 "Hep G2: 6.9" "Cancer enhanced" "Detected in some" "liver cancer: 1.8;melanoma: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "cerebellum: 0.2" "Secreted in other tissues" 570000 "unprognostic (1.82e-3)" "unprognostic (6.44e-2)" "unprognostic (3.25e-1)" "unprognostic (1.00e-2)" "unprognostic (5.98e-2)" "unprognostic (2.97e-2)" "unprognostic (7.64e-3)" "unprognostic (6.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 81.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERPINA3 "AACT, ACT" ENSG00000196136 "Serpin family A member 3" P01011 14 94612377-94624055 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 1244.8" "Cell line enriched" "Detected in some" 7 "Hep G2: 96.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000893, HPA002560, CAB016647" Enhanced "Secreted to blood" 95000000000 "CAB016647: AB_1611882, HPA000893: AB_10794315, HPA002560: AB_1856717" "prognostic favourable (8.92e-4)" "unprognostic (3.33e-3)" "unprognostic (9.21e-2)" "unprognostic (1.53e-2)" "unprognostic (1.05e-1)" "unprognostic (1.72e-1)" "unprognostic (2.00e-2)" "unprognostic (1.00e-2)" "unprognostic (2.23e-1)" "unprognostic (9.60e-2)" "unprognostic (1.20e-2)" "unprognostic (9.92e-2)" "unprognostic (3.74e-12)" "unprognostic (6.47e-2)" "unprognostic (1.33e-2)" "unprognostic (2.02e-2)" 11.1 2.1 5.4 5.7 17.6 1.2 26.0 1.9 16.1 43.8 2.3 10.0 1.4 2.3 2.2 2.4 3.3 4.3 18.1 10.7 13.4 6.5 61.9 1244.8 4.9 53.0 16.3 0.8 8.3 182.4 1.0 14.0 2.7 34.2 18.3 2.6 10.2 62.1 7.9 6.8 1.5 2.3 10.2 47.2 8.2 9.7 9.5 7.4 0.0 3.5 0.5 1.7 7.6 11.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.1 1.0 0.0 0.2 0.0 0.9 0.0 0.5 0.0 0.2 0.0 96.2 13.1 0.4 0.1 11.9 14.3 0.0 0.5 0.0 0.0 0.0 0.0 3.6 0.1 0.1 0.1 0.0 0.1 0.5 0.0 0.8 0.0 0.0 0.0 0.4 0.5 14.0 0.5 0.0 0.1 0.0 1.8 0.0 4.1 0.2 0.3 0.4 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 5.4 17.6 1.9 9.6 13.4 6.5 16.3 0.8 34.2 7.4 SERPINA6 CBG ENSG00000170099 "Serpin family A member 6" P08185 14 94304248-94323394 "Disease related genes, Plasma proteins, Predicted secreted proteins" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "liver: 223.9" "Cell line enriched" "Detected in some" 11 "T-47d: 116.8" "Cancer enriched" "Detected in many" 9 "liver cancer: 244.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA017864 Approved "Secreted to blood" 60800000000 59000000000 "HPA017864: AB_1856721" "unprognostic (2.82e-2)" "unprognostic (1.67e-1)" "unprognostic (1.02e-3)" "prognostic favourable (6.96e-5)" "unprognostic (2.93e-3)" "unprognostic (9.98e-3)" "unprognostic (4.43e-2)" "unprognostic (3.11e-1)" "unprognostic (4.80e-3)" "unprognostic (2.94e-1)" "unprognostic (2.47e-2)" "unprognostic (4.54e-2)" "unprognostic (1.43e-1)" "unprognostic (2.14e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.1 1.0 0.0 2.3 10.3 0.1 0.0 0.0 5.2 223.9 0.1 0.0 0.0 0.0 0.8 9.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 116.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERPINA7 TBG ENSG00000123561 "Serpin family A member 7" P05543 X 106032442-106038738 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 414 "liver: 101.8" "Cell line enriched" "Detected in single" 474 "Hep G2: 47.3" "Cancer enriched" "Detected in single" 203 "liver cancer: 82.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA002803 Approved "Secreted to blood" 19450000000 49000000000 "HPA002803: AB_1079915" "unprognostic (6.22e-2)" "unprognostic (1.63e-3)" "unprognostic (3.34e-1)" "unprognostic (2.62e-1)" "unprognostic (2.15e-3)" "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 101.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERPINA9 "CENTERIN, GCET1, SERPINA11b" ENSG00000170054 "Serpin family A member 9" Q86WD7 14 94462717-94479689 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 37.6" "Cell line enriched" "Detected in single" 64 "Daudi: 38.8" "Cancer enhanced" "Detected in single" "stomach cancer: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.2" "Lineage enhanced" "Detected in single" "monocytes: 1.2" "Region enriched" "Detected in single" 18 "basal ganglia: 64.3" "Secreted to blood" "unprognostic (1.32e-2)" "unprognostic (1.05e-1)" "unprognostic (1.94e-2)" "unprognostic (3.89e-3)" "unprognostic (6.10e-2)" "unprognostic (6.67e-2)" "unprognostic (1.38e-2)" "unprognostic (1.16e-1)" 0.1 0.1 0.1 37.6 0.1 0.0 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.1 1.8 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.6 0.2 20.3 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.1 6.0 2.7 0.0 0.1 0.6 0.1 0.1 0.0 0.4 0.3 0.3 36.0 0.1 0.2 0.0 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 SERPINC1 "AT3, ATIII, MGC22579" ENSG00000117601 "Serpin family C member 1" P01008 1 173903804-173917378 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 203 "liver: 450.5" "Cell line enriched" "Detected in some" 35 "Hep G2: 41.6" "Cancer enriched" "Detected in some" 871 "liver cancer: 1504.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001816, CAB016790, HPA024007" Supported "Secreted to blood" 210000000000 "CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732" "unprognostic (1.28e-2)" "unprognostic (2.22e-1)" "unprognostic (3.83e-2)" "unprognostic (5.98e-2)" "unprognostic (6.91e-2)" "unprognostic (1.93e-2)" "prognostic favourable (3.40e-5)" "unprognostic (1.75e-2)" "unprognostic (8.67e-2)" "unprognostic (3.48e-2)" "unprognostic (4.74e-2)" "unprognostic (1.91e-1)" "unprognostic (2.36e-2)" "unprognostic (5.28e-3)" "unprognostic (5.80e-2)" "unprognostic (6.35e-2)" "unprognostic (8.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 450.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 41.6 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.5 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SERPIND1 "D22S673, HC-II, HC2, HCF2, HLS2" ENSG00000099937 "Serpin family D member 1" P05546 22 20773879-20787720 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Chemotaxis, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "liver: 170.8" "Cell line enriched" "Detected in some" 10 "Hep G2: 62.7" "Cancer enriched" "Detected in many" 80 "liver cancer: 334.4" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008639, HPA055767" Supported Approved Vesicles "Secreted to blood" 94000000000 Vesicles "CAB008639: AB_1618010, HPA055767: " "unprognostic (1.68e-1)" "unprognostic (8.27e-2)" "unprognostic (4.40e-2)" "prognostic favourable (4.09e-4)" "unprognostic (5.42e-2)" "unprognostic (1.23e-1)" "unprognostic (1.12e-3)" "unprognostic (1.56e-1)" "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-2)" "unprognostic (2.88e-1)" "unprognostic (3.94e-9)" "unprognostic (2.01e-1)" "unprognostic (4.66e-2)" "unprognostic (8.36e-3)" "unprognostic (1.46e-1)" 0.0 0.0 0.0 0.0 2.3 0.0 0.2 0.6 0.9 0.3 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 170.8 0.3 0.0 0.0 0.7 0.3 0.0 3.6 0.1 0.2 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.1 1.9 2.7 0.7 0.4 1.3 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 62.7 0.0 0.2 0.1 0.0 0.0 0.5 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 4.3 0.0 0.4 0.0 1.0 0.2 1.7 0.4 0.5 0.6 0.1 1.9 0.9 0.7 0.7 1.3 0.2 2.7 0.7 0.1 0.0 2.3 0.6 0.9 0.0 0.0 0.0 0.7 2.6 0.5 SERPINE2 "GDN, nexin, PI7, PN1, PNI" ENSG00000135919 "Serpin family E member 2" P07093 2 223975112-224039319 "Plasma proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein, Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 257.0" "Cell line enhanced" "Detected in many" "BJ: 82.0;fHDF/TERT166: 350.3;SK-MEL-30: 156.2;WM-115: 120.4" "Cancer enriched" "Detected in all" 9 "melanoma: 271.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "naive CD4 T-cell: 10.5;naive CD8 T-cell: 5.3;NK-cell: 16.5" "Group enriched" "Detected in many" 13 "NK-cells: 16.5;T-cells: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in female reproductive system" 490000 "unprognostic (1.73e-1)" "unprognostic (7.08e-3)" "unprognostic (8.49e-2)" "unprognostic (7.78e-3)" "unprognostic (2.57e-3)" "unprognostic (5.57e-2)" "unprognostic (1.49e-2)" "unprognostic (7.43e-3)" "unprognostic (4.41e-1)" "unprognostic (7.12e-2)" "unprognostic (7.56e-3)" "unprognostic (2.40e-1)" "unprognostic (1.97e-3)" "unprognostic (1.23e-2)" "unprognostic (1.31e-1)" "unprognostic (6.18e-2)" "prognostic unfavourable (6.48e-5)" 8.0 5.8 34.7 18.0 30.6 2.2 4.8 14.9 35.2 8.6 6.1 13.0 0.1 7.4 5.1 4.4 9.7 6.0 11.9 24.5 21.9 25.3 10.6 3.3 3.2 7.7 33.0 14.4 38.4 2.9 1.3 2.0 257.0 25.2 6.6 6.2 4.9 3.1 2.8 3.2 3.5 6.0 28.1 23.0 7.8 2.7 14.2 11.9 1.6 6.2 3.2 10.8 18.3 6.9 1.0 0.1 0.3 0.0 16.5 10.5 2.2 0.1 4.4 1.6 1.7 67.4 25.4 0.2 82.0 47.0 6.6 6.4 0.2 0.3 0.0 1.8 350.3 0.2 0.1 5.6 5.7 0.0 1.4 0.8 2.9 1.2 3.3 0.6 0.0 7.3 3.8 19.0 28.6 0.5 0.0 0.0 22.8 0.2 0.1 0.2 3.1 4.9 0.5 1.4 3.3 61.5 5.1 2.3 0.4 15.6 0.0 156.2 0.0 0.3 57.8 39.3 5.4 11.9 3.8 0.3 0.6 0.0 25.1 0.6 120.4 0.0 0.0 0.0 0.6 0.0 0.3 0.7 0.4 0.5 0.0 1.0 10.5 5.3 0.3 16.5 0.0 0.1 0.5 2.2 34.7 30.6 14.9 29.8 21.9 25.3 33.0 14.4 25.2 11.9 SERPINE3 ENSG00000253309 "Serpin family E member 3" A8MV23 13 51335773-51364735 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "retina: 49.3" "Cell line enhanced" "Detected in some" "HeLa: 2.7;TIME: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA051904, HPA055804" Uncertain "Secreted in other tissues" "HPA051904: , HPA055804: " "unprognostic (1.60e-1)" "unprognostic (6.17e-2)" "unprognostic (9.66e-2)" "unprognostic (3.89e-2)" "unprognostic (5.52e-2)" "unprognostic (8.54e-3)" "unprognostic (2.67e-3)" "unprognostic (2.73e-1)" "unprognostic (1.87e-2)" "unprognostic (1.99e-3)" "unprognostic (1.70e-2)" "unprognostic (1.07e-1)" "unprognostic (3.94e-6)" "unprognostic (1.29e-2)" "unprognostic (1.12e-2)" "unprognostic (1.24e-1)" "unprognostic (3.31e-2)" 2.6 0.9 0.6 1.2 0.8 0.2 0.6 1.9 1.7 0.6 0.8 0.6 0.6 0.8 1.1 2.0 1.1 0.9 1.4 1.9 0.7 0.5 0.8 1.2 0.6 1.4 0.6 0.6 1.0 5.7 0.1 0.6 0.6 1.2 0.6 0.1 49.3 0.9 0.6 0.6 4.0 3.2 0.6 1.1 0.8 0.8 1.0 0.6 0.6 1.1 0.6 0.6 0.9 0.9 1.6 0.0 0.1 0.9 0.0 0.8 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.2 0.8 0.3 0.0 0.7 0.0 0.0 0.0 0.9 0.1 0.9 2.7 0.2 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.4 0.3 0.8 2.3 0.0 0.3 0.0 0.0 1.3 1.1 0.3 2.1 0.1 0.2 1.0 2.1 2.9 0.7 1.9 0.2 1.3 0.4 0.7 0.2 1.5 0.2 1.4 0.0 0.2 0.0 0.3 0.9 0.0 0.0 0.8 0.1 0.0 1.6 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.9 0.6 0.7 0.5 0.6 0.6 1.2 0.6 SERPINF2 "A2AP, AAP, ALPHA-2-PI, API, PLI" ENSG00000167711 "Serpin family F member 2" P08697 17 1742836-1755268 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Acute phase" "Protease inhibitor, Serine protease inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 21 "liver: 417.7" "Cell line enriched" "Detected in some" 32 "Hep G2: 55.8" "Cancer enriched" "Detected in all" 6 "liver cancer: 450.6" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 19.8" "Lineage enriched" "Detected in single" 27 "dendritic cells: 19.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA001885, CAB024863" Approved "Secreted to blood" 11890 110000000000 "CAB024863: , HPA001885: AB_1079922" "unprognostic (2.17e-3)" "unprognostic (2.56e-3)" "unprognostic (2.48e-1)" "unprognostic (7.57e-3)" "unprognostic (3.69e-2)" "unprognostic (1.45e-2)" "prognostic favourable (2.26e-5)" "unprognostic (1.44e-1)" "unprognostic (2.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.88e-3)" "unprognostic (2.18e-1)" "unprognostic (1.09e-3)" "unprognostic (7.05e-2)" "unprognostic (2.81e-1)" "unprognostic (7.68e-3)" "unprognostic (2.93e-1)" 0.9 0.0 0.2 0.6 0.2 0.0 1.8 0.2 0.2 0.6 0.3 0.2 6.6 0.0 0.7 17.2 0.2 2.1 0.2 0.3 0.2 0.0 10.2 417.7 1.3 3.4 0.2 0.2 0.7 0.8 0.0 0.2 0.2 0.8 2.1 0.0 1.8 0.5 9.0 0.2 0.4 1.0 0.2 0.2 0.6 0.2 1.7 0.2 0.2 0.7 0.2 0.5 0.6 0.4 0.2 19.8 0.5 0.7 0.4 0.0 0.4 0.3 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.3 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.2 55.8 0.4 0.1 0.0 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.2 0.0 0.2 0.0 0.0 4.6 0.1 0.0 0.0 0.0 0.4 0.0 19.8 0.0 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.8 0.2 SERPING1 "C1-INH, C1IN, C1NH, HAE1, HAE2" ENSG00000149131 "Serpin family G member 1" P05155 11 57597387-57614853 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Complement pathway, Fibrinolysis, Hemostasis, Immunity, Innate immunity" "Protease inhibitor, Serine protease inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "liver: 693.2" "Group enriched" "Detected in some" 6 "ASC diff: 144.9;ASC TERT1: 75.1;HSkMC: 124.5" "Cancer enhanced" "Detected in all" "liver cancer: 609.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 8.9;intermediate monocyte: 11.0;neutrophil: 32.1;plasmacytoid DC: 28.5" "Group enriched" "Detected in many" 143 "dendritic cells: 28.5;granulocytes: 32.1;monocytes: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026161, HPA048738" Supported "Secreted to blood" 38000000000 "CAB026161: , HPA048738: " "unprognostic (1.35e-2)" "unprognostic (2.24e-1)" "prognostic unfavourable (9.96e-4)" "unprognostic (4.26e-2)" "unprognostic (4.38e-2)" "unprognostic (2.32e-1)" "unprognostic (4.12e-3)" "unprognostic (2.13e-1)" "unprognostic (8.95e-2)" "prognostic favourable (8.03e-4)" "unprognostic (5.92e-3)" "unprognostic (3.76e-2)" "prognostic unfavourable (1.55e-4)" "unprognostic (2.60e-2)" "unprognostic (4.14e-2)" "unprognostic (2.56e-1)" "unprognostic (1.17e-1)" 88.8 16.3 3.6 18.2 5.4 1.6 75.0 3.8 6.3 62.7 37.8 7.3 16.7 6.2 63.4 58.8 58.3 63.4 61.6 55.5 3.4 3.0 53.4 693.2 73.8 22.4 5.7 4.1 116.4 38.1 8.0 18.4 33.1 14.9 70.3 11.9 82.6 20.7 33.2 36.5 23.1 20.3 38.7 17.3 42.7 30.3 39.2 3.6 1.8 41.5 24.4 16.8 68.7 122.2 0.0 28.5 32.1 11.0 0.1 0.0 2.8 0.0 0.0 5.5 0.0 144.9 75.1 0.9 9.2 6.5 1.9 3.5 0.3 0.0 0.0 11.1 4.7 0.0 0.0 0.6 1.2 0.0 0.0 4.5 0.0 0.2 19.2 0.2 0.9 124.5 1.8 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 5.6 0.0 0.7 0.4 0.0 0.8 0.0 0.0 1.8 0.0 0.0 0.1 0.1 0.4 0.0 0.3 2.9 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 8.9 0.1 0.0 11.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 32.1 0.1 4.4 28.5 0.0 2.8 3.6 5.4 3.8 6.3 3.4 3.0 5.7 4.1 14.9 3.6 SERPINI1 "neuroserpin, PI12" ENSG00000163536 "Serpin family I member 1" Q99574 3 167735243-167825568 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 96.0" "Cell line enhanced" "Detected in many" "Daudi: 15.6;HeLa: 16.2;Karpas-707: 18.1;U-266/84: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001565, HPA056092" Enhanced Approved Cytosol "Secreted in brain" 200000 Cytosol "HPA001565: AB_1079924, HPA056092: " "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (4.09e-3)" "unprognostic (1.35e-1)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "prognostic unfavourable (4.25e-4)" "unprognostic (2.48e-1)" "unprognostic (2.61e-1)" "unprognostic (6.07e-3)" "unprognostic (2.18e-2)" "unprognostic (1.01e-1)" "unprognostic (1.58e-3)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (1.22e-1)" "unprognostic (1.11e-1)" 5.9 8.2 31.9 2.4 27.9 1.3 6.1 3.6 96.0 4.2 2.8 7.1 0.4 1.5 4.3 4.3 3.2 3.9 3.4 6.4 35.9 35.3 14.5 2.5 3.4 2.3 36.9 35.7 4.0 16.3 3.7 10.3 3.5 22.9 5.8 2.5 2.4 9.9 3.6 1.7 2.1 2.5 3.1 51.6 4.1 3.6 7.0 15.9 0.0 5.2 0.3 3.8 3.1 1.6 15.4 4.4 1.0 0.4 6.0 16.0 3.4 0.4 1.9 3.2 0.2 5.9 1.5 0.2 1.1 1.8 0.8 1.3 0.7 3.8 15.6 6.0 0.8 0.8 2.1 2.1 0.8 4.9 4.5 5.3 16.2 6.6 0.4 0.8 0.6 2.2 0.8 0.4 0.7 0.2 9.9 18.1 0.6 1.5 0.4 1.1 2.0 2.4 1.8 0.1 2.0 6.7 0.5 1.3 8.2 2.2 4.3 5.0 6.4 2.4 0.5 3.4 0.3 0.3 5.5 13.7 16.7 11.4 2.9 4.0 1.9 1.0 0.2 0.5 6.2 0.4 4.5 12.7 6.5 6.6 0.3 15.4 4.7 5.7 0.6 6.0 0.3 4.4 16.0 3.4 31.9 27.9 3.6 78.9 35.9 35.3 36.9 35.7 22.9 15.9 SERPINI2 "MEPI, PANCPIN, PI14, TSA2004" ENSG00000114204 "Serpin family I member 2" O75830 3 167441789-167479004 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 73 "pancreas: 184.7" "Cell line enriched" "Detected in some" 6 "THP-1: 13.8" "Cancer enriched" "Detected in some" 6 "pancreatic cancer: 7.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.5" "Lineage enhanced" "Detected in single" "dendritic cells: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to digestive system" "unprognostic (1.88e-2)" "unprognostic (2.23e-3)" "unprognostic (1.14e-1)" "unprognostic (5.27e-2)" "unprognostic (1.17e-2)" "unprognostic (1.29e-2)" "unprognostic (1.11e-2)" "unprognostic (2.04e-1)" "unprognostic (3.13e-1)" "unprognostic (1.76e-5)" "unprognostic (5.35e-2)" "unprognostic (4.16e-2)" 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 184.7 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 2.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 13.8 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 2.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 SEZ6 ENSG00000063015 "Seizure related 6 homolog" Q53EL9 17 28954901-29006440 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.3" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 36.1" "Cancer enriched" "Detected in many" 11 "glioma: 16.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 2.8;neutrophil: 5.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011777 Enhanced "HPA011777: AB_1856758" "unprognostic (3.99e-2)" "unprognostic (1.24e-1)" "unprognostic (5.75e-3)" "unprognostic (5.33e-3)" "unprognostic (1.84e-2)" "unprognostic (1.76e-3)" "unprognostic (2.82e-2)" "unprognostic (2.22e-2)" "unprognostic (3.07e-1)" "unprognostic (4.75e-2)" "unprognostic (1.22e-3)" "unprognostic (3.15e-3)" "unprognostic (3.63e-6)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (1.45e-1)" "unprognostic (3.15e-3)" 1.2 2.0 18.8 1.4 67.3 1.6 1.1 43.5 48.2 1.1 1.6 3.1 0.0 2.4 1.1 1.5 1.2 1.2 1.1 1.2 10.5 10.0 1.2 1.1 1.3 1.2 4.9 9.4 1.1 1.9 1.1 4.9 1.2 9.1 1.3 1.8 3.3 1.2 1.2 1.4 1.4 1.4 1.3 2.7 1.2 1.7 1.6 5.4 0.0 1.2 0.0 1.1 1.3 0.0 0.8 0.9 5.7 0.5 0.5 0.9 0.4 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 36.1 6.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.8 0.5 0.9 0.2 0.5 0.9 0.8 0.4 0.5 0.6 0.5 0.6 0.7 5.7 0.5 0.5 0.9 0.2 0.4 18.8 67.3 43.5 18.8 10.5 10.0 4.9 9.4 9.1 5.4 SEZ6L ENSG00000100095 "Seizure related 6 homolog like" Q9BYH1 22 26169474-26383597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 60.8" "Group enriched" "Detected in some" 7 "SCLC-21H: 30.0;SH-SY5Y: 8.0" "Group enriched" "Detected in some" 6 "glioma: 14.6;pancreatic cancer: 3.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 7.4;myeloid DC: 7.2;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 73 "dendritic cells: 7.2;monocytes: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045135 Approved Vesicles 2400000 Vesicles "HPA045135: " "unprognostic (1.01e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (4.49e-2)" "unprognostic (6.47e-2)" "unprognostic (4.19e-1)" "unprognostic (1.09e-2)" "unprognostic (5.02e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-3)" "unprognostic (7.80e-2)" "unprognostic (2.40e-6)" "unprognostic (4.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.39e-4)" "unprognostic (3.18e-1)" 1.2 12.5 26.4 1.6 11.3 1.3 1.1 20.1 60.8 2.4 1.3 4.3 0.0 1.5 1.1 1.1 1.1 1.1 1.2 2.5 39.1 23.6 1.1 1.1 1.3 1.1 11.2 25.5 1.1 2.7 1.0 3.8 1.1 15.0 1.3 1.4 0.0 1.3 1.2 1.1 1.2 1.6 1.4 5.3 1.3 2.9 1.4 5.4 0.0 1.2 0.0 1.1 1.2 0.2 0.0 7.2 0.0 7.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 30.0 8.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.5 26.4 11.3 20.1 29.3 39.1 23.6 11.2 25.5 15.0 5.4 SFTA2 SFTPG ENSG00000196260 "Surfactant associated 2" Q6UW10 6 30931353-30955636 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lung: 104.5" "Group enriched" "Detected in some" 5 "CACO-2: 13.5;CAPAN-2: 7.3" "Cancer enhanced" "Detected in many" "lung cancer: 121.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 11 "B-cells: 1.7;T-cells: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted in other tissues" "unprognostic (5.82e-2)" "unprognostic (1.16e-1)" "unprognostic (7.20e-3)" "unprognostic (6.64e-2)" "unprognostic (3.12e-1)" "unprognostic (1.34e-1)" "unprognostic (6.37e-2)" "unprognostic (2.27e-1)" "prognostic unfavourable (1.26e-4)" "unprognostic (1.16e-1)" "unprognostic (3.96e-4)" "unprognostic (8.84e-2)" "unprognostic (2.36e-2)" "unprognostic (5.39e-3)" "unprognostic (7.95e-2)" 0.1 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.1 1.2 0.1 0.1 0.5 0.0 0.2 0.1 13.6 1.4 6.3 0.2 0.1 0.0 1.6 0.1 104.5 0.1 0.1 0.1 0.3 1.1 0.4 0.1 0.6 0.2 0.2 0.0 0.1 1.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 2.0 1.3 0.1 0.1 1.0 0.4 0.3 0.1 5.4 1.7 0.1 0.1 0.0 0.0 1.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 7.3 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 1.5 0.5 0.1 1.7 1.3 1.7 0.1 0.0 0.0 0.0 0.4 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 SFTPA1 "COLEC4, SFTP1, SP-A, SP-A1" ENSG00000122852 "Surfactant protein A1" Q8IWL2 10 79610939-79615455 "Disease related genes, Predicted secreted proteins" "Gaseous exchange" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "lung: 411.8" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 30.0" "Cancer enriched" "Detected in some" 25 "lung cancer: 706.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 63 "plasmacytoid DC: 6.2" "Lineage enriched" "Detected in single" 63 "dendritic cells: 6.2" "CAB016793, HPA042638, HPA045752, HPA049368" Supported "Secreted in other tissues" "CAB016793: , HPA042638: , HPA045752: , HPA049368: " "unprognostic (5.83e-4)" "unprognostic (1.17e-1)" "unprognostic (3.38e-2)" "unprognostic (4.24e-1)" "unprognostic (3.47e-2)" "unprognostic (9.09e-2)" 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 411.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.1 0.0 0.0 0.0 30.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SFTPA2 "COLEC5, SP-A2" ENSG00000185303 "Surfactant protein A2" Q8IWL1 10 79555852-79560402 "Disease related genes, Predicted secreted proteins" "Gaseous exchange" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 225 "lung: 501.0" "Group enriched" "Detected in some" 21 "BEWO: 6.3;NB-4: 6.6;RPMI-8226: 21.2;U-2197: 12.8" "Cancer enriched" "Detected in many" 21 "lung cancer: 863.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 2.2" "Lineage enriched" "Detected in single" 11 "dendritic cells: 2.2" "CAB002439, HPA042638, HPA045752, HPA049368" Enhanced "Secreted in other tissues" "CAB002439: AB_564143, HPA042638: , HPA045752: , HPA049368: " "unprognostic (2.51e-1)" "unprognostic (4.87e-2)" "unprognostic (4.99e-2)" "unprognostic (4.38e-2)" "unprognostic (4.29e-2)" "unprognostic (1.05e-1)" "unprognostic (5.78e-2)" "unprognostic (5.08e-1)" "unprognostic (4.94e-2)" "unprognostic (1.68e-3)" "unprognostic (3.10e-1)" "unprognostic (3.56e-2)" "unprognostic (1.20e-1)" "unprognostic (1.33e-1)" "unprognostic (4.69e-3)" 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 501.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.2 0.0 0.1 0.4 0.3 0.1 0.0 0.2 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.6 0.4 0.0 0.2 0.0 21.2 0.0 0.3 0.2 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.2 12.8 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SFTPB "SFTP3, SP-B" ENSG00000168878 "Surfactant protein B" P07988 2 85657314-85668741 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Gaseous exchange" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "lung: 757.8" "Cell line enhanced" "Detected in some" "BEWO: 4.8;NB-4: 5.5;U-2197: 11.2;U-266/70: 4.1" "Group enriched" "Detected in many" 149 "lung cancer: 1306.7;thyroid cancer: 270.2" "Region enriched" "Detected in single" 17 "pons and medulla: 2.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002440, HPA034820, HPA062148" Enhanced "Secreted in other tissues" 71000000 "CAB002440: AB_564142, HPA034820: , HPA062148: " "unprognostic (6.46e-3)" "unprognostic (4.94e-2)" "unprognostic (4.94e-2)" "prognostic unfavourable (1.71e-6)" "unprognostic (2.25e-3)" "unprognostic (4.57e-3)" "unprognostic (8.57e-3)" "unprognostic (6.45e-3)" "unprognostic (1.13e-1)" "unprognostic (3.04e-2)" "unprognostic (2.50e-2)" "unprognostic (1.89e-1)" "prognostic unfavourable (2.99e-6)" "unprognostic (2.37e-1)" "unprognostic (1.09e-1)" "unprognostic (7.90e-2)" "unprognostic (4.38e-2)" 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 757.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 44.1 0.0 0.0 0.0 0.0 1.1 1.4 2.6 4.1 0.8 1.5 1.2 0.2 0.4 0.4 0.8 0.5 0.9 4.8 0.4 0.3 0.1 0.1 0.5 1.0 0.1 0.4 0.1 3.2 0.4 0.1 0.1 0.6 0.4 0.5 1.1 0.4 0.1 0.2 2.4 0.0 0.5 0.3 0.2 0.0 0.4 0.8 0.2 0.5 1.7 5.5 2.6 0.7 2.1 0.4 0.5 0.3 0.5 0.7 0.5 0.1 0.8 0.3 0.6 0.4 0.1 0.3 1.0 11.2 0.2 4.1 0.8 0.3 1.0 0.7 0.2 0.9 2.5 0.8 0.9 4.1 0.7 1.0 1.0 0.8 1.4 1.1 1.4 0.8 2.6 0.8 2.5 0.7 1.5 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 SFTPC "BRICD6, PSP-C, SFTP2, SMDP2, SP-C" ENSG00000168484 "Surfactant protein C" P11686 8 22156913-22164479 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Gaseous exchange" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 718 "lung: 664.5" "Cell line enhanced" "Detected in some" "BEWO: 8.3;NB-4: 10.4;SCLC-21H: 4.5;U-2197: 22.2" "Cancer enriched" "Detected in some" 218 "lung cancer: 226.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010928 Enhanced "Secreted in other tissues" "HPA010928: AB_1857425" "unprognostic (1.84e-1)" "unprognostic (1.96e-1)" "unprognostic (1.44e-1)" "unprognostic (1.13e-1)" "unprognostic (2.97e-1)" "unprognostic (4.97e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (1.32e-2)" 0.1 0.8 0.2 0.3 0.5 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.3 0.1 0.1 0.1 664.5 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.9 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.1 0.1 0.5 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.4 0.3 0.0 0.4 0.0 0.0 0.0 0.0 4.5 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 22.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 0.3 0.1 0.4 0.1 0.9 0.1 SFTPD "COLEC7, SFTP4, SP-D" ENSG00000133661 "Surfactant protein D" P35247 10 79937740-79982614 "Predicted secreted proteins" "Gaseous exchange, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lung: 127.0" "Cell line enhanced" "Detected in some" "BEWO: 3.2;HaCaT: 2.4;HMC-1: 2.7;hTCEpi: 7.5;MCF7: 3.4;U-2197: 2.6" "Cancer enriched" "Detected in many" 16 "lung cancer: 106.4" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 11 "intermediate monocyte: 6.4;non-classical monocyte: 21.6" "Lineage enriched" "Detected in many" 17 "monocytes: 21.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004578, HPA044582, HPA056768" Enhanced "Secreted in other tissues" 5500000 "CAB004578: AB_628276, HPA044582: AB_2679004, HPA056768: AB_2683232" "unprognostic (3.81e-5)" "unprognostic (7.00e-2)" "unprognostic (1.19e-2)" "unprognostic (1.41e-2)" "unprognostic (4.78e-2)" "unprognostic (1.29e-1)" "unprognostic (1.66e-3)" "unprognostic (6.83e-2)" "unprognostic (3.85e-1)" "unprognostic (2.23e-1)" "unprognostic (5.29e-2)" "unprognostic (2.57e-1)" "unprognostic (4.70e-2)" "unprognostic (2.57e-2)" "unprognostic (2.38e-1)" "unprognostic (1.45e-1)" "unprognostic (8.86e-2)" 0.3 0.3 0.6 0.3 1.1 3.9 0.3 0.3 0.6 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.5 0.5 0.3 0.3 127.0 0.3 0.3 0.3 0.3 0.9 0.3 0.7 0.3 0.3 0.3 0.0 0.3 0.4 0.3 0.3 1.6 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.4 1.2 0.4 0.3 0.3 0.3 0.0 1.2 0.4 21.6 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.2 0.7 2.4 0.3 0.1 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.2 2.7 0.0 7.5 0.0 0.0 0.0 0.0 0.4 0.0 3.4 0.1 1.8 0.8 0.6 0.0 0.1 0.0 0.0 0.0 0.7 0.8 0.1 0.5 0.0 1.0 0.7 1.4 0.0 0.2 2.6 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.0 6.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.5 0.6 1.1 0.3 0.6 0.5 0.5 0.3 0.3 0.3 0.3 SGO1 "NY-BR-85, SGOL1" ENSG00000129810 "Shugoshin 1" Q5FBB7 3 20160593-20186292 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 40.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA035501, HPA069302, HPA069857" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA035501: , HPA069302: , HPA069857: " "unprognostic (6.87e-3)" "unprognostic (5.01e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-3)" "unprognostic (2.51e-2)" "unprognostic (4.10e-2)" "unprognostic (2.55e-6)" "unprognostic (9.49e-3)" "unprognostic (2.45e-2)" "unprognostic (3.69e-2)" "unprognostic (1.65e-4)" "unprognostic (1.52e-2)" "unprognostic (0.00e+0)" "unprognostic (2.29e-2)" "unprognostic (4.95e-2)" "unprognostic (4.14e-1)" "unprognostic (1.64e-1)" 0.6 0.6 0.4 9.1 0.4 8.9 1.0 0.4 1.5 0.9 3.4 0.3 0.6 2.7 0.8 0.5 4.0 0.3 1.7 0.4 0.3 0.4 0.8 1.0 0.9 6.9 0.4 0.1 0.5 0.5 0.0 0.4 3.7 0.2 0.6 3.5 0.1 1.0 0.1 0.3 1.1 3.4 0.8 0.4 4.9 1.5 8.6 0.2 40.1 0.5 2.4 7.4 1.2 1.5 9.0 4.5 8.3 0.2 0.3 2.7 0.6 9.4 10.8 14.7 9.0 0.7 1.3 10.0 10.2 5.2 14.9 16.3 7.6 11.7 14.5 5.1 4.2 5.5 13.9 5.6 18.8 18.4 9.2 16.4 7.4 6.1 0.1 14.9 14.2 0.1 0.4 16.3 6.9 8.8 14.0 25.9 12.3 9.3 23.4 8.4 15.7 8.2 15.0 18.9 8.4 3.7 6.9 7.3 7.7 11.2 13.9 6.7 9.0 10.5 2.4 11.3 13.5 10.0 20.3 11.1 25.9 16.8 6.2 15.1 16.9 8.3 0.1 1.5 0.3 0.2 0.1 8.6 0.7 0.8 0.4 9.0 0.2 0.4 1.6 0.3 0.2 4.5 2.7 0.6 0.4 0.4 0.4 1.5 0.3 0.4 0.4 0.1 0.2 0.2 SH2D1A "DSHP, EBVS, IMD5, LYP, MTCP1, SAP, XLP, XLPD" ENSG00000183918 "SH2 domain containing 1A" O60880 X 124227868-124373197 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 163.1" "Group enriched" "Detected in some" 5 "HDLM-2: 23.7;Karpas-707: 53.2;MOLT-4: 63.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 53 "gdT-cell: 27.3;MAIT T-cell: 36.5;memory CD4 T-cell: 20.6;memory CD8 T-cell: 40.1;naive CD4 T-cell: 21.0;naive CD8 T-cell: 25.2;NK-cell: 31.7;T-reg: 25.3" "Group enriched" "Detected in many" 67 "NK-cells: 31.7;T-cells: 40.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "prognostic favourable (2.03e-4)" "unprognostic (1.18e-3)" "unprognostic (4.35e-3)" "unprognostic (9.66e-5)" "unprognostic (1.60e-1)" "unprognostic (1.86e-3)" "unprognostic (9.25e-3)" "unprognostic (3.34e-2)" "unprognostic (1.88e-2)" "unprognostic (2.80e-3)" "unprognostic (9.33e-2)" "unprognostic (1.05e-1)" "prognostic unfavourable (4.94e-6)" "unprognostic (1.27e-1)" "unprognostic (9.00e-2)" "unprognostic (2.36e-1)" "unprognostic (3.14e-3)" 2.5 0.5 0.4 5.8 0.6 2.5 1.0 0.2 0.3 0.8 1.0 0.4 0.5 0.6 0.7 0.8 0.9 0.6 2.6 0.6 0.5 0.4 1.1 1.7 4.1 21.3 0.6 0.2 0.6 0.3 0.0 0.4 0.4 0.3 1.0 0.7 0.7 1.9 0.3 0.3 0.4 4.0 0.3 1.0 12.2 1.3 0.4 0.3 163.1 1.3 0.7 10.2 4.2 1.1 0.2 0.1 0.5 0.2 31.7 40.1 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.2 0.0 0.0 63.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 8.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 27.3 0.1 36.5 0.2 20.6 40.1 0.1 0.0 21.0 25.2 0.5 31.7 0.2 0.1 25.3 17.2 0.4 0.6 0.2 0.3 0.5 0.4 0.6 0.2 0.3 0.3 SH2D1B EAT2 ENSG00000198574 "SH2 domain containing 1B" O14796 1 162395266-162412138 "Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 67.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.9;EFO-21: 5.5;Karpas-707: 8.9;PC-3: 1.7;TIME: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 8 "NK-cell: 67.4;non-classical monocyte: 27.0" "Group enriched" "Detected in many" 34 "monocytes: 27.0;NK-cells: 67.4" "Low region specificity" "Detected in all" HPA054791 Uncertain "HPA054791: " "unprognostic (7.82e-3)" "unprognostic (6.06e-3)" "unprognostic (1.41e-1)" "unprognostic (2.52e-2)" "unprognostic (1.43e-3)" "unprognostic (2.55e-3)" "unprognostic (1.89e-2)" "unprognostic (6.54e-2)" "unprognostic (5.96e-2)" "unprognostic (4.35e-1)" "unprognostic (1.12e-1)" "unprognostic (4.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.72e-1)" "unprognostic (3.80e-1)" "unprognostic (8.45e-2)" "unprognostic (1.15e-3)" 1.2 0.2 0.4 2.2 0.3 5.3 0.5 0.2 1.1 2.7 3.7 0.1 0.0 1.2 3.0 0.7 3.2 0.3 0.7 1.0 0.5 0.3 0.6 3.9 9.1 6.8 0.4 0.0 0.6 0.2 0.0 0.4 3.7 0.1 1.4 0.6 2.6 1.6 0.9 15.0 0.3 2.6 0.1 1.0 14.8 0.3 0.6 0.0 1.3 0.3 0.4 2.6 0.4 1.7 0.0 1.3 0.6 27.0 67.4 1.3 10.7 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.9 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 8.9 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 1.3 5.9 0.0 0.0 0.0 0.3 1.3 0.0 0.1 0.2 0.6 67.4 27.0 0.1 0.0 10.7 0.4 0.3 0.2 1.1 0.5 0.3 0.4 0.0 0.1 0.0 SH2D7 LOC646892 ENSG00000183476 "SH2 domain containing 7" A6NKC9 15 78077808-78104909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 7 "testis: 37.1" "Cell line enhanced" "Detected in some" "AF22: 2.1;AN3-CA: 2.8;BEWO: 2.6;HEK 293: 2.0;SCLC-21H: 2.4;SH-SY5Y: 4.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA076728 Enhanced "HPA076728: " "unprognostic (1.22e-2)" "unprognostic (4.31e-2)" "unprognostic (2.24e-1)" "unprognostic (1.24e-2)" "unprognostic (2.53e-1)" "unprognostic (1.42e-1)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-3)" "unprognostic (4.73e-2)" "unprognostic (2.92e-1)" "unprognostic (2.32e-3)" "unprognostic (5.15e-3)" "unprognostic (1.01e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 0.1 0.2 0.6 0.5 0.4 0.0 0.1 0.5 0.5 0.1 4.3 0.1 0.1 5.0 0.1 0.1 0.1 0.0 1.0 0.2 0.4 0.4 0.1 0.1 0.6 0.1 0.3 0.1 0.1 0.3 0.0 0.2 0.3 0.1 0.2 0.5 0.2 0.2 0.1 0.1 0.1 4.2 0.1 0.3 0.1 0.3 37.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 2.1 2.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 1.4 0.0 1.1 1.4 0.0 0.0 0.4 2.4 4.4 0.4 0.6 0.2 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.5 0.5 0.4 0.4 0.3 0.1 0.1 0.1 SH3BGR 21-GARP ENSG00000185437 "SH3 domain binding glutamate rich protein" P55822 21 39445855-39515506 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 219.7" "Cell line enhanced" "Detected in many" "U-266/70: 15.3;U-87 MG: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "cerebellum: 34.0;midbrain: 14.7;olfactory region: 12.3;pons and medulla: 29.7" "Low region specificity" "Detected in all" "CAB003685, HPA030690" Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB003685: AB_425682, HPA030690: " "unprognostic (3.41e-2)" "unprognostic (1.26e-1)" "unprognostic (5.84e-3)" "unprognostic (1.68e-3)" "unprognostic (6.05e-2)" "unprognostic (6.12e-3)" "unprognostic (3.89e-2)" "unprognostic (9.78e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-3)" "unprognostic (3.59e-2)" "unprognostic (4.75e-1)" "unprognostic (5.98e-3)" "unprognostic (7.16e-2)" "unprognostic (4.60e-2)" "unprognostic (1.68e-2)" "unprognostic (2.06e-2)" 2.4 5.2 7.2 1.2 7.3 0.9 2.9 1.1 4.3 2.9 6.1 3.0 2.0 1.9 2.1 6.6 5.3 2.1 5.0 30.0 6.6 5.4 3.2 2.8 1.5 0.9 7.5 5.0 1.8 2.8 2.1 4.5 1.1 6.1 5.8 2.0 1.2 3.2 5.2 219.7 0.9 1.4 12.4 7.9 1.2 2.9 3.7 5.9 0.1 3.9 41.5 2.2 7.3 8.6 2.7 11.5 2.6 1.7 2.8 4.0 1.2 1.0 1.3 1.7 2.5 3.7 4.3 0.5 1.9 0.9 0.9 0.7 0.7 2.2 3.3 5.1 5.0 0.1 0.9 1.5 1.4 2.0 3.4 3.3 0.6 1.3 7.6 1.2 0.7 3.5 6.2 3.2 6.3 1.0 2.5 4.3 3.5 4.1 2.2 1.9 1.7 2.9 3.5 6.4 2.1 4.6 0.8 4.8 2.0 2.9 2.4 3.1 9.0 0.6 0.8 2.5 0.3 1.5 3.7 15.3 3.2 3.3 47.5 2.9 3.3 2.3 0.7 0.0 1.2 1.7 3.1 2.7 1.1 1.8 1.9 1.4 4.0 3.0 2.6 2.8 1.7 11.5 0.7 1.2 7.2 7.3 1.1 4.3 6.6 5.4 7.5 5.0 6.1 5.9 SH3GL2 "CNSA2, EEN-B1, SH3D2A, SH3P4" ENSG00000107295 "SH3 domain containing GRB2 like 2, endophilin A1" Q99962 9 17579082-17797129 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 83.0" "Cell line enhanced" "Detected in some" "HEK 293: 5.7;HeLa: 13.8;RT4: 26.7;SCLC-21H: 17.4" "Cancer enhanced" "Detected in many" "glioma: 8.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010056, HPA026685, HPA063573" Enhanced Supported Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: " "unprognostic (4.78e-2)" "unprognostic (3.24e-2)" "unprognostic (1.68e-2)" "unprognostic (5.05e-5)" "unprognostic (4.23e-2)" "unprognostic (3.40e-1)" "unprognostic (1.21e-1)" "unprognostic (5.90e-2)" "unprognostic (3.90e-1)" "unprognostic (5.07e-3)" "unprognostic (8.76e-3)" "unprognostic (1.26e-1)" "prognostic favourable (6.68e-12)" "unprognostic (2.65e-2)" "unprognostic (8.29e-2)" "unprognostic (2.25e-2)" "unprognostic (8.44e-2)" 1.1 1.2 16.7 1.1 17.3 1.0 1.1 68.4 83.0 3.1 1.5 1.6 0.0 1.2 2.8 2.1 1.4 2.6 1.1 4.1 17.1 11.3 13.7 1.1 1.9 1.0 9.1 22.2 2.5 3.4 1.2 6.6 1.0 12.8 2.5 1.6 1.6 1.0 1.1 1.1 1.1 1.5 2.4 6.3 1.1 4.5 5.8 2.2 0.0 2.2 0.0 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 4.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.7 0.0 13.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 1.5 0.0 0.0 0.0 0.0 26.7 17.4 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.9 0.0 0.2 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 17.3 68.4 41.1 17.1 11.3 9.1 22.2 12.8 2.2 SHANK1 "SPANK-1, SSTRIP, synamon" ENSG00000161681 "SH3 and multiple ankyrin repeat domains 1" Q9Y566 19 50661827-50719450 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 35.7" "Cell line enhanced" "Detected in some" "REH: 7.3;SH-SY5Y: 3.5;U-138 MG: 4.1;U-2 OS: 10.4;U-87 MG: 3.9;U-937: 4.3" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA032129, HPA032130" Uncertain Supported "Plasma membrane" "Plasma membrane" "HPA032129: AB_10602796, HPA032130: " "unprognostic (1.62e-1)" "unprognostic (4.40e-2)" "unprognostic (7.83e-3)" "unprognostic (4.62e-2)" "unprognostic (1.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.76e-2)" "unprognostic (1.35e-2)" "unprognostic (5.02e-2)" "unprognostic (1.61e-1)" "unprognostic (7.51e-2)" "unprognostic (3.27e-1)" "unprognostic (3.65e-2)" "unprognostic (1.61e-2)" "unprognostic (5.14e-2)" "unprognostic (4.66e-3)" "unprognostic (1.29e-3)" 0.9 2.6 27.9 0.9 10.0 1.2 0.9 13.6 35.7 1.3 0.9 1.1 0.0 0.9 1.3 1.0 0.9 2.2 1.1 0.9 25.6 12.3 0.9 0.8 0.8 0.9 6.0 11.1 0.9 0.9 2.1 2.8 1.0 4.1 1.0 0.8 0.2 0.9 1.0 1.0 1.2 0.9 1.1 2.2 0.9 0.8 1.4 3.5 0.4 0.9 0.0 0.9 0.9 0.0 0.0 0.7 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.5 0.0 1.2 1.2 0.1 0.1 0.0 0.0 0.0 1.9 0.7 0.0 0.2 0.0 0.1 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.1 0.6 0.0 0.0 0.7 0.1 0.1 0.8 1.2 0.1 7.3 0.0 0.7 0.0 0.0 0.0 3.5 0.0 0.0 1.1 0.0 3.1 2.2 4.1 10.4 0.0 0.0 0.0 0.0 0.0 3.9 4.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.0 27.9 10.0 13.6 23.0 25.6 12.3 6.0 11.1 4.1 3.5 SHCBP1L C1orf14 ENSG00000157060 "SHC binding and spindle associated 1 like" Q9BZQ2 1 182899865-182953525 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 198 "testis: 87.2" "Cell line enriched" "Detected in single" 16 "BEWO: 1.6" "Cancer enhanced" "Detected in single" "cervical cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036124, HPA036125, HPA064821" Enhanced "HPA036124: , HPA036125: AB_10671834, HPA064821: AB_2685360" "unprognostic (1.29e-3)" "unprognostic (1.03e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (6.44e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 SHF ENSG00000138606 "Src homology 2 domain containing F" Q7M4L6 15 45167214-45201175 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 84.3" "Cell line enhanced" "Detected in many" "SCLC-21H: 49.5;SH-SY5Y: 22.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 84.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 269.9" HPA057381 Approved Nucleoplasm Nucleoplasm "HPA057381: " "unprognostic (4.05e-2)" "unprognostic (2.02e-3)" "unprognostic (7.59e-2)" "unprognostic (1.54e-1)" "unprognostic (1.88e-2)" "unprognostic (2.18e-1)" "unprognostic (2.38e-1)" "unprognostic (7.61e-2)" "unprognostic (2.18e-1)" "unprognostic (3.50e-2)" "unprognostic (6.88e-2)" "unprognostic (5.12e-2)" "unprognostic (6.89e-2)" "unprognostic (2.83e-2)" "unprognostic (1.17e-1)" "unprognostic (5.09e-3)" "unprognostic (1.83e-2)" 2.9 19.3 6.9 3.3 10.4 0.6 3.3 84.3 14.5 7.3 6.3 3.9 2.2 10.5 8.5 4.0 4.1 6.2 5.3 4.5 5.9 7.2 1.8 18.9 2.9 1.8 4.5 6.7 20.5 2.5 2.5 3.5 1.5 7.1 5.3 4.4 6.3 5.3 5.2 2.6 6.5 7.9 6.3 5.2 2.3 2.9 4.1 3.2 1.6 4.9 2.4 1.8 5.8 5.5 3.3 2.6 2.5 1.9 5.1 4.2 1.5 0.0 0.5 9.7 0.3 0.7 0.4 4.6 1.2 0.8 2.7 3.9 1.4 4.6 0.5 3.9 1.6 0.8 3.7 0.3 1.3 0.8 1.7 0.3 0.8 9.6 0.4 0.0 3.2 0.9 0.2 0.3 0.0 2.1 1.9 0.2 3.8 1.6 2.1 0.3 3.8 0.2 5.8 7.7 0.2 0.9 0.2 49.5 22.1 0.3 0.3 0.1 0.4 0.9 0.1 0.3 4.2 0.3 0.1 0.4 0.3 0.4 0.1 0.2 1.5 0.3 1.9 1.2 3.8 1.7 4.2 2.4 1.6 2.4 1.8 3.3 2.2 1.7 2.5 5.1 1.7 2.6 0.3 1.5 6.9 10.4 84.3 12.1 5.9 7.2 4.5 6.7 7.1 3.2 SHISA4 "C1orf40, hShisa4, TMEM58" ENSG00000198892 "Shisa family member 4" Q96DD7 1 201888680-201892306 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 175.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "eosinophil: 18.3;intermediate monocyte: 6.4;neutrophil: 8.2;non-classical monocyte: 7.8" "Group enriched" "Detected in many" 9 "granulocytes: 18.3;monocytes: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061273, HPA067885" Uncertain "HPA061273: , HPA067885: " "unprognostic (1.13e-1)" "unprognostic (3.70e-3)" "unprognostic (1.48e-3)" "unprognostic (2.12e-3)" "unprognostic (6.59e-2)" "unprognostic (8.29e-3)" "unprognostic (7.06e-2)" "unprognostic (5.00e-2)" "unprognostic (2.32e-1)" "unprognostic (1.44e-1)" "unprognostic (8.29e-2)" "unprognostic (2.32e-2)" "unprognostic (1.63e-3)" "unprognostic (1.20e-1)" "unprognostic (1.82e-1)" "unprognostic (1.24e-1)" "unprognostic (2.76e-1)" 5.2 15.8 22.2 3.8 18.8 2.5 3.3 9.6 34.8 4.7 3.3 29.1 2.1 2.7 4.4 4.5 4.0 3.9 4.7 14.7 17.5 14.6 4.1 3.8 4.0 2.7 19.2 14.8 6.8 4.1 4.1 3.8 3.8 21.3 6.2 2.9 7.2 12.1 5.1 175.2 4.2 3.2 4.7 14.0 3.4 3.2 4.2 8.2 0.0 6.3 18.8 2.7 3.9 2.6 0.0 0.7 18.3 7.8 0.0 1.5 0.5 1.2 9.4 1.1 6.7 10.2 6.1 1.0 8.2 13.4 3.4 4.8 1.6 2.5 0.0 11.2 10.1 2.4 0.1 1.3 2.2 1.0 0.6 0.1 2.8 1.1 7.2 0.0 6.0 6.2 3.0 4.4 2.2 6.2 0.1 0.3 6.0 1.1 0.0 0.0 0.7 11.4 0.1 0.0 1.8 3.3 3.6 0.4 6.1 2.9 1.3 8.3 3.8 0.8 6.2 4.8 4.8 2.7 4.2 1.6 1.3 0.0 7.9 0.0 8.4 0.0 1.4 18.3 1.5 6.4 0.6 0.0 0.3 0.3 0.7 0.0 0.0 0.3 8.2 0.0 7.8 0.0 0.0 0.5 22.2 18.8 9.6 34.8 17.5 14.6 19.2 14.8 21.3 8.2 SHISA7 ENSG00000187902 "Shisa family member 7" A6NL88 19 55428740-55442863 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 24.9" "Group enriched" "Detected in some" 5 "HEL: 6.5;HMC-1: 6.9;THP-1: 3.5" "Cancer enriched" "Detected in single" 9 "glioma: 2.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058935 Uncertain Approved Cytosol Cytosol "HPA058935: " "unprognostic (3.98e-2)" "unprognostic (5.81e-2)" "unprognostic (1.16e-1)" "unprognostic (1.28e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (3.08e-1)" "unprognostic (4.40e-1)" "unprognostic (7.17e-2)" "unprognostic (2.11e-3)" "unprognostic (1.22e-2)" "unprognostic (6.87e-7)" "unprognostic (7.53e-3)" "unprognostic (2.82e-1)" "unprognostic (3.29e-4)" "unprognostic (4.04e-1)" 0.7 1.7 11.3 0.7 16.7 2.6 0.7 4.0 24.9 0.7 0.8 7.2 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 11.2 8.2 0.7 0.7 0.7 0.7 8.3 3.1 0.7 0.8 0.7 2.4 0.7 5.5 0.7 0.8 0.0 0.7 0.7 0.7 0.8 0.8 0.7 4.0 0.7 0.8 2.2 14.6 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 6.5 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 1.2 0.6 0.0 1.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 16.7 4.0 10.9 11.2 8.2 8.3 3.1 5.5 14.6 SHISA8 "C22orf17, Orf26" ENSG00000234965 "Shisa family member 8" B8ZZ34 22 41909554-41914667 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 42.2" "Cell line enriched" "Detected in some" 7 "HEK 293: 20.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 15 "cerebellum: 42.2" "Cell type enhanced" "Detected in single" "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 17 "B-cells: 1.7" "Group enriched" "Detected in some" 5 "cerebellum: 8.7;olfactory region: 19.4" "Group enriched" "Detected in all" 4 "cerebellum: 61.4;olfactory region: 45.2" HPA059173 Uncertain "HPA059173: " "unprognostic (8.76e-2)" "unprognostic (2.98e-4)" "unprognostic (1.03e-1)" "prognostic favourable (2.76e-4)" "unprognostic (4.42e-2)" "unprognostic (1.45e-3)" "unprognostic (4.40e-1)" "unprognostic (1.16e-2)" "unprognostic (2.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.45e-3)" "unprognostic (2.16e-1)" "unprognostic (1.12e-1)" "unprognostic (8.59e-2)" "unprognostic (2.60e-2)" "unprognostic (6.22e-4)" "unprognostic (7.84e-2)" 0.1 9.4 0.5 1.6 0.5 0.2 0.1 42.2 2.7 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.2 0.3 0.3 0.5 0.2 0.2 0.1 0.1 3.0 0.3 1.7 0.1 0.1 0.1 0.8 0.0 2.2 0.2 0.0 1.5 1.8 0.2 0.8 0.5 0.8 0.0 0.3 2.7 0.7 0.2 0.0 0.0 0.1 0.0 3.8 0.4 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 42.2 2.7 0.5 0.2 0.3 1.7 2.2 0.0 SI ENSG00000090402 Sucrase-isomaltase P14410 3 164978898-165078495 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 123 "intestine: 181.4" "Cell line enhanced" "Detected in some" "BEWO: 2.8;CACO-2: 4.0;HeLa: 3.1;NB-4: 3.3;RPMI-8226: 4.8;SH-SY5Y: 2.9" "Cancer enhanced" "Detected in some" "stomach cancer: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011897 Enhanced "HPA011897: AB_1856840" "unprognostic (2.71e-2)" "unprognostic (1.62e-2)" "unprognostic (2.68e-1)" "unprognostic (2.05e-1)" "unprognostic (4.41e-2)" 0.1 0.1 0.1 1.4 0.1 0.0 0.1 0.1 0.1 0.1 93.3 0.0 0.0 94.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 5.4 0.0 0.1 0.0 0.1 0.1 181.4 0.0 0.1 0.1 0.1 0.7 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.6 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 SIGLEC6 "CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6" ENSG00000105492 "Sialic acid binding Ig like lectin 6" O43699 19 51519525-51531856 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "placenta: 87.4" "Cell line enriched" "Detected in some" 7 "HMC-1: 100.5" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 6.5;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 33 "B-cells: 6.5;dendritic cells: 6.8;granulocytes: 2.3" "HPA009084, HPA018198" Enhanced "Intracellular and membrane" "HPA009084: AB_1079967, HPA018198: AB_1856868" "unprognostic (1.97e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-3)" "unprognostic (9.31e-3)" "unprognostic (8.46e-4)" "unprognostic (2.91e-1)" "unprognostic (2.02e-2)" "unprognostic (2.64e-1)" "unprognostic (8.96e-2)" "unprognostic (2.03e-1)" "unprognostic (6.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.15e-2)" "unprognostic (4.42e-2)" "unprognostic (3.28e-2)" "unprognostic (5.57e-3)" 1.8 0.0 0.0 5.6 0.0 0.1 0.8 0.0 0.1 1.2 1.7 0.0 0.3 0.9 2.0 1.2 1.5 0.5 8.6 0.4 0.0 0.0 0.4 0.1 4.2 1.5 0.0 0.0 0.1 0.3 0.1 0.1 87.4 0.0 3.7 1.5 0.5 1.4 1.0 0.2 1.3 6.0 3.1 0.0 1.3 1.7 1.0 0.0 0.3 0.2 1.0 2.6 2.2 1.9 6.5 6.8 2.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.2 100.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 1.4 2.8 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SIGLEC8 "MGC59785, SAF2, SIGLEC-8, SIGLEC8L" ENSG00000105366 "Sialic acid binding Ig like lectin 8" Q9NYZ4 19 51450847-51458456 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 63.0" "Cell line enriched" "Detected in some" 45 "HMC-1: 57.4" "Cancer enhanced" "Detected in many" "glioma: 7.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 42 "eosinophil: 63.0" "Lineage enriched" "Detected in single" 623 "granulocytes: 63.0" HPA012556 Uncertain Uncertain Cytosol Cytosol "HPA012556: AB_1856869" "unprognostic (1.27e-1)" "unprognostic (1.88e-4)" "unprognostic (1.28e-1)" "unprognostic (6.70e-2)" "unprognostic (2.97e-1)" "unprognostic (1.30e-2)" "unprognostic (7.84e-2)" "unprognostic (2.51e-2)" "unprognostic (2.72e-2)" "unprognostic (2.17e-1)" "unprognostic (1.10e-1)" "unprognostic (4.19e-1)" "unprognostic (8.62e-3)" "unprognostic (7.18e-2)" "unprognostic (6.02e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" 0.6 6.7 5.8 2.4 8.4 0.7 2.3 0.7 7.0 1.4 2.9 7.4 0.0 2.9 1.0 1.1 1.1 1.1 2.7 0.3 8.6 4.8 0.4 1.6 4.1 9.6 8.3 3.6 0.3 0.7 0.7 1.2 0.1 7.5 1.0 2.8 0.1 1.1 0.9 0.3 0.8 4.5 1.5 14.8 9.2 2.1 0.5 6.2 0.6 0.7 0.0 4.1 2.0 0.7 0.0 0.0 63.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 57.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.5 0.1 63.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.8 8.4 0.7 5.6 8.6 4.8 8.3 3.6 7.5 6.2 SIGLECL1 "C19orf75, FLJ40235, SIGLEC23P, SIGLECP7" ENSG00000179213 "SIGLEC family like 1" Q8N7X8 19 51246348-51269330 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 29.7" "Cell line enhanced" "Detected in some" "HDLM-2: 2.2;HEL: 2.6;HMC-1: 2.8;NB-4: 2.1;U-937: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 2.6" "Group enriched" "Detected in many" 19 "dendritic cells: 2.6;monocytes: 1.0" "unprognostic (5.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 2.6 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 1.8 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SIRPB1 "CD172b, SIRP-BETA-1" ENSG00000101307 "Signal regulatory protein beta 1" "O00241, Q5TFQ8" 20 1563521-1620061 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 137.6" "Group enriched" "Detected in some" 4 "HMC-1: 24.7;NB-4: 32.8;THP-1: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 137.6" "Group enriched" "Detected in many" 6 "granulocytes: 137.6;monocytes: 43.6" HPA047463 Uncertain Uncertain Vesicles 33000000 Vesicles "HPA047463: " "unprognostic (1.88e-2)" "unprognostic (6.19e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (5.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.40e-2)" "unprognostic (7.18e-2)" "unprognostic (4.11e-3)" "unprognostic (9.12e-2)" "unprognostic (6.31e-2)" "unprognostic (4.57e-2)" "unprognostic (2.65e-3)" "unprognostic (5.76e-2)" "unprognostic (2.39e-3)" "unprognostic (5.00e-3)" "unprognostic (1.19e-2)" 23.7 1.8 2.3 18.7 5.4 31.9 1.8 2.7 3.2 1.1 1.4 1.9 0.1 1.0 1.0 0.5 0.9 2.5 7.6 7.2 2.3 1.6 1.5 7.5 19.4 19.5 6.6 0.7 1.9 0.9 0.1 1.5 3.8 3.7 1.2 1.2 1.7 1.8 0.6 0.9 0.9 2.6 2.1 7.2 28.7 1.2 1.2 3.9 2.5 0.9 0.4 2.9 4.1 1.9 0.2 15.2 137.6 43.6 0.7 1.0 19.2 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.3 24.7 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 32.8 0.1 1.5 0.0 0.0 0.0 4.9 0.1 0.0 0.1 0.1 0.0 0.2 0.0 25.4 0.7 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.5 6.0 0.1 0.5 43.6 72.5 0.6 36.3 0.9 0.2 0.6 0.5 15.2 0.2 0.8 0.5 137.6 0.7 29.5 14.5 1.0 19.2 2.3 5.4 2.7 3.2 2.3 1.6 6.6 0.7 3.7 3.9 SIX6 "OPTX2, Six9" ENSG00000184302 "SIX homeobox 6" O95475 14 60508951-60512850 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cataract, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pituitary gland: 43.3" "Cell line enriched" "Detected in some" 16 "MOLT-4: 29.4" "Cancer enriched" "Detected in single" 8 "glioma: 1.0" "Region enriched" "Detected in single" 8 "hypothalamus: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA001403 Approved Approved Nucleoplasm Nucleoplasm "HPA001403: AB_1079993" "unprognostic (2.76e-1)" "unprognostic (6.14e-2)" "unprognostic (8.18e-2)" "unprognostic (5.75e-2)" 0.1 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.4 0.0 10.6 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 SKOR1 "CORL1, FUSSEL15, LBXCOR1" ENSG00000188779 "SKI family transcriptional corepressor 1" P84550 15 67819704-67834561 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 17.8" "Cell line enhanced" "Detected in some" "U-266/70: 5.8;U-266/84: 4.6;U-698: 5.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "cerebellum: 17.8;pons and medulla: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "cerebellum: 4.2;pons and medulla: 1.3" "Region enriched" "Detected in some" 6 "cerebellum: 9.0" HPA071150 Enhanced "HPA071150: " "unprognostic (8.98e-2)" "unprognostic (4.15e-2)" "unprognostic (5.44e-7)" "unprognostic (1.76e-1)" "unprognostic (2.90e-2)" "unprognostic (2.45e-3)" "unprognostic (8.40e-5)" "unprognostic (5.51e-3)" "unprognostic (1.00e-1)" "unprognostic (8.13e-2)" "unprognostic (9.31e-2)" "unprognostic (1.93e-1)" "unprognostic (4.28e-5)" "unprognostic (1.96e-1)" "unprognostic (1.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.35e-1)" 1.1 0.6 0.7 0.4 1.3 1.7 0.7 17.8 2.4 0.5 0.7 0.4 0.4 1.4 1.0 0.5 0.4 0.6 0.7 0.4 0.6 1.1 0.5 0.4 0.7 0.4 0.5 0.4 1.2 1.3 0.1 1.3 0.9 4.4 0.8 0.3 0.4 0.7 0.9 1.5 0.7 0.9 0.6 5.4 0.7 0.4 2.4 0.4 0.4 0.5 0.4 0.4 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.2 0.4 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.2 0.1 0.1 0.2 0.4 0.0 0.4 0.8 1.0 0.3 0.0 0.2 2.4 0.7 0.1 0.2 0.0 0.1 0.0 0.1 0.8 0.0 0.2 0.4 1.0 0.0 0.2 0.6 0.3 1.2 0.0 0.1 0.2 2.1 0.1 0.0 0.4 0.3 1.1 0.3 0.1 0.5 0.2 0.3 5.8 4.6 5.0 0.5 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 1.3 17.8 1.2 0.6 1.1 0.5 0.4 4.4 0.4 SLAIN1 "C13orf32, FLJ30046" ENSG00000139737 "SLAIN motif family member 1" Q8ND83 13 77697854-77764242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 89.3" "Cell line enhanced" "Detected in many" "HEK 293: 20.5;HL-60: 27.3;MOLT-4: 31.3;REH: 21.9;SCLC-21H: 21.7" "Cancer enhanced" "Detected in many" "glioma: 25.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 2.2;T-cells: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (8.76e-5)" "unprognostic (1.78e-2)" "unprognostic (3.11e-1)" "unprognostic (3.25e-3)" "unprognostic (1.60e-1)" "unprognostic (3.78e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-2)" "unprognostic (6.20e-2)" "prognostic favourable (9.07e-4)" "unprognostic (4.80e-3)" "unprognostic (3.83e-3)" "unprognostic (2.16e-2)" "unprognostic (4.53e-2)" "unprognostic (1.37e-1)" "unprognostic (3.34e-1)" "unprognostic (1.97e-2)" 1.4 6.0 27.6 3.0 41.5 8.7 4.1 14.2 73.1 3.6 1.7 74.8 0.3 1.9 4.4 7.4 2.6 10.2 2.4 3.7 39.1 20.7 5.1 4.5 6.0 5.8 56.7 19.6 4.8 6.5 7.5 2.7 2.4 38.3 4.5 2.0 1.3 5.6 3.8 1.9 1.3 1.6 3.2 89.3 4.6 6.6 17.6 51.9 4.1 6.5 0.0 6.0 2.5 1.0 0.7 2.2 0.0 0.2 0.8 4.7 1.0 0.1 1.2 15.1 0.3 0.0 0.0 2.6 0.1 0.0 0.0 0.0 1.4 3.1 11.5 0.7 0.0 0.1 14.3 0.0 0.0 14.3 20.5 9.8 2.8 0.2 0.4 27.3 0.7 0.0 0.0 0.0 0.0 0.5 0.3 15.4 0.0 0.3 31.3 2.7 5.7 4.6 21.9 1.3 0.0 7.0 1.2 21.7 11.0 0.0 4.2 2.8 0.0 12.4 0.1 0.1 0.6 0.1 3.9 14.9 6.8 13.8 1.7 3.2 0.9 0.0 0.1 0.0 2.1 0.2 3.0 0.7 2.5 2.3 0.2 0.6 2.7 4.2 0.0 0.8 0.2 2.2 4.7 1.0 27.6 41.5 14.2 26.2 39.1 20.7 56.7 19.6 38.3 51.9 SLAMF1 "CD150, SLAM" ENSG00000117090 "Signaling lymphocytic activation molecule family member 1" Q13291 1 160608100-160647295 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Cell adhesion, Host-virus interaction, Immunity, Innate immunity, Phagocytosis" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 97.8" "Cell line enriched" "Detected in single" 111 "HDLM-2: 57.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "MAIT T-cell: 24.1" "Group enriched" "Detected in many" 10 "B-cells: 8.8;T-cells: 24.1" "CAB002438, HPA069319" Enhanced "Secreted to blood" 590000 "CAB002438: AB_564011, HPA069319: " "unprognostic (2.99e-3)" "unprognostic (3.33e-4)" "unprognostic (2.93e-4)" "unprognostic (1.38e-4)" "unprognostic (5.87e-2)" "unprognostic (6.06e-5)" "unprognostic (1.64e-2)" "unprognostic (1.70e-3)" "unprognostic (1.69e-2)" "unprognostic (2.74e-4)" "unprognostic (6.12e-2)" "unprognostic (3.58e-1)" "unprognostic (1.24e-7)" "unprognostic (2.46e-1)" "unprognostic (8.46e-2)" "unprognostic (1.22e-1)" "unprognostic (2.18e-2)" 2.5 0.3 0.3 14.2 0.3 4.4 1.4 0.2 0.3 1.2 2.3 0.4 0.5 2.2 0.5 1.2 2.2 0.8 2.3 1.3 0.2 0.2 2.0 1.0 4.0 14.8 0.2 0.1 0.6 0.9 0.0 0.5 2.3 0.3 1.1 2.1 0.6 4.1 0.6 0.8 1.1 7.6 1.0 0.5 10.6 2.4 0.4 0.2 97.8 1.5 1.9 26.3 3.5 1.1 8.8 1.6 0.2 0.1 0.0 24.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.1 0.0 4.2 0.0 24.1 6.2 17.2 12.1 0.1 8.8 6.6 1.6 0.2 0.0 0.0 1.6 21.5 3.5 0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.1 0.3 0.2 SLC10A1 NTCP ENSG00000100652 "Solute carrier family 10 member 1" Q14973 14 69775417-69797289 "Predicted membrane proteins, Transporters" "Host-virus interaction, Ion transport, Sodium transport, Symport, Transport" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "liver: 121.2" "Cell line enhanced" "Detected in some" "CACO-2: 4.2" "Cancer enriched" "Detected in some" 79 "liver cancer: 65.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042727 Approved "HPA042727: AB_10960691" "unprognostic (3.42e-1)" "unprognostic (9.39e-2)" "unprognostic (1.51e-2)" "unprognostic (2.11e-2)" "unprognostic (1.93e-2)" "unprognostic (6.51e-3)" "prognostic favourable (9.53e-6)" "unprognostic (6.07e-3)" "unprognostic (8.95e-2)" "unprognostic (2.17e-1)" "unprognostic (5.75e-3)" "unprognostic (1.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.05e-1)" "unprognostic (3.21e-1)" "unprognostic (2.45e-1)" "unprognostic (5.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 2.7 0.5 0.1 0.6 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.4 0.0 0.0 0.1 0.0 4.2 0.1 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.6 0.3 0.6 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.8 0.1 0.1 0.8 0.5 0.0 0.4 0.5 1.1 0.1 0.6 0.0 0.3 0.0 0.1 0.8 0.1 0.6 0.1 0.0 0.3 1.7 0.5 0.3 0.4 0.8 0.5 0.2 0.3 1.0 0.6 0.4 2.7 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC10A2 "ASBT, ISBT" ENSG00000125255 "Solute carrier family 10 member 2" Q12908 13 103043998-103066846 "Disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 40.9" "Cell line enhanced" "Detected in some" "AF22: 1.1;HAP1: 2.4;NB-4: 1.2;U-2197: 1.1" "Cancer enriched" "Detected in single" 11 "renal cancer: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA004795 Approved "HPA004795: AB_1856953" "unprognostic (2.82e-2)" "prognostic favourable (5.78e-5)" "unprognostic (1.64e-2)" "unprognostic (1.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 2.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC12A1 NKCC2 ENSG00000074803 "Solute carrier family 12 member 1" Q13621 15 48178438-48304078 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Bartter syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "kidney: 143.2" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 23.7" "Cancer enhanced" "Detected in single" "renal cancer: 1.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "basophil: 1.9;neutrophil: 1.5" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA014967, HPA018107" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA014967: AB_1854503, HPA018107: AB_1854504" "unprognostic (3.52e-2)" "unprognostic (1.30e-2)" "unprognostic (9.65e-2)" "unprognostic (1.74e-2)" "unprognostic (7.77e-2)" "unprognostic (1.04e-1)" "unprognostic (8.72e-2)" "unprognostic (2.06e-1)" "unprognostic (9.85e-3)" "unprognostic (2.81e-4)" "unprognostic (9.75e-2)" "unprognostic (2.61e-1)" "unprognostic (5.47e-2)" "unprognostic (2.03e-1)" "unprognostic (5.20e-4)" "unprognostic (8.52e-2)" 0.0 0.0 0.3 0.0 1.0 0.0 0.0 1.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 143.2 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.0 0.1 0.0 0.0 0.3 1.0 1.4 1.5 0.1 0.3 0.3 0.4 1.4 0.1 SLC12A3 NCCT ENSG00000070915 "Solute carrier family 12 member 3" P55017 16 56865207-56915850 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 88.6" "Group enriched" "Detected in some" 12 "BEWO: 10.1;HAP1: 5.6;HeLa: 11.2" "Cancer enhanced" "Detected in some" "renal cancer: 2.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 14.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 14.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA028748 Enhanced "HPA028748: AB_10603886" "unprognostic (1.54e-3)" "unprognostic (7.09e-5)" "unprognostic (1.35e-1)" "unprognostic (1.41e-2)" "unprognostic (2.91e-1)" "unprognostic (2.38e-4)" "unprognostic (1.81e-1)" "unprognostic (9.70e-2)" "unprognostic (1.34e-1)" "unprognostic (7.25e-2)" "unprognostic (6.84e-2)" "unprognostic (1.83e-1)" "unprognostic (1.43e-1)" "unprognostic (2.09e-1)" "unprognostic (1.38e-1)" "unprognostic (1.40e-2)" "unprognostic (1.70e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 88.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 14.6 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.7 5.6 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 14.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 SLC12A5 "KCC2, KIAA1176" ENSG00000124140 "Solute carrier family 12 member 5" Q9H2X9 20 46021690-46060152 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 64.6" "Cell line enhanced" "Detected in many" "Hep G2: 13.4;NB-4: 27.6;SK-BR-3: 14.0;U-2 OS: 16.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072058 Enhanced "HPA072058: " "unprognostic (2.01e-1)" "unprognostic (3.58e-1)" "unprognostic (7.55e-2)" "unprognostic (9.44e-4)" "prognostic unfavourable (5.60e-4)" "unprognostic (2.48e-1)" "unprognostic (5.16e-3)" "unprognostic (3.61e-1)" "unprognostic (2.49e-1)" "unprognostic (6.63e-2)" "unprognostic (3.72e-3)" "unprognostic (5.61e-4)" "unprognostic (8.78e-4)" "unprognostic (3.25e-2)" "unprognostic (9.22e-2)" "unprognostic (1.99e-1)" "unprognostic (2.34e-2)" 1.4 11.2 21.1 2.0 28.8 1.5 1.7 52.1 64.6 2.3 2.1 2.7 0.0 2.2 1.6 2.2 1.3 1.7 1.9 2.1 20.5 19.2 1.4 2.2 2.7 3.1 9.5 32.1 2.0 3.6 1.5 4.8 3.3 15.3 1.5 2.1 4.9 1.9 1.8 1.5 1.5 2.1 1.6 6.3 2.8 3.1 3.4 5.8 0.0 1.3 0.0 2.6 1.2 0.5 1.3 0.2 0.1 1.5 0.7 5.7 1.3 0.0 8.4 3.7 2.7 0.3 0.0 0.8 0.3 0.0 0.0 0.3 1.1 0.0 3.1 12.8 0.2 0.7 2.4 1.2 0.2 2.0 3.2 2.7 1.6 13.4 1.4 0.0 3.7 0.5 0.0 0.0 0.2 0.7 5.0 0.0 0.0 12.7 1.8 27.6 1.3 4.3 3.1 2.4 0.7 1.3 0.0 4.6 6.6 1.6 14.0 4.0 5.1 7.9 1.3 1.5 16.0 0.1 0.6 0.0 2.1 4.4 3.4 3.2 0.1 0.0 1.5 0.0 2.6 0.8 1.0 1.0 0.3 0.4 0.2 1.3 5.7 3.2 0.1 0.7 0.2 0.0 3.5 1.3 21.1 28.8 52.1 36.4 20.5 19.2 9.5 32.1 15.3 5.8 SLC13A1 "NAS1, NaSi-1" ENSG00000081800 "Solute carrier family 13 member 1" Q9BZW2 7 123113531-123199986 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sulfate transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 67.5" "Cell line enhanced" "Detected in single" "BEWO: 1.0" "Cancer enriched" "Detected in single" 219 "renal cancer: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 0.9" "Low region specificity" "Detected in all" "HPA053615, HPA062714" Enhanced "HPA053615: , HPA062714: " "unprognostic (1.86e-1)" "prognostic favourable (8.95e-5)" "unprognostic (1.71e-1)" "unprognostic (3.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 67.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.0 0.9 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.2 0.3 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.8 0.1 0.6 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC13A2 NaDC-1 ENSG00000007216 "Solute carrier family 13 member 2" Q13183 17 28473293-28497781 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 181.4" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;RPMI-8226: 2.3;SH-SY5Y: 1.2;SK-BR-3: 1.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hippocampal formation: 1.8" HPA014963 Enhanced "HPA014963: AB_1857096" "unprognostic (8.47e-2)" "unprognostic (7.63e-3)" "unprognostic (4.36e-3)" "unprognostic (2.06e-1)" "unprognostic (2.36e-3)" "unprognostic (3.06e-1)" "unprognostic (2.28e-4)" "unprognostic (1.50e-1)" "unprognostic (1.74e-1)" "unprognostic (1.00e-2)" "prognostic favourable (9.00e-4)" "unprognostic (2.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.50e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 1.4 0.1 0.1 0.1 142.8 0.0 10.7 34.6 0.1 0.5 0.1 0.1 3.4 0.1 0.1 0.1 12.5 0.3 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 1.8 0.0 14.9 17.1 0.1 2.1 181.4 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.7 0.1 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 SLC13A3 "NADC3, SDCT2" ENSG00000158296 "Solute carrier family 13 member 3" Q8WWT9 20 46557823-46684467 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 128.6" "Cell line enhanced" "Detected in many" "BEWO: 9.8;EFO-21: 11.2;Hep G2: 31.9;HHSteC: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014333, HPA014353, HPA014736" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA014333: , HPA014353: AB_1856968, HPA014736: AB_1856970" "unprognostic (1.07e-2)" "unprognostic (7.40e-2)" "unprognostic (5.59e-2)" "unprognostic (1.19e-2)" "unprognostic (3.34e-1)" "unprognostic (3.19e-2)" "unprognostic (2.15e-1)" "unprognostic (2.82e-2)" "unprognostic (1.66e-2)" "unprognostic (9.50e-2)" "unprognostic (1.92e-2)" "unprognostic (1.03e-1)" "unprognostic (8.94e-2)" "unprognostic (3.87e-1)" "unprognostic (1.17e-1)" "unprognostic (1.87e-1)" "unprognostic (2.05e-2)" 0.7 0.9 2.6 0.5 6.2 0.4 0.9 2.5 3.6 0.9 0.5 15.1 0.0 0.4 0.9 0.7 0.6 1.1 0.9 0.6 3.4 3.1 128.6 7.0 0.8 0.5 9.3 2.1 1.8 3.0 0.4 0.6 12.9 6.5 2.3 0.5 8.1 1.7 0.6 0.6 1.0 0.4 0.9 7.8 0.5 1.7 2.7 5.6 0.0 0.8 0.0 0.6 1.0 0.4 0.6 2.4 2.7 0.4 0.7 0.9 0.0 0.0 0.0 0.9 3.3 5.0 4.7 9.8 2.0 1.2 1.1 0.8 0.0 0.0 0.1 11.2 0.1 1.2 0.0 1.5 2.6 0.0 0.3 3.8 0.2 31.9 11.2 0.0 2.8 6.3 4.4 6.4 3.2 0.0 8.5 0.2 0.0 0.3 0.0 0.4 6.0 0.0 0.1 0.0 0.0 0.7 0.2 0.4 0.1 0.0 2.3 0.5 1.7 0.1 0.1 0.1 2.4 5.1 0.0 0.3 0.6 0.0 0.3 0.0 0.2 2.7 0.4 0.3 0.9 0.2 0.2 0.4 0.3 0.3 0.1 0.6 0.6 0.6 1.3 0.7 0.3 2.4 0.3 0.0 2.6 6.2 2.5 3.6 3.4 3.1 9.3 2.1 6.5 5.6 SLC15A1 "HPECT1, HPEPT1, PEPT1" ENSG00000088386 "Solute carrier family 15 member 1" P46059 13 98683801-98752654 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "intestine: 134.9" "Group enriched" "Detected in some" 6 "CAPAN-2: 29.5;SK-BR-3: 29.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002827 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA002827: AB_1856974" "unprognostic (8.76e-2)" "unprognostic (1.87e-1)" "unprognostic (4.72e-2)" "unprognostic (1.49e-1)" "unprognostic (6.76e-3)" "unprognostic (6.26e-2)" "unprognostic (7.83e-2)" "unprognostic (5.47e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-1)" "unprognostic (6.79e-2)" "unprognostic (6.88e-4)" "unprognostic (2.11e-2)" "unprognostic (2.84e-1)" "unprognostic (2.64e-1)" "unprognostic (9.01e-2)" "unprognostic (3.87e-2)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.1 51.7 0.2 0.3 42.7 1.9 2.2 0.9 0.1 16.6 0.1 0.1 0.1 6.3 8.2 0.2 0.1 0.1 0.1 0.2 7.1 4.3 0.3 1.0 0.3 0.9 0.5 0.2 0.3 0.3 0.1 9.9 134.9 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.7 0.4 0.5 1.9 1.1 1.1 2.3 0.7 1.2 0.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.8 29.5 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.6 1.7 0.6 0.1 0.3 0.0 29.4 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.7 0.9 0.3 0.8 0.8 0.7 0.7 0.2 1.1 0.9 0.8 2.2 1.2 0.4 1.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 SLC16A13 MCT13 ENSG00000174327 "Solute carrier family 16 member 13" Q7RTY0 17 7036075-7040121 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 55.9" "Cell line enhanced" "Detected in many" "A549: 17.9;HaCaT: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065245 Supported "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA065245: " "unprognostic (5.61e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (1.78e-1)" "unprognostic (2.22e-3)" "unprognostic (9.53e-2)" "unprognostic (1.62e-1)" "unprognostic (8.72e-2)" "unprognostic (1.81e-1)" "unprognostic (2.60e-1)" "prognostic favourable (1.50e-4)" "unprognostic (2.44e-2)" "unprognostic (7.31e-3)" "unprognostic (9.70e-3)" "unprognostic (3.99e-2)" "unprognostic (1.25e-1)" "unprognostic (1.14e-1)" 2.5 1.3 1.4 3.5 0.8 0.2 1.6 1.5 1.0 1.8 4.9 0.7 1.2 8.0 1.1 1.4 5.0 1.5 3.2 1.3 1.2 0.7 12.0 55.9 2.9 7.6 0.8 0.5 1.7 2.8 2.7 1.0 3.3 0.7 1.5 1.3 1.8 3.5 1.5 0.5 4.5 10.2 0.7 0.6 4.8 1.6 0.7 0.3 3.6 3.0 2.4 5.8 1.8 2.4 6.8 2.8 2.4 2.2 2.7 3.9 1.3 10.0 17.9 4.2 2.6 2.6 1.5 1.8 1.0 2.6 2.3 5.3 5.8 11.3 6.4 1.7 1.6 15.9 3.3 5.5 0.9 7.9 2.2 2.6 1.4 13.8 3.0 0.9 6.2 1.7 6.3 3.4 2.8 9.5 3.0 1.8 2.4 5.0 3.8 1.6 1.7 1.4 1.8 1.4 1.1 2.2 2.8 0.2 1.1 3.1 1.8 1.4 4.8 1.4 3.5 1.5 3.5 2.4 1.5 3.2 6.6 0.4 4.4 2.3 0.7 0.0 2.0 2.2 3.2 1.9 2.3 2.3 2.9 3.9 2.1 6.8 3.1 2.9 2.4 2.7 2.2 2.8 3.0 1.3 1.4 0.8 1.5 1.0 1.2 0.7 0.8 0.5 0.7 0.3 SLC16A8 "MCT3, REMP" ENSG00000100156 "Solute carrier family 16 member 8" O95907 22 38078134-38084093 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 70.9" "Cell line enhanced" "Detected in some" "BEWO: 5.9;SiHa: 6.4;T-47d: 7.7;U-266/70: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075017 Enhanced Approved "Intermediate filaments,Focal adhesion sites" "Focal adhesion sites" "Intermediate filaments" "HPA075017: " "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (5.07e-6)" "unprognostic (2.99e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-2)" "unprognostic (2.99e-2)" "unprognostic (1.74e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.63e-2)" "unprognostic (1.32e-2)" "unprognostic (2.34e-4)" "unprognostic (7.69e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (9.71e-5)" 1.6 2.6 1.9 0.8 5.1 1.2 0.8 0.8 3.3 0.8 0.8 0.8 0.8 0.5 1.3 0.8 1.1 1.2 2.7 2.9 2.7 2.9 0.8 0.8 0.8 0.9 2.8 0.8 0.8 2.1 0.0 2.6 0.8 1.3 4.0 0.0 70.9 10.0 0.8 1.9 4.2 0.8 0.8 3.7 1.8 2.3 2.0 0.8 0.8 0.9 0.8 0.8 1.6 0.8 0.0 0.0 0.0 0.0 0.5 0.6 0.0 1.3 0.7 1.1 0.2 0.0 0.0 5.9 0.5 0.0 0.0 0.0 1.2 3.5 0.4 1.7 0.0 0.8 0.0 0.0 0.0 0.0 1.8 0.3 1.0 0.1 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 3.9 0.0 0.0 1.4 0.1 2.0 0.0 0.0 0.0 4.4 1.9 0.3 6.4 0.3 0.9 7.7 0.2 0.0 0.0 3.5 0.3 0.0 11.3 1.6 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 5.1 0.8 1.2 2.7 2.9 2.8 0.8 1.3 0.8 SLC17A2 NPT3 ENSG00000112337 "Solute carrier family 17 member 2" O00624 6 25912754-25930726 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 333 "liver: 80.2" "Cell line enriched" "Detected in single" 20 "Hep G2: 8.9" "Cancer enriched" "Detected in some" 8 "liver cancer: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038270 Uncertain "HPA038270: AB_10672511" "prognostic favourable (8.54e-4)" "unprognostic (1.90e-2)" "unprognostic (4.14e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 80.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC17A3 NPT4 ENSG00000124564 "Solute carrier family 17 member 3" O00476 6 25833066-25882286 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 62.3" "Cell line enriched" "Detected in single" 217 "RPTEC TERT1: 50.6" "Cancer enriched" "Detected in some" 17 "renal cancer: 57.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 1.1;MAIT T-cell: 1.9;memory CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (5.31e-3)" "unprognostic (1.56e-2)" "unprognostic (2.51e-1)" "unprognostic (4.65e-2)" "unprognostic (5.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.07e-1)" "unprognostic (2.34e-1)" "unprognostic (1.34e-1)" "unprognostic (4.49e-1)" 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 62.3 13.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.9 0.0 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SLC17A5 "AST, ISSD, NSD, SD, SIALIN, SIASD, SLD" ENSG00000119899 "Solute carrier family 17 member 5" Q9NRA2 6 73593379-73654155 "Disease related genes, Predicted membrane proteins" "Amino-acid transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "parathyroid gland: 155.6" "Cell line enhanced" "Detected in many" "ASC diff: 40.9;ASC TERT1: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044479 Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA044479: " "unprognostic (6.48e-3)" "unprognostic (7.95e-3)" "unprognostic (9.23e-2)" "unprognostic (1.45e-2)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (2.59e-3)" "unprognostic (4.44e-2)" "unprognostic (4.18e-2)" "unprognostic (2.60e-1)" "unprognostic (3.14e-2)" "unprognostic (8.29e-2)" "unprognostic (4.59e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "prognostic favourable (3.52e-4)" "unprognostic (1.09e-1)" 7.2 5.8 6.4 2.9 6.8 2.9 9.6 6.3 6.8 4.9 7.8 4.7 12.5 6.5 5.1 17.2 5.0 3.4 6.2 6.2 4.5 6.7 24.3 13.2 7.6 4.9 5.0 4.5 3.4 8.7 155.6 9.3 12.6 6.7 6.9 8.6 6.6 15.5 8.6 3.5 4.8 12.9 4.6 5.9 4.3 6.0 4.1 4.7 3.0 30.5 2.6 7.1 5.9 4.3 5.2 9.9 12.4 10.6 12.0 9.4 6.0 2.7 3.8 3.8 6.1 40.9 30.5 5.1 9.2 23.1 2.5 8.7 2.5 6.8 2.5 4.4 12.8 4.9 5.3 2.3 4.4 1.8 6.1 1.1 2.0 5.8 8.2 2.1 4.3 13.9 3.4 5.6 3.9 6.3 2.7 2.8 8.6 1.8 0.8 1.2 2.8 2.2 1.8 4.7 10.9 6.4 7.7 1.5 2.7 1.8 5.5 5.3 2.5 13.0 9.2 1.2 1.1 4.9 2.1 8.0 11.2 0.7 4.1 4.5 3.6 12.4 10.6 4.2 8.5 9.7 8.3 5.2 9.4 8.1 9.9 3.7 7.8 8.6 7.4 12.0 6.0 7.4 8.2 6.0 6.4 6.8 6.3 6.8 4.5 6.7 5.0 4.5 6.7 4.7 SLC17A6 "DNPI, VGLUT2" ENSG00000091664 "Solute carrier family 17 member 6" Q9P2U8 11 22338097-22379503 "Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 75.2" "Cell line enriched" "Detected in single" 222 "SCLC-21H: 26.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "hypothalamus: 20.2;pons and medulla: 75.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 54.1;hypothalamus: 163.2;midbrain: 206.4;pons and medulla: 90.5;thalamus: 180.7" "Low region specificity" "Detected in many" "CAB037130, HPA039226, CAB078204" Supported Supported "CAB037130: AB_477611, CAB078204: , HPA039226: " "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" 0.5 0.5 7.6 0.5 1.1 0.5 0.5 0.2 13.8 0.5 0.5 1.3 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.5 1.1 20.2 0.5 0.5 0.5 0.5 7.1 2.1 0.5 1.5 0.5 5.3 0.5 75.2 0.5 0.5 1.4 0.5 0.5 0.5 0.5 0.5 0.5 5.9 0.5 0.5 0.5 0.0 0.0 0.5 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 1.1 0.2 8.4 1.1 20.2 7.1 2.1 75.2 0.0 SLC17A7 "BNPI, VGLUT1" ENSG00000104888 "Solute carrier family 17 member 7" Q9P2U7 19 49429401-49442360 "Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "brain: 150.0" "Cell line enhanced" "Detected in some" "HMC-1: 20.7;K-562: 6.5;REH: 3.8;SCLC-21H: 4.8" "Cancer enriched" "Detected in some" 6 "glioma: 7.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 281.0;cerebellum: 378.0;cerebral cortex: 391.3;hippocampal formation: 626.6" "CAB037183, HPA050458, HPA063679" Enhanced Supported "CAB037183: AB_261840, HPA050458: , HPA063679: " "unprognostic (1.79e-1)" "unprognostic (3.35e-1)" "unprognostic (1.29e-1)" "unprognostic (1.52e-2)" "unprognostic (9.12e-2)" "unprognostic (3.03e-2)" "unprognostic (1.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.30e-1)" "unprognostic (2.70e-3)" "unprognostic (8.32e-2)" "unprognostic (6.61e-2)" "unprognostic (4.26e-12)" "unprognostic (8.36e-4)" "unprognostic (4.27e-1)" "unprognostic (1.35e-2)" "unprognostic (6.17e-3)" 2.1 1.2 58.3 1.0 27.6 1.0 1.7 52.7 150.0 1.3 1.3 1.5 0.0 1.1 1.2 1.2 1.4 1.3 1.3 1.4 74.3 1.7 1.1 1.0 1.1 1.3 6.0 36.4 1.0 1.0 1.0 0.1 1.0 20.0 1.0 1.2 9.1 1.1 1.1 1.4 1.6 1.3 1.2 0.9 1.0 1.1 1.5 0.0 0.0 1.2 0.0 1.2 1.2 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.4 1.6 0.3 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.2 0.3 0.5 0.1 1.8 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.1 0.3 0.0 0.0 6.5 0.9 0.0 0.2 0.0 0.1 0.0 0.3 3.8 0.1 0.1 0.0 0.0 4.8 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.3 2.3 0.8 0.0 0.4 0.3 0.3 0.6 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.3 27.6 52.7 76.0 74.3 1.7 6.0 36.4 20.0 0.0 SLC1A2 "EAAT2, GLT-1" ENSG00000110436 "Solute carrier family 1 member 2" P43004 11 35251205-35420063 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 160.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.4;BJ hTERT+: 4.8;fHDF/TERT166: 3.4;Hep G2: 5.6;NTERA-2: 6.2;SCLC-21H: 3.2" "Cancer enriched" "Detected in some" 5 "glioma: 28.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002574, HPA009172" Enhanced "CAB002574: AB_564087, HPA009172: AB_1849764" "unprognostic (8.00e-2)" "unprognostic (5.71e-3)" "unprognostic (1.39e-1)" "unprognostic (2.77e-2)" "unprognostic (1.33e-1)" "unprognostic (5.65e-3)" "unprognostic (1.39e-2)" "unprognostic (9.27e-3)" "unprognostic (1.55e-1)" "unprognostic (1.65e-2)" "unprognostic (1.79e-3)" "unprognostic (2.35e-1)" "unprognostic (8.33e-4)" "unprognostic (6.34e-2)" "unprognostic (8.06e-2)" "unprognostic (5.24e-2)" "unprognostic (3.49e-2)" 1.7 4.1 65.1 1.9 79.4 1.8 3.7 7.2 160.9 2.0 1.7 9.8 0.0 1.8 2.1 1.8 1.7 1.7 1.7 2.1 47.6 11.7 1.7 20.5 1.9 2.5 15.2 43.1 1.6 4.2 1.6 0.4 2.1 27.6 1.7 1.7 0.0 3.9 1.7 1.7 2.3 1.6 1.8 17.2 1.8 2.6 2.4 16.3 0.0 1.7 0.0 2.4 1.7 0.3 1.1 0.7 3.9 0.7 1.2 0.9 0.4 0.0 0.2 1.1 0.1 0.5 4.4 0.0 1.0 4.8 0.2 0.2 0.2 0.0 0.1 0.1 3.4 0.3 0.0 0.0 0.4 0.0 0.0 0.4 0.5 5.6 0.2 0.6 0.2 0.9 0.0 0.4 0.0 0.0 0.0 0.4 0.1 2.1 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.5 0.0 2.3 0.0 1.1 0.0 0.6 0.2 0.2 0.5 0.1 0.6 0.0 0.0 1.1 0.0 0.3 3.9 0.7 0.8 0.5 0.3 0.3 0.4 0.5 0.4 0.7 1.1 0.9 0.7 2.1 1.2 0.4 0.6 0.4 0.4 65.1 79.4 7.2 64.9 47.6 11.7 15.2 43.1 27.6 16.3 SLC1A3 "EA6, EAAT1, GLAST" ENSG00000079215 "Solute carrier family 1 member 3" P43003 5 36606355-36688334 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 188.6" "Cell line enhanced" "Detected in many" "AF22: 21.2;CACO-2: 34.1;HaCaT: 25.8" "Cancer enriched" "Detected in all" 21 "glioma: 168.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4" "Group enriched" "Detected in many" 39 "dendritic cells: 3.4;monocytes: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002573, HPA037467, HPA037468" Enhanced Supported Approved Nucleoli,Mitochondria Mitochondria Nucleoli "CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371" "unprognostic (1.23e-1)" "unprognostic (2.15e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (7.70e-2)" "unprognostic (3.89e-3)" "unprognostic (2.36e-1)" "unprognostic (1.24e-1)" "unprognostic (2.84e-2)" "unprognostic (4.17e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.17e-2)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" 17.3 10.3 76.1 5.9 70.6 3.1 6.3 45.8 188.6 6.9 3.2 26.3 0.0 2.1 2.8 2.3 7.2 5.4 5.9 12.0 57.9 27.3 3.1 3.6 4.7 8.6 32.7 39.6 8.6 4.0 2.6 3.7 12.7 28.5 3.3 2.6 1.9 3.0 4.4 7.6 5.5 2.3 4.1 29.4 5.8 2.9 2.7 33.6 0.0 2.6 0.7 4.5 4.8 1.2 0.0 3.4 0.0 4.3 0.0 0.0 0.8 0.4 0.1 21.2 1.8 2.1 5.9 13.5 0.0 0.0 0.8 1.8 34.1 1.7 0.0 10.3 0.3 25.8 6.2 2.8 0.9 0.3 12.7 0.0 0.1 0.0 0.4 0.4 0.1 10.9 12.8 5.2 2.1 0.0 0.0 0.1 3.6 0.0 0.0 0.0 2.5 2.1 0.0 0.1 0.0 0.0 1.3 1.8 0.0 2.1 6.2 0.3 0.0 1.0 0.0 1.9 3.1 0.0 7.5 0.0 0.0 0.0 8.6 14.3 4.8 0.0 4.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.8 76.1 70.6 45.8 57.8 57.9 27.3 32.7 39.6 28.5 33.6 SLC1A7 EAAT5 ENSG00000162383 "Solute carrier family 1 member 7" O00341 1 53087179-53142632 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "retina: 70.1" "Cell line enriched" "Detected in some" 9 "HHSteC: 23.8" "Cancer enhanced" "Detected in many" "lung cancer: 3.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "gdT-cell: 5.7;memory CD8 T-cell: 2.2;naive CD8 T-cell: 2.6" "Lineage enriched" "Detected in single" 58 "T-cells: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA049124 Enhanced "HPA049124: " "unprognostic (2.33e-1)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (9.48e-4)" "unprognostic (2.31e-1)" "unprognostic (8.73e-2)" "unprognostic (1.52e-2)" "unprognostic (6.26e-3)" "unprognostic (4.35e-1)" "unprognostic (1.45e-2)" "unprognostic (1.59e-1)" "unprognostic (7.65e-2)" "unprognostic (1.19e-3)" "unprognostic (2.58e-3)" "unprognostic (5.43e-2)" "unprognostic (8.12e-2)" "unprognostic (4.70e-3)" 2.0 0.2 1.1 0.6 0.6 0.0 1.2 0.6 0.7 0.9 1.0 0.7 0.6 4.1 1.3 1.2 2.1 2.2 9.6 2.9 1.7 1.1 0.7 2.8 0.9 0.6 1.2 0.6 3.8 0.6 0.0 0.6 0.6 1.1 0.9 0.0 70.1 0.6 0.6 2.1 1.2 5.3 0.6 1.3 0.6 1.1 0.9 0.6 0.6 0.6 0.6 0.6 2.5 0.9 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.1 0.8 1.1 0.6 0.6 0.7 1.7 1.1 1.2 0.6 1.1 0.6 SLC22A1 OCT1 ENSG00000175003 "Solute carrier family 22 member 1" O15245 6 160121789-160158718 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "liver: 175.8" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in some" 81 "liver cancer: 83.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "neutrophil: 7.3" "Lineage enriched" "Detected in single" 13 "granulocytes: 7.3" "Region enhanced" "Detected in single" "cerebral cortex: 0.7" "Not detected" "Not detected" HPA029846 Approved "HPA029846: AB_10603026" "unprognostic (8.28e-2)" "unprognostic (2.10e-1)" "unprognostic (7.80e-2)" "unprognostic (2.68e-1)" "unprognostic (1.93e-1)" "unprognostic (2.10e-2)" "prognostic favourable (1.35e-5)" "unprognostic (2.28e-1)" "unprognostic (8.61e-2)" "unprognostic (3.35e-1)" "unprognostic (9.11e-2)" "unprognostic (9.94e-2)" "unprognostic (1.46e-7)" "unprognostic (1.58e-1)" "unprognostic (1.24e-1)" "unprognostic (4.72e-2)" "unprognostic (8.07e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 175.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 7.3 0.3 0.0 0.5 0.0 0.0 1.0 1.0 1.8 1.6 0.6 0.7 0.4 0.2 0.5 0.5 1.4 0.5 0.5 1.1 0.1 0.3 0.0 1.8 0.8 1.5 1.0 0.6 0.6 2.5 0.0 1.5 1.1 0.0 2.0 0.0 1.1 0.1 0.5 0.3 0.3 0.2 0.1 1.1 0.0 0.7 0.0 1.9 1.6 0.3 0.9 0.7 0.0 2.5 0.0 1.6 0.3 0.1 0.0 0.6 0.7 1.8 1.2 1.5 2.8 0.9 0.2 1.0 0.3 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.1 7.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A10 "hOAT5, OAT5" ENSG00000184999 "Solute carrier family 22 member 10" Q63ZE4 11 63137867-63369718 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 32 "liver: 41.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 14 "liver cancer: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.17e-2)" "unprognostic (9.77e-2)" "unprognostic (7.07e-3)" "unprognostic (7.46e-4)" "unprognostic (7.62e-3)" "unprognostic (2.87e-1)" "unprognostic (1.56e-1)" "unprognostic (6.52e-2)" "unprognostic (4.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A12 "OAT4L, RST, URAT1" ENSG00000197891 "Solute carrier family 22 member 12" Q96S37 11 64590641-64602353 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 349 "kidney: 70.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 207 "liver cancer: 4.0;renal cancer: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA024575 Enhanced "HPA024575: AB_1858650" "unprognostic (5.88e-2)" "unprognostic (2.33e-1)" "prognostic favourable (2.63e-4)" "unprognostic (6.19e-2)" "unprognostic (3.91e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A13 "OAT10, OCTL1, OCTL3, ORCTL3" ENSG00000172940 "Solute carrier family 22 member 13" Q9Y226 3 38265812-38278315 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 16.4" "Cell line enhanced" "Detected in some" "HeLa: 2.2;hTERT-HME1: 1.5" "Cancer enriched" "Detected in single" 7 "renal cancer: 0.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.3" "Lineage enriched" "Detected in single" 5 "T-cells: 2.3" "Low region specificity" "Detected in all" "HPA035603, HPA035962" Enhanced "HPA035603: AB_10672869, HPA035962: " "unprognostic (2.73e-2)" "unprognostic (6.70e-2)" "unprognostic (2.80e-1)" "unprognostic (5.68e-2)" "unprognostic (7.13e-3)" "unprognostic (3.50e-3)" "unprognostic (6.83e-2)" "unprognostic (1.49e-1)" "unprognostic (3.48e-1)" "unprognostic (2.09e-1)" "unprognostic (3.04e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-5)" "unprognostic (3.39e-1)" "unprognostic (1.96e-2)" "unprognostic (5.24e-2)" "unprognostic (2.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 16.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.1 0.3 0.0 2.3 0.0 0.2 0.5 0.1 0.6 0.4 0.5 0.1 0.3 0.0 0.2 0.3 0.0 0.5 0.9 0.2 0.1 0.8 0.4 0.7 0.1 0.4 0.1 0.0 2.2 0.0 0.1 0.0 0.8 0.0 0.5 0.1 1.5 0.0 0.0 0.1 1.1 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.2 0.0 1.2 0.1 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.3 0.7 1.2 0.3 0.3 0.4 0.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.4 0.1 0.3 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A14 "OCTL2, ORCTL4" ENSG00000144671 "Solute carrier family 22 member 14" Q9Y267 3 38282294-38318575 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 13.2" "Cell line enhanced" "Detected in some" "HSkMC: 1.9;hTCEpi: 2.9;RT4: 1.9;TIME: 1.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "neutrophil: 1.4;plasmacytoid DC: 1.2" "Group enriched" "Detected in many" 13 "dendritic cells: 1.2;granulocytes: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (6.26e-2)" "unprognostic (6.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.17e-1)" "unprognostic (6.25e-2)" "unprognostic (4.78e-2)" "unprognostic (2.33e-1)" "unprognostic (1.52e-1)" "unprognostic (1.07e-1)" "unprognostic (4.97e-2)" "unprognostic (4.81e-2)" "unprognostic (1.69e-1)" "unprognostic (3.57e-4)" "unprognostic (2.19e-1)" "unprognostic (4.02e-2)" "unprognostic (1.69e-1)" "unprognostic (2.35e-1)" 0.1 0.0 0.2 0.0 0.3 0.5 0.0 1.6 0.9 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.3 1.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.2 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.2 13.2 0.0 0.0 0.0 0.0 0.0 1.2 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.7 0.7 1.3 0.2 0.1 0.6 0.4 1.0 1.6 0.1 0.0 0.4 0.9 0.8 0.0 0.0 0.1 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.9 2.9 0.0 0.8 0.1 0.0 0.0 0.7 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.4 0.7 0.1 0.0 0.0 1.9 0.0 1.1 0.6 0.3 0.3 0.3 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.2 0.0 0.0 SLC22A2 OCT2 ENSG00000112499 "Solute carrier family 22 member 2" O15244 6 160171061-160277638 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 61.8" "Cell line enhanced" "Detected in some" "NTERA-2: 1.8;U-2197: 3.7" "Cancer enriched" "Detected in single" 493 "renal cancer: 30.8" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "midbrain: 2.1" "HPA008549, CAB068236, CAB068237" Approved "CAB068236: AB_2493102, CAB068237: AB_2493103, HPA008549: " "unprognostic (1.01e-1)" "unprognostic (3.67e-1)" "unprognostic (2.26e-1)" "unprognostic (3.67e-2)" "unprognostic (4.24e-1)" "unprognostic (3.33e-1)" "unprognostic (2.51e-2)" "unprognostic (3.30e-1)" "unprognostic (1.42e-2)" "unprognostic (1.15e-4)" "unprognostic (1.41e-1)" "unprognostic (3.68e-1)" "prognostic favourable (1.85e-7)" "unprognostic (1.65e-2)" "unprognostic (8.20e-2)" "unprognostic (4.11e-1)" "unprognostic (2.45e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.1 61.8 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.3 0.2 1.9 0.1 0.0 2.7 0.0 0.6 0.3 0.0 0.1 0.1 6.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 1.0 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.7 0.3 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.0 3.7 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.5 0.0 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.5 0.0 0.3 0.1 0.0 0.0 0.2 0.6 0.3 0.2 0.1 0.8 0.8 1.9 0.0 SLC22A24 "MGC34821, NET46" ENSG00000197658 "Solute carrier family 22 member 24" Q8N4F4 11 63079940-63144221 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "kidney: 10.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 11 "renal cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA045015 Uncertain "HPA045015: " "unprognostic (5.72e-3)" "unprognostic (1.80e-7)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A25 "HIMTP, MGC120420, UST6" ENSG00000196600 "Solute carrier family 22 member 25" Q6T423 11 63163776-63229652 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 165 "liver: 16.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 66 "liver cancer: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA039390 Uncertain "HPA039390: AB_10671996" "unprognostic (3.19e-2)" "unprognostic (2.38e-1)" "unprognostic (4.51e-1)" "prognostic favourable (7.04e-4)" "unprognostic (1.01e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A6 "OAT1, PAHT, ROAT1" ENSG00000197901 "Solute carrier family 22 member 6" Q4U2R8 11 62936385-62984983 "FDA approved drug targets, Predicted membrane proteins, Transporters" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "kidney: 94.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 102 "renal cancer: 18.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA074559, CAB075704" Enhanced "CAB075704: , HPA074559: " "unprognostic (2.42e-2)" "unprognostic (2.25e-3)" "unprognostic (4.43e-1)" 0.2 0.2 0.8 0.2 1.3 0.2 0.2 0.4 1.4 0.2 0.2 0.7 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 1.8 94.2 0.2 0.2 0.2 2.4 0.6 0.2 0.2 0.2 0.1 0.2 4.1 0.2 0.2 9.4 0.2 0.2 0.2 0.2 0.2 0.2 2.4 0.2 0.2 0.2 0.5 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.4 1.4 0.8 1.8 2.4 0.6 4.1 0.5 SLC22A7 "NLT, OAT2" ENSG00000137204 "Solute carrier family 22 member 7" Q9Y694 6 43295694-43305538 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 88.9" "Cell line enriched" "Detected in single" 19 "Hep G2: 14.5" "Cancer enriched" "Detected in some" 37 "liver cancer: 81.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 4 "B-cells: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA030220 Approved "HPA030220: AB_10603027" "unprognostic (9.17e-2)" "unprognostic (9.73e-4)" "unprognostic (2.13e-1)" "prognostic favourable (5.48e-6)" "unprognostic (1.45e-1)" "unprognostic (1.54e-3)" "unprognostic (1.74e-2)" "prognostic favourable (8.98e-4)" "unprognostic (1.29e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.8 88.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.2 0.0 0.0 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 SLC22A9 "FLJ23666, OAT4, OAT7, UST3" ENSG00000149742 "Solute carrier family 22 member 9" Q8IVM8 11 63369789-63410294 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 32.2" "Cell line enhanced" "Detected in some" "Hep G2: 2.1;Karpas-707: 1.8;U-266/70: 2.4" "Cancer enriched" "Detected in single" 166 "liver cancer: 19.3" "Region enhanced" "Detected in single" "cerebral cortex: 1.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "unprognostic (2.45e-1)" "unprognostic (7.24e-2)" "unprognostic (8.86e-2)" "unprognostic (2.10e-2)" "unprognostic (1.08e-2)" "unprognostic (2.26e-1)" "unprognostic (2.17e-1)" "unprognostic (2.71e-1)" "unprognostic (3.09e-2)" 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 2.8 0.8 0.9 0.5 0.3 0.4 0.5 0.0 0.6 0.2 0.0 0.9 0.0 0.3 0.1 0.2 0.2 0.4 0.5 0.2 0.1 0.4 0.0 0.5 0.1 1.3 0.3 0.3 0.4 2.1 0.0 0.1 0.5 0.0 0.0 0.5 0.0 0.2 0.3 1.8 0.1 0.6 0.2 0.9 0.7 0.2 0.1 1.1 0.1 0.0 0.4 0.1 0.2 0.0 0.3 0.2 0.4 0.5 0.0 0.5 0.3 0.6 0.3 2.4 0.5 1.0 0.3 0.6 0.3 2.8 0.8 0.7 0.4 0.5 0.2 0.5 0.2 0.3 0.2 1.0 0.4 0.5 2.2 0.9 0.2 0.6 0.3 0.3 0.4 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 SLC24A1 "CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX" ENSG00000074621 "Solute carrier family 24 member 1" O60721 15 65611366-65660995 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision" "Congenital stationary night blindness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "retina: 91.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA039370 Enhanced Approved Microtubules Microtubules "HPA039370: AB_10960279" "unprognostic (9.47e-2)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (3.66e-3)" "unprognostic (6.39e-3)" "unprognostic (4.64e-1)" "unprognostic (8.82e-2)" "unprognostic (1.86e-1)" "unprognostic (4.69e-2)" "unprognostic (3.94e-1)" "unprognostic (2.01e-1)" "unprognostic (9.91e-2)" "prognostic favourable (2.33e-6)" "unprognostic (8.45e-2)" "unprognostic (9.22e-2)" "unprognostic (3.04e-2)" "unprognostic (1.96e-2)" 6.2 5.3 4.5 7.7 5.0 2.6 9.3 7.0 3.4 8.9 5.0 5.6 7.5 3.7 10.6 12.2 4.2 9.0 6.2 4.1 4.7 4.1 7.9 4.7 12.0 6.0 5.3 2.6 9.7 6.6 6.5 6.1 8.9 4.0 6.0 4.1 91.1 6.4 8.3 3.8 8.5 4.5 5.0 6.8 7.8 4.2 10.8 3.2 6.9 9.0 4.6 4.8 6.0 5.3 3.8 2.6 4.7 1.5 2.3 1.8 0.4 1.5 3.1 3.4 3.1 5.1 8.7 4.2 4.0 4.3 3.9 2.6 1.4 6.8 2.2 13.3 3.8 4.4 4.1 4.3 2.3 2.2 2.9 4.7 2.4 6.9 7.4 3.1 6.5 7.3 6.3 2.2 13.2 6.7 5.0 7.4 6.3 6.5 2.0 2.9 4.4 1.2 2.1 1.1 1.4 6.0 6.2 1.6 2.4 1.1 3.0 8.2 6.3 4.3 9.6 4.0 4.1 1.5 2.7 3.0 5.4 2.5 4.2 6.7 3.4 4.7 1.5 2.1 1.4 1.3 1.8 1.4 1.5 1.2 1.1 3.8 1.1 1.5 1.7 2.3 0.6 2.6 0.3 0.4 4.5 5.0 7.0 3.4 4.7 4.1 5.3 2.6 4.0 3.2 SLC24A2 NCKX2 ENSG00000155886 "Solute carrier family 24 member 2" Q9UI40 9 19507452-19786928 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport, Vision" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 31.8" "Group enriched" "Detected in some" 6 "K-562: 5.6;NTERA-2: 1.9;SCLC-21H: 5.0;U-87 MG: 6.7" "Cancer enhanced" "Detected in some" "glioma: 1.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.30e-1)" "unprognostic (8.57e-2)" "unprognostic (4.20e-1)" "unprognostic (1.05e-2)" "unprognostic (3.33e-2)" "unprognostic (1.48e-2)" "unprognostic (8.46e-2)" "unprognostic (8.37e-2)" "unprognostic (1.27e-1)" "unprognostic (1.50e-2)" "unprognostic (6.51e-2)" "unprognostic (1.57e-2)" "unprognostic (2.08e-4)" "unprognostic (1.58e-1)" "unprognostic (2.11e-3)" "unprognostic (1.51e-2)" 0.2 6.1 4.0 0.2 11.2 0.3 0.1 2.4 31.8 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.3 0.2 8.9 4.0 0.3 0.2 0.1 0.2 8.2 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 10.7 0.2 0.2 0.4 0.2 0.1 0.2 0.0 1.2 1.0 2.6 1.3 1.7 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 5.6 0.2 0.1 0.3 0.0 0.1 1.9 0.1 0.1 0.0 0.0 0.0 0.0 5.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.0 0.2 0.0 0.0 6.7 0.0 0.1 2.6 0.8 0.9 0.7 0.8 1.0 0.9 0.8 0.6 0.5 1.2 1.1 1.0 2.0 1.7 1.3 1.0 0.8 0.4 SLC24A5 "JSX, OCA6" ENSG00000188467 "Solute carrier family 24 member 5" Q71RS6 15 48120972-48142672 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport" Albinism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 71.9" "Cell line enriched" "Detected in single" 733 "SK-MEL-30: 73.2" "Cancer enriched" "Detected in single" 162 "melanoma: 8.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hippocampal formation: 3.3;pons and medulla: 4.4;thalamus: 1.7" "Low region specificity" "Detected in all" "unprognostic (3.47e-2)" "unprognostic (1.80e-1)" "unprognostic (1.35e-1)" "unprognostic (1.92e-3)" 0.1 0.1 0.5 0.1 0.6 0.1 0.6 1.5 0.5 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.1 0.4 0.1 0.5 1.0 0.3 0.1 0.2 0.1 1.7 0.1 0.1 0.1 0.1 1.5 0.1 0.4 0.1 0.1 71.9 0.2 0.1 0.1 15.4 0.7 0.1 0.6 0.1 0.1 3.0 0.4 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.6 1.5 0.5 0.5 1.0 1.7 0.1 0.4 0.4 SLC25A2 ORNT2 ENSG00000120329 "Solute carrier family 25 member 2" Q9BXI2 5 141302629-141304045 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 12.6" "Cell line enhanced" "Detected in single" "Daudi: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA042146 Uncertain "HPA042146: " "unprognostic (1.55e-1)" "unprognostic (3.53e-1)" "unprognostic (4.63e-2)" "unprognostic (4.30e-1)" "unprognostic (1.71e-1)" "unprognostic (1.30e-1)" "unprognostic (4.72e-3)" "unprognostic (2.81e-1)" "unprognostic (2.62e-2)" "unprognostic (6.69e-2)" "unprognostic (1.17e-1)" "unprognostic (8.82e-10)" "unprognostic (2.56e-1)" "unprognostic (1.87e-1)" "unprognostic (1.26e-2)" "unprognostic (1.14e-1)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 12.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 1.3 0.0 0.5 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SLC25A31 "ANT4, DKFZP434N1235" ENSG00000151475 "Solute carrier family 25 member 31" Q9H0C2 4 127730378-127774299 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 687 "testis: 68.6" "Cell line enhanced" "Detected in single" "hTCEpi: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA015064, HPA016841, HPA046835, HPA071684" Uncertain Enhanced Mitochondria Mitochondria "HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: , HPA071684: " "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.70e-1)" "unprognostic (5.32e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC25A47 C14orf68 ENSG00000140107 "Solute carrier family 25 member 47" Q6Q0C1 14 100323337-100330378 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 88 "liver: 127.2" "Cell line enhanced" "Detected in some" "Hep G2: 5.6;HL-60: 1.4;RH-30: 1.4;SCLC-21H: 2.0" "Cancer enriched" "Detected in single" 273 "liver cancer: 56.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "unprognostic (2.54e-3)" "unprognostic (2.57e-3)" "unprognostic (5.12e-2)" "unprognostic (2.27e-2)" "unprognostic (6.07e-2)" "unprognostic (1.30e-2)" "unprognostic (4.25e-2)" "unprognostic (1.14e-1)" "unprognostic (2.89e-2)" "unprognostic (2.50e-1)" "unprognostic (1.96e-3)" "unprognostic (4.46e-1)" "unprognostic (1.44e-1)" "unprognostic (4.50e-1)" "unprognostic (5.64e-2)" "unprognostic (1.02e-2)" "unprognostic (1.94e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 127.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 5.6 0.0 1.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 1.4 0.0 0.0 0.1 2.0 0.2 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SLC25A52 MCART2 ENSG00000141437 "Solute carrier family 25 member 52" 18 31759562-31760880 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 17 "testis: 18.2" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "pons and medulla: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046388, HPA058261" Uncertain Approved Mitochondria Mitochondria "HPA046388: , HPA058261: " "unprognostic (8.97e-2)" "unprognostic (4.85e-2)" "unprognostic (2.93e-1)" "unprognostic (4.87e-1)" "unprognostic (2.50e-1)" "unprognostic (9.05e-2)" "unprognostic (2.97e-2)" "unprognostic (1.30e-4)" "unprognostic (7.15e-3)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.41e-1)" "unprognostic (3.34e-2)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.3 0.4 0.4 0.0 0.8 0.4 0.5 1.3 0.4 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.3 1.2 0.5 0.0 1.0 0.0 0.3 0.2 0.5 0.0 0.9 2.4 0.6 0.0 1.4 1.1 0.0 0.2 0.0 0.3 0.0 0.7 1.0 0.0 0.0 1.3 0.1 0.3 0.0 1.1 0.9 0.0 0.0 0.4 0.7 1.5 0.8 1.0 0.2 0.6 1.7 1.3 0.6 0.5 0.5 0.7 1.3 1.4 0.7 0.8 0.6 1.2 0.8 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.2 0.2 0.2 0.4 0.4 0.0 0.4 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 SLC26A4 "DFNB4, PDS" ENSG00000091137 "Solute carrier family 26 member 4" O43511 7 107660635-107717809 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "thyroid gland: 79.2" "Cell line enhanced" "Detected in some" "HDLM-2: 4.2;LHCN-M2: 5.5;U-251 MG: 3.3" "Cancer enriched" "Detected in some" 8 "thyroid cancer: 37.6" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "naive B-cell: 3.1" "Lineage enriched" "Detected in single" 5 "B-cells: 3.1" "Region enriched" "Detected in some" 4 "hippocampal formation: 10.6" "Low region specificity" "Detected in all" HPA042860 Approved "HPA042860: AB_10796680" "unprognostic (1.19e-2)" "unprognostic (4.84e-2)" "unprognostic (5.44e-2)" "unprognostic (8.44e-2)" "unprognostic (3.25e-2)" "unprognostic (3.26e-2)" "unprognostic (6.69e-2)" "unprognostic (1.85e-1)" "unprognostic (5.72e-2)" "unprognostic (9.58e-2)" "unprognostic (1.60e-1)" "unprognostic (1.03e-1)" "unprognostic (6.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.41e-2)" "unprognostic (1.39e-1)" 0.1 0.0 0.8 0.2 0.5 0.0 0.2 0.0 2.9 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.2 3.3 0.0 0.2 0.0 0.1 0.6 0.1 0.1 0.1 0.1 0.0 0.0 1.8 0.0 1.4 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 79.2 0.0 0.1 0.8 0.1 3.1 0.1 0.1 0.2 0.1 0.5 0.3 0.8 0.4 0.6 0.1 0.8 1.8 0.5 0.4 0.2 0.3 0.1 0.0 0.2 0.1 3.0 0.3 0.2 0.6 0.2 0.1 4.2 1.0 0.0 0.3 0.2 0.5 0.5 1.3 0.1 1.1 0.5 0.0 0.1 0.0 0.4 5.5 0.8 0.1 0.5 0.0 1.0 0.2 1.5 0.0 0.0 0.1 3.0 0.2 0.0 0.0 2.1 0.0 0.5 0.8 0.8 0.6 0.3 3.3 0.8 0.8 0.3 1.0 0.5 2.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 3.1 0.0 0.1 0.1 0.1 0.2 0.1 0.5 0.3 0.8 0.5 0.0 1.4 0.5 0.2 0.1 0.6 0.0 0.0 SLC26A5 "DFNB61, PRES" ENSG00000170615 "Solute carrier family 26 member 5" P58743 7 103352730-103446177 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell shape, Hearing" "Motor protein" "Deafness, Non-syndromic deafness" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 20.4" "Cell line enhanced" "Detected in some" "Karpas-707: 2.9;PC-3: 2.5;U-2197: 1.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 8 "cerebellum: 20.4" "Cell type enriched" "Detected in single" 8 "basophil: 2.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.7" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 8 "basal ganglia: 9.5" "unprognostic (3.86e-2)" "unprognostic (5.13e-2)" "unprognostic (6.38e-3)" "unprognostic (2.76e-2)" "unprognostic (1.02e-2)" "unprognostic (5.09e-2)" "unprognostic (2.36e-1)" "unprognostic (3.56e-4)" "unprognostic (4.21e-3)" "unprognostic (8.92e-3)" "unprognostic (2.82e-1)" "unprognostic (2.97e-1)" "unprognostic (3.67e-5)" "unprognostic (3.05e-1)" "unprognostic (2.81e-1)" "unprognostic (2.94e-2)" "unprognostic (2.69e-3)" 1.3 1.0 0.6 0.3 0.7 2.3 3.1 20.4 0.8 0.6 0.3 0.5 0.0 0.9 0.5 0.0 0.2 0.4 0.2 0.4 0.8 0.4 0.7 0.9 2.2 1.2 1.3 0.4 0.4 0.7 2.5 4.6 0.1 2.6 3.1 0.1 0.9 1.4 1.0 0.6 2.2 0.5 1.2 2.9 0.9 3.2 0.9 0.2 0.0 1.8 0.0 0.2 3.2 0.4 0.2 0.0 2.7 0.1 0.3 0.1 0.0 0.2 0.0 0.3 0.7 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 1.1 0.7 0.4 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.2 0.9 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.3 2.9 0.0 1.1 0.8 0.3 0.1 2.5 0.2 0.1 0.4 0.0 0.8 0.9 1.4 0.3 0.3 0.0 0.7 0.0 0.0 0.6 0.5 1.7 0.4 0.7 0.4 0.4 0.2 0.2 0.3 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.7 20.4 0.8 0.8 0.4 1.3 0.4 2.6 0.2 SLC26A7 SUT2 ENSG00000147606 "Solute carrier family 26 member 7" Q8TE54 8 91209494-91398152 "Predicted membrane proteins" "Anion exchange, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "thyroid gland: 194.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.7;EFO-21: 1.3;HAP1: 2.9;HEK 293: 1.6;U-266/70: 3.1" "Group enriched" "Detected in some" 11 "renal cancer: 8.7;thyroid cancer: 32.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (5.84e-2)" "unprognostic (8.04e-3)" "unprognostic (4.15e-3)" "unprognostic (1.51e-1)" "unprognostic (2.39e-3)" "unprognostic (2.94e-3)" "unprognostic (1.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.41e-2)" "unprognostic (8.26e-2)" "unprognostic (4.82e-2)" "unprognostic (3.31e-2)" "unprognostic (2.07e-1)" "unprognostic (5.19e-3)" "unprognostic (6.83e-3)" 0.3 0.1 0.1 0.4 0.1 0.0 0.2 0.1 0.2 1.6 0.2 0.0 0.2 0.0 1.4 0.2 0.3 0.1 0.1 0.3 0.1 0.1 13.0 0.1 0.1 1.7 0.1 0.0 0.1 0.3 0.1 0.3 4.4 0.7 0.1 0.0 8.6 0.8 0.1 0.2 0.2 0.1 0.0 0.3 0.1 1.5 0.2 0.0 0.0 194.5 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 1.3 0.0 0.0 2.9 0.1 0.2 0.0 1.6 0.3 0.1 0.0 0.0 0.0 1.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.6 3.1 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.7 0.0 SLC26A8 ENSG00000112053 "Solute carrier family 26 member 8" Q96RN1 6 35943514-36024868 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 65.2" "Cell line enhanced" "Detected in some" "RT4: 2.8;T-47d: 1.0;THP-1: 2.2;TIME: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 5.4" "Lineage enriched" "Detected in single" 12 "granulocytes: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA038081 Enhanced "HPA038081: AB_10670653" "unprognostic (8.18e-2)" "unprognostic (1.74e-1)" "unprognostic (6.71e-2)" "unprognostic (1.31e-2)" "unprognostic (2.46e-1)" "unprognostic (7.07e-3)" "unprognostic (2.93e-1)" "unprognostic (6.31e-2)" "unprognostic (1.11e-1)" "unprognostic (1.11e-1)" "unprognostic (1.85e-1)" "unprognostic (3.78e-1)" "unprognostic (4.63e-6)" "unprognostic (7.14e-2)" "unprognostic (4.24e-1)" "unprognostic (2.31e-1)" "unprognostic (5.24e-8)" 0.3 0.2 1.3 0.5 2.2 3.7 0.3 4.2 1.8 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 2.1 0.2 0.2 0.2 1.1 0.7 1.7 0.2 0.3 0.2 0.1 0.2 1.9 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.6 0.9 0.2 65.2 0.1 0.1 0.4 0.0 0.2 0.2 0.0 0.0 0.2 5.4 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.7 0.2 0.0 0.4 0.0 0.0 0.8 2.8 0.8 0.0 0.0 0.0 0.1 1.0 2.2 1.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 1.3 2.2 4.2 1.8 0.8 2.1 0.7 1.7 1.9 0.1 SLC26A9 ENSG00000174502 "Solute carrier family 26 member 9" Q7LBE3 1 205913048-205943460 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "salivary gland: 108.4" "Group enriched" "Detected in some" 13 "CAPAN-2: 16.6;Hep G2: 6.2" "Cancer enhanced" "Detected in many" "pancreatic cancer: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051485 Enhanced Approved "Cell Junctions" "Cell Junctions" "HPA051485: " "unprognostic (1.55e-2)" "unprognostic (2.70e-2)" "unprognostic (8.77e-2)" "unprognostic (3.14e-1)" "unprognostic (1.83e-2)" "prognostic favourable (8.55e-5)" "unprognostic (1.26e-1)" "unprognostic (1.68e-1)" "unprognostic (3.49e-1)" "unprognostic (8.07e-2)" "unprognostic (8.85e-2)" "unprognostic (3.41e-1)" "unprognostic (2.43e-1)" "unprognostic (2.19e-1)" "unprognostic (1.05e-1)" "unprognostic (7.45e-3)" "unprognostic (2.01e-1)" 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.3 0.1 6.4 0.1 0.1 0.0 0.1 0.1 5.5 0.1 0.1 0.1 0.1 0.5 0.0 0.3 0.1 0.1 0.1 0.0 0.1 108.4 0.1 0.1 1.9 0.1 0.1 0.1 0.1 17.8 0.1 0.1 0.2 0.4 1.1 2.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 16.6 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SLC27A2 "ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS" ENSG00000140284 "Solute carrier family 27 member 2" O14975 15 50182196-50236395 "Enzymes, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 168.1" "Cell line enhanced" "Detected in many" "A549: 18.9;HaCaT: 34.0;HeLa: 17.5;HL-60: 24.4;NB-4: 16.5;RT4: 17.3" "Cancer enhanced" "Detected in many" "liver cancer: 49.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 27 "basophil: 27.3" "Lineage enriched" "Detected in many" 27 "granulocytes: 27.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 6 "hippocampal formation: 2.5" HPA026089 Enhanced "HPA026089: AB_1857060" "unprognostic (3.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (2.10e-2)" "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (4.06e-3)" "unprognostic (3.33e-1)" "unprognostic (1.89e-1)" "unprognostic (6.38e-3)" "unprognostic (4.83e-2)" "unprognostic (1.82e-1)" "prognostic favourable (7.48e-6)" "unprognostic (5.01e-3)" "unprognostic (4.08e-1)" "unprognostic (1.22e-2)" "prognostic favourable (6.40e-4)" 1.1 8.1 0.7 4.1 0.8 1.2 3.4 1.5 1.0 0.5 4.2 0.4 1.3 2.5 0.2 17.5 1.2 2.6 1.3 0.2 1.1 1.1 39.4 168.1 1.7 0.8 0.3 1.0 0.7 6.3 2.0 10.4 7.4 3.0 1.2 4.0 3.2 0.6 0.3 0.2 0.6 5.3 0.1 0.3 0.4 0.4 0.7 0.1 0.1 1.0 0.2 1.3 1.4 0.8 0.1 0.0 27.3 0.0 1.0 0.5 0.2 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.5 9.8 2.6 0.0 0.2 0.4 34.0 8.7 0.2 0.9 13.3 10.7 14.0 17.5 8.8 0.1 24.4 10.0 0.0 0.8 0.0 0.0 0.0 4.2 0.0 0.0 3.0 0.6 16.5 0.6 0.7 0.0 0.0 0.6 1.8 17.3 15.7 1.0 3.3 0.4 0.0 1.8 8.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 27.3 0.0 0.4 0.4 0.0 0.4 0.1 0.4 0.4 0.0 0.1 0.1 0.1 0.2 1.0 0.0 0.0 0.5 0.2 0.7 0.8 1.5 1.0 1.1 1.1 0.3 1.0 3.0 0.1 SLC27A5 "ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2" ENSG00000083807 "Solute carrier family 27 member 5" Q9Y2P5 19 58479512-58512413 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" "Ligase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 157.6" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in all" 26 "liver cancer: 49.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA007292, CAB056160, CAB068239" Enhanced "CAB056160: , CAB068239: , HPA007292: AB_1857064" "unprognostic (5.97e-2)" "unprognostic (9.12e-2)" "unprognostic (9.95e-2)" "unprognostic (6.36e-3)" "unprognostic (2.52e-1)" "unprognostic (7.46e-2)" "prognostic favourable (1.57e-4)" "unprognostic (1.04e-1)" "unprognostic (1.85e-2)" "unprognostic (2.46e-1)" "unprognostic (1.78e-2)" "unprognostic (8.56e-2)" "unprognostic (1.66e-4)" "unprognostic (2.27e-1)" "unprognostic (3.33e-2)" "unprognostic (7.80e-2)" "unprognostic (2.16e-1)" 1.3 2.0 5.4 1.4 5.3 1.1 2.0 1.9 3.9 1.7 1.0 1.7 1.2 1.0 1.1 1.1 1.4 2.6 1.1 1.3 3.7 3.8 1.9 157.6 0.9 1.4 4.3 2.5 1.4 2.6 1.1 1.3 0.8 3.4 1.4 0.8 1.3 2.7 2.1 1.4 1.1 0.9 1.5 2.7 1.1 1.1 2.3 3.0 1.4 1.8 0.6 1.4 1.1 1.6 13.3 10.8 2.2 3.0 9.6 18.7 8.9 15.9 21.8 3.9 4.1 3.7 3.9 2.4 0.9 2.1 3.0 4.2 1.7 3.4 20.7 2.6 1.1 3.3 4.4 14.0 1.3 9.6 14.7 13.9 22.7 18.1 5.6 7.3 4.9 4.5 2.4 0.4 8.4 1.5 12.8 0.0 3.6 13.0 17.9 15.4 2.3 12.8 9.1 0.1 28.2 10.0 7.6 5.3 7.3 0.0 21.6 4.7 6.4 6.3 1.2 0.0 2.8 0.0 1.8 13.6 15.3 8.4 4.5 13.6 0.8 0.0 2.4 2.2 8.7 3.0 18.7 13.3 11.2 11.4 6.5 8.9 13.9 14.3 0.3 9.6 2.1 10.8 13.3 8.9 5.4 5.3 1.9 3.9 3.7 3.8 4.3 2.5 3.4 3.0 SLC2A1 "CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR" ENSG00000117394 "Solute carrier family 2 member 1" P11166 1 42925375-42959176 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 194.0" "Cell line enhanced" "Detected in many" "BEWO: 44.2;CACO-2: 71.8;Hep G2: 49.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002759, HPA031345, HPA058494" Enhanced Supported Enhanced "Plasma membrane" 36000000 "Plasma membrane" "CAB002759: , HPA031345: , HPA058494: " "unprognostic (3.60e-2)" "unprognostic (5.85e-3)" "unprognostic (7.59e-2)" "unprognostic (1.31e-2)" "unprognostic (4.10e-3)" "unprognostic (3.22e-2)" "prognostic unfavourable (3.65e-8)" "prognostic unfavourable (1.09e-4)" "unprognostic (1.10e-1)" "unprognostic (4.84e-2)" "prognostic unfavourable (4.39e-5)" "unprognostic (1.87e-1)" "prognostic unfavourable (4.55e-9)" "unprognostic (1.11e-1)" "unprognostic (9.49e-2)" "unprognostic (1.17e-1)" "prognostic unfavourable (4.05e-4)" 4.2 3.7 12.4 3.9 16.9 45.2 4.1 6.7 15.5 15.2 4.8 15.1 4.3 2.4 7.6 3.4 28.8 8.5 8.6 5.0 15.4 13.7 7.6 2.1 2.4 5.3 18.2 5.0 3.4 3.7 7.3 2.9 194.0 15.5 5.2 3.3 44.2 8.4 7.9 1.8 42.1 2.9 2.5 17.8 3.4 5.5 2.5 12.5 1.8 4.0 11.5 12.0 22.2 24.5 8.4 14.7 1.3 0.2 3.0 7.5 2.7 10.6 15.3 12.7 3.2 1.5 0.5 44.2 7.0 15.2 8.6 12.8 71.8 29.7 4.0 21.0 2.1 9.9 2.8 16.3 3.8 2.4 2.6 6.6 8.9 49.0 4.4 3.6 1.9 1.8 12.6 5.4 5.9 1.4 14.8 0.9 3.9 18.9 1.6 2.5 8.1 3.9 1.6 4.1 5.6 7.9 5.2 6.7 4.7 8.2 26.0 3.0 1.1 4.6 3.2 7.9 5.7 1.4 15.8 0.7 1.5 2.4 15.6 2.5 6.4 0.3 0.2 1.3 7.5 0.2 6.9 8.4 4.1 5.1 2.9 7.3 3.2 4.7 1.0 3.0 0.1 14.7 4.7 2.7 12.4 16.9 6.7 15.5 15.4 13.7 18.2 5.0 15.5 12.5 SLC2A14 "GLUT14, SLC2A3P3" ENSG00000173262 "Solute carrier family 2 member 14" Q8TDB8 12 7812512-7891148 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis, Sugar transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 52.4" "Group enriched" "Detected in some" 4 "BEWO: 14.6;CACO-2: 23.7;Hep G2: 6.1" "Cancer enriched" "Detected in single" 35 "testis cancer: 7.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.9" HPA006539 Supported Approved "Plasma membrane" "Plasma membrane" "HPA006539: AB_1078984" "unprognostic (2.52e-1)" "unprognostic (4.74e-3)" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (1.82e-3)" "unprognostic (8.62e-2)" "unprognostic (7.15e-2)" "unprognostic (1.89e-1)" "unprognostic (9.91e-3)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" "unprognostic (8.46e-4)" "unprognostic (3.92e-2)" "unprognostic (3.41e-1)" "unprognostic (3.26e-2)" "unprognostic (1.22e-2)" 0.4 3.1 0.1 0.1 0.6 3.0 0.4 0.1 0.2 0.4 0.4 0.3 0.1 0.0 0.3 0.8 0.8 0.1 0.3 0.1 0.2 0.3 0.1 2.0 0.2 0.2 0.1 0.1 2.7 7.4 0.0 0.6 0.5 0.3 0.6 0.2 0.1 0.1 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.0 52.4 0.2 0.1 0.1 0.1 0.1 0.6 0.1 0.6 0.4 6.9 0.7 1.3 1.7 0.2 0.0 0.4 0.3 0.3 0.2 0.8 14.6 0.0 0.0 0.0 0.2 23.7 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.4 0.6 6.1 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 1.0 0.1 0.0 0.1 0.1 0.1 2.7 0.0 0.2 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.0 1.5 0.3 0.1 0.6 0.4 0.1 0.1 0.1 0.3 0.3 0.0 0.3 5.5 0.7 1.8 1.0 0.2 1.2 0.5 1.0 0.8 0.4 0.6 0.7 0.9 6.9 1.3 0.2 0.3 1.7 0.2 0.1 0.6 0.1 0.2 0.2 0.3 0.1 0.1 0.3 0.2 SLC2A7 GLUT7 ENSG00000197241 "Solute carrier family 2 member 7" Q6PXP3 1 9003300-9026345 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "intestine: 19.3" "Cell line enhanced" "Detected in single" "Daudi: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039931 Uncertain "HPA039931: AB_10671046" "unprognostic (4.19e-2)" "unprognostic (3.68e-1)" "unprognostic (1.96e-2)" "unprognostic (2.20e-1)" "unprognostic (1.05e-2)" "unprognostic (3.43e-1)" "unprognostic (9.05e-2)" "unprognostic (5.69e-4)" "unprognostic (5.09e-2)" "unprognostic (7.12e-2)" "unprognostic (1.60e-1)" "unprognostic (3.35e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 7.2 0.0 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 19.3 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC30A10 "DKFZp547M236, ZnT-10, ZNT8, ZRC1" ENSG00000196660 "Solute carrier family 30 member 10" Q6XR72 1 219685427-219958647 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation, Dystonia, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 33.4" "Cell line enhanced" "Detected in some" "HEK 293: 4.3;HEL: 2.2;Hep G2: 4.2;K-562: 2.7" "Cancer enriched" "Detected in some" 14 "liver cancer: 7.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064547 Enhanced "HPA064547: " "unprognostic (7.88e-2)" "unprognostic (1.07e-2)" "unprognostic (1.02e-1)" "unprognostic (7.25e-2)" "unprognostic (1.75e-2)" "unprognostic (3.74e-3)" "unprognostic (6.96e-2)" "unprognostic (3.72e-2)" "unprognostic (1.41e-1)" "unprognostic (1.95e-2)" "unprognostic (5.10e-2)" "unprognostic (3.10e-3)" "unprognostic (4.47e-7)" "unprognostic (3.16e-1)" "unprognostic (6.11e-2)" "unprognostic (6.19e-3)" "unprognostic (5.72e-2)" 0.3 0.3 2.9 0.7 3.5 0.4 0.3 1.8 3.9 0.3 7.1 1.9 0.0 5.9 0.3 0.3 0.3 0.3 0.5 0.3 3.5 1.6 0.3 33.4 0.3 0.3 1.7 1.7 0.6 0.3 0.3 0.4 0.4 2.5 0.3 1.7 0.6 0.3 0.3 0.3 0.3 6.8 0.3 0.8 0.3 0.3 1.9 1.9 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.3 2.2 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.5 1.8 3.9 3.5 1.6 1.7 1.7 2.5 1.9 SLC30A8 "ZnT-8, ZNT8" ENSG00000164756 "Solute carrier family 30 member 8" Q8IWU4 8 116950273-117176714 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pancreas: 37.1" "Group enriched" "Detected in some" 34 "U-266/70: 29.8;U-266/84: 20.8" "Group enriched" "Detected in some" 28 "breast cancer: 10.6;pancreatic cancer: 15.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA076165 Enhanced "HPA076165: " "unprognostic (2.14e-2)" "unprognostic (1.48e-2)" "unprognostic (1.61e-1)" "unprognostic (1.41e-1)" "unprognostic (5.38e-2)" "unprognostic (5.57e-2)" "unprognostic (4.38e-1)" "unprognostic (3.36e-1)" "unprognostic (1.19e-1)" "unprognostic (6.66e-2)" "unprognostic (6.51e-3)" "unprognostic (2.15e-2)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "unprognostic (9.16e-3)" 0.1 0.0 0.1 0.1 0.4 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.1 0.1 0.1 0.1 0.1 0.1 37.1 0.0 0.3 0.1 0.1 0.1 0.0 5.0 6.4 0.1 0.1 0.3 0.4 0.1 0.1 0.1 0.6 2.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.5 0.0 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 29.8 20.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 SLC32A1 "bA122O1.1, VGAT, VIAAT" ENSG00000101438 "Solute carrier family 32 member 1" Q9H598 20 38724462-38729372 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 38.3" "Group enriched" "Detected in some" 14 "MOLT-4: 5.4;SH-SY5Y: 1.6" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 20 "dendritic cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037156, HPA058859, HPA059985" Enhanced Supported "CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187" "unprognostic (1.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.17e-1)" "unprognostic (6.57e-2)" 1.0 1.1 4.6 1.0 38.3 1.5 1.0 4.9 25.8 1.0 1.0 0.8 0.0 1.0 1.0 1.0 1.0 1.1 1.0 1.0 3.9 9.7 1.0 1.0 1.0 1.0 4.4 6.8 1.0 1.1 1.0 4.1 1.0 10.4 1.0 1.0 0.7 1.0 1.0 1.0 1.0 1.1 1.0 4.4 1.0 1.0 1.6 7.9 0.0 1.0 0.0 1.0 1.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 4.6 38.3 4.9 11.9 3.9 9.7 4.4 6.8 10.4 7.9 SLC34A1 "NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2" ENSG00000131183 "Solute carrier family 34 member 1" Q06495 5 177379235-177398848 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 79 "kidney: 94.5" "Group enriched" "Detected in some" 12 "HEL: 6.6;U-937: 4.3" "Cancer enriched" "Detected in single" 12 "renal cancer: 1.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051255, HPA077175" Approved Approved "Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol" "Nuclear speckles, Plasma membrane" "Nucleoplasm, Mitotic spindle, Cytosol" "HPA051255: , HPA077175: " "unprognostic (1.17e-1)" "unprognostic (3.33e-3)" "unprognostic (1.49e-1)" "unprognostic (3.49e-2)" "unprognostic (1.56e-3)" "unprognostic (2.28e-1)" "unprognostic (4.50e-2)" "unprognostic (4.43e-3)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (5.95e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.2 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC35F1 "C6orf169, dJ230I3.1" ENSG00000196376 "Solute carrier family 35 member F1" Q5T1Q4 6 117907526-118317676 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 41.9" "Group enriched" "Detected in some" 9 "AF22: 23.3;WM-115: 39.2" "Group enriched" "Detected in some" 16 "glioma: 15.1;melanoma: 3.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019576 Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" Nucleoplasm "Centriolar satellite, Cytosol" "HPA019576: AB_2190216" "unprognostic (1.46e-1)" "unprognostic (5.67e-2)" "unprognostic (7.08e-2)" "unprognostic (1.37e-3)" "unprognostic (3.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.39e-1)" "unprognostic (4.04e-1)" "unprognostic (3.64e-2)" "unprognostic (3.04e-2)" "unprognostic (4.44e-3)" "unprognostic (2.19e-1)" "unprognostic (8.83e-4)" "unprognostic (3.04e-3)" "unprognostic (6.03e-2)" "unprognostic (8.32e-2)" "unprognostic (2.02e-1)" 2.8 2.7 13.8 2.1 14.5 0.9 1.2 3.6 41.9 1.7 3.5 4.3 0.0 1.6 2.7 5.5 1.8 1.5 1.8 5.3 10.4 10.2 1.7 1.0 1.1 1.0 9.3 15.3 1.4 1.4 1.0 0.6 1.0 5.6 2.3 2.3 2.6 1.7 2.9 1.2 1.6 1.8 2.6 4.1 1.6 1.4 1.8 5.6 0.0 1.8 0.0 1.0 1.4 2.6 0.2 0.6 1.0 0.1 0.3 0.9 0.1 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 2.9 3.3 0.0 0.0 0.1 0.0 39.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.0 0.3 0.0 0.6 0.0 0.1 13.8 14.5 3.6 17.4 10.4 10.2 9.3 15.3 5.6 5.6 SLC35G4 "AMAC1L1, SLC35G4P" ENSG00000236396 "Solute carrier family 35 member G4" P0C7Q5 18 11609596-11610612 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC35G6 "AMAC1L3, TMEM21B" ENSG00000259224 "Solute carrier family 35 member G6" P0C7Q6 17 7481332-7483496 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 8.5" "Cell line enhanced" "Detected in some" "CACO-2: 1.1;HeLa: 3.6;U-138 MG: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "unprognostic (3.81e-2)" "unprognostic (5.10e-2)" "unprognostic (2.05e-2)" "unprognostic (1.79e-1)" "unprognostic (1.65e-1)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (1.65e-3)" "unprognostic (3.29e-1)" "unprognostic (9.19e-3)" "unprognostic (1.69e-1)" "unprognostic (1.61e-1)" "unprognostic (3.13e-1)" "unprognostic (5.21e-2)" "unprognostic (3.79e-2)" "unprognostic (2.01e-2)" 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 8.5 0.2 0.0 0.0 0.0 1.1 0.9 1.1 0.3 0.0 0.3 0.0 0.0 0.7 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.1 3.6 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.3 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.2 1.2 0.1 0.6 0.4 0.1 0.2 0.1 0.4 0.2 0.1 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.1 1.1 0.3 0.1 1.1 0.0 0.0 0.9 0.0 0.0 SLC36A3 "PAT3, TRAMD2, tramdorin2" ENSG00000186334 "Solute carrier family 36 member 3" Q495N2 5 151276762-151303766 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 14.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (5.41e-1)" "unprognostic (5.38e-1)" "unprognostic (7.01e-2)" "unprognostic (2.13e-1)" "unprognostic (2.20e-2)" "unprognostic (3.98e-1)" "unprognostic (2.57e-2)" "unprognostic (2.18e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.2 0.3 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC38A3 "G17, SN1" ENSG00000188338 "Solute carrier family 38 member 3" Q99624 3 50205246-50221486 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 107.8" "Group enriched" "Detected in some" 4 "Hep G2: 31.7;SCLC-21H: 10.5" "Cancer enriched" "Detected in many" 9 "liver cancer: 140.0" "Cell type enhanced" "Detected in some" "basophil: 5.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031871 Approved Microtubules,Cytosol Cytosol Microtubules "HPA031871: " "unprognostic (2.14e-1)" "unprognostic (2.10e-1)" "unprognostic (8.60e-2)" "unprognostic (6.19e-4)" "unprognostic (7.37e-2)" "unprognostic (9.61e-2)" "unprognostic (2.34e-2)" "unprognostic (2.30e-2)" "unprognostic (4.68e-3)" "unprognostic (1.46e-1)" "unprognostic (2.06e-1)" "unprognostic (5.71e-2)" "unprognostic (1.23e-3)" "unprognostic (1.90e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.96e-1)" 0.7 0.3 3.4 0.3 5.2 0.5 0.7 2.4 10.5 0.3 0.3 10.3 0.0 0.7 0.4 0.4 0.6 0.4 0.4 2.0 4.1 1.5 107.8 0.3 0.4 3.4 4.0 2.4 11.6 1.8 0.7 0.6 7.8 0.4 0.3 22.2 0.9 0.3 10.4 0.5 0.4 0.3 4.7 0.3 0.9 0.7 5.2 0.0 0.6 1.9 0.4 0.3 0.0 1.1 1.0 5.6 0.8 1.5 0.8 0.2 0.0 0.0 0.8 4.8 0.0 0.0 1.2 0.0 0.0 0.9 0.4 2.9 0.1 0.1 0.8 0.0 0.0 1.2 0.0 0.6 0.1 0.4 0.0 0.6 31.7 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.4 0.5 0.0 0.4 0.3 0.0 0.1 0.2 10.5 0.9 0.5 0.1 0.0 1.3 0.2 0.0 0.2 0.9 0.0 0.6 0.3 0.0 0.1 0.1 0.2 0.1 5.6 0.8 0.9 0.6 0.2 0.4 0.7 0.5 0.4 0.2 1.1 0.6 0.8 3.3 1.5 0.2 1.0 0.4 0.2 SLC38A4 "ATA3, NAT3, PAAT" ENSG00000139209 "Solute carrier family 38 member 4" Q969I6 12 46764761-46832408 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "liver: 128.2" "Cell line enhanced" "Detected in some" "ASC diff: 8.6;LHCN-M2: 21.2;RH-30: 7.0;RT4: 41.4" "Cancer enriched" "Detected in many" 14 "liver cancer: 61.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "basophil: 3.0;NK-cell: 1.9" "Group enriched" "Detected in many" 8 "granulocytes: 3.0;NK-cells: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (3.81e-2)" "unprognostic (7.46e-3)" "unprognostic (5.22e-3)" "unprognostic (1.75e-2)" "unprognostic (3.12e-1)" "unprognostic (1.11e-1)" "prognostic favourable (5.37e-4)" "unprognostic (3.06e-2)" "unprognostic (2.57e-3)" "unprognostic (1.75e-2)" "unprognostic (1.95e-1)" "unprognostic (6.06e-2)" "unprognostic (2.84e-2)" "unprognostic (1.89e-2)" "unprognostic (8.28e-2)" "unprognostic (6.31e-3)" "unprognostic (2.21e-2)" 0.2 0.1 0.1 1.4 0.0 0.0 0.1 0.1 0.2 0.1 0.9 0.0 0.3 0.0 1.7 0.1 0.6 0.1 0.3 1.1 0.0 0.0 5.9 128.2 0.1 0.0 0.0 0.0 0.1 2.1 0.0 0.0 1.0 0.1 0.4 0.2 0.1 0.3 0.0 2.9 0.4 0.1 1.4 0.0 0.3 0.0 0.2 0.0 0.2 0.2 0.4 0.2 0.7 0.0 0.1 0.3 3.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 8.6 1.1 1.6 1.0 2.8 0.9 0.8 0.5 2.0 0.0 1.7 3.6 0.5 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 2.1 0.0 0.0 0.6 0.0 0.1 0.0 21.2 0.0 0.0 0.0 0.6 0.0 0.0 7.0 0.0 0.0 41.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 SLC38A5 "JM24, SN2" ENSG00000017483 "Solute carrier family 38 member 5" Q8WUX1 X 48458537-48470256 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pancreas: 87.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 53.2;HeLa: 52.4;hTCEpi: 39.6;Karpas-707: 46.8;RPMI-8226: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047411 Approved Approved "Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" Cytosol "HPA047411: AB_10964355" "unprognostic (2.81e-1)" "unprognostic (4.87e-2)" "unprognostic (7.92e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-3)" "unprognostic (1.26e-1)" "unprognostic (7.75e-2)" "unprognostic (5.79e-2)" "unprognostic (1.52e-1)" "unprognostic (3.80e-3)" "prognostic unfavourable (2.13e-4)" "unprognostic (2.99e-2)" "prognostic unfavourable (2.22e-16)" "unprognostic (1.27e-3)" "unprognostic (1.45e-1)" "unprognostic (2.86e-1)" "unprognostic (2.20e-1)" 1.5 0.9 5.3 4.7 7.1 17.3 0.9 3.5 11.6 4.0 4.9 7.7 0.1 5.1 1.8 1.3 3.7 2.0 1.5 2.4 6.9 5.7 0.7 0.4 9.4 3.3 7.0 2.7 3.7 87.7 0.4 0.4 2.8 14.6 5.1 6.4 1.5 4.4 3.7 0.4 8.0 3.5 2.8 7.3 4.8 4.5 0.5 4.6 2.4 7.9 3.6 3.4 4.8 3.1 7.4 8.3 0.3 0.4 5.4 16.2 5.7 22.5 0.0 0.0 0.2 0.4 2.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 23.7 0.0 9.9 34.9 27.0 53.2 0.0 7.5 0.0 12.9 52.4 16.3 3.9 26.3 0.0 3.7 39.6 0.4 0.1 0.4 23.6 46.8 5.3 0.0 5.7 9.1 12.2 0.1 20.9 0.1 86.2 0.0 0.0 2.2 0.1 0.0 0.1 0.0 0.0 1.1 0.7 0.1 0.0 0.0 0.0 0.0 0.1 8.5 0.2 0.1 0.1 0.0 0.2 0.2 11.5 0.4 16.2 7.4 12.6 10.8 1.5 4.7 6.0 7.7 0.3 5.4 0.0 8.3 13.0 5.7 5.3 7.1 3.5 11.6 6.9 5.7 7.0 2.7 14.6 4.6 SLC39A4 "AEZ, AWMS2, ZIP4" ENSG00000147804 "Solute carrier family 39 member 4" Q6P5W5 8 144409742-144416895 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 77.7" "Group enriched" "Detected in some" 11 "CAPAN-2: 17.3;Hep G2: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (2.59e-1)" "unprognostic (2.35e-3)" "unprognostic (9.16e-2)" "unprognostic (3.84e-2)" "unprognostic (5.63e-3)" "unprognostic (1.46e-1)" "unprognostic (5.40e-2)" "unprognostic (1.54e-1)" "unprognostic (1.61e-1)" "unprognostic (3.28e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-1)" "prognostic favourable (9.04e-4)" "unprognostic (2.78e-2)" "unprognostic (3.97e-1)" "unprognostic (9.04e-3)" "unprognostic (1.87e-1)" 0.2 0.0 0.5 1.1 0.2 0.1 0.2 0.2 1.1 0.2 73.9 0.2 0.2 42.1 0.2 0.4 0.2 0.3 0.7 0.2 0.2 0.0 8.3 0.4 1.3 0.2 0.2 0.2 1.5 0.6 0.0 0.3 0.4 0.2 0.4 0.1 0.2 0.5 0.2 0.2 0.0 77.7 0.2 0.2 0.2 1.2 0.4 0.2 0.2 2.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.1 17.3 0.0 0.5 0.0 0.1 0.0 0.0 0.0 2.9 0.4 0.7 0.1 44.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.4 0.9 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.2 1.1 0.2 0.0 0.2 0.2 0.2 0.2 SLC44A1 "CD92, CDw92, CHTL1, CTL1" ENSG00000070214 "Solute carrier family 44 member 1" Q8WWI5 9 105244622-105439171 "CD markers, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 111.6" "Cell line enhanced" "Detected in many" "ASC diff: 71.8;ASC TERT1: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064714 Supported Nucleoplasm,Mitochondria 270000 Mitochondria Nucleoplasm "HPA064714: " "unprognostic (3.49e-1)" "unprognostic (2.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.54e-3)" "unprognostic (4.77e-2)" "unprognostic (1.74e-2)" "unprognostic (2.21e-2)" "prognostic unfavourable (4.49e-4)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (1.64e-3)" "unprognostic (6.20e-2)" "prognostic favourable (1.85e-4)" "unprognostic (2.13e-1)" "unprognostic (2.07e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-2)" 8.7 7.4 40.0 6.4 48.8 5.3 14.6 7.2 37.0 9.9 26.7 69.5 10.2 12.0 8.8 18.4 10.1 8.5 11.0 6.9 50.0 29.6 12.0 20.3 9.8 4.6 64.3 21.3 8.0 8.0 20.5 3.9 12.3 38.2 6.6 26.9 4.6 6.0 14.8 4.8 11.4 14.0 9.5 111.6 4.8 18.9 2.3 59.4 2.3 24.0 5.1 7.9 12.4 7.9 2.4 3.7 2.5 5.4 8.7 1.8 1.6 6.7 5.7 1.5 1.9 71.8 56.8 4.9 5.7 14.9 3.7 5.0 6.0 18.0 9.0 2.9 21.5 13.5 4.6 8.2 6.4 7.8 3.8 11.2 4.0 7.5 4.8 2.2 5.8 31.5 6.8 7.1 6.5 11.7 0.3 18.8 4.2 9.6 8.9 2.5 8.7 5.5 1.8 6.0 6.8 5.1 15.9 7.5 2.9 8.0 8.9 8.0 8.8 6.8 10.0 3.7 3.4 4.0 4.1 14.5 9.5 6.8 7.2 4.9 4.9 2.5 5.4 1.1 1.1 2.1 0.8 2.0 1.2 0.8 3.7 2.4 1.8 0.6 1.0 8.7 1.2 1.3 1.1 1.6 40.0 48.8 7.2 29.8 50.0 29.6 64.3 21.3 38.2 59.4 SLC45A2 "AIM-1, MATP, OCA4" ENSG00000164175 "Solute carrier family 45 member 2" Q9UMX9 5 33944616-33984730 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Melanin biosynthesis, Sensory transduction, Vision" "Albinism, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 39.9" "Cell line enriched" "Detected in single" 40 "SK-MEL-30: 36.7" "Cancer enriched" "Detected in some" 18 "melanoma: 47.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (2.97e-1)" "unprognostic (3.99e-2)" "unprognostic (3.55e-1)" "unprognostic (2.39e-2)" "unprognostic (2.36e-2)" "unprognostic (1.09e-1)" "unprognostic (8.45e-2)" "unprognostic (5.34e-3)" "unprognostic (4.06e-2)" "unprognostic (8.45e-2)" "unprognostic (7.39e-4)" "unprognostic (1.40e-2)" "unprognostic (1.84e-3)" "unprognostic (1.55e-1)" "unprognostic (1.50e-3)" "unprognostic (2.48e-2)" "unprognostic (3.39e-1)" 0.2 0.0 0.3 0.2 0.4 0.0 0.2 0.7 0.4 0.2 1.1 0.2 0.2 0.0 0.5 0.2 0.2 0.4 0.3 1.5 0.4 0.6 0.8 3.1 0.2 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.8 1.2 39.9 0.2 0.2 0.4 4.5 0.2 0.3 0.4 0.2 0.6 2.8 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 36.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.7 0.4 0.4 0.6 0.3 0.2 0.2 0.2 SLC45A3 "IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein" ENSG00000158715 "Solute carrier family 45 member 3" Q96JT2 1 205657851-205680459 "Cancer-related genes, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "prostate: 115.0" "Cell line enriched" "Detected in some" 30 "HMC-1: 138.2" "Cancer enriched" "Detected in all" 49 "prostate cancer: 539.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 226 "basophil: 22.6" "Lineage enriched" "Detected in single" 226 "granulocytes: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019073, HPA019075" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA019073: AB_1857177, HPA019075: AB_1857179" "unprognostic (1.80e-1)" "unprognostic (1.08e-3)" "unprognostic (3.13e-2)" "prognostic unfavourable (4.04e-5)" "unprognostic (6.93e-2)" "unprognostic (2.36e-2)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" "unprognostic (1.10e-1)" "unprognostic (2.90e-2)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (3.16e-1)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "prognostic favourable (7.33e-5)" 0.8 1.5 2.5 1.5 6.2 0.7 0.8 0.4 5.8 1.9 2.1 19.0 0.0 2.1 0.9 0.6 0.9 1.1 1.8 0.7 4.2 2.0 1.1 4.0 1.7 1.6 13.2 1.6 1.0 0.7 0.5 1.9 0.6 7.2 115.0 1.6 0.2 0.9 0.7 2.2 0.9 2.1 0.8 12.4 5.0 6.4 1.4 11.1 0.0 0.5 0.7 0.7 1.5 0.4 0.0 0.0 22.6 0.0 0.0 0.0 0.2 1.5 0.4 0.4 0.4 0.0 0.0 0.3 0.2 0.0 0.5 0.4 1.1 2.9 0.4 0.7 0.0 0.5 0.2 0.5 0.0 0.6 0.4 4.6 0.1 0.3 0.3 0.7 138.2 0.0 0.1 0.3 0.0 1.5 0.7 0.2 0.2 0.3 0.1 1.3 2.0 1.7 0.1 0.6 0.2 0.6 2.1 0.2 0.4 0.2 3.4 0.6 0.7 0.2 1.5 0.2 1.5 0.5 1.1 0.0 0.1 0.0 0.3 0.2 1.1 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 6.2 0.4 5.8 4.2 2.0 13.2 1.6 7.2 11.1 SLC47A2 "FLJ31196, MATE2, MATE2-K" ENSG00000180638 "Solute carrier family 47 member 2" Q86VL8 17 19678288-19718979 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 55.5" "Cell line enhanced" "Detected in some" "EFO-21: 1.2;HaCaT: 1.9;HeLa: 1.4;hTCEpi: 6.5" "Cancer enhanced" "Detected in some" "renal cancer: 4.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (4.52e-3)" "unprognostic (8.28e-3)" "unprognostic (1.54e-1)" "unprognostic (4.99e-2)" "prognostic unfavourable (8.95e-4)" "unprognostic (5.22e-2)" "unprognostic (2.72e-1)" "unprognostic (1.99e-2)" "unprognostic (3.29e-2)" "unprognostic (1.51e-1)" "unprognostic (1.36e-3)" "unprognostic (7.77e-2)" "unprognostic (1.04e-3)" "unprognostic (4.33e-2)" "unprognostic (1.61e-1)" "unprognostic (6.44e-2)" "unprognostic (5.71e-2)" 0.2 0.3 3.0 0.1 4.4 0.1 0.3 0.2 0.4 0.1 0.2 10.3 0.6 0.2 0.2 6.5 0.2 8.6 0.1 0.3 6.2 5.5 55.5 0.1 0.1 0.1 1.1 0.1 0.6 0.1 0.1 0.0 0.1 12.8 0.1 0.1 0.7 0.1 0.3 0.7 1.8 0.4 0.2 2.0 0.1 0.1 0.2 2.8 0.0 0.3 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 1.2 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 1.4 1.0 0.0 0.0 0.0 0.0 6.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.3 0.0 0.1 0.3 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 3.0 4.4 0.2 0.4 6.2 5.5 1.1 0.1 12.8 2.8 SLC4A5 NBC4 ENSG00000188687 "Solute carrier family 4 member 5" Q9BY07 2 74216242-74343414 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Anion exchange, Ion transport, Sodium transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 109.1" "Cell line enhanced" "Detected in many" "U-266/70: 14.2" "Cancer enriched" "Detected in single" 11 "thyroid cancer: 3.3" "Group enriched" "Detected in many" 5 "cerebellum: 3.4;pons and medulla: 9.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA036621 Uncertain "HPA036621: AB_10696779" "unprognostic (1.30e-1)" "unprognostic (3.78e-2)" "unprognostic (2.75e-2)" "unprognostic (1.83e-4)" "unprognostic (3.38e-1)" "unprognostic (2.36e-2)" "unprognostic (2.56e-3)" "unprognostic (5.37e-4)" "unprognostic (1.39e-1)" "unprognostic (2.55e-1)" "unprognostic (1.55e-3)" "unprognostic (3.24e-2)" "unprognostic (1.72e-5)" "unprognostic (1.57e-1)" "unprognostic (1.06e-2)" "unprognostic (8.47e-2)" "unprognostic (9.27e-4)" 1.2 0.4 1.0 0.8 0.8 1.6 1.1 3.4 1.2 0.7 0.8 2.5 0.6 0.3 0.9 1.7 0.6 1.4 0.8 0.7 1.2 1.0 0.7 3.2 1.7 1.0 1.0 0.6 1.3 0.9 1.5 2.3 0.6 9.0 0.9 0.3 109.1 1.3 0.8 1.1 3.7 0.7 0.9 1.6 0.7 0.5 16.1 0.7 1.0 21.4 0.6 0.7 0.9 0.9 2.5 5.8 6.1 0.9 1.7 2.5 0.6 0.4 0.8 1.4 1.4 1.5 2.5 1.8 0.4 1.3 0.8 1.2 0.4 1.0 2.1 0.4 0.0 0.1 1.5 0.2 0.3 1.8 0.9 3.2 1.4 0.8 0.2 1.1 2.3 0.7 1.9 0.1 0.3 0.5 0.7 2.3 0.3 5.1 0.5 2.2 1.1 0.3 1.1 1.3 0.0 0.3 1.0 1.0 2.0 0.5 1.7 2.3 1.6 2.2 0.0 1.5 2.4 1.5 0.5 14.2 2.0 1.6 0.9 1.2 0.3 6.1 0.9 0.9 1.5 0.8 1.0 1.8 2.3 2.0 0.6 2.5 2.1 2.5 4.2 1.7 0.3 5.8 2.4 0.6 1.0 0.8 3.4 1.2 1.2 1.0 1.0 0.6 9.0 0.7 SLC4A9 AE4 ENSG00000113073 "Solute carrier family 4 member 9" Q96Q91 5 140360202-140375143 "Plasma proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "kidney: 26.7" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;Karpas-707: 1.0;U-266/70: 1.2;U-698: 2.6" "Cancer enriched" "Detected in single" 8 "renal cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "pons and medulla: 1.0" "Low region specificity" "Detected in all" HPA051307 Uncertain "HPA051307: " "unprognostic (1.68e-1)" "unprognostic (4.22e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (1.10e-1)" "unprognostic (2.13e-1)" "unprognostic (1.02e-2)" "unprognostic (3.28e-3)" "unprognostic (2.78e-1)" "unprognostic (2.47e-1)" "unprognostic (4.78e-2)" "unprognostic (1.19e-1)" "unprognostic (4.24e-2)" "unprognostic (2.99e-2)" "unprognostic (3.06e-2)" "unprognostic (5.04e-2)" "unprognostic (1.82e-2)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 26.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.1 0.0 0.5 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.7 0.2 0.3 0.0 0.8 0.1 0.3 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 1.0 0.0 0.5 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.1 0.3 0.1 0.0 1.2 0.6 2.6 0.0 0.1 0.3 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.1 0.2 0.1 0.4 0.0 0.0 0.0 SLC51B OSTbeta ENSG00000186198 "Solute carrier family 51 beta subunit" Q86UW2 15 65045370-65053396 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 85.0" "Group enriched" "Detected in some" 10 "CACO-2: 16.5;EFO-21: 11.1;Hep G2: 13.8" "Cancer enhanced" "Detected in many" "liver cancer: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008398, HPA008533" Enhanced Approved Vesicles,Mitochondria Mitochondria Vesicles "HPA008398: , HPA008533: AB_1854824" "unprognostic (6.18e-2)" "unprognostic (6.75e-3)" "unprognostic (1.66e-1)" "unprognostic (1.31e-2)" "unprognostic (5.88e-2)" "unprognostic (9.49e-2)" "unprognostic (9.77e-3)" "unprognostic (1.81e-2)" "unprognostic (3.35e-2)" "unprognostic (2.76e-1)" "unprognostic (2.24e-1)" "unprognostic (4.34e-2)" "prognostic favourable (8.46e-5)" "unprognostic (5.87e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.17e-2)" 0.4 0.5 0.4 3.8 0.6 0.0 0.4 0.4 0.8 14.0 34.9 0.4 0.4 28.1 0.9 3.3 0.4 1.0 0.5 0.4 0.5 0.6 7.5 2.4 1.6 0.4 0.6 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.8 9.5 0.4 0.4 0.8 0.4 0.1 85.0 0.4 0.4 0.4 0.2 4.1 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.0 0.0 0.7 0.1 0.0 0.5 0.3 0.0 1.4 0.2 0.7 0.0 0.1 0.4 0.0 0.0 0.2 0.0 16.5 0.0 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 13.8 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.3 0.4 0.4 0.0 0.0 0.8 0.4 0.0 0.6 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.5 0.0 0.3 0.2 0.0 0.0 0.1 0.3 0.7 0.0 0.1 0.0 0.0 0.3 0.4 0.6 0.4 0.4 0.5 0.6 0.6 0.4 0.4 0.4 SLC5A1 "D22S675, NAGT, SGLT1" ENSG00000100170 "Solute carrier family 5 member 1" P13866 22 32043032-32113029 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "intestine: 274.9" "Cell line enhanced" "Detected in some" "CACO-2: 6.3;NB-4: 2.4;RPMI-8226: 4.8;SCLC-21H: 1.8;SH-SY5Y: 2.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 26 "cerebellum: 8.6" "Low region specificity" "Detected in all" "CAB015467, HPA051805, HPA055106" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB015467: , HPA051805: , HPA055106: " "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "prognostic favourable (2.59e-4)" "unprognostic (3.85e-2)" "unprognostic (2.75e-2)" "unprognostic (1.60e-2)" "unprognostic (2.15e-1)" "unprognostic (9.22e-2)" "unprognostic (4.83e-2)" "unprognostic (6.21e-2)" "unprognostic (9.53e-2)" "prognostic favourable (6.97e-7)" "unprognostic (4.68e-3)" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.45e-2)" 0.2 0.0 0.2 1.3 0.2 0.0 1.5 0.2 0.2 2.2 181.5 0.2 2.9 95.5 0.3 0.8 1.9 0.0 14.1 24.5 0.2 0.0 1.0 0.9 0.3 0.2 0.2 0.2 0.2 0.4 0.0 1.0 0.2 0.2 0.8 1.6 0.2 5.7 3.5 0.2 4.6 274.9 0.2 0.2 0.7 1.2 0.8 0.2 0.2 0.2 3.5 1.5 0.2 2.0 0.3 0.1 0.6 0.8 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.6 0.0 0.0 0.0 0.0 6.3 1.3 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.0 2.4 0.1 0.0 0.0 0.0 4.8 0.0 0.1 1.8 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.8 0.1 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 SLC5A10 SGLT5 ENSG00000154025 "Solute carrier family 5 member 10" A0PJK1 17 18950345-19022595 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 70.6" "Cell line enriched" "Detected in some" 5 "U-937: 10.7" "Cancer enriched" "Detected in some" 11 "renal cancer: 6.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "intermediate monocyte: 3.0;non-classical monocyte: 7.9" "Lineage enriched" "Detected in many" 7 "monocytes: 7.9" "Not detected" "Not detected" HPA052014 Uncertain "HPA052014: " "unprognostic (3.74e-1)" "unprognostic (2.92e-1)" "unprognostic (3.04e-2)" "unprognostic (6.11e-2)" "unprognostic (6.56e-2)" "unprognostic (3.36e-4)" "unprognostic (7.36e-2)" "unprognostic (2.39e-1)" "unprognostic (1.52e-1)" "unprognostic (8.94e-2)" "unprognostic (3.24e-2)" "unprognostic (1.53e-1)" "unprognostic (1.09e-2)" "unprognostic (3.43e-2)" "unprognostic (2.61e-2)" "unprognostic (2.75e-2)" "unprognostic (2.11e-1)" 0.1 0.1 0.1 0.5 0.1 1.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.7 0.1 0.0 70.6 0.4 0.3 0.8 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 15.1 0.1 0.1 0.1 0.7 1.1 0.1 0.2 3.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.4 1.2 0.1 7.9 0.0 0.6 0.5 0.0 0.0 0.1 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.1 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 10.7 0.0 0.1 0.0 0.0 0.1 3.0 0.0 0.4 0.3 0.0 1.2 0.3 0.6 0.2 0.0 0.0 7.9 0.0 0.2 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SLC5A2 SGLT2 ENSG00000140675 "Solute carrier family 5 member 2" P31639 16 31483002-31490860 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "kidney: 33.7" "Cell line enhanced" "Detected in some" "BEWO: 1.2;EFO-21: 1.9;Hep G2: 2.6;NB-4: 1.3;U-2 OS: 1.2;U-266/84: 1.8;U-937: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.6" "Group enriched" "Detected in many" 16 "NK-cells: 1.4;T-cells: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041603 Enhanced "HPA041603: AB_10960540" "unprognostic (1.61e-1)" "unprognostic (2.95e-1)" "unprognostic (2.84e-1)" "unprognostic (3.00e-2)" "unprognostic (8.04e-2)" "unprognostic (8.23e-3)" "unprognostic (1.49e-1)" "unprognostic (2.25e-3)" "unprognostic (2.57e-1)" "unprognostic (1.12e-2)" "unprognostic (6.43e-2)" "unprognostic (2.47e-1)" "unprognostic (1.42e-3)" "unprognostic (5.88e-2)" "unprognostic (2.14e-1)" "unprognostic (4.18e-2)" "unprognostic (3.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.6 0.6 0.1 0.4 0.0 0.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.3 1.2 0.1 0.0 0.0 1.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.6 0.5 0.0 0.0 0.5 0.1 0.0 1.4 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC5A4 "DJ90G24.4, SAAT1, SGLT3" ENSG00000100191 "Solute carrier family 5 member 4" Q9NY91 22 32218476-32255341 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "intestine: 73.6" "Cell line enriched" "Detected in some" 19 "SK-MEL-30: 24.6" "Cancer enriched" "Detected in some" 10 "melanoma: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.93e-1)" "unprognostic (1.57e-1)" "unprognostic (3.10e-3)" "unprognostic (1.63e-2)" "unprognostic (1.28e-2)" "unprognostic (2.85e-3)" "unprognostic (2.97e-2)" "unprognostic (3.80e-2)" "unprognostic (3.58e-2)" "unprognostic (1.06e-1)" "unprognostic (2.65e-3)" "unprognostic (4.50e-1)" "unprognostic (1.99e-5)" "unprognostic (2.34e-1)" "unprognostic (1.63e-1)" "unprognostic (2.28e-1)" "unprognostic (2.69e-1)" 1.2 0.1 0.4 0.4 0.4 0.1 1.6 0.4 0.5 1.2 41.7 0.4 0.4 18.0 1.8 0.4 0.4 1.2 0.6 0.9 0.5 0.6 1.0 0.4 2.5 0.4 0.6 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.9 0.1 0.4 0.4 0.4 0.4 0.3 73.6 1.5 0.6 0.6 0.2 0.7 0.4 0.4 2.4 0.4 0.4 0.4 1.3 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 24.6 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.5 0.5 0.6 0.6 0.4 0.4 0.4 SLC5A7 "CHT1, hCHT" ENSG00000115665 "Solute carrier family 5 member 7" Q9GZV3 2 107986523-108013994 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport" "Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 45.1" "Group enriched" "Detected in some" 22 "RT4: 8.7;SCLC-21H: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Group enriched" "Detected in some" 13 "basal ganglia: 13.8;pons and medulla: 45.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1" "Group enriched" "Detected in some" 15 "basal ganglia: 20.7;hippocampal formation: 7.2;pons and medulla: 26.3" HPA046105 Approved "Nuclear bodies,Cell Junctions,Intermediate filaments" "Cell Junctions, Intermediate filaments" "Nuclear bodies" "HPA046105: " "unprognostic (2.98e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-3)" "unprognostic (7.10e-2)" "unprognostic (1.66e-1)" "unprognostic (3.39e-4)" "unprognostic (1.05e-2)" "unprognostic (9.78e-3)" "unprognostic (6.42e-2)" "unprognostic (1.61e-2)" 0.3 2.4 0.1 1.6 13.8 0.0 0.3 0.1 0.4 3.3 5.2 0.1 0.3 2.3 1.6 0.7 1.0 0.2 0.5 1.2 0.2 2.2 0.9 0.2 0.9 0.0 0.3 0.5 0.8 0.5 0.0 0.1 0.0 45.1 0.8 2.5 1.0 0.9 4.2 0.1 0.1 2.5 3.1 10.0 0.1 1.7 0.3 0.8 0.0 4.0 0.3 0.1 4.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 0.1 0.4 0.2 2.2 0.3 0.5 45.1 0.8 SLC5A9 SGLT4 ENSG00000117834 "Solute carrier family 5 member 9" Q2M3M2 1 48222685-48248644 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 77.3" "Cell line enriched" "Detected in some" 8 "Hep G2: 17.8" "Cancer enhanced" "Detected in many" "liver cancer: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050263 Approved "Actin filaments,Cytosol" "Actin filaments" Cytosol "HPA050263: " "unprognostic (3.09e-3)" "unprognostic (1.89e-1)" "unprognostic (6.75e-2)" "unprognostic (5.66e-2)" "unprognostic (2.36e-1)" "unprognostic (1.35e-3)" "unprognostic (3.64e-2)" "unprognostic (4.59e-2)" "unprognostic (3.60e-2)" "unprognostic (1.59e-1)" "unprognostic (7.42e-2)" "unprognostic (1.97e-1)" "prognostic unfavourable (1.84e-5)" "unprognostic (4.56e-1)" "unprognostic (2.11e-1)" "unprognostic (4.30e-3)" "unprognostic (1.06e-2)" 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 33.0 0.1 0.8 26.0 0.1 7.2 0.1 0.2 2.2 0.1 0.0 0.0 3.1 4.9 2.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.4 0.0 1.0 77.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC6A16 NTT5 ENSG00000063127 "Solute carrier family 6 member 16" Q9GZN6 19 49289638-49325225 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "testis: 102.2" "Cell line enhanced" "Detected in many" "AF22: 17.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA076812 Supported "Golgi apparatus" "Golgi apparatus" "HPA076812: " "unprognostic (1.98e-1)" "unprognostic (7.15e-3)" "unprognostic (6.39e-3)" "unprognostic (1.36e-1)" "unprognostic (1.29e-1)" "unprognostic (6.83e-3)" "unprognostic (7.89e-2)" "unprognostic (7.92e-2)" "unprognostic (1.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.55e-3)" "unprognostic (1.63e-1)" "unprognostic (3.23e-2)" "unprognostic (3.31e-1)" "unprognostic (2.10e-1)" "unprognostic (8.93e-2)" "unprognostic (4.18e-2)" 1.5 0.4 0.8 1.1 0.9 1.9 1.0 0.8 0.8 1.3 1.1 0.8 0.8 0.3 1.5 1.0 0.8 2.0 1.0 0.8 0.8 0.3 2.0 3.6 1.6 3.1 0.8 0.8 2.9 2.6 0.7 0.8 1.3 0.8 1.8 0.3 0.9 0.8 1.2 0.8 0.7 1.2 0.8 0.8 1.7 1.0 102.2 0.8 0.8 1.1 0.8 2.4 0.8 1.2 7.8 2.1 4.8 3.7 3.8 3.1 2.2 0.0 6.9 17.5 6.3 0.3 2.8 3.2 0.9 1.4 0.6 1.9 0.4 0.6 8.1 1.1 0.7 0.3 1.9 0.3 2.1 1.3 2.0 0.7 0.7 1.5 1.3 0.5 2.9 2.8 1.1 1.3 1.0 1.5 1.5 1.1 2.2 1.5 0.4 0.5 6.2 0.9 0.3 4.2 1.5 0.9 0.0 0.2 0.4 2.7 0.1 0.6 2.8 0.2 8.7 1.4 6.6 4.1 0.0 3.9 4.1 7.3 0.1 1.9 0.4 0.4 0.8 4.8 3.1 2.2 3.0 7.8 1.1 3.1 0.8 4.5 2.7 1.8 4.0 3.8 3.7 2.1 1.7 2.2 0.8 0.9 0.8 0.8 0.8 0.3 0.8 0.8 0.8 0.8 SLC6A17 ENSG00000197106 "Solute carrier family 6 member 17" Q9H1V8 1 110150486-110202202 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 53.5" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 27.6" "Cancer enriched" "Detected in some" 9 "melanoma: 17.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007663, HPA008044" Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA007663: AB_1857194, HPA008044: AB_1857192" "unprognostic (1.13e-1)" "unprognostic (1.37e-3)" "unprognostic (5.52e-3)" "unprognostic (3.00e-2)" "unprognostic (1.17e-1)" "unprognostic (4.88e-2)" "unprognostic (6.11e-3)" "unprognostic (3.87e-3)" "unprognostic (1.70e-2)" "unprognostic (1.80e-1)" "unprognostic (1.68e-2)" "unprognostic (2.94e-1)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (9.76e-2)" "unprognostic (1.38e-3)" "unprognostic (1.68e-3)" 1.4 7.8 9.3 1.2 18.3 1.1 1.3 21.8 53.5 1.0 1.1 2.3 0.0 1.0 1.0 2.1 1.3 1.0 1.1 1.0 11.2 14.9 2.1 0.9 1.0 0.9 6.0 16.2 1.0 2.6 1.0 12.4 1.8 19.5 1.0 1.0 2.6 1.2 1.0 1.0 7.6 1.1 1.1 1.8 1.0 1.8 2.4 0.7 0.0 1.3 0.0 0.9 1.0 0.1 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.2 0.4 1.6 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.6 4.7 1.4 27.6 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 5.6 0.0 2.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 9.3 18.3 21.8 37.3 11.2 14.9 6.0 16.2 19.5 0.7 SLC6A18 "FLJ31236, Xtrp2" ENSG00000164363 "Solute carrier family 6 member 18" Q96N87 5 1225355-1246189 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 32 "kidney: 14.1" "Cell line enhanced" "Detected in single" "MCF7: 1.2" "Cancer enriched" "Detected in single" 44 "renal cancer: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA011885 Enhanced "HPA011885: AB_1857198" "unprognostic (2.02e-1)" "unprognostic (5.69e-3)" "unprognostic (2.90e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.4 0.6 0.0 0.0 0.6 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC6A19 ENSG00000174358 "Solute carrier family 6 member 19" Q695T7 5 1201595-1225117 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 167.3" "Group enriched" "Detected in some" 6 "BEWO: 14.2;HEL: 17.4" "Cancer enhanced" "Detected in many" "renal cancer: 7.9;stomach cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037415, HPA043207" Enhanced "HPA037415: AB_10672346, HPA043207: AB_2678363" "unprognostic (1.26e-1)" "unprognostic (1.01e-3)" "unprognostic (6.04e-2)" "unprognostic (3.64e-1)" "prognostic favourable (4.14e-6)" "unprognostic (1.37e-1)" "unprognostic (7.36e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 55.3 0.0 0.0 44.6 0.1 0.0 0.1 0.1 30.0 0.1 0.1 0.1 28.7 0.5 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.5 1.7 0.0 0.1 0.0 0.1 0.1 167.3 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 SLC6A3 "DAT, DAT1" ENSG00000142319 "Solute carrier family 6 member 3" Q01959 5 1392790-1445430 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 48.4" "Group enriched" "Detected in some" 5 "NTERA-2: 1.2;RPMI-8226: 2.0;SCLC-21H: 3.7" "Cancer enriched" "Detected in some" 18 "renal cancer: 25.7" "Region enriched" "Detected in some" 47 "midbrain: 48.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "midbrain: 96.4;thalamus: 31.8" "Region enriched" "Detected in single" 139 "midbrain: 362.2" "HPA012763, HPA013602, CAB016249, CAB078172" Enhanced Supported Approved Vesicles Vesicles "CAB016249: AB_627402, CAB078172: , HPA012763: , HPA013602: AB_1847484" "unprognostic (2.25e-4)" "unprognostic (2.22e-1)" "unprognostic (8.45e-2)" "unprognostic (5.24e-2)" "unprognostic (7.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.64e-5)" "unprognostic (9.31e-2)" "unprognostic (7.89e-2)" "unprognostic (4.81e-2)" "unprognostic (1.30e-1)" "unprognostic (2.12e-2)" "prognostic unfavourable (3.40e-7)" "unprognostic (6.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.22e-2)" "unprognostic (4.74e-2)" 0.2 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.3 0.7 0.0 0.0 0.0 0.3 1.1 0.8 0.1 0.8 0.6 0.1 0.0 0.6 0.3 0.0 3.4 0.0 48.4 0.0 1.5 0.0 0.0 0.0 0.1 1.0 0.7 0.0 1.7 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.8 0.0 2.4 2.2 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 2.0 0.0 0.1 3.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.6 48.4 0.0 1.0 0.0 SLC6A5 "GLYT2, NET1" ENSG00000165970 "Solute carrier family 6 member 5" Q9Y345 11 20599400-20659285 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 21.3" "Cell line enriched" "Detected in single" 5 "SCLC-21H: 2.5" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "pons and medulla: 21.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 9 "pons and medulla: 51.6" "Region enriched" "Detected in some" 9 "pons and medulla: 33.2" CAB079052 Supported "CAB079052: " "unprognostic (6.94e-2)" "unprognostic (2.28e-1)" "unprognostic (4.75e-2)" 0.0 0.1 0.1 0.1 0.0 0.0 0.0 3.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 5.1 0.1 0.1 0.0 0.0 0.0 0.0 2.2 0.0 21.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 6.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.4 0.3 0.1 0.1 0.0 21.3 0.0 SLC6A7 PROT ENSG00000011083 "Solute carrier family 6 member 7" Q99884 5 150189957-150222788 "Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 40.2" "Cell line enhanced" "Detected in some" "HeLa: 1.9;SK-BR-3: 1.5;U-87 MG: 1.1" "Cancer enhanced" "Detected in single" "colorectal cancer: 0.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028907 Uncertain "HPA028907: AB_10602404" "unprognostic (3.01e-1)" "unprognostic (1.97e-2)" "unprognostic (3.70e-2)" "unprognostic (1.42e-3)" "unprognostic (1.09e-2)" "unprognostic (1.82e-4)" "unprognostic (6.42e-2)" "unprognostic (1.35e-1)" "unprognostic (1.59e-1)" "unprognostic (1.33e-1)" "unprognostic (2.55e-1)" "unprognostic (3.50e-1)" "unprognostic (3.73e-4)" "unprognostic (8.11e-2)" "unprognostic (5.46e-2)" "unprognostic (2.73e-1)" "unprognostic (3.70e-3)" 0.5 0.4 3.9 1.0 9.7 0.4 0.5 40.2 22.4 0.6 5.7 0.3 0.0 2.6 0.5 0.6 0.4 0.4 0.5 0.5 6.5 4.5 0.4 0.4 0.5 0.7 1.3 14.5 0.4 0.5 0.4 0.2 0.4 1.6 0.4 7.7 0.0 0.8 0.4 0.5 0.5 4.9 0.7 1.4 0.4 0.4 0.5 0.0 0.0 0.4 0.0 0.7 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 9.7 40.2 22.4 6.5 4.5 1.3 14.5 1.6 0.0 SLC7A13 "AGT-1, XAT2" ENSG00000164893 "Solute carrier family 7 member 13" Q8TCU3 8 86214052-86321146 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "kidney: 31.7" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.34e-1)" "unprognostic (2.62e-1)" "unprognostic (1.12e-1)" "unprognostic (2.96e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 31.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.6 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.0 1.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC7A3 "ATRC3, CAT-3, FLJ14541" ENSG00000165349 "Solute carrier family 7 member 3" Q8WY07 X 70925582-70931125 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 45.5" "Cell line enhanced" "Detected in some" "Daudi: 8.8;HAP1: 24.5;MOLT-4: 9.6;NTERA-2: 50.3;REH: 10.5" "Cancer enriched" "Detected in some" 12 "testis cancer: 43.0" "Region enhanced" "Detected in many" "hypothalamus: 6.7" "Cell type enriched" "Detected in single" 16 "naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003629 Approved "HPA003629: AB_2190964" "unprognostic (1.42e-4)" "unprognostic (4.30e-4)" "unprognostic (3.59e-3)" "unprognostic (1.81e-2)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (3.66e-1)" "unprognostic (9.18e-3)" "unprognostic (1.89e-1)" "unprognostic (7.99e-5)" "unprognostic (1.31e-2)" "unprognostic (5.42e-4)" "unprognostic (3.57e-2)" 0.1 0.0 1.0 0.1 1.0 1.3 1.4 0.1 2.1 2.0 0.1 1.1 0.8 0.1 9.1 6.2 0.7 2.7 0.1 0.0 1.2 6.7 0.2 0.0 0.1 0.5 0.5 0.5 1.7 0.0 0.0 0.6 0.0 1.2 10.4 0.0 0.5 0.2 9.4 0.0 0.0 0.3 4.6 0.2 0.1 5.6 2.4 0.4 45.5 0.0 0.2 0.5 4.0 1.4 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.2 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 50.3 0.0 10.5 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 1.0 1.0 0.1 2.1 1.2 6.7 0.5 0.5 1.2 0.4 SLC7A8 "LAT2, LPI-PC1" ENSG00000092068 "Solute carrier family 7 member 8" Q9UHI5 14 23125295-23183674 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 204.0" "Cell line enhanced" "Detected in many" "AF22: 21.1;ASC diff: 22.2;BEWO: 38.7;CACO-2: 21.4;K-562: 40.5;NTERA-2: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 7.6;eosinophil: 13.2;naive CD8 T-cell: 3.5" "Group enriched" "Detected in many" 46 "granulocytes: 13.2;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046015, HPA051950, HPA060672" Enhanced "CAB046015: AB_2239464, HPA051950: , HPA060672: " "unprognostic (1.50e-1)" "unprognostic (1.52e-1)" "unprognostic (2.88e-1)" "unprognostic (1.03e-2)" "unprognostic (1.12e-2)" "unprognostic (3.03e-2)" "prognostic unfavourable (1.97e-4)" "prognostic favourable (3.15e-4)" "unprognostic (1.24e-1)" "unprognostic (2.37e-1)" "unprognostic (1.39e-3)" "unprognostic (9.44e-2)" "unprognostic (7.00e-2)" "unprognostic (2.96e-2)" "unprognostic (8.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavourable (1.52e-4)" 10.5 5.9 4.6 3.0 6.6 1.3 11.0 10.9 10.7 12.7 5.9 2.5 28.2 11.7 23.0 7.2 13.2 21.7 6.2 3.1 7.8 3.0 37.6 3.0 6.2 5.8 2.4 5.6 33.7 9.1 204.0 16.7 19.8 6.9 13.0 5.1 31.2 9.5 50.9 23.6 11.2 8.8 7.5 1.9 10.0 19.3 10.5 4.7 0.3 12.8 5.2 4.9 15.2 14.5 0.1 0.0 13.2 0.1 0.0 3.5 1.7 0.4 0.0 21.1 0.0 22.2 2.7 38.7 2.1 8.5 0.0 0.6 21.4 1.1 0.1 0.3 4.6 3.6 2.8 1.1 0.1 0.0 2.0 0.1 0.0 0.0 8.7 0.0 12.0 19.1 10.6 0.3 0.2 1.7 40.5 0.0 0.4 0.3 0.0 0.2 21.1 15.8 0.0 0.2 4.0 0.2 7.9 2.6 0.1 0.0 3.7 10.0 13.4 0.1 0.1 0.7 0.5 0.2 0.0 0.1 4.6 0.0 2.4 0.0 0.1 7.6 0.1 13.2 0.0 0.1 1.1 0.1 0.9 0.1 0.0 0.0 0.9 3.5 0.4 0.0 0.0 0.0 0.5 1.7 4.6 6.6 10.9 10.7 7.8 3.0 2.4 5.6 6.9 4.7 SLC8A2 "KIAA1087, NCX2" ENSG00000118160 "Solute carrier family 8 member A2" Q9UPR5 19 47428017-47472168 "Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.9" "Group enriched" "Detected in some" 6 "NTERA-2: 4.3;SCLC-21H: 12.2;SH-SY5Y: 6.6;SiHa: 5.1;U-2 OS: 7.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "amygdala: 80.3;basal ganglia: 95.4;cerebral cortex: 125.2;hippocampal formation: 110.1" "Low region specificity" "Detected in all" "HPA050818, HPA054671" Enhanced "HPA050818: AB_2681248, HPA054671: AB_2682568" "unprognostic (3.75e-2)" "unprognostic (1.84e-1)" "unprognostic (1.42e-1)" "unprognostic (4.32e-2)" "unprognostic (1.34e-1)" "unprognostic (6.00e-3)" "unprognostic (1.38e-1)" "unprognostic (2.79e-1)" "unprognostic (1.34e-1)" "unprognostic (8.95e-2)" "unprognostic (4.77e-2)" "unprognostic (2.04e-2)" "unprognostic (2.81e-3)" "unprognostic (6.13e-2)" "unprognostic (9.40e-2)" "unprognostic (1.53e-1)" "unprognostic (1.63e-2)" 1.2 4.0 16.6 1.0 18.1 0.9 0.9 50.9 50.7 1.0 2.4 1.8 1.0 1.3 5.4 1.0 2.3 2.2 1.1 0.9 21.4 6.8 1.0 0.9 0.9 0.9 2.1 21.1 0.9 10.3 0.9 3.2 1.0 2.0 1.4 1.4 0.0 1.2 4.4 0.9 1.0 1.2 5.5 2.0 1.0 1.3 1.9 1.2 0.0 1.0 0.0 0.9 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.4 0.1 12.2 6.6 5.1 0.6 0.4 0.1 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 18.1 50.9 34.6 21.4 6.8 2.1 21.1 2.0 1.2 SLC9B1 "NHA1, NHEDC1" ENSG00000164037 "Solute carrier family 9 member B1" Q4ZJI4 4 102885048-103019739 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Fertilization, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 43.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.0;dendritic cells: 1.9;T-cells: 4.9" "Not detected" "Not detected" "HPA058971, HPA065520" Supported "Centriolar satellite,Mitochondria" Mitochondria "Centriolar satellite" "HPA058971: , HPA065520: " "unprognostic (4.87e-3)" "unprognostic (2.38e-1)" "unprognostic (1.18e-1)" "unprognostic (8.26e-4)" "unprognostic (2.53e-1)" "unprognostic (3.39e-1)" "unprognostic (5.06e-4)" "unprognostic (5.85e-2)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.07e-3)" "unprognostic (7.68e-2)" "unprognostic (3.03e-2)" "unprognostic (3.33e-1)" "unprognostic (1.85e-1)" "unprognostic (5.66e-5)" "unprognostic (5.78e-2)" 1.1 1.1 1.1 1.1 3.1 0.9 0.9 1.4 2.0 0.9 0.8 3.7 0.0 0.8 2.6 2.3 0.7 0.9 1.6 0.9 1.6 1.0 0.8 0.7 1.1 2.4 2.4 1.1 1.5 1.3 1.2 2.4 0.9 3.1 1.1 0.8 2.8 0.7 0.9 0.7 1.9 0.8 0.7 4.4 1.0 0.8 43.1 2.3 4.2 1.1 0.0 1.7 1.2 0.9 2.0 1.9 0.6 0.6 0.4 4.9 0.6 0.4 0.0 2.2 3.3 4.5 3.3 0.7 0.8 1.1 0.0 0.2 0.0 0.2 1.7 0.6 1.7 0.0 1.7 0.9 1.5 3.2 2.3 2.5 2.0 0.0 0.0 0.7 0.5 0.5 1.0 0.0 1.8 1.3 1.2 1.7 1.7 1.3 1.0 2.2 0.8 0.0 2.7 1.8 0.5 0.9 0.5 2.1 5.0 0.6 0.8 2.5 0.4 1.7 0.7 0.9 0.3 1.0 1.1 5.5 4.0 1.4 1.2 1.0 2.4 0.6 0.6 0.1 1.5 0.4 1.7 1.8 1.2 1.8 0.7 2.0 4.9 2.8 0.3 0.4 0.3 1.9 1.7 0.6 1.1 3.1 1.4 2.0 1.6 1.0 2.4 1.1 3.1 2.3 SLC9C1 "NHE, SLC9A10" ENSG00000172139 "Solute carrier family 9 member C1" Q4G0N8 3 112140887-112294258 "Predicted membrane proteins, Transporters" "Antiport, Differentiation, Ion transport, Sodium transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 25.5" "Cell line enhanced" "Detected in some" "AF22: 1.0;HaCaT: 1.5;Karpas-707: 1.0;REH: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 12 "B-cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (1.21e-2)" "unprognostic (3.63e-1)" "unprognostic (4.79e-2)" "unprognostic (2.92e-1)" "unprognostic (1.57e-3)" "unprognostic (9.56e-2)" "unprognostic (3.92e-2)" "unprognostic (1.24e-1)" "unprognostic (4.40e-2)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.98e-2)" "unprognostic (1.65e-2)" "unprognostic (8.32e-2)" "unprognostic (5.89e-2)" "unprognostic (9.62e-3)" "unprognostic (3.25e-1)" 0.3 0.1 0.1 1.4 0.2 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.4 0.0 0.2 0.1 0.1 0.3 1.7 0.5 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.1 0.3 1.2 0.0 0.8 0.7 0.4 0.1 0.1 0.3 0.2 1.1 0.1 4.0 1.0 0.2 0.3 0.4 0.3 25.5 0.0 1.0 0.5 0.5 0.4 0.3 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.3 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 SLC9C2 "MGC43026, SLC9A11" ENSG00000162753 "Solute carrier family 9 member C2 (putative)" Q5TAH2 1 173500464-173603094 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 24.9" "Group enriched" "Detected in some" 4 "BEWO: 1.7;THP-1: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.7" "Low region specificity" "Detected in all" "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (8.52e-2)" "unprognostic (5.88e-3)" "unprognostic (3.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-3)" "unprognostic (1.19e-1)" "unprognostic (4.21e-2)" "unprognostic (4.92e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-6)" "unprognostic (1.66e-1)" "unprognostic (1.01e-2)" "unprognostic (2.98e-1)" "unprognostic (1.81e-1)" 0.4 0.1 0.3 0.0 1.3 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.5 0.0 0.1 0.4 0.0 1.7 0.0 0.1 0.5 0.3 0.2 0.0 0.4 0.1 0.0 0.4 0.8 0.3 0.1 0.4 0.5 0.5 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.1 0.3 1.0 0.3 24.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.3 1.3 0.0 1.6 0.5 0.3 0.0 0.4 0.5 0.4 SLCO1B1 "LST-1, OATP-C, OATP1B1, SLC21A6" ENSG00000134538 "Solute carrier organic anion transporter family member 1B1" Q9Y6L6 12 21131202-21239246 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 618 "liver: 121.0" "Cell line enhanced" "Detected in some" "A-431: 2.6;A549: 2.1;HeLa: 3.3;NTERA-2: 3.0;RPMI-8226: 4.0" "Cancer enriched" "Detected in some" 96 "liver cancer: 52.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050892 Supported "HPA050892: " "unprognostic (5.45e-1)" "unprognostic (1.82e-4)" "unprognostic (2.43e-3)" "unprognostic (1.96e-3)" "unprognostic (1.80e-1)" "unprognostic (2.41e-1)" "unprognostic (8.82e-2)" "unprognostic (5.63e-2)" "unprognostic (3.86e-2)" "unprognostic (3.49e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.7 0.0 0.8 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.4 0.0 0.9 0.0 0.0 1.2 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLCO1B3 "OATP1B3, OATP8, SLC21A8" ENSG00000111700 "Solute carrier organic anion transporter family member 1B3" Q9NPD5 12 20810702-20916911 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 88.1" "Cell line enhanced" "Detected in some" "A-431: 35.2;A549: 9.7;CAPAN-2: 7.0;HeLa: 8.0;PC-3: 9.7;U-2 OS: 8.3" "Cancer enhanced" "Detected in many" "liver cancer: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004943, HPA050892" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA004943: AB_1854758, HPA050892: " "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (6.95e-2)" "unprognostic (1.63e-2)" "unprognostic (1.89e-2)" "unprognostic (7.09e-2)" "unprognostic (3.08e-2)" "unprognostic (1.54e-2)" "unprognostic (7.37e-2)" "unprognostic (1.50e-1)" "unprognostic (6.61e-3)" "unprognostic (2.36e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 4.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 88.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 8.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SLCO1B7 "LST3, SLC21A21" ENSG00000205754 "Solute carrier organic anion transporter family member 1B7 (putative)" G3V0H7 12 21015696-21092745 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "breast: 28.2" "Cell line enhanced" "Detected in some" "A-431: 5.9;A549: 4.0;CAPAN-2: 4.3;HeLa: 4.1;U-2 OS: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050892 Uncertain "HPA050892: " "unprognostic (8.82e-3)" "unprognostic (2.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 28.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.9 4.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.6 0.0 0.0 0.2 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 3.0 0.5 0.3 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 SLCO4C1 "OATP-H, OATP4C1, OATPX, SLC21A20" ENSG00000173930 "Solute carrier organic anion transporter family member 4C1" Q6ZQN7 5 102233986-102296549 "Predicted membrane proteins, Transporters" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 55.9" "Cell line enhanced" "Detected in some" "Karpas-707: 7.9;RPTEC TERT1: 44.8;U-937: 11.3" "Cancer enriched" "Detected in many" 5 "renal cancer: 22.4" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Group enriched" "Detected in many" 5 "granulocytes: 10.0;NK-cells: 2.6;T-cells: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA058249 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA058249: " "unprognostic (1.63e-2)" "unprognostic (2.47e-2)" "unprognostic (4.48e-4)" "unprognostic (5.70e-6)" "unprognostic (7.43e-2)" "unprognostic (7.71e-3)" "unprognostic (3.24e-3)" "unprognostic (2.05e-3)" "unprognostic (2.13e-1)" "unprognostic (7.12e-2)" "unprognostic (3.87e-3)" "unprognostic (5.83e-2)" "prognostic favourable (1.12e-4)" "unprognostic (3.29e-2)" "unprognostic (1.07e-1)" "unprognostic (5.91e-2)" "unprognostic (8.22e-2)" 0.4 0.4 0.3 0.7 0.7 5.4 0.3 0.2 1.8 0.3 1.9 0.0 5.2 1.4 0.2 0.6 0.3 0.3 1.6 1.1 0.3 0.4 55.9 5.2 11.0 0.2 0.3 1.0 0.3 0.9 0.0 0.7 0.1 0.2 0.4 0.5 0.0 3.2 11.8 0.3 0.6 2.1 0.0 0.3 1.6 0.4 1.3 0.0 1.5 1.0 0.3 0.1 0.7 1.1 0.1 0.4 10.0 1.1 2.6 4.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.5 44.8 0.0 0.3 0.2 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 11.3 0.0 7.9 1.1 7.5 4.3 0.0 0.4 0.0 0.7 2.3 0.4 0.1 0.2 1.5 10.0 2.6 0.0 0.3 0.0 1.0 0.3 0.7 0.2 1.8 0.3 0.4 0.3 1.0 0.2 0.0 SLCO6A1 "CT48, MGC26949, OATP6A1, OATPY" ENSG00000205359 "Solute carrier organic anion transporter family member 6A1" Q86UG4 5 102371782-102499016 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 93 "testis: 39.2" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;SCLC-21H: 2.4;U-266/84: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 9 "amygdala: 0.9;basal ganglia: 1.1;cerebral cortex: 0.8;hippocampal formation: 2.1" HPA054126 Enhanced "HPA054126: " "unprognostic (1.17e-1)" "unprognostic (2.59e-1)" "unprognostic (4.37e-2)" "unprognostic (4.65e-1)" "unprognostic (1.84e-1)" "unprognostic (2.60e-2)" "unprognostic (6.70e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.8 2.4 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLFNL1 FLJ23878 ENSG00000171790 "Schlafen like 1" Q499Z3 1 41015597-41023237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 49.7" "Cell line enhanced" "Detected in many" "CACO-2: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054956 Approved Cytosol Cytosol "HPA054956: " "unprognostic (7.01e-3)" "unprognostic (1.62e-1)" "unprognostic (1.54e-3)" "unprognostic (4.35e-2)" "unprognostic (3.39e-1)" "unprognostic (4.11e-4)" "unprognostic (8.98e-3)" "unprognostic (1.02e-3)" "unprognostic (8.40e-3)" "unprognostic (1.50e-1)" "unprognostic (2.51e-1)" "unprognostic (3.71e-4)" "unprognostic (2.70e-3)" "unprognostic (1.10e-1)" "unprognostic (2.09e-1)" "unprognostic (3.26e-1)" "unprognostic (2.43e-1)" 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.4 0.3 0.2 0.4 0.2 0.2 0.2 0.5 2.6 0.2 0.5 0.2 0.2 0.2 0.0 0.2 0.8 1.9 0.2 0.2 0.2 0.6 0.3 0.1 0.3 0.2 0.2 0.6 0.0 0.2 3.4 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.1 49.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.4 1.3 0.0 0.0 0.7 0.0 1.0 1.6 0.7 1.1 0.0 0.3 4.9 2.1 0.1 0.0 0.1 10.0 1.0 1.8 1.8 0.1 1.7 0.1 0.0 0.0 1.3 3.0 1.3 2.4 1.3 0.7 1.9 1.2 0.2 0.2 0.1 0.0 0.2 1.1 2.2 0.1 0.8 1.1 2.0 1.8 2.6 2.5 1.3 1.0 0.0 2.7 1.3 0.5 0.4 0.9 0.8 0.6 1.1 0.8 2.0 2.4 1.0 1.4 1.1 0.6 2.2 0.3 2.1 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.4 0.3 0.2 0.0 0.2 0.2 0.2 0.2 SLIT1 "MEGF4, SLIL1, Slit-1, slit1, SLIT3" ENSG00000187122 "Slit guidance ligand 1" O75093 10 96998038-97185920 "Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 44.3" "Cell line enriched" "Detected in some" 15 "MOLT-4: 41.2" "Group enriched" "Detected in many" 10 "glioma: 9.2;prostate cancer: 2.2;thyroid cancer: 10.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 1.6;plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006879 Approved "Plasma membrane" "Secreted in brain" "Plasma membrane" "HPA006879: AB_1078197" "unprognostic (2.72e-1)" "unprognostic (2.25e-2)" "unprognostic (5.67e-3)" "unprognostic (1.43e-5)" "unprognostic (8.40e-2)" "unprognostic (2.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.81e-2)" "unprognostic (3.53e-1)" "unprognostic (6.06e-2)" "unprognostic (2.28e-3)" "unprognostic (1.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.66e-1)" "unprognostic (2.18e-1)" "unprognostic (1.21e-1)" "unprognostic (4.39e-3)" 1.2 0.8 13.4 0.9 16.1 0.9 0.8 0.4 44.3 0.8 0.9 0.5 0.0 0.9 0.8 0.7 0.8 1.0 0.8 0.8 13.9 10.5 0.8 0.7 1.0 0.9 4.6 13.2 0.8 1.4 0.8 8.0 0.8 2.2 1.1 0.8 0.3 0.8 0.7 0.9 0.8 0.9 0.8 1.4 0.9 1.1 2.0 0.3 3.3 3.6 0.0 0.9 0.8 0.0 0.0 1.6 0.4 0.7 0.0 0.0 0.2 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 41.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.6 1.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.4 1.6 0.0 0.2 13.4 16.1 0.4 24.8 13.9 10.5 4.6 13.2 2.2 0.3 SLITRK1 "KIAA1910, LRRC12" ENSG00000178235 "SLIT and NTRK like family member 1" Q96PX8 13 83877205-83882393 "Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 30.6" "Group enriched" "Detected in some" 4 "A-431: 7.4;AF22: 3.1;LHCN-M2: 2.7" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012414 Enhanced "Secreted in brain" 270000 "HPA012414: AB_1857229" "unprognostic (2.29e-1)" "unprognostic (4.32e-1)" "unprognostic (4.71e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (7.95e-2)" 0.9 1.3 16.7 0.9 9.5 0.9 1.0 2.0 30.6 1.2 1.0 6.3 0.0 1.0 1.0 1.0 0.9 0.9 1.0 0.9 16.9 7.3 1.0 0.9 0.9 0.9 7.3 14.9 0.9 3.1 0.9 3.1 0.9 5.8 0.9 1.0 0.1 1.0 1.4 1.0 0.9 0.9 0.9 3.7 0.9 1.0 1.0 8.5 0.0 0.9 0.0 0.9 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 3.1 0.0 0.1 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 2.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 9.5 2.0 21.5 16.9 7.3 7.3 14.9 5.8 8.5 SLN "MGC12301, MGC125854, MGC125855" ENSG00000170290 Sarcolipin O00631 11 107707378-107719693 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 446.6" "Cell line enhanced" "Detected in some" "BEWO: 3.0;HSkMC: 6.5;Karpas-707: 3.1;PC-3: 2.9;SCLC-21H: 2.0;U-2 OS: 3.0" "Group enriched" "Detected in many" 13 "glioma: 21.6;head and neck cancer: 22.4;prostate cancer: 4.5" "Region enhanced" "Detected in some" "basal ganglia: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "basal ganglia: 19.0" "Low region specificity" "Detected in many" CAB011628 Approved Microtubules Microtubules "CAB011628: AB_2195046" "unprognostic (6.85e-2)" "unprognostic (6.18e-8)" "unprognostic (2.60e-1)" "unprognostic (3.66e-2)" "unprognostic (2.40e-3)" "unprognostic (4.12e-3)" "unprognostic (5.28e-3)" "unprognostic (1.31e-2)" "unprognostic (2.76e-1)" "unprognostic (6.35e-2)" "unprognostic (1.68e-1)" "prognostic unfavourable (3.52e-9)" "unprognostic (3.27e-2)" "unprognostic (2.54e-1)" "unprognostic (5.09e-4)" "unprognostic (3.77e-2)" 4.8 0.5 0.2 0.0 1.9 0.0 0.1 0.4 1.0 0.0 0.2 0.0 0.0 0.0 0.0 5.3 9.1 0.1 0.0 72.9 0.2 0.0 0.1 0.0 0.2 0.2 0.0 0.0 1.1 0.1 0.0 0.0 0.1 0.1 2.3 0.0 0.4 4.3 0.0 446.6 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.9 40.1 6.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.4 0.5 0.2 0.0 0.2 0.6 0.1 0.2 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.4 0.3 6.5 0.0 0.8 0.0 0.0 0.1 3.1 0.0 0.4 0.3 0.4 0.1 2.9 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.2 1.2 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 1.9 0.4 1.0 0.2 0.0 0.0 0.0 0.1 0.0 SMC1B "bK268H5, SMC1L2" ENSG00000077935 "Structural maintenance of chromosomes 1B" Q8NDV3 22 45344063-45413619 "Predicted intracellular proteins" "Cell cycle, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 46 "testis: 35.4" "Cell line enhanced" "Detected in some" "A-431: 9.0;EFO-21: 4.3;SiHa: 18.7;U-266/70: 4.2" "Cancer enriched" "Detected in many" 6 "cervical cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA001500 Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA001500: AB_1080030" "unprognostic (1.18e-2)" "unprognostic (6.16e-3)" "unprognostic (2.22e-1)" "unprognostic (3.38e-3)" "unprognostic (1.77e-1)" "unprognostic (3.21e-2)" "unprognostic (6.18e-2)" "unprognostic (1.87e-3)" "unprognostic (3.41e-2)" "unprognostic (3.65e-1)" "unprognostic (4.49e-2)" "unprognostic (3.79e-1)" "unprognostic (3.83e-9)" "unprognostic (2.10e-1)" "unprognostic (1.11e-2)" "unprognostic (1.78e-1)" "unprognostic (1.98e-3)" 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.7 0.2 0.0 0.5 0.0 9.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.8 0.1 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.4 0.2 0.1 0.0 18.7 0.1 0.0 0.1 1.6 0.1 0.0 0.0 0.5 0.0 4.2 0.0 0.0 0.0 0.3 1.9 0.0 0.2 0.7 0.4 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 0.1 0.3 0.6 0.0 0.0 0.0 0.2 0.0 SMCP MCSP ENSG00000163206 "Sperm mitochondria associated cysteine rich protein" P49901 1 152878317-152885047 "Predicted intracellular proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "testis: 121.7" "Group enriched" "Detected in some" 4 "BJ hTERT+: 4.2;hTERT-HME1: 4.0;U-2197: 2.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035105 Supported "HPA035105: AB_10601590" "unprognostic (5.51e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM17 ENSG00000268182 "Small integral membrane protein 17" P0DL12 19 56643145-56655766 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in many" 6 "brain: 26.5" "Cell line enhanced" "Detected in some" "AF22: 5.3;HEK 293: 5.2;RH-30: 4.2;SCLC-21H: 4.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "HPA071857, HPA071861" Enhanced Approved Vesicles Vesicles "HPA071857: , HPA071861: " "unprognostic (1.32e-1)" "unprognostic (2.82e-1)" "unprognostic (1.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.62e-1)" "unprognostic (4.57e-2)" "unprognostic (5.84e-2)" "unprognostic (3.00e-2)" "unprognostic (2.51e-1)" "unprognostic (6.50e-2)" "unprognostic (4.64e-2)" "unprognostic (9.02e-3)" "unprognostic (3.46e-3)" "unprognostic (6.26e-2)" "unprognostic (1.01e-1)" "unprognostic (3.71e-3)" "unprognostic (7.51e-3)" 1.8 1.2 7.0 0.6 10.4 0.8 2.4 4.5 17.3 0.9 1.1 0.9 0.0 1.0 2.2 4.8 1.2 1.5 1.0 1.7 6.0 13.8 1.3 0.8 1.3 0.7 5.9 7.7 1.8 1.2 0.5 2.2 1.1 26.5 1.7 1.2 0.4 1.3 2.6 1.1 1.9 0.7 1.4 2.7 1.0 0.7 1.6 0.1 0.0 1.1 0.0 0.8 0.5 0.5 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.2 0.0 5.3 1.5 1.2 0.9 1.1 0.7 0.6 1.2 0.3 0.0 0.2 0.4 0.8 0.3 0.3 0.1 0.4 0.7 0.0 5.2 3.1 0.6 0.8 0.8 2.4 0.4 1.7 0.7 0.0 1.4 0.5 0.1 0.0 1.1 0.0 2.8 0.3 0.0 0.6 1.5 4.2 0.1 0.7 0.0 4.8 0.9 1.2 0.1 0.7 0.0 0.8 0.8 1.8 0.2 0.5 0.5 0.3 0.8 1.3 0.6 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.0 10.4 4.5 17.3 6.0 13.8 5.9 7.7 26.5 0.1 SMIM2 "C13orf44, MGC5590" ENSG00000139656 "Small integral membrane protein 2" Q9BVW6 13 44143543-44161257 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 15.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 5.8;SiHa: 4.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA026891, HPA077071" Enhanced Uncertain "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA026891: AB_10602924, HPA077071: " "unprognostic (4.34e-2)" "unprognostic (8.70e-2)" "unprognostic (1.07e-1)" "unprognostic (4.87e-5)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (3.26e-1)" "unprognostic (1.26e-1)" "unprognostic (2.32e-1)" "unprognostic (1.85e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.10e-1)" "unprognostic (4.80e-2)" "unprognostic (2.39e-2)" "unprognostic (1.05e-2)" 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.2 0.8 0.9 0.1 2.9 0.1 0.2 0.3 1.2 0.2 0.2 0.9 0.4 0.1 0.0 0.2 0.1 0.7 0.0 0.3 0.2 0.2 0.0 0.6 0.0 1.0 0.1 2.2 0.2 0.2 0.1 0.4 15.9 0.1 0.0 0.2 0.1 0.5 0.0 0.0 0.2 1.8 0.4 0.0 1.2 1.1 1.3 0.3 0.0 0.0 1.4 0.0 5.8 1.4 0.0 2.1 0.3 2.3 1.5 0.0 3.6 0.0 2.2 1.6 0.0 2.3 0.0 2.6 0.0 2.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 1.5 0.0 0.9 1.6 1.3 0.1 0.3 0.0 0.6 3.1 1.6 4.5 2.0 3.0 0.1 0.2 0.5 0.0 1.1 1.7 0.3 0.0 0.1 0.9 1.7 0.5 1.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.3 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.1 0.0 0.0 0.0 SMIM21 C18orf62 ENSG00000206026 "Small integral membrane protein 21" Q3B7S5 18 75409476-75427703 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 48 "testis: 8.2" "Cell line enhanced" "Detected in some" "U-2197: 1.2;U-87 MG: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041686 Enhanced "HPA041686: AB_10961179" "unprognostic (7.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 1.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM23 "C5orf50, LOC644994" ENSG00000185662 "Small integral membrane protein 23" A6NLE4 5 171782432-171796126 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 166 "testis: 21.6" "Cell line enhanced" "Detected in some" "U-2197: 1.5;U-266/70: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (6.47e-3)" "unprognostic (1.71e-1)" "unprognostic (7.80e-2)" "unprognostic (1.15e-2)" "unprognostic (3.79e-2)" "unprognostic (2.72e-1)" "unprognostic (5.36e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM27 "C9orf133, TOPORS-AS1" ENSG00000235453 "Small integral membrane protein 27" 9 32551144-32568621 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in many" 6 "blood: 102.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 102.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 102.4" "prognostic favourable (4.18e-5)" "prognostic favourable (6.11e-4)" "unprognostic (1.47e-1)" "unprognostic (5.30e-2)" "unprognostic (4.88e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-1)" "unprognostic (4.74e-3)" "unprognostic (8.58e-2)" "prognostic favourable (8.39e-4)" "prognostic favourable (7.33e-5)" "unprognostic (1.30e-1)" "prognostic favourable (3.46e-4)" "unprognostic (7.64e-2)" "unprognostic (3.14e-1)" "unprognostic (2.38e-2)" "unprognostic (2.14e-3)" 4.0 6.9 5.0 4.3 12.2 7.9 5.6 4.8 11.0 4.0 4.0 2.4 4.4 4.8 2.2 7.8 2.3 4.0 2.1 8.6 5.1 6.2 3.9 5.6 8.8 5.7 5.8 3.7 11.5 3.7 5.5 2.1 8.9 4.4 1.6 4.0 5.9 4.6 13.8 2.1 3.9 4.5 11.4 6.6 5.1 16.2 6.1 4.5 2.8 4.7 4.1 2.6 0.0 18.4 8.4 102.4 7.6 13.3 22.0 9.9 7.1 4.0 7.4 6.7 3.2 10.0 4.1 3.8 5.5 2.9 5.9 1.0 1.9 5.5 5.5 5.4 2.9 5.0 3.3 4.2 10.7 11.3 27.1 12.3 9.0 7.5 6.6 4.7 7.3 5.3 2.8 6.7 6.6 3.8 14.0 5.2 5.4 11.7 27.4 9.2 7.8 6.1 3.5 9.7 6.7 3.7 5.6 6.9 8.9 3.5 4.5 2.8 5.8 3.8 2.0 5.5 2.7 3.6 15.6 11.9 19.4 12.4 4.1 1.8 13.6 7.3 47.4 12.7 7.2 16.9 17.6 18.3 14.7 6.1 18.4 22.0 19.0 102.4 13.3 7.6 8.4 18.3 9.9 SMIM31 LINC01207 ENSG00000248771 "Small integral membrane protein 31" 4 164754064-164803795 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "intestine: 42.7" "Cell line enhanced" "Detected in some" "A549: 3.2;RPTEC TERT1: 4.4" "Cancer enhanced" "Detected in many" "prostate cancer: 8.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted - unknown location" "unprognostic (2.84e-1)" "unprognostic (1.18e-1)" "unprognostic (2.47e-2)" "unprognostic (1.87e-4)" "unprognostic (2.95e-2)" "unprognostic (1.78e-1)" "unprognostic (4.17e-2)" "unprognostic (4.82e-1)" "unprognostic (9.47e-2)" "unprognostic (5.63e-3)" 0.0 0.0 0.1 4.0 0.0 0.2 0.6 0.0 0.0 3.1 25.4 0.0 0.0 13.7 0.7 0.2 0.1 0.0 6.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 9.8 9.8 0.0 2.1 0.0 0.0 0.0 42.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 1.1 1.4 3.1 0.5 1.3 0.5 0.0 0.4 3.2 0.2 0.8 0.2 0.4 0.8 0.3 0.1 0.3 0.3 1.2 0.4 0.6 0.3 0.2 0.7 0.1 0.4 0.1 0.3 0.4 0.0 0.4 0.2 0.4 0.6 0.9 0.3 0.3 0.2 0.2 0.0 0.5 1.4 0.0 0.6 0.3 1.4 0.4 0.1 0.6 0.2 1.4 4.4 0.6 0.5 0.2 0.4 0.5 0.6 0.4 0.7 0.4 0.4 0.2 0.8 0.5 1.7 0.4 0.7 0.7 0.7 1.2 3.1 0.5 0.6 0.4 0.3 0.4 0.4 0.4 0.4 0.2 1.1 0.5 0.5 2.8 1.3 0.4 1.4 0.3 0.0 SMIM36 ENSG00000261873 "Small integral membrane protein 36" 17 55448433-55511444 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 5 "retina: 29.3" "Cell line enhanced" "Detected in some" "TIME: 1.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "unprognostic (2.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.8 2.9 0.8 1.2 0.7 0.6 0.1 0.5 0.2 0.2 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.3 1.0 0.8 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.4 0.3 0.1 0.4 0.2 0.0 0.0 0.0 0.8 0.5 0.7 0.6 0.1 0.0 0.6 0.0 1.3 0.5 0.4 0.5 0.3 0.4 0.2 0.5 0.4 0.7 0.2 2.9 0.8 0.8 0.6 0.6 0.5 0.5 0.5 0.5 0.3 1.4 0.6 0.7 2.4 1.2 0.7 0.8 0.5 0.6 SMIM9 CXorf68 ENSG00000203870 "Small integral membrane protein 9" A6NGZ8 X 154823348-154834662 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 4 "testis: 4.1" "Cell line enhanced" "Detected in single" "Daudi: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060970 Uncertain "HPA060970: " "unprognostic (2.63e-5)" 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 SMKR1 ENSG00000240204 "Small lysine rich protein 1" H3BMG3 7 129502479-129512932 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "testis: 65.7" "Cell line enhanced" "Detected in many" "MCF7: 12.6;SCLC-21H: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 13 "B-cells: 2.9;NK-cells: 1.3;T-cells: 3.7" "Low region specificity" "Detected in all" HPA078358 Approved Nucleoli Nucleoli "HPA078358: " "unprognostic (5.08e-2)" "unprognostic (1.72e-1)" "unprognostic (1.64e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (2.13e-1)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (9.24e-2)" "unprognostic (4.05e-2)" "unprognostic (2.00e-1)" "unprognostic (6.30e-2)" "unprognostic (1.72e-6)" "unprognostic (1.67e-2)" "unprognostic (1.11e-2)" "unprognostic (6.40e-2)" "unprognostic (3.67e-2)" 0.3 1.0 3.1 0.5 6.3 0.3 1.5 0.8 3.3 0.6 0.3 0.1 0.0 0.5 0.4 1.7 0.4 4.6 0.4 0.2 2.7 2.2 0.7 0.2 0.5 0.7 1.1 2.7 0.3 2.6 2.9 2.7 0.9 1.0 0.5 0.4 0.0 0.3 0.4 0.2 0.5 0.4 0.3 0.5 0.3 0.5 65.7 0.7 0.0 0.7 0.1 0.7 0.2 0.0 2.9 0.0 0.2 0.0 1.3 3.7 0.4 8.6 8.4 0.2 7.4 0.0 0.0 0.0 0.0 0.2 0.7 0.7 0.0 2.3 0.0 0.8 0.5 1.0 1.5 0.0 1.1 8.0 0.9 0.0 1.7 0.0 1.6 0.1 5.6 0.0 3.7 2.3 1.5 0.3 0.5 0.2 0.4 12.6 1.6 0.8 1.1 7.5 0.8 0.0 1.8 3.1 0.0 22.1 6.0 6.3 0.7 0.5 1.9 1.1 0.1 0.0 0.2 4.9 1.8 2.1 2.7 0.1 3.0 0.3 0.6 0.0 0.0 0.0 3.7 0.0 1.7 2.9 0.7 1.9 0.0 1.5 1.5 1.4 0.2 1.3 0.0 0.0 0.0 0.4 3.1 6.3 0.8 3.3 2.7 2.2 1.1 2.7 1.0 0.7 SMR3A "PBI, PRL5, PROL5" ENSG00000109208 "Submaxillary gland androgen regulated protein 3A" Q99954 4 70360761-70367158 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 52 "salivary gland: 186.9" "Cell line enriched" "Detected in single" 13 "EFO-21: 1.3" "Cancer enhanced" "Detected in some" "breast cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044567 Enhanced "Secreted to digestive system" "HPA044567: AB_10796114" "unprognostic (2.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 186.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMR3B "P-B, PRL3, PROL3" ENSG00000171201 "Submaxillary gland androgen regulated protein 3B" P02814 4 70370093-70390244 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 2372 "salivary gland: 6520.0" "Cell line enriched" "Detected in single" 35 "EFO-21: 9.6" "Cancer enriched" "Detected in some" 22 "breast cancer: 32.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" 4500000 "unprognostic (3.72e-1)" 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 6520.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMTNL1 CHASM ENSG00000214872 "Smoothelin like 1" A8MU46 11 57542641-57550274 "Predicted intracellular proteins" "Calmodulin-binding, Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "skeletal muscle: 118.9" "Cell line enhanced" "Detected in some" "CACO-2: 2.5;HDLM-2: 2.8;U-266/70: 5.0;U-266/84: 2.8" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "unprognostic (1.35e-2)" "unprognostic (3.90e-1)" "unprognostic (1.10e-1)" "unprognostic (1.79e-3)" "unprognostic (3.09e-1)" "unprognostic (1.66e-1)" "unprognostic (2.22e-1)" "unprognostic (8.41e-2)" "unprognostic (1.41e-1)" "unprognostic (3.53e-3)" "unprognostic (4.04e-2)" "unprognostic (2.68e-2)" "unprognostic (1.04e-6)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" "unprognostic (4.49e-1)" "unprognostic (1.44e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 118.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 4.3 1.7 0.7 2.4 0.5 0.1 0.2 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.5 1.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.9 0.0 0.1 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.4 1.9 1.1 0.7 0.1 1.6 0.4 0.8 0.0 0.0 0.0 0.9 0.6 0.1 0.5 0.3 0.0 0.0 0.2 0.4 0.5 0.0 5.0 2.8 0.1 0.5 1.3 0.0 2.5 1.2 2.7 1.8 1.4 1.9 1.1 1.2 1.9 0.8 1.2 2.4 1.8 4.3 0.7 1.7 0.8 0.7 0.5 SMTNL2 FLJ42461 ENSG00000188176 "Smoothelin like 2" Q2TAL5 17 4583999-4608319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 99.7" "Cell line enriched" "Detected in some" 4 "CACO-2: 32.1" "Cancer enhanced" "Detected in many" "renal cancer: 10.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 2.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (8.62e-2)" "unprognostic (5.40e-2)" "unprognostic (7.13e-2)" "unprognostic (2.86e-1)" "unprognostic (1.05e-1)" "unprognostic (1.87e-2)" "unprognostic (4.89e-3)" "unprognostic (2.73e-1)" "unprognostic (3.73e-3)" "unprognostic (7.33e-2)" "unprognostic (1.55e-1)" "unprognostic (5.89e-2)" "prognostic favourable (1.28e-4)" "unprognostic (3.43e-2)" "unprognostic (1.01e-1)" "unprognostic (1.56e-3)" "unprognostic (2.22e-1)" 3.0 0.1 0.1 0.5 0.2 0.1 0.5 0.1 0.5 1.0 0.3 0.0 0.0 0.1 0.9 4.7 3.4 1.8 2.4 4.8 0.8 0.1 17.9 0.1 1.0 0.1 0.1 0.0 5.3 0.1 0.2 0.6 1.4 0.1 2.7 0.2 0.1 1.4 0.4 99.7 0.2 0.2 2.1 0.1 0.2 0.3 0.6 0.0 0.0 0.8 24.6 1.1 3.3 0.7 0.0 0.4 0.0 2.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 32.1 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.4 0.0 1.9 0.0 0.0 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.6 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.5 0.8 0.1 0.1 0.0 0.1 0.0 SNAP25 "bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25" ENSG00000132639 "Synaptosome associated protein 25" P60880 20 10218830-10307418 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 356.9" "Group enriched" "Detected in some" 4 "Karpas-707: 10.8;SCLC-21H: 35.7;SH-SY5Y: 21.3;U-87 MG: 25.7" "Group enriched" "Detected in many" 6 "glioma: 28.9;pancreatic cancer: 6.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000360, HPA001830, HPA071013" Enhanced Supported Approved "Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Vesicles "CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: " "unprognostic (1.64e-3)" "unprognostic (7.26e-3)" "unprognostic (4.36e-2)" "unprognostic (2.49e-7)" "unprognostic (6.86e-3)" "unprognostic (5.87e-3)" "unprognostic (1.15e-2)" "unprognostic (9.94e-2)" "unprognostic (3.13e-1)" "unprognostic (5.82e-3)" "unprognostic (4.80e-3)" "unprognostic (8.06e-2)" "unprognostic (1.09e-1)" "unprognostic (6.18e-3)" "unprognostic (2.48e-1)" "unprognostic (6.28e-3)" "unprognostic (1.02e-2)" 2.2 16.4 81.0 3.3 60.0 2.1 3.4 202.9 356.9 2.2 2.8 3.4 3.7 3.2 4.6 6.4 2.2 4.0 2.8 2.4 86.5 37.1 2.5 2.3 2.6 2.2 46.7 65.2 3.7 4.1 2.1 5.5 2.3 97.7 3.1 2.8 4.0 2.2 11.9 2.1 2.2 3.3 4.7 13.9 2.1 4.3 3.2 7.4 0.0 2.3 0.0 2.2 2.6 0.1 0.0 1.6 0.7 0.0 0.0 0.6 0.3 0.0 2.1 1.7 0.0 0.2 0.0 0.0 0.9 0.0 2.2 0.6 0.0 0.0 0.0 1.9 0.0 0.4 0.2 0.0 4.4 0.2 0.1 0.0 2.9 0.3 1.6 0.0 0.2 2.0 0.0 1.8 0.0 0.0 0.0 10.8 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 35.7 21.3 0.3 0.0 0.0 0.0 2.9 0.0 2.3 3.1 0.0 1.0 0.0 5.5 0.0 25.7 0.0 2.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.6 0.3 81.0 60.0 202.9 163.5 86.5 37.1 46.7 65.2 97.7 7.4 SNAP91 "AP180, CALM, KIAA0656" ENSG00000065609 "Synaptosome associated protein 91" O60641 6 83552880-83709691 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 81.9" "Group enriched" "Detected in some" 13 "SCLC-21H: 21.3;SH-SY5Y: 13.3" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 6.3" "Lineage enriched" "Detected in single" 20 "dendritic cells: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009745, HPA029632, HPA029633" Enhanced Uncertain Centrosome,Cytosol "Centrosome, Cytosol" "CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615" "unprognostic (1.07e-2)" "unprognostic (1.74e-1)" "unprognostic (7.55e-3)" "unprognostic (3.68e-2)" "unprognostic (1.03e-1)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.17e-1)" "unprognostic (4.54e-4)" "unprognostic (6.99e-2)" "unprognostic (1.75e-2)" "unprognostic (4.82e-2)" "unprognostic (2.15e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" 1.2 8.0 17.8 1.9 25.5 1.1 1.7 44.2 81.9 2.1 1.7 3.4 0.0 1.4 1.7 1.2 1.3 1.8 2.0 1.3 19.2 19.9 1.2 1.1 1.4 3.3 14.3 20.5 3.1 2.4 1.1 9.3 1.6 34.7 3.9 1.7 4.5 1.6 1.7 1.2 1.3 1.7 1.8 7.0 2.2 1.9 10.8 2.9 0.0 2.0 0.0 2.7 1.3 0.2 0.0 6.3 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.3 1.2 0.5 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.1 0.1 0.2 21.3 13.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.1 17.8 25.5 44.2 43.6 19.2 19.9 14.3 20.5 34.7 2.9 SNCB ENSG00000074317 "Synuclein beta" Q16143 5 176620084-176630556 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 24 "brain: 134.8" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 36.1" "Cancer enriched" "Detected in some" 8 "glioma: 11.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "naive B-cell: 3.1" "Lineage enriched" "Detected in single" 12 "B-cells: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002681, HPA035876" Enhanced Supported "CAB002681: , HPA035876: AB_10670592" "unprognostic (3.55e-2)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" "unprognostic (1.46e-2)" "unprognostic (3.41e-3)" "unprognostic (2.95e-2)" "unprognostic (6.07e-2)" "unprognostic (3.41e-1)" "unprognostic (2.39e-1)" "unprognostic (2.29e-3)" "unprognostic (3.31e-1)" "unprognostic (5.41e-5)" "unprognostic (1.31e-3)" "unprognostic (8.57e-2)" "unprognostic (2.81e-1)" "unprognostic (8.42e-3)" 1.6 3.9 53.7 1.6 24.9 1.5 1.6 64.1 134.8 1.5 1.7 2.2 0.0 1.6 1.6 1.5 1.5 1.6 1.6 1.8 39.4 31.0 1.6 1.5 1.5 1.7 27.5 30.0 1.5 2.1 1.5 1.9 1.6 31.5 1.6 1.6 5.6 1.5 1.5 2.7 1.6 1.6 1.6 7.4 1.6 1.6 1.7 1.5 0.0 1.5 0.0 1.6 1.6 0.0 3.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.5 0.0 0.1 1.6 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 1.1 0.6 0.0 0.0 2.7 1.6 0.0 0.0 0.1 0.0 0.0 36.1 1.3 0.0 0.1 3.4 1.6 0.1 0.0 0.0 1.4 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 53.7 24.9 64.1 87.6 39.4 31.0 27.5 30.0 31.5 1.5 SNX32 "FLJ30934, SNX6B" ENSG00000172803 "Sorting nexin 32" Q86XE0 11 65833641-65856896 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 16.6" "Cell line enhanced" "Detected in some" "HHSteC: 6.0;HSkMC: 7.8;REH: 2.5;SH-SY5Y: 3.0;U-266/70: 9.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 1.0;dendritic cells: 1.2;T-cells: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041775 Uncertain Uncertain "Cell Junctions,Focal adhesion sites" "Cell Junctions, Focal adhesion sites" "HPA041775: AB_10797268" "unprognostic (6.74e-4)" "unprognostic (1.06e-1)" "unprognostic (1.67e-2)" "unprognostic (4.50e-5)" "unprognostic (1.00e-1)" "unprognostic (9.28e-2)" "unprognostic (7.30e-2)" "unprognostic (9.17e-3)" "unprognostic (2.70e-1)" "unprognostic (2.87e-1)" "unprognostic (5.08e-2)" "unprognostic (1.52e-1)" "unprognostic (3.64e-4)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (9.80e-2)" "unprognostic (5.36e-2)" 0.8 1.0 9.0 1.1 16.6 1.3 1.3 3.5 16.1 1.6 2.2 1.6 0.0 3.4 2.0 1.3 0.9 2.5 2.8 0.9 10.2 5.0 0.9 0.7 0.8 1.0 3.6 10.9 1.3 0.8 0.8 0.3 0.9 3.4 0.8 1.9 0.1 0.7 0.9 0.6 1.1 1.5 2.0 1.8 0.9 0.9 3.5 3.7 0.0 0.7 0.0 1.3 1.0 0.2 1.0 1.2 0.2 0.3 0.1 3.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.0 0.6 7.8 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.1 0.0 2.5 0.0 2.2 0.1 0.0 0.0 3.0 0.0 0.0 1.7 0.0 0.4 0.0 0.3 0.0 0.0 0.0 9.1 1.5 0.0 0.7 0.0 0.3 0.0 0.1 0.0 1.2 0.3 3.0 0.3 1.6 1.2 1.2 1.0 1.4 0.6 0.2 0.1 0.0 0.7 1.2 0.4 9.0 16.6 3.5 15.4 10.2 5.0 3.6 10.9 3.4 3.7 SOAT2 ACAT2 ENSG00000167780 "Sterol O-acyltransferase 2" O75908 12 53103518-53124538 "Enzymes, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "intestine: 60.8" "Group enriched" "Detected in some" 5 "CACO-2: 9.6;Hep G2: 20.9;U-266/70: 7.0" "Group enriched" "Detected in some" 8 "liver cancer: 5.2;testis cancer: 5.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MAIT T-cell: 3.7;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.7;naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 7 "T-cells: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (2.53e-1)" "unprognostic (2.72e-3)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (1.30e-4)" "unprognostic (3.88e-3)" "unprognostic (9.26e-2)" "unprognostic (4.20e-2)" "unprognostic (1.32e-1)" "unprognostic (3.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.53e-1)" "unprognostic (1.83e-2)" "unprognostic (9.05e-2)" "unprognostic (2.37e-1)" "unprognostic (7.58e-3)" "unprognostic (3.28e-1)" 0.5 0.0 0.2 0.2 0.2 0.2 0.6 0.2 0.2 0.9 16.4 0.2 0.2 12.3 0.7 0.3 0.2 0.9 0.4 0.2 0.2 0.0 0.6 4.2 0.2 0.6 0.2 0.2 0.4 0.2 0.0 0.3 0.2 0.2 0.6 0.0 0.2 0.4 0.2 0.2 0.4 60.8 0.2 0.3 2.2 0.3 0.2 0.2 0.2 0.4 0.2 0.3 0.3 1.1 0.0 0.0 0.0 0.3 0.5 3.7 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.4 9.6 0.1 0.0 0.0 0.4 0.7 0.0 0.0 0.6 0.0 0.0 0.9 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 7.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.7 0.0 1.5 2.7 0.0 0.0 0.4 1.5 0.0 0.5 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 SOHLH2 "bHLHe81, FLJ20449, SPATA28, TEB1" ENSG00000120669 "Spermatogenesis and oogenesis specific basic helix-loop-helix 2" Q9NX45 13 36168208-36214615 "Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 23.6" "Cell line enhanced" "Detected in some" "A-431: 7.1;HL-60: 9.3;Karpas-707: 10.6;NB-4: 13.6;U-266/84: 13.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" HPA029182 Uncertain Vesicles Vesicles "HPA029182: AB_10602409" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" "unprognostic (1.99e-1)" "unprognostic (2.99e-2)" "unprognostic (2.54e-2)" "unprognostic (3.01e-2)" "unprognostic (2.95e-1)" "unprognostic (7.88e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-3)" "unprognostic (2.10e-1)" "unprognostic (8.56e-2)" "unprognostic (7.44e-2)" "unprognostic (5.93e-2)" 0.3 0.3 0.9 0.3 2.1 0.5 0.4 0.3 3.5 0.3 1.8 0.3 0.3 0.2 0.3 2.0 0.3 0.2 0.3 0.9 1.2 1.2 0.6 0.3 0.3 0.3 1.2 0.3 0.3 0.3 0.2 0.3 3.5 0.3 1.8 0.0 0.3 0.3 1.2 0.4 0.2 0.3 0.4 0.6 0.3 0.1 23.6 0.3 0.3 0.4 0.3 0.3 1.3 0.3 1.0 0.3 0.5 0.3 0.0 0.5 0.0 7.1 0.2 0.7 0.0 0.6 1.1 4.3 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.1 9.3 0.0 2.0 0.6 0.0 0.0 0.9 0.3 10.6 2.1 0.1 0.0 13.6 0.2 0.0 0.2 0.2 0.8 1.0 0.7 0.1 1.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.8 0.5 0.5 1.4 13.6 0.2 0.8 5.0 0.5 0.0 0.3 0.5 0.2 0.0 0.1 0.1 0.1 0.1 0.0 1.0 0.2 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.9 2.1 0.3 3.5 1.2 1.2 1.2 0.3 0.3 0.3 SOX2 ENSG00000181449 "SRY-box 2" P48431 3 181711924-181714436 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 80.1" "Cell line enhanced" "Detected in some" "AF22: 67.5;HAP1: 28.7;NTERA-2: 55.0;U-251 MG: 12.6" "Cancer enhanced" "Detected in many" "glioma: 136.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045725, HPA062851, HPA071379, CAB079745" Enhanced Supported Enhanced Nucleoplasm Nucleoplasm "CAB079745: , HPA045725: , HPA062851: , HPA071379: " "unprognostic (1.80e-2)" "unprognostic (3.18e-3)" "unprognostic (5.69e-2)" "unprognostic (6.96e-2)" "unprognostic (2.74e-3)" "unprognostic (1.60e-1)" "unprognostic (1.79e-2)" "unprognostic (4.48e-3)" "unprognostic (1.71e-1)" "unprognostic (4.38e-3)" "unprognostic (1.83e-1)" "unprognostic (7.68e-2)" "unprognostic (3.81e-9)" "unprognostic (1.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.12e-2)" 1.8 2.5 30.3 2.0 25.8 1.5 1.6 13.9 80.1 1.8 2.3 24.3 0.0 2.0 1.5 1.8 15.9 5.0 1.8 1.7 36.0 19.2 1.5 1.5 3.4 1.5 19.4 18.5 1.7 1.6 1.5 5.8 1.5 18.6 3.9 2.0 1.0 6.3 1.9 1.6 1.8 2.3 1.7 18.4 1.6 9.7 3.0 22.4 0.0 1.5 2.1 6.9 2.3 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 67.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 28.7 0.7 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 55.0 0.1 0.0 0.1 0.0 7.4 0.1 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 25.8 13.9 20.0 36.0 19.2 19.4 18.5 18.6 22.4 SOX30 ENSG00000039600 "SRY-box 30" O94993 5 157625679-157671480 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 42.5" "Cell line enhanced" "Detected in some" "A-431: 4.1;CACO-2: 2.8;HDLM-2: 8.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006159, CAB009382" Enhanced "CAB009382: AB_2195963, HPA006159: AB_1080062" "unprognostic (3.51e-2)" "unprognostic (4.72e-2)" "unprognostic (7.31e-2)" "unprognostic (4.70e-4)" "unprognostic (2.53e-2)" "unprognostic (6.12e-2)" "unprognostic (4.47e-2)" "unprognostic (2.22e-2)" "unprognostic (5.33e-2)" "unprognostic (1.36e-1)" "unprognostic (4.73e-2)" "unprognostic (7.85e-2)" "unprognostic (4.64e-4)" "unprognostic (5.88e-2)" "unprognostic (1.64e-1)" "unprognostic (3.72e-2)" "unprognostic (3.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 2.3 1.7 0.4 0.0 1.7 0.4 4.1 0.1 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.4 0.3 2.8 1.7 0.0 0.1 0.1 0.5 0.0 0.0 0.2 8.8 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.2 0.5 0.3 0.3 0.3 0.0 0.0 0.4 0.0 0.1 0.9 0.9 0.0 0.0 0.4 0.3 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.4 0.0 0.9 0.0 0.0 0.2 1.7 0.4 1.6 0.7 0.3 0.3 1.1 1.4 1.1 0.0 1.6 1.4 1.1 0.1 0.0 0.0 2.3 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SOX5 "L-SOX5, MGC35153" ENSG00000134532 "SRY-box 5" P35711 12 23529500-24562544 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 52.0" "Cell line enhanced" "Detected in some" "AF22: 11.8;Daudi: 11.7;HDLM-2: 24.7;K-562: 10.7;WM-115: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 4.3;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 6 "B-cells: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060499 Supported Nucleoplasm Nucleoplasm "HPA060499: " "unprognostic (9.11e-4)" "unprognostic (4.64e-3)" "unprognostic (3.23e-1)" "unprognostic (6.83e-2)" "unprognostic (1.67e-1)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (1.03e-3)" "unprognostic (1.36e-1)" "unprognostic (8.40e-2)" "unprognostic (1.70e-4)" "unprognostic (6.95e-2)" "unprognostic (4.53e-4)" "unprognostic (3.12e-3)" "unprognostic (2.37e-1)" "unprognostic (9.59e-2)" "unprognostic (2.75e-2)" 8.5 2.4 9.2 3.1 5.4 0.7 4.4 3.8 10.5 10.6 2.9 3.0 2.7 1.1 8.7 1.8 2.6 4.5 3.8 3.6 10.0 2.8 2.9 12.9 3.3 4.2 4.1 6.4 9.1 2.5 0.7 6.9 9.9 7.2 2.8 1.8 5.2 4.0 4.9 2.7 7.1 2.7 4.3 5.1 2.5 2.9 52.0 5.5 0.0 3.3 1.6 3.7 2.9 5.4 4.3 0.7 0.1 0.0 0.7 0.1 0.2 0.1 0.1 11.8 0.0 6.7 3.5 0.0 0.1 0.0 0.1 0.4 2.1 0.1 11.7 0.6 0.0 0.1 6.7 0.0 0.1 24.7 1.7 2.5 0.0 5.5 4.5 0.0 0.1 1.8 0.0 0.6 0.0 0.0 10.7 0.5 0.3 0.0 4.5 0.0 3.5 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.5 0.0 0.0 4.8 0.2 2.4 0.0 0.2 1.5 0.0 1.1 0.3 0.0 0.7 2.7 0.0 9.9 0.1 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.1 0.0 3.7 0.0 0.1 0.1 0.7 0.0 0.7 0.0 0.2 9.2 5.4 3.8 10.5 10.0 2.8 4.1 6.4 7.2 5.5 SOX8 ENSG00000005513 "SRY-box 8" P57073 16 981808-986979 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 64.9" "Cell line enriched" "Detected in some" 5 "RH-30: 50.5" "Cancer enriched" "Detected in many" 6 "glioma: 46.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.2;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 23 "T-cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041640, HPA058665" Enhanced Nucleoplasm Nucleoplasm "HPA041640: AB_10964357, HPA058665: " "unprognostic (1.40e-2)" "unprognostic (2.56e-3)" "unprognostic (1.59e-1)" "unprognostic (3.10e-2)" "unprognostic (4.58e-2)" "unprognostic (7.16e-3)" "unprognostic (6.05e-3)" "unprognostic (3.01e-2)" "unprognostic (2.53e-1)" "unprognostic (1.16e-1)" "unprognostic (4.53e-3)" "unprognostic (4.46e-2)" "unprognostic (1.20e-3)" "unprognostic (8.50e-2)" "unprognostic (6.18e-2)" "unprognostic (5.47e-1)" "unprognostic (9.09e-2)" 1.6 1.5 18.4 1.8 25.1 1.0 2.5 3.2 64.9 1.2 1.4 20.9 0.0 1.1 1.1 1.1 1.2 1.1 1.5 1.8 22.6 14.5 1.0 1.0 1.0 2.7 26.5 5.4 1.0 1.5 1.0 0.1 1.4 12.0 1.3 1.5 0.9 8.6 1.4 1.3 1.3 1.2 1.2 27.1 1.8 1.7 1.9 30.4 0.0 1.1 0.0 3.1 1.1 0.3 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.2 1.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.1 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 50.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.2 18.4 25.1 3.2 11.8 22.6 14.5 26.5 5.4 12.0 30.4 SP8 ENSG00000164651 "Sp8 transcription factor" Q8IXZ3 7 20782283-20786886 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "prostate: 14.3" "Cell line enhanced" "Detected in some" "HEK 293: 4.2;HUVEC TERT2: 5.8;NTERA-2: 12.0;PC-3: 20.2" "Cancer enhanced" "Detected in many" "testis cancer: 7.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "basal ganglia: 15.7;olfactory region: 66.8" "Region enriched" "Detected in some" 11 "olfactory region: 72.4" HPA054006 Uncertain Approved Nucleoplasm Nucleoplasm "HPA054006: " "unprognostic (1.56e-1)" "unprognostic (1.49e-1)" "unprognostic (2.91e-2)" "unprognostic (1.35e-1)" "unprognostic (7.90e-4)" "unprognostic (3.46e-1)" "unprognostic (5.49e-1)" "unprognostic (1.73e-2)" "unprognostic (2.42e-2)" "unprognostic (3.38e-1)" "unprognostic (7.44e-2)" 0.1 0.1 2.3 0.1 2.8 0.1 0.2 0.1 3.2 0.3 0.3 1.9 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.5 0.3 0.1 0.2 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.2 0.7 14.3 0.1 0.0 0.1 0.1 0.1 2.4 0.8 0.1 0.2 0.2 0.3 0.5 0.7 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 4.2 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.8 0.1 0.0 0.0 0.0 0.0 0.7 12.0 20.2 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 2.6 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.8 0.1 3.2 2.4 0.5 0.1 1.7 0.7 0.7 SPACA1 SAMP32 ENSG00000118434 "Sperm acrosome associated 1" Q9HBV2 6 88047789-88066832 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 99 "testis: 49.2" "Cell line enhanced" "Detected in single" "HSkMC: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026744, HPA043297" Enhanced "HPA026744: AB_2194642, HPA043297: AB_2678413" "unprognostic (4.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPACA4 SAMP14 ENSG00000177202 "Sperm acrosome associated 4" Q8TDM5 19 48606743-48607714 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 65.9" "Cell line enhanced" "Detected in some" "A549: 2.2;AN3-CA: 1.9;MCF7: 2.8;NTERA-2: 2.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041927, HPA061302" Enhanced "HPA041927: AB_10794162, HPA061302: AB_2684475" "unprognostic (2.48e-2)" "unprognostic (6.37e-4)" "unprognostic (6.59e-2)" "unprognostic (4.52e-2)" "unprognostic (2.09e-3)" "unprognostic (9.43e-6)" "unprognostic (6.67e-3)" "unprognostic (1.05e-1)" "unprognostic (2.87e-1)" "unprognostic (2.78e-1)" "unprognostic (3.43e-1)" "unprognostic (2.88e-1)" "unprognostic (4.47e-1)" "unprognostic (2.01e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 1.1 0.1 0.1 2.3 0.1 0.4 0.7 0.0 0.8 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 1.0 0.1 0.1 1.0 1.8 0.1 0.1 0.1 2.9 65.9 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.2 0.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 1.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.8 0.0 1.1 2.5 1.5 0.1 0.1 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.7 0.5 0.0 0.6 1.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SPACA5 "dJ54B20.3, LYC5, LYZL5, PNPK6288, SLLP2, UNQ6288" ENSG00000171489 "Sperm acrosome associated 5" Q96QH8 X 48004336-48009729 "Enzymes, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 15.1" "Cell line enhanced" "Detected in some" "CACO-2: 1.3;NB-4: 3.9;RPMI-8226: 1.1;T-47d: 1.1;U-266/70: 1.2;U-266/84: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 1.9" "Low lineage specificity" "Detected in single" "HPA044747, HPA047149" Supported "Secreted in male reproductive system" "HPA044747: , HPA047149: " 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.8 0.0 0.3 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.5 0.4 0.3 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.0 0.0 15.1 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.9 0.9 0.0 0.4 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.4 0.0 0.7 0.0 1.2 2.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 1.9 0.3 SPACA5B LYZL5B ENSG00000171478 "Sperm acrosome associated 5B" Q96QH8 X 48130657-48132613 "Enzymes, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 18.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "T-reg: 1.9" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "HPA044747, HPA047149" Supported "Secreted in male reproductive system" "HPA044747: , HPA047149: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 SPACA7 C13orf28 ENSG00000153498 "Sperm acrosome associated 7" Q96KW9 13 112376319-112434689 "Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 68.5" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 3.2;neutrophil: 4.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.5" HPA048349 Enhanced "Secreted in male reproductive system" "HPA048349: " "unprognostic (3.97e-2)" 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 68.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.5 4.5 0.8 0.6 0.5 0.2 0.6 0.9 0.5 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.1 1.2 1.0 0.0 0.5 0.0 0.3 0.0 0.8 0.0 0.6 1.7 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.2 2.2 1.1 0.0 1.0 1.1 0.6 0.6 0.9 0.8 0.1 0.3 0.0 0.8 2.6 0.7 0.3 0.8 0.9 0.4 1.1 0.0 0.7 0.4 1.7 0.3 0.9 1.1 0.9 0.1 0.2 0.4 3.2 0.8 0.7 0.5 0.5 0.2 0.2 0.2 0.2 0.2 0.7 0.3 0.5 4.5 0.6 0.5 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPAG11A "EDDM2A, HE2" ENSG00000178287 "Sperm associated antigen 11A" Q6PDA7 8 7847876-7868867 "Predicted intracellular proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 225 "epididymis: 332.8" "Cell line enriched" "Detected in some" 4 "NB-4: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023842, HPA057479" Supported Approved "Golgi apparatus" "Secreted in male reproductive system" "Golgi apparatus" "HPA023842: , HPA057479: " 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 332.8 1.4 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 SPAG11B "EDDM2B, EP2, EP2C, EP2D, HE2" ENSG00000164871 "Sperm associated antigen 11B" Q08648 8 7442684-7463674 "Predicted intracellular proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 232 "epididymis: 362.2" "Group enriched" "Detected in some" 11 "BEWO: 5.5;NB-4: 12.3;RPMI-8226: 5.7;SH-SY5Y: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023842, HPA057479" Supported Approved "Golgi apparatus" "Secreted in male reproductive system" "Golgi apparatus" "HPA023842: , HPA057479: " 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 362.2 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.1 0.0 0.0 0.0 5.7 0.0 0.0 0.6 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 SPAM1 "HYAL5, PH-20, SPAG15" ENSG00000106304 "Sperm adhesion molecule 1" P38567 7 123925237-123971414 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 38 "testis: 19.6" "Cell line enhanced" "Detected in some" "BEWO: 1.2;NTERA-2: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA017984 Enhanced "HPA017984: AB_1857413" "unprognostic (2.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXA1 "CT11.1, NAP-X, SPAN-Xa, SPAN-Xb, SPANX" ENSG00000198021 "Sperm protein associated with the nucleus, X-linked, family member A1" Q9NS26 X 141583674-141585011 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "testis: 14.1" "Cell line enhanced" "Detected in some" "PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXA2 SPANX ENSG00000203926 "SPANX family member A2" Q9NS26 X 141589435-141590772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "testis: 15.5" "Cell line enhanced" "Detected in some" "PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXB1 "CT11.2, SPANXB2, SPANXF1, SPANXF2" ENSG00000227234 "SPANX family member B1" Q9NS25 X 141002591-141003706 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 38.5" "Group enriched" "Detected in some" 26 "A-431: 40.4;U-2 OS: 14.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " "unprognostic (8.55e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 40.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.1 1.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXC "CT11.3, CTp11" ENSG00000198573 "SPANX family member C" Q9NY87 X 141241463-141242496 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 27.3" "Group enriched" "Detected in some" 5 "A-431: 13.0;U-2 OS: 6.3" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " "unprognostic (3.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 13.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 6.3 0.0 0.5 0.0 0.0 0.2 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXD "CT11.4, SPANXE" ENSG00000196406 "SPANX family member D" Q9BXN6 X 141697411-141698739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 216 "testis: 21.5" "Group enriched" "Detected in some" 10 "A-431: 5.0;U-2 OS: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 9.6 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXN1 "CT11.6, SPANX-N1" ENSG00000203923 "SPANX family member N1" Q5VSR9 X 145246828-145256112 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 17 "testis: 4.7" "Group enriched" "Detected in some" 4 "HDLM-2: 1.0;U-138 MG: 2.4;U-2 OS: 1.7;U-251 MG: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.7 0.0 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXN2 "CT11.7, SPANX-N2" ENSG00000268988 "SPANX family member N2" Q5MJ10 X 143711955-143721423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045652 Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA045652: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXN3 "CT11.8, SPANX-N3" ENSG00000189252 "SPANX family member N3" Q5MJ09 X 143508735-143517475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 28.4" "Cell line enriched" "Detected in some" 5 "U-2 OS: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045652 Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA045652: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXN4 "CT11.9, SPANX-N4" ENSG00000189326 "SPANX family member N4" Q5MJ08 X 143025918-143034702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 23.7" "Cell line enhanced" "Detected in some" "HEL: 2.4;HeLa: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 16 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 16 "granulocytes: 1.5" HPA045730 Uncertain "HPA045730: AB_10961036" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 4.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXN5 "CT11.10, SPANX-N5" ENSG00000204363 "SPANX family member N5" Q5MJ07 X 52796144-52798101 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 78 "testis: 15.8" "Group enriched" "Detected in some" 7 "HEK 293: 1.2;LHCN-M2: 1.0;U-2 OS: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA12 ENSG00000186451 "Spermatogenesis associated 12" Q7Z6I5 3 57060441-57075432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 26.6" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 2.8;RH-30: 3.5;RPTEC TERT1: 2.2;U-2 OS: 2.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.0" "Lineage enriched" "Detected in single" 10 "monocytes: 1.0" "HPA043323, HPA075578" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA043323: AB_10796792, HPA075578: " "unprognostic (2.31e-1)" "unprognostic (2.18e-4)" "unprognostic (3.47e-4)" "unprognostic (2.21e-2)" "unprognostic (2.66e-1)" "unprognostic (8.79e-3)" "unprognostic (1.69e-3)" "unprognostic (3.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.29e-1)" "unprognostic (6.80e-2)" "unprognostic (1.76e-2)" "unprognostic (4.71e-3)" "unprognostic (7.29e-2)" "unprognostic (1.62e-2)" "unprognostic (1.14e-1)" "unprognostic (2.44e-3)" 0.2 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.1 0.8 0.1 0.3 2.4 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.1 1.1 0.1 0.4 26.6 0.0 0.0 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.4 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.5 0.5 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.8 0.7 0.0 0.0 1.3 0.2 0.5 0.0 0.1 2.8 0.0 0.7 0.2 0.1 0.0 0.0 1.7 1.7 0.0 3.5 0.1 2.2 1.3 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.9 0.1 2.3 0.4 0.3 0.0 0.3 1.1 0.7 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 SPATA16 NYD-SP12 ENSG00000144962 "Spermatogenesis associated 16" Q9BXB7 3 172889358-173141268 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 50 "testis: 49.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA037884 Enhanced "HPA037884: " "unprognostic (3.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA17 IQCH ENSG00000162814 "Spermatogenesis associated 17" Q96L03 1 217631324-217871696 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 48.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 4.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030099 Enhanced Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA030099: AB_2270988" "unprognostic (4.72e-2)" "unprognostic (7.58e-3)" "unprognostic (4.30e-2)" "unprognostic (3.66e-2)" "unprognostic (3.69e-2)" "unprognostic (2.41e-2)" "unprognostic (3.31e-3)" "unprognostic (3.25e-2)" "unprognostic (1.39e-1)" "unprognostic (2.58e-2)" "unprognostic (1.21e-3)" "unprognostic (2.80e-2)" "unprognostic (3.24e-4)" "unprognostic (2.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.77e-3)" "unprognostic (1.82e-1)" 0.5 0.6 1.4 0.3 5.2 2.4 0.9 0.5 1.2 1.0 0.5 2.7 2.9 0.6 0.7 9.7 0.5 6.8 0.8 1.1 2.3 2.2 2.8 0.4 3.0 0.3 0.8 1.6 3.3 0.6 3.0 10.8 0.4 11.1 0.7 0.3 1.2 0.6 1.2 2.9 1.0 0.7 0.2 0.7 0.4 0.6 48.0 1.4 0.0 3.1 0.3 0.2 0.5 0.5 1.3 0.6 2.3 0.6 0.6 1.0 0.1 0.6 1.2 1.2 1.2 0.3 2.0 0.9 0.4 0.7 0.6 0.3 0.8 3.2 0.6 1.0 0.4 2.2 0.8 1.1 0.7 0.6 1.2 0.5 1.5 0.7 0.6 0.3 0.5 0.7 2.3 1.2 1.2 0.1 0.7 1.3 0.6 2.5 0.4 1.0 2.3 1.2 0.4 0.4 0.4 2.3 0.9 4.7 1.8 0.7 0.7 0.6 1.4 0.6 0.6 0.8 0.6 0.9 0.5 1.2 0.7 0.3 1.9 0.5 1.0 2.3 0.5 0.5 0.9 0.5 0.8 0.7 0.7 0.7 0.3 1.3 0.9 1.0 1.5 0.6 0.6 0.6 0.3 0.1 1.4 5.2 0.5 1.2 2.3 2.2 0.8 1.6 11.1 1.4 SPATA19 "CT132, FLJ25851, SPAS1, spergen1" ENSG00000166118 "Spermatogenesis associated 19" Q7Z5L4 11 133840631-133845538 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 128 "testis: 46.8" "Cell line enhanced" "Detected in some" "BEWO: 1.5;HBEC3-KT: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA040082 Enhanced "HPA040082: " "unprognostic (9.90e-3)" "unprognostic (3.34e-2)" "unprognostic (2.66e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 SPATA22 NYD-SP20 ENSG00000141255 "Spermatogenesis associated 22" Q8NHS9 17 3440019-3513852 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "testis: 75.9" "Group enriched" "Detected in some" 8 "K-562: 9.6;TIME: 14.0" "Cancer enriched" "Detected in single" 10 "testis cancer: 3.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "unprognostic (4.09e-2)" "unprognostic (9.31e-2)" "unprognostic (2.54e-2)" "unprognostic (7.07e-2)" "unprognostic (9.05e-2)" "unprognostic (1.98e-2)" "unprognostic (6.79e-4)" "unprognostic (4.33e-1)" "unprognostic (1.87e-1)" "unprognostic (1.27e-1)" 0.4 0.2 0.3 0.1 0.3 0.0 0.4 0.4 0.6 0.2 0.1 0.3 0.0 0.0 0.1 0.6 0.1 0.1 0.1 0.2 0.3 0.3 0.3 0.1 0.1 0.1 0.4 0.0 0.1 0.1 0.0 0.1 1.2 0.4 0.2 0.0 0.0 0.0 0.7 0.7 0.0 0.1 0.1 0.4 0.2 0.0 75.9 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.8 0.0 1.3 0.9 2.6 0.4 0.0 0.0 0.2 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.3 1.0 0.0 0.4 0.1 0.0 0.1 2.3 2.6 0.0 0.9 0.4 0.8 0.0 0.4 0.3 0.3 0.4 0.6 0.3 0.3 0.4 0.0 0.4 0.2 SPATA24 "CCDC161, T6441" ENSG00000170469 "Spermatogenesis associated 24" Q86W54 5 139396563-139404088 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 52.2" "Cell line enhanced" "Detected in many" "HDLM-2: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044000 Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044000: AB_10959668" "unprognostic (2.19e-3)" "unprognostic (1.18e-1)" "unprognostic (2.09e-1)" "unprognostic (9.30e-2)" "unprognostic (3.82e-1)" "unprognostic (7.71e-2)" "prognostic unfavourable (2.75e-4)" "unprognostic (1.26e-2)" "unprognostic (1.58e-1)" "unprognostic (2.87e-2)" "unprognostic (5.36e-3)" "unprognostic (1.07e-1)" "unprognostic (6.11e-2)" "unprognostic (1.24e-1)" "unprognostic (3.44e-1)" "unprognostic (1.46e-1)" "unprognostic (1.64e-1)" 1.0 2.8 3.6 1.0 3.2 0.3 1.4 1.5 2.7 1.3 1.6 2.7 1.8 2.5 1.6 9.4 1.4 6.4 2.9 8.5 3.4 2.6 6.2 1.9 1.9 2.5 2.4 2.1 1.6 2.2 6.1 7.0 1.0 3.2 2.2 0.9 1.7 3.2 1.5 8.7 0.9 2.6 1.9 2.7 1.9 1.5 52.2 2.1 1.8 2.9 3.4 1.9 1.8 3.5 5.7 3.6 2.0 3.1 2.4 7.7 2.5 6.4 4.1 5.8 3.1 1.7 3.2 4.7 1.6 3.1 3.4 6.0 9.3 8.6 10.3 4.8 3.1 3.6 4.4 7.2 3.8 41.2 5.1 3.1 7.7 7.0 6.4 0.7 5.7 2.8 3.6 5.1 6.2 4.1 3.1 18.2 4.6 3.7 6.5 4.9 4.2 3.5 15.2 3.8 13.9 8.1 3.3 4.5 4.1 6.3 12.2 2.9 3.5 7.1 7.6 2.0 2.8 3.9 4.6 4.4 4.2 9.5 4.0 5.4 1.7 0.0 3.1 2.0 4.6 2.3 6.5 5.7 4.9 5.5 3.6 3.3 5.5 7.7 0.2 2.4 0.9 2.1 2.4 2.5 3.6 3.2 1.5 2.7 3.4 2.6 2.4 2.1 3.2 2.1 SPATA3 TSARG1 ENSG00000173699 "Spermatogenesis associated 3" Q8NHX4 2 230990324-231025055 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 42 "testis: 82.0" "Cell line enhanced" "Detected in some" "BEWO: 3.6;U-698: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 13 "cerebellum: 11.0" HPA018254 Enhanced "HPA018254: AB_1857419" "unprognostic (6.94e-3)" "unprognostic (6.98e-2)" "unprognostic (9.62e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 1.5 0.2 0.2 0.3 0.0 0.1 0.3 0.2 0.1 0.0 0.2 3.6 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.0 0.1 0.5 0.1 1.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.9 0.0 0.2 0.7 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.7 0.0 0.2 0.0 1.1 0.3 0.1 0.1 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.4 0.2 0.3 0.2 0.2 0.1 0.3 0.3 0.0 0.2 0.5 0.0 0.0 1.5 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31A1 "C9orf36, C9orf36A, DKFZP434B204, FAM75A1, FAM75A2, SPATA31A2" ENSG00000204849 "SPATA31 subfamily A member 1" 9 39355669-39361959 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 103 "testis: 10.2" "Cell line enriched" "Detected in single" 32 "U-2197: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31A3 "DKFZp434B204, FAM75A3" ENSG00000275969 "SPATA31 subfamily A member 3" Q5VYP0 9 66986304-66992583 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 81 "testis: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31A5 FAM75A5 ENSG00000276581 "SPATA31 subfamily A member 5" Q5VU36 9 60914374-60920650 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 30 "testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31A6 FAM75A6 ENSG00000185775 "SPATA31 subfamily A member 6" Q5VVP1 9 42183659-42189882 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 17 "testis: 5.4" "Cell line enhanced" "Detected in single" "AF22: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.23e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31A7 "FAM75A4, FAM75A7, SPATA31A4" ENSG00000276040 "SPATA31 subfamily A member 7" Q8IWB4 9 61190003-61196280 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 57 "testis: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31D1 "FAM75D1, FLJ46321" ENSG00000214929 "SPATA31 subfamily D member 1" Q6ZQQ2 9 81988772-81995256 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 134 "testis: 13.3" "Cell line enriched" "Detected in single" 5 "HDLM-2: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047897 Uncertain "HPA047897: " "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31D3 "FAM75D3, FLJ44082" ENSG00000186788 "SPATA31 subfamily D member 3" P0C874 9 81943586-81950038 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 99 "testis: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31D4 "FAM75D4, FLJ43859" ENSG00000189357 "SPATA31 subfamily D member 4" 9 81928514-81934948 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 78 "testis: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31E1 "C9orf79, FAM75E1, FLJ35866" ENSG00000177992 "SPATA31 subfamily E member 1" Q6ZUB1 9 87882826-87888899 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 139 "testis: 18.6" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.4;hTEC/SVTERT24-B: 1.2;Karpas-707: 1.1;SCLC-21H: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA024253 Enhanced "HPA024253: AB_1845839" "unprognostic (2.16e-1)" "unprognostic (2.29e-2)" "unprognostic (4.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA32 "AEP2, C17orf46, FLJ25414, TEX34, VAD1.2" ENSG00000184361 "Spermatogenesis associated 32" Q96LK8 17 45254393-45262112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 51.7" "Cell line enhanced" "Detected in some" "A549: 3.8;EFO-21: 1.7;HDLM-2: 2.0;HeLa: 2.1;REH: 1.5;U-266/84: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0;naive CD4 T-cell: 2.2" "Low lineage specificity" "Detected in many" HPA024549 Approved "HPA024549: AB_1845589" "unprognostic (5.27e-2)" "unprognostic (1.15e-1)" "unprognostic (5.88e-2)" "unprognostic (1.79e-4)" "unprognostic (7.84e-2)" "unprognostic (1.36e-2)" "unprognostic (3.58e-1)" "unprognostic (6.76e-2)" "unprognostic (1.39e-1)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (3.76e-1)" "unprognostic (2.87e-3)" "unprognostic (8.93e-4)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" "unprognostic (5.75e-4)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 51.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.5 0.0 0.1 2.2 1.4 1.3 3.8 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.7 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 2.1 0.1 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.3 0.6 1.9 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 2.0 0.8 0.4 0.0 0.3 2.2 0.9 0.5 0.1 0.0 0.3 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA33 "C16orf55, FLJ31606" ENSG00000167523 "Spermatogenesis associated 33" Q96N06 16 89657802-89671272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 70.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045648, HPA073096" Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA045648: AB_2679405, HPA073096: " "unprognostic (1.05e-2)" "prognostic favourable (1.06e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (7.18e-3)" "unprognostic (1.37e-1)" "unprognostic (3.97e-1)" "unprognostic (3.63e-2)" "unprognostic (2.03e-3)" "unprognostic (8.82e-2)" "unprognostic (4.02e-2)" "unprognostic (4.52e-2)" "unprognostic (3.26e-1)" "unprognostic (2.04e-1)" "unprognostic (1.60e-1)" 2.0 2.7 6.9 2.8 7.3 3.3 3.2 7.8 7.7 2.9 2.9 4.3 1.8 4.8 3.2 9.2 2.7 14.8 3.7 2.1 6.0 5.7 5.3 2.9 4.3 2.3 4.7 6.5 2.1 3.0 4.0 7.3 1.9 5.3 3.2 3.4 2.5 2.4 2.8 1.5 4.1 5.7 2.6 3.6 3.0 3.8 70.4 4.3 2.4 5.1 2.2 3.1 2.1 2.5 5.7 5.5 5.8 3.3 7.3 6.3 3.6 10.1 9.7 12.1 4.3 3.2 2.8 4.2 6.9 2.8 10.0 4.3 9.1 8.5 1.0 3.7 4.6 13.7 5.3 3.7 7.6 2.0 7.5 1.7 11.8 13.4 1.4 2.1 4.1 2.9 4.4 6.9 3.0 2.2 10.8 1.4 6.5 11.9 6.4 5.5 6.6 7.4 13.0 6.7 3.4 5.9 3.5 11.3 6.2 15.3 2.8 3.7 12.5 2.9 2.1 7.7 9.7 6.4 5.5 3.5 5.2 4.1 7.5 12.2 2.7 5.8 3.3 5.4 5.2 3.2 6.3 5.7 4.7 6.2 2.6 3.2 5.2 4.1 4.1 7.3 2.9 5.5 3.5 3.6 6.9 7.3 7.8 7.7 6.0 5.7 4.7 6.5 5.3 4.3 SPATA4 "SPEF1B, TSARG2" ENSG00000150628 "Spermatogenesis associated 4" Q8NEY3 4 176184638-176195671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "testis: 84.3" "Cell line enhanced" "Detected in some" "hTCEpi: 2.4;U-87 MG: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 5.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA019220 Enhanced "HPA019220: AB_1857420" "unprognostic (1.97e-3)" "unprognostic (6.08e-2)" "unprognostic (2.83e-1)" "unprognostic (8.50e-3)" "unprognostic (3.17e-2)" "unprognostic (1.87e-2)" "unprognostic (2.25e-1)" "unprognostic (1.51e-1)" "unprognostic (3.09e-3)" "unprognostic (9.77e-2)" "unprognostic (4.38e-6)" "unprognostic (1.89e-2)" "unprognostic (3.64e-2)" "unprognostic (1.96e-2)" "unprognostic (1.59e-1)" 0.0 0.2 0.4 0.0 2.3 0.0 0.3 0.1 0.7 0.2 0.2 0.7 0.1 0.0 0.1 2.2 0.2 3.9 0.1 0.2 0.5 0.6 1.0 0.0 0.9 0.0 0.4 1.5 0.7 0.2 0.1 1.3 0.0 0.8 0.1 0.0 0.2 0.1 0.2 0.5 0.0 0.1 0.1 0.4 0.0 0.1 84.3 0.2 0.0 1.1 0.0 0.0 0.1 0.0 0.8 0.9 5.2 1.3 1.5 1.0 0.6 0.2 1.0 0.1 0.0 0.5 1.2 0.0 0.5 0.9 0.3 1.0 0.5 0.5 0.2 0.0 0.5 0.0 0.0 1.6 0.4 0.1 0.0 0.0 0.4 0.4 0.7 0.0 0.2 0.2 2.4 0.9 0.9 0.0 0.1 0.6 0.8 0.1 0.2 0.3 0.2 0.7 0.1 1.2 0.1 0.9 0.0 0.8 0.4 1.4 0.1 0.1 0.2 0.0 0.0 0.5 0.4 0.2 0.8 0.1 0.1 0.0 7.2 0.0 0.2 5.2 0.5 0.9 0.5 0.8 1.0 0.8 0.7 0.6 0.6 0.8 0.8 0.8 1.5 1.5 1.3 0.9 0.8 0.6 0.4 2.3 0.1 0.7 0.5 0.6 0.4 1.5 0.8 0.2 SPATA46 C1orf111 ENSG00000171722 "Spermatogenesis associated 46" Q5T0L3 1 162373203-162376870 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 60.1" "Cell line enhanced" "Detected in some" "A-431: 1.7;AF22: 2.2;HaCaT: 1.8;SCLC-21H: 3.9;SH-SY5Y: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (8.71e-3)" "unprognostic (2.13e-2)" "unprognostic (1.40e-1)" "unprognostic (3.55e-1)" "unprognostic (1.10e-2)" "unprognostic (1.49e-3)" "unprognostic (6.42e-2)" "unprognostic (3.80e-2)" "unprognostic (1.32e-1)" "unprognostic (3.44e-1)" "unprognostic (2.38e-1)" "unprognostic (4.59e-4)" "unprognostic (1.78e-1)" "unprognostic (1.46e-1)" "unprognostic (5.22e-2)" "unprognostic (1.76e-2)" 0.1 4.2 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.5 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 60.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 2.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.5 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.0 0.0 0.7 3.9 2.3 0.3 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 SPATA48 C7orf72 ENSG00000164500 "Spermatogenesis associated 48" A4D263 7 50096036-50159830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 13.8" "Cell line enriched" "Detected in some" 12 "U-698: 15.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.0" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enhanced" "Detected in single" "B-cells: 1.1" "Low region specificity" "Detected in many" HPA026094 Uncertain "HPA026094: AB_1859516" 0.0 0.0 0.4 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SPATA8 MGC44294 ENSG00000185594 "Spermatogenesis associated 8" Q6RVD6 15 96783389-96785615 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 292 "testis: 172.8" "Cell line enhanced" "Detected in some" "NTERA-2: 1.5;U-2 OS: 1.4;U-2197: 1.1;U-87 MG: 1.6" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (7.61e-3)" "unprognostic (8.45e-2)" "unprognostic (1.94e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 172.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.1 0.0 0.0 0.0 0.0 1.6 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SPATA9 "FLJ35906, NYD-SP16" ENSG00000145757 "Spermatogenesis associated 9" Q9BWV2 5 95652181-95698711 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 29.5" "Cell line enhanced" "Detected in some" "ASC diff: 2.7;HaCaT: 2.8;NB-4: 2.3;THP-1: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 20 "eosinophil: 2.0" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA010848, HPA076967" Approved Approved Mitochondria Mitochondria "HPA010848: AB_1857422, HPA076967: " "unprognostic (4.46e-2)" "unprognostic (4.02e-2)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (9.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.33e-2)" "unprognostic (2.08e-1)" "unprognostic (3.27e-2)" "unprognostic (7.58e-2)" "unprognostic (1.28e-2)" "unprognostic (3.08e-2)" "unprognostic (9.49e-13)" "unprognostic (3.39e-1)" "unprognostic (2.37e-1)" "unprognostic (1.26e-2)" "unprognostic (2.87e-2)" 0.9 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 29.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.0 2.7 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.1 0.0 0.5 0.3 2.8 0.0 0.0 0.0 0.2 0.5 1.7 0.2 0.0 0.6 0.5 0.4 1.6 0.0 0.6 0.0 0.5 1.7 0.0 2.1 0.0 0.7 2.3 0.8 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.4 0.0 3.9 0.0 0.7 0.2 0.5 0.4 0.0 0.2 0.0 0.0 0.4 1.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SPC25 "AD024, MGC22228, SPBC25" ENSG00000152253 "SPC25, NDC80 kinetochore complex component" Q9HBM1 2 168834132-168913371 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 38.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 2.5" "Group enriched" "Detected in many" 4 "B-cells: 1.1;T-cells: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047144, HPA050544" Enhanced Enhanced Cytosol Cytosol "HPA047144: , HPA050544: " "unprognostic (3.52e-2)" "unprognostic (2.28e-2)" "unprognostic (2.23e-1)" "prognostic unfavourable (8.61e-5)" "unprognostic (3.15e-1)" "unprognostic (1.84e-2)" "prognostic unfavourable (4.74e-6)" "prognostic unfavourable (9.44e-5)" "unprognostic (1.84e-3)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.30e-2)" "unprognostic (1.11e-16)" "unprognostic (9.91e-3)" "unprognostic (1.85e-1)" "unprognostic (3.43e-1)" "unprognostic (1.57e-1)" 0.9 1.6 3.6 7.2 2.2 6.7 2.1 0.4 3.5 1.3 4.0 0.9 0.0 6.8 1.3 1.5 8.5 0.6 1.0 1.1 2.7 1.6 1.5 1.6 1.9 7.5 1.2 2.5 1.2 2.6 0.7 0.2 3.3 1.1 0.8 3.1 1.3 2.1 0.0 0.7 2.1 3.8 1.8 0.7 4.1 3.0 5.9 1.1 38.0 0.6 5.6 8.0 1.5 2.7 1.1 0.0 0.4 0.1 0.0 2.5 0.4 1.0 8.4 19.5 10.9 0.9 0.9 7.0 11.2 4.3 11.3 9.1 4.3 7.8 6.9 4.9 1.8 10.4 7.5 0.0 10.1 4.7 11.5 13.9 5.3 1.9 0.0 10.3 4.2 0.0 0.5 7.2 0.1 5.7 1.1 7.9 3.2 5.1 7.5 12.5 0.6 11.2 13.5 19.4 3.1 4.5 6.6 14.6 0.9 10.0 6.8 1.8 0.5 7.3 1.6 1.7 20.6 6.6 9.4 15.2 26.5 6.9 2.2 1.6 6.6 0.0 0.1 0.2 0.0 0.1 0.0 0.9 0.4 0.0 0.0 1.1 0.2 0.5 0.4 0.0 0.0 0.0 2.5 0.4 3.6 2.2 0.4 3.5 2.7 1.6 1.2 2.5 1.1 1.1 SPDYA "Ringo3, SPDY1, SPY1" ENSG00000163806 "Speedy/RINGO cell cycle regulator family member A" Q5MJ70 2 28782517-28850611 "Predicted intracellular proteins" "Cell cycle, DNA damage" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 50 "testis: 93.4" "Cell line enhanced" "Detected in many" "NB-4: 5.9;THP-1: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035162, HPA066214" Enhanced Supported Nucleoplasm Nucleoplasm "HPA035162: , HPA066214: " "unprognostic (3.41e-2)" "unprognostic (3.20e-3)" "unprognostic (2.45e-1)" "unprognostic (3.53e-2)" "unprognostic (4.21e-2)" "unprognostic (4.04e-3)" "unprognostic (1.10e-4)" "unprognostic (3.04e-3)" "unprognostic (1.95e-2)" "unprognostic (6.54e-3)" "unprognostic (1.45e-1)" "unprognostic (1.99e-2)" "unprognostic (1.66e-13)" "unprognostic (8.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.85e-1)" "unprognostic (5.55e-5)" 0.4 0.7 0.7 0.4 0.8 0.7 0.4 1.8 0.6 0.7 0.4 0.5 0.4 0.6 0.4 0.8 0.4 0.3 0.7 0.4 0.8 0.6 0.5 0.6 0.4 0.7 0.6 0.4 0.9 0.6 0.1 0.8 0.4 0.4 1.0 0.2 0.4 0.6 0.4 0.5 1.8 0.5 0.5 0.5 1.1 0.3 93.4 0.4 0.8 0.7 0.4 0.4 0.6 0.4 0.6 1.4 0.0 0.3 0.6 1.0 0.0 1.0 0.5 1.6 3.7 0.0 0.0 2.0 0.9 0.1 0.3 0.1 1.0 0.8 0.9 1.1 0.0 2.4 0.4 0.0 0.4 0.5 1.0 0.8 2.1 3.0 0.1 1.0 1.7 0.3 0.2 0.2 0.5 0.0 0.4 1.5 0.7 0.4 0.4 5.9 0.5 0.4 0.8 2.9 0.9 1.1 0.6 1.3 0.8 1.9 2.4 0.7 0.7 5.6 0.2 2.9 2.3 1.6 1.3 0.8 1.5 1.5 0.8 0.8 0.6 0.0 0.3 0.0 1.0 0.3 0.2 0.5 0.5 0.5 0.1 0.6 0.7 0.8 0.0 0.6 0.2 1.4 0.1 0.0 0.7 0.8 1.8 0.6 0.8 0.6 0.6 0.4 0.4 0.4 SPDYE4 ENSG00000183318 "Speedy/RINGO cell cycle regulator family member E4" A6NLX3 17 8753106-8758559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 17.4" "Cell line enhanced" "Detected in some" "A549: 4.5;HeLa: 4.6;NB-4: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA025704, HPA051750" Enhanced "HPA025704: AB_1853093, HPA051750: " "unprognostic (3.20e-1)" "unprognostic (7.16e-4)" "unprognostic (3.15e-3)" "unprognostic (2.79e-1)" 0.1 0.0 0.1 0.2 0.2 1.3 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.2 17.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.6 0.7 1.2 0.9 0.0 1.1 0.4 0.9 4.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.6 0.0 0.0 1.2 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.5 0.0 2.8 0.0 0.0 0.7 0.0 0.0 0.0 2.1 0.7 0.2 0.7 1.0 0.0 0.9 0.0 0.0 0.4 0.2 1.4 1.0 0.7 0.1 0.8 0.0 0.2 0.5 0.7 0.9 1.2 1.0 0.4 0.5 0.5 0.6 0.6 0.0 1.6 0.8 1.1 0.4 0.0 0.9 0.7 0.1 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SPEM1 "C17orf83, FLJ40081" ENSG00000181323 "Spermatid maturation 1" Q8N4L4 17 7420360-7421632 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "testis: 61.9" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;hTEC/SVTERT24-B: 1.2;U-2 OS: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "unprognostic (1.28e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.2 0.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SPEM2 C17orf74 ENSG00000184560 "SPEM family member 2" Q0P670 17 7425615-7427568 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 45.9" "Cell line enhanced" "Detected in some" "HDLM-2: 1.2;hTEC/SVTERT24-B: 1.0;U-2 OS: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA023649 Uncertain "HPA023649: AB_1845606" "unprognostic (3.00e-1)" "unprognostic (3.88e-1)" "unprognostic (1.12e-4)" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPEM3 ENSG00000283439 "SPEM family member 3" 17 7428863-7432762 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 73 "testis: 43.2" "Cell line enhanced" "Detected in single" "U-2 OS: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPERT "CBY2, NURIT" ENSG00000174015 "Spermatid associated" Q8NA61 13 45702311-45714559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 66.5" "Cell line enhanced" "Detected in some" "EFO-21: 1.7;HDLM-2: 3.4;hTCEpi: 1.2;MCF7: 1.3;SCLC-21H: 1.2;SK-BR-3: 2.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 32 "T-cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039359, HPA040046" Enhanced Approved "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "HPA039359: AB_10794088, HPA040046: AB_10796117" "unprognostic (2.86e-1)" "unprognostic (3.38e-1)" "unprognostic (1.64e-2)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (4.19e-4)" "unprognostic (8.52e-2)" "unprognostic (8.87e-2)" "unprognostic (1.23e-1)" "unprognostic (4.38e-1)" "unprognostic (2.38e-2)" "unprognostic (1.21e-1)" "unprognostic (1.56e-2)" "unprognostic (1.97e-2)" "unprognostic (4.15e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.7 0.8 0.0 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPHAR ENSG00000213029 "S-phase response (cyclin related)" Q15513 1 229304857-229305504 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 31 "brain: 3.1" "Cell line enriched" "Detected in single" 20 "Daudi: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPIC "MGC40611, SPI-C" ENSG00000166211 "Spi-C transcription factor" Q8N5J4 12 101475421-101486997 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 16 "lymphoid tissue: 74.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "intermediate monocyte: 4.1;non-classical monocyte: 1.2" "Lineage enriched" "Detected in single" 7 "monocytes: 4.1" "Not detected" "Not detected" "unprognostic (9.82e-2)" "unprognostic (2.43e-2)" "unprognostic (9.03e-3)" "unprognostic (2.51e-1)" "unprognostic (4.85e-2)" "unprognostic (5.78e-2)" "unprognostic (5.30e-2)" "unprognostic (1.77e-1)" 0.1 0.1 0.1 1.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.1 0.1 0.1 4.7 0.1 16.7 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.3 0.0 0.1 74.6 0.1 0.1 0.0 3.1 0.1 0.0 2.4 0.1 0.1 0.0 0.0 0.0 4.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 1.2 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 SPINK1 "PCTT, PSTI, Spink3, TATI" ENSG00000164266 "Serine peptidase inhibitor, Kazal type 1" P00995 5 147824568-147831786 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "pancreas: 1767.1" "Group enriched" "Detected in some" 8 "CACO-2: 43.1;RT4: 118.4" "Cancer enhanced" "Detected in many" "pancreatic cancer: 513.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026366, HPA027498" Enhanced "Secreted to digestive system" 7900000 "CAB026366: , HPA027498: AB_10603115" "unprognostic (1.05e-1)" "unprognostic (1.00e-1)" "unprognostic (9.96e-3)" "unprognostic (3.55e-1)" "unprognostic (6.12e-3)" "unprognostic (1.79e-4)" "unprognostic (8.34e-3)" "unprognostic (2.43e-1)" "unprognostic (2.66e-1)" "unprognostic (1.88e-1)" "unprognostic (3.82e-2)" "unprognostic (8.13e-2)" "prognostic unfavourable (5.44e-7)" "unprognostic (7.98e-2)" "unprognostic (2.07e-1)" "prognostic favourable (2.15e-5)" 0.3 0.0 0.3 1.6 0.3 0.0 0.3 0.3 0.3 0.3 6.0 0.3 0.3 6.3 0.3 0.3 0.3 0.0 1.5 0.3 0.3 0.0 2.0 13.3 0.4 0.3 0.3 0.3 0.3 1767.1 0.0 0.3 0.3 0.3 1.4 6.4 0.3 0.3 0.3 0.3 0.0 6.9 1.0 0.3 0.3 25.8 0.4 0.3 0.3 0.3 0.3 0.3 13.1 2.2 0.7 0.5 1.9 0.5 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 43.1 0.0 0.0 0.8 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 10.7 0.0 0.0 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 118.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.4 0.3 0.5 0.2 2.1 0.0 0.0 1.9 0.4 0.2 0.4 0.5 0.2 0.4 0.4 0.3 0.1 0.7 0.5 0.6 1.8 0.3 0.4 0.5 0.1 0.1 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 SPINK2 HUSI-II ENSG00000128040 "Serine peptidase inhibitor, Kazal type 2" P20155 4 56809860-56821742 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "epididymis: 376.2" "Cell line enriched" "Detected in some" 4 "U-266/70: 43.8" "Group enriched" "Detected in some" 5 "lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 6 "NK-cell: 43.3" "Lineage enriched" "Detected in many" 6 "NK-cells: 43.3" "CAB020824, HPA026813" Enhanced "Secreted to blood" "CAB020824: , HPA026813: AB_1857446" "unprognostic (5.56e-3)" "unprognostic (3.60e-1)" "unprognostic (7.54e-2)" "unprognostic (2.35e-2)" "unprognostic (1.54e-1)" "unprognostic (1.60e-1)" "prognostic favourable (2.82e-4)" "unprognostic (9.83e-2)" "unprognostic (6.62e-2)" "unprognostic (9.40e-3)" "unprognostic (2.06e-1)" "unprognostic (2.49e-1)" "unprognostic (4.10e-3)" "unprognostic (3.18e-2)" "unprognostic (2.19e-2)" "unprognostic (3.87e-2)" 0.2 0.1 0.2 0.5 0.2 0.7 0.3 0.1 0.3 0.4 0.4 0.0 85.2 0.0 0.2 376.2 0.1 0.2 0.0 2.2 0.3 0.3 0.2 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.0 1.4 0.0 1.1 1.1 0.1 0.0 0.6 49.9 0.5 0.2 0.5 0.0 0.2 0.6 0.2 85.5 0.0 0.3 0.2 0.0 0.2 1.3 1.3 3.9 0.4 1.3 0.0 43.3 7.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 8.4 0.2 0.0 0.0 0.0 2.0 0.0 2.8 0.1 1.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 43.8 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.2 0.0 0.2 2.3 1.7 1.8 0.4 3.9 3.9 7.3 0.3 43.3 0.0 0.2 0.1 2.0 0.2 0.2 0.1 0.3 0.3 0.3 0.2 0.0 1.1 0.0 SPINK8 ENSG00000229453 "Serine peptidase inhibitor, Kazal type 8 (putative)" P0C7L1 3 48306842-48328341 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "breast: 33.5" "Cell line enriched" "Detected in single" 62 "SK-BR-3: 40.2" "Group enriched" "Detected in some" 10 "breast cancer: 8.6;glioma: 9.6;prostate cancer: 2.4" "Group enriched" "Detected in some" 10 "eosinophil: 3.3;neutrophil: 4.5" "Lineage enriched" "Detected in single" 11 "granulocytes: 4.5" "Region enriched" "Detected in some" 9 "hippocampal formation: 80.7" HPA053151 Uncertain "Secreted to blood" "HPA053151: " "prognostic unfavourable (8.47e-4)" "unprognostic (1.98e-1)" "unprognostic (1.75e-2)" "unprognostic (1.99e-1)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" 0.0 0.0 1.4 0.0 1.0 7.3 33.5 0.3 0.6 0.0 0.0 0.0 0.0 1.8 4.1 0.0 0.0 0.0 2.2 1.7 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.2 0.0 0.4 0.0 1.8 0.1 0.0 0.2 0.0 0.0 2.3 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 40.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.4 0.0 0.0 0.0 SPINK9 ENSG00000204909 "Serine peptidase inhibitor, Kazal type 9" Q5DT21 5 148321203-148339849 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "tongue: 65.0" "Cell line enhanced" "Detected in many" "EFO-21: 18.2;U-266/84: 19.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" HPA038288 Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" "Nucleoplasm, Vesicles" "HPA038288: AB_10795400" "unprognostic (1.84e-1)" "unprognostic (4.87e-3)" "unprognostic (2.88e-1)" "unprognostic (9.02e-2)" "unprognostic (5.49e-3)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.35e-1)" "unprognostic (1.51e-3)" "unprognostic (2.82e-2)" "unprognostic (1.91e-2)" "unprognostic (3.93e-1)" "unprognostic (2.01e-1)" "unprognostic (3.99e-2)" "unprognostic (1.90e-1)" 1.0 2.3 2.3 2.2 4.0 6.2 1.0 1.3 3.2 1.0 1.2 1.0 1.0 1.1 2.0 1.5 1.5 0.5 1.0 2.3 2.2 3.3 1.3 1.0 1.0 1.9 1.5 1.0 1.4 1.4 0.5 1.4 2.5 1.0 1.8 1.2 1.0 1.0 1.0 2.4 2.7 1.7 1.0 1.1 1.1 2.0 3.8 1.0 2.7 1.0 65.0 1.1 1.2 1.0 3.4 2.7 10.7 2.9 5.8 2.8 0.2 10.9 2.0 2.8 3.0 0.4 1.0 2.4 3.0 0.1 0.2 0.5 4.5 8.4 3.2 18.2 0.2 2.3 0.9 0.6 0.8 4.6 2.2 6.3 6.8 2.0 0.2 2.2 2.6 0.1 0.6 0.3 0.1 0.0 3.8 14.1 0.4 9.4 2.2 3.3 11.2 4.4 2.9 2.8 3.5 1.4 9.0 5.1 5.8 2.9 6.4 1.9 10.4 2.1 6.9 3.3 10.6 3.2 3.4 8.9 19.3 3.2 2.7 1.9 4.5 10.7 2.9 1.3 1.8 1.6 2.1 1.3 2.0 2.1 0.7 3.4 2.6 2.8 10.5 5.8 2.8 2.7 1.3 0.2 2.3 4.0 1.3 3.2 2.2 3.3 1.5 1.0 1.0 1.0 SPINT3 HKIB9 ENSG00000101446 "Serine peptidase inhibitor, Kunitz type 3" P49223 20 45512461-45515624 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "epididymis: 113.9" "Group enriched" "Detected in some" 14 "Karpas-707: 1.4;NTERA-2: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA026852 Enhanced "Secreted in male reproductive system" "HPA026852: " 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 113.9 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 16.7 0.0 4.8 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPINT4 "C20orf137, dJ601O1.1" ENSG00000149651 "Serine peptidase inhibitor, Kunitz type 4" Q6UDR6 20 45722351-45725830 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "epididymis: 134.6" "Group enriched" "Detected in some" 5 "NB-4: 4.5;U-87 MG: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046703 Enhanced "Secreted in male reproductive system" "HPA046703: " "unprognostic (3.61e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 11.5 0.0 0.1 134.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 2.1 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 SPO11 "CT35, SPATA43, TOPVIA" ENSG00000054796 "SPO11, initiator of meiotic double stranded breaks" Q9Y5K1 20 57329759-57343994 "Enzymes, Plasma proteins, Predicted intracellular proteins" Meiosis "DNA-binding, Hydrolase, Isomerase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 142 "testis: 14.2" "Group enriched" "Detected in some" 19 "Daudi: 1.7;SiHa: 1.3;U-698: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPP2 SPP24 ENSG00000072080 "Secreted phosphoprotein 2" Q13103 2 234050679-234077134 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 879 "liver: 113.0" "Cell line enhanced" "Detected in some" "HEL: 1.1;RH-30: 3.4;RPTEC TERT1: 1.0;U-698: 1.4" "Cancer enriched" "Detected in some" 112 "liver cancer: 65.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Secreted to blood" 540000000 "prognostic favourable (2.33e-6)" "unprognostic (7.02e-3)" "unprognostic (9.62e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.4 0.0 1.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPPL2C IMP5 ENSG00000185294 "Signal peptide peptidase like 2C" Q8IUH8 17 45844835-45847072 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "testis: 45.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "cerebellum: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (6.70e-4)" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SPRR1A ENSG00000169474 "Small proline rich protein 1A" P35321 1 152985231-152985500 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "esophagus: 495.3" "Group enriched" "Detected in some" 7 "HaCaT: 12.7;hTCEpi: 37.2;RT4: 14.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 1736.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB011237 Enhanced "CAB011237: " "unprognostic (1.39e-1)" "unprognostic (5.45e-2)" "unprognostic (2.64e-2)" "unprognostic (1.19e-2)" "unprognostic (1.25e-2)" "unprognostic (2.92e-1)" "prognostic unfavourable (1.03e-4)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" 0.4 0.0 0.4 0.4 0.4 0.0 0.7 0.4 0.4 72.3 0.4 0.4 0.4 0.0 0.4 0.4 495.3 0.0 3.8 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.4 52.5 0.4 0.4 11.7 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 70.7 47.3 0.5 111.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.4 0.0 0.0 12.7 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 14.1 0.2 0.0 1.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 SPRR2F ENSG00000244094 "Small proline rich protein 2F" Q96RM1 1 153112114-153113515 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "tongue: 310.0" "Cell line enriched" "Detected in single" 8 "K-562: 7.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 53.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (7.40e-2)" "unprognostic (1.14e-2)" "unprognostic (1.48e-2)" "unprognostic (2.41e-2)" "unprognostic (4.37e-2)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.96e-1)" "unprognostic (1.78e-3)" 0.4 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 4.5 0.1 0.1 0.1 0.0 0.2 0.3 66.8 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 28.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 7.1 0.2 0.2 0.5 0.1 0.1 0.1 0.1 0.0 2.2 0.1 0.1 0.1 310.0 24.8 0.1 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SPRYD4 DKFZp686N0877 ENSG00000176422 "SPRY domain containing 4" Q8WW59 12 56468567-56479707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 58.4" "Cell line enhanced" "Detected in all" "Karpas-707: 14.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053469 Uncertain Approved Nucleoplasm Nucleoplasm "HPA053469: " "unprognostic (1.14e-1)" "unprognostic (1.20e-1)" "unprognostic (8.00e-2)" "prognostic unfavourable (8.85e-5)" "unprognostic (7.76e-2)" "unprognostic (1.20e-1)" "unprognostic (3.06e-3)" "prognostic favourable (4.52e-4)" "unprognostic (5.59e-3)" "unprognostic (1.19e-2)" "unprognostic (3.14e-2)" "unprognostic (9.98e-2)" "unprognostic (1.27e-3)" "unprognostic (1.81e-1)" "unprognostic (1.69e-1)" "unprognostic (3.44e-1)" "unprognostic (1.14e-1)" 3.8 9.6 3.3 6.0 4.6 4.4 6.2 4.2 6.1 3.8 5.1 6.0 6.7 4.2 4.5 6.3 7.1 3.8 7.4 7.2 3.6 3.6 12.0 58.4 3.1 3.5 4.4 4.3 4.9 12.3 5.0 7.0 4.3 3.7 5.2 6.5 5.8 8.2 6.3 10.5 4.6 6.4 4.3 3.3 4.8 5.0 2.6 3.3 3.8 7.6 7.3 6.1 5.2 4.1 4.6 5.0 3.8 3.8 4.8 3.2 2.5 2.7 3.7 3.2 2.5 2.8 1.8 4.3 2.3 2.3 4.8 2.9 3.4 4.9 3.4 3.1 2.9 4.8 2.7 3.9 3.0 1.7 5.6 5.0 3.8 5.0 2.7 3.4 5.0 4.0 2.6 3.5 2.9 4.9 2.7 14.9 4.0 4.5 1.6 2.4 2.1 4.2 2.0 2.4 7.1 5.1 3.5 3.2 1.5 4.4 5.3 3.4 9.0 1.0 2.3 2.1 3.9 3.0 1.8 2.5 1.4 1.2 1.7 2.9 2.6 3.8 3.8 2.0 3.0 3.0 3.2 3.8 2.8 3.0 3.3 4.6 3.2 3.2 3.8 4.8 3.2 5.0 1.2 2.5 3.3 4.6 4.2 6.1 3.6 3.6 4.4 4.3 3.7 3.3 SPSB3 "C16orf31, SSB-3" ENSG00000162032 "SplA/ryanodine receptor domain and SOCS box containing 3" Q6PJ21 16 1776712-1793700 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 138.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046602 Uncertain Approved Mitochondria Mitochondria "HPA046602: " "unprognostic (1.18e-1)" "unprognostic (2.37e-2)" "unprognostic (1.79e-1)" "unprognostic (1.15e-3)" "unprognostic (1.82e-1)" "unprognostic (8.91e-4)" "unprognostic (1.07e-2)" "unprognostic (8.31e-2)" "unprognostic (5.65e-2)" "unprognostic (8.43e-2)" "unprognostic (3.41e-2)" "unprognostic (4.83e-2)" "unprognostic (5.25e-7)" "unprognostic (2.16e-2)" "unprognostic (2.02e-1)" "unprognostic (3.77e-1)" "unprognostic (4.72e-4)" 8.5 19.4 7.8 8.2 8.3 12.8 9.5 25.3 11.3 10.5 10.4 10.1 11.0 10.0 7.6 9.5 14.1 9.0 17.7 9.1 6.7 5.7 8.2 138.5 8.3 7.8 11.1 8.8 15.9 19.5 7.5 5.6 7.6 8.4 9.3 4.2 10.6 14.0 12.9 29.4 18.1 8.3 9.4 6.9 8.3 8.6 5.8 8.3 16.3 10.5 6.5 8.9 8.5 9.3 18.0 15.9 32.6 16.8 15.6 34.5 17.0 3.4 5.2 6.4 7.6 9.0 8.8 10.5 4.2 7.0 7.5 8.3 3.8 11.6 1.7 8.5 3.9 6.9 3.2 6.6 1.2 6.0 7.7 3.4 7.5 5.0 12.5 1.3 6.0 7.7 17.2 4.9 5.7 11.5 3.9 9.1 3.7 12.5 8.7 8.6 4.4 2.6 14.7 2.5 14.0 6.7 0.7 8.5 8.4 5.5 17.1 15.6 8.4 8.1 8.1 3.5 5.2 6.1 2.9 13.5 15.6 4.4 2.8 4.9 3.9 32.3 16.8 29.7 26.1 15.2 32.6 18.0 24.4 24.1 15.4 16.8 17.6 18.4 32.6 15.6 13.3 15.9 34.5 17.0 7.8 8.3 25.3 11.3 6.7 5.7 11.1 8.8 8.4 8.3 SPSB4 SSB-4 ENSG00000175093 "SplA/ryanodine receptor domain and SOCS box containing 4" Q96A44 3 141051402-141148611 "Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 22.0" "Cell line enhanced" "Detected in some" "AF22: 15.9;NTERA-2: 4.5;RH-30: 5.4;SH-SY5Y: 4.5;U-2 OS: 3.7" "Group enriched" "Detected in some" 5 "glioma: 4.6;testis cancer: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062793 Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA062793: " "unprognostic (5.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.12e-1)" "unprognostic (1.23e-3)" "prognostic favourable (3.72e-4)" "unprognostic (7.49e-2)" "unprognostic (6.58e-2)" "unprognostic (1.76e-1)" "unprognostic (8.48e-2)" "unprognostic (2.47e-1)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-3)" "unprognostic (2.30e-2)" "unprognostic (2.46e-4)" "unprognostic (9.80e-3)" 0.8 0.9 1.0 0.2 1.5 0.2 0.2 0.2 2.0 0.1 0.3 0.7 0.0 0.2 0.1 0.3 0.2 0.1 0.2 2.2 1.1 1.1 0.4 0.3 1.3 3.2 1.5 0.6 0.1 22.0 0.1 4.6 0.2 1.2 0.2 0.1 0.0 0.1 0.1 1.7 0.2 0.2 0.2 1.9 2.5 0.1 3.6 0.2 0.1 0.1 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 15.9 0.3 0.0 0.0 2.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.9 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 4.5 0.0 0.0 5.4 0.8 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.3 0.4 0.0 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 1.5 0.2 1.2 1.1 1.1 1.5 0.6 1.2 0.2 SPTA1 EL2 ENSG00000163554 "Spectrin alpha, erythrocytic 1" P02549 1 158610706-158686715 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape" "Actin capping, Actin-binding" "Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 41.0" "Cell line enriched" "Detected in some" 4 "K-562: 27.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016193, HPA028048, HPA028253, CAB037246" Enhanced 45000000 "CAB016193: AB_669050, CAB037246: AB_261445, HPA028048: AB_10603341, HPA028253: " "unprognostic (3.39e-1)" "unprognostic (1.03e-1)" "unprognostic (2.25e-2)" "unprognostic (1.94e-1)" "unprognostic (2.99e-1)" "unprognostic (1.34e-1)" "unprognostic (3.65e-3)" "unprognostic (1.50e-3)" "unprognostic (9.08e-2)" "unprognostic (2.58e-2)" "unprognostic (2.29e-1)" "unprognostic (9.09e-2)" "unprognostic (6.73e-8)" "unprognostic (6.08e-2)" "unprognostic (6.33e-2)" "unprognostic (1.76e-2)" "unprognostic (5.85e-3)" 0.6 0.0 0.0 1.1 0.0 41.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 4.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 8.1 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.6 4.6 0.0 2.2 0.0 0.3 0.9 0.0 0.0 0.0 2.8 0.9 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPTBN4 "KIAA1642, SPTBN3" ENSG00000160460 "Spectrin beta, non-erythrocytic 4" Q9H254 19 40466241-40576464 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 36.3" "Cell line enhanced" "Detected in some" "K-562: 3.5;Karpas-707: 5.0;SCLC-21H: 7.9;SH-SY5Y: 4.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054481 Enhanced Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA054481: " "unprognostic (1.97e-3)" "unprognostic (1.02e-1)" "unprognostic (5.65e-4)" "unprognostic (3.72e-4)" "unprognostic (7.79e-3)" "unprognostic (9.77e-2)" "unprognostic (2.62e-1)" "unprognostic (2.50e-2)" "unprognostic (3.19e-2)" "unprognostic (1.65e-1)" "unprognostic (1.78e-4)" "unprognostic (4.54e-1)" "unprognostic (2.55e-2)" "unprognostic (6.79e-2)" "unprognostic (1.42e-1)" "unprognostic (1.85e-2)" "unprognostic (2.02e-1)" 3.1 5.9 13.4 1.2 15.3 1.2 1.2 36.3 27.1 1.4 1.3 1.8 0.0 1.7 2.3 1.3 1.6 2.0 1.8 3.3 9.8 10.8 1.9 1.3 1.2 1.0 7.5 13.0 4.1 3.0 3.3 8.0 1.0 10.4 2.8 1.1 2.6 2.2 2.0 5.1 1.3 1.5 1.8 2.8 1.3 2.5 3.5 3.7 0.0 1.6 0.0 1.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.5 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.4 2.3 1.9 0.4 0.0 0.0 0.0 0.0 0.4 2.3 0.5 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.0 0.0 0.0 3.5 5.0 0.0 1.3 0.0 0.0 0.2 0.8 0.5 0.0 1.1 0.0 0.0 7.9 4.8 0.1 0.2 0.0 0.7 0.0 0.0 0.0 1.4 0.8 0.0 0.2 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 15.3 36.3 22.7 9.8 10.8 7.5 13.0 10.4 3.7 SPTLC3 "C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L" ENSG00000172296 "Serine palmitoyltransferase long chain base subunit 3" Q9NUV7 20 13008979-13169103 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "placenta: 154.0" "Cell line enhanced" "Detected in many" "Karpas-707: 16.0;RPTEC TERT1: 21.4;U-2197: 14.9;U-87 MG: 28.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "pons and medulla: 10.5" "Group enriched" "Detected in some" 5 "MAIT T-cell: 3.0;NK-cell: 4.1" "Group enriched" "Detected in many" 13 "NK-cells: 4.1;T-cells: 3.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA044247, HPA048079" Enhanced Approved Microtubules Microtubules "HPA044247: , HPA048079: " "unprognostic (6.81e-2)" "unprognostic (7.76e-2)" "unprognostic (4.46e-2)" "unprognostic (1.25e-3)" "unprognostic (5.43e-2)" "unprognostic (2.12e-1)" "unprognostic (5.70e-2)" "unprognostic (7.99e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "prognostic unfavourable (6.02e-4)" "unprognostic (5.08e-2)" "prognostic favourable (4.51e-7)" "unprognostic (2.80e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.18e-1)" 3.2 4.5 1.3 1.6 2.2 0.0 4.3 1.7 1.7 4.3 5.0 2.2 4.4 8.3 4.8 9.6 5.6 3.4 5.8 4.8 2.0 1.5 15.6 11.9 5.7 0.7 2.5 2.2 4.3 3.8 10.2 4.2 154.0 10.5 4.5 3.8 3.8 7.8 5.8 1.0 25.1 9.0 3.0 6.9 1.9 2.2 4.2 1.4 5.7 24.3 3.6 1.9 4.8 6.0 0.0 0.2 0.1 0.0 4.1 3.0 0.2 0.6 1.1 0.8 0.0 7.0 10.1 5.4 0.0 1.5 1.0 4.1 8.7 4.4 0.0 0.5 0.2 12.0 0.0 3.3 1.4 0.0 0.0 0.0 2.8 12.3 0.6 0.0 0.1 5.7 10.4 4.0 1.3 0.6 0.0 16.0 11.3 0.2 0.0 0.0 0.0 1.4 1.1 2.0 7.0 21.4 8.6 0.0 0.1 0.1 1.1 0.0 8.9 0.2 1.5 4.5 1.5 14.9 1.0 0.1 0.0 0.0 28.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 3.0 0.0 0.4 0.1 0.0 0.0 0.7 0.1 0.1 4.1 0.0 0.2 0.0 0.2 1.3 2.2 1.7 1.7 2.0 1.5 2.5 2.2 10.5 1.4 SPTY2D1OS SPTY2D1-AS1 ENSG00000247595 "SPTY2D1 opposite strand" 11 18588781-18610255 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 18 "testis: 70.2" "Cell line enhanced" "Detected in many" "HeLa: 10.0" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Secreted in male reproductive system" "unprognostic (1.07e-1)" "unprognostic (1.24e-1)" "unprognostic (8.60e-3)" "unprognostic (5.14e-2)" "unprognostic (6.61e-2)" "unprognostic (9.32e-2)" "unprognostic (4.44e-7)" "unprognostic (1.75e-1)" "unprognostic (1.39e-2)" "unprognostic (7.83e-2)" "unprognostic (5.36e-2)" "unprognostic (6.50e-3)" "unprognostic (5.41e-4)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (1.48e-2)" 0.1 0.2 0.1 0.1 0.1 0.0 0.4 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 1.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.1 3.9 0.1 0.1 0.1 0.1 0.0 70.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.6 2.6 1.0 1.0 2.4 0.8 0.7 6.9 2.7 3.7 2.4 3.7 3.5 0.5 0.7 1.3 1.7 5.1 2.0 1.1 0.4 0.6 1.4 0.0 0.0 0.0 2.1 2.5 0.7 10.0 6.4 0.4 0.9 2.3 1.4 0.5 0.3 2.2 1.4 1.9 0.6 0.5 2.4 0.3 2.6 1.9 4.2 0.3 0.8 0.4 2.7 2.7 0.9 0.5 2.5 0.1 0.1 1.3 0.4 1.3 2.7 2.1 1.5 0.3 0.1 0.3 0.0 1.1 1.3 1.7 1.3 1.0 2.6 1.0 0.2 2.4 0.3 0.6 0.3 0.2 0.9 0.4 0.6 2.4 1.0 0.5 0.6 1.5 0.8 SPZ1 "FLJ25709, NYD-TSP1, PPP1R148" ENSG00000164299 "Spermatogenic leucine zipper 1" Q9BXG8 5 80319625-80321842 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "testis: 24.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "prostate cancer: 1.0;testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" "unprognostic (2.22e-1)" "unprognostic (2.73e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRPK3 "MSSK1, STK23" ENSG00000184343 "SRSF protein kinase 3" Q9UPE1 X 153776412-153785732 "Enzymes, Predicted intracellular proteins" "Differentiation, Myogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 73.4" "Cell line enhanced" "Detected in many" "RH-30: 30.8;U-266/70: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.79e-3)" "unprognostic (6.21e-2)" "unprognostic (1.79e-2)" "unprognostic (7.24e-2)" "unprognostic (1.44e-1)" "unprognostic (2.51e-1)" "unprognostic (1.97e-1)" "unprognostic (4.47e-4)" "unprognostic (2.83e-1)" "unprognostic (1.71e-1)" "unprognostic (4.10e-4)" "unprognostic (8.70e-2)" "unprognostic (5.38e-7)" "unprognostic (1.97e-2)" "unprognostic (1.97e-1)" "unprognostic (3.83e-2)" "unprognostic (1.07e-4)" 1.6 1.8 1.3 0.9 1.8 0.8 0.3 7.7 1.5 0.9 4.5 1.1 0.2 1.3 2.5 3.3 2.6 0.7 1.7 16.7 2.0 1.8 0.2 0.2 0.4 0.8 2.0 0.7 0.7 0.7 1.0 5.8 0.3 1.1 2.8 0.8 0.9 2.9 0.5 73.4 2.3 1.3 4.0 2.0 0.8 1.3 0.5 0.9 0.3 0.6 18.3 1.6 2.0 0.8 0.4 2.6 0.9 0.3 0.1 0.6 0.3 3.2 4.3 0.7 2.2 0.0 0.1 1.0 0.4 0.0 0.2 0.0 3.6 0.6 3.2 0.4 0.3 0.9 0.0 0.1 0.0 2.8 3.0 1.7 2.7 0.5 0.0 0.8 5.0 2.7 0.0 0.0 0.0 0.0 2.1 3.8 0.8 6.9 0.6 4.7 0.8 1.2 1.5 30.8 0.9 0.0 1.4 5.2 2.5 0.0 2.3 1.0 2.9 3.7 0.0 1.2 2.8 2.3 0.4 12.8 2.0 2.2 0.6 6.1 1.6 0.8 0.3 0.2 0.5 0.1 0.6 0.2 0.1 0.1 0.0 0.4 0.1 0.1 0.9 0.1 0.0 2.6 0.0 0.3 1.3 1.8 7.7 1.5 2.0 1.8 2.0 0.7 1.1 0.9 SRRM3 FLJ37078 ENSG00000177679 "Serine/arginine repetitive matrix 3" 7 76201900-76287288 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 43.2" "Group enriched" "Detected in some" 11 "SCLC-21H: 14.1;SH-SY5Y: 10.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019337 Approved "Plasma membrane,Intermediate filaments,Microtubules" "Plasma membrane" "Intermediate filaments, Microtubules" "HPA019337: AB_1848909" "unprognostic (1.65e-1)" "unprognostic (1.96e-1)" "unprognostic (8.37e-3)" "unprognostic (4.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "unprognostic (8.53e-2)" "unprognostic (6.51e-2)" "unprognostic (1.89e-3)" "unprognostic (1.62e-2)" "unprognostic (5.07e-3)" "unprognostic (6.37e-2)" "unprognostic (3.73e-3)" "unprognostic (5.05e-1)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.15e-2)" 0.6 6.2 8.1 0.7 18.1 0.4 0.4 43.2 14.6 0.4 0.6 0.0 0.0 0.9 0.7 1.1 0.5 0.5 0.5 0.5 5.1 0.5 0.4 0.5 0.4 0.0 10.9 0.6 0.5 0.5 4.4 0.4 10.0 0.5 0.7 1.8 0.6 0.5 0.6 0.5 0.6 0.5 0.6 0.4 1.6 2.9 2.9 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.2 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 14.1 10.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 SRRM4 "KIAA1853, nSR100" ENSG00000139767 "Serine/arginine repetitive matrix 4" A7MD48 12 118981495-119163051 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 62.1" "Group enriched" "Detected in some" 6 "HeLa: 6.5;SCLC-21H: 7.6;SH-SY5Y: 6.1" "Cancer enriched" "Detected in single" 7 "glioma: 1.3" "Region enhanced" "Detected in many" "cerebellum: 62.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052783 Uncertain "HPA052783: " "unprognostic (2.44e-2)" "unprognostic (2.66e-1)" "unprognostic (2.40e-2)" "unprognostic (1.25e-1)" "unprognostic (1.64e-1)" "unprognostic (1.37e-1)" "unprognostic (1.11e-1)" "unprognostic (1.61e-5)" "unprognostic (1.10e-2)" "unprognostic (1.75e-1)" "unprognostic (5.70e-3)" "unprognostic (2.23e-1)" "unprognostic (6.88e-2)" "unprognostic (1.61e-1)" 0.8 3.6 11.0 0.9 11.6 1.0 0.8 62.1 21.5 0.8 0.8 0.4 0.0 0.9 1.1 1.0 0.8 0.8 0.8 2.0 6.6 4.7 1.1 0.8 1.0 0.8 2.0 18.2 0.8 0.7 0.9 1.4 0.9 3.8 0.9 0.9 5.9 0.8 1.1 1.4 0.9 0.9 0.9 1.3 0.8 1.3 1.4 0.8 0.0 0.9 0.0 0.8 0.7 0.3 0.0 0.1 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 7.6 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.0 11.0 11.6 62.1 20.5 6.6 4.7 2.0 18.2 3.8 0.8 SRRM5 ENSG00000226763 "Serine/arginine repetitive matrix 5" B3KS81 19 43596617-43614497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "testis: 47.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Low region specificity" "Detected in all" HPA047399 Uncertain "HPA047399: AB_10963088" "unprognostic (3.95e-3)" "unprognostic (7.56e-3)" "unprognostic (6.72e-2)" "unprognostic (3.40e-2)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (1.10e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.89e-2)" "unprognostic (3.69e-2)" "unprognostic (2.16e-2)" "unprognostic (2.68e-5)" "unprognostic (2.44e-1)" "unprognostic (3.31e-1)" "unprognostic (2.07e-1)" "unprognostic (1.00e-3)" 1.9 2.6 2.9 2.5 4.1 2.2 2.0 6.8 4.3 1.8 1.9 3.1 2.0 2.2 2.0 2.1 2.1 1.9 2.4 1.8 2.5 2.1 2.2 5.5 1.8 3.4 3.2 3.6 2.1 2.5 2.0 2.8 1.8 3.5 3.0 1.8 1.5 2.2 2.0 2.1 3.0 3.1 1.7 2.6 2.1 2.4 47.6 2.6 2.6 2.6 1.1 1.7 1.9 2.0 0.0 0.0 0.0 0.4 0.0 1.2 0.1 3.6 3.2 1.2 2.2 1.1 0.9 0.9 0.8 0.3 0.3 0.5 2.0 1.5 1.3 2.0 0.3 2.2 1.2 0.3 0.6 1.5 1.4 1.3 2.8 1.6 0.5 0.9 1.8 1.1 1.3 0.2 0.3 0.3 1.0 3.1 0.2 3.0 1.4 1.5 0.5 0.8 2.2 0.9 0.9 0.8 4.7 2.3 0.9 0.5 1.4 1.1 2.6 0.7 1.8 3.3 2.0 1.3 1.9 3.7 2.5 1.4 2.0 1.1 1.6 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 2.9 4.1 6.8 4.3 2.5 2.1 3.2 3.6 3.5 2.6 SSMEM1 "C7orf45, FLJ40316" ENSG00000165120 "Serine rich single-pass membrane protein 1" Q8WWF3 7 130207860-130216843 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "testis: 31.7" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 1.7;U-87 MG: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (3.08e-1)" "unprognostic (1.79e-1)" "unprognostic (5.24e-1)" "unprognostic (2.24e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.3 0.2 0.5 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.8 0.9 0.1 0.1 0.2 0.3 0.2 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SSTR4 ENSG00000132671 "Somatostatin receptor 4" P31391 20 23035386-23036812 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 3.8" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA064252 Uncertain "HPA064252: " 0.0 0.0 1.7 0.0 1.1 0.0 0.0 3.0 3.8 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 1.3 0.4 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSU72P4 ENSG00000283873 "SSU72 pseudogene 4" 11 4287499-4288083 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 24 "intestine: 2.4" "Cell line enriched" "Detected in single" 16 "U-2 OS: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSU72P8 ENSG00000230268 "SSU72 pseudogene 8" 7 124476371-124476955 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 39 "testis: 5.6" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1.8;HeLa: 1.2;U-2 OS: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSUH2 "C3orf32, fls485, ssu-2" ENSG00000125046 "Ssu-2 homolog (C. elegans)" Q9Y2M2 3 8619400-8745040 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 45.1" "Cell line enriched" "Detected in some" 20 "Hep G2: 23.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049777 Approved "HPA049777: " "unprognostic (2.49e-1)" "unprognostic (7.62e-2)" "unprognostic (9.65e-2)" "unprognostic (1.68e-1)" "unprognostic (2.46e-1)" "unprognostic (8.86e-2)" "unprognostic (1.46e-3)" "unprognostic (9.79e-2)" "unprognostic (1.53e-1)" "unprognostic (4.09e-1)" "unprognostic (7.97e-3)" "unprognostic (1.52e-1)" "unprognostic (3.15e-3)" "unprognostic (1.31e-1)" "unprognostic (3.65e-2)" "unprognostic (4.96e-2)" "unprognostic (7.50e-2)" 0.7 0.3 0.3 0.4 0.6 0.0 0.6 0.3 0.4 0.7 37.3 0.3 0.2 8.5 1.0 0.2 0.3 0.7 1.4 2.8 0.3 0.3 1.1 0.5 0.2 0.2 0.2 0.3 0.3 0.2 0.0 0.3 0.5 0.5 0.4 0.3 0.3 1.7 0.2 0.3 0.2 45.1 0.8 0.2 2.0 0.4 5.6 0.2 0.2 1.1 1.5 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 23.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.3 0.4 0.3 0.3 0.2 0.3 0.5 0.2 SSX1 CT5.1 ENSG00000126752 "SSX family member 1" Q16384 X 48255317-48267444 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 12.6" "Cell line enhanced" "Detected in some" "Daudi: 28.1;Karpas-707: 40.8;U-2197: 9.5" "Cancer enhanced" "Detected in many" "liver cancer: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045683 Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " "unprognostic (2.25e-1)" "unprognostic (3.51e-3)" "unprognostic (2.36e-1)" "unprognostic (4.32e-3)" "unprognostic (3.38e-1)" "unprognostic (5.41e-2)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.9 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 40.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 9.5 0.0 0.0 2.0 0.0 2.3 0.0 0.0 0.9 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX2 "CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX" ENSG00000241476 "SSX family member 2" Q16385 X 52696896-52707189 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 24.1" "Cell line enhanced" "Detected in some" "PC-3: 3.1;U-2197: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045683, CAB046020" Enhanced Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB046020: AB_2194010, HPA045683: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.6 0.1 0.6 1.9 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SSX2B CT5.2b ENSG00000268447 "SSX family member 2B" Q16385 X 52751132-52790305 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "testis: 13.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;HMC-1: 5.3;PC-3: 5.1;T-47d: 2.2;U-2197: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045683 Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.9 0.0 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.5 0.1 0.0 0.0 0.2 5.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 2.2 0.0 1.0 0.0 0.5 3.2 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 SSX3 CT5.3 ENSG00000165584 "SSX family member 3" Q99909 X 48346428-48356707 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 18.0" "Cell line enriched" "Detected in some" 4 "Karpas-707: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" HPA045683 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " "unprognostic (1.86e-1)" "unprognostic (2.13e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 1.6 0.2 0.4 0.4 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 1.6 0.5 0.2 0.2 0.0 0.0 1.6 0.2 0.8 0.3 0.1 0.2 0.8 0.3 0.4 0.0 0.9 0.4 0.4 0.2 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX4 CT5.4 ENSG00000268009 "SSX family member 4" O60224 X 48383516-48393347 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 6.8" "Group enriched" "Detected in some" 10 "BEWO: 3.5;Karpas-707: 8.6;U-266/70: 5.1;U-266/84: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045683 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 8.6 0.0 0.0 0.0 0.0 0.3 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 5.1 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 SSX4B OTTHUMT00000056510 ENSG00000269791 "SSX family member 4B" O60224 X 48402078-48411910 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 6.7" "Group enriched" "Detected in some" 10 "BEWO: 3.5;Karpas-707: 8.6;U-266/70: 5.1;U-266/84: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045683 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 8.6 0.0 0.0 0.0 0.0 0.3 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 5.1 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 ST18 "KIAA0535, NZF3, ZC2H2C3, ZC2HC10, ZNF387" ENSG00000147488 "ST18, C2H2C-type zinc finger" O60284 8 52110839-52460959 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 47.8" "Cell line enhanced" "Detected in some" "HAP1: 4.0;SCLC-21H: 14.3;U-87 MG: 2.3" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "myeloid DC: 1.7" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.7" "Region enhanced" "Detected in many" "cerebellum: 45.1" "Low region specificity" "Detected in all" HPA044919 Uncertain "HPA044919: AB_10959756" "unprognostic (3.66e-1)" "unprognostic (4.34e-2)" "unprognostic (7.47e-2)" "unprognostic (2.04e-2)" "unprognostic (2.78e-1)" "unprognostic (2.42e-2)" "unprognostic (1.22e-1)" "unprognostic (7.11e-2)" "unprognostic (2.12e-1)" "unprognostic (1.58e-1)" "unprognostic (1.55e-3)" "unprognostic (2.82e-1)" "unprognostic (2.53e-5)" "unprognostic (3.29e-1)" "unprognostic (1.35e-1)" "unprognostic (9.34e-2)" "unprognostic (9.84e-3)" 1.0 3.4 7.6 1.2 40.5 1.0 0.9 27.8 20.8 1.1 1.4 31.1 0.0 2.3 0.9 0.9 1.0 0.9 1.4 0.9 11.0 5.8 1.9 1.0 1.2 1.0 47.8 8.8 0.9 6.1 0.9 3.1 1.2 23.8 1.3 1.8 0.0 0.9 0.9 0.9 0.9 2.2 0.9 38.0 1.0 5.2 1.7 41.6 0.0 1.0 0.0 1.2 1.1 0.2 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 40.5 27.8 19.7 11.0 5.8 47.8 8.8 23.8 41.6 ST8SIA3 SIAT8C ENSG00000177511 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3" O43173 18 57350813-57371731 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 24.0" "Group enriched" "Detected in some" 42 "NTERA-2: 5.9;SCLC-21H: 10.1;SH-SY5Y: 11.4" "Group enriched" "Detected in some" 11 "glioma: 0.9;pancreatic cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063398, HPA066783" Enhanced Supported "Golgi apparatus" "Golgi apparatus" "HPA063398: , HPA066783: " "unprognostic (1.75e-1)" "unprognostic (7.85e-2)" "unprognostic (1.41e-2)" "unprognostic (5.50e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.82e-1)" 0.1 4.5 3.4 0.1 12.0 0.0 0.0 7.9 24.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 1.1 0.0 3.8 4.8 0.1 0.2 0.1 0.0 1.2 0.0 4.2 0.0 3.5 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 10.1 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STAB2 "DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2" ENSG00000136011 "Stabilin 2" Q8WWQ8 12 103587273-103766727 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 71.3" "Cell line enhanced" "Detected in some" "BEWO: 15.7;HaCaT: 4.3;RH-30: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA026871 Enhanced Supported Cytosol 210000 Cytosol "HPA026871: AB_1857536" "unprognostic (5.66e-3)" "unprognostic (7.51e-2)" "unprognostic (3.31e-1)" "unprognostic (3.84e-2)" "unprognostic (8.47e-2)" "unprognostic (2.15e-2)" "unprognostic (1.23e-1)" "unprognostic (2.81e-1)" "unprognostic (5.72e-2)" "unprognostic (1.92e-1)" "unprognostic (4.24e-2)" "unprognostic (1.05e-1)" "unprognostic (9.72e-4)" "unprognostic (1.37e-2)" "unprognostic (5.00e-1)" "unprognostic (1.26e-1)" "unprognostic (2.06e-1)" 0.6 0.2 0.1 0.5 0.1 0.4 0.5 0.1 0.1 0.7 1.4 0.1 0.1 0.1 1.1 1.1 2.5 0.9 0.6 0.4 0.1 0.1 0.1 11.7 0.5 19.9 0.1 0.1 0.4 0.2 0.0 0.2 0.4 0.2 0.5 0.2 0.1 2.1 0.3 0.1 0.2 0.3 0.2 0.1 71.3 0.3 1.5 0.1 0.2 0.7 0.5 0.4 0.3 0.4 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.7 0.2 0.0 0.0 15.7 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 4.3 0.0 0.0 0.0 0.0 1.1 0.4 0.7 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.7 0.5 0.1 2.5 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.1 0.3 0.1 0.6 0.8 0.4 0.0 1.1 0.2 0.2 0.0 0.3 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 STAG3 ENSG00000066923 "Stromal antigen 3" Q9UJ98 7 100177563-100221488 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Chromosome partition, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 85.4" "Group enriched" "Detected in some" 6 "BEWO: 26.4;HMC-1: 33.4;U-698: 9.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 8 "memory B-cell: 4.8;naive B-cell: 7.6" "Lineage enriched" "Detected in single" 10 "B-cells: 7.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA049106, HPA058330" Enhanced "HPA049106: AB_2680634, HPA058330: AB_2683681" "unprognostic (6.56e-4)" "prognostic favourable (8.45e-4)" "unprognostic (1.25e-2)" "unprognostic (7.54e-2)" "unprognostic (1.73e-1)" "unprognostic (1.86e-3)" "unprognostic (3.59e-2)" "unprognostic (4.62e-2)" "unprognostic (1.12e-1)" "unprognostic (3.46e-1)" "unprognostic (3.31e-4)" "unprognostic (4.26e-4)" "unprognostic (7.48e-2)" "unprognostic (6.80e-2)" "unprognostic (2.72e-1)" "unprognostic (3.13e-2)" "unprognostic (5.07e-4)" 0.4 0.7 0.4 0.9 1.0 0.3 0.2 0.6 3.8 0.3 0.3 1.1 0.5 0.1 0.5 0.4 0.3 7.8 0.4 0.5 0.6 0.2 0.2 3.9 0.3 1.2 0.5 0.6 0.4 1.4 0.0 0.2 0.4 0.5 0.3 0.2 0.5 0.2 0.5 4.1 0.5 2.2 0.4 0.7 5.1 0.1 85.4 0.8 0.7 0.3 0.2 1.6 0.3 0.2 7.6 0.5 0.2 0.7 0.2 0.5 0.3 0.0 1.9 0.8 0.1 0.1 0.0 26.4 1.3 0.0 0.1 0.1 0.0 0.0 0.9 0.2 0.3 0.0 0.0 0.1 0.0 3.7 0.4 0.0 0.0 0.6 0.0 0.0 33.4 0.0 0.0 0.6 0.1 0.1 0.4 0.0 0.0 0.5 1.6 0.1 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.5 1.5 0.6 0.4 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 9.6 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.7 0.1 4.8 0.2 0.5 0.5 7.6 0.4 0.3 0.2 0.2 0.3 0.1 0.0 0.3 0.4 1.0 0.6 0.7 0.6 0.2 0.5 0.6 0.5 0.8 STARD6 ENSG00000174448 "StAR related lipid transfer domain containing 6" P59095 18 54324358-54357964 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 25.3" "Cell line enhanced" "Detected in some" "HDLM-2: 4.3;Karpas-707: 5.8;U-266/70: 7.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "NK-cells: 2.2;T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "unprognostic (7.81e-2)" "unprognostic (1.50e-1)" "unprognostic (5.56e-3)" "unprognostic (1.70e-1)" "unprognostic (3.25e-1)" "unprognostic (8.14e-2)" "unprognostic (1.31e-1)" "unprognostic (8.98e-3)" "unprognostic (6.98e-5)" "unprognostic (1.90e-1)" "unprognostic (2.33e-3)" "unprognostic (2.68e-1)" "unprognostic (9.97e-2)" "unprognostic (1.91e-3)" "unprognostic (1.16e-3)" 0.1 0.3 0.3 0.0 0.8 0.1 0.1 0.3 0.6 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.4 1.2 0.1 0.0 0.0 0.1 0.1 1.2 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.7 0.1 0.0 25.3 0.0 0.7 0.3 0.0 0.1 0.1 0.0 0.3 0.2 0.2 0.3 2.2 1.9 0.2 0.1 0.0 1.7 0.2 0.4 0.0 0.1 0.4 0.4 0.8 0.2 0.4 0.7 0.6 0.3 0.0 0.2 0.0 1.6 0.4 4.3 0.8 0.2 0.0 0.3 0.6 1.5 0.8 1.1 0.2 0.5 0.3 0.7 0.3 5.8 0.8 0.3 0.4 0.3 0.0 0.4 0.4 0.1 0.0 1.6 0.6 1.6 1.5 0.9 0.0 0.3 0.1 0.5 1.6 0.6 1.2 0.6 0.5 7.1 3.3 0.8 2.0 0.5 1.7 0.2 0.2 0.1 1.1 0.1 0.9 0.3 0.3 1.9 0.2 0.3 0.2 1.1 0.2 2.2 0.3 0.2 1.0 0.2 0.3 0.8 0.3 0.6 0.4 0.3 0.4 1.2 1.2 0.0 STATH STR ENSG00000126549 Statherin P02808 4 69995930-70002570 "Plasma proteins, Predicted secreted proteins, Transporters" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 162 "salivary gland: 5940.6" "Cell line enhanced" "Detected in single" "HHSteC: 1.5" "Group enriched" "Detected in some" 14 "head and neck cancer: 3.5;lung cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044569 Enhanced "Secreted to digestive system" "HPA044569: AB_10966146" "unprognostic (2.00e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.3 1.5 0.0 0.1 0.1 0.0 0.5 0.0 0.0 5940.6 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 36.5 5.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.0 0.0 STEAP2 "IPCA-1, PCANAP1, STAMP1, STMP" ENSG00000157214 "STEAP2 metalloreductase" Q8NFT2 7 90167590-90238137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "prostate: 100.2" "Cell line enhanced" "Detected in many" "A549: 13.2;CAPAN-2: 28.4;U-138 MG: 16.5" "Cancer enriched" "Detected in many" 12 "prostate cancer: 88.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029115, HPA055603" Uncertain Supported Vesicles Vesicles "HPA029115: AB_10603894, HPA055603: " "unprognostic (6.26e-3)" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-4)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (3.67e-3)" "unprognostic (7.91e-2)" "unprognostic (1.70e-1)" "unprognostic (9.92e-2)" "unprognostic (1.34e-1)" "unprognostic (2.71e-2)" "unprognostic (9.73e-2)" "unprognostic (6.11e-2)" "unprognostic (9.86e-5)" "unprognostic (3.69e-2)" 10.7 4.1 6.2 9.7 14.5 1.3 13.6 8.7 18.2 7.0 8.3 2.3 2.2 5.7 5.4 3.6 9.1 7.5 8.8 9.4 5.1 5.2 6.5 3.6 10.8 1.6 3.2 11.1 19.5 6.4 10.3 17.6 1.4 6.0 100.2 7.0 3.8 6.8 6.7 2.3 3.5 5.9 9.0 2.9 3.0 9.2 2.3 1.6 1.6 5.8 1.2 2.5 10.4 19.9 1.1 0.4 1.3 0.4 0.3 0.2 0.0 1.8 13.2 0.3 3.7 7.1 6.9 0.2 1.6 3.4 0.2 0.5 2.4 28.4 0.0 0.2 4.4 1.1 2.9 2.0 0.5 0.0 2.8 0.0 0.0 0.6 0.6 0.0 0.0 5.0 0.4 6.9 1.4 3.6 0.0 0.2 3.9 0.0 0.0 0.4 5.4 1.4 0.0 0.0 0.1 6.2 3.9 0.3 1.3 2.0 0.0 0.0 10.0 0.0 3.0 16.5 3.7 2.3 1.4 0.0 0.0 0.0 7.1 0.0 0.6 1.3 0.4 0.5 0.2 0.2 0.1 1.1 0.1 0.1 0.0 0.4 0.2 0.2 1.2 0.3 0.2 0.4 0.0 0.0 6.2 14.5 8.7 18.2 5.1 5.2 3.2 11.1 6.0 1.6 STK25 "SOK1, YSK1" ENSG00000115694 "Serine/threonine kinase 25" O00506 2 241492674-241509730 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 164.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047147 Uncertain "HPA047147: AB_10966137" "unprognostic (1.75e-1)" "unprognostic (8.29e-2)" "prognostic unfavourable (6.03e-4)" "unprognostic (3.42e-2)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (3.91e-8)" "unprognostic (6.16e-2)" "unprognostic (7.15e-3)" "unprognostic (1.11e-1)" "unprognostic (2.58e-3)" "unprognostic (1.55e-1)" "unprognostic (2.47e-2)" "unprognostic (2.00e-1)" "unprognostic (1.37e-1)" "unprognostic (3.19e-1)" "unprognostic (4.58e-1)" 17.8 13.6 22.3 14.2 26.0 16.3 12.9 22.3 35.3 16.4 17.1 17.0 13.0 14.6 17.7 15.9 19.3 15.4 16.7 19.0 19.4 20.0 17.3 13.5 13.4 13.5 16.3 20.4 17.5 19.2 18.9 17.1 15.6 16.4 15.1 12.9 13.5 14.2 17.6 164.2 15.3 14.2 17.3 12.6 15.8 16.1 16.8 14.4 15.2 20.0 24.6 12.6 14.6 16.6 15.0 13.6 13.7 16.4 21.5 19.9 10.6 18.3 11.7 23.4 29.0 28.8 20.1 36.0 30.7 20.7 23.4 26.8 13.0 16.2 7.0 8.7 40.9 15.7 32.9 33.4 28.5 26.2 34.5 19.6 24.8 33.6 26.1 11.9 15.1 28.9 24.0 22.6 18.2 52.8 30.2 6.2 42.8 19.3 17.6 18.5 32.6 16.8 29.7 29.8 10.4 20.6 15.6 39.3 18.0 14.9 11.3 19.2 9.0 21.1 61.5 17.7 21.7 20.3 21.7 12.9 2.9 11.9 17.1 9.8 20.0 13.7 14.8 11.5 16.9 13.4 15.5 14.5 15.5 17.5 13.6 15.0 12.0 11.6 5.5 21.5 16.4 10.7 19.9 10.6 22.3 26.0 22.3 35.3 19.4 20.0 16.3 20.4 16.4 14.4 STK31 "SgK396, TDRD8" ENSG00000196335 "Serine/threonine kinase 31" Q9BXU1 7 23710167-23832513 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 56.0" "Cell line enriched" "Detected in some" 8 "CACO-2: 19.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023194 Enhanced "HPA023194: AB_1857590" "unprognostic (4.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.98e-2)" "unprognostic (5.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.50e-2)" "unprognostic (1.09e-2)" "unprognostic (1.26e-1)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (2.42e-3)" "unprognostic (2.92e-1)" "unprognostic (1.29e-6)" "unprognostic (7.83e-2)" "unprognostic (9.21e-3)" "unprognostic (1.46e-1)" "unprognostic (3.65e-1)" 0.1 0.0 0.1 0.1 0.7 0.0 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 56.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 19.7 2.4 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.8 0.1 0.2 0.0 0.1 0.1 0.1 0.1 STKLD1 "C9orf96, MGC43306, SGK071" ENSG00000198870 "Serine/threonine kinase like domain containing 1" Q8NE28 9 133376367-133406096 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 16.2" "Low cell line specificity" "Detected in some" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA029902 Uncertain "HPA029902: AB_10603554" "unprognostic (6.65e-2)" "unprognostic (9.43e-3)" "unprognostic (7.54e-4)" "unprognostic (8.15e-2)" "unprognostic (9.51e-2)" "unprognostic (1.39e-2)" "unprognostic (1.99e-2)" "unprognostic (1.41e-3)" "unprognostic (6.05e-2)" "unprognostic (2.94e-4)" "unprognostic (1.92e-4)" "unprognostic (1.19e-1)" "unprognostic (7.93e-2)" "unprognostic (4.69e-2)" "unprognostic (3.65e-1)" "unprognostic (5.86e-2)" "unprognostic (4.52e-2)" 0.4 0.4 0.4 0.2 1.4 0.5 0.4 0.7 2.2 0.4 0.3 2.2 1.3 0.5 0.9 2.1 0.3 0.6 0.5 0.3 0.8 0.3 0.3 0.4 0.3 0.8 0.5 1.3 0.8 0.4 0.1 0.3 0.5 1.5 0.5 0.1 0.8 0.6 0.4 0.6 0.8 0.5 0.3 0.5 0.4 0.4 16.2 0.7 0.0 0.3 0.0 0.3 0.3 0.3 0.6 0.4 0.0 0.2 0.2 0.6 0.0 0.0 0.6 0.4 0.6 0.5 0.5 1.1 0.2 0.0 0.1 0.2 0.9 0.3 0.3 0.2 0.0 0.6 0.1 0.0 0.0 0.4 0.8 0.7 0.9 0.5 0.3 0.5 0.4 0.4 0.1 0.0 0.1 0.0 0.8 1.0 0.0 0.2 0.6 0.8 0.3 1.0 0.3 0.3 0.8 0.1 0.1 1.0 1.0 0.3 0.9 2.1 1.3 0.2 0.6 1.0 0.6 0.9 0.1 2.2 2.1 0.6 0.4 0.4 0.3 0.0 0.2 0.0 0.3 0.0 0.2 0.2 0.4 0.2 0.1 0.6 0.6 0.2 0.0 0.2 0.1 0.4 0.0 0.0 0.4 1.4 0.7 2.2 0.8 0.3 0.5 1.3 1.5 0.7 STMN2 "SCG10, SCGN10" ENSG00000104435 "Stathmin 2" Q93045 8 79610814-79666175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 153.3" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 120.5" "Group enriched" "Detected in many" 5 "glioma: 26.1;pancreatic cancer: 10.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 5.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026922 Approved "Endoplasmic reticulum,Vesicles" Vesicles "Endoplasmic reticulum" "HPA026922: AB_1857605" "unprognostic (4.41e-1)" "unprognostic (3.35e-2)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (8.20e-2)" "unprognostic (9.48e-2)" "unprognostic (1.82e-1)" "unprognostic (6.08e-2)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-13)" "unprognostic (1.14e-1)" "unprognostic (3.86e-1)" "unprognostic (5.77e-3)" "unprognostic (9.59e-2)" 1.7 35.4 35.2 5.6 35.0 1.4 2.5 99.8 153.3 5.3 10.7 4.2 0.0 7.7 1.9 1.3 1.8 1.4 3.0 1.3 40.3 71.9 1.4 1.8 1.5 1.6 44.7 60.4 1.4 3.2 1.4 1.5 1.4 102.4 2.5 14.2 2.6 1.7 2.1 1.3 6.4 9.8 4.3 19.0 3.1 2.4 2.2 6.6 0.0 1.3 0.0 1.9 1.5 0.9 0.0 5.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.4 120.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 5.6 0.0 0.0 35.2 35.0 99.8 68.3 40.3 71.9 44.7 60.4 102.4 6.6 STMN3 SCLIP ENSG00000197457 "Stathmin 3" Q9NZ72 20 63639705-63657682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 90.9" "Cell line enhanced" "Detected in many" "AN3-CA: 31.7;MOLT-4: 34.3;REH: 35.3;SCLC-21H: 49.5;SH-SY5Y: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 3.3;MAIT T-cell: 3.5;memory CD4 T-cell: 6.8;memory CD8 T-cell: 5.8;naive CD4 T-cell: 8.3;naive CD8 T-cell: 6.8" "Lineage enriched" "Detected in many" 6 "T-cells: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012947 Enhanced "HPA012947: AB_1857606" "unprognostic (7.59e-2)" "unprognostic (4.36e-1)" "unprognostic (5.28e-2)" "unprognostic (2.33e-1)" "unprognostic (3.60e-2)" "unprognostic (6.30e-2)" "unprognostic (2.75e-1)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "unprognostic (4.35e-2)" "unprognostic (1.65e-3)" "unprognostic (7.52e-2)" "unprognostic (2.52e-3)" "unprognostic (2.73e-2)" "unprognostic (9.87e-2)" "unprognostic (4.08e-2)" "unprognostic (9.08e-3)" 9.0 21.0 53.5 13.1 52.7 6.9 7.7 48.8 90.9 10.9 5.3 6.7 1.2 4.2 10.9 4.2 5.9 10.3 7.6 5.0 48.9 47.7 4.6 1.6 6.2 15.2 34.2 63.6 19.8 7.6 6.2 18.6 7.0 45.8 8.2 4.2 6.2 7.5 9.5 3.3 11.6 6.5 10.1 29.5 20.3 6.5 4.1 12.3 11.0 20.9 1.9 8.4 6.6 3.5 1.0 1.3 1.2 0.1 0.0 8.3 2.5 2.5 2.9 19.0 31.7 0.5 1.9 1.3 3.0 0.1 9.2 4.3 18.2 3.4 0.1 9.3 1.1 17.2 13.2 0.3 2.8 1.2 3.5 1.2 4.0 6.7 2.6 0.9 10.8 4.0 0.0 2.9 0.7 0.3 23.8 0.5 2.4 2.8 34.3 4.3 19.5 20.7 35.3 3.1 14.1 15.5 0.5 49.5 37.7 1.4 0.8 3.6 0.5 6.4 0.4 0.2 5.3 0.2 0.6 1.2 2.5 0.8 0.5 3.5 12.3 1.0 0.1 1.2 3.3 0.1 3.5 0.3 6.8 5.8 0.1 1.0 8.3 6.8 0.2 0.0 0.1 1.3 1.1 2.5 53.5 52.7 48.8 74.0 48.9 47.7 34.2 63.6 45.8 12.3 STMN4 RB3 ENSG00000015592 "Stathmin 4" Q9H169 8 27235323-27258420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 132.2" "Cell line enriched" "Detected in some" 26 "SCLC-21H: 44.0" "Cancer enriched" "Detected in some" 27 "glioma: 14.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027765 Uncertain "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA027765: AB_1857607" "unprognostic (1.52e-1)" "unprognostic (3.45e-2)" "unprognostic (2.37e-2)" "unprognostic (3.19e-6)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (8.27e-2)" "unprognostic (1.37e-1)" "unprognostic (3.57e-3)" "unprognostic (2.36e-1)" "unprognostic (2.31e-3)" "unprognostic (9.84e-2)" "unprognostic (1.68e-3)" "unprognostic (1.37e-2)" "unprognostic (5.96e-2)" "unprognostic (4.15e-1)" "unprognostic (7.63e-2)" 1.5 7.9 30.8 1.5 23.4 1.5 1.5 22.2 132.2 1.5 2.3 37.3 0.0 1.8 1.5 2.0 1.5 1.5 1.6 1.4 36.3 27.9 1.5 1.4 1.5 1.5 34.9 37.2 1.4 1.4 1.5 0.0 1.4 21.4 1.5 2.3 0.0 1.5 1.5 1.4 1.5 2.2 1.8 71.8 1.4 1.5 1.6 6.6 0.0 1.4 0.0 1.4 1.5 0.0 1.0 0.9 0.3 0.2 0.1 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.7 0.0 0.1 0.3 0.2 0.4 0.1 1.0 0.7 0.2 0.3 0.1 0.2 0.9 0.4 0.0 30.8 23.4 22.2 34.4 36.3 27.9 34.9 37.2 21.4 6.6 STPG3 "C9orf173, FLJ40246" ENSG00000197768 "Sperm-tail PG-rich repeat containing 3" Q8N7X2 9 137251261-137253483 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 55.3" "Cell line enhanced" "Detected in some" "HDLM-2: 7.1;RPMI-8226: 3.0;SK-BR-3: 2.9;T-47d: 4.5;U-266/70: 2.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044352 Uncertain Vesicles Vesicles "HPA044352: AB_10965328" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (4.32e-3)" "unprognostic (4.72e-4)" "unprognostic (2.56e-1)" "unprognostic (1.22e-2)" "unprognostic (1.08e-2)" "unprognostic (2.77e-3)" "unprognostic (1.29e-1)" "unprognostic (3.93e-2)" "unprognostic (8.59e-4)" "unprognostic (2.09e-1)" "unprognostic (7.25e-2)" "unprognostic (2.65e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (7.95e-2)" 0.8 0.4 0.2 0.2 0.2 0.1 0.4 0.2 0.2 0.3 0.2 0.2 0.2 4.4 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.0 1.1 1.7 0.2 0.2 0.2 0.2 0.2 1.4 0.0 1.1 0.2 0.2 0.2 0.0 0.2 1.5 0.2 0.2 0.5 3.2 0.2 0.2 0.2 0.5 55.3 0.2 0.2 1.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.9 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.6 2.0 1.2 0.3 0.0 1.0 0.0 0.0 0.0 7.1 0.0 0.1 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 1.3 1.1 0.0 1.7 0.0 0.2 0.0 0.4 0.0 0.0 3.0 0.0 0.0 0.9 0.6 0.4 2.9 0.0 4.5 0.0 0.0 0.8 1.4 0.2 0.0 2.8 1.5 1.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 STPG4 "C2orf61, FLJ40172" ENSG00000239605 "Sperm-tail PG-rich repeat containing 4" Q8N801 2 47045538-47155378 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 29.4" "Cell line enhanced" "Detected in some" "Karpas-707: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.0;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047366, HPA052691" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA047366: , HPA052691: " "unprognostic (6.74e-3)" "unprognostic (5.81e-4)" "unprognostic (3.43e-2)" "unprognostic (1.23e-3)" "unprognostic (1.72e-1)" "unprognostic (1.55e-3)" "unprognostic (4.36e-2)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (2.78e-2)" "unprognostic (2.36e-3)" "unprognostic (6.23e-2)" "unprognostic (3.64e-6)" "unprognostic (5.14e-2)" "unprognostic (6.00e-2)" "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 29.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.5 2.0 0.6 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.6 0.1 0.0 0.2 0.4 0.0 0.2 0.7 0.5 0.4 0.4 0.4 0.0 0.2 0.0 0.6 0.5 0.5 0.6 0.0 0.1 0.0 0.0 0.6 0.0 1.1 0.9 0.1 0.3 0.1 6.5 0.8 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.4 1.7 0.4 0.0 0.0 0.3 0.1 0.0 0.2 0.6 0.3 0.9 0.1 0.2 0.8 0.2 0.0 0.0 0.6 0.2 0.0 0.1 0.9 0.0 0.6 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.0 2.0 0.0 0.1 1.5 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.0 STRC DFNB16 ENSG00000242866 Stereocilin Q7RTU9 15 43599563-43618800 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 22.9" "Cell line enhanced" "Detected in some" "HEK 293: 1.5;hTCEpi: 2.2;SCLC-21H: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA048083 Enhanced "HPA048083: " "unprognostic (8.60e-3)" "unprognostic (5.77e-3)" "unprognostic (6.14e-2)" "unprognostic (1.60e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-3)" "unprognostic (1.65e-1)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.84e-2)" "unprognostic (5.92e-3)" "unprognostic (1.99e-4)" "unprognostic (1.58e-1)" "unprognostic (6.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.59e-4)" 0.2 0.5 1.7 0.2 4.2 0.1 0.8 22.9 5.1 0.0 0.2 0.4 0.1 4.7 0.1 0.3 0.2 0.0 2.3 3.2 0.0 0.1 0.1 0.0 1.6 0.4 0.5 0.1 1.7 0.0 0.7 0.2 1.5 0.1 0.4 2.7 0.4 0.0 1.1 0.2 0.2 3.3 0.6 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.0 0.1 1.0 1.5 0.0 0.7 0.0 0.0 0.5 0.6 0.5 2.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.2 0.0 0.3 0.5 0.0 0.0 0.1 0.1 1.9 0.1 0.0 0.4 0.9 0.4 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STS "ARSC, ARSC1" ENSG00000101846 "Steroid sulfatase" P08842 X 7219456-7354810 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Pregnancy, Steroid metabolism" Hydrolase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "placenta: 258.8" "Cell line enhanced" "Detected in many" "ASC diff: 19.9;RPMI-8226: 25.4;U-266/70: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.7" "Low lineage specificity" "Detected in many" HPA002904 Enhanced "HPA002904: AB_1080116" "unprognostic (1.09e-1)" "unprognostic (3.90e-2)" "unprognostic (1.44e-2)" "unprognostic (2.75e-1)" "unprognostic (6.72e-2)" "unprognostic (1.94e-2)" "unprognostic (2.62e-1)" "unprognostic (1.84e-1)" "unprognostic (8.23e-2)" "unprognostic (4.67e-2)" "prognostic unfavourable (3.47e-4)" "unprognostic (4.05e-2)" "unprognostic (2.78e-2)" "unprognostic (2.77e-1)" "unprognostic (2.56e-1)" "unprognostic (1.92e-2)" "unprognostic (1.34e-1)" 10.3 2.2 3.0 2.2 3.9 0.0 4.1 2.3 9.0 3.4 3.5 2.3 2.2 0.8 2.4 2.2 2.2 2.6 4.1 3.6 3.9 4.0 2.5 4.7 5.0 2.2 3.8 2.4 2.4 2.2 1.6 2.2 258.8 2.4 2.9 3.0 2.3 2.2 3.3 4.0 2.3 2.4 3.8 2.4 2.2 6.7 2.2 2.3 2.2 2.4 2.2 2.2 4.9 2.7 0.9 1.9 1.9 4.7 1.0 0.7 1.0 4.0 1.2 2.7 0.9 19.9 10.3 14.7 8.3 3.0 2.2 2.1 7.2 3.8 7.6 1.6 6.0 1.0 1.6 1.3 2.2 0.6 3.2 0.4 4.6 2.0 1.1 1.1 4.3 3.4 0.2 1.4 0.8 3.4 0.4 7.9 5.9 0.9 0.6 1.0 1.0 1.8 1.0 1.6 25.4 5.6 5.9 2.0 1.7 1.6 3.0 0.9 1.2 0.4 5.9 8.9 0.5 11.4 1.3 42.2 0.0 17.7 2.1 0.9 2.3 0.0 3.2 0.6 0.5 4.7 0.2 0.6 0.2 0.3 1.9 0.9 0.1 0.5 1.9 1.0 2.5 0.3 0.7 1.0 3.0 3.9 2.3 9.0 3.9 4.0 3.8 2.4 2.4 2.3 STX1B "STX1B1, STX1B2" ENSG00000099365 "Syntaxin 1B" P61266 16 30989256-31010661 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 64.9" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 9.7;hTEC/SVTERT24-B: 11.8" "Cancer enriched" "Detected in some" 7 "glioma: 5.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069176, CAB079008" Supported Approved "CAB079008: , HPA069176: " "unprognostic (1.43e-3)" "unprognostic (5.27e-2)" "unprognostic (2.40e-4)" "unprognostic (3.90e-3)" "unprognostic (3.98e-2)" "unprognostic (1.90e-2)" "unprognostic (2.21e-3)" "unprognostic (2.53e-2)" "unprognostic (1.72e-1)" "unprognostic (3.72e-3)" "unprognostic (1.73e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (7.93e-2)" "unprognostic (1.57e-2)" 1.6 1.9 12.7 1.9 31.8 1.3 1.8 45.8 64.9 1.2 1.4 2.9 0.0 1.4 2.7 4.2 1.9 1.4 1.3 2.1 10.5 10.0 1.4 2.5 1.2 2.4 6.8 26.2 1.3 1.3 1.3 2.2 1.2 39.3 1.8 1.4 1.0 1.9 2.8 1.3 4.0 1.8 2.5 3.8 2.2 1.3 3.2 4.5 0.0 1.3 0.0 2.3 1.3 0.7 0.6 0.3 1.3 0.4 0.5 1.7 0.1 0.1 3.2 5.0 0.8 0.5 0.2 0.2 4.4 6.7 5.5 9.7 0.0 3.6 0.8 0.2 5.8 0.8 2.2 0.6 6.6 2.6 0.4 0.4 2.6 2.5 0.4 0.2 3.1 1.8 0.2 11.8 1.1 0.0 0.5 0.2 5.8 1.3 2.0 0.2 2.5 0.3 7.2 0.2 0.2 0.5 0.0 6.8 4.3 0.5 0.2 0.0 0.8 0.1 0.9 3.2 2.6 0.4 0.2 0.3 0.2 0.3 3.5 0.3 0.1 0.9 0.4 0.7 0.3 0.2 0.1 0.5 1.7 0.3 0.1 0.6 0.3 0.4 1.3 0.5 0.1 0.3 0.2 0.1 12.7 31.8 45.8 60.5 10.5 10.0 6.8 26.2 39.3 4.5 STXBP1 "hUNC18, MUNC18-1, rbSec1, UNC18" ENSG00000136854 "Syntaxin binding protein 1" P61764 9 127579370-127696027 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 127.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 47.1;SK-MEL-30: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 3.4" "Lineage enriched" "Detected in single" 7 "T-cells: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008209, HPA023483, CAB034434" Enhanced Approved Nucleoplasm,Cytosol 6400 "Nucleoplasm, Cytosol" "CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625" "unprognostic (2.32e-2)" "unprognostic (7.33e-2)" "unprognostic (3.85e-2)" "prognostic unfavourable (4.78e-4)" "unprognostic (1.80e-1)" "prognostic unfavourable (1.47e-4)" "prognostic unfavourable (5.73e-4)" "unprognostic (2.87e-2)" "unprognostic (2.31e-1)" "unprognostic (3.08e-3)" "prognostic favourable (9.81e-4)" "unprognostic (1.30e-2)" "unprognostic (1.67e-1)" "unprognostic (2.68e-2)" "unprognostic (5.51e-2)" "unprognostic (7.66e-2)" "unprognostic (3.36e-3)" 14.1 16.0 32.4 4.7 42.2 1.5 5.1 86.8 127.4 8.1 4.6 6.5 1.9 3.7 13.2 4.7 6.3 17.9 6.7 12.7 35.0 31.5 7.1 2.7 16.8 3.7 24.6 55.5 14.3 13.2 8.1 22.3 7.9 61.9 6.5 5.3 12.6 8.1 6.6 5.0 5.6 4.6 11.7 13.3 5.9 5.2 5.4 5.3 0.0 10.7 0.9 4.3 5.7 7.6 0.0 0.5 0.0 0.4 0.0 3.4 0.6 4.0 8.5 8.2 9.2 18.6 16.0 7.4 14.3 7.3 8.6 7.6 0.4 4.8 4.0 8.0 9.3 1.4 7.2 8.8 10.6 9.2 4.8 5.4 23.1 1.5 9.4 0.5 4.7 12.1 4.9 22.6 11.0 10.2 5.4 6.2 14.5 7.5 3.8 1.7 7.0 11.8 2.3 3.9 9.7 7.1 0.2 47.1 22.9 24.1 11.9 40.8 1.8 1.7 15.2 9.8 5.0 19.2 5.3 13.4 22.1 5.4 19.2 5.8 9.0 0.0 0.4 0.0 0.8 0.1 0.3 0.0 2.2 3.4 0.5 0.0 1.4 1.7 0.0 0.0 0.1 0.3 0.3 0.6 32.4 42.2 86.8 87.7 35.0 31.5 24.6 55.5 61.9 5.3 SULT1B1 ST1B2 ENSG00000173597 "Sulfotransferase family 1B member 1" O43704 4 69721162-69787961 "Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 137.6" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 47.5;TIME: 15.4;U-2197: 13.7" "Group enriched" "Detected in some" 11 "colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 21.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 21.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002107 Enhanced Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA002107: " "unprognostic (9.58e-2)" "unprognostic (4.05e-2)" "unprognostic (1.66e-2)" "unprognostic (1.16e-1)" "unprognostic (2.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "unprognostic (4.77e-2)" "unprognostic (5.14e-2)" "unprognostic (8.78e-2)" "unprognostic (2.81e-2)" "unprognostic (3.27e-1)" "unprognostic (1.15e-3)" "unprognostic (1.89e-1)" "unprognostic (1.06e-2)" "unprognostic (6.93e-2)" "unprognostic (5.46e-2)" 1.2 0.6 0.9 9.3 1.8 1.3 1.1 0.5 1.5 1.1 38.6 0.5 0.7 31.8 0.8 0.6 1.0 1.5 1.2 1.2 0.9 0.9 1.1 24.8 2.4 12.9 1.2 0.7 0.7 0.5 0.0 0.4 0.6 2.0 0.6 20.3 1.3 0.6 0.2 0.4 0.4 137.6 1.4 3.6 13.3 13.9 0.5 0.7 2.0 0.6 0.3 2.0 0.7 1.2 0.2 1.8 21.9 3.2 1.8 3.6 1.6 0.3 0.2 0.3 0.4 0.8 0.9 0.6 0.4 0.2 0.1 0.1 0.3 0.3 0.5 0.3 0.4 0.5 0.0 0.1 0.3 0.6 0.4 0.5 0.4 0.2 1.2 0.6 0.7 5.5 0.0 0.1 0.2 47.5 0.2 1.1 0.4 0.3 0.3 0.5 0.4 0.2 0.2 1.6 0.3 0.1 0.8 0.7 0.4 0.2 0.2 0.2 0.7 0.3 15.4 0.4 0.8 13.7 0.3 0.8 0.4 0.2 0.2 1.4 0.6 5.8 3.2 0.8 0.7 1.9 0.2 0.1 1.1 0.3 1.8 0.2 3.6 1.7 21.9 1.8 2.2 0.2 0.5 1.6 0.9 1.8 0.5 1.5 0.9 0.9 1.2 0.7 2.0 0.7 SULT1C3 ENSG00000196228 "Sulfotransferase family 1C member 3" Q6IMI6 2 108247195-108265351 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "breast: 91.1" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;U-87 MG: 1.8" "Cancer enhanced" "Detected in some" "breast cancer: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.14e-3)" "unprognostic (1.78e-1)" "unprognostic (4.13e-1)" "unprognostic (6.64e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 91.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SULT2A1 "DHEA-ST, STD" ENSG00000105398 "Sulfotransferase family 2A member 1" Q06520 19 47870466-47886397 "Enzymes, Predicted intracellular proteins" "Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 211.7" "Group enriched" "Detected in some" 34 "Hep G2: 26.0;RT4: 17.7" "Cancer enriched" "Detected in some" 52 "liver cancer: 244.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB018755, HPA041487, HPA063633" Enhanced Supported Cytosol 210000 Cytosol "CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066" "unprognostic (2.14e-1)" "unprognostic (6.79e-3)" "unprognostic (6.82e-2)" "unprognostic (1.36e-1)" "unprognostic (1.31e-2)" 0.1 46.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 11.4 1.1 1.1 8.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 211.7 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.1 0.2 0.6 0.0 0.1 0.1 3.9 0.1 0.0 42.7 0.1 0.1 0.1 2.8 0.7 0.1 0.1 0.2 0.1 0.1 0.6 0.2 1.3 1.0 5.3 0.8 2.3 1.3 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 26.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.2 0.0 17.7 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 5.3 0.8 0.7 0.9 0.4 0.6 0.7 1.0 0.6 0.3 1.3 1.3 1.0 3.1 2.3 0.4 1.0 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 SULT4A1 "hBR-STL-1, SULTX3" ENSG00000130540 "Sulfotransferase family 4A member 1" Q9BR01 22 43824509-43862503 "Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "brain: 80.3" "Group enriched" "Detected in some" 4 "HEK 293: 2.5;THP-1: 3.8" "Cancer enhanced" "Detected in many" "testis cancer: 6.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003129 Enhanced "HPA003129: AB_1080130" "unprognostic (2.61e-3)" "unprognostic (1.05e-2)" "unprognostic (2.62e-1)" "unprognostic (6.30e-2)" "unprognostic (6.12e-3)" "unprognostic (1.32e-1)" "unprognostic (1.63e-1)" "unprognostic (8.74e-2)" "unprognostic (2.82e-1)" "unprognostic (2.48e-4)" "unprognostic (1.91e-2)" "unprognostic (6.10e-2)" "unprognostic (7.59e-4)" "unprognostic (7.89e-2)" "unprognostic (1.22e-1)" "unprognostic (8.20e-3)" "unprognostic (8.34e-3)" 1.2 4.0 12.1 1.5 17.2 1.2 1.2 27.8 80.3 1.2 1.7 1.1 0.0 1.3 1.2 1.2 1.2 1.2 1.3 1.2 15.7 19.3 1.2 1.2 1.2 1.2 13.1 18.9 1.2 1.4 1.2 0.8 1.2 18.0 1.2 1.4 0.6 1.3 1.2 1.2 1.2 1.6 1.5 3.1 1.3 1.3 1.9 1.3 0.0 1.2 0.0 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 17.2 27.8 44.4 15.7 19.3 13.1 18.9 18.0 1.3 SUN3 "MGC33329, SUNC1" ENSG00000164744 "Sad1 and UNC84 domain containing 3" Q8TAQ9 7 47987148-48029119 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 30.9" "Cell line enriched" "Detected in some" 7 "U-2 OS: 21.5" "Cancer enhanced" "Detected in single" "testis cancer: 2.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA008344, HPA076890" Enhanced Approved "Golgi apparatus" "Golgi apparatus" "HPA008344: AB_1857656, HPA076890: " "unprognostic (5.11e-2)" "unprognostic (4.96e-2)" "unprognostic (1.13e-1)" "unprognostic (1.61e-4)" "unprognostic (2.31e-2)" "unprognostic (5.62e-2)" "unprognostic (1.35e-2)" "unprognostic (2.24e-2)" "unprognostic (1.59e-5)" "unprognostic (4.88e-1)" "unprognostic (1.47e-1)" "unprognostic (2.65e-1)" "unprognostic (1.81e-2)" "unprognostic (1.64e-1)" "unprognostic (3.48e-1)" "unprognostic (2.58e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 1.5 0.1 0.7 1.2 0.3 0.2 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.3 21.5 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.4 1.2 0.1 0.1 0.7 0.4 0.4 0.0 0.8 0.5 0.2 1.5 0.7 0.1 0.2 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SUN5 "dJ726C3.1, SPAG4L, TSARG4" ENSG00000167098 "Sad1 and UNC84 domain containing 5" Q8TC36 20 32983773-33004433 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 361 "testis: 36.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048529 Enhanced "HPA048529: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SV2B "HsT19680, KIAA0735" ENSG00000185518 "Synaptic vesicle glycoprotein 2B" Q7L1I2 15 91099950-91301309 "Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 44.2" "Group enriched" "Detected in some" 4 "RPMI-8226: 4.6;SCLC-21H: 8.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046247 Approved "HPA046247: AB_10963538" "unprognostic (2.92e-1)" "unprognostic (7.92e-2)" "unprognostic (1.32e-3)" "unprognostic (4.01e-5)" "unprognostic (2.66e-3)" "unprognostic (7.77e-2)" "unprognostic (3.36e-2)" "unprognostic (1.01e-1)" "unprognostic (3.57e-2)" "unprognostic (9.89e-2)" "unprognostic (1.20e-2)" "unprognostic (2.49e-1)" "unprognostic (1.39e-1)" "unprognostic (3.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-2)" "unprognostic (3.10e-4)" 3.5 2.7 13.1 1.4 16.8 1.1 1.6 26.2 44.2 1.2 1.4 1.4 0.0 1.2 1.2 1.3 1.2 1.3 1.4 1.8 19.7 3.3 1.3 1.3 1.4 1.6 5.1 21.3 1.1 3.1 1.1 1.3 1.4 25.6 2.2 1.6 7.3 2.4 1.2 1.7 1.4 1.6 1.3 1.5 1.3 1.4 2.2 0.2 0.0 1.2 0.0 2.7 1.2 0.6 0.6 0.4 1.2 0.3 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 4.6 0.0 0.1 8.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.1 0.2 0.9 0.4 1.2 0.3 0.3 0.2 0.1 0.1 0.6 0.3 0.3 0.0 0.6 0.4 0.3 1.1 0.7 0.1 0.4 0.1 0.0 13.1 16.8 26.2 31.3 19.7 3.3 5.1 21.3 25.6 0.2 SV2C ENSG00000122012 "Synaptic vesicle glycoprotein 2C" Q496J9 5 76083172-76353939 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 52.2" "Group enriched" "Detected in some" 5 "Karpas-707: 11.9;SCLC-21H: 4.9;SH-SY5Y: 11.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 52.2;pons and medulla: 26.6" "Cell type enriched" "Detected in single" 14 "basophil: 4.2" "Lineage enriched" "Detected in single" 21 "granulocytes: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040722, HPA040770" Supported Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA040722: AB_10795624, HPA040770: AB_10805828" "unprognostic (7.91e-2)" "unprognostic (2.33e-1)" "unprognostic (2.05e-1)" "unprognostic (2.41e-2)" "unprognostic (1.07e-1)" "unprognostic (9.93e-2)" "unprognostic (1.09e-2)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (2.34e-2)" "unprognostic (1.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (6.66e-2)" "unprognostic (1.16e-1)" 0.5 5.5 0.8 1.3 52.2 0.7 1.2 1.2 9.5 0.7 0.8 0.5 0.0 1.0 0.7 0.9 0.6 1.8 0.6 0.8 0.6 8.3 0.4 0.4 0.4 0.5 5.6 1.9 2.6 0.8 0.9 0.8 0.4 26.6 1.0 1.1 1.1 1.7 1.2 0.3 0.7 1.3 1.0 5.8 0.6 1.6 1.0 6.7 0.0 0.5 0.0 0.4 0.6 0.4 0.1 0.1 4.2 0.2 0.1 0.2 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.3 4.9 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.2 0.2 0.8 52.2 1.2 9.5 0.6 8.3 5.6 1.9 26.6 6.7 SVEP1 "bA427L11.3, C9orf13, FLJ13529, POLYDOM" ENSG00000165124 "Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1" Q4LDE5 9 110365251-110579880 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 141.1" "Group enriched" "Detected in some" 5 "ASC diff: 50.4;ASC TERT1: 29.3;BJ hTERT+: 20.6;HHSteC: 18.5;HSkMC: 22.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 7 "cerebellum: 31.1" "HPA020610, HPA021520" Enhanced "Intracellular and membrane" 160000000 "HPA020610: AB_2197021, HPA021520: AB_1855533" "unprognostic (4.47e-2)" "unprognostic (6.01e-2)" "unprognostic (1.62e-2)" "unprognostic (1.04e-2)" "unprognostic (2.31e-1)" "unprognostic (2.62e-2)" "unprognostic (9.13e-3)" "unprognostic (1.32e-1)" "unprognostic (2.08e-2)" "unprognostic (3.31e-3)" "unprognostic (2.25e-1)" "unprognostic (1.51e-1)" "unprognostic (4.11e-2)" "prognostic unfavourable (8.33e-4)" "unprognostic (9.84e-2)" "unprognostic (2.21e-1)" "unprognostic (1.55e-3)" 18.8 2.5 1.0 3.9 1.8 0.0 11.9 6.7 0.9 7.1 8.6 0.5 3.6 0.6 6.1 7.8 4.7 4.4 5.4 4.4 1.1 0.7 2.1 1.5 8.6 5.8 1.1 0.5 4.2 2.7 2.2 0.7 141.1 0.7 4.3 3.1 1.5 2.2 1.3 7.4 3.5 3.3 5.7 0.6 3.4 3.6 4.0 0.9 0.0 3.5 2.3 1.3 9.6 7.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 50.4 29.3 0.0 5.3 20.6 0.4 0.6 0.5 0.0 0.0 0.0 1.2 0.0 0.0 4.0 0.3 0.0 0.1 0.0 0.4 0.0 18.5 0.0 1.0 22.9 0.0 4.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.4 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.4 0.8 0.0 2.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 6.7 0.9 1.1 0.7 1.1 0.5 0.7 0.9 SVOP DKFZp761H039 ENSG00000166111 "SV2 related protein" Q8N4V2 12 108907741-109021240 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 30.3" "Group enriched" "Detected in some" 13 "Karpas-707: 6.1;RPMI-8226: 6.2;SCLC-21H: 3.4;SH-SY5Y: 3.0;U-266/84: 2.8" "Group enriched" "Detected in some" 9 "glioma: 0.6;pancreatic cancer: 1.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016573 Uncertain "HPA016573: AB_2197027" "unprognostic (6.88e-2)" "unprognostic (1.10e-1)" "unprognostic (2.09e-1)" "unprognostic (6.51e-3)" "unprognostic (2.18e-2)" "unprognostic (3.79e-1)" "unprognostic (1.84e-2)" "unprognostic (1.25e-1)" "unprognostic (3.38e-2)" "unprognostic (4.29e-3)" "unprognostic (3.07e-1)" "unprognostic (4.28e-3)" "unprognostic (3.94e-2)" "unprognostic (2.26e-2)" "unprognostic (6.17e-2)" 0.6 2.9 6.9 0.7 14.0 0.7 0.6 8.2 30.3 0.6 0.8 0.5 0.0 1.3 0.6 0.7 0.6 1.1 0.6 1.1 8.9 1.9 0.7 0.6 0.7 0.6 0.7 10.0 0.6 1.7 0.5 6.8 0.6 6.4 0.8 0.8 1.5 0.6 0.7 0.7 0.6 1.0 0.6 0.8 0.6 1.8 1.0 0.7 0.0 0.7 0.0 0.5 0.6 0.7 0.6 0.4 2.0 0.4 0.9 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 6.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.0 3.4 3.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 2.8 0.1 0.0 0.1 0.0 1.5 0.4 0.4 0.3 0.2 0.2 0.2 0.3 0.2 0.1 0.6 0.3 0.3 2.0 0.9 0.3 0.4 0.2 0.1 6.9 14.0 8.2 21.6 8.9 1.9 0.7 10.0 6.4 0.7 SYCE1 "bA108K14.6, C10orf94, CT76" ENSG00000171772 "Synaptonemal complex central element protein 1" Q8N0S2 10 133553901-133569835 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 75.4" "Group enriched" "Detected in some" 8 "K-562: 17.0;U-2 OS: 15.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040208 Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA040208: AB_10796450" "unprognostic (5.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.85e-1)" "unprognostic (9.05e-2)" "unprognostic (1.61e-1)" "unprognostic (3.20e-1)" "unprognostic (5.75e-1)" "unprognostic (5.38e-2)" "unprognostic (3.36e-1)" "unprognostic (2.22e-2)" "unprognostic (7.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (2.42e-1)" 1.8 1.8 4.9 0.7 5.4 0.3 1.3 8.1 8.2 0.4 0.7 0.9 0.0 0.4 0.8 0.5 0.6 1.4 1.6 0.7 4.0 3.3 0.9 3.9 0.5 1.1 1.5 6.7 1.1 1.5 0.2 0.3 8.6 3.5 1.8 0.6 0.2 0.4 0.6 0.9 0.3 0.5 0.7 1.7 0.8 0.5 75.4 0.0 0.1 1.4 0.1 0.7 0.4 0.0 1.3 2.0 0.3 2.6 0.2 3.2 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.7 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.1 0.0 0.5 0.3 0.3 1.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.2 0.1 0.1 0.1 15.8 0.2 0.3 0.2 0.3 0.4 0.0 0.1 0.0 0.0 1.7 0.3 3.2 1.8 3.0 0.9 2.4 0.8 1.2 1.3 1.4 2.7 0.0 0.2 2.6 2.0 2.2 1.8 4.9 5.4 8.1 8.2 4.0 3.3 1.5 6.7 3.5 0.0 SYCE2 CESC1 ENSG00000161860 "Synaptonemal complex central element protein 2" Q6PIF2 19 12898786-12919276 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 41.2" "Cell line enhanced" "Detected in many" "EFO-21: 11.8;MOLT-4: 10.6;SiHa: 11.6;U-266/70: 12.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 4 "NK-cell: 6.3" "Lineage enriched" "Detected in many" 4 "NK-cells: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA042080, HPA062919" Enhanced Supported Nucleoplasm Nucleoplasm "HPA042080: AB_10794411, HPA062919: " "unprognostic (3.00e-1)" "prognostic favourable (3.85e-5)" "unprognostic (9.99e-3)" "prognostic unfavourable (9.91e-4)" "unprognostic (1.75e-1)" "unprognostic (3.48e-2)" "unprognostic (2.19e-1)" "unprognostic (1.75e-1)" "unprognostic (1.78e-1)" "unprognostic (8.28e-3)" "unprognostic (1.30e-2)" "unprognostic (8.39e-4)" "unprognostic (1.79e-10)" "unprognostic (7.55e-3)" "unprognostic (9.93e-2)" "unprognostic (1.09e-1)" "unprognostic (7.87e-5)" 0.4 0.4 0.3 0.3 0.4 2.9 0.3 2.0 1.6 0.5 0.4 0.3 0.3 0.2 0.3 0.6 0.3 0.4 0.3 0.3 0.5 0.2 0.3 1.1 0.5 1.0 0.3 0.3 0.8 0.4 0.0 0.4 0.8 0.4 0.6 0.1 0.3 0.6 0.3 0.3 1.1 0.3 0.3 0.4 0.5 0.3 41.2 0.3 2.6 0.4 0.3 0.7 0.5 0.4 0.1 0.2 1.4 0.1 6.3 0.6 0.1 5.7 1.1 3.0 1.8 0.3 0.8 3.2 1.4 0.6 0.8 1.0 0.2 0.8 4.4 11.8 0.8 1.2 1.0 0.3 0.9 1.6 0.7 1.2 2.5 0.5 0.1 2.8 4.0 0.8 0.2 0.3 0.6 0.2 1.1 1.3 0.6 2.4 10.6 1.9 1.9 3.3 3.2 1.4 1.1 0.6 0.9 2.1 1.4 11.6 0.6 0.7 2.3 3.1 0.8 0.8 1.6 4.3 0.4 12.3 1.5 4.9 1.0 3.9 5.5 0.0 0.1 1.4 0.2 0.0 0.1 0.0 0.6 0.0 0.2 0.1 0.2 0.4 0.0 6.3 0.0 0.0 0.5 0.1 0.3 0.4 2.0 0.6 0.5 0.2 0.3 0.3 0.4 0.3 SYCE3 C22orf41 ENSG00000217442 "Synaptonemal complex central element protein 3" A1L190 22 50551112-50562905 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 61.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.7;Karpas-707: 7.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047813 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA047813: " "unprognostic (2.55e-1)" "unprognostic (2.52e-1)" "unprognostic (2.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.73e-2)" "unprognostic (2.22e-1)" "unprognostic (2.98e-3)" "unprognostic (1.68e-2)" "unprognostic (4.05e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.55e-2)" "unprognostic (5.20e-2)" 0.4 0.4 0.7 0.5 0.9 0.1 0.7 0.2 0.6 0.2 0.4 0.5 0.4 0.1 0.2 1.1 0.2 0.8 0.6 0.1 0.5 0.7 1.0 0.8 0.4 0.9 0.9 0.3 0.1 0.2 0.2 0.4 0.4 0.7 0.1 0.0 0.2 0.7 0.1 0.0 0.2 0.0 0.5 0.7 0.1 0.2 61.5 0.4 0.0 1.1 0.2 0.3 0.7 0.0 0.5 1.9 8.0 1.3 0.0 0.3 0.3 0.3 0.7 0.1 0.3 0.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 8.7 0.4 3.2 0.0 0.0 0.9 1.0 0.0 0.0 0.5 0.0 0.6 0.0 3.9 0.0 1.6 2.3 2.0 0.3 1.4 0.0 0.0 7.3 0.4 3.3 0.0 0.0 0.3 0.0 0.0 0.0 3.8 1.2 2.6 0.8 2.3 0.0 2.2 1.4 2.1 1.7 0.0 0.7 0.8 0.0 0.1 1.9 0.4 1.1 0.9 0.3 0.2 0.0 1.3 1.5 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 0.2 8.0 0.0 0.9 0.0 0.0 0.3 0.7 0.9 0.2 0.6 0.5 0.7 0.9 0.3 0.7 0.4 SYCN "FLJ27441, INSSA1, SYL" ENSG00000179751 Syncollin Q0VAF6 19 39202831-39204266 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 681 "pancreas: 1347.2" "Cell line enhanced" "Detected in some" "U-2 OS: 1.3;U-266/84: 2.4" "Cancer enriched" "Detected in single" 842 "pancreatic cancer: 369.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA047654 Enhanced "Intracellular and membrane" 1100000 "HPA047654: " "unprognostic (8.02e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1347.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SYCP1 "CT8, HOM-TES-14, SCP1" ENSG00000198765 "Synaptonemal complex protein 1" Q15431 1 114854803-114995370 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 30.6" "Cell line enriched" "Detected in single" 93 "THP-1: 19.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 51 "cerebellum: 16.5" "Low region specificity" "Detected in some" HPA021083 Enhanced "HPA021083: AB_1857685" "unprognostic (2.91e-1)" "unprognostic (6.89e-3)" "unprognostic (4.87e-1)" "unprognostic (8.74e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SYCP2L "C6orf177, dJ62D2.1, NO145" ENSG00000153157 "Synaptonemal complex protein 2 like" Q5T4T6 6 10886831-10979320 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "parathyroid gland: 54.0" "Cell line enhanced" "Detected in some" "HL-60: 8.9;HMC-1: 27.9;K-562: 7.0;NB-4: 9.6;THP-1: 7.2" "Cancer enhanced" "Detected in single" "testis cancer: 1.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "basophil: 2.9;eosinophil: 5.5;plasmacytoid DC: 7.6" "Group enriched" "Detected in many" 17 "dendritic cells: 7.6;granulocytes: 5.5" HPA034679 Supported Nucleoplasm Nucleoplasm "HPA034679: AB_10669729" "unprognostic (3.25e-1)" "unprognostic (2.58e-2)" "unprognostic (3.23e-1)" "unprognostic (3.72e-5)" "unprognostic (2.20e-1)" "unprognostic (1.21e-2)" "unprognostic (5.57e-3)" "unprognostic (4.23e-1)" "unprognostic (6.03e-2)" "unprognostic (2.16e-1)" "unprognostic (1.40e-1)" "unprognostic (3.04e-1)" "unprognostic (1.21e-3)" "unprognostic (1.07e-2)" "unprognostic (1.86e-1)" "unprognostic (3.85e-2)" "unprognostic (2.74e-2)" 0.9 0.4 0.9 0.8 1.0 0.7 0.7 2.6 1.5 0.5 1.1 0.8 3.7 0.4 1.1 8.9 0.6 0.5 0.7 3.0 0.8 0.7 1.6 0.4 10.1 0.5 1.0 0.5 1.5 5.5 54.0 0.7 4.0 0.6 0.8 0.4 2.9 1.2 0.5 1.9 0.6 0.3 0.5 0.9 0.6 0.4 5.1 0.6 0.7 2.5 0.0 2.2 0.5 0.3 0.0 7.6 5.5 0.3 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.1 0.0 3.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.1 0.1 4.3 0.0 0.0 0.0 0.0 8.9 27.9 0.0 0.6 0.0 0.0 0.0 7.0 0.0 0.0 0.0 2.2 9.6 0.5 0.0 0.1 0.3 0.0 0.2 0.0 0.4 2.5 0.0 2.4 0.0 0.1 7.2 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.8 2.9 0.1 5.5 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.9 1.0 2.6 1.5 0.8 0.7 1.0 0.5 0.6 0.6 SYCP3 ENSG00000139351 "Synaptonemal complex protein 3" Q8IZU3 12 101728648-101739472 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 47.0" "Cell line enhanced" "Detected in some" "Karpas-707: 5.1;RPMI-8226: 2.5" "Cancer enriched" "Detected in single" 16 "testis cancer: 5.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB032978, HPA039635, HPA043938" Enhanced "CAB032978: AB_656732, HPA039635: , HPA043938: " "unprognostic (2.86e-3)" "unprognostic (3.91e-1)" "unprognostic (3.18e-1)" "unprognostic (9.61e-3)" "unprognostic (1.40e-1)" "unprognostic (1.22e-2)" "unprognostic (7.49e-2)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (2.86e-2)" "unprognostic (7.15e-3)" "unprognostic (7.81e-3)" "unprognostic (4.85e-2)" "unprognostic (1.93e-2)" "unprognostic (2.24e-1)" "unprognostic (4.07e-2)" "unprognostic (5.86e-4)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 3.2 0.6 0.2 0.6 0.1 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.9 0.6 0.0 0.2 0.6 0.1 1.3 0.1 0.0 0.7 0.2 0.7 0.5 0.3 0.0 0.3 0.4 0.0 0.0 1.5 1.3 0.4 0.5 0.2 0.0 0.1 0.4 5.1 1.2 0.0 1.3 0.9 0.0 0.2 0.3 1.0 2.5 1.9 0.8 0.1 0.6 0.0 0.2 2.1 1.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 1.0 0.3 0.0 0.2 0.0 3.2 0.6 0.4 0.1 0.2 0.0 0.2 0.1 0.1 0.1 1.5 0.0 0.6 0.5 0.2 0.1 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SYN1 ENSG00000008056 "Synapsin I" P17600 X 47571898-47619943 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 127.0" "Cell line enhanced" "Detected in some" "HaCaT: 6.9;HHSteC: 6.4;NTERA-2: 13.5;SCLC-21H: 23.6;SH-SY5Y: 6.1" "Cancer enhanced" "Detected in many" "glioma: 11.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000397, CAB021929" Enhanced "CAB021929: , HPA000397: AB_1080146" "unprognostic (1.22e-1)" "unprognostic (9.25e-2)" "unprognostic (2.16e-3)" "unprognostic (4.48e-3)" "unprognostic (3.05e-3)" "unprognostic (7.57e-2)" "unprognostic (1.63e-1)" "unprognostic (4.31e-1)" "unprognostic (3.49e-2)" "unprognostic (6.68e-2)" "unprognostic (3.97e-3)" "unprognostic (1.32e-1)" "unprognostic (2.64e-4)" "unprognostic (2.73e-3)" "unprognostic (5.79e-2)" "unprognostic (2.95e-3)" "unprognostic (5.27e-2)" 1.7 7.1 31.8 2.9 33.3 2.0 1.3 34.4 127.0 1.7 1.9 2.1 0.0 1.4 1.6 1.9 1.5 2.1 2.5 7.6 33.6 24.9 1.4 1.8 1.7 1.3 13.3 27.1 2.5 2.0 2.1 6.1 3.4 24.0 2.0 2.1 0.9 1.3 2.0 1.5 1.7 2.0 2.0 3.7 1.3 1.9 2.4 2.1 0.0 1.2 0.0 1.5 1.9 0.1 0.0 0.8 0.0 0.6 0.0 0.9 0.0 0.0 0.0 3.8 0.5 0.1 0.8 0.0 0.6 0.1 1.1 0.3 0.0 0.0 0.0 1.2 0.1 6.9 0.3 0.0 0.3 0.5 0.1 0.3 0.0 0.0 6.4 0.0 1.7 1.5 0.0 1.1 0.3 0.0 0.4 0.2 0.2 0.2 0.2 0.2 13.5 0.1 0.0 0.0 0.2 0.0 0.0 23.6 6.1 0.0 0.0 0.1 1.7 0.0 0.2 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.9 0.0 0.0 0.6 0.8 0.0 0.0 31.8 33.3 34.4 56.9 33.6 24.9 13.3 27.1 24.0 2.1 SYN2 "SYNII, SYNIIa, SYNIIb" ENSG00000157152 "Synapsin II" 3 12004402-12191400 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 20 "brain: 72.5" "Cell line enhanced" "Detected in some" "HAP1: 3.4;HEK 293: 3.3;HMC-1: 6.1;NTERA-2: 5.1;SCLC-21H: 4.1;SH-SY5Y: 16.2" "Cancer enhanced" "Detected in many" "glioma: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037012, CAB079005" Supported Approved Nucleoplasm Nucleoplasm "CAB079005: , HPA037012: " "unprognostic (1.62e-3)" "unprognostic (1.60e-2)" "unprognostic (7.54e-2)" "unprognostic (9.87e-3)" "unprognostic (1.73e-1)" "unprognostic (3.19e-1)" "unprognostic (6.32e-3)" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (9.77e-2)" "unprognostic (4.89e-4)" "unprognostic (9.94e-2)" "unprognostic (7.35e-2)" "unprognostic (1.78e-2)" 3.7 2.7 28.2 0.7 23.3 0.5 1.4 9.2 72.5 1.0 0.8 0.2 0.0 0.8 1.2 1.2 0.5 0.8 0.7 0.7 15.4 1.4 0.4 0.8 0.5 0.0 33.4 1.5 0.5 1.8 0.0 2.3 15.3 0.7 0.9 0.0 0.9 0.6 0.9 0.9 1.2 1.9 2.2 0.8 1.2 2.4 1.6 0.0 0.5 0.0 0.5 0.5 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 0.7 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 3.4 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 6.1 0.1 0.0 0.1 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 5.1 0.4 0.0 0.0 0.0 0.0 0.2 4.1 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 SYNGR3 ENSG00000127561 "Synaptogyrin 3" O43761 16 1989660-1994275 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.3" "Cell line enhanced" "Detected in many" "HDLM-2: 25.1;HMC-1: 16.2;Karpas-707: 13.7;SK-BR-3: 17.1;U-266/70: 21.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 3.7;NK-cells: 4.6;T-cells: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034278, HPA042842" Enhanced Approved "Plasma membrane" "Plasma membrane" "CAB034278: AB_2200905, HPA042842: " "unprognostic (8.89e-3)" "prognostic favourable (6.92e-4)" "unprognostic (6.07e-3)" "unprognostic (2.94e-3)" "unprognostic (2.92e-2)" "unprognostic (8.06e-3)" "unprognostic (2.52e-1)" "unprognostic (5.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.06e-1)" "unprognostic (3.69e-3)" "unprognostic (1.05e-1)" "prognostic favourable (7.12e-7)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.79e-1)" "unprognostic (8.78e-2)" 1.1 11.1 20.3 3.7 21.8 1.6 1.1 24.2 55.3 1.5 2.3 2.6 0.0 2.2 1.0 1.0 1.3 1.1 1.3 1.4 14.6 40.8 1.7 1.0 1.3 4.0 27.1 20.1 1.5 1.0 9.4 3.1 5.4 28.2 1.3 2.2 0.9 2.1 1.1 0.9 1.1 2.5 1.7 4.4 2.2 2.1 4.2 2.0 0.0 1.0 0.0 4.7 1.4 0.2 3.7 0.7 0.0 0.8 4.6 2.7 0.9 0.4 2.1 1.9 0.2 0.2 0.2 2.4 0.9 1.6 0.8 0.6 3.2 1.5 3.1 0.7 0.7 1.8 2.1 0.3 0.2 25.1 1.5 0.0 2.7 1.5 1.1 0.0 16.2 0.5 0.1 0.0 0.5 0.2 9.0 13.7 0.4 2.4 0.1 0.1 10.1 0.9 0.0 0.2 2.4 1.3 0.0 4.5 5.7 2.3 17.1 0.2 2.3 0.2 0.3 0.5 7.9 0.0 0.3 21.6 2.5 3.6 0.3 2.8 0.3 0.0 0.8 0.0 0.9 0.3 2.1 3.2 1.7 2.7 0.7 3.7 2.0 0.8 0.0 4.6 0.7 0.0 1.6 0.9 20.3 21.8 24.2 39.3 14.6 40.8 27.1 20.1 28.2 2.0 SYNGR4 ENSG00000105467 "Synaptogyrin 4" O95473 19 48364395-48376376 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 41.5" "Group enriched" "Detected in some" 5 "A549: 8.9;SCLC-21H: 22.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 4 "cerebellum: 4.1" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA030075, HPA059286" Enhanced Approved "Golgi apparatus" "Golgi apparatus" "HPA030075: AB_10610559, HPA059286: AB_2683965" "unprognostic (1.58e-2)" "unprognostic (3.44e-2)" "unprognostic (3.18e-2)" "unprognostic (9.49e-4)" "unprognostic (2.51e-2)" "unprognostic (7.10e-2)" "unprognostic (2.52e-3)" "unprognostic (3.72e-3)" "unprognostic (2.87e-2)" "unprognostic (6.19e-2)" "unprognostic (6.69e-2)" "unprognostic (2.41e-2)" "unprognostic (2.02e-7)" "unprognostic (1.06e-2)" "unprognostic (1.74e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" 0.0 0.0 0.2 0.0 0.7 0.0 0.0 4.1 2.0 0.0 0.2 0.0 0.9 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.0 0.7 3.0 0.2 0.2 0.3 0.1 0.2 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.1 0.1 0.0 41.5 0.0 0.3 0.1 0.0 0.2 0.2 0.0 1.3 0.7 0.1 0.5 0.0 0.9 0.6 0.1 8.9 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.5 0.2 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.5 2.9 0.5 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 3.3 0.1 0.2 0.5 0.2 0.0 1.7 0.6 0.0 2.5 0.0 0.0 22.3 0.6 0.1 0.4 0.0 0.3 0.1 0.1 0.0 0.8 0.0 0.0 3.1 1.0 0.7 0.0 0.2 0.4 0.1 0.5 0.0 0.0 0.0 0.0 1.3 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.7 4.1 0.9 0.2 0.1 0.3 0.0 0.3 0.0 SYNJ2 INPP5H ENSG00000078269 "Synaptojanin 2" O15056 6 157981887-158099176 "Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 62.0" "Cell line enhanced" "Detected in many" "TIME: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031575 Approved Approved Microtubules,Cytosol Microtubules Cytosol "HPA031575: AB_10604101" "prognostic unfavourable (2.63e-4)" "unprognostic (1.94e-2)" "unprognostic (7.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.48e-2)" "unprognostic (7.68e-2)" "unprognostic (1.24e-1)" "unprognostic (7.06e-2)" "unprognostic (2.91e-1)" "unprognostic (7.29e-3)" "unprognostic (1.26e-1)" "unprognostic (1.36e-1)" "prognostic unfavourable (4.02e-6)" "unprognostic (1.66e-2)" "unprognostic (3.75e-2)" "unprognostic (1.75e-1)" "unprognostic (9.45e-2)" 2.8 3.9 12.2 4.9 25.1 15.3 6.7 3.0 18.7 3.9 8.7 50.5 3.7 5.8 5.2 9.4 6.0 4.6 8.0 8.5 17.8 10.9 3.2 4.0 2.8 4.4 46.8 8.8 2.9 6.6 1.1 2.9 2.6 33.0 5.3 8.9 1.4 13.5 5.1 4.3 3.1 5.6 6.6 62.0 3.3 7.0 6.5 24.4 3.0 4.4 1.4 5.3 5.9 3.0 3.2 1.1 9.3 1.3 2.4 3.8 0.8 5.9 20.9 1.7 2.7 1.3 4.3 9.3 11.0 22.4 13.2 15.6 10.7 5.1 0.2 7.5 21.2 5.7 3.7 6.9 15.4 8.3 3.4 11.6 10.9 11.3 2.5 4.0 12.6 2.2 3.7 20.1 4.7 22.9 8.8 2.6 6.0 2.8 5.0 4.5 2.0 11.7 2.2 7.2 5.3 4.4 6.9 13.3 0.7 8.5 5.4 2.1 4.2 2.5 40.5 10.0 10.3 23.1 13.3 1.1 2.8 0.3 18.8 6.4 6.9 4.5 1.3 1.1 1.9 0.6 3.8 1.9 2.6 1.7 1.1 3.2 2.2 1.7 9.3 2.4 0.8 1.1 2.1 0.8 12.2 25.1 3.0 18.7 17.8 10.9 46.8 8.8 33.0 24.4 SYNPR "MGC26651, SPO" ENSG00000163630 Synaptoporin Q8TBG9 3 63228315-63616921 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 99.9" "Cell line enhanced" "Detected in some" "NTERA-2: 1.4;SCLC-21H: 4.6;SH-SY5Y: 1.2" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Region enhanced" "Detected in all" "basal ganglia: 99.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051368, HPA061671" Enhanced "HPA051368: AB_2681456, HPA061671: AB_2684582" "unprognostic (1.69e-1)" "unprognostic (3.77e-2)" "unprognostic (3.14e-3)" "unprognostic (3.02e-1)" "unprognostic (2.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.50e-1)" "unprognostic (5.32e-2)" "unprognostic (1.82e-1)" "unprognostic (1.89e-1)" 1.1 1.5 13.3 1.3 99.9 1.1 1.1 26.9 58.4 1.2 1.2 1.5 0.0 1.4 1.1 1.2 1.1 1.2 1.2 6.1 20.4 7.6 1.2 1.1 1.1 1.1 4.6 14.4 1.1 1.3 1.1 0.1 1.1 4.3 1.1 1.2 11.9 1.8 1.2 1.1 1.1 1.2 1.2 2.2 1.1 1.8 1.1 4.6 0.0 1.2 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 4.6 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 99.9 26.9 31.2 20.4 7.6 4.6 14.4 4.3 4.6 SYP MRX96 ENSG00000102003 Synaptophysin P08247 X 49187804-49200259 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 179.2" "Cell line enhanced" "Detected in some" "K-562: 8.5;SCLC-21H: 45.7;SH-SY5Y: 16.5" "Group enriched" "Detected in many" 6 "glioma: 12.8;pancreatic cancer: 5.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000076, HPA002858, CAB055505, CAB078999" Enhanced Supported "CAB000076: AB_2315411, CAB055505: AB_564017, CAB078999: , HPA002858: AB_1080153" "unprognostic (2.08e-1)" "unprognostic (8.72e-2)" "unprognostic (1.56e-1)" "unprognostic (5.37e-3)" "unprognostic (4.37e-2)" "unprognostic (2.11e-1)" "unprognostic (1.87e-1)" "unprognostic (6.46e-5)" "unprognostic (8.52e-3)" "unprognostic (1.62e-1)" "unprognostic (3.44e-3)" "unprognostic (8.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.95e-1)" "unprognostic (3.54e-1)" "unprognostic (1.79e-2)" "unprognostic (1.94e-1)" 2.7 21.4 34.5 3.2 42.5 1.9 1.9 53.8 179.2 2.0 3.6 7.2 0.0 7.4 2.2 2.6 2.2 2.0 2.0 2.3 44.4 45.3 2.7 1.8 2.8 2.0 25.5 39.0 2.1 5.2 1.9 17.4 2.0 46.7 2.1 3.5 11.5 2.0 2.1 2.4 2.3 8.1 2.5 15.5 2.4 3.9 2.0 4.0 0.0 2.1 0.0 1.9 1.8 0.2 1.3 1.6 5.3 0.8 0.5 0.7 0.1 0.4 1.7 1.3 2.6 1.4 0.2 0.2 0.1 0.0 0.3 0.3 1.5 0.9 1.3 0.2 0.0 1.3 1.3 0.1 0.3 2.7 1.5 2.1 0.5 0.5 0.0 0.2 4.7 0.2 0.0 0.2 0.3 0.1 8.5 3.3 0.3 0.5 0.7 0.1 4.2 0.3 0.3 0.2 0.6 0.1 0.2 45.7 16.5 0.5 0.2 0.6 0.8 0.8 0.2 0.3 1.4 0.4 0.2 0.2 2.8 0.3 0.7 0.5 1.4 1.7 0.8 0.4 0.2 0.7 0.4 0.7 0.5 0.7 0.4 1.3 0.5 0.5 5.3 0.5 0.4 1.6 0.3 0.1 34.5 42.5 53.8 84.8 44.4 45.3 25.5 39.0 46.7 4.0 SYT1 "P65, SVP65, SYT" ENSG00000067715 "Synaptotagmin 1" P21579 12 78863993-79452008 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Differentiation "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 141.7" "Cell line enhanced" "Detected in many" "hTERT-HME1: 22.5;LHCN-M2: 18.0;SH-SY5Y: 17.4;WM-115: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.3;memory B-cell: 3.3;naive B-cell: 3.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008394, HPA064788" Enhanced Supported "HPA008394: AB_1857696, HPA064788: AB_2685351" "unprognostic (1.02e-3)" "unprognostic (2.55e-1)" "unprognostic (4.21e-3)" "unprognostic (3.77e-2)" "unprognostic (3.16e-2)" "unprognostic (3.68e-5)" "unprognostic (2.78e-2)" "unprognostic (1.83e-2)" "unprognostic (7.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.11e-1)" "unprognostic (6.14e-3)" "unprognostic (3.05e-8)" "unprognostic (2.89e-2)" "unprognostic (8.26e-2)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" 1.3 11.5 23.9 2.1 31.8 1.3 1.4 44.3 141.7 1.8 2.3 1.8 0.0 1.8 5.6 1.4 1.4 1.4 1.7 1.1 32.4 22.9 2.0 2.0 1.5 1.2 23.1 38.6 3.6 1.2 1.1 1.4 2.3 28.9 4.3 2.5 2.7 1.2 3.8 1.1 1.2 2.6 12.9 2.5 2.2 1.8 1.4 3.6 0.0 1.2 0.0 1.2 1.3 0.7 3.4 0.9 0.0 2.3 0.0 0.0 0.1 0.0 10.5 7.9 0.0 0.8 2.3 0.0 0.7 0.9 0.6 0.6 0.5 0.3 0.0 1.6 0.1 0.3 0.1 1.2 0.9 0.1 0.4 0.6 0.2 0.0 2.0 0.0 0.1 0.6 0.8 2.9 22.5 7.5 0.4 1.2 18.0 1.6 1.0 0.0 5.8 3.0 0.0 8.2 0.0 0.0 3.0 10.5 17.4 0.0 1.3 0.2 3.9 0.0 3.0 1.1 0.4 0.0 3.3 1.9 4.2 0.0 2.6 0.0 16.2 0.0 2.3 0.0 0.0 0.2 0.0 3.3 0.0 0.0 0.9 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.9 31.8 44.3 74.8 32.4 22.9 23.1 38.6 28.9 3.6 SYT11 "DKFZp781D015, KIAA0080, MGC10881, MGC17226" ENSG00000132718 "Synaptotagmin 11" Q9BT88 1 155859509-155885199 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 148.3" "Cell line enhanced" "Detected in many" "Karpas-707: 56.5;SCLC-21H: 22.5;SH-SY5Y: 24.6;U-87 MG: 27.2" "Cancer enriched" "Detected in all" 12 "glioma: 117.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064091 Enhanced "HPA064091: " "unprognostic (1.83e-1)" "unprognostic (5.99e-2)" "unprognostic (1.24e-1)" "prognostic unfavourable (2.93e-5)" "unprognostic (2.14e-1)" "unprognostic (8.02e-3)" "unprognostic (7.90e-2)" "unprognostic (4.43e-3)" "unprognostic (3.93e-1)" "unprognostic (1.16e-1)" "unprognostic (1.42e-2)" "unprognostic (9.65e-2)" "unprognostic (2.28e-2)" "unprognostic (1.66e-1)" "unprognostic (6.38e-2)" "unprognostic (1.10e-1)" "unprognostic (2.22e-3)" 6.0 13.3 34.4 6.2 52.0 3.3 2.7 35.4 148.3 9.3 5.1 44.5 0.0 3.4 11.5 8.6 4.7 5.2 7.9 8.9 32.9 32.3 4.5 2.4 6.0 7.2 35.9 32.2 9.6 3.2 2.4 11.8 7.0 48.3 8.7 5.4 4.4 2.6 11.3 2.8 2.3 4.3 12.7 42.0 6.9 3.8 4.7 29.0 0.0 2.8 0.0 6.5 7.3 3.3 1.6 5.6 4.1 6.1 5.8 14.4 5.7 0.0 0.2 14.5 0.3 10.6 5.7 0.0 2.7 7.3 2.8 5.2 0.0 0.3 2.8 1.2 9.6 0.2 1.2 0.0 4.3 13.5 0.2 2.7 0.4 0.0 3.0 1.5 8.4 3.5 0.0 10.4 0.2 9.2 0.0 56.5 3.9 0.0 0.1 0.7 9.4 0.0 0.5 1.4 0.0 0.4 0.0 22.5 24.6 0.4 0.0 3.2 0.0 0.3 6.8 5.4 3.4 3.6 3.4 15.1 7.3 5.7 27.2 0.0 4.1 4.1 3.8 0.1 14.4 4.8 4.0 1.6 7.6 9.9 5.6 1.4 0.8 7.8 2.1 5.8 6.1 0.3 13.3 5.7 34.4 52.0 35.4 59.4 32.9 32.3 35.9 32.2 48.3 29.0 SYT2 ENSG00000143858 "Synaptotagmin 2" Q8N9I0 1 202590596-202710417 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" Differentiation "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 40.1" "Cell line enhanced" "Detected in some" "AF22: 12.4;NTERA-2: 8.6;U-2 OS: 2.6" "Cancer enriched" "Detected in some" 7 "testis cancer: 3.8" "Group enriched" "Detected in many" 5 "cerebellum: 36.2;cerebral cortex: 14.7;pons and medulla: 40.1" "Cell type enriched" "Detected in single" 8 "neutrophil: 2.4" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA063655 Enhanced Supported "HPA063655: " "unprognostic (1.32e-2)" "unprognostic (4.99e-2)" "unprognostic (4.89e-2)" "unprognostic (1.03e-2)" "unprognostic (2.21e-1)" "unprognostic (2.24e-2)" "unprognostic (3.00e-1)" "unprognostic (2.35e-3)" "unprognostic (8.81e-3)" "unprognostic (1.17e-1)" "unprognostic (1.53e-2)" "unprognostic (6.33e-2)" "unprognostic (1.56e-2)" "unprognostic (6.23e-2)" "unprognostic (3.26e-1)" "unprognostic (2.54e-1)" "unprognostic (5.17e-3)" 1.1 6.1 0.4 1.1 5.9 0.5 0.3 36.2 14.7 0.6 0.7 0.3 0.0 1.1 1.7 4.1 0.4 0.8 1.1 1.5 0.6 1.5 0.5 0.4 0.6 0.7 5.5 0.4 3.1 0.4 0.2 0.3 0.5 40.1 0.9 0.7 1.6 1.1 0.5 1.1 0.7 1.3 0.5 7.1 1.2 0.7 2.4 1.1 0.0 0.6 0.0 0.5 1.0 0.3 0.1 0.0 2.4 0.1 0.1 0.2 0.0 0.0 0.2 12.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.2 1.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 8.6 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.4 5.9 36.2 14.7 0.6 1.5 5.5 0.4 40.1 1.1 SYT3 ENSG00000213023 "Synaptotagmin 3" Q9BQG1 19 50621307-50639827 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 24.2" "Cell line enhanced" "Detected in some" "HEK 293: 9.9;HMC-1: 7.0;NTERA-2: 7.2;SH-SY5Y: 8.1;U-2 OS: 5.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (5.17e-2)" "unprognostic (1.90e-1)" "unprognostic (3.86e-3)" "unprognostic (1.57e-1)" "unprognostic (6.62e-2)" "unprognostic (4.36e-3)" "unprognostic (1.00e-1)" "unprognostic (9.42e-2)" "unprognostic (1.59e-1)" "unprognostic (1.22e-1)" "unprognostic (1.19e-4)" "unprognostic (1.12e-1)" "unprognostic (3.49e-4)" "unprognostic (1.82e-4)" "unprognostic (3.40e-1)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" 0.9 1.8 8.7 1.0 8.8 0.7 0.8 16.1 24.2 1.0 0.9 1.0 0.0 1.0 0.9 1.1 0.9 0.9 0.8 0.7 10.9 8.9 1.2 0.8 1.1 0.9 6.7 6.6 0.7 2.1 1.0 2.2 2.3 6.3 1.2 0.8 0.3 1.4 1.7 0.8 0.8 1.0 0.9 2.4 0.8 0.8 2.7 2.2 0.0 1.3 0.0 0.9 1.0 0.0 0.0 1.3 0.1 0.0 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.1 0.0 0.1 0.4 0.0 0.0 0.1 9.9 0.0 0.0 0.0 0.4 0.0 7.0 0.3 0.0 0.0 0.0 0.2 1.2 0.0 0.0 2.9 0.0 0.0 7.2 0.0 2.4 0.0 0.1 0.0 0.0 0.1 8.1 0.4 0.0 0.2 0.2 2.3 0.0 0.0 5.1 0.0 0.0 0.8 0.1 0.0 0.3 3.6 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.3 0.0 0.1 8.7 8.8 16.1 16.3 10.9 8.9 6.7 6.6 6.3 2.2 SYT5 ENSG00000129990 "Synaptotagmin 5" O00445 19 55171199-55180441 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 73.0" "Group enriched" "Detected in some" 4 "EFO-21: 15.4;HMC-1: 34.1;K-562: 12.0;SCLC-21H: 9.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA078390 Enhanced "HPA078390: " "unprognostic (1.18e-1)" "unprognostic (1.44e-1)" "unprognostic (9.76e-2)" "unprognostic (4.59e-2)" "prognostic unfavourable (6.54e-4)" "unprognostic (9.85e-2)" "unprognostic (3.24e-3)" "unprognostic (5.94e-2)" "unprognostic (1.36e-3)" "unprognostic (1.82e-1)" "prognostic favourable (5.54e-4)" "unprognostic (1.15e-3)" "unprognostic (3.71e-7)" "unprognostic (7.09e-2)" "unprognostic (5.21e-2)" "unprognostic (4.42e-2)" "unprognostic (3.55e-1)" 1.2 9.8 20.0 2.7 30.9 1.4 1.0 1.3 73.0 1.8 1.7 1.0 0.0 2.2 1.2 1.0 1.2 1.3 1.3 1.1 22.0 18.8 1.1 1.1 1.2 1.2 6.1 19.8 1.1 2.6 1.1 16.3 1.1 8.3 1.1 1.7 0.0 1.1 1.0 1.2 1.4 1.8 1.5 1.9 1.2 2.9 3.5 3.6 0.0 1.2 0.0 1.3 1.1 0.0 1.0 1.8 3.6 0.8 1.1 0.5 0.5 0.1 0.1 0.2 0.2 0.5 0.0 0.2 0.3 0.0 0.0 0.5 0.0 0.6 0.9 15.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.6 0.0 34.1 0.4 0.1 0.0 0.0 0.3 12.0 2.1 0.0 0.3 0.3 0.0 0.0 2.1 0.1 0.2 0.2 0.0 0.0 9.0 4.0 0.0 0.5 0.4 0.2 0.0 0.0 0.7 0.7 1.0 0.0 0.1 0.7 0.4 0.3 0.0 0.2 3.6 0.8 1.1 0.4 0.5 0.4 0.7 0.3 0.5 1.8 1.0 0.4 0.5 3.4 1.1 0.4 0.8 0.3 0.5 20.0 30.9 1.3 36.6 22.0 18.8 6.1 19.8 8.3 3.6 TAAR1 "TA1, TAR1, TRAR1" ENSG00000146399 "Trace amine associated receptor 1" Q96RJ0 6 132644984-132646003 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "stomach 1: 13.6" "Cell line enhanced" "Detected in some" "EFO-21: 1.7;HBF TERT88: 1.1" "Cancer enhanced" "Detected in single" "cervical cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055614 Approved "HPA055614: " "unprognostic (2.19e-2)" "unprognostic (1.87e-1)" "unprognostic (1.47e-1)" "unprognostic (2.68e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 13.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR2 GPR58 ENSG00000146378 "Trace amine associated receptor 2 (gene/pseudogene)" Q9P1P5 6 132617022-132624275 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAC3 "NKB, NKNB, ZNEUROK1" ENSG00000166863 "Tachykinin 3" Q9UHF0 12 57010000-57028883 "Disease related genes, Predicted secreted proteins" Neuropeptide "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 133.5" "Cell line enriched" "Detected in some" 5 "K-562: 17.2" "Cancer enriched" "Detected in many" 7 "urothelial cancer: 40.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045919 Supported Supported Approved Vesicles "Secreted in female reproductive system" Vesicles "HPA045919: AB_10960533" "unprognostic (4.53e-2)" "unprognostic (1.97e-2)" "unprognostic (8.41e-2)" "unprognostic (3.00e-2)" "unprognostic (3.61e-2)" "unprognostic (1.76e-2)" "unprognostic (5.99e-2)" "unprognostic (8.41e-2)" "unprognostic (1.34e-1)" "unprognostic (2.03e-1)" "unprognostic (5.28e-2)" "unprognostic (4.71e-14)" "unprognostic (1.58e-2)" "unprognostic (1.76e-1)" "unprognostic (1.01e-1)" "unprognostic (2.39e-1)" 0.5 0.6 3.9 1.5 20.0 0.8 0.5 0.0 11.0 0.5 1.2 0.1 0.0 1.5 0.6 0.5 0.5 0.5 0.6 0.5 4.4 9.5 0.5 0.5 0.5 0.5 0.8 2.1 0.5 0.7 0.5 0.0 133.5 1.5 0.5 1.0 0.3 0.5 0.5 0.5 0.7 3.2 2.0 9.4 0.5 8.1 0.8 0.2 0.0 0.5 0.0 0.6 2.2 0.5 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.5 0.0 0.0 1.6 0.0 1.3 0.4 0.0 3.4 0.0 1.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.3 0.0 0.0 17.2 0.4 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.0 1.7 2.9 0.8 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.9 20.0 0.0 11.0 4.4 9.5 0.8 2.1 1.5 0.2 TAF1L ENSG00000122728 "TATA-box binding protein associated factor 1 like" Q8IZX4 9 32629454-32635669 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 6.2" "Cell line enriched" "Detected in single" 11 "U-87 MG: 4.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA056605 Uncertain "HPA056605: " "unprognostic (7.81e-2)" "unprognostic (1.35e-1)" "unprognostic (1.73e-1)" "unprognostic (1.24e-1)" "unprognostic (2.17e-1)" "unprognostic (5.79e-2)" "unprognostic (4.35e-2)" "unprognostic (1.25e-1)" "unprognostic (9.13e-2)" "unprognostic (1.60e-1)" "unprognostic (9.55e-3)" "unprognostic (1.68e-1)" "unprognostic (8.33e-2)" "unprognostic (4.07e-1)" "unprognostic (4.86e-2)" 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.3 0.3 1.2 0.2 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.3 0.2 0.0 4.4 0.1 0.0 1.0 0.2 0.3 0.2 0.1 0.2 0.1 0.1 0.2 0.0 0.3 0.2 0.4 1.2 0.4 0.1 0.3 0.1 0.1 TAF7L "CT40, TAF2Q" ENSG00000102387 "TATA-box binding protein associated factor 7 like" Q5H9L4 X 101268253-101293057 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 36.1" "Cell line enriched" "Detected in some" 17 "SiHa: 35.2" "Cancer enhanced" "Detected in some" "cervical cancer: 2.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 10 "basophil: 1.6" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.6" "Low region specificity" "Detected in all" HPA001879 Approved Approved Nucleoplasm Nucleoplasm "HPA001879: AB_1857751" "unprognostic (1.70e-2)" "prognostic favourable (8.71e-4)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (2.52e-2)" "unprognostic (4.97e-3)" "unprognostic (3.87e-3)" "unprognostic (1.72e-1)" "unprognostic (4.67e-3)" "unprognostic (2.16e-1)" "unprognostic (3.29e-1)" "unprognostic (1.36e-1)" "unprognostic (3.49e-3)" "unprognostic (6.76e-2)" "unprognostic (2.88e-1)" "unprognostic (5.97e-2)" "unprognostic (1.12e-2)" 0.1 0.0 1.4 0.1 1.7 0.2 0.1 0.1 0.6 1.6 0.5 0.2 0.1 0.0 0.7 3.5 0.1 0.0 0.1 0.1 0.8 0.2 0.3 0.5 0.1 0.1 0.1 0.8 0.1 0.1 2.5 0.2 0.4 0.3 1.8 0.0 0.4 0.1 1.8 0.1 0.6 0.3 0.1 0.4 0.1 0.1 36.1 0.1 0.1 0.1 0.1 0.1 0.2 0.5 0.1 0.1 1.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.6 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.6 0.0 0.1 0.2 0.1 1.7 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 35.2 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.4 1.7 0.1 0.6 0.8 0.2 0.1 0.8 0.3 0.1 TAGLN3 "NP22, NP25" ENSG00000144834 "Transgelin 3" Q9UI15 3 111998664-112013887 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 139.0" "Group enriched" "Detected in some" 5 "AF22: 38.5;RPTEC TERT1: 15.7;SCLC-21H: 21.0;SH-SY5Y: 35.5" "Cancer enhanced" "Detected in many" "glioma: 24.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062620 Enhanced "HPA062620: " "unprognostic (1.55e-2)" "unprognostic (2.28e-1)" "unprognostic (1.81e-1)" "unprognostic (1.36e-3)" "unprognostic (4.28e-1)" "unprognostic (4.07e-1)" "unprognostic (1.48e-1)" "unprognostic (2.02e-1)" "unprognostic (8.92e-2)" "unprognostic (6.82e-3)" "unprognostic (2.51e-1)" "unprognostic (5.49e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (8.60e-2)" "unprognostic (7.67e-3)" 1.7 21.9 47.3 2.4 40.6 1.5 1.6 40.2 139.0 1.5 2.7 4.6 0.0 1.9 1.6 1.5 1.6 1.6 1.7 1.7 32.9 37.9 4.2 1.5 1.8 1.6 30.5 33.2 1.6 4.6 1.6 13.5 1.5 29.8 1.7 2.9 2.3 1.5 1.7 1.5 1.6 2.2 2.2 8.3 1.5 3.7 1.6 2.7 0.0 1.8 0.0 1.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.1 0.1 0.0 1.4 0.0 0.2 0.0 2.7 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 1.4 3.4 5.3 1.0 0.0 15.7 0.0 21.0 35.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 40.6 40.2 65.7 32.9 37.9 30.5 33.2 29.8 2.7 TAS2R1 "T2R1, TRB7" ENSG00000169777 "Taste 2 receptor member 1" Q9NYW7 5 9628997-9712378 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 13.0" "Group enriched" "Detected in some" 5 "BJ hTERT+: 3.5;U-266/84: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051879 Uncertain "HPA051879: " "unprognostic (2.19e-1)" 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAT ENSG00000198650 "Tyrosine aminotransferase" P17735 16 71565660-71577130 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Aminotransferase, Transferase" "Disease mutation, Mental retardation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "liver: 387.0" "Group enriched" "Detected in some" 5 "Daudi: 2.3;Hep G2: 7.1" "Cancer enriched" "Detected in some" 10 "liver cancer: 152.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.66e-3)" "unprognostic (1.29e-1)" "unprognostic (8.17e-2)" "unprognostic (2.21e-1)" "unprognostic (1.67e-1)" "unprognostic (1.01e-2)" "prognostic favourable (6.51e-4)" "unprognostic (1.69e-1)" "unprognostic (9.32e-2)" "unprognostic (2.27e-1)" "unprognostic (3.73e-3)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (1.19e-1)" "unprognostic (1.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.05e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 387.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.9 2.6 1.5 0.4 0.2 0.5 0.2 0.1 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.2 7.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.2 0.4 0.1 0.0 0.7 0.9 0.0 0.1 0.3 0.1 0.6 0.0 0.2 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.5 0.2 0.5 0.0 0.3 0.2 1.5 0.4 0.2 0.3 0.1 0.4 1.2 0.5 0.4 0.2 1.9 0.5 0.5 1.5 0.2 0.1 2.6 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 TBATA "C10orf27, FLJ32820, spatial" ENSG00000166220 "Thymus, brain and testes associated" Q96M53 10 70771239-70785401 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "testis: 34.7" "Cell line enriched" "Detected in single" 29 "SK-BR-3: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebellum: 31.5;hippocampal formation: 18.1" "Low region specificity" "Detected in many" "unprognostic (2.54e-1)" "unprognostic (2.97e-1)" "unprognostic (1.93e-2)" "unprognostic (2.14e-1)" "unprognostic (6.24e-2)" "unprognostic (1.45e-1)" "unprognostic (4.88e-1)" "unprognostic (1.09e-2)" "unprognostic (1.15e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 34.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D21 "MGC34741, MgcRabGAP" ENSG00000167139 "TBC1 domain family member 21" Q8IYX1 15 73873608-73889214 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 173 "testis: 40.3" "Cell line enriched" "Detected in single" 8 "RPMI-8226: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043319 Enhanced "HPA043319: AB_10966214" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D26 MGC51025 ENSG00000214946 "TBC1 domain family member 26" Q86UD7 17 15732247-15749192 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 15.3" "Cell line enhanced" "Detected in some" "AN3-CA: 1.4;HMC-1: 1.9;U-698: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050460 Uncertain "HPA050460: " "unprognostic (3.65e-2)" "unprognostic (2.31e-1)" "unprognostic (7.90e-2)" "unprognostic (3.22e-1)" "unprognostic (1.16e-1)" "unprognostic (3.20e-1)" "unprognostic (5.15e-9)" "unprognostic (9.32e-2)" "unprognostic (1.51e-1)" "unprognostic (3.24e-1)" "unprognostic (6.16e-2)" 0.1 0.0 1.5 0.1 3.3 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.1 0.1 0.0 15.3 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 1.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.9 0.2 0.0 1.9 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.2 1.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 1.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D28 FLJ40244 ENSG00000189375 "TBC1 domain family member 28" Q2M2D7 17 18635006-18661950 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 64 "testis: 19.0" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;Karpas-707: 3.2;U-266/70: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.56e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 19.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D29 DKFZP434O047 ENSG00000266733 "TBC1 domain family member 29" Q9UFV1 17 30557112-30563493 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 10.9" "Cell line enhanced" "Detected in some" "U-937: 4.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" HPA059178 Uncertain "HPA059178: " "unprognostic (5.64e-2)" "unprognostic (1.01e-1)" "unprognostic (8.58e-2)" "unprognostic (9.36e-2)" "unprognostic (1.01e-1)" "unprognostic (1.56e-1)" "unprognostic (3.69e-1)" "unprognostic (1.50e-1)" "unprognostic (7.96e-2)" "unprognostic (2.57e-1)" "unprognostic (3.49e-4)" "unprognostic (7.32e-2)" "unprognostic (2.97e-3)" "unprognostic (1.15e-1)" "unprognostic (2.13e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-4)" 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.5 0.1 0.0 0.0 0.1 0.0 1.5 0.0 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.0 0.2 0.1 0.2 0.1 0.3 0.8 0.1 0.0 0.1 0.2 0.2 10.9 0.3 0.3 0.2 0.0 0.9 0.3 1.1 0.2 0.0 0.4 0.0 1.5 1.4 1.0 0.5 0.5 0.5 2.0 0.6 0.2 0.3 0.7 0.8 1.3 0.5 0.5 0.1 2.5 0.3 0.3 0.4 0.5 1.2 0.7 2.8 0.1 0.0 1.0 1.5 1.0 0.8 1.1 0.3 0.2 0.1 1.5 0.2 0.6 0.2 1.2 0.4 0.7 0.7 0.7 0.9 0.3 2.2 0.4 0.7 0.1 0.2 0.2 1.6 0.2 0.6 0.6 1.3 0.8 0.3 1.5 1.2 0.1 0.4 4.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.9 0.0 0.4 1.1 0.0 0.0 0.2 0.0 0.0 TBC1D3F ENSG00000275954 "TBC1 domain family member 3F" 17 36428618-36439566 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 4.8" "Cell line enhanced" "Detected in single" "HL-60: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046969 Uncertain Vesicles Vesicles "HPA046969: " 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 TBC1D3G ENSG00000260287 "TBC1 domain family member 3G" Q6DHY5 17 36323884-36334759 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 8.7" "Group enriched" "Detected in some" 35 "SiHa: 5.4;U-2197: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046969, HPA047745, HPA052553" Supported Approved Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " "unprognostic (4.41e-1)" "unprognostic (1.17e-2)" "unprognostic (5.01e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.1 TBR1 ENSG00000136535 "T-box, brain 1" Q16650 2 161416094-161425870 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "brain: 34.9" "Cell line enhanced" "Detected in some" "HAP1: 1.6;HMC-1: 1.3;Karpas-707: 1.0;SCLC-21H: 1.7;U-266/84: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 45.6;basal ganglia: 28.5;cerebral cortex: 70.3;hippocampal formation: 50.1" "Region enhanced" "Detected in many" "cerebral cortex: 63.6" "HPA051256, HPA078644, HPA078657" Enhanced Supported "HPA051256: , HPA078644: AB_2732387, HPA078657: AB_2732388" "unprognostic (3.08e-2)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "unprognostic (1.35e-2)" "unprognostic (7.43e-3)" "unprognostic (1.95e-1)" "unprognostic (1.83e-2)" "unprognostic (1.14e-1)" "unprognostic (1.39e-9)" "unprognostic (5.72e-2)" "unprognostic (1.72e-1)" "unprognostic (5.37e-2)" 0.6 0.5 11.2 0.5 13.7 0.5 0.5 0.3 34.9 0.6 0.5 0.0 0.0 0.5 0.5 0.6 0.5 0.6 0.5 0.5 6.1 1.3 0.5 0.5 0.5 0.5 0.8 21.0 0.5 0.6 0.6 0.3 0.5 0.0 0.5 0.6 0.0 0.5 0.7 0.5 0.5 0.5 0.5 0.4 0.5 0.5 1.3 0.0 0.0 0.5 0.0 0.5 0.5 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.6 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.2 0.2 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.5 1.5 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 11.2 13.7 0.3 34.9 6.1 1.3 0.8 21.0 0.0 0.0 TBX1 "CATCH22, VCF" ENSG00000184058 "T-box 1" O43435 22 19756703-19783593 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 36.5" "Cell line enhanced" "Detected in some" "HEK 293: 9.9;K-562: 47.6;NB-4: 11.2;TIME: 15.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "basal ganglia: 3.0" "Group enriched" "Detected in some" 13 "basophil: 1.0;eosinophil: 2.7" "Lineage enriched" "Detected in single" 19 "granulocytes: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA029330 Approved "Nuclear bodies,Cytoplasmic bodies" "Nuclear bodies, Cytoplasmic bodies" "HPA029330: " "unprognostic (2.54e-1)" "unprognostic (4.28e-3)" "unprognostic (7.53e-3)" "unprognostic (1.59e-1)" "unprognostic (4.03e-2)" "unprognostic (2.63e-3)" "unprognostic (1.16e-1)" "unprognostic (2.53e-1)" "unprognostic (5.48e-2)" "unprognostic (1.18e-1)" "unprognostic (4.42e-2)" "unprognostic (2.25e-2)" "unprognostic (8.30e-3)" "unprognostic (9.14e-2)" "unprognostic (4.44e-1)" "unprognostic (8.31e-2)" "prognostic favourable (8.90e-4)" 1.4 0.2 0.6 0.6 3.0 0.0 3.7 0.6 0.6 2.5 2.3 0.6 0.6 0.4 0.9 0.6 2.5 2.8 0.6 0.6 0.6 0.0 0.6 0.6 2.2 1.7 0.6 0.6 0.7 0.6 3.7 0.6 0.6 0.6 2.3 0.2 0.6 3.4 0.6 36.5 4.6 0.8 0.6 0.6 0.6 0.1 7.0 0.6 0.6 5.3 0.6 1.9 1.1 3.3 0.0 0.1 2.7 0.0 0.0 0.1 0.0 5.9 0.6 0.1 4.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.1 0.3 5.1 4.4 0.0 0.2 9.9 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 47.6 0.0 3.2 1.1 0.1 11.2 0.7 6.9 0.1 4.5 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 2.0 3.0 15.2 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 1.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 3.0 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 TBX10 "TBX13, TBX7" ENSG00000167800 "T-box 10" O75333 11 67631303-67639560 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "intestine: 12.1" "Cell line enhanced" "Detected in some" "Daudi: 2.9;NTERA-2: 6.6;RPMI-8226: 4.3;SK-BR-3: 15.5;U-2 OS: 3.3" "Group enriched" "Detected in some" 5 "breast cancer: 0.8;colorectal cancer: 2.6;liver cancer: 0.5;prostate cancer: 1.9;stomach cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "pons and medulla: 0.4" "Low region specificity" "Detected in many" HPA047881 Uncertain "Intracellular and membrane" "HPA047881: " "unprognostic (4.66e-2)" "unprognostic (2.96e-2)" "unprognostic (7.71e-3)" "unprognostic (1.79e-1)" "unprognostic (2.37e-1)" "unprognostic (1.83e-4)" "unprognostic (3.12e-1)" "unprognostic (3.29e-2)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (4.90e-1)" "unprognostic (1.17e-10)" "unprognostic (6.77e-2)" "unprognostic (1.68e-1)" "unprognostic (2.95e-1)" "unprognostic (2.75e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 9.9 0.2 0.2 6.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.8 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 9.1 0.2 0.4 0.2 0.2 0.0 12.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 6.6 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 15.5 0.0 0.0 0.1 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 TBX19 "dj747L4.1, TPIT" ENSG00000143178 "T-box 19" O60806 1 168281040-168314426 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "pituitary gland: 50.4" "Cell line enhanced" "Detected in many" "HaCaT: 9.5;HDLM-2: 8.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005800, HPA072686" Enhanced Approved "Nuclear speckles" "Nuclear speckles" "HPA005800: AB_1080219, HPA072686: " "unprognostic (2.47e-1)" "unprognostic (1.20e-2)" "unprognostic (8.76e-4)" "unprognostic (1.43e-2)" "unprognostic (3.09e-2)" "unprognostic (8.36e-2)" "unprognostic (7.14e-7)" "unprognostic (1.83e-1)" "unprognostic (2.04e-1)" "unprognostic (5.58e-2)" "unprognostic (9.78e-3)" "unprognostic (1.28e-1)" "prognostic unfavourable (4.55e-9)" "unprognostic (8.57e-2)" "unprognostic (6.63e-2)" "unprognostic (9.06e-2)" "unprognostic (1.05e-2)" 1.0 0.4 1.0 1.0 1.0 0.5 2.5 1.0 1.0 1.5 1.3 1.0 1.0 0.8 5.3 1.0 1.1 2.0 1.4 1.0 1.0 0.8 1.0 1.0 2.2 2.1 1.0 1.0 2.9 1.0 0.2 50.4 1.0 1.0 1.2 1.1 1.0 2.2 1.4 1.0 1.9 1.0 3.6 1.0 2.1 0.6 1.0 1.0 1.0 1.0 1.0 1.3 1.3 1.2 1.6 6.3 2.7 2.4 2.6 3.1 1.3 1.6 0.1 1.4 5.3 2.5 1.2 1.7 2.9 1.5 1.0 1.6 2.4 1.7 1.5 2.9 1.1 9.5 0.8 0.7 1.4 8.1 1.4 0.3 1.7 0.7 2.9 2.6 3.6 2.2 2.6 0.3 1.5 1.2 1.8 2.4 1.3 0.3 1.4 2.4 0.4 1.0 2.2 0.7 0.5 2.3 0.7 1.9 2.8 1.6 1.2 1.6 0.4 2.2 2.1 1.0 2.4 2.0 2.9 1.6 1.3 1.2 0.2 0.8 2.8 0.5 1.8 0.8 3.1 1.3 1.4 1.2 2.2 2.0 1.8 1.6 1.5 1.3 2.7 2.6 2.4 6.3 2.0 1.3 1.0 1.0 1.0 1.0 1.0 0.8 1.0 1.0 1.0 1.0 TCF7 TCF-1 ENSG00000081059 "Transcription factor 7" P36402 5 134114711-134151865 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 326.1" "Cell line enriched" "Detected in many" 15 "MOLT-4: 166.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "MAIT T-cell: 10.3;memory CD4 T-cell: 17.8;memory CD8 T-cell: 10.4;naive CD4 T-cell: 35.8;naive CD8 T-cell: 21.8;NK-cell: 14.2" "Group enriched" "Detected in many" 19 "NK-cells: 14.2;T-cells: 35.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019403, HPA058863, HPA070505" Enhanced Enhanced Nucleoplasm Nucleoplasm "CAB019403: AB_2199302, HPA058863: , HPA070505: " "unprognostic (3.63e-3)" "unprognostic (1.98e-3)" "unprognostic (1.03e-1)" "unprognostic (5.08e-3)" "unprognostic (1.70e-1)" "unprognostic (6.74e-2)" "unprognostic (1.12e-1)" "unprognostic (6.38e-2)" "unprognostic (2.31e-1)" "unprognostic (1.65e-1)" "unprognostic (5.35e-2)" "unprognostic (2.32e-1)" "unprognostic (3.04e-1)" "unprognostic (1.50e-2)" "unprognostic (2.33e-2)" "unprognostic (1.90e-1)" "unprognostic (4.10e-2)" 1.8 3.6 1.3 21.8 1.5 5.2 3.1 0.9 1.2 2.1 3.3 2.5 2.2 5.6 1.4 16.3 2.7 16.1 2.6 1.6 1.5 1.2 2.7 3.7 4.0 41.8 1.3 1.0 2.5 7.2 0.2 6.1 1.4 4.7 2.9 2.3 3.6 7.9 1.8 0.9 2.9 15.1 0.9 3.3 14.4 3.7 2.4 1.1 326.1 4.4 2.2 32.5 3.3 1.5 1.2 0.1 1.0 0.1 14.2 35.8 6.9 0.0 1.0 1.1 3.8 0.5 2.1 1.5 0.3 0.5 0.1 0.1 7.9 2.5 0.0 1.9 1.7 0.1 1.7 0.4 0.0 0.3 1.6 0.0 1.0 5.9 0.0 0.0 0.2 0.1 0.0 1.6 0.0 0.2 1.0 0.0 0.1 0.0 166.9 0.1 1.2 1.4 0.2 0.0 0.1 0.4 0.1 0.4 3.3 0.8 0.2 0.2 0.2 0.9 0.2 10.8 0.0 4.9 0.3 0.1 0.0 0.0 5.7 0.0 0.5 0.7 0.1 1.0 4.4 0.0 10.3 1.2 17.8 10.4 0.0 0.4 35.8 21.8 0.7 14.2 0.0 0.1 2.1 6.9 1.3 1.5 0.9 1.2 1.5 1.2 1.3 1.0 4.7 1.1 TCP10 ENSG00000203690 "T-complex 10" Q12799 6 167357031-167384510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 16.8" "Group enriched" "Detected in some" 7 "NTERA-2: 2.4;SCLC-21H: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044709, HPA078219" Enhanced "HPA044709: AB_10961410, HPA078219: " "unprognostic (8.33e-2)" "unprognostic (1.52e-1)" "unprognostic (2.27e-1)" "unprognostic (7.79e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCP10L PRED77 ENSG00000242220 "T-complex 10 like" Q8TDR4 21 32574841-32587373 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 75.3" "Cell line enriched" "Detected in many" 4 "SCLC-21H: 16.6" "Cancer enhanced" "Detected in single" "liver cancer: 1.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA044709 Approved "HPA044709: AB_10961410" "unprognostic (2.31e-2)" "unprognostic (7.14e-2)" "unprognostic (1.85e-3)" "unprognostic (5.05e-2)" "unprognostic (1.03e-1)" "unprognostic (1.63e-1)" "unprognostic (1.33e-3)" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (1.85e-1)" "unprognostic (1.05e-1)" "unprognostic (1.63e-1)" "unprognostic (8.41e-5)" "unprognostic (4.98e-2)" "unprognostic (5.94e-2)" "unprognostic (5.67e-2)" "unprognostic (1.64e-3)" 0.1 0.2 0.7 0.1 0.8 0.0 0.2 3.9 2.4 0.2 0.2 0.2 0.4 0.3 0.3 0.7 0.1 0.5 0.3 0.6 0.8 0.7 0.3 8.6 0.3 0.1 0.8 1.0 0.5 0.4 0.4 0.7 0.1 1.0 0.3 0.1 0.2 0.3 0.5 0.1 0.1 0.2 0.1 0.9 0.2 0.0 75.3 0.7 0.2 0.3 0.1 0.1 0.2 0.2 0.8 2.7 1.2 2.0 0.2 1.5 0.7 0.3 1.2 0.8 0.7 1.5 1.1 0.6 0.2 0.5 0.7 0.1 1.1 0.3 0.3 0.5 0.1 0.2 1.6 0.5 0.7 0.7 1.3 0.4 0.8 3.7 1.1 1.7 0.6 0.5 2.0 0.7 0.8 0.6 0.5 0.2 0.1 1.3 1.2 1.4 1.5 1.3 0.5 0.8 0.8 0.1 0.1 16.6 0.5 0.4 1.0 1.8 0.5 2.8 0.3 0.0 1.3 0.7 0.3 2.1 2.4 0.5 0.5 1.4 0.6 0.0 0.7 1.2 0.3 2.0 1.1 0.8 0.4 0.5 2.4 0.7 1.3 0.6 0.0 0.2 0.0 2.7 1.5 0.7 0.7 0.8 3.9 2.4 0.8 0.7 0.8 1.0 1.0 0.7 TCP11 "D6S230E, FPPR, KIAA0229" ENSG00000124678 "T-complex 11" Q8WWU5 6 35118071-35148610 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 64 "testis: 140.4" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 4.7;WM-115: 5.8" "Cancer enhanced" "Detected in some" "cervical cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA048311 Supported "HPA048311: " "unprognostic (1.35e-1)" "prognostic favourable (5.02e-4)" "unprognostic (2.78e-1)" "unprognostic (1.16e-1)" "unprognostic (6.43e-4)" "unprognostic (8.09e-7)" "unprognostic (4.06e-3)" "unprognostic (1.25e-1)" "unprognostic (9.98e-2)" "unprognostic (9.53e-2)" "unprognostic (2.95e-1)" "unprognostic (1.61e-1)" "unprognostic (5.54e-4)" "unprognostic (9.41e-2)" "unprognostic (4.56e-2)" "unprognostic (2.77e-2)" "unprognostic (2.49e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 2.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 140.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.3 1.7 0.5 1.0 1.2 0.0 0.5 0.0 0.0 0.0 1.5 0.5 0.0 0.1 0.0 0.9 0.1 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 4.7 0.4 0.5 0.0 0.0 1.2 0.0 0.0 0.6 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.6 0.8 0.0 0.8 1.3 0.2 0.2 0.5 0.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 TCTE3 TCTEX1D3 ENSG00000184786 "T-complex-associated-testis-expressed 3" Q8IZS6 6 169740114-169751587 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 23.6" "Cell line enhanced" "Detected in some" "HL-60: 1.4;MCF7: 1.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.29e-1)" "unprognostic (1.70e-1)" "unprognostic (1.69e-1)" "unprognostic (2.22e-2)" "unprognostic (1.05e-2)" "unprognostic (6.15e-2)" "unprognostic (1.70e-2)" "unprognostic (2.63e-2)" "unprognostic (5.11e-2)" "unprognostic (1.87e-1)" "unprognostic (6.11e-5)" "unprognostic (1.58e-1)" "unprognostic (2.04e-10)" "unprognostic (1.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.35e-1)" "unprognostic (3.56e-5)" 0.9 1.0 1.3 3.0 3.8 1.2 1.0 3.8 3.8 0.9 1.3 0.4 1.2 0.9 1.1 0.9 0.9 0.9 0.9 0.9 3.0 0.8 1.0 0.9 0.9 0.9 4.2 0.8 1.6 0.9 0.9 4.9 0.9 2.8 1.0 0.9 0.7 1.0 0.9 0.9 1.0 1.1 1.0 2.7 1.1 0.9 23.6 2.9 1.8 1.1 0.4 1.1 1.0 5.3 0.7 0.0 0.2 0.2 0.0 0.4 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.7 0.5 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.3 3.8 3.8 3.8 3.0 0.8 4.2 0.8 2.8 2.9 TDO2 "TDO, TPH2" ENSG00000151790 "Tryptophan 2,3-dioxygenase" P48775 4 155854738-155920406 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "liver: 187.9" "Cell line enhanced" "Detected in some" "EFO-21: 8.4;HDLM-2: 16.4;U-87 MG: 9.6" "Cancer enriched" "Detected in many" 18 "liver cancer: 35.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "cerebellum: 7.0;hippocampal formation: 5.9" "Not detected" "Not detected" HPA039611 Uncertain Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039611: " "unprognostic (1.10e-1)" "unprognostic (3.00e-3)" "unprognostic (3.84e-2)" "unprognostic (1.95e-1)" "unprognostic (7.06e-2)" "unprognostic (3.50e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (4.68e-8)" "unprognostic (7.99e-2)" "unprognostic (9.29e-3)" "unprognostic (1.28e-1)" "unprognostic (1.95e-2)" 0.2 0.5 0.2 2.5 0.5 0.0 0.1 0.1 2.0 0.1 0.2 0.0 0.1 0.6 0.1 0.2 0.2 0.1 0.3 0.1 1.5 0.2 0.2 187.9 0.8 2.9 0.2 0.7 0.1 0.1 0.0 5.8 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 1.1 0.4 0.2 1.5 0.3 0.1 0.0 0.0 0.1 0.0 0.4 1.2 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 8.4 0.0 0.0 0.1 0.0 0.0 16.4 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.1 1.3 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.1 0.3 0.4 0.0 2.6 0.0 0.0 9.6 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 2.0 1.5 0.2 0.2 0.7 0.1 0.0 TDRD1 CT41.1 ENSG00000095627 "Tudor domain containing 1" Q9BXT4 10 114179270-114232304 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 35.3" "Cell line enriched" "Detected in some" 4 "SK-BR-3: 33.0" "Cancer enhanced" "Detected in some" "prostate cancer: 4.1" "Region enriched" "Detected in single" 4 "cerebral cortex: 2.1" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA037729 Enhanced "HPA037729: AB_10670527" "unprognostic (6.77e-2)" "unprognostic (2.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.68e-1)" "unprognostic (1.10e-2)" "unprognostic (1.26e-2)" "unprognostic (3.96e-2)" "unprognostic (3.15e-2)" "unprognostic (6.13e-2)" "unprognostic (1.55e-1)" "unprognostic (1.82e-1)" "unprognostic (1.51e-2)" "unprognostic (9.60e-2)" "unprognostic (3.98e-2)" "unprognostic (4.75e-1)" "unprognostic (1.68e-1)" 0.3 0.2 0.2 0.3 0.2 0.0 0.4 0.2 2.1 0.2 0.3 0.0 0.0 0.2 0.6 0.7 0.3 0.2 0.6 0.8 0.3 0.2 2.8 0.7 0.2 0.2 0.2 0.4 0.5 0.6 0.0 0.3 0.0 0.4 2.9 0.1 0.0 0.3 0.2 0.4 0.2 0.3 0.2 0.7 1.6 0.3 35.3 0.0 0.0 0.2 1.0 0.2 0.2 0.2 0.8 4.5 0.2 0.2 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.2 0.1 0.1 0.5 0.2 0.8 0.8 0.0 0.2 0.4 0.0 4.5 0.2 0.0 0.2 0.2 0.2 2.1 0.3 0.2 0.2 0.4 0.4 0.0 TDRD10 DKFZp434M202 ENSG00000163239 "Tudor domain containing 10" Q5VZ19 1 154502219-154548147 "Cancer-related genes, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 48.4" "Group enriched" "Detected in some" 10 "EFO-21: 2.2;HUVEC TERT2: 7.5;RPMI-8226: 2.1;TIME: 4.0" "Cancer enhanced" "Detected in many" "testis cancer: 5.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054327 Approved Vesicles Vesicles "HPA054327: " "unprognostic (1.30e-1)" "unprognostic (6.33e-2)" "unprognostic (1.78e-1)" "unprognostic (5.33e-3)" "unprognostic (9.69e-3)" "unprognostic (5.80e-3)" "unprognostic (2.99e-1)" "unprognostic (5.97e-3)" "unprognostic (2.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.00e-3)" "unprognostic (1.61e-1)" "unprognostic (1.34e-3)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "prognostic favourable (8.04e-5)" "unprognostic (1.62e-1)" 4.1 1.4 0.7 1.1 0.9 0.0 2.6 0.7 1.4 1.3 0.8 0.9 1.4 0.5 2.1 2.0 1.0 2.1 1.2 2.3 0.7 0.0 1.0 1.5 3.3 1.6 0.9 1.2 4.6 0.7 0.8 0.8 1.4 1.2 1.1 1.1 0.7 0.7 1.0 1.1 0.7 1.0 1.4 1.2 3.5 0.5 48.4 0.8 0.7 4.9 1.5 1.0 1.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 4.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.9 0.7 1.4 0.7 0.0 0.9 1.2 1.2 0.8 TDRD12 "ECAT8, FLJ13072" ENSG00000173809 "Tudor domain containing 12" Q587J7 19 32719753-32829580 "Enzymes, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 36.1" "Group enriched" "Detected in some" 30 "HDLM-2: 12.5;NTERA-2: 41.6" "Cancer enriched" "Detected in many" 9 "testis cancer: 10.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 4 "T-cells: 1.8" "Low region specificity" "Detected in many" "unprognostic (5.43e-2)" "unprognostic (3.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.87e-7)" "unprognostic (5.44e-2)" "unprognostic (1.78e-1)" "unprognostic (6.79e-2)" "unprognostic (1.20e-1)" "unprognostic (2.07e-1)" "unprognostic (1.40e-1)" "unprognostic (9.69e-2)" "unprognostic (1.90e-1)" "unprognostic (1.43e-4)" "unprognostic (2.09e-1)" "unprognostic (4.75e-2)" "unprognostic (3.08e-2)" "unprognostic (2.69e-2)" 0.2 0.7 0.2 0.1 0.4 0.0 0.4 0.2 0.5 0.9 0.3 0.2 0.6 0.0 1.1 8.5 0.2 1.1 0.3 0.3 0.1 0.2 0.9 0.1 0.2 0.8 0.3 0.1 1.8 0.1 0.0 0.2 0.2 0.6 0.2 0.0 0.3 0.2 0.6 0.1 1.7 1.2 0.1 0.1 0.9 0.2 36.1 0.1 0.6 0.9 0.1 0.6 0.5 0.3 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.1 0.6 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 12.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 41.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.4 0.2 0.5 0.1 0.2 0.3 0.1 0.6 0.1 TDRD15 ENSG00000218819 "Tudor domain containing 15" B5MCY1 2 21123917-21143272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 11.3" "Group enriched" "Detected in some" 4 "U-266/70: 12.7;U-266/84: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051770, HPA054675" Uncertain "HPA051770: , HPA054675: " "unprognostic (4.20e-3)" "unprognostic (1.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 12.7 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TDRD5 "FLJ34823, TUDOR3" ENSG00000162782 "Tudor domain containing 5" Q8NAT2 1 179591613-179691272 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 37.7" "Cell line enhanced" "Detected in some" "MCF7: 3.5;SK-BR-3: 5.8;T-47d: 10.3;U-266/70: 14.4;U-266/84: 12.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA029418 Enhanced "HPA029418: AB_10603035" "unprognostic (1.87e-1)" "unprognostic (1.43e-1)" "unprognostic (2.08e-1)" "unprognostic (2.15e-4)" "unprognostic (3.96e-1)" "unprognostic (4.39e-3)" "unprognostic (4.41e-4)" "unprognostic (3.18e-1)" "unprognostic (4.30e-1)" "unprognostic (3.75e-2)" "unprognostic (1.18e-1)" "unprognostic (3.37e-1)" "unprognostic (1.44e-2)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (6.89e-2)" "unprognostic (2.31e-1)" 0.1 0.2 0.9 0.3 3.0 0.4 4.1 0.0 1.4 0.1 0.7 0.1 2.0 0.6 0.0 7.6 0.6 1.0 0.8 0.0 0.7 1.1 1.2 0.0 0.1 0.0 0.8 1.4 0.2 0.2 0.3 3.4 0.2 3.1 0.8 0.8 0.5 1.1 1.6 0.0 0.3 0.5 0.0 0.2 0.0 0.4 37.7 0.5 0.1 0.8 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.8 0.0 10.3 0.2 0.0 0.0 1.6 0.0 0.0 14.4 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.0 0.0 1.4 0.7 1.1 0.8 1.4 3.1 0.5 TDRD6 "bA446F17.4, CT41.2, NY-CO-45, SPATA36" ENSG00000180113 "Tudor domain containing 6" O60522 6 46687875-46704319 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 37.9" "Cell line enhanced" "Detected in some" "HEK 293: 1.6;HeLa: 3.9;hTCEpi: 2.2;PC-3: 3.3;SCLC-21H: 1.6" "Cancer enhanced" "Detected in some" "prostate cancer: 2.1" "Region enriched" "Detected in many" 6 "cerebellum: 8.2" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;intermediate monocyte: 1.4" "Lineage enhanced" "Detected in single" "monocytes: 2.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA075923 Enhanced "HPA075923: " "unprognostic (2.01e-1)" "unprognostic (7.41e-3)" "unprognostic (7.25e-3)" "unprognostic (3.88e-2)" "unprognostic (3.54e-1)" "unprognostic (4.10e-2)" "unprognostic (1.03e-1)" "unprognostic (4.32e-2)" "unprognostic (7.97e-2)" "unprognostic (2.50e-1)" "unprognostic (2.20e-3)" "unprognostic (2.20e-1)" "unprognostic (2.79e-1)" "unprognostic (2.86e-1)" "unprognostic (2.00e-1)" "unprognostic (2.16e-2)" "unprognostic (4.38e-3)" 0.7 1.4 0.7 2.6 1.3 0.0 0.7 8.2 1.3 0.7 0.7 0.7 0.7 0.3 0.7 2.9 0.7 0.3 1.7 0.7 1.0 0.8 0.7 1.3 0.7 3.0 1.1 0.7 0.7 0.7 0.4 1.8 1.1 0.7 1.6 0.0 0.9 0.9 0.7 1.5 2.9 0.7 0.7 0.9 1.9 0.3 37.9 0.7 0.7 5.2 0.7 0.7 1.6 0.7 0.0 0.7 0.1 2.4 0.0 0.0 0.4 0.0 0.0 0.2 1.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.4 0.0 0.0 0.0 1.6 0.0 3.9 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.3 0.0 0.0 0.0 0.9 0.6 1.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.1 0.0 1.1 0.0 0.4 0.0 0.0 0.7 0.0 2.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.7 1.3 8.2 0.9 1.0 0.8 1.1 0.7 0.7 0.7 TECRL "DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL" ENSG00000205678 "Trans-2,3-enoyl-CoA reductase like" Q5HYJ1 4 64275257-64409468 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 131.5" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 131.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 19.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.2 0.2 1.3 0.0 0.0 0.3 0.0 0.9 1.0 0.7 1.2 0.6 0.2 0.3 1.2 0.0 0.2 0.2 1.2 0.8 0.6 0.3 0.3 0.6 0.3 0.1 0.4 0.6 0.0 0.8 1.5 1.5 0.2 1.3 0.7 0.1 0.5 0.2 0.3 0.2 0.8 1.2 0.2 0.2 0.5 0.9 0.7 0.2 0.6 0.9 0.5 2.7 0.6 0.2 0.7 0.5 0.1 0.1 0.4 0.5 0.7 1.2 0.9 0.8 0.8 1.1 0.3 0.8 0.5 0.9 0.6 0.6 0.0 0.2 0.3 0.0 0.2 0.1 0.1 0.1 0.0 0.2 0.2 0.2 1.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 TECTB ENSG00000119913 "Tectorin beta" Q96PL2 10 112283400-112305035 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "retina: 15.8" "Group enriched" "Detected in some" 7 "Hep G2: 7.2;U-2197: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" "unprognostic (3.14e-2)" "unprognostic (2.84e-2)" "unprognostic (9.75e-3)" "unprognostic (1.65e-1)" "unprognostic (1.32e-2)" "unprognostic (5.54e-2)" "unprognostic (2.80e-2)" "unprognostic (8.10e-2)" 0.1 0.0 0.8 0.1 1.3 0.0 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.1 3.5 0.1 0.0 0.1 0.1 0.4 0.2 0.1 2.4 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 15.8 0.1 0.1 0.1 0.0 0.3 0.1 0.5 0.1 0.0 0.2 0.1 0.1 1.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.1 0.3 0.4 0.2 0.9 0.1 0.1 0.1 TEDDM1 "EDDM9, Epdd1, HE9, TMEM45C" ENSG00000203730 "Transmembrane epididymal protein 1" Q5T9Z0 1 182398117-182400616 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "epididymis: 128.3" "Cell line enhanced" "Detected in some" "BEWO: 1.2;NB-4: 4.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 1.3" "Cell type enhanced" "Detected in some" "neutrophil: 3.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "unprognostic (4.21e-2)" "unprognostic (8.89e-2)" "unprognostic (2.18e-1)" "unprognostic (4.22e-2)" "unprognostic (6.71e-4)" "unprognostic (4.43e-3)" "unprognostic (2.86e-2)" "unprognostic (4.57e-2)" "unprognostic (4.20e-1)" "unprognostic (7.22e-3)" "unprognostic (1.23e-1)" "unprognostic (3.39e-2)" "unprognostic (2.47e-2)" "unprognostic (6.99e-3)" 0.1 0.0 0.1 0.1 0.2 0.0 0.4 1.3 0.1 0.5 0.1 0.1 1.8 0.0 0.4 128.3 0.1 0.7 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 1.0 0.3 0.0 0.3 0.1 0.1 0.4 0.0 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 2.3 0.1 0.1 0.3 0.1 0.1 0.1 0.6 0.9 0.4 3.8 0.5 0.4 0.6 0.1 0.0 0.2 0.1 0.2 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.2 0.7 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.4 0.1 4.2 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.4 0.3 0.4 0.2 0.1 0.4 0.4 0.3 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.0 1.3 0.5 1.0 0.6 0.1 0.4 0.1 0.2 0.1 0.1 0.9 0.5 0.3 3.8 0.4 0.5 0.4 0.1 0.1 0.1 0.2 1.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 TEKT3 FLJ32828 ENSG00000125409 "Tektin 3" Q9BXF9 17 15303811-15341641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 36.7" "Cell line enhanced" "Detected in some" "CACO-2: 2.8;HMC-1: 5.2;NB-4: 2.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 4.0" "Group enriched" "Detected in many" 5 "B-cells: 1.0;granulocytes: 4.0;NK-cells: 1.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA044354, HPA073565" Enhanced "HPA044354: AB_10962623, HPA073565: " "unprognostic (1.85e-1)" "unprognostic (6.64e-3)" "unprognostic (9.73e-2)" "unprognostic (5.38e-4)" "unprognostic (4.59e-2)" "unprognostic (3.09e-2)" "unprognostic (9.07e-2)" "unprognostic (8.63e-3)" "unprognostic (4.91e-2)" "unprognostic (1.23e-1)" "unprognostic (9.67e-4)" "unprognostic (1.29e-1)" "unprognostic (1.09e-4)" "unprognostic (1.69e-2)" "unprognostic (3.00e-1)" "unprognostic (2.90e-3)" "unprognostic (7.85e-2)" 0.6 0.1 0.6 0.3 1.3 0.3 2.2 1.8 0.4 0.7 0.4 1.4 0.1 0.3 0.6 1.4 0.1 4.9 0.4 0.8 0.6 0.7 0.2 0.1 2.0 0.1 0.2 0.1 1.0 0.7 0.2 0.8 0.2 2.3 0.5 0.2 0.2 0.5 0.1 0.1 0.6 0.4 0.2 0.3 0.2 0.0 36.7 0.4 0.1 0.4 0.5 0.1 0.1 0.2 1.0 0.4 4.0 0.4 1.4 0.4 0.1 0.2 0.0 1.7 1.9 0.0 0.3 1.2 0.6 1.4 0.1 0.0 2.8 0.0 0.4 0.2 0.9 0.8 0.0 0.0 0.2 0.7 0.6 0.7 1.3 0.5 0.3 0.5 5.2 0.0 0.7 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.3 2.5 0.0 0.3 0.2 0.9 0.0 0.5 0.9 0.8 0.7 0.0 0.5 0.6 0.0 0.1 0.0 0.1 0.6 0.3 0.3 0.8 0.5 0.6 0.0 0.0 0.5 4.0 0.4 0.3 0.3 0.4 0.2 0.8 0.4 0.1 0.1 1.0 0.3 0.3 2.6 1.4 0.2 0.4 0.3 0.1 0.6 1.3 1.8 0.4 0.6 0.7 0.2 0.1 2.3 0.4 TEKT5 "CT149, FLJ32871" ENSG00000153060 "Tektin 5" Q96M29 16 10627501-10694945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "testis: 30.4" "Cell line enriched" "Detected in some" 13 "BEWO: 16.6" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.0" "Lineage enhanced" "Detected in single" "dendritic cells: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA043578 Supported "Actin filaments" "Actin filaments" "HPA043578: AB_10795772" "unprognostic (5.90e-2)" "unprognostic (1.37e-2)" "unprognostic (1.39e-2)" "unprognostic (7.53e-2)" "unprognostic (2.69e-2)" "unprognostic (9.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.39e-2)" "unprognostic (1.89e-1)" "unprognostic (5.09e-2)" "unprognostic (5.88e-2)" "unprognostic (5.02e-2)" "unprognostic (3.24e-7)" "unprognostic (3.80e-2)" "unprognostic (2.31e-1)" "unprognostic (3.76e-2)" "unprognostic (8.12e-5)" 0.1 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.2 0.2 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.9 30.4 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 16.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.6 0.2 0.9 0.2 0.4 0.1 0.2 1.3 0.3 0.0 0.2 0.1 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.2 0.2 0.1 0.1 0.1 0.1 TEPP ENSG00000159648 "Testis, prostate and placenta expressed" Q6URK8 16 57976435-57988116 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 46.3" "Cell line enhanced" "Detected in some" "BEWO: 2.9;HMC-1: 2.0;RPMI-8226: 2.4;TIME: 2.1" "Cancer enhanced" "Detected in some" "thyroid cancer: 3.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 4.5" "Lineage enriched" "Detected in single" 6 "T-cells: 4.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA062092 Enhanced "Secreted in male reproductive system" "HPA062092: " "unprognostic (4.86e-2)" "unprognostic (2.72e-1)" "unprognostic (4.12e-2)" "unprognostic (2.56e-2)" "unprognostic (1.79e-2)" "unprognostic (8.04e-2)" "unprognostic (3.67e-1)" "unprognostic (2.40e-2)" "unprognostic (2.74e-1)" "unprognostic (2.48e-1)" "unprognostic (1.52e-1)" "unprognostic (1.42e-1)" "unprognostic (1.27e-2)" "unprognostic (2.09e-2)" "unprognostic (1.46e-1)" "unprognostic (3.97e-3)" "unprognostic (2.59e-1)" 0.1 0.7 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.3 0.1 0.4 0.1 0.0 0.1 0.5 0.3 0.6 0.1 0.3 0.1 0.2 0.1 0.1 0.8 0.1 0.1 0.3 0.7 0.1 0.0 0.1 0.1 0.4 0.3 0.0 0.1 0.2 1.2 0.1 0.1 0.1 0.1 0.3 0.1 0.0 46.3 0.2 0.1 2.6 0.1 0.2 1.6 0.5 0.7 0.2 0.3 0.0 0.2 4.5 1.3 0.0 0.0 0.6 0.0 0.0 0.0 2.9 0.0 0.4 0.5 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 2.5 0.1 3.0 2.0 0.0 0.7 2.9 4.5 0.0 0.2 0.0 0.2 1.4 1.3 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.3 0.4 0.2 TERB1 "CCDC79, FLJ35894" ENSG00000249961 "Telomere repeat binding bouquet formation protein 1" Q8NA31 16 66754976-66801620 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 23.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (2.15e-1)" "unprognostic (9.15e-2)" "unprognostic (1.30e-1)" "unprognostic (2.29e-1)" "unprognostic (3.91e-2)" "unprognostic (9.75e-2)" "unprognostic (5.79e-2)" "unprognostic (1.03e-1)" "unprognostic (7.57e-5)" "unprognostic (6.49e-2)" "unprognostic (3.23e-3)" "unprognostic (2.88e-2)" "unprognostic (6.81e-6)" "unprognostic (1.66e-1)" "unprognostic (2.56e-1)" "unprognostic (2.34e-1)" "unprognostic (6.14e-3)" 0.1 0.2 0.1 0.1 0.1 1.9 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.1 23.2 0.1 0.1 0.4 0.1 0.1 0.1 0.1 2.0 3.3 4.1 0.9 4.3 1.0 0.7 0.8 2.1 1.1 0.4 1.6 0.1 0.0 0.4 0.0 0.7 0.3 2.7 1.6 1.2 0.2 0.0 1.6 0.0 1.1 0.2 0.4 2.3 0.5 2.8 1.8 0.0 0.0 1.8 0.7 1.5 0.4 0.0 0.5 0.4 2.6 0.0 0.5 1.0 1.7 0.3 0.0 0.8 1.0 1.6 0.0 2.1 1.0 0.9 0.6 0.8 0.4 0.2 1.2 0.2 1.6 0.7 1.9 0.6 1.3 0.8 1.9 2.0 1.1 0.2 4.1 0.9 0.5 0.7 0.4 0.6 1.2 0.5 0.8 0.1 2.0 0.8 1.0 3.0 4.3 0.4 3.3 0.4 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 TERB2 "C15orf43, MGC33951" ENSG00000167014 "Telomere repeat binding bouquet formation protein 2" Q8NHR7 15 44956702-44979229 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 51.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041780 Uncertain Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA041780: AB_10796460" "unprognostic (1.42e-3)" "unprognostic (4.19e-2)" "unprognostic (1.29e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TESMIN "CXCDC2, MTL5" ENSG00000132749 "Testis expressed metallothionein like protein" Q9Y4I5 11 68707440-68751564 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "testis: 81.0" "Cell line enhanced" "Detected in many" "HMC-1: 10.5;T-47d: 20.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA018539 Supported Nucleoplasm Nucleoplasm "HPA018539: " "unprognostic (1.99e-1)" "unprognostic (3.97e-3)" "unprognostic (1.34e-2)" "prognostic unfavourable (1.75e-5)" "unprognostic (3.22e-2)" "unprognostic (6.71e-2)" "unprognostic (1.76e-2)" "unprognostic (6.99e-3)" "unprognostic (2.54e-1)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (8.47e-2)" "unprognostic (5.27e-2)" "unprognostic (6.39e-2)" "unprognostic (2.99e-1)" "unprognostic (9.85e-2)" "unprognostic (3.17e-1)" 0.3 0.5 0.3 1.6 1.4 4.8 3.3 0.1 0.6 0.6 1.9 0.0 3.8 1.0 0.5 1.2 1.3 1.3 1.0 0.4 0.2 0.9 3.2 0.3 0.4 0.9 0.6 0.4 0.8 2.6 2.6 1.9 0.4 1.8 1.7 2.2 0.6 2.5 5.2 0.1 0.5 1.2 0.3 0.7 1.2 0.6 81.0 0.1 5.5 1.5 0.9 2.0 0.5 0.7 0.4 0.1 2.8 1.1 0.0 1.1 0.4 6.0 2.7 1.1 0.0 0.0 0.0 3.1 1.4 0.6 1.9 0.9 0.8 6.1 2.4 1.4 0.2 2.9 0.9 1.2 1.5 2.5 2.1 1.7 0.9 0.0 0.0 1.3 10.5 0.0 3.3 0.1 2.0 0.6 3.8 4.7 0.3 4.0 0.6 3.5 6.4 2.7 1.6 0.3 0.7 2.2 0.1 3.9 4.2 0.0 1.3 0.0 20.7 8.5 2.3 0.2 0.4 0.1 0.1 1.9 1.6 2.4 0.1 3.6 1.6 0.0 1.0 1.0 0.3 0.4 0.6 0.0 1.1 0.2 0.1 0.4 0.4 0.3 2.8 0.0 1.1 0.1 0.8 0.4 0.3 1.4 0.1 0.6 0.2 0.9 0.6 0.4 1.8 0.1 TEX12 ENSG00000150783 "Testis expressed 12" Q9BXU0 11 112167372-112172559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 29.9" "Cell line enhanced" "Detected in some" "U-698: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA038289, HPA038290" Enhanced "HPA038289: AB_10672742, HPA038290: AB_2675934" "unprognostic (1.49e-1)" "unprognostic (6.57e-2)" "unprognostic (1.01e-1)" "unprognostic (2.92e-2)" "unprognostic (1.07e-1)" "unprognostic (2.93e-3)" "unprognostic (2.03e-1)" "unprognostic (1.55e-1)" "unprognostic (1.26e-1)" "unprognostic (1.21e-1)" "unprognostic (2.91e-1)" "unprognostic (9.20e-4)" "unprognostic (1.71e-2)" "unprognostic (2.97e-1)" "unprognostic (6.54e-2)" "unprognostic (4.10e-2)" "unprognostic (3.16e-3)" 0.3 0.0 0.1 0.6 0.2 0.3 0.4 0.1 0.4 0.2 0.2 0.3 0.1 0.6 0.2 0.5 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.9 0.7 0.4 0.2 0.1 0.2 0.2 29.9 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.5 0.5 1.5 0.5 0.0 0.9 0.3 0.1 0.0 0.6 0.3 1.1 0.7 0.2 0.3 0.4 0.4 1.1 0.4 1.4 2.5 0.6 0.7 0.0 0.5 0.4 0.7 1.5 0.0 1.1 0.0 0.0 1.5 1.4 0.8 0.9 0.6 1.0 0.4 0.1 0.3 1.2 0.0 0.0 1.1 2.4 0.1 0.9 0.8 0.3 2.1 1.1 0.1 0.3 0.4 0.0 1.4 0.0 0.1 2.5 0.0 0.4 1.5 0.8 0.5 0.2 0.2 4.8 0.6 1.3 0.0 0.0 0.1 1.5 0.1 0.5 0.0 0.5 0.5 0.9 0.0 0.0 0.0 0.3 0.8 0.0 0.4 0.5 0.0 0.3 0.1 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 TEX13A ENSG00000268629 "Testis expressed 13A" Q9BXU3 X 105218929-105220674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 100 "testis: 9.9" "Cell line enhanced" "Detected in single" "ASC TERT1: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA072257 Enhanced "HPA072257: " "unprognostic (3.70e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX13B "TGC3B, TSGA5" ENSG00000170925 "Testis expressed 13B" Q9BXU2 X 107980864-107982370 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 3.3" "Cell line enhanced" "Detected in some" "NTERA-2: 1.5;U-138 MG: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.58e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX13C ENSG00000282815 "TEX13 family member C" A0A0J9YWL9 X 125320120-125325214 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "testis: 5.9" "Cell line enhanced" "Detected in some" "SK-BR-3: 1.4;U-2 OS: 3.2;U-266/70: 1.1;WM-115: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.2 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.7 0.0 0.0 0.1 3.2 0.9 0.0 1.1 0.6 0.0 0.0 0.0 1.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 TEX13D ENSG00000282419 "TEX13 family member D" X 124246249-124336862 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 64 "testis: 6.4" "Cell line enriched" "Detected in single" 5 "NB-4: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX14 CT113 ENSG00000121101 "Testis expressed 14, intercellular bridge forming factor" Q8IWB6 17 58556678-58692055 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "testis: 52.7" "Cell line enhanced" "Detected in some" "HDLM-2: 8.9;Karpas-707: 11.6;MCF7: 4.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030620, HPA077020" Enhanced Approved "Vesicles,Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cytosol" "Vesicles, Cell Junctions" "HPA030620: AB_10601598, HPA077020: " "unprognostic (1.21e-2)" "unprognostic (2.12e-1)" "unprognostic (2.06e-1)" "unprognostic (9.49e-2)" "unprognostic (2.48e-1)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (6.17e-2)" "unprognostic (2.07e-2)" "unprognostic (1.61e-3)" "unprognostic (2.67e-2)" "unprognostic (8.10e-2)" "unprognostic (1.76e-9)" "unprognostic (1.77e-1)" "unprognostic (2.54e-1)" "unprognostic (5.00e-3)" "unprognostic (5.88e-2)" 0.1 0.1 0.2 0.1 0.3 1.5 0.1 0.9 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.3 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.5 0.2 0.0 52.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.8 0.2 0.1 0.0 0.2 2.5 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.2 0.0 0.0 0.3 0.0 0.2 8.9 1.3 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.0 0.0 0.1 11.6 0.0 4.7 0.4 0.1 0.6 0.1 0.5 0.4 1.7 0.0 0.1 1.4 0.2 0.0 0.0 0.6 0.4 0.1 0.0 0.1 0.3 0.0 0.0 2.0 0.5 1.1 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.8 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.9 0.2 0.3 0.2 0.2 0.1 0.4 0.1 TEX19 FLJ35767 ENSG00000182459 "Testis expressed 19" Q8NA77 17 82359247-82363776 "Predicted intracellular proteins" "Differentiation, Meiosis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 114 "testis: 40.7" "Cell line enhanced" "Detected in some" "Daudi: 18.3;HMC-1: 15.3;MOLT-4: 12.7;U-266/70: 19.8;U-937: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA054577 Enhanced "HPA054577: " "unprognostic (3.58e-2)" "unprognostic (5.43e-2)" "unprognostic (8.63e-3)" "unprognostic (3.85e-2)" "unprognostic (2.43e-1)" "unprognostic (4.03e-2)" "unprognostic (4.51e-5)" "unprognostic (4.14e-1)" "unprognostic (2.72e-1)" "unprognostic (1.44e-1)" "unprognostic (3.59e-1)" "unprognostic (1.67e-15)" "unprognostic (2.15e-1)" "unprognostic (1.01e-1)" "unprognostic (3.43e-2)" "unprognostic (3.35e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.2 0.3 0.0 0.2 2.5 0.1 0.0 0.1 0.1 1.5 0.0 18.3 3.5 0.0 0.7 1.2 0.0 0.0 0.0 1.9 0.0 0.0 0.9 0.0 0.0 15.3 0.0 0.0 0.0 0.1 0.0 0.8 0.3 0.0 0.9 12.7 0.6 0.3 0.2 0.9 0.2 3.2 0.1 0.0 0.1 0.3 0.1 5.9 0.9 0.5 0.4 0.0 0.0 0.5 1.3 0.1 19.8 0.9 1.7 0.0 7.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 TEX22 ENSG00000226174 "Testis expressed 22" C9J3V5 14 105398579-105450106 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 25.4" "Cell line enhanced" "Detected in some" "HDLM-2: 6.3;U-266/70: 5.3;U-937: 3.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA065576 Enhanced "HPA065576: " "unprognostic (3.99e-2)" "unprognostic (6.00e-2)" "unprognostic (1.30e-3)" "unprognostic (2.06e-1)" "unprognostic (3.36e-1)" "unprognostic (1.62e-2)" "unprognostic (7.48e-2)" "unprognostic (1.52e-2)" "unprognostic (3.95e-2)" "unprognostic (1.53e-5)" "unprognostic (1.42e-4)" "unprognostic (8.13e-2)" "unprognostic (5.96e-2)" "unprognostic (2.18e-2)" "unprognostic (5.25e-2)" "unprognostic (1.68e-2)" "unprognostic (5.91e-3)" 1.2 0.7 3.2 2.4 3.1 2.3 4.2 4.6 4.2 1.5 0.8 1.5 1.4 1.3 1.3 3.8 0.8 2.9 1.3 0.9 4.3 1.5 1.5 0.7 3.0 2.9 3.0 3.0 2.3 4.6 2.0 1.0 1.0 3.0 2.0 0.8 0.9 1.9 2.5 1.2 1.7 1.5 0.6 2.7 2.5 1.6 25.4 2.9 4.0 1.4 0.5 1.7 1.0 1.7 0.5 1.1 0.0 1.4 0.0 0.6 0.1 0.3 0.7 0.7 3.1 1.0 0.1 0.7 0.3 0.1 0.0 0.4 0.4 0.4 1.9 0.2 0.2 0.3 0.5 0.1 0.1 6.3 0.3 0.3 0.8 0.0 0.4 0.5 2.0 0.7 0.4 0.1 0.1 0.1 0.1 2.0 0.1 1.8 0.2 0.4 0.2 0.1 1.8 0.1 0.1 0.4 0.5 0.6 0.7 0.0 0.1 0.3 0.5 0.7 0.0 0.3 0.1 0.7 0.1 5.3 0.7 0.7 0.1 3.9 2.7 0.0 1.4 0.0 0.0 0.3 0.5 0.2 0.0 0.6 0.1 0.5 0.3 0.0 0.0 0.0 0.4 1.1 0.5 0.1 3.2 3.1 4.6 4.2 4.3 1.5 3.0 3.0 3.0 2.9 TEX28 "CXorf2, fTEX" ENSG00000278057 "Testis expressed 28" O15482 X 154271265-154295853 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.6;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 4 "T-cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.1 0.0 0.2 0.2 0.3 0.5 0.0 TEX29 "bA474D23.1, C13orf16, MGC35169" ENSG00000153495 "Testis expressed 29" Q8N6K0 13 111316184-111344249 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 36.8" "Cell line enriched" "Detected in single" 54 "U-698: 21.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebral cortex: 6.1" "Cell type enhanced" "Detected in some" "eosinophil: 1.8;memory B-cell: 1.3" "Low lineage specificity" "Detected in many" "unprognostic (2.93e-1)" "unprognostic (2.26e-2)" "unprognostic (8.62e-4)" "unprognostic (4.56e-1)" "unprognostic (7.26e-2)" "unprognostic (4.93e-1)" "unprognostic (2.08e-2)" "unprognostic (8.51e-2)" "unprognostic (5.45e-2)" "unprognostic (2.43e-1)" "unprognostic (2.78e-2)" "unprognostic (7.86e-2)" "unprognostic (1.13e-9)" "unprognostic (3.41e-1)" "unprognostic (1.51e-1)" "unprognostic (5.07e-2)" "unprognostic (4.21e-2)" 0.3 0.2 2.7 0.3 1.7 0.0 0.3 0.3 6.1 0.3 0.3 0.3 0.3 0.1 0.3 0.5 0.4 0.1 0.3 0.3 0.9 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.6 0.1 0.5 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.5 0.1 0.4 0.3 0.3 0.3 0.2 36.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.3 0.6 1.8 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 21.9 0.3 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.1 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.1 2.7 1.7 0.3 6.1 0.9 0.2 0.3 0.3 0.3 0.3 TEX33 "C22orf33, EAN57, MGC35206" ENSG00000185264 "Testis expressed 33" O43247 22 36991120-37007841 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 465 "testis: 49.1" "Cell line enhanced" "Detected in single" "CACO-2: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA005998 Enhanced "HPA005998: AB_1078352" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX35 "C1orf49, DKFZP564J047, TSC24" ENSG00000240021 "Testis expressed 35" Q5T0J7 1 178513077-178548602 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 66.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA039190 Approved "HPA039190: AB_10794425" "unprognostic (2.20e-1)" "unprognostic (1.77e-2)" "unprognostic (1.26e-1)" "unprognostic (1.89e-2)" "unprognostic (8.92e-3)" "unprognostic (1.08e-2)" "unprognostic (7.04e-2)" "unprognostic (9.60e-2)" "unprognostic (1.21e-1)" "unprognostic (2.51e-3)" "unprognostic (2.01e-2)" "unprognostic (1.92e-1)" "unprognostic (5.23e-1)" "unprognostic (5.41e-2)" 0.2 0.1 0.2 0.2 0.3 1.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.2 1.0 0.2 0.1 0.2 0.4 0.2 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 1.5 0.2 0.2 0.2 0.2 0.6 66.9 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.7 1.0 3.4 0.9 0.4 1.1 0.0 1.4 0.8 2.9 3.8 2.4 3.5 8.3 1.4 2.2 1.3 0.8 2.0 1.0 2.5 1.4 1.0 1.1 2.6 0.8 1.2 2.1 1.0 2.6 3.2 3.7 0.5 3.2 1.3 2.9 1.3 1.7 3.4 0.6 2.1 2.3 1.1 1.0 1.8 2.1 5.1 1.5 1.6 1.3 2.0 2.1 2.0 2.1 1.7 2.9 3.5 0.8 1.5 2.1 2.3 3.4 2.4 2.0 2.1 2.6 3.1 1.9 2.6 2.4 0.7 0.9 0.8 1.2 1.0 0.3 0.3 0.9 0.9 0.7 0.5 1.7 1.1 0.7 3.4 0.4 0.9 1.0 0.5 0.0 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 TEX36 "bA383C5.1, C10orf122" ENSG00000175018 "Testis expressed 36" Q5VZQ5 10 125576522-125683144 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 52 "testis: 24.6" "Cell line enriched" "Detected in some" 6 "U-2197: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 14 "cerebellum: 2.6" "Low region specificity" "Detected in all" "unprognostic (7.72e-3)" "unprognostic (3.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 24.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 13.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX37 "C2orf51, FLJ25369, TSC21" ENSG00000172073 "Testis expressed 37" Q96LM6 2 88524651-88529584 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 221 "testis: 54.4" "Cell line enriched" "Detected in single" 43 "BEWO: 33.4" "Cancer enriched" "Detected in single" 17 "testis cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA043987 Enhanced "HPA043987: AB_10961125" "unprognostic (1.08e-3)" "unprognostic (2.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 33.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX38 "ATPAF1-AS1, C1orf223, LOC374973, THEG4" ENSG00000186118 "Testis expressed 38" Q6PEX7 1 46668855-46673594 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "testis: 109.8" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.0;SK-BR-3: 2.2;TIME: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "unprognostic (8.46e-2)" "unprognostic (1.99e-1)" "unprognostic (3.14e-2)" "unprognostic (8.86e-2)" "unprognostic (6.81e-3)" "unprognostic (3.50e-1)" "unprognostic (1.99e-1)" "unprognostic (9.21e-2)" "unprognostic (5.39e-2)" "unprognostic (4.15e-3)" "unprognostic (4.93e-4)" "unprognostic (2.64e-1)" "unprognostic (5.28e-2)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (7.84e-2)" "unprognostic (3.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 2.5 0.3 0.1 1.6 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.0 1.3 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.8 0.3 0.0 0.5 0.4 0.0 0.6 0.6 0.5 0.0 0.1 0.9 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.9 0.0 0.6 0.6 2.0 1.4 1.0 2.2 0.0 0.8 0.0 2.5 0.3 0.0 1.0 0.2 0.9 0.3 0.6 0.2 0.0 0.2 0.0 0.3 2.5 1.2 0.2 1.6 0.9 0.1 0.9 0.4 0.4 0.9 0.2 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 TEX43 "C5orf48, FLJ27505, MGC163367, MGC163369, Tseg7" ENSG00000196900 "Testis expressed 43" Q6ZNM6 5 126631722-126636287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 23.8" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 2.1;BJ hTERT+ SV40 Large T+ RasG12V: 2.1;HeLa: 1.1;SK-BR-3: 1.8" "Cancer enriched" "Detected in single" 7 "colorectal cancer: 1.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.0" "Low lineage specificity" "Detected in single" "Region enhanced" "Detected in single" "pons and medulla: 0.4" "Low region specificity" "Detected in single" "unprognostic (1.73e-1)" "unprognostic (3.85e-2)" "unprognostic (4.06e-2)" "unprognostic (2.76e-1)" "unprognostic (1.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 2.1 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX44 "C2orf57, MGC35154" ENSG00000177673 "Testis expressed 44" Q53QW1 2 231592901-231594283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "testis: 98.8" "Cell line enhanced" "Detected in single" "HDLM-2: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049917, HPA056433" Enhanced "HPA049917: AB_2680951, HPA056433: AB_2683131" "unprognostic (5.42e-2)" "unprognostic (3.90e-1)" "unprognostic (6.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX45 "C19orf45, FLJ35784" ENSG00000198723 "Testis expressed 45" Q8NA69 19 7492976-7508450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 40.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "unprognostic (7.96e-3)" "unprognostic (3.90e-2)" "unprognostic (5.17e-2)" "unprognostic (1.84e-3)" "unprognostic (7.44e-2)" "unprognostic (1.50e-2)" "unprognostic (3.74e-2)" "unprognostic (3.72e-2)" "unprognostic (6.42e-2)" "unprognostic (4.71e-2)" "unprognostic (4.07e-2)" "unprognostic (1.94e-1)" "unprognostic (4.72e-1)" "unprognostic (4.32e-2)" "unprognostic (3.35e-2)" "unprognostic (1.11e-1)" "unprognostic (1.58e-3)" 0.2 0.6 0.3 0.2 0.3 2.2 0.2 0.3 0.4 0.2 0.2 0.2 0.2 0.1 0.3 0.4 0.2 0.1 0.4 0.2 0.4 0.3 0.2 0.2 0.3 0.2 0.5 0.2 0.2 0.2 0.0 1.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 2.7 1.5 0.2 0.6 0.2 0.2 40.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.6 1.0 3.0 0.8 0.4 0.9 0.2 0.4 0.0 0.5 1.7 0.0 0.0 0.1 0.9 0.0 0.8 0.5 1.2 1.5 0.3 0.7 0.5 1.0 0.2 0.0 0.0 0.4 0.9 0.0 1.3 0.8 0.1 0.0 2.5 0.0 1.1 0.0 0.6 0.0 1.2 2.4 0.3 1.9 1.6 1.0 0.4 0.4 0.3 0.3 1.0 0.1 1.1 2.9 0.7 1.4 1.6 0.0 1.5 2.9 0.8 0.2 0.9 0.6 0.9 1.3 0.3 1.2 1.0 1.4 0.0 3.0 0.4 0.5 0.9 0.8 0.7 1.0 0.6 0.5 0.1 1.6 0.8 0.7 1.7 0.4 0.3 1.0 0.3 0.2 0.3 0.3 0.3 0.2 0.4 0.3 0.5 0.2 0.2 0.2 TEX46 C1orf234 ENSG00000227868 "Testis expressed 46" H3BTG2 1 23010834-23015850 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 39.7" "Cell line enhanced" "Detected in some" "ASC diff: 3.1;HSkMC: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 7 "T-cells: 1.7" "Not detected" "Not detected" "unprognostic (3.11e-1)" "unprognostic (1.86e-1)" "unprognostic (9.04e-2)" "unprognostic (2.13e-1)" "unprognostic (1.24e-2)" "unprognostic (6.33e-2)" "unprognostic (2.84e-1)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (9.76e-2)" "unprognostic (8.12e-2)" "unprognostic (3.82e-3)" "unprognostic (2.29e-5)" "unprognostic (1.06e-1)" "unprognostic (1.15e-1)" "unprognostic (7.60e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 39.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 1.4 0.5 3.1 0.8 1.4 0.0 0.6 1.1 0.9 0.0 0.8 0.4 1.2 0.0 1.0 0.0 0.0 0.0 0.0 2.5 0.0 1.5 0.0 0.0 0.0 0.3 3.9 1.3 0.6 0.8 0.7 0.7 0.4 0.7 1.1 0.0 0.7 1.2 0.0 0.0 0.3 0.0 0.0 0.0 2.0 0.0 1.4 0.5 0.2 1.4 0.0 1.5 0.3 0.4 0.4 0.0 2.4 0.0 0.2 0.4 0.5 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 TEX47 "C7orf62, MGC26647" ENSG00000164645 "Testis expressed 47" Q8TBZ9 7 88794106-88795721 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 158 "testis: 26.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA023817, HPA024163" Uncertain Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA023817: AB_1853868, HPA024163: AB_1853869" "unprognostic (1.43e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TEX48 ENSG00000230601 "Testis expressed 48" A0A1B0GUV7 9 114666434-114682066 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "testis: 24.2" "Cell line enriched" "Detected in some" 8 "Karpas-707: 12.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.4" "Lineage enhanced" "Detected in single" "T-cells: 2.4" "unprognostic (2.70e-1)" "unprognostic (6.41e-2)" "unprognostic (7.83e-2)" "unprognostic (2.53e-1)" "unprognostic (5.10e-2)" "unprognostic (2.33e-2)" "unprognostic (1.70e-1)" "unprognostic (5.11e-2)" "unprognostic (1.51e-1)" "unprognostic (4.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 24.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 2.4 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.7 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 12.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 0.1 0.2 1.5 0.1 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.3 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.6 1.1 0.0 TEX49 LINC00935 ENSG00000257987 "Testis expressed 49" A0A1B0GTD5 12 48727435-48765786 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "testis: 20.1" "Cell line enhanced" "Detected in some" "CACO-2: 1.5;MCF7: 3.5" "Group enriched" "Detected in some" 6 "stomach cancer: 0.6;testis cancer: 1.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.9" "Lineage enhanced" "Detected in single" "dendritic cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (2.63e-2)" "unprognostic (6.32e-3)" "unprognostic (8.28e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX50 ENSG00000232113 "Testis expressed 50" A0A1B0GTY4 1 173635333-173637134 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 176 "testis: 17.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX51 ENSG00000237524 "Testis expressed 51" A0A1B0GUA7 2 126898864-126902097 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 79 "testis: 51.3" "Cell line enriched" "Detected in single" 6 "U-2197: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 TEX53 ENSG00000230054 "Testis expressed 53" 9 114656304-114662374 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 36 "testis: 36.2" "Cell line enhanced" "Detected in some" "Karpas-707: 6.0;T-47d: 1.6;U-266/70: 1.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "unprognostic (2.37e-1)" "unprognostic (2.17e-1)" "unprognostic (1.02e-1)" "unprognostic (8.79e-2)" "unprognostic (2.94e-1)" "unprognostic (2.85e-2)" "unprognostic (1.90e-2)" "unprognostic (6.83e-2)" "unprognostic (4.19e-2)" "unprognostic (8.18e-4)" "unprognostic (8.64e-6)" "unprognostic (9.94e-2)" "unprognostic (1.79e-1)" "unprognostic (1.94e-3)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 36.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 1.0 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.0 0.0 0.8 0.3 0.0 0.3 0.9 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 1.6 0.4 0.0 0.0 0.0 0.0 0.3 1.8 1.0 1.1 0.0 0.1 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TF "PRO1557, PRO2086" ENSG00000091513 Transferrin P02787 3 133745956-133796640 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Ion transport, Iron transport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "liver: 711.5" "Cell line enriched" "Detected in some" 48 "Hep G2: 129.1" "Cancer enriched" "Detected in many" 42 "liver cancer: 783.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001527, HPA005692, CAB009538" Enhanced "Secreted to blood" 2500000000000 120000000000 "CAB009538: AB_793365, HPA001527: AB_1080357, HPA005692: AB_1080354" "prognostic favourable (4.05e-4)" "unprognostic (2.45e-2)" "unprognostic (1.78e-1)" "unprognostic (1.50e-1)" "unprognostic (8.99e-2)" "unprognostic (5.18e-2)" "unprognostic (6.63e-2)" "unprognostic (8.46e-2)" "unprognostic (2.82e-1)" "unprognostic (3.08e-1)" "unprognostic (1.37e-1)" "unprognostic (7.60e-2)" "prognostic unfavourable (2.35e-13)" "unprognostic (2.17e-3)" "unprognostic (5.49e-2)" "unprognostic (3.47e-3)" "unprognostic (9.70e-2)" 7.8 1.3 6.7 1.2 26.7 1.3 1.9 3.7 20.4 1.4 1.3 57.2 0.0 1.2 1.3 1.3 1.8 1.3 1.3 2.4 11.3 7.4 1.5 711.5 1.3 1.3 50.8 12.3 1.4 1.6 1.4 0.8 1.3 40.2 1.5 1.3 14.0 4.0 1.3 1.3 1.3 1.2 1.3 46.9 1.3 1.3 2.4 39.9 0.0 1.4 0.0 1.4 1.3 0.6 1.1 1.0 2.6 1.1 0.9 0.8 0.4 0.3 0.2 0.3 0.2 0.9 0.6 0.1 0.3 0.3 0.1 0.1 0.5 0.2 0.2 0.2 0.3 0.3 0.2 0.3 0.2 0.1 0.1 2.7 0.4 129.1 0.2 0.7 0.4 0.4 0.6 0.1 0.2 0.3 1.0 0.3 0.4 0.2 0.1 0.2 0.2 0.3 0.2 0.5 0.1 0.1 0.5 0.3 0.2 0.3 0.4 1.0 0.3 0.2 0.4 0.4 0.2 0.2 0.1 0.3 0.4 0.2 0.3 0.2 0.2 2.6 1.1 0.7 0.6 0.7 0.6 0.6 0.6 0.6 0.6 1.1 0.8 0.8 2.4 0.9 0.7 1.0 0.4 0.4 6.7 26.7 3.7 19.6 11.3 7.4 50.8 12.3 40.2 39.9 TFAP2B AP2-B ENSG00000008196 "Transcription factor AP-2 beta" Q92481 6 50818723-50847613 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "epididymis: 65.5" "Group enriched" "Detected in some" 4 "AF22: 31.7;SH-SY5Y: 59.0" "Cancer enriched" "Detected in some" 8 "breast cancer: 12.1" "Group enriched" "Detected in some" 41 "cerebellum: 4.7;pons and medulla: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 11.2" "Low region specificity" "Detected in many" "HPA034683, HPA062942" Enhanced Approved Nucleoplasm Nucleoplasm "HPA034683: AB_10670966, HPA062942: " "unprognostic (2.02e-1)" "unprognostic (2.29e-2)" "unprognostic (4.27e-2)" "unprognostic (5.88e-4)" "unprognostic (9.76e-2)" "unprognostic (2.10e-1)" "unprognostic (1.00e-1)" "unprognostic (4.57e-1)" "unprognostic (6.58e-6)" "unprognostic (1.13e-2)" "unprognostic (1.88e-1)" "unprognostic (7.17e-3)" 0.2 3.0 0.0 0.0 0.0 0.0 9.4 4.7 0.0 0.2 0.2 0.0 8.8 0.0 0.0 65.5 5.8 0.0 0.0 0.1 0.0 0.1 6.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 6.3 0.1 0.0 12.2 7.0 0.6 0.0 6.3 0.0 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 59.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 0.1 0.0 6.3 0.0 TFAP2D TFAP2BL1 ENSG00000008197 "Transcription factor AP-2 delta" Q7Z6R9 6 50713828-50772988 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 4.4" "Group enriched" "Detected in some" 5 "HAP1: 5.1;U-2197: 1.6" "Cancer enriched" "Detected in single" 10 "lung cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "midbrain: 14.1" "Region enriched" "Detected in some" 7 "midbrain: 16.3" 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TFDP3 "CT30, E2F-like, HCA661" ENSG00000183434 "Transcription factor Dp family member 3" Q5H9I0 X 133216669-133218348 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "testis: 17.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "testis cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (3.22e-1)" "unprognostic (2.91e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TFPI2 "PP5, REF1, TFPI-2" ENSG00000105825 "Tissue factor pathway inhibitor 2" P48307 7 93885397-93890991 "Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "placenta: 1024.1" "Cell line enhanced" "Detected in many" "EFO-21: 178.0;hTEC/SVTERT24-B: 88.4;U-138 MG: 85.9;U-2197: 76.5;U-87 MG: 145.4" "Cancer enhanced" "Detected in all" "renal cancer: 65.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB010142, HPA049158" Enhanced "Secreted to extracellular matrix" "CAB010142: AB_628166, HPA049158: " "prognostic favourable (8.33e-7)" "unprognostic (2.20e-2)" "unprognostic (2.10e-2)" "prognostic favourable (5.42e-4)" "unprognostic (5.19e-3)" "unprognostic (3.98e-2)" "unprognostic (1.38e-1)" "unprognostic (2.72e-2)" "unprognostic (1.15e-2)" "unprognostic (6.86e-2)" "unprognostic (7.54e-3)" "unprognostic (7.01e-2)" "prognostic unfavourable (8.53e-4)" "unprognostic (3.38e-3)" "unprognostic (3.65e-2)" "unprognostic (1.97e-1)" "unprognostic (7.91e-2)" 21.5 14.6 0.6 5.1 0.7 0.0 4.8 0.6 0.6 1.0 1.0 0.6 0.9 0.0 4.8 1.3 0.7 5.4 2.2 3.3 0.6 1.5 4.7 3.1 3.5 0.6 0.6 0.6 14.9 10.0 0.0 4.4 1024.1 0.9 2.2 0.1 58.2 0.7 0.8 1.0 0.0 0.6 1.2 0.6 0.7 1.5 0.8 0.6 1.5 0.6 0.7 0.6 1.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 9.6 3.0 0.0 7.0 1.2 0.0 12.7 2.2 1.3 1.0 0.0 0.0 0.0 178.0 2.9 1.0 0.0 13.6 2.0 0.1 0.0 0.0 0.8 0.0 36.2 0.0 0.0 0.6 0.7 88.4 6.4 30.4 0.0 0.1 16.1 0.0 0.0 0.0 0.7 2.2 0.0 0.0 0.0 3.4 0.3 0.0 8.0 0.0 0.9 0.0 0.0 0.1 43.8 85.9 0.6 76.5 0.1 0.0 0.1 0.3 145.4 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.7 0.6 0.6 0.6 1.5 0.6 0.6 0.9 0.6 TFR2 "HFE3, TFRC2" ENSG00000106327 "Transferrin receptor 2" Q9UP52 7 100620416-100642779 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 112.6" "Group enriched" "Detected in some" 11 "HEL: 27.8;HMC-1: 38.6;K-562: 25.7" "Cancer enriched" "Detected in many" 70 "liver cancer: 136.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 46 "basophil: 5.5;eosinophil: 3.9" "Lineage enriched" "Detected in single" 54 "granulocytes: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011937, CAB016255" Enhanced "CAB016255: AB_628395, HPA011937: AB_1858243" "unprognostic (4.18e-2)" "unprognostic (1.97e-2)" "unprognostic (2.74e-1)" "unprognostic (1.04e-1)" "unprognostic (1.26e-2)" "unprognostic (4.13e-2)" "prognostic favourable (2.48e-4)" "unprognostic (2.29e-2)" "unprognostic (4.49e-2)" "unprognostic (9.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.90e-1)" "unprognostic (1.18e-9)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" "unprognostic (3.28e-1)" "unprognostic (8.18e-2)" 0.1 0.0 0.1 0.1 0.1 5.3 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.3 0.1 0.0 0.1 112.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 2.8 0.0 0.6 38.6 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 TG "AITD3, TGN" ENSG00000042832 Thyroglobulin P01266 8 132866958-133134903 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Thyroid hormones biosynthesis" "Hormone, Thyroid hormone" "Cancer-related genes, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 247 "thyroid gland: 994.3" "Cell line enhanced" "Detected in some" "HDLM-2: 3.5;HSkMC: 4.2;Karpas-707: 9.7;PC-3: 4.8;U-266/70: 3.5" "Cancer enriched" "Detected in some" 1672 "thyroid cancer: 3072.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.0" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 5 "cerebellum: 1.3" "Low region specificity" "Detected in many" "CAB000077, HPA002740, CAB056155" Enhanced "Secreted in other tissues" 1000000 "CAB000077: , CAB056155: , HPA002740: AB_1080277" "unprognostic (1.18e-1)" "unprognostic (6.86e-2)" "unprognostic (7.40e-4)" "unprognostic (1.20e-2)" "unprognostic (2.55e-1)" "unprognostic (1.02e-1)" "unprognostic (2.77e-2)" "unprognostic (7.38e-2)" "unprognostic (4.96e-2)" "unprognostic (1.19e-1)" "unprognostic (3.08e-2)" "unprognostic (3.68e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.82e-1)" "unprognostic (5.11e-2)" "unprognostic (3.64e-2)" 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.6 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.0 0.1 3.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 994.3 0.1 0.1 0.1 0.1 0.3 1.2 4.0 0.6 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.9 1.4 0.6 0.0 1.7 0.0 0.1 0.9 0.0 0.0 0.2 0.4 0.5 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.2 2.9 1.1 0.0 0.0 0.0 9.7 0.2 0.0 0.1 0.0 0.0 4.8 0.1 0.0 0.3 0.2 2.8 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.6 0.0 3.5 2.9 0.0 0.2 1.2 0.0 0.0 0.6 0.7 0.2 0.0 0.9 0.0 0.4 0.0 0.0 0.3 0.3 0.2 4.0 0.0 0.3 1.2 0.4 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 TGFBR3L ENSG00000260001 "Transforming growth factor beta receptor 3 like" H3BV60 19 7916145-7919097 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "pituitary gland: 56.6" "Cell line enhanced" "Detected in some" "PC-3: 5.6;REH: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.9" "Lineage enriched" "Detected in single" 8 "T-cells: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA074356 Enhanced Approved Vesicles Vesicles "HPA074356: " "unprognostic (1.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (2.63e-1)" "unprognostic (7.65e-2)" "unprognostic (9.51e-3)" "unprognostic (1.09e-1)" "unprognostic (6.96e-2)" "unprognostic (3.41e-2)" "unprognostic (2.81e-1)" "unprognostic (2.04e-1)" "unprognostic (3.50e-3)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (1.06e-1)" "unprognostic (8.62e-3)" 0.3 2.0 1.6 0.2 2.8 0.6 0.3 1.9 6.4 5.0 0.6 0.0 0.3 6.0 2.8 0.5 0.3 0.7 0.2 2.1 0.7 0.8 3.7 4.0 0.3 0.1 0.5 1.7 0.3 0.3 0.9 56.6 0.4 1.9 2.5 0.1 0.6 0.8 0.7 0.3 0.5 5.7 2.0 0.6 0.3 0.4 0.5 0.0 0.0 0.3 0.0 0.1 1.1 0.8 0.1 0.3 0.0 0.1 0.0 2.9 0.1 0.1 0.2 0.1 0.5 0.1 0.0 3.3 2.6 0.0 0.2 0.0 0.5 0.0 0.1 3.0 0.1 1.9 0.0 0.0 0.0 3.4 1.1 0.5 0.2 0.6 0.2 1.7 0.3 0.2 0.1 0.0 0.0 0.0 0.7 0.5 0.0 1.5 1.2 0.2 0.6 5.6 13.6 0.0 3.0 0.2 0.0 1.0 2.5 0.3 0.0 0.6 0.9 0.5 0.2 1.8 2.9 2.0 0.9 0.8 0.9 0.8 0.4 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.6 0.1 0.9 1.9 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.3 0.0 0.1 1.6 2.8 1.9 6.4 0.7 0.8 0.5 1.7 1.9 0.0 TGIF2LX ENSG00000153779 "TGFB induced factor homeobox 2 like, X-linked" Q8IUE1 X 89921882-89922883 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 13.3" "Group enriched" "Detected in some" 11 "SH-SY5Y: 10.0;U-2 OS: 11.7;U-266/84: 18.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA034543 Supported Approved Nucleoplasm Nucleoplasm "HPA034543: AB_10603037" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 11.7 0.3 0.0 1.0 18.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TGIF2LY ENSG00000176679 "TGFB induced factor homeobox 2 like, Y-linked" Q8IUE0 Y 3579041-3580041 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 98 "testis: 9.7" "Group enriched" "Detected in some" 14 "U-138 MG: 2.6;U-266/70: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TGM4 TGP ENSG00000163810 "Transglutaminase 4" P49221 3 44874608-44914990 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "prostate: 107.8" "Cell line enhanced" "Detected in some" "BEWO: 9.5;hTERT-HME1: 2.6;NB-4: 5.1;RPMI-8226: 3.6;SH-SY5Y: 2.8" "Cancer enriched" "Detected in single" 312 "prostate cancer: 75.4" "Region enriched" "Detected in single" 254 "cerebral cortex: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA032072, CAB033571" Enhanced "CAB033571: AB_2287329, HPA032072: AB_10603350" "unprognostic (4.40e-2)" "unprognostic (4.68e-2)" "unprognostic (1.92e-1)" "unprognostic (2.17e-3)" "unprognostic (2.84e-1)" "unprognostic (2.19e-2)" "unprognostic (1.37e-1)" "unprognostic (1.92e-1)" "unprognostic (2.41e-2)" "unprognostic (1.65e-1)" "unprognostic (8.56e-3)" "unprognostic (5.08e-2)" "unprognostic (1.44e-8)" "unprognostic (1.10e-1)" "unprognostic (1.98e-2)" "unprognostic (3.68e-1)" "unprognostic (6.41e-2)" 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 25.4 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.6 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.1 2.6 0.3 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.2 0.0 0.0 3.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.7 0.7 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 THEG "CT56, THEG1" ENSG00000105549 "Theg spermatid protein" Q9P2T0 19 361747-376670 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 28.8" "Cell line enriched" "Detected in some" 4 "HDLM-2: 42.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "unprognostic (2.48e-1)" "unprognostic (6.37e-3)" "unprognostic (7.89e-3)" "unprognostic (2.34e-1)" "unprognostic (3.00e-1)" "unprognostic (5.17e-2)" "unprognostic (2.57e-1)" "unprognostic (5.57e-2)" "unprognostic (7.09e-4)" "unprognostic (1.73e-1)" "unprognostic (1.39e-1)" "unprognostic (1.14e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.3 0.3 2.0 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 3.5 0.1 0.3 0.1 0.1 0.0 28.8 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 THEMIS "bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA" ENSG00000172673 "Thymocyte selection associated" Q8N1K5 6 127708072-127918631 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 109.6" "Cell line enhanced" "Detected in some" "HDLM-2: 18.8;MOLT-4: 29.3;RPMI-8226: 12.5;U-266/70: 5.4" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebral cortex: 7.1" "Group enriched" "Detected in many" 23 "gdT-cell: 11.3;MAIT T-cell: 14.5;memory CD4 T-cell: 14.5;memory CD8 T-cell: 20.5;naive CD4 T-cell: 13.1;naive CD8 T-cell: 25.2" "Lineage enriched" "Detected in single" 88 "T-cells: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA031422, HPA031425" Enhanced "HPA031422: , HPA031425: AB_10670129" "unprognostic (1.47e-4)" "unprognostic (2.50e-3)" "unprognostic (1.31e-2)" "unprognostic (1.41e-4)" "unprognostic (1.41e-1)" "unprognostic (5.20e-3)" "unprognostic (7.48e-3)" "unprognostic (9.01e-3)" "unprognostic (1.47e-1)" "unprognostic (7.41e-3)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (2.65e-4)" "unprognostic (2.04e-1)" "unprognostic (3.91e-2)" "unprognostic (4.98e-2)" "unprognostic (1.60e-2)" 1.4 0.6 1.9 9.6 0.8 2.4 0.8 0.2 7.1 1.0 2.8 0.1 0.5 2.2 0.9 0.9 1.2 0.8 2.4 0.5 1.8 0.6 0.9 0.9 3.6 13.2 1.1 0.1 0.9 0.6 0.0 0.4 0.2 0.5 0.9 1.3 0.8 5.2 0.9 0.3 0.5 5.0 0.8 1.5 5.8 2.0 0.4 0.4 109.6 1.3 1.6 10.4 2.3 1.2 0.0 0.0 0.2 0.0 0.0 25.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.3 0.0 14.5 0.0 14.5 20.5 0.0 0.0 13.1 25.2 0.2 0.0 0.0 0.0 0.7 7.4 1.9 0.8 0.2 7.1 1.8 0.6 1.1 0.1 0.5 0.4 THPO "MGDF, MPLLG, TPO" ENSG00000090534 Thrombopoietin P40225 3 184371935-184381968 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cytokine, Hormone" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 55.5" "Cell line enhanced" "Detected in some" "CACO-2: 6.8;Hep G2: 17.4;K-562: 3.1;RPMI-8226: 4.6" "Cancer enriched" "Detected in many" 5 "liver cancer: 8.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to blood" 44000 "unprognostic (5.57e-2)" "unprognostic (3.15e-2)" "unprognostic (1.75e-1)" "unprognostic (2.21e-2)" "unprognostic (6.20e-2)" "unprognostic (1.97e-1)" "unprognostic (1.37e-2)" "unprognostic (2.75e-1)" "unprognostic (1.00e-1)" "unprognostic (1.81e-1)" "unprognostic (8.40e-2)" "unprognostic (1.37e-1)" "prognostic unfavourable (2.48e-6)" "unprognostic (1.40e-3)" "unprognostic (4.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.25e-2)" 1.7 1.3 2.3 0.5 0.7 0.0 1.4 4.3 3.3 1.5 0.7 0.4 0.4 0.1 2.6 1.7 0.4 0.9 0.4 1.7 1.5 0.0 8.6 55.5 0.4 0.4 0.4 0.4 1.5 2.7 0.0 1.3 0.6 0.4 0.7 0.3 0.5 0.9 0.7 6.0 0.1 0.4 2.1 0.7 0.9 0.2 2.4 0.4 0.4 0.7 0.7 0.5 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.5 0.0 0.0 0.1 0.0 6.8 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 17.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 3.1 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.3 0.8 4.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.1 1.9 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 4.3 3.3 1.5 0.0 0.4 0.4 0.4 0.4 TIAM1 ENSG00000156299 "T cell lymphoma invasion and metastasis 1" Q13009 21 31118416-31559977 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 110.1" "Cell line enhanced" "Detected in many" "BEWO: 18.9;HEL: 18.3;HMC-1: 16.0;RT4: 19.0;SCLC-21H: 17.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 8 "cerebellum: 110.1" "Group enriched" "Detected in many" 5 "classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 574.6" "CAB010416, HPA034853" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol" "Nucleoplasm, Cell Junctions" "Nuclear membrane, Cytokinetic bridge, Cytosol" "CAB010416: AB_2240410, HPA034853: " "unprognostic (9.59e-2)" "unprognostic (7.44e-3)" "unprognostic (5.64e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.81e-3)" "unprognostic (2.84e-2)" "unprognostic (3.73e-1)" "unprognostic (8.08e-2)" "unprognostic (2.70e-3)" "unprognostic (7.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.20e-3)" "unprognostic (2.38e-3)" "unprognostic (1.61e-1)" "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" 3.3 11.4 13.4 5.3 12.4 2.1 4.4 110.1 15.1 10.1 2.2 9.7 0.5 1.5 7.9 3.0 18.9 9.4 4.0 2.1 11.6 7.0 1.7 3.7 4.1 8.8 6.2 7.9 1.5 1.9 0.3 4.2 4.4 8.9 3.7 2.8 7.0 2.2 3.1 0.7 20.4 1.7 10.0 6.4 4.2 2.1 5.9 7.1 6.2 1.3 5.3 9.3 8.1 5.0 0.1 5.9 0.6 12.4 6.9 16.8 3.6 1.5 0.5 11.9 0.7 0.2 2.8 18.9 0.0 0.0 1.4 0.5 0.1 2.1 4.0 0.8 0.3 2.8 1.4 2.4 2.4 0.3 6.5 18.3 0.3 0.1 0.3 0.0 16.0 1.2 0.8 8.1 3.2 0.0 0.0 6.0 6.0 7.7 2.8 0.1 3.8 5.1 3.6 3.7 0.0 1.8 19.0 17.9 4.4 0.8 6.2 0.7 2.5 0.0 0.1 1.7 6.9 0.0 0.8 6.7 5.0 3.6 4.0 1.4 13.1 0.6 10.7 0.0 0.3 9.6 2.1 0.1 8.3 1.6 5.9 0.0 10.9 0.6 0.6 6.9 12.4 0.3 16.8 3.6 13.4 12.4 110.1 14.4 11.6 7.0 6.2 7.9 8.9 7.1 TINF2 TIN2 ENSG00000092330 "TERF1 interacting nuclear factor 2" Q9BSI4 14 24239643-24242674 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "parathyroid gland: 268.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059061, HPA069807" Enhanced "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" "Nuclear bodies" Nucleoplasm "HPA059061: , HPA069807: " "prognostic favourable (4.96e-4)" "unprognostic (8.58e-2)" "unprognostic (1.53e-1)" "unprognostic (5.47e-2)" "unprognostic (3.20e-2)" "unprognostic (2.78e-2)" "unprognostic (4.75e-2)" "unprognostic (2.50e-1)" "unprognostic (4.70e-1)" "unprognostic (8.05e-2)" "unprognostic (1.05e-1)" "unprognostic (8.71e-2)" "unprognostic (9.59e-3)" "unprognostic (2.04e-3)" "unprognostic (2.17e-1)" "unprognostic (4.78e-2)" "unprognostic (7.44e-2)" 15.8 27.8 10.4 17.0 11.3 13.3 18.2 10.1 16.7 14.5 13.1 17.9 12.9 9.5 16.8 16.1 22.4 12.6 13.7 12.4 9.3 8.9 14.8 11.4 18.8 27.0 13.7 9.8 15.4 17.1 268.9 11.9 15.3 10.9 13.5 12.5 11.3 14.8 15.5 14.9 13.9 12.9 15.1 11.7 21.0 14.5 7.7 12.4 26.1 16.6 12.6 19.5 14.9 14.2 27.3 17.7 46.9 21.4 25.4 27.4 28.8 11.6 10.7 15.5 8.1 17.1 12.8 7.9 12.0 15.2 17.6 16.5 4.6 13.1 17.1 6.9 16.9 11.5 8.7 10.7 11.2 21.7 4.4 10.7 9.8 18.3 14.8 11.3 15.5 14.0 17.3 14.1 13.5 19.0 4.2 21.9 14.2 12.8 17.0 5.6 3.6 13.3 14.0 9.9 12.4 15.7 16.8 9.5 8.8 12.5 11.9 10.7 8.5 7.3 15.2 8.3 10.1 14.0 9.3 16.9 12.0 9.7 9.9 6.4 12.2 41.6 20.6 46.9 27.4 21.4 21.8 25.7 21.6 25.5 17.7 27.3 22.8 22.8 26.0 25.4 19.6 15.0 25.2 28.8 10.4 11.3 10.1 16.7 9.3 8.9 13.7 9.8 10.9 12.4 TKTL2 "DKFZP434L1717, FLJ32975" ENSG00000151005 "Transketolase like 2" Q9H0I9 4 163471093-163473746 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 109 "testis: 66.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (2.19e-1)" "unprognostic (1.55e-1)" "unprognostic (8.62e-2)" "unprognostic (2.05e-2)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (7.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 66.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TLE7 chico ENSG00000260734 "Transducin like enhancer of split family member 7" 16 71430262-71442060 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 10 "testis: 7.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 26 "testis cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.29e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TLR9 CD289 ENSG00000239732 "Toll like receptor 9" Q9NR96 3 52221080-52226163 "CD markers, FDA approved drug targets, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "blood: 33.8" "Group enriched" "Detected in some" 12 "Daudi: 24.1;RPMI-8226: 15.4;U-698: 9.3" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 10 "plasmacytoid DC: 33.8" "Lineage enriched" "Detected in many" 10 "dendritic cells: 33.8" "unprognostic (6.03e-2)" "unprognostic (5.08e-2)" "unprognostic (3.58e-3)" "unprognostic (6.69e-7)" "unprognostic (1.16e-1)" "unprognostic (1.89e-2)" "unprognostic (2.69e-1)" "unprognostic (1.58e-1)" "unprognostic (7.02e-2)" "unprognostic (1.89e-1)" "unprognostic (4.40e-2)" "unprognostic (7.60e-2)" "unprognostic (2.65e-3)" "unprognostic (2.44e-2)" "unprognostic (3.70e-1)" "unprognostic (2.27e-1)" "unprognostic (7.91e-3)" 0.5 0.2 0.0 2.8 0.5 2.5 0.4 4.9 0.4 0.8 1.2 0.7 0.9 0.0 0.2 1.0 0.9 0.3 0.2 0.3 0.3 0.1 0.6 6.5 0.1 2.5 0.0 0.0 0.3 0.1 0.9 0.1 1.4 0.4 1.8 0.1 2.2 0.1 0.4 3.9 0.5 0.3 0.7 3.9 1.2 1.2 3.3 33.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.9 0.7 9.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.1 TLX3 "HOX11L2, RNX" ENSG00000164438 "T cell leukemia homeobox 3" O43711 5 171309284-171312134 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "brain: 46.6" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 24.0" "Cancer enhanced" "Detected in some" "cervical cancer: 1.7" "Region enriched" "Detected in some" 22 "cerebellum: 46.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "cerebellum: 2.5" "Region enriched" "Detected in some" 11 "cerebellum: 48.1" "HPA030504, HPA060957, HPA069359" Enhanced Enhanced Nucleoplasm Nucleoplasm "HPA030504: , HPA060957: , HPA069359: " "unprognostic (3.52e-2)" "unprognostic (2.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.11e-1)" "unprognostic (9.80e-2)" "unprognostic (2.76e-2)" "unprognostic (4.48e-2)" 0.4 0.5 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 24.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 TM4SF19 ENSG00000145107 "Transmembrane 4 L six family member 19" Q96DZ7 3 196319342-196338503 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "adipose tissue: 69.9" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 11.6;hTERT-HME1: 19.6;PC-3: 22.2;U-138 MG: 11.8;U-87 MG: 12.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 14.8;memory CD8 T-cell: 3.8;naive CD8 T-cell: 5.4" "Lineage enriched" "Detected in single" 19 "T-cells: 14.8" "unprognostic (9.90e-2)" "unprognostic (1.17e-2)" "unprognostic (3.60e-2)" "unprognostic (1.89e-2)" "unprognostic (1.67e-1)" "unprognostic (7.19e-2)" "unprognostic (8.90e-5)" "unprognostic (8.86e-3)" "unprognostic (1.30e-1)" "unprognostic (3.21e-2)" "unprognostic (1.85e-1)" "unprognostic (2.86e-1)" "unprognostic (1.06e-3)" "unprognostic (4.23e-2)" "unprognostic (4.20e-3)" "unprognostic (2.60e-1)" "unprognostic (1.18e-3)" 69.9 0.4 0.4 0.7 0.4 0.9 4.5 0.4 0.5 2.1 0.4 0.4 0.4 0.0 0.4 0.6 5.0 0.3 0.8 0.4 0.4 0.1 0.4 0.8 4.9 0.6 0.4 0.4 1.2 0.4 0.0 0.4 1.1 0.4 0.6 0.1 0.4 2.2 0.4 2.1 3.2 0.4 0.4 0.4 0.8 0.6 8.2 0.4 0.5 1.0 2.0 1.3 0.9 2.1 0.3 0.5 0.6 0.4 0.8 14.8 1.4 9.1 4.3 0.2 0.3 0.5 3.0 0.3 0.0 2.7 1.0 1.8 0.1 5.0 0.1 1.6 0.0 1.3 0.0 1.0 0.7 0.3 0.1 0.3 1.2 0.0 0.6 0.5 0.3 0.3 0.8 11.6 19.6 0.0 5.7 0.5 2.9 0.7 0.1 0.5 0.0 22.2 0.1 2.0 0.5 0.0 0.2 0.2 0.0 1.6 0.0 0.4 0.4 0.1 0.8 11.8 9.7 1.8 5.4 0.3 3.1 0.2 12.6 0.4 0.3 0.6 0.3 0.4 14.8 0.4 0.1 0.1 1.4 3.8 0.1 0.3 0.8 5.4 0.6 0.8 0.1 0.5 0.3 1.4 0.4 0.4 0.4 0.5 0.4 0.1 0.4 0.4 0.4 0.4 TM4SF20 "FLJ22800, TCCE518" ENSG00000168955 "Transmembrane 4 L six family member 20" Q53R12 2 227362156-227381995 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 86 "intestine: 147.8" "Cell line enhanced" "Detected in some" "A549: 7.1;RPMI-8226: 4.4" "Group enriched" "Detected in many" 6 "colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA051838, HPA063184, HPA065531" Uncertain Supported "Plasma membrane,Focal adhesion sites" "Plasma membrane, Focal adhesion sites" "HPA051838: , HPA063184: , HPA065531: " "unprognostic (4.68e-2)" "unprognostic (1.13e-1)" "unprognostic (8.75e-2)" "unprognostic (4.96e-2)" "unprognostic (2.84e-2)" "unprognostic (1.63e-1)" "unprognostic (2.51e-1)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-1)" "unprognostic (3.44e-3)" "unprognostic (7.76e-2)" "unprognostic (2.60e-2)" "unprognostic (3.04e-3)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 46.5 0.0 0.0 73.5 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.1 0.1 147.8 0.2 0.1 0.1 0.1 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.1 1.2 1.1 0.5 1.7 0.7 0.0 0.1 7.1 0.2 0.1 0.0 0.0 1.3 0.8 0.1 0.0 0.0 1.3 0.5 0.2 0.1 0.4 0.2 0.0 0.0 0.1 0.1 0.4 0.0 1.3 0.2 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.8 0.3 0.0 0.1 1.6 0.3 0.1 0.4 0.1 4.4 0.1 0.3 0.6 1.7 1.0 0.1 0.0 0.3 0.1 0.3 0.6 0.3 1.9 0.2 0.5 0.3 0.4 0.2 0.2 0.2 0.8 0.5 0.1 0.7 0.3 0.3 0.7 0.4 0.4 0.0 1.1 0.7 0.5 1.1 1.7 0.1 1.2 0.4 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 TM6SF2 Lpr4 ENSG00000213996 "Transmembrane 6 superfamily member 2" Q9BZW4 19 19264364-19273391 "Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 89.4" "Cell line enhanced" "Detected in some" "Hep G2: 3.3;HHSteC: 4.9;LHCN-M2: 3.8;NTERA-2: 2.6;SH-SY5Y: 4.3" "Cancer enhanced" "Detected in many" "liver cancer: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA066026 Uncertain "HPA066026: " "unprognostic (2.41e-1)" "unprognostic (4.81e-3)" "unprognostic (1.49e-1)" "unprognostic (1.15e-3)" "unprognostic (3.29e-1)" "unprognostic (2.35e-1)" "unprognostic (1.39e-3)" "unprognostic (4.00e-2)" "unprognostic (4.15e-2)" "unprognostic (4.53e-4)" "unprognostic (9.55e-3)" "unprognostic (4.37e-2)" "unprognostic (1.38e-1)" "unprognostic (1.61e-1)" "unprognostic (4.56e-2)" "unprognostic (1.51e-1)" "unprognostic (6.15e-2)" 0.1 0.1 0.2 0.2 0.1 0.0 0.3 0.3 0.3 0.6 43.2 0.2 0.2 36.8 0.4 1.7 0.2 0.2 1.0 0.4 0.2 0.5 3.2 18.5 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.5 0.5 0.9 0.4 0.2 0.4 0.0 0.1 89.4 0.2 0.1 0.1 1.1 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.4 0.1 2.1 1.2 1.0 1.3 1.0 0.1 0.0 1.0 1.7 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 3.3 4.9 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.8 2.6 0.0 0.0 0.0 0.4 0.0 0.0 1.9 4.3 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.3 0.2 0.5 0.1 0.1 0.5 0.1 TMC3 ENSG00000188869 "Transmembrane channel like 3" Q7Z5M5 15 81331217-81374213 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 15 "parathyroid gland: 66.9" "Cell line enhanced" "Detected in many" "U-266/70: 4.6" "Cancer enhanced" "Detected in single" "breast cancer: 0.5" "Region enhanced" "Detected in some" "pons and medulla: 1.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA040265, HPA040510" Enhanced Supported Cytosol Cytosol "HPA040265: AB_10795379, HPA040510: AB_10796123" "unprognostic (1.17e-2)" "unprognostic (3.43e-1)" "unprognostic (3.14e-1)" "unprognostic (8.33e-2)" "unprognostic (1.22e-2)" "unprognostic (1.63e-2)" "unprognostic (4.85e-3)" "unprognostic (2.20e-2)" "unprognostic (3.12e-2)" "unprognostic (1.77e-1)" "unprognostic (6.20e-5)" "unprognostic (2.32e-1)" "unprognostic (1.97e-7)" "unprognostic (1.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.26e-1)" "unprognostic (5.96e-2)" 0.0 0.1 0.0 1.7 0.0 0.3 0.2 0.4 1.4 1.5 1.5 0.0 0.0 0.2 0.8 4.6 0.7 0.8 0.2 0.2 0.0 0.1 0.1 1.3 0.0 0.1 0.0 0.0 0.2 0.2 66.9 1.5 0.7 1.6 1.0 0.1 0.4 0.2 2.9 0.0 0.2 0.5 1.7 1.9 0.1 0.8 3.0 0.0 0.0 1.5 0.0 0.0 1.3 3.6 1.6 0.7 0.2 0.2 0.2 1.8 0.7 0.9 1.0 0.5 2.7 0.4 0.2 1.9 0.8 0.3 0.2 0.3 0.7 1.9 2.3 0.1 0.0 0.7 0.3 0.2 0.1 1.7 1.4 1.9 1.1 0.9 0.3 1.5 1.1 0.5 0.1 0.4 0.3 0.0 0.6 2.8 0.2 0.8 1.0 1.4 1.5 0.9 0.7 1.0 4.3 0.2 0.6 1.1 2.0 0.9 1.0 2.0 2.3 1.1 0.4 1.5 1.8 1.3 0.5 4.6 1.8 1.4 1.1 2.5 0.9 0.1 0.0 0.2 0.7 0.1 0.6 1.2 0.8 0.4 0.1 1.6 1.8 1.3 0.2 0.2 0.2 0.7 0.9 0.7 0.0 0.0 0.4 1.4 0.0 0.1 0.0 0.0 1.6 0.0 TMC5 FLJ13593 ENSG00000103534 "Transmembrane channel like 5" Q6UXY8 16 19410496-19499113 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 108.7" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 38.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA040810, HPA042037" Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA040810: AB_10795627, HPA042037: AB_10804126" "unprognostic (2.47e-2)" "unprognostic (3.68e-1)" "unprognostic (3.50e-2)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (3.64e-2)" "prognostic unfavourable (7.96e-4)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "unprognostic (9.74e-2)" "unprognostic (3.27e-2)" "unprognostic (3.71e-1)" "unprognostic (2.28e-2)" "unprognostic (2.69e-1)" "unprognostic (7.88e-2)" "unprognostic (8.88e-3)" "unprognostic (1.75e-1)" 0.7 0.3 0.3 4.8 0.3 0.1 5.6 0.3 0.7 3.8 66.1 0.6 0.6 19.1 2.1 16.9 1.4 1.9 15.9 0.4 0.4 0.3 0.3 1.8 17.6 0.2 0.3 0.4 1.8 5.4 4.5 1.0 3.7 1.0 8.4 9.8 1.7 18.9 0.2 0.3 0.8 108.7 0.3 0.2 0.3 19.5 2.6 0.2 0.2 0.8 1.7 4.1 1.5 1.1 0.5 0.7 2.2 0.6 0.9 0.8 0.3 3.6 6.0 0.0 0.1 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 38.9 0.0 0.2 0.0 2.4 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.1 1.4 1.7 0.0 0.0 1.4 0.1 0.1 0.4 0.1 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.6 0.2 0.3 0.3 0.2 0.4 0.8 0.3 0.2 0.5 0.2 0.3 2.2 0.9 0.4 0.7 0.1 0.3 0.3 0.3 0.3 0.7 0.4 0.3 0.3 0.4 1.0 0.2 TMCO2 dJ39G22.2 ENSG00000188800 "Transmembrane and coiled-coil domains 2" Q7Z6W1 1 40245947-40251691 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 85 "testis: 74.7" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;NB-4: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "unprognostic (5.30e-2)" "unprognostic (2.71e-1)" "unprognostic (3.26e-2)" "unprognostic (3.58e-2)" "unprognostic (1.25e-1)" "unprognostic (3.93e-2)" "unprognostic (2.70e-5)" "unprognostic (6.16e-2)" "unprognostic (2.29e-1)" "unprognostic (1.62e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TMCO5A "MGC35118, TMCO5" ENSG00000166069 "Transmembrane and coiled-coil domains 5A" Q8N6Q1 15 37921939-37967724 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 130 "testis: 43.9" "Cell line enhanced" "Detected in some" "HeLa: 1.2;hTERT-HME1: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "amygdala: 6.0;basal ganglia: 2.2;cerebral cortex: 5.7;hippocampal formation: 6.7" "Low region specificity" "Detected in many" HPA056530 Enhanced "HPA056530: " "unprognostic (2.60e-1)" "unprognostic (1.69e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMED6 "MGC23911, p24g5, p24gamma5" ENSG00000157315 "Transmembrane p24 trafficking protein 6" Q8WW62 16 69343248-69351809 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "pancreas: 144.2" "Cell line enhanced" "Detected in many" "Hep G2: 17.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA012532 Approved "HPA012532: AB_1858065" "unprognostic (6.85e-2)" "unprognostic (1.42e-1)" "unprognostic (6.31e-3)" "prognostic favourable (7.74e-5)" "unprognostic (9.84e-3)" "unprognostic (7.57e-2)" "unprognostic (2.40e-1)" "unprognostic (1.20e-1)" "unprognostic (7.94e-2)" "unprognostic (3.74e-1)" "unprognostic (2.94e-2)" "unprognostic (4.76e-2)" "unprognostic (4.58e-3)" "unprognostic (9.71e-2)" "unprognostic (1.50e-1)" "unprognostic (1.36e-1)" "unprognostic (4.52e-3)" 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 0.2 0.4 0.9 0.2 2.0 2.7 0.3 4.5 0.2 5.6 0.3 0.2 0.2 0.1 6.1 3.1 0.7 0.2 0.2 0.2 1.0 144.2 0.0 0.2 0.2 0.2 0.2 1.7 0.2 0.2 3.5 0.2 0.1 2.8 0.2 0.2 0.3 16.6 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.2 0.0 0.6 0.0 2.0 0.2 0.7 1.9 1.6 1.1 0.1 0.1 1.0 2.3 0.1 0.0 0.3 2.4 1.0 4.8 0.8 0.0 1.2 0.2 0.2 0.4 0.7 2.0 2.4 0.8 17.3 0.1 3.0 1.1 0.2 0.9 0.1 0.3 0.1 1.6 0.6 0.3 1.9 1.3 3.3 2.2 1.8 2.6 1.4 1.8 0.7 2.0 3.8 1.5 3.1 1.1 1.2 0.6 2.1 2.1 2.7 1.5 0.9 1.5 1.6 1.5 5.2 1.4 2.5 0.9 0.0 0.4 0.0 0.8 0.6 1.5 0.6 2.0 0.4 0.2 0.3 0.5 2.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 TMEFF1 "C9orf2, CT120.1, H7365" ENSG00000241697 "Transmembrane protein with EGF like and two follistatin like domains 1" Q8IYR6 9 100473113-100577636 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 21.1" "Cell line enhanced" "Detected in some" "AF22: 7.7;BEWO: 9.6;NTERA-2: 19.4;REH: 13.0;SCLC-21H: 16.6;SH-SY5Y: 11.1" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051501 Uncertain "HPA051501: " "unprognostic (1.96e-1)" "unprognostic (2.30e-1)" "unprognostic (9.69e-3)" "unprognostic (2.32e-2)" "unprognostic (9.02e-2)" "unprognostic (3.59e-2)" "unprognostic (2.87e-2)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (1.05e-1)" "unprognostic (5.04e-6)" "unprognostic (1.30e-4)" "unprognostic (1.52e-1)" "unprognostic (3.97e-2)" "unprognostic (3.44e-3)" 1.2 1.2 5.0 1.0 13.9 1.2 1.1 1.4 21.1 1.6 1.3 15.0 0.0 1.0 3.0 1.0 1.0 1.2 1.6 1.0 9.1 8.9 1.2 1.0 1.1 1.4 10.3 7.9 1.0 1.0 1.1 0.4 1.8 11.7 1.5 1.1 0.1 1.1 1.4 1.0 1.0 1.3 1.4 13.8 1.2 1.3 4.1 12.6 0.0 3.1 0.0 1.1 1.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.4 0.1 0.2 9.6 0.6 0.1 0.4 0.5 0.5 0.1 0.0 1.7 0.2 0.0 2.9 0.0 0.4 0.0 4.3 0.0 0.2 0.4 0.4 0.0 0.0 0.2 0.0 0.4 0.1 1.2 0.1 0.0 0.6 0.0 4.8 0.0 19.4 0.2 13.0 6.6 0.0 0.3 0.0 16.6 11.1 0.0 0.0 0.2 0.0 0.0 1.7 1.5 2.6 0.1 0.6 3.0 2.1 2.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.0 13.9 1.4 15.4 9.1 8.9 10.3 7.9 11.7 12.6 TMEM132B "KIAA1786, KIAA1906" ENSG00000139364 "Transmembrane protein 132B" Q14DG7 12 125186836-125662377 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 19.3" "Cell line enhanced" "Detected in some" "HSkMC: 7.8;NTERA-2: 8.9;RPMI-8226: 3.8;U-138 MG: 13.9;U-937: 3.9" "Cancer enriched" "Detected in single" 7 "glioma: 3.3" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.0" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035661, HPA035662" Uncertain "HPA035661: AB_10669774, HPA035662: " "unprognostic (3.38e-3)" "unprognostic (4.39e-2)" "unprognostic (6.73e-2)" "unprognostic (6.33e-2)" "unprognostic (1.06e-1)" "unprognostic (7.46e-2)" "unprognostic (3.46e-1)" "unprognostic (1.26e-1)" "unprognostic (4.58e-1)" "unprognostic (1.12e-1)" "unprognostic (6.23e-3)" "unprognostic (1.29e-2)" "unprognostic (4.29e-4)" "unprognostic (1.20e-1)" "unprognostic (2.94e-2)" "unprognostic (1.06e-1)" "unprognostic (3.73e-3)" 0.2 0.2 6.1 0.1 7.5 0.0 0.1 0.2 19.3 0.6 0.3 0.2 0.8 1.0 0.5 0.2 0.3 0.7 5.1 2.6 0.1 0.0 0.0 0.1 2.6 0.1 0.2 0.0 1.1 0.2 0.4 0.4 2.8 0.6 0.5 2.4 0.2 0.2 0.5 0.0 0.3 0.8 2.7 0.3 0.1 0.0 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 2.6 2.8 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.1 0.0 0.0 2.9 0.3 0.0 0.0 0.0 8.9 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.9 0.0 0.1 0.0 0.0 0.2 0.0 2.2 3.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 TMEM132D "KIAA1944, MOLT, PPP1R153" ENSG00000151952 "Transmembrane protein 132D" Q14C87 12 129071725-129903666 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 18.0" "Cell line enhanced" "Detected in some" "AF22: 5.4;Karpas-707: 1.7;MOLT-4: 9.1;NTERA-2: 3.5;U-266/84: 1.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 19.1;cerebral cortex: 57.9;hippocampal formation: 46.6" HPA010739 Approved 150000 "HPA010739: AB_2204753" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (1.19e-1)" "unprognostic (2.07e-2)" "unprognostic (5.39e-1)" "unprognostic (1.47e-2)" "unprognostic (2.89e-1)" "unprognostic (3.07e-2)" "unprognostic (1.55e-2)" "unprognostic (1.55e-1)" "unprognostic (4.31e-4)" 0.4 0.9 4.5 0.7 6.6 0.7 0.4 0.4 18.0 0.4 0.8 0.6 0.0 0.8 0.5 0.4 0.4 0.4 0.4 0.4 2.9 4.2 0.6 0.7 0.8 0.4 1.7 6.2 0.5 1.1 0.4 0.7 0.4 0.8 1.1 0.7 1.2 0.4 0.4 0.4 0.5 0.9 0.5 0.6 0.4 1.0 1.6 0.8 0.0 0.5 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.0 9.1 0.0 3.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 6.6 0.4 11.7 2.9 4.2 1.7 6.2 0.8 0.8 TMEM144 FLJ11155 ENSG00000164124 "Transmembrane protein 144" Q7Z5S9 4 158201604-158255411 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 88.7" "Cell line enhanced" "Detected in many" "BEWO: 23.3;hTCEpi: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.3;intermediate monocyte: 1.4;myeloid DC: 3.7;plasmacytoid DC: 4.3" "Group enriched" "Detected in many" 10 "dendritic cells: 4.3;monocytes: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063554 Approved Mitochondria Mitochondria "HPA063554: " "unprognostic (1.26e-2)" "unprognostic (7.05e-2)" "unprognostic (2.06e-2)" "prognostic favourable (2.89e-4)" "unprognostic (2.90e-1)" "unprognostic (1.71e-5)" "unprognostic (8.27e-2)" "unprognostic (3.32e-1)" "unprognostic (2.21e-1)" "unprognostic (3.33e-2)" "prognostic unfavourable (8.48e-4)" "unprognostic (9.34e-2)" "unprognostic (1.13e-2)" "unprognostic (1.35e-1)" "unprognostic (9.26e-2)" "unprognostic (3.88e-2)" "unprognostic (4.05e-2)" 4.7 6.7 20.7 2.0 60.9 1.5 9.2 4.7 37.7 4.7 7.4 88.7 0.2 14.3 3.7 8.3 3.1 3.9 6.8 8.2 31.5 18.3 1.9 1.7 3.5 0.9 80.4 26.6 8.6 3.8 3.0 1.4 3.5 48.9 5.4 8.6 0.0 3.1 7.2 1.4 1.9 9.6 4.2 79.2 2.2 5.4 15.8 67.4 0.0 9.2 0.0 0.8 5.1 1.9 0.0 4.3 0.1 3.3 0.4 0.1 0.7 2.5 7.0 0.1 1.4 5.1 7.7 23.3 1.1 1.9 1.0 1.6 8.8 9.6 0.0 1.4 0.3 1.2 3.2 10.8 1.4 0.0 3.2 4.3 2.1 7.8 1.8 5.4 1.3 5.5 13.4 4.6 1.6 5.8 2.8 0.1 8.0 3.0 0.0 0.0 1.8 1.7 0.0 0.0 0.3 2.0 7.4 1.1 0.0 0.2 9.5 2.6 6.7 1.5 1.1 2.2 1.7 0.4 1.3 0.0 0.6 0.6 3.0 0.8 1.5 0.0 3.3 0.0 0.0 1.4 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.4 0.7 4.3 0.0 0.7 20.7 60.9 4.7 35.1 31.5 18.3 80.4 26.6 48.9 67.4 TMEM145 FLJ90805 ENSG00000167619 "Transmembrane protein 145" Q8NBT3 19 42313325-42325062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 74.5" "Cell line enhanced" "Detected in many" "HMC-1: 11.7;SCLC-21H: 22.2;SH-SY5Y: 10.6" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Region enriched" "Detected in all" 4 "cerebellum: 74.5" "Group enriched" "Detected in some" 8 "basophil: 4.5;neutrophil: 15.5" "Lineage enriched" "Detected in many" 12 "granulocytes: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060462 Enhanced Approved Approved Vesicles Vesicles "HPA060462: " "unprognostic (9.56e-3)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (2.96e-1)" "unprognostic (3.02e-1)" "unprognostic (1.47e-1)" "unprognostic (6.62e-2)" "unprognostic (2.14e-1)" "unprognostic (4.27e-3)" "unprognostic (1.53e-2)" "unprognostic (9.85e-2)" "unprognostic (4.20e-4)" "unprognostic (7.35e-2)" "unprognostic (7.64e-2)" "unprognostic (2.30e-1)" "unprognostic (6.31e-2)" 1.6 6.2 8.0 1.2 7.7 2.5 1.3 74.5 30.5 0.6 1.2 3.8 0.0 1.7 1.1 1.6 1.0 1.1 1.4 1.3 5.8 8.5 0.9 1.4 0.8 1.5 5.1 7.6 1.2 3.7 3.0 6.4 0.6 9.3 1.2 1.2 2.8 1.1 0.9 2.3 3.3 1.1 1.2 3.9 1.5 2.0 3.3 3.2 0.0 1.3 0.0 1.1 1.0 0.3 1.3 0.8 15.5 0.9 0.6 0.9 0.8 0.5 2.7 2.1 6.4 0.2 0.2 0.8 0.2 0.1 1.0 2.6 0.5 0.7 1.5 0.3 0.6 0.2 1.5 0.4 1.2 6.7 1.6 2.8 2.5 2.4 0.2 1.6 11.7 0.5 0.5 0.4 0.6 1.1 1.5 5.5 0.1 0.6 0.4 1.9 1.3 8.6 0.2 0.6 5.2 0.1 1.0 22.2 10.6 0.9 0.7 1.3 1.9 1.8 0.3 1.8 1.9 1.3 0.7 1.2 3.0 1.4 0.7 1.1 5.1 4.5 0.9 0.9 0.6 0.8 0.3 1.0 0.6 0.4 0.2 1.3 0.6 0.9 15.5 0.6 0.7 0.8 0.4 0.8 8.0 7.7 74.5 18.1 5.8 8.5 5.1 7.6 9.3 3.2 TMEM151A "MGC33486, TMEM151" ENSG00000179292 "Transmembrane protein 151A" Q8N4L1 11 66291870-66296664 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 48.5" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 18.2" "Cancer enhanced" "Detected in some" "glioma: 4.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041035 Uncertain Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA041035: AB_10794404" "unprognostic (1.20e-1)" "unprognostic (8.24e-3)" "unprognostic (4.80e-2)" "unprognostic (1.75e-2)" "unprognostic (3.44e-1)" "unprognostic (7.60e-2)" "unprognostic (9.48e-3)" "unprognostic (8.57e-2)" "unprognostic (8.73e-4)" "unprognostic (2.41e-3)" "unprognostic (2.02e-2)" "unprognostic (6.11e-3)" "unprognostic (1.69e-3)" "unprognostic (2.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.38e-2)" "unprognostic (2.67e-2)" 1.4 3.8 12.4 1.5 16.8 1.4 1.4 5.9 48.5 1.4 1.5 41.8 0.0 1.5 1.4 1.4 1.4 1.4 2.8 1.6 22.7 14.3 1.4 1.4 1.4 1.4 21.2 13.1 1.5 2.4 1.8 3.3 1.4 22.2 1.4 1.4 1.0 1.5 1.4 1.4 1.4 1.5 1.4 43.2 1.4 3.9 1.6 13.6 0.0 1.4 0.0 1.4 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.6 0.0 1.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 18.2 4.1 0.5 0.0 0.3 0.1 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.4 16.8 5.9 31.1 22.7 14.3 21.2 13.1 22.2 13.6 TMEM151B "bA444E17.5, C6orf137, TMEM193" ENSG00000178233 "Transmembrane protein 151B" Q8IW70 6 44270466-44307506 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 52.2" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 24.7" "Cancer enhanced" "Detected in single" "glioma: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 7 "T-cells: 1.0" "Low region specificity" "Detected in all" HPA055167 Uncertain "HPA055167: " "unprognostic (1.28e-3)" "unprognostic (6.25e-2)" "unprognostic (5.06e-2)" "unprognostic (7.02e-3)" "unprognostic (6.61e-2)" "unprognostic (1.22e-3)" "unprognostic (2.41e-2)" "unprognostic (3.01e-2)" "unprognostic (6.92e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-4)" "unprognostic (1.48e-1)" "unprognostic (4.56e-3)" "unprognostic (1.85e-1)" "unprognostic (9.15e-2)" "unprognostic (3.86e-2)" "unprognostic (1.66e-1)" 1.0 5.7 16.9 1.6 8.4 1.2 1.0 52.2 39.5 0.9 1.7 1.2 0.0 1.7 1.3 1.0 1.2 1.0 1.0 1.1 21.6 8.9 1.0 0.9 1.0 1.2 7.9 18.1 1.0 1.1 0.9 1.4 1.0 10.0 1.1 1.5 0.0 1.2 0.9 1.2 1.2 2.0 1.1 2.3 1.0 1.4 1.6 3.7 0.0 0.9 0.0 1.0 0.9 0.1 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 5.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.5 4.2 0.2 0.4 0.0 0.1 0.0 0.1 24.7 5.1 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.0 0.1 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 16.9 8.4 52.2 28.1 21.6 8.9 7.9 18.1 10.0 3.7 TMEM155 FLJ30834 ENSG00000164112 "Transmembrane protein 155" Q4W5P6 4 121758933-121765427 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 25.6" "Group enriched" "Detected in some" 5 "fHDF/TERT166: 7.2;HAP1: 3.3;LHCN-M2: 10.2;MOLT-4: 6.2" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "cerebral cortex: 25.6" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.3;T-reg: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 2.3" HPA077585 Approved "Secreted in brain" "HPA077585: " "unprognostic (9.67e-3)" "unprognostic (3.25e-3)" "unprognostic (3.13e-2)" "unprognostic (1.09e-1)" "unprognostic (1.61e-1)" "unprognostic (5.73e-3)" "unprognostic (3.63e-2)" "unprognostic (1.49e-2)" "unprognostic (1.19e-1)" "unprognostic (2.42e-3)" "unprognostic (4.40e-3)" "unprognostic (1.38e-1)" "unprognostic (3.82e-7)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.02e-2)" "unprognostic (2.04e-1)" 0.6 0.3 5.9 0.5 8.3 0.3 0.3 0.3 25.6 0.4 1.3 0.0 0.0 0.4 0.3 0.3 0.5 0.3 0.4 0.4 7.9 1.6 0.3 0.3 0.6 4.0 0.9 8.9 0.3 0.3 0.2 0.2 6.1 0.7 0.5 0.7 0.9 0.5 0.6 0.3 0.3 0.6 0.9 0.3 0.8 0.5 0.7 0.0 0.0 0.3 0.0 0.6 0.5 0.3 0.0 0.0 0.7 0.0 0.0 2.3 0.3 0.0 0.0 0.1 0.0 1.4 0.2 1.0 0.7 0.2 0.3 0.5 0.0 0.0 0.0 0.0 7.2 0.0 3.3 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.3 0.0 0.0 10.2 0.0 6.2 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.1 0.3 5.9 8.3 0.3 25.6 7.9 1.6 0.9 8.9 0.7 0.0 TMEM174 "FLJ31268, MGC13034" ENSG00000164325 "Transmembrane protein 174" Q8WUU8 5 73173195-73175143 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 282 "kidney: 61.5" "Cell line enhanced" "Detected in some" "Daudi: 2.7;RPTEC TERT1: 1.5" "Cancer enriched" "Detected in single" 126 "renal cancer: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA037975 Enhanced "HPA037975: AB_10672732" "unprognostic (8.11e-2)" "prognostic favourable (3.30e-6)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM178A "MGC33926, TMEM178" ENSG00000152154 "Transmembrane protein 178A" Q8NBL3 2 39664982-39717963 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 87.4" "Cell line enriched" "Detected in some" 5 "AF22: 55.0" "Cancer enhanced" "Detected in many" "prostate cancer: 19.0" "Region enriched" "Detected in all" 5 "cerebellum: 87.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052128 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA052128: " "unprognostic (3.35e-2)" "unprognostic (3.18e-1)" "unprognostic (5.94e-2)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (5.85e-2)" "unprognostic (3.24e-3)" "unprognostic (1.82e-3)" "unprognostic (2.22e-1)" "unprognostic (9.74e-2)" "unprognostic (5.11e-4)" "unprognostic (1.13e-1)" "unprognostic (6.01e-3)" "unprognostic (2.80e-3)" "unprognostic (3.46e-2)" "unprognostic (2.83e-2)" "unprognostic (3.01e-3)" 2.9 4.2 13.3 0.9 10.6 0.6 6.8 87.4 35.6 1.6 1.9 6.4 0.0 2.3 3.8 2.0 1.8 3.3 3.1 3.6 16.4 7.4 18.9 2.7 5.8 0.8 10.7 10.9 1.8 2.2 1.3 2.5 3.6 17.0 12.2 2.2 3.7 3.8 2.1 2.3 3.5 2.4 2.9 22.6 1.6 3.5 1.2 5.3 0.0 5.7 0.8 2.2 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.0 0.1 1.7 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 7.0 0.0 0.6 0.0 0.0 0.4 0.1 10.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 10.6 87.4 18.8 16.4 7.4 10.7 10.9 17.0 5.3 TMEM202 FLJ27523 ENSG00000187806 "Transmembrane protein 202" A6NGA9 15 72398273-72408029 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 219 "testis: 23.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (1.31e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM207 ENSG00000198398 "Transmembrane protein 207" Q6UWW9 3 190428655-190449876 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 75 "kidney: 21.1" "Cell line enriched" "Detected in single" 6 "U-266/70: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA014332 Uncertain "HPA014332: AB_2204907" "unprognostic (4.81e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM210 ENSG00000185863 "Transmembrane protein 210" A6NLX4 9 137170858-137172409 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 18.7" "Cell line enriched" "Detected in some" 7 "RPMI-8226: 15.4" "Cancer enhanced" "Detected in single" "prostate cancer: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.1" "Group enriched" "Detected in many" 4 "dendritic cells: 4.1;granulocytes: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA066907 Enhanced "HPA066907: " "unprognostic (5.17e-2)" "unprognostic (5.04e-2)" "unprognostic (2.87e-5)" "unprognostic (4.18e-2)" "unprognostic (3.63e-2)" "unprognostic (3.14e-2)" "unprognostic (8.00e-2)" 0.1 0.0 0.1 0.1 0.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.1 4.0 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.0 18.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.6 4.1 1.4 0.3 0.5 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.7 0.1 15.4 0.0 0.0 0.1 0.1 0.0 2.0 0.1 1.4 0.0 0.0 0.1 0.1 0.6 0.0 0.3 0.2 0.0 0.3 0.2 0.0 1.4 0.3 0.1 0.2 0.2 0.3 0.1 0.2 0.2 0.2 0.6 0.3 0.3 1.2 0.5 0.2 4.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 TMEM217 "C6orf128, dJ355M6.2" ENSG00000172738 "Transmembrane protein 217" Q8N7C4 6 37212180-37258155 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 20.1" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 3.6;HEL: 4.7;hTEC/SVTERT24-B: 3.3;HUVEC TERT2: 4.9;TIME: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA045432, HPA071187" Supported Nucleoli Nucleoli "HPA045432: , HPA071187: " "unprognostic (7.78e-2)" "unprognostic (5.49e-2)" "unprognostic (2.22e-2)" "unprognostic (1.29e-2)" "unprognostic (7.79e-2)" "unprognostic (2.02e-1)" "unprognostic (6.77e-3)" "unprognostic (1.40e-2)" "unprognostic (3.51e-2)" "unprognostic (4.23e-4)" "unprognostic (8.22e-2)" "unprognostic (2.18e-1)" "unprognostic (5.62e-2)" "unprognostic (7.26e-2)" "unprognostic (1.33e-2)" "unprognostic (6.99e-2)" "unprognostic (1.59e-1)" 0.3 2.7 0.4 0.4 1.4 1.3 0.3 0.4 1.1 0.3 0.3 1.6 0.0 0.4 0.2 1.1 1.4 0.4 0.7 0.4 0.3 0.4 0.9 0.5 0.5 0.1 0.9 1.0 1.1 3.1 0.6 2.3 0.2 1.0 0.4 0.3 1.1 1.5 0.1 1.0 0.5 0.4 0.5 1.6 0.2 0.2 20.1 0.9 0.0 0.5 0.0 0.3 0.4 0.3 0.1 0.4 0.2 0.0 0.0 0.6 0.1 0.1 0.0 0.3 0.0 0.2 1.2 0.0 0.3 2.7 1.0 3.6 0.7 0.5 0.1 0.2 0.0 0.5 0.3 0.3 1.0 0.1 0.2 4.7 0.0 0.1 0.3 0.0 2.7 0.5 0.7 3.3 0.2 4.9 1.3 0.0 0.5 0.0 0.1 0.4 0.2 0.0 0.2 0.0 0.0 1.2 0.2 0.0 0.0 0.5 0.0 0.2 0.0 0.1 12.8 0.2 0.1 0.0 0.2 0.1 0.2 0.5 0.0 0.9 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.4 0.0 0.1 0.4 1.4 0.4 1.1 0.3 0.4 0.9 1.0 1.0 0.9 TMEM225 "PMP22CD, PPP1R154, SPATA47" ENSG00000204300 "Transmembrane protein 225" Q6GV28 11 123882926-123885642 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 79 "testis: 35.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.38e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM225B ENSG00000244219 "Transmembrane protein 225B" P0DP42 7 99598066-99610813 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 86.7" "Cell line enhanced" "Detected in many" "Karpas-707: 14.5;U-266/70: 8.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.91e-3)" "unprognostic (5.04e-3)" "unprognostic (1.04e-1)" "unprognostic (1.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.95e-1)" "unprognostic (6.27e-3)" "unprognostic (2.75e-2)" "unprognostic (1.11e-1)" "unprognostic (2.58e-2)" "unprognostic (1.25e-1)" "unprognostic (7.08e-2)" "unprognostic (1.62e-1)" "unprognostic (4.00e-1)" "unprognostic (6.86e-2)" "unprognostic (1.17e-1)" "unprognostic (2.50e-1)" 0.1 0.2 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 1.1 0.1 0.6 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.0 86.7 0.1 0.1 0.4 0.1 0.1 0.1 0.1 4.5 3.6 2.9 0.3 3.0 3.6 1.8 1.2 1.8 0.9 0.2 4.8 1.3 0.0 0.6 3.1 1.7 2.0 0.2 1.1 1.3 0.0 0.1 0.1 0.5 0.1 3.6 4.6 0.8 0.2 0.0 0.3 1.4 1.0 1.0 0.4 0.6 0.1 2.8 0.0 0.8 14.5 0.7 0.0 2.4 5.4 0.1 0.0 0.8 1.3 1.9 0.5 0.0 0.6 1.3 0.3 0.0 0.5 0.0 0.7 0.1 0.7 2.2 4.3 0.2 8.2 1.8 2.8 0.8 1.7 1.4 0.0 0.1 2.9 1.7 0.3 3.0 2.9 2.2 1.1 1.2 4.5 2.1 3.6 0.7 3.0 0.3 3.6 1.4 1.8 TMEM233 IFITMD2 ENSG00000224982 "Transmembrane protein 233" B4DJY2 12 119593459-119643066 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 88.0" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 11.3;RH-30: 6.0;U-2197: 9.0;U-87 MG: 36.2" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 12.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047506, HPA075435" Uncertain Approved Nucleoplasm Nucleoplasm "HPA047506: AB_10963068, HPA075435: " "unprognostic (1.46e-2)" "unprognostic (1.16e-2)" "unprognostic (1.39e-3)" "unprognostic (1.03e-2)" "unprognostic (1.99e-3)" "unprognostic (1.71e-2)" "unprognostic (5.86e-2)" "unprognostic (1.55e-2)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-2)" "unprognostic (4.41e-2)" "unprognostic (6.06e-2)" "unprognostic (3.10e-3)" "unprognostic (2.94e-1)" "unprognostic (4.38e-2)" "unprognostic (3.66e-1)" 0.6 0.3 0.8 0.0 0.4 0.0 0.6 0.1 8.8 0.2 0.2 0.0 0.0 0.1 0.9 0.6 0.2 0.2 1.0 0.7 0.2 0.5 0.5 0.3 0.6 0.2 0.1 1.4 0.6 0.1 1.7 0.4 0.0 0.4 0.4 0.1 0.7 0.5 0.3 88.0 0.1 0.2 0.5 0.3 0.2 0.2 0.2 0.0 0.1 11.1 5.2 0.3 0.4 1.8 0.3 0.3 0.7 0.1 0.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 11.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.5 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 36.2 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.2 0.3 0.3 0.2 0.0 0.3 0.2 0.5 0.7 0.6 0.1 0.3 0.1 0.1 0.8 0.4 0.1 1.5 0.2 0.5 0.1 1.4 0.4 0.0 TMEM235 ENSG00000204278 "Transmembrane protein 235" A6NFC5 17 78231310-78240987 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 26 "brain: 33.0" "Cell line enhanced" "Detected in some" "Daudi: 1.0;HUVEC TERT2: 1.2" "Cancer enriched" "Detected in single" 15 "glioma: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA053939 Uncertain "HPA053939: " "unprognostic (1.47e-1)" "unprognostic (6.91e-3)" "unprognostic (3.92e-2)" "unprognostic (1.71e-1)" 1.0 1.0 12.2 1.0 17.4 1.0 1.0 2.0 25.6 1.0 1.0 33.0 0.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 20.9 9.7 1.0 1.0 1.0 1.1 18.3 8.6 1.1 1.0 1.0 0.0 1.2 10.3 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0 1.0 20.7 1.0 1.0 1.2 18.0 0.0 1.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 17.4 2.0 10.2 20.9 9.7 18.3 8.6 10.3 18.0 TMEM236 "bA162I21.2, bA16O1.2, FAM23A, FAM23B" ENSG00000148483 "Transmembrane protein 236" Q5W0B7 10 17752252-17800868 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "intestine: 76.4" "Cell line enriched" "Detected in some" 10 "MOLT-4: 14.9" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045096 Enhanced "HPA045096: " "unprognostic (4.95e-2)" "unprognostic (2.48e-1)" "unprognostic (2.88e-3)" "unprognostic (2.47e-1)" "unprognostic (1.96e-1)" "unprognostic (3.36e-2)" "unprognostic (2.52e-3)" "unprognostic (1.37e-1)" "unprognostic (3.98e-1)" "unprognostic (1.42e-1)" "unprognostic (5.06e-3)" "unprognostic (1.75e-1)" "unprognostic (1.62e-2)" "unprognostic (1.72e-1)" "unprognostic (3.43e-2)" "unprognostic (3.16e-2)" "unprognostic (1.54e-2)" 0.5 0.3 0.3 4.9 0.3 0.0 0.3 0.3 0.3 0.4 32.0 0.1 0.1 13.7 0.5 0.1 0.4 0.2 0.1 0.3 0.3 0.3 0.5 0.4 0.6 0.1 0.3 0.1 0.3 0.7 0.0 0.3 0.6 0.1 0.3 9.1 0.1 0.3 0.1 0.5 0.3 76.4 0.3 0.3 0.3 0.3 0.5 0.1 0.1 0.3 0.1 0.1 0.3 0.3 1.3 0.9 2.6 0.6 1.0 0.6 0.1 0.3 0.2 0.4 0.5 0.1 0.1 0.5 0.3 0.0 0.1 0.3 0.5 0.5 0.2 0.2 0.2 0.3 0.2 0.2 0.8 0.2 0.5 0.6 0.5 0.5 0.1 0.5 1.5 0.2 0.4 0.1 0.2 0.4 0.2 0.4 0.2 0.3 14.9 0.3 0.3 0.1 0.6 0.4 0.3 0.1 0.3 0.3 0.2 0.2 0.1 0.5 0.2 0.0 0.7 0.5 0.6 0.2 0.2 0.3 0.2 0.3 0.2 0.2 0.2 2.6 0.6 0.9 0.6 0.4 0.4 0.7 0.5 0.4 0.4 1.3 0.5 0.6 2.2 1.0 0.4 0.9 0.4 0.1 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.1 0.1 TMEM239 ENSG00000198326 "Transmembrane protein 239" Q8WW34 20 2816302-2820284 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 42.1" "Cell line enriched" "Detected in some" 7 "HDLM-2: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.7" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.12e-3)" "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.7 0.5 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.5 0.2 0.3 0.2 0.0 0.1 0.2 0.1 0.1 0.3 0.2 0.2 1.7 0.3 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM247 ENSG00000284701 "Transmembrane protein 247" A6NEH6 2 46479565-46484425 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 21.8" "Cell line enriched" "Detected in single" 21 "U-266/84: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM249 C8orfK29 ENSG00000261587 "Transmembrane protein 249" Q2WGJ8 8 144352219-144354914 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 70 "testis: 35.1" "Cell line enhanced" "Detected in some" "BEWO: 2.5;PC-3: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA078901 Approved "HPA078901: " "unprognostic (2.23e-1)" "unprognostic (8.91e-3)" "unprognostic (1.72e-2)" "unprognostic (1.10e-1)" "unprognostic (4.13e-2)" "unprognostic (2.41e-1)" "unprognostic (1.03e-4)" "unprognostic (1.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.30e-1)" "unprognostic (8.44e-2)" "unprognostic (3.21e-1)" "unprognostic (1.13e-7)" "unprognostic (6.56e-3)" "unprognostic (1.62e-2)" "unprognostic (8.44e-3)" "unprognostic (3.46e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.3 0.0 0.6 0.2 0.1 2.5 0.8 0.0 0.2 0.2 0.0 0.7 1.5 0.0 0.3 0.2 0.0 0.1 0.0 1.5 0.4 0.4 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.7 2.3 1.6 0.7 0.0 0.0 1.1 1.3 1.7 0.0 0.3 2.1 0.8 1.0 0.0 0.5 2.0 0.8 0.2 0.5 0.4 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM253 "C14orf176, C14orf95, NCRNA00220" ENSG00000232070 "Transmembrane protein 253" P0C7T8 14 21098937-21103724 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 31 "intestine: 110.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA052329, HPA065092" Enhanced "HPA052329: , HPA065092: " "unprognostic (7.48e-3)" "unprognostic (1.33e-2)" "unprognostic (7.19e-2)" "unprognostic (3.84e-2)" "unprognostic (1.41e-2)" "unprognostic (1.50e-2)" "unprognostic (2.07e-1)" "unprognostic (2.90e-2)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (1.28e-2)" "unprognostic (5.46e-2)" "unprognostic (9.93e-2)" "unprognostic (3.59e-1)" "unprognostic (1.80e-1)" "unprognostic (2.20e-2)" "unprognostic (1.04e-1)" 0.4 1.5 0.4 2.2 0.4 0.0 0.3 0.5 0.5 0.5 32.6 0.4 2.0 41.8 0.4 0.8 0.9 0.2 3.1 0.9 0.3 0.4 0.4 0.5 0.4 0.2 0.5 0.4 0.4 0.7 0.4 0.3 0.5 0.4 0.5 5.7 0.4 2.8 0.7 0.3 0.6 110.5 0.6 0.3 0.4 0.2 0.4 0.2 0.2 3.6 0.8 0.7 0.3 0.5 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.4 0.9 2.7 2.6 4.0 1.0 4.4 1.0 2.0 0.5 0.9 2.3 2.1 3.2 0.6 0.2 4.2 0.9 5.0 0.6 1.9 0.2 1.6 3.0 2.7 0.6 0.0 0.1 1.9 4.3 2.1 3.4 0.3 1.1 0.2 1.3 0.9 0.1 0.3 3.5 0.1 0.7 1.3 1.8 2.3 2.0 0.7 1.4 1.1 0.8 2.4 0.8 0.0 0.0 0.0 1.5 0.5 0.3 0.8 0.4 0.0 0.2 1.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.5 0.5 0.3 0.4 0.5 0.4 0.4 0.2 TMEM26 "Em:AC068892.1, MGC35010" ENSG00000196932 "Transmembrane protein 26" Q6ZUK4 10 61406643-61453450 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 30.2" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.1;fHDF/TERT166: 2.2;HSkMC: 3.9;HUVEC TERT2: 2.9;MOLT-4: 4.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hypothalamus: 2.7" "Low region specificity" "Detected in many" "unprognostic (1.21e-3)" "unprognostic (2.84e-1)" "unprognostic (7.34e-2)" "unprognostic (7.83e-2)" "unprognostic (1.38e-3)" "unprognostic (1.30e-1)" "unprognostic (7.56e-2)" "unprognostic (3.69e-2)" "unprognostic (3.13e-1)" "unprognostic (9.41e-2)" "unprognostic (5.38e-2)" "unprognostic (5.24e-2)" "unprognostic (2.29e-5)" "unprognostic (2.55e-2)" "unprognostic (1.51e-2)" "unprognostic (8.53e-2)" "unprognostic (1.95e-1)" 1.3 1.2 3.7 1.0 2.1 0.0 7.4 0.3 2.0 3.2 1.1 0.9 1.1 1.8 5.6 0.9 0.6 0.8 1.2 0.6 0.9 1.0 3.6 4.5 1.8 5.8 1.5 1.3 2.1 0.4 5.6 0.7 1.8 1.1 3.5 1.1 3.6 0.5 3.2 0.7 0.3 1.9 2.5 0.9 30.2 0.5 4.4 1.2 6.2 0.7 0.2 0.1 0.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.7 0.2 0.0 9.1 1.0 1.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 3.9 0.0 1.0 0.0 2.9 0.0 0.0 0.3 0.0 4.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 2.1 0.3 2.0 0.9 1.0 1.5 1.3 1.1 1.2 TMEM262 ENSG00000187066 "Transmembrane protein 262" E9PQX1 11 65084979-65089375 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "testis: 18.1" "Cell line enhanced" "Detected in some" "Karpas-707: 1.9;T-47d: 1.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 1.5;neutrophil: 1.1" "Group enriched" "Detected in many" 5 "B-cells: 1.5;granulocytes: 1.1" "Low region specificity" "Detected in single" "unprognostic (4.36e-2)" "unprognostic (2.77e-1)" "unprognostic (1.78e-3)" "unprognostic (1.62e-1)" "unprognostic (1.61e-1)" "unprognostic (1.71e-4)" "unprognostic (1.85e-5)" "unprognostic (3.28e-1)" "unprognostic (2.87e-1)" "unprognostic (1.12e-1)" "unprognostic (3.19e-3)" "unprognostic (7.18e-3)" "unprognostic (7.13e-9)" "unprognostic (9.53e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.84e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 1.5 0.1 1.1 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.1 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.1 0.0 0.0 TMEM266 "C15orf27, FLJ38190" ENSG00000169758 "Transmembrane protein 266" Q2M3C6 15 76059837-76229121 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 50.7" "Cell line enhanced" "Detected in some" "HDLM-2: 1.9;HEK 293: 3.6;NTERA-2: 3.6;U-937: 3.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Region enriched" "Detected in many" 12 "cerebellum: 50.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in all" 6 "cerebellum: 65.8" "Region enriched" "Detected in all" 6 "cerebellum: 66.4" "HPA041921, HPA049425" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041921: AB_10796789, HPA049425: " "unprognostic (8.63e-3)" "unprognostic (6.11e-3)" "unprognostic (3.44e-3)" "unprognostic (9.17e-5)" "unprognostic (4.67e-1)" "unprognostic (2.61e-2)" "unprognostic (9.34e-3)" "unprognostic (5.61e-2)" "unprognostic (8.48e-3)" "unprognostic (2.89e-2)" "unprognostic (1.18e-2)" "unprognostic (3.95e-2)" "unprognostic (1.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-2)" "unprognostic (7.86e-2)" 0.1 1.9 1.1 0.2 1.9 0.2 0.4 50.7 4.2 0.2 0.2 0.6 0.0 0.3 0.2 0.1 0.3 0.3 0.1 0.1 0.9 1.3 0.9 0.1 1.1 0.3 0.7 0.3 0.1 2.4 0.2 5.1 2.4 1.9 0.4 0.2 1.1 0.2 0.1 10.6 1.5 0.1 0.1 0.4 0.6 0.3 1.4 0.0 0.0 0.2 0.7 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.8 0.8 0.0 1.9 3.6 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 50.7 4.2 0.9 1.3 0.7 0.3 1.9 0.0 TMEM270 "MGC26719, WBSCR28" ENSG00000175877 "Transmembrane protein 270" Q6UE05 7 73861159-73865893 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 35.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.1;MCF7: 5.3;PC-3: 1.8;RPMI-8226: 1.4;U-2197: 1.4;U-87 MG: 1.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "T-reg: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA077196 Approved Vesicles Vesicles "HPA077196: " "unprognostic (3.84e-2)" "unprognostic (6.91e-2)" "unprognostic (6.87e-5)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (2.81e-3)" "unprognostic (1.34e-1)" "unprognostic (8.31e-3)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-1)" "unprognostic (2.56e-2)" "unprognostic (3.35e-2)" "unprognostic (1.26e-1)" "unprognostic (1.44e-1)" "unprognostic (7.23e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 2.1 0.2 0.0 0.3 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.4 0.0 1.8 0.0 0.0 1.4 0.3 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.1 1.4 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM31 MGC39655 ENSG00000179363 "Transmembrane protein 31" Q5JXX7 X 103710909-103714028 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 46.6" "Cell line enhanced" "Detected in some" "AF22: 3.0;BEWO: 7.1;MCF7: 10.2;NTERA-2: 3.1;U-937: 3.8" "Cancer enhanced" "Detected in some" "testis cancer: 1.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA052760 Approved "Nucleoli fibrillar center" "Nucleoli fibrillar center" "HPA052760: " "unprognostic (9.42e-5)" "unprognostic (1.46e-2)" "unprognostic (1.18e-1)" "unprognostic (7.51e-2)" "unprognostic (7.75e-3)" "unprognostic (1.22e-2)" "unprognostic (2.43e-1)" "unprognostic (4.50e-2)" "unprognostic (1.06e-2)" "unprognostic (1.59e-1)" "unprognostic (1.39e-2)" "unprognostic (3.77e-1)" "unprognostic (5.91e-5)" "unprognostic (1.75e-2)" "unprognostic (1.12e-1)" "unprognostic (2.72e-1)" "unprognostic (4.68e-2)" 0.2 0.0 0.3 0.2 0.6 0.0 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.4 1.4 0.2 0.4 0.2 0.2 0.5 0.8 0.2 0.2 0.2 0.2 0.6 0.2 0.8 0.2 0.4 0.2 0.6 0.2 0.3 0.0 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.7 0.2 0.0 46.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 2.0 1.8 0.0 0.9 0.0 0.8 0.1 0.0 0.0 3.0 0.1 0.2 0.0 7.1 0.1 0.1 0.3 0.5 0.0 0.3 0.1 0.2 0.0 0.0 1.2 0.0 0.4 0.0 2.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.3 10.2 0.3 1.9 3.1 0.0 1.2 0.0 0.1 0.0 0.0 0.9 0.6 0.7 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.8 0.0 3.8 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.9 0.2 0.0 1.4 2.0 0.8 0.4 0.0 0.0 0.9 1.8 0.0 0.1 0.3 0.6 0.2 0.2 0.5 0.8 0.6 0.2 0.2 0.2 TMEM38A "MGC3169, TRIC-A" ENSG00000072954 "Transmembrane protein 38A" Q9H6F2 19 16661127-16690029 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 158.8" "Cell line enhanced" "Detected in many" "Daudi: 12.1;U-266/70: 12.2;U-698: 20.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048100, HPA050463" Enhanced Approved Nucleoplasm Nucleoplasm "HPA048100: , HPA050463: AB_2681137" "unprognostic (1.56e-1)" "unprognostic (1.04e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-1)" "unprognostic (2.99e-1)" "unprognostic (3.49e-1)" "prognostic favourable (2.78e-5)" "unprognostic (2.94e-2)" "prognostic unfavourable (7.96e-4)" "unprognostic (1.06e-1)" "unprognostic (2.68e-1)" "prognostic favourable (2.99e-10)" "unprognostic (1.93e-1)" "unprognostic (1.80e-1)" "unprognostic (4.50e-3)" "unprognostic (1.96e-2)" 1.3 1.6 3.6 1.1 7.9 2.3 1.2 5.1 12.2 1.3 1.4 2.1 3.1 1.3 1.1 6.6 3.5 1.8 1.0 5.4 3.0 3.8 2.0 2.7 2.1 1.3 5.2 3.7 1.2 1.3 1.7 2.2 0.9 4.8 2.9 1.5 8.3 2.7 2.4 158.8 1.0 1.1 1.1 1.9 1.0 5.3 1.6 1.4 0.0 1.8 30.1 1.9 1.1 0.4 3.9 0.5 20.3 2.9 2.1 0.5 0.6 3.0 0.6 0.8 4.7 2.6 0.3 0.4 1.1 0.6 0.7 1.5 0.9 4.4 12.1 1.9 0.2 2.5 6.2 1.3 0.7 0.8 1.8 0.0 1.8 1.0 0.7 0.1 0.2 1.1 4.8 0.9 0.5 0.3 0.1 1.1 0.5 4.6 0.1 1.2 1.2 7.2 6.3 1.1 3.2 4.6 2.3 7.8 5.4 3.3 0.4 1.5 2.3 1.0 0.0 0.9 2.3 2.9 0.5 12.2 8.8 20.3 1.1 7.2 0.9 20.3 2.9 8.2 0.0 1.1 0.0 2.8 0.4 0.0 0.2 3.9 0.1 0.1 1.6 2.1 0.7 0.5 0.5 0.6 3.6 7.9 5.1 12.2 3.0 3.8 5.2 3.7 4.8 1.4 TMEM52B "C12orf59, FLJ31166" ENSG00000165685 "Transmembrane protein 52B" Q4KMG9 12 10170542-10191801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "kidney: 85.1" "Cell line enriched" "Detected in some" 8 "CACO-2: 45.3" "Cancer enriched" "Detected in some" 5 "renal cancer: 6.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 3.7" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA058096 Enhanced Approved "Focal adhesion sites" "Focal adhesion sites" "HPA058096: AB_2683603" "unprognostic (1.10e-2)" "unprognostic (7.61e-2)" "unprognostic (1.37e-3)" "unprognostic (1.22e-1)" "unprognostic (1.67e-1)" "unprognostic (5.33e-3)" "unprognostic (1.37e-1)" "unprognostic (8.65e-2)" "unprognostic (7.14e-4)" "unprognostic (2.23e-1)" "unprognostic (6.36e-2)" "unprognostic (7.33e-2)" "unprognostic (3.24e-2)" "unprognostic (5.80e-2)" "unprognostic (5.51e-2)" "unprognostic (1.66e-1)" "unprognostic (3.18e-1)" 0.1 0.0 0.1 0.1 0.6 0.9 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 85.1 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.1 2.0 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 3.7 1.4 1.3 0.6 0.5 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 45.3 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.8 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.3 4.3 0.0 2.4 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 1.4 1.3 1.0 0.4 0.2 0.4 0.4 0.4 0.5 3.7 0.9 0.5 0.5 1.0 0.6 0.2 0.6 0.4 0.4 0.1 0.6 0.1 0.2 0.2 0.1 0.3 0.1 0.1 0.1 TMEM59L "BSMAP, C19orf4" ENSG00000105696 "Transmembrane protein 59 like" Q9UK28 19 18607430-18621039 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 148.3" "Cell line enhanced" "Detected in some" "AN3-CA: 20.3;ASC diff: 24.7;EFO-21: 14.6;Hep G2: 14.8;HSkMC: 9.1;SH-SY5Y: 12.0" "Cancer enriched" "Detected in many" 8 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010661, HPA070701" Approved Approved "Nucleoplasm,Actin filaments" "Actin filaments" Nucleoplasm "HPA010661: AB_1078338, HPA070701: " "unprognostic (3.24e-2)" "unprognostic (5.53e-2)" "unprognostic (1.24e-4)" "prognostic unfavourable (1.62e-4)" "unprognostic (1.70e-1)" "unprognostic (5.40e-3)" "unprognostic (3.53e-2)" "unprognostic (6.91e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-3)" "prognostic favourable (8.80e-4)" "unprognostic (4.65e-2)" "unprognostic (9.17e-7)" "unprognostic (1.47e-3)" "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-5)" 2.6 12.8 36.9 2.5 39.4 1.7 1.9 41.9 148.3 2.2 2.9 7.5 0.0 2.0 2.5 2.0 2.5 2.1 2.9 3.5 39.9 49.6 1.9 1.8 1.9 1.8 17.7 32.8 1.8 2.8 4.9 13.2 2.3 24.1 2.2 2.2 1.9 2.3 2.6 2.5 1.8 3.0 3.1 7.3 1.7 2.0 2.4 5.2 0.0 1.8 0.0 1.7 2.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.4 0.0 0.6 0.2 20.3 24.7 1.2 0.0 2.1 0.4 0.8 0.4 0.0 1.0 0.1 14.6 1.3 0.3 6.0 0.0 0.7 0.1 0.9 0.0 0.3 14.8 3.8 0.0 0.3 9.1 0.0 0.2 0.7 0.0 0.0 0.1 0.5 0.8 0.1 0.0 1.8 0.6 0.1 0.0 0.2 0.0 0.0 0.3 12.0 1.4 0.0 0.0 0.2 0.0 0.2 0.4 4.9 0.1 1.3 3.0 1.1 0.1 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.4 36.9 39.4 41.9 70.3 39.9 49.6 17.7 32.8 24.1 5.2 TMEM64 DKFZp762C1112 ENSG00000180694 "Transmembrane protein 64" Q6YI46 8 90621995-90791632 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "epididymis: 84.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB034221 Enhanced "CAB034221: AB_1567653" "unprognostic (3.61e-1)" "unprognostic (1.42e-1)" "unprognostic (1.58e-1)" "unprognostic (3.70e-2)" "unprognostic (1.14e-1)" "unprognostic (2.27e-1)" "unprognostic (2.55e-3)" "unprognostic (4.84e-1)" "unprognostic (2.04e-1)" "unprognostic (1.26e-2)" "unprognostic (3.30e-1)" "unprognostic (2.35e-1)" "unprognostic (2.59e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (6.17e-2)" "unprognostic (1.97e-1)" 9.2 12.6 4.3 5.2 5.3 2.1 6.1 2.7 6.1 10.6 10.8 16.2 14.5 5.7 11.9 84.0 7.3 5.7 6.3 5.8 6.2 5.5 11.6 11.7 7.2 6.7 11.2 3.3 10.1 11.3 4.1 5.9 6.1 10.0 10.7 3.7 15.1 12.4 11.0 8.2 6.8 11.3 9.6 12.1 7.2 5.4 9.7 7.5 2.3 20.0 5.2 7.2 11.9 10.9 5.7 0.6 3.2 0.8 5.9 3.7 1.6 12.6 9.9 5.0 2.6 23.3 17.0 2.7 9.4 9.0 7.4 8.2 2.7 8.7 8.2 3.8 5.7 4.4 13.2 6.3 9.8 16.6 4.8 15.4 3.9 6.2 8.2 0.9 2.6 22.1 7.0 3.0 6.9 7.4 6.9 18.3 12.4 16.9 0.0 2.2 0.7 5.2 1.8 11.0 4.2 14.6 24.6 3.5 10.0 6.1 5.4 11.3 5.4 0.7 7.3 7.5 6.6 5.4 7.6 12.1 0.2 9.0 6.8 1.9 9.8 3.2 0.2 0.3 3.0 0.6 3.7 5.7 3.2 3.4 0.6 2.9 1.5 2.1 0.1 5.9 0.8 0.4 1.4 1.6 4.3 5.3 2.7 6.1 6.2 5.5 11.2 3.3 10.0 7.5 TMEM88B ENSG00000205116 "Transmembrane protein 88B" A6NKF7 1 1426128-1427787 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 36.9" "Cell line enhanced" "Detected in some" "EFO-21: 2.2;Hep G2: 9.0;SCLC-21H: 3.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065743 Enhanced "HPA065743: " "unprognostic (3.17e-2)" "unprognostic (1.42e-2)" "unprognostic (1.63e-4)" "unprognostic (1.11e-1)" "unprognostic (3.35e-2)" "unprognostic (2.67e-1)" "unprognostic (2.91e-2)" "unprognostic (5.30e-5)" "unprognostic (2.00e-1)" "unprognostic (2.64e-1)" "unprognostic (3.53e-2)" "unprognostic (7.19e-2)" "unprognostic (1.45e-1)" "unprognostic (7.95e-2)" 1.1 1.1 10.2 1.4 24.7 1.2 1.1 1.0 23.3 1.1 1.1 34.0 0.0 1.1 1.1 1.1 1.1 1.4 1.3 1.2 19.6 8.3 1.5 1.1 1.4 1.2 30.8 11.2 1.1 1.1 1.1 0.0 1.2 16.1 1.3 1.1 0.0 1.1 1.1 1.1 1.7 1.1 1.1 36.9 1.1 1.3 2.4 28.5 0.0 1.1 0.0 1.1 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 3.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 24.7 1.0 20.6 19.6 8.3 30.8 11.2 16.1 28.5 TMEM89 ENSG00000183396 "Transmembrane protein 89" A2RUT3 3 48620759-48621855 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 28.3" "Cell line enhanced" "Detected in some" "NB-4: 2.8;U-2197: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053577 Uncertain "HPA053577: " "unprognostic (1.61e-1)" "unprognostic (2.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (1.07e-1)" "unprognostic (1.94e-3)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (7.12e-2)" "unprognostic (2.02e-2)" "unprognostic (6.31e-3)" "unprognostic (5.90e-3)" "unprognostic (3.35e-2)" "unprognostic (3.83e-2)" "unprognostic (8.41e-2)" "unprognostic (2.71e-1)" "unprognostic (3.86e-2)" 0.1 0.0 0.1 0.1 0.1 2.8 0.1 0.1 0.5 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.2 0.1 0.1 0.5 0.5 0.1 0.1 0.1 0.7 28.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.7 0.4 1.1 0.3 1.1 0.7 0.0 0.2 0.0 1.1 0.2 0.4 0.0 0.0 0.3 0.0 0.5 0.8 0.6 0.5 0.0 1.5 0.0 1.4 1.9 0.6 0.0 0.0 0.0 0.0 0.8 0.0 2.8 0.6 0.0 0.7 0.5 0.0 0.7 1.2 0.1 0.9 0.0 0.7 0.4 0.8 0.0 0.0 1.4 1.5 3.1 1.5 0.5 0.8 0.5 1.8 0.7 2.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 TMEM92 FLJ33318 ENSG00000167105 "Transmembrane protein 92" Q6UXU6 17 50271406-50281485 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 74.7" "Group enriched" "Detected in some" 4 "A549: 9.7;CACO-2: 16.5;CAPAN-2: 15.9;EFO-21: 33.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 21 "neutrophil: 5.5" "Lineage enriched" "Detected in single" 21 "granulocytes: 5.5" "Low region specificity" "Detected in all" "HPA063009, HPA069820" Approved Enhanced Nucleoplasm Nucleoplasm "HPA063009: , HPA069820: " "unprognostic (3.54e-3)" "unprognostic (2.39e-2)" "unprognostic (9.85e-2)" "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "prognostic unfavourable (8.35e-4)" "unprognostic (4.37e-3)" "unprognostic (2.45e-2)" "unprognostic (1.11e-1)" "unprognostic (4.39e-1)" "unprognostic (3.88e-3)" "unprognostic (2.97e-2)" "prognostic unfavourable (1.14e-6)" "unprognostic (3.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (7.81e-2)" 0.2 0.1 0.3 1.9 0.3 0.4 0.3 0.3 0.3 3.3 27.9 0.3 0.1 23.3 1.2 0.3 1.0 0.7 11.7 0.1 0.8 0.3 0.4 10.2 6.1 0.1 0.3 0.2 2.4 1.2 0.0 0.1 0.3 0.9 1.2 1.8 1.1 4.3 1.2 0.1 0.2 74.7 0.4 0.4 0.3 17.9 0.5 0.3 0.1 0.1 0.4 1.6 2.2 3.7 0.1 0.2 5.5 0.1 0.0 0.0 0.0 1.0 9.7 0.2 0.0 0.0 0.4 2.1 0.2 0.3 0.0 0.0 16.5 15.9 0.0 33.0 0.7 0.1 0.2 1.8 0.1 2.6 0.1 0.0 1.0 1.6 0.1 0.1 0.1 0.1 1.9 0.1 0.5 0.0 1.5 0.0 0.0 0.0 0.0 0.2 3.6 4.3 0.2 0.0 4.1 3.6 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.5 0.0 0.1 2.3 0.0 0.0 0.0 0.2 0.1 0.2 1.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.3 0.8 0.3 0.3 0.2 0.9 0.3 TMEM95 "MGC129793, UNQ9390" ENSG00000182896 "Transmembrane protein 95" Q3KNT9 17 7355123-7357219 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 21 "testis: 19.3" "Cell line enhanced" "Detected in some" "BEWO: 1.0;BJ: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" "unprognostic (1.54e-1)" "unprognostic (1.03e-1)" "unprognostic (1.15e-1)" "unprognostic (5.15e-2)" "unprognostic (7.42e-2)" "unprognostic (7.44e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM97 MAC30 ENSG00000109084 "Transmembrane protein 97" Q5BJF2 17 28319095-28328685 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "pancreas: 228.7" "Cell line enhanced" "Detected in all" "CACO-2: 71.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044795, HPA076689" Enhanced Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA044795: AB_10959306, HPA076689: " "unprognostic (1.35e-2)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.10e-3)" "unprognostic (1.81e-1)" "unprognostic (4.34e-2)" "unprognostic (3.20e-2)" "unprognostic (9.03e-2)" "unprognostic (1.04e-2)" "unprognostic (1.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.17e-2)" "prognostic unfavourable (1.24e-4)" "unprognostic (1.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.99e-1)" "unprognostic (4.01e-2)" 2.0 11.5 3.1 2.8 3.3 1.7 3.4 2.9 4.9 2.6 4.2 2.2 1.2 4.7 2.9 1.9 3.1 4.0 8.1 1.6 2.4 3.0 2.2 33.7 12.5 3.4 2.4 2.7 8.2 228.7 1.7 0.6 2.0 7.7 6.9 3.8 3.2 1.5 2.8 5.7 3.6 3.2 3.4 4.0 1.7 13.2 31.5 1.3 4.6 1.3 3.9 2.5 12.5 6.0 9.0 13.8 1.7 2.3 8.2 10.0 4.6 9.9 25.1 48.1 23.7 6.4 9.2 15.8 9.6 6.2 15.3 20.5 71.0 7.6 27.3 10.6 3.7 10.7 30.5 16.4 12.1 12.8 21.4 10.2 13.1 30.2 5.8 16.2 8.2 18.7 2.1 15.0 6.2 4.6 21.4 20.6 5.1 16.8 25.3 15.3 21.2 6.5 20.4 52.9 24.6 18.8 45.4 34.7 15.2 15.4 12.3 7.8 21.6 7.5 3.0 16.5 13.1 14.1 17.6 16.6 32.7 24.9 3.3 11.7 9.7 0.4 2.0 1.7 7.3 2.3 8.5 9.0 6.2 8.8 13.8 5.1 10.0 9.3 0.9 8.2 0.8 8.0 5.8 4.6 3.1 3.3 2.9 4.2 2.4 3.0 2.4 2.7 7.7 1.3 TMIGD1 "TMIGD, UNQ9372" ENSG00000182271 "Transmembrane and immunoglobulin domain containing 1" Q6UXZ0 17 30316333-30334059 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "intestine: 47.3" "Cell line enhanced" "Detected in some" "BEWO: 1.4;NB-4: 1.3;U-2197: 1.8;U-698: 1.9" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA021946 Approved Mitochondria Mitochondria "HPA021946: AB_1858140" "unprognostic (1.28e-1)" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" 0.2 0.0 0.2 1.1 0.2 0.0 0.2 0.2 0.2 0.2 26.8 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 1.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 33.9 0.2 0.2 0.2 0.2 0.0 47.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 1.9 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 TMOD2 NTMOD ENSG00000128872 "Tropomodulin 2" Q9NZR1 15 51751561-51816368 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 68.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 26.3" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.8" "Group enriched" "Detected in all" 4 "granulocytes: 12.8;monocytes: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041365 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA041365: AB_10794665" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-3)" "unprognostic (9.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.18e-1)" "unprognostic (1.81e-1)" "unprognostic (3.32e-1)" "unprognostic (5.33e-4)" "prognostic favourable (4.53e-4)" "unprognostic (2.82e-1)" "unprognostic (1.39e-3)" "unprognostic (2.36e-2)" "unprognostic (6.86e-2)" "unprognostic (2.62e-1)" "unprognostic (2.89e-1)" 5.9 6.3 25.4 6.1 29.6 1.6 5.1 22.0 68.6 7.0 6.1 9.1 4.6 3.1 6.0 4.4 4.9 6.0 5.2 4.9 21.6 18.1 3.5 2.2 4.5 4.9 16.9 22.6 6.5 3.1 6.7 4.4 3.0 29.5 3.7 5.1 2.9 3.8 9.6 2.7 4.6 4.7 6.7 11.4 4.5 3.7 3.1 9.6 1.2 4.3 0.2 4.7 4.7 4.6 2.5 1.6 12.8 8.8 1.3 2.2 1.1 0.8 0.5 1.7 4.0 8.2 8.8 0.3 4.5 1.5 3.4 3.7 0.0 0.4 3.6 0.1 3.5 2.3 7.1 4.0 1.1 0.0 3.5 0.0 0.7 0.0 1.4 1.4 0.2 5.1 5.4 0.5 1.0 0.7 0.0 0.1 4.2 0.6 2.9 0.5 1.1 0.8 2.2 1.0 0.1 0.5 1.2 26.3 6.4 4.2 0.0 1.2 1.0 0.2 1.6 9.3 0.7 5.8 3.2 0.0 0.0 0.0 2.9 9.7 4.2 0.1 5.9 7.8 2.2 2.3 1.0 2.5 1.3 1.0 1.6 1.8 1.7 0.7 12.8 1.3 8.8 1.2 0.4 1.1 25.4 29.6 22.0 38.3 21.6 18.1 16.9 22.6 29.5 9.6 TMOD4 Sk-Tmod ENSG00000163157 "Tropomodulin 4" Q9NZQ9 1 151169986-151176284 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 153.5" "Cell line enhanced" "Detected in many" "HEK 293: 6.4;NB-4: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 1.5;memory B-cell: 1.7;memory CD4 T-cell: 1.5;naive B-cell: 1.0;naive CD4 T-cell: 1.6;naive CD8 T-cell: 3.5;plasmacytoid DC: 1.0" "Group enriched" "Detected in many" 5 "B-cells: 1.7;dendritic cells: 1.0;T-cells: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA028203 Enhanced "HPA028203: AB_10600830" 2.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 4.0 1.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 1.2 0.1 0.0 1.6 0.1 153.5 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.0 0.0 0.3 35.0 1.6 0.4 0.1 1.7 1.0 0.4 0.3 0.0 3.5 0.6 0.5 0.4 0.9 0.1 0.7 0.2 1.6 0.1 0.6 0.4 0.1 0.0 0.6 1.4 0.7 1.6 0.5 1.4 0.3 0.5 2.7 6.4 2.6 2.2 0.0 1.0 1.4 3.2 0.0 0.4 1.2 3.0 0.8 1.6 2.3 0.2 2.3 0.7 8.0 1.4 2.6 2.5 0.3 0.1 0.5 1.5 1.8 1.1 0.7 0.0 0.1 0.8 4.9 1.0 0.2 1.1 2.3 0.7 2.9 5.5 1.2 0.8 4.4 0.6 0.0 0.3 0.4 1.5 0.0 0.4 1.7 1.5 0.2 0.1 1.0 1.6 3.5 0.2 0.0 0.3 1.0 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 TMPRSS12 "CT151, MGC57341" ENSG00000186452 "Transmembrane serine protease 12" Q86WS5 12 50842920-50887884 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 52.7" "Cell line enhanced" "Detected in some" "BEWO: 2.9;Karpas-707: 1.1;NTERA-2: 1.3;SK-BR-3: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in some" "unprognostic (1.04e-1)" "unprognostic (9.09e-2)" "unprognostic (3.03e-2)" "unprognostic (7.25e-3)" "unprognostic (1.70e-1)" "unprognostic (1.39e-1)" "unprognostic (3.88e-1)" "unprognostic (2.98e-2)" "unprognostic (2.60e-1)" "unprognostic (1.88e-1)" "unprognostic (1.29e-1)" "unprognostic (5.65e-3)" "unprognostic (1.03e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 52.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 1.6 0.1 0.4 0.3 0.0 0.0 0.7 0.0 0.5 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.2 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.0 0.3 0.4 1.3 0.5 0.1 0.0 0.2 0.0 0.3 0.3 0.1 0.6 1.1 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.0 0.4 0.1 0.1 0.3 0.2 0.2 1.3 0.1 0.5 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.4 0.3 0.3 1.6 0.4 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMPRSS15 "ENTK, MGC133046, PRSS7" ENSG00000154646 "Transmembrane serine protease 15" P98073 21 18269116-18485879 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 67 "intestine: 154.6" "Group enriched" "Detected in some" 20 "U-138 MG: 19.8;U-87 MG: 55.3" "Group enriched" "Detected in some" 12 "liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "olfactory region: 9.3" "HPA015611, HPA034857, HPA072934" Enhanced Approved "Nucleoli,Plasma membrane" "Plasma membrane" Nucleoli "HPA015611: AB_1855791, HPA034857: , HPA072934: " "unprognostic (9.26e-2)" "unprognostic (4.14e-1)" "unprognostic (3.52e-1)" "unprognostic (8.33e-2)" "unprognostic (1.19e-1)" "unprognostic (7.20e-2)" "unprognostic (4.70e-2)" "unprognostic (6.35e-2)" "unprognostic (5.92e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 80.5 0.0 0.0 154.6 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 42.4 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.5 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.1 0.0 0.3 0.0 0.0 55.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 TMPRSS6 FLJ30744 ENSG00000187045 "Transmembrane serine protease 6" Q8IU80 22 37065436-37109563 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 59.3" "Group enriched" "Detected in some" 4 "Hep G2: 7.5;SCLC-21H: 12.9" "Group enriched" "Detected in many" 14 "liver cancer: 51.3;thyroid cancer: 14.1" "Region enriched" "Detected in single" 10 "basal ganglia: 1.8" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 2.2" "unprognostic (3.93e-1)" "unprognostic (3.28e-1)" "unprognostic (8.62e-2)" "unprognostic (6.29e-5)" "unprognostic (7.95e-2)" "unprognostic (1.62e-1)" "prognostic favourable (8.16e-6)" "unprognostic (2.44e-1)" "unprognostic (3.07e-1)" "unprognostic (2.41e-1)" "unprognostic (1.16e-2)" "unprognostic (3.58e-2)" "unprognostic (1.15e-7)" "unprognostic (2.38e-1)" "unprognostic (9.15e-2)" "unprognostic (2.39e-2)" "unprognostic (3.86e-5)" 0.1 0.0 0.1 0.1 1.8 0.0 0.8 0.1 0.1 0.1 0.3 0.1 0.1 1.1 0.1 0.4 0.1 0.2 0.4 0.1 0.1 0.0 0.1 59.3 1.9 0.1 0.1 0.1 0.5 0.9 0.0 5.3 0.6 0.1 0.2 0.2 0.1 0.1 0.1 0.1 1.1 0.6 0.1 0.1 0.1 2.3 2.6 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.0 0.1 0.0 1.3 0.0 0.2 0.8 0.2 0.4 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.8 2.3 0.3 0.1 7.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 1.3 0.0 0.0 0.3 0.1 0.4 0.2 0.3 0.0 0.0 12.9 0.4 0.2 1.0 0.0 0.1 0.0 0.6 0.5 1.6 0.1 0.0 1.5 0.4 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.8 0.5 0.2 1.3 0.1 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 TMSB4X "TB4X, TMSB4" ENSG00000205542 "Thymosin beta 4, X-linked" P62328 X 12975108-12977227 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "blood: 1074.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033806 Approved Approved Nucleoplasm,Vesicles,Cytosol 400000000 "Nucleoplasm, Vesicles, Cytosol" "CAB033806: AB_2256019" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.72e-2)" "unprognostic (3.27e-2)" "unprognostic (7.98e-3)" "unprognostic (1.71e-2)" "unprognostic (2.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-2)" "unprognostic (1.21e-1)" "prognostic unfavourable (6.20e-4)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (3.77e-2)" "unprognostic (1.98e-1)" 122.3 97.5 79.8 105.4 76.4 169.0 87.1 33.2 74.8 92.3 93.3 62.0 59.7 38.5 83.7 67.2 62.7 53.0 92.5 54.9 90.8 67.8 69.6 50.8 134.4 205.2 111.4 84.0 61.9 51.0 4.4 23.4 53.4 74.3 46.6 86.6 31.2 42.3 100.4 28.9 39.6 71.5 75.1 195.6 205.7 98.9 26.4 63.8 96.8 34.4 48.6 154.5 112.2 62.1 296.5 495.3 775.0 554.0 272.7 521.9 1074.5 141.5 118.6 233.1 367.2 285.8 313.3 0.5 75.1 196.5 58.3 100.5 24.4 119.2 33.9 72.6 227.8 62.4 34.5 50.3 78.5 198.2 1.9 42.2 70.3 0.3 66.6 164.9 350.9 145.8 72.2 69.0 60.4 350.3 5.3 0.5 206.3 50.4 196.0 357.9 83.8 81.8 151.1 82.5 138.5 347.1 41.5 24.8 10.5 108.8 5.1 13.8 136.7 167.5 281.7 85.2 42.2 482.6 74.5 110.6 80.3 65.8 130.3 68.4 61.3 544.9 512.5 775.0 364.8 524.7 309.6 296.5 407.3 391.0 495.3 275.6 345.8 349.0 576.0 272.7 554.0 204.1 521.9 1074.5 79.8 76.4 33.2 74.8 90.8 67.8 111.4 84.0 74.3 63.8 TNFRSF10C "CD263, DcR1, LIT, TRAILR3, TRID" ENSG00000173535 "TNF receptor superfamily member 10c" O14798 8 23102590-23117437 "Cancer-related genes, CD markers, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "blood: 173.4" "Group enriched" "Detected in some" 5 "BEWO: 37.1;HUVEC TERT2: 30.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "neutrophil: 173.4" "Lineage enriched" "Detected in many" 113 "granulocytes: 173.4" CAB025635 Enhanced "CAB025635: " "unprognostic (2.63e-1)" "unprognostic (4.49e-3)" "unprognostic (7.21e-3)" "unprognostic (2.07e-2)" "unprognostic (3.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.81e-2)" "unprognostic (2.11e-3)" "unprognostic (5.56e-2)" "unprognostic (4.37e-2)" "unprognostic (8.98e-2)" "unprognostic (1.94e-3)" "unprognostic (2.74e-3)" "unprognostic (4.83e-1)" "unprognostic (1.84e-1)" "unprognostic (1.34e-3)" "unprognostic (6.54e-2)" 5.5 1.5 1.9 14.0 3.6 12.6 2.0 1.4 3.9 2.9 1.5 0.7 0.1 1.2 1.5 1.2 1.4 3.7 13.5 5.6 1.9 1.1 2.8 3.2 13.7 28.4 9.2 0.0 2.4 2.1 2.5 4.5 12.8 3.1 2.7 1.8 1.7 1.7 0.8 2.3 0.8 2.2 1.9 4.4 26.4 1.8 1.4 2.3 0.8 4.4 0.5 0.9 5.2 1.9 0.0 0.3 173.4 1.5 0.0 0.0 0.4 0.4 1.4 0.5 2.4 0.0 0.3 37.1 1.5 0.0 0.1 0.1 0.0 1.4 0.1 0.7 1.4 0.2 0.1 0.1 0.1 2.5 0.5 0.1 0.3 1.1 3.6 0.2 1.0 4.1 0.3 0.7 0.3 30.9 0.0 0.0 0.2 1.0 0.0 0.9 1.6 0.0 0.1 0.1 0.0 5.9 0.1 0.0 0.0 0.1 0.2 0.7 5.1 0.2 6.5 0.6 1.2 1.4 0.1 1.5 0.8 0.0 2.2 0.3 0.9 2.7 1.5 25.4 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 173.4 0.0 1.1 0.0 0.0 0.4 1.9 3.6 1.4 3.9 1.9 1.1 9.2 0.0 3.1 2.3 TNNC2 ENSG00000101470 "Troponin C2, fast skeletal type" P02585 20 45823214-45833745 "FDA approved drug targets, Predicted intracellular proteins" "Muscle protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 851.6" "Group enriched" "Detected in some" 7 "Hep G2: 9.7;HSkMC: 15.3;SCLC-21H: 11.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 6.0" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043174, HPA058481" Enhanced Approved Nucleoplasm,Vesicles 63000 Nucleoplasm Vesicles "HPA043174: AB_10806380, HPA058481: " "unprognostic (1.13e-1)" "unprognostic (7.25e-2)" "unprognostic (3.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.21e-5)" "unprognostic (1.80e-2)" "unprognostic (5.72e-3)" "unprognostic (3.12e-3)" "unprognostic (2.19e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (1.05e-1)" "unprognostic (9.03e-3)" "unprognostic (7.15e-3)" "unprognostic (4.79e-1)" "unprognostic (5.23e-2)" "unprognostic (1.13e-1)" 12.0 0.2 0.1 0.1 0.4 0.1 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 2.7 4.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 1.4 0.1 0.0 7.8 0.1 851.6 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.6 169.1 6.6 0.1 0.1 6.0 0.8 2.4 1.1 0.3 4.1 11.9 0.1 0.0 0.2 0.5 1.7 1.2 1.7 0.2 0.4 0.0 0.1 0.2 1.1 0.4 1.2 1.0 0.4 0.0 0.4 0.0 0.0 0.3 0.0 0.9 9.7 0.4 0.3 0.2 15.3 0.2 0.1 0.7 0.0 0.1 0.5 0.2 1.2 0.7 0.1 0.0 0.6 0.2 0.6 0.2 0.3 0.0 11.5 0.5 1.7 0.1 0.4 1.3 0.4 0.5 0.3 0.4 0.9 0.2 1.5 0.4 0.3 1.6 0.1 0.2 0.0 0.7 1.4 0.2 1.1 0.7 6.0 1.5 0.2 0.3 3.8 0.0 0.3 2.4 0.3 0.8 0.8 4.1 11.9 0.1 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 TNNI1 ENSG00000159173 "Troponin I1, slow skeletal type" P19237 1 201403768-201429866 "Predicted intracellular proteins" "Actin-binding, Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 559.6" "Cell line enriched" "Detected in some" 9 "RH-30: 103.8" "Group enriched" "Detected in many" 5 "head and neck cancer: 9.6;prostate cancer: 3.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028190 Approved Uncertain Nucleoplasm,Nucleoli 25000 Nucleoplasm Nucleoli "HPA028190: AB_10600831" "unprognostic (2.82e-2)" "unprognostic (2.27e-1)" "unprognostic (2.91e-1)" "unprognostic (5.39e-2)" "unprognostic (2.31e-2)" "prognostic unfavourable (9.27e-4)" "unprognostic (1.93e-2)" "unprognostic (2.37e-1)" "unprognostic (4.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.92e-2)" "unprognostic (1.05e-2)" "unprognostic (2.59e-2)" "unprognostic (3.52e-1)" "unprognostic (2.11e-1)" "unprognostic (1.71e-1)" 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 22.9 9.5 0.0 0.1 6.6 0.1 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 6.8 0.0 559.6 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 2.7 83.8 10.7 0.0 0.1 0.2 0.6 1.7 0.4 0.4 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 103.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.3 0.3 0.3 0.1 0.2 0.2 0.2 0.6 0.2 0.3 0.5 1.7 0.4 0.3 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TNNI3 "CMD2A, CMH7, TNNC1" ENSG00000129991 "Troponin I3, cardiac type" P19429 19 55151767-55157773 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 367 "heart muscle: 419.3" "Cell line enhanced" "Detected in some" "HEK 293: 8.6;HMC-1: 14.4;K-562: 26.2;THP-1: 6.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "thalamus: 1.0" "CAB009349, HPA046428" Enhanced Approved Vesicles,Cytosol 1700000 Cytosol Vesicles "CAB009349: AB_793465, HPA046428: " "unprognostic (2.12e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-2)" "unprognostic (1.36e-1)" "unprognostic (2.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.37e-3)" "unprognostic (2.13e-1)" "unprognostic (9.62e-3)" "unprognostic (9.40e-2)" "unprognostic (3.34e-2)" "unprognostic (2.17e-3)" "unprognostic (4.02e-3)" "unprognostic (8.89e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (9.82e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 1.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 419.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.7 0.8 0.3 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.2 1.1 4.5 0.0 0.6 0.9 0.2 0.0 0.0 8.6 2.0 0.0 1.2 0.4 0.0 14.4 0.0 0.4 0.0 0.2 0.0 26.2 0.5 0.0 0.4 0.1 0.0 0.5 0.3 1.1 0.3 0.0 1.3 0.0 0.0 1.5 0.0 0.0 0.2 2.0 6.6 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 TNNI3K CARK ENSG00000116783 "TNNI3 interacting kinase" Q59H18 1 74235401-74544428 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 44.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.9;HSkMC: 2.7;RPTEC TERT1: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.3;plasmacytoid DC: 1.9" "Group enriched" "Detected in many" 5 "dendritic cells: 1.9;monocytes: 2.3;T-cells: 1.0" "unprognostic (1.04e-2)" "unprognostic (1.34e-2)" "unprognostic (3.83e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-1)" "unprognostic (3.40e-2)" "unprognostic (3.05e-1)" "unprognostic (2.48e-3)" "unprognostic (2.00e-1)" "unprognostic (9.66e-2)" "unprognostic (5.04e-2)" "unprognostic (1.80e-1)" "unprognostic (3.59e-3)" "unprognostic (4.88e-3)" "unprognostic (1.20e-1)" "unprognostic (8.80e-2)" "unprognostic (8.77e-2)" 0.7 0.6 1.1 0.5 1.5 0.0 1.0 6.0 1.7 0.5 0.5 0.5 0.5 0.2 0.5 1.7 0.5 0.7 0.5 44.6 1.1 1.3 2.2 0.5 0.5 0.5 0.6 0.5 0.7 0.5 0.3 0.6 0.5 0.9 0.5 0.3 0.5 0.5 1.2 0.5 0.9 0.5 0.6 0.5 0.5 0.1 1.8 0.5 0.5 0.6 0.5 0.5 0.5 0.5 0.3 1.9 0.0 2.3 0.0 1.0 0.1 0.0 0.6 0.7 0.0 0.5 1.6 0.0 0.0 1.3 0.3 1.0 0.0 3.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.5 2.7 1.6 0.2 0.0 0.5 0.0 0.8 1.1 0.0 0.2 0.2 1.1 0.0 0.2 0.0 0.0 2.6 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.8 1.3 0.0 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.1 2.3 0.0 0.1 0.3 1.0 0.1 0.3 0.2 0.4 0.0 0.0 0.2 1.9 0.0 0.1 1.1 1.5 6.0 1.7 1.1 1.3 0.6 0.5 0.9 0.5 TNNT1 "ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS" ENSG00000105048 "Troponin T1, slow skeletal type" P13805 19 55132794-55149354 "Disease related genes, Predicted intracellular proteins" "Muscle protein" "Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 1047.7" "Cell line enhanced" "Detected in many" "HMC-1: 119.1;RH-30: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "eosinophil: 53.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 53.3" "Region enriched" "Detected in many" 5 "thalamus: 136.6" "Low region specificity" "Detected in many" "CAB015168, HPA058448" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus, Cytosol" "CAB015168: AB_2206426, HPA058448: " "unprognostic (1.88e-1)" "unprognostic (7.23e-2)" "prognostic unfavourable (4.66e-4)" "prognostic unfavourable (4.66e-4)" "unprognostic (3.47e-3)" "unprognostic (3.92e-3)" "unprognostic (1.35e-3)" "unprognostic (1.03e-3)" "unprognostic (2.46e-1)" "unprognostic (1.95e-1)" "prognostic unfavourable (2.53e-4)" "unprognostic (3.23e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (4.91e-2)" "unprognostic (4.01e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-2)" 3.2 0.0 1.6 0.0 1.0 0.1 0.1 0.1 1.0 0.0 0.1 0.0 0.0 0.1 0.0 24.4 22.3 0.4 0.1 6.1 0.9 0.4 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 7.2 0.0 0.0 11.5 0.0 1047.7 1.8 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 9.2 124.4 17.8 0.3 0.1 0.1 9.9 53.3 11.6 0.1 0.1 2.6 24.3 14.3 0.1 3.1 0.0 0.2 4.7 1.1 4.2 1.6 4.7 5.2 16.2 0.3 9.5 0.4 12.4 3.4 10.6 1.3 1.6 27.0 4.6 1.5 0.9 0.5 0.3 119.1 5.3 17.2 0.4 18.3 0.0 23.1 22.6 1.5 23.2 0.4 0.0 3.0 28.4 15.5 89.7 2.9 3.7 0.8 0.9 7.0 1.5 0.2 7.8 14.8 14.2 0.5 23.6 35.1 0.9 1.7 0.1 0.9 1.1 24.8 3.6 7.1 0.5 11.6 53.3 0.0 5.9 0.1 0.0 0.1 0.0 9.9 0.1 0.1 0.1 0.5 0.1 2.6 0.2 0.0 2.6 1.6 1.0 0.1 1.0 0.9 0.4 0.5 0.0 0.0 0.0 TNNT2 "CMD1D, CMH2, CMPD2" ENSG00000118194 "Troponin T2, cardiac type" P45379 1 201359008-201377762 "Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 241 "heart muscle: 679.2" "Cell line enriched" "Detected in some" 26 "RH-30: 185.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 5.7" "CAB015371, HPA015774, HPA017888" Enhanced Uncertain "Nucleoplasm,Nucleoli,Focal adhesion sites" 50000 "Nucleoplasm, Nucleoli" "Focal adhesion sites" "CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "unprognostic (2.33e-4)" "unprognostic (1.85e-1)" "unprognostic (7.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-2)" "unprognostic (5.50e-3)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (9.98e-2)" 0.1 0.3 0.1 0.1 0.7 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.2 679.2 0.9 0.0 1.9 0.0 0.7 0.3 0.1 1.1 0.1 0.3 0.0 0.2 0.7 0.1 0.7 0.0 0.0 0.2 0.1 2.0 1.3 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.4 0.0 0.0 185.3 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 2.1 0.9 0.0 0.1 1.1 0.1 0.0 TNP1 ENSG00000118245 "Transition protein 1" P09430 2 216859458-216860064 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 103 "testis: 349.0" "Cell line enhanced" "Detected in some" "HeLa: 1.1;Hep G2: 6.8;NB-4: 2.5;U-2197: 3.2" "Group enriched" "Detected in some" 58 "liver cancer: 6.0;testis cancer: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA044387 Enhanced "HPA044387: " "unprognostic (1.67e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 349.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 TNP2 TP2 ENSG00000178279 "Transition protein 2" Q05952 16 11267748-11269533 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 166 "testis: 38.8" "Cell line enhanced" "Detected in single" "HBEC3-KT: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.30e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TNR ENSG00000116147 "Tenascin R" Q92752 1 175315194-175743770 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "brain: 56.4" "Cell line enhanced" "Detected in some" "SH-SY5Y: 5.7;THP-1: 2.3;U-937: 4.2" "Cancer enriched" "Detected in single" 46 "glioma: 9.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022343, HPA027134, HPA027150, HPA029859" Enhanced "Secreted in brain" 230000 "CAB022343: , HPA027134: AB_1851983, HPA027150: AB_1851985, HPA029859: AB_10600916" "unprognostic (1.04e-1)" "unprognostic (7.43e-2)" "unprognostic (3.11e-2)" "unprognostic (1.12e-3)" "unprognostic (2.38e-1)" "unprognostic (1.51e-2)" "unprognostic (9.66e-2)" "unprognostic (2.57e-2)" "unprognostic (5.79e-2)" "unprognostic (5.06e-2)" "unprognostic (3.03e-3)" "unprognostic (7.26e-4)" "unprognostic (4.48e-4)" "unprognostic (3.26e-3)" "unprognostic (3.83e-1)" "unprognostic (1.07e-1)" "unprognostic (5.83e-2)" 1.2 3.0 21.8 1.4 14.2 1.3 1.2 9.1 56.4 1.2 1.2 17.2 0.0 1.2 1.3 1.4 1.3 1.2 1.3 1.2 18.1 14.4 1.2 1.7 1.7 1.4 16.5 13.3 1.2 1.7 1.2 2.0 1.2 16.1 1.2 1.3 0.1 1.2 1.2 1.2 1.2 1.3 1.3 8.2 1.4 1.6 1.6 14.3 0.0 1.3 0.0 1.6 1.3 0.1 0.4 0.1 0.6 0.0 1.9 0.1 0.0 0.0 0.2 1.2 0.2 0.1 0.1 0.7 0.3 0.2 0.3 0.1 0.7 0.2 0.4 0.6 1.1 0.7 0.0 0.6 0.2 0.3 0.0 0.1 0.5 0.4 0.0 0.4 0.1 0.4 0.8 0.1 0.4 0.2 0.2 0.4 0.0 0.6 0.2 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.3 5.7 0.6 0.3 0.2 0.4 2.3 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.5 4.2 0.3 0.6 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.1 0.1 0.4 1.9 0.0 0.1 0.0 0.0 21.8 14.2 9.1 23.7 18.1 14.4 16.5 13.3 16.1 14.3 TOMM20L UNQ9438 ENSG00000196860 "Translocase of outer mitochondrial membrane 20 like" Q6UXN7 14 58395916-58408701 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 28.3" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.9" "Group enriched" "Detected in many" 10 "B-cells: 1.0;T-cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA076397 Enhanced "HPA076397: " "unprognostic (1.72e-1)" "unprognostic (2.34e-4)" "unprognostic (8.13e-2)" "unprognostic (7.80e-3)" "unprognostic (5.08e-2)" "unprognostic (2.15e-1)" "unprognostic (1.35e-1)" "unprognostic (4.28e-2)" "unprognostic (4.93e-1)" "unprognostic (1.37e-3)" "unprognostic (3.06e-2)" "unprognostic (5.66e-3)" "unprognostic (4.57e-6)" "unprognostic (8.75e-2)" "unprognostic (1.50e-1)" "unprognostic (1.32e-1)" "unprognostic (7.66e-3)" 0.5 0.4 0.2 0.2 0.6 0.1 0.5 0.6 0.8 0.5 0.5 0.8 0.0 0.0 0.9 1.8 0.2 0.4 0.5 0.3 0.2 0.2 0.7 0.3 0.4 2.2 0.3 0.0 0.7 1.2 1.1 0.5 0.3 0.6 0.8 0.5 1.7 0.5 0.5 0.2 0.3 0.4 1.4 0.3 0.3 0.6 28.3 0.0 0.0 0.9 0.0 0.6 0.3 0.2 1.0 0.1 0.0 0.1 0.0 1.9 0.4 1.8 0.0 0.5 1.9 0.0 0.0 2.0 0.3 0.0 0.3 0.0 0.0 0.5 1.6 0.2 1.0 0.3 0.0 0.0 0.0 2.8 0.6 0.5 0.0 0.5 0.0 1.8 1.3 0.0 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.9 1.2 0.5 0.8 2.0 2.1 0.7 0.3 0.3 0.5 3.3 2.3 0.5 0.4 0.5 1.4 2.8 0.0 0.2 0.4 0.0 0.5 0.0 0.3 0.2 1.5 1.4 0.5 0.0 0.0 0.0 0.4 0.1 0.0 1.0 0.1 0.5 0.0 0.2 0.1 1.9 0.0 0.0 0.1 0.1 0.0 0.4 0.2 0.6 0.6 0.8 0.2 0.2 0.3 0.0 0.6 0.0 TOPAZ1 "C3orf77, FLJ36157" ENSG00000173769 "Testis and ovary specific PAZ domain containing 1" Q8N9V7 3 44241886-44332098 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 49 "testis: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047431, HPA051034" Uncertain "HPA047431: , HPA051034: " "unprognostic (1.68e-1)" "unprognostic (8.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TOX "KIAA0808, TOX1" ENSG00000198846 "Thymocyte selection associated high mobility group box" O94900 8 58805418-59119208 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 88.8" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 9.8;MOLT-4: 53.9;SH-SY5Y: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 21.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018322, HPA073241" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA018322: AB_1858199, HPA073241: " "unprognostic (7.60e-4)" "unprognostic (6.16e-3)" "unprognostic (5.65e-2)" "unprognostic (2.27e-1)" "unprognostic (9.53e-2)" "unprognostic (4.52e-1)" "unprognostic (1.22e-1)" "prognostic favourable (5.20e-4)" "unprognostic (1.46e-1)" "unprognostic (3.46e-3)" "unprognostic (6.73e-3)" "unprognostic (4.66e-2)" "prognostic unfavourable (1.90e-7)" "unprognostic (1.12e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-1)" "unprognostic (1.97e-1)" 1.3 1.2 10.5 15.7 6.3 2.8 1.5 1.9 15.6 2.1 13.4 1.5 1.2 10.0 1.5 1.1 3.7 1.1 5.0 0.9 6.3 9.8 3.2 1.7 4.9 17.7 4.8 12.0 6.6 2.4 2.9 3.7 1.5 2.2 2.4 9.3 2.6 1.8 1.3 0.5 1.0 10.7 2.8 2.3 5.7 10.0 6.5 2.5 88.8 1.5 0.8 19.4 2.6 2.3 3.4 0.8 10.2 0.1 10.4 21.0 3.1 0.3 0.0 6.0 0.0 0.6 1.4 0.0 1.2 2.8 0.7 0.1 0.0 0.0 0.0 0.0 5.4 0.4 1.4 0.0 0.1 0.2 0.5 0.0 1.1 0.0 5.0 1.0 0.2 0.7 0.2 0.9 1.1 9.8 0.0 0.0 0.4 0.0 53.9 0.0 1.0 0.1 1.1 4.1 0.0 0.1 0.1 5.5 16.9 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.7 4.9 1.6 0.0 0.0 3.7 0.2 0.0 1.0 10.2 0.1 1.8 7.5 0.0 3.4 3.4 5.5 11.3 0.8 0.6 2.1 6.3 0.2 10.4 0.0 0.0 21.0 3.1 10.5 6.3 1.9 15.6 6.3 9.8 4.8 12.0 2.2 2.5 TP53TG3B ENSG00000261509 "TP53 target 3B" Q9ULZ0 16 33360274-33363478 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "epididymis: 21.5" "Cell line enhanced" "Detected in some" "EFO-21: 1.4;HMC-1: 3.5;K-562: 2.0;SH-SY5Y: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 21.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TP53TG5 "C20orf10, CLG01, dJ453C12.5" ENSG00000124251 "TP53 target 5" Q9Y2B4 20 45372563-45407889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 35.4" "Cell line enhanced" "Detected in many" "CACO-2: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA041979 Enhanced "HPA041979: " "unprognostic (2.86e-1)" "unprognostic (1.28e-1)" "unprognostic (2.18e-1)" "unprognostic (3.40e-3)" "unprognostic (1.70e-1)" "unprognostic (1.63e-3)" "unprognostic (2.29e-3)" "unprognostic (3.10e-3)" "unprognostic (9.26e-2)" "unprognostic (3.56e-2)" "unprognostic (1.72e-5)" "unprognostic (2.09e-2)" "unprognostic (7.46e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" "unprognostic (4.72e-4)" "unprognostic (1.41e-1)" 0.1 0.1 0.2 0.2 2.0 0.8 0.1 0.1 1.5 0.1 0.1 1.9 0.0 0.0 0.1 0.5 0.1 0.1 0.3 0.2 0.4 0.1 0.1 0.1 0.1 0.4 4.1 1.0 0.2 0.1 0.0 0.1 0.0 1.2 0.1 0.0 0.0 0.2 0.0 0.2 0.3 0.3 0.0 0.8 0.2 0.2 35.4 2.1 0.0 0.3 0.0 0.0 0.1 0.1 0.3 0.4 0.3 0.1 0.0 1.1 0.0 1.0 2.0 1.1 3.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 5.2 0.9 0.8 0.7 0.0 2.1 0.0 0.0 0.0 0.3 0.9 1.1 2.5 1.6 0.0 1.4 1.1 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 1.4 1.0 0.9 0.3 0.8 0.0 0.6 0.6 0.0 1.2 1.2 1.0 2.8 1.1 0.7 2.9 0.3 2.0 3.8 1.2 2.3 0.7 0.9 1.0 0.1 2.0 0.7 1.1 0.0 0.1 0.0 0.3 0.1 1.1 0.0 0.3 0.0 0.1 0.3 0.3 0.4 0.3 0.0 0.1 0.4 0.2 0.0 0.2 2.0 0.1 0.9 0.4 0.1 4.1 1.0 1.2 2.1 TPD52L3 NYD-SP25 ENSG00000170777 "Tumor protein D52 like 3" Q96J77 9 6328375-6331900 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 111 "testis: 107.6" "Cell line enriched" "Detected in single" 15 "BEWO: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (4.33e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TPH2 "FLJ37295, NTPH" ENSG00000139287 "Tryptophan hydroxylase 2" Q8IWU9 12 71938846-72186618 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Serotonin biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 46.2" "Group enriched" "Detected in some" 9 "EFO-21: 2.8;NTERA-2: 3.1;SCLC-21H: 1.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 15 "pons and medulla: 46.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "midbrain: 127.6;pons and medulla: 36.3" "Group enriched" "Detected in some" 10 "midbrain: 95.6;pons and medulla: 91.5" CAB078198 Enhanced "CAB078198: " "unprognostic (1.19e-1)" "unprognostic (6.01e-1)" "unprognostic (3.46e-2)" "unprognostic (2.31e-1)" "unprognostic (5.91e-2)" "unprognostic (2.02e-1)" "unprognostic (5.01e-2)" "unprognostic (7.32e-2)" "unprognostic (1.34e-1)" 0.1 0.2 0.4 0.3 0.5 0.1 0.1 0.3 4.4 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.2 3.0 1.5 0.1 0.3 0.1 0.1 0.9 0.0 0.1 1.7 0.1 3.2 0.1 46.2 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.3 0.1 0.1 1.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.3 1.4 3.0 1.5 0.9 0.0 46.2 0.0 TPO TPX ENSG00000115705 "Thyroid peroxidase" P07202 2 1374223-1543711 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Congenital hypothyroidism, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "thyroid gland: 411.3" "Group enriched" "Detected in some" 5 "Karpas-707: 14.0;RPMI-8226: 5.9" "Cancer enriched" "Detected in some" 364 "thyroid cancer: 188.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "memory CD4 T-cell: 5.1;T-reg: 3.0" "Lineage enriched" "Detected in single" 21 "T-cells: 5.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007987, CAB009587" Enhanced "Intracellular and membrane" "CAB009587: , HPA007987: AB_1080270" "unprognostic (1.55e-1)" "unprognostic (1.04e-1)" "unprognostic (2.88e-1)" "unprognostic (1.77e-2)" "unprognostic (3.56e-2)" "unprognostic (9.11e-2)" "unprognostic (2.24e-2)" "unprognostic (1.85e-1)" "unprognostic (1.32e-1)" "unprognostic (1.19e-4)" "unprognostic (2.61e-2)" "unprognostic (3.29e-1)" "unprognostic (5.44e-4)" "unprognostic (1.21e-1)" "unprognostic (3.73e-2)" "unprognostic (4.98e-3)" "unprognostic (7.10e-3)" 1.1 0.0 0.1 0.1 0.1 0.0 0.9 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.4 1.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.1 0.5 0.0 0.2 0.1 0.1 7.1 0.2 0.1 0.1 0.1 411.3 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 5.1 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 1.4 0.0 0.0 0.1 0.2 0.0 0.0 5.9 0.0 0.0 0.0 0.1 0.0 2.0 0.0 1.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.3 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 3.0 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 TPPP "p25, p25alpha, TPPP/p25, TPPP1" ENSG00000171368 "Tubulin polymerization promoting protein" O94811 5 659862-693395 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 77.5" "Cell line enhanced" "Detected in some" "A549: 8.4;AN3-CA: 6.2;SCLC-21H: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.5;NK-cell: 1.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036575, HPA036576" Enhanced Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA036575: AB_10673501, HPA036576: AB_2675200" "unprognostic (3.66e-2)" "unprognostic (3.70e-3)" "unprognostic (9.98e-3)" "unprognostic (7.82e-2)" "unprognostic (2.05e-2)" "unprognostic (3.20e-2)" "unprognostic (2.12e-1)" "unprognostic (3.80e-3)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-3)" "unprognostic (5.48e-2)" "prognostic favourable (5.40e-6)" "unprognostic (4.03e-2)" "unprognostic (2.30e-1)" "unprognostic (2.03e-2)" "unprognostic (3.31e-2)" 3.5 5.8 27.0 1.3 29.6 1.0 2.7 17.0 77.5 2.1 3.2 69.0 0.1 4.6 2.3 1.3 9.0 8.6 2.1 6.0 33.9 23.9 3.2 2.3 8.3 1.0 25.8 25.0 1.8 5.2 2.4 4.4 2.4 30.1 2.4 2.2 0.2 4.8 3.7 6.2 5.6 7.5 3.5 24.7 2.7 3.8 1.6 4.3 0.0 6.0 1.9 1.8 3.4 0.6 0.0 0.2 1.5 0.0 1.0 0.5 0.1 0.3 8.4 0.4 6.2 0.9 0.0 1.1 0.2 0.0 0.0 0.0 0.3 0.9 0.2 0.6 0.0 3.3 3.4 0.0 0.0 1.7 2.9 0.2 3.6 0.2 0.9 0.3 0.4 0.0 0.8 0.0 0.2 0.1 0.1 3.1 0.0 0.3 0.2 0.5 0.2 0.8 0.3 0.1 1.2 0.3 1.1 15.5 1.9 0.9 0.4 4.1 0.8 0.2 0.1 0.2 3.3 0.1 0.2 1.2 0.3 0.0 0.6 0.7 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.2 0.1 0.1 27.0 29.6 17.0 40.8 33.9 23.9 25.8 25.0 30.1 4.3 TPPP2 "C14orf8, CT152, p18, p25beta" ENSG00000179636 "Tubulin polymerization promoting protein family member 2" P59282 14 21024109-21036276 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 99.4" "Cell line enhanced" "Detected in some" "CACO-2: 2.6;HAP1: 1.7;Hep G2: 1.2;RT4: 1.7" "Cancer enhanced" "Detected in single" "liver cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA004120 Enhanced "HPA004120: AB_2303582" "unprognostic (2.91e-2)" "unprognostic (2.49e-3)" "unprognostic (2.54e-1)" "unprognostic (1.66e-2)" "unprognostic (2.14e-2)" "unprognostic (2.57e-3)" "unprognostic (4.63e-4)" "unprognostic (3.83e-1)" "unprognostic (3.16e-1)" "unprognostic (1.09e-1)" "unprognostic (4.64e-4)" "unprognostic (2.51e-4)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (3.21e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 1.8 0.1 0.0 0.1 0.1 0.1 0.0 0.2 4.8 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.9 0.0 0.1 0.1 0.1 0.1 0.0 99.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 TPRX1 FLJ40321 ENSG00000178928 "Tetrapeptide repeat homeobox 1" Q8N7U7 19 47801243-47819051 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044922 Uncertain "HPA044922: AB_10962509" "unprognostic (8.56e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.6 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TPTE "CT44, PTEN2" ENSG00000274391 "Transmembrane phosphatase with tensin homology" P56180 21 10521553-10606140 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 69 "testis: 78.6" "Cell line enhanced" "Detected in some" "BEWO: 7.5;K-562: 8.7;Karpas-707: 7.1;MCF7: 5.2;PC-3: 5.3;RPMI-8226: 9.6;U-2 OS: 4.7;U-266/70: 8.6" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049690, HPA068342" Enhanced Approved "Endoplasmic reticulum,Cytosol" Cytosol "Endoplasmic reticulum" "HPA049690: , HPA068342: " "unprognostic (3.63e-2)" 0.1 0.0 0.0 0.7 0.2 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.8 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.7 0.3 0.0 0.0 0.2 0.4 0.0 0.9 0.0 78.6 0.0 0.4 0.1 0.4 0.8 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 7.1 0.0 5.2 0.0 0.0 1.2 5.3 0.0 0.0 9.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 4.7 2.4 0.0 8.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 TPTE2 TPIP ENSG00000132958 "Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2" Q6XPS3 13 19422877-19536762 "Enzymes, Plasma proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 12.3" "Group enriched" "Detected in some" 4 "HDLM-2: 9.9;Karpas-707: 2.9" "Cancer enriched" "Detected in single" 6 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA068342 Approved "Endoplasmic reticulum,Cytosol" Cytosol "Endoplasmic reticulum" "HPA068342: " "unprognostic (2.50e-1)" "unprognostic (2.10e-1)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (1.25e-2)" "unprognostic (5.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.24e-1)" "unprognostic (5.40e-2)" "unprognostic (3.67e-2)" "unprognostic (2.81e-1)" "unprognostic (1.05e-12)" "unprognostic (1.04e-1)" "unprognostic (1.47e-1)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" 0.0 0.1 0.4 0.2 1.0 0.0 0.1 0.7 0.8 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.2 12.3 0.0 0.6 0.0 0.0 0.5 0.4 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 9.9 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 2.9 0.0 0.3 0.3 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 TPX2 "C20orf1, C20orf2, DIL-2, p100" ENSG00000088325 "TPX2, microtubule nucleation factor" Q9ULW0 20 31739271-31801805 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 92.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Group enriched" "Detected in many" 5 "granulocytes: 4.0;NK-cells: 4.8;T-cells: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005487 Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "HPA005487: AB_1858223" "unprognostic (2.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-2)" "prognostic unfavourable (2.43e-6)" "unprognostic (2.99e-1)" "unprognostic (7.56e-2)" "prognostic unfavourable (8.07e-7)" "prognostic unfavourable (6.46e-4)" "unprognostic (3.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (2.68e-5)" "unprognostic (5.99e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (4.56e-2)" "unprognostic (2.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.39e-1)" 1.8 1.7 1.0 13.4 2.0 21.7 1.2 2.2 1.7 2.2 5.7 0.5 0.3 4.6 1.2 2.3 13.3 0.5 1.9 1.5 0.8 0.7 1.2 2.7 2.6 12.9 0.7 1.1 0.8 0.5 0.0 0.7 6.6 0.9 0.7 7.4 0.5 2.3 0.5 2.2 5.9 4.7 3.2 0.9 5.9 3.2 22.0 0.6 92.7 0.7 11.0 16.2 2.2 3.8 1.0 1.4 4.0 0.1 4.8 10.4 1.3 69.6 23.4 28.3 22.1 2.2 4.2 27.3 29.3 16.6 42.6 32.2 49.6 30.1 32.8 17.3 16.3 36.8 32.3 26.6 48.6 14.1 12.5 64.3 22.4 33.8 0.7 24.6 16.6 1.4 1.4 26.7 19.5 22.9 47.5 30.0 33.3 28.6 41.2 19.2 31.5 25.3 23.4 76.4 19.8 11.4 11.4 20.6 13.8 44.8 17.0 13.2 29.5 15.0 15.4 47.8 29.4 21.9 44.9 12.0 20.7 29.4 14.9 87.9 31.0 4.0 0.0 0.5 0.6 0.0 0.3 1.0 1.9 2.3 0.6 0.4 0.4 0.7 0.4 4.8 0.1 1.4 10.4 1.3 1.0 2.0 2.2 1.7 0.8 0.7 0.7 1.1 0.9 0.6 TREH "MGC129621, TRE, TREA" ENSG00000118094 Trehalase O43280 11 118657316-118679690 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 51.8" "Cell line enhanced" "Detected in some" "BEWO: 5.3;Hep G2: 2.1;RPMI-8226: 1.9;SiHa: 1.8;U-2 OS: 2.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039913, HPA042045" Enhanced "Intracellular and membrane" 12000000 "HPA039913: AB_10674988, HPA042045: AB_2677817" "unprognostic (1.29e-1)" "unprognostic (1.58e-1)" "unprognostic (1.01e-2)" "unprognostic (5.22e-4)" "unprognostic (2.52e-1)" "unprognostic (9.83e-2)" "prognostic favourable (3.76e-4)" "unprognostic (1.17e-1)" "unprognostic (1.34e-1)" "unprognostic (2.42e-1)" "unprognostic (1.04e-1)" "unprognostic (1.63e-2)" "prognostic favourable (2.33e-6)" "unprognostic (2.09e-2)" "unprognostic (6.30e-2)" "unprognostic (1.22e-1)" "unprognostic (1.15e-1)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.1 24.1 0.0 0.0 28.9 0.1 3.3 0.6 0.1 3.7 0.1 0.1 0.1 6.1 2.6 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.1 0.2 0.4 0.0 0.2 0.0 0.1 0.1 51.8 0.0 0.1 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.3 5.3 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 1.9 0.0 0.0 0.2 0.9 1.8 0.2 1.4 0.7 0.0 0.8 0.1 2.5 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.0 TRIM36 "HAPRIN, RBCC728, RNF98" ENSG00000152503 "Tripartite motif containing 36" Q9NQ86 5 115124762-115180546 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 88.8" "Cell line enhanced" "Detected in many" "RH-30: 17.8;SCLC-21H: 19.9;SH-SY5Y: 14.5" "Cancer enhanced" "Detected in many" "prostate cancer: 9.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 7.5;non-classical monocyte: 7.7" "Group enriched" "Detected in many" 43 "dendritic cells: 7.5;granulocytes: 4.2;monocytes: 7.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061321 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA061321: " "unprognostic (6.36e-2)" "unprognostic (2.99e-1)" "unprognostic (4.54e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (2.31e-2)" "unprognostic (5.33e-6)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (1.84e-1)" "unprognostic (1.90e-1)" "unprognostic (2.82e-13)" "unprognostic (4.95e-2)" "unprognostic (1.38e-1)" "unprognostic (2.19e-1)" "unprognostic (6.80e-3)" 1.0 1.4 6.8 1.4 7.6 0.8 3.2 0.6 11.7 1.4 4.8 7.7 0.0 8.2 1.1 1.0 0.8 1.9 1.0 0.7 10.1 7.2 0.9 0.9 1.6 0.8 7.1 8.6 3.5 1.5 0.7 8.2 1.3 18.3 5.7 4.8 5.1 1.0 1.0 0.7 1.0 7.9 1.1 8.7 0.9 2.0 88.8 4.7 0.0 0.8 0.0 0.9 0.8 1.0 0.1 7.5 4.2 7.7 0.0 0.0 0.8 2.4 0.7 1.2 6.2 0.1 0.1 1.5 0.5 2.1 1.1 1.3 0.9 1.2 0.0 1.0 0.1 0.6 5.8 1.1 0.8 0.4 1.9 4.3 2.5 1.2 0.2 4.2 3.6 0.1 1.1 0.5 1.5 0.0 0.1 5.9 1.7 3.3 1.1 3.8 4.9 2.8 0.9 17.8 1.4 0.6 0.0 19.9 14.5 3.8 0.4 2.3 4.2 5.3 0.5 1.7 1.3 1.3 1.9 0.9 0.5 0.0 1.9 2.4 0.8 0.0 1.7 4.2 0.0 1.6 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.3 0.0 7.7 1.6 0.0 0.8 6.8 7.6 0.6 11.7 10.1 7.2 7.1 8.6 18.3 4.7 TRIM42 "FLJ40097, PPP1R40, T4A1" ENSG00000155890 "Tripartite motif containing 42" Q8IWZ5 3 140678039-140701150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 85 "testis: 43.2" "Cell line enhanced" "Detected in single" "CACO-2: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003581, HPA022481" Uncertain Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA003581: AB_1080383, HPA022481: AB_1858301" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49D1 "TRIM49D, TRIM49D1P, TRIM49DP" ENSG00000223417 "Tripartite motif containing 49D1" C9J1S8 11 89911111-89921767 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "blood: 19.8" "Cell line enhanced" "Detected in single" "U-2 OS: 2.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 199 "basophil: 19.8" "Lineage enriched" "Detected in single" 199 "granulocytes: 19.8" 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49D2 "TRIM49D2P, TRIM49L, TRIM49L1" ENSG00000233802 "Tripartite motif containing 49D2" C9J1S8 11 89924064-89933063 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "blood: 15.9" "Cell line enriched" "Detected in single" 6 "U-2 OS: 3.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 160 "basophil: 15.9" "Lineage enriched" "Detected in single" 160 "granulocytes: 15.9" 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM51 "SPRYD5, TRIM51A" ENSG00000124900 "Tripartite motif-containing 51" Q9BSJ1 11 55883297-55891810 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "blood: 11.0" "Group enriched" "Detected in some" 124 "SK-MEL-30: 35.2;WM-115: 9.0" "Cancer enriched" "Detected in single" 50 "melanoma: 4.3" "Cell type enriched" "Detected in single" 111 "basophil: 11.0" "Lineage enriched" "Detected in single" 111 "granulocytes: 11.0" "HPA044988, HPA077883" Uncertain Approved Nucleoli,Vesicles Vesicles Nucleoli "HPA044988: , HPA077883: " "unprognostic (9.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM54 "MURF, MURF-3, RNF30" ENSG00000138100 "Tripartite motif containing 54" Q9BYV2 2 27282392-27307439 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 187.1" "Group enriched" "Detected in some" 9 "HAP1: 8.2;NTERA-2: 17.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "Cell type enriched" "Detected in single" 16 "NK-cell: 7.0" "Lineage enriched" "Detected in single" 16 "NK-cells: 7.0" "Region enhanced" "Detected in some" "amygdala: 3.2" "Group enriched" "Detected in some" 11 "cerebral cortex: 1.4;hippocampal formation: 0.8" HPA019690 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA019690: AB_1858306" "unprognostic (6.98e-3)" "unprognostic (4.56e-3)" "unprognostic (3.22e-2)" "unprognostic (2.24e-2)" "unprognostic (1.58e-3)" "unprognostic (7.49e-2)" "unprognostic (1.25e-7)" "unprognostic (3.88e-3)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.56e-3)" "unprognostic (6.91e-2)" "prognostic unfavourable (6.46e-4)" "unprognostic (2.41e-2)" "unprognostic (3.19e-1)" "unprognostic (1.15e-1)" "unprognostic (6.92e-2)" 2.1 1.8 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.9 0.1 6.3 1.6 0.0 0.0 35.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.0 187.1 0.0 0.4 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.3 40.3 2.2 0.1 0.0 0.3 0.0 0.0 0.0 7.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 8.2 0.0 0.0 0.0 0.3 0.0 1.4 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 17.6 0.0 0.6 0.7 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 TRIM63 "IRF, MURF-1, RNF28, SMRZ" ENSG00000158022 "Tripartite motif containing 63" Q969Q1 1 26051304-26068436 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Muscle protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 271.4" "Group enriched" "Detected in some" 38 "ASC diff: 10.5;SK-MEL-30: 33.5" "Cancer enriched" "Detected in some" 10 "melanoma: 31.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.10e-1)" "unprognostic (4.80e-4)" "unprognostic (1.45e-2)" "unprognostic (7.52e-3)" "unprognostic (1.44e-1)" "unprognostic (2.05e-2)" "unprognostic (3.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.71e-1)" "unprognostic (1.06e-1)" "unprognostic (3.17e-1)" "unprognostic (1.01e-1)" "unprognostic (2.16e-2)" "unprognostic (5.90e-2)" "unprognostic (1.33e-2)" "unprognostic (2.32e-1)" "unprognostic (5.58e-2)" 3.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 1.2 1.7 0.0 0.6 38.2 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.5 0.0 3.6 1.0 0.0 271.4 0.6 0.1 0.9 0.1 0.0 0.1 0.1 0.0 0.0 1.7 12.7 0.8 1.2 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 TRIM67 TNL ENSG00000119283 "Tripartite motif containing 67" Q6ZTA4 1 231162112-231221556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 14.4" "Cell line enhanced" "Detected in some" "ASC diff: 1.3;HMC-1: 1.6;HSkMC: 1.3;SCLC-21H: 7.0;SH-SY5Y: 1.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "cerebellum: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034776 Uncertain "HPA034776: AB_10603997" "unprognostic (1.56e-3)" "unprognostic (1.54e-1)" "unprognostic (5.20e-2)" "unprognostic (5.39e-3)" "unprognostic (2.95e-1)" "unprognostic (3.82e-2)" "unprognostic (6.02e-2)" "unprognostic (4.63e-3)" "unprognostic (1.84e-2)" "unprognostic (1.74e-1)" "unprognostic (4.93e-10)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (4.25e-2)" "unprognostic (1.53e-1)" "unprognostic (2.30e-2)" "unprognostic (5.10e-3)" 0.3 0.7 1.3 0.2 1.3 0.1 0.1 13.3 14.4 0.2 0.2 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.2 0.3 1.2 1.9 0.2 0.1 0.1 0.2 1.5 0.0 0.2 0.2 0.1 1.9 0.4 1.9 0.1 0.2 1.7 0.2 0.1 0.1 0.4 0.3 0.2 0.9 0.2 0.2 0.5 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 1.6 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.1 0.0 0.0 7.0 1.9 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.3 13.3 1.9 1.2 1.9 1.5 0.0 1.9 0.2 TRIM69 "RNF36, Trif, TRIMLESS" ENSG00000185880 "Tripartite motif containing 69" Q86WT6 15 44728988-44767829 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 68.6" "Cell line enhanced" "Detected in some" "Karpas-707: 4.0;U-266/70: 13.5;U-266/84: 3.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "T-reg: 8.2" "Lineage enriched" "Detected in many" 7 "T-cells: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA028894 Enhanced "HPA028894: AB_10603136" "unprognostic (4.82e-3)" "unprognostic (1.23e-2)" "unprognostic (4.10e-1)" "unprognostic (2.01e-1)" "unprognostic (1.75e-2)" "unprognostic (4.20e-1)" "unprognostic (9.27e-2)" "unprognostic (4.95e-2)" "unprognostic (6.49e-2)" "unprognostic (3.53e-3)" "unprognostic (1.38e-1)" "unprognostic (3.72e-2)" "prognostic favourable (2.26e-5)" "unprognostic (4.79e-2)" "unprognostic (1.82e-1)" "unprognostic (1.91e-2)" "unprognostic (1.49e-2)" 4.6 3.9 9.0 4.0 10.8 3.0 3.9 7.2 9.1 3.5 4.4 5.1 1.7 3.6 3.4 3.7 4.7 3.4 4.1 11.0 7.9 7.9 4.7 3.8 3.8 4.9 7.5 5.4 3.8 2.8 3.4 4.9 3.1 5.3 5.9 4.2 3.7 3.7 3.2 14.0 4.1 4.0 5.3 5.7 6.7 3.9 68.6 4.7 3.9 5.3 5.2 5.5 4.1 8.1 1.2 0.0 0.1 0.3 0.0 8.2 0.3 0.2 0.0 0.4 0.7 0.5 1.2 0.0 0.1 0.5 0.8 2.4 0.0 0.3 0.2 0.2 0.0 0.0 0.3 0.0 0.6 2.6 0.0 0.3 0.1 0.0 0.9 0.0 0.2 1.4 0.9 0.2 0.2 0.2 0.0 4.0 0.4 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.3 13.5 3.3 2.0 0.4 0.4 0.1 0.0 0.0 0.0 0.6 0.2 1.2 1.2 1.9 1.8 0.0 0.0 0.3 1.2 0.1 0.0 0.3 0.0 8.2 0.3 9.0 10.8 7.2 9.1 7.9 7.9 7.5 5.4 5.3 4.7 TRIM9 "RNF91, SPRING" ENSG00000100505 "Tripartite motif containing 9" Q9C026 14 50975262-51096061 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 61.5" "Cell line enhanced" "Detected in some" "AN3-CA: 19.3;HAP1: 13.7;HDLM-2: 21.0;SCLC-21H: 19.9" "Cancer enriched" "Detected in some" 8 "glioma: 25.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.22e-1)" "unprognostic (6.37e-2)" "unprognostic (1.17e-1)" "unprognostic (1.10e-3)" "unprognostic (6.67e-2)" "unprognostic (1.13e-2)" "unprognostic (2.24e-3)" "unprognostic (7.66e-2)" "unprognostic (1.88e-1)" "unprognostic (3.06e-2)" "unprognostic (2.38e-3)" "unprognostic (1.06e-1)" "unprognostic (1.20e-1)" "unprognostic (1.55e-1)" "unprognostic (9.00e-2)" "unprognostic (7.57e-6)" "unprognostic (1.85e-3)" 1.9 3.9 21.5 2.7 20.9 2.2 2.7 49.1 61.5 2.1 2.5 10.3 0.0 1.5 4.8 3.0 1.7 1.5 6.5 1.7 17.4 11.4 1.9 3.6 1.5 1.5 10.8 21.7 2.3 1.9 1.5 5.7 1.6 13.0 2.0 2.4 1.8 3.9 5.2 1.5 1.6 1.7 5.2 7.1 1.6 1.7 2.0 11.5 0.0 1.5 0.0 1.5 2.0 0.9 0.0 0.1 0.8 0.0 0.0 0.4 0.4 0.0 2.2 3.4 19.3 0.0 0.0 1.3 0.0 0.0 0.2 0.5 1.5 0.1 0.2 0.1 0.3 0.0 13.7 0.0 0.5 21.0 2.8 1.0 0.0 0.0 0.0 0.7 0.7 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 4.1 0.5 1.1 2.9 2.4 5.0 0.1 0.0 0.0 19.9 1.5 0.3 0.0 4.2 0.3 0.5 0.0 1.3 0.5 0.0 0.9 0.3 0.0 0.2 5.8 0.5 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.4 21.5 20.9 49.1 28.6 17.4 11.4 10.8 21.7 13.0 11.5 TRIML1 "FLJ36180, RNF209" ENSG00000184108 "Tripartite motif family like 1" Q8N9V2 4 188139419-188147743 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 14.1" "Cell line enriched" "Detected in single" 9 "BEWO: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (6.99e-2)" "unprognostic (5.21e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRPC5OS TRPC5-AS1 ENSG00000204025 "TRPC5 opposite strand" A6NMA1 X 111876051-111903990 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 58 "testis: 34.2" "Group enriched" "Detected in some" 4 "REH: 1.1;THP-1: 4.5;U-937: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.77e-2)" "unprognostic (8.15e-2)" "unprognostic (7.51e-2)" "unprognostic (2.99e-1)" "unprognostic (1.47e-2)" "unprognostic (9.90e-2)" "unprognostic (1.72e-1)" "unprognostic (1.40e-6)" "unprognostic (6.23e-3)" "unprognostic (1.71e-1)" "unprognostic (1.85e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.5 0.4 1.1 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.0 0.3 0.0 4.5 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRPM1 "CSNB1C, LTRPC1, MLSN1" ENSG00000134160 "Transient receptor potential cation channel subfamily M member 1" Q7Z4N2 15 31001061-31161273 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 99.0" "Cell line enriched" "Detected in single" 122 "SK-MEL-30: 15.9" "Cancer enriched" "Detected in single" 179 "melanoma: 14.6" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014779, HPA071139" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Centriolar satellite" "Centriolar satellite" "Golgi apparatus, Plasma membrane" "HPA014779: , HPA071139: " "unprognostic (5.28e-2)" "unprognostic (1.35e-1)" "unprognostic (9.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-3)" "unprognostic (2.83e-1)" "unprognostic (2.89e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (2.58e-1)" "unprognostic (7.84e-2)" "unprognostic (6.20e-4)" "unprognostic (1.48e-1)" "unprognostic (2.63e-2)" 0.1 0.0 0.4 0.0 0.6 0.0 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.3 0.1 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 99.0 0.4 0.0 0.2 10.4 0.0 0.1 1.9 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.1 0.3 0.7 0.2 1.6 0.0 0.3 0.1 TRPV5 "CaT2, ECAC1" ENSG00000127412 "Transient receptor potential cation channel subfamily V member 5" Q9NQA5 7 142908101-142933808 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 26.0" "Cell line enhanced" "Detected in single" "RT4: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063175 Uncertain "HPA063175: " "unprognostic (7.44e-2)" "unprognostic (3.93e-2)" "unprognostic (1.22e-2)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (3.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.78e-2)" "unprognostic (1.07e-1)" "unprognostic (7.95e-2)" "unprognostic (7.73e-4)" "unprognostic (4.87e-2)" "unprognostic (3.41e-1)" "unprognostic (4.58e-1)" "unprognostic (7.76e-3)" 0.1 0.0 0.8 0.4 0.7 0.5 0.5 0.1 0.8 0.1 0.1 0.1 0.1 0.7 0.1 0.3 0.1 0.1 0.1 0.1 1.1 0.7 26.0 0.1 0.1 0.2 1.6 0.4 0.1 0.3 0.0 0.1 0.1 0.7 0.1 0.0 0.1 0.3 0.1 0.2 0.1 0.1 0.1 3.5 0.2 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.1 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.5 1.1 0.7 1.6 0.4 0.7 0.1 TSACC "C1orf182, SIP, SSTK-IP" ENSG00000163467 "TSSK6 activating cochaperone" Q96A04 1 156337314-156346995 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 262.0" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in many" "testis cancer: 5.3" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 5 "basophil: 12.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.0" "Low region specificity" "Detected in all" HPA029897 Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA029897: AB_2756315" "unprognostic (3.95e-1)" "unprognostic (5.82e-3)" "unprognostic (8.24e-2)" "unprognostic (9.34e-2)" "unprognostic (1.04e-1)" "unprognostic (8.36e-3)" "unprognostic (1.18e-2)" "unprognostic (5.95e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (3.53e-2)" "unprognostic (4.85e-2)" "unprognostic (2.63e-6)" "unprognostic (1.05e-1)" "unprognostic (6.78e-2)" "unprognostic (2.44e-1)" "unprognostic (3.28e-2)" 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.2 0.1 0.0 1.6 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 262.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 2.0 2.1 12.0 0.6 2.3 2.1 0.4 3.4 4.6 2.0 2.3 1.5 2.8 3.8 1.6 1.0 2.3 2.5 4.2 2.4 5.0 2.7 1.0 3.9 3.9 0.5 2.1 2.9 8.5 3.4 6.8 4.5 1.0 3.1 3.0 1.0 6.6 2.3 3.0 0.7 9.3 3.2 0.4 5.8 3.0 1.8 6.4 5.6 3.5 0.8 4.9 5.8 2.1 3.1 1.7 2.4 6.5 2.6 3.5 3.3 1.7 1.4 2.4 1.2 2.3 5.8 9.3 7.5 0.9 1.7 1.3 12.0 0.5 0.1 1.5 0.3 0.7 1.7 1.1 1.3 0.3 2.0 2.1 1.8 0.2 2.3 0.6 2.1 1.2 0.4 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.2 0.1 TSGA13 ENSG00000213265 "Testis specific 13" Q96PP4 7 130668648-130687432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 16.5" "Cell line enhanced" "Detected in single" "THP-1: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA022968 Uncertain "HPA022968: " "unprognostic (1.49e-1)" "unprognostic (1.13e-2)" "unprognostic (1.86e-1)" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.2 0.6 0.8 0.5 0.3 0.1 0.4 0.0 0.0 0.8 0.7 0.2 0.4 0.0 0.2 0.9 0.0 0.6 0.2 0.1 0.0 0.1 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.4 0.9 0.1 0.3 0.4 0.1 0.2 1.1 0.6 0.2 0.5 0.2 0.3 0.2 0.2 0.1 0.2 0.6 0.5 0.4 1.2 0.8 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSHB ENSG00000134200 "Thyroid stimulating hormone beta" P01222 1 115029824-115034309 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 77 "pituitary gland: 192.4" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;SH-SY5Y: 1.0;U-937: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "NK-cell: 2.0" "Lineage enriched" "Detected in single" 6 "NK-cells: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB022202, HPA042681" Enhanced "Secreted to blood" "CAB022202: , HPA042681: " "unprognostic (2.14e-4)" "unprognostic (1.37e-1)" "unprognostic (1.73e-1)" 0.1 0.0 0.1 0.9 0.1 2.4 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.0 1.4 0.1 1.4 0.0 1.8 0.1 0.1 0.0 0.3 0.1 1.4 0.1 0.1 0.1 0.1 1.6 0.0 192.4 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.6 0.1 0.1 0.1 0.4 1.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.2 0.1 2.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 TSHR LGR3 ENSG00000165409 "Thyroid stimulating hormone receptor" P16473 14 80954989-81146302 "Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Congenital hypothyroidism, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "thyroid gland: 158.0" "Group enriched" "Detected in some" 17 "MOLT-4: 18.1;SCLC-21H: 18.7;U-266/70: 9.2;U-266/84: 4.7" "Cancer enriched" "Detected in some" 116 "thyroid cancer: 100.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 9.9" "Lineage enriched" "Detected in many" 5 "T-cells: 9.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" CAB000473 Approved "Intracellular and membrane" "CAB000473: AB_2303782" "unprognostic (3.36e-3)" "unprognostic (1.31e-3)" "unprognostic (1.02e-2)" "unprognostic (4.17e-6)" "unprognostic (3.01e-3)" "unprognostic (1.85e-3)" "unprognostic (1.83e-1)" "unprognostic (2.66e-2)" "unprognostic (3.39e-2)" "unprognostic (2.60e-2)" "unprognostic (1.70e-1)" "unprognostic (7.11e-3)" "unprognostic (5.08e-7)" "unprognostic (1.32e-1)" "unprognostic (7.40e-2)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" 0.1 0.2 0.1 0.2 0.4 0.3 0.2 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.3 0.3 0.5 0.1 0.0 0.8 0.2 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.1 0.1 0.1 27.3 158.0 0.2 0.4 0.1 0.1 1.8 0.8 1.3 0.3 0.1 9.9 0.1 0.3 0.2 0.6 0.4 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.3 0.4 0.6 0.2 0.1 0.2 0.7 0.0 0.1 0.2 0.1 0.3 0.6 0.3 0.0 0.2 0.3 0.3 0.1 0.1 0.2 0.1 0.3 0.6 0.1 0.4 18.1 0.4 0.4 0.2 0.6 0.2 0.7 0.0 0.4 18.7 0.3 0.1 0.2 0.2 0.3 0.0 0.2 0.5 0.4 0.5 0.2 9.2 4.7 0.4 0.2 0.2 0.3 0.6 0.2 0.2 0.2 0.1 0.2 1.0 0.8 0.5 0.1 1.8 0.3 0.2 1.3 0.1 0.3 0.8 9.9 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.1 TSKS "PPP1R161, TSSKS" ENSG00000126467 "Testis specific serine kinase substrate" Q9UJT2 19 49739753-49763330 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 54.3" "Cell line enriched" "Detected in some" 5 "NB-4: 15.4" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "classical monocyte: 1.4;intermediate monocyte: 1.3;memory CD4 T-cell: 2.5;myeloid DC: 2.5;naive CD4 T-cell: 1.2;non-classical monocyte: 3.0;plasmacytoid DC: 2.1;T-reg: 1.8" "Group enriched" "Detected in many" 27 "dendritic cells: 2.5;monocytes: 3.0;T-cells: 2.5" "Low region specificity" "Detected in single" "Region enriched" "Detected in many" 6 "basal ganglia: 4.9" HPA045729 Enhanced "HPA045729: AB_10963430" "unprognostic (3.56e-1)" "unprognostic (3.75e-3)" "unprognostic (8.33e-2)" "unprognostic (1.67e-1)" "unprognostic (1.92e-2)" "unprognostic (1.46e-1)" "unprognostic (1.67e-1)" "unprognostic (1.93e-1)" "unprognostic (3.55e-1)" "unprognostic (1.54e-1)" "unprognostic (3.04e-2)" "unprognostic (2.44e-1)" "unprognostic (1.51e-8)" "unprognostic (7.89e-3)" "unprognostic (1.37e-1)" "unprognostic (2.79e-2)" "unprognostic (3.52e-2)" 0.5 0.0 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.7 0.1 0.2 0.2 0.5 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.1 0.0 54.3 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.0 2.5 0.0 3.0 0.0 2.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.1 0.0 0.1 2.5 0.0 0.0 0.0 0.0 15.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.3 0.0 0.0 2.5 0.0 2.5 0.0 1.2 0.2 0.0 0.0 3.0 2.1 1.8 0.6 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 TSPAN10 OCSP ENSG00000182612 "Tetraspanin 10" 17 81637171-81648749 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 29 "retina: 117.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 6.0;SK-MEL-30: 17.7;U-138 MG: 6.4;U-87 MG: 8.1" "Cancer enriched" "Detected in many" 15 "melanoma: 32.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 12 "olfactory region: 1.6" "Low region specificity" "Detected in many" "unprognostic (1.81e-2)" "unprognostic (3.67e-1)" "unprognostic (2.17e-3)" "unprognostic (1.08e-3)" "unprognostic (3.74e-1)" "unprognostic (3.48e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-1)" "unprognostic (2.33e-1)" "unprognostic (1.95e-1)" "unprognostic (5.59e-3)" "unprognostic (1.21e-1)" "unprognostic (1.01e-1)" "unprognostic (2.43e-2)" "unprognostic (7.31e-2)" "unprognostic (2.81e-1)" "unprognostic (1.58e-1)" 1.0 0.1 0.1 1.3 0.1 0.0 0.4 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.9 1.1 0.5 0.3 0.7 0.1 0.1 0.1 0.2 0.5 2.2 0.1 0.1 0.2 0.9 0.0 0.1 1.4 0.2 1.1 0.0 117.4 0.3 1.0 0.1 4.0 0.1 0.1 0.1 0.2 0.2 0.5 0.1 0.4 0.1 0.5 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 1.8 0.2 0.2 0.6 0.7 0.2 1.9 6.0 2.9 1.6 0.6 3.1 0.7 0.7 1.7 0.1 0.1 0.4 0.3 0.6 3.5 0.0 0.4 0.4 0.4 0.0 1.1 0.7 0.8 3.3 0.1 0.0 0.0 0.2 2.8 0.2 0.1 0.4 0.2 2.9 1.3 0.0 0.0 0.2 0.5 0.0 1.3 3.2 0.4 17.7 3.5 0.4 0.1 6.4 2.0 0.5 1.7 0.0 0.0 0.0 8.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPAN7 "A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2" ENSG00000156298 "Tetraspanin 7" P41732 X 38561370-38688920 "CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 131.1" "Cell line enhanced" "Detected in some" "HDLM-2: 13.3;Hep G2: 10.6;MOLT-4: 55.3;SCLC-21H: 31.0;U-266/70: 20.5" "Cancer enhanced" "Detected in all" "glioma: 71.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.9" "Low lineage specificity" "Detected in single" "HPA003140, CAB062566, CAB068245" Enhanced "CAB062566: , CAB068245: , HPA003140: AB_1078454" "unprognostic (1.12e-2)" "unprognostic (1.42e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (3.40e-4)" "unprognostic (5.06e-2)" "unprognostic (3.90e-3)" "unprognostic (3.88e-3)" "unprognostic (1.37e-2)" "unprognostic (1.14e-1)" "unprognostic (2.01e-2)" "prognostic favourable (1.70e-4)" "unprognostic (1.54e-1)" "prognostic favourable (5.48e-7)" "unprognostic (5.65e-3)" "unprognostic (9.53e-2)" "unprognostic (1.48e-1)" "unprognostic (1.03e-3)" 15.2 28.7 39.6 3.5 83.0 0.8 7.3 83.8 131.1 12.4 18.5 11.5 2.3 7.9 11.6 9.2 7.9 10.5 5.8 17.1 34.5 30.7 15.8 12.0 16.2 8.8 19.4 37.7 5.2 4.4 4.1 11.4 6.6 23.8 5.6 17.3 8.1 3.3 7.4 17.9 4.9 7.8 14.5 11.9 21.3 4.6 1.7 9.5 0.0 11.8 5.4 8.2 8.2 4.2 0.9 0.5 0.3 0.2 0.3 2.9 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.9 0.3 0.0 13.3 2.5 0.0 0.0 10.6 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 55.3 0.0 2.9 0.0 2.7 1.1 0.0 1.4 0.2 31.0 3.2 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.7 0.0 0.2 20.5 5.8 0.0 1.3 0.1 0.4 0.2 0.1 0.0 0.6 0.2 0.7 0.4 1.1 2.9 0.1 0.9 2.1 1.8 0.3 0.3 0.0 0.5 0.0 0.1 39.6 83.0 83.8 86.3 34.5 30.7 19.4 37.7 23.8 9.5 TSPAN8 "CO-029, TM4SF3" ENSG00000127324 "Tetraspanin 8" P19075 12 71125085-71441898 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 235.3" "Cell line enhanced" "Detected in some" "CACO-2: 14.9;HeLa: 18.0;PC-3: 57.3;RPTEC TERT1: 11.0;RT4: 13.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 283.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB026009, HPA044337" Enhanced Approved Nucleoplasm Nucleoplasm "CAB026009: , HPA044337: " "unprognostic (1.64e-1)" "unprognostic (2.18e-2)" "unprognostic (1.64e-1)" "unprognostic (6.40e-2)" "unprognostic (6.81e-2)" "unprognostic (7.29e-3)" "unprognostic (1.90e-1)" "unprognostic (1.15e-1)" "unprognostic (5.62e-2)" "unprognostic (1.06e-1)" "unprognostic (4.01e-3)" "unprognostic (2.93e-1)" "prognostic unfavourable (9.66e-5)" "unprognostic (1.88e-2)" "unprognostic (1.00e-1)" "unprognostic (2.97e-2)" "prognostic favourable (7.36e-5)" 1.9 0.8 0.7 24.1 2.3 0.0 1.1 0.6 1.3 2.0 139.5 2.8 1.5 83.2 1.2 1.5 1.1 1.3 30.8 1.0 0.7 0.7 7.6 3.7 5.1 1.0 4.7 1.0 6.9 9.9 0.0 0.8 0.7 3.5 14.2 79.5 2.6 11.7 1.0 12.5 2.4 235.3 3.4 9.7 0.6 55.5 1.6 2.7 0.6 1.8 3.1 5.0 3.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.2 0.9 0.0 0.0 0.0 0.0 14.9 1.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 18.0 1.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 1.0 0.1 57.3 0.0 0.0 1.5 11.0 13.2 1.3 2.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.3 0.6 1.3 0.7 0.7 4.7 1.0 3.5 2.7 TSPO2 "BZRPL1, dJ34B21.2" ENSG00000112212 "Translocator protein 2" Q5TGU0 6 41042554-41044337 "Predicted intracellular proteins, Predicted membrane proteins" Transport Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 32.4" "Cell line enhanced" "Detected in some" "CACO-2: 5.2;Hep G2: 3.5;U-266/70: 1.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.89e-3)" "unprognostic (8.35e-3)" "unprognostic (2.57e-3)" "unprognostic (2.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-2)" "unprognostic (6.61e-3)" "unprognostic (2.29e-1)" "unprognostic (3.37e-1)" "unprognostic (2.89e-1)" "unprognostic (2.71e-1)" "unprognostic (4.92e-2)" "unprognostic (1.86e-2)" "unprognostic (2.70e-2)" "unprognostic (1.16e-1)" "unprognostic (5.37e-2)" "unprognostic (1.76e-2)" 0.1 0.0 0.1 0.1 0.1 32.4 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.8 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 1.3 2.5 0.4 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.9 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 1.3 0.1 3.3 4.5 1.3 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.3 0.8 0.4 0.0 0.0 3.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.6 0.4 1.2 0.1 0.0 0.9 0.0 0.0 0.7 0.3 1.3 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.9 0.4 1.8 0.6 0.5 0.0 1.0 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 TSPY1 "CT78, TSPY" ENSG00000258992 "Testis specific protein, Y-linked 1" Q01534 Y 9466955-9469748 "Disease related genes, Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 105 "testis: 10.5" "Group enriched" "Detected in some" 361 "U-266/70: 63.4;U-266/84: 59.3" "Cancer enriched" "Detected in single" 9 "testis cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA049384 Supported Approved Cytosol Cytosol "HPA049384: " "unprognostic (2.91e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.4 59.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPY10 ENSG00000236424 "Testis specific protein, Y-linked 10" Y 9527880-9530682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 6.3" "Cell line enriched" "Detected in some" 5 "U-266/84: 35.7" "Cancer enriched" "Detected in single" 13 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA049384 Supported Approved Cytosol Cytosol "HPA049384: " "unprognostic (5.36e-1)" 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.2 35.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPY2 TSPYQ1 ENSG00000168757 "Testis specific protein, Y-linked 2" A6NKD2 Y 6246223-6249019 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 104 "testis: 13.5" "Group enriched" "Detected in some" 416 "U-266/70: 41.0;U-266/84: 42.2" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA049384 Supported Approved Cytosol Cytosol "HPA049384: " "unprognostic (3.69e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPY3 CT78 ENSG00000228927 "Testis specific protein, Y-linked 3" P0CV98 Y 9398421-9401223 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "testis: 7.6" "Group enriched" "Detected in some" 75 "U-266/70: 49.7;U-266/84: 45.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049384 Supported Approved Cytosol Cytosol "HPA049384: " "unprognostic (4.19e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 49.7 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPY4 ENSG00000233803 "Testis specific protein, Y-linked 4" "P0CV99, P0CW01" Y 9337464-9340284 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 222 "testis: 28.0" "Group enriched" "Detected in some" 604 "U-266/70: 174.1;U-266/84: 183.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049384 Supported Approved Cytosol Cytosol "HPA049384: " 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 174.1 183.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPY8 ENSG00000229549 "Testis specific protein, Y-linked 8" P0CW00 Y 9357797-9360599 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 10 "testis: 4.1" "Cell line enriched" "Detected in single" 230 "U-266/84: 75.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049384 Supported Approved Cytosol Cytosol "HPA049384: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 75.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPYL6 ENSG00000178021 "TSPY like 6" Q8N831 2 54253184-54256272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 41.1" "Cell line enriched" "Detected in single" 131 "K-562: 13.1" "Cancer enriched" "Detected in single" 27 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034699, HPA034700" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA034699: , HPA034700: AB_10670159" "unprognostic (8.21e-2)" "unprognostic (4.25e-1)" "unprognostic (1.06e-2)" "unprognostic (1.00e-1)" "unprognostic (5.54e-6)" "unprognostic (4.50e-2)" "unprognostic (1.77e-1)" "unprognostic (5.73e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 TSSK1B "FKSG81, SPOGA4, STK22D, TSSK1" ENSG00000212122 "Testis specific serine kinase 1B" Q9BXA7 5 113432554-113435031 "Enzymes, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 50 "testis: 59.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.3;EFO-21: 2.1;RT4: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA027827 Enhanced "HPA027827: AB_10603138" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 59.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.6 0.1 0.2 0.0 1.0 0.0 0.0 0.0 0.2 0.0 1.3 0.2 2.1 0.0 0.4 0.2 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.5 0.1 0.0 0.1 0.3 0.0 0.4 0.0 0.5 0.2 0.2 0.3 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSSK2 "FLJ38613, SPOGA2, STK22B" ENSG00000206203 "Testis specific serine kinase 2" Q96PF2 22 19130808-19132623 "Enzymes, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 57 "testis: 95.7" "Cell line enhanced" "Detected in some" "HL-60: 1.7;SCLC-21H: 3.4;THP-1: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 1.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 95.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 1.0 0.0 1.6 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 0.0 1.2 0.0 0.8 0.0 0.5 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.7 3.2 0.8 1.4 0.5 0.0 0.2 0.1 0.9 0.3 0.0 0.3 1.2 0.0 0.0 1.0 0.4 0.0 0.0 0.5 0.1 0.8 0.3 0.7 0.2 0.5 0.2 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSSK3 "SPOGA3, STK22C" ENSG00000162526 "Testis specific serine kinase 3" Q96PN8 1 32351521-32364312 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 68.1" "Cell line enhanced" "Detected in many" "HeLa: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA037516 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA037516: " "unprognostic (5.71e-2)" "unprognostic (1.42e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-1)" "unprognostic (7.69e-2)" "unprognostic (2.02e-4)" "unprognostic (2.06e-1)" "unprognostic (1.98e-3)" "unprognostic (2.05e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (9.20e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.68e-3)" 1.1 2.0 0.8 1.7 0.8 8.2 1.1 3.9 0.8 1.3 0.9 0.8 1.4 2.5 1.8 2.9 0.8 1.3 1.0 0.9 0.8 0.0 0.9 1.3 1.4 2.4 0.8 0.8 2.0 1.2 0.0 0.8 0.8 1.0 1.0 0.0 0.8 1.4 0.8 1.7 3.4 2.9 0.8 0.8 3.4 1.2 68.1 0.8 0.8 1.3 0.8 0.8 0.9 1.1 0.6 0.1 0.1 0.7 0.3 2.3 0.1 2.3 2.3 6.0 3.6 0.0 1.2 5.4 0.7 1.1 0.0 0.0 0.5 1.2 1.2 0.9 0.0 3.7 0.0 0.0 0.0 3.5 7.2 2.7 9.8 3.7 4.4 1.1 3.4 0.1 0.9 0.0 1.3 0.0 3.1 5.8 0.0 0.6 1.4 1.5 1.5 1.2 1.9 1.7 4.4 0.0 1.9 1.8 3.8 0.8 2.8 4.1 1.9 2.7 2.9 2.1 3.4 3.0 2.4 8.5 2.8 1.8 3.7 3.9 0.5 0.0 0.1 0.0 1.1 0.7 0.0 0.0 0.2 0.0 0.1 0.6 2.3 0.9 0.1 0.3 0.5 0.0 0.0 0.1 0.8 0.8 3.9 0.8 0.8 0.0 0.8 0.8 1.0 0.8 TSSK4 "C14orf20, STK22E" ENSG00000139908 "Testis specific serine kinase 4" Q6SA08 14 24205697-24208362 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 46.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA060660, HPA077103" Approved Approved "Cell Junctions" "Cell Junctions" "HPA060660: , HPA077103: " "unprognostic (1.95e-1)" "unprognostic (4.30e-2)" "unprognostic (1.52e-1)" "unprognostic (5.69e-2)" "unprognostic (2.36e-1)" "unprognostic (3.38e-5)" "unprognostic (1.06e-1)" "unprognostic (6.25e-3)" "unprognostic (1.64e-1)" "unprognostic (3.39e-1)" "unprognostic (7.03e-3)" "unprognostic (1.27e-3)" "unprognostic (3.42e-1)" "unprognostic (4.30e-2)" "unprognostic (6.28e-2)" "unprognostic (8.98e-2)" "unprognostic (7.26e-2)" 0.6 0.9 0.6 1.7 0.6 3.1 0.6 1.5 1.8 0.6 0.6 0.6 0.6 1.5 0.8 0.9 1.4 0.8 1.7 0.6 0.6 0.4 0.6 0.6 0.8 2.8 0.6 0.6 0.8 0.9 0.0 0.6 0.6 0.6 0.6 0.0 0.6 1.4 0.6 1.0 4.7 1.6 0.6 0.6 1.5 0.6 46.1 0.6 0.6 1.4 0.6 0.6 1.0 0.6 2.1 1.7 2.0 1.0 1.8 2.0 0.7 1.0 4.0 3.9 1.5 0.1 0.0 4.3 1.6 0.1 0.0 0.0 2.1 3.7 3.1 0.9 0.1 3.8 0.0 0.1 0.0 1.6 3.0 3.4 4.8 3.0 0.0 1.5 3.7 0.0 0.0 0.0 0.6 0.1 1.3 2.0 0.0 3.8 3.6 1.6 0.7 3.2 2.9 1.5 2.6 0.0 5.2 2.2 2.0 2.7 2.5 0.8 1.6 1.7 1.4 2.9 1.8 3.7 1.3 4.2 4.8 4.7 1.0 2.8 0.9 0.0 1.0 2.0 2.0 1.0 0.7 2.0 1.6 1.6 0.6 2.1 1.6 1.7 2.0 1.8 0.9 1.7 0.7 0.7 0.6 0.6 1.5 0.6 0.6 0.4 0.6 0.6 0.6 0.6 TSSK6 "CT72, FLJ24002, SSTK" ENSG00000178093 "Testis specific serine kinase 6" Q9BXA6 19 19512418-19515685 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "testis: 50.8" "Cell line enhanced" "Detected in many" "BEWO: 8.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.12e-1)" "unprognostic (7.89e-2)" "unprognostic (7.26e-2)" "unprognostic (6.64e-2)" "unprognostic (3.39e-1)" "unprognostic (7.20e-5)" "unprognostic (3.38e-1)" "unprognostic (5.51e-3)" "unprognostic (5.17e-2)" "unprognostic (1.46e-1)" "unprognostic (3.98e-4)" "unprognostic (2.28e-2)" "unprognostic (5.34e-3)" "unprognostic (2.74e-3)" "unprognostic (2.78e-2)" "unprognostic (1.52e-3)" "unprognostic (9.89e-2)" 0.9 1.2 1.0 1.2 1.5 1.3 1.0 0.9 1.9 0.9 1.1 2.2 1.6 2.1 0.9 3.7 1.1 1.1 1.0 0.7 1.2 0.8 1.8 2.2 0.7 1.2 2.5 1.0 0.9 3.3 1.1 1.0 0.6 1.3 1.4 0.6 0.9 1.3 1.0 1.0 2.7 1.9 1.2 1.9 2.1 1.7 50.8 1.7 3.1 2.0 0.1 1.7 1.1 1.0 3.1 1.0 2.2 0.7 0.4 3.8 0.8 1.7 2.7 0.1 1.1 0.4 1.0 8.1 1.1 0.5 0.6 0.3 4.3 1.3 1.4 2.0 0.1 1.4 0.5 1.1 0.2 1.1 2.0 0.7 1.7 0.9 1.2 0.9 3.2 0.7 1.0 0.6 1.9 0.3 1.9 0.8 0.0 0.5 3.4 2.0 3.7 4.5 2.8 0.7 1.2 0.1 0.5 0.6 2.9 1.6 0.4 1.4 2.7 0.7 0.3 2.0 0.6 4.0 1.7 3.6 1.5 0.8 2.2 1.2 1.9 0.0 0.6 2.2 0.8 0.2 1.1 3.1 1.7 2.0 0.3 1.9 3.8 2.1 1.1 0.4 0.7 1.0 1.0 0.8 1.0 1.5 0.9 1.9 1.2 0.8 2.5 1.0 1.3 1.7 TTC21A "IFT139A, STI2" ENSG00000168026 "Tetratricopeptide repeat domain 21A" Q8NDW8 3 39107704-39138903 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 51.9" "Cell line enhanced" "Detected in some" "Karpas-707: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0;naive B-cell: 2.7" "Group enriched" "Detected in many" 6 "B-cells: 2.7;monocytes: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035510, HPA035511" Enhanced Supported Nucleoplasm Nucleoplasm "HPA035510: , HPA035511: AB_10671514" "unprognostic (1.85e-3)" "unprognostic (6.95e-3)" "unprognostic (7.74e-3)" "prognostic favourable (1.79e-4)" "unprognostic (1.55e-1)" "unprognostic (1.58e-5)" "unprognostic (2.29e-2)" "unprognostic (4.93e-2)" "unprognostic (1.33e-1)" "unprognostic (1.15e-1)" "unprognostic (3.01e-4)" "unprognostic (2.19e-2)" "unprognostic (1.29e-3)" "unprognostic (6.54e-2)" "unprognostic (3.35e-1)" "unprognostic (9.76e-2)" "unprognostic (3.91e-4)" 0.9 0.8 2.5 2.2 4.1 0.7 0.8 1.0 2.9 0.9 0.9 2.2 1.9 0.9 1.8 3.0 0.9 2.0 0.7 0.9 2.4 0.8 0.9 0.9 1.0 1.0 0.9 3.6 1.0 2.1 0.9 7.0 0.7 2.9 0.9 0.7 1.4 1.0 0.8 1.0 0.9 0.8 0.6 0.9 0.8 0.9 51.9 1.9 0.0 0.9 0.0 1.6 0.8 0.9 2.7 0.3 0.3 1.7 0.0 0.0 0.1 0.6 1.1 0.3 0.7 0.0 0.7 0.9 1.2 0.9 0.8 0.5 0.0 0.6 2.5 0.0 0.4 0.5 0.4 1.6 0.2 1.1 0.5 0.1 1.1 0.0 1.3 1.0 0.7 0.9 0.9 0.0 1.3 0.0 0.0 3.8 0.0 1.2 0.1 0.4 0.1 0.0 0.2 0.2 0.4 0.0 1.1 1.3 0.5 1.2 3.0 1.3 2.8 0.1 0.6 0.3 0.5 2.4 0.5 2.6 0.3 0.2 1.0 0.0 0.6 0.0 0.5 0.0 0.0 1.7 0.0 2.0 0.0 0.0 0.3 2.7 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 2.5 4.1 1.0 2.9 2.4 0.8 0.9 3.6 2.9 1.9 TTC29 NYD-SP14 ENSG00000137473 "Tetratricopeptide repeat domain 29" Q8NA56 4 146706638-146945882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 55.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.9;hTERT-HME1: 3.1;Karpas-707: 2.2;U-266/70: 4.1;U-87 MG: 2.1" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.9" "Group enriched" "Detected in many" 5 "basal ganglia: 4.3;pons and medulla: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA037006, HPA061473" Uncertain "HPA037006: AB_10670379, HPA061473: " "unprognostic (1.28e-3)" "unprognostic (1.52e-2)" "unprognostic (8.21e-2)" "unprognostic (1.70e-1)" "unprognostic (6.70e-2)" "unprognostic (1.35e-1)" "unprognostic (6.94e-3)" "unprognostic (1.32e-1)" "unprognostic (5.67e-4)" "unprognostic (9.81e-4)" "unprognostic (7.30e-2)" "unprognostic (6.88e-4)" 0.2 0.1 0.9 0.1 4.3 0.1 0.1 0.1 1.2 0.8 0.1 1.7 0.5 0.1 0.3 10.7 0.1 13.3 0.1 0.1 1.5 1.3 0.2 0.1 7.0 0.1 0.3 0.7 2.6 0.1 0.8 0.2 0.1 12.7 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.4 0.1 0.1 55.9 0.6 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 9.9 0.0 0.0 0.8 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.1 0.9 3.1 0.3 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 4.1 0.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.3 0.1 1.2 1.5 1.3 0.3 0.7 12.7 0.6 TTC36 HBP21 ENSG00000172425 "Tetratricopeptide repeat domain 36" A6NLP5 11 118527472-118531197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 53.9" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 12.2" "Group enriched" "Detected in some" 7 "breast cancer: 5.0;liver cancer: 12.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.4" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038731 Enhanced Uncertain Nucleoplasm 20000 Nucleoplasm "HPA038731: AB_10672651" "unprognostic (1.57e-3)" "unprognostic (2.58e-3)" "unprognostic (1.16e-1)" "unprognostic (6.50e-2)" "unprognostic (1.02e-2)" "unprognostic (2.17e-1)" "prognostic favourable (1.81e-5)" "unprognostic (6.32e-2)" "unprognostic (8.80e-2)" "unprognostic (6.14e-2)" "unprognostic (4.77e-3)" "unprognostic (3.38e-2)" "unprognostic (5.77e-7)" "unprognostic (5.60e-2)" "unprognostic (2.24e-1)" "unprognostic (1.59e-1)" "unprognostic (8.95e-3)" 2.9 0.4 0.2 0.4 0.3 0.0 3.7 0.6 0.2 0.1 5.5 0.1 0.1 3.4 0.3 8.3 0.1 0.1 0.6 0.7 0.1 0.2 3.2 53.9 0.2 0.1 0.1 0.1 0.1 0.3 0.0 0.5 0.1 0.1 0.2 0.0 0.1 1.0 0.6 0.4 0.1 2.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.8 2.4 0.0 0.0 0.7 0.5 0.0 0.2 0.2 0.2 0.8 0.0 0.0 2.7 0.4 0.0 0.0 0.0 0.2 0.5 0.3 1.7 0.0 0.8 0.1 0.0 0.0 1.5 2.0 0.1 0.1 0.5 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.5 0.0 0.4 2.6 0.6 0.5 1.3 0.0 0.0 0.7 1.7 0.6 12.2 0.0 2.1 0.0 0.3 0.0 0.9 0.0 0.2 1.0 1.4 1.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.8 0.2 0.3 0.2 0.1 0.5 0.0 0.0 0.7 0.0 2.4 0.0 0.0 0.2 0.3 0.6 0.2 0.1 0.2 0.1 0.1 0.1 0.1 TTC9B FLJ30373 ENSG00000174521 "Tetratricopeptide repeat domain 9B" Q8N6N2 19 40216058-40218399 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 47.9" "Cell line enriched" "Detected in some" 19 "SCLC-21H: 24.5" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042496 Approved "Secreted in brain" "HPA042496: AB_10795506" "unprognostic (2.31e-1)" "unprognostic (1.39e-4)" "unprognostic (5.09e-2)" "unprognostic (5.24e-2)" "unprognostic (8.47e-2)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (7.95e-2)" "unprognostic (2.78e-1)" "unprognostic (1.54e-2)" "unprognostic (3.69e-1)" "unprognostic (8.75e-6)" "unprognostic (1.39e-1)" "unprognostic (8.23e-2)" "unprognostic (1.95e-1)" "unprognostic (5.24e-2)" 1.0 1.8 45.5 1.4 10.3 1.0 1.0 24.6 47.9 1.0 1.2 1.2 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 22.3 14.0 1.0 1.0 1.0 1.0 7.5 9.9 1.0 1.0 1.0 0.0 1.0 7.1 1.0 1.0 0.3 1.0 1.0 1.0 1.0 1.2 1.1 2.5 1.0 1.1 1.1 1.0 0.0 1.0 0.0 1.0 1.0 0.0 0.1 0.5 0.0 1.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 24.5 1.3 0.1 0.0 0.9 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.3 0.0 45.5 10.3 24.6 31.3 22.3 14.0 7.5 9.9 7.1 1.0 TTLL10 "FLJ36119, TTLL5" ENSG00000162571 "Tubulin tyrosine ligase like 10" Q6ZVT0 1 1173884-1197935 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 48.2" "Cell line enriched" "Detected in single" 24 "SCLC-21H: 22.7" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "pons and medulla: 2.2" "Cell type enriched" "Detected in single" 29 "NK-cell: 2.9" "Lineage enriched" "Detected in single" 29 "NK-cells: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA042712 Uncertain "HPA042712: AB_10797019" "unprognostic (1.74e-1)" "unprognostic (7.95e-2)" "unprognostic (2.66e-3)" "prognostic favourable (1.61e-5)" "unprognostic (5.33e-2)" "unprognostic (2.68e-3)" "unprognostic (4.93e-3)" "unprognostic (2.14e-3)" "unprognostic (4.50e-1)" "unprognostic (3.69e-2)" "unprognostic (1.28e-2)" "unprognostic (6.63e-2)" "unprognostic (6.00e-4)" "unprognostic (8.35e-2)" "unprognostic (2.65e-1)" "unprognostic (1.12e-1)" "unprognostic (4.39e-2)" 1.2 0.0 0.1 0.1 0.5 0.0 0.6 0.1 0.2 1.7 0.1 1.0 0.1 0.0 0.2 1.1 0.1 10.9 0.1 0.1 0.3 0.3 0.1 0.1 3.1 0.1 0.1 0.3 0.7 0.1 0.0 1.3 1.5 2.2 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.5 48.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.2 0.3 0.3 0.1 0.3 2.2 0.3 TTLL13P "FLJ46079, MGC33417, TTLL13" ENSG00000213471 "Tubulin tyrosine ligase like 13, pseudogene" A6NNM8 15 90249530-90265482 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 50 "testis: 34.4" "Cell line enhanced" "Detected in some" "BEWO: 1.1;CACO-2: 1.3;HEL: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041305 Enhanced "HPA041305: " "unprognostic (6.23e-3)" "unprognostic (2.19e-2)" "unprognostic (6.49e-4)" "unprognostic (6.09e-4)" "unprognostic (2.46e-1)" "unprognostic (1.43e-1)" "unprognostic (8.58e-2)" "unprognostic (5.17e-3)" "unprognostic (3.61e-3)" "unprognostic (9.23e-3)" "unprognostic (2.89e-1)" "unprognostic (1.79e-2)" "unprognostic (1.63e-3)" "unprognostic (1.04e-2)" "unprognostic (3.12e-1)" "unprognostic (8.32e-2)" "unprognostic (1.88e-4)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.6 0.1 0.0 0.4 0.0 0.0 0.9 0.0 1.1 0.2 0.0 0.5 0.2 1.3 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.6 1.2 0.9 0.5 0.4 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.6 0.3 0.3 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.3 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 TTLL2 "C6orf104, dJ366N23.3, NYD-TSPG" ENSG00000120440 "Tubulin tyrosine ligase like 2" Q9BWV7 6 167325086-167359503 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "testis: 54.1" "Cell line enriched" "Detected in some" 5 "CACO-2: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA027985 Approved "Nuclear membrane,Nucleoli" "Nuclear membrane, Nucleoli" "HPA027985: AB_2211832" "unprognostic (5.98e-2)" "unprognostic (1.51e-1)" "unprognostic (2.47e-1)" "unprognostic (6.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.79e-1)" "unprognostic (5.29e-2)" "unprognostic (9.47e-4)" "unprognostic (7.57e-2)" "unprognostic (2.63e-4)" "unprognostic (3.50e-2)" "unprognostic (2.39e-1)" "unprognostic (8.14e-3)" "unprognostic (1.94e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.8 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 TTLL8 ENSG00000138892 "Tubulin tyrosine ligase like 8" A6PVC2 22 50015123-50056935 "Predicted intracellular proteins" Ligase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "testis: 8.4" "Cell line enriched" "Detected in single" 5 "U-266/70: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA016882 Uncertain "HPA016882: AB_10603223" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (8.18e-2)" "unprognostic (1.21e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TTPA AVED ENSG00000137561 "Alpha tocopherol transfer protein" P49638 8 63048553-63086053 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "liver: 74.1" "Cell line enhanced" "Detected in some" "SK-BR-3: 10.2;T-47d: 3.8;U-2 OS: 5.3;U-2197: 6.3" "Cancer enriched" "Detected in some" 9 "liver cancer: 21.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "unprognostic (1.48e-1)" "unprognostic (3.42e-1)" "unprognostic (7.82e-3)" "unprognostic (1.30e-7)" "unprognostic (1.78e-1)" "unprognostic (8.44e-2)" "unprognostic (1.25e-2)" "unprognostic (7.84e-2)" "unprognostic (4.04e-2)" "unprognostic (3.50e-1)" "unprognostic (5.40e-2)" "unprognostic (3.28e-1)" "unprognostic (1.14e-2)" "unprognostic (1.49e-2)" "unprognostic (3.57e-2)" "unprognostic (5.46e-3)" "unprognostic (6.16e-3)" 0.9 0.4 2.4 0.4 3.3 0.3 2.5 3.5 2.0 0.3 1.6 2.1 0.0 0.4 0.3 0.3 0.3 0.3 0.4 0.3 3.9 1.1 1.4 74.1 0.6 0.3 2.4 1.8 0.3 0.8 0.4 0.3 1.0 3.8 0.3 2.3 0.0 0.3 0.3 0.3 0.4 0.4 0.4 3.1 0.3 0.4 0.4 2.4 0.0 0.3 0.0 0.3 0.3 0.2 0.9 0.3 2.0 0.5 0.3 0.4 0.0 0.1 1.5 1.0 0.2 0.5 0.0 0.0 0.1 0.0 0.4 0.1 0.2 2.4 0.0 0.1 0.0 0.0 2.7 0.2 0.5 0.0 0.1 0.1 0.2 0.6 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.1 0.2 0.4 1.2 0.1 0.2 1.0 0.7 0.1 0.0 0.0 0.0 0.7 0.4 0.1 1.0 10.2 1.0 3.8 0.4 0.3 0.1 5.3 6.3 1.1 0.4 0.0 0.1 2.3 0.1 1.9 2.0 0.5 0.3 0.4 0.1 0.3 0.4 0.3 0.2 0.2 0.9 0.3 0.3 1.6 0.3 0.2 0.3 0.2 0.0 2.4 3.3 3.5 2.0 3.9 1.1 2.4 1.8 3.8 2.4 TTYH1 ENSG00000167614 "Tweety family member 1" Q9H313 19 54415219-54436900 "Predicted membrane proteins, Transporters" "Cell adhesion, Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 66.9" "Group enriched" "Detected in some" 4 "AF22: 6.2;AN3-CA: 19.2;U-2 OS: 7.1" "Cancer enriched" "Detected in many" 15 "glioma: 63.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023617, HPA050655" Approved "HPA023617: AB_10600836, HPA050655: " "prognostic favourable (3.64e-4)" "unprognostic (1.71e-1)" "unprognostic (1.24e-2)" "unprognostic (1.25e-1)" "unprognostic (1.46e-2)" "unprognostic (2.50e-3)" "unprognostic (8.93e-2)" "unprognostic (1.51e-2)" "unprognostic (5.94e-3)" "unprognostic (1.11e-1)" "unprognostic (3.66e-1)" "unprognostic (1.60e-1)" "unprognostic (0.00e+0)" "unprognostic (2.09e-1)" "unprognostic (1.41e-1)" "unprognostic (4.45e-2)" "unprognostic (1.69e-1)" 2.2 2.7 49.5 2.1 55.4 2.1 2.3 17.9 66.9 2.4 2.3 33.9 0.0 2.4 2.6 2.1 2.2 4.4 2.3 2.3 31.0 23.4 2.1 2.1 2.1 2.1 39.3 24.4 2.2 10.4 2.1 1.9 2.1 19.7 2.5 2.1 1.9 2.8 2.4 3.0 2.2 2.1 2.2 29.7 2.4 2.2 7.4 18.0 0.0 2.1 0.0 2.1 2.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 6.2 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 49.5 55.4 17.9 42.9 31.0 23.4 39.3 24.4 19.7 18.0 TTYH2 C17orf29 ENSG00000141540 "Tweety family member 2" Q9BSA4 17 74213514-74262020 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 84.1" "Cell line enhanced" "Detected in many" "HSkMC: 11.5;SK-MEL-30: 40.1" "Group enriched" "Detected in all" 6 "glioma: 16.7;melanoma: 20.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 16.6" "Group enriched" "Detected in many" 5 "dendritic cells: 11.5;monocytes: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.19e-1)" "unprognostic (5.08e-1)" "unprognostic (1.58e-3)" "unprognostic (3.51e-4)" "unprognostic (1.59e-1)" "unprognostic (2.44e-1)" "unprognostic (1.67e-2)" "unprognostic (5.90e-2)" "unprognostic (8.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.81e-2)" "unprognostic (2.87e-1)" "prognostic unfavourable (9.74e-5)" "unprognostic (8.98e-3)" "unprognostic (5.70e-3)" "unprognostic (2.50e-3)" "unprognostic (3.51e-3)" 4.6 4.4 20.7 5.8 32.1 2.8 2.9 4.6 63.5 3.8 3.1 84.1 0.0 2.6 4.4 3.4 3.1 4.8 4.5 12.8 31.6 15.9 1.8 1.9 4.3 5.9 59.3 19.0 12.9 4.9 5.4 3.1 8.2 28.7 2.8 2.6 8.5 5.4 3.9 10.5 4.5 3.2 3.6 48.6 8.8 2.3 9.2 45.6 0.7 8.5 2.1 4.8 3.0 2.1 0.2 11.5 0.8 16.6 0.1 3.1 3.8 0.1 0.9 4.6 4.3 0.5 0.6 0.1 0.2 0.0 0.2 0.0 2.9 0.0 2.6 0.6 0.1 7.2 4.5 0.1 0.1 6.0 2.5 2.8 0.1 0.2 3.2 0.3 1.9 11.5 2.3 0.1 0.8 0.1 0.5 1.3 0.1 0.5 1.3 0.2 0.9 7.9 4.3 8.2 4.9 0.1 0.3 1.6 5.6 0.0 2.8 40.1 1.5 0.5 0.1 0.0 2.3 0.0 0.1 0.2 0.1 0.0 0.1 0.8 2.4 0.6 8.0 0.7 1.6 13.9 0.2 0.2 3.1 2.6 9.0 0.2 0.5 1.1 0.8 0.1 16.6 11.5 2.7 3.8 20.7 32.1 4.6 29.8 31.6 15.9 59.3 19.0 28.7 45.6 TUBA3C "bA408E5.3, TUBA2" ENSG00000198033 "Tubulin alpha 3c" Q13748 13 19173770-19181852 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 415 "testis: 161.0" "Group enriched" "Detected in some" 50 "HDLM-2: 27.4;U-2 OS: 69.7;U-266/70: 22.6;U-266/84: 27.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039247, HPA043684, HPA063394" Uncertain Supported Microtubules Microtubules "HPA039247: , HPA043684: , HPA063394: " "unprognostic (3.76e-3)" "unprognostic (1.33e-1)" "unprognostic (3.00e-1)" "unprognostic (1.04e-1)" "unprognostic (1.26e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 161.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 69.7 0.0 0.0 22.6 27.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TUBA3D H2-ALPHA ENSG00000075886 "Tubulin alpha 3d" Q13748 2 131476093-131482934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 104.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "CAB004972, HPA039247, HPA043684, HPA063394" Uncertain Supported Microtubules Microtubules "CAB004972: AB_425727, HPA039247: , HPA043684: , HPA063394: " "prognostic favourable (4.65e-4)" "unprognostic (6.66e-2)" "unprognostic (1.10e-1)" "unprognostic (2.96e-3)" "unprognostic (1.82e-1)" "unprognostic (1.50e-3)" "unprognostic (2.17e-1)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (2.89e-1)" "unprognostic (1.08e-1)" "unprognostic (2.05e-1)" "prognostic unfavourable (4.75e-9)" "unprognostic (4.60e-2)" "unprognostic (2.28e-1)" "unprognostic (9.96e-4)" "unprognostic (2.28e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.7 0.2 0.2 0.2 0.0 1.2 2.9 0.2 1.6 0.2 20.4 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 2.9 0.0 0.2 0.6 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 104.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 1.1 0.0 0.0 0.3 0.0 0.8 0.4 1.6 0.8 0.6 3.0 0.0 0.0 2.0 0.6 0.0 0.0 0.0 2.6 1.2 1.1 0.3 0.0 2.0 0.0 0.0 0.0 1.4 2.3 0.4 0.9 1.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.9 0.1 1.8 1.4 3.2 2.4 1.2 1.1 0.1 0.7 0.0 0.7 1.9 0.3 0.5 0.3 0.0 0.4 0.0 0.9 1.0 1.6 1.5 1.1 0.6 0.6 0.7 0.8 1.1 0.5 0.0 0.2 0.0 0.3 0.0 0.2 0.8 0.6 0.4 0.0 1.1 0.7 0.8 0.0 0.0 0.3 0.0 0.6 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 TUBA4B "FLJ13940, TUBA4" ENSG00000243910 "Tubulin alpha 4b" Q9H853 2 219253243-219272188 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "fallopian tube: 29.7" "Cell line enhanced" "Detected in some" "Hep G2: 3.1;SCLC-21H: 3.6" "Cancer enriched" "Detected in some" 6 "endometrial cancer: 8.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "unprognostic (3.20e-5)" "unprognostic (1.47e-4)" "unprognostic (1.85e-1)" "unprognostic (3.70e-3)" "unprognostic (9.63e-2)" "unprognostic (8.97e-2)" "unprognostic (2.18e-3)" "unprognostic (7.32e-2)" "unprognostic (9.50e-2)" "unprognostic (6.56e-2)" "unprognostic (2.50e-1)" "unprognostic (2.12e-1)" "unprognostic (2.41e-3)" "unprognostic (3.78e-2)" "unprognostic (9.57e-2)" "unprognostic (3.91e-2)" "unprognostic (4.08e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 29.7 0.0 0.0 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 2.4 0.6 0.6 1.5 4.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.5 0.7 0.0 0.7 0.0 0.7 0.0 0.4 0.2 0.2 0.6 3.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.1 0.0 0.1 3.6 0.1 0.9 0.3 0.0 0.2 0.4 0.0 0.0 0.5 0.3 0.1 0.4 0.0 0.6 0.8 0.5 0.0 0.7 0.4 1.4 0.7 0.4 0.8 1.0 1.5 1.2 0.2 0.8 1.2 1.4 2.4 0.6 0.6 0.1 1.3 4.0 TUBAL3 FLJ21665 ENSG00000178462 "Tubulin alpha like 3" A6NHL2 10 5393098-5404830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 41.5" "Group enriched" "Detected in some" 6 "HEL: 16.5;K-562: 5.2" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045900, HPA063394" Uncertain "HPA045900: AB_10961130, HPA063394: " "unprognostic (2.63e-1)" "unprognostic (1.69e-2)" "unprognostic (5.33e-2)" "unprognostic (1.09e-1)" "unprognostic (7.59e-2)" "unprognostic (2.13e-2)" "unprognostic (3.02e-2)" "unprognostic (4.02e-1)" "unprognostic (1.02e-1)" "unprognostic (2.68e-2)" "unprognostic (1.26e-1)" "unprognostic (3.44e-1)" "unprognostic (4.52e-2)" "unprognostic (2.75e-1)" "unprognostic (1.35e-4)" "unprognostic (7.93e-4)" 0.2 0.0 0.3 0.7 0.4 0.0 0.2 0.1 0.9 0.1 16.1 0.1 0.1 18.0 0.4 0.1 0.3 0.1 0.3 0.5 0.2 0.2 4.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.7 0.2 8.1 0.1 0.8 0.1 0.1 0.4 41.5 0.1 0.4 0.1 0.1 1.2 0.2 0.1 0.1 1.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.9 0.0 1.6 0.0 0.4 0.0 0.9 0.0 0.0 0.0 16.5 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.1 0.9 0.2 0.2 0.2 0.1 0.7 0.2 TUBB2A "dJ40E16.7, TUBB, TUBB2" ENSG00000137267 "Tubulin beta 2A class IIa" Q13885 6 3153669-3157526 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 158.3" "Cell line enhanced" "Detected in many" "AF22: 53.3;CACO-2: 53.8;WM-115: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 6.0;monocytes: 2.6;T-cells: 5.5" "Low region specificity" "Detected in all" "CAB015339, HPA043640, HPA046280" Supported Supported Microtubules Microtubules "CAB015339: AB_2210539, HPA043640: , HPA046280: " "unprognostic (2.57e-1)" "unprognostic (9.86e-3)" "unprognostic (5.90e-3)" "unprognostic (7.98e-3)" "unprognostic (4.02e-3)" "unprognostic (1.67e-1)" "unprognostic (1.82e-3)" "unprognostic (7.53e-2)" "unprognostic (1.48e-3)" "unprognostic (9.99e-2)" "unprognostic (1.24e-2)" "unprognostic (1.42e-2)" "prognostic favourable (4.65e-4)" "unprognostic (2.39e-2)" "unprognostic (1.79e-1)" "unprognostic (3.10e-2)" "prognostic unfavourable (1.61e-4)" 19.6 9.1 59.4 8.7 46.9 26.8 7.9 46.5 158.3 5.4 8.7 9.1 1.2 11.1 6.7 13.5 17.2 4.8 10.9 6.1 56.5 76.0 7.7 16.9 4.1 5.4 58.4 43.3 2.6 14.3 1.6 6.9 11.0 78.6 6.1 4.5 4.6 5.8 8.0 7.3 24.7 13.8 17.7 24.3 2.3 17.6 2.9 5.4 0.1 1.9 10.4 4.7 5.4 5.8 6.0 0.9 0.7 2.6 0.6 5.5 1.8 11.4 9.7 53.3 12.0 6.7 7.5 3.1 25.5 9.5 17.5 25.4 53.8 3.9 5.7 15.8 24.1 5.5 18.8 5.8 6.1 27.6 12.5 1.9 2.8 16.2 7.0 0.3 1.9 7.8 6.8 18.3 1.2 8.0 6.8 2.0 15.6 5.1 3.0 0.6 45.6 12.5 2.6 5.0 4.3 5.9 5.9 13.3 12.2 6.4 1.9 36.5 4.1 0.4 16.0 11.8 12.9 25.5 13.7 0.8 0.9 3.8 4.3 1.5 59.5 0.0 1.9 0.0 4.0 2.6 4.4 6.0 3.9 5.5 0.9 1.2 2.1 3.7 0.7 0.6 2.0 0.3 5.3 1.8 59.4 46.9 46.5 89.2 56.5 76.0 58.4 43.3 78.6 5.4 TUBB2B "bA506K6.1, DKFZp566F223, MGC8685" ENSG00000137285 "Tubulin beta 2B class IIb" Q9BVA1 6 3224261-3231730 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 125.4" "Cell line enhanced" "Detected in some" "AF22: 72.9;CACO-2: 53.5;NTERA-2: 35.7;RPMI-8226: 36.6;SCLC-21H: 109.3;SH-SY5Y: 53.1" "Cancer enriched" "Detected in many" 9 "glioma: 216.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 21 "B-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Supported "HPA043640: , HPA046280: " "unprognostic (2.66e-2)" "unprognostic (3.41e-1)" "unprognostic (5.92e-3)" "prognostic unfavourable (1.94e-4)" "unprognostic (6.81e-2)" "unprognostic (3.26e-2)" "unprognostic (9.03e-3)" "unprognostic (8.33e-2)" "unprognostic (1.08e-1)" "unprognostic (2.02e-1)" "unprognostic (3.78e-3)" "unprognostic (3.34e-2)" "unprognostic (2.03e-2)" "unprognostic (6.24e-3)" "unprognostic (6.04e-2)" "unprognostic (3.58e-4)" "unprognostic (2.30e-3)" 3.8 5.9 53.6 5.9 63.1 1.5 4.4 23.2 125.4 4.7 4.6 22.6 0.0 2.8 4.0 29.7 2.5 2.0 3.6 2.1 34.3 48.6 6.6 1.4 1.6 6.0 56.7 18.6 1.5 2.9 1.4 4.8 3.9 36.1 2.1 3.1 2.3 3.6 4.3 4.5 3.0 4.7 5.5 80.5 1.8 3.3 1.7 16.2 0.0 1.6 0.0 4.6 2.1 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 72.9 22.0 0.0 0.0 0.0 0.4 0.8 2.7 5.9 53.5 0.2 0.0 0.7 0.5 0.0 28.4 0.0 1.6 0.0 13.0 0.0 0.0 4.1 0.2 0.0 0.8 0.4 0.0 0.3 0.0 0.0 0.8 0.1 0.7 0.0 0.1 0.0 35.7 2.3 0.0 3.5 36.6 0.3 0.0 109.3 53.1 0.0 0.2 0.3 0.4 0.0 0.0 0.0 12.4 0.6 0.0 7.2 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 53.6 63.1 23.2 39.2 34.3 48.6 56.7 18.6 36.1 16.2 TUBB3 "beta-4, CFEOM3, CFEOM3A, FEOM3" ENSG00000258947 "Tubulin beta 3 class III" Q13509 16 89921392-89938761 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 85.1" "Cell line enhanced" "Detected in many" "A549: 65.2;SCLC-21H: 66.4;SH-SY5Y: 67.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "naive B-cell: 5.2" "Lineage enriched" "Detected in single" 7 "B-cells: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Approved 250000000 "HPA043640: , HPA046280: " "unprognostic (7.08e-2)" "unprognostic (3.37e-4)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "unprognostic (8.01e-2)" "unprognostic (3.12e-2)" "unprognostic (4.04e-3)" "unprognostic (1.12e-3)" "unprognostic (1.22e-2)" "unprognostic (6.06e-2)" "unprognostic (1.99e-2)" "unprognostic (1.38e-2)" "unprognostic (7.57e-2)" "unprognostic (1.27e-3)" "unprognostic (3.70e-2)" "unprognostic (3.05e-1)" "unprognostic (1.91e-2)" 5.1 19.4 23.9 8.9 23.3 3.2 1.2 24.1 85.1 2.4 4.1 7.8 0.0 3.6 7.9 1.1 2.2 1.0 7.3 1.8 25.0 66.5 1.1 1.1 1.6 5.7 44.5 15.9 1.1 2.5 1.0 9.9 2.2 60.9 1.6 2.8 5.5 1.9 1.3 1.0 4.1 4.8 9.3 12.9 1.1 2.5 11.2 3.3 0.0 1.0 1.7 4.4 5.3 0.6 5.2 0.7 0.2 0.3 0.0 0.2 0.2 4.5 65.2 24.3 27.6 2.9 28.0 1.0 27.9 4.8 16.9 7.7 8.8 8.4 13.8 14.6 21.1 17.2 23.4 4.1 4.3 3.4 2.3 0.1 5.5 57.7 0.9 0.0 10.8 16.0 1.2 25.8 2.2 13.8 1.4 0.4 19.2 43.4 0.1 4.6 42.6 35.8 0.0 8.5 1.4 20.9 1.3 66.4 67.0 39.2 0.7 19.0 2.1 0.2 17.4 23.1 24.9 30.9 28.2 0.2 2.8 5.2 23.9 1.7 40.8 0.2 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.2 0.0 5.2 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.2 23.9 23.3 24.1 51.0 25.0 66.5 44.5 15.9 60.9 3.3 TUBB8P12 ENSG00000173213 "Tubulin beta 8 pseudogene 12" A6NNZ2 18 47390-49557 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 7.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.3;Hep G2: 2.1;MCF7: 1.7;T-47d: 2.3;U-266/70: 1.7;U-266/84: 1.9" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.7" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.3;neutrophil: 1.1" "Low lineage specificity" "Detected in many" "HPA043640, HPA046280" Uncertain "HPA043640: , HPA046280: " "unprognostic (4.34e-1)" "unprognostic (3.15e-2)" "unprognostic (1.29e-1)" "unprognostic (6.73e-2)" "unprognostic (1.76e-1)" "unprognostic (6.91e-2)" "unprognostic (1.92e-1)" "unprognostic (4.36e-2)" "unprognostic (1.29e-1)" "unprognostic (2.09e-1)" "unprognostic (4.46e-2)" "unprognostic (7.42e-4)" "unprognostic (3.96e-2)" "unprognostic (5.98e-2)" "unprognostic (4.88e-2)" "unprognostic (3.21e-2)" "unprognostic (1.78e-1)" 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.5 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.0 1.3 0.1 0.3 0.5 0.8 0.3 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.3 7.4 0.1 0.1 0.6 0.1 0.4 0.0 1.1 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 2.1 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.7 0.1 2.3 0.0 0.0 0.0 0.0 0.6 0.0 1.7 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 TULP1 "LCA15, RP14, TUBL1" ENSG00000112041 "Tubby like protein 1" O00294 6 35497874-35512938 "Disease related genes, Predicted intracellular proteins" "Phagocytosis, Sensory transduction, Vision" "Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "retina: 56.1" "Cell line enhanced" "Detected in some" "BEWO: 7.3;MCF7: 4.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 4 "hippocampal formation: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" "unprognostic (7.98e-2)" "unprognostic (2.33e-2)" "unprognostic (4.38e-2)" "unprognostic (4.60e-5)" "unprognostic (2.28e-2)" "unprognostic (3.12e-3)" "unprognostic (3.30e-1)" "unprognostic (5.49e-3)" "unprognostic (1.85e-1)" "unprognostic (2.66e-2)" "unprognostic (7.42e-2)" "unprognostic (1.66e-6)" "unprognostic (1.72e-1)" "unprognostic (1.30e-1)" "unprognostic (5.42e-2)" "unprognostic (4.11e-2)" 0.3 0.2 0.3 0.6 0.5 0.0 0.3 0.3 0.3 1.0 0.3 0.3 0.3 0.0 1.2 2.3 0.7 1.4 0.3 0.3 2.4 0.0 0.3 0.3 0.3 0.3 0.3 0.3 1.3 0.3 0.0 0.6 0.8 0.4 2.7 0.0 56.1 1.1 1.9 0.3 2.5 0.3 0.3 0.3 0.3 0.2 0.9 0.3 0.3 0.3 0.3 0.3 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 7.3 0.1 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.4 0.1 0.2 0.0 1.1 0.0 0.0 0.4 0.3 0.0 0.1 0.4 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.3 2.4 0.0 0.3 0.3 0.4 0.3 TUNAR "HI-LNC78, LINC00617, TUNA" ENSG00000250366 "TCL1 upstream neural differentiation-associated RNA" 14 95876392-95925571 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 28.7" "Group enriched" "Detected in some" 4 "AF22: 4.8;EFO-21: 2.8;NTERA-2: 10.0;SCLC-21H: 10.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.28e-3)" "unprognostic (3.94e-1)" "unprognostic (4.10e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-2)" "unprognostic (1.34e-1)" "prognostic favourable (1.55e-4)" "unprognostic (5.33e-2)" "unprognostic (2.92e-2)" "unprognostic (1.18e-1)" 0.2 0.2 0.9 0.2 18.6 0.5 0.4 1.2 8.8 0.4 0.3 1.3 0.0 0.5 3.7 0.2 0.2 5.1 0.5 0.3 6.0 0.3 0.2 0.2 0.4 0.0 3.7 0.2 6.1 0.2 0.0 0.3 28.7 0.2 0.4 0.7 0.2 3.4 0.2 0.7 0.2 0.3 1.3 0.2 0.3 1.1 6.8 0.0 0.9 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 1.6 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 10.0 0.0 0.4 0.0 0.0 0.2 0.0 10.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 TXNDC2 SPTRX1 ENSG00000168454 "Thioredoxin domain containing 2" Q86VQ3 18 9885726-9889275 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 73.0" "Cell line enhanced" "Detected in some" "K-562: 4.5;U-2 OS: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.9" "Low lineage specificity" "Detected in many" "CAB016414, HPA018817" Enhanced "CAB016414: , HPA018817: AB_2241329" "unprognostic (1.21e-2)" "unprognostic (3.55e-3)" "unprognostic (6.31e-2)" "unprognostic (5.25e-2)" "unprognostic (1.33e-1)" "unprognostic (1.25e-1)" "unprognostic (6.13e-1)" "unprognostic (1.21e-1)" "unprognostic (3.17e-2)" "unprognostic (8.95e-3)" "unprognostic (3.75e-2)" "unprognostic (1.13e-2)" "unprognostic (1.88e-1)" "unprognostic (1.71e-1)" "unprognostic (2.18e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.9 2.9 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.7 0.3 0.8 0.0 1.1 0.4 0.8 0.0 0.2 0.0 0.3 0.4 0.1 0.4 0.0 0.9 0.2 0.6 1.7 1.1 0.0 2.2 0.2 2.4 0.1 0.1 1.1 0.0 0.5 4.5 0.0 0.3 0.3 0.0 0.4 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.8 1.2 0.9 3.8 1.7 1.2 0.1 0.3 0.0 1.4 0.0 0.7 0.0 0.6 0.9 0.0 2.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TXNDC8 "bA427L11.2, SPTRX-3, TRX6" ENSG00000204193 "Thioredoxin domain containing 8" Q6A555 9 110303521-110337884 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 23.9" "Cell line enhanced" "Detected in some" "Daudi: 1.3;HeLa: 1.4;NTERA-2: 1.0;SK-BR-3: 1.4;THP-1: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.4" "Low region specificity" "Detected in single" "unprognostic (1.50e-1)" "unprognostic (1.13e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TYRP1 "b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP" ENSG00000107165 "Tyrosinase related protein 1" P17643 9 12685439-12710290 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Melanin biosynthesis" "Monooxygenase, Oxidoreductase" "Albinism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 277.3" "Cell line enriched" "Detected in some" 52 "SK-MEL-30: 173.5" "Cancer enriched" "Detected in some" 262 "melanoma: 313.2" "Region enriched" "Detected in some" 5 "pons and medulla: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "olfactory region: 5.6;thalamus: 2.0" "Low region specificity" "Detected in all" "HPA000937, CAB002520" Enhanced Supported Vesicles 16000 Vesicles "CAB002520: AB_564153, HPA000937: AB_1080437" "unprognostic (7.48e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-1)" "unprognostic (3.16e-3)" "unprognostic (8.10e-2)" "unprognostic (3.82e-3)" "unprognostic (1.53e-1)" "unprognostic (2.25e-3)" "unprognostic (4.46e-1)" "unprognostic (8.71e-2)" "unprognostic (6.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.68e-6)" "unprognostic (1.27e-1)" "unprognostic (5.99e-2)" "unprognostic (1.95e-2)" 0.2 0.0 0.2 0.2 0.3 0.0 1.7 0.2 1.0 0.2 0.5 1.3 0.2 1.6 0.2 0.3 3.6 0.2 1.4 21.5 0.9 0.1 5.7 0.2 2.1 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 5.0 0.2 1.8 277.3 1.1 0.2 1.3 51.1 1.4 0.4 1.1 0.2 0.6 0.5 0.2 0.2 0.2 0.9 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 173.5 2.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 1.0 0.9 0.1 0.2 0.3 5.0 0.2 UBAC1 "GBDR1, KPC2, UBADC1" ENSG00000130560 "UBA domain containing 1" Q9BSL1 9 135932969-135961380 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 113.2" "Cell line enhanced" "Detected in all" "HDLM-2: 59.3;K-562: 75.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005651 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" 54000 "Plasma membrane, Cytosol" "Golgi apparatus" "HPA005651: AB_1858489" "unprognostic (8.41e-2)" "prognostic favourable (4.34e-6)" "unprognostic (2.10e-1)" "unprognostic (9.15e-2)" "unprognostic (4.11e-1)" "unprognostic (3.85e-2)" "unprognostic (7.68e-3)" "unprognostic (2.85e-1)" "unprognostic (4.37e-2)" "unprognostic (3.23e-1)" "unprognostic (3.92e-3)" "unprognostic (1.20e-1)" "prognostic favourable (3.58e-7)" "unprognostic (1.95e-3)" "unprognostic (9.46e-2)" "unprognostic (3.16e-2)" "unprognostic (5.78e-2)" 7.6 5.7 12.4 5.8 13.4 27.1 6.2 10.9 12.7 6.1 11.0 8.0 6.8 9.9 6.2 10.3 10.0 9.4 5.1 22.2 11.0 8.6 8.8 7.6 6.4 5.8 11.6 7.4 7.8 6.7 6.9 6.6 9.3 8.7 7.4 7.8 7.7 9.2 9.2 113.2 15.7 9.6 9.3 10.1 5.7 6.1 10.9 7.8 3.9 6.1 21.9 9.0 7.6 8.3 3.2 9.7 5.1 18.8 2.2 3.6 4.0 8.9 10.5 7.5 10.8 5.6 6.6 14.0 7.9 6.7 9.8 7.9 14.5 11.5 10.8 7.6 6.4 30.7 10.4 9.1 4.4 59.3 9.8 9.0 18.9 8.1 5.9 11.7 8.7 6.2 12.0 6.2 6.0 8.1 75.2 8.8 7.7 18.5 9.6 12.1 17.7 17.9 10.8 14.1 14.3 7.0 5.8 11.6 12.8 11.4 10.3 8.0 8.7 12.7 6.6 5.6 8.4 6.6 9.7 5.1 9.6 12.9 10.3 10.7 7.6 3.4 11.3 5.1 3.1 17.2 3.3 3.2 3.6 2.1 9.7 2.0 1.9 2.2 2.5 2.2 18.8 1.0 2.7 4.0 12.4 13.4 10.9 12.7 11.0 8.6 11.6 7.4 8.7 7.8 UBAP1L ENSG00000246922 "Ubiquitin associated protein 1 like" F5GYI3 15 65092770-65115197 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "retina: 91.1" "Cell line enhanced" "Detected in some" "SK-MEL-30: 6.8;U-266/70: 3.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 10 "cerebellum: 49.0;pons and medulla: 8.6" HPA065334 Uncertain "Nuclear bodies" "Nuclear bodies" "HPA065334: " "unprognostic (6.89e-3)" "unprognostic (2.62e-1)" "unprognostic (2.66e-3)" "unprognostic (2.73e-2)" "unprognostic (1.64e-1)" "unprognostic (2.98e-3)" "unprognostic (6.59e-2)" "unprognostic (7.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.56e-1)" "unprognostic (5.62e-5)" "unprognostic (6.40e-3)" "unprognostic (3.11e-6)" "unprognostic (5.03e-2)" "unprognostic (1.39e-1)" "unprognostic (3.70e-1)" "unprognostic (6.11e-3)" 1.4 1.5 2.4 0.9 2.4 1.1 1.3 11.5 3.6 1.5 0.9 0.9 0.9 0.4 2.7 1.1 1.2 1.5 0.9 0.9 2.8 3.2 0.9 1.1 1.0 1.1 2.6 0.9 3.2 1.0 0.5 0.9 0.9 3.6 1.1 0.2 91.1 2.0 1.8 6.2 1.5 1.1 1.2 3.1 2.0 0.9 1.5 0.9 0.9 1.2 0.9 2.2 0.9 0.9 0.1 1.3 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.8 2.0 0.6 0.2 1.8 1.3 0.1 0.6 0.6 1.1 0.3 0.9 1.6 0.2 1.4 1.1 0.1 0.0 1.7 1.1 0.1 1.1 0.2 0.8 1.0 0.9 0.6 0.9 0.3 0.4 0.2 0.5 0.7 0.2 0.2 0.3 1.2 0.7 0.7 1.5 0.5 1.1 0.0 0.3 1.0 0.6 0.6 0.2 6.8 0.4 1.0 0.0 0.6 0.3 0.6 0.6 3.6 0.6 0.4 0.4 0.7 0.5 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.4 0.0 1.3 0.0 0.0 2.4 2.4 11.5 3.1 2.8 3.2 2.6 0.9 3.6 0.9 UBE2C UBCH10 ENSG00000175063 "Ubiquitin conjugating enzyme E2 C" O00762 20 45812576-45816957 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 130.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "CAB011464, HPA034569, CAB035990, HPA054975" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB011464: AB_442965, CAB035990: , HPA034569: , HPA054975: " "unprognostic (1.45e-2)" "unprognostic (2.19e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.35e-1)" "prognostic unfavourable (6.24e-6)" "unprognostic (2.27e-3)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (6.91e-4)" "unprognostic (3.76e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (3.09e-1)" "unprognostic (3.61e-1)" "unprognostic (4.65e-2)" "unprognostic (2.68e-1)" 3.1 2.3 0.4 24.0 0.9 25.1 4.3 0.4 0.7 3.8 9.5 0.4 0.8 7.8 2.0 2.6 25.6 0.6 3.2 2.8 0.5 0.4 2.1 2.1 4.6 15.6 0.6 0.5 1.2 1.3 0.0 0.6 12.6 0.9 1.3 11.7 0.7 3.7 0.6 1.0 8.3 10.0 3.5 1.2 11.6 7.0 15.3 0.5 130.8 0.8 17.6 26.3 2.8 7.8 1.2 0.9 2.7 0.6 2.4 10.0 4.2 39.2 28.8 52.0 24.9 1.4 3.2 29.9 31.2 15.8 51.4 36.9 94.6 45.4 41.6 30.6 14.8 38.8 0.2 33.4 52.5 17.7 27.4 12.8 22.1 24.8 0.4 18.3 32.2 1.0 3.6 34.8 34.1 25.0 0.2 35.4 42.3 64.6 30.2 5.2 31.2 69.0 32.1 47.1 0.2 17.3 13.6 30.0 25.0 49.1 36.0 19.7 36.3 27.0 9.1 46.1 40.3 31.3 60.3 11.2 0.3 46.4 28.0 13.1 43.7 0.0 0.1 0.0 0.2 0.0 0.0 1.2 1.2 2.3 0.9 0.2 0.2 0.1 2.7 2.4 0.6 0.5 10.0 4.2 0.4 0.9 0.4 0.7 0.5 0.4 0.6 0.5 0.9 0.5 UBE2L5 UBE2L5P ENSG00000236444 "Ubiquitin conjugating enzyme E2 L5" 13 30422488-30428616 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 31.5" "Low cell line specificity" "Detected in some" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA045609, HPA062415" Approved Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA045609: AB_10961322, HPA062415: " "unprognostic (2.09e-1)" "unprognostic (1.18e-2)" "unprognostic (8.01e-3)" "unprognostic (6.41e-4)" "unprognostic (1.78e-1)" "unprognostic (7.13e-2)" "unprognostic (2.20e-1)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (6.49e-3)" "unprognostic (1.78e-1)" "unprognostic (8.00e-2)" "unprognostic (3.50e-2)" "unprognostic (9.37e-2)" "unprognostic (2.60e-1)" "unprognostic (2.44e-2)" "unprognostic (8.75e-2)" 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.3 0.3 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.7 0.3 0.2 0.2 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 31.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.2 1.9 2.7 3.6 1.9 2.0 2.8 0.6 0.3 1.2 1.6 0.6 0.6 0.6 1.1 0.6 0.4 0.2 0.0 3.0 1.4 0.5 1.3 0.6 0.8 0.4 1.1 2.4 0.6 0.4 0.8 0.2 0.2 0.7 1.5 0.2 0.3 0.6 0.2 0.9 0.7 1.3 0.3 0.0 1.6 2.5 1.3 0.2 0.4 0.6 0.4 0.9 1.5 1.2 0.3 0.4 0.1 1.8 0.6 2.4 0.0 0.7 0.5 0.7 1.1 1.5 0.3 1.6 1.0 0.9 0.4 1.8 1.1 1.9 1.4 3.6 1.2 3.2 1.5 1.6 1.5 1.7 1.4 2.0 2.7 1.9 1.6 1.9 2.0 2.8 UBE2U MGC35130 ENSG00000177414 "Ubiquitin conjugating enzyme E2 U (putative)" Q5VVX9 1 64203627-64267368 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 31.8" "Cell line enhanced" "Detected in some" "EFO-21: 2.3;U-266/84: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 19.5" "unprognostic (9.44e-4)" "unprognostic (5.52e-2)" "unprognostic (1.81e-1)" "unprognostic (2.37e-1)" "unprognostic (4.01e-2)" "unprognostic (3.63e-1)" "unprognostic (7.69e-2)" 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 UBL4B FLJ25690 ENSG00000186150 "Ubiquitin like 4B" Q8N7F7 1 110112468-110113945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 79 "testis: 65.3" "Cell line enriched" "Detected in some" 5 "BJ hTERT+: 21.0" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031364 Enhanced "HPA031364: AB_10604000" "unprognostic (2.92e-1)" "unprognostic (3.48e-2)" "unprognostic (3.53e-1)" "unprognostic (9.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.24e-2)" "unprognostic (1.29e-2)" "unprognostic (3.43e-2)" "unprognostic (6.87e-3)" "unprognostic (4.46e-1)" "unprognostic (2.20e-9)" "unprognostic (3.29e-2)" "unprognostic (7.39e-2)" "unprognostic (1.59e-4)" "unprognostic (3.90e-2)" 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 65.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 UBQLN3 TUP-1 ENSG00000175520 "Ubiquilin 3" Q9H347 11 5507300-5509985 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 130 "testis: 86.9" "Cell line enhanced" "Detected in single" "U-2197: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020547, HPA062018" Enhanced "HPA020547: AB_1858577, HPA062018: " "unprognostic (3.79e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 UBQLNL "MGC20470, MGC26958" ENSG00000175518 "Ubiquilin like" Q8IYU4 11 5514393-5516705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 31.9" "Cell line enhanced" "Detected in some" "HSkMC: 1.7;hTCEpi: 2.6;REH: 1.7;SK-BR-3: 2.6;U-266/70: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.6" "unprognostic (2.86e-1)" "unprognostic (1.79e-1)" "unprognostic (2.98e-4)" "unprognostic (1.43e-1)" "unprognostic (6.17e-2)" "unprognostic (7.60e-2)" "unprognostic (7.69e-2)" "unprognostic (2.22e-2)" "unprognostic (3.64e-1)" "unprognostic (1.17e-3)" "unprognostic (1.73e-1)" "unprognostic (1.54e-1)" "unprognostic (1.52e-8)" "unprognostic (1.17e-1)" "unprognostic (9.16e-2)" "unprognostic (1.17e-1)" "unprognostic (9.69e-5)" 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.6 0.6 0.3 0.2 0.2 0.1 0.5 1.2 0.2 0.4 0.2 0.2 0.2 0.0 0.5 0.4 0.3 0.2 0.2 0.2 1.6 0.3 0.1 0.2 0.2 0.2 0.8 0.1 0.2 0.3 0.2 0.2 0.5 0.3 0.3 0.2 0.8 0.1 31.9 0.2 0.2 0.6 0.2 0.2 0.2 0.4 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.0 1.1 0.7 0.5 0.2 0.5 0.3 0.4 0.0 0.6 0.0 0.2 0.6 0.2 0.2 0.3 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.5 0.3 1.7 2.6 0.0 0.1 0.0 0.1 0.0 0.4 0.2 0.0 1.1 0.0 0.7 1.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 2.6 0.3 0.0 0.0 0.3 0.1 1.1 0.0 0.0 1.7 0.4 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.2 0.0 0.2 0.2 0.2 0.2 UCHL1 "PARK5, PGP9.5, Uch-L1" ENSG00000154277 "Ubiquitin C-terminal hydrolase L1" P09936 4 41256413-41268455 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 225.8" "Cell line enhanced" "Detected in many" "EFO-21: 97.1;SCLC-21H: 96.9;U-251 MG: 88.7;U-266/84: 85.5;U-87 MG: 94.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 3.6" "Lineage enriched" "Detected in single" 37 "B-cells: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002580, HPA005993, CAB079024" Enhanced Supported Supported Nucleoplasm,Cytosol 440000 Cytosol Nucleoplasm "CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560" "unprognostic (1.54e-1)" "unprognostic (1.96e-1)" "unprognostic (1.12e-1)" "prognostic unfavourable (4.08e-5)" "unprognostic (2.34e-1)" "unprognostic (1.98e-1)" "unprognostic (6.28e-3)" "unprognostic (1.09e-2)" "unprognostic (4.31e-2)" "unprognostic (8.77e-3)" "unprognostic (3.56e-3)" "unprognostic (3.70e-2)" "unprognostic (1.82e-3)" "unprognostic (1.24e-2)" "unprognostic (7.12e-3)" "unprognostic (2.10e-2)" "prognostic unfavourable (1.93e-4)" 8.2 40.2 52.4 8.9 65.1 2.0 3.1 17.5 225.8 4.5 6.3 11.5 0.0 5.5 6.0 1.8 2.7 5.7 6.5 5.4 53.4 97.4 14.0 2.0 2.7 6.5 62.0 57.1 15.4 6.3 1.8 30.5 2.7 100.6 5.3 4.7 6.0 3.0 4.4 7.5 2.7 8.6 5.2 38.6 2.3 2.8 8.0 8.3 0.0 3.9 0.0 4.5 5.6 2.8 3.6 0.0 0.0 0.0 0.0 0.0 0.6 0.2 55.0 11.4 0.0 1.5 1.9 0.0 57.6 29.7 20.4 20.6 11.1 0.0 0.0 97.1 29.3 0.1 21.0 0.0 8.3 0.1 8.6 0.0 0.3 0.0 44.0 0.0 0.0 10.6 0.2 16.3 0.0 0.1 0.0 0.2 10.8 0.0 0.0 0.9 32.9 62.2 0.0 24.4 0.0 30.8 0.0 96.9 60.9 0.3 0.2 0.1 0.0 0.4 0.3 1.3 0.4 0.0 88.7 45.5 85.5 0.2 94.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 52.4 65.1 17.5 92.6 53.4 97.4 62.0 57.1 100.6 8.3 UCP3 SLC25A9 ENSG00000175564 "Uncoupling protein 3" P55916 11 74000281-74009435 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 99.6" "Cell line enriched" "Detected in many" 4 "HDLM-2: 17.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 4 "cerebellum: 1.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010771, HPA072225" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "CAB010771: AB_261839, HPA072225: " "unprognostic (3.76e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-1)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-2)" "unprognostic (3.95e-3)" "unprognostic (6.61e-2)" "unprognostic (1.25e-1)" "unprognostic (8.58e-2)" "unprognostic (2.13e-4)" "unprognostic (1.61e-2)" "unprognostic (3.25e-6)" "unprognostic (2.68e-1)" "unprognostic (1.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.50e-4)" 0.9 0.2 0.2 0.3 0.2 0.6 0.2 1.1 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.5 0.9 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 1.0 0.2 99.6 0.3 0.2 0.2 0.2 0.5 0.1 0.6 0.2 0.2 0.6 6.4 0.8 0.2 0.2 0.8 0.1 0.7 0.3 0.2 2.1 0.4 0.2 2.0 2.0 1.7 0.8 0.4 0.4 0.5 0.5 0.5 0.3 0.5 0.4 1.0 0.3 0.4 2.2 0.8 0.4 0.8 17.8 0.7 0.4 2.4 0.2 0.6 1.2 1.7 0.5 1.4 1.3 0.1 0.6 0.5 1.4 0.7 1.2 0.8 1.6 1.0 1.4 1.6 4.2 0.6 1.1 0.6 1.2 1.2 0.5 0.9 0.7 0.2 1.1 0.4 0.3 1.4 0.6 1.2 1.6 1.7 0.8 0.3 1.1 0.6 0.0 0.3 0.7 2.1 0.1 0.9 0.0 1.5 1.8 0.0 0.8 0.6 1.2 0.1 0.2 0.0 0.1 0.4 0.4 0.2 0.2 1.1 0.2 0.2 0.1 0.2 0.2 0.2 0.2 UGDH ENSG00000109814 "UDP-glucose 6-dehydrogenase" O60701 4 39498755-39528311 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 125.8" "Cell line enhanced" "Detected in all" "A549: 84.2;Hep G2: 97.5;U-2197: 60.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034444, HPA036656, HPA036657" Enhanced Supported Nucleoplasm 42000 Nucleoplasm "CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360" "unprognostic (1.22e-2)" "unprognostic (1.62e-1)" "unprognostic (2.73e-2)" "unprognostic (3.96e-2)" "unprognostic (5.54e-2)" "unprognostic (1.63e-1)" "unprognostic (8.78e-3)" "unprognostic (6.07e-2)" "unprognostic (1.34e-1)" "unprognostic (1.41e-1)" "unprognostic (9.81e-3)" "unprognostic (6.86e-2)" "prognostic unfavourable (5.51e-10)" "unprognostic (2.48e-1)" "unprognostic (2.04e-1)" "unprognostic (1.66e-1)" "unprognostic (4.97e-2)" 25.9 11.3 4.4 24.7 3.2 0.2 12.7 4.0 3.1 13.0 29.3 3.8 10.2 13.7 11.5 9.7 22.9 9.9 12.9 10.1 3.6 3.5 28.2 125.8 13.5 4.7 4.0 2.2 20.6 24.9 5.1 4.7 26.8 5.3 13.2 23.3 7.5 8.2 7.3 7.5 5.5 24.2 17.7 3.7 3.3 14.1 5.0 3.8 1.7 16.7 12.7 7.1 30.2 24.1 12.0 12.3 17.1 12.0 21.8 22.4 10.2 4.8 84.2 9.3 12.1 30.4 33.8 7.8 16.0 19.1 15.9 14.6 11.8 18.2 3.1 10.1 22.2 5.0 9.6 4.5 16.7 3.9 1.7 3.4 10.9 97.5 12.0 4.2 3.5 11.3 2.5 27.1 8.5 10.1 4.5 2.6 10.9 14.3 4.1 4.6 7.5 6.2 7.1 14.4 3.1 8.7 19.3 4.7 6.9 9.9 5.8 6.7 3.2 3.5 11.8 16.3 7.6 60.6 7.6 5.9 4.3 3.1 13.7 3.6 8.5 17.1 12.0 10.9 14.3 10.6 22.4 10.9 11.4 14.8 10.7 12.0 9.8 12.0 2.3 21.8 6.1 12.3 7.3 10.2 4.4 3.2 4.0 3.0 3.6 3.5 4.0 2.2 5.3 3.8 UGT1A3 UGT1C ENSG00000243135 "UDP glucuronosyltransferase family 1 member A3" P35503 2 233729108-233773299 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "liver: 40.6" "Cell line enriched" "Detected in some" 9 "HaCaT: 16.4" "Cancer enriched" "Detected in single" 6 "liver cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.15e-2)" "unprognostic (9.93e-2)" "unprognostic (2.97e-1)" "unprognostic (4.59e-2)" "unprognostic (1.04e-4)" "unprognostic (8.22e-2)" "unprognostic (2.08e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT1A4 "HUG-BR2, UGT1D" ENSG00000244474 "UDP glucuronosyltransferase family 1 member A4" P22310 2 233718778-233773299 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 51 "liver: 99.4" "Cell line enhanced" "Detected in some" "HaCaT: 1.6;HL-60: 1.3;RH-30: 2.2" "Cancer enriched" "Detected in single" 487 "liver cancer: 24.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (9.89e-3)" "unprognostic (6.77e-5)" "unprognostic (2.59e-1)" "unprognostic (3.50e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 99.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 2.2 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT1A9 "HLUGP4, LUGP4, UGT1AI" ENSG00000241119 "UDP glucuronosyltransferase family 1 member A9" O60656 2 233671853-233773300 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 169.8" "Group enriched" "Detected in some" 20 "A549: 4.8;RT4: 3.9" "Group enriched" "Detected in some" 157 "liver cancer: 16.1;renal cancer: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.46e-2)" "unprognostic (3.56e-1)" "prognostic unfavourable (5.04e-5)" "unprognostic (4.26e-2)" "unprognostic (1.60e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 169.8 39.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2B10 ENSG00000109181 "UDP glucuronosyltransferase family 2 member B10" P36537 4 68815993-68831196 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 277 "liver: 120.4" "Cell line enriched" "Detected in single" 39 "Hep G2: 15.8" "Cancer enriched" "Detected in single" 296 "liver cancer: 93.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045108 Uncertain "HPA045108: " "unprognostic (3.50e-3)" "unprognostic (1.92e-3)" "unprognostic (4.17e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 120.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2B11 ENSG00000213759 "UDP glucuronosyltransferase family 2 member B11" O75310 4 69199951-69214731 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "breast: 77.4" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;HL-60: 3.0;NB-4: 2.4;RPTEC TERT1: 3.6;U-2197: 1.4" "Group enriched" "Detected in some" 17 "breast cancer: 17.4;liver cancer: 13.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 62 "basophil: 6.8;eosinophil: 5.6" "Lineage enriched" "Detected in single" 68 "granulocytes: 6.8" HPA045108 Uncertain "HPA045108: " "unprognostic (1.12e-1)" "unprognostic (1.18e-3)" "unprognostic (1.49e-1)" "unprognostic (6.53e-2)" "unprognostic (2.26e-2)" "unprognostic (1.65e-1)" "unprognostic (7.84e-3)" "unprognostic (5.47e-1)" "unprognostic (1.32e-1)" "unprognostic (1.51e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 77.4 0.1 0.1 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.0 3.3 0.1 0.1 0.0 1.2 7.3 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 7.0 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 3.6 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 6.8 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 UGT2B4 UGT2B11 ENSG00000156096 "UDP glucuronosyltransferase family 2 member B4" P06133 4 69480165-69526014 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 105 "liver: 175.1" "Cell line enriched" "Detected in some" 9 "RH-30: 10.1" "Cancer enriched" "Detected in some" 96 "liver cancer: 351.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB033260, HPA045108" Enhanced "Intracellular and membrane" "CAB033260: AB_2241496, HPA045108: " "unprognostic (7.46e-2)" "unprognostic (1.50e-1)" "unprognostic (9.37e-2)" "unprognostic (1.51e-1)" "unprognostic (2.47e-2)" "unprognostic (1.47e-1)" "unprognostic (9.43e-3)" "unprognostic (3.52e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.1 175.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.1 0.1 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT8 CGT ENSG00000174607 "UDP glycosyltransferase 8" Q16880 4 114598455-114678224 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 96.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.3;RH-30: 12.1;RPTEC TERT1: 25.0;SCLC-21H: 14.2;U-87 MG: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 7.3;naive B-cell: 10.6" "Lineage enriched" "Detected in single" 12 "B-cells: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014405, HPA065785" Enhanced Approved Mitochondria Mitochondria "HPA014405: AB_1858606, HPA065785: " "unprognostic (7.38e-3)" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (2.38e-1)" "unprognostic (1.63e-1)" "unprognostic (1.63e-2)" "unprognostic (1.16e-2)" "unprognostic (2.38e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-3)" "unprognostic (4.49e-2)" "unprognostic (2.76e-1)" "prognostic favourable (8.55e-5)" "unprognostic (2.80e-1)" "unprognostic (1.78e-2)" "unprognostic (7.53e-2)" "unprognostic (1.49e-1)" 0.9 0.8 13.2 2.8 30.0 1.0 3.1 2.7 44.8 4.9 15.5 66.6 0.0 18.4 2.7 0.6 1.2 3.0 7.1 0.9 24.2 12.4 20.1 0.8 1.0 3.2 53.9 15.9 0.8 4.8 0.3 0.9 0.5 38.3 0.9 17.3 0.0 4.5 0.8 0.8 1.8 16.1 1.5 96.6 1.3 10.0 3.3 42.6 0.0 8.5 0.0 3.4 0.8 1.0 10.6 0.0 0.9 0.0 0.0 0.6 0.3 0.3 0.1 2.0 0.3 0.1 0.0 0.3 0.1 0.0 0.0 1.5 6.8 25.3 7.6 0.6 0.1 10.7 0.0 0.0 0.0 0.1 5.3 0.1 11.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 6.4 1.5 0.0 0.1 0.1 0.8 3.0 3.8 0.7 12.1 0.2 25.0 0.3 14.2 2.1 0.1 2.2 0.3 0.4 2.4 0.5 0.5 8.6 0.3 7.9 2.5 0.4 0.2 12.5 0.4 7.8 0.2 0.0 0.9 0.0 0.0 0.6 7.3 0.1 0.0 0.0 10.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.3 13.2 30.0 2.7 24.4 24.2 12.4 53.9 15.9 38.3 42.6 UHRF1 "FLJ21925, ICBP90, Np95, RNF106, TDRD22" ENSG00000276043 "Ubiquitin like with PHD and ring finger domains 1" Q96T88 19 4903080-4962154 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 75.6" "Cell line enhanced" "Detected in many" "MOLT-4: 62.6;REH: 142.1" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.2" "Group enriched" "Detected in many" 4 "dendritic cells: 8.2;T-cells: 4.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA049408, HPA055446" Enhanced Supported Nucleoplasm Nucleoplasm "HPA049408: AB_2756317, HPA055446: AB_2732597" "unprognostic (3.83e-2)" "unprognostic (6.83e-3)" "unprognostic (5.13e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (7.21e-2)" "prognostic unfavourable (1.63e-4)" "unprognostic (4.30e-2)" "prognostic unfavourable (6.81e-4)" "unprognostic (2.82e-1)" "prognostic unfavourable (4.52e-5)" "unprognostic (2.33e-3)" "unprognostic (0.00e+0)" "unprognostic (3.75e-3)" "unprognostic (2.45e-1)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" 0.7 0.0 0.7 8.2 3.7 16.5 0.7 0.3 4.2 0.3 1.5 1.6 0.0 2.1 0.3 0.2 2.0 0.0 1.0 0.9 1.2 0.1 0.1 0.3 10.0 4.3 0.7 0.3 0.6 0.0 0.0 1.0 1.4 0.0 1.4 0.0 0.0 0.0 0.3 1.9 2.2 0.8 0.7 2.2 1.9 3.1 4.0 75.6 0.0 4.0 6.6 1.1 0.0 0.4 8.2 1.5 0.4 0.9 4.2 0.9 15.6 11.3 17.2 12.2 0.5 2.0 2.7 12.7 6.1 13.3 12.9 13.5 7.9 8.9 3.1 5.6 7.8 11.8 6.9 9.4 14.4 13.4 7.7 10.6 14.4 0.2 18.9 11.7 0.9 0.5 7.2 1.8 3.9 11.0 10.3 7.9 12.2 62.6 11.6 7.7 12.3 142.1 38.3 6.5 3.6 11.5 12.7 10.1 10.0 5.5 1.7 9.9 18.1 4.9 14.1 11.5 18.2 15.3 4.4 4.5 26.2 8.1 18.4 17.9 0.6 0.4 0.2 1.1 0.1 0.1 0.3 1.5 1.9 2.2 0.4 0.4 1.5 1.5 0.9 0.3 8.2 4.2 0.9 UMOD ENSG00000169344 Uromodulin P07911 16 20333052-20356301 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Ciliopathy, Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 417 "kidney: 237.4" "Cell line enriched" "Detected in single" 32 "EFO-21: 3.8" "Cancer enriched" "Detected in single" 39 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009446, HPA043420, HPA054721" Enhanced "Secreted in other tissues" 83000000 "CAB009446: AB_2212378, HPA043420: AB_2678474, HPA054721: AB_2682585" "unprognostic (2.51e-2)" "unprognostic (1.33e-1)" "unprognostic (6.45e-2)" "unprognostic (3.02e-2)" "unprognostic (1.49e-2)" "unprognostic (1.43e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 237.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 UMODL1 ENSG00000177398 "Uromodulin like 1" Q5DID0 21 42062959-42143453 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 22.7" "Group enriched" "Detected in some" 5 "SCLC-21H: 3.6;U-266/70: 8.9" "Group enriched" "Detected in some" 7 "lung cancer: 0.6;testis cancer: 2.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA067245 Uncertain "HPA067245: " "unprognostic (4.70e-3)" "unprognostic (3.75e-5)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (4.92e-2)" "unprognostic (1.32e-2)" "unprognostic (2.72e-7)" "unprognostic (2.38e-1)" "unprognostic (9.47e-2)" "unprognostic (2.63e-2)" "unprognostic (3.82e-1)" "unprognostic (9.24e-3)" "unprognostic (4.37e-2)" "unprognostic (1.78e-1)" "unprognostic (4.02e-4)" "unprognostic (2.68e-1)" 0.6 0.1 0.4 3.6 0.1 0.3 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 4.9 0.0 0.2 0.2 0.3 0.4 0.4 0.6 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.1 0.8 0.2 3.8 0.0 22.7 0.1 0.0 2.0 0.1 0.0 0.5 0.1 0.3 0.5 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.5 0.5 0.0 0.1 0.3 0.7 0.6 0.0 0.0 0.5 0.0 1.0 0.2 0.4 0.1 0.1 0.3 0.2 0.3 0.0 0.0 0.0 0.0 UNC119 "HRG4, POC7, POC7A" ENSG00000109103 "Unc-119 lipid binding chaperone" Q13432 17 28546707-28552668 "Disease related genes, Predicted intracellular proteins" "Endocytosis, Protein transport, Sensory transduction, Transport, Vision" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "retina: 197.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041912 Enhanced "HPA041912: AB_10795267" "unprognostic (8.93e-2)" "unprognostic (3.34e-1)" "unprognostic (1.98e-1)" "unprognostic (1.14e-3)" "unprognostic (4.95e-3)" "unprognostic (2.10e-1)" "unprognostic (1.44e-2)" "unprognostic (6.64e-2)" "prognostic unfavourable (2.38e-4)" "unprognostic (2.76e-3)" "prognostic favourable (8.09e-5)" "unprognostic (2.65e-1)" "unprognostic (8.08e-3)" "unprognostic (5.51e-3)" "unprognostic (1.87e-1)" "prognostic unfavourable (9.82e-4)" "unprognostic (1.71e-3)" 10.0 12.3 15.0 15.1 16.1 34.8 10.3 16.3 21.6 10.1 8.2 6.8 9.1 8.1 9.3 12.9 11.5 9.5 10.2 9.8 15.4 19.8 14.3 20.7 9.0 18.1 13.3 10.1 10.6 13.5 10.5 12.5 8.3 13.3 12.1 7.6 197.8 17.3 15.0 4.4 15.3 10.2 9.5 6.5 23.7 7.7 22.9 6.4 11.4 12.1 5.7 19.7 11.4 10.3 9.1 22.4 32.3 47.9 4.3 4.9 7.4 12.0 15.2 15.3 21.3 16.2 15.9 7.5 10.0 13.7 18.2 17.2 21.2 4.1 9.9 10.9 15.3 20.1 12.9 14.9 9.8 18.4 24.1 6.9 7.4 6.4 11.1 10.1 21.6 14.5 20.5 13.1 6.5 14.6 7.0 8.2 11.1 19.0 10.0 10.2 14.9 11.1 16.0 25.1 4.3 13.8 13.5 6.0 21.1 14.4 23.5 14.9 18.5 17.6 11.0 10.5 20.1 16.9 9.7 9.5 9.7 2.1 17.3 16.4 9.6 5.2 11.5 28.2 2.2 27.9 2.3 6.8 4.3 3.5 20.0 9.1 4.9 3.4 32.3 4.3 47.9 22.4 3.7 7.4 15.0 16.1 16.3 21.6 15.4 19.8 13.3 10.1 13.3 6.4 UNCX Uncx4.1 ENSG00000164853 "UNC homeobox" A6NJT0 7 1232907-1237318 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 44.8" "Cell line enriched" "Detected in some" 20 "NB-4: 46.1" "Not detected" "Not detected" "Region enriched" "Detected in some" 20 "cerebellum: 44.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 3.6" "Region enriched" "Detected in many" 9 "cerebellum: 19.3" HPA063294 Approved Nucleoplasm Nucleoplasm "HPA063294: " "unprognostic (1.15e-1)" "unprognostic (9.71e-2)" 0.1 0.1 0.0 0.2 0.0 0.1 0.1 44.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 3.5 0.1 0.1 0.1 0.9 0.0 0.1 0.1 0.1 0.3 0.1 2.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.8 0.0 0.0 1.1 0.9 0.0 2.2 0.5 UPB1 BUP1 ENSG00000100024 "Beta-ureidopropionase 1" Q9UBR1 22 24494107-24528390 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 85.7" "Group enriched" "Detected in some" 5 "CACO-2: 10.9;NB-4: 4.5;THP-1: 6.0;U-937: 6.8" "Cancer enriched" "Detected in some" 8 "liver cancer: 25.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 27 "basophil: 11.4;neutrophil: 3.0" "Lineage enriched" "Detected in single" 43 "granulocytes: 11.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA000728 Enhanced 790000 "HPA000728: AB_1080471" "unprognostic (7.27e-2)" "unprognostic (4.57e-3)" "unprognostic (2.27e-1)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" "unprognostic (1.09e-4)" "prognostic favourable (2.30e-7)" "unprognostic (8.41e-2)" "unprognostic (1.06e-1)" "unprognostic (2.93e-1)" "unprognostic (4.89e-6)" "unprognostic (3.82e-2)" "unprognostic (1.93e-2)" "unprognostic (1.81e-1)" "unprognostic (2.56e-1)" "unprognostic (1.99e-1)" "unprognostic (4.63e-3)" 0.1 0.0 0.1 0.1 0.2 1.0 0.1 0.1 0.1 0.1 1.1 0.1 0.1 0.6 0.1 0.5 0.1 0.0 0.1 0.5 0.1 0.0 13.5 85.7 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.2 0.2 1.5 0.1 0.1 0.2 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 11.4 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 10.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.2 0.0 0.3 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.4 0.3 0.1 0.0 0.2 1.1 1.3 0.3 0.0 0.0 6.0 0.5 0.1 0.1 0.0 0.0 1.1 0.0 1.3 1.3 6.8 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 3.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 UROC1 "FLJ31300, HMFN0320" ENSG00000159650 "Urocanate hydratase 1" Q96N76 3 126481281-126517773 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "liver: 50.7" "Cell line enriched" "Detected in some" 8 "NB-4: 9.3" "Cancer enriched" "Detected in single" 100 "liver cancer: 12.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enhanced" "Detected in single" "granulocytes: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069863 Enhanced 510000 "HPA069863: " "unprognostic (1.28e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (7.43e-2)" "unprognostic (6.43e-2)" "unprognostic (1.43e-1)" "unprognostic (2.23e-3)" "unprognostic (2.95e-1)" "unprognostic (2.57e-2)" "unprognostic (7.71e-2)" "unprognostic (9.97e-2)" "unprognostic (3.04e-1)" "unprognostic (3.65e-5)" "unprognostic (3.97e-2)" "unprognostic (2.66e-1)" "unprognostic (5.52e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 50.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP26 ENSG00000134588 "Ubiquitin specific peptidase 26" Q9BXU7 X 133024631-133097109 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 3.8" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (7.92e-4)" "unprognostic (3.59e-2)" "unprognostic (1.99e-2)" "unprognostic (2.08e-1)" 0.1 0.1 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.4 0.1 0.1 0.1 0.1 0.1 3.8 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.5 0.1 0.2 0.3 0.0 0.0 0.5 0.4 0.5 0.4 0.1 0.1 0.2 0.2 0.7 0.1 0.2 0.1 0.7 0.1 0.1 0.1 0.7 0.1 0.2 0.3 1.0 0.3 1.0 0.3 0.1 0.1 0.0 1.5 0.6 0.4 0.1 0.1 0.4 0.4 0.2 0.2 0.1 0.7 0.4 0.3 0.4 0.1 0.0 0.9 0.5 0.5 0.2 0.1 0.1 0.2 0.1 0.7 0.3 0.9 0.1 0.3 0.4 0.9 0.3 0.1 0.2 0.4 0.3 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 USP50 ENSG00000170236 "Ubiquitin specific peptidase 50" Q70EL3 15 50500562-50546708 "Enzymes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "testis: 20.2" "Cell line enhanced" "Detected in some" "HaCaT: 1.2;HEL: 1.1;RH-30: 1.0;SK-BR-3: 1.7;SK-MEL-30: 2.9;U-698: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in single" 9 "hippocampal formation: 0.4" "Low region specificity" "Detected in single" HPA039470 Uncertain "HPA039470: AB_10672964" "unprognostic (7.05e-3)" "unprognostic (2.38e-1)" "unprognostic (2.01e-2)" "unprognostic (4.04e-3)" "unprognostic (3.37e-1)" "unprognostic (2.53e-2)" "unprognostic (3.95e-2)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.42e-1)" "unprognostic (1.85e-1)" "unprognostic (3.81e-2)" "unprognostic (4.65e-2)" "unprognostic (2.47e-1)" "unprognostic (7.49e-4)" "unprognostic (3.03e-1)" 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.2 1.7 2.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.6 1.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP51 ENSG00000247746 "Ubiquitin specific peptidase 51" Q70EK9 X 55484616-55489202 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "epididymis: 34.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 2.4;naive CD4 T-cell: 2.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA001942 Uncertain Approved "Nucleoli fibrillar center,Cytosol" Cytosol "Nucleoli fibrillar center" "HPA001942: AB_1080536" "unprognostic (1.19e-2)" "unprognostic (4.65e-2)" "unprognostic (3.67e-2)" "unprognostic (1.02e-3)" "unprognostic (8.08e-2)" "unprognostic (3.26e-1)" "unprognostic (3.17e-3)" "unprognostic (2.07e-3)" "unprognostic (5.69e-2)" "prognostic favourable (5.70e-4)" "unprognostic (1.01e-3)" "unprognostic (1.27e-1)" "prognostic favourable (2.63e-5)" "unprognostic (2.81e-3)" "unprognostic (5.92e-2)" "unprognostic (5.85e-2)" "unprognostic (1.63e-1)" 0.6 2.7 2.0 0.3 2.9 0.1 0.9 2.3 1.8 1.4 0.6 0.0 1.8 34.1 0.2 3.4 0.3 1.0 1.8 3.7 2.2 0.5 0.7 0.4 1.6 4.1 0.8 3.6 1.8 1.3 1.3 0.3 0.3 1.5 0.0 0.5 0.5 1.1 1.4 0.9 0.3 1.3 3.2 0.5 0.7 0.5 0.9 0.0 2.4 0.0 0.6 2.4 0.1 0.0 0.9 5.7 1.7 2.9 1.5 0.0 0.9 0.5 1.1 1.3 1.8 0.8 0.0 6.9 1.2 0.3 1.5 0.6 1.8 1.8 0.1 1.5 0.3 0.0 1.2 3.5 0.3 5.9 0.1 0.6 0.0 0.4 4.4 4.4 0.9 3.8 3.4 1.8 7.2 0.3 4.9 1.1 2.2 1.4 0.2 0.0 1.1 1.6 0.2 5.4 1.4 1.8 0.3 2.3 3.1 0.6 0.2 7.0 2.7 1.4 1.5 2.0 1.5 0.0 0.0 2.4 0.3 0.0 0.0 0.6 0.6 0.0 0.0 0.9 2.4 0.2 0.0 0.6 0.0 0.0 0.0 0.1 VAX1 ENSG00000148704 "Ventral anterior homeobox 1" Q5SQQ9 10 117128521-117138301 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 21.8" "Group enriched" "Detected in some" 7 "A-431: 7.5;WM-115: 5.7" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 21.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 5.8;hypothalamus: 3.8;olfactory region: 1.8" "Low region specificity" "Detected in many" HPA028946 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA028946: AB_10602679" "unprognostic (1.08e-2)" "unprognostic (1.92e-2)" "unprognostic (1.46e-1)" "unprognostic (2.96e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (5.72e-2)" "unprognostic (2.09e-1)" "unprognostic (2.99e-1)" 0.4 0.4 1.4 0.4 21.8 0.4 0.4 0.0 7.0 0.5 0.5 9.5 0.0 0.4 0.4 0.4 0.5 0.4 0.5 0.4 1.5 5.2 0.4 0.4 0.4 0.4 0.7 4.3 0.4 0.4 0.7 0.5 0.4 1.2 0.4 0.5 0.0 0.4 0.5 0.7 0.4 0.5 0.4 1.3 0.4 0.4 2.1 2.9 0.0 0.4 0.0 0.4 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.5 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 21.8 0.0 7.0 1.5 5.2 0.7 4.3 1.2 2.9 VCX "VCX-10r, VCX-B1, VCX1, VCX10R" ENSG00000182583 "Variable charge, X-linked" Q9H320 X 7842262-7844143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 51 "testis: 22.7" "Cell line enhanced" "Detected in some" "NB-4: 3.7;RPMI-8226: 3.0;THP-1: 3.4;U-138 MG: 3.3;U-266/70: 6.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044996, HPA049357" Supported "HPA044996: , HPA049357: " "unprognostic (1.65e-1)" "unprognostic (3.39e-1)" "unprognostic (1.17e-3)" "unprognostic (1.71e-1)" "unprognostic (1.50e-1)" "unprognostic (2.73e-1)" "unprognostic (7.89e-2)" "unprognostic (6.44e-2)" "unprognostic (1.20e-1)" "unprognostic (7.18e-3)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.4 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.8 0.0 3.7 1.8 0.4 0.5 0.0 3.0 0.0 1.5 0.1 0.2 0.0 0.0 0.0 1.5 3.4 0.0 3.3 0.8 2.2 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 VCX2 VCX-2r ENSG00000177504 "Variable charge, X-linked 2" Q9H322 X 8169944-8171267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 106 "testis: 21.5" "Group enriched" "Detected in some" 5 "T-47d: 1.8;U-266/70: 2.4" "Cancer enhanced" "Detected in some" "stomach cancer: 0.8;testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044642, HPA044996, HPA049357" Enhanced "HPA044642: , HPA044996: , HPA049357: " "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 21.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VCX3A "VCX-8r, VCX-A, VCX3" ENSG00000169059 "Variable charge, X-linked 3A" Q9NNX9 X 6533618-6535118 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 195 "testis: 28.8" "Cell line enhanced" "Detected in some" "HMC-1: 7.3;PC-3: 3.7;U-138 MG: 11.0;U-2197: 2.7;U-266/70: 6.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044996, HPA049357" Supported "HPA044996: , HPA049357: " "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (2.43e-1)" "unprognostic (3.29e-2)" "unprognostic (1.64e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 3.7 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 1.6 0.0 0.0 11.0 0.0 2.7 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VCX3B VCX-C ENSG00000205642 "Variable charge, X-linked 3B" Q9H321 X 8464830-8466510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 61 "testis: 21.7" "Cell line enriched" "Detected in some" 19 "U-138 MG: 20.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044996, HPA049357" Supported "HPA044996: , HPA049357: " "unprognostic (1.60e-1)" "unprognostic (1.25e-1)" "unprognostic (1.67e-1)" "unprognostic (7.51e-2)" "unprognostic (2.07e-1)" "unprognostic (4.19e-3)" "unprognostic (4.41e-2)" "unprognostic (3.06e-2)" "unprognostic (1.99e-1)" "unprognostic (3.58e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 20.4 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VCY "BPY1, VCY1, VCY1A" ENSG00000129864 "Variable charge, Y-linked" O14598 Y 13985772-13986513 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 122 "testis: 31.5" "Cell line enriched" "Detected in single" 6 "U-266/70: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044996, HPA049357" Supported "HPA044996: , HPA049357: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.5 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VCY1B BPY1B ENSG00000129862 "Variable charge, Y-linked 1B" O14598 Y 14056217-14056958 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 113 "testis: 30.4" "Cell line enriched" "Detected in single" 6 "U-266/70: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044996, HPA049357" Supported "HPA044996: , HPA049357: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.5 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VGLL1 "TDU, TONDU" ENSG00000102243 "Vestigial like family member 1" Q99990 X 136532152-136556807 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 124.6" "Cell line enhanced" "Detected in some" "A-431: 24.7;BEWO: 38.1;CAPAN-2: 13.9;RT4: 65.4;SK-BR-3: 64.3" "Cancer enhanced" "Detected in many" "urothelial cancer: 47.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042403, HPA064616" Supported Supported Nucleoplasm Nucleoplasm "HPA042403: , HPA064616: " "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (3.09e-1)" "prognostic unfavourable (4.54e-4)" "unprognostic (5.16e-2)" "unprognostic (1.80e-1)" "unprognostic (4.28e-1)" "unprognostic (6.14e-3)" "unprognostic (1.92e-3)" "unprognostic (1.37e-2)" "unprognostic (5.53e-2)" "unprognostic (3.05e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 2.6 0.1 0.1 0.5 0.1 0.1 0.2 0.0 0.1 0.7 1.4 0.4 0.3 0.1 0.1 0.0 3.7 0.1 0.9 0.1 0.1 0.1 0.2 0.6 0.0 1.3 124.6 0.1 2.8 0.0 0.1 5.0 2.3 0.1 0.1 0.1 0.6 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.7 19.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 38.1 0.0 0.0 0.0 0.0 3.7 13.9 0.0 0.0 0.0 1.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.4 0.0 0.0 0.0 64.3 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 VGLL2 ENSG00000170162 "Vestigial like family member 2" Q8N8G2 6 117265558-117273565 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 75.9" "Group enriched" "Detected in some" 6 "RH-30: 17.1;U-2 OS: 6.0" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 0.4" "Low region specificity" "Detected in many" "unprognostic (3.02e-2)" "unprognostic (3.09e-2)" "unprognostic (1.75e-1)" "unprognostic (4.92e-1)" 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.0 0.0 0.0 9.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 1.7 0.3 75.9 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 1.0 7.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 2.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 1.7 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.3 0.0 VGLL3 VGL-3 ENSG00000206538 "Vestigial like family member 3" A8MV65 3 86876388-86991119 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "placenta: 195.7" "Cell line enriched" "Detected in many" 4 "U-2197: 103.9" "Cancer enhanced" "Detected in many" "prostate cancer: 7.9" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054983 Approved Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA054983: " "unprognostic (9.08e-2)" "unprognostic (4.47e-3)" "unprognostic (5.97e-2)" "unprognostic (1.54e-1)" "unprognostic (2.98e-2)" "unprognostic (1.13e-1)" "unprognostic (2.77e-2)" "unprognostic (3.86e-2)" "unprognostic (1.38e-2)" "unprognostic (4.94e-2)" "unprognostic (3.70e-2)" "unprognostic (3.44e-2)" "unprognostic (2.73e-8)" "unprognostic (3.85e-3)" "unprognostic (1.27e-1)" "unprognostic (5.42e-3)" "unprognostic (1.05e-1)" 22.5 1.0 0.5 3.4 0.5 0.2 8.6 0.2 0.3 6.3 6.2 0.4 3.3 0.6 8.2 7.8 6.1 5.2 6.8 4.3 1.0 0.7 1.8 0.6 16.1 3.6 0.6 0.3 10.6 2.7 0.7 0.4 195.7 0.8 8.0 1.6 2.8 1.9 3.1 7.5 4.0 2.1 11.9 0.8 2.4 2.9 8.0 0.3 0.1 3.4 1.9 1.0 12.2 9.2 1.1 0.6 2.3 0.5 0.8 0.7 0.1 1.5 2.5 13.9 0.0 18.6 23.2 0.2 9.6 6.7 8.2 10.3 2.9 0.6 0.0 0.0 15.0 1.3 0.9 0.9 11.3 5.4 0.0 0.7 0.9 0.0 8.5 0.1 0.0 17.7 1.5 12.0 5.4 1.2 0.0 0.0 10.2 0.0 0.1 0.0 0.2 0.0 0.0 18.4 0.0 0.0 1.6 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.5 18.3 2.7 103.9 0.3 0.0 0.0 0.0 3.4 0.0 0.7 2.3 0.5 0.7 0.4 0.3 0.4 0.5 0.5 0.3 0.2 1.1 0.6 0.7 2.0 0.8 0.4 0.6 0.5 0.1 0.5 0.5 0.2 0.3 1.0 0.7 0.6 0.3 0.8 0.3 VIL1 "D2S1471, VIL" ENSG00000127831 "Villin 1" P09327 2 218419092-218453295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Actin capping, Actin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 129.3" "Group enriched" "Detected in some" 106 "CACO-2: 122.1;Hep G2: 57.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 56.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 2.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB002452, HPA006884, HPA006885" Enhanced Enhanced "Plasma membrane" 41000000 "Plasma membrane" "CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564" "unprognostic (1.28e-1)" "unprognostic (1.91e-2)" "unprognostic (1.61e-2)" "unprognostic (1.09e-1)" "unprognostic (1.83e-1)" "unprognostic (3.36e-1)" "unprognostic (3.03e-1)" "unprognostic (5.90e-2)" "unprognostic (2.44e-2)" "unprognostic (7.06e-2)" "unprognostic (4.14e-1)" "unprognostic (1.03e-1)" "unprognostic (2.25e-3)" "unprognostic (3.90e-1)" "unprognostic (2.58e-1)" "unprognostic (4.79e-2)" "unprognostic (4.65e-2)" 0.3 0.2 0.6 5.7 0.8 0.0 0.3 0.7 0.4 0.3 36.6 0.3 0.3 68.9 0.3 1.2 0.3 0.2 22.6 0.3 0.5 0.5 4.6 6.1 0.3 0.3 0.5 0.3 0.3 7.2 0.0 0.4 0.3 0.3 0.3 32.6 0.3 0.5 0.3 0.3 0.3 129.3 1.2 0.5 0.4 0.9 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.4 2.5 0.1 0.1 0.1 7.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 122.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.5 0.1 0.0 0.4 0.0 7.8 0.6 0.8 0.7 0.4 0.5 0.5 0.5 0.3 0.3 0.3 VMP1 "EPG3, TANGO5, TMEM49" ENSG00000062716 "Vacuole membrane protein 1" Q96GC9 17 59707192-59842255 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "blood: 193.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 193.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 193.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030773, HPA064780" Approved Approved "Nucleoli,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoli "HPA030773: AB_10602248, HPA064780: " "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (4.09e-2)" "prognostic unfavourable (1.56e-5)" "unprognostic (3.14e-2)" "unprognostic (3.17e-1)" "prognostic unfavourable (8.02e-4)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" "unprognostic (2.98e-1)" "unprognostic (8.43e-2)" "unprognostic (4.21e-2)" "prognostic unfavourable (2.77e-8)" "unprognostic (1.88e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-2)" "unprognostic (7.96e-3)" 22.0 37.8 20.4 21.9 24.9 13.0 18.6 20.0 28.7 18.2 32.0 27.8 16.7 40.5 18.3 15.4 22.9 14.4 25.2 19.6 21.7 22.3 22.9 43.0 22.4 20.1 23.1 15.6 16.5 22.9 19.0 20.1 27.9 29.8 17.3 29.3 20.0 17.8 13.9 19.8 19.2 39.7 14.3 26.4 36.6 19.0 17.6 16.2 14.4 18.1 12.5 16.8 19.5 17.6 3.3 10.9 193.2 39.9 3.8 4.1 24.7 20.4 41.2 13.4 20.7 28.7 17.7 21.6 32.6 23.3 20.4 27.4 27.0 29.5 11.8 48.8 22.0 25.5 15.5 18.7 25.4 30.2 19.5 15.1 23.6 28.4 28.0 17.1 18.6 27.0 16.0 26.2 22.3 21.6 19.8 20.9 21.0 56.4 15.9 9.0 15.1 21.3 8.8 23.5 24.3 25.2 23.9 9.6 21.9 18.6 15.8 21.6 32.8 14.7 30.4 27.4 26.2 21.7 26.9 32.4 37.2 16.4 30.2 10.5 27.6 7.0 35.1 4.4 3.8 24.4 4.0 3.3 3.7 4.0 10.9 2.8 3.5 3.8 193.2 3.8 39.9 3.6 4.1 24.7 20.4 24.9 20.0 28.7 21.7 22.3 23.1 15.6 29.8 16.2 VSIG8 ENSG00000243284 "V-set and immunoglobulin domain containing 8" P0DPA2 1 159854316-159862657 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "tongue: 83.5" "Cell line enhanced" "Detected in some" "HeLa: 3.5;Karpas-707: 1.7;U-2 OS: 1.1;U-266/70: 1.3;U-87 MG: 2.1" "Group enriched" "Detected in some" 6 "cervical cancer: 3.0;endometrial cancer: 3.0;head and neck cancer: 4.6;urothelial cancer: 1.0" "Region enriched" "Detected in single" 13 "cerebellum: 4.2" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA023219 Uncertain "HPA023219: AB_1845635" "unprognostic (8.66e-3)" "unprognostic (2.17e-1)" "unprognostic (2.74e-1)" "unprognostic (9.13e-3)" "unprognostic (4.50e-3)" "unprognostic (1.15e-2)" "unprognostic (9.26e-2)" "unprognostic (6.28e-2)" "unprognostic (1.68e-2)" "unprognostic (2.79e-1)" "unprognostic (2.93e-3)" "unprognostic (9.32e-2)" "unprognostic (7.94e-7)" "unprognostic (1.72e-2)" "unprognostic (4.25e-1)" "unprognostic (1.81e-3)" "unprognostic (1.99e-1)" 0.4 0.1 0.2 0.2 0.3 0.0 0.2 4.2 0.2 2.2 0.2 0.2 0.2 0.2 0.2 0.2 2.5 1.0 0.2 0.2 0.2 0.2 2.7 0.2 0.2 0.2 0.2 0.2 1.2 0.2 0.0 0.2 0.3 0.2 0.2 0.0 0.2 4.3 0.2 0.2 18.9 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.8 0.4 83.5 9.2 0.2 2.0 0.6 0.0 0.1 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.2 0.2 0.4 1.0 1.1 0.2 0.0 1.3 0.0 0.0 2.1 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.5 0.6 0.3 0.5 0.0 0.0 0.7 0.5 0.1 0.7 0.0 0.0 0.3 0.0 0.2 0.3 4.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 VSNL1 "HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1" ENSG00000163032 "Visinin like 1" P62760 2 17539126-17657018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 165.7" "Group enriched" "Detected in some" 5 "HaCaT: 43.2;Hep G2: 43.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053808 Approved Cytosol Cytosol "HPA053808: " "unprognostic (1.04e-1)" "unprognostic (7.90e-2)" "unprognostic (3.44e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (6.90e-4)" "unprognostic (4.90e-2)" "unprognostic (5.48e-2)" "unprognostic (2.81e-2)" "unprognostic (4.66e-2)" "unprognostic (2.99e-1)" "unprognostic (1.65e-1)" "unprognostic (2.18e-1)" "unprognostic (5.14e-4)" "unprognostic (3.26e-2)" "unprognostic (1.23e-1)" "unprognostic (6.19e-3)" "unprognostic (1.51e-2)" 1.4 13.6 36.5 1.7 48.8 1.2 3.9 91.6 165.7 1.8 3.0 3.3 0.0 1.3 1.7 1.2 18.0 1.9 1.3 17.5 34.8 27.9 2.0 10.5 2.4 1.2 19.9 66.1 2.8 1.7 1.2 0.2 3.4 64.0 3.0 3.6 0.1 3.2 1.5 1.7 5.2 1.3 1.6 7.1 1.3 1.7 1.5 1.4 0.0 1.5 3.1 4.1 2.3 3.4 0.1 0.7 0.2 0.1 0.1 0.5 0.1 0.2 0.0 0.5 7.8 0.9 1.3 0.0 0.0 0.0 0.0 0.2 0.1 4.7 0.0 0.0 0.0 43.2 0.3 1.5 0.0 0.0 0.2 0.0 0.0 43.6 0.0 0.0 0.1 0.3 2.3 0.0 1.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.1 3.5 3.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.1 0.4 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.5 0.1 0.2 0.1 0.1 0.7 0.0 0.1 36.5 48.8 91.6 138.6 34.8 27.9 19.9 66.1 64.0 1.4 VSTM2B ENSG00000187135 "V-set and transmembrane domain containing 2B" A6NLU5 19 29526499-29564479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 40.8" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 13.1" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.8;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 19 "T-cells: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.74e-1)" "unprognostic (1.87e-3)" "unprognostic (6.64e-2)" "unprognostic (1.08e-2)" "unprognostic (5.35e-2)" 1.0 1.2 16.2 1.0 17.0 0.9 1.0 13.4 40.8 3.1 1.0 8.6 0.0 1.0 1.0 1.6 0.9 1.0 1.0 1.0 14.2 9.4 1.0 0.9 0.9 1.1 12.5 9.2 1.0 0.9 0.9 0.0 0.9 4.5 0.9 1.0 0.3 0.9 1.0 0.9 1.0 1.0 1.3 11.7 1.0 1.0 1.0 2.2 0.0 0.9 0.0 1.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 17.0 13.4 16.6 14.2 9.4 12.5 9.2 4.5 2.2 VSX2 "CHX10, HOX10, RET1" ENSG00000119614 "Visual system homeobox 2" P58304 14 74239472-74262738 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding, Repressor" "Cataract, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "retina: 29.0" "Cell line enhanced" "Detected in some" "BEWO: 1.2;HAP1: 1.0;SK-BR-3: 1.2;U-698: 1.4" "Cancer enriched" "Detected in single" 34 "testis cancer: 2.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003436 Enhanced "HPA003436: AB_1078523" "unprognostic (2.87e-1)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-1)" "unprognostic (3.21e-4)" "unprognostic (7.77e-2)" "unprognostic (8.39e-4)" "unprognostic (3.13e-1)" 0.3 0.1 0.3 0.4 1.0 0.2 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.1 1.7 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 29.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.0 0.2 0.2 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.1 0.0 0.8 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.3 0.2 0.5 0.4 0.5 0.0 0.2 0.0 VTN VN ENSG00000109072 Vitronectin P04004 17 28367276-28373091 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 42 "liver: 321.7" "Cell line enriched" "Detected in some" 11 "CACO-2: 164.9" "Cancer enriched" "Detected in many" 85 "liver cancer: 2216.6" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016695, CAB016765, HPA060933" Supported Supported "Endoplasmic reticulum,Vesicles" "Secreted to blood" 224300000000 32000000000 "Endoplasmic reticulum, Vesicles" "CAB016695: AB_1624536, CAB016765: , HPA060933: " "unprognostic (1.19e-1)" "unprognostic (2.12e-1)" "unprognostic (2.29e-2)" "unprognostic (6.13e-2)" "unprognostic (9.74e-2)" "unprognostic (8.42e-2)" "prognostic favourable (3.74e-4)" "unprognostic (6.20e-2)" "unprognostic (3.97e-1)" "unprognostic (8.95e-2)" "unprognostic (3.24e-3)" "unprognostic (1.01e-2)" "prognostic unfavourable (4.10e-11)" "unprognostic (8.82e-3)" "unprognostic (2.27e-1)" "unprognostic (4.86e-3)" "unprognostic (7.09e-2)" 0.2 7.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.2 0.0 0.0 0.0 321.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.2 0.7 2.1 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.1 0.0 164.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 8.5 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 15.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 1.0 0.0 0.9 0.0 0.9 0.9 0.1 0.3 0.6 2.1 0.6 0.7 0.0 0.2 0.0 0.1 VWDE FLJ14712 ENSG00000146530 "Von Willebrand factor D and EGF domains" Q8N2E2 7 12330885-12403941 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pituitary gland: 29.5" "Cell line enhanced" "Detected in many" "K-562: 10.6;NTERA-2: 5.3;SCLC-21H: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA026619, HPA036044" Uncertain Approved Nucleoplasm,Cytosol "Secreted - unknown location" Cytosol Nucleoplasm "HPA026619: , HPA036044: " "unprognostic (6.39e-2)" "unprognostic (1.65e-3)" "unprognostic (5.36e-3)" "unprognostic (1.78e-4)" "unprognostic (1.39e-2)" "unprognostic (4.19e-3)" "unprognostic (2.38e-1)" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (6.25e-2)" "unprognostic (1.68e-1)" "unprognostic (6.72e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-3)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (2.73e-1)" 0.4 0.5 1.6 0.3 2.7 2.3 2.3 0.4 2.3 0.8 0.9 0.0 0.9 0.2 0.7 4.9 0.8 1.5 0.7 4.1 0.8 0.5 0.7 0.5 0.7 0.2 0.4 0.5 0.5 0.9 0.0 29.5 0.3 0.5 1.5 0.3 0.1 5.7 5.5 0.4 0.6 0.6 0.2 0.4 0.5 2.0 0.6 0.0 0.1 6.2 0.0 1.3 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.6 0.0 0.5 0.0 0.3 1.7 0.0 2.0 0.7 0.8 0.4 3.0 0.2 0.0 0.0 0.4 2.1 1.9 0.6 3.9 2.2 3.5 4.7 0.0 0.0 1.0 2.3 0.1 0.3 0.0 1.2 0.8 10.6 0.0 0.0 1.2 0.0 0.0 5.3 0.6 0.0 0.0 1.6 0.0 1.3 8.5 1.3 0.0 1.7 0.0 0.0 1.1 0.1 0.0 1.0 0.0 0.8 3.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.9 0.1 1.6 2.7 0.4 2.3 0.8 0.5 0.4 0.5 0.5 0.0 WBP2NL "FLJ26145, GRAMD7, MGC26816, PAWP" ENSG00000183066 "WBP2 N-terminal like" Q6ICG8 22 41998725-42058456 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 24.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.2;HDLM-2: 1.0;HHSteC: 1.1;HSkMC: 1.0;THP-1: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA048557 Enhanced "HPA048557: " "unprognostic (1.90e-2)" "unprognostic (2.25e-4)" "unprognostic (2.77e-3)" "unprognostic (6.12e-2)" "unprognostic (6.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.41e-2)" "unprognostic (1.04e-2)" "unprognostic (1.38e-1)" "unprognostic (2.96e-1)" "unprognostic (9.84e-4)" "unprognostic (3.31e-2)" "unprognostic (4.19e-2)" "unprognostic (1.79e-1)" "unprognostic (2.06e-1)" "unprognostic (2.85e-3)" "unprognostic (9.36e-5)" 1.1 0.9 3.0 1.2 2.9 0.6 2.4 3.6 4.6 0.9 0.9 3.2 1.8 0.8 1.4 4.1 0.8 2.0 1.1 0.8 2.3 1.2 1.2 0.9 1.3 1.1 2.0 2.4 2.4 2.8 2.6 2.4 0.8 2.8 1.3 1.0 2.0 1.9 1.5 0.8 1.6 1.0 0.9 3.7 1.0 1.1 24.8 3.3 0.0 2.3 0.0 1.1 0.9 1.7 1.1 1.5 0.0 0.6 0.4 1.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 4.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.1 1.6 0.0 0.0 0.2 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.1 0.0 0.0 0.9 0.4 0.0 1.5 1.1 0.3 0.3 0.0 0.4 0.2 0.6 1.4 0.2 3.0 2.9 3.6 4.6 2.3 1.2 2.0 2.4 2.8 3.3 WDR38 ENSG00000136918 "WD repeat domain 38" Q5JTN6 9 124853417-124857890 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "fallopian tube: 51.4" "Cell line enhanced" "Detected in some" "A549: 1.3;CAPAN-2: 2.5;HDLM-2: 2.9;HeLa: 1.9" "Cancer enhanced" "Detected in some" "endometrial cancer: 12.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA056607 Uncertain "HPA056607: " "unprognostic (5.66e-3)" "unprognostic (2.15e-3)" "unprognostic (1.51e-2)" "prognostic favourable (3.97e-4)" "unprognostic (1.14e-1)" "unprognostic (2.17e-3)" "unprognostic (4.29e-3)" "unprognostic (7.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.82e-1)" "unprognostic (1.38e-1)" "unprognostic (5.90e-2)" "unprognostic (7.75e-5)" "unprognostic (1.01e-1)" "unprognostic (3.25e-2)" "unprognostic (6.36e-2)" "unprognostic (4.42e-2)" 0.2 0.2 2.0 0.2 3.1 0.2 0.2 0.2 0.5 2.9 0.2 10.6 0.0 0.2 0.7 11.9 0.2 51.4 0.2 0.3 2.8 3.3 0.2 0.2 10.8 0.2 0.3 0.4 6.0 0.2 0.2 1.0 0.2 8.8 0.2 0.2 0.0 0.2 0.3 0.3 0.3 0.2 0.3 0.7 0.2 0.2 7.0 1.3 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.3 0.5 0.2 0.0 0.3 0.2 0.0 0.2 0.1 0.1 0.4 2.5 0.1 0.1 0.2 0.1 0.2 0.0 0.0 2.9 0.3 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.7 0.1 0.6 0.1 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.7 0.0 1.3 0.0 0.0 0.0 0.4 0.5 0.2 0.4 0.5 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.1 0.2 0.5 2.8 3.3 0.3 0.4 8.8 1.3 WDR64 FLJ32978 ENSG00000162843 "WD repeat domain 64" B1ANS9 1 241652278-241802133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 17.8" "Group enriched" "Detected in some" 4 "ASC TERT1: 3.1;U-266/84: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA046186 Uncertain "HPA046186: AB_10960064" "unprognostic (6.44e-2)" "unprognostic (1.13e-1)" "unprognostic (2.34e-1)" "unprognostic (2.78e-1)" "unprognostic (1.87e-3)" "unprognostic (1.52e-1)" "unprognostic (9.26e-2)" "unprognostic (2.35e-1)" "unprognostic (1.40e-2)" "unprognostic (2.43e-2)" "unprognostic (2.03e-1)" "unprognostic (4.49e-2)" "unprognostic (4.56e-4)" "unprognostic (2.43e-1)" "unprognostic (1.93e-1)" "unprognostic (7.28e-3)" "unprognostic (2.21e-1)" 0.1 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.5 0.2 0.5 0.1 0.1 0.2 0.1 1.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.5 0.1 0.0 0.1 0.9 0.1 0.1 0.0 0.1 0.5 0.3 0.1 0.0 0.3 0.1 0.1 0.2 0.2 17.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.1 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.0 1.7 0.3 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 WDR87 NYD-SP11 ENSG00000171804 "WD repeat domain 87" Q6ZQQ6 19 37884823-37906677 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 94 "testis: 48.4" "Group enriched" "Detected in some" 5 "U-266/70: 2.0;U-266/84: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (6.37e-3)" "unprognostic (1.26e-2)" "unprognostic (5.59e-2)" "unprognostic (1.11e-1)" "unprognostic (1.00e-1)" "unprognostic (1.89e-2)" "unprognostic (2.60e-1)" "unprognostic (4.22e-1)" "unprognostic (5.43e-2)" "unprognostic (2.58e-2)" "unprognostic (1.78e-8)" "unprognostic (1.19e-1)" "unprognostic (2.42e-1)" "unprognostic (5.48e-2)" "unprognostic (4.12e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 48.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 WDR88 PQWD ENSG00000166359 "WD repeat domain 88" Q6ZMY6 19 33132090-33175795 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 25.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA041916, HPA050336" Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA041916: AB_10804121, HPA050336: " "unprognostic (1.02e-1)" "unprognostic (9.40e-2)" "unprognostic (3.12e-1)" "unprognostic (1.33e-4)" "unprognostic (5.14e-2)" "unprognostic (7.98e-2)" "unprognostic (8.44e-2)" "unprognostic (2.01e-1)" "unprognostic (6.62e-2)" "unprognostic (1.60e-1)" "unprognostic (1.06e-4)" "unprognostic (3.40e-1)" "unprognostic (1.87e-2)" "unprognostic (2.28e-1)" "unprognostic (1.63e-1)" "unprognostic (2.43e-2)" "unprognostic (6.67e-2)" 0.3 0.5 0.4 1.1 0.6 1.0 0.3 0.7 1.4 0.3 0.3 0.3 0.3 0.7 0.3 0.3 0.7 0.2 0.6 1.2 0.4 0.4 0.3 0.3 0.3 1.6 0.3 0.3 1.0 1.0 0.0 0.5 0.3 0.3 0.3 0.0 0.3 1.1 0.3 0.3 0.9 0.9 0.3 0.3 0.6 0.3 25.2 0.3 0.3 1.4 0.3 0.3 0.3 0.3 1.2 0.6 0.6 1.3 2.9 1.4 0.3 1.1 2.3 1.5 2.8 0.8 0.0 2.1 0.9 0.0 0.2 0.0 1.1 2.2 2.8 1.4 0.0 0.8 0.0 0.3 0.0 5.7 0.8 2.6 1.8 0.5 0.0 2.0 2.3 0.0 0.0 0.0 0.0 0.0 1.8 2.9 0.0 3.3 1.1 1.2 1.1 0.9 2.1 0.8 0.5 0.0 1.3 4.1 4.1 2.8 1.3 0.6 3.5 2.1 1.5 0.7 2.2 1.2 0.4 2.7 1.8 1.6 0.5 4.4 1.2 0.0 0.4 0.4 1.4 1.3 1.3 0.0 1.2 1.0 0.3 1.2 0.8 0.7 0.6 2.9 0.6 0.6 0.2 0.3 0.4 0.6 0.7 0.8 0.4 0.4 0.3 0.3 0.3 0.3 WFDC10A "C20orf146, dJ688G8.3, WAP10" ENSG00000180305 "WAP four-disulfide core domain 10A" Q9H1F0 20 45629526-45631196 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "epididymis: 62.4" "Cell line enhanced" "Detected in some" "BEWO: 1.1;CACO-2: 2.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebral cortex: 1.6" "Cell type enriched" "Detected in single" 7 "naive CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 8 "T-cells: 1.2" "Not detected" "Not detected" "Secreted in male reproductive system" "unprognostic (1.76e-1)" "unprognostic (2.95e-1)" 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.5 0.0 0.1 62.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 1.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 WFDC11 WAP11 ENSG00000180083 "WAP four-disulfide core domain 11" Q8NEX6 20 45648563-45670270 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "epididymis: 46.2" "Group enriched" "Detected in some" 5 "HeLa: 12.7;RPMI-8226: 7.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.7" "Low lineage specificity" "Detected in many" "Secreted in male reproductive system" 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 46.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.4 0.0 0.8 0.7 4.7 0.4 1.3 0.8 0.1 0.2 1.1 0.0 0.2 0.6 0.8 1.2 1.1 0.1 0.0 0.0 0.7 0.3 0.6 0.4 0.0 0.6 0.0 0.2 0.0 0.0 0.8 1.1 12.7 0.8 0.0 0.6 0.8 0.3 0.0 0.0 0.2 0.0 0.6 0.2 0.0 0.2 0.5 1.1 1.1 0.6 0.2 0.5 7.7 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.1 1.1 0.0 0.2 0.7 0.3 0.1 0.5 0.5 0.0 0.1 2.1 0.3 4.7 0.4 0.2 0.4 0.2 0.4 0.3 0.3 0.3 0.1 0.8 0.4 0.8 1.2 1.3 0.2 0.7 0.0 0.1 WFDC13 "C20orf138, dJ601O1.3, WAP13" ENSG00000168634 "WAP four-disulfide core domain 13" Q8IUB5 20 45702016-45708817 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "epididymis: 92.8" "Cell line enhanced" "Detected in some" "Daudi: 1.9;RT4: 3.3;U-87 MG: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "naive CD4 T-cell: 3.1" "Lineage enriched" "Detected in single" 7 "T-cells: 3.1" "Secreted in male reproductive system" "unprognostic (2.53e-1)" "unprognostic (1.30e-2)" "unprognostic (7.84e-3)" "unprognostic (7.96e-3)" "unprognostic (2.04e-1)" "unprognostic (1.02e-11)" "unprognostic (1.17e-1)" "unprognostic (1.44e-2)" "unprognostic (2.22e-2)" 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.2 0.0 8.3 0.0 0.1 92.8 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.4 0.0 3.1 1.3 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.2 0.0 3.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.3 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 WFDC5 "dJ211D12.5, WAP1" ENSG00000175121 "WAP four-disulfide core domain 5" Q8TCV5 20 45109452-45115172 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skin 1: 99.0" "Group enriched" "Detected in some" 4 "HBEC3-KT: 2.4;Karpas-707: 3.7;RT4: 3.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" "unprognostic (1.32e-1)" "unprognostic (3.22e-2)" "unprognostic (3.05e-1)" "unprognostic (1.54e-1)" "unprognostic (1.28e-4)" "unprognostic (6.59e-2)" "unprognostic (2.23e-2)" "prognostic unfavourable (2.32e-5)" "unprognostic (4.12e-2)" "unprognostic (2.17e-1)" "unprognostic (5.96e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.4 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.4 0.7 0.2 99.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 1.8 0.0 22.6 11.4 0.2 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 WFDC8 "C20orf170, dJ461P17.1, WAP8" ENSG00000158901 "WAP four-disulfide core domain 8" Q8IUA0 20 45551153-45579326 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "epididymis: 103.1" "Cell line enriched" "Detected in some" 6 "U-87 MG: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA042710, HPA071119" Enhanced "Secreted in male reproductive system" "HPA042710: AB_2732501, HPA071119: AB_2732172" "unprognostic (5.63e-3)" "unprognostic (1.09e-2)" "unprognostic (2.34e-1)" "unprognostic (9.96e-2)" "unprognostic (1.07e-2)" 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 5.6 0.0 1.0 103.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.7 0.0 0.0 0.1 0.1 1.0 0.6 1.0 0.9 0.7 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.1 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 7.7 0.0 0.1 0.6 0.9 0.2 0.3 0.3 0.2 0.2 0.2 0.1 0.1 1.0 0.4 0.4 1.0 0.7 0.4 0.6 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 WFDC9 "dJ688G8.2, WAP9" ENSG00000180205 "WAP four-disulfide core domain 9" Q8NEX5 20 45607939-45631268 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "epididymis: 162.4" "Cell line enhanced" "Detected in some" "BEWO: 1.1;NB-4: 4.7;SH-SY5Y: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 0.5;thalamus: 0.9" "Not detected" "Not detected" "Secreted in male reproductive system" 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.5 0.1 0.1 0.0 10.1 0.0 0.1 162.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.3 0.1 0.0 0.1 0.1 0.1 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.0 XAGE1A "CT12.1a, GAGED2, XAGE-1, XAGE1" ENSG00000204379 "X antigen family member 1A" Q9HD64 X 52495676-52500812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 28.7" "Cell line enhanced" "Detected in some" "HMC-1: 73.0;NB-4: 71.1;THP-1: 73.0;U-2 OS: 53.3;U-266/70: 34.8;U-266/84: 94.4;U-937: 58.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046363 Approved Nucleoplasm Nucleoplasm "HPA046363: " 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 73.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 71.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.4 0.0 0.1 0.2 5.0 73.0 0.0 0.0 53.3 0.0 10.2 34.8 94.4 0.1 0.0 58.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XAGE1B CT12.1b ENSG00000204382 "X antigen family member 1B" Q9HD64 X 52512077-52520803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 28.8" "Cell line enhanced" "Detected in some" "HMC-1: 76.7;NB-4: 74.6;THP-1: 72.5;U-2 OS: 55.6;U-266/70: 34.9;U-266/84: 95.3;U-937: 59.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 19 "dendritic cells: 4.7" HPA046363 Approved Nucleoplasm Nucleoplasm "HPA046363: " 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.3 0.0 0.0 0.0 4.7 0.0 0.2 0.0 0.0 0.0 0.3 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 76.7 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.1 74.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.4 0.0 0.2 0.3 5.2 72.5 0.0 0.0 55.6 0.0 10.3 34.9 95.3 0.1 0.0 59.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 XAGE2 "CT12.2, GAGED3, XAGE-2, XAGE2B" ENSG00000155622 "X antigen family member 2" Q96GT9 X 52369030-52375680 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "placenta: 106.9" "Cell line enriched" "Detected in some" 4 "BEWO: 45.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052507, HPA060900" Supported "HPA052507: , HPA060900: " "unprognostic (1.21e-1)" "unprognostic (9.67e-2)" "unprognostic (1.49e-1)" "unprognostic (4.47e-2)" 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 4.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 106.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.7 0.5 9.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 XAGE3 "CT12.3a, CT12.3b, GAGED4, PLAC6, pp9012, XAGE-3" ENSG00000171402 "X antigen family member 3" Q8WTP9 X 52862525-52868068 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "placenta: 98.5" "Cell line enhanced" "Detected in some" "BEWO: 3.2;U-266/70: 5.7;U-266/84: 5.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 10 "B-cells: 1.7" "HPA052507, HPA060900" Supported "HPA052507: , HPA060900: " "unprognostic (6.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.92e-1)" 1.0 0.0 0.1 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 98.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 1.1 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.7 5.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 XAGE5 "CT12.5, GAGED5, XAGE-5" ENSG00000171405 "X antigen family member 5" Q8WWM1 X 52812204-52818301 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 6 "testis: 5.1" "Cell line enriched" "Detected in single" 34 "U-2 OS: 22.2" "Cancer enhanced" "Detected in single" "liver cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052507, HPA055941" Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA052507: , HPA055941: " "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XIRP2 CMYA3 ENSG00000163092 "Xin actin binding repeat containing 2" A4UGR9 2 166888487-167259753 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 292.8" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;HEL: 1.5;HUVEC TERT2: 8.5;U-2197: 6.0" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034813, HPA074599" Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA034813: AB_10602588, HPA074599: " "unprognostic (5.27e-4)" "unprognostic (5.96e-3)" "unprognostic (7.42e-2)" "unprognostic (2.42e-1)" "unprognostic (1.74e-1)" "unprognostic (2.56e-1)" 7.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.3 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 4.3 0.0 292.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 2.3 51.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.2 0.2 0.0 0.0 0.9 0.0 0.2 0.7 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XKR8 FLJ10307 ENSG00000158156 "XK related 8" Q9H6D3 1 27959462-27968096 "Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "blood: 47.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 10 "eosinophil: 47.1;neutrophil: 24.3" "Lineage enriched" "Detected in all" 15 "granulocytes: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049984, HPA053529" Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA049984: , HPA053529: " "prognostic favourable (8.63e-4)" "unprognostic (2.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.10e-3)" "unprognostic (1.97e-2)" "unprognostic (1.38e-2)" "unprognostic (6.25e-3)" "unprognostic (1.64e-1)" "unprognostic (7.87e-2)" "unprognostic (8.41e-2)" "unprognostic (1.83e-3)" "unprognostic (6.29e-2)" "unprognostic (8.55e-2)" "unprognostic (2.93e-2)" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (4.20e-2)" 2.6 2.3 2.8 4.2 3.8 10.3 1.8 8.3 1.8 2.3 2.5 4.1 3.3 2.9 2.4 3.2 2.9 3.2 2.8 1.9 3.3 8.6 3.1 3.0 3.0 3.6 8.7 3.5 2.4 7.8 3.5 2.4 5.6 3.7 2.9 2.0 3.1 3.5 4.9 5.6 4.7 1.6 3.5 2.4 2.8 2.4 1.3 2.6 47.1 2.5 2.8 3.0 1.9 4.5 2.4 2.9 2.9 3.3 6.1 7.5 6.8 7.4 8.6 8.9 6.5 3.6 0.0 5.6 7.5 2.5 5.5 3.2 3.1 7.4 9.8 6.0 2.0 4.4 5.3 0.0 0.0 6.5 5.4 9.4 2.6 8.5 0.0 1.8 4.9 2.2 3.3 2.2 13.7 5.6 5.3 0.0 3.2 5.6 2.4 2.1 0.0 2.0 2.7 0.1 2.0 4.6 3.6 6.9 0.2 12.9 2.2 7.2 6.9 0.7 17.1 0.0 0.3 3.5 2.5 47.1 3.0 2.4 2.9 1.3 3.0 2.6 2.6 1.3 2.6 2.6 24.3 2.8 1.7 1.2 2.9 1.9 YBX2 "Contrin, CSDA3, MSY2" ENSG00000006047 "Y-box binding protein 2" Q9Y2T7 17 7288252-7294615 "Predicted intracellular proteins, Transcription factors" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "testis: 97.3" "Cell line enhanced" "Detected in some" "CACO-2: 8.1;MCF7: 14.1;SH-SY5Y: 5.5;SK-BR-3: 7.2;T-47d: 21.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB012332, HPA053904, HPA056744" Enhanced "CAB012332: AB_776541, HPA053904: , HPA056744: " "unprognostic (1.76e-2)" "unprognostic (4.62e-3)" "unprognostic (3.99e-2)" "prognostic unfavourable (6.50e-5)" "unprognostic (9.80e-4)" "unprognostic (4.68e-2)" "unprognostic (2.23e-1)" "unprognostic (3.44e-1)" "unprognostic (1.41e-1)" "unprognostic (1.20e-1)" "unprognostic (2.20e-1)" "unprognostic (1.38e-1)" "unprognostic (2.38e-4)" "unprognostic (1.78e-2)" "unprognostic (2.15e-1)" "unprognostic (5.31e-1)" "unprognostic (2.35e-2)" 1.8 0.0 0.5 1.2 0.2 0.1 0.5 0.0 0.6 0.5 1.6 0.0 0.6 0.8 0.5 1.4 0.7 0.5 0.0 0.2 0.5 0.0 0.2 0.3 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.3 0.2 0.4 0.7 1.4 0.2 2.0 0.4 0.1 0.0 0.2 97.3 0.1 0.1 0.2 0.3 0.2 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.5 0.0 0.0 2.5 0.0 0.0 0.0 0.0 8.1 4.0 0.0 3.9 0.0 0.7 1.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.1 0.5 0.6 2.4 0.0 0.1 0.1 0.1 0.3 0.0 0.1 5.5 2.2 7.2 0.4 21.6 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.6 0.5 0.0 0.1 0.2 0.2 0.1 YBX3 "CSDA, CSDA1, dbpA, ZONAB" ENSG00000060138 "Y-box binding protein 3" P16989 12 10699089-10723312 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "skeletal muscle: 612.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 9.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034838 Approved Supported Cytosol 56000 Cytosol "HPA034838: AB_10670980" "unprognostic (1.93e-2)" "unprognostic (6.20e-2)" "unprognostic (3.56e-1)" "unprognostic (3.61e-2)" "unprognostic (4.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.10e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-1)" "unprognostic (2.41e-1)" "unprognostic (3.23e-3)" "unprognostic (1.20e-1)" "prognostic unfavourable (6.17e-13)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (4.25e-2)" "unprognostic (2.44e-1)" 23.8 5.0 3.0 6.4 6.0 11.2 15.9 2.1 4.6 12.4 14.3 2.0 3.7 3.2 8.5 14.7 25.0 8.4 6.7 91.6 3.2 1.7 7.6 6.5 17.2 6.8 5.5 0.8 17.2 20.6 1.3 8.1 9.5 6.2 12.4 5.3 6.2 12.9 6.8 612.6 29.9 5.0 14.9 5.8 8.6 9.5 30.2 4.1 4.5 18.5 54.2 12.0 27.2 24.6 9.5 4.5 1.0 5.7 0.9 2.3 1.4 17.7 15.6 7.0 22.8 29.2 54.2 51.2 27.8 23.7 23.8 22.4 27.3 43.1 17.4 9.3 22.1 34.1 29.9 57.9 20.7 0.1 53.7 14.4 22.0 16.6 36.5 25.9 1.6 62.5 75.2 22.1 72.7 54.7 19.4 0.0 25.5 19.0 21.3 22.3 70.6 12.8 12.0 32.0 19.7 32.3 23.6 8.7 0.0 21.1 21.0 25.8 6.0 20.4 35.7 16.3 45.9 17.4 31.2 0.1 5.7 2.0 22.5 0.0 17.5 0.0 5.7 0.0 0.7 5.4 0.0 1.6 0.0 2.1 4.5 9.5 0.1 2.3 1.0 0.9 3.0 0.2 0.1 1.4 3.0 6.0 2.1 4.6 3.2 1.7 5.5 0.8 6.2 4.1 YJEFN3 "FLJ44968, hYjeF_N3-19p13.11" ENSG00000250067 "YjeF N-terminal domain containing 3" A6XGL0 19 19528861-19537581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.8" "Cell line enhanced" "Detected in some" "BEWO: 11.2;HEK 293: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA060789 Enhanced Approved Mitochondria Mitochondria "HPA060789: " "unprognostic (2.59e-2)" "unprognostic (2.50e-1)" "unprognostic (5.99e-6)" "unprognostic (1.65e-1)" "unprognostic (3.16e-1)" "unprognostic (2.28e-2)" "unprognostic (4.37e-4)" "unprognostic (2.38e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "prognostic favourable (7.25e-4)" "unprognostic (2.11e-2)" "prognostic unfavourable (1.30e-7)" "unprognostic (1.17e-2)" "unprognostic (8.26e-2)" "unprognostic (2.48e-1)" "unprognostic (9.49e-3)" 1.2 0.9 24.2 1.4 47.8 0.8 1.0 0.8 26.5 1.1 1.3 1.1 0.0 1.0 1.3 6.6 1.0 1.6 0.9 0.8 29.5 8.3 1.0 0.8 1.4 1.4 7.7 10.2 1.1 1.0 1.7 0.8 1.3 3.6 2.0 1.6 4.1 0.9 1.5 1.6 3.0 1.6 1.2 1.0 1.1 1.4 7.1 5.1 0.0 1.7 0.0 1.3 1.5 0.0 0.5 0.5 0.3 1.1 0.0 2.2 0.3 0.2 0.8 1.9 0.8 0.3 0.5 11.2 0.5 0.1 0.4 0.7 0.9 0.6 0.4 1.4 0.1 1.1 0.3 0.2 0.0 0.1 13.1 0.0 1.5 0.0 0.1 0.3 0.5 0.1 0.5 0.2 0.4 0.0 0.9 0.6 0.0 0.9 0.0 0.1 3.5 2.6 2.1 0.4 0.4 0.0 0.1 0.3 3.1 0.2 0.0 0.2 1.2 1.6 0.7 0.3 0.7 3.4 0.7 3.2 2.1 0.6 0.2 1.7 0.4 0.0 0.7 0.0 0.7 1.1 0.8 0.3 1.2 0.6 0.5 0.5 0.7 1.1 0.3 0.0 0.7 0.0 2.2 0.3 24.2 47.8 0.8 26.5 29.5 8.3 7.7 10.2 3.6 5.1 YWHAH YWHA1 ENSG00000128245 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta" Q04917 22 31944461-31957603 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 154.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025918, HPA061603" Uncertain Approved Nucleoli,Cytosol 130000000 Cytosol Nucleoli "CAB025918: , HPA061603: " "unprognostic (3.77e-1)" "unprognostic (6.13e-2)" "unprognostic (1.67e-2)" "unprognostic (1.86e-2)" "unprognostic (1.13e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (1.59e-5)" "unprognostic (8.62e-2)" "unprognostic (1.63e-1)" "unprognostic (4.51e-2)" "unprognostic (3.92e-2)" "unprognostic (1.14e-1)" "unprognostic (1.40e-1)" "unprognostic (1.59e-1)" "unprognostic (5.60e-2)" "unprognostic (7.00e-2)" "unprognostic (6.81e-2)" 21.5 18.6 87.9 20.6 47.4 16.3 19.3 41.9 154.3 13.7 24.4 10.0 4.3 17.2 13.1 14.1 14.0 16.4 18.6 15.2 78.8 59.1 11.7 11.5 25.0 13.5 35.5 101.6 10.0 16.7 5.2 10.4 22.4 49.5 12.3 20.1 6.8 9.9 15.6 13.9 9.9 17.4 25.9 19.4 12.8 26.9 3.7 9.1 6.3 10.5 5.5 15.1 18.5 10.6 8.1 16.6 14.9 14.4 17.7 12.8 9.6 67.9 27.2 30.4 17.7 18.5 17.1 19.3 66.1 32.7 38.1 43.6 28.8 23.7 40.1 16.1 60.6 32.9 36.4 36.3 36.0 35.5 31.7 23.7 21.4 25.7 18.7 76.3 26.5 15.5 19.4 32.1 22.9 31.1 32.7 29.4 29.0 27.4 23.1 35.1 36.2 29.8 33.2 41.9 21.3 24.0 29.4 65.4 21.5 37.6 26.3 23.5 15.0 18.9 49.7 38.5 38.5 28.2 41.9 16.4 25.3 50.2 27.9 30.8 33.8 7.8 14.4 14.9 5.7 11.8 8.1 8.1 7.0 8.1 16.6 7.6 2.8 3.6 8.7 17.7 12.2 4.5 12.8 9.6 87.9 47.4 41.9 126.3 78.8 59.1 35.5 101.6 49.5 9.1 ZAN ENSG00000146839 "Zonadhesin (gene/pseudogene)" 7 100733626-100797797 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 14.3" "Group enriched" "Detected in some" 6 "REH: 1.1;SK-BR-3: 1.4" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.3" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.6" "Not detected" "Not detected" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (3.69e-1)" "unprognostic (4.60e-2)" "unprognostic (5.83e-6)" "unprognostic (9.44e-2)" "unprognostic (4.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.97e-1)" "unprognostic (5.70e-2)" "unprognostic (4.10e-9)" "unprognostic (5.70e-2)" "unprognostic (2.58e-1)" "unprognostic (8.43e-2)" "unprognostic (3.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 ZBTB32 "FAXF, FAZF, Rog, TZFP, ZNF538" ENSG00000011590 "Zinc finger and BTB domain containing 32" Q9Y2Y4 19 35704527-35717038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 81.0" "Cell line enhanced" "Detected in some" "HDLM-2: 8.8;hTEC/SVTERT24-B: 4.3;U-266/70: 2.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 12.6" "Lineage enriched" "Detected in many" 5 "B-cells: 12.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA076730 Enhanced "HPA076730: " "unprognostic (2.11e-3)" "unprognostic (1.08e-4)" "unprognostic (3.87e-2)" "unprognostic (1.13e-2)" "unprognostic (2.43e-1)" "unprognostic (1.04e-5)" "unprognostic (2.59e-1)" "unprognostic (1.76e-1)" "unprognostic (2.16e-2)" "unprognostic (1.63e-3)" "unprognostic (1.01e-2)" "unprognostic (3.78e-1)" "unprognostic (1.02e-8)" "unprognostic (2.44e-3)" "unprognostic (2.25e-1)" "unprognostic (6.26e-5)" "unprognostic (1.94e-3)" 0.1 0.1 0.0 2.3 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.4 0.1 0.0 0.0 0.1 0.1 0.5 2.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.7 0.0 0.0 0.0 1.2 0.2 0.0 2.0 0.4 81.0 0.0 0.1 0.1 0.0 3.6 0.5 0.1 12.6 0.0 0.0 0.1 0.0 2.5 0.6 1.5 1.3 0.3 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.3 0.0 0.0 0.0 8.8 0.3 0.0 1.6 0.0 0.0 0.0 1.6 0.0 0.0 4.3 0.0 0.0 0.0 1.1 0.0 1.4 0.1 0.2 0.0 0.7 1.5 0.0 0.0 0.0 0.1 0.3 0.3 0.9 0.9 0.0 0.6 0.0 0.0 0.9 0.3 0.7 0.1 2.6 2.1 0.6 0.1 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.0 12.6 0.7 0.7 0.0 3.4 0.2 0.3 0.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 ZC2HC1B "C6orf94, dJ468K18.5, FAM164B" ENSG00000118491 "Zinc finger C2HC-type containing 1B" Q5TFG8 6 143864436-143938356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 36 "testis: 29.1" "Cell line enhanced" "Detected in some" "Karpas-707: 3.2;U-266/70: 1.1;U-266/84: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.4 1.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 ZC2HC1C "C14orf140, FAM164C" ENSG00000119703 "Zinc finger C2HC-type containing 1C" Q53FD0 14 75064170-75079987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 75.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 10.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA050928, HPA065062" Enhanced Approved "Nuclear speckles,Mitochondria" "Nuclear speckles" Mitochondria "HPA050928: , HPA065062: " "unprognostic (8.01e-2)" "unprognostic (2.01e-2)" "unprognostic (9.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.97e-3)" "unprognostic (6.00e-2)" "unprognostic (8.94e-2)" "unprognostic (1.20e-2)" "unprognostic (3.71e-3)" "unprognostic (3.22e-2)" "unprognostic (1.09e-3)" "unprognostic (2.26e-1)" "prognostic favourable (4.63e-13)" "unprognostic (4.69e-3)" "unprognostic (7.37e-2)" "unprognostic (3.12e-1)" "unprognostic (1.81e-1)" 0.7 2.1 2.3 0.5 5.3 0.2 1.3 1.8 3.4 1.5 2.0 2.3 4.6 2.5 1.0 18.2 1.3 8.2 1.5 2.9 3.0 3.0 4.3 6.8 2.2 0.1 2.3 2.3 0.8 3.6 5.2 10.9 3.3 4.7 1.0 1.8 1.2 2.3 5.7 3.0 1.1 1.9 1.0 1.9 0.6 1.2 75.7 2.3 0.6 5.9 0.5 0.4 1.2 0.4 1.6 0.6 0.8 0.3 3.8 3.8 0.8 5.9 4.7 1.0 5.2 0.3 0.3 2.7 0.5 2.0 2.6 1.1 7.5 10.9 5.5 4.2 0.5 2.3 0.0 0.1 1.8 5.8 0.6 1.4 1.6 2.6 3.6 0.1 3.6 1.0 0.6 3.4 0.1 1.5 7.8 2.4 1.3 1.3 0.6 0.7 1.7 3.2 0.1 0.3 2.7 5.9 0.3 9.5 2.3 3.4 3.0 2.7 4.3 1.7 0.8 1.6 1.9 2.8 1.1 5.5 8.2 2.8 2.4 1.0 0.8 0.8 0.3 0.8 1.9 0.0 0.5 1.6 1.6 0.5 0.3 0.8 0.7 0.8 0.4 3.8 0.2 0.6 3.8 0.8 2.3 5.3 1.8 3.4 3.0 3.0 2.3 2.3 4.7 2.3 ZC3H11B ZC3HDC11B ENSG00000215817 "Zinc finger CCCH-type containing 11B" 1 219608347-219613145 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 8.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "HPA026439, HPA028490, HPA028526" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533" "unprognostic (1.75e-1)" "unprognostic (5.54e-2)" "unprognostic (2.21e-1)" "unprognostic (2.82e-1)" "unprognostic (3.42e-1)" "unprognostic (1.92e-1)" "unprognostic (5.07e-1)" "unprognostic (1.15e-1)" "unprognostic (1.02e-1)" "unprognostic (2.44e-1)" "unprognostic (1.30e-1)" "unprognostic (8.19e-2)" "unprognostic (2.28e-2)" "unprognostic (7.87e-2)" "unprognostic (9.15e-2)" "unprognostic (2.56e-2)" "unprognostic (1.87e-2)" 0.1 0.1 0.5 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.8 0.1 0.0 0.1 0.0 8.9 0.0 0.0 0.0 0.5 0.7 2.1 0.9 0.6 0.9 0.6 0.9 0.8 2.1 1.3 0.4 0.3 1.9 1.9 0.2 0.3 0.4 0.9 0.8 0.7 0.5 0.2 1.5 0.2 0.2 0.3 3.1 0.8 0.5 1.1 0.7 0.1 0.8 1.8 0.2 0.1 0.4 0.5 0.0 2.2 2.3 0.2 0.4 1.6 1.1 1.2 0.6 0.7 1.5 0.7 0.2 0.9 0.9 1.4 1.1 1.7 1.3 1.4 3.2 1.1 1.0 1.3 1.0 2.0 1.3 1.2 1.1 2.2 1.3 2.0 1.0 0.9 0.7 0.7 0.4 0.8 0.5 0.6 0.7 0.7 0.5 0.7 0.6 2.1 0.6 0.3 0.3 0.9 0.6 ZC3H12D "C6orf95, dJ281H8.1, MCPIP4" ENSG00000178199 "Zinc finger CCCH-type containing 12D" A2A288 6 149446795-149485061 "Disease related genes, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 38.1" "Cell line enriched" "Detected in some" 4 "HDLM-2: 26.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA036897 Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" "Nucleoplasm, Cytoplasmic bodies" "HPA036897: AB_10672104" "unprognostic (2.89e-2)" "unprognostic (3.91e-4)" "unprognostic (1.68e-2)" "unprognostic (1.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.47e-6)" "unprognostic (2.20e-2)" "unprognostic (2.50e-3)" "unprognostic (1.34e-1)" "unprognostic (3.30e-2)" "unprognostic (2.33e-2)" "unprognostic (1.86e-1)" "unprognostic (1.28e-4)" "unprognostic (1.21e-2)" "unprognostic (9.24e-3)" "unprognostic (6.99e-2)" "unprognostic (5.52e-2)" 3.3 0.8 0.5 33.4 1.0 3.4 1.2 0.7 0.6 0.8 3.0 0.1 1.0 3.0 0.6 1.2 0.8 0.8 0.9 0.6 0.5 0.7 1.3 0.8 2.0 10.6 0.5 0.0 0.4 0.7 0.0 0.6 0.8 0.5 0.7 1.5 0.9 2.0 0.2 0.4 1.1 7.7 0.4 0.7 9.5 0.7 0.7 0.4 4.8 0.9 1.6 38.1 1.7 0.6 3.2 1.7 1.3 2.7 0.7 7.2 1.5 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.1 6.2 0.1 0.0 0.1 0.0 0.0 0.1 26.4 0.2 0.2 0.8 2.1 0.0 2.1 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.0 1.9 0.0 0.0 5.4 0.0 0.6 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 3.5 0.0 0.2 0.1 0.1 0.1 0.1 0.2 2.3 0.3 2.0 0.1 1.3 1.8 0.4 0.3 1.0 0.5 3.1 3.2 1.5 1.7 3.2 2.0 0.5 1.3 0.7 2.7 1.0 7.2 1.5 0.5 1.0 0.7 0.6 0.5 0.7 0.5 0.0 0.5 0.4 ZCCHC13 "4930513O09RIK, Cnbp2, ZNF9L" ENSG00000187969 "Zinc finger CCHC-type containing 13" Q8WW36 X 74304190-74305031 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 88 "testis: 27.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA003382 Enhanced "HPA003382: AB_10967182" "unprognostic (1.61e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZCCHC2 "C18orf49, FLJ20222, FLJ20281, KIAA1744" ENSG00000141664 "Zinc finger CCHC-type containing 2" Q9C0B9 18 62523007-62587709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 99.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040943 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA040943: AB_10795496" "unprognostic (9.32e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (2.84e-3)" "unprognostic (1.40e-1)" "unprognostic (4.07e-2)" "unprognostic (4.79e-2)" "unprognostic (2.60e-1)" "unprognostic (1.93e-1)" "unprognostic (8.25e-2)" "unprognostic (2.32e-2)" "unprognostic (1.30e-1)" "unprognostic (5.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.72e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 12.6 5.0 6.8 7.0 7.5 22.8 16.0 8.0 6.8 7.5 8.5 6.0 5.3 6.8 6.9 7.1 6.5 7.4 9.0 8.5 5.3 5.7 5.8 23.0 10.1 7.6 8.1 5.7 8.8 6.3 7.8 8.5 8.2 5.5 8.1 5.8 4.5 99.1 5.9 16.8 11.3 7.5 7.6 5.6 8.9 6.5 13.4 8.9 10.8 7.8 4.3 6.4 11.0 19.3 1.6 1.0 4.9 1.6 0.6 2.0 0.4 5.8 5.1 4.4 8.7 13.5 5.8 8.4 3.4 5.1 8.1 8.1 2.7 3.6 16.6 4.5 5.6 10.0 14.2 7.5 3.4 11.4 6.7 4.4 11.8 18.6 4.6 8.3 6.4 5.7 9.7 5.1 9.6 15.2 4.6 5.6 2.6 4.8 5.4 3.5 2.8 5.1 7.2 4.7 0.1 5.6 6.0 5.6 3.5 5.7 12.8 5.0 4.5 6.6 6.4 8.0 5.5 3.1 4.8 2.2 4.2 7.1 6.0 3.5 2.9 0.0 1.0 2.4 1.7 1.6 1.2 0.5 1.1 1.5 0.3 1.6 2.0 1.3 4.9 0.6 0.3 1.0 1.2 0.4 6.8 7.5 8.0 6.8 5.3 5.7 8.1 5.7 5.5 8.9 ZDHHC19 MGC33345 ENSG00000163958 "Zinc finger DHHC-type containing 19" Q8WVZ1 3 196197449-196211437 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 53.4" "Cell line enhanced" "Detected in some" "HMC-1: 1.6;K-562: 1.1;NTERA-2: 1.1;SH-SY5Y: 1.8;THP-1: 2.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "eosinophil: 2.4;memory B-cell: 3.9;naive B-cell: 5.2;neutrophil: 3.4" "Group enriched" "Detected in many" 24 "B-cells: 5.2;granulocytes: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.15e-1)" "unprognostic (7.50e-4)" "unprognostic (2.87e-3)" "unprognostic (6.72e-3)" "unprognostic (3.79e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (3.66e-3)" "unprognostic (4.63e-2)" "unprognostic (6.52e-2)" "unprognostic (2.86e-2)" "unprognostic (3.46e-7)" "unprognostic (8.05e-4)" "unprognostic (4.71e-1)" "unprognostic (7.08e-3)" "unprognostic (4.28e-2)" 0.0 0.6 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.1 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 3.9 0.0 0.0 0.0 5.2 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZDHHC22 C14orf59 ENSG00000177108 "Zinc finger DHHC-type containing 22" Q8N966 14 77131270-77142734 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 52.3" "Group enriched" "Detected in some" 4 "AF22: 5.2;NTERA-2: 5.5;RH-30: 9.2;SCLC-21H: 10.2" "Cancer enriched" "Detected in single" 40 "glioma: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049471, HPA072213" Enhanced "Plasma membrane" "Plasma membrane" "HPA049471: , HPA072213: " "unprognostic (1.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.22e-4)" "unprognostic (1.66e-1)" "unprognostic (8.86e-2)" "unprognostic (2.68e-1)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "unprognostic (6.94e-4)" "unprognostic (3.05e-1)" "unprognostic (6.30e-2)" "unprognostic (1.16e-1)" "unprognostic (4.02e-1)" "unprognostic (1.95e-1)" "unprognostic (4.79e-1)" 1.1 1.5 11.2 1.1 12.6 1.1 1.1 8.4 52.3 1.1 1.2 6.7 0.0 1.1 1.1 1.4 1.3 1.2 1.1 1.2 14.5 18.4 1.1 1.1 1.1 1.1 10.7 19.5 1.1 1.1 1.1 3.1 1.1 9.2 1.1 1.3 0.5 1.1 1.1 1.3 1.1 1.1 1.2 3.6 1.1 1.3 1.4 5.1 0.0 1.3 0.0 1.1 1.4 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 5.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 5.5 0.7 0.0 9.2 0.0 0.0 0.0 10.2 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 11.2 12.6 8.4 29.5 14.5 18.4 10.7 19.5 9.2 5.1 ZFYVE28 KIAA1643 ENSG00000159733 "Zinc finger FYVE-type containing 28" Q9HCC9 4 2269582-2418663 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 63.6" "Cell line enhanced" "Detected in many" "HMC-1: 11.0;NB-4: 11.9;U-266/70: 12.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 63.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038175, HPA057587" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA038175: AB_10697244, HPA057587: " "unprognostic (1.59e-1)" "unprognostic (4.60e-2)" "unprognostic (7.68e-2)" "unprognostic (3.08e-3)" "unprognostic (9.89e-3)" "unprognostic (3.79e-2)" "unprognostic (3.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.64e-2)" "prognostic favourable (1.35e-6)" "unprognostic (6.05e-2)" "unprognostic (5.27e-2)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" 4.5 8.6 7.7 5.1 15.8 3.1 3.7 63.6 15.1 3.7 7.4 4.6 1.8 10.4 4.1 3.1 3.4 4.3 5.9 2.4 7.1 5.5 5.7 4.2 4.4 6.1 7.9 8.0 3.4 7.3 7.9 7.5 1.8 9.9 2.9 5.1 5.8 9.5 5.4 4.3 5.7 11.9 2.8 9.4 7.0 7.5 7.9 6.7 1.2 5.3 3.1 4.0 4.5 3.2 3.1 0.7 0.9 0.4 0.3 4.4 1.3 0.8 1.0 0.2 3.7 2.1 0.7 0.1 1.8 3.1 1.0 0.3 0.1 6.6 0.0 1.9 3.2 3.8 1.2 0.3 0.6 9.5 1.3 0.2 4.2 0.3 4.3 0.7 11.0 3.0 0.6 1.1 0.1 3.0 1.8 8.1 0.9 2.2 0.1 11.9 0.1 8.1 0.0 0.0 3.9 1.5 0.5 5.8 0.4 1.8 0.1 1.0 2.4 0.3 0.5 1.7 0.0 5.4 0.1 12.6 9.1 0.1 5.3 2.3 1.8 0.9 0.4 0.1 4.4 0.0 1.9 0.9 2.3 3.2 0.7 3.1 3.2 3.2 0.1 0.3 0.3 0.2 4.0 1.3 7.7 15.8 63.6 15.1 7.1 5.5 7.9 8.0 9.9 6.7 ZG16 "hZG16, JCLN, JCLN1, ZG16A" ENSG00000174992 "Zymogen granule protein 16" O60844 16 29778240-29782973 "Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 84.6" "Cell line enhanced" "Detected in some" "MCF7: 1.8;SK-BR-3: 6.9" "Cancer enriched" "Detected in some" 6 "colorectal cancer: 21.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA052066, HPA052512" Enhanced "Secreted to digestive system" 250000 "HPA052066: AB_2681716, HPA052512: AB_2681857" "unprognostic (1.64e-2)" "unprognostic (2.05e-1)" "unprognostic (2.60e-3)" "unprognostic (8.20e-2)" "unprognostic (3.50e-2)" "unprognostic (1.93e-2)" "unprognostic (5.14e-2)" "unprognostic (1.65e-1)" "unprognostic (7.77e-2)" "unprognostic (3.27e-1)" "unprognostic (2.56e-2)" "unprognostic (9.99e-2)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" 0.2 0.0 0.2 13.3 0.2 0.0 0.2 0.2 0.2 0.2 67.8 0.2 0.2 9.9 0.2 0.2 0.2 0.1 0.4 0.2 0.2 0.0 0.2 3.6 0.2 0.2 0.2 0.2 0.2 8.9 0.0 0.2 0.2 0.2 0.2 84.6 0.2 0.2 0.2 0.2 0.0 51.6 2.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 0.2 0.4 0.7 1.1 1.0 0.1 0.7 0.2 0.1 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.2 0.1 0.1 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 1.2 0.1 0.1 0.0 0.1 0.7 0.0 0.3 0.2 0.4 0.0 6.9 0.0 0.4 0.0 0.1 0.0 0.0 0.7 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.7 0.1 0.5 0.3 0.6 0.3 0.6 0.5 0.0 0.7 0.9 1.0 0.4 1.1 0.3 0.2 0.5 0.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 ZG16B "HRPE773, JCLN2, PRO1567" ENSG00000162078 "Zymogen granule protein 16B" Q96DA0 16 2830169-2839585 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "salivary gland: 1069.4" "Cell line enhanced" "Detected in some" "MCF7: 18.8;SK-BR-3: 17.4;T-47d: 15.9" "Cancer enhanced" "Detected in many" "prostate cancer: 47.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "classical monocyte: 6.7;intermediate monocyte: 11.4;non-classical monocyte: 7.3" "Lineage enriched" "Detected in many" 7 "monocytes: 11.4" "HPA041125, HPA053549" Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" 1200000 Vesicles Nucleoplasm "HPA041125: AB_10794264, HPA053549: AB_2682184" "unprognostic (5.29e-2)" "unprognostic (2.71e-1)" "unprognostic (4.37e-2)" "prognostic favourable (3.48e-6)" "unprognostic (1.39e-3)" "unprognostic (1.94e-2)" "unprognostic (2.34e-3)" "unprognostic (4.13e-2)" "unprognostic (1.01e-1)" "unprognostic (3.45e-3)" "unprognostic (1.37e-1)" "unprognostic (1.47e-2)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.17e-1)" "unprognostic (1.04e-1)" "unprognostic (8.33e-2)" 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.7 0.2 0.0 0.2 0.1 0.1 0.1 0.5 0.0 1.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.0 0.6 0.0 0.0 0.0 1.6 0.3 0.0 1069.4 0.2 0.1 0.8 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 78.5 3.7 0.2 0.2 0.0 1.1 1.7 11.4 1.1 0.4 1.7 0.0 0.8 0.0 0.0 0.2 1.4 0.1 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.2 0.0 1.5 0.0 3.1 0.0 0.0 0.0 6.3 1.8 1.6 1.2 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.1 2.6 0.2 18.8 0.0 0.3 0.1 3.6 0.0 0.0 5.9 0.1 4.4 0.0 0.0 0.0 17.4 0.0 15.9 0.0 2.2 0.0 0.4 1.3 0.0 0.0 0.3 0.2 0.2 4.5 0.2 1.7 6.7 0.0 0.0 11.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.5 1.1 7.3 0.0 0.4 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZIC1 "ZIC, ZNF201" ENSG00000152977 "Zic family member 1" Q15915 3 147393422-147510293 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 124.7" "Cell line enriched" "Detected in many" 4 "AF22: 60.8" "Cancer enhanced" "Detected in many" "glioma: 9.5" "Region enriched" "Detected in all" 8 "cerebellum: 124.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 232.6" "Region enriched" "Detected in many" 9 "cerebellum: 491.0" HPA004098 Supported Supported Nucleoplasm Nucleoplasm "HPA004098: AB_1859065" "unprognostic (1.33e-2)" "unprognostic (1.82e-1)" "unprognostic (4.01e-2)" "unprognostic (2.36e-1)" "unprognostic (9.32e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-2)" "unprognostic (2.19e-1)" "unprognostic (5.01e-1)" "unprognostic (2.61e-7)" "unprognostic (2.95e-3)" "unprognostic (1.67e-2)" "unprognostic (3.01e-1)" 0.7 0.6 1.5 0.5 8.6 0.5 0.8 124.7 25.5 0.5 0.7 12.3 0.0 0.9 0.6 3.8 1.0 0.5 0.8 0.5 6.2 5.2 0.5 7.3 0.7 0.7 5.2 8.0 0.9 0.5 0.6 0.6 0.5 15.3 0.5 0.7 3.0 0.5 0.6 7.4 4.1 1.9 0.5 10.0 0.5 0.5 1.0 4.5 0.0 0.5 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 60.8 0.0 6.4 7.0 3.4 3.9 4.7 4.2 3.5 0.0 0.0 0.0 3.2 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.1 0.0 0.0 1.0 0.0 3.7 14.7 0.0 0.0 0.1 0.0 0.0 6.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 3.5 0.0 0.0 0.0 6.3 0.0 9.9 3.7 0.0 0.0 0.0 4.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 8.6 124.7 5.2 6.2 5.2 5.2 8.0 15.3 4.5 ZIC2 HPE5 ENSG00000043355 "Zic family member 2" O95409 13 99981772-99986773 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "brain: 63.0" "Cell line enhanced" "Detected in many" "AF22: 27.0;HDLM-2: 13.0;HEK 293: 20.5;NTERA-2: 25.2;SCLC-21H: 56.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 63.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 214.5" HPA055031 Supported "Nuclear bodies" "Nuclear bodies" "HPA055031: " "unprognostic (6.43e-6)" "prognostic favourable (2.64e-4)" "unprognostic (5.73e-2)" "unprognostic (1.99e-2)" "unprognostic (4.39e-1)" "unprognostic (3.12e-2)" "prognostic unfavourable (2.91e-4)" "unprognostic (4.66e-2)" "unprognostic (3.10e-1)" "unprognostic (1.59e-1)" "unprognostic (9.36e-3)" "unprognostic (7.42e-2)" "unprognostic (0.00e+0)" "unprognostic (3.26e-1)" "unprognostic (2.11e-1)" "unprognostic (5.36e-3)" 0.6 0.5 3.9 0.5 2.9 0.5 0.7 63.0 14.7 0.5 0.8 7.7 0.0 0.6 0.8 0.5 0.8 0.5 0.5 0.5 6.1 2.1 0.6 0.5 0.7 0.6 1.7 7.4 0.5 0.6 0.5 0.5 0.5 13.4 0.6 0.6 3.8 0.5 0.5 0.5 0.8 0.5 0.6 2.2 0.5 0.6 2.5 1.0 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.5 27.0 1.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 1.7 0.0 2.3 0.0 0.0 1.2 0.0 0.0 13.0 20.5 1.9 1.2 1.3 0.0 0.0 1.3 0.0 1.9 0.0 1.2 0.0 1.9 0.0 0.0 0.8 0.1 10.3 25.2 0.6 5.9 1.0 0.0 0.1 0.6 56.7 0.0 0.8 0.1 0.0 1.3 10.1 0.0 6.4 0.0 1.1 1.7 0.2 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 2.9 63.0 7.1 6.1 2.1 1.7 7.4 13.4 1.0 ZIC3 "HTX, HTX1, ZNF203" ENSG00000156925 "Zic family member 3" O60481 X 137566142-137577691 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 50.6" "Group enriched" "Detected in some" 40 "AF22: 24.4;NTERA-2: 27.3" "Cancer enriched" "Detected in single" 14 "testis cancer: 5.0" "Region enriched" "Detected in all" 8 "cerebellum: 50.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052936, HPA069523" Uncertain Supported Nucleoplasm Nucleoplasm "HPA052936: , HPA069523: " "unprognostic (3.55e-5)" "unprognostic (3.82e-1)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" 0.3 0.2 1.4 0.4 2.5 1.1 0.4 50.6 5.8 0.3 0.4 2.7 0.0 0.5 0.5 0.2 0.3 0.3 0.4 0.3 1.9 2.2 0.3 0.3 0.4 0.4 2.4 1.2 0.4 0.5 0.4 1.1 0.4 6.1 0.5 0.3 3.9 0.7 0.3 0.5 0.8 0.5 0.2 1.9 0.5 0.4 3.9 2.2 0.0 0.5 0.0 0.4 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 2.5 50.6 2.6 1.9 2.2 2.4 1.2 6.1 2.2 ZIC4 ENSG00000174963 "Zic family member 4" Q8N9L1 3 147386046-147406860 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 52.2" "Cell line enhanced" "Detected in some" "AF22: 18.2;ASC diff: 5.2;MCF7: 5.2;SH-SY5Y: 5.5;U-2197: 4.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 18 "cerebellum: 52.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 118.4" HPA030194 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030194: " "unprognostic (1.12e-1)" "unprognostic (9.95e-2)" "unprognostic (5.59e-3)" "unprognostic (1.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-1)" "unprognostic (2.20e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-10)" "unprognostic (3.50e-2)" "unprognostic (8.69e-2)" 0.2 0.0 0.2 0.0 0.4 0.0 0.0 52.2 7.9 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 1.0 0.0 0.0 3.7 3.5 0.5 0.0 1.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.2 0.0 5.2 2.1 3.9 1.9 0.4 0.2 0.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.2 0.0 0.4 5.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.5 0.0 0.0 2.5 0.0 0.0 0.0 1.3 0.0 4.3 1.9 0.0 0.0 0.0 1.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 52.2 0.4 0.3 0.8 0.3 0.4 2.9 0.3 ZIC5 ENSG00000139800 "Zic family member 5" Q96T25 13 99962964-99971909 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 48.9" "Cell line enhanced" "Detected in some" "AF22: 10.9;HEK 293: 6.3;NTERA-2: 7.5;SCLC-21H: 42.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 24 "cerebellum: 48.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 19.3;cerebellum: 20.7;thalamus: 5.7" "Region enriched" "Detected in many" 6 "cerebellum: 53.2" HPA074045 Uncertain Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA074045: " "unprognostic (2.78e-5)" "unprognostic (1.71e-2)" "unprognostic (2.44e-2)" "unprognostic (2.29e-3)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (4.38e-4)" "unprognostic (2.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.06e-2)" "unprognostic (3.87e-2)" "unprognostic (1.13e-1)" "unprognostic (3.12e-2)" "unprognostic (4.94e-2)" 0.1 0.0 1.2 0.0 0.5 0.0 0.1 48.9 4.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.5 0.1 0.1 0.1 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 10.9 0.9 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 1.6 0.0 0.0 2.2 0.0 0.0 1.9 6.3 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 1.5 0.0 0.0 0.8 0.0 0.8 7.5 0.1 0.9 0.4 0.0 0.0 0.0 42.8 0.0 1.1 1.0 0.0 0.0 1.3 0.0 0.6 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.5 48.9 1.3 1.5 0.5 0.4 0.3 2.0 0.0 ZNF479 KR19 ENSG00000185177 "Zinc finger protein 479" Q96JC4 7 57119614-57139864 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "unprognostic (1.54e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.7 0.2 1.2 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.5 0.2 0.3 0.4 0.3 0.3 0.2 0.5 0.8 0.8 0.2 1.2 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF536 KIAA0390 ENSG00000198597 "Zinc finger protein 536" O15090 19 30228290-30713538 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 44.5" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 3.9;HAP1: 8.7;SH-SY5Y: 23.8;U-937: 5.8;WM-115: 10.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077341 Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA077341: " "unprognostic (1.98e-1)" "unprognostic (4.11e-1)" "unprognostic (1.92e-2)" "unprognostic (1.70e-2)" "unprognostic (2.09e-1)" "unprognostic (1.03e-1)" "unprognostic (4.70e-2)" "unprognostic (4.68e-1)" "unprognostic (5.50e-2)" "unprognostic (1.74e-2)" "unprognostic (1.25e-2)" "unprognostic (4.46e-4)" "unprognostic (1.58e-1)" "unprognostic (2.01e-2)" "unprognostic (1.55e-2)" "unprognostic (3.45e-1)" 1.1 6.0 9.9 2.0 21.0 0.6 0.8 14.3 24.1 4.2 4.0 44.5 0.0 2.7 1.7 1.3 6.9 1.0 1.3 2.9 13.3 7.7 0.8 0.7 1.0 0.7 20.9 9.6 0.9 0.9 0.7 3.4 0.7 18.3 3.7 4.1 4.8 1.6 2.4 1.4 1.2 4.2 1.2 23.1 1.5 2.1 5.0 18.4 0.0 6.9 0.0 0.7 2.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 8.7 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 23.8 0.0 0.0 1.5 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 5.8 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.9 21.0 14.3 15.1 13.3 7.7 20.9 9.6 18.3 18.4 ZNF541 DKFZp434I1930 ENSG00000118156 "Zinc finger protein 541" Q9H0D2 19 47520685-47555856 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 17.7" "Group enriched" "Detected in some" 5 "HEL: 3.1;SiHa: 10.0;U-87 MG: 3.5" "Cancer enhanced" "Detected in some" "cervical cancer: 2.7" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.3" "Lineage enriched" "Detected in single" 23 "T-cells: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058541, HPA076453" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA058541: , HPA076453: " "unprognostic (4.49e-2)" "prognostic favourable (2.94e-4)" "unprognostic (8.33e-2)" "unprognostic (3.09e-1)" "unprognostic (2.74e-1)" "unprognostic (5.92e-5)" "unprognostic (7.98e-2)" "unprognostic (5.19e-3)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-2)" "unprognostic (7.52e-2)" "unprognostic (3.09e-2)" "unprognostic (5.20e-2)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (1.59e-2)" 1.2 2.6 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.9 0.0 0.1 0.1 0.0 2.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.5 0.0 17.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.1 0.0 0.5 0.2 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 1.0 0.2 0.2 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 ZNF560 FLJ31986 ENSG00000198028 "Zinc finger protein 560" Q96MR9 19 9466507-9498607 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 21.1" "Group enriched" "Detected in some" 5 "HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.9" "Cancer enriched" "Detected in some" 7 "testis cancer: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045439, HPA074438" Enhanced "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "HPA045439: , HPA074438: " "unprognostic (4.43e-3)" "unprognostic (8.91e-2)" "unprognostic (9.85e-3)" "unprognostic (2.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.29e-1)" "unprognostic (1.04e-1)" "unprognostic (1.39e-1)" "unprognostic (6.57e-3)" "unprognostic (6.33e-5)" "unprognostic (5.60e-2)" "unprognostic (2.32e-1)" "unprognostic (9.15e-3)" "unprognostic (1.65e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.4 2.6 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 21.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.8 2.4 0.0 1.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 1.0 17.9 0.0 0.0 1.3 0.0 4.4 2.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 ZNF658 "DKFZp572C163, FLJ32813, MGC35232" ENSG00000274349 "Zinc finger protein 658" Q5TYW1 9 66856426-66932141 "Predicted intracellular proteins, Transcription factors" "Ribosome biogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 20.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in some" 11 "neutrophil: 20.9" "Lineage enriched" "Detected in many" 11 "granulocytes: 20.9" "HPA047730, HPA048668" Uncertain Approved Nucleoplasm Nucleoplasm "HPA047730: , HPA048668: " "unprognostic (9.54e-2)" "unprognostic (1.60e-1)" "unprognostic (9.06e-3)" "unprognostic (1.97e-1)" "unprognostic (1.02e-1)" "unprognostic (3.32e-2)" "unprognostic (1.45e-1)" "unprognostic (1.38e-2)" "unprognostic (1.35e-1)" "unprognostic (1.40e-1)" "unprognostic (2.75e-3)" "unprognostic (8.04e-2)" "unprognostic (1.18e-4)" "unprognostic (2.68e-2)" "unprognostic (6.99e-2)" "unprognostic (1.06e-2)" "unprognostic (1.71e-1)" 0.5 0.8 0.1 0.0 2.8 1.4 1.6 0.6 0.3 1.5 0.8 1.4 1.8 0.1 1.8 1.5 0.5 0.9 0.5 3.5 1.1 2.4 0.1 1.8 0.7 1.6 1.4 1.9 4.5 0.0 0.9 1.1 0.6 1.2 2.1 0.9 0.9 1.3 0.4 20.9 0.5 1.8 1.4 0.1 2.7 4.7 4.6 8.7 4.7 5.7 3.5 2.2 4.0 3.0 3.4 0.4 2.1 6.4 2.4 2.1 7.5 3.7 4.3 3.3 0.2 2.3 1.0 3.9 1.0 5.2 3.9 2.3 4.5 9.7 2.9 4.3 5.9 1.2 1.3 3.9 1.6 3.2 2.0 3.9 8.1 0.3 7.4 2.3 3.3 7.2 6.7 4.0 3.4 1.9 3.4 2.7 10.2 1.3 3.9 5.1 3.5 2.6 0.8 3.7 1.5 1.8 1.4 4.1 0.5 0.5 1.5 0.6 0.4 0.1 0.6 0.9 0.8 0.2 1.3 1.4 0.7 20.9 1.8 0.4 0.4 0.5 0.1 ZNF679 MGC42415 ENSG00000197123 "Zinc finger protein 679" Q8IYX0 7 64228474-64266931 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 4.6" "Group enriched" "Detected in some" 6 "SH-SY5Y: 2.2;T-47d: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.27e-1)" "unprognostic (8.09e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 2.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.3 0.0 0.0 0.0 0.1 ZNF705B ENSG00000215356 "Zinc finger protein 705B" P0CI00 8 7926337-7952413 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 16 "testis: 4.9" "Cell line enhanced" "Detected in single" "U-698: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 ZNF705D ENSG00000215343 "Zinc finger protein 705D" P0CH99 8 12104389-12115516 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "epididymis: 9.7" "Cell line enhanced" "Detected in single" "HaCaT: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.04e-1)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF710 "DKFZp547K1113, FLJ00306, FLJ37393" ENSG00000140548 "Zinc finger protein 710" Q8N1W2 15 90001392-90082206 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "pancreas: 79.6" "Cell line enhanced" "Detected in all" "SK-BR-3: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.9" "Group enriched" "Detected in many" 5 "dendritic cells: 2.3;granulocytes: 3.0;monocytes: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030226, HPA030227, HPA030228" Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA030226: , HPA030227: AB_10599855, HPA030228: AB_10601899" "unprognostic (6.24e-2)" "unprognostic (7.07e-2)" "unprognostic (1.49e-2)" "unprognostic (2.40e-1)" "unprognostic (2.32e-1)" "unprognostic (1.36e-2)" "unprognostic (4.34e-2)" "unprognostic (8.45e-2)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.86e-2)" "unprognostic (1.57e-1)" "unprognostic (2.91e-3)" "unprognostic (1.03e-2)" "unprognostic (3.24e-2)" "unprognostic (1.65e-2)" "unprognostic (8.65e-2)" 2.6 2.1 5.6 8.7 6.7 4.3 3.2 2.9 5.0 3.1 4.3 6.6 1.7 5.3 3.3 4.1 9.5 2.9 4.8 5.9 3.9 3.5 2.7 3.4 6.4 7.9 4.0 4.1 3.4 79.6 1.5 2.5 3.2 5.0 4.2 4.0 3.5 5.2 2.6 18.3 6.7 4.5 4.3 6.3 8.6 5.9 2.4 4.1 11.7 3.5 5.2 7.0 4.4 4.9 0.3 2.3 3.0 7.9 0.4 0.8 0.9 5.7 6.8 13.1 4.9 1.8 2.6 6.8 6.0 5.6 4.4 5.7 4.8 5.3 5.9 2.8 5.8 4.0 3.3 8.6 2.5 3.7 6.1 10.7 2.7 8.1 3.7 3.1 16.7 4.4 4.7 9.5 5.2 7.6 3.6 4.0 1.7 14.8 6.9 8.6 10.2 4.4 8.5 2.9 6.4 1.8 7.2 12.0 8.1 8.0 29.0 4.1 6.3 10.7 10.8 9.2 4.5 2.7 4.7 3.3 1.6 5.7 7.0 9.2 4.7 0.0 2.6 1.8 0.4 5.7 0.3 0.2 0.2 0.3 1.9 0.3 0.8 0.8 3.0 0.4 7.9 2.3 0.7 0.9 5.6 6.7 2.9 4.3 3.9 3.5 4.0 4.1 5.0 4.1 ZNF723 ZNF723P ENSG00000268696 "Zinc finger protein 723" 19 22832321-22858667 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 14.5" "Cell line enhanced" "Detected in some" "HEL: 2.2;U-2197: 2.4" "Cancer enriched" "Detected in single" 25 "testis cancer: 3.6" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Low lineage specificity" "Detected in many" "unprognostic (4.37e-2)" "unprognostic (5.02e-2)" "unprognostic (7.20e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 1.5 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 14.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.4 3.5 0.3 0.5 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.4 0.2 0.1 0.0 0.0 0.5 0.5 0.0 2.2 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.9 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.2 2.4 0.0 0.0 0.0 0.3 0.1 0.0 0.0 3.5 0.2 1.3 0.3 0.2 0.5 0.5 0.4 0.4 0.2 1.0 0.7 0.5 2.2 0.5 0.3 0.4 0.2 0.6 ZNF777 KIAA1285 ENSG00000196453 "Zinc finger protein 777" Q9ULD5 7 149431363-149461123 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "placenta: 65.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003252 Approved Approved Nucleoplasm Nucleoplasm "HPA003252: AB_1080755" "unprognostic (7.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (3.37e-2)" "unprognostic (4.78e-2)" "unprognostic (6.64e-2)" "unprognostic (5.87e-3)" "unprognostic (4.52e-2)" "unprognostic (1.10e-1)" "unprognostic (6.15e-2)" "unprognostic (5.17e-3)" "unprognostic (2.64e-1)" "unprognostic (4.00e-2)" "unprognostic (6.33e-2)" "unprognostic (1.68e-1)" "unprognostic (8.23e-2)" "unprognostic (5.72e-2)" 5.0 4.3 5.5 4.1 8.8 6.9 4.9 7.1 9.3 5.2 5.2 5.4 3.5 4.5 7.3 3.5 4.1 6.5 3.5 4.7 5.3 5.1 3.8 4.4 4.4 4.7 4.3 5.3 9.1 6.6 6.6 5.9 65.7 6.6 5.8 3.3 5.0 7.3 5.8 10.6 7.3 4.4 5.4 6.2 6.0 4.9 4.2 3.5 3.5 5.2 4.8 3.9 6.2 5.0 0.4 0.2 0.6 0.3 0.1 1.5 0.1 10.1 12.6 8.6 12.3 6.3 5.2 11.0 6.6 7.0 9.0 7.8 7.8 6.5 6.5 13.4 7.4 6.8 8.3 10.0 4.9 10.5 12.6 6.4 3.6 7.8 10.9 8.9 9.3 6.1 11.5 7.3 10.6 4.8 20.4 0.0 5.1 13.1 18.9 12.3 10.3 7.4 15.6 4.3 13.6 5.5 8.0 9.3 13.1 11.4 11.7 11.0 5.5 15.0 7.5 7.6 3.0 14.9 10.7 6.2 5.4 3.0 5.7 6.2 9.6 0.0 0.3 0.0 0.5 0.3 0.1 0.3 0.4 0.4 0.0 0.4 0.1 1.5 0.6 0.1 0.1 0.2 0.0 0.1 5.5 8.8 7.1 9.3 5.3 5.1 4.3 5.3 6.6 3.5 ZNF804B FLJ32110 ENSG00000182348 "Zinc finger protein 804B" A4D1E1 7 88759368-89337057 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "thyroid gland: 31.4" "Cell line enriched" "Detected in single" 5 "AF22: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA026702 Uncertain "HPA026702: AB_1859459" "unprognostic (1.10e-1)" "unprognostic (5.00e-2)" "unprognostic (1.29e-1)" "unprognostic (1.99e-1)" 0.2 0.2 0.6 0.7 1.3 0.1 0.4 0.2 2.0 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.6 0.2 0.4 2.5 0.2 0.2 3.3 0.2 0.5 0.5 1.3 0.1 0.4 0.6 1.6 0.6 0.1 1.3 1.2 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.0 0.0 31.4 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.3 0.2 2.0 0.2 0.4 0.2 0.5 1.6 0.0 ZNRF4 "RNF204, spzn, Ssrzf1" ENSG00000105428 "Zinc and ring finger 4" Q8WWF5 19 5455431-5456856 "Enzymes, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 243 "testis: 90.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZP2 ZPA ENSG00000103310 "Zona pellucida glycoprotein 2" Q05996 16 21197450-21214510 "Predicted membrane proteins, Predicted secreted proteins" Fertilization Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 35.2" "Cell line enriched" "Detected in single" 35 "HDLM-2: 8.9" "Not detected" "Not detected" "Region enriched" "Detected in some" 22 "cerebellum: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA011296 Approved "Secreted in female reproductive system" "HPA011296: AB_1859485" "unprognostic (2.35e-2)" "unprognostic (3.12e-2)" "unprognostic (6.60e-2)" "unprognostic (9.83e-2)" "unprognostic (3.44e-3)" "unprognostic (3.12e-1)" "unprognostic (1.66e-1)" "unprognostic (4.41e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 1.1 35.2 0.1 0.8 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.9 1.6 0.0 0.1 0.0 3.1 0.0 0.0 0.1 1.5 0.1 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.1 0.0 0.0 0.0 0.0 1.6 0.0 ZPBP "SP38, ZPBP1" ENSG00000042813 "Zona pellucida binding protein" Q9BS86 7 49850421-50121329 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 95 "testis: 90.4" "Cell line enhanced" "Detected in some" "K-562: 1.4;NTERA-2: 1.2;SCLC-21H: 1.6;U-698: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058673 Enhanced "Secreted in male reproductive system" "HPA058673: " "unprognostic (1.16e-1)" "unprognostic (6.46e-2)" "unprognostic (7.80e-2)" "unprognostic (1.98e-1)" "unprognostic (1.46e-2)" "unprognostic (2.15e-7)" "unprognostic (9.49e-2)" "unprognostic (2.34e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.4 0.1 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 ZPBP2 "MGC41930, ZPBPL" ENSG00000186075 "Zona pellucida binding protein 2" Q6X784 17 39868164-39877896 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 85.7" "Cell line enhanced" "Detected in some" "Daudi: 2.8;U-698: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.6" "Group enriched" "Detected in many" 8 "B-cells: 2.6;T-cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA027997, HPA053070" Enhanced "Secreted in male reproductive system" "HPA027997: AB_1859488, HPA053070: AB_2682033" "unprognostic (2.14e-2)" "unprognostic (3.38e-1)" "unprognostic (1.62e-1)" "unprognostic (2.87e-1)" "unprognostic (5.39e-1)" "unprognostic (2.54e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 85.7 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2.6 0.1 0.1 0.2 0.0 1.0 0.2 0.1 0.1 1.0 0.4 0.3 0.5 0.1 0.3 0.2 0.2 0.5 0.4 0.1 2.8 0.2 0.4 0.1 0.5 0.2 0.5 0.6 1.3 0.4 0.4 0.0 0.3 0.4 0.2 0.2 0.7 0.1 0.2 0.3 0.3 0.8 0.0 0.1 0.1 0.6 0.9 0.7 0.4 0.9 2.1 0.3 0.3 1.0 0.3 0.1 0.6 0.3 0.2 0.0 0.4 0.3 0.3 0.6 0.1 1.0 0.2 10.2 0.3 0.4 0.5 0.0 0.0 0.1 0.4 0.0 0.1 0.8 0.4 1.0 0.0 2.6 1.0 0.5 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 ZSWIM2 "MEX, MGC33890, ZZZ2" ENSG00000163012 "Zinc finger SWIM-type containing 2" Q8NEG5 2 186827835-186849208 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 17.4" "Cell line enhanced" "Detected in some" "HSkMC: 1.1;U-138 MG: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (2.00e-1)" 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.3 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.1 0.4 0.0 0.0 0.3 0.0